PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Pardanaud, L; Eichmann, A				Pardanaud, Luc; Eichmann, Anne			Extraembryonic Origin of Circulating Endothelial Cells	PLOS ONE			English	Article							BONE-MARROW; PROGENITOR CELLS; MICROGLIA DERIVE; CHICK-EMBRYO; YOLK-SAC; ANGIOGENESIS; VASCULOGENESIS; RECRUITMENT; NEOVASCULARIZATION; ERYTHROPOIESIS	Circulating endothelial cells (CEC) are contained in the bone marrow and peripheral blood of adult humans and participate to the revascularization of ischemic tissues. These cells represent attractive targets for cell or gene therapy aimed at improving ischemic revascularization or inhibition of tumor angiogenesis. The embryonic origin of CEC has not been addressed previously. Here we use quail-chick chimeras to study CEC origin and participation to the developing vasculature. CEC are traced with different markers, in particular the QH1 antibody recognizing only quail endothelial cells. Using yolk-sac chimeras, where quail embryos are grafted onto chick yolk sacs and vice-versa, we show that CEC are generated in the yolk sac. These cells are mobilized during wound healing, demonstrating their participation to angiogenic repair processes. Furthermore, we found that the allantois is also able to give rise to CEC in situ. In contrast to the yolk sac and allantois, the embryo proper does not produce CEC. Our results show that CEC exclusively originate from extra-embryonic territories made with splanchnopleural mesoderm and endoderm, while definitive hematopoietic stem cells and endothelial cells are of intra-embryonic origin.	[Pardanaud, Luc; Eichmann, Anne] Coll France, CIRB, F-75231 Paris, France; [Pardanaud, Luc; Eichmann, Anne] INSERM U1050, F-75005 Paris, France; [Pardanaud, Luc; Eichmann, Anne] CNRS UMR 7241, F-75005 Paris, France	UDICE-French Research Universities; PSL Research University Paris; College de France; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Pardanaud, L (corresponding author), Coll France, CIRB, F-75231 Paris, France.	luc.pardanaud@college-de-france.fr		Luc, Pardanaud/0000-0002-7358-6730	Inserm; Fondation pour la recherche medicale (FRM); Fondation Bettencourt-Schueller	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation pour la recherche medicale (FRM)(Fondation pour la Recherche Medicale); Fondation Bettencourt-Schueller	This work was supported by Inserm, Fondation pour la recherche medicale (FRM) and Fondation Bettencourt-Schueller. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo L, 2009, NATURE, V459, P1131, DOI 10.1038/nature08073; Alliot F, 1999, DEV BRAIN RES, V117, P145, DOI 10.1016/S0165-3806(99)00113-3; Alvarez-Silva M, 2003, DEVELOPMENT, V130, P5437, DOI 10.1242/dev.00755; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Bouvree K, 2008, DEV BIOL, V318, P172, DOI 10.1016/j.ydbio.2008.03.023; Caprioli A, 1998, P NATL ACAD SCI USA, V95, P1641, DOI 10.1073/pnas.95.4.1641; Carr CA, 2008, AM J PHYSIOL-HEART C, V295, pH533, DOI 10.1152/ajpheart.00094.2008; CUADROS MA, 1992, DEVELOPMENT, V115, P157; Cumano A, 2007, ANNU REV IMMUNOL, V25, P745, DOI 10.1146/annurev.immunol.25.022106.141538; Dieterlen-Lievre F, 2010, INT J DEV BIOL, V54, P1079, DOI 10.1387/ijdb.093047fd; DIETERLENLIEVRE F, 1981, DEV BIOL, V88, P180, DOI 10.1016/0012-1606(81)90228-1; Dudek AZ, 2010, TRANSL RES, V156, P136, DOI 10.1016/j.trsl.2010.07.003; Dudley AC, 2010, BLOOD, V116, P3367, DOI 10.1182/blood-2010-02-271122; Erbs S, 2007, CIRCULATION, V116, P366, DOI 10.1161/CIRCULATIONAHA.106.671545; FLAMME I, 1989, ANAT EMBRYOL, V180, P259, DOI 10.1007/BF00315884; Gao DC, 2008, SCIENCE, V319, P195, DOI 10.1126/science.1150224; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Hagedorn M, 2005, P NATL ACAD SCI USA, V102, P1643, DOI 10.1073/pnas.0408622102; HALFTER W, 1993, J COMP NEUROL, V327, P442, DOI 10.1002/cne.903270309; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Ingram DA, 2005, BLOOD, V106, P1525, DOI 10.1182/blood-2005-04-1509; KESSEL J, 1987, DEVELOPMENT, V101, P45; Le Douarin N. M., 1964, B BIOL FR BELG, V98, P544; LIPPINCOTTSCHWARTZ J, 1986, J CELL BIOL, V102, P1593, DOI 10.1083/jcb.102.5.1593; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; MARTIN C, 1972, CR SOC BIOL, V166, P283; MARTIN C, 1980, DEV BIOL, V75, P303, DOI 10.1016/0012-1606(80)90165-7; Murray PDF, 1932, P R SOC LOND B-CONTA, V111, P497, DOI 10.1098/rspb.1932.0070; Navarro M, 2003, J ANAT, V202, P213, DOI 10.1046/j.1469-7580.2003.00156.x; North TE, 2009, CELL, V137, P736, DOI 10.1016/j.cell.2009.04.023; PARDANAUD L, 1987, DEVELOPMENT, V100, P339; PARDANAUD L, 1989, DEVELOPMENT, V105, P473; Pardanaud L, 2006, DEVELOPMENT, V133, DOI 10.1242/dev.02461; Pardanaud L, 2009, NATURE, V459, P1068, DOI 10.1038/4591068a; Pearson JD, 2009, J THROMB HAEMOST, V7, P255, DOI 10.1111/j.1538-7836.2008.03214.x; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; POURQUIE O, 1990, DEVELOPMENT, V109, P743; Pudliszewski M, 2005, INT J DEV BIOL, V49, P355, DOI 10.1387/ijdb.041956mp; Purhonen S, 2008, P NATL ACAD SCI USA, V105, P6620, DOI 10.1073/pnas.0710516105; Rajantie I, 2004, BLOOD, V104, P2084, DOI 10.1182/blood-2004-01-0336; SABIN F, 1932, CONTR EMBRYOL, V9, P215; Schachinger V, 2006, EUR HEART J, V27, P2775, DOI 10.1093/eurheartj/ehl388; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Vajkoczy P, 2003, J EXP MED, V197, P1755, DOI 10.1084/jem.20021659; WILT FH, 1965, SCIENCE, V147, P1588, DOI 10.1126/science.147.3665.1588; ZACCHEI A M, 1961, Arch Ital Anat Embriol, V66, P36; Zambidis ET, 2007, ANN NY ACAD SCI, V1106, P223, DOI 10.1196/annals.1392.010; Zentilin L, 2006, BLOOD, V107, P3546, DOI 10.1182/blood-2005-08-3215	50	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e25889	10.1371/journal.pone.0025889	http://dx.doi.org/10.1371/journal.pone.0025889			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022461	Green Published, gold, Green Submitted			2022-12-27	WOS:000295981600018
J	Lee, N; Wong, CK; Chan, PKS; Chan, MCW; Wong, RYK; Lun, SWM; Ngai, KLK; Lui, GCY; Wong, BCK; Lee, SKW; Choi, KW; Hui, DSC				Lee, Nelson; Wong, Chun Kwok; Chan, Paul K. S.; Chan, Martin C. W.; Wong, Rity Y. K.; Lun, Samantha W. M.; Ngai, Karry L. K.; Lui, Grace C. Y.; Wong, Bonnie C. K.; Lee, Sharon K. W.; Choi, Kin Wing; Hui, David S. C.			Cytokine Response Patterns in Severe Pandemic 2009 H1N1 and Seasonal Influenza among Hospitalized Adults	PLOS ONE			English	Article							CLINICAL-ASPECTS; HOST RESPONSES; WHOLE-BLOOD; VIRUS; CELLS; FERRETS; HYPERCYTOKINEMIA; INTERFERON; ACTIVATION; INFECTION	Background: Studying cytokine/chemokine responses in severe influenza infections caused by different virus subtypes may improve understanding on pathogenesis. Methods: Adults hospitalized for laboratory-confirmed seasonal and pandemic 2009 A/H1N1 (pH1N1) influenza were studied. Plasma concentrations of 13 cytokines/chemokines were measured at presentation and then serially, using cytometric-bead-array with flow-cytometry and ELISA. PBMCs from influenza patients were studied for cytokine/chemokine expression using ex-vivo culture (Whole Blood Assay,+/- PHA/LPS stimulation). Clinical variables were prospectively recorded and analyzed. Results: 63 pH1N1 and 53 seasonal influenza patients were studied. pH1N1 patients were younger (mean +/- S.D. 42.8 +/- 19.2 vs 70.5 +/- 16.7 years), and fewer had comorbidities. Respiratory/cardiovascular complications were common in both groups (71.4% vs 81.1%), although severe pneumonia with hypoxemia (54.0% vs 28.3%) and ICU admissions (25.4% vs 1.9%) were more frequent with pH1N1. Hyperactivation of the proinflammatory cytokines IL-6, CXCL8/IL-8, CCL2/MCP-1 and sTNFR-1 was found in pH1N1 pneumonia (2-15 times normal) and in complicated seasonal influenza, but not in milder pH1N1 infections. The adaptive-immunity (Th1/Th17)-related CXCL10/IP-10, CXCL9/MIG and IL-17A however, were markedly suppressed in severe pH1N1 pneumonia (2-27 times lower than seasonal influenza; P-values<0.01). This pattern was further confirmed with serial measurements. Hypercytokinemia tended to be sustained in pH1N1 pneumonia, associated with a slower viral clearance [PCR-negativity: day 3-4, 55% vs 85%; day 6-7, 67% vs 100%]. Elevated proinflammatory cytokines, particularly IL-6, predicted ICU admission (adjusted OR 12.6, 95% CI 2.6-61.5, per log(10)unit increase; P = 0.002), and correlated with fever, tachypnoea, deoxygenation, and length-of-stay (Spearman's rho, P-values<0.01) in influenza infections. PBMCs in seasonal influenza patients were activated and expressed cytokines ex vivo (e.g. IL-6, CXCL8/IL-8, CCL2/MCP-1, CXCL10/IP-10, CXCL9/MIG); their 'responsiveness' to stimuli was shown to change dynamically during the illness course. Conclusions: A hyperactivated proinflammatory, but suppressed adaptive-immunity (Th1/Th17)-related cytokine response pattern was found in severe pH1N1 pneumonia, different from seasonal influenza. Cytokine/immune-dysregulation may be important in its pathogenesis.	[Lee, Nelson; Chan, Martin C. W.; Wong, Rity Y. K.; Lui, Grace C. Y.; Wong, Bonnie C. K.; Lee, Sharon K. W.; Choi, Kin Wing; Hui, David S. C.] Chinese Univ Hong Kong, Dept Med & Therapeut, Fac Med, Hong Kong, Hong Kong, Peoples R China; [Lee, Nelson; Chan, Paul K. S.; Hui, David S. C.] Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Fac Med, Hong Kong, Hong Kong, Peoples R China; [Wong, Chun Kwok; Lun, Samantha W. M.; Lee, Sharon K. W.] Chinese Univ Hong Kong, Dept Chem Pathol, Fac Med, Hong Kong, Hong Kong, Peoples R China; [Chan, Paul K. S.; Ngai, Karry L. K.] Chinese Univ Hong Kong, Dept Microbiol, Fac Med, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Lee, N (corresponding author), Chinese Univ Hong Kong, Dept Med & Therapeut, Fac Med, Hong Kong, Hong Kong, Peoples R China.	leelsn@cuhk.edu.hk	Chan, Martin/B-3588-2009; Chan, Paul KS/J-9360-2013; Lui, Grace/N-4498-2019; Lee, Nelson/B-6418-2008; Wong, CK/H-3256-2016; Hui, David Shu-Cheong/O-2754-2015; Lui, Chung Yan Grace/N-5178-2016	Chan, Martin/0000-0002-1568-1596; Chan, Paul KS/0000-0002-6360-4608; Lee, Nelson/0000-0002-0783-6607; Wong, CK/0000-0002-5637-8331; Hui, David Shu-Cheong/0000-0003-4382-2445; Lui, Chung Yan Grace/0000-0001-5242-2967	Stanley Ho Centre for Emerging Infectious Diseases (The Chinese University of Hong Kong); Department of Medicine and Therapeutics, Faculty of Medicine (The Chinese University of Hong Kong); F. Hoffmann-La Roche Ltd.	Stanley Ho Centre for Emerging Infectious Diseases (The Chinese University of Hong Kong)(Chinese University of Hong Kong); Department of Medicine and Therapeutics, Faculty of Medicine (The Chinese University of Hong Kong)(Chinese University of Hong Kong); F. Hoffmann-La Roche Ltd.(Hoffmann-La Roche)	This study was jointly supported by a research fund from the Stanley Ho Centre for Emerging Infectious Diseases and a research fund from the Department of Medicine and Therapeutics, Faculty of Medicine; both are internal funding sources (The Chinese University of Hong Kong). The third source was an unrestricted, educational grant from F. Hoffmann-La Roche Ltd for this principle investigator-initiated study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrati C, 2010, J INFECT DIS, V202, P681, DOI 10.1086/655469; [Anonymous], INFL; Arankalle V.A., 2010, PLOS ONE, V5; Baskin CR, 2009, P NATL ACAD SCI USA, V106, P3455, DOI 10.1073/pnas.0813234106; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Bermejo-Martin JF, 2010, CRIT CARE, V14, DOI 10.1186/cc9259; Bermejo-Martin JF, 2009, CRIT CARE, V13, DOI 10.1186/cc8208; Brun-Buisson C, 2011, AM J RESP CRIT CARE, V183, P1200, DOI 10.1164/rccm.201101-0135OC; Chan MCW, 2010, AM J PATHOL, V176, P1828, DOI 10.2353/ajpath.2010.091087; Crowe CR, 2009, J IMMUNOL, V183, P5301, DOI 10.4049/jimmunol.0900995; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Geiler J, 2011, MED MICROBIOL IMMUN, V200, P53, DOI 10.1007/s00430-010-0173-y; Giamarellos-Bourboulis EJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008393; Hagau N, 2010, CRIT CARE, V14, DOI 10.1186/cc9324; Hamada H, 2009, J IMMUNOL, V182, P3469, DOI 10.4049/jimmunol.0801814; Han K, 2011, CLIN INFECT DIS, V53, P326, DOI 10.1093/cid/cir398; Hui DS, 2010, CHEST, V137, P916, DOI 10.1378/chest.09-2344; Hussain R, 2002, J IMMUNOL METHODS, V264, P95, DOI 10.1016/S0022-1759(02)00092-3; Ison MG, 2010, CLEV CLIN J MED, V77, P812, DOI 10.3949/ccjm.77a.10135; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Jiang TJ, 2010, CLIN IMMUNOL, V137, P303, DOI 10.1016/j.clim.2010.07.010; Kudva A, 2011, J IMMUNOL, V186, P1666, DOI 10.4049/jimmunol.1002194; Lee N, 2007, CLIN INFECT DIS, V45, P723, DOI 10.1086/520981; LEE N, 2011, LANCET IN PRESS; Lee N, 2011, J INFECT DIS, V203, P1739, DOI 10.1093/infdis/jir187; Lee N, 2011, ANTIVIR THER, V16, P237, DOI 10.3851/IMP1722; Lee N, 2009, J INFECT DIS, V200, P492, DOI 10.1086/600383; Lee SMY, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-147; Lit LCW, 2006, ANN RHEUM DIS, V65, P209, DOI 10.1136/ard.2005.038315; Longhi MP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000006; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; McGill J, 2009, J LEUKOCYTE BIOL, V86, P803, DOI 10.1189/jlb.0509368; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Osterlund P, 2010, J VIROL, V84, P1414, DOI 10.1128/JVI.01619-09; Peiris JSM, 2009, TRENDS IMMUNOL, V30, P574, DOI 10.1016/j.it.2009.09.004; Rigato O, 2003, SHOCK, V19, P113, DOI 10.1097/00024382-200302000-00004; Rowe T, 2010, VIROLOGY, V401, P257, DOI 10.1016/j.virol.2010.02.020; Sato M, 2009, CYTOKINE, V47, P65, DOI 10.1016/j.cyto.2009.05.003; Simmons C, 2008, NEW ENGL J MED, V359, P1621, DOI 10.1056/NEJMcibr0805865; Svitek N, 2008, VIROLOGY, V376, P53, DOI 10.1016/j.virol.2008.02.035; To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581; van den Brand JMA, 2010, J INFECT DIS, V201, P993, DOI 10.1086/651132; Walsh KB, 2011, P NATL ACAD SCI USA, V108, P12018, DOI 10.1073/pnas.1107024108; Wu WX, 2010, VIROLOGY, V396, P178, DOI 10.1016/j.virol.2009.10.016	44	103	107	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e26050	10.1371/journal.pone.0026050	http://dx.doi.org/10.1371/journal.pone.0026050			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022504	Green Published, gold, Green Submitted			2022-12-27	WOS:000295978600037
J	Siddiqui, RA; Krawczak, M; Platzer, M; Sauermann, U				Siddiqui, Roman A.; Krawczak, Michael; Platzer, Matthias; Sauermann, Ulrike			Association of TLR7 Variants with AIDS-Like Disease and AIDS Vaccine Efficacy in Rhesus Macaques	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; T-CELL RESPONSES; PLASMACYTOID DENDRITIC CELLS; TOLL-LIKE RECEPTORS; RNA SECONDARY STRUCTURE; NONHUMAN-PRIMATES; IFN-ALPHA; INTERFERON-ALPHA; HIV-1 INFECTION; VECTOR VACCINE	In HIV infection, TLR7-triggered IFN-alpha production exerts a direct antiviral effect through the inhibition of viral replication, but may also be involved in immune pathogenesis leading to AIDS. TLR7 could also be an important mediator of vaccine efficacy. In this study, we analyzed polymorphisms in the X-linked TLR7 gene in the rhesus macaque model of AIDS. Upon resequencing of the TLR7 gene in 36 rhesus macaques of Indian origin, 12 polymorphic sites were detected. Next, we identified three tightly linked single nucleotide polymorphisms (SNP) as being associated with survival time. Genotyping of 119 untreated, simian immunodeficiency virus (SIV)-infected male rhesus macaques, including an 'MHC adjusted' subset, revealed that the three TLR7 SNPs are also significantly associated with set-point viral load. Surprisingly, this effect was not observed in 72 immunized SIV-infected male monkeys. We hypothesize (i) that SNP c.13G > A in the leader peptide is causative for the observed genotype-phenotype association and that (ii) the underlying mechanism is related to RNA secondary structure formation. Therefore, we investigated a fourth SNP (c.-17C > T), located 17 bp upstream of the ATG translation initiation codon, that is also potentially capable of influencing RNA structure. In c.13A carriers, neither set-point viral load nor survival time were related to the c.-17C > T genotype. In c.13G carriers, by contrast, the c.-17C allele was significantly associated with prolonged survival. Again, no such association was detected among immunized SIV-infected macaques. Our results highlight the dual role of TLR7 in immunodeficiency virus infection and vaccination and imply that it may be important to control human AIDS vaccine trials, not only for MHC genotype, but also for TLR7 genotype.	[Siddiqui, Roman A.; Sauermann, Ulrike] Leibniz Inst Primate Res, German Primate Ctr, Gottingen, Germany; [Siddiqui, Roman A.; Platzer, Matthias] Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany; [Krawczak, Michael] Univ Kiel, Inst Med Informat & Stat, Kiel, Germany	Deutsches Primatenzentrum (DPZ); Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); University of Kiel	Siddiqui, RA (corresponding author), TMF Technol Methods & Infrastruct Networked Med R, Berlin, Germany.	usauerm@dpz.eu	Krawczak, Michael/A-8964-2010	Krawczak, Michael/0000-0003-2603-1502	German Ministry of Education and Research (BMBF) through National Genome Research Network (NGFN) [0313360]	German Ministry of Education and Research (BMBF) through National Genome Research Network (NGFN)(Federal Ministry of Education & Research (BMBF))	This study was supported by the German Ministry of Education and Research (BMBF) through National Genome Research Network (NGFN) grant 0313360. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adalid-Peralta L, 2008, J LEUKOCYTE BIOL, V83, P1060, DOI 10.1189/jlb.1007675; Baenziger S, 2009, BLOOD, V113, P377, DOI 10.1182/blood-2008-04-151712; Berghofer B, 2006, J IMMUNOL, V177, P2088, DOI 10.4049/jimmunol.177.4.2088; Bessa J, 2009, J IMMUNOL, V183, P3788, DOI 10.4049/jimmunol.0804004; Brassard DL, 2002, J LEUKOCYTE BIOL, V71, P565; Chen JM, 2006, HUM GENET, V120, P1, DOI 10.1007/s00439-006-0180-7; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Emu B, 2008, J VIROL, V82, P5398, DOI 10.1128/JVI.02176-07; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Francis PJ, 2008, HUM MOL GENET, V17, P2673, DOI 10.1093/hmg/ddn167; Geeraedts F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000138; Gibson SJ, 2002, CELL IMMUNOL, V218, P74, DOI 10.1016/S0008-8749(02)00517-8; Goujon C, 2010, J VIROL, V84, P9254, DOI 10.1128/JVI.00854-10; Grillo G, 2010, NUCLEIC ACIDS RES, V38, pD75, DOI 10.1093/nar/gkp902; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Jarjanazi H, 2008, PROTEINS, V70, P394, DOI 10.1002/prot.21548; Johnson TR, 2009, VACCINE, V27, P3045, DOI 10.1016/j.vaccine.2009.03.026; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322; Ketloy C, 2008, VET IMMUNOL IMMUNOP, V125, P18, DOI 10.1016/j.vetimm.2008.05.001; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Limou S, 2009, J INFECT DIS, V199, P419, DOI 10.1086/596067; Lore K, 2003, J IMMUNOL, V171, P4320, DOI 10.4049/jimmunol.171.8.4320; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Mandl JN, 2008, NAT MED, V14, P1077, DOI 10.1038/nm.1871; Mattapallil JJ, 2006, J EXP MED, V203, P1533, DOI 10.1084/jem.20060657; MCMICHAEL A, 2010, NAT P; Meier A, 2009, NAT MED, V15, P955, DOI 10.1038/nm.2004; Mohren S, 2009, BIOCHEM BIOPH RES CO, V379, P1015, DOI 10.1016/j.bbrc.2009.01.011; Moller-Larsen S, 2008, THORAX, V63, P1064, DOI 10.1136/thx.2007.094128; Negri DRM, 2004, J GEN VIROL, V85, P1191, DOI 10.1099/vir.0.79794-0; Oh DY, 2009, AIDS, V23, P297, DOI 10.1097/QAD.0b013e32831fb540; Ortiz M, 2009, MOL BIOL EVOL, V26, P2865, DOI 10.1093/molbev/msp197; Rajagopal D, 2010, BLOOD, V115, P1949, DOI 10.1182/blood-2009-08-238543; Sato K, 2009, NUCLEIC ACIDS RES, V37, pW277, DOI 10.1093/nar/gkp367; Sauermann U, 2008, GENES IMMUN, V9, P69, DOI 10.1038/sj.gene.6364448; Schlaepfer E, 2006, J IMMUNOL, V176, P2888, DOI 10.4049/jimmunol.176.5.2888; Schlaepfer E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001999; Schott E, 2008, J VIRAL HEPATITIS, V15, P71, DOI 10.1111/j.1365-2893.2007.00898.x; Schulte R, 2009, VIROLOGY, V383, P300, DOI 10.1016/j.virol.2008.10.012; Shen N, 2010, P NATL ACAD SCI USA, V107, P15838, DOI 10.1073/pnas.1001337107; Siddiqui RA, 2009, AM J HUM GENET, V85, P228, DOI 10.1016/j.ajhg.2009.07.013; Stolte-Leeb N, 2008, VIRAL IMMUNOL, V21, P235, DOI 10.1089/vim.2007.0103; Suh YS, 2008, VACCINE, V26, P6690, DOI 10.1016/j.vaccine.2008.07.055; Suh YS, 2006, VACCINE, V24, P1811, DOI 10.1016/j.vaccine.2005.10.026; Tavel JA, 2010, J INTERF CYTOK RES, V30, P461, DOI 10.1089/jir.2009.0090; Ten Haaft P, 1998, J VIROL, V72, P10281, DOI 10.1128/JVI.72.12.10281-10285.1998; Uematsu S, 2007, J BIOL CHEM, V282, P15319, DOI 10.1074/jbc.R700009200; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Wille-Reece U, 2005, P NATL ACAD SCI USA, V102, P15190, DOI 10.1073/pnas.0507484102; Wille-Reece U, 2006, J EXP MED, V203, P1249, DOI 10.1084/jem.20052433; Xagorari Angeliki, 2008, Open Microbiol J, V2, P49, DOI 10.2174/1874285800802010049; YAMADA O, 1988, AIDS RES HUM RETROV, V4, P287, DOI 10.1089/aid.1988.4.287; Zhang SY, 2007, IMMUNOL REV, V220, P225, DOI 10.1111/j.1600-065X.2007.00564.x	59	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e25474	10.1371/journal.pone.0025474	http://dx.doi.org/10.1371/journal.pone.0025474			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022401	gold, Green Published, Green Submitted			2022-12-27	WOS:000295978600016
J	Segaert, K; Menenti, L; Weber, K; Hagoort, P				Segaert, Katrien; Menenti, Laura; Weber, Kirsten; Hagoort, Peter			A Paradox of Syntactic Priming: Why Response Tendencies Show Priming for Passives, and Response Latencies Show Priming for Actives	PLOS ONE			English	Article							SPOKEN SENTENCE PRODUCTION; LANGUAGE PRODUCTION; PHRASE STRUCTURE; PERSISTENCE; MODEL; ACTIVATION	Speakers tend to repeat syntactic structures across sentences, a phenomenon called syntactic priming. Although it has been suggested that repeating syntactic structures should result in speeded responses, previous research has focused on effects in response tendencies. We investigated syntactic priming effects simultaneously in response tendencies and response latencies for active and passive transitive sentences in a picture description task. In Experiment 1, there were priming effects in response tendencies for passives and in response latencies for actives. However, when participants' pre-existing preference for actives was altered in Experiment 2, syntactic priming occurred for both actives and passives in response tendencies as well as in response latencies. This is the first investigation of the effects of structure frequency on both response tendencies and latencies in syntactic priming. We discuss the implications of these data for current theories of syntactic processing.	[Segaert, Katrien; Hagoort, Peter] Max Planck Inst Psycholinguist, Nijmegen, Netherlands; [Segaert, Katrien; Menenti, Laura; Weber, Kirsten; Hagoort, Peter] Radboud Univ Nijmegen, Ctr Cognit Neuroimaging, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Menenti, Laura] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland	Max Planck Society; Radboud University Nijmegen; University of Glasgow	Segaert, K (corresponding author), Max Planck Inst Psycholinguist, Nijmegen, Netherlands.	Katrien.Segaert@mpi.nl	Segaert, Katrien/AAT-9387-2021; Weber, Kirsten/U-5244-2018; Hagoort, Peter/B-7417-2012	Segaert, Katrien/0000-0002-3002-5837; Weber, Kirsten/0000-0001-8192-2207; 	NWO	NWO(Netherlands Organization for Scientific Research (NWO))	KW was funded by an NWO Toptalent Grant (http://www.nwo.nl/nwohome.nsf/pages/NWOA_6SQDWG_Eng). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allum PH, 2007, J EXP PSYCHOL LEARN, V33, P791, DOI 10.1037/0278-7393.33.4.791; Anderson JR, 1996, AM PSYCHOL, V51, P355, DOI 10.1037/0003-066X.51.4.355; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Bernolet S, 2010, COGNITION, V114, P455, DOI 10.1016/j.cognition.2009.11.005; Bernolet S, 2009, COGNITION, V112, P300, DOI 10.1016/j.cognition.2009.05.013; BOCK K, 1992, PSYCHOL REV, V99, P150, DOI 10.1037/0033-295X.99.1.150; Bock K, 2000, J EXP PSYCHOL GEN, V129, P177, DOI 10.1037//0096-3445.129.2.177; BOCK K, 1990, COGNITION, V35, P1, DOI 10.1016/0010-0277(90)90035-I; Bock K, 1986, COGNITIVE PSYCHOL, V18, P355, DOI [10.1016/0010-0285(86)90004-6, DOI 10.1016/0010-0285(86)90004-6]; Bock K, 2007, COGNITION, V104, P437, DOI 10.1016/j.cognition.2006.07.003; Boyland J, 1998, EVIDENCE SYNTACTIC P; Chang F, 2006, PSYCHOL REV, V113, P234, DOI 10.1037/0033-295X.113.2.234; Chang F, 2000, J PSYCHOLINGUIST RES, V29, P217, DOI 10.1023/A:1005101313330; Cleland AA, 2003, J MEM LANG, V49, P214, DOI 10.1016/S0749-596X(03)00060-3; Corley M, 2002, PSYCHON B REV, V9, P126, DOI 10.3758/BF03196267; Cornelis L., 1996, LANG SCI, V18, P247, DOI [10.1016/0388-0001(96)00018-6, DOI 10.1016/0388-0001(96)00018-6]; Ferreira VS, 2006, LANG COGNITIVE PROC, V21, P1011, DOI 10.1080/016909600824609; Ferreira VS, 2003, J MEM LANG, V48, P379, DOI 10.1016/S0749-596X(02)00523-5; Gries S.T.h., 2005, ANN REV COGNITIVE LI, V3, P182, DOI 10.1075/arcl.3.10gri; Hartsuiker RJ, 1999, Q J EXP PSYCHOL-A, V52, P129, DOI 10.1080/027249899391250; Hartsuiker RJ, 1998, LANG SPEECH, V41, P143, DOI 10.1177/002383099804100202; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Jaeger T.Florian., 2007, U ROCHESTER WORKING, V3, P26; Kaschak MP, 2007, MEM COGNITION, V35, P925, DOI 10.3758/BF03193466; LEVELT WJM, 1982, COGNITIVE PSYCHOL, V14, P78, DOI 10.1016/0010-0285(82)90005-6; MCCLELLAND JL, 1981, PSYCHOL REV, V88, P375, DOI 10.1037/0033-295X.88.5.375; Menenti L, 2011, PSYCHOL SCI, V22, P1173, DOI 10.1177/0956797611418347; Miller J., 1998, SPONTANEOUS SPOKEN L; Pickering MJ, 2008, PSYCHOL BULL, V134, P427, DOI 10.1037/0033-2909.134.3.427; Pickering MJ, 1998, J MEM LANG, V39, P633, DOI 10.1006/jmla.1998.2592; Pinheiro J, 2001, MIXED EFFECTS MODELS; R Core Team, 2020, R LANG ENV STAT COMP; RATCLIFF R, 1993, PSYCHOL BULL, V114, P510, DOI 10.1037/0033-2909.114.3.510; Reitter D, 2011, COGNITIVE SCI, V35, P587, DOI 10.1111/j.1551-6709.2010.01165.x; Scheepers C, 2003, COGNITION, V89, P179, DOI 10.1016/S0010-0277(03)00119-7; Segaert K, 2009, CUNY C HUM SENT PROC; Smith M, 2001, COGNITION, V78, P123, DOI 10.1016/S0010-0277(00)00110-4; Vosse T, 2000, COGNITION, V75, P105, DOI 10.1016/S0010-0277(00)00063-9; Wheeldon LR, 2003, LANG COGNITIVE PROC, V18, P431, DOI 10.1080/01690960244000063	39	36	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e24209	10.1371/journal.pone.0024209	http://dx.doi.org/10.1371/journal.pone.0024209			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834OZ	22022352	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000295973200001
J	Hu, Y; Galkin, AV; Wu, CL; Reddy, V; Su, AI				Hu, Yue; Galkin, Anna V.; Wu, Chunlei; Reddy, Venkateshwar; Su, Andrew I.			CAFET Algorithm Reveals Wnt/PCP Signature in Lung Squamous Cell Carcinoma	PLOS ONE			English	Article							BETA-CATENIN; GENE-EXPRESSION; PROMOTER HYPERMETHYLATION; NEGATIVE REGULATOR; SIGNALING PATHWAY; MICROARRAY DATA; DIX DOMAIN; CANCER; WNT; ADENOCARCINOMA	We analyzed the gene expression patterns of 138 Non-Small Cell Lung Cancer (NSCLC) samples and developed a new algorithm called Coverage Analysis with Fisher's Exact Test (CAFET) to identify molecular pathways that are differentially activated in squamous cell carcinoma (SCC) and adenocarcinoma (AC) subtypes. Analysis of the lung cancer samples demonstrated hierarchical clustering according to the histological subtype and revealed a strong enrichment for the Wnt signaling pathway components in the cluster consisting predominantly of SCC samples. The specific gene expression pattern observed correlated with enhanced activation of the Wnt Planar Cell Polarity (PCP) pathway and inhibition of the canonical Wnt signaling branch. Further real time RT-PCR follow-up with additional primary tumor samples and lung cancer cell lines confirmed enrichment of Wnt/PCP pathway associated genes in the SCC subtype. Dysregulation of the canonical Wnt pathway, characterized by increased levels of beta-catenin and epigenetic silencing of negative regulators, has been reported in adenocarcinoma of the lung. Our results suggest that SCC and AC utilize different branches of the Wnt pathway during oncogenesis.	[Hu, Yue; Galkin, Anna V.; Wu, Chunlei; Reddy, Venkateshwar; Su, Andrew I.] Novartis Res Fdn, Genom Inst, San Diego, CA USA	Novartis	Hu, Y (corresponding author), NCI, Genet Branch, Ctr Canc Res, Bethesda, MD 20892 USA.	asu@scripps.edu	Wu, Chunlei/ABF-4720-2020	Wu, Chunlei/0000-0002-2629-6124; Su, Andrew I./0000-0002-9859-4104				Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Borczuk Alain C, 2009, Proc Am Thorac Soc, V6, P152, DOI 10.1513/pats.200807-076LC; Borok Z, 2006, PEDIATR RES, V59, p84R, DOI 10.1203/01.pdr.0000203563.37626.77; Chien AJ, 2009, J INVEST DERMATOL, V129, P1614, DOI 10.1038/jid.2008.445; Cho SH, 2006, DEVELOPMENT, V133, P3167, DOI 10.1242/dev.02474; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Curtis RK, 2005, TRENDS BIOTECHNOL, V23, P429, DOI 10.1016/j.tibtech.2005.05.011; Fukui T, 2005, ONCOGENE, V24, P6323, DOI 10.1038/sj.onc.1208777; Golan T, 2004, J BIOL CHEM, V279, P14879, DOI 10.1074/jbc.M306421200; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Hussenet T, 2010, CELL CYCLE, V9, P1480, DOI 10.4161/cc.9.8.11203; Inamura K, 2005, ONCOGENE, V24, P7105, DOI 10.1038/sj.onc.1208858; Jessen JR, 2009, ZEBRAFISH, V6, P21, DOI 10.1089/zeb.2008.0571; Kadoya T, 2002, MOL CELL BIOL, V22, P3803, DOI 10.1128/MCB.22.11.3803-3819.2002; Katoh M, 2005, ONCOL REP, V14, P1583; Koch A, 2005, CLIN CANCER RES, V11, P4295, DOI 10.1158/1078-0432.CCR-04-1162; Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022; Kuner R, 2009, LUNG CANCER, V63, P32, DOI 10.1016/j.lungcan.2008.03.033; Lee ES, 2008, CLIN CANCER RES, V14, P7397, DOI 10.1158/1078-0432.CCR-07-4937; Lee JH, 2004, CANCER RES, V64, P4235, DOI 10.1158/0008-5472.CAN-04-0275; Lemjabbar-Alaoui H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000093; Mazieres J, 2004, CANCER RES, V64, P4717, DOI 10.1158/0008-5472.CAN-04-1389; Newton MA, 2007, ANN APPL STAT, V1, P85, DOI 10.1214/07-AOAS104; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; Ohgaki H, 2004, CANCER LETT, V207, P197, DOI 10.1016/j.canlet.2003.10.020; Oloumi A, 2006, ONCOGENE, V25, P7747, DOI 10.1038/sj.onc.1209752; Paul S, 2008, NEOPLASMA, V55, P165; Person AD, 2005, DEV BIOL, V278, P35, DOI 10.1016/j.ydbio.2004.10.013; Raponi M, 2006, CANCER RES, V66, P7466, DOI 10.1158/0008-5472.CAN-06-1191; Rawlins Emma L, 2008, Proc Am Thorac Soc, V5, P675, DOI 10.1513/pats.200801-006AW; Sartor MA, 2009, BIOINFORMATICS, V25, P211, DOI 10.1093/bioinformatics/btn592; Shiomi K, 2003, CURR BIOL, V13, P73, DOI 10.1016/S0960-9822(02)01398-2; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sunaga N, 2001, GENE CHROMOSOME CANC, V30, P316, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1097>3.0.CO;2-9; Tiseo M, 2009, EXPERT REV ANTICANC, V9, P425, DOI 10.1586/ERA.09.3; Wada H, 2009, ZEBRAFISH, V6, P3, DOI 10.1089/zeb.2008.0557; Wang YQ, 2009, MOL CANCER THER, V8, P2103, DOI 10.1158/1535-7163.MCT-09-0282; Werner T, 2008, CURR OPIN BIOTECH, V19, P50, DOI 10.1016/j.copbio.2007.11.005; Westfall TA, 2003, J CELL BIOL, V162, P889, DOI 10.1083/jcb.200303107; Wilkerson MD, 2010, CLIN CANCER RES, V16, P4864, DOI 10.1158/1078-0432.CCR-10-0199; Wong CK, 2004, J BIOL CHEM, V279, P39366, DOI 10.1074/jbc.M404598200; Yamagata N, 2003, CLIN CANCER RES, V9, P4695; Yuan P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009112	45	5	6	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25807	10.1371/journal.pone.0025807	http://dx.doi.org/10.1371/journal.pone.0025807			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016777	Green Published, gold, Green Submitted			2022-12-27	WOS:000295971700019
J	Salyakina, D; Cukier, HN; Lee, JM; Sacharow, S; Nations, LD; Ma, DQ; Jaworski, JM; Konidari, I; Whitehead, PL; Wright, HH; Abramson, RK; Williams, SM; Menon, R; Haines, JL; Gilbert, JR; Cuccaro, ML; Pericak-Vance, MA				Salyakina, Daria; Cukier, Holly N.; Lee, Joycelyn M.; Sacharow, Stephanie; Nations, Laura D.; Ma, Deqiong; Jaworski, James M.; Konidari, Ioanna; Whitehead, Patrice L.; Wright, Harry H.; Abramson, Ruth K.; Williams, Scott M.; Menon, Ramkumar; Haines, Jonathan L.; Gilbert, John R.; Cuccaro, Michael L.; Pericak-Vance, Margaret A.			Copy Number Variants in Extended Autism Spectrum Disorder Families Reveal Candidates Potentially Involved in Autism Risk	PLOS ONE			English	Article							STRUCTURAL VARIATION; GENOME; MICRODELETION; ASSOCIATION; EXPRESSION; IMPLICATE; 16P11.2; LOCI; MICRODUPLICATIONS; REARRANGEMENTS	Copy number variations (CNVs) are a major cause of genetic disruption in the human genome with far more nucleotides being altered by duplications and deletions than by single nucleotide polymorphisms (SNPs). In the multifaceted etiology of autism spectrum disorders (ASDs), CNVs appear to contribute significantly to our understanding of the pathogenesis of this complex disease. A unique resource of 42 extended ASD families was genotyped for over 1 million SNPs to detect CNVs that may contribute to ASD susceptibility. Each family has at least one avuncular or cousin pair with ASD. Families were then evaluated for co-segregation of CNVs in ASD patients. We identified a total of five deletions and seven duplications in eleven families that co-segregated with ASD. Two of the CNVs overlap with regions on 7p21.3 and 15q24.1 that have been previously reported in ASD individuals and two additional CNVs on 3p26.3 and 12q24.32 occur near regions associated with schizophrenia. These findings provide further evidence for the involvement of ICA1 and NXPH1 on 7p21.3 in ASD susceptibility and highlight novel ASD candidates, including CHL1, FGFBP3 and POUF41. These studies highlight the power of using extended families for gene discovery in traits with a complex etiology.	[Salyakina, Daria; Cukier, Holly N.; Lee, Joycelyn M.; Sacharow, Stephanie; Nations, Laura D.; Ma, Deqiong; Jaworski, James M.; Konidari, Ioanna; Whitehead, Patrice L.; Gilbert, John R.; Cuccaro, Michael L.; Pericak-Vance, Margaret A.] Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Miami, FL 33136 USA; [Sacharow, Stephanie; Ma, Deqiong; Gilbert, John R.; Cuccaro, Michael L.; Pericak-Vance, Margaret A.] Univ Miami, Miller Sch Med, Dr John T Macdonald Fdn, Dept Human Genet, Miami, FL 33136 USA; [Wright, Harry H.; Abramson, Ruth K.] Univ S Carolina, Sch Med, Dept Neuropsychiat, Columbia, SC USA; [Williams, Scott M.; Haines, Jonathan L.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN USA; [Menon, Ramkumar] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Menon, Ramkumar] Emory Univ, Rollins Sch Publ Hlth, Dept Obstet & Gynecol, Atlanta, GA 30322 USA	University of Miami; University of Miami; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Vanderbilt University; Emory University; Rollins School Public Health; Emory University; Rollins School Public Health	Salyakina, D (corresponding author), Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Miami, FL 33136 USA.	mpericak@med.miami.edu	Williams, Scott/B-9491-2012; Williams, Scott/Q-4812-2019; Haines, Jonathan/C-3374-2012	Williams, Scott/0000-0002-4835-9544; Haines, Jonathan/0000-0002-4351-4728; Cukier, Holly/0000-0003-3459-7792; Salyakina, Daria/0000-0003-3283-3691; Lee, Joycelyn/0000-0002-3811-8755	National Institutes of Health [R01MH080647]; National Institute of Neurological Disorders and Stroke [P01NS026630]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS026630] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by grants from the National Institutes of Health (R01MH080647), www.nih.gov; the National Institute of Neurological Disorders and Stroke (P01NS026630), www.ninds.nih.gov; and by a gift from the Hussman Foundation, www.hussmanfoundation.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Andreyeva A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012018; Bijlsma EK, 2009, EUR J MED GENET, V52, P77, DOI 10.1016/j.ejmg.2009.03.006; Brouwers N, 2011, MOL PSYCHIAT; Brugha TS, 2011, ARCH GEN PSYCHIAT, V68, P459, DOI 10.1001/archgenpsychiatry.2011.38; Bucan M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000536; Cao M, 2007, J NEUROSCI, V27, P12945, DOI 10.1523/JNEUROSCI.2040-07.2007; Cukier HN, 2011, AM J MED GENET B, V156B, P493, DOI 10.1002/ajmg.b.31188; Cusco I, 2009, HUM MOL GENET, V18, P1795, DOI 10.1093/hmg/ddp092; Dono R, 1998, EMBO J, V17, P4213, DOI 10.1093/emboj/17.15.4213; El-Hattab AW, 2009, HUM GENET, V126, P589, DOI 10.1007/s00439-009-0706-x; Fernandez BA, 2010, J MED GENET, V47, P195, DOI 10.1136/jmg.2009.069369; FOLSTEIN S, 1977, J CHILD PSYCHOL PSYC, V18, P297, DOI 10.1111/j.1469-7610.1977.tb00443.x; Fombonne E, 2009, PEDIATR RES, V65, P591, DOI 10.1203/PDR.0b013e31819e7203; Frints SGM, 2003, HUM MOL GENET, V12, P1463, DOI 10.1093/hmg/ddg165; Gai X, 2011, MOL PSYCHIATR; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Jacquemont ML, 2006, J MED GENET, V43, P843, DOI 10.1136/jmg.2006.043166; Klejbor I, 2006, J NEUROCHEM, V97, P1243, DOI 10.1111/j.1471-4159.2006.03754.x; Klejbor I, 2009, SCHIZOPHR RES, V113, P308, DOI 10.1016/j.schres.2009.06.006; Kumar RA, 2009, CURR NEUROL NEUROSCI, V9, P188, DOI 10.1007/s11910-009-0029-2; Lanier J, 2009, DEV DYNAM, V238, P3065, DOI 10.1002/dvdy.22145; Lien YJ, 2010, GENES BRAIN BEHAV, V9, P695, DOI 10.1111/j.1601-183X.2010.00599.x; Liu SX, 2003, IMMUNOL LETT, V86, P169, DOI 10.1016/S0165-2478(03)00004-X; LORD C, RISI S AUTISM DIAGNO; Ma DQ, 2009, ANN HUM GENET, V73, P263, DOI 10.1111/j.1469-1809.2009.00523.x; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; Missler M, 1998, J NEUROSCI, V18, P3630; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; PIVEN J, 1991, J AM ACAD CHILD PSY, V30, P471, DOI 10.1097/00004583-199105000-00019; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rauch A, 2001, AM J MED GENET, V99, P338, DOI 10.1002/ajmg.1203; RITVO ER, 1985, AM J PSYCHIAT, V142, P74; RUTTER M, LORD C AUTISM DIAGNO; Rutter M., 2003, SOCIAL COMMUNICATION; Sanchez-Calderon H, 2007, INT J DEV BIOL, V51, P557, DOI 10.1387/ijdb.072373hs; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sharp AJ, 2007, HUM MOL GENET, V16, P567, DOI 10.1093/hmg/ddm016; Shen YP, 2011, AM J MED GENET B, V156B, P225, DOI 10.1002/ajmg.b.31147; Sparrow S. S., 2016, VINELAND ADAPTIVE BE, V3rd; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; STEFFENBURG S, 1989, J CHILD PSYCHOL PSYC, V30, P405, DOI 10.1111/j.1469-7610.1989.tb00254.x; Tam GWC, 2010, BIOCHEM SOC T, V38, P445, DOI 10.1042/BST0380445; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Weiss LA, 2009, NATURE, V461, P802, DOI 10.1038/nature08490; Wu Y, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-72; XIANG MQ, 1995, J NEUROSCI, V15, P4762; Yan J, 2008, NEUROSCI LETT, V438, P368, DOI 10.1016/j.neulet.2008.04.074	54	62	64	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e26049	10.1371/journal.pone.0026049	http://dx.doi.org/10.1371/journal.pone.0026049			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22016809	Green Submitted, Green Published, gold			2022-12-27	WOS:000295970300053
J	Schmidt, MFH; Sommerville, JA				Schmidt, Marco F. H.; Sommerville, Jessica A.			Fairness Expectations and Altruistic Sharing in 15-Month-Old Human Infants	PLOS ONE			English	Article							COOPERATION; PUNISHMENT; COMPETITION; STRANGERS; EVOLUTION; JUSTICE; ORIGINS; OBJECT; REWARD; RULES	Human cooperation is a key driving force behind the evolutionary success of our hominin lineage. At the proximate level, biologists and social scientists have identified other-regarding preferences - such as fairness based on egalitarian motives, and altruism - as likely candidates for fostering large-scale cooperation. A critical question concerns the ontogenetic origins of these constituents of cooperative behavior, as well as whether they emerge independently or in an interrelated fashion. The answer to this question will shed light on the interdisciplinary debate regarding the significance of such preferences for explaining how humans become such cooperative beings. We investigated 15-month-old infants' sensitivity to fairness, and their altruistic behavior, assessed via infants' reactions to a third-party resource distribution task, and via a sharing task. Our results challenge current models of the development of fairness and altruism in two ways. First, in contrast to past work suggesting that fairness and altruism may not emerge until early to mid-childhood, 15-month-old infants are sensitive to fairness and can engage in altruistic sharing. Second, infants' degree of sensitivity to fairness as a third-party observer was related to whether they shared toys altruistically or selfishly, indicating that moral evaluations and prosocial behavior are heavily interconnected from early in development. Our results present the first evidence that the roots of a basic sense of fairness and altruism can be found in infancy, and that these other-regarding preferences develop in a parallel and interwoven fashion. These findings support arguments for an evolutionary basis - most likely in dialectical manner including both biological and cultural mechanisms - of human egalitarianism given the rapidly developing nature of other-regarding preferences and their role in the evolution of human-specific forms of cooperation. Future work of this kind will help determine to what extent uniquely human sociality and morality depend on other-regarding preferences emerging early in life.	[Schmidt, Marco F. H.] Max Planck Inst Evolutionary Anthropol, Dept Dev & Comparat Psychol, Leipzig, Germany; [Schmidt, Marco F. H.; Sommerville, Jessica A.] Univ Washington, Dept Psychol, Seattle, WA 98195 USA; [Schmidt, Marco F. H.; Sommerville, Jessica A.] Univ Washington, Inst Learning & Brain Sci, Seattle, WA 98195 USA	Max Planck Society; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Schmidt, MFH (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Dev & Comparat Psychol, Leipzig, Germany.	marco_schmidt@eva.mpg.de		Schmidt, Marco F. H./0000-0001-7651-1681	Ludwig Maximilian University of Munich; National Institute of Child Health and Development [HD053616-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD053616] Funding Source: NIH RePORTER	Ludwig Maximilian University of Munich; National Institute of Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported in part by a grant to MFH Schmidt from the Ludwig Maximilian University of Munich (stipend program 'Hochschule International'), and by a grant to Dr. Sommerville from the National Institute of Child Health and Development (grant #R03 HD053616-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R., 2008, ESSAYS PEDAGOGY; BAILLARGEON R, 1985, COGNITION, V20, P191, DOI 10.1016/0010-0277(85)90008-3; Blake PR, 2010, EVOL HUM BEHAV, V31, P210, DOI 10.1016/j.evolhumbehav.2009.06.012; Boehm C., 1999, HIERARCHY FOREST EVO; BOYD R, 1992, ETHOL SOCIOBIOL, V13, P171, DOI 10.1016/0162-3095(92)90032-Y; Boyd R, 2010, SCIENCE, V328, P617, DOI 10.1126/science.1183665; Brandt H, 2004, J THEOR BIOL, V231, P475, DOI 10.1016/j.jtbi.2004.06.032; BROOKS J, 1976, CHILD DEV, V47, P323, DOI 10.2307/1128785; Brownell CA, 2009, INFANCY, V14, P117, DOI 10.1080/15250000802569868; Camerer C, 2003, BEHAV GAME THEORY EX; Darwin C., 1871, P423; Dawes CT, 2007, NATURE, V446, P794, DOI 10.1038/nature05651; Dawkins R., 1982, pi; de Waal FBM, 2010, PHILOS T R SOC B, V365, P2711, DOI 10.1098/rstb.2010.0119; Eisenberg N., 2006, HDB CHILD PSYCHOL VO, V(6th ed., pp., P646, DOI 10.1002/9780470147658.chpsy0311; El Mouden C, 2010, EVOLUTION, V64, P2139, DOI 10.1111/j.1558-5646.2010.00963.x; Fehr E, 2004, TRENDS COGN SCI, V8, P185, DOI 10.1016/j.tics.2004.02.007; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Fehr E, 2008, NATURE, V454, P1079, DOI 10.1038/nature07155; FEINMAN S, 1980, INFANT BEHAV DEV, V3, P187, DOI 10.1016/S0163-6383(80)80025-7; Fetchenhauer D, 2004, PERS INDIV DIFFER, V36, P1015, DOI 10.1016/S0191-8869(03)00197-1; Franus E, 1962, PSYCHOLOGICA WYCHOWA, V5, P392; Hamlin JK, 2007, NATURE, V450, P557, DOI 10.1038/nature06288; Haruno M, 2010, NAT NEUROSCI, V13, P160, DOI 10.1038/nn.2468; Helbing D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000758; Jensen K, 2006, P ROY SOC B-BIOL SCI, V273, P1013, DOI 10.1098/rspb.2005.3417; Johansson LO, 2009, ORGAN BEHAV HUM DEC, V109, P107, DOI 10.1016/j.obhdp.2009.02.001; Johnson T, 2009, ECON LETT, V102, P192, DOI 10.1016/j.econlet.2009.01.003; Kopp C.B., 2007, SOCIOEMOTIONAL DEV T, P101; Kuhlmeier V, 2003, PSYCHOL SCI, V14, P402, DOI 10.1111/1467-9280.01454; Mikula G., 1994, ENTITLEMENT AFFECTIO, DOI [10.1007/978-1-4899-0984-8_8, DOI 10.1007/978-1-4899-0984-8_8]; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Olson KR, 2008, COGNITION, V108, P222, DOI 10.1016/j.cognition.2007.12.003; Pacheco JM, 2006, PLOS COMPUT BIOL, V2, P1634, DOI 10.1371/journal.pcbi.0020178; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Rand DG, 2009, SCIENCE, V325, P1272, DOI 10.1126/science.1177418; Rochat P, 2009, J CROSS CULT PSYCHOL, V40, P416, DOI 10.1177/0022022109332844; SEARS DO, 1991, ADV EXP SOC PSYCHOL, V24, P1; Sell J, 1999, SOC FORCES, V77, P1551, DOI 10.2307/3005886; Sigmund K, 2001, P NATL ACAD SCI USA, V98, P10757, DOI 10.1073/pnas.161155698; Sigmund K, 2010, NATURE, V466, P861, DOI 10.1038/nature09203; Sober E., 1998, OTHERS EVOLUTION PSY; SPELKE ES, 1992, PSYCHOL REV, V99, P605, DOI 10.1037/0033-295X.99.4.605; SROUFE LA, 1977, CHILD DEV, V48, P731, DOI 10.2307/1128323; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/38003; Tabibnia G, 2008, PSYCHOL SCI, V19, P339, DOI 10.1111/j.1467-9280.2008.02091.x; Tomasello M, 2008, NATURE, V454, P1057, DOI 10.1038/4541057a; Warneken F, 2006, SCIENCE, V311, P1301, DOI 10.1126/science.1121448; Warneken F, 2007, PLOS BIOL, V5, P1414, DOI 10.1371/journal.pbio.0050184; WESTEBERHARD MJ, 1983, Q REV BIOL, V58, P155, DOI 10.1086/413215; Williams G. C., 1966, P307; Woodward AL, 1998, COGNITION, V69, P1, DOI 10.1016/S0010-0277(98)00058-4; Woodward AL, 1999, INFANT BEHAV DEV, V22, P145, DOI 10.1016/S0163-6383(99)00007-7; ZAHNWAXLER C, 1990, MOTIV EMOTION, V14, P107, DOI 10.1007/BF00991639; ZAHNWAXLER C, 1992, DEV PSYCHOL, V28, P126, DOI 10.1037/0012-1649.28.1.126	58	291	305	7	144	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e23223	10.1371/journal.pone.0023223	http://dx.doi.org/10.1371/journal.pone.0023223			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834OC	22003380	gold, Green Published			2022-12-27	WOS:000295970300001
J	Boichuk, S; Hu, L; Makielski, K; Pandolfi, PP; Gjoerup, OV				Boichuk, Sergei; Hu, Liang; Makielski, Kathleen; Pandolfi, Pier Paolo; Gjoerup, Ole V.			Functional Connection between Rad51 and PML in Homology-Directed Repair	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; LEUKEMIA NUCLEAR-BODIES; LARGE T-ANTIGEN; RECOMBINATIONAL REPAIR; SUMO MODIFICATION; END RESECTION; IN-VIVO; REPLICATION; PROTEIN; ND10	The promyelocytic leukemia protein (PML) is a tumor suppressor critical for formation of nuclear bodies (NBs) performing important functions in transcription, apoptosis, DNA repair and antiviral responses. Earlier studies demonstrated that simian virus 40 (SV40) initiates replication near PML NBs. Here we show that PML knockdown inhibits viral replication in vivo, thus indicating a positive role of PML early in infection. SV40 large T antigen (LT) induces DNA damage and, consequently, nuclear foci of the key homologous recombination repair protein Rad51 that colocalize with PML. PML depletion abrogates LT-induced Rad51 foci. LT may target PML NBs to gain access to DNA repair factors like Rad51 that are required for viral replication. We have used the SV40 model to gain insight to DNA repair events involving PML. Strikingly, even in normal cells devoid of viral oncoproteins, PML is found to be instrumental for foci of Rad51, Mre11 and BRCA1, as well as homology-directed repair after double-strand break (DSB) induction. Following LT expression or external DNA damage, PML associates with Rad51. PML depletion also causes a loss of RPA foci following gamma-irradiation, suggesting that PML is required for processing of DSBs. Immunofluorescent detection of incorporated BrdU without prior denaturation indicates a failure to generate ssDNA foci in PML knockdown cells upon gamma-irradiation. Consistent with the lack of RPA and BrdU foci, gamma-irradiation fails to induce Chk1 activation, when PML is depleted. Taken together, we have discovered a novel functional connection between PML and the homologous recombination-mediated repair machinery, which might contribute to PML tumor suppressor activity.	[Boichuk, Sergei; Hu, Liang; Makielski, Kathleen; Gjoerup, Ole V.] Univ Pittsburgh, Canc Virol Program, Inst Canc, Pittsburgh, PA 15260 USA; [Pandolfi, Pier Paolo] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Med, Sch Med, Boston, MA 02215 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Boichuk, S (corresponding author), Univ Pittsburgh, Canc Virol Program, Inst Canc, Pittsburgh, PA 15260 USA.	ogjoerup@tuftsmedicalcenter.org		Pandolfi, Pier Paolo/0000-0002-5352-5295; Boichuk, Sergei/0000-0003-2415-1084	NIH [AI078926]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078926] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NIH grant AI078926. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Bischof O, 2001, J CELL BIOL, V153, P367, DOI 10.1083/jcb.153.2.367; Boe SO, 2006, J CELL SCI, V119, P3284, DOI 10.1242/jcs.03068; Boichuk S, 2010, J VIROL, V84, P8007, DOI 10.1128/JVI.00334-10; Brand Peter, 2010, PMC Biophys, V3, P3, DOI 10.1186/1757-5036-3-3; Bruno S, 2003, BLOOD, V101, P3514, DOI 10.1182/blood-2002-11-3335; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Campbell KS, 1997, GENE DEV, V11, P1098, DOI 10.1101/gad.11.9.1098; Carbone R, 2002, ONCOGENE, V21, P1633, DOI 10.1038/sj.onc.1205227; CARVALHO T, 1995, J CELL BIOL, V131, P45, DOI 10.1083/jcb.131.1.45; Dedes KJ, 2011, CELL CYCLE, V10, P1192, DOI 10.4161/cc.10.8.15273; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; Dellaire G, 2006, J CELL BIOL, V175, P55, DOI 10.1083/jcb.200604009; Dou H, 2010, MOL CELL, V39, P333, DOI 10.1016/j.molcel.2010.07.021; Eladad S, 2005, HUM MOL GENET, V14, P1351, DOI 10.1093/hmg/ddi145; Everett RD, 2006, CELL MICROBIOL, V8, P365, DOI 10.1111/j.1462-5822.2005.00677.x; Everett RD, 2001, ONCOGENE, V20, P7266, DOI 10.1038/sj.onc.1204759; Everett RD, 2006, J VIROL, V80, P7995, DOI 10.1128/JVI.00734-06; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fradet-Turcotte A, 2010, VIROLOGY, V399, P65, DOI 10.1016/j.virol.2009.12.026; Gurrieri C, 2004, JNCI-J NATL CANCER I, V96, P269, DOI 10.1093/jnci/djh043; Hein J, 2009, J VIROL, V83, P117, DOI 10.1128/JVI.01515-08; Hoppe A, 2006, J VIROL, V80, P3042, DOI 10.1128/JVI.80.6.3042-3049.2006; Ishov AM, 1996, J CELL BIOL, V134, P815, DOI 10.1083/jcb.134.4.815; Jensen K, 2001, ONCOGENE, V20, P7223, DOI 10.1038/sj.onc.1204765; Jul-Larsen A, 2004, EXP CELL RES, V298, P58, DOI 10.1016/j.yexcr.2004.03.045; Kudoh A, 2009, J VIROL, V83, P6641, DOI 10.1128/JVI.00049-09; Lilley CE, 2007, TRENDS MICROBIOL, V15, P119, DOI 10.1016/j.tim.2007.01.003; Longhese MP, 2010, EMBO J, V29, P2864, DOI 10.1038/emboj.2010.165; Marmorstein LY, 1998, P NATL ACAD SCI USA, V95, P13869, DOI 10.1073/pnas.95.23.13869; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Nacerddine K, 2005, DEV CELL, V9, P769, DOI 10.1016/j.devcel.2005.10.007; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; Niedzwiedz W, 2004, MOL CELL, V15, P607, DOI 10.1016/j.molcel.2004.08.009; Ouyang KJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000252; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Raderschall E, 1999, P NATL ACAD SCI USA, V96, P1921, DOI 10.1073/pnas.96.5.1921; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Shi YL, 2005, J BIOL CHEM, V280, P40195, DOI 10.1074/jbc.C500400200; Takata M, 2001, MOL CELL BIOL, V21, P2858, DOI 10.1128/MCB.21.8.2858-2866.2001; Tang QY, 2000, J VIROL, V74, P9694, DOI 10.1128/JVI.74.20.9694-9700.2000; Tarsounas M, 2004, PHILOS T R SOC B, V359, P87, DOI 10.1098/rstb.2003.1368; Tavalai N, 2008, BBA-MOL CELL RES, V1783, P2207, DOI 10.1016/j.bbamcr.2008.08.004; Tavalai N, 2006, J VIROL, V80, P8006, DOI 10.1128/JVI.00743-06; Tsuzuki T, 1996, P NATL ACAD SCI USA, V93, P6236, DOI 10.1073/pnas.93.13.6236; Wang ZG, 1998, SCIENCE, V279, P1547; Wimmer P, 2010, ONCOGENE; Xu ZX, 2003, MOL CELL BIOL, V23, P4247, DOI 10.1128/MCB.23.12.4247-4256.2003; Yeager TR, 1999, CANCER RES, V59, P4175; You ZS, 2009, MOL CELL, V36, P954, DOI 10.1016/j.molcel.2009.12.002; Yuan SSF, 1999, CANCER RES, V59, P3547; Zhang JR, 2005, NAT STRUCT MOL BIOL, V12, P902, DOI 10.1038/nsmb991; Zhao X, 2008, J VIROL, V82, P5316, DOI 10.1128/JVI.02677-07; Zhong S, 2000, BLOOD, V95, P2748, DOI 10.1182/blood.V95.9.2748.009k31a_2748_2752; Zhu JM, 2008, J BIOL CHEM, V283, P29405, DOI 10.1074/jbc.M803632200; Zong S, 1999, ONCOGENE, V18, P7941, DOI 10.1038/sj.onc.1203367; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	58	38	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25814	10.1371/journal.pone.0025814	http://dx.doi.org/10.1371/journal.pone.0025814			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998700	Green Published, gold, Green Accepted			2022-12-27	WOS:000295966900057
J	Buck, M; Chojkier, M				Buck, Martina; Chojkier, Mario			C/EBP beta-Thr217 Phosphorylation Signaling Contributes to the Development of Lung Injury and Fibrosis in Mice	PLOS ONE			English	Article							IDIOPATHIC PULMONARY FIBROSIS; C/EBP-BETA PHOSPHORYLATION; RIBOSOMAL S-6 KINASE; TRANSCRIPTIONAL ACTIVATOR; OXIDATIVE STRESS; LIVER; PROTEIN; EXPRESSION; LAP; NF-IL6	Background: Although C/EBP beta(ko) mice are refractory to Bleomycin-induced lung fibrosis the molecular mechanisms remain unknown. Here we show that blocking the ribosomal S-6 kinase (RSK) phosphorylation of the CCAAT/Enhancer Binding Protein (C/EBP)-beta on Thr217 (a RSK phosphoacceptor) with either a single point mutation (Ala217), dominant negative transgene or a blocking peptide containing the mutated phosphoacceptor ameliorates the progression of lung injury and fibrosis induced by Bleomycin in mice. Methodology/Principal Findings: Mice expressing the non-phosphorylatable C/EBP beta-Ala217 transgene had a marked reduction in lung injury on day-13 after Bleomycin exposure, compared to C/EBP beta(wt) mice, judging by the decrease of CD68(+) activated monocytes/macrophages, bone marrow-derived CD45(+) cells and lung cytokines as well as by the normal surfactant protein-C expression by lung pneumocytes. On day-21 after Bleomycin treatment, C/EBPbwt mice but not mice expressing the dominant negative C/EBPb-Ala217 transgene developed severe lung fibrosis as determined by quantitative collagen assays. All mice were of identical genetic background and back-crossed to the parental wild-type inbreed FVB mice for at least ten generations. Treatment of C/EBPbwt mice with a cell permeant, C/EBP beta peptide that inhibits phosphorylation of C/EBP beta on Thr217 (40 mu g instilled intracheally on day-2 and day-6 after the single Bleomycin dose) also blocked the progression of lung injury and fibrosis induced by Bleomycin. Phosphorylation of human C/EBP beta on Thr266 (human homologue phosphoacceptor) was induced in collagen-activated human lung fibroblasts in culture as well as in activated lung fibroblasts in situ in lungs of patients with severe lung fibrosis but not in control lungs, suggesting that this signaling pathway may be also relevant in human lung injury and fibrosis. Conclusions/Significance: These data suggest that the RSK-C/EBP beta phosphorylation pathway may contribute to the development of lung injury and fibrosis.	[Buck, Martina; Chojkier, Mario] VA Healthcare Ctr, Dept Med, San Diego, CA USA; [Buck, Martina; Chojkier, Mario] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Buck, Martina; Chojkier, Mario] Univ Calif San Diego, Program Biomed Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Buck, M (corresponding author), VA Healthcare Ctr, Dept Med, San Diego, CA USA.	mbuck@ucsd.edu			National Institutes of Health [RC1 Challenge-DK 087031, MERIT R37-DK-46071, R01-DK-38652, R01-DK084139, K-22-CA-96932]; Department of Veterans Affairs (Merit Review); National Cancer Institute; NATIONAL CANCER INSTITUTE [K01CA096932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC1DK087031, R01DK038652, R01DK084139] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs (Merit Review)(US Department of Veterans Affairs); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health (RC1 Challenge-DK 087031; MERIT R37-DK-46071; R01-DK-38652, R01-DK084139 and K-22-CA-96932), and the Department of Veterans Affairs (Merit Review). M.B. was a recipient of the Howard Temin Award from the National Cancer Institute during part of this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JS, 1983, J CLIN INVEST, V72, P1856, DOI 10.1172/JCI111147; AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646; An MR, 1996, MOL CELL BIOL, V16, P2295; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Bhatt RR, 1999, SCIENCE, V286, P1362, DOI 10.1126/science.286.5443.1362; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Buck M, 1996, EMBO J, V15, P1753, DOI 10.1002/j.1460-2075.1996.tb00524.x; Buck M, 2003, HEPATOLOGY, V37, P731, DOI 10.1053/jhep.2003.50155; BUCK M, 1994, EMBO J, V13, P851, DOI 10.1002/j.1460-2075.1994.tb06328.x; Buck M, 1999, MOL CELL, V4, P1087, DOI 10.1016/S1097-2765(00)80237-3; Buck M, 2001, MOL CELL, V8, P807, DOI 10.1016/S1097-2765(01)00374-4; Buck M, 2001, EMBO J, V20, P6712, DOI 10.1093/emboj/20.23.6712; Buck M, 2008, DRUG NEWS PERSPECT, V21, P301, DOI 10.1358/dnp.2008.21.6.1246796; Buck M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001372; Buck M, 2007, AM J PHYSIOL-CELL PH, V293, pC1788, DOI 10.1152/ajpcell.00141.2007; Chojkier M, 1995, Prog Liver Dis, V13, P37; Chojkier M, 1998, LIVER GROWTH REPAIR, P430; Crystal RG, 2002, AM J RESP CRIT CARE, V166, P236, DOI 10.1164/rccm.2201069; Cutroneo KR, 2007, J CELL PHYSIOL, V211, P585, DOI 10.1002/jcp.20972; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; DESCOMBES P, 1990, GENE DEV, V4, P1541, DOI 10.1101/gad.4.9.1541; Friedman AD, 2007, ONCOGENE, V26, P6816, DOI 10.1038/sj.onc.1210764; Garantziotis S, 2004, J CLIN INVEST, V114, P319, DOI 10.1172/jci200422497; Gauldie J, 2008, AM J PHYSIOL-LUNG C, V294, pL151, DOI 10.1152/ajplung.00520.2007; Gross SD, 1999, SCIENCE, V286, P1365, DOI 10.1126/science.286.5443.1365; Hardie WD, 2009, AM J PATHOL, V175, P3, DOI 10.2353/ajpath.2009.081170; Hilgendorff A, 2006, CRIT CARE MED, V34, P203, DOI 10.1097/01.CCM.0000190624.77908.E2; Hu B, 2007, J PATHOL, V211, P455, DOI 10.1002/path.2119; JIMENEZ W, 1985, HEPATOLOGY, V5, P815, DOI 10.1002/hep.1840050517; Konigshoff M, 2009, J CLIN INVEST, V119, P772, DOI 10.1172/JCI33950; Lawson WE, 2005, AM J PATHOL, V167, P1267, DOI 10.1016/S0002-9440(10)61214-X; LEE KS, 1995, J CLIN INVEST, V96, P2461, DOI 10.1172/JCI118304; Liu TJ, 2007, J CLIN INVEST, V117, P3800, DOI 10.1172/JCI32369; McKnight SL, 2001, CELL, V107, P259, DOI 10.1016/S0092-8674(01)00543-8; Meneghin A, 2007, J CLIN INVEST, V117, P530, DOI 10.1172/JCI30595; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Moore BB, 2008, AM J PHYSIOL-LUNG C, V294, pL152, DOI 10.1152/ajplung.00313.2007; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nogee LM, 2001, NEW ENGL J MED, V344, P573, DOI 10.1056/NEJM200102223440805; Olson AL, 2007, AM J RESP CRIT CARE, V176, P277, DOI 10.1164/rccm.200701-044OC; Orens JB, 2006, J HEART LUNG TRANSPL, V25, P745, DOI 10.1016/j.healun.2006.03.011; Pardo A, 2005, PLOS MED, V2, P891, DOI 10.1371/journal.pmed.0020251; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Raghu G, 2006, AM J RESP CRIT CARE, V174, P810, DOI 10.1164/rccm.200602-163OC; Ramamoorthy S, 2009, AM J PHYSIOL-ENDOC M, V297, pE392, DOI 10.1152/ajpendo.90529.2008; Ranjan P, 2006, APOPTOSIS, V11, P1837, DOI 10.1007/s10495-006-9530-0; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; SCHRIER DJ, 1983, AM REV RESPIR DIS, V127, P63, DOI 10.1164/arrd.1983.127.1.63; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; TANAKA T, 1995, CELL, V80, P353, DOI 10.1016/0092-8674(95)90418-2; TRAUTWEIN C, 1994, J CLIN INVEST, V93, P2554, DOI 10.1172/JCI117266; TRAUTWEIN C, 1993, NATURE, V364, P544, DOI 10.1038/364544a0; Walther FJ, 2007, NEONATOLOGY, V91, P303, DOI 10.1159/000101346; Yoon K, 2007, ONCOGENE, V26, P360, DOI 10.1038/sj.onc.1209797	55	7	12	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25497	10.1371/journal.pone.0025497	http://dx.doi.org/10.1371/journal.pone.0025497			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998664	Green Submitted, gold, Green Published			2022-12-27	WOS:000295966900031
J	David, GK; Condon, CH; Bywater, CL; Ortiz-Barrientos, D; Wilson, RS				David, Gwendolyn K.; Condon, Catriona H.; Bywater, Candice L.; Ortiz-Barrientos, Daniel; Wilson, Robbie S.			Receivers Limit the Prevalence of Deception in Humans: Evidence from Diving Behaviour in Soccer Players	PLOS ONE			English	Article							SIGNALS; COST; EVOLUTION; DISPLAYS; HONESTY	Deception remains a hotly debated topic in evolutionary and behavioural research. Our understanding of what impedes or facilitates the use and detection of deceptive signals in humans is still largely limited to studies of verbal deception under laboratory conditions. Recent theoretical models of non-human behaviour have suggested that the potential outcome for deceivers and the ability of receivers to discriminate signals can effectively maintain their honesty. In this paper, we empirically test these predictions in a real-world case of human deception, simulation in soccer. In support of theoretical predictions in signalling theory, we show that cost-free deceit by soccer players decreases as the potential outcome for the signaller becomes more costly. We further show that the ability of receivers (referees) to detect deceptive signals may limit the prevalence of deception by soccer players. Our study provides empirical support to recent theoretical models in signalling theory, and identifies conditions that may facilitate human deception and hinder its detection.	[David, Gwendolyn K.; Condon, Catriona H.; Bywater, Candice L.; Ortiz-Barrientos, Daniel; Wilson, Robbie S.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia	University of Queensland	David, GK (corresponding author), Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia.	g.david@uq.edu.au	David, Gwendolyn/M-1703-2018; Ortiz-Barrientos, Daniel/N-3294-2019; Ortiz-Barrientos, Daniel/B-2274-2010; Bywater, Candice L./AAW-5481-2021	David, Gwendolyn/0000-0002-8422-9093; Ortiz-Barrientos, Daniel/0000-0002-7493-416X; Ortiz-Barrientos, Daniel/0000-0002-7493-416X; Bywater, Candice L./0000-0001-6270-0422; Wilson, Robbie/0000-0002-0116-5427	Australian Postgraduate Award	Australian Postgraduate Award(Australian Government)	This work was supported by the Australian Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N, 2011, NEUROSCIENTIST; Abe N, 2009, CURR OPIN NEUROL, V22, P594, DOI 10.1097/WCO.0b013e328332c3cf; Andrewartha D, 2008, PSYCHIAT PSYCHOL LAW, V15, P88, DOI 10.1080/13218710701873940; Backwell PRY, 2000, P ROY SOC B-BIOL SCI, V267, P719, DOI 10.1098/rspb.2000.1062; BOND CF, 1988, J NONVERBAL BEHAV, V12, P295, DOI 10.1007/BF00987597; Bond GD, 2008, LAW HUMAN BEHAV, V32, P339, DOI 10.1007/s10979-007-9110-z; Cheney D.L., 1990, MONKEYS SEE WORLD IN, DOI [10.7208/chicago/9780226218526.001.0001, DOI 10.7208/CHICAGO/9780226218526.001.0001]; Daly M, 1999, ANIM BEHAV, V57, P509, DOI 10.1006/anbe.1998.1027; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; Hirschberg J, 2010, SPEECH TECHNOLOGY: THEORY AND APPLICATIONS, P79, DOI 10.1007/978-0-387-73819-2_5; Joron M, 2003, ENCY INSECTS; Lachmann M, 2001, P NATL ACAD SCI USA, V98, P13189, DOI 10.1073/pnas.231216498; Laidre ME, 2008, ANIM BEHAV, V75, P2041, DOI 10.1016/j.anbehav.2007.11.011; Mallet J, 1999, ANNU REV ECOL SYST, V30, P201, DOI 10.1146/annurev.ecolsys.30.1.201; Mawby R, 1986, DECEPTION PERSPECTIV; MAYNARD-SMITH J., 2003, ANIMAL SIGNALS; Morris PH, 2010, J NONVERBAL BEHAV, V34, P1, DOI 10.1007/s10919-009-0075-0; Peters RA, 2007, J EXP BIOL, V210, P395, DOI 10.1242/jeb.02676; Reddy V, 2007, PHILOS T R SOC B, V362, P621, DOI 10.1098/rstb.2006.1999; Santos E, 2010, IEEE T SYST MAN CY A, V40, P224, DOI 10.1109/TSMCA.2009.2034862; Searcy W.N.S, 2005, EVOLUTION ANIMAL COM; Szamado S, 1999, J THEOR BIOL, V198, P593, DOI 10.1006/jtbi.1999.0935; Szamado S, 2008, ANIM BEHAV, V76, P1455, DOI 10.1016/j.anbehav.2008.07.010; Szamado S, 2011, ANIM BEHAV, V81, P3, DOI 10.1016/j.anbehav.2010.08.022; Tibbetts EA, 2010, CURR BIOL, V20, P1637, DOI 10.1016/j.cub.2010.07.042; Wiley RH, 2006, ADV STUD BEHAV, V36, P217, DOI 10.1016/S0065-3454(06)36005-6; Wiley R. Haven, 1994, P157; ZAHAVI A, 1977, J THEOR BIOL, V67, P603, DOI 10.1016/0022-5193(77)90061-3; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	29	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e26017	10.1371/journal.pone.0026017	http://dx.doi.org/10.1371/journal.pone.0026017			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998745	Green Submitted, Green Published, gold			2022-12-27	WOS:000295966900091
J	Ku, SW; Lee, U; Noh, GJ; Jun, IG; Mashour, GA				Ku, Seung-Woo; Lee, UnCheol; Noh, Gyu-Jeong; Jun, In-Gu; Mashour, George A.			Preferential Inhibition of Frontal-to-Parietal Feedback Connectivity Is a Neurophysiologic Correlate of General Anesthesia in Surgical Patients	PLOS ONE			English	Article							PROPOFOL-INDUCED LOSS; CONSCIOUSNESS; AWARENESS; DIRECTIONALITY; FEEDFORWARD; BREAKDOWN; FLASH; MODEL	Background: The precise mechanism and optimal measure of anesthetic-induced unconsciousness has yet to be elucidated. Preferential inhibition of feedback connectivity from frontal to parietal brain networks is one potential neurophysiologic correlate, but has only been demonstrated in animals or under limited conditions in healthy volunteers. Methods and Findings: We recruited eighteen patients presenting for surgery under general anesthesia; electroencephalography of the frontal and parietal regions was acquired during (i) baseline consciousness, (ii) anesthetic induction with propofol or sevoflurane, (iii) general anesthesia, (iv) recovery of consciousness, and (v) post-recovery states. We used two measures of effective connectivity, evolutional map approach and symbolic transfer entropy, to analyze causal interactions of the frontal and parietal regions. The dominant feedback connectivity of the baseline conscious state was inhibited after anesthetic induction and during general anesthesia, resulting in reduced asymmetry of feedback and feedforward connections in the frontoparietal network. Dominant feedback connectivity returned when patients recovered from anesthesia. Both analytic techniques and both classes of anesthetics demonstrated similar results in this heterogeneous population of surgical patients. Conclusions: The disruption of dominant feedback connectivity in the frontoparietal network is a common neurophysiologic correlate of general anesthesia across two anesthetic classes and two analytic measures. This study represents a key translational step from the underlying cognitive neuroscience of consciousness to more sophisticated monitoring of anesthetic effects in human surgical patients.	[Ku, Seung-Woo; Noh, Gyu-Jeong; Jun, In-Gu] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Anesthesiol & Pain Med, Seoul, South Korea; [Ku, Seung-Woo; Lee, UnCheol; Mashour, George A.] Univ Michigan, Sch Med, Dept Anesthesiol, Ann Arbor, MI USA	University of Ulsan; Asan Medical Center; University of Michigan System; University of Michigan	Ku, SW (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Anesthesiol & Pain Med, Seoul, South Korea.	gmashour@umich.edu						[Anonymous], 1956, MODERN MATH ENG; Boehler CN, 2008, P NATL ACAD SCI USA, V105, P8742, DOI 10.1073/pnas.0801999105; Boly M, 2011, SCIENCE, V332, P858, DOI 10.1126/science.1202043; Boveroux P, 2010, ANESTHESIOLOGY, V113, P1038, DOI 10.1097/ALN.0b013e3181f697f5; Chicharro D, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026217; Cimenser A, 2011, P NATL ACAD SCI USA, V108, P8832, DOI 10.1073/pnas.1017041108; CRICK F, 1995, NATURE, V375, P121, DOI 10.1038/375121a0; Del Cul A, 2007, PLOS BIOL, V5, P2408, DOI 10.1371/journal.pbio.0050260; Fahrenfort JJ, 2007, J COGNITIVE NEUROSCI, V19, P1488, DOI 10.1162/jocn.2007.19.9.1488; Ferrarelli F, 2010, P NATL ACAD SCI USA, V107, P2681, DOI 10.1073/pnas.0913008107; Florin E, 2010, NEUROIMAGE, V50, P577, DOI 10.1016/j.neuroimage.2009.12.050; Goncharova II, 2003, CLIN NEUROPHYSIOL, V114, P1580, DOI 10.1016/S1388-2457(03)00093-2; Hudetz A., 2006, SEMIN ANESTH PERIO M, V25, P196, DOI [DOI 10.1053/j.sane.2006.09.003, 10.1053/j.sane.2006.09.003]; Hudetz AG, 2009, CONSCIOUS COGN, V18, P1079, DOI 10.1016/j.concog.2009.08.004; Hudetz AG, 2009, ANESTHESIOLOGY, V111, P231, DOI 10.1097/ALN.0b013e3181ab671e; Imas OA, 2005, NEUROSCI LETT, V387, P145, DOI 10.1016/j.neulet.2005.06.018; Imas OA, 2006, NEUROSCI LETT, V402, P216, DOI 10.1016/j.neulet.2006.04.003; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Lee U, 2011, ANESTHESIOLOGY, V114, P872, DOI 10.1097/ALN.0b013e31821102c9; Lee U, 2009, CONSCIOUS COGN, V18, P1069, DOI 10.1016/j.concog.2009.04.004; Martuzzi R, 2010, NEUROIMAGE, V49, P823, DOI 10.1016/j.neuroimage.2009.07.028; Mhuircheartaigh RN, 2010, J NEUROSCI, V30, P9095, DOI 10.1523/JNEUROSCI.5516-09.2010; Mrowka R, 2003, AM J PHYSIOL-REG I, V285, pR1395, DOI 10.1152/ajpregu.00373.2003; Naghavi HR, 2005, CONSCIOUS COGN, V14, P390, DOI 10.1016/j.concog.2004.10.003; Nalatore H, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.031123; Orser BA, 2008, CAN MED ASSOC J, V178, P185, DOI 10.1503/cmaj.071761; Palanca BA, 2009, CURR OPIN ANESTHESIO, V22, P553, DOI 10.1097/ACO.0b013e3283304032; Pascual-Leone A, 2001, SCIENCE, V292, P510, DOI 10.1126/science.1057099; Plourde G, 2006, ANESTHESIOLOGY, V104, P448, DOI 10.1097/00000542-200603000-00011; Quan MN, 2011, BRAIN RES BULL, V85, P109, DOI 10.1016/j.brainresbull.2011.03.002; Ro T, 2003, CURR BIOL, V13, P1038, DOI 10.1016/S0960-9822(03)00337-3; Rosenblum MG, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041909; Rosenblum MG, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.045202; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Schrouff J, 2011, NEUROIMAGE, V57, P198, DOI 10.1016/j.neuroimage.2011.04.020; Shao ZW, 1996, J NEUROSCI, V16, P7353; Stamatakis EA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014224; Staniek M, 2009, BIOMED TECH, V54, P323, DOI 10.1515/BMT.2009.040; Staniek M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.158101; Tononi G, 2008, ANN NY ACAD SCI, V1124, P239, DOI 10.1196/annals.1440.004; Vicente R, 2011, J COMPUT NEUROSCI, V30, P45, DOI 10.1007/s10827-010-0262-3; Zheng CG, 2011, NEUROSCI LETT, V490, P52, DOI 10.1016/j.neulet.2010.12.024	43	154	158	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25155	10.1371/journal.pone.0025155	http://dx.doi.org/10.1371/journal.pone.0025155			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998638	gold, Green Published, Green Submitted			2022-12-27	WOS:000295966900011
J	Salomon, R; Szpiro-Grinberg, S; Lamy, D				Salomon, Roy; Szpiro-Grinberg, Sarit; Lamy, Dominique			Self-Motion Holds a Special Status in Visual Processing	PLOS ONE			English	Article							AGENCY; AWARENESS; PERCEPTION; MOVEMENTS; SEARCH; HAND	Agency plays an important role in self-recognition from motion. Here, we investigated whether our own movements benefit from preferential processing even when the task is unrelated to self-recognition, and does not involve agency judgments. Participants searched for a moving target defined by its known shape among moving distractors, while continuously moving the computer mouse with one hand. They thereby controlled the motion of one item, which was randomly either the target or any of the distractors, while the other items followed pre-recorded motion pathways. Performance was more accurate and less prone to degradation as set size increased when the target was the self-controlled item. An additional experiment confirmed that participant-controlled motion was not physically more salient than motion recorded offline. We found no evidence that self-controlled items captured attention. Taken together, these results suggest that visual events are perceived more accurately when they are the consequences of our actions, even when self-motion is task irrelevant.	[Salomon, Roy; Lamy, Dominique] Tel Aviv Univ, Dept Psychol, IL-69978 Tel Aviv, Israel; [Szpiro-Grinberg, Sarit] NYU, Dept Psychol, New York, NY 10003 USA	Tel Aviv University; New York University	Salomon, R (corresponding author), Tel Aviv Univ, Dept Psychol, IL-69978 Tel Aviv, Israel.	royesal@gmail.com	Salomon, Roy/N-8249-2015; Lamy, Dominique/L-5032-2013	Salomon, Roy/0000-0002-6688-617X; Szpiro, Sarit/0000-0001-7814-0757				Ahissar M, 1999, CURR DIR PSYCHOL SCI, V8, P124, DOI 10.1111/1467-8721.00029; Blakemore SJ, 1998, NEUROPSYCHOLOGIA, V36, P521, DOI 10.1016/S0028-3932(97)00145-0; Blakemore SJ, 2003, CURR OPIN NEUROBIOL, V13, P219, DOI 10.1016/S0959-4388(03)00043-6; Blakemore SJ, 2000, NEUROREPORT, V11, pR11, DOI 10.1097/00001756-200008030-00002; Blakemore SJ, 1999, J COGNITIVE NEUROSCI, V11, P551, DOI 10.1162/089892999563607; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Crowell JA, 1998, NAT NEUROSCI, V1, P732, DOI 10.1038/3732; de Vignemont F, 2004, CONSCIOUS COGN, V13, P1, DOI 10.1016/S1053-8100(03)00022-9; Ehrsson HH, 2005, J NEUROSCI, V25, P10564, DOI 10.1523/JNEUROSCI.0800-05.2005; Farrer C, 2003, NEUROIMAGE, V18, P324, DOI 10.1016/S1053-8119(02)00041-1; Fourneret P, 1998, NEUROPSYCHOLOGIA, V36, P1133, DOI 10.1016/S0028-3932(98)00006-2; KAPTEIN NA, 1995, J EXP PSYCHOL HUMAN, V21, P1053, DOI 10.1037/0096-1523.21.5.1053; Leube DT, 2003, NEUROIMAGE, V20, P2084, DOI 10.1016/j.neuroimage.2003.07.033; Makin TR, 2007, J NEUROSCI, V27, P731, DOI 10.1523/JNEUROSCI.3653-06.2007; NIELSEN TI, 1963, SCAND J PSYCHOL, V4, P225, DOI 10.1111/j.1467-9450.1963.tb01326.x; NORMAN DA, 1975, COGNITIVE PSYCHOL, V7, P44, DOI 10.1016/0010-0285(75)90004-3; Preston C, 2010, NEUROPSYCHOLOGIA, V48, P3443, DOI 10.1016/j.neuropsychologia.2010.07.027; Salomon R, 2009, INVOLVEMENT INTRINSI; Slachevsky A, 2001, J COGNITIVE NEUROSCI, V13, P332, DOI 10.1162/08989290151137386; Spence SA, 2002, COGN NEUROPSYCHIATRY, P211, DOI 10.1080/13546800244000094; Synofzik M, 2008, CONSCIOUS COGN, V17, P219, DOI 10.1016/j.concog.2007.03.010; Tsakiris M, 2005, COGNITION, V96, P215, DOI 10.1016/j.cognition.2004.08.002; Tsakiris M, 2005, COGN NEUROPSYCHOL, V22, P387, DOI 10.1080/02643290442000158; Wegner DM, 2004, J PERS SOC PSYCHOL, V86, P838, DOI 10.1037/0022-3514.86.6.838; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5; YANTIS S, 1984, J EXP PSYCHOL HUMAN, V10, P601, DOI 10.1037/0096-1523.10.5.601	26	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e24347	10.1371/journal.pone.0024347	http://dx.doi.org/10.1371/journal.pone.0024347			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834NA	21998629	Green Submitted, Green Published, gold			2022-12-27	WOS:000295966900002
J	Chang, CW; Su, YC; Her, GM; Ken, CF; Hong, JR				Chang, Chih-Wei; Su, Yu-Chin; Her, Guor-Mour; Ken, Chuian-Fu; Hong, Jiann-Ruey			Betanodavirus Induces Oxidative Stress-Mediated Cell Death That Prevented by Anti-Oxidants and Zfcatalase in Fish Cells	PLOS ONE			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; MITOCHONDRIAL FISSION; HYDROGEN-PEROXIDE; MAMMALIAN-CELLS; MARINE FISH; VIRUS; NECROSIS; FUSION; REPLICATION; ZFBCL-X(L)	The role of oxidative stress in the pathogenesis of RNA nervous necrosis virus infection is still unknown. Red-spotted grouper nervous necrosis virus (RGNNV) induced free radical species (ROS) production at 12-24 h post-infection (pi; early replication stage) in fish GF-1 cells, and then at middle replication stage (24-48 h pi), this ROS signal may upregulate some expressions of the anti-oxidant enzymes Cu/Zn SOD and catalase, and eventually expression of the transcription factor Nrf2. Furthermore, both antioxidants diphenyliodonium and N-acetylcysteine or overexpression of zebrafish catalase in GF-1 cells also reduced ROS production and protected cells for enhancing host survival rate due to RGNNV infection. Furthermore, localization of ROS production using esterase activity and Mitotracker staining assays found that the ROS generated can affect mitochondrial morphology changes and causes Delta Psi loss, both of which can be reversed by antioxidant treatment. Taken together, our data suggest that RGNNV induced oxidative stress response for playing dual role that can initiate the host oxidative stress defense system to upregulate expression of antioxidant enzymes and induces cell death via disrupting the mitochondrial morphology and inducing DY loss, which can be reversed by anti-oxidants and zfcatalase, which provide new insight into betanodavirus-induced ROS-mediated pathogenesis.	[Chang, Chih-Wei; Su, Yu-Chin; Hong, Jiann-Ruey] Natl Cheng Kung Univ, Inst Biotechnol, Lab Mol Virol & Biotechnol, Tainan 70101, Taiwan; [Her, Guor-Mour] Natl Taiwan Ocean Univ, Inst Biosci & Biotechnol, Keelung, Taiwan; [Ken, Chuian-Fu] Natl Changhua Univ Educ, Dept Biotechnol, Changhua, Taiwan	National Cheng Kung University; National Taiwan Ocean University; National Changhua University of Education	Chang, CW (corresponding author), Natl Cheng Kung Univ, Inst Biotechnol, Lab Mol Virol & Biotechnol, Tainan 70101, Taiwan.	jrhong@mail.ncku.edu.tw			National Science Council, Taiwan, Republic of China [NSC 98-2313-B-006-004-MY3]	National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by a grant (NSC 98-2313-B-006-004-MY3) awarded to Dr. Jiann-Ruey Hong from the National Science Council, Taiwan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball LA, 1999, ADV VIRUS RES, V53, P229, DOI 10.1016/S0065-3527(08)60350-4; Bossy-Wetzel E, 2003, CURR OPIN CELL BIOL, V15, P706, DOI 10.1016/j.ceb.2003.10.015; Bovo G, 1999, VIRUS RES, V63, P143, DOI 10.1016/S0168-1702(99)00068-4; Camello-Almaraz C, 2006, AM J PHYSIOL-CELL PH, V291, pC1082, DOI 10.1152/ajpcell.00217.2006; Cerveny KL, 2007, TRENDS CELL BIOL, V17, P563, DOI 10.1016/j.tcb.2007.08.006; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen LJ, 2009, VIROLOGY, V385, P444, DOI 10.1016/j.virol.2008.11.048; Chen SP, 2006, J FISH DIS, V29, P347, DOI 10.1111/j.1365-2761.2006.00725.x; Chen SP, 2007, APOPTOSIS, V12, P1043, DOI 10.1007/s10495-006-0032-x; Chen SP, 2006, VIROLOGY, V347, P379, DOI 10.1016/j.virol.2005.11.052; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; De Giorgi F, 2000, CELL CALCIUM, V28, P365, DOI 10.1054/ceca.2000.0177; de Mochel NSR, 2010, HEPATOLOGY, V52, P47, DOI 10.1002/hep.23671; Delsert C, 1997, ARCH VIROL, V142, P2359, DOI 10.1007/s007050050248; Desagher S, 1996, J NEUROSCI, V16, P2553; DOBOS P, 1979, J VIROL, V32, P593, DOI 10.1128/JVI.32.2.593-605.1979; Dringen R, 1997, BRAIN RES, V759, P67, DOI 10.1016/S0006-8993(97)00233-3; Gao N, 2005, ONCOGENE, V24, P3797, DOI 10.1038/sj.onc.1208530; Gou DM, 2003, FEBS LETT, V548, P113, DOI 10.1016/S0014-5793(03)00630-6; Hong JR, 1998, VIROLOGY, V250, P76, DOI 10.1006/viro.1998.9347; Iwamoto T, 2005, J GEN VIROL, V86, P2807, DOI 10.1099/vir.0.80902-0; Jellinger KA, 2003, J NEURAL TRANSM-SUPP, P101; Johnson KN, 2000, J VIROL, V74, P5123, DOI 10.1128/JVI.74.11.5123-5132.2000; KAIN SR, 1994, BIOTECHNIQUES, V17, P982; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Kelly G S, 1998, Altern Med Rev, V3, P114; Ken CF, 2000, J AGR FOOD CHEM, V48, P2092, DOI 10.1021/jf990838+; Krapfenbauer K, 2003, BRAIN RES, V967, P152, DOI 10.1016/S0006-8993(02)04243-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; Lu R, 2005, NATURE, V436, P1040, DOI 10.1038/nature03870; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; McClung CR, 1997, FREE RADICAL BIO MED, V23, P489, DOI 10.1016/S0891-5849(97)00109-3; MORI KI, 1992, VIROLOGY, V187, P368, DOI 10.1016/0042-6822(92)90329-N; MULLEN OL, 1975, J NATL CANCER I, V54, P229, DOI 10.1093/jnci/54.1.229; MULLER F, 1992, FREE RADICAL BIO MED, V13, P651, DOI 10.1016/0891-5849(92)90039-J; Munday BL, 2002, J FISH DIS, V25, P127, DOI 10.1046/j.1365-2761.2002.00350.x; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Peterhans E, 1987, Free Radic Res Commun, V3, P39, DOI 10.3109/10715768709069768; Qi XP, 1997, INVEST OPHTH VIS SCI, V38, P1203; SCHIAVONE JR, 1988, ANAL BIOCHEM, V168, P455, DOI 10.1016/0003-2697(88)90343-0; Schneemann A, 1998, ADV VIRUS RES, V50, P381, DOI 10.1016/S0065-3527(08)60812-X; Schroder K, 2010, CURR OPIN PHARMACOL, V10, P122, DOI 10.1016/j.coph.2010.01.002; SHULL S, 1991, J BIOL CHEM, V266, P24398; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Su YC, 2010, J BIOL CHEM, V285, P39801, DOI 10.1074/jbc.M110.164988; Su YC, 2009, VIROLOGY, V385, P143, DOI 10.1016/j.virol.2008.11.036; SUGIOKA K, 1988, BIOCHIM BIOPHYS ACTA, V936, P377, DOI 10.1016/0005-2728(88)90014-X; Tanaka S, 2003, J FISH DIS, V26, P109, DOI 10.1046/j.1365-2761.2003.00440.x; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; Vassort G, 2010, CARDIOVASC TOXICOL, V10, P73, DOI 10.1007/s12012-010-9064-0; VIERUCCI A, 1983, PEDIATR RES, V17, P814, DOI 10.1203/00006450-198310000-00010; Wang M, 2003, J MED VIROL, V70, P470, DOI 10.1002/jmv.10419; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Wu HC, 2008, FISH SHELLFISH IMMUN, V24, P436, DOI 10.1016/j.fsi.2008.01.001; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003	61	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25853	10.1371/journal.pone.0025853	http://dx.doi.org/10.1371/journal.pone.0025853			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991373	Green Submitted, Green Published, gold			2022-12-27	WOS:000295943000086
J	Ishida, JK; Yoshida, S; Ito, M; Namba, S; Shirasu, K				Ishida, Juliane K.; Yoshida, Satoko; Ito, Masaki; Namba, Shigetou; Shirasu, Ken			Agrobacterium rhizogenes-Mediated Transformation of the Parasitic Plant Phtheirospermum japonicum	PLOS ONE			English	Article							TRIPHYSARIA-VERSICOLOR; GENETIC-TRANSFORMATION; PHENOLIC-COMPOUNDS; EFFICIENCY; TUMEFACIENS	Background: Plants within the Orobanchaceae are an agriculturally important group of parasites that attack economically important crops to obtain water and nutrients from their hosts. Despite their agricultural importance, molecular mechanisms of the parasitism are poorly understood. Methodology/Principal Findings: We developed transient and stable transformation systems for Phtheirospermum japonicum, a facultative parasitic plant in the Orobanchaceae. The transformation protocol was established by a combination of sonication and acetosyringone treatments using the hairy-root-inducing bacterium, Agrobacterium rhizogenes and young seedlings. Transgenic hairy roots of P. japonicum were obtained from cotyledons 2 to 3 weeks after A. rhizogenes inoculation. The presence and the expression of transgenes in P. japonicum were verified by genomic PCR, Southern blot and RT-PCR methods. Transgenic roots derived from A. rhizogenes-mediated transformation were able to develop haustoria on rice and maize roots. Transgenic roots also formed apparently competent haustoria in response to 2,6-dimethoxy-1,4-benzoquinone (DMBQ), a haustorium-inducing chemical. Using this system, we introduced a reporter gene with a Cyclin B1 promoter into P. japonicum, and visualized cell division during haustorium formation. Conclusions: We provide an easy and efficient method for hairy-root transformation of P. japonicum. Transgenic marker analysis revealed that cell divisions during haustorium development occur 24 h after DMBQ treatment. The protocols described here will allow functional analysis of genes involved in plant parasitism.	[Ishida, Juliane K.; Namba, Shigetou] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan; [Ishida, Juliane K.; Yoshida, Satoko; Shirasu, Ken] RIKEN, Plant Sci Ctr, Yokohama, Kanagawa, Japan; [Ito, Masaki] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan	University of Tokyo; RIKEN; Nagoya University	Ishida, JK (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan.	ken.shirasu@psc.riken.jp	Ito, Masaki/G-4252-2013; ishida, juliane/O-9414-2015; Yoshida, Satoko/G-5003-2010; Shirasu, Ken/A-4455-2010; Shirasu, Ken/ABF-5306-2020; yoshida, satoko/AAO-4892-2020; Yoshida, Satoko/AAZ-4757-2021	Ito, Masaki/0000-0002-9635-9709; ishida, juliane/0000-0002-0956-7578; Yoshida, Satoko/0000-0002-9999-7861; Shirasu, Ken/0000-0002-0349-3870; Shirasu, Ken/0000-0002-0349-3870; yoshida, satoko/0000-0002-9999-7861; 	Ministry of Education, Culture, Sports, Science, and Technology (MEXT-Japan) [21780044, 19678001]; RIKEN President Fund; MEXT	Ministry of Education, Culture, Sports, Science, and Technology (MEXT-Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN President Fund; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT-Japan, no. 21780044 to SY and no. 19678001 to KS) and the RIKEN President Fund. JKI is supported by the MEXT scholarship program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht H, 1999, PLANT PHYSIOL, V119, P585, DOI 10.1104/pp.119.2.585; BAIRD WV, 1984, AM J BOT, V71, P803, DOI 10.2307/2443471; Bandaranayake PCG, 2010, PLANT CELL, V22, P1404, DOI 10.1105/tpc.110.074831; Bennett JR, 2006, AM J BOT, V93, P1039, DOI 10.3732/ajb.93.7.1039; Beranova M, 2008, PLANT CELL TISS ORG, V94, P253, DOI 10.1007/s11240-007-9335-z; Cheng M, 2003, IN VITRO CELL DEV-PL, V39, P595, DOI 10.1079/IVP2003471; DIAZ CL, 1989, NATURE, V338, P579, DOI 10.1038/338579a0; Estrada-Navarrete G, 2007, NAT PROTOC, V2, P1819, DOI 10.1038/nprot.2007.259; Ito M, 2000, PLANT MOL BIOL, V43, P677, DOI 10.1023/A:1006336005587; Krens FA, 1996, PLANT SCI, V116, P97, DOI 10.1016/0168-9452(96)04357-9; Kubo M, 2005, GENE DEV, V19, P1855, DOI 10.1101/gad.1331305; LYNN DG, 1990, ANNU REV PLANT PHYS, V41, P497, DOI 10.1146/annurev.pp.41.060190.002433; MATERN U, 1988, PHYTOPARASITICA, V16, P153, DOI 10.1007/BF02980469; Matvienko M, 2001, PLANT PHYSIOL, V127, P272, DOI 10.1104/pp.127.1.272; NICHOLSON RL, 1992, ANNU REV PHYTOPATHOL, V30, P369, DOI 10.1146/annurev.py.30.090192.002101; OFFRINGA IA, 1986, P NATL ACAD SCI USA, V83, P6935, DOI 10.1073/pnas.83.18.6935; Parker A., 1993, PARASITIC WEEDS WORL; Parker C, 2009, PEST MANAG SCI, V65, P453, DOI 10.1002/ps.1713; Pennisi E, 2010, SCIENCE, V327, P804, DOI 10.1126/science.327.5967.804; Santarem ER, 1998, PLANT CELL REP, V17, P752, DOI 10.1007/s002990050478; Scholes JD, 2008, CURR OPIN PLANT BIOL, V11, P180, DOI 10.1016/j.pbi.2008.02.004; Stiller J, 1997, J EXP BOT, V48, P1357, DOI 10.1093/jxb/48.7.1357; STOUGAARD J, 1987, MOL GEN GENET, V207, P251, DOI 10.1007/BF00331586; Tiwari RK, 2007, PLANT CELL REP, V26, P199, DOI 10.1007/s00299-006-0236-0; Tomilov AA, 2005, PLANT PHYSIOL, V138, P1469, DOI 10.1104/pp.104.057836; Tomilov A, 2007, PLANTA, V225, P1059, DOI 10.1007/s00425-006-0415-9; Torres MJ, 2005, BMC PLANT BIOL, V5, DOI 10.1186/1471-2229-5-24; Trick HN, 1997, TRANSGENIC RES, V6, P329, DOI 10.1023/A:1018470930944; VERVLIET G, 1975, J GEN VIROL, V26, P33, DOI 10.1099/0022-1317-26-1-33; Yoder JI, 2001, CURR OPIN PLANT BIOL, V4, P359, DOI 10.1016/S1369-5266(00)00185-0; Yoshida S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-55; Yoshida S, 2009, NEW PHYTOL, V183, P180, DOI 10.1111/j.1469-8137.2009.02840.x	32	52	56	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25802	10.1371/journal.pone.0025802	http://dx.doi.org/10.1371/journal.pone.0025802			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991355	Green Submitted, Green Published, gold			2022-12-27	WOS:000295943000073
J	Raman, J; Mauff, K; Muianga, P; Mussa, A; Maharaj, R; Barnes, KI				Raman, Jaishree; Mauff, Katya; Muianga, Pedro; Mussa, Abdul; Maharaj, Rajendra; Barnes, Karen I.			Five Years of Antimalarial Resistance Marker Surveillance in Gaza Province, Mozambique, Following Artemisinin-Based Combination Therapy Roll Out	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM INFECTIONS; DRUG-RESISTANCE; SULFADOXINE-PYRIMETHAMINE; SOUTHERN MOZAMBIQUE; PFMDR1 GENE; DIHYDROFOLATE-REDUCTASE; ARTEMETHER-LUMEFANTRINE; MALARIA; AFRICA; IDENTIFICATION	Antimalarial drug resistance is a major obstacle to malaria control and eventual elimination. The routine surveillance for molecular marker of resistance is an efficient way to assess drug efficacy, which remains feasible in areas where malaria control interventions have succeeded in substantially reducing malaria transmission. Community based asexual parasite prevalence surveys were conducted annually in sentinel sites in Gaza Province, Mozambique from 2006 until 2010, before, during and after antimalarial policy changes to artesunate plus sulfadoxine-pyrimethamine in 2006 and to artemether-lumefantrine in 2008. Genetic analysis of dhfr, dhps, crt, and mdr1 resistant genes was conducted on 3 331 (14.4%) Plasmodium falciparum PCR positive samples collected over the study period from 23 229 children aged 2 to 15 years. The quintuple dhfr/dhps mutation associated with sulfadoxine-pyrimethamine resistance increased from 56.2% at baseline to 75.8% by 2010. At baseline the crt76T and mdr186Y mutants were approaching fixation, 96.1% and 74.7%, respectively. Following the deployment of artemisinin-based combination therapy, prevalence of both these chloroquine-resistance markers began declining, reaching 32.4% and 30.9%, respectively, by 2010. All samples analysed over the 5-year period possessed a single copy of the mdr1 gene. The high and increasing prevalence of the quintuple mutation supports the change in drug policy from artesunate plus sulfadoxine-pyrimethamine to artemether-lumefantrine in Mozambique. As chloroquine related drug pressure decreased in the region, so did the molecular markers associated with chloroquine resistance (crt76T and mdr186Y). However, this reversion to the wild-type mdr186N predisposes parasites towards developing lumefantrine resistance. Close monitoring of artemether-lumefantrine efficacy is therefore essential, particularly given the high drug pressure within the region where most countries now use artemether-lumefantrine as first line treatment.	[Raman, Jaishree; Maharaj, Rajendra] MRC, Malaria Res Programme, Durban, South Africa; [Mauff, Katya; Barnes, Karen I.] Univ Cape Town, Dept Med, Div Clin Pharmacol, ZA-7925 Cape Town, South Africa; [Mauff, Katya] Univ Cape Town, Dept Stat Sci, ZA-7925 Cape Town, South Africa; [Muianga, Pedro] Gaza Prov Directorate Hlth, Xai Xai, Mozambique; [Mussa, Abdul] Natl Malaria Control Programme, Maputo City, Mozambique	University of Cape Town; University of Cape Town	Raman, J (corresponding author), MRC, Malaria Res Programme, Durban, South Africa.	jaishree.raman@mrc.ac.za	Raman, Jaishree/AAB-8960-2020	Raman, Jaishree/0000-0003-0728-3093	Global Fund to Fight AIDS, Tuberculosis and Malaria [MAF-202-GO2-M-00]	Global Fund to Fight AIDS, Tuberculosis and Malaria	This study was funded by a grant from The Global Fund to Fight AIDS, Tuberculosis and Malaria (MAF-202-GO2-M-00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EN, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-141; [Anonymous], 2003, ASS MON ANT DRUG EFF; BARNES AJ, 1991, LANCET, V338, P1338, DOI 10.1016/0140-6736(91)92644-H; Barnes KI, 2008, J INFECT DIS, V197, P1605, DOI 10.1086/587645; Djimde A, 2001, NEW ENGL J MED, V344, P257, DOI 10.1056/NEJM200101253440403; Djimde AA, 2008, AM J TROP MED HYG, V78, P455, DOI 10.4269/ajtmh.2008.78.455; Dlamini SV, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-68; Duraisingh MT, 2000, MOL BIOCHEM PARASIT, V108, P13, DOI 10.1016/S0166-6851(00)00201-2; Enosse S, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-115; Harrington WE, 2011, CLIN INFECT DIS, V53, P224, DOI 10.1093/cid/cir376; Hastings IM, 2005, J INFECT DIS, V192, P1303, DOI 10.1086/432554; Kublin JG, 2003, J INFECT DIS, V187, P1870, DOI 10.1086/375419; Lopes Dinora, 2002, Malar J, V1, P12, DOI 10.1186/1475-2875-1-12; Mangold KA, 2005, J CLIN MICROBIOL, V43, P2435, DOI 10.1128/JCM.43.5.2435-2440.2005; Menard D, 2006, AM J TROP MED HYG, V75, P381, DOI 10.4269/ajtmh.2006.75.381; Mobula L, 2009, AM J TROP MED HYG, V80, P555, DOI 10.4269/ajtmh.2009.80.555; Mungthin M, 2010, AM J TROP MED HYG, V83, P1005, DOI 10.4269/ajtmh.2010.10-0339; Plowe CV, 1997, J INFECT DIS, V176, P1590, DOI 10.1086/514159; Price RN, 2004, LANCET, V364, P438, DOI 10.1016/S0140-6736(04)16767-6; Raman J, 2008, AM J TROP MED HYG, V78, P256, DOI 10.4269/ajtmh.2008.78.256; Raman J, 2010, AM J TROP MED HYG, V82, P788, DOI 10.4269/ajtmh.2010.09-0401; Roper C, 2003, LANCET, V361, P1174, DOI 10.1016/S0140-6736(03)12951-0; Roper C, 2004, SCIENCE, V305, P1124, DOI 10.1126/science.1098876; Sharp BL, 2007, AM J TROP MED HYG, V76, P42, DOI 10.4269/ajtmh.2007.76.42; Sisowath C, 2007, TROP MED INT HEALTH, V12, P736, DOI 10.1111/j.1365-3156.2007.01843.x; Spalding MD, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-338; Sutherland CJ, 2007, J ANTIMICROB CHEMOTH, V59, P1197, DOI 10.1093/jac/dkm104; White N, 1999, PHILOS T R SOC B, V354, P739, DOI 10.1098/rstb.1999.0426; White NJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-9; White NJ, 2004, J CLIN INVEST, V113, P1084, DOI [10.1172/JCI21682, 10.1172/JCI200421682]; *WHO, 2010, MAL WORLD REP 2010; WHO, 2020, REP ANT DRUG EFF RES; WOODEN J, 1993, PARASITOL TODAY, V9, P303, DOI 10.1016/0169-4758(93)90131-X	33	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e25992	10.1371/journal.pone.0025992	http://dx.doi.org/10.1371/journal.pone.0025992			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022487	Green Submitted, gold, Green Published			2022-12-27	WOS:000295981600025
J	Barden, HE; Wogelius, RA; Li, DQ; Manning, PL; Edwards, NP; van Dongen, BE				Barden, Holly E.; Wogelius, Roy A.; Li, Daqing; Manning, Phillip L.; Edwards, Nicholas P.; van Dongen, Bart E.			Morphological and Geochemical Evidence of Eumelanin Preservation in the Feathers of the Early Cretaceous Bird, Gansus yumenensis	PLOS ONE			English	Article							BACTERIAL-DEGRADATION; PLUMAGE COLORATION; ORGANIC-MATTER; COPPER SULFIDE; MELANIN; BLACK; EVOLUTION	Recent studies have shown evidence for the preservation of colour in fossilized soft tissues by imaging melanosomes, melanin pigment containing organelles. This study combines geochemical analyses with morphological observations to investigate the preservation of melanosomes and melanin within feathers of the Early Cretaceous bird, Gansus yumenensis. Scanning electron microscopy reveals structures concordant with those previously identified as eumelanosomes within visually dark areas of the feathers but not in lighter areas or sedimentary matrices. Fourier transform infrared analyses show different spectra for the feathers and their matrices; melanic functional groups appear in the feather including carboxylic acid and ketone groups that are not seen in the matrix. When mapped, the carboxylic acid group absorption faithfully replicates the visually dark areas of the feathers. Electron Paramagnetic Resonance spectroscopy of one specimen demonstrates the presence of organic signals but proved too insensitive to resolve melanin. Pyrolysis gas chromatography mass spectrometry shows a similar distribution of aliphatic material within both feathers that are different from those of their respective matrices. In combination, these techniques strongly suggest that not only do the feathers contain endogenous organic material, but that both geochemical and morphological evidence supports the preservation of original eumelanic pigment residue.	[Barden, Holly E.; Wogelius, Roy A.; Manning, Phillip L.; Edwards, Nicholas P.; van Dongen, Bart E.] Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester, Lancs, England; [Barden, Holly E.; Wogelius, Roy A.; Manning, Phillip L.; Edwards, Nicholas P.; van Dongen, Bart E.] Univ Manchester, Williamson Res Ctr Mol Environm Sci, Manchester, Lancs, England; [Li, Daqing] Gansu Geol Museum, Lanzhou, Peoples R China; [Manning, Phillip L.] Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA	University of Manchester; University of Manchester; University of Pennsylvania	Barden, HE (corresponding author), Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester, Lancs, England.	holly.barden@postgrad.manchester.ac.uk	Manning, Phillip/F-9966-2011; Wogelius, Roy/C-4917-2008	Manning, Phillip/0000-0002-7161-6246; van Dongen, Bart/0000-0003-1189-142X; Wogelius, Roy/0000-0002-5781-2152; Edwards, Nicholas/0000-0002-3760-4225	Natural Environment Research Council; National Natural Science Foundation of China [40672007, 41072019]	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	HEB is supported by a PhD studentship from the Natural Environment Research Council, additional funding for collection was provided by the National Natural Science Foundation of China (40672007 and 41072019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcamo IE, 1994, FUNDAMENTALS MICROBI; [Anonymous], 2006, BROCK BIOL MICROORGA; BLOIS MS, 1964, BIOPHYS J, V4, P471, DOI 10.1016/S0006-3495(64)86797-7; Bokony V, 2003, P ROY SOC B-BIOL SCI, V270, P2491, DOI 10.1098/rspb.2003.2506; Butler MJ, 2005, MYCOLOGIA, V97, P312, DOI 10.3852/mycologia.97.2.312; CAESARTONTHAT TC, 1995, APPL ENVIRON MICROB, V61, P1968, DOI 10.1128/AEM.61.5.1968-1975.1995; Centeno SA, 2008, J MOL STRUCT, V873, P149, DOI 10.1016/j.molstruc.2007.03.026; Cesarini JP, 1996, ADV SPACE RES, V18, P35, DOI 10.1016/0273-1177(96)00025-7; Clarke JA, 2010, SCIENCE, V330, P954, DOI 10.1126/science.1193604; DAVIS PG, 1995, GEOLOGY, V23, P783, DOI 10.1130/0091-7613(1995)023<0783:FOF>2.3.CO;2; Edwards NP, 2011, P ROY SOC B-BIOL SCI, V278, P3209, DOI 10.1098/rspb.2011.0135; Erukhimovitch V, 2005, J PHARMACEUT BIOMED, V37, P1105, DOI 10.1016/j.jpba.2004.08.010; Filip Z, 2001, EUR J SOIL BIOL, V37, P137, DOI 10.1016/S1164-5563(01)01078-0; Goldstein G, 2004, AUK, V121, P656, DOI 10.1642/0004-8038(2004)121[0656:BDOBAW]2.0.CO;2; Grande JM, 2004, ARDEOLA, V51, P375; Gunderson AR, 2008, J AVIAN BIOL, V39, P539, DOI 10.1111/j.0908-8857.2008.04413.x; Gupta NS, 2007, ORG GEOCHEM, V38, P28, DOI 10.1016/j.orggeochem.2006.09.014; Gupta NS, 2006, P R SOC B, V273, P2777, DOI 10.1098/rspb.2006.3646; HEARING VJ, 1991, FASEB J, V5, P2902, DOI 10.1096/fasebj.5.14.1752358; Latocha M, 2000, J ANAL APPL PYROL, V56, P89, DOI 10.1016/S0165-2370(00)00082-6; Latocha M., 2004, POLISH J MED PHYS EN, V10, P119; Li QG, 2010, SCIENCE, V327, P1369, DOI 10.1126/science.1186290; Lingham-Soliar T, 2010, NATURWISSENSCHAFTEN, V97, P479, DOI 10.1007/s00114-010-0661-3; Liu Y, 2005, PHOTOCHEM PHOTOBIOL, V81, P135, DOI 10.1562/2004-08-03-RA-259.1; Marshall CP, 2011, NAT GEOSCI, V4, P240, DOI 10.1038/NGEO1084; McGraw KJ, 2003, OIKOS, V102, P402; Pacton M, 2006, TERRA NOVA, V18, P380, DOI 10.1111/j.1365-3121.2006.00702.x; Pacton M, 2007, GEOMICROBIOL J, V24, P571, DOI 10.1080/01490450701672042; Riley PA, 1997, INT J BIOCHEM CELL B, V29, P1235, DOI 10.1016/S1357-2725(97)00013-7; Russell J.D., 1987, HDB DETERMINATIVE ME, P133; Stepien K, 2009, J AM SOC MASS SPECTR, V20, P464, DOI 10.1016/j.jasms.2008.11.003; Suarez M, 2008, J VERTEBRATE PAL S28, V28, p149A; Vinther J, 2008, BIOL LETTERS, V4, P522, DOI 10.1098/rsbl.2008.0302; Vinther J, 2010, BIOL LETTERS, V6, P128, DOI 10.1098/rsbl.2009.0524; Wogelius RA, 2011, SCIENCE, V333, P1622, DOI 10.1126/science.1205748; Wood JM, 1999, EXP DERMATOL, V8, P153, DOI 10.1111/j.1600-0625.1999.tb00365.x; You HL, 2006, SCIENCE, V312, P1640, DOI 10.1126/science.1126377; Zhang FC, 2010, NATURE, V463, P1075, DOI 10.1038/nature08740; Zhang J, 2007, FRONT BIOL, V2, P26, DOI [10.1007/s11515-007-0004-8, DOI 10.1007/S11515-007-0004-8]	39	29	29	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e25494	10.1371/journal.pone.0025494	http://dx.doi.org/10.1371/journal.pone.0025494			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022404	Green Published, Green Submitted, gold			2022-12-27	WOS:000295978600019
J	Klempin, F; Kronenberg, G; Cheung, G; Kettenmann, H; Kempermann, G				Klempin, Friederike; Kronenberg, Golo; Cheung, Giselle; Kettenmann, Helmut; Kempermann, Gerd			Properties of Doublecortin-(DCX)-Expressing Cells in the Piriform Cortex Compared to the Neurogenic Dentate Gyrus of Adult Mice	PLOS ONE			English	Article							DOUBLECORTIN-LIKE-KINASE; GENERATED GRANULE CELLS; HIPPOCAMPAL NEUROGENESIS; PROGENITOR CELLS; SYNAPTIC PLASTICITY; NEURONAL MIGRATION; PYRAMIDAL NEURONS; OLFACTORY CORTEX; YOUNG NEURONS; IN-VIVO	The piriform cortex receives input from the olfactory bulb and (via the entorhinal cortex) sends efferents to the hippocampus, thereby connecting the two canonical neurogenic regions of the adult rodent brain. Doublecortin (DCX) is a cytoskeleton-associated protein that is expressed transiently in the course of adult neurogenesis. Interestingly, the adult piriform cortex, which is usually considered non-neurogenic (even though some reports exist that state otherwise), also contains an abundant population of DCX-positive cells. We asked how similar these cells would be to DCX-positive cells in the course of adult hippocampal neurogenesis. Using BAC-generated transgenic mice that express GFP under the DCX promoter, we studied DCX-expression and electrophysiological properties of DCX-positive cells in the mouse piriform cortex in comparison with the dentate gyrus. While one class of cells in the piriform cortex indeed showed features similar to newly generated immature granule neurons, the majority of DCX cells in the piriform cortex was mature and revealed large Na+ currents and multiple action potentials. Furthermore, when proliferative activity was assessed, we found that all DCX-expressing cells in the piriform cortex were strictly postmitotic, suggesting that no DCX-positive "neuroblasts'' exist here as they do in the dentate gyrus. We conclude that DCX in the piriform cortex marks a unique population of postmitotic neurons with a subpopulation that retains immature characteristics associated with synaptic plasticity. DCX is thus, per se, no marker of neurogenesis but might be associated more broadly with plasticity.	[Klempin, Friederike] Univ Washington, ISCRM, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; [Kronenberg, Golo] Charite, Dept Neurol, D-13353 Berlin, Germany; [Kronenberg, Golo] Charite, Ctr Stroke Res Berlin, D-13353 Berlin, Germany; [Cheung, Giselle; Kettenmann, Helmut] Max Delbruck Ctr Mol Med MDC Berlin Buch, Berlin, Germany; [Cheung, Giselle] Univ Edinburgh, Ctr Integrat Physiol, Sch Biomed Sci, Edinburgh, Midlothian, Scotland; [Kempermann, Gerd] Tech Univ Dresden, CRTD Ctr Regenerat Therapies Dresden, Dresden, Germany	University of Washington; University of Washington Seattle; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Edinburgh; Technische Universitat Dresden	Klempin, F (corresponding author), Univ Washington, ISCRM, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA.	gerd.kempermann@crt-dresden.de	Kronenberg, Golo/F-8772-2010; Kempermann, Gerd/F-5416-2010; Kettenmann, Helmut/AAJ-5142-2021	Kempermann, Gerd/0000-0002-5304-4061; Cheung, Giselle/0000-0001-8457-2572; Kronenberg, Golo/0000-0002-5310-9849; Kettenmann, Helmut/0000-0001-8208-0291; , Rike/0000-0003-3171-0497	Volkswagenstiftung [I/77 459]	Volkswagenstiftung(Volkswagen)	This study was supported by Volkswagenstiftung (www.volkswagenstiftung.de), grant number I/77 459. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attardo A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002388; Bartkowska K, 2010, BRAIN BEHAV EVOLUT, V76, P128, DOI 10.1159/000320944; Brandt MD, 2003, MOL CELL NEUROSCI, V24, P603, DOI 10.1016/S1044-7431(03)00207-0; Breunig JJ, 2007, CELL STEM CELL, V1, P612, DOI 10.1016/j.stem.2007.11.008; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Cooper-Kuhn CM, 2002, DEV BRAIN RES, V134, P13, DOI 10.1016/S0165-3806(01)00243-7; Corbo JC, 2002, J NEUROSCI, V22, P7548; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Couillard-Despres S, 2006, EUR J NEUROSCI, V24, P1535, DOI 10.1111/j.1460-9568.2006.05039.x; Dayer AG, 2005, J CELL BIOL, V168, P415, DOI 10.1083/jcb.200407053; Demir R, 1999, J NEUROSCI, V19, P1294; Deuel TAS, 2006, NEURON, V49, P41, DOI 10.1016/j.neuron.2005.10.038; Dhaliwal J, 2011, EUR J NEUROSCI, V33, P1025, DOI 10.1111/j.1460-9568.2011.07600.x; Ehninger D, 2011, CELL TISSUE RES; Filippov V, 2003, MOL CELL NEUROSCI, V23, P373, DOI 10.1016/S1044-7431(03)00060-5; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Garthe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005464; Gomez-Climent MA, 2011, NEUROSCIENCE, V181, P18, DOI 10.1016/j.neuroscience.2011.03.004; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Guo FZ, 2010, J NEUROSCI, V30, P12036, DOI 10.1523/JNEUROSCI.1360-10.2010; HABERLY LB, 1989, TRENDS NEUROSCI, V12, P258, DOI 10.1016/0166-2236(89)90025-8; HABERLY LB, 1983, J COMP NEUROL, V213, P163, DOI 10.1002/cne.902130205; Haberly LB, 1990, OLFACTORY CORTEX; Jabs R, 2005, J CELL SCI, V118, P3791, DOI 10.1242/jcs.02515; Johnson DMG, 2000, J NEUROSCI, V20, P6974, DOI 10.1523/JNEUROSCI.20-18-06974.2000; Jung KH, 2009, EPILEPSIA, V50, P537, DOI 10.1111/j.1528-1167.2008.01718.x; Kaslin J, 2008, PHILOS T R SOC B, V363, P101, DOI 10.1098/rstb.2006.2015; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kempermann G., 2011, ADULT NEUROGENESIS, V2; Koizumi H, 2006, NEURON, V49, P55, DOI 10.1016/j.neuron.2005.10.040; Koizumi H, 2006, NAT NEUROSCI, V9, P779, DOI 10.1038/nn1704; Kronenberg G, 2003, J COMP NEUROL, V467, P455, DOI 10.1002/cne.10945; Kronenberg G, 2007, BRAIN STRUCT FUNCT, V212, P19, DOI 10.1007/s00429-007-0141-5; Kronenberg G, 2007, DEV NEUROSCI-BASEL, V29, P124, DOI 10.1159/000096217; Kumar S, 2009, NEUROSCI RES, V65, P367, DOI 10.1016/j.neures.2009.08.015; LoTurco J, 2004, NEURON, V41, P175, DOI 10.1016/S0896-6273(04)00006-6; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Moores CA, 2004, MOL CELL, V14, P833, DOI 10.1016/j.molcel.2004.06.009; Nacher J, 2002, BRAIN RES, V927, P111, DOI 10.1016/S0006-8993(01)03241-3; Nacher J, 2001, EUR J NEUROSCI, V14, P629, DOI 10.1046/j.0953-816x.2001.01683.x; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Ohira K, 2010, NAT NEUROSCI, V13, P173, DOI 10.1038/nn.2473; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Pekcec A, 2006, NEUROREPORT, V17, P571, DOI 10.1097/00001756-200604240-00003; Phillips W, 2005, J NEUROSCI, V25, P11564, DOI 10.1523/JNEUROSCI.3796-05.2005; Plumpe T, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-77; Rao MS, 2004, EUR J NEUROSCI, V19, P234, DOI 10.1111/j.0953-816X.2003.03123.x; Richardson WD, 2011, NEURON, V70, P661, DOI 10.1016/j.neuron.2011.05.013; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; SEKI T, 1993, J NEUROSCI, V13, P2351, DOI 10.1523/JNEUROSCI.13-06-02351.1993; Shapiro LA, 2007, BRAIN STRUCT FUNCT, V212, P133, DOI 10.1007/s00429-007-0151-3; Snyder JS, 2001, J NEUROPHYSIOL, V85, P2423, DOI 10.1152/jn.2001.85.6.2423; Steiner B, 2006, GLIA, V54, P805, DOI 10.1002/glia.20407; Suzuki N, 2010, J COMP NEUROL, V518, P1670, DOI 10.1002/cne.22295; Tamura Y, 2007, EUR J NEUROSCI, V25, P3489, DOI 10.1111/j.1460-9568.2007.05617.x; Trotter J, 2010, BRAIN RES REV, V63, P72, DOI 10.1016/j.brainresrev.2009.12.006; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wang LP, 2005, MOL CELL NEUROSCI, V29, P181, DOI 10.1016/j.mcn.2005.02.002; Wang X, 2007, J NEUROSCI RES, V85, P3567, DOI 10.1002/jnr.21440; Winner B, 2008, J NEUROPATH EXP NEUR, V67, P105, DOI 10.1097/nen.0b013e3181630cff; Zhang T, 2010, BRAIN INJURY, V24, P1350, DOI 10.3109/02699052.2010.504525	63	102	104	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e25760	10.1371/journal.pone.0025760	http://dx.doi.org/10.1371/journal.pone.0025760			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022443	Green Published, gold, Green Accepted			2022-12-27	WOS:000295978600028
J	Singh, T; Katiyar, SK				Singh, Tripti; Katiyar, Santosh K.			Green Tea Catechins Reduce Invasive Potential of Human Melanoma Cells by Targeting COX-2, PGE(2) Receptors and Epithelial-to-Mesenchymal Transition	PLOS ONE			English	Article							NF-KAPPA-B; GRAPE SEED PROANTHOCYANIDINS; PROSTAGLANDIN E-2; NITRIC-OXIDE; SKIN-CANCER; CYCLOOXYGENASE-2; INHIBITION; (-)-EPIGALLOCATECHIN-3-GALLATE; MIGRATION; PHOTOCARCINOGENESIS	Melanoma is the most serious type of skin disease and a leading cause of death from skin disease due to its highly metastatic ability. To develop more effective chemopreventive agents for the prevention of melanoma, we have determined the effect of green tea catechins on the invasive potential of human melanoma cells and the molecular mechanisms underlying these effects using A375 (BRAF-mutated) and Hs294t (Non-BRAF-mutated) melanoma cell lines as an in vitro model. Employing cell invasion assays, we found that the inhibitory effects of green tea catechins on the cell migration were in the order of (-)-epigallocatechin-3-gallate (EGCG)>(-)-epigallocatechin >(-)-epicatechin-3-gallate >(-)-gallocatechin >(-)-epicatechin. Treatment of A375 and Hs294t cells with EGCG resulted in a dose-dependent inhibition of cell migration or invasion of these cells, which was associated with a reduction in the levels of cyclooxygenase (COX)-2, prostaglandin (PG) E-2 and PGE(2) receptors (EP2 and EP4). Treatment of cells with celecoxib, a COX-2 inhibitor, also inhibited melanoma cell migration. EGCG inhibits 12-O-tetradecanoylphorbol-13-acetate-, an inducer of COX-2, and PGE(2)-induced cell migration of cells. EGCG decreased EP2 agonist (butaprost)- and EP4 agonist (Cay10580)-induced cell migration ability. Moreover, EGCG inhibited the activation of NF-kappa B/p65, an upstream regulator of COX-2, in A375 melanoma cells, and treatment of cells with caffeic acid phenethyl ester, an inhibitor of NF-kappa B, also inhibited cell migration. Inhibition of melanoma cell migration by EGCG was associated with transition of mesenchymal stage to epithelial stage, which resulted in an increase in the levels of epithelial biomarkers (E-cadherin, cytokeratin and desmoglein 2) and a reduction in the levels of mesenchymal biomarkers (vimentin, fibronectin and N-cadherin) in A375 melanoma cells. Together, these results indicate that EGCG, a major green tea catechin, has the ability to inhibit melanoma cell invasion/migration, an essential step of metastasis, by targeting the endogenous expression of COX-2, PGE2 receptors and epithelial-to-mesenchymal transition.	[Singh, Tripti; Katiyar, Santosh K.] Univ Alabama Birmingham, Dept Dermatol, Birmingham, AL 35294 USA; [Katiyar, Santosh K.] Univ Alabama Birmingham, Nutr Obes Res Ctr, Birmingham, AL USA; [Katiyar, Santosh K.] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Katiyar, Santosh K.] Birmingham Vet Affairs Med Ctr, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham	Singh, T (corresponding author), Univ Alabama Birmingham, Dept Dermatol, Birmingham, AL 35294 USA.	skatiyar@uab.edu			National Center for Complementary and Alternative Medicine, NCCAM/NIH [5RO1 AT002536]; Veterans Administration; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT002536] Funding Source: NIH RePORTER	National Center for Complementary and Alternative Medicine, NCCAM/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Veterans Administration(US Department of Veterans Affairs); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was supported by funds from the 5RO1 AT002536 by National Center for Complementary and Alternative Medicine, NCCAM/NIH (SKK) (http//www.cancer.gov), and Veterans Administration Merit Review Award (SKK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	America Cancer Society, 2011, CANC FACTS FIG; American Family Physician, 2000, EARL DET TREATM SKIN; Balch CM, 2000, CANCER-AM CANCER SOC, V88, P1484, DOI 10.1002/(SICI)1097-0142(20000315)88:6<1484::AID-CNCR29>3.0.CO;2-D; Chua HL, 2007, ONCOGENE, V26, P711, DOI 10.1038/sj.onc.1209808; Dannenberg AJ, 2003, CANCER CELL, V4, P431, DOI 10.1016/S1535-6108(03)00310-6; Dohadwala M, 2002, J BIOL CHEM, V277, P50828, DOI 10.1074/jbc.M210707200; Hall HI, 1999, J AM ACAD DERMATOL, V40, P35, DOI 10.1016/S0190-9622(99)70562-1; Huber MA, 2004, CELL CYCLE, V3, P1477, DOI 10.4161/cc.3.12.1280; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Katiyar SK, 2007, CANCER LETT, V255, P1, DOI 10.1016/j.canlet.2007.02.010; Katiyar SK, 2010, CANCER PREV RES, V3, P179, DOI 10.1158/1940-6207.CAPR-09-0044; Katiyar SK, 2001, CARCINOGENESIS, V22, P287, DOI 10.1093/carcin/22.2.287; Katiyar SK, 1996, INT J ONCOL, V8, P221; Katiyar SK, 2001, INT J ONCOL, V18, P1307; Katiyar SK, 1999, PHOTOCHEM PHOTOBIOL, V69, P148, DOI 10.1111/j.1751-1097.1999.tb03267.x; Katiyar S, 2007, J NUTR BIOCHEM, V18, P287, DOI 10.1016/j.jnutbio.2006.08.004; Kim JI, 2010, MOL CANCER RES, V8, P569, DOI 10.1158/1541-7786.MCR-09-0511; Lin MT, 2001, J BIOL CHEM, V276, P48997, DOI 10.1074/jbc.M107829200; Maier Harald J, 2010, Cancers (Basel), V2, P2058, DOI 10.3390/cancers2042058; Mantena SK, 2006, MOL CANCER THER, V5, P296, DOI 10.1158/1535-7163.MCT-05-0448; Mantena SK, 2005, J NUTR, V135, P2871, DOI 10.1093/jn/135.12.2871; Meeran SM, 2006, CANCER RES, V66, P5512, DOI 10.1158/0008-5472.CAN-06-0218; Meeran SM, 2009, CARCINOGENESIS, V30, P520, DOI 10.1093/carcin/bgp019; Min CY, 2008, J CELL BIOCHEM, V104, P733, DOI 10.1002/jcb.21695; Mukhtar H, 1996, PHOTOCHEM PHOTOBIOL, V63, P355, DOI 10.1111/j.1751-1097.1996.tb03040.x; Punathil T, 2008, BIOCHEM BIOPH RES CO, V375, P162, DOI 10.1016/j.bbrc.2008.07.157; Punathil T, 2009, MOL CARCINOGEN, V48, P232, DOI 10.1002/mc.20473; Regan JW, 2003, LIFE SCI, V74, P143, DOI 10.1016/j.lfs.2003.09.031; Riedl K, 2004, DRUG RESIST UPDATE, V7, P169, DOI 10.1016/j.drup.2004.04.003; Sheng HM, 2001, J BIOL CHEM, V276, P18075, DOI 10.1074/jbc.M009689200; Singh T, 2011, CARCINOGENESIS, V32, P86, DOI 10.1093/carcin/bgq215; Strouse JJ, 2005, J CLIN ONCOL, V23, P4735, DOI 10.1200/JCO.2005.02.899; Thun MJ, 2002, JNCI-J NATL CANCER I, V94, P252, DOI 10.1093/jnci/94.4.252; TSUJII M, 1995, CELL, V83, P493, DOI 10.1016/0092-8674(95)90127-2; Vaid M, 2011, PLOS ONE IN PRESS; WANG ZY, 1992, CANCER RES, V52, P1162; Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641	37	67	71	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e25224	10.1371/journal.pone.0025224	http://dx.doi.org/10.1371/journal.pone.0025224			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022384	Green Published, gold, Green Submitted			2022-12-27	WOS:000295978600011
J	Sondermeijer, BM; Bakker, A; Halliani, A; de Ronde, MWJ; Marquart, AA; Tijsen, AJ; Mulders, TA; Kok, MGM; Battjes, S; Maiwald, S; Sivapalaratnam, S; Trip, MD; Moerland, PD; Meijers, JCM; Creemers, EE; Pinto-Sietsma, SJ				Sondermeijer, Brigitte M.; Bakker, Annemieke; Halliani, Amalia; de Ronde, Maurice W. J.; Marquart, Arnoud A.; Tijsen, Anke J.; Mulders, Ties A.; Kok, Maayke G. M.; Battjes, Suzanne; Maiwald, Steffi; Sivapalaratnam, Suthesh; Trip, Mieke D.; Moerland, Perry D.; Meijers, Joost C. M.; Creemers, Esther E.; Pinto-Sietsma, Sara-Joan			Platelets in Patients with Premature Coronary Artery Disease Exhibit Upregulation of miRNA340*and miRNA624*	PLOS ONE			English	Article							RISK-FACTORS; MICRORNA EXPRESSION; CIRCULATING MICRORNAS; PERIPHERAL-BLOOD; BIOMARKER; SIGNATURES; PROFILES	Background: Coronary artery disease (CAD) is the leading cause of human morbidity and mortality worldwide, underscoring the need to improve diagnostic strategies. Platelets play a major role, not only in the process of acute thrombosis during plaque rupture, but also in the formation of atherosclerosis itself. MicroRNAs are endogenous small non-coding RNAs that control gene expression and are expressed in a tissue and disease-specific manner. Therefore they have been proposed to be useful biomarkers. It remains unknown whether differences in miRNA expression levels in platelets can be found between patients with premature CAD and healthy controls. Methodology/Principal Findings: In this case-control study we measured relative expression levels of platelet miRNAs using microarrays from 12 patients with premature CAD and 12 age- and sex-matched healthy controls. Six platelet microRNAs were significantly upregulated (miR340*, miR451, miR454*, miR545:9.1. miR615-5p and miR624*) and one miRNA (miR1280) was significantly downregulated in patients with CAD as compared to healthy controls. To validate these results, we measured the expression levels of these candidate miRNAs by qRT-PCR in platelets of individuals from two independent cohorts; validation cohort I consisted of 40 patients with premature CAD and 40 healthy controls and validation cohort II consisted of 27 patients with artery disease and 40 healthy relatives. MiR340* and miR624* were confirmed to be upregulated in patients with CAD as compared to healthy controls in both validation cohorts. Conclusion/Significance: Two miRNAs in platelets are significantly upregulated in patients with CAD as compared to healthy controls. Whether the two identified miRNAs can be used as biomarkers and whether they are cause or consequence of the disease remains to be elucidated in a larger prospective study.	[Sondermeijer, Brigitte M.; Bakker, Annemieke; de Ronde, Maurice W. J.; Mulders, Ties A.; Kok, Maayke G. M.; Battjes, Suzanne; Maiwald, Steffi; Sivapalaratnam, Suthesh; Trip, Mieke D.; Meijers, Joost C. M.; Pinto-Sietsma, Sara-Joan] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Halliani, Amalia; Tijsen, Anke J.; Creemers, Esther E.] Univ Amsterdam, Acad Med Ctr, Heart Failure Res Ctr, NL-1105 AZ Amsterdam, Netherlands; [Marquart, Arnoud A.] Univ Amsterdam, Acad Med Ctr, Dept Expt Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Moerland, Perry D.; Pinto-Sietsma, Sara-Joan] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Sondermeijer, BM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	S.J.Pinto@amc.uva.nl	SJ, Pinto-Sietsma/AAI-3207-2021; Meijers, J.C.M./S-5981-2019; Moerland, Perry/AAG-1425-2020	Meijers, J.C.M./0000-0002-4198-6780; Moerland, Perry/0000-0002-2357-3659; Creemers, Esther/0000-0002-9001-3854; Tijsen, Anke/0000-0002-8030-8894	Academic Medical Center	Academic Medical Center	This research was supported by institutional funding of the Academic Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2010, CLIN CHEM, V56, P1183, DOI 10.1373/clinchem.2010.144121; AI J, 2009, BIOCH BIOPHYS RES CO; Arad Y, 2005, J AM COLL CARDIOL, V46, P158, DOI 10.1016/j.jacc.2005.02.088; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Bostjancic E, 2010, CARDIOLOGY, V115, P163, DOI 10.1159/000268088; Bruchova H, 2008, HAEMATOL-HEMATOL J, V93, P1009, DOI 10.3324/haematol.12706; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002360; Cheng YH, 2010, CLIN SCI, V119, P87, DOI 10.1042/CS20090645; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Corsten MF, 2010, CIRC-CARDIOVASC GENE, V3, P499, DOI 10.1161/CIRCGENETICS.110.957415; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; Erson AE, 2008, CLIN GENET, V74, P296, DOI 10.1111/j.1399-0004.2008.01076.x; Ferket BS, 2010, ARCH INTERN MED, V170, P27, DOI 10.1001/archinternmed.2009.434; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Greenland P, 2003, JAMA-J AM MED ASSOC, V290, P891, DOI 10.1001/jama.290.7.891; Greenland P, 2001, CIRCULATION, V104, P1863, DOI 10.1161/hc4201.097189; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Ji X, 2009, CLIN CHEM, V55, P1944, DOI 10.1373/clinchem.2009.125310; Khot UN, 2003, JAMA-J AM MED ASSOC, V290, P898, DOI 10.1001/jama.290.7.898; Landry P, 2009, NAT STRUCT MOL BIOL, V16, P961, DOI 10.1038/nsmb.1651; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Meder B, 2011, BASIC RES CARDIOL, V106, P13, DOI 10.1007/s00395-010-0123-2; Merkerova M, 2008, EUR J HAEMATOL, V81, P304, DOI 10.1111/j.1600-0609.2008.01111.x; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; MURPHY TP, ATHEROSCLER IN PRESS; RODRIGUES AC, MICRORNA EXPRESSION; Scheuner MT, 2001, CURR OPIN CARDIOL, V16, P251, DOI 10.1097/00001573-200107000-00006; Tijsen AJ, 2010, CIRC RES, V106, P1035, DOI 10.1161/CIRCRESAHA.110.218297; Van Rooij E, 2007, J CLIN INVEST, V117, P2369, DOI 10.1172/JCI33099; Wang GK, 2010, EUR HEART J, V31, P659, DOI 10.1093/eurheartj/ehq013; Weber M, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/532915; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Zhang CX, 2008, PHYSIOL GENOMICS, V33, P139, DOI 10.1152/physiolgenomics.00034.2008	36	78	85	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e25946	10.1371/journal.pone.0025946	http://dx.doi.org/10.1371/journal.pone.0025946			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022480	gold, Green Published, Green Submitted			2022-12-27	WOS:000295978600032
J	Bie, L; Zhao, G; Cheng, P; Rondeau, G; Porwollik, S; Ju, Y; Xia, XQ; McClelland, M				Bie, Li; Zhao, Gang; Cheng, Pui; Rondeau, Gaelle; Porwollik, Steffen; Ju, Yan; Xia, Xiao-Qin; McClelland, Michael			The Accuracy of Survival Time Prediction for Patients with Glioma Is Improved by Measuring Mitotic Spindle Checkpoint Gene Expression	PLOS ONE			English	Article							CHROMOSOMAL INSTABILITY; CELL-PROLIFERATION; CANCER-CELLS; ANEUPLOIDY; BUBR1; ASTROCYTOMAS; TUMORS; GRADE; CLASSIFICATION; GLIOBLASTOMA	Identification of gene expression changes that improve prediction of survival time across all glioma grades would be clinically useful. Four Affymetrix GeneChip datasets from the literature, containing data from 771 glioma samples representing all WHO grades and eight normal brain samples, were used in an ANOVA model to screen for transcript changes that correlated with grade. Observations were confirmed and extended using qPCR assays on RNA derived from 38 additional glioma samples and eight normal samples for which survival data were available. RNA levels of eight major mitotic spindle assembly checkpoint (SAC) genes (BUB1, BUB1B, BUB3, CENPE, MAD1L1, MAD2L1, CDC20, TTK) significantly correlated with glioma grade and six also significantly correlated with survival time. In particular, the level of BUB1B expression was highly correlated with survival time (p<0.0001), and significantly outperformed all other measured parameters, including two standards; WHO grade and MIB-1 (Ki-67) labeling index. Measurement of the expression levels of a small set of SAC genes may complement histological grade and other clinical parameters for predicting survival time.	[Bie, Li; Zhao, Gang; Ju, Yan] Jilin Univ, Clin Hosp 1, Dept Neurosurg, Changchun 130023, Peoples R China; [Bie, Li; Xia, Xiao-Qin; McClelland, Michael] Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA USA; [Cheng, Pui; Rondeau, Gaelle; Porwollik, Steffen; Xia, Xiao-Qin; McClelland, Michael] Vaccine Res Inst San Diego, San Diego, CA USA; [Xia, Xiao-Qin] Chinese Acad Sci, Inst Hydrobiol, Wuhan, Peoples R China	Jilin University; University of California System; University of California Irvine; Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Bie, L (corresponding author), Jilin Univ, Clin Hosp 1, Dept Neurosurg, Changchun 130023, Peoples R China.	xqxia@ihb.ac.cn; mmcclell@uci.edu		McClelland, Michael/0000-0003-1788-9347; xia, xiao qin/0000-0002-8034-1096	National Cancer Institute Early Detection Research Network [U01CA152738]; CDMRP BCRP [W81XWH-08-1-0720]; State Scholarship Fund from China [2009104187]; Jilin University; NATIONAL CANCER INSTITUTE [U01CA152738] Funding Source: NIH RePORTER	National Cancer Institute Early Detection Research Network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CDMRP BCRP; State Scholarship Fund from China; Jilin University(Jilin University); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	MM was supported in part by a National Cancer Institute Early Detection Research Network grant U01CA152738 and by CDMRP BCRP W81XWH-08-1-0720. LB was supported by the State Scholarship Fund from China (no. 2009104187). YJ and GZ were supported by Jilin University. MM, XQ, PC and GR donated part of their time. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando K, 2010, CANCER SCI, V101, P639, DOI 10.1111/j.1349-7006.2009.01457.x; Bharadwaj R, 2004, ONCOGENE, V23, P2016, DOI 10.1038/sj.onc.1207374; Bredel M, 2009, JAMA-J AM MED ASSOC, V302, P261, DOI 10.1001/jama.2009.997; Burum-Auensen E, 2008, CELL PROLIFERAT, V41, P645, DOI 10.1111/j.1365-2184.2008.00539.x; Chan GK, 2005, TRENDS CELL BIOL, V15, P589, DOI 10.1016/j.tcb.2005.09.010; Chang EF, 2009, J NEUROSURG, V111, P203, DOI 10.3171/2009.2.JNS081101; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Claus EB, 2006, CANCER-AM CANCER SOC, V106, P1358, DOI 10.1002/cncr.21733; Colman H, 2010, NEURO-ONCOLOGY, V12, P49, DOI 10.1093/neuonc/nop007; de Reynies A, 2009, J CLIN ONCOL, V27, P1108, DOI 10.1200/JCO.2008.18.5678; DeAngelis LM, 2001, NEW ENGL J MED, V344, P114, DOI 10.1056/NEJM200101113440207; Duchrow M, 2003, HISTOPATHOLOGY, V42, P566, DOI 10.1046/j.1365-2559.2003.01613.x; Faria MHG, 2006, NEUROPATHOLOGY, V26, P519, DOI 10.1111/j.1440-1789.2006.00724.x; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Garside R, 2007, Health Technol Assess, V11, piii; Garside R, 2007, HEALTH TECHNOL ASSES, V11, P221; Gerstner ER, 2009, NEUROLOGY, V73, P1509, DOI 10.1212/WNL.0b013e3181bf9907; Gladhaug IP, 2010, HISTOPATHOLOGY, V56, P345, DOI 10.1111/j.1365-2559.2010.03489.x; Gladson CL, 2010, ANNU REV PATHOL-MECH, V5, P33, DOI 10.1146/annurev-pathol-121808-102109; Grabsch H, 2003, J PATHOL, V200, P16, DOI 10.1002/path.1324; Gravendeel LAM, 2009, CANCER RES, V69, P9065, DOI 10.1158/0008-5472.CAN-09-2307; Hardwick KG, 2005, CURR BIOL, V15, pR122, DOI 10.1016/j.cub.2005.02.008; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hoyt MA, 2001, J CELL BIOL, V154, P909, DOI 10.1083/jcb.200108010; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Ihmann T, 2004, J CANCER RES CLIN, V130, P749, DOI 10.1007/s00432-004-0612-5; Jeuken J, 2009, BRAIN PATHOL, V19, P661, DOI 10.1111/j.1750-3639.2009.00320.x; Johannessen AL, 2006, PATHOL ONCOL RES, V12, P143, DOI 10.1007/BF02893360; KAMIKUBO K, 1986, JPN J PHARMACOL, V40, P342, DOI 10.1254/jjp.40.342; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Kidokoro T, 2008, ONCOGENE, V27, P1562, DOI 10.1038/sj.onc.1210799; Kops GJPL, 2004, P NATL ACAD SCI USA, V101, P8699, DOI 10.1073/pnas.0401142101; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Lausen B, 2004, BIOMETRICAL J, V46, P364, DOI 10.1002/bimj.200310030; Lee YK, 2009, BRIT J CANCER, V101, P504, DOI 10.1038/sj.bjc.6605161; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Maes L, 2007, CELL PROLIFERAT, V40, P14; Marucci G, 2008, VIRCHOWS ARCH, V453, P599, DOI 10.1007/s00428-008-0685-7; Molinie V, 2003, ANN PATHOL, V23, P306; Olesen SH, 2001, CARCINOGENESIS, V22, P813, DOI 10.1093/carcin/22.5.813; Paulus W, 2009, ACTA NEUROPATHOL, V118, P603, DOI 10.1007/s00401-009-0600-6; Percy MJ, 2000, GENE CHROMOSOME CANC, V29, P356, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1044>3.0.CO;2-N; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pich A, 2004, ANN ONCOL, V15, P1319, DOI 10.1093/annonc/mdh299; Rao CV, 2009, CARCINOGENESIS, V30, P1469, DOI 10.1093/carcin/bgp081; Reis RM, 2001, ACTA NEUROPATHOL, V101, P297; Rindi G, 2007, ENDOCR PATHOL, V18, P145, DOI 10.1007/s12022-007-0020-x; Rousseau A, 2008, CURR OPIN NEUROL, V21, P720, DOI 10.1097/WCO.0b013e328312c3a7; Salvatore G, 2007, CANCER RES, V67, P10148, DOI 10.1158/0008-5472.CAN-07-1887; Schvartzman JM, 2010, NAT REV CANCER, V10, P102, DOI 10.1038/nrc2781; Shichiri M, 2002, CANCER RES, V62, P13; Shigeishi H, 2001, ONCOL REP, V8, P791; Taylor SS, 2004, CHROMOSOME RES, V12, P599, DOI 10.1023/B:CHRO.0000036610.78380.51; Torp SH, 2002, PATHOL RES PRACT, V198, P261; Torp SH, 2002, CLIN NEUROPATHOL, V21, P252; Torp SH, 2001, APMIS, V109, P865, DOI 10.1034/j.1600-0463.2001.091209.x; Tran B, 2010, J CLIN NEUROSCI, V17, P417, DOI 10.1016/j.jocn.2009.09.004; Valente V, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-17; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Walker DG, 2003, J CLIN NEUROSCI, V10, P1, DOI 10.1016/S0967-5868(02)00261-8; Wang Yun-wei, 2005, Zhonghua Wei Chang Wai Ke Za Zhi, V8, P503; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Weigel MT, 2010, ENDOCR-RELAT CANCER, V17, pR245, DOI 10.1677/ERC-10-0136; Wong KK, 2005, CANCER RES, V65, P76; Xia XQ, 2009, BIOINFORMATICS, V25, P2425, DOI 10.1093/bioinformatics/btp430; Xiao Y, 2008, PROG NAT SCI, V18, P945, DOI 10.1016/j.pnsc.2008.03.003; Xu LJ, 2009, MOL IMMUNOL, V46, P569, DOI 10.1016/j.molimm.2008.07.035; Yamamoto Y, 2007, CANCER GENET CYTOGEN, V174, P42, DOI 10.1016/j.cancergencyto.2006.11.012; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yerushalmi R, 2010, LANCET ONCOL, V11, P174, DOI 10.1016/S1470-2045(09)70262-1; Yoshida Y, 2010, J NEURO-ONCOL, V98, P41, DOI 10.1007/s11060-009-0064-5; Yuan BB, 2006, CLIN CANCER RES, V12, P405, DOI 10.1158/1078-0432.CCR-05-0903	73	48	49	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25631	10.1371/journal.pone.0025631	http://dx.doi.org/10.1371/journal.pone.0025631			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022424	gold, Green Published			2022-12-27	WOS:000295976000026
J	Bunt, J; Hasselt, NE; Zwijnenburg, DA; Koster, J; Versteeg, R; Kool, M				Bunt, Jens; Hasselt, Nancy E.; Zwijnenburg, Danny A.; Koster, Jan; Versteeg, Rogier; Kool, Marcel			Joint Binding of OTX2 and MYC in Promotor Regions Is Associated with High Gene Expression in Medulloblastoma	PLOS ONE			English	Article							EMBRYONIC STEM; REGULATES EXPRESSION; TRANSCRIPTION; INDUCTION; PROFILES; NETWORK; IDENTIFICATION; AMPLIFICATION; METHYLATIONS; OCCUPANCY	Both OTX2 and MYC are important oncogenes in medulloblastoma, the most common malignant brain tumor in childhood. Much is known about MYC binding to promoter regions, but OTX2 binding is hardly investigated. We used ChIP-on-chip data to analyze the binding patterns of both transcription factors in D425 medulloblastoma cells. When combining the data for all promoter regions in the genome, OTX2 binding showed a remarkable bi-modal distribution pattern with peaks around 2250 bp upstream and +650 bp downstream of the transcription start sites (TSSs). Indeed, 40.2% of all OTX2-bound TSSs had more than one significant OTX2-binding peak. This OTX2-binding pattern was very different from the TSS-centered single peak binding pattern observed for MYC and other known transcription factors. However, in individual promoter regions, OTX2 and MYC have a strong tendency to bind in proximity of each other. OTX2-binding sequences are depleted near TSSs in the genome, providing an explanation for the observed bi-modal distribution of OTX2 binding. This contrasts to the enrichment of E-box sequences at TSSs. Both OTX2 and MYC binding independently correlated with higher gene expression. Interestingly, genes of promoter regions with multiple OTX2 binding as well as MYC binding showed the highest expression levels in D425 cells and in primary medulloblastomas. Genes within this class of promoter regions were enriched for medulloblastoma and stem cell specific genes. Our data suggest an important functional interaction between OTX2 and MYC in regulating gene expression in medulloblastoma.	[Bunt, Jens; Hasselt, Nancy E.; Zwijnenburg, Danny A.; Koster, Jan; Versteeg, Rogier; Kool, Marcel] Univ Amsterdam, Acad Med Ctr, Dept Oncogen, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Bunt, J (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Oncogen, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	m.kool@dkfz-heidelberg.de	Kool, Marcel/H-2541-2013; Versteeg, Rogier/AAQ-1765-2020; Bunt, Jens/C-4775-2014; Koster, Jan/C-5934-2008	Bunt, Jens/0000-0003-0397-2019; Koster, Jan/0000-0002-0890-7585; Versteeg, Rogier/0000-0001-7172-0388; Zwijnenburg, Danny/0000-0002-9353-8904				Adamson DC, 2010, CANCER RES, V70, P181, DOI 10.1158/0008-5472.CAN-09-2331; Agoston Z, 2009, DEVELOPMENT, V136, P3311, DOI 10.1242/dev.037770; Albert T, 2001, J BIOL CHEM, V276, P20482, DOI 10.1074/jbc.M100265200; Aldosari N, 2002, ARCH PATHOL LAB MED, V126, P540; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Boon K, 2005, CANCER RES, V65, P703; Boon K, 2003, ONCOGENE, V22, P7687, DOI 10.1038/sj.onc.1207043; Briata P, 1999, FEBS LETT, V445, P160, DOI 10.1016/S0014-5793(99)00113-1; Bunt J, 2011, INT J CANC IN PRESS; Bunt J, 2010, MOL CANCER RES, V8, P1344, DOI 10.1158/1541-7786.MCR-09-0546; Chatelain G, 2006, J MOL MED, V84, P604, DOI 10.1007/s00109-006-0048-2; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cho YJ, 2011, J CLIN ONCOL, V29, P1424, DOI 10.1200/JCO.2010.28.5148; Danno H, 2008, P NATL ACAD SCI USA, V105, P5408, DOI 10.1073/pnas.0710954105; de Haas T, 2006, J NEUROPATH EXP NEUR, V65, P176, DOI 10.1097/01.jnen.0000199576.70923.8a; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Di CH, 2005, CANCER RES, V65, P919; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; Fattet S, 2009, J PATHOL, V218, P86, DOI 10.1002/path.2514; Hatzis P, 2008, MOL CELL BIOL, V28, P2732, DOI 10.1128/MCB.02175-07; Heimbucher T, 2007, MOL CELL BIOL, V27, P340, DOI 10.1128/MCB.00811-06; Kelley CG, 2000, MOL ENDOCRINOL, V14, P1246, DOI 10.1210/me.14.8.1246; Kidder BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003932; Kim HH, 2007, MOL ENDOCRINOL, V21, P457, DOI 10.1210/me.2005-0216; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Kool M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003088; Larder R, 2009, J BIOL CHEM, V284, P16966, DOI 10.1074/jbc.M109.002485; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Masuda T, 2010, J BIOL CHEM, V285, P26933, DOI 10.1074/jbc.M110.130294; Michiels EMC, 1999, PHYSIOL GENOMICS, V1, P83, DOI 10.1152/physiolgenomics.1999.1.2.83; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morgan R, 1999, MECH DEVELOP, V85, P97, DOI 10.1016/S0925-4773(99)00091-X; Nakano T, 2000, BIOCHEM BIOPH RES CO, V267, P64, DOI 10.1006/bbrc.1999.1872; Northcott PA, 2009, NAT GENET, V41, P465, DOI 10.1038/ng.336; Palhan VB, 2005, P NATL ACAD SCI USA, V102, P8472, DOI 10.1073/pnas.0503505102; Peng GH, 2007, HUM MOL GENET, V16, P2433, DOI 10.1093/hmg/ddm200; Pfister S, 2009, J CLIN ONCOL, V27, P1627, DOI 10.1200/JCO.2008.17.9432; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Smith AD, 2006, P NATL ACAD SCI USA, V103, P6275, DOI 10.1073/pnas.0508169103; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takeda K, 2003, BIOCHEM BIOPH RES CO, V300, P908, DOI 10.1016/S0006-291X(02)02934-0; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wederell ED, 2008, NUCLEIC ACIDS RES, V36, P4549, DOI 10.1093/nar/gkn382; Zitterbart K, 2011, J NEURO-ONCOL, V102, P25, DOI 10.1007/s11060-010-0289-3	47	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e26058	10.1371/journal.pone.0026058	http://dx.doi.org/10.1371/journal.pone.0026058			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016811	gold, Green Published, Green Submitted			2022-12-27	WOS:000295971700036
J	Kawahara-Miki, R; Wada, K; Azuma, N; Chiba, S				Kawahara-Miki, Ryouka; Wada, Kenta; Azuma, Noriko; Chiba, Susumu			Expression Profiling without Genome Sequence Information in a Non-Model Species, Pandalid Shrimp (Pandalus latirostris), by Next-Generation Sequencing	PLOS ONE			English	Article							MESSENGER-RNA; DROSOPHILA-MELANOGASTER; ENVIRONMENT INTERACTION; ALLELE FREQUENCIES; MOUSE OOCYTES; EGG SIZE; TRANSCRIPTOME; POPULATION; EVOLUTION; MATURATION	While the study of phenotypic variation is a central theme in evolutionary biology, the genetic approaches available to understanding this variation are usually limited because of a lack of genomic information in non-model organisms. This study explored the utility of next-generation sequencing (NGS) technologies for studying phenotypic variations between 2 populations of a non-model species, the Hokkai shrimp (Pandalus latirostris; Decapoda, Pandalidae). Before we performed transcriptome analyses using NGS, we examined the genetic and phenotypic differentiation between the populations. Analyses using microsatellite DNA markers suggested that these populations genetically differed from one another and that gene flow is restricted between them. Moreover, the results of our 4-year field observations indicated that the egg traits varied genetically between the populations. Using mRNA extracted from the ovaries of 5 females in each population of Hokkai shrimp, we then performed a transcriptome analysis of the 2 populations. A total of 13.66 gigabases (Gb) of 75-bp reads was obtained. Further, 58,804 and 33,548 contigs for the first and second population, respectively, and 47,467 contigs for both populations were produced by de novo assembly. We detected 552 sequences with the former approach and 702 sequences with the later one; both sets of sequences showed greater than twofold differences in the expression levels between the 2 populations. Twenty-nine sequences were found in both approaches and were considered to be differentially expressed genes. Among them, 9 sequences showed significant similarity to functional genes. The present study showed a de novo assembly approach for the transcriptome of a non-model species using only short-read sequence data, and provides a strategy for identifying sequences showing significantly different expression levels between populations.	[Kawahara-Miki, Ryouka] Tokyo Univ Agr, Genome Res Ctr, NODAI Res Inst, Setagaya Ku, Tokyo, Japan; [Wada, Kenta; Azuma, Noriko; Chiba, Susumu] Tokyo Univ Agr, Fac Bioind, Abashiri, Hokkaido, Japan	Tokyo University of Agriculture; Tokyo University of Agriculture	Kawahara-Miki, R (corresponding author), Tokyo Univ Agr, Genome Res Ctr, NODAI Res Inst, Setagaya Ku, Tokyo, Japan.	s2chiba@bioindustry.nodai.ac.jp	Chiba, Susumu/D-1697-2017; Miki, Ryoka/E-7857-2017	Chiba, Susumu/0000-0003-1545-1552; Miki, Ryoka/0000-0003-2072-8851	Ministry of Education, Culture, Sports, Science and Technology [S0801025, 21780184]; Tokyo University of Agriculture; Grants-in-Aid for Scientific Research [21780184] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Tokyo University of Agriculture; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (S0801025, and 21780184) and by a Grant-in-Aid for Advanced Study Projects from the Tokyo University of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwahid E, 2001, HISTOCHEM CELL BIOL, V115, P95; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2010, R LANG ENV STAT COMP; Azuma N, 2011, CONSERV GENET RESOUR, V3, P529, DOI 10.1007/s12686-011-9396-5; Bergstrom BI, 2000, ADV MAR BIOL, V38, P55, DOI 10.1016/S0065-2881(00)38003-8; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Birzele F, 2010, NUCLEIC ACIDS RES, V38, P3999, DOI 10.1093/nar/gkq116; Chiba S, 2004, FISHERIES SCI, V70, P1174, DOI 10.1111/j.1444-2906.2004.00920.x; Chiba S, 2000, MAR ECOL PROG SER, V203, P215, DOI 10.3354/meps203215; Chiba S, 2003, AQUACULTURE SCI, V51, P375; Chittenden CM, 2010, PLOS ONE, V5; Conover DO, 2002, SCIENCE, V297, P94, DOI 10.1126/science.1074085; CONOVER DO, 1995, TRENDS ECOL EVOL, V10, P248, DOI 10.1016/S0169-5347(00)89081-3; Dalloul RA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000475; Edeline E, 2007, P NATL ACAD SCI USA, V104, P15799, DOI 10.1073/pnas.0705908104; Ernsting G, 2000, AM NAT, V155, P804, DOI 10.1086/303361; Falconer D. S., 1996, INTRO QUANTITATIVE G; Falush D, 2003, GENETICS, V164, P1567; Fujii T, 2010, J GENETICS, V89; Gebauer F, 1996, P NATL ACAD SCI USA, V93, P14602, DOI 10.1073/pnas.93.25.14602; Geraci F, 2003, BIOCHEM BIOPH RES CO, V310, P748, DOI 10.1016/j.bbrc.2003.09.067; Gibbons JG, 2009, MOL BIOL EVOL, V26, P2731, DOI 10.1093/molbev/msp188; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Han D, 2009, J EXPT BIOL, V212; Heino M, 2002, EVOLUTION, V56, P669, DOI 10.1111/j.0014-3820.2002.tb01378.x; Hoffman JI, 2011, MOL ECOL RESOUR, V11, P703, DOI 10.1111/j.1755-0998.2011.02999.x; Hokkaido Research Organization, 2011, MAR NET HOKK DAT BAS; Ibarra AM, 2009, AQUACULTURE, V297, P64, DOI 10.1016/j.aquaculture.2009.09.015; KAWAMURA N, 1990, GENETICA, V81, P205, DOI 10.1007/BF00360866; Kim EK, 2006, PHYSIOL RES, V55, P405, DOI 10.33549/physiolres.930773; KUBO ITSUO, 1951, BULL JAPANESE SOC SCI FISH, V16, P71; Leimar O, 2009, EVOL ECOL, V23, P125, DOI 10.1007/s10682-007-9194-4; LEROI AM, 1994, EVOLUTION, V48, P1244, DOI [10.2307/2410382, 10.1111/j.1558-5646.1994.tb05309.x]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; MIZUSHIMA T, 1987, Scientific Reports of Hokkaido Fisheries Experimental Station, P25; Mizushima T, 1980, MONTH J FISH EXP STN, V37, P87; Mizushima T, 1979, MONTHLY J FISHERIES, V36, P53; Mizushima T, 1986, MONTHLY J FISHERIES, V43, P77; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nishihama Yuji, 1997, Scientific Reports of Hokkaido Fisheries Experimental Station, V50, P1; Oh B, 2000, DEVELOPMENT, V127, P3795; Olsen EM, 2004, NATURE, V428, P932, DOI 10.1038/nature02430; Onishi Yuta, 2001, Benthos Research, V56, P9; PARKER GA, 1986, AM NAT, V128, P573, DOI 10.1086/284589; Pitts RJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-271; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Renaut S, 2010, MOL ECOL, V19, P115, DOI 10.1111/j.1365-294X.2009.04477.x; REZNICK DA, 1990, NATURE, V346, P357, DOI 10.1038/346357a0; Roff Derek A., 1992; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sambandan D, 2008, GENETICS, V179, P1079, DOI 10.1534/genetics.108.086769; Schneider S, 2000, ARLEQIN VER 2 000 SO; Sitonikov AV, 1997, RUSSIAN J GENETICS, V33, P1158; SLATKIN M, 1995, GENETICS, V139, P457; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; Stutz A, 1998, GENE DEV, V12, P2535, DOI 10.1101/gad.12.16.2535; Tartia AP, 2009, DEVELOPMENT, V136, P2247, DOI 10.1242/dev.036756; Tay J, 2000, DEV BIOL, V221, P1, DOI 10.1006/dbio.2000.9669; Tay J, 2001, DEV CELL, V1, P201, DOI 10.1016/S1534-5807(01)00025-9; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wolf JBW, 2010, MOL ECOL, V19, P703; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	66	32	33	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e26043	10.1371/journal.pone.0026043	http://dx.doi.org/10.1371/journal.pone.0026043			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016807	gold, Green Published			2022-12-27	WOS:000295971700035
J	Wang, YH; Savage, K; Grills, C; McCavigan, A; James, JA; Fennell, DA; Hamilton, PW				Wang, Yinhai; Savage, Kienan; Grills, Claire; McCavigan, Andrena; James, Jacqueline A.; Fennell, Dean A.; Hamilton, Peter W.			A TMA De-Arraying Method for High Throughput Biomarker Discovery in Tissue Research	PLOS ONE			English	Article							CELL-NUCLEI; SEGMENTATION; ALGORITHM; BCL-2; MICROARRAYS; DIAGNOSIS; IMAGES	Background: Tissue MicroArrays (TMAs) represent a potential high-throughput platform for the analysis and discovery of tissue biomarkers. As TMA slides are produced manually and subject to processing and sectioning artefacts, the layout of TMA cores on the final slide and subsequent digital scan (TMA digital slide) is often disturbed making it difficult to associate cores with their original position in the planned TMA map. Additionally, the individual cores can be greatly altered and contain numerous irregularities such as missing cores, grid rotation and stretching. These factors demand the development of a robust method for de-arraying TMAs which identifies each TMA core, and assigns them to their appropriate coordinates on the constructed TMA slide. Methodology: This study presents a robust TMA de-arraying method consisting of three functional phases: TMA core segmentation, gridding and mapping. The segmentation of TMA cores uses a set of morphological operations to identify each TMA core. Gridding then utilises a Delaunay Triangulation based method to find the row and column indices of each TMA core. Finally, mapping correlates each TMA core from a high resolution TMA whole slide image with its name within a TMAMap. Conclusion: This study describes a genuine robust TMA de-arraying algorithm for the rapid identification of TMA cores from digital slides. The result of this de-arraying algorithm allows the easy partition of each TMA core for further processing. Based on a test group of 19 TMA slides (3129 cores), 99.84% of cores were segmented successfully, 99.81% of cores were gridded correctly and 99.96% of cores were mapped with their correct names via TMAMaps. The gridding of TMA cores were also extensively tested using a set of 113 pseudo slide (13,536 cores) with a variety of irregular grid layouts including missing cores, rotation and stretching. 100% of the cores were gridded correctly.	[Wang, Yinhai; Savage, Kienan; Grills, Claire; McCavigan, Andrena; James, Jacqueline A.; Fennell, Dean A.; Hamilton, Peter W.] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland	Queens University Belfast	Wang, YH (corresponding author), Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland.	y.wang@qub.ac.uk		Savage, Kienan/0000-0002-4898-899X	Department for Employment and Learning through its ''Strengthening the all-Island Research Base'' initiative; Public Health Agency [SPI/3521/06] Funding Source: researchfish	Department for Employment and Learning through its ''Strengthening the all-Island Research Base'' initiative; Public Health Agency	This work was supported by the Department for Employment and Learning through its ''Strengthening the all-Island Research Base'' initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamford P, 1998, SIGNAL PROCESS, V71, P203, DOI 10.1016/S0165-1684(98)00145-5; Barber CB, 1996, ACM T MATH SOFTWARE, V22, P469, DOI 10.1145/235815.235821; Berg M. D., 2008, COMPUTATIONAL GEOMET, V3rd, DOI DOI 10.1007/978-3-540-77974-2; Chen W, 2002, UNSUPERVISED IMAGING; Chen WJ, 2004, IEEE T INF TECHNOL B, V8, P89, DOI 10.1109/TITB.2004.828891; Chen XW, 2006, IEEE T BIO-MED ENG, V53, P762, DOI 10.1109/TBME.2006.870201; CHITTENDEN T, 1995, NATURE, V374, P733, DOI 10.1038/374733a0; Cignoni P, 1998, COMPUT AIDED DESIGN, V30, P333, DOI 10.1016/S0010-4485(97)00082-1; Conway C, 2008, HISTOCHEM CELL BIOL, V130, P447, DOI 10.1007/s00418-008-0480-1; Delaunay B., 1934, J PHYS RADIUM, V6, P793, DOI DOI 10.1051/JPHYSRAD:01951001207073500; Dell'Anna R, 2005, COMPUT METH PROG BIO, V79, P197, DOI 10.1016/j.cmpb.2005.04.004; DIVITO K., 2005, BREAST CANC ONLINE, V8; FORTUNE S, 1987, ALGORITHMICA, V2, P153, DOI 10.1007/BF01840357; Gonzalez R.C., 2002, DIGITAL IMAGE PROCES, P655; Karel Z, 1994, CONTRAST LTD ADAPTIV, P474; Kayser K, 2006, DIAGN PATHOL, V1, DOI 10.1186/1746-1596-1-10; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Lahrmann B, 2010, CYTOM PART A, V77A, P1169, DOI 10.1002/cyto.a.20949; Lleti R, 2004, ANAL CHIM ACTA, V515, P87, DOI 10.1016/j.aca.2003.12.020; Mouroutis T, 1998, BIOIMAGING, V6, P79, DOI 10.1002/1361-6374(199806)6:2<79::AID-BIO3>3.0.CO;2-#; Neumann A, 1998, COMPUT MED IMAG GRAP, V22, P133, DOI 10.1016/S0895-6111(98)00015-9; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Rabinovich A, 2006, IEEE T INF TECHNOL B, V10, P209, DOI 10.1109/TITB.2005.855544; Sugar CA, 2003, J AM STAT ASSOC, V98, P750, DOI 10.1198/016214503000000666; Teverovskiy M, 2004, 2004 2ND IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING: MACRO TO NANO, VOLS 1 and 2, P257; Thallinger GG, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-81; Wang YH, 2010, ANAL CELL PATHOL, V33, P271, DOI [10.1155/2010/918306, 10.3233/ACP-CLO-2010-0551]; Wang YH, 2009, IEEE J-STSP, V3, P112, DOI 10.1109/JSTSP.2008.2011157; Zha HB, 1996, J BIOL CHEM, V271, P7440, DOI 10.1074/jbc.271.13.7440	30	7	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e26007	10.1371/journal.pone.0026007	http://dx.doi.org/10.1371/journal.pone.0026007			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22016800	Green Published, gold, Green Submitted			2022-12-27	WOS:000295970300048
J	Barrantes-Reynolds, R; Wallace, SS; Bond, JP				Barrantes-Reynolds, Ramiro; Wallace, Susan S.; Bond, Jeffrey P.			Using Shifts in Amino Acid Frequency and Substitution Rate to Identify Latent Structural Characters in Base-Excision Repair Enzymes	PLOS ONE			English	Article							FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE; FUNCTIONALLY IMPORTANT RESIDUES; COLI ENDONUCLEASE-VIII; LIKELIHOOD PHYLOGENETICS; 3-DIMENSIONAL STRUCTURE; CRYSTAL-STRUCTURE; PROTEIN-SEQUENCE; PREDICTION; DIVERGENCE; BINDING	Protein evolution includes the birth and death of structural motifs. For example, a zinc finger or a salt bridge may be present in some, but not all, members of a protein family. We propose that such transitions are manifest in sequence phylogenies as concerted shifts in substitution rates of amino acids that are neighbors in a representative structure. First, we identified rate shifts in a quartet from the Fpg/Nei family of base excision repair enzymes using a method developed by Xun Gu and coworkers. We found the shifts to be spatially correlated, more precisely, associated with a flexible loop involved in bacterial Fpg substrate specificity. Consistent with our result, sequences and structures provide convincing evidence that this loop plays a very different role in other family members. Second, then, we developed a method for identifying latent protein structural characters (LSC) given a set of homologous sequences based on Gu's method and proximity in a high-resolution structure. Third, we identified LSC and assigned states of LSC to clades within the Fpg/Nei family of base excision repair enzymes. We describe seven LSC; an accompanying Proteopedia page (http://proteopedia.org/wiki/index.php/Fpg_Nei_Protein_Family) describes these in greater detail and facilitates 3D viewing. The LSC we found provided a surprisingly complete picture of the interaction of the protein with the DNA capturing familiar examples, such as a Zn finger, as well as more subtle interactions. Their preponderance is consistent with an important role as phylogenetic characters. Phylogenetic inference based on LSC provided convincing evidence of independent losses of Zn fingers. Structural motifs may serve as important phylogenetic characters and modeling transitions involving structural motifs may provide a much deeper understanding of protein evolution.	[Barrantes-Reynolds, Ramiro; Wallace, Susan S.; Bond, Jeffrey P.] Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA	University of Vermont	Barrantes-Reynolds, R (corresponding author), Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA.	jeffrey.bond@uvm.edu		Wallace, Susan S./0000-0002-3906-0321	National Institutes of Health [P01 CA098993]; National Cancer Institute; NASA at the University of Vermont [NNX 06AC88G]; University of Vermont; Vermont Genetics Network [P20 RR16462]; National Institutes of Health (NIH); NATIONAL CANCER INSTITUTE [P01CA098993] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016462] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NASA at the University of Vermont; University of Vermont; Vermont Genetics Network; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the National Institutes of Health [P01 CA098993], grant awarded by the National Cancer Institute; the Vermont Advanced Computing Center which is supported by NASA [NNX 06AC88G], at the University of Vermont for providing high-performance computing resources that have contributed to the research results reported within this paper; the Vermont Genetics Network [P20 RR16462] from the INBRE Program of the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2008, NUCLEIC ACIDS RES, V36, P5922, DOI 10.1093/nar/gkn573; Aloy P, 2001, J MOL BIOL, V311, P395, DOI 10.1006/jmbi.2001.4870; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amara P, 2006, DNA REPAIR, V5, P947, DOI 10.1016/j.dnarep.2006.05.042; Bandaru V, 2007, DNA REPAIR, V6, P1629, DOI 10.1016/j.dnarep.2007.05.011; Barclay AN, 2003, SEMIN IMMUNOL, V15, P215, DOI 10.1016/S1044-5323(03)00047-2; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; BrõndÚn CI., 1991, INTRO PROTEIN STRUCT; Brown DP, 2007, PLOS COMPUT BIOL, V3, P1526, DOI 10.1371/journal.pcbi.0030160; Burgess S, 2002, J BIOL CHEM, V277, P2938, DOI 10.1074/jbc.M110499200; Caffrey DR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-381; Capra JA, 2008, BIOINFORMATICS, V24, P1473, DOI 10.1093/bioinformatics/btn214; Capra JA, 2007, BIOINFORMATICS, V23, P1875, DOI 10.1093/bioinformatics/btm270; CASARI G, 1995, NAT STRUCT BIOL, V2, P171, DOI 10.1038/nsb0295-171; Cheng Q, 2008, GENE; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Coste F, 2004, J BIOL CHEM, V279, P44074, DOI 10.1074/jbc.M405928200; de Jesus KP, 2005, NUCLEIC ACIDS RES, V33, P5936, DOI 10.1093/nar/gki879; del Sol A, 2007, PLOS COMPUT BIOL, V3, P2446, DOI 10.1371/journal.pcbi.0030239; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Deu E, 2002, PROTEIN SCI, V11, P1062, DOI 10.1110/ps.0200902; Doublie S, 2004, P NATL ACAD SCI USA, V101, P10284, DOI 10.1073/pnas.0402051101; Elcock AH, 2001, J MOL BIOL, V312, P885, DOI 10.1006/jmbi.2001.5009; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Fromme JC, 2003, J BIOL CHEM, V278, P51543, DOI 10.1074/jbc.M307768200; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Gaucher EA, 2005, MOL PHYLOGENET EVOL, V37, P928, DOI 10.1016/j.ympev.2005.03.027; George RA, 2005, P NATL ACAD SCI USA, V102, P12299, DOI 10.1073/pnas.0504833102; Gilboa R, 2002, J BIOL CHEM, V277, P19811, DOI 10.1074/jbc.M202058200; Golan G, 2005, NUCLEIC ACIDS RES, V33, P5006, DOI 10.1093/nar/gki796; Gribaldo S, 2003, MOL BIOL EVOL, V20, P1754, DOI 10.1093/molbev/msg171; Gu X, 1999, MOL BIOL EVOL, V16, P1664, DOI 10.1093/oxfordjournals.molbev.a026080; Gu X, 2003, GENETICA, V118, P133, DOI 10.1023/A:1024197424306; Gu X, 2002, BIOINFORMATICS, V18, P500, DOI 10.1093/bioinformatics/18.3.500; Gu X, 2001, J COMPUT BIOL, V8, P221, DOI 10.1089/10665270152530827; Gu X, 2001, MOL BIOL EVOL, V18, P453, DOI 10.1093/oxfordjournals.molbev.a003824; Gu X, 1997, MOL BIOL EVOL, V14, P1106, DOI 10.1093/oxfordjournals.molbev.a025720; Gu X, 2006, MOL BIOL EVOL, V23, P1937, DOI 10.1093/molbev/msl056; Guharoy M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-286; Gutteridge A, 2005, TRENDS BIOCHEM SCI, V30, P622, DOI 10.1016/j.tibs.2005.09.006; Gutteridge A, 2003, J MOL BIOL, V330, P719, DOI 10.1016/S0022-2836(03)00515-1; Hannenhalli SS, 2000, J MOL BIOL, V303, P61, DOI 10.1006/jmbi.2000.4036; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hirano Hisashi, 2003, Methods Mol Biol, V211, P355; Hodis E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r121; Imamura K, 2009, J BIOL CHEM; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kalinina OV, 2004, PROTEIN SCI, V13, P443, DOI 10.1110/ps.03191704; Kathe SD, 2009, DNA REPAIR, V8, P643, DOI 10.1016/j.dnarep.2008.12.013; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Ko J, 2005, BIOINFORMATICS, V21, pI258, DOI 10.1093/bioinformatics/bti1039; Kolaczkowski B, 2004, NATURE, V431, P980, DOI 10.1038/nature02917; Koshi J M, 2001, Pac Symp Biocomput, P191; Kraut DA, 2003, ANNU REV BIOCHEM, V72, P517, DOI 10.1146/annurev.biochem.72.121801.161617; Kropachev KY, 2006, BIOCHEMISTRY-US, V45, P12039, DOI 10.1021/bi060663e; Kuznetsov SV, 1998, EUR J BIOCHEM, V253, P413, DOI 10.1046/j.1432-1327.1998.2530413.x; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Landgraf R, 2001, J MOL BIOL, V307, P1487, DOI 10.1006/jmbi.2001.4540; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Limbird LE, 2005, CELL SURFACE RECEPTO; Lio Pietro, 2008, V452, P255, DOI 10.1007/978-1-60327-159-2_13; Lopez P, 2002, MOL BIOL EVOL, V19, P1; Madabushi S, 2002, J MOL BIOL, V316, P139, DOI 10.1006/jmbi.2001.5327; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Marttinen P, 2006, BIOINFORMATICS, V22, P2466, DOI 10.1093/bioinformatics/btl411; Martz E, 2009, BIOPOLYMERS, V92, P76, DOI 10.1002/bip.21126; Mihalek I, 2004, J MOL BIOL, V336, P1265, DOI 10.1016/j.jmb.2003.12.078; Mirny LA, 2002, J MOL BIOL, V321, P7, DOI 10.1016/S0022-2836(02)00587-9; MIYATAKE N, 1993, EUR J BIOCHEM, V212, P785, DOI 10.1111/j.1432-1033.1993.tb17719.x; Naylor GJP, 1997, NATURE, V388, P527, DOI 10.1038/41460; Nimrod G, 2005, BIOINFORMATICS, V21, pI328, DOI 10.1093/bioinformatics/bti1023; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ondrechen MJ, 2001, P NATL ACAD SCI USA, V98, P12473, DOI 10.1073/pnas.211436698; Panchenko AR, 2004, PROTEIN SCI, V13, P884, DOI 10.1110/ps.03465504; Pei JM, 2006, BIOINFORMATICS, V22, P164, DOI 10.1093/bioinformatics/bti766; Peters KP, 1996, J MOL BIOL, V256, P201, DOI 10.1006/jmbi.1996.0077; Petrova NV, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-312; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Pumo DE, 2009, EPIGENETICS MECH FUN; Rabow L, 2001, PROG NUCLEIC ACID RE, V68, P223; Rahat O, 2008, PROTEINS, V71, P621, DOI 10.1002/prot.21749; Reva B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r232; Robertson AB, 2009, CELL MOL LIFE SCI, V66, P981, DOI 10.1007/s00018-009-8736-z; Rogacheva M, 2006, J BIOL CHEM, V281, P32353, DOI 10.1074/jbc.M606217200; Ruano-Rubio V, 2007, SYST BIOL, V56, P68, DOI 10.1080/10635150601175578; Sankararaman S, 2008, BIOINFORMATICS, V24, P2445, DOI 10.1093/bioinformatics/btn474; Saparbaev M, 2002, ENVIRON MOL MUTAGEN, V39, P10, DOI 10.1002/em.10041; Sarkar IN, 2002, MOL PHYLOGENET EVOL, V24, P388; Schueler-Furman O, 2003, PROTEINS, V52, P225, DOI 10.1002/prot.10365; Sidorkina OM, 2000, J BIOL CHEM, V275, P9924, DOI 10.1074/jbc.275.14.9924; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Standley DM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-116; Sugahara M, 2000, EMBO J, V19, P3857, DOI 10.1093/emboj/19.15.3857; Wallace SS, 2003, DNA REPAIR, V2, P441, DOI 10.1016/S1568-7864(02)00182-9; Wolfram S., 2003, MATH BOOK; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Youn E, 2007, PROTEIN SCI, V16, P216, DOI 10.1110/ps.062523907; Zharkov DO, 2008, CELL MOL LIFE SCI, V65, P1544, DOI 10.1007/s00018-008-7543-2; Zharkov DO, 2003, DNA REPAIR, V2, P839, DOI 10.1016/S1568-7864(03)00084-3; Zharkov DO, 2002, EMBO J, V21, P789, DOI 10.1093/emboj/21.4.789	102	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e25246	10.1371/journal.pone.0025246	http://dx.doi.org/10.1371/journal.pone.0025246			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998646	Green Submitted, gold, Green Published			2022-12-27	WOS:000295968700007
J	D'Alba, L; Van Hemert, C; Handel, CM; Shawkey, MD				D'Alba, Liliana; Van Hemert, Caroline; Handel, Colleen M.; Shawkey, Matthew D.			A Natural Experiment on the Condition-Dependence of Achromatic Plumage Reflectance in Black-Capped Chickadees	PLOS ONE			English	Article							REPRODUCTIVE SUCCESS; BEAK DEFORMITIES; COLOR VARIATION; HONEST SIGNAL; QUALITY; TRAITS; BIRDS; PIGMENTATION; EXPRESSION; ORNAMENTS	Honest advertisement models posit that only individuals in good health can produce and/or maintain ornamental traits. Even though disease has profound effects on condition, few studies have experimentally tested its effects on trait expression and even fewer have identified a mechanistic basis for these effects. Recent evidence suggests that black and white, but not grey, plumage colors of black-capped chickadees (Poecile atricapillus) are sexually selected. We therefore hypothesized that birds afflicted with avian keratin disorder, a condition that affects the beak and other keratinized tissues, would show reduced expression of black and white, but not grey, color. UV-vis spectrometry of black-capped chickadees affected and unaffected by avian keratin disorder revealed spectral differences between them consistent with this hypothesis. To elucidate the mechanistic bases of these differences, we used scanning electron microscopy (SEM), electron-dispersive x-ray spectroscopy (EDX) and a feather cleaning experiment. SEM showed extreme feather soiling in affected birds, and EDX revealed that this was most likely from external sources. Experimentally cleaning the feathers increased color expression of ornamental feathers of affected, but not unaffected, birds. These data provide strong evidence that black and white color is an honest indicator in chickadees, and that variation in feather dirtiness, likely due to differences in preening behavior is a mechanism for this association.	[D'Alba, Liliana; Shawkey, Matthew D.] Univ Akron, Dept Biol, Akron, OH 44325 USA; [D'Alba, Liliana; Shawkey, Matthew D.] Univ Akron, Integrated Biosci Program, Akron, OH 44325 USA; [Van Hemert, Caroline; Handel, Colleen M.] US Geol Survey, Alaska Sci Ctr, Anchorage, AK USA; [Van Hemert, Caroline] Univ Alaska Fairbanks, Dept Biol & Wildlife, Fairbanks, AK USA	University System of Ohio; University of Akron; University System of Ohio; University of Akron; United States Department of the Interior; United States Geological Survey; University of Alaska System; University of Alaska Fairbanks	D'Alba, L (corresponding author), Univ Akron, Dept Biol, Akron, OH 44325 USA.	liliana@uakron.edu	D'Alba, Liliana/AAC-4969-2022	D'Alba, Liliana/0000-0002-2478-3455; Handel, Colleen/0000-0002-0267-7408; Shawkey, Matthew/0000-0002-5131-8209	U. S. Geological Survey; National Science Foundation; University of Alaska Foundation; AFOSR [FA9550-09-1-0159]	U. S. Geological Survey(United States Geological Survey); National Science Foundation(National Science Foundation (NSF)); University of Alaska Foundation; AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	Funding was provided by the U. S. Geological Survey, the National Science Foundation Graduate Research Fellowship (http://www.nsfgrfp.org/) Program, the University of Alaska Foundation Angus Gavin Memorial Bird Research Grant (http://www.alaska.edu/foundation/donor_relations/grants-and-awards/), and the AFOSR (FA9550-09-1-0159)(http://www.wpafb.af.mil/library/factsheets/factsheet.asp?id=8973). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson S, 1997, P ROY SOC B-BIOL SCI, V264, P1587, DOI 10.1098/rspb.1997.0221; Andersson S, 2006, BIRD COLOURATION MEC, P40; Bennett ATD, 1997, P NATL ACAD SCI USA, V94, P8618, DOI 10.1073/pnas.94.16.8618; Blanco G, 2005, P ROY SOC B-BIOL SCI, V272, P1893, DOI 10.1098/rspb.2005.3157; Brawner WR, 2000, AUK, V117, P952, DOI 10.1642/0004-8038(2000)117[0952:EOCAMI]2.0.CO;2; Burtt E.H., 1986, ORNITHOL MONOGR, V38, P1; Burtt EH, 1999, AUK, V116, P364, DOI 10.2307/4089371; Cohen J.E., 1988, STAT POWER ANAL BEHA; COTGREAVE P, 1994, BEHAVIOUR, V131, P171, DOI 10.1163/156853994X00424; Delhey K, 2006, BEHAV ECOL, V17, P790, DOI 10.1093/beheco/arl012; Doucet SM, 2002, CONDOR, V104, P30, DOI 10.1650/0010-5422(2002)104[0030:SPCMBS]2.0.CO;2; Doucet SM, 2003, J AVIAN BIOL, V34, P237, DOI 10.1034/j.1600-048X.2003.03113.x; Doucet SM, 2005, BEHAV ECOL, V16, P218, DOI 10.1093/beheco/arh154; Fecchio RS, 2010, MAT SCI ENG C-MATER, V30, P460, DOI 10.1016/j.msec.2010.01.001; FRENKEL MJ, 1976, AUST J BIOL SCI, V29, P467, DOI 10.1071/BI9760467; GRAFEN A, 1990, J THEOR BIOL, V144, P473, DOI 10.1016/S0022-5193(05)80087-6; Griggio M, 2011, ITAL J ZOOL, V78, P90, DOI 10.1080/11250003.2010.504238; Griggio M, 2009, J EVOLUTION BIOL, V22, P782, DOI 10.1111/j.1420-9101.2009.01700.x; Griggio M, 2010, BEHAV PROCESS, V84, P739, DOI 10.1016/j.beproc.2010.05.003; Griggio M, 2010, ECOL RES, V25, P77, DOI 10.1007/s11284-009-0632-3; Handel CM, 2006, WILDLIFE SOC B, V34, P1094, DOI 10.2193/0091-7648(2006)34[1094:UOBSFS]2.0.CO;2; Handel CM, 2010, AUK, V127, P882, DOI 10.1525/auk.2010.10111; Heindl M, 2003, BEHAV ECOL SOCIOBIOL, V53, P153, DOI 10.1007/s00265-002-0562-3; Hill GE, 2005, ANIM BEHAV, V69, P387, DOI 10.1016/j.anbehav.2004.03.013; HILL GE, 1994, P ROY SOC B-BIOL SCI, V258, P47, DOI 10.1098/rspb.1994.0140; Horak P, 2004, J ANIM ECOL, V73, P935, DOI 10.1111/j.0021-8790.2004.00870.x; Jacot A, 2007, BEHAV ECOL, V18, P34, DOI 10.1093/beheco/arl054; Keyser AJ, 2000, BEHAV ECOL, V11, P202, DOI 10.1093/beheco/11.2.202; Keyser AJ, 1999, P ROY SOC B-BIOL SCI, V266, P771, DOI 10.1098/rspb.1999.0704; KODRICBROWN A, 1984, AM NAT, V124, P309, DOI 10.1086/284275; McGraw KJ, 2008, PIGM CELL MELANOMA R, V21, P133, DOI 10.1111/j.1755-148X.2008.00454.x; McGraw KJ, 2004, CAN J ZOOL, V82, P734, DOI 10.1139/Z04-043; Mennill DJ, 2003, BEHAV ECOL SOCIOBIOL, V53, P350, DOI 10.1007/s00265-003-0581-8; Montgomerie Robert, 2006, P399; Nolan PM, 1998, P ROY SOC B-BIOL SCI, V265, P961, DOI 10.1098/rspb.1998.0384; Pearn SM, 2003, ETHOLOGY, V109, P961, DOI 10.1046/j.0179-1613.2003.00936.x; Poston JP, 2005, ANIM BEHAV, V70, P1171, DOI 10.1016/j.anbehav.2005.02.015; Prum RO, 2006, BIRD COLORATION, V1, P295; Senar J.C., 2006, BIRD COLORATION, V2, P87; Shawkey MD, 2007, AM NAT, V169, pS112, DOI 10.1086/510100; Shawkey MD, 2005, BIOL LETTERS, V1, P121, DOI 10.1098/rsbl.2004.0289; Siefferman L, 2003, BEHAV ECOL, V14, P855, DOI 10.1093/beheco/arg063; Siefferman L, 2007, BEHAV ECOL SOCIOBIOL, V61, P1839, DOI 10.1007/s00265-007-0416-0; Siitari H, 2002, BEHAV ECOL, V13, P737, DOI 10.1093/beheco/13.6.737; Siitari H, 2002, ANIM BEHAV, V63, P97, DOI 10.1006/anbe.2001.1870; Surmacki A, 2007, NATURWISSENSCHAFTEN, V94, P829, DOI 10.1007/s00114-007-0263-x; Van Hemert C, 2010, AUK, V127, P746, DOI 10.1525/auk.2010.10132; Walther BA, 2005, BEHAV ECOL, V16, P89, DOI 10.1093/beheco/arh135; Wolfenbarger LL, 1999, BEHAV ECOL, V10, P80, DOI 10.1093/beheco/10.1.80; Woodcock EA, 2005, ETHOLOGY, V111, P891, DOI 10.1111/j.1439-0310.2005.01120.x; Yorinks N, 2000, AUK, V117, P731, DOI 10.1642/0004-8038(2000)117[0731:EOMOAB]2.0.CO;2; ZAHAVI A, 1977, J THEOR BIOL, V67, P603, DOI 10.1016/0022-5193(77)90061-3; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3; Zampiga E, 2004, ETHOL ECOL EVOL, V16, P339, DOI 10.1080/08927014.2004.9522625	54	13	13	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25877	10.1371/journal.pone.0025877	http://dx.doi.org/10.1371/journal.pone.0025877			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991378	Green Published, gold, Green Submitted			2022-12-27	WOS:000295943000089
J	Arah, OA; Hoekstra, JBL; Bos, AP; Lombarts, KMJMH				Arah, Onyebuchi A.; Hoekstra, Joost B. L.; Bos, Albert P.; Lombarts, Kiki M. J. M. H.			New Tools for Systematic Evaluation of Teaching Qualities of Medical Faculty: Results of an Ongoing Multi-Center Survey	PLOS ONE			English	Article							SELF-ASSESSMENT; EDUCATIONAL FRAMEWORK; FACTORIAL VALIDATION; INTERNAL-MEDICINE; PERFORMANCE; COMPETENCE; COEFFICIENT; RELIABILITY; ASSESSMENTS; STRATEGIES	Background: Tools for the evaluation, improvement and promotion of the teaching excellence of faculty remain elusive in residency settings. This study investigates (i) the reliability and validity of the data yielded by using two new instruments for evaluating the teaching qualities of medical faculty, (ii) the instruments' potential for differentiating between faculty, and (iii) the number of residents' evaluations needed per faculty to reliably use the instruments. Methods and Materials: Multicenter cross-sectional survey among 546 residents and 629 medical faculty representing 29 medical (non-surgical) specialty training programs in the Netherlands. Two instruments-one completed by residents and one by faculty-for measuring teaching qualities of faculty were developed. Statistical analyses included factor analysis, reliability and validity exploration using standard psychometric methods, calculation of the numbers of residents' evaluations needed per faculty to achieve reliable assessments and variance components and threshold analyses. Results: A total of 403 (73.8%) residents completed 3575 evaluations of 570 medical faculty while 494 (78.5%) faculty self-evaluated. In both instruments five composite-scales of faculty teaching qualities were detected with high internal consistency and reliability: learning climate (Cronbach's alpha of 0.85 for residents' instrument, 0.71 for self-evaluation instrument, professional attitude and behavior (0.84/0.75), communication of goals (0.90/0.84), evaluation of residents (0.91/0.81), and feedback (0.91/0.85). Faculty tended to evaluate themselves higher than did the residents. Up to a third of the total variance in various teaching qualities can be attributed to between-faculty differences. Some seven residents' evaluations per faculty are needed for assessments to attain a reliability level of 0.90. Conclusions: The instruments for evaluating teaching qualities of medical faculty appear to yield reliable and valid data. They are feasible for use in medical residencies, can detect between-faculty differences and supply potentially useful information for improving graduate medical education.	[Arah, Onyebuchi A.] Univ Calif Los Angeles, Dept Epidemiol, UCLA Sch Publ Hlth, Los Angeles, CA 90095 USA; [Arah, Onyebuchi A.] UCLA Ctr Hlth Policy Res, Los Angeles, CA USA; [Arah, Onyebuchi A.; Lombarts, Kiki M. J. M. H.] Univ Amsterdam, Acad Med Ctr, Dept Qual Management & Proc Innovat, NL-1105 AZ Amsterdam, Netherlands; [Hoekstra, Joost B. L.] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands; [Bos, Albert P.] Univ Amsterdam, Acad Med Ctr, Dept Pediat, NL-1105 AZ Amsterdam, Netherlands	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Arah, OA (corresponding author), Univ Calif Los Angeles, Dept Epidemiol, UCLA Sch Publ Hlth, Los Angeles, CA 90095 USA.	m.j.lombarts@amc.uva.nl		Lombarts, Kiki/0000-0001-6167-0620; Arah, Onyebuchi/0000-0002-9067-1697	Academic Medical Center, Amsterdam, The Netherlands; Netherlands Organization for Scientific Research (NWO) [916.96.059]	Academic Medical Center, Amsterdam, The Netherlands(Netherlands Government); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This study was financed by the Academic Medical Center, Amsterdam, The Netherlands. Dr. Arah is also supported by a Grant (Veni # 916.96.059) from The Netherlands Organization for Scientific Research (NWO). No additional external funding was received for this study. For his contributions Dr. Arah received honoraria from the Department of Quality Management and Process Innovation of the Academic Medical Center (AMC), Amsterdam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AGME, RES COMP EV; Arah OA, 2006, HEALTH SERV RES, V41, P284, DOI 10.1111/j.1475-6773.2005.00462.x; Atasoylu AA, 2003, J GEN INTERN MED, V18, P711, DOI 10.1046/j.1525-1497.2003.10425.x; Baker K, 2010, ANESTHESIOLOGY, V113, P693, DOI 10.1097/ALN.0b013e3181eaacf4; Beckman TJ, 2006, MED EDUC, V40, P1209, DOI 10.1111/j.1365-2929.2006.02632.x; Beckman TJ, 2005, J GEN INTERN MED, V20, P1159, DOI 10.1111/j.1525-1497.2005.0258.x; Beckman TJ, 2004, J GEN INTERN MED, V19, P971, DOI 10.1111/j.1525-1497.2004.40066.x; Brennan T, 2002, LANCET, V359, P520, DOI 10.1016/s0140-6736(02)07684-5; Carifio J, 2008, MED EDUC, V42, P1150, DOI 10.1111/j.1365-2923.2008.03172.x; *CCMS, 2009, 0960842 CCMS; Chesire L, 1932, J AM STAT ASSOC, V27, P121, DOI 10.2307/2277653; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; CRONBACH LJ, 1957, AM PSYCHOL, V12, P671, DOI 10.1037/h0043943; Davis DA, 2006, JAMA-J AM MED ASSOC, V296, P1094, DOI 10.1001/jama.296.9.1094; de Oliveira GR, 2008, ANESTH ANALG, V107, P1316, DOI 10.1213/ane.0b013e318182fbdd; Duffy FD, 2008, J CONTIN EDUC HEALTH, V28, P38, DOI 10.1002/chp.154; Duffy FD, 2006, JAMA-J AM MED ASSOC, V296, P1137, DOI 10.1001/jama.296.9.1137; Dunlap HF, 1931, ANN MATH STAT, V2, P66, DOI 10.1214/aoms/1177733043; Eva KW, 2005, ACAD MED, V80, pS46, DOI 10.1097/00001888-200510001-00015; Fitzgibbons JP, 2006, ANN INTERN MED, V144, P920, DOI 10.7326/0003-4819-144-12-200606200-00010; FRANK JR, 2004, ROYAL COLL OUTLOOK, V1, P27; *GEN MED COUNC, 2010, QUAL FRAM SPEC INCL; General Medical Council, STAND CURR ASS SYST; Gien L T, 1991, J Nurs Educ, V30, P92; HAVLICEK LL, 1976, PERCEPT MOTOR SKILL, V43, P1319, DOI 10.2466/pms.1976.43.3f.1319; Holmboe ES, 2005, J GEN INTERN MED, V20, P1165, DOI 10.1111/j.1525-1497.2005.0249.x; Litzelman DK, 1998, ACAD MED, V73, P688, DOI 10.1097/00001888-199806000-00016; Litzelman DK, 1999, ACAD MED, V74, pS25, DOI 10.1097/00001888-199910000-00030; Lombarts KMJMH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015202; Lombarts KMJMH, 2009, ANESTHESIOLOGY, V111, P709, DOI 10.1097/ALN.0b013e3181b76516; Lombarts M J M H, 2007, Ned Tijdschr Geneeskd, V151, P2004; Lombarts M J M H Kiki, 2010, Ned Tijdschr Geneeskd, V154, pA1222; Maker Vijay K, 2006, Curr Surg, V63, P80, DOI 10.1016/j.cursur.2005.08.010; Maker Vijay K, 2004, Curr Surg, V61, P111, DOI 10.1016/j.cursur.2003.09.003; Marr N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020585; McLean M, 2008, MED TEACH, V30, P555, DOI 10.1080/01421590802109834; McLeod PJ, 2010, MED TEACH, V32, pE31, DOI 10.3109/01421590903199684; Metheny WP, 2005, AM J OBSTET GYNECOL, V192, P34, DOI 10.1016/j.ajog.2004.07.036; *NFU, 2010, MED SPEC STRAKS; Norcini J, 2009, INT J SURG, V7, P313, DOI 10.1016/j.ijsu.2009.06.011; Norman G, 2010, ADV HEALTH SCI EDUC, V15, P625, DOI 10.1007/s10459-010-9222-y; O'Malley PG, 2005, ARCH INTERN MED, V165, P2561, DOI 10.1001/archinte.165.22.2561; Overeem K, 2010, MED EDUC, V44, P140, DOI 10.1111/j.1365-2923.2009.03580.x; Holgado-Tello FP, 2010, QUAL QUANT, V44, P153, DOI 10.1007/s11135-008-9190-y; Pearson ES, 1932, J AM STAT ASSOC, V27, P424, DOI 10.2307/2278641; Pearson ES, 1931, BIOMETRIKA, V23, P114, DOI 10.1093/biomet/23.1-2.114; Ramani S, 2006, MED TEACH, V28, P19, DOI 10.1080/01421590500441786; Raykov T, 2006, STRUCT EQU MODELING, V13, P130, DOI 10.1207/s15328007sem1301_7; Raykov T, 2009, BRIT J MATH STAT PSY, V62, P129, DOI 10.1348/000711007X255345; Scheele F, 2008, MED TEACH, V30, P248, DOI 10.1080/01421590801993022; Seifert CF, 2003, J APPL PSYCHOL, V88, P561, DOI 10.1037/0021-9010.88.3.561; SKEFF KM, 1992, ARCH INTERN MED, V152, P1156, DOI 10.1001/archinte.1992.00400180028004; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012; Steinert Y, 2006, MED TEACH, V28, P497, DOI 10.1080/01421590600902976; Stevens J. P, 1992, APPL MULTIVARIATE ST; Streiner DL, 2015, HLTH MEASUREMENT SCA, DOI [10.1891/1521-0987.17.3.150, DOI 10.1891/1521-0987.17.3.150]; van der Vleuten CPM, 2005, MED EDUC, V39, P309, DOI 10.1111/j.1365-2929.2005.02094.x; Veloski J, 2006, MED TEACH, V28, P117, DOI 10.1080/01421590600622665; Weinberger SE, 2006, ANN INTERN MED, V144, P927, DOI 10.7326/0003-4819-144-12-200606200-00124; Wilkerson L, 1998, ACAD MED, V73, P387, DOI 10.1097/00001888-199804000-00011; Williams BC, 2002, ACAD MED, V77, P177, DOI 10.1097/00001888-200202000-00020; Wright SM, 1998, NEW ENGL J MED, V339, P1986, DOI 10.1056/NEJM199812313392706; [No title captured]	63	49	49	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e25983	10.1371/journal.pone.0025983	http://dx.doi.org/10.1371/journal.pone.0025983			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834RQ	22022486	Green Published, gold			2022-12-27	WOS:000295981600024
J	Nelson, ER; Levi, B; Sorkin, M; James, AW; Liu, KJ; Quarto, N; Longaker, MT				Nelson, Emily R.; Levi, Benjamin; Sorkin, Michael; James, Aaron W.; Liu, Karen J.; Quarto, Natalina; Longaker, Michael T.			Role of GSK-3 beta in the Osteogenic Differentiation of Palatal Mesenchyme	PLOS ONE			English	Article							CLEFT-PALATE; BONE-FORMATION; CELL FATE; WNT; ACTIVATION; MICE; PROLIFERATION; CHONDROCYTES; REQUIREMENT; MECHANISM	Introduction: The function of Glycogen Synthase Kinases 3 beta (GSK-3 beta) has previously been shown to be necessary for normal secondary palate development. Using GSK-3 beta null mouse embryos, we examine the potential coordinate roles of Wnt and Hedgehog signaling on palatal ossification. Methods: Palates were harvested from GSK-3 beta, embryonic days 15.0-18.5 (e15.0-e18.5), and e15.5 Indian Hedgehog (Ihh) null embryos, and their wild-type littermates. The phenotype of GSK-3 beta null embryos was analyzed with skeletal whole mount and pentachrome stains. Spatiotemporal regulation of osteogenic gene expression, in addition to Wnt and Hedgehog signaling activity, were examined in vivo on GSK-3 beta and Ihh +/+ and -/- e15.5 embryos using in situ hybridization and immunohistochemistry. To corroborate these results, expression of the same molecular targets were assessed by qRT-PCR of e15.5 palates, or e13.5 palate cultures treated with both Wnt and Hedgehog agonists and anatagonists. Results: GSK-3 beta null embryos displayed a 48 percent decrease (*p < 0.05) in palatine bone formation compared to wild-type littermates. GSK-3 beta null embryos also exhibited decreased osteogenic gene expression that was associated with increased Wnt and decreased Hedgehog signaling. e13.5 palate culture studies demonstrated that Wnt signaling negatively regulates both osteogenic gene expression and Hedgehog signaling activity, while inhibition of Wnt signaling augments both osteogenic gene expression and Hedgehog signaling activity. In addition, no differences in Wnt signaling activity were noted in Ihh null embryos, suggesting that canonical Wnt may be upstream of Hedgehog in secondary palate development. Lastly, we found that GSK-3 beta -/- palate cultures were "rescued" with the Wnt inhibitor, Dkk-1. Conclusions: Here, we identify a critical role for GSK-3 beta in palatogenesis through its direct regulation of canonical Wnt signaling. These findings shed light on critical developmental pathways involved in palatogenesis and may lead to novel molecular targets to prevent cleft palate formation.	[Nelson, Emily R.; Levi, Benjamin; Sorkin, Michael; James, Aaron W.; Quarto, Natalina; Longaker, Michael T.] Stanford Univ, Hagey Lab Pediat Regenerat Med, Div Plast & Reconstruct Surg, Dept Surg,Sch Med, Stanford, CA 94305 USA; [Liu, Karen J.] Kings Coll London, Dept Craniofacial Dev, London WC2R 2LS, England; [Quarto, Natalina] Univ Naples Federico 2, Dipartimento Sci Chirurg Anestesiol Rianimatorie, Naples, Italy; [Longaker, Michael T.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA	Stanford University; University of London; King's College London; University of Naples Federico II; Stanford University	Nelson, ER (corresponding author), Stanford Univ, Hagey Lab Pediat Regenerat Med, Div Plast & Reconstruct Surg, Dept Surg,Sch Med, Stanford, CA 94305 USA.	longaker@stanford.edu	Liu, Karen/F-2870-2010	Liu, Karen/0000-0002-2483-2165	National Institutes of Health, National Institute of Dental and Craniofacial Research [1R21DE018727]; Oak Foundation and Hagey Laboratory for Pediatric Regenerative Medicine; National Endowment for Plastic Surgery; National Institutes of Health, National Institute of Arthritis, and Musculoskeletal and Skin Diseases [1F32AR057302]; BBSRC [BB/E013872/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E013872/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR057302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE018727] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Oak Foundation and Hagey Laboratory for Pediatric Regenerative Medicine; National Endowment for Plastic Surgery; National Institutes of Health, National Institute of Arthritis, and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by National Institutes of Health, National Institute of Dental and Craniofacial Research grant 1R21DE018727, the Oak Foundation and Hagey Laboratory for Pediatric Regenerative Medicine, and the National Endowment for Plastic Surgery to Dr. Longaker. Dr. Levi was supported by the National Institutes of Health, National Institute of Arthritis, and Musculoskeletal and Skin Diseases grant 1F32AR057302. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron R, 2007, ENDOCRINOLOGY, V148, P2635, DOI 10.1210/en.2007-0270; Behr B, 2010, DEV BIOL, V344, P922, DOI 10.1016/j.ydbio.2010.06.009; Canalis E, 2007, NEW ENGL J MED, V357, P905, DOI 10.1056/NEJMra067395; Cordero D, 2004, J CLIN INVEST, V114, P485, DOI 10.1172/JCI200419596; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Doble BW, 2007, CELLS TISSUES ORGANS, V185, P73, DOI 10.1159/000101306; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Enomoto H, 2010, DEVELOPMENT, V137, P4029, DOI 10.1242/dev.050591; Grumolato L, 2010, GENE DEV, V24, P2517, DOI 10.1101/gad.1957710; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; James AW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007120; Jin YR, 2011, DEV BIOL, V352, P1, DOI 10.1016/j.ydbio.2011.01.004; Juriloff DM, 2006, BIRTH DEFECTS RES A, V76, P574, DOI 10.1002/bdra.20302; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Lan Y, 2006, DEV DYNAM, V235, P1448, DOI 10.1002/dvdy.20723; Levi B, 2011, PLAST RECONSTR SURG, V127, P1182, DOI 10.1097/PRS.0b013e3182043a07; Liu KJ, 2007, NATURE, V446, P79, DOI 10.1038/nature05557; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; Nalesso G, 2011, J CELL BIOL, V193, P551, DOI 10.1083/jcb.201011051; Nusse R, 2008, COLD SH Q B, V73, P59, DOI 10.1101/sqb.2008.73.035; Pongracz JE, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-15; Quarto N, 2010, TISSUE ENG PT A, V16, P3185, DOI 10.1089/ten.tea.2010.0133; Reinhold MI, 2006, J BIOL CHEM, V281, P1381, DOI 10.1074/jbc.M504875200; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Taya Y, 1999, DEVELOPMENT, V126, P3869; ten Berge D, 2008, DEVELOPMENT, V135, P3247, DOI 10.1242/dev.023176; YAVROPOULOU MP, 2007, GUT, V6, P279	29	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e25847	10.1371/journal.pone.0025847	http://dx.doi.org/10.1371/journal.pone.0025847			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022457	gold, Green Published, Green Submitted			2022-12-27	WOS:000295981600015
J	Baliki, MN; Schnitzer, TJ; Bauer, WR; Apkarian, AV				Baliki, Marwan N.; Schnitzer, Thomas J.; Bauer, William R.; Apkarian, A. Vania			Brain Morphological Signatures for Chronic Pain	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; GRAY-MATTER DECREASE; FIBROMYALGIA PATIENTS; CINGULATE CORTEX; AMYGDALA; OSTEOARTHRITIS; CONNECTIVITY; PERFORMANCE; PERCEPTION; MECHANISMS	Chronic pain can be understood not only as an altered functional state, but also as a consequence of neuronal plasticity. Here we use in vivo structural MRI to compare global, local, and architectural changes in gray matter properties in patients suffering from chronic back pain (CBP), complex regional pain syndrome (CRPS) and knee osteoarthritis (OA), relative to healthy controls. We find that different chronic pain types exhibit unique anatomical 'brain signatures'. Only the CBP group showed altered whole-brain gray matter volume, while regional gray matter density was distinct for each group. Voxel-wise comparison of gray matter density showed that the impact on the extent of chronicity of pain was localized to a common set of regions across all conditions. When gray matter density was examined for large regions approximating Brodmann areas, it exhibited unique large-scale distributed networks for each group. We derived a barcode, summarized by a single index of within-subject co-variation of gray matter density, which enabled classification of individual brains to their conditions with high accuracy. This index also enabled calculating time constants and asymptotic amplitudes for an exponential increase in brain re-organization with pain chronicity, and showed that brain reorganization with pain chronicity was 6 times slower and twice as large in CBP in comparison to CRPS. The results show an exuberance of brain anatomical reorganization peculiar to each condition and as such reflecting the unique maladaptive physiology of different types of chronic pain.	[Baliki, Marwan N.; Apkarian, A. Vania] Northwestern Univ, Dept Physiol, Chicago, IL 60611 USA; [Schnitzer, Thomas J.] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Bauer, William R.] Univ Toledo, Dept Neurosci, Toledo, OH 43606 USA; [Apkarian, A. Vania] Feinberg Sch Med, Dept Anesthesia, Chicago, IL USA; [Apkarian, A. Vania] Feinberg Sch Med, Dept Surg, Chicago, IL USA	Northwestern University; Northwestern University; University System of Ohio; University of Toledo; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Baliki, MN (corresponding author), Northwestern Univ, Dept Physiol, Chicago, IL 60611 USA.	a-apkarian@northwestern.edu		Apkarian, A. Vania/0000-0002-9788-7458	National Institutes of Health National Institute of Neurological Disorders and Stroke [NS35115]; anonymous foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035115] Funding Source: NIH RePORTER	National Institutes of Health National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); anonymous foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by the National Institutes of Health National Institute of Neurological Disorders and Stroke NS35115. MNB was funded by an anonymous foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambroggi F, 2008, NEURON, V59, P648, DOI 10.1016/j.neuron.2008.07.004; Apkarian AV, 2009, PROG NEUROBIOL, V87, P81, DOI 10.1016/j.pneurobio.2008.09.018; Apkarian AV, 2008, CURR OPIN NEUROBIOL, V18, P464, DOI 10.1016/j.conb.2008.09.012; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Apkarian AV, 2004, J NEUROSCI, V24, P10410, DOI 10.1523/JNEUROSCI.2541-04.2004; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Baliki MN, 2008, J NEUROSCI, V28, P1398, DOI 10.1523/JNEUROSCI.4123-07.2008; Baliki MN, 2010, NEURON, V66, P149, DOI 10.1016/j.neuron.2010.03.002; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Blankstein U, 2010, GASTROENTEROLOGY, V138, P1783, DOI 10.1053/j.gastro.2009.12.043; Burgmer M, 2009, PSYCHOSOM MED, V71, P566, DOI 10.1097/PSY.0b013e3181a32da0; Cauda F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004542; Davis KD, 1995, NEUROREPORT, V7, P321, DOI 10.1097/00001756-199512290-00077; Fields H., 2006, P 11 WORLD C PAIN SE, P449; Geha PY, 2008, NEURON, V60, P570, DOI 10.1016/j.neuron.2008.08.022; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Gwilym SE, 2010, ARTHRITIS RHEUM-US, V62, P2930, DOI 10.1002/art.27585; Gwilym SE, 2009, ARTHRIT RHEUM-ARTHR, V61, P1226, DOI 10.1002/art.24837; Harden RN, 2005, J PAIN, V6, P364, DOI 10.1016/j.jpain.2005.01.350; Hsu MC, 2009, PAIN, V143, P262, DOI 10.1016/j.pain.2009.03.017; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Kim J, 2008, CEPHALALGIA, V28, P598, DOI 10.1111/j.1468-2982.2008.01550.x; Kuchinad A, 2007, J NEUROSCI, V27, P4004, DOI 10.1523/JNEUROSCI.0098-07.2007; Lerch JP, 2006, NEUROIMAGE, V31, P993, DOI 10.1016/j.neuroimage.2006.01.042; Luerding R, 2008, BRAIN, V131, P3222, DOI 10.1093/brain/awn229; May A, 2009, NAT REV NEUROL, V5, P199, DOI 10.1038/nrneurol.2009.28; Mayer E.A., 2009, FUNCTIONAL PAIN SYND; Metz AE, 2009, P NATL ACAD SCI USA, V106, P2423, DOI 10.1073/pnas.0809897106; Napadow V, 2010, ARTHRITIS RHEUM-US, V62, P2545, DOI 10.1002/art.27497; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Obermann M, 2009, NEUROLOGY, V73, P978, DOI 10.1212/WNL.0b013e3181b8791a; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Resnick SM, 2003, J NEUROSCI, V23, P3295; Rodriguez-Raecke R, 2009, J NEUROSCI, V29, P13746, DOI 10.1523/JNEUROSCI.3687-09.2009; Rousseeuw PJ, 1999, AM STAT, V53, P382, DOI 10.2307/2686061; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Schmidt-Wilcke T, 2007, PAIN, V132, pS109, DOI 10.1016/j.pain.2007.05.010; Schmidt-Wilcke T, 2005, NEUROLOGY, V65, P1483, DOI 10.1212/01.wnl.0000183067.94400.80; Schmidt-Wilcke Tobias, 2008, Curr Rheumatol Rep, V10, P467; SCHMIDTWILCKE T, 2006, PAIN; Schweinhardt P, 2008, PAIN, V140, P411, DOI 10.1016/j.pain.2008.09.014; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Seminowicz DA, 2007, J NEUROPHYSIOL, V97, P3651, DOI 10.1152/jn.01210.2006; Seminowicz DA, 2010, GASTROENTEROLOGY, V139, P48, DOI 10.1053/j.gastro.2010.03.049; Seminowicz DA, 2009, NEUROIMAGE, V47, P1007, DOI 10.1016/j.neuroimage.2009.05.068; Senjem ML, 2005, NEUROIMAGE, V26, P600, DOI 10.1016/j.neuroimage.2005.02.005; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Tagliazucchi E, 2010, NEUROSCI LETT, V485, P26, DOI 10.1016/j.neulet.2010.08.053; Tu CH, 2010, PAIN, V150, P462, DOI 10.1016/j.pain.2010.05.026; Valfre W, 2008, HEADACHE, V48, P109, DOI 10.1111/j.1526-4610.2007.00723.x; Wood PB, 2007, J PAIN, V8, P51, DOI 10.1016/j.jpain.2006.05.014; Wright IC, 1999, CEREB CORTEX, V9, P366, DOI 10.1093/cercor/9.4.366; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	55	247	254	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e26010	10.1371/journal.pone.0026010	http://dx.doi.org/10.1371/journal.pone.0026010			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022493	Green Published, Green Submitted, gold			2022-12-27	WOS:000295978600035
J	Silliman, BR; Bertness, MD; Altieri, AH; Griffin, JN; Bazterrica, MC; Hidalgo, FJ; Crain, CM; Reyna, MV				Silliman, Brian R.; Bertness, Mark D.; Altieri, Andrew H.; Griffin, John N.; Cielo Bazterrica, M.; Hidalgo, Fernando J.; Crain, Caitlin M.; Reyna, Maria V.			Whole-Community Facilitation Regulates Biodiversity on Patagonian Rocky Shores	PLOS ONE			English	Article							POSITIVE INTERACTIONS; SPECIES INTERACTIONS; SALT MARSHES; NEW-ZEALAND; DIVERSITY; NETWORKS; HABITAT; DISTURBANCE; PREDATION; PRODUCTIVITY	Background: Understanding the factors that generate and maintain biodiversity is a central goal in ecology. While positive species interactions (i.e., facilitation) have historically been underemphasized in ecological research, they are increasingly recognized as playing important roles in the evolution and maintenance of biodiversity. Dominant habitat-forming species (foundation species) buffer environmental conditions and can therefore facilitate myriad associated species. Theory predicts that facilitation will be the dominant community-structuring force under harsh environmental conditions, where organisms depend on shelter for survival and predation is diminished. Wind-swept, arid Patagonian rocky shores are one of the most desiccating intertidal rocky shores ever studied, providing an opportunity to test this theory and elucidate the context-dependency of facilitation. Methodology/Principal Findings: Surveys across 2100 km of southern Argentinean coastline and experimental manipulations both supported theoretical predictions, with 43 out of 46 species in the animal assemblage obligated to living within the matrices of mussels for protection from potentially lethal desiccation stress and predators having no detectable impact on diversity. Conclusions/Significance: These results provide the first experimental support of long-standing theoretical predictions and reveal that in extreme climates, maintenance of whole-community diversity can be maintained by positive interactions that ameliorate physical stress. These findings have important conservation implications and emphasize that preserving foundation species should be a priority in remediating the biodiversity consequences of global climate change.	[Silliman, Brian R.; Griffin, John N.] Univ Florida, Dept Biol, Gainesville, FL 32610 USA; [Bertness, Mark D.; Altieri, Andrew H.; Crain, Caitlin M.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Cielo Bazterrica, M.; Hidalgo, Fernando J.; Reyna, Maria V.] Univ Patagonia, Dept Biol, Puerto Madryn, Chibut, Argentina; [Reyna, Maria V.] Natl Univ Mar del Plata, Dept Biol, Mar Del Plata, Buenos Aires, Argentina	State University System of Florida; University of Florida; Brown University; National University of Mar del Plata	Silliman, BR (corresponding author), Univ Florida, Dept Biol, Gainesville, FL 32610 USA.	brs@ufl.edu	Altieri, Andrew H/P-1738-2017; Hidalgo, Fernando/L-8046-2013	Altieri, Andrew/0000-0001-7439-8742; Griffin, John/0000-0003-3295-6480; Silliman, Brian/0000-0001-6360-650X	Mellon Foundation; NSF [0542822]; University of Florida	Mellon Foundation; NSF(National Science Foundation (NSF)); University of Florida(University of Florida)	A grant from the Mellon Foundation (www.mellon.org) to M. D. Bertness supported this work as well as an NSF award (#0542822) to M. D. Bertness and B. R. Silliman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Publication of this article was funded in part by the University of Florida Open-Access Publishing Fund.	Alberti J, 2007, MAR ECOL PROG SER, V349, P235, DOI 10.3354/meps07089; Altieri AH, 2007, AM NAT, V169, P195, DOI 10.1086/510603; Angelini C, BIO SCI IN PRESS; Barbier EB, 2008, SCIENCE, V319, P321, DOI 10.1126/science.1150349; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bazterrica MC, 2007, J EXP MAR BIOL ECOL, V353, P22, DOI 10.1016/j.jembe.2007.08.018; Bertness MD, 2006, ECOL MONOGR, V76, P439, DOI 10.1890/0012-9615(2006)076[0439:TCSOWA]2.0.CO;2; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Brose U, 2005, ECOL LETT, V8, P1317, DOI 10.1111/j.1461-0248.2005.00838.x; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Bruno JF, 2000, ECOLOGY, V81, P1179, DOI 10.2307/177200; Bunker D.E., 2009, BIODIVERSITY ECOSYST; Byrnes JE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000295; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Dayton P.K., 1972, P C CONSERVATION PRO, P81; Fortuna MA, 2006, ECOL LETT, V9, P278, DOI 10.1111/j.1461-0248.2005.00868.x; Gaines, 2007, ENCY TIDEPOOLS ROCKY; Halpern BS, 2007, FRONT ECOL ENVIRON, V5, P153, DOI 10.1890/1540-9295(2007)5[153:IPIIAR]2.0.CO;2; HART DD, 1992, OECOLOGIA, V91, P220, DOI 10.1007/BF00317787; Hidalgo FJ, 2007, ESTUAR COAST, V30, P886, DOI 10.1007/BF02841342; Kiers ET, 2010, ECOL LETT, V13, P1459, DOI 10.1111/j.1461-0248.2010.01538.x; Klanderud K, 2005, ECOLOGY, V86, P2047, DOI 10.1890/04-1563; LUBCHENCO J, 1978, ECOL MONOGR, V48, P67, DOI 10.2307/2937360; McClain CR, 2010, ECOLOGY, V91, P964, DOI 10.1890/09-0087.1; MENGE BA, 1987, AM NAT, V130, P730, DOI 10.1086/284741; Millennium Ecosystem Assessment, 2005, ECOSYSTEMS HUMAN WEL; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; PAINE RT, 1985, AM NAT, V125, P679, DOI 10.1086/284371; PAINE RT, 1971, ECOLOGY, V52, P1096, DOI 10.2307/1933819; Palmer TM, 2008, SCIENCE, V319, P192, DOI 10.1126/science.1151579; Power ME, 1996, BIOSCIENCE, V46, P609, DOI 10.2307/1312990; Sanford E, 1999, SCIENCE, V283, P2095, DOI 10.1126/science.283.5410.2095; SEED R, 1969, OECOLOGIA, V3, P317, DOI 10.1007/BF00390381; Silliman BR, 2005, SCIENCE, V310, P1803, DOI 10.1126/science.1118229; Silliman BR, 2003, OIKOS, V101, P549, DOI 10.1034/j.1600-0706.2003.12070.x; Sokolov AP, 2009, J CLIMATE, V22, P5175, DOI 10.1175/2009JCLI2863.1; SOUSA WP, 1979, ECOLOGY, V60, P1225, DOI 10.2307/1936969; Suchanek TH, 1986, ECOLOGY ROCKY COASTS; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Verdu M, 2008, AM NAT, V172, P751, DOI 10.1086/593003; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	44	90	91	1	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e24502	10.1371/journal.pone.0024502	http://dx.doi.org/10.1371/journal.pone.0024502			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022356	Green Submitted, Green Published, gold			2022-12-27	WOS:000295978600003
J	Inglis, TJJ; Merritt, AJ; Levy, A; Vietheer, P; Bradbury, R; Scholler, A; Chidlow, G; Smith, DW				Inglis, Timothy J. J.; Merritt, Adam J.; Levy, Avram; Vietheer, Patricia; Bradbury, Richard; Scholler, Adam; Chidlow, Glenys; Smith, David W.			Deployable Laboratory Response to Influenza Pandemic; PCR Assay Field Trials and Comparison with Reference Methods	PLOS ONE			English	Article							H1N1 2009; VIRUS; OUTBREAK	Background: The influenza A/H1N1/09 pandemic spread quickly during the Southern Hemisphere winter in 2009 and reached epidemic proportions within weeks of the official WHO alert. Vulnerable population groups included indigenous Australians and remote northern population centres visited by international travellers. At the height of the Australian epidemic a large number of troops converged on a training area in northern Australia for an international exercise, raising concerns about their potential exposure to the emerging influenza threat before, during and immediately after their arrival in the area. Influenza A/H1N1/09 became the dominant seasonal variant and returned to Australia during the Southern winter the following year. Methods: A duplex nucleic acid amplification assay was developed within weeks of the first WHO influenza pandemic alert, demonstrated in northwestern Australia shortly afterwards and deployed as part of the pathology support for a field hospital during a military exercise during the initial epidemic surge in June 2009. Results: The nucleic acid amplification assay was twice as sensitive as a point of care influenza immunoassay, as specific but a little less sensitive than the reference laboratory nucleic acid amplification assay. Repetition of the field assay with blinded clinical samples obtained during the 2010 winter influenza season demonstrated a 91.7% congruence with the reference laboratory method. Conclusions: Rapid in-house development of a deployable epidemic influenza assay allowed a flexible laboratory response, effective targeting of limited disease control resources in an austere military environment, and provided the public health laboratory service with a set of verification tools for resource-limited settings. The assay method was suitable for rapid deployment in time for the 2010 Northern winter.	[Inglis, Timothy J. J.; Merritt, Adam J.; Levy, Avram; Chidlow, Glenys; Smith, David W.] QEII Med Ctr, PathWest Lab Med WA, Div Microbiol & Infect Dis, Nedlands, WA, Australia; [Inglis, Timothy J. J.; Vietheer, Patricia; Bradbury, Richard] Australian Army, Combat Support Serv Brigade 17, Hlth Support Battal, Keswick, SA, Australia; [Inglis, Timothy J. J.; Merritt, Adam J.; Smith, David W.] Univ Western Australia, Fac Med Dent & Hlth Sci, Sch Pathol & Lab Med, Nedlands, WA 6009, Australia; [Vietheer, Patricia] Burnet Inst, Viral Fus Lab, Ctr Virol, Melbourne, Vic, Australia; [Bradbury, Richard] Univ Tasmania, Sch Med, Hobart, Tas, Australia; [Scholler, Adam] Australian Army, Combat Support Serv Brigade 17, Hlth Support Battal, Enoggera, Qld, Australia; [Scholler, Adam] Rockhampton Base Hosp, Pathol Lab, Rockhampton, Qld, Australia	University of Western Australia; University of Western Australia; Burnet Institute; University of Tasmania	Inglis, TJJ (corresponding author), QEII Med Ctr, PathWest Lab Med WA, Div Microbiol & Infect Dis, Nedlands, WA, Australia.	tim.inglis@health.wa.gov.au	Bradbury, Richard Stewart/N-3273-2013	Bradbury, Richard Stewart/0000-0002-5524-506X; Levy, Avram/0000-0002-0934-2387; Smith, David/0000-0002-3107-5182				Barry JM, 2008, J INFECT DIS, V198, P1427, DOI 10.1086/592454; Chidlow G, 2010, J CLIN MICROBIOL, V48, P862, DOI 10.1128/JCM.01435-09; Currie AJ, 2011, AUSTRALAS EMERG NURS, V14, P103, DOI 10.1016/j.aenj.2011.03.002; Daum LT, 2007, INFLUENZA OTHER RESP, V1, P167, DOI 10.1111/j.1750-2659.2007.00024.x; Dill CE, 2009, DISASTER MED PUBLIC, V3, pS117, DOI 10.1097/DMP.0b013e3181bf249b; Faix DJ, 2009, NEW ENGL J MED, V361, P728, DOI 10.1056/NEJMc0904264; Foo H, 2009, J CLIN VIROL, V46, P384, DOI 10.1016/j.jcv.2009.09.019; Hurt AC, 2009, INFLUENZA OTHER RESP, V3, P171, DOI 10.1111/j.1750-2659.2009.00086.x; Inglis TJJ, 2008, J CLIN MICROBIOL, V46, P3479, DOI 10.1128/JCM.01254-08; Inglis Timothy J J, 2009, Med J Aust, V191, P597; Kallstrom G, 2009, MIL MED, V174, P35, DOI 10.7205/MILMED-D-00-5108; Kelly HA, 2009, MED J AUSTRALIA, V191, P146, DOI 10.5694/j.1326-5377.2009.tb02723.x; Montero EM, 2010, REV ESP SALUD PUBLIC, V84, P597, DOI 10.1590/s1135-57272010000500011; Popowitch EB, 2011, J CLIN MICROBIOL, V49, P3368, DOI 10.1128/JCM.01162-11; Takekawa JY, 2011, JOVE-J VIS EXP, DOI 10.3791/2829; Teo J, 2011, ARCH VIROL, V156, P1371, DOI 10.1007/s00705-011-0999-7; Whiley DM, 2009, J CLIN VIROL, V45, P203, DOI 10.1016/j.jcv.2009.05.032	17	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25526	10.1371/journal.pone.0025526	http://dx.doi.org/10.1371/journal.pone.0025526			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022407	Green Published, gold			2022-12-27	WOS:000295976000019
J	Mng'ong'o, FC; Sambali, JJ; Sabas, E; Rubanga, J; Magoma, J; Ntamatungiro, AJ; Turner, EL; Nyogea, D; Ensink, JHJ; Moore, SJ				Mng'ong'o, Frank C.; Sambali, Joseph J.; Sabas, Eustachkius; Rubanga, Justine; Magoma, Jaka; Ntamatungiro, Alex J.; Turner, Elizabeth L.; Nyogea, Daniel; Ensink, Jeroen H. J.; Moore, Sarah J.			Repellent Plants Provide Affordable Natural Screening to Prevent Mosquito House Entry in Tropical Rural Settings-Results from a Pilot Efficacy Study	PLOS ONE			English	Article							ANOPHELES-GAMBIAE DIPTERA; WESTERN KENYA; MALARIA VECTORS; FEEDING-BEHAVIOR; LANTANA-CAMARA; BODY-SIZE; SUGAR AVAILABILITY; FUNESTUS DIPTERA; FIELD-EVALUATION; CULICIDAE	Sustained malaria control is underway using a combination of vector control, prompt diagnosis and treatment of malaria cases. Progress is excellent, but for long-term control, low-cost, sustainable tools that supplement existing control programs are needed. Conventional vector control tools such as indoor residual spraying and house screening are highly effective, but difficult to deliver in rural areas. Therefore, an additional means of reducing mosquito house entry was evaluated: the screening of mosquito house entry points by planting the tall and densely foliated repellent plant Lantana camara L. around houses. A pilot efficacy study was performed in Kagera Region, Tanzania in an area of high seasonal malaria transmission, where consenting families within the study village planted L. camara (Lantana) around their homes and were responsible for maintaining the plants. Questionnaire data on house design, socioeconomic status, malaria prevention knowledge, attitude and practices was collected from 231 houses with Lantana planted around them 90 houses without repellent plants. Mosquitoes were collected using CDC Light Traps between September 2008 and July 2009. Data were analysed with generalised negative binomial regression, controlling for the effect of sampling period. Indoor catches of mosquitoes in houses with Lantana were compared using the Incidence Rate Ratio (IRR) relative to houses without plants in an adjusted analysis. There were 56% fewer Anopheles gambiae s.s. (IRR 0.44, 95% CI 0.28-0.68, p<0.0001); 83% fewer Anopheles funestus s.s. (IRR 0.17, 95% CI 0.09-0.32, p<0.0001), and 50% fewer mosquitoes of any kind (IRR 0.50, 95% CI 0.38-0.67, p<0.0001) in houses with Lantana relative to controls. House screening using Lantana reduced indoor densities of malaria vectors and nuisance mosquitoes with broad community acceptance. Providing sufficient plants for one home costs US $1.50 including maintenance and labour costs, (30 cents per person). L. camara mode of action and suitability for mosquito control is discussed.	[Mng'ong'o, Frank C.; Sabas, Eustachkius; Rubanga, Justine; Magoma, Jaka] Concern Worldwide Tanzania, Dar Es Salaam, Tanzania; [Mng'ong'o, Frank C.; Ensink, Jeroen H. J.; Moore, Sarah J.] London Sch Hyg & Trop Med, Dis Control Dept, London WC1, England; [Sambali, Joseph J.; Ntamatungiro, Alex J.; Nyogea, Daniel; Moore, Sarah J.] Ifakara Hlth Inst, Biomed & Environm Grp, Ifakara, Tanzania; [Sambali, Joseph J.] Univ Durham, Dept Geog, Durham, England; [Turner, Elizabeth L.] London Sch Hyg & Trop Med, Dept Med Stat, London WC1, England	University of London; London School of Hygiene & Tropical Medicine; Ifakara Health Institute; Durham University; University of London; London School of Hygiene & Tropical Medicine	Mng'ong'o, FC (corresponding author), Concern Worldwide Tanzania, Dar Es Salaam, Tanzania.	sarah.moore@lshtm.ac.uk	Moore, Sarah J/HGE-7143-2022	Moore, Sarah J/0000-0002-0938-6654	Xerox Foundation; Concern Worldwide Tanzania	Xerox Foundation; Concern Worldwide Tanzania	Funding was provided by the Xerox Foundation. http://www.xerox.com/corporate-citizenship-2010/our-communities/xerox-foundation.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would also like to express our appreciations to Manu Mwaipopo, Andrew Fitzgibon and James Davey (Country Director-Concern Worldwide Tanzania) for their untiring encouragement and support.	Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000401; [Anonymous], 2003, ACIAR MONOGRAPH; [Anonymous], WHO GLOB MAL PROGR P; BAEZ JE, J DEV EC, V96, P391; Beier JC, 1996, J MED ENTOMOL, V33, P613, DOI 10.1093/jmedent/33.4.613; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Bonner K, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-73; BRIEGEL H, 1990, J MED ENTOMOL, V27, P839, DOI 10.1093/jmedent/27.5.839; Broughton S, 2000, BIOL CONTROL, V17, P272, DOI 10.1006/bcon.1999.0793; BURKOT TR, 1988, PARASITOL TODAY, V4, P156, DOI 10.1016/0169-4758(88)90151-2; Carstairs SD, 2010, PEDIATRICS, V126, pE1585, DOI 10.1542/peds.2010-1669; DEWEERDT J, EC DEV INITIATIVES; Diallo DA, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P377; Dua VK, 2010, INDIAN J MED RES, V131, P434; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Foster WA, 2004, B ENTOMOL RES, V94, P145, DOI 10.1079/BER2003288; FOSTER WA, 1995, ANNU REV ENTOMOL, V40, P443, DOI 10.1146/annurev.en.40.010195.002303; FOURIE N, 1987, Journal of the South African Veterinary Association, V58, P173; Gary RE, 2004, MED VET ENTOMOL, V18, P102, DOI 10.1111/j.0269-283X.2004.00483.x; Gary RE, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-19; Ghisalberti EL, 2000, FITOTERAPIA, V71, P467, DOI 10.1016/S0367-326X(00)00202-1; GILLIES MT, 1954, B ENTOMOL RES, V45, P375, DOI 10.1017/S000748530002719X; Gu WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015996; Impoinvil DE, 2004, MED VET ENTOMOL, V18, P108, DOI 10.1111/j.0269-283X.2004.00484.x; Jones AE, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-162; Kaufmann C, 2004, J VECTOR ECOL, V29, P140; Kirby MJ, 2009, LANCET, V374, P998, DOI 10.1016/S0140-6736(09)60871-0; Koekemoer LL, 2002, AM J TROP MED HYG, V66, P804, DOI 10.4269/ajtmh.2002.66.804; Kolaczinski K, 2007, T ROY SOC TROP MED H, V101, P852, DOI 10.1016/j.trstmh.2007.04.003; Lindsay SW, 2002, TRENDS PARASITOL, V18, P510, DOI 10.1016/S1471-4922(02)02382-6; LINES JD, 1991, B ENTOMOL RES, V81, P77, DOI 10.1017/S0007485300053268; LINES JD, 1987, MED VET ENTOMOL, V1, P37, DOI 10.1111/j.1365-2915.1987.tb00321.x; Llusia J, 2010, GLOBAL ECOL BIOGEOGR, V19, P863, DOI 10.1111/j.1466-8238.2010.00557.x; LYIMO EO, 1993, MED VET ENTOMOL, V7, P328, DOI 10.1111/j.1365-2915.1993.tb00700.x; Manda H, 2007, MED VET ENTOMOL, V21, P103, DOI 10.1111/j.1365-2915.2007.00672.x; Manda H, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-113; Mboera LEG, 1998, AM J TROP MED HYG, V59, P595, DOI 10.4269/ajtmh.1998.59.595; Moore SJ, 2007, J MED ENTOMOL, V44, P624, DOI 10.1603/0022-2585(2007)44[624:FEOTUP]2.0.CO;2; Moore SJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-344; National Bureau of Statistics and Office of the Chief Government Statistician-Zanzibar, 2005, TANZ DEM HLTH SURV 2; Ogoma SB, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-221; Okech BA, 2003, J MED ENTOMOL, V40, P657, DOI 10.1603/0022-2585-40.5.657; OKOTH JO, 1986, ACTA TROP, V43, P283; Omolo MO, 2005, PHYTOMEDICINE, V12, P241, DOI 10.1016/j.phymed.2003.10.004; Padhy PK, 2005, CHEMOSPHERE, V59, P1643, DOI 10.1016/j.chemosphere.2005.01.046; Pulford J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-83; Rabarison P, 1997, Sante, V7, P39; Saul A, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-32; SEXTON JD, 1990, AM J TROP MED HYG, V43, P11, DOI 10.4269/ajtmh.1990.43.11; Seyoum A, 2003, TROP MED INT HEALTH, V8, P1005, DOI 10.1046/j.1360-2276.2003.01125.x; Steketee RW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-299; Stone CM, 2011, ANIM BEHAV, V81, P765, DOI 10.1016/j.anbehav.2011.01.008; Straif SC, 1996, J MED ENTOMOL, V33, P608, DOI 10.1093/jmedent/33.4.608; TACAIDS/Tanzania ZAC/Tanzania NBS/Tanzania OCGS/Tanzania and Macro International, 2008, TANZ HIV AIDS MAL IN; Takken W, 2002, TROP MED INT HEALTH, V7, P1022, DOI 10.1046/j.1365-3156.2002.00983.x; *USDA, 1947, E733 USDA BUR ENT PL; Van den Broeck J, 2005, PLOS MED, V2, P966, DOI 10.1371/journal.pmed.0020267; Walker TW, 1996, J AM MOSQUITO CONTR, V12, P172; Yukich JO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-258	59	23	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25927	10.1371/journal.pone.0025927	http://dx.doi.org/10.1371/journal.pone.0025927			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022471	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000295976000046
J	Sheena, A; Mohan, SS; Haridas, NPA; Anilkumar, G				Sheena, Aswathy; Mohan, Suma S.; Haridas, Nidhina Pachakkil A.; Anilkumar, Gopalakrishnapillai			Elucidation of the Glucose Transport Pathway in Glucose Transporter 4 via Steered Molecular Dynamics Simulations	PLOS ONE			English	Article							CYSTEINE-SCANNING MUTAGENESIS; EXOFACIAL LIGAND-BINDING; SUGAR-TRANSPORT; HUMAN ERYTHROCYTE; C-TERMINI; GLUT1; ACCESSIBILITY; MECHANISM; HELIX; ATP	Background: GLUT4 is a predominant insulin regulated glucose transporter expressed in major glucose disposal tissues such as adipocytes and muscles. Under the unstimulated state, GLUT4 resides within intracellular vesicles. Various stimuli such as insulin translocate this protein to the plasma membrane for glucose transport. In the absence of a crystal structure for GLUT4, very little is known about the mechanism of glucose transport by this protein. Earlier we proposed a homology model for GLUT4 and performed a conventional molecular dynamics study revealing the conformational rearrangements during glucose and ATP binding. However, this study could not explain the transport of glucose through the permeation tunnel. Methodology/Principal Findings: To elucidate the molecular mechanism of glucose transport and its energetic, a steered molecular dynamics study (SMD) was used. Glucose was pulled from the extracellular end of GLUT4 to the cytoplasm along the pathway using constant velocity pulling method. We identified several key residues within the tunnel that interact directly with either the backbone ring or the hydroxyl groups of glucose. A rotation of glucose molecule was seen near the sugar binding site facilitating the sugar recognition process at the QLS binding site. Conclusions/Significance: This study proposes a possible glucose transport pathway and aids the identification of several residues that make direct interactions with glucose during glucose transport. Mutational studies are required to further validate the observation made in this study.	[Sheena, Aswathy; Mohan, Suma S.; Haridas, Nidhina Pachakkil A.; Anilkumar, Gopalakrishnapillai] Amrita Sch Biotechnol, Amrita Vishwa Vidyapeeth, Kollam, India	Amrita Vishwa Vidyapeetham; Amrita Vishwa Vidyapeetham Amritapuri	Sheena, A (corresponding author), Amrita Sch Biotechnol, Amrita Vishwa Vidyapeeth, Kollam, India.	g.soanil@gmail.com	Mohan S, Suma/GNW-4180-2022; gopala, Anilkumar/AAG-2713-2021	Mohan S, Suma/0000-0001-7692-163X; Gopalakrishnapillai, Anilkumar/0000-0002-0465-578X; Nidhina Haridas, Pachakkil antharaparambath/0000-0003-3096-206X	Bioinformatics Division, Department of Biotechnology, The Ministry of Science and Technology, Government of India [BT/PR11427/BID/07/270/2008]	Bioinformatics Division, Department of Biotechnology, The Ministry of Science and Technology, Government of India	This work is supported by the Bioinformatics Division, Department of Biotechnology, The Ministry of Science and Technology, Government of India, grant no: BT/PR11427/BID/07/270/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hasani H, 2002, J CELL SCI, V115, P131; Alisio A, 2004, J BIOL CHEM, V279, P26540, DOI 10.1074/jbc.M402303200; Araki S, 1996, BIOCHEM J, V315, P153, DOI 10.1042/bj3150153; BARNETT JEG, 1973, BIOCHEM J, V135, P539, DOI 10.1042/bj1350539; BARNETT JEG, 1973, BIOCHEM J, V131, P211, DOI 10.1042/bj1310211; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BIRNBAUM MJ, 1989, CELL, V57, P305, DOI 10.1016/0092-8674(89)90968-9; Blodgett DM, 2007, J GEN PHYSIOL, V130, P157, DOI 10.1085/jgp.200709818; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Doege H, 1998, BIOCHEM J, V329, P289, DOI 10.1042/bj3290289; EZAKI O, 1982, J BIOL CHEM, V257, P4306; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; GARCIA JC, 1992, J BIOL CHEM, V267, P7770; Gua Y, 2009, P NATL ACAD SCI USA, V106, P2589, DOI 10.1073/pnas.0812299106; Gullingsrud J, 2003, BIOPHYS J, V85, P2087, DOI 10.1016/S0006-3495(03)74637-2; HASHIRAMOTO M, 1992, J BIOL CHEM, V267, P17502; Heinze M, 2004, BIOCHEMISTRY-US, V43, P931, DOI 10.1021/bi030175w; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hruz PW, 2000, BIOCHEMISTRY-US, V39, P9367, DOI 10.1021/bi000821g; Hub JS, 2008, P NATL ACAD SCI USA, V105, P1198, DOI 10.1073/pnas.0707662104; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; INUKAI K, 1994, BIOCHEM J, V302, P355, DOI 10.1042/bj3020355; Jensen MO, 2002, P NATL ACAD SCI USA, V99, P6731, DOI 10.1073/pnas.102649299; Jensen MO, 2007, BIOPHYS J, V93, P92, DOI 10.1529/biophysj.107.103994; Joost HG, 2002, AM J PHYSIOL-ENDOC M, V282, pE974, DOI 10.1152/ajpendo.00407.2001; Khalili-Araghi F, 2009, CURR OPIN STRUC BIOL, V19, P128, DOI 10.1016/j.sbi.2009.02.011; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Levine KB, 2002, BIOCHEMISTRY-US, V41, P12629, DOI 10.1021/bi0258997; Manolescu AR, 2007, PHYSIOLOGY, V22, P234, DOI 10.1152/physiol.00011.2007; MARGER MD, 1993, TRENDS BIOCHEM SCI, V18, P13, DOI 10.1016/0968-0004(93)90081-W; Mohan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014217; Mohan S, 2009, J BIOMOL STRUCT DYN, V26, P455, DOI 10.1080/07391102.2009.10507260; MORI H, 1994, J BIOL CHEM, V269, P11578; Mueckler M, 1999, J BIOL CHEM, V274, P10923, DOI 10.1074/jbc.274.16.10923; Mueckler M, 2004, J BIOL CHEM, V279, P10494, DOI 10.1074/jbc.M310786200; Mueckler M, 2002, J BIOL CHEM, V277, P3498, DOI 10.1074/jbc.M109157200; MUECKLER M, 1994, J BIOL CHEM, V269, P20533; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; Mueckler M, 2005, J BIOL CHEM, V280, P39562, DOI 10.1074/jbc.M509050200; Olsowski A, 2000, BIOCHEMISTRY-US, V39, P2469, DOI 10.1021/bi992160x; Prasad CNV, 2009, BIOCHEM BIOPH RES CO, V380, P39, DOI 10.1016/j.bbrc.2009.01.008; Roux B, 2004, STRUCTURE, V12, P1343, DOI 10.1016/j.str.2004.06.013; ROUX B, 1995, COMPUT PHYS COMMUN, V91, P275, DOI 10.1016/0010-4655(95)00053-I; Seatter MJ, 1998, BIOCHEMISTRY-US, V37, P1322, DOI 10.1021/bi972322u; Tsigelny Igor F., 2008, Journal of Bioinformatics and Computational Biology, V6, P885, DOI 10.1142/S0219720008003801; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VERHEY KJ, 1993, J CELL BIOL, V123, P137, DOI 10.1083/jcb.123.1.137; Zou HJ, 2008, J PHYS CHEM B, V112, P13070, DOI 10.1021/jp710964x	49	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25747	10.1371/journal.pone.0025747	http://dx.doi.org/10.1371/journal.pone.0025747			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022441	gold, Green Published, Green Submitted			2022-12-27	WOS:000295976000035
J	Walensky, RP; Morris, BL; Reichmann, WM; Paltiel, AD; Arbelaez, C; Donnell-Fink, L; Katz, JN; Losina, E				Walensky, Rochelle P.; Morris, Bethany L.; Reichmann, William M.; Paltiel, A. David; Arbelaez, Christian; Donnell-Fink, Laurel; Katz, Jeffrey N.; Losina, Elena			Resource Utilization and Cost-Effectiveness of Counselor-vs. Provider-Based Rapid Point-of-Care HIV Screening in the Emergency Department	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; RANDOMIZED CONTROLLED-TRIAL; UNITED-STATES; OPPORTUNISTIC INFECTIONS; PREVENTION; LOPINAVIR/RITONAVIR; RECOMMENDATIONS; EMTRICITABINE; ADOLESCENTS	Background: Routine HIV screening in emergency department (ED) settings may require dedicated personnel. We evaluated the outcomes, costs and cost-effectiveness of HIV screening when offered by either a member of the ED staff or by an HIV counselor. Methods: We employed a mathematical model to extend data obtained from a randomized clinical trial of provider-vs. counselor-based HIV screening in the ED. We compared the downstream survival, costs, and cost-effectiveness of three HIV screening modalities: 1) no screening program; 2) an ED provider-based program; and 3) an HIV counselor-based program. Trial arm-specific data were used for test offer and acceptance rates (provider offer 36%, acceptance 75%; counselor offer 80%, acceptance 71%). Undiagnosed HIV prevalence (0.4%) and linkage to care rates (80%) were assumed to be equal between the screening modalities. Personnel costs were derived from trial-based resource utilization data. We examined the generalizability of results by conducting sensitivity analyses on offer and acceptance rates, undetected HIV prevalence, and costs. Results: Estimated HIV screening costs in the provider and counselor arms averaged $8.10 and $31.00 per result received. The Provider strategy (compared to no screening) had an incremental cost-effectiveness ratio of $58,700/quality-adjusted life year (QALY) and the Counselor strategy (compared to the Provider strategy) had an incremental cost-effectiveness ratio of $64,500/QALY. Results were sensitive to the relative offer and acceptance rates by strategy and the capacity of providers to target-screen, but were robust to changes in undiagnosed HIV prevalence and programmatic costs. Conclusions: The cost-effectiveness of provider-based HIV screening in an emergency department setting compares favorably to other US screening programs. Despite its additional cost, counselor-based screening delivers just as much return on investment as provider based-screening. Investment in dedicated HIV screening personnel is justified in situations where ED staff resources may be insufficient to provide comprehensive, sustainable screening services.	[Walensky, Rochelle P.] Massachusetts Gen Hosp, Dept Med, Div Infect Dis, Boston, MA 02114 USA; [Walensky, Rochelle P.; Morris, Bethany L.] Massachusetts Gen Hosp, Dept Med, Div Gen Med, Boston, MA 02114 USA; [Walensky, Rochelle P.] Brigham & Womens Hosp, Dept Med, Div Infect Dis, Boston, MA 02115 USA; [Katz, Jeffrey N.] Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Reichmann, William M.; Donnell-Fink, Laurel; Katz, Jeffrey N.; Losina, Elena] Brigham & Womens Hosp, Dept Orthoped Surg, Boston, MA 02115 USA; [Arbelaez, Christian] Brigham & Womens Hosp, Dept Emergency Med, Boston, MA 02115 USA; [Walensky, Rochelle P.; Losina, Elena] Harvard Univ, Sch Med, Ctr AIDS Res, Boston, MA USA; [Paltiel, A. David] Yale Univ, Sch Med, New Haven, CT USA; [Reichmann, William M.; Losina, Elena] Boston Univ Sch Publ Hlth, Dept Biostat, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Yale University; Boston University	Walensky, RP (corresponding author), Massachusetts Gen Hosp, Dept Med, Div Infect Dis, Boston, MA 02114 USA.	rwalensky@partners.org	Morris, Bethany L./GNH-4419-2022	Walensky, Rochelle P./0000-0002-8795-379X; Losina, ELENA/0000-0002-3424-0892	National Institute of Mental Health [R01 MH073445, R01 MH65869]; Doris Duke Charitable Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065869, R01MH073445] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by the National Institute of Mental Health (R01 MH073445, R01 MH65869), and the Doris Duke Charitable Foundation, Clinical Scientist Development Award to RPW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accessed 2011 Jul 27, 2008, MED PHYS FEE SCHED; [Anonymous], 2009, 2009 RED BOOK; Arbelaez C, 2009, J EMERG MED IN PRESS; Arbelaez C, 2009, INT J EMERG MED, V2, P187, DOI 10.1007/s12245-009-0123-x; Arias Elizabeth, 2007, Natl Vital Stat Rep, V56, P1; Association of American Medical Colleges, 2008, FAC SAL SURV REP; Bozzette SA, 2001, NEW ENGL J MED, V344, P817, DOI 10.1056/NEJM200103153441107; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Brown J, 2007, JAIDS-J ACQ IMM DEF, V46, P395, DOI 10.1097/QAI.0b013e3181582d82; [Bureau of HIV/STD Viral Hepatitis Prevention], 2008, ROUT OPT OUT HIV SCR; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1051; Department of Health and Human Services, 2011, GUID US ANT AG HIV I; Ekwueme DU, 2003, AM J PREV MED, V25, P112, DOI 10.1016/S0749-3797(03)00115-6; Farnham PG, 1996, PUBLIC HEALTH REP, V111, P44; Freedberg KA, 1998, JAMA-J AM MED ASSOC, V279, P130, DOI 10.1001/jama.279.2.130; Freedberg KA, 2001, NEW ENGL J MED, V344, P824, DOI 10.1056/NEJM200103153441108; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Gebo Kelly A, 2003, Hopkins HIV Rep, V15, P5; George C, 2009, HOUSTON CHRONICLE; Gold MR, 1996, COST EFFECTIVENESS H; Grinsztejn B, 2007, LANCET, V369, P1261, DOI 10.1016/S0140-6736(07)60597-2; Haley N, 2002, PREV MED, V34, P632, DOI 10.1006/pmed.2002.1030; Haukoos JS, 2010, JAMA-J AM MED ASSOC, V304, P284, DOI 10.1001/jama.2010.953; Hewitt P, 2011, ANN EMERG MED, V57, p16A, DOI 10.1016/j.annemergmed.2011.02.007; Irwin K, 2001, AIDS Alert, V16, P113; Johnson M, 2005, AIDS, V19, P685, DOI 10.1097/01.aids.0000166091.39317.99; Johnson MA, 2006, JAIDS-J ACQ IMM DEF, V43, P153, DOI 10.1097/01.qai.0000242449.67155.1a; Kaplan Jonathan E., 2009, Morbidity and Mortality Weekly Report, V58, P1; LALEZARI J, 2007, 14 C RETR OPP INF FE; Losina E, 2009, CLIN INFECT DIS, V49, P1570, DOI 10.1086/644772; Martin EG, 2010, VALUE HEALTH, V13, P893, DOI 10.1111/j.1524-4733.2010.00763.x; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; MERRILL JM, 1990, SOUTHERN MED J, V83, P613, DOI 10.1097/00007611-199006000-00004; Mylonakis E, 2000, AM J MED, V109, P568, DOI 10.1016/S0002-9343(00)00583-0; *NAT TECHN INF SER, 1995, MULT AIDS COH STUD M; Nelson M, 2005, JAIDS-J ACQ IMM DEF, V40, P404, DOI 10.1097/01.qai.0000185314.56556.c3; Paltiel AD, 2006, ANN INTERN MED, V145, P797, DOI 10.7326/0003-4819-145-11-200612050-00004; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; Parish SJ, 2007, J SEX MED, V4, P259, DOI 10.1111/j.1743-6109.2007.00430.x; Pinkerton SD, 2010, AIDS PATIENT CARE ST, V24, P409, DOI 10.1089/apc.2009.0348; Pisculli ML, 2011, AIDS BEHAV, V15, P734, DOI 10.1007/s10461-010-9837-2; Pozniak AL, 2006, JAIDS-J ACQ IMM DEF, V43, P535; Samet JH, 2001, AIDS, V15, P77, DOI 10.1097/00002030-200101050-00012; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Schackman BR, 2006, MED CARE, V44, P990, DOI 10.1097/01.mlr.0000228021.89490.2a; Telzak E. E., 2007, Morbidity and Mortality Weekly Report, V56, P597; Texas Department of State Health Services, 2005, TEX VIT STAT LIF TAB; University HealthSystems Consortium, 2008, CDP ONL REP; Walensky RP, 2008, ANN INTERN MED, V149, P153, DOI 10.7326/0003-4819-149-3-200808050-00003; Walensky RP, 2006, J INFECT DIS, V194, P11, DOI 10.1086/505147; Walensky RP, 2011, ANN EMERG MED, V58, pS126, DOI 10.1016/j.annemergmed.2011.03.023; Watensky RP, 2005, AM J MED, V118, P292, DOI 10.1016/j.amjmed.2004.07.055; *WHO, 2009, CHOOSING INT AR COST	53	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25575	10.1371/journal.pone.0025575	http://dx.doi.org/10.1371/journal.pone.0025575			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022415	gold, Green Published, Green Submitted			2022-12-27	WOS:000295976000022
J	Wang, K; Cheung, EFC; Gong, QY; Chan, RCK				Wang, Kui; Cheung, Eric F. C.; Gong, Qi-yong; Chan, Raymond C. K.			Semantic Processing Disturbance in Patients with Schizophrenia: A Meta-Analysis of the N400 Component	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; FORMAL THOUGHT-DISORDER; FILE-DRAWER PROBLEM; SPREADING ACTIVATION; ELECTROPHYSIOLOGICAL INSIGHTS; ABNORMALITIES; ERP; INFORMATION; LANGUAGE; COMPREHENSION	Background: Theoretically semantic processing can be separated into early automatic semantic activation and late contextualization. Semantic processing deficits have been suggested in patients with schizophrenia, however it is not clear which stage of semantic processing is impaired. We attempted to clarify this issue by conducting a meta-analysis of the N400 component. Methods: Twenty-one studies met the inclusion criteria for the meta-analysis procedure. The Comprehensive Meta-Analysis software package was used to compute pooled effect sizes and homogeneity. Results: Studies favoring early automatic activation produced a significant effect size of -0.41 for the N400 effect. Studies favoring late contextualization generated a significant effect size of -0.36 for the N400 effect, a significant effect size of -0.52 for N400 for congruent/related target words, and a significant effect size of 0.82 for the N400 peak latency. Conclusion: These findings suggest the automatic spreading activation process in patients with schizophrenia is very similar for closely related concepts and weakly or remotely related concepts, while late contextualization may be associated with impairments in processing semantically congruent context accompanied by slow processing speed.	[Wang, Kui; Chan, Raymond C. K.] Chinese Acad Sci, Inst Psychol, Neuropsychol & Appl Cognit Neurosci Lab, Key Lab Mental Hlth, Beijing 100101, Peoples R China; [Cheung, Eric F. C.] Castle Peak Hosp, Hong Kong, Hong Kong, Peoples R China; [Gong, Qi-yong] Sichuan Univ, Huaxi MR Res Ctr, Dept Radiol, W China Hosp W China Sch Med, Chengdu 610064, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Sichuan University	Wang, K (corresponding author), Chinese Acad Sci, Inst Psychol, Neuropsychol & Appl Cognit Neurosci Lab, Key Lab Mental Hlth, Beijing 100101, Peoples R China.	rckchan@psych.ac.cn	Chan, Raymond CK/B-6717-2009; Gong, Qiyong/W-3052-2019	Chan, Raymond CK/0000-0002-3414-450X; Gong, Qiyong/0000-0002-5912-4871; Wang, Kui/0000-0002-8902-3756	Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences [O7CX031003]; Chinese Academy of Sciences [KSCX2-YW-R-131, KSCX2-EW-J-8]; National Basic Research Programme (973 Programme) [2007CB512302/5]; National Science Foundation China [81088001]; China Postdoctoral Science Foundation [20100470594]	Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences(Chinese Academy of Sciences); Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Programme (973 Programme)(National Basic Research Program of China); National Science Foundation China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This study was supported partially by the Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences, Project-Oriented Hundred Talents Programme (O7CX031003), and the Knowledge Innovation Project of the Chinese Academy of Sciences (KSCX2-YW-R-131 and KSCX2-EW-J-8), and a grant from the National Basic Research Programme (973 Programme No. 2007CB512302/5), and an Outstanding National Young Investigator Award from the National Science Foundation China (81088001) to RCK Chan, and a fund from the China Postdoctoral Science Foundation to K Wang (20100470594). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS J, 1993, SCHIZOPHR RES, V10, P247, DOI 10.1016/0920-9964(93)90059-R; ANDREASEN NC, 1986, SCHIZOPHRENIA BULL, V12, P348, DOI 10.1093/schbul/12.3.348; ANDREWS S, 1993, BIOL PSYCHIAT, V34, P443, DOI 10.1016/0006-3223(93)90235-6; Bobes MA, 1996, BIOL PSYCHIAT, V40, P189, DOI 10.1016/0006-3223(95)00352-5; COLLINS AM, 1975, PSYCHOL REV, V82, P407, DOI 10.1037/0033-295X.82.6.407; Condray R, 2003, BIOL PSYCHIAT, V54, P1134, DOI 10.1016/S0006-3223(03)00699-1; Debruille JB, 2007, BRAIN RES REV, V56, P472, DOI 10.1016/j.brainresrev.2007.10.001; Debruille JB, 2007, SCHIZOPHR RES, V89, P261, DOI 10.1016/j.schres.2006.07.014; Ditman T, 2007, PSYCHOPHYSIOLOGY, V44, P991, DOI 10.1111/j.1469-8986.2007.00565.x; GRILLON C, 1991, BIOL PSYCHIAT, V29, P467, DOI 10.1016/0006-3223(91)90269-R; Guerra S, 2009, BRAIN COGNITION, V70, P221, DOI 10.1016/j.bandc.2009.02.004; Iakimova G, 2005, PSYCHOPHYSIOLOGY, V42, P380, DOI 10.1111/j.1469-8986.2005.00303.x; Kiang M, 2005, SCHIZOPHR RES, V77, P329, DOI 10.1016/j.schres.2005.03.021; Kiang M, 2008, AM J PSYCHIAT, V165, P74, DOI 10.1176/appi.ajp.2007.07050763; Kiang M, 2007, SCHIZOPHR RES, V92, P225, DOI 10.1016/j.schres.2007.02.001; Kostova M, 2005, SCHIZOPHR RES, V78, P285, DOI 10.1016/j.schres.2005.05.015; Kostova M, 2003, NEUROPHYSIOL CLIN, V33, P11, DOI 10.1016/S0987-7053(03)00006-6; KOYAMA S, 1991, ELECTROEN CLIN NEURO, V78, P124, DOI 10.1016/0013-4694(91)90112-H; Kreher DA, 2008, SCHIZOPHRENIA BULL, V34, P473, DOI 10.1093/schbul/sbm108; Kreher DA, 2009, SCHIZOPHR RES, V111, P174, DOI 10.1016/j.schres.2009.03.013; Kumar N, 2004, J PSYCHIATR NEUROSCI, V29, P89; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Laurent JP, 2010, INT J PSYCHOPHYSIOL, V75, P177, DOI 10.1016/j.ijpsycho.2009.10.001; Lipsey MW, 2001, EVAL HEALTH PROF, V24, P236, DOI 10.1177/01632780122034902; Mathalon DH, 2010, INT J PSYCHOPHYSIOL, V75, P157, DOI 10.1016/j.ijpsycho.2009.12.003; Mathalon DH, 2002, ARCH GEN PSYCHIAT, V59, P641, DOI 10.1001/archpsyc.59.7.641; Minzenberg MJ, 2002, J INT NEUROPSYCH SOC, V8, P699, DOI 10.1017/S1355617702801357; Neely J. H., 1991, BASIC PROCESSES READ, P264; NEELY JH, 1977, J EXP PSYCHOL GEN, V106, P226, DOI 10.1037/0096-3445.106.3.226; Niznikiewicz M, 2010, INT J PSYCHOPHYSIOL, V75, P133, DOI 10.1016/j.ijpsycho.2009.10.006; Niznikiewicz MA, 1997, J ABNORM PSYCHOL, V106, P85, DOI 10.1037/0021-843X.106.1.85; Ohta K, 1999, SCHIZOPHR RES, V40, P159, DOI 10.1016/S0920-9964(99)00048-1; Olichney JM, 1997, BIOL PSYCHIAT, V42, P13, DOI 10.1016/S0006-3223(96)00242-9; Pomarol-Clotet E, 2008, BRIT J PSYCHIAT, V192, P92, DOI 10.1192/bjp.bp.106.032102; Rosenberg MS, 2005, EVOLUTION, V59, P464, DOI 10.1111/j.0014-3820.2005.tb01004.x; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; Rossell SL, 2007, CURR PSYCHIATRY REV, V3, P137, DOI 10.2174/157340007780599050; Salisbury DF, 2000, PSYCHOPHYSIOLOGY, V37, P456, DOI 10.1017/S0048577200980028; Salisbury DF, 2002, CLIN NEUROPHYSIOL, V113, P383, DOI 10.1016/S1388-2457(02)00003-2; SHENTON HV, 1989, ARCH GEN PSYCHIAT, V46, P897; Shin KS, 2008, NEUROSCI LETT, V448, P226, DOI 10.1016/j.neulet.2008.10.053; Sitnikova T, 2002, PSYCHOPHYSIOLOGY, V39, P851, DOI 10.1111/1469-8986.3960851; Sitnikova T, 2009, J ABNORM PSYCHOL, V118, P256, DOI 10.1037/a0015619; Spitzer M, 1997, NERVENARZT, V68, P212, DOI 10.1007/s001150050116; Strandburg RJ, 1997, BIOL PSYCHIAT, V42, P596, DOI 10.1016/S0006-3223(96)00410-6; Szoke A, 2008, BRIT J PSYCHIAT, V192, P248, DOI 10.1192/bjp.bp.106.029009; Yoshida S, 2006, TOHOKU J EXP MED, V209, P159, DOI 10.1620/tjem.209.159	47	43	43	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25435	10.1371/journal.pone.0025435	http://dx.doi.org/10.1371/journal.pone.0025435			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834PW	22022395	Green Published, gold			2022-12-27	WOS:000295976000016
J	Antonelou, MH; Kriebardis, AG; Stamoulis, KE; Trougakos, IP; Papassideri, IS				Antonelou, Marianna H.; Kriebardis, Anastasios G.; Stamoulis, Konstantinos E.; Trougakos, Ioannis P.; Papassideri, Issidora S.			Apolipoprotein J/Clusterin in Human Erythrocytes Is Involved in the Molecular Process of Defected Material Disposal during Vesiculation	PLOS ONE			English	Article							RED-CELLS; OXIDATIVE STRESS; IN-VIVO; CLUSTERIN; PROTEIN; STORAGE; MEMBRANE; TRANSFUSION; HEMOGLOBIN; APOPTOSIS	Background: We have showed that secretory Apolipoprotein J/Clusterin (sCLU) is down-regulated in senescent, stressed or diseased red blood cells (RBCs). It was hypothesized that sCLU loss relates to RBCs vesiculation, a mechanism that removes erythrocyte membrane patches containing defective or potentially harmful components. Methodology/Principal Findings: To investigate this issue we employed a combination of biochemical and microscopical approaches in freshly prepared RBCs or RBCs stored under standard blood bank conditions, an in vitro model system of cellular aging. We found that sCLU is effectively exocytosed in vivo during membrane vesiculation of freshly prepared RBCs. In support, the RBCs' sCLU content was progressively reduced during RBCs ex vivo maturation and senescence under cold storage due to its selective exocytosis in membrane vesicles. A range of typical vesicular components, also involved in RBCs senescence, like Band 3, CD59, hemoglobin and carbonylated membrane proteins were found to physically interact with sCLU. Conclusions/Significance: The maturation of RBCs is associated with a progressive loss of sCLU. We propose that sCLU is functionally involved in the disposal of oxidized/defected material through RBCs vesiculation. This process most probably takes place through sCLU interaction with RBCs membrane proteins that are implicit vesicular components. Therefore, sCLU represents a pro-survival factor acting for the postponement of the untimely clearance of RBCs.	[Antonelou, Marianna H.; Kriebardis, Anastasios G.; Trougakos, Ioannis P.; Papassideri, Issidora S.] Univ Athens, Dept Cell Biol & Biophys, Fac Biol, Athens, Greece; [Kriebardis, Anastasios G.] Technol & Educ Inst Athens, Fac Hlth & Caring Profess, Dept Med Labs, Athens, Greece; [Stamoulis, Konstantinos E.] Ctr Blood Transfus, Nikea, Piraeus, Greece	National & Kapodistrian University of Athens; University of West Attica	Antonelou, MH (corresponding author), Univ Athens, Dept Cell Biol & Biophys, Fac Biol, Athens, Greece.	itrougakos@biol.uoa.gr; ipapasid@biol.uoa.gr	Trougakos, Ioannis/R-6149-2018; Antonelou, Marianna H/C-1267-2011	Trougakos, Ioannis/0000-0002-6179-2772; Antonelou, Marianna H/0000-0003-3787-3596; Kriebardis, Anastasios/0000-0003-3915-1829	Hellenic General Secretariat for Research and Technology [2009 - 09FR-56]; University of Athens Special Account for Research	Hellenic General Secretariat for Research and Technology(Greek Ministry of Development-GSRT); University of Athens Special Account for Research	This work was partially supported by a "Greece-France R and T Cooperation Grant, 2009 - 09FR-56" of the Hellenic General Secretariat for Research and Technology to IPT, as well as by a "Kapodistrias" Grant of the University of Athens Special Account for Research Grants to ISP. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonelou MH, 2010, BLOOD TRANSFUS-ITALY, V8, pS39, DOI 10.2450/2010.007S; Antonelou MH, 2010, TRANSFUSION, V50, P376, DOI 10.1111/j.1537-2995.2009.02449.x; Bartl MM, 2001, EXP CELL RES, V271, P130, DOI 10.1006/excr.2001.5358; Bosman GJCGM, 2010, J PROTEOMICS, V73, P396, DOI 10.1016/j.jprot.2009.07.010; Bosman GJCGM, 2008, TRANSFUSION MED, V18, P335, DOI 10.1111/j.1365-3148.2008.00892.x; D'Alessandro A, 2010, J PROTEOME RES, V9, P144, DOI 10.1021/pr900831f; D'Amici GM, 2007, J PROTEOME RES, V6, P3242, DOI 10.1021/pr070179d; Hess JR, 2006, VOX SANG, V91, P13, DOI 10.1111/j.1423-0410.2006.00778.x; Kang SW, 2005, EXP CELL RES, V309, P305, DOI 10.1016/j.yexcr.2005.06.012; Kay M, 2005, ANN NY ACAD SCI, V1057, P85, DOI 10.1196/annals.1356.005; Kiefer CR, 2000, CURR OPIN HEMATOL, V7, P113, DOI 10.1097/00062752-200003000-00007; Kriebardis AG, 2006, BLOOD CELL MOL DIS, V36, P279, DOI 10.1016/j.bcmd.2006.01.003; Kriebardis AG, 2008, TRANSFUSION, V48, P1943, DOI 10.1111/j.1537-2995.2008.01794.x; Kriebardis AG, 2007, J CELL MOL MED, V11, P148, DOI 10.1111/j.1582-4934.2007.00008.x; Mandal D, 2005, J BIOL CHEM, V280, P39460, DOI 10.1074/jbc.M506928200; MERI S, 1990, IMMUNOLOGY, V71, P1; Poon S, 2000, BIOCHEMISTRY-US, V39, P15953, DOI 10.1021/bi002189x; Reddy KB, 1996, BIOCHEMISTRY-US, V35, P6157, DOI 10.1021/bi952981b; Stahl AL, 2009, MOL IMMUNOL, V46, P2236, DOI 10.1016/j.molimm.2009.04.012; Trougakos IP, 2006, FREE RADICAL RES, V40, P1324, DOI 10.1080/10715760600902310; Trougakos IP, 2009, ADV CANCER RES, V104, P171, DOI 10.1016/S0065-230X(09)04009-3; Trougakos IP, 2009, CLIN CANCER RES, V15, P48, DOI 10.1158/1078-0432.CCR-08-1805; WAGNER GM, 1987, BLOOD, V69, P1777; WHITLOW M, 1993, BLOOD, V81, P510; Willekens FLA, 2003, BLOOD, V101, P747, DOI 10.1182/blood-2002-02-0500; Willekens FLA, 2008, BRIT J HAEMATOL, V141, P549, DOI 10.1111/j.1365-2141.2008.07055.x; WOLFE LC, 1985, TRANSFUSION, V25, P185, DOI 10.1046/j.1537-2995.1985.25385219897.x; Wyatt A, 2009, ADV CANCER RES, V104, P89, DOI 10.1016/S0065-230X(09)04006-8; Zhang HL, 2005, NAT CELL BIOL, V7, P909, DOI 10.1038/ncb1291	29	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e26033	10.1371/journal.pone.0026033	http://dx.doi.org/10.1371/journal.pone.0026033			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22016805	Green Submitted, gold, Green Published			2022-12-27	WOS:000295970300051
J	Li, L; Zhao, B; Du, J; Zhang, KZ; Ling, CX; Li, SSC				Li, Lei; Zhao, Bing; Du, Jun; Zhang, Kaizhong; Ling, Charles X.; Li, Shawn Shun-Cheng			DomPep-A General Method for Predicting Modular Domain-Mediated Protein-Protein Interactions	PLOS ONE			English	Article							PHOSPHORYLATION SITES; SH2 DOMAIN; BINDING PEPTIDE; PDZ-DOMAINS; SPECIFICITY; NETWORKS; SCRIBBLE; TOOL; IDENTIFICATION; RECOGNITION	Protein-protein interactions (PPIs) are frequently mediated by the binding of a modular domain in one protein to a short, linear peptide motif in its partner. The advent of proteomic methods such as peptide and protein arrays has led to the accumulation of a wealth of interaction data for modular interaction domains. Although several computational programs have been developed to predict modular domain-mediated PPI events, they are often restricted to a given domain type. We describe DomPep, a method that can potentially be used to predict PPIs mediated by any modular domains. DomPep combines proteomic data with sequence information to achieve high accuracy and high coverage in PPI prediction. Proteomic binding data were employed to determine a simple yet novel parameter Ligand-Binding Similarity which, in turn, is used to calibrate Domain Sequence Identity and Position-Weighted-Matrix distance, two parameters that are used in constructing prediction models. Moreover, DomPep can be used to predict PPIs for both domains with experimental binding data and those without. Using the PDZ and SH2 domain families as test cases, we show that DomPep can predict PPIs with accuracies superior to existing methods. To evaluate DomPep as a discovery tool, we deployed DomPep to identify interactions mediated by three human PDZ domains. Subsequent in-solution binding assays validated the high accuracy of DomPep in predicting authentic PPIs at the proteome scale. Because DomPep makes use of only interaction data and the primary sequence of a domain, it can be readily expanded to include other types of modular domains.	[Li, Lei; Zhao, Bing; Li, Shawn Shun-Cheng] Univ Western Ontario, Dept Biochem, Siebens Drake Med Res Inst, Schulich Sch Med & Dent, London, ON, Canada; [Du, Jun; Zhang, Kaizhong; Ling, Charles X.] Univ Western Ontario, Dept Comp Sci, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Li, L (corresponding author), Univ Western Ontario, Dept Biochem, Siebens Drake Med Res Inst, Schulich Sch Med & Dent, London, ON, Canada.	sli@uwo.ca	Li, Lei/A-8647-2012; Li, Shawn/A-9007-2012		Canadian Cancer Society; Genome Canada through the Ontario Genomics Institute	Canadian Cancer Society(Canadian Cancer Society (CCS)); Genome Canada through the Ontario Genomics Institute(Genome Canada)	This work was supported by grants (to SSCL) from the Canadian Cancer Society and Genome Canada through the Ontario Genomics Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Audebert S, 2004, CURR BIOL, V14, P987, DOI 10.1016/j.cub.2004.05.051; Beuming T, 2005, BIOINFORMATICS, V21, P827, DOI 10.1093/bioinformatics/bti098; Brannetti B, 2000, J MOL BIOL, V298, P313, DOI 10.1006/jmbi.2000.3670; Chen JR, 2008, NAT BIOTECHNOL, V26, P1041, DOI 10.1038/nbt.1489; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Diella F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-79; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Gasteiger E, 2001, Curr Issues Mol Biol, V3, P47; Hou TJ, 2009, MOL CELL PROTEOMICS, V8, P639, DOI 10.1074/mcp.M800450-MCP200; Huang HM, 2008, MOL CELL PROTEOMICS, V7, P768, DOI 10.1074/mcp.M700312-MCP200; Huang HD, 2005, NUCLEIC ACIDS RES, V33, pW226, DOI 10.1093/nar/gki471; Joachims T., 1999, ADV KERNEL METHODS S; Kallay LM, 2006, J CELL BIOCHEM, V99, P647, DOI 10.1002/jcb.20992; KANEKO T, 2011, TRENDS BIOCH SCI; Kaneko T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000796; Kim JH, 2004, BIOINFORMATICS, V20, P3179, DOI 10.1093/bioinformatics/bth382; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Li L, 2008, NUCLEIC ACIDS RES, V36, P3263, DOI 10.1093/nar/gkn161; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Li TT, 2008, PROTEINS, V70, P404, DOI 10.1002/prot.21563; LINDING R, 2007, NUCL ACIDS RES; Liu BA, 2006, MOL CELL, V22, P851, DOI 10.1016/j.molcel.2006.06.001; Liu BA, 2010, MOL CELL PROTEOMICS, V9, P2391, DOI 10.1074/mcp.M110.001586; Metais JY, 2005, FEBS LETT, V579, P3725, DOI 10.1016/j.febslet.2005.05.062; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; PASCAL SM, 1994, CELL, V77, P461, DOI 10.1016/0092-8674(94)90160-0; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Pawson T, 2008, FEBS LETT, V582, P1266, DOI 10.1016/j.febslet.2008.02.011; Petit MM, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-1; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Takizawa S, 2006, GENES CELLS, V11, P453, DOI 10.1111/j.1365-2443.2006.00954.x; Tan CSH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000316; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Wu CG, 2007, PROTEOMICS, V7, P1775, DOI 10.1002/pmic.200601006; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; YAFFE MB, 2006, SCI STKE, pPE28; Zhang L, 2006, MOL CELL PROTEOMICS, V5, P1224, DOI 10.1074/mcp.M500346-MCP200; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	44	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25528	10.1371/journal.pone.0025528	http://dx.doi.org/10.1371/journal.pone.0025528			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003397	Green Published, Green Submitted, gold			2022-12-27	WOS:000295970300018
J	Jun, GG; Nicolaou, M; Morrison, MA; Buros, J; Morgan, DJ; Radeke, MJ; Yonekawa, Y; Tsironi, EE; Kotoula, MG; Zacharaki, F; Mollema, N; Yuan, Y; Miller, JW; Haider, NB; Hageman, GS; Kim, IK; Schaumberg, DA; Farrer, LA; DeAngelis, MM				Jun, Gyungah; Nicolaou, Michael; Morrison, Margaux A.; Buros, Jacqueline; Morgan, Denise J.; Radeke, Monte J.; Yonekawa, Yoshihiro; Tsironi, Evangelia E.; Kotoula, Maria G.; Zacharaki, Fani; Mollema, Nissa; Yuan, Yang; Miller, Joan W.; Haider, Neena B.; Hageman, Gregory S.; Kim, Ivana K.; Schaumberg, Debra A.; Farrer, Lindsay A.; DeAngelis, Margaret M.			Influence of ROBO1 and RORA on Risk of Age-Related Macular Degeneration Reveals Genetically Distinct Phenotypes in Disease Pathophysiology	PLOS ONE			English	Article							COMPLEMENT FACTOR-H; GENE-EXPRESSION; AXON GUIDANCE; SMOKING; DRUSEN; ALPHA; SUSCEPTIBILITY; POLYMORPHISM; VARIANT; COMMON	ROBO1 is a strong candidate gene for age-related macular degeneration (AMD) based upon its location under a linkage peak on chromosome 3p12, its expression pattern, and its purported function in a pathway that includes RORA, a gene previously associated with risk for neovascular AMD. Previously, we observed that expression of ROBO1 and RORA is down-regulated among wet AMD cases, as compared to their unaffected siblings. Thus, we hypothesized that contribution of association signals in ROBO1, and interaction between these two genes may be important for both wet and dry AMD. We evaluated association of 19 single nucleotide polymorphisms (SNPs) in ROBO1 with wet and dry stages of AMD in a sibling cohort and a Greek case-control cohort containing 491 wet AMD cases, 174 dry AMD cases and 411 controls. Association signals and interaction results were replicated in an independent prospective cohort (1070 controls, 164 wet AMD cases, 293 dry AMD cases). The most significantly associated ROBO1 SNPs were rs1387665 under an additive model (meta P = 0.028) for wet AMD and rs9309833 under a recessive model (meta P = 6x10(-4)) for dry AMD. Further analyses revealed interaction between ROBO1 rs9309833 and RORA rs8034864 for both wet and dry AMD (interaction P<0.05). These studies were further supported by whole transcriptome expression profile studies from 66 human donor eyes and chromatin immunoprecipitation assays from mouse retinas. These findings suggest that distinct ROBO1 variants may influence the risk of wet and dry AMD, and the effects of ROBO1 on AMD risk may be modulated by RORA variants.	[Jun, Gyungah; Nicolaou, Michael; Buros, Jacqueline; Farrer, Lindsay A.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Morrison, Margaux A.; Yonekawa, Yoshihiro; Miller, Joan W.; Kim, Ivana K.; DeAngelis, Margaret M.] Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA; [Morrison, Margaux A.; Morgan, Denise J.; Hageman, Gregory S.; DeAngelis, Margaret M.] Univ Utah, Ctr Translat Med, John Moran Eye Ctr, Salt Lake City, UT USA; [Radeke, Monte J.] Univ Calif Santa Barbara, Neurosci Res Inst, Ctr Study Macular Degenerat, Santa Barbara, CA 93106 USA; [Yonekawa, Yoshihiro] Weill Cornell Med Coll, New York, NY USA; [Tsironi, Evangelia E.; Kotoula, Maria G.; Zacharaki, Fani] Univ Thessaly, Larisa, Greece; [Mollema, Nissa; Yuan, Yang; Haider, Neena B.] Univ Nebraska Med Ctr, Omaha, NE USA; [Schaumberg, Debra A.] Brigham & Womens Hosp, Harvard Med Sch, Div Prevent Med, Boston, MA 02115 USA; [Jun, Gyungah; Nicolaou, Michael; Buros, Jacqueline; Schaumberg, Debra A.; Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Boston, MA 02118 USA	Boston University; Harvard University; Massachusetts Eye & Ear Infirmary; Utah System of Higher Education; University of Utah; University of California System; University of California Santa Barbara; Cornell University; University of Thessaly; University of Nebraska System; University of Nebraska Medical Center; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Boston University	Jun, GG (corresponding author), Boston Univ, Sch Med, Boston, MA 02118 USA.	Margaret.DeAngelis@utah.edu	Kotoula, Maria/Y-6539-2019; Farrer, Lindsay/AAS-1035-2020; DeAngelis, e/J-7863-2015; Nicolaou, Michael/AAU-1054-2021	Jun, Gyungah/0000-0002-3230-8697; Kim, Ivana/0000-0003-0310-6129; Buros, Jacqueline/0000-0001-9588-4889; Farrer, Lindsay/0000-0001-5533-4225	Thome Memorial Foundation; Bank of America N.A.; Lincy Foundation; Massachusetts Lions; Friends of the Massachusetts Eye and Ear Infirmary; Genetics of Age-related Macular Degeneration Fund; Research to Prevent Blindness; Hope for Vision; National Institutes of Health [EY014458, EY14104, EY017362, EY017404]; Massachusetts Eye and Ear Infirmary; NATIONAL EYE INSTITUTE [R01EY014458, R01EY017362, P30EY014800, R24EY017404, P30EY014104] Funding Source: NIH RePORTER	Thome Memorial Foundation; Bank of America N.A.; Lincy Foundation; Massachusetts Lions; Friends of the Massachusetts Eye and Ear Infirmary; Genetics of Age-related Macular Degeneration Fund; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Hope for Vision; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts Eye and Ear Infirmary; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants from the Thome Memorial Foundation; Bank of America N.A.; Lincy Foundation; the Massachusetts Lions; Friends of the Massachusetts Eye and Ear Infirmary; the Massachusetts Eye and Ear Infirmary; Genetics of Age-related Macular Degeneration Fund; Unrestricted Grant from Research to Prevent Blindness to the Department of Ophthalmology and Visual Sciences, University of Utah; Hope for Vision; and the National Institutes of Health (EY014458, EY14104, EY017362, EY017404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DH, 2002, AM J OPHTHALMOL, V134, P411, DOI 10.1016/S0002-9394(02)01624-0; Anitha A, 2008, AM J MED GENET B, V147B, P1019, DOI 10.1002/ajmg.b.30697; Bates TC, 2011, BEHAV GENET, V41, P50, DOI 10.1007/s10519-010-9402-9; Chakravarthy U, 2010, BMC OPHTHALMOL, V10, DOI 10.1186/1471-2415-10-31; Chen HY, 2010, ADV EXP MED BIOL, V664, P457, DOI 10.1007/978-1-4419-1399-9_52; Chen MH, 2010, BIOINFORMATICS, V26, P580, DOI 10.1093/bioinformatics/btp710; CHEN W, 2010, P NATL ACAD SCI US; Chong NHV, 2005, AM J PATHOL, V166, P241, DOI 10.1016/S0002-9440(10)62248-1; Cong RH, 2008, ANN EPIDEMIOL, V18, P647, DOI 10.1016/j.annepidem.2008.04.002; DeAngelis MM, 2007, ARCH OPHTHALMOL-CHIC, V125, P49, DOI 10.1001/archopht.125.1.49; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Erskine L, 2000, J NEUROSCI, V20, P4975; Fujieda H, 2009, J NEUROCHEM, V108, P91, DOI 10.1111/j.1471-4159.2008.05739.x; Haddad S, 2006, SURV OPHTHALMOL, V51, P316, DOI 10.1016/j.survophthal.2006.05.001; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haider NB, 2009, EXP EYE RES, V89, P365, DOI 10.1016/j.exer.2009.04.006; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hamdi HK, 2003, FRONT BIOSCI-LANDMRK, V8, pE305, DOI 10.2741/1019; Hamilton BA, 1996, NATURE, V379, P736, DOI 10.1038/379736a0; Huang LZ, 2010, INVEST OPHTH VIS SCI, V51, P3193, DOI 10.1167/iovs.09-3779; Huang LZ, 2009, CURR EYE RES, V34, P1019, DOI 10.3109/02713680903308495; Huang LZ, 2009, EXP EYE RES, V88, P583, DOI 10.1016/j.exer.2008.11.016; Ip BK, 2010, J ANAT, V217, P300, DOI 10.1111/j.1469-7580.2010.01259.x; Jetten Anton M, 2009, Nucl Recept Signal, V7, pe003, DOI 10.1621/nrs.07003; Jun G, 2005, INVEST OPHTH VIS SCI, V46, P3081, DOI 10.1167/iovs.04-1360; Kanda A, 2007, P NATL ACAD SCI USA, V104, P16227, DOI 10.1073/pnas.0703933104; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Klein R, 2011, ARCH OPHTHALMOL-CHIC, V129, P75, DOI 10.1001/archophthalmol.2010.318; Liu AH, 2010, J LIPID RES, V51, P3217, DOI 10.1194/jlr.M007518; Melen E, 2010, J ALLERGY CLIN IMMUN, V126, P631, DOI 10.1016/j.jaci.2010.06.030; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Nguyen A, 2010, FASEB J, V24, P3036, DOI 10.1096/fj.10-154484; Plachez C, 2008, MOL CELL NEUROSCI, V37, P719, DOI 10.1016/j.mcn.2007.12.017; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; SanGiovanni JP, 2009, AM J CLIN NUTR, V90, P1601, DOI 10.3945/ajcn.2009.27594; Schaumberg DA, 2010, ARCH OPHTHALMOL-CHIC, V128, P1462, DOI 10.1001/archophthalmol.2010.261; Seddon JM, 2006, HUM HERED, V61, P157, DOI 10.1159/000094141; Silveira AC, 2010, VISION RES, V50, P698, DOI 10.1016/j.visres.2009.09.016; Swaroop A, 2007, HUM MOL GENET, V16, pR174, DOI 10.1093/hmg/ddm212; Swaroop A, 2009, ANNU REV GENOM HUM G, V10, P19, DOI 10.1146/annurev.genom.9.081307.164350; Thornton J, 2005, EYE, V19, P935, DOI 10.1038/sj.eye.6701978; Wang YJ, 2010, J BIOL CHEM, V285, P15668, DOI 10.1074/jbc.M110.102160; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Yang ZL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000836	49	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e25775	10.1371/journal.pone.0025775	http://dx.doi.org/10.1371/journal.pone.0025775			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998696	gold, Green Published, Green Submitted			2022-12-27	WOS:000295968700018
J	Park, MT; Song, MJ; Lee, H; Oh, ET; Choi, BH; Jeong, SY; Choi, EK; Park, HJ				Park, Moon-Taek; Song, Min-Jeong; Lee, Hyemi; Oh, Eun-Taex; Choi, Bo-Hwa; Jeong, Seong-Yun; Choi, Eun-Kyung; Park, Heon Joo			beta-Lapachone Significantly Increases the Effect of Ionizing Radiation to Cause Mitochondrial Apoptosis via JNK Activation in Cancer Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; MAP KINASES; NAD(P)H-QUINONE OXIDOREDUCTASE; CASPASE-8 ACTIVATION; MEDIATED APOPTOSIS; ARSENIC TRIOXIDE; DEATH PATHWAY; UP-REGULATION; BID CLEAVAGE	Background: beta-lapachone (beta-lap), has been known to cause NQO1-dependnet death in cancer cells and sensitize cancer cells to ionizing radiation (IR). We investigated the mechanisms underlying the radiosensitization caused by beta-lap. Methodology/Principal Findings: beta-lap enhanced the effect of IR to cause clonogenic cells in NQO1(+)-MDA-MB-231 cells but not in NQO1(-)-MDA-MB-231 cells. beta-lap caused apoptosis only in NQO1(+) cells and not in NQO1(-) cells and it markedly increased IR-induced apoptosis only in NQO1(+) cells. Combined treatment of NQO1(+) cells induced ROS generation, triggered ER stress and stimulated activation of ERK and JNK. Inhibition of ROS generation by NAC effectively attenuated the activation of ERK and JNK, induction of ER stress, and subsequent apoptosis. Importantly, inhibition of ERK abolished ROS generation and ER stress, whereas inhibition of JNK did not, indicating that positive feedback regulation between ERK activation and ROS generation triggers ER stress in response to combined treatment. Furthermore, prevention of ER stress completely blocked combination treatment-induced JNK activation and subsequent apoptotic cell death. In addition, combined treatment efficiently induced the mitochondrial translocation of cleaved Bax, disrupted mitochondrial membrane potential, and the nuclear translocation of AIF, all of which were efficiently blocked by a JNK inhibitor. Caspases 3, 8 and 9 were activated by combined treatment but inhibition of these caspases did not abolish apoptosis indicating caspase activation played a minor role in the induction of apoptosis. Conclusions/Significance: beta-lap causes NQO1-dependent radiosensitization of cancer cells. When NQO1(+) cells are treated with combination of IR and beta-lap, positive feedback regulation between ERK and ROS leads to ER stress causing JNK activation and mitochondrial translocation of cleaved Bax. The resultant decrease in mitochondrial membrane leads to translocation of AIF and apoptosis.	[Park, Moon-Taek; Song, Min-Jeong; Lee, Hyemi; Oh, Eun-Taex; Choi, Bo-Hwa; Park, Heon Joo] Inha Univ, Dept Microbiol, Ctr Adv Med Educ, BK21 Project,Coll Med, Inchon, South Korea; [Jeong, Seong-Yun; Choi, Eun-Kyung] Univ Ulsan, Dept Radiat Oncol, Asan Med Ctr, Coll Med, Seoul, South Korea	Inha University; University of Ulsan; Asan Medical Center	Park, MT (corresponding author), Inha Univ, Dept Microbiol, Ctr Adv Med Educ, BK21 Project,Coll Med, Inchon, South Korea.	park001@inha.ac.kr			Korea Health 21 RD Project [A062254]; Korea Science and Engineering Foundation [2009-0093747]; National Research Foundation of Korea; Korea government (MEST) [20110018954]	Korea Health 21 RD Project; Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); National Research Foundation of Korea(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by grants from the Korea Health 21 R&D Project (A062254), the nuclear research and development program of the Korea Science and Engineering Foundation (2009-0093747), and by the National Research Foundation of Korea grant funded by the Korea government (MEST) (20110018954). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariyama H, 2006, J CELL BIOCHEM, V97, P724, DOI 10.1002/jcb.20678; Asher G, 2001, P NATL ACAD SCI USA, V98, P1188, DOI 10.1073/pnas.021558898; BOORSTEIN RJ, 1984, BIOCHEM BIOPH RES CO, V118, P828, DOI 10.1016/0006-291X(84)91469-4; BOOTHMAN DA, 1989, CANCER RES, V49, P605; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Camacho-Leal P, 2008, ONCOGENE, V27, P1545, DOI 10.1038/sj.onc.1210789; Cao XF, 2003, BLOOD, V102, P2605, DOI 10.1182/blood-2003-01-0211; Chandel NS, 2001, J BIOL CHEM, V276, P42728, DOI 10.1074/jbc.M103074200; Choi EK, 2007, NEOPLASIA, V9, P634, DOI 10.1593/neo.07397; Dang PMC, 2006, FASEB J, V20, P1504, DOI 10.1096/fj.05-5395fje; Daugas E, 2000, FEBS LETT, V476, P118, DOI 10.1016/S0014-5793(00)01731-2; Debatin KM, 2002, ONCOGENE, V21, P8786, DOI 10.1038/sj.onc.1206039; Dong Y, 2010, CANCER RES, V70, P8088, DOI 10.1158/0008-5472.CAN-10-1418; Engels IH, 2000, ONCOGENE, V19, P4563, DOI 10.1038/sj.onc.1203824; Goossens V, 1999, BIOFACTORS, V10, P145, DOI 10.1002/biof.5520100210; Haupt S, 2003, J CELL SCI, V116, P4077, DOI 10.1242/jcs.00739; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Kadowaki H, 2004, J CHEM NEUROANAT, V28, P93, DOI 10.1016/j.jchemneu.2004.05.004; Kang YH, 2004, CANCER RES, V64, P8960, DOI 10.1158/0008-5472.CAN-04-1830; Karlsson J, 2004, CLIN CANCER RES, V10, P3179, DOI 10.1158/1078-0432.CCR-03-0309; Katagiri C, 2005, J BIOL CHEM, V280, P14716, DOI 10.1074/jbc.M500200200; Kerkela R, 2006, NAT MED, V12, P908, DOI 10.1038/nm1446; Kim HJ, 2010, J NEUROSCI, V30, P3933, DOI 10.1523/JNEUROSCI.6054-09.2010; Klekotka PA, 2001, J BIOL CHEM, V276, P32353, DOI 10.1074/jbc.M101921200; Kumi-Diaka J, 2002, BIOL CELL, V94, P37, DOI 10.1016/S0248-4900(01)01175-3; Lee H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021533; Li CJ, 1999, P NATL ACAD SCI USA, V96, P13369, DOI 10.1073/pnas.96.23.13369; Lien YC, 2008, HISTOL HISTOPATHOL, V23, P1299, DOI 10.14670/HH-23.1299; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Masuda K, 2003, J BIOL CHEM, V278, P32448, DOI 10.1074/jbc.M213254200; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Nioi P, 2004, MUTAT RES-FUND MOL M, V555, P149, DOI 10.1016/j.mrfmmm.2004.05.023; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Park HJ, 2005, INT J RADIAT ONCOL, V61, P212, DOI 10.1016/j.ijrobp.2004.09.018; Park MT, 2005, BLOOD, V105, P1724, DOI 10.1182/blood-2004-07-2938; Park MT, 2003, J BIOL CHEM, V278, P50624, DOI 10.1074/jbc.M309011200; Paumelle R, 2000, MOL BIOL CELL, V11, P3751, DOI 10.1091/mbc.11.11.3751; Pink JJ, 2000, J BIOL CHEM, V275, P5416, DOI 10.1074/jbc.275.8.5416; Pink JJ, 2000, EXP CELL RES, V255, P144, DOI 10.1006/excr.1999.4790; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schulz JB, 1997, J NEUROCHEM, V69, P2075; Song JJ, 2002, J BIOL CHEM, V277, P46566, DOI 10.1074/jbc.M206826200; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tagawa Y, 2008, FREE RADICAL BIO MED, V45, P50, DOI 10.1016/j.freeradbiomed.2008.03.003; Tagliarino C, 2001, J BIOL CHEM, V276, P19150, DOI 10.1074/jbc.M100730200; Tang DM, 2000, J BIOL CHEM, V275, P9303, DOI 10.1074/jbc.275.13.9303; Terai K, 2009, ANTI-CANCER DRUG, V20, P901, DOI 10.1097/CAD.0b013e328330098d; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Toyota H, 2003, CANCER LETT, V189, P221, DOI 10.1016/S0304-3835(02)00552-9; Van de Craen M, 1999, CELL DEATH DIFFER, V6, P1117, DOI 10.1038/sj.cdd.4400589; Viswanath V, 2001, J NEUROSCI, V21, P9519, DOI 10.1523/JNEUROSCI.21-24-09519.2001; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Zou W, 2008, CANCER RES, V68, P7484, DOI 10.1158/0008-5472.CAN-08-1318	56	27	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e25976	10.1371/journal.pone.0025976	http://dx.doi.org/10.1371/journal.pone.0025976			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998736	Green Published, Green Submitted, gold			2022-12-27	WOS:000295968700028
J	Petty, E; Laughlin, E; Csankovszki, G				Petty, Emily; Laughlin, Emily; Csankovszki, Gyoergyi			Regulation of DCC Localization by HTZ-1/H2A. Z and DPY-30 Does not Correlate with H3K4 Methylation Levels	PLOS ONE			English	Article							DOSAGE COMPENSATION COMPLEX; X-CHROMOSOMES; HISTONE H3; MOLECULAR REGULATION; GENOME-WIDE; METHYLTRANSFERASE COMPLEX; SACCHAROMYCES-CEREVISIAE; ESSENTIAL COMPONENT; DNA METHYLATION; SET1 COMPLEX	Dosage compensation is a specialized form of gene regulation that balances sex-chromosome linked gene expression between the sexes. In C. elegans, dosage compensation is achieved by the activity of the dosage compensation complex (DCC). The DCC binds along both X chromosomes in hermaphrodites to down-regulate gene expression by half, limiting X-linked gene products to levels produced in XO males. Sequence motifs enriched on the X chromosome play an important role in targeting the DCC to the X. However, these motifs are not strictly X-specific and therefore other factors, such as the chromatin environment of the X chromosome, are likely to aid in DCC targeting. Previously, we found that loss of HTZ-1 results in partial disruption of dosage compensation localization to the X chromosomes. We wanted to know whether other chromatin components coordinated with HTZ-1 to regulate DCC localization. One candidate is DPY-30, a protein known to play a role in DCC localization. DPY-30 homologs in yeast, flies, and mammals are highly conserved members of histone H3 lysine 4 (H3K4) methyltransferase Set1/MLL complexes. Therefore, we investigated the hypothesis that the dosage compensation function of DPY-30 involves H3K4 methylation. We found that in dpy-30 animals the DCC fails to stably bind chromatin. Interestingly, of all the C. elegans homologs of Set1/MLL complex subunits, only DPY-30 is required for stable DCC binding to chromatin. Additionally, loss of H3K4 methylation does not enhance DCC mislocalization in htz-1 animals. We conclude that DPY-30 and HTZ-1 have unique functions in DCC localization, both of which are largely independent of H3K4 methylation.	[Petty, Emily; Laughlin, Emily; Csankovszki, Gyoergyi] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Petty, E (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.	gyorgyi@umich.edu		Csankovszki, Gyorgyi/0000-0001-5918-034X	NIH [R01 GM079533]; University of Michigan; Genetics Predoctoral Training Program [NIH T32 GM07544]; Center for Organogenesis Predoctoral Training Program [NIH 5 T32 HD007505]; NIH Center for Research Resources (NCRR); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007505] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079533, T32GM007544] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan(University of Michigan System); Genetics Predoctoral Training Program; Center for Organogenesis Predoctoral Training Program; NIH Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH R01 GM079533 to GC, funding from the Biological Sciences Scholar Program at the University of Michigan to GC, and Genetics Predoctoral Training Program, NIH T32 GM07544 and Center for Organogenesis Predoctoral Training Program, NIH 5 T32 HD007505, to ELP. Some nematode strains were provided by the Caenorhabditis Genetics Center, which is funded by the NIH Center for Research Resources (NCRR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam M, 2001, MOL CELL BIOL, V21, P6270, DOI 10.1128/MCB.21.18.6270-6279.2001; Ahringer J, 2005, REVERSE GENETICS WOR; Alekseyenko AA, 2006, GENE DEV, V20, P848, DOI 10.1101/gad.1400206; Alekseyenko AA, 2008, CELL, V134, P599, DOI 10.1016/j.cell.2008.06.033; ALLIS CD, 1986, J BIOL CHEM, V261, P1941; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Blauwkamp TA, 2009, MOL CELL BIOL, V29, P2023, DOI 10.1128/MCB.01448-08; BRENNER S, 1974, GENETICS, V77, P71; Brickner DG, 2007, PLOS BIOL, V5, P704, DOI 10.1371/journal.pbio.0050081; Cao F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014102; Chan RC, 2004, J CELL BIOL, V167, P613, DOI 10.1083/jcb.200408061; Chuang PT, 1996, SCIENCE, V274, P1736, DOI 10.1126/science.274.5293.1736; Clarkson MJ, 1999, NATURE, V399, P694, DOI 10.1038/21436; Conerly ML, 2010, GENOME RES, V20, P1383, DOI 10.1101/gr.106542.110; Csankovszki G, 2004, SCIENCE, V303, P1182, DOI 10.1126/science.1092938; Csankovszki G, 2009, CHROMOSOME RES, V17, P621, DOI 10.1007/s10577-009-9061-y; Csankovszki G, 2009, CURR BIOL, V19, P9, DOI 10.1016/j.cub.2008.12.006; Davis TL, 1997, DEVELOPMENT, V124, P1019; Dawes HE, 1999, SCIENCE, V284, P1800, DOI 10.1126/science.284.5421.1800; Dehe PM, 2006, J BIOL CHEM, V281, P35404, DOI 10.1074/jbc.M603099200; Dhillon N, 2000, MOL CELL, V6, P769, DOI 10.1016/S1097-2765(00)00076-9; Dhillon N, 2006, MOL CELL BIOL, V26, P489, DOI 10.1128/MCB.26.2.489-501.2006; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Ercan S, 2007, NAT GENET, V39, P403, DOI 10.1038/ng1983; Ercan S, 2011, GENOME RES, V21, P237, DOI 10.1101/gr.115931.110; Ercan S, 2009, CURR BIOL, V19, P1777, DOI 10.1016/j.cub.2009.09.047; Ercan S, 2009, CHROMOSOME RES, V17, P215, DOI 10.1007/s10577-008-9011-0; Fakhouri THI, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001060; Fisher K, 2010, DEV BIOL, V341, P142, DOI 10.1016/j.ydbio.2010.02.023; Gelbart ME, 2009, DEVELOPMENT, V136, P1399, DOI 10.1242/dev.029645; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Gilfillan GD, 2006, GENE DEV, V20, P858, DOI 10.1101/gad.1399406; Gladden JM, 2007, GENETICS, V177, P1639, DOI 10.1534/genetics.107.078071; Gorchakov AA, 2009, GENE DEV, V23, P2266, DOI 10.1101/gad.1840409; Greer EL, 2010, NATURE, V466, P383, DOI 10.1038/nature09195; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Hardy S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000687; HODGKIN J, 1979, GENETICS, V91, P67; HSU DR, 1995, DEVELOPMENT, V121, P3323; HSU DR, 1994, GENETICS, V137, P999; Jans J, 2009, GENE DEV, V23, P602, DOI 10.1101/gad.1751109; Jiang H, 2011, CELL, V144, P513, DOI 10.1016/j.cell.2011.01.020; Krogan NJ, 2002, J BIOL CHEM, V277, P10753, DOI 10.1074/jbc.C200023200; Larochelle M, 2003, EMBO J, V22, P4512, DOI 10.1093/emboj/cdg427; Larschan E, 2006, COLD SPRING HARB SYM, V71, P385, DOI 10.1101/sqb.2006.71.026; Lee JH, 2005, J BIOL CHEM, V280, P41725, DOI 10.1074/jbc.M508312200; Li J, 2008, PLOS BIOL, V6, P1870, DOI 10.1371/journal.pbio.0060233; Li TG, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001349; Li XY, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r34; Li XG, 2011, BLOOD, V118, P1386, DOI 10.1182/blood-2010-11-319111; Lieb JD, 1996, SCIENCE, V274, P1732, DOI 10.1126/science.274.5293.1732; Lieb JD, 1998, CELL, V92, P265, DOI 10.1016/S0092-8674(00)80920-4; Liu T, 2011, GENOME RES, V21, P227, DOI 10.1101/gr.115519.110; Liu XW, 1996, MOL CELL BIOL, V16, P4305; McDonel P, 2006, NATURE, V444, P614, DOI 10.1038/nature05338; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Meyer BJ, 2010, CURR OPIN GENET DEV, V20, P179, DOI 10.1016/j.gde.2010.03.008; Millar CB, 2006, GENE DEV, V20, P711, DOI 10.1101/gad.1395506; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Mohan M, 2011, MOL CELLULAR BIOL; Mueller JE, 2006, GENETICS, V173, P557, DOI 10.1534/genetics.106.055400; Nagy PL, 2002, P NATL ACAD SCI USA, V99, P90, DOI 10.1073/pnas.221596698; Narayanan A, 2007, P NATL ACAD SCI USA, V104, P10835, DOI 10.1073/pnas.0704351104; Patel A, 2011, J BIOL CHEM, V286, P3359, DOI 10.1074/jbc.M110.174524; Petty EL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000699; Pferdehirt RR, 2011, GENE DEV, V25, P499, DOI 10.1101/gad.2016011; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Ridgway P, 2004, J BIOL CHEM, V279, P43815, DOI 10.1074/jbc.M408409200; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Santisteban MS, 2000, CELL, V103, P411, DOI 10.1016/S0092-8674(00)00133-1; Schneider J, 2005, MOL CELL, V19, P849, DOI 10.1016/j.molcel.2005.07.024; Simonet T, 2007, DEV BIOL, V312, P367, DOI 10.1016/j.ydbio.2007.09.035; South PF, 2010, J BIOL CHEM, V285, P595, DOI 10.1074/jbc.M109.042697; Southall SM, 2009, MOL CELL, V33, P181, DOI 10.1016/j.molcel.2008.12.029; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Straub T, 2011, CURR OPIN GENET DEV, V21, P147, DOI 10.1016/j.gde.2011.01.012; Straub T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000302; Sural TH, 2008, NAT STRUCT MOL BIOL, V15, P1318, DOI 10.1038/nsmb.1520; Tsai CJ, 2008, GENE DEV, V22, P194, DOI 10.1101/gad.1618508; Venkatasubrahmanyam S, 2007, P NATL ACAD SCI USA, V104, P16609, DOI 10.1073/pnas.0700914104; Wang XP, 2009, J MOL BIOL, V390, P530, DOI 10.1016/j.jmb.2009.05.061; Weber CM, 2010, NAT STRUCT MOL BIOL, V17, P1500, DOI 10.1038/nsmb.1926; Whittle CM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000187; Wu M, 2008, MOL CELL BIOL, V28, P7337, DOI 10.1128/MCB.00976-08; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Xiao Y, 2011, P NATL ACAD SCI USA, V108, P8305, DOI 10.1073/pnas.1019290108; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Yonker SA, 2003, DEVELOPMENT, V130, P6519, DOI 10.1242/dev.00886; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036; Zilberman D, 2008, NATURE, V456, P125, DOI 10.1038/nature07324	91	4	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25973	10.1371/journal.pone.0025973	http://dx.doi.org/10.1371/journal.pone.0025973			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998734	Green Submitted, Green Published, gold			2022-12-27	WOS:000295966900084
J	van Doremalen, N; Shelton, H; Roberts, KL; Jones, IM; Pickles, RJ; Thompson, CI; Barclay, WS				van Doremalen, Neeltje; Shelton, Holly; Roberts, Kim L.; Jones, Ian M.; Pickles, Ray J.; Thompson, Catherine I.; Barclay, Wendy S.			A Single Amino Acid in the HA of pH1N1 2009 Influenza Virus Affects Cell Tropism in Human Airway Epithelium, but Not Transmission in Ferrets	PLOS ONE			English	Article							RECEPTOR-BINDING SPECIFICITY; LOWER RESPIRATORY-TRACT; A VIRUSES; UNITED-STATES; HEMAGGLUTININ; ORIGIN; INFECTION; H1; PATHOGENESIS; REPLICATION	The first pandemic of the 21(st) century, pandemic H1N1 2009 (pH1N1 2009), emerged from a swine-origin source. Although human infections with swine-origin influenza have been reported previously, none went on to cause a pandemic or indeed any sustained human transmission. In previous pandemics, specific residues in the receptor binding site of the haemagglutinin (HA) protein of influenza have been associated with the ability of the virus to transmit between humans. In the present study we investigated the effect of residue 227 in HA on cell tropism and transmission of pH1N1 2009. In pH1N1 2009 and recent seasonal H1N1 viruses this residue is glutamic acid, whereas in swine influenza it is alanine. Using human airway epithelium, we show a differential cell tropism of pH1N1 2009 compared to pH1N1 2009 E227A and swine influenza suggesting this residue may alter the sialic acid conformer binding preference of the HA. Furthermore, both pH1N1 2009 E227A and swine influenza multi-cycle viral growth was found to be attenuated in comparison to pH1N1 2009 in human airway epithelium. However this altered tropism and viral growth in human airway epithelium did not abrogate respiratory droplet transmission of pH1N1 2009 E227A in ferrets. Thus, acquisition of E at residue 227 was not solely responsible for the ability of pH1N1 2009 to transmit between humans.	[van Doremalen, Neeltje; Shelton, Holly; Roberts, Kim L.; Barclay, Wendy S.] Univ London Imperial Coll Sci Technol & Med, Div Infect Dis, Dept Virol, London, England; [van Doremalen, Neeltje; Thompson, Catherine I.] Hlth Protect Agcy Microbiol Serv Colindale, Virus Reference Dept, London, England; [Jones, Ian M.] Univ Reading, Sch Biol Sci, Reading, Berks, England; [Pickles, Ray J.] Univ N Carolina, Dept Microbiol & Immunol, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC USA	Imperial College London; University of Reading; University of North Carolina; University of North Carolina Chapel Hill	van Doremalen, N (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Infect Dis, Dept Virol, St Marys Campus, London, England.	w.barclay@imperial.ac.uk	Jones, Ian/AAF-4986-2019; van Doremalen, Neeltje/AAD-2315-2021	Jones, Ian/0000-0002-7738-2516; Van Doremalen, Neeltje/0000-0003-4368-6359; Barclay, Wendy/0000-0002-3948-0895; shelton, Holly/0000-0002-5776-0735	Health Protection Agency; Society for General Microbiology; Medical Research Council [G0600504]; Medical Research Council [G0500597] Funding Source: researchfish; MRC [G0600504, G0500597] Funding Source: UKRI	Health Protection Agency; Society for General Microbiology; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a PhD studentship awarded to NvD by the Health Protection Agency, and a Society for General Microbiology Presidents Fund award to NvD, and a Medical Research Council project grant G0600504 awarded to WSB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayora-Talavera G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007836; Belser JA, 2011, J VIROL, V85, P1563, DOI 10.1128/JVI.02231-10; Bradley KC, 2011, VIROLOGY, V413, P169, DOI 10.1016/j.virol.2011.01.027; Chen LM, 2011, VIROLOGY, V412, P401, DOI 10.1016/j.virol.2011.01.015; Childs RA, 2009, NAT BIOTECHNOL, V27, P797, DOI 10.1038/nbt0909-797; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; de Vries RP, 2011, J BIOL CHEM, V286, P5868, DOI 10.1074/jbc.M110.193557; Elleman CJ, 2004, VIROLOGY, V321, P144, DOI 10.1016/j.virol.2003.12.009; Galiano M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023779; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; GAUSH CR, 1968, APPL MICROBIOL, V16, P588, DOI 10.1128/AEM.16.4.588-594.1968; Glaser L, 2005, J VIROL, V79, P11533, DOI 10.1128/JVI.79.17.11533-11536.2005; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jayaraman A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017616; Karasin AI, 2002, J CLIN MICROBIOL, V40, P1073, DOI 10.1128/JCM.40.3.1073-1079.2002; Kirkeby S, 2009, VIRUS RES, V144, P225, DOI 10.1016/j.virusres.2009.05.004; Langlois Isabelle, 2005, Vet Clin North Am Exot Anim Pract, V8, P139, DOI 10.1016/j.cvex.2004.09.008; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Martin J, 1998, VIROLOGY, V241, P101, DOI 10.1006/viro.1997.8958; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; Matrosovich M, 2007, VIROLOGY, V361, P384, DOI 10.1016/j.virol.2006.11.030; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; Matrosovich MN, 1997, VIROLOGY, V233, P224, DOI 10.1006/viro.1997.8580; MATROSOVICH MN, 1993, VIROLOGY, V196, P111, DOI 10.1006/viro.1993.1459; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Neumann G, 1999, ADV VIRUS RES, V53, P265, DOI 10.1016/S0065-3527(08)60352-8; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Pickles RJ, 1998, J VIROL, V72, P6014, DOI 10.1128/JVI.72.7.6014-6023.1998; ROBERTS KL, 2011, J GEN VIROLOGY; ROGERS GN, 1983, NATURE, V304, P76, DOI 10.1038/304076a0; ROGERS GN, 1983, VIROLOGY, V127, P361, DOI 10.1016/0042-6822(83)90150-2; ROGERS GN, 1989, VIROLOGY, V173, P317, DOI 10.1016/0042-6822(89)90249-3; Scull MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000424; Shelton H, 2011, J VIROL, V85, P1875, DOI 10.1128/JVI.01822-10; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Soundararajan V, 2009, NAT BIOTECHNOL, V27, P510, DOI 10.1038/nbt0609-510; Srinivasan A, 2008, P NATL ACAD SCI USA, V105, P2800, DOI 10.1073/pnas.0711963105; Thompson CI, 2006, J VIROL, V80, P8060, DOI 10.1128/JVI.00384-06; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248; van Riel D, 2010, AM J PATHOL, V176, P1614, DOI 10.2353/ajpath.2010.090949; VINCENT AL, 2009, VIRUS GENES; Vines A, 1998, J VIROL, V72, P7626, DOI 10.1128/JVI.72.9.7626-7631.1998; Webby RJ, 2004, VIRUS RES, V103, P67, DOI 10.1016/j.virusres.2004.02.015; World Health Organization, 2010, PAND H1N1 2009 UPD 1; 2009, MMWR MORBIDITY MORTA, V58, P400	49	23	23	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25755	10.1371/journal.pone.0025755	http://dx.doi.org/10.1371/journal.pone.0025755			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998692	Green Submitted, Green Published, gold			2022-12-27	WOS:000295966900052
J	Davies, MJ; Marino, JL; Willson, KJ; March, WA; Moore, VM				Davies, Michael J.; Marino, Jennifer L.; Willson, Kristyn J.; March, Wendy A.; Moore, Vivienne M.			Intergenerational Associations of Chronic Disease and Polycystic Ovary Syndrome	PLOS ONE			English	Article							II DIABETES-MELLITUS; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; METABOLIC FEATURES; FAMILY-HISTORY; RISK-FACTORS; WOMEN; PREVALENCE; ENDOCRINE; RELATIVES	Background: Polycystic ovary syndrome (PCOS) is a common female endocrine disorder of heterogeneous clinical presentation, high disease burden, and unknown aetiology. The disease and associated conditions cluster in families, suggesting that PCOS may be the reproductive consequence of underlying chronic disease susceptibility. Objective: To determine whether parents of young women with PCOS were more likely to have a history of diabetes or cardiovascular disease in later adult life. Design, Setting and Participants: Structured interviews with 715 members of a cohort constructed by tracing female infants born at a single general hospital in Adelaide between 1973 and 1975. Participants were asked whether they had a pre-existing medical diagnosis of PCOS, and whether each parent had ever had high blood pressure, high cholesterol, diabetes, stroke, or heart disease. Maternal high blood pressure during pregnancy was taken from the medical record of the pregnancy with the study participant. Results and Conclusions: Mothers of women with PCOS were more likely than mothers of other women to have any cardiovascular disease (RR 1.78, 95% CI 1.29, 2.47), and nearly twice as likely to have high blood pressure (RR 1.95, 95% CI 1.38, 2.76). Fathers of women with PCOS were more than twice as likely to have heart disease (RR 2.36, 95% CI 1.44, 3.88) and over four times as likely to have had a stroke (RR 4.37, 95% CI 1.97, 9.70). Occurrence of cardiovascular disease in both mother and father are associated with the risk of PCOS in daughters. Further detailed study is required to elucidate the precise pathways that may be causally related to the observations.	[Davies, Michael J.; Marino, Jennifer L.; March, Wendy A.] Univ Adelaide, Discipline Obstet & Gynaecol, Robinson Inst, Adelaide, SA, Australia; [Marino, Jennifer L.; Willson, Kristyn J.; March, Wendy A.; Moore, Vivienne M.] Univ Adelaide, Discipline Publ Hlth, Adelaide, SA, Australia	Robinson Research Institute; University of Adelaide; University of Adelaide	Davies, MJ (corresponding author), Univ Adelaide, Discipline Obstet & Gynaecol, Robinson Inst, Adelaide, SA, Australia.	michael.davies@adelaide.edu.au	Davies, Michael John/Y-3542-2018; Marino, Jennifer L/O-2909-2017; Davies, Michael/GWV-2527-2022	Davies, Michael John/0000-0003-1526-0801; Marino, Jennifer L/0000-0001-6742-1940; 	National Health and Medical Research Council of Australia (NHMRC) [465455]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This project was funded by a grant from the National Health and Medical Research Council of Australia (NHMRC) Strategic Award No. 465455. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, SOC IND AR SEIFA; Azziz R, 2005, J CLIN ENDOCR METAB, V90, P4650, DOI 10.1210/jc.2005-0628; Bensen JT, 1999, GENET EPIDEMIOL, V17, P141, DOI 10.1002/(SICI)1098-2272(1999)17:2<141::AID-GEPI4>3.0.CO;2-Q; Cheang Kai I, 2008, Endocr Pract, V14, P1084; DAHLGREN E, 1992, ACTA OBSTET GYN SCAN, V71, P599, DOI 10.3109/00016349209006227; Escobar-Morreale HF, 2005, ENDOCR REV, V26, P251, DOI 10.1210/er.2004-0004; Holte J, 1998, J CLIN ENDOCR METAB, V83, P1143, DOI 10.1210/jc.83.4.1143; Hunter A, 2007, J OBSTET GYNAECOL, V27, P591, DOI 10.1080/01443610701497520; JAHANFAR S, 1995, FERTIL STERIL, V63, P478, DOI 10.1016/S0015-0282(16)57412-3; Kahsar-Miller M, 1998, TRENDS ENDOCRIN MET, V9, P55, DOI 10.1016/S1043-2760(98)00021-6; Leibel NI, 2006, J CLIN ENDOCR METAB, V91, P1275, DOI 10.1210/jc.2005-1707; Lesser K B, 1997, J Matern Fetal Med, V6, P303, DOI 10.1002/(SICI)1520-6661(199709/10)6:5<303::AID-MFM14>3.0.CO;2-L; March WA, 2010, HUM REPROD, V25, P544, DOI 10.1093/humrep/dep399; Moini A, 2009, J ASSIST REPROD GEN, V26, P123, DOI 10.1007/s10815-009-9297-7; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Paradisi G, 1998, HUM REPROD, V13, P542, DOI 10.1093/humrep/13.3.542; Robbins AS, 2002, ANN EPIDEMIOL, V12, P452, DOI 10.1016/S1047-2797(01)00278-2; Sam S, 2006, P NATL ACAD SCI USA, V103, P7030, DOI 10.1073/pnas.0602025103; SHEAR CL, 1985, AM J EPIDEMIOL, V122, P762, DOI 10.1093/oxfordjournals.aje.a114159; Sir-Petermann T, 2002, DIABETOLOGIA, V45, P959, DOI 10.1007/s00125-002-0836-3; Yilmaz M, 2005, HUM REPROD, V20, P2414, DOI 10.1093/humrep/dei070	21	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e25947	10.1371/journal.pone.0025947	http://dx.doi.org/10.1371/journal.pone.0025947			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21991389	Green Published, gold			2022-12-27	WOS:000295963300031
J	Wijenayaka, AR; Kogawa, M; Lim, HP; Bonewald, LF; Findlay, DM; Atkins, GJ				Wijenayaka, Asiri R.; Kogawa, Masakazu; Lim, Hui Peng; Bonewald, Lynda F.; Findlay, David M.; Atkins, Gerald J.			Sclerostin Stimulates Osteocyte Support of Osteoclast Activity by a RANKL-Dependent Pathway	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN; KAPPA-B LIGAND; HUMAN PRIMARY OSTEOBLASTS; RECEPTOR ACTIVATOR; MECHANICAL STIMULATION; CELL-DIFFERENTIATION; PARATHYROID-HORMONE; MESSENGER-RNA; EXPRESSION; WNT	Sclerostin is a product of mature osteocytes embedded in mineralised bone and is a negative regulator of bone mass and osteoblast differentiation. While evidence suggests that sclerostin has an anti-anabolic role, the possibility also exists that sclerostin has catabolic activity. To test this we treated human primary pre-osteocyte cultures, cells we have found are exquisitely sensitive to sclerostin, or mouse osteocyte-like MLO-Y4 cells, with recombinant human sclerostin (rhSCL) and measured effects on pro-catabolic gene expression. Sclerostin dose-dependently up-regulated the expression of receptor activator of nuclear factor kappa B (RANKL) mRNA and down-regulated that of osteoprotegerin (OPG) mRNA, causing an increase in the RANKL: OPG mRNA ratio. To examine the effects of rhSCL on resulting osteoclastic activity, MLO-Y4 cells plated onto a bone-like substrate were primed with rhSCL for 3 days and then either mouse splenocytes or human peripheral blood mononuclear cells (PBMC) were added. This resulted in cultures with elevated osteoclastic resorption (approximately 7-fold) compared to untreated co-cultures. The increased resorption was abolished by co-addition of recombinant OPG. In co-cultures of MLO-Y4 cells with PBMC, SCL also increased the number and size of the TRAP-positive multinucleated cells formed. Importantly, rhSCL had no effect on TRAP-positive cell formation from monocultures of either splenocytes or PBMC. Further, rhSCL did not induce apoptosis of MLO-Y4 cells, as determined by caspase activity assays, demonstrating that the osteoclastic response was not driven by dying osteocytes. Together, these results suggest that sclerostin may have a catabolic action through promotion of osteoclast formation and activity by osteocytes, in a RANKL-dependent manner.	[Wijenayaka, Asiri R.; Kogawa, Masakazu; Lim, Hui Peng; Findlay, David M.; Atkins, Gerald J.] Univ Adelaide, Bone Cell Biol Grp, Discipline Orthopaed & Trauma, Adelaide, SA, Australia; [Wijenayaka, Asiri R.; Kogawa, Masakazu; Lim, Hui Peng; Findlay, David M.; Atkins, Gerald J.] Hanson Inst, Adelaide, SA, Australia; [Bonewald, Lynda F.] Univ Missouri, Kansas City Sch Dent, Dept Oral Biol, Kansas City, MO 64110 USA	University of Adelaide; Hanson Institute; University of Missouri System; University of Missouri Kansas City	Wijenayaka, AR (corresponding author), Univ Adelaide, Bone Cell Biol Grp, Discipline Orthopaed & Trauma, Adelaide, SA, Australia.	Gerald.atkins@adelaide.edu.au	Bonewald, Lynda/Q-3638-2019	Atkins, Gerald/0000-0002-3123-9861	National Health and Medical Research Council of Australia (NHMRC) [ID565372]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by a Project Grant (ID565372) from the National Health and Medical Research Council of Australia (NHMRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins GJ, 2009, OSTEOPOROSIS INT, V20, P653, DOI 10.1007/s00198-008-0728-6; Atkins GJ, 2007, BONE, V40, P1517, DOI 10.1016/j.bone.2007.02.024; Atkins GJ, 2006, J BONE MINER RES, V21, P1339, DOI 10.1359/JBMR.060604; Atkins GJ, 2011, J BONE MINER RES, V26, P1425, DOI 10.1002/jbmr.345; Atkins GJ, 2009, AM J PHYSIOL-CELL PH, V297, pC1358, DOI 10.1152/ajpcell.00216.2009; Atkins GJ, 2009, BIOMATERIALS, V30, P3672, DOI 10.1016/j.biomaterials.2009.03.035; Atkins GJ, 2002, BONE, V31, P448, DOI 10.1016/S8756-3282(02)00858-X; Atkins GJ, 2003, J BONE MINER RES, V18, P1088, DOI 10.1359/jbmr.2003.18.6.1088; Balemans W, 2002, J MED GENET, V39, P91, DOI 10.1136/jmg.39.2.91; Baron R, 2006, CURR TOP DEV BIOL, V76, P103, DOI 10.1016/S0070-2153(06)76004-5; Bellido T, 2005, ENDOCRINOLOGY, V146, P4577, DOI 10.1210/en.2005-0239; Cardoso L, 2009, J BONE MINER RES, V24, P597, DOI 10.1359/JBMR.081210; Chandrasegaran AL, 2007, CHEM EDUC RES PRACT, V8, P293; Choi HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007930; Drake MT, 2010, J CLIN ENDOCRINOL ME; Findlay DM, 2011, ADV EXP MED BIOL, V691, P337, DOI 10.1007/978-1-4419-6612-4_34; Findlay DM, 2004, BIOMATERIALS, V25, P2215, DOI 10.1016/j.biomaterials.2003.09.005; Gaudio A, 2010, J CLIN ENDOCR METAB, V95, P2248, DOI 10.1210/jc.2010-0067; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Gronthos S, 1999, J BONE MINER RES, V14, P47, DOI 10.1359/jbmr.1999.14.1.47; Ikeda T, 2001, J BONE MINER RES, V16, P1416, DOI 10.1359/jbmr.2001.16.8.1416; Jager A, 2010, J PERIODONTAL RES, V45, P246, DOI 10.1111/j.1600-0765.2009.01227.x; Kaneuji T, 2011, BIOCHEM BIOPH RES CO, V408, P103, DOI 10.1016/j.bbrc.2011.03.128; Kato Y, 1997, J BONE MINER RES, V12, P2014, DOI 10.1359/jbmr.1997.12.12.2014; Kogawa M, 2010, ENDOCRINOLOGY, V151, P4613, DOI 10.1210/en.2010-0334; Kogianni G, 2008, J BONE MINER RES, V23, P915, DOI 10.1359/JBMR.080207; Kramer I, 2010, MOL CELL BIOL, V30, P3071, DOI 10.1128/MCB.01428-09; Kramer I, 2010, J BONE MINER RES, V25, P178, DOI 10.1359/jbmr.090730; Krause C, 2010, J BIOL CHEM, V285, P41614, DOI 10.1074/jbc.M110.153890; Kurata K, 2006, J BONE MINER RES, V21, P616, DOI 10.1359/JBMR.060106; Kusu N, 2003, J BIOL CHEM, V278, P24113, DOI 10.1074/jbc.M301716200; Leupin O, 2011, J BIOL CHEM, V286, P19489, DOI 10.1074/jbc.M110.190330; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Li XD, 2009, J BONE MINER RES, V24, P578, DOI 10.1359/JBMR.081206; Loots GG, 2005, GENOME RES, V15, P928, DOI 10.1101/gr.3437105; Medina V, 1997, CANCER RES, V57, P3697; Modder UI, 2010, J BONE MINER RES; Mueller RJ, 2004, J MATER SCI-MATER M, V15, P367, DOI 10.1023/B:JMSM.0000021103.39114.cd; Nakashima T, NAT MED IN PRESS, DOI nm.2452; Padhi D, 2011, J BONE MINER RES, V26, P19, DOI 10.1002/jbmr.173; Poole KES, 2005, FASEB J, V19, P1842, DOI 10.1096/fj.05-4221fje; Rey JP, 2010, DEV DYNAM, V239, P102, DOI 10.1002/dvdy.22181; Robling A. G., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P354; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Shiotani A, 2001, J ELECTRON MICROSC, V50, P365, DOI 10.1093/jmicro/50.4.365; Silvestrini G, 2007, J MOL HISTOL, V38, P261, DOI 10.1007/s10735-007-9096-3; Staehling-Hampton K, 2002, AM J MED GENET, V110, P144, DOI 10.1002/ajmg.10401; Sutherland MK, 2004, BONE, V35, P828, DOI 10.1016/j.bone.2004.05.023; Sutherland MK, 2004, BONE, V35, P448, DOI 10.1016/j.bone.2004.04.019; ten Dijke P, 2008, J BONE JOINT SURG AM, V90A, P31, DOI 10.2106/JBJS.G.01183; Tian XY, 2010, BONE, V47, P529, DOI 10.1016/j.bone.2010.05.032; Tomkinson A, 1997, J CLIN ENDOCR METAB, V82, P3128, DOI 10.1210/jc.82.9.3128; van Bezooijen RL, 2009, J DENT RES, V88, P569, DOI 10.1177/0022034509338340; van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454; van Bezooijen RL, 2007, J BONE MINER RES, V22, P19, DOI 10.1359/JBMR.061002; Verborgt O, 2000, J BONE MINER RES, V15, P60, DOI 10.1359/jbmr.2000.15.1.60; Vincent C, 2009, J BONE MINER RES, V24, P1434, DOI [10.1359/jbmr.090305, 10.1359/JBMR.090305]; Weinstein RS, 1998, J CLIN INVEST, V102, P274, DOI 10.1172/JCI2799; Winkler DG, 2005, J BIOL CHEM, V280, P2498, DOI 10.1074/jbc.M400524200; Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599; Xiong J, NAT MED IN PRESS, DOI nm.2448; Zhao S, 2002, J BONE MINER RES, V17, P2068, DOI 10.1359/jbmr.2002.17.11.2068	63	332	350	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e25900	10.1371/journal.pone.0025900	http://dx.doi.org/10.1371/journal.pone.0025900			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21991382	Green Published, gold, Green Submitted			2022-12-27	WOS:000295963300028
J	Dahl, CD; Logothetis, NK; Bulthoff, HH; Wallraven, C				Dahl, Christoph D.; Logothetis, Nikos K.; Buelthoff, Heinrich H.; Wallraven, Christian			Second-Order Relational Manipulations Affect Both Humans and Monkeys	PLOS ONE			English	Article							FEATURE DISPLACEMENT; PERCEPTION; INVERSION; FACES; CONFIGURATION; FEATURES	Recognition and individuation of conspecifics by their face is essential for primate social cognition. This ability is driven by a mechanism that integrates the appearance of facial features with subtle variations in their configuration (i.e., second-order relational properties) into a holistic representation. So far, there is little evidence of whether our evolutionary ancestors show sensitivity to featural spatial relations and hence holistic processing of faces as shown in humans. Here, we directly compared macaques with humans in their sensitivity to configurally altered faces in upright and inverted orientations using a habituation paradigm and eye tracking technologies. In addition, we tested for differences in processing of conspecific faces (human faces for humans, macaque faces for macaques) and non-conspecific faces, addressing aspects of perceptual expertise. In both species, we found sensitivity to second-order relational properties for conspecific (expert) faces, when presented in upright, not in inverted, orientation. This shows that macaques possess the requirements for holistic processing, and thus show similar face processing to that of humans.	[Dahl, Christoph D.; Logothetis, Nikos K.] Max Planck Inst Biol Cybernet, Physiol Cognit Proc Dept, Tubingen, Germany; [Dahl, Christoph D.; Buelthoff, Heinrich H.] Max Planck Inst Biol Cybernet, Human Percept Cognit & Act Dept, Tubingen, Germany; [Dahl, Christoph D.] Kyoto Univ, Language & Intelligence Sect, Aichi, Japan; [Logothetis, Nikos K.] Univ Manchester, Div Imaging Sci & Biomed Engn, Manchester, Lancs, England; [Buelthoff, Heinrich H.; Wallraven, Christian] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea	Max Planck Society; Max Planck Society; Kyoto University; University of Manchester; Korea University	Dahl, CD (corresponding author), Max Planck Inst Biol Cybernet, Physiol Cognit Proc Dept, Tubingen, Germany.	wallraven@korea.ac.kr	Bülthoff, Heinrich H/J-6579-2012; Bülthoff, Heinrich/AAC-8818-2019; Logothetis, Nikos/U-9282-2019	Bülthoff, Heinrich H/0000-0003-2568-0607; Wallraven, Christian/0000-0002-2604-9115; Dahl, Christoph D/0000-0002-4296-1526	Max Planck Society; Swiss National Science Foundation; Japan Society for the Promotion of Science; World Class University through the National Research Foundation of Korea; Ministry of Education, Science and Technology [R31-2008-000-10008-0]; Grants-in-Aid for Scientific Research [10F00312] Funding Source: KAKEN	Max Planck Society(Max Planck SocietyFoundation CELLEX); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); World Class University through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Max Planck Society, a fellowship for Prospective Researchers by the Swiss National Science Foundation (CDD), a fellowship by the Japan Society for the Promotion of Science (CDD), and the World Class University program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (R31-2008-000-10008-0) (CW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing Interests: The authors have declared	Adachi I, 2009, CURR BIOL, V19, P1270, DOI 10.1016/j.cub.2009.05.067; BARTLETT JC, 1993, COGNITIVE PSYCHOL, V25, P281, DOI 10.1006/cogp.1993.1007; BRUCE V, 1991, COGNITION, V38, P109, DOI 10.1016/0010-0277(91)90049-A; Dahl CD, 2007, P R SOC B, V274, P2069, DOI 10.1098/rspb.2007.0477; Dahl CD, 2010, P ROY SOC B-BIOL SCI, V277, P2973, DOI 10.1098/rspb.2010.0438; Dahl CD, 2009, CURR BIOL, V19, P509, DOI 10.1016/j.cub.2009.01.061; DIAMOND R, 1986, J EXP PSYCHOL GEN, V115, P107, DOI 10.1037/0096-3445.115.2.107; HAIG ND, 1984, PERCEPTION, V13, P505, DOI 10.1068/p130505; Hirata S, 2010, ANIM COGN, V13, P679, DOI 10.1007/s10071-010-0316-y; HOSIE JA, 1988, PERCEPTION, V17, P461, DOI 10.1068/p170461; JOLICOEUR P, 1984, COGNITIVE PSYCHOL, V16, P243, DOI 10.1016/0010-0285(84)90009-4; KEMP R, 1990, PERCEPTION, V19, P531, DOI 10.1068/p190531; Lewis MB, 2003, PERCEPTION, V32, P903, DOI 10.1068/p5007; Logothetis NK, 2002, NEURON, V35, P227, DOI 10.1016/S0896-6273(02)00775-4; Mondloch CJ, 2003, J EXP CHILD PSYCHOL, V86, P67, DOI 10.1016/S0022-0965(03)00102-4; Mondloch CJ, 2002, PERCEPTION, V31, P553, DOI 10.1068/p3339; Parr LA, 2008, J COMP PSYCHOL, V122, P390, DOI 10.1037/0735-7036.122.4.390; Rakover SS, 1997, PERCEPT PSYCHOPHYS, V59, P752, DOI 10.3758/BF03206021; ROSCH E, 1976, COGNITIVE PSYCHOL, V8, P382, DOI 10.1016/0010-0285(76)90013-X; Schwaninger A, 2006, PROG BRAIN RES, V156, P321, DOI 10.1016/S0079-6123(06)56018-2; Sugita Y, 2008, P NATL ACAD SCI USA, V105, P394, DOI 10.1073/pnas.0706079105; Tanaka JW, 1997, MEM COGNITION, V25, P583, DOI 10.3758/BF03211301; Tanaka JW, 2001, J EXP PSYCHOL GEN, V130, P534, DOI 10.1037/0096-3445.130.3.534; VALENTINE T, 1988, BRIT J PSYCHOL, V79, P471, DOI 10.1111/j.2044-8295.1988.tb02747.x; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474	25	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25793	10.1371/journal.pone.0025793	http://dx.doi.org/10.1371/journal.pone.0025793			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834EU	21991354	Green Published, Green Submitted, gold			2022-12-27	WOS:000295943000072
J	De Barro, P; Ahmed, MZ				De Barro, Paul; Ahmed, Muhammad Z.			Genetic Networking of the Bemisia tabaci Cryptic Species Complex Reveals Pattern of Biological Invasions	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; DELIMITATION; TREES; POPULATIONS; HEMIPTERA; HAPLOTYPES; LIKELIHOOD; DIVERSITY; ALIEN; LIFE	Background: A challenge within the context of cryptic species is the delimitation of individual species within the complex. Statistical parsimony network analytics offers the opportunity to explore limits in situations where there are insufficient species-specific morphological characters to separate taxa. The results also enable us to explore the spread in taxa that have invaded globally. Methodology/Principal Findings: Using a 657 bp portion of mitochondrial cytochrome oxidase 1 from 352 unique haplotypes belonging to the Bemisia tabaci cryptic species complex, the analysis revealed 28 networks plus 7 unconnected individual haplotypes. Of the networks, 24 corresponded to the putative species identified using the rule set devised by Dinsdale et al. (2010). Only two species proposed in Dinsdale et al. (2010) departed substantially from the structure suggested by the analysis. The analysis of the two invasive members of the complex, Mediterranean (MED) and Middle East - Asia Minor 1 (MEAM1), showed that in both cases only a small number of haplotypes represent the majority that have spread beyond the home range; one MEAM1 and three MED haplotypes account for >80% of the GenBank records. Israel is a possible source of the globally invasive MEAM1 whereas MED has two possible sources. The first is the eastern Mediterranean which has invaded only the USA, primarily Florida and to a lesser extent California. The second are western Mediterranean haplotypes that have spread to the USA, Asia and South America. The structure for MED supports two home range distributions, a Sub-Saharan range and a Mediterranean range. The MEAM1 network supports the Middle East - Asia Minor region. Conclusion/Significance: The network analyses show a high level of congruence with the species identified in a previous phylogenetic analysis. The analysis of the two globally invasive members of the complex support the view that global invasion often involve very small portions of the available genetic diversity.	[De Barro, Paul] CSIRO Ecosyst Sci, Brisbane, Qld, Australia; [Ahmed, Muhammad Z.] Univ Pretoria, Dept Genet, ZA-0002 Pretoria, South Africa	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Pretoria	De Barro, P (corresponding author), CSIRO Ecosyst Sci, Brisbane, Qld, Australia.	paul.debarro@csiro.au	De Barro, Paul J/C-1724-2008; Ahmed, Muhammad Z/E-5735-2011	Ahmed, Muhammad Z/0000-0003-2486-157X	University of Pretoria	University of Pretoria	M.Z. Ahmed thanks University of Pretoria for awarding him a Commonwealth scholarship to support his doctoral studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo Z, 2007, SYST BIOL, V56, P44, DOI 10.1080/10635150601167005; Ahmed MZ, 2009, J APPL ENTOMOL, V133, P733, DOI 10.1111/j.1439-0418.2009.01442.x; Avise JC, 1999, P NATL ACAD SCI USA, V96, P992, DOI 10.1073/pnas.96.3.992; Bandelt HJ, 1992, MOL PHYLOGENET EVOL, V1, P242, DOI 10.1016/1055-7903(92)90021-8; Bandelt HJ, 2000, MOL PHYLOGENET EVOL, V16, P8, DOI 10.1006/mpev.2000.0792; BANDELT HJ, 1995, GENETICS, V141, P743; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Boykin LM, 2007, MOL PHYLOGENET EVOL, V44, P1306, DOI 10.1016/j.ympev.2007.04.020; CHEEK S, 1994, PESTIC SCI, V42, P135, DOI 10.1002/ps.2780420211; Chen HL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0009318, 10.1371/journal.pone.0012885]; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cracraft J., 1983, Current Ornithology, V1, P159; Crowder DW, 2010, J ANIM ECOL, V79, P563, DOI 10.1111/j.1365-2656.2010.01666.x; Crowder DW, 2010, ANIM BEHAV, V79, P579, DOI 10.1016/j.anbehav.2009.11.025; Cummings MP, 2008, EVOLUTION, V62, P2411, DOI 10.1111/j.1558-5646.2008.00442.x; Dalton R, 2006, NATURE, V443, P898, DOI 10.1038/443898a; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; de Queiroz K, 1999, SPECIES, P49; DIDAY E, 1986, PATTERN RECOGN, P411; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; EIGEN M, 1988, P NATL ACAD SCI USA, V85, P5913, DOI 10.1073/pnas.85.16.5913; Elbaz M, 2010, B ENTOMOL RES, V100, P581, DOI 10.1017/S0007485309990630; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Ence DD, 2011, MOL ECOL RESOUR, V11, P473, DOI 10.1111/j.1755-0998.2010.02947.x; Estoup A, 2010, MOL ECOL, V19, P4113, DOI 10.1111/j.1365-294X.2010.04773.x; EXCOFFIER L, 1994, GENETICS, V136, P343; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fitch WM, 1997, J MOL EVOL, V44, pS65, DOI 10.1007/PL00000059; FOULDS LR, 1979, J MOL EVOL, V13, P127, DOI 10.1007/BF01732868; Gentile G, 2002, GENETICS, V161, P1561; Goldstein PZ, 2011, BIOESSAYS, V33, P135, DOI 10.1002/bies.201000036; Goldstien SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016755; Hart MW, 2007, BIOL LETTERS, V3, P509, DOI 10.1098/rsbl.2007.0307; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016061; Kelly DW, 2006, MOL ECOL, V15, P3641, DOI 10.1111/j.1365-294X.2006.03012.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kubatko LS, 2009, BIOINFORMATICS, V25, P971, DOI 10.1093/bioinformatics/btp079; Kubatko LS, 2009, SYST BIOL, V58, P478, DOI 10.1093/sysbio/syp055; Lee PLM, 2004, INT J PLANT SCI, V165, P833, DOI 10.1086/422043; Lejeusne C, 2011, BIOL INVASIONS, V13, P635, DOI 10.1007/s10530-010-9854-0; Liu L, 2008, BIOINFORMATICS, V24, P2542, DOI 10.1093/bioinformatics/btn484; Makarenkov V, 2000, ST CLASS DAT ANAL, P35; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Novak SJ, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P201; O'Meara BC, 2010, SYST BIOL, V59, P59, DOI 10.1093/sysbio/syp077; Pilgrim EM, 2010, DIVERS DISTRIB, V16, P827, DOI 10.1111/j.1472-4642.2010.00681.x; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Rodrigo A, 2008, PHILOS T R SOC B, V363, P3893, DOI 10.1098/rstb.2008.0173; Rosenberg NA, 2007, EVOLUTION, V61, P317, DOI 10.1111/j.1558-5646.2007.00023.x; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Seal JN, 2011, J BIOGEOGR, V38, P868, DOI 10.1111/j.1365-2699.2010.02447.x; Sites JW, 2003, TRENDS ECOL EVOL, V18, P462, DOI 10.1016/S0169-5347(03)00184-8; Strimmer K, 2000, MOL BIOL EVOL, V17, P875, DOI 10.1093/oxfordjournals.molbev.a026367; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tautz D, 2003, TRENDS ECOL EVOL, V18, P70, DOI 10.1016/S0169-5347(02)00041-1; TEMPLETON AR, 1992, GENETICS, V132, P619; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsutsui ND, 2000, P NATL ACAD SCI USA, V97, P5948, DOI 10.1073/pnas.100110397; Wang P, 2010, INSECT SCI, V17, P508, DOI 10.1111/j.1744-7917.2010.01353.x; Wang P, 2011, INSECT SCI, V18, P67, DOI 10.1111/j.1744-7917.2010.01381.x; Wares JP, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P229; Wiens JJ, 2007, SYST BIOL, V56, P875, DOI 10.1080/10635150701748506; Xavier R, 2009, MOL ECOL, V18, P3283, DOI 10.1111/j.1365-294X.2009.04260.x; Xu J, 2010, B ENTOMOL RES, V100, P359, DOI 10.1017/S0007485310000015; Xu SZ, 2000, MOL BIOL EVOL, V17, P897, DOI 10.1093/oxfordjournals.molbev.a026370; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107	70	73	78	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25579	10.1371/journal.pone.0025579	http://dx.doi.org/10.1371/journal.pone.0025579			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21998669	Green Published, gold, Green Submitted			2022-12-27	WOS:000295943000042
J	Li, WB; Zeng, TY				Li, Wenbing; Zeng, Tingying			Preparation of TiO2 Anatase Nanocrystals by TiCl4 Hydrolysis with Additive H2SO4	PLOS ONE			English	Article							SINGLET OXYGEN PRODUCTION; PHOTOCATALYTIC ACTIVITY; HYDROTHERMAL SYNTHESIS; SIZE QUANTIZATION; AMORPHOUS TITANIA; AQUEOUS-SOLUTION; RUTILE TIO2; NANOPARTICLES; HYDROPHILICITY; SEMICONDUCTOR	A new methodology was developed to synthesize uniform titania anatase nanocrystals by the hydrolysis of titanium chloride in sulfuric acid aqueous solutions at 0-90 degrees C. The samples were characterized by Raman spectroscopy, UV-visible spectroscopy, transmission electron microscopy (TEM), electron diffraction (ED), and an Energy dispersive X-ray spectroscopy (EDS). The effects of the reaction temperature, mole ratio of SO42- to Ti4+, and the calcinations temperature on the particle size and crystal phase were investigated. Depending on the acidity, the hydrolysis temperature, and the calcination temperature, rhombic anatase nanocrystals sizes in the range of 10 nm to 50 nm were obtained. In the additive of sulfuric acid, Raman spectra and electron diffraction confirmed that the nanoparticles are composed of anatase TiO2. No other titania phases, such as rutile or brookite, were detected.	[Li, Wenbing] Jackson State Univ, Dept Biol & Chem, Jackson, MS 39217 USA; [Zeng, Tingying] MIT, Ctr Exciton, Cambridge, MA 02139 USA	Jackson State University; Massachusetts Institute of Technology (MIT)	Li, WB (corresponding author), Jackson State Univ, Dept Biol & Chem, Jackson, MS 39217 USA.	wenbinglee@gmail.com			U.S. National Science Foundation [0520789]	U.S. National Science Foundation(National Science Foundation (NSF))	U.S. National Science Foundation under contract #0520789. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANPO M, 1987, J PHYS CHEM-US, V91, P4305, DOI 10.1021/j100300a021; Bessekhouad Y, 2004, J PHOTOCH PHOTOBIO A, V167, P49, DOI 10.1016/j.jphotochem.2003.12.001; Davis ME, 2002, NATURE, V417, P813, DOI 10.1038/nature00785; Ding WP, 2002, J CATAL, V206, P14, DOI 10.1006/jcat.2001.3457; Fujishima A., 2000, J PHOTOCHEM PHOTOB C, V1, P1, DOI [10.1016/s1389-5567(00)00002-2, DOI 10.1016/S1389-5567(00)00002-2]; Henderson MA, 2003, J AM CHEM SOC, V125, P14974, DOI 10.1021/ja037764+; Hu SW, 2003, J CATAL, V220, P240, DOI 10.1016/S0021-9517(03)00294-X; Inagaki S, 2002, NATURE, V416, P304, DOI 10.1038/416304a; Innocenzi P, 2000, CHEM MATER, V12, P3726, DOI 10.1021/cm001139b; Kavan L, 1996, J AM CHEM SOC, V118, P6716, DOI 10.1021/ja954172l; Li WB, 2010, J PHYS CHEM C, V114, P7263, DOI 10.1021/jp908160m; Li WB, 2009, ACS APPL MATER INTER, V1, P1778, DOI 10.1021/am9003039; Li WB, 2009, CHEMPHYSCHEM, V10, P1789, DOI 10.1002/cphc.200900155; Li YZ, 2004, LANGMUIR, V20, P10838, DOI 10.1021/la0489716; Li YZ, 2002, J MATER CHEM, V12, P1387, DOI 10.1039/b200018k; Mandelbaum PA, 1999, J PHYS CHEM B, V103, P5505, DOI 10.1021/jp984812h; Moritz T, 1997, J PHYS CHEM B, V101, P8052, DOI 10.1021/jp9705131; Nagaveni K, 2004, APPL CATAL B-ENVIRON, V48, P83, DOI 10.1016/j.apcatb.2003.09.013; OLLIS D F, 1991, Environmental Science and Technology, V25, P1523; Parala H, 2002, J MATER CHEM, V12, P1625, DOI 10.1039/b202767d; Park HK, 1997, J AM CERAM SOC, V80, P743, DOI 10.1111/j.1151-2916.1997.tb02891.x; Park NG, 2000, J PHYS CHEM B, V104, P8989, DOI 10.1021/jp994365l; Pottier A, 2001, J MATER CHEM, V11, P1116, DOI 10.1039/b100435m; Roy S, 2000, MATER RES BULL, V35, P1195, DOI 10.1016/S0025-5408(00)00314-7; Seifert G, 2002, J PHYS CHEM B, V106, P2497, DOI 10.1021/jp0131323; Seo DS, 2001, J CRYST GROWTH, V229, P428, DOI 10.1016/S0022-0248(01)01196-4; SERPONE N, 1995, J PHYS CHEM-US, V99, P16646, DOI 10.1021/j100045a026; Stathatos E, 1997, LANGMUIR, V13, P4295, DOI 10.1021/la9701642; Sun J, 2003, J AM CERAM SOC, V86, P1677, DOI 10.1111/j.1151-2916.2003.tb03539.x; Takeuchi M, 2003, J PHYS CHEM B, V107, P14278, DOI 10.1021/jp0308514; TOMPSETT GA, 1995, J RAMAN SPECTROSC, V26, P57, DOI 10.1002/jrs.1250260110; Vorontsov AV, 2001, J PHOTOCH PHOTOBIO A, V144, P193, DOI 10.1016/S1010-6030(01)00462-2; Wang R, 1997, NATURE, V388, P431, DOI 10.1038/41233; White JM, 2003, J PHYS CHEM B, V107, P9029, DOI 10.1021/jp0345046; Wu MM, 2002, CHEM MATER, V14, P1974, DOI 10.1021/cm0102739; Yanagisawa K, 1999, J PHYS CHEM B, V103, P7781, DOI 10.1021/jp990521c; Yin HB, 2001, J MATER CHEM, V11, P1694, DOI 10.1039/b008974p; Zeng TY, 1998, MATER CHEM PHYS, V56, P163, DOI 10.1016/S0254-0584(98)00170-9; Zhang HZ, 2001, NANO LETT, V1, P81, DOI 10.1021/nl0055198; Zhang HZ, 2000, J PHYS CHEM B, V104, P3481, DOI 10.1021/jp000499j; Zhang QH, 1999, NANOSTRUCT MATER, V11, P1293, DOI 10.1016/S0965-9773(99)00421-3; Zhang YH, 2001, CATAL TODAY, V68, P89, DOI 10.1016/S0920-5861(01)00295-4	42	25	26	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e21082	10.1371/journal.pone.0021082	http://dx.doi.org/10.1371/journal.pone.0021082			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	22022494	Green Published, gold, Green Submitted			2022-12-27	WOS:000291730000050
J	Sullivan, R; Kinra, S; Ekelund, U; Bharathi, AV; Vaz, M; Kurpad, A; Collier, T; Reddy, KS; Prabhakaran, D; Ben-Shlomo, Y; Smith, GD; Ebrahim, S; Kuper, H				Sullivan, Ruth; Kinra, Sanjay; Ekelund, Ulf; Bharathi, A., V; Vaz, Mario; Kurpad, Anura; Collier, Tim; Reddy, Kolli Srinath; Prabhakaran, Dorairaj; Ben-Shlomo, Yoav; Smith, George Davey; Ebrahim, Shah; Kuper, Hannah			Socio-Demographic Patterning of Physical Activity across Migrant Groups in India: Results from the Indian Migration Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ENERGY COSTS; RISK-FACTORS; URBAN; QUESTIONNAIRE; OBESITY; SEDENTARY; EPIDEMIC; EXERCISE	Objective: To investigate the relationship between rural to urban migration and physical activity (PA) in India. Methods: 6,447 (42% women) participants comprising 2077 rural, 2,094 migrants and 2,276 urban were recruited. Total activity (MET hr/day), activity intensity (min/day), PA Level (PAL) television viewing and sleeping (min/day) were estimated and associations with migrant status examined, adjusting for the sib-pair design, age, site, occupation, education, and socioeconomic position (SEP). Results: Total activity was highest in rural men whereas migrant and urban men had broadly similar activity levels (p < 0.001). Women showed similar patterns, but slightly lower levels of total activity. Sedentary behaviour and television viewing were lower in rural residents and similar in migrant and urban groups. Sleep duration was highest in the rural group and lowest in urban non-migrants. Migrant men had considerably lower odds of being in the highest quartile of total activity than rural men, a finding that persisted after adjustment for age, SEP and education (OR 0.53, 95% CI 0.37, 0.74). For women, odds ratios attenuated and associations were removed after adjusting for age, SEP and education. Conclusion: Our findings suggest that migrants have already acquired PA levels that closely resemble long-term urban residents. Effective public health interventions to increase PA are needed.	[Sullivan, Ruth; Kinra, Sanjay; Ebrahim, Shah; Kuper, Hannah] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1, England; [Ekelund, Ulf] MRC, Epidemiol Unit, Cambridge, England; [Bharathi, A., V] Indira Gandhi Natl Open Univ, Bangalore, Karnataka, India; [Vaz, Mario; Kurpad, Anura] St Johns Res Inst, Bangalore, Karnataka, India; [Collier, Tim] London Sch Hyg & Trop Med, Dept Med Stat, London WC1, England; [Ebrahim, Shah] Publ Hlth Fdn India, S Asia Network Chron Dis, New Delhi, India; [Prabhakaran, Dorairaj] Ctr Chron Dis Control, New Delhi, India; [Ben-Shlomo, Yoav; Smith, George Davey] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Smith, George Davey] Univ Bristol, Med Res Council Ctr Causal Anal Translat Epidemio, Bristol, Avon, England	University of London; London School of Hygiene & Tropical Medicine; St. John's National Academy of Health Sciences; St. John's Research Institute; University of London; London School of Hygiene & Tropical Medicine; Public Health Foundation of India; University of Bristol; University of Bristol	Sullivan, R (corresponding author), London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1, England.	ruth.sullivan@lshtm.ac.uk	Ekelund, Ulf/AAE-8471-2019; Ben-Shlomo, Yoav/ABD-2004-2021; Davey Smith, George/A-7407-2013; Prabhakaran, Dorairaj/B-4147-2011	Ekelund, Ulf/0000-0003-2115-9267; Ben-Shlomo, Yoav/0000-0001-6648-3007; Davey Smith, George/0000-0002-1407-8314; Prabhakaran, Dorairaj/0000-0002-3172-834X; s, hema/0000-0002-3440-9475; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Reddy, K Srinath/0000-0003-3416-3548	Wellcome Trust [GR070797MF]; Economic and Social Research Council; MRC [MC_U106179473] Funding Source: UKRI; Medical Research Council [MC_U106179473] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Indian Migration Study was funded by the Wellcome Trust (grant no. GR070797MF). RS is funded by a 3-year PhD studentship from the Economic and Social Research Council. The funders had no role in study design, in data collection, analysis, or interpretation, in writing the report, or in the decision to submit the article for publication. The researchers are independent from the funding source.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Allender S, 2010, B WORLD HEALTH ORGAN, V88, P297, DOI 10.2471/BLT.09.065847; [Anonymous], 1985, WHO TECH REP SER, P1; Azevedo MR, 2007, INT J PUBLIC HEALTH, V52, P8, DOI 10.1007/s00038-006-5062-1; Bansal D., 2010, PUBLIC HEALTH NUTR, P1; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bauman A, 2005, REV BEST PRACTICE IN; Bharathi AV, 2010, PUBLIC HEALTH NUTR, V13, P47, DOI 10.1017/S1368980009005850; Bharathi AV, 2000, INDIAN J MED RES, V111, P95; Bharathi AV, 2009, ASSESSMENT PHYS ACTI; Creber RMM, 2010, REV PANAM SALUD PUBL, V28, P1, DOI 10.1590/S1020-49892010000700001; Ebrahim S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000268; Fall CHD, 2001, BRIT MED BULL, V60, P33, DOI 10.1093/bmb/60.1.33; FAO/WHO/UNU, 2005, JOINT FAO WHO UNU EX, P35; Gautam Yogesh, 2009, Indian J Community Med, V34, P346, DOI 10.4103/0970-0218.58397; Guilbert J J, 2003, Educ Health (Abingdon), V16, P230; Gupta R, 2008, HEART, V94, P16, DOI 10.1136/hrt.2007.132951; Hamilton MT, 2008, CURR CARDIOVASC RISK, V2, P292, DOI 10.1007/s12170-008-0054-8; Handy SL, 2002, AM J PREV MED, V23, P64, DOI 10.1016/S0749-3797(02)00475-0; James W. P. T., 1990, HUMAN ENERGY REQUIRE; Katzmarzyk PT, 2009, J PHYS ACT HEALTH, V6, P269, DOI 10.1123/jpah.6.3.269; Kinra S, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4974; Kuriyan R, 2006, BRIT J NUTR, V96, P71, DOI 10.1079/BJN20061672; LEE IM, 1995, JAMA-J AM MED ASSOC, V273, P1179, DOI 10.1001/jama.273.15.1179; Lyngdoh T, 2006, EMERG THEMES EPIDEMI, V3, DOI 10.1186/1742-7622-3-2; Margetts B, 2004, PUBLIC HEALTH NUTR, V7, P361, DOI 10.1079/PHN2004622; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Plasqui G, 2007, OBESITY, V15, P2371, DOI 10.1038/oby.2007.281; Pucher J, 2005, TRANSP POLICY, V12, P185, DOI 10.1016/j.tranpol.2005.02.008; Rao S, 2008, PUBLIC HEALTH NUTR, V11, P142, DOI 10.1017/S1368980007000055; Rastogi T, 2004, INT J EPIDEMIOL, V33, P759, DOI 10.1093/ije/dyh042; Reddy KS, 2006, B WORLD HEALTH ORGAN, V84, P461, DOI 10.2471/BLT.05.027037; Reddy KS, 1998, CIRCULATION, V97, P596; Reddy KS, 2005, LANCET, V366, P1744, DOI [10.1016/s0140-6736(05)67343-6, 10.1016/S0140-6736(05)67343-6]; SACN Energy Requirements Working Group, 2010, SACN EN REQ IN PRESS; Schofield W N, 1985, Hum Nutr Clin Nutr, V39 Suppl 1, P5; Shetty P, 2005, PUBLIC HEALTH NUTR, V8, P994, DOI 10.1079/PHN2005792; SHETTY PS, 1994, EUR J CLIN NUTR, V48, pS28; Soares MJ, 1998, BRIT J NUTR, V79, P333, DOI 10.1079/BJN19980057; Sobngwi E, 2001, INT J EPIDEMIOL, V30, P1361, DOI 10.1093/ije/30.6.1361; U.S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; Vaz M, 2004, J Assoc Physicians India, V52, P541; Vaz M, 2005, PUBLIC HEALTH NUTR, V8, P1153, DOI 10.1079/PHN2005802; Vaz M, 2004, OCCUP MED-OXFORD, V54, P369, DOI 10.1093/occmed/kqg100; Waxman Amalia, 2004, Food and Nutrition Bulletin, V25, P292; WHO, 2003, WHO TECHN REP SER, V916, P54; Yadav K, 2008, OBES REV, V9, P400, DOI 10.1111/j.1467-789X.2008.00505.x; Yajnik CS, 2004, P NUTR SOC, V63, P387, DOI 10.1079/PNS2004365; Yajnik CS, 2004, J NUTR, V134, P205, DOI 10.1093/jn/134.1.205	49	47	47	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e24898	10.1371/journal.pone.0024898	http://dx.doi.org/10.1371/journal.pone.0024898			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022366	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000295981600004
J	Idema, S; Caretti, V; Lamfers, MLM; van Beusechem, VW; Noske, DP; Vandertop, WP; Dirven, CMF				Idema, Sander; Caretti, Viola; Lamfers, Martine L. M.; van Beusechem, Victor W.; Noske, David P.; Vandertop, W. Peter; Dirven, Clemens M. F.			Anatomical Differences Determine Distribution of Adenovirus after Convection-Enhanced Delivery to the Rat Brain	PLOS ONE			English	Article							MEDIATED GENE-TRANSFER; CENTRAL-NERVOUS-SYSTEM; VIRUS-SIZED PARTICLES; IN-VIVO; MALIGNANT GLIOMAS; CANINE BRAIN; PHASE-I; EXTRACELLULAR-SPACE; INFUSION; VECTORS	Background: Convection-enhanced delivery (CED) of adenoviruses offers the potential of widespread virus distribution in the brain. In CED, the volume of distribution (Vd) should be related to the volume of infusion (Vi) and not to dose, but when using adenoviruses contrasting results have been reported. As the characteristics of the infused tissue can affect convective delivery, this study was performed to determine the effects of the gray and white matter on CED of adenoviruses and similar sized super paramagnetic iron oxide nanoparticles (SPIO). Methodology/Principal Findings: We convected AdGFP, an adenovirus vector expressing Green Fluorescent Protein, a virus sized SPIO or trypan blue in the gray and white matter of the striatum and external capsule of Wistar rats and towards orthotopic infiltrative brain tumors. The resulting Vds were compared to Vi and transgene expression to SPIO distribution. Results show that in the striatum Vd is not determined by the Vi but by the infused virus dose, suggesting diffusion, active transport or receptor saturation rather than convection. Distribution of virus and SPIO in the white matter is partly volume dependent, which is probably caused by preferential fluid pathways from the external capsule to the surrounding gray matter, as demonstrated by co-infusing trypan blue. Distant tumors were reached using the white matter tracts but tumor penetration was limited. Conclusions/Significance: CED of adenoviruses in the rat brain and towards infiltrative tumors is feasible when regional anatomical differences are taken into account while SPIO infusion could be considered to validate proper catheter positioning and predict adenoviral distribution.	[Idema, Sander; Caretti, Viola; Lamfers, Martine L. M.; Noske, David P.; Vandertop, W. Peter; Dirven, Clemens M. F.] Vrije Univ Amsterdam Med Ctr, Neurooncol Res Grp, Neurosurg Ctr Amsterdam, Amsterdam, Netherlands; [Idema, Sander; Caretti, Viola; Lamfers, Martine L. M.; Noske, David P.; Vandertop, W. Peter; Dirven, Clemens M. F.] Vrije Univ Amsterdam Med Ctr, Neurooncol Res Grp, Canc Ctr Amsterdam, Amsterdam, Netherlands; [van Beusechem, Victor W.] Vrije Univ Amsterdam Med Ctr, Dept Med Oncol, Sect Oncogen, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Idema, S (corresponding author), Vrije Univ Amsterdam Med Ctr, Neurooncol Res Grp, Neurosurg Ctr Amsterdam, Amsterdam, Netherlands.	s.idema@vumc.nl	Vandertop, William P./K-9288-2018; Lamfers, Martine/C-6246-2016	Vandertop, William/0000-0001-5417-0265; Noske, David/0000-0001-5992-4468; Lamfers, Martine/0000-0001-7745-9029	Dutch Cancer Society [VU2002-2594]; Hersenstichting Nederland [10F02.27]; Semmy foundation; Egbers foundation	Dutch Cancer Society(KWF Kankerbestrijding); Hersenstichting Nederland; Semmy foundation; Egbers foundation	This work was supported by the Dutch Cancer Society, grant VU2002-2594, the Hersenstichting Nederland, grant 10F02.27 and by the Semmy and Egbers foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSER PJ, 1992, MICROVASC RES, V44, P143, DOI 10.1016/0026-2862(92)90077-3; Betz AL, 1998, EXP NEUROL, V150, P136, DOI 10.1006/exnr.1997.6755; BOBO RH, 1994, P NATL ACAD SCI USA, V91, P2076, DOI 10.1073/pnas.91.6.2076; Candolfi M, 2007, NEURO-ONCOLOGY, V9, P245, DOI 10.1215/15228517-2007-012; Candolfi M, 2007, NEUROSURGERY, V60, P167, DOI 10.1227/01.NEU.0000249210.89096.6C; Chen MY, 2005, J NEUROSURG, V103, P311, DOI 10.3171/jns.2005.103.2.0311; Chen MY, 1999, J NEUROSURG, V90, P315, DOI 10.3171/jns.1999.90.2.0315; Chiocca EA, 2004, MOL THER, V10, P958, DOI 10.1016/j.ymthe.2004.07.021; ChoiLundberg DL, 1997, SCIENCE, V275, P838, DOI 10.1126/science.275.5301.838; Claes A, 2007, ACTA NEUROPATHOL, V114, P443, DOI 10.1007/s00401-007-0293-7; Dechecchi MC, 2000, VIROLOGY, V268, P382, DOI 10.1006/viro.1999.0171; Fueyo J, 2000, ONCOGENE, V19, P2, DOI 10.1038/sj.onc.1203251; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; Grill J, 2002, MOL THER, V6, P609, DOI 10.1006/mthe.2002.0713; Hadaczek P, 2006, MOL THER, V14, P69, DOI 10.1016/j.ymthe.2006.02.018; Horellou P, 1997, EXP NEUROL, V144, P131, DOI 10.1006/exnr.1996.6399; Hosokawa M, 2002, J VIROL METHODS, V103, P191, DOI 10.1016/S0166-0934(02)00028-9; Huynh GH, 2006, J CONTROL RELEASE, V110, P236, DOI 10.1016/j.jconrel.2005.09.053; KARTHIKEYAN L, 1994, J CELL SCI, V107, P3213; Kirn D, 2001, GENE THER, V8, P89, DOI 10.1038/sj.gt.3301377; Krauze MT, 2005, EXP NEUROL, V196, P104, DOI 10.1016/j.expneurol.2005.07.009; Kroll RA, 1996, NEUROSURGERY, V38, P746, DOI 10.1227/00006123-199604000-00024; Kunwar Sandeep, 2006, Neurosurg Focus, V20, pE15; Kunwar S, 2007, J CLIN ONCOL, V25, P837, DOI 10.1200/JCO.2006.08.1117; Kuroiwa T, 1999, J NEUROSURG, V90, P499, DOI 10.3171/jns.1999.90.3.0499; Lang FF, 2003, J CLIN ONCOL, V21, P2508, DOI 10.1200/JCO.2003.21.13.2508; LIEBERMAN DM, 1995, J NEUROSURG, V82, P1021, DOI 10.3171/jns.1995.82.6.1021; Lonser RR, 1999, J NEUROSURG, V91, P294, DOI 10.3171/jns.1999.91.2.0294; Lonser RR, 1998, J NEUROSURG, V89, P616, DOI 10.3171/jns.1998.89.4.0616; Lopez KA, 2006, NEUROL RES, V28, P542, DOI 10.1179/016164106X116836; Mamot C, 2004, J NEURO-ONCOL, V68, P1, DOI 10.1023/B:NEON.0000024743.56415.4b; Muldoon LL, 2005, NEUROSURGERY, V57, P785, DOI 10.1227/01.NEU.0000175731.25414.4c; Oh S, 2007, J NEUROSURG, V107, P568, DOI 10.3171/JNS-07/09/0568; Oh S, 2007, J NEUROSURG, V107, P136, DOI 10.3171/JNS-07/07/0136; Parsa AT, 2000, NEUROSURGERY, V47, P993, DOI 10.1097/00006123-200010000-00050; Puumalainen AM, 1998, HUM GENE THER, V9, P1769, DOI 10.1089/hum.1998.9.12-1769; Sampson JH, 2003, J NEURO-ONCOL, V65, P27, DOI 10.1023/A:1026290315809; Sampson JH, 2007, NEURO-ONCOLOGY, V9, P343, DOI 10.1215/15228517-2007-007; Sampson JH, 2007, NEUROSURGERY, V60, P89, DOI 10.1227/01.NEU.0000249256.09289.5F; Szerlip NJ, 2007, J NEUROSURG, V107, P560, DOI 10.3171/JNS-07/09/0560; Thorne RG, 2006, P NATL ACAD SCI USA, V103, P5567, DOI 10.1073/pnas.0509425103; van Beusechem VW, 2000, GENE THER, V7, P1940, DOI 10.1038/sj.gt.3301323; van Beusechem VW, 2002, CANCER RES, V62, P6165; Vargova L, 2003, GLIA, V42, P77, DOI 10.1002/glia.10204; Vavra M, 2004, NEURO-ONCOLOGY, V6, P104, DOI 10.1215/S1152851703000449; WHITTLE IR, 1990, ACTA NEUROCHIR, V105, P158, DOI 10.1007/BF01670001; Zamecnik J, 2005, Cesk Patol, V41, P12; ZHANG ET, 1992, ACTA NEUROPATHOL, V83, P233, DOI 10.1007/BF00296784	48	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e24396	10.1371/journal.pone.0024396	http://dx.doi.org/10.1371/journal.pone.0024396			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022354	Green Published, gold, Green Submitted			2022-12-27	WOS:000295978600002
J	Bruintjes, R; Bonfils, D; Heg, D; Taborsky, M				Bruintjes, Rick; Bonfils, Danielle; Heg, Dik; Taborsky, Michael			Paternity of Subordinates Raises Cooperative Effort in Cichlids	PLOS ONE			English	Article							BROODCARE HELPERS; HELPING-BEHAVIOR; MULTIPLE PATERNITY; UNRELATED HELPERS; COMPUTER-PROGRAM; LAKE TANGANYIKA; BREEDING GROUPS; GROUP-SIZE; RELATEDNESS; EVOLUTION	Background: In cooperative breeders, subordinates generally help a dominant breeding pair to raise offspring. Parentage studies have shown that in several species subordinates can participate in reproduction. This suggests an important role of direct fitness benefits for cooperation, particularly where groups contain unrelated subordinates. In this situation parentage should influence levels of cooperation. Here we combine parentage analyses and detailed behavioural observations in the field to study whether in the highly social cichlid Neolamprologus pulcher subordinates participate in reproduction and if so, whether and how this affects their cooperative care, controlling for the effect of kinship. Methodology/Principal Findings: We show that: (i) male subordinates gained paternity in 27.8% of all clutches and (ii) if they participated in reproduction, they sired on average 11.8% of young. Subordinate males sharing in reproduction showed more defence against experimentally presented egg predators compared to subordinates not participating in reproduction, and they tended to stay closer to the breeding shelter. No effects of relatedness between subordinates and dominants (to mid-parent, dominant female or dominant male) were detected on parentage and on helping behaviour. Conclusions/Significance: This is the first evidence in a cooperatively breeding fish species that the helping effort of male subordinates may depend on obtained paternity, which stresses the need to consider direct fitness benefits in evolutionary studies of helping behaviour.	[Bruintjes, Rick; Bonfils, Danielle; Heg, Dik; Taborsky, Michael] Univ Bern, Inst Ecol & Evolut, Dept Behav Ecol, Hinterkappelen, Switzerland; [Bruintjes, Rick] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Heg, Dik] Univ Bern, ISPM, Bern, Switzerland	University of Bern; University of Bristol; University of Bern	Bruintjes, R (corresponding author), Univ Bern, Inst Ecol & Evolut, Dept Behav Ecol, Hinterkappelen, Switzerland.	rbruintjes@yahoo.com	Taborsky, Michael/F-8420-2013	Taborsky, Michael/0000-0002-1357-4316; Heg, Dik/0000-0002-8766-7945	Swiss National Science Foundation (SNSF) [30100A0-105626, 31003A_118464, 31003A_122511]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF))	The project was supported by the Swiss National Science Foundation (SNSF grants 30100A0-105626, 31003A_118464 and 31003A_122511 to Dr. Taborsky). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage KB, 2000, P NATL ACAD SCI USA, V97, P12149, DOI 10.1073/pnas.200196097; Awata S, 2005, BEHAV ECOL SOCIOBIOL, V58, P506, DOI 10.1007/s00265-005-0934-6; AWATA S, 2006, BEHAV ECOLOGY, P1; Balshine S, 2001, BEHAV ECOL SOCIOBIOL, V50, P134, DOI 10.1007/s002650100343; Balshine-Earn S, 1998, BEHAV ECOL, V9, P432, DOI 10.1093/beheco/9.5.432; Bergmuller R, 2007, BEHAV PROCESS, V76, P61, DOI 10.1016/j.beproc.2007.07.001; Bergmuller R, 2005, P ROY SOC B-BIOL SCI, V272, P325, DOI 10.1098/rspb.2004.2960; Bergmuller R, 2005, ANIM BEHAV, V69, P19, DOI 10.1016/j.anbehav.2004.05.009; Brouwer L, 2005, BEHAV ECOL, V16, P667, DOI 10.1093/beheco/ari042; Bruintjes R, 2008, ANIM BEHAV, V75, P1843, DOI 10.1016/j.anbehav.2007.12.004; Bruintjes R, 2011, ANIM BEHAV, V81, P387, DOI 10.1016/j.anbehav.2010.10.004; Bruintjes R, 2010, FUNCT ECOL, V24, P1054, DOI 10.1111/j.1365-2435.2010.01715.x; Canestrari D, 2005, BEHAV ECOL SOCIOBIOL, V57, P422, DOI 10.1007/s00265-004-0879-1; Cant MA, 2003, J ZOOL, V259, P115, DOI 10.1017/S0952836902003011; Cochran GR, 2000, J MAMMAL, V81, P746, DOI 10.1644/1545-1542(2000)081<0746:EOFSOT>2.3.CO;2; Cockburn A, 1998, ANNU REV ECOL SYST, V29, P141, DOI 10.1146/annurev.ecolsys.29.1.141; Davies N. B., 1992, DUNNOCK BEHAV SOCIAL; Dickinson JL, 2004, BEHAV ECOL, V15, P233, DOI 10.1093/beheco/arh001; Dierkes P, 2008, BEHAV ECOL SOCIOBIOL, V62, P1581, DOI 10.1007/s00265-008-0587-3; Dierkes P, 2005, ECOL LETT, V8, P968, DOI 10.1111/j.1461-0248.2005.00801.x; Dierkes P, 1999, BEHAV ECOL, V10, P510, DOI 10.1093/beheco/10.5.510; Duftner N, 2007, MOL PHYLOGENET EVOL, V45, P706, DOI 10.1016/j.ympev.2007.08.001; Fitzpatrick JL, 2006, BEHAV ECOL, V17, P25, DOI 10.1093/beheco/ari090; Gashagaza M.M., 1986, AFR STUDY MONOGR, V6, P37; GASTON AJ, 1978, AM NAT, V112, P1091, DOI 10.1086/283348; Gilchrist JS, 2007, BEHAV ECOL SOCIOBIOL, V61, P1053, DOI 10.1007/s00265-006-0338-2; Goossens B, 1998, BEHAV ECOL SOCIOBIOL, V43, P281, DOI 10.1007/s002650050492; Hamilton IM, 2005, P ROY SOC B-BIOL SCI, V272, P445, DOI 10.1098/rspb.2004.2961; HAMILTON WD, 1963, AM NAT, V97, P354, DOI 10.1086/497114; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; HARTLEY IR, 1995, ANIM BEHAV, V49, P789, DOI 10.1016/0003-3472(95)80210-X; Heg D, 2008, ENVIRON BIOL FISH, V83, P191, DOI 10.1007/s10641-007-9317-3; Heg D, 2006, BEHAV ECOL, V17, P419, DOI 10.1093/beheco/arj056; Heg D, 2005, BEHAVIOUR, V142, P1615, DOI 10.1163/156853905774831891; Heg D, 2004, P ROY SOC B-BIOL SCI, V271, P2367, DOI 10.1098/rspb.2004.2855; Heg D, 2008, MOL ECOL, V17, P4359, DOI 10.1111/j.1365-294X.2008.03920.x; Heg D, 2008, BEHAV ECOL SOCIOBIOL, V62, P1249, DOI 10.1007/s00265-008-0553-0; Heg D, 2006, ENVIRON BIOL FISH, V76, P265, DOI 10.1007/s10641-006-9032-5; Heg D, 2011, BEHAV ECOL, V22, P82, DOI 10.1093/beheco/arq170; Heg D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010784; Heg D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005458; Houston AI, 1997, P ROY SOC B-BIOL SCI, V264, P173, DOI 10.1098/rspb.1997.0025; Jones AG, 2005, MOL ECOL NOTES, V5, P708, DOI 10.1111/j.1471-8286.2005.01029.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; KELLER L, 1994, TRENDS ECOL EVOL, V9, P98, DOI 10.1016/0169-5347(94)90204-6; Kingma SA, 2011, AM NAT, V177, P486, DOI 10.1086/658989; Kokko H, 2002, BEHAV ECOL, V13, P291, DOI 10.1093/beheco/13.3.291; Kokko H, 2001, P ROY SOC B-BIOL SCI, V268, P187, DOI 10.1098/rspb.2000.1349; Konovalov DA, 2004, MOL ECOL NOTES, V4, P779, DOI 10.1111/j.1471-8286.2004.00796.x; Konovalov DA, 2008, MOL ECOL RESOUR, V8, P256, DOI 10.1111/j.1471-8286.2007.01940.x; Kreiberg Henrik, 2000, P503, DOI 10.1016/B978-012529650-2/50038-X; Le Vin AL, 2010, ANIM BEHAV, V79, P1109, DOI 10.1016/j.anbehav.2010.02.006; Lehmann L, 2006, J EVOLUTION BIOL, V19, P1365, DOI 10.1111/j.1420-9101.2006.01119.x; LEVIN AL, 2011, ANIMAL BEHA IN PRESS; Magrath RD, 1997, BEHAV ECOL SOCIOBIOL, V41, P185, DOI 10.1007/s002650050378; Mitchell JS, 2009, BEHAVIOUR, V146, P1665, DOI 10.1163/000579509X12459328580026; Mitchell JS, 2009, ETHOLOGY, V115, P1162, DOI 10.1111/j.1439-0310.2009.01705.x; Nam KB, 2010, P ROY SOC B-BIOL SCI, V277, P3299, DOI 10.1098/rspb.2010.0737; Norusis M. J., 2010, PASW STAT 18 ADV STA; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; Schurch R, 2010, BEHAV ECOL, V21, P588, DOI 10.1093/beheco/arq024; Skubic E, 2004, J THEOR BIOL, V227, P487, DOI 10.1016/j.jtbi.2003.11.021; Stacey P.B., 1990, COOPERATIVE BREEDING; Stiver KA, 2009, J FISH BIOL, V74, P1129, DOI 10.1111/j.1095-8649.2009.02173.x; Stiver KA, 2005, P ROY SOC B-BIOL SCI, V272, P1593, DOI 10.1098/rspb.2005.3123; Taborsky B, 2007, BEHAV ECOL, V18, P652, DOI 10.1093/beheco/arm026; TABORSKY M, 1984, ANIM BEHAV, V32, P1236, DOI 10.1016/S0003-3472(84)80241-9; TABORSKY M, 1994, ADV STUD BEHAV, V23, P1, DOI 10.1016/S0065-3454(08)60351-4; TABORSKY M, 1981, BEHAV ECOL SOCIOBIOL, V8, P143, DOI 10.1007/BF00300826; TABORSKY M, 1985, BEHAVIOUR, V95, P45, DOI 10.1163/156853985X00046; Taborsky M, 2009, REPRODUCTIVE SKEW IN VERTEBRATES: PROXIMATE AND ULTIMATE CAUSES, P265, DOI 10.1017/CBO9780511641954.012; Whittingham LA, 1997, BEHAV ECOL SOCIOBIOL, V40, P261, DOI 10.1007/s002650050341; Whittingham LA, 1998, ANIM BEHAV, V55, P629, DOI 10.1006/anbe.1997.0751; WONG M, 2011, BIOL REV; Wright J, 2010, P ROY SOC B-BIOL SCI, V277, P437, DOI 10.1098/rspb.2009.1360; ZAHAVI A, 1995, J AVIAN BIOL, V26, P1, DOI 10.2307/3677205	76	24	24	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25673	10.1371/journal.pone.0025673	http://dx.doi.org/10.1371/journal.pone.0025673			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022428	Green Submitted, Green Published, gold			2022-12-27	WOS:000295976000029
J	Marion, RM; Schotta, G; Ortega, S; Blasco, MA				Marion, Rosa M.; Schotta, Gunnar; Ortega, Sagrario; Blasco, Maria A.			Suv4-20h Abrogation Enhances Telomere Elongation during Reprogramming and Confers a Higher Tumorigenic Potential to iPS Cells	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; H4 LYSINE-20 TRIMETHYLATION; MAMMALIAN TELOMERES; HUMAN FIBROBLASTS; HISTONE H4; DEFINED FACTORS; DNA-DAMAGE; CANCER; GENERATION; LENGTH	Reprogramming of adult differentiated cells to induced pluripotent stem cells (iPS) cells has been achieved by overexpression of specific transcription factors. Nuclear reprogramming induces a series of profound changes at the telomeres of the parental differentiated cells, including a telomerase-dependent telomere elongation and the remodeling of telomeric chromatin. In particular, iPS cells show a decreased density of H4K20me3 heterochromatic mark at telomeres compared to the parental cells. Suv4-20h1 and Suv4-20h2 histone methytransferases (HMTases) are responsible for the trimethylation of H4K20 at telomeres, as cells deficient for both HMTases show decreased levels of H4K20me3 at telomeric chromatin. Here, we set to address the role of the Suv4-20h enzymes in telomere reprogramming by generating bona-fide iPS cells from mouse embryonic fibroblasts (MEFs) double null for both HMTases (Suv4-20dn MEFs). We found that Suv4-20h deficiency enhances telomere elongation during reprogramming without altering their ability to protect the chromosome ends or the efficiency of reprogramming. Moreover, teratomas generated from Suv4-20dn iPS cells also have elongated telomeres and an increased growth rate when compared to wild-type controls. These results indicate that abrogation of Suv4-20h enzymes and loss of heterochromatic mark H4K20me3 at telomeric heterochromatin facilitates telomere reprogramming and provides an increased tumorigenic potential to the resulting iPS cells.	[Marion, Rosa M.; Blasco, Maria A.] Spanish Natl Canc Ctr, Mol Oncol Program, Telomeres & Telomerase Grp, Madrid, Spain; [Schotta, Gunnar] Univ Munich, Munich Ctr Integrated Prot Sci, Munich, Germany; [Schotta, Gunnar] Univ Munich, Adolf Butenandt Inst, Munich, Germany; [Ortega, Sagrario] Spanish Natl Canc Ctr, Biotechnol Program, Transgen Mice Unit, Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); University of Munich; University of Munich; Centro Nacional de Investigaciones Oncologicas (CNIO)	Marion, RM (corresponding author), Spanish Natl Canc Ctr, Mol Oncol Program, Telomeres & Telomerase Grp, Melchor Fernandez Almagro 3, Madrid, Spain.	mblasco@cnio.es	Blasco, Maria A./M-1694-2014; Marión, Rosa/AAE-8657-2020; Marión, Rosa/L-1488-2015	Blasco, Maria A./0000-0002-4211-233X; Marión, Rosa/0000-0002-0374-3884; Marión, Rosa/0000-0002-0374-3884; Schotta, Gunnar/0000-0003-4940-6135	Spanish Ministry of Science and Innovation [SAF2008-05384, CSD2007-00017]; European Union [2007-A-201630, 2007-A-200950]; European Research Council [232854]; Korber Foundation; Fundacion Botin; Fundacion Lilly (Spain)	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Union(European Commission); European Research Council(European Research Council (ERC)European Commission); Korber Foundation; Fundacion Botin; Fundacion Lilly (Spain)	MB's laboratory is funded by the Spanish Ministry of Science and Innovation Projects SAF2008-05384 and CSD2007-00017, European Union FP7 Projects 2007-A-201630 (GENICA) and 2007-A-200950 (TELOMARKER), European Research Council Advanced Grant GA#232854, Korber Foundation, Fundacion Botin and Fundacion Lilly (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abollo-Jimenez F, 2010, SEMIN CANCER BIOL, V20, P98, DOI 10.1016/j.semcancer.2010.02.002; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Benetti R, 2007, J CELL BIOL, V178, P925, DOI 10.1083/jcb.200703081; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Blanco R, 2007, GENE DEV, V21, P206, DOI 10.1101/gad.406207; Blasco MA, 2003, EUR J CELL BIOL, V82, P441, DOI 10.1078/0171-9335-00335; Blasco MA, 1996, NAT GENET, V12, P200, DOI 10.1038/ng0296-200; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Blasco MA, 2007, NAT CHEM BIOL, V3, P640, DOI 10.1038/nchembio.2007.38; Blelloch R, 2007, CELL STEM CELL, V1, P245, DOI 10.1016/j.stem.2007.08.008; CHADENEAU C, 1995, ONCOGENE, V11, P893; Chan SRWL, 2004, PHILOS T R SOC B, V359, P109, DOI 10.1098/rstb.2003.1370; COUNTER CM, 1994, P NATL ACAD SCI USA, V91, P2900, DOI 10.1073/pnas.91.8.2900; Deng Z, 2009, MOL CELL, V35, P403, DOI 10.1016/j.molcel.2009.06.025; Efeyan A, 2007, CELL CYCLE, V6, P1006, DOI 10.4161/cc.6.9.4211; Flores I, 2005, SCIENCE, V309, P1253, DOI 10.1126/science.1115025; Flores I, 2006, CURR OPIN CELL BIOL, V18, P254, DOI 10.1016/j.ceb.2006.03.003; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Garcia-Cao M, 2004, NAT GENET, V36, P94, DOI 10.1038/ng1278; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Gonzalo S, 2006, NAT CELL BIOL, V8, P416, DOI 10.1038/ncb1386; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kourmouli N, 2004, J CELL SCI, V117, P2491, DOI 10.1242/jcs.01238; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Liu L, 2007, NAT CELL BIOL, V9, P1436, DOI 10.1038/ncb1664; Lopez de Silanes I, 2010, NATURE COMMUNICATION; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Marion RM, 2010, CURR OPIN GENET DEV, V20, P190, DOI 10.1016/j.gde.2010.01.005; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Marion RM, 2009, CELL STEM CELL, V4, P141, DOI 10.1016/j.stem.2008.12.010; Martinez P, 2010, AGING CELL; Martinez P, 2009, GENE DEV, V23, P2060, DOI 10.1101/gad.543509; McNees CJ, 2010, J CELL BIOL, V188, P639, DOI 10.1083/jcb.200908136; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Munoz P, 2005, NAT GENET, V37, P1063, DOI 10.1038/ng1633; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pogribny IP, 2006, CARCINOGENESIS, V27, P1180, DOI 10.1093/carcin/bgi364; Samper E, 2000, EMBO REP, V1, P244, DOI 10.1093/embo-reports/kvd051; Schoeftner S, 2008, NAT CELL BIOL, V10, P228, DOI 10.1038/ncb1685; Schoeftner S, 2010, SEMIN CELL DEV BIOL, V21, P186, DOI 10.1016/j.semcdb.2009.09.015; Schoeftner S, 2009, EMBO J, V28, P2323, DOI 10.1038/emboj.2009.197; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schotta G, 2008, GENE DEV, V22, P2048, DOI 10.1101/gad.476008; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Singhal N, 2010, CELL, V141, P943, DOI 10.1016/j.cell.2010.04.037; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tryndyak VP, 2006, CANCER BIOL THER, V5, P65, DOI 10.4161/cbt.5.1.2288; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Van Den Broeck A, 2008, CLIN CANCER RES, V14, P7237, DOI 10.1158/1078-0432.CCR-08-0869; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Zijlmans JMJM, 1997, P NATL ACAD SCI USA, V94, P7423, DOI 10.1073/pnas.94.14.7423	63	19	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25680	10.1371/journal.pone.0025680	http://dx.doi.org/10.1371/journal.pone.0025680			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022429	gold, Green Published, Green Submitted			2022-12-27	WOS:000295976000030
J	Pedersen, L; Jensen, MH; Krishna, S				Pedersen, Lykke; Jensen, Mogens Hogh; Krishna, Sandeep			Dickkopf1-A New Player in Modelling the Wnt Pathway	PLOS ONE			English	Article							SEGMENTATION CLOCK; NEGATIVE REGULATOR; BETA-CATENIN/TCF; CELL FATE; MECHANISM; MOUSE; FRONT; GRADIENT; NOTCH; AXIN	The Wnt signaling pathway transducing the stabilization of beta-catenin is essential for metazoan embryo development and is misregulated in many diseases such as cancers. In recent years models have been proposed for the Wnt signaling pathway during the segmentation process in developing embryos. Many of these include negative feedback loops where Axin2 plays a key role. However, Axin2 null mice show no segmentation phenotype. We therefore propose a new model where the negative feedback involves Dkk1 rather than Axin2. We show that this model can exhibit the same type of oscillations as the previous models with Axin2 and as observed in experiments. We show that a spatial Wnt gradient can consistently convert this temporal periodicity into the spatial periodicity of somites, provided the oscillations in new cells arising in the presomitic mesoderm are synchronized with the oscillations of older cells. We further investigate the hypothesis that a change in the Wnt level in the tail bud during the later stages of somitogenesis can lengthen the time period of the oscillations and hence the size and separation of the later somites.	[Pedersen, Lykke; Jensen, Mogens Hogh] Niels Bohr Inst, Ctr Models Life, DK-2100 Copenhagen, Denmark; [Krishna, Sandeep] Natl Ctr Biol Sci, Bangalore, Karnataka, India	University of Copenhagen; Niels Bohr Institute; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Pedersen, L (corresponding author), Niels Bohr Inst, Ctr Models Life, Blegdamsvej 17, DK-2100 Copenhagen, Denmark.	lykkep@nbi.dk	Pedersen, Lykke/AAM-2297-2020; Pedersen, Lykke/J-8049-2012; Jensen, Mogens H./U-5510-2017	Pedersen, Lykke/0000-0002-8935-415X; Pedersen, Lykke/0000-0002-8935-415X; Jensen, Mogens H./0000-0001-8104-4299; krishna, sandeep/0000-0002-0581-173X	Danish National Science Research Foundation	Danish National Science Research Foundation(Danmarks Grundforskningsfond)	This research is supported by the Danish National Science Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulehla A, 2004, GENE DEV, V18, P2060, DOI 10.1101/gad.1217404; Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Aulehla A, 2008, NAT CELL BIOL, V10, P186, DOI 10.1038/ncb1679; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Baig-Lewis S, 2007, DEV BIOL, V306, P94, DOI 10.1016/j.ydbio.2007.03.005; Baker RE, 2006, DEV BIOL, V293, P116, DOI 10.1016/j.ydbio.2006.01.018; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Campanelli M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000728; COOKE J, 1976, J THEOR BIOL, V58, P455, DOI 10.1016/S0022-5193(76)80131-2; Dequeant ML, 2006, SCIENCE, V314, P1595, DOI 10.1126/science.1133141; Dubrulle J, 2004, NATURE, V427, P419, DOI 10.1038/nature02216; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; Fagotto F, 1999, J CELL BIOL, V145, P741, DOI 10.1083/jcb.145.4.741; Francois P, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100192; Gibb S, 2009, DEV BIOL, V330, P21, DOI 10.1016/j.ydbio.2009.02.035; Giudicelli F, 2007, PLOS BIOL, V5, P1309, DOI 10.1371/journal.pbio.0050150; Goldbeter A, 2008, J THEOR BIOL, V252, P574, DOI 10.1016/j.jtbi.2008.01.006; Gonzalex-Sancho JM, 2005, ONCOGENE, V24, P1098, DOI 10.1038/sj.onc.1208303; Horikawa K, 2006, NATURE, V441, P719, DOI 10.1038/nature04861; Ishitani T, 2005, NAT CELL BIOL, V7, P1106, DOI 10.1038/ncb1311; Jensen PB, 2010, BIOPHYS J, V98, P943, DOI 10.1016/j.bpj.2009.11.039; Jiang YJ, 2000, NATURE, V408, P475, DOI 10.1038/35044091; Korinek V, 1998, MOL CELL BIOL, V18, P1248, DOI 10.1128/MCB.18.3.1248; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2004, DEVELOPMENT, V131, P2543, DOI 10.1242/dev.01126; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Morelli LG, 2009, HFSP J, V3, P55, DOI 10.2976/1.3027088; Mukhopadhyay M, 2001, DEV CELL, V1, P423, DOI 10.1016/S1534-5807(01)00041-7; Naiche L, 2011, PNAS, V108, P4010; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Ozbudak EM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040015; Riedel-Kruse IH, 2007, SCIENCE, V317, P1911, DOI 10.1126/science.1142538; Santillan M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001561; Semenov MV, 2008, J BIOL CHEM, V283, P21427, DOI 10.1074/jbc.M800014200; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; TAM PPL, 1981, J EMBRYOL EXP MORPH, V65, P103; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; ten Berge D, 2008, DEVELOPMENT, V135, P3247, DOI 10.1242/dev.023176; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; Wawra C, 2007, FEBS LETT, V581, P4043, DOI 10.1016/j.febslet.2007.07.043; Wolpert L., 2011, PRINCIPLES DEV; Yamamoto H, 1999, J BIOL CHEM, V274, P10681, DOI 10.1074/jbc.274.16.10681; Yu HMI, 2005, DEVELOPMENT, V132, P1995, DOI 10.1242/dev.01786; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540	46	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25550	10.1371/journal.pone.0025550	http://dx.doi.org/10.1371/journal.pone.0025550			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022411	Green Submitted, Green Published, gold			2022-12-27	WOS:000295976000020
J	Seno, T; Hamaguchi, M; Ashihara, E; Kohno, M; Ishino, H; Yamamoto, A; Kadoya, M; Nakamura, K; Murakami, K; Matoba, S; Maekawa, T; Kawahito, Y				Seno, Takahiro; Hamaguchi, Masahide; Ashihara, Eishi; Kohno, Masataka; Ishino, Hidetaka; Yamamoto, Aihiro; Kadoya, Masatoshi; Nakamura, Kaoru; Murakami, Ken; Matoba, Satoaki; Maekawa, Taira; Kawahito, Yutaka			15-Deoxy-Delta(12,14) Prostaglandin J(2) Reduces the Formation of Atherosclerotic Lesions in Apolipoprotein E Knockout Mice	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; LOW-DENSITY-LIPOPROTEIN; INFLAMMATORY CYTOKINES; ENDOTHELIAL-CELLS; PPAR-GAMMA; IN-VITRO; EXPRESSION; APOPTOSIS; CHOLESTEROL; MODULATION	Aim: 15-Deoxy-Delta(12,14) Prostaglandin J(2) (15d-PGJ(2)) is a ligand of peroxisome proliferator-activated receptor gamma (PPAR gamma) having diverse effects such as the differentiation of adipocytes and atherosclerotic lesion formation. 15d-PGJ(2) can also regulate the expression of inflammatory mediators on immune cells independent of PPAR gamma. We investigated the antiatherogenic effect of 15d-PGJ(2). Methods: We fed apolipoprotein (apo) E-deficient female mice a Western-type diet from 8 to 16 wk of age and administered 1 mg/kg/day 15d-PGJ(2) intraperitoneally. We measured atherosclerotic lesions at the aortic root, and examined the expression of macrophage and inflammatory atherosclerotic molecules by immunohistochemical and real-time PCR in the lesion. Results: Atherosclerotic lesion formation was reduced in apo E-null mice treated with 15d-PGJ(2), as compared to in the controls. Immunohistochemical and real-time PCR analyses showed that the expression of MCP-1, TNF-alpha, and MMP-9 in atherosclerotic lesions was significantly decreased in 15d-PGJ(2) treated mice. The 15d-PGJ(2) also reduced the expression of macrophages and RelA mRNA in atherosclerotic lesions. Conclusion: This is the first report 15d-PGJ(2), a natural PPARc agonist, can improve atherosclerotic lesions in vivo. 15d-PGJ(2) may be a beneficial therapeutic agent for atherosclerosis.	[Seno, Takahiro; Kohno, Masataka; Ishino, Hidetaka; Yamamoto, Aihiro; Kadoya, Masatoshi; Nakamura, Kaoru; Murakami, Ken; Kawahito, Yutaka] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Inflammat & Immunol, Kyoto, Japan; [Hamaguchi, Masahide] Osaka Univ, Immunol Frontier Res Ctr, World Premier Int Res Ctr, Osaka, Japan; [Ashihara, Eishi] Kyoto Prefectural Univ Med, Dept Mol Cell Physiol, Grad Sch Med Sci, Kyoto, Japan; [Matoba, Satoaki] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Cardiovasc Med, Kyoto, Japan; [Maekawa, Taira] Kyoto Univ Hosp, Dept Transfus Med & Cell Therapy, Kyoto 606, Japan	Kyoto Prefectural University of Medicine; Osaka University; Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Kyoto University	Seno, T (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Inflammat & Immunol, Kyoto, Japan.	kawahity@koto.kpu-m.ac.jp		Hamaguchi, Masahide/0000-0002-8651-4445; Kawahito, Yutaka/0000-0002-3860-0488				Bishop-Bailey D, 1999, J BIOL CHEM, V274, P17042, DOI 10.1074/jbc.274.24.17042; Blanco M, 2005, STROKE, V36, P1189, DOI 10.1161/01.STR.0000166054.55993.e5; Bonfield TL, 2008, J IMMUNOL, V181, P235, DOI 10.4049/jimmunol.181.1.235; Chen Z, 2001, ARTERIOSCL THROM VAS, V21, P372, DOI 10.1161/01.ATV.21.3.372; Dong YG, 2004, ACTA PHARMACOL SIN, V25, P47; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Hamaguchi M, 2010, J CLIN BIOCHEM NUTR, V47, P138, DOI 10.3164/jcbn.10-33; Harris SG, 2002, TRENDS IMMUNOL, V23, P144, DOI 10.1016/S1471-4906(01)02154-8; Ide T, 2003, THROMB RES, V110, P311, DOI 10.1016/S0049-3848(03)00418-3; Jackson SM, 1999, ARTERIOSCL THROM VAS, V19, P2094, DOI 10.1161/01.ATV.19.9.2094; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Kawahito Y, 2000, J CLIN INVEST, V106, P189, DOI 10.1172/JCI9652; Libby P, 2006, J AM COLL CARDIOL, V48, pA33, DOI 10.1016/j.jacc.2006.08.011; Okazaki M, 2005, ARTERIOSCL THROM VAS, V25, P578, DOI 10.1161/01.ATV.0000155017.60171.88; PAIGEN B, 1987, ATHEROSCLEROSIS, V68, P231, DOI 10.1016/0021-9150(87)90202-4; Pan JH, 2004, CIRCULATION, V109, P3149, DOI 10.1161/01.CIR.0000134704.84454.D2; Pasceri V, 2000, CIRCULATION, V101, P235, DOI 10.1161/01.CIR.101.3.235; PIEDRAHITA JA, 1992, P NATL ACAD SCI USA, V89, P4471, DOI 10.1073/pnas.89.10.4471; Ricote M, 1998, P NATL ACAD SCI USA, V95, P7614, DOI 10.1073/pnas.95.13.7614; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Shinohara E, 1998, ATHEROSCLEROSIS, V136, P275, DOI 10.1016/S0021-9150(97)00220-7; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; Tanaka T, 2005, EUR J PHARMACOL, V508, P255, DOI 10.1016/j.ejphar.2004.10.056; Toriumi Y, 2003, FEBS LETT, V553, P419, DOI 10.1016/S0014-5793(03)01040-8; Usui S, 2002, J LIPID RES, V43, P805; Xin XH, 1999, J BIOL CHEM, V274, P9116, DOI 10.1074/jbc.274.13.9116; Yousefipour Z, 2009, AM J NEPHROL, V30, P201, DOI 10.1159/000218061; Zhang WY, 2008, ARTERIOSCL THROM VAS, V28, P2312, DOI 10.1161/ATVBAHA.108.175687	29	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25541	10.1371/journal.pone.0025541	http://dx.doi.org/10.1371/journal.pone.0025541			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003398	Green Submitted, Green Published, gold			2022-12-27	WOS:000295970300019
J	Lai, JN; Wu, CT; Chen, PC; Huang, CS; Chow, SN; Wang, JD				Lai, Jung-Nien; Wu, Chien-Tung; Chen, Pau-Chung; Huang, Chiun-Sheng; Chow, Song-Nan; Wang, Jung-Der			Increased Risk for Invasive Breast Cancer Associated with Hormonal Therapy: A Nation-Wide Random Sample of 65,723 Women Followed from 1997 to 2008	PLOS ONE			English	Article							PROGESTIN-REPLACEMENT THERAPY; HEALTH INITIATIVE WHI; POSTMENOPAUSAL WOMEN; MENOPAUSAL SYMPTOMS; ESTROGEN; TAIWAN; COHORT; CELLS	Background: Hormonal therapy (HT) either estrogen alone (E-alone) or estrogen plus progesterone (E+P) appears to increase the risk for breast cancer in Western countries. However, limited information is available on the association between HT and breast cancer in Asian women characterized mainly by dietary phytoestrogens intake and low prevalence of contraceptive pills prescription. Methodology: A total of 65,723 women (20-79 years of age) without cancer or the use of Chinese herbal products were recruited from a nation-wide one-million representative sample of the National Health Insurance of Taiwan and followed from 1997 to 2008. Seven hundred and eighty incidents of invasive breast cancer were diagnosed. Using a reference group that comprised 40,052 women who had never received a hormone prescription, Cox proportional hazard models were constructed to determine the hazard ratios for receiving different types of HT and the occurrence of breast cancer. Conclusions: 5,156 (20%) women ever used E+P, 2,798 (10.8%) ever used E-alone, and 17,717 (69%) ever used other preparation types. The Cox model revealed adjusted hazard ratios (HRs) of 2.05 (95% CI 1.37-3.07) for current users of E-alone and 8.65 (95% CI 5.45-13.70) for current users of E+P. Using women who had ceased to take hormonal medication for 6 years or more as the reference group, the adjusted HRs were significantly elevated and greater than current users and women who had discontinued hormonal medication for less than 6 years. Current users of either E-alone or E+P have an increased risk for invasive breast cancer in Taiwan, and precautions should be taken when such agents are prescribed.	[Lai, Jung-Nien] Natl Yang Ming Univ, Sch Med, Inst Tradit Med, Taipei 112, Taiwan; [Lai, Jung-Nien] Taipei City Hosp, Yangming Branch, Dept Obstet & Gynecol, Taipei, Taiwan; [Wu, Chien-Tung] Taipei City Hosp, Dept Chinese Med, Taipei, Taiwan; [Chen, Pau-Chung; Wang, Jung-Der] Natl Taiwan Univ, Inst Occupat Med & Ind Hyg, Coll Publ Hlth, Taipei 10764, Taiwan; [Huang, Chiun-Sheng] Natl Taiwan Univ, Coll Med, Dept Surg, Taipei 10764, Taiwan; [Huang, Chiun-Sheng] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Chow, Song-Nan] Natl Taiwan Univ Hosp, Dept Obstet & Gynecol, Taipei 100, Taiwan; [Wang, Jung-Der] Natl Cheng Kung Univ, Coll Med, Dept Publ Hlth, Tainan 70101, Taiwan; [Wang, Jung-Der] Natl Cheng Kung Univ Hosp, Dept Occupat & Environm Med, Tainan 70428, Taiwan	National Yang Ming Chiao Tung University; Taipei City Hospital; Taipei City Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital	Lai, JN (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Tradit Med, Taipei 112, Taiwan.	jdwang121@gmail.com	Chen, Pau-Chung/H-5686-2011	Chen, Pau-Chung/0000-0002-6242-5974; Huang, Chiun-Sheng/0000-0002-6557-211X	National Health Research Institute; National Research Institute of Chinese Medicine	National Health Research Institute(National Health Research Institutes - Taiwan); National Research Institute of Chinese Medicine	This study was funded by the National Health Research Institute and National Research Institute of Chinese Medicine. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. And no additional external funding was received for this study. The database was kindly provided by the Bureau of National Health Insurance, the Department of Health, and the National Health Research Institutes.	Adlercreutz H, 2002, LANCET ONCOL, V3, P364, DOI 10.1016/S1470-2045(02)00777-5; Amato P, 2002, MENOPAUSE, V9, P145, DOI 10.1097/00042192-200203000-00010; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Bush TM, 2007, J GEN INTERN MED, V22, P1311, DOI 10.1007/s11606-007-0296-z; Centers for Disease Control and Prevention, 1979, INT CLASS DIS 9 REV; Chen SB, 2006, J CHROMATOGR A, V1121, P114, DOI 10.1016/j.chroma.2006.04.082; Chlebowski RT, 2010, J CLIN ONCOL, V28, P2690, DOI 10.1200/JCO.2009.24.8799; COLDITZ GA, 1995, NEW ENGL J MED, V332, P1589, DOI 10.1056/NEJM199506153322401; Cust Michael P, 2007, Menopause Int, V13, P141, DOI 10.1258/175404507783004285; Druss BG, 1999, JAMA-J AM MED ASSOC, V282, P651, DOI 10.1001/jama.282.7.651; Government Information Office, 2004, TAIW YB 2004; Haines CJ, 2005, MATURITAS, V52, P264, DOI 10.1016/j.maturitas.2005.03.012; Hines LM, 2010, CANCER-AM CANCER SOC, V116, P3215, DOI 10.1002/cncr.25154; Hsieh SC, 2008, PHARMACOEPIDEM DR S, V17, P609, DOI 10.1002/pds.1611; Hu CY, 2009, J STEROID BIOCHEM, V113, P209, DOI 10.1016/j.jsbmb.2008.12.019; Kuo DJ, 2007, MATURITAS, V58, P259, DOI 10.1016/j.maturitas.2007.08.013; Lau WS, 2009, BRIT J PHARMACOL, V156, P1136, DOI 10.1111/j.1476-5381.2009.00123.x; Lee SH, 2004, J NUTR BIOCHEM, V15, P452, DOI 10.1016/j.jnutbio.2004.01.007; Lyytinen H, 2006, OBSTET GYNECOL, V108, P1354, DOI 10.1097/01.AOG.0000241091.86268.6e; Magnusson C, 1999, INT J CANCER, V81, P339, DOI 10.1002/(SICI)1097-0215(19990505)81:3<339::AID-IJC5>3.3.CO;2-Y; National Health Research Institutes, 2003, NAT HLTH INS RES DAT; Pedersen AT, 2003, HUM REPROD, V18, P2241, DOI 10.1093/humrep/deg435; Piersen Colleen E, 2003, Integr Cancer Ther, V2, P120, DOI 10.1177/1534735403002002004; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Santen RJ, 2010, J CLIN ENDOCR METAB, V95, pS7, DOI 10.1210/jc.2009-2509; Schairer C, 2000, JAMA-J AM MED ASSOC, V283, P485, DOI 10.1001/jama.283.4.485; Smigal C, 2006, CA-CANCER J CLIN, V56, P168, DOI 10.3322/canjclin.56.3.168; Stahlberg C, 2004, INT J CANCER, V109, P721, DOI 10.1002/ijc.20016; Tjonneland A, 2004, CANCER-AM CANCER SOC, V100, P2328, DOI 10.1002/cncr.20250; Weissmann-Brenner A, 2010, MED SCI MONITOR, V16, pPH35	30	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e25183	10.1371/journal.pone.0025183	http://dx.doi.org/10.1371/journal.pone.0025183			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998640	Green Published, gold, Green Submitted			2022-12-27	WOS:000295968700006
J	Arola-Arnal, A; Blade, C				Arola-Arnal, Anna; Blade, Cinta			Proanthocyanidins Modulate MicroRNA Expression in Human HepG2 Cells	PLOS ONE			English	Article							GRAPE SEED PROCYANIDINS; ANTIOXIDANT ACTIVITY; TEA POLYPHENOLS; IN-VITRO; CANCER; BIOAVAILABILITY; MECHANISMS; PREVENTION; TANNINS; DISEASE	Mi(cro)RNAs are small non-coding RNAs of 18-25 nucleotides in length that modulate gene expression at the post-transcriptional level. These RNAs have been shown to be involved in a several biological processes, human diseases and metabolic disorders. Proanthocyanidins, which are the most abundant polyphenol class in the human diet, have positive health effects on a variety of metabolic disorders such as inflammation, obesity, diabetes and insulin resistance. The present study aimed to evaluate whether proanthocyanidin-rich natural extracts modulate miRNA expression. Using microarray analysis and Q-PCR, we investigated miRNA expression in HepG2 cells treated with proanthocyanidins. Our results showed that when HepG2 cells were treated with grape seed proanthocyanidin extract (GSPE), cocoa proanthocyanidin extract (CPE) or pure epigallocatechin gallate isolated from green tea (EGCG), fifteen, six and five differentially expressed miRNAs, respectively, were identified out of 904 mRNAs. Specifically, miR-30b* was downregulated by the three treatments, and treatment with GSPE or CPE upregulated miR-1224-3p, miR-197 and miR-532-3p. Therefore, these results provide evidence of the capacity of dietary proanthocyanidins to influence microRNA expression, suggesting a new mechanism of action of proanthocyanidins.	[Arola-Arnal, Anna; Blade, Cinta] Univ Rovira & Virgili, Dept Biochem & Biotechnol, Tarragona, Spain; [Arola-Arnal, Anna] CTNS, Reus, Spain	Universitat Rovira i Virgili	Arola-Arnal, A (corresponding author), Univ Rovira & Virgili, Dept Biochem & Biotechnol, Tarragona, Spain.	anna.arola@urv.cat	Arola-Arnal, Anna/C-2087-2015	Arola-Arnal, Anna/0000-0001-6529-1345; Blade, Cinta/0000-0003-2838-2402	Spanish Government [AGL 2008-00387/ALI]; European Union [244995]	Spanish Government(Spanish GovernmentEuropean Commission); European Union(European Commission)	This work was supported by grant number AGL 2008-00387/ALI from the Spanish Government. The research leading to these results has received funding from the European Union's Seventh Framework Programme FP7 2007-2013 under grant agreement no 244995 (BIOCLAIMS Project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Blade C, 2010, MOL NUTR FOOD RES, V54, P37, DOI 10.1002/mnfr.200900476; Chen J, 2010, ADV GENET, V71, P237, DOI [10.1016/B978-0-12-380864-6.00008-0, 10.1016/S0065-2660(10)71009-9]; Chiba Y, 2010, J PHARMACOL SCI, V114, P262, DOI 10.1254/jphs.10R09FM; Counet C, 2003, J AGR FOOD CHEM, V51, P6816, DOI 10.1021/jf030349g; Crozier A, 2009, NAT PROD REP, V26, P1001, DOI 10.1039/b802662a; De Bruyne T, 1999, BIOCHEM SYST ECOL, V27, P445, DOI 10.1016/S0305-1978(98)00101-X; Del Bas JM, 2005, FASEB J, V19, P479, DOI 10.1096/fj.04-3095fje; Del Bas JM, 2008, MOL NUTR FOOD RES, V52, P1172, DOI 10.1002/mnfr.200800054; Dorn C, 2010, INT J CLIN EXP PATHO, V3, P505; Esau CC, 2007, ADV DRUG DELIVER REV, V59, P101, DOI 10.1016/j.addr.2007.03.007; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Garcia-Ramirez B, 2006, J AGR FOOD CHEM, V54, P2543, DOI 10.1021/jf0527753; Iglesias J, 2010, J AGR FOOD CHEM, V58, P7423, DOI 10.1021/jf100832z; Kobayashi M, 2009, J AGR FOOD CHEM, V57, P7131, DOI 10.1021/jf900855v; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Krutzfeldt J, 2006, CELL METAB, V4, P9, DOI 10.1016/j.cmet.2006.05.009; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Link A, 2010, BIOCHEM PHARMACOL, V80, P1771, DOI 10.1016/j.bcp.2010.06.036; Del Bas JM, 2009, MOL NUTR FOOD RES, V53, P805, DOI 10.1002/mnfr.200800364; Montagut G, 2010, J NUTR BIOCHEM, V21, P476, DOI 10.1016/j.jnutbio.2009.02.003; Montagut G, 2009, FOOD CHEM, V116, P265, DOI 10.1016/j.foodchem.2009.02.044; Moore KJ, 2011, ANNU REV NUTR, V31, P49, DOI 10.1146/annurev-nutr-081810-160756; Nakai M, 2005, J AGR FOOD CHEM, V53, P4593, DOI 10.1021/jf047814+; Nandakumar V, 2008, CANCER LETT, V269, P378, DOI 10.1016/j.canlet.2008.03.049; Ortega N, 2008, J AGR FOOD CHEM, V56, P9621, DOI 10.1021/jf8014415; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Puiggros F, 2005, J AGR FOOD CHEM, V53, P6080, DOI 10.1021/jf050343m; Qin SS, 2011, J CARDIOVASC PHARM, V57, P8, DOI 10.1097/FJC.0b013e318203759b; Serra A, 2010, BRIT J NUTR, V103, P944, DOI 10.1017/S0007114509992741; Serrano J, 2009, MOL NUTR FOOD RES, V53, pS310, DOI 10.1002/mnfr.200900039; Terra X, 2011, FREE RADICAL RES, V45, P611, DOI 10.3109/10715762.2011.564165; Terra X, 2011, J NUTR BIOCHEM, V22, P380, DOI 10.1016/j.jnutbio.2010.03.006; Tsang WP, 2010, J NUTR BIOCHEM, V21, P140, DOI 10.1016/j.jnutbio.2008.12.003; United States Department of Agriculture, 2014, USDA DATABASE FLAVON	37	79	87	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25982	10.1371/journal.pone.0025982	http://dx.doi.org/10.1371/journal.pone.0025982			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998738	gold, Green Published			2022-12-27	WOS:000295966900086
J	Fre, S; Hannezo, E; Sale, S; Huyghe, M; Lafkas, D; Kissel, H; Louvi, A; Greve, J; Louvard, D; Artavanis-Tsakonas, S				Fre, Silvia; Hannezo, Edouard; Sale, Sanja; Huyghe, Mathilde; Lafkas, Daniel; Kissel, Holger; Louvi, Angeliki; Greve, Jeffrey; Louvard, Daniel; Artavanis-Tsakonas, Spyros			Notch Lineages and Activity in Intestinal Stem Cells Determined by a New Set of Knock-In Mice	PLOS ONE			English	Article							PROGENITOR CELLS; RECEPTOR EXPRESSION; MUTATION; SIGNALS; BRAIN; FATE; RENEWAL; CRYPTS; COLON; VIVO	The conserved role of Notch signaling in controlling intestinal cell fate specification and homeostasis has been extensively studied. Nevertheless, the precise identity of the cells in which Notch signaling is active and the role of different Notch receptor paralogues in the intestine remain ambiguous, due to the lack of reliable tools to investigate Notch expression and function in vivo. We generated a new series of transgenic mice that allowed us, by lineage analysis, to formally prove that Notch1 and Notch2 are specifically expressed in crypt stem cells. In addition, a novel Notch reporter mouse, Hes1-EmGFP(SAT), demonstrated exclusive Notch activity in crypt stem cells and absorptive progenitors. This roster of knock-in and reporter mice represents a valuable resource to functionally explore the Notch pathway in vivo in virtually all tissues.	[Fre, Silvia; Huyghe, Mathilde; Louvard, Daniel] Inst Curie, CNRS, UMR144, F-75231 Paris, France; [Hannezo, Edouard] UPMC, CNRS, Inst Curie, UMR 168, Paris, France; [Sale, Sanja; Artavanis-Tsakonas, Spyros] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA; [Lafkas, Daniel; Artavanis-Tsakonas, Spyros] INSERM, Dept Dev Biol & Genet, Inst Curie, CNRS,U934,UMR3215, Paris, France; [Kissel, Holger] TaconicArtemis GmbH, Cologne, Germany; [Louvi, Angeliki] Yale Univ, Sch Med, Program Neurogenet, New Haven, CT USA; [Louvi, Angeliki] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT USA; [Louvi, Angeliki] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA; [Greve, Jeffrey] Exelixis Inc, San Francisco, CA USA; [Artavanis-Tsakonas, Spyros] Coll France, F-75231 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Harvard University; Harvard Medical School; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Yale University; Yale University; Yale University; Exelixis, Inc.; UDICE-French Research Universities; PSL Research University Paris; College de France	Fre, S (corresponding author), Inst Curie, CNRS, UMR144, F-75231 Paris, France.	artavanis@hms.harvard.edu	Lafkas, Daniel/AAI-8718-2021; Fre, Silvia/C-7540-2017	Lafkas, Daniel/0000-0001-7395-476X; Fre, Silvia/0000-0002-7209-7636; huyghe, mathilde/0000-0002-8473-2924; Hannezo, Edouard/0000-0001-6005-1561	Institut National du Cancer [2009-175]; Ligue Nationale contre le Cancer [EL2008.LNCC/SR1]; NIH [NS26084, CA098402]; Exelixis, Inc.; NATIONAL CANCER INSTITUTE [R01CA098402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026084, R37NS026084] Funding Source: NIH RePORTER	Institut National du Cancer(Institut National du Cancer (INCA) France); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Exelixis, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by grants from "Institut National du Cancer" (2009-175) (http://www.e-cancer.fr/) and "Ligue Nationale contre le Cancer" (EL2008.LNCC/SR1) (http://www.ligue-cancer.net/) to SF and DL and by the NIH (NS26084, CA098402) (http://www.nih.gov/) to SAT. Exelixis, Inc. funded the construction of the Notch transgenic mice used in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Boni A, 2008, P NATL ACAD SCI USA, V105, P15529, DOI 10.1073/pnas.0808357105; Buske P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001045; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Farnie G, 2007, STEM CELL REV, V3, P169, DOI 10.1007/s12015-007-0023-5; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Finan GM, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.170217; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Fre S, 2009, P NATL ACAD SCI USA, V106, P6309, DOI 10.1073/pnas.0900427106; Grandbarbe L, 2003, DEVELOPMENT, V130, P1391, DOI 10.1242/dev.00374; GRIFFITHS DFR, 1988, NATURE, V333, P461, DOI 10.1038/333461a0; Hamada Y, 1999, DEVELOPMENT, V126, P3415; Klein AM, 2010, CELL STEM CELL, V7, P214, DOI 10.1016/j.stem.2010.05.017; Kopinke D, 2011, DEVELOPMENT, V138, P431, DOI 10.1242/dev.053843; Lee G, 2009, P NATL ACAD SCI USA, V106, P4701, DOI 10.1073/pnas.0900751106; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Liu JN, 2010, CURR TOP DEV BIOL, V92, P367, DOI [10.1016/S0070-2153(10)92012-7, 10.1016/S0070-2153(10)91012-7]; Loomes KM, 2002, AM J MED GENET, V112, P181, DOI 10.1002/ajmg.10592; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; Murphy PA, 2009, LAB INVEST, V89, P971, DOI 10.1038/labinvest.2009.62; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nijjar SS, 2001, HEPATOLOGY, V34, P1184, DOI 10.1053/jhep.2001.29399; PARK HS, 1995, AM J PATHOL, V147, P1416; Pellegrinet L, 2011, GASTROENTEROLOGY; Prakash N, 2002, EXP CELL RES, V278, P31, DOI 10.1006/excr.2002.5544; Riccio O, 2008, EMBO REP, V9, P377, DOI 10.1038/embor.2008.7; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stillman AA, 2009, J COMP NEUROL, V513, P21, DOI 10.1002/cne.21919; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Tanigaki K, 2001, NEURON, V29, P45, DOI 10.1016/S0896-6273(01)00179-9; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Varnum-Finney B, 2000, NAT MED, V6, P1278, DOI 10.1038/81390; Vooijs M, 2007, DEVELOPMENT, V134, P535, DOI 10.1242/dev.02733; WINTON DJ, 1988, NATURE, V333, P463, DOI 10.1038/333463a0; Wu Y, 2010, NATURE, V464, P1052, DOI 10.1038/nature08878	40	99	99	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25785	10.1371/journal.pone.0025785	http://dx.doi.org/10.1371/journal.pone.0025785			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991352	Green Submitted, Green Published, gold			2022-12-27	WOS:000295943000070
J	Qiu, LL; Tian, L; Pan, C; Zhu, RS; Liu, Q; Yan, J; Zhao, Q; Yuan, HS; Han, YH; Yue, WH; Yan, H; Zhang, D				Qiu, Linlin; Tian, Lin; Pan, Chao; Zhu, Risheng; Liu, Qi; Yan, Jun; Zhao, Qiang; Yuan, Huishu; Han, Yonghua; Yue, Weihua; Yan, Hao; Zhang, Dai			Neuroanatomical Circuitry Associated with Exploratory Eye Movement in Schizophrenia: A Voxel-Based Morphometric Study	PLOS ONE			English	Article							SPATIAL WORKING-MEMORY; SMOOTH-PURSUIT; VISUAL-OBJECT; FUNCTIONAL NEUROANATOMY; TRACKING DYSFUNCTION; CORTICAL CONTROL; RECOGNITION; DEFICITS; LESIONS; FIELD	Schizophrenic patients present abnormalities in a variety of eye movement tasks. Exploratory eye movement (EEM) dysfunction appears to be particularly specific to schizophrenia. However, the underlying mechanisms of EEM dysfunction in schizophrenia are not clearly understood. To assess the potential neuroanatomical substrates of EEM, we recorded EEM performance and conducted a voxel-based morphometric analysis of gray matter in 33 schizophrenic patients and 29 well matched healthy controls. In schizophrenic patients, decreased responsive search score (RSS) and widespread gray matter density (GMD) reductions were observed. Moreover, the RSS was positively correlated with GMD in distributed brain regions in schizophrenic patients. Furthermore, in schizophrenic patients, some brain regions with neuroanatomical deficits overlapped with some ones associated with RSS. These brain regions constituted an occipito-tempro-frontal circuitry involved in visual information processing and eye movement control, including the left calcarine cortex [ Brodmann area (BA) 17], the left cuneus (BA 18), the left superior occipital cortex (BA 18/19), the left superior frontal gyrus (BA 6), the left cerebellum, the right lingual cortex (BA 17/18), the right middle occipital cortex (BA19), the right inferior temporal cortex (BA 37), the right dorsolateral prefrontal cortex (BA 46) and bilateral precentral gyri (BA 6) extending to the frontal eye fields (FEF, BA 8). To our knowledge, we firstly reported empirical evidence that gray matter loss in the occipito-tempro-frontal neuroanatomical circuitry of visual processing system was associated with EEM performance in schizophrenia, which may be helpful for the future effort to reveal the underlying neural mechanisms for EEM disturbances in schizophrenia.	[Qiu, Linlin; Tian, Lin; Pan, Chao; Zhu, Risheng; Liu, Qi; Yan, Jun; Han, Yonghua; Yue, Weihua; Yan, Hao; Zhang, Dai] Peking Univ, Inst Mental Hlth, Beijing 100871, Peoples R China; [Qiu, Linlin; Tian, Lin; Pan, Chao; Zhu, Risheng; Liu, Qi; Yan, Jun; Han, Yonghua; Yue, Weihua; Yan, Hao; Zhang, Dai] Minist Hlth, Key Lab Mental Hlth, Beijing, Peoples R China; [Zhao, Qiang; Yuan, Huishu] Peking Univ, Dept Radiol, Hosp 3, Beijing 100871, Peoples R China	Peking University; Peking University	Qiu, LL (corresponding author), Peking Univ, Inst Mental Hlth, Beijing 100871, Peoples R China.	hao_y@hsc.pku.edu.cn; daizhang@hsc.pku.edu.cn	Yan, Hao/U-1330-2017	Yan, Hao/0000-0003-0376-9037	National Basic Research Program of China [2011CB707805, 2007CB512301]; National Natural Science Foundation of China [81071088, 81000580]; Capital Foundation of Medical Developments [2007-1001]; International Science and Technology Cooperation Program of China [2010DFB30820]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Capital Foundation of Medical Developments; International Science and Technology Cooperation Program of China	This work was supported by grants from National Basic Research Program of China (2011CB707805, 2007CB512301), National Natural Science Foundation of China (81071088 and 81000580), Capital Foundation of Medical Developments (2007-1001) and International Science and Technology Cooperation Program of China (2010DFB30820). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGGLETON JP, 1990, BEHAV BRAIN RES, V39, P262, DOI 10.1016/0166-4328(90)90032-A; Bagary MS, 2004, BIOL PSYCHIAT, V56, P620, DOI 10.1016/j.biopsych.2004.08.017; Bai YM, 2007, J CLIN PSYCHIAT, V68, P1218, DOI 10.4088/JCP.v68n0808; Barash S, 1999, J NEUROSCI, V19, P10931, DOI 10.1523/JNEUROSCI.19-24-10931.1999; Barton JJS, 1996, ANN NEUROL, V40, P387, DOI 10.1002/ana.410400308; Bense S, 2001, J NEUROPHYSIOL, V85, P886, DOI 10.1152/jn.2001.85.2.886; Blumberg J, 2010, J CLIN INVEST, V120, P3054, DOI 10.1172/JCI42161; BRAFF DL, 1993, SCHIZOPHRENIA BULL, V19, P233, DOI 10.1093/schbul/19.2.233; Cadenhead KS, 1997, SCHIZOPHR RES, V28, P51, DOI 10.1016/S0920-9964(97)00085-6; Chen SHA, 2005, NEUROIMAGE, V24, P332, DOI 10.1016/j.neuroimage.2004.08.032; COFFMAN JA, 1981, LANCET, V1, P666; Courtney SM, 1998, SCIENCE, V279, P1347, DOI 10.1126/science.279.5355.1347; Cuadra MB, 2005, IEEE T MED IMAGING, V24, P1548, DOI 10.1109/TMI.2005.857652; Eckert MA, 2006, NEUROIMAGE, V32, P1001, DOI 10.1016/j.neuroimage.2006.05.014; Fornito A, 2009, SCHIZOPHR RES, V108, P104, DOI 10.1016/j.schres.2008.12.011; Gegeshidze K, 2004, WORLD J BIOL PSYCHIA, V5, P26, DOI 10.1080/15622970410029904; Goebel R, 1998, EUR J NEUROSCI, V10, P1563, DOI 10.1046/j.1460-9568.1998.00181.x; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; KATSANIS J, 1991, J ABNORM PSYCHOL, V100, P526, DOI 10.1037/0021-843X.100.4.526; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Keshavan MS, 2008, SCHIZOPHR RES, V106, P89, DOI 10.1016/j.schres.2008.07.020; KOJIMA T, 1989, PSYCHIAT RES, V28, P307, DOI 10.1016/0165-1781(89)90211-4; KOJIMA T, 1992, SCHIZOPHRENIA BULL, V18, P85, DOI 10.1093/schbul/18.1.85; Kojima T, 2001, SCHIZOPHR RES, V52, P203, DOI 10.1016/S0920-9964(00)00181-X; KOJIMA T, 1990, BIOL PSYCHIAT, V27, P975, DOI 10.1016/0006-3223(90)90035-Z; Krauzlis RJ, 2005, NEUROSCIENTIST, V11, P124, DOI 10.1177/1073858404271196; Lehman AF, 1998, SCHIZOPHRENIA BULL, V24, P1; Levy DL, 2010, CURR TOP BEHAV NEURO, V4, P311, DOI 10.1007/7854_2010_60; LEVY DL, 1993, SCHIZOPHRENIA BULL, V19, P461, DOI 10.1093/schbul/19.3.461; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; Luna B, 2008, BRAIN COGNITION, V68, P293, DOI 10.1016/j.bandc.2008.08.019; MARPLEHORVAT DE, 1990, J PHYSIOL-LONDON, V428, P595, DOI 10.1113/jphysiol.1990.sp018230; MATSUE Y, 1986, BIOL PSYCHIAT, V21, P382, DOI 10.1016/0006-3223(86)90166-6; MATSUSHIMA E, 1992, EUR ARCH PSY CLIN N, V241, P210, DOI 10.1007/BF02190255; Matsushima E, 1998, J PSYCHIAT RES, V32, P289, DOI 10.1016/S0022-3956(98)00019-3; Meisenzahl EM, 2008, SCHIZOPHR RES, V102, P150, DOI 10.1016/j.schres.2008.02.023; Miall RC, 1998, NOVART FDN SYMP, V218, P272; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; MISHKIN M, 1954, J COMP PHYSIOL PSYCH, V47, P187, DOI 10.1037/h0057551; Miyata J, 2009, SCHIZOPHR RES, V111, P78, DOI 10.1016/j.schres.2009.03.010; Moncrieff J, 2010, PSYCHOL MED, V40, P1409, DOI 10.1017/S0033291709992297; Monti MM, 2007, NEUROIMAGE, V37, P1005, DOI 10.1016/j.neuroimage.2007.04.069; Nassi JJ, 2009, NAT REV NEUROSCI, V10, P360, DOI 10.1038/nrn2619; O'Driscoll GA, 2000, NEUROREPORT, V11, P1335, DOI 10.1097/00001756-200004270-00037; Obayashi S, 2001, EUR ARCH PSY CLIN N, V251, P211, DOI 10.1007/s004060170029; ODonnell BF, 1996, AM J PSYCHIAT, V153, P687; Oliveri M, 2001, CEREB CORTEX, V11, P606, DOI 10.1093/cercor/11.7.606; PARK S, 1992, ARCH GEN PSYCHIAT, V49, P975; Paus T, 1996, NEUROPSYCHOLOGIA, V34, P475, DOI 10.1016/0028-3932(95)00134-4; Pierrot-Deseilligny C, 2002, ANN NEUROL, V52, P10, DOI 10.1002/ana.10273; PIERROTDESEILLIGNY C, 1991, EXP BRAIN RES, V83, P607; Raemaekers M, 2002, ARCH GEN PSYCHIAT, V59, P313, DOI 10.1001/archpsyc.59.4.313; SCHALL JD, 1993, NATURE, V366, P467, DOI 10.1038/366467a0; Schall JD, 2004, VISION RES, V44, P1453, DOI 10.1016/j.visres.2003.10.025; Sehatpour P, 2010, ARCH GEN PSYCHIAT, V67, P772, DOI 10.1001/archgenpsychiatry.2010.85; Straube A, 1997, ANN NEUROL, V42, P891, DOI 10.1002/ana.410420611; Suzuki M, 2009, EUR ARCH PSY CLIN N, V259, P186, DOI 10.1007/s00406-008-0850-7; Takagi M, 1998, J NEUROPHYSIOL, V80, P1911, DOI 10.1152/jn.1998.80.4.1911; Takahashi S, 2003, AM J MED GENET B, V123B, P27, DOI 10.1002/ajmg.b.10046; Takahashi S, 2008, PSYCHIAT CLIN NEUROS, V62, P487, DOI 10.1111/j.1440-1819.2008.01840.x; Tek C, 2002, ARCH GEN PSYCHIAT, V59, P146, DOI 10.1001/archpsyc.59.2.146; Tootell RBH, 1998, TRENDS COGN SCI, V2, P174, DOI 10.1016/S1364-6613(98)01171-1; Tregellas JR, 2004, AM J PSYCHIAT, V161, P315, DOI 10.1176/appi.ajp.161.2.315; Tsunoda M, 2005, EUR ARCH PSY CLIN N, V255, P104, DOI 10.1007/s00406-004-0540-z; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Weiskrantz L, 1996, CURR OPIN NEUROBIOL, V6, P215, DOI 10.1016/S0959-4388(96)80075-4; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663, DOI 10.4088/JCP.v64n0607; World Health Organization, 1993, ICD 10 ICD 10 CLASSI, pxiii; Wright IC, 2000, AM J PSYCHIAT, V157, P16, DOI 10.1176/ajp.157.1.16; Yan XH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010931; Zeki S, 1998, BRAIN, V121, P25, DOI 10.1093/brain/121.1.25	72	18	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25805	10.1371/journal.pone.0025805	http://dx.doi.org/10.1371/journal.pone.0025805			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834EU	21991357	Green Published, Green Submitted, gold			2022-12-27	WOS:000295943000074
J	Chau, BNT; Nguyen, HT; Ha, TTP; Van Tran, N; Wills, B; Farrar, J; Santangelo, JD; Simmons, CP				Chau Bich Nguyen Tran; Hieu Trong Nguyen; Ha Thanh Thi Phan; Ngoc Van Tran; Wills, Bridget; Farrar, Jeremy; Santangelo, Joseph D.; Simmons, Cameron P.			The Seroprevalence and Seroincidence of Enterovirus71 Infection in Infants and Children in Ho Chi Minh City, Viet Nam	PLOS ONE			English	Article							EPIDEMIOLOGIC FEATURES; ENTERIC VIRUSES; MOUTH-DISEASE; TAIWAN; WATER; ANTIBODIES; SINGAPORE; HAND	Enterovirus 71 (EV71)-associated hand, foot and mouth disease has emerged as a serious public health problem in South East Asia over the last decade. To better understand the prevalence of EV71 infection, we determined EV71 seroprevalence and seroincidence amongst healthy infants and children in Ho Chi Minh City, Viet Nam. In a cohort of 200 newborns, 55% of cord blood samples contained EV71 neutralizing antibodies and these decayed to undetectable levels by 6 months of age in 98% of infants. The EV71 neutralizing antibody seroconversion rate was 5.6% in the first year and 14% in the second year of life. In children 5-15 yrs of age, seroprevalence of EV71 neutralizing antibodies was 84% and in cord blood it was 55%. Taken together, these data suggest EV71 force of infection is high and highlights the need for more research into its epidemiology and pathogenesis in high disease burden countries.	[Chau Bich Nguyen Tran; Wills, Bridget; Farrar, Jeremy; Simmons, Cameron P.] Univ Oxford, Clin Res Unit, Ho Chi Minh City, Vietnam; [Wills, Bridget; Farrar, Jeremy; Simmons, Cameron P.] Univ Oxford, Ctr Trop Med, Oxford, England; [Hieu Trong Nguyen] Hung Vuong Hosp, Dept Neonatol, Ho Chi Minh City, Vietnam; [Ngoc Van Tran] Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Santangelo, Joseph D.] Inviragen Pte Ltd, Singapore, Singapore; [Ha Thanh Thi Phan] Dist 8 Hosp, Ho Chi Minh City, Vietnam	University of Oxford; University of Oxford	Chau, BNT (corresponding author), Univ Oxford, Clin Res Unit, Ho Chi Minh City, Vietnam.	chautnb@oucru.org	Farrar, Jeremy J./HGA-7610-2022; Simmons, Cameron P/ABA-3896-2021; Huy, Nguyen Tien/B-2573-2010	Simmons, Cameron P/0000-0002-9039-7392; Huy, Nguyen Tien/0000-0002-9543-9440; Hirayama, Kenji/0000-0001-9467-1777; Ha Manh, Tuan/0000-0002-4998-2581	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust, which had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Inviragen Ltd., made available laboratory resources for the conduct of the laboratory tests, but were not involved in the analysis, decision to publish, or preparation of the manuscript.	Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106; Chan YF, 2010, INFECT GENET EVOL, V10, P404, DOI 10.1016/j.meegid.2009.05.010; Chang GH, 2010, VIRUS RES, V151, P66, DOI 10.1016/j.virusres.2010.04.001; Chen KT, 2007, PEDIATRICS, V120, pE244, DOI 10.1542/peds.2006-3331; Chen SC, 2007, AM J TROP MED HYG, V77, P188, DOI 10.4269/ajtmh.2007.77.188; Ehlers MM, 2005, WATER RES, V39, P2253, DOI 10.1016/j.watres.2005.04.014; Gibson KE, 2011, AM J TROP MED HYG, V84, P20, DOI 10.4269/ajtmh.2011.10-0389; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Lee TC, 2009, PEDIATR INFECT DIS J, V28, P904, DOI 10.1097/INF.0b013e3181a41d63; Lodder WJ, 2010, APPL ENVIRON MICROB, V76, P5965, DOI 10.1128/AEM.00245-10; Luo ST, 2009, EMERG INFECT DIS, V15, P581, DOI 10.3201/eid1504.081550; Ooi EE, 2002, EMERG INFECT DIS, V8, P995, DOI 10.3201/eid0809.010397; Rabaa MA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000766; Rabenau HF, 2010, MED MICROBIOL IMMUN, V199, P45, DOI 10.1007/s00430-009-0133-6; Tran NBC, 2009, J INFECT DIS, V200, P1893, DOI 10.1086/648407; Van Tu P, 2007, EMERG INFECT DIS, V13, P1733, DOI 10.3201/eid1311.070632; Wang SM, 2009, EXPERT REV ANTI-INFE, V7, P735, DOI 10.1586/ERI.09.45; Wang Shih-Min, 2008, Pediatrics and Neonatology, V49, P113, DOI 10.1016/S1875-9572(08)60024-8; Watanaveeradej V, 2003, AM J TROP MED HYG, V69, P123, DOI 10.4269/ajtmh.2003.69.123; *WHO WPR, 2009, WHO WARNS GROW THREA	20	28	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e21116	10.1371/journal.pone.0021116	http://dx.doi.org/10.1371/journal.pone.0021116			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	22016795	Green Published, gold			2022-12-27	WOS:000292699000004
J	Hubner, RA; Riley, RD; Billingham, LJ; Popat, S				Hubner, Richard A.; Riley, Richard D.; Billingham, Lucinda J.; Popat, Sanjay			Excision Repair Cross-Complementation Group 1 (ERCC1) Status and Lung Cancer Outcomes: A Meta-Analysis of Published Studies and Recommendations	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; III BETA-TUBULIN; DNA-REPAIR; PLUS GEMCITABINE; SURVIVAL; CISPLATIN; CHEMOTHERAPY; PLATINUM; PREDICTS; PROTEIN	Purpose: Despite discrepant results on clinical utility, several trials are already prospectively randomizing non-small cell lung cancer (NSCLC) patients by ERCC1 status. We aimed to characterize the prognostic and predictive effect of ERCC1 by systematic review and meta-analysis. Methods: Eligible studies assessed survival and/or chemotherapy response in NSCLC or SCLC by ERCC1 status. Effect measures of interest were hazard ratio (HR) for survival or relative risk (RR) for chemotherapy response. Random-effects meta-analyses were used to account for between-study heterogeneity, with unadjusted/adjusted effect estimates considered separately. Results: 23 eligible studies provided survival results in 2,726 patients. Substantial heterogeneity was observed in all meta-analyses (I-2 always > 30%), partly due to variability in thresholds defining 'low' and 'high' ERCC1. Meta-analysis of unadjusted estimates showed high ERCC1 was associated with significantly worse overall survival in platinum-treated NSCLC (average unadjusted HR = 1.61, 95% CI: 1.23-2.1, p = 0.014), but not in NSCLC untreated with chemotherapy (average unadjusted HR = 0.82, 95% CI: 0.51-1.31). Meta-analysis of adjusted estimates was limited by variable choice of adjustment factors and potential publication bias (Egger's p < 0.0001). There was evidence that high ERCC1 was associated with reduced response to platinum (average RR = 0.80; 95% CI: 0.64-0.99). SCLC data were inadequate to draw firm conclusions. Conclusions: Current evidence suggests high ERCC1 may adversely influence survival and response in platinum-treated NSCLC patients, but not in non-platinum treated, although definitive evidence of a predictive influence is lacking. International consensus is urgently required to provide consistent, validated ERCC1 assessment methodology. ERCC1 assessment for treatment selection should currently be restricted to, and evaluated within, clinical trials.	[Hubner, Richard A.] Christie NHS Fdn Trust, Dept Med Oncol, Manchester, Lancs, England; [Riley, Richard D.] Univ Birmingham, Dept Publ Hlth Epidemiol & Biostat, Birmingham, W Midlands, England; [Billingham, Lucinda J.] Univ Birmingham, Canc Res UK Clin Trials Unit, Birmingham, W Midlands, England; [Billingham, Lucinda J.] Univ Birmingham, MRC Midland Hub Trials Methodol Res, Birmingham, W Midlands, England; [Popat, Sanjay] Univ London Imperial Coll Sci Technol & Med, Mol Genet Grp, London, England; [Popat, Sanjay] Royal Marsden NHS Fdn Trust, Dept Med, London, England	Christie NHS Foundation Trust; University of Birmingham; Cancer Research UK; University of Birmingham; University of Birmingham; Imperial College London; Royal Marsden NHS Foundation Trust	Hubner, RA (corresponding author), Christie NHS Fdn Trust, Dept Med Oncol, Manchester, Lancs, England.	sanjay.popat@rmh.nhs.uk	Popat, Sanjay/AAO-1634-2021; Riley, Richard/G-2406-2011; Riley, Richard David/ABE-5877-2020; Hubner, Richard/N-8051-2015	Popat, Sanjay/0000-0003-2087-4963; Riley, Richard David/0000-0001-8699-0735; Hubner, Richard/0000-0002-7081-8823; Billingham, Lucinda/0000-0001-8581-4262	Cancer Research UK; Medical Research Council; UK Higher Education Funding Council of England; NHS; MRC [G0800808] Funding Source: UKRI; Medical Research Council [G0800808] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Higher Education Funding Council of England; NHS; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	LJB is funded by Cancer Research UK and Medical Research Council; SP is funded by an Award from the UK Higher Education Funding Council of England. The authors also acknowledge NHS funding to the Royal Marsden Hospital/Institute of Cancer Research NIHR Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation on the manuscript.	Alderson P., 2004, COCHRANE REVIEWERS H; ALTMAN DG, 1995, BRIT J CANCER, V72, P511, DOI 10.1038/bjc.1995.364; Ardizzoni A, 2007, J NATL CANCER I, V99, P847, DOI 10.1093/jnci/djk196; Azuma K, 2007, CANCER SCI, V98, P1336, DOI 10.1111/j.1349-7006.2007.00557.x; Azuma K, 2009, LUNG CANCER, V64, P326, DOI 10.1016/j.lungcan.2008.09.002; Azuma K, 2009, CANCER CHEMOTH PHARM, V64, P565, DOI 10.1007/s00280-008-0907-3; Bang Y, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.18_suppl.3; Bartolucci R, 2009, CLIN LUNG CANCER, V10, P47, DOI 10.3816/CLC.2009.n.007; Bhagwat NR, 2009, CANCER RES, V69, P6831, DOI 10.1158/0008-5472.CAN-09-1237; Booton R, 2007, J THORAC ONCOL, V2, P902, DOI 10.1097/JTO.0b013e318155a637; Bradburn MJ, 1999, STATA TECHNICAL B, V44, P4; Ceppi P, 2006, ANN ONCOL, V17, P1818, DOI 10.1093/annonc/mdl300; Ceppi P, 2008, J THORAC ONCOL, V3, P583, DOI 10.1097/JTO.0b013e3181734f24; Chen SF, 2010, LUNG CANCER, V70, P63, DOI 10.1016/j.lungcan.2010.05.010; Cobo M, 2007, J CLIN ONCOL, V25, P2747, DOI 10.1200/JCO.2006.09.7915; Friedberg EC, 2003, NATURE, V421, P436, DOI 10.1038/nature01408; Fujii T, 2008, LUNG CANCER, V59, P377, DOI 10.1016/j.lungcan.2007.08.025; Hayden JA, 2006, ANN INTERN MED, V144, P427, DOI 10.7326/0003-4819-144-6-200603210-00010; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins JPT, 2009, J R STAT SOC A STAT, V172, P137, DOI 10.1111/j.1467-985X.2008.00552.x; Holm B, 2009, J CLIN ONCOL, V27, P4254, DOI 10.1200/JCO.2008.18.8631; Hwang IG, 2008, CANCER-AM CANCER SOC, V113, P1379, DOI 10.1002/cncr.23693; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jeong SH, 2010, LUNG CANCER, V68, P288, DOI 10.1016/j.lungcan.2009.06.003; Kim YH, 2009, LUNG CANCER, V65, P105, DOI 10.1016/j.lungcan.2008.10.008; Lee HW, 2008, LUNG CANCER, V59, P95, DOI 10.1016/j.lungcan.2007.07.023; Lee HW, 2009, LUNG CANCER, V65, P377, DOI 10.1016/j.lungcan.2008.12.005; Lee KH, 2008, LUNG CANCER, V60, P401, DOI 10.1016/j.lungcan.2007.10.014; Lord RVN, 2002, CLIN CANCER RES, V8, P2286; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Niedernhofer LJ, 2007, NEW ENGL J MED, V356, P2538; Okuda K, 2008, LUNG CANCER, V62, P105, DOI 10.1016/j.lungcan.2008.02.021; Olaussen KA, 2006, NEW ENGL J MED, V355, P983, DOI 10.1056/NEJMoa060570; Ota S, 2009, LUNG CANCER, V64, P98, DOI 10.1016/j.lungcan.2008.07.014; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Phillips DH, 2002, CARCINOGENESIS, V23, P1979, DOI 10.1093/carcin/23.12.1979; Riley RD, 2003, BRIT J CANCER, V88, P1191, DOI 10.1038/sj.bjc.6600886; Riley RD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d549; Rosell R, 2004, CLIN CANCER RES, V10, p4215S, DOI 10.1158/1078-0432.CCR-040006; Rosell R, 2004, CLIN CANCER RES, V10, P1318, DOI 10.1158/1078-0432.CCR-03-0156; Rosell R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001129; Simon G, 2007, J CLIN ONCOL, V25, P2741, DOI 10.1200/JCO.2006.08.2099; Simon GR, 2005, CHEST, V127, P978, DOI 10.1378/chest.127.3.978; Smit EF, 2003, J CLIN ONCOL, V21, P3909, DOI 10.1200/JCO.2003.03.195; Steichen T, 1998, STATA TECHNICAL B RE, V41, P9; Sterne J.A., 2008, COCHRANE HDB SYSTEMA, DOI [10.1002/9780470712184.ch10, DOI 10.1002/9780470712184.CH10]; Tsao MS, 2005, NEW ENGL J MED, V353, P133, DOI 10.1056/NEJMoa050736; Wang X, 2009, MED ONCOL; Williamson PR, 2002, STAT MED, V21, P3337, DOI 10.1002/sim.1303; Yau T, 2006, BRIT J CANCER, V94, P18, DOI 10.1038/sj.bjc.6602888; Zheng Z, 2007, NEW ENGL J MED, V356, P800, DOI 10.1056/NEJMoa065411	54	69	72	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e25164	10.1371/journal.pone.0025164	http://dx.doi.org/10.1371/journal.pone.0025164			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022380	gold, Green Published, Green Submitted			2022-12-27	WOS:000295981600005
J	Aster, JC; Bodnar, N; Xu, LW; Karnell, F; Milholland, JM; Maillard, I; Histen, G; Nam, Y; Blacklow, SC; Pear, WS				Aster, Jon C.; Bodnar, Nick; Xu, Lanwei; Karnell, Fredrick; Milholland, John M.; Maillard, Ivan; Histen, Gavin; Nam, Yunsun; Blacklow, Stephen C.; Pear, Warren S.			Notch Ankyrin Repeat Domain Variation Influences Leukemogenesis and Myc Transactivation	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; PROTEIN SECONDARY STRUCTURE; T-CELL LEUKEMIA; CHRONIC LYMPHOCYTIC-LEUKEMIA; C-MYC; CIRCULAR-DICHROISM; INTRACELLULAR DOMAINS; TRANSCRIPTIONAL ACTIVATION; NEGATIVE AUTOREGULATION; CRYSTAL-STRUCTURE	Background: The functional interchangeability of mammalian Notch receptors (Notch1-4) in normal and pathophysiologic contexts such as cancer is unsettled. We used complementary in vivo, cell-based and structural analyses to compare the abilities of activated Notch1-4 to support T cell development, induce T cell acute lymphoblastic leukemia/lymphoma (T-ALL), and maintain T-ALL cell growth and survival. Principal Findings: We find that the activated intracellular domains of Notch1-4 (ICN1-4) all support T cell development in mice and thymic organ culture. However, unlike ICN1-3, ICN4 fails to induce T-cell acute lymphoblastic leukemia/lymphoma (T-ALL) and is unable to rescue the growth of Notch1-dependent T-ALL cell lines. The ICN4 phenotype is mimicked by weak gain-of-function forms of Notch1, suggesting that it stems from a failure to transactivate one or more critical target genes above a necessary threshold. Experiments with chimeric receptors demonstrate that the Notch ankyrin repeat domains differ in their leukemogenic potential, and that this difference correlates with activation of Myc, a direct Notch target that has an important role in Notch-associated T-ALL. Conclusions/Significance: We conclude that the leukemogenic potentials of Notch receptors vary, and that this functional difference stems in part from divergence among the highly conserved ankyrin repeats, which influence the transactivation of specific target genes involved in leukemogenesis.	[Aster, Jon C.; Histen, Gavin; Blacklow, Stephen C.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Xu, Lanwei; Karnell, Fredrick; Milholland, John M.; Maillard, Ivan; Pear, Warren S.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Abramson Family Canc Res Inst,Inst Med & Engn, Philadelphia, PA 19104 USA; [Bodnar, Nick; Blacklow, Stephen C.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Bodnar, Nick; Nam, Yunsun; Blacklow, Stephen C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Aster, JC (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.	jaster@rics.bwh.harvard.edu; wpear@mail.med.upenn.edu		Bodnar, Nicholas/0000-0003-2410-7542; Nam, Yunsun/0000-0002-7939-8626; Maillard, Ivan/0000-0003-1312-6748	National Institutes of Health [T32 CA09140]; Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [R01CA092433, T32CA009140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (WSP, JCA, and SCB) and the Leukemia and Lymphoma Society SCOR Program (WSP, JCA, and SCB). JMM was supported by NIH training grant T32 CA09140. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Arnett KL, 2010, NAT STRUCT MOL BIOL, V17, P1312, DOI 10.1038/nsmb.1938; Aster JC, 2000, MOL CELL BIOL, V20, P7505, DOI 10.1128/MCB.20.20.7505-7515.2000; Aster JC, 2011, J PATHOL, V223, P262, DOI 10.1002/path.2789; Beatus P, 2001, MECH DEVELOP, V104, P3, DOI 10.1016/S0925-4773(01)00373-2; Bellavia D, 2002, P NATL ACAD SCI USA, V99, P3788, DOI 10.1073/pnas.062050599; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Chan SM, 2007, BLOOD, V110, P278, DOI 10.1182/blood-2006-08-039883; Chiang MY, 2008, J CLIN INVEST, V118, P3181, DOI 10.1172/JCI35090; Chiang MY, 2006, MOL CELL BIOL, V26, P6261, DOI 10.1128/MCB.02478-05; CULLION K, 2009, BLOOD; Del Bianco C, 2008, J MOL BIOL, V376, P131, DOI 10.1016/j.jmb.2007.11.061; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Ehebauer MT, 2005, BIOCHEM J, V392, P13, DOI 10.1042/BJ20050515; Espinosa L, 2003, J BIOL CHEM, V278, P32227, DOI 10.1074/jbc.M304001200; Fabbri G, 2011, J EXP MED, V208, P1389, DOI 10.1084/jem.20110921; Fan X, 2004, CANCER RES, V64, P7787, DOI 10.1158/0008-5472.CAN-04-1446; Foltz DR, 2002, CURR BIOL, V12, P1006, DOI 10.1016/S0960-9822(02)00888-6; Gallahan D, 1996, CANCER RES, V56, P1775; Goodliffe JM, 2005, GENE DEV, V19, P2941, DOI 10.1101/gad.1352305; GRIGNANI F, 1990, EMBO J, V9, P3913, DOI 10.1002/j.1460-2075.1990.tb07612.x; IKUTA K, 1992, P NATL ACAD SCI USA, V89, P1502, DOI 10.1073/pnas.89.4.1502; Ingles-Esteve J, 2001, J BIOL CHEM, V276, P44873, DOI 10.1074/jbc.M104703200; Izon DJ, 2002, IMMUNITY, V16, P231, DOI 10.1016/S1074-7613(02)00271-6; Johnson SE, 2010, J BIOL CHEM, V285, P6681, DOI 10.1074/jbc.M109.019968; Keeshan K, 2006, CANCER CELL, V10, P401, DOI 10.1016/j.ccr.2006.09.012; Klinakis A, 2006, P NATL ACAD SCI USA, V103, P9262, DOI 10.1073/pnas.0603371103; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kraman M, 2005, FASEB J, V19, P1311, DOI 10.1096/fj.04-3407fje; Kurooka H, 1998, NUCLEIC ACIDS RES, V26, P5448, DOI 10.1093/nar/26.23.5448; Lauring AS, 2000, MOL CELL, V6, P939, DOI 10.1016/S1097-2765(05)00084-5; Li XY, 2008, J EXP MED, V205, P2851, DOI 10.1084/jem.20081561; Liu HD, 2010, GENE DEV, V24, P2395, DOI 10.1101/gad.1975210; Lubman OY, 2007, J MOL BIOL, V365, P577, DOI 10.1016/j.jmb.2006.09.071; Maillard I, 2004, BLOOD, V104, P1696, DOI 10.1182/blood-2004-02-0514; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Nam Y, 2003, J BIOL CHEM, V278, P21232, DOI 10.1074/jbc.M301567200; Nam YS, 2007, P NATL ACAD SCI USA, V104, P2103, DOI 10.1073/pnas.0611092104; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Ong CT, 2006, J BIOL CHEM, V281, P5106, DOI 10.1074/jbc.M506108200; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; PENN LJZ, 1990, EMBO J, V9, P1113, DOI 10.1002/j.1460-2075.1990.tb08217.x; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Proweller A, 2006, CANCER RES, V66, P7438, DOI 10.1158/0008-5472.CAN-06-0793; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Rand MD, 2000, MOL CELL BIOL, V20, P1825, DOI 10.1128/MCB.20.5.1825-1835.2000; Real PJ, 2009, NAT MED, V15, P50, DOI 10.1038/nm.1900; Sharma VM, 2006, MOL CELL BIOL, V26, P8022, DOI 10.1128/MCB.01091-06; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Vercauteren SM, 2004, BLOOD, V104, P2315, DOI 10.1182/blood-2004-01-0204; Wallberg AE, 2002, MOL CELL BIOL, V22, P7812, DOI 10.1128/MCB.22.22.7812-7819.2002; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Weng AP, 2003, MOL CELL BIOL, V23, P655, DOI 10.1128/MCB.23.2.655-664.2003; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wilson JJ, 2006, CELL, V124, P985, DOI 10.1016/j.cell.2006.01.035; Zweifel ME, 2003, PROTEIN SCI, V12, P2622, DOI 10.1110/ps.03279003	57	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e25645	10.1371/journal.pone.0025645	http://dx.doi.org/10.1371/journal.pone.0025645			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022427	gold, Green Published, Green Submitted			2022-12-27	WOS:000295978600025
J	Lehtonen, S				Lehtonen, Samuli			Towards Resolving the Complete Fern Tree of Life	PLOS ONE			English	Article							NONCODING CHLOROPLAST DNA; RBCL NUCLEOTIDE-SEQUENCES; PHYLOGENETIC-RELATIONSHIPS; GENE-SEQUENCES; MISSING DATA; EXTANT FERNS; DATA SETS; PTERIDACEAE; ACCURACY; TAXA	In the past two decades, molecular systematic studies have revolutionized our understanding of the evolutionary history of ferns. The availability of large molecular data sets together with efficient computer algorithms, now enables us to reconstruct evolutionary histories with previously unseen completeness. Here, the most comprehensive fern phylogeny to date, representing over one-fifth of the extant global fern diversity, is inferred based on four plastid genes. Parsimony and maximum-likelihood analyses provided a mostly congruent results and in general supported the prevailing view on the higher-level fern systematics. At a deep phylogenetic level, the position of horsetails depended on the optimality criteria chosen, with horsetails positioned as the sister group either of Marattiopsida-Polypodiopsida clade or of the Polypodiopsida. The analyses demonstrate the power of using a 'supermatrix' approach to resolve large-scale phylogenies and reveal questionable taxonomies. These results provide a valuable background for future research on fern systematics, ecology, biogeography and other evolutionary studies.	Univ Turku, Dept Biol, SF-20500 Turku, Finland	University of Turku	Lehtonen, S (corresponding author), Univ Turku, Dept Biol, SF-20500 Turku, Finland.	samile@utu.fi		Lehtonen, Samuli/0000-0001-6235-2026	Kone Foundation; Academy of Finland	Kone Foundation; Academy of Finland(Academy of Finland)	This study received funding from the Kone Foundation and the Academy of Finland grants to SL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Bidartondo MI, 2008, SCIENCE, V319, P1616, DOI 10.1126/science.319.5870.1616a; Bouma WLM, 2010, AUST SYST BOT, V23, P143, DOI 10.1071/SB09047; Christenhusz MJM, 2011, PHYTOTAXA, V19, P7, DOI 10.11646/phytotaxa.19.1.2; de Queiroz A, 2007, TRENDS ECOL EVOL, V22, P34, DOI 10.1016/j.tree.2006.10.002; Driskell AC, 2004, SCIENCE, V306, P1172, DOI 10.1126/science.1102036; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Ebihara A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015136; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gatesy J, 2004, SYST BIOL, V53, P342, DOI 10.1080/10635150490423971; Goloboff PA, 1999, CLADISTICS, V15, P415, DOI 10.1111/j.1096-0031.1999.tb00278.x; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Goloboff PA, 2009, CLADISTICS, V25, P211, DOI 10.1111/j.1096-0031.2009.00255.x; HASEBE M, 1994, P NATL ACAD SCI USA, V91, P5730, DOI 10.1073/pnas.91.12.5730; Hasebe M, 1995, AM FERN J, V85, P134, DOI 10.2307/1547807; Hauk WD, 2003, MOL PHYLOGENET EVOL, V28, P131, DOI 10.1016/S1055-7903(03)00032-0; Heath TA, 2008, J SYST EVOL, V46, P239, DOI 10.3724/SP.J.1002.2008.08016; Ho SYW, 2004, SYST BIOL, V53, P623, DOI 10.1080/10635150490503035; HongMei L, 2007, SCI CHINA SER C, V50, P789, DOI 10.1007/s11427-007-0099-9; Kuo LY, 2011, MOL PHYLOGENET EVOL, V59, P556, DOI 10.1016/j.ympev.2011.03.010; Lehtonen S, 2010, BOT J LINN SOC, V163, P305, DOI 10.1111/j.1095-8339.2010.01063.x; Maddison W., 2018, MESQUITE MODULAR SYS; MasonGamer RJ, 1996, SYST BIOL, V45, P524, DOI 10.1093/sysbio/45.4.524; McMahon MM, 2006, SYST BIOL, V55, P818, DOI 10.1080/10635150600999150; Moran RC, 2008, BIOLOGY AND EVOLUTION OF FERNS AND LYCOPHYTES, P367, DOI 10.1017/CBO9780511541827.015; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; Ott M, 2007, P ACM IEEE SUP C; Philippe H, 2004, MOL BIOL EVOL, V21, P1740, DOI 10.1093/molbev/msh182; Prado J, 2007, TAXON, V56, P355, DOI 10.1002/tax.562008; Pryer KM, 2004, AM J BOT, V91, P1582, DOI 10.3732/ajb.91.10.1582; Pryer KM, 1995, AM FERN J, V85, P205, DOI 10.2307/1547810; Pryer KM, 2001, NATURE, V409, P618, DOI 10.1038/35054555; Rambaut A, 2009, FIGTREE V1 3 1; Rothfels CJ, 2008, TAXON, V57, P712, DOI 10.1002/tax.573005; Rothwell GW, 2006, INT J PLANT SCI, V167, P737, DOI 10.1086/503298; Sanderson MJ, 2008, SYST BIOL, V57, P335, DOI 10.1080/10635150802158688; Sanderson Michael J., 1994, American Journal of Botany, V81, P183; Sanderson MJ, 2000, SYST BIOL, V49, P671, DOI 10.1080/106351500750049761; Sano R, 2000, MOL PHYLOGENET EVOL, V15, P403, DOI 10.1006/mpev.1999.0708; Schoch CL, 2009, SYST BIOL, V58, P224, DOI 10.1093/sysbio/syp020; Schuettpelz E, 2007, TAXON, V56, P1037, DOI 10.2307/25065903; Schuettpelz E, 2007, MOL PHYLOGENET EVOL, V44, P1172, DOI 10.1016/j.ympev.2007.04.011; Schuettpelz E, 2006, TAXON, V55, P897, DOI 10.2307/25065684; Shavit L, 2007, MOL BIOL EVOL, V24, P2400, DOI 10.1093/molbev/msm178; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Small RL, 2005, MOL PHYLOGENET EVOL, V36, P509, DOI 10.1016/j.ympev.2005.04.018; Smith AR, 2006, TAXON, V55, P705, DOI 10.2307/25065646; Smith SA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-37; Stamatakis A., 2008, RAXML 7 0 4 MANUAL; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Thomson RC, 2010, SYST BIOL, V59, P42, DOI 10.1093/sysbio/syp075; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; Vilgalys R, 2003, NEW PHYTOL, V160, P4, DOI 10.1046/j.1469-8137.2003.00894.x; Wiens JJ, 2006, J BIOMED INFORM, V39, P34, DOI 10.1016/j.jbi.2005.04.001; Wiens JJ, 2003, SYST BIOL, V52, P528, DOI 10.1080/10635150390218330; Wolf PG, 1997, AM J BOT, V84, P1429, DOI 10.2307/2446141; WOLF PG, 1994, MOL PHYLOGENET EVOL, V3, P383, DOI 10.1006/mpev.1994.1044; Wolf PG, 1999, PLANT SYST EVOL, V219, P263, DOI 10.1007/BF00985583; Wolf PG, 1995, AM FERN J, V85, P306, DOI 10.2307/1547812; Wolsan M, 2010, CLADISTICS, V26, P168, DOI 10.1111/j.1096-0031.2009.00281.x; Zwickl DJ, 2002, SYST BIOL, V51, P588, DOI 10.1080/10635150290102339	61	98	105	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e24851	10.1371/journal.pone.0024851	http://dx.doi.org/10.1371/journal.pone.0024851			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022365	Green Submitted, Green Published, gold			2022-12-27	WOS:000295978600006
J	Mizuguchi, N; Sakamoto, M; Muraoka, T; Nakagawa, K; Kanazawa, S; Nakata, H; Moriyama, N; Kanosue, K				Mizuguchi, Nobuaki; Sakamoto, Masanori; Muraoka, Tetsuro; Nakagawa, Kento; Kanazawa, Shoichi; Nakata, Hiroki; Moriyama, Noriyoshi; Kanosue, Kazuyuki			The Modulation of Corticospinal Excitability during Motor Imagery of Actions with Objects	PLOS ONE			English	Article							EVOKED-POTENTIALS MEPS; REPRESENTATION; FACILITATION; RESPONSES; POSTURE; MUSCLE; TASKS	We investigated whether corticospinal excitability during motor imagery of actions (the power or the pincer grip) with objects was influenced by actually touching objects (tactile input) and by the congruency of posture with the imagined action (proprioceptive input). Corticospinal excitability was assessed by monitoring motor evoked potentials (MEPs) in the first dorsal interosseous following transcranial magnetic stimulation over the motor cortex. MEPs were recorded during imagery of the power grip of a larger-sized ball (7 cm) or the pincer grip of a smaller-sized ball (3 cm) with or without passively holding the larger-sized ball with the holding posture or the smaller-sized ball with the pinching posture. During imagery of the power grip, MEPs amplitude was increased only while the actual posture was the same as the imagined action (the holding posture). On the other hand, during imagery of the pincer grip while touching the ball, MEPs amplitude was enhanced in both postures. To examine the pure effect of touching (tactile input), we recorded MEPs during imagery of the power and pincer grip while touching various areas of an open palm with a flat foam pad. The MEPs amplitude was not affected by the palmer touching. These findings suggest that corticospinal excitability during imagery with an object is modulated by actually touching an object through the combination of tactile and proprioceptive inputs.	[Mizuguchi, Nobuaki; Nakagawa, Kento; Kanazawa, Shoichi] Waseda Univ, Grad Sch Sport Sci, Tokorozawa, Saitama, Japan; [Mizuguchi, Nobuaki] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan; [Sakamoto, Masanori] Kumamoto Univ, Dept Phys Educ, Fac Educ, Kumamoto, Japan; [Muraoka, Tetsuro] Nihon Univ, Coll Econ, Chiyoda Ku, Tokyo, Japan; [Nakata, Hiroki; Moriyama, Noriyoshi; Kanosue, Kazuyuki] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan	Waseda University; Japan Society for the Promotion of Science; Kumamoto University; Nihon University; Waseda University	Mizuguchi, N (corresponding author), Waseda Univ, Grad Sch Sport Sci, Tokorozawa, Saitama, Japan.	mizuguchi@suou.waseda.jp		Muraoka, Tetsuro/0000-0002-2303-1139; Nakagawa, Kento/0000-0002-6203-6602	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant for the fellows of the Japan Society for the Promotion of Science awarded to NM and the Grant-in-Aid for the Global COE "Sport Sciences for the Promotion of Active Life,'' Waseda University, from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ehrsson HH, 2000, J NEUROPHYSIOL, V83, P528, DOI 10.1152/jn.2000.83.1.528; Ellis R, 2000, BRIT J PSYCHOL, V91, P451, DOI 10.1348/000712600161934; Fadiga L, 1999, NEUROPSYCHOLOGIA, V37, P147; Fluet MC, 2010, J NEUROSCI, V30, P15175, DOI 10.1523/JNEUROSCI.3343-10.2010; Fourkas AD, 2006, BEHAV BRAIN RES, V168, P190, DOI 10.1016/j.bbr.2005.10.015; Fourkas AD, 2008, CEREB CORTEX, V18, P2382, DOI 10.1093/cercor/bhn005; Grezes J, 2003, EUR J NEUROSCI, V17, P2735, DOI 10.1046/j.1460-9568.2003.02695.x; HASEGAWA Y, FURTHER INSIGHT TASK; Hashimoto R, 1999, EXP BRAIN RES, V125, P75, DOI 10.1007/s002210050660; Isaac AR., 1992, SPORT PSYCHOL, V6, P192, DOI [10.1123/tsp.6.2.192, DOI 10.1123/TSP.6.2.192, DOI 10.1123/tsp.6.2.192]; Kasai T, 1997, BRAIN RES, V744, P147, DOI 10.1016/S0006-8993(96)01101-8; Li S, 2004, COGNITIVE BRAIN RES, V20, P273, DOI 10.1016/j.cogbrainres.2004.03.003; Liang N, 2007, NEUROREPORT, V18, P1241, DOI 10.1097/WNR.0b013e3282202707; McAvinue LP, 2008, EUR J COGN PSYCHOL, V20, P232, DOI 10.1080/09541440701394624; Mercier C, 2008, CEREB CORTEX, V18, P272, DOI 10.1093/cercor/bhm052; Mizuguchi N, 2009, EXP BRAIN RES, V196, P529, DOI 10.1007/s00221-009-1875-5; PASCUALLEONE A, 1995, J NEUROPHYSIOL, V74, P1037, DOI 10.1152/jn.1995.74.3.1037; Roosink M, 2010, BEHAV BRAIN RES, V213, P35, DOI 10.1016/j.bbr.2010.04.027; Sakamoto M, 2009, NEUROSCI RES, V65, P23, DOI 10.1016/j.neures.2009.05.003; Stevens JA, 2005, COGNITION, V95, P329, DOI 10.1016/j.cognition.2004.02.008; Stevens JA, 2003, ARCH PHYS MED REHAB, V84, P1090, DOI 10.1016/S0003-9993(03)00042-X; Sturmer B, 2000, J EXP PSYCHOL HUMAN, V26, P1746, DOI 10.1037//0096-1523.26.6.1746; Tinazzi M, 2003, EXP BRAIN RES, V150, P222, DOI 10.1007/s00221-003-1448-y; Vargas CD, 2004, CEREB CORTEX, V14, P1200, DOI 10.1093/cercor/bhh080; Villiger M, 2011, EXP BRAIN RES, V209, P85, DOI 10.1007/s00221-010-2522-x; Yahagi S, 1998, ELECTROMYOGR MOTOR C, V109, P409, DOI 10.1016/S0924-980X(98)00041-1	26	24	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e26006	10.1371/journal.pone.0026006	http://dx.doi.org/10.1371/journal.pone.0026006			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834QT	22022491	Green Published, Green Submitted, gold			2022-12-27	WOS:000295978600034
J	Gebuis, T; van der Smagt, MJ				Gebuis, Titia; van der Smagt, Maarten J.			False Approximations of the Approximate Number System?	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; PRESCHOOL-CHILDREN; VISUAL NUMBER; HUMAN INFANTS; DISCRIMINATION; NUMEROSITY; SENSE; SIZE; REPRESENTATION; HETEROGENEITY	Prior research suggests that the acuity of the approximate number system (ANS) predicts future mathematical abilities. Modelling the development of the ANS might therefore allow monitoring of children's mathematical skills and instigate educational intervention if necessary. A major problem however, is that our knowledge of the development of the ANS is acquired using fundamentally different paradigms, namely detection in infants versus discrimination in children and adults. Here, we question whether such a comparison is justified, by testing the adult ANS with both a discrimination and a detection task. We show that adults perform markedly better in the discrimination compared to the detection task. Moreover, performance on discrimination but not detection, correlated with performance on mathematics. With a second similar experiment, in which the detection task was replaced by a same-different task, we show that the results of experiment 1 cannot be attributed to differences in chance level. As only task instruction differed, the discrimination and the detection task most likely reflect differences at the decisional level. Future studies intending to model the development of the ANS should therefore rely on data derived from a single paradigm for different age groups. The same-different task appears a viable candidate, due to its applicability across age groups.	[Gebuis, Titia; van der Smagt, Maarten J.] Univ Utrecht, Helmholtz Inst, Utrecht, Netherlands; [Gebuis, Titia] Katholieke Univ Leuven, Expt Psychol Lab, Louvain, Belgium	Utrecht University; KU Leuven	Gebuis, T (corresponding author), Univ Utrecht, Helmholtz Inst, Utrecht, Netherlands.	Titia.Gebuis@psy.kuleuven.be		van der Smagt, Maarten/0000-0003-2772-6429	Netherlands Organization for Scientific Research (NWO) [051.04.050]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This research was supported by NWO Grant 051.04.050 of the Cognition Program of the Netherlands Organization for Scientific Research (NWO). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barth H, 2005, P NATL ACAD SCI USA, V102, P14116, DOI 10.1073/pnas.0505512102; Brannon EM, 2007, DEVELOPMENTAL SCI, V10, P770, DOI 10.1111/j.1467-7687.2007.00635.x; Cantlon J, 2007, DEVELOPMENTAL SCI, V10, P431, DOI 10.1111/j.1467-7687.2007.00597.x; GEBUIS T, BEHAV RES M IN PRESS, DOI DOI 10.3758/S13428-13011-10097-13425; Gilmore C, 2011, Q J EXP PSYCHOL, V64, P2099, DOI 10.1080/17470218.2011.574710; GINSBURG N, 1988, PERCEPT MOTOR SKILL, V67, P656, DOI 10.2466/pms.1988.67.2.656; Halberda J, 2008, NATURE, V455, P665, DOI 10.1038/nature07246; Halberda J, 2008, DEV PSYCHOL, V44, P1457, DOI 10.1037/a0012682; Holloway ID, 2009, J EXP CHILD PSYCHOL, V103, P17, DOI 10.1016/j.jecp.2008.04.001; Izard V, 2008, PLOS BIOL, V6, P275, DOI 10.1371/journal.pbio.0060011; Izard V, 2009, P NATL ACAD SCI USA, V106, P10382, DOI 10.1073/pnas.0812142106; Kadosh RC, 2005, NEUROPSYCHOLOGIA, V43, P1238, DOI 10.1016/j.neuropsychologia.2004.12.017; Kadosh RC, 2008, CEREB CORTEX, V18, P337, DOI 10.1093/cercor/bhm058; Kadosh RC, 2008, CORTEX, V44, P470, DOI 10.1016/j.cortex.2007.08.002; Kadosh RC, 2007, J COGNITIVE NEUROSCI, V19, P957, DOI 10.1162/jocn.2007.19.6.957; Libertus ME, 2009, CURR DIR PSYCHOL SCI, V18, P346, DOI 10.1111/j.1467-8721.2009.01665.x; Lipton JS, 2003, PSYCHOL SCI, V14, P396, DOI 10.1111/1467-9280.01453; MILLER AI, 1968, AM J PSYCHOL, V81, P83, DOI 10.2307/1420810; Piazza M, 2004, NEURON, V44, P547, DOI 10.1016/j.neuron.2004.10.014; Piazza M, 2010, COGNITION, V116, P33, DOI 10.1016/j.cognition.2010.03.012; Pica P, 2004, SCIENCE, V306, P499, DOI 10.1126/science.1102085; Rousselle L, 2004, J EXP CHILD PSYCHOL, V87, P57, DOI 10.1016/j.jecp.2003.10.005; Rousselle L, 2008, DEV PSYCHOL, V44, P544, DOI 10.1037/0012-1649.44.2.544; Rousselle L, 2007, COGNITION, V102, P361, DOI 10.1016/j.cognition.2006.01.005; Soltesz F, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-13; Sophian C, 2007, LECT NOTES ARTIF INT, V4565, P157; van Opstal F, 2011, J COGN PSYCHOL, V23, P112, DOI 10.1080/20445911.2011.466796; VANOEFFELEN MP, 1982, PERCEPT PSYCHOPHYS, V32, P163, DOI 10.3758/BF03204275; Wood JN, 2005, DEVELOPMENTAL SCI, V8, P173, DOI 10.1111/j.1467-7687.2005.00404.x; Xu F, 2005, DEVELOPMENTAL SCI, V8, P88, DOI 10.1111/j.1467-7687.2005.00395.x	30	49	50	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25405	10.1371/journal.pone.0025405	http://dx.doi.org/10.1371/journal.pone.0025405			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834PW	22022390	gold, Green Published, Green Submitted			2022-12-27	WOS:000295976000014
J	Maragno, AL; Pironin, M; Alcalde, H; Cong, XL; Knobeloch, KP; Tangy, F; Zhang, DE; Ghysdael, J; Quang, CT				Maragno, Ana Leticia; Pironin, Martine; Alcalde, Helene; Cong, Xiuli; Knobeloch, Klaus-Peter; Tangy, Frederic; Zhang, Dong-Er; Ghysdael, Jacques; Christine Tran Quang			ISG15 Modulates Development of the Erythroid Lineage	PLOS ONE			English	Article							UBIQUITIN-LIKE PROTEIN; BCL-X-L; FLI-1-TRANSFORMED ERYTHROBLASTS; RETICULOCYTE MATURATION; STRESS ERYTHROPOIESIS; CONJUGATION SYSTEM; CASPASE ACTIVATION; E2 ENZYME; IN-VIVO; DIFFERENTIATION	Activation of erythropoietin receptor allows erythroblasts to generate erythrocytes. In a search for genes that are up-regulated during this differentiation process, we have identified ISG15 as being induced during late erythroid differentiation. ISG15 belongs to the ubiquitin-like protein family and is covalently linked to target proteins by the enzymes of the ISGylation machinery. Using both in vivo and in vitro differentiating erythroblasts, we show that expression of ISG15 as well as the ISGylation process related enzymes Ube1L, UbcM8 and Herc6 are induced during erythroid differentiation. Loss of ISG15 in mice results in decreased number of BFU-E/CFU-E in bone marrow, concomitant with an increased number of these cells in the spleen of these animals. ISG15(-/-) bone marrow and spleen-derived erythroblasts show a less differentiated phenotype both in vivo and in vitro, and over-expression of ISG15 in erythroblasts is found to facilitate erythroid differentiation. Furthermore, we have shown that important players of erythroid development, such as STAT5, Globin, PLC gamma and ERK2 are ISGylated in erythroid cells. This establishes a new role for ISG15, besides its well-characterized anti-viral functions, during erythroid differentiation.	[Maragno, Ana Leticia; Pironin, Martine; Alcalde, Helene; Ghysdael, Jacques; Christine Tran Quang] CNRS, UMR3306, F-91405 Orsay, France; [Maragno, Ana Leticia; Pironin, Martine; Alcalde, Helene; Ghysdael, Jacques; Christine Tran Quang] Univ Paris 11, INSERM, U1005, F-91405 Orsay, France; [Maragno, Ana Leticia; Pironin, Martine; Alcalde, Helene; Ghysdael, Jacques; Christine Tran Quang] Ctr Univ Orsay, Inst Curie, F-91405 Orsay, France; [Knobeloch, Klaus-Peter] Univ Clin Freiburg, Freiburg, Germany; [Tangy, Frederic] Inst Pasteur, CNRS, Unite Genom Virale & Vaccinat, URA 3015, Paris, France; [Cong, Xiuli; Zhang, Dong-Er] Univ Calif San Diego, Moores Univ Calif San Diego Canc Ctr, La Jolla, CA 92093 USA	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay; University of Freiburg; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of California System; University of California San Diego	Maragno, AL (corresponding author), CNRS, UMR3306, F-91405 Orsay, France.	Christine.Tran-Quang@curie.u-psud.fr	QUANG, christine TRAN/G-7508-2016; GHYSDAEL, Jacques/F-3377-2013		Institut Curie; Centre National de la Recherche Scientifique; Institut Nationale de la Sante et de la Recherche Medicale; Ligue Nationale Contre le Cancer; National Institutes of Health [GM066955]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066955] Funding Source: NIH RePORTER	Institut Curie; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut Nationale de la Sante et de la Recherche Medicale; Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	ALM was supported by a predoctoral fellowship from the Institut Curie. This work was supported by funds from Centre National de la Recherche Scientifique, Institut Nationale de la Sante et de la Recherche Medicale, Ligue Nationale Contre le Cancer (JG, equipe labellisee) and National Institutes of Health grant GM066955 to D-EZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerbajinai W, 2003, BLOOD, V102, P712, DOI 10.1182/blood-2002-11-3324; Desai SD, 2006, CANCER RES, V66, P921, DOI 10.1158/0008-5472.CAN-05-1123; Diwan A, 2007, P NATL ACAD SCI USA, V104, P6794, DOI 10.1073/pnas.0610666104; Dolznig H, 2006, ONCOGENE, V25, P2890, DOI 10.1038/sj.onc.1209308; Dolznig H, 2002, CURR BIOL, V12, P1076, DOI 10.1016/S0960-9822(02)00930-2; Dolznig H, 2001, FASEB J, V15, P1442, DOI 10.1096/fj.00-0705fje; Durfee LA, 2010, MOL CELL, V38, P722, DOI 10.1016/j.molcel.2010.05.002; Fang J, 2008, BLOOD, V112, P886, DOI 10.1182/blood-2008-02-138909; Gregoli PA, 1997, BLOOD, V90, P630, DOI 10.1182/blood.V90.2.630.630_630_640; Guihard S, 2010, BLOOD, V115, P3686, DOI 10.1182/blood-2009-09-242487; Halupa A, 2005, BLOOD, V105, P552, DOI 10.1182/blood-2003-09-3237; Kerenyi MA, 2008, BLOOD, V112, P3878, DOI 10.1182/blood-2008-02-138339; Kim KI, 2004, MOL CELL BIOL, V24, P9592, DOI 10.1128/MCB.24.21.9592-9600.2004; Kolbus A, 2002, J EXP MED, V196, P1347, DOI 10.1084/jem.20020562; Lebigot I, 2003, BLOOD, V102, P4555, DOI 10.1182/blood-2003-06-2077; Lee TL, 2008, BIOCHEM BIOPH RES CO, V375, P326, DOI 10.1016/j.bbrc.2008.07.164; Lesault I, 2002, EMBO J, V21, P694, DOI 10.1093/emboj/21.4.694; Li BH, 2006, BLOOD, V107, P4291, DOI 10.1182/blood-2005-08-3349; Liao HJ, 2002, J BIOL CHEM, V277, P9335, DOI 10.1074/jbc.M109955200; Liu J, 2010, BLOOD, V115, P2021, DOI 10.1182/blood-2009-08-241182; Malakhova OA, 2008, J BIOL CHEM, V283, P8783, DOI 10.1074/jbc.C800030200; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Okumura A, 2008, P NATL ACAD SCI USA, V105, P3974, DOI 10.1073/pnas.0710629105; Okumura F, 2007, GENE DEV, V21, P255, DOI 10.1101/gad.1521607; Osiak A, 2005, MOL CELL BIOL, V25, P6338, DOI 10.1128/MCB.25.15.6338-6345.2005; Owhashi M, 2003, BIOCHEM BIOPH RES CO, V309, P533, DOI 10.1016/j.bbrc.2003.08.038; Pincetic A, 2010, J VIROL, V84, P4725, DOI 10.1128/JVI.02478-09; Quadrini KJ, 2006, FEBS LETT, V580, P2285, DOI 10.1016/j.febslet.2006.03.039; REICH N, 1987, P NATL ACAD SCI USA, V84, P6394, DOI 10.1073/pnas.84.18.6394; Ritchie KJ, 2004, SEMIN CELL DEV BIOL, V15, P237, DOI 10.1016/j.semcdb.2003.12.005; Schweers RL, 2007, P NATL ACAD SCI USA, V104, P19500, DOI 10.1073/pnas.0708818104; Shi HX, 2010, MOL CELL BIOL, V30, P2424, DOI 10.1128/MCB.01466-09; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Socolovsky M, 2007, CURR OPIN HEMATOL, V14, P215, DOI 10.1097/MOH.0b013e3280de2bf1; Takeuchi T, 2005, J BIOCHEM, V138, P711, DOI 10.1093/jb/mvi172; Tian CX, 2003, BLOOD, V101, P2235, DOI 10.1182/blood-2002-04-1217; Versteeg GA, 2010, J VIROL, V84, P5423, DOI 10.1128/JVI.02395-09; von Lindern M, 2004, CELL CYCLE, V3, P876; von Lindern M, 2001, ONCOGENE, V20, P3651, DOI 10.1038/sj.onc.1204494; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Yao ZJ, 2006, P NATL ACAD SCI USA, V103, P1000, DOI 10.1073/pnas.0507350103; Zermati Y, 2001, J EXP MED, V193, P247, DOI 10.1084/jem.193.2.247; Zhang J, 2003, BLOOD, V102, P3938, DOI 10.1182/blood-2003-05-1479; ZHANG X, 2010, J INTERFERO IN PRESS; Zhao C, 2004, P NATL ACAD SCI USA, V101, P7578, DOI 10.1073/pnas.0402528101; Zhu BM, 2008, BLOOD, V112, P2071, DOI 10.1182/blood-2007-12-127480	47	11	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26068	10.1371/journal.pone.0026068	http://dx.doi.org/10.1371/journal.pone.0026068			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022510	Green Published, Green Submitted, gold			2022-12-27	WOS:000295976000062
J	Sotoyama, H; Zheng, YJ; Iwakura, Y; Mizuno, M; Aizawa, M; Shcherbakova, K; Wang, R; Namba, H; Nawa, H				Sotoyama, Hidekazu; Zheng, Yingjun; Iwakura, Yuriko; Mizuno, Makoto; Aizawa, Miho; Shcherbakova, Ksenia; Wang, Ran; Namba, Hisaaki; Nawa, Hiroyuki			Pallidal Hyperdopaminergic Innervation Underlying D2 Receptor-Dependent Behavioral Deficits in the Schizophrenia Animal Model Established by EGF	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; PRENATAL IMMUNE ACTIVATION; PREPULSE INHIBITION; BASAL GANGLIA; PREFRONTAL CORTEX; IN-VIVO; NEUROLEPTIC-NAIVE; GABAERGIC NEURONS; GENE-EXPRESSION; AMNIOTIC-FLUID	Epidermal growth factor (EGF) is one of the ErbB receptor ligands implicated in schizophrenia neuropathology as well as in dopaminergic development. Based on the immune inflammatory hypothesis for schizophrenia, neonatal rats are exposed to this cytokine and later develop neurobehavioral abnormality such as prepulse inhibition (PPI) deficit. Here we found that the EGF-treated rats exhibited persistent increases in tyrosine hydroxylase levels and dopamine content in the globus pallidus. Furthermore, pallidal dopamine release was elevated in EGF-treated rats, but normalized by subchronic treatment with risperidone concomitant with amelioration of their PPI deficits. To evaluate pathophysiologic roles of the dopamine abnormality, we administered reserpine bilaterally to the globus pallidus to reduce the local dopamine pool. Reserpine infusion ameliorated PPI deficits of EGF-treated rats without apparent aversive effects on locomotor activity in these rats. We also administered dopamine D1-like and D2-like receptor antagonists (SCH23390 and raclopride) and a D2-like receptor agonist (quinpirole) to the globus pallidus and measured PPI and bar-hang latencies. Raclopride (0.5 and 2.0 mu g/site) significantly elevated PPI levels of EGF-treated rats, but SCH23390 (0.5 and 2.0 mu g/site) had no effect. The higher dose of raclopride induced catalepsy-like changes in control animals but not in EGF-treated rats. Conversely, local quinpirole administration to EGF-untreated control rats induced PPI deficits and anti-cataleptic behaviors, confirming the pathophysiologic role of the pallidal hyperdopaminergic state. These findings suggest that the pallidal dopaminergic innervation is vulnerable to circulating EGF at perinatal and/or neonatal stages and has strong impact on the D2-like receptor-dependent behavioral deficits relevant to schizophrenia.	[Sotoyama, Hidekazu; Zheng, Yingjun; Iwakura, Yuriko; Mizuno, Makoto; Aizawa, Miho; Shcherbakova, Ksenia; Wang, Ran; Namba, Hisaaki; Nawa, Hiroyuki] Niigata Univ, Brain Res Inst, Dept Mol Neurobiol, Niigata, Japan	Niigata University	Sotoyama, H (corresponding author), Niigata Univ, Brain Res Inst, Dept Mol Neurobiol, Niigata, Japan.	hnawa@bri.niigata-u.ac.jp	Sotoyama, Hidekazu/AAD-4953-2019; Shcherbakova, Ksenia/GZK-5646-2022	Shcherbakova, Ksenia/0000-0001-5091-6795; Sotoyama, Hidekazu/0000-0002-7206-0454	JST Agency; Takeda Science Foundation	JST Agency; Takeda Science Foundation(Takeda Science Foundation (TSF))	This study was supported by a Grant-in-Aid for Basic Scientific Research (B), Health and Labor Sciences Research Grants, Core Research for Evolutional Science and Technology from the JST Agency, Takeda Science Foundation, and grants for Promotion of Niigata University Research Projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2009, NEUROSCIENCE, V161, P95, DOI 10.1016/j.neuroscience.2009.03.022; Anttila S, 2004, NEUROREPORT, V15, P1215, DOI 10.1097/00001756-200405190-00027; Benzel I, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-31; Boksa P, 2010, BRAIN BEHAV IMMUN, V24, P881, DOI 10.1016/j.bbi.2010.03.005; Borrell J, 2002, NEUROPSYCHOPHARMACOL, V26, P204, DOI 10.1016/S0893-133X(01)00360-8; Bouali-Benazzouz R, 2009, NEUROSCIENCE, V164, P588, DOI 10.1016/j.neuroscience.2009.07.034; Brody SA, 2004, MOL PSYCHIATR, V9, P35, DOI 10.1038/sj.mp.4001404; Chiken S, 2008, J NEUROSCI, V28, P13967, DOI 10.1523/JNEUROSCI.3834-08.2008; Chong VZ, 2008, SCHIZOPHR RES, V100, P270, DOI 10.1016/j.schres.2007.12.474; EARLY TS, 1987, P NATL ACAD SCI USA, V84, P561, DOI 10.1073/pnas.84.2.561; Ehninger D, 2012, MOL PSYCHIATR, V17, P469, DOI 10.1038/mp.2011.39; ElKhodor BF, 1997, EXP NEUROL, V145, P118, DOI 10.1006/exnr.1997.6437; Fazzari P, 2010, NATURE, V464, P1376, DOI 10.1038/nature08928; Fuchs H, 2004, NEUROCHEM INT, V45, P1029, DOI 10.1016/j.neuint.2004.05.008; Fuchs H, 2004, EXP BRAIN RES, V154, P66, DOI 10.1007/s00221-003-1638-7; Futamura T, 2002, MOL PSYCHIATR, V7, P673, DOI 10.1038/sj.mp.4001081; Futamura T, 2003, MOL PSYCHIATR, V8, P19, DOI 10.1038/sj.mp.4001138; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Goldman AL, 2008, BIOL PSYCHIAT, V63, P475, DOI 10.1016/j.biopsych.2007.06.006; Goto Y, 2007, INT REV NEUROBIOL, V78, P41, DOI 10.1016/S0074-7742(06)78002-3; Gur RE, 1998, AM J PSYCHIAT, V155, P1711, DOI 10.1176/ajp.155.12.1711; Harrison PJ, 2006, BIOL PSYCHIAT, V60, P132, DOI 10.1016/j.biopsych.2005.11.002; Hashimoto R, 2004, MOL PSYCHIATR, V9, P299, DOI 10.1038/sj.mp.4001434; Hashimoto R, 2009, WORLD J BIOL PSYCHIA, V10, P65, DOI 10.1080/15622970701762536; Hauber W, 1999, BEHAV BRAIN RES, V106, P143, DOI 10.1016/S0166-4328(99)00102-3; Hofmann GE, 1990, ACTA OBSTET GYN SCAN, V69, P217, DOI 10.3109/00016349009028683; Hokama H, 1995, PSYCHIAT RES-NEUROIM, V61, P209, DOI 10.1016/0925-4927(95)02729-H; IWAKURA Y, 2011, J NEUROCHEM IN PRESS; Iwakura Y, 2008, J BIOL CHEM, V283, P15799, DOI 10.1074/jbc.M801553200; Iwakura Y, 2011, J NEUROCHEM, V118, P45, DOI 10.1111/j.1471-4159.2011.07287.x; Kato T, 2011, MOL PSYCHIATR, V16, P307, DOI 10.1038/mp.2010.10; KODSI MH, 1995, BEHAV NEUROSCI, V109, P912, DOI 10.1037/0735-7044.109.5.912; KORNBLUM HI, 1995, NEUROSCIENCE, V69, P1025, DOI 10.1016/0306-4522(95)00392-V; Mamah D, 2007, SCHIZOPHR RES, V89, P59, DOI 10.1016/j.schres.2006.08.031; Marchese G, 2003, BRIT J PHARMACOL, V140, P520, DOI 10.1038/sj.bjp.0705478; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Menon V, 2001, AM J PSYCHIAT, V158, P646, DOI 10.1176/appi.ajp.158.4.646; Meyer U, 2009, NEUROSCI BIOBEHAV R, V33, P1061, DOI 10.1016/j.neubiorev.2009.05.001; Mizuno M, 2004, ANN NY ACAD SCI, V1025, P612, DOI 10.1196/annals.1316.076; Munafo MR, 2006, MOL PSYCHIATR, V11, P539, DOI 10.1038/sj.mp.4001817; Nagano T, 2007, EUR J NEUROSCI, V25, P380, DOI 10.1111/j.1460-9568.2007.05297.x; Namba H, 2006, MOL CELL NEUROSCI, V31, P628, DOI 10.1016/j.mcn.2005.12.002; Nawa H, 2006, NEUROSCI RES, V56, P2, DOI 10.1016/j.neures.2006.06.002; OGREN SO, 1988, NEUROSCI LETT, V85, P333, DOI 10.1016/0304-3940(88)90588-5; Patterson PH, 2007, SCIENCE, V318, P576, DOI 10.1126/science.1150196; Prensa L, 2009, J NEURAL TRANSM-SUPP, P49, DOI 10.1007/978-3-211-92660-4_4; Qu Y, 2008, PHARMACOL BIOCHEM BE, V90, P686, DOI 10.1016/j.pbb.2008.05.012; Qu Y, 2009, PSYCHOPHARMACOLOGY, V207, P271, DOI 10.1007/s00213-009-1654-9; Querejeta E, 2001, NEUROSCI LETT, V300, P79, DOI 10.1016/S0304-3940(01)01550-6; Romero E, 2010, MOL PSYCHIATR, V15, P372, DOI 10.1038/mp.2008.44; Rommelfanger KS, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00139; Sano H, 2003, J NEUROSCI, V23, P9078; Shibuya M, 2010, J NEURAL TRANSM, V117, P887, DOI 10.1007/s00702-010-0418-3; Simpson EH, 2010, NEURON, V65, P585, DOI 10.1016/j.neuron.2010.02.014; Smith Y, 1998, NEUROSCIENCE, V86, P353; SOLBRIG M, 2004, RAT NERVOUS SYSTEM; Sotoyama H, 2007, PSYCHOPHARMACOLOGY, V191, P783, DOI 10.1007/s00213-006-0595-9; Spinks R, 2005, SCHIZOPHR RES, V73, P229, DOI 10.1016/j.schres.2004.05.020; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Swerdlow NR, 2001, PSYCHOPHARMACOLOGY, V156, P194, DOI 10.1007/s002130100799; Takahashi K, 2007, BIOL PSYCHIAT, V62, P148, DOI 10.1016/j.biopsych.2006.06.035; Toda Mitsuru, 2007, Curr Psychiatry Rep, V9, P329, DOI 10.1007/s11920-007-0041-7; Tohmi M, 2005, BEHAV GENET, V35, P615, DOI 10.1007/s10519-005-5357-7; Tsuda N, 2008, BRAIN DEV-JPN, V30, P533, DOI 10.1016/j.braindev.2008.01.006; Varner MW, 1996, J SOC GYNECOL INVEST, V3, P17, DOI 10.1016/1071-5576(95)00044-5; Virgintino D, 1998, INT J DEV BIOL, V42, P1165; VONBOHLEN, 2009, DEV ENG DOPAMINE NEU, P73; Vuillermot S, 2010, J NEUROSCI, V30, P1270, DOI 10.1523/JNEUROSCI.5408-09.2010; Wakuda T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003648; Winter C, 2008, EUR NEUROPSYCHOPHARM, V18, P712, DOI 10.1016/j.euroneuro.2008.06.001; Winter C, 2009, INT J NEUROPSYCHOPH, V12, P513, DOI 10.1017/S1461145708009206; Woo RS, 2007, NEURON, V54, P599, DOI 10.1016/j.neuron.2007.04.009; Yamamoto M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025812; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zscheppang K, 2006, PEDIATR PULM, V41, P1205, DOI 10.1002/ppul.20518	76	29	30	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25831	10.1371/journal.pone.0025831	http://dx.doi.org/10.1371/journal.pone.0025831			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022452	Green Published, gold, Green Submitted			2022-12-27	WOS:000295976000042
J	Liu, FC; Hwang, TL; Lau, YT; Yu, HP				Liu, Fu-Chao; Hwang, Tsong-Long; Lau, Ying-Tung; Yu, Huang-Ping			Mechanism of Salutary Effects of Astringinin on Rodent Hepatic Injury following Trauma-Hemorrhage: Akt-Dependent Hemeoxygenase-1 Signaling Pathways	PLOS ONE			English	Article							RECEPTOR-RELATED PATHWAY; UP-REGULATION; HEME OXYGENASE-1; ISCHEMIA/REPERFUSION INJURY; MEDIATED ATTENUATION; DOWN-REGULATION; ORGAN FUNCTION; LUNG INJURY; ESTROGEN; RESVERATROL	Astringinin can attenuate organ injury following trauma-hemorrhage, the mechanism remains unknown. Protein kinase B/hemeoxygenase-1 (Akt/HO-1) pathway exerts potent anti-inflammatory effects in various tissues. The aim of this study is to elucidate whether Akt/HO-1 plays any role in astringinin-mediated attenuation of hepatic injury following trauma-hemorrhage. For study this, male Sprague-Dawley rats underwent trauma-hemorrhage (mean blood pressure 35-40 mmHg for 90 min) followed by fluid resuscitation. A single dose of astringinin (0.3 mg/kg body weight) with or without a PI3K inhibitor (wortmannin) or a HO antagonist (chromium-mesoporphyrin) was administered during resuscitation. Various parameters were measured at 24 h post-resuscitation. Results showed that trauma-hemorrhage increased plasma aspartate and alanine aminotransferases (AST and ALT) concentrations and hepatic myeloperoxidase activity, cytokine induced neutrophil chemoattractant (CINC)-1, CINC-3, intercellular adhesion molecule-1, and interleukin-6 levels. These parameters were significantly improved in the astringinin-treated rats subjected to trauma-hemorrhage. Astringinin treatment also increased hepatic Akt activation and HO-1 expression as compared with vehicle-treated trauma-hemorrhaged rats. Co-administration of wortmannin or chromium-mesoporphyrin abolished the astringinin-induced beneficial effects on post-resuscitation pro-inflammatory responses and hepatic injury. These findings collectively suggest that the salutary effects of astringinin administration on attenuation of hepatic injury after trauma-hemorrhage are likely mediated via Akt dependent HO-1 up-regulation.	[Liu, Fu-Chao; Yu, Huang-Ping] Chang Gung Mem Hosp, Dept Anesthesiol, Tao Yuan, Taiwan; [Liu, Fu-Chao; Yu, Huang-Ping] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Hwang, Tsong-Long] Chang Gung Univ, Grad Inst Nat Prod, Tao Yuan, Taiwan; [Lau, Ying-Tung] Chang Gung Univ, Dept Physiol & Pharmacol, Tao Yuan, Taiwan; [Lau, Ying-Tung] Chang Gung Inst Technol, Dept Cosmet Sci, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung University of Science & Technology	Liu, FC (corresponding author), Chang Gung Mem Hosp, Dept Anesthesiol, Tao Yuan, Taiwan.	yuhp2001@adm.cgmh.org.tw	Liu, Fu-Chao/AAB-3780-2021; Hwang, Tsong-Long/AAE-6944-2020	Hwang, Tsong-Long/0000-0002-5780-3977; Liu, F-C/0000-0003-1712-4053	National Science Council (NSC) [98-2314-B-182A-034-MY3, 99-2314-B-182A-057-MY2]; Chang Gung Memorial Hospital [CMRPG381072, CMRPG392121]	National Science Council (NSC)(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported in part by grants from the National Science Council (NSC 98-2314-B-182A-034-MY3) and Chang Gung Memorial Hospital (CMRPG381072) to H-PY and from the National Science Council (NSC 99-2314-B-182A-057-MY2) and Chang Gung Memorial Hospital (CMRPG392121) to F-CL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alten JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001605; ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; Bastianetto S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012935; Cai ZQ, 2004, CIRCULATION, V109, P2050, DOI 10.1161/01.CIR.0000127954.98131.23; Chen WP, 2009, BRIT J PHARMACOL, V157, P381, DOI 10.1111/j.1476-5381.2008.00106.x; Choi BM, 2008, EUR J PHARMACOL, V580, P12, DOI 10.1016/j.ejphar.2007.10.044; Cremer TJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008508; Dorman Robert B, 2004, Comp Hepatol, V3 Suppl 1, pS42, DOI 10.1186/1476-5926-2-S1-S42; Doucet D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009421; Fukao T, 2003, TRENDS IMMUNOL, V24, P358, DOI 10.1016/S1471-4906(03)00139-X; Grochot-Przeczek A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005803; Hing LM, 2001, FREE RADICAL BIO MED, V30, P877, DOI 10.1016/S0891-5849(01)00474-9; Huang YS, 2011, CHINESE J PHYSIOL, V54, P183, DOI 10.4077/CJP.2011.AMM024; Kim HJ, 2008, J NUTR BIOCHEM, V19, P459, DOI 10.1016/j.jnutbio.2007.06.001; Lee YM, 2009, CANCER LETT, V285, P166, DOI 10.1016/j.canlet.2009.05.011; Liu FC, 2009, ANESTH ANALG, V108, P1855, DOI 10.1213/ane.0b013e3181a1a194; Puri KD, 2004, BLOOD, V103, P3448, DOI 10.1182/blood-2003-05-1667; Salinas M, 2004, FEBS LETT, V578, P90, DOI 10.1016/j.febslet.2004.10.077; Schabbauer G, 2004, ARTERIOSCL THROM VAS, V24, P1963, DOI 10.1161/01.ATV.0000143096.15099.ce; Shen XD, 2005, AM J TRANSPLANT, V5, P1793, DOI 10.1111/j.1600-6143.2005.00932.x; Shimizu T, 2007, ANN SURG, V245, P297, DOI 10.1097/01.sla.0000232523.88621.17; Suda K, 2010, SHOCK, V33, P526, DOI 10.1097/SHK.0b013e3181cc064b; Szalay L, 2006, AM J PHYSIOL-REG I, V290, pR812, DOI 10.1152/ajpregu.00658.2005; Szalay L, 2005, AM J PHYSIOL-HEART C, V289, pH92, DOI 10.1152/ajpheart.01247.2004; Williams DL, 2006, SHOCK, V25, P432, DOI 10.1097/01.shk.0000209542.76305.55; Wymann MP, 2000, IMMUNOL TODAY, V21, P260, DOI 10.1016/S0167-5699(00)01649-2; Yang SL, 2009, J LEUKOCYTE BIOL, V85, P1015, DOI 10.1189/jlb.0508288; Yu HP, 2008, SHOCK, V30, P324, DOI 10.1097/SHK.0b013e318164f013; Yu HP, 2007, J LEUKOCYTE BIOL, V82, P774, DOI 10.1189/jlb.0307182; Yu HP, 2011, SHOCK, V35, P517, DOI 10.1097/SHK.0b013e318209e931; Yu HP, 2010, SURGERY, V148, P103, DOI 10.1016/j.surg.2009.12.008; Yu HP, 2009, SHOCK, V31, P227, DOI 10.1097/SHK.0b013e31818347e7; Yu HP, 2006, J LEUKOCYTE BIOL, V79, P277, DOI 10.1189/jlb.0705363; Yu HP, 2006, J LEUKOCYTE BIOL, V79, P963, DOI 10.1189/jlb.1005596	34	18	18	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e25907	10.1371/journal.pone.0025907	http://dx.doi.org/10.1371/journal.pone.0025907			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022464	gold, Green Submitted, Green Published			2022-12-27	WOS:000295973200019
J	Cortes-Canteli, M; Aguilar-Morante, D; Sanz-SanCristobal, M; Megias, D; Santos, A; Perez-Castillo, A				Cortes-Canteli, Marta; Aguilar-Morante, Diana; Sanz-SanCristobal, Marina; Megias, Diego; Santos, Angel; Perez-Castillo, Ana			Role of C/EBP beta Transcription Factor in Adult Hippocampal Neurogenesis	PLOS ONE			English	Article							BINDING-PROTEIN-BETA; CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELLS; DENTATE GYRUS; PROLIFERATION; MEMORY; NEURONS; CONSOLIDATION; INJURY; BRAIN	Background: The dentate gyrus of the hippocampus is one of the regions in which neurogenesis takes place in the adult brain. We have previously demonstrated that CCAAT/enhancer binding protein beta (C/EBP beta) is expressed in the granular layer of the dentate gyrus of the adult mouse hippocampus. Taking into account the important role of C/EBP beta in the consolidation of long term memory, the fact that newborn neurons in the hippocampus contribute to learning and memory processes, and the role of this transcription factor, previously demonstrated by our group, in regulating neuronal differentiation, we speculated that this transcription factor could regulate stem/progenitor cells in this region of the brain. Methodology/Principal Findings: Here, we show, using C/EBP beta knockout mice, that C/EBP beta expression is observed in the subset of newborn cells that proliferate in the hippocampus of the adult brain. Mice lacking C/EBP beta present reduced survival of newborn cells in the hippocampus, a decrease in the number of these cells that differentiate into neurons and a diminished number of cells that are proliferating in the subgranular zone of the dentate gyrus. These results were further confirmed in vitro. Neurosphere cultures from adult mice deficient in C/EBP beta present less proliferation and neuronal differentiation than neurospheres derived from wild type mice. Conclusions/Significance: In summary, using in vivo and in vitro strategies, we have identified C/EBP beta as a key player in the proliferation and survival of the new neurons produced in the adult mouse hippocampus. Our results support a novel role of C/EBP beta in the processes of adult hippocampal neurogenesis, providing new insights into the mechanisms that control neurogenesis in this region of the brain.	[Cortes-Canteli, Marta; Aguilar-Morante, Diana; Sanz-SanCristobal, Marina; Perez-Castillo, Ana] Univ Autonoma Madrid, CSIC, Inst Invest Biomed Alberto Sols, Madrid, Spain; [Cortes-Canteli, Marta; Aguilar-Morante, Diana; Sanz-SanCristobal, Marina; Perez-Castillo, Ana] CIBERNED, Madrid, Spain; [Megias, Diego] Ctr Nacl Invest Oncol, Madrid, Spain; [Santos, Angel] Univ Complutense Madrid, Fac Med, Dept Bioquim & Biol Mol, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); CIBERNED; Complutense University of Madrid	Cortes-Canteli, M (corresponding author), Rockefeller Univ, Lab Neurobiol & Genet, 1230 York Ave, New York, NY 10021 USA.	aperez@iib.uam.es	Santos, Angel/K-3744-2014; Cortes-Canteli, Marta/L-5449-2014; Megías, Diego/L-6008-2014; Aguilar-Morante, Diana/AAE-8572-2019; Perez-Castillo, Ana/A-9505-2015	Santos, Angel/0000-0002-7551-8483; Cortes-Canteli, Marta/0000-0001-8802-4338; Aguilar-Morante, Diana/0000-0001-9775-0841; Megias, Diego/0000-0003-0755-0518; Perez-Castillo, Ana/0000-0002-2632-5853	Consejo Superior de Investigaciones Cientificas; Ministerio de Investigacion y Ciencia [SAF2007-62811, SAF2010-16365]; Instituto de Salud Carlos III	Consejo Superior de Investigaciones Cientificas; Ministerio de Investigacion y Ciencia; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by a postdoctoral fellowship of the Consejo Superior de Investigaciones Cientificas (M.C.-C.) Grant Sponsor: Ministerio de Investigacion y Ciencia; Grant numbers: SAF2007-62811 and SAF2010-16365. CIBERNED is funded by the Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; ALBERINI CM, 1994, CELL, V76, P1099, DOI 10.1016/0092-8674(94)90386-7; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Ambrogini P, 2000, NEUROSCI LETT, V286, P21, DOI 10.1016/S0304-3940(00)01074-0; BUCK M, 1994, EMBO J, V13, P851, DOI 10.1002/j.1460-2075.1994.tb06328.x; Choi YS, 2003, MOL CELLS, V16, P232; Cortes-Canteli M, 2004, J BIOL CHEM, V279, P14409, DOI 10.1074/jbc.M313253200; Cortes-Canteli M, 2002, J BIOL CHEM, V277, P5460, DOI 10.1074/jbc.M108761200; Cortes-Canteli M, 2008, J CELL SCI, V121, P1224, DOI 10.1242/jcs.025031; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Drapeau E, 2008, AGING CELL, V7, P569, DOI 10.1111/j.1474-9726.2008.00369.x; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fuentealba L, 2004, GLIA, V45, P238, DOI 10.1002/glia.10325; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gage FH, 1998, J NEUROBIOL, V36, P249, DOI 10.1002/(SICI)1097-4695(199808)36:2<249::AID-NEU11>3.0.CO;2-9; Gagliardi M, 2003, J BIOL CHEM, V278, P43846, DOI 10.1074/jbc.M304085200; Greenbaum LE, 1998, J CLIN INVEST, V102, P996, DOI 10.1172/JCI3135; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; Luna-Medina R, 2005, J BIOL CHEM, V280, P21453, DOI 10.1074/jbc.M414390200; Mandyam CD, 2007, NEUROSCIENCE, V146, P108, DOI 10.1016/j.neuroscience.2006.12.064; Menard C, 2002, NEURON, V36, P597, DOI 10.1016/S0896-6273(02)01026-7; Nadeau S, 2005, MOL CELL NEUROSCI, V29, P525, DOI 10.1016/j.mcn.2005.04.004; Poli V, 1998, J BIOL CHEM, V273, P29279, DOI 10.1074/jbc.273.45.29279; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Robinson GW, 1998, GENE DEV, V12, P1907, DOI 10.1101/gad.12.12.1907; SCREPANTI I, 1995, EMBO J, V14, P1932, DOI 10.1002/j.1460-2075.1995.tb07185.x; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Sterneck E, 1998, J NEUROCHEM, V70, P2424; Taubenfeld SM, 2001, NAT NEUROSCI, V4, P813, DOI 10.1038/90520; Taubenfeld SM, 2001, J NEUROSCI, V21, P84, DOI 10.1523/JNEUROSCI.21-01-00084.2001; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; VINSON CR, 1989, SCIENCE, V246, P911, DOI 10.1126/science.2683088; Yukawa K, 1998, J BIOL CHEM, V273, P31345, DOI 10.1074/jbc.273.47.31345	36	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e24842	10.1371/journal.pone.0024842	http://dx.doi.org/10.1371/journal.pone.0024842			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003384	Green Submitted, Green Published, gold			2022-12-27	WOS:000295970300005
J	Speed, JS; George, EM; Arany, M; Cockrell, K; Granger, JP				Speed, Joshua S.; George, Eric M.; Arany, Marietta; Cockrell, Kathy; Granger, Joey P.			Role of 20-Hydroxyeicosatetraenoic Acid in Mediating Hypertension in Response to Chronic Renal Medullary Endothelin Type B Receptor Blockade	PLOS ONE			English	Article							SALT-SENSITIVE HYPERTENSION; P-450 METABOLITES; ARACHIDONIC-ACID; RATS; 20-HETE; EXCRETION	Background: The renal medullary endothelin (ET-1) system plays an important role in the control of sodium excretion and arterial pressure (AP) through the activation of renal medullary ET-B receptors. We have previously shown that blockade of endothelin type B receptors (ET-B) leads to salt-sensitive hypertension through mechanisms that are not fully understood. One possible mechanism is through a reduction in renal medullary production of 20-hydroxyeicosatetraenoic acid (20-HETE). 20-HETE, a metabolite of arachidonic acid, has natriuretic properties similar to ET-B activation. While these findings suggest a possible interaction between ET-B receptor activation and 20-HETE production, it is unknown whether blockade of medullary ET-B receptors in rats maintained on a high sodium intake leads to reductions in 20-HETE production. Methodology/Principal Findings: The effect of increasing sodium intake from low (NS = .8%) to high (HS = 8%) on renal medullary production of 20-HETE in the presence and absence of renal medullary ET-B receptor antagonism was examined. Renal medullary blockade of ET-B receptors resulted in salt sensitive hypertension. In control rats, blood pressure rose from 112.8 +/- 2.4 mmHg (NS) to 120.7 +/- 9.3 mmHg (HS). In contrast, when treated with an ET-B receptor blocker, blood pressure was significantly elevated from 123.7 +/- 3.2 (NS) to 164.2 +/- 7.1 (HS). Furthermore, increasing sodium intake was associated with elevated medullary 20-HETE (5.6 +/-.8 in NS vs. 14.3 +/- 3.7 pg/mg in HS), an effect that was completely abolished by renal medullary ET-B receptor blockade (4.9 +/-.8 for NS and 4.5 +/-.6 pg/mg for HS). Finally, the hypertensive response to intramedullary ET-B receptor blockade was blunted in rats pretreated with a specific 20-HETE synthesis inhibitor. Conclusion: These data suggest that increases in renal medullary production of 20-HETE associated with elevating salt intake may be, in part, due to ET-B receptor activation within the renal medulla.	[Speed, Joshua S.; George, Eric M.; Arany, Marietta; Cockrell, Kathy; Granger, Joey P.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA; [Speed, Joshua S.; George, Eric M.; Arany, Marietta; Cockrell, Kathy; Granger, Joey P.] Univ Mississippi, Med Ctr, Ctr Excellence Cardiovasc Renal Res, Jackson, MS 39216 USA	University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center	Speed, JS (corresponding author), Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA.	jgranger@umc.edu	George, Eric/ABE-2767-2020	George, Eric/0000-0002-6622-7369	National Institutes of Health (NIH) [HL51971]; American Heart Association (AHA) [09PRE2250470]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL051971] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health (NIH) grant HL51971 (www.nih.gov) and American Heart Association (AHA) grant 09PRE2250470 (http://www.heart.org/HEARTORG/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn D, 2004, J CLIN INVEST, V114, P504, DOI 10.1172/JCI200421064; Elijovich F, 2002, J HUM HYPERTENS, V16, P459, DOI 10.1038/sj.jhh.1001419; Escalante BA, 2002, AM J PHYSIOL-RENAL, V282, pF144, DOI 10.1152/ajprenal.0064.2001; Gariepy CE, 2000, J CLIN INVEST, V105, P925, DOI 10.1172/JCI8609; Gurbanov K, 1996, AM J PHYSIOL-RENAL, V271, pF1166, DOI 10.1152/ajprenal.1996.271.6.F1166; Herrera M, 2009, J BIOL CHEM, V284, P1454, DOI 10.1074/jbc.M804322200; Hoagland KM, 2003, HYPERTENSION, V42, P669, DOI 10.1161/01.HYP.0000084634.97353.1A; HOFFMAN A, 1994, KIDNEY INT, V45, P556, DOI 10.1038/ki.1994.72; Hsieh TJ, 2000, AM J PHYSIOL-RENAL, V279, pF112, DOI 10.1152/ajprenal.2000.279.1.F112; KITAMURA K, 1989, BIOCHEM BIOPH RES CO, V161, P348, DOI 10.1016/0006-291X(89)91603-3; Maier KG, 2000, AM J PHYSIOL-HEART C, V279, pH863, DOI 10.1152/ajpheart.2000.279.2.H863; MORTENSEN LH, 1990, HYPERTENSION, V15, P729, DOI 10.1161/01.HYP.15.6.729; Nakano D, 2008, AM J PHYSIOL-RENAL, V294, pF1205, DOI 10.1152/ajprenal.00578.2007; Pavlov TS, 2010, J AM SOC NEPHROL, V21, P833, DOI 10.1681/ASN.2009080885; Plato CF, 2000, AM J PHYSIOL-RENAL, V279, pF326, DOI 10.1152/ajprenal.2000.279.2.F326; Pollock DM, 2001, AM J PHYSIOL-RENAL, V281, pF144, DOI 10.1152/ajprenal.2001.281.1.F144; Roman RJ, 2002, PHYSIOL REV, V82, P131, DOI 10.1152/physrev.00021.2001; Schneider MP, 2008, HYPERTENSION, V51, P1605, DOI 10.1161/HYPERTENSIONAHA.107.108126; Stec DE, 1997, HYPERTENSION, V29, P315, DOI 10.1161/01.HYP.29.1.315; Wessale JL, 2002, CLIN SCI, V103, p112S, DOI 10.1042/CS103S112S; Williams JM, 2005, HYPERTENSION, V46, P366, DOI 10.1161/01.HYP.0000172755.25382.fc; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Yu M, 2007, AM J PHYSIOL-REG I, V292, pR2400, DOI 10.1152/ajpregu.00791.2006	23	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e26063	10.1371/journal.pone.0026063	http://dx.doi.org/10.1371/journal.pone.0026063			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22016812	gold, Green Published, Green Submitted			2022-12-27	WOS:000295970300055
J	Bhat, A; Boyadjiev, SA; Senders, CW; Leach, JK				Bhat, Archana; Boyadjiev, Simeon A.; Senders, Craig W.; Leach, J. Kent			Differential Growth Factor Adsorption to Calvarial Osteoblast-Secreted Extracellular Matrices Instructs Osteoblastic Behavior	PLOS ONE			English	Article							CRANIAL SUTURE FUSION; BONE MORPHOGENETIC PROTEIN-2; MARROW STROMAL CELLS; FACTOR-BETA; MESSENGER-RNA; OSTEOGENIC DIFFERENTIATION; DEFICIENT MICE; STEM-CELLS; CRANIOSYNOSTOSIS; BIOLOGY	Craniosynostosis (CS), the premature ossification of cranial sutures, is attributed to increased osteogenic potential of resident osteoblasts, yet the contribution of the surrounding extracellular matrix (ECM) on osteogenic differentiation is unclear. The osteoblast-secreted ECM provides binding sites for cellular adhesion and regulates the transport and signaling of osteoinductive factors secreted by the underlying dura mater. The binding affinity of each osteoinductive factor for the ECM may amplify or mute its relative effect, thus contributing to the rate of suture fusion. The purpose of this paper was to examine the role of ECM composition derived from calvarial osteoblasts on protein binding and its resultant effect on cell phenotype. We hypothesized that potent osteoinductive proteins present during sutural fusion (e.g., bone morphogenetic protein-2 (BMP-2) and transforming growth factor beta-1 (TGF-beta 1)) would exhibit distinct differences in binding when exposed to ECMs generated by human calvarial osteoblasts from unaffected control individuals (CI) or CS patients. Decellularized ECMs produced by osteoblasts from CI or CS patients were incubated in the presence of BMP-2 or TGF-beta 1, and the affinity of each protein was analyzed. The contribution of ECM composition to protein binding was interrogated by enzymatically modulating proteoglycan content within the ECM. BMP-2 had a similar binding affinity for each ECM, while TGF-beta 1 had a greater affinity for ECMs produced by osteoblasts from CI compared to CS patients. Enzymatic treatment of ECMs reduced protein binding. CS osteoblasts cultured on enzymatically-treated ECMs secreted by osteoblasts from CI patients in the presence of BMP-2 exhibited impaired osteogenic differentiation compared to cells on untreated ECMs. These data demonstrate the importance of protein binding to cell-secreted ECMs and confirm that protein-ECM interactions have an important role in directing osteoblastic differentiation of calvarial osteoblasts.	[Bhat, Archana; Leach, J. Kent] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Boyadjiev, Simeon A.] Univ Calif Davis, Sch Med, Genet Sect, Dept Pediat, Sacramento, CA 95817 USA; [Senders, Craig W.] Univ Calif Davis, Sch Med, Dept Otolaryngol Head & Neck Surg, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Bhat, A (corresponding author), Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.	jkleach@ucdavis.edu			The Hartwell Foundation; National Institute on Deafness and Other Communication Disorders (NIDCD)/National Institutes of Health (NIH) [K23DE00462, R03 DE016342, R01 DE016886]; National Center for Research Resources (NCRR)/NIH [M01-RR00052]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016886] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [K23DE000462, R03DE016342] Funding Source: NIH RePORTER	The Hartwell Foundation; National Institute on Deafness and Other Communication Disorders (NIDCD)/National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Center for Research Resources (NCRR)/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors are thankful to The Hartwell Foundation for their generous financial support of this work (to KL). SAB is partially funded through a Children's Miracle Network Endowed Chair and through grants K23DE00462, R03 DE016342, and R01 DE016886 from National Institute on Deafness and Other Communication Disorders (NIDCD)/National Institutes of Health (NIH) and M01-RR00052 from the National Center for Research Resources (NCRR)/NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi YM, 2005, J BIOL CHEM, V280, P30481, DOI 10.1074/jbc.M500573200; Boyadjiev SA, 2007, ORTHOD CRANIOFAC RES, V10, P129, DOI 10.1111/j.1601-6343.2007.00393.x; Carinci P, 2000, INT J DEV BIOL, V44, P715; Chen XD, 2002, J BONE MINER RES, V17, P331, DOI 10.1359/jbmr.2002.17.2.331; Chen XD, 2007, J BONE MINER RES, V22, P1943, DOI 10.1359/JBMR.070725; COHEN MM, 1993, AM J MED GENET, V47, P581, DOI 10.1002/ajmg.1320470507; Cooper GM, 2011, PLAST RECONSTR SURG, V127, P88, DOI 10.1097/PRS.0b013e3181fad311; Davis HE, 2009, J BIOMED MATER RES A, V90A, P1021, DOI 10.1002/jbm.a.32169; Decaris ML, 2011, ANN BIOMED ENG, V39, P1174, DOI 10.1007/s10439-010-0217-x; Decaris ML, 2009, ANGIOGENESIS, V12, P303, DOI 10.1007/s10456-009-9152-6; DePollack C, 1996, J BONE MINER RES, V11, P401; Foster KA, 2008, PLAST RECONSTR SURG, V121, p70E, DOI 10.1097/01.prs.0000299393.36063.de; Fragale A, 1999, AM J PATHOL, V154, P1465, DOI 10.1016/S0002-9440(10)65401-6; Gosain AK, 2004, PLAST RECONSTR SURG, V113, P1675, DOI 10.1097/01.PRS.0000117362.33347.43; Gutierrez J, 2006, J CELL PHYSIOL, V206, P58, DOI 10.1002/jcp.20428; HARRIS SE, 1994, J BONE MINER RES, V9, P855; He JW, 2010, J CELL BIOCHEM, V110, P87, DOI 10.1002/jcb.22514; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Hoshiba T, 2009, J BIOL CHEM, V284, P31164, DOI 10.1074/jbc.M109.054676; Jiao XY, 2007, J BIOL CHEM, V282, P1080, DOI 10.1074/jbc.M513414200; Kram V, 2006, J CELL PHYSIOL, V207, P784, DOI 10.1002/jcp.20625; Manton KJ, 2007, STEM CELLS, V25, P2845, DOI 10.1634/stemcells.2007-0065; Mefford HC, 2010, AM J MED GENET A, V152A, P2203, DOI 10.1002/ajmg.a.33557; Miyazaki T, 2010, DENT MATER J, V29, P403, DOI 10.4012/dmj.2009-132; Most D, 1998, PLAST RECONSTR SURG, V101, P1431, DOI 10.1097/00006534-199805000-00001; Nishigaki F, 2002, EUR J PHARMACOL, V437, P123, DOI 10.1016/S0014-2999(02)01269-4; Passos-Bueno Maria Rita, 2008, V12, P107, DOI 10.1159/000115035; Prabhakar V, 2005, BIOCHEM J, V386, P103, DOI 10.1042/BJ20041222; REARDON W, 1994, NAT GENET, V8, P98, DOI 10.1038/ng0994-98; Robin NH, 1999, PLAST RECONSTR SURG, V103, P1060, DOI 10.1097/00006534-199903000-00053; Roth DA, 1996, PLAST RECONSTR SURG, V97, P693, DOI 10.1097/00006534-199604000-00001; Roth DA, 1997, PLAST RECONSTR SURG, V99, P300, DOI 10.1097/00006534-199702000-00002; Roth DA, 1997, J BONE MINER RES, V12, P311, DOI 10.1359/jbmr.1997.12.3.311; SHEFFIELD JB, 1987, ANAL BIOCHEM, V166, P49, DOI 10.1016/0003-2697(87)90544-6; STANFORD CM, 1995, J BIOL CHEM, V270, P9420, DOI 10.1074/jbc.270.16.9420; Takada T, 2003, J BIOL CHEM, V278, P43229, DOI 10.1074/jbc.M300937200; TAKEUCHI Y, 1994, J BIOL CHEM, V269, P32634; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Wadhwa S, 2007, BONE, V40, P861, DOI 10.1016/j.bone.2006.11.003; Warren SM, 2003, NATURE, V422, P625, DOI 10.1038/nature01545; Xu Y, 2007, PLAST RECONSTR SURG, V119, P819, DOI 10.1097/01.prs.0000255540.91987.a0	41	14	15	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25990	10.1371/journal.pone.0025990	http://dx.doi.org/10.1371/journal.pone.0025990			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998741	Green Submitted, gold, Green Published			2022-12-27	WOS:000295966900087
J	Pitino, M; Coleman, AD; Maffei, ME; Ridout, CJ; Hogenhout, SA				Pitino, Marco; Coleman, Alexander D.; Maffei, Massimo E.; Ridout, Christopher J.; Hogenhout, Saskia A.			Silencing of Aphid Genes by dsRNA Feeding from Plants	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; PROTEIN-KINASE-C; MYZUS-PERSICAE; EXPRESSION; RACK1; IDENTIFICATION; INTERFERENCE; COMPONENTS; PATHWAY; HOST	Background: RNA interference (RNAi) is a valuable reverse genetics tool to study gene function in various organisms, including hemipteran insects such as aphids. Previous work has shown that RNAi-mediated knockdown of pea aphid (Acyrthosiphon pisum) genes can be achieved through direct injection of double-stranded RNA (dsRNA) or small-interfering RNAs (siRNA) into the pea aphid hemolymph or by feeding these insects on artificial diets containing the small RNAs. Methodology/Principal Findings: In this study, we have developed the plant-mediated RNAi technology for aphids to allow for gene silencing in the aphid natural environment and minimize handling of these insects during experiments. The green peach aphid M. persicae was selected because it has a broad plant host range that includes the model plants Nicotiana benthamiana and Arabidopsis thaliana for which transgenic materials can relatively quickly be generated. We targeted M. persicae Rack1, which is predominantly expressed in the gut, and M. persicae C002 (MpC002), which is predominantly expressed in the salivary glands. The aphids were fed on N. benthamiana leaf disks transiently producing dsRNA corresponding to these genes and on A. thaliana plants stably producing the dsRNAs. MpC002 and Rack-1 expression were knocked down by up to 60% on transgenic N. benthamiana and A. thaliana. Moreover, silenced M. persicae produced less progeny consistent with these genes having essential functions. Conclusions/Significance: Similar levels of gene silencing were achieved in our plant-mediated RNAi approach and published silencing methods for aphids. Furthermore, the N. benthamiana leaf disk assay can be developed into a screen to assess which genes are essential for aphid survival on plants. Our results also demonstrate the feasibility of the plant-mediated RNAi approach for aphid control.	[Pitino, Marco; Coleman, Alexander D.; Ridout, Christopher J.; Hogenhout, Saskia A.] John Innes Ctr, Dept Dis & Stress Biol, Norwich, Norfolk, England; [Pitino, Marco; Maffei, Massimo E.] Univ Turin, Innovat Ctr, Dept Plant Biol, Plant Physiol Unit, Turin, Italy	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Turin	Pitino, M (corresponding author), John Innes Ctr, Dept Dis & Stress Biol, Norwich Res Pk, Norwich, Norfolk, England.	saskia.hogenhout@jic.ac.uk	Hogenhout, Saskia A/D-9266-2012; Maffei, Massimo E/K-9593-2015	Hogenhout, Saskia A/0000-0003-1371-5606; Maffei, Massimo E/0000-0001-6814-2353; Coleman, Alexander/0000-0001-7771-2290; Ridout, Christopher/0000-0001-9287-938X	The John Innes Centre; The Gatsby Charitable Foundation in the UK; Doctorate School of Pharmaceutical and Molecular Sciences of the University of Turin, Italy; Biotechnology and Biological Sciences Research Council (BBSRC); Home Grown Cereals Authority; Biotechnology and Biological Sciences Research Council [BBS/E/J/000C0623] Funding Source: researchfish; BBSRC [BBS/E/J/000C0623] Funding Source: UKRI	The John Innes Centre; The Gatsby Charitable Foundation in the UK; Doctorate School of Pharmaceutical and Molecular Sciences of the University of Turin, Italy; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Home Grown Cereals Authority; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was funded by The John Innes Centre and The Gatsby Charitable Foundation in the UK, and a grant from the Doctorate School of Pharmaceutical and Molecular Sciences of the University of Turin, Italy. The John Innes Centre is grant-aided by the Biotechnology and Biological Sciences Research Council (BBSRC). A.C. is funded from a studentship co-funded by the BBSRC and the Home Grown Cereals Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albinsson B, 1999, VIRUS RES, V64, P125, DOI 10.1016/S0168-1702(99)00087-8; Araujo RN, 2006, INSECT BIOCHEM MOLEC, V36, P683, DOI 10.1016/j.ibmb.2006.05.012; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Bos JIB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001216; Brault V, 2007, MICRON, V38, P302, DOI 10.1016/j.micron.2006.04.005; Carolan JC, 2011, J PROTEOME RES, V10, P1505, DOI 10.1021/pr100881q; Chen T, 2002, J AM SOC NEPHROL, V13, p501A; Ciche TA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-101; Dong Y, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-25; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Goto A, 2003, NUCLEIC ACIDS RES, V31, P6619, DOI 10.1093/nar/gkg852; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; HANLEY BA, 1991, NUCLEIC ACIDS RES, V19, P6319, DOI 10.1093/nar/19.22.6319; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Harmel N, 2008, INSECT MOL BIOL, V17, P165, DOI 10.1111/j.1365-2583.2008.00790.x; Hogenhout SA, 2008, ANNU REV PHYTOPATHOL, V46, P327, DOI 10.1146/annurev.phyto.022508.092135; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Jaubert-Possamai S, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-63; Jaubert-Possamai S, 2010, MOL BIOL EVOL, V27, P979, DOI 10.1093/molbev/msp256; Johansen LK, 2001, PLANT PHYSIOL, V126, P930, DOI 10.1104/pp.126.3.930; Kadrmas JL, 2007, DEV DYNAM, V236, P2207, DOI 10.1002/dvdy.21217; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kucherenko MM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002418; Liliental J, 1998, J BIOL CHEM, V273, P2379, DOI 10.1074/jbc.273.4.2379; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Gomollon S, 2011, DETECTING SRNAS NO B, P25; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mlotshwa S, 2002, PLANT CELL, V14, pS289, DOI 10.1105/tpc.001677; Moran PJ, 2002, ARCH INSECT BIOCHEM, V51, P182, DOI 10.1002/arch.10064; Mutti NS, 2008, P NATL ACAD SCI USA, V105, P9965, DOI 10.1073/pnas.0708958105; Mutti NS, 2006, J INSECT SCI, V6, DOI 10.1673/031.006.3801; Rajagopal R, 2002, J BIOL CHEM, V277, P46849, DOI 10.1074/jbc.C200523200; Ramsey JS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-423; Robles MS, 2010, SCIENCE, V327, P463, DOI 10.1126/science.1180067; Seddas P, 2004, VIROLOGY, V325, P399, DOI 10.1016/j.virol.2004.05.014; Shakesby AJ, 2009, INSECT BIOCHEM MOLEC, V39, P1, DOI 10.1016/j.ibmb.2008.08.008; Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012; VANEMDEN HF, 1969, ANNU REV ENTOMOL, V14, P197, DOI 10.1146/annurev.en.14.010169.001213; Whyard S, 2009, INSECT BIOCHEM MOLEC, V39, P824, DOI 10.1016/j.ibmb.2009.09.007; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; YANG NS, 1990, DEV GENET, V11, P289, DOI 10.1002/dvg.1020110407; Zha WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020504	45	269	306	1	171	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25709	10.1371/journal.pone.0025709	http://dx.doi.org/10.1371/journal.pone.0025709			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998682	Green Published, gold, Green Submitted			2022-12-27	WOS:000295966900045
J	Weis, E; Schoen, H; Victor, A; Spix, C; Ludwig, M; Schneider-Raetzke, B; Kohlschmidt, N; Bartsch, O; Gerhold-Ay, A; Boehm, N; Grus, F; Haaf, T; Galetzka, D				Weis, Eva; Schoen, Holger; Victor, Anja; Spix, Claudia; Ludwig, Marco; Schneider-Raetzke, Brigitte; Kohlschmidt, Nicolai; Bartsch, Oliver; Gerhold-Ay, Aslihan; Boehm, Nils; Grus, Franz; Haaf, Thomas; Galetzka, Danuta			Reduced mRNA and Protein Expression of the Genomic Caretaker RAD9A in Primary Fibroblasts of Individuals with Childhood and Independent Second Cancer	PLOS ONE			English	Article							DNA METHYLATION; MALIGNANT NEOPLASMS; GENES; SUSCEPTIBILITY; CHECKPOINTS; INSTABILITY; STABILITY; DAMAGE	Background: The etiology of secondary cancer in childhood cancer survivors is largely unclear. Exposure of normal somatic cells to radiation and/or chemotherapy can damage DNA and if not all DNA lesions are properly fixed, the mis-repair may lead to pathological consequences. It is plausible to assume that genetic differences, i.e. in the pathways responsible for cell cycle control and DNA repair, play a critical role in the development of secondary cancer. Methodology/Findings: To identify factors that may influence the susceptibility for second cancer formation, we recruited 20 individuals who survived a childhood malignancy and then developed a second cancer as well as 20 carefully matched control individuals with childhood malignancy but without a second cancer. By antibody microarrays, we screened primary fibroblasts of matched patients for differences in the amount of representative DNA repair-associated proteins. We found constitutively decreased levels of RAD9A and several other DNA repair proteins in two-cancer patients, compared to one-cancer patients. The RAD9A protein level increased in response to DNA damage, however to a lesser extent in the two-cancer patients. Quantification of mRNA expression by real-time RT PCR revealed lower RAD9A mRNA levels in both untreated and 1 Gy gamma-irradiated cells of two-cancer patients. Conclusions/Significance: Collectively, our results support the idea that modulation of RAD9A and other cell cycle arrest and DNA repair proteins contribute to the risk of developing a second malignancy in childhood cancer patients.	[Weis, Eva; Schoen, Holger; Ludwig, Marco; Schneider-Raetzke, Brigitte; Kohlschmidt, Nicolai; Bartsch, Oliver; Galetzka, Danuta] Univ Med Ctr, Inst Human Genet, Mainz, Germany; [Victor, Anja; Spix, Claudia; Gerhold-Ay, Aslihan] Univ Med Ctr, Inst Med Biometry Epidemiol & Informat, Mainz, Germany; [Boehm, Nils; Grus, Franz] Univ Med Ctr, Expt Ophthalmol Ocular Prote & Immunol Ctr, Mainz, Germany; [Haaf, Thomas] Julius Maximilians Univ, Inst Human Genet, Wurzburg, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; University of Wurzburg	Weis, E (corresponding author), Univ Med Ctr, Inst Human Genet, Mainz, Germany.	thomas.haaf@uni-wuerzburg.de	Galetzka, Danuta/D-2199-2012; Bartsch, Oliver/ABE-2681-2020		Stiftung Rheinland-Pfalz fur Innovation [698]; FAZIT-Stiftung	Stiftung Rheinland-Pfalz fur Innovation; FAZIT-Stiftung	This study was supported by the Stiftung Rheinland-Pfalz fur Innovation (project no. 698) and the FAZIT-Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khodairy Fahad M, 2004, Asian Pac J Cancer Prev, V5, P139; Anand P, 2008, PHARM RES-DORDR, V25, P2097, DOI 10.1007/s11095-008-9661-9; Boulton E, 2001, INT J RADIAT BIOL, V77, P21, DOI 10.1080/0955300010001880; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; Cheng CK, 2005, CANCER RES, V65, P8646, DOI 10.1158/0008-5472.CAN-04-4243; Chuang EY, 2006, CANCER RES, V66, P3428, DOI 10.1158/0008-5472.CAN-05-2847; Dang TY, 2005, GENES CELLS, V10, P287, DOI 10.1111/j.1365-2443.2005.00840.x; Hopkins KM, 2004, MOL CELL BIOL, V24, P7235, DOI 10.1128/MCB.24.16.7235-7248.2004; Hu Z, 2008, CANCER RES, V68, P1; Infante-Rivard C, 2000, ENVIRON HEALTH PERSP, V108, P495, DOI 10.2307/3454609; Kaatsch P, 2009, CANCER CAUSE CONTROL, V20, P965, DOI 10.1007/s10552-009-9315-1; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kebebew E, 2006, WORLD J SURG, V30, P767, DOI 10.1007/s00268-005-0308-2; Klein G, 2003, EUR J CANCER, V39, P808, DOI 10.1016/S0959-8049(02)00875-4; Lieberman HB, 2006, J CELL BIOCHEM, V97, P690, DOI 10.1002/jcb.20759; Lieberman HB, 2011, J MOL CELL BIOL, V3, P39, DOI 10.1093/jmcb/mjq039; MacDonald D, 2001, INT J RADIAT BIOL, V77, P1023, DOI 10.1080/09553000110073411; Maniwa Y, 2005, CANCER, V103, P1261; Niida H, 2006, MUTAGENESIS, V21, P3, DOI 10.1093/mutage/gei063; Nomura T, 2004, CYTOGENET GENOME RES, V104, P252, DOI 10.1159/000077499; Pandita RK, 2006, MOL CELL BIOL, V26, P1850, DOI 10.1128/MCB.26.5.1850-1864.2006; Plon SE, 2005, CANCER J, V11, P255, DOI 10.1097/00130404-200507000-00002; Rahman N, 2007, HUM MOL GENET, V16, pR60, DOI 10.1093/hmg/ddm026; Sontag LB, 2006, J THEOR BIOL, V242, P890, DOI 10.1016/j.jtbi.2006.05.012; Strahm B, 2006, INT J CANCER, V119, P2001, DOI 10.1002/ijc.21962; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Zhu A, 2008, CANCER RES, V68, P1267, DOI 10.1158/0008-5472.CAN-07-2304	28	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25750	10.1371/journal.pone.0025750	http://dx.doi.org/10.1371/journal.pone.0025750			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991345	Green Published, gold, Green Submitted			2022-12-27	WOS:000295943000064
J	Yang, CY; Tai, MF; Lin, CP; Lu, CW; Wang, JL; Hsiao, JK; Liu, HM				Yang, Chung-Yi; Tai, Ming-Fong; Lin, Chih-Peng; Lu, Chen-Wen; Wang, Jaw-Lin; Hsiao, Jong-Kai; Liu, Hon-Man			Mechanism of Cellular Uptake and Impact of Ferucarbotran on Macrophage Physiology	PLOS ONE			English	Article							SUPERPARAMAGNETIC IRON-OXIDE; MR CONTRAST AGENTS; MESENCHYMAL STEM-CELLS; MAGNETIC-RESONANCE; ATHEROSCLEROTIC PLAQUES; ENHANCED MRI; NANOPARTICLES; TRACKING; INFLAMMATION; FERUMOXIDES	Superparamagnetic iron oxide (SPIO) nanoparticles are contrast agents used for magnetic resonance imaging. Ferucarbotran is a clinically approved SPIO-coated carboxydextran with a diameter of about 45-60 nm. We investigated the mechanism of cellular uptake of Ferucarbotran with a cell model using the murine macrophage cell line Raw 264.7. We observed a dose-dependent uptake of these SPIO particles by spectrophotometer analysis and also a dose-dependent increase in the granularity of the macrophages as determined by flow cytometry. There was a linear correlation between the side scattering mean value and iron content (P<0.001, R(2) = 0.8048). For evaluation of the endocytotic pathway of these ingested SPIO particles, different inhibitors of the endocytotic pathways were employed. There was a significant decrease of side scattering counts in the cells and a less significant change in signal intensity based on magnetic resonance in the phenylarsine oxide-treated macrophages. After labeling with SPIO particles, the macrophages showed an increase in the production of reactive oxygen species at 2, 24, and 48 h; a decrease in mitochondrial membrane potential at 24 h; and an increase in cell proliferation at 24 h. We concluded that Ferucarbotran was internalized into macrophages via the clathrin-mediated pathway and can change the cellular behavior of these cells after labeling.	[Yang, Chung-Yi; Wang, Jaw-Lin] Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan; [Yang, Chung-Yi; Lu, Chen-Wen; Liu, Hon-Man] Natl Taiwan Univ Hosp, Dept Med Imaging, Taipei, Taiwan; [Yang, Chung-Yi; Lin, Chih-Peng; Lu, Chen-Wen; Liu, Hon-Man] Coll Med, Taipei, Taiwan; [Tai, Ming-Fong] Natl Tsing Hua Univ, Dept Phys, Hsinchu, Taiwan; [Lin, Chih-Peng] Natl Taiwan Univ Hosp, Dept Anesthesiol, Taipei, Taiwan; [Hsiao, Jong-Kai] Buddhist Tzu Chi Gen Hosp, Dept Med Imaging, Taipei Branch, New Taipei City, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Tsing Hua University; National Taiwan University; National Taiwan University Hospital; Buddhist Tzu Chi General Hospital	Yang, CY (corresponding author), Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan.	hmliu@ntu.edu.tw	Liu, Hon-Man/B-1352-2012; Lin, Chih-Peng/H-5979-2019	Lin, Chih-Peng/0000-0003-2928-3203; WANG, JAW-LIN/0000-0002-5734-9276; LIU, HON-MAN/0000-0001-6715-6366	National Science Council, Taiwan [NSC 98-2218-E-002-035, NSC 99-2314-B-303-012-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council, Taiwan (grants NSC 98-2218-E-002-035, NSC 99-2314-B-303-012-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbab AS, 2005, NMR BIOMED, V18, P383, DOI 10.1002/nbm.970; Bishop NE, 1997, REV MED VIROL, V7, P199, DOI 10.1002/(SICI)1099-1654(199712)7:4<199::AID-RMV203>3.0.CO;2-F; Bogdanov A, 2002, MOL IMAGING, V1, P16, DOI 10.1162/153535002753395671; Bulte JWM, 2004, NMR BIOMED, V17, P484, DOI 10.1002/nbm.924; Chang Y, 2005, TOXICOL APPL PHARM, V204, P27, DOI 10.1016/j.taap.2004.08.011; Chen YC, 2010, TOXICOL APPL PHARM, V245, P272, DOI 10.1016/j.taap.2010.03.011; Daldrup-Link HE, 2003, RADIOLOGY, V228, P760, DOI 10.1148/radiol.2283020322; de Vries IJM, 2005, NAT BIOTECHNOL, V23, P1407, DOI 10.1038/nbt1154; Denis MC, 2004, P NATL ACAD SCI USA, V101, P12634, DOI 10.1073/pnas.0404307101; Dubey P, 2003, P NATL ACAD SCI USA, V100, P1232, DOI 10.1073/pnas.0337418100; GANDHI SN, 2006, MR CONTRAST AGENTS L, P1621; HSIAO JK, 2008, NMR BIOMED; Hsiao JK, 2007, IEEE T MAGN, V43, P2421, DOI 10.1109/TMAG.2007.893860; Hsiao JK, 2007, MAGN RESON MED, V58, P717, DOI 10.1002/mrm.21377; Hsiao JK, 2006, J MAGN MAGN MATER, V304, pE4, DOI 10.1016/j.jmmm.2006.01.134; Huang DM, 2005, FASEB J, V19, P2014, DOI 10.1096/fj.05-4288fje; Huang DM, 2009, BIOMATERIALS, V30, P3645, DOI 10.1016/j.biomaterials.2009.03.032; Huth US, 2006, J CONTROL RELEASE, V110, P490, DOI 10.1016/j.jconrel.2005.10.018; Kagan VE, 2006, TOXICOL LETT, V165, P88, DOI 10.1016/j.toxlet.2006.02.001; Kircher MF, 2003, CANCER RES, V63, P6838; Koehne G, 2003, NAT BIOTECHNOL, V21, P405, DOI 10.1038/nbt805; Lunov O, 2010, BIOMATERIALS, V31, P9015, DOI 10.1016/j.biomaterials.2010.08.003; Lunov O, 2010, BIOMATERIALS, V31, P5063, DOI 10.1016/j.biomaterials.2010.03.023; Marchetti P, 1996, J EXP MED, V184, P1155, DOI 10.1084/jem.184.3.1155; Metz S, 2004, EUR RADIOL, V14, P1851, DOI 10.1007/s00330-004-2405-2; Pawelczyk E, 2006, NMR BIOMED, V19, P581, DOI 10.1002/nbm.1038; POULIQUEN D, 1991, MAGN RESON IMAGING, V9, P275, DOI 10.1016/0730-725X(91)90412-F; Raynal I, 2004, INVEST RADIOL, V39, P56, DOI 10.1097/01.rli.0000101027.57021.28; Reimer P, 2003, EUR RADIOL, V13, P1266, DOI 10.1007/s00330-002-1721-7; Schmitz SA, 2002, INVEST RADIOL, V37, P405, DOI 10.1097/00004424-200207000-00008; Schmitz SA, 2000, INVEST RADIOL, V35, P460, DOI 10.1097/00004424-200008000-00002; Simon GH, 2006, EUR J NUCL MED MOL I, V33, P998, DOI 10.1007/s00259-006-0081-y; Sista AK, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-94; Turvey SE, 2005, J CLIN INVEST, V115, P2454, DOI 10.1172/JCI25048; Valable S, 2008, NEUROIMAGE, V40, P973, DOI 10.1016/j.neuroimage.2008.01.005; WEISSLEDER R, 1990, RADIOLOGY, V175, P489, DOI 10.1148/radiology.175.2.2326474; YANG CY, 2010, DIRECT LABELING HMSC; YEH TC, 1993, MAGN RESON MED, V30, P617, DOI 10.1002/mrm.1910300513	38	40	41	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25524	10.1371/journal.pone.0025524	http://dx.doi.org/10.1371/journal.pone.0025524			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834CT	21991395	Green Submitted, Green Published, gold			2022-12-27	WOS:000295936900074
J	Wang, X; Li, X; Zhang, YB; Zhang, F; Sun, LY; Lin, J; Wang, DM; Wang, LY				Wang, Xu; Li, Xin; Zhang, Yong-Biao; Zhang, Feng; Sun, Liyuan; Lin, Jie; Wang, Duen-Mei; Wang, Lu-Ya			Genome-Wide Linkage Scan of a Pedigree with Familial Hypercholesterolemia Suggests Susceptibility Loci on Chromosomes 3q25-26 and 21q22	PLOS ONE			English	Article							AUTOSOMAL-DOMINANT HYPERCHOLESTEROLEMIA; COMBINED HYPERLIPIDEMIA; COMPLEX TRAIT; GENE; CHOLESTEROL; DISEASE; ABCG1; HETEROGENEITY; MUTATIONS; DISORDER	Background: Familial hypercholesterolemia (FH) is a heritable disorder that can increase the risk of premature coronary heart disease. Studies suggest there are substantial genetic heterogeneities for different populations. Here we tried to identify novel susceptibility loci for FH in a Chinese pedigree. Methodology/Principal Findings: We performed a SNP-based genome-wide linkage scan with the Chinese FH pedigree. Two suggestive linkage loci not previously reported were identified on chromosomes 3q25.1-26.1 (NPL = 9.01, nominal P < 0.00001, and simulated occurrence per genome scan = 1.08) and 21q22.3 (NPL = 8.95, nominal P < 0.00001, and simulated occurrence per genome scan = 1.26). In the interaction analysis with a trimmed version of the pedigree, we obtained a significantly increased joint LOD score (2.70) compared with that obtained when assuming the two loci uncorrelated, suggesting that more than one locus was involved in this pedigree. Exon screening of two candidate genes ABCG1 and LSS from one of the suggestive region 21q22 didn't report any causative mutations. Conclusions/Significances: These results confirm complex etiologies and suggest new genetic casual factors for the FH disorder. Further study of the two candidate regions is advocated.	[Wang, Xu; Sun, Liyuan; Lin, Jie; Wang, Lu-Ya] Capital Med Univ, Key Lab Remodeling Related Cardiovasc Dis, Minist Educ, Beijing, Peoples R China; [Wang, Xu; Sun, Liyuan; Lin, Jie; Wang, Lu-Ya] Capital Univ Med Sci, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing Anzhen Hosp, Beijing, Peoples R China; [Li, Xin; Zhang, Yong-Biao; Zhang, Feng; Wang, Duen-Mei] Chinese Acad Sci, CAS Key Lab Genome Sci & Informat, Beijing Inst Genom, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Wang, X (corresponding author), Capital Med Univ, Key Lab Remodeling Related Cardiovasc Dis, Minist Educ, Beijing, Peoples R China.	wangluya@126.com			National Natural Science Foundation of China [30771986]; Beijing Natural Science Foundation [7112022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This study was supported by grants from the National Natural Science Foundation of China (No. 30771986) and Beijing Natural Science Foundation (No. 7112022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Abou Jamra R, 2007, AM J HUM GENET, V81, P974, DOI 10.1086/521690; Al-Kateb H, 2002, CIRC RES, V90, P951, DOI 10.1161/01.RES.0000018002.43041.08; Berger M, 2005, BLOOD, V105, P638, DOI 10.1182/blood-2004-05-2018; Bhatnagar D, 2006, ANN CLIN BIOCHEM, V43, P441, DOI 10.1258/000456306778904641; Ciccarese M, 2000, AM J HUM GENET, V66, P453, DOI 10.1086/302753; Coon H, 2000, ARTERIOSCL THROM VAS, V20, P2275, DOI 10.1161/01.ATV.20.10.2275; Eden ER, 2001, AM J HUM GENET, V68, P653, DOI 10.1086/318795; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Furuyama S, 2009, J ATHEROSCLER THROMB, V16, P194, DOI 10.5551/jat.E380; GOLDSTEIN JL, 1973, J CLIN INVEST, V52, P1544, DOI 10.1172/JCI107332; INNERARITY TL, 1987, P NATL ACAD SCI USA, V84, P6919, DOI 10.1073/pnas.84.19.6919; Kennedy MA, 2005, CELL METAB, V1, P121, DOI 10.1016/j.cmet.2005.01.002; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Medeiros AM, 2010, ATHEROSCLEROSIS, V212, P553, DOI 10.1016/j.atherosclerosis.2010.07.012; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; Robles-Osorio L, 2006, ARCH MED RES, V37, P102, DOI 10.1016/j.arcmed.2005.04.018; Soutar AK, 2007, NAT CLIN PRACT CARD, V4, P214, DOI 10.1038/ncpcardio0836; Strauch K, 2003, HUM HERED, V56, P200, DOI 10.1159/000076394; Strauch K, 2003, HUM HERED, V55, P202, DOI 10.1159/000073204; Vaughan AM, 2006, J LIPID RES, V47, P2433, DOI 10.1194/jlr.M600218-JLR200; Wang L, 2009, NUTR METAB CARDIOVAS, V19, P391, DOI 10.1016/j.numecd.2008.07.011; WILLIAMS RR, 1993, AM J CARDIOL, V72, P171, DOI 10.1016/0002-9149(93)90155-6	26	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e24838	10.1371/journal.pone.0024838	http://dx.doi.org/10.1371/journal.pone.0024838			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022364	Green Published, Green Submitted, gold			2022-12-27	WOS:000295981600003
J	El Ayadi, A; Zigmond, MJ				El Ayadi, Amina; Zigmond, Michael J.			Low Concentrations of Methamphetamine Can Protect Dopaminergic Cells against a Larger Oxidative Stress Injury: Mechanistic Study	PLOS ONE			English	Article							SIGNAL-REGULATED KINASE; PARKINSONS-DISEASE; NEUROTROPHIC FACTOR; RAT-BRAIN; IN-VITRO; NEURODEGENERATIVE DISEASES; 6-HYDROXYDOPAMINE LESIONS; PRECONDITIONING PROTECTS; EXTRACELLULAR DOPAMINE; ACTIVATED RECEPTOR-1	Mild stress can protect against a larger insult, a phenomenon termed preconditioning or tolerance. To determine if a low intensity stressor could also protect cells against intense oxidative stress in a model of dopamine deficiency associated with Parkinson disease, we used methamphetamine to provide a mild, preconditioning stress, 6-hydroxydopamine (6-OHDA) as a source of potentially toxic oxidative stress, and MN9D cells as a model of dopamine neurons. We observed that prior exposure to subtoxic concentrations of methamphetamine protected these cells against 6-OHDA toxicity, whereas higher concentrations of methamphetamine exacerbated it. The protection by methamphetamine was accompanied by decreased uptake of both [H-3] dopamine and 6-OHDA into the cells, which may have accounted for some of the apparent protection. However, a number of other effects of methamphetamine exposure suggest that the drug also affected basic cellular survival mechanisms. First, although methamphetamine preconditioning decreased basal pERK1/2 and pAkt levels, it enhanced the 6-OHDA-induced increase in these phosphokinases. Second, the apparent increase in pERK1/2 activity was accompanied by increased pMEK1/2 levels and decreased activity of protein phosphatase 2. Third, methamphetamine upregulated the pro-survival protein Bcl-2. Our results suggest that exposure to low concentrations of methamphetamine cause a number of changes in dopamine cells, some of which result in a decrease in their vulnerability to subsequent oxidative stress. These observations may provide insights into the development of new therapies for prevention or treatment of PD.	[El Ayadi, Amina; Zigmond, Michael J.] Univ Pittsburgh, Pittsburgh Inst Neurodegenerat Dis, Pittsburgh, PA 15260 USA; [El Ayadi, Amina] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; University of Texas Medical Branch Galveston	El Ayadi, A (corresponding author), Univ Pittsburgh, Pittsburgh Inst Neurodegenerat Dis, Pittsburgh, PA 15260 USA.	amelayad@utmb.edu; zigmond@pitt.edu		El Ayadi, Amina/0000-0002-3657-0633	National Institute of Neurological Disorders and Stroke "NINDS'' [NS19608]; US Department of Army [DAMD 17-03-047]; Levi Montalcini/International Brain Research Organization (IBRO); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS019608, P01NS019608, R01NS070825] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke "NINDS''(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); US Department of Army; Levi Montalcini/International Brain Research Organization (IBRO); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute of Neurological Disorders and Stroke "NINDS'' (NS19608), the US Department of Army grant (DAMD 17-03-047) and the Levi Montalcini/International Brain Research Organization (IBRO) fellowship for AE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abekawa T, 1997, BRAIN RES, V767, P34, DOI 10.1016/S0006-8993(97)00542-8; Ajimaporn A, 2008, BRAIN RES BULL, V77, P361, DOI 10.1016/j.brainresbull.2008.09.006; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Alexi T, 2000, PROG NEUROBIOL, V60, P409, DOI 10.1016/S0301-0082(99)00032-5; Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624; Begum N, 1996, J BIOL CHEM, V271, P31166, DOI 10.1074/jbc.271.49.31166; Behl C, 1999, PROG NEUROBIOL, V57, P301, DOI 10.1016/S0301-0082(98)00055-0; Belcheva MM, 2002, NEUROSIGNALS, V11, P34, DOI 10.1159/000057320; Berman SB, 1996, J NEUROCHEM, V67, P593; Bezard E, 2003, J NEUROSCI, V23, P10999; Cadet JL, 2007, NEUROTOX RES, V11, P183, DOI 10.1007/BF03033567; Cadet JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007812; Cadet JL, 1997, SYNAPSE, V25, P176; Cannon JR, 2006, BRAIN RES, V1116, P177, DOI 10.1016/j.brainres.2006.07.094; Cannon JR, 2005, NEUROSCI LETT, V373, P189, DOI 10.1016/j.neulet.2004.10.089; Carvalho F, 2001, ADDICT BIOL, V6, P213, DOI 10.1080/13556210120056544; CHAN PH, 1995, J NEUROTRAUM, V12, P815, DOI 10.1089/neu.1995.12.815; CHOI HK, 1992, P NATL ACAD SCI USA, V89, P8943, DOI 10.1073/pnas.89.19.8943; Crossthwaite AJ, 2002, J NEUROCHEM, V80, P24, DOI 10.1046/j.0022-3042.2001.00637.x; Danaceau JP, 2007, EUR J PHARMACOL, V559, P46, DOI 10.1016/j.ejphar.2006.11.045; De Miglio MR, 2002, CANCER RES, V62, P4459; Defazio G, 1996, BRAIN RES BULL, V40, P257, DOI 10.1016/0361-9230(96)00041-X; Ding YM, 2004, J NEUROCHEM, V89, P776, DOI 10.1111/j.1471-4159.2004.02415.x; Dirnagl U, 2003, TRENDS NEUROSCI, V26, P248, DOI 10.1016/S0166-2236(03)00071-7; Dobrossy MD, 2003, EXP NEUROL, V184, P274, DOI 10.1016/S0014-4886(03)00028-1; Donovan FM, 1998, J BIOL CHEM, V273, P12746, DOI 10.1074/jbc.273.21.12746; Ebert AD, 2005, EXP NEUROL, V191, pS80, DOI 10.1016/j.expneurol.2004.08.024; El Ayadi A, 2001, METAB BRAIN DIS, V16, P121; Faherty CJ, 2005, MOL BRAIN RES, V134, P170, DOI 10.1016/j.molbrainres.2004.08.008; Feng H, 2004, ONCOGENE, V23, P7310, DOI 10.1038/sj.onc.1208041; Fleckenstein AE, 1997, J PHARMACOL EXP THER, V282, P834; Graham DL, 2008, J NEUROCHEM, V105, P1873, DOI 10.1111/j.1471-4159.2008.05269.x; Greenamyre JT, 2004, SCIENCE, V304, P1120, DOI 10.1126/science.1098966; Guilarte TR, 2001, NEUROTOXICOLOGY, V22, P725, DOI 10.1016/S0161-813X(01)00046-8; Hanson GR, 1998, ANN NY ACAD SCI, V844, P103, DOI 10.1111/j.1749-6632.1998.tb08225.x; Haq SEA, 1998, FEBS LETT, V434, P305, DOI 10.1016/S0014-5793(98)01000-X; Hausenloy DJ, 2006, CARDIOVASC RES, V70, P240, DOI 10.1016/j.cardiores.2006.01.017; Hausenloy DJ, 2005, AM J PHYSIOL-HEART C, V288, pH971, DOI 10.1152/ajpheart.00374.2004; Hoshida S, 2002, CARDIOVASC RES, V55, P495, DOI 10.1016/S0008-6363(02)00337-1; Imam SZ, 2002, ANN NY ACAD SCI, V965, P204; Johnson-Davis KL, 2004, J PHARMACOL EXP THER, V309, P578, DOI 10.1124/jpet.103.062695; Johnson-Davis KL, 2003, EUR J PHARMACOL, V482, P151, DOI 10.1016/j.ejphar.2003.09.063; Kita T, 2003, J PHARMACOL SCI, V92, P178; Kokoshka JM, 1998, BRAIN RES, V799, P78, DOI 10.1016/S0006-8993(98)00472-7; Kulich SM, 2001, J NEUROCHEM, V77, P1058, DOI 10.1046/j.1471-4159.2001.00304.x; Kweon GR, 2004, J BIOL CHEM, V279, P51783, DOI 10.1074/jbc.M407336200; Leak RK, 2008, J NEUROCHEM, V106, P860, DOI 10.1111/j.1471-4159.2008.05459.x; Leak RK, 2006, J NEUROCHEM, V99, P1151, DOI 10.1111/j.1471-4159.2006.04149.x; Lebuffe G, 2003, AM J PHYSIOL-HEART C, V284, pH299, DOI 10.1152/ajpheart.00706.2002; Lee EJ, 2010, J IMMUNOL, V185, P615, DOI 10.4049/jimmunol.0903480; Lee SM, 2009, J CEREBR BLOOD F MET, V29, P1589, DOI 10.1038/jcbfm.2009.81; Li RCX, 2000, AM J PHYSIOL-HEART C, V279, pH1679, DOI 10.1152/ajpheart.2000.279.4.H1679; Lin AN, 2002, AGING CELL, V1, P112, DOI 10.1046/j.1474-9728.2002.00014.x; Lin E, 2008, J NEUROSCI RES, V86, P108, DOI 10.1002/jnr.21478; Linsenbardt AJ, 2009, NEUROTOXICOLOGY, V30, P1030, DOI 10.1016/j.neuro.2009.07.006; Liu JW, 2006, BRAIN RES, V1098, P113, DOI 10.1016/j.brainres.2006.04.086; Lotharius J, 2001, ANN NEUROL, V49, P79, DOI 10.1002/1531-8249(200101)49:1<79::AID-ANA11>3.0.CO;2-D; Luo W, 2007, BRAIN RES REV, V56, P331, DOI 10.1016/j.brainresrev.2007.08.002; Marini M, 1996, INT J RADIAT BIOL, V70, P337, DOI 10.1080/095530096145076; Matsuzaki H, 2004, BIOL PSYCHIAT, V55, P52, DOI 10.1016/S0006-3223(03)00785-6; Mattson Mark P, 2004, NeuroRx, V1, P111, DOI 10.1007/BF03206571; Miyazaki I, 2006, FASEB J, V20, P571, DOI 10.1096/fj.05-4996fje; Mocanu MM, 2002, J MOL CELL CARDIOL, V34, P661, DOI 10.1006/jmcc.2002.2006; Mockridge JW, 2000, AM J PHYSIOL-HEART C, V279, pH492, DOI 10.1152/ajpheart.2000.279.2.H492; Moroz IA, 2004, EXP NEUROL, V189, P78, DOI 10.1016/j.expneurol.2004.05.012; Oh YJ, 1995, NEUROBIOL DIS, V2, P157, DOI 10.1006/nbdi.1995.0017; Olanow CW, 2007, MOVEMENT DISORD, V22, pS335, DOI 10.1002/mds.21675; Park KM, 2002, J BIOL CHEM, V277, P2040, DOI 10.1074/jbc.M107525200; Park SU, 2002, J NEUROSCI, V22, P4399, DOI 10.1523/JNEUROSCI.22-11-04399.2002; Peng J, 2003, IUBMB LIFE, V55, P267, DOI 10.1080/1521654031000121666; Perez RG, 2002, J NEUROSCI, V22, P3090, DOI 10.1523/JNEUROSCI.22-08-03090.2002; Pike CJ, 1996, J NEUROCHEM, V66, P1374; Ravati A, 2001, J NEUROCHEM, V78, P909, DOI 10.1046/j.1471-4159.2001.00463.x; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Ruffels J, 2004, EUR J PHARMACOL, V483, P163, DOI 10.1016/j.ejphar.2003.10.032; Saporito MS, 2002, PROGR MED CHEM, V40, P23, DOI 10.1016/S0079-6468(08)70081-X; Sato M, 2000, AM J PHYSIOL-HEART C, V279, pH901, DOI 10.1152/ajpheart.2000.279.3.H901; Shankaran M, 1998, PHARMACOL BIOCHEM BE, V61, P361, DOI 10.1016/S0091-3057(98)00103-8; Simola N, 2007, NEUROTOX RES, V11, P151, DOI 10.1007/BF03033565; Smith AD, 2002, NEUROPSYCHOPHARMACOL, V26, P756, DOI 10.1016/S0893-133X(01)00420-1; Smith KJ, 2007, BRAIN RES, V1157, P74, DOI 10.1016/j.brainres.2007.04.056; Sokolova E, 2008, THROMB HAEMOSTASIS, V100, P576, DOI 10.1160/TH08-03-0131; Sommer C, 2008, J NEUROPATH EXP NEUR, V67, P85, DOI 10.1097/nen.0b013e3181630ba6; Stanciu M, 2002, J BIOL CHEM, V277, P4010, DOI 10.1074/jbc.M104479200; Stowe DF, 2004, ANTIOXID REDOX SIGN, V6, P439, DOI 10.1089/152308604322899512; Sukhodub A, 2007, J CELL PHYSIOL, V210, P224, DOI 10.1002/jcp.20862; Tai KK, 2002, J NEUROSCI RES, V69, P559, DOI 10.1002/jnr.10309; Tang XQ, 2005, BRAIN RES, V1057, P57, DOI 10.1016/j.brainres.2005.07.072; Tillerson JL, 2001, J NEUROSCI, V21, P4427, DOI 10.1523/JNEUROSCI.21-12-04427.2001; Tong HY, 2000, CIRC RES, V87, P309, DOI 10.1161/01.RES.87.4.309; Tsang A, 2005, DIABETES, V54, P2360, DOI 10.2337/diabetes.54.8.2360; Ugarte SD, 2003, J NEUROSCI RES, V73, P105, DOI 10.1002/jnr.10632; Veit C, 2004, CANCER RES, V64, P5291, DOI 10.1158/0008-5472.CAN-04-1112; WALL SC, 1995, MOL PHARMACOL, V47, P544; Warren MW, 2007, INT J NEUROPSYCHOPH, V10, P479, DOI 10.1017/S1461145706007061; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yamamoto Bryan K., 2005, Critical Reviews in Neurobiology, V17, P87; Yu ZF, 1999, J NEUROSCI RES, V57, P830, DOI 10.1002/(SICI)1097-4547(19990915)57:6&lt;830::AID-JNR8&gt;3.0.CO;2-2; Zhang QG, 2009, NEUROSCI RES, V63, P205, DOI 10.1016/j.neures.2008.12.010; Zhang Y, 2000, NEUROBIOL DIS, V7, P240, DOI 10.1006/nbdi.2000.0319; Zhao ZQ, 2003, AM J PHYSIOL-HEART C, V285, pH579, DOI 10.1152/ajpheart.01064.2002; ZIGMOND MJ, 1997, 6 HYDROXYDOPAMINE TO, P75; Zuo ZY, 2006, EUR J PHARMACOL, V542, P84, DOI 10.1016/j.ejphar.2006.05.027	103	20	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e24722	10.1371/journal.pone.0024722	http://dx.doi.org/10.1371/journal.pone.0024722			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022363	Green Accepted, Green Published, gold			2022-12-27	WOS:000295976000005
J	Henderson, BR; Saeedi, BJ; Campagnola, G; Geiss, BJ				Henderson, Brittney R.; Saeedi, Bejan J.; Campagnola, Grace; Geiss, Brian J.			Analysis of RNA Binding by the Dengue Virus NS5 RNA Capping Enzyme	PLOS ONE			English	Article							TYPE-2 NONSTRUCTURAL PROTEIN-3; MESSENGER-RNA; NTPASE ACTIVITY; CAP STRUCTURE; METHYLTRANSFERASE; HELICASE; 5'-TRIPHOSPHATASE; IDENTIFICATION; METHYLATIONS; RECOGNITION	Flaviviruses are small, capped positive sense RNA viruses that replicate in the cytoplasm of infected cells. Dengue virus and other related flaviviruses have evolved RNA capping enzymes to form the viral RNA cap structure that protects the viral genome and directs efficient viral polyprotein translation. The N-terminal domain of NS5 possesses the methyltransferase and guanylyltransferase activities necessary for forming mature RNA cap structures. The mechanism for flavivirus guanylyltransferase activity is currently unknown, and how the capping enzyme binds its diphosphorylated RNA substrate is important for deciphering how the flavivirus guanylyltransferase functions. In this report we examine how flavivirus NS5 N-terminal capping enzymes bind to the 5' end of the viral RNA using a fluorescence polarization-based RNA binding assay. We observed that the K-D for RNA binding is approximately 200 nM Dengue, Yellow Fever, and West Nile virus capping enzymes. Removal of one or both of the 5' phosphates reduces binding affinity, indicating that the terminal phosphates contribute significantly to binding. RNA binding affinity is negatively affected by the presence of GTP or ATP and positively affected by S-adensyl methoninine (SAM). Structural superpositioning of the dengue virus capping enzyme with the Vaccinia virus VP39 protein bound to RNA suggests how the flavivirus capping enzyme may bind RNA, and mutagenesis analysis of residues in the putative RNA binding site demonstrate that several basic residues are critical for RNA binding. Several mutants show differential binding to 5' di-, mono-, and un-phosphorylated RNAs. The mode of RNA binding appears similar to that found with other methyltransferase enzymes, and a discussion of diphosphorylated RNA binding is presented.	[Henderson, Brittney R.; Saeedi, Bejan J.; Geiss, Brian J.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Campagnola, Grace; Geiss, Brian J.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University	Henderson, BR (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	Brian.Geiss@colostate.edu	Geiss, Brian/J-3021-2017	Geiss, Brian/0000-0001-8180-5772; Saeedi, Bejan/0000-0001-8356-5960	Rocky Mountain Regional Center for Excellence 10 [U54 AI-065357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065357] Funding Source: NIH RePORTER	Rocky Mountain Regional Center for Excellence 10; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported by a grant from the Rocky Mountain Regional Center for Excellence 10 (U54 AI-065357) to BJG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartelma G, 2002, VIROLOGY, V299, P122, DOI 10.1006/viro.2002.1504; Benarroch D, 2004, VIROLOGY, V328, P208, DOI 10.1016/j.virol.2004.07.004; Bisaillon M, 1997, VIROLOGY, V236, P1, DOI 10.1006/viro.1997.8698; CONG PJ, 1995, MOL CELL BIOL, V15, P6222; Dong HP, 2008, J VIROL, V82, P4295, DOI 10.1128/JVI.02202-07; Dong HP, 2007, J VIROL, V81, P4412, DOI 10.1128/JVI.02455-06; Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757; Geiss BJ, 2009, J MOL BIOL, V385, P1643, DOI 10.1016/j.jmb.2008.11.058; Hodel AE, 1998, MOL CELL, V1, P443, DOI 10.1016/S1097-2765(00)80044-1; Issur M, 2009, RNA, V15, P2340, DOI 10.1261/rna.1609709; KOONIN EV, 1993, J GEN VIROL, V74, P733, DOI 10.1099/0022-1317-74-4-733; Kuo MD, 1996, J GEN VIROL, V77, P2077, DOI 10.1099/0022-1317-77-9-2077; Lij J, 2008, J VIROL, V82, P775, DOI 10.1128/JVI.02107-07; MARTIN RL, 1991, ARCH BIOCHEM BIOPHYS, V284, P26, DOI 10.1016/0003-9861(91)90257-J; Milani M, 2009, ANTIVIR RES, V83, P28, DOI 10.1016/j.antiviral.2009.03.001; Ogino T, 2008, J VIROL, V82, P7729, DOI 10.1128/JVI.00326-08; PRITCHARD CE, 1994, NUCLEIC ACIDS RES, V22, P2592, DOI 10.1093/nar/22.13.2592; Qiu T, 2003, VIROLOGY, V316, P313, DOI 10.1016/j.virol.2003.08.027; Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06; Sippl MJ, 2008, BIOINFORMATICS, V24, P870, DOI 10.1093/bioinformatics/btn020; Sippl MJ, 2008, BIOINFORMATICS, V24, P426, DOI 10.1093/bioinformatics/btm622; Suaya JA, 2009, AM J TROP MED HYG, V80, P846, DOI 10.4269/ajtmh.2009.80.846; WARRENER P, 1993, J VIROL, V67, P989, DOI 10.1128/JVI.67.2.989-996.1993; Wu JH, 2005, J VIROL, V79, P10268, DOI 10.1128/JVI.79.16.10268-10277.2005; Xu T, 2005, J VIROL, V79, P10278, DOI 10.1128/JVI.79.16.10278-10288.2005; Yap LJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012836; Yon C, 2005, J BIOL CHEM, V280, P27412, DOI 10.1074/jbc.M501393200; Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06	28	19	20	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25795	10.1371/journal.pone.0025795	http://dx.doi.org/10.1371/journal.pone.0025795			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022449	Green Submitted, Green Published, gold			2022-12-27	WOS:000295976000039
J	Muroi, A; Ramadan, A; Nishihara, M; Yamamoto, M; Ozawa, R; Takabayashi, J; Arimura, G				Muroi, Atsushi; Ramadan, Abdelaziz; Nishihara, Masahiro; Yamamoto, Masaki; Ozawa, Rika; Takabayashi, Junji; Arimura, Gen-ichiro			The Composite Effect of Transgenic Plant Volatiles for Acquired Immunity to Herbivory Caused by Inter-Plant Communications	PLOS ONE			English	Article							LIMA-BEAN LEAVES; AIRBORNE SIGNALS; INDUCED RESISTANCE; PREDATORY MITE; DEFENSE GENES; RESPONSES; DAMAGE; ARABIDOPSIS; SAGEBRUSH; EMISSION	A blend of volatile organic compounds (VOCs) emitted from plants induced by herbivory enables the priming of defensive responses in neighboring plants. These effects may provide insights useful for pest control achieved with transgenic-plant-emitted volatiles. We therefore investigated, under both laboratory and greenhouse conditions, the priming of defense responses in plants (lima bean and corn) by exposing them to transgenic-plant-volatiles (VOCos) including (E)-beta-ocimene, emitted from transgenic tobacco plants (NtOS2) that were constitutively overexpressing (E)-beta-ocimene synthase. When lima bean plants that had previously been placed downwind of NtOS2 in an open-flow tunnel were infested by spider mites, they were more defensive to spider mites and more attractive to predatory mites, in comparison to the infested plants that had been placed downwind of wild-type tobacco plants. This was similarly observed when the NtOS2-downwind maize plants were infested with Mythimna separata larvae, resulting in reduced larval growth and greater attraction of parasitic wasps (Cotesia kariyai). In a greenhouse experiment, we also found that lima bean plants (VOCos-receiver plants) placed near NtOS2 were more attractive when damaged by spider mites, in comparison to the infested plants that had been placed near the wild-type plants. More intriguingly, VOCs emitted from infested VOCos-receiver plants affected their conspecific neighboring plants to prime indirect defenses in response to herbivory. Altogether, these data suggest that transgenic-plant- emitted volatiles can enhance the ability to prime indirect defenses via both plant-plant and plant-plant-plant communications.	[Muroi, Atsushi; Ramadan, Abdelaziz; Arimura, Gen-ichiro] Kyoto Univ, Global COE Program Evolut & Biodivers, Grad Sch Sci, Kyoto, Japan; [Muroi, Atsushi; Ramadan, Abdelaziz; Yamamoto, Masaki; Ozawa, Rika; Takabayashi, Junji; Arimura, Gen-ichiro] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga, Japan; [Ramadan, Abdelaziz] Ain Shams Univ, Fac Sci, Dept Bot, Cairo, Egypt; [Nishihara, Masahiro] Iwate Biotechnol Res Ctr, Kitakami, Iwate, Japan	Kyoto University; Kyoto University; Egyptian Knowledge Bank (EKB); Ain Shams University; Iwate Biotechnology Research Center	Muroi, A (corresponding author), Ehime Univ, Cell Free Sci & Technol Res Ctr, Matsuyama, Ehime, Japan.	garimura@ecology.kyoto-u.ac.jp	Takabayashi, Junji/G-2212-2010	Takabayashi, Junji/0000-0002-3575-9952; Nishihara, Masahiro/0000-0002-1454-8785; Ramadan, Abdelaziz/0000-0003-4794-5602	Global COE Program Kyoto University [A06]; Research Institute for Sustainable Humanosphere, Kyoto University; Grants-in-Aid for Scientific Research [19101009] Funding Source: KAKEN	Global COE Program Kyoto University; Research Institute for Sustainable Humanosphere, Kyoto University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was financially supported in part by the Global COE Program A06 of Kyoto University, and by a research grant for Exploratory Research on Sustainable Humanosphere Science from the Research Institute for Sustainable Humanosphere, Kyoto University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura G, 2000, NATURE, V406, P512, DOI 10.1038/35020072; Arimura G, 2004, PLANT PHYSIOL, V135, P1976, DOI 10.1104/pp.104.042929; Arimura GI, 2008, PLANT PHYSIOL, V146, P965, DOI 10.1104/pp.107.111088; Arimura G, 2010, PHYTOCHEMISTRY, V71, P1642, DOI 10.1016/j.phytochem.2010.06.021; Asai N, 2009, PLANT SIGNAL BEHAV, V4, P294, DOI 10.4161/psb.4.4.8275; BALDWIN IT, 1983, SCIENCE, V221, P277, DOI 10.1126/science.221.4607.277; BRUIN J, 1995, TRENDS ECOL EVOL, V10, P167, DOI 10.1016/S0169-5347(00)89033-3; Choh Y, 2006, J CHEM ECOL, V32, P2073, DOI 10.1007/s10886-006-9130-z; De Boer JG, 2004, J CHEM ECOL, V30, P2215, DOI 10.1023/B:JOEC.0000048784.79031.5e; De Boer JG, 2004, J CHEM ECOL, V30, P255, DOI 10.1023/B:JOEC.0000017976.60630.8c; Engelberth J, 2004, P NATL ACAD SCI USA, V101, P1781, DOI 10.1073/pnas.0308037100; Frost CJ, 2008, NEW PHYTOL, V180, P722, DOI 10.1111/j.1469-8137.2008.02599.x; Frost CJ, 2007, ECOL LETT, V10, P490, DOI 10.1111/j.1461-0248.2007.01043.x; Godard KA, 2008, PHYTOCHEMISTRY, V69, P1838, DOI 10.1016/j.phytochem.2008.02.011; Heil M, 2008, J CHEM ECOL, V34, P601, DOI 10.1007/s10886-008-9464-9; Heil M, 2007, P NATL ACAD SCI USA, V104, P5467, DOI 10.1073/pnas.0610266104; Heil M, 2006, ECOL LETT, V9, P813, DOI 10.1111/j.1461-0248.2006.00932.x; Heil M, 2010, BIOL LETTERS, V6, P843, DOI 10.1098/rsbl.2010.0440; Heil M, 2010, TRENDS ECOL EVOL, V25, P137, DOI 10.1016/j.tree.2009.09.010; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Kappers IF, 2005, SCIENCE, V309, P2070, DOI 10.1126/science.1116232; Karban R, 2000, OECOLOGIA, V125, P66, DOI 10.1007/PL00008892; Karban R, 2006, ECOLOGY, V87, P922, DOI 10.1890/0012-9658(2006)87[922:DRISVA]2.0.CO;2; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; Karban R, 2008, ECOL LETT, V11, P727, DOI 10.1111/j.1461-0248.2008.01183.x; Karban R, 2009, ECOL LETT, V12, P502, DOI 10.1111/j.1461-0248.2009.01313.x; Kessler A, 2006, OECOLOGIA, V148, P280, DOI 10.1007/s00442-006-0365-8; Kost C, 2006, J ECOL, V94, P619, DOI 10.1111/j.1365-2745.2006.01120.x; Mishiba K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009670; Paschold A, 2006, PLANT J, V45, P275, DOI 10.1111/j.1365-313X.2005.02623.x; TAKABAYASHI J, 1992, ENTOMOL EXP APPL, V64, P187, DOI 10.1111/j.1570-7458.1992.tb01608.x; Ton J, 2007, PLANT J, V49, P16, DOI 10.1111/j.1365-313X.2006.02935.x	32	40	44	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e24594	10.1371/journal.pone.0024594	http://dx.doi.org/10.1371/journal.pone.0024594			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022359	Green Submitted, Green Published, gold			2022-12-27	WOS:000295976000003
J	Thang, ND; Yajima, I; Kumasaka, MY; Ohnuma, S; Yanagishita, T; Hayashi, R; Shekhar, HU; Watanabe, D; Kato, M				Nguyen Dinh Thang; Yajima, Ichiro; Kumasaka, Mayuko Y.; Ohnuma, Shoko; Yanagishita, Takeshi; Hayashi, Rumiko; Shekhar, Hossain U.; Watanabe, Daisuke; Kato, Masashi			Barium Promotes Anchorage-Independent Growth and Invasion of Human HaCaT Keratinocytes via Activation of c-SRC Kinase	PLOS ONE			English	Article							TUBE-WELL WATER; MESENCHYMAL TRANSITION; DRINKING-WATER; TRACE-ELEMENTS; CANCER CELLS; EXPRESSION; MATRIX; RET; CONTAMINATION; BANGLADESH	Explosive increases in skin cancers have been reported in more than 36 million patients with arsenicosis caused by drinking arsenic-polluted well water. This study and previous studies showed high levels of barium as well as arsenic in the well water. However, there have been no reports showing a correlation between barium and cancer. In this study, we examined whether barium (BaCl(2)) may independently have cancer-related effects on human precancerous keratinocytes (HaCaT). Barium (5-50 mu M) biologically promoted anchorage-independent growth and invasion of HaCaT cells in vitro. Barium (5 mu M) biochemically enhanced activities of c-SRC, FAK, ERK and MT1-MMP molecules, which regulate anchorage-independent growth and/or invasion. A SRC kinase specific inhibitor, protein phosphatase 2 (PP2), blocked barium-mediated promotion of anchorage-independent growth and invasion with decreased c-SRC kinase activity. Barium (2.5-5 mu M) also promoted anchorage-independent growth and invasion of fibroblasts (NIH3T3) and immortalized nontumorigenic melanocytes (melan-a), but not transformed cutaneous squamous cell carcinoma (HSC5 and A431) and malignant melanoma (Mel-ret) cells, with activation of c-SRC kinase. Taken together, our biological and biochemical findings newly suggest that the levels of barium shown in drinking well water independently has the cancer-promoting effects on precancerous keratinocytes, fibroblast and melanocytes in vitro.	[Nguyen Dinh Thang; Yajima, Ichiro; Kumasaka, Mayuko Y.; Shekhar, Hossain U.; Kato, Masashi] Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Units Environm Hlth Sci, Kasugai, Aichi 487, Japan; [Nguyen Dinh Thang; Yanagishita, Takeshi; Watanabe, Daisuke] Aichi Med Univ, Dept Dermatol, Sch Med, Nagakute, Aichi 48011, Japan; [Ohnuma, Shoko; Kato, Masashi] Chubu Univ, Voluntary Body Int Hlth Care, Kasugai, Aichi 487, Japan; [Hayashi, Rumiko] Aichi Prefectural Inst Publ Hlth, Nagoya, Aichi 462, Japan	Chubu University; Aichi Medical University; Chubu University	Thang, ND (corresponding author), Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Units Environm Hlth Sci, Kasugai, Aichi 487, Japan.	katomasa@isc.chubu.ac.jp	KATO, Masashi/I-7250-2014; Watanabe, Daisuke/AAG-2962-2021; YAJIMA, Ichiro/I-7467-2014	Shekhar, Hossain/0000-0002-8960-0840; Watanabe, Daisuke/0000-0001-6817-3993	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [19390168, 20406003, 23650241, S0801055]; Japan Society for the Promotion of Science (JSPS); Lydia O'Leary Memorial Foundation; Tokyo Biochemical Research Foundation (TBRF); Mitsui Co., Ltd. [R08-C097]	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Lydia O'Leary Memorial Foundation; Tokyo Biochemical Research Foundation (TBRF); Mitsui Co., Ltd.(Mitsui & Co., LTD.)	This work was supported in part by Grants-in-Aid for Scientific Research (B)(No. 19390168, 20406003), Grant-in-Aid for Challenging Exploratory Research (No. 23650241) and COE Project for Private Universities (Health Science Hills) (S0801055) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan Society for the Promotion of Science (JSPS) Asia Africa Science Platform Program, Lydia O'Leary Memorial Foundation, Research Grant from the Tokyo Biochemical Research Foundation (TBRF) and Mitsui & Co., Ltd. Environment Fund (R08-C097). The authors also declare that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusa T, 2006, ENVIRON POLLUT, V139, P95, DOI 10.1016/j.envpol.2005.04.033; Avizienyte E, 2005, CURR OPIN CELL BIOL, V17, P542, DOI 10.1016/j.ceb.2005.08.007; Berg M, 2007, SCI TOTAL ENVIRON, V372, P413, DOI 10.1016/j.scitotenv.2006.09.010; Bertotti A, 2006, J CELL BIOL, V175, P993, DOI 10.1083/jcb.200605114; Biswas BK, 1998, CURR SCI INDIA, V74, P134; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Calay D, 2010, J INVEST DERMATOL, V130, P1136, DOI 10.1038/jid.2009.415; Chanpiwat P, 2011, ENVIRON POLLUT, V159, P567, DOI 10.1016/j.envpol.2010.10.007; Chowdhury UK, 2000, ENVIRON HEALTH PERSP, V108, P393, DOI 10.2307/3454378; DIETZ DD, 1992, FUND APPL TOXICOL, V19, P527, DOI 10.1016/0272-0590(92)90091-U; Elias MC, 2005, NEOPLASIA, V7, P824, DOI 10.1593/neo.04352; Frisbie SH, 2009, ENVIRON HEALTH PERSP, V117, P410, DOI 10.1289/ehp.11886; Hsia DA, 2003, J CELL BIOL, V160, P753, DOI 10.1083/jcb.200212114; Kang J, 2008, INT J MOL MED, V21, P777; Kato M, 2003, P NATL ACAD SCI USA, V100, P6398, DOI 10.1073/pnas.1132162100; Kato M., 2010, Toxicological and Environmental Chemistry, V92, P1609, DOI 10.1080/02772241003707454; Kato M, 2002, CANCER RES, V62, P2414; Kato M, 1999, ONCOGENE, V18, P837, DOI 10.1038/sj.onc.1202329; KATO M, 2011, CANC EPIDEM IN PRESS; Kato M, 2008, J TOXICOL ENV HEAL A, V71, P1053, DOI 10.1080/15287390802114998; Kato M, 2011, TOXICOL IN VITRO, V25, P623, DOI 10.1016/j.tiv.2010.12.012; Kato M, 2010, J CELL BIOCHEM, V110, P399, DOI 10.1002/jcb.22550; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Kurokawa M, 2001, ARCH DERMATOL, V137, P102; LAKSHMI SC, 2007, AM J PHYSIOL-CELL PH, V292, P1701; Li ZG, 2008, P NATL ACAD SCI USA, V105, P162, DOI 10.1073/pnas.0710905105; Nagaharu K, 2011, AM J PATHOL, V178, P754, DOI 10.1016/j.ajpath.2010.10.015; Nakashima I, 2002, ANTIOXID REDOX SIGN, V4, P517, DOI 10.1089/15230860260196326; National Toxicology Program, 1994, Natl Toxicol Program Tech Rep Ser, V432, P1; NISHIOKA H, 1975, MUTAT RES, V31, P185, DOI 10.1016/0165-1161(75)90088-6; Ohshima Y, 2010, J DERMATOL SCI, V57, P140, DOI 10.1016/j.jdermsci.2009.11.004; PERRY HM, 1983, TRACE SUBST ENV HLTH, V16, P155; Pu MY, 1996, ONCOGENE, V13, P2615; Seo MR, 2007, J BIOL CHEM, V282, P24720, DOI 10.1074/jbc.M702343200; Seomun Y, 2008, J CELL BIOCHEM, V104, P934, DOI 10.1002/jcb.21675; SMITH AH, 1992, ENVIRON HEALTH PERSP, V97, P259, DOI 10.2307/3431362; Smola-Hess S, 2005, J GEN VIROL, V86, P1291, DOI 10.1099/vir.0.80551-0; Takino T, 2010, BIOCHEM BIOPH RES CO, V396, P1042, DOI 10.1016/j.bbrc.2010.05.059; TANIGUCHI M, 1992, ONCOGENE, V7, P1491; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Yajima I, 2009, J DERMATOL SCI, V55, P68, DOI 10.1016/j.jdermsci.2009.02.010	41	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25636	10.1371/journal.pone.0025636	http://dx.doi.org/10.1371/journal.pone.0025636			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022425	Green Published, Green Submitted, gold			2022-12-27	WOS:000295976000027
J	Stieler, K; Schindler, S; Schlomm, T; Hohn, O; Bannert, N; Simon, R; Minner, S; Schindler, M; Fischer, N				Stieler, Kristin; Schindler, Sarah; Schlomm, Thorsten; Hohn, Oliver; Bannert, Norbert; Simon, Ronald; Minner, Sarah; Schindler, Michael; Fischer, Nicole			No Detection of XMRV in Blood Samples and Tissue Sections from Prostate Cancer Patients in Northern Europe	PLOS ONE			English	Article							VIRUS-RELATED VIRUS; CHRONIC-FATIGUE-SYNDROME; INFECTIOUS RETROVIRUS; PREVALENCE; EPITHELIUM; ABSENCE; PCR	Background: We recently published the rare detection of xenotropic murine leukemia virus-related virus (XMRV) (1/105) in prostate cancer (PCA) tissue of patients in Northern Europe by PCR. The controversial discussion about the virus being detected in PCA tissue, blood samples from patients suffering from chronic fatigue syndrome (CFS), as well as from a significant number of healthy controls prompted us to deepen our studies about detection of XMRV infection applying different detection methods (PCR, cocultivation and immunohistochemistry [IHC]). Methodology/Principal Findings: Peripheral bloodmononuclear cells (PBMCs) from 92 PCA and 7 healthy controls were isolated, PHA activated and cocultivated with LNCaP cells for up to 8 weeks. Supernatant of these cells was applied to a reporter cell line, DERSE-iGFP. Furthermore, the PBMCs and cocultivated LNCaP cells were tested for the presence of XMRV by PCR as well as Western Blot analysis. While all PCR amplifications and Western Blot analyses were negative for signs of XMRV infection, DERSE-iGFP cells displayed isolated GFP positive cells in three cases. In all three cases XMRV presence could not be confirmed by PCR technology. In addition, we performed XMRV specific IHC on PCA tissue sections. Whole tissue sections (n = 20), as well as tissuemicroarrays (TMA) including 50 benign prostate hyperplasia (BPH), 50 low grade and 50 high grade PCA sections and TMAs including breast cancer, colon cancer and normal tissues were stained with two XMRV specific antisera. XMRV protein expression was not detected in any cancer sections included. One BPH tissue displayed XMRV specific protein expression in random isolated basal cells. Conclusion: We were unable to conclusively detect XMRV in the blood from PCA patients or from healthy controls and there is no conclusive evidence of XMRV protein expression in PCA, breast cancer and colon cancer tissue sections tested by IHC staining.	[Stieler, Kristin; Schindler, Sarah; Fischer, Nicole] Univ Med Ctr Hamburg Eppendorf, Inst Med Microbiol & Virol, Hamburg, Germany; [Schindler, Sarah; Schindler, Michael] Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany; [Schlomm, Thorsten] Univ Med Ctr Hamburg Eppendorf, Martini Clin, Prostate Canc Ctr, Hamburg, Germany; [Hohn, Oliver; Bannert, Norbert] Ctr HIV & Retrovirol, Robert Koch Inst, Berlin, Germany; [Simon, Ronald; Minner, Sarah] Univ Med Ctr Hamburg Eppendorf, Inst Pathol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Heinrich Pette Institute; University of Hamburg; University Medical Center Hamburg-Eppendorf; Robert Koch Institute; University of Hamburg; University Medical Center Hamburg-Eppendorf	Stieler, K (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Med Microbiol & Virol, Hamburg, Germany.	nfischer@uke.de	Schlomm, Thorsten/G-8046-2011; Schindler, Michael/C-1647-2015	Schindler, Michael/0000-0001-8989-5813; Simon, Ronald/0000-0003-0158-4258				Alberts B, 2011, SCIENCE, V333, P35, DOI 10.1126/science.333.6038.35-a; Aloia AL, 2010, CANCER RES, V70, P10028, DOI 10.1158/0008-5472.CAN-10-2837; Arnold RS, 2010, UROLOGY, V75, P755, DOI 10.1016/j.urology.2010.01.038; Baraniuk JN, 2010, CURR ALLERGY ASTHM R, V10, P210, DOI 10.1007/s11882-010-0106-2; Chaipan C, 2011, J VIROL, V85, P4888, DOI 10.1128/JVI.00046-11; Cohen J, 2011, SCIENCE, V331, P1253, DOI 10.1126/science.331.6022.1253; Danielson BP, 2010, J INFECT DIS, V202, P1470, DOI 10.1086/656146; Dong B, 2007, P NATL ACAD SCI USA, V104, P1655, DOI 10.1073/pnas.0610291104; Erlwein O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023484; Erlwein O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017592; Erlwein O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008519; Fischera N, 2008, J CLIN VIROL, V43, P277, DOI 10.1016/j.jcv.2008.04.016; Furuta RA, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-20; Garson JA, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-13; Groom HCT, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-10; Groom HC, 2010, P NATL ACAD SCI US; Hohn O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015632; Hohn O, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-92; Knox K, 2011, SCIENCE, V333, P94, DOI 10.1126/science.1204963; Lo SC, 2010, P NATL ACAD SCI USA, V107, P15874, DOI 10.1073/pnas.1006901107; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Menendez-Arias L, 2011, REV MED VIROL, V21, P3, DOI 10.1002/rmv.673; Oakes B, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-109; Paprotka T, 2011, SCIENCE, V333, P97, DOI 10.1126/science.1205292; Paprotka T, 2010, J VIROL, V84, P5719, DOI 10.1128/JVI.00134-10; Robinson MJ, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-108; Rodriguez JJ, 2010, J VIROL, V84, P2556, DOI 10.1128/JVI.01969-09; Sakuma T, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-23; Sato E, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-110; Sauter D, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-103; Schlaberg R, 2009, P NATL ACAD SCI USA, V106, P16351, DOI 10.1073/pnas.0906922106; Shin CH, 2011, J VIROL; Simon R, 2004, BIOTECHNIQUES, V36, P98, DOI 10.2144/04361RV01; Smith RA, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-112; Stieler K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011738; Stieler KSC, 2010, VIROLOGY; Switzer WM, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-57; Switzer WM, 2011, PLOS ONE, P6; Trottier G, 2010, EUR UROL, V57, P358, DOI 10.1016/j.eururo.2009.11.021; Tuke PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019953; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; van Kuppeveld FJM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1018; Verhaegh GW, 2011, PROSTATE, V71, P415, DOI 10.1002/pros.21255	43	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25592	10.1371/journal.pone.0025592	http://dx.doi.org/10.1371/journal.pone.0025592			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022417	Green Published, Green Submitted, gold			2022-12-27	WOS:000295976000023
J	Huang, HJ; Angelo, LS; Rodon, J; Sun, M; Kuenkele, KP; Parsons, HA; Trent, JC; Kurzrock, R				Huang, Helen J.; Angelo, Laura S.; Rodon, Jordi; Sun, Michael; Kuenkele, Klaus-Peter; Parsons, Henrique A.; Trent, Jonathan C.; Kurzrock, Razelle			R1507, an Anti-Insulin-Like Growth Factor-1 Receptor (IGF-1R) Antibody, and EWS/FLI-1 siRNA in Ewing's Sarcoma: Convergence at the IGF/IGFR/Akt Axis	PLOS ONE			English	Article							NEUROECTODERMAL-TUMOR; SITU HYBRIDIZATION; LUNG-CANCER; CELL-LINE; INSULIN-LIKE-GROWTH-FACTOR-2; TRANSLOCATION; INHIBITORS; M6P/IGF2R; RATIONALE; EWS-FLI1	A subset of patients with Ewing's sarcoma responds to anti-insulin-like growth factor-1 receptor (IGF-1R) antibodies. Mechanisms of sensitivity and resistance are unknown. We investigated whether an anti-IGF-1R antibody acts via a pathway that could also be suppressed by small interfering (si) RNA against the EWS/FLI-1 fusion protein, the hallmark of Ewing's sarcoma. The growth of two Ewing's sarcoma cell lines (TC-32 and TC-71) was inhibited by the fully human anti-IGF-1R antibody, R1507 (clonogenic and MTT assays). TC-32 and TC-71 cells express high levels of IGF-2, while RD-ES and A4573 Ewing's cell lines, which were less responsive to R1507 in our assays, express low or undetectable IGF-2, respectively. TC-71 cells also expressed high levels of IGF-1R, and R1507 decreased steady-state levels of this receptor by internalization/degradation, an effect which was associated with a decrease in p-IGF-1R, p-IRS-1, and p-Akt. EWS/FLI-1 siRNA also decreased p-Akt, due to its ability to increase IGF-BP3 levels and subsequently decrease IGF-1 and IGF-2 levels, thus inhibiting signaling through p-IGF-1R. This inhibition correlated with growth suppression and apoptosis. The attenuation of Akt activation was confirmed in TC-71 and HEK-293 (human embryonic kidney) cells by transfecting them with IGF-1R siRNA. We conclude that antibodies and siRNA to IGF-1R, as well as siRNA to EWS/FLI-1, act via intersecting IGF/IGF-1R signals that suppress a common point in this pathway, namely the phosphorylation of Akt.	[Huang, Helen J.; Angelo, Laura S.; Rodon, Jordi; Sun, Michael; Parsons, Henrique A.; Kurzrock, Razelle] Univ Texas MD Anderson Canc Ctr, Phase Program 1, Dept Invest Canc Therapeut, Houston, TX 77030 USA; [Rodon, Jordi] Hosp Univ Vall dHebron, Vall dHebron Inst Oncol, Med Oncol Serv, Barcelona, Spain; [Kuenkele, Klaus-Peter] Roche Diagnost GmbH, Penzberg, Germany; [Trent, Jonathan C.] Univ Texas MD Anderson Canc Ctr, Dept Sarcoma Med Oncol, Div Canc Med, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO); Roche Holding; University of Texas System; UTMD Anderson Cancer Center	Huang, HJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Phase Program 1, Dept Invest Canc Therapeut, Houston, TX 77030 USA.	rkurzroc@mdanderson.org	Trent, Jonathan/AAR-7113-2021; Kurzrock, Razelle/AAU-9782-2020	Trent, Jonathan/0000-0001-6169-5238; Afonseca Parsons, Henrique/0000-0002-0436-4368	National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research [RR024148]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER	National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by grant number RR024148 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research (http://www.ncrr.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beltran PJ, 2011, J PHARMACOL EXP THER, V337, P644, DOI 10.1124/jpet.110.178400; Bernstein M, 2006, ONCOLOGIST, V11, P503, DOI 10.1634/theoncologist.11-5-503; Buck E, 2010, MOL CANCER THER, V9, P2652, DOI 10.1158/1535-7163.MCT-10-0318; Burchill SA, 2008, EXPERT REV ANTICANC, V8, P1675, DOI 10.1586/14737140.8.10.1675; Cao L, 2008, CANCER RES, V68, P8039, DOI 10.1158/0008-5472.CAN-08-1712; Chao W, 2008, CYTOKINE GROWTH F R, V19, P111, DOI 10.1016/j.cytogfr.2008.01.005; Chapuis N, 2009, HAEMATOLOGICA, V95, P415; Cironi L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002634; Erkizan HV, 2009, NAT MED, V15, P750, DOI 10.1038/nm.1983; Gong Y, 2009, PLOS ONE, V4, P1; Gonzalez I, 2007, J MOL MED, V85, P1015, DOI 10.1007/s00109-007-0202-5; Guix M, 2008, J CLIN INVEST, V118, P2609, DOI 10.1172/JCI34588; Hailey J, 2002, MOL CANCER THER, V1, P1349; Herrero-Martin D, 2009, BRIT J CANCER, V101, P80, DOI 10.1038/sj.bjc.6605104; Hu CK, 2006, PROSTATE CANCER P D, V9, P62, DOI 10.1038/sj.pcan.4500842; Huang F, 2009, CANCER RES, V69, P161, DOI 10.1158/0008-5472.CAN-08-0835; Hung G, 2002, INT J ONCOL, V20, P475; Jambhekar NA, 2006, ARCH PATHOL LAB MED, V130, P1813; Jamieson TA, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-4; Janknecht R, 2005, GENE, V363, P1, DOI 10.1016/j.gene.2005.08.007; Kolb EA, 2010, PEDIATR BLOOD CANCER, V55, P67, DOI 10.1002/pbc.22479; Kong FM, 2000, ONCOGENE, V19, P1572, DOI 10.1038/sj.onc.1203437; Kotsinas A, 2008, CANCER LETT, V259, P177, DOI 10.1016/j.canlet.2007.10.013; Kurzrock R, 2010, CLIN CANCER RES, V16, P2458, DOI 10.1158/1078-0432.CCR-09-3220; Le Deley MC, 2010, J CLIN ONCOL, V28, P1982, DOI 10.1200/JCO.2009.23.3585; Lee KW, 2005, J BIOL CHEM, V280, P16942, DOI 10.1074/jbc.M412757200; Maki RG, 2010, J CLIN ONCOL, V28, P4985, DOI 10.1200/JCO.2009.27.5040; Mateo-Lozano S, 2006, CLIN CANCER RES, V12, P6781, DOI 10.1158/1078-0432.CCR-06-0609; MAY WA, 1993, P NATL ACAD SCI USA, V90, P5752, DOI 10.1073/pnas.90.12.5752; Meric F, 2000, CLIN CANCER RES, V6, P3832; O'Sullivan MJ, 2001, HUM PATHOL, V32, P1109, DOI 10.1053/hupa.2001.28247; Olmos D, 2010, CANCER J, V16, P183, DOI 10.1097/PPO.0b013e3181dbebf9; Olmos D, 2010, LANCET ONCOL, V11, P129, DOI 10.1016/S1470-2045(09)70354-7; Parija T, 2005, J BIOSCIENCES, V30, P371, DOI 10.1007/BF02703674; Pavelic J, 2005, AM J RESP CELL MOL, V32, P65, DOI 10.1165/rcmb.2004-0232OC; Pavelic J, 2007, GYNECOL ONCOL, V105, P727, DOI 10.1016/j.ygyno.2007.02.012; Pavelic K, 2003, J PATHOL, V201, P430, DOI 10.1002/path.1465; Pavelic K, 2002, MOL MED, V8, P771, DOI 10.1007/BF03402082; Prieur A, 2004, MOL CELL BIOL, V24, P7275, DOI 10.1128/MCB.24.16.7275-7283.2004; Qian X, 2005, DIAGN MOL PATHOL, V14, P23, DOI 10.1097/01.pdm.0000140192.27878.97; Rikhof B, 2009, J PATHOL, V217, P469, DOI 10.1002/path.2499; Rodon J, 2008, MOL CANCER THER, V7, P2575, DOI 10.1158/1535-7163.MCT-08-0265; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Savage SA, 2007, CANCER EPIDEM BIOMAR, V16, P1667, DOI 10.1158/1055-9965.EPI-07-0214; Tolcher AW, 2009, J CLIN ONCOL, V27, P5800, DOI 10.1200/JCO.2009.23.6745; Toretsky JA, 1999, CANCER RES, V59, P5745; van Doorninck JA, 2010, J CLIN ONCOL, V28, P1989, DOI 10.1200/JCO.2009.24.5845; Wang Q, 2008, J CLIN INVEST, V118, P2389, DOI 10.1172/JCI36260; Yeh J, 2008, LUNG CANCER, V60, P166, DOI 10.1016/j.lungcan.2007.09.023	49	31	32	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e26060	10.1371/journal.pone.0026060	http://dx.doi.org/10.1371/journal.pone.0026060			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022506	Green Published, Green Submitted, gold			2022-12-27	WOS:000295973200028
J	Tyagi, A; Ahmed, F; Thakur, N; Sharma, A; Raghava, GPS; Kumar, M				Tyagi, Atul; Ahmed, Firoz; Thakur, Nishant; Sharma, Arun; Raghava, Gajendra P. S.; Kumar, Manoj			HIVsirDB: A Database of HIV Inhibiting siRNAs	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RNA INTERFERENCE; DESIGN; ESCAPE; SHRNA; REPLICATION; EXPRESSION; INFECTION; SEQUENCES; COVERAGE	Background: Human immunodeficiency virus (HIV) is responsible for millions of deaths every year. The current treatment involves the use of multiple antiretroviral agents that may harm patients due to their toxic nature. RNA interference (RNAi) is a potent candidate for the future treatment of HIV, uses short interfering RNA (siRNA/shRNA) for silencing HIV genes. In this study, attempts have been made to create a database HIVsirDB of siRNAs responsible for silencing HIV genes. Descriptions: HIVsirDB is a manually curated database of HIV inhibiting siRNAs that provides comprehensive information about each siRNA or shRNA. Information was collected and compiled from literature and public resources. This database contains around 750 siRNAs that includes 75 partially complementary siRNAs differing by one or more bases with the target sites and over 100 escape mutant sequences. HIVsirDB structure contains sixteen fields including siRNA sequence, HIV strain, targeted genome region, efficacy and conservation of target sequences. In order to facilitate user, many tools have been integrated in this database that includes; i) siRNAmap for mapping siRNAs on target sequence, ii) HIVsirblast for BLAST search against database, iii) siRNAalign for aligning siRNAs. Conclusion: HIVsirDB is a freely accessible database of siRNAs which can silence or degrade HIV genes. It covers 26 types of HIV strains and 28 cell types. This database will be very useful for developing models for predicting efficacy of HIV inhibiting siRNAs. In summary this is a useful resource for researchers working in the field of siRNA based HIV therapy. HIVsirDB database is accessible at http://crdd.osdd.net/raghava/hivsir/.	[Tyagi, Atul; Ahmed, Firoz; Thakur, Nishant; Sharma, Arun; Raghava, Gajendra P. S.; Kumar, Manoj] Inst Microbial Technol CSIR, Bioinformat Ctr, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Tyagi, A (corresponding author), Inst Microbial Technol CSIR, Bioinformat Ctr, Chandigarh, India.	manojk@imtech.res.in	Raghava, Gajendra P.S./AAA-2413-2022; Raghava, Gajendra/B-1717-2009; Ahmed, Firoz/AAR-6971-2021; Kumar, Manoj/G-1274-2010; Tyagi, Atul/AAK-5620-2020; Thakur, Nishant/L-7590-2016	Raghava, Gajendra P.S./0000-0002-8902-2876; Ahmed, Firoz/0000-0003-4702-5144; Kumar, Manoj/0000-0003-3769-052X; Sharma, Arun/0000-0003-3854-7944; Tyagi, Atul/0000-0001-9569-3273	Council of Scientific and Industrial Research (CSIR) India	Council of Scientific and Industrial Research (CSIR) India(Council of Scientific & Industrial Research (CSIR) - India)	Council of Scientific and Industrial Research (CSIR) India has provided the financial support as Institute of Microbial Technology is an estiblishment of CSIR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnor JS, 2009, ANTIVIR RES, V83, P156, DOI 10.1016/j.antiviral.2009.04.008; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Boden D, 2003, J VIROL, V77, P11531, DOI 10.1128/JVI.77.21.11531-11535.2003; Capodici J, 2002, J IMMUNOL, V169, P5196, DOI 10.4049/jimmunol.169.9.5196; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chalk AM, 2005, NUCLEIC ACIDS RES, V33, pD131, DOI 10.1093/nar/gki136; Chang LJ, 2005, GENE THER, V12, P1133, DOI 10.1038/sj.gt.3302509; Eekels JJM, 2011, ANTIVIR RES, V89, P43, DOI 10.1016/j.antiviral.2010.11.005; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; GALLO RC, 1983, SCIENCE, V220, P865, DOI 10.1126/science.6601823; Hajeri PB, 2009, DRUG DISCOV TODAY, V14, P851, DOI 10.1016/j.drudis.2009.06.001; Hel Z, 2006, TRENDS IMMUNOL, V27, P274, DOI 10.1016/j.it.2006.04.007; Huesken D, 2005, NAT BIOTECHNOL, V23, P995, DOI 10.1038/nbt1118; Jacque JM, 2002, NATURE, V418, P435, DOI 10.1038/nature00896; Kanzaki LIB, 2008, REV MED VIROL, V18, P5, DOI 10.1002/rmv.553; Konstantinova P, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-15; Lee NS, 2002, NAT BIOTECHNOL, V20, P500, DOI 10.1038/nbt0502-500; Lee SK, 2005, BLOOD, V106, P818, DOI 10.1182/blood-2004-10-3959; Mcintyre GJ, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-1; Mcintyre GJ, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-55; McQuisten KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007522; Montagnier L, 2010, VIROLOGY, V397, P248, DOI 10.1016/j.virol.2009.10.045; Naito Y, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-80; Novina CD, 2002, NAT MED, V8, P681, DOI 10.1038/nm725; Plantier JC, 2009, NAT MED, V15, P871, DOI 10.1038/nm.2016; Rambaut A, 2004, NAT REV GENET, V5, P52, DOI 10.1038/nrg1246; Ren YL, 2009, NUCLEIC ACIDS RES, V37, pD146, DOI 10.1093/nar/gkn817; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Robb ML, 2008, LANCET, V372, P1857, DOI 10.1016/S0140-6736(08)61593-7; Rossi JJ, 2006, BIOTECHNIQUES, V40, P25, DOI 10.2144/000112167; Sabariegos R, 2006, J VIROL, V80, P571, DOI 10.1128/JVI.80.2.571-577.2006; Singh SK, 2008, EXPERT OPIN BIOL TH, V8, P449, DOI [10.1517/14712598.8.4.449, 10.1517/14712598.8.4.449 ]; Tatt ID, 2001, AIDS, V15, pS59, DOI 10.1097/00002030-200100005-00009; ter Brake O, 2008, MOL THER, V16, P557, DOI 10.1038/sj.mt.6300382; ter Brake Olivier, 2005, J RNAi Gene Silencing, V1, P56; Truss M, 2005, NUCLEIC ACIDS RES, V33, pD108, DOI 10.1093/nar/gkil131; Westerhout EM, 2005, NUCLEIC ACIDS RES, V33, P796, DOI 10.1093/nar/gki220	37	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e25917	10.1371/journal.pone.0025917	http://dx.doi.org/10.1371/journal.pone.0025917			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022467	Green Published, Green Submitted, gold			2022-12-27	WOS:000295973200020
J	Xin, ZS; Han, W; Zhao, ZQ; Xia, Q; Yin, B; Yuan, JG; Peng, XZ				Xin, Zhongshuai; Han, Wei; Zhao, Zhiqiang; Xia, Qing; Yin, Bin; Yuan, Jiangang; Peng, Xiaozhong			PCBP2 Enhances the Antiviral Activity of IFN-alpha against HCV by Stabilizing the mRNA of STAT1 and STAT2	PLOS ONE			English	Article							3'-UNTRANSLATED REGION; COMPLEX; REPLICATION; PROTEIN; GENES	Interferon-alpha (IFN-alpha) is a natural choice for the treatment of hepatitis C, but half of the chronically infected individuals do not achieve sustained clearance of hepatitis C virus (HCV) during treatment with IFN-alpha alone. The virus can impair IFN-alpha signaling and cellular factors that have an effect on the viral life cycles. We found that the protein PCBP2 is down-regulated in HCV-replicon containing cells (R1b). However, the effects and mechanisms of PCBP2 on HCV are unclear. To determine the effect of PCBP2 on HCV, overexpression and knockdown of PCBP2 were performed in R1b cells. Interestingly, we found that PCBP2 can facilitate the antiviral activity of IFN-alpha against HCV, although the RNA level of HCV was unaffected by either the overexpression or absence of PCBP2 in R1b cells. RIP-qRT-PCR and RNA half-life further revealed that PCBP2 stabilizes the mRNA of STAT1 and STAT2 through binding the 3'Untranslated Region (UTR) of these two molecules, which are pivotal for the IFN-alpha anti-HCV effect. RNA pull-down assay confirmed that there were binding sites located in the C-rich tracts in the 3'UTR of their mRNAs. Stabilization of mRNA by PCBP2 leads to the increased protein expression of STAT1 and STAT2 and a consistent increase of phosphorylated STAT1 and STAT2. These effects, in turn, enhance the antiviral effect of IFN-alpha. These findings indicate that PCBP2 may play an important role in the IFN-alpha response against HCV and may benefit the HCV clinical therapy.	[Xin, Zhongshuai; Han, Wei; Zhao, Zhiqiang; Yin, Bin; Yuan, Jiangang; Peng, Xiaozhong] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100730, Peoples R China; [Xin, Zhongshuai; Han, Wei; Zhao, Zhiqiang; Yin, Bin; Yuan, Jiangang; Peng, Xiaozhong] Peking Union Med Coll, Beijing 100021, Peoples R China; [Xin, Zhongshuai] Natl Inst Food & Drug Control, Div Biochem & Gene Engn Med, Beijing, Peoples R China; [Xia, Qing] Natl Ctr Biomed Anal, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; National Institute of Food & Drug Control - China	Xin, ZS (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100730, Peoples R China.	yuanjiangang@pumc.edu.cn; pengxiaozhong@pumc.edu.cn			National 863 Program [2006AA020504]; National Natural Sciences Foundation of China [30825023, 30721063, 31071203]; 973 Program [2007CB946902, 2009CB825403, 2011CB504902]; National Project for Communicable Diseases Control [2008ZX10003-012]; Program for New Century Excellent Talents in University [NCET-07-0505]	National 863 Program(National High Technology Research and Development Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China); National Project for Communicable Diseases Control; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by funds from the National 863 Program 2006AA020504; National Natural Sciences Foundation of China, 30825023, 30721063 and 31071203; 973 Program 2007CB946902, 2009CB825403 and 2011CB504902; National Project for Communicable Diseases Control 2008ZX10003-012, and the Program for New Century Excellent Talents in University NCET-07-0505. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLYN S, 2008, VIROLOGY, V374, P280; AMAR T, 2004, J BIOL CHEM, V279, P49680; AMY BR, 2005, J VIROL, V79, P10126; ANGELA MD, 2005, VIROLOGY, V335, P72; ANNA ME, 2010, CELL, V140, P652; ARTUR K, 2009, PLOS PATHOG, V5, P1; Bartenschlager R, 2007, VIRUS RES, V127, P127, DOI 10.1016/j.virusres.2007.07.003; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; DEBJANI G, 2008, P NATL ACAD SCI USA, V105, P11673; Di Bisceglie AM, 2002, HEPATOLOGY, V36, pS121, DOI 10.1053/jhep.2002.36228; Du ZH, 2008, J BIOL CHEM, V283, P28757, DOI 10.1074/jbc.M803046200; Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082; Fontanes V, 2009, VIROLOGY, V394, P82, DOI 10.1016/j.virol.2009.08.012; Frese M, 2001, J GEN VIROL, V82, P723, DOI 10.1099/0022-1317-82-4-723; Fried Michael W., 2002, NEW ENGL J MED, V347, P975, DOI [10.1056/NEJMoa020047, DOI 10.1056/NEJMOA020047]; FUPING Y, 2009, NATURE IMMUNOL, V10, P1300; Gale M, 2005, NATURE, V436, P939, DOI 10.1038/nature04078; Gale M, 2003, HEPATOLOGY, V37, P975, DOI 10.1053/jhep.2003.50201; HIDEKI A, 2006, J BIOMED SCI, V13, P469; JACK DK, 2006, NAT PROTOC, V1, P302; Ji S. C., 2007, BLOOD, V110, P994; Ji XJ, 2007, MOL CELL BIOL, V27, P3290, DOI 10.1128/MCB.02289-05; JIAN K, 2003, MOL CELL BIO, V23, P1125; JIAN K, 2006, MOL CELL BIO, V26, P5603; KAMRAN G, 2009, IMMUNOL REV, V228, P273; KARLA JH, 2008, ANTIVIR RES, V77, P169; KENG HL, 2007, J HEPATOL, V46, P759; KRLSTER M, 2000, J HEPATOL, V33, P764; KYUNG SC, 2006, VIRUS RES, V115, P1; Lee PT, 2007, MOL BIOL CELL, V18, P5004, DOI 10.1091/mbc.E07-04-0384; Lindsay KL, 2001, HEPATOLOGY, V34, P395, DOI 10.1053/jhep.2001.26371; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Miao RD, 2008, J BIOSCIENCES, V33, P723, DOI 10.1007/s12038-008-0092-x; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; MORTIMER K, 2005, J HEPATOL, V43, P225; NOBUYUKI K, 2009, VIRUS RES, V146, P41; Pan TT, 2006, BIOCHEM BIOPH RES CO, V347, P683, DOI 10.1016/j.bbrc.2006.06.144; POLEN S, 2008, VIROLOGY, V378, P243; Rieder E, 2003, J GEN VIROL, V84, P2203, DOI 10.1099/vir.0.19013-0; ROLAND Z, 2008, BIOCHEM BIOPH RES CO, V366, P917; SHELLY AW, 2009, J BIOL CHEM, V284, P9039; SHELLY AW, 2003, MOL CELL BIO, V23, P7055; SHERRI LC, 2009, J VIROL, V83, P6717; Shirasaki T, 2010, J INFECT DIS, V202, P75, DOI 10.1086/653081; SHUETSU F, 2001, VIRUS RES, V73, P67; Watashi K, 2005, MOL CELL, V19, P111, DOI 10.1016/j.molcel.2005.05.014; WENYU L, 2005, GASTROENTEROLOGY, V128, P1034; Wu Jin-ming, 2005, Zhonghua Gan Zang Bing Za Zhi, V13, P702; Xu L, 2009, MOL PHARMACOL, V76, P872, DOI 10.1124/mol.109.057596; YEVGENY B, 2003, J VIROL METHODS, V107, P245; ZHIHUA D, 2007, RNA, V13, P1043	51	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e25419	10.1371/journal.pone.0025419	http://dx.doi.org/10.1371/journal.pone.0025419			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022391	Green Published, gold, Green Submitted			2022-12-27	WOS:000295973200007
J	Garza, AS; Khan, SH; Moure, CM; Edwards, DP; Kumar, R				Garza, Anna S.; Khan, Shagufta H.; Moure, Carmen M.; Edwards, Dean P.; Kumar, Raj			Binding-Folding Induced Regulation of AF1 Transactivation Domain of the Glucocorticoid Receptor by a Cofactor That Binds to Its DNA Binding Domain	PLOS ONE			English	Article							INTRINSICALLY UNSTRUCTURED PROTEINS; JUN DIMERIZATION PROTEIN-2; NUCLEAR HORMONE-RECEPTORS; PROGESTERONE-RECEPTOR; TRANSCRIPTIONAL ACTIVATION; ANDROGEN RECEPTOR; GENE ACTIVATION; DISORDER; COMPLEX; REGION	Intrinsically disordered (ID) regions of proteins commonly exist within transcription factors, including the N-terminal domain (NTD) of steroid hormone receptors (SHRs) that possesses a powerful activation function, AF1 region. The mechanisms by which SHRs pass signals from a steroid hormone to control gene expression remain a central unresolved problem. The role of N-terminal activation function AF1, which exists in an intrinsically disordered (ID) conformation, in this process is of immense importance. It is hypothesized that under physiological conditions, ID AF1 undergoes disorder/order transition via inter- and intra-molecular communications, which allows AF1 surfaces to interact with specific co-regulatory proteins, critical for the final outcome of target gene expression regulated by SHRs. However, the means by which AF1 acquires functionally folded conformations is not well understood. In this study, we tested whether binding of jun dimerization protein 2 (JDP2) within the DNA binding domain (DBD) of the glucocorticoid receptor (GR) leads to acquisition of functionally active structure in its AF1/NTD. Our results show that signals mediated from GR DBD:JDP2 interactions in a two domain GR fragment, consisting of the entire NTD and little beyond DBD, significantly increased secondary/tertiary structure formation in the NTD/AF1. This increased structure formation facilitated AF1's interaction with specific co-regulatory proteins and subsequent glucocorticoid response element-mediated AF1 promoter:reporter activity. These results support the hypothesis that inter- and intra-molecular signals give a functionally active structure(s) to the GR AF1, which is important for its transcriptional activity.	[Khan, Shagufta H.; Kumar, Raj] Commonwealth Med Coll, Dept Basic Sci, Scranton, PA USA; [Garza, Anna S.] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Moure, Carmen M.; Edwards, Dean P.] Baylor Coll Med, Dept Mol & Cellular Biol & Pathol, Houston, TX 77030 USA	Geisinger Commonwealth School of Medicine; University of Texas System; University of Texas Medical Branch Galveston; Baylor College of Medicine	Garza, AS (corresponding author), Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA.	rkumar@tcmedc.org			NIH NIDDK [R01DK058829]; NIH NCI [CA046938, DK049030]; NATIONAL CANCER INSTITUTE [R01CA046938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058829, R01DK049030] Funding Source: NIH RePORTER	NIH NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH NIDDK Grant R01DK058829 (to RK), and NIH NCI CA046938 and DK049030 (to DPE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almlof T, 1998, BIOCHEMISTRY-US, V37, P9586, DOI 10.1021/bi973029x; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Bai YL, 2003, MOL ENDOCRINOL, V17, P589, DOI 10.1210/me.2002-0351; Bain DL, 2000, J BIOL CHEM, V275, P7313, DOI 10.1074/jbc.275.10.7313; Baskakov IV, 1999, J BIOL CHEM, V274, P10693, DOI 10.1074/jbc.274.16.10693; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; Blazek E, 2003, ONCOGENE, V22, P2151, DOI 10.1038/sj.onc.1206312; Bledsoe RK, 2002, CELL, V110, P93, DOI 10.1016/S0092-8674(02)00817-6; BOCQUEL MT, 1989, NUCLEIC ACIDS RES, V17, P2581, DOI 10.1093/nar/17.7.2581; Chen H, 1997, J BIOL CHEM, V272, P25873, DOI 10.1074/jbc.272.41.25873; Copik AJ, 2006, MOL ENDOCRINOL, V20, P1218, DOI 10.1210/me.2005-0257; DANIELIAN PS, 1992, EMBO J, V11, P1025, DOI 10.1002/j.1460-2075.1992.tb05141.x; DIEKEN ES, 1992, MOL CELL BIOL, V12, P589, DOI 10.1128/MCB.12.2.589; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Engel KB, 2011, MOL CELL BIOL, V31, P3267, DOI 10.1128/MCB.05351-11; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Ford J, 1997, MOL ENDOCRINOL, V11, P1467, DOI 10.1210/me.11.10.1467; Garza AMS, 2010, MOL CELL BIOL, V30, P220, DOI 10.1128/MCB.00552-09; GIGUERE V, 1986, CELL, V46, P645, DOI 10.1016/0092-8674(86)90339-9; GODOWSKI PJ, 1987, NATURE, V325, P365, DOI 10.1038/325365a0; Han SJ, 2009, TRENDS ENDOCRIN MET, V20, P8, DOI 10.1016/j.tem.2008.10.001; Henriksson A, 1997, MOL CELL BIOL, V17, P3065, DOI 10.1128/MCB.17.6.3065; Hill KK, 2009, J BIOL CHEM, V284, P24415, DOI 10.1074/jbc.M109.003244; Hilser VJ, 2007, P NATL ACAD SCI USA, V104, P8311, DOI 10.1073/pnas.0700329104; HOLLENBERG SM, 1987, CELL, V49, P39, DOI 10.1016/0092-8674(87)90753-7; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Jin CY, 2002, MOL CELL BIOL, V22, P4815, DOI 10.1128/MCB.22.13.4815-4826.2002; Jin CY, 2001, FEBS LETT, V489, P34, DOI 10.1016/S0014-5793(00)02387-5; Khan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021939; Khan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019689; Kumar R, 1999, STEROIDS, V64, P310, DOI 10.1016/S0039-128X(99)00014-8; Kumar R, 1999, J BIOL CHEM, V274, P24737, DOI 10.1074/jbc.274.35.24737; Kumar R, 2003, MOL ENDOCRINOL, V17, P1, DOI 10.1210/me.2002-0258; Kumar R, 2005, J STEROID BIOCHEM, V94, P383, DOI 10.1016/j.jsbmb.2004.12.046; Kumar R, 2004, P NATL ACAD SCI USA, V101, P16425, DOI 10.1073/pnas.0407160101; Kumar R, 2004, ESSAYS BIOCHEM, V40, P27, DOI 10.1042/bse0400027; Kumar R, 2004, BIOCHEMISTRY-US, V43, P3008, DOI 10.1021/bi035934p; Kumar R, 2001, J BIOL CHEM, V276, P18146, DOI 10.1074/jbc.M100825200; LAVIGNE P, 1995, J MOL BIOL, V254, P505, DOI 10.1006/jmbi.1995.0634; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; MIESFELD R, 1987, SCIENCE, V236, P423, DOI 10.1126/science.3563519; NAGPAL S, 1993, EMBO J, V12, P2349, DOI 10.1002/j.1460-2075.1993.tb05889.x; NAZARETH LV, 1991, J BIOL CHEM, V266, P12976; OMALLEY B, 1990, MOL ENDOCRINOL, V4, P363, DOI 10.1210/mend-4-3-363; Reid J, 2002, J BIOL CHEM, V277, P20079, DOI 10.1074/jbc.M201003200; Roemer SC, 2006, MOL ENDOCRINOL, V20, P3042, DOI 10.1210/me.2005-0511; Rogatsky I, 2003, P NATL ACAD SCI USA, V100, P13845, DOI 10.1073/pnas.2336092100; SIMENTAL JA, 1991, J BIOL CHEM, V266, P510; Thompson EB, 2003, BIOCHEM BIOPH RES CO, V306, P1, DOI 10.1016/S0006-291X(03)00877-5; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wardell SE, 2005, MOL CELL BIOL, V25, P8792, DOI 10.1128/MCB.25.20.8792-8808.2005; Wardell SE, 2002, MOL CELL BIOL, V22, P5451, DOI 10.1128/MCB.22.15.5451-5466.2002; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; YAMAMOTO KR, 1985, ANNU REV GENET, V19, P209, DOI 10.1146/annurev.genet.19.1.209	59	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25875	10.1371/journal.pone.0025875	http://dx.doi.org/10.1371/journal.pone.0025875			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003412	Green Published, Green Submitted, gold			2022-12-27	WOS:000295970300035
J	Isagawa, T; Nagae, G; Shiraki, N; Fujita, T; Sato, N; Ishikawa, S; Kume, S; Aburatani, H				Isagawa, Takayuki; Nagae, Genta; Shiraki, Nobuaki; Fujita, Takanori; Sato, Noriko; Ishikawa, Shumpei; Kume, Shoen; Aburatani, Hiroyuki			DNA Methylation Profiling of Embryonic Stem Cell Differentiation into the Three Germ Layers	PLOS ONE			English	Article							HOMEOBOX GENE-CLUSTER; MODEL-BASED ANALYSIS; HUMAN GENOME; HISTONE H3; DEVELOPMENTAL REGULATORS; CHIP-CHIP; POLYCOMB; EXPRESSION; WIDE; PLURIPOTENT	Embryogenesis is tightly regulated by multiple levels of epigenetic regulation such as DNA methylation, histone modification, and chromatin remodeling. DNA methylation patterns are erased in primordial germ cells and in the interval immediately following fertilization. Subsequent developmental reprogramming occurs by de novo methylation and demethylation. Variance in DNA methylation patterns between different cell types is not well understood. Here, using methylated DNA immunoprecipitation and tiling array technology, we have comprehensively analyzed DNA methylation patterns at proximal promoter regions in mouse embryonic stem (ES) cells, ES cell-derived early germ layers (ectoderm, endoderm and mesoderm) and four adult tissues (brain, liver, skeletal muscle and sperm). Most of the methylated regions are methylated across all three germ layers and in the three adult somatic tissues. This commonly methylated gene set is enriched in germ cell-associated genes that are generally transcriptionally inactive in somatic cells. We also compared DNA methylation patterns by global mapping of histone H3 lysine 4/27 trimethylation, and found that gain of DNA methylation correlates with loss of histone H3 lysine 4 trimethylation. Our combined findings indicate that differentiation of ES cells into the three germ layers is accompanied by an increased number of commonly methylated DNA regions and that these tissue-specific alterations in methylation occur for only a small number of genes. DNA methylation at the proximal promoter regions of commonly methylated genes thus appears to be an irreversible mark which functions to fix somatic lineage by repressing the transcription of germ cell-specific genes.	[Isagawa, Takayuki; Nagae, Genta; Fujita, Takanori; Aburatani, Hiroyuki] Univ Tokyo, Genome Sci Div, Res Ctr Adv Sci & Technol, Tokyo, Japan; [Shiraki, Nobuaki; Kume, Shoen] Kumamoto Univ, Inst Mol Embryol & Genet, Div Stem Cell Biol, Kumamoto, Japan; [Sato, Noriko] Tokyo Metropolitan Inst Med Sci, Dept Allergy & Immunol, Tokyo 113, Japan; [Ishikawa, Shumpei] Univ Tokyo, Grad Sch Med, Dept Human Pathol, Tokyo, Japan	University of Tokyo; Kumamoto University; Tokyo Metropolitan Institute of Medical Science; University of Tokyo	Isagawa, T (corresponding author), Univ Tokyo, Genome Sci Div, Res Ctr Adv Sci & Technol, Tokyo, Japan.	haburata-tky@umin.ac.jp	Nagae, Genta/H-6579-2019; Nagae, Genta/AAN-1167-2021; Sato, Noriko/Y-7693-2019	Nagae, Genta/0000-0002-2929-7990; shiraki, nobuaki/0000-0001-6708-9976	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [20221009]; National Institute of Biomedical Innovation (NIBIO), Japan; Grants-in-Aid for Scientific Research [22659070] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation (NIBIO), Japan(National Institute of Biomedical Innovation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was mainly supported by a Grant-in-Aid for Scientific Research (S) 20221009 (H.A.) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, and the Program of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Brunner AL, 2009, GENOME RES, V19, P1044, DOI 10.1101/gr.088773.108; Cheng Y, 2007, MOL CELL BIOL, V27, P2582, DOI 10.1128/MCB.01722-06; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Eissenberg JC, 2007, NAT STRUCT MOL BIOL, V14, P344, DOI 10.1038/nsmb1217; Farthing CR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000116; Gottardo R, 2008, BIOMETRICS, V64, P468, DOI 10.1111/j.1541-0420.2007.00899.x; Gu GQ, 2004, DEVELOPMENT, V131, P165, DOI 10.1242/dev.00921; Hayashi H, 2007, HUM GENET, V120, P701, DOI 10.1007/s00439-006-0254-6; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hayashi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001738; Hemberger M, 2009, NAT REV MOL CELL BIO, V10, P526, DOI 10.1038/nrm2727; HUIZINGA JD, 1995, NATURE, V373, P347, DOI 10.1038/373347a0; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Kaneda A, 2004, CANCER SCI, V95, P58, DOI 10.1111/j.1349-7006.2004.tb03171.x; Kawaguchi M, 2008, J BIOL CHEM, V283, P12064, DOI 10.1074/jbc.M709648200; Korb M, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-7; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lee MG, 2007, CELL, V128, P877, DOI 10.1016/j.cell.2007.02.004; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; LESKOWITZ S, 1968, NATURE, V218, P479, DOI 10.1038/218479a0; Liu CL, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-19; MacLean JA, 2005, CELL, V120, P369, DOI 10.1016/j.cell.2004.12.022; MacLean JA, 2006, GENESIS, V44, P122, DOI 10.1002/gene.20193; Maitra A, 2005, NAT GENET, V37, P1099, DOI 10.1038/ng1631; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Modutlwa Nkaelang, 2009, Nucleic Acids Symp Ser (Oxf), P105, DOI 10.1093/nass/nrp053; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Morishita H, 2004, EUR J NEUROSCI, V20, P2843, DOI 10.1111/j.1460-9568.2004.03803.x; Oda M, 2006, GENE DEV, V20, P3382, DOI 10.1101/gad.1470906; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Otani J, 2009, EMBO REP, V10, P1235, DOI 10.1038/embor.2009.218; Pasini D, 2008, GENE DEV, V22, P1345, DOI 10.1101/gad.470008; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Shiraki A, 2009, OPT EXPRESS, V17, P16038, DOI 10.1364/OE.17.016038; Shiraki N, 2008, STEM CELLS, V26, P874, DOI 10.1634/stemcells.2007-0608; Shiraki N, 2009, BIOCHEM BIOPH RES CO, V381, P694, DOI 10.1016/j.bbrc.2009.02.120; Siegfried Z, 1999, NAT GENET, V22, P203, DOI 10.1038/9727; Smith ER, 2008, MOL CELL BIOL, V28, P1041, DOI 10.1128/MCB.01504-07; STEIN R, 1982, P NATL ACAD SCI-BIOL, V79, P3418, DOI 10.1073/pnas.79.11.3418; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tanay A, 2007, P NATL ACAD SCI USA, V104, P5521, DOI 10.1073/pnas.0609746104; Wang XX, 2006, GENOMICS, V88, P34, DOI 10.1016/j.ygeno.2006.02.007; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; YAGI K, CLIN CANC RES, V16, P21; Yamasaki Y, 2005, HUM MOL GENET, V14, P2511, DOI 10.1093/hmg/ddi255; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	54	35	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e26052	10.1371/journal.pone.0026052	http://dx.doi.org/10.1371/journal.pone.0026052			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22016810	Green Published, Green Submitted, gold			2022-12-27	WOS:000295970300054
J	Gutierrez, A; Arendt, BK; Tschumper, RC; Kay, NE; Zent, CS; Jelinek, DF				Gutierrez, Albert, Jr.; Arendt, Bonnie K.; Tschumper, Renee C.; Kay, Neil E.; Zent, Clive S.; Jelinek, Diane F.			Differentiation of Chronic Lymphocytic Leukemia B Cells into Immunoglobulin Secreting Cells Decreases LEF-1 Expression	PLOS ONE			English	Article							GENE-EXPRESSION; RECEPTOR AGONISTS; SIGNALING PATHWAY; ACTIVATION; OLIGODEOXYNUCLEOTIDES; OLIGONUCLEOTIDE; PROLIFERATION; PHENOTYPE; MECHANISM; APOPTOSIS	Lymphocyte enhancer binding factor 1 (LEF-1) plays a crucial role in B lineage development and is only expressed in B cell precursors as B cell differentiation into mature B and plasma cells silences its expression. Chronic lymphocytic leukemia (CLL) cells aberrantly express LEF-1 and its expression is required for cellular survival. We hypothesized that modification of the differentiation status of CLL cells would result in loss of LEF-1 expression and eliminate the survival advantage provided by its aberrant expression. In this study, we first established a methodology that induces CLL cells to differentiate into immunoglobulin (Ig) secreting cells (ISC) using the TLR9 agonist, CpG, together with cytokines (CpG/c). CpG/c stimulation resulted in dramatic CLL cell phenotypic and morphologic changes, expression of cytoplasmic Ig, and secretion of light chain restricted Ig. CpG/c stimulation also resulted in decreased CLL cell LEF-1 expression and increased Blimp-1 expression, which is crucial for plasma cell differentiation. Further, Wnt pathway activation and cellular survival were impaired in differentiated CLL cells compared to undifferentiated CLL cells. These data support the notion that CLL can differentiate into ISC and that this triggers decreased leukemic cell survival secondary to the down regulation of LEF-1 and decreased Wnt pathway activation.	[Gutierrez, Albert, Jr.; Arendt, Bonnie K.; Tschumper, Renee C.; Jelinek, Diane F.] Mayo Clin, Dept Immunol, Mayo Grad Sch, Coll Med, Rochester, MN 55905 USA; [Kay, Neil E.; Zent, Clive S.] Mayo Clin, Dept Internal Med, Mayo Grad Sch, Coll Med, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Gutierrez, A (corresponding author), Mayo Clin, Dept Immunol, Mayo Grad Sch, Coll Med, Rochester, MN 55905 USA.	jelinek.diane@mayo.edu			National Cancer Institute (NCI); National Institutes of Health [R01CA136591, R01CA95241, R01CA111953, F31CA142310]; NATIONAL CANCER INSTITUTE [R01CA095241, R01CA136591, R01CA111953, F31CA142310] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Cancer Institute (NCI), National Institutes of Health (R01CA136591 awarded to DFJ, R01CA95241 and R01CA111953 awarded to NEK, and F31CA142310 awarded to AG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CARLSSON M, 1988, LEUKEMIA, V2, P734; COSSMAN J, 1984, J CLIN INVEST, V73, P587, DOI 10.1172/JCI111247; Darce JR, 2007, J IMMUNOL, V178, P5612, DOI 10.4049/jimmunol.178.9.5612; Decker T, 2000, BLOOD, V95, P999, DOI 10.1182/blood.V95.3.999.003k10_999_1006; Dicker F, 2006, BLOOD, V108, P3152, DOI 10.1182/blood-2006-02-005322; FU SM, 1978, J EXP MED, V148, P1570, DOI 10.1084/jem.148.6.1570; Gandhirajan RK, 2010, NEOPLASIA, V12, P326, DOI 10.1593/neo.91972; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Gutierrez A, 2010, BLOOD, V116, P2975, DOI 10.1182/blood-2010-02-269878; Holtick U, 2011, EXPERT OPIN INV DRUG, V20, P361, DOI 10.1517/13543784.2011.553187; Huggins J, 2007, BLOOD, V109, P1611, DOI 10.1182/blood-2006-03-008441; Jahrsdorfer B, 2005, CLIN CANCER RES, V11, P1490, DOI 10.1158/1078-0432.CCR-04-1890; Jelinek DF, 2003, MOL CANCER RES, V1, P346; Klein U, 2001, J EXP MED, V194, P1625, DOI 10.1084/jem.194.11.1625; Liang XQ, 2010, BLOOD, V115, P5041, DOI 10.1182/blood-2009-03-213363; Longo PG, 2007, LEUKEMIA, V21, P110, DOI 10.1038/sj.leu.2404417; Lu DS, 2004, P NATL ACAD SCI USA, V101, P3118, DOI 10.1073/pnas.0308648100; Meyer T, 2008, EXPERT OPIN INV DRUG, V17, P1051, DOI [10.1517/13543784.17.7.1051, 10.1517/13543784.17.7.1051 ]; Nowak D, 2009, BLOOD, V113, P3655, DOI 10.1182/blood-2009-01-198911; Puissant A, 2010, CELL CYCLE, V9, P3470, DOI 10.4161/cc.9.17.13048; Put N, 2009, GENE CHROMOSOME CANC, V48, P843, DOI 10.1002/gcc.20691; Reya T, 2000, IMMUNITY, V13, P15, DOI 10.1016/S1074-7613(00)00004-2; Schnaiter A, 2010, ONCOTARGET, V1, P472; Sherborne AL, 2010, ONCOTARGET, V1, P367; Skokowa J, 2006, NAT MED, V12, P1191, DOI 10.1038/nm1484; Slager SL, 2011, BLOOD, V117, P1911, DOI 10.1182/blood-2010-09-308205; Spaner DE, 2007, LEUKEMIA, V21, P53, DOI 10.1038/sj.leu.2404456; Spaulding C, 2007, BLOOD, V110, P2650, DOI 10.1182/blood-2007-04-084202; TOTTERMAN TH, 1987, LEUKEMIA, V1, P667; TRAVIS A, 1991, GENE DEV, V5, P880, DOI 10.1101/gad.5.5.880; VEDANTHAM S, 1992, CANCER RES, V52, P1056; Wang B, 2011, STEM CELL REV REP, V7, P458, DOI 10.1007/s12015-010-9175-9; Westendorf JJ, 1996, LEUKEMIA, V10, P866; Zupo S, 2000, BLOOD, V95, P1199, DOI 10.1182/blood.V95.4.1199.004k21_1199_1206	34	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e26056	10.1371/journal.pone.0026056	http://dx.doi.org/10.1371/journal.pone.0026056			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998751	Green Submitted, Green Published, gold			2022-12-27	WOS:000295968700036
J	Cui, Y; Su, WY; Xing, J; Wang, YC; Wang, P; Chen, XY; Shen, ZY; Cao, H; Lu, YY; Fang, JY				Cui, Yun; Su, Wen-Yu; Xing, Jing; Wang, Ying-Chao; Wang, Ping; Chen, Xiao-Yu; Shen, Zhi-Yong; Cao, Hui; Lu, You-Yong; Fang, Jing-Yuan			MiR-29a Inhibits Cell Proliferation and Induces Cell Cycle Arrest through the Downregulation of p42.3 in Human Gastric Cancer	PLOS ONE			English	Article								As a newly identified and characterized gene, p42.3 is associated with cell proliferation and tumorigenicity. The expression of p42.3 is upregulated in human gastric cancer (GC), but its underlying mechanisms of action are not well understood. MicroRNAs (miRNAs) are known to play vital regulatory roles in many cellular processes. Here we utilized bioinformatics and experimental approaches to investigate the regulatory relationship between miRNAs and the p42.3 gene. We showed that miR-29a could repress p42.3 expression at both the mRNA and protein levels via directly binding to its 3'UTR. Furthermore, an inverse relationship was observed between miR-29a and p42.3 expression in gastric cancer cell lines and GC tissue samples, especially in cases where p42.3 was downregulated. Taken together, we have elucidated previously unrecognized roles of miR-29a and indicated that miR-29a may function, at least partially, by targeting the p42.3 gene in human GC.	[Cui, Yun; Su, Wen-Yu; Xing, Jing; Wang, Ying-Chao; Chen, Xiao-Yu; Fang, Jing-Yuan] Shanghai Jiao Tong Univ, Div Gastroenterol & Hepatol, Renji Hosp, Sch Med,Shanghai Inst Digest Dis, Shanghai 200030, Peoples R China; [Wang, Ping] Shanghai Jiao Tong Univ, GI Div, Peoples Hosp 9, Sch Med, Shanghai 200030, Peoples R China; [Shen, Zhi-Yong; Cao, Hui] Shanghai Jiao Tong Univ, GI Surg Div, Sch Med, Renji Hosp, Shanghai 200030, Peoples R China; [Lu, You-Yong] Peking Univ, Mol Oncol Lab, Beijing Inst Canc Res, Sch Oncol, Beijing 100871, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Peking University	Cui, Y (corresponding author), Shanghai Jiao Tong Univ, Div Gastroenterol & Hepatol, Renji Hosp, Sch Med,Shanghai Inst Digest Dis, Shanghai 200030, Peoples R China.	jingyuanfang@yahoo.com	wang, yingying/GRS-3058-2022		National Basic Research Program of China 973 program [2010CB5293]; National High Technology Research and Development Program of China (863 Program) [2006AA02A402]; National Natural Science Foundation [30830055]; Ministry of Public Health, China [200802094]	National Basic Research Program of China 973 program(National Basic Research Program of China); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Public Health, China	This work was supported by grants from the National Basic Research Program of China 973 program (2010CB5293, the National High Technology Research and Development Program of China (863 Program)(2006AA02A402, the National Natural Science Foundation of Key Program (No. 30830055) and the Ministry of Public Health, China (No. 200802094) to FJY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; Chawla G, 2011, INT REV CEL MOL BIO, V286, P1, DOI 10.1016/B978-0-12-385859-7.00001-X; Chiang YP, 2011, J GASTROINTEST SURG, V15, P63, DOI 10.1007/s11605-010-1367-8; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gavet O, 2010, DEV CELL, V18, P533, DOI 10.1016/j.devcel.2010.02.013; Golan A, 2010, CELL CYCLE, V13; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Han YC, 2010, J EXP MED, V207, P475, DOI 10.1084/jem.20090831; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; KONG L, 2010, ACTA DIABETOL; Kruger N J, 1994, Methods Mol Biol, V32, P9; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Megraw M, 2007, NUCLEIC ACIDS RES, V35, pD149, DOI 10.1093/nar/gkl904; Meng XZ, 2011, J GASTROEN HEPATOL, V26, P186, DOI 10.1111/j.1440-1746.2010.06317.x; Muniyappa MK, 2009, EUR J CANCER, V45, P3104, DOI 10.1016/j.ejca.2009.09.014; Mutallip M, 2011, INT J MOL MED, V27, P345, DOI 10.3892/ijmm.2010.589; Ohtani K, 2011, BASIC RES CARDIOL, V106, P5, DOI 10.1007/s00395-010-0139-7; Pandey AK, 2011, MOL CELL ENDOCRINOL, V332, P125, DOI 10.1016/j.mce.2010.10.004; Persson H, 2011, CANCER RES, V71, P78, DOI 10.1158/0008-5472.CAN-10-1869; Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922; Santanam U, 2010, P NATL ACAD SCI USA, V107, P12210, DOI 10.1073/pnas.1007186107; Shioya M, 2010, NEUROPATH APPL NEURO, V36, P320, DOI 10.1111/j.1365-2990.2010.01076.x; Song YX, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-1; Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Xu H, 2009, CANCER RES, V69, P6275, DOI 10.1158/0008-5472.CAN-08-4517; Xu X, 2007, ONCOGENE, V26, P7371, DOI 10.1038/sj.onc.1210538; Zimmerman AL, 2011, CANCER LETT, V300, P10, DOI 10.1016/j.canlet.2010.09.019	34	87	95	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25872	10.1371/journal.pone.0025872	http://dx.doi.org/10.1371/journal.pone.0025872			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998710	Green Submitted, Green Published, gold			2022-12-27	WOS:000295966900065
J	Heidary, F; Gharebaghi, R; Hitam, WHW; Naing, NN; Wan-Arfah, N; Shatriah, I				Heidary, Fatemah; Gharebaghi, Reza; Hitam, Wan Hazabbah Wan; Naing, Nyi Nyi; Wan-Arfah, Nadiah; Shatriah, Ismail			Central Corneal Thickness and Intraocular Pressure in Malay Children	PLOS ONE			English	Article							TONO-PEN; SPECULAR MICROSCOPE; NONCONTACT; CURVATURE; TONOMETER; JAPANESE; CHINESE; WHITE; AGE	Background: To determine the mean values for central corneal thickness (CCT) and intraocular pressure (IOP) and the relationship between these values, in healthy Malay children to serve as reference values in diagnosis and treatment. Design: A cross-sectional study. Methodology/Principal Findings: One hundred and eight eyes (54 subjects) of Malay children without diagnosis of ocular abnormality or disease meeting our inclusion and exclusion criteria were selected. The CCT and IOP were measured by specular microscopy and non-contact air-puff tonometry respectively, for analysis and comparison with the values obtained in previous studies. Mean CCT and IOP was found to be 530.87630.79 mm and 15.6563.05 mm Hg respectively. CCT was found not to vary with age. A positive relationship was found between CCT and IOP; specifically, with every 100-mm increase in CCT, IOP increased by 3.5 mm Hg. Conclusions/Significance: CCT and IOP are strongly related in healthy Malay children aged 8 to 16. The mean CCT of Malay children is lower than that of majority children of other ethnic groups, supporting the existence of CCT variation among different populations and that ethnicity should be a key consideration when applying CCT data to the general pediatric population.	[Heidary, Fatemah; Gharebaghi, Reza; Hitam, Wan Hazabbah Wan; Shatriah, Ismail] Univ Sains Malaysia, Sch Med Sci, Dept Ophthalmol, Kubang Kerian, Kelantan, Malaysia; [Naing, Nyi Nyi; Wan-Arfah, Nadiah] Univ Sains Malaysia, Sch Med Sci, Unit Biostat & Res Methodol, Kubang Kerian, Kelantan, Malaysia	Universiti Sains Malaysia; Universiti Sains Malaysia	Heidary, F (corresponding author), Univ Sains Malaysia, Sch Med Sci, Dept Ophthalmol, Kubang Kerian, Kelantan, Malaysia.	shatriah@kck.usm.my	Naing, Nyi Nyi/AAB-3851-2021; Nadiah, Wan Arfah/H-8553-2016; Shatriah, Ismail/D-3637-2016; Naing, Nyi Nyi/M-3455-2015; Wan Hitam, Wan Hazabbah/M-3262-2016; Wan-Arfah, Nadiah/AAZ-1317-2021	Nadiah, Wan Arfah/0000-0002-4265-442X; Shatriah, Ismail/0000-0002-4753-4814; Naing, Nyi Nyi/0000-0001-8308-5625; Heidary, A/Prof. Fatemeh/0000-0002-6558-6132; Wan Hitam, Wan Hazabbah/0000-0002-3737-1820				Aghaian E, 2004, OPHTHALMOLOGY, V111, P2211, DOI 10.1016/j.ophtha.2004.06.013; Bovelle R, 1999, ARCH OPHTHALMOL-CHIC, V117, P868; Coste R, 2008, J FR OPHTALMOL, V31, P273, DOI 10.1016/S0181-5512(08)74804-6; Dai E, 2006, J AAPOS, V10, P22, DOI 10.1016/j.jaapos.2005.12.007; Dohadwala AA, 1998, OPHTHALMOLOGY, V105, P1849, DOI 10.1016/S0161-6420(98)91029-6; Doughty MJ, 2002, OPHTHAL PHYSL OPT, V22, P491, DOI 10.1046/j.1475-1313.2002.00053.x; Foster PJ, 1998, OPHTHALMOLOGY, V105, P969, DOI 10.1016/S0161-6420(98)96021-3; Gharebaghi R, 2010, CLIN OPTOM, V2, P119, DOI 10.2147/OPTO.S15290; Haider KM, 2008, J PEDIAT OPHTH STRAB, V45, P227, DOI 10.3928/01913913-20080701-07; HANSEN FK, 1971, ACTA OPHTHALMOL, V49, P82; Heidary F, 2010, OPHTHALMOLOGY, V117, P1861, DOI 10.1016/j.ophtha.2010.05.024; Heidary F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003705; HERSE P, 1993, ACTA OPHTHALMOL, V71, P360; Hikoya A, 2009, JPN J OPHTHALMOL, V53, P7, DOI 10.1007/s10384-008-0619-6; Husni MA, 2004, THESIS U SAINS MALAY; Hussein MAW, 2004, AM J OPHTHALMOL, V138, P744, DOI 10.1016/j.ajo.2004.06.030; Kim HY, 2008, AM J OPHTHALMOL, V145, P228, DOI 10.1016/j.ajo.2007.09.030; Kohli Poonam G., 2010, Journal of Medical Engineering & Technology, V34, P1, DOI 10.3109/03091900903247919; Lee AJ, 2004, BRIT J OPHTHALMOL, V88, P5, DOI 10.1136/bjo.88.1.5; Lim L, 2009, INVEST OPHTH VIS SCI, V50, P121, DOI 10.1167/iovs.08-2352; Muir KW, 2006, J GLAUCOMA, V15, P520, DOI 10.1097/01.ijg.0000212284.78045.45; Muir KW, 2004, OPHTHALMOLOGY, V111, P2220, DOI 10.1016/j.ophtha.2004.06.020; Muller A, 2000, BRIT J OPHTHALMOL, V84, P692, DOI 10.1136/bjo.84.7.692; Naing NN, 2010, PRACTICAL GUIDE DETE; Nangia V, 2010, OPHTHALMOLOGY, V117, P705, DOI 10.1016/j.ophtha.2009.09.003; Oliveira C, 2006, J GLAUCOMA, V15, P190, DOI 10.1097/01.ijg.0000212220.42675.c5; Osmera J, 2009, Cesk Slov Oftalmol, V65, P19; Randleman JB, 2003, OPHTHALMOLOGY, V110, P267, DOI 10.1016/S0161-6420(02)01727-X; Recep OF, 2001, J CATARACT REFR SURG, V27, P1787, DOI 10.1016/S0886-3350(01)00900-2; Sahin A, 2008, J GLAUCOMA, V17, P57, DOI 10.1097/IJG.0b013e31806ab33e; Sauer A, 2011, J FR OPHTALMOL, V34, P238, DOI 10.1016/j.jfo.2011.01.010; Shih CY, 2004, ARCH OPHTHALMOL-CHIC, V122, P1270, DOI 10.1001/archopht.122.9.1270; Suzuki S, 2003, J CATARACT REFR SURG, V29, P1313, DOI 10.1016/S0886-3350(03)00123-8; Tong L, 2004, INVEST OPHTH VIS SCI, V45, P4004, DOI 10.1167/iovs.04-0121; Yildirim N, 2007, J PEDIAT OPHTH STRAB, V44, P216, DOI 10.3928/01913913-20070701-02; Yip JLY, 2007, BRIT J OPHTHALMOL, V91, P56, DOI 10.1136/bjo.2006.099549; Zheng YF, 2008, INVEST OPHTH VIS SCI, V49, P4303, DOI 10.1167/iovs.08-1934	37	14	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25208	10.1371/journal.pone.0025208	http://dx.doi.org/10.1371/journal.pone.0025208			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998644	Green Submitted, gold, Green Published			2022-12-27	WOS:000295966900015
J	Heining, E; Bhushan, R; Paarmann, P; Henis, YI; Knaus, P				Heining, Eva; Bhushan, Raghu; Paarmann, Pia; Henis, Yoav I.; Knaus, Petra			Spatial Segregation of BMP/Smad Signaling Affects Osteoblast Differentiation in C2C12 Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR OSTERIX; LARGE GENE LISTS; BONE-FORMATION; OSTEOGENIC DIFFERENTIATION; RECEPTOR ENDOCYTOSIS; MESENCHYMAL CELLS; CAUSES OSTEOPENIA; COMPLEX-FORMATION; SMAD ANCHOR; PROTEIN	Background: Bone morphogenetic proteins (BMPs) are involved in a plethora of cellular processes in embryonic development and adult tissue homeostasis. Signaling specificity is achieved by dynamic processes involving BMP receptor oligomerization and endocytosis. This allows for spatiotemporal control of Smad dependent and non-Smad pathways. In this study, we investigate the spatiotemporal regulation within the BMP-induced Smad transcriptional pathway. Methodology/Principal Findings: Here we discriminate between Smad signaling events that are dynamin-dependent (i.e., require an intact endocytic pathway) and dynamin-independent. Inhibition of dynamin-dependent endocytosis in fluorescence microscopy and fractionation studies revealed a delay in Smad1/5/8 phosphorylation and nuclear translocation after BMP-2 stimulation of C2C12 cells. Using whole genome microarray and qPCR analysis, we identified two classes of BMP-2 induced genes that are differentially affected by inhibition of endocytosis. Thus, BMP-2 induced gene expression of Id1, Id3, Dlx2 and Hey1 is endocytosis-dependent, whereas BMP-2 induced expression of Id2, Dlx3, Zbtb2 and Krt16 is endocytosis-independent. Furthermore, we demonstrate that short term inhibition of endocytosis interferes with osteoblast differentiation as measured by alkaline phosphatase (ALP) production and qPCR analysis of osteoblast marker gene expression. Conclusions/Significance: Our study demonstrates that dynamin-dependent endocytosis is crucial for the concise spatial activation of the BMP-2 induced signaling cascade. Inhibition of endocytic processes during BMP-2 stimulation leads to altered Smad1/5/8 signaling kinetics and results in differential target gene expression. We show that interfering with the BMP-2 induced transcriptional network by endocytosis inhibition results in an attenuation of osteoblast differentiation. This implies that selective sensitivity of gene expression to endocytosis provides an additional mechanism for the cell to respond to BMP in a context specific manner. Moreover, we suggest a novel Smad dependent signal cascade induced by BMP-2, which does not require endocytosis.	[Heining, Eva; Bhushan, Raghu; Paarmann, Pia; Knaus, Petra] Free Univ Berlin, Inst Chem & Biochem, D-1000 Berlin, Germany; [Henis, Yoav I.] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel	Free University of Berlin; Tel Aviv University	Heining, E (corresponding author), Free Univ Berlin, Inst Chem & Biochem, D-1000 Berlin, Germany.	knaus@chemie.fu-berlin.de		Henis, Yoav/0000-0002-1408-3877; Bhushan, Raghu/0000-0001-6960-6025	German-Israeli Foundation for Scientific Research and Development (GIF) [932-244.13/2006]	German-Israeli Foundation for Scientific Research and Development (GIF)(German-Israeli Foundation for Scientific Research and Development)	This work was supported by the German-Israeli Foundation for Scientific Research and Development (GIF, grant number 932-244.13/2006 to PK and YIH). EH is a member of the Berlin-Brandenburg School for Regenerative Therapies (GSC 203). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; Balint E, 2003, J CELL BIOCHEM, V89, P401, DOI 10.1002/jcb.10515; Bengtsson L, 2006, MOL BIOL CELL, V17, P1154, DOI 10.1091/mbc.E05-04-0356; Bragdon B, 2009, BIOPHYS J, V97, P1428, DOI 10.1016/j.bpj.2009.05.061; Chen YG, 2007, J BIOL CHEM, V282, P9688, DOI 10.1074/jbc.M611704200; Chen YG, 2009, CELL RES, V19, P58, DOI 10.1038/cr.2008.315; de Jong DS, 2004, J BONE MINER RES, V19, P947, DOI 10.1359/JBMR.040216; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Genetos DC, 2010, CELL TISSUE RES, V340, P81, DOI 10.1007/s00441-010-0929-0; Greenblatt MB, 2010, J CLIN INVEST, V120, P2457, DOI 10.1172/JCI42285; Hartung A, 2006, MOL CELL BIOL, V26, P7791, DOI 10.1128/MCB.00022-06; Hassan MQ, 2006, J BIOL CHEM, V281, P40515, DOI 10.1074/jbc.M604508200; Heymann JAW, 2009, J CELL SCI, V122, P3427, DOI 10.1242/jcs.051714; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jeon BN, 2009, J BIOL CHEM, V284, P17935, DOI 10.1074/jbc.M809559200; Karner E, 2009, J CELL PHYSIOL, V218, P323, DOI 10.1002/jcp.21605; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Kim YJ, 2006, GENE, V366, P145, DOI 10.1016/j.gene.2005.08.021; Kimura SH, 2002, GENES CELLS, V7, P869, DOI 10.1046/j.1365-2443.2002.00564.x; Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3; Kishigami S, 2005, CYTOKINE GROWTH F R, V16, P265, DOI 10.1016/j.cytogfr.2005.04.002; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Krause C, 2011, INT J BIOCHEM CELL B, V43, P478, DOI 10.1016/j.biocel.2011.01.007; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Lengner CJ, 2005, J BIOL CHEM, V280, P15872, DOI 10.1074/jbc.M411144200; Liu WG, 2001, J CELL BIOL, V155, P157, DOI 10.1083/jcb.200105052; Lu ZX, 2002, J BIOL CHEM, V277, P29363, DOI 10.1074/jbc.M203495200; Luan Y, 2008, MOL BIOL CELL, V19, P2113, DOI 10.1091/mbc.E07-10-1057; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mardaryev AN, 2010, FASEB J, V24, P3869, DOI 10.1096/fj.10-160663; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Merlo GR, 2000, INT J DEV BIOL, V44, P619; MIYAZONO K, 2002, SCI STKE, pPE40; Nakahiro T, 2010, BIOCHEM BIOPH RES CO, V399, P416, DOI 10.1016/j.bbrc.2010.07.090; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200; Rosen V, 1996, ANN NY ACAD SCI, V785, P59, DOI 10.1111/j.1749-6632.1996.tb56244.x; Runyan CE, 2005, J BIOL CHEM, V280, P8300, DOI 10.1074/jbc.M407939200; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sakamoto K, 2008, J CELL SCI, V121, P1613, DOI 10.1242/jcs.023119; Schwickart M, 2004, MOL CELL BIOL, V24, P3562, DOI 10.1128/MCB.24.8.3562-3576.2004; Sharff KA, 2009, J BIOL CHEM, V284, P649, DOI 10.1074/jbc.M806389200; Shi WB, 2007, J CELL SCI, V120, P1216, DOI 10.1242/jcs.03400; Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007; Silvestris F, 2008, CLIN CANCER RES, V14, P6081, DOI 10.1158/1078-0432.CCR-08-0219; Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Souchelnytskyi S, 1997, J BIOL CHEM, V272, P28107, DOI 10.1074/jbc.272.44.28107; Stein GS, 2004, ONCOGENE, V23, P4315, DOI 10.1038/sj.onc.1207676; Takeuchi Y, 2002, J BIOL CHEM, V277, P49011, DOI 10.1074/jbc.M207804200; Tournay O, 1996, MOL CELL BIOL, V16, P2418; Trost A, 2010, MECH AGEING DEV, V131, P346, DOI 10.1016/j.mad.2010.04.002; Uhles S, 2007, FASEB J, V21, P1609, DOI 10.1096/fj.06-7589com; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Xing WR, 2010, MOL CELL BIOL, V30, P711, DOI 10.1128/MCB.00610-09; Zanotti S, 2009, J ENDOCRINOL, V201, P263, DOI 10.1677/JOE-08-0514; Zhou YL, 2004, MOL ENDOCRINOL, V18, P1818, DOI 10.1210/me.2004-0079	64	37	41	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25163	10.1371/journal.pone.0025163	http://dx.doi.org/10.1371/journal.pone.0025163			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998639	gold, Green Published, Green Submitted			2022-12-27	WOS:000295966900012
J	Nguyen, HV; Legras, JL; Neuveglise, C; Gaillardin, C				Huu-Vang Nguyen; Legras, Jean-Luc; Neuveglise, Cecile; Gaillardin, Claude			Deciphering the Hybridisation History Leading to the Lager Lineage Based on the Mosaic Genomes of Saccharomyces bayanus Strains NBRC1948 and CBS380(T)	PLOS ONE			English	Article							INTERSPECIES HYBRIDIZATION; MALTOTRIOSE UTILIZATION; EVOLUTIONARY GENETICS; GENUS SACCHAROMYCES; NATURAL HYBRIDS; BREWING YEAST; CEREVISIAE; SEQUENCE; WINE; CARLSBERGENSIS	Saccharomyces bayanus is a yeast species described as one of the two parents of the hybrid brewing yeast S. pastorianus. Strains CBS380(T) and NBRC1948 have been retained successively as pure-line representatives of S. bayanus. In the present study, sequence analyses confirmed and upgraded our previous finding: S. bayanus type strain CBS380(T) harbours a mosaic genome. The genome of strain NBRC1948 was also revealed to be mosaic. Both genomes were characterized by amplification and sequencing of different markers, including genes involved in maltotriose utilization or genes detected by array-CGH mapping. Sequence comparisons with public Saccharomyces spp. nucleotide sequences revealed that the CBS380(T) and NBRC1948 genomes are composed of: a predominant non-cerevisiae genetic background belonging to S. uvarum, a second unidentified species provisionally named S. lagerae, and several introgressed S. cerevisiae fragments. The largest cerevisiae-introgressed DNA common to both genomes totals 70kb in length and is distributed in three contigs, cA, cB and cC. These vary in terms of length and presence of MAL31 or MTY1 (maltotriose-transporter gene). In NBRC1948, two additional cerevisiae-contigs, cD and cE, totaling 12kb in length, as well as several smaller cerevisiae fragments were identified. All of these contigs were partially detected in the genomes of S. pastorianus lager strains CBS1503 (S. monacensis) and CBS1513 (S. carlsbergensis) explaining the noticeable common ability of S. bayanus and S. pastorianus to metabolize maltotriose. NBRC1948 was shown to be inter-fertile with S. uvarum CBS7001. The cross involving these two strains produced F1 segregants resembling the strains CBS380(T) or NRRLY-1551. This demonstrates that these S. bayanus strains were the offspring of a cross between S. uvarum and a strain similar to NBRC1948. Phylogenies established with selected cerevisiae and non-cerevisiae genes allowed us to decipher the complex hybridisation events linking S. lagerae/S. uvarum/S. cerevisiae with their hybrid species, S. bayanus/pastorianus.	[Huu-Vang Nguyen; Neuveglise, Cecile; Gaillardin, Claude] INRA, Micalis UMR1319, Jouy En Josas, France; [Huu-Vang Nguyen; Neuveglise, Cecile; Gaillardin, Claude] AgroParisTech, Micalis, Jouy En Josas, France; [Legras, Jean-Luc] INRA, Sci CEnol UMR1083, F-34060 Montpellier, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; INRAE	Nguyen, HV (corresponding author), INRA, Micalis UMR1319, Jouy En Josas, France.	Huu-Vang.Nguyen@grignon.inra.fr	Legras, Jean-Luc/A-7589-2008	Legras, Jean-Luc/0000-0002-4006-4389; Neuveglise, Cecile/0000-0001-5017-7830	Institut National de la Recherche Agronomique (INRA)	Institut National de la Recherche Agronomique (INRA)	This work was only supported by the proper funds of the Institut National de la Recherche Agronomique (INRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves SL, 2008, APPL ENVIRON MICROB, V74, P1494, DOI 10.1128/AEM.02570-07; BANNO I, 1989, YEAST, V5, P373; BARNETT JA, 1992, YEAST, V8, P1, DOI 10.1002/yea.320080102; Bon E, 2000, FEBS LETT, V487, P37, DOI 10.1016/S0014-5793(00)02276-6; Borneman AR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001287; Cliften PF, 2001, GENOME RES, V11, P1175, DOI 10.1101/gr.182901; CORRAN H. S., 1975, HIST BREWING; D Anderson B, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-91; DEAR S, 1991, NUCLEIC ACIDS RES, V19, P3907, DOI 10.1093/nar/19.14.3907; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Dietvorst J, 2005, YEAST, V22, P775, DOI 10.1002/yea.1279; Dietvorst J, 2010, FEMS MICROBIOL LETT, V310, P152, DOI 10.1111/j.1574-6968.2010.02056.x; Dunn B, 2008, GENOME RES, V18, P1610, DOI 10.1101/gr.076075.108; Galeote V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017872; Gonzalez SS, 2008, APPL ENVIRON MICROB, V74, P2314, DOI 10.1128/AEM.01867-07; Groth G, 1999, INT J SYST BACTERIOL, V49, P1933; HANSEN J, 1994, GENE, V140, P33, DOI 10.1016/0378-1119(94)90727-7; Hinchliffe E, 1989, MOL CELL BIOL YEAST, P281; Joubert R, 2000, YEAST, V16, P511, DOI 10.1002/(SICI)1097-0061(200004)16:6<511::AID-YEA544>3.0.CO;2-I; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kodama Y, 2001, APPL ENVIRON MICROB, V67, P3455, DOI 10.1128/AEM.67.8.3455-3462.2001; LACHANCE MA, 1985, MICROBIOL SCI, V2, P122; Langkjaer RB, 2000, J MOL BIOL, V304, P271, DOI 10.1006/jmbi.2000.4209; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Legras JL, 2007, MOL ECOL, V16, P2091, DOI 10.1111/j.1365-294X.2007.03266.x; Liti G, 2006, GENETICS, V174, P839, DOI 10.1534/genetics.106.062166; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Lopes CA, 2010, FEMS YEAST RES, V10, P412, DOI 10.1111/j.1567-1364.2010.00614.x; Marinoni G, 1999, J BACTERIOL, V181, P6488, DOI 10.1128/JB.181.20.6488-6496.1999; MARTINI AV, 1985, INT J SYST BACTERIOL, V35, P508; Masneuf I, 1998, APPL ENVIRON MICROB, V64, P3887; Muller-Wille S, 2007, STUD HIST PHI PART C, V38, P796, DOI 10.1016/j.shpsc.2007.09.012; Muller LAH, 2009, FEMS YEAST RES, V9, P143, DOI 10.1111/j.1567-1364.2008.00464.x; Nakao Y, 2009, DNA RES, V16, P115, DOI 10.1093/dnares/dsp003; NAUMOV G, 1993, SYST APPL MICROBIOL, V16, P274; Naumov G. I., 2000, Mikrobiologiya, V69, P410; Naumova ES, 2005, YEAST, V22, P1099, DOI 10.1002/yea.1298; NESS F, 1995, GENETICS, V140, P945; Nguyen HV, 2000, SYST APPL MICROBIOL, V23, P71, DOI 10.1016/S0723-2020(00)80048-X; Nguyen HV, 2005, FEMS YEAST RES, V5, P471, DOI 10.1016/j.femsyr.2004.12.004; Novo M, 2009, P NATL ACAD SCI USA, V106, P16333, DOI 10.1073/pnas.0904673106; PEDERSEN MB, 1986, CARLSBERG RES COMMUN, V51, P185, DOI 10.1007/BF02907323; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; Rainieri S, 2006, APPL ENVIRON MICROB, V72, P3968, DOI 10.1128/AEM.02769-05; Robinson MD, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-35; Rozpedowska E, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P145; Ryu SL, 1996, YEAST, V12, P757, DOI 10.1002/(SICI)1097-0061(19960630)12:8<757::AID-YEA970>3.0.CO;2-H; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salema-Oom M, 2005, APPL ENVIRON MICROB, V71, P5044, DOI 10.1128/AEM.71.9.5044-5049.2005; Sampaio JP, 2008, APPL ENVIRON MICROB, V74, P2144, DOI 10.1128/AEM.02396-07; Scannell DR, 2011, G3-GENES GENOM GENET, V1, P11, DOI 10.1534/g3.111.000273; Sipiczki M, 2008, FEMS YEAST RES, V8, P996, DOI 10.1111/j.1567-1364.2008.00369.x; Stewart GG, 1983, YEAST GENETICS FUNDA, P461; Tamai Y, 2000, YEAST, V16, P1335, DOI 10.1002/1097-0061(200010)16:14<1335::AID-YEA623>3.0.CO;2-P; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teste MA, 2010, J BIOL CHEM, V285, P26815, DOI 10.1074/jbc.M110.145946; TURAKAINEN H, 1991, GENE, V101, P97, DOI 10.1016/0378-1119(91)90229-5; van der Walt J.P., 1970, YEASTS TAXONOMIC STU, P555; Winzeler EA, 1998, SCIENCE, V281, P1194, DOI 10.1126/science.281.5380.1194; Zhang HY, 2010, FEMS YEAST RES, V10, P941, DOI 10.1111/j.1567-1364.2010.00681.x	61	73	75	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25821	10.1371/journal.pone.0025821	http://dx.doi.org/10.1371/journal.pone.0025821			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998701	Green Published, gold, Green Submitted			2022-12-27	WOS:000295966900058
J	Mehrbod, M; Mofrad, MRK				Mehrbod, Mehrdad; Mofrad, Mohammad R. K.			On the Significance of Microtubule Flexural Behavior in Cytoskeletal Mechanics	PLOS ONE			English	Article							INTERMEDIATE-FILAMENTS; LIVING CELLS; RIGIDITY; KINESIN; FORCE; MODEL	Quantitative description of cell mechanics has challenged biological scientists for the past two decades. Various structural models have been attempted to analyze the structure of the cytoskeleton. One important aspect that has been largely ignored in all these modeling approaches is related to the flexural and buckling behavior of microtubular filaments. The objective of this paper is to explore the influence of this flexural and buckling behavior in cytoskeletal mechanics. In vitro the microtubules are observed to buckle in the first mode, reminiscent of a free, simply-supported beam. In vivo images of microtubules, however, indicate that the buckling mostly occurs in higher modes. This buckling mode switch takes place mostly because of the lateral support of microtubules via their connections to actin and intermediate filaments. These lateral loads are exerted throughout the microtubule length and yield a considerable bending behavior that, unless properly accounted for, would produce erroneous results in the modeling and analysis of the cytoskeletal mechanics. One of the promising attempts towards mechanical modeling of the cytoskeleton is the tensegrity model, which simplifies the complex network of cytoskeletal filaments into a combination merely of tension-bearing actin filaments and compression-bearing microtubules. Interestingly, this discrete model can qualitatively explain many experimental observations in cell mechanics. However, evidence suggests that the simplicity of this model may undermine the accuracy of its predictions, given the model's underlying assumption that "every single member bears solely either tensile or compressive behavior,'' i.e. neglecting the flexural behavior of the microtubule filaments. We invoke an anisotropic continuum model for microtubules and compare the bending energy stored in a single microtubule with its axial strain energy at the verge of buckling. Our results suggest that the bending energy can exceed the axial energy of microtubules by 40 folds. A modification to tensegrity model is, therefore, proved necessary in order to take into account the flexural response of microtubules. The concept of "bendo-tensegrity'' is proposed as a modification to contemporary cytoskeletal tensegrity models.	[Mehrbod, Mehrdad; Mofrad, Mohammad R. K.] Univ Calif Berkeley, Dept Bioengn, Mol Cell Biomech Lab, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Mehrbod, M (corresponding author), Univ Calif Berkeley, Dept Bioengn, Mol Cell Biomech Lab, Berkeley, CA 94720 USA.	mofrad@berkeley.edu	/R-6010-2019	/0000-0001-7004-4859				Baudriller H, 2006, CR MECANIQUE, V334, P662, DOI 10.1016/j.crme.2006.08.004; Blundell JR, 2009, SOFT MATTER, V5, P4015, DOI 10.1039/b903583d; Brangwynne CP, 2006, J CELL BIOL, V173, P733, DOI 10.1083/jcb.200601060; BRUNELLE EJ, 1970, J COMPOS MATER, V4, P404, DOI 10.1177/002199837000400311; Chandran PL, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.031920; Gao Y, 2010, PHYSICA E; Gregory MS, 1967, ELASTIC INSTABILITY, Vxii; Guilak F, 2006, CYTOSKELETAL MECH MO, P256; Hawkins T, 2010, J BIOMECH, V43, P23, DOI 10.1016/j.jbiomech.2009.09.005; HEUSER JE, 1980, J CELL BIOL, V86, P212, DOI 10.1083/jcb.86.1.212; Hibbeler R. C., 2010, ENG MECH STATICS; Howard J., 2001, MECH MOTOR PROTEINS; Ingber D, 1994, CELLULAR TENSEGRITY; Ingber DE, 2003, J CELL SCI, V116, P1397, DOI 10.1242/jcs.00360; Ingber DE, 2003, J CELL SCI, V116, P1157, DOI 10.1242/jcs.00359; Ingber DE., 1985, GENE EXPRESSION NORM, P13; Ingber DE, 2008, PROG BIOPHYS MOL BIO, V97, P163, DOI 10.1016/j.pbiomolbio.2008.02.005; Jiang HQ, 2008, J APPL MECH-T ASME, V75, DOI 10.1115/1.2966216; Karimi R, 2011, PHYS REV L UNPUB; Kikumoto M, 2006, BIOPHYS J, V90, P1687, DOI 10.1529/biophysj.104.055483; Kiss B, 2006, J STRUCT BIOL, V155, P327, DOI 10.1016/j.jsb.2006.03.020; Li C, 2006, BIOCHEM BIOPH RES CO, V349, P1145, DOI 10.1016/j.bbrc.2006.08.153; Liao GJ, 1998, J BIOL CHEM, V273, P9797, DOI 10.1074/jbc.273.16.9797; Liedert A, 2006, BIOCHEM BIOPH RES CO, V349, P1, DOI 10.1016/j.bbrc.2006.07.214; Liu YF, 2006, P NATL ACAD SCI USA, V103, P10654, DOI 10.1073/pnas.0510381103; MEYHOFER E, 1995, P NATL ACAD SCI USA, V92, P574, DOI 10.1073/pnas.92.2.574; Mofrad MRK, 2010, CELLULAR MECHANOTRAN, V465, pxii; Moore SW, 2010, DEV CELL, V19, P194, DOI 10.1016/j.devcel.2010.07.018; Pirentis A, 2009, INT J SOLIDS STRUCTU; Pirentis AP, 2010, INT J SOLIDS STRUCT, V47, P759, DOI 10.1016/j.ijsolstr.2009.11.010; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Schaap IAT, 2006, BIOPHYS J, V91, P1521, DOI 10.1529/biophysj.105.077826; Shen HS, 2010, J THEOR BIOL, V264, P386, DOI 10.1016/j.jtbi.2010.02.014; Shi YJ, 2008, PHYSICA E, V41, P213, DOI 10.1016/j.physe.2008.06.025; Svitkina TM, 1996, J CELL BIOL, V135, P991, DOI 10.1083/jcb.135.4.991; Li T, 2008, J BIOMECH, V41, P1722, DOI 10.1016/j.jbiomech.2008.03.003; Wagner OI, 2007, EXP CELL RES, V313, P2228, DOI 10.1016/j.yexcr.2007.04.025; Wang N, 2001, P NATL ACAD SCI USA, V98, P7765, DOI 10.1073/pnas.141199598	38	36	38	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25627	10.1371/journal.pone.0025627	http://dx.doi.org/10.1371/journal.pone.0025627			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998675	Green Published, Green Submitted, gold			2022-12-27	WOS:000295966900038
J	Meissner, CS; Koppen-Rung, P; Dittmer, A; Lapp, S; Bogner, E				Meissner, Christina Sylvia; Koeppen-Rung, Panja; Dittmer, Alexandra; Lapp, Sara; Bogner, Elke			A "Coiled-Coil" Motif Is Important for Oligomerization and DNA Binding Properties of Human Cytomegalovirus Protein UL77	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; TERMINASE SUBUNIT PUL56; OPEN READING FRAME; UL25 GENE-PRODUCT; PACKAGING PROTEIN; PSEUDORABIES VIRUS; UL6 GENE; TYPE-1; CLEAVAGE; IDENTIFICATION	Human cytomegalovirus (HCMV) UL77 gene encodes the essential protein UL77, its function is characterized in the present study. Immunoprecipitation identified monomeric and oligomeric pUL77 in HCMV infected cells. Immunostaining of purified virions and subviral fractions showed that pUL77 is a structural protein associated with capsids. In silico analysis revealed the presence of a coiled-coil motif (CCM) at the N-terminus of pUL77. Chemical cross-linking of either wild-type pUL77 or CCM deletion mutant (pUL77 Delta CCM) implicated that CCM is critical for oligomerization of pUL77. Furthermore, co-immunoprecipitations of infected and transfected cells demonstrated that pUL77 interacts with the capsid-associated DNA packaging motor components, pUL56 and pUL104, as well as the major capsid protein. The ability of pUL77 to bind dsDNA was shown by an in vitro assay. Binding to certain DNA was further confirmed by an assay using biotinylated 36-, 250-, 500-, 1000-meric dsDNA and 966-meric HCMV-specific dsDNA designed for this study. The binding efficiency (BE) was determined by image processing program defining values above 1.0 as positive. While the BE of the pUL56 binding to the 36-mer bio-pac1 containing a packaging signal was 10.0+/-0.63, the one for pUL77 was only 0.2+/-0.03. In contrast to this observation the BE of pUL77 binding to bio-500 bp or bio-1000 bp was 2.2+/-0.41 and 4.9+/-0.71, respectively. By using pUL77 Delta CCM it was demonstrated that this protein could not bind to dsDNA. These data indicated that pUL77 (i) could form homodimers, (ii) CCM of pUL77 is crucial for oligomerization and (iii) could bind to dsDNA in a sequence independent manner.	[Meissner, Christina Sylvia; Koeppen-Rung, Panja; Dittmer, Alexandra; Lapp, Sara; Bogner, Elke] Charite, Inst Virol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Meissner, CS (corresponding author), Charite, Inst Virol, D-13353 Berlin, Germany.	elke.bogner@charite.de	Bogner, Elke/AAG-2207-2019	Bogner, Elke/0000-0001-7622-2900	Deutsche Forschungsgesellschaft [Bo 1214/15-1]; DFG [Graduiertenkolleg 1121, A9]	Deutsche Forschungsgesellschaft(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	The work was funded by the Deutsche Forschungsgesellschaft (Bo 1214/15-1) and DFG Graduiertenkolleg 1121 (Project Bogner A9)(http://www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALKOBAISI MF, 1991, VIROLOGY, V180, P380, DOI 10.1016/0042-6822(91)90043-B; Baines JD, 1997, J VIROL, V71, P2666, DOI 10.1128/JVI.71.4.2666-2673.1997; BLACK LW, 1989, ANNU REV MICROBIOL, V43, P267, DOI 10.1146/annurev.micro.43.1.267; BOGNER E, 1993, VIROLOGY, V196, P290, DOI 10.1006/viro.1993.1477; Bogner E, 1998, J VIROL, V72, P2259, DOI 10.1128/JVI.72.3.2259-2264.1998; Bogner E, 2002, REV MED VIROL, V12, P115, DOI 10.1002/rmv.344; Borst EM, 2008, J VIROL, V82, P2065, DOI 10.1128/JVI.01967-07; Bowman BR, 2006, J VIROL, V80, P2309, DOI 10.1128/JVI.80.5.2309-2317.2006; Brown J, 2002, STRUCTURE FUNCTION R, P111; CASJENS S, 1982, J MOL BIOL, V157, P287, DOI 10.1016/0022-2836(82)90235-2; Chang YJE, 1996, J VIROL, V70, P3938, DOI 10.1128/JVI.70.6.3938-3946.1996; Cockrell SK, 2011, J VIROL, V85, P4875, DOI 10.1128/JVI.00242-11; Cockrell SK, 2009, J VIROL, V83, P47, DOI 10.1128/JVI.01889-08; Dittmer A, 2005, J VIROL, V79, P14660, DOI 10.1128/JVI.79.23.14660-14667.2005; Dittmer A, 2005, BIOCHEMISTRY-US, V44, P759, DOI 10.1021/bi047911w; Dong Y, 2003, P NATL ACAD SCI USA, V100, P12396; Dunn W, 2003, P NATL ACAD SCI USA, V100, P14223, DOI 10.1073/pnas.2334032100; FLECKENSTEIN B, 1982, GENE, V18, P39, DOI 10.1016/0378-1119(82)90054-3; Giesen K, 2000, J GEN VIROL, V81, P2231, DOI 10.1099/0022-1317-81-9-2231; Gruber M, 2006, J STRUCT BIOL, V155, P140, DOI 10.1016/j.jsb.2006.03.009; Guo PX, 2007, MOL MICROBIOL, V64, P886, DOI 10.1111/j.1365-2958.2007.05706.x; Holzenburg A, 2009, J GEN VIROL, V90, P2381, DOI 10.1099/vir.0.013292-0; Hwang JS, 2002, J BIOL CHEM, V277, P6943, DOI 10.1074/jbc.M108984200; Klupp BG, 2006, J VIROL, V80, P6235, DOI 10.1128/JVI.02662-05; Kuhn J, 2008, J VIROL, V82, P5725, DOI 10.1128/JVI.02441-07; Lamberti C, 1996, VIROLOGY, V226, P403, DOI 10.1006/viro.1996.0668; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; McNab AR, 1998, J VIROL, V72, P1060, DOI 10.1128/JVI.72.2.1060-1070.1998; Newcomb WW, 2006, J VIROL, V80, P6286, DOI 10.1128/JVI.02648-05; Newcomb WW, 2001, J VIROL, V75, P10923, DOI 10.1128/JVI.75.22.10923-10932.2001; Ogasawara M, 2001, J VIROL, V75, P1427, DOI 10.1128/JVI.75.3.1427-1436.2001; PATEL AH, 1995, VIROLOGY, V206, P465, DOI 10.1016/S0042-6822(95)80062-X; PETERS J, 1995, J MOL BIOL, V245, P385, DOI 10.1006/jmbi.1994.0032; PLACHTER B, 1993, VIROLOGY, V193, P642, DOI 10.1006/viro.1993.1172; Preston VG, 2008, J VIROL, V82, P6654, DOI 10.1128/JVI.00257-08; Salmon B, 1998, J VIROL, V72, P3779, DOI 10.1128/JVI.72.5.3779-3788.1998; Savva CGW, 2004, FEBS LETT, V563, P135, DOI 10.1016/S0014-5793(04)00283-2; Scheffczik H, 2002, NUCLEIC ACIDS RES, V30, P1695, DOI 10.1093/nar/30.7.1695; Scholz B, 2003, NUCLEIC ACIDS RES, V31, P1426, DOI 10.1093/nar/gkg229; Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581; Stow ND, 2001, J VIROL, V75, P10755, DOI 10.1128/JVI.75.22.10755-10765.2001; TALBOT P, 1977, J GEN VIROL, V36, P345, DOI 10.1099/0022-1317-36-2-345; TENGELSEN LA, 1993, J VIROL, V67, P3470, DOI 10.1128/JVI.67.6.3470-3480.1993; Thurlow JK, 2006, J VIROL, V80, P2118, DOI 10.1128/JVI.80.5.2118-2126.2006; Thurlow JK, 2005, J VIROL, V79, P150, DOI 10.1128/JVI.79.1.150-158.2005; To A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017796; Trus BL, 2007, MOL CELL, V26, P479, DOI 10.1016/j.molcel.2007.04.010; Varnum SM, 2004, J VIROL, V78, P10960, DOI 10.1128/JVI.78.20.10960-10966.2004; Yu D, 2003, P NATL ACAD SCI USA, V100, P12396, DOI 10.1073/pnas.1635160100; Yu D, 1998, J VIROL, V72, P7428, DOI 10.1128/JVI.72.9.7428-7439.1998	50	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25115	10.1371/journal.pone.0025115	http://dx.doi.org/10.1371/journal.pone.0025115			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998635	Green Published, gold, Green Submitted			2022-12-27	WOS:000295966900007
J	Schleicher, TR; Nyholm, SV				Schleicher, Tyler R.; Nyholm, Spencer V.			Characterizing the Host and Symbiont Proteomes in the Association between the Bobtail Squid, Euprymna scolopes, and the Bacterium, Vibrio fischeri	PLOS ONE			English	Article							NF-KAPPA-B; THIOESTER-CONTAINING PROTEINS; LIGHT-ORGAN COLONIZATION; MASS-SPECTROMETRY; NITRIC-OXIDE; BENEFICIAL ASSOCIATION; STATIONARY-PHASE; OXIDATIVE STRESS; GENE-EXPRESSION; SCALE ANALYSIS	The beneficial symbiosis between the Hawaiian bobtail squid, Euprymna scolopes, and the bioluminescent bacterium, Vibrio fischeri, provides a unique opportunity to study host/microbe interactions within a natural microenvironment. Colonization of the squid light organ by V. fischeri begins a lifelong association with a regulated daily rhythm. Each morning the host expels an exudate from the light organ consisting of 95% of the symbiont population in addition to host hemocytes and shed epithelial cells. We analyzed the host and symbiont proteomes of adult squid exudate and surrounding light organ epithelial tissue using 1D- and 2D-polyacrylamide gel electrophoresis and multidimensional protein identification technology (MudPIT) in an effort to understand the contribution of both partners to the maintenance of this association. These proteomic analyses putatively identified 1581 unique proteins, 870 proteins originating from the symbiont and 711 from the host. Identified host proteins indicate a role of the innate immune system and reactive oxygen species (ROS) in regulating the symbiosis. Symbiont proteins detected enhance our understanding of the role of quorum sensing, two-component signaling, motility, and detoxification of ROS and reactive nitrogen species (RNS) inside the light organ. This study offers the first proteomic analysis of the symbiotic microenvironment of the adult light organ and provides the identification of proteins important to the regulation of this beneficial association.	[Schleicher, Tyler R.; Nyholm, Spencer V.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA	University of Connecticut	Schleicher, TR (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA.	spencer.nyholm@uconn.edu			National Science Foundation [IOS-0958006]; University of Connecticut Research Foundation; Direct For Biological Sciences [0958006] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); University of Connecticut Research Foundation; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation IOS-0958006 (nsf.gov) and the University of Connecticut Research Foundation (research.uconn.edu) to SVN. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas K, 2008, IMMUNOBIOLOGY, V213, P815, DOI 10.1016/j.imbio.2008.07.029; Aeckersberg F, 2001, J BACTERIOL, V183, P6590, DOI 10.1128/JB.183.22.6590-6597.2001; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Antunes LCM, 2007, J BACTERIOL, V189, P8387, DOI 10.1128/JB.00736-07; Aoun RB, 2011, J INNATE IMMUN, V3, P52, DOI 10.1159/000321554; Baek WK, 2009, J MICROBIOL, V47, P624, DOI 10.1007/s12275-009-0130-x; Balhesteros H, 2010, ARCH MICROBIOL, V192, P747, DOI 10.1007/s00203-010-0602-8; Barth KR, 2009, MICROBIOL-SGM, V155, P2532, DOI 10.1099/mic.0.028092-0; Blandin S, 2004, MOL IMMUNOL, V40, P903, DOI 10.1016/j.molimm.2003.10.010; BOETTCHER KJ, 1990, J BACTERIOL, V172, P3701, DOI 10.1128/jb.172.7.3701-3706.1990; Boettcher KJ, 1996, J COMP PHYSIOL A, V179, P65; Bose JL, 2007, MOL MICROBIOL, V65, P538, DOI 10.1111/j.1365-2958.2007.05809.x; Callahan SM, 2000, J BACTERIOL, V182, P2811, DOI 10.1128/JB.182.10.2811-2822.2000; Castillo MG, 2009, DEV COMP IMMUNOL, V33, P69, DOI 10.1016/j.dci.2008.07.013; Cerliani JP, 2011, J CLIN IMMUNOL, V31, P10, DOI 10.1007/s10875-010-9494-2; Chun CK, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-154; Davidson SK, 2004, CELL MICROBIOL, V6, P1139, DOI 10.1111/j.1462-5822.2004.00429.x; Delmotte N, 2010, PROTEOMICS, V10, P1391, DOI 10.1002/pmic.200900710; Dunn AK, 2008, J BACTERIOL, V190, P5814, DOI 10.1128/JB.00227-08; ENGEBRECHT J, 1984, P NATL ACAD SCI-BIOL, V81, P4154, DOI 10.1073/pnas.81.13.4154; Fagerlund R, 2005, J BIOL CHEM, V280, P15942, DOI 10.1074/jbc.M500814200; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; Faraldo-Gomez JD, 2003, NAT REV MOL CELL BIO, V4, P105, DOI 10.1038/nrm1015; Felix G, 2003, J BIOL CHEM, V278, P6201, DOI 10.1074/jbc.M209880200; Feng XS, 2002, P NATL ACAD SCI USA, V99, P14212, DOI 10.1073/pnas.212306199; Foster JS, 2000, DEV BIOL, V226, P242, DOI 10.1006/dbio.2000.9868; Froese N, 2006, MOL CELL BIOL, V26, P293, DOI 10.1128/MCB.26.1.293-302.2006; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Goodson MS, 2005, APPL ENVIRON MICROB, V71, P6934, DOI 10.1128/AEM.71.11.6934-6946.2005; Graf J, 2000, MOL MICROBIOL, V37, P168, DOI 10.1046/j.1365-2958.2000.01984.x; Graf J, 1998, P NATL ACAD SCI USA, V95, P1818, DOI 10.1073/pnas.95.4.1818; Guerrero-Ferreira RC, 2010, ENV MICROBIOL REP, V2, P514, DOI 10.1111/j.1758-2229.2009.00077.x; HEUKESHOVEN J, 1985, ELECTROPHORESIS, V6, P103, DOI 10.1002/elps.1150060302; HIROSAWA M, 1993, COMPUT APPL BIOSCI, V9, P161; Ho YP, 2002, J CHROMATOGR A, V976, P103, DOI 10.1016/S0021-9673(02)00939-1; Hussa EA, 2007, J BACTERIOL, V189, P5825, DOI 10.1128/JB.00242-07; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Jones BW, 2006, CAN J MICROBIOL, V52, P1218, DOI 10.1139/W06-088; Jones BM, 2011, MAR BIOTECHNOL, V13, P496, DOI 10.1007/s10126-010-9320-0; Jones BW, 2004, MAR BIOL, V144, P1151, DOI 10.1007/s00227-003-1285-3; Koropatnick TA, 2004, SCIENCE, V306, P1186, DOI 10.1126/science.1102218; LEE KH, 1994, APPL ENVIRON MICROB, V60, P1565, DOI 10.1128/AEM.60.5.1565-1571.1994; Lemus JD, 2000, APPL ENVIRON MICROB, V66, P4091, DOI 10.1128/AEM.66.9.4091-4097.2000; Lin YP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011301; Lupp C, 2004, J BACTERIOL, V186, P3873, DOI 10.1128/JB.186.12.3873-3881.2004; Lupp C, 2003, MOL MICROBIOL, V50, P319, DOI 10.1046/j.1365-2958.2003.t01-1-03585.x; Mandel MJ, 2010, TRENDS MICROBIOL, V18, P504, DOI 10.1016/j.tim.2010.07.005; Markert S, 2007, SCIENCE, V315, P247, DOI 10.1126/science.1132913; Mastronunzio JE, 2010, SYMBIOSIS, V50, P13, DOI 10.1007/s13199-009-0030-1; McFall-Ngai M, 2008, ADV EXP MED BIOL, V635, P102, DOI 10.1007/978-0-387-09550-9_9; McFall-Ngai M, 2010, SEMIN IMMUNOL, V22, P48, DOI 10.1016/j.smim.2009.11.003; Millikan DS, 2003, J BACTERIOL, V185, P3547, DOI 10.1128/JB.185.12.3547-3557.2003; Millikan DS, 2004, J BACTERIOL, V186, P4315, DOI 10.1128/JB.186.13.4315-4325.2004; NEALSON KH, 1977, ARCH MICROBIOL, V112, P73, DOI 10.1007/BF00446657; Nguyen DT, 2009, FEMS MICROBIOL LETT, V298, P37, DOI 10.1111/j.1574-6968.2009.01693.x; Nyholm SV, 2009, ENVIRON MICROBIOL, V11, P483, DOI 10.1111/j.1462-2920.2008.01788.x; Nyholm SV, 1998, BIOL BULL, V195, P89, DOI 10.2307/1542815; Nyholm SV, 2004, NAT REV MICROBIOL, V2, P632, DOI 10.1038/nrmicro957; Nyholm SV, 2002, APPL ENVIRON MICROB, V68, P5113, DOI 10.1128/AEM.68.10.5113-5122.2002; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; Parsonage D, 2010, P NATL ACAD SCI USA, V107, P6240, DOI 10.1073/pnas.0910057107; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Poliakov A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.007039; Raivio TL, 1999, J BACTERIOL, V181, P5263, DOI 10.1128/JB.181.17.5263-5272.1999; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Robinson MW, 2010, PARASITE IMMUNOL, V32, P305, DOI 10.1111/j.1365-3024.2010.01201.x; Ruby EG, 1999, TRENDS MICROBIOL, V7, P414, DOI 10.1016/S0966-842X(99)01588-7; RUBY EG, 1993, ARCH MICROBIOL, V159, P160, DOI 10.1007/BF00250277; Rus H, 2005, IMMUNOL RES, V33, P103, DOI 10.1385/IR:33:2:103; Shinoda K, 2010, BIOINFORMATICS, V26, P576, DOI 10.1093/bioinformatics/btp700; Small AL, 1999, J CELL BIOCHEM, V72, P445, DOI 10.1002/(SICI)1097-4644(19990315)72:4<445::AID-JCB1>3.0.CO;2-P; Studer SV, 2008, J BACTERIOL, V190, P5915, DOI 10.1128/JB.00148-08; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tian Y, 2008, BIOSCI BIOTECH BIOCH, V72, P1063, DOI 10.1271/bbb.70812; TOMAREV SI, 1993, GENE, V132, P219, DOI 10.1016/0378-1119(93)90199-D; Troll JV, 2010, ENVIRON MICROBIOL, V12, P2190, DOI 10.1111/j.1462-2920.2009.02121.x; Verberkmoes NC, 2009, ISME J, V3, P179, DOI 10.1038/ismej.2008.108; Visick KL, 2006, CURR OPIN MICROBIOL, V9, P632, DOI 10.1016/j.mib.2006.10.001; Visick KL, 1998, J BACTERIOL, V180, P2087, DOI 10.1128/JB.180.8.2087-2092.1998; Wang YL, 2011, CELL MICROBIOL, V13, P518, DOI 10.1111/j.1462-5822.2011.01576.x; Wang YL, 2010, MOL MICROBIOL, V78, P903, DOI 10.1111/j.1365-2958.2010.07376.x; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Whistler CA, 2003, J BACTERIOL, V185, P7202, DOI 10.1128/JB.185.24.7202-7212.2003; Whistler CA, 2007, CELL MICROBIOL, V9, P766, DOI 10.1111/j.1462-5822.2006.00826.x; WHITAKER JR, 1980, ANAL BIOCHEM, V109, P156, DOI 10.1016/0003-2697(80)90024-X; Wier AM, 2010, P NATL ACAD SCI USA, V107, P2259, DOI 10.1073/pnas.0909712107; Yamanaka K, 2001, MOL MICROBIOL, V39, P1572, DOI 10.1046/j.1365-2958.2001.02345.x; Yates JR, 2009, ANNU REV BIOMED ENG, V11, P49, DOI 10.1146/annurev-bioeng-061008-124934	89	40	41	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25649	10.1371/journal.pone.0025649	http://dx.doi.org/10.1371/journal.pone.0025649			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998678	Green Published, gold, Green Submitted			2022-12-27	WOS:000295966900041
J	Wang, DZ; Jiang, ZW; Shen, ZY; Wang, H; Wang, BL; Shou, WH; Zheng, H; Chu, X; Shi, JX; Huang, W				Wang, Dazhi; Jiang, Zhengwen; Shen, Zhongyang; Wang, Hui; Wang, Beilan; Shou, Weihua; Zheng, Hong; Chu, Xun; Shi, Jinxiu; Huang, Wei			Functional Evaluation of Genetic and Environmental Regulators of P450 mRNA Levels	PLOS ONE			English	Article							CONSTITUTIVE ANDROSTANE RECEPTOR; HEPATIC NUCLEAR FACTOR-4-ALPHA; ARYL-HYDROCARBON RECEPTOR; HUMAN LIVER; INTERINDIVIDUAL VARIABILITY; TRANSCRIPTIONAL ACTIVATION; EXPRESSION; CYP2C9; SEQUENCE; CYP1A2	Variations in the activities of Cytochrome P450s are one of the major factors responsible for inter-individual differences in drug clearance rates, which may cause serious toxicity or inefficacy of therapeutic drugs. Various mRNA level is one of the key factors for different activity of the major P450 genes. Although both genetic and environmental regulators of P450 gene expression have been widely investigated, few studies have evaluated the functional importance of cis- and trans-regulatory factors and environmental factors in the modulation of inter-individual expression variations of the P450 genes. In this study, we measured the mRNA levels of seven major P450 genes (CYP1A1, CYP1A2, CYP2C9, CYP2C19, CYP2D6, CYP3A4 and CYP3A5) in 96 liver biopsy samples from Chinese population. Both trans-acting (mRNA levels and non-synonymous SNPs of putative regulator genes) and cis-acting (gene copy number and functional SNPs) factors were investigated to identify the determinants of the expression variations of these seven P450 genes. We found that expression variations of most P450 genes, regulator genes and housekeeping genes were positively correlated at the mRNA level. After partial correlation analysis using ACTB and GAPDH expression to eliminate the effect of global regulators, a UPGMA (Unweighted Pair Group Method with Arithmetic Mean) tree was constructed to reveal the effects of specific regulation networks potentially masked by global regulators. Combined with the functional analysis of regulators, our results suggested that expression variation at the mRNA level was mediated by several factors in a gene-specific manner. Cis-acting genetic variants might play key roles in the expression variation of CYP2D6 and CYP3A5, environmental inducers might play key roles in CYP1A1 and CYP1A2 variation and global regulators might play key roles in CYP2C9 variation. In addition, the functions of regulators that play less important roles in controlling expression variation for each P450 gene were determined.	[Wang, Dazhi; Shou, Weihua; Chu, Xun; Huang, Wei] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Shanghai 200030, Peoples R China; [Wang, Dazhi; Jiang, Zhengwen; Wang, Beilan; Shou, Weihua; Chu, Xun; Shi, Jinxiu; Huang, Wei] Chinese Natl Human Genome Ctr, Shanghai MOST Key Lab Hlth & Dis Genom, Dept Genet, Shanghai, Peoples R China; [Shen, Zhongyang; Wang, Hui; Zheng, Hong] Tianjin First Cent Hosp, Organ Transplant Ctr, Tianjin, Peoples R China	Shanghai Jiao Tong University; Tianjin Medical University	Wang, DZ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Shanghai 200030, Peoples R China.	weihuangsh@gmail.com			Chinese High-Tech Program [2009AA022709]; Chinese National Natural Science Fund for Distinguished Young Scholars [30625019]; Chinese National Natural Science Fund for Youth [30900828]	Chinese High-Tech Program; Chinese National Natural Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Chinese National Natural Science Fund for Youth	This work was supported by the grants from Chinese High-Tech Program (2009AA022709), Chinese National Natural Science Fund for Distinguished Young Scholars (30625019) and Chinese National Natural Science Fund for Youth (30900828). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen YP, 2005, J PHARMACOL EXP THER, V314, P1125, DOI 10.1124/jpet.105.087072; Cirulli ET, 2007, HUM MOL GENET, V16, P1931, DOI 10.1093/hmg/ddm140; DAHL ML, 1995, J PHARMACOL EXP THER, V274, P516; Gaedigk A, 2005, PHARMACOGENOMICS J, V5, P173, DOI 10.1038/sj.tpj.6500305; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; GONZALEZ FJ, 1990, TRENDS GENET, V6, P182, DOI 10.1016/0168-9525(90)90174-5; IKEYA K, 1989, MOL ENDOCRINOL, V3, P1399, DOI 10.1210/mend-3-9-1399; Jiang Zhengwen, 2005, Nucleic Acids Res, V33, pe91, DOI 10.1093/nar/gni089; Johnson AD, 2008, PHARMACOGENET GENOM, V18, P781, DOI 10.1097/FPC.0b013e3283050107; Jung D, 2003, HEPATOLOGY, V37, P622, DOI 10.1053/jhep.2003.50100; Koch I, 2002, DRUG METAB DISPOS, V30, P1108, DOI 10.1124/dmd.30.10.1108; Kuehl P, 2001, NAT GENET, V27, P383, DOI 10.1038/86882; Kumar V, 2006, DRUG METAB DISPOS, V34, P1966, DOI 10.1124/dmd.106.010926; Lasker JM, 1998, ARCH BIOCHEM BIOPHYS, V353, P16, DOI 10.1006/abbi.1998.0615; Lee CR, 2003, J CLIN PHARMACOL, V43, P84, DOI 10.1177/0091270002239710; Li W, 1998, BIOCHEM PHARMACOL, V56, P599, DOI 10.1016/S0006-2952(98)00208-1; Martin J, 2007, MOL PSYCHIATR, V12, P421, DOI 10.1038/sj.mp.4001952; Martinez-Jimenez CP, 2006, MOL PHARMACOL, V70, P1681, DOI 10.1124/mol.106.025403; Nebert DW, 2004, J BIOL CHEM, V279, P23847, DOI 10.1074/jbc.R400004200; Nebert DW, 2004, EUR J PHARMACOL, V500, P267, DOI 10.1016/j.ejphar.2004.07.031; Nelson DR, 2004, PHARMACOGENETICS, V14, P1, DOI 10.1097/00008571-200401000-00001; Parkinson A, 2004, TOXICOL APPL PHARM, V199, P193, DOI 10.1016/j.taap.2004.01.010; Pitarque M, 2001, BIOCHEM BIOPH RES CO, V284, P455, DOI 10.1006/bbrc.2001.4990; Qadri I, 2006, MOL PHARMACOL, V70, P627, DOI 10.1124/mol.106.023499; Rebbeck TR, 2000, J NATL CANCER I, V92, P76, DOI 10.1093/jnci/92.1.76; Rodriguez-Antona C, 2001, ARCH BIOCHEM BIOPHYS, V393, P308, DOI 10.1006/abbi.2001.2499; Sachse C, 1997, AM J HUM GENET, V60, P284; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Ueda R, 2006, MOL PHARMACOL, V69, P1924, DOI 10.1124/mol.105.021220; Uno Y, 2003, J HUM GENET, V48, P594, DOI 10.1007/s10038-003-0076-5; Wortham M, 2007, DRUG METAB DISPOS, V35, P1700, DOI 10.1124/dmd.107.016436; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545; Yang X, 2010, GENOME RES, V20, P1020, DOI 10.1101/gr.103341.109	33	22	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e24900	10.1371/journal.pone.0024900	http://dx.doi.org/10.1371/journal.pone.0024900			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998633	Green Submitted, gold, Green Published			2022-12-27	WOS:000295966900005
J	Hars, M; Hars, M; Stam, CJ; Calmels, C				Hars, Magaly; Hars, Melany; Stam, Cornelis J.; Calmels, Claire			Effects of Visual Context upon Functional Connectivity during Observation of Biological Motions	PLOS ONE			English	Article							EVENT-RELATED DESYNCHRONIZATION; NONLINEAR EEG SYNCHRONIZATION; ATTENTIONAL MODULATION; PERCEPTION; MEMORY; ALPHA; MOTOR; BRAIN; AREAS; OSCILLATIONS	The aim of this study was to examine brain responses, in particular functional connectivity, to different visual stimuli depicting familiar biological motions. Ten subjects actively observed familiar biological motions embedded in point-light and video displays. Electroencephalograms were recorded from 64 electrodes. Activity was considered in three frequency bands (4-8 Hz, 8-10 Hz, and 10-13 Hz) using a non-linear measure of functional connectivity. In the 4-8 Hz and 8-10 Hz frequency bands, functional connectivity for the SMA was greater during the observation of biological motions presented in a point-light display compared to the observation of motions presented in a video display. The reverse was observed for the 4-8 Hz frequency band for the left temporal area. Explanations related to: (i) the task demands (i. e., attention and mental effort), (ii) the role(s) of theta and alpha oscillations in cognitive processes, and (iii) the function(s) of cortical areas are discussed. It has been suggested that attention was required to process human biological motions under unfamiliar viewing conditions such as point-light display.	[Hars, Magaly; Calmels, Claire] Inst Natl Sport, INSEP, Paris, France; [Hars, Magaly] Univ Reims, Reims, France; [Hars, Melany] Univ Hosp Geneva, Dept Rehabil & Geriatr, Geneva, Switzerland; [Hars, Melany] Univ Valenciennes & Hainaut Cambresis, LAMIH UMR CNRS 8530, Valenciennes, France; [Stam, Cornelis J.] Vrije Univ Amsterdam Med Ctr, Dept Clin Neurophysiol, Amsterdam, Netherlands	Universite de Reims Champagne-Ardenne; University of Geneva; Centre National de la Recherche Scientifique (CNRS); Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Hars, M (corresponding author), Inst Natl Sport, INSEP, Paris, France.	claire.calmels@insep.fr	Hars, Mélany/AAI-1125-2021; Hars, Magaly/H-1879-2012	HARS, MELANY/0000-0002-5108-0528; Stam, Cornelis/0000-0001-9163-7274	French Ministry of Sport	French Ministry of Sport	This study was supported by a grant from the French Ministry of Sport. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaerts K, 2009, NEUROSCI LETT, V461, P240, DOI 10.1016/j.neulet.2009.06.055; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Babiloni C, 2009, NEUROIMAGE, V45, P512, DOI 10.1016/j.neuroimage.2008.11.035; Battelli L, 2003, NEUROPSYCHOLOGIA, V41, P1808, DOI 10.1016/S0028-3932(03)00182-9; Beauchamp MS, 2003, J COGNITIVE NEUROSCI, V15, P991, DOI 10.1162/089892903770007380; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blake R, 2007, ANNU REV PSYCHOL, V58, P47, DOI 10.1146/annurev.psych.57.102904.190152; BOITEN F, 1992, ELECTROEN CLIN NEURO, V82, P302, DOI 10.1016/0013-4694(92)90110-4; Calmels C, 2009, NEUROPHYSIOL CLIN, V39, P303, DOI 10.1016/j.neucli.2009.09.003; Calmels C, 2008, EXP BRAIN RES, V190, P389, DOI 10.1007/s00221-008-1480-z; Calmels C, 2010, PSYCHOPHYSIOLOGY, V47, P799, DOI 10.1111/j.1469-8986.2010.00985.x; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Calvo-Merino B, 2006, CURR BIOL, V16, P1905, DOI 10.1016/j.cub.2006.07.065; Cavanagh P, 2001, COGNITION, V80, P47, DOI 10.1016/S0010-0277(00)00153-0; Chandrasekaran C, 2005, 139 M PLANCK I BIOL; Chandrasekaran C, 2010, PSIHOLOGIJA, V43, P5, DOI 10.2298/PSI1001005C; Cohen J.E., 1988, STAT POWER ANAL BEHA; Fingelkurts AA, 2005, NEUROSCI BIOBEHAV R, V28, P827, DOI 10.1016/j.neubiorev.2004.10.009; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Friston KJ, 2000, PHILOS T R SOC B, V355, P215, DOI 10.1098/rstb.2000.0560; Garamszegi LZ, 2006, BEHAV ECOL, V17, P682, DOI 10.1093/beheco/ark005; Gazzola V, 2009, CEREB CORTEX, V19, P1239, DOI 10.1093/cercor/bhn181; Gerloff C, 1998, BRAIN, V121, P1513, DOI 10.1093/brain/121.8.1513; Giese MA, 2003, NAT REV NEUROSCI, V4, P179, DOI 10.1038/nrn1057; Grafton ST, 1996, EXP BRAIN RES, V112, P103; Grezes J, 2001, HUM BRAIN MAPP, V12, P1, DOI 10.1002/1097-0193(200101)12:1<1::AID-HBM10>3.0.CO;2-V; Grossman E, 2000, J COGNITIVE NEUROSCI, V12, P711, DOI 10.1162/089892900562417; Grossman ED, 2002, NEURON, V35, P1167, DOI 10.1016/S0896-6273(02)00897-8; HAXBY JV, 1991, P NATL ACAD SCI USA, V88, P1621, DOI 10.1073/pnas.88.5.1621; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Jonas M, 2007, NEUROIMAGE, V36, pT44, DOI 10.1016/j.neuroimage.2007.03.028; Kahana MJ, 2001, CURR OPIN NEUROBIOL, V11, P739, DOI 10.1016/S0959-4388(01)00278-1; Kahana MJ, 1999, NATURE, V399, P781, DOI 10.1038/21645; Klimesch W, 1996, INT J PSYCHOPHYSIOL, V24, P61, DOI 10.1016/S0167-8760(96)00057-8; Klimesch W, 1997, INT J PSYCHOPHYSIOL, V26, P319, DOI 10.1016/S0167-8760(97)00773-3; Klimesch W, 1999, COGNITIVE BRAIN RES, V7, P493, DOI 10.1016/S0926-6410(98)00056-1; KLIMESCH W, 1994, ELECTROEN CLIN NEURO, V91, P428, DOI 10.1016/0013-4694(94)90164-3; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Krause CM, 2000, CLIN NEUROPHYSIOL, V111, P2071, DOI 10.1016/S1388-2457(00)00429-6; Lagerlund TD, 2005, ELECTROENCEPHALOGRAP, P829; LONG BC, 1995, J APPL SPORT PSYCHOL, V7, P167, DOI 10.1080/10413209508406963; Manganotti P, 1998, ELECTROMYOGR MOTOR C, V109, P50, DOI 10.1016/S0924-980X(97)00074-X; MATHER G, 1992, P ROY SOC B-BIOL SCI, V249, P149, DOI 10.1098/rspb.1992.0097; Michels L, 2005, NEUROREPORT, V16, P1037, DOI 10.1097/00001756-200507130-00002; MISHKIN M, 1983, TRENDS NEUROSCI, V6, P414, DOI 10.1016/0166-2236(83)90190-X; Montez T, 2006, NEUROIMAGE, V33, P1117, DOI 10.1016/j.neuroimage.2006.06.066; Mukamel R, 2010, CURR BIOL, V20, P750, DOI 10.1016/j.cub.2010.02.045; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Nunez PL, 1997, ELECTROEN CLIN NEURO, V103, P499, DOI 10.1016/S0013-4694(97)00066-7; Nuwer MR, 1999, EEG CL N SU, V50, P150; OBRIEN RG, 1985, PSYCHOL BULL, V97, P316, DOI 10.1037/0033-2909.97.2.316; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Onton J, 2005, NEUROIMAGE, V27, P341, DOI 10.1016/j.neuroimage.2005.04.014; Parasuraman R, 2009, J EXP PSYCHOL-APPL, V15, P275, DOI 10.1037/a0017132; Passingham RE, 1996, PHILOS T ROY SOC B, V351, P1473, DOI 10.1098/rstb.1996.0132; Pavlova M, 2006, CEREB CORTEX, V16, P321, DOI 10.1093/cercorbhi108; Peuskens H, 2005, EUR J NEUROSCI, V21, P2864, DOI 10.1111/j.1460-9568.2005.04106.x; PFURTSCHELLER G, 1988, ELECTROEN CLIN NEURO, V70, P190, DOI 10.1016/0013-4694(88)90119-8; PFURTSCHELLER G, 1977, ELECTROEN CLIN NEURO, V42, P817, DOI 10.1016/0013-4694(77)90235-8; Pfurtscheller G, 1996, INT J PSYCHOPHYSIOL, V24, P39, DOI 10.1016/S0167-8760(96)00066-9; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Puce A, 2003, NEUROIMAGE, V19, P861, DOI 10.1016/S1053-8119(03)00189-7; Safford AS, 2010, J NEUROSCI, V30, P9064, DOI 10.1523/JNEUROSCI.1779-10.2010; SALMELIN R, 1994, NEUROSCIENCE, V60, P537, DOI 10.1016/0306-4522(94)90263-1; Sarnthein J, 1998, P NATL ACAD SCI USA, V95, P7092, DOI 10.1073/pnas.95.12.7092; Saygin AP, 2004, J NEUROSCI, V24, P6181, DOI 10.1523/JNEUROSCI.0504-04.2004; Schubotz RI, 2001, CEREB CORTEX, V11, P210, DOI 10.1093/cercor/11.3.210; Sokal R. H., 1995, BIOMETRY PRINCIPLES; Stam CJ, 2002, PHYSICA D, V163, P236, DOI 10.1016/S0167-2789(01)00386-4; Stam CJ, 2004, HUM BRAIN MAPP, V22, P97, DOI 10.1002/hbm.20016; Stam CJ, 2002, INT J PSYCHOPHYSIOL, V46, P53, DOI 10.1016/S0167-8760(02)00041-7; Thornton IM, 2002, PERCEPTION, V31, P837, DOI 10.1068/p3072; Ulloa ER, 2007, BEHAV BRAIN RES, V183, P188, DOI 10.1016/j.bbr.2007.06.007; Urgesi C, 2006, EUR J NEUROSCI, V23, P2522, DOI 10.1111/j.1460-9568.2006.04772.x; Vaina LM, 2001, P NATL ACAD SCI USA, V98, P11656, DOI 10.1073/pnas.191374198; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Zentgraf K, 2005, NEUROIMAGE, V26, P662, DOI 10.1016/j.neuroimage.2005.02.015	78	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e25903	10.1371/journal.pone.0025903	http://dx.doi.org/10.1371/journal.pone.0025903			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834MB	21991384	gold, Green Published, Green Submitted			2022-12-27	WOS:000295963300029
J	Hussain, R; Ansari, A; Talat, N; Hasan, Z; Dawood, G				Hussain, Rabia; Ansari, Ambreen; Talat, Najeeha; Hasan, Zahra; Dawood, Ghaffar			CCL2/MCP-I Genotype-Phenotype Relationship in Latent Tuberculosis Infection	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT; PULMONARY TUBERCULOSIS; GENE POLYMORPHISMS; HOUSEHOLD CONTACTS; MCP-1 GENE; EXPRESSION; CHEMOKINES; SUSCEPTIBILITY; ASSOCIATION; RESPONSES	Among the known biomarkers, chemokines, secreted by activated macrophages and T cells, attract groups of immune cells to the site of infection and may determine the clinical outcome. Association studies of CCL-2/MCP-1 -2518 A/G functional SNP linked to high and low phenotypes with tuberculosis disease susceptibility have shown conflicting results in tuberculosis. Some of these differences could be due the variability of latent infection and recent exposure in the control groups. We have therefore carried out a detailed analysis of CCL-2 genotype SNP -2518 (A/G transition) with plasma CCL-2 levels and related these levels to tuberculin skin test positivity in asymptomatic community controls with no known exposure to tuberculosis and in recently exposed household contacts of pulmonary tuberculosis patients. TST positivity was linked to higher concentrations of plasma CCL2 (Mann Whitney U test; p = 0.004) and was more marked when the G allele was present in TST+ asymptomatic controls (A/G; p = 0.01). Recent exposure also had a significant effect on CCL-2 levels and was linked to the G allele (p = 0.007). Therefore association studies for susceptibility or protection from disease should take into consideration the PPD status as well as recent exposure of the controls group used for comparison. Our results also suggest a role for CCL-2 in maintaining the integrity of granuloma in asymptomatic individuals with latent infection in high TB burden settings. Therefore additional studies into the role of CCL-2 in disease reactivation and progression are warranted.	[Hussain, Rabia; Ansari, Ambreen; Talat, Najeeha; Hasan, Zahra] Aga Khan Univ, Dept Pathol & Microbiol, Karachi, Pakistan; [Dawood, Ghaffar] Masoomeen Trust Hosp, Karachi, Pakistan	Aga Khan University	Hussain, R (corresponding author), Aga Khan Univ, Dept Pathol & Microbiol, Karachi, Pakistan.	rabia.hussain@aku.edu	Hasan, Zahra/F-5111-2015; Hussain, Rabia/M-6649-2015; Hasan, Zahra/AAF-2191-2020; Hussain, Rabia/E-9982-2015	Hussain, Rabia/0000-0001-9995-8742; Hasan, Zahra/0000-0001-7580-372X; 	Pakistan Academy of Sciences, Government of Pakistan [5/9/PAS/3031]	Pakistan Academy of Sciences, Government of Pakistan	The authors acknowledge the Pakistan Academy of Sciences, Government of Pakistan for providing financial support for this project through Grant No. 5/9/PAS/3031. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alagarasu K, 2009, INDIAN J MED RES, V130, P444; Ansari A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004778; Ben-Selma W, 2011, MOL BIOL REP, V38, P5413, DOI 10.1007/s11033-011-0695-4; Buijtels PCAM, 2008, INT J TUBERC LUNG D, V12, P1485; Cardona PJ, 2009, INFECTION, V37, P80, DOI 10.1007/s15010-008-8087-y; CARR MW, 1994, P NATL ACAD SCI USA, V91, P3652, DOI 10.1073/pnas.91.9.3652; Chu SF, 2007, GENES IMMUN, V8, P475, DOI 10.1038/sj.gene.6364412; CROFTON J, 1990, CROFTON DOUGLAS RESP, P395; Denkinger CM, 2011, CLIN MICROBIOL INFEC, V17, P806, DOI 10.1111/j.1469-0691.2011.03555.x; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Fenoglio C, 2004, NEUROBIOL AGING, V25, P1169, DOI 10.1016/j.neurobiolaging.2003.11.008; Flores-Villanueva PO, 2005, J EXP MED, V202, P1649, DOI 10.1084/jem.20050126; Gale LM, 1999, BIOESSAYS, V21, P17, DOI 10.1002/(SICI)1521-1878(199901)21:1<17::AID-BIES3>3.0.CO;2-4; Gonzalez E, 2002, P NATL ACAD SCI USA, V99, P13795, DOI 10.1073/pnas.202357499; Hasan Z, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-14; Hasan Z, 2006, SCAND J IMMUNOL, V63, P241, DOI 10.1111/j.1365-3083.2006.01733.x; Hasan Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008459; Hasan Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005158; Hussain R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007444; Larcombe LA, 2008, J INFECT DIS, V198, P1175, DOI 10.1086/592049; Liu ML, 2011, CYTOKINE GROWTH F R, V22, P121, DOI 10.1016/j.cytogfr.2011.06.001; Mendez A, 2011, TUBERCULOSIS, V91, P140, DOI 10.1016/j.tube.2010.12.008; Mendez-Samperio P, 2008, J INFECTION, V57, P374, DOI 10.1016/j.jinf.2008.08.010; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Moller M, 2009, TUBERCULOSIS, V89, P189, DOI 10.1016/j.tube.2008.10.001; Mori Honami, 2005, Clin Exp Nephrol, V9, P297, DOI 10.1007/s10157-005-0375-6; Rathi SK, 2002, INT J TUBERC LUNG D, V6, P851; Rovin BH, 1999, BIOCHEM BIOPH RES CO, V259, P344, DOI 10.1006/bbrc.1999.0796; Simeoni E, 2004, DIABETOLOGIA, V47, P1574, DOI 10.1007/s00125-004-1494-4; Siveke JT, 1998, J IMMUNOL, V160, P550; Tabara Y, 2003, HYPERTENS RES, V26, P677, DOI 10.1291/hypres.26.677; Talat N, 2009, SCAND J IMMUNOL, V69, P537, DOI 10.1111/j.1365-3083.2009.02250.x; Tapaninen P, 2010, INT J TUBERC LUNG D, V14, P347; Thye T, 2009, HUM MOL GENET, V18, P381, DOI 10.1093/hmg/ddn352; Wright EK, 2008, GENES IMMUN, V9, P419, DOI 10.1038/gene.2008.33; Xu Zhen-e, 2009, Zhonghua Er Ke Za Zhi, V47, P200	36	27	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e25803	10.1371/journal.pone.0025803	http://dx.doi.org/10.1371/journal.pone.0025803			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21991356	Green Published, gold, Green Submitted			2022-12-27	WOS:000295963300021
J	Pfister, CA; McCoy, SJ; Wootton, JT; Martin, PA; Colman, AS; Archer, D				Pfister, Catherine A.; McCoy, Sophie J.; Wootton, J. Timothy; Martin, Pamela A.; Colman, Albert S.; Archer, David			Rapid Environmental Change over the Past Decade Revealed by Isotopic Analysis of the California Mussel in the Northeast Pacific	PLOS ONE			English	Article							METABOLIC CARBON CONTRIBUTION; OCEAN ACIDIFICATION; CO2; COASTAL; C-13; PH; TEMPERATURE; PATTERNS; IMPACTS; RECORD	The anthropogenic input of fossil fuel carbon into the atmosphere results in increased carbon dioxide (CO2) into the oceans, a process that lowers seawater pH, decreases alkalinity and can inhibit the production of shell material. Corrosive water has recently been documented in the northeast Pacific, along with a rapid decline in seawater pH over the past decade. A lack of instrumentation prior to the 1990s means that we have no indication whether these carbon cycle changes have precedence or are a response to recent anthropogenic CO2 inputs. We analyzed stable carbon and oxygen isotopes (delta C-13, delta O-18) of decade-old California mussel shells (Mytilus californianus) in the context of an instrumental seawater record of the same length. We further compared modern shells to shells from 1000 to 1340 years BP and from the 1960s to the present and show declines in the delta C-13 of modern shells that have no historical precedent. Our finding of decline in another shelled mollusk (limpet) and our extensive environmental data show that these delta C-13 declines are unexplained by changes to the coastal food web, upwelling regime, or local circulation. Our observed decline in shell delta C-13 parallels other signs of rapid changes to the nearshore carbon cycle in the Pacific, including a decline in pH that is an order of magnitude greater than predicted by an equilibrium response to rising atmospheric CO2, the presence of low pH water throughout the region, and a record of a similarly steep decline in delta C-13 in algae in the Gulf of Alaska. These unprecedented changes and the lack of a clear causal variable underscores the need for better quantifying carbon dynamics in nearshore environments.	[Pfister, Catherine A.; McCoy, Sophie J.; Wootton, J. Timothy] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Martin, Pamela A.; Colman, Albert S.; Archer, David] Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Pfister, CA (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA.	cpfister@uchicago.edu	Martin, Pamela A/C-3678-2012; McCoy, Sophie/H-9877-2019; Wootton, J. Timothy/F-3191-2015; Archer, David/K-7371-2012	McCoy, Sophie/0000-0003-1324-1578; Wootton, J. Timothy/0000-0002-7715-0344; Archer, David/0000-0002-4523-7912	SeaDoc Foundation; Department of Defense (DoD) NDSEG; National Science Foundation (NSF); Direct For Biological Sciences [0919420] Funding Source: National Science Foundation; Directorate For Geosciences [0928232] Funding Source: National Science Foundation	SeaDoc Foundation; Department of Defense (DoD) NDSEG(United States Department of Defense); National Science Foundation (NSF)(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The SeaDoc Foundation provided funding for this study. SJM was supported by Department of Defense (DoD) NDSEG and National Science Foundation (NSF) GRFP Fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyce DG, 2010, NATURE, V466, P591, DOI 10.1038/nature09268; CANE MA, 1983, SCIENCE, V222, P1189, DOI 10.1126/science.222.4629.1189; Chan F, 2008, SCIENCE, V319, P920, DOI 10.1126/science.1149016; Coe WR, 1944, BIOL BULL-US, V87, P59, DOI 10.2307/1538129; DODD JR, 1964, J PALEONTOL, V38, P1065; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; DRUFFEL ERM, 1986, NATURE, V321, P58, DOI 10.1038/321058a0; DUGGINS DO, 1989, SCIENCE, V245, P170, DOI 10.1126/science.245.4914.170; Feely RA, 2008, SCIENCE, V320, P1490, DOI 10.1126/science.1155676; Feely RA, 2010, ESTUAR COAST SHELF S, V88, P442, DOI 10.1016/j.ecss.2010.05.004; Ford HL, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2008PA001677; Gillikin DP, 2007, GEOCHIM COSMOCHIM AC, V71, P2936, DOI 10.1016/j.gca.2007.04.003; Gruber N, 1999, GLOBAL BIOGEOCHEM CY, V13, P307, DOI 10.1029/1999GB900019; KILLINGLEY JS, 1979, SCIENCE, V205, P186, DOI 10.1126/science.205.4402.186; Kim ST, 1997, GEOCHIM COSMOCHIM AC, V61, P3461, DOI 10.1016/S0016-7037(97)00169-5; Klein RT, 1996, GEOLOGY, V24, P415, DOI 10.1130/0091-7613(1996)024<0415:BSRSST>2.3.CO;2; Lorrain A, 2004, GEOCHIM COSMOCHIM AC, V68, P3509, DOI 10.1016/j.gca.2004.01.025; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; McConnaughey TA, 2008, GEO-MAR LETT, V28, P287, DOI 10.1007/s00367-008-0116-4; McMillan AD, 1999, SCI TIME TRANSFORMER; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Ortiz JD, 2000, GLOBAL BIOGEOCHEM CY, V14, P917, DOI 10.1029/1999GB001155; Paine RT, 2004, ECOL LETT, V7, P441, DOI 10.1111/j.1461-0248.2004.00601.x; Pfister CA, 2007, LIMNOL OCEANOGR, V52, P1767, DOI 10.4319/lo.2007.52.5.1767; Provoost P, 2010, BIOGEOSCIENCES, V7, P3869, DOI 10.5194/bg-7-3869-2010; QUAY PD, 1992, SCIENCE, V256, P74, DOI 10.1126/science.256.5053.74; Schell DM, 2001, LIMNOL OCEANOGR, V46, P999; Schone BR, 2005, PALAEOGEOGR PALAEOCL, V228, P130, DOI 10.1016/j.palaeo.2005.03.049; Sonnerup RE, 1999, GLOBAL BIOGEOCHEM CY, V13, P857, DOI 10.1029/1999GB900027; Spero HJ, 1997, NATURE, V390, P497, DOI 10.1038/37333; Takahashi T, 2009, DEEP-SEA RES PT II, V56, P554, DOI 10.1016/j.dsr2.2008.12.009; Ullmann CV, 2010, CHEM GEOL, V277, P160, DOI 10.1016/j.chemgeo.2010.07.019; Williams B, 2011, BIOGEOSCIENCES, V8, P165, DOI 10.5194/bg-8-165-2011; Wootton JT, 2008, P NATL ACAD SCI USA, V105, P18848, DOI 10.1073/pnas.0810079105	34	19	19	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25766	10.1371/journal.pone.0025766	http://dx.doi.org/10.1371/journal.pone.0025766			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991348	gold, Green Published, Green Submitted			2022-12-27	WOS:000295943000067
J	Butala, NM; Desai, MM; Linnander, EL; Wong, YR; Mikhail, DG; Ott, LS; Spertus, JA; Bradley, EH; Aaty, AA; Abdelfattah, A; Gamal, A; Kholeif, H; El Baz, M; Allam, AH; Krumholz, HM				Butala, Neel M.; Desai, Mayur M.; Linnander, Erika L.; Wong, Y. Rex; Mikhail, Daoud G.; Ott, Lesli S.; Spertus, John A.; Bradley, Elizabeth H.; Aaty, Ahmed Abdel; Abdelfattah, Alia; Gamal, Ayman; Kholeif, Hatem; El Baz, Mohamed; Allam, A. H.; Krumholz, Harlan M.			Gender Differences in Presentation, Management, and In-Hospital Outcomes for Patients with AMI in a Lower-Middle Income Country: Evidence from Egypt	PLOS ONE			English	Article							ACUTE-CORONARY-SYNDROME; ACUTE MYOCARDIAL-INFARCTION; SEX-DIFFERENCES; WOMEN; MEN; SYMPTOMS; REGISTRY; IMPACT	Background: Many studies in high-income countries have investigated gender differences in the care and outcomes of patients hospitalized with acute myocardial infarction (AMI). However, little evidence exists on gender differences among patients with AMI in lower-middle-income countries, where the proportion deaths stemming from cardiovascular disease is projected to increase dramatically. This study examines gender differences in patients in the lower-middle-income country of Egypt to determine if female patients with AMI have a different presentation, management, or outcome compared with men. Methods and Findings: Using registry data collected over 18 months from 5 Egyptian hospitals, we considered 1204 patients (253 females, 951 males) with a confirmed diagnosis of AMI. We examined gender differences in initial presentation, clinical management, and in-hospital outcomes using t-tests and x(2) tests. Additionally, we explored gender differences in in-hospital death using multivariate logistic regression to adjust for age and other differences in initial presentation. We found that women were older than men, had higher BMI, and were more likely to have hypertension, diabetes mellitus, dyslipidemia, heart failure, and atrial fibrillation. Women were less likely to receive aspirin upon admission (p<0.01) or aspirin or statins at discharge (p = 0.001 and p<0.05, respectively), although the magnitude of these differences was small. While unadjusted in-hospital mortality was significantly higher for women (OR: 2.10; 95% CI: 1.54 to 2.87), this difference did not persist in the fully adjusted model (OR: 1.18; 95% CI: 0.55 to 2.55). Conclusions: We found that female patients had a different profile than men at the time of presentation. Clinical management of men and women with AMI was similar, though there are small but significant differences in some areas. These gender differences did not translate into differences in in-hospital outcome, but highlight differences in quality of care and represent important opportunities for improvement.	[Butala, Neel M.; Desai, Mayur M.; Bradley, Elizabeth H.; Krumholz, Harlan M.] Yale Univ, Robert Wood Johnson Clin Scholars Program, Dept Internal Med, Sch Med, New Haven, CT 06520 USA; [Desai, Mayur M.; Linnander, Erika L.; Wong, Y. Rex; Bradley, Elizabeth H.; Krumholz, Harlan M.] Yale Univ, Sch Publ Hlth, New Haven, CT USA; [Desai, Mayur M.; Mikhail, Daoud G.; Ott, Lesli S.; Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; [Spertus, John A.] St Lukes Hosp, Mid Amer Heart Inst, Kansas City, MO 64111 USA; [Spertus, John A.] Univ Missouri, Kansas City Sch Med, Kansas City, MO 64110 USA; [Aaty, Ahmed Abdel] Univ Alexandria, Alexandria, Egypt; [Abdelfattah, Alia] Cairo Univ, Cairo, Egypt; [Gamal, Ayman] Medinat Nasr Hosp, Cairo, Egypt; [Kholeif, Hatem; El Baz, Mohamed; Allam, A. H.] Al Azhar Univ, Cairo, Egypt	Yale University; Yale University; Yale University; Saint Luke's Hospital - Missouri; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; Egyptian Knowledge Bank (EKB); Alexandria University; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Al Azhar University	Butala, NM (corresponding author), Yale Univ, Robert Wood Johnson Clin Scholars Program, Dept Internal Med, Sch Med, New Haven, CT 06520 USA.	neel.butala@yale.edu	, Harlan/AAI-2875-2020; Spertus, John/ABD-3075-2021	Desai, Mayur/0000-0001-6616-0945; Linnander, Erika/0000-0002-3417-1049	National Bank of Egypt; Wilbur Downs Fellowship	National Bank of Egypt; Wilbur Downs Fellowship	This research was supported by the National Bank of Egypt and the Wilbur Downs Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfredsson J, 2007, HEART, V93, P1357, DOI 10.1136/hrt.2006.102012; Anand SS, 2005, J AM COLL CARDIOL, V46, P1845, DOI 10.1016/j.jacc.2005.05.091; Arslanian-Engoren C, 2006, AM J CARDIOL, V98, P1177, DOI 10.1016/j.amjcard.2006.05.049; Beaglehole R., 2003, WORLD HLTH REPORT 20; Bello N, 2004, PROG CARDIOVASC DIS, V46, P287, DOI 10.1016/j.pcad.2003.08.001; Cannon CP, 2001, J AM COLL CARDIOL, V38, P2114, DOI 10.1016/S0735-1097(01)01702-8; Centers for Medicare & Medicaid Services The Joint Commission, 2011, SPEC MAN NAT HOSP IN; Dey S, 2009, HEART, V95, P20, DOI 10.1136/hrt.2007.138537; El-Menyar A, 2009, AM J CARDIOL, V104, P1018, DOI 10.1016/j.amjcard.2009.06.003; Hasdai D, 2003, AM J CARDIOL, V91, P1466, DOI 10.1016/S0002-9149(03)00400-4; Heer T, 2006, AM J CARDIOL, V98, P160, DOI 10.1016/j.amjcard.2006.01.072; Hochman JS, 1999, NEW ENGL J MED, V341, P226, DOI 10.1056/NEJM199907223410402; Jneid H, 2008, CIRCULATION, V118, P2803, DOI 10.1161/CIRCULATIONAHA.108.789800; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Meischke H, 1998, AM J EMERG MED, V16, P363, DOI 10.1016/S0735-6757(98)90128-0; Njolstad I, 1996, CIRCULATION, V93, P450; Peterson ED, 2010, HEART, V96, P1798, DOI 10.1136/hrt.2010.200261; Radovanovic D, 2007, HEART, V93, P1369, DOI 10.1136/hrt.2006.106781; Safavi K, 2010, ASIA-PAC J PUBLIC HE, V22, p90S, DOI 10.1177/1010539510373017; Shafey O, 2003, TOBACCO CONTROL COUN; SHAW LJ, 1994, ANN INTERN MED, V120, P559, DOI 10.7326/0003-4819-120-7-199404010-00005; Song XT, 2007, CHINESE MED J-PEKING, V120, P1063, DOI 10.1097/00029330-200706020-00007; Srichaiveth Boonchu, 2007, Journal of the Medical Association of Thailand, V90, P65; Vaccarino V, 2005, NEW ENGL J MED, V353, P671, DOI 10.1056/NEJMsa032214; Vaccarino V, 1998, ARCH INTERN MED, V158, P2054, DOI 10.1001/archinte.158.18.2054; World Bank Group, 2011, COUNTR LEND GROUPS; World Health Organization (WHO), 2006, HLTH SYST PROF EG; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; ZUBAID M, 2007, PRELIMINARY RESULTS	29	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e25904	10.1371/journal.pone.0025904	http://dx.doi.org/10.1371/journal.pone.0025904			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022463	Green Submitted, gold, Green Published			2022-12-27	WOS:000295978600031
J	Sivakumaran, TA; Igo, RP; Kidd, JM; Itsara, A; Kopplin, LJ; Chen, W; Hagstrom, SA; Peachey, NS; Francis, PJ; Klein, ML; Chew, EY; Ramprasad, VL; Tay, WT; Mitchell, P; Seielstad, M; Stambolian, DE; Edwards, AO; Lee, KE; Leontiev, DV; Jun, G; Wang, Y; Tian, LP; Qiu, FY; Henning, AK; LaFramboise, T; Sen, P; Aarthi, M; George, R; Raman, R; Das, MK; Vijaya, L; Kumaramanickavel, G; Wong, TY; Swaroop, A; Abecasis, GR; Klein, R; Klein, BEK; Nickerson, DA; Eichler, EE; Iyengar, SK				Sivakumaran, Theru A.; Igo, Robert P., Jr.; Kidd, Jeffrey M.; Itsara, Andy; Kopplin, Laura J.; Chen, Wei; Hagstrom, Stephanie A.; Peachey, Neal S.; Francis, Peter J.; Klein, Michael L.; Chew, Emily Y.; Ramprasad, Vedam L.; Tay, Wan-Ting; Mitchell, Paul; Seielstad, Mark; Stambolian, Dwight E.; Edwards, Albert O.; Lee, Kristine E.; Leontiev, Dmitry V.; Jun, Gyungah; Wang, Yang; Tian, Liping; Qiu, Feiyou; Henning, Alice K.; LaFramboise, Thomas; Sen, Parveen; Aarthi, Manoharan; George, Ronnie; Raman, Rajiv; Das, Manmath Kumar; Vijaya, Lingam; Kumaramanickavel, Govindasamy; Wong, Tien Y.; Swaroop, Anand; Abecasis, Goncalo R.; Klein, Ronald; Klein, Barbara E. K.; Nickerson, Deborah A.; Eichler, Evan E.; Iyengar, Sudha K.			A 32 kb Critical Region Excluding Y402H in CFH Mediates Risk for Age-Related Macular Degeneration	PLOS ONE			English	Article							COMPLEMENT FACTOR-H; SEGMENTAL DUPLICATIONS; SUSCEPTIBILITY; HAPLOTYPE; VARIANT; GENOME; GENES; ASSOCIATION; MACULOPATHY; PROTEINS	Complement factor H shows very strong association with Age-related Macular Degeneration (AMD), and recent data suggest that multiple causal variants are associated with disease. To refine the location of the disease associated variants, we characterized in detail the structural variation at CFH and its paralogs, including two copy number polymorphisms (CNP), CNP147 and CNP148, and several rare deletions and duplications. Examination of 34 AMD-enriched extended families (N = 293) and AMD cases (White N = 4210 Indian = 134; Malay = 140) and controls (White N = 3229; Indian = 117; Malay = 2390) demonstrated that deletion CNP148 was protective against AMD, independent of SNPs at CFH. Regression analysis of seven common haplotypes showed three haplotypes, H1, H6 and H7, as conferring risk for AMD development. Being the most common haplotype H1 confers the greatest risk by increasing the odds of AMD by 2.75-fold (95% CI = [2.51, 3.01]; p = 8.31 x 10(-109)); Caucasian (H6) and Indian-specific (H7) recombinant haplotypes increase the odds of AMD by 1.85-fold (p = 3.52 x 10(-9)) and by 15.57-fold (P = 0.007), respectively. We identified a 32-kb region downstreamof Y402H (rs1061170), shared by all three risk haplotypes, suggesting that this region may be critical for AMD development. Further analysis showed that two SNPs within the 32 kb block, rs1329428 and rs203687, optimally explain disease association. rs1329428 resides in 20 kb unique sequence block, but rs203687 resides in a 12 kb block that is 89% similar to a noncoding region contained in Delta CNP148. We conclude that causal variation in this region potentially encompasses both regulatory effects at single markers and copy number.	[Sivakumaran, Theru A.; Igo, Robert P., Jr.; Leontiev, Dmitry V.; Jun, Gyungah; Wang, Yang; Tian, Liping; Qiu, Feiyou] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Sivakumaran, Theru A.] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH USA; [Kopplin, Laura J.; LaFramboise, Thomas; Iyengar, Sudha K.] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; [Iyengar, Sudha K.] Case Western Reserve Univ, Dept Ophthalmol, Cleveland, OH 44106 USA; [Kidd, Jeffrey M.; Itsara, Andy; Nickerson, Deborah A.; Eichler, Evan E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Chen, Wei; Abecasis, Goncalo R.] Univ Michigan Sch Publ Hlth, Ctr Stat Genet, Dept Biostat, Ann Arbor, MI USA; [Hagstrom, Stephanie A.; Peachey, Neal S.] Cleveland Clin, Cole Eye Inst, Cleveland, OH 44106 USA; [Hagstrom, Stephanie A.; Peachey, Neal S.] Case Western Reserve Univ, Dept Ophthalmol, Cleveland Clin Lerner Coll Med, Cleveland, OH 44106 USA; [Peachey, Neal S.] Vet Affairs Med Ctr, Louis Stokes Cleveland Dept, Res Serv, Cleveland, OH USA; [Francis, Peter J.; Klein, Michael L.] Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA; [Chew, Emily Y.] NEI, Div Epidemiol & Clin Applicat, Bethesda, MD 20892 USA; [Ramprasad, Vedam L.; Aarthi, Manoharan; Kumaramanickavel, Govindasamy] Sankara Nethralaya, Vis Res Fdn, SNONGC Dept Genet & Mol Biol, Chennai, Tamil Nadu, India; [Tay, Wan-Ting; Wong, Tien Y.] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore Eye Res Inst, Singapore 117595, Singapore; [Mitchell, Paul] Univ Sydney, Ctr Vis Res, Sydney, NSW 2006, Australia; [Seielstad, Mark] Genome Inst Singapore, Singapore, Singapore; [Stambolian, Dwight E.] Univ Penn, Dept Ophthalmol, Philadelphia, PA 19104 USA; [Stambolian, Dwight E.] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; [Edwards, Albert O.] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; [Lee, Kristine E.; Klein, Ronald; Klein, Barbara E. K.] Univ Wisconsin Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, Madison, WI USA; [Jun, Gyungah] Boston Univ, Dept Med, Boston, MA 02215 USA; [Jun, Gyungah] Boston Univ, Dept Ophthalmol, Boston, MA 02215 USA; [Jun, Gyungah] Boston Univ, Dept Biostat, Boston, MA 02215 USA; [Henning, Alice K.] EMMES Corp, Rockville, MD USA; [Sen, Parveen; Raman, Rajiv; Das, Manmath Kumar; Vijaya, Lingam] Sankara Nethralaya, Vis Res Fdn, Dept Med Retina, Chennai, Tamil Nadu, India; [George, Ronnie] Sankara Nethralaya, Vis Res Fdn, Dept Glaucoma, Chennai, Tamil Nadu, India; [Wong, Tien Y.] Univ Melbourne, Ctr Eye Res Australia, Melbourne, Australia; [Swaroop, Anand] NEI, Neurobiol Neurodegenerat & Repair Lab, Bethesda, MD 20892 USA; [Swaroop, Anand] Univ Michigan, Kellogg Eye Ctr, Ann Arbor, MI 48109 USA; [Swaroop, Anand] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	Case Western Reserve University; Cincinnati Children's Hospital Medical Center; Case Western Reserve University; Case Western Reserve University; University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Oregon Health & Science University; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National University of Singapore; Singapore National Eye Center; University of Sydney; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of Pennsylvania; University of Pennsylvania; University of Oregon; University of Wisconsin System; Boston University; Boston University; Boston University; Emmes Corporation; Centre for Eye Research Australia; University of Melbourne; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Sivakumaran, TA (corresponding author), Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA.	ski@case.edu	Peachey, Neal/G-5533-2010; Wong, Tien Yin/AAC-9724-2020; KUMARAMANICKAVEL, GOVINDASAMY/AAN-9203-2021; Sen, Parveen/W-4707-2019; Raman, Rajiv/A-7234-2009; Seielstad, Mark/T-7841-2019; Mitchell, Paul/P-1498-2014; /S-1190-2019; Chen, Wei/AAX-5994-2020; Igo, Rob/P-3438-2019	Peachey, Neal/0000-0002-4419-7226; Wong, Tien Yin/0000-0002-8448-1264; KUMARAMANICKAVEL, GOVINDASAMY/0000-0001-8516-8301; Raman, Rajiv/0000-0001-5842-0233; /0000-0001-7488-250X; Chen, Wei/0000-0001-7196-8703; Igo, Rob/0000-0002-0024-1993; Seielstad, Mark/0000-0001-5783-1401; Abecasis, Goncalo/0000-0003-1509-1825; george, ronnie/0000-0001-7368-0252; Manoharan, Aarthi/0000-0003-2318-2786; Jun, Gyungah/0000-0002-3230-8697; Kidd, Jeffrey/0000-0002-9631-1465; Swaroop, Anand/0000-0002-1975-1141; Klein, Ronald/0000-0002-4428-6237	National Eye Institute [EY015810, U10EY06594, EY015286, EY13438, EY10605, T32 EY007157]; Retina Research Foundation; Department of Biotechnology, Government of India, New Delhi, India [DBT/PR7788/MED/12/299/2006]; National Heart, Lung, and Blood Institute [HL07567]; National Institute of Diabetes and Digestive and Kidney Diseases [U01DK057292]; National Institutes of Health [T32 GM07250]; Singapore's National Medical Research Council [0796/2003, 0863/2004, CSI/0002/2005]; Biomedical Research Council [501/1/25-5]; Singapore Tissue Network; U.S. Public Health Service Resource from National Center for Research Resources [RR03655]; Gene Expression and Genotyping Facility of the Comprehensive Cancer Center at Case Western Reserve University; University Hospitals of Cleveland [P30CA43703]; NATIONAL CANCER INSTITUTE [P30CA043703] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY010605, T32EY007157, R03EY013438, R01EY015286, U10EY006594, ZIAEY000475, R01EY015810] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK057292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266, T32GM007250] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Retina Research Foundation; Department of Biotechnology, Government of India, New Delhi, India(Department of Biotechnology (DBT) India); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Singapore's National Medical Research Council(National Medical Research Council, Singapore); Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Singapore Tissue Network; U.S. Public Health Service Resource from National Center for Research Resources; Gene Expression and Genotyping Facility of the Comprehensive Cancer Center at Case Western Reserve University; University Hospitals of Cleveland; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported, in part, by EY015810, U10EY06594, EY015286, EY13438, EY10605 and T32 EY007157 from the National Eye Institute; the Retina Research Foundation; the Department of Biotechnology (DBT/PR7788/MED/12/299/2006), Government of India, New Delhi, India (GK); training grant HL07567, from the National Heart, Lung, and Blood Institute; U01DK057292 from the National Institute of Diabetes and Digestive and Kidney Diseases; and the Medical Sciences Training Program T32 GM07250 (LJK), National Institutes of Health; grants from Singapore's National Medical Research Council Grant (0796/2003, 0863/2004 and CSI/0002/2005), Biomedical Research Council (501/1/25-5) and Singapore Tissue Network. Some of the analyses were carried out using the software package S.A.G.E., which is supported by a U.S. Public Health Service Resource Grant (RR03655) from the National Center for Research Resources. This research was also supported by the Gene Expression and Genotyping Facility of the Comprehensive Cancer Center at Case Western Reserve University and University Hospitals of Cleveland (P30CA43703). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Chen W, 2010, P NATL ACAD SCI USA, V107, P7401, DOI 10.1073/pnas.0912702107; Dewan A, 2007, CURR OPIN GENET DEV, V17, P228, DOI 10.1016/j.gde.2007.04.004; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Eichler EE, 2007, NATURE, V447, P161, DOI 10.1038/447161a; Fagerness JA, 2009, EUR J HUM GENET, V17, P100, DOI 10.1038/ejhg.2008.140; Francis PJ, 2008, HUM MOL GENET, V17, P2673, DOI 10.1093/hmg/ddn167; Fritsche LG, 2010, HUM MOL GENET, V19, P4694, DOI 10.1093/hmg/ddq399; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Hageman GS, 2006, ANN MED, V38, P592, DOI 10.1080/07853890601097030; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hakobyan S, 2008, INVEST OPHTH VIS SCI, V49, P1983, DOI 10.1167/iovs.07-1523; Heinen S, 2009, BLOOD, V114, P2439, DOI 10.1182/blood-2009-02-205641; Hellwage J, 1999, FEBS LETT, V462, P345, DOI 10.1016/S0014-5793(99)01554-9; Huang L, 2009, AM J HUM GENET, V84, P235, DOI 10.1016/j.ajhg.2009.01.013; Hughes AE, 2006, NAT GENET, V38, P1173, DOI 10.1038/ng1890; Iyengar SK, 2004, AM J HUM GENET, V74, P20, DOI 10.1086/380912; Jokiranta TS, 2000, J BIOL CHEM, V275, P27657; Jozsi M, 2008, TRENDS IMMUNOL, V29, P380, DOI 10.1016/j.it.2008.04.008; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kidd JM, 2008, GENOME RES, V18, P2016, DOI 10.1101/gr.081786.108; KLEIN R, 1992, OPHTHALMOLOGY, V99, P933; Klein R, 2002, AM J EPIDEMIOL, V156, P589, DOI 10.1093/aje/kwf092; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kopplin LJ, 2010, GENES IMMUN, V11, P609, DOI 10.1038/gene.2010.39; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Li M, 2006, NAT GENET, V38, P1049, DOI 10.1038/ng1871; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Marchini J, 2006, AM J HUM GENET, V78, P437, DOI 10.1086/500808; Marques-Bonet T, 2009, NATURE, V457, P877, DOI 10.1038/nature07744; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Patel N, 2008, EYE, V22, P768, DOI 10.1038/sj.eye.6702844; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raychaudhuri S, 2010, NAT GENET, V42, P553, DOI 10.1038/ng0710-553; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Schick JH, 2003, AM J HUM GENET, V72, P1412, DOI 10.1086/375500; Seddon JM, 2009, INVEST OPHTH VIS SCI, V50, P2044, DOI 10.1167/iovs.08-3064; Spencer KL, 2008, HUM MOL GENET, V17, P971, DOI 10.1093/hmg/ddm369; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Swaroop A, 2009, ANNU REV GENOM HUM G, V10, P19, DOI 10.1146/annurev.genom.9.081307.164350; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson CL, 2007, HUM MOL GENET, V16, P2135, DOI 10.1093/hmg/ddm164; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618	46	45	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25598	10.1371/journal.pone.0025598	http://dx.doi.org/10.1371/journal.pone.0025598			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022419	Green Published, gold			2022-12-27	WOS:000295976000025
J	Nagaraja, SB; Satyanarayana, S; Chadha, SS; Kalemane, S; Jaju, J; Achanta, S; Reddy, K; Potharaju, V; Shamrao, SRM; Dewan, P; Rony, Z; Tetali, S; Anchala, R; Kannuri, NK; Harries, AD; Singh, SK				Nagaraja, Sharath Burugina; Satyanarayana, Srinath; Chadha, Sarabjit Singh; Kalemane, Santosha; Jaju, Jyoti; Achanta, Shanta; Reddy, Kishore; Potharaju, Vishnu; Shamrao, Srinivas Rao Motta; Dewan, Puneet; Rony, Zachariah; Tetali, Shailaja; Anchala, Raghupathi; Kannuri, Nanda Kishore; Harries, Anthony David; Singh, Sachdeva Kuldeep			How Do Patients Who Fail First-Line TB Treatment but Who Are Not Placed on an MDR-TB Regimen Fare in South India?	PLOS ONE			English	Article							CHEMOTHERAPY; TUBERCULOSIS; OUTCOMES	Setting: Seven districts in Andhra Pradesh, South India Objectives: To a) determine treatment outcomes of patients who fail first line anti-TB treatment and are not placed on an multi-drug resistant TB (MDR-TB) regimen, and b) relate the treatment outcomes to culture and drug susceptibility patterns (C&DST). Design: Retrospective cohort study using routine programme data and Mycobacterium TB Culture C&DST between July 2008 and December 2009. Results: There were 202 individuals given a re-treatment regimen and included in the study. Overall treatment outcomes were: 68 (34%) with treatment success, 84 (42%) failed, 36 (18%) died, 13 (6.5%) defaulted and 1 transferred out. Treatment success for category I and II failures was low at 37%. In those with positive cultures, 81 had pan-sensitive strains with 31 (38%) showing treatment success, while 61 had drug-resistance strains with 9 (15%) showing treatment success. In 58 patients with negative cultures, 28 (48%) showed treatment success. Conclusion: Treatment outcomes of patients who fail a first-line anti-TB treatment and who are not placed on an MDR-TB regimen are unacceptably poor. The worst outcomes are seen among category II failures and those with negative cultures or drug-resistance. There are important programmatic implications which need to be addressed.	[Nagaraja, Sharath Burugina; Jaju, Jyoti; Achanta, Shanta; Dewan, Puneet] Off WHO Representat India, New Delhi, India; [Satyanarayana, Srinath; Chadha, Sarabjit Singh; Harries, Anthony David] Int Union Against TB & Lung Dis The Union, Paris, France; [Kalemane, Santosha] Impact Hlth Solut, Hyderabad, Andhra Pradesh, India; [Reddy, Kishore; Potharaju, Vishnu] State TB Training & Demonstrat Ctr, Hyderabad, Andhra Pradesh, India; [Shamrao, Srinivas Rao Motta] State TB Cell, Directorate Hlth Serv, Hyderabad, Andhra Pradesh, India; [Rony, Zachariah] Med Sans Frontieres, Med Dept Operat Res, Brussels Operat Ctr, Luxembourg, Luxembourg; [Tetali, Shailaja; Anchala, Raghupathi; Kannuri, Nanda Kishore] Publ Hlth Fdn India, Indian Inst Publ Hlth Hyderabad, Hyderabad, Andhra Pradesh, India; [Singh, Sachdeva Kuldeep] Govt India, Cent TB Div, Minist Hlth & Family Welf, New Delhi, India; [Harries, Anthony David] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England	World Health Organization; Doctors Without Borders; Public Health Foundation of India; University of London; London School of Hygiene & Tropical Medicine	Nagaraja, SB (corresponding author), Off WHO Representat India, New Delhi, India.	sharathb@rntcp.org	Nagaraja, Sharath Burugina/ABD-7238-2021; Nagaraja, Sharath Burugina/ABD-7748-2021	Nagaraja, Sharath Burugina/0000-0002-6599-5753; Nagaraja, Sharath Burugina/0000-0002-6599-5753; Kannuri, Nanda Kishore/0000-0003-2352-6972; zachariah, rony/0000-0002-2915-9328; Satyanarayana, Srinath/0000-0002-5420-2551; Anchala, Raghupathy/0000-0003-4733-211X	Centre for Operational Research at The International Union against Tuberculosis and Lung Disease (The Union); Public Health Foundation of India	Centre for Operational Research at The International Union against Tuberculosis and Lung Disease (The Union); Public Health Foundation of India	The research was supported through an operational research course which was funded through a memorandum of understanding between the Centre for Operational Research at The International Union against Tuberculosis and Lung Disease (The Union) and the Public Health Foundation of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Central TB Division, 2006, PROC MAN REV NAT TUB; Central Tuberculosis Division, 2005, TECHN OP GUID TUB CO; Central Tuberculosis Division, 2010, DOTS PLUS GUID; Central Tuberculosis Division, 2010, TUB IND 2010; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Matthys F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007954; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; World Health Organization, 2003, TREATM TUB GUID NAT	10	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e25698	10.1371/journal.pone.0025698	http://dx.doi.org/10.1371/journal.pone.0025698			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022433	Green Published, gold, Green Submitted			2022-12-27	WOS:000295973200012
J	Vogt, KE; Gerharz, S; Graham, J; Canepari, M				Vogt, Kaspar E.; Gerharz, Stephan; Graham, Jeremy; Canepari, Marco			Combining Membrane Potential Imaging with L-Glutamate or GABA Photorelease	PLOS ONE			English	Article							METABOTROPIC SLOW EPSC; CA1 PYRAMIDAL NEURONS; INOSITOL TRISPHOSPHATE; PURKINJE NEURONS; LASER PHOTOLYSIS; CAGED COMPOUNDS; RAT; VOLTAGE; RECEPTORS; RELEASE	Combining membrane potential imaging using voltage sensitive dyes with photolysis of L-glutamate or GABA allows the monitoring of electrical activity elicited by the neurotransmitter at different sub-cellular sites. Here we describe a simple system and some basic experimental protocols to achieve these measurements. We show how to apply the neurotransmitter and how to vary the dimension of the area of photolysis. We assess the localisation of photolysis and of the recorded membrane potential changes by depolarising the dendrites of cerebellar Purkinje neurons with L-glutamate photorelease using different experimental protocols. We further show in the apical dendrites of CA1 hippocampal pyramidal neurons how L-glutamate photorelease can be used to calibrate fluorescence changes from voltage sensitive dyes in terms of membrane potential changes (in mV) and how GABA photorelease can be used to investigate the phenomenon of shunting inhibition. We also show how GABA photorelease can be used to measure chloride-mediated changes of membrane potential under physiological conditions originating from different regions of a neuron, providing important information on the local intracellular chloride concentrations. The method and the proof of principle reported here open the gateway to a variety of important applications where the advantages of this approach are necessary.	[Vogt, Kaspar E.; Gerharz, Stephan; Canepari, Marco] Univ Basel, Biozentrum, Div Pharmacol & Neurobiol, Basel, Switzerland; [Graham, Jeremy] CAIRN Res Ltd, Faversham, England; [Canepari, Marco] INSERM, U836, Team 3, Grenoble, France; [Canepari, Marco] Univ Grenoble 1, Inst Neurosci, Grenoble, France	University of Basel; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Vogt, KE (corresponding author), Univ Basel, Biozentrum, Div Pharmacol & Neurobiol, Basel, Switzerland.	marco.canepari@ujf-grenoble.fr	Canepari, Marco/AAJ-6709-2021; Canepari, Marco/H-6772-2012	Canepari, Marco/0000-0001-9759-2388; Canepari, Marco/0000-0001-9759-2388; Vogt, Kaspar/0000-0002-0859-876X	Swiss National Science Foundation [3100A0_122000]; Agence nationale de la recherche [Voltimagmicro, Emergence-10]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Agence nationale de la recherche(French National Research Agency (ANR))	The experiments (new equipment and running costs) were purchased with the grant of the Swiss National Science Foundation (grant 3100A0_122000). The publication fee is covered by the grant of the Agence nationale de la recherche (grant: Voltimagmicro, Emergence-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRY PH, 1994, J NEUROSCI METH, V51, P107, DOI 10.1016/0165-0270(94)90031-0; Canepari M, 2004, J NEUROSCI, V24, P3563, DOI 10.1523/JNEUROSCI.5374-03.2004; Canepari M, 2003, J NEUROSCI, V23, P4066; Canepari M, 2001, J PHYSIOL-LONDON, V533, P765, DOI 10.1111/j.1469-7793.2001.00765.x; Canepari M, 2001, J NEUROSCI METH, V112, P29, DOI 10.1016/S0165-0270(01)00451-4; Canepari M, 2007, J PHYSIOL-LONDON, V580, P463, DOI 10.1113/jphysiol.2006.125005; Canepari M, 2006, J PHYSIOL-LONDON, V573, P65, DOI 10.1113/jphysiol.2005.103770; Canepari M, 2010, BIOPHYS J, V98, P2032, DOI 10.1016/j.bpj.2010.01.024; Canepari M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004011; Canepari M, 2008, CELL MOL NEUROBIOL, V28, P1079, DOI 10.1007/s10571-008-9285-y; Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; Cash S, 1999, NEURON, V22, P383, DOI 10.1016/S0896-6273(00)81098-3; CHERUBINI E, 1991, TRENDS NEUROSCI, V14, P515, DOI 10.1016/0166-2236(91)90003-D; Djurisic M, 2004, J NEUROSCI, V24, P6703, DOI 10.1523/JNEUROSCI.0307-04.2004; Gasparini S, 2002, J PHYSIOL-LONDON, V541, P665, DOI 10.1113/jphysiol.2002.020503; Graham BP, 2001, NETWORK-COMP NEURAL, V12, P473, DOI 10.1088/0954-898X/12/4/304; Gulledge AT, 2003, NEURON, V37, P299, DOI 10.1016/S0896-6273(02)01146-7; Khirug S, 2008, J NEUROSCI, V28, P4635, DOI 10.1523/JNEUROSCI.0908-08.2008; KHODAKHAH K, 1995, J PHYSIOL-LONDON, V487, P343, DOI 10.1113/jphysiol.1995.sp020884; KHODAKHAH K, 1993, P NATL ACAD SCI USA, V90, P4976, DOI 10.1073/pnas.90.11.4976; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; M Canepari, MEMBRANE POTENTIAL I; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Mann EO, 2007, TRENDS NEUROSCI, V30, P343, DOI 10.1016/j.tins.2007.05.003; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2010, NAT CHEM BIOL, V6, P255, DOI [10.1038/nchembio.321, 10.1038/NCHEMBIO.321]; MCCRAY JA, 1989, ANNU REV BIOPHYS BIO, V18, P239, DOI 10.1146/annurev.biophys.18.1.239; Pettit DL, 1997, NEURON, V19, P465, DOI 10.1016/S0896-6273(00)80361-X; Pettit DL, 2000, J NEUROPHYSIOL, V84, P28, DOI 10.1152/jn.2000.84.1.28; Routh BN, 2009, J NEUROPHYSIOL, V102, P2288, DOI 10.1152/jn.00082.2009; Sobie EA, 2007, PFLUG ARCH EUR J PHY, V454, P663, DOI 10.1007/s00424-007-0229-z; STUART G, 1994, NEURON, V13, P703, DOI 10.1016/0896-6273(94)90037-X; Szabadics J, 2006, SCIENCE, V311, P233, DOI 10.1126/science.1121325; Trigo FF, 2010, NEURON, V66, P235, DOI 10.1016/j.neuron.2010.03.030; Trigo FF, 2009, J NEUROSCI METH, V181, P159, DOI 10.1016/j.jneumeth.2009.04.022; Trigo FF, 2009, J NEUROSCI METH, V180, P9, DOI 10.1016/j.jneumeth.2009.01.032; Vogt KE, 2011, J PHYSIOL-LONDON, V589, P489, DOI 10.1113/jphysiol.2010.200220; WANG SSH, 1995, NEURON, V15, P755, DOI 10.1016/0896-6273(95)90167-1	38	22	25	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e24911	10.1371/journal.pone.0024911	http://dx.doi.org/10.1371/journal.pone.0024911			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022367	Green Published, gold, Green Submitted			2022-12-27	WOS:000295973200003
J	Barzegar, A; Moosavi-Movahedi, AA				Barzegar, Abolfazl; Moosavi-Movahedi, Ali A.			Intracellular ROS Protection Efficiency and Free Radical-Scavenging Activity of Curcumin	PLOS ONE			English	Article							OXIDATIVE STRESS; ANTIOXIDANT MECHANISM; LIPID-PEROXIDATION; IN-VIVO; DISEASE; METABOLISM; THERAPY; DAMAGE; BRAIN; MODEL	Curcumin has many pharmaceutical applications, many of which arise from its potent antioxidant properties. The present research examined the antioxidant activities of curcumin in polar solvents by a comparative study using ESR, reduction of ferric iron in aqueous medium and intracellular ROS/toxicity assays. ESR data indicated that the steric hindrance among adjacent big size groups within a galvinoxyl molecule limited the curcumin to scavenge galvinoxyl radicals effectively, while curcumin showed a powerful capacity for scavenging intracellular smaller oxidative molecules such as H(2)O(2), HO(center dot), ROO(center dot). Cell viability and ROS assays demonstrated that curcumin was able to penetrate into the polar medium inside the cells and to protect them against the highly toxic and lethal effects of cumene hydroperoxide. Curcumin also showed good electron-transfer capability, with greater activity than trolox in aqueous solution. Curcumin can readily transfer electron or easily donate H-atom from two phenolic sites to scavenge free radicals. The excellent electron transfer capability of curcumin is because of its unique structure and different functional groups, including a beta-diketone and several pi electrons that have the capacity to conjugate between two phenyl rings. Therfore, since curcumin is inherently a lipophilic compound, because of its superb intracellular ROS scavenging activity, it can be used as an effective antioxidant for ROS protection within the polar cytoplasm.	[Barzegar, Abolfazl] Univ Tabriz, Res Inst Fundamental Sci RIFS, Tabriz, Iran; [Moosavi-Movahedi, Ali A.] Univ Tehran, Inst Biochem & Biophys, Tehran, Iran	University of Tabriz; University of Tehran	Barzegar, A (corresponding author), Univ Tabriz, Res Inst Fundamental Sci RIFS, Tabriz, Iran.	barzegar@tabrizu.ac.ir	Moosavi-Movahedi, Ali A./K-7453-2013	Moosavi-Movahedi, Ali Akbar/0000-0002-1707-8432; Barzegar, Abolfazl/0000-0002-1237-0848	Iran National Science Foundation (INSF); Research Institute for Fundamental Sciences (RIFS)-University of Tabriz	Iran National Science Foundation (INSF)(Iran National Science Foundation (INSF)); Research Institute for Fundamental Sciences (RIFS)-University of Tabriz	Financial support was provided by the Iran National Science Foundation (INSF) and the Research Institute for Fundamental Sciences (RIFS)-University of Tabriz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali SS, 2008, FOOD RES INT, V41, P1, DOI 10.1016/j.foodres.2007.10.001; Angelopoulou R, 2009, REPROD TOXICOL, V28, P167, DOI 10.1016/j.reprotox.2009.04.003; Arun N, 2002, PLANT FOOD HUM NUTR, V57, P41, DOI 10.1023/A:1013106527829; Ayala A, 1996, J BIOL CHEM, V271, P23105, DOI 10.1074/jbc.271.38.23105; Barclay LRC, 2000, ORG LETT, V2, P2841, DOI 10.1021/ol000173t; BARZEGAR A, 2011, J IRANIAN C IN PRESS; Baum L, 2004, J ALZHEIMERS DIS, V6, P367; Butterfield DA, 2001, TRENDS MOL MED, V7, P548, DOI 10.1016/S1471-4914(01)02173-6; Daniel S, 2004, J INORG BIOCHEM, V98, P266, DOI 10.1016/j.jinorgbio.2003.10.014; Di Matteo V, 2003, CNS NEUROL DISORD-DR, V2, P95, DOI 10.2174/1568007033482959; Garcia-Alloza M, 2007, J NEUROCHEM, V102, P1095, DOI 10.1111/j.1471-4159.2007.04613.x; Gerber M, 2002, B CANCER, V89, P293; Gomes A, 2005, J BIOCHEM BIOPH METH, V65, P45, DOI 10.1016/j.jbbm.2005.10.003; Heim KE, 2002, J NUTR BIOCHEM, V13, P572, DOI 10.1016/S0955-2863(02)00208-5; Holt PR, 2005, DIGEST DIS SCI, V50, P2191, DOI 10.1007/s10620-005-3032-8; Hureau C, 2009, BIOCHIMIE, V91, P1212, DOI 10.1016/j.biochi.2009.03.013; Jovanovic SV, 1999, J AM CHEM SOC, V121, P9677, DOI 10.1021/ja991446m; Jovanovic SV, 2001, J AM CHEM SOC, V123, P3064, DOI 10.1021/ja003823x; Jung KK, 2006, LIFE SCI, V79, P2022, DOI 10.1016/j.lfs.2006.06.048; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; Lefer DJ, 2000, AM J MED, V109, P315, DOI 10.1016/S0002-9343(00)00467-8; Manikandan P, 2004, INT J BIOCHEM CELL B, V36, P1967, DOI 10.1016/j.biocel.2004.01.030; Nelson SK, 2006, FREE RADICAL BIO MED, V40, P341, DOI 10.1016/j.freeradbiomed.2005.08.043; Ono K, 2004, J NEUROSCI RES, V75, P742, DOI 10.1002/jnr.20025; OYAIZU M, 1986, Japanese Journal of Nutrition, V44, P307; REDDY ACP, 1992, MOL CELL BIOCHEM, V111, P117; Riboulet-Chavey A, 2006, DIABETES, V55, P1289, DOI 10.2337/db05-0857; Ringman John M., 2005, Current Alzheimer Research, V2, P131, DOI 10.2174/1567205053585882; Rukkumani R, 2004, J PHARM PHARM SCI, V7, P274; Shi HL, 2001, METHOD ENZYMOL, V335, P157; SLATER TF, 1963, BIOCHIM BIOPHYS ACTA, V77, P383, DOI 10.1016/0006-3002(63)90513-4; Steer P, 2002, LIPIDS, V37, P231, DOI 10.1007/s11745-002-0885-3; Sun YM, 2002, ORG LETT, V4, P2909, DOI 10.1021/ol0262789; Teruya K, 2002, CYTOTECHNOLOGY, V40, P107, DOI 10.1023/A:1023926407877; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Venkateswarlu S, 2005, BIOORGAN MED CHEM, V13, P6374, DOI 10.1016/j.bmc.2005.06.050	36	208	214	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e26012	10.1371/journal.pone.0026012	http://dx.doi.org/10.1371/journal.pone.0026012			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016801	Green Published, gold, Green Submitted			2022-12-27	WOS:000295971700032
J	Shen, CL; Craigo, J; Ding, M; Chen, Y; Gupta, P				Shen, Chengli; Craigo, Jodi; Ding, Ming; Chen, Yue; Gupta, Phalguni			Origin and Dynamics of HIV-1 Subtype C Infection in India	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MOLECULAR EPIDEMIOLOGY; GENETIC DIVERSITY; SOUTH; STRAINS; HISTORY; IDENTIFICATION; SURVEILLANCE; PHYLOGENIES; PREVALENCE	Objective: To investigate the geographical origin and evolution dynamics of HIV-1 subtype C infection in India. Design: Ninety HIV-1 subtype C env gp120 subtype C sequences from India were compared with 312 env gp120 reference subtype C sequences from 27 different countries obtained from Los Alamos HIV database. All the HIV-1 subtype C env gp120 sequences from India were used for the geographical origin analysis and 61 subtype C env gp120 sequences with known sampling year (from 1991 to 2008) were employed to determine the origin of HIV infection in India. Methods: Phylogenetic analysis of HIV-1 env sequences was used to investigate the geographical origin and tMRCA of Indian HIV-1 subtype C. Evolutionary parameters including origin date and demographic growth patterns of Indian subtype C were estimated using a Bayesian coalescent-based approach under relaxed molecular clock models. Findings: The majority of the analyzed Indian and South African HIV-1 subtype C sequences formed a single monophyletic cluster. The most recent common ancestor date was calculated to be 1975.56 (95% HPD, 1968.78-1981.52). Reconstruction of the effective population size revealed three phases of epidemic growth: an initial slow growth, followed by exponential growth, and then a plateau phase approaching present time. Stabilization of the epidemic growth phase correlated with the foundation of National AIDS Control Organization in India. Interpretation: Indian subtype C originated from a single South African lineage in the middle of 1970s. The current study emphasizes not only the utility of HIV-1 sequence data for epidemiological studies but more notably highlights the effectiveness of community or government intervention strategies in controlling the trend of the epidemic.	[Shen, Chengli; Ding, Ming; Chen, Yue; Gupta, Phalguni] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA; [Craigo, Jodi] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA USA; [Craigo, Jodi] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA USA; [Shen, Chengli] Capital Med Univ Beijing Youan Hosp, Beijing, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Capital Medical University	Gupta, P (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA.	pgupta1@pitt.edu			National Institutes of Health [R01HD052436]; AIDS International Fogarty [TW001038-06]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD052436] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW001038] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AIDS International Fogarty; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by a grant R01HD052436 from National Institutes of Health. Dr. Chengli Shen was also partially supported by an AIDS International Fogarty grant TW001038-06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bello G, 2008, AIDS, V22, P1993, DOI 10.1097/QAD.0b013e328315e0aa; Beyrer C, 2000, AIDS, V14, P75, DOI 10.1097/00002030-200001070-00009; Carrion G, 2004, AIDS RES HUM RETROV, V20, P1022, DOI 10.1089/aid.2004.20.1022; Cassol S, 1996, AIDS RES HUM RETROV, V12, P1435, DOI 10.1089/aid.1996.12.1435; Castro E, 2005, J CLIN VIROL, V32, P257, DOI 10.1016/j.jcv.2004.11.004; Dalai SC, 2009, AIDS, V23, P2523, DOI 10.1097/QAD.0b013e3283320ef3; Delwart EL, 1998, J VIROL, V72, P617, DOI 10.1128/JVI.72.1.617-623.1998; DIETRICH U, 1993, AIDS, V7, P23, DOI 10.1097/00002030-199301000-00003; Dilernia DA, 2007, AIDS RES HUM RETROV, V23, P1201, DOI 10.1089/aid.2007.0068; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Fontella R, 2008, AIDS, V22, P2001, DOI 10.1097/QAD.0b013e3283108f69; GREZ M, 1994, J VIROL, V68, P2161, DOI 10.1128/JVI.68.4.2161-2168.1994; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789; Kousiappa I, 2009, AIDS RES HUM RETROV, V25, P23, DOI 10.1089/aid.2008.0168; Leitner T, 1996, P NATL ACAD SCI USA, V93, P10864, DOI 10.1073/pnas.93.20.10864; Liitsola K, 2000, SCAND J INFECT DIS, V32, P475, DOI 10.1080/003655400458721; LUO CC, 1995, LANCET, V345, P1051, DOI 10.1016/S0140-6736(95)90792-0; Mahanta J, 2008, AIDS, V22, pS59, DOI 10.1097/01.aids.0000343764.62455.9e; Maitra A, 1999, AIDS RES HUM RETROV, V15, P941, DOI 10.1089/088922299310656; Mandal D, 2002, AIDS RES HUM RETROV, V18, P1219, DOI 10.1089/08892220260387968; Mandal D, 2000, INDIAN J MED RES, V112, P165; Mullick R, 2010, VIRUS RES, V147, P195, DOI 10.1016/j.virusres.2009.10.024; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Renjifo B, 1998, AIDS RES HUM RETROV, V14, P635, DOI 10.1089/aid.1998.14.635; Robbins KE, 2003, J VIROL, V77, P6359, DOI 10.1128/JVI.77.11.6359-6366.2003; Shankarappa R, 2001, J VIROL, V75, P10479, DOI 10.1128/JVI.75.21.10479-10487.2001; SIMOES EAF, 1987, INDIAN J MED RES, V85, P335; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tripathy S, 1996, AIDS RES HUM RETROV, V12, P1199, DOI 10.1089/aid.1996.12.1199; Van Harmelen JH, 1999, AIDS RES HUM RETROV, V15, P395	34	18	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25956	10.1371/journal.pone.0025956	http://dx.doi.org/10.1371/journal.pone.0025956			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016790	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000295971700029
J	Hale, LA; Fowler, DK; Eisen, JS				Hale, Laura A.; Fowler, Daniel K.; Eisen, Judith S.			Netrin Signaling Breaks the Equivalence between Two Identified Zebrafish Motoneurons Revealing a New Role of Intermediate Targets	PLOS ONE			English	Article							CELL-CELL INTERACTIONS; EMBRYONIC ZEBRAFISH; AXON GUIDANCE; MOTOR AXONS; SPINAL-CORD; GENE-EXPRESSION; NERVOUS-SYSTEM; GROWTH CONES; RECEPTOR; NEURONS	Background: We previously showed that equivalence between two identified zebrafish motoneurons is broken by interactions with identified muscle fibers that act as an intermediate target for the axons of these motoneurons. Here we investigate the molecular basis of the signaling interaction between the intermediate target and the motoneurons. Principal Findings: We provide evidence that Netrin 1a is an intermediate target-derived signal that causes two equivalent motoneurons to adopt distinct fates. We show that although these two motoneurons express the same Netrin receptors, their axons respond differently to Netrin 1a encountered at the intermediate target. Furthermore, we demonstrate that when Netrin 1a is knocked down, more distal intermediate targets that express other Netrins can also function to break equivalence between these motoneurons. Significance: Our results suggest a new role for intermediate targets in breaking neuronal equivalence. The data we present reveal that signals encountered during axon pathfinding can cause equivalent neurons to adopt distinct fates. Such signals may be key in diversifying a neuronal population and leading to correct circuit formation.	[Hale, Laura A.; Fowler, Daniel K.; Eisen, Judith S.] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA	University of Oregon	Hale, LA (corresponding author), Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA.	eisen@uoneuro.uoregon.edu			NIH [NS23915, HD22486, GM07413]; American Heart Association [AHA 0610097Z]; University of Oregon Clarence; Lucille Dunbar Scholarship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD022486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS023915, R01NS023915] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); University of Oregon Clarence; Lucille Dunbar Scholarship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The study was supported by NIH grants NS23915 and HD22486 to JSE. LAH was also supported by American Heart Association Predoctoral Fellowship AHA 0610097Z, NIH Training Grant GM07413, and a University of Oregon Clarence and Lucille Dunbar Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel B, 2001, BMC Dev Biol, V1, P13, DOI 10.1186/1471-213X-1-13; Appel B, 1998, DEVELOPMENT, V125, P371; Appel B, 1995, DEVELOPMENT, V121, P4117; Bai G, 2011, CELL, V144, P106, DOI 10.1016/j.cell.2010.11.053; Balciunas D, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-62; Beattie CE, 2000, DEVELOPMENT, V127, P2653; Bradford D, 2009, INT J BIOCHEM CELL B, V41, P487, DOI 10.1016/j.biocel.2008.03.014; Bruses JL, 2011, J COMP NEUROL, V519, P1797, DOI 10.1002/cne.22602; Bullock TH, 2000, BRAIN BEHAV EVOLUT, V55, P236, DOI 10.1159/000006657; Chao DL, 2009, NAT REV NEUROSCI, V10, P262, DOI 10.1038/nrn2594; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; CROW MT, 1986, DEV BIOL, V113, P238, DOI 10.1016/0012-1606(86)90126-0; Deiner MS, 1997, NEURON, V19, P575, DOI 10.1016/S0896-6273(00)80373-6; Dickson BJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002055; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; EISEN JS, 1990, J NEUROSCI, V10, P34; EISEN JS, 1992, NEURON, V8, P231, DOI 10.1016/0896-6273(92)90290-T; EISEN JS, 1989, NEURON, V2, P1097, DOI 10.1016/0896-6273(89)90234-1; EISEN JS, 1986, NATURE, V320, P269, DOI 10.1038/320269a0; Eisen JS, 2001, NAT NEUROSCI, V4, P1065, DOI 10.1038/nn742; FELSENFELD AL, 1991, DEV BIOL, V148, P23, DOI 10.1016/0012-1606(91)90314-S; Flanagan-Steet H, 2005, DEVELOPMENT, V132, P4471, DOI 10.1242/dev.02044; Fricke C, 2005, DEV DYNAM, V234, P732, DOI 10.1002/dvdy.20492; GREENWALD I, 1992, CELL, V68, P271, DOI 10.1016/0092-8674(92)90470-W; Hilario JD, 2010, DEVELOPMENT, V137, P4261, DOI 10.1242/dev.051730; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Huberman AD, 2008, ANNU REV NEUROSCI, V31, P479, DOI 10.1146/annurev.neuro.31.060407.125533; Hutchinson SA, 2007, DEVELOPMENT, V134, P1671, DOI 10.1242/dev.02826; Hutchinson SA, 2006, DEVELOPMENT, V133, P2137, DOI 10.1242/dev.02355; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Keleman K, 2002, CELL, V110, P415, DOI 10.1016/S0092-8674(02)00901-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; KIMBLE J, 1979, CELL LINEAGE STEM CE, P59; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KUWADA JY, 1985, DEV BIOL, V110, P114, DOI 10.1016/0012-1606(85)90069-7; Lauderdale JD, 1997, MOL CELL NEUROSCI, V9, P293, DOI 10.1006/mcne.1997.0624; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; Lim AH, 2011, DEVELOPMENT, V138, P3847, DOI 10.1242/dev.068403; LIU DWC, 1990, J NEUROSCI, V10, P3947, DOI 10.1523/JNEUROSCI.10-12-03947.1990; Lu XW, 2004, NATURE, V432, P179, DOI 10.1038/nature03080; Mawdsley DJ, 2004, DEV BIOL, V269, P302, DOI 10.1016/j.ydbio.2004.02.001; MILLER JB, 1989, J BIOL CHEM, V264, P13122; Moore SW, 2008, DEVELOPMENT, V135, P2855, DOI 10.1242/dev.024133; Muto A, 2011, P NATL ACAD SCI USA, V108, P5425, DOI 10.1073/pnas.1000887108; MYERS PZ, 1986, J NEUROSCI, V6, P2278; O'Donnell M, 2009, ANNU REV NEUROSCI, V32, P383, DOI 10.1146/annurev.neuro.051508.135614; Park KW, 2005, DEV DYNAM, V234, P726, DOI 10.1002/dvdy.20474; Pineda RH, 2006, DEVELOPMENT, V133, P3827, DOI 10.1242/dev.02559; RAIBLE DW, 1995, CURR OPIN GENET DEV, V5, P444, DOI 10.1016/0959-437X(95)90047-K; Rajasekharan S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-239; Ren XR, 2008, NEUROSIGNALS, V16, P235, DOI 10.1159/000111566; Sanes JR, 2009, ANNU REV CELL DEV BI, V25, P161, DOI 10.1146/annurev.cellbio.24.110707.175402; Sato-Maeda M, 2006, DEVELOPMENT, V133, P937, DOI 10.1242/dev.02268; Sato-Maeda M, 2008, DEVELOPMENT, V135, P323, DOI 10.1242/dev.007559; Schweitzer J, 2005, DEV DYNAM, V234, P550, DOI 10.1002/dvdy.20525; Seibt J, 2003, NEURON, V39, P439, DOI 10.1016/S0896-6273(03)00435-5; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shirasaki R, 1998, SCIENCE, V279, P105, DOI 10.1126/science.279.5347.105; Strahle U, 1997, MECH DEVELOP, V62, P147, DOI 10.1016/S0925-4773(97)00657-6; SULI A, 2007, THESIS U UTAH SALT L; Suli A, 2006, J NEUROSCI, V26, P13328, DOI 10.1523/JNEUROSCI.2858-06.2006; Sun KLW, 2011, DEVELOPMENT, V138, P2153, DOI 10.1242/dev.044529; Talbot JC, 2010, DEVELOPMENT, V137, P2506, DOI 10.1242/dev.049700; Tallafuss A, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-18; TREVARROW B, 1990, NEURON, V4, P669, DOI 10.1016/0896-6273(90)90194-K; VarelaEchavarria A, 1997, NEURON, V18, P193, DOI 10.1016/S0896-6273(00)80261-5; Welten MCM, 2006, ZEBRAFISH, V3, P465, DOI 10.1089/zeb.2006.3.465; Yimlamai D, 2005, DEV BIOL, V279, P44, DOI 10.1016/j.ydbio.2004.12.001; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748; Ziel JW, 2010, DEV DYNAM, V239, P1296, DOI 10.1002/dvdy.22225	71	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25841	10.1371/journal.pone.0025841	http://dx.doi.org/10.1371/journal.pone.0025841			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003409	Green Submitted, gold, Green Published			2022-12-27	WOS:000295970300030
J	Mehta, MV; Gandal, MJ; Siegel, SJ				Mehta, Mili V.; Gandal, Michael J.; Siegel, Steven J.			mGluR5-Antagonist Mediated Reversal of Elevated Stereotyped, Repetitive Behaviors in the VPA Model of Autism	PLOS ONE			English	Article							MGLUR5 ANTAGONIST MPEP; CORE SYMPTOM DOMAINS; FRAGILE-X-SYNDROME; SPECTRUM DISORDERS; ANXIOLYTIC-LIKE; MOUSE MODEL; RECEPTOR ANTAGONIST; GROOMING BEHAVIOR; VALPROIC ACID; ANIMAL-MODEL	Autism spectrum disorders (ASD) are highly disabling developmental disorders with a population prevalence of 1-3%. Despite a strong genetic etiology, there are no current therapeutic options that target the core symptoms of ASD. Emerging evidence suggests that dysfunction of glutamatergic signaling, in particular through metabotropic glutamate receptor 5 (mGluR5) receptors, may contribute to phenotypic deficits and may be appropriate targets for pharmacologic intervention. This study assessed the therapeutic potential of 2-methyl-6-phenylethyl-pyrididine (MPEP), an mGluR5-receptor antagonist, on repetitive and anxiety-like behaviors in the valproic acid (VPA) mouse model of autism. Mice were exposed prenatally on day E13 to VPA and assessed for repetitive self-grooming and marble burying behaviors as adults. Anxiety-like behavior and locomotor activity were measured in an open-field. VPA-exposed mice displayed increased repetitive and anxiety-like behaviors, consistent with previously published results. Across both marble burying and self-grooming assays, MPEP significantly reduced repetitive behaviors in VPA-treated mice, but had no effect on locomotor activity. These results are consistent with emerging preclinical literature that mGluR5-antagonists may have therapeutic efficacy for core symptoms of autism.	[Mehta, Mili V.; Gandal, Michael J.; Siegel, Steven J.] Univ Penn, Dept Psychiat, Translat Neurosci Program, Philadelphia, PA 19104 USA	University of Pennsylvania	Mehta, MV (corresponding author), Univ Penn, Dept Psychiat, Translat Neurosci Program, Philadelphia, PA 19104 USA.	siegels@upenn.edu	Gandal, Michael/AAE-4282-2020	Gandal, Michael/0000-0001-5800-5128; Siegel, Steven/0000-0001-8058-9713	National Institutes of Health [R01-DA023210, T32-MH017168]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH017168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA023210] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was funded by the National Institutes of Health Grants R01-DA023210 (SJS) and T32-MH017168 (MJG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adetunji B, 2006, AM J PSYCHIAT, V163, P551, DOI 10.1176/appi.ajp.163.3.551; Anderson JJ, 2003, EUR J PHARMACOL, V473, P35, DOI 10.1016/S0014-2999(03)01935-6; BANGASH MA, 2011, CELL; Blundell J, 2010, J NEUROSCI, V30, P2115, DOI 10.1523/JNEUROSCI.4517-09.2010; Brodkin J, 2002, PHARMACOL BIOCHEM BE, V73, P359, DOI 10.1016/S0091-3057(02)00828-6; BROEKKAMP CL, 1986, EUR J PHARMACOL, V126, P223, DOI 10.1016/0014-2999(86)90051-8; Bromley RL, 2008, NEUROLOGY, V71, P1923, DOI 10.1212/01.wnl.0000339399.64213.1a; Brugha TS, 2011, ARCH GEN PSYCHIAT, V68, P459, DOI 10.1001/archgenpsychiatry.2011.38; Busse CS, 2004, NEUROPSYCHOPHARMACOL, V29, P1971, DOI 10.1038/sj.npp.1300540; CARLSON GC, 2011, PHARM BIOCH BEHAV; Comer JS, 2004, CLIN PSYCHOL REV, V24, P663, DOI 10.1016/j.cpr.2004.04.004; Crawley JN, 2007, BRAIN PATHOL, V17, P448, DOI 10.1111/j.1750-3639.2007.00096.x; Crawley JN, 2004, MENT RETARD DEV D R, V10, P248, DOI 10.1002/mrdd.20039; de Vrij FMS, 2008, NEUROBIOL DIS, V31, P127, DOI 10.1016/j.nbd.2008.04.002; Gandal MJ, 2010, BIOL PSYCHIAT, V68, P1100, DOI 10.1016/j.biopsych.2010.09.031; Geschwind DH, 2009, ANNU REV MED, V60, P367, DOI 10.1146/annurev.med.60.053107.121225; Gogolla N, 2009, J NEURODEV DISORD, V1, P172, DOI 10.1007/s11689-009-9023-x; Greer JM, 2002, NEURON, V33, P23, DOI 10.1016/S0896-6273(01)00564-5; Guclu B, 2007, SOMATOSENS MOT RES, V24, P21, DOI 10.1080/08990220601179418; Homayoun H, 2010, EUR J PHARMACOL, V639, P33, DOI 10.1016/j.ejphar.2009.12.042; Jesner OS, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005040.pub2; Kalueff AV, 2005, BEHAV BRAIN RES, V160, P1, DOI 10.1016/j.bbr.2004.11.010; Kim Y, 2011, AM J PSYCHIAT; King BH, 2009, ARCH GEN PSYCHIAT, V66, P583, DOI 10.1001/archgenpsychiatry.2009.30; Levy SE, 2009, LANCET, V374, P1627, DOI 10.1016/S0140-6736(09)61376-3; Lewis MH, 2007, BEHAV BRAIN RES, V176, P66, DOI 10.1016/j.bbr.2006.08.023; Markram H, 2007, FRONT NEUROSCI-SWITZ, V1, P77, DOI 10.3389/neuro.01.1.1.006.2007; Markram K, 2008, NEUROPSYCHOPHARMACOL, V33, P901, DOI 10.1038/sj.npp.1301453; McBride SMJ, 2005, NEURON, V45, P753, DOI 10.1016/j.neuron.2005.01.038; McDougle CJ, 2005, AM J PSYCHIAT, V162, P1142, DOI 10.1176/appi.ajp.162.6.1142; McPheeters ML, 2011, PEDIATRICS, V127, pE1312, DOI 10.1542/peds.2011-0427; Montana MC, 2009, J PHARMACOL EXP THER, V330, P834, DOI 10.1124/jpet.109.154138; Moy SS, 2008, BEHAV BRAIN RES, V188, P178, DOI 10.1016/j.bbr.2007.10.029; Pearson BL, 2011, GENES BRAIN BEHAV, V10, P228, DOI 10.1111/j.1601-183X.2010.00659.x; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Pittenger Christopher, 2006, NeuroRx, V3, P69, DOI 10.1016/j.nurx.2005.12.006; Rasalam AD, 2005, DEV MED CHILD NEUROL, V47, P551, DOI 10.1017/S0012162205001076; Richler J, 2007, J AUTISM DEV DISORD, V37, P73, DOI 10.1007/s10803-006-0332-6; Rinaldi T, 2007, P NATL ACAD SCI USA, V104, P13501, DOI 10.1073/pnas.0704391104; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Scahill L, 2007, J CHILD ADOL PS NURS, V20, P188, DOI 10.1111/j.1744-6171.2007.00112.x; Schneider T, 2005, NEUROPSYCHOPHARMACOL, V30, P80, DOI 10.1038/sj.npp.1300518; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Silverman JL, 2010, NEUROPSYCHOPHARMACOL, V35, P976, DOI 10.1038/npp.2009.201; Spooren WPJM, 2000, J PHARMACOL EXP THER, V295, P1267; Tatarczynska E, 2001, BRIT J PHARMACOL, V132, P1423, DOI 10.1038/sj.bjp.0703923; Thomas A, 2009, PSYCHOPHARMACOLOGY, V204, P361, DOI 10.1007/s00213-009-1466-y; West L, 2009, J PEDIATR HEALTH CAR, V23, P75, DOI 10.1016/j.pedhc.2008.12.001; Yan QJ, 2005, NEUROPHARMACOLOGY, V49, P1053, DOI 10.1016/j.neuropharm.2005.06.004	49	114	119	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e26077	10.1371/journal.pone.0026077	http://dx.doi.org/10.1371/journal.pone.0026077			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22016815	Green Submitted, gold, Green Published			2022-12-27	WOS:000295970300057
J	Pericacho, M; Alonso-Martin, S; Larrucea, S; Gonzalez-Manchon, C; Fernandez, D; Sanchez, I; Ayuso, MS; Parrilla, R				Pericacho, Miguel; Alonso-Martin, Sonia; Larrucea, Susana; Gonzalez-Manchon, Consuelo; Fernandez, Dario; Sanchez, Ines; Ayuso, Matilde S.; Parrilla, Roberto			Diminished Thrombogenic Responses by Deletion of the Podocalyxin Gene in Mouse Megakaryocytes	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; EMBRYONIC STEM-CELLS; L-SELECTIN; INTEGRIN ACTIVATION; MAJOR SIALOPROTEIN; PODOCYTE BIOLOGY; IN-VIVO; PLATELETS; BINDING; TALIN	Podocalyxin (Podxl) is a type I membrane sialoprotein of the CD34 family, originally described in the epithelial glomerular cells of the kidney (podocytes) in which it plays an important function. Podxl can also be found in megakaryocytes and platelets among other extrarenal places. The surface exposure of Podxl upon platelet activation suggested it could play some physiological role. To elucidate the function of Podxl in platelets, we generated mice with restricted ablation of the podxl gene in megakaryocytes using the Cre-LoxP gene targeting methodology. Mice with Podxl-null megakaryocytes did not show any apparent phenotypical change and their rates of growth, life span and fertility did not differ from the floxed controls. However, Podxl-null mice showed prolonged bleeding time and decreased platelet aggregation in response to physiological agonists. The number, size- distribution and polyploidy of Podxl-null megakaryocytes were similar to the floxed controls. Podxl-null platelets showed normal content of surface receptors and normal activation by agonists. However, the mice bearing Podxl-null platelets showed a significant retardation in the ferric chloride-induced occlusion of the carotid artery. Moreover, acute thrombosis induced by the i.v. injection of sublethal doses of collagen and phenylephrine produced a smaller fall in the number of circulating platelets in Podxl-null mice than in control mice. In addition, perfusion of uncoagulated blood from Podxl-null mice in parallel flow chamber showed reduced adhesion of platelets and formation of aggregates under high shear stress. It is concluded that platelet Podxl is involved in the control of hemostasis acting as a platelet co-stimulator, likely due to its pro-adhesive properties.	[Alonso-Martin, Sonia; Gonzalez-Manchon, Consuelo; Sanchez, Ines; Ayuso, Matilde S.; Parrilla, Roberto] CSIC, Ctr Invest Biol, Dept Cellular & Mol Med, Madrid, Spain; [Pericacho, Miguel; Gonzalez-Manchon, Consuelo; Fernandez, Dario; Ayuso, Matilde S.; Parrilla, Roberto] CIBERER, Madrid, Spain; [Larrucea, Susana] Hosp Cruces, Lab Inmunol, Baracaldo, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitario Cruces	Pericacho, M (corresponding author), CIBERER, Madrid, Spain.	rparrilla@cib.csic.es	Milagros Rodriguez, Biblioteca-CIB/H-7697-2015; Fernández, Darío/B-9516-2013; Fernández, Darío/K-2587-2019; Alonso-Martin, Sonia/F-3021-2013; Ayuso, Matilde Sánchez/B-2777-2008; Alonso-Martin, Sonia/L-2751-2019; Fernández, Darío/P-6505-2019; Larrucea, Susana/E-4743-2012; Pericacho, Miguel/H-1786-2016; Gonzalez-Manchon, Consuelo/H-9257-2015	Fernández, Darío/0000-0003-1481-6660; Fernández, Darío/0000-0002-9763-7328; Alonso-Martin, Sonia/0000-0002-3254-0365; Ayuso, Matilde Sánchez/0000-0003-2504-0925; Alonso-Martin, Sonia/0000-0002-3254-0365; Pericacho, Miguel/0000-0003-0226-482X; Gonzalez-Manchon, Consuelo/0000-0002-3081-0253; Larrucea, Susana/0000-0002-4019-2751	Spanish Ministry of Science and Innovation [SAF2007-61701, BFU2010-15237]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	present work was supported by a grant from the Spanish Ministry of Science and Innovation (SAF2007-61701 and BFU2010-15237) (http://www.micinn.es). The CIBER de Enfermedades Raras (CIBERER) (http://www.ciberer.es) is an initiative of the Spanish National Health Institute Carlos III (ISCIII). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander WS, 2006, P NATL ACAD SCI USA, V103, P16442, DOI 10.1073/pnas.0607872103; ALONSOMARTIN S, THROMB RES, V125, pE300; Furness SGB, 2006, IMMUNOL RES, V34, P13, DOI 10.1385/IR:34:1:13; BAUMHUETER S, 1993, SCIENCE, V262, P436, DOI 10.1126/science.7692600; Bergmeier W, 2006, P NATL ACAD SCI USA, V103, P16900, DOI 10.1073/pnas.0608207103; BURRIDGE K, 1984, NATURE, V308, P744, DOI 10.1038/308744a0; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Casey G, 2006, HUM MOL GENET, V15, P735, DOI 10.1093/hmg/ddi487; Doyonnas R, 2005, BLOOD, V105, P4170, DOI 10.1182/blood-2004-10-4077; EDDY A, 1998, SEMIN NEPHROL, V18, P12; Endlich K, 2001, CURR OPIN NEPHROL HY, V10, P331, DOI 10.1097/00041552-200105000-00006; GROTTUM KA, 1969, BRIT J HAEMATOL, V16, P277, DOI 10.1111/j.1365-2141.1969.tb00402.x; Hemmings L, 1996, J CELL SCI, V109, P2715; HORVAT R, 1986, J CELL BIOL, V102, P484, DOI 10.1083/jcb.102.2.484; Jiang MS, 2002, METHOD ENZYMOL, V344, P277; KERJASCHKI D, 1984, J CELL BIOL, V98, P1591, DOI 10.1083/jcb.98.4.1591; Kerosuo L, 2004, BRIT J HAEMATOL, V124, P809, DOI 10.1111/j.1365-2141.2004.04840.x; Larrucea S, 2007, CELL MOL LIFE SCI, V64, P2965, DOI 10.1007/s00018-007-7374-6; Larrucea S, 2008, EXP CELL RES, V314, P2004, DOI 10.1016/j.yexcr.2008.03.009; Li J, 2001, DNA SEQUENCE, V12, P407, DOI 10.3109/10425170109084466; Liu SC, 2000, J CELL SCI, V113, P3563; McNagny KM, 1997, J CELL BIOL, V138, P1395, DOI 10.1083/jcb.138.6.1395; MESTER L, 1972, NATURE-NEW BIOL, V236, P213, DOI 10.1038/newbio236213a0; Miettinen A, 1999, AM J PATHOL, V154, P813, DOI 10.1016/S0002-9440(10)65328-X; Mundel P, 2002, J AM SOC NEPHROL, V13, P3005, DOI 10.1097/01.ASN.0000039661.06947.FD; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Ni HY, 2000, J CLIN INVEST, V106, P385, DOI 10.1172/JCI9896; Ni HY, 2003, P NATL ACAD SCI USA, V100, P2415, DOI 10.1073/pnas.2628067100; PAAVONEN T, 1992, AM J PATHOL, V141, P1259; Rasband W., 2006, IMAGEJ; Rodriguez RB, 2006, TISSUE ANTIGENS, V68, P407, DOI 10.1111/j.1399-0039.2006.00692.x; Sassetti C, 1998, J EXP MED, V187, P1965, DOI 10.1084/jem.187.12.1965; Schopperle WM, 2003, BIOCHEM BIOPH RES CO, V300, P285; Somasiri A, 2004, CANCER RES, V64, P5068, DOI 10.1158/0008-5472.CAN-04-0240; Somlo S, 2000, NAT GENET, V24, P333, DOI 10.1038/74139; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tiedt R, 2007, BLOOD, V109, P1503, DOI 10.1182/blood-2006-04-020362; Torres M, 1998, CURR TOP DEV BIOL, V36, P99; Yang H, 2006, J THROMB HAEMOST, V4, P2230, DOI 10.1111/j.1538-7836.2006.02116.x	40	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e26025	10.1371/journal.pone.0026025	http://dx.doi.org/10.1371/journal.pone.0026025			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22016802	Green Published, Green Submitted, gold			2022-12-27	WOS:000295970300049
J	Aimon, S; Manzi, J; Schmidt, D; Larrosa, JAP; Bassereau, P; Toombes, GES				Aimon, Sophie; Manzi, John; Schmidt, Daniel; Poveda Larrosa, Jose Antonio; Bassereau, Patricia; Toombes, Gilman E. S.			Functional Reconstitution of a Voltage-Gated Potassium Channel in Giant Unilamellar Vesicles	PLOS ONE			English	Article							MEMBRANE-PROTEINS; CRYSTAL-STRUCTURE; ION CHANNELS; PATCH; CELL; ELECTROFORMATION; CONDUCTANCE; CURVATURE; MOBILITY; KCSA	Voltage-gated ion channels are key players in cellular excitability. Recent studies suggest that their behavior can depend strongly on the membrane lipid composition and physical state. In vivo studies of membrane/channel and channel/channel interactions are challenging as membrane properties are actively regulated in living cells, and are difficult to control in experimental settings. We developed a method to reconstitute functional voltage-gated ion channels into cell-sized Giant Unilamellar Vesicles (GUVs) in which membrane composition, tension and geometry can be controlled. First, a voltage-gated potassium channel, KvAP, was purified, fluorescently labeled and reconstituted into small proteoliposomes. Small proteoliposomes were then converted into GUVs via electroformation. GUVs could be formed using different lipid compositions and buffers containing low (5 mM) or near-physiological (100 mM) salt concentrations. Protein incorporation into GUVs was characterized with quantitative confocal microscopy, and the protein density of GUVs was comparable to the small proteoliposomes from which they were formed. Furthermore, patch-clamp measurements confirmed that the reconstituted channels retained potassium selectivity and voltage-gated activation. GUVs containing functional voltage-gated ion channels will allow the study of channel activity, distribution and diffusion while controlling membrane state, and should prove a powerful tool for understanding how the membrane modulates cellular excitability.	[Aimon, Sophie; Manzi, John; Bassereau, Patricia; Toombes, Gilman E. S.] Univ Paris 06, CNRS, Inst Curie, Ctr Rech,Unite Mixte Rech UMR 168, Paris, France; [Schmidt, Daniel] Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, New York, NY 10021 USA; [Poveda Larrosa, Jose Antonio] Univ Miguel Hernandez, Inst Biol Mol & Celular, Elche, Spain	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Howard Hughes Medical Institute; Rockefeller University; Universidad Miguel Hernandez de Elche	Aimon, S (corresponding author), Univ Paris 06, CNRS, Inst Curie, Ctr Rech,Unite Mixte Rech UMR 168, Paris, France.	Patricia.Bassereau@curie.fr	Manzi, John/AAI-8253-2021; Poveda Larrosa, Jose Antonio/H-5925-2015; Bassereau, Patricia/P-8657-2018	Manzi, John/0000-0003-2574-4260; Poveda Larrosa, Jose Antonio/0000-0003-0722-3752; Toombes, Gilman/0000-0001-8346-1790; Bassereau, Patricia/0000-0002-8544-6778	Agence Nationale de la Recherche by the European Commission (NoE SoftComp) [BLAN-0057-01]; Universite Pierre et Marie Curie (FED21, Dynamique des Systemes Complexes); Fondation pour la Recherche Medicale; European Commission; Universite Pierre et Marie Curie	Agence Nationale de la Recherche by the European Commission (NoE SoftComp)(French National Research Agency (ANR)); Universite Pierre et Marie Curie (FED21, Dynamique des Systemes Complexes); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); European Commission(European CommissionEuropean Commission Joint Research Centre); Universite Pierre et Marie Curie	The project was funded by the Agence Nationale de la Recherche (grant BLAN-0057-01) by the European Commission (NoE SoftComp) and by the Universite Pierre et Marie Curie (grant from the FED21, Dynamique des Systemes Complexes). Dr. Aimon was supported by a fellowship from the Fondation pour la Recherche Medicale. Dr. Toombes was supported by a Marie Curie Incoming International Fellowship from the European Commission and a grant from the Universite Pierre et Marie Curie. Dr. Bassereau's group belongs to the French research consortium "CellTiss''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. ANR Website: http://www.agence-nationale-recherche.fr/. NoE SoftComp Website: http://www.eu-softcomp.net/. UPMC Website: http://www.upmc.fr/. EU FP7 Marie Curie Website: http://cordis.europa.eu/fp7/home_en.html. Fondation pour la Recherche Medicale Website: http://www.frm.org/.	Akashi K, 1996, BIOPHYS J, V71, P3242, DOI 10.1016/S0006-3495(96)79517-6; ANGELOVA MI, 1986, FARADAY DISCUSS, V81, P303, DOI 10.1039/dc9868100303; BARRY PH, 1991, J MEMBRANE BIOL, V121, P101, DOI 10.1007/BF01870526; Baumgart T, 2007, BBA-BIOMEMBRANES, V1768, P2182, DOI 10.1016/j.bbamem.2007.05.012; Bezanilla F, 2008, NEURON, V60, P456, DOI 10.1016/j.neuron.2008.10.035; Chakrapani S, 2007, J GEN PHYSIOL, V130, P465, DOI 10.1085/jgp.200709843; Cheng WWL, 2009, J GEN PHYSIOL, V133, P295, DOI 10.1085/jgp.200810125; Davidson M, 2003, J AM CHEM SOC, V125, P374, DOI 10.1021/ja027699o; DILGER JP, 1985, J MEMBRANE BIOL, V85, P181, DOI 10.1007/BF01871270; Doeven MK, 2005, BIOPHYS J, V88, P1134, DOI 10.1529/biophysj.104.053413; Domanov YA, 2011, P NATL ACAD SCI USA, V108, P12605, DOI 10.1073/pnas.1102646108; ELALAOUI F, 2009, PHYS REV LETT, V102; EVANS E, 1990, PHYS REV LETT, V64, P2094, DOI 10.1103/PhysRevLett.64.2094; Finol-Urdaneta RK, 2010, BIOPHYS J, V98, P762, DOI 10.1016/j.bpj.2009.10.053; Galush WJ, 2008, BIOPHYS J, V95, P2512, DOI 10.1529/biophysj.108.131540; Gamper N, 2007, NAT REV NEUROSCI, V8, P921, DOI 10.1038/nrn2257; Gassmann O, 2009, J STRUCT BIOL, V168, P168, DOI 10.1016/j.jsb.2009.02.004; Girard P, 2004, BIOPHYS J, V87, P419, DOI 10.1529/biophysj.104.040360; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Heinrich V, 1999, BIOPHYS J, V76, P2056, DOI 10.1016/S0006-3495(99)77362-5; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Kahya N, 2002, J BIOL CHEM, V277, P39304, DOI 10.1074/jbc.M202635200; Kahya N, 2001, BIOPHYS J, V81, P1464, DOI 10.1016/S0006-3495(01)75801-8; Kahya N, 2010, BBA-BIOMEMBRANES, V1798, P1392, DOI 10.1016/j.bbamem.2010.02.028; Kreir M, 2008, LAB CHIP, V8, P587, DOI 10.1039/b713982a; Kullmann DM, 2010, ANNU REV NEUROSCI, V33, P151, DOI 10.1146/annurev-neuro-060909-153122; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Lai HC, 2006, NAT REV NEUROSCI, V7, P548, DOI 10.1038/nrn1938; LEE SY, 2005, STRUCTURE, V102, P15441; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Mahendran KR, 2010, J BIOMOL SCREEN, V15, P302, DOI 10.1177/1087057109357791; Marban E, 2002, NATURE, V415, P213, DOI 10.1038/415213a; Marsh D, 2007, BIOPHYS J, V93, P3884, DOI 10.1529/biophysj.107.107938; Martens JR, 2004, TRENDS PHARMACOL SCI, V25, P16, DOI 10.1016/j.tips.2003.11.007; Mathivet L, 1996, BIOPHYS J, V70, P1112, DOI 10.1016/S0006-3495(96)79693-5; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Meleard P, 2009, METHOD ENZYMOL, V465, P161, DOI 10.1016/S0076-6879(09)65009-6; Miller C., 1986, ION CHANNEL RECONSTI; Molina ML, 2006, J BIOL CHEM, V281, P18837, DOI 10.1074/jbc.M600342200; Morales-Penningston NF, 2010, BBA-BIOMEMBRANES, V1798, P1324, DOI 10.1016/j.bbamem.2010.03.011; Phillips R, 2009, NATURE, V459, P379, DOI 10.1038/nature08147; Ramadurai S, 2010, BIOPHYS J, V99, P1482, DOI 10.1016/j.bpj.2010.06.036; Ramu Y, 2006, NATURE, V442, P696, DOI 10.1038/nature04880; Reeves D, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.041901; REQUENA J, 1975, J COLLOID INTERF SCI, V51, P315, DOI 10.1016/0021-9797(75)90119-8; Rodriguez N, 2005, COLLOID SURFACE B, V42, P125, DOI 10.1016/j.colsurfb.2005.01.010; RUTA V, 2003, FUNCTIONAL ANAL, V422, P180; Ryan DP, 2010, NEURON, V68, P282, DOI 10.1016/j.neuron.2010.10.008; SCHMIDT D, 2008, CELL, V105, P19276; Schmidt D, 2009, J MOL BIOL, V390, P902, DOI 10.1016/j.jmb.2009.05.062; Shimanouchi T, 2009, LANGMUIR, V25, P4835, DOI 10.1021/la8040488; Streicher P, 2009, BBA-BIOMEMBRANES, V1788, P2291, DOI 10.1016/j.bbamem.2009.07.025; Suchyna TM, 2009, BIOPHYS J, V97, P738, DOI 10.1016/j.bpj.2009.05.018; Uysal S, 2009, P NATL ACAD SCI USA, V106, P6644, DOI 10.1073/pnas.0810663106; Varnier A, 2010, J MEMBRANE BIOL, V233, P85, DOI 10.1007/s00232-010-9227-8; Veatch SL, 2006, BIOPHYS J, V90, P4428, DOI 10.1529/biophysj.105.080283; Veatch SL, 2005, BBA-MOL CELL RES, V1746, P172, DOI 10.1016/j.bbamcr.2005.06.010; Wang A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018598; WAUGH RE, 1992, BIOPHYS J, V61, P974, DOI 10.1016/S0006-3495(92)81904-5; Yanagisawa M, 2011, J AM CHEM SOC, V133, P11774, DOI 10.1021/ja2040859; Zhang Y, 2000, J PHYSIOL-LONDON, V523, P101, DOI 10.1111/j.1469-7793.2000.00101.x	61	86	87	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e25529	10.1371/journal.pone.0025529	http://dx.doi.org/10.1371/journal.pone.0025529			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998666	Green Published, gold, Green Submitted			2022-12-27	WOS:000295968700012
J	Brody, JP				Brody, James P.			Age-Specific Incidence Data Indicate Four Mutations Are Required for Human Testicular Cancers	PLOS ONE			English	Article							GERM-CELL TUMORS; MULTISTAGE CARCINOGENESIS; TEMPORAL VARIATION; BREAST-CANCER; COHORT MODELS; IN-UTERO; DISEASE; GENOME; TRENDS; PERIOD	Normal human cells require a series of genetic alterations to undergo malignant transformation. Direct sequencing of human tumors has identified hundreds of mutations in tumors, but many of these are thought to be unnecessary and a result of, rather than a cause of, the tumor. The exact number of mutations to transform a normal human cell into a tumor cell is unknown. Here I show that male gonadal germ cell tumors, the most common form of testicular cancers, occur after four mutations. I infer this by constructing a mathematical model based upon the multi-hit hypothesis and comparing it to the age-specific incidence data. This result is consistent with the multi-hit hypothesis, and implies that these cancers are genetically or epigenetically predetermined at birth or an early age.	Univ Calif Irvine, Dept Biomed Engn, Ctr Complex Biol Syst, Irvine, CA 92717 USA	University of California System; University of California Irvine	Brody, JP (corresponding author), Univ Calif Irvine, Dept Biomed Engn, Ctr Complex Biol Syst, Irvine, CA 92717 USA.	jpbrody@uci.edu		Brody, James/0000-0002-7995-5197	University of California	University of California(University of California System)	This research was supported by the University of California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMITAGE P, 1954, BRIT J CANCER, V8, P1, DOI 10.1038/bjc.1954.1; Arnheim N, 2009, NAT REV GENET, V10, P478, DOI 10.1038/nrg2529; Brody JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007053; Byrne HM, 2010, NAT REV CANCER, V10, P221, DOI 10.1038/nrc2808; Calabrese P, 2004, AM J PATHOL, V164, P1337, DOI 10.1016/S0002-9440(10)63220-8; Chanock S, 2009, NAT GENET, V41, P765, DOI 10.1038/ng0709-765; Chia VM, 2010, CANCER EPIDEM BIOMAR, V19, P1151, DOI 10.1158/1055-9965.EPI-10-0031; CLAYTON D, 1987, STAT MED, V6, P449, DOI 10.1002/sim.4780060405; CLAYTON D, 1987, STAT MED, V6, P469, DOI 10.1002/sim.4780060406; Czene K, 2002, INT J CANCER, V99, P260, DOI 10.1002/ijc.10332; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Ekbom A, 1998, SEMIN CANCER BIOL, V8, P237, DOI 10.1006/scbi.1998.0073; FEARON ER, 1987, SCIENCE, V238, P193, DOI 10.1126/science.2889267; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Frank S. A., 2007, Dynamics of cancer: incidence, inheritance and evolution; Frank SA, 2004, CURR BIOL, V14, P242, DOI 10.1016/j.cub.2003.12.026; Gordon RA, 2003, TOXICOL IND HEALTH, V19, P125, DOI 10.1191/0748233703th195oa; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hahn WC, 2002, NEW ENGL J MED, V347, P1593, DOI 10.1056/NEJMra021902; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harding C, 2008, CANCER RES, V68, P4465, DOI 10.1158/0008-5472.CAN-07-1670; Houldsworth J, 2006, J CLIN ONCOL, V24, P5512, DOI 10.1200/JCO.2006.08.4285; Johnson NL, 2005, WILEY SER PROBAB ST, P1, DOI 10.1002/0471715816; Kanetsky PA, 2009, NAT GENET, V41, P811, DOI 10.1038/ng.393; Loeb LA, 2003, P NATL ACAD SCI USA, V100, P776, DOI 10.1073/pnas.0334858100; Looijenga LHJ, 1999, REV REPROD, V4, P90, DOI 10.1530/ror.0.0040090; Luebeck EG, 2002, P NATL ACAD SCI USA, V99, P15095, DOI 10.1073/pnas.222118199; Manecksha RP, 2009, BJU INT, V104, P1329, DOI 10.1111/j.1464-410X.2009.08854.x; Mdzinarishvili T, 2010, CANCER INFORM, V9, P179; Meza R, 2008, P NATL ACAD SCI USA, V105, P16284, DOI 10.1073/pnas.0801151105; Moger TA, 2004, BIOSTATISTICS, V5, P1, DOI 10.1093/biostatistics/5.1.1; Moolgavkar SH, 2004, INT J EPIDEMIOL, V33, P1182, DOI 10.1093/ije/dyh288; Moolgavkar SH, 2003, GENE CHROMOSOME CANC, V38, P302, DOI 10.1002/gcc.10264; Myrup C, 2007, NEW ENGL J MED, V357, P825; National Cancer Institute, SEER STAT SOFTW VERS; Oosterhuis JW, 2005, NAT REV CANCER, V5, P210, DOI 10.1038/nrc1568; Pettersson A, 2007, NEW ENGL J MED, V356, P1835, DOI 10.1056/NEJMoa067588; Pompei F, 2002, TOXICOL IND HEALTH, V18, P365, DOI 10.1191/0748233702th164oa; Rapley EA, 2009, NAT GENET, V41, P807, DOI 10.1038/ng.394; Rothman N, 2001, BBA-REV CANCER, V1471, pC1, DOI 10.1016/S0304-419X(00)00021-4; Shah MN, 2007, INT J ANDROL, V30, P206, DOI 10.1111/j.1365-2605.2007.00795.x; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Surveillance Epidemiology and End Results (SEER) Program, 2010, SEER STAT DAT INC SE; Thilly WG, 2003, NAT GENET, V34, P255, DOI 10.1038/ng1205; Thornburg KL, 2010, ADV GENET, V71, P57, DOI [10.1016/B978-0-12-380864-6.00003-1, 10.1016/S0065-2660(10)71003-8]; TRICHOPOULOS D, 1990, LANCET, V335, P939, DOI 10.1016/0140-6736(90)91000-Z; VOGELSTEIN B, 1993, TRENDS GENET, V9, P138, DOI 10.1016/0168-9525(93)90209-Z; Westergaard T, 1996, INT J CANCER, V66, P627, DOI 10.1002/(SICI)1097-0215(19960529)66:5<627::AID-IJC8>3.3.CO;2-Y; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Zhang XN, 2005, BREAST CANCER RES TR, V91, P121, DOI 10.1007/s10549-004-5782-y	51	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e25978	10.1371/journal.pone.0025978	http://dx.doi.org/10.1371/journal.pone.0025978			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998737	gold, Green Published			2022-12-27	WOS:000295968700029
J	Garabedian, M; Jarnik, M; Kotova, E; Tulin, AV				Garabedian, Mikael; Jarnik, Michael; Kotova, Elena; Tulin, Alexei V.			Generating a Knockdown Transgene against Drosophila Heterochromatic Tim17b Gene Encoding Mitochondrial Translocase Subunit	PLOS ONE			English	Article							MELANOGASTER HETEROCHROMATIN; MOLECULAR EVOLUTION; CHROMATIN-STRUCTURE; P-ELEMENTS; RAT-LIVER; MUTAGENESIS; PROTEINS; GENOME; RECOMBINATION; ORGANIZATION	Heterochromatic regions of eukaryotic genomes contain multiple functional elements involved in chromosomal dynamics, as well as multiple housekeeping genes. Cytological and molecular peculiarities of heterochromatic loci complicate genetic studies based on standard approaches developed using euchromatic genes. Here, we report the development of an RNAi-based knockdown transgenic construct and red fluorescent reporter transgene for a small gene, Tim17b, which localizes in constitutive heterochromatin of Drosophila melanogaster third chromosome and encodes a mitochondrial translocase subunit. We demonstrate that Tim17b protein is required strictly for protein delivery to mitochondrial matrix. Knockdown of Tim17b completely disrupts functions of the mitochondrial translocase complex. Using fluorescent recovery after photobleaching assay, we show that Tim17b protein has a very stable localization in the membranes of the mitochondrial network and that its exchange rate is close to zero when compared with soluble proteins of mitochondrial matrix. These results confirm that we have developed comprehensive tools to study functions of heterochromatic Tim17b gene.	[Garabedian, Mikael; Jarnik, Michael; Kotova, Elena; Tulin, Alexei V.] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Garabedian, M (corresponding author), Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	Alexei.Tulin@fccc.edu	Kotova, Elena/V-3767-2019	Garabedian, Mikael/0000-0001-7826-7491	National Institutes of Health [R01 GM077452]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077452] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by a grant from the National Institutes of Health (R01 GM077452) to AVT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Baker MJ, 2007, TRENDS CELL BIOL, V17, P456, DOI 10.1016/j.tcb.2007.07.010; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; CARAFOLI E, 1980, MOL ASPECTS MED, V3, P295, DOI 10.1016/0098-2997(80)90005-9; CHANG LO, 1971, CANCER RES, V31, P108; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; COOLEY L, 1988, SCIENCE, V239, P1121, DOI 10.1126/science.2830671; Coulthard AB, 2010, GENETICS, V185, P479, DOI 10.1534/genetics.110.117259; Cox RT, 2003, DEVELOPMENT, V130, P1579, DOI 10.1242/dev.00365; Cryderman DE, 1999, EMBO J, V18, P3724, DOI 10.1093/emboj/18.13.3724; Dimitri P, 2009, CHROMOSOMA, V118, P419, DOI 10.1007/s00412-009-0211-y; Ellermeier C, 2010, P NATL ACAD SCI USA, V107, P8701, DOI 10.1073/pnas.0914160107; Fortier E, 2000, GENESIS, V26, P240, DOI 10.1002/(SICI)1526-968X(200004)26:4<240::AID-GENE40>3.0.CO;2-P; GATTI M, 1992, ANNU REV GENET, V26, P239, DOI 10.1146/annurev.ge.26.120192.001323; GATTI M, 1983, CHROMOSOMA, V88, P593; Gelbart WM, 1999, NUCLEIC ACIDS RES, V27, P85, DOI 10.1093/nar/27.1.85; Giordano E, 2002, GENETICS, V160, P637; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Grewal SIS, 2002, CURR OPIN GENET DEV, V12, P178, DOI 10.1016/S0959-437X(02)00284-8; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; HEITZ E, 1933, J JH WISS, V69, P762; HILLIKER AJ, 1980, CELL, V21, P607, DOI 10.1016/0092-8674(80)90424-9; IRWIN CC, 1978, CANCER RES, V38, P1584; Kotova E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000387; LOHE AR, 1993, GENETICS, V134, P1149; Manseau L, 1997, DEV DYNAM, V209, P310, DOI 10.1002/(SICI)1097-0177(199707)209:3<310::AID-AJA6>3.0.CO;2-L; Modica-Napolitano Josephine S, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S1462399402004453; NURMINSKY DI, 1994, CHROMOSOMA, V103, P277, DOI 10.1007/BF00352252; Pedersen P L, 1978, Prog Exp Tumor Res, V22, P190; Peluso G, 2000, J CELL PHYSIOL, V182, P339, DOI 10.1002/(SICI)1097-4652(200003)182:3<339::AID-JCP4>3.3.CO;2-2; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; PIMPINELLI S, 1995, P NATL ACAD SCI USA, V92, P3804, DOI 10.1073/pnas.92.9.3804; Pinnola A, 2007, J BIOL CHEM, V282, P32511, DOI 10.1074/jbc.M705989200; PROKHOROVA AV, 1994, GENETIKA+, V30, P874; Rong YKS, 2002, GENE DEV, V16, P1568, DOI 10.1101/gad.986602; Rossi F, 2007, GENETICS, V175, P595, DOI 10.1534/genetics.106.065441; Schulze S, 2001, MOL GEN GENET, V264, P782, DOI 10.1007/s004380000367; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; Sinclair DAR, 2000, GENETICA, V109, P9, DOI 10.1023/A:1026500620158; SONDEK J, 1992, P NATL ACAD SCI USA, V89, P3581, DOI 10.1073/pnas.89.8.3581; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; TAUTZ D, 1988, MOL BIOL EVOL, V5, P366; Tavernarakis N, 2000, NAT GENET, V24, P180, DOI 10.1038/72850; Tulin A, 2002, GENE DEV, V16, P2108, DOI 10.1101/gad.1003902; Tulin AV, 1997, GENETICS, V146, P253; WEINHOUSE S, 1955, ADV CANCER RES, V3, P269, DOI 10.1016/S0065-230X(08)60922-7; Westermann B, 2002, EMBO REP, V3, P527, DOI 10.1093/embo-reports/kvf113	47	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e25945	10.1371/journal.pone.0025945	http://dx.doi.org/10.1371/journal.pone.0025945			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998726	Green Published, gold, Green Submitted			2022-12-27	WOS:000295968700026
J	Tenuta, T; Monopoli, MP; Kim, J; Salvati, A; Dawson, KA; Sandin, P; Lynch, I				Tenuta, Tiziana; Monopoli, Marco P.; Kim, JongAh; Salvati, Anna; Dawson, Kenneth A.; Sandin, Peter; Lynch, Iseult			Elution of Labile Fluorescent Dye from Nanoparticles during Biological Use	PLOS ONE			English	Article							PROTEINS	Cells act as extremely efficient filters for elution of unbound fluorescent tags or impurities associated with nanoparticles, including those that cannot be removed by extensive cleaning. This has consequences for quantification of nanoparticle uptake and sub-cellular localization in vitro and in vivo as a result of the presence of significant amount of labile dye even following extensive cleaning by dialysis. Polyacrylamide gel electrophoresis (PAGE) can be used to monitor the elution of unbound fluorescent probes from nanoparticles, either commercially available or synthesized in-house, and to ensure their complete purification for biological studies, including cellular uptake and sub-cellular localisation. Very different fluorescence distribution within cells is observed after short dialysis times versus following extensive dialysis against a solvent in which the free dye is more soluble, due to the contribution from free dye. In the absence of an understanding of the presence of residual free dye in (most) labeled nanoparticle solutions, the total fluorescence intensity in cells following exposure to nanoparticle solutions could be mis-ascribed to the presence of nanoparticles through the cell, rather than correctly assigned to either a combination of free-dye and nanoparticle-bound dye, or even entirely to free dye depending on the exposure conditions (i.e. aggregation of the particles etc). Where all of the dye is nanoparticle-bound, the particles are highly localized in sub-cellular organelles, likely lysosomes, whereas in a system containing significant amounts of free dye, the fluorescence is distributed through the cell due to the free diffusion of the molecule dye across all cellular barriers and into the cytoplasm.	[Tenuta, Tiziana; Monopoli, Marco P.; Kim, JongAh; Salvati, Anna; Dawson, Kenneth A.; Sandin, Peter; Lynch, Iseult] Univ Coll Dublin, Ctr BioNano Interact, Sch Chem & Chem Biol, Dublin 2, Ireland	University College Dublin	Tenuta, T (corresponding author), Univ Coll Dublin, Ctr BioNano Interact, Sch Chem & Chem Biol, Dublin 2, Ireland.	Iseult.Lynch@cbni.ucd.ie	Monopoli, Marco P./AAM-6527-2021; Monopoli, Marco P/I-7060-2018; Dawson, Kenneth A. A/L-2540-2016; Lynch, Iseult/I-3915-2014	Monopoli, Marco P./0000-0002-2035-6894; Monopoli, Marco P/0000-0002-2035-6894; Dawson, Kenneth A. A/0000-0002-0568-6588; Lynch, Iseult/0000-0003-4250-4584; Salvati, Anna/0000-0002-9339-0161	Irish Government; EPA [2006-PhD-RCA-19]; EU [NMP4-CT-2006-033231]; Knut and Alice Wallenberg foundation; SFI SRC BioNanoInteract [07 SRC B1155]	Irish Government; EPA(United States Environmental Protection Agency); EU(European Commission); Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); SFI SRC BioNanoInteract(Science Foundation Ireland)	This work was conducted under the framework of the INSPIRE programme, funded by the Irish Government's Programme for Research in Third Level Institutions, Cycle 4, National Development Plan 2007-2013 (J-AK, MM). Additional funding from EPA (2006-PhD-RCA-19, TT), EU FP6 STREP project NanoInteract (NMP4-CT-2006-033231, IL, AS), the Knut and Alice Wallenberg foundation (PS) and SFI SRC BioNanoInteract (07 SRC B1155) is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cedervall T, 2007, ANGEW CHEM INT EDIT, V46, P5754, DOI 10.1002/anie.200700465; Cedervall T, 2007, P NATL ACAD SCI USA, V104, P2050, DOI 10.1073/pnas.0608582104; Lynch I, 2003, J PHYS CHEM B, V107, P9629, DOI 10.1021/jp022008w; Pietzonka P, 2002, PHARMACEUT RES, V19, P595, DOI 10.1023/A:1015393710253; PRESTON RA, 1987, J CELL BIOL, V105, P1981, DOI 10.1083/jcb.105.5.1981; SALVATI A, 2011, NANOMEDICIN IN PRESS; TAYLOR LD, 1975, J POLYM SCI POL CHEM, V13, P2551, DOI 10.1002/pol.1975.170131113	7	70	70	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e25556	10.1371/journal.pone.0025556	http://dx.doi.org/10.1371/journal.pone.0025556			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998668	Green Published, gold, Green Submitted			2022-12-27	WOS:000295968700013
J	Mujugira, A; Baeten, JM; Donnell, D; Ndase, P; Mugo, NR; Barnes, L; Campbell, JD; Wangisi, J; Tappero, JW; Bukusi, E; Cohen, CR; Katabira, E; Ronald, A; Tumwesigye, E; Were, E; Fife, KH; Kiarie, J; Farquhar, C; John-Stewart, G; Kidoguchi, L; Panteleeff, D; Krows, M; Shah, H; Revall, J; Morrison, S; Ondrejcek, L; Ingram, C; Coombs, RW; Lingappa, JR; Celum, C				Mujugira, Andrew; Baeten, Jared M.; Donnell, Deborah; Ndase, Patrick; Mugo, Nelly R.; Barnes, Linda; Campbell, James D.; Wangisi, Jonathan; Tappero, Jordan W.; Bukusi, Elizabeth; Cohen, Craig R.; Katabira, Elly; Ronald, Allan; Tumwesigye, Elioda; Were, Edwin; Fife, Kenneth H.; Kiarie, James; Farquhar, Carey; John-Stewart, Grace; Kidoguchi, Lara; Panteleeff, Dana; Krows, Meighan; Shah, Heena; Revall, Jennifer; Morrison, Susan; Ondrejcek, Lisa; Ingram, Charlotte; Coombs, Robert W.; Lingappa, Jairam R.; Celum, Connie		Partners PrEp Study Team	Characteristics of HIV-1 Serodiscordant Couples Enrolled in a Clinical Trial of Antiretroviral Pre-Exposure Prophylaxis for HIV-1 Prevention	PLOS ONE			English	Article							TENOFOVIR DISOPROXIL FUMARATE; HUMAN-IMMUNODEFICIENCY-VIRUS; PROSPECTIVE COHORT; RENAL SAFETY; HEPATITIS-B; TRANSMISSION; INFECTION; MACAQUES	Introduction: Stable heterosexual HIV-1 serodiscordant couples in Africa have high HIV-1 transmission rates and are a critical population for evaluation of new HIV-1 prevention strategies. The Partners PrEP Study is a randomized, double-blind, placebo-controlled trial of tenofovir and emtricitabine-tenofovir pre-exposure prophylaxis to decrease HIV-1 acquisition within heterosexual HIV-1 serodiscordant couples. We describe the trial design and characteristics of the study cohort. Methods: HIV-1 serodiscordant couples, in which the HIV-1 infected partner did not meet national guidelines for initiation of antiretroviral therapy, were enrolled at 9 research sites in Kenya and Uganda. The HIV-1 susceptible partner was randomized to daily oral tenofovir, emtricitabine-tenofovir, or matching placebo with monthly follow-up for 24-36 months. Results: From July 2008 to November 2010, 7920 HIV-1 serodiscordant couples were screened and 4758 enrolled. For 62% (2966/4758) of enrolled couples, the HIV-1 susceptible partner was male. Median age was 33 years for HIV-1 susceptible and HIV-1 infected partners [IQR (28-40) and (26-39) respectively]. Most couples (98%) were married, with a median duration of partnership of 7.0 years (IQR 3.0-14.0) and recent knowledge of their serodiscordant status [median 0.4 years (IQR 0.1-2.0)]. During the month prior to enrollment, couples reported a median of 4 sex acts (IQR 2-8); 27% reported unprotected sex and 14% of male and 1% of female HIV-1 susceptible partners reported sex with outside partners. Among HIV-1 infected partners, the median plasma HIV-1 level was 3.94 log(10) copies/mL (IQR 3.31-4.53) and median CD4 count was 496 cells/mu L (IQR 375-662); the majority (64%) had WHO stage 1 HIV-1 disease. Conclusions: Couples at high risk of HIV-1 transmission were rapidly recruited into the Partners PrEP Study, the largest efficacy trial of oral PrEP. (ClinicalTrials.gov NCT00557245)	[Mujugira, Andrew; Baeten, Jared M.; Donnell, Deborah; Ndase, Patrick; Mugo, Nelly R.; Barnes, Linda; Bukusi, Elizabeth; Farquhar, Carey; John-Stewart, Grace; Kidoguchi, Lara; Panteleeff, Dana; Krows, Meighan; Shah, Heena; Revall, Jennifer; Morrison, Susan; Lingappa, Jairam R.; Celum, Connie] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Baeten, Jared M.; Farquhar, Carey; John-Stewart, Grace; Coombs, Robert W.; Lingappa, Jairam R.; Celum, Connie] Univ Washington, Dept Med, Seattle, WA USA; [Baeten, Jared M.; Farquhar, Carey; John-Stewart, Grace; Celum, Connie] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Coombs, Robert W.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Lingappa, Jairam R.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Donnell, Deborah] Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, Seattle, WA 98104 USA; [Mugo, Nelly R.; Bukusi, Elizabeth; Kiarie, James] Univ Nairobi, Dept Obstet & Gynecol, Nairobi, Kenya; [Mugo, Nelly R.; Bukusi, Elizabeth; Kiarie, James] Kenyatta Natl Hosp, Nairobi, Kenya; [Campbell, James D.] Ctr Dis Control & Prevent, Entebbe, Uganda; [Wangisi, Jonathan] AIDS Support Org, Kampala, Uganda; [Tappero, Jordan W.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Bukusi, Elizabeth] Kenya Govt Med Res Ctr, Ctr Microbiol Res, Nairobi, Kenya; [Bukusi, Elizabeth; Cohen, Craig R.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA; [Katabira, Elly; Ronald, Allan] Makerere Univ, Infect Dis Inst, Kampala, Uganda; [Ronald, Allan] Univ Manitoba, Dept Med, Winnipeg, MB, Canada; [Tumwesigye, Elioda] Kabwohe Clin Res Ctr, Kabwohe, Uganda; [Were, Edwin] Moi Univ, Dept Reprod Hlth, Eldoret, Kenya; [Fife, Kenneth H.] Indiana Univ, Dept Med, Indianapolis, IN USA; [Ondrejcek, Lisa] DF Net Res Inc, Seattle, WA USA; [Ingram, Charlotte] Univ Witwatersrand, Dept Mol Med & Hematol, Johannesburg, South Africa; [Ingram, Charlotte] Wits Hlth Consortium, CLS, Johannesburg, South Africa	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Nairobi; Kenyatta National Hospital; Centers for Disease Control & Prevention - USA; Kenya Medical Research Institute; University of California System; University of California San Francisco; Makerere University; University of Manitoba; Moi University; Indiana University System; Indiana University-Purdue University Indianapolis; University of Witwatersrand; University of Witwatersrand	Mujugira, A (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.	mujugira@uw.edu	John-Stewart, Grace/U-3351-2019; Campbell, James D/AFN-5982-2022; Lingappa, Jairam/N-7760-2017; John-Stewart, Grace/L-3650-2019	Ronald, Allan/0000-0002-5746-3490; Donnell, Deborah/0000-0002-0587-7480; Mujugira, Andrew/0000-0001-6646-6733; Were, Edwin/0000-0002-4783-0795; kiarie, james/0000-0003-4180-7858	Bill & Melinda Gates Foundation [47674]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, P30AI027757] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported through a research grant from the Bill & Melinda Gates Foundation (grant ID # 47674). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen S, 2003, AIDS, V17, P733, DOI 10.1097/00002030-200303280-00012; AVAC, OR TOP PREP TRIAL TI; Bongaarts J, 2010, 20 POP COUNC; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cooper RD, 2010, CLIN INFECT DIS, V51, P496, DOI 10.1086/655681; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; FHI, FHI IN ORD CLOS FEM; Gallant JE, 2008, AIDS, V22, P2155, DOI 10.1097/QAD.0b013e3283112b8e; Garcia-Lerma JG, 2008, PLOS MED, V5, P291, DOI 10.1371/journal.pmed.0050028; Garcia-Lerma JG, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000391; GRANT RM, 2010, N ENGL J MED; Hallett T, 2011, 18 C RETR OPP INF; Heffron R, 2010, SEX TRANSM DIS, V37, P621, DOI 10.1097/OLQ.0b013e3181e1a162; Hugonnet S, 2002, J ACQ IMMUN DEF SYND, V30, P73, DOI 10.1097/00042560-200205010-00010; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Lim SG, 2002, GUT, V51, P597, DOI 10.1136/gut.51.4.597; Nebie Y, 2001, J ACQ IMMUN DEF SYND, V28, P367, DOI 10.1097/00126334-200112010-00010; Nunez M, 2005, LANCET INFECT DIS, V5, P374, DOI 10.1016/S1473-3099(05)70141-9; Parikh UM, 2009, J VIROL, V83, P10358, DOI 10.1128/JVI.01073-09; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Shiboski SC, 1998, J ACQ IMMUN DEF SYND, V19, P527, DOI 10.1097/00042560-199812150-00013; Subbarao S, 2006, J INFECT DIS, V194, P904, DOI 10.1086/507306; TSAI CC, 1995, SCIENCE, V270, P1197, DOI 10.1126/science.270.5239.1197; Vernazza PL, 1999, AIDS, V13, P155, DOI 10.1097/00002030-199902040-00003; Wabwire-Mangen F, 2009, UGANDA HIV MODES TRA	27	71	73	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25828	10.1371/journal.pone.0025828	http://dx.doi.org/10.1371/journal.pone.0025828			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998703	Green Submitted, Green Published, gold			2022-12-27	WOS:000295966900060
J	Romero, Y; Meikar, O; Papaioannou, MD; Conne, B; Grey, C; Weier, M; Pralong, F; De Massy, B; Kaessmann, H; Vassalli, JD; Kotaja, N; Nef, S				Romero, Yannick; Meikar, Oliver; Papaioannou, Marilena D.; Conne, Beatrice; Grey, Corinne; Weier, Manuela; Pralong, Francois; De Massy, Bernard; Kaessmann, Henrik; Vassalli, Jean-Dominique; Kotaja, Noora; Nef, Serge			Dicer1 Depletion in Male Germ Cells Leads to Infertility Due to Cumulative Meiotic and Spermiogenic Defects	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; SMALL RNAS; ENDOGENOUS SIRNAS; GENE-EXPRESSION; MOUSE; SPERMATOGENESIS; MICRORNAS; FERTILITY; RETROTRANSPOSONS; DIFFERENTIATION	Background: Spermatogenesis is a complex biological process that requires a highly specialized control of gene expression. In the past decade, small non-coding RNAs have emerged as critical regulators of gene expression both at the transcriptional and post-transcriptional level. DICER1, an RNAse III endonuclease, is essential for the biogenesis of several classes of small RNAs, including microRNAs (miRNAs) and endogenous small interfering RNAs (endo-siRNAs), but is also critical for the degradation of toxic transposable elements. In this study, we investigated to which extent DICER1 is required for germ cell development and the progress of spermatogenesis in mice. Principal Findings: We show that the selective ablation of Dicer1 at the early onset of male germ cell development leads to infertility, due to multiple cumulative defects at the meiotic and post-meiotic stages culminating with the absence of functional spermatozoa. Alterations were observed in the first spermatogenic wave and include delayed progression of spermatocytes to prophase I and increased apoptosis, resulting in a reduced number of round spermatids. The transition from round to mature spermatozoa was also severely affected, since the few spermatozoa formed in mutant animals were immobile and misshapen, exhibiting morphological defects of the head and flagellum. We also found evidence that the expression of transposable elements of the SINE family is up-regulated in Dicer1-depleted spermatocytes. Conclusions/Significance: Our findings indicate that DICER1 is dispensable for spermatogonial stem cell renewal and mitotic proliferation, but is required for germ cell differentiation through the meiotic and haploid phases of spermatogenesis.	[Romero, Yannick; Papaioannou, Marilena D.; Conne, Beatrice; Vassalli, Jean-Dominique; Nef, Serge] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Meikar, Oliver; Kotaja, Noora] Univ Turku, Dept Physiol, Inst Biomed, Turku, Finland; [Grey, Corinne; De Massy, Bernard] CNRS, IGH, Montpellier, France; [Weier, Manuela; Kaessmann, Henrik] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland; [Pralong, Francois] Univ Lausanne Hosp, Dept Internal Med, Lausanne, Switzerland	University of Geneva; University of Turku; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Romero, Y (corresponding author), Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland.	serge.nef@unige.ch	Nef, Serge/AAV-6445-2020; Kaessmann, Henrik/B-4989-2013	Nef, Serge/0000-0001-5462-0676; Kaessmann, Henrik/0000-0001-7563-839X; Kotaja, Noora/0000-0003-1503-9170	Swiss National Science Foundation [3100A0-119862]; Centre National de la Recherche Scientifique; Agence Nationale de la Recherche [ANR-09-BLAN-0269-01]; Academy of Finland; Emil Aaltonen Foundation; Turku Graduate School of Biomedical Sciences	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Academy of Finland(Academy of Finland); Emil Aaltonen Foundation; Turku Graduate School of Biomedical Sciences	This project is supported by grant no. 3100A0-119862 to SN from the Swiss National Science Foundation. CG and BdM are supported by grants from the Centre National de la Recherche Scientifique and the Agence Nationale de la Recherche (ANR-09-BLAN-0269-01). NK and OM are supported by the Academy of Finland, Emil Aaltonen Foundation and Turku Graduate School of Biomedical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Barchi M, 2009, METHODS MOL BIOL, V558, P299, DOI 10.1007/978-1-60761-103-5_18; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bouhallier F, 2010, RNA, V16, P720, DOI 10.1261/rna.1963810; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Buchold GM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015317; Cederroth CR, 2010, MOL CELL ENDOCRINOL, V321, P152, DOI 10.1016/j.mce.2010.02.011; Chen JF, 2008, P NATL ACAD SCI USA, V105, P2111, DOI 10.1073/pnas.0710228105; Eddy EM, 2002, RECENT PROG HORM RES, V57, P103, DOI 10.1210/rp.57.1.103; Fernandez-Capetillo O, 2003, DEV CELL, V4, P497, DOI 10.1016/S1534-5807(03)00093-5; Gallardo T, 2007, GENESIS, V45, P413, DOI 10.1002/dvg.20310; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Gonzalez G, 2009, MOL REPROD DEV, V76, P678, DOI 10.1002/mrd.21010; Gonzalez-Gonzalez E, 2008, BIOCH BIOPHYS ACTA; Grad I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015770; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Guerif F, 2002, INT J ANDROL, V25, P358, DOI 10.1046/j.1365-2605.2002.00382.x; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103; Hayashi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001738; He ZP, 2009, REPRODUCTION, V137, P901, DOI 10.1530/REP-08-0494; Huang CCJ, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-66; Kaneko H, 2011, NATURE, V471, P325, DOI 10.1038/nature09830; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kimmins S, 2007, MOL ENDOCRINOL, V21, P726, DOI 10.1210/me.2006-0332; KOBAYASHI T, 2008, P NATL ACAD SCI US; Kotaja N, 2006, P NATL ACAD SCI USA, V103, P2647, DOI 10.1073/pnas.0509333103; Kuramochi-Miyagawa S, 2010, GENE DEV, V24, P887, DOI 10.1101/gad.1902110; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lomeli H, 2000, GENESIS, V26, P116, DOI 10.1002/(SICI)1526-968X(200002)26:2<116::AID-GENE4>3.0.CO;2-X; Luense LJ, 2009, TRENDS ENDOCRIN MET, V20, P265, DOI 10.1016/j.tem.2009.05.001; Maatouk DM, 2008, BIOL REPROD, V79, P696, DOI 10.1095/biolreprod.108.067827; Mandal PK, 2008, CELL, V135, DOI 10.1016/j.cell.2008.09.028; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; Mattiske DM, 2009, REPRODUCTION, V137, P625, DOI 10.1530/REP-08-0475; Meikar O, 2010, EXP CELL RES, V316, P1567, DOI 10.1016/j.yexcr.2010.02.023; Murchison EP, 2007, GENE DEV, V21, P682, DOI 10.1101/gad.1521307; O'Rourke JR, 2007, DEV BIOL, V311, P359, DOI 10.1016/j.ydbio.2007.08.032; OAKBERG EF, 1956, AM J ANAT, V99, P507, DOI 10.1002/aja.1000990307; Papaioannou MD, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M900587-MCP200; Papaioannou MD, 2010, J ANDROL, V31, P26, DOI 10.2164/jandrol.109.008128; Papaioannou MD, 2009, DEV BIOL, V326, P250, DOI 10.1016/j.ydbio.2008.11.011; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Siomi MC, 2009, CURR OPIN CELL BIOL, V21, P426, DOI 10.1016/j.ceb.2009.02.003; Song R, 2011, P NATL ACAD SCI USA, V108, P13159, DOI 10.1073/pnas.1108567108; Suarez Y, 2008, P NATL ACAD SCI USA, V105, P14082, DOI 10.1073/pnas.0804597105; Suh N, 2010, CURR BIOL; Svoboda P, 2004, DEV BIOL, V269, P276, DOI 10.1016/j.ydbio.2004.01.028; Swetloff A, 2009, MOL CELL BI IN PRESS; Tam W, 2008, J MOL DIAGN, V10, P411, DOI 10.2353/jmoldx.2008.080067; Tang F, 2007, GENE DEV, V21, P644, DOI 10.1101/gad.418707; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Watanabe T, 2006, GENE DEV, V20, P1732, DOI 10.1101/gad.1425706	54	102	110	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25241	10.1371/journal.pone.0025241	http://dx.doi.org/10.1371/journal.pone.0025241			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998645	Green Published, Green Submitted, gold			2022-12-27	WOS:000295966900016
J	Schafer, MG; Ross, AA; Londo, JP; Burdick, CA; Lee, EH; Travers, SE; Van de Water, PK; Sagers, CL				Schafer, Meredith G.; Ross, Andrew A.; Londo, Jason P.; Burdick, Connie A.; Lee, E. Henry; Travers, Steven E.; Van de Water, Peter K.; Sagers, Cynthia L.			The Establishment of Genetically Engineered Canola Populations in the US	PLOS ONE			English	Article							BENTGRASS AGROSTIS-STOLONIFERA; BRASSICA-NAPUS L.; GENE FLOW; CREEPING BENTGRASS; HERBICIDE RESISTANCE; HYBRIDIZATION; PERSISTENCE	Concerns regarding the commercial release of genetically engineered (GE) crops include naturalization, introgression to sexually compatible relatives and the transfer of beneficial traits to native and weedy species through hybridization. To date there have been few documented reports of escape leading some researchers to question the environmental risks of biotech products. In this study we conducted a systematic roadside survey of canola (Brassica napus) populations growing outside of cultivation in North Dakota, USA, the dominant canola growing region in the U.S. We document the presence of two escaped, transgenic genotypes, as well as non-GE canola, and provide evidence of novel combinations of transgenic forms in the wild. Our results demonstrate that feral populations are large and widespread. Moreover, flowering times of escaped populations, as well as the fertile condition of the majority of collections suggest that these populations are established and persistent outside of cultivation.	[Schafer, Meredith G.; Londo, Jason P.; Sagers, Cynthia L.] Univ Arkansas, Dept Biol Sci, Fayetteville, AR 72701 USA; [Ross, Andrew A.; Travers, Steven E.] N Dakota State Univ, Dept Biol Sci, Fargo, ND 58105 USA; [Burdick, Connie A.; Lee, E. Henry] US EPA, Western Ecol Div, Natl Hlth & Environm Effects Res Lab, Corvallis, OR USA; [Van de Water, Peter K.] Calif State Univ Fresno, Earth & Environm Sci Dept, Fresno, CA 93740 USA	University of Arkansas System; University of Arkansas Fayetteville; North Dakota State University Fargo; United States Environmental Protection Agency; California State University System; California State University Fresno	Schafer, MG (corresponding author), Univ Arkansas, Dept Biol Sci, Fayetteville, AR 72701 USA.	csagers@uark.edu		Londo, Jason/0000-0003-0535-4820	USDA CREES [NRI 35615-19216]	USDA CREES(United States Department of Agriculture (USDA))	Provided by: USDA CREES NRI 35615-19216, "Ecological Impacts from the Interactions of Climate Change, Land-Use Change and Invasive Species.'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aono Mitsuko, 2006, Environmental Biosafety Research, V5, P77, DOI 10.1051/ebr:2006017; Beckie HJ, 2003, ECOL APPL, V13, P1276, DOI 10.1890/02-5231; Corvalan C, 2005, ECOSYSTEMS HUMAN WEL; CRAWLEY MJ, 1995, P ROY SOC B-BIOL SCI, V259, P49, DOI 10.1098/rspb.1995.0008; Dale PJ, 2002, NAT BIOTECHNOL, V20, P567, DOI 10.1038/nbt0602-567; Ellstrand NC, 1999, ANNU REV ECOL SYST, V30, P539, DOI 10.1146/annurev.ecolsys.30.1.539; Fedoroff NV, 2010, SCIENCE, V327, P833, DOI 10.1126/science.1186834; FitzJohn RG, 2007, EUPHYTICA, V158, P209, DOI 10.1007/s10681-007-9444-0; Gomez-Campo C, 1999, DEV PL GEN, V4, P33; Gulden RH, 2003, WEED SCI, V51, P904, DOI 10.1614/P2002-170; Gulden RH, 2003, WEED SCI, V51, P83, DOI 10.1614/0043-1745(2003)051[0083:HLOCBN]2.0.CO;2; Knispel AL, 2008, WEED SCI, V56, P72, DOI 10.1614/WS-07-097.1; Knispel AL, 2010, ENVIRON SCI POLLUT R, V17, P13, DOI 10.1007/s11356-009-0219-0; Levin DA, 1996, CONSERV BIOL, V10, P10, DOI 10.1046/j.1523-1739.1996.10010010.x; Lu BR, 2005, BIOSCIENCE, V55, P669, DOI 10.1641/0006-3568(2005)055[0669:GFFGMR]2.0.CO;2; Pessel FD, 2001, THEOR APPL GENET, V102, P841, DOI 10.1007/s001220100583; Reichman JR, 2006, MOL ECOL, V15, P4243, DOI 10.1111/j.1365-294X.2006.03072.x; Rieger MA, 2002, SCIENCE, V296, P2386, DOI 10.1126/science.1071682; Sinemus K, 2009, EUROPEAN COMMISSION; USDA NRCS, 2011, PLANTS DAT; Warwick SI, 2003, THEOR APPL GENET, V107, P528, DOI 10.1007/s00122-003-1278-0; Watrud LS, 2004, P NATL ACAD SCI USA, V101, P14533, DOI 10.1073/pnas.0405154101; Wolfenbarger LL, 2000, SCIENCE, V290, P2088, DOI 10.1126/science.290.5499.2088; Zapiola ML, 2008, J APPL ECOL, V45, P486, DOI 10.1111/j.1365-2664.2007.01430.x	24	58	61	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25736	10.1371/journal.pone.0025736	http://dx.doi.org/10.1371/journal.pone.0025736			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998689	Green Published, Green Submitted, gold			2022-12-27	WOS:000295966900050
J	Zhang, XB; Zhang, SC; Sun, DJ; Hu, J; Wali, A; Pass, H; Fernandez-Madrid, F; Harbut, MR; Tang, NM				Zhang, Xinbo; Zhang, Siyu Crystal; Sun, Dejun; Hu, Jiang; Wali, Anil; Pass, Harvey; Fernandez-Madrid, Felix; Harbut, Michael R.; Tang, Naimei			New Insight into the Molecular Mechanisms of the Biological Effects of DNA Minor Groove Binders	PLOS ONE			English	Article							HOECHST 33342-INDUCED APOPTOSIS; 33342 INDUCES APOPTOSIS; BOX-BINDING PROTEIN; I IN-VIVO; BC3H-1 MYOCYTES; TOPOISOMERASE-I; HL-60 CELLS; AGENTS; 33258-HOECHST; CONDENSATION	Background: Bisbenzimides, or Hoechst 33258 (H258), and its derivative Hoechst 33342 (H342) are archetypal molecules for designing minor groove binders, and widely used as tools for staining DNA and analyzing side population cells. They are supravital DNA minor groove binders with AT selectivity. H342 and H258 share similar biological effects based on the similarity of their chemical structures, but also have their unique biological effects. For example, H342, but not H258, is a potent apoptotic inducer and both H342 and H258 can induce transgene overexpression in in vitro studies. However, the molecular mechanisms by which Hoechst dyes induce apoptosis and enhance transgene overexpression are unclear. Methodology/Principal Findings: To determine the molecular mechanisms underlying different biological effects between H342 and H258, microarray technique coupled with bioinformatics analyses and multiple other techniques has been utilized to detect differential global gene expression profiles, Hoechst dye-specific gene expression signatures, and changes in cell morphology and levels of apoptosis-associated proteins in malignant mesothelioma cells. H342-induced apoptosis occurs in a dose-dependent fashion and is associated with morphological changes, caspase-3 activation, cytochrome c mitochondrial translocation, and cleavage of apoptosis-associated proteins. The antagonistic effect of H258 on H342-induced apoptosis indicates a pharmacokinetic basis for the two dyes' different biological effects. Differential global gene expression profiles induced by H258 and H342 are accompanied by unique gene expression signatures determined by DNA microarray and bioinformatics software, indicating a genetic basis for their different biological effects. Conclusions/Significance: A unique gene expression signature associated with H342-induced apoptosis provides a new avenue to predict and classify the therapeutic class of minor groove binders in the drug development process. Further analysis of H258-upregulated genes of transcription regulation may identify the genes that enhance transgene overexpression in gene therapy and promote recombinant protein products in biopharmaceutical companies. Data Deposition: The microarray data reported in this article have been deposited in the Gene Expression Omnibus (GEO) database, www.ncbi.nlm.nih.gov/geo (accession no.GSE28616).	[Zhang, Xinbo; Zhang, Siyu Crystal] Wayne State Univ, MedStart Program, Detroit, MI 48202 USA; [Harbut, Michael R.; Tang, Naimei] Karmanos Canc Inst, Environm Canc Initiat, Natl Ctr Vermiculite & Asbestos Related Canc, Detroit, MI USA; [Sun, Dejun] Res Inst Resp & Crit Care Med, Baotou, Inner Mongolia, Peoples R China; [Hu, Jiang] Cent Hosp, Dept Surg, Baotou, Inner Mongolia, Peoples R China; [Wali, Anil] NCI, Ctr Reduce Canc Hlth Dispar, Rockville, MD USA; [Pass, Harvey] NYU, Med Ctr, Dept Cardiothorac Surg, New York, NY 10016 USA; [Harbut, Michael R.] Providence Hosp, Ctr Occupat & Environm Med, Southfield, MI 48037 USA	Wayne State University; Barbara Ann Karmanos Cancer Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); New York University	Zhang, XB (corresponding author), Wayne State Univ, MedStart Program, Detroit, MI 48202 USA.	ntang@med.wayne.edu		Pass, Harvey/0000-0003-3222-3471				Athar M, 2011, MOL CELL BIOCHEM, V352, P281, DOI 10.1007/s11010-011-0764-y; Athar M, 2010, FREE RADICAL RES, V44, P936, DOI 10.3109/10715762.2010.492829; Babu MM, 2004, CURR OPIN STRUC BIOL, V14, P283, DOI 10.1016/j.sbi.2004.05.004; Baraldi PG, 2004, MED RES REV, V24, P475, DOI 10.1002/med.20000; BEERMAN TA, 1992, BIOCHIM BIOPHYS ACTA, V1131, P53, DOI 10.1016/0167-4781(92)90098-K; Cai XM, 2009, CANCER TREAT REV, V35, P437, DOI 10.1016/j.ctrv.2009.02.004; Ceresoli GL, 2010, CANCER TREAT REV, V36, P24, DOI 10.1016/j.ctrv.2009.09.003; CHEN AY, 1993, P NATL ACAD SCI USA, V90, P8131, DOI 10.1073/pnas.90.17.8131; Chen JC, 2004, ANN CLIN LAB SCI, V34, P458; CHIANG SY, 1994, BIOCHEMISTRY-US, V33, P7033, DOI 10.1021/bi00189a003; D'Amelio M, 2010, CELL DEATH DIFFER, V17, P1104, DOI 10.1038/cdd.2009.180; DURAND RE, 1982, J HISTOCHEM CYTOCHEM, V30, P111, DOI 10.1177/30.2.7061816; Fujii M, 2006, MOL CELL, V24, P771, DOI 10.1016/j.molcel.2006.11.006; Goodell Margaret A, 2005, Methods Mol Biol, V290, P343; Heintz NH, 2010, AM J RESP CELL MOL, V42, P133, DOI 10.1165/rcmb.2009-0206TR; HIRSCHBERG J, 1980, EXP CELL RES, V130, P63, DOI 10.1016/0014-4827(80)90042-7; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jerome KR, 2000, ARCH PATHOL LAB MED, V124, P802; Jia Y, 2010, J BIOL CHEM, V285, P1726, DOI 10.1074/jbc.M109.046847; Karagiannis TC, 2006, J PHOTOCH PHOTOBIO B, V83, P195, DOI 10.1016/j.jphotobiol.2005.12.013; Kiechle FL, 2002, CLIN CHIM ACTA, V326, P27, DOI 10.1016/S0009-8981(02)00297-8; KRAUT EH, 1991, INVEST NEW DRUG, V9, P95; KUSYK CJ, 1979, CYTOGENET CELL GENET, V23, P39, DOI 10.1159/000131300; LALANDE ME, 1981, P NATL ACAD SCI-BIOL, V78, P363, DOI 10.1073/pnas.78.1.363; Li LN, 2005, J GENE MED, V7, P420, DOI 10.1002/jgm.681; MARCUS M, 1979, EXP CELL RES, V123, P406, DOI 10.1016/0014-4827(79)90488-9; Marquis JF, 2003, PARASITOLOGY, V126, P21, DOI 10.1017/S0031182002002524; Morandi E, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-66; Nautiyal J, 2010, MOL CANCER THER, V9, P1503, DOI 10.1158/1535-7163.MCT-10-0019; Ohta Y, 1999, BRIT J CANCER, V81, P54, DOI 10.1038/sj.bjc.6690650; PASS HI, 1995, ANN THORAC SURG, V59, P835, DOI 10.1016/0003-4975(95)00045-M; PATEL SR, 1991, INVEST NEW DRUG, V9, P53; Puckowska A, 2004, EUR J MED CHEM, V39, P99, DOI 10.1016/j.ejmech.2003.11.005; Reddy BSP, 2001, CURR MED CHEM, V8, P475; Rishi AK, 2010, CURR CANCER THER REV, V6, P262, DOI 10.2174/157339410793358075; Sacconi S, 2005, BIOCHEM BIOPH RES CO, V337, P832, DOI 10.1016/j.bbrc.2005.09.127; SMITH PJ, 1990, CARCINOGENESIS, V11, P659, DOI 10.1093/carcin/11.4.659; Soderlind KJ, 1999, ANTI-CANCER DRUG DES, V14, P19; SRIRAM M, 1992, EMBO J, V11, P225, DOI 10.1002/j.1460-2075.1992.tb05045.x; Tawar U, 2007, MOL CELL BIOCHEM, V305, P221, DOI 10.1007/s11010-007-9546-y; TOBEY RA, 1990, P NATL ACAD SCI USA, V87, P5104, DOI 10.1073/pnas.87.13.5104; Tomasetti Marco, 2009, Curr Mol Pharmacol, V2, P190; Tse WC, 2004, CHEM BIOL, V11, P1607, DOI 10.1016/j.chembiol.2003.08.012; Turner P. R., 2000, Current Drug Targets, V1, P1, DOI 10.2174/1389450003349407; Van Dang Chi, 2010, Genes Cancer, V1, P560; Varfolomeev E, 2008, CELL CYCLE, V7, P1511, DOI 10.4161/cc.7.11.5959; Wang Y, 2010, CANCER CHEMOTH PHARM, V66, P455, DOI 10.1007/s00280-009-1181-8; Welsenfeld RB, 2007, BIOORGAN MED CHEM, V15, P6361, DOI 10.1016/j.bme.2007.06.061; WOYNAROWSKI JM, 1989, MOL PHARMACOL, V35, P177; Zhang XB, 1999, ARCH PATHOL LAB MED, V123, P921; Zhang XB, 1998, BIOCHEM BIOPH RES CO, V248, P18, DOI 10.1006/bbrc.1998.8906; Zhang XB, 1998, ANN CLIN LAB SCI, V28, P104; Zhang XB, 2003, ARCH PATHOL LAB MED, V127, P1124; Zhang XB, 1997, ANN CLIN LAB SCI, V27, P260; Zhang XB, 2001, BIOCHEM BIOPH RES CO, V287, P865, DOI 10.1006/bbrc.2001.5676; Zhang XB, 2001, ARCH PATHOL LAB MED, V125, P99; Zhang XB, 2001, ANN CLIN LAB SCI, V31, P187; Zhang XB, 2006, ANN CLIN LAB SCI, V36, P185	58	72	75	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25822	10.1371/journal.pone.0025822	http://dx.doi.org/10.1371/journal.pone.0025822			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998702	gold, Green Submitted, Green Published			2022-12-27	WOS:000295966900059
J	Harvey, SC; Orbidans, HE				Harvey, Simon C.; Orbidans, Helen E.			All Eggs Are Not Equal: The Maternal Environment Affects Progeny Reproduction and Developmental Fate in Caenorhabditis elegans	PLOS ONE			English	Article							LIFE-HISTORY; DAUER LARVA; EVOLUTION; GROWTH; CYCLE; GENE; FOOD	Background: Maternal effects on progeny traits are common and these can profoundly alter progeny life history. Maternal effects can be adaptive, representing attempts to appropriately match offspring phenotype to the expected environment and are often mediated via trade-offs between progeny number and quality. Here we have investigated the effect of maternal food availability on progeny life history in the free-living nematode Caenorhabditis elegans. Methodology/Principal Findings: The maternal environment affects both reproductive traits and progeny development. Comparisons of the progeny of worms from high and low maternal food environments indicates that low maternal food availability reduces progeny reproduction in good environments, increases progeny reproduction in poor environments and decreases the likelihood that progeny will develop as dauer larvae. These analyses also indicate that the effects on progeny are not a simple consequence of changes in maternal body size, but are associated with an increase in the size of eggs produced by worms at low maternal food availabilities. Conclusions/Significance: These results indicate that the maternal environment affects both progeny reproduction and development in C. elegans and therefore that all progeny are not equal. The observed effects are consistent with changes to egg provisioning, which are beneficial in harsh environments, and of changes to progeny development, which are beneficial in harsh environments and detrimental in benign environments. These changes in progeny life history suggest that mothers in poor quality environments may be producing larger eggs that are better suited to poor conditions.	[Harvey, Simon C.; Orbidans, Helen E.] Canterbury Christ Church Univ, Ecol Res Grp, Dept Geog & Life Sci, Canterbury, Kent, England	Canterbury Christ Church University	Harvey, SC (corresponding author), Canterbury Christ Church Univ, Ecol Res Grp, Dept Geog & Life Sci, Canterbury, Kent, England.	simon.harvey@canterbury.ac.uk	Harvey, Simon/A-1263-2011	Harvey, Simon/0000-0002-7504-2227				Barriere A, 2005, CURR BIOL, V15, P1176, DOI 10.1016/j.cub.2005.06.022; Barriere Antoine, 2005, P1; Bashey F, 2006, EVOLUTION, V60, P348, DOI 10.1554/05-087.1; Benton TG, 2008, J ANIM ECOL, V77, P1038, DOI 10.1111/j.1365-2656.2008.01434.x; Bernardo J, 1996, AM ZOOL, V36, P83; Bonte D, 2009, J EVOLUTION BIOL, V22, P1242, DOI 10.1111/j.1420-9101.2009.01737.x; Bowerman B, 1998, CURR TOP DEV BIOL, V39, P73, DOI 10.1016/S0070-2153(08)60453-6; BYERLY L, 1976, DEV BIOL, V51, P23, DOI 10.1016/0012-1606(76)90119-6; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Cleuvers M, 1997, OECOLOGIA, V110, P337, DOI 10.1007/s004420050167; Cutter AD, 2006, GENETICS, V172, P171, DOI 10.1534/genetics.105.048207; Fitzsimmons JM, 2006, HYDROBIOLOGIA, V568, P187, DOI 10.1007/s10750-006-0104-5; GLIWICZ ZM, 1992, OECOLOGIA, V91, P463, DOI 10.1007/BF00650317; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; Grech K, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-130; Harvey SC, 2007, J EXP ZOOL PART B, V308B, P409, DOI 10.1002/jez.b.21161; Harvey SC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-15; HODGKIN J, 1991, P ROY SOC B-BIOL SCI, V246, P19, DOI 10.1098/rspb.1991.0119; Hu PJ, 2007, DAUER WORMBOOK; LYNCH M, 1983, EXP GERONTOL, V18, P147, DOI 10.1016/0531-5565(83)90008-6; Mitchell SE, 2005, P ROY SOC B-BIOL SCI, V272, P2601, DOI 10.1098/rspb.2005.3253; Mousseau T.A., 1998, MATERNAL EFFECTS ADA; Mugabo M, 2010, J EVOLUTION BIOL, V23, P1886, DOI 10.1111/j.1420-9101.2010.02052.x; Muschiol Daniel, 2009, BMC Ecol, V9, P14, DOI 10.1186/1472-6785-9-14; Rasanen K, 2007, FUNCT ECOL, V21, P408, DOI 10.1111/j.1365-2435.2007.01246.x; Rasband W.S., 1997, IMAGEJ; Roff Derek, 2002, pi; SKORPING A, 1991, OIKOS, V60, P365, DOI 10.2307/3545079; Stiernagle Theresa, 2006, WormBook, P1; Van Voorhies WA, 2005, BIOL LETTERS, V1, P247, DOI 10.1098/rsbl.2004.0278; Viney ME, 2003, DEV GROWTH DIFFER, V45, P389, DOI 10.1046/j.1440-169X.2003.00703.x; WARD S, 1979, DEV BIOL, V73, P304, DOI 10.1016/0012-1606(79)90069-1; WONG A, 1995, GENETICS, V139, P1247; Zhang TY, 2006, BIOL PSYCHOL, V73, P72, DOI 10.1016/j.biopsycho.2006.01.009	34	31	31	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e25840	10.1371/journal.pone.0025840	http://dx.doi.org/10.1371/journal.pone.0025840			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21991370	Green Published, Green Submitted, gold			2022-12-27	WOS:000295963300025
J	Quental, TB; Marshall, CR				Quental, Tiago B.; Marshall, Charles R.			The Molecular Phylogenetic Signature of Clades in Decline	PLOS ONE			English	Article							DIVERSIFICATION RATES; EVOLUTIONARY RADIATIONS; EXTINCTION RATES; FOSSIL RECORD; MACROEVOLUTIONARY; MODELS	Molecular phylogenies have been used to study the diversification of many clades. However, current methods for inferring diversification dynamics from molecular phylogenies ignore the possibility that clades may be decreasing in diversity, despite the fact that the fossil record shows this to be the case for many groups. Here we investigate the molecular phylogenetic signature of decreasing diversity using the most widely used statistic for inferring diversity dynamics from molecular phylogenies, the gamma statistic. We show that if a clade is in decline its molecular phylogeny may show evidence of the decrease in the diversification rate that occurred between its diversification and decline phases. The ability to detect the change in diversification rate depends largely on the ratio of the speciation rates of the diversification and decline phases, the higher the ratio the stronger the signal of the change in diversification rate. Consequently, molecular phylogenies of clades in relative rapid decline do not carry a signature of their decreasing diversification. Further, the signal of the change in diversification rate, if present, declines as the diversity drop. Unfortunately, the molecular signature of clades in decline is the same as the signature produced by diversity dependent diversification. Given this similarity, and the inability of current methods to detect declining diversity, it is likely that some of the extant clades that show a decrease in diversification rate, currently interpreted as evidence for diversity dependent diversification, are in fact in decline. Unless methods can be developed that can discriminate between the different modes of diversification, specifically diversity dependent diversification and declining diversity, we will need the fossil record, or data from some other source, to distinguish between these very different diversity trajectories.	[Quental, Tiago B.] Univ Estadual Sao Paulo USP, Dept Ecol, Sao Paulo, Brazil; [Marshall, Charles R.] Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA; [Marshall, Charles R.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Quental, TB (corresponding author), Univ Estadual Sao Paulo USP, Dept Ecol, Sao Paulo, Brazil.	tbquental@usp.br	Quental, Tiago B/C-7077-2013		University of California, Berkeley; Universidade de Sao Paulo, Brazil	University of California, Berkeley(University of California System); Universidade de Sao Paulo, Brazil	University of California, Berkeley and Universidade de Sao Paulo, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cusimano N, 2010, SYST BIOL, V59, P458, DOI 10.1093/sysbio/syq032; Ezard THG, 2009, PALEOBIOLOGY, V35, P460, DOI 10.1666/0094-8373-35.3.460; Foote M, 2007, PALEOBIOLOGY, V33, P517, DOI 10.1666/06084.1; Fordyce JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011781; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; HARVEY PH, 1994, EVOLUTION, V48, P523, DOI 10.1111/j.1558-5646.1994.tb01341.x; Liow LH, 2007, P R SOC B, V274, P2745, DOI 10.1098/rspb.2007.1006; Liow LH, 2010, SYST BIOL, V59, P646, DOI 10.1093/sysbio/syq052; Losos JB, 2000, NATURE, V408, P847, DOI 10.1038/35048558; McPeek MA, 2008, AM NAT, V172, pE270, DOI 10.1086/593137; Morlon H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000493; NEE S, 1994, PHILOS T ROY SOC B, V344, P77, DOI 10.1098/rstb.1994.0054; NEE S, 1994, PHILOS T ROY SOC B, V344, P305, DOI 10.1098/rstb.1994.0068; Nee S, 2006, ANNU REV ECOL EVOL S, V37, P1, DOI 10.1146/annurev.ecolsys.37.091305.110035; Phillimore AB, 2008, PLOS BIOL, V6, P483, DOI 10.1371/journal.pbio.0060071; PURVIS A, 1995, P ROY SOC B-BIOL SCI, V260, P329, DOI 10.1098/rspb.1995.0100; Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278; Pyron RA, EVOLUTION  IN PRESS, DOI [10.1111/j.1558-5646.2011.01437.x, DOI 10.1111/J.1558-5646.2011.01437.X]; Quental TB, 2010, TRENDS ECOL EVOL, V25, P434, DOI 10.1016/j.tree.2010.05.002; Quental TB, 2009, EVOLUTION, V63, P3158, DOI 10.1111/j.1558-5646.2009.00794.x; Rabosky DL, 2008, EVOLUTION, V62, P1866, DOI 10.1111/j.1558-5646.2008.00409.x; Rabosky DL, 2006, EVOLUTION, V60, P1152; Rabosky DL, 2010, EVOLUTION, V64, P1816, DOI 10.1111/j.1558-5646.2009.00926.x; Rabosky DL, 2009, P ROY SOC B-BIOL SCI, V276, P995, DOI 10.1098/rspb.2008.1584; Revell LJ, 2005, SYST BIOL, V54, P973, DOI 10.1080/10635150500354647; Ricklefs RE, 2007, TRENDS ECOL EVOL, V22, P601, DOI 10.1016/j.tree.2007.06.013; Stadler T., 2010, TREESIM R SIMULATING; Stadler T, 2011, SYST BIOL, V60, P676, DOI 10.1093/sysbio/syr029; Steeman ME, 2009, SYST BIOL, V58, P573, DOI 10.1093/sysbio/syp060; Turgeon J, 2005, AM NAT, V165, pE78, DOI 10.1086/428682	30	28	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e25780	10.1371/journal.pone.0025780	http://dx.doi.org/10.1371/journal.pone.0025780			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21991349	Green Submitted, gold, Green Published			2022-12-27	WOS:000295963300020
J	Anbazhagan, V; Sankhala, RS; Singh, BP; Swamy, MJ				Anbazhagan, V.; Sankhala, Rajeshwer S.; Singh, Bhanu Pratap; Swamy, Musti J.			Isothermal Titration Calorimetric Studies on the Interaction of the Major Bovine Seminal Plasma Protein, PDC-109 with Phospholipid Membranes	PLOS ONE			English	Article							OVIDUCTAL SPERM RESERVOIR; ELECTRON-SPIN-RESONANCE; AMINO-ACID-SEQUENCE; APOLIPOPROTEIN-A-I; BINDING PROTEINS; HEPARIN-BINDING; MODEL MEMBRANES; BULL SPERM; CHOLESTEROL; PHOSPHORYLCHOLINE	The interaction of the major bovine seminal plasma protein, PDC-109 with lipid membranes was investigated by isothermal titration calorimetry. Binding of the protein to model membranes made up of diacyl phospholipids was found to be endothermic, with positive values of binding enthalpy and entropy, and could be analyzed in terms of a single type of binding sites on the protein. Enthalpies and entropies for binding to diacylphosphatidylcholine membranes increased with increase in temperature, although a clear-cut linear dependence was not observed. The entropically driven binding process indicates that hydrophobic interactions play a major role in the overall binding process. Binding of PDC-109 with dimyristoylphosphatidylcholine membranes containing 25 mol% cholesterol showed an initial increase in the association constant as well as enthalpy and entropy of binding with increase in temperature, whereas the values decreased with further increase in temperature. The affinity of PDC-109 for phosphatidylcholine increased at higher pH, which is physiologically relevant in view of the basic nature of the seminal plasma. Binding of PDC-109 to Lyso-PC could be best analysed in terms of two types of binding interactions, a high affinity interaction with Lyso-PC micelles and a low-affinity interaction with the monomeric lipid. Enthalpy-entropy compensation was observed for the interaction of PDC-109 with phospholipid membranes, suggesting that water structure plays an important role in the binding process.	[Anbazhagan, V.; Sankhala, Rajeshwer S.; Singh, Bhanu Pratap; Swamy, Musti J.] Univ Hyderabad, Sch Chem, Hyderabad 500134, Andhra Pradesh, India	University of Hyderabad	Anbazhagan, V (corresponding author), Univ Hyderabad, Sch Chem, Hyderabad 500134, Andhra Pradesh, India.	mjssc@uohyd.ernet.in	Swamy, Musti/B-9418-2009	Swamy, Musti/0000-0002-3108-3633; Veerappan, Anbazhagan/0000-0002-0931-8192; Singh, Bhanu/0000-0003-3309-8772	Department of Science and Technology (India); Council of Scientific and Industrial Research (India); University Grants Commission (UGC) (India); UGC through UPE; UGC through CAS	Department of Science and Technology (India)(Department of Science & Technology (India)); Council of Scientific and Industrial Research (India)(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission (UGC) (India)(University Grants Commission, India); UGC through UPE; UGC through CAS	This work was supported by a research grant from the Department of Science and Technology (India) to MJS. VA and RSS were supported by Senior Research Fellowships from Council of Scientific and Industrial Research (India), and BPS was supported by a Junior Research Fellowship from University Grants Commission (UGC) (India). We acknowledge the UGC for their support through the UPE and CAS programs, to the University of Hyderabad and School of Chemistry, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham T, 2005, BIOCHEMISTRY-US, V44, P2103, DOI 10.1021/bi048077d; Anbazhagan V, 2008, BBA-PROTEINS PROTEOM, V1784, P891, DOI 10.1016/j.bbapap.2008.03.002; Anbazhagan V, 2005, FEBS LETT, V579, P2933, DOI 10.1016/j.febslet.2005.04.046; Arnulphi C, 2004, BIOCHEMISTRY-US, V43, P12258, DOI 10.1021/bi036118k; BAKER ME, 1985, BIOCHEM BIOPH RES CO, V130, P1010, DOI 10.1016/0006-291X(85)91715-2; Bergeron A, 2005, MOL REPROD DEV, V71, P461, DOI 10.1002/mrd.20310; Boisvert M, 2004, BIOL REPROD, V70, P656, DOI 10.1095/biolreprod.103.023069; BRUMMELL DA, 1993, BIOCHEMISTRY-US, V32, P1180, DOI 10.1021/bi00055a024; Cabra V, 2006, BBA-PROTEINS PROTEOM, V1764, P1110, DOI 10.1016/j.bbapap.2006.04.002; Calvete JJ, 1996, PROTEIN EXPRES PURIF, V8, P48, DOI 10.1006/prep.1996.0073; CALVETE JJ, 1994, FEBS LETT, V350, P203, DOI 10.1016/0014-5793(94)00768-3; CALVETE JJ, 1995, BIOCHEM J, V310, P615, DOI 10.1042/bj3100615; Calvete JJ, 1997, FEBS LETT, V407, P201, DOI 10.1016/S0014-5793(97)00344-X; CHANDONNET L, 1990, MOL REPROD DEV, V26, P313, DOI 10.1002/mrd.1080260404; DESNOYERS L, 1992, J BIOL CHEM, V267, P10149; Epand RM, 2006, PROG LIPID RES, V45, P279, DOI 10.1016/j.plipres.2006.02.001; ESCH FS, 1983, BIOCHEM BIOPH RES CO, V113, P861, DOI 10.1016/0006-291X(83)91078-1; Gasset M, 1997, EUR J BIOCHEM, V250, P735, DOI 10.1111/j.1432-1033.1997.00735.x; Gasset M, 2000, ARCH BIOCHEM BIOPHYS, V374, P241, DOI 10.1006/abbi.1999.1593; Greube A, 2001, BIOCHEMISTRY-US, V40, P8326, DOI 10.1021/bi010552+; Harper Michael J. K., 1994, P123; Harrison RAP, 1996, REPROD FERT DEVELOP, V8, P581, DOI 10.1071/RD9960581; Ignotz GG, 2001, BIOL REPROD, V64, P1806, DOI 10.1095/biolreprod64.6.1806; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lassiseraye D, 2008, BBA-BIOMEMBRANES, V1778, P502, DOI 10.1016/j.bbamem.2007.10.025; Liberda J, 2001, FOLIA BIOL-PRAGUE, V47, P113; Lin MS, 2007, COLLOID SURFACE B, V58, P231, DOI 10.1016/j.colsurfb.2007.03.014; MANJUNATH P, 1987, BIOSCIENCE REP, V7, P231, DOI 10.1007/BF01124794; MANJUNATH P, 1989, J BIOL CHEM, V264, P16853; MANJUNATH P, 1987, BIOCHEM J, V241, P685, DOI 10.1042/bj2410685; Manjunath P, 2002, BIOL REPROD, V67, P1250, DOI 10.1095/biolreprod67.4.1250; Marsh D., 1990, CRC HDB LIPID BILAYE; Moreau R, 1998, BIOCHEM BIOPH RES CO, V246, P148, DOI 10.1006/bbrc.1998.8513; Ramakrishnan M, 2001, BIOPHYS J, V81, P2215, DOI 10.1016/S0006-3495(01)75869-9; Revah I, 2000, BIOL REPROD, V62, P1010, DOI 10.1095/biolreprod62.4.1010; Sankhala RS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017330; Sankhala RS, 2010, BIOCHEMISTRY-US, V49, P3908, DOI 10.1021/bi100051d; SCHEIT KH, 1988, BIOSCIENCE REP, V8, P589, DOI 10.1007/BF01117339; Scolari S, 2010, BIOCHEMISTRY-US, V49, P9027, DOI 10.1021/bi101257c; SEIDAH NG, 1987, BIOCHEM J, V243, P195, DOI 10.1042/bj2430195; SHIVAJI S, 1990, PROTEINS SEMINAL PLA, P526; SIGURSKJOLD BW, 1992, J BIOL CHEM, V267, P8371; Suarez SS, 1998, BIOL REPROD, V58, P1105, DOI 10.1095/biolreprod58.5.1105; Sultan NAM, 2005, ARCH BIOCHEM BIOPHYS, V437, P115, DOI 10.1016/j.abb.2005.03.005; Swamy MJ, 2000, BIOCHEMISTRY-US, V39, P12476, DOI 10.1021/bi000699l; Swamy MJ, 2004, CURR SCI INDIA, V87, P203; Swamy MJ, 2002, FEBS LETT, V528, P230, DOI 10.1016/S0014-5793(02)03316-1; Therien I, 1998, BIOL REPROD, V59, P768, DOI 10.1095/biolreprod59.4.768; Thomas CJ, 2003, BIOPHYS J, V84, P3037, DOI 10.1016/S0006-3495(03)70029-0; Torrecillas A, 2004, BIOCHEMISTRY-US, V43, P11727, DOI 10.1021/bi0489659; Villemure Michele, 2003, Reprod Biol Endocrinol, V1, P39, DOI 10.1186/1477-7827-1-39; Visconti PE, 1998, J ANDROL, V19, P242; Wah DA, 2002, STRUCTURE, V10, P505, DOI 10.1016/S0969-2126(02)00751-7; Wieprecht T, 1999, BIOCHEMISTRY-US, V38, P10377, DOI 10.1021/bi990913+; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Yanagimachi R., 1994, P189; Zhang WM, 2006, ARCH BIOCHEM BIOPHYS, V445, P174, DOI 10.1016/j.abb.2005.10.022; 1998, ITC DATA ANAL ORIGIN	58	40	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e25993	10.1371/journal.pone.0025993	http://dx.doi.org/10.1371/journal.pone.0025993			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022488	Green Published, gold, Green Submitted			2022-12-27	WOS:000295981600026
J	Koutras, C; Levesque, G				Koutras, Carolina; Levesque, Georges			Identification of Novel NPRAP/delta-Catenin-Interacting Proteins and the Direct Association of NPRAP with Dynamin 2	PLOS ONE			English	Article							DELTA-CATENIN; BETA-CATENIN; EXPRESSION ANALYSIS; ALPHA-INTERNEXIN; E-CADHERIN; REGION; LOCALIZATION; SPECIFICITY; ADHESION; COMPLEX	Neural plakophilin-related armadillo protein (NPRAP or delta-catenin) is a neuronal-specific protein that is best known for its interaction with presenilin 1 (PS1). Interestingly, the hemizygous loss of NPRAP is associated with severe mental retardation in cri du chat syndrome (CDCS), and mutations in PS1 cause an aggressive, early-onset form of Alzheimer's disease. Until recently, studies on the function of NPRAP have focused on its ability to modulate dendritic protrusion elaboration through its binding to cell adhesion and scaffolding molecules. However, mounting evidence indicates that NPRAP participates in intracellular signaling and exists in the nucleus, where it modulates gene expression. This apparent bifunctional nature suggests an elaborate neuronal role, but how NPRAP came to participate in such distinct subcellular events remains a mystery. To gain insight into this pathway, we immunoprecipitated NPRAP from human SH SY5Y cells and identified several novel interacting proteins by mass spectrometry. These included neurofilament alpha-internexin, interferon regulatory protein 2 binding factors, and dynamins 1 and 2. We further validated dynamin 2/NPRAP colocalization and direct interaction in vivo, confirming their bona fide partnership. Interestingly, dynamin 2 has established roles in endocytosis and actin assembly, and both of these processes have the potential to interface with the cell adhesion and intracellular signaling processes that involve NPRAP. Our data provide new avenues for approaching NPRAP biology and suggest a broader role for this protein than previously thought.	[Koutras, Carolina; Levesque, Georges] Univ Laval, Fac Med, Dept Psychiat Neurosci, Quebec City, PQ G1K 7P4, Canada; [Koutras, Carolina; Levesque, Georges] CHUL, Neurosci Unit, Quebec City, PQ, Canada	Laval University; Laval University	Koutras, C (corresponding author), Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada.	Georges.levesque@crchul.ulaval.ca		Koutras, Carolina/0000-0002-9854-8458	Canadian Institutes of Health Research [MOP-64309]; Fonds de Recherche en Sante du Quebec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by grants from the Canadian Institutes of Health Research (www.cihr-irsc.gc.ca, MOP-64309) and the Fonds de Recherche en Sante du Quebec (www.frsq.gouv.qc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Elneel K, 2008, J BIOL CHEM, V283, P32781, DOI 10.1074/jbc.M804688200; [Anonymous], NIXON RAYA CYTOSKELE; [Anonymous], HGNC DAT HGNCH EMBL; BARRONCASELLA EA, 1995, J BIOL CHEM, V270, P21472, DOI 10.1074/jbc.270.37.21472; Beisvag V, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-470; Benson DL, 1996, J NEUROCYTOL, V25, P181, DOI 10.1007/BF02284795; Bessonov S, 2008, NATURE, V452, P846, DOI 10.1038/nature06842; Bruford EA, 2008, NUCLEIC ACIDS RES, V36, pD445, DOI 10.1093/nar/gkm881; Burger MJ, 2002, INT J CANCER, V100, P228, DOI 10.1002/ijc.10468; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; Carnahan RH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015747; Chien CL, 2005, J NEUROSCI RES, V80, P693, DOI 10.1002/jnr.20506; Childs KS, 2003, NUCLEIC ACIDS RES, V31, P3016, DOI 10.1093/nar/gkg431; Church DM, 1997, GENOME RES, V7, P787, DOI 10.1101/gr.7.8.787; Crosetto N, 2008, J BIOL CHEM, V283, P35173, DOI 10.1074/jbc.M803219200; Deguchi M, 2000, J BIOL CHEM, V275, P29875, DOI 10.1074/jbc.M005384200; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Dubois T, 2005, NAT CELL BIOL, V7, P353, DOI 10.1038/ncb1244; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gold ES, 1999, J EXP MED, V190, P1849, DOI 10.1084/jem.190.12.1849; Gu C, 2010, EMBO J, V29, P3593, DOI 10.1038/emboj.2010.249; Hatzfeld M, 2005, EUR J CELL BIOL, V84, P205, DOI 10.1016/j.ejcb.2004.12.016; Heger S, 2007, J CLIN INVEST, V117, P2145, DOI 10.1172/JCI31752; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Huntzinger E, 2010, EMBO J, V29, P4146, DOI 10.1038/emboj.2010.274; Ide N, 1999, BIOCHEM BIOPH RES CO, V256, P456, DOI 10.1006/bbrc.1999.0364; Israely I, 2004, CURR BIOL, V14, P1657, DOI 10.1016/j.cub.2004.08.065; Izawa I, 2002, J BIOL CHEM, V277, P5345, DOI 10.1074/jbc.M110052200; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; Jones SM, 1998, SCIENCE, V279, P573, DOI 10.1126/science.279.5350.573; Kruchten AE, 2006, J CELL SCI, V119, P1683, DOI 10.1242/jcs.02963; Laura RP, 2002, J BIOL CHEM, V277, P12906, DOI 10.1074/jbc.M200818200; Levesque G, 1999, J NEUROCHEM, V72, P999, DOI 10.1046/j.1471-4159.1999.0720999.x; Lu Q, 2005, HUM PATHOL, V36, P1037, DOI 10.1016/j.humpath.2005.07.012; Mainardi PC, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-33; Martinez MC, 2003, J CELL BIOL, V162, P99, DOI 10.1083/jcb.200211025; Medina M, 2000, GENOMICS, V63, P157, DOI 10.1006/geno.1999.6090; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Ochoa GC, 2000, J CELL BIOL, V150, P377, DOI 10.1083/jcb.150.2.377; Orth JD, 2003, CURR OPIN CELL BIOL, V15, P31, DOI 10.1016/S0955-0674(02)00010-8; OVERHAUSER J, 1994, HUM MOL GENET, V3, P247, DOI 10.1093/hmg/3.2.247; Paffenholz R, 1997, DIFFERENTIATION, V61, P293, DOI 10.1046/j.1432-0436.1997.6150293.x; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pokutta S, 2000, MOL CELL, V5, P533, DOI 10.1016/S1097-2765(00)80447-5; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Rodova M, 2004, MOL CELL BIOL, V24, P7188, DOI 10.1128/MCB.24.16.7188-7196.2004; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Silverman JB, 2007, J NEUROSCI, V27, P8505, DOI 10.1523/JNEUROSCI.1395-07.2007; Tanahashi H, 1999, NEUROREPORT, V10, P563, DOI 10.1097/00001756-199902250-00022; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Zhou JH, 1997, NEUROREPORT, V8, P2085, DOI 10.1097/00001756-199705260-00054	54	6	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e25379	10.1371/journal.pone.0025379	http://dx.doi.org/10.1371/journal.pone.0025379			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022388	Green Published, Green Submitted, gold			2022-12-27	WOS:000295981600007
J	Li, CC; Dabrowska, J; Hazra, R; Rainnie, DG				Li, Chenchen; Dabrowska, Joanna; Hazra, Rimi; Rainnie, Donald G.			Synergistic Activation of Dopamine D1 and TrkB Receptors Mediate Gain Control of Synaptic Plasticity in the Basolateral Amygdala	PLOS ONE			English	Article							LONG-TERM POTENTIATION; ANTAGONIST SCH 23390; PROTEIN-KINASE-A; NEUROTROPHIC FACTOR; TYROSINE KINASE; LATE-PHASE; FREQUENCY STIMULATION; MEMORY CONSOLIDATION; SIGNALING PATHWAY; NMDA RECEPTOR	Fear memory formation is thought to require dopamine, brain-derived neurotrophic factor (BDNF) and zinc release in the basolateral amygdala (BLA), as well as the induction of long term potentiation (LTP) in BLA principal neurons. However, no study to date has shown any relationship between these processes in the BLA. Here, we have used in vitro whole-cell patch clamp recording from BLA principal neurons to investigate how dopamine, BDNF, and zinc release may interact to modulate the LTP induction in the BLA. LTP was induced by either theta burst stimulation (TBS) protocol or spaced 5 times high frequency stimulation (5xHFS). Significantly, both TBS and 5xHFS induced LTP was fully blocked by the dopamine D1 receptor antagonist, SCH23390. LTP induction was also blocked by the BDNF scavenger, TrkB-FC, the zinc chelator, DETC, as well as by an inhibitor of matrix metalloproteinases (MMPs), gallardin. Conversely, prior application of the dopamine reuptake inhibitor, GBR12783, or the D1 receptor agonist, SKF39393, induced robust and stable LTP in response to a sub-threshold HFS protocol (2xHFS), which does not normally induce LTP. Similarly, prior activation of TrkB receptors with either a TrkB receptor agonist, or BDNF, also reduced the threshold for LTP-induction, an effect that was blocked by the MEK inhibitor, but not by zinc chelation. Intriguingly, the TrkB receptor agonist-induced reduction of LTP threshold was fully blocked by prior application of SCH23390, and the reduction of LTP threshold induced by GBR12783 was blocked by prior application of TrkB-FC. Together, our results suggest a cellular mechanism whereby the threshold for LTP induction in BLA principal neurons is critically dependent on the level of dopamine in the extracellular milieu and the synergistic activation of postsynaptic D1 and TrkB receptors. Moreover, activation of TrkB receptors appears to be dependent on concurrent release of zinc and activation of MMPs.	[Li, Chenchen; Dabrowska, Joanna; Hazra, Rimi; Rainnie, Donald G.] Yerkes Natl Primate Res Ctr, Atlanta, GA USA; [Li, Chenchen; Dabrowska, Joanna; Hazra, Rimi; Rainnie, Donald G.] Emory Univ, Sch Med, Dept Psychiat, Atlanta, GA 30322 USA	Emory University	Li, CC (corresponding author), Yerkes Natl Primate Res Ctr, Atlanta, GA USA.	drainni@emory.edu	Rainnie, Donald/L-3853-2016	Rainnie, Donald/0000-0003-0758-0530	National Institute of Mental Health [MH069852]; base center [RR-00165]; NIH; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069852] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); base center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institute of Mental Health grant (MH069852) to D. G. R. and the base center grant to the Yerkes National Primate Research Center #RR-00165, Animal Resource Program at NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andero R, 2011, AM J PSYCHIAT, V168, P163, DOI 10.1176/appi.ajp.2010.10030326; Braga AFM, 2004, MOL NEUROBIOL, V30, P127; Chen LY, 2010, P NATL ACAD SCI USA, V107, P7030, DOI 10.1073/pnas.0912973107; Christensen MK, 1998, J COMP NEUROL, V400, P375, DOI 10.1002/(SICI)1096-9861(19981026)400:3<375::AID-CNE7>3.0.CO;2-5; Conner JM, 1997, J NEUROSCI, V17, P2295; COWANSAGE KK, 2009, CURR MOL PHARM, V3, P12; Dabrowska J, 2010, NEUROSCIENCE, V171, P721, DOI 10.1016/j.neuroscience.2010.09.011; Faber ESL, 2005, NAT NEUROSCI, V8, P635, DOI 10.1038/nn1450; Fadok JP, 2009, J NEUROSCI, V29, P11089, DOI 10.1523/JNEUROSCI.1616-09.2009; Gao C, 2006, J NEUROCHEM, V98, P1664, DOI 10.1111/j.1471-4159.2006.03999.x; Goosens KA, 2002, HIPPOCAMPUS, V12, P592, DOI 10.1002/hipo.10099; Greba Q, 2000, BEHAV NEUROSCI, V114, P262, DOI 10.1037//0735-7044.114.2.262; Gurden H, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0003.2000; Hartmann M, 2001, EMBO J, V20, P5887, DOI 10.1093/emboj/20.21.5887; Huang Y Y, 1994, Learn Mem, V1, P74; Huang YY, 2007, LEARN MEMORY, V14, P497, DOI 10.1101/lm.593407; Huang YZ, 2008, NEURON, V57, P546, DOI 10.1016/j.neuron.2007.11.026; Huber KM, 1998, NEUROPHARMACOLOGY, V37, P571, DOI 10.1016/S0028-3908(98)00050-1; Humeau Y, 2003, NATURE, V426, P841, DOI 10.1038/nature02194; Hwang JJ, 2005, J BIOL CHEM, V280, P11995, DOI 10.1074/jbc.M403172200; Iwakura Y, 2008, J BIOL CHEM, V283, P15799, DOI 10.1074/jbc.M801553200; Jaworski DM, 2005, BRAIN RES, V1051, P81, DOI 10.1016/j.brainres.2005.05.057; Jovanovic T, 2010, AM J PSYCHIAT, V167, P648, DOI 10.1176/appi.ajp.2009.09071074; Kim M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000691; Kodirov SA, 2006, P NATL ACAD SCI USA, V103, P15218, DOI 10.1073/pnas.0607131103; Kovalchuk Y, 2002, SCIENCE, V295, P1729, DOI 10.1126/science.1067766; Lamont EW, 1998, BRAIN RES, V795, P128, DOI 10.1016/S0006-8993(98)00281-9; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Li SM, 2003, NAT NEUROSCI, V6, P526, DOI 10.1038/nn1049; Lin CH, 2001, NEURON, V31, P841, DOI 10.1016/S0896-6273(01)00433-0; MADSEN TE, 2009, NEUR M PLANN CHIC IL; Martel G, 2010, LEARN MEMORY, V17, P582, DOI 10.1101/lm.1962010; McDonald AJ, 2005, BRAIN RES, V1035, P32, DOI 10.1016/j.brainres.2004.11.052; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; Monfils MH, 2007, MOL PHARMACOL, V72, P235, DOI 10.1124/mol.107.038232; Muller T, 2009, LEARN MEMORY, V16, P395, DOI 10.1101/lm.1398709; Muly EC, 2009, BRAIN STRUCT FUNCT, V213, P375, DOI 10.1007/s00429-009-0214-8; Musumeci G, 2009, J NEUROSCI, V29, P10131, DOI 10.1523/JNEUROSCI.1707-09.2009; Nagappan G, 2009, P NATL ACAD SCI USA, V106, P1267, DOI 10.1073/pnas.0807322106; Nguyen PV, 1997, LEARN MEMORY, V4, P230, DOI 10.1101/lm.4.2.230; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; ODELL TJ, 1991, NATURE, V353, P558, DOI 10.1038/353558a0; Okulski P, 2007, BIOL PSYCHIAT, V62, P359, DOI 10.1016/j.biopsych.2006.09.012; Ou LC, 2006, NEUROPSYCHOPHARMACOL, V31, P287, DOI 10.1038/sj.npp.1300830; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Paoletti P, 2009, NEUROSCIENCE, V158, P126, DOI 10.1016/j.neuroscience.2008.01.061; Pawlak R, 2003, NAT NEUROSCI, V6, P168, DOI 10.1038/nn998; Pickel VM, 2006, NEUROSCIENCE, V142, P671, DOI 10.1016/j.neuroscience.2006.06.059; Purcell AL, 2003, NEURON, V37, P473, DOI 10.1016/S0896-6273(03)00030-8; RAINNIE DG, 1992, J NEUROPHYSIOL, V67, P443, DOI 10.1152/jn.1992.67.2.443; Rainnie DG, 1999, J NEUROPHYSIOL, V82, P69, DOI 10.1152/jn.1999.82.1.69; RAINNIE DG, 1993, J NEUROPHYSIOL, V69, P1350, DOI 10.1152/jn.1993.69.4.1350; Rattiner LM, 2005, NEUROSCIENTIST, V11, P323, DOI 10.1177/1073858404272255; Rattiner LM, 2004, J NEUROSCI, V24, P4796, DOI 10.1523/JNEUROSCI.5654-03.2004; Reznikov LR, 2008, J COMP NEUROL, V508, P458, DOI 10.1002/cne.21687; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Rossato JI, 2009, SCIENCE, V325, P1017, DOI 10.1126/science.1172545; Schafe GE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-18-j0003.2000; Schafe GE, 1999, LEARN MEMORY, V6, P97; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; Shin RM, 2010, P NATL ACAD SCI USA, V107, P19073, DOI 10.1073/pnas.1009803107; Takahashi H, 2010, J NEUROSCI, V30, P3043, DOI 10.1523/JNEUROSCI.5689-09.2010; Volkow ND, 2004, MOL PSYCHIATR, V9, P557, DOI 10.1038/sj.mp.4001507; Woo NH, 2003, HIPPOCAMPUS, V13, P293, DOI 10.1002/hipo.10086; Wright JW, 2007, NEURAL PLAST, V2007, P73813, DOI DOI 10.1155/2007/73813; Yang JM, 2009, NAT NEUROSCI, V12, P113, DOI 10.1038/nn.2244; Zhang JC, 2009, P NATL ACAD SCI USA, V106, P13028, DOI 10.1073/pnas.0900546106; ZIRRGIEBEL U, 1995, J NEUROCHEM, V65, P2241	68	32	32	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26065	10.1371/journal.pone.0026065	http://dx.doi.org/10.1371/journal.pone.0026065			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022509	Green Published, gold			2022-12-27	WOS:000295981600029
J	Maati, HMO; Peyronnet, R; Devader, C; Veyssiere, J; Labbal, F; Gandin, C; Mazella, J; Heurteaux, C; Borsotto, M				Maati, Hamid Moha Ou; Peyronnet, Remi; Devader, Christelle; Veyssiere, Julie; Labbal, Fabien; Gandin, Carine; Mazella, Jean; Heurteaux, Catherine; Borsotto, Marc			A Human TREK-1/HEK Cell Line: A Highly Efficient Screening Tool for Drug Development in Neurological Diseases	PLOS ONE			English	Article							DOMAIN POTASSIUM CHANNELS; POLYUNSATURATED FATTY-ACIDS; FOCAL CEREBRAL-ISCHEMIA; CENTRAL-NERVOUS-SYSTEM; K+ CHANNELS; GENERAL-ANESTHESIA; LINOLENIC ACID; K-2P CHANNELS; RILUZOLE; NEUROPROTECTION	TREK-1 potassium channels are involved in a number of physiopathological processes such as neuroprotection, pain and depression. Molecules able to open or to block these channels can be clinically important. Having a cell model for screening such molecules is of particular interest. Here, we describe the development of the first available cell line that constituvely expresses the TREK-1 channel. The TREK-1 channel expressed by the h-TREK-1/HEK cell line has conserved all its modulation properties. It is opened by stretch, pH, polyunsaturated fatty acids and by the neuroprotective molecule, riluzole and it is blocked by spadin or fluoxetine. We also demonstrate that the h-TREK-1/HEK cell line is protected against ischemia by using the oxygen-glucose deprivation model.	[Maati, Hamid Moha Ou; Peyronnet, Remi; Devader, Christelle; Veyssiere, Julie; Labbal, Fabien; Gandin, Carine; Mazella, Jean; Heurteaux, Catherine; Borsotto, Marc] Univ Nice Sophia Antipolis, CNRS, Inst Pharmacol Mol & Cellulaire, UMR6097, Valbonne, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Maati, HMO (corresponding author), Univ Nice Sophia Antipolis, CNRS, Inst Pharmacol Mol & Cellulaire, UMR6097, Valbonne, France.	borsotto@ipmc.cnrs.fr	Mazella, Jean/A-6767-2012; Maati, Hamid Moha ou/M-2240-2019; HEURTEAUX, Catherine/M-4947-2016; BORSOTTO, Marc/M-5096-2016	Maati, Hamid Moha ou/0000-0002-8711-1760; HEURTEAUX, Catherine/0000-0002-9741-9777; BORSOTTO, Marc/0000-0002-1302-7419; Peyronnet, Remi/0000-0002-5708-6410	Centre National de la Recherche Scientifique (CNRS); Agence Nationale de la Recherche -Maladies NeuroPsychiatriques [ANR-2009-MNPS-026.01]; Fondation Coeur et arteres; CIFRE	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche -Maladies NeuroPsychiatriques(French National Research Agency (ANR)); Fondation Coeur et arteres; CIFRE	This work is supported by the Centre National de la Recherche Scientifique (CNRS), the Agence Nationale de la Recherche -Maladies NeuroPsychiatriques (ANR-2009-MNPS-026.01), and the Fondation Coeur et arteres. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr A. Patel for careful reading of the manuscript. J. V. was supported by a CIFRE fellowship.	Alloui A, 2006, EMBO J, V25, P2368, DOI 10.1038/sj.emboj.7601116; Barel O, 2008, AM J HUM GENET, V83, P193, DOI 10.1016/j.ajhg.2008.07.010; Bittner S, 2009, BRAIN, V132, P2501, DOI 10.1093/brain/awp163; Blondeau N, 2002, NEUROSCIENCE, V109, P231, DOI 10.1016/S0306-4522(01)00473-0; Blondeau N, 2002, J CEREBR BLOOD F MET, V22, P821, DOI 10.1097/00004647-200207000-00007; Blondeau N, 2007, CIRC RES, V101, P176, DOI 10.1161/CIRCRESAHA.107.154443; Buckler KJ, 2005, J PHYSIOL-LONDON, V562, P213, DOI 10.1113/jphysiol.2004.077503; Cohen A, 2009, MOL CELL NEUROSCI, V40, P382, DOI 10.1016/j.mcn.2008.12.004; Davies LA, 2008, P NATL ACAD SCI USA, V105, P2203, DOI 10.1073/pnas.0712000105; Ducroq J, 2010, BRIT J PHARMACOL, V159, P93, DOI 10.1111/j.1476-5381.2009.00371.x; Duprat F, 2000, MOL PHARMACOL, V57, P906; Fink M, 1996, EMBO J, V15, P6854, DOI 10.1002/j.1460-2075.1996.tb01077.x; Finlayson K, 2004, EUR J PHARMACOL, V500, P129, DOI 10.1016/j.ejphar.2004.07.019; Franks NP, 2004, TRENDS PHARMACOL SCI, V25, P601, DOI 10.1016/j.tips.2004.09.003; Gardener MJ, 2004, BRIT J PHARMACOL, V142, P192, DOI 10.1038/sj.bjp.0705691; Garry A, 2007, EMBO REP, V8, P354, DOI 10.1038/sj.embor.7400916; GOLDBERG MP, 1993, J NEUROSCI, V13, P3510; Gruss M, 2004, MOL PHARMACOL, V65, P443, DOI 10.1124/mol.65.2.443; Hervieu GJ, 2001, NEUROSCIENCE, V103, P899, DOI 10.1016/S0306-4522(01)00030-6; Heurteaux C, 2004, EMBO J, V23, P2684, DOI 10.1038/sj.emboj.7600234; Heurteaux C, 2006, NEUROSCIENCE, V137, P241, DOI 10.1016/j.neuroscience.2005.08.083; Heurteaux C, 2006, NAT NEUROSCI, V9, P1134, DOI 10.1038/nn1749; Honore E, 2007, NAT REV NEUROSCI, V8, P251, DOI 10.1038/nrn2117; Kang JS, 2010, J PHARMACOL EXP THER, V334, P619, DOI 10.1124/jpet.110.169391; Kim D, 2005, CURR PHARM DESIGN, V11, P2717, DOI 10.2174/1381612054546824; Lafreniere RG, 2010, NAT MED, V16, P1157, DOI 10.1038/nm.2216; Lang-Lazdunski L, 2003, J VASC SURG, V38, P564, DOI 10.1016/S0741-5214(03)00473-7; Lang-Lazdunski L, 1999, J THORAC CARDIOV SUR, V117, P881, DOI 10.1016/S0022-5223(99)70367-3; Lauritzen I, 2000, EMBO J, V19, P1784, DOI 10.1093/emboj/19.8.1784; Lauritzen I, 2003, J BIOL CHEM, V278, P32068, DOI 10.1074/jbc.M302631200; Li ZB, 2005, BIOCHEM BIOPH RES CO, V327, P1163, DOI 10.1016/j.bbrc.2004.12.124; Maati HMO, 2012, NEUROPHARMACOLOGY, V62, P278, DOI 10.1016/j.neuropharm.2011.07.019; Maingret F, 2000, EMBO J, V19, P2483, DOI 10.1093/emboj/19.11.2483; Maingret F, 2000, J BIOL CHEM, V275, P10128, DOI 10.1074/jbc.275.14.10128; Maingret F, 1999, J BIOL CHEM, V274, P26691, DOI 10.1074/jbc.274.38.26691; MALGOURIS C, 1989, J NEUROSCI, V9, P3720; Mazella J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000355; Medhurst AD, 2001, MOL BRAIN RES, V86, P101, DOI 10.1016/S0169-328X(00)00263-1; Noel J, 2009, EMBO J, V28, P1308, DOI 10.1038/emboj.2009.57; Patel AJ, 1998, EMBO J, V17, P4283, DOI 10.1093/emboj/17.15.4283; Patel AJ, 2001, CURR OPIN CELL BIOL, V13, P422, DOI 10.1016/S0955-0674(00)00231-3; PRATT J, 1992, NEUROSCI LETT, V140, P225, DOI 10.1016/0304-3940(92)90108-J; Ren XQ, 2010, AM J PHYSIOL-HEART C, V299, pH1525, DOI 10.1152/ajpheart.00479.2009; Sandoz G, 2011, P NATL ACAD SCI USA, V108, P2605, DOI 10.1073/pnas.1015788108; Talley EM, 2001, J NEUROSCI, V21, P7491, DOI 10.1523/JNEUROSCI.21-19-07491.2001; Tan JHC, 2004, EXP PHYSIOL, V89, P237, DOI 10.1113/expphysiol.2003.027052; Tauskela JS, 2005, FASEB J, V19, P1734, DOI 10.1096/fj.05-3795fje; Terrenoire C, 2001, CIRC RES, V89, P336, DOI 10.1161/hh1601.094979; WAHL F, 1993, EUR J PHARMACOL, V230, P209, DOI 10.1016/0014-2999(93)90804-Q	50	29	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e25602	10.1371/journal.pone.0025602	http://dx.doi.org/10.1371/journal.pone.0025602			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022421	Green Published, Green Submitted, gold			2022-12-27	WOS:000295981600010
J	Aksu, Y; Miller, DJ; Kesidis, G; Bigler, DC; Yang, QX				Aksu, Yaman; Miller, David J.; Kesidis, George; Bigler, Don C.; Yang, Qing X.			An MRI-Derived Definition of MCI-to-AD Conversion for Long-Term, Automatic Prognosis of MCI Patients	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; BRAIN ATROPHY; PATTERN-CLASSIFICATION; CSF BIOMARKERS; DIAGNOSIS; RATES; SELECTION; HAMMER; IMAGES; ONSET	Alzheimer's disease (AD) and mild cognitive impairment (MCI) are of great current research interest. While there is no consensus on whether MCIs actually "convert'' to AD, this concept is widely applied. Thus, the more important question is not whether MCIs convert, but what is the best such definition. We focus on automatic prognostication, nominally using only a baseline brain image, of whether an MCI will convert within a multi-year period following the initial clinical visit. This is not a traditional supervised learning problem since, in ADNI, there are no definitive labeled conversion examples. It is not unsupervised, either, since there are (labeled) ADs and Controls, as well as cognitive scores for MCIs. Prior works have defined MCI subclasses based on whether or not clinical scores significantly change from baseline. There are concerns with these definitions, however, since, e.g., most MCIs (and ADs) do not change from a baseline CDR = 0.5 at any subsequent visit in ADNI, even while physiological changes may be occurring. These works ignore rich phenotypical information in an MCI patient's brain scan and labeled AD and Control examples, in defining conversion. We propose an innovative definition, wherein an MCI is a converter if any of the patient's brain scans are classified "AD'' by a Control-AD classifier. This definition bootstraps design of a second classifier, specifically trained to predict whether or not MCIs will convert. We thus predict whether an AD-Control classifier will predict that a patient has AD. Our results demonstrate that this definition leads not only to much higher prognostic accuracy than by-CDR conversion, but also to subpopulations more consistent with known AD biomarkers (including CSF markers). We also identify key prognostic brain region biomarkers.	[Aksu, Yaman; Yang, Qing X.] Penn State Univ Coll Med, Dept Radiol, Ctr NMR Res, Hershey, PA 17033 USA; [Miller, David J.; Kesidis, George] Penn State Univ, Dept Elect Engn, University Pk, PA 16802 USA; [Kesidis, George] Penn State Univ, Comp Sci & Engn Dept, University Pk, PA 16802 USA; [Bigler, Don C.] Penn State Univ Coll Med, Ctr Emerging Neurotechnol & Imaging, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Aksu, Y (corresponding author), Penn State Univ Coll Med, Dept Radiol, Ctr NMR Res, Hershey, PA 17033 USA.	djmiller@engr.psu.edu	Yang, Heroine/GRY-2630-2022		NIH [R01 AG02771, P30 AG010129, K01, AG030514]; Pennsylvania Department of Health; Dana Foundation; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health [U01 AG024904]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; NATIONAL INSTITUTE ON AGING [U19AG010483, P30AG010129, U01AG024904, K01AG030514] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; Dana Foundation; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding supporting this work has been provided in part through NIH R01 AG02771 and the Pennsylvania Department of Health. The authors thank Dr. Michelle Shaffer for assistance with statistical testing and Jianli Wang and Zachary Herse for assistance with segmentation. This research was supported by NIH grants P30 AG010129, K01, AG030514, and the Dana Foundation. Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott, AstraZeneca AB, Bayer Schering Pharma AG, Bristol-Myers Squibb, Eisai Global Clinical Development, Elan Corporation, Genentech, GE Healthcare, GlaxoSmithKline, Innogenetics, Johnson and Johnson, Eli Lilly and Co., Medpace, Inc., Merck and Co., Inc., Novartis AG, Pfizer Inc, F. Hoffman-La Roche, Schering-Plough, Synarc, Inc., as well as non-profit partners the Alzheimer's Association and Alzheimer's Drug Discovery Foundation, with participation from the U.S. Food and Drug Administration. Private sector contributions to ADNI are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California, Los Angeles. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksu Y, 2010, IEEE T NEURAL NETWOR, V21, P701, DOI 10.1109/TNN.2010.2041069; [Anonymous], STAT PARAMETRIC MAPP; Braak H, 1997, NEUROBIOL AGING, V18, pS85, DOI 10.1016/S0197-4580(97)00062-6; Chambers J. M., 1993, STAT MODELS S; Chan D, 2003, LANCET, V362, P1121, DOI 10.1016/S0140-6736(03)14469-8; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chetelat G, 2002, NEUROREPORT, V13, P1939; Chou YY, 2010, NEUROBIOL AGING, V31, P1386, DOI 10.1016/j.neurobiolaging.2010.05.001; CHOU YY, 2009, P SPIE, V7259; Csernansky JG, 2005, NEUROIMAGE, V25, P783, DOI 10.1016/j.neuroimage.2004.12.036; Davatzikos C, 1998, HUM BRAIN MAPP, V6, P334; Davatzikos C, 2001, NEUROIMAGE, V14, P1361, DOI 10.1006/nimg.2001.0937; DAVATZIKOS C, 2011, NEUROBIOL AGING, V32, P2322, DOI [DOI 10.1016/J.NEUR0BI0LAGING.2010.05.023, DOI 10.1016/J.NEUROBIOLAGING.2010.05.023]; Davatzikos C, 2008, NEUROBIOL AGING, V29, P514, DOI 10.1016/j.neurobiolaging.2006.11.010; de Leon MJ, 2006, NEUROBIOL AGING, V27, P394, DOI 10.1016/j.neurobiolaging.2005.07.003; De Meyer G, 2010, ARCH NEUROL-CHICAGO, V67, P949, DOI 10.1001/archneurol.2010.179; DUDA RO, 2001, PATTERN CLASSIFICATI; Fan Y, 2008, NEUROIMAGE, V39, P1731, DOI 10.1016/j.neuroimage.2007.10.031; Fan Y, 2007, IEEE T MED IMAGING, V26, P93, DOI 10.1109/TMI.2006.886812; Fennema-Notestine C, 2009, HUM BRAIN MAPP, V30, P3238, DOI 10.1002/hbm.20744; Frisoni GB, 2009, J NEUROL, V256, P916, DOI 10.1007/s00415-009-5040-7; Fung GM, 2004, COMPUT OPTIM APPL, V28, P185, DOI 10.1023/B:COAP.0000026884.66338.df; Goldszal AF, 1998, J COMPUT ASSIST TOMO, V22, P827, DOI 10.1097/00004728-199809000-00030; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Leow AD, 2009, NEUROIMAGE, V45, P645, DOI 10.1016/j.neuroimage.2009.01.004; Lerch JP, 2005, NEUROIMAGE, V24, P163, DOI 10.1016/j.neuroimage.2004.07.045; MENG XL, 1992, PSYCHOL BULL, V111, P172, DOI 10.1037/0033-2909.111.1.172; Misra C, 2009, NEUROIMAGE, V44, P1415, DOI 10.1016/j.neuroimage.2008.10.031; PETERSEN RC, 2004, MILD COGNITIVE IMPAI; Rusinek H, 2004, NEUROLOGY, V63, P2354, DOI 10.1212/01.WNL.0000148602.30175.AC; Schott JM, 2005, NEUROLOGY, V65, P119, DOI 10.1212/01.wnl.0000167542.89697.0f; Schott JM, 2010, ANN NEUROL, V68, P825, DOI 10.1002/ana.22315; SCHUFF N, 2010, NEUROBIOL AGING, DOI DOI 10.1016/J.NEUROIOLAGING.2010.07.012; Shen DG, 2002, IEEE T MED IMAGING, V21, P1421, DOI 10.1109/TMI.2002.803111; Shen DG, 2003, NEUROIMAGE, V18, P28, DOI 10.1006/nimg.2002.1301; Stoub TR, 2005, NEUROLOGY, V64, P1520, DOI 10.1212/01.WNL.0000160089.43264.1A; Thompson PM, 2003, J NEUROSCI, V23, P994; Vapnik V., 1998, STAT LEARNING THEORY, V3, DOI DOI 10.1007/978-1-4419-1428-6_5864; Vemuri P, 2009, NEUROLOGY, V73, P294, DOI 10.1212/WNL.0b013e3181af79fb; Vemuri P, 2008, NEUROIMAGE, V39, P1186, DOI 10.1016/j.neuroimage.2007.09.073; Wang Y, 2010, NEUROIMAGE, V50, P1519, DOI 10.1016/j.neuroimage.2009.12.092; Zhang DQ, 2011, NEUROIMAGE, V55, P856, DOI 10.1016/j.neuroimage.2011.01.008	44	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25074	10.1371/journal.pone.0025074	http://dx.doi.org/10.1371/journal.pone.0025074			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022375	Green Published, Green Submitted, gold			2022-12-27	WOS:000295976000008
J	Tabara, H; Naito, Y; Ito, A; Katsuma, A; Sakurai, MA; Ohno, S; Shimizu, H; Yabuta, N; Nojima, H				Tabara, Hiroe; Naito, Yoko; Ito, Akihiko; Katsuma, Asako; Sakurai, Minami A.; Ohno, Shouichi; Shimizu, Hiroyuki; Yabuta, Norikazu; Nojima, Hiroshi			Neonatal Lethality in Knockout Mice Expressing the Kinase-Dead Form of the Gefitinib Target GAK Is Caused by Pulmonary Dysfunction	PLOS ONE			English	Article							CELL LUNG-CANCER; CLATHRIN-MEDIATED ENDOCYTOSIS; EGFR; REGULATOR; PROTEIN; TRAFFICKING; INHIBITORS	Gefitinib (Iressa) is an inhibitor of the epidermal growth factor receptor (EGFR) that has shown promising activity in the treatment of patients with non-small cell lung cancer (NSCLC). However, adverse side effects of gefitinib treatment, such as respiratory dysfunction, have limited the therapeutic benefit of this targeting strategy. The present results show that this adverse effect can be attributed to the inhibition of the novel gefitinib target GAK (Cyclin G-associated kinase), which is as potently inhibited by the drug as the tyrosine kinase activity of EGFR. Knockout mice expressing the kinase-dead form of GAK (GAK-kd) died within 30 min after birth primarily due to respiratory dysfunction. Immunohistochemical analysis revealed that surfactant protein A (SP-A) was abundant within alveolar spaces in GAK-kd(+/+) mice but not in GAK-kd(-/-) pups. E-cadherin and phosphorylated EGFR signals were also abnormal, suggesting the presence of flat alveolar cells with thin junctions. These results suggest that inhibition of GAK by gefitinib may cause pulmonary alveolar dysfunction, and the present study may help prevent side effects associated with gefitinib therapy in NSCLC patients.	[Tabara, Hiroe; Naito, Yoko; Katsuma, Asako; Sakurai, Minami A.; Ohno, Shouichi; Shimizu, Hiroyuki; Yabuta, Norikazu; Nojima, Hiroshi] Osaka Univ, Microbial Dis Res Inst, Dept Mol Genet, Osaka, Japan; [Ito, Akihiko] Kinki Univ, Dept Pathol, Fac Med, Osaka, Japan	Osaka University; Kindai University (Kinki University)	Tabara, H (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Mol Genet, Osaka, Japan.	snj-0212@biken.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [15101006, 20370081, 21651085]; Grants-in-Aid for Scientific Research [23370086] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for Scientific Research S (No. 15101006), Scientific Research B (No. 20370081) and Exploratory Research (No. 21651085) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www.mext.go.jp/english/) to Hiroshi Nojima. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brehmer D, 2005, CANCER RES, V65, P379; Conner SD, 2002, J CELL BIOL, V156, P921, DOI 10.1083/jcb.200108123; Costa DB, 2007, PLOS MED, V4, P1669, DOI 10.1371/journal.pmed.0040315; Cragg MS, 2007, PLOS MED, V4, P1681, DOI 10.1371/journal.pmed.0040316; Eisenberg E, 2007, TRAFFIC, V8, P640, DOI 10.1111/j.1600-0854.2007.00568.x; Enari M, 2006, GENE DEV, V20, P1087, DOI 10.1101/gad.1381906; Gazdar AF, 2009, ONCOGENE, V28, pS24, DOI 10.1038/onc.2009.198; Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962; Hirsch FR, 2009, ONCOGENE, V28, pS32, DOI 10.1038/onc.2009.199; Inoue A, 2003, LANCET, V361, P137, DOI 10.1016/S0140-6736(03)12190-3; Ito A, 2000, EMBO J, V19, P562, DOI 10.1093/emboj/19.4.562; Ito A, 2003, LAB INVEST, V83, P1175, DOI 10.1097/01.LAB.0000081391.28136.80; John T, 2009, ONCOGENE, V28, pS14, DOI 10.1038/onc.2009.197; Kanaoka Y, 1997, FEBS LETT, V402, P73, DOI 10.1016/S0014-5793(96)01484-6; Kimura SH, 2002, GENES CELLS, V7, P869, DOI 10.1046/j.1365-2443.2002.00564.x; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Korolchuk VI, 2002, TRAFFIC, V3, P428, DOI 10.1034/j.1600-0854.2002.30606.x; Lee D, 2008, MOL BIOL CELL, V19, P2766, DOI 10.1091/mbc.E07-11-1115; Ray MR, 2006, INT J CANCER, V118, P1108, DOI 10.1002/ijc.21469; Robertson EJ, 1987, TERATOCARCINOMAS EMB, P71; Sanford M, 2009, DRUGS, V69, P2303, DOI 10.2165/10489100-000000000-00000; Sato J, 2009, GENES CELLS, V14, P627, DOI 10.1111/j.1365-2443.2009.01296.x; Shimizu H, 2009, J CELL SCI, V122, P3145, DOI 10.1242/jcs.052795; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Sun Q, 2009, ONCOGENE, V28, P2348, DOI 10.1038/onc.2009.108; Tsukamoto S, 2008, SCIENCE, V321, P117, DOI 10.1126/science.1154822; Zhang L, 2004, P NATL ACAD SCI USA, V101, P10296, DOI 10.1073/pnas.0403175101	28	18	19	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26034	10.1371/journal.pone.0026034	http://dx.doi.org/10.1371/journal.pone.0026034			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022498	Green Submitted, Green Published, gold			2022-12-27	WOS:000295976000056
J	Caruso, F; Mendoza, L; Castro, P; Cotoras, M; Aguirre, M; Matsuhiro, B; Isaacs, M; Rossi, M; Viglianti, A; Antonioletti, R				Caruso, Francesco; Mendoza, Leonora; Castro, Paulo; Cotoras, Milena; Aguirre, Maria; Matsuhiro, Betty; Isaacs, Mauricio; Rossi, Miriam; Viglianti, Angela; Antonioletti, Roberto			Antifungal Activity of Resveratrol against Botrytis cinerea Is Improved Using 2-Furyl Derivatives	PLOS ONE			English	Article							APOPTOSIS-INDUCING AGENTS; MOLECULAR-STRUCTURE; TRANS-RESVERATROL; STILBENE ANALOGS; METHYL ETHERS; PTEROSTILBENE; STYRYLHETEROCYCLES; PHYTOALEXINS; LACCASE; INHIBITION	The antifungal effect of three furyl compounds closely related to resveratrol, (E)-3,4,5-trimethoxy-beta-(2-furyl)-styrene (1), (E)-4-methoxy-beta-(2-furyl)-styrene (2) and (E)-3,5-dimethoxy-beta-(2-furyl)-styrene (3) against Botrytis cinerea was analyzed. The inhibitory effect, at 100 mu g ml(-1) 21 of compounds 1, 2, 3 and resveratrol on conidia germination, was determined to be about 70%, while at the same concentration pterostilbene (a dimethoxyl derivative of resveratrol) produced complete inhibition. The title compounds were more fungitoxic towards in vitro mycelial growth than resveratrol and pterostilbene. Compound 3 was the most active and a potential explanation of this feature is given using density functional theory (DFT) calculations on the demethoxylation/demethylation process. Compound 3 was further evaluated for its effects on laccase production, oxygen consumption and membrane integrity of B. cinerea. An increase of the laccase activity was observed in the presence of compound 3 and, using Sytox Green nucleic acid stain, it was demonstrated that this compound altered B. cinerea membrane. Finally, compound 3 partially affected conidia respiration.	[Caruso, Francesco; Antonioletti, Roberto] Univ Rome, Ist Chim Biomol, CNR, Ist Chim, Rome, Italy; [Mendoza, Leonora; Castro, Paulo; Cotoras, Milena; Aguirre, Maria; Matsuhiro, Betty] Univ Santiago Chile, Fac Quim & Biol, Santiago, Chile; [Isaacs, Mauricio] Univ Chile, Fac Ciencias, Dept Quim, Santiago, Chile; [Rossi, Miriam] Vassar Coll, Dept Chem, Poughkeepsie, NY 12601 USA	Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica Biomolecolare (ICB-CNR); Sapienza University Rome; Universidad de Santiago de Chile; Universidad de Chile; Vassar College	Caruso, F (corresponding author), Univ Rome, Ist Chim Biomol, CNR, Ist Chim, Rome, Italy.	caruso@vassar.edu; rossi@vassar.edu	Isaacs, Mauricio/N-3027-2013; Aguirre, Maria J/A-3935-2013	Aguirre, Maria/0000-0003-1134-4469; Isaacs Casanova, Mauricio/0000-0003-0503-0949; Rossi, Miriam/0000-0001-9609-474X	Consiglio Nazionale delle Ricerche, Rome, Italy; Departamento de Investigaciones Cientificas y Tecnologicas (DICYT) at Universidad de Santiago de Chile; International Foundation for Science [F/3115-1, C/2807-2]; FONDECYT [N 1090723]	Consiglio Nazionale delle Ricerche, Rome, Italy(Consiglio Nazionale delle Ricerche (CNR)); Departamento de Investigaciones Cientificas y Tecnologicas (DICYT) at Universidad de Santiago de Chile; International Foundation for Science(International Foundation for Science); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by Consiglio Nazionale delle Ricerche, Rome, Italy; Departamento de Investigaciones Cientificas y Tecnologicas (DICYT) at Universidad de Santiago de Chile; the International Foundation for Science Grants No F/3115-1 (LM) and C/2807-2 (MC), and FONDECYT N 1090723 (LM, MC and FC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian M, 1997, J CHEM ECOL, V23, P1689, DOI 10.1023/B:JOEC.0000006444.79951.75; Antonioletti R, 2008, TETRAHEDRON, V64, P4644, DOI 10.1016/j.tet.2008.02.091; AUN CE, 1990, J CHEM SOC PERK T 2, P645, DOI 10.1039/p29900000645; Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caruso F, 2004, J AGR FOOD CHEM, V52, P7279, DOI 10.1021/jf048794e; Chefetz B, 1998, APPL ENVIRON MICROB, V64, P3175; Chong JL, 2009, PLANT SCI, V177, P143, DOI 10.1016/j.plantsci.2009.05.012; Chu LT, 2007, HETEROCYCLES, V71, P165; Delley B, 1996, J PHYS CHEM-US, V100, P6107, DOI 10.1021/jp952713n; Delley B, 2000, J CHEM PHYS, V113, P7756, DOI 10.1063/1.1316015; ELAD Y, 1995, PHYTOPATHOLOGY, V85, P637; Gledhill JR, 2007, P NATL ACAD SCI USA, V104, P13632, DOI 10.1073/pnas.0706290104; Grayer RJ, 2001, PHYTOCHEMISTRY, V56, P253, DOI 10.1016/S0031-9422(00)00450-7; HART JH, 1981, ANNU REV PHYTOPATHOL, V19, P437, DOI 10.1146/annurev.py.19.090181.002253; Ho JH, 2001, ORG LETT, V3, P409, DOI 10.1021/ol006917k; Ho TI, 2000, J AM CHEM SOC, V122, P8575, DOI 10.1021/ja0011562; Katsuyama Yohei, 2007, Biotechnology Journal, V2, P1286, DOI 10.1002/biot.200700098; Kim S, 2003, CHEM PHARM BULL, V51, P516; Kim S, 2002, J MED CHEM, V45, P160, DOI 10.1021/jm010298j; LATORRE BA, 1994, PLANT DIS, V78, P990, DOI 10.1094/PD-78-0990; Lee SK, 2003, BIOORG MED CHEM LETT, V13, P3689, DOI 10.1016/j.bmcl.2003.08.013; Mendoza L, 2005, J AGR FOOD CHEM, V53, P10080, DOI 10.1021/jf0511749; Meng XL, 2008, CHEM-BIOL INTERACT, V174, P51, DOI 10.1016/j.cbi.2008.04.015; MEUNIER G, 1985, J AM CHEM SOC, V107, P2558, DOI 10.1021/ja00294a064; Mikstacka R, 2007, MOL NUTR FOOD RES, V51, P517, DOI 10.1002/mnfr.200600135; Munoz G, 2002, MYCOL RES, V106, P594, DOI 10.1017/S0953756202005981; Murias M, 2005, BIOCHEM PHARMACOL, V69, P903, DOI 10.1016/j.bcp.2004.12.001; Niewiadomy A, 2006, J PESTIC SCI, V31, P14, DOI 10.1584/jpestics.31.14; Pan ZQ, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-7; PERDEW JP, 1992, PHYS REV B, V46, P6671, DOI 10.1103/PhysRevB.46.6671; PEZET R, 1990, J PHYTOPATHOL, V129, P19, DOI 10.1111/j.1439-0434.1990.tb04286.x; PEZET R, 1991, PHYSIOL MOL PLANT P, V39, P441, DOI 10.1016/0885-5765(91)90010-F; Pezet Roger, 1995, P317; Roberti M, 2003, J MED CHEM, V46, P3546, DOI 10.1021/jm030785u; Rossi M, 2008, J AGR FOOD CHEM, V56, P10557, DOI 10.1021/jf801923j; Sang KL, 2004, BIOORG MED CHEM LETT, V14, P2105, DOI 10.1016/j.bmcl.2004.02.038; SANGHEE K, 2003, Patent No. 2003018013; Sbaghi M, 1996, PLANT PATHOL, V45, P139, DOI 10.1046/j.1365-3059.1996.d01-101.x; Schouten A, 2002, MOL MICROBIOL, V43, P883, DOI 10.1046/j.1365-2958.2002.02801.x; Sobarzo-Sanchez E, 2006, STRUCT CHEM, V17, P483, DOI 10.1007/s11224-006-9070-9; Tamura H, 1999, PESTIC SCI, V55, P681, DOI 10.1002/(SICI)1096-9063(199907)55:7&lt;681::AID-PS16&gt;3.0.CO;2-8; Thevissen K, 1999, APPL ENVIRON MICROB, V65, P5451; Tofi M, 2005, ORG LETT, V7, P3347, DOI 10.1021/ol051205l; Tolomeo M, 2005, INT J BIOCHEM CELL B, V37, P1709, DOI 10.1016/j.biocel.2005.03.004; van Baarlen P, 2004, BOTRYTIS: BIOLOGY, PATHOLOGY AND CONTROL, P143; Voda K, 2004, J MOL MODEL, V10, P76, DOI 10.1007/s00894-003-0174-5; Wang ZY, 2009, ORG BIOMOL CHEM, V7, P863, DOI 10.1039/b821870f; Wu JY, 1999, ORG LETT, V1, P1039, DOI 10.1021/ol990828u; Yang GF, 2002, PEST MANAG SCI, V58, P1063, DOI 10.1002/ps.584	50	46	49	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e25421	10.1371/journal.pone.0025421	http://dx.doi.org/10.1371/journal.pone.0025421			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022392	gold, Green Published, Green Submitted			2022-12-27	WOS:000295973200008
J	Ponce, J; Calvet, X; Gallach, M; Ponce, M				Ponce, Julio; Calvet, Xavier; Gallach, Marta; Ponce, Marta		AEG	Esophagitis in a High H. pylori Prevalence Area: Severe Disease Is Rare but Concomitant Peptic Ulcer Is Frequent	PLOS ONE			English	Article							GASTROESOPHAGEAL-REFLUX DISEASE; LOS-ANGELES CLASSIFICATION; POPULATION-BASED COHORT; ENDOSCOPIC ASSESSMENT; EROSIVE ESOPHAGITIS; SYMPTOMS; INTEROBSERVER; DYSPEPSIA; HEARTBURN; INFECTION	Background: Few data are available on the prevalence of erosive and severe esophagitis in Western countries. Objective: To retrospectively determine the prevalence and the factors predicting erosive esophagitis and severe esophagitis in a large series of endoscopies in Spain. Design: Retrospective observational study. A multivariate analysis was performed to determine variables predicting severe esophagitis. Setting: Databases of 29 Spanish endoscopy units. Patients: Patients submitted to a diagnostic endoscopy during the year 2005. Interventions: Retrospective review of the databases. Main Outcome Measurements: Esophagitis severity (graded according to the Los Angeles classification) and associated endoscopic findings. Results: Esophagitis was observed in 8.7% of the 93,699 endoscopies reviewed. Severe esophagitis (LA grade C or D) accounted for 22.5% of cases of the disease and was found in 1.9% of all endoscopies. Incidences of esophagitis and those of severe esophagitis were 86.2 and 18.7 cases per 100,000 inhabitants per year respectively. Male sex (OR 1.89) and advanced age (OR 4.2 for patients in the fourth age quartile) were the only variables associated with severe esophagitis. Associated peptic ulcer was present in 8.8% of cases. Limitations: Retrospective study, no data on individual proton pump inhibitors use. Conclusions: Severe esophagitis is an infrequent finding in Spain. It occurs predominantly in males and in older individuals. Peptic ulcer disease is frequently associated with erosive esophagitis.	[Ponce, Julio; Ponce, Marta] Hosp Univ La Fe, Serv Aparato Digest, Valencia, Spain; [Ponce, Julio; Calvet, Xavier; Ponce, Marta] CIBEREHD Inst Salud Carlos III, Barcelona, Spain; [Calvet, Xavier; Gallach, Marta] Univ Autonoma Barcelona, Dept Med, Inst Univ Parc Tauli, E-08193 Barcelona, Spain; [Calvet, Xavier; Gallach, Marta] Hosp Sabadell, Unitat Malalties Digest, Sabadell, Barcelona, Spain	Hospital Universitari i Politecnic La Fe; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Autonomous University of Barcelona; Autonomous University of Barcelona; Parc Tauli Hospital Universitari	Ponce, J (corresponding author), Hosp Univ La Fe, Serv Aparato Digest, Valencia, Spain.	xcalvet@cspt.es	Calvet, Xavier/H-3288-2019; Bujanda, Luis/AAB-2485-2021; Dolz Abadía, Carlos/I-1757-2017	Calvet, Xavier/0000-0002-6278-9663; Bujanda, Luis/0000-0002-4353-9968; Calvet, Xavier/0000-0002-4413-4209	Astra-Zeneca; Instituto de Salud Carlos III [C03/02, PI 05/1157, CIBEREHD]	Astra-Zeneca(AstraZeneca); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This study was supported by a grant from Astra-Zeneca and by grants from the Instituto de Salud Carlos III (C03/02 and PI 05/1157 and CIBEREHD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong D, 1996, GASTROENTEROLOGY, V111, P85, DOI 10.1053/gast.1996.v111.pm8698230; Carlsson R, 1998, EUR J GASTROEN HEPAT, V10, P119, DOI 10.1097/00042737-199802000-00004; Dent J, 2005, GUT, V54, P710, DOI 10.1136/gut.2004.051821; Diaz-Rubio M, 2004, ALIMENT PHARM THER, V19, P95, DOI 10.1046/j.1365-2036.2003.01769.x; El-Serag HB, 2002, SCAND J GASTROENTERO, V37, P899, DOI 10.1080/003655202760230847; FENNERTY B, 2004, GUT S6, V53, pA111; Haque M, 2000, NEW ZEAL MED J, V113, P178; Ho KY, 2005, AM J GASTROENTEROL, V100, P1923, DOI 10.1111/j.1572-0241.2005.50138.x; *I NAC EST, 2007, REV PADR MUN 2005 DA; JOHANSSON KE, 1986, SCAND J GASTROENTERO, V21, P837, DOI 10.3109/00365528609011128; Johnson DA, 2004, GASTROENTEROLOGY, V126, P660, DOI 10.1053/j.gastro.2003.12.001; KANG JY, 1993, J CLIN GASTROENTEROL, V16, P70, DOI 10.1097/00004836-199301000-00019; Kang JY, 1999, EUR J GASTROEN HEPAT, V11, P845, DOI 10.1097/00042737-199908000-00006; Kennedy T, 2000, ALIMENT PHARM THER, V14, P1589, DOI 10.1046/j.1365-2036.2000.00884.x; KNILLJONES RP, 1984, SCAND J GASTROENTERO, V19, P72; Kotzan J, 2001, PHARM RES-DORDR, V18, P1367, DOI 10.1023/A:1013010616496; Kusano M, 1999, GASTROINTEST ENDOSC, V49, P700, DOI 10.1016/S0016-5107(99)70285-3; Lassen A, 2006, AM J GASTROENTEROL, V101, P1193, DOI 10.1111/j.1572-0241.2006.00550.x; Lassen A, 2005, SCAND J GASTROENTERO, V40, P705, DOI 10.1080/00365520510015476; Louis E, 2002, EUR J GASTROEN HEPAT, V14, P279, DOI 10.1097/00042737-200203000-00012; Lundell LR, 1999, GUT, V45, P172, DOI 10.1136/gut.45.2.172; Martinez SD, 2003, ALIMENT PHARM THER, V17, P537, DOI 10.1046/j.1365-2036.2003.01423.x; Mishima I, 2005, SCAND J GASTROENTERO, V40, P1005, DOI 10.1080/00365520510023260; Moayyedi P, 2005, ALIMENT PHARM THER, V22, P11, DOI 10.1111/j.1365-2036.2005.02605.x; Navarro M., 1999, Clinical Microbiology and Infection, V5, P704, DOI 10.1111/j.1469-0691.1999.tb00518.x; Pandolfino JE, 2002, GASTROINTEST ENDOSC, V56, P639, DOI 10.1067/mge.2002.129220; Pilotto A, 2006, J AM GERIATR SOC, V54, P1537, DOI 10.1111/j.1532-5415.2006.00899.x; Ponce J, 2006, ALIMENT PHARM THER, V23, P175, DOI 10.1111/j.1365-2036.2006.02733.x; Rath HC, 2004, GASTROINTEST ENDOSC, V60, P44, DOI 10.1016/S0016-5107(04)01289-1; Ronkainen J, 2006, ALIMENT PHARM THER, V23, P1725, DOI 10.1111/j.1365-2036.2006.02952.x; Rosaida MS, 2004, EUR J GASTROEN HEPAT, V16, P495, DOI 10.1097/00042737-200405000-00010; Ruigomez A, 2004, ALIMENT PHARM THERAP, V20, P751, DOI 10.1111/j.1365-2036.2004.02169.x; Smith T, 2003, GASTROINTEST ENDOSC, V58, P9, DOI 10.1067/mge.2003.308; Wu JCY, 2002, GASTROINTEST ENDOSC, V55, P461, DOI 10.1067/mge.2002.122617; Yeh C, 1997, DIGEST DIS SCI, V42, P702, DOI 10.1023/A:1018835324210	35	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e25051	10.1371/journal.pone.0025051	http://dx.doi.org/10.1371/journal.pone.0025051			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022373	gold, Green Published, Green Submitted			2022-12-27	WOS:000295973200005
J	Karhunen, M				Karhunen, Markku			Dynamics of a Sex-Linked Deleterious Mutation in Populations Subject to Sex Reversal	PLOS ONE			English	Article							Y-CHROMOSOMES; RECOMBINATION; EVOLUTION; DEGENERATION; FEMALE	The heterogametic sex chromosomes (i.e. mammalian Y and avian W) do not usually recombine with the homogametic sex chromosomes which is known to lead into rapid degeneration of Y and W due to accumulation of deleterious mutations. On the other hand, some 96% of amphibian species have homomorphic, i.e. nondegenerate Y chromosomes. Nicolas Perrin's fountainofyouth hypothesis states that this is a result of recombination between X and Y chromosomes in sexreversed individuals. In this study, I model the consequences of such recombination for the dynamics of a deleterious mutation occurring in Y chromosomes. As expected, even relatively low levels of sex reversal help to purge deleterious mutations. However, the populationdynamic consequences of this depend on the type of selection that operates on the population undergoing sex reversal. Under fecundity selection, sex reversal can be beneficial for some parameter values, whereas under survival selection, it seems to be always harmful.	Univ Helsinki, Dept Biosci, Helsinki, Finland	University of Helsinki	Karhunen, M (corresponding author), Univ Helsinki, Dept Biosci, Helsinki, Finland.	markku.karhunen@helsinki.fi		Karhunen, Markku/0000-0001-9086-8214	Academy of Finland [124242, 213457]; European Research Council (ERC) [205905]	Academy of Finland(Academy of Finland); European Research Council (ERC)(European Research Council (ERC)European Commission)	This research was supported by Academy of Finland (grants 124242 and 213457 to Otso Ovaskainen) and the European Research Council (ERC Starting Grant 205905 to Otso Ovaskainen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ah-King M, 2010, EVOL BIOL, V37, P234, DOI 10.1007/s11692-010-9101-8; Aida T, 1921, GENETICS, V6, P554; Alho JS, 2010, MOL ECOL, V19, P1763, DOI 10.1111/j.1365-294X.2010.04607.x; Bachtrog D, 2006, CURR OPIN GENET DEV, V16, P578, DOI 10.1016/j.gde.2006.10.007; Bull J.J., 1983, EVOLUTION SEX DETERM; BURT A, 1991, J EVOLUTION BIOL, V4, P259, DOI 10.1046/j.1420-9101.1991.4020259.x; Charlesworth B, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-226; Charlesworth B, 2000, PHILOS T R SOC B, V355, P1563, DOI 10.1098/rstb.2000.0717; CHARLESWORTH B, 1994, GENET RES, V63, P213, DOI 10.1017/S0016672300032365; Engelstadter J, 2008, GENETICS, V180, P957, DOI 10.1534/genetics.108.092379; Grossen C, 2011, EVOLUTION, V65, P64, DOI 10.1111/j.1558-5646.2010.01098.x; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; Janzen FJ, 2006, J EVOLUTION BIOL, V19, P1775, DOI 10.1111/j.1420-9101.2006.01138.x; KEENEY S, 2011, SCIENCE, V331, P916; Kondo M, 2001, GENET RES, V78, P23, DOI 10.1017/S0016672301005109; Lynn A, 2005, AM J HUM GENET, V77, P670, DOI 10.1086/491718; Marais GAB, 2010, GENOME BIOL EVOL, V2, P347, DOI 10.1093/gbe/evq026; Matsuba C, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-3; Matsuba C, 2010, EVOLUTION, V64, P3634, DOI 10.1111/j.1558-5646.2010.01076.x; Matsuba C, 2009, MOL ECOL RESOUR, V9, P555, DOI 10.1111/j.1755-0998.2008.02368.x; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; Ospina-Alvarez N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002837; Perrin N, 2009, EVOLUTION, V63, P3043, DOI 10.1111/j.1558-5646.2009.00837.x; RICE WR, 1987, GENETICS, V116, P161; Rice WR, 1996, BIOSCIENCE, V46, P331, DOI 10.2307/1312947; Sarre SD, 2004, BIOESSAYS, V26, P639, DOI 10.1002/bies.20050; Schartl M, 2004, CURR OPIN GENET DEV, V14, P634, DOI 10.1016/j.gde.2004.09.005; Shine R, 2002, ECOL LETT, V5, P486, DOI 10.1046/j.1461-0248.2002.00351.x; STEINEMANN M, 1993, P NATL ACAD SCI USA, V90, P5737, DOI 10.1073/pnas.90.12.5737; Steinemann S, 2005, BIOESSAYS, V27, P1076, DOI 10.1002/bies.20288; Stelkens RB, 2010, MOL ECOL, V19, P627, DOI 10.1111/j.1365-294X.2010.04526.x; SWITONSKI M, 2010, CHROMOSOME RES, V18, P720; Tease C, 2004, CYTOGENET GENOME RES, V107, P208, DOI 10.1159/000080599; Wallace H, 1997, CHROMOSOMA, V106, P526; Wedekind C, 2010, MOL ECOL, V19, P1760, DOI 10.1111/j.1365-294X.2010.04608.x; West SA, 2007, J EVOLUTION BIOL, V20, P415, DOI 10.1111/j.1420-9101.2006.01258.x	36	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25362	10.1371/journal.pone.0025362	http://dx.doi.org/10.1371/journal.pone.0025362			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016765	Green Submitted, Green Published, gold			2022-12-27	WOS:000295971700007
J	Odaka, K; Aoki, I; Moriya, J; Tateno, K; Tadokoro, H; Kershaw, J; Minamino, T; Irie, T; Fukumura, T; Komuro, I; Saga, T				Odaka, Kenichi; Aoki, Ichio; Moriya, Junji; Tateno, Kaoru; Tadokoro, Hiroyuki; Kershaw, Jeff; Minamino, Tohru; Irie, Toshiaki; Fukumura, Toshimitsu; Komuro, Issei; Saga, Tsuneo			In Vivo Tracking of Transplanted Mononuclear Cells Using Manganese-Enhanced Magnetic Resonance Imaging (MEMRI)	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; ENDOTHELIAL PROGENITOR CELLS; MRI; NEOVASCULARIZATION; MUSCLE; BRAIN; IRON; ANGIOGENESIS; CHANNELS; NICKEL	Background: Transplantation of mononuclear cells (MNCs) has previously been tested as a method to induce therapeutic angiogenesis to treat limb ischemia in clinical trials. Non-invasive high resolution imaging is required to track the cells and evaluate clinical relevance after cell transplantation. The hypothesis that MRI can provide in vivo detection and long-term observation of MNCs labeled with manganese contrast-agent was investigated in ischemic rat legs. Methods and Findings: The Mn-labeled MNCs were evaluated using 7-tesla high-field magnetic resonance imaging (MRI). Intramuscular transplanted Mn-labeled MNCs were visualized with MRI for at least 7 and up to 21 days after transplantation in the ischemic leg. The distribution of Mn-labeled MNCs was similar to that of In-111-labeled MNCs measured with single-photon emission computed tomography (SPECT) and Dil-dyed MNCs with fluorescence microscopy. In addition, at 1-2 days after transplantation the volume of the site injected with intact Mn-labeled MNCs was significantly larger than that injected with dead MNCs, although the dead Mn-labeled MNCs were also found for approximately 2 weeks in the ischemic legs. The area covered by CD31-positive cells (as a marker of capillary endothelial cells) in the intact Mn-MNCs implanted site at 43 days was significantly larger than that at a site implanted with dead Mn-MNCs. Conclusions: The present Mn-enhanced MRI method enabled visualization of the transplanted area with a 150-175 mu m in-plane spatial resolution and allowed the migration of labeled-MNCs to be observed for long periods in the same subject. After further optimization, MRI-based Mn-enhanced cell-tracking could be a useful technique for evaluation of cell therapy both in research and clinical applications.	[Odaka, Kenichi; Aoki, Ichio; Kershaw, Jeff; Irie, Toshiaki; Fukumura, Toshimitsu; Saga, Tsuneo] Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba 260, Japan; [Moriya, Junji; Tateno, Kaoru; Minamino, Tohru; Komuro, Issei] Chiba Univ, Grad Sch Med, Dept Cardiovasc Sci & Med, Chiba, Japan; [Tadokoro, Hiroyuki] Tokai Univ, Dept Biomed Engn, Shizuoka, Japan	National Institutes for Quantum Science & Technology; Chiba University; Tokai University	Odaka, K (corresponding author), Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba 260, Japan.	aoki@nirs.go.jp	Aoki, Ichio/G-2529-2011; Aoki, Ichio/ABF-7336-2020; Minamino, Tohru/P-8145-2018; Fukumura, Toshimitsu/E-2847-2012	Aoki, Ichio/0000-0002-4429-5053; Minamino, Tohru/0000-0003-1627-6151; 	Japan Society for the Promotion of Science (JSPS); Japan Cardiovascular Research Foundation; Grants-in-Aid for Scientific Research [21390237] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Cardiovascular Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research Japan (Kakenhi) from the Japan Society for the Promotion of Science (JSPS) and a grant from the Japan Cardiovascular Research Foundation. The research was also partly supported by the JSPS through its Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicher A, 2003, CIRCULATION, V107, P2134, DOI 10.1161/01.CIR.0000062649.63838.C9; Amsalem Y, 2007, CIRCULATION, V116, pI38, DOI 10.1161/CIRCULATIONAHA.106.680231; Aoki I, 2004, NEUROIMAGE, V22, P1046, DOI 10.1016/j.neuroimage.2004.03.031; Aoki I, 2006, NMR BIOMED, V19, P50, DOI 10.1002/nbm.1000; Aoki I, 2002, MAGNET RESON MED, V48, P927, DOI 10.1002/mrm.10320; ARCHIBALD FS, 1987, ARCH BIOCHEM BIOPHYS, V256, P638, DOI 10.1016/0003-9861(87)90621-7; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Assmus B, 2006, NEW ENGL J MED, V355, P1222, DOI 10.1056/NEJMoa051779; Brurok H, 1999, NMR BIOMED, V12, P364, DOI 10.1002/(SICI)1099-1492(199910)12:6<364::AID-NBM585>3.3.CO;2-Q; Bulte JWM, 2001, NAT BIOTECHNOL, V19, P1141, DOI 10.1038/nbt1201-1141; BULTE JWM, 1993, MAGNET RESON MED, V29, P32, DOI 10.1002/mrm.1910290108; Daldrup-Link HE, 2005, EUR RADIOL, V15, P4, DOI 10.1007/s00330-004-2526-7; GIMI B, 2002, P 10 ANN M ISMRM 18; GRAHAM DG, 1984, NEUROTOXICOLOGY, V5, P83; HENDRICK RE, 1993, JMRI-J MAGN RESON IM, V3, P137, DOI 10.1002/jmri.1880030126; Hoehn M, 2002, P NATL ACAD SCI USA, V99, P16267, DOI 10.1073/pnas.242435499; Hu TCC, 2005, MAGN RESON MED, V54, P196, DOI 10.1002/mrm.20516; Hu TCC, 2004, NMR BIOMED, V17, P620, DOI 10.1002/nbm.933; Hu TCC, 2001, MAGNET RESON MED, V46, P884, DOI 10.1002/mrm.1273; HUNTER DR, 1980, CIRC RES, V47, P721, DOI 10.1161/01.RES.47.5.721; Ikenaga S, 2001, J SURG RES, V96, P277, DOI 10.1006/jsre.2000.6080; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Kraitchman DL, 2003, CIRCULATION, V107, P2290, DOI 10.1161/01.CIR.0000070931.62772.4E; Leor J, 2006, CIRCULATION, V114, pI94, DOI 10.1161/CIRCULATIONAHA.105.000331; Lin YJ, 1997, MAGN RESON MED, V38, P378, DOI 10.1002/mrm.1910380305; Moriya J, 2009, CIRC-CARDIOVASC INTE, V2, P245, DOI 10.1161/CIRCINTERVENTIONS.108.799361; NARITA K, 1990, BRAIN RES, V510, P289, DOI 10.1016/0006-8993(90)91379-U; Nowak B, 2007, EUR J NUCL MED MOL I, V34, P715, DOI 10.1007/s00259-006-0275-3; Pautler RG, 1998, MAGNET RESON MED, V40, P740, DOI 10.1002/mrm.1910400515; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Shapiro EM, 2004, P NATL ACAD SCI USA, V101, P10901, DOI 10.1073/pnas.0403918101; SHIBUYA I, 1992, ENDOCRINOLOGY, V131, P1936, DOI 10.1210/en.131.4.1936; Shintani S, 2001, CIRCULATION, V103, P897, DOI 10.1161/01.CIR.103.6.897; Sotak CH, 2008, CONTRAST MEDIA MOL I, V3, P95, DOI 10.1002/cmmi.235; Suzuki K, 2004, CIRCULATION, V110, pII219, DOI 10.1161/01.CIR.0000138388.55416.06; Swirski FK, 2006, P NATL ACAD SCI USA, V103, P10340, DOI 10.1073/pnas.0604260103; Tang GL, 2005, J VASC SURG, V41, P312, DOI 10.1016/j.jvs.2004.11.012; Tateishi-Yuyama E, 2002, LANCET, V360, P427, DOI 10.1016/S0140-6736(02)09670-8; Tateno K, 2006, CIRC RES, V98, P1194, DOI 10.1161/01.RES.0000219901.13974.15; Tatsumi T, 2007, CIRC J, V71, P1199, DOI 10.1253/circj.71.1199; Toyoda KI, 2004, NEUROREPORT, V15, P589, DOI 10.1097/00001756-200403220-00004; Trumbo P, 2001, J AM DIET ASSOC, V101, P294, DOI 10.1016/S0002-8223(01)00078-5; Watanabe T, 2001, MAGNET RESON MED, V46, P424, DOI 10.1002/mrm.1209; WEISSKOFF RM, 1994, MAGNET RESON MED, V31, P601, DOI 10.1002/mrm.1910310605; *WHO, 1996, HLTH CRIT OTH SUPP I, P276; Winkler T, 2008, TISSUE ENG PT A, V14, P1149, DOI [10.1089/ten.tea.2007.0179, 10.1089/tea.2007.0179]; Yamada M, 2009, MAGN RESON MED, V62, P1047, DOI 10.1002/mrm.22071; Zelivyanskaya ML, 2003, J NEUROSCI RES, V73, P284, DOI 10.1002/jnr.10693; Ziegelhoeffer T, 2004, CIRC RES, V94, P230, DOI 10.1161/01.RES.0000110419.50982.1C	49	5	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25487	10.1371/journal.pone.0025487	http://dx.doi.org/10.1371/journal.pone.0025487			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003393	Green Submitted, Green Published, gold			2022-12-27	WOS:000295970300014
J	Siemen, H; Colas, D; Heller, HC; Brustle, O; Pera, RAR				Siemen, Henrike; Colas, Damien; Heller, H. Craig; Bruestle, Oliver; Pera, Renee A. Reijo			Pumilio-2 Function in the Mouse Nervous System	PLOS ONE			English	Article							MENTAL-RETARDATION PROTEIN; MESSENGER-RNA; SELF-RENEWAL; MICE; BEHAVIORS; STRESS; IDENTIFICATION; STEROIDS; HOMOLOG; SEIZURE	Coordinated mRNA translation at the synapse is increasingly recognized as a critical mechanism for neuronal regulation. Pumilio, a translational regulator, is known to be involved in neuronal homeostasis and memory formation in Drosophila. Most recently, the mammalian Pumilio homolog Pumilio-2 (Pum2) has been found to play a role in the mammalian nervous system, in particular in regulating morphology, arborization and excitability of neuronal dendrites, in vitro. However, the role of Pum2 in vivo remains unclear. Here, we report our investigation of the functional and molecular consequences of Pum2 disruption in vivo using an array of neurophysiology, behavioral and gene expression profiling techniques. We used Pum2-deficient mice to monitor in vivo brain activity using EEG and to study behavior traits, including memory, locomotor activity and nesting capacities. Because of the suspected role of Pum2 in neuronal excitability, we also examined the susceptibility to seizure induction. Finally, we used a quantitative gene expression profiling assay to identify key molecular partners of Pum2. We found that Pum2-deficient mice have abnormal behavioral strategies in spatial and object memory test. Additionally, Pum2 deficiency is associated with increased locomotor activity and decreased body weight. We also observed environmentally-induced impairment in nesting behavior. Most importantly, Pum2-deficient mice showed spontaneous EEG abnormalities and had lower seizure thresholds using a convulsing dosage of pentylenetetrazole. Finally, some genes, including neuronal ion channels, were differentially expressed in the hippocampus of Pum2-deficient mice. These findings demonstrate that Pum2 serves key functions in the adult mammalian central nervous system encompassing neuronal excitability and behavioral response to environmental challenges.	[Siemen, Henrike; Pera, Renee A. Reijo] Stanford Univ, Sch Med, Dept Obstet & Gynecol, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Siemen, Henrike; Bruestle, Oliver] Univ Bonn, Inst Reconstruct Neurobiol, Life & Brain Ctr, D-5300 Bonn, Germany; [Colas, Damien; Heller, H. Craig] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University; University of Bonn; Stanford University	Siemen, H (corresponding author), Stanford Univ, Sch Med, Dept Obstet & Gynecol, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.	reneer@stanford.edu		Heller, H Craig/0000-0003-4479-5880; Reijo Pera, Renee/0000-0002-6487-1329; Colas, Damien/0000-0002-7008-3257	"Stiftung der deutschen Wirtschaft'', Germany; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047721] Funding Source: NIH RePORTER	"Stiftung der deutschen Wirtschaft'', Germany; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by an anonymous donor to the Stanford Institute for Stem Cell Biology and Regenerative Medicine. HS was supported by a fellowship from the "Stiftung der deutschen Wirtschaft'', Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Chen GX, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000026; Colas D, 2008, NEUROBIOL DIS, V30, P1, DOI 10.1016/j.nbd.2007.07.014; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Deacon RMJ, 2002, BEHAV BRAIN RES, V132, P203, DOI 10.1016/S0166-4328(01)00401-6; Deacon RMJ, 2006, NAT PROTOC, V1, P1117, DOI 10.1038/nprot.2006.170; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; Filali M, 2009, GENES BRAIN BEHAV, V8, P143, DOI 10.1111/j.1601-183X.2008.00453.x; Fiore R, 2009, EMBO J, V28, P697, DOI 10.1038/emboj.2009.10; Fox M, 2005, GENOMICS, V85, P92, DOI 10.1016/j.ygeno.2004.10.003; Galgano A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003164; Gamberi C, 2002, DEVELOPMENT, V129, P2699; Gould E, 2007, NAT REV NEUROSCI, V8, P481, DOI 10.1038/nrn2147; Jin P, 2004, NAT CELL BIOL, V6, P1048, DOI 10.1038/ncb1104-1048; Karlsson RM, 2009, NEUROPSYCHOPHARMACOL, V34, P1578, DOI 10.1038/npp.2008.215; Kim SH, 2006, J NEUROSCI, V26, P2413, DOI 10.1523/JNEUROSCI.3680-05.2006; Koh HY, 2008, GENES BRAIN BEHAV, V7, P120, DOI 10.1111/j.1601-183X.2007.00351.x; Kwak JE, 2008, P NATL ACAD SCI USA, V105, P14644, DOI 10.1073/pnas.0803185105; Lee MH, 2007, PLOS GENET, V3, P2540, DOI 10.1371/journal.pgen.0030233; LOSCHER W, 1991, EPILEPSY RES, V8, P171, DOI 10.1016/0920-1211(91)90062-K; Marshall KM, 2011, CURR TOP BEHAV NEURO, V8, P1, DOI 10.1007/7854_2011_136; McGinnis MY, 2007, PHYSIOL BEHAV, V92, P1010, DOI 10.1016/j.physbeh.2007.07.010; McKinney BC, 2005, AM J MED GENET B, V136B, P98, DOI 10.1002/ajmg.b.30183; Menon KP, 2004, NEURON, V44, P663, DOI 10.1016/j.neuron.2004.10.028; Miyakawa T, 2003, P NATL ACAD SCI USA, V100, P8987, DOI 10.1073/pnas.1432926100; Muraro NI, 2008, J NEUROSCI, V28, P2099, DOI 10.1523/JNEUROSCI.5092-07.2008; Pfeiffer BE, 2009, NEUROSCIENTIST, V15, P549, DOI 10.1177/1073858409333075; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Richter JD, 2009, GENE DEV, V23, P1, DOI 10.1101/gad.1735809; Salehi A, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000258; Salvetti A, 2005, DEVELOPMENT, V132, P1863, DOI 10.1242/dev.01785; Schweers BA, 2002, GENETICS, V161, P1177; Touma C, 2004, HORM BEHAV, V45, P10, DOI 10.1016/j.yhbeh.2003.07.002; VELISEK L, 1992, N-S ARCH PHARMACOL, V346, P588, DOI 10.1007/BF00169017; Vessey JP, 2006, J NEUROSCI, V26, P6496, DOI 10.1523/JNEUROSCI.0649-06.2006; Vessey JP, 2010, P NATL ACAD SCI USA, V107, P3222, DOI 10.1073/pnas.0907128107; Viggiano D, 2008, BEHAV BRAIN RES, V194, P1, DOI 10.1016/j.bbr.2008.06.033; Wang Z, 2004, SCIENCE, V303, P2016, DOI 10.1126/science.1093983; Weston Andrew J., 2007, Invertebrate Neuroscience, V7, P75, DOI 10.1007/s10158-006-0037-8; Xu EY, 2007, MOL REPROD DEV, V74, P912, DOI 10.1002/mrd.20687; Zalfa F, 2007, NAT NEUROSCI, V10, P578, DOI 10.1038/nn1893	42	54	54	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25932	10.1371/journal.pone.0025932	http://dx.doi.org/10.1371/journal.pone.0025932			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22016787	Green Published, Green Submitted, gold			2022-12-27	WOS:000295970300040
J	Feng, Y; Zhao, WH; Feng, YM; Dai, JJ; Li, Z; Zhang, XY; Liu, L; Bai, J; Zhang, HT; Lu, L; Xia, XS				Feng, Yue; Zhao, Wenhua; Feng, Yuemei; Dai, Jiejie; Li, Zheng; Zhang, Xiaoyan; Liu, Li; Bai, Jie; Zhang, Huatang; Lu, Ling; Xia, Xueshan			A Novel Genotype of GB Virus C: Its Identification and Predominance among Injecting Drug Users in Yunnan, China	PLOS ONE			English	Article							HEPATITIS-G VIRUS; C/HEPATITIS-G-VIRUS; PHYLOGENETIC ANALYSIS; SYNTHETIC PEPTIDES; SOUTHERN CHINA; MOLECULAR EPIDEMIOLOGY; 5'-UNTRANSLATED REGION; BLOOD-DONORS; HIV; INFECTION	GB virus C (GBV-C) is prevalent globally and particularly among individuals at risk of parental exposures. Based on genetic diversity, this virus is now classified into six genotypes and many subtypes with distinct geographical distribution. In this study, 120 Injecting Drug Users (IDUs) were recruited from Yunnan province, China. Among them, 43 (35.8%) were positive for GBV-C RNA, 70 (58.3%) and 103 (85.8%) sero-positive for HIV-1 and HCV respectively. This revealed 18.3% of IDUs having GBV-C/HIV/HCV triple infection, which is significantly higher than 7.5% of GBV-C/HIV-1 and 10% of GBV-C/HCV dual infection rates (P<0.05). Based on 5'UTR sequences, the identified 43 viral isolates can be classified into three phylogenetic groups: one (2.3%) and two (4.7%) belonged to genotype 3 and 4, respectively, and the remaining 40 (93%) formed a new group with 97% of bootstrap support. This new GBV-C group was further confirmed by characterizing the E2 region and full-length genome sequences. Analysis of 187 nt 5'UTR sequence showed three previous reported isolates from Southeast Asia were re-classified into this new group. It implies they have the same origin with strains from Yunnan. Although we provisionally assigned this new group as GBV-C genotype 7, a simpler five groups of GBV-C nomenclature is recommended. Genotype 4, 6 and the newly designated genotype 7 could be reclassified as one group, which may represent a single GBV-C genotype. The classification of the other four groups was corresponding to that of previous reported genotype 1, 2, 3 and 5. Furthermore, the diversity of amino acid sequence in the E2 region was analyzed. The inhibitory effect of GBV-C genotype 7 on HIV-1 cell entry could be deduced. Since GBV-C may have a beneficial effect on AIDS disease progression and interact with HCV during co-infection, this finding may raise interests in future studies on this virus that was previously thought to be a "non-pathogenic virus''.	[Feng, Yue; Liu, Li; Bai, Jie; Xia, Xueshan] Kunming Univ Sci & Technol, Fac Environm Sci & Engn, Kunming, Yunnan, Peoples R China; [Feng, Yue; Liu, Li; Bai, Jie; Xia, Xueshan] Kunming Univ Sci & Technol, Fac Life Sci & Technol, Kunming, Yunnan, Peoples R China; [Zhao, Wenhua] Key Lab Trop & Subtrop Anim Viral Dis Yunnan Prov, Kunming, Yunnan, Peoples R China; [Feng, Yuemei; Zhang, Huatang] Chinese Acad Sci & Yunnan Prov, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming, Peoples R China; [Dai, Jiejie] Chinese Acad Med Sci, Inst Med Biol, Kunming, Yunnan, Peoples R China; [Dai, Jiejie] Peking Union Med Coll, Kunming, Yunnan, Peoples R China; [Li, Zheng] Kunming Med Coll, Affiliated Kunhua Hosp, Clin Lab, Ctr Yunnan Prov, Kunming, Peoples R China; [Zhang, Xiaoyan] Fudan Univ, Res Ctr Shanghai Publ Hlth Clin Ctr, Inst Biomed Sci, Shanghai, Peoples R China; [Lu, Ling] Univ Kansas, Med Ctr, Dept Pathol, Viral Oncol Ctr, Kansas City, KS 66103 USA; Sun Yat Sen Univ, Affiliated Hosp 3, Lab Hepatol, Guangzhou 510275, Guangdong, Peoples R China	Kunming University of Science & Technology; Kunming University of Science & Technology; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Kunming Medical University; Fudan University; University of Kansas; University of Kansas Medical Center; Sun Yat Sen University	Feng, Y (corresponding author), Kunming Univ Sci & Technol, Fac Environm Sci & Engn, Kunming, Yunnan, Peoples R China.	oliverxia2000@yahoo.com.cn		zhao, wenhua/0000-0003-0811-7978	Natural Science Foundation of China (NSFC) [30960346, 30960005]; National Basic Research Program of China (973 Program) [2009CB522502]; Chinese Key Projects in the National Science & Technology Pillar Program [2009BAI83B02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080734] Funding Source: NIH RePORTER	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Chinese Key Projects in the National Science & Technology Pillar Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was financially supported by grants from the Natural Science Foundation of China (NSFC) (No. 30960346 and No. 30960005) and the National Basic Research Program of China (973 Program, 2009CB522502), and partially supported by Chinese Key Projects in the National Science & Technology Pillar Program during the Eleventh Five-Year Plan Period (2009BAI83B02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham P, 2007, INDIAN J MED RES, V125, P717; Alcalde R, 2010, VIRUS RES, V151, P148, DOI 10.1016/j.virusres.2010.04.008; An P, 1997, J GEN VIROL, V78, P2477, DOI 10.1099/0022-1317-78-10-2477; Berzsenyi MD, 2007, GASTROENTEROLOGY, V133, P1821, DOI 10.1053/j.gastro.2007.08.076; Beyrer C, 2005, AIDS, V19, P1535, DOI 10.1097/01.aids.0000183122.01583.c7; Beyrer C, 2000, AIDS, V14, P75, DOI 10.1097/00002030-200001070-00009; Bjorkman P, 2001, VOX SANG, V81, P148, DOI 10.1046/j.1423-0410.2001.00098.x; Branco C, 2010, J MED VIROL, V82, P452, DOI 10.1002/jmv.21703; Fukushi S, 1996, BIOCHEM BIOPH RES CO, V226, P314, DOI 10.1006/bbrc.1996.1353; Garten RJ, 2005, CLIN INFECT DIS, V41, pS18, DOI 10.1086/429491; George Sarah L, 2005, Curr Gastroenterol Rep, V7, P54, DOI 10.1007/s11894-005-0067-0; Handajani R, 2000, J CLIN MICROBIOL, V38, P662, DOI 10.1128/JCM.38.2.662-668.2000; Hekmat S, 2008, J MED VIROL, V80, P1941, DOI 10.1002/jmv.21314; Herrera E, 2010, J MED CHEM, V53, P6054, DOI 10.1021/jm100452c; Herrera E, 2009, J PHYS CHEM B, V113, P7383, DOI 10.1021/jp900707t; Hwang SJ, 1999, J MED VIROL, V57, P85, DOI 10.1002/(SICI)1096-9071(199901)57:1&lt;85::AID-JMV13&gt;3.0.CO;2-2; Jung S, 2007, AIDS, V21, P645, DOI 10.1097/QAD.0b013e32803277c7; Laeyendecker O, 2005, JAIDS-J ACQ IMM DEF, V38, P356; Lai S, 2001, J ACQ IMMUN DEF SYND, V26, P365, DOI 10.1097/00126334-200104010-00014; Larios C, 2005, LUMINESCENCE, V20, P279, DOI 10.1002/bio.850; Larios C, 2005, ARCH BIOCHEM BIOPHYS, V442, P149, DOI 10.1016/j.abb.2005.06.027; Li G, 2002, WORLD J GASTROENTERO, V8, P1081, DOI 10.3748/wjg.v8.i6.1081; LI G, 2002, WORLD J GASTROENTERO, V9, P1739; Liu HF, 2003, J MED VIROL, V71, P385, DOI 10.1002/jmv.10491; Lu L, 2001, VIRUS RES, V73, P131, DOI 10.1016/S0168-1702(00)00231-8; Mphahlele MJ, 1998, LIVER, V18, P143; Muerhoff AS, 2006, J MED VIROL, V78, P105, DOI 10.1002/jmv.20510; Muerhoff AS, 2005, J GEN VIROL, V86, P1729, DOI 10.1099/vir.0.80854-0; Muerhoff AS, 1996, J HEPATOL, V25, P379, DOI 10.1016/S0168-8278(96)80125-5; Petrik J, 1998, GUT, V42, P103, DOI 10.1136/gut.42.1.103; Sathar MA, 2004, CLIN INFECT DIS, V38, P405, DOI 10.1086/381092; Schleicher SB, 2003, J MED VIROL, V71, P226, DOI 10.1002/jmv.10474; Schwarze-Zander C, 2006, J INFECT DIS, V194, P410, DOI 10.1086/505713; Shang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010631; Shankar EM, 2008, T ROY SOC TROP MED H, V102, P1176, DOI 10.1016/j.trstmh.2008.04.034; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Smith DB, 2000, J GEN VIROL, V81, P769, DOI 10.1099/0022-1317-81-3-769; Stapleton JT, 2003, SEMIN LIVER DIS, V23, P137; Stark K, 1996, J INFECT DIS, V174, P1320, DOI 10.1093/infdis/174.6.1320; Takebe Y, 2004, PEDIATR INT, V46, P236, DOI 10.1046/j.1442-200x.2004.01869.x; Tee KK, 2008, J VIROL, V82, P9206, DOI 10.1128/JVI.00399-08; Wang YZ, 2009, J CLIN VIROL, V44, P195, DOI 10.1016/j.jcv.2008.12.009; Xia XS, 2008, J MED VIROL, V80, P1740, DOI 10.1002/jmv.21287; Xia XS, 2008, J MED VIROL, V80, P1142, DOI 10.1002/jmv.21204; Yu XF, 2003, AIDS RES HUM RETROV, V19, P1051, DOI 10.1089/088922203322588422; Zhou YQ, 2010, J CLIN VIROL, V49, P272, DOI 10.1016/j.jcv.2010.08.007	46	45	48	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e21151	10.1371/journal.pone.0021151	http://dx.doi.org/10.1371/journal.pone.0021151			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998624	gold, Green Submitted, Green Published			2022-12-27	WOS:000295968700001
J	Zheng, HX; Yan, S; Qin, ZD; Wang, Y; Tan, JZ; Li, H; Jin, L				Zheng, Hong-Xiang; Yan, Shi; Qin, Zhen-Dong; Wang, Yi; Tan, Jing-Ze; Li, Hui; Jin, Li			Major Population Expansion of East Asians Began before Neolithic Time: Evidence of mtDNA Genomes	PLOS ONE			English	Article							AGRICULTURAL ORIGINS; NORTH CHINA; DOMESTICATION; JOMON; EVOLUTION; SELECTION; INSIGHTS; REVEALS; HUMANS; SIZE	It is a major question in archaeology and anthropology whether human populations started to grow primarily after the advent of agriculture, i.e., the Neolithic time, especially in East Asia, which was one of the centers of ancient agricultural civilization. To answer this question requires an accurate estimation of the time of lineage expansion as well as that of population expansion in a population sample without ascertainment bias. In this study, we analyzed all available mtDNA genomes of East Asians ascertained by random sampling, a total of 367 complete mtDNA sequences generated by the 1000 Genome Project, including 249 Chinese (CHB, CHD, and CHS) and 118 Japanese (JPT). We found that major mtDNA lineages underwent expansions, all of which, except for two JPT-specific lineages, including D4, D4b2b, D4a, D4j, D5a2a, A, N9a, F1a1'4, F2, B4, B4a, G2a1 and M7b1'2'4, occurred before 10 kya, i.e., before the Neolithic time (symbolized by Dadiwan Culture at 7.9 kya) in East Asia. Consistent to this observation, the further analysis showed that the population expansion in East Asia started at 13 kya and lasted until 4 kya. The results suggest that the population growth in East Asia constituted a need for the introduction of agriculture and might be one of the driving forces that led to the further development of agriculture.	[Zheng, Hong-Xiang; Yan, Shi; Qin, Zhen-Dong; Wang, Yi; Tan, Jing-Ze; Li, Hui; Jin, Li] Fudan Univ, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Zheng, Hong-Xiang; Yan, Shi; Qin, Zhen-Dong; Wang, Yi; Tan, Jing-Ze; Li, Hui; Jin, Li] Fudan Univ, Sch Life Sci, MOE Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Zheng, Hong-Xiang; Yan, Shi; Qin, Zhen-Dong; Wang, Yi; Tan, Jing-Ze; Li, Hui; Jin, Li] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Yan, Shi; Jin, Li] Chinese Acad Sci, Max Planck Soc, CAS MPG Partner Inst Computat Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Yan, Shi; Jin, Li] Chinese Acad Sci, Key Lab Computat Biol, CAS MPG Partner Inst Computat Biol, Shanghai, Peoples R China; [Wang, Yi] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA	Fudan University; Fudan University; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Baylor College of Medicine	Zheng, HX (corresponding author), Fudan Univ, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	lijin.fudan@gmail.com	Jin, Li/C-1468-2009; Li, Hui/A-2014-2010; Jin, Li/M-5063-2019; Yan, Shi/GYR-3441-2022	Jin, Li/0000-0002-4546-2415; Yan, Shi/0000-0001-8304-8445	National Science Foundation of China [30890034, 31071098, 31071102]; National Outstanding Youth Science Foundation of China [30625016]; Shanghai Leading Academic Discipline Project [B111]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Outstanding Youth Science Foundation of China; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This research was supported by grants from the National Science Foundation of China (30890034, 31071098, 31071102), and National Outstanding Youth Science Foundation of China (30625016). LJ is also supported by Shanghai Leading Academic Discipline Project (B111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Atkinson QD, 2008, MOL BIOL EVOL, V25, P468, DOI 10.1093/molbev/msm277; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bar-Yosef O, 2002, ANNU REV ANTHROPOL, V31, P363, DOI 10.1146/annurev.anthro.31.040402.085416; Barton L, 2009, P NATL ACAD SCI USA, V106, P5523, DOI 10.1073/pnas.0809960106; Batini C, 2011, MOL BIOL EVOL, V28, P1099, DOI 10.1093/molbev/msq294; Bettinger RL, 2010, EVOL ANTHROPOL, V19, P9, DOI 10.1002/evan.20236; Chu JY, 1998, P NATL ACAD SCI USA, V95, P11763, DOI 10.1073/pnas.95.20.11763; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Crawford GW, 2008, WORLD ARCHAEOL, V40, P445, DOI 10.1080/00438240802451181; Crawford GW, 2009, P NATL ACAD SCI USA, V106, P7271, DOI 10.1073/pnas.0903375106; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fan L, 2011, MITOCHONDRION, V11, P351, DOI 10.1016/j.mito.2010.09.013; Forster P, 1996, AM J HUM GENET, V59, P935; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fuller DQ, 2007, ANN BOT-LONDON, V100, P903, DOI 10.1093/aob/mcm048; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gignoux CR, 2011, P NATL ACAD SCI USA, V108, P6044, DOI 10.1073/pnas.0914274108; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gunnarsdottir ED, 2011, GENOME RES, V21, P1, DOI 10.1101/gr.107615.110; Hammer MF, 2006, J HUM GENET, V51, P47, DOI 10.1007/s10038-005-0322-0; Ho SYW, 2008, AM J HUM GENET, V83, P142, DOI 10.1016/j.ajhg.2008.06.014; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lu HY, 2009, P NATL ACAD SCI USA, V106, P7367, DOI 10.1073/pnas.0900158106; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Matsui A, 2006, WORLD ARCHAEOL, V38, P259, DOI 10.1080/00438240600708295; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Pearson R, 2006, WORLD ARCHAEOL, V38, P239, DOI 10.1080/00438240600693976; Peng MS, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-46; Qin ZD, 2010, AM J PHYS ANTHROPOL, V143, P555, DOI 10.1002/ajpa.21350; Ray N, 2001, INTERNET ARCHAEOLOGY, V11; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Shi H, 2005, AM J HUM GENET, V77, P408, DOI 10.1086/444436; SHI WT, MOL BIOL EVOLUTION, V27, P385; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Stiner MC, 2001, P NATL ACAD SCI USA, V98, P6993, DOI 10.1073/pnas.121176198; Tanaka M, 2004, GENOME RES, V14, P1832, DOI 10.1101/gr.2286304; UNDERHILL AP, 2008, EARLY COMMUNITIES E, P121; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Wall JD, 2000, GENETICS, V155, P1865; Wu XZ, 2004, QUATERN INT, V117, P131, DOI 10.1016/S1040-6182(03)00123-X; Xu SH, 2009, AM J HUM GENET, V85, P762, DOI 10.1016/j.ajhg.2009.10.015; Xue FH, 2008, EUR J HUM GENET, V16, P705, DOI 10.1038/sj.ejhg.5201998; Xue YL, 2006, GENETICS, V172, P2431, DOI 10.1534/genetics.105.054270; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	49	58	64	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e25835	10.1371/journal.pone.0025835	http://dx.doi.org/10.1371/journal.pone.0025835			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998705	gold, Green Published, Green Submitted			2022-12-27	WOS:000295968700021
J	Cai, KL; Hua, GH; Ahmad, S; Liang, AX; Han, L; Wu, CJ; Yang, FF; Yang, LG				Cai, Kailai; Hua, Guohua; Ahmad, Sibtain; Liang, Aaixin; Han, Li; Wu, Canjie; Yang, Feifei; Yang, Liguo			Action Mechanism of Inhibin alpha-Subunit on the Development of Sertoli Cells and First Wave of Spermatogenesis in Mice	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; RNA INTERFERENCE; SPERM PRODUCTION; POSTNATAL-DEVELOPMENT; SIGNALING PATHWAYS; TESTIS; EXPRESSION; MOUSE; GERM; GENE	Inhibin is an important marker of Sertoli cell (SC) activity in animals with impaired spermatogenesis. However, the precise relationship between inhibin and SC activity is unknown. To investigate this relationship, we partially silenced both the transcription and translation of the gene for the alpha-subunit of inhibin, Inha, using recombinant pshRNA vectors developed with RNAi-Ready pSIREN-RetroQ-ZsGreen Vector (Clontech Laboratories, Mountain View, Calif). We found that Inha silencing suppresses the cell-cycle regulators Cyclin D1 and Cyclin E and up-regulates the cell-cycle inhibitor P21 (as detected by Western blot analysis), thereby increasing the number of SCs in the G1 phase of the cell cycle and decreasing the amount in the S-phase of the cell cycle (as detected by flow cytometry). Inha silencing also suppressed Pdgfa, Igf1, and Kitl mRNA levels and up-regulated Tgfbrs, Inhba, Inhbb, Cyp11a1, Dhh, and Tjp1 mRNA levels (as indicated by real-time polymerase chain reaction [PCR] analysis). These findings indicate that Inha has the potential to influence the availability of the ligand inhibin and its antagonist activin in the SC in an autocrine manner and inhibit the progression of SC from G1 to S. It may also participate in the development of the blood-testis barrier, Leydig cells, and spermatogenesis through its effect on Dhh, Tjp1, Kitl, and Pdgfa. Real-time PCR and Western blot analyses of Inha, Inhba, and Inhbb mRNA and Inha levels over time show that Inha plays an important role in the formation of round spermatid during the first wave of spermatogenesis in mice.	[Cai, Kailai; Hua, Guohua; Ahmad, Sibtain; Liang, Aaixin; Han, Li; Wu, Canjie; Yang, Feifei; Yang, Liguo] Huazhong Agr Univ, Key Lab Agr Anim Genet Breeding & Reprod, Educ Minist China, Wuhan, Peoples R China; [Ahmad, Sibtain] Univ Agr Faisalabad, Dept Livestock Management, Faisalabad, Pakistan	Huazhong Agricultural University; University of Agriculture Faisalabad	Cai, KL (corresponding author), Huazhong Agr Univ, Key Lab Agr Anim Genet Breeding & Reprod, Educ Minist China, Wuhan, Peoples R China.	yangliguo2006@yahoo.com.cn			Special Fund for Agro-scientific Research in the Public Interest [201003060]; Earmarked Fund for Modern Agro-industry Technology Research System [CARS-37-04B]	Special Fund for Agro-scientific Research in the Public Interest; Earmarked Fund for Modern Agro-industry Technology Research System	This work was supported by the Special Fund for Agro-scientific Research in the Public Interest (No. 201003060) and the Earmarked Fund for Modern Agro-industry Technology Research System (No. CARS-37-04B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alao JP, 2006, MOL CANCER, V5, P11; Anawalt BD, 1996, J CLIN ENDOCR METAB, V81, P3341, DOI 10.1210/jc.81.9.3341; Bame JH, 1999, BIOL REPROD, V60, P1360, DOI 10.1095/biolreprod60.6.1360; Barakat B, 2008, REPRODUCTION, V136, P345, DOI 10.1530/REP-08-0140; BEAMER WG, 1988, BIOL REPROD, V38, P899, DOI 10.1095/biolreprod38.4.899; Bitgood MJ, 1996, CURR BIOL, V6, P298, DOI 10.1016/S0960-9822(02)00480-3; Brennan J, 2003, GENE DEV, V17, P800, DOI 10.1101/gad.1052503; BYERS S, 1991, AM J ANAT, V191, P35, DOI 10.1002/aja.1001910104; Chen C, 2005, NATURE, V436, P1030, DOI 10.1038/nature03894; Cheng CY, 2002, PHYSIOL REV, V82, P825, DOI 10.1152/physrev.00009.2002; de Kretser DM, 2004, MOL CELL ENDOCRINOL, V225, P57, DOI 10.1016/j.mce.2004.07.008; Ding Y, 2004, NUCLEIC ACIDS RES, V32, pW135, DOI 10.1093/nar/gkh449; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Falender AE, 2005, GENE DEV, V19, P794, DOI 10.1101/gad.1290105; Findlay JK, 2000, MOL CELL ENDOCRINOL, V163, P81, DOI 10.1016/S0303-7207(99)00243-9; Gnessi L, 2000, J CELL BIOL, V149, P1019, DOI 10.1083/jcb.149.5.1019; Greep RO, 1937, ENDOCRINOLOGY, V21, P611, DOI 10.1210/endo-21-5-611; Hammond SM, 2001, NAT REV GENET, V2, P110, DOI 10.1038/35052556; HARPER JW, 1993, CELL, V75, P805; HESS RA, 1993, ENDOCRINOLOGY, V132, P2607, DOI 10.1210/en.132.6.2607; Johnston H, 2004, ENDOCRINOLOGY, V145, P318, DOI 10.1210/en.2003-1055; JOYCE KL, 1993, J ANDROL, V14, P448; Kananen K, 1996, MOL ENDOCRINOL, V10, P1667, DOI 10.1210/me.10.12.1667; Kawai Y, 2011, REPRODUCTION, V141, P217, DOI 10.1530/REP-10-0006; KERR JB, 1992, CELL TISSUE RES, V268, P179, DOI 10.1007/BF00338067; Knight PG, 1996, FRONT NEUROENDOCRIN, V17, P476, DOI 10.1006/frne.1996.0013; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Looyenga BD, 2010, MOL ENDOCRINOL, V24, P608, DOI 10.1210/me.2008-0374; Loveland KL, 2007, INT J ANDROL, V30, P377, DOI 10.1111/j.1365-2605.2007.00785.x; Luisi S, 2005, HUM REPROD UPDATE, V11, P123, DOI 10.1093/humupd/dmh057; Mackay S, 2000, INT REV CYTOL, V200, P47, DOI 10.1016/S0074-7696(00)00002-4; Majdic G, 1997, ENDOCRINOLOGY, V138, P2136, DOI 10.1210/en.138.5.2136; MANN GE, 1992, J ENDOCRINOL, V133, P381, DOI 10.1677/joe.0.1330381; MANOVA K, 1993, DEV BIOL, V157, P85, DOI 10.1006/dbio.1993.1114; MARTIN TL, 1991, BIOL REPROD, V45, P73, DOI 10.1095/biolreprod45.1.73; MASON AJ, 1985, NATURE, V318, P659, DOI 10.1038/318659a0; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Mazerbourg S, 2005, J BIOL CHEM, V280, P32122, DOI 10.1074/jbc.M504629200; McLaren A, 2000, MOL CELL ENDOCRINOL, V163, P3, DOI 10.1016/S0303-7207(99)00234-8; Medras M, 2010, ENDOKRYNOL POL, V61, P695; Mehta MN, 2003, AM J REPROD IMMUNOL, V49, P42, DOI 10.1034/j.1600-0897.2003.01042.x; Morita K, 1999, J CELL BIOL, V145, P579, DOI 10.1083/jcb.145.3.579; MUNSTERBERG A, 1991, DEVELOPMENT, V113, P613; OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612; ORTH JM, 1988, ENDOCRINOLOGY, V122, P787, DOI 10.1210/endo-122-3-787; ROBERTS V, 1989, ENDOCRINOLOGY, V125, P2350, DOI 10.1210/endo-125-5-2350; RUSSELL LD, 1985, INT REV CYTOL, V94, P177, DOI 10.1016/S0074-7696(08)60397-6; SCHANBACHER BD, 1991, J ANIM SCI, V69, P252; Shen WG, 2004, CHINESE MED J-PEKING, V117, P1084; Sliva K, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-248; Spiliotis M, 2010, MOL BIOCHEM PARASIT, V174, P83, DOI 10.1016/j.molbiopara.2010.07.001; Vanamala J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-238; Voge JL, 2007, J ANIM SCI, V85, P3249, DOI 10.2527/jas.2007-0506; Yan W, 2000, J CELL SCI, V113, P161; Yao HHC, 2002, GENE DEV, V16, P1433, DOI 10.1101/gad.981202; Yomgogida K, 2008, DEV GROWTH DIFFER, V50, P513, DOI [10.1111/j.1440-169x.2008.01042.x, 10.1111/j.1440-169X.2008.01042.x]; Zhou WB, 2010, MOL CELL BIOCHEM, V343, P231, DOI 10.1007/s11010-010-0518-2	57	57	58	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25585	10.1371/journal.pone.0025585	http://dx.doi.org/10.1371/journal.pone.0025585			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998670	Green Published, Green Submitted, gold			2022-12-27	WOS:000295966900034
J	Cheng, S; Scigalla, FP; di Fenizio, PS; Zhang, ZG; Stolzenburg, JU; Neuhaus, J				Cheng, Sheng; Scigalla, Frank Peter; di Fenizio, Pietro Speroni; Zhang, Zhi Geng; Stolzenburg, Jens-Uwe; Neuhaus, Jochen			ATP Enhances Spontaneous Calcium Activity in Cultured Suburothelial Myofibroblasts of the Human Bladder	PLOS ONE			English	Article							URINARY-BLADDER; SMOOTH-MUSCLE; CONNEXIN EXPRESSION; RECEPTOR; CELLS; CONTRACTIONS; OSCILLATIONS	Background: Suburothelial myofibroblasts (sMF) are located underneath the urothelium in close proximity to afferent nerves. They express purinergic receptors and show calcium transients in response to ATP. Therefore they are supposed to be involved in afferent signaling of the bladder fullness. Since ATP concentration is likely to be very low during the initial filling phase, we hypothesized that sMF Ca2+ activity is affected even at very low ATP concentrations. We investigated ATP induced modulation of spontaneous activity, intracellular calcium response and purinergic signaling in cultured sMF. Methodology/Principal Findings: Myofibroblast cultures, established from cystectomies, were challenged by exogenous ATP in presence or absence of purinergic antagonist. Fura-2 calcium imaging was used to monitor ATP (10(-16) to 10(-4) mol/l) induced alterations of calcium activity. Purinergic receptors (P2X1, P2X2, P2X3) were analysed by confocal immunofluorescence. We found spontaneous calcium activity in 55.18% +/- 61.65 of the sMF (N = 48 experiments). ATP significantly increased calcium activity even at 10(-16) mol/l. The calcium transients were partially attenuated by subtype selective antagonist (TNP-ATP, 1 mu M; A-317491, 1 mu M), and were mimicked by the P2X1, P2X3 selective agonist alpha,beta-methylene ATP. The expression of purinergic receptor subtypes in sMF was confirmed by immunofluorescence. Conclusions/Significance: Our experiments demonstrate for the first time that ATP can modulate spontaneous activity and induce intracellular Ca2+ response in cultured sMF at very low concentrations, most likely involving P2X receptors. These findings support the notion that sMF are able to register bladder fullness very sensitively, which predestines them for the modulation of the afferent bladder signaling in normal and pathological conditions.	[Cheng, Sheng; Scigalla, Frank Peter; Stolzenburg, Jens-Uwe; Neuhaus, Jochen] Univ Leipzig, Dept Urol, Leipzig, Germany; [Cheng, Sheng; Zhang, Zhi Geng] Zhejiang Univ, Dept Urol, Sir Run Run Shaw Hosp, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China; [di Fenizio, Pietro Speroni] Univ Coimbra, CISUC, Dept Informat Engn, Coimbra, Portugal	Leipzig University; Zhejiang University; Universidade de Coimbra	Cheng, S (corresponding author), Univ Leipzig, Dept Urol, Leipzig, Germany.	jochen.neuhaus@medizin.uni-leipzig.de	cheng, sheng/HHD-0386-2022	Speroni di Fenizio, Pietro/0000-0001-9909-8068	Deutsche Forschungsgemeinschaft (DFG) [NE425/4-4]; Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou, China	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou, China	This work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG) (JN:NE425/4-4) and Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou, China (SC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akino H, 2008, BJU INT, V102, P1168, DOI 10.1111/j.1464-410X.2008.07782.x; Birder LA, 2002, NAT NEUROSCI, V5, P856, DOI 10.1038/nn902; CHEN CC, 1995, NATURE, V377, P428, DOI 10.1038/377428a0; Drake MJ, 2003, EXP PHYSIOL, V88, P19, DOI 10.1113/eph8802473; Ferguson DR, 1997, J PHYSIOL-LONDON, V505, P503, DOI 10.1111/j.1469-7793.1997.503bb.x; Fry CH, 2007, NEUROUROL URODYNAM, V26, P914, DOI 10.1002/nau.20483; Heinrich M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020792; Ikeda Y, 2007, AM J PHYSIOL-RENAL, pF1018; Jarvis MF, 2009, NEUROPHARMACOLOGY, V56, P208, DOI 10.1016/j.neuropharm.2008.06.067; Lee HY, 2000, J UROLOGY, V163, P2002, DOI 10.1016/S0022-5347(05)67618-5; Liu F, 2009, INT J UROL, V16, P570, DOI 10.1111/j.1442-2042.2009.02307.x; Mahoney MG, 1998, BIOPHYS J, V75, P2050, DOI 10.1016/S0006-3495(98)77647-7; McCloskey KD, 2010, NEUROUROL URODYNAM, V29, P82, DOI 10.1002/nau.20739; Meng F, 2007, J CELL PHYSIOL, V213, P79, DOI 10.1002/jcp.21092; Mills IW, 2000, J UROLOGY, V163, P646, DOI 10.1016/S0022-5347(05)67951-7; Neuhaus J, 2008, UROLOGE, V47, P1085, DOI 10.1007/s00120-008-1817-z; Neuhaus J, 2007, UROLOGE, V46, P1197, DOI 10.1007/s00120-007-1480-9; Neuhaus J, 2005, BJU INT, V96, P670, DOI 10.1111/j.1464-410X.2005.05703.x; North RA, 2000, ANNU REV PHARMACOL, V40, P563, DOI 10.1146/annurev.pharmtox.40.1.563; Oger S, 2010, BJU INT; Ralevic V, 1998, PHARMACOL REV, V50, P413; Roosen A, 2009, EUR UROL, V55, P1440, DOI 10.1016/j.eururo.2008.11.009; Streng T, 2006, BJU INT, V97, P1094, DOI 10.1111/j.1464-410X.2006.06137.x; Sui G, 2009, CELL CALCIUM, V45, P456, DOI 10.1016/j.ceca.2009.03.001; Sui GP, 2002, BJU INT, V90, P118, DOI 10.1046/j.1464-410X.2002.02834.x; Sui GP, 2008, AM J PHYSIOL-RENAL, V295, pF688, DOI 10.1152/ajprenal.00133.2008; Sui GP, 2006, BJU INT, V97, P1327, DOI 10.1111/j.1464-410X.2006.06200.x; VALERA S, 1994, NATURE, V371, P516, DOI 10.1038/371516a0; Vlaskovska M, 2001, J NEUROSCI, V21, P5670, DOI 10.1523/JNEUROSCI.21-15-05670.2001; Wiseman OJ, 2003, BJU INT, V91, P89, DOI 10.1046/j.1464-410X.2003.03802.x; Wu C, 2004, J PHYSIOL-LONDON, V559, P231, DOI 10.1113/jphysiol.2004.067934	31	17	18	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25769	10.1371/journal.pone.0025769	http://dx.doi.org/10.1371/journal.pone.0025769			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998694	Green Published, Green Submitted, gold			2022-12-27	WOS:000295966900054
J	Danilov, SM; Gordon, K; Nesterovitch, AB; Lunsdorf, H; Chen, ZL; Castellon, M; Popova, IA; Kalinin, S; Mendonca, E; Petukhov, PA; Schwartz, DE; Minshall, RD; Sturrock, ED				Danilov, Sergei M.; Gordon, Kerry; Nesterovitch, Andrew B.; Luensdorf, Heinrich; Chen, Zhenlong; Castellon, Maricela; Popova, Isolda A.; Kalinin, Sergey; Mendonca, Emma; Petukhov, Pavel A.; Schwartz, David E.; Minshall, Richard D.; Sturrock, Edward D.			An Angiotensin I-Converting Enzyme Mutation (Y465D) Causes a Dramatic Increase in Blood ACE via Accelerated ACE Shedding	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; N-DOMAIN; CELL-SURFACE; ENDOTHELIAL-CELLS; CRYSTAL-STRUCTURE; TERMINAL DOMAIN; SERUM; SARCOIDOSIS; LOCALIZATION; ELEVATION	Background: Angiotensin I-converting enzyme (ACE) metabolizes a range of peptidic substrates and plays a key role in blood pressure regulation and vascular remodeling. Thus, elevated ACE levels may be associated with an increased risk for different cardiovascular or respiratory diseases. Previously, a striking familial elevation in blood ACE was explained by mutations in the ACE juxtamembrane region that enhanced the cleavage-secretion process. Recently, we found a family whose affected members had a 6-fold increase in blood ACE and a Tyr465Asp (Y465D) substitution, distal to the stalk region, in the N domain of ACE. Methodology/Principal Findings: HEK and CHO cells expressing mutant (Tyr465Asp) ACE demonstrate a 3- and 8-fold increase, respectively, in the rate of ACE shedding compared to wild-type ACE. Conformational fingerprinting of mutant ACE demonstrated dramatic changes in ACE conformation in several different epitopes of ACE. Cell ELISA carried out on CHO-ACE cells also demonstrated significant changes in local ACE conformation, particularly proximal to the stalk region. However, the cleavage site of the mutant ACE - between Arg1203 and Ser1204 - was the same as that of WT ACE. The Y465D substitution is localized in the interface of the N-domain dimer (from the crystal structure) and abolishes a hydrogen bond between Tyr465 in one monomer and Asp462 in another. Conclusions/Significance: The Y465D substitution results in dramatic increase in the rate of ACE shedding and is associated with significant local conformational changes in ACE. These changes could result in increased ACE dimerization and accessibility of the stalk region or the entire sACE, thus increasing the rate of cleavage by the putative ACE secretase (sheddase).	[Danilov, Sergei M.; Castellon, Maricela; Kalinin, Sergey; Schwartz, David E.; Minshall, Richard D.] Univ Illinois, Dept Anesthesiol, Chicago, IL 60680 USA; [Danilov, Sergei M.] Univ Illinois, Inst Personalized Med, Chicago, IL USA; [Gordon, Kerry; Sturrock, Edward D.] Univ Cape Town, Inst Infect Dis & Mol Med, Div Med Biochem, ZA-7925 Cape Town, South Africa; [Nesterovitch, Andrew B.] Rush Univ, Dept Dermatol, Chicago, IL 60612 USA; [Luensdorf, Heinrich] Helmholtz Ctr Infect Res, Dept Vaccinol & Appl Microbiol, Braunschweig, Germany; [Chen, Zhenlong; Castellon, Maricela; Minshall, Richard D.] Univ Illinois, Dept Pharmacol, Chicago, IL USA; [Popova, Isolda A.] Northwestern Univ, Chem Life Proc Inst, Evanston, IL USA; [Mendonca, Emma] Univ Illinois, Dept Bioengn, Chicago, IL USA; [Petukhov, Pavel A.] Univ Illinois, Coll Pharm, Dept Med Chem & Pharmacognosy, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Cape Town; Rush University; Helmholtz Association; Helmholtz-Center for Infection Research; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Northwestern University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Danilov, SM (corresponding author), Univ Illinois, Dept Anesthesiol, Chicago, IL 60680 USA.	danilov@uic.edu	Nesterovitch, Andrew/K-7286-2014; Chen, Zhenlong/AAQ-9578-2021	Nesterovitch, Andrew/0000-0002-9508-5363; 	South African National Research Foundation; German Academic Exchange; National Institutes of Health [P41 RR001081]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER	South African National Research Foundation(National Research Foundation - South Africa); German Academic Exchange(Deutscher Akademischer Austausch Dienst (DAAD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Partial funding was provided by South African National Research Foundation, the German Academic Exchange. Molecular graphics images were produced using the University of California San Francisco Chimera package from the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by National Institutes of Health P41 RR001081). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony CS, 2010, J BIOL CHEM, V285, P35685, DOI 10.1074/jbc.M110.167866; Balyasnikova IV, 2008, TISSUE ANTIGENS, V72, P354, DOI 10.1111/j.1399-0039.2008.01112.x; Balyasnikova IV, 2007, J PROTEOME RES, V6, P1580, DOI 10.1021/pr060658x; Balyasnikova IV, 2005, J PROTEOME RES, V4, P258, DOI 10.1021/pr049859w; Balyasnikova IV, 2005, HYBRIDOMA, V24, P14, DOI 10.1089/hyb.2005.24.14; Balyasnikova IV, 2003, TISSUE ANTIGENS, V61, P49, DOI 10.1034/j.1399-0039.2003.610104.x; Balyasnikova IV, 2002, BIOCHEM J, V362, P585, DOI 10.1042/0264-6021:3620585; Balyasnikova IV, 1999, TUMOR TARGET, V4, P70; Balyasnikova IV, 1998, IN VITRO CELL DEV-AN, V34, P545; BENETEAUBURNAT B, 1991, CRIT REV CL LAB SCI, V28, P337, DOI 10.3109/10408369109106868; Bernstein KE, 2005, CIRC RES, V96, P1135, DOI 10.1161/01.RES.0000169536.73576.66; BRUNEVAL P, 1986, HISTOCHEMISTRY, V85, P73, DOI 10.1007/BF00508656; CALDWELL PRB, 1976, SCIENCE, V191, P1050, DOI 10.1126/science.175444; Chen HL, 2010, MICRON, V41, P674, DOI 10.1016/j.micron.2010.01.005; CHING SF, 1983, ARTERIOSCLEROSIS, V3, P581, DOI 10.1161/01.ATV.3.6.581; Chubb AJ, 2002, BIOCHEM BIOPH RES CO, V297, P1225, DOI 10.1016/S0006-291X(02)02324-0; Corradi HR, 2006, J MOL BIOL, V357, P964, DOI 10.1016/j.jmb.2006.01.048; Corvol P., 2004, HDB PROTEOLYTIC ENZY, V1, P332, DOI DOI 10.1016/B978-0-12-079611-3.50090-2; COSTEROUSSE O, 1993, BIOCHEM J, V290, P33, DOI 10.1042/bj2900033; DANILOV S, 1994, J BIOL CHEM, V269, P26806; Danilov S, 1996, J HYPERTENS, V14, P719, DOI 10.1097/00004872-199606000-00007; Danilov SM, 2007, BIOCHEMISTRY-US, V46, P9019, DOI 10.1021/bi700489v; Danilov SM, 2010, J PROTEOME RES, V9, P5782, DOI 10.1021/pr100564r; Danilov SM, 2005, CLIN CHEM, V51, P1040, DOI 10.1373/clinchem.2004.045633; Danilov SM, 2003, EXP HEMATOL, V31, P1301, DOI 10.1016/j.exphem.2003.08.018; Danilov SM, 2001, AM J PHYSIOL-LUNG C, V280, pL1335, DOI 10.1152/ajplung.2001.280.6.L1335; DEFENDINI R, 1983, NEUROENDOCRINOLOGY, V37, P32, DOI 10.1159/000123512; EHLERS MRW, 1989, BIOCHEMISTRY-US, V28, P5311, DOI 10.1021/bi00439a001; Eyries M, 2001, J BIOL CHEM, V276, P5525, DOI 10.1074/jbc.M007706200; Franke FE., 1997, LEUCOCYTE TYPING, P749; FRIEDLAND J, 1976, AM J CLIN PATHOL, V66, P416; Gordon K, 2010, TISSUE ANTIGENS, V75, P136, DOI 10.1111/j.1399-0039.2009.01416.x; HOOPER NM, 1987, BIOCHEM J, V241, P625, DOI 10.1042/bj2410625; HOOPER NM, 1987, BIOCHEM J, V247, P85, DOI 10.1042/bj2470085; JASPARD E, 1995, BIOCHEM BIOPH RES CO, V211, P528, DOI 10.1006/bbrc.1995.1845; Kishimoto, 1997, LEUCOCYTE TYPING, P746; Kohlstedt K, 2006, MOL PHARMACOL, V69, P1725, DOI 10.1124/mol.105.020636; Kost OA, 2003, BIOCHEMISTRY-US, V42, P6965, DOI 10.1021/bi034645y; Kramers C, 2003, Ned Tijdschr Geneeskd, V147, P473; Kramers C, 2001, CIRCULATION, V104, P1236, DOI 10.1161/hc3601.095932; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LIEBERMAN J, 1976, NEW ENGL J MED, V294, P1442, DOI 10.1056/NEJM197606242942609; LIEBERMAN J, 1989, CLIN LAB MED, V9, P745, DOI 10.1016/S0272-2712(18)30602-4; LIEBERMAN J, 1975, AM J MED, V59, P365, DOI 10.1016/0002-9343(75)90395-2; Linnebank M, 2003, NEUROLOGY, V61, P1819, DOI 10.1212/01.WNL.0000098990.12845.DA; Metzger R, 2011, MICROVASC RES, V81, P206, DOI 10.1016/j.mvr.2010.12.003; Naperova IA, 2008, J PROTEOME RES, V7, P3396, DOI 10.1021/pr800142w; Natesh R, 2003, NATURE, V421, P551, DOI 10.1038/nature01370; Nesterovitch AB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008282; Parkin ET, 2004, PROTEIN PEPTIDE LETT, V11, P423, DOI 10.2174/0929866043406544; Pauls K, 2003, ANDROLOGIA, V35, P32, DOI 10.1046/j.1439-0272.2003.00535.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PIQUILLO.Y, 1970, BIOCHIM BIOPHYS ACTA, V206, P136, DOI 10.1016/0005-2744(70)90090-2; RYAN US, 1976, TISSUE CELL, V8, P125, DOI 10.1016/0040-8166(76)90025-2; Semmler A, 2006, CLIN CHEM LAB MED, V44, P1088, DOI 10.1515/CCLM.2006.200; SIBONY M, 1993, HYPERTENSION, V21, P827, DOI 10.1161/01.HYP.21.6.827; SILVERSTEIN E, 1978, ISRAEL J MED SCI, V14, P314; SILVERSTEIN E, 1976, ANN NY ACAD SCI, V278, P498, DOI 10.1111/j.1749-6632.1976.tb47062.x; SKIDGEL RA, 1993, RENIN ANGIOTENSIN SY; Skirgello OE, 2006, BIOCHEMISTRY-US, V45, P4831, DOI 10.1021/bi052591h; SOUBRIER F, 1988, P NATL ACAD SCI USA, V85, P9386, DOI 10.1073/pnas.85.24.9386; WEI L, 1991, J BIOL CHEM, V266, P5540; Woodman ZL, 2000, BIOCHEM J, V347, P711, DOI 10.1042/0264-6021:3470711	63	34	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25952	10.1371/journal.pone.0025952	http://dx.doi.org/10.1371/journal.pone.0025952			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998728	Green Submitted, Green Published, gold			2022-12-27	WOS:000295966900079
J	Xiong, Y; Zhang, L; Holloway, AK; Wu, XL; Su, L; Kebebew, E				Xiong, Yin; Zhang, Lisa; Holloway, Alisha K.; Wu, Xiaolin; Su, Ling; Kebebew, Electron			MiR-886-3p Regulates Cell Proliferation and Migration, and Is Dysregulated in Familial Non-Medullary Thyroid Cancer	PLOS ONE			English	Article							CDNA MICROARRAY DATA; SUSCEPTIBILITY LOCUS; LINKAGE ANALYSIS; EXPRESSION; CARCINOMA; ZYXIN; TUMORS; PREDISPOSITION; NORMALIZATION; REPLICATION	Background: The molecular basis and characteristics of familial non-medullary thyroid cancer are poorly understood. In this study, we performed microRNA (miRNA) profiling of familial and sporadic papillary thyroid cancer tumor samples. Methodology/Principal Findings: Genome wide miRNA profiling of sporadic and familial papillary thyroid cancer was performed. Differentially expressed miRNAs were validated by quantitative RT-PCR. Ectopic expression of miR-886-3p in thyroid cancer lines was performed to identify pathways targeted by the miRNA, as well as, to determine its effect on tumor cell biology. We found four differentially expressed miRNAs between familial and sporadic papillary thyroid cancer tumor samples. MiR-886-3p and miR-20a were validated to be differentially expressed by 3- and 4-fold, respectively. Pathway analysis of genome-wide expression data on cells overexpressing miR-886-3p and target prediction analysis showed genes involved in DNA replication and focal adhesion pathways were regulated by miR-886-3p. Overexpression of miR-886-3p in thyroid cancer cell lines significantly inhibited cellular proliferation, the number and size of spheroids and cellular migration. Additionally, overexpression of miR-886-3p increased the number of cells in S phase. Conclusions/Significance: Our findings for the first time suggest that miR-886-3p plays an important role in thyroid cancer tumor cell biology and regulates genes involved in DNA replication and focal adhesion. Thus, miR-886-3p may play a role in the initiation and or progression of papillary thyroid cancer.	[Xiong, Yin; Zhang, Lisa; Kebebew, Electron] NCI, Endocrine Oncol Sect, Surg Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Holloway, Alisha K.] Univ Calif San Francisco, Gladstone Inst, San Francisco, CA 94143 USA; [Wu, Xiaolin; Su, Ling] NCI, Lab Mol Technol, Sci Applicat Int Coorporat Frederick Inc, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California San Francisco; The J David Gladstone Institutes; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Xiong, Y (corresponding author), NCI, Endocrine Oncol Sect, Surg Branch, Ctr Canc Res, Bethesda, MD 20892 USA.	kebebewe@mail.nih.gov	Holloway, Alisha/H-9574-2013	Holloway, Alisha/0000-0001-9810-389X	National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC011275, ZIABC011287] Funding Source: NIH RePORTER	National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by the Intramural Research Program of the National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcinas A, 2009, J PROTEOME RES, V8, P3958, DOI 10.1021/pr900278c; Avissar M, 2009, CLIN CANCER RES, V15, P2850, DOI 10.1158/1078-0432.CCR-08-3131; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonora E, 2006, BRIT J CANCER, V95, P1529, DOI 10.1038/sj.bjc.6603455; Borlado LR, 2008, CARCINOGENESIS, V29, P237, DOI 10.1093/carcin/bgm268; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Canzian F, 1998, AM J HUM GENET, V63, P1743, DOI 10.1086/302164; Cattaruzza M, 2004, HYPERTENSION, V43, P726, DOI 10.1161/01.HYP.0000119189.82659.52; Cavaco BM, 2008, ENDOCR-RELAT CANCER, V15, P207, DOI 10.1677/ERC-07-0214; Cavaco BM, 2008, J CLIN ENDOCR METAB, V93, P4426, DOI 10.1210/jc.2008-0449; Chen AY, 2009, CANCER-AM CANCER SOC, V115, P3801, DOI 10.1002/cncr.24416; Clay-Farrace L, 2003, EMBO J, V22, P704, DOI 10.1093/emboj/cdg046; Decraene C, 2004, BIOCHEM BIOPH RES CO, V318, P439, DOI 10.1016/j.bbrc.2004.04.047; Fan XX, 2010, ACTA BIOCH BIOPH SIN, V42, P318, DOI 10.1093/abbs/gmq026; Frich L, 2001, CANCER EPIDEM BIOMAR, V10, P113; Guo JM, 2009, J GASTROEN HEPATOL, V24, P652, DOI 10.1111/j.1440-1746.2008.05666.x; He HL, 2009, CANCER RES, V69, P625, DOI 10.1158/0008-5472.CAN-08-1071; Hemminki K, 2004, INT J CANCER, V108, P109, DOI 10.1002/ijc.11478; Hervy M, 2006, CURR OPIN CELL BIOL, V18, P524, DOI 10.1016/j.ceb.2006.08.006; Hu ZB, 2010, J CLIN ONCOL, V28, P1721, DOI 10.1200/JCO.2009.24.9342; Hui ABY, 2010, CLIN CANCER RES, V16, P1129, DOI 10.1158/1078-0432.CCR-09-2166; Ito Y, 2009, SURGERY, V145, P100, DOI 10.1016/j.surg.2008.08.004; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Joglekar MV, 2009, GENE EXPR PATTERNS, V9, P109, DOI 10.1016/j.gep.2008.10.001; Kebebew E, 1999, J CLIN ENDOCR METAB, V84, P2840, DOI 10.1210/jc.84.8.2840; Lupoli G, 1999, LANCET, V353, P637, DOI 10.1016/S0140-6736(98)08004-0; McKay JD, 2004, J MED GENET, V41, P407, DOI 10.1136/jmg.2003.017350; Menon MP, 2009, J CLIN PATHOL, V62, P978, DOI 10.1136/jcp.2008.063909; Mori M, 2009, MOL BIOL CELL, V20, P3115, DOI 10.1091/mbc.E09-01-0046; Moses W, 2011, THYROID, V21, P367, DOI 10.1089/thy.2010.0256; Motoyama K, 2009, INT J ONCOL, V34, P1069, DOI 10.3892/ijo_00000233; Pesta M, 2010, ANTICANCER RES, V30, P3579; Prazeres HJ, 2008, FAM CANCER, V7, P141, DOI 10.1007/s10689-007-9160-x; Robenshtok E, 2011, THYROID, V21, P43, DOI 10.1089/thy.2009.0406; RON E, 1991, ONCOLOGY, V48, P309; Schweppe RE, 2008, J CLIN ENDOCR METAB, V93, P4331, DOI 10.1210/jc.2008-1102; Sheu SY, 2010, BRIT J CANCER, V102, P376, DOI 10.1038/sj.bjc.6605493; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Suh I, 2009, SURGERY, V146, P1073, DOI 10.1016/j.surg.2009.09.012; Theodore SC, 2010, ETHN DIS, V20; van Staveren WCG, 2009, BBA-REV CANCER, V1795, P92, DOI 10.1016/j.bbcan.2008.12.004; Vriens MR, 2009, THYROID, V19, P1343, DOI 10.1089/thy.2009.1607; Wang M, 2008, J PATHOL, V215, P13, DOI 10.1002/path.2333; Xu WW, 2010, IMMUNITY, V33, P340, DOI 10.1016/j.immuni.2010.08.015; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yu YP, 2006, CANCER RES, V66, P7414, DOI 10.1158/0008-5472.CAN-06-0227; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792	49	37	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e24717	10.1371/journal.pone.0024717	http://dx.doi.org/10.1371/journal.pone.0024717			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998631	Green Submitted, gold, Green Published			2022-12-27	WOS:000295966900004
J	Haider, AJ; Briggs, D; Self, TJ; Chilvers, HL; Holliday, ND; Kerr, ID				Haider, Ameena J.; Briggs, Deborah; Self, Tim J.; Chilvers, Hannah L.; Holliday, Nicholas D.; Kerr, Ian D.			Dimerization of ABCG2 Analysed by Bimolecular Fluorescence Complementation	PLOS ONE			English	Article							CANCER RESISTANCE PROTEIN; ATP-BINDING; MULTIDRUG-RESISTANCE; TRANSPORTER ABCG2; MUTATIONAL ANALYSIS; DISULFIDE BOND; BCRP/ABCG2; DOMAIN; IDENTIFICATION; LOCALIZATION	ABCG2 is one of three human ATP binding cassette transporters that are functionally capable of exporting a diverse range of substrates from cells. The physiological consequence of ABCG2 multidrug transport activity in leukaemia, and some solid tumours is the acquisition of cancer multidrug resistance. ABCG2 has a primary structure that infers that a minimal functional transporting unit would be a homodimer. Here we investigated the ability of a bimolecular fluorescence complementation approach to examine ABCG2 dimers, and to probe the role of individual amino acid substitutions in dimer formation. ABCG2 was tagged with fragments of venus fluorescent protein (vYFP), and this tagging did not perturb trafficking or function. Co-expression of two proteins bearing N-terminal and C-terminal fragments of YFP resulted in their association and detection of dimerization by fluorescence microscopy and flow cytometry. Point mutations in ABCG2 which may affect dimer formation were examined for alterations in the magnitude of fluorescence complementation signal. Bimolecular fluorescence complementation (BiFC) demonstrated specific ABCG2 dimer formation, but no changes in dimer formation, resulting from single amino acid substitutions, were detected by BiFC analysis.	[Haider, Ameena J.; Briggs, Deborah; Self, Tim J.; Chilvers, Hannah L.; Holliday, Nicholas D.; Kerr, Ian D.] Univ Nottingham, Sch Biomed Sci, Nottingham NG7 2RD, England	University of Nottingham	Haider, AJ (corresponding author), Univ Nottingham, Sch Biomed Sci, Nottingham NG7 2RD, England.	Ian.kerr@nottingham.ac.uk	Kerr, Ian D/B-3803-2015	Kerr, Ian D/0000-0002-7544-8454; Holliday, Nicholas/0000-0002-2900-828X	Government of Kuwait; BBSRC; Biochemical Society; Medical Research Council [G0700049] Funding Source: researchfish; MRC [G0700049] Funding Source: UKRI	Government of Kuwait; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biochemical Society; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding for this study came from a PhD scholarship award from the Government of Kuwait to AJH, a BBSRC summer vacation bursary to HLC, and a Biochemical Society Guildford Bench Methodology Fund award to IDK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatia A, 2005, BIOCHEMISTRY-US, V44, P10893, DOI 10.1021/bi0503807; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Clark R, 2006, BRIT J PHARMACOL, V149, P506, DOI 10.1038/sj.bjp.0706904; Cooray HC, 2002, NEUROREPORT, V13, P2059, DOI 10.1097/00001756-200211150-00014; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Godbey WT, 1999, J CONTROL RELEASE, V60, P149, DOI 10.1016/S0168-3659(99)00090-5; Hegedus C, 2008, ADV DRUG DELIV REV; Henriksen U, 2005, J BIOL CHEM, V280, P36926, DOI 10.1074/jbc.M502937200; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Hou YX, 2009, BIOCHEMISTRY-US, V48, P9122, DOI 10.1021/bi900675v; Kage K, 2005, CANCER SCI, V96, P866, DOI 10.1111/j.1349-7006.2005.00126.x; KERPPOLA RE, 1992, J BIOL CHEM, V267, P2329; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Kerr ID, 2010, FEBS J, V277, P550, DOI 10.1111/j.1742-4658.2009.07486.x; Kerr ID, 2011, BR J PHARM; Kilpatrick LE, 2010, BRIT J PHARMACOL, V160, P892, DOI 10.1111/j.1476-5381.2010.00676.x; Kodama Y, 2010, BIOTECHNIQUES, V49, P793, DOI 10.2144/000113519; Lawson J, 2008, BBA-BIOMEMBRANES, V1778, P376, DOI 10.1016/j.bbamem.2007.10.021; Liu Y, 2008, J PHARMACOL EXP THER, V326, P33, DOI 10.1124/jpet.108.138115; Maliepaard M, 2001, CANCER RES, V61, P3458; McDevitt CA, 2008, FEBS J, V275, P4354, DOI 10.1111/j.1742-4658.2008.06578.x; McDevitt CA, 2009, ADV DRUG DELIVER REV, V61, P57, DOI 10.1016/j.addr.2008.07.004; McFarlane HE, 2010, PLANT CELL, V22, P3066, DOI 10.1105/tpc.110.077974; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Ni Zhanglin, 2010, Int J Biochem Mol Biol, V1, P1; Oswald C, 2006, N-S ARCH PHARMACOL, V372, P385, DOI 10.1007/s00210-005-0031-4; Polgar O, 2004, BIOCHEMISTRY-US, V43, P9448, DOI 10.1021/bi0497953; Polgar O, 2006, BIOCHEMISTRY-US, V45, P5251, DOI 10.1021/bi0521590; Polgar O, 2010, BIOCHEMISTRY-US, V49, P2235, DOI 10.1021/bi902085q; Popot JL, 2000, ANNU REV BIOCHEM, V69, P881, DOI 10.1146/annurev.biochem.69.1.881; Pozza A, 2006, CELL MOL LIFE SCI, V63, P1912, DOI 10.1007/s00018-006-6159-7; Rabindran SK, 2000, CANCER RES, V60, P47; Robey RW, 2001, BBA-BIOMEMBRANES, V1512, P171, DOI 10.1016/S0005-2736(01)00308-X; Robida AM, 2009, J MOL BIOL, V394, P391, DOI 10.1016/j.jmb.2009.08.069; Rose RH, 2010, BRIT J PHARMACOL, V159, P738, DOI 10.1111/j.1476-5381.2009.00480.x; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Storm J, 2007, BIOCHEMISTRY-US, V46, P9899, DOI 10.1021/bi700447p; Takada T, 2005, PHARM RES-DORDR, V22, P458, DOI 10.1007/s11095-004-1884-9; Tombline G, 2005, BIOCHEMISTRY-US, V44, P12879, DOI 10.1021/bi0509797; Wakabayashi K, 2007, J BIOL CHEM, V282, P27841, DOI 10.1074/jbc.C700133200; Wakabayashi K, 2006, J EXP THER ONCOL, V5, P205; Wang HG, 2008, BIOCHEMISTRY-US, V47, P13778, DOI 10.1021/bi801644v; Xie Y, 2008, J BIOL CHEM, V283, P3349, DOI 10.1074/jbc.M707773200; Yang JY, 2010, NATURE, V467, P465, DOI 10.1038/nature09357	48	21	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25818	10.1371/journal.pone.0025818	http://dx.doi.org/10.1371/journal.pone.0025818			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991363	Green Published, gold, Green Submitted			2022-12-27	WOS:000295943000079
J	Hibert, F; Sabatier, D; Andrivot, J; Scotti-Saintagne, C; Gonzalez, S; Prevost, MF; Grenand, P; Chave, J; Caron, H; Richard-Hansen, C				Hibert, Fabrice; Sabatier, Daniel; Andrivot, Judith; Scotti-Saintagne, Caroline; Gonzalez, Sophie; Prevost, Marie-Francoise; Grenand, Pierre; Chave, Jerome; Caron, Henri; Richard-Hansen, Cecile			Botany, Genetics and Ethnobotany: A Crossed Investigation on the Elusive Tapir's Diet in French Guiana	PLOS ONE			English	Article							TRADITIONAL ECOLOGICAL KNOWLEDGE; SEED-DISPERSAL; TROPICAL FORESTS; DNA-SEQUENCES; HABITAT USE; CONSERVATION; RECRUITMENT; TERRESTRIS; STRATEGIES; COMMUNITY	While the populations of large herbivores are being depleted in many tropical rainforests, the importance of their trophic role in the ecological functioning and biodiversity of these ecosystems is still not well evaluated. This is due to the outstanding plant diversity that they feed upon and the inherent difficulties involved in observing their elusive behaviour. Classically, the diet of elusive tropical herbivores is studied through the observation of browsing signs and macroscopic analysis of faeces or stomach contents. In this study, we illustrate that the original coupling of classic methods with genetic and ethnobotanical approaches yields information both about the diet diversity, the foraging modalities and the potential impact on vegetation of the largest terrestrial mammal of Amazonia, the lowland tapir. The study was conducted in the Guianan shield, where the ecology of tapirs has been less investigated. We identified 92 new species, 51 new genera and 13 new families of plants eaten by tapirs. We discuss the relative contribution of our different approaches, notably the contribution of genetic barcoding, used for the first time to investigate the diet of a large tropical mammal, and how local traditional ecological knowledge is accredited and valuable for research on the ecology of elusive animals.	[Hibert, Fabrice; Andrivot, Judith; Richard-Hansen, Cecile] Off Natl Chasse & Faune Sauvage, Direct Etud & Rech Guyane, Kourou, French Guiana; [Sabatier, Daniel; Gonzalez, Sophie; Prevost, Marie-Francoise] IRD, UMR AMAP, Herbier Guyane, Cayenne, French Guiana; [Sabatier, Daniel] IRD, UMR AMAP, Montpellier, France; [Grenand, Pierre] OHM Oyapock CNRS, UPS IRD 3188, Cayenne, French Guiana; [Andrivot, Judith; Scotti-Saintagne, Caroline] INRA, UMR EcoFoG 0745, Kourou, French Guiana; [Chave, Jerome] Univ Toulouse 3, CNRS, UMR 5174, Lab Evolut & Divers Biol, F-31062 Toulouse, France; [Caron, Henri] Univ Bordeaux, INRA, BIOGECO UMR1202, Cestas, France	Institut de Recherche pour le Developpement (IRD); CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); INRAE; UDICE-French Research Universities; Universite de Bordeaux	Hibert, F (corresponding author), Off Natl Chasse & Faune Sauvage, Direct Etud & Rech Guyane, Kourou, French Guiana.	fabricenz@gmail.com	Scotti-Saintagne, Caroline/C-3119-2009; Gonzalez, Sophie/U-1674-2017; Sabatier, Daniel/D-9117-2011; Scotti-Saintagne, Caroline/AAC-1938-2020	Gonzalez, Sophie/0000-0003-4109-2004; Scotti-Saintagne, Caroline/0000-0001-6891-7315; Richard-Hansen, Cecile/0000-0002-9353-791X; Sabatier, Daniel/0000-0003-0883-1530				AGRAWAL A, 1995, DEV CHANGE, V26, P413, DOI 10.1111/j.1467-7660.1995.tb00560.x; Aublet JBCF, 1775, HIST PLANTES GUYANE, P327; Beck H, 2006, J MAMMAL, V87, P519, DOI 10.1644/05-MAMM-A-174R1.1; Berkes F, 2000, ECOL APPL, V10, P1251, DOI 10.1890/1051-0761(2000)010[1251:ROTEKA]2.0.CO;2; Biegert A, 2010, NUCLEIC ACIDS RES, V34, pW335; BODMER RE, 1991, OECOLOGIA, V85, P361, DOI 10.1007/BF00320611; BODMER RE, 1990, J ZOOL, V222, P121, DOI 10.1111/j.1469-7998.1990.tb04034.x; BODMER RE, 1991, BIOTROPICA, V23, P255, DOI 10.2307/2388202; BONGERS F, 2001, NOURAGUES DYNAMICS P; Bradford MG, 2008, BIOTROPICA, V40, P338, DOI 10.1111/j.1744-7429.2007.00372.x; Bradley BJ, 2007, AM J PRIMATOL, V69, P699, DOI 10.1002/ajp.20384; Calix M., 2018, EUROPEAN RED LIST SA; Campos-Arceiz A, 2008, ECOL RES, V23, P1057, DOI 10.1007/s11284-008-0466-4; Coley PD, 2005, ECOLOGY, V86, P2633, DOI 10.1890/04-1283; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; COLWELL R. K, 2009, ESTIMATES STAT ESTIM; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; Corlett RT, 2007, BIOTROPICA, V39, P292, DOI 10.1111/j.1744-7429.2007.00271.x; Costa-Neto EM, 2000, INTERCIENCIA, V25, P423; de Thoisy B, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-278; Deagle BE, 2010, CONSERV GENET, V11, P2039, DOI 10.1007/s10592-010-0096-6; Deagle BE, 2009, MOL ECOL, V18, P2022, DOI 10.1111/j.1365-294X.2009.04158.x; DIRZO R, 1990, CONSERV BIOL, V4, P444, DOI 10.1111/j.1523-1739.1990.tb00320.x; Fazekas AJ, 2009, MOL ECOL RESOUR, V9, P130, DOI 10.1111/j.1755-0998.2009.02652.x; FEER F, 1995, J TROP ECOL, V11, P683, DOI 10.1017/S0266467400009238; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Foerster CR, 2002, BIOTROPICA, V34, P423, DOI 10.1111/j.1744-7429.2002.tb00556.x; Forget PM, 2007, CONSERV BIOL, V21, P106, DOI 10.1111/j.1523-1739.2006.00590.x; Fragoso JMV, 1997, J ECOL, V85, P519, DOI 10.2307/2960574; Fragoso JMV, 2003, ECOLOGY, V84, P1998, DOI 10.1890/01-0621; Fragoso JMV, 2000, J TROP ECOL, V16, P369, DOI 10.1017/S0266467400001462; FREELAND WJ, 1974, AM NAT, V108, P269, DOI 10.1086/282907; Freeman M.M., 1992, N PERSPECT, V20, P9; Funk V.A., 2007, CONTRIB U S NATL HER, V55, P1; GADGIL M, 1993, AMBIO, V22, P151; Galetti M, 2001, BIOTROPICA, V33, P723, DOI 10.1111/j.1744-7429.2001.tb00232.x; Gayot M, 2004, J TROP ECOL, V20, P31, DOI 10.1017/S0266467404006157; Giombini MI, 2009, BIOTROPICA, V41, P408, DOI 10.1111/j.1744-7429.2009.00526.x; Gonzalez MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007483; Grenand F, 2008, PEUT ON CLASSER VIVA, P119; GRENAND P, 1993, MAN BIOSPH, V13, P425; GRENAND P, 1992, SUSTAINABLE HARVEST, P28; GUILLOTIN M, 1994, J ZOOL, V233, P551, DOI 10.1111/j.1469-7998.1994.tb05365.x; Henry O, 2000, BIOTROPICA, V32, P364, DOI 10.1646/0006-3606(2000)032[0364:DOTLTT]2.0.CO;2; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Hollingsworth PM, 2009, P NATL ACAD SCI USA, V106, P12794, DOI 10.1073/pnas.0905845106; Huntington HP, 1999, ARCTIC, V52, P49; Jurado-Rivera JA, 2009, P ROY SOC B-BIOL SCI, V276, P639, DOI 10.1098/rspb.2008.1264; Keuroghlian A, 2009, BIODIVERS CONSERV, V18, P1733, DOI 10.1007/s10531-008-9554-6; Kitamura S, 2002, OECOLOGIA, V133, P559, DOI 10.1007/s00442-002-1073-7; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Marsh KJ, 2006, ECOLOGY, V87, P2103, DOI 10.1890/0012-9658(2006)87[2103:CDODPI]2.0.CO;2; Montenegro O, 2004, THESIS U FLORIDA FLO; MORI SA, 2002, GUIDE VASCULAR PLA 2; Mueller JG, 2010, CONSERV BIOL, V24, P140, DOI 10.1111/j.1523-1739.2009.01392.x; Norden N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001079; Olmos F, 1999, BIOTROPICA, V31, P375, DOI 10.1111/j.1744-7429.1999.tb00151.x; Poncy O, 2001, MONOG BIOL, V80, P31; Quiroga-Castro VD, 2001, BIOTROPICA, V33, P472, DOI 10.1111/j.1744-7429.2001.tb00200.x; REDFORD KH, 1992, BIOSCIENCE, V42, P412, DOI 10.2307/1311860; Rist L, 2010, ECOL SOC, V15; Roldan AI, 2001, CONSERV BIOL, V15, P617, DOI 10.1046/j.1523-1739.2001.015003617.x; Royo AA, 2005, OECOLOGIA, V145, P66, DOI 10.1007/s00442-005-0079-3; Russo SE, 2005, INT J PRIMATOL, V26, P1017, DOI 10.1007/s10764-005-6456-2; SABATIER D, 1985, REV ECOL-TERRE VIE, V40, P289; Salas LA, 1996, CAN J ZOOL, V74, P1444, DOI 10.1139/z96-159; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Santos LGRO, 2005, TAPIR CONSERV, V14, P22; SHARMA AD, 2002, PLANT MOL BIOL REP, V20, pA415, DOI [10.1007/BF02772129, DOI 10.1007/BF02772129]; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Sheil D, 2004, TRENDS ECOL EVOL, V19, P634, DOI 10.1016/j.tree.2004.09.019; Simmen B, 1996, INT J PRIMATOL, V17, P661, DOI 10.1007/BF02735260; Stoner KE, 2007, BIOTROPICA, V39, P385, DOI 10.1111/j.1744-7429.2007.00291.x; Stoner KE, 2007, BIOTROPICA, V39, P316, DOI 10.1111/j.1744-7429.2007.00292.x; Taber A, 2008, DESTINO ARQUITECTOS; Talamoni SA, 2009, ZOOLOGIA-CURITIBA, V26, P251, DOI 10.1590/S1984-46702009000200007; Tate JA, 2003, SYST BOT, V28, P723; TERBORGH J, 1988, CONSERV BIOL, V2, P402, DOI 10.1111/j.1523-1739.1988.tb00207.x; Terborgh J, 2008, ECOLOGY, V89, P1757, DOI 10.1890/07-0479.1; Timm RM, 2009, FOREST ECOL MANAG, V258, P997, DOI 10.1016/j.foreco.2008.10.027; Tobler M, 2008, THESIS TEXAS A M U; Tobler MW, 2010, BIOTROPICA, V42, P215, DOI 10.1111/j.1744-7429.2009.00549.x; Tobler MW, 2009, J TROP ECOL, V25, P261, DOI 10.1017/S0266467409005896; Valentini A, 2009, MOL ECOL RESOUR, V9, P51, DOI 10.1111/j.1755-0998.2008.02352.x; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Walther BA, 2005, ECOGRAPHY, V28, P815, DOI 10.1111/j.2005.0906-7590.04112.x; Wright SJ, 2003, PERSPECT PLANT ECOL, V6, P73, DOI 10.1078/1433-8319-00043; Wright SJ, 2001, BIOTROPICA, V33, P583, DOI 10.1111/j.1744-7429.2001.tb00217.x; Wright SJ, 2000, CONSERV BIOL, V14, P227, DOI 10.1046/j.1523-1739.2000.98333.x	90	32	32	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25850	10.1371/journal.pone.0025850	http://dx.doi.org/10.1371/journal.pone.0025850			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991372	Green Published, gold			2022-12-27	WOS:000295943000085
J	McKeone, R; Vieira, H; Gregory-Evans, K; Gregory-Evans, CY; Denny, P				McKeone, Richard; Vieira, Helena; Gregory-Evans, Kevin; Gregory-Evans, Cheryl Y.; Denny, Paul			Foxf2: A Novel Locus for Anterior Segment Dysgenesis Adjacent to the Foxc1 Gene	PLOS ONE			English	Article							FORKHEAD/WINGED-HELIX GENE; TRANSCRIPTION FACTOR FOXF2; AXENFELD-RIEGER SYNDROME; CONGENITAL GLAUCOMA; IRIS HYPOPLASIA; MUTATIONS; EXPRESSION; SPECTRUM; CHAMBER; MOUSE	Anterior segment dysgenesis (ASD) is characterised by an abnormal migration of neural crest cells or an aberrant differentiation of the mesenchymal cells during the formation of the eye's anterior segment. These abnormalities result in multiple tissue defects affecting the iris, cornea and drainage structures of the iridocorneal angle including the ciliary body, trabecular meshwork and Schlemm's canal. In some cases, abnormal ASD development leads to glaucoma, which is usually associated with increased intraocular pressure. Haploinsufficiency through mutation or chromosomal deletion of the human FOXC1 transcription factor gene or duplications of the 6p25 region is associated with a spectrum of ocular abnormalities including ASD. However, mapping data and phenotype analysis of human deletions suggests that an additional locus for this condition may be present in the same chromosomal region as FOXC1. DHPLC screening of ENU mutagenised mouse archival tissue revealed five novel mouse Foxf2 mutations. Re-derivation of one of these (the Foxf2(W174R) mouse lineage) resulted in heterozygote mice that exhibited thinning of the iris stroma, hyperplasia of the trabecular meshwork, small or absent Schlemm's canal and a reduction in the iridocorneal angle. Homozygous E18.5 mice showed absence of ciliary body projections, demonstrating a critical role for Foxf2 in the developing eye. These data provide evidence that the Foxf2 gene, separated from Foxc1 by less than 70 kb of genomic sequence (250 kb in human DNA), may explain human abnormalities in some cases of ASD where FOXC1 has been excluded genetically.	[McKeone, Richard; Denny, Paul] MRC Mammalian Genet Unit, Oxford, England; [Vieira, Helena] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Cell & Mol Biol, London, England; [Gregory-Evans, Kevin; Gregory-Evans, Cheryl Y.] Univ British Columbia, Dept Ophthalmol & Visual Sci, Vancouver, BC V5Z 1M9, Canada	Imperial College London; University of British Columbia	McKeone, R (corresponding author), Univ Western Australia, Lions Eye Inst, Dept Mol Ophthalmol, Perth, WA 6009, Australia.	paul.denny3@gmail.com	Gregory-Evans, Kevin/G-9551-2011; Vieira, Helena/M-1623-2017; Vieira, Helena/GWC-5973-2022; Gregory-Evans, Cheryl Y/G-9550-2011	Vieira, Helena/0000-0002-3663-289X; Denny, Paul/0000-0003-4659-6893; Gregory-Evans, Kevin/0000-0003-3572-3105; Gregory-Evans, Kevin/0000-0002-0104-7893	Medical Research Council; The Funding for Science and Technology; Birth Defects Foundation; Medical Research Council [MC_U142684174] Funding Source: researchfish; MRC [MC_U142684174] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); The Funding for Science and Technology; Birth Defects Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding for this work was provided by the Medical Research Council (RM & PD), The Funding for Science and Technology (HV) and Birth Defects Foundation (CYGE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitola M, 2000, DEV DYNAM, V218, P136, DOI 10.1002/(SICI)1097-0177(200005)218:1<136::AID-DVDY12>3.0.CO;2-U; Beauchamp G R, 1984, J Pediatr Ophthalmol Strabismus, V21, P209; Chanda B, 2008, HUM MOL GENET, V17, P3446, DOI 10.1093/hmg/ddn238; Coca-Prados M, 1999, PROG RETIN EYE RES, V18, P403, DOI 10.1016/S1350-9462(98)00026-3; Coghill EL, 2002, NAT GENET, V30, P255, DOI 10.1038/ng847; Davies AF, 1999, J MED GENET, V36, P708; De Baere E, 2001, HUM MOL GENET, V10, P1591, DOI 10.1093/hmg/10.15.1591; DeScipio C, 2005, AM J MED GENET A, V134A, P3, DOI 10.1002/ajmg.a.30573; Dobson-Stone C, 2000, EUR J HUM GENET, V8, P24, DOI 10.1038/sj.ejhg.5200409; Evans MJ, 1997, TRENDS GENET, V13, P370, DOI 10.1016/S0168-9525(97)01240-7; Fang JM, 2000, AM J HUM GENET, V67, P1382, DOI 10.1086/316915; Fujikawa K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009050; Gouge A, 2001, MECH DEVELOP, V107, P203, DOI 10.1016/S0925-4773(01)00465-8; Gould Douglas B, 2004, BMC Med Genet, V5, P17, DOI 10.1186/1471-2350-5-17; Hannenhalli S, 2009, NAT REV GENET, V10, P233, DOI 10.1038/nrg2523; HATINI V, 1994, J NEUROBIOL, V25, P1293, DOI 10.1002/neu.480251010; Hellqvist M, 1998, J BIOL CHEM, V273, P23335, DOI 10.1074/jbc.273.36.23335; Iseri SU, 2009, HUM MUTAT, V30, P1378, DOI 10.1002/humu.21079; Ittner Lars M, 2005, J Biol, V4, P11, DOI 10.1186/jbiol29; Izzotti A, 2009, INVEST OPHTH VIS SCI, V50, P5251, DOI 10.1167/iovs.09-3871; JERNDAL T, 1983, AM J HUM GENET, V35, P645; Jordan T, 1997, AM J HUM GENET, V61, P882, DOI 10.1086/514874; Kidson SH, 1999, DEV BIOL, V211, P306, DOI 10.1006/dbio.1999.9314; Koolen DA, 2005, EUR J HUM GENET, V13, P1169, DOI 10.1038/sj.ejhg.5201487; Kulak SC, 1998, HUM MOL GENET, V7, P1113, DOI 10.1093/hmg/7.7.1113; KUPFER C, 1979, AM J OPHTHALMOL, V88, P424, DOI 10.1016/0002-9394(79)90643-3; Lehmann OJ, 2002, INVEST OPHTH VIS SCI, V43, P1843; Lehmann OJ, 2000, AM J HUM GENET, V67, P1129; Mears AJ, 1996, AM J HUM GENET, V59, P1321; Mears AJ, 1998, AM J HUM GENET, V63, P1316, DOI 10.1086/302109; Miura N, 1998, GENOMICS, V50, P346, DOI 10.1006/geno.1998.5288; Nishimura DY, 1998, NAT GENET, V19, P140, DOI 10.1038/493; Nishimura DY, 2001, AM J HUM GENET, V68, P364, DOI 10.1086/318183; Ormestad M, 2006, DEVELOPMENT, V133, P833, DOI 10.1242/dev.02252; Ormestad M, 2004, DEV DYNAM, V229, P328, DOI 10.1002/dvdy.10426; Quwailid MM, 2004, MAMM GENOME, V15, P585, DOI 10.1007/s00335-004-2379-z; Saleem RA, 2001, AM J HUM GENET, V68, P627, DOI 10.1086/318792; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SHIELDS MB, 1985, SURV OPHTHALMOL, V29, P387, DOI 10.1016/0039-6257(85)90205-X; Skarie JM, 2009, INVEST OPHTH VIS SCI, V50, P5026, DOI 10.1167/iovs.09-3447; Smith RS, 2000, HUM MOL GENET, V9, P1021, DOI 10.1093/hmg/9.7.1021; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Strungaru MH, 2007, INVEST OPHTH VIS SCI, V48, P228, DOI 10.1167/iovs.06-0472; Thaung C, 2002, HUM MOL GENET, V11, P755, DOI 10.1093/hmg/11.7.755; Tumer Z, 2009, EUR J HUM GENET, V17, P1527, DOI 10.1038/ejhg.2009.93; Wang T, 2003, DEV BIOL, V259, P83, DOI 10.1016/S0012-1606(03)00176-3; WEATHERI.JR, 1969, BRIT J OPHTHALMOL, V53, P433, DOI 10.1136/bjo.53.7.433; Yuasa J, 1996, NATURE, V382, P632, DOI 10.1038/382632a0; ZURCHER VL, 1990, AM J MED GENET, V35, P261, DOI 10.1002/ajmg.1320350223	49	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e25489	10.1371/journal.pone.0025489	http://dx.doi.org/10.1371/journal.pone.0025489			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022403	Green Published, Green Submitted, gold			2022-12-27	WOS:000295978600018
J	Ausec, L; Zakrzewski, M; Goesmann, A; Schluter, A; Mandic-Mulec, I				Ausec, Luka; Zakrzewski, Martha; Goesmann, Alexander; Schlueter, Andreas; Mandic-Mulec, Ines			Bioinformatic Analysis Reveals High Diversity of Bacterial Genes for Laccase-Like Enzymes	PLOS ONE			English	Article							STREPTOMYCES-COELICOLOR; MICROBIAL COMMUNITY; POLYPHENOL OXIDASE; ALKALINE LACCASE; PURIFICATION; CLONING; FOREST; ALIGNMENT; SEQUENCE	Fungal laccases have been used in various fields ranging from processes in wood and paper industries to environmental applications. Although a few bacterial laccases have been characterized in recent years, prokaryotes have largely been neglected as a source of novel enzymes, in part due to the lack of knowledge about the diversity and distribution of laccases within Bacteria. In this work genes for laccase-like enzymes were searched for in over 2,200 complete and draft bacterial genomes and four metagenomic datasets, using the custom profile Hidden Markov Models for two-and three-domain laccases. More than 1,200 putative genes for laccase-like enzymes were retrieved from chromosomes and plasmids of diverse bacteria. In 76% of the genes, signal peptides were predicted, indicating that these bacterial laccases may be exported from the cytoplasm, which contrasts with the current belief. Moreover, several examples of putatively horizontally transferred bacterial laccase genes were described. Many metagenomic sequences encoding fragments of laccase-like enzymes could not be phylogenetically assigned, indicating considerable novelty. Laccase-like genes were also found in anaerobic bacteria, autotrophs and alkaliphiles, thus opening new hypotheses regarding their ecological functions. Bacteria identified as carrying laccase genes represent potential sources for future biotechnological applications.	[Ausec, Luka; Mandic-Mulec, Ines] Univ Ljubljana, Dept Food Sci, Ljubljana, Slovenia; [Ausec, Luka; Mandic-Mulec, Ines] Univ Ljubljana, Technol Biotech Fac, Ljubljana, Slovenia; [Zakrzewski, Martha; Goesmann, Alexander] Univ Bielefeld, Inst Bioinformat, Ctr Biotechnol CeBiTec, Bielefeld, Germany; [Zakrzewski, Martha; Schlueter, Andreas] Univ Bielefeld, Inst Genome Res & Syst Biol, Ctr Biotechnol CeBiTec, Bielefeld, Germany	University of Ljubljana; University of Ljubljana; University of Bielefeld; University of Bielefeld	Ausec, L (corresponding author), Univ Ljubljana, Dept Food Sci, Ljubljana, Slovenia.	ines.mandic@bf.uni-lj.si		Schluter, Andreas/0000-0003-4830-310X; Goesmann, Alexander/0000-0002-7086-2568	European Commission [KBBE-222625]; CLIB Graduate Cluster Industrial Biotechnology	European Commission(European CommissionEuropean Commission Joint Research Centre); CLIB Graduate Cluster Industrial Biotechnology	This work was supported by the METAEXPLORE grant from the European Commission (KBBE-222625). MZ received a scholarship from the CLIB Graduate Cluster Industrial Biotechnology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 2010, MOL BIOSYST, V6, P815, DOI 10.1039/b908966g; Alexandre G, 2000, TRENDS BIOTECHNOL, V18, P41, DOI 10.1016/S0167-7799(99)01406-7; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arias ME, 2003, APPL ENVIRON MICROB, V69, P1953, DOI 10.1128/AEM.69.4.1953-1958.2003; Arora DS, 2010, APPL BIOCHEM BIOTECH, V160, P1760, DOI 10.1007/s12010-009-8676-y; Auriol M, 2007, WATER RES, V41, P3281, DOI 10.1016/j.watres.2007.05.008; Ausec L, 2011, SOIL BIOL BIOCHEM, V43, P975, DOI 10.1016/j.soilbio.2011.01.013; Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; Bugg TDH, 2011, CURR OPIN BIOTECH, V22, P394, DOI 10.1016/j.copbio.2010.10.009; Claus H, 2003, ARCH MICROBIOL, V179, P145, DOI 10.1007/s00203-002-0510-7; Couto SR, 2006, BIOTECHNOL ADV, V24, P500, DOI 10.1016/j.biotechadv.2006.04.003; Dube E, 2008, APPL MICROBIOL BIOT, V79, P597, DOI 10.1007/s00253-008-1475-5; Dufraigne C, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni004; Durbin R., 1998, BIOL SEQUENCE ANAL P; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Endo K, 2003, J BIOCHEM, V133, P671, DOI 10.1093/jb/mvg086; Fang Z, 2011, APPL MICROBIOL BIOT, V89, P1103, DOI 10.1007/s00253-010-2934-3; GIVAUDAN A, 1993, FEMS MICROBIOL LETT, V108, P205, DOI 10.1111/j.1574-6968.1993.tb06100.x; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Hoegger PJ, 2006, FEBS J, V273, P2308, DOI 10.1111/j.1742-4658.2006.05247.x; Jaenicke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014519; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kellner H, 2008, SOIL BIOL BIOCHEM, V40, P638, DOI 10.1016/j.soilbio.2007.09.013; Kilaru S, 2006, CURR GENET, V50, P45, DOI 10.1007/s00294-006-0074-1; Komori H, 2009, FEBS LETT, V583, P1189, DOI 10.1016/j.febslet.2009.03.008; Koschorreck K, 2008, APPL MICROBIOL BIOT, V79, P217, DOI 10.1007/s00253-008-1417-2; Krause L, 2008, J BIOTECHNOL, V136, P91, DOI 10.1016/j.jbiotec.2008.06.003; Lawton TJ, 2009, J BIOL CHEM, V284, P10174, DOI 10.1074/jbc.M900179200; Luis P, 2004, SOIL BIOL BIOCHEM, V36, P1025, DOI 10.1016/j.soilbio.2004.02.017; Machczynski MC, 2004, PROTEIN SCI, V13, P2388, DOI 10.1110/ps.04759104; Martins LO, 2002, J BIOL CHEM, V277, P18849, DOI 10.1074/jbc.M200827200; Miyazaki K, 2005, EXTREMOPHILES, V9, P415, DOI 10.1007/s00792-005-0458-z; Molina-Guijarro JM, 2009, INT MICROBIOL, V12, P13, DOI 10.2436/20.1501.01.77; Nakamura K, 2003, FEBS LETT, V553, P239, DOI 10.1016/S0014-5793(03)01000-7; Niladevi KN, 2008, PROCESS BIOCHEM, V43, P654, DOI 10.1016/j.procbio.2008.02.002; Pereira L, 2009, J BIOTECHNOL, V139, P68, DOI 10.1016/j.jbiotec.2008.09.001; Roberts SA, 2003, J BIOL CHEM, V278, P31958, DOI 10.1074/jbc.M302963200; Rodriguez-Rodriguez CE, 2011, BIORESOURCE TECHNOL, V102, P5602, DOI 10.1016/j.biortech.2011.02.029; Ruijssenaars HJ, 2004, APPL MICROBIOL BIOT, V65, P177, DOI 10.1007/s00253-004-1571-0; Sanchez-Amat A, 2001, BBA-PROTEIN STRUCT M, V1547, P104, DOI 10.1016/S0167-4838(01)00174-1; Schluter A, 2008, J BIOTECHNOL, V136, P77, DOI 10.1016/j.jbiotec.2008.05.008; Seshadri R, 2007, PLOS BIOL, V5, P394, DOI 10.1371/journal.pbio.0050075; Sharma P, 2007, WORLD J MICROB BIOT, V23, P823, DOI 10.1007/s11274-006-9305-3; Singh G, 2007, ENZYME MICROB TECH, V41, P794, DOI 10.1016/j.enzmictec.2007.07.001; Singh G, 2009, BRAZ J MICROBIOL, V40, P26, DOI 10.1590/S1517-83822009000100004; Sirim Demet, 2011, Database (Oxford), V2011, pbar006, DOI 10.1093/database/bar006; Suzuki T, 2003, BIOSCI BIOTECH BIOCH, V67, P2167, DOI 10.1271/bbb.67.2167; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Theuerl S, 2010, BIOL FERT SOILS, V46, P215, DOI 10.1007/s00374-010-0440-5; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Widsten P, 2008, ENZYME MICROB TECH, V42, P293, DOI 10.1016/j.enzmictec.2007.12.003; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; Ye M, 2010, APPL MICROBIOL BIOT, V87, P1023, DOI 10.1007/s00253-010-2507-5	54	87	94	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25724	10.1371/journal.pone.0025724	http://dx.doi.org/10.1371/journal.pone.0025724			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022440	Green Submitted, Green Published, gold			2022-12-27	WOS:000295976000034
J	Fielding, K; Koba, A; Grant, AD; Charalambous, S; Day, J; Spak, C; Wald, A; Huang, ML; Corey, L; Churchyard, GJ				Fielding, Katherine; Koba, Ai; Grant, Alison D.; Charalambous, Salome; Day, John; Spak, Cedric; Wald, Anna; Huang, Meei-Li; Corey, Lawrence; Churchyard, Gavin J.			Cytomegalovirus Viremia as a Risk Factor for Mortality Prior to Antiretroviral Therapy among HIV-Infected Gold Miners in South Africa	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS DISEASE; END-ORGAN-DISEASE; HIV-1-INFECTED WOMEN; AIDS PATIENTS; PROGRESSION; CMV; PLASMA; SURVIVAL; LOAD; DNA	Background: Cytomegalovirus (CMV) viremia has been shown to be an independent risk factor for increased mortality among HIV-infected individuals in the developing world. While CMV infection is nearly ubiquitous in resource-poor settings, few data are available on the role of subclinical CMV reactivation on HIV. Methods: Using a cohort of mineworkers with stored plasma samples, we investigated the association between CMV DNA concentration and mortality prior to antiretroviral therapy availability. Results: Among 1341 individuals (median CD4 count 345 cells/mu l, 70% WHO stage 1 or 2, median follow-up 0.9 years), 70 (5.2%) had CMV viremia at baseline; 71 deaths occurred. In univariable analysis CMV viremia at baseline was associated with a three-fold increase in mortality (hazard ratio [HR] 3.37; 95% confidence intervals [CI] 1.60, 7.10). After adjustment for CD4 count, WHO stage and HIV viral load (N = 429 with complete data), the association was attenuated (HR 2.27; 95% CI 0.88, 5.83). Mortality increased with higher CMV viremia (>= 1,000 copies/ml vs. no viremia, adjusted HR 3.65, 95% CI: 1.29, 10.41). Results were similar using time-updated CMV viremia. Conclusions: High copy number, subclinical CMV viremia was an independent risk factor for mortality among male HIV-infected adults in South Africa with relatively early HIV disease. Studies to determine whether anti-CMV therapy to mitigate high copy number viremia would increase lifespan are warranted.	[Fielding, Katherine; Churchyard, Gavin J.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [Koba, Ai; Grant, Alison D.; Day, John] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England; [Charalambous, Salome; Day, John; Churchyard, Gavin J.] Aurum Inst, Johannesburg, South Africa; [Spak, Cedric; Wald, Anna; Corey, Lawrence] Univ Washington, Dept Med, Seattle, WA USA; [Wald, Anna; Huang, Meei-Li; Corey, Lawrence] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Wald, Anna] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Wald, Anna; Corey, Lawrence] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Fielding, K (corresponding author), London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England.	Katherine.fielding@lshtm.ac.uk	Wald, Anna/B-6272-2012; Corey, Lawrence/AAE-1796-2020	Wald, Anna/0000-0003-3486-6438; Corey, Lawrence/0000-0002-2179-2436; Charalambous, Salome/0000-0001-7143-1009; Churchyard, Gavin/0000-0002-4269-3699	Anglogold; National Institutes of Health (NIH) [AI-30731]; Fred Hutchinson ALC [CA018029]; UK Department of Health; AngloGold Health Services; Medical Research Council [G0700837] Funding Source: researchfish; National Institute for Health Research [PHCS/03/01] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P01CA018029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI030731] Funding Source: NIH RePORTER; MRC [G0700837] Funding Source: UKRI	Anglogold; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fred Hutchinson ALC; UK Department of Health; AngloGold Health Services; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by financial support from Anglogold. Additional laboratory work was funded by National Institutes of Health (NIH) Grant AI-30731 and the Fred Hutchinson ALC award grant number CA018029. Alison Grant was supported by a Public Health Career Scientist Award from the UK Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts. 1. The parent study referred to in the manuscript was funded by Anglogold. 2. Aurum Health Research, which at the time was a wholly owned subsidiary company of AngloGold Health Services, provided salary support to KF, SC, JD and GJC. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Adjei AA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-111; Boeckh M, 2004, J CLIN MICROBIOL, V42, P1142, DOI 10.1128/JCM.42.3.1142-1148.2004; Bowen EF, 1996, AIDS, V10, P1515, DOI 10.1097/00002030-199611000-00009; Burak KW, 2002, LIVER TRANSPLANT, V8, P362, DOI 10.1053/jlts.2002.32282; Charalambous S, 2004, AIDS CARE, V16, P47, DOI 10.1080/09540120310001633967; Day JH, 2004, J INFECT DIS, V190, P1677, DOI 10.1086/424851; Deayton JR, 2004, LANCET, V363, P2116, DOI 10.1016/S0140-6736(04)16500-8; DREW WL, 1992, CLIN INFECT DIS, V14, P608, DOI 10.1093/clinids/14.2.608-a; Erice A, 2003, CLIN INFECT DIS, V37, P567, DOI 10.1086/375843; GALLANT JE, 1992, J INFECT DIS, V166, P1223, DOI 10.1093/infdis/166.6.1223; George B, 2010, TRANSPL INFECT DIS, V12, P322, DOI 10.1111/j.1399-3062.2010.00504.x; Griffiths PP, 2006, J CLIN VIROL, V35, P489, DOI 10.1016/j.jcv.2005.10.016; Jabs DA, 2005, OPHTHALMOLOGY, V112, P771, DOI 10.1016/j.ophtha.2004.10.049; Kempen JH, 2003, CLIN INFECT DIS, V37, P1365, DOI 10.1086/379077; Kovacs A, 1999, NEW ENGL J MED, V341, P77, DOI 10.1056/NEJM199907083410203; Micol R, 2009, JAIDS-J ACQ IMM DEF, V51, P486, DOI 10.1097/QAI.0b013e3181a254c2; Robain M, 2001, AIDS, V15, P251, DOI 10.1097/00002030-200101260-00016; SABIN CA, 1995, EPIDEMIOL INFECT, V114, P361, DOI 10.1017/S095026880005799X; Slyker JA, 2009, AIDS, V23, P117, DOI 10.1097/QAD.0b013e32831c8abd; Spector SA, 1998, J CLIN INVEST, V101, P497, DOI 10.1172/JCI1101; WEBSTER A, 1989, LANCET, V2, P681; Wohl DA, 2005, JAIDS-J ACQ IMM DEF, V38, P538, DOI 10.1097/01.qai.0000155204.96973.c3; Zuckerman RA, 2007, J INFECT DIS, V196, P1500, DOI 10.1086/522523	23	31	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25571	10.1371/journal.pone.0025571	http://dx.doi.org/10.1371/journal.pone.0025571			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022413	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000295976000021
J	Saleh, AD; Savage, JE; Cao, L; Soule, BP; Ly, D; DeGraff, W; Harris, CC; Mitchell, JB; Simone, NL				Saleh, Anthony D.; Savage, Jason E.; Cao, Liu; Soule, Benjamin P.; Ly, David; DeGraff, William; Harris, Curtis C.; Mitchell, James B.; Simone, Nicole L.			Cellular Stress Induced Alterations in MicroRNA let-7a and let-7b Expression Are Dependent on p53	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; MESSENGER-RNA; CANCER; CELLS; GROWTH; PROLIFERATION; MODULATION; RESISTANCE; PROFILES; THERAPY	Genotoxic stressors, such as radiation, induce cellular damage that activates pre-programmed repair pathways, some of which involve microRNAs (miRNA) that alter gene expression. The let-7 family of miRNA regulates multiple cellular processes including cell division and DNA repair pathways. However, the role and mechanism underlying regulation of let-7 genes in response to stress have yet to be elucidated. In this study we demonstrate that let-7a and let-7b expression decreases significantly following exposure to agents that induce stress including ionizing radiation. This decrease in expression is dependent on p53 and ATM in vitro and is not observed in a p53(-/-) colon cancer cell line (HCT116) or ATM(-/-) human fibroblasts. Chromatin Immunoprecipitation (ChIP) analysis showed p53 binding to a region upstream of the let-7 gene following radiation exposure. Luciferase transient transfections demonstrated that this p53 binding site is necessary for radiation-induced decreases in let-7 expression. A radiation-induced decrease in let-7a and let-7b expression is also observed in radiation-sensitive tissues in vivo and correlates with altered expression of proteins in p53-regulated proapoptotic signaling pathways. In contrast, this decreased expression is not observed in p53 knock-out mice suggesting that p53 directly repress let-7 expression. Exogenous expression of let-7a and let-7b increased radiation-induced cytotoxicity in HCT116 p53(+/+) cells but not HCT116 p53(-/-) cells. These results are the first demonstration of a mechanistic connection between the radiation-induced stress response and the regulation of miRNA and radiation-induced cytotoxicity and suggest that this process may be a molecular target for anticancer agents.	[Saleh, Anthony D.; Savage, Jason E.; Ly, David; Simone, Nicole L.] NCI, Radiat Oncol Branch, NIH, Bethesda, MD 20892 USA; [Cao, Liu] NHLBI, Translat Med Branch, NIH, Bethesda, MD 20892 USA; [Soule, Benjamin P.] NIAID, Host Def Lab, NIH, Bethesda, MD 20892 USA; [DeGraff, William; Mitchell, James B.] NCI, Radiat Biol Branch, NIH, Bethesda, MD 20892 USA; [Harris, Curtis C.] NCI, Human Carcinogenesis Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Saleh, AD (corresponding author), NCI, Radiat Oncol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	simonen@mail.nih.gov		Simone, Nicole/0000-0002-7662-7470	National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIASC006321] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Farid E., 2009, Cancer Genomics & Proteomics, V6, P109; BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Brosh R, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.65; Cha HJ, 2009, INT J ONCOL, V34, P1661, DOI 10.3892/ijo_00000297; Chaudhry MA, 2009, CANCER BIOTHER RADIO, V24, P49, DOI 10.1089/cbr.2008.0513; Cuddihy AR, 2004, CANCER METAST REV, V23, P237, DOI 10.1023/B:CANC.0000031764.81141.e4; Esquela-Kerscher A, 2008, CELL CYCLE, V7, P759, DOI 10.4161/cc.7.6.5834; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Ho J, 2003, CELL DEATH DIFFER, V10, P404, DOI 10.1038/sj.cdd.4401191; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Josson S, 2008, PROSTATE, V68, P1599, DOI 10.1002/pros.20827; Li JW, 2002, MOL CELL BIOL, V22, P5688, DOI 10.1128/MCB.22.16.5688-5697.2002; Liu HF, 2010, MOL CANCER THER, V9, P1080, DOI 10.1158/1535-7163.MCT-09-0965; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Saleh AD, 2011, NUCLEOS NUCLEOT NUCL, V30, P235, DOI 10.1080/15257770.2011.569810; Schultz J, 2008, CELL RES, V18, P549, DOI 10.1038/cr.2008.45; Simone NL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006377; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Weidhaas JB, 2007, CANCER RES, V67, P11111, DOI 10.1158/0008-5472.CAN-07-2858; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yu CC, 2011, ORAL ONCOL, V47, P202, DOI 10.1016/j.oraloncology.2010.12.001	25	78	81	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e24429	10.1371/journal.pone.0024429	http://dx.doi.org/10.1371/journal.pone.0024429			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022355	Green Published, gold			2022-12-27	WOS:000295973200002
J	Aveic, S; Pigazzi, M; Basso, G				Aveic, Sanja; Pigazzi, Martina; Basso, Giuseppe			BAG1: The Guardian of Anti-Apoptotic Proteins in Acute Myeloid Leukemia	PLOS ONE			English	Article							BCL-2-BINDING PROTEIN; BCL-2 PROTEIN; EXPRESSION; CELLS; ISOFORMS; SURVIVAL; FAMILY; MCL-1; DEGRADATION; UBIQUITIN	BCL2 associated Athano-Gene 1 (BAG1) is a multifunctional protein that has been described to be involved in different cell processes linked to cell survival. It has been reported as deregulated in diverse cancer types. Here, BAG1 protein was found highly expressed in children with acute myeloid leukemia at diagnosis, and in a cohort of leukemic cell lines. A silencing approach was used for determining BAG1's role in AML, finding that its down-regulation decreased expression of BCL2, BCL-XL, MCL1, and phospho-ERK1/2, all proteins able to sustain leukemia, without affecting the pro-apoptotic protein BAX. BAG1 down-regulation was also found to increase expression of BAG3, whose similar activity was able to compensate the loss of function of BAG1. BAG1/BAG3 co-silencing caused an enhanced cell predisposition to death in cell lines and also in primary AML cultures, affecting the same proteins. Cell death was CASPASE-3 dependent, was accompanied by PARP cleavage and documented by an increased release of pro-apoptotic molecules Smac/DIABLO and Cytochrome c. BAG1 was found to directly maintain BCL2 and to protect MCL1 from proteasomal degradation by controlling USP9X expression, which appeared to be its novel target. Finally, BAG1 was found able to affect leukemia cell fate by influencing the expression of anti-apoptotic proteins crucial for AML maintenance.	[Aveic, Sanja; Pigazzi, Martina; Basso, Giuseppe] Univ Padua, Dept Pediat, Hematol Oncol Lab, Padua, Italy	University of Padua	Aveic, S (corresponding author), Univ Padua, Dept Pediat, Hematol Oncol Lab, Padua, Italy.	martina.pigazzi@unipd.it	Aveic, Sanja/J-9456-2014; Pigazzi, Martina/K-7997-2016	Aveic, Sanja/0000-0002-3886-4360; PIGAZZI, MARTINA/0000-0002-4793-5263; BASSO, GIUSEPPE/0000-0002-2634-9302	Universita di Padova; AIRC; PRIN/Programmi di ricerca di Rilevante Interesse Nazionale; Ministero della Salute	Universita di Padova; AIRC(Fondazione AIRC per la ricerca sul cancro); PRIN/Programmi di ricerca di Rilevante Interesse Nazionale(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Ministero della Salute(Ministry of Health, Italy)	This study was supported by grants from the Fondazione CARIPARO, Fondazione Citta della Speranza, from Universita di Padova (SA, MP); from AIRC (Associazione Italiana Ricerca sul Cancro, to GB), from PRIN/Programmi di ricerca di Rilevante Interesse Nazionale (to GB), and from Ministero della Salute (GB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LR, 2010, ONCOGENE, V29, P527, DOI 10.1038/onc.2009.362; BENSI L, 1995, HAEMATOLOGICA, V80, P98; Blagosklonny MV, 1996, BIOCHEM BIOPH RES CO, V227, P564, DOI 10.1006/bbrc.1996.1546; Bonelli P, 2004, LEUKEMIA, V18, P358, DOI 10.1038/sj.leu.2403219; BRADBURY DA, 1995, BRIT J HAEMATOL, V91, P374, DOI 10.1111/j.1365-2141.1995.tb05306.x; Brimmell M, 1999, BRIT J CANCER, V81, P1042, DOI 10.1038/sj.bjc.6690805; Cammareri P, 2010, CANCER RES, V70, P4655, DOI 10.1158/0008-5472.CAN-09-3953; CAMPOS L, 1993, BLOOD, V81, P3091; Chen J, 2002, ONCOGENE, V21, P7050, DOI 10.1038/sj.onc.1205845; Cutress RI, 2002, BRIT J CANCER, V87, P834, DOI 10.1038/sj.bjc.6600538; Del Poeta G, 2003, BLOOD, V101, P2125, DOI 10.1182/blood-2002-06-1714; Derenne S, 2002, BLOOD, V100, P194, DOI 10.1182/blood.V100.1.194; Dimmeler S, 1999, J EXP MED, V189, P1815, DOI 10.1084/jem.189.11.1815; Doong H, 2002, CANCER LETT, V188, P25, DOI 10.1016/S0304-3835(02)00456-1; Doong H, 2003, J BIOL CHEM, V278, P28490, DOI 10.1074/jbc.M209682200; Dou QP, 1999, DRUG RESIST UPDATE, V2, P215, DOI 10.1054/drup.1999.0095; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Elliott E, 2007, J BIOL CHEM, V282, P37276, DOI 10.1074/jbc.M706379200; Frascella E, 2004, LEUKEMIA, V18, P1427, DOI 10.1038/sj.leu.2403410; Gamerdinger M, 2009, EMBO J, V28, P889, DOI 10.1038/emboj.2009.29; Gotz R, 2005, NAT NEUROSCI, V8, P1169, DOI 10.1038/nn1524; Herrant M, 2004, ONCOGENE, V23, P7863, DOI 10.1038/sj.onc.1208069; HOCHSTRASSER M, 1995, CURR OPIN CELL BIOL, V7, P215, DOI 10.1016/0955-0674(95)80031-X; Kaufmann SH, 1998, BLOOD, V91, P991, DOI 10.1182/blood.V91.3.991.991_991_1000; Ko RH, 2010, J CLIN ONCOL, V28, P648, DOI 10.1200/JCO.2009.22.2950; Konopleva M, 2000, BLOOD, V95, P3929; Konopleva M, 2002, BRIT J HAEMATOL, V118, P521, DOI 10.1046/j.1365-2141.2002.03637.x; Kudoh M, 2002, CANCER RES, V62, P1904; Lee JH, 1999, ONCOGENE, V18, P6183, DOI 10.1038/sj.onc.1203043; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luders J, 2000, J BIOL CHEM, V275, P4613, DOI 10.1074/jbc.275.7.4613; MAUNG ZT, 1994, BRIT J HAEMATOL, V88, P105, DOI 10.1111/j.1365-2141.1994.tb04984.x; Michels J, 2005, INT J BIOCHEM CELL B, V37, P267, DOI 10.1016/j.biocel.2004.04.007; Packham G, 1997, BIOCHEM J, V328, P807, DOI 10.1042/bj3280807; Pession A, 2005, LEUKEMIA, V19, P2043, DOI 10.1038/sj.leu.2403869; Pession A, 2009, BLOOD, V114, P13, DOI 10.1182/blood.V114.22.17.17; Pigazzi M, 2009, CANCER RES, V69, P2471, DOI 10.1158/0008-5472.CAN-08-3404; Rosati A, 2007, INT J BIOCHEM CELL B, V39, P1337, DOI 10.1016/j.biocel.2007.03.007; Schwickart M, 2010, NATURE, V463, P103, DOI 10.1038/nature08646; Scorrano L, 2003, BIOCHEM BIOPH RES CO, V304, P437, DOI 10.1016/S0006-291X(03)00615-6; Sun HS, 2011, BLOOD, V117, P3151, DOI 10.1182/blood-2010-03-276477; Takayama S, 1998, CANCER RES, V58, P3116; TAKAYAMA S, 1995, CELL, V80, P279, DOI 10.1016/0092-8674(95)90410-7; TAKAYAMA S, 1999, EMBO J, V21, P6135; TESTA U, 2007, HAEMATOLOGICA, V98, P81; Townsend PA, 2005, INT J BIOCHEM CELL B, V37, P251, DOI 10.1016/j.biocel.2004.03.016; Townsend PA, 2003, BBA-REV CANCER, V1603, P83, DOI 10.1016/S0304-419X(03)00002-7; Tsujimoto Y, 2003, J CELL PHYSIOL, V195, P158, DOI 10.1002/jcp.10254; Tsukahara F, 2010, BLOOD, V116, P3582, DOI 10.1182/blood-2009-10-249623; Wang HG, 1996, P NATL ACAD SCI USA, V93, P7063, DOI 10.1073/pnas.93.14.7063; Yang XL, 1998, ONCOGENE, V17, P981, DOI 10.1038/sj.onc.1202032; Zhou P, 1997, BLOOD, V89, P630, DOI 10.1182/blood.V89.2.630	52	32	33	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e26097	10.1371/journal.pone.0026097	http://dx.doi.org/10.1371/journal.pone.0026097			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016818	Green Submitted, Green Published, gold			2022-12-27	WOS:000295971700039
J	Bardaji, L; Anorga, M; Jackson, RW; Martinez-Bilbao, A; Yanguas-Casas, N; Murillo, J				Bardaji, Leire; Anorga, Maite; Jackson, Robert W.; Martinez-Bilbao, Alejandro; Yanguas-Casas, Natalia; Murillo, Jesus			Miniature Transposable Sequences Are Frequently Mobilized in the Bacterial Plant Pathogen Pseudomonas syringae pv. phaseolicola	PLOS ONE			English	Article							ARTEMIS COMPARISON TOOL; FLANK AVIRULENCE GENES; INSERTION SEQUENCES; TOMATO DC3000; PATHOVAR PHASEOLICOLA; COMPARATIVE GENOMICS; PROKARYOTIC GENOMES; NUCLEOTIDE-SEQUENCE; VIRULENCE; ELEMENTS	Mobile genetic elements are widespread in Pseudomonas syringae, and often associate with virulence genes. Genome reannotation of the model bean pathogen P. syringae pv. phaseolicola 1448A identified seventeen types of insertion sequences and two miniature inverted-repeat transposable elements (MITEs) with a biased distribution, representing 2.8% of the chromosome, 25.8% of the 132-kb virulence plasmid and 2.7% of the 52-kb plasmid. Employing an entrapment vector containing sacB, we estimated that transposition frequency oscillated between 2.6 x 10(-5) and 1.1 x 10(-6), depending on the clone, although it was stable for each clone after consecutive transfers in culture media. Transposition frequency was similar for bacteria grown in rich or minimal media, and from cells recovered from compatible and incompatible plant hosts, indicating that growth conditions do not influence transposition in strain 1448A. Most of the entrapped insertions contained a full-length IS801 element, with the remaining insertions corresponding to sequences smaller than any transposable element identified in strain 1448A, and collectively identified as miniature sequences. From these, fragments of 229, 360 and 679-nt of the right end of IS801 ended in a consensus tetranucleotide and likely resulted from one-ended transposition of IS801. An average 0.7% of the insertions analyzed consisted of IS801 carrying a fragment of variable size from gene PSPPH_0008/PSPPH_0017, showing that IS801 can mobilize DNA in vivo. Retrospective analysis of complete plasmids and genomes of P. syringae suggests, however, that most fragments of IS801 are likely the result of reorganizations rather than one-ended transpositions, and that this element might preferentially contribute to genome flexibility by generating homologous regions of recombination. A further miniature sequence previously found to affect host range specificity and virulence, designated MITEPsy1 (100-nt), represented an average 2.4% of the total number of insertions entrapped in sacB, demonstrating for the first time the mobilization of a MITE in bacteria.	[Bardaji, Leire; Anorga, Maite; Martinez-Bilbao, Alejandro; Yanguas-Casas, Natalia; Murillo, Jesus] Univ Publ Navarra, Escuela Tecn Super Ingenieros Agronomos, Dept Agr Prod, Lab Patol Vegetal, Pamplona, Spain; [Jackson, Robert W.] Univ Reading, Sch Biol Sci, Reading, Berks, England	Universidad Publica de Navarra; University of Reading	Bardaji, L (corresponding author), Univ Publ Navarra, Escuela Tecn Super Ingenieros Agronomos, Dept Agr Prod, Lab Patol Vegetal, Pamplona, Spain.	jesus.murillo@unavarra.es	Casás, Natalia Yanguas/AAB-6704-2019; Murillo, Jesus/D-2901-2009; Jackson, Robert W/C-2973-2009	Casás, Natalia Yanguas/0000-0003-4368-0176; Murillo, Jesus/0000-0001-6585-2421; Jackson, Robert W/0000-0002-2042-4105; Anorga, Maite/0000-0002-5239-7615	Ministerio de Ciencia e Innovacion [AGL2008-55311-CO2-01]; FEDER	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); FEDER(European Commission)	This work was funded with the Spanish Plan Nacional I+D+I grant AGL2008-55311-CO2-01 (Ministerio de Ciencia e Innovacion; http://www.micinn.es/)co financed by FEDER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JC, 2005, BIOINFORMATICS, V21, P3665, DOI 10.1093/bioinformatics/bti601; Arnold DL, 2011, MOL PLANT PATHOL, V12, P617, DOI [10.1111/j.1364-3703.2010.00697.x, 10.1111/J.1364-3703.2010.00697.X]; Arnold DL, 2001, MICROBIOL-SGM, V147, P1171, DOI 10.1099/00221287-147-5-1171; Bardaji L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025705; Bertels F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002132; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; Burt A, 2006, GENES CONFLICT BIOL; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chen Y, 2009, GENE, V436, P1, DOI 10.1016/j.gene.2009.01.019; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; CRAIG NL, 2002, MOBILE DNA, V2; Cummings L, 2002, FEMS MICROBIOL LETT, V216, P133, DOI 10.1016/S0378-1097(02)00955-2; Delihas N, 2008, MOL MICROBIOL, V67, P475, DOI 10.1111/j.1365-2958.2007.06068.x; Drevinek P, 2010, J CLIN MICROBIOL, V48, P34, DOI 10.1128/JCM.01433-09; Feil H, 2005, P NATL ACAD SCI USA, V102, P11064, DOI 10.1073/pnas.0504930102; Fuhrer ME, 2008, PSEUDOMONAS SYRINGAE, P175; Garcillan-Barcia MP, 2002, FEMS MICROBIOL ECOL, V42, P303, DOI 10.1111/j.1574-6941.2002.tb01020.x; Garcillan-Barcia MP, 2002, MOBILE DNA, VII, P891; GAY P, 1985, J BACTERIOL, V164, P918, DOI 10.1128/JB.164.2.918-921.1985; Han Y, 2010, NUCLEIC ACIDS RES, V193, P4259; HARPER S, 1987, PHYSIOL MOL PLANT P, V31, P153, DOI 10.1016/0885-5765(87)90061-0; Jackson Robert W, 2011, Mob Genet Elements, V1, P55; Jackson RW, 1999, P NATL ACAD SCI USA, V96, P10875, DOI 10.1073/pnas.96.19.10875; Joardar V, 2005, J BACTERIOL, V187, P6488, DOI 10.1128/JB.187.18.6488-6498.2005; Kamiunten Hiroshi, 2002, Journal of General Plant Pathology, V68, P75, DOI 10.1007/PL00013057; KEANE PJ, 1970, AUST J BIOL SCI, V23, P585, DOI 10.1071/BI9700585; Kim JF, 1998, MOL PLANT MICROBE IN, V11, P1247, DOI 10.1094/MPMI.1998.11.12.1247; KING EO, 1954, J LAB CLIN MED, V44, P301; Landgraf A, 2006, MOL PLANT PATHOL, V7, P355, DOI 10.1111/j.1364-3703.2006.00343.x; Lindeberg M, 2008, MOL PLANT MICROBE IN, V21, P685, DOI 10.1094/MPMI-21-6-0685; Lovell HC, 2011, MOL PLANT PATHOL, V12, P167, DOI 10.1111/j.1364-3703.2010.00658.x; Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725, DOI 10.1128/MMBR.62.3.725-774.1998; Mansfield JW, 2009, MOL PLANT PATHOL, V10, P721, DOI 10.1111/j.1364-3703.2009.00576.x; McEvoy CRE, 2007, TUBERCULOSIS, V87, P393, DOI 10.1016/j.tube.2007.05.010; MENDIOLA MV, 1994, P NATL ACAD SCI USA, V91, P1922, DOI 10.1073/pnas.91.5.1922; Miche L, 2001, ENVIRON MICROBIOL, V3, P766, DOI 10.1046/j.1462-2920.2001.00251.x; Nagy Z, 2004, RES MICROBIOL, V155, P387, DOI 10.1016/j.resmic.2004.01.008; Norman A, 2009, PHILOS T R SOC B, V364, P2275, DOI 10.1098/rstb.2009.0037; Oguiza JA, 2004, MICROBIOL-SGM, V150, P473, DOI 10.1099/mic.0.26635-0; Ohtsubo Y, 2005, APPL ENVIRON MICROB, V71, P1822, DOI 10.1128/AEM.71.4.1822-1828.2005; Poirel L, 2009, ANTIMICROB AGENTS CH, V53, P2492, DOI 10.1128/AAC.00033-09; Richter GY, 1998, MOL GEN GENET, V260, P381, DOI 10.1007/s004380050907; Rivas LA, 2005, APPL ENVIRON MICROB, V71, P3778, DOI 10.1128/AEM.71.7.3778-3785.2005; Robertson AE, 2004, MOL PLANT MICROBE IN, V17, P1376, DOI 10.1094/MPMI.2004.17.12.1376; Rodriguez-Palenzuela P, 2010, ENVIRON MICROBIOL, V12, P1604, DOI 10.1111/j.1462-2920.2010.02207.x; ROMANTSCHUK M, 1991, MOL MICROBIOL, V5, P617, DOI 10.1111/j.1365-2958.1991.tb00732.x; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sambrook J., 2002, MOL CLONING LAB MANU; Sarkar SF, 2006, GENETICS, V174, P1041, DOI 10.1534/genetics.106.060996; Sarkar SF, 2004, APPL ENVIRON MICROB, V70, P1999, DOI 10.1128/AEM.70.4.1999-2012.2004; Sesma A, 1998, APPL ENVIRON MICROB, V64, P3948; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Siguier P, 2006, CURR OPIN MICROBIOL, V9, P526, DOI 10.1016/j.mib.2006.08.005; Stavrinides J, 2004, J BACTERIOL, V186, P5101, DOI [10.1128/JB.186.15.5101-5115.2004, 10.1128/jb.186.15.5101-5115.2004]; Stavrinides J, 2006, PLOS PATHOG, V2, P913, DOI 10.1371/journal.ppat.0020104; Stevens C, 1998, MOL MICROBIOL, V29, P165, DOI 10.1046/j.1365-2958.1998.00918.x; Sundin GW, 2007, ANNU REV PHYTOPATHOL, V45, P129, DOI 10.1146/annurev.phyto.45.062806.094317; Sundin George W., 2009, P295; SZABO LJ, 1984, J BACTERIOL, V157, P821, DOI 10.1128/JB.157.3.821-827.1984; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Taylor JD, 1996, PLANT PATHOL, V45, P469, DOI 10.1046/j.1365-3059.1996.d01-147.x; Teverson DM, 1991, THESIS U BIRMINGHAM; Toleman MA, 2006, MICROBIOL MOL BIOL R, V70, P296, DOI 10.1128/MMBR.00048-05; Touchon M, 2007, MOL BIOL EVOL, V24, P969, DOI 10.1093/molbev/msm014; Valle J, 2007, J BACTERIOL, V189, P2886, DOI 10.1128/JB.01767-06; Vivian A, 2001, MICROBIOL-SGM, V147, P763, DOI 10.1099/00221287-147-4-763; Wallden K, 2010, CELL MICROBIOL, V12, P1203, DOI 10.1111/j.1462-5822.2010.01499.x; YAMADA T, 1986, P NATL ACAD SCI USA, V83, P8263, DOI 10.1073/pnas.83.21.8263; Yan SC, 2008, APPL ENVIRON MICROB, V74, P3171, DOI 10.1128/AEM.00180-08; Young JM, 2010, J PLANT PATHOL, V92, pS5; Zhou F, 2008, BIOCHEM BIOPH RES CO, V365, P790, DOI 10.1016/j.bbrc.2007.11.038	71	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25773	10.1371/journal.pone.0025773	http://dx.doi.org/10.1371/journal.pone.0025773			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016774	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000295971700016
J	Li, X; Chu, JL; Wang, AJ; Zhu, YQ; Chu, WK; Yang, L; Li, S				Li, Xian; Chu, Julia; Wang, Aijun; Zhu, Yiqian; Chu, Wai Keung; Yang, Li; Li, Song			Uniaxial Mechanical Strain Modulates the Differentiation of Neural Crest Stem Cells into Smooth Muscle Lineage on Micropatterned Surfaces	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; PROGENITOR CELLS; CYCLIC STRAIN; IN-VITRO; EXPRESSION; TISSUE; STIMULATION; DIVERSITY; PHENOTYPE	Neural crest stem cells (NCSCs) play an important role in the development and represent a valuable cell source for tissue engineering. However, how mechanical factors in vivo regulate NCSC differentiation is not understood. Here NCSCs were derived from induced pluripotent stem cells and used as a model to determine whether vascular mechanical strain modulates the differentiation of NCSCs into smooth muscle (SM) lineage. NCSCs were cultured on micropatterned membranes to mimic the organization of smooth muscle cells (SMCs), and subjected to cyclic uniaxial strain. Mechanical strain enhanced NCSC proliferation and ERK2 phosphorylation. In addition, mechanical strain induced contractile marker calponin-1 within 2 days and slightly induced SM myosin within 5 days. On the other hand, mechanical strain suppressed the differentiation of NCSCs into Schwann cells. The induction of calponin-1 by mechanical strain was inhibited by neural induction medium but further enhanced by TGF-beta. For NCSCs pre-treated with TGF-beta, mechanical strain induced the gene expression of both calponin-1 and SM myosin. Our results demonstrated that mechanical strain regulates the differentiation of NCSCs in a manner dependent on biochemical factors and the differentiation stage of NCSCs. Understanding the mechanical regulation of NCSC differentiation will shed light on the development and remodeling of vascular tissues, and how transplanted NCSCs respond to mechanical factors.	[Li, Xian; Yang, Li] Chongqing Univ, Bioengn Coll, Chongqing 630044, Peoples R China; [Li, Xian; Chu, Julia; Wang, Aijun; Zhu, Yiqian; Li, Song] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Chu, Wai Keung] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	Chongqing University; University of California System; University of California Berkeley; University of California System; University of California San Diego	Li, X (corresponding author), Chongqing Univ, Bioengn Coll, Chongqing 630044, Peoples R China.	yanglicqu@gmail.com; song_li@berkeley.edu	Wang, Aijun/C-7559-2013	Wang, Aijun/0000-0002-2985-3627	National Institutes of Health [EB012240, HL083900]; College and University of China [B06023]; California Institute for Regenerative Medicine [TG2-01164]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB012240] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); College and University of China; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This study was supported in part by grants from the National Institutes of Health (EB012240 and HL083900 to S.L.), Innovation and Attracting Talents Program for College and University of China ('111' Project) (B06023; to L.Y.), a postdoctoral training grant TG2-01164 from California Institute for Regenerative Medicine (to A.W.), and a Predoctoral Fellowship from the American Heart Association (to Y.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam PJ, 2000, J BIOL CHEM, V275, P37798, DOI 10.1074/jbc.M006323200; BIRUKOV KG, 1995, MOL CELL BIOCHEM, V144, P131, DOI 10.1007/BF00944392; Cevallos M, 2006, DIFFERENTIATION, V74, P552, DOI 10.1111/j.1432-0436.2006.00089.x; Chen SY, 2004, CIRC RES, V94, P1195, DOI 10.1161/01.RES.0000126897.41658.81; Crane JF, 2006, ANNU REV CELL DEV BI, V22, P267, DOI 10.1146/annurev.cellbio.22.010305.103814; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Gong ZD, 2008, FASEB J, V22, P1635, DOI 10.1096/fj.07-087924; Hamilton DW, 2004, TISSUE ENG, V10, P361, DOI 10.1089/107632704323061726; Hautmann MB, 1997, J BIOL CHEM, V272, P10948; Hirschi KK, 2004, ANAT REC PART A, V276A, P22, DOI 10.1002/ar.a.10128; Hirschi KK, 2002, J BIOL CHEM, V277, P6287, DOI 10.1074/jbc.M106649200; Huang NF, 2006, NANO LETT, V6, P537, DOI 10.1021/nl060060o; Kim BS, 1999, NAT BIOTECHNOL, V17, P979, DOI 10.1038/13671; Kinner B, 2002, EXP CELL RES, V278, P72, DOI 10.1006/excr.2002.5561; Kurpinski K, 2006, P NATL ACAD SCI USA, V103, P16095, DOI 10.1073/pnas.0604182103; Kurpinski K, 2010, STEM CELLS, V28, P734, DOI 10.1002/stem.319; Kurpinski K, 2009, CELL MOL BIOENG, V2, P606, DOI 10.1007/s12195-009-0090-6; Lee G, 2007, NAT BIOTECHNOL, V25, P1468, DOI 10.1038/nbt1365; Li CH, 2000, CELL SIGNAL, V12, P435, DOI 10.1016/S0898-6568(00)00096-6; Li SH, 2001, CIRC RES, V89, P517, DOI 10.1161/hh1801.097165; LIU Y, 2003, J BIOL CHEM; Majesky MW, 2007, ARTERIOSCL THROM VAS, V27, P1248, DOI 10.1161/ATVBAHA.107.141069; Moustakas A, 2001, J CELL SCI, V114, P4359; Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Park JS, 2004, BIOTECHNOL BIOENG, V88, P359, DOI 10.1002/bit.20250; Reusch P, 1996, CIRC RES, V79, P1046, DOI 10.1161/01.RES.79.5.1046; Seliktar D, 2000, ANN BIOMED ENG, V28, P351, DOI 10.1114/1.275; Stegemann JP, 2003, ANN BIOMED ENG, V31, P391, DOI 10.1114/1.1558031; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; Topper JN, 2000, TRENDS CARDIOVAS MED, V10, P132, DOI 10.1016/S1050-1738(00)00061-X; Topper JN, 1997, P NATL ACAD SCI USA, V94, P9314, DOI 10.1073/pnas.94.17.9314; Wang AJ, 2011, BIOMATERIALS, V32, P5023, DOI 10.1016/j.biomaterials.2011.03.070; Wang DJ, 2004, J BIOL CHEM, V279, P43725, DOI 10.1074/jbc.M407368200; Williams B, 1998, J HYPERTENS, V16, P1921, DOI 10.1097/00004872-199816121-00011	35	35	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e26029	10.1371/journal.pone.0026029	http://dx.doi.org/10.1371/journal.pone.0026029			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22016804	Green Published, Green Submitted, gold			2022-12-27	WOS:000295970300050
J	May, M; Gueler, F; Barg-Hock, H; Heiringhoff, KH; Engeli, S; Heusser, K; Diedrich, A; Brandt, A; Strassburg, CP; Tank, J; Sweep, FCGJ; Jordan, J				May, Marcus; Gueler, Faikah; Barg-Hock, Hannelore; Heiringhoff, Karl-Heinz; Engeli, Stefan; Heusser, Karsten; Diedrich, Andre; Brandt, Andre; Strassburg, Christian P.; Tank, Jens; Sweep, Fred C. G. J.; Jordan, Jens			Liver Afferents Contribute to Water Drinking-Induced Sympathetic Activation in Human Subjects: A Clinical Trial	PLOS ONE			English	Article							IMPROVES ORTHOSTATIC TOLERANCE; OXIDATIVE STRESS; NERVE ACTIVITY; WEIGHT-LOSS; INGESTION; TRANSPLANTATION; REINNERVATION; NEUROTOXICITY; DIET	Water drinking acutely increases sympathetic activity in human subjects. In animals, the response appears to be mediated through transient receptor potential channel TRPV4 activation on osmosensitive hepatic spinal afferents, described as osmopressor response. We hypothesized that hepatic denervation attenuates water drinking-induced sympathetic activation. We studied 20 liver transplant recipients (44 +/- 2.6 years, 1.2 +/- 0.1 years post transplant) as model of hepatic denervation and 20 kidney transplant recipients (43 +/- 2.6 years, 0.8 +/- 0.1 years post transplant) as immunosuppressive drug matched control group. Before and after 500 ml water ingestion, we obtained venous blood samples for catecholamine analysis. We also monitored brachial and finger blood pressure, ECG, and thoracic bioimpedance. Plasma norepinephrine concentration had changed by 0.01 +/- 0.07 nmol/l in liver and by 0.21 +/- 0.07 nmol/l in kidney transplant recipients (p<0.05 between groups) after 30-40 minutes of water drinking. While blood pressure and systemic vascular resistance increased in both groups, the responses tended to be attenuated in liver transplant recipients. Our findings support the idea that osmosensitive hepatic afferents are involved in water drinking-induced sympathetic activation in human subjects.	[May, Marcus; Engeli, Stefan; Heusser, Karsten; Tank, Jens; Jordan, Jens] Hannover Med Sch, Inst Clin Pharmacol, D-3000 Hannover, Germany; [Gueler, Faikah] Hannover Med Sch, Dept Nephrol, D-3000 Hannover, Germany; [Barg-Hock, Hannelore; Heiringhoff, Karl-Heinz] Hannover Med Sch, Dept Gen Abdominal & Transplant Surg, D-3000 Hannover, Germany; [Diedrich, Andre] Vanderbilt Univ, Sch Med, Auton Dysfunct Ctr, Dept Med,Div Clin Pharmacol, Nashville, TN 37212 USA; [Diedrich, Andre] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Brandt, Andre; Sweep, Fred C. G. J.] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, NL-6525 ED Nijmegen, Netherlands; [Strassburg, Christian P.] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-3000 Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; Vanderbilt University; Vanderbilt University; Radboud University Nijmegen; Hannover Medical School	May, M (corresponding author), Hannover Med Sch, Inst Clin Pharmacol, D-3000 Hannover, Germany.	jordan.jens@mh-hannover.de	May, Marcus/A-1456-2017; Sweep, C.G.J./H-8096-2014	May, Marcus/0000-0002-7513-4244; Sweep, C.G.J./0000-0003-1103-3070; Heusser, Karsten/0000-0002-2571-5585; Tank, Jens/0000-0002-5672-1187	Hannover Medical School; Deutsche Forschungsgemeinschaft	Hannover Medical School; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was funded by the Hannover Medical School. Publication costs are funded by the support Program 'open access publication' of the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bechstein WO, 2000, TRANSPL INT, V13, P313, DOI 10.1111/j.1432-2277.2000.tb01004.x; BERTINIERI G, 1985, J HYPERTENS, V3, pS79; BOON AP, 1992, J PATHOL, V167, P217, DOI 10.1002/path.1711670210; Boschmann M, 2003, J CLIN ENDOCR METAB, V88, P6015, DOI 10.1210/jc.2003-030780; Boschmann M, 2007, J CLIN ENDOCR METAB, V92, P3334, DOI 10.1210/jc.2006-1438; Camm AJ, 1996, EUR HEART J, V17, P354; Cariga P, 2001, CLIN SCI, V101, P313, DOI 10.1042/CS20000253; Claydon VE, 2006, CLIN SCI, V110, P343, DOI 10.1042/CS20050279; Dennis EA, 2010, OBESITY, V18, P300, DOI 10.1038/oby.2009.235; Esler M D, 1984, J Hypertens Suppl, V2, pS123; Geelen G, 1996, J CLIN ENDOCR METAB, V81, P2131, DOI 10.1210/jc.81.6.2131; Hanson SA, 2004, TRANSFUSION, V44, P924, DOI 10.1111/j.1537-2995.2004.03426.x; Hausberg M, 2002, CIRCULATION, V106, P1974, DOI 10.1161/01.CIR.0000034043.16664.96; Jordan J, 2000, CIRCULATION, V101, P504, DOI 10.1161/01.CIR.101.5.504; KJAER M, 1994, J HEPATOL, V20, P97; Klawitter J, 2010, CHEM RES TOXICOL, V23, P608, DOI 10.1021/tx900351q; Lechner SG, 2011, NEURON, V69, P332, DOI 10.1016/j.neuron.2010.12.028; Lipp A, 2005, NEUROLOGY, V65, P905, DOI 10.1212/01.wnl.0000176060.90959.36; Lu CC, 2003, CIRCULATION, V108, P2660, DOI 10.1161/01.CIR.0000101966.24899.CB; May M, 2011, AM J PHYSIOL-REG I, V300, pR40, DOI 10.1152/ajpregu.00544.2010; McHugh J, 2010, HYPERTENSION, V55, P1438, DOI 10.1161/HYPERTENSIONAHA.110.151860; Perseghin G, 1997, J CLIN INVEST, V100, P931, DOI 10.1172/JCI119609; Raj SR, 2006, HYPERTENSION, V48, P329, DOI 10.1161/01.HYP.0000229906.27330.4f; Schroeder C, 2002, CIRCULATION, V106, P2806, DOI 10.1161/01.CIR.0000038921.64575.D0; Scott EM, 2001, CLIN SCI, V100, P335, DOI 10.1042/CS20000177; Shannon JR, 2002, AM J MED, V112, P355, DOI 10.1016/S0002-9343(02)01025-2; Sramek B B, 1982, Med Electron, V13, P93; Stookey JD, 2008, OBESITY, V16, P2481, DOI 10.1038/oby.2008.409; Tank J, 2003, HYPERTENSION, V41, P1234, DOI 10.1161/01.HYP.0000070957.08219.C9; WILLEMSEN JJ, 1995, CLIN CHEM, V41, P1455; Ye SH, 2006, HYPERTENSION, V48, P309, DOI 10.1161/01.HYP.0000231307.69761.2e	31	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25898	10.1371/journal.pone.0025898	http://dx.doi.org/10.1371/journal.pone.0025898			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22016786	Green Published, Green Submitted, gold			2022-12-27	WOS:000295970300039
J	Taube, W; Lundbye-Jensen, J; Schubert, M; Gollhofer, A; Leukel, C				Taube, Wolfgang; Lundbye-Jensen, Jesper; Schubert, Martin; Gollhofer, Albert; Leukel, Christian			Evidence That the Cortical Motor Command for the Initiation of Dynamic Plantarflexion Consists of Excitation followed by Inhibition	PLOS ONE			English	Article							MAGNETIC BRAIN-STIMULATION; CORTICOSPINAL PATHWAYS; SURROUND INHIBITION; LOWER-LIMB; MOTONEURONS; MOVEMENT; ADAPTATIONS; HUMANS; REFLEX; STANCE	At the onset of dynamic movements excitation of the motor cortex (M1) is spatially restricted to areas representing the involved muscles whereas adjacent areas are inhibited. The current study elucidates whether the cortical motor command for dynamic contractions is also restricted to a certain population of cortical neurons responsible for the fast corticospinal projections. Therefore, corticospinal transmission was assessed with high temporal resolution during dynamic contractions after both, magnetic stimulation over M1 and the brainstem. The high temporal resolution could be obtained by conditioning the soleus H-reflex with different interstimulus intervals by cervicomedullary stimulation (CMS-conditioning) and transcranial magnetic stimulation (TMS) of M1 (M1-conditioning). This technique provides a precise time course of facilitation and inhibition. CMS- and M1-conditioning produced an 'early facilitation' of the H-reflex, which occurred around 3 ms earlier with CMS-conditioning. The early facilitation is believed to be caused by activation of direct monosynaptic projections to the spinal motoneurons. CMS-conditioning resulted in a subsequent 'late facilitation', which is considered to reflect activity of slow-conducting and/or indirect corticospinal pathways. In contrast, M1-conditioning produced a 'late dis-facilitation' or even 'late inhibition'. As the late dis-facilitation was only seen following M1- but not CMS-conditioning, it is argued that cortical activation during dynamic tasks is restricted to fast, direct corticospinal projections whereas corticomotoneurons responsible for slow and/or indirectly projecting corticospinal pathways are inhibited. The functional significance of restricting the descending cortical drive to fast corticospinal pathways may be to ensure a temporally focused motor command during the execution of dynamic movements.	[Taube, Wolfgang; Leukel, Christian] Univ Fribourg, Dept Med Movement & Sport Sci, CH-1700 Fribourg, Switzerland; [Lundbye-Jensen, Jesper] Univ Copenhagen, Dept Exercise & Sport Sci, Copenhagen, Denmark; [Lundbye-Jensen, Jesper] Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark; [Schubert, Martin] Univ Zurich, Balgrist Univ Hosp, Spinal Cord Injury Ctr, Zurich, Switzerland; [Gollhofer, Albert; Leukel, Christian] Univ Freiburg, Dept Sport Sci, Freiburg, Germany	University of Fribourg; University of Copenhagen; University of Copenhagen; University of Zurich; University of Freiburg	Taube, W (corresponding author), Univ Fribourg, Dept Med Movement & Sport Sci, CH-1700 Fribourg, Switzerland.	wolfgang.taube@unifr.ch	Lundbye-Jensen, Jesper/ABH-4025-2020; Taube, Wolfgang/E-4018-2012; Gollhofer, Albert/ABF-5766-2020; Albert, Gollhofer/V-3291-2019	Lundbye-Jensen, Jesper/0000-0003-3144-861X; Taube, Wolfgang/0000-0002-8802-2065; 				Beck S, 2008, J NEUROSCI, V28, P10363, DOI 10.1523/JNEUROSCI.3564-08.2008; Berg RW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003218; CRONE C, 1990, EXP BRAIN RES, V81, P35; Kammer T, 2001, CLIN NEUROPHYSIOL, V112, P250, DOI 10.1016/S1388-2457(00)00513-7; Morita H, 1998, EXP BRAIN RES, V120, P143, DOI 10.1007/s002210050388; NIELSEN J, 1995, J PHYSIOL-LONDON, V484, P777, DOI 10.1113/jphysiol.1995.sp020703; NIELSEN J, 1993, J PHYSIOL-LONDON, V471, P223, DOI 10.1113/jphysiol.1993.sp019899; NIELSEN J, 1995, J PHYSIOL-LONDON, V484, P791, DOI 10.1113/jphysiol.1995.sp020704; NIELSEN J, 1995, J PHYSIOL-LONDON, V486, P779, DOI 10.1113/jphysiol.1995.sp020853; Petersen N, 1998, J PHYSIOL-LONDON, V513, P599, DOI 10.1111/j.1469-7793.1998.599bb.x; Schubert M, 2008, EUR J NEUROSCI, V27, P2007, DOI 10.1111/j.1460-9568.2008.06186.x; Sohn YH, 2004, EXP BRAIN RES, V158, P397, DOI 10.1007/s00221-004-1909-y; Sommer M, 2006, CLIN NEUROPHYSIOL, V117, P838, DOI 10.1016/j.clinph.2005.10.029; Taube W, 2007, ACTA PHYSIOL, V189, P347, DOI 10.1111/j.1748-1716.2007.01665.x; Taube W, 2006, J APPL PHYSIOL, V101, P420, DOI 10.1152/japplphysiol.01447.2005; Taylor JL, 2006, J ELECTROMYOGR KINES, V16, P215, DOI 10.1016/j.jelekin.2005.07.001; UGAWA Y, 1994, ANN NEUROL, V36, P618, DOI 10.1002/ana.410360410; Wasaka T, 2005, EUR J NEUROSCI, V22, P1239, DOI 10.1111/j.1460-9568.2005.04289.x	18	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25657	10.1371/journal.pone.0025657	http://dx.doi.org/10.1371/journal.pone.0025657			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003402	Green Published, Green Submitted, gold			2022-12-27	WOS:000295970300023
J	Olotu, A; Moris, P; Mwacharo, J; Vekemans, J; Kimani, D; Janssens, M; Kai, O; Jongert, E; Lievens, M; Leach, A; Villafana, T; Savarese, B; Marsh, K; Cohen, J; Bejon, P				Olotu, Ally; Moris, Philippe; Mwacharo, Jedidah; Vekemans, Johan; Kimani, Domtila; Janssens, Michel; Kai, Oscar; Jongert, Erik; Lievens, Marc; Leach, Amanda; Villafana, Tonya; Savarese, Barbara; Marsh, Kevin; Cohen, Joe; Bejon, Philip			Circumsporozoite-Specific T Cell Responses in Children Vaccinated with RTS,S/AS01(E) and Protection against P falciparum Clinical Malaria	PLOS ONE			English	Article							PRIME-BOOST IMMUNIZATION; SEMI-IMMUNE ADULTS; PHASE 2A TRIAL; DOUBLE-BLIND; EFFICACY; RTS,S; CD4(+); SAFETY; IMMUNOGENICITY; INDUCTION	Background: RTS,S/AS01(E) is the lead candidate pre-erythrocytic malaria vaccine. In Phase IIb field trials the safety profile was acceptable and the efficacy was 53% (95%CI 31%-72%) for protecting children against clinical malaria caused by P. falciparum. We studied CS-specific T cell responses in order to identify correlates of protection. Methods and Findings: We used intracellular cytokine staining (for IL2, IFN gamma, and TNF alpha), ex-vivo ELISPOTs (IFN gamma and IL2) and IFN gamma cultured ELISPOT assays to characterize the CS-specific cellular responses in 407 children (5-17 months of age) in a phase IIb randomized controlled trial of RTS,S/AS01(E) (NCT00380393). RTS,S/AS01(E) vaccinees had higher frequencies of CS-specific CD4+ T cells producing IFN gamma, TNF alpha or IL2 compared to control vaccinees. In a multivariable analysis TNF alpha(+) CD4(+) T cells were independently associated with a reduced risk for clinical malaria among RTS,S/AS01(E) vaccinees (HR = 0.64, 95%CI 0.49-0.86, p = 0.002). There was a non-significant tendency towards reduced risk among control vaccinees (HR = 0.80, 95%CI 0.62-1.03, p = 0.084), albeit with lower CS-specific T cell frequencies and higher rates of clinical malaria. When data from both RTS,S/AS01(E) vaccinees and control vaccinees were combined (with adjusting for vaccination group), the HR was 0.74 (95%CI 0.62-0.89, p = 0.001). After a Bonferroni correction for multiple comparisons (n-18), the finding was still significant at p = 0.018. There was no significant correlation between cultured or ex vivo ELISPOT data and protection from clinical malaria. The combination of TNF alpha(+) CD4(+) T cells and anti-CS antibody statistically accounted for the protective effect of vaccination in a Cox regression model. Conclusions: RTS,S/AS01(E) induces CS-specific Th1 T cell responses in young children living in a malaria endemic area. The combination of anti-CS antibody concentrations titers and CS-specific TNF alpha(+) CD4(+) T cells could account for the level of protection conferred by RTS,S/AS01(E). The correlation between CS-specific TNF alpha(+) CD4(+) T cells and protection needs confirmation in other datasets.	[Olotu, Ally; Mwacharo, Jedidah; Kimani, Domtila; Kai, Oscar; Marsh, Kevin; Bejon, Philip] Kenya Med Res Inst Wellcome Trust Programme, Ctr Geog Med Res, Coast, Kilifi, Kenya; [Moris, Philippe; Vekemans, Johan; Janssens, Michel; Jongert, Erik; Lievens, Marc; Leach, Amanda; Cohen, Joe] GlaxoSmithKline Biol, Rixensart, Belgium; [Villafana, Tonya; Savarese, Barbara] PATH Malaria Vaccine Initiat MVI, Bethesda, MD USA; [Villafana, Tonya] LLC, Gaithersburg, MD USA; [Marsh, Kevin; Bejon, Philip] Univ Oxford, Nuffield Dept Med, Ctr Clin Vaccinol & Trop Med, Oxford, England	Kenya Medical Research Institute; GlaxoSmithKline; University of Oxford	Olotu, A (corresponding author), Kenya Med Res Inst Wellcome Trust Programme, Ctr Geog Med Res, Coast, Kilifi, Kenya.	pbejon@kilifi.kemri-wellcome.org	Leach, Amanda/AAS-1120-2020	Leach, Amanda/0000-0002-7114-9967	PATH Malaria Vaccine Initiative (MVI); Wellcome Trust; Biomedical Research Centre in Oxford	PATH Malaria Vaccine Initiative (MVI); Wellcome Trust(Wellcome TrustEuropean Commission); Biomedical Research Centre in Oxford	This project has been funded by PATH Malaria Vaccine Initiative (MVI). Prof. Marsh is supported by the Wellcome Trust. Philip Bejon is supported by the Biomedical Research Centre in Oxford. Two authors (TV and BS) are MVI employees and were involved in trial design and writing the report. Dr. Villafana was an employee of MVI throughout the duration of the study, but has since moved to MedImmune, LLC. MedImmune, LLC had no role in the study design, data collection, analysis, decision to publish, preparation of the manuscript or any other aspect of the study. The Wellcome Trust and Biomedical Research Centre had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MVI had no other role in data collection or analysis, and the decision to publish was covered by a pre-study agreement.	Agnandji ST, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018559; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Ansong D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018891; Ballou WR, 2009, PARASITE IMMUNOL, V31, P492, DOI 10.1111/j.1365-3024.2009.01143.x; Barbosa A, 2009, INFECT IMMUN, V77, P4502, DOI 10.1128/IAI.00442-09; Bejon P, 2005, J INFECT DIS, V191, P619, DOI 10.1086/427243; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Bejon P, 2007, J IMMUNOL, V179, P4193, DOI 10.4049/jimmunol.179.6.4193; Bejon P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021711; Bejon P, 2011, J INFECT DIS, V204, P9, DOI 10.1093/infdis/jir222; Bejon P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000304; Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4; Bojang KA, 2005, VACCINE, V23, P4148, DOI 10.1016/j.vaccine.2005.03.019; Butler NS, 2010, J IMMUNOL, V184, P2528, DOI 10.4049/jimmunol.0903529; Casares S, 2010, VACCINE, V28, P4880, DOI 10.1016/j.vaccine.2010.05.033; Depinay N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017464; Doherty JF, 1999, AM J TROP MED HYG, V61, P865, DOI 10.4269/ajtmh.1999.61.865; Doolan DL, 2000, J IMMUNOL, V165, P1453, DOI 10.4049/jimmunol.165.3.1453; Dunachie SJ, 2006, VACCINE, V24, P2850, DOI 10.1016/j.vaccine.2005.12.041; Flanagan KL, 2001, J IMMUNOL, V167, P4729, DOI 10.4049/jimmunol.167.8.4729; Godkin AJ, 2002, J IMMUNOL, V169, P2210, DOI 10.4049/jimmunol.169.4.2210; Guinovart C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005165; HOLLINGDALE MR, 1990, T ROY SOC TROP MED H, V84, P325, DOI 10.1016/0035-9203(90)90303-V; Keating SM, 2005, J IMMUNOL, V175, P5675, DOI 10.4049/jimmunol.175.9.5675; Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120; Kinyanjui SM, 2003, J INFECT DIS, V187, P667, DOI 10.1086/373994; Kohberger RC, 2008, VACCINE, V26, P3516, DOI 10.1016/j.vaccine.2008.04.016; Lalvani A, 1999, J INFECT DIS, V180, P1656, DOI 10.1086/315074; Lell B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007611; Macete EV, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-11; McConkey SJ, 2003, NAT MED, V9, P729, DOI 10.1038/nm881; Moorthy VS, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-312; Olotu A, 2011, LANCET INFECT DIS, V11, P102, DOI 10.1016/S1473-3099(10)70262-0; Olotu AI, 2010, J INFECT DIS, V201, P970, DOI 10.1086/651025; Pinder M, 2004, CLIN EXP IMMUNOL, V135, P286, DOI 10.1111/j.1365-2249.2004.02371.x; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; PRENTICE RL, 1989, STAT MED, V8, P431, DOI 10.1002/sim.4780080407; Qin L, 2007, J INFECT DIS, V196, P1304, DOI 10.1086/522428; Ray ME, 2009, J NATL CANCER I, V101, P228, DOI 10.1093/jnci/djn489; Reece WHH, 2004, NAT MED, V10, P406, DOI 10.1038/nm1009; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Stoute JA, 1998, J INFECT DIS, V178, P1139, DOI 10.1086/515657; Sun PF, 2003, J IMMUNOL, V171, P6961, DOI 10.4049/jimmunol.171.12.6961; Todryk SM, 2009, IMMUNOLOGY, V128, P83, DOI 10.1111/j.1365-2567.2009.03073.x; Wang RB, 1996, J IMMUNOL, V157, P4061	45	74	76	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e25786	10.1371/journal.pone.0025786	http://dx.doi.org/10.1371/journal.pone.0025786			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998698	Green Published, Green Submitted, gold			2022-12-27	WOS:000295968700020
J	Aulagnier, M; Janssens, W; De Beer, I; van Rooy, G; Gaeb, E; Hesp, C; van der Gaag, J; de Wit, TFR				Aulagnier, Marielle; Janssens, Wendy; De Beer, Ingrid; van Rooy, Gert; Gaeb, Esegiel; Hesp, Cees; van der Gaag, Jacques; de Wit, Tobias F. Rinke			Incidence of HIV in Windhoek, Namibia: Demographic and Socio-Economic Associations	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; SOCIAL DETERMINANTS; URBAN HEALTH; PREVALENCE; POVERTY; WOMEN; POPULATION; PREVENTION; BEHAVIOR; SEROSTATUS	Objective: To estimate HIV incidence and prevalence in Windhoek, Namibia and to analyze socio-economic factors related to HIV infection. Method: In 2006/7, baseline surveys were performed with 1,753 private households living in the greater Windhoek area; follow-up visits took place in 2008 and 2009. Face-to-face socio-economic questionnaires were administrated by trained interviewers; biomedical markers were collected by nurses; GPS codes of household residences were recorded. Results: The HIV prevalence in the population (aged>12 years) was 11.8% in 2006/7 and 14.6% in 2009. HIV incidence between 2007 and 2009 was 2.4 per 100 person year (95%CI = 1.9-2.9). HIV incidence and prevalence were higher in female populations. HIV incidence appeared non-associated with any socioeconomic factor, indicating universal risk for the population. For women a positive trend was found between low per-capita consumption and HIV acquisition. A HIV knowledge score was strongly associated with HIV incidence for both men and women. High HIV prevalence and incidence was concentrated in the north-western part of the city, an area with lower HIV knowledge, higher HIV risk perception and lower per-capita consumption. Discussion: The HIV incidence and prevalence figures do not suggest a declining epidemic in Windhoek. Higher vulnerability of women is recorded, most likely related to economic dependency and increasing transactional sex in Namibia. The lack of relation between HIV incidence and socio-economic factors confirms HIV risks for the overall urban community. Appropriate knowledge is strongly associated to lower HIV incidence and prevalence, underscoring the importance of continuous information and education activities for prevention of infection. Geographical areas were identified that would require prioritized HIV campaigning.	[Aulagnier, Marielle; Hesp, Cees; de Wit, Tobias F. Rinke] PharmAccess Fdn, Amsterdam, Netherlands; [Janssens, Wendy; van der Gaag, Jacques] Vrije Univ Amsterdam, Dept Dev Econ, Amsterdam, Netherlands; [De Beer, Ingrid] PharmAccess Fdn Namibia, Windhoek, Namibia; [van Rooy, Gert] Univ Namibia, Multidisciplinary Res Ctr, Windhoek, Namibia; [Gaeb, Esegiel] Namibia Inst Pathol, Windhoek, Namibia; [Janssens, Wendy; van der Gaag, Jacques] Amsterdam Inst Int Dev, Amsterdam, Netherlands; [van der Gaag, Jacques] Brookings Inst, Washington, DC 20036 USA; [de Wit, Tobias F. Rinke] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, Amsterdam Inst Global Hlth & Dev, NL-1105 AZ Amsterdam, Netherlands	Vrije Universiteit Amsterdam; University of Namibia; Brookings Institution; University of Amsterdam; Academic Medical Center Amsterdam	Aulagnier, M (corresponding author), PharmAccess Fdn, Amsterdam, Netherlands.	m_aulagnier@yahoo.fr	de Wit, Tobias TF Rinke/A-1224-2013; Van Rooy, Gert/Q-6636-2019	Van Rooy, Gert/0000-0002-8013-8768; Janssens, Wendy/0000-0002-2085-8608	Netherlands Ministry of Foreign Affairs (DSI/SB) [13298]	Netherlands Ministry of Foreign Affairs (DSI/SB)	This work was supported by a grant from the Netherlands Ministry of Foreign Affairs (DSI/SB, project number 13298). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, World Health Statistics 2010; [Anonymous], NAM HLTH RES TRACK 2; [Anonymous], 2008, NAM DEM HLTH SURV 20; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Braunstein SL, 2009, AIDS REV, V11, P140; Daniels N, 1999, DAEDALUS, V128, P215; Dunkle KL, 2004, SOC SCI MED, V59, P1581, DOI 10.1016/j.socscimed.2004.02.003; Fox AM, 2010, PUBLIC HEALTH REP, V125, P16, DOI 10.1177/00333549101250S405; Frayne B, 2004, GEOFORUM, V35, P489, DOI 10.1016/j.geoforum.2004.01.003; Galea S, 2005, ANNU REV PUBL HEALTH, V26, P341, DOI 10.1146/annurev.publhealth.26.021304.144708; Garcia-Calleja JM, 2006, SEX TRANSM INFECT, V82, pIII64, DOI 10.1136/sti.2006.019901; Gregson S, 2006, SCIENCE, V311, P664, DOI 10.1126/science.1121054; Grosh M., 2000, DESIGNING HOUSEHOLD; Gustafsson-Wright E, 2011, HEALTH POLICY PLANN, V26, P142, DOI 10.1093/heapol/czq029; Harpham T, 2009, HEALTH PLACE, V15, P107, DOI 10.1016/j.healthplace.2008.03.004; Holtgrave DR, 2003, SEX TRANSM INFECT, V79, P62, DOI 10.1136/sti.79.1.62; Homers RL, 2008, JAIDS-J ACQ IMM DEF, V48, P116, DOI 10.1097/QAI.0b013e31816bcdcf; Hunter Mark., 2002, AFR STUD-UK, V61, P99, DOI [DOI 10.1080/00020180220140091, 10.1080/00020180220140091]; Janssens W, 2008, NONRESPONSE BIAS MEA; Janssens W, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6323; Jewkes RK, 2003, SOC SCI MED, V56, P125, DOI 10.1016/S0277-9536(02)00012-6; Karim QA, 2010, CLIN INFECT DIS, V50, pS122, DOI 10.1086/651483; Kumwenda N, 2006, SEX TRANSM DIS, V33, P646, DOI 10.1097/01.olq.0000223283.27142.9f; Kyobutungi Catherine, 2008, Popul Health Metr, V6, P1, DOI 10.1186/1478-7954-6-1; Lopman B, 2007, AIDS, V21, pS57, DOI 10.1097/01.aids.0000300536.82354.52; MacPhail C, 2001, SOC SCI MED, V52, P1613, DOI 10.1016/S0277-9536(00)00272-0; Marston M, 2008, SEX TRANSM INFECT, V84, pI71, DOI 10.1136/sti.2008.030353; Mishra V, 2008, SEX TRANSM INFECT, V84, pI63, DOI 10.1136/sti.2008.030411; MoHSS, 2009, 2008 9 EST PROJ IMP; Mwaluko G, 2003, AIDS, V17, P2645, DOI 10.1097/00002030-200312050-00012; Padian NS, 2007, LANCET, V370, P251, DOI 10.1016/S0140-6736(07)60950-7; Rambura M, 2007, JAIDS-J ACQ IMM DEF, V46, P616, DOI 10.1097/QAI.0b013e31815a571a; Schellekens O, 2009, HEALTH AFFAIR, V28, P6; Schmidt M, 2009, POVERTY INEQUALITY N; Shelton JD, 2005, LANCET, V366, P1057, DOI 10.1016/S0140-6736(05)67401-6; Stringer EM, 2004, JAIDS-J ACQ IMM DEF, V35, P60, DOI 10.1097/00126334-200401010-00009; UNAIDS, 2010, REP GLOB AIDS EP; [USAID MOHSS], 2009, HIV AIDS NAM BEHAV C; Vearey J, 2010, HEALTH PLACE, V16, P694, DOI 10.1016/j.healthplace.2010.02.007; Vlahov David, 2005, Cad. Saúde Pública, V21, P949, DOI 10.1590/S0102-311X2005000300031; Voeten HA, 2009, SEX TRANSM DIS, V2; World Health Organization, 2010, UN ACC SCAL PRIOR HI; Zaba B, 2004, SEX TRANSM INFECT, V80, P28, DOI 10.1136/sti.2004.012674	43	10	10	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e25860	10.1371/journal.pone.0025860	http://dx.doi.org/10.1371/journal.pone.0025860			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834MB	21991374	Green Published, gold, Green Submitted			2022-12-27	WOS:000295963300026
J	Bartels, SJJ; Spruijt, CG; Brinkman, AB; Jansen, PWTC; Vermeulen, M; Stunnenberg, HG				Bartels, Stefanie J. J.; Spruijt, Cornelia G.; Brinkman, Arie B.; Jansen, Pascal W. T. C.; Vermeulen, Michiel; Stunnenberg, Hendrik G.			A SILAC-Based Screen for Methyl-CpG Binding Proteins Identifies RBP-J as a DNA Methylation and Sequence-Specific Binding Protein	PLOS ONE			English	Article							B-VIRUS ENHANCER; ZINC-FINGER PROTEINS; HUMAN FMR1 GENE; TRANSCRIPTIONAL REPRESSOR; HUMAN CYTOMEGALOVIRUS; CHROMOSOMAL PROTEIN; SRA DOMAIN; PROMOTER; MECP2; COMPLEX	Background: DNA methylation is an epigenetic modification that plays a crucial role in a variety of biological processes. Methylated DNA is specifically bound by Methyl-CpG Binding Proteins (MBPs). Three different types of MBPs have been identified so far: the Methyl-CpG Binding Domain (MBD) family proteins, three BTB/POZ-Zn-finger proteins, and UHRF1. Most of the known MBPs have been identified via homology with the MBD and Zn-finger domains as present in MeCP2 and Kaiso, respectively. It is conceivable that other proteins are capable of recognizing methylated DNA. Methodology/Principal Findings: For the purpose of identifying novel 'readers' we set up a methyl-CpG pull-down assay combined with stable-isotope labeling by amino acids in cell culture (SILAC). In a methyl-CpG pull-down with U937 nuclear extracts, we recovered several known MBPs and almost all subunits of the MBD2/NuRD complex as methylation specific binders, providing proof-of-principle. Interestingly, RBP-J, the transcription factor downstream of Notch receptors, also bound the DNA in a methylation dependent manner. Follow-up pull-downs and electrophoretic mobility shift assays (EMSAs) showed that RBP-J binds methylated DNA in the context of a mutated RBP-J consensus motif. Conclusions/Significance: The here described SILAC/methyl-CpG pull-down constitutes a new approach to identify potential novel DNAme readers and will advance unraveling of the complete methyl-DNA interactome.	[Bartels, Stefanie J. J.; Brinkman, Arie B.; Stunnenberg, Hendrik G.] Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, Dept Mol Biol, NL-6525 ED Nijmegen, Netherlands; [Spruijt, Cornelia G.; Jansen, Pascal W. T. C.; Vermeulen, Michiel] Univ Med Ctr Utrecht, Dept Mol Canc Res, Utrecht, Netherlands	Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center	Bartels, SJJ (corresponding author), Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, Dept Mol Biol, NL-6525 ED Nijmegen, Netherlands.	H.Stunnenberg@ncmls.ru.nl	Brinkman, Arie/V-1533-2018; Stunnenberg, Hendrik G./D-6875-2012; Vermeulen, Michiel/C-8883-2013	Brinkman, Arie/0000-0002-9875-1835; Stunnenberg, Hendrik G./0000-0002-0066-1576; Vermeulen, Michiel/0000-0003-0836-6894; Spruijt, Cornelia/0000-0002-1789-670X	Netherlands Organisation for Scientific Research (NWO) [VIDI 864-05-002]; Dutch Cancer Foundation (KWF) [KUN 2008-4130]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Foundation (KWF)(KWF Kankerbestrijding)	This work was supported by the Netherlands Organisation for Scientific Research (NWO) grant VIDI 864-05-002 and the Dutch Cancer Foundation (KWF) grant KUN 2008-4130. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Bartke T, 2010, CELL, V143, P470, DOI 10.1016/j.cell.2010.10.012; Borggrefe T, 2009, CELL MOL LIFE SCI, V66, P1631, DOI 10.1007/s00018-009-8668-7; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Clouaire T, 2008, CELL MOL LIFE SCI, V65, P1509, DOI 10.1007/s00018-008-7324-y; Clouaire T, 2010, NUCLEIC ACIDS RES, V38, P4620, DOI 10.1093/nar/gkq228; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cross SH, 1997, NAT GENET, V16, P256, DOI 10.1038/ng0797-256; Deissler H, 1997, J BIOL CHEM, V272, P16761, DOI 10.1074/jbc.272.27.16761; Deissler H, 1996, J BIOL CHEM, V271, P4327; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Eberl HC, 2011, CHEMBIOCHEM, V12, P224, DOI 10.1002/cbic.201000429; Emery P, 1996, NUCLEIC ACIDS RES, V24, P803, DOI 10.1093/nar/24.5.803; Filion GJP, 2006, MOL CELL BIOL, V26, P169, DOI 10.1128/MCB.26.1.169-181.2006; Frauer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021306; GHAZAL P, 1987, P NATL ACAD SCI USA, V84, P3658, DOI 10.1073/pnas.84.11.3658; Hashimoto H, 2008, NATURE, V455, P826, DOI 10.1038/nature07280; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Ho KL, 2008, MOL CELL, V29, P525, DOI 10.1016/j.molcel.2007.12.028; HUANG LH, 1984, NATURE, V308, P293, DOI 10.1038/308293a0; Jin SG, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq223; KARPEN S, 1988, MOL CELL BIOL, V8, P5159, DOI 10.1128/MCB.8.12.5159; Klose RJ, 2005, MOL CELL, V19, P667, DOI 10.1016/j.molcel.2005.07.021; Kovall RA, 2004, EMBO J, V23, P3441, DOI 10.1038/sj.emboj.7600349; Laget S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011982; Le Guezennec X, 2006, MOL CELL BIOL, V26, P843, DOI 10.1128/MCB.26.3.843-851.2006; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Lopez-Serra L, 2006, CANCER RES, V66, P8342, DOI 10.1158/0008-5472.CAN-06-1932; Maier S, 2005, J VIROL, V79, P8784, DOI 10.1128/JVI.79.14.8784-8792.2005; MEEHAN RR, 1989, CELL, V58, P499, DOI 10.1016/0092-8674(89)90430-3; Mittler G, 2009, GENOME RES, V19, P284, DOI 10.1101/gr.081711.108; Nakayama M, 2004, J CELL BIOCHEM, V91, P540, DOI 10.1002/jcb.10740; NAN XS, 1993, NUCLEIC ACIDS RES, V21, P4886, DOI 10.1093/nar/21.21.4886; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Oda H, 2010, MOL CELL, V40, P364, DOI 10.1016/j.molcel.2010.10.011; Ohki I, 2001, CELL, V105, P487, DOI 10.1016/S0092-8674(01)00324-5; OSTAPCHUK P, 1989, MOL CELL BIOL, V9, P2787, DOI 10.1128/MCB.9.7.2787; Prokhortchouk A, 2001, GENE DEV, V15, P1613, DOI 10.1101/gad.198501; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rauch Tibor A., 2009, V507, P65, DOI 10.1007/978-1-59745-522-0_6; REITH W, 1994, MOL CELL BIOL, V14, P1230, DOI 10.1128/MCB.14.2.1230; Sasai N, 2010, NUCLEIC ACIDS RES, V38, P5015, DOI 10.1093/nar/gkq280; Sasai N, 2009, INT J DEV BIOL, V53, P323, DOI 10.1387/ijdb.082652ns; Sengupta PK, 1999, J BIOL CHEM, V274, P36649, DOI 10.1074/jbc.274.51.36649; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; TUN T, 1994, NUCLEIC ACIDS RES, V22, P965, DOI 10.1093/nar/22.6.965; Unoki M, 2004, ONCOGENE, V23, P7601, DOI 10.1038/sj.onc.1208053; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; WANG RYH, 1986, NUCLEIC ACIDS RES, V14, P1599, DOI 10.1093/nar/14.4.1599; Yoon HG, 2003, MOL CELL, V12, P723, DOI 10.1016/j.molcel.2003.08.008; ZHANG XY, 1991, VIROLOGY, V182, P865, DOI 10.1016/0042-6822(91)90631-K; ZHANG XY, 1990, CANCER RES, V50, P6865; ZHANG XY, 1993, MOL CELL BIOL, V13, P6810, DOI 10.1128/MCB.13.11.6810; ZHANG XY, 1989, NUCLEIC ACIDS RES, V17, P1459, DOI 10.1093/nar/17.4.1459; ZHANG XY, 1990, NUCLEIC ACIDS RES, V18, P6253, DOI 10.1093/nar/18.21.6253	58	38	39	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25884	10.1371/journal.pone.0025884	http://dx.doi.org/10.1371/journal.pone.0025884			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991380	Green Published, gold, Green Submitted			2022-12-27	WOS:000295943000091
J	Guillen-Ahlers, H; Tan, JN; Castellino, FJ; Ploplis, VA				Guillen-Ahlers, Hector; Tan, Jiangning; Castellino, Francis J.; Ploplis, Victoria A.			Effect of Sulindac Sulfide on Metallohydrolases in the Human Colon Cancer Cell Line HT-29	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; METALLOPROTEINASE MATRILYSIN; APC(MIN/+) MICE; EXPRESSION; GROWTH; CARCINOMAS; HYDROLASE; APOPTOSIS; POLYPOSIS	Matrix metalloproteinase 7 (MMP7), a metallohydrolase involved in the development of several cancers, is downregulated in the Apc(Min/+) colon cancer mouse model following sulindac treatment. To determine whether this effect is relevant to the human condition, HT-29 human colon cancer cells were treated with sulindac and its metabolites, and compared to results obtained from in vivo mouse studies. The expression of MMP7 was monitored. The results demonstrated that sulindac sulfide effectively downregulated both MMP7 expression and activity. Furthermore, activity-based proteomics demonstrated that sulindac sulfide dramatically decreased the activity of leukotriene A4 hydrolase in HT-29 cells as reflected by a decrease in the level of its product, leukotriene B4. This study demonstrates that the effect of sulindac treatment in a mouse model of colon cancer may be relevant to the human counterpart and highlights the effect of sulindac treatment on metallohydrolases.	[Guillen-Ahlers, Hector; Tan, Jiangning; Castellino, Francis J.; Ploplis, Victoria A.] Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA; [Guillen-Ahlers, Hector; Castellino, Francis J.; Ploplis, Victoria A.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Castellino, Francis J.; Ploplis, Victoria A.] Univ Notre Dame, Harper Canc Res Inst, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame; University of Notre Dame	Guillen-Ahlers, H (corresponding author), Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA.	vploplis@nd.edu	Tan, Jiangning/B-9069-2014	Guillen Ahlers, Hector/0000-0001-6077-3425	National Institutes of Health (National Heart, Lung, and Blood Institute) [PO1HL07375]	National Institutes of Health (National Heart, Lung, and Blood Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (National Heart, Lung, and Blood Institute) grant PO1HL07375 (to FJC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almendro V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004728; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Boolbol SK, 1996, CANCER RES, V56, P2556; Bortuzzo C, 1996, BBA-LIPID LIPID MET, V1300, P240, DOI 10.1016/0005-2760(96)00003-3; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Chen X, 2004, CURR CANCER DRUG TAR, V4, P267, DOI 10.2174/1568009043333041; FRIEND WG, 1990, AM FAM PHYSICIAN, V41, P891; Guillen-Ahlers H, 2008, CARCINOGENESIS, V29, P1421, DOI 10.1093/carcin/bgn123; Guillen-Ahlers H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009070; Hashida H, 2002, GASTROENTEROLOGY, V122, P376, DOI 10.1053/gast.2002.31095; HIXSON LJ, 1994, CANCER EPIDEM BIOMAR, V3, P433; HIXSON LJ, 1993, AM J GASTROENTEROL, V88, P1652; Jeong CH, 2009, CANCER RES, V69, P5584, DOI 10.1158/0008-5472.CAN-09-0491; Kawabata K, 2005, BIOSCI BIOTECH BIOCH, V69, P307, DOI 10.1271/bbb.69.307; Larrinaga G, 2007, REGUL PEPTIDES, V144, P56, DOI 10.1016/j.regpep.2007.06.002; Mannello F, 2006, RECENT PAT ANTI-CANC, V1, P91, DOI 10.2174/157489206775246421; MCDONNELL S, 1991, MOL CARCINOGEN, V4, P527, DOI 10.1002/mc.2940040617; Powell WC, 1999, CURR BIOL, V9, P1441, DOI 10.1016/S0960-9822(00)80113-X; Sieber SA, 2006, NAT CHEM BIOL, V2, P274, DOI 10.1038/nchembio781; Speers AE, 2004, CHEM BIOL, V11, P535, DOI 10.1016/j.chembiol.2004.03.012; Sun Q, 2007, J BIOL CHEM, V282, P21998, DOI 10.1074/jbc.M701737200; WADDELL WR, 1983, J SURG ONCOL, V24, P83, DOI 10.1002/jso.2930240119; Wang WS, 2006, CARCINOGENESIS, V27, P1113, DOI 10.1093/carcin/bgi351; Wilson CL, 1997, P NATL ACAD SCI USA, V94, P1402, DOI 10.1073/pnas.94.4.1402; Wolfe MM, 1999, NEW ENGL J MED, V340, P1888, DOI 10.1056/NEJM199906173402407	25	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25725	10.1371/journal.pone.0025725	http://dx.doi.org/10.1371/journal.pone.0025725			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991341	Green Submitted, Green Published, gold			2022-12-27	WOS:000295943000060
J	Anrather, J; Gallo, EF; Kawano, T; Orio, M; Abe, T; Gooden, C; Zhou, P; Iadecola, C				Anrather, Josef; Gallo, Eduardo F.; Kawano, Takayuki; Orio, Marcello; Abe, Takato; Gooden, Camile; Zhou, Ping; Iadecola, Costantino			Purinergic Signaling Induces Cyclooxygenase-1-Dependent Prostanoid Synthesis in Microglia: Roles in the Outcome of Excitotoxic Brain Injury	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; PROSTAGLANDIN E-2; IN-VIVO; NEUROLOGICAL DISEASE; ALZHEIMERS-DISEASE; CEREBRAL-ISCHEMIA; P2X(7) RECEPTORS; OXIDATIVE DAMAGE; MOUSE-BRAIN; ATP	Cyclooxygenases (COX) are prostanoid synthesizing enzymes constitutively expressed in the brain that contribute to excitotoxic neuronal cell death. While the neurotoxic role of COX-2 is well established and has been linked to prostaglandin E-2 synthesis, the role of COX-1 is not clearly understood. In a model of N-Methyl-D-aspartic acid (NMDA) induced excitotoxicity in the mouse cerebral cortex we found a distinctive temporal profile of COX-1 and COX-2 activation where COX-1, located in microglia, is responsible for the early phase of prostaglandin E-2 synthesis (10 minutes after NMDA), while both COX-1 and COX-2 contribute to the second phase (3-24 hours after NMDA). Microglial COX-1 is strongly activated by ATP but not excitatory neurotransmitters or the Toll-like receptor 4 ligand bacterial lipopolysaccharide. ATP induced microglial COX-1 dependent prostaglandin E-2 synthesis is dependent on P2X7 receptors, extracellular Ca2+ and cytoplasmic phospholipase A2. NMDA receptor activation induces ATP release from cultured neurons leading to microglial P2X7 receptor activation and COX-1 dependent prostaglandin E-2 synthesis in mixed microglial-neuronal cultures. Pharmacological inhibition of COX-1 has no effect on the cortical lesion produced by NMDA, but counteracts the neuroprotection exerted by inhibition of COX-2 or observed in mice lacking the prostaglandin E-2 receptor type 1. Similarly, the neuroprotection exerted by the prostaglandin E-2 receptor type 2 agonist butaprost is not observed after COX-1 inhibition. P2X7 receptors contribute to NMDA induced prostaglandin E-2 production in vivo and blockage of P2X7 receptors reverses the neuroprotection offered by COX-2 inhibition. These findings suggest that purinergic signaling in microglia triggered by neuronal ATP modulates excitotoxic cortical lesion by regulating COX-1 dependent prostanoid production and unveil a previously unrecognized protective role of microglial COX-1 in excitotoxic brain injury.	[Anrather, Josef; Gallo, Eduardo F.; Kawano, Takayuki; Orio, Marcello; Abe, Takato; Gooden, Camile; Zhou, Ping; Iadecola, Costantino] Weill Cornell Med Coll, Div Neurobiol, Dept Neurol & Neurosci, New York, NY USA	Cornell University	Anrather, J (corresponding author), Weill Cornell Med Coll, Div Neurobiol, Dept Neurol & Neurosci, New York, NY USA.	joa2006@med.cornell.edu	Gallo, Eduardo/GPP-1460-2022; Iadecola, c/ABB-8377-2020; Abe, Takato/L-8393-2013	Abe, Takato/0000-0002-4185-5254; Iadecola, Costantino/0000-0001-9797-073X; Gallo, Eduardo F./0000-0001-9906-1425	US National Institutes of Health (NIH) [NS035806]; NIH/National Institute of Neurological Disorders and Stroke; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035806] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by US National Institutes of Health (NIH) grant NS035806. C.I. is the recipient of a Javits award from NIH/National Institute of Neurological Disorders and Stroke. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad AS, 2006, J NEUROTRAUM, V23, P1895, DOI 10.1089/neu.2006.23.1895; Ahmad AS, 2005, BRAIN RES, V1066, P71, DOI 10.1016/j.brainres.2005.10.068; Ahmad AS, 2006, TOXICOL SCI, V89, P265, DOI 10.1093/toxsci/kfj022; Akanuma S, 2010, J PHARMACOL EXP THER, V333, P912, DOI 10.1124/jpet.109.165332; Akundi RS, 2005, GLIA, V51, P199, DOI 10.1002/glia.20198; Andreasson K, 2010, PROSTAG OTH LIPID M, V91, P104, DOI 10.1016/j.prostaglandins.2009.04.003; Bernardo A, 2006, CURR PHARM DESIGN, V12, P93, DOI 10.2174/138161206780574579; Bianchi BR, 1999, EUR J PHARMACOL, V376, P127, DOI 10.1016/S0014-2999(99)00350-7; Brostjan C, 1996, J BIOL CHEM, V271, P19612, DOI 10.1074/jbc.271.32.19612; Brown P, 2002, J PHYSIOL-LONDON, V540, P851; Candelario-Jalil E, 2003, J NEUROCHEM, V86, P545, DOI 10.1046/j.1471-4159.2003.01812.x; Choi SH, 2008, FASEB J, V22, P1491, DOI 10.1096/fj.07-9411com; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Deininger MH, 1999, J NEUROIMMUNOL, V95, P202, DOI 10.1016/S0165-5728(98)00257-4; Farber K, 2006, PFLUG ARCH EUR J PHY, V452, P615, DOI 10.1007/s00424-006-0064-7; HASSAN NF, 1991, J LEUKOCYTE BIOL, V50, P86, DOI 10.1002/jlb.50.1.86; Hoozemans JJM, 2002, BRAIN RES, V951, P218, DOI 10.1016/S0006-8993(02)03164-5; HUANG PL, 1993, CELL, V75, P1273, DOI 10.1016/0092-8674(93)90615-W; Iadecola C, 2001, J CEREBR BLOOD F MET, V21, P1436, DOI 10.1097/00004647-200112000-00008; Kang YJ, 2007, PROG LIPID RES, V46, P108, DOI 10.1016/j.plipres.2007.01.001; Kawano T, 2006, NAT MED, V12, P225, DOI 10.1038/nm1362; Kwon KJ, 2005, J NEUROSCI RES, V81, P73, DOI 10.1002/jnr.20520; Ladecola C, 2001, P NATL ACAD SCI USA, V98, P1294, DOI 10.1073/pnas.98.3.1294; LANGENBACH R, 1995, CELL, V83, P483, DOI 10.1016/0092-8674(95)90126-4; Liang X, 2007, J MOL NEUROSCI, V33, P94, DOI 10.1007/s12031-007-0058-8; Liang XB, 2005, J NEUROSCI, V25, P10180, DOI 10.1523/JNEUROSCI.3591-05.2005; Liang XB, 2005, J NEUROCHEM, V92, P477, DOI 10.1111/j.1471-4159.2004.02870.x; Manabe Y, 2004, ANN NEUROL, V55, P668, DOI 10.1002/ana.20078; MARTINS JP, 2011, BRIT J PHARM; McCullough L, 2004, J NEUROSCI, V24, P257, DOI 10.1523/JNEUROSCI.4485-03.2004; Melani A, 2005, NEUROCHEM INT, V47, P442, DOI 10.1016/j.neuint.2005.05.014; Minghetti L, 2004, J NEUROPATH EXP NEUR, V63, P901, DOI 10.1093/jnen/63.9.901; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; MURGIA M, 1993, J BIOL CHEM, V268, P8199; Niwa K, 2001, CIRC RES, V88, P600, DOI 10.1161/01.RES.88.6.600; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Pankratov Y, 2006, PFLUG ARCH EUR J PHY, V452, P589, DOI 10.1007/s00424-006-0061-x; Pearson VL, 1999, GLIA, V25, P311, DOI 10.1002/(SICI)1098-1136(19990215)25:4<311::AID-GLIA1>3.3.CO;2-5; Pepicelli O, 2005, J NEUROCHEM, V93, P1561, DOI 10.1111/j.1471-4159.2005.03150.x; Phillis JW, 2006, BRAIN RES REV, V52, P201, DOI 10.1016/j.brainresrev.2006.02.002; Sasaki T, 2004, J CEREBR BLOOD F MET, V24, P107, DOI 10.1097/01.WCB.0000100065.36077.4A; Saura J, 2003, GLIA, V44, P183, DOI 10.1002/glia.10274; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Sperlagh B, 2006, PROG NEUROBIOL, V78, P327, DOI 10.1016/j.pneurobio.2006.03.007; Stock JL, 2001, J CLIN INVEST, V107, P325, DOI 10.1172/JCI6749; Taniguchi H, 2007, J NEUROSCI, V27, P4303, DOI 10.1523/JNEUROSCI.0321-07.2007; Turrin NP, 2006, MOL NEUROBIOL, V34, P221, DOI 10.1385/MN:34:3:221; Wang H, 2005, CEREB CORTEX, V15, P1250, DOI 10.1093/cercor/bhi008; Wu KK, 2005, PROSTAG LEUKOTR ESS, V72, P89, DOI 10.1016/j.plefa.2004.11.001; YAMAGATA K, 1993, NEURON, V11, P371, DOI 10.1016/0896-6273(93)90192-T; Yermakova AV, 1999, J NEUROPATH EXP NEUR, V58, P1135, DOI 10.1097/00005072-199911000-00003; Zhang YH, 2003, J COMP NEUROL, V463, P3, DOI 10.1002/cne.10743	52	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e25916	10.1371/journal.pone.0025916	http://dx.doi.org/10.1371/journal.pone.0025916			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022466	gold, Green Published, Green Submitted			2022-12-27	WOS:000295981600019
J	Stanger-Hall, KF; Hall, DW				Stanger-Hall, Kathrin F.; Hall, David W.			Abstinence-Only Education and Teen Pregnancy Rates: Why We Need Comprehensive Sex Education in the U.S	PLOS ONE			English	Article							5 DEVELOPED-COUNTRIES; UNINTENDED PREGNANCY; UNITED-STATES; POLICIES	The United States ranks first among developed nations in rates of both teenage pregnancy and sexually transmitted diseases. In an effort to reduce these rates, the U.S. government has funded abstinence-only sex education programs for more than a decade. However, a public controversy remains over whether this investment has been successful and whether these programs should be continued. Using the most recent national data (2005) from all U. S. states with information on sex education laws or policies (N = 48), we show that increasing emphasis on abstinence education is positively correlated with teenage pregnancy and birth rates. This trend remains significant after accounting for socioeconomic status, teen educational attainment, ethnic composition of the teen population, and availability of Medicaid waivers for family planning services in each state. These data show clearly that abstinence-only education as a state policy is ineffective in preventing teenage pregnancy and may actually be contributing to the high teenage pregnancy rates in the U. S. In alignment with the new evidence-based Teen Pregnancy Prevention Initiative and the Precaution Adoption Process Model advocated by the National Institutes of Health, we propose the integration of comprehensive sex and STD education into the biology curriculum in middle and high school science classes and a parallel social studies curriculum that addresses risk-aversion behaviors and planning for the future.	[Stanger-Hall, Kathrin F.] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Hall, David W.] Univ Georgia, Dept Genet, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Stanger-Hall, KF (corresponding author), Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA.	ksh@uga.edu	Stanger-Hall, Kathrin/L-1695-2019	Stanger-Hall, Kathrin/0000-0002-6941-4178; Hall, David/0000-0001-7708-6656	University of Georgia Research Foundation	University of Georgia Research Foundation	This work was funded by the University of Georgia Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*ADV YOUTH SEX ED, STAT PROF; Advocates for Youth, 2007, HIST FED ABST ONL FU; Alford S., 2009, ADOLESCENT SEXUAL HL; Bleakley A, 2006, ARCH PEDIAT ADOL MED, V160, P1151, DOI 10.1001/archpedi.160.11.1151; *BZGA, 2006, BZGA WHO C YOUTH SEX; BZgA, 2006, COUNTR PAP YOUTH SEX; Callahan J., 2007, ABSTINENCE ED STATE; *CAN STAT CAN, 2005, PREGN OUTC AG GROUP; *CDC TASKF COMM PR, 2009, GUID COMM PREV SERV; Collins C., 2002, POLICY MONOGRAPH SER; *COUNC COMM EC RES, ACCRA COST LIV IND C; Darroch JE, 2001, FAM PLANN PERSPECT, V33, P244, DOI 10.2307/3030191; Finer LB, 2006, PERSPECT SEX REPRO H, V38, P90, DOI 10.1363/3809006; Frost J. J., 2008, IMPROVING CONTRACEPT; GOLD RB, 2005, MEDICAID CRITCAL SOU; GOODSON P, 2004, ABSTINENCE ED EVALUA; Guttmacher Institute, 2011, STAT POL BRIEF SEX S; HOFFMANN SD, 2006, NUMBERS PUBLIC COSTS; Horn B, 1983, Nurse Pract, V8, P74; *INT COMP, 2006, NAT CAMP PREV TEEN U; Jemmott JB, 2010, ARCH PEDIAT ADOL MED, V164, P152, DOI 10.1001/archpediatrics.2009.267; Kaye K., 2009, FOG ZONE MISPERCEPTI; Kirby D.R., 2007, NATL CAMPAIGN PREVEN; Kohler PK, 2008, J ADOLESCENT HEALTH, V42, P344, DOI 10.1016/j.jadohealth.2007.08.026; Kost K., 2010, US TEENAGE PREGNANCI; KREININ T, 2001, SEXUALLY HLTH AM; MARTIN JA, 2007, NAT VITAL STAT REPOR, V56; *NAT CTR ED STAT, 2007, SAT DAT TABL FIG TAB; National Institutes of Health, 2005, THEOR GLANC APPL HLT; National Research Council (NRC), 1996, NAT SCI ED STAND; Perper K, 2010, CHILD TRENDS PUBLICA; Richards, 2009, NEXT STEPS AM FAMILY; RODRIGUEZ M, 1995, SIECUS REPORT, V28, P1; Santelli J, 2006, J ADOLESCENT HEALTH, V38, P83, DOI 10.1016/j.jadohealth.2005.06.002; *SAS I INC, JMP STAT DISC SOFTW; SCHALET A, 2004, MED GEN MED, V44; *SIECUS, 2005, SIECUS STAT PROF FIS; *SIECUS, REST FAIL TITL 5 ABS; Singh S, 2001, FAM PLANN PERSPECT, V33, P251, DOI 10.2307/3030192; *SPSS INC, SPSS MAC VERS 17 0; Strayhorn Joseph M, 2009, Reprod Health, V6, P14, DOI 10.1186/1742-4755-6-14; Trenholm Christopher, 2007, MATH POLICY RES; Trussell J, 2007, CONTRACEPTION, V75, P168, DOI 10.1016/j.contraception.2006.11.009; *UK DEP ED, 2011, UK DEP ED 2011 18 16; Underhill K, 2007, PLOS MED, V4, P1471, DOI 10.1371/journal.pmed.0040275; *US BUR CENS, 2006, R1901 MED HOUS INC 2; *US HR, CONT FED FUND ABST O; Yang Z, 2010, J ADOLESCENT HEALTH, V46, P517, DOI 10.1016/j.jadohealth.2010.03.021; ZINTH K, 2007, SEX ED LAWS STATES S	49	162	164	4	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e24658	10.1371/journal.pone.0024658	http://dx.doi.org/10.1371/journal.pone.0024658			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834RQ	22022362	Green Published, Green Submitted, gold			2022-12-27	WOS:000295981600002
J	Ashktorab, H; Nguza, B; Fatemi, M; Nouraie, M; Smoot, DT; Schaffer, AA; Kupfer, SS; Camargo, CA; Brim, H				Ashktorab, Hassan; Nguza, Bijou; Fatemi, Mehrnaz; Nouraie, Mehdi; Smoot, Duane T.; Schaeffer, Alejandro A.; Kupfer, Sonia S.; Camargo, Carlos A., Jr.; Brim, Hassan			Case-Control Study of Vitamin D, dickkopf homolog 1 (DKK1) Gene Methylation, VDR Gene Polymorphism and the Risk of Colon Adenoma in African Americans	PLOS ONE			English	Article							D-RECEPTOR GENE; BREAST-CANCER RISK; COLORECTAL-CANCER; RECTAL-CANCER; CIRCULATING 25-HYDROXYVITAMIN-D; D DEFICIENCY; PREVENTION; POPULATION; ASSOCIATIONS; METAANALYSIS	Background: There are sparse data on genetic, epigenetic and vitamin D exposure in African Americans (AA) with colon polyp. Consequently, we evaluated serum 25(OH) D levels, vitamin D receptor (VDR) polymorphisms and the methylation status of the tumor suppressor gene dickkopf homolog 1 (DKK1) as risk factors for colon polyp in this population. Methods: The case-control study consisted of 93 patients with colon polyp (cases) and 187 healthy individuals (controls) at Howard University Hospital. Serum levels of 25(OH)D (including D3, D2, and total) were measured by liquid chromatography-mass spectrometry. DNA analysis focused on 49 single nucleotide polymorphisms (SNPs) in the VDR gene. Promoter methylation analysis of DKK1 was also performed. The resulting data were processed in unadjusted and multivariable logistic regression analyses. Results: Cases and controls differed in vitamin D status (D-3 < 50 nmol/L: Median of 35.5 in cases vs. 36.8 in controls nmol/L; P = 0.05). Low levels of 25(OH)D-3 (< 50 nmol/L) were observed in 86% of cases and 68% of controls and it was associated with higher risks of colon polyp (odds ratio of 2.7, 95% confidence interval 1.3-3.4). The SNP analysis showed no association between 46 VDR polymorphisms and colon polyp. The promoter of the DKK1 gene was unmethylated in 96% of the samples. Conclusion: We found an inverse association between serum 25(OH)D-3 and colon polyp in AAs. VDR SNPs and DKK1 methylation were not associated with colon polyp. Vitamin D levels may in part explain the higher incidence of polyp in AAs.	[Ashktorab, Hassan; Nguza, Bijou; Fatemi, Mehrnaz; Smoot, Duane T.] Howard Univ, Coll Med, Dept Med, Washington, DC 20059 USA; [Ashktorab, Hassan; Nguza, Bijou; Fatemi, Mehrnaz; Smoot, Duane T.] Howard Univ, Ctr Canc, Coll Med, Washington, DC 20059 USA; [Nouraie, Mehdi] Howard Univ, Coll Med, Ctr Sickle Cell Dis, Washington, DC USA; [Brim, Hassan] Howard Univ, Coll Med, Dept Pathol, Washington, DC USA; [Schaeffer, Alejandro A.] NIH, Natl Ctr Biotechnol Informat, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Kupfer, Sonia S.] Univ Chicago, Dept Med, Gastroenterol Sect, Chicago, IL 60637 USA; [Camargo, Carlos A., Jr.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Emergency Med, Boston, MA USA	Howard University; Howard University; Howard University; Howard University; National Institutes of Health (NIH) - USA; University of Chicago; Harvard University; Harvard Medical School; Massachusetts General Hospital	Ashktorab, H (corresponding author), Howard Univ, Coll Med, Dept Med, Washington, DC 20059 USA.	hashktorab@howard.edu	Nouraie, Seyed Mehdi/O-4071-2018; Kupfer, Sonia S/ABD-9416-2021; Ashktorab, hassan/AAJ-2908-2020; Camargo, Carlos A./C-2145-2008; Schaffer, Alejandro A/F-2902-2012; Schaffer, Alejandro/N-1222-2019	Nouraie, Seyed Mehdi/0000-0001-7465-0581; Camargo, Carlos A./0000-0002-5071-7654; 	National Institutes of Health [CA102681]; Massachusetts General Hospital Center for D-receptor Activation Research; NIH, NLM; NATIONAL CANCER INSTITUTE [R01CA102681, K08CA142892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK042086] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM000097] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts General Hospital Center for D-receptor Activation Research; NIH, NLM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported in part by a PHS grant from the National Institutes of Health CA102681, (H.A) and by the Massachusetts General Hospital Center for D-receptor Activation Research (C.A.C). The Cancer Research Foundation (S.S.K.) and the Digestive Disease Research Core Center (P30 DK42086). This work was also supported by the Intramural Research Program of the NIH, NLM (A.A.S.). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SV, 2011, NUTR CANCER, V63, P319, DOI 10.1080/01635581.2011.535960; Ashktorab H, 2003, CLIN CANCER RES, V9, P1112; Ashktorab H, 2009, DIGEST DIS SCI, V54, P1985, DOI 10.1007/s10620-009-0866-5; Barroso E, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-385; Botella-Carretero JI, 2007, CLIN NUTR, V26, P573, DOI 10.1016/j.clnu.2007.05.009; Bronowski C, 2008, MICROBIOL-SGM, V154, P571, DOI 10.1099/mic.0.2007/013086-0; Chan AT, 2010, GASTROENTEROLOGY, V138, P2029, DOI 10.1053/j.gastro.2010.01.057; Chen QY, 2005, P NATL ACAD SCI USA, V102, P14142, DOI 10.1073/pnas.0505018102; Davis CD, 2008, AM J CLIN NUTR, V88, p565S, DOI 10.1093/ajcn/88.2.565S; Dong LM, 2009, CANCER EPIDEM BIOMAR, V18, P2540, DOI 10.1158/1055-9965.EPI-09-0228; Engelman CD, 2008, J CLIN ENDOCR METAB, V93, P3381, DOI 10.1210/jc.2007-2702; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fedirko V, 2010, AM J EPIDEMIOL, V172, P489, DOI 10.1093/aje/kwq157; Gandini S, 2011, INT J CANCER, V128, P1414, DOI 10.1002/ijc.25439; Gao L, 2010, INT J TUBERC LUNG D, V14, P15; Garland CF, 2009, ANN EPIDEMIOL, V19, P468, DOI 10.1016/j.annepidem.2009.03.021; GARLAND CF, 1980, INT J EPIDEMIOL, V9, P227, DOI 10.1093/ije/9.3.227; Houghton LA, 2006, AM J CLIN NUTR, V84, P694, DOI 10.1093/ajcn/84.4.694; Howie BN, 2006, HUM GENET, V120, P58, DOI 10.1007/s00439-006-0182-5; Jemal A, 2009, CANCER EPIDEM BIOMAR, V18, P3349, DOI 10.1158/1055-9965.EPI-09-0740; Jenab M, 2009, CANCER EPIDEM BIOMAR, V18, P2485, DOI 10.1158/1055-9965.EPI-09-0319; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Lee JE, 2011, CANCER PREV RES, V4, P735, DOI 10.1158/1940-6207.CAPR-10-0289; Li C, 2009, DIGEST DIS SCI, V54, P634, DOI 10.1007/s10620-008-0375-y; Looker AC, 2008, J BONE MINER RES, V23, P143, DOI 10.1359/JBMR.071003; Lorente A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-61; Mai V, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-49; Mckay JD, 2009, CANCER EPIDEM BIOMAR, V18, P297, DOI 10.1158/1055-9965.EPI-08-0539; Mohr SB, 2009, ANN EPIDEMIOL, V19, P79, DOI 10.1016/j.annepidem.2008.10.003; Murtaugh MA, 2006, NUTR CANCER, V55, P35, DOI 10.1207/s15327914nc5501_5; Newmark HL, 2009, CARCINOGENESIS, V30, P88, DOI 10.1093/carcin/bgn229; Nouraie M, 2010, DIGEST DIS SCI, V55, P1442, DOI 10.1007/s10620-010-1133-5; Pendas-Franco N, 2008, ANTICANCER RES, V28, P2613; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Roth HJ, 2008, ANN CLIN BIOCHEM, V45, P153, DOI 10.1258/acb.2007.007091; Sharma N, 2004, J CLIN GASTROENTEROL, V38, P844, DOI 10.1097/00004836-200411000-00003; Singh RJ, 2006, J CLIN ENDOCR METAB, V91, P3055, DOI 10.1210/jc.2006-0710; Slattery ML, 2007, NUTR REV, V65, pS102, DOI 10.1111/j.1753-4887.2007.tb00332.x; Slattery ML, 2009, MUTAT RES-FUND MOL M, V660, P12, DOI 10.1016/j.mrfmmm.2008.10.001; Slattery ML, 2006, INT J CANCER, V118, P3140, DOI 10.1002/ijc.21791; Tangpricha V, 2005, J NUTR, V135, P2350, DOI 10.1093/jn/135.10.2350; Touvier M, 2011, CANCER EPIDEM BIOMAR, V20, P1003, DOI 10.1158/1055-9965.EPI-10-1141; Trabert B, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1833; Wei MY, 2008, CANCER EPIDEM BIOMAR, V17, P2958, DOI 10.1158/1055-9965.EPI-08-0402; Zhang CL, 2008, CLIN CHIM ACTA, V395, P111, DOI 10.1016/j.cca.2008.05.019	45	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e25314	10.1371/journal.pone.0025314	http://dx.doi.org/10.1371/journal.pone.0025314			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022386	Green Submitted, gold, Green Published			2022-12-27	WOS:000295978600012
J	Pinto, A; Halliday, C; Zahra, M; van Hal, S; Olma, T; Maszewska, K; Iredell, JR; Meyer, W; Chen, SCA				Pinto, Angie; Halliday, Catriona; Zahra, Melissa; van Hal, Sebastian; Olma, Tom; Maszewska, Krystyna; Iredell, Jonathan R.; Meyer, Wieland; Chen, Sharon C. -A.			Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Identification of Yeasts Is Contingent on Robust Reference Spectra	PLOS ONE			English	Article							CRYPTOCOCCUS-NEOFORMANS; CANDIDA-BRACARENSIS; MULTICENTER; SUSCEPTIBILITY; NIVARIENSIS; GATTII	Background: Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) for yeast identification is limited by the requirement for protein extraction and for robust reference spectra across yeast species in databases. We evaluated its ability to identify a range of yeasts in comparison with phenotypic methods. Methods: MALDI-TOF MS was performed on 30 reference and 167 clinical isolates followed by prospective examination of 67 clinical strains in parallel with biochemical testing (total n = 264). Discordant/unreliable identifications were resolved by sequencing of the internal transcribed spacer region of the rRNA gene cluster. Principal Findings: Twenty (67%; 16 species), and 24 (80%) of 30 reference strains were identified to species, (spectral score >= 2.0) and genus (score >= 1.70)-level, respectively. Of clinical isolates, 140/167 (84%) strains were correctly identified with scores of >= 2.0 and 160/167 (96%) with scores of >= 1.70; amongst Candida spp. (n = 148), correct species assignment at scores of >= 2.0, and >= 1.70 was obtained for 86% and 96% isolates, respectively (vs. 76.4% by biochemical methods). Prospectively, species-level identification was achieved for 79% of isolates, whilst 91% and 94% of strains yielded scores of >= 1.90 and >= 1.70, respectively (100% isolates identified by biochemical methods). All test scores of 1.70-1.90 provided correct species assignment despite being identified to "genus-level''. MALDI-TOF MS identified uncommon Candida spp., differentiated Candida parapsilosis from C. orthopsilosis and C. metapsilosis and distinguished between C. glabrata, C. nivariensis and C. bracarensis. Yeasts with scores of <1.70 were rare species such as C. nivariensis (3/10 strains) and C. bracarensis (n = 1) but included 4/12 Cryptococcus neoformans. There were no misidentifications. Four novel species-specific spectra were obtained. Protein extraction was essential for reliable results. Conclusions: MALDI-TOF MS enabled rapid, reliable identification of clinically-important yeasts. The addition of spectra to databases and reduction in identification scores required for species-level identification may improve its utility.	[Pinto, Angie; Halliday, Catriona; Olma, Tom; Iredell, Jonathan R.; Meyer, Wieland; Chen, Sharon C. -A.] Westmead Hosp, Ctr Infect Dis & Microbiol Lab Serv, Sydney, NSW, Australia; [Zahra, Melissa; van Hal, Sebastian] Sydney SW Pathol Serv, Dept Microbiol & Infect Dis, Sydney, NSW, Australia; [Maszewska, Krystyna; Meyer, Wieland; Chen, Sharon C. -A.] Univ Sydney, Mol Mycol Res Lab, Westmead Millenium Inst, Sydney Med Sch,Westmead Hosp, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; Westmead Institute for Medical Research	Pinto, A (corresponding author), Westmead Hosp, Ctr Infect Dis & Microbiol Lab Serv, Sydney, NSW, Australia.	Sharon.chen@swahs.health.nsw.gov.au	Halliday, Catriona/AAX-7689-2020; Meyer, Wieland/G-1204-2015	Meyer, Wieland/0000-0001-9933-8340; van Hal, Sebastiaan/0000-0001-5852-4155				Alatoom AA, 2011, J CLIN MICROBIOL, V49, P2868, DOI 10.1128/JCM.00506-11; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Atkinson BJ, 2008, MED MYCOL, V46, P541, DOI 10.1080/13693780801968571; Bader O, 2011, CLIN MICROBIOL INFEC, V17, P1359, DOI 10.1111/j.1469-0691.2010.03398.x; Borman AM, 2008, J CLIN MICROBIOL, V46, P933, DOI 10.1128/JCM.02116-07; Carbonnelle E, 2011, CLIN BIOCHEM, V44, P104, DOI 10.1016/j.clinbiochem.2010.06.017; Chen SCA, 2009, CLIN MICROBIOL INFEC, V15, P662, DOI 10.1111/j.1469-0691.2009.02821.x; Ciardo DE, 2006, J CLIN MICROBIOL, V44, P77, DOI 10.1128/JCM.44.1.77-84.2006; Correia A, 2006, INT J SYST EVOL MICR, V56, P313, DOI 10.1099/ijs.0.64076-0; Cuenca-Estrella M, 2011, MED MYCOL, V49, P525, DOI 10.3109/13693786.2010.546373; Dhiman N, 2011, J CLIN MICROBIOL, V49, P1614, DOI 10.1128/JCM.02381-10; Eigner U, 2009, CLIN LAB, V55, P289; Ferroni A, 2010, J CLIN MICROBIOL, V48, P1542, DOI 10.1128/JCM.02485-09; Garey KW, 2006, CLIN INFECT DIS, V43, P25, DOI 10.1086/504810; Girmenia C, 2005, J CLIN MICROBIOL, V43, P1818, DOI 10.1128/JCM.43.4.1818-1828.2005; Hazen KC, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P1762; Hsu DI, 2010, J ANTIMICROB CHEMOTH, V65, P1765, DOI 10.1093/jac/dkq216; Iranzo Tatay A, 2011, 21 ECCMID 27 ICC; James SA, 2001, INT J SYST EVOL MICR, V51, P1917, DOI 10.1099/00207713-51-5-1917; KURTZMAN CP, 1998, YEASTS TAXONOMIC STU, P77; KWONCHUNG KJ, 1982, J CLIN MICROBIOL, V15, P535, DOI 10.1128/JCM.15.3.535-537.1982; Lartigue MF, 2009, J CLIN MICROBIOL, V47, P2284, DOI 10.1128/JCM.00175-09; Lau A, 2009, FUTURE MICROBIOL, V4, P1185, DOI [10.2217/fmb.09.70, 10.2217/FMB.09.70]; Leaw SN, 2006, J CLIN MICROBIOL, V44, P693, DOI 10.1128/JCM.44.3.693-699.2006; Marklein G, 2009, J CLIN MICROBIOL, V47, P2912, DOI 10.1128/JCM.00389-09; McTaggart LR, 2011, J CLIN MICROBIOL, V49, P3050, DOI 10.1128/JCM.00651-11; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Petti CA, 2008, MM18A CLIN LAB STAND, P54; Pfaller MA, 2010, CRIT REV MICROBIOL, V36, P1, DOI 10.3109/10408410903241444; Quiles-Melero I, 2012, EUR J CLIN MICROBIOL, V31, P67, DOI 10.1007/s10096-011-1277-z; Ruan SY, 2009, CLIN INFECT DIS, V49, pE11, DOI 10.1086/599614; Saffert RT, 2011, J CLIN MICROBIOL, V49, P887, DOI 10.1128/JCM.01890-10; Sauer S, 2010, NAT REV MICROBIOL, V8, P74, DOI 10.1038/nrmicro2243; Shepard JR, 2008, J CLIN MICROBIOL, V46, P50, DOI 10.1128/JCM.01385-07; Stevenson LG, 2010, J CLIN MICROBIOL, V48, P3482, DOI 10.1128/JCM.00687-09; Tavanti A, 2005, J CLIN MICROBIOL, V43, P284, DOI 10.1128/JCM.43.1.284-292.2005; van Asbeck E, 2008, DIAGN MICR INFEC DIS, V62, P106, DOI 10.1016/j.diagmicrobio.2008.04.019; van Veen SQ, 2010, J CLIN MICROBIOL, V48, P900, DOI 10.1128/JCM.02071-09; White TJ., 1990, PCR PROTOCOLS GUIDE, P315	39	112	115	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e25712	10.1371/journal.pone.0025712	http://dx.doi.org/10.1371/journal.pone.0025712			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022438	Green Published, Green Submitted, gold			2022-12-27	WOS:000295978600027
J	Denic, A; Macura, SI; Warrington, AE; Pirko, I; Grossardt, BR; Pease, LR; Rodriguez, M				Denic, Aleksandar; Macura, Slobodan I.; Warrington, Arthur E.; Pirko, Istvan; Grossardt, Brandon R.; Pease, Larry R.; Rodriguez, Moses			A Single Dose of Neuron-Binding Human Monoclonal Antibody Improves Spontaneous Activity in a Murine Model of Demyelination	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; BEHAVIORAL-RESPONSES; DEFICITS; RATS; INJURY; METHYLPHENIDATE; ABSENCE; LESIONS; MYELIN; MICE	Our laboratory demonstrated that a natural human serum antibody, sHIgM12, binds to neurons in vitro and promotes neurite outgrowth. We generated a recombinant form, rHIgM12, with identical properties. Intracerebral infection with Theiler's Murine Encephalomyelitis Virus (TMEV) of susceptible mouse strains results in chronic demyelinating disease with progressive axonal loss and neurologic dysfunction similar to progressive forms of multiple sclerosis. To study the effects of rHIgM12 on the motor function of TMEV-infected mice, we monitored spontaneous nocturnal activity over many weeks. Nocturnal behavior is a sensitive measure of rodent neurologic function because maximal activity changes are expected to occur during the normally active night time monitoring period. Mice were placed in activity boxes eight days prior to treatment to collect baseline spontaneous activity. After treatment, activity in each group was continuously recorded over 8 weeks. We chose a long 8-week monitoring period for two reasons: (1) we previously demonstrated that IgM induced remyelination is present by 5 weeks post treatment, and (2) TMEV-induced demyelinating disease in this strain progresses very slowly. Due to the long observation periods and large data sets, differences among treatment groups may be difficult to appreciate studying the original unfiltered recordings. To clearly delineate changes in the highly fluctuating original data we applied three different methods: (1) binning, (2) application of Gaussian low-pass filters (GF) and (3) polynomial fitting. Using each of the three methods we showed that compared to control IgM and saline, early treatment with rHIgM12 induced improvement in both horizontal and vertical motor function, whereas later treatment improved only horizontal activity. rHIgM12 did not alter activity of normal, uninfected mice. This study supports the hypothesis that treatment with a neuron-binding IgM not only protects neurons in vitro, but also influences functional motor improvement.	[Denic, Aleksandar; Warrington, Arthur E.; Pirko, Istvan; Rodriguez, Moses] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA; [Macura, Slobodan I.] Mayo Clin, Dept Biochem, Rochester, MN USA; [Grossardt, Brandon R.] Mayo Clin, Dept Biomed Stat, Rochester, MN USA; [Pease, Larry R.; Rodriguez, Moses] Mayo Clin, Dept Immunol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Denic, A (corresponding author), Mayo Clin, Dept Neurol, Rochester, MN 55905 USA.	rodriguez.moses@mayo.edu	Grossardt, Brandon R/A-9554-2019	Grossardt, Brandon R/0000-0001-7112-9061; Denic, Aleksandar/0000-0001-9157-5405; Rodriguez, Moses/0000-0001-6328-6497	National Institutes of Health [R01 GM092993, R01 NS024180, R01 NS032129, R01 NS048357, R21 NS073684]; National Multiple Sclerosis Society [CA 1060A11]; Applebaum Foundation; Hilton Foundation; Minnesota Partnership Award for Biotechnology and Medical Genomics; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032129, R01NS024180, R01NS048357, R21NS073684] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Applebaum Foundation; Hilton Foundation; Minnesota Partnership Award for Biotechnology and Medical Genomics; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health (R01 GM092993, R01 NS024180, R01 NS032129, R01 NS048357 and R21 NS073684) and the National Multiple Sclerosis Society (CA 1060A11). The authors also acknowledge, with thanks, support from the Applebaum and Hilton Foundations and the Minnesota Partnership Award for Biotechnology and Medical Genomics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Denic A., 2010, PATHOPHYSIOLOGY, V18, P21; Hoch JC, 1996, NMR DATA PROCESSING; Howe CL, 2007, NEUROBIOL DIS, V25, P354, DOI 10.1016/j.nbd.2006.10.001; JACOBS L, 1986, ARCH NEUROL-CHICAGO, V43, P452, DOI 10.1001/archneur.1986.00520050032017; Jones MV, 2008, J NEUROIMMUNOL, V199, P83, DOI 10.1016/j.jneuroim.2008.05.013; Li X, 2009, PSYCHOPHARMACOLOGY, V204, P1, DOI 10.1007/s00213-008-1432-0; McGavern DB, 1999, EXP NEUROL, V158, P171, DOI 10.1006/exnr.1999.7082; McGavern DB, 2000, BRAIN, V123, P519, DOI 10.1093/brain/123.3.519; Melnick SM, 2001, PHARMACOL BIOCHEM BE, V69, P219, DOI 10.1016/S0091-3057(01)00545-7; Mikami Y, 2004, J NEUROSCI RES, V76, P453, DOI 10.1002/jnr.20086; Mikami Y, 2002, J NEUROSURG, V97, P142, DOI 10.3171/spi.2002.97.1.0142; Pohl D, 2006, J PEDIATR-US, V149, P125, DOI 10.1016/j.jpeds.2006.01.003; Rivera-Quinones C, 1998, NAT MED, V4, P187, DOI 10.1038/nm0298-187; Rodriguez M, 2003, BRAIN, V126, P751, DOI 10.1093/brain/awg070; Shen H, 2005, STROKE, V36, P654, DOI 10.1161/01.STR.0000155747.15679.04; Torres-Reveron A, 2006, NEUROTOXICOL TERATOL, V28, P165, DOI 10.1016/j.ntt.2005.12.005; Warrington AE, 2004, J NEUROPATH EXP NEUR, V63, P461, DOI 10.1093/jnen/63.5.461; Warrington AE, 2000, P NATL ACAD SCI USA, V97, P6820, DOI 10.1073/pnas.97.12.6820; Warrington AE, 2007, J NEUROSCI RES, V85, P967, DOI 10.1002/jnr.21217; Zhu N, 2007, BEHAV NEUROSCI, V121, P1272, DOI 10.1037/0735-7044.121.6.1272	21	17	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26001	10.1371/journal.pone.0026001	http://dx.doi.org/10.1371/journal.pone.0026001			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022490	gold, Green Submitted, Green Published			2022-12-27	WOS:000295976000052
J	Reinhold, WC; Erliandri, I; Liu, HF; Zoppoli, G; Pommier, Y; Larionov, V				Reinhold, William C.; Erliandri, Indri; Liu, Hongfang; Zoppoli, Gabriele; Pommier, Yves; Larionov, Vladimir			Identification of a Predominant Co-Regulation among Kinetochore Genes, Prospective Regulatory Elements, and Association with Genomic Instability	PLOS ONE			English	Article							CELL-LINE PANEL; CENP-A; CHROMOSOME SEGREGATION; MICROTUBULE INTERFACE; EXPRESSION PROFILES; OUTER KINETOCHORE; COLORECTAL-CANCER; CENTROMERE; COMPLEX; ANEUPLOIDY	The NCI-60 cell line panel is the most extensively characterized set of cells in existence, and has been used extensively as a screening tool for drug discovery. Previously, the potential of this panel has not been applied to the fundamental cellular processes of chromosome segregation. In the current study, we used data from multiple microarray platforms accumulated for the NCI-60 to characterize an expression pattern of genes involved in kinetochore assembly. This analysis revealed that 17 genes encoding the constitutive centromere associated network of the kinetochore core (the CCAN complex) plus four additional genes with established importance in kinetochore maintenance (CENPE, CENPF, INCENP, and MIS12) exhibit similar patterns of expression in the NCI-60, suggesting a mechanism for co-regulated transcription of these genes which is maintained despite the multiple genetic and epigenetic rearrangements accumulated in these cells (such as variations in DNA copy number and karyotypic complexity). A complex group of potential regulatory influences are identified for these genes, including the transcription factors CREB1, E2F1, FOXE1, and FOXM1, DNA copy number variation, and microRNAs has-miR-200a, 23a, 23b, 30a, 30c, 27b, 374b, 365. Thus, our results provide a template for experimental studies on the regulation of genes encoding kinetochore proteins, the process that, when aberrant, leads to the aneuploidy that is a hallmark of many cancers. We propose that the comparison of expression profiles in the NCI-60 cell line panel could be a tool for the identification of other gene groups whose products are involved in the assembly of organelle protein complexes.	[Reinhold, William C.; Erliandri, Indri; Liu, Hongfang; Zoppoli, Gabriele; Pommier, Yves; Larionov, Vladimir] NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Liu, Hongfang] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA; [Zoppoli, Gabriele] Univ Genoa, Dept Internal Med, I-16126 Genoa, Italy	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Mayo Clinic; University of Genoa	Reinhold, WC (corresponding author), NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	wcr@mail.nih.gov; larionov@mail.nih.gov	Zoppoli, Gabriele/B-6935-2016; Zoppoli, Gabriele/B-6935-2016; Reinhold, William/J-6704-2017	Zoppoli, Gabriele/0000-0003-3890-5588; Zoppoli, Gabriele/0000-0002-1619-1708; Reinhold, William/0000-0001-5513-9323	National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC010413] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009959] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Funding for this work is from the National Cancer Institute's intramural funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RR, 2001, CHROMOSOMA, V110, P65, DOI 10.1007/s004120100130; Amato A, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-119; Amor DJ, 2004, TRENDS CELL BIOL, V14, P359, DOI 10.1016/j.tcb.2004.05.009; Bomont P, 2005, EMBO J, V24, P3927, DOI 10.1038/sj.emboj.7600848; Boyd M. R., 1989, CANCER PRINCIPLES PR, V3, P1; Bussey KJ, 2006, MOL CANCER THER, V5, P853, DOI 10.1158/1535-7163.MCT-05-0155; CARROLL CW, 2010, J CELL BIOL; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Chiu SH, 2008, ARTIF INTELL MED, V44, P221, DOI 10.1016/j.artmed.2008.06.005; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Dunleavy EM, 2009, CELL, V137, P485, DOI 10.1016/j.cell.2009.02.040; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Goshima G, 1999, GENE DEV, V13, P1664, DOI 10.1101/gad.13.13.1664; Haferlach T, 2010, J CLIN ONCOL, V28, P2529, DOI 10.1200/JCO.2009.23.4732; Hemmerich P, 2008, J CELL BIOL, V180, P1101, DOI 10.1083/jcb.200710052; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Hori T, 2008, MOL BIOL CELL, V19, P843, DOI 10.1091/mbc.E07-06-0556; Hori T, 2008, CELL, V135, P1039, DOI 10.1016/j.cell.2008.10.019; Ikediobi ON, 2006, MOL CANCER THER, V5, P2606, DOI 10.1158/1535-7163.MCT-06-0433; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kline SL, 2006, J CELL BIOL, V173, P9, DOI 10.1083/jcb.200509158; Larsen R, 2000, INTRO MATH STAT ITS; LEUNG W, 2010, CANC EPIDEMIOL; LIU H, 2010, CANC BIOL THER, V9; Liu HF, 2010, MOL CANCER THER, V9, P1080, DOI 10.1158/1535-7163.MCT-09-0965; Liu ST, 2006, J CELL BIOL, V175, P41, DOI 10.1083/jcb.200606020; Lorenzi PL, 2009, MOL CANCER THER, V8, P713, DOI 10.1158/1535-7163.MCT-08-0921; Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536; Nishizuka S, 2003, P NATL ACAD SCI USA, V100, P14229, DOI 10.1073/pnas.2331323100; Obuse C, 2004, NAT CELL BIOL, V6, P1135, DOI 10.1038/ncb1187; Oh HJ, 2010, CURR BIOL, V20, P416, DOI 10.1016/j.cub.2009.12.054; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; ONKEN MD, 2010, J MOL DIAGN; Pellman D, 2007, NATURE, V446, P38, DOI 10.1038/446038a; Rajagopalan H, 2004, NATURE, V432, P338, DOI 10.1038/nature03099; Reinhold WC, 2010, CANCER RES, V70, P2191, DOI 10.1158/0008-5472.CAN-09-3528; Ren J, 2010, NUCLEIC ACIDS RES, V38, pD155, DOI 10.1093/nar/gkp784; Roschke AV, 2003, CANCER RES, V63, P8634; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; Schueler MG, 2006, ANNU REV GENOM HUM G, V7, P301, DOI 10.1146/annurev.genom.7.080505.115613; Shankavaram UT, 2007, MOL CANCER THER, V6, P820, DOI 10.1158/1535-7163.MCT-06-0650; Sillars-Hardebol AH, 2010, TUMOR BIOL, V31, P89, DOI 10.1007/s13277-009-0012-1; SULLIVAN KF, 1994, J CELL BIOL, V127, P581, DOI 10.1083/jcb.127.3.581; Suzuki N, 2004, J BIOL CHEM, V279, P5934, DOI 10.1074/jbc.M306477200; Tomonaga T, 2005, CANCER RES, V65, P4683, DOI 10.1158/0008-5472.CAN-04-3613; Tomonaga T, 2003, CANCER RES, V63, P3511; Wu ZJ, 2005, J COMPUT BIOL, V12, P882, DOI 10.1089/cmb.2005.12.882; YEN TJ, 1992, NATURE, V359, P536, DOI 10.1038/359536a0	50	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25991	10.1371/journal.pone.0025991	http://dx.doi.org/10.1371/journal.pone.0025991			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016797	Green Published, gold, Green Submitted			2022-12-27	WOS:000295971700031
J	Gilson, M; Fukai, T				Gilson, Matthieu; Fukai, Tomoki			Stability versus Neuronal Specialization for STDP: Long-Tail Weight Distributions Solve the Dilemma	PLOS ONE			English	Article							TIMING-DEPENDENT PLASTICITY; ASYMMETRIC HEBBIAN PLASTICITY; SYNAPTIC PLASTICITY; LEARNING RULE; MODELS; CONNECTIVITY; RETENTION; SYNAPSES; NETWORKS; DYNAMICS	Spike-timing-dependent plasticity (STDP) modifies the weight (or strength) of synaptic connections between neurons and is considered to be crucial for generating network structure. It has been observed in physiology that, in addition to spike timing, the weight update also depends on the current value of the weight. The functional implications of this feature are still largely unclear. Additive STDP gives rise to strong competition among synapses, but due to the absence of weight dependence, it requires hard boundaries to secure the stability of weight dynamics. Multiplicative STDP with linear weight dependence for depression ensures stability, but it lacks sufficiently strong competition required to obtain a clear synaptic specialization. A solution to this stability-versus-function dilemma can be found with an intermediate parametrization between additive and multiplicative STDP. Here we propose a novel solution to the dilemma, named log-STDP, whose key feature is a sublinear weight dependence for depression. Due to its specific weight dependence, this new model can produce significantly broad weight distributions with no hard upper bound, similar to those recently observed in experiments. Log-STDP induces graded competition between synapses, such that synapses receiving stronger input correlations are pushed further in the tail of (very) large weights. Strong weights are functionally important to enhance the neuronal response to synchronous spike volleys. Depending on the input configuration, multiple groups of correlated synaptic inputs exhibit either winner-share-all or winner-take-all behavior. When the configuration of input correlations changes, individual synapses quickly and robustly readapt to represent the new configuration. We also demonstrate the advantages of log-STDP for generating a stable structure of strong weights in a recurrently connected network. These properties of log-STDP are compared with those of previous models. Through long-tail weight distributions, log-STDP achieves both stable dynamics for and robust competition of synapses, which are crucial for spike-based information processing.	[Gilson, Matthieu; Fukai, Tomoki] Riken Brain Sci Inst, Lab Neural Circuit Theory, Saitama, Japan; [Gilson, Matthieu; Fukai, Tomoki] Japan Sci & Technol Agcy, Tokyo, Japan; [Gilson, Matthieu; Fukai, Tomoki] RIKEN Computat Sci Res Program, Brain & Neural Syst Team, Saitama, Japan	RIKEN; Japan Science & Technology Agency (JST); RIKEN	Gilson, M (corresponding author), Riken Brain Sci Inst, Lab Neural Circuit Theory, Saitama, Japan.	gilson@brain.riken.jp	Fukai, Tomoki/A-3936-2015	Fukai, Tomoki/0000-0001-6977-5638	Japan Science and Technology Agency; Core Research for Evolutional Science and Technology	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Core Research for Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST))	The present research was supported by the Japan Science and Technology Agency and Core Research for Evolutional Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asrican B, 2007, J NEUROSCI, V27, P14007, DOI 10.1523/JNEUROSCI.3587-07.2007; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Billings G, 2009, J NEUROPHYSIOL, V101, P2775, DOI 10.1152/jn.91007.2008; Buchanan Katherine A, 2010, Front Synaptic Neurosci, V2, P11, DOI 10.3389/fnsyn.2010.00011; Burkitt AN, 2004, NEURAL COMPUT, V16, P885, DOI 10.1162/089976604773135041; Caporale N, 2008, ANNU REV NEUROSCI, V31, P25, DOI 10.1146/annurev.neuro.31.060407.125639; Cateau H, 2003, NEURAL COMPUT, V15, P597, DOI 10.1162/089976603321192095; Chen W, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-3; Clopath C, 2010, NAT NEUROSCI, V13, P344, DOI 10.1038/nn.2479; Froemke Robert C, 2010, Front Synaptic Neurosci, V2, P19, DOI 10.3389/fnsyn.2010.00019; Fukai T, 2001, BIOL CYBERN, V85, P107, DOI 10.1007/PL00007998; Gerstner W, 1996, NATURE, V383, P76, DOI 10.1038/383076a0; Gilson M, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00023; Gilson M, 2010, BIOL CYBERN, V103, P365, DOI 10.1007/s00422-010-0405-7; Gilson M, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.021912; Graupner M, 2007, PLOS COMPUT BIOL, V3, P2299, DOI 10.1371/journal.pcbi.0030221; Gutig R, 2003, J NEUROSCI, V23, P3697; Hennequin G, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00143; Izhikevich EM, 2003, NEURAL COMPUT, V15, P1511, DOI 10.1162/089976603321891783; Izhikevich EM, 2006, NEURAL COMPUT, V18, P245, DOI 10.1162/089976606775093882; Kang S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000022; Kempter R, 1999, PHYS REV E, V59, P4498, DOI 10.1103/PhysRevE.59.4498; Koulakov AA, 2009, J NEUROSCI, V29, P3685, DOI 10.1523/JNEUROSCI.4500-08.2009; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Lubenov EV, 2008, NEURON, V58, P118, DOI 10.1016/j.neuron.2008.01.036; Masquelier T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001377; Meffin H, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.041911; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Morrison A, 2008, BIOL CYBERN, V98, P459, DOI 10.1007/s00422-008-0233-1; Morrison A, 2007, NEURAL COMPUT, V19, P1437, DOI 10.1162/neco.2007.19.6.1437; Nishiyama Makoto, 2010, Front Synaptic Neurosci, V2, P22, DOI 10.3389/fnsyn.2010.00022; Petersen CCH, 1998, P NATL ACAD SCI USA, V95, P4732, DOI 10.1073/pnas.95.8.4732; Pfister JP, 2006, J NEUROSCI, V26, P9673, DOI 10.1523/JNEUROSCI.1425-06.2006; Rubin J, 2001, PHYS REV LETT, V86, P364, DOI 10.1103/PhysRevLett.86.364; Savin C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000757; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Song S, 2001, NEURON, V32, P339, DOI 10.1016/S0896-6273(01)00451-2; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; van Rossum MCW, 2001, NEUROCOMPUTING, V38, P409, DOI 10.1016/S0925-2312(01)00360-5; van Rossum MCW, 2000, J NEUROSCI, V20, P8812; Yasumatsu N, 2008, J NEUROSCI, V28, P13592, DOI 10.1523/JNEUROSCI.0603-08.2008; Zou Q, 2007, BIOL CYBERN, V97, P81, DOI [10.1007/s00422-007-0155-3, 10.1007/S00422-007-0155-3]	42	55	60	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25339	10.1371/journal.pone.0025339	http://dx.doi.org/10.1371/journal.pone.0025339			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003389	Green Published, gold, Green Submitted			2022-12-27	WOS:000295970300010
J	Redondo, N; Sanz, MA; Welnowska, E; Carrasco, L				Redondo, Natalia; Angel Sanz, Miguel; Welnowska, Ewelina; Carrasco, Luis			Translation without eIF2 Promoted by Poliovirus 2A Protease	PLOS ONE			English	Article							INITIATION-FACTOR 4G; CAP-INDEPENDENT TRANSLATION; YEAST SACCHAROMYCES-CEREVISIAE; RIBOSOME ENTRY SITES; EUKARYOTIC TRANSLATION; MESSENGER-RNA; MAMMALIAN-CELLS; FACTOR-II; IN-VIVO; MEMBRANE PROLIFERATION	Poliovirus RNA utilizes eIF2 for the initiation of translation in cell free systems. Remarkably, we now describe that poliovirus translation takes place at late times of infection when eIF2 is inactivated by phosphorylation. By contrast, translation directed by poliovirus RNA is blocked when eIF2 is inactivated at earlier times. Thus, poliovirus RNA translation exhibits a dual mechanism for the initiation of protein synthesis as regards to the requirement for eIF2. Analysis of individual poliovirus non-structural proteins indicates that the presence of 2A(pro) alone is sufficient to provide eIF2 independence for IRES-driven translation. This effect is not observed with a 2A(pro) variant unable to cleave eIF4G. The level of 2A(pro) synthesized in culture cells is crucial for obtaining eIF2 independence. Expression of the N-or C-terminus fragments of eIF4G did not stimulate IRES-driven translation, nor provide eIF2 independence, consistent with the idea that the presence of 2A(pro) at high concentrations is necessary. The finding that 2A(pro) provides eIF2-independent translation opens a new and unsuspected area of research in the field of picornavirus protein synthesis.	[Redondo, Natalia; Angel Sanz, Miguel; Welnowska, Ewelina; Carrasco, Luis] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, CSIC, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Redondo, N (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, CSIC, Madrid, Spain.	nsevillano@cbm.uam.es	Carrasco, Luis/E-2435-2012; Carrasco, Luis/H-3001-2017; Sanz, Miguel A/H-1914-2015; sanz-gomez, miguel/Y-6244-2019	Carrasco, Luis/0000-0003-3833-8835; Sanz, Miguel A/0000-0001-6573-883X; sanz-gomez, miguel/0000-0002-5761-9010; REDONDO, NATALIA/0000-0001-9356-8102	DGICYT (Direccion General de Investigacion Cientifica y Tecnica. Ministerio de Educacion y Ciencia. SPAIN) [BFU2009-07352]; FPI (Formacion de Personal Investigador); FPU (Formacion de Profesorado Universitario); Fundacion Ramon Areces	DGICYT (Direccion General de Investigacion Cientifica y Tecnica. Ministerio de Educacion y Ciencia. SPAIN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FPI (Formacion de Personal Investigador)(Spanish Government); FPU (Formacion de Profesorado Universitario)(Spanish Government); Fundacion Ramon Areces	This study was supported by a DGICYT (Direccion General de Investigacion Cientifica y Tecnica. Ministerio de Educacion y Ciencia. SPAIN) grant (BFU2009-07352). NR and EW are holders of FPI (Formacion de Personal Investigador) and FPU (Formacion de Profesorado Universitario) fellowships, respectively. The Institutional Grant awarded to the Centro de Biologia Molecular "Severo Ochoa'' by the Fundacion Ramon Areces is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDABE R, 1995, BIOCHEM BIOPH RES CO, V215, P928, DOI 10.1006/bbrc.1995.2553; ALDABE R, 1995, BIOCHEM BIOPH RES CO, V206, P64, DOI 10.1006/bbrc.1995.1010; Aldabe R, 1996, J BIOL CHEM, V271, P23134, DOI 10.1074/jbc.271.38.23134; Aldabe R, 1995, FEBS LETT, V377, P1, DOI 10.1016/0014-5793(95)01269-9; Ali IK, 2001, J VIROL, V75, P7854, DOI 10.1128/JVI.75.17.7854-7863.2001; Alvarez E, 2003, J VIROL, V77, P12392, DOI 10.1128/JVI.77.23.12392-12400.2003; ANDINO R, 1993, EMBO J, V12, P3587, DOI 10.1002/j.1460-2075.1993.tb06032.x; Sanz MA, 2010, J MOL BIOL, V402, P101, DOI 10.1016/j.jmb.2010.07.014; Sanz MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004772; Aragon T, 2000, MOL CELL BIOL, V20, P6259, DOI 10.1128/MCB.20.17.6259-6268.2000; Barco A, 1997, J BIOL CHEM, V272, P12683, DOI 10.1074/jbc.272.19.12683; BARCO A, 1995, EMBO J, V14, P3349, DOI 10.1002/j.1460-2075.1995.tb07341.x; Belsham GJ, 2009, VIRUS RES, V139, P183, DOI 10.1016/j.virusres.2008.07.001; BLACK TL, 1993, J VIROL, V67, P791, DOI 10.1128/JVI.67.2.791-800.1993; BLACK TL, 1989, J VIROL, V63, P2244, DOI 10.1128/JVI.63.5.2244-2251.1989; Borman AM, 1997, VIROLOGY, V237, P129, DOI 10.1006/viro.1997.8761; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; Burgui I, 2007, J VIROL, V81, P12427, DOI 10.1128/JVI.01105-07; Castello A, 2006, J MOL BIOL, V355, P942, DOI 10.1016/j.jmb.2005.11.024; Castello A, 2006, J BIOL CHEM, V281, P33206, DOI 10.1074/jbc.M604340200; Castello A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/369648; de Breyne S, 2009, P NATL ACAD SCI USA, V106, P9197, DOI 10.1073/pnas.0900153106; De Gregorio E, 1999, EMBO J, V18, P4865, DOI 10.1093/emboj/18.17.4865; Deniz N, 2009, RNA, V15, P932, DOI 10.1261/rna.1315109; Dmitriev SE, 2010, J BIOL CHEM, V285, P26779, DOI 10.1074/jbc.M110.119693; DOUGHERTY WG, 1993, MICROBIOL REV, V57, P781, DOI 10.1128/MMBR.57.4.781-822.1993; Fernandez J, 2002, J BIOL CHEM, V277, P19198, DOI 10.1074/jbc.M201052200; Foeger N, 2002, J BIOL CHEM, V277, P44300, DOI 10.1074/jbc.M208006200; Garrey JL, 2010, J VIROL, V84, P1124, DOI 10.1128/JVI.02006-09; Gradi A, 1998, MOL CELL BIOL, V18, P334, DOI 10.1128/MCB.18.1.334; HAMBIDGE SJ, 1992, P NATL ACAD SCI USA, V89, P10272, DOI 10.1073/pnas.89.21.10272; Hundsdoerfer P, 2005, P NATL ACAD SCI USA, V102, P13421, DOI 10.1073/pnas.0506536102; Kaiser C, 2008, RNA, V14, P2170, DOI 10.1261/rna.1171808; Lomakin IB, 2000, MOL CELL BIOL, V20, P6019, DOI 10.1128/MCB.20.16.6019-6029.2000; Lukavsky PJ, 2009, VIRUS RES, V139, P166, DOI 10.1016/j.virusres.2008.06.004; MACADAM AJ, 1994, EMBO J, V13, P924, DOI 10.1002/j.1460-2075.1994.tb06336.x; Merrick WC, 2004, GENE, V332, P1, DOI 10.1016/j.gene.2004.02.051; MOLLA A, 1993, J VIROL, V67, P4688, DOI 10.1128/JVI.67.8.4688-4695.1993; Neznanov N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001887; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; ONEILL RE, 1989, J VIROL, V63, P5069, DOI 10.1128/JVI.63.12.5069-5075.1989; Pestova TV, 1996, MOL CELL BIOL, V16, P6870; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Piron M, 1998, EMBO J, V17, P5811, DOI 10.1093/emboj/17.19.5811; RANSONE LJ, 1987, J VIROL, V61, P1781, DOI 10.1128/JVI.61.6.1781-1787.1987; RANSONE LJ, 1988, J VIROL, V62, P3551, DOI 10.1128/JVI.62.10.3551-3557.1988; Roberts LO, 1998, RNA, V4, P520, DOI 10.1017/S1355838298971989; RODRIGUEZ PL, 1993, J BIOL CHEM, V268, P8105; Skabkin MA, 2010, GENE DEV, V24, P1787, DOI 10.1101/gad.1957510; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Terenin IM, 2008, NAT STRUCT MOL BIOL, V15, P836, DOI 10.1038/nsmb.1445; Tong L, 2002, CHEM REV, V102, P4609, DOI 10.1021/cr010184f; Ventoso I, 2006, GENE DEV, V20, P87, DOI 10.1101/gad.357006; Ventoso I, 1998, J BIOL CHEM, V273, P27960, DOI 10.1074/jbc.273.43.27960; Ventoso I, 2001, P NATL ACAD SCI USA, V98, P12966, DOI 10.1073/pnas.231343498; Wehner KA, 2010, MOL CELL BIOL, V30, P2006, DOI 10.1128/MCB.01350-09; Welnowska E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022230; WHETTER LE, 1994, J VIROL, V68, P5253, DOI 10.1128/JVI.68.8.5253-5263.1994; White JP, 2011, J VIROL, V85, P8884, DOI 10.1128/JVI.00792-11; Willcocks MM, 2004, J GEN VIROL, V85, P1125, DOI 10.1099/vir.0.19564-0; Wilson JE, 2000, MOL CELL BIOL, V20, P4990, DOI 10.1128/MCB.20.14.4990-4999.2000; Xi QR, 2004, GENE DEV, V18, P1997, DOI 10.1101/gad.1212504; Yanagiya A, 2009, MOL CELL BIOL, V29, P1661, DOI 10.1128/MCB.01187-08	63	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25699	10.1371/journal.pone.0025699	http://dx.doi.org/10.1371/journal.pone.0025699			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003403	gold, Green Published, Green Submitted			2022-12-27	WOS:000295970300024
J	Hu, M; Wang, Y; Wang, Y				Hu, Ming; Wang, Yong; Wang, Yi			Rapid Dynamics of Contrast Responses in the Cat Primary Visual Cortex	PLOS ONE			English	Article							STRIATE CORTEX; GAIN-CONTROL; TEMPORAL DYNAMICS; SPATIAL-FREQUENCY; STIMULUS CONTRAST; CORTICAL-NEURONS; EYE-MOVEMENTS; SINGLE CELLS; ADAPTATION; INFORMATION	The visual information we receive during natural vision changes rapidly and continuously. The visual system must adapt to the spatiotemporal contents of the environment in order to efficiently process the dynamic signals. However, neuronal responses to luminance contrast are usually measured using drifting or stationary gratings presented for a prolonged duration. Since motion in our visual field is continuous, the signals received by the visual system contain an abundance of transient components in the contrast domain. Here using a modified reverse correlation method, we studied the properties of responses of neurons in the cat primary visual cortex to different contrasts of grating stimuli presented statically and transiently for 40 ms, and showed that neurons can effectively discriminate the rapidly changing contrasts. The change in the contrast response function (CRF) over time mainly consisted of an increment in contrast gain (CRF shifts to left) in the developing phase of temporal responses and a decrement in response gain (CRF shifts downward) in the decay phase. When the distribution range of stimulus contrasts was increased, neurons demonstrated decrement in contrast gain and response gain. Our results suggest that contrast gain control (contrast adaptation) and response gain control mechanisms are well established during the first tens of milliseconds after stimulus onset and may cooperatively mediate the rapid dynamic responses of visual cortical neurons to the continuously changing contrast. This fast contrast adaptation may play a role in detecting contrast contours in the context of visual scenes that are varying rapidly.	[Hu, Ming; Wang, Yong; Wang, Yi] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China; [Hu, Ming; Wang, Yong] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Hu, M (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China.	yiwang@ibp.ac.cn			National Natural Science Foundation of China [30570587, 30623004, 30870831]; Ministry of Science and Technology [2007AA02Z313]; Chinese Academy of Sciences [KSCX1-YW-R-32]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was supported by grants to Yi Wang from the National Natural Science Foundation of China (30570587, 30623004, 30870831), by National High-Tech Research & Development Program (2007AA02Z313 of 863 Program) from Ministry of Science and Technology, by the Knowledge Innovation Program from Chinese Academy of Sciences (KSCX1-YW-R-32). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRECHT DG, 1995, VISUAL NEUROSCI, V12, P1191, DOI 10.1017/S0952523800006817; ALBRECHT DG, 1982, J NEUROPHYSIOL, V48, P217, DOI 10.1152/jn.1982.48.1.217; Albrecht DG, 2002, J NEUROPHYSIOL, V88, P888, DOI 10.1152/jn.2002.88.2.888; ALBRECHT DG, 1984, J PHYSIOL-LONDON, V347, P713, DOI 10.1113/jphysiol.1984.sp015092; BONDS AB, 1991, VISUAL NEUROSCI, V6, P239, DOI 10.1017/S0952523800006258; Bredfeldt CE, 2002, J NEUROSCI, V22, P1976, DOI 10.1523/JNEUROSCI.22-05-01976.2002; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; Butts DA, 2007, NATURE, V449, P92, DOI [10.1038/nature06105, 10.1038/natureO6105]; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; CARANDINI M, 1994, SCIENCE, V264, P1333, DOI 10.1126/science.8191289; Carandini M, 1997, J NEUROSCI, V17, P8621; Carandini M, 2004, J VISION, V4, P130, DOI 10.1167/4.3.1; Chelaru MI, 2008, CEREB CORTEX, V18, P771, DOI 10.1093/cercor/bhm119; Crowder NA, 2008, J PHYSIOL-LONDON, V586, P4107, DOI 10.1113/jphysiol.2008.156273; Dai J, 2012, CEREB CORTEX, V22, P776, DOI 10.1093/cercor/bhr133; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1091, DOI 10.1152/jn.1993.69.4.1091; Dragoi V, 2000, NEURON, V28, P287, DOI 10.1016/S0896-6273(00)00103-3; Dragoi V, 2002, NAT NEUROSCI, V5, P883, DOI 10.1038/nn900; Frazor RA, 2004, J NEUROPHYSIOL, V91, P2607, DOI 10.1152/jn.00858.2003; GEISLER WS, 1992, VISION RES, V32, P1409, DOI 10.1016/0042-6989(92)90196-P; Gutnisky DA, 2008, NATURE, V452, P220, DOI 10.1038/nature06563; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Lesica NA, 2007, NEURON, V55, P479, DOI 10.1016/j.neuron.2007.07.013; Mante V, 2005, NAT NEUROSCI, V8, P1690, DOI 10.1038/nn1556; Mante V, 2008, NEURON, V58, P625, DOI 10.1016/j.neuron.2008.03.011; Martinez-Conde S, 2004, NAT REV NEUROSCI, V5, P229, DOI 10.1038/nrn1348; Martinez-Conde S, 2000, NAT NEUROSCI, V3, P251, DOI 10.1038/72961; Mazer JA, 2002, P NATL ACAD SCI USA, V99, P1645, DOI 10.1073/pnas.022638499; McLean J, 1996, VISUAL NEUROSCI, V13, P1069, DOI 10.1017/S0952523800007720; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; Muller JR, 2001, J NEUROSCI, V21, P6978, DOI 10.1523/JNEUROSCI.21-17-06978.2001; Nauhaus I, 2009, NAT NEUROSCI, V12, P70, DOI 10.1038/nn.2232; Nishimoto S, 2005, J NEUROPHYSIOL, V93, P3524, DOI 10.1152/jn.01169.2004; O'Keefe LP, 1998, J NEUROPHYSIOL, V80, P594, DOI 10.1152/jn.1998.80.2.594; OHZAWA I, 1985, J NEUROPHYSIOL, V54, P651, DOI 10.1152/jn.1985.54.3.651; Reich DS, 2001, J NEUROPHYSIOL, V85, P1039, DOI 10.1152/jn.2001.85.3.1039; Reinagel P, 1999, NETWORK-COMP NEURAL, V10, P341, DOI 10.1088/0954-898X/10/4/304; Ringach DL, 1997, NATURE, V387, P281, DOI 10.1038/387281a0; Samonds JM, 2005, J NEUROPHYSIOL, V93, P223, DOI 10.1152/jn.00548.2004; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4286; SCLAR G, 1989, VISION RES, V29, P747, DOI 10.1016/0042-6989(89)90087-4; SCLAR G, 1990, VISION RES, V30, P1, DOI 10.1016/0042-6989(90)90123-3; Sharpee TO, 2006, NATURE, V439, P936, DOI 10.1038/nature04519; Simoncelli EP, 2003, CURR OPIN NEUROBIOL, V13, P144, DOI 10.1016/S0959-4388(03)00047-3; Sit YF, 2009, NEURON, V64, P943, DOI 10.1016/j.neuron.2009.08.041; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; Stanley GB, 2008, NEURON, V58, P467, DOI 10.1016/j.neuron.2008.05.003; Tolhurst DJ, 1997, VISUAL NEUROSCI, V14, P19, DOI 10.1017/S0952523800008725; Varela JA, 1997, J NEUROSCI, V17, P7926; von der Malsburg C, 1981, CORRELATION THEORY B; WANG Y, 1995, NEUROREPORT, V6, P1969, DOI 10.1097/00001756-199510010-00005; Webb BS, 2003, VISUAL NEUROSCI, V20, P221, DOI 10.1017/S0952523803203011; Williams PE, 2007, J NEUROSCI, V27, P5706, DOI 10.1523/JNEUROSCI.4743-06.2007; Yarbus AL, 1967, EYE MOVEMENTS VISION, Vxiii	54	19	20	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25410	10.1371/journal.pone.0025410	http://dx.doi.org/10.1371/journal.pone.0025410			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998655	Green Published, gold, Green Submitted			2022-12-27	WOS:000295966900024
J	McCambridge, J; Kypri, K				McCambridge, Jim; Kypri, Kypros			Can Simply Answering Research Questions Change Behaviour? Systematic Review and Meta Analyses of Brief Alcohol Intervention Trials	PLOS ONE			English	Review							RANDOMIZED CONTROLLED-TRIAL; ASKING QUESTIONS; RISK; REACTIVITY; IMPACT; BIAS; PREFERENCES; UNITS	Background: Participant reports of their own behaviour are critical for the provision and evaluation of behavioural interventions. Recent developments in brief alcohol intervention trials provide an opportunity to evaluate longstanding concerns that answering questions on behaviour as part of research assessments may inadvertently influence it and produce bias. The study objective was to evaluate the size and nature of effects observed in randomized manipulations of the effects of answering questions on drinking behaviour in brief intervention trials. Methodology/Principal Findings: Multiple methods were used to identify primary studies. Between-group differences in total weekly alcohol consumption, quantity per drinking day and AUDIT scores were evaluated in random effects meta-analyses. Ten trials were included in this review, of which two did not provide findings for quantitative study, in which three outcomes were evaluated. Between-group differences were of the magnitude of 13.7 (-0.17 to 27.6) grams of alcohol per week (approximately 1.5 U. K. units or 1 standard U. S. drink) and 1 point (0.1 to 1.9) in AUDIT score. There was no difference in quantity per drinking day. Conclusions/Significance: Answering questions on drinking in brief intervention trials appears to alter subsequent self-reported behaviour. This potentially generates bias by exposing non-intervention control groups to an integral component of the intervention. The effects of brief alcohol interventions may thus have been consistently under-estimated. These findings are relevant to evaluations of any interventions to alter behaviours which involve participant self-report.	[McCambridge, Jim] London Sch Hyg & Trop Med, Ctr Res Drugs & Hlth Behav, Dept Publ Hlth & Policy, London WC1, England; [Kypri, Kypros] Univ Newcastle, Sch Med & Publ Hlth, Ctr Clin Epidemiol & Biostat, Newcastle, NSW 2300, Australia	University of London; London School of Hygiene & Tropical Medicine; University of Newcastle	McCambridge, J (corresponding author), London Sch Hyg & Trop Med, Ctr Res Drugs & Hlth Behav, Dept Publ Hlth & Policy, London WC1, England.	Jim.McCambridge@lshtm.ac.uk	Kypri, Kypros/D-2809-2009	Kypri, Kypros/0000-0002-9657-9904; McCambridge, Jim/0000-0002-5461-7001	Wellcome Trust [WT086516MA]; Australian Academy of Science	Wellcome Trust(Wellcome Trust); Australian Academy of Science	The authors are grateful to the Wellcome Trust for an award to the first author (WT086516MA) and to the Australian Academy of Science for an award to the second author that have enabled the conduct of this study. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson J, 2006, CONTEMP CLIN TRIALS, V27, P305, DOI 10.1016/j.cct.2005.11.003; Anderson P, 1990, BRIT J ADDICT, V87, P891; [Anonymous], 1997, PEOPLE STUDYING PEOP; Babor T, 1992, PROJECT IDENTIFICATI, P191; Babor T.F., 2001, ALCOHOL USE IDENTIFI, V2nd; Bateson M, 2006, BIOL LETTERS, V2, P412, DOI 10.1098/rsbl.2006.0509; Bernstein JA, 2010, DRUG ALCOHOL REV, V29, P498, DOI 10.1111/j.1465-3362.2010.00174.x; Bouchet C, 1996, J CLIN EPIDEMIOL, V49, P15, DOI 10.1016/0895-4356(95)00540-4; BREWIN CR, 1989, BRIT MED J, V299, P313, DOI 10.1136/bmj.299.6694.313; CAMPBELL JP, 1995, ANN EMERG MED, V26, P590, DOI 10.1016/S0196-0644(95)70009-9; Carabin H, 1999, EPIDEMIOLOGY, V10, P219, DOI 10.1097/00001648-199905000-00005; Carey KB, 2006, J CONSULT CLIN PSYCH, V74, P943, DOI 10.1037/0022-006X.74.5.943; Cherpitel CJ, 2010, ALCOHOL CLIN EXP RES, V34, P1922, DOI 10.1111/j.1530-0277.2010.01281.x; Clemes SA, 2009, MED SCI SPORT EXER, V41, P674, DOI 10.1249/MSS.0b013e31818cae32; Clifford PR, 2007, J STUD ALCOHOL DRUGS, V68, P519, DOI 10.15288/jsad.2007.68.519; Cook TD., 1979, QUASIEXPERIMENTATION; Daeppen JB, 2007, ADDICTION, V102, P1224, DOI 10.1111/j.1360-0443.2007.01869.x; De Amici D, 2000, CONTROL CLIN TRIALS, V21, P103, DOI 10.1016/S0197-2456(99)00054-9; del Junco DJ, 2008, JNCI-J NATL CANCER I, V100, P333, DOI 10.1093/jnci/djn027; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Eckmanns T, 2006, INFECT CONT HOSP EP, V27, P931, DOI 10.1086/507294; Feil Philip H, 2002, J Dent Educ, V66, P1129; Fitzsimons GJ, 2008, J CONSUM PSYCHOL, V18, P82, DOI 10.1016/j.jcps.2008.01.002; Gentilello LM, 1999, ANN SURG, V230, P473, DOI 10.1097/00000658-199910000-00003; Gillespie R, 1991, MANUFACTURING KNOWLE; Godin G, 2008, HEALTH PSYCHOL, V27, P179, DOI 10.1037/0278-6133.27.2.179; GREENWALD AG, 1987, J APPL PSYCHOL, V72, P315, DOI 10.1037/0021-9010.72.2.315; Havard A, 2008, ADDICTION, V103, P368, DOI 10.1111/j.1360-0443.2007.02072.x; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Kaner EFS, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004148.pub4; King M, 2005, JAMA-J AM MED ASSOC, V293, P1089, DOI 10.1001/jama.293.9.1089; Kinmonth AL, 2008, LANCET, V371, P41, DOI 10.1016/S0140-6736(08)60070-7; Kuntsche E, 2009, ALCOHOL ALCOHOLISM, V44, P423, DOI 10.1093/alcalc/agp033; Kypri K, 2005, PREV MED, V41, P761, DOI 10.1016/j.ypmed.2005.07.010; Kypri K, 2007, ADDICTION, V102, P62, DOI 10.1111/j.1360-0443.2006.01632.x; Kypri K, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-42; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Mayo, 1933, HUMAN PROBLEMS IND C; McCambridge J, PLOS ONE IN PRESS; McCambridge J, 2008, ADDICTION, V103, P241, DOI 10.1111/j.1360-0443.2007.02080.x; Mccambridge J, 2009, ADDICTION, V104, P1311, DOI 10.1111/j.1360-0443.2009.02684.x; McCambridge J, 2009, NEW ENGL J MED, V360, P2373; McCarney R, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-30; MILLER WR, 1991, BRIT J ADDICT, V86, P43; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; O' Sullivan I, 2004, J HEALTH PSYCHOL, V9, P355, DOI 10.1177/1359105304042345; PARSONS HM, 1974, SCIENCE, V183, P922, DOI 10.1126/science.183.4128.922; RICHMOND R, 1995, ADDICTION, V90, P119, DOI 10.1046/j.1360-0443.1995.90111915.x; Roethlisberger F. J., 1939, MANAGEMENT WORKER; Sandberg T, 2009, BRIT J SOC PSYCHOL, V48, P221, DOI 10.1348/014466608X347001; Scott E, 1991, Drug Alcohol Rev, V10, P313; Serrano C, 1992, PROJECT IDENTIFICATI, P129; SOLOMON RL, 1949, PSYCHOL BULL, V46, P137, DOI 10.1037/h0062958; Voogt RJJ, 2002, QUAL QUANT, V36, P325; Walters ST, 2009, ADDICTION, V104, P1305, DOI 10.1111/j.1360-0443.2009.02632.x; ZELEN M, 1990, STAT MED, V9, P645, DOI 10.1002/sim.4780090611	56	177	179	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e23748	10.1371/journal.pone.0023748	http://dx.doi.org/10.1371/journal.pone.0023748			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834NA	21998626	Green Published, gold, Green Accepted			2022-12-27	WOS:000295966900001
J	Nardo, G; Pozzi, S; Pignataro, M; Lauranzano, E; Spano, G; Garbelli, S; Mantovani, S; Marinou, K; Papetti, L; Monteforte, M; Torri, V; Paris, L; Bazzoni, G; Lunetta, C; Corbo, M; Mora, G; Bendotti, C; Bonetto, V				Nardo, Giovanni; Pozzi, Silvia; Pignataro, Mauro; Lauranzano, Eliana; Spano, Giorgia; Garbelli, Silvia; Mantovani, Stefania; Marinou, Kalliopi; Papetti, Laura; Monteforte, Marta; Torri, Valter; Paris, Luca; Bazzoni, Gianfranco; Lunetta, Christian; Corbo, Massimo; Mora, Gabriele; Bendotti, Caterina; Bonetto, Valentina			Amyotrophic Lateral Sclerosis Multiprotein Biomarkers in Peripheral Blood Mononuclear Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; HUMAN CEREBROSPINAL-FLUID; INCREASED 3-NITROTYROSINE; PROTEOMIC ANALYSIS; OXIDATIVE DAMAGE; SKELETAL-MUSCLE; TRANSGENIC MICE; EXTEND SURVIVAL; MOTOR-NEURONS	Background: Amyotrophic lateral sclerosis (ALS) is a fatal progressive motor neuron disease, for which there are still no diagnostic/prognostic test and therapy. Specific molecular biomarkers are urgently needed to facilitate clinical studies and speed up the development of effective treatments. Methodology/Principal Findings: We used a two-dimensional difference in gel electrophoresis approach to identify in easily accessible clinical samples, peripheral blood mononuclear cells (PBMC), a panel of protein biomarkers that are closely associated with ALS. Validations and a longitudinal study were performed by immunoassays on a selected number of proteins. The same proteins were also measured in PBMC and spinal cord of a G93A SOD1 transgenic rat model. We identified combinations of protein biomarkers that can distinguish, with high discriminatory power, ALS patients from healthy controls (98%), and from patients with neurological disorders that may resemble ALS (91%), between two levels of disease severity (90%), and a number of translational biomarkers, that link responses between human and animal model. We demonstrated that TDP-43, cyclophilin A and ERp57 associate with disease progression in a longitudinal study. Moreover, the protein profile changes detected in peripheral blood mononuclear cells of ALS patients are suggestive of possible intracellular pathogenic mechanisms such as endoplasmic reticulum stress, nitrative stress, disturbances in redox regulation and RNA processing. Conclusions/Significance: Our results indicate that PBMC multiprotein biomarkers could contribute to determine amyotrophic lateral sclerosis diagnosis, differential diagnosis, disease severity and progression, and may help to elucidate pathogenic mechanisms.	[Nardo, Giovanni; Pozzi, Silvia; Pignataro, Mauro; Lauranzano, Eliana; Spano, Giorgia; Bonetto, Valentina] Dulbecco Telethon Inst, Milan, Italy; [Nardo, Giovanni; Pozzi, Silvia; Pignataro, Mauro; Lauranzano, Eliana; Paris, Luca; Bazzoni, Gianfranco; Bonetto, Valentina] Mario Negri Inst Pharmacol Res, Dept Mol Biochem & Pharmacol, Milan, Italy; [Spano, Giorgia; Bendotti, Caterina] Mario Negri Inst Pharmacol Res, Dept Neurosci, Milan, Italy; [Garbelli, Silvia; Mantovani, Stefania] Ist Ricovero & Cura Carattere Sci IRCCS Fdn Salva, Pavia, Italy; [Garbelli, Silvia; Mantovani, Stefania] IRCCS Fdn Salvato Maugeri, Natl Inst Occupat Safety & Prevent ISPESL, Res Ctr, Pavia, Italy; [Monteforte, Marta; Torri, Valter] Mario Negri Inst Pharmacol Res, Dept Oncol, Milan, Italy; [Lunetta, Christian; Corbo, Massimo] Osped Niguarda Ca Granda, NEuroMuscular Omnictr NEMO, Milan, Italy; [Marinou, Kalliopi; Papetti, Laura; Mora, Gabriele] IRCCS Fdn Salvatore Maugeri, Milan, Italy	Fondazione Telethon; Dulbecco Telethon Institute (DTI); Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituti Clinici Scientifici Maugeri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; Istituti Clinici Scientifici Maugeri IRCCS	Nardo, G (corresponding author), Dulbecco Telethon Inst, Milan, Italy.	valentina.bonetto@marionegri.it	MANTOVANI, STEFANIA/K-4634-2016; Bonetto, Valentina/I-4694-2018; Mora, Gabriele/Z-2346-2019; Bonetto, Valentina/ABB-6383-2020; Lunetta, Christian/K-9214-2016; Torri, Valter/H-7550-2015; Marinou Aktipi, Kalliopi/AAB-8246-2020; Monteforte, Marta/ABG-1301-2020; Bendotti, Caterina/AAB-2273-2020; Papetti, Laura/B-1262-2013; Nardo, Giovanni/C-1406-2014; Silvia, Pozzi/AAF-9396-2019	MANTOVANI, STEFANIA/0000-0002-5885-2842; Bonetto, Valentina/0000-0003-0456-2054; Mora, Gabriele/0000-0002-8388-2373; Bonetto, Valentina/0000-0003-0456-2054; Lunetta, Christian/0000-0002-4788-1875; Torri, Valter/0000-0001-9541-9354; Marinou Aktipi, Kalliopi/0000-0003-3384-0367; Monteforte, Marta/0000-0002-1591-7810; Bendotti, Caterina/0000-0003-1055-1271; Papetti, Laura/0000-0002-3336-9205; Nardo, Giovanni/0000-0002-1803-1484; Silvia, Pozzi/0000-0002-1500-8158; Corbo, Massimo/0000-0003-0793-9830; Lauranzano, Eliana/0000-0002-9297-3242	Telethon Foundation [S01010, TCR08002]; Cariplo Foundation; Compagnia San Paolo Foundation; Fondazione Aldo e Cele Dacco per la ricerca scientifica; Vialli and Mauro Foundation for Research and Sport; European Community [FP7/2007-2013, 259867]	Telethon Foundation(Fondazione Telethon); Cariplo Foundation(Fondazione Cariplo); Compagnia San Paolo Foundation(Compagnia di San Paolo); Fondazione Aldo e Cele Dacco per la ricerca scientifica; Vialli and Mauro Foundation for Research and Sport; European Community(European Commission)	This work was supported by Telethon Foundation (S01010 and TCR08002 to V. B.), Cariplo Foundation (to V.B. and C.B.), Compagnia San Paolo Foundation (to V.B.), Fondazione Aldo e Cele Dacco per la ricerca scientifica (to V. B.), Vialli and Mauro Foundation for Research and Sport (to S.P. and V.B.), and the European Community's Seventh Framework Programme (FP7/2007-2013) under the Health Cooperation Programme, grant agreement no 259867 (to V.B. and C.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achiron A, 2006, AUTOIMMUN REV, V5, P517, DOI 10.1016/j.autrev.2006.02.009; Aguirre T, 1998, ANN NEUROL, V43, P452, DOI 10.1002/ana.410430407; Appel SH, 2010, TRENDS IMMUNOL, V31, P7, DOI 10.1016/j.it.2009.09.003; Atkin JD, 2008, NEUROBIOL DIS, V30, P400, DOI 10.1016/j.nbd.2008.02.009; Atkin JD, 2006, J BIOL CHEM, V281, P30152, DOI 10.1074/jbc.M603393200; Barber SC, 2006, BBA-MOL BASIS DIS, V1762, P1051, DOI 10.1016/j.bbadis.2006.03.008; Basso M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008130; Beal MF, 1997, ANN NEUROL, V42, P644, DOI 10.1002/ana.410420416; Beckman JS, 1996, CHEM RES TOXICOL, V9, P836, DOI 10.1021/tx9501445; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Board PG, 2000, J BIOL CHEM, V275, P24798, DOI 10.1074/jbc.M001706200; Borovecki F, 2005, P NATL ACAD SCI USA, V102, P11023, DOI 10.1073/pnas.0504921102; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Carpi D, 2009, TOXICOL SCI, V108, P330, DOI 10.1093/toxsci/kfp021; Casoni F, 2005, J BIOL CHEM, V280, P16295, DOI 10.1074/jbc.M413111200; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Cova E, 2006, NEUROSCI LETT, V399, P186, DOI 10.1016/j.neulet.2006.01.057; Curti D, 1996, NEUROLOGY, V47, P1060, DOI 10.1212/WNL.47.4.1060; Davenport RJ, 1996, J NEUROL NEUROSUR PS, V60, P147, DOI 10.1136/jnnp.60.2.147; De Giessen EV, 2008, AMYOTROPH LATERAL SC, V9, P81, DOI 10.1080/17482960701702553; De Marco G, 2011, ACTA NEUROPATHOL, V121, P611, DOI 10.1007/s00401-010-0786-7; Dobrowolny G, 2008, CELL METAB, V8, P425, DOI 10.1016/j.cmet.2008.09.002; Ferrante RJ, 1997, ANN NEUROL, V42, P326, DOI 10.1002/ana.410420309; Ganesalingam J, 2010, J NEUROCHEM; Ghezzi P, 2006, PROTEOMICS, V6, P817, DOI 10.1002/pmic.200500177; Gladkevich A, 2004, PROG NEURO-PSYCHOPH, V28, P559, DOI 10.1016/j.pnpbp.2004.01.009; Hu Y, 2005, MOL CELL PROTEOMICS, V4, P2000, DOI 10.1074/mcp.M500207-MCP200; Ilieva EV, 2007, BRAIN, V130, P3111, DOI 10.1093/brain/awm190; Kato S, 2005, ACTA NEUROPATHOL, V110, P101, DOI 10.1007/s00401-005-1019-3; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kraemer M, 2010, CLIN NEUROL NEUROSUR, V112, P103, DOI 10.1016/j.clineuro.2009.10.014; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; Lemmens R, 2010, TRENDS NEUROSCI, V33, P249, DOI 10.1016/j.tins.2010.02.003; Maes OC, 2007, NEUROBIOL AGING, V28, P1795, DOI 10.1016/j.neurobiolaging.2006.08.004; Mantovani S, 2009, J NEUROIMMUNOL, V210, P73, DOI 10.1016/j.jneuroim.2009.02.012; Massignan T, 2007, BIOCHEM BIOPH RES CO, V353, P719, DOI 10.1016/j.bbrc.2006.12.075; Milton RH, 2008, J NEUROSCI, V28, P11488, DOI 10.1523/JNEUROSCI.2431-08.2008; Mitchell RM, 2009, NEUROLOGY, V72, P14, DOI 10.1212/01.wnl.0000333251.36681.a5; Mitchell RM, 2010, MUSCLE NERVE, V42, P95, DOI 10.1002/mus.21625; Nardo G, 2009, ANTIOXID REDOX SIGN, V11, P1559, DOI [10.1089/ars.2009.2548, 10.1089/ARS.2009.2548]; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Ono S, 2000, AMYOTROPH LATERAL SC, V1, P191, DOI 10.1080/14660820050515188; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; Pasinetti GM, 2006, NEUROLOGY, V66, P1218, DOI 10.1212/01.wnl.0000203129.82104.07; Poulopoulou C, 2005, ANN NEUROL, V58, P946, DOI 10.1002/ana.20675; Sharp FR, 2006, ARCH NEUROL-CHICAGO, V63, P1529, DOI 10.1001/archneur.63.11.1529; Srinivasan J, 2006, MUSCLE NERVE, V34, P359, DOI 10.1002/mus.20555; Staschke KA, 2009, J IMMUNOL, V183, P568, DOI 10.4049/jimmunol.0802361; Tang Y, 2001, ANN NEUROL, V50, P699, DOI 10.1002/ana.10042; Traynor BJ, 2000, ARCH NEUROL-CHICAGO, V57, P109, DOI 10.1001/archneur.57.1.109; Turner MR, 2009, LANCET NEUROL, V8, P94, DOI 10.1016/S1474-4422(08)70293-X; Watanabe M, 2001, NEUROBIOL DIS, V8, P933, DOI 10.1006/nbdi.2001.0443; Wong M, 2010, HUM MOL GENET, V19, P2284, DOI 10.1093/hmg/ddq106; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Zhang J, 2007, PROTEOM CLIN APPL, V1, P805, DOI 10.1002/prca.200700081	56	94	94	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25545	10.1371/journal.pone.0025545	http://dx.doi.org/10.1371/journal.pone.0025545			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998667	Green Published, Green Submitted, gold			2022-12-27	WOS:000295966900033
J	't Hart, BM; Abresch, TGJ; Einhauser, W				't Hart, Bernard Marius; Abresch, Tilman Gerrit Jakob; Einhaeuser, Wolfgang			Faces in Places: Humans and Machines Make Similar Face Detection Errors	PLOS ONE			English	Article							HIGH-LEVEL POP; EYE; PERCEPTION; MOVEMENTS	The human visual system seems to be particularly efficient at detecting faces. This efficiency sometimes comes at the cost of wrongfully seeing faces in arbitrary patterns, including famous examples such as a rock configuration on Mars or a toast's roast patterns. In machine vision, face detection has made considerable progress and has become a standard feature of many digital cameras. The arguably most wide-spread algorithm for such applications ("Viola-Jones" algorithm) achieves high detection rates at high computational efficiency. To what extent do the patterns that the algorithm mistakenly classifies as faces also fool humans? We selected three kinds of stimuli from real-life, first-person perspective movies based on the algorithm's output: correct detections ("real faces"), false positives ("illusory faces") and correctly rejected locations ("non faces"). Observers were shown pairs of these for 20 ms and had to direct their gaze to the location of the face. We found that illusory faces were mistaken for faces more frequently than non faces. In addition, rotation of the real face yielded more errors, while rotation of the illusory face yielded fewer errors. Using colored stimuli increases overall performance, but does not change the pattern of results. When replacing the eye movement by a manual response, however, the preference for illusory faces over non faces disappeared. Taken together, our data show that humans make similar face-detection errors as the Viola-Jones algorithm, when directing their gaze to briefly presented stimuli. In particular, the relative spatial arrangement of oriented filters seems of relevance. This suggests that efficient face detection in humans is likely to be pre-attentive and based on rather simple features as those encoded in the early visual system.	['t Hart, Bernard Marius; Abresch, Tilman Gerrit Jakob; Einhaeuser, Wolfgang] Univ Marburg, Marburg, Germany	Philipps University Marburg	't Hart, BM (corresponding author), Univ Marburg, Marburg, Germany.	thart@staff.uni-marburg.de	't Hart, Bernard/AHD-9519-2022; Einhäuser, Wolfgang/A-3041-2012	't Hart, Bernard/0000-0002-0045-3769; Einhäuser, Wolfgang/0000-0001-7516-9589	DFG [EI852/1]	DFG(German Research Foundation (DFG))	Funded by DFG (http://www.dfg.de/en) under grant no. EI852/1 (BMtH, WE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradski G., 2005, INTEL TECHNOL J, V9, P119; Busigny T, 2010, NEUROPSYCHOLOGIA, V48, P4057, DOI 10.1016/j.neuropsychologia.2010.09.017; CERF M, 2008, ADV NEURAL INFORM PR, V20, P241; Cerf M, 2009, J VISION, V9, DOI 10.1167/9.12.10; Crouzet SM, 2010, J VISION, V10, DOI 10.1167/10.4.16; Dakin SC, 2009, J VISION, V9, DOI 10.1167/9.2.13; Einhauser W, 2009, ANN NY ACAD SCI, V1164, P188, DOI 10.1111/j.1749-6632.2008.03714.x; Felisberti FM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012939; Ferri F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013126; Garrido L, 2008, J NEUROPSYCHOL, V2, P119, DOI 10.1348/174866407X246843; Goffaux V, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00143; Graf ABA, 2006, NEURAL COMPUT, V18, P143, DOI 10.1162/089976606774841611; Hershler O, 2005, VISION RES, V45, P1707, DOI 10.1016/j.visres.2004.12.021; Hershler O, 2006, VISION RES, V46, P3028, DOI 10.1016/j.visres.2006.03.023; Hochstein S, 2002, NEURON, V36, P791, DOI 10.1016/S0896-6273(02)01091-7; Honey C, 2008, J VISION, V8, DOI 10.1167/8.12.9; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Joyce CA, 2006, VISION RES, V46, P800, DOI 10.1016/j.visres.2005.09.016; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kirchner H, 2006, VISION RES, V46, P1762, DOI 10.1016/j.visres.2005.10.002; Li ZP, 2002, TRENDS COGN SCI, V6, P9, DOI 10.1016/S1364-6613(00)01817-9; Mondloch CJ, 2006, PSYCHOL SCI, V17, P930, DOI 10.1111/j.1467-9280.2006.01806.x; Mondloch CJ, 1999, PSYCHOL SCI, V10, P419, DOI 10.1111/1467-9280.00179; Pascalis O, 2005, P NATL ACAD SCI USA, V102, P5297, DOI 10.1073/pnas.0406627102; Rossion B, 2011, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00225; Schneider E, 2009, ANN NY ACAD SCI, V1164, P461, DOI 10.1111/j.1749-6632.2009.03858.x; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; Tong F, 2000, COGNITIVE NEUROPSYCH, V17, P257, DOI 10.1080/026432900380607; VanRullen R, 2006, VISION RES, V46, P3017, DOI 10.1016/j.visres.2005.07.009; Viola P, 2001, PROC CVPR IEEE, P511, DOI 10.1109/cvpr.2001.990517; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474	31	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25373	10.1371/journal.pone.0025373	http://dx.doi.org/10.1371/journal.pone.0025373			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834NA	21998653	Green Published, Green Submitted, gold			2022-12-27	WOS:000295966900022
J	Zinn, PO; Majadan, B; Sathyan, P; Singh, SK; Majumder, S; Jolesz, FA; Colen, RR				Zinn, Pascal O.; Majadan, Bhanu; Sathyan, Pratheesh; Singh, Sanjay K.; Majumder, Sadhan; Jolesz, Ferenc A.; Colen, Rivka R.			Radiogenomic Mapping of Edema/Cellular Invasion MRI-Phenotypes in Glioblastoma Multiforme	PLOS ONE			English	Article							GENE-EXPRESSION; MICROARRAY ANALYSIS; CELL-MIGRATION; HIGH-GRADE; TUMOR; BRAIN; GLIOMAS; CANCER; CLASSIFICATION; TEMOZOLOMIDE	Background: Despite recent discoveries of new molecular targets and pathways, the search for an effective therapy for Glioblastoma Multiforme (GBM) continues. A newly emerged field, radiogenomics, links gene expression profiles with MRI phenotypes. MRI-FLAIR is a noninvasive diagnostic modality and was previously found to correlate with cellular invasion in GBM. Thus, our radiogenomic screen has the potential to reveal novel molecular determinants of invasion. Here, we present the first comprehensive radiogenomic analysis using quantitative MRI volumetrics and large-scale gene- and microRNA expression profiling in GBM. Methods: Based on The Cancer Genome Atlas (TCGA), discovery and validation sets with gene, microRNA, and quantitative MR-imaging data were created. Top concordant genes and microRNAs correlated with high FLAIR volumes from both sets were further characterized by Kaplan Meier survival statistics, microRNA-gene correlation analyses, and GBM molecular subtype-specific distribution. Results: The top upregulated gene in both the discovery (4 fold) and validation (11 fold) sets was PERIOSTIN (POSTN). The top downregulated microRNA in both sets was miR-219, which is predicted to bind to POSTN. Kaplan Meier analysis demonstrated that above median expression of POSTN resulted in significantly decreased survival and shorter time to disease progression (P<0.001). High POSTN and low miR-219 expression were significantly associated with the mesenchymal GBM subtype (P<0.0001). Conclusion: Here, we propose a novel diagnostic method to screen for molecular cancer subtypes and genomic correlates of cellular invasion. Our findings also have potential therapeutic significance since successful molecular inhibition of invasion will improve therapy and patient survival in GBM.	[Zinn, Pascal O.; Sathyan, Pratheesh; Singh, Sanjay K.; Majumder, Sadhan] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Zinn, Pascal O.] Univ Hosp CHUV BH19 110, Dept Clin Neurosci, Lausanne, Switzerland; [Majadan, Bhanu; Jolesz, Ferenc A.; Colen, Rivka R.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Radiol, Boston, MA 02115 USA	University of Texas System; UTMD Anderson Cancer Center; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Zinn, PO (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA.	pozinn@mdanderson.org; rrcolen@partners.org	Colen, Rivka/Y-4062-2019		National Institute of Health [P41-RR019703, R25 CA089017-06A2]; NATIONAL CANCER INSTITUTE [R25CA089017] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR019703, U41RR019703] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by National Institute of Health grants: P41-RR019703 (FAJ) and R25 CA089017-06A2 (RRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archip N, 2007, ACAD RADIOL, V14, P1242, DOI 10.1016/j.acra.2007.05.025; Barajas RF, 2010, RADIOLOGY, V254, P564, DOI 10.1148/radiol.09090663; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Delic S, 2011, NEUROPATHOL APPL NEU; Diehn M, 2008, P NATL ACAD SCI USA, V105, P5213, DOI 10.1073/pnas.0801279105; DWEEP H, 2011, J BIOMED INFORM; Ebos JML, 2009, CLIN CANCER RES, V15, P5020, DOI 10.1158/1078-0432.CCR-09-0095; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gaziel-Sovran A, 2011, CANCER CELL, V20, P104, DOI 10.1016/j.ccr.2011.05.027; George A, 2011, BRIT J BIOMED SCI, V68, P100, DOI 10.1080/09674845.2011.11730334; Gering DT, 2001, J MAGN RESON IMAGING, V13, P967, DOI 10.1002/jmri.1139; Gottlieb A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-300; Gould J, 2006, BIOINFORMATICS, V22, P1924, DOI 10.1093/bioinformatics/btl196; Hammoud MA, 1996, J NEURO-ONCOL, V27, P65, DOI 10.1007/BF00146086; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hoelzinger DB, 2005, NEOPLASIA, V7, P7, DOI 10.1593/neo.04535; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kanno A, 2008, INT J CANCER, V122, P2707, DOI 10.1002/ijc.23332; KELLY PJ, 1987, J NEUROSURG, V66, P865, DOI 10.3171/jns.1987.66.6.0865; Kwak HJ, 2011, ONCOGENE, V30, P2433, DOI 10.1038/onc.2010.620; Law M, 2002, RADIOLOGY, V222, P715, DOI 10.1148/radiol.2223010558; Lim PK, 2011, CANCER RES, V71, P1550, DOI 10.1158/0008-5472.CAN-10-2372; McMillan KM, 2009, J MAGN RESON IMAGING, V29, P251, DOI 10.1002/jmri.21659; Mikheeva SA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-194; Mischel PS, 2004, NAT REV NEUROSCI, V5, P782, DOI 10.1038/nrn1518; Nagashima G, 1999, SURG NEUROL, V51, P292, DOI 10.1016/S0090-3019(98)00056-1; Nakada M, 2010, INT J CANCER, V126, P1155, DOI 10.1002/ijc.24849; Nutt CL, 2003, CANCER RES, V63, P1602; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Pavlisa G, 2009, CLIN IMAG, V33, P96, DOI 10.1016/j.clinimag.2008.06.035; Pichon E, 2004, MED IMAGE ANAL, V8, P267, DOI 10.1016/j.media.2004.06.006; Pope WB, 2005, AM J NEURORADIOL, V26, P2466; Pope WB, 2008, RADIOLOGY, V249, P268, DOI 10.1148/radiol.2491072000; Quant EC, 2010, NEUROIMAG CLIN N AM, V20, P425, DOI 10.1016/j.nic.2010.04.007; Rao SAM, 2010, MODERN PATHOL, V23, P1404, DOI 10.1038/modpathol.2010.135; Reardon DA, 2006, ONCOLOGIST, V11, P152, DOI 10.1634/theoncologist.11-2-152; Rickman DS, 2001, CANCER RES, V61, P6885; Rothe F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020980; Rutman AM, 2009, EUR J RADIOL, V70, P232, DOI 10.1016/j.ejrad.2009.01.050; Sanai N, 2008, NEUROSURGERY, V62, P753, DOI 10.1227/01.neu.0000318159.21731.cf; Singh S, 2004, LAB INVEST, V84, P1666, DOI 10.1038/labinvest.3700181; Stevenson CB, 2008, NEUROSURGERY, V63, P560, DOI 10.1227/01.NEU.0000324896.26088.EF; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tate MC, 2009, NEUROTHERAPEUTICS, V6, P447, DOI 10.1016/j.nurt.2009.04.001; Van Meter T, 2006, DIAGN MOL PATHOL, V15, P195, DOI 10.1097/01.pdm.0000213464.06387.36; Vaupel P, 2004, SEMIN RADIAT ONCOL, V14, P198, DOI 10.1016/j.semradonc.2004.04.008; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yan W, 2006, J BIOL CHEM, V281, P19700, DOI 10.1074/jbc.M601856200	50	198	211	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25451	10.1371/journal.pone.0025451	http://dx.doi.org/10.1371/journal.pone.0025451			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998659	Green Published, Green Submitted, gold			2022-12-27	WOS:000295966900028
J	Barrett, AN; Zimmermann, BG; Wang, D; Holloway, A; Chitty, LS				Barrett, Angela N.; Zimmermann, Bernhard G.; Wang, Darrell; Holloway, Andrew; Chitty, Lyn S.			Implementing Prenatal Diagnosis Based on Cell-Free Fetal DNA: Accurate Identification of Factors Affecting Fetal DNA Yield	PLOS ONE			English	Article							MATERNAL PLASMA; FORMALDEHYDE; PROPORTION; IMPACT; BLOOD; SIZE; PCR	Objective: Cell-free fetal DNA is a source of fetal genetic material that can be used for non-invasive prenatal diagnosis. Usually constituting less than 10% of the total cell free DNA in maternal plasma, the majority is maternal in origin. Optimizing conditions for maximizing yield of cell-free fetal DNA will be crucial for effective implementation of testing. We explore factors influencing yield of fetal DNA from maternal blood samples, including assessment of collection tubes containing cell-stabilizing agents, storage temperature, interval to sample processing and DNA extraction method used. Methods: Microfluidic digital PCR was performed to precisely quantify male (fetal) DNA, total DNA and long DNA fragments (indicative of maternal cellular DNA). Real-time qPCR was used to assay for the presence of male SRY signal in samples. Results: Total cell-free DNA quantity increased significantly with time in samples stored in K(3)EDTA tubes, but only minimally in cell stabilizing tubes. This increase was solely due to the presence of additional long fragment DNA, with no change in quantity of fetal or short DNA, resulting in a significant decrease in proportion of cell-free fetal DNA over time. Storage at 4 degrees C did not prevent these changes. Conclusion: When samples can be processed within eight hours of blood draw, K(3)EDTA tubes can be used. Prolonged transfer times in K(3)EDTA tubes should be avoided as the proportion of fetal DNA present decreases significantly; in these situations the use of cell stabilising tubes is preferable. The DNA extraction kit used may influence success rate of diagnostic tests.	[Barrett, Angela N.] Great Ormond St Hosp Sick Children, NE Thames Reg Mol Genet Labs, London WC1N 3JH, England; [Zimmermann, Bernhard G.] Fluidigm Corp, San Francisco, CA USA; [Barrett, Angela N.; Wang, Darrell; Chitty, Lyn S.] UCL, Inst Child Hlth, London, England; [Holloway, Andrew; Chitty, Lyn S.] Univ Coll Hosp NHS Fdn Trust, London, England	University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; University of London; University College London	Barrett, AN (corresponding author), Great Ormond St Hosp Sick Children, NE Thames Reg Mol Genet Labs, Great Ormond St, London WC1N 3JH, England.	l.chitty@ich.ucl.ac.uk	Barrett, Angela/H-8181-2019	Barrett, Angela/0000-0002-4529-0940; chitty, lyn/0000-0002-4857-7138	European Commission [LSHCT-2004-503241]; NIHR; NIHR Biomedical Research Centre for Paediatric/Child Health at Great Ormond Street Hospital NHS Trust; UCL Institute of Child Health; Great Ormond Street Hospital Children's Charity; NIHR Central and East London Comprehensive Local Research Network; National Institute for Health Research [RP-PG-0707-10107] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); NIHR(National Institute for Health Research (NIHR)); NIHR Biomedical Research Centre for Paediatric/Child Health at Great Ormond Street Hospital NHS Trust; UCL Institute of Child Health; Great Ormond Street Hospital Children's Charity; NIHR Central and East London Comprehensive Local Research Network; National Institute for Health Research(National Institute for Health Research (NIHR))	This article presents independent research commissioned by the National Institute for Health Research (NIHR) under the Programme Grants for Applied Research programme (the "RAPID" project). The authors acknowledge the support from the European Commission (Framework 6) Special Non-Invasive Advances in Fetal and Neonatal Evaluation (SAFE) Network of Excellence (LSHCT-2004-503241), the NIHR Programme Grants for Applied Research scheme and the NIHR Central and East London Comprehensive Local Research Network. LSC receives some funding from the NIHR Biomedical Research Centre for Paediatric/Child Health at Great Ormond Street Hospital NHS Trust and UCL Institute of Child Health and the Great Ormond Street Hospital Children's Charity. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angert RM, 2003, CLIN CHEM, V49, P195, DOI 10.1373/49.1.195; Benachi A, 2005, CLIN CHEM, V51, P242; Chan KCA, 2005, CLIN CHEM, V51, P781, DOI 10.1373/clinchem.2004.046219; Chan KCA, 2004, CLIN CHEM, V50, P88, DOI 10.1373/clinchem.2003.024893; Chinnapapagari SKR, 2005, CLIN CHEM, V51, P652, DOI 10.1373/clinchem.2004.042119; Chitty LS, 2011, ULTRASOUND OBST GYN, V37, P283, DOI 10.1002/uog.8893; Chitty LS, 2008, PRENATAL DIAG, V28, P83, DOI 10.1002/pd.1929; Chiu RWK, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7401; Chiu RWK, 2001, CLIN CHEM, V47, P1607; Chung GTY, 2005, CLIN CHEM, V51, P655, DOI 10.1373/clinchem.2004.042168; Dhallan R, 2004, JAMA-J AM MED ASSOC, V291, P1114, DOI 10.1001/jama.291.9.1114; Ehrich M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.060; Fernando MR, 2010, PRENATAL DIAG, V30, P418, DOI 10.1002/pd.2484; Finning K, 2008, BRIT MED J, V336, P816, DOI 10.1136/bmj.39518.463206.25; Finning KM, 2008, SEMIN FETAL NEONAT M, V13, P69, DOI 10.1016/j.siny.2007.12.007; Galbiati S, 2011, CLIN CHEM, V57, P136, DOI 10.1373/clinchem.2010.155671; Hill M, 2010, CLIN GENET      0819; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lun FMF, 2008, P NATL ACAD SCI USA, V105, P19920, DOI 10.1073/pnas.0810373105; Mujezinovic F, 2007, OBSTET GYNECOL, V110, P687, DOI 10.1097/01.AOG.0000278820.54029.e3; Picchiassi E, 2008, PRENATAL DIAG, V28, P525, DOI 10.1002/pd.2018; Raymond FL, 2010, PRENATAL DIAG, V30, P674, DOI 10.1002/pd.2575; Sehnert AJ, 2011, CLIN CHEM, V57, P1042, DOI 10.1373/clinchem.2011.165910; Sikora A, 2010, CLIN CHEM, V56, P136, DOI 10.1373/clinchem.2009.132951; Tsui NBY, 2011, BLOOD, V117, P3684, DOI 10.1182/blood-2010-10-310789; van der Schoot CE, 2008, SEMIN FETAL NEONAT M, V13, P63, DOI 10.1016/j.siny.2007.12.012; Zhang Y, 2008, CLIN CHIM ACTA, V397, P60, DOI 10.1016/j.cca.2008.07.017; Zimmermann BG, 2008, PRENATAL DIAG, V28, P1087, DOI 10.1002/pd.2150	29	26	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e25202	10.1371/journal.pone.0025202	http://dx.doi.org/10.1371/journal.pone.0025202			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21998643	Green Submitted, Green Published, gold			2022-12-27	WOS:000295963300005
J	Gibb, EA; Vucic, EA; Enfield, KSS; Stewart, GL; Lonergan, KM; Kennett, JY; Becker-Santos, DD; MacAulay, CE; Lam, S; Brown, CJ; Lam, WL				Gibb, Ewan A.; Vucic, Emily A.; Enfield, Katey S. S.; Stewart, Greg L.; Lonergan, Kim M.; Kennett, Jennifer Y.; Becker-Santos, Daiana D.; MacAulay, Calum E.; Lam, Stephen; Brown, Carolyn J.; Lam, Wan L.			Human Cancer Long Non-Coding RNA Transcriptomes	PLOS ONE			English	Article							HOUSEKEEPING GENES; FUNCTIONAL-ROLE; CELL; EXPRESSION; IDENTIFICATION; INACTIVATION; CHROMATIN; MEG3; ASSOCIATION; CARCINOMA	Once thought to be a part of the 'dark matter' of the genome, long non-coding RNAs (lncRNAs) are emerging as an integral functional component of the mammalian transcriptome. LncRNAs are a novel class of mRNA-like transcripts which, despite no known protein-coding potential, demonstrate a wide range of structural and functional roles in cellular biology. However, the magnitude of the contribution of lncRNA expression to normal human tissues and cancers has not been investigated in a comprehensive manner. In this study, we compiled 272 human serial analysis of gene expression (SAGE) libraries to delineate lncRNA transcription patterns across a broad spectrum of normal human tissues and cancers. Using a novel lncRNA discovery pipeline we parsed over 24 million SAGE tags and report lncRNA expression profiles across a panel of 26 different normal human tissues and 19 human cancers. Our findings show extensive, tissue-specific lncRNA expression in normal tissues and highly aberrant lncRNA expression in human cancers. Here, we present a first generation atlas for lncRNA profiling in cancer.	[Gibb, Ewan A.; Vucic, Emily A.; Enfield, Katey S. S.; Stewart, Greg L.; Lonergan, Kim M.; Kennett, Jennifer Y.; Becker-Santos, Daiana D.; MacAulay, Calum E.; Lam, Stephen; Brown, Carolyn J.; Lam, Wan L.] British Columbia Canc Agcy, Res Ctr, Vancouver, BC V5Z 4E6, Canada; [Gibb, Ewan A.; Vucic, Emily A.; Kennett, Jennifer Y.; MacAulay, Calum E.; Lam, Wan L.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Enfield, Katey S. S.; Stewart, Greg L.; Becker-Santos, Daiana D.; MacAulay, Calum E.; Lam, Wan L.] Univ British Columbia, Interdisciplinary Oncol Program, Vancouver, BC V5Z 1M9, Canada; [Brown, Carolyn J.] Univ British Columbia, Dept Med Genet, Vancouver, BC V5Z 1M9, Canada	British Columbia Cancer Agency; University of British Columbia; University of British Columbia; University of British Columbia	Gibb, EA (corresponding author), British Columbia Canc Agcy, Res Ctr, Vancouver, BC V5Z 4E6, Canada.	egibb@bccrc.ca	Brown, Carolyn J/A-5159-2014; MacAulay, Calum/K-1795-2016	Brown, Carolyn J/0000-0002-8959-0101; Vucic, Emily/0000-0002-2728-8708; MacAulay, Calum/0000-0003-4440-2792	Canadian Institutes for Health Research (CIHR) [MOP 86731, MOP 77903, MOP 13690]; National Institutes of Health [NIH] [2R01 CA103830 - 6A1]; Department of Defense [CDMRP W81XWH-10-1-0634]; Michael Smith Foundation for Health Research (MSFHR); CIHR, Canada; NATIONAL CANCER INSTITUTE [R01CA103830] Funding Source: NIH RePORTER	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Institutes of Health [NIH](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); CIHR, Canada(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Canadian Institutes for Health Research (CIHR) [MOP 86731, MOP 77903 to W.L.L., MOP 13690 to C.J.B.]; National Institutes of Health [NIH 2R01 CA103830 - 6A1]; Department of Defense [CDMRP W81XWH-10-1-0634]; CIHR and Michael Smith Foundation for Health Research (MSFHR) Postdoctoral Fellowships [to E.A.G.]; and CIHR Frederick Banting and Charles Best Canada Graduate Scholarship [to E.A.V.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augui S, 2011, NAT REV GENET, V12, P429, DOI 10.1038/nrg2987; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Benetatos L, 2011, INT J CANC; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; BRANNAN CI, 1990, MOL CELL BIOL, V10, P28, DOI 10.1128/MCB.10.1.28; Brosnan CA, 2009, CURR OPIN CELL BIOL, V21, P416, DOI 10.1016/j.ceb.2009.04.001; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; Buschges R, 1999, BRAIN PATHOL, V9, P435; Caley DP, 2010, THESCIENTIFICWORLDJO, V10, P90, DOI 10.1100/tsw.2010.7; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carninci P, 2007, CURR OPIN GENET DEV, V17, P139, DOI 10.1016/j.gde.2007.02.008; Castle JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011779; Chari R, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-32; Chen LL, 2009, MOL CELL, V35, P467, DOI 10.1016/j.molcel.2009.06.027; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Costa FF, 2010, BIOESSAYS, V32, P599, DOI 10.1002/bies.200900112; Costa FF, 2005, GENE, V357, P83, DOI 10.1016/j.gene.2005.06.019; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Gejman R, 2008, J CLIN ENDOCR METAB, V93, P4119, DOI 10.1210/jc.2007-2633; Gibb EA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-38; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Greer S, 2010, J IMMUNOL METHODS, V355, P76, DOI 10.1016/j.jim.2010.02.006; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huarte M, 2010, HUM MOL GENET, V19, pR152, DOI 10.1093/hmg/ddq353; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Kanduri C, 2011, SEMIN CELL DEV BIOL; Kang JU, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-237; Kapranov P, 2005, GENOME RES, V15, P987, DOI 10.1101/gr.3455305; Kapranov P, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-149; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kerr KM, 2001, J CLIN PATHOL, V54, P257, DOI 10.1136/jcp.54.4.257; Kiss T, 2001, EMBO J, V20, P3617, DOI 10.1093/emboj/20.14.3617; Kotake Y, 2011, ONCOGENE, V30, P1956, DOI 10.1038/onc.2010.568; Letessier A, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-245; Lipovich L, 2010, BBA-GENE REGUL MECH, V1799, P597, DOI 10.1016/j.bbagrm.2010.10.001; MARUYAMA R, 2010, P NATL ACAD SCI US; Mattick JS, 2011, SCIENCE, V331, P874, DOI 10.1126/science.1203703; Mattick JS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000459; Mattick JS, 2001, EMBO REP, V2, P986, DOI 10.1093/embo-reports/kve230; Mestdagh P, 2010, ONCOGENE, V29, P3583, DOI 10.1038/onc.2010.106; Mestdagh P, 2010, MOL CELL, V40, P762, DOI 10.1016/j.molcel.2010.11.038; Miyoshi N, 2000, GENES CELLS, V5, P211, DOI 10.1046/j.1365-2443.2000.00320.x; Morris KV, 2009, OLIGONUCLEOTIDES, V19, P299, DOI 10.1089/oli.2009.0212; Nagano T, 2011, CELL, V145, P178, DOI 10.1016/j.cell.2011.03.014; Pauli A, 2011, NAT REV GENET, V12, P136, DOI 10.1038/nrg2904; Rearick D, 2011, NUCLEIC ACIDS RES, V39, P2357, DOI 10.1093/nar/gkq1080; Rubie C, 2005, MOL CELL PROBE, V19, P101, DOI 10.1016/j.mcp.2004.10.001; Schiffman JD, 2010, CANCER RES, V70, P512, DOI 10.1158/0008-5472.CAN-09-1851; Shevtsov SP, 2011, NAT CELL BIOL, V13, P167, DOI 10.1038/ncb2157; Steele BK, 2002, ANAL BIOCHEM, V307, P341, DOI 10.1016/S0003-2697(02)00045-3; Strausberg RL, 2000, TRENDS GENET, V16, P103, DOI 10.1016/S0168-9525(99)01937-X; Takeuchi S, 2007, BRIT J HAEMATOL, V137, P380, DOI 10.1111/j.1365-2141.2007.06581.x; Ting DT, 2011, SCIENCE, V331, P593, DOI 10.1126/science.1200801; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Tsai MC, 2011, CANCER RES, V71, P3, DOI 10.1158/0008-5472.CAN-10-2483; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; van Leeuwen S, 2010, DIFFERENTIATION, V80, P175, DOI 10.1016/j.diff.2010.07.003; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Wang F, 2008, FEBS LETT, V582, P1919, DOI 10.1016/j.febslet.2008.05.012; Wistuba II, 2006, ANNU REV PATHOL-MECH, V1, P331, DOI 10.1146/annurev.pathol.1.110304.100103; Yang L, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r16; Yu W, 2009, CANCER GENET CYTOGEN, V193, P29, DOI 10.1016/j.cancergencyto.2009.03.017; Zhang X, 2003, J CLIN ENDOCR METAB, V88, P5119, DOI 10.1210/jc.2003-030222	71	299	329	1	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25915	10.1371/journal.pone.0025915	http://dx.doi.org/10.1371/journal.pone.0025915			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991387	gold, Green Published, Green Submitted			2022-12-27	WOS:000295943000095
J	Nori, J; Urbina-Cardona, JN; Loyola, RD; Lescano, JN; Leynaud, GC				Nori, Javier; Nicolas Urbina-Cardona, J.; Loyola, Rafael D.; Lescano, Julian N.; Leynaud, Gerardo C.			Climate Change and American Bullfrog Invasion: What Could We Expect in South America?	PLOS ONE			English	Article							LITHOBATES-CATESBEIANUS; BIOLOGICAL INVASIONS; SPECIES DISTRIBUTIONS; NICHE; PREDICTION; POPULATIONS; AMPHIBIANS; IMPACTS; RANGES; SHIFTS	Background: Biological invasion and climate change pose challenges to biodiversity conservation in the 21(st) century. Invasive species modify ecosystem structure and functioning and climatic changes are likely to produce invasive species' range shifts pushing some populations into protected areas. The American Bullfrog (Lithobates catesbeianus) is one of the hundred worst invasive species in the world. Native from the southeast of USA, it has colonized more than 75% of South America where it has been reported as a highly effective predator, competitor and vector of amphibian diseases. Methodology/Principal Findings: We modeled the potential distribution of the bullfrog in its native range based on different climate models and green-house gases emission scenarios, and projected the results onto South America for the years of 2050 and 2080. We also overlaid projected models onto the South American network of protected areas. Our results indicate a slight decrease in potential suitable area for bullfrog invasion, although protected areas will become more climatically suitable. Therefore, invasion of these sites is forecasted. Conclusion/Significance: We provide new evidence supporting the vulnerability of the Atlantic Forest Biodiversity Hotspot to bullfrog invasion and call attention to optimal future climatic conditions of the Andean-Patagonian forest, eastern Paraguay, and northwestern Bolivia, where invasive populations have not been found yet. We recommend several management and policy strategies to control bullfrog invasion and argue that these would be possible if based on appropriate articulation among government agencies, NGOs, research institutions and civil society.	[Nori, Javier; Lescano, Julian N.; Leynaud, Gerardo C.] Univ Nacl Cordoba, Ctr Zool Aplicada, Fac Ciencias Exactas Fis & Nat, RA-5000 Cordoba, Argentina; [Nicolas Urbina-Cardona, J.] Pontificia Univ Javeriana, Dept Ecol & Terr, Fac Estudios Ambientales & Rurales, Bogota, Colombia; [Loyola, Rafael D.] Univ Fed Goias, Dept Ecol, Goias, Brazil; [Lescano, Julian N.] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina	National University of Cordoba; Pontificia Universidad Javeriana; Universidade Federal de Goias; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Nori, J (corresponding author), Univ Nacl Cordoba, Ctr Zool Aplicada, Fac Ciencias Exactas Fis & Nat, RA-5000 Cordoba, Argentina.	javiernori@gmail.com	Loyola, Rafael/A-4425-2008; Urbina-Cardona, J. Nicolas/B-5447-2008; Loyola, Rafael/S-3978-2019	Loyola, Rafael/0000-0001-5323-2735; Urbina-Cardona, J. Nicolas/0000-0002-4174-8467; Loyola, Rafael/0000-0001-5323-2735; Lescano, Julian Norberto/0000-0002-8776-012X; Nori, Javier/0000-0002-7127-7934	MINCyT [000113/2011]; CNPq [475886/2009-7]; CAPES-FCT [12/2009]; Brazilian Research Network on Global Climate Change; Consejo Nacional de Investigaciones Cientificas y Tecnicas	MINCyT; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES-FCT(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)Portuguese Foundation for Science and Technology); Brazilian Research Network on Global Climate Change; Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	JN, JNL and GCL research is supported by MINCyT - PID 2010 (project #000113/2011). RDL research is supported by CNPq (project #475886/2009-7), CAPES-FCT Program (project #12/2009) and the Brazilian Research Network on Global Climate Change. JNL has a doctoral fellowship from Consejo Nacional de Investigaciones Cientificas y Tecnicas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; Beaumont LJ, 2009, DIVERS DISTRIB, V15, P409, DOI 10.1111/j.1472-4642.2008.00547.x; Becker CG, 2011, P NATL ACAD SCI USA, V108, P9893, DOI 10.1073/pnas.1014497108; Broennimann O, 2008, BIOL LETTERS, V4, P585, DOI 10.1098/rsbl.2008.0254; Calix M., 2018, EUROPEAN RED LIST SA; Coutts-Smith A., 2006, TECHNICAL SERIES CRC, V11; Diniz JAF, 2010, INSECT CONSERV DIVER, V3, P213, DOI 10.1111/j.1752-4598.2010.00090.x; Diniz JAF, 2009, ECOGRAPHY, V32, P897, DOI 10.1111/j.1600-0587.2009.06196.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Environmental Systems Research Institute (ESRI), 2005, ARCMAP GIS VER 9 3 1; Ficetola GF, 2007, DIVERS DISTRIB, V13, P476, DOI 10.1111/j.1472-4642.2007.00377.x; Franklin J, 2010, DIVERS DISTRIB, V16, P321, DOI 10.1111/j.1472-4642.2010.00641.x; Gallagher RV, 2010, J ECOL, V98, P790, DOI 10.1111/j.1365-2745.2010.01677.x; Giovanelli JGR, 2008, BIOL INVASIONS, V10, P585, DOI 10.1007/s10530-007-9154-5; Hellmann JJ, 2008, CONSERV BIOL, V22, P534, DOI 10.1111/j.1523-1739.2008.00951.x; Hierro JL, 2005, J ECOL, V93, P5, DOI 10.1111/j.0022-0477.2004.00953.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; IPCC, 2007, CLIM CHANG 2007 SCI; ISSG (Invasive Species Specialist Group), 2009, GLOB INV SPEC DAT; Jamsranjav J, 2008, WORLDS PROTECTED ARE, P88; Kearney M, 2008, ECOGRAPHY, V31, P423, DOI 10.1111/j.0906-7590.2008.05457.x; Lever C, 2003, NATURALIZED REPTILES; Loyola RD, 2011, CLIMATE CHA IN PRESS; Lutz C.G., 1999, SO REGIONAL AQUACULT, V436; Mack MC, 1998, TRENDS ECOL EVOL, V13, P195, DOI 10.1016/S0169-5347(97)01286-X; Martinez-Meyer E, 2006, J BIOGEOGR, V33, P1779, DOI [10.1111/j.1365-2699.2006.01612.x, 10.1111/j.1365-2699.2006.01482_33_10.x]; Matthews S., 2005, SUDAMERICA INVADIDA; McNeely Jeffrey A., 2005, SCOPE, V63, P332; Nori J, 2011, BIODIVERS CONSERV, V20, P1125, DOI 10.1007/s10531-011-0014-3; Parrish JD, 2003, BIOSCIENCE, V53, P851, DOI 10.1641/0006-3568(2003)053[0851:AWCWWS]2.0.CO;2; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Peterson AT, 2003, Q REV BIOL, V78, P419, DOI 10.1086/378926; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Pyke CR, 2008, CONSERV BIOL, V22, P585, DOI 10.1111/j.1523-1739.2008.00956.x; Pyron RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002931; Reaser JK, 2005, ESPECIES ALIENIGENAS; Rodda GH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014670; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sanabria E, 2011, REV MEX BIODIVERS, V82, P311; Schloegel LM, 2009, BIOL CONSERV, V142, P1420, DOI 10.1016/j.biocon.2009.02.007; Akmentins MS, 2010, BIOL INVASIONS, V12, P735, DOI 10.1007/s10530-009-9515-3; Sharma GP, 2005, CURR SCI INDIA, V88, P726; Simberloff D, 1997, STRANGERS PARADISE I; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Thuiller Wilfried, 2007, V193, P197; Tingley R, 2011, AM NAT, V177, P382, DOI 10.1086/658342; Urbina-Cardona J. N., 2010, BIODIVERSIDAD CAMBIO, P65; Urbina-Cardona JN, 2011, BIOTA COLOM IN PRESS; USHER MB, 1988, BIOL CONSERV, V44, P1, DOI 10.1016/0006-3207(88)90002-X; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Wilcove David S., 2000, P239	54	47	53	6	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25718	10.1371/journal.pone.0025718	http://dx.doi.org/10.1371/journal.pone.0025718			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991339	gold, Green Submitted, Green Published			2022-12-27	WOS:000295943000059
J	Poljac, E; Verfaillie, K; Wagemans, J				Poljac, Ervin; Verfaillie, Karl; Wagemans, Johan			Integrating Biological Motion: The Role of Grouping in the Perception of Point-Light Actions	PLOS ONE			English	Article							FRAGMENTED OBJECT OUTLINES; VISUAL-PERCEPTION; STIMULUS SET; FACE PERCEPTION; HUMAN GAIT; IDENTIFICATION; INVERSION; ORGANIZATION; RECOGNITION; SPECIFICITY	The human visual system is highly sensitive to biological motion and manages to organize even a highly reduced point-light stimulus into a vivid percept of human action. The current study investigated to what extent the origin of this saliency of point-light displays is related to its intrinsic Gestalt qualities. In particular, we studied whether biological motion perception is facilitated when the elements can be grouped according to good continuation and similarity as Gestalt principles of perceptual organization. We found that both grouping principles enhanced biological motion perception but their effects differed when stimuli were inverted. These results provide evidence that Gestalt principles of good continuity and similarity also apply to more complex and dynamic meaningful stimuli.	[Poljac, Ervin; Verfaillie, Karl; Wagemans, Johan] Univ Leuven, KU Leuven, Expt Psychol Lab, Louvain, Belgium	KU Leuven	Poljac, E (corresponding author), Univ Leuven, KU Leuven, Expt Psychol Lab, Louvain, Belgium.	Ervin.Poljac@psy.kuleuven.be	Wagemans, Johan/M-3878-2019	Wagemans, Johan/0000-0002-7970-1541	Flemish Government [METH/08/02]	Flemish Government(European Commission)	This work was supported by the Methusalem programme by the Flemish Government (METH/08/02), awarded to Johan Wagemans. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beintema JA, 2006, PERCEPT PSYCHOPHYS, V68, P613, DOI 10.3758/BF03208763; Beintema JA, 2002, P NATL ACAD SCI USA, V99, P5661, DOI 10.1073/pnas.082483699; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Casco C, 2009, VISION RES, V49, P583, DOI 10.1016/j.visres.2009.02.004; Casile A, 2005, J VISION, V5, P348, DOI 10.1167/5.4.6; Claessens PM, 2005, PERCEPT PSYCHOPHYS, V67, P1446, DOI 10.3758/BF03193649; CUTTING JE, 1988, PERCEPT PSYCHOPHYS, V44, P339, DOI 10.3758/BF03210415; Dakin SC, 2009, J VISION, V9, DOI 10.1167/9.2.13; Dekeyser M, 2002, BEHAV RES METH INS C, V34, P375, DOI 10.3758/BF03195465; Feldman J, 2007, PERCEPT PSYCHOPHYS, V69, P816, DOI 10.3758/BF03193781; FIELD DJ, 1993, VISION RES, V33, P173, DOI 10.1016/0042-6989(93)90156-Q; Fitzpatrick D, 1996, CEREB CORTEX, V6, P329, DOI 10.1093/cercor/6.3.329; Hunt AR, 2008, J VISION, V8, DOI 10.1167/8.9.12; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Kubovy M, 2008, PSYCHOL REV, V115, P131, DOI 10.1037/0033-295X.115.1.131; Kuhlmann S, 2009, J VISION, V9, DOI 10.1167/9.10.11; Lange J, 2006, J VISION, V6, P836, DOI 10.1167/6.8.6; Lee SH, 1999, SCIENCE, V284, P1165, DOI 10.1126/science.284.5417.1165; Machilsen B, 2011, VISION RES, V51, P179, DOI 10.1016/j.visres.2010.11.005; Manera V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014594; Manera V, 2010, BEHAV RES METHODS, V42, P168, DOI 10.3758/BRM.42.1.168; Panis S, 2009, J EXP PSYCHOL HUMAN, V35, P661, DOI 10.1037/a0013547; Pavlova M, 2003, PERCEPTION, V32, P937, DOI 10.1068/p3428; Pavlova M, 2000, PERCEPT PSYCHOPHYS, V62, P889, DOI 10.3758/BF03212075; Peelen MV, 2007, NAT REV NEUROSCI, V8, P636, DOI 10.1038/nrn2195; Pelli DG, 2009, COGN NEUROPSYCHOL, V26, P36, DOI 10.1080/13546800802550134; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Peuskens H, 2005, EUR J NEUROSCI, V21, P2864, DOI 10.1111/j.1460-9568.2005.04106.x; Reid R, 2009, PERCEPTION, V38, P613, DOI 10.1068/p6320; Rossion B, 2008, ACTA PSYCHOL, V128, P274, DOI 10.1016/j.actpsy.2008.02.003; Sassi M, 2010, I-PERCEPTION, V1, P121, DOI 10.1068/i0384; Saunders DR, 2009, PERCEPTION, V38, P522, DOI 10.1068/p6140; Schmidt KE, 1997, EUR J NEUROSCI, V9, P1083, DOI 10.1111/j.1460-9568.1997.tb01459.x; Schouten B, 2011, ATTEN PERCEPT PSYCHO, V73, P130, DOI 10.3758/s13414-010-0018-1; SUMI S, 1984, PERCEPTION, V13, P283, DOI 10.1068/p130283; Tadin D, 2002, NAT NEUROSCI, V5, P1010, DOI 10.1038/nn914; Thirkettle M, 2010, VISION RES, V50, P118, DOI 10.1016/j.visres.2009.10.021; Thirkettle M, 2009, J VISION, V9, DOI 10.1167/9.3.28; Thornton IM, 1998, COGNITIVE NEUROPSYCH, V15, P535, DOI 10.1080/026432998381014; Torfs K, 2010, VIS COGN, V18, P1133, DOI 10.1080/13506281003693593; Troje NF, 2006, CURR BIOL, V16, P821, DOI 10.1016/j.cub.2006.03.022; Troje NF, 2002, J VISION, V2, P371, DOI 10.1167/2.5.2; Van Belle G, 2010, J VISION, V10, DOI 10.1167/10.5.10; Van Belle G, 2009, BEHAV RES METHODS, V41, P279, DOI 10.3758/BRM.41.2.279; Vanrie J, 2004, BEHAV RES METH INS C, V36, P625, DOI 10.3758/BF03206542; Vanrie J, 2004, PERCEPTION, V33, P547, DOI 10.1068/p5004; Wertheimer M, 1923, PSYCHOL FORSCH, V4, P301, DOI 10.1007/BF00410640; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544	48	5	5	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25867	10.1371/journal.pone.0025867	http://dx.doi.org/10.1371/journal.pone.0025867			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834EU	21991376	Green Published, gold			2022-12-27	WOS:000295943000087
J	Soulieres, I; Dawson, M; Gernsbacher, MA; Mottron, L				Soulieres, Isabelle; Dawson, Michelle; Gernsbacher, Morton Ann; Mottron, Laurent			The Level and Nature of Autistic Intelligence II: What about Asperger Syndrome?	PLOS ONE			English	Article							PERVASIVE DEVELOPMENTAL DISORDERS; SPECTRUM DISORDERS; FLUID INTELLIGENCE; CHILDREN; PERSPECTIVE; ABILITY; IQ; INDIVIDUALS; PERFORMANCE; PERCEPTION	A distinctively uneven profile of intelligence is a feature of the autistic spectrum. Within the spectrum, Asperger individuals differ from autistics in their early speech development and in being less likely to be characterized by visuospatial peaks. While different specific strengths characterize different autistic spectrum subgroups, all such peaks of ability have been interpreted as deficits: isolated, aberrant, and irreconcilable with real human intelligence. This view has recently been challenged by findings of autistic strengths in performance on Raven's Progressive Matrices (RPM), an important marker of general and fluid intelligence. We investigated whether these findings extend to Asperger syndrome, an autistic spectrum subgroup characterized by verbal peaks of ability, and whether the cognitive mechanisms underlying autistic and Asperger RPM performance differ. Thirty-two Asperger adults displayed a significant advantage on RPM over Wechsler Full-Scale and Performance scores relative to their typical controls, while in 25 Asperger children an RPM advantage was found over Wechsler Performance scores only. As previously found with autistics, Asperger children and adults achieved RPM scores at a level reflecting their Wechsler peaks of ability. Therefore, strengths in RPM performance span the autistic spectrum and imply a common mechanism advantageously applied to different facets of cognition. Autistic spectrum intelligence is atypical, but also genuine, general, and underestimated.	[Soulieres, Isabelle; Dawson, Michelle; Mottron, Laurent] Univ Montreal, Ctr Excellence Troubles Envahissants Dev, Montreal, PQ, Canada; [Soulieres, Isabelle] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Psychiat, Boston, MA USA; [Gernsbacher, Morton Ann] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA	Universite de Montreal; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Wisconsin System; University of Wisconsin Madison	Soulieres, I (corresponding author), Univ Montreal, Ctr Excellence Troubles Envahissants Dev, Montreal, PQ, Canada.	isabelle@nmr.mgh.harvard.edu		Mottron, Laurent/0000-0001-5668-5422; Gernsbacher, Morton Ann/0000-0003-0397-3329	Canadian Institutes for Health Research (CIHR) [MOP-84243]	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from Canadian Institutes for Health Research (CIHR; grant MOP-84243) to LM and a postdoctoral award from CIHR to IS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Asperger H., 1944, AUTISM ASPERGER SYND, P37; Blair C, 2006, BEHAV BRAIN SCI, V29, P109; Bolte S, 2009, J AUTISM DEV DISORD, V39, P678, DOI 10.1007/s10803-008-0667-2; Caron MJ, 2006, BRAIN, V129, P1789, DOI 10.1093/brain/awl072; CARPENTER PA, 1990, PSYCHOL REV, V97, P404, DOI 10.1037/0033-295X.97.3.404; Chakrabarti S, 2005, AM J PSYCHIAT, V162, P1133, DOI 10.1176/appi.ajp.162.6.1133; Charman T, 2011, PSYCHOL MED, V41, P619, DOI 10.1017/S0033291710000991; Dawson M, 2007, PSYCHOL SCI, V18, P657, DOI 10.1111/j.1467-9280.2007.01954.x; DILLON R, 1978, EDUC PSYCHOL MEAS, V38, P437, DOI 10.1177/001316447803800227; Ehlers S, 1997, J CHILD PSYCHOL PSYC, V38, P207, DOI 10.1111/j.1469-7610.1997.tb01855.x; Flynn J R, 2000, Novartis Found Symp, V233, P202, DOI 10.1002/0470870850.ch13; Gray JR, 2004, NAT REV NEUROSCI, V5, P471, DOI 10.1038/nrn1405; HAPPE FGE, 1994, J CHILD PSYCHOL PSYC, V35, P1461, DOI 10.1111/j.1469-7610.1994.tb01287.x; Hayashi M, 2008, BRAIN COGNITION, V66, P306, DOI 10.1016/j.bandc.2007.09.008; HOBSON RP, 2002, CRADLE THOUGHT CHALL; Kane MJ, 2002, PSYCHON B REV, V9, P637, DOI 10.3758/BF03196323; Kanner L, 1943, NERV CHILD, V2, P217; KLIN A, 1995, J CHILD PSYCHOL PSYC, V36, P1127, DOI 10.1111/j.1469-7610.1995.tb01361.x; Lohman DF, 2005, GIFTED CHILD QUART, V49, P111, DOI 10.1177/001698620504900203; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; MACKINTOSH NJ, 1998, IQ HUMAN INTELLIGENC, V9, P419; Minshew NJ, 2002, MOL PSYCHIATR, V7, pS14, DOI 10.1038/sj.mp.4001166; Morrison R.G., 2005, CAMBRIDGE HDB THINKI, P457; Morsanyi K, 2010, DEVELOPMENTAL SCI, V13, P578, DOI 10.1111/j.1467-7687.2009.00915.x; Mottron L, 2006, J AUTISM DEV DISORD, V36, P27, DOI 10.1007/s10803-005-0040-7; Mottron L, 2009, PHILOS T R SOC B, V364, P1385, DOI 10.1098/rstb.2008.0333; Pennington BF, 1996, J CHILD PSYCHOL PSYC, V37, P51, DOI 10.1111/j.1469-7610.1996.tb01380.x; RAVEN J, 1998, STANDARD PROGR MATRI; SHAH A, 1993, J CHILD PSYCHOL PSYC, V34, P1351, DOI 10.1111/j.1469-7610.1993.tb02095.x; Snow R., 1984, ADV PSYCHOL HUMAN IN, P47; Solomon M, 2011, J AUTISM DEV DISORD, V41, P32, DOI 10.1007/s10803-010-1017-8; Soulieres I, 2009, HUM BRAIN MAPP, V30, P4082, DOI 10.1002/hbm.20831; Williams W. M., 1998, RISING CURVE LONG TE, P125; [No title captured]	37	54	54	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2011	6	9							e25372	10.1371/journal.pone.0025372	http://dx.doi.org/10.1371/journal.pone.0025372			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834CT	21991394	Green Submitted, Green Published, gold			2022-12-27	WOS:000295936900056
J	Blattler, F; Hahnloser, RHR				Blaettler, Florian; Hahnloser, Richard H. R.			An Efficient Coding Hypothesis Links Sparsity and Selectivity of Neural Responses	PLOS ONE			English	Article							SONG SYSTEM; FOREBRAIN CIRCUIT; AUDITORY NEURONS; NATURAL SOUNDS; REPRESENTATIONS; INHIBITION; EXCITATION; CONNECTIONS; ADAPTATION; ALGORITHMS	To what extent are sensory responses in the brain compatible with first-order principles? The efficient coding hypothesis projects that neurons use as few spikes as possible to faithfully represent natural stimuli. However, many sparsely firing neurons in higher brain areas seem to violate this hypothesis in that they respond more to familiar stimuli than to nonfamiliar stimuli. We reconcile this discrepancy by showing that efficient sensory responses give rise to stimulus selectivity that depends on the stimulus-independent firing threshold and the balance between excitatory and inhibitory inputs. We construct a cost function that enforces minimal firing rates in model neurons by linearly punishing suprathreshold synaptic currents. By contrast, subthreshold currents are punished quadratically, which allows us to optimally reconstruct sensory inputs from elicited responses. We train synaptic currents on many renditions of a particular bird's own song (BOS) and few renditions of conspecific birds' songs (CONs). During training, model neurons develop a response selectivity with complex dependence on the firing threshold. At low thresholds, they fire densely and prefer CON and the reverse BOS (REV) over BOS. However, at high thresholds or when hyperpolarized, they fire sparsely and prefer BOS over REV and over CON. Based on this selectivity reversal, our model suggests that preference for a highly familiar stimulus corresponds to a high-threshold or strong-inhibition regime of an efficient coding strategy. Our findings apply to songbird mirror neurons, and in general, they suggest that the brain may be endowed with simple mechanisms to rapidly change selectivity of neural responses to focus sensory processing on either familiar or nonfamiliar stimuli. In summary, we find support for the efficient coding hypothesis and provide new insights into the interplay between the sparsity and selectivity of neural responses.	[Blaettler, Florian; Hahnloser, Richard H. R.] Univ Zurich, ETH Zurich, Inst Neuroinformat, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Blattler, F (corresponding author), Univ Zurich, ETH Zurich, Inst Neuroinformat, Zurich, Switzerland.	rich@ini.phys.ethz.ch		Hahnloser, Richard/0000-0002-4039-7773	ETH Zurich [TH-03 06-1]; Swiss National Science Foundation (SNF)	ETH Zurich(ETH Zurich); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF))	F.B. was supported by a TH grant of the ETH Zurich (TH-03 06-1), and R.H. was supported by the Swiss National Science Foundation (SNF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin N, 2004, J COMP PHYSIOL A, V190, P469, DOI 10.1007/s00359-004-0511-x; Amin N, 2007, J NEUROPHYSIOL, V97, P3517, DOI 10.1152/jn.01066.2006; Amin N, 2010, J NEUROPHYSIOL, V104, P784, DOI 10.1152/jn.00128.2010; Andalman AS, 2009, P NATL ACAD SCI USA, V106, P12518, DOI 10.1073/pnas.0903214106; Aronov D, 2008, SCIENCE, V320, P630, DOI 10.1126/science.1155140; Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371; Bauer EE, 2008, J NEUROSCI, V28, P1509, DOI 10.1523/JNEUROSCI.3838-07.2008; BELL AJ, 1995, INT CONF ACOUST SPEE, P3415, DOI 10.1109/ICASSP.1995.479719; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Brainard MS, 2000, NAT REV NEUROSCI, V1, P31, DOI 10.1038/35036205; Coleman MJ, 2004, J NEUROSCI, V24, P7251, DOI 10.1523/JNEUROSCI.0947-04.2004; Crist RE, 2001, NAT NEUROSCI, V4, P519, DOI 10.1038/87470; D'Souza P, 2010, P NATL ACAD SCI USA, V107, P4722, DOI 10.1073/pnas.0909394107; Davison IG, 2007, J NEUROSCI, V27, P2091, DOI 10.1523/JNEUROSCI.3779-06.2007; Fiete IR, 2010, NEURON, V65, P563, DOI 10.1016/j.neuron.2010.02.003; Gentner TQ, 2003, NATURE, V424, P669, DOI 10.1038/nature01731; Grace JA, 2003, J NEUROPHYSIOL, V89, P472, DOI 10.1152/jn.00088.2002; Green DM, 1966, SIGNAL DETECTION THE; Greene G, 2009, NETWORK-COMP NEURAL, V20, P162, DOI 10.1080/09548980903108267; GRIFFIN DW, 1984, IEEE T ACOUST SPEECH, V32, P236, DOI 10.1109/TASSP.1984.1164317; Heiss JE, 2008, J NEUROSCI, V28, P13320, DOI 10.1523/JNEUROSCI.2646-08.2008; Hochstein S, 2002, NEURON, V36, P791, DOI 10.1016/S0896-6273(02)01091-7; Hoyer PO, 2002, NEURAL NETWORKS FOR SIGNAL PROCESSING XII, PROCEEDINGS, P557, DOI 10.1109/NNSP.2002.1030067; Hromadka T, 2008, PLOS BIOL, V6, P124, DOI 10.1371/journal.pbio.0060016; Hyvarinen A, 1997, NEURAL COMPUT, V9, P1483, DOI 10.1162/neco.1997.9.7.1483; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Jun JK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000723; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Lewicki MS, 1996, J NEUROSCI, V16, P6987; MARGOLIASH D, 1986, J NEUROSCI, V6, P1643; MARGOLIASH D, 1983, J NEUROSCI, V3, P1039; Mooney R, 2000, J NEUROSCI, V20, P5420, DOI 10.1523/JNEUROSCI.20-14-05420.2000; Moreau AW, 2010, CEREB CORTEX, V20, P456, DOI 10.1093/cercor/bhp114; Nagel KI, 2008, NEURON, V58, P938, DOI 10.1016/j.neuron.2008.04.028; Nick TA, 2005, J NEUROBIOL, V62, P469, DOI 10.1002/neu.20115; NOTTEBOHM F, 1982, J COMP NEUROL, V207, P344, DOI 10.1002/cne.902070406; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Perez-Orive J, 2004, J NEUROSCI, V24, P6037, DOI 10.1523/JNEUROSCI.1084-04.2004; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; Plumbley MD, 2003, IEEE T NEURAL NETWOR, V14, P534, DOI 10.1109/TNN.2003.810616; Prather JF, 2008, NATURE, V451, P305, DOI 10.1038/nature06492; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; Rosen MJ, 2003, NEURON, V39, P177, DOI 10.1016/S0896-6273(03)00357-X; Sen K, 2001, J NEUROPHYSIOL, V86, P1445, DOI 10.1152/jn.2001.86.3.1445; Sharpee T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000646; Smith EC, 2006, NATURE, V439, P978, DOI 10.1038/nature04485; Theunissen FE, 2004, ANN NY ACAD SCI, V1016, P222, DOI 10.1196/annals.1298.023; Theunissen FE, 2000, J NEUROSCI, V20, P2315; Tumer EC, 2007, NATURE, V450, P1240, DOI 10.1038/nature06390; Vates GE, 1996, J COMP NEUROL, V366, P613, DOI 10.1002/(SICI)1096-9861(19960318)366:4<613::AID-CNE5>3.0.CO;2-7; Waydo S, 2006, J NEUROSCI, V26, P10232, DOI 10.1523/JNEUROSCI.2101-06.2006; WELIKY M, 1995, NEURON, V15, P541, DOI 10.1016/0896-6273(95)90143-4; Woolley SMN, 2010, DEV NEUROBIOL, V70, P235, DOI 10.1002/dneu.20783; Woolley SMN, 2009, J NEUROSCI, V29, P2780, DOI 10.1523/JNEUROSCI.2042-08.2009	57	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e25506	10.1371/journal.pone.0025506	http://dx.doi.org/10.1371/journal.pone.0025506			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022405	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000295978600020
J	Anderson, N; Borlak, J				Anderson, Nora; Borlak, Juergen			Correlation versus Causation? Pharmacovigilance of the Analgesic Flupirtine Exemplifies the Need for Refined Spontaneous ADR Reporting	PLOS ONE			English	Article							ADVERSE DRUG-REACTIONS; CAUSALITY ASSESSMENT; UNITED-STATES; LIVER-INJURY; BACK-PAIN; ASSOCIATION; EFFICACY; DISEASE; EVENTS; PHARMACOEPIDEMIOLOGY	Annually, adverse drug reactions result in more than 2,000,000 hospitalizations and rank among the top 10 causes of death in the United States. Consequently, there is a need to continuously monitor and to improve the safety assessment of marketed drugs. Nonetheless, pharmacovigilance practice frequently lacks causality assessment. Here, we report the case of flupirtine, a centrally acting non-opioid analgesic. We re-evaluated the plausibility and causality of 226 unselected, spontaneously reported hepatobiliary adverse drug reactions according to the adapted Bradford-Hill criteria, CIOMS score and WHO-UMC scales. Thorough re-evaluation showed that only about 20% of the reported cases were probable or likely for flupirtine treatment, suggesting an incidence of flupirtine-related liver injury of 1: 100,000 when estimated prescription data are considered, or 0.8 in 10,000 on the basis of all 226 reported adverse drug reactions. Neither daily or cumulative dose nor duration of treatment correlated with markers of liver injury. In the majority of cases (151/226), an average of 3 co-medications with drugs known for their liver liability was observed that may well be causative for adverse drug reactions, but were reported under a suspected flupirtine ADR. Our study highlights the need to improve the quality and standards of ADR reporting. This should be done with utmost care taking into account contributing factors such as concomitant medications including over-the-counter drugs, the medical history and current health conditions, in order to avoid unjustified flagging and drug warnings that may erroneously cause uncertainty among healthcare professionals and patients, and may eventually lead to unjustified safety signals of useful drugs with a reasonable risk to benefit ratio.	[Anderson, Nora; Borlak, Juergen] Hannover Med Sch, Ctr Pharmacol & Toxicol, D-3000 Hannover, Germany; [Borlak, Juergen] Fraunhofer Inst Toxicol & Expt Med, Dept Mol Med & Med Biotechnol, Hannover, Germany	Hannover Medical School; Fraunhofer Gesellschaft	Anderson, N (corresponding author), Hannover Med Sch, Ctr Pharmacol & Toxicol, D-3000 Hannover, Germany.	Borlak.Juergen@mh-hannover.de			Lower Saxony Ministry of Culture and Sciences; Volkswagen Foundation, Germany [25A.5-7251-99-3/00]; MEDA Pharma GmbH; Company KG (Bad Homburg, Germany)	Lower Saxony Ministry of Culture and Sciences; Volkswagen Foundation, Germany(Volkswagen); MEDA Pharma GmbH; Company KG (Bad Homburg, Germany)	This work was in part funded by the Lower Saxony Ministry of Culture and Sciences and the Volkswagen Foundation, Germany (grant no. 25A.5-7251-99-3/00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to disclose that the Fraunhofer Institute of Toxicology and Experimental Medicine is currently carrying out a study that is sponsored by MEDA Pharma GmbH and Company KG (Bad Homburg, Germany) which is one of the marketing authorisation holders of the analgesic flupirtine. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. The authors wish to emphasize that funding did not influence the design of the study, data collection and analysis, decision to publish, or preparation of the manuscript. Furthermore the sponsor of the study did not influence the outcome or interpretation of the data.	Aithal Guruprasad P, 2007, Clin Liver Dis, V11, P563, DOI 10.1016/j.cld.2007.06.004; *ARZN DTSCH ARZT, 2007, DTSCH ARZTEBL, V104, pA3200; Bate A, 2008, FUND CLIN PHARMACOL, V22, P127, DOI 10.1111/j.1472-8206.2007.00552.x; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Bates DW, 1997, JAMA-J AM MED ASSOC, V277, P307, DOI 10.1001/jama.277.4.307; BERO LA, 1991, MED CARE, V29, P989, DOI 10.1097/00005650-199110000-00005; Boscia F, 2006, NEUROPHARMACOLOGY, V51, P283, DOI 10.1016/j.neuropharm.2006.03.024; Brown DA, 2009, BRIT J PHARMACOL, V156, P1185, DOI 10.1111/j.1476-5381.2009.00111.x; Clinard F, 2004, EUR J CLIN PHARMACOL, V60, P279, DOI 10.1007/s00228-004-0761-0; DANAN G, 1993, J CLIN EPIDEMIOL, V46, P1323, DOI 10.1016/0895-4356(93)90101-6; Dartnell JGA, 1996, MED J AUSTRALIA, V164, P659, DOI 10.5694/j.1326-5377.1996.tb122235.x; Dhar S, 2002, ANN NEUROL, V51, P448, DOI 10.1002/ana.10143; Garcia-Cortes M, 2008, ALIMENT PHARM THERAP, V27, P780, DOI 10.1111/j.1365-2036.2008.03655.x; Gassen M, 2003, J NEURAL TRANSM, V110, P171, DOI 10.1007/s00702-002-0784-6; Goodchild CS, 2008, PAIN MED, V9, P939, DOI 10.1111/j.1526-4637.2008.00512.x; Harpe SE, 2009, PHARMACOTHERAPY, V29, P138, DOI 10.1592/phco.29.2.138; Hennekens CH, 1987, EPIDEMIOLOGY MED, P327; HERRMANN WM, 1987, POSTGRAD MED J, V63, P87; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; HLAVICA P, 1985, ARZNEIMITTEL-FORSCH, V35, P67; Kamchatnov PR, 2006, ZH NEVROL PSIKHIATR, V106, P46; Kornhuber J, 1999, J NEURAL TRANSM, V106, P857, DOI 10.1007/s007020050206; Laine L, 2009, AM J GASTROENTEROL, V104, P356, DOI 10.1038/ajg.2008.149; Lee WM, 2003, NEW ENGL J MED, V349, P474, DOI 10.1056/NEJMra021844; Li C, 2008, CURR MED RES OPIN, V24, P3523, DOI [10.1185/03007990802579769, 10.1185/03007990802579769 ]; Methling K, 2009, DRUG METAB DISPOS, V37, P479, DOI 10.1124/dmd.108.024364; Meyboom RHB, 1997, DRUG SAFETY, V17, P374, DOI 10.2165/00002018-199717060-00004; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Muller-Schwefe G H H, 2008, MMW Fortschr Med, V149 Suppl 4, P153; Naprienko MV, 2006, ZH NEVROL PSIKHIATR, V106, P38; NIEBCH G, 1992, ARZNEIMITTEL-FORSCH, V42-2, P1343; PEROVIC S, 1994, EUR J PHARM-MOLEC PH, V288, P27, DOI 10.1016/0922-4106(94)90006-X; Pothmann R, 2000, SCHMERZ, V14, P1, DOI 10.1007/PL00009797; POWELLJACKSON P, 1985, BRIT J CLIN PRACT, V39, P63; Rajab M, 2004, THERAPIE, V59, P603, DOI 10.2515/therapie:2004104; Ringe JD, 2003, ARZNEIMITTELFORSCH, V53, P496; Schluter T, 2000, FEBS LETT, V481, P42, DOI 10.1016/S0014-5793(00)01923-2; Schroder HC, 2002, DRUGS TODAY, V38, P49, DOI 10.1358/dot.2002.38.1.660505; SCHWABE U, 2008, ARZNEIVERORDNUNGS RE; Shakir SAW, 2002, DRUG SAFETY, V25, P467, DOI 10.2165/00002018-200225060-00012; Stricker BHC, 2004, BRIT MED J, V329, P44, DOI 10.1136/bmj.329.7456.44; Teschke R, 2008, BRIT J CLIN PHARMACO, V66, P758, DOI 10.1111/j.1365-2125.2008.03264.x; Welsch RL, 2000, PRESSE MED, V29, P102; Wysowski DK, 2005, ARCH INTERN MED, V165, P1363, DOI 10.1001/archinte.165.12.1363	44	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e25221	10.1371/journal.pone.0025221	http://dx.doi.org/10.1371/journal.pone.0025221			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022383	gold, Green Published, Green Submitted			2022-12-27	WOS:000295973200006
J	Batut, J; Duboe, C; Vandel, L				Batut, Julie; Duboe, Carine; Vandel, Laurence			The Methyltransferases PRMT4/CARM1 and PRMT5 Control Differentially Myogenesis in Zebrafish	PLOS ONE			English	Article							PROTEIN ARGININE METHYLATION; REGULATORY FACTORS; TAIL MESODERM; NO-TAIL; MUSCLE; CARM1; SLOW; SPADETAIL; IDENTIFICATION; TRANSCRIPTION	In vertebrates, skeletal myogenesis involves the sequential activation of myogenic factors to lead ultimately to the differentiation into slow and fast muscle fibers. How transcriptional co-regulators such as arginine methyltransferases PRMT4/CARM1 and PRMT5 control myogenesis in vivo remains poorly understood. Loss-of-function experiments using morpholinos against PRMT4/CARM1 and PRMT5 combined with in situ hybridization, quantitative polymerase chain reaction, as well as immunohistochemistry indicate a positive, but differential, role of these enzymes during myogenesis in vivo. While PRMT5 regulates myod, myf5 and myogenin expression and thereby slow and fast fiber formation, PRMT4/CARM1 regulates myogenin expression, fast fiber formation and does not affect slow fiber formation. However, our results show that PRMT4/CARM1 is required for proper slow myosin heavy chain localization. Altogether, our results reveal a combinatorial role of PRMT4/CARM1 and PRMT5 for proper myogenesis in zebrafish.	[Batut, Julie; Duboe, Carine; Vandel, Laurence] Univ Toulouse Paul Sabatier, Ctr Dev Biol, Toulouse, France; [Batut, Julie; Duboe, Carine; Vandel, Laurence] CNRS, Ctr Dev Biol, UMR 5547, Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Batut, J (corresponding author), Univ Toulouse Paul Sabatier, Ctr Dev Biol, Toulouse, France.	vandel@cict.fr	Batut, Julie/ABC-1505-2021	Batut, Julie/0000-0002-1984-2094; Vandel, Laurence/0000-0002-3692-2942	Action Thematique et Incitative sur Programme from the Centre National de la Recherche Scientifique; Association pour la Recherche contre le Cancer; Association Francaise contre les Myopathies	Action Thematique et Incitative sur Programme from the Centre National de la Recherche Scientifique; Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	This work was supported by Action Thematique et Incitative sur Programme from the Centre National de la Recherche Scientifique (http://www.cnrs.fr/), Association pour la Recherche contre le Cancer (http://www.arc-cancer.net/), and Association Francaise contre les Myopathies (http://www.afm-telethon.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amacher SL, 2002, DEVELOPMENT, V129, P3311; Blagden CS, 1997, GENE DEV, V11, P2163, DOI 10.1101/gad.11.17.2163; Bryson-Richardson R, 2005, DEV DYNAM, V233, P1018, DOI 10.1002/dvdy.20380; Buckingham M, 2001, CURR OPIN GENET DEV, V11, P440, DOI 10.1016/S0959-437X(00)00215-X; Ceschin DG, 2011, GENE DEV, V25, P1132, DOI 10.1101/gad.619211; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Chen SL, 2002, J BIOL CHEM, V277, P4324, DOI 10.1074/jbc.M109835200; Chevillard-Briet M, 2002, EMBO J, V21, P5457, DOI 10.1093/emboj/cdf548; Cortes F, 2003, DEV CELL, V5, P865, DOI 10.1016/S1534-5807(03)00362-9; Dacwag CS, 2007, MOL CELL BIOL, V27, P384, DOI 10.1128/MCB.01528-06; Dacwag CS, 2009, MOL CELL BIOL, V29, P1909, DOI 10.1128/MCB.00742-08; Devoto SH, 1996, DEVELOPMENT, V122, P3371; El Messaoudi S, 2006, P NATL ACAD SCI USA, V103, P13351, DOI 10.1073/pnas.0605692103; Fabbrizio E, 2002, EMBO REP, V3, P641, DOI 10.1093/embo-reports/kvf136; Fauquier L, 2008, FASEB J, V22, P3337, DOI 10.1096/fj.07-104604; Fujiwara T, 2006, MOL CELL BIOL, V26, P2273, DOI 10.1128/MCB.26.6.2273-2285.2006; Griffin KJP, 1998, DEVELOPMENT, V125, P3379; Groves JA, 2005, DEVELOPMENT, V132, P4211, DOI 10.1242/dev.01958; Henry CA, 2005, DEV BIOL, V287, P346, DOI 10.1016/j.ydbio.2005.08.049; Hinits Y, 2007, DEVELOPMENT, V134, P2511, DOI 10.1242/dev.007088; Hinits Y, 2009, DEVELOPMENT, V136, P403, DOI 10.1242/dev.028019; Holley SA, 2007, DEV DYNAM, V236, P1422, DOI 10.1002/dvdy.21162; Lee YH, 2005, P NATL ACAD SCI USA, V102, P3611, DOI 10.1073/pnas.0407159102; Lee YH, 2009, MOL ENDOCRINOL, V23, P425, DOI 10.1210/me.2008-0380; Mallappa C, 2011, NUCLEIC ACIDS RES, V39, P1243, DOI 10.1093/nar/gkq896; Pahlich S, 2006, BBA-PROTEINS PROTEOM, V1764, P1890, DOI 10.1016/j.bbapap.2006.08.008; Pal S, 2003, MOL CELL BIOL, V23, P7475, DOI 10.1128/MCB.23.21.7475-7487.2003; Pal S, 2007, J CELL PHYSIOL, V213, P306, DOI 10.1002/jcp.21180; Pownall ME, 2002, ANNU REV CELL DEV BI, V18, P747, DOI 10.1146/annurev.cellbio.18.012502.105758; Schurter BT, 2001, BIOCHEMISTRY-US, V40, P5747, DOI 10.1021/bi002631b; Weinberg ES, 1996, DEVELOPMENT, V122, P271; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Xu W, 2001, SCIENCE, V294, P2507, DOI 10.1126/science.1065961; Xu YF, 1999, DNA CELL BIOL, V18, P85, DOI 10.1089/104454999315655; Yahi H, 2006, EXPERT OPIN THER TAR, V10, P923, DOI 10.1517/14728222.10.6.923	35	35	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25427	10.1371/journal.pone.0025427	http://dx.doi.org/10.1371/journal.pone.0025427			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016767	Green Submitted, Green Published, gold			2022-12-27	WOS:000295971700009
J	Lai, Y; Yi, GH; Chen, A; Bhardwaj, K; Tragesser, BJ; Valverde, RA; Zlotnick, A; Mukhopadhyay, S; Ranjith-Kumar, CT; Kao, CC				Lai, Yvonne; Yi, Guanghui; Chen, Alice; Bhardwaj, Kanchan; Tragesser, Brady J.; Valverde, Rodrigo A.; Zlotnick, Adam; Mukhopadhyay, Suchetana; Ranjith-Kumar, C. T.; Kao, C. Cheng			Viral Double-Strand RNA-Binding Proteins Can Enhance Innate Immune Signaling by Toll-Like Receptor 3	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; DE-NOVO INITIATION; FUNCTIONAL ANALYSES; EPITHELIAL-CELLS; COAT PROTEIN; RIG-I; LUPUS-ERYTHEMATOSUS; POLYMERASE; NS5B; INFECTION	Toll-like Receptor 3 (TLR3) detects double-stranded (ds) RNAs to activate innate immune responses. While poly(I:C) is an excellent agonist for TLR3 in several cell lines and in human peripheral blood mononuclear cells, viral dsRNAs tend to be poor agonists, leading to the hypothesis that additional factor(s) are likely required to allow TLR3 to respond to viral dsRNAs. TLR3 signaling was examined in a lung epithelial cell line by quantifying cytokine production and in human embryonic kidney cells by quantifying luciferase reporter levels. Recombinant 1b hepatitis C virus polymerase was found to enhance TLR3 signaling in the lung epithelial BEAS-2B cells when added to the media along with either poly(I:C) or viral dsRNAs. The polymerase from the genotype 2a JFH-1 HCV was a poor enhancer of TLR3 signaling until it was mutated to favor a conformation that could bind better to a partially duplexed RNA. The 1b polymerase also co-localizes with TLR3 in endosomes. RNA-binding capsid proteins (CPs) from two positive-strand RNA viruses and the hepadenavirus hepatitis B virus (HBV) were also potent enhancers of TLR3 signaling by poly(I:C) or viral dsRNAs. A truncated version of the HBV CP that lacked an arginine-rich RNA-binding domain was unable to enhance TLR3 signaling. These results demonstrate that several viral RNA-binding proteins can enhance the dsRNA-dependent innate immune response initiated by TLR3.	[Lai, Yvonne; Yi, Guanghui; Chen, Alice; Bhardwaj, Kanchan; Tragesser, Brady J.; Zlotnick, Adam; Ranjith-Kumar, C. T.; Kao, C. Cheng] Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA; [Valverde, Rodrigo A.] Louisiana State Univ, Ctr Agr, Dept Plant Pathol & Crop Physiol, Baton Rouge, LA 70803 USA; [Mukhopadhyay, Suchetana] Indiana Univ, Dept Biol, Bloomington, IN USA	Indiana University System; Indiana University Bloomington; Louisiana State University System; Louisiana State University; Indiana University System; Indiana University Bloomington	Lai, Y (corresponding author), Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA.	ckao@indiana.edu	Mackie, Ken/E-3384-2013; Bhardwaj, Kanchan/CAH-2291-2022; Kumar CT, Ranjith/J-5701-2016	Bhardwaj, Kanchan/0000-0002-7331-7717; Zlotnick, Adam/0000-0001-9945-6267	National Institute of Allergy and Infectious Diseases [RAI075015A, 1RO1AI073335, 1RO1090280]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090280, R01AI067417, R01AI073335, R21AI075015] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	CCK acknowledges funding from National Institute of Allergy and Infectious Diseases grants RAI075015A, 1RO1AI073335 and 1RO1090280. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum A, 2010, P NATL ACAD SCI USA, V107, P16303, DOI 10.1073/pnas.1005077107; Bell JK, 2006, P NATL ACAD SCI USA, V103, P8792, DOI 10.1073/pnas.0603245103; Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; Bhardwaj K, 2008, J BIOL CHEM, V283, P3655, DOI 10.1074/jbc.M708375200; Botos I, 2009, BBA-GENE REGUL MECH, V1789, P667, DOI 10.1016/j.bbagrm.2009.06.005; Bressanelli S, 2002, J VIROL, V76, P3482, DOI 10.1128/JVI.76.7.3482-3492.2002; Chinnaswamy S, 2010, J VIROL, V84, P5923, DOI 10.1128/JVI.02446-09; Chinnaswamy S, 2008, J BIOL CHEM, V283, P20535, DOI 10.1074/jbc.M801490200; Dolganiuc A, 2004, GASTROENTEROLOGY, V127, P1513, DOI 10.1053/j.gastro.2004.08.067; Dragnea B, 2003, J AM CHEM SOC, V125, P6374, DOI 10.1021/ja0343609; FISHER AJ, 1993, NATURE, V361, P176, DOI 10.1038/361176a0; Fox JM, 1998, VIROLOGY, V244, P212, DOI 10.1006/viro.1998.9107; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Gauzzi MC, 2010, IMMUNOBIOLOGY, V215, P713, DOI 10.1016/j.imbio.2010.05.008; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; GUIALIS A, 1994, CLIN EXP IMMUNOL, V95, P385; Harley D, 2001, CLIN MICROBIOL REV, V14, P909, DOI 10.1128/CMR.14.4.909-932.2001; Hidaka F, 2006, CLIN IMMUNOL, V119, P188, DOI 10.1016/j.clim.2006.01.005; Hobson SD, 2001, EMBO J, V20, P1153, DOI 10.1093/emboj/20.5.1153; Homma T, 2004, AM J RESP CELL MOL, V31, P463, DOI 10.1165/rcmb.2004-0161OC; Kao CC, 2011, MOL PLANT PATHOL, V12, P403, DOI 10.1111/j.1364-3703.2010.00678.x; Kao CC, 2001, VIROLOGY, V287, P251, DOI 10.1006/viro.2001.1039; Kao CC, 2000, J VIROL, V74, P11121, DOI 10.1128/JVI.74.23.11121-11128.2000; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kono DH, 2009, P NATL ACAD SCI USA, V106, P12061, DOI 10.1073/pnas.0905441106; Lai Y, 2011, LL37 CATIONIC UNPUB; Le Goffic R, 2007, J IMMUNOL, V178, P3368, DOI 10.4049/jimmunol.178.6.3368; Leonard JN, 2008, P NATL ACAD SCI USA, V105, P258, DOI 10.1073/pnas.0710779105; Leonard Joshua N., 2009, V517, P55, DOI 10.1007/978-1-59745-541-1_4; LERNER MR, 1981, SCIENCE, V211, P400, DOI 10.1126/science.6164096; Limmon GV, 2008, FASEB J, V22, P159, DOI 10.1096/fj.07-8348com; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Lu C, 2011, NUCLEIC ACIDS RES, V39, P1565, DOI 10.1093/nar/gkq974; Luo GX, 2000, J VIROL, V74, P851, DOI 10.1128/JVI.74.2.851-863.2000; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Mukhopadhyay S, 2002, J VIROL, V76, P11128, DOI 10.1128/JVI.76.21.11128-11132.2002; Munakata T, 2005, P NATL ACAD SCI USA, V102, P18159, DOI 10.1073/pnas.0505605102; Munakata T, 2007, PLOS PATHOG, V3, P1335, DOI 10.1371/journal.ppat.0030139; Myong S, 2009, SCIENCE, V323, P1070, DOI 10.1126/science.1168352; Nahum A, 2011, J ALLERGY CLIN IMMUN, V127, P528, DOI 10.1016/j.jaci.2010.09.031; Naka K, 2006, VIROLOGY, V346, P348, DOI 10.1016/j.virol.2005.10.023; Nakase I, 2009, MOL THER, V17, P1868, DOI 10.1038/mt.2009.192; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; O'Neill LAJ, 2010, CURR BIOL, V20, pR328, DOI 10.1016/j.cub.2010.01.044; Porterfield JZ, 2010, J VIROL, V84, P7174, DOI 10.1128/JVI.00586-10; Qi XP, 2011, MOL PLANT MICROBE IN, V24, P25, DOI 10.1094/MPMI-07-10-0147; Qin WP, 2002, J BIOL CHEM, V277, P2132, DOI 10.1074/jbc.M106880200; Rabe B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000563; Ranjith-Kumar CT, 2008, MOL CELL BIOL, V28, P4507, DOI 10.1128/MCB.00308-08; Ranjith-Kumar CT, 2007, J BIOL CHEM, V282, P17696, DOI 10.1074/jbc.M700209200; Ranjith-Kumar CT, 2007, J BIOL CHEM, V282, P7668, DOI 10.1074/jbc.M610946200; Ranjith-Kumar CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022575; Ranjith-Kumar CT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012878; Ranjith-Kumar CT, 2004, J VIROL, V78, P12207, DOI 10.1128/JVI.78.22.12207-12217.2004; Ranjith-Kumar CT, 2002, J VIROL, V76, P12526, DOI 10.1128/JVI.76.24.12526-12536.2002; Ranjith-Kumar CT, 2002, J VIROL, V76, P12513, DOI 10.1128/JVI.76.24.12513-12525.2002; RAO ALN, 1995, VIROLOGY, V211, P42, DOI 10.1006/viro.1995.1377; Ronald PC, 2010, SCIENCE, V330, P1061, DOI 10.1126/science.1189468; SACHER R, 1989, J VIROL, V63, P4545, DOI 10.1128/JVI.63.11.4545-4552.1989; Schmitt M, 2011, J VIROL, V85, P2565, DOI 10.1128/JVI.02177-10; Seeger CZF, 2007, HEPADNAVIRUSES FIELD, P2977; Simister P, 2009, J VIROL, V83, P11926, DOI 10.1128/JVI.01008-09; Sun JC, 2006, J BIOL CHEM, V281, P11144, DOI 10.1074/jbc.M510442200; Valverde RA, 2007, VIRUS GENES, V35, P399, DOI 10.1007/s11262-007-0092-1; Wang QM, 2002, J VIROL, V76, P3865, DOI 10.1128/JVI.76.8.3865-3872.2002; Watkins WJ, 2010, CURR OPIN DRUG DISC, V13, P441; Yoon JS, 2007, PEDIATR PULM, V42, P277, DOI 10.1002/ppul.20574; Zaheer RS, 2010, AM J RESP CELL MOL, V43, P413, DOI 10.1165/rcmb.2009-0203OC; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522; Zlotnick A, 2011, TRENDS MICROBIOL, V19, P14, DOI 10.1016/j.tim.2010.11.003	73	26	29	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25837	10.1371/journal.pone.0025837	http://dx.doi.org/10.1371/journal.pone.0025837			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016778	gold, Green Published, Green Submitted			2022-12-27	WOS:000295971700020
J	Lauterbach, L; Idris, Z; Vincent, KA; Lenz, O				Lauterbach, Lars; Idris, Zulkifli; Vincent, Kylie A.; Lenz, Oliver			Catalytic Properties of the Isolated Diaphorase Fragment of the NAD(+)-Reducing [NiFe]-Hydrogenase from Ralstonia eutropha	PLOS ONE			English	Article							NADH-UBIQUINONE OXIDOREDUCTASE; RESPIRATORY COMPLEX-I; NOCARDIA-OPACA 1B; BOVINE HEART-MITOCHONDRIA; ALCALIGENES-EUTROPHUS; ESCHERICHIA-COLI; REDUCING HYDROGENASE; SOLUBLE HYDROGENASE; ACTIVE-SITE; THERMUS-THERMOPHILUS	The NAD(+)-reducing soluble hydrogenase (SH) from Ralstonia eutropha H16 catalyzes the H-2-driven reduction of NAD(+), as well as reverse electron transfer from NADH to H+, in the presence of O-2. It comprises six subunits, HoxHYFUI(2), and incorporates a [NiFe] H+/H-2 cycling catalytic centre, two non-covalently bound flavin mononucleotide (FMN) groups and an iron-sulfur cluster relay for electron transfer. This study provides the first characterization of the diaphorase sub-complex made up of HoxF and HoxU. Sequence comparisons with the closely related peripheral subunits of Complex I in combination with UV/Vis spectroscopy and the quantification of the metal and FMN content revealed that HoxFU accommodates a [2Fe2S] cluster, FMN and a series of [4Fe4S] clusters. Protein film electrochemistry (PFE) experiments show clear electrocatalytic activity for both NAD(+) reduction and NADH oxidation with minimal overpotential relative to the potential of the NAD(+)/NADH couple. Michaelis-Menten constants of 56 mu M and 197 mu M were determined for NADH and NAD(+), respectively. Catalysis in both directions is product inhibited with K-I values of around 0.2 mM. In PFE experiments, the electrocatalytic current was unaffected by O-2, however in aerobic solution assays, a moderate superoxide production rate of 54 nmol per mg of protein was observed, meaning that the formation of reactive oxygen species (ROS) observed for the native SH can be attributed mainly to HoxFU. The results are discussed in terms of their implications for aerobic functioning of the SH and possible control mechanism for the direction of catalysis.	[Lauterbach, Lars; Lenz, Oliver] Humboldt Univ, Dept Microbiol, Inst Biol, Berlin, Germany; [Idris, Zulkifli; Vincent, Kylie A.] Univ Oxford, Inorgan Chem Lab, Dept Chem, Oxford, England	Humboldt University of Berlin; University of Oxford	Lauterbach, L (corresponding author), Humboldt Univ, Dept Microbiol, Inst Biol, Berlin, Germany.	kylie.vincent@chem.ox.ac.uk; oliver.lenz@cms.hu-berlin.de	Lenz, Oliver/N-5130-2019; Lauterbach, Lars/L-6671-2014; Vincent, Kylie/H-1224-2011; Lenz, Oliver/C-1582-2019; Lauterbach, Lars/P-6741-2019	Lenz, Oliver/0000-0003-4550-5128; Lauterbach, Lars/0000-0002-6601-6473; Lenz, Oliver/0000-0003-4550-5128; Lauterbach, Lars/0000-0002-6601-6473; Vincent, Kylie/0000-0001-6444-9382	Royal Society for an International Joint Project; Cluster of Excellence; Deutsche Forschungsgemeinschaft (DFG)	Royal Society for an International Joint Project; Cluster of Excellence; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The authors are grateful to the Royal Society for an International Joint Project Grant. The work of OL and LL was supported by the Cluster of Excellence "Unifying Concepts in Catalysis" funded by the Deutsche Forschungsgemeinschaft (DFG). KAV is a Royal Society Research Fellow and a Research Councils United Kingdom Academic Fellow and has received support from the Oxford University Press John Fell Fund and the European Research Council (ERC Starting Grant 258600). ZI is grateful for a scholarship from the Malaysian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMOVITZ AS, 1976, J BIOL CHEM, V251, P5327; Albracht SPJ, 2003, BBA-BIOENERGETICS, V1557, P41, DOI 10.1016/S0005-2728(02)00393-6; Appel J, 2000, ARCH MICROBIOL, V173, P333, DOI 10.1007/s002030000139; Barker CD, 2007, BIOCHEMISTRY-US, V46, P3454, DOI 10.1021/bi061988y; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Berrisford JM, 2008, BIOCHEMISTRY-US, V47, P10262, DOI 10.1021/bi801160u; Berrisford JM, 2009, J BIOL CHEM, V284, P29773, DOI 10.1074/jbc.M109.032144; Biskup T, 2009, ANGEW CHEM INT EDIT, V48, P404, DOI 10.1002/anie.200803102; Bleijlevens B, 2004, J BIOL CHEM, V279, P46686, DOI 10.1074/jbc.M406942200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braun M, 1998, BIOCHEMISTRY-US, V37, P1861, DOI 10.1021/bi971176p; Burgdorf T, 2005, J MOL MICROB BIOTECH, V10, P181, DOI 10.1159/000091564; Burgdorf T, 2005, J BACTERIOL, V187, P3122, DOI 10.1128/JB.187.9.3122-3132.2005; Burgdorf T, 2005, J AM CHEM SOC, V127, P576, DOI 10.1021/ja0461926; Cornish-Bowden A, 2012, FUNDAMENTALS ENZYME, V4th; Cotruvo JA, 2008, P NATL ACAD SCI USA, V105, P14383, DOI 10.1073/pnas.0807348105; Cramm R, 2009, J MOL MICROB BIOTECH, V16, P38, DOI 10.1159/000142893; Esterhazy D, 2008, BIOCHEMISTRY-US, V47, P3964, DOI 10.1021/bi702243b; FRIEDRICH B, 1981, J BACTERIOL, V145, P1144, DOI 10.1128/JB.145.3.1144-1149.1981; Friedrich T, 2000, FEBS LETT, V479, P1, DOI 10.1016/S0014-5793(00)01867-6; GAVRIKOVA EV, 1995, BBA-BIOENERGETICS, V1230, P23, DOI 10.1016/0005-2728(95)00015-B; GHISLA S, 1974, BIOCHEMISTRY-US, V13, P589, DOI 10.1021/bi00700a029; Grivennikova VG, 2003, BBA-BIOENERGETICS, V1607, P79, DOI 10.1016/j.bbabio.2003.09.001; Happe RP, 2000, FEBS LETT, V466, P259, DOI 10.1016/S0014-5793(99)01799-8; Hinchliffe P, 2005, SCIENCE, V309, P771, DOI 10.1126/science.1113988; Hirst J, 2010, BIOCHEM J, V425, P327, DOI 10.1042/BJ20091382; Horch M, 2010, ANGEW CHEM INT EDIT, V49, P8026, DOI 10.1002/anie.201002197; IMLAY JA, 1995, J BIOL CHEM, V270, P19767; Jackson JB, 2003, FEBS LETT, V555, P176, DOI 10.1016/S0014-5793(03)01123-2; JOHANNSSEN W, 1991, ARCH MICROBIOL, V155, P303, DOI 10.1007/BF00252217; Kohlstadt M, 2008, BIOCHEMISTRY-US, V47, P13036, DOI 10.1021/bi801307n; KUHN M, 1984, J BACTERIOL, V159, P633, DOI 10.1128/JB.159.2.633-639.1984; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lauterbach L, 2011, EUR J INORG CHEM, P1067, DOI 10.1002/ejic.201001053; Lippard S. J., 1994, PRINCIPLES BIOINORGA; LOOMIS AG, 1928, INT CRIT TABLES, V3, P255; Lukey MJ, 2010, J BIOL CHEM, V285, P3928, DOI 10.1074/jbc.M109.067751; Massanz C, 1998, J BACTERIOL, V180, P1023, DOI 10.1128/JB.180.5.1023-1029.1998; MASSEY V, 1966, BIOCHEMISTRY-US, V5, P3181, DOI 10.1021/bi00874a016; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Neubauer O, 2009, J BACTERIOL, V191, P6482, DOI 10.1128/JB.00965-09; Noll G, 2008, J PHOTOCH PHOTOBIO A, V200, P34, DOI 10.1016/j.jphotochem.2008.06.019; Pandelia ME, 2010, J AM CHEM SOC, V132, P6991, DOI 10.1021/ja910838d; RAGAN CI, 1982, BIOCHEMISTRY-US, V21, P590, DOI 10.1021/bi00532a027; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; SCHNEIDER K, 1981, BIOCHEM J, V193, P99, DOI 10.1042/bj1930099; SCHNEIDER K, 1976, BIOCHIM BIOPHYS ACTA, V452, P66, DOI 10.1016/0005-2744(76)90058-9; SCHNEIDER K, 1984, EUR J BIOCHEM, V138, P533, DOI 10.1111/j.1432-1033.1984.tb07948.x; SCHNEIDER K, 1984, EUR J BIOCHEM, V142, P75, DOI 10.1111/j.1432-1033.1984.tb08252.x; SCHNEIDER K, 1978, BIOCHEM BIOPH RES CO, V84, P564, DOI 10.1016/0006-291X(78)90743-X; Schwartz E, 1998, J BACTERIOL, V180, P3197, DOI 10.1128/JB.180.12.3197-3204.1998; SLED VD, 1993, BIOCHIM BIOPHYS ACTA, V1143, P199, DOI 10.1016/0005-2728(93)90143-4; Spiegelhauer O, 2009, BIOCHEMISTRY-US, V48, P11412, DOI 10.1021/bi901370u; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; van der Linden E, 2006, J BIOL INORG CHEM, V11, P247, DOI 10.1007/s00775-005-0075-4; Van der Linden E, 2004, J BIOL INORG CHEM, V9, P616, DOI 10.1007/s00775-004-0555-y; van der Linden E, 2004, EUR J BIOCHEM, V271, P801, DOI 10.1111/j.1432-1033.2004.03984.x; Vincent KA, 2005, P NATL ACAD SCI USA, V102, P16951, DOI 10.1073/pnas.0504499102; Zhao T, 2001, J BACTERIOL, V183, P6225, DOI 10.1128/JB.183.21.6225-6233.2001	60	39	39	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25939	10.1371/journal.pone.0025939	http://dx.doi.org/10.1371/journal.pone.0025939			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016788	Green Published, Green Submitted, gold			2022-12-27	WOS:000295971700026
J	Stitz, M; Baldwin, IT; Gaquerel, E				Stitz, Michael; Baldwin, Ian T.; Gaquerel, Emmanuel			Diverting the Flux of the JA Pathway in Nicotiana attenuata Compromises the Plant's Defense Metabolism and Fitness in Nature and Glasshouse	PLOS ONE			English	Article							MANDUCA-SEXTA LEPIDOPTERA; PREDATOR-PREY INTERACTIONS; JASMONIC ACID; METHYL JASMONATE; MOLECULAR-INTERACTIONS; HERBIVORE RESISTANCE; RESPONSES; SIGNAL; GROWTH; ROLES	A plant's inducible defenses against herbivores as well as certain developmental processes are known to be controlled by the jasmonic acid (JA) pathway. We have previously shown that ectopically expressing Arabidopsis thaliana JA O-methyltransferase in Nicotiana attenuata (35S-jmt) strongly reduces the herbivory-elicited jasmonate bursts by acting as metabolic sink that redirects free JA towards methylation; here we examine the consequences of this metabolic sink on N. attenuata's secondary metabolism and performance in nature. In the glasshouse, 35S-jmt plants produced fewer seed capsules due to shorter floral styles, which could be restored to wild type (WT) levels after hand-pollination, and were more susceptible to Manduca sexta larvae attack. When transplanted into the Great Basin Desert in Utah, 35S-jmt plants grew as well as WT empty vector, but were highly attacked by native herbivores of different feeding guilds: leaf chewers, miners, and single cell feeders. This greater susceptibility was strongly associated with reduced emissions of volatile organic compounds (hexenylesters, monoterpenes and sesquiterpenes) and profound alterations in the production of direct defenses (trypsin proteinase inhibitors [TPI], nicotine, diterpene glycosides [DTGs] and phenylpropanoid-polyamine conjugates) as revealed by a combination of targeted and metabolomics analyses of field collected samples. Complementation experiments with JA-Ile, whose formation is outcompeted in 35S-jmt plants by the methylation reaction, restored the local TPI activation to WT levels and partially complemented nicotine and DTG levels in elicited but not systemic leaves. These findings demonstrate that MeJA, the major JA metabolite in 35S-jmt plants, is not an active signal in defense activation and highlights the value of creating JA sinks to disrupt JA signaling, without interrupting the complete octadecanoid pathway, in order to investigate the regulation of plants' defense metabolism in nature.	[Stitz, Michael; Baldwin, Ian T.; Gaquerel, Emmanuel] Max Planck Inst Chem Ecol, Dept Mol Ecol, Jena, Germany	Max Planck Society	Stitz, M (corresponding author), Max Planck Inst Chem Ecol, Dept Mol Ecol, Jena, Germany.	egaquerel@ice.mpg.de	Baldwin, Ian T/K-1809-2013; Gaquerel, Emmanuel/I-2503-2014; Gaquerel, Emmanuel/ABE-6313-2020	Gaquerel, Emmanuel/0000-0003-0796-6417; Gaquerel, Emmanuel/0000-0003-0796-6417; Baldwin, Ian/0000-0001-5371-2974	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	The Max Planck Society was the only funder of this work. The Max Planck Society had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allmann S, 2010, PLANT CELL ENVIRON, V33, P2028, DOI 10.1111/j.1365-3040.2010.02203.x; Allmann S, 2010, SCIENCE, V329, P1075, DOI 10.1126/science.1191634; Baldwin IT, 2006, SCIENCE, V311, P812, DOI 10.1126/science.1118446; Baldwin IT, 1998, P NATL ACAD SCI USA, V95, P8113, DOI 10.1073/pnas.95.14.8113; Browse J, 2005, VITAM HORM, V72, P431, DOI 10.1016/S0083-6729(05)72012-4; Cipollini D, 2007, NEW PHYTOL, V173, P146, DOI 10.1111/j.1469-8137.2006.01882.x; Cipollini D, 2010, EVOL ECOL, V24, P59, DOI 10.1007/s10682-008-9290-0; CREELMAN RA, 1995, P NATL ACAD SCI USA, V92, P4114, DOI 10.1073/pnas.92.10.4114; De Moraes CM, 2001, NATURE, V410, P577, DOI 10.1038/35069058; DEMOLE E, 1962, HELV CHIM ACTA, V45, P1951, DOI 10.1002/hlca.19620450629; DICKE M, 1990, J CHEM ECOL, V16, P3091, DOI 10.1007/BF00979614; DICKE M, 1988, EXP APPL ACAROL, V5, P225, DOI 10.1007/BF02366096; DICKE M, 1990, J CHEM ECOL, V16, P381, DOI 10.1007/BF01021772; FARMER EE, 1990, P NATL ACAD SCI USA, V87, P7713, DOI 10.1073/pnas.87.19.7713; Gaquerel E, 2010, J AGR FOOD CHEM, V58, P9418, DOI 10.1021/jf1017737; Gaquerel E, 2009, PLANT PHYSIOL, V149, P1408, DOI 10.1104/pp.108.130799; Halitschke R, 2001, PLANT PHYSIOL, V125, P711, DOI 10.1104/pp.125.2.711; Halitschke R, 2003, PLANT J, V36, P794, DOI 10.1046/j.1365-313X.2003.01921.x; Halitschke R, 2008, ECOL LETT, V11, P24, DOI 10.1111/j.1461-0248.2007.01123.x; Hause B, 2000, PLANT J, V24, P113, DOI 10.1046/j.1365-313x.2000.00861.x; Heil M, 2002, TRENDS PLANT SCI, V7, P61, DOI 10.1016/S1360-1385(01)02186-0; Heiling S, 2010, PLANT CELL, V22, P273, DOI 10.1105/tpc.109.071449; Howe GA, 2004, J PLANT GROWTH REGUL, V23, P223, DOI 10.1007/s00344-004-0030-6; Jassbi AR, 2008, PLANT PHYSIOL, V146, P974, DOI 10.1104/pp.107.108811; Jung Choonkyun, 2003, Journal of Applied Biological Chemistry, V46, P52; Kallenbach M, 2010, PLANT PHYSIOL, V152, P1760, DOI 10.1104/pp.110.900317; Kang JH, 2006, PLANT CELL, V18, P3303, DOI 10.1105/tpc.106.041103; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; Kaur H, 2010, PLANT PHYSIOL, V152, P1731, DOI 10.1104/pp.109.151738; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Kessler A, 2006, OECOLOGIA, V148, P280, DOI 10.1007/s00442-006-0365-8; Kim EH, 2009, PLANT PHYSIOL, V149, P1751, DOI 10.1104/pp.108.134684; Koo AJK, 2009, PLANT J, V59, P974, DOI 10.1111/j.1365-313X.2009.03924.x; Krugel T, 2002, CHEMOECOLOGY, V12, P177, DOI 10.1007/PL00012666; Li L, 2004, PLANT CELL, V16, P126, DOI 10.1105/tpc.017954; Li L, 2002, P NATL ACAD SCI USA, V99, P6416, DOI 10.1073/pnas.072072599; McConn M, 1997, P NATL ACAD SCI USA, V94, P5473, DOI 10.1073/pnas.94.10.5473; MEYER A, 1984, J PLANT GROWTH REGUL, V3, P1, DOI 10.1007/BF02041987; Pandey SP, 2008, PLANT J, V54, P845, DOI 10.1111/j.1365-313X.2008.03450.x; Paschold A, 2007, PLANT J, V51, P79, DOI 10.1111/j.1365-313X.2007.03119.x; Roda A, 2004, MOL ECOL, V13, P2421, DOI 10.1111/j.1365-294X.2004.02260.x; SABELIS MW, 1983, ENTOMOL EXP APPL, V33, P303, DOI 10.1111/j.1570-7458.1983.tb03273.x; Schittko U, 2001, PLANT PHYSIOL, V125, P701, DOI 10.1104/pp.125.2.701; Seo HS, 2001, P NATL ACAD SCI USA, V98, P4788, DOI 10.1073/pnas.081557298; Song JT, 2000, PLANT MOL BIOL, V42, P647, DOI 10.1023/A:1006381625421; Steppuhn A, 2004, PLOS BIOL, V2, P1074, DOI 10.1371/journal.pbio.0020217; Steppuhn A, 2007, ECOL LETT, V10, P499, DOI 10.1111/j.1461-0248.2007.01045.x; Stintzi A, 2000, P NATL ACAD SCI USA, V97, P10625, DOI 10.1073/pnas.190264497; Stintzi A, 2001, P NATL ACAD SCI USA, V98, P12837, DOI 10.1073/pnas.211311098; Tautenhahn R., 2008, BMC BIOINFORMATICS, V9; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Van Dam NM, 2001, J CHEM ECOL, V27, P547, DOI 10.1023/A:1010341022761; Wang L, 2008, PLANT PHYSIOL, V146, P904, DOI 10.1104/pp.107.109264; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; Wu JS, 2008, PLANTA, V227, P1161, DOI 10.1007/s00425-008-0690-8; Xue Rengao, 2007, Journal of Genetics and Genomics, V34, P339, DOI 10.1016/S1673-8527(07)60036-8; Yan JB, 2009, PLANT CELL, V21, P2220, DOI 10.1105/tpc.109.065730; YAO KN, 1995, PLANT CELL, V7, P1787, DOI 10.1105/tpc.7.11.1787; Zavala JA, 2004, PLANT PHYSIOL, V134, P1181, DOI 10.1104/pp.103.035634; Zavala JA, 2006, PLANT CELL ENVIRON, V29, P1751, DOI 10.1111/j.1365-3040.2006.01551.x	61	29	29	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25925	10.1371/journal.pone.0025925	http://dx.doi.org/10.1371/journal.pone.0025925			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22022469	Green Submitted, gold, Green Published			2022-12-27	WOS:000295971700025
J	Siebers, B; Zaparty, M; Raddatz, G; Tjaden, B; Albers, SV; Bell, SD; Blombach, F; Kletzin, A; Kyrpides, N; Lanz, C; Plagens, A; Rampp, M; Rosinus, A; von Jan, M; Makarova, KS; Klenk, HP; Schuster, SC; Hensel, R				Siebers, Bettina; Zaparty, Melanie; Raddatz, Guenter; Tjaden, Britta; Albers, Sonja-Verena; Bell, Steve D.; Blombach, Fabian; Kletzin, Arnulf; Kyrpides, Nikos; Lanz, Christa; Plagens, Andre; Rampp, Markus; Rosinus, Andrea; von Jan, Mathias; Makarova, Kira S.; Klenk, Hans-Peter; Schuster, Stephan C.; Hensel, Reinhard			The Complete Genome Sequence of Thermoproteus tenax: A Physiologically Versatile Member of the Crenarchaeota	PLOS ONE			English	Article							CENTRAL CARBOHYDRATE-METABOLISM; TRANSFER-RNA GENES; SULFOLOBUS-SOLFATARICUS; DNA-REPLICATION; FACTOR B; PROTEIN; TRANSCRIPTION; IDENTIFICATION; ARCHAEA; BINDING	Here, we report on the complete genome sequence of the hyperthermophilic Crenarchaeum Thermoproteus tenax (strain Kra 1, DSM 2078(T)) a type strain of the crenarchaeotal order Thermoproteales. Its circular 1.84-megabase genome harbors no extrachromosomal elements and 2,051 open reading frames are identified, covering 90.6% of the complete sequence, which represents a high coding density. Derived from the gene content, T. tenax is a representative member of the Crenarchaeota. The organism is strictly anaerobic and sulfur-dependent with optimal growth at 86 degrees C and pH 5.6. One particular feature is the great metabolic versatility, which is not accompanied by a distinct increase of genome size or information density as compared to other Crenarchaeota. T. tenax is able to grow chemolithoautotrophically (CO2/H-2) as well as chemoorganoheterotrophically in presence of various organic substrates. All pathways for synthesizing the 20 proteinogenic amino acids are present. In addition, two presumably complete gene sets for NADH:quinone oxidoreductase (complex I) were identified in the genome and there is evidence that either NADH or reduced ferredoxin might serve as electron donor. Beside the typical archaeal A(0)A(1)-ATP synthase, a membrane-bound pyrophosphatase is found, which might contribute to energy conservation. Surprisingly, all genes required for dissimilatory sulfate reduction are present, which is confirmed by growth experiments. Mentionable is furthermore, the presence of two proteins (ParA family ATPase, actin-like protein) that might be involved in cell division in Thermoproteales, where the ESCRT system is absent, and of genes involved in genetic competence (DprA, ComF) that is so far unique within Archaea.	[Siebers, Bettina] Univ Duisburg Essen, Biofilm Ctr, Fac Chem, Essen, Germany; [Zaparty, Melanie] Univ Regensburg, Inst Mol & Cellular Anat, Regensburg, Germany; [Raddatz, Guenter] Max Planck Inst Biol Cybernet, Tubingen, Germany; [Tjaden, Britta; Albers, Sonja-Verena; Plagens, Andre; Hensel, Reinhard] Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany; [Bell, Steve D.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Blombach, Fabian] Wageningen Univ, Microbiol Lab, Wageningen, Netherlands; [Kletzin, Arnulf] Tech Univ Darmstadt, Inst Microbiol & Genet, Darmstadt, Germany; [Kyrpides, Nikos] DOE Joint Genome Inst, Walnut Creek, CA USA; [Lanz, Christa; Rosinus, Andrea] Max Planck Inst Dev Biol, Genome Ctr, Tubingen, Germany; [Rampp, Markus] Max Planck Inst Plasma Phys, Comp Ctr Garching, Max Planck Soc RZG, Munich, Germany; [von Jan, Mathias; Klenk, Hans-Peter] German Collect Microorganisms & Cell Cultures, DSMZ, Braunschweig, Germany; [Makarova, Kira S.] NIH, Natl Ctr Biotechnol Informat, Bethesda, MD 20892 USA; [Schuster, Stephan C.] Penn State Univ, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA	University of Duisburg Essen; University of Regensburg; Max Planck Society; Max Planck Society; University of Oxford; Wageningen University & Research; Technical University of Darmstadt; United States Department of Energy (DOE); Max Planck Society; Max Planck Society; Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); National Institutes of Health (NIH) - USA; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Siebers, B (corresponding author), Univ Duisburg Essen, Biofilm Ctr, Fac Chem, Essen, Germany.	bettina.siebers@uni-due.de; melanie.zaparty@vkl.uni-regensburg.de	Kyrpides, Nikos C./A-6305-2014; Albers, Sonja-Verena/H-8689-2019; Blombach, Fabian/AAT-9241-2020; Albers, Sonja-Verena/H-1213-2012; Kletzin, Arnulf/AAO-7366-2020	Kyrpides, Nikos C./0000-0002-6131-0462; Albers, Sonja-Verena/0000-0003-2459-2226; Blombach, Fabian/0000-0001-5337-8662; Rampp, Markus/0000-0001-8177-8698; Kletzin, Arnulf/0000-0002-4500-2232; Siebers, Bettina/0000-0002-9905-541X	University of Duisburg-Essen (Germany); Deutsche Forschungsgemeinschaft (DFG) [SPP1112, He1238/16-2]; Dutch Science Organization (NWO); Max Planck society	University of Duisburg-Essen (Germany); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Dutch Science Organization (NWO)(Netherlands Organization for Scientific Research (NWO)); Max Planck society(Max Planck Society)	This work was supported by the University of Duisburg-Essen (Germany) and the Deutsche Forschungsgemeinschaft (DFG; SPP1112) by grant He1238/16-2, 3 (Dr. Hensel). Dr. Albers was supported by a VIDI grant of the Dutch Science Organization (NWO) and intramural funds of the Max Planck society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn DG, 2006, VIROLOGY, V351, P280, DOI 10.1016/j.virol.2006.03.039; Albers SV, 2006, NAT REV MICROBIOL, V4, P537, DOI 10.1038/nrmicro1440; Albers SV, 1999, J BACTERIOL, V181, P4285, DOI 10.1128/JB.181.14.4285-4291.1999; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson I, 2008, J BACTERIOL, V190, P2957, DOI 10.1128/JB.01949-07; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; Baar C, 2003, P NATL ACAD SCI USA, V100, P11690, DOI 10.1073/pnas.1932838100; Badger JH, 1999, MOL BIOL EVOL, V16, P512, DOI 10.1093/oxfordjournals.molbev.a026133; Baliga NS, 2000, MOL MICROBIOL, V36, P1184, DOI 10.1046/j.1365-2958.2000.01916.x; Bandeiras TM, 2009, BBA-BIOENERGETICS, V1787, P37, DOI 10.1016/j.bbabio.2008.09.009; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barry ER, 2006, MICROBIOL MOL BIOL R, V70, P876, DOI 10.1128/MMBR.00029-06; BAUMEISTER W, 1992, J BIOENERG BIOMEMBR, V24, P567, DOI 10.1007/BF00762349; Bell SD, 2000, J BIOL CHEM, V275, P12934, DOI 10.1074/jbc.275.17.12934; Bell SD, 2001, CURR OPIN MICROBIOL, V4, P208, DOI 10.1016/S1369-5274(00)00190-9; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Born TL, 1999, CURR OPIN CHEM BIOL, V3, P607, DOI 10.1016/S1367-5931(99)00016-2; Brochier-Armanet C, 2008, NAT REV MICROBIOL, V6, P245, DOI 10.1038/nrmicro1852; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Coenye T, 2005, FEMS MICROBIOL LETT, V242, P117, DOI 10.1016/j.femsle.2004.10.050; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; Csuros M, 2009, MOL BIOL EVOL, V26, P2087, DOI 10.1093/molbev/msp123; Dirmeier R, 1998, EUR J BIOCHEM, V252, P486, DOI 10.1046/j.1432-1327.1998.2520486.x; Drozdowicz YM, 1999, FEBS LETT, V460, P505, DOI 10.1016/S0014-5793(99)01404-0; Drozdowicz YM, 2001, TRENDS PLANT SCI, V6, P206, DOI 10.1016/S1360-1385(01)01923-9; Easter J, 2002, MOL CELL, V10, P427, DOI 10.1016/S1097-2765(02)00594-4; EIKMANNS B, 1983, ARCH MICROBIOL, V136, P111, DOI 10.1007/BF00404783; Elferink MGL, 2001, MOL MICROBIOL, V39, P1494, DOI 10.1046/j.1365-2958.2001.02336.x; Elkins J.G., 2008, P NATL ACAD SCI USA, V105, P8805; Elkins JG, 2008, P NATL ACAD SCI USA, V105, P8102, DOI 10.1073/pnas.0801980105; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Eppinger M, 2006, PLOS GENET, V2, P1097, DOI 10.1371/journal.pgen.0020120; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Facciotti MT, 2007, P NATL ACAD SCI USA, V104, P4630, DOI 10.1073/pnas.0611663104; FISCHER F, 1983, NATURE, V301, P511, DOI 10.1038/301511a0; Fitz-Gibbon ST, 2002, P NATL ACAD SCI USA, V99, P984, DOI 10.1073/pnas.241636498; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gordon D, 2001, GENOME RES, V11, P614, DOI 10.1101/gr.171401; Graupner M, 2001, J BACTERIOL, V183, P5203, DOI 10.1128/JB.183.17.5203-5205.2001; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hallam SJ, 2006, P NATL ACAD SCI USA, V103, P18296, DOI 10.1073/pnas.0608549103; Haring M, 2004, VIROLOGY, V323, P233, DOI 10.1016/j.virol.2004.03.002; Hedderich R, 1998, FEMS MICROBIOL REV, V22, P353, DOI 10.1111/j.1574-6976.1998.tb00376.x; Higuchi S, 1999, P JPN ACAD B-PHYS, V75, P241, DOI 10.2183/pjab.75.241; Hiller A, 2003, J BIOENERG BIOMEMBR, V35, P121, DOI 10.1023/A:1023742002493; Huber H, 2008, P NATL ACAD SCI USA, V105, P7851, DOI 10.1073/pnas.0801043105; Jahn U, 2007, J BACTERIOL, V189, P4108, DOI 10.1128/JB.00047-07; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; Klenk HP, 1997, NATURE, V390, P364, DOI 10.1038/37052; Koonin EV, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-38; Koonin EV, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r19; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Laska S, 2003, MICROBIOL-SGM, V149, P2357, DOI 10.1099/mic.0.26455-0; Lewalter K, 2006, BBA-BIOENERGETICS, V1757, P437, DOI 10.1016/j.bbabio.2006.04.027; Li F, 2008, J BACTERIOL, V190, P843, DOI 10.1128/JB.01417-07; Lillestol Reidun K., 2006, Archaea, V2, P59, DOI 10.1155/2006/542818; Linke Burkhard, 2006, Appl Bioinformatics, V5, P193, DOI 10.2165/00822942-200605030-00008; Liolios K, 2006, NUCLEIC ACIDS RES, V34, pD332, DOI 10.1093/nar/gkj145; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Luo X, 2007, J BACTERIOL, V189, P403, DOI 10.1128/JB.01246-06; Makarova KS, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-33; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 1999, GENOME RES, V9, P608; Marinsek N, 2006, EMBO REP, V7, P539, DOI 10.1038/sj.embor.7400649; Markowitz VM, 2010, NUCLEIC ACIDS RES, V38, pD382, DOI 10.1093/nar/gkp887; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Meyer F, 2003, NUCLEIC ACIDS RES, V31, P2187, DOI 10.1093/nar/gkg312; Mogi T, 2009, J BIOCHEM, V145, P763, DOI 10.1093/jb/mvp033; Muller V, 2004, J BIOENERG BIOMEMBR, V36, P115, DOI 10.1023/B:JOBB.0000019603.68282.04; Nather DJ, 2004, BIOCHEM SOC T, V32, P199, DOI 10.1042/BST0320199; NEUMANN H, 1990, MOL GEN GENET, V222, P435, DOI 10.1007/BF00633851; Orita I, 2005, J BACTERIOL, V187, P3636, DOI 10.1128/JB.187.11.3636-3642.2005; Orita I, 2006, J BACTERIOL, V188, P4698, DOI 10.1128/JB.00492-06; Paytubi S, 2009, MOL MICROBIOL, V72, P1487, DOI 10.1111/j.1365-2958.2009.06737.x; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Qureshi SA, 1997, EMBO J, V16, P2927, DOI 10.1093/emboj/16.10.2927; Ramos-Vera WH, 2011, J BACTERIOL, V193, P1201, DOI 10.1128/JB.01156-10; Ramos-Vera WH, 2009, J BACTERIOL, V191, P4286, DOI 10.1128/JB.00145-09; Reeve JN, 2003, MOL MICROBIOL, V48, P587, DOI 10.1046/j.1365-2958.2003.03439.x; Ren QH, 2007, NUCLEIC ACIDS RES, V35, pD274, DOI 10.1093/nar/gkl925; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Robinson NP, 2004, CELL, V116, P25, DOI 10.1016/S0092-8674(03)01034-1; Rose RW, 2002, MOL MICROBIOL, V45, P943, DOI 10.1046/j.1365-2958.2002.03090.x; Salzberg SL, 1998, NUCLEIC ACIDS RES, V26, P544, DOI 10.1093/nar/26.2.544; Samson RY, 2009, TRENDS MICROBIOL, V17, P507, DOI 10.1016/j.tim.2009.08.003; SANGER F, 1973, P NATL ACAD SCI USA, V70, P1209, DOI 10.1073/pnas.70.4.1209; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; SCHAFER S, 1989, EUR J BIOCHEM, V186, P695, DOI 10.1111/j.1432-1033.1989.tb15262.x; Schramm A, 2000, J BACTERIOL, V182, P2001, DOI 10.1128/JB.182.7.2001-2009.2000; SELIG M, 1994, ARCH MICROBIOL, V162, P286, DOI 10.1007/BF00301853; Siebers B, 2004, J BACTERIOL, V186, P2179, DOI 10.1128/JB.186.7.2179-2194.2004; Smith DR, 1997, J BACTERIOL, V179, P7135, DOI 10.1128/jb.179.22.7135-7155.1997; Soderberg Tim, 2005, Archaea, V1, P347, DOI 10.1155/2005/314760; SUMPER M, 1990, J BACTERIOL, V172, P7111, DOI 10.1128/jb.172.12.7111-7118.1990; Swiatek A, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-17; Szabo Z, 2007, J BACTERIOL, V189, P772, DOI 10.1128/JB.01547-06; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tsoka S, 2003, ARCHAEA, V1, P223; Tsubaki M, 2000, J INORG BIOCHEM, V82, P19, DOI 10.1016/S0162-0134(00)00140-9; van der Oost J, 2007, ARCHAEA EVOLUTION PH, V22, P247; Vaupel M, 1996, EUR J BIOCHEM, V236, P294, DOI 10.1111/j.1432-1033.1996.00294.x; Veith A, 2009, MOL MICROBIOL, V73, P58, DOI 10.1111/j.1365-2958.2009.06746.x; Verhees CH, 2001, J BIOL CHEM, V276, P40926, DOI 10.1074/jbc.M104603200; Walker CB, 2010, P NATL ACAD SCI USA, V107, P8818, DOI 10.1073/pnas.0913533107; Waters E, 2003, P NATL ACAD SCI USA, V100, P12984, DOI 10.1073/pnas.1735403100; Werner F, 2007, MOL MICROBIOL, V65, P1395, DOI 10.1111/j.1365-2958.2007.05876.x; White RH, 2004, BIOCHEMISTRY-US, V43, P7618, DOI 10.1021/bi0495127; WILDHABER I, 1987, EMBO J, V6, P1475, DOI 10.1002/j.1460-2075.1987.tb02389.x; Yarza P, 2008, SYST APPL MICROBIOL, V31, P241, DOI 10.1016/j.syapm.2008.07.001; Yutin N, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-9; Zabriskie TM, 2000, NAT PROD REP, V17, P85, DOI 10.1039/a801345d; Zaparty M, 2008, ARCH MICROBIOL, V190, P231, DOI 10.1007/s00203-008-0375-5; Zaparty M, 2008, J BACTERIOL, V190, P2231, DOI 10.1128/JB.01524-07; ZILLIG W, 1981, ZBL BAKT MIK HYG I C, V2, P205, DOI 10.1016/S0721-9571(81)80001-4	119	40	59	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e24222	10.1371/journal.pone.0024222	http://dx.doi.org/10.1371/journal.pone.0024222			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003381	Green Submitted, Green Published, gold			2022-12-27	WOS:000295970300002
J	Wu, J; Park, JP; Dooley, K; Cropek, DM; West, AC; Banta, S				Wu, Jun; Park, Jong Pil; Dooley, Kevin; Cropek, Donald M.; West, Alan C.; Banta, Scott			Rapid Development of New Protein Biosensors Utilizing Peptides Obtained via Phage Display	PLOS ONE			English	Article							QUARTZ-CRYSTAL MICROBALANCE; MODIFIED GOLD ELECTRODES; ALANINE AMINOTRANSFERASE; ASPARTATE-AMINOTRANSFERASE; IMPEDANCE SPECTROSCOPY; CYTOCHROME-C; RECOGNITION; SERUM; IMMUNOSENSOR; TRANSAMINASE	There is a consistent demand for new biosensors for the detection of protein targets, and a systematic method for the rapid development of new sensors is needed. Here we present a platform where short unstructured peptides that bind to a desired target are selected using M13 phage display. The selected peptides are then chemically synthesized and immobilized on gold, allowing for detection of the target using electrochemical techniques such as electrochemical impedance spectroscopy (EIS). A quartz crystal microbalance (QCM) is also used as a diagnostic tool during biosensor development. We demonstrate the utility of this approach by creating a novel peptide-based electrochemical biosensor for the enzyme alanine aminotransferase (ALT), a well-known biomarker of hepatotoxicity. Biopanning of the M13 phage display library over immobilized ALT, led to the rapid identification of a new peptide (ALT5-8) with an amino acid sequence of WHWRNPDFWYLK. Phage particles expressing this peptide exhibited nanomolar affinity for immobilized ALT (K(d,app)= 85 +/- 20 nM). The newly identified ALT5-8 peptide was then chemically synthesized with a C-terminal cysteine for gold immobilization. The performance of the gold-immobilized peptides was studied with cyclic voltammetry (CV), QCM, and EIS. Using QCM, the sensitivity for ALT detection was 8.9 +/- 0.9 Hz/(mu g/mL) and the limit of detection (LOD) was 60 ng/mL. Using EIS measurements, the sensitivity was 142 +/- 12 impedance percentage change %/(mu g/mL) and the LOD was 92 ng/mL. In both cases, the LOD was below the typical concentration of ALT in human blood. Although both QCM and EIS produced similar LODs, EIS is preferable due to a larger linear dynamic range. Using QCM, the immobilized peptide exhibited a nanomolar dissociation constant for ALT (K(d) = 20.1 +/- 0.6 nM). These results demonstrate a simple and rapid platform for developing and assessing the performance of sensitive, peptide-based biosensors for new protein targets.	[Wu, Jun; Park, Jong Pil; Dooley, Kevin; West, Alan C.; Banta, Scott] Columbia Univ, Dept Chem Engn, New York, NY USA; [Cropek, Donald M.] USA, Engineer Res & Dev Ctr, CERL, Champaign, IL USA	Columbia University; United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC); Construction Engineering Research Laboratory (CERL); Geospatial Research Laboratory (GRL)	Wu, J (corresponding author), Atotech USA Inc, Albany, NY USA.	sbanta@columbia.edu			United States Army Corps of Engineers Applied Research program	United States Army Corps of Engineers Applied Research program	This study was funded by the United States Army Corps of Engineers Applied Research program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HW, 2008, NAT METHODS, V5, P401, DOI [10.1038/nmeth.1207, 10.1038/NMETH.1207]; Amacher DE, 1998, REGUL TOXICOL PHARM, V27, P119, DOI 10.1006/rtph.1998.1201; Amacher DE, 2002, HUM EXP TOXICOL, V21, P253, DOI 10.1191/0960327102ht247oa; Archer MJ, 2009, SENSORS-BASEL, V9, P6298, DOI 10.3390/s90806298; BARKER PD, 1990, EUR J BIOCHEM, V190, P171, DOI 10.1111/j.1432-1033.1990.tb15561.x; BERGMEYER HU, 1978, CLIN CHEM, V24, P58; Binz HK, 2005, NAT BIOTECHNOL, V23, P1257, DOI 10.1038/nbt1127; Casero E, 2010, ANALYST, V135, P1878, DOI 10.1039/c0an00120a; Ceriotti L, 2007, BIOSENS BIOELECTRON, V22, P3057, DOI 10.1016/j.bios.2007.01.004; Chang KS, 2007, BIOSENS BIOELECTRON, V22, P2914, DOI 10.1016/j.bios.2006.12.001; Chen XJJ, 2008, ANAL CHEM, V80, P9622, DOI 10.1021/ac800796b; Cho EJ, 2009, ANNU REV ANAL CHEM, V2, P241, DOI 10.1146/annurev.anchem.1.031207.112851; Curtis TM, 2009, LAB CHIP, V9, P2176, DOI [10.1039/b901314h, 10.1039/b901314b]; DIGLERIA K, 1986, J ELECTROANAL CHEM, V213, P333, DOI 10.1016/0022-0728(86)80216-9; Dover JE, 2009, J MICROBIOL METH, V78, P10, DOI 10.1016/j.mimet.2009.04.008; GRUBER W, 1977, J CLIN CHEM CLIN BIO, V15, P565; HAFKENSCHEID JCM, 1979, CLIN CHEM, V25, P55; Homola J, 2003, ANAL BIOANAL CHEM, V377, P528, DOI 10.1007/s00216-003-2101-0; Huang XJ, 2006, SENSORS-BASEL, V6, P756, DOI 10.3390/s6070756; Inamori K, 2008, ANAL CHEM, V80, P643, DOI 10.1021/ac701667g; Iqbal SS, 2000, BIOSENS BIOELECTRON, V15, P549, DOI 10.1016/S0956-5663(00)00108-1; JUNG K, 1977, CLIN CHIM ACTA, V79, P515, DOI 10.1016/0009-8981(77)90171-1; Kaplan MM, 2002, ANN INTERN MED, V137, P49, DOI 10.7326/0003-4819-137-1-200207020-00012; Kara P, 2010, BIOSENS BIOELECTRON, V26, P1715, DOI 10.1016/j.bios.2010.07.090; Kehoe JW, 2005, CHEM REV, V105, P4056, DOI 10.1021/cr000261r; Laricchia-Robbio L, 2004, BIOSENS BIOELECTRON, V19, P1753, DOI 10.1016/j.bios.2003.11.026; Lisdat F, 2008, ANAL BIOANAL CHEM, V391, P1555, DOI 10.1007/s00216-008-1970-7; Liu FF, 2009, SENSOR ACTUAT B-CHEM, V136, P133, DOI 10.1016/j.snb.2008.11.031; Luong JHT, 2008, BIOTECHNOL ADV, V26, P492, DOI 10.1016/j.biotechadv.2008.05.007; Luppa PB, 2001, CLIN CHIM ACTA, V314, P1, DOI 10.1016/S0009-8981(01)00629-5; Mantzila AG, 2007, BIOSENS BIOELECTRON, V23, P362, DOI 10.1016/j.bios.2007.04.017; Marx KA, 2007, SPRINGER SER CHEM SE, V5, P371, DOI 10.1007/5346_033; Nanduri V, 2007, BIOSENS BIOELECTRON, V22, P986, DOI 10.1016/j.bios.2006.03.025; Newman JD, 2006, MOL BIOTECHNOL, V32, P249, DOI 10.1385/MB:32:3:249; Nilsson F, 2000, ADV DRUG DELIVER REV, V43, P165, DOI 10.1016/S0169-409X(00)00068-5; Ohgami N, 2007, BIOSENS BIOELECTRON, V22, P1330, DOI 10.1016/j.bios.2006.06.007; Ozer J, 2008, TOXICOLOGY, V245, P194, DOI 10.1016/j.tox.2007.11.021; Park JP, 2010, BIOTECHNOL BIOENG, V105, P678, DOI 10.1002/bit.22597; Privett BJ, 2008, ANAL CHEM, V80, P4499, DOI 10.1021/ac8007219; Ronkainen NJ, 2010, CHEM SOC REV, V39, P1747, DOI 10.1039/b714449k; Sadik OA, 2009, BIOSENS BIOELECTRON, V24, P2749, DOI 10.1016/j.bios.2008.10.003; Shen Z, 2005, ANAL CHEM, V77, P797, DOI 10.1021/ac048655w; Wang J, 2001, ELECTROANAL, V13, P13, DOI 10.1002/1521-4109(200101)13:1<13::AID-ELAN13>3.0.CO;2-F; Wang J, 2008, CHEM REV, V108, P814, DOI 10.1021/cr068123a; Wu J, 2010, ANAL CHEM, V82, P8235, DOI 10.1021/ac101657h; Xuan GS, 2003, BIOSENS BIOELECTRON, V19, P365, DOI 10.1016/S0956-5663(03)00194-5	46	46	47	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e24948	10.1371/journal.pone.0024948	http://dx.doi.org/10.1371/journal.pone.0024948			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003385	Green Submitted, Green Published, gold			2022-12-27	WOS:000295970300006
J	Yamamoto, M; Kato, T; Hotta, C; Nishiyama, A; Kurotaki, D; Yoshinari, M; Takami, M; Ichino, M; Nakazawa, M; Matsuyama, T; Kamijo, R; Kitagawa, S; Ozato, K; Tamura, T				Yamamoto, Michio; Kato, Takayuki; Hotta, Chie; Nishiyama, Akira; Kurotaki, Daisuke; Yoshinari, Masahiro; Takami, Masamichi; Ichino, Motohide; Nakazawa, Masatoshi; Matsuyama, Toshifumi; Kamijo, Ryutaro; Kitagawa, Seiichi; Ozato, Keiko; Tamura, Tomohiko			Shared and Distinct Functions of the Transcription Factors IRF4 and IRF8 in Myeloid Cell Development	PLOS ONE			English	Article							SEQUENCE-BINDING-PROTEIN; INTERFERON-REGULATORY FACTOR-4; PROGENITOR CELLS; STEM-CELLS; LEUKEMIA; MACROPHAGES; EXPRESSION; DIFFERENTIATION; ICSBP; RESPONSES	Interferon regulatory factor (IRF) 8 and IRF4 are structurally-related, hematopoietic cell-specific transcription factors that cooperatively regulate the differentiation of dendritic cells and B cells. Whilst in myeloid cells IRF8 is known to modulate growth and differentiation, the role of IRF4 is poorly understood. In this study, we show that IRF4 has activities similar to IRF8 in regulating myeloid cell development. The ectopic expression of IRF4 in myeloid progenitor cells in vitro inhibits cell growth, promotes macrophages, but hinders granulocytic cell differentiation. We also show that IRF4 binds to and activates transcription through the IRF-Ets composite sequence (IECS). Furthermore, we demonstrate that Irf8(-/-)Irf4(-/-) mice exhibit a more severe chronic myeloid leukemia (CML)-like disease than Irf8(-/-) mice, involving a disproportionate expansion of granulocytes at the expense of monocytes/macrophages. Irf4(-/-) mice, however, display no obvious abnormality in myeloid cell development, presumably because IRF4 is expressed at a much lower level than IRF8 in granulocyte-macrophage progenitors. Our results also suggest that IRF8 and IRF4 have not only common but also specific activities in myeloid cells. Since the expression of both the IRF8 and IRF4 genes is downregulated in CML patients, these results may add to our understanding of CML pathogenesis.	[Yamamoto, Michio; Hotta, Chie; Nishiyama, Akira; Kurotaki, Daisuke; Yoshinari, Masahiro; Ichino, Motohide; Tamura, Tomohiko] Yokohama City Univ, Dept Immunol, Grad Sch Med, Yokohama, Kanagawa 232, Japan; [Kato, Takayuki; Kitagawa, Seiichi; Tamura, Tomohiko] Osaka City Univ, Dept Physiol, Grad Sch Med, Osaka 558, Japan; [Takami, Masamichi; Kamijo, Ryutaro] Showa Univ, Sch Dent, Dept Biochem, Tokyo 142, Japan; [Nakazawa, Masatoshi] Yokohama City Univ, Dept Expt Anim Sci, Grad Sch Med, Yokohama, Kanagawa 232, Japan; [Matsuyama, Toshifumi] Nagasaki Univ, Dept Mol Microbiol & Immunol, Grad Sch Biomed Sci, Nagasaki 852, Japan; [Ozato, Keiko; Tamura, Tomohiko] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Genom Differentiat, NIH, Bethesda, MD USA	Yokohama City University; Osaka Metropolitan University; Showa University; Yokohama City University; Nagasaki University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Yamamoto, M (corresponding author), Yokohama City Univ, Dept Immunol, Grad Sch Med, Yokohama, Kanagawa 232, Japan.	tamurat@yokohama-cu.ac.jp		Kurotaki, Daisuke/0000-0002-4728-0113; Takami, Masamichi/0000-0002-4506-3975	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Yokohama City University; Takeda Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Uehara Memorial Foundation; Kato Memorial Bioscience Foundation; Yokohama Foundation for Advancement of Medical Science; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001310] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23659492] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yokohama City University; Takeda Science Foundation(Takeda Science Foundation (TSF)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Uehara Memorial Foundation(Uehara Memorial Foundation); Kato Memorial Bioscience Foundation; Yokohama Foundation for Advancement of Medical Science; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Grant-in-Aid for Scientific Research (B), the Grant-in-Aid for Exploratory Research, and the research grant for the Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, the Grant for Strategic Research Promotion from Yokohama City University, and research grants from the Takeda Science Foundation, the Mochida Memorial Foundation for Medical and Pharmaceutical Research, the Uehara Memorial Foundation, the Kato Memorial Bioscience Foundation, and the Yokohama Foundation for Advancement of Medical Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatia R, 2003, BLOOD, V101, P4701, DOI 10.1182/blood-2002-09-2780; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; CHEN W, 1992, P NATL ACAD SCI USA, V89, P1468, DOI 10.1073/pnas.89.4.1468; EISENBEIS CF, 1995, GENE DEV, V9, P1377, DOI 10.1101/gad.9.11.1377; Giese NA, 1997, J EXP MED, V186, P1535, DOI 10.1084/jem.186.9.1535; Graham SM, 2002, BLOOD, V99, P319, DOI 10.1182/blood.V99.1.319; Hambleton S, 2011, NEW ENGL J MED, V365, P127, DOI 10.1056/NEJMoa1100066; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Honma K, 2005, P NATL ACAD SCI USA, V102, P16001, DOI 10.1073/pnas.0504226102; Jo SH, 2010, BLOOD, V116, P2759, DOI 10.1182/blood-2009-07-234559; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Lohoff M, 2002, P NATL ACAD SCI USA, V99, P11808, DOI 10.1073/pnas.182425099; Lu RQ, 2003, GENE DEV, V17, P1703, DOI 10.1101/gad.1104803; Marecki S, 1999, J IMMUNOL, V163, P2713; Negishi H, 2005, P NATL ACAD SCI USA, V102, P15989, DOI 10.1073/pnas.0508327102; Ouyang XS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1311; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; SchartonKersten T, 1997, J EXP MED, V186, P1523, DOI 10.1084/jem.186.9.1523; Scheller M, 1999, BLOOD, V94, P3764, DOI 10.1182/blood.V94.11.3764.423k03_3764_3771; Schmidt M, 2000, J CLIN ONCOL, V18, P3331, DOI 10.1200/JCO.2000.18.19.3331; Schmidt M, 1998, BLOOD, V91, P22, DOI 10.1182/blood.V91.1.22.22_22_29; Schmidt M, 2001, BLOOD, V97, P3648, DOI 10.1182/blood.V97.11.3648; Staudt V, 2010, IMMUNITY, V33, P192, DOI 10.1016/j.immuni.2010.07.014; Suzuki S, 2004, P NATL ACAD SCI USA, V101, P8981, DOI 10.1073/pnas.0402139101; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Tamura T, 2000, IMMUNITY, V13, P155, DOI 10.1016/S1074-7613(00)00016-9; Tamura T, 2005, BLOOD, V106, P1938, DOI 10.1182/blood-2005-01-0080; Tamura T, 2005, J IMMUNOL, V174, P2573, DOI 10.4049/jimmunol.174.5.2573; Tamura T, 2003, BLOOD, V102, P4547, DOI 10.1182/blood-2003-01-0291; Tamura T, 2002, J INTERF CYTOK RES, V22, P145, DOI 10.1089/107999002753452755; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Tenen DG, 1997, BLOOD, V90, P489, DOI 10.1182/blood.V90.2.489.489_489_519; Tsujimura H, 2004, J IMMUNOL, V172, P6820, DOI 10.4049/jimmunol.172.11.6820; Tsujimura H, 2002, J IMMUNOL, V169, P1261, DOI 10.4049/jimmunol.169.3.1261; Wang HS, 2008, BLOOD, V112, P4028, DOI 10.1182/blood-2008-01-129049; Wang IM, 2000, J IMMUNOL, V165, P271, DOI 10.4049/jimmunol.165.1.271; Zhao J, 2006, J BIOL CHEM, V281, P10073, DOI 10.1074/jbc.M507788200	39	66	67	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25812	10.1371/journal.pone.0025812	http://dx.doi.org/10.1371/journal.pone.0025812			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003407	Green Published, Green Submitted, gold			2022-12-27	WOS:000295970300028
J	Brodersen, J; Rodriguez-Gil, JL; Jonsson, M; Hansson, LA; Bronmark, C; Nilsson, PA; Nicolle, A; Berglund, O				Brodersen, Jakob; Rodriguez-Gil, Jose Luis; Jonsson, Mikael; Hansson, Lars-Anders; Bronmark, Christer; Nilsson, P. Anders; Nicolle, Alice; Berglund, Olof			Temperature and Resource Availability May Interactively Affect Over-Wintering Success of Juvenile Fish in a Changing Climate	PLOS ONE			English	Article							COMPENSATORY GROWTH; WATER TEMPERATURE; ENERGY RESERVES; SEASONAL SUCCESSION; LAKE; MORTALITY; SIZE; CONSEQUENCES; ZOOPLANKTON; MIGRATION	The predicted global warming may affect freshwater systems at several organizational levels, from organism to ecosystem. Specifically, in temperate regions, the projected increase of winter temperatures may have important effects on the over-winter biology of a range of organisms and especially for fish and other ectothermic animals. However, temperature effects on organisms may be directed strongly by resource availability. Here, we investigated whether over-winter loss of biomass and lipid content of juvenile roach (Rutilus rutilus) was affected by the physiologically relatively small (2-5 degrees C) changes of winter temperatures predicted by the Intergovernmental Panel on Climate Change (IPCC), under both natural and experimental conditions. This was investigated in combination with the effects of food availability. Finally, we explored the potential for a correlation between lake temperature and resource levels for planktivorous fish, i.e., zooplankton biomass, during five consecutive winters in a south Swedish lake. We show that small increases in temperature (+2 degrees C) affected fish biomass loss in both presence and absence of food, but negatively and positively respectively. Temperature alone explained only a minor part of the variation when food availability was not taken into account. In contrast to other studies, lipid analyses of experimental fish suggest that critical somatic condition rather than critical lipid content determined starvation induced mortality. Our results illustrate the importance of considering not only changes in temperature when predicting organism response to climate change but also food-web interactions, such as resource availability and predation. However, as exemplified by our finding that zooplankton over-winter biomass in the lake was not related to over-winter temperature, this may not be a straightforward task.	[Brodersen, Jakob; Rodriguez-Gil, Jose Luis; Jonsson, Mikael; Hansson, Lars-Anders; Bronmark, Christer; Nilsson, P. Anders; Nicolle, Alice; Berglund, Olof] Lund Univ, Dept Biol Aquat Ecol, Lund, Sweden	Lund University	Brodersen, J (corresponding author), EAWAG Swiss Fed Inst Aquat Sci & Technol, Dept Fish Ecol & Evolut, Ctr Ecol Evolut & Biochem, Kastanienbaum, Switzerland.	jakob.brodersen@eawag.ch	Hansson, Lars-Anders/HCI-2735-2022; Nilsson, Anders/H-6836-2014; Rodriguez Gil, Jose Luis/B-3479-2010; Jönsson, Mikael/M-7449-2013	Nilsson, Anders/0000-0002-3541-9835; Rodriguez Gil, Jose Luis/0000-0001-9325-9131; Jönsson, Mikael/0000-0002-9799-6435; Hansson, Lars-Anders/0000-0002-3035-1317	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS); Swedish Research Council (VR); Physiographic Society in Lund	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)(Swedish Research Council Formas); Swedish Research Council (VR)(Swedish Research Council); Physiographic Society in Lund	The work was supported by the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS), the Swedish Research Council (VR) and the Physiographic Society in Lund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian R, 1999, FRESHWATER BIOL, V41, P621, DOI 10.1046/j.1365-2427.1999.00411.x; Adrian R, 2006, GLOBAL CHANGE BIOL, V12, P652, DOI 10.1111/j.1365-2486.2006.01125.x; Ali M, 2003, FISH FISH, V4, P147, DOI 10.1046/j.1467-2979.2003.00120.x; ARTS MT, 1991, LIMNOL OCEANOGR, V36, P289, DOI 10.4319/lo.1991.36.2.0289; Berger SA, 2007, OECOLOGIA, V150, P643, DOI 10.1007/s00442-006-0550-9; Biro PA, 2004, CAN J FISH AQUAT SCI, V61, P1513, DOI 10.1139/F04-083; Biro PA, 2007, P NATL ACAD SCI USA, V104, P9715, DOI 10.1073/pnas.0701638104; Blenckner T, 2007, GLOBAL CHANGE BIOL, V13, P1314, DOI 10.1111/j.1365-2486.2007.01364.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOHL E, 1980, OECOLOGIA, V44, P368, DOI 10.1007/BF00545241; BOTTRELL HH, 1976, NORW J ZOOL, V24, P419; Brodersen J, 2008, ECOLOGY, V89, P1195, DOI 10.1890/07-1318.1; Brodersen J, 2008, OIKOS, V117, P40, DOI 10.1111/j.2007.0030-1299.16118.x; Bronmark C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001957; Bystrom P, 2006, OIKOS, V115, P43, DOI 10.1111/j.2006.0030-1299.15014.x; Carpenter S.R., 1993, TROPHIC CASCADE LAKE; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; COSTANZO JP, 1995, ECOLOGY, V76, P1772, DOI 10.2307/1940709; CRYER M, 1986, LIMNOL OCEANOGR, V31, P1022, DOI 10.4319/lo.1986.31.5.1022; CUNJAK RA, 1987, T AM FISH SOC, V116, P817, DOI 10.1577/1548-8659(1987)116<817:SEBOBT>2.0.CO;2; DERICKSON WK, 1976, AM ZOOL, V16, P711; DRATNAL E, 1993, FUNCT ECOL, V7, P91, DOI 10.2307/2389871; FITZPATRICK LC, 1976, AM ZOOL, V16, P725; Freyhof J., 2007, HDB EUROPEAN FRESHWA; Fry F.E.J., 1971, P1; Garvey JE, 2004, ECOLOGY, V85, P2860, DOI 10.1890/03-0329; Garvey JE, 1998, CAN J FISH AQUAT SCI, V55, P2414, DOI 10.1139/cjfas-55-11-2414; GEORGE DG, 1985, NATURE, V316, P536, DOI 10.1038/316536a0; George G, 2007, FRESHWATER BIOL, V52, P1647, DOI 10.1111/j.1365-2427.2007.01773.x; Gerten D, 2000, LIMNOL OCEANOGR, V45, P1058, DOI 10.4319/lo.2000.45.5.1058; Graeb BDS, 2004, T AM FISH SOC, V133, P504, DOI 10.1577/T03-050.1; Hansson LA, 2007, LIMNOL OCEANOGR, V52, P696, DOI 10.4319/lo.2007.52.2.0696; Hari RE, 2006, GLOBAL CHANGE BIOL, V12, P10, DOI 10.1111/j.1365-2486.2005.001051.x; Henen BT, 1997, ECOLOGY, V78, P283; Hoxmeier RJH, 2004, T AM FISH SOC, V133, P45, DOI 10.1577/T01-082; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Hurst TP, 2007, J FISH BIOL, V71, P315, DOI 10.1111/j.1095-8649.2007.01596.x; Hurst TP, 2003, ECOLOGY, V84, P3360, DOI 10.1890/02-0562; Huss M, 2008, CAN J FISH AQUAT SCI, V65, P2149, DOI 10.1139/F08-115; Jeppesen E, 2003, ECOSYSTEMS, V6, P313, DOI 10.1007/PL00021503; Jespersen LB, 2003, FUNCT ECOL, V17, P737, DOI 10.1111/j.1365-2435.2003.00788.x; JOHNSON M. G., 1960, PROGR FISH CULTURIST, V22, P155, DOI 10.1577/1548-8659(1960)22[155:SEOTOT]2.0.CO;2; Johnsson JI, 2006, P ROY SOC B-BIOL SCI, V273, P1281, DOI 10.1098/rspb.2005.3437; Lehtonen H., 1996, Fisheries Management and Ecology, V3, P59, DOI 10.1111/j.1365-2400.1996.tb00130.x; MACCULLOCH RD, 1983, CAN J ZOOL, V61, P1499, DOI 10.1139/z83-202; Magnuson JJ, 1997, HYDROL PROCESS, V11, P825; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; MullerNavarra DC, 1997, GLOB CHANGE BIOL, V3, P429, DOI 10.1046/j.1365-2486.1997.00080.x; Nielsen T, 2008, THESIS AAHUS U; Raisanen J, 2004, CLIM DYNAM, V22, P13, DOI 10.1007/s00382-003-0365-x; Reading CJ, 2007, OECOLOGIA, V151, P125, DOI 10.1007/s00442-006-0558-1; REZNICK DN, 1987, OECOLOGIA, V73, P401, DOI 10.1007/BF00385257; Rummukainen M, 2001, CLIM DYNAM, V17, P339, DOI 10.1007/s003820000109; Scheffer M., 1998, ECOLOGY SHALLOW LAKE; SCHULTZ ET, 1991, AM NAT, V138, P1408, DOI 10.1086/285294; Schultz ET, 1999, OECOLOGIA, V119, P474, DOI 10.1007/s004420050810; Seebens H, 2007, LIMNOL OCEANOGR, V52, P2364, DOI 10.4319/lo.2007.52.6.2364; SHUTER BJ, 1990, T AM FISH SOC, V119, P314, DOI 10.1577/1548-8659(1990)119<0314:CPVATZ>2.3.CO;2; SHUTER BJ, 1980, T AM FISH SOC, V109, P1, DOI 10.1577/1548-8659(1980)109&lt;1:SSOTEO&gt;2.0.CO;2; Skov C, 2008, ECOL FRESHW FISH, V17, P406, DOI 10.1111/j.1600-0633.2008.00291.x; Sogard SM, 2000, J FISH BIOL, V56, P1; SOMERO GN, 1971, AM ZOOL, V11, P157; SOMMER U, 1986, ARCH HYDROBIOL, V106, P433; Stefan HG, 1995, SPEC PUBL FISH AQUAT, V121, P57; ULTSCH GR, 1989, BIOL REV, V64, P435, DOI 10.1111/j.1469-185X.1989.tb00683.x; Van Dijk PLM, 2005, J FISH BIOL, V66, P167, DOI 10.1111/j.0022-1112.2005.00590.x; van Dijk PLM, 2002, OECOLOGIA, V130, P496, DOI 10.1007/s00442-001-0830-3; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Weatherley AH, 1987, BIOL FISH GROWTH; Winder M, 2004, ECOLOGY, V85, P2100, DOI 10.1890/04-0151	70	24	25	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e24022	10.1371/journal.pone.0024022	http://dx.doi.org/10.1371/journal.pone.0024022			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998627	Green Published, Green Submitted, gold			2022-12-27	WOS:000295968700003
J	Clark, LC; Hoskisson, PA				Clark, Laura C.; Hoskisson, Paul A.			Duplication and Evolution of devA-Like Genes in Streptomyces Has Resulted in Distinct Developmental Roles	PLOS ONE			English	Article							AERIAL MYCELIUM FORMATION; ANTIBIOTIC PRODUCTION; TRANSCRIPTIONAL REGULATOR; ADAPTIVE EVOLUTION; COELICOLOR A3(2); SP-NOV; FAMILY; MORPHOGENESIS; SPORULATION; PROTEINS	Understanding morphological transformations is essential to elucidating the evolution and developmental biology of many organisms. The Gram-positive soil bacterium, Streptomyces coelicolor has a complex lifecycle which lends itself well to such studies. We recently identified a transcriptional regulator, devA, which is required for correct sporulation in this organism, with mutants forming short, mis-septate aerial hyphae. devA is highly conserved within the Streptomyces genus along with a duplicate copy, devE. Disruption of devE indicates this gene also plays a role in sporulation; however the phenotype of a devE mutant differs from a devA mutant, forming long un-septate aerial hyphae. Transcriptional analysis of devA and devE indicates that they are expressed at different stages of the lifecycle. This suggests that following duplication they have diverged in regulation and function. Analysis of fully sequenced actinomycete genomes shows that devA is found in a single copy in morphologically simpler actinobacteria, suggesting that duplication has lead to increased morphological complexity. Complementation studies with devA from Salinispora, which sporulates but does not form aerial hyphae, indicates the ancestral gene cannot complement devA or devE, suggesting neo-functionalisation has occurred. Analysis of the synonymous and non-synonymous nucleotide changes within the devA paralogues suggest subfunctionalisation has occurred as both copies have diverged from the ancestral sequences. Divergence is also asymmetric with a higher level of functional constraint observed in the DNA binding domain compared with the effector binding/oligomerisation domain, suggesting diversification in the substrate specificity of these paralogues has contributed to their evolution.	[Clark, Laura C.; Hoskisson, Paul A.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland	University of Strathclyde	Clark, LC (corresponding author), Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland.	Paul.hoskisson@strath.ac.uk		Hoskisson, Paul/0000-0003-4332-1640; Clark, Laura/0000-0001-9471-2743				Andersson DI, 2009, ANNU REV GENET, V43, P167, DOI 10.1146/annurev-genet-102108-134805; Bergthorsson U, 2007, P NATL ACAD SCI USA, V104, P17004, DOI 10.1073/pnas.0707158104; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; Bishop A, 2004, GENOME RES, V14, P893, DOI 10.1101/gr.1710304; Campanaro S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-313; Chater KF, 2006, FEMS MICROBIOL REV, V30, P651, DOI 10.1111/j.1574-6976.2006.00033.x; Chater KF, 2001, CURR OPIN MICROBIOL, V4, P667, DOI 10.1016/S1369-5274(01)00267-3; Claessen D, 2003, GENE DEV, V17, P1714, DOI 10.1101/gad.264303; Claessen D, 2002, MOL MICROBIOL, V44, P1483, DOI 10.1046/j.1365-2958.2002.02980.x; Elliot MA, 2004, CURR OPIN MICROBIOL, V7, P594, DOI 10.1016/j.mib.2004.10.013; Elliot MA, 2003, GENE DEV, V17, P1727, DOI 10.1101/gad.264403; Flardh K, 2009, NAT REV MICROBIOL, V7, P36, DOI 10.1038/nrmicro1968; Goldman BS, 2006, P NATL ACAD SCI USA, V103, P15200, DOI 10.1073/pnas.0607335103; GOODFELLOW M, 1983, BIOL ACTINOMYCETES; Gregory MA, 2003, J BACTERIOL, V185, P5320, DOI 10.1128/JB.185.17.5320-5323.2003; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; HASEGAWA T, 1978, INT J SYST BACTERIOL, V28, P304, DOI 10.1099/00207713-28-2-304; HAYDON DJ, 1991, FEMS MICROBIOL LETT, V79, P291, DOI 10.1016/0378-1097(91)90101-F; He XL, 2005, CURR BIOL, V15, P1016, DOI 10.1016/j.cub.2005.04.035; Hillerich B, 2006, J BACTERIOL, V188, P7477, DOI 10.1128/JB.00898-06; HOBBS G, 1989, APPL MICROBIOL BIOT, V31, P272; Hoskisson PA, 2006, J BACTERIOL, V188, P5014, DOI 10.1128/JB.00307-06; Hoskisson Paul A, 2009, Adv Appl Microbiol, V69, P1, DOI 10.1016/S0065-2164(09)69001-8; Huang J, 2005, MOL MICROBIOL, V58, P1276, DOI 10.1111/j.1365-2958.2005.04879.x; Huminiecki L, 2004, GENOME RES, V14, P1870, DOI 10.1101/gr.2705204; Johnson DA, 2007, MOL BIOL EVOL, V24, P2412, DOI 10.1093/molbev/msm184; Karandikar A, 1997, MICROBIOL-SGM, V143, P3581, DOI 10.1099/00221287-143-11-3581; Kelemen GH, 1996, MOL MICROBIOL, V21, P593, DOI 10.1111/j.1365-2958.1996.tb02567.x; Kieser T., 2000, PRACTICAL STREPTOMYC, DOI DOI 10.2436/im.v3i4.9291; Labeda DP, 2005, INT J SYST EVOL MICR, V55, P1687, DOI 10.1099/ijs.0.63496-0; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2000, GENETICS, V154, P459; Maldonado LA, 2005, INT J SYST EVOL MICR, V55, P1759, DOI 10.1099/ijs.0.63625-0; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nodwell JR, 1999, GENETICS, V151, P569; Nodwell JR, 1996, MOL MICROBIOL, V22, P881, DOI 10.1046/j.1365-2958.1996.01540.x; Nowak MA, 1997, NATURE, V388, P167, DOI 10.1038/40618; Ohno S., 1970, P1; Park YH, 1999, INT J SYST BACTERIOL, V49, P743, DOI 10.1099/00207713-49-2-743; Prud'homme B, 2007, P NATL ACAD SCI USA, V104, P8605, DOI 10.1073/pnas.0700488104; Rigali S, 2008, EMBO REP, V9, P670, DOI 10.1038/embor.2008.83; Ryding NJ, 1998, MOL MICROBIOL, V29, P343, DOI 10.1046/j.1365-2958.1998.00939.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Skamnioti P, 2008, NEW PHYTOL, V180, P711, DOI 10.1111/j.1469-8137.2008.02598.x; Skamnioti Pari, 2008, Commun Integr Biol, V1, P196; Sprusansky O, 2003, J BACTERIOL, V185, P6147, DOI 10.1128/JB.185.20.6147-6157.2003; Stackebrandt E, 1997, INT J SYST BACTERIOL, V47, P479, DOI 10.1099/00207713-47-2-479; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teichmann SA, 2004, NAT GENET, V36, P492, DOI 10.1038/ng1340; Thomaides HB, 2007, J BACTERIOL, V189, P591, DOI 10.1128/JB.01381-06; Thompson JD, 2002, CURR PROTOC BIOINFOR, V2, P23, DOI 10.1002/0471250953.bi0203s00; Traag BA, 2008, ANTON LEEUW INT J G, V94, P85, DOI 10.1007/s10482-008-9225-3; Treangen TJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001284; Veening JW, 2005, MOL MICROBIOL, V56, P1481, DOI 10.1111/j.1365-2958.2005.04659.x; Ventura M, 2007, MICROBIOL MOL BIOL R, V71, P495, DOI 10.1128/MMBR.00005-07; Willey JM, 2006, MOL MICROBIOL, V59, P731, DOI 10.1111/j.1365-2958.2005.05018.x; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8	57	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25049	10.1371/journal.pone.0025049	http://dx.doi.org/10.1371/journal.pone.0025049			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998634	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000295966900006
J	Scully, S; Yan, W; Bentley, B; Cao, QJ; Shao, R				Scully, Steve; Yan, Wei; Bentley, Brooke; Cao, Qing Jackie; Shao, Rong			Inhibitory Activity of YKL-40 in Mammary Epithelial Cell Differentiation and Polarization Induced by Lactogenic Hormones: A Role in Mammary Tissue Involution	PLOS ONE			English	Article							CHITINASE PROTEIN FAMILY; HUMAN CARTILAGE GLYCOPROTEIN-39; BREAST-CANCER; SERUM YKL-40; GENE-EXPRESSION; STIMULATES PROLIFERATION; BRANCHING MORPHOGENESIS; DUCTAL MORPHOGENESIS; NONLACTATING PERIOD; SIGNALING PATHWAYS	We previously reported that a secreted glycoprotein YKL-40 acts as an angiogenic factor to promote breast cancer angiogenesis. However, its functional role in normal mammary gland development is poorly understood. Here we investigated its biophysiological activity in mammary epithelial development and mammary tissue morphogenesis. YKL-40 was expressed exclusively by ductal epithelial cells of parous and non-parous mammary tissue, but was dramatically up-regulated at the beginning of involution. To mimic ductal development and explore activity of elevated YKL-40 during mammary tissue regression in vivo, we grew a mammary epithelial cell line 76N MECs in a 3-D Matrigel system in the presence of lactogenic hormones including prolactin, hydrocortisone, and insulin. Treatment of 76N MECs with recombinant YKL-40 significantly inhibited acinar formation, luminal polarization, and secretion. YKL-40 also suppressed expression of E-cadherin but increased MMP-9 and cell motility, the crucial mechanisms that mediate mammary tissue remodeling during involution. In addition, engineering of 76N MECs with YKL-40 gene to express ectopic YKL-40 recapitulated the same activities as recombinant YKL-40 in the inhibition of cell differentiation. These results suggest that YKL-40-mediated inhibition of cell differentiation and polarization in the presence of lactogenic hormones may represent its important function during mammary tissue involution. Identification of this biophysiological property will enhance our understanding of its pathologic role in the later stage of breast cancer that is developed from poorly differentiated and highly invasive cells.	[Scully, Steve; Yan, Wei; Bentley, Brooke; Shao, Rong] Univ Massachusetts, Pioneer Valley Life Sci Inst, Springfield, MA USA; [Scully, Steve; Shao, Rong] Univ Massachusetts, Mol & Cellular Biol Program, Morrill Sci Ctr, Amherst, MA 01003 USA; [Cao, Qing Jackie] Tufts Univ, Dept Pathol, Baystate Med Ctr, Springfield, MA USA; [Shao, Rong] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts System; University of Massachusetts Amherst; Baystate Medical Center; Tufts University; University of Massachusetts System; University of Massachusetts Amherst	Scully, S (corresponding author), Univ Massachusetts, Pioneer Valley Life Sci Inst, Springfield, MA USA.	rong.shao@bhs.org			National Institutes of Health (National Cancer Institutes) [RO1 CA120659]; Department Of Defense [W81XWH-06-1-0563]; NATIONAL CANCER INSTITUTE [R01CA120659] Funding Source: NIH RePORTER	National Institutes of Health (National Cancer Institutes)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Institute of Neurological Disorders & Stroke (NINDS)); Department Of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (National Cancer Institutes) RO1 CA120659 "Role of a novel angiogenic factor YKL-40 in breast cancer development" and Department Of Defense W81XWH-06-1-0563 "PVLSI Breast Cancer Research Program: Biomarkers and Chemoprevention." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badariotti F, 2006, J BIOL CHEM, V281, P29583, DOI 10.1074/jbc.M605687200; BAND V, 1990, P NATL ACAD SCI USA, V87, P463, DOI 10.1073/pnas.87.1.463; Beauvais DLM, 2004, J CELL BIOL, V167, P171, DOI 10.1083/jcb.200404171; Bergmann OJ, 2005, CLIN CANCER RES, V11, P8644, DOI 10.1158/1078-0432.CCR-05-1317; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Brill B, 2008, LAB ANIM-UK, V42, P104, DOI 10.1258/la.2007.06003e; Cao YA, 1997, CANCER RES, V57, P5584; Chen CC, 2011, CLIN IMMUNOL, V140, P268, DOI 10.1016/j.clim.2011.04.007; Chen CC, 2011, AM J PATHOL, V179, P1494, DOI 10.1016/j.ajpath.2011.05.038; Cintin C, 1999, BRIT J CANCER, V79, P1494, DOI 10.1038/sj.bjc.6690238; Clarkson RWE, 2004, BREAST CANCER RES, V6, pR92, DOI 10.1186/bcr754; De Ceuninck F, 2001, BIOCHEM BIOPH RES CO, V285, P926, DOI 10.1006/bbrc.2001.5253; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; El-Sabban ME, 2003, J CELL SCI, V116, P3531, DOI 10.1242/jcs.00656; Francescone RA, 2011, J BIOL CHEM, V286, P15332, DOI 10.1074/jbc.M110.212514; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Fusetti F, 2003, J BIOL CHEM, V278, P37753, DOI 10.1074/jbc.M303137200; HAKALA BE, 1993, J BIOL CHEM, V268, P25803; Helguero LA, 2008, CANCER RES, V68, P8695, DOI 10.1158/0008-5472.CAN-08-0788; Hennighausen L, 2001, DEV CELL, V1, P467, DOI 10.1016/S1534-5807(01)00064-8; Hogdall EVS, 2003, ONCOL REP, V10, P1535; Hu B, 1996, J BIOL CHEM, V271, P19415, DOI 10.1074/jbc.271.32.19415; Humphreys RC, 1996, DEVELOPMENT, V122, P4013; Jahchan NS, 2010, CANCER RES, V70, P4204, DOI 10.1158/0008-5472.CAN-10-0135; Jensen BV, 2003, CLIN CANCER RES, V9, P4423; Johansen JS, 2000, J HEPATOL, V32, P911, DOI 10.1016/S0168-8278(00)80095-1; Johansen JS, 2003, BREAST CANCER RES TR, V80, P15, DOI 10.1023/A:1024431000710; JOHANSEN JS, 1992, J BONE MINER RES, V7, P501; Kawamura K, 1999, DEVELOPMENT, V126, P211; Kronborg G, 2002, SCAND J INFECT DIS, V34, P323, DOI 10.1080/00365540110080233; Kzhyshkowska J, 2007, BIOMARK INSIGHTS, V2, P128; Lee CG, 2009, J EXP MED, V206, P1149, DOI 10.1084/jem.20081271; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Lian ZL, 2006, J CELL PHYSIOL, V208, P255, DOI 10.1002/jcp.20681; Mailleux AA, 2007, DEV CELL, V12, P221, DOI 10.1016/j.devcel.2006.12.003; McDaniel SM, 2006, AM J PATHOL, V168, P608, DOI 10.2353/ajpath.2006.050677; Mohanty AK, 2003, J BIOL CHEM, V278, P14451, DOI 10.1074/jbc.M208967200; Muraoka-Cook RS, 2006, MOL BIOL CELL, V17, P4118, DOI 10.1091/mbc.E06-02-0101; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Novitskaya V, 2010, CANCER RES, V70, P4698, DOI 10.1158/0008-5472.CAN-09-4330; NYIRKOS P, 1990, BIOCHEM J, V269, P265, DOI 10.1042/bj2690265; Pelloski CE, 2005, CLIN CANCER RES, V11, P3326, DOI 10.1158/1078-0432.CCR-04-1765; Proia DA, 2006, NAT PROTOC, V1, P206, DOI 10.1038/nprot.2006.31; Qin WY, 2007, INT J CANCER, V121, P1536, DOI 10.1002/ijc.22881; Recklies AD, 2002, BIOCHEM J, V365, P119, DOI 10.1042/BJ20020075; Rehli M, 1997, GENOMICS, V43, P221, DOI 10.1006/geno.1997.4778; REJMAN JJ, 1988, BIOCHEM BIOPH RES CO, V150, P329, DOI 10.1016/0006-291X(88)90524-4; Renkema GH, 1998, EUR J BIOCHEM, V251, P504, DOI 10.1046/j.1432-1327.1998.2510504.x; SHACKELTON LM, 1995, J BIOL CHEM, V270, P13076, DOI 10.1074/jbc.270.22.13076; Shao R, 2009, ONCOGENE, V28, P4456, DOI 10.1038/onc.2009.292; Stein T, 2004, BREAST CANCER RES, V6, pR75, DOI 10.1186/bcr753; Sternlicht MD, 2006, DIFFERENTIATION, V74, P365, DOI 10.1111/j.1432-0436.2006.00105.x; Streuli CH, 1999, J MAMMARY GLAND BIOL, V4, P183, DOI 10.1023/A:1018729308878; STREULI CH, 1991, J CELL BIOL, V115, P1383, DOI 10.1083/jcb.115.5.1383; Vallorosi CJ, 2000, J BIOL CHEM, V275, P3328, DOI 10.1074/jbc.275.5.3328; Vind I, 2003, SCAND J GASTROENTERO, V38, P599, DOI 10.1080/00365520310000537; Volck B, 2001, OSTEOARTHR CARTILAGE, V9, P203, DOI 10.1053/joca.2000.0377; Xian W, 2005, J CELL BIOL, V171, P663, DOI 10.1083/jcb.200505098; Yamac D, 2008, ADV THER, V25, P801, DOI 10.1007/s12325-008-0082-2; Yamada M, 2002, ELECTROPHORESIS, V23, P1153, DOI 10.1002/1522-2683(200204)23:7/8&lt;1153::AID-ELPS1153&gt;3.0.CO;2-Y; Yan W, 2010, J BIOL CHEM, V285, P14042, DOI 10.1074/jbc.M110.105262; ZHAO X, 2006, P NATL ACAD SCI USA, V107, P14146	62	31	32	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25819	10.1371/journal.pone.0025819	http://dx.doi.org/10.1371/journal.pone.0025819			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991364	Green Published, Green Submitted, gold			2022-12-27	WOS:000295943000080
J	Yanagihara, S; Hessler, NA				Yanagihara, Shin; Hessler, Neal A.			Common Features of Neural Activity during Singing and Sleep Periods in a Basal Ganglia Nucleus Critical for Vocal Learning in a Juvenile Songbird	PLOS ONE			English	Article							ZEBRA FINCH; SOCIAL-CONTEXT; AUDITORY RESPONSES; ANTERIOR FOREBRAIN; BEHAVIORAL STATE; CIRCUIT; SYSTEM; NEURONS; MODULATION; BIRDSONG	Reactivations of waking experiences during sleep have been considered fundamental neural processes for memory consolidation. In songbirds, evidence suggests the importance of sleep-related neuronal activity in song system motor pathway nuclei for both juvenile vocal learning and maintenance of adult song. Like those in singing motor nuclei, neurons in the basal ganglia nucleus Area X, part of the basal ganglia-thalamocortical circuit essential for vocal plasticity, exhibit singing-related activity. It is unclear, however, whether Area X neurons show any distinctive spiking activity during sleep similar to that during singing. Here we demonstrate that, during sleep, Area X pallidal neurons exhibit phasic spiking activity, which shares some firing properties with activity during singing. Shorter interspike intervals that almost exclusively occurred during singing in awake periods were also observed during sleep. The level of firing variability was consistently higher during singing and sleep than during awake non-singing states. Moreover, deceleration of firing rate, which is considered to be an important firing property for transmitting signals from Area X to the thalamic nucleus DLM, was observed mainly during sleep as well as during singing. These results suggest that songbird basal ganglia circuitry may be involved in the off-line processing potentially critical for vocal learning during sensorimotor learning phase.	[Yanagihara, Shin; Hessler, Neal A.] RIKEN Brain Sci Inst, Wako, Saitama, Japan	RIKEN	Yanagihara, S (corresponding author), RIKEN Brain Sci Inst, Wako, Saitama, Japan.	syanagihara@brain.riken.jp	Yanagihara, Shin/G-4998-2015		RIKEN BSI; Sound Technology Promotion Foundation; Japan Society for the Promotion of Science [20700306, 23700396]	RIKEN BSI; Sound Technology Promotion Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was funded by RIKEN BSI and grants to Dr. Yanagihara from The Sound Technology Promotion Foundation and Japan Society for the Promotion of Science (Grant-in-aid-for Young Scientists (B), 20700306, 23700396). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOTTJER SW, 1984, SCIENCE, V224, P901, DOI 10.1126/science.6719123; BOTTJER SW, 1993, J NEUROBIOL, V24, P51, DOI 10.1002/neu.480240105; Brainard MS, 2000, NATURE, V404, P762, DOI 10.1038/35008083; Cardin JA, 2004, J NEUROPHYSIOL, V91, P2148, DOI 10.1152/jn.00918.2003; Cardin JA, 2003, J NEUROPHYSIOL, V90, P2884, DOI 10.1152/jn.00391.2003; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; Dave AS, 1998, SCIENCE, V282, P2250, DOI 10.1126/science.282.5397.2250; Deregnaucourt S, 2005, NATURE, V433, P710, DOI 10.1038/nature03275; Doupe AJ, 2005, TRENDS NEUROSCI, V28, P353, DOI 10.1016/j.tins.2005.05.005; Doupe AJ, 1997, J NEUROSCI, V17, P1147; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Farries MA, 2005, J COMP NEUROL, V484, P93, DOI 10.1002/cne.20464; Farries MA, 2002, J NEUROSCI, V22, P3776; Goldberg JH, 2010, J NEUROSCI, V30, P7088, DOI 10.1523/JNEUROSCI.0168-10.2010; Goldberg JH, 2010, J NEUROPHYSIOL; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Hahnloser RHR, 2006, J NEUROPHYSIOL, V96, P794, DOI 10.1152/jn.01064.2005; Hessler NA, 1999, NAT NEUROSCI, V2, P209, DOI 10.1038/6306; Hessler NA, 1999, J NEUROSCI, V19, P10461; Huang YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003281; Kao MH, 2005, NATURE, V433, P638, DOI 10.1038/nature03127; Kojima S, 2009, J NEUROSCI, V29, P4782, DOI 10.1523/JNEUROSCI.4903-08.2009; Kozhevnikov AA, 2007, J NEUROPHYSIOL, V97, P4271, DOI 10.1152/jn.00952.2006; Leblois A, 2010, J NEUROSCI, V30, P5730, DOI 10.1523/JNEUROSCI.5974-09.2010; Leblois A, 2009, J NEUROSCI, V29, P15420, DOI 10.1523/JNEUROSCI.3060-09.2009; LEWIS JW, 1981, J COMP NEUROL, V196, P347, DOI 10.1002/cne.901960212; Low PS, 2008, P NATL ACAD SCI USA, V105, P9081, DOI 10.1073/pnas.0703452105; Luo MM, 1999, J COMP NEUROL, V403, P68; Margoliash D, 2005, NAT NEUROSCI, V8, P546, DOI 10.1038/nn0505-546; Margoliash D, 2010, BRAIN LANG, V115, P45, DOI 10.1016/j.bandl.2009.09.005; Mooney R, 2009, LEARN MEMORY, V16, P655, DOI 10.1101/lm.1065209; Nick TA, 2005, J NEUROBIOL, V62, P231, DOI 10.1002/neu.20087; Nick TA, 2001, P NATL ACAD SCI USA, V98, P14012, DOI 10.1073/pnas.251525298; O'Neill J, 2010, TRENDS NEUROSCI, V33, P220, DOI 10.1016/j.tins.2010.01.006; Olveczky BP, 2005, PLOS BIOL, V3, P902, DOI 10.1371/journal.pbio.0030153; Person AL, 2007, J NEUROSCI, V27, P8687, DOI 10.1523/JNEUROSCI.2045-07.2007; Person AL, 2005, NEURON, V46, P129, DOI 10.1016/j.neuron.2004.12.057; Prather JF, 2008, NATURE, V451, P305, DOI 10.1038/nature06492; Rauske PL, 2003, J NEUROPHYSIOL, V89, P1688, DOI 10.1152/jn.00655.2002; Roberts TF, 2010, NATURE, V463, P948, DOI 10.1038/nature08759; Sasaki A, 2006, J NEUROSCI, V26, P9010, DOI 10.1523/JNEUROSCI.1335-06.2006; SCHARFF C, 1991, J NEUROSCI, V11, P2896; Schmidt MF, 1998, NAT NEUROSCI, V1, P513, DOI 10.1038/2232; Shank SS, 2009, NATURE, V458, P73, DOI 10.1038/nature07615; SOHRABJI F, 1990, BEHAV NEURAL BIOL, V53, P51, DOI 10.1016/0163-1047(90)90797-A; Solis MM, 1997, J NEUROSCI, V17, P6447; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Yanagihara S, 2006, EUR J NEUROSCI, V24, P3619, DOI 10.1111/j.1460-9568.2006.05228.x; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871	49	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25879	10.1371/journal.pone.0025879	http://dx.doi.org/10.1371/journal.pone.0025879			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991379	Green Published, gold, Green Submitted			2022-12-27	WOS:000295943000090
J	Abel, U; Deichmann, A; Nowrouzi, A; Gabriel, R; Bartholomae, CC; Glimm, H; von Kalle, C; Schmidt, M				Abel, Ulrich; Deichmann, Annette; Nowrouzi, Ali; Gabriel, Richard; Bartholomae, Cynthia C.; Glimm, Hanno; von Kalle, Christof; Schmidt, Manfred			Analyzing the Number of Common Integration Sites of Viral Vectors - New Methods and Computer Programs	PLOS ONE			English	Article							CELL GENE-THERAPY; SEVERE COMBINED IMMUNODEFICIENCY; CHRONIC GRANULOMATOUS-DISEASE; LENTIVIRAL VECTOR; IDENTIFIES GENES; SCID-X1; ACTIVATION; CANCER	Vectors based on gamma-retroviruses or lentiviruses have been shown to stably express therapeutical transgenes and effectively cure different hematological diseases. Molecular follow up of the insertional repertoire of gene corrected cells in patients and preclinical animal models revealed different integration preferences in the host genome including clusters of integrations in small genomic areas (CIS; common integrations sites). In the majority, these CIS were found in or near genes, with the potential to influence the clonal fate of the affected cell. To determine whether the observed degree of clustering is statistically compatible with an assumed standard model of spatial distribution of integrants, we have developed various methods and computer programs for gamma-retroviral and lentiviral integration site distribution. In particular, we have devised and implemented mathematical and statistical approaches for comparing two experimental samples with different numbers of integration sites with respect to the propensity to form CIS as well as for the analysis of coincidences of integration sites obtained from different blood compartments. The programs and statistical tools described here are available as workspaces in R code and allow the fast detection of excessive clustering of integration sites from any retrovirally transduced sample and thus contribute to the assessment of potential treatment-related risks in preclinical and clinical retroviral gene therapy studies.	[Abel, Ulrich] Heidelberg Univ, Dept Med Biometry, Heidelberg, Germany; [Abel, Ulrich; Deichmann, Annette; Nowrouzi, Ali; Gabriel, Richard; Bartholomae, Cynthia C.; Glimm, Hanno; von Kalle, Christof; Schmidt, Manfred] German Canc Res Ctr, Heidelberg, Germany; [Abel, Ulrich; Deichmann, Annette; Nowrouzi, Ali; Gabriel, Richard; Bartholomae, Cynthia C.; Glimm, Hanno; von Kalle, Christof; Schmidt, Manfred] Natl Ctr Tumor Dis NCT, Dept Translat Oncol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Abel, U (corresponding author), Heidelberg Univ, Dept Med Biometry, Heidelberg, Germany.	abel@imbi.uni-heidelberg.de; manfred.schmidt@nct-heidelberg.de			Deutsche Forschungsgemeinschaft DFG [SCHM 2134/1-1, SCHM 2134/1-2, SFB873-A7]; Bundesministerium fur Bildung und Forschung BMBF [01GU0809 (iGene)]; European Commission [LSHB-CT-2004-005242-CONSERT, LSHB-CT-2006-018933-CLINIGENE, HEALTH-F5-2009-222878-PERSIST]; Helmholtz-Alliance (HAIT)	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung BMBF(Federal Ministry of Education & Research (BMBF)); European Commission(European CommissionEuropean Commission Joint Research Centre); Helmholtz-Alliance (HAIT)	This work was supported by the Deutsche Forschungsgemeinschaft DFG (http://www.dfg.de) grant (SCHM 2134/1-1, SCHM 2134/1-2 and SFB873-A7), by the Bundesministerium fur Bildung und Forschung BMBF (www.bmbf.de) grant (01GU0809 (iGene)), by the European Commission's 6th and 7th Framework Programs (http://ec.europa.eu/research) contracts (LSHB-CT-2004-005242-CONSERT, LSHB-CT-2006-018933-CLINIGENE and HEALTH-F5-2009-222878-PERSIST) and by the Helmholtz-Alliance (HAIT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel U, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000570; Aiuti A, 2002, SCIENCE, V296, P2410, DOI 10.1126/science.1070104; BARNARD GA, 1947, BIOMETRIKA, V34, P123, DOI 10.2307/2332517; Bartholomae CC, 2011, MOL THER, V19, P703, DOI 10.1038/mt.2011.19; Boztug K, 2010, NEW ENGL J MED, V363, P1918, DOI 10.1056/NEJMoa1003548; Calmels B, 2005, BLOOD, V106, P2530, DOI 10.1182/blood-2005-03-1115; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; de Ridder J, 2006, PLOS COMPUT BIOL, V2, P1530, DOI 10.1371/journal.pcbi.0020166; Deichmann A, 2007, J CLIN INVEST, V117, P2225, DOI 10.1172/JCI31659; Du Y, 2005, BLOOD, V106, P3932, DOI 10.1182/blood-2005-03-1113; Gabriel R, 2009, NAT MED, V15, P1431, DOI 10.1038/nm.2057; Gaspar HB, 2004, LANCET, V364, P2181, DOI 10.1016/S0140-6736(04)17590-9; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314; Hematti P, 2004, PLOS BIOL, V2, P2183, DOI 10.1371/journal.pbio.0020423; Heuser H., 1980, LEHRBUCH ANAL 1; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; Hsu J., 1996, MULTIPLE COMP THEORY; Kustikova O, 2005, SCIENCE, V308, P1171, DOI 10.1126/science.1105063; Li JL, 2009, J NONPARAMETR STAT, V21, P649, DOI 10.1080/10485250902770035; Li ZX, 2002, SCIENCE, V296, P497, DOI 10.1126/science.1068893; Lund AH, 2002, NAT GENET, V32, P160, DOI 10.1038/ng956; Manfred S, 2007, NAT METHODS, V4, P1051, DOI 10.1038/nmeth1103; Mikkers H, 2002, NAT GENET, V32, P459, DOI 10.1038/ng1102-459b; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; Modlich U, 2005, BLOOD, V105, P4235, DOI 10.1182/blood-2004-11-4535; Montini E, 2006, NAT BIOTECHNOL, V24, P687, DOI 10.1038/nbt1216; Ott MG, 2007, CURR GENE THER, V7, P155, DOI 10.2174/156652307780859044; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Paruzynski A, 2010, NAT PROTOC, V5, P1379, DOI 10.1038/nprot.2010.87; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Schwarzwaelder K, 2007, J CLIN INVEST, V117, P2241, DOI 10.1172/JCI31661; Starr TK, 2009, SCIENCE, V323, P1747, DOI 10.1126/science.1163040; Stein S, 2010, NAT MED, V16, P198, DOI 10.1038/nm.2088; Suzuki T, 2002, NAT GENET, V32, P166, DOI 10.1038/ng949; Wu XL, 2006, VIROLOGY, V344, P292, DOI 10.1016/j.virol.2005.08.047	36	20	20	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e24247	10.1371/journal.pone.0024247	http://dx.doi.org/10.1371/journal.pone.0024247			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022353	Green Submitted, gold, Green Published			2022-12-27	WOS:000295981600001
J	Banerjee, S; Paik, R; Mino, RE; Blauth, K; Fisher, ES; Madden, VJ; Fanning, AS; Bhat, MA				Banerjee, Swati; Paik, Raehum; Mino, Rosa E.; Blauth, Kevin; Fisher, Elizabeth S.; Madden, Victoria J.; Fanning, Alan S.; Bhat, Manzoor A.			A Laminin G-EGF-Laminin G Module in Neurexin IV Is Essential for the Apico-Lateral Localization of Contactin and Organization of Septate Junctions	PLOS ONE			English	Article							BLOOD-NERVE BARRIER; TUBE SIZE CONTROL; DROSOPHILA-VARICOSE; MYELINATED AXONS; EPITHELIAL-CELLS; PROTEIN; DOMAINS; COMPLEX; GLIA; REQUIRES	Septate junctions (SJs) display a unique ultrastructural morphology with ladder-like electron densities that are conserved through evolution. Genetic and molecular analyses have identified a highly conserved core complex of SJ proteins consisting of three cell adhesion molecules Neurexin IV, Contactin, and Neuroglian, which interact with the cytoskeletal FERM domain protein Coracle. How these individual proteins interact to form the septal arrays that create the paracellular barrier is poorly understood. Here, we show that point mutations that map to specific domains of neurexin IV lead to formation of fewer septae and disorganization of SJs. Consistent with these observations, our in vivo domain deletion analyses identified the first Laminin G-EGF-Laminin G module in the extracellular region of Neurexin IV as necessary for the localization of and association with Contactin. Neurexin IV protein that is devoid of its cytoplasmic region is able to create septae, but fails to form a full complement of SJs. These data provide the first in vivo evidence that specific domains in Neurexin IV are required for protein-protein interactions and organization of SJs. Given the molecular conservation of SJ proteins across species, our studies may provide insights into how vertebrate axo-glial SJs are organized in myelinated axons.	[Banerjee, Swati; Paik, Raehum; Mino, Rosa E.; Fisher, Elizabeth S.; Fanning, Alan S.; Bhat, Manzoor A.] Univ N Carolina, Sch Med, Dept Cell & Mol Physiol, Chapel Hill, NC 27515 USA; [Mino, Rosa E.; Blauth, Kevin; Fisher, Elizabeth S.; Bhat, Manzoor A.] Univ N Carolina, Sch Med, Curriculum Neurobiol, Chapel Hill, NC USA; [Madden, Victoria J.] Univ N Carolina, Sch Med, Microscopy Serv Lab, Dept Pathol & Lab Med, Chapel Hill, NC USA; [Bhat, Manzoor A.] Univ N Carolina, Sch Med, UNC Neurosci Ctr, Chapel Hill, NC USA; [Bhat, Manzoor A.] Univ N Carolina, Sch Med, Neurodev Disorders Res Ctr, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Banerjee, S (corresponding author), Univ N Carolina, Sch Med, Dept Cell & Mol Physiol, Chapel Hill, NC 27515 USA.	Manzoor_Bhat@med.unc.edu	, UNC Neuroscience Microscopy Core/AAE-8305-2022; Ariel, Pablo/AGJ-4118-2022; BHAT, MANZOOR/S-9273-2018	BHAT, MANZOOR/0000-0003-0989-1498; Fisher, Elizabeth/0000-0003-3430-2974; Mino, Rosa Eliana/0000-0001-6992-4744	National Institute of Neurological Disorders and Stroke [NS030356]; National Institute of General Medical Sciences [GM63074]; State of North Carolina; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063074] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); State of North Carolina; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was funded by the following: National Institute of Neurological Disorders and Stroke (NS030356); National Institute of General Medical Sciences (GM63074), URL www.nih.gov; funds from the State of North Carolina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AULD VJ, 1995, CELL, V81, P757, DOI 10.1016/0092-8674(95)90537-5; Bachmann A, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-55; Banerjee S, 2006, J NEUROSCI, V26, P3319, DOI 10.1523/JNEUROSCI.5383-05.2006; Banerjee S, 2008, DEV BIOL, V317, P585, DOI 10.1016/j.ydbio.2008.03.007; Banerjee S, 2007, ANNU REV NEUROSCI, V30, P235, DOI 10.1146/annurev.neuro.30.051606.094345; Banerjee S, 2006, CELL BIOCHEM BIOPHYS, V46, P65, DOI 10.1385/CBB:46:1:65; Banerjee S, 2010, J NEUROSCI, V30, P5653, DOI 10.1523/JNEUROSCI.6187-09.2010; Baumgartner S, 1996, CELL, V87, P1059, DOI 10.1016/S0092-8674(00)81800-0; Behr M, 2003, DEV CELL, V5, P611, DOI 10.1016/S1534-5807(03)00275-2; Bellen HJ, 1998, TRENDS NEUROSCI, V21, P444, DOI 10.1016/S0166-2236(98)01267-3; Bhat MA, 2003, CURR OPIN NEUROBIOL, V13, P552, DOI 10.1016/j.conb.2003.09.004; Bhat MA, 2001, NEURON, V30, P369, DOI 10.1016/S0896-6273(01)00294-X; Blauth K, 2010, INT REV CEL MOL BIO, V283, P93, DOI 10.1016/S1937-6448(10)83003-5; Bonnon C, 2003, J BIOL CHEM, V278, P48339, DOI 10.1074/jbc.M309120200; Bonnon C, 2007, MOL BIOL CELL, V18, P229, DOI 10.1091/mbc.E06-06-0570; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bulgakova NA, 2008, J CELL SCI, V121, P2018, DOI 10.1242/jcs.031088; Denisenko-Nehrbass N, 2003, EUR J NEUROSCI, V17, P411, DOI 10.1046/j.1460-9568.2003.02441.x; DEUTZMANN R, 1988, EUR J BIOCHEM, V177, P35, DOI 10.1111/j.1432-1033.1988.tb14342.x; Faivre-Sarrailh C, 2004, DEVELOPMENT, V131, P4931, DOI 10.1242/dev.01372; Genova JL, 2003, J CELL BIOL, V161, P979, DOI 10.1083/jcb.200212054; Gollan L, 2002, J CELL BIOL, V157, P1247, DOI 10.1083/jcb.200203050; Hijazi A, 2009, DEVELOPMENT, V136, P2199, DOI 10.1242/dev.033845; Hortsch M, 2003, TRENDS CELL BIOL, V13, P557, DOI 10.1016/j.tcb.2003.09.004; Hough CD, 1997, GENE DEV, V11, P3242, DOI 10.1101/gad.11.23.3242; LaJeunesse DR, 1998, J CELL BIOL, V141, P1589, DOI 10.1083/jcb.141.7.1589; Lamb RS, 1998, MOL BIOL CELL, V9, P3505, DOI 10.1091/mbc.9.12.3505; Lecuit T, 2002, TRAFFIC, V3, P92, DOI 10.1034/j.1600-0854.2002.030202.x; Llimargas M, 2004, DEVELOPMENT, V131, P181, DOI 10.1242/dev.00917; Nelson KS, 2010, GENETICS, V185, P831, DOI 10.1534/genetics.110.114959; Nilton A, 2010, DEVELOPMENT, V137, P2427, DOI 10.1242/dev.052605; Pillai AM, 2007, J NEUROSCI RES, V85, P2318, DOI 10.1002/jnr.21374; Pillai AM, 2009, J NEUROSCI RES, V87, P1773, DOI 10.1002/jnr.22015; REBAY I, 1993, CELL, V74, P319, DOI 10.1016/0092-8674(93)90423-N; ROTHBERG JM, 1992, J MOL BIOL, V227, P367, DOI 10.1016/0022-2836(92)90891-M; Sanson B, 1996, NATURE, V383, P627, DOI 10.1038/383627a0; TEPASS U, 1994, DEV BIOL, V161, P563, DOI 10.1006/dbio.1994.1054; Thaxton C, 2010, J NEUROSCI, V30, P4868, DOI 10.1523/JNEUROSCI.5951-09.2010; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; Ward RE, 1998, J CELL BIOL, V140, P1463, DOI 10.1083/jcb.140.6.1463; Woods DF, 1996, J CELL BIOL, V134, P1469, DOI 10.1083/jcb.134.6.1469; WOODS DF, 1993, MECH DEVELOP, V44, P85, DOI 10.1016/0925-4773(93)90059-7; Wu VM, 2007, DEVELOPMENT, V134, P999, DOI 10.1242/dev.02785; Wu VM, 2004, J CELL BIOL, V164, P313, DOI 10.1083/jcb.200309134	44	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e25926	10.1371/journal.pone.0025926	http://dx.doi.org/10.1371/journal.pone.0025926			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022470	Green Published, Green Submitted, gold			2022-12-27	WOS:000295981600020
J	Herges, K; Millward, JM; Hentschel, N; Infante-Duarte, C; Aktas, O; Zipp, F				Herges, Katja; Millward, Jason M.; Hentschel, Nicole; Infante-Duarte, Carmen; Aktas, Orhan; Zipp, Frauke			Neuroprotective Effect of Combination Therapy of Glatiramer Acetate and Epigallocatechin-3-Gallate in Neuroinflammation	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; AXONAL GROWTH; IN-VITRO; CELLS; DEMYELINATION; BRAIN; DEATH; MICE	Multiple sclerosis (MS) is an inflammatory autoimmune disease of the central nervous system. However, studies of MS and the animal model, experimental autoimmune encephalomyelitis (EAE), indicate that neuronal pathology is the principle cause of clinical disability. Thus, there is need to develop new therapeutic strategies that not only address immunomodulation but also neuroprotection. Here we show that the combination therapy of Glatiramer acetate (GA), an immunomodulatory MS therapeutic, and the neuroprotectant epigallocatechin-3-gallate (EGCG), the main phenol in green tea, have synergistic protective effects in vitro and in the EAE model. EGCG and GA together led to increased protection from glutamate- and TRAIL-induced neuronal cell death in vitro. EGCG combined with GA induced regeneration of hippocampal axons in an outgrowth assay. The combined application of EGCG and GA did not result in unexpected adverse events in vivo. Neuroprotective and neuroregenerative effects could be translated in the in vivo model, where combination treatment with EGCG and GA significantly delayed disease onset, strongly reduced clinical severity, even after onset of symptoms and reduced inflammatory infiltrates. These results illustrate the promise of combining neuroprotective and anti-inflammatory treatments and strengthen the prospects of EGCG as an adjunct therapy for neuroinflammatory and neurodegenerative diseases.	[Herges, Katja; Zipp, Frauke] Univ Med Mainz, Dept Neurol, Mainz, Germany; [Herges, Katja] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Herges, Katja; Millward, Jason M.; Hentschel, Nicole; Infante-Duarte, Carmen] Charite, Expt & Clin Res Ctr, Berlin, Germany; [Aktas, Orhan] Univ Dusseldorf, Dept Neurol, D-4000 Dusseldorf, Germany	Johannes Gutenberg University of Mainz; Stanford University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Heinrich Heine University Dusseldorf	Herges, K (corresponding author), Univ Med Mainz, Dept Neurol, Mainz, Germany.	frauke.zipp@unimedizin-mainz.de	Aktas, Orhan/B-7623-2009; Zipp, Frauke/C-9968-2015	Aktas, Orhan/0000-0002-2020-9210; Zipp, Frauke/0000-0002-1231-1928; Infante Duarte, Carmen/0000-0003-3005-351X; Millward, Jason/0000-0003-4484-2798	Deutsche Forschungsgemeinschaft (DFG) [SFB-TRR 43]; Will Foundation; DAAD	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Will Foundation; DAAD(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) with SFB-TRR 43 to F.Z. and by the Will Foundation. K.H. received a fellowship from the German academic exchange program (DAAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni R, 2005, P NATL ACAD SCI USA, V102, P19045, DOI 10.1073/pnas.0509438102; Aharoni R, 2005, J NEUROSCI, V25, P8217, DOI 10.1523/JNEUROSCI.1859-05.2005; Aharoni R, 2000, P NATL ACAD SCI USA, V97, P11472, DOI 10.1073/pnas.97.21.11472; Aharoni R, 2008, P NATL ACAD SCI USA, V105, P11358, DOI 10.1073/pnas.0804632105; Aktas O, 2004, J IMMUNOL, V173, P5794, DOI 10.4049/jimmunol.173.9.5794; Aktas O, 2005, NEURON, V46, P421, DOI 10.1016/j.neuron.2005.03.018; Aktas O, 2007, FRONT BIOSCI-LANDMRK, V12, P2912, DOI 10.2741/2281; Aktas O, 2006, NEUROSCIENTIST, V12, P305, DOI 10.1177/1073858405285208; Bjartmar C, 2000, ANN NEUROL, V48, P893, DOI 10.1002/1531-8249(200012)48:6<893::AID-ANA10>3.3.CO;2-2; Bjartmar C, 2003, J NEUROL SCI, V206, P165, DOI 10.1016/S0022-510X(02)00069-2; Chu KO, 2007, HUM REPROD, V22, P280, DOI 10.1093/humrep/del353; Costello F, 2007, CURR OPIN NEUROL, V20, P281, DOI 10.1097/WCO.0b013e328122de1b; DelRio JA, 1997, NATURE, V385, P70, DOI 10.1038/385070a0; Fleming KK, 2005, J NEUROIMMUNOL, V170, P71, DOI 10.1016/j.jneuroim.2005.08.020; Hechler D, 2006, BRAIN RES REV, V52, P160, DOI 10.1016/j.brainresrev.2006.01.005; Holtje M, 2009, FASEB J, V23, P1115, DOI 10.1096/fj.08-116855; Kang KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011951; Karnezis T, 2004, NAT NEUROSCI, V7, P736, DOI 10.1038/nn1261; Kornek B, 2000, AM J PATHOL, V157, P267, DOI 10.1016/S0002-9440(10)64537-3; Liu J, 2007, EUR J IMMUNOL, V37, P3143, DOI 10.1002/eji.200737398; Lykissas MG, 2007, CURR NEUROVASC RES, V4, P143, DOI 10.2174/156720207780637216; Mandel SA, 2005, NEUROSIGNALS, V14, P46, DOI 10.1159/000085385; Pitt D, 2000, NAT MED, V6, P67, DOI 10.1038/71555; Schmitt KRL, 2007, NEUROSCI RES, V59, P68, DOI 10.1016/j.neures.2007.05.011; Schmitt KR, 2009, BRAIN PATHOL; Schori H, 2001, P NATL ACAD SCI USA, V98, P3398, DOI 10.1073/pnas.041609498; Schroeder EK, 2008, ANTIOXID REDOX SIGNA; Siffrin V, 2007, ADV IMMUNOL, V96, P1, DOI 10.1016/S0065-2776(07)96001-0; Siffrin V, 2010, TRENDS NEUROSCI, V33, P202, DOI 10.1016/j.tins.2010.01.002; Steup A, 2000, MOL CELL NEUROSCI, V15, P141, DOI 10.1006/mcne.1999.0818; Stuve O, 2006, J CLIN INVEST, V116, P1037, DOI 10.1172/JCI25805; Vogt J, 2009, ANN NEUROL, V66, P310, DOI 10.1002/ana.21719; Wang CH, 2006, J NEUROCHEM, V98, P1817, DOI 10.1111/j.1471-4159.2006.04081.x; Weber MS, 2007, NAT MED, V13, P935, DOI 10.1038/nm1620; Werner P, 2000, ADV RES NEURODEGENER, V8, P375; Youdim KA, 2003, J NEUROCHEM, V85, P180, DOI 10.1046/j.1471-4159.2003.01652.x; Zipp F, 2006, TRENDS NEUROSCI, V29, P518, DOI 10.1016/j.tins.2006.07.006	37	60	63	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e25456	10.1371/journal.pone.0025456	http://dx.doi.org/10.1371/journal.pone.0025456			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022398	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000295978600015
J	Echeverria, PC; Bernthaler, A; Dupuis, P; Mayer, B; Picard, D				Echeverria, Pablo C.; Bernthaler, Andreas; Dupuis, Pierre; Mayer, Bernd; Picard, Didier			An Interaction Network Predicted from Public Data as a Discovery Tool: Application to the Hsp90 Molecular Chaperone Machine	PLOS ONE			English	Article							PROTEIN-INTERACTION NETWORKS; BIOLOGICAL NETWORKS; NUCLEAR IMPORT; GENE ONTOLOGY; COMPLEX; UPDATE; CANCER; CYTOSCAPE; SNAPSHOT; RECEPTOR	Understanding the functions of proteins requires information about their protein-protein interactions (PPI). The collective effort of the scientific community generates far more data on any given protein than individual experimental approaches. The latter are often too limited to reveal an interactome comprehensively. We developed a workflow for parallel mining of all major PPI databases, containing data from several model organisms, and to integrate data from the literature for a protein of interest. We applied this novel approach to build the PPI network of the human Hsp90 molecular chaperone machine (Hsp90Int) for which previous efforts have yielded limited and poorly overlapping sets of interactors. We demonstrate the power of the Hsp90Int database as a discovery tool by validating the prediction that the Hsp90 cochaperone Aha1 is involved in nucleocytoplasmic transport. Thus, we both describe how to build a custom database and introduce a powerful new resource for the scientific community.	[Echeverria, Pablo C.; Dupuis, Pierre; Picard, Didier] Univ Geneva, Dept Biol Cellulaire, Geneva, Switzerland; [Bernthaler, Andreas; Mayer, Bernd] Emergentec Biodev GmbH, Vienna, Austria	University of Geneva; Emergentec Biodevelopment GmbH	Echeverria, PC (corresponding author), Univ Geneva, Dept Biol Cellulaire, Geneva, Switzerland.	didier.picard@unige.ch	Echeverria, Pablo Christian/A-9098-2010	Echeverria, Pablo Christian/0000-0003-1367-9692	Canton de Geneve; Swiss National Science Foundation	Canton de Geneve; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Canton de Geneve and the Swiss National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanese V, 2006, CELL, V124, P75, DOI 10.1016/j.cell.2005.11.039; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Caldas-Lopes E, 2009, P NATL ACAD SCI USA, V106, P8368, DOI 10.1073/pnas.0903392106; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; De Las Rivas J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000807; DeZwaan DC, 2010, TRENDS BIOCHEM SCI, V35, P384, DOI 10.1016/j.tibs.2010.02.005; Echeverria PC, 2010, BBA-MOL CELL RES, V1803, P641, DOI 10.1016/j.bbamcr.2009.11.012; Echeverria PC, 2009, MOL CELL BIOL, V29, P4788, DOI 10.1128/MCB.00649-09; Endo T, 2010, BBA-MOL CELL RES, V1803, P706, DOI 10.1016/j.bbamcr.2009.11.007; Falsone SF, 2007, PROTEOMICS, V7, P2375, DOI 10.1002/pmic.200600996; Falsone SF, 2005, FEBS LETT, V579, P6350, DOI 10.1016/j.febslet.2005.10.020; Freedman ND, 2004, MOL BIOL CELL, V15, P2276, DOI 10.1091/mbc.E03-11-0839; Galigniana MD, 2010, NUCLEUS-PHILA, V1, P299, DOI 10.4161/nucl.1.4.11743; Gano JJ, 2010, MOL CELL PROTEOMICS, V9, P255, DOI 10.1074/mcp.M900261-MCP200; Gong YC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.26; Grad I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015770; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hartson SD, 2011, BIOCH BIOPH IN PRESS; He F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-519; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jain E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136; Kim YS, 2009, CURR TOP MED CHEM, V9, P1479, DOI 10.2174/156802609789895728; Kovacs-Bogdan E, 2010, BBA-MOL CELL RES, V1803, P740, DOI 10.1016/j.bbamcr.2010.01.015; Lehne Benjamin, 2009, Human Genomics, V3, P291; Martin A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-91; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; McClellan AJ, 2007, CELL, V131, P121, DOI 10.1016/j.cell.2007.07.036; Millson SH, 2005, EUKARYOT CELL, V4, P849, DOI 10.1128/EC.4.5.849-860.2005; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Nathan DF, 1997, P NATL ACAD SCI USA, V94, P12949, DOI 10.1073/pnas.94.24.12949; Neckers L, 2009, TRENDS BIOCHEM SCI, V34, P223, DOI 10.1016/j.tibs.2009.01.006; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Palotai R, 2008, IUBMB LIFE, V60, P10, DOI 10.1002/iub.8; Pavithra SR, 2007, PLOS COMPUT BIOL, V3, P1701, DOI 10.1371/journal.pcbi.0030168; Platzer A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-224; Porter JR, 2010, CURR OPIN CHEM BIOL, V14, P412, DOI 10.1016/j.cbpa.2010.03.019; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Seebacher J, 2011, CELL, V144, P1000, DOI 10.1016/j.cell.2011.02.025; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shin CJ, 2009, PROTEOMICS, V9, P5256, DOI 10.1002/pmic.200900262; Skarra DV, 2011, PROTEOMICS, V11, P1508, DOI 10.1002/pmic.201000770; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Te JN, 2007, J PROTEOME RES, V6, P1963, DOI 10.1021/pr060595i; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Tsan MF, 2009, J LEUKOCYTE BIOL, V85, P905, DOI 10.1189/jlb.0109005; Tsaytler PA, 2009, CELL STRESS CHAPERON, V14, P629, DOI 10.1007/s12192-009-0115-z; Walhout AJM, 2001, NAT REV MOL CELL BIO, V2, P55, DOI 10.1038/35048107; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Wang TY, 2011, MOL BIOSYST, V7, P2278, DOI 10.1039/c1mb05028a; Wang X, 2010, CANCER INVEST, V28, P635, DOI 10.3109/07357901003630983; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Zanzoni A, 2002, FEBS LETT, V513, P135, DOI 10.1016/S0014-5793(01)03293-8; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024; Zhu XW, 2007, GENE DEV, V21, P1010, DOI 10.1101/gad.1528707	62	152	158	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e26044	10.1371/journal.pone.0026044	http://dx.doi.org/10.1371/journal.pone.0026044			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022502	Green Submitted, Green Published, gold			2022-12-27	WOS:000295973200027
J	Shabrova, EV; Tarnopolsky, O; Singh, AP; Plutzky, J; Vorsa, N; Quadro, L				Shabrova, Elena V.; Tarnopolsky, Olga; Singh, Ajay P.; Plutzky, Jorge; Vorsa, Nicholi; Quadro, Loredana			Insights into the Molecular Mechanisms of the Anti-Atherogenic Actions of Flavonoids in Normal and Obese Mice	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; HIGH-FAT DIET; SKELETAL-MUSCLE CELLS; INSULIN-RESISTANCE; ACID OXIDATION; PLASMA ADIPONECTIN; GENE-EXPRESSION; RECEPTOR-ALPHA; POTENTIAL ROLE; PPAR-ALPHA	Obesity is a major and independent risk factor for cardiovascular disease and it is strongly associated with the development of dyslipidemia, insulin resistance and type 2 diabetes. Flavonoids, a diverse group of polyphenol compounds of plant origin widely distributed in human diet, have been reported to have numerous health benefits, although the mechanisms underlying these effects have remained obscure. We analyzed the effects of chronic dietary supplementation with flavonoids extracted from cranberry (FLS) in normal and obese C57/BL6 mice compared to mice maintained on the same diets lacking FLS. Obese mice supplemented with flavonoids showed an amelioration of insulin resistance and plasma lipid profile, and a reduction of visceral fat mass. We provide evidence that the adiponectin-AMPK pathway is the main mediator of the improvement of these metabolic disorders. In contrast, the reduced plasma atherogenic cholesterol observed in normal mice under FLS seems to be due to a downregulation of the hepatic cholesterol synthesis pathway. Overall, we demonstrate for the first time that the molecular mechanisms underlying the beneficial effects of flavonoids are determined by the metabolic state.	[Shabrova, Elena V.; Tarnopolsky, Olga; Singh, Ajay P.; Vorsa, Nicholi] Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08903 USA; [Plutzky, Jorge] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Cambridge, MA USA; [Plutzky, Jorge] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Vorsa, Nicholi] Rutgers State Univ, PE Marucci Ctr, Chatsworth, NJ USA; [Shabrova, Elena V.; Quadro, Loredana] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08903 USA; [Shabrova, Elena V.; Quadro, Loredana] Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick; Harvard University; Brigham & Women's Hospital; Harvard University; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Shabrova, EV (corresponding author), Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08903 USA.	vorsa@aesop.rutgers.edu; quadro@aesop.rutgers.edu	Plutzky, Jorge/V-3410-2019		PE Marucci Center for Blueberry and Cranberry Research; Extension Program Enhancement Grants (BCPEG) Program; USDA [2009-34155-19957]	PE Marucci Center for Blueberry and Cranberry Research; Extension Program Enhancement Grants (BCPEG) Program; USDA(United States Department of Agriculture (USDA))	This work was supported by a grant from the PE Marucci Center for Blueberry and Cranberry Research and Extension Program Enhancement Grants (BCPEG) Program to LQ, and by the National Research Initiative Grant no. 2009-34155-19957 from the USDA Cooperative State Research, Education, and Extension Service to NV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin-Perez R, 2010, FASEB J, V24, P627, DOI 10.1096/fj.09-142281; Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Argaud D, 1996, DIABETES, V45, P1563, DOI 10.2337/diabetes.45.11.1563; Barger PM, 2001, J BIOL CHEM, V276, P44495, DOI 10.1074/jbc.M105945200; Barnea M, 2006, OBESITY, V14, P2145, DOI 10.1038/oby.2006.251; Barnes S, 2005, CURR OPIN PLANT BIOL, V8, P324, DOI 10.1016/j.pbi.2005.03.010; Bhagwat SA, 2006, USDA DATABASE FLAVON; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; Briskin DP, 2000, PLANT PHYSIOL, V124, P507, DOI 10.1104/pp.124.2.507; Bursill CA, 2007, ATHEROSCLEROSIS, V193, P86, DOI 10.1016/j.atherosclerosis.2006.08.033; Chan DC, 2009, J CLIN ENDOCR METAB, V94, P989, DOI 10.1210/jc.2008-1457; Civitarese AE, 2006, CELL METAB, V4, P75, DOI 10.1016/j.cmet.2006.05.002; CLARKE PR, 1990, EMBO J, V9, P2439, DOI 10.1002/j.1460-2075.1990.tb07420.x; Council N, 1996, GUID CAR US LAB AN; Decorde K, 2009, MOL NUTR FOOD RES, V53, P659, DOI 10.1002/mnfr.200800165; Despres Jean-Pierre, 2007, Crit Pathw Cardiol, V6, P51, DOI 10.1097/HPC.0b013e318057d4c9; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; FOLCH J, 1957, J BIOL CHEM, V226, P497; Frizzell N, 2009, J BIOL CHEM, V284, P25772, DOI 10.1074/jbc.M109.019257; Getz GS, 2006, ARTERIOSCL THROM VAS, V26, P242, DOI 10.1161/01.ATV.0000201071.49029.17; Gimeno RE, 2007, CURR OPIN LIPIDOL, V18, P271, DOI 10.1097/MOL.0b013e3281338558; Guerre-Millo M, 2008, DIABETES METAB, V34, P12, DOI 10.1016/j.diabet.2007.08.002; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hayashida K, 2004, AM J PHYSIOL-REG I, V286, pR359, DOI 10.1152/ajpregu.00214.2003; Holloway GP, 2008, AM J PHYSIOL-ENDOC M, V294, pE1060, DOI 10.1152/ajpendo.00726.2007; Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jayaprakasam B, 2006, J AGR FOOD CHEM, V54, P243, DOI 10.1021/jf0520342; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kliewer SA, 2001, RECENT PROG HORM RES, V56, P239, DOI 10.1210/rp.56.1.239; Knekt P, 2002, AM J CLIN NUTR, V76, P560, DOI 10.1093/ajcn/76.3.560; Kobayashi H, 2004, CIRC RES, V94, pE27, DOI 10.1161/01.RES.0000119921.86460.37; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lara-Castro C, 2006, DIABETES, V55, P249, DOI 10.2337/diabetes.55.1.249; Lee WJ, 2006, BIOCHEM BIOPH RES CO, V340, P291, DOI 10.1016/j.bbrc.2005.12.011; Liburt NR, 2009, COMP EXERC PHYSIOL, V6, P157, DOI 10.1017/S175525401000005X; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin S, 2000, INT J OBESITY, V24, P639, DOI 10.1038/sj.ijo.0801209; Liu RH, 2003, AM J CLIN NUTR, V78, p517S, DOI 10.1093/ajcn/78.3.517S; Masella R, 2005, J NUTR BIOCHEM, V16, P577, DOI 10.1016/j.jnutbio.2005.05.013; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; Miyoshi H, 2006, J BIOL CHEM, V281, P15837, DOI 10.1074/jbc.M601097200; Moskaug JO, 2005, AM J CLIN NUTR, V81, p277S, DOI 10.1093/ajcn/81.1.277S; Naderali EK, 2003, CLIN SCI, V105, P403, DOI 10.1042/CS20030094; Nagai R, 2007, J BIOL CHEM, V282, P34219, DOI 10.1074/jbc.M703551200; Nagasako-Akazome Yoko, 2007, J Oleo Sci, V56, P417; Ng TWK, 2005, DIABETES, V54, P795, DOI 10.2337/diabetes.54.3.795; Ortiz B, 2009, J LIPID RES, V50, P2278, DOI 10.1194/jlr.M900054-JLR200; Pajvani UB, 2003, J BIOL CHEM, V278, P9073, DOI 10.1074/jbc.M207198200; Pajvani UB, 2004, J BIOL CHEM, V279, P12152, DOI 10.1074/jbc.M311113200; Palanivel R, 2005, FEBS LETT, V579, P5049, DOI 10.1016/j.febslet.2005.08.011; Pappas E, 2009, CRIT REV FOOD SCI, V49, P741, DOI 10.1080/10408390802145377; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Pietta PG, 2000, J NAT PROD, V63, P1035, DOI 10.1021/np9904509; Qi C, 2000, CELL BIOCHEM BIOPHYS, V32, P187, DOI 10.1385/CBB:32:1-3:187; Qiao LP, 2008, DIABETES, V57, P1824, DOI 10.2337/db07-0435; Rader DJ, 2003, AM J CARDIOL, V92, p42J, DOI 10.1016/S0002-9149(03)00615-5; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Rao TP, 2005, J MED FOOD, V8, P362, DOI 10.1089/jmf.2005.8.362; Rasmussen SE, 2005, MOL NUTR FOOD RES, V49, P159, DOI 10.1002/mnfr.200400082; Reimer MK, 2002, DIABETES, V51, pS138, DOI 10.2337/diabetes.51.2007.S138; Ruel G, 2006, BRIT J NUTR, V96, P357, DOI 10.1079/BJN20061814; Schraw T, 2008, ENDOCRINOLOGY, V149, P2270, DOI 10.1210/en.2007-1561; Shockley KR, 2009, PHYSIOL GENOMICS, V39, P172, DOI 10.1152/physiolgenomics.90350.2008; SPADY DK, 1983, J LIPID RES, V24, P303; Terra X, 2009, J NUTR BIOCHEM, V20, P210, DOI 10.1016/j.jnutbio.2008.02.005; Torra IP, 2002, MOL ENDOCRINOL, V16, P1013; Tran TT, 2008, CELL METAB, V7, P410, DOI 10.1016/j.cmet.2008.04.004; Trayhurn P, 2001, P NUTR SOC, V60, P329, DOI 10.1079/PNS200194; Unger RH, 2000, REGUL PEPTIDES, V92, P87, DOI 10.1016/S0167-0115(00)00154-3; Vance DE, 2002, BIOCH LIPIDS LIPOPRO; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Verges B, 2006, ARTERIOSCL THROM VAS, V26, P1364, DOI 10.1161/01.ATV.0000219611.50066.bd; Wang CY, 2004, J CLIN ENDOCR METAB, V89, P4762, DOI 10.1210/jc.2004-0820; Wang H, 2009, AM J PHYSIOL-ENDOC M, V297, pE271, DOI 10.1152/ajpendo.90920.2008; Wang Y, 2002, J BIOL CHEM, V277, P19521, DOI 10.1074/jbc.M200601200; Wang Y, 2008, BIOCHEM J, V409, P623, DOI 10.1042/BJ20071492; Whitehead JP, 2006, DIABETES OBES METAB, V8, P264, DOI 10.1111/j.1463-1326.2005.00510.x; Williams RJ, 2004, FREE RADICAL BIO MED, V36, P838, DOI 10.1016/j.freeradbiomed.2004.01.001; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Xu AM, 2009, ENDOCRINOLOGY, V150, P625, DOI 10.1210/en.2008-0999; Yamamoto Y, 2006, BIOSCI BIOTECH BIOCH, V70, P933, DOI 10.1271/bbb.70.933; Yang DJ, 2010, J AGR FOOD CHEM, V58, P2020, DOI 10.1021/jf903355q; Yang J, 2001, P NATL ACAD SCI USA, V98, P13607, DOI 10.1073/pnas.201524598; Yoon MJ, 2006, DIABETES, V55, P2562, DOI 10.2337/db05-1322	86	41	43	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e24634	10.1371/journal.pone.0024634	http://dx.doi.org/10.1371/journal.pone.0024634			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016761	Green Submitted, Green Published, gold			2022-12-27	WOS:000295971700002
J	Brand, MT; Carter, MQ; Parker, CT; Chapman, MR; Huynh, S; Zhou, YG				Brand, Maria T.; Carter, Michelle Q.; Parker, Craig T.; Chapman, Matthew R.; Huynh, Steven; Zhou, Yaguang			Salmonella Biofilm Formation on Aspergillus niger Involves Cellulose - Chitin Interactions	PLOS ONE			English	Article							ENTERICA SEROVAR THOMPSON; ESCHERICHIA-COLI K-12; CURLI FIBERS; TYPHIMURIUM; EXPRESSION; FAMILY; BIOSYNTHESIS; COLONIZATION; ENDOBACTERIA; ATTACHMENT	Salmonella cycles between host and nonhost environments, where it can become an active member of complex microbial communities. The role of fungi in the environmental adaptation of enteric pathogens remains relatively unexplored. We have discovered that S. enterica Typhimurium rapidly attaches to and forms biofilms on the hyphae of the common fungus, Aspergillus niger. Several Salmonella enterica serovars displayed a similar interaction, whereas other bacterial species were unable to bind to the fungus. Bacterial attachment to chitin, a major constituent of fungal cell walls, mirrored this specificity. Pre-incubation of S. Typhimurium with N-acetylglucosamine, the monomeric component of chitin, reduced binding to chitin beads by as much as 727-fold and inhibited attachment to A. niger hyphae considerably. A cellulose-deficient mutant of S. Typhimurium failed to attach to chitin beads and to the fungus. Complementation of this mutant with the cellulose operon restored binding to chitin beads to 79% of that of the parental strain and allowed for attachment and biofilm formation on A. niger, indicating that cellulose is involved in bacterial attachment to the fungus via the chitin component of its cell wall. In contrast to cellulose, S. Typhimurium curli fimbriae were not required for attachment and biofilm development on the hyphae but were critical for its stability. Our results suggest that cellulose-chitin interactions are required for the production of mixed Salmonella-A. niger biofilms, and support the hypothesis that encounters with chitinaceous alternate hosts may contribute to the ecological success of human pathogens.	[Brand, Maria T.; Carter, Michelle Q.; Parker, Craig T.; Huynh, Steven; Zhou, Yaguang] ARS, Produce Safety & Microbiol Res Unit, USDA, Albany, CA USA; [Chapman, Matthew R.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	United States Department of Agriculture (USDA); University of Michigan System; University of Michigan	Brand, MT (corresponding author), ARS, Produce Safety & Microbiol Res Unit, USDA, Albany, CA USA.	maria.brandl@ars.usda.gov		Chapman, Matthew/0000-0002-2645-1294; Parker, Craig/0000-0002-7719-8882; Carter, Michelle Qiu/0000-0002-0710-7420	USDA National Research Initiative [2002-51110-01986]; USDA Agricultural Research Service [5325-42000-044-00D, 5325-42000-045-00D]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073847] Funding Source: NIH RePORTER	USDA National Research Initiative(United States Department of Agriculture (USDA)); USDA Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by USDA National Research Initiative Competitive Grant no. 2002-51110-01986 and by USDA Agricultural Research Service CRIS projects 5325-42000-044-00D and 5325-42000-045-00D. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREA DH, 2003, MOL MICROBIOL, V48, P1357; Artursson V, 2006, ENVIRON MICROBIOL, V8, P1, DOI 10.1111/j.1462-2920.2005.00942.x; Barak JD, 2007, MOL PLANT MICROBE IN, V20, P1083, DOI 10.1094/MPMI-20-9-1083; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Bertaux J, 2005, ENVIRON MICROBIOL, V7, P1786, DOI 10.1111/j.1462-2920.2005.00867.x; Bianciotto V, 2004, APPL ENVIRON MICROB, V70, P3600, DOI 10.1128/aem.70.6.3600-3608.2004; Brandl MT, 2005, APPL ENVIRON MICROB, V71, P2653, DOI 10.1128/AEM.71.5.2653-2662.2005; Brandl MT, 2002, APPL ENVIRON MICROB, V68, P3614, DOI 10.1128/AEM.68.7.3614-3621.2002; Brown PK, 2001, MOL MICROBIOL, V41, P349, DOI 10.1046/j.1365-2958.2001.02529.x; Campbell JV, 2001, J INFECT DIS, V183, P984, DOI 10.1086/319254; CHAUDHURI S, 2010, APPL ENV MICROBIOL; Coynault C, 1996, MOL MICROBIOL, V22, P149, DOI 10.1111/j.1365-2958.1996.tb02664.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DebRoy S, 2006, P NATL ACAD SCI USA, V103, P19146, DOI 10.1073/pnas.0608279103; Frases S, 2006, APPL ENVIRON MICROB, V72, P1542, DOI 10.1128/AEM.72.2.1542-1550.2006; Frey-Klett P, 2007, NEW PHYTOL, V176, P22, DOI 10.1111/j.1469-8137.2007.02191.x; Garcia B, 2004, MOL MICROBIOL, V54, P264, DOI 10.1111/j.1365-2958.2004.04269.x; Gerstel U, 2003, RES MICROBIOL, V154, P659, DOI 10.1016/j.resmic.2003.08.005; Hammar M, 1995, MOL MICROBIOL, V18, P661, DOI 10.1111/j.1365-2958.1995.mmi_18040661.x; Hogan DA, 2002, SCIENCE, V296, P2229, DOI 10.1126/science.1070784; Humphries AD, 2003, MOL MICROBIOL, V48, P1357, DOI 10.1046/j.1365-2958.2003.03507.x; Inami GB, 1999, J FOOD PROTECT, V62, P662, DOI 10.4315/0362-028X-62.6.662; Jarvik T, 2010, J BACTERIOL, V192, P560, DOI 10.1128/JB.01233-09; Kikuchi T, 2005, MICROBIOL IMMUNOL, V49, P875, DOI 10.1111/j.1348-0421.2005.tb03678.x; Kirn TJ, 2005, NATURE, V438, P863, DOI 10.1038/nature04249; Kobayashi D. Y, 2005, FUNGAL COMMUNITY ITS, P399; Kobayashi DY, 2005, APPL ENVIRON MICROB, V71, P261, DOI 10.1128/AEM.71.1.261-269.2005; Kondo T, 2004, CELLULOSE, V11, P463, DOI 10.1023/B:CELL.0000046413.91309.55; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Leveau JHJ, 2010, ENVIRON MICROBIOL, V12, P281, DOI 10.1111/j.1462-2920.2009.02010.x; Maeyama R, 2004, J BIOMED MATER RES A, V70A, P274, DOI 10.1002/jbm.a.30077; MATTHYSSE AG, 1983, J BACTERIOL, V154, P906, DOI 10.1128/JB.154.2.906-915.1983; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Meibom KL, 2004, P NATL ACAD SCI USA, V101, P2524, DOI 10.1073/pnas.0308707101; MONREAL J, 1969, CAN J MICROBIOL, V15, P689, DOI 10.1139/m69-122; Monteiro C, 2009, ENVIRON MICROBIOL, V11, P1105, DOI 10.1111/j.1462-2920.2008.01840.x; PEL R, 1990, J GEN MICROBIOL, V136, P695, DOI 10.1099/00221287-136-4-695; Prigent-Combaret C, 2000, ENVIRON MICROBIOL, V2, P450, DOI 10.1046/j.1462-2920.2000.00128.x; Pruzzo C, 2008, ENVIRON MICROBIOL, V10, P1400, DOI 10.1111/j.1462-2920.2007.01559.x; Romling U, 1998, J BACTERIOL, V180, P722; Romling U, 2000, MOL MICROBIOL, V36, P10, DOI 10.1046/j.1365-2958.2000.01822.x; Romling U, 2005, CELL MOL LIFE SCI, V62, P1234, DOI 10.1007/s00018-005-4557-x; Romling U, 2002, RES MICROBIOL, V153, P205, DOI 10.1016/S0923-2508(02)01316-5; ROSS P, 1991, MICROBIOL REV, V55, P35, DOI 10.1128/MMBR.55.1.35-58.1991; SANDHU GS, 1995, J CLIN MICROBIOL, V33, P2913, DOI 10.1128/JCM.33.11.2913-2919.1995; SHAUN MB, 2006, BIOESSAYS, V28, P799, DOI DOI 10.1002/BIES.20441; SMIT G, 1987, J BACTERIOL, V169, P4294, DOI 10.1128/jb.169.9.4294-4301.1987; Tarsi R, 1999, APPL ENVIRON MICROB, V65, P1348; Uesugi AR, 2007, J FOOD PROTECT, V70, P1784, DOI 10.4315/0362-028X-70.8.1784; Wang X, 2008, J BIOL CHEM, V283, P21530, DOI 10.1074/jbc.M800466200; Wargo MJ, 2006, CURR OPIN MICROBIOL, V9, P359, DOI 10.1016/j.mib.2006.06.001; Winfield MD, 2003, APPL ENVIRON MICROB, V69, P3687, DOI 10.1128/AEM.69.7.3687-3694.2003; Zogaj X, 2001, MOL MICROBIOL, V39, P1452, DOI 10.1046/j.1365-2958.2001.02337.x; Zogaj X, 2003, INFECT IMMUN, V71, P4151, DOI 10.1128/IAI.71.7.4151-4158.2003	54	47	48	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25553	10.1371/journal.pone.0025553	http://dx.doi.org/10.1371/journal.pone.0025553			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003399	Green Published, gold, Green Submitted			2022-12-27	WOS:000295970300020
J	Murray, DC; Bunce, M; Cannell, BL; Oliver, R; Houston, J; White, NE; Barrero, RA; Bellgard, MI; Haile, J				Murray, Daithi C.; Bunce, Michael; Cannell, Belinda L.; Oliver, Rebecca; Houston, Jayne; White, Nicole E.; Barrero, Roberto A.; Bellgard, Matthew I.; Haile, James			DNA-Based Faecal Dietary Analysis: A Comparison of qPCR and High Throughput Sequencing Approaches	PLOS ONE			English	Article							PENGUINS EUDYPTULA-MINOR; PREY DNA; MOLECULAR ANALYSIS; FECES; PREDATOR; PCR; VICTORIA; PRIMERS; ECOLOGY; ISLAND	The genetic analysis of faecal material represents a relatively non-invasive way to study animal diet and has been widely adopted in ecological research. Due to the heterogeneous nature of faecal material the primary obstacle, common to all genetic approaches, is a means to dissect the constituent DNA sequences. Traditionally, bacterial cloning of PCR amplified products was employed; less common has been the use of species-specific quantitative PCR (qPCR) assays. Currently, with the advent of High-Throughput Sequencing (HTS) technologies and indexed primers it has become possible to conduct genetic audits of faecal material to a much greater depth than previously possible. To date, no studies have systematically compared the estimates obtained by HTS with that of qPCR. What are the relative strengths and weaknesses of each technique and how quantitative are deep-sequencing approaches that employ universal primers? Using the locally threatened Little Penguin (Eudyptula minor) as a model organism, it is shown here that both qPCR and HTS techniques are highly correlated and produce strikingly similar quantitative estimates of fish DNA in faecal material, with no statistical difference. By designing four species-specific fish qPCR assays and comparing the data to the same four fish in the HTS data it was possible to directly compare the strengths and weaknesses of both techniques. To obtain reproducible quantitative data one of the key, and often overlooked, steps common to both approaches is ensuring that efficient DNA isolation methods are employed and that extracts are free of inhibitors. Taken together, the methodology chosen for long-term faecal monitoring programs is largely dependent on the complexity of the prey species present and the level of accuracy that is desired. Importantly, these methods should not be thought of as mutually exclusive, as the use of both HTS and qPCR in tandem will generate datasets with the highest fidelity.	[Murray, Daithi C.; Bunce, Michael; Oliver, Rebecca; Houston, Jayne; White, Nicole E.; Haile, James] Murdoch Univ, Australian Wildlife Forens Serv, Murdoch, WA 6150, Australia; [Murray, Daithi C.; Bunce, Michael; Oliver, Rebecca; Houston, Jayne; White, Nicole E.; Haile, James] Murdoch Univ, Sch Biol Sci & Biotechnol, Ancient DNA Lab, Murdoch, WA 6150, Australia; [Barrero, Roberto A.; Bellgard, Matthew I.] Murdoch Univ, Ctr Comparat Genom, Murdoch, WA 6150, Australia	Murdoch University; Murdoch University; Murdoch University	Murray, DC (corresponding author), Murdoch Univ, Australian Wildlife Forens Serv, Murdoch, WA 6150, Australia.	m.bunce@murdoch.edu.au		Bellgard, Matthew/0000-0002-6303-9469; Barrero, Roberto/0000-0002-7735-665X; White, Nicole/0000-0002-0068-6693; Bunce, Michael/0000-0002-0302-4206; Cannell, Belinda/0000-0001-9214-8958	Foundation for National Parks and Wildlife; Department of Environment and Conservation; Centre for Fish and Fisheries Research at Murdoch University; Robert Hammond Research Studentship; Australian Research Council [FT0991741]	Foundation for National Parks and Wildlife; Department of Environment and Conservation; Centre for Fish and Fisheries Research at Murdoch University; Robert Hammond Research Studentship; Australian Research Council(Australian Research Council)	Funding was obtained from the Foundation for National Parks and Wildlife, the Department of Environment and Conservation, and the Centre for Fish and Fisheries Research at Murdoch University. NEW received support from the Robert Hammond Research Studentship and MB from the Australian Research Council grant FT0991741. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Benson DA, 2006, NUCLEIC ACIDS RES, V34, pD16, DOI 10.1093/nar/gkj157; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Boersma PD, 2008, BIOSCIENCE, V58, P597, DOI 10.1641/B580707; Boersma PD, 2009, ECOL MONOGR, V79, P59, DOI 10.1890/06-0419.1; Bohmann K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021441; Bowles E, 2011, MOL ECOL RESOUR, V11, P530, DOI 10.1111/j.1755-0998.2010.02974.x; Bradley J. S., 1997, RADIO TRACKING STUDY; CANNELL BL, 2001, MMSLNESIS402001 DEP; CASPER RM, 1997, J EXP MAR BIOL ECOL, V347, P144; CHAPE S, 1984, PENGUIN ISLAND DRAFT; Chiaradia A, 2003, EMU, V103, P43, DOI 10.1071/MU02020; Clare EL, 2011, MOL ECOL, V20, P1772, DOI 10.1111/j.1365-294X.2011.05040.x; Clare EL, 2009, MOL ECOL, V18, P2532, DOI 10.1111/j.1365-294X.2009.04184.x; Dann P., 2009, CLIMATE CHANGE LITTL; Deagle BE, 2005, MOL ECOL, V14, P1831, DOI 10.1111/j.1365-294X.2005.02531.x; DEAGLE BE, 2006, FRONT ZOOL, V3, P10; Deagle BE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000831; Deagle BE, 2007, CONSERV GENET, V8, P743, DOI 10.1007/s10592-006-9197-7; Deagle BE, 2010, CONSERV GENET, V11, P2039, DOI 10.1007/s10592-010-0096-6; Deagle BE, 2009, MOL ECOL, V18, P2022, DOI 10.1111/j.1365-294X.2009.04158.x; DELABASTIDE M, 2007, CURR PROTOC BIOINFOR, pCH11, DOI DOI 10.1002/0471250953.BI1104S17; *DEP WAF, 2008, STAT FISH REP; Drummond A., 2011, GENEIOUS V5 5; Frank DN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-362; HARRIGAN KE, 1992, EMU, V91, P273, DOI 10.1071/MU9910273; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Kim BJ, 2011, CONSERV GENET, V12, P851, DOI 10.1007/s10592-011-0192-2; King RA, 2008, MOL ECOL, V17, P947, DOI 10.1111/j.1365-294X.2007.03613.x; KLOMP NI, 1988, AUST J MAR FRESH RES, V39, P633; Kowalczyk R, 2011, FOREST ECOL MANAG, V261, P821, DOI 10.1016/j.foreco.2010.11.026; Mallory ML, 2010, MAR POLLUT BULL, V60, P7, DOI 10.1016/j.marpolbul.2009.08.024; Marchant S., 1990, HDB AUSTR NZ ANTARCT, V1; Matejusova I, 2008, J APPL ECOL, V45, P632, DOI 10.1111/j.1365-2664.2007.01429.x; MILLER KM, 1995, J FIELD ORNITHOL, V66, P152; MONTAGUE TL, 1985, AUST WILDLIFE RES, V12, P327; Pegard A, 2009, J AGR FOOD CHEM, V57, P5700, DOI 10.1021/jf803680c; Pichegru L, 2009, MAR ECOL PROG SER, V391, P199, DOI 10.3354/meps08283; Poinar HN, 1998, SCIENCE, V281, P402, DOI 10.1126/science.281.5375.402; Poinar HN, 2001, P NATL ACAD SCI USA, V98, P4317, DOI 10.1073/pnas.061014798; Raye G, 2011, ECOL RES, V26, P265, DOI 10.1007/s11284-010-0780-5; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; *ROCH, 2009, TECHN B TCB; Sheppard SK, 2005, FUNCT ECOL, V19, P751, DOI 10.1111/j.1365-2435.2005.01041.x; Sipos R, 2007, FEMS MICROBIOL ECOL, V60, P341, DOI 10.1111/j.1574-6941.2007.00283.x; Soininen EM, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-16; Symondson WOC, 2002, MOL ECOL, V11, P627, DOI 10.1046/j.1365-294X.2002.01471.x; Taberlet P, 1999, TRENDS ECOL EVOL, V14, P323, DOI 10.1016/S0169-5347(99)01637-7; Tollit DJ, 2009, ECOL APPL, V19, P889, DOI 10.1890/07-1701.1; Valentini A, 2009, MOL ECOL RESOUR, V9, P51, DOI 10.1111/j.1755-0998.2008.02352.x; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Vestheim H, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-12; Vila AR, 2011, FOREST ECOL MANAG, V261, P1306, DOI 10.1016/j.foreco.2011.01.009; WHITEHEAD PJP., 1985, Clupeoid fishes of the world (suborder Clupeoidei), P125; Wienecke BC, 1995, PENGUINS: ECOLOGY AND MANAGEMENT, P440; WIENECKE BC, 1989, THESIS MURDOCH U; WIENECKE BC, 1993, THESIS MURODCH U; Williams CT, 2010, J ORNITHOL, V151, P531, DOI 10.1007/s10336-010-0513-0; WOOLLER R D, 1991, Journal of the Royal Society of Western Australia, V74, P129	59	93	100	0	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e25776	10.1371/journal.pone.0025776	http://dx.doi.org/10.1371/journal.pone.0025776			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998697	Green Published, gold, Green Submitted			2022-12-27	WOS:000295968700019
J	Park, B; Iwase, T; Liu, GY				Park, Bonggoo; Iwase, Tadayuki; Liu, George Y.			Intranasal Application of S. epidermidis Prevents Colonization by Methicillin-Resistant Staphylococcus aureus in Mice	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; BACTERIAL INTERFERENCE; NASAL COLONIZATION; MUPIROCIN; IMPLANTATION; COMPETITION; INFECTIONS; CARRIAGE; CAVITIES; CHILDREN	Methicillin-resistant S. aureus emerged in recent decades to become a leading cause of infection worldwide. Colonization with MRSA predisposes to infection and facilitates transmission of the pathogen; however, available regimens are ineffective at preventing MRSA colonization. Studies of human nasal flora suggest that resident bacteria play a critical role in limiting S. aureus growth, and prompted us to query whether application of commensal resident bacteria could prevent nasal colonization with MRSA. We established a murine model system to study this question, and showed that mice nasally pre-colonized with S. epidermidis became more resistant to colonization with MRSA. Our study suggests that application of commensal bacteria with antibiotics could represent a more effective strategy to prevent MRSA colonization.	[Park, Bonggoo; Liu, George Y.] Cedars Sinai Med Ctr, Dept Pediat, Div Infect Dis, Res Div Immunol,Dept Biomed Sci, Los Angeles, CA 90048 USA; [Park, Bonggoo; Liu, George Y.] Cedars Sinai Med Ctr, Immunobiol Res Inst, Los Angeles, CA 90048 USA; [Iwase, Tadayuki] Jikei Univ, Sch Med, Dept Bacteriol, Tokyo, Japan	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Jikei University	Park, B (corresponding author), Cedars Sinai Med Ctr, Dept Pediat, Div Infect Dis, Res Div Immunol,Dept Biomed Sci, Los Angeles, CA 90048 USA.	george.liu@cshs.org		Iwase, Tadayuki/0000-0003-4915-3983	Burroughs Wellcome; National Institute of Health [AI074832]; Uehara Memorial Foundation; The Promotion and Mutual Aid Corporation for Private Schools of Japan; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074832] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23590521, 22770241] Funding Source: KAKEN	Burroughs Wellcome(Burroughs Wellcome Fund); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Uehara Memorial Foundation(Uehara Memorial Foundation); The Promotion and Mutual Aid Corporation for Private Schools of Japan; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Burroughs Wellcome Career Award in Biomedical Sciences (GYL), a National Institute of Health Grant AI074832 (GYL), and Grants from the Uehara Memorial Foundation (TI) and from the Science Research Promotion Fund of The Promotion and Mutual Aid Corporation for Private Schools of Japan (TI). The funders had no role in study design, data collection and analysis, decision to publish, or prepartion of the manuscript.	Bogaert D, 2004, LANCET, V363, P1871, DOI 10.1016/S0140-6736(04)16357-5; Coates T, 2009, J ANTIMICROB CHEMOTH, V64, P9, DOI 10.1093/jac/dkp159; DRUTZ DJ, 1966, NEW ENGL J MED, V275, P1161, DOI 10.1056/NEJM196611242752104; Iwase T, 2010, NATURE, V465, P346, DOI 10.1038/nature09074; Ji GY, 1997, SCIENCE, V276, P2027, DOI 10.1126/science.276.5321.2027; Kiser KB, 1999, INFECT IMMUN, V67, P5001, DOI 10.1128/IAI.67.10.5001-5006.1999; Lina G, 2003, APPL ENVIRON MICROB, V69, P18, DOI 10.1128/AEM.69.1.18-23.2003; Lysenko ES, 2005, PLOS PATHOG, V1, P3, DOI 10.1371/journal.ppat.0010001; Park B, 2008, J BACTERIOL, V190, P2275, DOI 10.1128/JB.00006-08; Patel JB, 2009, CLIN INFECT DIS, V49, P935, DOI 10.1086/605495; Regev-Yochay G, 2004, JAMA-J AM MED ASSOC, V292, P716, DOI 10.1001/jama.292.6.716; Regev-Yochay G, 2006, J BACTERIOL, V188, P4996, DOI 10.1128/JB.00317-06; SHINEFIE.HR, 1974, ANN NY ACAD SCI, V236, P444, DOI 10.1111/j.1749-6632.1974.tb41509.x; Tseng CW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006387; Uehara Y, 2001, CLIN INFECT DIS, V32, P1399, DOI 10.1086/320147; Uehara Y, 2000, J HOSP INFECT, V44, P127, DOI 10.1053/jhin.1999.0680; WARD A, 1986, DRUGS, V32, P425, DOI 10.2165/00003495-198632050-00002; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4	18	45	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25880	10.1371/journal.pone.0025880	http://dx.doi.org/10.1371/journal.pone.0025880			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998712	Green Submitted, Green Published, gold			2022-12-27	WOS:000295966900066
J	Rydstrom, A; Deshayes, S; Konate, K; Crombez, L; Padari, K; Boukhaddaoui, H; Aldrian, G; Pooga, M; Divita, G				Rydstroem, Anna; Deshayes, Sebastien; Konate, Karidia; Crombez, Laurence; Padari, Kaert; Boukhaddaoui, Hassan; Aldrian, Gudrun; Pooga, Margus; Divita, Gilles			Direct Translocation as Major Cellular Uptake for CADY Self-Assembling Peptide-Based Nanoparticles	PLOS ONE			English	Article							PENETRATING PEPTIDES; MOLECULAR-MECHANISMS; SIRNA DELIVERY; INTERNALIZATION; PATHWAYS; INSIGHT; STRATEGIES; PROTEINS; CARRIER; REPAIR	Cell penetrating peptides constitute a potent approach to overcome the limitations of in vivo siRNA delivery. We recently proposed a peptide-based nanoparticle system, CADY, for efficient delivery of siRNA into numerous cell lines. CADY is a secondary amphipathic peptide that forms stable complexes with siRNA thereby improving both their cellular uptake and biological response. With the aim of understanding the cellular uptake mechanism of CADY: siRNA complexes, we have combined biochemical, confocal and electron microscopy approaches. In the present work, we provide evidence that the major route for CADY: siRNA cellular uptake involves direct translocation through the membrane but not the endosomal pathway. We have demonstrated that CADY: siRNA complexes do not colocalize with most endosomal markers and remain fully active in the presence of inhibitors of the endosomal pathway. Moreover, neither electrostatic interactions with cell surface heparan sulphates nor membrane potential are essential for CADY: siRNA cell entry. In contrast, we have shown that CADY: siRNA complexes clearly induce a transient cell membrane permeabilization, which is rapidly restored by cell membrane fluidity. Therefore, we propose that direct translocation is the major gate for cell entry of CADY: siRNA complexes. Membrane perturbation and uptake are driven mainly by the ability of CADY to interact with phospholipids within the cell membrane, followed by rapid localization of the complex in the cytoplasm, without affecting cell integrity or viability.	[Rydstroem, Anna; Deshayes, Sebastien; Konate, Karidia; Crombez, Laurence; Aldrian, Gudrun; Divita, Gilles] Univ Montpellier, Ctr Rech Biochim Macromol, Dept Mol Biophys & Therapeut, UMR 5237,UM1 UM2,CRBM,CNRS, F-34059 Montpellier, France; [Padari, Kaert; Pooga, Margus] Univ Tartu, Dept Dev Biol, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia; [Boukhaddaoui, Hassan] Inst Neurosci Montpellier, INSERM, U1051, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; University of Tartu; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Rydstrom, A (corresponding author), Univ Montpellier, Ctr Rech Biochim Macromol, Dept Mol Biophys & Therapeut, UMR 5237,UM1 UM2,CRBM,CNRS, F-34059 Montpellier, France.	gilles.divita@crbm.cnrs.fr	DIVITA, GILLES/AAV-9214-2021; Deshayes, Sebastien/J-9228-2018; Pooga, Margus/A-8575-2011	Deshayes, Sebastien/0000-0002-4684-9152; Pooga, Margus/0000-0003-4532-4087; BOUKHADDAOUI, HASSAN/0000-0003-1808-7901; Aldrian, Gudrun/0000-0002-7899-0572; Rydstrom, Anna/0000-0002-3404-7195	Centre National de la Recherche Scientifique; Agence Nationale de la Recherche [ANR- ANR-06-BLAN-0071]; Estonian Science Foundation [ESF8705]; Estonian Ministry of Education and Research [180019s11]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Estonian Science Foundation; Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia)	This work was supported by the Centre National de la Recherche Scientifique and grants from the Agence Nationale de la Recherche (ANR- ANR-06-BLAN-0071), the Estonian Science Foundation (ESF8705) and the Estonian Ministry of Education and Research (180019s11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves ID, 2010, BBA-BIOMEMBRANES, V1798, P2231, DOI 10.1016/j.bbamem.2010.02.009; Andaloussi SEL, 2011, NUCLEIC ACIDS RES, V39, P3972, DOI 10.1093/nar/gkq1299; Brasseur R, 2010, BBA-BIOMEMBRANES, V1798, P2177, DOI 10.1016/j.bbamem.2010.09.001; Broeck DV, 2007, ACTA BIOCHIM POL, V54, P757, DOI 10.18388/abp.2007_3154; Castanotto D, 2009, NATURE, V457, P426, DOI 10.1038/nature07758; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Crombez L, 2009, NUCLEIC ACIDS RES, V37, P4559, DOI 10.1093/nar/gkp451; Crombez L, 2009, MOL THER, V17, P95, DOI 10.1038/mt.2008.215; de Fougerolles A, 2007, NAT REV DRUG DISCOV, V6, P443, DOI 10.1038/nrd2310; de Toledo M, 2003, MOL BIOL CELL, V14, P4846, DOI 10.1091/mbc.E03-04-0254; Deshayes S, 2004, BIOCHEMISTRY-US, V43, P1449, DOI 10.1021/bi035682s; Deshayes S, 2004, BBA-BIOMEMBRANES, V1667, P141, DOI 10.1016/j.bbamem.2004.09.010; Deshayes S, 2010, BBA-BIOMEMBRANES, V1798, P2304, DOI 10.1016/j.bbamem.2010.06.005; Dorsett Y, 2004, NAT REV DRUG DISCOV, V3, P318, DOI 10.1038/nrd1345; Duchardt F, 2007, TRAFFIC, V8, P848, DOI 10.1111/j.1600-0854.2007.00572.x; Eguchi A, 2009, TRENDS PHARMACOL SCI, V30, P341, DOI 10.1016/j.tips.2009.04.009; Eguchi A, 2009, NAT BIOTECHNOL, V27, P567, DOI 10.1038/nbt.1541; Eiriksdottir E, 2010, BBA-BIOMEMBRANES, V1798, P1119, DOI 10.1016/j.bbamem.2010.03.005; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fischer R, 2005, CHEMBIOCHEM, V6, P2126, DOI 10.1002/cbic.200500044; Gao K, 2009, MOL PHARMACEUT, V6, P651, DOI 10.1021/mp800134q; Gerbal-Chaloin S, 2007, BIOL CELL, V99, P223, DOI 10.1042/BC20060123; Gump JM, 2010, J BIOL CHEM, V285, P1500, DOI 10.1074/jbc.M109.021964; Hassane FS, 2010, CELL MOL LIFE SCI, V67, P715, DOI 10.1007/s00018-009-0186-0; Heitz F, 2009, BRIT J PHARMACOL, V157, P195, DOI 10.1111/j.1476-5381.2009.00057.x; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Henriques ST, 2006, BIOCHEM J, V399, P1, DOI 10.1042/BJ20061100; Jarver P, 2010, TRENDS PHARMACOL SCI, V31, P528, DOI 10.1016/j.tips.2010.07.006; Juliano R, 2008, NUCLEIC ACIDS RES, V36, P4158, DOI 10.1093/nar/gkn342; Konate K, 2010, BIOCHEMISTRY-US, V49, P3393, DOI 10.1021/bi901791x; McNeil PL, 2003, ANNU REV CELL DEV BI, V19, P697, DOI 10.1146/annurev.cellbio.19.111301.140101; Morris MC, 2008, BIOL CELL, V100, P201, DOI 10.1042/BC20070116; Morris MC, 2001, NAT BIOTECHNOL, V19, P1173, DOI 10.1038/nbt1201-1173; Morris MC, 1997, NUCLEIC ACIDS RES, V25, P2730, DOI 10.1093/nar/25.14.2730; Nakase I, 2007, BIOCHEMISTRY-US, V46, P492, DOI 10.1021/bi0612824; Padari K, 2005, BIOCONJUGATE CHEM, V16, P1399, DOI 10.1021/bc050125z; Palm-Apergi C, 2009, FASEB J, V23, P214, DOI 10.1096/fj.08-110254; Raagel H, 2010, BBA-BIOMEMBRANES, V1798, P2240, DOI 10.1016/j.bbamem.2010.02.013; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; Rothbard JB, 2004, J AM CHEM SOC, V126, P9506, DOI 10.1021/ja0482536; Sibley CR, 2010, MOL THER, V18, P466, DOI 10.1038/mt.2009.306; Simeoni F, 2003, NUCLEIC ACIDS RES, V31, P2717, DOI 10.1093/nar/gkg385; Torgersen ML, 2001, J CELL SCI, V114, P3737; TRAN D, 1987, P NATL ACAD SCI USA, V84, P7957, DOI 10.1073/pnas.84.22.7957; Vercauteren D, 2010, MOL THER, V18, P561, DOI 10.1038/mt.2009.281; Via LE, 1998, J CELL SCI, V111, P897; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Watkins CL, 2009, BIOCHEM J, V420, P179, DOI 10.1042/BJ20090042; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742	49	85	90	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25924	10.1371/journal.pone.0025924	http://dx.doi.org/10.1371/journal.pone.0025924			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998722	Green Published, Green Submitted, gold			2022-12-27	WOS:000295966900074
J	Shimmura, C; Suda, S; Tsuchiya, KJ; Hashimoto, K; Ohno, K; Matsuzaki, H; Iwata, K; Matsumoto, K; Wakuda, T; Kameno, Y; Suzuki, K; Tsujii, M; Nakamura, K; Takei, N; Mori, N				Shimmura, Chie; Suda, Shiro; Tsuchiya, Kenji J.; Hashimoto, Kenji; Ohno, Koji; Matsuzaki, Hideo; Iwata, Keiko; Matsumoto, Kaori; Wakuda, Tomoyasu; Kameno, Yosuke; Suzuki, Katsuaki; Tsujii, Masatsugu; Nakamura, Kazuhiko; Takei, Nori; Mori, Norio			Alteration of Plasma Glutamate and Glutamine Levels in Children with High-Functioning Autism	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; CEREBROSPINAL-FLUID; AMINO-ACIDS; CENTRAL MECHANISM; SEX-DIFFERENCES; PARIETAL; INDUCTION; TRANSPORT; SERUM	Background: It has recently been hypothesized that hyperglutamatergia in the brain is involved in the pathophysiology of autism. However, there is no conclusive evidence of the validity of this hypothesis. As peripheral glutamate/glutamine levels have been reported to be correlated with those of the central nervous system, the authors examined whether the levels of 25 amino acids, including glutamate and glutamine, in the platelet-poor plasma of drug-naive, male children with high-functioning autism (HFA) would be altered compared with those of normal controls. Methodology/Principal Findings: Plasma levels of 25 amino acids in male children (N = 23) with HFA and normally developed healthy male controls (N = 22) were determined using high-performance liquid chromatography. Multiple testing was allowed for in the analyses. Compared with the normal control group, the HFA group had higher levels of plasma glutamate and lower levels of plasma glutamine. No significant group difference was found in the remaining 23 amino acids. The effect size (Cohen's d) for glutamate and glutamine was large: 1.13 and 1.36, respectively. Using discriminant analysis with logistic regression, the two values of plasma glutamate and glutamine were shown to well-differentiate the HFA group from the control group; the rate of correct classification was 91%. Conclusions/Significance: The present study suggests that plasma glutamate and glutamine levels can serve as a diagnostic tool for the early detection of autism, especially normal IQ autism. These findings indicate that glutamatergic abnormalities in the brain may be associated with the pathobiology of autism.	[Shimmura, Chie; Wakuda, Tomoyasu; Kameno, Yosuke; Nakamura, Kazuhiko; Mori, Norio] Hamamatsu Univ Sch Med, Dept Psychiat & Neurol, Hamamatsu, Shizuoka 4313192, Japan; [Suda, Shiro; Tsuchiya, Kenji J.; Matsuzaki, Hideo; Iwata, Keiko; Matsumoto, Kaori; Suzuki, Katsuaki; Tsujii, Masatsugu; Takei, Nori; Mori, Norio] Hamamatsu Univ Sch Med, Res Ctr Child Mental Dev, Hamamatsu, Shizuoka 4313192, Japan; [Ohno, Koji] Hamamatsu Univ Sch Med, Dept Anat & Neurosci, Hamamatsu, Shizuoka 4313192, Japan; [Hashimoto, Kenji] Chiba Univ, Ctr Forens Mental Hlth, Chiba, Japan; [Tsujii, Masatsugu] Chukyo Univ, Fac Sociol, Nagoya, Aichi, Japan; [Takei, Nori] Inst Psychiat, Div Psychol Med, London, England	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Chiba University; Chukyo University; University of London; King's College London	Shimmura, C (corresponding author), Hamamatsu Univ Sch Med, Dept Psychiat & Neurol, Hamamatsu, Shizuoka 4313192, Japan.	sudash@jichi.ac.jp	Takei, Nori/AAC-8578-2019; MATSUZAKI, HIDEO/AAE-5246-2020; Tsuchiya, Kenji J./I-9123-2019; Takei, Nori/GWZ-7464-2022; Hashimoto, Kenji/I-5800-2015	MATSUZAKI, HIDEO/0000-0002-6869-1261; Tsuchiya, Kenji J./0000-0002-1314-4199; Suzuki, Katsuaki/0000-0003-0446-3355; Hashimoto, Kenji/0000-0002-8892-0439; Wakuda, Tomoyasu/0000-0002-1924-8167	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan; Takeda Science Foundation; Mitsubishi Pharma Research Foundation	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mitsubishi Pharma Research Foundation	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan (CS, SS); by the Takeda Science Foundation (SS); and by the Mitsubishi Pharma Research Foundation (SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldred S, 2003, J AUTISM DEV DISORD, V33, P93, DOI 10.1023/A:1022238706604; ALFREDSSON G, 1988, BIOL PSYCHIAT, V23, P689, DOI 10.1016/0006-3223(88)90052-2; Arnold GL, 2003, J AUTISM DEV DISORD, V33, P449, DOI 10.1023/A:1025071014191; Association AP DSM-IV APA on, 2000, DIAGN STAT MAN MENT; Bak LK, 2006, J NEUROCHEM, V98, P641, DOI 10.1111/j.1471-4159.2006.03913.x; Baron-Cohen S, 2009, BRIT J PSYCHIAT, V194, P500, DOI 10.1192/bjp.bp.108.059345; Blaylock RL, 2009, CURR MED CHEM, V16, P157, DOI 10.2174/092986709787002745; Blaylock RL, 2008, ALTERN THER HEALTH M, V14, P46; Brune CW, 2008, AUTISM RES, V1, P108, DOI 10.1002/aur.11; Croonenburghs J, 2002, ACTA NEUROPSYCHIATR, V14, P93, DOI 10.1034/j.1601-5215.2002.140209.x; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Fatemi SH, 2008, PROG NEURO-PSYCHOPH, V32, P911, DOI 10.1016/j.pnpbp.2007.11.004; Fatemi SH, 2002, BIOL PSYCHIAT, V52, P805, DOI 10.1016/S0006-3223(02)01430-0; Hawkins RA, 2006, J NUTR, V136, p218S, DOI 10.1093/jn/136.1.218S; Hosoya K, 1999, J NEUROCHEM, V73, P1206, DOI 10.1046/j.1471-4159.1999.0731206.x; Howlin P, 1999, DEV MED CHILD NEUROL, V41, P834, DOI 10.1017/S0012162299001656; Ilzecka J, 2003, AMINO ACIDS, V25, P69, DOI 10.1007/s00726-002-0352-2; Kantojarvi K, 2010, PSYCHIAT GENET, V20, P102, DOI 10.1097/YPG.0b013e32833a2080; Laurence JA, 2005, CEREBELLUM, V4, P206, DOI 10.1080/14734220500208846; LORD C, 1982, J AUTISM DEV DISORD, V12, P317, DOI 10.1007/BF01538320; LORD CRM, 1994, J AUTISM DEV DISORD, V24, P27; MANEV H, 1989, MOL PHARMACOL, V36, P106; MCGALE EHF, 1977, J NEUROCHEM, V29, P291, DOI 10.1111/j.1471-4159.1977.tb09621.x; MCLENNAN JD, 1993, J AUTISM DEV DISORD, V23, P217, DOI 10.1007/BF01046216; Miulli Dan E., 1993, Journal of the American Osteopathic Association, V93, P670; Moreno-Fuenmayor H, 1996, Invest Clin, V37, P113; OHSAWA S, 1998, MED TECHNOLOGY, V26, P7; OLNEY JW, 1969, SCIENCE, V164, P719, DOI 10.1126/science.164.3880.719; Ortinski PI, 2010, NAT NEUROSCI, V13, P584, DOI 10.1038/nn.2535; Page LA, 2006, AM J PSYCHIAT, V163, P2189, DOI 10.1176/appi.ajp.163.12.2189; Pais TF, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-43; Rainesalo S, 2004, NEUROCHEM RES, V29, P319, DOI 10.1023/B:NERE.0000010461.34920.0c; ROLF LH, 1993, ACTA PSYCHIAT SCAND, V87, P312, DOI 10.1111/j.1600-0447.1993.tb03378.x; SCHWARZ E, 2010, MOL PSYCHIAT; Sheldon AL, 2007, NEUROCHEM INT, V51, P333, DOI 10.1016/j.neuint.2007.03.012; Shinohe A, 2006, PROG NEURO-PSYCHOPH, V30, P1472, DOI 10.1016/j.pnpbp.2006.06.013; Stichter JP, 2010, J AUTISM DEV DISORD, V40, P1067, DOI [10.1007/s10803-010-0959-1, 10.1007/s10803-010-0961-7]; Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315; Volkmar FR, 2003, LANCET, V362, P1133, DOI 10.1016/S0140-6736(03)14471-6; Yao JK, 2010, MOL PSYCHIATR, V15, P938, DOI 10.1038/mp.2009.33; 2007, MMWR SURVEILL SUMM, V56, P11	41	116	123	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25340	10.1371/journal.pone.0025340	http://dx.doi.org/10.1371/journal.pone.0025340			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998651	gold, Green Submitted, Green Published			2022-12-27	WOS:000295966900020
J	Zhu, L; Hu, W; Liu, DT; Tian, WH; Yu, G; Liu, XK; Wang, J; Feng, E; Zhang, XM; Chen, B; Zeng, M; Wang, HL				Zhu, Li; Hu, Wei; Liu, Datao; Tian, Wanhong; Yu, Gang; Liu, Xiankai; Wang, Jie; Feng, Erling; Zhang, Xuemin; Chen, Bei; Zeng, Ming; Wang, Hengliang			A Reference Proteomic Database of Lactobacillus plantarum CMCC-P0002	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; KEY PROTEINS; BIFIDOBACTERIUM; ADHESION; 2-DE; ACID	Lactobacillus plantarum is a widespread probiotic bacteria found in many fermented food products. In this study, the wholecell proteins and secretory proteins of L. plantarum were separated by two-dimensional electrophoresis method. A total of 434 proteins were identified by tandem mass spectrometry, including a plasmid-encoded hypothetical protein pLP9000_05. The information of first 20 highest abundance proteins was listed for the further genetic manipulation of L. plantarum, such as construction of high-level expressions system. Furthermore, the first interaction map of L. plantarum was established by Blue-Native/SDS-PAGE technique. A heterodimeric complex composed of maltose phosphorylase Map3 and Map2, and two homodimeric complexes composed of Map3 and Map2 respectively, were identified at the same time, indicating the important roles of these proteins. These findings provided valuable information for the further proteomic researches of L. plantarum.	[Zhu, Li; Hu, Wei; Liu, Xiankai; Feng, Erling; Wang, Hengliang] Beijing Inst Biotechnol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Hu, Wei; Tian, Wanhong; Yu, Gang; Zeng, Ming] Natl Inst Control Pharmaceut & Biol Prod, Beijing, Peoples R China; [Liu, Datao; Chen, Bei] Sine Pharmaceut Corp Ltd, Shanghai, Peoples R China; [Wang, Jie; Zhang, Xuemin] Natl Ctr Biomed Anal, Beijing, Peoples R China	National Institute of Food & Drug Control - China	Zhu, L (corresponding author), Beijing Inst Biotechnol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	zengming@nicpbp.org.cn; wanghl@nic.bmi.ac.cn	Wang, Hengliang/AAL-5340-2021; wang, hengliang/AAA-8300-2020; Wang, Hengliang/AAT-4586-2021; Zhu, Li/Q-7499-2017	Wang, Hengliang/0000-0001-8476-4320; Zhu, Li/0000-0001-9975-8978	National Key Basic Research Program of China (973 Program) [2011CB504900]	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the National Key Basic Research Program of China (973 Program, No. 2011CB504900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck HC, 2009, FEMS MICROBIOL LETT, V297, P61, DOI 10.1111/j.1574-6968.2009.01662.x; Cecconi D, 2009, ELECTROPHORESIS, V30, P957, DOI 10.1002/elps.200800310; Cohen DPA, 2006, PROTEOMICS, V6, P6485, DOI 10.1002/pmic.200600361; Curiel JA, 2011, MOL NUTR FOOD RES; del Rio B, 2008, CLIN VACCINE IMMUNOL, V15, P1429, DOI 10.1128/CVI.00169-08; Guillot A, 2003, PROTEOMICS, V3, P337, DOI 10.1002/pmic.200390047; Hamon E, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-63; Izquierdo E, 2009, ELECTROPHORESIS, V30, P949, DOI 10.1002/elps.200800399; Kleerebezem M, 2003, P NATL ACAD SCI USA, V100, P1990, DOI 10.1073/pnas.0337704100; Lee K, 2011, J BIOTECHNOL, V153, P1, DOI 10.1016/j.jbiotec.2011.02.008; Molin G, 2001, AM J CLIN NUTR, V73, p380S, DOI 10.1093/ajcn/73.2.380s; O'Mahony L, 2005, GASTROENTEROLOGY, V128, P541, DOI 10.1053/j.gastro.2004.11.050; Sanchez B, 2008, FEMS IMMUNOL MED MIC, V54, P1, DOI 10.1111/j.1574-695X.2008.00454.x; Swamy M, 2006, SCI STKE, P14; Wang YY, 2011, J BACTERIOL, V193, P313, DOI 10.1128/JB.01159-10; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Yuan J, 2006, MOL CELL PROTEOMICS, V5, P1105, DOI 10.1074/mcp.M500410-MCP200; Zhang ZY, 2009, J BACTERIOL, V191, P5020, DOI 10.1128/JB.00587-09	18	11	12	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25596	10.1371/journal.pone.0025596	http://dx.doi.org/10.1371/journal.pone.0025596			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998671	Green Published, Green Submitted, gold			2022-12-27	WOS:000295966900035
J	Jakubowski, AR; Casler, MD; Jackson, RD				Jakubowski, Andrew R.; Casler, Michael D.; Jackson, Randall D.			Has Selection for Improved Agronomic Traits Made Reed Canarygrass Invasive?	PLOS ONE			English	Article							GRASS PHALARIS-ARUNDINACEA; ECONOMIC COSTS; PLANT; BIOENERGY; PROGRESS; BIOMASS; ESTABLISHMENT; ADAPTATION; STABILITY; BIOFUELS	Plant breeders have played an essential role in improving agricultural crops, and their efforts will be critical to meet the increasing demand for cellulosic bioenergy feedstocks. However, a major concern is the potential development of novel invasive species that result from breeders' efforts to improve agronomic traits in a crop. We use reed canarygrass as a case study to evaluate the potential of plant breeding to give rise to invasive species. Reed canarygrass has been improved by breeders for use as a forage crop, but it is unclear whether breeding efforts have given rise to more vigorous populations of the species. We evaluated cultivars, European wild, and North American invader populations in upland and wetland environments to identify differences in vigor between the groups of populations. While cultivars were among the most vigorous populations in an agricultural environment (upland soils with nitrogen addition), there were no differences in above-or below-ground production between any populations in wetland environments. These results suggest that breeding has only marginally increased vigor in upland environments and that these gains are not maintained in wetland environments. Breeding focuses on selection for improvements of a specific target population of environments, and stability across a wide range of environments has proved elusive for even the most intensively bred crops. We conclude that breeding efforts are not responsible for wetland invasion by reed canarygrass and offer guidelines that will help reduce the possibility of breeding programs releasing cultivars that will become invasive.	[Jakubowski, Andrew R.; Jackson, Randall D.] Univ Wisconsin, Dept Agron, Madison, WI 53706 USA; [Casler, Michael D.] USDA ARS, US Dairy Forage Res Ctr, Madison, WI 53706 USA; [Casler, Michael D.; Jackson, Randall D.] Univ Wisconsin, US Dept Energy, Great Lakes Bioenergy Res Ctr, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; United States Department of Agriculture (USDA); United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison	Jakubowski, AR (corresponding author), Univ Wisconsin, Dept Agron, 1575 Linden Dr, Madison, WI 53706 USA.	Jakubowski@wisc.edu	Jackson, Randall/AAE-5573-2022		Grazing Lands Conservation Initiative [941-3]; United States Department of Energy-Great Lakes Bioenergy Research Center (DOE Office of Science) [BER DE-FC02-07ER64494]	Grazing Lands Conservation Initiative; United States Department of Energy-Great Lakes Bioenergy Research Center (DOE Office of Science)(United States Department of Energy (DOE))	This work was funded in part by Grazing Lands Conservation Initiative grant 941-3 and by the United States Department of Energy-Great Lakes Bioenergy Research Center (DOE Office of Science BER DE-FC02-07ER64494). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PR, 2007, ECOL APPL, V17, P675, DOI 10.1890/05-2018; ALWAY FREDERICK J., 1931, JOUR AMER SOC AGRON, V23, P64; Baeten L, 2010, OECOLOGIA, V163, P1021, DOI 10.1007/s00442-010-1599-z; Barney JN, 2008, BIOSCIENCE, V58, P64, DOI 10.1641/B580111; BORLAUG NE, 1983, SCIENCE, V219, P689, DOI 10.1126/science.219.4585.689; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; Burvall J, 1997, BIOMASS BIOENERG, V12, P149, DOI 10.1016/S0961-9534(96)00064-5; Buxton DR, 1996, ANIM FEED SCI TECH, V59, P37, DOI 10.1016/0377-8401(95)00885-3; BYERS RA, 1979, ENVIRON ENTOMOL, V8, P408, DOI 10.1093/ee/8.3.408; Carlson I. T., 1996, COOL SEASON FORAGE G, V34, P569, DOI [10.2134/agronmonogr34.c18, DOI 10.2134/AGRONMONOGR34.C18]; Casler MD, 2009, CROP SCI, V49, P2139, DOI 10.2135/cropsci2009.02.0055; Casler M.D., 1996, COOL SEASON FORAGE G, V34, P413, DOI DOI 10.2134/AGR0NM0N0GR34.C14; Casler M.D., 2010, INT J PLANT BREEDING, V4, P30; Casler MD, 2004, CROP SCI, V44, P1601, DOI 10.2135/cropsci2004.1601; Casler MD, 2002, THEOR APPL GENET, V104, P127, DOI 10.1007/s001220200015; Casler MD, 2009, BIOENERG RES, V2, P165, DOI 10.1007/s12155-009-9043-0; Clements DR, 2011, WEED RES, V51, P227, DOI 10.1111/j.1365-3180.2011.00850.x; Conway G, 1999, NATURE, V402, pC55, DOI [10.1038/35011545, 10.1038/990141]; Coops H, 1996, AQUAT BOT, V54, P11, DOI 10.1016/0304-3770(96)01025-X; Crawley M.J., 2007, R BOOK; Cully AC, 2003, CONSERV BIOL, V17, P990, DOI 10.1046/j.1523-1739.2003.02107.x; Davis AS, 2010, FRONT ECOL ENVIRON, V8, P533, DOI 10.1890/090030; Dore W, 1980, GRASSES ONTARIO AGR; EBERHART SA, 1966, CROP SCI, V6, P36, DOI 10.2135/cropsci1966.0011183X000600010011x; Edgerton MD, 2009, PLANT PHYSIOL, V149, P7, DOI 10.1104/pp.108.130195; Green EK, 2002, J APPL ECOL, V39, P134, DOI 10.1046/j.1365-2664.2002.00702.x; Green EK, 2001, CAN J BOT, V79, P170, DOI 10.1139/cjb-79-2-170; GROSS MF, 1991, ESTUARIES, V14, P180, DOI 10.2307/1351692; Heaton EA, 2008, CURR OPIN BIOTECH, V19, P202, DOI 10.1016/j.copbio.2008.05.001; HEICHEL GH, 1980, CROP SCI, V20, P683, DOI 10.2135/cropsci1980.0011183X002000060002x; Jakubowski AR, 2010, RESTOR ECOL, V18, P789, DOI 10.1111/j.1526-100X.2010.00738.x; Jakubowski AR, 2010, WETLANDS, V30, P685, DOI 10.1007/s13157-010-0078-y; Jung C, 2009, TRENDS PLANT SCI, V14, P563, DOI 10.1016/j.tplants.2009.07.005; Keeney D, 2006, FORAGES SCI GRASSLAN, P167; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Koonin SE, 2006, SCIENCE, V311, P435, DOI 10.1126/science.1124886; Kucharik CJ, 2006, GLOBAL CHANGE BIOL, V12, P122, DOI 10.1111/j.1365-2486.2005.01053.x; Lavergne S, 2004, CRIT REV PLANT SCI, V23, P415, DOI 10.1080/07352680490505934; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; Lawrence CJ, 2004, NUCLEIC ACIDS RES, V32, pD393, DOI 10.1093/nar/gkh011; Li JZ, 2011, MOL BREEDING, V28, P611, DOI 10.1007/s11032-010-9513-2; Marten G.C., 1989, CSSA SPEC PUBL, V15, P71; Maurer DA, 2002, OECOLOGIA, V131, P279, DOI 10.1007/s00442-002-0886-8; McLaughlin SB, 2005, BIOMASS BIOENERG, V28, P515, DOI 10.1016/j.biombioe.2004.05.006; Merigliano MF, 1998, NAT AREA J, V18, P223; Miller RC, 2003, PLANT ECOL, V167, P57, DOI 10.1023/A:1023918619073; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Perlack R.D., 2005, BIOMASS FEEDSTOCK BI; PIMENTEL D, 1995, SCIENCE, V267, P1117, DOI 10.1126/science.267.5201.1117; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Raghu S, 2006, SCIENCE, V313, P1742, DOI 10.1126/science.1129313; Robertson GP, 2008, SCIENCE, V322, P49, DOI 10.1126/science.1161525; Sahramaa M, 2003, AGR FOOD SCI FINLAND, V12, P227, DOI 10.23986/afsci.5751; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Salehi H, 2005, J PLANT PHYSIOL, V162, P711, DOI 10.1016/j.jplph.2004.12.002; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Sharp W.C., 1994, GRASS VARIETIES US, DOI 10.5962/bhl.title.97052; SIMMONDS NW, 1991, THEOR APPL GENET, V82, P363, DOI 10.1007/BF02190624; Storchova H, 2000, TAXON, V49, P79, DOI 10.2307/1223934; Theoharides KA, 2007, NEW PHYTOL, V176, P256, DOI 10.1111/j.1469-8137.2007.02207.x; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; Wilkins PW, 2003, J AGR SCI-CAMBRIDGE, V140, P129, DOI 10.1017/S0021859603003058	63	27	28	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25757	10.1371/journal.pone.0025757	http://dx.doi.org/10.1371/journal.pone.0025757			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991347	Green Published, Green Submitted, gold			2022-12-27	WOS:000295943000066
J	Butler, RJ; Brusatte, SL; Reich, M; Nesbitt, SJ; Schoch, RR; Hornung, JJ				Butler, Richard J.; Brusatte, Stephen L.; Reich, Mike; Nesbitt, Sterling J.; Schoch, Rainer R.; Hornung, Jahn J.			The Sail-Backed Reptile Ctenosauriscus from the Latest Early Triassic of Germany and the Timing and Biogeography of the Early Archosaur Radiation	PLOS ONE			English	Article							POPOSAURUS-GRACILIS; EVOLUTIONARY RADIATION; MIDDLE; BUNTSANDSTEIN; TIMESCALE; DIVERSIFICATION; BIOSTRATIGRAPHY; REDESCRIPTION; RAUISUCHIA; FOOTPRINTS	Background: Archosaurs (birds, crocodilians and their extinct relatives including dinosaurs) dominated Mesozoic continental ecosystems from the Late Triassic onwards, and still form a major component of modern ecosystems (> 10,000 species). The earliest diverse archosaur faunal assemblages are known from the Middle Triassic (c. 244 Ma), implying that the archosaur radiation began in the Early Triassic (252.3-247.2 Ma). Understanding of this radiation is currently limited by the poor early fossil record of the group in terms of skeletal remains. Methodology/Principal Findings: We redescribe the anatomy and stratigraphic position of the type specimen of Ctenosauriscus koeneni (Huene), a sail-backed reptile from the Early Triassic (late Olenekian) Solling Formation of northern Germany that potentially represents the oldest known archosaur. We critically discuss previous biomechanical work on the 'sail' of Ctenosauriscus, which is formed by a series of elongated neural spines. In addition, we describe Ctenosauriscus-like postcranial material from the earliest Middle Triassic (early Anisian) Rot Formation of Waldhaus, southwestern Germany. Finally, we review the spatial and temporal distribution of the earliest archosaur fossils and their implications for understanding the dynamics of the archosaur radiation. Conclusions/Significance: Comprehensive numerical phylogenetic analyses demonstrate that both Ctenosauriscus and the Waldhaus taxon are members of a monophyletic grouping of poposauroid archosaurs, Ctenosauriscidae, characterised by greatly elongated neural spines in the posterior cervical to anterior caudal vertebrae. The earliest archosaurs, including Ctenosauriscus, appear in the body fossil record just prior to the Olenekian/Anisian boundary (c. 248 Ma), less than 5 million years after the Permian-Triassic mass extinction. These earliest archosaur assemblages are dominated by ctenosauriscids, which were broadly distributed across northern Pangea and which appear to have been the first global radiation of archosaurs.	[Butler, Richard J.] Bayer Staatssammlung Palaontol & Geol, Munich, Germany; [Butler, Richard J.] Univ Munich, GeoBioctr, Munich, Germany; [Brusatte, Stephen L.] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Brusatte, Stephen L.] Columbia Univ, Dept Earth & Environm Sci, New York, NY USA; [Reich, Mike; Hornung, Jahn J.] Univ Gottingen, Geowissenschaftliches Zentrum, Gottingen, Germany; [Nesbitt, Sterling J.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Schoch, Rainer R.] Staatliches Museum Nat Kunde, Stuttgart, Germany	University of Munich; American Museum of Natural History (AMNH); Columbia University; University of Gottingen; University of Washington; University of Washington Seattle	Butler, RJ (corresponding author), Bayer Staatssammlung Palaontol & Geol, Munich, Germany.	r.butler@lrz.uni-muenchen.de	Reich, Mike/A-3745-2012; Butler, Richard J./A-5239-2011; Brusatte, Stephen/O-9663-2014	Butler, Richard J./0000-0003-2136-7541; Hornung, Jahn/0000-0002-4929-5490; Nesbitt, Sterling/0000-0002-7017-1652; Reich, Mike/0000-0003-3837-3497; Brusatte, Stephen/0000-0001-7525-7319	personal Alexander von Humboldt Research Fellowship; National Science Foundation [DEB 1110357]	personal Alexander von Humboldt Research Fellowship; National Science Foundation(National Science Foundation (NSF))	This work was supported by a personal Alexander von Humboldt Research Fellowship to the lead author (RJB). The participation of the second author (SLB) was funded by a National Science Foundation Graduate Research Fellowship and Doctoral Dissertation Improvement Grant (DEB 1110357). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL O, 1939, REICH TIERE ERGANZUN; Alcober O, 1997, J VERTEBR PALEONTOL, V17, P548, DOI 10.1080/02724634.1997.10011001; ARP G, 2004, GEOBIOLOGIE, V2, P147; ATTRIDGE J, 1964, NATURE, V201, P445, DOI 10.1038/201445a0; Benton M.J., 1995, FOSSIL REPTILES GREA; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Benton MJ, 2011, P GEOLOGIST ASSOC, V122, P25, DOI 10.1016/j.pgeola.2010.08.004; BENTON MJ, 1994, IN THE SHADOW OF THE DINOSAURS, P366; Benton MJ, 1997, J VERTEBR PALEONTOL, V17, P74, DOI 10.1080/02724634.1997.10010955; Brochu CA, 1996, J VERTEBR PALEONTOL, V16, P49, DOI 10.1080/02724634.1996.10011283; Brusatte SL, 2008, SCIENCE, V321, P1485, DOI 10.1126/science.1161833; Brusatte SL, 2010, EARTH ENV SCI T R SO, V101, P367, DOI 10.1017/S1755691011020056; Brusatte SL, 2011, P ROY SOC B-BIOL SCI, V278, P1107, DOI 10.1098/rspb.2010.1746; Brusatte SL, 2010, J SYST PALAEONTOL, V8, P3, DOI 10.1080/14772010903537732; Buffetaut Eric, 1993, Paleontologia Lombarda, V2, P39; Butler RJ, 2009, J VERTEBR PALEONTOL, V29, P1022, DOI 10.1671/039.029.0404; Carrano MT, 1998, PALEOBIOLOGY, V24, P450, DOI 10.1017/S0094837300020108; Carroll RL, 1988, VERTEBRATE PALEONTOL; CASE EC, 1907, PUBLICATIONS CARNEGI, V55, P1; Catuneanu O, 2005, J AFR EARTH SCI, V43, P211, DOI 10.1016/j.jafrearsci.2005.07.007; CHATTERJEE S, 1985, PHILOS T ROY SOC B, V309, P395, DOI 10.1098/rstb.1985.0092; Cheng ZW, 1980, MESOZOIC STRATIGRAPH, P114; Cisneros JC, 2008, J SYST PALAEONTOL, V6, P345, DOI 10.1017/S1477201907002350; Cope E.D., 1869, T AM PHIL SOC, V14, P1; Ebel Klaus, 1998, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V261, P1; EBERT T, 1894, ERLAUTERUNGEN GEOLOG; FALKENSTEIN F, 2001, AUFSCHLUSS, V52, P227; Farlow JO, 2000, AM ZOOL, V40, P640, DOI 10.1668/0003-1569(2000)040[0640:TL]2.0.CO;2; Fraas O, 1877, WURTTEMBERGISCHE NAT, V33, P1; Franca MAG, 2011, NATURWISSENSCHAFTEN, V98, P389, DOI 10.1007/s00114-011-0782-3; Frobisch J, 2009, EARTH-SCI REV, V95, P119, DOI 10.1016/j.earscirev.2009.04.001; Galton Peter M., 1996, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V201, P303; Galton PM, STUTTGARTER BEITRAGE, V116, P1; GAUTHIER JA, 1986, MEM CALIF ACAD SCI, V8, P1; Gauthier JA, 2011, B PEABODY MUS NAT HI, V52, P107, DOI 10.3374/014.052.0102; Gebauer EVI, 2004, NEUES JAHRB GEOL P-A, V231, P1; Goloboff P, 2008, CLADISTICS, V24, P91; Gower David J., 2000, P140; Gower DJ, 1997, J VERTEBR PALEONTOL, V17, P60, DOI 10.1080/02724634.1997.10010954; Gower DJ, 2000, NEUES JAHRB GEOL P-A, V218, P447, DOI 10.1127/njgpa/218/2000/447; Grauvogel-Stamm L., 1999, TRIAS GANZ ANDERE WE, P271; GRAUVOGELSTAMM L, 1993, REV PALAEOBOT PALYNO, V77, P185, DOI 10.1016/0034-6667(93)90004-E; Hounslow MW, 2010, GEOL SOC SPEC PUBL, V334, P61, DOI 10.1144/SP334.4; Huene F. von, 1902, GEOLOGISCHE PALAONTO, V6, P1; HUENE FRIEDRICH V., 1939, NEUES JAHRB MINERAL GEOL U PALAONT ABT B BEILAGE BD, V81, P61; Huxley T.H., 1877, GEOL SOC AM MEM, VIII, P1; Kallies H.-B., 1963, GEOLOGISCHES JB, V80, P367; KAMPHAUSEN D, 1993, VEREINS, V75, P217; Kozur H., 2005, ALBERTIANA, V32, P21; KOZUR H.W., 2008, BER GEOL B A, V76, P53; Kozur HW, 2010, GEOL SOC SPEC PUBL, V334, P315, DOI 10.1144/SP334.13; Krebs B., 1969, Eclogae Geologicae Helvetiae, V62, P697; KREBS B, 1976, GUSTAV, V13, P40; Krebs B. E., 1965, Schweizerische Palaeontologische Abhandlungen, V81, P1; Kubo T, 2007, PALAEONTOLOGY, V50, P1519, DOI 10.1111/j.1475-4983.2007.00723.x; Kuhn O., 1964, Jahresheft des Vereins fuer Vaterlaendische Naturkunde in Wuerttemberg, V118-119, P293; KUHN O, 1968, DTSCH SAURIER; Kuhn O., 1971, SAURIER DTSCH TRIAS; Kuhn O, 1966, REPTILIEN; KUMM A, 1941, GEOLOGIE LAGERSTATTE, P5; Kurschner WM, 2010, GEOL SOC SPEC PUBL, V334, P263, DOI 10.1144/SP334.11; Lange W., 1922, Zeitschrift der Deutschen Geologischen Gesellschaft Berlin Abhandl, V74, P162; Laurenti JN, 1768, SPECIMEN MED EXHIBEN; Lautenschlager S, 2011, PALAEONTOL Z, V85, P357, DOI 10.1007/s12542-011-0105-1; Li C, 2006, NATURWISSENSCHAFTEN, V93, P200, DOI 10.1007/s00114-006-0097-y; Linnaeus C., 1758, SYSTEMA NATURAE REGN, DOI [10.5962/bhl.title.542, DOI 10.5962/BHL.TITLE.542]; Long R.A., 1995, NEW MEXICO MUSEUM NA, V4, P1; Lucas SG, 1998, PALAEOGEOGR PALAEOCL, V143, P345; Lucas SG, 2002, LETHAIA, V35, P97, DOI 10.1080/002411602320183962; LUCAS SG, 1993, NM MUS NAT HIST SCI, V3, P301; Lucas SG, 2010, GEOL SOC SPEC PUBL, V334, P447, DOI 10.1144/SP334.15; MADER D, 1984, NATURWISSENSCHAFTEN, V71, P137, DOI 10.1007/BF01137774; MADER D, 1982, NATURWISSENSCHAFTEN, V69, P311, DOI 10.1007/BF00480451; Mehl MG, 1915, J GEOL, V23, P516, DOI 10.1086/622268; MEISCHNER KD, 1962, PALAEONTOL Z, V70, P185; MILNER AR, 1990, PALAEONTOLOGY, V33, P873; MULLER AH, 1968, LEHRBUCH PALAOZOOLOG, V3; MULLER AH, 1985, LEHRBUCH PALAOZOOLOG, V3; Muller J, 2005, BIOESSAYS, V27, P1069, DOI 10.1002/bies.20286; Mundil R, 2010, GEOL SOC SPEC PUBL, V334, P41, DOI 10.1144/SP334.3; NAGEL U, 1968, GEOL JB, V86, P5; Nesbitt SJ, 2006, P ROY SOC B-BIOL SCI, V273, P1045, DOI 10.1098/rspb.2005.3426; Nesbitt SJ, 2003, P ROY SOC B-BIOL SCI, V270, pS234, DOI 10.1098/rsbl.2003.0066; NESBITT SJ, 2005, NEUES JB GEOL PAL, V332, P332; Nesbitt S, 2007, B AM MUS NAT HIST, P1; Nesbitt Sterling J., 2005, Historical Biology, V17, P19, DOI 10.1080/08912960500476499; Nesbitt SJ, 2010, EARTH ENV SCI T R SO, V101, P271, DOI 10.1017/S1755691011020044; Nesbitt SJ, 2011, B AM MUS NAT HIST, P1, DOI 10.1206/352.1; Nesbitt SJ, 2010, NATURE, V464, P95, DOI 10.1038/nature08718; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; PEABODY FRANK E., 1948, UNIV CALIFORNIA PUBL BULL DEPT GEOL SCI, V27, P295; Peyer K, 2008, J VERTEBR PALEONTOL, V28, P363, DOI 10.1671/0272-4634(2008)28[363:ANSAFT]2.0.CO;2; Ptaszynski T, 2000, ACTA PALAEONTOL POL, V45, P151; Rettig B, 1996, MITT GEOL I U HANNOV, V35, P1; Rubidge BS, 2005, S AFR J GEOL, V108, P135, DOI 10.2113/108.1.135; SCHACHNER ER, J MORPH IN PRESS, DOI DOI 10.1002/JMOR.10997); SCHLUTER HEINR, 1927, NEUES JAHRB MINERAL GEOL U PALAONT ABHANDL ABT B BEILAGE, V57, P12; Schmidt M., 1938, LEBEWELT UNSERER TRI; Schmidt M., 1928, LEBEWELT UNSERER TRI; Schoch RR, 2011, NEUES JAHRB GEOL P-A, V261, P49, DOI 10.1127/0077-7749/2011/0147; Schoch RR, 2010, NEUES JAHRB GEOL P-A, V255, P345, DOI 10.1127/0077-7749/2009/0030; Sen K, 2005, PALAEONTOLOGY, V48, P185, DOI 10.1111/j.1475-4983.2004.00438.x; SERENO PC, 2005, PHYLOINFORMATICS, V8, P1, DOI DOI 10.5281/ZENODO.59797; Sereno PC, 2005, STEM ARCHOSAURIA; Shishkin Mikhail A., 2000, P120; SHU OY, 1988, REV PALAEOBOT PALYNO, V54, P187, DOI 10.1016/0034-6667(88)90015-2; Spielmann Justin A., 2009, Palaeodiversity, P283; Stille H., 1933, HOCHSCHULEXKURSIONSK, V3; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; Szurlies M, 2007, EARTH PLANET SC LETT, V261, P602, DOI 10.1016/j.epsl.2007.07.018; von Huene F, 1956, PALAONTOLOGIE PHYLOG; von Zittel KA., 1911, GRUNDZUGE PALAONTOLO; von Zittel KA, 1887, HDB PALAEONTOLOGIE; VONHUENE F, 1938, NEUES JB MINERALOG B, V80, P264; VONHUENE F, 1932, PALAEONTOL Z, V14, P200; VONHUENE F, 1940, NEUES JB MINERALOG B, V83, P246; VONHUENE F, 1942, ZENTRALBLATT MINER B, V220, P220; VONHUENE F, 1917, CENTRALBLATT MINER G, V89, P89; VONHUENE F, 1914, CENTRALBLATT MINER G, V496, P496; VONNOPCSA F, 1928, PALAEOBIOLOGICA, V1, P163; VONZITTEL KA, 1923, GRUNDZUGE PALAONTOLO; VONZITTEL KA, 1927, TXB PALAEONTOLOGY, V2; VUSKOV BP, 1964, OSNOVY PALEONTOLOGII, V12, P235; Warrington G., 1980, GEOLOGICAL SOC LONDO, V13, P1; Weber J, 2002, GEOL SOC SPEC PUBL, V205, P103, DOI 10.1144/GSL.SP.2002.205.01.09; WEBER J, 2000, KOLNER FORUM GEOL PA, V7, P1; Wedel M, 2007, SPEC PAP PALAEONTOL, P207; Weinbaum JC, 2007, PALAEONTOL Z, V81, P131, DOI 10.1007/BF02988388; WELLES S. P., 1947, UNIV CALIFORNIA PUBL BULL DEPT GEOL SCI, V27, P241; Wilson JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017114; Wu X, 2008, CHINESE FOSSIL REPTI, P167; WU XC, 1981, VERTEBRAT PALASIATIC, V19, P122; Wu XC, 2001, J VERTEBR PALEONTOL, V21, P40, DOI 10.1671/0272-4634(2001)021[0040:ROTDAA]2.0.CO;2; YOUNG CC, 1964, PALAEONTOL SINICA, V151, P1; Zhang Fa-kui, 1975, Vertebrata Palasiatica, V13, P144	135	98	100	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e25693	10.1371/journal.pone.0025693	http://dx.doi.org/10.1371/journal.pone.0025693			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022431	Green Published, Green Submitted, gold			2022-12-27	WOS:000295981600012
J	O'Meara, WP; Smith, N; Ekal, E; Cole, D; Ndege, S				O'Meara, Wendy Prudhomme; Smith, Nathan; Ekal, Emmanuel; Cole, Donald; Ndege, Samson			Spatial Distribution of Bednet Coverage under Routine Distribution through the Public Health Sector in a Rural District in Kenya	PLOS ONE			English	Article							MALARIA MORBIDITY; MOSQUITO NETS; INSECTICIDE; OWNERSHIP; DETERMINANTS; SUBSIDIES; TANZANIA; DISEASE; SYSTEMS; AFRICA	Insecticide-treated nets (ITNs) are one of the most important and cost-effective tools for malaria control. Maximizing individual and community benefit from ITNs requires high population-based coverage. Several mechanisms are used to distribute ITNs, including health facility-based targeted distribution to high-risk groups; community-based mass distribution; social marketing with or without private sector subsidies; and integrating ITN delivery with other public health interventions. The objective of this analysis is to describe bednet coverage in a district in western Kenya where the primary mechanism for distribution is to pregnant women and infants who attend antenatal and immunization clinics. We use data from a population-based census to examine the extent of, and factors correlated with, ownership of bednets. We use both multivariable logistic regression and spatial techniques to explore the relationship between household bednet ownership and sociodemographic and geographic variables. We show that only 21% of households own any bednets, far lower than the national average, and that ownership is not significantly higher amongst pregnant women attending antenatal clinic. We also show that coverage is spatially heterogeneous with less than 2% of the population residing in zones with adequate coverage to experience indirect effects of ITN protection.	[O'Meara, Wendy Prudhomme] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA; [O'Meara, Wendy Prudhomme; Smith, Nathan] Duke Global Hlth Inst, Durham, NC USA; [O'Meara, Wendy Prudhomme; Ndege, Samson] Moi Univ, Sch Publ Hlth, Dept Epidemiol & Nutr, Eldoret, Kenya; [O'Meara, Wendy Prudhomme; Ndege, Samson] US Agcy Int Dev Acad Model Providing Access Healt, Eldoret, Kenya; [Ekal, Emmanuel] Minist Publ Hlth & Sanitat, Nairobi, Kenya; [Cole, Donald] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Global Hlth, Toronto, ON, Canada	Duke University; Duke University; Moi University; United States Agency for International Development (USAID); University of Toronto	O'Meara, WP (corresponding author), Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA.	wendypomeara@gmail.com	Borrmann, Steffen/G-1838-2013; Cole, Donald C/K-1040-2013	Borrmann, Steffen/0000-0001-9189-4393; Cole, Donald C/0000-0002-1009-603X	Abbott Laboratories; Purpleville Foundation; Global Business Coalition; Bungoma East district	Abbott Laboratories(Abbott Laboratories); Purpleville Foundation; Global Business Coalition; Bungoma East district	The HCT programme was made possible through grants from Abbott Laboratories, the Purpleville Foundation and the Global Business Coalition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge A. Noor (KEMRI-Wellcome Trust, Nairobi) for providing us with GPS coordinates for health facilities and R. Anthopolos (Children's Environmental Health Initiative, Duke University) for assistance with the cluster analysis. Special thanks to the communities and community leaders of Bungoma East district, the community mobilizers and counselors, as well as all the staff who support HCT.	[Anonymous], 2004, COCHRANE DB SYST REV; [Anonymous], 2009, WORLD MAL REP 2009; [Anonymous], Kenya open data; Eng JLV, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-133; Garcia-Basteiro AL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-179; Githinji S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-250; Gosoniu L, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-356; Hawley WA, 2003, AM J TROP MED HYG, V68, P121, DOI 10.4269/ajtmh.2003.68.121; Howard SC, 2000, T ROY SOC TROP MED H, V94, P357, DOI 10.1016/S0035-9203(00)90103-2; Kenya National Bureau of Statistics, 2010, KEN DEM HLTH SURV 20; Khatib RA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-98; KILIAN A, 2007, 4 M RBM WORK GROUP S; Killeen GF, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-121; Killeen GF, 2007, PLOS MED, V4, P1246, DOI 10.1371/journal.pmed.0040229; Kimaiyo S, 2010, East Afr Med J, V87, P100; Larsen DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013129; Macintyre Kate, 2002, Malar J, V1, P14, DOI 10.1186/1475-2875-1-14; Matovu F, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-109; Ministry of Public Health and Sanitation, 2009, KEN NAT MAL STRAT 20; Muller O, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003182; Muller I, 1998, INT J EPIDEMIOL, V27, P878, DOI 10.1093/ije/27.5.878; Noor AM, 2007, PLOS MED, V4, P1341, DOI 10.1371/journal.pmed.0040255; Noor AM, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-13; Noor AM, 2009, LANCET, V373, P58, DOI 10.1016/S0140-6736(08)61596-2; O'Meara WP, 2009, TROP MED INT HEALTH, V14, P29, DOI 10.1111/j.1365-3156.2008.02194.x; Shililu JI, 1998, TROP MED INT HEALTH, V3, P706; Skarbinski J, 2007, AM J TROP MED HYG, V76, P1100, DOI 10.4269/ajtmh.2007.76.1100; Tami A, 2006, HEALTH POLICY PLANN, V21, P1, DOI 10.1093/heapol/czj005; Webster J, 2007, HEALTH POLICY PLANN, V22, P277, DOI 10.1093/heapol/czm021; Wiseman V, 2006, TROP MED INT HEALTH, V11, P419, DOI 10.1111/j.1365-3156.2006.01586.x; Worrall E, 2005, TROP MED INT HEALTH, V10, P1047, DOI 10.1111/j.1365-3156.2005.01476.x	31	19	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25949	10.1371/journal.pone.0025949	http://dx.doi.org/10.1371/journal.pone.0025949			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022481	Green Published, gold, Green Submitted			2022-12-27	WOS:000295976000050
J	Stevens, JR; O'Donnell, AF; Perry, TE; Benjamin, JJR; Barnes, CA; Johnston, GC; Singer, RA				Stevens, Jennifer R.; O'Donnell, Allyson F.; Perry, Troy E.; Benjamin, Jeremy J. R.; Barnes, Christine A.; Johnston, Gerald C.; Singer, Richard A.			FACT, the Bur Kinase Pathway, and the Histone Co-Repressor HirC Have Overlapping Nucleosome-Related Roles in Yeast Transcription Elongation	PLOS ONE			English	Article							RNA-POLYMERASE-II; N-TERMINAL DOMAIN; CELL-CYCLE PROGRESSION; SACCHAROMYCES-CEREVISIAE; IN-VIVO; DNA-REPLICATION; CHROMATIN TRANSCRIPTION; SPURIOUS TRANSCRIPTION; SYNTHETIC LETHAL; GENE-EXPRESSION	Gene transcription is constrained by the nucleosomal nature of chromosomal DNA. This nucleosomal barrier is modulated by FACT, a conserved histone-binding heterodimer. FACT mediates transcription-linked nucleosome disassembly and also nucleosome reassembly in the wake of the RNA polymerase II transcription complex, and in this way maintains the repression of 'cryptic' promoters found within some genes. Here we focus on a novel mutant version of the yeast FACT subunit Spt16 that supplies essential Spt16 activities but impairs transcription-linked nucleosome reassembly in dominant fashion. This Spt16 mutant protein also has genetic effects that are recessive, which we used to show that certain Spt16 activities collaborate with histone acetylation and the activities of a Bur-kinase/Spt4-Spt5/Paf1C pathway that facilitate transcription elongation. These collaborating activities were opposed by the actions of Rpd3S, a histone deacetylase that restores a repressive chromatin environment in a transcription-linked manner. Spt16 activity paralleling that of HirC, a corepressor of histone gene expression, was also found to be opposed by Rpd3S. Our findings suggest that Spt16, the Bur/Spt4-Spt5/Paf1C pathway, and normal histone abundance and/or stoichiometry, in mutually cooperative fashion, facilitate nucleosome disassembly during transcription elongation. The recessive nature of these effects of the mutant Spt16 protein on transcription-linked nucleosome disassembly, contrasted to its dominant negative effect on transcription-linked nucleosome reassembly, indicate that mutant FACT harbouring the mutant Spt16 protein competes poorly with normal FACT at the stage of transcription-linked nucleosome disassembly, but effectively with normal FACT for transcription-linked nucleosome reassembly. This functional difference is consistent with the idea that FACT association with the transcription elongation complex depends on nucleosome disassembly, and that the same FACT molecule that associates with an elongation complex through nucleosome disassembly is retained for reassembly of the same nucleosome.	[Stevens, Jennifer R.; O'Donnell, Allyson F.; Perry, Troy E.; Singer, Richard A.] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada; [Benjamin, Jeremy J. R.; Barnes, Christine A.; Johnston, Gerald C.] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada	Dalhousie University; Dalhousie University	Stevens, JR (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada.	richard.singer@dal.ca			Canadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council of Canada (NSERC); NSERC; Canada Graduate Scholarships; Killam Foundation; Nova Scotia Health Research Foundation; Cancer Nova Scotia; Beatrice Hunter Cancer Research Institute; Terry Fox Foundation at CIHR	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Graduate Scholarships; Killam Foundation; Nova Scotia Health Research Foundation; Cancer Nova Scotia; Beatrice Hunter Cancer Research Institute; Terry Fox Foundation at CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by grants to RAS and GCJ from the Canadian Institutes of Health Research (CIHR) and the Natural Sciences and Engineering Research Council of Canada (NSERC), and to CAB from NSERC. JRS was supported by NSERC and Canada Graduate Scholarships; AFO by studentships from CIHR, NSERC, the Killam Foundation, and the Nova Scotia Health Research Foundation; TEF by a Norah Stephen Oncology Summer Scholarship from Cancer Nova Scotia; and JJRB by a trainee award from the Beatrice Hunter Cancer Research Institute with funds provided by The Terry Fox Foundation Strategic Health Research Training Program in Cancer Research at CIHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard S, 1999, EMBO J, V18, P5108, DOI 10.1093/emboj/18.18.5108; Barbour L, 2000, GENOME, V43, P910, DOI 10.1139/gen-43-5-910; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; BENDER A, 1991, MOL CELL BIOL, V11, P1295, DOI 10.1128/MCB.11.3.1295; Betz JL, 2002, MOL GENET GENOMICS, V268, P272, DOI 10.1007/s00438-002-0752-8; Birch JL, 2009, EMBO J, V28, P854, DOI 10.1038/emboj.2009.33; Biswas D, 2005, MOL CELL BIOL, V25, P5812, DOI 10.1128/MCB.25.14.5812-5822.2005; Biswas D, 2008, GENETICS, V178, P649, DOI 10.1534/genetics.107.084202; Biswas D, 2006, EMBO J, V25, P4479, DOI 10.1038/sj.emboj.7601333; Bondarenko VA, 2006, MOL CELL, V24, P469, DOI 10.1016/j.molcel.2006.09.009; Braun MA, 2007, MOL CELL BIOL, V27, P2800, DOI 10.1128/MCB.01947-06; Brewster NK, 1998, J BIOL CHEM, V273, P21972, DOI 10.1074/jbc.273.34.21972; Brewster NK, 2001, MOL CELL BIOL, V21, P3491, DOI 10.1128/MCB.21.10.3491-3502.2001; Carey M, 2006, MOL CELL, V24, P481, DOI 10.1016/j.molcel.2006.09.012; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Cheung V, 2008, PLOS BIOL, V6, P2550, DOI 10.1371/journal.pbio.0060277; Chu Y, 2007, EMBO J, V26, P4646, DOI 10.1038/sj.emboj.7601887; Chu YY, 2006, MOL CELL BIOL, V26, P3029, DOI 10.1128/MCB.26.8.3029-3038.2006; Clarke AS, 1999, MOL CELL BIOL, V19, P2515; Daniel JA, 2007, MUTAT RES-FUND MOL M, V618, P135, DOI 10.1016/j.mrfmmm.2006.09.008; DeSilva H, 1998, GENETICS, V148, P657; Drouin S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001173; Duina AA, 2007, GENETICS, V177, P101, DOI 10.1534/genetics.106.067140; Evans DRH, 1998, GENETICS, V150, P1393; Formosa T, 2001, EMBO J, V20, P3506, DOI 10.1093/emboj/20.13.3506; Formosa T, 2002, GENETICS, V162, P1557; Forsburg SL, 2001, NAT REV GENET, V2, P659, DOI 10.1038/35088500; Freiberg G, 2000, CURR GENET, V37, P221, DOI 10.1007/s002940050523; Ginsburg DS, 2009, MOL CELL BIOL, V29, P6473, DOI 10.1128/MCB.01033-09; Goldstein AL, 1999, YEAST, V15, P507, DOI 10.1002/(SICI)1097-0061(199904)15:6<507::AID-YEA369>3.0.CO;2-P; Govind CK, 2007, MOL CELL, V25, P31, DOI 10.1016/j.molcel.2006.11.020; Govind CK, 2010, MOL CELL, V39, P234, DOI 10.1016/j.molcel.2010.07.003; Green EM, 2005, CURR BIOL, V15, P2044, DOI 10.1016/j.cub.2005.10.053; Guo M, 2008, STRUCTURE, V16, P1649, DOI 10.1016/j.str.2008.08.013; Hartzog GA, 1998, GENE DEV, V12, P357, DOI 10.1101/gad.12.3.357; Howe L, 2001, GENE DEV, V15, P3144, DOI 10.1101/gad.931401; Imbeault D, 2008, J BIOL CHEM, V283, P27350, DOI 10.1074/jbc.C800147200; Jaehning JA, 2010, BBA-GENE REGUL MECH, V1799, P379, DOI 10.1016/j.bbagrm.2010.01.001; Jamai A, 2009, MOL CELL, V35, P377, DOI 10.1016/j.molcel.2009.07.001; John S, 2000, GENE DEV, V14, P1196; Kang SW, 2000, GENES CELLS, V5, P251, DOI 10.1046/j.1365-2443.2000.00323.x; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Keogh MC, 2003, MOL CELL BIOL, V23, P7005, DOI 10.1128/MCB.23.19.7005-7018.2003; Kihara T, 2008, EXP CELL RES, V314, P629, DOI 10.1016/j.yexcr.2007.10.004; Kim HJ, 2007, EMBO J, V26, P4467, DOI 10.1038/sj.emboj.7601870; Kim J, 2010, CELL, V140, P491, DOI 10.1016/j.cell.2009.12.050; Kim M, 2004, EMBO J, V23, P354, DOI 10.1038/sj.emboj.7600053; Kim T, 2007, J BIOL CHEM, V282, P20827, DOI 10.1074/jbc.M703034200; KRANZ JE, 1990, P NATL ACAD SCI USA, V87, P6629, DOI 10.1073/pnas.87.17.6629; Kulaeva OI, 2007, MUTAT RES-FUND MOL M, V618, P116, DOI 10.1016/j.mrfmmm.2006.05.040; Lejeune E, 2007, CURR BIOL, V17, P1219, DOI 10.1016/j.cub.2007.06.028; Li B, 2009, J BIOL CHEM, V284, P7970, DOI 10.1074/jbc.M808220200; Lindstrom DL, 2003, MOL CELL BIOL, V23, P1368, DOI 10.1128/MCB.23.4.1368-1378.2003; LIU Y, 2009, MOL CELL BIOL; Liu YW, 2010, J BIOL CHEM, V285, P4251, DOI 10.1074/jbc.M109.055996; LORCH Y, 1994, P NATL ACAD SCI USA, V91, P11032, DOI 10.1073/pnas.91.23.11032; MALONE EA, 1991, MOL CELL BIOL, V11, P5710, DOI 10.1128/MCB.11.11.5710; Marton HA, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-4; Mason PB, 2003, MOL CELL BIOL, V23, P8323, DOI 10.1128/MCB.23.22.8323-8333.2003; MCCULLOUGH L, 2011, GENETICS IN PRESS; MUHLRAD D, 1992, YEAST, V8, P79, DOI 10.1002/yea.320080202; Myers CN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020847; O'Donnell AF, 2004, NUCLEIC ACIDS RES, V32, P5894, DOI 10.1093/nar/gkh922; O'Donnell AF, 2009, MOL GENET GENOMICS, V282, P487, DOI 10.1007/s00438-009-0480-4; Okuhara K, 1999, CURR BIOL, V9, P341, DOI 10.1016/S0960-9822(99)80160-2; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; OSLEY MA, 1987, MOL CELL BIOL, V7, P4204, DOI 10.1128/MCB.7.12.4204; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Prochasson P, 2005, GENE DEV, V19, P2534, DOI 10.1101/gad.1341105; Qiu HF, 2009, MOL CELL, V33, P752, DOI 10.1016/j.molcel.2009.02.018; Quan TK, 2010, GENETICS, V184, P321, DOI 10.1534/genetics.109.111526; Ransom M, 2009, J BIOL CHEM, V284, P23461, DOI 10.1074/jbc.M109.019562; ROWLEY A, 1991, MOL CELL BIOL, V11, P5718, DOI 10.1128/MCB.11.11.5718; Santisteban MS, 1997, EMBO J, V16, P2493, DOI 10.1093/emboj/16.9.2493; Saunders A, 2003, SCIENCE, V301, P1094, DOI 10.1126/science.1085712; Schlesinger MB, 2000, GENETICS, V155, P1593; Schneider J, 2005, MOL CELL, V19, P849, DOI 10.1016/j.molcel.2005.07.024; Schwabish MA, 2004, MOL CELL BIOL, V24, P10111, DOI 10.1128/MCB.24.23.10111-10117.2004; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Spencer JA, 1999, J BIOL CHEM, V274, P15686, DOI 10.1074/jbc.274.22.15686; Squazzo SL, 2002, EMBO J, V21, P1764, DOI 10.1093/emboj/21.7.1764; Stuwe T, 2008, P NATL ACAD SCI USA, V105, P8884, DOI 10.1073/pnas.0712293105; Takahata S, 2009, EMBO J, V28, P3378, DOI 10.1038/emboj.2009.270; Takahata S, 2009, MOL CELL, V34, P405, DOI 10.1016/j.molcel.2009.04.010; Tan BCM, 2006, EMBO J, V25, P3975, DOI 10.1038/sj.emboj.7601271; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tu SJ, 2007, J BIOL CHEM, V282, P14262, DOI 10.1074/jbc.M609900200; Uhler JP, 2007, P NATL ACAD SCI USA, V104, P8011, DOI 10.1073/pnas.0702431104; VanDemark AP, 2008, J BIOL CHEM, V283, P5058, DOI 10.1074/jbc.M708682200; VanDemark AP, 2006, MOL CELL, V22, P363, DOI 10.1016/j.molcel.2006.03.025; Winkler DD, 2011, J BIOL CHEM, V286, P18369, DOI 10.1074/jbc.R110.180778; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wittschieben BO, 1999, MOL CELL, V4, P123, DOI 10.1016/S1097-2765(00)80194-X; Wood A, 2005, MOL CELL, V20, P589, DOI 10.1016/j.molcel.2005.09.010; Wood A, 2006, CELL CYCLE, V5, P1066, DOI 10.4161/cc.5.10.2769; Workman JL, 2006, GENE DEV, V20, P2009, DOI 10.1101/gad.1435706; Wyce A, 2007, MOL CELL, V27, P275, DOI 10.1016/j.molcel.2007.01.035; Xin H, 2009, MOL CELL, V35, P365, DOI 10.1016/j.molcel.2009.06.024; Yao S, 2000, MOL CELL BIOL, V20, P7080, DOI 10.1128/MCB.20.19.7080-7087.2000; Youdell ML, 2008, MOL CELL BIOL, V28, P4915, DOI 10.1128/MCB.00001-08; Zeng SX, 2002, EMBO J, V21, P5487, DOI 10.1093/emboj/cdf540; Zhou K, 2009, P NATL ACAD SCI USA, V106, P6956, DOI 10.1073/pnas.0806302106	104	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25644	10.1371/journal.pone.0025644	http://dx.doi.org/10.1371/journal.pone.0025644			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022426	Green Submitted, gold, Green Published			2022-12-27	WOS:000295976000028
J	Nogueira, NPD; de Souza, CF; Saraiva, FMD; Sultano, PE; Dalmau, SR; Bruno, RE; Goncalves, RDS; Laranja, GAT; Leal, LHM; Coelho, MGP; Masuda, CA; Oliveira, MF; Paes, MC				de Almeida Nogueira, Natalia Pereira; de Souza, Cintia Fernandes; de Souza Saraiva, Francis Monique; Sultano, Pedro Elias; Dalmau, Sergio Ranto; Bruno, Roberta Eitler; Sales Goncalves, Renata de Lima; Travassos Laranja, Gustavo Augusto; Monteiro Leal, Luis Henrique; Pinto Coelho, Marsen Garcia; Masuda, Claudio A.; Oliveira, Marcus F.; Paes, Marcia Cristina			Heme-Induced ROS in Trypanosoma Cruzi Activates CaMKII-Like That Triggers Epimastigote Proliferation. One Helpful Effect of ROS	PLOS ONE			English	Article							REDOX REGULATION; HYDROGEN-PEROXIDE; FREE-RADICALS; BLOODSUCKING INSECT; CELL-DEATH; KINASES; HEMATIN; MIDGUT; DEGRADATION; SEQUENCE	Heme is a ubiquitous molecule that has a number of physiological roles. The toxic effects of this molecule have been demonstrated in various models, based on both its pro-oxidant nature and through a detergent mechanism. It is estimated that about 10 mM of heme is released during blood digestion in the blood-sucking bug's midgut. The parasite Trypanosoma cruzi, the agent of Chagas' disease, proliferates in the midgut of the insect vector; however, heme metabolism in trypanosomatids remains to be elucidated. Here we provide a mechanistic explanation for the proliferative effects of heme on trypanosomatids. Heme, but not other porphyrins, induced T. cruzi proliferation, and this phenomenon was accompanied by a marked increase in reactive oxygen species (ROS) formation in epimastigotes when monitored by ROS-sensitive fluorescent probes. Heme-induced ROS production was time-and concentration-dependent. In addition, lipid peroxidation and the formation of 4-hydroxy-2-nonenal (4-HNE) adducts with parasite proteins were increased in epimastigotes in the presence of heme. Conversely, the antioxidants urate and GSH reversed the heme-induced ROS. Urate also decreased parasite proliferation. Among several protein kinase inhibitors tested only specific inhibitors of CaMKII, KN93 and Myr-AIP, were able to abolish heme-induced ROS formation in epimastigotes leading to parasite growth impairment. Taken together, these data provide new insight into T. cruzi-insect vector interactions: heme, a molecule from the blood digestion, triggers epimastigote proliferation through a redox-sensitive signalling mechanism.	[de Souza, Cintia Fernandes; de Souza Saraiva, Francis Monique; Sultano, Pedro Elias; Dalmau, Sergio Ranto; Bruno, Roberta Eitler; Travassos Laranja, Gustavo Augusto; Pinto Coelho, Marsen Garcia; Paes, Marcia Cristina] Univ Estado Rio De Janeiro, Lab Interacao Tripanossomatideos & Vetores, Dept Bioquim, IBRAG, Rio De Janeiro, Brazil; [de Almeida Nogueira, Natalia Pereira] Univ Fed Rio de Janeiro, Lab Artropodos Hematofagos, Inst Bioquim Med, Rio de Janeiro, Brazil; [Monteiro Leal, Luis Henrique] Univ Estado Rio De Janeiro, Lab Microscopia & Proc Imagens, Rio De Janeiro, Brazil; [Sales Goncalves, Renata de Lima; Oliveira, Marcus F.] Univ Fed Rio de Janeiro, Lab Bioquim Redox, Inst Bioquim Med, Rio de Janeiro, Brazil; [Masuda, Claudio A.] Univ Fed Rio de Janeiro, Lab Biol Mol Leveduras, Programa Biol Mol & Biotecnol, Inst Bioquim Med, Rio de Janeiro, Brazil; [Oliveira, Marcus F.] Univ Fed Rio de Janeiro, Lab Inflamacao & Metab, Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, Rio de Janeiro, Brazil; [Paes, Marcia Cristina] Univ Fed Rio de Janeiro, INCT EM, Rio de Janeiro, Brazil	Universidade do Estado do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Nogueira, NPD (corresponding author), Univ Fed Rio de Janeiro, Lab Artropodos Hematofagos, Inst Bioquim Med, Rio de Janeiro, Brazil.	mcpaes@uerj.br	Masuda, Claudio A/F-7214-2014; Coelho, M.G.P./AAR-8546-2021; PAES, MARCIA CRISTINA/AAL-9530-2021; Nogueira, Natalia Pereira Almeida/A-2043-2015; Oliveira, Marcus/G-3158-2011	Masuda, Claudio A/0000-0002-0310-7108; Coelho, M.G.P./0000-0002-8945-7415; Oliveira, Marcus/0000-0002-9890-8425; Pereira de Almeida Nogueira, Natalia/0000-0003-3258-607X; Souza, Cintia/0000-0001-6068-5097; Saraiva, Francis/0000-0002-6744-3549	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); PIBIC/UERJ; FAPERJ Jovens Cientistas do Nosso Estado	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PIBIC/UERJ; FAPERJ Jovens Cientistas do Nosso Estado(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and PIBIC/UERJ. MFO is a research scholar from CNPq and is a recipient of the FAPERJ Jovens Cientistas do Nosso Estado scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFT RL, 1983, J BIOL CHEM, V258, P2069; AFT RL, 1984, J BIOL CHEM, V259, P301; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Barrera G, 2004, FREE RADICAL BIO MED, V37, P597, DOI 10.1016/j.freeradbiomed.2004.05.023; Bonizzi G, 2000, BIOCHEM PHARMACOL, V59, P7, DOI 10.1016/S0006-2952(99)00290-7; Bouallegue A, 2009, FREE RADICAL BIO MED, V47, P858, DOI 10.1016/j.freeradbiomed.2009.06.022; Catala A, 2009, CHEM PHYS LIPIDS, V157, P1, DOI 10.1016/j.chemphyslip.2008.09.004; Chagas C, 1909, MEM I OSWALDO CRUZ, V1, P159, DOI DOI 10.1590/S0074-02761909000200008; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cosentino-Gomes D, 2009, FREE RADICAL BIO MED, V47, P152, DOI 10.1016/j.freeradbiomed.2009.04.020; Deterding LJ, 2004, J BIOL CHEM, V279, P11600, DOI 10.1074/jbc.M310704200; Dhalla NS, 2000, J HYPERTENS, V18, P655, DOI 10.1097/00004872-200018060-00002; DOCAMPO R, 1981, J BIOL CHEM, V256, P930; Dreher D, 1996, EUR J CANCER, V32A, P30, DOI 10.1016/0959-8049(95)00531-5; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Flohe L, 2010, METHOD ENZYMOL, V473, P1, DOI 10.1016/S0076-6879(10)73001-9; Franklin RA, 2006, ANTIOXID REDOX SIGN, V8, P1807, DOI 10.1089/ars.2006.8.1807; Frein D, 2005, BIOCHEM PHARMACOL, V70, P811, DOI 10.1016/j.bcp.2005.04.012; Goldshmit Y, 2001, J BIOL CHEM, V276, P46379, DOI 10.1074/jbc.M105637200; Gough NR, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.281eg10; Graca-Souza AV, 2006, INSECT BIOCHEM MOLEC, V36, P322, DOI 10.1016/j.ibmb.2006.01.009; Halliwell B., 2007, FREE RADICALS BIOL M; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Howe CJ, 2002, J BIOL CHEM, V277, P30469, DOI 10.1074/jbc.M205036200; Howe CJ, 2004, J BIOL CHEM, V279, P44573, DOI 10.1074/jbc.M404175200; Jones DP, 2008, AM J PHYSIOL-CELL PH, V295, pC849, DOI 10.1152/ajpcell.00283.2008; Jones DP, 2006, ANTIOXID REDOX SIGN, V8, P1865, DOI 10.1089/ars.2006.8.1865; KALYANARAMAN B, 1983, J BIOL CHEM, V258, P3855; Lara FA, 2007, BIOCHEM BIOPH RES CO, V355, P16, DOI 10.1016/j.bbrc.2006.12.238; Leslie NR, 2006, ANTIOXID REDOX SIGN, V8, P1765, DOI 10.1089/ars.2006.8.1765; Leslie NR, 2003, EMBO J, V22, P5501, DOI 10.1093/emboj/cdg513; Lombardo ME, 2003, INT J BIOCHEM CELL B, V35, P1263, DOI 10.1016/S1357-2725(03)00033-5; LOWRY OH, 1951, J BIOL CHEM, V193, P265; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1745, DOI 10.1089/ars.2006.8.1745; Menezes D, 2006, PARASITOL RES, V98, P99, DOI 10.1007/s00436-005-0010-1; Menna-Barreto RFS, 2009, FREE RADICAL BIO MED, V47, P644, DOI 10.1016/j.freeradbiomed.2009.06.004; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; Oliveira MF, 2007, COMP BIOCHEM PHYS C, V146, P168, DOI 10.1016/j.cbpc.2006.12.007; Oliveira MF, 2000, FEBS LETT, V477, P95, DOI 10.1016/S0014-5793(00)01786-5; Paes MC, 2001, ARCH INSECT BIOCHEM, V48, P63, DOI 10.1002/arch.1058; Parsons M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-127; Petersen DR, 2004, FREE RADICAL BIO MED, V37, P937, DOI 10.1016/j.freeradbiomed.2004.06.012; Ponka P, 1999, AM J MED SCI, V318, P241, DOI 10.1097/00000441-199910000-00004; Rodriguez-Mora OG, 2006, CANCER BIOL THER, V5, P1022, DOI 10.4161/cbt.5.8.2910; Rudolph TK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.290re7; Ryter SW, 2000, FREE RADICAL BIO MED, V28, P289, DOI 10.1016/S0891-5849(99)00223-3; Sah JF, 2002, J BIOL CHEM, V277, P14902, DOI 10.1074/jbc.M200107200; SCHMITT TH, 1993, ARCH BIOCHEM BIOPHYS, V307, P96, DOI 10.1006/abbi.1993.1566; Singal P K, 2000, Curr Cardiol Rep, V2, P206, DOI 10.1007/s11886-000-0070-x; Souza CF, 2009, BIOCHEM BIOPH RES CO, V390, P541, DOI 10.1016/j.bbrc.2009.09.135; Stiebler R, 2010, INSECT BIOCHEM MOLEC, V40, P284, DOI 10.1016/j.ibmb.2009.12.013; Swulius MT, 2008, CELL MOL LIFE SCI, V65, P2637, DOI 10.1007/s00018-008-8086-2; TAPPEL AL, 1955, J BIOL CHEM, V217, P721; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; VanderZee J, 1996, FREE RADICAL BIO MED, V20, P199, DOI 10.1016/0891-5849(95)02031-4; Wilkinson SR, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001252; Zhang Y, 2005, HYPERTENSION, V46, P732, DOI 10.1161/01.HYP.0000182660.74266.6d	59	39	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e25935	10.1371/journal.pone.0025935	http://dx.doi.org/10.1371/journal.pone.0025935			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022475	Green Submitted, Green Published, gold			2022-12-27	WOS:000295973200023
J	Nilsson, T; Wallinius, M; Gustavson, C; Anckarsater, H; Kerekes, N				Nilsson, Thomas; Wallinius, Marta; Gustavson, Christina; Anckarsater, Henrik; Kerekes, Nora			Violent Recidivism: A Long-Time Follow-Up Study of Mentally Disordered Offenders	PLOS ONE			English	Article							PSYCHOPATHIC TRAITS; AFTER-DISCHARGE; PERSONALITY; PREDICTION; ONSET; AGGRESSION; VALIDITY	Background: In this prospective study, mentally disordered perpetrators of severe violent and/or sexual crimes were followed through official registers for 59 (range 8 to 73) months. The relapse rate in criminality was assessed, compared between offenders sentenced to prison versus forensic psychiatric care, and the predictive ability of various risk factors (criminological, clinical, and of structured assessment instruments) was investigated. Method: One hundred perpetrators were consecutively assessed between 1998 and 2001 by a clinical battery of established instruments covering DSM-IV diagnoses, psychosocial background factors, and structured assessment instruments (HCR-20, PCL-R, and life-time aggression (LHA)). Follow-up data was collected from official registers for: (i) recidivistic crimes, (ii) crimes during ongoing sanction. Results: Twenty subjects relapsed in violent criminality during ongoing sanctions (n = 6) or after discharge/parole (n = 14). Individuals in forensic psychiatric care spent significantly more time at liberty after discharge compared to those in prison, but showed significantly fewer relapses. Criminological (age at first conviction), and clinical (conduct disorder and substance abuse/dependence) risk factors, as well as scores on structured assessment instruments, were moderately associated with violent recidivism. Logistic regression analyses showed that the predictive ability of criminological risk factors versus clinical risk factors combined with scores from assessment instruments was comparable, with each set of variables managing to correctly classify about 80% of all individuals, but the only predictors that remained significant in multiple models were criminological (age at first conviction, and a history of substance abuse among primary relatives). Conclusions: Only one in five relapsed into serious criminality, with significantly more relapses among subjects sentenced to prison as compared to forensic psychiatric care. Criminological risk factors tended to be the best predictors of violent relapses, while few synergies were seen when the risk factors were combined. Overall, the predictive validity of common risk factors for violent criminality was rather weak.	[Nilsson, Thomas] Natl Board Forens Med, Gothenburg, Sweden; [Nilsson, Thomas; Anckarsater, Henrik; Kerekes, Nora] Univ Gothenburg, Inst Neurosci & Physiol, Gothenburg, Sweden; [Wallinius, Marta; Gustavson, Christina; Anckarsater, Henrik] Lund Univ, Dept Clin Sci, Lund, Sweden; [Kerekes, Nora] Swedish Prison & Probat Serv, R&D Unit, Gothenburg, Sweden	Swedish National Board of Forensic Medicine; University of Gothenburg; Lund University	Nilsson, T (corresponding author), Natl Board Forens Med, Gothenburg, Sweden.	thomas.nilsson@neuro.gu.se	Kerekes, Nora/C-6474-2009; Nilsson, Thomas/AAS-3201-2020	Kerekes, Nora/0000-0002-8854-0399; Nilsson, Thomas/0000-0002-7771-3696	National Board of Forensic Medicine in Sweden; Region of Vastra Gotaland under the ALF; Swedish Research Council [2009-62X-20049-04-2, 2010-29950-75655-114]	National Board of Forensic Medicine in Sweden; Region of Vastra Gotaland under the ALF; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the National Board of Forensic Medicine in Sweden, the Region of Vastra Gotaland under the ALF-agreement, and by funds from the Swedish Research Council (No. 2009-62X-20049-04-2, and 2010-29950-75655-114) for HA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, DIAGN STAT MAN MENT; Bonta J, 1998, PSYCHOL BULL, V123, P123, DOI 10.1037/0033-2909.123.2.123; Brennan PA, 2000, ARCH GEN PSYCHIAT, V57, P494, DOI 10.1001/archpsyc.57.5.494; BROWN GL, 1982, AM J PSYCHIAT, V139, P741; Buchanan A, 1998, BRIT J PSYCHIAT, V172, P472, DOI 10.1192/bjp.172.6.472; Dolan M, 2000, BRIT J PSYCHIAT, V177, P303, DOI 10.1192/bjp.177.4.303; Eronen M, 1996, SCHIZOPHRENIA BULL, V22, P83, DOI 10.1093/schbul/22.1.83; Fazel S, 2006, AM J PSYCHIAT, V163, P1397, DOI 10.1176/appi.ajp.163.8.1397; Fazel S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000120; First M. B., 1997, STRUCTURED CLIN INTE; First M. D., 1996, USERS GUIDE STRUCTUR; Friendship C., 1999, CRIM BEHAV MENT HEAL, V9, P226, DOI [10.1002/cbm.315, DOI 10.1002/CBM.315]; Grann M, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-92; Gustavson C, 2007, PSYCHIAT RES, V153, P195, DOI 10.1016/j.psychres.2006.12.020; Gustavson C, 2010, NEUROPSYCHOBIOLOGY, V61, P87, DOI 10.1159/000275820; Hare R. D., 2003, HARE PSYCHOPATHY CHE, V2nd; Hare RD, 2000, BEHAV SCI LAW, V18, P623, DOI 10.1002/1099-0798(200010)18:5<623::AID-BSL409>3.0.CO;2-W; Hare RD., 2003, MANUAL REVISED PSYCH, V2; Hemphill J., 1998, LEGAL CRIMINOL PSYCH, V3, P139, DOI DOI 10.1111/J.2044-8333.1998.TB00355.X; HODGINS S, 1992, ARCH GEN PSYCHIAT, V49, P476, DOI 10.1001/archpsyc.1992.01820060056009; Hodgins S, 1993, MENTAL DISORDER CRIM; Hofvander B, 2009, INT J LAW PSYCHIAT, V32, P224, DOI 10.1016/j.ijlp.2009.04.004; HomeOffice, 2004, PROB STAT ENGL WAL 2; Kim-Cohen J, 2003, ARCH GEN PSYCHIAT, V60, P709, DOI 10.1001/archpsyc.60.7.709; Langan P, 2002, RECIDIVISM PRISONERS; Maden A, 2004, BRIT MED J, V328, P1534, DOI 10.1136/bmj.38075.467569.EE; MOFFITT TE, 1993, PSYCHOL REV, V100, P674, DOI 10.1037/0033-295X.100.4.674; Monahan J, 2005, PSYCHIAT SERV, V56, P810, DOI 10.1176/appi.ps.56.7.810; Monahan J., 2001, RETHINKING RISK ASSE; Quinsey V. L., 2006, VIOLENT OFFENDERS AP, V2nd, DOI 10.1037/11367-000; Quinsey Vernon L., 1998, VIOLENT OFFENDERS AP; Rockhill B, 2001, AM J PUBLIC HEALTH, V91, P365, DOI 10.2105/AJPH.91.3.365; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; SBU, 2005, RISKB INOM PSYK KAN; Singh JP, 2011, CLIN PSYCHOL REV, V31, P499, DOI 10.1016/j.cpr.2010.11.009; Snowden RJ, 2007, PSYCHOL MED, V37, P1539, DOI 10.1017/S0033291707000876; Soderstrom H, 2005, COMPR PSYCHIAT, V46, P111, DOI 10.1016/j.comppsych.2004.07.030; Soderstrom H, 2004, PSYCHIAT RES, V121, P271, DOI 10.1016/S0165-1781(03)00270-1; Steadman HJ, 1998, ARCH GEN PSYCHIAT, V55, P393, DOI 10.1001/archpsyc.55.5.393; Tiihonen J, 1997, AM J PSYCHIAT, V154, P840; Walters GD, 2008, J ABNORM PSYCHOL, V117, P396, DOI 10.1037/0021-843X.117.2.396; Webster C.D., 1997, HCR 20 ASSESSING RIS; Woodward M, 1999, J Epidemiol Biostat, V4, P101; Yoshikawa Kazuo, 2007, Crim Behav Ment Health, V17, P137, DOI 10.1002/cbm.652	44	56	56	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e25768	10.1371/journal.pone.0025768	http://dx.doi.org/10.1371/journal.pone.0025768			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834OZ	22022445	gold, Green Published, Green Submitted			2022-12-27	WOS:000295973200015
J	Burger, KNJ; Beulens, JWJ; Boer, JMA; Spijkerman, AMW; van der A, DL				Burger, Koert N. J.; Beulens, Joline W. J.; Boer, Jolanda M. A.; Spijkerman, Annemieke M. W.; van der A, Daphne L.			Dietary Glycemic Load and Glycemic Index and Risk of Coronary Heart Disease and Stroke in Dutch Men and Women: The EPIC-MORGEN Study	PLOS ONE			English	Article							FOOD-FREQUENCY QUESTIONNAIRE; OBESE YOUNG-ADULTS; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; CARBOHYDRATE INTAKE; RELATIVE VALIDITY; ENERGY-INTAKE; CANCER; CHOLESTEROL; WEIGHT	Background: The associations of glycemic load (GL) and glycemic index (GI) with the risk of cardiovascular diseases (CVD) are not well-established, particularly in men, and may be modified by gender. Objective: To assess whether high dietary GL and GI increase the risk of CVD in men and women. Methods: A large prospective cohort study (EPIC-MORGEN) was conducted within the general Dutch population among 8,855 men and 10,753 women, aged 21-64 years at baseline (1993-1997) and free of diabetes and CVD. Dietary intake was assessed with a validated food-frequency questionnaire and GI and GL were calculated using Foster-Powell's international table of GI. Information on morbidity and mortality was obtained through linkage with national registries. Cox proportional hazards analysis was performed to estimate hazard ratios (HRs) for incident coronary heart disease (CHD) and stroke, while adjusting for age, CVD risk factors, and dietary factors. Results: During a mean follow-up of 11.9 years, 581 CHD cases and 120 stroke cases occurred among men, and 300 CHD cases and 109 stroke cases occurred among women. In men, GL was associated with an increased CHD risk (adjusted HR per SD increase, 1.17 [95% CI, 1.02-1.35]), while no significant association was found in women (1.09 [0.89-1.33]). GI was not associated with CHD risk in both genders, while it was associated with increased stroke risk in men (1.27 [1.02-1.58]) but not in women (0.96 [0.75-1.22]). Similarly, total carbohydrate intake and starch intake were associated with a higher CHD risk in men (1.23 [1.04-1.46]; and 1.24 [1.07-1.45]), but not in women. Conclusion: Among men, high GL and GI, and high carbohydrate and starch intake, were associated with increased risk of CVD.	[Burger, Koert N. J.; Boer, Jolanda M. A.; Spijkerman, Annemieke M. W.; van der A, Daphne L.] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands; [Burger, Koert N. J.; Beulens, Joline W. J.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center	Burger, KNJ (corresponding author), Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands.	Daphne.van.der.A@rivm.nl		Beulens, Joline/0000-0002-4181-0937	Ministry of Health, Welfare and Sport of the Netherlands; National Institute of Public Health and the Environment, Bilthoven, the Netherlands; European Union	Ministry of Health, Welfare and Sport of the Netherlands; National Institute of Public Health and the Environment, Bilthoven, the Netherlands(Netherlands Government); European Union(European Commission)	The MORGEN Study was funded by the Ministry of Health, Welfare and Sport of the Netherlands, the National Institute of Public Health and the Environment, Bilthoven, the Netherlands, and the Europe Against Cancer Program of the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aryangat AV, 2010, VASC HEALTH RISK MAN, V6, P145; Aston LM, 2006, P NUTR SOC, V65, P125, DOI 10.1079/PNS2005485; Atkinson FS, 2008, DIABETES CARE, V31, P2281, DOI 10.2337/dc08-1239; Beulens JWJ, 2007, J AM COLL CARDIOL, V50, P14, DOI 10.1016/j.jacc.2007.02.068; Chrysant SG, 2010, AM J CARDIOL, V106, P825, DOI 10.1016/j.amjcard.2010.05.006; Dickinson S, 2008, AM J CLIN NUTR, V87, P1188; Du HD, 2009, BRIT J NUTR, V102, P601, DOI 10.1017/S0007114508207269; Ebbeling CB, 2007, JAMA-J AM MED ASSOC, V297, P2092, DOI 10.1001/jama.297.19.2092; Ebbeling CB, 2005, AM J CLIN NUTR, V81, P976; Foster-Powell K, 2002, AM J CLIN NUTR, V76, P5, DOI 10.1093/ajcn/76.1.5; Frost G, 1999, LANCET, V353, P1045, DOI 10.1016/S0140-6736(98)07164-5; Gerich JE, 2003, ARCH INTERN MED, V163, P1306, DOI 10.1001/archinte.163.11.1306; GOLDBERG GR, 1991, EUR J CLIN NUTR, V45, P569; HERINGS RMC, 1992, J EPIDEMIOL COMMUN H, V46, P136, DOI 10.1136/jech.46.2.136; Hoekstra T, 2009, MATURITAS, V63, P20, DOI 10.1016/j.maturitas.2009.02.003; Howlett J, 2008, AM J CLIN NUTR, V87, p212S, DOI 10.1093/ajcn/87.1.212S; Jakobsen MU, 2010, AM J CLIN NUTR, V91, P1764, DOI 10.3945/ajcn.2009.29099; JENKINS DJA, 1981, AM J CLIN NUTR, V34, P362, DOI 10.1093/ajcn/34.3.362; Knopp Robert H, 2006, Curr Cardiol Rep, V8, P452, DOI 10.1007/s11886-006-0104-0; Leppala JM, 1999, STROKE, V30, P2535, DOI 10.1161/01.STR.30.12.2535; Levitan EB, 2008, METABOLISM, V57, P437, DOI 10.1016/j.metabol.2007.11.002; Levitan EB, 2007, AM J CLIN NUTR, V85, P1521, DOI 10.1093/ajcn/85.6.1521; Levitan EB, 2010, BRIT J NUTR, V103, P1049, DOI 10.1017/S0007114509992674; Liu SM, 2000, AM J CLIN NUTR, V71, P1455; Liu SM, 2001, AM J CLIN NUTR, V73, P560; Lopez-Miranda J, 2007, BRIT J NUTR, V98, P458, DOI 10.1017/S000711450774268X; Maki KC, 2007, AM J CLIN NUTR, V85, P724, DOI 10.1093/ajcn/85.3.724; McKeown NM, 2009, J AM COLL NUTR, V28, P150, DOI 10.1080/07315724.2009.10719766; McMillan-Price J, 2006, ARCH INTERN MED, V166, P1466, DOI 10.1001/archinte.166.14.1466; Mursu J, 2011, NUTR METAB CARDIOVAS, V21, P144, DOI 10.1016/j.numecd.2009.08.001; Oba S, 2010, METABOLISM, V59, P1574, DOI 10.1016/j.metabol.2010.02.004; Ocke MC, 1997, INT J EPIDEMIOL, V26, pS37, DOI 10.1093/ije/26.suppl_1.S37; Ocke MC, 1997, INT J EPIDEMIOL, V26, pS49, DOI 10.1093/ije/26.suppl_1.S49; Oh K, 2005, AM J EPIDEMIOL, V161, P161, DOI 10.1093/aje/kwi026; Pereira MA, 2004, JAMA-J AM MED ASSOC, V292, P2482, DOI 10.1001/jama.292.20.2482; Rayner M, 2009, EUR J CARDIOV PREV R, V16, pS43, DOI 10.1097/01.hjr.0000359235.59808.ba; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Rizkalla SW, 2004, DIABETES CARE, V27, P1866, DOI 10.2337/diacare.27.8.1866; Salmeron J, 1997, JAMA-J AM MED ASSOC, V277, P472, DOI 10.1001/jama.277.6.472; Schurks M, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5702; Sieri S, 2010, ARCH INTERN MED, V170, P640, DOI 10.1001/archinternmed.2010.15; Sluijs I, 2010, AM J CLIN NUTR, V92, P905, DOI 10.3945/ajcn.2010.29620; Tavani A, 2003, HEART, V89, P722, DOI 10.1136/heart.89.7.722; van Dam RM, 2000, EUR J CLIN NUTR, V54, P726, DOI 10.1038/sj.ejcn.1601086; Verschuren WMM, 2008, INT J EPIDEMIOL, V37, P1236, DOI 10.1093/ije/dym292; Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; Williams SM, 2008, BRIT J NUTR, V100, P364, DOI 10.1017/S0007114507894311; Wolever TMS, 2010, BRIT J NUTR, V103, P1695, DOI 10.1017/S0007114510000620; Wolever TMS, 1997, DIABETES CARE, V20, P452, DOI 10.2337/diacare.20.3.452; WOLEVER TMS, 1994, AM J CLIN NUTR, V59, P1265, DOI 10.1093/ajcn/59.6.1265	51	54	54	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25955	10.1371/journal.pone.0025955	http://dx.doi.org/10.1371/journal.pone.0025955			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998729	Green Published, gold, Green Submitted			2022-12-27	WOS:000295966900080
J	Marsh, AA; Crowe, SL; Yu, HH; Gorodetsky, EK; Goldman, D; Blair, RJR				Marsh, Abigail A.; Crowe, Samantha L.; Yu, Henry H.; Gorodetsky, Elena K.; Goldman, David; Blair, R. J. R.			Serotonin Transporter Genotype (5-HTTLPR) Predicts Utilitarian Moral Judgments	PLOS ONE			English	Article							NEGATIVE AFFECTIVITY; PREFRONTAL CORTEX; SUSCEPTIBILITY; POLYMORPHISM; PSYCHOPATHY; DEPRESSION; AMYGDALA; RISK; GENE	Background: The psychological and neurobiological processes underlying moral judgment have been the focus of extensive recent research. Here we show that serotonin transporter (5-HTTLPR) genotype predicts responses to moral dilemmas featuring foreseen harm to an innocent. Methodology/Principal Findings: Participants in this study judged the acceptability of actions that would unintentionally or intentionally harm an innocent victim in order to save others' lives. An analysis of variance revealed a genotype 6 scenario interaction, F(2, 63)=4.52, p=.02. Results showed that, relative to long allele homozygotes (LL), carriers of the short (S) allele showed particular reluctance to endorse utilitarian actions resulting in foreseen harm to an innocent individual. LL genotype participants rated perpetrating unintentional harm as more acceptable (M=4.98, SEM=0.20) than did SL genotype participants (M=4.65, SEM=0.20) or SS genotype participants (M=4.29, SEM=0.30). No group differences in moral judgments were observed in response to scenarios featuring intentional harm. Conclusions/Significance: The results indicate that inherited variants in a genetic polymorphism that influences serotonin neurotransmission influence utilitarian moral judgments as well. This finding is interpreted in light of evidence that the S allele is associated with elevated emotional responsiveness.	[Marsh, Abigail A.] Georgetown Univ, Dept Psychol, Washington, DC 20057 USA; [Marsh, Abigail A.; Crowe, Samantha L.; Yu, Henry H.; Blair, R. J. R.] NIMH, Mood & Anxiety Program, Bethesda, MD 20892 USA; [Gorodetsky, Elena K.; Goldman, David] NIAAA, Sect Human Neurogenet, Bethesda, MD 90034 USA	Georgetown University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Marsh, AA (corresponding author), Georgetown Univ, Dept Psychol, Washington, DC 20057 USA.	aam72@georgetown.edu	Majid, Salma/AAT-2616-2020; Blair, Robert James/ABH-7982-2020; Goldman, David/F-9772-2010	Majid, Salma/0000-0002-1724-5405; Goldman, David/0000-0002-1724-5405; Blair, Robert James/0000-0002-6377-2361; Yu, Henry/0000-0003-3789-5250	National Institute of Mental Health/Nathional Institutes of Health; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000301] Funding Source: NIH RePORTER	National Institute of Mental Health/Nathional Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by the Intramural Research Program at the National Institute of Mental Health/Nathional Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blair RJR, 2007, TRENDS COGN SCI, V11, P387, DOI 10.1016/j.tics.2007.07.003; Borg JS, 2006, J COGNITIVE NEUROSCI, V18, P803, DOI 10.1162/jocn.2006.18.5.803; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452; Collier DA, 1996, MOL PSYCHIATR, V1, P453; Crockett MJ, 2010, P NATL ACAD SCI USA, V107, P17433, DOI 10.1073/pnas.1009396107; Emanuel EJ, 2001, NEW ENGL J MED, V345, P915, DOI 10.1056/NEJM200109203451211; Glenn AL, 2011, NEUROSCI BIOBEHAV R, V35, P612, DOI 10.1016/j.neubiorev.2010.07.005; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Hariri AR, 2006, TRENDS COGN SCI, V10, P182, DOI 10.1016/j.tics.2006.02.011; Harmon A, 2010, NY TIMES        0918; Jacobs N, 2006, ARCH GEN PSYCHIAT, V63, P989, DOI 10.1001/archpsyc.63.9.989; Koenigs M, 2007, NATURE, V446, P908, DOI 10.1038/nature05631; Kogut T, 2005, ORGAN BEHAV HUM DEC, V97, P106, DOI 10.1016/j.obhdp.2005.02.003; Miczek KA, 2007, J NEUROSCI, V27, P11803, DOI 10.1523/JNEUROSCI.3500-07.2007; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Quill TE, 1997, NEW ENGL J MED, V337, P1768, DOI 10.1056/NEJM199712113372413; WATSON D, 1984, PSYCHOL BULL, V96, P465, DOI 10.1037/0033-2909.96.3.465	18	27	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25148	10.1371/journal.pone.0025148	http://dx.doi.org/10.1371/journal.pone.0025148			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998637	gold, Green Published, Green Submitted			2022-12-27	WOS:000295966900010
J	Oosting, M; ter Hofstede, H; Sturm, P; Adema, GJ; Kullberg, BJ; van der Meer, JWM; Netea, MG; Joosten, LAB				Oosting, Marije; ter Hofstede, Hadewych; Sturm, Patrick; Adema, Gosse J.; Kullberg, Bart-Jan; van der Meer, Jos W. M.; Netea, Mihai G.; Joosten, Leo A. B.			TLR1/TLR2 Heterodimers Play an Important Role in the Recognition of Borrelia Spirochetes	PLOS ONE			English	Article							RECEPTOR SIGNALING PATHWAY; TOLL-LIKE RECEPTOR-6; LYME-DISEASE; CUTTING EDGE; HUMAN MONOCYTES; ERYTHEMA MIGRANS; IMMUNE-RESPONSE; HOST-DEFENSE; BURGDORFERI; TLR1	After infection with Borrelia species, the risk for developing Lyme disease varies significantly between individuals. Recognition of Borrelia by the immune system is mediated by pattern recognition receptors (PRRs), such as TLRs. While TLR2 is the main recognition receptor for Borrelia spp., little is known about the role of TLR1 and TLR6, which both can form functionally active heterodimers with TLR2. Here we investigated the recognition of Borrelia by both murine and human TLR1 and TLR6. Peritoneal macrophages from TLR1- and TLR6- gene deficient mice were isolated and exposed to Borrelia. Human PBMCs were stimulated with Borrelia with or without specific TLR1 and TLR6 blocking using specific antibodies. Finally, the functional consequences of TLR polymorphisms on Borrelia-induced cytokine production were assessed. Splenocytes isolated from both TLR1-/- and TLR-/- mice displayed a distorted Th1/Th2 cytokine balance after stimulation with B. burgdorferi, while no differences in pro-inflammatory cytokine production were observed. In contrast, blockade of TLR1 with specific neutralizing antibodies led to decreased cytokine production by human PBMCs after exposure to B. burgdorferi. Blockade of human TLR6 did not lead to suppression of cytokine production. When PBMCs from healthy individuals bearing polymorphisms in TLR1 were exposed to B. burgdorferi, a remarkably decreased in vitro cytokine production was observed in comparison to wild-type controls. TLR6 polymorphisms lead to a minor modified cytokine production. This study indicates a dominant role for TLR1/TLR2 heterodimers in the induction of the early inflammatory response by Borrelia spirochetes in humans.	[Oosting, Marije; ter Hofstede, Hadewych; Kullberg, Bart-Jan; van der Meer, Jos W. M.; Netea, Mihai G.; Joosten, Leo A. B.] Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6525 ED Nijmegen, Netherlands; [Oosting, Marije; Kullberg, Bart-Jan; van der Meer, Jos W. M.; Netea, Mihai G.; Joosten, Leo A. B.] Radboud Univ Nijmegen, Nijmegen Inst Infect Inflammat & Immun N4i, NL-6525 ED Nijmegen, Netherlands; [Sturm, Patrick] Radboud Univ Nijmegen, Med Ctr, Dept Microbiol, NL-6525 ED Nijmegen, Netherlands; [Adema, Gosse J.] Radboud Univ Nijmegen, Med Ctr, Dept Tumor Immunol, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Oosting, M (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6525 ED Nijmegen, Netherlands.	l.joosten@aig.umcn.nl	Joosten, Leo AB/H-3138-2015; Oosting, Marije/H-7437-2015; Kullberg, BJ/C-8520-2013; Hofstede, Hadewych ter/AAD-1118-2019; Adema, G.J./H-8007-2014; Netea, Mihai/N-5155-2014; van der Meer, Jos W.M./C-8521-2013	Joosten, Leo AB/0000-0001-6166-9830; Kullberg, BJ/0000-0002-6813-8167; van der Meer, Jos W.M./0000-0001-5120-3690	Dutch Arthritis Association [NR 10-1-303]; Netherlands Organization for Scientific Research	Dutch Arthritis Association; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This study was supported by the Dutch Arthritis Association (NR 10-1-303). M.G.N. was supported by a Vici grant of the Netherlands Organization for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou L, 2002, NAT MED, V8, P878, DOI 10.1038/nm732; BALMELLI T, 1995, RES MICROBIOL, V146, P329, DOI 10.1016/0923-2508(96)81056-4; Bulut Y, 2001, J IMMUNOL, V167, P987, DOI 10.4049/jimmunol.167.2.987; BURGDORFER W, 1982, SCIENCE, V216, P1317, DOI 10.1126/science.7043737; Cabral ES, 2006, J INFECT DIS, V193, P849, DOI 10.1086/500467; Cruz AR, 2008, INFECT IMMUN, V76, P56, DOI 10.1128/IAI.01039-07; Dennis VA, 2009, INFECT IMMUN, V77, P1238, DOI 10.1128/IAI.01078-08; Fikrig E, 2009, J INFECT DIS, V200, P1331, DOI 10.1086/605950; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Glickstein L, 2003, INFECT IMMUN, V71, P6051, DOI 10.1128/IAI.71.10.6051-6053.2003; Hawn TR, 2007, EUR J IMMUNOL, V37, P2280, DOI 10.1002/eji.200737034; Hirschfeld M, 1999, J IMMUNOL, V163, P2382; Hoshino K, 1999, J IMMUNOL, V162, P3749; Infante-Duarte C, 2000, J IMMUNOL, V165, P6107, DOI 10.4049/jimmunol.165.11.6107; Johnson CM, 2007, J IMMUNOL, V178, P7520, DOI 10.4049/jimmunol.178.12.7520; Jones KL, 2008, CLIN INFECT DIS, V46, P85, DOI 10.1086/524022; Kesh S, 2005, ANN NY ACAD SCI, V1062, P95, DOI 10.1196/annals.1358.012; Leoratti FMS, 2008, J INFECT DIS, V198, P772, DOI 10.1086/590440; Misch EA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000231; Morr M, 2002, EUR J IMMUNOL, V32, P3337, DOI 10.1002/1521-4141(2002012)32:12<3337::AID-IMMU3337>3.0.CO;2-I; Netea MG, 1996, J CLIN INVEST, V97, P1366, DOI 10.1172/JCI118556; Netea MG, 2008, FEMS IMMUNOL MED MIC, V52, P118, DOI 10.1111/j.1574-695X.2007.00353.x; Oosting M, 2010, J INFECT DIS, V201, P1849, DOI 10.1086/652871; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Pierik M, 2006, INFLAMM BOWEL DIS, V12, P1, DOI 10.1097/01.MIB.0000195389.11645.ab; Sandor F, 2003, J CELL BIOL, V162, P1099, DOI 10.1083/jcb.200304093; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Tantisira K, 2004, GENES IMMUN, V5, P343, DOI 10.1038/sj.gene.6364096; Wang XH, 2008, FEMS IMMUNOL MED MIC, V52, P124, DOI 10.1111/j.1574-695X.2007.00356.x; Wooten RM, 2002, J IMMUNOL, V168, P348, DOI 10.4049/jimmunol.168.1.348	31	44	46	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25998	10.1371/journal.pone.0025998	http://dx.doi.org/10.1371/journal.pone.0025998			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998742	Green Published, gold, Green Submitted			2022-12-27	WOS:000295966900088
J	Elfaitouri, A; Shao, XW; Ulfstedt, JM; Muradrasoli, S; Wiener, AB; Golbob, S; Ohrmalm, C; Matousek, M; Zachrisson, O; Gottfries, CG; Blomberg, J				Elfaitouri, Amal; Shao, Xingwu; Ulfstedt, Johan Mattsson; Muradrasoli, Shaman; Wiener, Agnes Bolin; Golbob, Sultan; Ohrmalm, Christina; Matousek, Michael; Zachrisson, Olof; Gottfries, Carl-Gerhard; Blomberg, Jonas			Murine Gammaretrovirus Group G3 Was Not Found in Swedish Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Fibromyalgia	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; ENDOGENOUS RETROVIRAL SEQUENCES; LEUKEMIA-VIRUS; PROSTATE-CANCER; INFECTIOUS RETROVIRUS; BLOOD-CELLS; XMRV; CONTAMINATION; PCR; DNA	Background: The recent report of gammaretroviruses of probable murine origin in humans, called xenotropic murine retrovirus related virus (XMRV) and human murine leukemia virus related virus (HMRV), necessitated a bioinformatic search for this virus in genomes of the mouse and other vertebrates, and by PCR in humans. Results: Three major groups of murine endogenous gammaretroviruses were identified. The third group encompassed both exogenous and endogenous Murine Leukemia Viruses (MLVs), and most XMRV/HMRV sequences reported from patients suffering from myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Two sensitive real-time PCRs for this group were developed. The predicted and observed amplification range for these and three published XMRV/HMRV PCRs demonstrated conspicuous differences between some of them, partly explainable by a recombinatorial origin of XMRV. Three reverse transcription real-time PCRs (RTQPCRs), directed against conserved and not overlapping stretches of env, gag and integrase (INT) sequences of XMRV/HMRV were used on human samples. White blood cells from 78 patients suffering from ME/CFS, of which 30 patients also fulfilled the diagnostic criteria for fibromyalgia (ME/CFS/FM) and in 7 patients with fibromyalgia (FM) only, all from the Gothenburg area of Sweden. As controls we analyzed 168 sera from Uppsala blood donors. We controlled for presence and amplifiability of nucleic acid and for mouse DNA contamination. To score as positive, a sample had to react with several of the XMRV/HMRV PCRs. None of the samples gave PCR reactions which fulfilled the positivity criteria. Conclusions: XMRV/HMRV like proviruses occur in the third murine gammaretrovirus group, characterized here. PCRs developed by us, and others, approximately cover this group, except for the INT RTQPCR, which is rather strictly XMRV specific. Using such PCRs, XMRV/HMRV could not be detected in PBMC and plasma samples from Swedish patients suffering from ME/CFS/FM, and in sera from Swedish blood donors.	[Elfaitouri, Amal; Shao, Xingwu; Ulfstedt, Johan Mattsson; Muradrasoli, Shaman; Wiener, Agnes Bolin; Golbob, Sultan; Ohrmalm, Christina; Blomberg, Jonas] Uppsala Univ, Dept Med Sci, Sect Clin Virol, Uppsala, Sweden; [Matousek, Michael; Zachrisson, Olof; Gottfries, Carl-Gerhard] Univ Gothenburg, Gottfries Clin AB, Inst Neurosci & Physiol, Gothenburg, Sweden	Uppsala University; University of Gothenburg	Elfaitouri, A (corresponding author), Uppsala Univ, Dept Med Sci, Sect Clin Virol, Uppsala, Sweden.	Jonas.Blomberg@medsci.uu.se	Elfaitouri, Amal/GRO-7027-2022	Elfaitouri, Amal/0000-0002-0704-3252; Blomberg, Jonas/0000-0001-6492-2491; Ohrmalm, Christina/0000-0002-3287-3549	ME Research UK [SC 036942]; Irish ME Trust; stiftelsen Lars Hiertas minne [FO2010-0672]	ME Research UK; Irish ME Trust; stiftelsen Lars Hiertas minne	This work was supported by ME Research UK (Charity number SC 036942), and the Irish ME Trust and stiftelsen Lars Hiertas minne (FO2010-0672). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken CEM, 2008, REPROD BIOMED ONLINE, V17, P806, DOI 10.1016/S1472-6483(10)60409-9; Andersson AC, 2005, J VIROL, V79, P9270, DOI 10.1128/JVI.79.14.9270-9284.2005; BLOMBERG J, 2011, ADV VIROLOG IN PRESS; BLOMBERG J, 2010, APR 29 MAY 4 PRAG ME, P19; Bromham L, 2001, J VIROL, V75, P3053, DOI 10.1128/JVI.75.6.3053-3057.2001; BUCHWALD D, 1995, ANN INTERN MED, V123, P81, DOI 10.7326/0003-4819-123-2-199507150-00001; Carruthers BM, 2007, J CLIN PATHOL, V60, P117, DOI 10.1136/jcp.2006.042754; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Forsman A, 2003, J VIROL METHODS, V111, P1, DOI 10.1016/S0166-0934(03)00127-7; Garson JA, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-13; HALTMEIER M, 1995, VIROLOGY, V209, P550, DOI 10.1006/viro.1995.1287; Hohn O, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-92; Jason LA, 2010, BEHAV MED, V36, P24, DOI 10.1080/08964280903521370; Jern P, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-50; Jern P, 2007, PLOS GENET, V3, P2014, DOI 10.1371/journal.pgen.0030183; Kaiser J, 2011, SCIENCE, V331, P17, DOI 10.1126/science.331.6013.17; KAWAKAMI TG, 1978, J NATL CANCER I, V61, P1113; KAWAKAMI TG, 1980, INT J CANCER, V25, P641, DOI 10.1002/ijc.2910250514; KEWALRAMANI VN, 1992, J VIROL, V66, P3026, DOI 10.1128/JVI.66.5.3026-3031.1992; Lo SC, 2010, P NATL ACAD SCI USA, V107, P15874, DOI 10.1073/pnas.1006901107; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Mikovits JA, 2010, VIRULENCE, V1, P386, DOI 10.4161/viru.1.5.12486; Mikovits JA, 2010, AIDS REV, V12, P149; Oakes B, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-109; OHRMALM C, 2010, NUCLEIC ACIDS RES, P1; Paprotka T, 2011, SCIENCE, V333, P97, DOI 10.1126/science.1205292; Ribet D, 2008, J VIROL, V82, P4413, DOI 10.1128/JVI.02141-07; Robinson MJ, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-108; Roca AL, 2004, J VIROL, V78, P4370, DOI 10.1128/JVI.78.8.4370-4375.2004; Sato E, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-110; Sauter D, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-103; Schlaberg R, 2009, P NATL ACAD SCI USA, V106, P16351, DOI 10.1073/pnas.0906922106; Smith RA, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-112; Sperber G, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S6-S4; Sperber GO, 2007, NUCLEIC ACIDS RES, V35, P4964, DOI 10.1093/nar/gkm515; Stocking C, 2008, CELL MOL LIFE SCI, V65, P3383, DOI 10.1007/s00018-008-8497-0; STOYE JP, 1987, J VIROL, V61, P2659, DOI 10.1128/JVI.61.9.2659-2669.1987; Switzer WM, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-57; Tamura K, 2011, MOL BIOL EVOLUTION; Tarlinton R, 2008, CELL MOL LIFE SCI, V65, P3413, DOI 10.1007/s00018-008-8499-y; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tipper CH, 2005, J VIROL, V79, P8316, DOI 10.1128/JVI.79.13.8316-8329.2005; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; Voisset C, 2008, MICROBIOL MOL BIOL R, V72, P157, DOI 10.1128/MMBR.00033-07; Weiss RA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-124; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Zachrisson O, 2002, J PSYCHOSOM RES, V52, P501, DOI 10.1016/S0022-3999(01)00315-4	48	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e24602	10.1371/journal.pone.0024602	http://dx.doi.org/10.1371/journal.pone.0024602			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022360	Green Submitted, gold, Green Published			2022-12-27	WOS:000295976000004
J	Faggioli, F; Vezzoni, P; Montagna, C				Faggioli, Francesca; Vezzoni, Paolo; Montagna, Cristina			Single-Cell Analysis of Ploidy and Centrosomes Underscores the Peculiarity of Normal Hepatocytes	PLOS ONE			English	Article							MOUSE-LIVER; TETRAPLOIDY; POLYPLOIDY; ANEUPLOIDY; ABNORMALITIES; CYTOKINESIS; CENTRIOLES; DISEASE; CANCER; FUSION	Polyploidization is the most well recognized feature of the liver. Yet, a quantitative and behavioral analysis of centrosomes and DNA content in normal hepatocytes has been limited by the technical challenges of methods available. By using a novel approach employing FISH for chromosomes 18, X and Y we provide, for the first time, a detailed analysis of DNA copies during physiological development in the liver at single cell level. We demonstrate that aneuploidy and unbalanced DNA content in binucleated hepatocytes are common features in normal adult liver. Despite the common belief that hepatocytes contain 1, 2 or no more than 4 centrosomes, our double staining for centrosome associated proteins reveals extranumerary centrosomes in a high percentage of cells as early as 15 days of age. We show that in murine liver the period between 15 days and 1.5 months marks the transition from a prevalence of mononucleated cells to up to 75% of binucleated cells. Our data demonstrate that this timing correlates with a switch in centrosomes number. At 15 days the expected 1 or 2 centrosomes converge with several hepatocytes that contain 3 centrosomes; at 1.5 months the percentage of cells with 3 centrosomes decreases concomitantly with the increase of cells with more than 4 centrosomes. Our analysis shows that the extranumerary centrosomes emerge in concomitance with the process of binucleation and polyploidization and maintain alpha-tubulin nucleation activity. Finally, by integrating interphase FISH and immunofluorescent approaches, we detected an imbalance between centrosome number and DNA content in liver cells that deviates from the equilibrium expected in normal cells. We speculate that these unique features are relevant to the peculiar biological function of liver cells which are continuously challenged by stress, a condition that could predispose to genomic instability.	[Faggioli, Francesca; Vezzoni, Paolo] CNR, Ist Ric Genet & Biomed, Milan Unit, I-20133 Milan, Italy; [Faggioli, Francesca; Vezzoni, Paolo] Ist Clin Humanitas, Med Biotechnol Unit, Milan, Italy; [Montagna, Cristina] Albert Einstein Coll Med, Dept Genet, New York, NY USA	Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); IRCCS Humanitas Research Hospital; Yeshiva University	Faggioli, F (corresponding author), CNR, Ist Ric Genet & Biomed, Milan Unit, I-20133 Milan, Italy.	paolo.vezzoni@itb.cnr.it	Vezzoni, Paolo/R-3416-2019; Vezzoni, Paolo/K-3197-2018; Faggioli, Francesca/K-1592-2016	Faggioli, Francesca/0000-0001-8030-3674; Vezzoni, Paolo/0000-0002-6382-3923	Associazione Italiana per la Ricerca sul Cancro; Ministry of University and Research "Fondo per gli Investimenti della Ricerca di Base" [RBAP11H2R9-04]	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Ministry of University and Research "Fondo per gli Investimenti della Ricerca di Base"	This work was partially funded by Associazione Italiana per la Ricerca sul Cancro, Project "A straightforward approach to the study of the role of cell fusion in cancer" to PV and by Ministry of University and Research "Fondo per gli Investimenti della Ricerca di Base" RBAP11H2R9-04 to PV. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassen PR, 2001, MOL BIOL CELL, V12, P1315, DOI 10.1091/mbc.12.5.1315; Celton-Morizur S, 2010, ADV EXP MED BIOL, V676, P123; Celton-Morizur S, 2009, J CLIN INVEST, V119, P1880, DOI 10.1172/JCI38677; Chang MY, 2008, NEPHRON PHYSIOL, V108, P1, DOI 10.1159/000112495; Difilippantonio MJ, 2009, ENVIRON MOL MUTAGEN, V50, P672, DOI 10.1002/em.20532; Duncan AW, 2010, NATURE, V467, P707, DOI 10.1038/nature09414; Duncan AW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000385; FAGGIOLI F, MECH AGEING IN PRESS; Faggioli F, 2008, HEPATOLOGY, V48, P1655, DOI 10.1002/hep.22488; FAKTOR VM, 1975, TSITOLOGIYA+, V17, P909; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Guidotti JE, 2003, J BIOL CHEM, V278, P19095, DOI 10.1074/jbc.M300982200; Gupta S, 2000, SEMIN CANCER BIOL, V10, P161; Lee HO, 2009, GENE DEV, V23, P2461, DOI 10.1101/gad.1829209; Margall-Ducos G, 2007, J CELL SCI, V120, P3633, DOI 10.1242/jcs.016907; Margolis RL, 2005, CANCER CELL, V8, P353, DOI 10.1016/j.ccr.2005.10.017; Nelsen CJ, 2005, J BIOL CHEM, V280, P768, DOI 10.1074/jbc.M407105200; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; SIGAL SH, 1995, DIFFERENTIATION, V59, P35, DOI 10.1046/j.1432-0436.1995.5910035.x; Storchova Z, 2008, J CELL SCI, V121, P3859, DOI 10.1242/jcs.039537; Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211; Valente EM, 2010, NAT GENET, V42, P619, DOI 10.1038/ng.594; Villa A, 2009, CALCIFIED TISSUE INT, V84, P1, DOI 10.1007/s00223-008-9196-4; Willenbring H, 2004, NAT MED, V10, P744, DOI 10.1038/nm1062; Wong C, 2003, NAT CELL BIOL, V5, P539, DOI 10.1038/ncb993	26	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26080	10.1371/journal.pone.0026080	http://dx.doi.org/10.1371/journal.pone.0026080			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022514	gold, Green Published, Green Submitted			2022-12-27	WOS:000295976000064
J	McCormick, KE; Gaertner, BE; Sottile, M; Phillips, PC; Lockery, SR				McCormick, Kathryn E.; Gaertner, Bryn E.; Sottile, Matthew; Phillips, Patrick C.; Lockery, Shawn R.			Microfluidic Devices for Analysis of Spatial Orientation Behaviors in Semi-Restrained Caenorhabditis elegans	PLOS ONE			English	Article							C.-ELEGANS; NEURAL CIRCUITS; THERMOTAXIS; CHEMOTAXIS; NEURONS; MECHANISMS; GRADIENTS; OXYGEN	This article describes the fabrication and use of microfluidic devices for investigating spatial orientation behaviors in nematode worms (Caenorhabditis elegans). Until now, spatial orientation has been studied in freely moving nematodes in which the frequency and nature of encounters with the gradient are uncontrolled experimental variables. In the new devices, the nematode is held in place by a restraint that aligns the longitudinal axis of the body with the border between two laminar fluid streams, leaving the animal's head and tail free to move. The content of the fluid streams can be manipulated to deliver step gradients in space or time. We demonstrate the utility of the device by identifying previously uncharacterized aspects of the behavioral mechanisms underlying chemotaxis, osmotic avoidance, and thermotaxis in this organism. The new devices are readily adaptable to behavioral and imaging studies involving fluid borne stimuli in a wide range of sensory modalities.	[McCormick, Kathryn E.; Gaertner, Bryn E.; Lockery, Shawn R.] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA; [Gaertner, Bryn E.; Phillips, Patrick C.] Univ Oregon, Inst Ecol & Evolut, Eugene, OR 97403 USA; [Sottile, Matthew] Galois Inc, Res & Dev, Portland, OR USA	University of Oregon; University of Oregon	McCormick, KE (corresponding author), Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA.	shawn@chinook.uoregon.edu	Sottile, Matthew/J-1386-2019	Sottile, Matthew/0000-0001-7436-5246	National Institutes of Health [MH051383, NS069491]; National Science Foundation [IOS-0909816]; John Simon Guggenheim Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH112105, R29MH051383, R01MH051383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS069491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); John Simon Guggenheim Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health (MH051383 and NS069491), the National Science Foundation (IOS-0909816), and the John Simon Guggenheim Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER J, 1966, SCIENCE, V153, P708, DOI 10.1126/science.153.3737.708; Ahmed T, 2010, INTEGR BIOL-UK, V2, P604, DOI 10.1039/c0ib00049c; ALBRECHT DR, 2011, NAT METHODS; Ardiel EL, 2010, LEARN MEMORY, V17, P191, DOI 10.1101/lm.960510; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; Bargmann CI., 2006, WORMBOOK, P1, DOI [10.1895/wormbook.1.123.1, DOI 10.1895/WORMBOOK.1.123.1]; Ben-Yakar A, 2009, CURR OPIN NEUROBIOL, V19, P561, DOI 10.1016/j.conb.2009.10.010; Bretscher AJ, 2011, NEURON, V69, P1099, DOI 10.1016/j.neuron.2011.02.023; Chokshi TV, 2010, LAB CHIP, V10, P2758, DOI 10.1039/c004658b; CULOTTI JG, 1978, GENETICS, V90, P243; DUSENBERY DB, 1975, GENETICS, V80, P297; Faumont S, 2006, J NEUROPHYSIOL, V95, P1976, DOI 10.1152/jn.01050.2005; Faumont S, 2005, J NEUROBIOL, V65, P171, DOI 10.1002/neu.20196; FRAENKEL GS, 1940, ORIENTATION ANIMALS; Garrity PA, 2010, GENE DEV, V24, P2365, DOI 10.1101/gad.1953710; Giuffre C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015274; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; Hilliard MA, 2002, CURR BIOL, V12, P730, DOI 10.1016/S0960-9822(02)00813-8; Iino Y, 2009, J NEUROSCI, V29, P5370, DOI 10.1523/JNEUROSCI.3633-08.2009; Ito H, 2006, J NEUROSCI METH, V154, P45, DOI 10.1016/j.jneumeth.2005.11.011; Izquierdo EJ, 2010, J NEUROSCI, V30, P12908, DOI 10.1523/JNEUROSCI.2606-10.2010; Jeon NL, 2000, LANGMUIR, V16, P8311, DOI 10.1021/la000600b; Jurado P, 2010, GENES BRAIN BEHAV, V9, P120, DOI 10.1111/j.1601-183X.2009.00549.x; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; Koyama S, 2006, ANAL CHEM, V78, P3354, DOI 10.1021/ac052087i; Leifer AM, 2011, NAT METHODS, V8, P147, DOI 10.1038/NMETH.1554; Lockery SR, 2008, J NEUROPHYSIOL, V99, P3136, DOI 10.1152/jn.91327.2007; LOCKERY SR, 2011, CURR OPIN N IN PRESS; Pierce-Shimomura JT, 2008, P NATL ACAD SCI USA, V105, P20982, DOI 10.1073/pnas.0810359105; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Porter J, 2007, NAT NEUROSCI, V10, P27, DOI 10.1038/nn1819; Qin D, 2010, NAT PROTOC, V5, P491, DOI 10.1038/nprot.2009.234; Ramot D, 2008, J NEUROSCI, V28, P12546, DOI 10.1523/JNEUROSCI.2857-08.2008; Riddle Donald L., 1997, Cold Spring Harbor Monograph Series, V33, P739; Ryu WS, 2002, J NEUROSCI, V22, P5727; Sambongi Y, 1999, NEUROREPORT, V10, P753, DOI 10.1097/00001756-199903170-00017; Stiernagle Theresa, 2006, WormBook, P1; Stirman JN, 2011, NAT METHODS, V8, P153, DOI 10.1038/NMETH.1555; WARD S, 1973, P NATL ACAD SCI USA, V70, P817, DOI 10.1073/pnas.70.3.817; White JQ, 2007, CURR BIOL, V17, P1847, DOI 10.1016/j.cub.2007.09.011; Wicks SR, 2000, DEV BIOL, V221, P295, DOI 10.1006/dbio.2000.9686; Zariwala HA, 2003, J NEUROSCI, V23, P4369	43	39	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25710	10.1371/journal.pone.0025710	http://dx.doi.org/10.1371/journal.pone.0025710			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022437	Green Submitted, Green Published, gold			2022-12-27	WOS:000295976000032
J	Liu, ZJ; Chen, LJ; Chen, SC; Cai, J; Tsai, WC; Hsiao, YY; Rao, WH; Ma, XY; Zhang, GQ				Liu, Zhong-Jian; Chen, Li-Jun; Chen, Sing-Chi; Cai, Jing; Tsai, Wen-Chieh; Hsiao, Yu-Yun; Rao, Wen-Hui; Ma, Xue-Yong; Zhang, Guo-Qiang			Paraholcoglossum and Tsiorchis, Two New Orchid Genera Established by Molecular and Morphological Analyses of the Holcoglossum Alliance	PLOS ONE			English	Article								Background: Holcoglossum is a small orchid genus of 12 species ranging from SW China to Thailand and NE India. Although molecular and morphological analyses have been performed to establish the phylogenetic relationships within this genus, the interspecific relations and its relations with allied genera, such as Rhynchostylis, Aerides and Vanda, remain unclear. Methodology/Principal Findings: In addition to morphological analysis, maximum parsimony, maximum likelihood, and Bayesian inference analyses were performed based on fragments of the nuclear ITS and chloroplast trnL-F and matK genes of 31 taxa (15 Holcoglossum, 14 Aeridinae, 2 outgroups) representing all major clades of the Holcoglossum alliance. The results suggest that Holcoglossum is triphyletic, comprising three clades: the Holcoglossum clade, its sister clade, and a distant clade more closely related to Rhynchostylis, Aerides, and Vanda than to the Holcoglossum clade. The Holcoglossum clade is further divided into three subclades; the genetic distances between these three subclades also support this delimitation. The molecular conclusion is consistent with their distinct morphological characters. Conclusions: We propose that the latter two clades comprise two new genera, Paraholcoglossum and Tsiorchis, and Holcoglossum clade divides into three sections. In addition, a new section, Holcoglossum sect. Nujiangensia, and a new species, Holcoglossum linearifolium, are proposed. Some new combinations are made, and a new scheme is provided for the classification of all species of Holcoglossum, Paraholcoglossum, and Tsiorchis.	[Liu, Zhong-Jian; Chen, Li-Jun; Chen, Sing-Chi; Cai, Jing; Rao, Wen-Hui; Ma, Xue-Yong; Zhang, Guo-Qiang] Natl Orchid Conservat Ctr China, Shenzhen Key Lab Orchid Conservat & Utilizat, Shenzhen, Peoples R China; [Liu, Zhong-Jian; Chen, Li-Jun; Chen, Sing-Chi; Cai, Jing; Rao, Wen-Hui; Ma, Xue-Yong; Zhang, Guo-Qiang] Orchid Conservat & Res Ctr Shenzhen, Shenzhen, Peoples R China; [Liu, Zhong-Jian] Tsinghua Univ, Grad Sch Shenzhen, Ctr Biotechnol & BioMed, Shenzhen 518057, Peoples R China; [Liu, Zhong-Jian] S China Agr Univ, Coll Forestry, Guangzhou, Guangdong, Peoples R China; [Chen, Sing-Chi] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Tsai, Wen-Chieh] Natl Cheng Kung Univ, Inst Trop Plant Sci, Tainan 70101, Taiwan; [Tsai, Wen-Chieh] Natl Cheng Kung Univ, Orchid Res Ctr, Tainan 70101, Taiwan; [Hsiao, Yu-Yun] Natl Cheng Kung Univ, Dept Life Sci, Tainan 70101, Taiwan	Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; South China Agricultural University; Chinese Academy of Sciences; Institute of Botany, CAS; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University	Liu, ZJ (corresponding author), Natl Orchid Conservat Ctr China, Shenzhen Key Lab Orchid Conservat & Utilizat, Shenzhen, Peoples R China.	liuzj@sinicaorchid.org; zhang2384539@163.com	Zhang, Guo-Qiang/AAG-6817-2019	Zhang, Guo-Qiang/0000-0001-6439-019X; Cai, Jing/0000-0002-2496-4731; Liu, Zhong-Jian/0000-0003-4390-3878	State Forestry Administration, People's Republic of China [2005-122]; Science and Technology Project of Shenzhen, China [SYF200646408, SY200806270123A]	State Forestry Administration, People's Republic of China; Science and Technology Project of Shenzhen, China	This work is supported by the State Forestry Administration, People's Republic of China, (grant no. 2005-122) and the Science and Technology Project of Shenzhen, China (grant no. SYF200646408, SY200806270123A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cameron KM, 2004, MOL PHYLOGENET EVOL, V31, P1157, DOI 10.1016/j.ympev.2003.10.010; Cameron KM, 1999, AM J BOT, V86, P208, DOI 10.2307/2656938; Carlsward BS, 2006, AM J BOT, V93, P770, DOI 10.3732/ajb.93.5.770; Chase M. W, 1994, P 14 WORLD ORCH C, P61; CHRISTENSON E A, 1987, Notes from the Royal Botanic Garden Edinburgh, V44, P249; Christenson Eric A., 1998, Lindleyana, V13, P121; Fan J, 2009, TAXON, V58, P849, DOI 10.1002/tax.583013; Freudenstein JV, 2004, AM J BOT, V91, P149, DOI 10.3732/ajb.91.1.149; GARAY L A, 1972, BOT MUS LEAFL HARV UNIV, V23, P149; Hidayat T, 2005, J PLANT RES, V118, P271, DOI 10.1007/s10265-005-0217-3; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jin XH, 2005, BOT J LINN SOC, V149, P465, DOI 10.1111/j.1095-8339.2005.00463.x; Jin XH, 2009, FLORA CHINA, V25, P499; MARCIN G, 2010, MOL PHYLOGENET EVOL, V56, P784; McNeill J., 2006, V146, P1; Neubig KM, 2009, PLANT SYST EVOL, V277, P75, DOI 10.1007/s00606-008-0105-0; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Schlechter R., 1919, FEDDES REPERT SPEC N, V4; Seidenfaden G., 1988, OPERA BOT, V95, P304; SEIDENFADEN G, 1992, OPERA BOT, V114, P441; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thiv M, 1999, PLANT SYST EVOL, V218, P299, DOI 10.1007/BF01089233; Tsi Z.H., 1982, ACTA PHYTOTAX SINICA, V20, P439	26	23	25	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e24864	10.1371/journal.pone.0024864	http://dx.doi.org/10.1371/journal.pone.0024864			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016762	gold, Green Published, Green Submitted			2022-12-27	WOS:000295971700003
J	McCarron, CE; Pullenayegum, EM; Thabane, L; Goeree, R; Tarride, JE				McCarron, C. Elizabeth; Pullenayegum, Eleanor M.; Thabane, Lehana; Goeree, Ron; Tarride, Jean-Eric			Bayesian Hierarchical Models Combining Different Study Types and Adjusting for Covariate Imbalances: A Simulation Study to Assess Model Performance	PLOS ONE			English	Article							DESIGN	Background: Bayesian hierarchical models have been proposed to combine evidence from different types of study designs. However, when combining evidence from randomised and non-randomised controlled studies, imbalances in patient characteristics between study arms may bias the results. The objective of this study was to assess the performance of a proposed Bayesian approach to adjust for imbalances in patient level covariates when combining evidence from both types of study designs. Methodology/Principal Findings: Simulation techniques, in which the truth is known, were used to generate sets of data for randomised and non-randomised studies. Covariate imbalances between study arms were introduced in the non-randomised studies. The performance of the Bayesian hierarchical model adjusted for imbalances was assessed in terms of bias. The data were also modelled using three other Bayesian approaches for synthesising evidence from randomised and non-randomised studies. The simulations considered six scenarios aimed at assessing the sensitivity of the results to changes in the impact of the imbalances and the relative number and size of studies of each type. For all six scenarios considered, the Bayesian hierarchical model adjusted for differences within studies gave results that were unbiased and closest to the true value compared to the other models. Conclusions/Significance: Where informed health care decision making requires the synthesis of evidence from randomised and non-randomised study designs, the proposed hierarchical Bayesian method adjusted for differences in patient characteristics between study arms may facilitate the optimal use of all available evidence leading to unbiased results compared to unadjusted analyses.	[McCarron, C. Elizabeth; Pullenayegum, Eleanor M.; Thabane, Lehana; Goeree, Ron; Tarride, Jean-Eric] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [McCarron, C. Elizabeth; Goeree, Ron; Tarride, Jean-Eric] St Josephs Healthcare Hamilton, Programs Assessment Technol Hlth PATH Res Inst, Hamilton, ON, Canada; [Pullenayegum, Eleanor M.; Thabane, Lehana] St Josephs Healthcare Hamilton, Biostat Unit, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University	McCarron, CE (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada.	mccarrce@mcmaster.ca	Pullenayegum, Eleanor/AAT-1712-2020	Pullenayegum, Eleanor/0000-0003-4265-1330	Social Sciences and Humanities Research Council of Canada; Ontario Ministry of Health and Long-Term Care	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario)	CEM was funded through a Doctoral Fellowship from the Social Sciences and Humanities Research Council of Canada. JET holds a 2007 Career Scientist Award, Ontario Ministry of Health and Long-Term Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ades AE, 2006, J R STAT SOC A STAT, V169, P5, DOI 10.1111/j.1467-985X.2005.00377.x; Bayesian Output Analysis Program (BOA), BAYESIAN OUTPUT ANAL; Burton A, 2006, STAT MED, V25, P4279, DOI 10.1002/sim.2673; Deeks J J, 2003, Health Technol Assess, V7, piii; Grines CL, 2008, J INTERV CARDIOL, V21, P459, DOI 10.1111/j.1540-8183.2008.00416.x; Hopkins R, 2008, VASC HEALTH RISK MAN, V4, P1011, DOI 10.2147/VHRM.S3810; Lambert PC, 2005, STAT MED, V24, P2401, DOI 10.1002/sim.2112; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; McCarron CE, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-64; Prevost TC, 2000, STAT MED, V19, P3359, DOI 10.1002/1097-0258(20001230)19:24<3359::AID-SIM710>3.0.CO;2-N; *R PROJ, R PROJ STAT COMP; Sampath S, 2007, CRIT CARE MED, V35, P2516, DOI 10.1097/01.CCM.0000284503.88148.6F; Spiegelhalter DJ, 2004, BAYESIAN APPROACHES, DOI DOI 10.1002/0470092602; Sutton AJ, 2001, STAT METHODS MED RES, V10, P277, DOI 10.1191/096228001678227794; Turner RM, 2009, J R STAT SOC A STAT, V172, P21, DOI 10.1111/j.1467-985X.2008.00547.x	15	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25635	10.1371/journal.pone.0025635	http://dx.doi.org/10.1371/journal.pone.0025635			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016772	Green Submitted, Green Published, gold			2022-12-27	WOS:000295971700014
J	Ma, Q; Zhou, J; Zhang, WW; Meng, XX; Sun, JW; Yuan, YJ				Ma, Qian; Zhou, Jian; Zhang, Weiwen; Meng, Xinxin; Sun, Junwei; Yuan, Ying-jin			Integrated Proteomic and Metabolomic Analysis of an Artificial Microbial Community for Two-Step Production of Vitamin C	PLOS ONE			English	Article							MOTHER-CELL; BACILLUS-SUBTILIS; COG DATABASE; SPORULATION; BIOLOGY; GROWTH; MICROORGANISMS; TRANSCRIPTOME; ADAPTATION	An artificial microbial community consisted of Ketogulonicigenium vulgare and Bacillus megaterium has been used in industry to produce 2-keto-gulonic acid (2-KGA), the precursor of vitamin C. During the mix culture fermentation process, sporulation and cell lysis of B. megaterium can be observed. In order to investigate how these phenomena correlate with 2-KGA production, and to explore how two species interact with each other during the fermentation process, an integrated time-series proteomic and metabolomic analysis was applied to the system. The study quantitatively identified approximate 100 metabolites and 258 proteins. Principal Component Analysis of all the metabolites identified showed that glutamic acid, 5-oxo-proline, L-sorbose, 2-KGA, 2, 6-dipicolinic acid and tyrosine were potential biomarkers to distinguish the different time-series samples. Interestingly, most of these metabolites were closely correlated with the sporulation process of B. megaterium. Together with several sporulation-relevant proteins identified, the results pointed to the possibility that Bacillus sporulation process might be important part of the microbial interaction. After sporulation, cell lysis of B. megaterium was observed in the co-culture system. The proteomic results showed that proteins combating against intracellular reactive oxygen stress (ROS), and proteins involved in pentose phosphate pathway, L-sorbose pathway, tricarboxylic acid cycle and amino acids metabolism were up-regulated when the cell lysis of B. megaterium occurred. The cell lysis might supply purine substrates needed for K. vulgare growth. These discoveries showed B. megaterium provided key elements necessary for K. vulgare to grow better and produce more 2-KGA. The study represents the first attempt to decipher 2-KGA-producing microbial communities using quantitative systems biology analysis.	[Ma, Qian; Zhou, Jian; Zhang, Weiwen; Yuan, Ying-jin] Tianjin Univ, Key Lab Syst Bioengn, Minist Educ, Tianjin 300072, Peoples R China; [Ma, Qian; Zhou, Jian; Zhang, Weiwen; Yuan, Ying-jin] Tianjin Univ, Dept Pharmaceut Engn, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China; [Meng, Xinxin; Sun, Junwei] Welcome Pharmaceut Co Ltd, N China Pharmaceut Grp, Shijiazhuang, Hebei, Peoples R China	Tianjin University; Tianjin University	Ma, Q (corresponding author), Tianjin Univ, Key Lab Syst Bioengn, Minist Educ, Tianjin 300072, Peoples R China.	yjyuan@tju.edu.cn		Sun, Junwei/0000-0001-8518-5064; Zhang, Weiwen/0000-0001-8305-5653	National Basic Research Program of China ("973" Program) [2007CB714301, 2011CBA00802]; National Natural Science Foundation of China [20736006, 21020102040]	National Basic Research Program of China ("973" Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors are grateful for the financial support from the National Basic Research Program of China ("973" Program: 2007CB714301, 2011CBA00802), the National Natural Science Foundation of China (Key Program: 20736006, Major International Joint Research Project: 21020102040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bremus C, 2006, J BIOTECHNOL, V124, P196, DOI 10.1016/j.jbiotec.2006.01.010; Budde I, 2006, MICROBIOL-SGM, V152, P831, DOI 10.1099/mic.0.28530-0; BUONO F, 1966, J BACTERIOL, V91, P2291, DOI 10.1128/JB.91.6.2291-2299.1966; Cheng JS, 2009, APPL MICROBIOL BIOT, V83, P909, DOI 10.1007/s00253-009-2037-1; Ding MZ, 2010, METABOLOMICS, V6, P42, DOI 10.1007/s11306-009-0173-3; EATON MW, 1974, BIOCHEM J, V144, P327, DOI 10.1042/bj1440327; ERRINGTON J, 1993, MICROBIOL REV, V57, P1; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Halliwell B, 1989, FREE RADICALS BIOL M, VUK; Hancock Robert D, 2009, Recent Pat Food Nutr Agric, V1, P39; Hosoya S, 2007, J BACTERIOL, V189, P2561, DOI 10.1128/JB.01738-06; Jackson CR, 2008, APPL ENVIRON MICROB, V74, P5237, DOI 10.1128/AEM.00923-08; Knaysi G, 1934, J BACTERIOL, V27, P109, DOI 10.1128/JB.27.2.109-119.1934; Kromer JO, 2004, J BACTERIOL, V186, P1769, DOI 10.1128/JB.186.6.1769-1784.2004; Lacerda CMR, 2007, J PROTEOME RES, V6, P1145, DOI 10.1021/pr060477v; Leduc S, 2004, APPL MICROBIOL BIOT, V65, P163, DOI 10.1007/s00253-004-1562-1; Lushchak VI, 2001, BIOCHEMISTRY-MOSCOW+, V66, P476, DOI 10.1023/A:1010294415625; Manefield M, 2002, APPL ENVIRON MICROB, V68, P5367, DOI 10.1128/AEM.68.11.5367-5373.2002; Maron PA, 2007, MICROB ECOL, V53, P486, DOI 10.1007/s00248-006-9196-8; Matsuno K, 1999, J BACTERIOL, V181, P3392, DOI 10.1128/JB.181.11.3392-3401.1999; PANDOLFI PP, 1995, EMBO J, V14, P5209, DOI 10.1002/j.1460-2075.1995.tb00205.x; Raes J, 2008, NAT REV MICROBIOL, V6, P693, DOI 10.1038/nrmicro1935; Ram RJ, 2005, SCIENCE, V308, P1915, DOI 10.1126/science. 1109070; Rochfort S, 2005, J NAT PROD, V68, P1813, DOI 10.1021/np050255w; SEDDON AP, 1986, J BIOL CHEM, V261, P1538; SPUDICH JA, 1968, J BIOL CHEM, V243, P4600; STEINKRAUS KH, 1957, J BACTERIOL, V74, P621, DOI 10.1128/JB.74.5.621-624.1957; Takagi Y, 2010, APPL MICROBIOL BIOT, V86, P469, DOI 10.1007/s00253-009-2312-1; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Trauger SA, 2008, J PROTEOME RES, V7, P1027, DOI 10.1021/pr700609j; VANDERWERF P, 1971, P NATL ACAD SCI USA, V68, P2982; Wang LJ, 2007, J BACTERIOL, V189, P8467, DOI 10.1128/JB.01285-07; WARD DM, 1990, NATURE, V345, P63, DOI 10.1038/345063a0; Wilmes P, 2004, ENVIRON MICROBIOL, V6, P911, DOI 10.1111/j.1462-2920.2004.00687.x; Winder CL, 2008, ANAL CHEM, V80, P2939, DOI 10.1021/ac7023409; Yin GL, 1997, IND MICROBIOL, V27, P1; Zhang J, 2011, BIORESOURCE TECHNOL, V102, P4807, DOI 10.1016/j.biortech.2010.10.124; Zhang WW, 2010, MICROBIOL-SGM, V156, P287, DOI 10.1099/mic.0.034793-0; Zhou J, 2011, APPL ENVIRON MICROB, V77, P7023, DOI 10.1128/AEM.05123-11	41	68	84	2	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e26108	10.1371/journal.pone.0026108	http://dx.doi.org/10.1371/journal.pone.0026108			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22016820	gold, Green Published, Green Submitted			2022-12-27	WOS:000295970300061
J	Steinsbekk, A; Rise, MB; Bishop, F; Lewith, G				Steinsbekk, Aslak; Rise, Marit By; Bishop, Felicity; Lewith, George			Predictors for Adolescent Visits to Practitioners of Complementary and Alternative Medicine in a Total Population (the Young-HUNT Studies)	PLOS ONE			English	Article							CHILDREN; CAM; PREVALENCE; PROVIDERS; CARE	Aim: To investigate the factors predicting adolescent visits to practitioners of complementary and alternative medicine (CAM). Methods: A longitudinal cohort study conducted in an adolescent total population in Central Norway (The Nord-Trondelag Health Studies (HUNT)). In Young-HUNT 1, all inhabitants aged 13 to 19 years (N = 8944, 89% response rate) were invited to participate, and the youngest group (13 to 15 year olds) was surveyed again 4 years later (Young-HUNT 2, N = 2429, 82% response rate). The participants completed a comprehensive questionnaire on health and life style which included a question regarding visits to a CAM practitioner in the last 12 months. Results: One in eleven (8.7%, 95% CI 7.6-9.8%) had visited a CAM practitioner, an increase of 26% in 4 years (1.8% points). The final multivariable analysis predicted increased odds of an adolescent becoming a CAM visitor four years later (p<0.05) if she or he had previously visited a CAM practitioner (adjOR 3.4), had musculoskeletal pain (adjOR 1.5), had migraine (adjOR 2.3), used asthma medicines (adjOR 1.8) or suffered from another disease lasting more than three months (adjOR 2.1). Being male predicted reduced odds of visiting a CAM practitioner in the future (adjOR 0.6). Conclusion: We can conclude from this study that future visits to a CAM practitioner are predicted by both predisposing factors (being female, having visited a CAM practitioner previously) and medical need factors (having had musculoskeletal pain, migraine, used asthma medicines or experienced another disease lasting more than three months). None of the specific variables associated with CAM visits were predictive for CAM visits four years later.	[Steinsbekk, Aslak; Rise, Marit By] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway; [Bishop, Felicity; Lewith, George] Univ Southampton, Complementary & Integrated Med Res Unit, Southampton, Hants, England	Norwegian University of Science & Technology (NTNU); University of Southampton	Steinsbekk, A (corresponding author), Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway.	aslak.steinsbekk@ntnu.no	Steinsbekk, Aslak/E-9223-2012	Steinsbekk, Aslak/0000-0001-9090-0739; Lewith, George/0000-0002-2364-3960; Bishop, Felicity/0000-0002-8737-6662				ANDERSEN R, 1973, MILBANK FUND Q, V51, P95, DOI 10.2307/3349613; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; April KT, 2009, COMPLEMENT THER MED, V17, P208, DOI 10.1016/j.ctim.2009.03.003; Barnes Patricia M, 2008, Natl Health Stat Report, P1; Birdee GS, 2010, PEDIATRICS, V125, P249, DOI 10.1542/peds.2009-1406; Bishop Felicity L, 2009, Complement Ther Clin Pract, V15, P8, DOI 10.1016/j.ctcp.2008.09.005; Bishop FL, 2010, PEDIATRICS, V125, P768, DOI 10.1542/peds.2009-1775; Braun C A, 2000, J Holist Nurs, V18, P176, DOI 10.1177/089801010001800208; Breuner CC, 1998, ARCH PEDIAT ADOL MED, V152, P1071; FOULADBAKHSH JM, 2007, J COMPLEMENTARY INTE, V4, P1, DOI DOI 10.2202/1553-3840.1035; Gross-Tsur V, 2003, PEDIATR NEUROL, V29, P53, DOI 10.1016/s0887-8994(03)00027-4; Harris P, 2000, COMPLEMENT THER MED, V8, P88, DOI 10.1054/ctim.2000.0353; Heuschkel R, 2002, AM J GASTROENTEROL, V97, P382, DOI 10.1111/j.1572-0241.2002.05474.x; Holmen J, 2003, NORSK EPIDEMIOLOGI, V13, P19, DOI DOI 10.1093/eurheartj/eht019; Hughes SC, 2006, AMBUL PEDIATR, V6, P293, DOI 10.1016/j.ambp.2005.11.007; Little P, 2001, BRIT J GEN PRACT, V51, P977; Lorenc A, 2009, BMC COMPLEM ALTERN M, V9, DOI 10.1186/1472-6882-9-9; Quandt SA, 2009, J ALTERN COMPLEM MED, V15, P331, DOI 10.1089/acm.2008.0521; Steinsbekk A, 2008, FORSCH KOMPLEMENTMED, V15, P146, DOI 10.1159/000134904; Steinsbekk A, 2006, FORSCH KOMP KLAS NAT, V13, P88, DOI 10.1159/000092004; Yussman SM, 2004, AMBUL PEDIATR, V4, P429, DOI 10.1367/A03-091R1.1; Zwaanswijk M, 2003, EUR CHILD ADOLES PSY, V12, P153, DOI 10.1007/S00787-003-0322-6	22	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25719	10.1371/journal.pone.0025719	http://dx.doi.org/10.1371/journal.pone.0025719			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003404	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000295970300025
J	Guo, XL; Pace, RG; Stonebraker, JR; Commander, CW; Dang, AT; Drumm, ML; Harris, A; Zou, F; Swallow, DM; Wright, FA; O'Neal, WK; Knowles, MR				Guo, XueLiang; Pace, Rhonda G.; Stonebraker, Jaclyn R.; Commander, Clayton W.; Dang, Anthony T.; Drumm, Mitchell L.; Harris, Ann; Zou, Fei; Swallow, Dallas M.; Wright, Fred A.; O'Neal, Wanda K.; Knowles, Michael R.			Mucin Variable Number Tandem Repeat Polymorphisms and Severity of Cystic Fibrosis Lung Disease: Significant Association with MUC5AC	PLOS ONE			English	Article							ALLELIC ASSOCIATION; GENE; IDENTIFICATION; EXPRESSION; COMPLEX; MUCUS	Variability in cystic fibrosis (CF) lung disease is partially due to non-CFTR genetic modifiers. Mucin genes are very polymorphic, and mucins play a key role in the pathogenesis of CF lung disease; therefore, mucin genes are strong candidates as genetic modifiers. DNA from CF patients recruited for extremes of lung phenotype was analyzed by Southern blot or PCR to define variable number tandem repeat (VNTR) length polymorphisms for MUC1, MUC2, MUC5AC, and MUC7. VNTR length polymorphisms were tested for association with lung disease severity and for linkage disequilibrium (LD) with flanking single nucleotide polymorphisms (SNPs). No strong associations were found for MUC1, MUC2, or MUC7. A significant association was found between the overall distribution of MUC5AC VNTR length and CF lung disease severity (p = 0.025; n = 468 patients); plus, there was robust association of the specific 6.4 kb HinfI VNTR fragment with severity of lung disease (p = 6.2 x 10(-4) after Bonferroni correction). There was strong LD between MUC5AC VNTR length modes and flanking SNPs. The severity-associated 6.4 kb VNTR allele of MUC5AC was confirmed to be genetically distinct from the 6.3 kb allele, as it showed significantly stronger association with nearby SNPs. These data provide detailed respiratory mucin gene VNTR allele distributions in CF patients. Our data also show a novel link between the MUC5AC 6.4 kb VNTR allele and severity of CF lung disease. The LD pattern with surrounding SNPs suggests that the 6.4 kb allele contains, or is linked to, important functional genetic variation.	[Guo, XueLiang; Pace, Rhonda G.; Stonebraker, Jaclyn R.; Commander, Clayton W.; Dang, Anthony T.; O'Neal, Wanda K.; Knowles, Michael R.] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27515 USA; [Drumm, Mitchell L.] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Harris, Ann] Northwestern Univ, Human Mol Genet Program, Childrens Mem Res Ctr, Feinberg Sch Med, Chicago, IL 60611 USA; [Zou, Fei; Wright, Fred A.] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Swallow, Dallas M.] UCL, Res Dept Genet Evolut & Environm, London, England; [Knowles, Michael R.] Gene Modifier Study Grp, Chapel Hill, NC USA; [Drumm, Mitchell L.] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA	University of North Carolina; University of North Carolina Chapel Hill; Case Western Reserve University; Northwestern University; Feinberg School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of London; University College London; Case Western Reserve University	Guo, XL (corresponding author), Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27515 USA.	knowles@med.unc.edu		Commander, Clayton/0000-0001-8477-932X; Pace, Rhonda/0000-0001-8606-0327	United States Cystic Fibrosis Foundation [STONEB08G0, KNOWLE00A0, DRUMM00A0, R026-CR02]; National Institutes of Health [CTRC RR00046, CTSA UL1RR025747, HL068890, HL094585]; British Lung Foundation [P96/14]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025747, M01RR000046] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094585, R01HL068890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK027651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	United States Cystic Fibrosis Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Lung Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grants from the United States Cystic Fibrosis Foundation: STONEB08G0 (J.R.S.), KNOWLE00A0 (M.R.K.), DRUMM00A0 (M.L.D.), R026-CR02 (W.K.O.); the National Institutes of Health: CTRC RR00046, CTSA UL1RR025747, HL068890 (M.R.K.) and HL094585 (A.H.); and the British Lung Foundation P96/14 (D.M.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Caramori G, 2009, HISTOPATHOLOGY, V55, P321, DOI 10.1111/j.1365-2559.2009.03377.x; Cutting GR, 2010, ANN NY ACAD SCI, V1214, P57, DOI 10.1111/j.1749-6632.2010.05879.x; Drumm ML, 2005, NEW ENGL J MED, V353, P1443, DOI 10.1056/NEJMoa051469; Du J., 2002, COMBINED ALGORITHMS; Engelmann K, 2001, J BIOL CHEM, V276, P27764, DOI 10.1074/jbc.M103187200; Escande F, 2001, BIOCHEM J, V358, P763, DOI 10.1042/0264-6021:3580763; Fowler J, 2001, FRONT BIOSCI-LANDMRK, V6, pD1207, DOI 10.2741/Fowler; Fowler JC, 2003, HUM GENET, V113, P473, DOI 10.1007/s00439-003-1011-8; GUM JR, 1994, J BIOL CHEM, V269, P2440; Hasnain SZ, 2011, J EXP MED, V208, P893, DOI 10.1084/jem.20102057; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; Henke MO, 2007, AM J RESP CRIT CARE, V175, P816, DOI 10.1164/rccm.200607-1011OC; Kirkbride HJ, 2001, EUR J HUM GENET, V9, P347, DOI 10.1038/sj.ejhg.5200642; Kirkham S, 2002, BIOCHEM J, V361, P537, DOI 10.1042/0264-6021:3610537; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Mitsuta K, 2005, ONCOL REP, V14, P185; Ng W, 2008, BRIT J CANCER, V99, P978, DOI 10.1038/sj.bjc.6604617; Pratt WS, 1996, ANN HUM GENET, V60, P21, DOI 10.1111/j.1469-1809.1996.tb01168.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rose MC, 2006, PHYSIOL REV, V86, P245, DOI 10.1152/physrev.00010.2005; Rousseau K, 2007, ANN HUM GENET, V71, P561, DOI 10.1111/j.1469-1809.2007.00374.x; Rousseau K, 2006, ANN HUM GENET, V70, P417, DOI 10.1111/j.1469-1809.2006.00250.x; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Seibold MA, 2011, NEW ENGL J MED, V364, P1503, DOI 10.1056/NEJMoa1013660; Silva F, 2001, EUR J HUM GENET, V9, P548, DOI 10.1038/sj.ejhg.5200677; Taylor C, 2011, PEDIATR PULM, V46, P857, DOI 10.1002/ppul.21456; Thornton DJ, 2008, ANNU REV PHYSIOL, V70, P459, DOI 10.1146/annurev.physiol.70.113006.100702; Vanscoy LL, 2007, AM J RESP CRIT CARE, V175, P1036, DOI 10.1164/rccm.200608-1164OC; Vinall LE, 1998, HUM GENET, V102, P357, DOI 10.1007/s004390050705; Vinall LE, 2002, GASTROENTEROLOGY, V123, P41, DOI 10.1053/gast.2002.34157; Vinall LE, 2000, METH MOL B, V125, P337; Vinall LE, 2000, AM J RESP CELL MOL, V23, P678, DOI 10.1165/ajrcmb.23.5.4176; Voynow JA, 2006, AM J RESP CELL MOL, V34, P661, DOI 10.1165/rcmb.2006-0035SF; Watson AM, 2009, J INVEST MED, V57, P882, DOI 10.2310/JIM.0b013e3181c0466d; Wright FA, 2011, NAT GENET, V43, P539, DOI 10.1038/ng.838	36	33	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e25452	10.1371/journal.pone.0025452	http://dx.doi.org/10.1371/journal.pone.0025452			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998660	Green Published, Green Submitted, gold			2022-12-27	WOS:000295968700010
J	Lougheed, R; Turnbull, J				Lougheed, Rosamond; Turnbull, John			Lack of Effect of Methylene Blue in the SOD1 G93A Mouse Model of Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; INCREASED 3-NITROTYROSINE; OXIDATIVE DAMAGE; PROTEIN; MUTATIONS; GENE; MICE; ALS; IMPAIRMENT; INCLUSIONS	Background: Methylene blue (MB) is a drug with a long history and good safety profile, and with recently-described features desirable in a treatment for ALS. Methodology/Principal Findings: We tested oral MB in inbred high-copy number SOD1 G93A mice, at 25 mg/kg/day beginning at 45 days of age. We measured disease onset, progression, and survival. There was no difference in disease onset between MB-treated mice and controls, although subgroup analysis showed a modest but statistically significant delay in disease onset in MB-treated female mice only (control 122 +/- 10.2 versus MB 129 +/- 10.0 days). MB-treated mice of both sexes spent more time in less severe stages of disease, and less time in later, more severe stages of disease. There was a nonsignificant trend to longer survival in MB-treated animals (control males reached endpoint at 161 +/- 14.1 days, versus 166 +/- 10.0 days for MB-treated animals, and control females reached endpoint at 171 +/- 6.2 days versus 173 +/- 13.4 days for MB-treated animals). Conclusions/Significance: In spite of a strong theoretical rationale, MB had no significant effects on onset or survival in the inbred SOD1 G93A mouse model of ALS.	[Lougheed, Rosamond; Turnbull, John] McMaster Univ, Dept Med, Hamilton, ON, Canada	McMaster University	Lougheed, R (corresponding author), McMaster Univ, Dept Med, Hamilton, ON, Canada.	turnbull@mcmaster.ca			Andrew Bruce Douglas Endowed Chair in Neurology	Andrew Bruce Douglas Endowed Chair in Neurology	This work was supported by the Andrew Bruce Douglas Endowed Chair in Neurology and Mr. David Hunt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almer G, 1999, J NEUROCHEM, V72, P2415, DOI 10.1046/j.1471-4159.1999.0722415.x; Andrus PK, 1998, J NEUROCHEM, V71, P2041; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Atamna H, 2008, FASEB J, V22, P703, DOI 10.1096/fj.07-9610com; Barber SC, 2006, BBA-MOL BASIS DIS, V1762, P1051, DOI 10.1016/j.bbadis.2006.03.008; Beal MF, 1997, ANN NEUROL, V42, P644, DOI 10.1002/ana.410420416; Ben Jilani KE, 2007, INT J BIOL SCI, V3, P198; Ferrante RJ, 1997, ANN NEUROL, V42, P326, DOI 10.1002/ana.410420309; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Greenway MJ, 2006, NAT GENET, V38, P411, DOI 10.1038/ng1742; Gura T, 2008, NAT MED, V14, P894, DOI 10.1038/nm0908-894; Gurney ME, 1997, J NEUROL SCI, V152, pS67, DOI 10.1016/S0022-510X(97)00247-5; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Harrington C., 2008, ALZHEIMERS DEMENT, V4, pT120, DOI DOI 10.1016/J.JALZ.2008.05.259; Hayworth CR, 2009, NEUROSCIENCE, V164, P975, DOI 10.1016/j.neuroscience.2009.08.031; Kolb SJ, 2010, MUSCLE NERVE, V41, P5, DOI 10.1002/mus.21428; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; MacGowan DJL, 2001, NEUROLOGY, V57, P1094, DOI 10.1212/WNL.57.6.1094; MAYER B, 1993, BIOCHEM PHARMACOL, V45, P367, DOI 10.1016/0006-2952(93)90072-5; MCCOMAS AJ, 1973, LANCET, V2, P1477; Meyer T, 2005, NEUROLOGY, V65, P141, DOI 10.1212/01.wnl.0000167130.31618.0a; Munch C, 2004, NEUROLOGY, V63, P724, DOI 10.1212/01.WNL.0000134608.83927.B1; National Toxicology Program, 2008, NATL TOXICOL PROGRAM, V540, P1; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; O'Leary JC, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-45; Oz M, 2011, MED RES REV, V31, P93, DOI 10.1002/med.20177; Papp LV, 2010, ANTIOXID REDOX SIGN, V12, P793, DOI 10.1089/ars.2009.2973; Peter C, 2000, EUR J CLIN PHARMACOL, V56, P247, DOI 10.1007/s002280000124; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sasaki S, 1996, NEUROLOGY, V47, P535, DOI 10.1212/WNL.47.2.535; Scott S, 2008, AMYOTROPH LATERAL SC, V9, P4, DOI 10.1080/17482960701856300; Silva MTT, 2005, NEUROLOGY, V65, P1332, DOI 10.1212/01.wnl.0000180962.47653.5e; Strong MJ, 2006, NEUROLOGY, V66, P1770, DOI 10.1212/01.wnl.0000218161.15834.db; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Walter-Sack I, 2009, EUR J CLIN PHARMACOL, V65, P179, DOI 10.1007/s00228-008-0563-x; Wiedemann FR, 1998, J NEUROL SCI, V156, P65, DOI 10.1016/S0022-510X(98)00008-2; Wiklund L, 2007, ANN NY ACAD SCI, V1122, P231, DOI 10.1196/annals.1403.016; Wooley CM, 2005, MUSCLE NERVE, V32, P43, DOI 10.1002/mus.20228; Yang WC, 2003, NEUROLOGY, V61, P1766, DOI 10.1212/01.WNL.0000099372.75786.F8; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160	41	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e23141	10.1371/journal.pone.0023141	http://dx.doi.org/10.1371/journal.pone.0023141			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998625	Green Published, Green Submitted, gold			2022-12-27	WOS:000295968700002
J	Fu, S; Guo, Y; Chen, H; Xu, ZM; Qiu, GB; Zhong, M; Sun, KL; Fu, WN				Fu, Shuang; Guo, Yan; Chen, Hong; Xu, Zhen-Ming; Qiu, Guang-Bin; Zhong, Ming; Sun, Kai-Lai; Fu, Wei-Neng			MYCT1-TV, A Novel MYCT1 Transcript, Is Regulated by c-Myc and May Participate in Laryngeal Carcinogenesis	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; BINDING-SITES; TARGET; EXPRESSION; GENE; P53; IDENTIFICATION; METASTASIS; MICRORNAS; MIGRATION	Background: MYCT1, a putative target of c-Myc, is a novel candidate tumor suppressor gene cloned from laryngeal squamous cell carcinoma (LSCC). Its transcriptional regulation and biological effects on LSCC have not been clarified. Methodology/Principal Findings: Using RACE assay, we cloned a 1106 bp transcript named Myc target 1 transcript variant 1 (MYCT1-TV) and confirmed its transcriptional start site was located at 140 bp upstream of the ATG start codon of MYCT1-TV. Luciferase, electrophoretic mobility shift and chromatin immunoprecipitation assays confirmed c-Myc could regulate the promoter activity of MYCT1-TV by specifically binding to the E-box elements within 2886 to 2655 bp region. These results were further verified by site-directed mutagenesis and RNA interference (RNAi) assays. MYCT1-TV and MYCT1 expressed lower in LSCC than those in paired adjacent normal laryngeal tissues, and overexpression of MYCT1-TV and MYCT1 could inhibit cell proliferation and invasion and promote apoptosis in LSCC cells. Conclusions/Significance: Our data indicate that MYCT1-TV, a novel MYCT1 transcript, is regulated by c-Myc and downregulation of MYCT1-TV/MYCT1 could contribute to LSCC development and function.	[Fu, Shuang; Chen, Hong; Sun, Kai-Lai; Fu, Wei-Neng] China Med Univ, Dept Med Genet, Shenyang, Peoples R China; [Guo, Yan; Zhong, Ming] China Med Univ, Dept Cent Lab, Sch Stomatol, Shenyang, Peoples R China; [Xu, Zhen-Ming] 463 Hosp PLA, Dept Otolaryngol, Shenyang, Peoples R China; [Qiu, Guang-Bin] 202 Hosp PLA, Dept Clin Lab, Shenyang, Peoples R China	China Medical University; China Medical University	Fu, WN (corresponding author), China Med Univ, Dept Med Genet, Shenyang, Peoples R China.	wnfu@mail.cmu.edu.cn			National Nature Science Foundation of China [30700980]; National 863 Project of China [2002BA711A08-18]; Natural Science Foundation of Liaoning Province [20092110]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 863 Project of China(National High Technology Research and Development Program of China); Natural Science Foundation of Liaoning Province(Natural Science Foundation of Liaoning Province)	This work was supported by the National Nature Science Foundation of China (30700980), the National 863 Project (2002BA711A08-18) of China and the Natural Science Foundation of Liaoning Province (20092110). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almadori G, 2006, Acta Otorhinolaryngol Ital, V26, P326; Ashraf MJ, 2010, INDIAN J PATHOL MICR, V53, P661, DOI 10.4103/0377-4929.72019; BLACKWELL TK, 1993, MOL CELL BIOL, V13, P5216, DOI 10.1128/MCB.13.9.5216; Bohlig L, 2011, NUCLEIC ACIDS RES, V39, P440, DOI 10.1093/nar/gkq796; Che XH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-306; Chen L, 2010, NATURE, V464, P1062, DOI 10.1038/nature08978; Chou ST, 2010, J BIOL CHEM, V285, P17833, DOI 10.1074/jbc.M109.078386; Coppola V, 2010, ENDOCR-RELAT CANCER, V17, pF1, DOI 10.1677/ERC-09-0172; Cretu Alexandra, 2009, Cancer Ther, V7, P268; Cripps C, 2010, CURR ONCOL, V17, P37; Dang CV, 1999, MOL CELL BIOL, V19, P1; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Goel A, 2010, CURR OPIN GASTROEN, V26, P47, DOI 10.1097/MOG.0b013e328332b850; Graf F, 2009, J ONCOL, V2009, DOI 10.1155/2009/106378; Guo Y, 2008, ONCOL REP, V19, P1453; Haggerty TJ, 2003, P NATL ACAD SCI USA, V100, P5313, DOI 10.1073/pnas.0931346100; Hawksworth D, 2010, PROSTATE CANCER P D, V13, P311, DOI 10.1038/pcan.2010.31; Hermeking H, 2000, P NATL ACAD SCI USA, V97, P2229, DOI 10.1073/pnas.050586197; Kim J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001798; Krecicki T, 2004, ACTA OTO-LARYNGOL, V124, P634, DOI 10.1080/00016480310016064; Kuznetsov VA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S1-S12; Le Devedec SE, 2010, CELL MOL LIFE SCI, V67, P3219, DOI 10.1007/s00018-010-0419-2; Lewis BC, 2000, CANCER RES, V60, P6178; Li JP, 2007, MOL CELL BIOL, V27, P7345, DOI 10.1128/MCB.02201-06; Li N, 2011, PATHOL ONCOL RES, V10, pe1007; Lin CP, 2010, WORLD J HEPATOL, V2, P16, DOI 10.4254/wjh.v2.i1.16; Liu Tingyan, 2010, Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V24, P648; Mareel M, 2009, VIRCHOWS ARCH, V454, P599, DOI 10.1007/s00428-009-0784-0; Morshed K, 2008, EUR ARCH OTO-RHINO-L, V265, pS89, DOI 10.1007/s00405-007-0569-5; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Ozdek A, 2004, OTOLARYNG HEAD NECK, V131, P77, DOI 10.1016/j.otohns.2004.02.015; Pavese JM, 2010, CANCER METAST REV, V29, P465, DOI 10.1007/s10555-010-9238-z; Perez EA, 2011, J CLIN ONCOL, V29, P651, DOI 10.1200/JCO.2010.30.2125; Pietruszewska Wioletta, 2007, Otolaryngol Pol, V61, P951, DOI 10.1016/S0030-6657(07)70559-0; Qiu GB, 2003, WORLD J GASTROENTERO, V9, P2160; Qiu Guangbin, 2003, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V20, P94; REISMAN D, 1993, CELL GROWTH DIFFER, V4, P57; Ross J, 2009, NUCLEIC ACIDS RES, V37, P5295, DOI 10.1093/nar/gkp545; Takahashi Y, 2007, PATHOL INT, V57, P437, DOI 10.1111/j.1440-1827.2007.02120.x; Wang W, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-60; Wang YY, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-174; Wood LJ, 2000, MOL CELL BIOL, V20, P5490, DOI 10.1128/MCB.20.15.5490-5502.2000; Yin XY, 2002, J BIOL CHEM, V277, P19998, DOI 10.1074/jbc.M200860200	43	26	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25648	10.1371/journal.pone.0025648	http://dx.doi.org/10.1371/journal.pone.0025648			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998677	Green Published, gold, Green Submitted			2022-12-27	WOS:000295966900040
J	Jia, ZW; Wang, L; Chen, RY; Li, DM; Wang, L; Qin, QQ; Ding, ZW; Ding, GW; Zang, CP; Wang, N				Jia, Zhongwei; Wang, Lu; Chen, Ray Y.; Li, Dongmin; Wang, Lan; Qin, Qianqian; Ding, Zhengwei; Ding, Guowei; Zang, Chunpeng; Wang, Ning			Tracking the Evolution of HIV/AIDS in China from 1989-2009 to Inform Future Prevention and Control Efforts	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; MIGRANT WORKERS; HIV; EPIDEMIOLOGY; SHANGHAI; PROGRAM	Background: To determine policy implications, this analysis tracks the evolution of HIV/AIDS infection across China to understand current trends and potential risk factors. Methods and Principal Findings: A retrospective study with spatial analytical model and multilevel spatial models was conducted among 326,157 HIV/AIDS cases reported from 1989-2009. The results indicate that the distribution of HIV/AIDS was clustered at the county level with different directional distributions across China from 2003 to 2009. Compared to 2003, by 2009 there was a 122% increase in HIV cases among rural residents, 294% increase among urban residents, 211% increase among migrants, and 237% increase among permanent residents. The overall proportion of HIV by different routes of transmission showed dramatic changes with a 504% increase in sexual transmission of HIV, 90% decrease in blood/plasma transmission, and 35% decrease in injecting drug user transmission. Sexual transmission was the major transmission route among women (44%) and the elderly (59% in men, 44% in women) as well as among permanent (36%) and urban residents (33%). Among those < 65 years old, women increased more than men, but among those >= 65 years, men increased more than women. Migrants contributed to the variance of HIV infection between counties but not within counties. The length of highway and urbanization combined with illiteracy were risk factors for HIV/AIDS. Conclusions/Significance: Rates of HIV/AIDS among permanent urban residents, particularly women and elderly men, have increased significantly in recent years. To prevent HIV from spreading further among the general population, additional attention should be paid to these populations as well as to migrants.	[Jia, Zhongwei] Peking Univ, Natl Inst Drug Dependence, Beijing 100871, Peoples R China; [Jia, Zhongwei; Wang, Lu; Li, Dongmin; Wang, Lan; Qin, Qianqian; Ding, Zhengwei; Ding, Guowei; Zang, Chunpeng; Wang, Ning] China CDC, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Chen, Ray Y.] US Embassy, NIAID, US Natl Inst Hlth, Beijing, Peoples R China	Peking University; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Jia, ZW (corresponding author), Peking Univ, Natl Inst Drug Dependence, Beijing 100871, Peoples R China.	wangnbj@163.com	Qin, Qin/GVT-5910-2022; qin, qin x/GXG-6164-2022; Chen, Ray/GRJ-6736-2022; Chen, Ray/T-5102-2019	Chen, Ray/0000-0001-6344-1442	Eleventh Five-year Plan [2008ZX100 (01-003), 03-008]; National Natural Science Foundation [30973981]; U.S. NIH Fogarty [R24 TW007988]; Beijing Municipal Commission of Education [KM201010025010]; FOGARTY INTERNATIONAL CENTER [R24TW007988] Funding Source: NIH RePORTER	Eleventh Five-year Plan; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); U.S. NIH Fogarty; Beijing Municipal Commission of Education(Beijing Municipal Commission of Education); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The Eleventh Five-year Plan (No. 2008ZX100 (01-003), (03-008)), National Natural Science Foundation (No. 30973981), and U.S. NIH Fogarty R24 TW007988, and Beijing Municipal Commission of Education (No. KM201010025010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, CHIN STAT YB 2004 20; Cao HJ, 2010, AIDS EDUC PREV, V22, P445, DOI 10.1521/aeap.2010.22.5.445; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Dou ZH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013737; He N, 2007, AIDS, V21, pS73, DOI 10.1097/01.aids.0000304700.85379.f3; Jia ZW, 2008, EMERG INFECT DIS, V14, P1413, DOI [10.3201/1409.071543, 10.3201/eid1409.071543]; Jia ZW, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000371; Li S, 2010, INT J STD AIDS, V21, P82, DOI 10.1258/ijsa.2009.008514; Li SH, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-195; Li XJ, 2005, AIDS RES HUM RETROV, V21, P977, DOI 10.1089/aid.2005.21.977; Liu HJ, 2005, AIDS PATIENT CARE ST, V19, P49, DOI 10.1089/apc.2005.19.49; LU Z, 2004, GERIATRICS HLTH CARE, V10, P206; Mardia V., 2000, DIRECTIONAL STAT, V2nd; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; *NAT POP FAM PLANN, 2009, REP CHIN MIGR POP DE; PAN SM, 1994, J PSYCHOL HUMAN SEXU, V6, P1; Ruan Fang Fu, 1991, SEX CHINA STUDIES SE; SHAO YM, 1998, INT C AIDS, V12, P111; *STAT COUNC AIDS W, 2010, JOINT ASS HIV AIDS P; WU JP, 1986, SEXUAL MED; Wu ZY, 2006, SCIENCE, V312, P1475, DOI 10.1126/science.1120682; Xiao ZW, 2011, AIDS CARE, V23, P105, DOI 10.1080/09540121.2010.532537; YUAN FF, 1985, SEXUAL KNOWLEDGE MAN; Zhang FJ, 2008, CLIN INFECT DIS, V47, P825, DOI 10.1086/590945; Zhang FJ, 2011, LANCET INFECT DIS, V11, P516, DOI 10.1016/S1473-3099(11)70097-4; Zhang FJ, 2009, ANN INTERN MED, V151, P241, DOI 10.7326/0003-4819-151-4-200908180-00006; Zhang KL, 2002, BMJ-BRIT MED J, V324, P803, DOI 10.1136/bmj.324.7341.803	28	30	38	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25671	10.1371/journal.pone.0025671	http://dx.doi.org/10.1371/journal.pone.0025671			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998679	Green Published, gold, Green Submitted			2022-12-27	WOS:000295966900042
J	Lindsay, WR; Webster, MS; Schwabl, H				Lindsay, Willow R.; Webster, Michael S.; Schwabl, Hubert			Sexually Selected Male Plumage Color Is Testosterone Dependent in a Tropical Passerine Bird, the Red-Backed Fairy-Wren (Malurus melanocephalus)	PLOS ONE			English	Article							MALE HOUSE SPARROWS; ELEVATED TESTOSTERONE; EUROPEAN STONECHATS; SOCIAL-DOMINANCE; LIFE-HISTORIES; MOLT; CAROTENOIDS; ORNAMENTS; YOLK; REPRODUCTION	Background: Sexual signals, such as bright plumage coloration in passerine birds, reflect individual quality, and testosterone (T) may play a critical role in maintaining signal honesty. Manipulations of T during molt have yielded mixed effects on passerine plumage color, in most cases delaying molt or leading to production of drab plumage. However, the majority of these studies have been conducted on species that undergo a post-nuptial molt when T is low; the role of T in species that acquire breeding plumage during a pre-nuptial molt remains largely unexplored. Methodology/Principal Findings: We experimentally tested the effects of increased T on plumage color in second-year male red-backed fairy-wrens (Malurus melanocephalus), a species in which after-second-year males undergo a pre-nuptial molt into red/black (carotenoid and melanin-based) plumage and second-year males either assume red/black or brown breeding plumage. T treatment stimulated a rapid and early onset pre-nuptial molt and resulted in red/black plumage acquisition, bill darkening, and growth of the sperm storage organ, but had no effect on body condition or corticosterone concentrations. Control males molted later and assumed brown plumage. T treated males produced feathers with similar but not identical reflectance parameters to those of unmanipulated after-second-year red/black males; while reflectance spectra of red back and black crown feathers were similar, black breast feathers differed in UV chroma, hue and brightness, indicating a potentially age and plumage patch-dependent response to T for melanin-vs. carotenoid-pigmentation. Conclusions/Significance: We show that testosterone is the primary mechanism functioning during the pre-nuptial molt to regulate intrasexually variable plumage color and breeding phenotype in male red-backed fairy-wrens. Our results suggest that the effects of T on plumage coloration may vary with timing of molt (pre- vs. post-nuptial), and that the role of T in mediating plumage signal production may differ across age classes, plumage patches, and between pigment-types.	[Lindsay, Willow R.; Schwabl, Hubert] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA; [Lindsay, Willow R.; Schwabl, Hubert] Washington State Univ, Ctr Reprod Biol, Pullman, WA 99164 USA; [Webster, Michael S.] Cornell Univ, Cornell Lab Ornithol, Ithaca, NY USA; [Webster, Michael S.] Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA	Washington State University; Washington State University; Cornell University; Cornell University	Lindsay, WR (corresponding author), Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA.	willowlindsay@gmail.com	Webster, Michael/AAB-7151-2020	Webster, Michael/0000-0001-7585-4578	National Science Foundation (United States of America) [0213075, 0818962, 0750540]; Direct For Biological Sciences [0964826] Funding Source: National Science Foundation	National Science Foundation (United States of America)(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded by grants 0213075 and 0818962 to MW, and 0750540 to John Wingfield from the National Science Foundation (United States of America; www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Alvarez C, 2007, P ROY SOC B-BIOL SCI, V274, P819, DOI 10.1098/rspb.2006.3764; Andersson Malte, 1994; Blas J, 2006, P NATL ACAD SCI USA, V103, P18633, DOI 10.1073/pnas.0609189103; Bokony V, 2008, BEHAV ECOL SOCIOBIOL, V62, P1229, DOI 10.1007/s00265-008-0551-2; Buchanan KL, 2001, P ROY SOC B-BIOL SCI, V268, P1337, DOI 10.1098/rspb.2001.1669; Casagrande S, 2011, J COMP PHYSIOL A, V197, P1, DOI 10.1007/s00359-010-0579-4; Chard T., 1995, INTRO RADIOIMMUNOASS; Clotfelter ED, 2004, HORM BEHAV, V46, P171, DOI 10.1016/j.yhbeh.2004.03.003; COLLIS K, 1992, AUK, V109, P422; Cotton S, 2004, P ROY SOC B-BIOL SCI, V271, P771, DOI 10.1098/rspb.2004.2688; DAWSON A, 1994, IBIS, V136, P335, DOI 10.1111/j.1474-919X.1994.tb01104.x; Day LB, 2006, HORM BEHAV, V49, P223, DOI 10.1016/j.yhbeh.2005.07.006; Duckworth RA, 2004, BEHAV ECOL, V15, P779, DOI 10.1093/beheco/arh079; Eens M, 2000, HORM BEHAV, V37, P126, DOI 10.1006/hbeh.1999.1569; Eising CM, 2006, BIOL LETTERS, V2, P20, DOI 10.1098/rsbl.2005.0391; Evans MR, 2000, BEHAV ECOL SOCIOBIOL, V47, P156, DOI 10.1007/s002650050006; Fair J., 2010, ORNITHOLOGICAL COUNC; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Galvan I, 2010, J EXP BIOL, V213, P3127, DOI 10.1242/jeb.045096; Gonzalez G, 2001, BEHAV ECOL SOCIOBIOL, V50, P557; Goymann W, 2004, AM NAT, V164, P327, DOI 10.1086/422856; Goymann W, 2002, AUK, V119, P1167, DOI 10.1642/0004-8038(2002)119[1167:CMCBMN]2.0.CO;2; Goymann W, 2002, GEN COMP ENDOCR, V129, P80, DOI 10.1016/S0016-6480(02)00520-8; GRAFEN A, 1990, J THEOR BIOL, V144, P473, DOI 10.1016/S0022-5193(05)80087-6; Hill G. E., 2006, BIRD COLORATION, V2; Hill G. E., 2006, BIRD COLORATION, V1; Jawor JM, 2003, AUK, V120, P249, DOI 10.1642/0004-8038(2003)120[0249:MOHASS]2.0.CO;2; Karubian J, 2002, EVOLUTION, V56, P1673; Karubian J, 2008, BEHAV ECOL, V19, P508, DOI 10.1093/beheco/arm159; Karubian J, 2008, J AVIAN BIOL, V39, P81, DOI 10.1111/j.0908-8857.2008.04161.x; Karubian J, 2011, ANIM BEHAV, V81, P795, DOI 10.1016/j.anbehav.2011.01.012; KETTERSON ED, 1992, AM NAT, V140, pS33, DOI 10.1086/285396; Kimball Rebecca T., 2006, P431; Kurvers RHJM, 2008, HORM BEHAV, V54, P263, DOI 10.1016/j.yhbeh.2008.03.011; Lindsay WR, 2009, ANIM BEHAV, V77, P1525, DOI 10.1016/j.anbehav.2009.02.027; McGraw KJ, 2006, BEHAV ECOL SOCIOBIOL, V60, P117, DOI 10.1007/s00265-005-0135-3; MOLLER AP, 1992, BEHAV ECOL SOCIOBIOL, V31, P271; Montgomerie, 2008, CLR VERSION 1 05; MULDER RA, 1993, AUK, V110, P588, DOI 10.2307/4088422; NOLAN V, 1992, CONDOR, V94, P364, DOI 10.2307/1369209; OWENS IPF, 1995, TRENDS ECOL EVOL, V10, P44, DOI 10.1016/S0169-5347(00)88967-3; Perez-Rodriguez L, 2006, ANIM BEHAV, V72, P97, DOI 10.1016/j.anbehav.2005.09.021; Peters A, 2006, BEHAV ECOL SOCIOBIOL, V59, P666, DOI 10.1007/s00265-005-0095-7; Peters A, 2000, P ROY SOC B-BIOL SCI, V267, P883, DOI 10.1098/rspb.2000.1085; Peters A, 2000, BEHAV ECOL SOCIOBIOL, V47, P438, DOI 10.1007/s002650050688; Peters A, 2007, BIOESSAYS, V29, P427, DOI 10.1002/bies.20563; Peters A, 2007, IBIS, V149, P121; Pyle P, 1987, IDENTIFICATION GUIDE, P273; Roberts M, 2009, J EXP BIOL, V212, P1811, DOI 10.1242/jeb.031047; Roberts ML, 2009, BEHAV ECOL, V20, P535, DOI 10.1093/beheco/arp028; Roberts ML, 2004, ANIM BEHAV, V68, P227, DOI 10.1016/j.anbehav.2004.05.001; Rowe M, 2010, ANIM BEHAV, V79, P1239, DOI 10.1016/j.anbehav.2010.02.020; Rowe M, 2008, CONDOR, V110, P694, DOI 10.1525/cond.2008.8604; RUNFELDT S, 1985, ANIM BEHAV, V33, P403, DOI 10.1016/S0003-3472(85)80064-6; SAINO N, 1994, ANIM BEHAV, V48, P1325, DOI 10.1006/anbe.1994.1369; SCHLEUSSNER G, 1985, PHYSIOL ZOOL, V58, P597, DOI 10.1086/physzool.58.5.30158586; SCHWABL H, 1993, P NATL ACAD SCI USA, V90, P11446, DOI 10.1073/pnas.90.24.11446; Sokal R.R., 2012, BIOMETRY; Stoehr AM, 2001, J AVIAN BIOL, V32, P153, DOI 10.1034/j.1600-048X.2001.320208.x; Strasser R, 2004, BEHAV ECOL SOCIOBIOL, V56, P491, DOI 10.1007/s00265-004-0810-9; Varian-Ramos CW, 2010, BEHAV ECOL SOCIOBIOL, V64, P967, DOI 10.1007/s00265-010-0912-5; Vinkler M, 2010, NATURWISSENSCHAFTEN, V97, P19, DOI 10.1007/s00114-009-0595-9; Webster MS, 2008, BEHAV ECOL, V19, P517, DOI 10.1093/beheco/arn015; Wikelski M, 2003, CONDOR, V105, P683, DOI 10.1650/7251; WINGFIELD JC, 1984, GEN COMP ENDOCR, V56, P406, DOI 10.1016/0016-6480(84)90083-2; Wingfield JC, 2001, BRAIN BEHAV EVOLUT, V57, P239, DOI 10.1159/000047243; Witschi E., 1961, BIOL COMP PHYSL BIRD, P115; ZUK M, 1995, P ROY SOC B-BIOL SCI, V260, P205, DOI 10.1098/rspb.1995.0081	68	50	51	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e26067	10.1371/journal.pone.0026067	http://dx.doi.org/10.1371/journal.pone.0026067			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998753	Green Submitted, Green Published, gold			2022-12-27	WOS:000295966900094
J	Rentsch, MB; Zimmer, G				Rentsch, Marianne Berger; Zimmer, Gert			A Vesicular Stomatitis Virus Replicon-Based Bioassay for the Rapid and Sensitive Determination of Multi-Species Type I Interferon	PLOS ONE			English	Article							HEPATITIS-C; V-PROTEIN; ALPHA; INFECTION; RESPONSES; CELLS; GAMMA; EFFECTORS; DEFENSE; CANCER	Type I interferons (IFN) comprise a family of cytokines that signal through a common cellular receptor to induce a plethora of genes with antiviral and other activities. Recombinant IFNs are used for the treatment of hepatitis C virus infection, multiple sclerosis, and certain malignancies. The capability of type I IFN to suppress virus replication and resultant cytopathic effects is frequently used to measure their bioactivity. However, these assays are time-consuming and require appropriate biosafety containment. In this study, an improved IFN assay is presented which is based on a recombinant vesicular stomatitis virus (VSV) replicon encoding two reporter proteins, firefly luciferase and green fluorescent protein. The vector lacks the essential envelope glycoprotein (G) gene of VSV and is propagated on a G protein-expressing transgenic cell line. Several mammalian and avian cells turned out to be susceptible to infection with the complemented replicon particles. Infected cells readily expressed the reporter proteins at high levels five hours post infection. When human fibroblasts were treated with serial dilutions of human IFN-beta prior to infection, reporter expression was accordingly suppressed. This method was more sensitive and faster than a classical IFN bioassay based on VSV cytopathic effects. In addition, the antiviral activity of human IFN-lambda (interleukin-29), a type III IFN, was determined on Calu-3 cells. Both IFN-beta and IFN-lambda were acid-stable, but only IFN-beta was resistant to alkaline treatment. The antiviral activities of canine, porcine, and avian type I IFN were analysed with cell lines derived from the corresponding species. This safe bioassay will be useful for the rapid and sensitive quantification of multi-species type I IFN and potentially other antiviral cytokines.	[Rentsch, Marianne Berger; Zimmer, Gert] Inst Viruskrankheiten & Immunprophylaxe, Mittelhausern, Switzerland		Rentsch, MB (corresponding author), Inst Viruskrankheiten & Immunprophylaxe, Mittelhausern, Switzerland.	gert.zimmer@ivi.admin.ch		Zimmer, Gert/0000-0002-2708-2507	Wilhelm Sander Foundation [2007.101.1]; Swiss National Science Foundation [310030_129669]	Wilhelm Sander Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was funded by Wilhelm Sander Foundation (www.sanst.de) (grant no. 2007.101.1); Swiss National Science Foundation (www.snf.ch), grant no. 310030_129669. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balmelli C, 2005, EUR J IMMUNOL, V35, P2406, DOI 10.1002/eji.200525998; Bloor S, 2010, P NATL ACAD SCI USA, V107, P6970, DOI 10.1073/pnas.0908536107; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Faria PA, 2005, MOL CELL, V17, P93, DOI 10.1016/j.molcel.2004.11.023; Ferrantini M, 2007, BIOCHIMIE, V89, P884, DOI 10.1016/j.biochi.2007.04.006; Hanika A, 2005, J GEN VIROL, V86, P1455, DOI 10.1099/vir.0.80788-0; Hoffmann M, 2010, J GEN VIROL, V91, P2782, DOI 10.1099/vir.0.023978-0; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; JARIWALLA R, 1975, ARCH VIROL, V49, P261, DOI 10.1007/BF01317544; Kalhoro NH, 2009, VACCINE, V27, P1174, DOI 10.1016/j.vaccine.2008.12.019; Kopecky-Bromberg SA, 2007, J VIROL, V81, P548, DOI 10.1128/JVI.01782-06; Kuri T, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-50; Larocque L, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/174615; Maher SG, 2007, CURR MED CHEM, V14, P1279, DOI 10.2174/092986707780597907; Malucchi S, 2011, J NEUROL, V258, P895, DOI 10.1007/s00415-010-5844-5; Meager A, 2002, J IMMUNOL METHODS, V261, P21, DOI 10.1016/S0022-1759(01)00570-1; Mordstein M, 2010, J VIROL, V84, P5670, DOI 10.1128/JVI.00272-10; Park MS, 2003, J VIROL, V77, P1501, DOI 10.1128/JVI.77.2.1501-1511.2003; Perler L, 1999, J IMMUNOL METHODS, V222, P189, DOI 10.1016/S0022-1759(98)00198-7; Pott J, 2011, P NATL ACAD SCI USA, V108, P7944, DOI 10.1073/pnas.1100552108; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Rizza P, 2010, AUTOIMMUNITY, V43, P204, DOI 10.3109/08916930903510880; Rothlisberger A, 2010, J VIROL, V84, P6328, DOI 10.1128/JVI.01878-09; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Schnell MJ, 1996, J VIROL, V70, P2318, DOI 10.1128/JVI.70.4.2318-2323.1996; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; SCHULTZ U, 1995, EUR J BIOCHEM, V229, P73, DOI 10.1111/j.1432-1033.1995.tb20439.x; Schwarz H, 2004, J INTERF CYTOK RES, V24, P179, DOI 10.1089/107999004322917025; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; TAYLORPA.J, 1971, NATURE-NEW BIOL, V230, P114, DOI 10.1038/newbio230114a0; Tsubota A, 2011, WORLD J GASTROENTERO, V17, P419, DOI 10.3748/wjg.v17.i4.419; Valmas C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000721; VIRELIZIER JL, 1977, INFECT IMMUN, V17, P282, DOI 10.1128/IAI.17.2.282-285.1977; Vosoughi R, 2010, CLIN NEUROL NEUROSUR, V112, P365, DOI 10.1016/j.clineuro.2010.03.010; Vrolijk JM, 2003, J VIROL METHODS, V110, P201, DOI 10.1016/S0166-0934(03)00134-4	36	127	129	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25858	10.1371/journal.pone.0025858	http://dx.doi.org/10.1371/journal.pone.0025858			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998709	Green Submitted, Green Published, gold			2022-12-27	WOS:000295966900064
J	Plaisance, L; Caley, MJ; Brainard, RE; Knowlton, N				Plaisance, Laetitia; Caley, M. Julian; Brainard, Russell E.; Knowlton, Nancy			The Diversity of Coral Reefs: What Are We Missing?	PLOS ONE			English	Article							BIOLOGICAL IDENTIFICATIONS; BIODIVERSITY HOTSPOTS; MARINE BIODIVERSITY; SPECIES RICHNESS; EXTINCTION RISK; CLIMATE-CHANGE; CONSERVATION	Tropical reefs shelter one quarter to one third of all marine species but one third of the coral species that construct reefs are now at risk of extinction. Because traditional methods for assessing reef diversity are extremely time consuming, taxonomic expertise for many groups is lacking, and marine organisms are thought to be less vulnerable to extinction, most discussions of reef conservation focus on maintenance of ecosystem services rather than biodiversity loss. In this study involving the three major oceans with reef growth, we provide new biodiversity estimates based on quantitative sampling and DNA barcoding. We focus on crustaceans, which are the second most diverse group of marine metazoans. We show exceptionally high numbers of crustacean species associated with coral reefs relative to sampling effort (525 species from a combined, globally distributed sample area of 6.3 m(2)). The high prevalence of rare species (38% encountered only once), the low level of spatial overlap (81% found in only one locality) and the biogeographic patterns of diversity detected (Indo-West Pacific > Central Pacific > Caribbean) are consistent with results from traditional survey methods, making this approach a reliable and efficient method for assessing and monitoring biodiversity. The finding of such large numbers of species in a small total area suggests that coral reef diversity is seriously under-detected using traditional survey methods, and by implication, underestimated.	[Plaisance, Laetitia; Knowlton, Nancy] Smithsonian Inst, Natl Museum Nat Hist, Dept Invertebrate Zool, Washington, DC 20560 USA; [Plaisance, Laetitia; Knowlton, Nancy] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biodivers & Conservat, La Jolla, CA 92093 USA; [Caley, M. Julian] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Brainard, Russell E.] Natl Ocean & Atmospher Adm Fisheries, Pacific Islands Fisheries Sci Ctr, Coral Reef Ecosyst Div, Honolulu, HI USA	Smithsonian Institution; Smithsonian National Museum of Natural History; University of California System; University of California San Diego; Scripps Institution of Oceanography; Australian Institute of Marine Science; National Oceanic Atmospheric Admin (NOAA) - USA	Plaisance, L (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Dept Invertebrate Zool, Washington, DC 20560 USA.	plaisancel@si.edu	Caley, Julian/A-4042-2008	Caley, Julian/0000-0001-5739-749X	Alfred P. Sloan Foundation; Census of Marine Life; Census of Coral Reefs; BHP Billiton (Australia)	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Census of Marine Life; Census of Coral Reefs; BHP Billiton (Australia)	This work was supported by the Alfred P. Sloan Foundation, Census of Marine Life, Census of Coral Reefs, and BHP Billiton (Australia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beger M, 2007, CONSERV BIOL, V21, P1584, DOI 10.1111/j.1523-1739.2007.00795.x; Bellwood DR, 2001, SCIENCE, V292, P1532, DOI 10.1126/science.1058635; Bouchet P, 2002, BIOL J LINN SOC, V75, P421, DOI 10.1046/j.1095-8312.2002.00052.x; Bouchet Philippe, 2006, P31; Bouchet P, 2009, RAFFLES B ZOOL, P1; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Coddington JA, 2009, J ANIM ECOL, V78, P573, DOI 10.1111/j.1365-2656.2009.01525.x; Costa FO, 2007, CAN J FISH AQUAT SCI, V64, P272, DOI 10.1139/F07-008; Crawley MJ, 2001, SCIENCE, V291, P864, DOI 10.1126/science.291.5505.864; Dornelas M, 2006, NATURE, V440, P80, DOI 10.1038/nature04534; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Guilhaumon F, 2008, P NATL ACAD SCI USA, V105, P15458, DOI 10.1073/pnas.0803610105; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hortal J, 2006, J ANIM ECOL, V75, P274, DOI 10.1111/j.1365-2656.2006.01048.x; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Hughes TP, 2002, ECOL LETT, V5, P775, DOI 10.1046/j.1461-0248.2002.00383.x; Idjadi JA, 2006, MAR ECOL PROG SER, V319, P117, DOI 10.3354/meps319117; Jackson JBC, 2008, P NATL ACAD SCI USA, V105, P11458, DOI 10.1073/pnas.0802812105; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Mellin C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020141; Plaisance L, 2009, CORAL REEFS, V28, P977, DOI 10.1007/s00338-009-0543-3; Reaka-Kudla Marjorie L., 1997, P83; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Roberts CM, 1999, TRENDS ECOL EVOL, V14, P241, DOI 10.1016/S0169-5347(98)01584-5; Santelli CM, 2008, NATURE, V453, P653, DOI 10.1038/nature06899; Schloss PD, 2009, INTRO MOTHUR COMPUTA; SMALL AM, 1998, ATOLL RES B, V458, P1, DOI DOI 10.5479/SI.00775630.458.1; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857	30	129	134	17	132	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e25026	10.1371/journal.pone.0025026	http://dx.doi.org/10.1371/journal.pone.0025026			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022371	gold, Green Published, Green Submitted			2022-12-27	WOS:000295978600008
J	Gosby, AK; Conigrave, AD; Lau, NS; Iglesias, MA; Hall, RM; Jebb, SA; Brand-Miller, J; Caterson, ID; Raubenheimer, D; Simpson, SJ				Gosby, Alison K.; Conigrave, Arthur D.; Lau, Namson S.; Iglesias, Miguel A.; Hall, Rosemary M.; Jebb, Susan A.; Brand-Miller, Jennie; Caterson, Ian D.; Raubenheimer, David; Simpson, Stephen J.			Testing Protein Leverage in Lean Humans: A Randomised Controlled Experimental Study	PLOS ONE			English	Article							FOOD-INTAKE; BODY-WEIGHT; DIETARY-PROTEIN; ENERGY DENSITY; AD-LIBITUM; MACRONUTRIENT CONTENT; OVERWEIGHT SUBJECTS; GEOMETRIC ANALYSIS; APPETITE CONTROL; LIFE-SPAN	A significant contributor to the rising rates of human obesity is an increase in energy intake. The 'protein leverage hypothesis' proposes that a dominant appetite for protein in conjunction with a decline in the ratio of protein to fat and carbohydrate in the diet drives excess energy intake and could therefore promote the development of obesity. Our aim was to test the 'protein leverage hypothesis' in lean humans by disguising the macronutrient composition of foods offered to subjects under ad libitum feeding conditions. Energy intakes and hunger ratings were measured for 22 lean subjects studied over three 4-day periods of in-house dietary manipulation. Subjects were restricted to fixed menus in random order comprising 28 foods designed to be similar in palatability, availability, variety and sensory quality and providing 10%, 15% or 25% energy as protein. Nutrient and energy intake was calculated as the product of the amount of each food eaten and its composition. Lowering the percent protein of the diet from 15% to 10% resulted in higher (+12 +/- 4.5%, p = 0.02) total energy intake, predominantly from savoury-flavoured foods available between meals. This increased energy intake was not sufficient to maintain protein intake constant, indicating that protein leverage is incomplete. Urinary urea on the 10% and 15% protein diets did not differ statistically, nor did they differ from habitual values prior to the study. In contrast, increasing protein from 15% to 25% did not alter energy intake. On the fourth day of the trial, however, there was a greater increase in the hunger score between 1-2 h after the 10% protein breakfast versus the 25% protein breakfast (1.6 +/- 0.4 vs 25%: 0.5 +/- 0.3, p = 0.005). In our study population a change in the nutritional environment that dilutes dietary protein with carbohydrate and fat promotes overconsumption, enhancing the risk for potential weight gain.	[Gosby, Alison K.; Iglesias, Miguel A.; Simpson, Stephen J.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Conigrave, Arthur D.; Brand-Miller, Jennie; Caterson, Ian D.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Lau, Namson S.; Brand-Miller, Jennie; Caterson, Ian D.] Univ Sydney, Boden Inst Obes Nutr & Exercise, Sydney, NSW 2006, Australia; [Hall, Rosemary M.; Jebb, Susan A.] MRC, Cambridge, England; [Raubenheimer, David] Massey Univ, Inst Nat Sci, Auckland, New Zealand	University of Sydney; University of Sydney; University of Sydney; Massey University	Gosby, AK (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	alison.gosby@sydney.edu.au; stephen.simpson@sydney.edu.au	Iglesias, Miguel A/J-7879-2014; Brand-Miller, Jennie C/A-6835-2013	Iglesias, Miguel A/0000-0001-5781-2091; Brand-Miller, Jennie C/0000-0002-6797-8754; Conigrave, Arthur/0000-0002-7232-3891; Simpson, Stephen J./0000-0003-0256-7687; Raubenheimer, David/0000-0001-9050-1447; Lau, Namson/0000-0002-9400-8470; Jebb, Susan/0000-0001-9190-2920	Australian National Health and Medical Research Council [457522]; National Research Centre for Growth and Development; Australian Research Council; Medical Research Council [MC_U105960389] Funding Source: researchfish; MRC [MC_U105960389] Funding Source: UKRI	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Research Centre for Growth and Development; Australian Research Council(Australian Research Council); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was entirely funded by an Australian National Health and Medical Research Council project grant (no. 457522). DR is partly funded by the National Research Centre for Growth and Development. SJS is funded by an Australian Research Council Laureate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Austin GL, 2011, AM J CLIN NUTR, V93, P836, DOI 10.3945/ajcn.110.000141; Brondel L, 2009, PHYSIOL BEHAV, V97, P44, DOI 10.1016/j.physbeh.2009.01.019; Brooks RC, 2010, OBES REV, V11, P887, DOI 10.1111/j.1467-789X.2010.00733.x; Brown WJ, 2005, OBES RES, V13, P1431, DOI 10.1038/oby.2005.173; Cheng K, 2008, AM NAT, V172, P681, DOI 10.1086/591686; Cordain L, 2000, AM J CLIN NUTR, V71, P682, DOI 10.1093/ajcn/71.3.682; Due A, 2005, DIABETES OBES METAB, V7, P223, DOI 10.1111/j.1463-1326.2004.00426.x; Due A, 2004, INT J OBESITY, V28, P1283, DOI 10.1038/sj.ijo.0802767; Eaton SB, 2006, P NUTR SOC, V65, P1, DOI 10.1079/PNS2005471; El Khoury DTD, 2006, ANN NUTR METAB, V50, P260, DOI 10.1159/000091684; Felton AM, 2009, FUNCT ECOL, V23, P70, DOI 10.1111/j.1365-2435.2008.01526.x; Flint A, 2000, INT J OBESITY, V24, P38, DOI 10.1038/sj.ijo.0801083; Gietzen DW, 2007, ANNU REV NUTR, V27, P63, DOI 10.1146/annurev.nutr.27.061406.093726; Gosby AK, 2010, APPETITE, V55, P367, DOI 10.1016/j.appet.2010.06.009; Hall KD, 2011, LANCET, V378, P826, DOI 10.1016/S0140-6736(11)60812-X; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Johnson L, 2009, OBES REV, V10, P681, DOI 10.1111/j.1467-789X.2009.00580.x; Johnstone AM, 2000, BRIT J NUTR, V83, P7, DOI 10.1017/S0007114500000039; Keast DR, 2010, AM J CLIN NUTR, V92, P428, DOI 10.3945/ajcn.2009.28421; Kerver JM, 2006, J AM DIET ASSOC, V106, P46, DOI 10.1016/j.jada.2005.09.045; KYRIAZAKIS I, 1991, PHYSIOL BEHAV, V50, P1197, DOI 10.1016/0031-9384(91)90582-9; Larsen TM, 2010, NEW ENGL J MED, V363, P2102, DOI 10.1056/NEJMoa1007137; Lee KP, 2008, P NATL ACAD SCI USA, V105, P2498, DOI 10.1073/pnas.0710787105; Leidy HJ, 2010, OBESITY, V18, P1725, DOI 10.1038/oby.2010.45; Lejeune MPGM, 2006, AM J CLIN NUTR, V83, P89; Long SJ, 2000, APPETITE, V35, P79, DOI 10.1006/appe.2000.0332; Maillot M, 2009, J NUTR, V139, P1721, DOI 10.3945/jn.109.107318; Marmonier C, 2000, APPETITE, V34, P161, DOI 10.1006/appe.1999.0302; Metges CC, 2000, J NUTR, V130, P886, DOI 10.1093/jn/130.4.886; Nolan LJ, 2009, APPETITE, V52, P720, DOI 10.1016/j.appet.2009.03.012; Norton GNM, 2006, PHYSIOL BEHAV, V87, P714, DOI 10.1016/j.physbeh.2006.01.010; Popkin BM, 2010, AM J CLIN NUTR, V91, P1342, DOI 10.3945/ajcn.2009.28962; Potier M, 2009, CURR OPIN CLIN NUTR, V12, P54, DOI 10.1097/MCO.0b013e32831b9e01; Potier M, 2009, BRIT J NUTR, V102, P625, DOI 10.1017/S0007114509236026; Prentice A, 2004, NUTR REV, V62, pS98, DOI 10.1111/j.1753-4887.2004.tb00095.x; Raubenheimer D, 1997, NUTR RES REV, V10, P151, DOI 10.1079/NRR19970009; Raubenheimer D, 2005, ECOLOGY, V86, P2601, DOI 10.1890/04-1472; SHARIATMADARI F, 1993, BRIT POULTRY SCI, V34, P959, DOI 10.1080/00071669308417656; Simpson SJ, 2005, OBES REV, V6, P133, DOI 10.1111/j.1467-789X.2005.00178.x; Simpson SJ, 1997, APPETITE, V28, P201, DOI 10.1006/appe.1996.0077; Simpson SJ, 2003, APPETITE, V41, P123, DOI 10.1016/S0195-6663(03)00049-7; Simpson SJ, 2009, AGING-US, V1, P875, DOI 10.18632/aging.100098; Skov AR, 1999, INT J OBESITY, V23, P528, DOI 10.1038/sj.ijo.0800867; Sorensen A, 2008, OBESITY, V16, P566, DOI 10.1038/oby.2007.58; Stock MJ, 1999, INT J OBESITY, V23, P1105, DOI 10.1038/sj.ijo.0801108; STUBBS RJ, 1995, AM J CLIN NUTR, V62, P316; Stubbs RJ, 2001, EUR J CLIN NUTR, V55, P19, DOI 10.1038/sj.ejcn.1601117; Swinburn BA, 2009, AM J CLIN NUTR, V89, P1723, DOI 10.3945/ajcn.2008.27061; Tome D, 2000, J NUTR, V130, p1868S, DOI 10.1093/jn/130.7.1868S; WEBSTER AJF, 1993, P NUTR SOC, V52, P69, DOI 10.1079/PNS19930038; Weigle DS, 2005, AM J CLIN NUTR, V82, P41, DOI 10.1093/ajcn/82.1.41; Westerterp-Plantenga MS, 2004, PHYSIOL BEHAV, V83, P579, DOI 10.1016/j.physbeh.2004.07.027; [No title captured]; [No title captured]	55	107	109	4	310	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25929	10.1371/journal.pone.0025929	http://dx.doi.org/10.1371/journal.pone.0025929			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022472	Green Published, Green Submitted, gold			2022-12-27	WOS:000295976000047
J	Rahn, E; Petermann, P; Hsu, MJ; Rixon, FJ; Knebel-Morsdorf, D				Rahn, Elena; Petermann, Philipp; Hsu, Mei-Ju; Rixon, Frazer J.; Knebel-Morsdorf, Dagmar			Entry Pathways of Herpes Simplex Virus Type 1 into Human Keratinocytes Are Dynamin- and Cholesterol-Dependent	PLOS ONE			English	Article							POLARIZED EPITHELIAL-CELLS; COATED VESICLE FORMATION; LIPID RAFTS; MEDIATED ENDOCYTOSIS; LOW-PH; INHIBITION; ENDOSOMES; RECEPTOR; PROTEIN; ACTIN	Herpes simplex virus type 1 (HSV-1) can enter cells via endocytic pathways or direct fusion at the plasma membrane depending on the cell line and receptor(s). Most studies into virus entry have used cultured fibroblasts but since keratinocytes represent the primary entry site for HSV-1 infection in its human host, we initiated studies to characterize the entry pathway of HSV-1 into human keratinocytes. Electron microscopy studies visualized free capsids in the cytoplasm and enveloped virus particles in vesicles suggesting viral uptake both by direct fusion at the plasma membrane and by endocytic vesicles. The ratio of the two entry modes differed in primary human keratinocytes and in the keratinocyte cell line HaCaT. Inhibitor studies further support a role for endocytosis during HSV-1 entry. Infection was inhibited by the cholesterol-sequestering drug methyl-beta-cyclodextrin, which demonstrates the requirement for host cholesterol during virus entry. Since the dynamin-specific inhibitor dynasore and overexpression of a dominant-negative dynamin mutant blocked infection, we conclude that the entry pathways into keratinocytes are dynamin-mediated. Electron microscopy studies confirmed that virus uptake is completely blocked when the GTPase activity of dynamin is inhibited. Ex vivo infection of murine epidermis that was treated with dynasore further supports the essential role of dynamin during entry into the epithelium. Thus, we conclude that HSV-1 can enter human keratinocytes by alternative entry pathways that require dynamin and host cholesterol.	[Rahn, Elena; Petermann, Philipp; Hsu, Mei-Ju; Knebel-Morsdorf, Dagmar] Univ Cologne, Ctr Biochem, Cologne, Germany; [Knebel-Morsdorf, Dagmar] Univ Cologne, Dept Dermatol, D-5000 Cologne, Germany; [Rixon, Frazer J.] MRC Univ Glasgow Ctr Virus Res, Glasgow, Lanark, Scotland; [Hsu, Mei-Ju] Natl Yang Ming Univ, Inst Oral Biol, Taipei 112, Taiwan	University of Cologne; University of Cologne; University of Glasgow; National Yang Ming Chiao Tung University	Rahn, E (corresponding author), Univ Cologne, Ctr Biochem, Cologne, Germany.	dagmar.moersdorf@uni-koeln.de			Deutsche Forschungsgemeinschaft [KN536/16-1]; Faculty of Medicine, University of Cologne; Boehringer Ingelheim Fonds; National Science Council (Taiwan); Deutscher Akademischer Austausch Dienst (Germany); Sandwich scholarship; UK Medical Research Council; Medical Research Council [MC_U130115834] Funding Source: researchfish; MRC [MC_U130115834] Funding Source: UKRI	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Faculty of Medicine, University of Cologne; Boehringer Ingelheim Fonds(Boehringer Ingelheim); National Science Council (Taiwan)(Ministry of Science and Technology, Taiwan); Deutscher Akademischer Austausch Dienst (Germany)(Deutscher Akademischer Austausch Dienst (DAAD)); Sandwich scholarship; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported by grant KN536/16-1 from the Deutsche Forschungsgemeinschaft, the Koln Fortune Program/Faculty of Medicine, University of Cologne, and the Boehringer Ingelheim Fonds. MJH is supported by the National Science Council (Taiwan) and the Deutscher Akademischer Austausch Dienst (Germany) by a Sandwich scholarship. FR is funded by the UK Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anantharam A, 2011, MOL BIOL CELL, V22, P1907, DOI 10.1091/mbc.E11-02-0101; Apodaca G, 2001, TRAFFIC, V2, P149, DOI 10.1034/j.1600-0854.2001.020301.x; Arii J, 2009, J VIROL, V83, P4520, DOI 10.1128/JVI.02601-08; Bayer N, 1998, J VIROL, V72, P9645, DOI 10.1128/JVI.72.12.9645-9655.1998; Bender FC, 2003, J VIROL, V77, P9542, DOI 10.1128/JVI.77.17.9542-9552.2003; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Christian AE, 1997, J LIPID RES, V38, P2264; Clement C, 2006, J CELL BIOL, V174, P1009, DOI 10.1083/jcb.200509155; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; DAUTRYVARSAT A, 1986, BIOCHIMIE, V68, P375, DOI 10.1016/S0300-9084(86)80004-9; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; EVERETT RD, 1993, VIROLOGY, V197, P751, DOI 10.1006/viro.1993.1651; Fretz M, 2006, J CONTROL RELEASE, V116, P247, DOI 10.1016/j.jconrel.2006.07.009; Gianni T, 2004, J VIROL, V78, P12268, DOI 10.1128/JVI.78.22.12268-12276.2004; Gianni T, 2010, P NATL ACAD SCI USA, V107, P22260, DOI 10.1073/pnas.1014923108; GOSLIN K, 1989, J CELL BIOL, V108, P1507, DOI 10.1083/jcb.108.4.1507; Gu C, 2010, EMBO J, V29, P3593, DOI 10.1038/emboj.2010.249; Harris C, 1999, INT J MOL MED, V3, P315; Heldwein EE, 2008, CELL MOL LIFE SCI, V65, P1653, DOI 10.1007/s00018-008-7570-z; Huber MT, 2001, J VIROL, V75, P10309, DOI 10.1128/JVI.75.21.10309-10318.2001; Ilangumaran S, 1998, BIOCHEM J, V335, P433, DOI 10.1042/bj3350433; Ivanov Andrei I., 2008, V440, P15, DOI 10.1007/978-1-59745-178-9_2; Jaiswal JK, 2009, CELL, V137, P1308, DOI 10.1016/j.cell.2009.04.064; Kerr MC, 2009, TRAFFIC, V10, P364, DOI 10.1111/j.1600-0854.2009.00878.x; Kruchten AE, 2006, J CELL SCI, V119, P1683, DOI 10.1242/jcs.02963; Lee DA, 1998, BIOPHYS J, V74, P2747, DOI 10.1016/S0006-3495(98)77983-4; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; McCLelland DA, 2002, J VIROL, V76, P7407, DOI 10.1128/JVI.76.15.7407-7417.2002; Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510; Mettlen M, 2009, BIOCHEM SOC T, V37, P1022, DOI 10.1042/BST0371022; Milne RSB, 2005, J VIROL, V79, P6655, DOI 10.1128/JVI.79.11.6655-6663.2005; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Newton AJ, 2006, P NATL ACAD SCI USA, V103, P17955, DOI 10.1073/pnas.0606212103; Nicola AV, 2005, J VIROL, V79, P7609, DOI 10.1128/JVI.79.12.7609-7616.2005; Nicola AV, 2004, J VIROL, V78, P7508, DOI 10.1128/JVI.78.14.7508-7517.2004; Nicola AV, 2003, J VIROL, V77, P5324, DOI 10.1128/JVI.77.9.5324-5332.2003; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; Petermann P, 2009, J VIROL, V83, P9759, DOI 10.1128/JVI.00835-09; Quan A, 2007, MOL PHARMACOL, V72, P1425, DOI 10.1124/mol.107.034207; Raghu H, 2009, J VIROL, V83, P4895, DOI 10.1128/JVI.02498-08; Ren XF, 2011, CURR MICROBIOL, V62, P261, DOI 10.1007/s00284-010-9700-8; Roberts APE, 2009, J VIROL, V83, P105, DOI 10.1128/JVI.01032-08; Schelhaas M, 2003, J GEN VIROL, V84, P2473, DOI 10.1099/vir.0.19226-0; Sodeik B, 1997, J CELL BIOL, V136, P1007, DOI 10.1083/jcb.136.5.1007; Thompson HM, 2006, NAT CHEM BIOL, V2, P355, DOI 10.1038/nchembio0706-355; Torgersen ML, 2001, J CELL SCI, V114, P3737; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Watt FM, 1998, PHILOS T R SOC B, V353, P831, DOI 10.1098/rstb.1998.0247; Yancey PG, 1996, J BIOL CHEM, V271, P16026, DOI 10.1074/jbc.271.27.16026	50	59	60	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25464	10.1371/journal.pone.0025464	http://dx.doi.org/10.1371/journal.pone.0025464			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022400	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000295976000018
J	Rebuffo-Scheer, C; Bose, M; He, J; Khaja, S; Ulatowski, M; Beck, ET; Fan, J; Kumar, S; Nelson, MI; Henrickson, KJ				Rebuffo-Scheer, Cecilia; Bose, Michael; He, Jie; Khaja, Shamim; Ulatowski, Michael; Beck, Eric T.; Fan, Jiang; Kumar, Swati; Nelson, Martha I.; Henrickson, Kelly J.			Whole Genome Sequencing and Evolutionary Analysis of Human Respiratory Syncytial Virus A and B from Milwaukee, WI 1998-2010	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; SUBGROUP-B; GROUP-A; GENETIC-VARIABILITY; G-PROTEIN; TRANSCRIPTION TERMINATION; CIRCULATION PATTERNS; G-GLYCOPROTEIN; CONSECUTIVE SEASONS; SOUTH-AFRICA	Background: Respiratory Syncytial Virus (RSV) is the leading cause of lower respiratory-tract infections in infants and young children worldwide. Despite this, only six complete genome sequences of original strains have been previously published, the most recent of which dates back 35 and 26 years for RSV group A and group B respectively. Methodology/Principal Findings: We present a semi-automated sequencing method allowing for the sequencing of four RSV whole genomes simultaneously. We were able to sequence the complete coding sequences of 13 RSV A and 4 RSV B strains from Milwaukee collected from 1998-2010. Another 12 RSV A and 5 RSV B strains sequenced in this study cover the majority of the genome. All RSV A and RSV B sequences were analyzed by neighbor-joining, maximum parsimony and Bayesian phylogeny methods. Genetic diversity was high among RSV A viruses in Milwaukee including the circulation of multiple genotypes (GA1, GA2, GA5, GA7) with GA2 persisting throughout the 13 years of the study. However, RSV B genomes showed little variation with all belonging to the BA genotype. For RSV A, the same evolutionary patterns and clades were seen consistently across the whole genome including all intergenic, coding, and non-coding regions sequences. Conclusions/Significance: The sequencing strategy presented in this work allows for RSV A and B genomes to be sequenced simultaneously in two working days and with a low cost. We have significantly increased the amount of genomic data that is available for both RSV A and B, providing the basic molecular characteristics of RSV strains circulating in Milwaukee over the last 13 years. This information can be used for comparative analysis with strains circulating in other communities around the world which should also help with the development of new strategies for control of RSV, specifically vaccine development and improvement of RSV diagnostics.	[Rebuffo-Scheer, Cecilia; Bose, Michael; He, Jie; Khaja, Shamim; Ulatowski, Michael; Beck, Eric T.; Fan, Jiang; Kumar, Swati; Henrickson, Kelly J.] Midwest Resp Virus Program, Milwaukee, WI 53214 USA; [Rebuffo-Scheer, Cecilia; Bose, Michael; He, Jie; Khaja, Shamim; Ulatowski, Michael; Beck, Eric T.; Fan, Jiang; Kumar, Swati; Henrickson, Kelly J.] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [Henrickson, Kelly J.] Childrens Res Inst, Milwaukee, WI USA; [Nelson, Martha I.] NIH, Fogarty Int Ctr, Bethesda, MD USA	Medical College of Wisconsin; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Rebuffo-Scheer, C (corresponding author), Midwest Resp Virus Program, Milwaukee, WI 53214 USA.	Khenrick@mcw.edu			National Institute of Allergy and Infectious Diseases (NIAID) from the National Institutes of Health (NIH) [U01-AI-066584, U01-AI-070428, U01-AI-077988]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI077988, U01AI070428, U01AI066584] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID) from the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported with funds from the National Institute of Allergy and Infectious Diseases (NIAID) grants U01-AI-066584, U01-AI-070428, and U01-AI-077988 from the National Institutes of Health (NIH) (http://www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON LJ, 1985, J INFECT DIS, V151, P626, DOI 10.1093/infdis/151.4.626; Beck ET, 2010, J MOL DIAGN, V12, P74, DOI 10.2353/jmoldx.2010.090095; Choi EH, 2000, J INFECT DIS, V181, P1547, DOI 10.1086/315468; Collins PL, 2007, FIELDS VIROLOGY, P1601; Crowe JE, 1996, J INFECT DIS, V173, P829, DOI 10.1093/infdis/173.4.829; Dapat IC, 2010, J CLIN MICROBIOL, V48, P3423, DOI 10.1128/JCM.00646-10; Deng Jie, 2006, Zhonghua Weishengwuxue He Mianyixue Zazhi, V26, P1; Fields B. N, 1996, FIELDS VIROLOGY, V1, P1177; Galiano MC, 2005, J CLIN MICROBIOL, V43, P2266, DOI 10.1128/JCM.43.5.2266-2273.2005; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hardy RW, 1999, J VIROL, V73, P170, DOI 10.1128/JVI.73.1.170-176.1999; Harmon SB, 2002, VIROLOGY, V300, P304, DOI 10.1006/viro.2002.1541; Henrickson KJ, 2004, PEDIATR INFECT DIS J, V23, pS11, DOI 10.1097/01.inf.0000108188.37237.48; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; JOHNSON PR, 1987, J VIROL, V61, P3163, DOI 10.1128/JVI.61.10.3163-3166.1987; JOHNSON PR, 1988, J GEN VIROL, V69, P2901, DOI 10.1099/0022-1317-69-11-2901; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; KAWANO M, 1991, NUCLEIC ACIDS RES, V19, P2739, DOI 10.1093/nar/19.10.2739; Kehl SC, 2001, J CLIN MICROBIOL, V39, P1696, DOI 10.1128/JCM.39.5.1696-1701.2001; Kolakofsky D, 1998, J VIROL, V72, P891, DOI 10.1128/JVI.72.2.891-899.1998; KORBER B, 2000, COMPUTATIONAL ANAL H, P55, DOI DOI 10.1007/B112102; Kuo L, 1997, J VIROL, V71, P4944, DOI 10.1128/JVI.71.7.4944-4953.1997; Kuo LL, 1996, J VIROL, V70, P6143, DOI 10.1128/JVI.70.9.6143-6150.1996; Kuroiwa Y, 2005, J MED VIROL, V76, P241, DOI 10.1002/jmv.20348; Lazar I, 2006, J CLIN VIROL, V37, P168, DOI 10.1016/j.jcv.2006.07.006; Matheson JW, 2006, J MED VIROL, V78, P1354, DOI 10.1002/jmv.20702; MIYATA T, 1980, J MOL EVOL, V16, P23, DOI 10.1007/BF01732067; Moudy RM, 2004, VIROLOGY, V327, P121, DOI 10.1016/j.virol.2004.06.013; Moudy RM, 2003, VIROLOGY, V313, P250, DOI 10.1016/S0042-6822(03)00299-X; MUFSON MA, 1985, J GEN VIROL, V66, P2111, DOI 10.1099/0022-1317-66-10-2111; Nair H, 2010, LANCET; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nokes JD, 2008, CURR OPIN INFECT DIS, V21, P639, DOI 10.1097/QCO.0b013e3283184245; Ostlund MR, 2008, J MED VIROL, V80, P159, DOI 10.1002/jmv.21066; Parveen S, 2006, J CLIN MICROBIOL, V44, P3055, DOI 10.1128/JCM.00187-06; Peret TCT, 1998, J GEN VIROL, V79, P2221, DOI 10.1099/0022-1317-79-9-2221; Peret TCT, 2000, J INFECT DIS, V181, P1891, DOI 10.1086/315508; Reiche J, 2009, J CLIN MICROBIOL, V47, P1800, DOI 10.1128/JCM.02286-08; RUEDA P, 1991, J VIROL, V65, P3374, DOI 10.1128/JVI.65.6.3374-3378.1991; Salter A, 2011, J MED VIROL, V83, P337, DOI 10.1002/jmv.21957; Sato M, 2005, J CLIN MICROBIOL, V43, P36, DOI 10.1128/JCM.43.1.36-40.2005; Scott PD, 2004, J MED VIROL, V74, P344, DOI 10.1002/jmv.20183; Shobugawa Y, 2009, J CLIN MICROBIOL, V47, P2475, DOI 10.1128/JCM.00115-09; Sutherland KA, 2001, VIROLOGY, V288, P295, DOI 10.1006/viro.2001.1105; Swofford DL, 1998, PHYLOGENETIC ANAL US; Techaarpornkul S, 2001, J VIROL, V75, P6825, DOI 10.1128/JVI.75.15.6825-6834.2001; Tolley KP, 1996, VACCINE, V14, P1637, DOI 10.1016/S0264-410X(96)00136-3; Trento A, 2006, J VIROL, V80, P975, DOI 10.1128/JVI.80.2.975-984.2006; Trento A, 2003, J GEN VIROL, V84, P3115, DOI 10.1099/vir.0.19357-0; Trento A, 2010, J VIROL, V84, P7500, DOI 10.1128/JVI.00345-10; United Nations Population Division, WORLD POP PROSP 2008; Venter M, 2002, J MED VIROL, V68, P452, DOI 10.1002/jmv.10225; Venter M, 2001, J GEN VIROL, V82, P2117, DOI 10.1099/0022-1317-82-9-2117; Viegas M, 2005, J MED VIROL, V77, P302, DOI 10.1002/jmv.20457; Zhang ZY, 2010, J CLIN MICROBIOL, V48, P1201, DOI 10.1128/JCM.02258-09; Zlateva KT, 2007, J CLIN MICROBIOL, V45, P3022, DOI 10.1128/JCM.00339-07; Zlateva KT, 2005, J VIROL, V79, P9157, DOI 10.1128/JVI.79.14.9157-9167.2005	57	51	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e25468	10.1371/journal.pone.0025468	http://dx.doi.org/10.1371/journal.pone.0025468			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998661	Green Submitted, Green Published, gold			2022-12-27	WOS:000295968700011
J	Cavallo, M; Adenzato, M; MacPherson, SE; Karwig, G; Enrici, I; Abrahams, S				Cavallo, Marco; Adenzato, Mauro; MacPherson, Sarah E.; Karwig, Gillian; Enrici, Ivan; Abrahams, Sharon			Evidence of Social Understanding Impairment in Patients with Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							MOTOR-NEURON DISEASE; FRONTOTEMPORAL LOBAR DEGENERATION; EPWORTH SLEEPINESS SCALE; ASPERGER-SYNDROME; COGNITIVE IMPAIRMENT; COMPUTED-TOMOGRAPHY; SCORE DIFFERENCES; NORMAL ADULTS; DEMENTIA; MIND	The present study aims at clarifying the nature of the Theory of Mind (ToM) deficits associated with Amyotrophic Lateral Sclerosis (ALS). ToM is the ability to attribute mental states such as intentions and beliefs to others in order to understand and predict their behaviour and to behave accordingly. Several neuroimaging studies reported the prefrontal cortices as the brain region underlying a key ToM ability, i.e. the comprehension of social intentions. Dysfunction of the prefrontal cortices in patients with ALS has been indicated by a range of neuroimaging studies. The frontal syndrome that appears to characterize up to 50% of ALS has been noted to be similar to the profile that characterizes patients with frontotemporal dementia (FTD), a neurodegenerative condition characterised by ToM deficits. In the present paper, we hypothesize that the performance of patients with ALS is significantly worse than healthy controls' performance on tasks requiring the comprehension of social contexts, whereas patients' performance is comparable to healthy controls' performance on tasks not requiring the comprehension of social contexts. To this end, we tested 15 patients with ALS with an experimental protocol that distinguishes between private (non-social) intentions and social intentions. The pattern of results followed the experimental hypothesis: the performance of patients with ALS and healthy controls significantly differed on the comprehension of social context only, with an impairment in patients with ALS. Single case analysis confirmed the findings at an individual level. The present study is the first which has examined and compared the understanding of social and non-social contexts in patients with ALS and shown a specific and selective deficit in the former only. The current findings further support the notion of a continuum of cognitive dysfunction ranging from ALS to FTD, with parallel cognitive profiles in both disorders.	[Cavallo, Marco] Univ Turin, Dept Mental Hlth, San Luigi Gonzaga Hosp Med Sch, Turin, Italy; [Cavallo, Marco] Amedeo Avogadro Univ Eastern Piedmont, Dept Med Sci, Novara, Italy; [Adenzato, Mauro; Enrici, Ivan] Univ Turin, Dept Psychol, Ctr Cognit Sci, Turin, Italy; [Adenzato, Mauro] Neurosci Inst Turin, Turin, Italy; [MacPherson, Sarah E.; Karwig, Gillian; Abrahams, Sharon] Univ Edinburgh, Human Cognit Neurosci Psychol, Edinburgh, Midlothian, Scotland; [MacPherson, Sarah E.; Abrahams, Sharon] Univ Edinburgh, Ctr Cognit Aging & Epidemiol, Edinburgh, Midlothian, Scotland; [Abrahams, Sharon] Univ Edinburgh, Euan MacDonald Ctr, Edinburgh, Midlothian, Scotland	Azienda Ospedaliero-Universitaria San Luigi Gonzaga; University of Turin; University of Eastern Piedmont Amedeo Avogadro; University of Turin; University of Edinburgh; University of Edinburgh; University of Edinburgh	Cavallo, M (corresponding author), Univ Turin, Dept Mental Hlth, San Luigi Gonzaga Hosp Med Sch, Turin, Italy.	mauro.adenzato@unito.it	Enrici, Ivan/C-3810-2018; MacPherson, Sarah E/G-8524-2013; Adenzato, Mauro/I-5127-2012; Adenzato, Mauro/AFQ-8675-2022	Enrici, Ivan/0000-0002-1289-5855; MacPherson, Sarah E/0000-0001-8676-6514; Adenzato, Mauro/0000-0002-6997-9283; Adenzato, Mauro/0000-0002-6997-9283; Cavallo, Marco/0000-0002-4784-0803	University of Turin (Ricerca scientifica finanziata dall'Universita); Medical Research Council [G0700704B] Funding Source: researchfish	University of Turin (Ricerca scientifica finanziata dall'Universita); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the University of Turin (Ricerca scientifica finanziata dall'Universita 2007 e 2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams S, 1997, J NEUROL NEUROSUR PS, V62, P464, DOI 10.1136/jnnp.62.5.464; Abrahams S, 2005, NEUROLOGY, V64, P1222, DOI 10.1212/01.WNL.0000156519.41681.27; Abrahams S, 2005, J NEUROL, V252, P321, DOI 10.1007/s00415-005-0646-x; Abrahams S, 1996, BRAIN, V119, P2105, DOI 10.1093/brain/119.6.2105; Abrahams S, 2000, NEUROPSYCHOLOGIA, V38, P734, DOI 10.1016/S0028-3932(99)00146-3; Adenzato M, 2006, THEOR PSYCHOL, V16, P747, DOI 10.1177/0959354306070515; Adenzato M, 2010, NEUROPSYCHOLOGIA, V48, P2, DOI 10.1016/j.neuropsychologia.2009.08.001; Adolphs R, 2003, NEUROPSYCHOLOGIA, V41, P119, DOI 10.1016/S0028-3932(02)00142-2; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Bak TH, 2004, BRAIN LANG, V89, P354, DOI 10.1016/S0093-934X(03)00357-2; Bara BG, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00007; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Baron-Cohen S., 1995, MINDBLINDNESS ESSAY; BaronCohen S, 1997, VIS COGN, V4, P311, DOI 10.1080/713756761; BaronCohen S, 1997, J CHILD PSYCHOL PSYC, V38, P813, DOI 10.1111/j.1469-7610.1997.tb01599.x; Bigio EH, 2003, NEUROPATH APPL NEURO, V29, P239, DOI 10.1046/j.1365-2990.2003.00466.x; Boersma P., 2016, PRAAT DOING PHONETIC; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0; BRUN A, 1994, J NEUROL NEUROSUR PS, V57, P416; Burgess P.W., 1997, HAYLING BRIXTON TEST; Cavallo M, 2011, ACTA NEUROPSYCHOL, V9, P167; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Channon S, 2007, NEUROPSYCHOLOGIA, V45, P1725, DOI 10.1016/j.neuropsychologia.2006.12.021; Chervin RD, 1997, J PSYCHOSOM RES, V42, P145, DOI 10.1016/S0022-3999(96)00239-5; Ciaramidaro A, 2007, NEUROPSYCHOLOGIA, V45, P3105, DOI 10.1016/j.neuropsychologia.2007.05.011; Crawford JR, 2005, NEUROPSYCHOLOGY, V19, P318, DOI 10.1037/0894-4105.19.3.318; Crawford JR, 1998, J CLIN EXP NEUROPSYC, V20, P898, DOI 10.1076/jcen.20.6.898.1112; Crawford JR, 2002, NEUROPSYCHOLOGIA, V40, P1196, DOI 10.1016/S0028-3932(01)00224-X; Enrici I, 2011, J COGNITIVE NEUROSCI, V23, P2415, DOI 10.1162/jocn.2010.21594; Gibbons ZC, 2007, NEUROPSYCHOLOGIA, V45, P1196, DOI 10.1016/j.neuropsychologia.2006.10.008; Girardi A, 2011, NEUROPSYCHOLOGY, V25, P53, DOI 10.1037/a0020357; Gregory C, 2002, BRAIN, V125, P752, DOI 10.1093/brain/awf079; Grossman AB, 2007, AMYOTROPH LATERAL SC, V8, P56, DOI 10.1080/17482960601044106; Jeong Y, 2005, NEUROLOGY, V64, P734, DOI 10.1212/01.WNL.0000152047.58767.9D; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; KATO S, 1993, J NEUROL SCI, V116, P52, DOI 10.1016/0022-510X(93)90089-H; Kipps CM, 2006, SOC NEUROSCI-UK, V1, P235, DOI 10.1080/17470910600989847; Lipton AM, 2004, ACTA NEUROPATHOL, V108, P379, DOI 10.1007/s00401-004-0900-9; Lomen-Hoerth C, 2003, NEUROLOGY, V60, P1094, DOI 10.1212/01.WNL.0000055861.95202.8D; Lough S, 2001, NEUROCASE, V7, P123, DOI 10.1076/neur.7.2.123.16266; Maekawa S, 2004, BRAIN, V127, P1237, DOI 10.1093/brain/awh132; Mantovan MC, 2003, EUR J NEUROL, V10, P221, DOI 10.1046/j.1468-1331.2003.00607.x; McKenna P., 1983, GRADED NAMING TEST; Meier SL, 2010, BRAIN, V133, P3444, DOI 10.1093/brain/awq254; Murphy J, 2007, ARCH NEUROL-CHICAGO, V64, P330, DOI 10.1001/archneur.64.3.330; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; NEARY D, 1988, J NEUROL NEUROSUR PS, V51, P353, DOI 10.1136/jnnp.51.3.353; NEARY D, 1990, J NEUROL NEUROSUR PS, V53, P23, DOI 10.1136/jnnp.53.1.23; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Rankin KP, 2003, NEUROLOGY, V60, P266, DOI 10.1212/01.WNL.0000041497.07694.D2; Ringholz GM, 2005, NEUROLOGY, V65, P586, DOI 10.1212/01.wnl.0000172911.39167.b6; Schreiber H, 2005, J NEUROL, V252, P772, DOI 10.1007/s00415-005-0739-6; Shi J, 2005, ACTA NEUROPATHOL, V110, P501, DOI 10.1007/s00401-005-1079-4; Snowden JS, 2003, NEUROPSYCHOLOGIA, V41, P688, DOI 10.1016/S0028-3932(02)00221-X; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Strong MJ, 1999, NEUROLOGY, V53, P1665, DOI 10.1212/WNL.53.8.1665; Stuss DT, 2001, BRAIN, V124, P279, DOI 10.1093/brain/124.2.279; TALBOT PR, 1995, J NEUROL NEUROSUR PS, V58, P541, DOI 10.1136/jnnp.58.5.541; Tsiakiri A., 2022, APPL NEUROPSYCH-ADUL, DOI [10.1080/23279095.2022.2074850, DOI 10.1080/23279095.2022.2074850]; Walter H, 2004, J COGNITIVE NEUROSCI, V16, P1854, DOI 10.1162/0898929042947838; Walter H, 2009, SOC COGN AFFECT NEUR, V4, P166, DOI 10.1093/scan/nsn047; Warrington EK., 1991, VISUAL OBJECT SPACE; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	65	69	69	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25948	10.1371/journal.pone.0025948	http://dx.doi.org/10.1371/journal.pone.0025948			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834NA	21998727	Green Published, Green Submitted, gold			2022-12-27	WOS:000295966900078
J	Hempel, CM; Sivula, M; Levenson, JM; Rose, DM; Li, B; Sirianni, AC; Xia, E; Ryan, TA; Gerber, DJ; Cottrell, JR				Hempel, Chris M.; Sivula, Michael; Levenson, Jonathan M.; Rose, David M.; Li, Bing; Sirianni, Ana C.; Xia, Eva; Ryan, Timothy A.; Gerber, David J.; Cottrell, Jeffrey R.			A System for Performing High Throughput Assays of Synaptic Function	PLOS ONE			English	Article							NEUROTRANSMITTER RELEASE; CALCIUM-CHANNELS; GENE-EXPRESSION; TRANSMISSION; STIMULATION; ASSOCIATION; SECRETION; MEMBRANE; DISORDER; SCREENS	Unbiased, high-throughput screening has proven invaluable for dissecting complex biological processes. Application of this general approach to synaptic function would have a major impact on neuroscience research and drug discovery. However, existing techniques for studying synaptic physiology are labor intensive and low-throughput. Here, we describe a new high-throughput technology for performing assays of synaptic function in primary neurons cultured in microtiter plates. We show that this system can perform 96 synaptic vesicle cycling assays in parallel with high sensitivity, precision, uniformity, and reproducibility and can detect modulators of presynaptic function. By screening libraries of pharmacologically defined compounds on rat forebrain cultures, we have used this system to identify novel effects of compounds on specific aspects of presynaptic function. As a system for unbiased compound as well as genomic screening, this technology has significant applications for basic neuroscience research and for the discovery of novel, mechanism-based treatments for central nervous system disorders.	[Hempel, Chris M.; Sivula, Michael; Levenson, Jonathan M.; Rose, David M.; Li, Bing; Sirianni, Ana C.; Xia, Eva; Gerber, David J.; Cottrell, Jeffrey R.] Galenea Corp, Cambridge, MA USA; [Ryan, Timothy A.] Weill Cornell Med Coll, Dept Biochem, New York, NY USA	Cornell University	Hempel, CM (corresponding author), Galenea Corp, Cambridge, MA USA.	jcottrell@galenea.com	Ryan, Timothy/AAO-8286-2020	Ryan, Timothy/0000-0003-2533-9548	Otsuka Pharmaceutical Co., Ltd.; NIMH [1RC4MH092889-01]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085783, RC4MH092889] Funding Source: NIH RePORTER	Otsuka Pharmaceutical Co., Ltd.(Otsuka Pharmaceutical); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by a research and development collaboration with Otsuka Pharmaceutical Co., Ltd. and by NIMH grant 1RC4MH092889-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov E, 2009, NAT NEUROSCI, V12, P1567, DOI 10.1038/nn.2433; Brophy K, 2002, MOL PSYCHIATR, V7, P913, DOI 10.1038/sj.mp.4001092; Bugianesi RM, 2006, ASSAY DRUG DEV TECHN, V4, P21, DOI 10.1089/adt.2006.4.21; Burrone J, 2006, NAT PROTOC, V1, P2970, DOI 10.1038/nprot.2006.449; Carbone E, 2006, PFLUG ARCH EUR J PHY, V453, P373, DOI 10.1007/s00424-006-0100-7; CUERVO LA, 1970, J GEN PHYSIOL, V55, P309, DOI 10.1085/jgp.55.3.309; Dreosti E, 2009, NAT METHODS, V6, P883, DOI 10.1038/nmeth.1399; Enna SJ, 2009, J PHARMACOL EXP THER, V329, P404, DOI 10.1124/jpet.108.143420; Fernandez-Alfonso T, 2004, NEURON, V41, P943, DOI 10.1016/S0896-6273(04)00113-8; Forsburg SL, 2001, NAT REV GENET, V2, P659, DOI 10.1038/35088500; Gasparini S, 2001, J NEUROSCI, V21, P8715, DOI 10.1523/JNEUROSCI.21-22-08715.2001; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Huang CJ, 2006, NAT BIOTECHNOL, V24, P439, DOI 10.1038/nbt1194; Huang KS, 2006, METHOD ENZYMOL, V414, P589, DOI 10.1016/S0076-6879(06)14030-6; Jensen K, 1999, J NEUROPHYSIOL, V81, P1225, DOI 10.1152/jn.1999.81.3.1225; Kugler S, 2003, VIROLOGY, V311, P89, DOI 10.1016/S0042-6822(03)00162-4; Mao T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001796; Maycox PR, 2009, MOL PSYCHIATR, V14, P1083, DOI 10.1038/mp.2009.18; McCown TJ, 2005, CURR GENE THER, V5, P333, DOI 10.2174/1566523054064995; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; MINTZ IM, 1992, NATURE, V355, P827, DOI 10.1038/355827a0; Mirnics K, 2000, NEURON, V28, P53, DOI 10.1016/S0896-6273(00)00085-4; Moore KA, 2003, P NATL ACAD SCI USA, V100, P14397, DOI 10.1073/pnas.1835831100; Nakamura K, 2008, INT J NEUROPSYCHOPH, V11, P1073, DOI 10.1017/S1461145708009036; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Newcomb R, 1998, BIOCHEMISTRY-US, V37, P15353, DOI 10.1021/bi981255g; Persidis A, 1998, NAT BIOTECHNOL, V16, P488, DOI 10.1038/nbt0598-488; PRINCE DA, 1992, P NATL ACAD SCI USA, V89, P8586, DOI 10.1073/pnas.89.18.8586; Royle Stephen J., 2008, V457, P293, DOI 10.1007/978-1-59745-261-8_22; Rozas JL, 2010, BIOCHEM SOC T, V38, P488, DOI 10.1042/BST0380488; Ryan TA, 2001, CURR OPIN NEUROBIOL, V11, P544, DOI 10.1016/S0959-4388(00)00247-6; Saitsu H, 2008, NAT GENET, V40, P782, DOI 10.1038/ng.150; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Scanziani M, 2009, NATURE, V461, P930, DOI 10.1038/nature08540; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Silinsky EM, 2003, BRIT J PHARMACOL, V138, P1191, DOI 10.1038/sj.bjp.0705213; St Johnston D, 2002, NAT REV GENET, V3, P176, DOI 10.1038/nrg751; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sullivan PF, 2009, MOL PSYCHIATR, V14, P359, DOI 10.1038/mp.2008.125; Tolu S, 2010, FASEB J, V24, P723, DOI 10.1096/fj.09-139790; Tottene A, 2009, NEURON, V61, P762, DOI 10.1016/j.neuron.2009.01.027; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; Wu LG, 1997, TRENDS NEUROSCI, V20, P204, DOI 10.1016/S0166-2236(96)01015-6; Yu YG, 2010, J NEUROSCI, V30, P11858, DOI 10.1523/JNEUROSCI.2651-10.2010; Zanella F, 2010, TRENDS BIOTECHNOL, V28, P237, DOI 10.1016/j.tibtech.2010.02.005	45	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25999	10.1371/journal.pone.0025999	http://dx.doi.org/10.1371/journal.pone.0025999			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998743	Green Published, Green Submitted, gold			2022-12-27	WOS:000295966900089
J	Li, HL; Lei, GC; Zhi, YB; An, SQ; Huang, HP; Ouyang, Y; Zhao, L; Deng, ZF; Liu, YH				Li, Hong-li; Lei, Guang-chun; Zhi, Ying-biao; An, Shu-qing; Huang, He-ping; Ouyang, Yan; Zhao, Lei; Deng, Zi-fa; Liu, Yu-hong			Nitrogen Level Changes the Interactions between a Native (Scirpus triqueter) and an Exotic Species (Spartina anglica) in Coastal China	PLOS ONE			English	Article							INTER-SPECIFIC COMPETITION; SALT-MARSH PLANTS; HYDRILLA-VERTICILLATA; ENVIRONMENTAL-FACTORS; INVASIVE PLANT; SALINITY; ZONATION; GROWTH; ALTERNIFLORA; PLANTATIONS	The exotic species Spartina anglica, introduced from Europe in 1963, has been experiencing a decline in the past decade in coastal China, but the reasons for the decline are still not clear. It is hypothesized that competition with the native species Scirpus triqueter may have played an important role in the decline due to niche overlap in the field. We measured biomass, leaf number and area, asexual reproduction and relative neighborhood effect (RNE) of the two species in both monoculture and mixture under three nitrogen levels (control, low and high). S. anglica showed significantly lower biomass accumulation, leaf number and asexual reproduction in mixture than in monoculture. The inter- and intra-specific RNE of S. anglica were all positive, and the inter- specific RNE was significantly higher than the intra-specific RNE in the control. For S. triqueter, interand intra-specific RNE were negative at the high nitrogen level but positive in the control and at the low nitrogen level. This indicates that S. triqueter exerted an asymmetric competitive advantage over S. anglica in the control and low nitrogen conditions; however, S. anglica facilitated growth of S. triqueter in high nitrogen conditions. Nitrogen level changed the interactions between the two species because S. triqueter better tolerated low nitrogen. Since S. anglica is increasingly confined to upper, more nitrogen-limited marsh areas in coastal China, increased competition from S. triqueter may help explain its decline.	[Li, Hong-li; Lei, Guang-chun] Beijing Forestry Univ, Coll Nat Conservat, Beijing, Peoples R China; [Li, Hong-li; Zhi, Ying-biao; An, Shu-qing; Ouyang, Yan; Zhao, Lei; Deng, Zi-fa] Nanjing Univ, State Key Lab Pollut Control & Resource Reuse, Sch Life Sci, Nanjing 210008, Peoples R China; [An, Shu-qing] Nanjing Univ, Inst Wetland Ecol, Sch Life Sci, Nanjing 210008, Peoples R China; [Huang, He-ping] Jiangxi Univ Finance & Econ, Sch Tourism & Urban Management, Nanchang, Peoples R China; [Liu, Yu-hong] Chinese Acad Sci, Yantai Inst Coastal Zone Res Sustainable Dev, Yantai, Peoples R China	Beijing Forestry University; Nanjing University; Nanjing University; Jiangxi University of Finance & Economics; Chinese Academy of Sciences; Yantai Institute of Coastal Zone Research, CAS	Li, HL (corresponding author), Beijing Forestry Univ, Coll Nat Conservat, Beijing, Peoples R China.	anshq@nju.edu.cn	Guangchun, Lei/ABC-8081-2021		National Forestry Special Public Foundation of China [200804005]; Beijing Forestry University [BLX2009-;021]; Fundamental Research Funds for the Central Universities [2011-34]; Forestry Soft-Science Research Project [2008-R02]	National Forestry Special Public Foundation of China; Beijing Forestry University; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Forestry Soft-Science Research Project	This research was supported by the National Forestry Special Public Foundation of China (No. 200804005), the Research Funds for the New Teacher of Beijing Forestry University (BLX2009-;021), the Fundamental Research Funds for the Central Universities (2011-34) and the Forestry Soft-Science Research Project (2008-R02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SQ, 2007, WEED RES, V47, P183, DOI 10.1111/j.1365-3180.2007.00559.x; Ayres DR, 2004, BIOL INVASIONS, V6, P221, DOI 10.1023/B:BINV.0000022140.07404.b7; Boyer KE, 1999, RESTOR ECOL, V7, P74, DOI 10.1046/j.1526-100X.1999.07109.x; Brewer JS, 2003, PLANT ECOL, V168, P93, DOI 10.1023/A:1024478714291; Callaway JC, 1998, WETLANDS ECOLOGY MAN, V5, P179, DOI 10.1023/A:1008224204102; Charpentier A, 1999, PLANT ECOL, V141, P129, DOI 10.1023/A:1009825905117; Chen ZY, 2004, HYDROBIOLOGIA, V528, P99, DOI 10.1007/s10750-004-1888-9; Chung C., 1985, BRIEF HIST SPARTINA, P30; Chung CH, 2004, ECOL ENG, V23, P135, DOI 10.1016/j.ecoleng.2004.07.004; CHUNG CH, 1993, ECOL ENG, V2, P261, DOI 10.1016/0925-8574(93)90019-C; Daehler CC, 1996, BIOL CONSERV, V78, P51, DOI 10.1016/0006-3207(96)00017-1; Dormann CF, 2000, J ECOL, V88, P571, DOI 10.1046/j.1365-2745.2000.00469.x; Doyle RD, 2003, AQUAT BOT, V77, P223, DOI 10.1016/S0304-3770(03)00104-9; Fargione J, 2006, FUNCT ECOL, V20, P533, DOI 10.1111/j.1365-2435.2006.01116.x; Ferris C, 1997, MOL ECOL, V6, P185, DOI 10.1046/j.1365-294X.1997.00165.x; Fetene M, 2003, J ARID ENVIRON, V55, P441, DOI 10.1016/S0140-1963(03)00052-1; GOLDBERG DE, 1992, AM NAT, V139, P771, DOI 10.1086/285357; Grace JB, 1997, AM NAT, V149, P436, DOI 10.1086/285999; GRAY AJ, 1991, ADV ECOL RES, V21, P1, DOI 10.1016/S0065-2504(08)60096-3; Greenwood ME, 2009, AQUAT BOT, V90, P23, DOI 10.1016/j.aquabot.2008.05.001; Hofstra DE, 1999, AQUAT BOT, V63, P305, DOI 10.1016/S0304-3770(98)00125-9; Huckle JM, 2002, OIKOS, V96, P307, DOI 10.1034/j.1600-0706.2002.960213.x; Huckle JM, 2000, J ECOL, V88, P492, DOI 10.1046/j.1365-2745.2000.00464.x; Ikegami M, 2007, PLANT ECOL, V189, P247, DOI 10.1007/s11258-006-9181-9; Kiehl K, 1997, OECOLOGIA, V111, P325, DOI 10.1007/s004420050242; Kolb A, 2002, J ECOL, V90, P871, DOI 10.1046/j.1365-2745.2002.00719.x; Kool A, 2009, PLANT ECOL, V204, P125, DOI 10.1007/s11258-009-9574-7; Levine JM, 1998, J ECOL, V86, P285, DOI 10.1046/j.1365-2745.1998.00253.x; Li HL, 2008, PLANT SCI, V174, P299, DOI 10.1016/j.plantsci.2007.11.015; Lillebo AI, 2003, AQUAT BOT, V77, P111, DOI 10.1016/S0304-3770(03)00088-3; PARTRIDGE TR, 1987, NEW ZEAL J BOT, V25, P567, DOI 10.1080/0028825X.1987.10410087; Pennings SC, 2005, J ECOL, V93, P159, DOI 10.1111/j.1365-2745.2004.00959.x; Pennings SC, 2001, OECOLOGIA, V126, P587, DOI 10.1007/s004420000548; Perry LG, 2009, PLANT ECOL, V204, P247, DOI 10.1007/s11258-009-9588-1; Rossell IM, 1995, ENVIRON EXP BOT, V35, P507, DOI 10.1016/0098-8472(95)00027-5; THOMPSON JD, 1991, BIOSCIENCE, V41, P393, DOI 10.2307/1311746; Van TK, 1999, AQUAT BOT, V62, P225, DOI 10.1016/S0304-3770(98)00100-4; van Wijnen HJ, 1999, J ECOL, V87, P265, DOI 10.1046/j.1365-2745.1999.00349.x; Wang Q, 2006, BIOL INVASIONS, V8, P1547, DOI 10.1007/s10530-005-5846-x; Yu FH, 2009, AM J BOT, V96, P1983, DOI 10.3732/ajb.0800426; Zhang JY, 2008, J INTEGR PLANT BIOL, V50, P1570, DOI 10.1111/j.1744-7909.2008.00699.x; Zhi YB, 2007, ESTUAR COAST SHELF S, V74, P437, DOI 10.1016/j.ecss.2007.04.026	42	9	11	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25629	10.1371/journal.pone.0025629	http://dx.doi.org/10.1371/journal.pone.0025629			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998676	Green Published, Green Submitted, gold			2022-12-27	WOS:000295966900039
J	Sanchez-Garcia, C; Alsius, A; Enns, JT; Soto-Faraco, S				Sanchez-Garcia, Carolina; Alsius, Agnes; Enns, James T.; Soto-Faraco, Salvador			Cross-Modal Prediction in Speech Perception	PLOS ONE			English	Article							CLASSICAL RECEPTIVE-FIELD; PRIMARY VISUAL-CORTEX; HEARING LIPS; SEEING VOICES; COMPREHENSION; COMPETITION; ACTIVATION; EVENTS; BRAIN	Speech perception often benefits from vision of the speaker's lip movements when they are available. One potential mechanism underlying this reported gain in perception arising from audio-visual integration is on-line prediction. In this study we address whether the preceding speech context in a single modality can improve audiovisual processing and whether this improvement is based on on-line information-transfer across sensory modalities. In the experiments presented here, during each trial, a speech fragment (context) presented in a single sensory modality (voice or lips) was immediately continued by an audiovisual target fragment. Participants made speeded judgments about whether voice and lips were in agreement in the target fragment. The leading single sensory context and the subsequent audiovisual target fragment could be continuous in either one modality only, both (context in one modality continues into both modalities in the target fragment) or neither modalities (i.e., discontinuous). The results showed quicker audiovisual matching responses when context was continuous with the target within either the visual or auditory channel (Experiment 1). Critically, prior visual context also provided an advantage when it was cross-modally continuous (with the auditory channel in the target), but auditory to visual cross-modal continuity resulted in no advantage (Experiment 2). This suggests that visual speech information can provide an on-line benefit for processing the upcoming auditory input through the use of predictive mechanisms. We hypothesize that this benefit is expressed at an early level of speech analysis.	[Sanchez-Garcia, Carolina; Soto-Faraco, Salvador] Univ Pompeu Fabra, Dept Tecnol Informacio & Comunicac, Barcelona, Spain; [Alsius, Agnes] Queens Univ, Dept Psychol, Kingston, ON K7L 3N6, Canada; [Enns, James T.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [Soto-Faraco, Salvador] ICREA, Barcelona, Spain	Pompeu Fabra University; Queens University - Canada; University of British Columbia; ICREA	Sanchez-Garcia, C (corresponding author), Univ Pompeu Fabra, Dept Tecnol Informacio & Comunicac, Barcelona, Spain.	Salvador.Soto@icrea.es	Enns, James T/O-7583-2017; 2010, BRAINGLOT Consolider Ingenio/D-1235-2009; SOTO-FARACO, SALVADOR/B-8400-2011	Enns, James T/0000-0002-3676-8316; SOTO-FARACO, SALVADOR/0000-0002-4799-3762	Spanish Ministry of Science and Innovation [PSI2010-15426, CSD2007-00012]; Comissionat per a Universitats i Recerca del DIUE-Generalitat de Catalunya [SRG2009-092, PIV2009-00122]; European Research Council [StG-2010 263145]; ICREA Funding Source: Custom	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comissionat per a Universitats i Recerca del DIUE-Generalitat de Catalunya(Generalitat de Catalunya); European Research Council(European Research Council (ERC)European Commission); ICREA(ICREA)	This research was supported by the Spanish Ministry of Science and Innovation (PSI2010-15426 and Consolider INGENIO CSD2007-00012), Comissionat per a Universitats i Recerca del DIUE-Generalitat de Catalunya (SRG2009-092 and PIV2009-00122), and the European Research Council (StG-2010 263145). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelucci A, 2003, J PHYSIOL-PARIS, V97, P141, DOI 10.1016/j.jphysparis.2003.09.001; Arnal LH, 2009, J NEUROSCI, V29, P13445, DOI 10.1523/JNEUROSCI.3194-09.2009; Arnold P, 2001, BRIT J PSYCHOL, V92, P339, DOI 10.1348/000712601162220; Bar M, 2004, NAT REV NEUROSCI, V5, P617, DOI 10.1038/nrn1476; Bubic A, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00025; Calvert G., 2004, HDB MULTISENSORY PRO; Chandrasekaran C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000436; Dambacher M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005047; DeLong KA, 2005, NAT NEUROSCI, V8, P1117, DOI 10.1038/nn1504; Di Lollo V, 2000, J EXP PSYCHOL GEN, V129, P481, DOI 10.1037/0096-3445.129.4.481; Enns JT, 2008, TRENDS COGN SCI, V12, P327, DOI 10.1016/j.tics.2008.06.001; Forster KI, 2003, BEHAV RES METH INS C, V35, P116, DOI 10.3758/BF03195503; Fowler CA, 2004, HDB MULTISENSORY PRO, P189; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Kamachi M, 2003, CURR BIOL, V13, P1709, DOI 10.1016/j.cub.2003.09.005; Keller PE, 2008, Q J EXP PSYCHOL, V61, P275, DOI 10.1080/17470210601160864; LAMME VAF, 1995, J NEUROSCI, V15, P1605; MACLEOD A, 1987, British Journal of Audiology, V21, P131, DOI 10.3109/03005368709077786; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Murray SO, 2002, P NATL ACAD SCI USA, V99, P15164, DOI 10.1073/pnas.192579399; Navarra J, 2007, PSYCHOL RES-PSYCH FO, V71, P4, DOI 10.1007/s00426-005-0031-5; Pickering MJ, 2007, TRENDS COGN SCI, V11, P105, DOI 10.1016/j.tics.2006.12.002; Poeppel D, 2008, PHILOS T R SOC B, V363, P1071, DOI 10.1098/rstb.2007.2160; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Rosenblum LD, 2007, PSYCHOL SCI, V18, P392, DOI 10.1111/j.1467-9280.2007.01911.x; Ross LA, 2007, CEREB CORTEX, V17, P1147, DOI 10.1093/cercor/bhl024; Schwartz J.-L., 1998, HEARING EYE, P85; Skipper JI, 2007, CEREB CORTEX, V17, P2387, DOI 10.1093/cercor/bhl147; Skipper JI, 2005, NEUROIMAGE, V25, P76, DOI 10.1016/j.neuroimage.2004.11.006; Soto-Faraco S, 2007, PERCEPT PSYCHOPHYS, V69, P218, DOI 10.3758/BF03193744; Spratling MW, 2008, VISION RES, V48, P1391, DOI 10.1016/j.visres.2008.03.009; Stein BE, 1993, MERGING SENSES; Stekelenburg JJ, 2007, J COGNITIVE NEUROSCI, V19, P1964, DOI 10.1162/jocn.2007.19.12.1964; Stevens KN, 1967, MODELS PERCEPTION SP, P88; SUMBY WH, 1954, J ACOUST SOC AM, V26, P212, DOI 10.1121/1.1907309; Summerfield A.Q., 1987, HEARING EYE PSYCHOL, P3, DOI DOI 10.2307/1423237; Summerfield C, 2009, TRENDS COGN SCI, V13, P403, DOI 10.1016/j.tics.2009.06.003; Van Berkum JJA, 2005, J EXP PSYCHOL LEARN, V31, P443, DOI 10.1037/0278-7393.31.3.443; van Wassenhove V, 2005, P NATL ACAD SCI USA, V102, P1181, DOI 10.1073/pnas.0408949102; Wolpert DM, 1997, TRENDS COGN SCI, V1, P209, DOI 10.1016/S1364-6613(97)01070-X	40	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25198	10.1371/journal.pone.0025198	http://dx.doi.org/10.1371/journal.pone.0025198			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834NA	21998642	Green Published, Green Submitted, gold			2022-12-27	WOS:000295966900014
J	Carrero, ZI; Velma, V; Douglas, HE; Hebert, MD				Carrero, Zunamys I.; Velma, Venkatramreddy; Douglas, Heather E.; Hebert, Michael D.			Coilin Phosphomutants Disrupt Cajal Body Formation, Reduce Cell Proliferation and Produce a Distinct Coilin Degradation Product	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; BODIES; SMN; PHOSPHORYLATION; LOCALIZATION; PROTEINS; SNRNPS; METHYLATION; INTERPHASE; INTERACTS	Coilin is a nuclear phosphoprotein that accumulates in Cajal bodies (CBs). CBs participate in ribonucleoprotein and telomerase biogenesis, and are often found in cells with high transcriptional demands such as neuronal and cancer cells, but can also be observed less frequently in other cell types such as fibroblasts. Many proteins enriched within the CB are phosphorylated, but it is not clear what role this modification has on the activity of these proteins in the CB. Coilin is considered to be the CB marker protein and is essential for proper CB formation and composition in mammalian cells. In order to characterize the role of coilin phosphorylation on CB formation, we evaluated various coilin phosphomutants using transient expression. Additionally, we generated inducible coilin phosphomutant cell lines that, when used in combination with endogenous coilin knockdown, allow for the expression of the phosphomutants at physiological levels. Transient expression of all coilin phosphomutants except the phosphonull mutant (OFF) significantly reduces proliferation. Interestingly, a stable cell line induced to express the coilin S489D phosphomutant displays nucleolar accumulation of the mutant and generates a N-terminal degradation product; neither of which is observed upon transient expression. A N-terminal degradation product and nucleolar localization are also observed in a stable cell line induced to express a coilin phosphonull mutant (OFF). The nucleolar localization of the S489D and OFF coilin mutants observed in the stable cell lines is decreased when endogenous coilin is reduced. Furthermore, all the phosphomutant cells lines show a significant reduction in CB formation when compared to wild-type after endogenous coilin knockdown. Cell proliferation studies on these lines reveal that only wild-type coilin and the OFF mutant are sufficient to rescue the reduction in proliferation associated with endogenous coilin depletion. These results emphasize the role of coilin phosphorylation in the formation and activity of CBs.	[Carrero, Zunamys I.; Velma, Venkatramreddy; Douglas, Heather E.; Hebert, Michael D.] Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA	University of Mississippi; University of Mississippi Medical Center	Carrero, ZI (corresponding author), Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA.	mhebert@umc.edu		Carrero, Zunamys/0000-0001-8501-1566	National Institutes of Health [R01GM081448]; University of Mississippi Medical Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Mississippi Medical Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant R01GM081448. Heather E. Douglas was supported in part by the Medical Student Research Program of The University of Mississippi Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Boisvert FM, 2002, J CELL BIOL, V159, P957, DOI 10.1083/jcb.200207028; CARMOFONSECA M, 1993, J CELL BIOL, V120, P841, DOI 10.1083/jcb.120.4.841; Cioce M, 2006, J CELL BIOL, V175, P401, DOI 10.1083/jcb.200604099; Clelland AK, 2009, TRAFFIC, V10, P1585, DOI 10.1111/j.1600-0854.2009.00972.x; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Fuentes JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015769; Gilder AS, 2011, MOL BIOL CELL, V22, P1070, DOI 10.1091/mbc.E10-08-0731; Hearst SM, 2009, J CELL SCI, V122, P1872, DOI 10.1242/jcs.044040; Hebert MD, 2002, DEV CELL, V3, P329, DOI 10.1016/S1534-5807(02)00222-8; Hebert MD, 2001, GENE DEV, V15, P2720, DOI 10.1101/gad.908401; Hebert MD, 2000, MOL BIOL CELL, V11, P4159, DOI 10.1091/mbc.11.12.4159; Hebert MD, 2010, ARCH BIOCHEM BIOPHYS, V496, P69, DOI 10.1016/j.abb.2010.02.012; Lam YW, 2002, MOL BIOL CELL, V13, P2461, DOI 10.1091/mbc.02-03-0034; Lemm I, 2006, MOL BIOL CELL, V17, P3221, DOI 10.1091/mbc.E06-03-0247; Liu JL, 2009, MOL BIOL CELL, V20, P1661, DOI 10.1091/mbc.E08-05-0525; Liu JL, 2000, J CELL SCI, V113, P1543; Lyon CE, 1997, EXP CELL RES, V230, P84, DOI 10.1006/excr.1996.3380; Matera AG, 2009, DEV CELL, V17, P639, DOI 10.1016/j.devcel.2009.10.017; Morency E, 2007, J CELL BIOL, V177, P757, DOI 10.1083/jcb.200612107; Morris GE, 2008, BBA-MOL CELL RES, V1783, P2108, DOI 10.1016/j.bbamcr.2008.07.016; Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Shababi M, 2010, DRUG NEWS PERSPECT, V23, P475, DOI 10.1358/dnp.2010.23.8.1507295; Shanbhag R, 2010, FEBS LETT, V584, P4351, DOI 10.1016/j.febslet.2010.09.034; Shpargel KB, 2003, J CELL SCI, V116, P303, DOI 10.1242/jcs.00211; Strzelecka M, 2010, NUCLEUS IN PRESS; Sun J, 2005, J CELL SCI, V118, P4995, DOI 10.1242/jcs.02613; Tapia O, 2010, CHROMOSOMA, V119, P527, DOI 10.1007/s00412-010-0276-7; Toyota CG, 2010, CHROMOSOMA, V119, P205, DOI 10.1007/s00412-009-0249-x; Tucker KE, 2001, J CELL BIOL, V154, P293, DOI 10.1083/jcb.200104083; Velma V, 2010, FEBS LETT, V584, P4735, DOI 10.1016/j.febslet.2010.11.004; Walker MP, 2008, HUM MOL GENET, V17, P3399, DOI 10.1093/hmg/ddn234; Walker MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006171; Whittom AA, 2008, CELL MOL LIFE SCI, V65, P1256, DOI 10.1007/s00018-008-7587-3; Xu HZ, 2005, CHROMOSOMA, V114, P155, DOI 10.1007/s00412-005-0003-y	37	20	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25743	10.1371/journal.pone.0025743	http://dx.doi.org/10.1371/journal.pone.0025743			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991343	gold, Green Published, Green Submitted			2022-12-27	WOS:000295943000062
J	Ringler, M; Ringler, E; Mendoza, DM; Hodl, W				Ringler, Max; Ringler, Eva; Mendoza, Daniela Magana; Hoedl, Walter			Intrusion Experiments to Measure Territory Size: Development of the Method, Tests through Simulations, and Application in the Frog Allobates femoralis	PLOS ONE			English	Article							DART-POISON FROG; EPIPEDOBATES-FEMORALIS; HOME; BEHAVIOR; SHAPE; COMPETITION; PATTERN; KERNEL; MODELS	Territoriality is a widespread behaviour in animals and its analysis is crucial in several areas of behavioural, ecological and evolutionary research. Commonly, territory size is assessed through territory mapping and the application of simple area estimators such as minimum convex polygons. In the present study we demonstrate that territory size can be determined adequately with an active approach through intrusion experiments, a technique that is commonly used in behavioural research in other contexts. Tests with simulated data indicate that a minimum of twelve trials needs to be performed to establish reliable orders of relative territory size. To estimate absolute territory size, detailed hull techniques are most appropriate when analyzing point patterns of intrusion experiments, while the local convex hull estimator enables the construction of internal utilization distributions based on such point patterns. Additionally we suggest a 'stretch the centre' approach to emphasize the actual process of intrusion experiments in the construction of internal utilization distributions. To demonstrate the utility of the method, we apply all findings from the simulations to data from fieldwork with the model species Allobates femoralis, a territorial aromobatid frog from the lowland rainforest of French Guiana.	[Ringler, Max; Ringler, Eva; Mendoza, Daniela Magana; Hoedl, Walter] Univ Vienna, Dept Evolutionary Biol, Vienna, Austria	University of Vienna	Ringler, M (corresponding author), Univ Vienna, Dept Evolutionary Biol, Vienna, Austria.	max.ringler@univie.ac.at	, Eva/F-9064-2014; Ringler, Max/J-4821-2012	, Eva/0000-0003-3273-6568; Ringler, Max/0000-0002-4530-4919	French Centre National de la Recherche Scientifique (CNRS); Austrian Science Fund (FWF) [18811]; University of Vienna; Austrian Academy of Sciences	French Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); University of Vienna; Austrian Academy of Sciences	Field work was funded by the Nouragues Grant from the French Centre National de la Recherche Scientifique (CNRS, http://www.guyane.cnrs.fr) to Max Ringler and supported through the Austrian Science Fund (FWF, Project: 18811, PI Walter Hodl, http://www.fwf.ac.at). Max Ringler and Eva Ursprung were supported by a Forschungsstipendium of the University of Vienna (http://www.univie.ac.at) and Eva Ursprung was funded by a DOC-fFORTE scholarship from the Austrian Academy of Sciences (http://www.oeaw.ac.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcay C, 2010, ANIM BEHAV, V80, P1041, DOI 10.1016/j.anbehav.2010.09.009; Amezquita A, 2009, BIOL J LINN SOC, V98, P826, DOI 10.1111/j.1095-8312.2009.01324.x; Anich NM, 2009, AUK, V126, P626, DOI 10.1525/auk.2009.08219; Animal Behaviour Society, 2006, ANIM BEHAV, V71, P245, DOI DOI 10.1016/J.ANBEHAV.2005.10.001; BART J, 1995, ECOL APPL, V5, P411, DOI 10.2307/1942032; Beyer H. L, 2007, HAWTHS ANAL TOOLS AR; Borger L, 2006, AM NAT, V168, P471, DOI 10.1086/507883; Both C, 2000, J ANIM ECOL, V69, P1021, DOI 10.1046/j.1365-2656.2000.00458.x; BOULANGER JG, 1990, J WILDLIFE MANAGE, V54, P310, DOI 10.2307/3809048; Boyle SA, 2009, FOLIA PRIMATOL, V80, P33, DOI 10.1159/000201092; Brown J. L., 1964, Wilson Bulletin, V76, P160; Brown J.L., 1970, ANNU REV ECOL SYST, V1, P239; Burgman MA, 2003, ANIM CONSERV, V6, P19, DOI 10.1017/S1367943003003044; Burt W. H., 1943, Journal of Mammalogy, V24, P346, DOI 10.2307/1374834; Candolin U, 2001, OIKOS, V95, P225, DOI 10.1034/j.1600-0706.2001.950204.x; Clark DJ, 2001, J ECON, V73, P167, DOI 10.1007/BF02340174; Dalke P. D., 1942, Bulletin Connecticut State Geological and Natural History Survey, Vno. 65, P1; *DAT E LLC, 2003, XTOOLS PRO ARCGIS DE; Desiardins JK, 2008, ANIM BEHAV, V75, P595, DOI 10.1016/j.anbehav.2007.05.025; Downs JA, 2008, J WILDLIFE MANAGE, V72, P1813, DOI 10.2193/2007-454; Downs JA, 2009, T GIS, V13, P527, DOI 10.1111/j.1467-9671.2009.01177.x; EDELSBRUNNER H, 1983, IEEE T INFORM THEORY, V29, P551, DOI 10.1109/TIT.1983.1056714; ENEMAR A, 1978, ORNIS SCAND, V9, P31, DOI 10.2307/3676136; Environmental Systems Research Institute (ESRI), 2009, ARCGIS DESKT 9 3 HEL; Fieberg J, 2007, ECOLOGY, V88, P1059, DOI 10.1890/06-0930; GALTON A, 2006, GEOGRAPHIC INFORM SC; Galton A, 2008, LECT NOTES ARTIF INT, V5248, P409, DOI 10.1007/978-3-540-87601-4_29; GETTY T, 1981, ECOLOGY, V62, P907, DOI 10.2307/1936988; Getz WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000207; Getz WM, 2004, ECOGRAPHY, V27, P489, DOI 10.1111/j.0906-7590.2004.03835.x; GIRALDEAU LA, 1987, AUK, V104, P535, DOI 10.2307/4087559; Gitzen RA, 2006, J WILDLIFE MANAGE, V70, P1334, DOI 10.2193/0022-541X(2006)70[1334:BSFFAO]2.0.CO;2; GIVEN MF, 1987, HERPETOLOGICA, V43, P467; Haines A. M, 2006, GAMEBIRD, P489; Harvey M. J., 1965, Journal of Mammalogy, V46, P398, DOI 10.2307/1377624; HODL W, 1983, VERH DTSCH ZOOL GES, V172; HODL W, 1983, PHYLLOBATES FEMORALI; HOOGE PN, 2000, ANIMAL MOVEMENT VER; HUFF DL, 1977, J MARKETING RES, V14, P581, DOI 10.2307/3151205; KAUFMANN JH, 1983, BIOL REV, V58, P1, DOI 10.1111/j.1469-185X.1983.tb00379.x; Korsten P, 2007, BEHAVIOUR, V144, P447, DOI 10.1163/156853907780756030; Kraaijeveld K, 2003, OSTRICH, V74, P117, DOI 10.2989/00306520309485377; Laver PN, 2008, J WILDLIFE MANAGE, V72, P290, DOI 10.2193/2005-589; LAVER PN, 2005, ABODE USER MANUAL BE; LAVER PN, 2006, ABODE BETA V 5 KERNE; Lawson EJ, 1997, WILDLIFE SOC B, V25, P721; Lichti NI, 2011, J WILDLIFE MANAGE, V75, P413, DOI 10.1002/jwmg.48; LYONS A, 2004, LOCOH  LOCAL CONVEX; MENDOZA DM, 2008, THESIS DEP EVOLUTION; MITCHELL BR, 2006, REMOTELY WILD WILDLI, V21; Montanarin A, 2011, ETHOL ECOL EVOL, V23, P141, DOI 10.1080/03949370.2011.554884; Mu L, 2011, APPL GEOGR, V31, P621, DOI 10.1016/j.apgeog.2010.11.012; Narins PM, 2005, P NATL ACAD SCI USA, V102, P2425, DOI 10.1073/pnas.0406407102; Narins PM, 2003, P NATL ACAD SCI USA, V100, P577, DOI 10.1073/pnas.0237165100; ODUM E. P., 1955, AUK, V72, P128; Poesel A, 2005, ANIM BEHAV, V70, P1419, DOI 10.1016/j.anbehav.2005.04.004; Ringler M, 2009, BEHAV ECOL SOCIOBIOL, V63, P1281, DOI 10.1007/s00265-009-0793-7; RODGERS AR, 2007, HRT HOME RANGE TOOLS; ROITHMAIR ME, 1994, HERPETOL J, V4, P77; ROITHMAIR ME, 1992, ETHOLOGY, V92, P331, DOI 10.1111/j.1439-0310.1992.tb00970.x; Rooney SM, 1998, MAMMAL REV, V28, P89, DOI 10.1046/j.1365-2907.1998.00028.x; SCHOENER TW, 1983, AM NAT, V121, P608, DOI 10.1086/284090; SIEGEL S, 1957, AM STAT, V11, P13, DOI 10.2307/2685679; Sogge MK, 2007, CONDOR, V109, P475, DOI 10.1650/0010-5422(2007)109[475:WFNTDB]2.0.CO;2; STAMPS J, 1994, ADV STUD BEHAV, V23, P173, DOI 10.1016/S0065-3454(08)60354-X; SUTHERLAND WJ, 2009, ECOLOGICAL CENSUS TE; SVENSSON SE, 1979, J APPL ECOL, V16, P61, DOI 10.2307/2402728; Tinbergen N., 1957, Bird Study, V4, P14; Ursprung E, 2011, MOL ECOL, V20, P1759, DOI 10.1111/j.1365-294X.2011.05056.x; Ursprung E, 2009, BEHAVIOUR, V146, P153, DOI 10.1163/156853909X410711; van Dongen WFD, 2008, BEHAV ECOL, V19, P1025, DOI 10.1093/beheco/arn061; Vanpe C, 2009, J ANIM ECOL, V78, P42, DOI 10.1111/j.1365-2656.2008.01467.x; WHITE MS, 1985, AM CARTOGRAPHER, V12, P123, DOI 10.1559/152304085783915135; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423	74	32	32	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e25844	10.1371/journal.pone.0025844	http://dx.doi.org/10.1371/journal.pone.0025844			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022456	Green Published, Green Submitted, gold			2022-12-27	WOS:000295981600014
J	Carpi, G; Cagnacci, F; Wittekindt, NE; Zhao, FQ; Qi, J; Tomsho, LP; Drautz, DI; Rizzoli, A; Schuster, SC				Carpi, Giovanna; Cagnacci, Francesca; Wittekindt, Nicola E.; Zhao, Fangqing; Qi, Ji; Tomsho, Lynn P.; Drautz, Daniela I.; Rizzoli, Annapaola; Schuster, Stephan C.			Metagenomic Profile of the Bacterial Communities Associated with Ixodes ricinus Ticks	PLOS ONE			English	Article							CANDIDATUS NEOEHRLICHIA-MIKURENSIS; CANONICAL CORRESPONDENCE-ANALYSIS; BURGDORFERI SENSU-LATO; BORRELIA-BURGDORFERI; MICROBIAL COMMUNITIES; AMBLYOMMA-AMERICANUM; PATHOGEN DNA; ROE DEER; DIVERSITY; IXODIDAE	Assessment of the microbial diversity residing in arthropod vectors of medical importance is crucial for monitoring endemic infections, for surveillance of newly emerging zoonotic pathogens, and for unraveling the associated bacteria within its host. The tick Ixodes ricinus is recognized as the primary European vector of disease-causing bacteria in humans. Despite I. ricinus being of great public health relevance, its microbial communities remain largely unexplored to date. Here we evaluate the pathogen-load and the microbiome in single adult I. ricinus by using 454- and Illumina-based metagenomic approaches. Genomic DNA-derived sequences were taxonomically profiled using a computational approach based on the BWA algorithm, allowing for the identification of known tick-borne pathogens at the strain level and the putative tick core microbiome. Additionally, we assessed and compared the bacterial taxonomic profile in nymphal and adult I. ricinus pools collected from two distinct geographic regions in Northern Italy by means of V6-16S rRNA amplicon pyrosequencing and community based ecological analysis. A total of 108 genera belonging to representatives of all bacterial phyla were detected and a rapid qualitative assessment for pathogenic bacteria, such as Borrelia, Rickettsia and Candidatus Neoehrlichia, and for other bacteria with mutualistic relationship or undetermined function, such as Wolbachia and Rickettsiella, was possible. Interestingly, the ecological analysis revealed that the bacterial community structure differed between the examined geographic regions and tick life stages. This finding suggests that the environmental context (abiotic and biotic factors) and host-selection behaviors affect their microbiome. Our data provide the most complete picture to date of the bacterial communities present within I. ricinus under natural conditions by using high-throughput sequencing technologies. This study further demonstrates a novel detection strategy for the microbiomes of arthropod vectors in the context of epidemiological and ecological studies.	[Carpi, Giovanna; Cagnacci, Francesca; Rizzoli, Annapaola] Fdn Edmund Mach, Res & Innovat Ctr, Dept Biodivers & Mol Ecol, San Michele All Adige, Italy; [Carpi, Giovanna; Wittekindt, Nicola E.; Zhao, Fangqing; Qi, Ji; Tomsho, Lynn P.; Drautz, Daniela I.; Schuster, Stephan C.] Penn State Univ, Ctr Comparat Genom & Bioinformat, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Fondazione Edmund Mach; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Carpi, G (corresponding author), Fdn Edmund Mach, Res & Innovat Ctr, Dept Biodivers & Mol Ecol, San Michele All Adige, Italy.	guc12@psu.edu	QI, JI/E-2797-2016; Carpi, Giovanna/HHM-5942-2022; Rizzoli, Annapaola/B-8583-2011; Wittekindt, Nicola/G-3469-2013; Zhao, Fangqing/P-6309-2019; Cagnacci, Francesca/L-7377-2013; Rizzoli, Annapaola/J-2439-2012; Cagnacci, Francesca/B-9397-2011	Wittekindt, Nicola/0000-0002-3310-0919; Cagnacci, Francesca/0000-0002-4954-9980; Rizzoli, Annapaola/0000-0003-3997-6783; Cagnacci, Francesca/0000-0002-4954-9980; Zhao, Fangqing/0000-0002-6216-1235	European Union [GOCE-2003-010284 EDEN]; Fondazione Edmund Mach; The Autonomous Province of Trento, "Trentino - The Trentino programme of research, training and mobility of post-doctoral researcher" - "People" specific programme - Marie Curie actions	European Union(European Commission); Fondazione Edmund Mach; The Autonomous Province of Trento, "Trentino - The Trentino programme of research, training and mobility of post-doctoral researcher" - "People" specific programme - Marie Curie actions	This research was partially funded by European Union grant GOCE-2003-010284 EDEN and by additional research funds provided by the Fondazione Edmund Mach. The paper is cataloged by the Emerging Diseases in a changing European eNvironment (EDEN) Steering Committee as EDEN0261 (http://www.eden-fp6project.net/). The contents of this publication are the sole responsibility of the authors and do not necessarily reflect the views of the European Commission. This research was also partially funded by The Autonomous Province of Trento, "Trentino - The Trentino programme of research, training and mobility of post-doctoral researcher" project, within the context of the 7th research framework programme for the period 2007-2013 - "People" specific programme - Marie Curie actions - COFUND. Post-doctoral project GENOTICK, Principal investigator: GC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andreotti R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-6; Carpi G, 2009, VECTOR-BORNE ZOONOT, V9, P179, DOI 10.1089/vbz.2008.0068; Chakravorty S, 2007, J MICROBIOL METH, V69, P330, DOI 10.1016/j.mimet.2007.02.005; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Clay K, 2008, MOL ECOL, V17, P4371, DOI 10.1111/j.1365-294X.2008.03914.x; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; COLWELL RK, 1971, ECOLOGY, V52, P567, DOI 10.2307/1934144; Cordaux R, 2007, APPL ENVIRON MICROB, V73, P5045, DOI 10.1128/AEM.00378-07; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; de la Fuente J, 2003, CLIN DIAGN LAB IMMUN, V10, P182, DOI 10.1128/CDLI.10.1.182-184.2003; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Epis S, 2008, PARASITOLOGY, V135, P485, DOI 10.1017/S0031182007004052; Fehr JS, 2010, EMERG INFECT DIS, V16, P1127, DOI 10.3201/eid1607.091907; Gilbert MTP, 2007, SCIENCE, V317, P1927, DOI 10.1126/science.1146971; Goodman J., 2005, TICK BORNE DIS HUMAN; Halos LG, 2006, VET RES, V37, P245, DOI 10.1051/vetres:2005055; Heise SR, 2010, J MED ENTOMOL, V47, P258, DOI 10.1603/ME09197; HILL MO, 1980, VEGETATIO, V42, P47, DOI 10.1007/BF00048870; Hubalek Zdenek, 2009, V37, P31, DOI 10.1159/000213069; Huson DH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S12; Jensen K, 2007, TRENDS PARASITOL, V23, P439, DOI 10.1016/j.pt.2007.07.006; Kawahara M, 2004, INT J SYST EVOL MICR, V54, P1837, DOI 10.1099/ijs.0.63260-0; Lambin EF, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-54; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Macaluso KR, 2002, J MED ENTOMOL, V39, P809, DOI 10.1603/0022-2585-39.6.809; Manilla, 1998, FAUNA ITALIA ACARI I; Mannelli A, 2005, J MED ENTOMOL, V42, P168, DOI 10.1603/0022-2585(2005)042[0168:BBSLII]2.0.CO;2; Margos G, 2009, APPL ENVIRON MICROB, V75, P5410, DOI 10.1128/AEM.00116-09; Moreno CX, 2006, ENVIRON MICROBIOL, V8, P761, DOI 10.1111/j.1462-2920.2005.00955.x; Nakamura S, 2008, EMERG INFECT DIS, V14, P1784, DOI 10.3201/eid1411.080589; Noda H, 1997, APPL ENVIRON MICROB, V63, P3926, DOI 10.1128/AEM.63.10.3926-3932.1997; Parola P, 2001, CLIN INFECT DIS, V32, P897, DOI 10.1086/319347; Piccolin G, 2006, VECTOR-BORNE ZOONOT, V6, P24, DOI 10.1089/vbz.2006.6.24; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Qi J, 2010, BIOINFORMATICS, V26, P127, DOI 10.1093/bioinformatics/btp615; RIJPKEMA SGT, 1995, J CLIN MICROBIOL, V33, P3091, DOI 10.1128/JCM.33.12.3091-3095.1995; Rizzoli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004336; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schabereiter-Gurtner C, 2003, J MICROBIOL METH, V52, P251, DOI 10.1016/S0167-7012(02)00186-0; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Sparagano OAE, 1999, EXP APPL ACAROL, V23, P929, DOI 10.1023/A:1006313803979; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; Ter Braak C. J. F., 1995, P91; TER BRAAK CJF, 1987, VEGETATIO, V69, P69, DOI 10.1007/BF00038688; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; van Overbeek L, 2008, FEMS MICROBIOL ECOL, V66, P72, DOI 10.1111/j.1574-6941.2008.00468.x; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Victoria JG, 2009, J VIROL, V83, P4642, DOI 10.1128/JVI.02301-08; von Loewenich FD, 2010, J CLIN MICROBIOL, V48, P2630, DOI 10.1128/JCM.00588-10; Weinert LA, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-6; Wittekindt NE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013432	53	187	192	0	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e25604	10.1371/journal.pone.0025604	http://dx.doi.org/10.1371/journal.pone.0025604			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022422	Green Submitted, Green Published, gold			2022-12-27	WOS:000295978600024
J	Hyams, C; Opel, S; Hanage, W; Yuste, J; Bax, K; Henriques-Normark, B; Spratt, BG; Brown, JS				Hyams, Catherine; Opel, Sophia; Hanage, William; Yuste, Jose; Bax, Katie; Henriques-Normark, Birgitta; Spratt, Brian G.; Brown, Jeremy S.			Effects of Streptococcus pneumoniae Strain Background on Complement Resistance	PLOS ONE			English	Article							HISTIDINE TRIAD PROTEINS; CAPSULAR SEROTYPE; MEDIATED IMMUNITY; INNATE IMMUNITY; PHASE VARIATION; MOSAIC GENES; DEPOSITION; INFECTION; PHAGOCYTOSIS; ACTIVATION	Background: Immunity to infections caused by Streptococcus pneumoniae is dependent on complement. There are wide variations in sensitivity to complement between S. pneumoniae strains that could affect their ability to cause invasive infections. Although capsular serotype is one important factor causing differences in complement resistance between strains, there is also considerable other genetic variation between S. pneumoniae strains that may affect complement-mediated immunity. We have therefore investigated whether genetically distinct S. pneumoniae strains with the same capsular serotype vary in their sensitivity to complement mediated immunity. Methodology and Principal Findings: C3b/iC3b deposition and neutrophil association were measured using flow cytometry assays for S. pneumoniae strains with different genetic backgrounds for each of eight capsular serotypes. For some capsular serotypes there was marked variation in C3b/iC3b deposition between different strains that was independent of capsule thickness and correlated closely to susceptibility to neutrophil association. C3b/iC3b deposition results also correlated weakly with the degree of IgG binding to each strain. However, the binding of C1q (the first component of the classical pathway) correlated more closely with C3b/iC3b deposition, and large differences remained in complement sensitivity between strains with the same capsular serotype in sera in which IgG had been cleaved with IdeS. Conclusions: These data demonstrate that bacterial factors independent of the capsule and recognition by IgG have strong effects on the susceptibility of S. pneumoniae to complement, and could therefore potentially account for some of the differences in virulence between strains.	[Hyams, Catherine; Opel, Sophia; Brown, Jeremy S.] Univ Coll Med Sch, Rayne Inst, Dept Med, Ctr Resp Res, London, England; [Hanage, William] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Yuste, Jose] Inst Salud Carlos III, Ctr Nacl Microbiol, Spanish Pneumococcal Reference Lab, Madrid, Spain; [Bax, Katie] UCL, Dept Anat, London, England; [Henriques-Normark, Birgitta] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Henriques-Normark, Birgitta] Swedish Inst Infect Dis Control, Stockholm, Sweden; [Spratt, Brian G.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England	University of London; King's College London; University College London; Harvard University; Harvard T.H. Chan School of Public Health; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); University of London; University College London; Karolinska Institutet; Swedish Institute for Infectious Disease Control; Imperial College London	Hyams, C (corresponding author), Univ Coll Med Sch, Rayne Inst, Dept Med, Ctr Resp Res, London, England.	jeremy.brown@ucl.ac.uk	Hyams, Catherine/AAH-1721-2019; YUSTE, JOSE/ABG-9851-2020; Hanage, Bill/CAF-1813-2022	Hyams, Catherine/0000-0003-3923-1773; YUSTE, JOSE/0000-0001-7996-0837; Brown, Jeremy/0000-0002-5650-5361	Department of Health's NIHR Biomedical Research Centre; Astor Foundation; Glaxo Smith Kline through the University College London; British Lung Foundation [P05/3]; Ragnar and Torsten Soderberg foundation; Swedish Research Council; GlaxoSmithKline	Department of Health's NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Astor Foundation; Glaxo Smith Kline through the University College London; British Lung Foundation; Ragnar and Torsten Soderberg foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); GlaxoSmithKline(GlaxoSmithKline)	This work was undertaken at University College London, which received a proportion of funding from the Department of Health's NIHR Biomedical Research Centre's funding scheme. CH was supported by the Astor Foundation and Glaxo Smith Kline through the University College London MB PhD programme. JY was supported by the British Lung Foundation (P05/3). BHN is supported by the Ragnar and Torsten Soderberg foundation and the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: JSB has received unrestricted travel funds to attend conferences from pharmaceutical companies (GlaxoSmithKline). CH was partially funded by an unrestricted grant from a pharmaceutical company (GlaxoSmithKline) to University College London to support the MD PhD programme. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Abeyta M, 2003, INFECT IMMUN, V71, P218, DOI 10.1128/IAI.71.1.218-225.2003; ANGEL CS, 1994, J INFECT DIS, V170, P600, DOI 10.1093/infdis/170.3.600; BRILES DE, 1981, J EXP MED, V153, P694, DOI 10.1084/jem.153.3.694; Brown JS, 2002, P NATL ACAD SCI USA, V99, P16969, DOI 10.1073/pnas.012669199; Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; Dagerhamn J, 2008, J CLIN MICROBIOL, V46, P863, DOI 10.1128/JCM.01438-07; Dalia AB, 2010, INFECT IMMUN, V78, P2108, DOI 10.1128/IAI.01125-09; Dave S, 2004, INDIAN J MED RES, V119, P66; Dieudonne-Vatran A, 2009, J IMMUNOL, V182, P7865, DOI 10.4049/jimmunol.0802376; Embry A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-80; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Haas KM, 2002, IMMUNITY, V17, P713, DOI 10.1016/S1074-7613(02)00483-1; Hakenbeck R, 2001, INFECT IMMUN, V69, P2477, DOI 10.1128/IAI.69.4.2477-2486.2001; Hammerschmidt S, 2005, INFECT IMMUN, V73, P4653, DOI 10.1128/IAI.73.8.4653-4667.2005; Hanage WP, 2005, INFECT IMMUN, V73, P431, DOI 10.1128/IAI.73.1.431-435.2005; Hiller NL, 2007, J BACTERIOL, V189, P8186, DOI 10.1128/JB.00690-07; Hollingshead SK, 2000, INFECT IMMUN, V68, P5889, DOI 10.1128/IAI.68.10.5889-5900.2000; HOSTETTER MK, 1986, J INFECT DIS, V153, P682, DOI 10.1093/infdis/153.4.682; Hyams C, 2010, INFECT IMMUN, V78, P704, DOI 10.1128/IAI.00881-09; Hyams C, 2010, INFECT IMMUN, V78, P716, DOI 10.1128/IAI.01056-09; Iannelli F, 2002, GENE, V284, P63, DOI 10.1016/S0378-1119(01)00896-4; Jonsson G, 2005, MEDICINE, V84, P23, DOI 10.1097/01.md.0000152371.22747.1e; Kang YS, 2006, CELL, V125, P47, DOI 10.1016/j.cell.2006.01.046; Kerr AR, 2005, INFECT IMMUN, V73, P4245, DOI 10.1128/IAI.73.7.4245-4252.2005; Kim JO, 1998, J INFECT DIS, V177, P368, DOI 10.1086/514205; Melin M, 2010, INFECT IMMUN, V78, P5252, DOI 10.1128/IAI.00739-10; Melin M, 2010, INFECT IMMUN, V78, P5262, DOI 10.1128/IAI.00740-10; Melin M, 2010, INFECT IMMUN, V78, P2089, DOI 10.1128/IAI.00811-09; Melin M, 2009, INFECT IMMUN, V77, P676, DOI 10.1128/IAI.01186-08; Neth O, 2000, INFECT IMMUN, V68, P688, DOI 10.1128/IAI.68.2.688-693.2000; Ogunniyi AD, 2009, FASEB J, V23, P731, DOI 10.1096/fj.08-119537; Ren B, 2004, J IMMUNOL, V173, P7506, DOI 10.4049/jimmunol.173.12.7506; Sabharwal V, 2009, INFECT IMMUN, V77, P1121, DOI 10.1128/IAI.01148-08; Sandgren A, 2004, J INFECT DIS, V189, P785, DOI 10.1086/381686; SEGAL AW, 1980, FEBS LETT, V110, P111, DOI 10.1016/0014-5793(80)80035-4; Sleeman KL, 2006, J INFECT DIS, V194, P682, DOI 10.1086/505710; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tu AHT, 1999, INFECT IMMUN, V67, P4720, DOI 10.1128/IAI.67.9.4720-4724.1999; von Pawel-Rammingen U, 2002, EMBO J, V21, P1607, DOI 10.1093/emboj/21.7.1607; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Weinberger DM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000476; Weiser JN, 1998, MICROB DRUG RESIST, V4, P129, DOI 10.1089/mdr.1998.4.129; Xu YY, 2001, P NATL ACAD SCI USA, V98, P14577, DOI 10.1073/pnas.261428398; Yuste J, 2005, J IMMUNOL, V175, P1813, DOI 10.4049/jimmunol.175.3.1813; Yuste J, 2007, PLOS PATHOG, V3, P1208, DOI 10.1371/journal.ppat.0030120; Yuste J, 2008, INFECT IMMUN, V76, P3761, DOI 10.1128/IAI.00291-08; Yuste J, 2006, J IMMUNOL, V176, P6112, DOI 10.4049/jimmunol.176.10.6112; Yuste J, 2010, INFECT IMMUN, V78, P283, DOI 10.1128/IAI.00541-09	48	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e24581	10.1371/journal.pone.0024581	http://dx.doi.org/10.1371/journal.pone.0024581			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022358	Green Published, Green Submitted, gold			2022-12-27	WOS:000295978600004
J	Alhadeff, R; Ganoth, A; Krugliak, M; Arkin, IT				Alhadeff, Raphael; Ganoth, Assaf; Krugliak, Miriam; Arkin, Isaiah T.			Promiscuous Binding in a Selective Protein: The Bacterial Na+/H+ Antiporter	PLOS ONE			English	Article							GATED ION CHANNELS; ESCHERICHIA-COLI; MOLECULAR-DYNAMICS; POTASSIUM CHANNELS; MEMBRANE-VESICLES; CALCIUM-PUMP; NHAA; SODIUM; PROTON; FAMILY	The ability to discriminate between highly similar substrates is one of the remarkable properties of enzymes. For example, transporters and channels that selectively distinguish between various solutes enable living organisms to maintain and control their internal environment in the face of a constantly changing surrounding. Herein, we examine in detail the selectivity properties of one of the most important salt transporters: the bacterial Na+/H+ antiporter. Selectivity can be achieved at either the substrate binding step or in subsequent antiporting. Surprisingly, using both computational and experimental analyses synergistically, we show that binding per se is not a sufficient determinant of selectively. All alkali ions from Li+ to Cs+ were able to competitively bind the antiporter's binding site, whether the protein was capable of pumping them or not. Hence, we propose that NhaA's binding site is relatively promiscuous and that the selectivity is determined at a later stage of the transport cycle.	[Alhadeff, Raphael; Ganoth, Assaf; Krugliak, Miriam; Arkin, Isaiah T.] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Alhadeff, R (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel.	arkin@huji.ac.il	Arkin, Isaiah/GQA-4328-2022	Arkin, Isaiah/0000-0002-7659-1746	Rudin Fellowship Trust; Lady Davis Fellowship Trust; Valazzi-Pikovsky Fellowship Fund; Israeli Science Foundation [784/01, 1249/05, 1581/08]	Rudin Fellowship Trust; Lady Davis Fellowship Trust; Valazzi-Pikovsky Fellowship Fund; Israeli Science Foundation(Israel Science Foundation)	This work was supported in part by grants from The Rudin Fellowship Trust (to RA), The Lady Davis Fellowship Trust and The Valazzi-Pikovsky Fellowship Fund (to AG), and the Israeli Science Foundation (784/01, 1249/05, 1581/08 to ITA). ITA is the Arthur Lejwa Professor of Structural Biochemistry at the Hebrew University of Jerusalem. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderie I, 1996, J MEMBRANE BIOL, V152, P195, DOI 10.1007/s002329900097; Arkin IT, 2007, SCIENCE, V317, P799, DOI 10.1126/science.1142824; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; BEZANILLA F, 1972, J GEN PHYSIOL, V60, P588, DOI 10.1085/jgp.60.5.588; Corry B, 2006, MOL BIOSYST, V2, P527, DOI 10.1039/b610062g; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dickson A, 2010, ANNU REV PHYS CHEM, V61, P441, DOI 10.1146/annurev.physchem.012809.103433; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Gouaux E, 2005, SCIENCE, V310, P1461, DOI 10.1126/science.1113666; Hachez C, 2010, ADV EXP MED BIOL, V679, P1; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; IMPEY RW, 1987, J AM CHEM SOC, V109, P5900, DOI 10.1021/ja00254a002; INABA K, 1994, BIOL PHARM BULL, V17, P573; INOUE H, 1995, FEBS LETT, V363, P264, DOI 10.1016/0014-5793(95)00331-3; Jensen ML, 2005, J NEUROCHEM, V92, P217, DOI 10.1111/j.1471-4159.2004.02883.x; KARPEL R, 1988, J BIOL CHEM, V263, P10408; Keramidas A, 2004, PROG BIOPHYS MOL BIO, V86, P161, DOI 10.1016/j.pbiomolbio.2003.09.002; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Michaelis L, 1913, BIOCHEM Z, V49, P333; Miloshevsky GV, 2004, TRENDS NEUROSCI, V27, P308, DOI 10.1016/j.tins.2004.03.013; Moomaw AS, 2008, PHYSIOLOGY, V23, P275, DOI 10.1152/physiol.00019.2008; MULLINS LJ, 1959, J GEN PHYSIOL, V42, P817, DOI 10.1085/jgp.42.4.817; Noskov SY, 2006, BIOPHYS CHEM, V124, P279, DOI 10.1016/j.bpc.2006.05.033; Nozaki K, 1996, BIOCHEM BIOPH RES CO, V222, P774, DOI 10.1006/bbrc.1996.0820; Ohgaki R, 2005, BBA-BIOMEMBRANES, V1712, P185, DOI 10.1016/j.bbamem.2005.03.011; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Padan E, 2004, BBA-BIOENERGETICS, V1658, P2, DOI 10.1016/j.bbabio.2004.04.018; Padan E, 2008, TRENDS BIOCHEM SCI, V33, P435, DOI 10.1016/j.tibs.2008.06.007; RAHAVMANOR O, 1992, J BIOL CHEM, V267, P10433; Roux B, 2005, ANNU REV BIOPH BIOM, V34, P153, DOI 10.1146/annurev.biophys.34.040204.144655; SCHULDINER S, 1972, EUR J BIOCHEM, V25, P64, DOI 10.1111/j.1432-1033.1972.tb01667.x; SCHULDINER S, 1978, BIOCHEMISTRY-US, V17, P706, DOI 10.1021/bi00597a023; Siu SWI, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2897760; TAGLICHT D, 1993, J BIOL CHEM, V268, P5382; Tieleman DP, 1998, BIOPHYS J, V74, P2786, DOI 10.1016/S0006-3495(98)77986-X; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; TSUCHIYA T, 1975, J BIOL CHEM, V250, P7687; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; WEST IC, 1974, BIOCHEM J, V144, P87, DOI 10.1042/bj1440087; Yamaoka K, 2006, CURR PHARM DESIGN, V12, P429, DOI 10.2174/138161206775474468; Zhou HX, 2010, TRENDS BIOCHEM SCI, V35, P179, DOI 10.1016/j.tibs.2009.10.007; Zuber D, 2005, BBA-BIOENERGETICS, V1709, P240, DOI 10.1016/j.bbabio.2005.07.009	49	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25182	10.1371/journal.pone.0025182	http://dx.doi.org/10.1371/journal.pone.0025182			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022382	Green Submitted, gold, Green Published			2022-12-27	WOS:000295976000012
J	Li, J; Li, ZH; Ruan, JB; Xu, C; Tong, YF; Pan, PW; Tempel, W; Crombet, L; Min, JR; Zang, JY				Li, Jing; Li, Zhihong; Ruan, Jianbin; Xu, Chao; Tong, Yufeng; Pan, Patricia W.; Tempel, Wolfram; Crombet, Lissete; Min, Jinrong; Zang, Jianye			Structural Basis for Specific Binding of Human MPP8 Chromodomain to Histone H3 Methylated at Lysine 9	PLOS ONE			English	Article							STATE-SPECIFIC RECOGNITION; MOLECULE E-CADHERIN; PHD FINGER; PROTEIN; COMPLEX; DOMAIN; MECHANISM; REPEATS; H3K4ME3; MODULES	Background: M-phase phosphoprotein 8 (MPP8) was initially identified to be a component of the RanBPM-containing large protein complex, and has recently been shown to bind to methylated H3K9 both in vivo and in vitro. MPP8 binding to methylated H3K9 is suggested to recruit the H3K9 methyltransferases GLP and ESET, and DNA methyltransferase 3A to the promoter of the E-cadherin gene, mediating the E-cadherin gene silencing and promote tumor cell motility and invasion. MPP8 contains a chromodomain in its N-terminus, which is used to bind the methylated H3K9. Methodology/Principal Findings: Here, we reported the crystal structures of human MPP8 chromodomain alone and in complex with the trimethylated histone H3K9 peptide (residue 1-15). The complex structure unveils that the human MPP8 chromodomain binds methylated H3K9 through a conserved recognition mechanism, which was also observed in Drosophila HP1, a chromodomain containing protein that binds to methylated H3K9 as well. The structure also reveals that the human MPP8 chromodomain forms homodimer, which is mediated via an unexpected domain swapping interaction through two beta strands from the two protomer subunits. Conclusions/Significance: Our findings reveal the molecular mechanism of selective binding of human MPP8 chromodomain to methylated histone H3K9. The observation of human MPP8 chromodomain in both solution and crystal lattice may provide clues to study MPP8-mediated gene regulation furthermore.	[Li, Jing; Ruan, Jianbin; Zang, Jianye] Chinese Acad Sci, Key Lab Struct Biol, Hefei, Anhui, Peoples R China; [Li, Jing; Ruan, Jianbin; Zang, Jianye] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Li, Zhihong; Xu, Chao; Tong, Yufeng; Pan, Patricia W.; Tempel, Wolfram; Crombet, Lissete; Min, Jinrong] Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada; [Min, Jinrong] Univ Toronto, Dept Physiol, Toronto, ON, Canada	Chinese Academy of Sciences; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Toronto; Structural Genomics Consortium; University of Toronto	Li, J (corresponding author), Chinese Acad Sci, Key Lab Struct Biol, Hefei, Anhui, Peoples R China.	jr.min@utoronto.ca; zangjy@ustc.edu.cn	Xu, Chao/G-3885-2010; Min, Jinrong/G-3449-2011; Zang, Jianye/E-5228-2013; Tong, Yufeng/D-2785-2011	Xu, Chao/0000-0003-0444-7080; Min, Jinrong/0000-0001-5210-3130; Tong, Yufeng/0000-0001-7740-1812; Ruan, Jianbin/0000-0001-5843-8273	Chinese Ministry of Science and Technology [2009CB825502, 2006CB806501]; Chinese Academy of Sciences; National Natural Science Foundation of China [30970576]; Canadian Institutes for Health Research [1097737]; Structural Genomics Consortium; Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institute; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Structural Genomics Consortium(University of Toronto); Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute(Genome CanadaCanada Foundation for Innovation); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institute(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome Trust)	This work was supported by the grants from the Chinese Ministry of Science and Technology (Nos. 2009CB825502, 2006CB806501), "100 talents program'' of the Chinese Academy of Sciences, and the grant from National Natural Science Foundation of China (No 30970576) to JZ. This research was also supported by the Structural Genomics Consortium, a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institute, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust to JM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Cioaba MA, 2009, BIOCHEM CELL BIOL, V87, P93, DOI 10.1139/O08-129; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Bua DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006789; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; CHANG Y, 2011, J MOL BIOL; Christofori G, 1999, TRENDS BIOCHEM SCI, V24, P73, DOI 10.1016/S0968-0004(98)01343-7; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Collins RE, 2008, NAT STRUCT MOL BIOL, V15, P245, DOI 10.1038/nsmb.1384; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P140, DOI 10.1038/nsmb1045; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eryilmaz J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007274; Feng LJ, 2005, MOL CELL BIOL, V25, P5389, DOI 10.1128/MCB.25.13.5389-5395.2005; Fischle W, 2008, J BIOL CHEM, V283, P19626, DOI 10.1074/jbc.M802655200; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Guo YH, 2009, NUCLEIC ACIDS RES, V37, P2204, DOI 10.1093/nar/gkp086; Hake S B, 2007, Br J Cancer, V96 Suppl, pR31; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Kaustov L, 2011, J BIOL CHEM, V286, P521, DOI 10.1074/jbc.M110.191411; Kokura K, 2010, EMBO J, V29, P3673, DOI 10.1038/emboj.2010.239; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Larschan E, 2007, MOL CELL, V28, P121, DOI 10.1016/j.molcel.2007.08.011; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li H, 2007, MOL CELL, V28, P677, DOI 10.1016/j.molcel.2007.10.023; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Min JR, 2007, NAT STRUCT MOL BIOL, V14, P1229, DOI 10.1038/nsmb1340; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARO R, 1991, P NATL ACAD SCI USA, V88, P263, DOI 10.1073/pnas.88.1.263; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Umeda M, 2003, GENE, V303, P47, DOI 10.1016/S0378-1119(02)01153-8; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; VAQUERO A, 2003, SCI AGING KNOWLEDGE, pRE4, DOI DOI 10.1126/SAGEKE.2003.14.RE4; Vezzoli A, 2010, NAT STRUCT MOL BIOL, V17, P617, DOI 10.1038/nsmb.1797; Xu C, 2008, STRUCTURE, V16, P1740, DOI 10.1016/j.str.2008.08.008; Xu C, 2011, PROTEIN CELL, V2, P202, DOI 10.1007/s13238-011-1018-1; Xu C, 2010, P NATL ACAD SCI USA, V107, P19266, DOI 10.1073/pnas.1008937107; YAP KL, 2011, BIOCHEMISTRY	50	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25104	10.1371/journal.pone.0025104	http://dx.doi.org/10.1371/journal.pone.0025104			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022377	Green Published, Green Submitted, gold			2022-12-27	WOS:000295976000009
J	Mancini, A; Betti, V; Panasiti, MS; Pavone, EF; Aglioti, SM				Mancini, Alessandra; Betti, Viviana; Panasiti, Maria Serena; Pavone, Enea Francesco; Aglioti, Salvatore Maria			Suffering Makes You Egoist: Acute Pain Increases Acceptance Rates and Reduces Fairness during a Bilateral Ultimatum Game	PLOS ONE			English	Article							ECONOMIC DECISION-MAKING; NEURAL BASIS; RECIPROCAL FAIRNESS; STIMULATION; COOPERATION; APPRAISAL; CIRCUITRY; RESPONSES; EMOTIONS; PATTERNS	Social preferences like interpersonal altruism, fairness, reciprocity and inequity aversion are inherently linked to departures from pure self-interest. During economic interactions, for example, defectors may be punished even if this implies a cost for the punishers. This violation of canonical assumptions in economics indicates that socially oriented decisions may predominate over self-centred stances. Here we explore whether the personal experience of pain changes the balance between self-gain and socially based choices. We used laser stimulation to induce pain or a warm sensation in subjects playing a modified version of the Ultimatum Game (UG) both in the role of responder and proposer. After each shot, responders evaluated the fairness of the offer. Moreover, responders and proposers rated the intensity and unpleasantness of the sensation evoked by the laser stimulation. Results show that suffering proposers decrease fair offers and suffering responders increase their acceptance rate irrespective of economic offer. Crucially, the intensity of painful stimulation has a predictive role on Moderately Unfair offers' acceptance rates. Thus the personal experience of pain may favour the emergence of a self-centered perspective aimed at maximizing self-gain. The results suggest that bodily states play a fundamental role in higher-order interpersonal negotiations and interactions.	[Mancini, Alessandra; Panasiti, Maria Serena; Pavone, Enea Francesco; Aglioti, Salvatore Maria] Univ Rome, Dept Psychol, Rome, Italy; [Pavone, Enea Francesco; Aglioti, Salvatore Maria] Santa Lucia Fdn, IRCCS, Rome, Italy; [Betti, Viviana] Univ G dAnnunzio, Inst Adv Biomed Technol, Chieti, Italy	Sapienza University Rome; IRCCS Santa Lucia; G d'Annunzio University of Chieti-Pescara	Mancini, A (corresponding author), Univ Rome, Dept Psychol, Rome, Italy.	alessandra.mancini@uniroma1.it	Panasiti, Maria Serena/J-5893-2016; Aglioti, Salvatore M/E-9829-2012; Mancini, Alessandra/AAC-1706-2019; Betti, Viviana/K-5516-2016	Panasiti, Maria Serena/0000-0002-3149-8855; Mancini, Alessandra/0000-0003-1139-2890; Aglioti, Salvatore Maria/0000-0001-8175-7563; Betti, Viviana/0000-0003-3429-2104; Pavone, Enea Francesco/0000-0002-8263-3594				Andrade EB, 2009, ORGAN BEHAV HUM DEC, V109, P1, DOI 10.1016/j.obhdp.2009.02.003; Apkarian AV, 2004, PAIN, V108, P129, DOI 10.1016/j.pain.2003.12.015; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Bonini N, 2011, EMOTION, V11, P965, DOI 10.1037/a0022820; CAMERER C, 2003, BEHAV GAME THEORY EX, P8; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Derbyshire SWG, 1997, PAIN, V73, P431, DOI 10.1016/S0304-3959(97)00138-3; Fehr E, 2002, HUM NATURE-INT BIOS, V13, P1, DOI 10.1007/s12110-002-1012-7; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fehr E, 2007, TRENDS COGN SCI, V11, P419, DOI 10.1016/j.tics.2007.09.002; FRIJDA NH, 1989, J PERS SOC PSYCHOL, V57, P212, DOI 10.1037/0022-3514.57.2.212; Gintis H, 2000, J THEOR BIOL, V206, P169, DOI 10.1006/jtbi.2000.2111; Glimcher PW, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P1; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Harbaugh WT, 2007, SCIENCE, V316, P1622, DOI 10.1126/science.1140738; Harle KM, 2007, EMOTION, V7, P876, DOI 10.1037/1528-3542.7.4.876; Haselhuhn MP, 2005, COGNITIVE BRAIN RES, V23, P24, DOI 10.1016/j.cogbrainres.2005.01.005; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; Koenigs M, 2007, J NEUROSCI, V27, P951, DOI 10.1523/JNEUROSCI.4606-06.2007; Moll J, 2006, P NATL ACAD SCI USA, V103, P15623, DOI 10.1073/pnas.0604475103; Moretti L, 2010, EMOTION, V10, P169, DOI 10.1037/a0017826; Moretti L, 2009, J COGNITIVE NEUROSCI, V21, P128, DOI 10.1162/jocn.2009.21011; Nowak MA, 2000, SCIENCE, V289, P1773, DOI 10.1126/science.289.5485.1773; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Sanfey AG, 2007, SCIENCE, V318, P598, DOI 10.1126/science.1142996; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; SMITH CA, 1985, J PERS SOC PSYCHOL, V48, P813, DOI 10.1037/0022-3514.48.4.813; Srivastava J, 2009, J BEHAV DECIS MAKING, V22, P475, DOI 10.1002/bdm.631; Tabibnia G, 2008, PSYCHOL SCI, V19, P339, DOI 10.1111/j.1467-9280.2008.02091.x; Thibaut J., 1959, SOCIAL PSYCHOL GROUP; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Valeriani M, 2008, NEUROIMAGE, V40, P1419, DOI 10.1016/j.neuroimage.2007.12.056; Van Lange PAM, 1999, J PERS SOC PSYCHOL, V77, P337, DOI 10.1037/0022-3514.77.2.337; van't Wout M, 2005, NEUROREPORT, V16, P1849, DOI 10.1097/01.wnr.0000183907.08149.14; Wright ND, 2011, J NEUROSCI, V31, P5244, DOI 10.1523/JNEUROSCI.3138-10.2011; YARINSKY D, 1995, PAIN, V60, P329; Zhou XY, 2009, PSYCHOL SCI, V20, P700, DOI 10.1111/j.1467-9280.2009.02353.x	40	25	26	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26008	10.1371/journal.pone.0026008	http://dx.doi.org/10.1371/journal.pone.0026008			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834PW	22022492	gold, Green Published, Green Submitted			2022-12-27	WOS:000295976000053
J	Schroepfer, KK; Rosati, AG; Chartrand, T; Hare, B				Schroepfer, Kara K.; Rosati, Alexandra G.; Chartrand, Tanya; Hare, Brian			Use of "Entertainment" Chimpanzees in Commercials Distorts Public Perception Regarding Their Conservation Status	PLOS ONE			English	Article							WILLINGNESS-TO-PAY; ATTITUDES; KNOWLEDGE; WILDLIFE	Chimpanzees (Pan troglodytes) are often used in movies, commercials and print advertisements with the intention of eliciting a humorous response from audiences. The portrayal of chimpanzees in unnatural, human-like situations may have a negative effect on the public's understanding of their endangered status in the wild while making them appear as suitable pets. Alternatively, media content that elicits a positive emotional response toward chimpanzees may increase the public's commitment to chimpanzee conservation. To test these competing hypotheses, participants (n = 165) watched a series of commercials in an experiment framed as a marketing study. Imbedded within the same series of commercials was one of three chimpanzee videos. Participants either watched 1) a chimpanzee conservation commercial, 2) commercials containing "entertainment" chimpanzees or 3) control footage of the natural behavior of wild chimpanzees. Results from a post-viewing questionnaire reveal that participants who watched the conservation message understood that chimpanzees were endangered and unsuitable as pets at higher levels than those viewing the control footage. Meanwhile participants watching commercials with entertainment chimpanzees showed a decrease in understanding relative to those watching the control footage. In addition, when participants were given the opportunity to donate part of their earnings from the experiment to a conservation charity, donations were least frequent in the group watching commercials with entertainment chimpanzees. Control questions show that participants did not detect the purpose of the study. These results firmly support the hypothesis that use of entertainment chimpanzees in the popular media negatively distorts the public's perception and hinders chimpanzee conservation efforts.	[Schroepfer, Kara K.; Rosati, Alexandra G.; Hare, Brian] Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27710 USA; [Rosati, Alexandra G.; Hare, Brian] Duke Univ, Ctr Cognit Neurosci, Durham, NC USA; [Chartrand, Tanya] Duke Univ, Fuqua Sch Business, Durham, NC 27706 USA; [Chartrand, Tanya] Duke Univ, Dept Psychol & Neurosci, Durham, NC USA	Duke University; Duke University; Duke University; Duke University	Schroepfer, KK (corresponding author), Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27710 USA.	k.schroepfer@duke.edu		Rosati, Alexandra/0000-0002-6906-7807	European Research Commission [233297]; National Science Foundation [NSF-BCS-27552, NSF-BCS-25172]	European Research Commission(European CommissionEuropean Commission Joint Research Centre); National Science Foundation(National Science Foundation (NSF))	This work was supported in part by European Research Commission Advanced Grant Agreement 233297 and by National Science Foundation grant NSF-BCS-27552 and NSF-BCS-25172 to BH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre C, 2008, DEV PRIMATOL-PROG PR, P303, DOI 10.1007/978-0-387-74787-3_16; Bargh J. A., 2000, HDB RES METHODS SOCI, P253; Brent Linda, 2001, Special Topics in Primatology, V2, P1; CARTER J, 2003, STATUS SURVEY CONSER, P157; *CHIMP COLL, 2000, SERV LIF SENT YOUR V; Farmer KH, 2002, AM J PRIMATOL, V58, P117, DOI 10.1002/ajp.10054; Feinberg M, 2011, PSYCHOL SCI, V22, P34, DOI 10.1177/0956797610391911; Gunnthorsdottir A, 2001, ANTHROZOOS, V14, P204, DOI 10.2752/089279301786999355; Kabasawa Asami, 2009, African Study Monographs, V30, P37; Kellert S.R., 1986, P50; KELLERT SR, 1987, WILDLIFE SOC B, V15, P363; Liska J, 1999, ANTHROZOOS, V12, P88, DOI 10.2752/089279399787000372; Lukas KE., 2005, J ENVIRON EDUC, V36, P33; Martin-Lopez B, 2008, CONSERV BIOL, V22, P624, DOI 10.1111/j.1523-1739.2008.00921.x; Martin-Lopez B, 2007, BIOL CONSERV, V139, P67, DOI 10.1016/j.biocon.2007.06.005; Milinski M, 2002, P ROY SOC B-BIOL SCI, V269, P881, DOI 10.1098/rspb.2002.1964; Oates JF, 2008, PAN TROGLODYTES IUCN; Ojea E, 2007, ECOL ECON, V63, P807, DOI 10.1016/j.ecolecon.2007.02.003; PALMER C, 2010, SHOOTING WILD; PLOUS S, 1993, J SOC ISSUES, V49, P11, DOI 10.1111/j.1540-4560.1993.tb00907.x; ROSS S, 2010, CHIMPCARE; Ross SR, 2008, SCIENCE, V319, P1487, DOI 10.1126/science.1154490; Ross SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022050; Soulsbury CD, 2009, J APPL ANIM WELF SCI, V12, P1, DOI 10.1080/10888700802536483; Tankersley D, 2007, NAT NEUROSCI, V10, P150, DOI 10.1038/nn1833; Taylor N, 2009, ANTHROZOOS, V22, P129, DOI 10.2752/175303709X434158; Teel TL, 2010, CONSERV BIOL, V24, P128, DOI 10.1111/j.1523-1739.2009.01374.x; Tisdell C, 2007, ECOL ECON, V60, P627, DOI 10.1016/j.ecolecon.2006.01.007; Tisdell C, 2006, ECOL MODEL, V198, P515, DOI 10.1016/j.ecolmodel.2006.04.021; VANNORMAN J, 2011, FED REGISTER, V76, P54423; Yen ST, 1997, J AGR RESOUR ECON, V22, P246	31	39	39	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26048	10.1371/journal.pone.0026048	http://dx.doi.org/10.1371/journal.pone.0026048			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834PW	22022503	Green Published, gold, Green Submitted			2022-12-27	WOS:000295976000060
J	Gao, F; Luo, YL; Li, ST; Li, J; Lin, L; Nielsen, AL; Sorensen, CB; Vajta, G; Wang, J; Zhang, XQ; Du, YT; Yang, HM; Bolund, L				Gao, Fei; Luo, Yonglun; Li, Shengting; Li, Jian; Lin, Lin; Nielsen, Anders Lade; Sorensen, Charlotte Brandt; Vajta, Gabor; Wang, Jun; Zhang, Xiuqing; Du, Yutao; Yang, Huanming; Bolund, Lars			Comparison of Gene Expression and Genome-Wide DNA Methylation Profiling between Phenotypically Normal Cloned Pigs and Conventionally Bred Controls	PLOS ONE			English	Article							CELL NUCLEAR-TRANSFER; PREIMPLANTATION DEVELOPMENT; IMPRINTED GENES; IN-VITRO; EMBRYOS; TRANSCRIPTION; BLASTOCYSTS; CLONING; STEM	Animal breeding via Somatic Cell Nuclear Transfer (SCNT) has enormous potential in agriculture and biomedicine. However, concerns about whether SCNT animals are as healthy or epigenetically normal as conventionally bred ones are raised as the efficiency of cloning by SCNT is much lower than natural breeding or In-vitro fertilization (IVF). Thus, we have conducted a genome-wide gene expression and DNA methylation profiling between phenotypically normal cloned pigs and control pigs in two tissues (muscle and liver), using Affymetrix Porcine expression array as well as modified methylation-specific digital karyotyping (MMSDK) and Solexa sequencing technology. Typical tissue-specific differences with respect to both gene expression and DNA methylation were observed in muscle and liver from cloned as well as control pigs. Gene expression profiles were highly similar between cloned pigs and controls, though a small set of genes showed altered expression. Cloned pigs presented a more different pattern of DNA methylation in unique sequences in both tissues. Especially a small set of genomic sites had different DNA methylation status with a trend towards slightly increased methylation levels in cloned pigs. Molecular network analysis of the genes that contained such differential methylation loci revealed a significant network related to tissue development. In conclusion, our study showed that phenotypically normal cloned pigs were highly similar with normal breeding pigs in their gene expression, but moderate alteration in DNA methylation aspects still exists, especially in certain unique genomic regions.	[Gao, Fei; Luo, Yonglun; Li, Shengting; Li, Jian; Lin, Lin; Nielsen, Anders Lade; Sorensen, Charlotte Brandt; Bolund, Lars] Aarhus Univ, Dept Biomed, Aarhus C, Denmark; [Lin, Lin; Vajta, Gabor] Aarhus Univ, Dept Anim Sci, Tjele, Denmark; [Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Wang, Jun; Zhang, Xiuqing; Du, Yutao; Yang, Huanming; Bolund, Lars] BGI Huada, Shenzhen, Guangdong, Peoples R China	Aarhus University; Aarhus University; University of Copenhagen	Gao, F (corresponding author), Aarhus Univ, Dept Biomed, Aarhus C, Denmark.	gaofei@humgen.au.dk	Luo, Yonglun/C-4708-2013; Luo, Yonglun/AAG-9253-2020; Vajta, Gabor/I-3672-2016; Nielsen, Anders Lade L/Q-9604-2016; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Luo, Yonglun/0000-0002-0007-7759; Nielsen, Anders Lade L/0000-0003-4372-9961; Lin, Lin/0000-0002-7546-4948; Wang, Jun/0000-0002-2113-5874; Wang, Jun/0000-0002-8540-8931; Sorensen, Charlotte Brandt/0000-0002-4469-8696	Danish "Hojteknologifonden" (HTF, "Pigs and Health"); NovoNordisk Foundation; Danish Research Council FSS	Danish "Hojteknologifonden" (HTF, "Pigs and Health"); NovoNordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Research Council FSS(Det Frie Forskningsrad (DFF)Danish Medical Research Council)	This study was supported by grants from the Danish "Hojteknologifonden" (HTF, "Pigs and Health"), NovoNordisk Foundation and the Danish Research Council FSS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arney KL, 2004, J CELL SCI, V117, P4355, DOI 10.1242/jcs.01390; Beyhan Z, 2007, DEV BIOL, V305, P637, DOI 10.1016/j.ydbio.2007.01.041; Bonk AJ, 2008, MOL REPROD DEV, V75, P250, DOI 10.1002/mrd.20786; Cai L, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r51; Cho SK, 2007, DEV DYNAM, V236, P3369, DOI 10.1002/dvdy.21308; Cibelli JB, 2002, NAT BIOTECHNOL, V20, P13, DOI 10.1038/nbt0102-13; Dinnyes A, 2008, REPROD DOMEST ANIM, V43, P302, DOI 10.1111/j.1439-0531.2008.01178.x; Du YT, 2008, CLONING STEM CELLS, V10, P325, DOI 10.1089/clo.2007.0089; Du YT, 2007, CLONING STEM CELLS, V9, P469, DOI 10.1089/clo.2007.0037; Everts RE, 2008, PHYSIOL GENOMICS, V33, P65, DOI 10.1152/physiolgenomics.00223.2007; Farin PW, 2006, THERIOGENOLOGY, V65, P178, DOI 10.1016/j.theriogenology.2005.09.022; Flori L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-123; Hall VJ, 2005, MOL REPROD DEV, V72, P16, DOI 10.1002/mrd.20337; Han DW, 2008, MOL REPROD DEV, V75, P777, DOI 10.1002/mrd.20802; Hemberger M, 2009, NAT REV MOL CELL BIO, V10, P526, DOI 10.1038/nrm2727; Hollborn M, 2008, INVEST OPHTH VIS SCI, V49, P1262, DOI 10.1167/iovs.07-0879; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jiang L, 2007, CLONING STEM CELLS, V9, P97, DOI 10.1089/clo.2006.0041; Kang YK, 2001, J BIOL CHEM, V276, P39980, DOI 10.1074/jbc.M106516200; Kim SH, 2004, BIOCHEM BIOPH RES CO, V324, P58, DOI 10.1016/j.bbrc.2004.09.023; Kragh PM, 2004, REPROD FERT DEVELOP, V16, P315, DOI 10.1071/RD04007; Li J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-223; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Ohgane J, 2001, GENESIS, V30, P45, DOI 10.1002/gene.1031; Park SH, 2003, ZYGOTE, V11, P355, DOI 10.1017/S0967199403002454; Ponger L, 2002, BIOINFORMATICS, V18, P631, DOI 10.1093/bioinformatics/18.4.631; Prokhortchouk E, 2008, BBA-MOL CELL RES, V1783, P2167, DOI 10.1016/j.bbamcr.2008.07.015; Quilter CR, 2008, AM J MED GENET B; Schmidt M, 2010, THERIOGENOLOGY, V74, P1233, DOI 10.1016/j.theriogenology.2010.05.026; Shiota K, 2002, GENES CELLS, V7, P961, DOI 10.1046/j.1365-2443.2002.00574.x; Smit A, 1996, REPEATMASKER OPEN 30; Smith SL, 2005, P NATL ACAD SCI USA, V102, P17582, DOI 10.1073/pnas.0508952102; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tsai S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-328; Vassena R, 2007, DEV BIOL, V304, P75, DOI 10.1016/j.ydbio.2006.12.015; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Wilmut I, 2002, NATURE, V419, P583, DOI 10.1038/nature01079; Yang XZ, 2007, NAT GENET, V39, P295, DOI 10.1038/ng1973; Yoav Benjamini, 2001, Behavioural Brain Research, V125, P279, DOI 10.1016/S0166-4328(01)00297-2	41	17	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e25901	10.1371/journal.pone.0025901	http://dx.doi.org/10.1371/journal.pone.0025901			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022462	Green Published, Green Submitted, gold			2022-12-27	WOS:000295973200018
J	Parsons, CE; Young, KS; Parsons, E; Dean, A; Murray, L; Goodacre, T; Dalton, L; Stein, A; Kringelbach, ML				Parsons, Christine E.; Young, Katherine S.; Parsons, Emma; Dean, Annika; Murray, Lynne; Goodacre, Tim; Dalton, Louise; Stein, Alan; Kringelbach, Morten L.			The Effect of Cleft Lip on Adults' Responses to Faces: Cross-Species Findings	PLOS ONE			English	Article							INFANT; PALATE; ATTRACTIVENESS; APPEARANCE; BEHAVIOR; REPAIR; GENDER; YOUNG	Cleft lip and palate is the most common of the congenital conditions affecting the face and cranial bones and is associated with a raised risk of difficulties in infant- caregiver interaction; the reasons for such difficulties are not fully understood. Here, we report two experiments designed to explore how adults respond to infant faces with and without cleft lip, using behavioural measures of attractiveness appraisal ('liking') and willingness to work to view or remove the images ('wanting'). We found that infants with cleft lip were rated as less attractive and were viewed for shorter durations than healthy infants, an effect that was particularly apparent where the cleft lip was severe. Women rated the infant faces as more attractive than men did, but there were no differences in men and women's viewing times of these faces. In a second experiment, we found that the presence of a cleft lip in domestic animals affected adults' 'liking' and 'wanting' responses in a comparable way to that seen for human infants. Adults' responses were also remarkably similar for images of infants and animals with cleft lip, although no gender difference in attractiveness ratings or viewing times emerged for animals. We suggest that the presence of a cleft lip can substantially change the way in which adults respond to human and animal faces. Furthermore, women may respond in different ways to men when asked to appraise infant attractiveness, despite the fact that men and women 'want' to view images of infants for similar durations.	[Parsons, Christine E.; Young, Katherine S.; Parsons, Emma; Dean, Annika; Stein, Alan; Kringelbach, Morten L.] Univ Oxford, Dept Psychiat, Oxford, England; [Parsons, Christine E.; Young, Katherine S.; Kringelbach, Morten L.] Aarhus Univ, Ctr Funct Integrat Neurosci, Aarhus, Denmark; [Parsons, Emma; Dean, Annika] Univ Bath, Dept Psychol, Bath BA2 7AY, Avon, England; [Murray, Lynne] Univ Reading, Sch Psychol & Clin Language Sci, Reading, Berks, England; [Goodacre, Tim; Dalton, Louise] John Radcliffe Hosp, Spires Cleft Ctr, Oxford OX3 9DU, England	University of Oxford; Aarhus University; University of Bath; University of Reading; University of Oxford	Parsons, CE (corresponding author), Univ Oxford, Dept Psychiat, Oxford, England.	Morten.Kringelbach@queens.ox.ac.uk	Parsons, Christine/V-3571-2019; Kringelbach, Morten/AAW-5847-2021; Kringelbach, Morten L/AAF-5508-2020; Goodacre, Timothy/AAY-7888-2020; Parsons, Christine/G-9286-2016; Young, Katherine/O-9198-2017	Parsons, Christine/0000-0003-2856-6308; Kringelbach, Morten/0000-0002-3908-6898; Goodacre, Timothy/0000-0001-6812-2934; Parsons, Christine/0000-0003-2856-6308; Young, Katherine/0000-0002-1378-6415; Stein, Alan/0000-0001-8207-2822; Dalton, Louise/0000-0003-1923-5769	Wellcome Trust UK [017571]; TrygFonden Charitable Foundation; Medical Research Council	Wellcome Trust UK(Wellcome Trust); TrygFonden Charitable Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported by funding from the Wellcome Trust, UK (017571), the TrygFonden Charitable Foundation, and the Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; BERMAN PW, 1980, PSYCHOL BULL, V88, P668, DOI 10.1037/0033-2909.88.3.668; BOUKYDIS CFZ, 1982, CHILD DEV, V53, P1291, DOI 10.2307/1129019; Dai XC, 2010, EMOTION, V10, P324, DOI 10.1037/a0017987; Elman I, 2005, PSYCHIAT RES, V135, P179, DOI 10.1016/j.psychres.2005.04.002; FIELD TM, 1984, INFANT BEHAV DEV, V7, P527, DOI 10.1016/S0163-6383(84)80012-0; Goodacre T, 2008, PAEDIAT CHILD HLTH, V18, P283, DOI DOI 10.1016/J.PAED.2008.03.008; Goodacre TEE, 2004, CLEFT PALATE-CRAN J, V41, P603, DOI 10.1597/03-028.1; HUTT C, 1972, HUM DEV, V15, P153, DOI 10.1159/000271239; KOOMEN HMY, 1993, J CHILD PSYCHOL PSYC, V34, P917, DOI 10.1111/j.1469-7610.1993.tb01098.x; Kringelbach ML, 2003, CEREB CORTEX, V13, P1064, DOI 10.1093/cercor/13.10.1064; Kringelbach ML, 2009, TRENDS COGN SCI, V13, P479, DOI 10.1016/j.tics.2009.08.006; Kringelbach ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001664; Levy B, 2008, LEARN MOTIV, V39, P136, DOI 10.1016/j.lmot.2007.09.002; Marcusson A, 2002, SCAND J PLAST RECONS, V36, P16, DOI 10.1080/028443102753478327; Murray L, 2008, J CHILD PSYCHOL PSYC, V49, P115, DOI 10.1111/j.1469-7610.2007.01833.x; Parsons CE, 2010, PROG NEUROBIOL, V91, P220, DOI 10.1016/j.pneurobio.2010.03.001; Parsons CE, 2011, PLOS ONE, V6; RICHMAN LC, 1985, CLEFT PALATE J, V22, P93; Seifritz E, 2003, BIOL PSYCHIAT, V54, P1367, DOI 10.1016/S0006-3223(03)00697-8; SPELTZ ML, 1994, INFANT BEHAV DEV, V17, P131, DOI 10.1016/0163-6383(94)90048-5; Sprengelmeyer R, 2009, PSYCHOL SCI, V20, P149, DOI 10.1111/j.1467-9280.2009.02272.x; STARR P, 1982, PSYCHOL REP, V50, P467, DOI 10.2466/pr0.1982.50.2.467; Yamamoto R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006042	24	26	26	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25897	10.1371/journal.pone.0025897	http://dx.doi.org/10.1371/journal.pone.0025897			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834OO	22016785	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000295971700023
J	Bucardo, F; Lindgren, PE; Svensson, L; Nordgren, J				Bucardo, Filemon; Lindgren, Per-Eric; Svensson, Lennart; Nordgren, Johan			Low Prevalence of Rotavirus and High Prevalence of Norovirus in Hospital and Community Wastewater after Introduction of Rotavirus Vaccine in Nicaragua	PLOS ONE			English	Article							ENTERIC VIRUSES; MOLECULAR CHARACTERIZATION; GENETIC DIVERSITY; SURFACE WATERS; SEWAGE SAMPLES; GENOGROUP-I; RT-PCR; GENOTYPES; CHILDREN; POPULATION	Rotavirus (RV) and norovirus (NoV) are major causes of pediatric diarrhea and are altogether associated with approximately 800,000 deaths in young children every year. In Nicaragua, national RV vaccination program using the pentavalent RV5 vaccine from Merck was implemented in October 2006. To determine whether RV vaccination decreased the overall number of RV infections, we investigated the occurrence of RV and NoV in wastewater in the city of Leon from July 2007 to July 2008 and compared these data with pre-vaccination data. The major finding was the low prevalence of RV compared to NoV in all sampling points (11% vs 44%, p<0.05), and that RV concentration was lower as compared to NoV. RV was observed mainly during the rainy season (July-September), and the majority of all RV detected (6/9) belonged to subgroup (SG) I. The partial VP7-gene obtained from one RV positive sample was similar (99% nt identity) to a G6 VP7-gene of bovine origin and similar to the corresponding gene of the vaccine strain (98%). Furthermore RV G-types 2 and 4 were found in the incoming wastewater. NoV strains were detected throughout the year, of which a majority (20/21) were of genotype GII.4. We conclude that the introduction of RV vaccination reduced the transmission of RV in the community in Nicaragua. However, the burden of diarrhea in the country remains high, and the high prevalence of NoVs in hospital and municipal wastewater is noteworthy. This study highlights the need for further assessment of NoV following RV vaccine introduction.	[Bucardo, Filemon] Univ Leon, Dept Microbiol, Leon, Nicaragua; [Bucardo, Filemon; Svensson, Lennart; Nordgren, Johan] Linkoping Univ, Div Mol Virol, Dept Clin & Expt Med, Linkoping, Sweden; [Lindgren, Per-Eric] Linkoping Univ, Div Med Microbiol, Dept Clin & Expt Med, Linkoping, Sweden	Linkoping University; Linkoping University	Bucardo, F (corresponding author), Univ Leon, Dept Microbiol, Leon, Nicaragua.	johan.nordgren@liu.se	Bucardo, Filemon/AFK-4817-2022; svensson, lennart/K-6163-2019	Bucardo, Filemon/0000-0002-9819-870X; 	Swedish International Development Cooperation Agency [0.75007109]; Swedish Research Council [10392]; NETROPICA	Swedish International Development Cooperation Agency; Swedish Research Council(Swedish Research CouncilEuropean Commission); NETROPICA	The study was supported by grants from the Swedish International Development Cooperation Agency (http://www.sida.se/English/) (grant 0.75007109) and by the Swedish Research Council (http://www.vr.se/) (grant 10392). Dr. Bucardo received a travel grant from NETROPICA (http://www.netropica.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan F, 2010, VET MICROBIOL, V141, P231, DOI 10.1016/j.vetmic.2009.09.016; Arraj A, 2008, J WATER HEALTH, V6, P351, DOI 10.2166/wh.2008.053; Aw TG, 2009, APPL ENVIRON MICROB, V75, P4984, DOI 10.1128/AEM.00489-09; Banyai K, 2009, J CLIN VIROL, V46, P391, DOI 10.1016/j.jcv.2009.08.005; Barril PA, 2010, J MED VIROL, V82, P1277, DOI 10.1002/jmv.21800; Becker-Dreps S, 2011, PEDIATR INFECT DIS J, V30, P243, DOI 10.1097/INF.0b013e3181f87ffe; Boccia D, 2002, EMERG INFECT DIS, V8, P563, DOI 10.3201/eid0806.010371; Bohm S. R., 2007, Morbidity and Mortality Weekly Report, V56, P1212; Bourdett-Stanziola L, 2010, INTERVIROLOGY, V53, P390, DOI 10.1159/000317288; Bucardo F, 2008, J CLIN MICROBIOL, V46, P2573, DOI 10.1128/JCM.00505-08; Bucardo F, 2007, J CLIN MICROBIOL, V45, P990, DOI 10.1128/JCM.01992-06; Bucardo F, 2010, PEDIATR INFECT DIS J, V29, P934, DOI 10.1097/INF.0b013e3181ed9f2f; Cashman O, 2010, VET MICROBIOL, V146, P238, DOI 10.1016/j.vetmic.2010.05.012; da Silva AK, 2007, APPL ENVIRON MICROB, V73, P7891, DOI 10.1128/AEM.01428-07; Duclos P, 2011, EXPERT REV VACCINES, V10, P163, DOI [10.1586/erv.10.171, 10.1586/ERV.10.171]; Espinoza F, 2006, PEDIATR INFECT DIS J, V25, P1078, DOI 10.1097/01.inf.0000242739.44424.0e; Fumian TM, 2010, J VIROL METHODS, V170, P42, DOI 10.1016/j.jviromet.2010.08.017; Gallimore CI, 2007, ARCH VIROL, V152, P1295, DOI 10.1007/s00705-007-0954-9; Gomara MI, 2002, J VIROL, V76, P6596, DOI 10.1128/JVI.76.13.6596-6601.2002; Hamza IA, 2009, WATER RES, V43, P2657, DOI 10.1016/j.watres.2009.03.020; He XQ, 2011, WATER SCI TECHNOL, V63, P191, DOI 10.2166/wst.2011.032; Iturriza-Gomara M, 2004, J CLIN VIROL, V31, P259, DOI 10.1016/j.jcv.2004.04.009; Iwai M, 2009, APPL ENVIRON MICROB, V75, P1264, DOI 10.1128/AEM.01166-08; Kamel AH, 2010, J APPL MICROBIOL, V108, P1620, DOI 10.1111/j.1365-2672.2009.04562.x; Kitajima M, 2010, ENVIRON SCI TECHNOL, V44, P7116, DOI 10.1021/es100346a; Kojima S, 2002, J VIROL METHODS, V100, P107, DOI 10.1016/S0166-0934(01)00404-9; Kremer JR, 2011, CLIN MICROBIOL INFEC, V17, P1173, DOI 10.1111/j.1469-0691.2010.03407.x; Laverick MA, 2004, LETT APPL MICROBIOL, V39, P127, DOI 10.1111/j.1472-765X.2004.01534.x; Lodder WJ, 2005, APPL ENVIRON MICROB, V71, P1453, DOI 10.1128/AEM.71.3.1453-1461.2005; Lysen M, 2009, J CLIN MICROBIOL, V47, P2411, DOI 10.1128/JCM.02168-08; Mast TC, 2011, PEDIAT INFECT DIS J, V30; Matthijnssens J, 2010, VIROLOGY, V403, P111, DOI 10.1016/j.virol.2010.04.004; Matthijnssens J, 2009, FUTURE MICROBIOL, V4, P1303, DOI [10.2217/fmb.09.96, 10.2217/FMB.09.96]; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Myrmel M., 2006, Journal of Water and Health, V4, P197, DOI 10.2166/wh.2006.0016; Nordgren J, 2008, J CLIN MICROBIOL, V46, P164, DOI 10.1128/JCM.01316-07; Nordgren J, 2010, J CLIN MICROBIOL, V48, P1859, DOI 10.1128/JCM.02288-09; Nordgren J, 2010, EMERG INFECT DIS, V16, P81, DOI 10.3201/eid1601.090633; Nordgren J, 2009, WATER RES, V43, P1117, DOI 10.1016/j.watres.2008.11.053; Orozco Maribel, 2009, J Infect Dis, V200 Suppl 1, pS125, DOI 10.1086/605053; Parashar UD, 2006, EMERG INFECT DIS, V12, P304; Parashar UD, 2009, J INFECT DIS, V200, pS9, DOI 10.1086/605025; Patel M, 2009, JAMA-J AM MED ASSOC, V301, P2243, DOI 10.1001/jama.2009.756; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Payne DC, 2010, PEDIATRICS, V125, pE438, DOI 10.1542/peds.2009-1901; Prado T, 2011, WATER RES, V45, P1287, DOI 10.1016/j.watres.2010.10.012; Ramani S, 2010, J MED VIROL, V82, P1803, DOI 10.1002/jmv.21872; Sdiri-Loulizi K, 2010, J APPL MICROBIOL, V109, P1093, DOI 10.1111/j.1365-2672.2010.04772.x; Siebenga JJ, 2009, J INFECT DIS, V200, P802, DOI 10.1086/605127; Swedish Environmental Protection Agency, 2008, GUID SWED ENV PROT A; Tang BZ, 1997, VIROLOGY, V237, P89, DOI 10.1006/viro.1997.8762; Tate JE, 2009, PEDIATRICS, V124, P465, DOI 10.1542/peds.2008-3528; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; Yen C, 2011, VACCINE, V29, P4151, DOI 10.1016/j.vaccine.2011.03.074	54	33	33	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25962	10.1371/journal.pone.0025962	http://dx.doi.org/10.1371/journal.pone.0025962			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22016794	Green Published, gold, Green Submitted			2022-12-27	WOS:000295970300043
J	Cohen, JM; Khandavilli, S; Camberlein, E; Hyams, C; Baxendale, HE; Brown, JS				Cohen, Jonathan M.; Khandavilli, Suneeta; Camberlein, Emilie; Hyams, Catherine; Baxendale, Helen E.; Brown, Jeremy S.			Protective Contributions against Invasive Streptococcus pneumoniae Pneumonia of Antibody and Th17-Cell Responses to Nasopharyngeal Colonisation	PLOS ONE			English	Article							INDEPENDENT ACQUIRED-IMMUNITY; ABC TRANSPORTER; DISEASE; CELLS; PNEUMOCOCCI; ESTABLISHMENT; PHAGOCYTOSIS; VACCINATION; BURDEN; INNATE	The nasopharyngeal commensal bacteria Streptococcus pneumoniae is also a frequent cause of serious infections. Nasopharyngeal colonisation with S. pneumoniae inhibits subsequent re-colonisation by inducing Th17-cell adaptive responses, whereas vaccination prevents invasive infections by inducing antibodies to S. pneumoniae capsular polysaccharides. In contrast, protection against invasive infection after nasopharyngeal colonisation with mutant S. pneumoniae strains was associated with antibody responses to protein antigens. The role of colonisation-induced Th17-cell responses during subsequent invasive infections is unknown. Using mouse models, we show that previous colonisation with S. pneumoniae protects against subsequent lethal pneumonia mainly by preventing bacteraemia with a more modest effect on local control of infection within the lung. Previous colonisation resulted in CD4-dependent increased levels of Th17-cell cytokines during subsequent infectious challenge. However, mice depleted of CD4 cells prior to challenge remained protected against bacteraemia, whereas no protection was seen in antibody deficient mice and similar protection could be achieved through passive transfer of serum. Serum from colonised mice but not antibody deficient mice promoted phagocytosis of S. pneumoniae, and previously colonised mice were able to rapidly clear S. pneumoniae from the blood after intravenous inoculation. Thus, despite priming for a Th17-cell response during subsequent infection, the protective effects of prior colonisation in this model was not dependent on CD4 cells but on rapid clearance of bacteria from the blood by antibody-mediated phagocytosis. These data suggest that whilst nasopharyngeal colonisation induces a range of immune responses, the effective protective responses depend upon the site of subsequent infection.	[Cohen, Jonathan M.; Khandavilli, Suneeta; Camberlein, Emilie; Hyams, Catherine; Brown, Jeremy S.] UCL, Dept Med, Ctr Resp Res, London, England; [Cohen, Jonathan M.; Baxendale, Helen E.] UCL, Inst Child Hlth, Infect Dis & Microbiol Unit, London, England; [Baxendale, Helen E.] UCL, Dept Immunol, London, England	University of London; University College London; University of London; University College London; University of London; University College London	Cohen, JM (corresponding author), UCL, Dept Med, Ctr Resp Res, London, England.	jeremy.brown@ucl.ac.uk	Cohen, Jonathan/C-4588-2008; Hyams, Catherine/AAH-1721-2019	Cohen, Jonathan/0000-0002-3966-3640; Hyams, Catherine/0000-0003-3923-1773; Brown, Jeremy/0000-0002-5650-5361; Cohen, Jonathan/0000-0003-1004-5598	Department of Health's National Institute for Health Research Biomedical Research Centre; Medical Research Council [G0700829, G0600410]; Astor Foundation; GlaxoSmithKline; MRC [G0600410, G0700829] Funding Source: UKRI	Department of Health's National Institute for Health Research Biomedical Research Centre(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Astor Foundation; GlaxoSmithKline(GlaxoSmithKline); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was undertaken at University College London Hospitals and University College London (UCL) which received a proportion of funding from the Department of Health's National Institute for Health Research Biomedical Research Centre's funding scheme. JMC was supported by a Clinical Research Training Fellowship from the Medical Research Council (G0700829). EC was supported by the Medical Research Council (grant G0600410). CH was supported by the Astor Foundation and with an unrestricted educational grant from GlaxoSmithKline towards the UCL MBPhD program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arredouani MS, 2006, AM J RESP CELL MOL, V35, P474, DOI 10.1165/rcmb.2006-0128OC; Basavanna S, 2009, INFECT IMMUN, V77, P3412, DOI 10.1128/IAI.01543-08; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Brown JS, 2001, MOL MICROBIOL, V40, P572, DOI 10.1046/j.1365-2958.2001.02414.x; Fedson DS, 1999, VACCINE, V17, pS11, DOI 10.1016/S0264-410X(99)00122-X; Granat SM, 2009, J INFECT DIS, V200, P99, DOI 10.1086/599364; Higgins SC, 2006, J IMMUNOL, V177, P7980, DOI 10.4049/jimmunol.177.11.7980; HOLDSWORTH RJ, 1989, BRIT J EXP PATHOL, V70, P669; Hussell T, 2009, BIOCHEM SOC T, V37, P811, DOI 10.1042/BST0370811; Hyams C, 2010, INFECT IMMUN, V78, P704, DOI 10.1128/IAI.00881-09; Jackson LA, 2008, CLIN INFECT DIS, V47, P1328, DOI 10.1086/592691; Khader SA, 2009, MUCOSAL IMMUNOL, V2, P403, DOI 10.1038/mi.2009.100; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kirby AC, 2007, EUR J IMMUNOL, V37, P3404, DOI 10.1002/eji.200737216; LeMessurier K, 2010, INFECT IMMUN, V78, P5287, DOI 10.1128/IAI.00431-10; Lipsitch M, 2005, PLOS MED, V2, P62, DOI 10.1371/journal.pmed.0020015; Lu YJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000159; Malley R, 2005, P NATL ACAD SCI USA, V102, P4848, DOI 10.1073/pnas.0501254102; McCool TL, 2003, INFECT IMMUN, V71, P5724, DOI 10.1128/IAI.71.10.5724-5732.2003; Morona JK, 2004, J INFECT DIS, V189, P1905, DOI 10.1086/383352; MUSHER DM, 1993, CLIN INFECT DIS, V17, P66, DOI 10.1093/clinids/17.1.66; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Richards L, 2010, IMMUNOBIOLOGY, V215, P251, DOI 10.1016/j.imbio.2009.12.004; Roche AM, 2007, INFECT IMMUN, V75, P2469, DOI 10.1128/IAI.01972-06; Roche AM, 2010, INFECT IMMUN, V78, P2231, DOI 10.1128/IAI.01058-09; Trotter CL, 2010, J INFECTION, V60, P200, DOI 10.1016/j.jinf.2009.12.008; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; Weber SE, 2011, J IMMUNOL, V186, P432, DOI 10.4049/jimmunol.1001963; Wu HY, 1997, MICROB PATHOGENESIS, V23, P127, DOI 10.1006/mpat.1997.0142; Yuste J, 2007, PLOS PATHOG, V3, P1208, DOI 10.1371/journal.ppat.0030120; Yuste J, 2008, INFECT IMMUN, V76, P3761, DOI 10.1128/IAI.00291-08; Zhang QB, 2007, J INFECT DIS, V195, P1194, DOI 10.1086/512617; Zhang Z, 2009, J CLIN INVEST, V119, P1899, DOI 10.1172/JCI36731	33	64	66	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25558	10.1371/journal.pone.0025558	http://dx.doi.org/10.1371/journal.pone.0025558			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003400	Green Published, Green Submitted, gold			2022-12-27	WOS:000295970300021
J	Sedegah, M; Tamminga, C; McGrath, S; House, B; Ganeshan, H; Lejano, J; Abot, E; Banania, GJ; Sayo, R; Farooq, F; Belmonte, M; Manohar, N; Richie, NO; Wood, C; Long, CA; Regis, D; Williams, FT; Shi, M; Chuang, I; Spring, M; Epstein, JE; Mendoza-Silveiras, J; Limbach, K; Patterson, NB; Bruder, JT; Doolan, DL; King, CR; Soisson, L; Diggs, C; Carucci, D; Dutta, S; Hollingdale, MR; Ockenhouse, CF; Richie, TL				Sedegah, Martha; Tamminga, Cindy; McGrath, Shannon; House, Brent; Ganeshan, Harini; Lejano, Jennylynn; Abot, Esteban; Banania, Glenna J.; Sayo, Renato; Farooq, Fouzia; Belmonte, Maria; Manohar, Nalini; Richie, Nancy O.; Wood, Chloe; Long, Carole A.; Regis, David; Williams, Francis T.; Shi, Meng; Chuang, Ilin; Spring, Michele; Epstein, Judith E.; Mendoza-Silveiras, Jose; Limbach, Keith; Patterson, Noelle B.; Bruder, Joseph T.; Doolan, Denise L.; King, C. Richter; Soisson, Lorraine; Diggs, Carter; Carucci, Daniel; Dutta, Sheetij; Hollingdale, Michael R.; Ockenhouse, Christian F.; Richie, Thomas L.			Adenovirus 5-Vectored P. falciparum Vaccine Expressing CSP and AMA1. Part A: Safety and Immunogenicity in Seronegative Adults	PLOS ONE			English	Article							APICAL MEMBRANE ANTIGEN-1; T-CELL EPITOPES; CANDIDATE MALARIA VACCINE; PLASMODIUM-BERGHEI SPOROZOITES; NATURAL IMMUNE-RESPONSES; PRIME-BOOST REGIMENS; PHASE I/IIA SAFETY; CIRCUMSPOROZOITE PROTEIN; PROTECTIVE IMMUNITY; VIRAL VECTORS	Background: Models of immunity to malaria indicate the importance of CD8+ T cell responses for targeting intrahepatic stages and antibodies for targeting sporozoite and blood stages. We designed a multistage adenovirus 5 (Ad5)-vectored Plasmodium falciparum malaria vaccine, aiming to induce both types of responses in humans, that was tested for safety and immunogenicity in a Phase 1 dose escalation trial in Ad5-seronegative volunteers. Methodology/Principal Findings: The NMRC-M3V-Ad-PfCA vaccine combines two adenovectors encoding circumsporozoite protein (CSP) and apical membrane antigen-1 (AMA1). Group 1 (n = 6) healthy volunteers received one intramuscular injection of 2x10(boolean AND) 10 particle units (1610(boolean AND) 10 each construct) and Group 2 (n = 6) a five-fold higher dose. Transient, mild to moderate adverse events were more pronounced with the higher dose. ELISpot responses to CSP and AMA1 peaked at 1 month, were higher in the low dose (geomean CSP = 422, AMA1 = 862 spot forming cells/million) than in the high dose (CSP = 154, p = 0.049, AMA1 = 423, p = 0.045) group and were still positive at 12 months in a number of volunteers. ELISpot depletion assays identified dependence on CD4+ or on both CD4+ and CD8+ T cells, with few responses dependent only on CD8+ T cells. Intracellular cytokine staining detected stronger CD8+ than CD4+ T cell IFN-gamma responses (CSP p = 0.0001, AMA1 p = 0.003), but similar frequencies of multifunctional CD4+ and CD8+ T cells secreting two or more of IFN-gamma, TNF-alpha or IL-2. Median fluorescence intensities were 7-10 fold higher in triple than single secreting cells. Antibody responses were low but trended higher in the high dose group and did not inhibit growth of cultured P. falciparum blood stage parasites. Significance: As found in other trials, adenovectored vaccines appeared safe and well-tolerated at doses up to 1x10(boolean AND) 11 particle units. This is the first demonstration in humans of a malaria vaccine eliciting strong CD8+ T cell IFN-gamma responses.	[Sedegah, Martha; Tamminga, Cindy; House, Brent; Ganeshan, Harini; Lejano, Jennylynn; Abot, Esteban; Banania, Glenna J.; Sayo, Renato; Farooq, Fouzia; Belmonte, Maria; Manohar, Nalini; Regis, David; Chuang, Ilin; Epstein, Judith E.; Mendoza-Silveiras, Jose; Limbach, Keith; Patterson, Noelle B.; Doolan, Denise L.; Carucci, Daniel; Richie, Thomas L.] USN, Med Res Ctr, US Mil Malaria Vaccine Program, Silver Spring, MD USA; [McGrath, Shannon; Richie, Nancy O.; Wood, Chloe; Spring, Michele; Dutta, Sheetij; Ockenhouse, Christian F.] Walter Reed Army Inst Res, US Mil Malaria Vaccine Program, Silver Spring, MD USA; [McGrath, Shannon; Richie, Nancy O.; Wood, Chloe; Dutta, Sheetij] Clin Res Management, Hinckley, OH USA; [Ganeshan, Harini; Lejano, Jennylynn; Abot, Esteban; Banania, Glenna J.; Sayo, Renato; Farooq, Fouzia; Belmonte, Maria; Manohar, Nalini; Spring, Michele; Mendoza-Silveiras, Jose; Limbach, Keith; Patterson, Noelle B.] Henry M Jackson Fdn Adv Mil Med, Rockville, MD USA; [Long, Carole A.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA; [Williams, Francis T.] Natl Naval Med Ctr, Bethesda, MD USA; [Shi, Meng] Walter Reed Army Inst Res, Div Med Audio Visual Lib & Stat Serv, Silver Spring, MD USA; [Shi, Meng] Allied Technol Grp Inc, Rockville, MD USA; [Bruder, Joseph T.; King, C. Richter] GenVec Inc, Gaithersburg, MD USA; [Soisson, Lorraine; Diggs, Carter] USAID, Washington, DC USA; [Hollingdale, Michael R.] NMRC, Malaria Dept, USMMVP, Silver Spring, MD USA	United States Department of Defense; United States Navy; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Walter Reed National Military Medical Center; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); United States Agency for International Development (USAID); Naval Medical Research Center (NMRC)	Sedegah, M (corresponding author), USN, Med Res Ctr, US Mil Malaria Vaccine Program, Silver Spring, MD USA.	Martha.Sedegah@med.navy.mil	Doolan, Denise L/F-1969-2015; Belmonte, Maria/A-8032-2011	Doolan, Denise/0000-0001-7354-8817; Richie, Thomas/0000-0002-2946-5456; Farooq, Fouzia/0000-0001-6491-6323	Pfizer Australia; Congressionally Directed Medical Research Program [W81XWH-05-2-0041]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001020] Funding Source: NIH RePORTER	Pfizer Australia(PfizerPfizer Australia); Congressionally Directed Medical Research Program(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	SM NOR CW worked for Clinical Research Management and performed some of the experiments, JTB CRK worked for GenVec and helped design the vaccine. DLD held a Pfizer Australia Senior Research Fellowship and helped design the vaccine. The following funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript: Congressionally Directed Medical Research Program "Development of Recombinant Adenoviral-based Vaccines against Malaria'' Grant #: W81XWH-05-2-0041. Website:https://cdmrp.org. Military Infectious ResearcCongressionally Directed Medical Research Programh Program "Phase 1/2a clinical trials assessing the safety, tolerability, immunogenicity & protective efficacy of Ad5-CA, a two-antigen, adenovirus-vectored Plasmodium falciparum malaria vaccine, in healthy, malaria-naive adults'', work unit. Website: https://midrp.amedd.army.mil.	Aponte JJ, 2007, LANCET, V370, P1543, DOI 10.1016/S0140-6736(07)61542-6; Barouch DH, 2004, J IMMUNOL, V172, P6290, DOI 10.4049/jimmunol.172.10.6290; Beeson JG, 2008, TRENDS PARASITOL, V24, P578, DOI 10.1016/j.pt.2008.08.008; Bergmann-Leitner ES, 2006, AM J TROP MED HYG, V75, P437, DOI 10.4269/ajtmh.2006.75.437; BLUMTIROUVANZIAM U, 1995, J IMMUNOL, V154, P3922; Bojang KA, 2005, VACCINE, V23, P4148, DOI 10.1016/j.vaccine.2005.03.019; Bongfen SE, 2009, VACCINE, V27, P328, DOI 10.1016/j.vaccine.2008.09.097; Brough DE, 1996, J VIROL, V70, P6497, DOI 10.1128/JVI.70.9.6497-6501.1996; Bruder JT, 2010, VACCINE, V28, P3201, DOI 10.1016/j.vaccine.2010.02.024; Bruder JT, 2010, HUM VACCINES, V6, P54, DOI 10.4161/hv.6.1.10463; Bruna-Romero O, 2004, VACCINE, V22, P3575, DOI 10.1016/j.vaccine.2004.03.050; CHAROENVIT Y, 1991, J IMMUNOL, V146, P1020; Cheng C, 2007, PLOS PATHOG, V3, P239, DOI 10.1371/journal.ppat.0030025; CLYDE DF, 1975, AM J TROP MED HYG, V24, P397, DOI 10.4269/ajtmh.1975.24.397; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Doolan DL, 2000, J IMMUNOL, V165, P1123, DOI 10.4049/jimmunol.165.2.1123; Doolan DL, 2003, P NATL ACAD SCI USA, V100, P9952, DOI 10.1073/pnas.1633254100; Doolan DL, 1997, IMMUNITY, V7, P97, DOI 10.1016/S1074-7613(00)80513-0; Doolan DL, 2006, CURR MOL MED, V6, P169, DOI 10.2174/156652406776055249; Draper SJ, 2008, NAT MED, V14, P819, DOI 10.1038/nm.1850; Draper SJ, 2009, CELL HOST MICROBE, V5, P95, DOI 10.1016/j.chom.2008.12.004; EGAN JE, 1993, AM J TROP MED HYG, V49, P166, DOI 10.4269/ajtmh.1993.49.166; FANDEUR T, 1984, J IMMUNOL, V132, P432; Geiben-Lynn R, 2008, CLIN VACCINE IMMUNOL, V15, P691, DOI 10.1128/CVI.00418-07; GOOD MF, 1988, P NATL ACAD SCI USA, V85, P1199, DOI 10.1073/pnas.85.4.1199; Harro C, 2009, CLIN VACCINE IMMUNOL, V16, P1285, DOI 10.1128/CVI.00144-09; Harro CD, 2009, AIDS RES HUM RETROV, V25, P103, DOI 10.1089/aid.2008.0212; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; HOLLINGDALE MR, 1990, T ROY SOC TROP MED H, V84, P325, DOI 10.1016/0035-9203(90)90303-V; Huaman MC, 2009, VACCINE, V27, P5239, DOI 10.1016/j.vaccine.2009.06.066; Jiang G, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-135; Jobe O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005075; Kaufhold RM, 2005, J VIROL, V79, P5684, DOI 10.1128/JVI.79.9.5684-5694.2005; Kester KE, 2007, VACCINE, V25, P5359, DOI 10.1016/j.vaccine.2007.05.005; Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120; Koup RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009015; Kumar KA, 2006, NATURE, V444, P937, DOI 10.1038/nature05361; Lal AA, 1996, INFECT IMMUN, V64, P1054, DOI 10.1128/IAI.64.3.1054-1059.1996; Li SQ, 2007, VACCINE, V25, P2567, DOI 10.1016/j.vaccine.2006.07.035; Limbach KJ, 2009, PARASITE IMMUNOL, V31, P501, DOI 10.1111/j.1365-3024.2009.01141.x; Lindsay RW, J IMMUNOL, V185, P1513; Liu JY, 2008, J VIROL, V82, P4844, DOI 10.1128/JVI.02616-07; LOCKYER MJ, 1989, MOL BIOCHEM PARASIT, V37, P275, DOI 10.1016/0166-6851(89)90159-X; Lore K, 2007, J IMMUNOL, V179, P1721, DOI 10.4049/jimmunol.179.3.1721; Malkin EM, 2005, INFECT IMMUN, V73, P3677, DOI 10.1128/IAI.73.6.3677-3685.2005; Marsh K, 2006, PARASITE IMMUNOL, V28, P51, DOI 10.1111/j.1365-3024.2006.00808.x; Mettens P, 2008, VACCINE, V26, P1072, DOI 10.1016/j.vaccine.2007.12.018; Minigo G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000402; Moorthy VS, 2004, J INFECT DIS, V189, P2213, DOI 10.1086/421118; Nardin EH, 2001, J IMMUNOL, V166, P481, DOI 10.4049/jimmunol.166.1.481; NARUM DL, 1994, MOL BIOCHEM PARASIT, V67, P59, DOI 10.1016/0166-6851(94)90096-5; NETER J, 1996, APPL LINEAR STAT MET; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; Ockenhouse CF, 1998, J INFECT DIS, V177, P1664, DOI 10.1086/515331; Okitsu SL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001278; Oliveira GA, 2008, INFECT IMMUN, V76, P1200, DOI 10.1128/IAI.00566-07; Peduzzi E, 2008, CLIN IMMUNOL, V127, P188, DOI 10.1016/j.clim.2008.01.012; Pierce MA, 2010, VACCINE, V28, P2236, DOI 10.1016/j.vaccine.2009.12.049; Polley SD, 2004, VACCINE, V23, P718, DOI 10.1016/j.vaccine.2004.05.031; Priddy FH, 2008, CLIN INFECT DIS, V46, P1769, DOI 10.1086/587993; Reyes-Sandoval A, 2008, EUR J IMMUNOL, V38, P732, DOI 10.1002/eji.200737672; Reyes-Sandoval A, 2010, INFECT IMMUN, V78, P145, DOI 10.1128/IAI.00740-09; Rodriguez A, 2008, INFECT IMMUN, V76, P1709, DOI 10.1128/IAI.01614-07; Russell WC, 2009, J GEN VIROL, V90, P1, DOI 10.1099/vir.0.003087-0; Sedegah M, 2002, INFECT IMMUN, V70, P3493, DOI 10.1128/IAI.70.7.3493-3499.2002; Sedegah M, MALAR J, V9, P241; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Shott JP, 2008, VACCINE, V26, P2818, DOI 10.1016/j.vaccine.2008.03.080; SIGLER CI, 1984, AM J TROP MED HYG, V33, P544, DOI 10.4269/ajtmh.1984.33.544; Silvie O, 2004, J BIOL CHEM, V279, P9490, DOI 10.1074/jbc.M311331200; Sprangers MC, 2003, J CLIN MICROBIOL, V41, P5046, DOI 10.1128/JCM.41.11.5046-5052.2003; Spring MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005254; Stewart VA, 2007, INFECT IMMUN, V75, P2283, DOI 10.1128/IAI.01879-06; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Stoute JA, 1998, J INFECT DIS, V178, P1139, DOI 10.1086/515657; Stowers AW, 2002, INFECT IMMUN, V70, P6961, DOI 10.1128/IAI.70.12.6961-6967.2002; Sun PF, 2003, J IMMUNOL, V171, P6961, DOI 10.4049/jimmunol.171.12.6961; Udhayakumar V, 2001, AM J TROP MED HYG, V65, P100, DOI 10.4269/ajtmh.2001.65.100; Vuola JM, 2005, J IMMUNOL, V174, P449, DOI 10.4049/jimmunol.174.1.449; Wang RB, 2001, P NATL ACAD SCI USA, V98, P10817, DOI 10.1073/pnas.181123498; Wang RB, 1998, SCIENCE, V282, P476, DOI 10.1126/science.282.5388.476; Zaiss AK, 2009, J CELL BIOCHEM, V108, P778, DOI 10.1002/jcb.22328; ZEVERING Y, 1990, INT IMMUNOL, V2, P945, DOI 10.1093/intimm/2.10.945	83	55	57	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e24586	10.1371/journal.pone.0024586	http://dx.doi.org/10.1371/journal.pone.0024586			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003383	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000295970300004
J	Antonelou, MH; Kriebardis, AG; Stamoulis, KE; Trougakos, IP; Papassideri, IS				Antonelou, Marianna H.; Kriebardis, Anastasios G.; Stamoulis, Konstantinos E.; Trougakos, Ioannis P.; Papassideri, Issidora S.			Apolipoprotein J/Clusterin Is a Novel Structural Component of Human Erythrocytes and a Biomarker of Cellular Stress and Senescence	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; IN-VIVO; CLUSTERIN/APOLIPOPROTEIN-J; HEREDITARY SPHEROCYTOSIS; IDENTIFIES VARIANTS; OXIDATIVE STRESS; CLUSTERIN; PROTEIN; MEMBRANE; PROGRESSION	Background: Secretory Apolipoprotein J/Clusterin (sCLU) is a ubiquitously expressed chaperone that has been functionally implicated in several pathological conditions of increased oxidative injury, including aging. Nevertheless, the biological role of sCLU in red blood cells (RBCs) remained largely unknown. In the current study we identified sCLU as a component of human RBCs and we undertook a detailed analysis of its cellular topology. Moreover, we studied the erythrocytic membrane sCLU content during organismal aging, in conditions of increased organismal stress and accelerated RBCs senescence, as well as during physiological in vivo cellular senescence. Methodology/Principal Findings: By using a combination of molecular, biochemical and high resolution microscopical methods we found that sCLU is a novel structural component of RBCs extra-and intracellular plasma membrane and cytosol. We observed that the RBCs membrane-associated sCLU decreases during organismal aging or exposure to acute stress (e.g. smoking), in patients with congenital hemolytic anemia, as well as during RBCs in vivo senescence. In all cases, sCLU reduction paralleled the expression of typical cellular senescence, redox imbalance and erythrophagocytosis markers which are also indicative of the senescence-and oxidative stress-mediated RBCs membrane vesiculation. Conclusions/Significance: We propose that sCLU at the mature RBCs is not a silent remnant of the erythroid precursors, but an active component being functionally implicated in the signalling mechanisms of cellular senescence and oxidative stress-responses in both healthy and diseased organism. The reduced sCLU protein levels in the RBCs membrane following cell exposure to various endogenous or exogenous stressors closely correlates to the levels of cellular senescence and redox imbalance markers, suggesting the usefulness of sCLU as a sensitive biomarker of senescence and cellular stress.	[Antonelou, Marianna H.; Kriebardis, Anastasios G.; Trougakos, Ioannis P.; Papassideri, Issidora S.] Univ Athens, Dept Cell Biol & Biophys, Fac Biol, Athens, Greece; [Kriebardis, Anastasios G.] Technol & Educ Inst Athens, Dept Med Labs, Fac Hlth & Caring Profess, Athens, Greece; [Stamoulis, Konstantinos E.] Ctr Blood Transfus, Nikea, Piraeus, Greece	National & Kapodistrian University of Athens; University of West Attica	Antonelou, MH (corresponding author), Univ Athens, Dept Cell Biol & Biophys, Fac Biol, Athens, Greece.	itrougakos@biol.uoa.gr; ipapasid@biol.uoa.gr	Trougakos, Ioannis/R-6149-2018; Antonelou, Marianna H/C-1267-2011	Trougakos, Ioannis/0000-0002-6179-2772; Antonelou, Marianna H/0000-0003-3787-3596; Kriebardis, Anastasios/0000-0003-3915-1829	Hellenic General Secretariat for Research and Technology [2009 - 09FR-56]; ISP of the University of Athens Special Account for Research	Hellenic General Secretariat for Research and Technology(Greek Ministry of Development-GSRT); ISP of the University of Athens Special Account for Research	IPT was partially supported by a "Greece-France R&T Cooperation Grant, 2009 - 09FR-56'' of the Hellenic General Secretariat for Research and Technology and ISP by a "Kapodistrias" Grant of the University of Athens Special Account for Research Grants. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonelou MH, 2010, BLOOD TRANSFUS-ITALY, V8, pS39, DOI 10.2450/2010.007S; Antonelou MH, 2010, TRANSFUSION, V50, P376, DOI 10.1111/j.1537-2995.2009.02449.x; Antonelou MH, 2011, J PROTEOMIC IN PRESS; Arese P, 2005, CELL PHYSIOL BIOCHEM, V16, P133, DOI 10.1159/000089839; ARONOW BJ, 1993, P NATL ACAD SCI USA, V90, P725, DOI 10.1073/pnas.90.2.725; Bartl MM, 2001, EXP CELL RES, V271, P130, DOI 10.1006/excr.2001.5358; BEUTLER E, 1976, J LAB CLIN MED, V88, P328; BOSCH FH, 1992, BLOOD, V79, P254; Bosman GJCGM, 2008, TRANSFUSION MED, V18, P335, DOI 10.1111/j.1365-3148.2008.00892.x; Bosman GJCGM, 2008, TRANSFUSION, V48, P827, DOI 10.1111/j.1537-2995.2007.01630.x; Bosman GJCGM, 2005, CELL PHYSIOL BIOCHEM, V16, P1, DOI 10.1159/000087725; Bratosin D, 2009, CYTOM PART A, V75A, P236, DOI 10.1002/cyto.a.20693; Bruce LJ, 2002, BLOOD, V100, P1878, DOI 10.1182/blood-2002-03-0706; Catalgol B, 2009, CURR PHARM DESIGN, V15, P3043, DOI 10.2174/138161209789058129; Chi KN, 2008, EXPERT OPIN INV DRUG, V17, P1955, DOI [10.1517/13543780802528609, 10.1517/13543780802528609 ]; Cimen MYB, 2008, CLIN CHIM ACTA, V390, P1, DOI 10.1016/j.cca.2007.12.025; CRESPO P, 1993, LEUKEMIA RES, V17, P771, DOI 10.1016/0145-2126(93)90111-W; DESILVA HV, 1990, J BIOL CHEM, V265, P13240; GUDI T, 1993, J BIOL CHEM, V268, P21344; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hulea S. A., 1995, Journal of Environmental Pathology Toxicology and Oncology, V14, P173; Kang SW, 2005, EXP CELL RES, V309, P305, DOI 10.1016/j.yexcr.2005.06.012; Kay M, 2005, ANN NY ACAD SCI, V1057, P85, DOI 10.1196/annals.1356.005; Kiefer CR, 2000, CURR OPIN HEMATOL, V7, P113, DOI 10.1097/00062752-200003000-00007; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; LEONARD MB, 1995, DIABETIC MED, V12, P46, DOI 10.1111/j.1464-5491.1995.tb02061.x; Mandal D, 2005, J BIOL CHEM, V280, P39460, DOI 10.1074/jbc.M506928200; Margetis P, 2007, BLOOD CELL MOL DIS, V38, P210, DOI 10.1016/j.bcmd.2006.10.163; Mazzanti L, 1997, METABOLISM, V46, P59, DOI 10.1016/S0026-0495(97)90168-2; MCKENNEY J, 1990, BLOOD, V76, P206; MOHANDAS N, 1989, ANN NY ACAD SCI, V554, P217, DOI 10.1111/j.1749-6632.1989.tb22423.x; MUELLER TJ, 1987, J CLIN INVEST, V79, P492, DOI 10.1172/JCI112839; Olearczyk JJ, 2004, AM J PHYSIOL-HEART C, V287, pH748, DOI 10.1152/ajpheart.00161.2004; Perrotta S, 2008, LANCET, V372, P1411, DOI 10.1016/S0140-6736(08)61588-3; Poon S, 2000, BIOCHEMISTRY-US, V39, P15953, DOI 10.1021/bi002189x; Reddy KB, 1996, BIOCHEMISTRY-US, V35, P6157, DOI 10.1021/bi952981b; Saha S, 2011, EUR J HAEMATOL, V87, P259, DOI 10.1111/j.1600-0609.2011.01648.x; Shannan B, 2006, CELL DEATH DIFFER, V13, P12, DOI 10.1038/sj.cdd.4401779; Thambisetty M, 2010, ARCH GEN PSYCHIAT, V67, P739, DOI 10.1001/archgenpsychiatry.2010.78; Trougakos IP, 2006, BIOGERONTOLOGY, V7, P375, DOI 10.1007/s10522-006-9052-8; Trougakos IP, 2006, FREE RADICAL RES, V40, P1324, DOI 10.1080/10715760600902310; Trougakos IP, 2009, ADV CANCER RES, V104, P171, DOI 10.1016/S0065-230X(09)04009-3; Trougakos IP, 2009, CLIN CANCER RES, V15, P48, DOI 10.1158/1078-0432.CCR-08-1805; Trougakos IP, 2002, EXP GERONTOL, V37, P1175, DOI 10.1016/S0531-5565(02)00139-0; Venerando B, 2002, BLOOD, V99, P1064, DOI 10.1182/blood.V99.3.1064; Willekens FLA, 2008, BRIT J HAEMATOL, V141, P549, DOI 10.1111/j.1365-2141.2008.07055.x; Wyatt A, 2009, ADV CANCER RES, V104, P89, DOI 10.1016/S0065-230X(09)04006-8; Zhang HL, 2005, NAT CELL BIOL, V7, P909, DOI 10.1038/ncb1291	48	29	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e26032	10.1371/journal.pone.0026032	http://dx.doi.org/10.1371/journal.pone.0026032			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998749	Green Submitted, Green Published, gold			2022-12-27	WOS:000295968700034
J	Goodman, AG; Heinen, PP; Guerra, S; Vijayan, A; Sorzano, COS; Gomez, CE; Esteban, M				Goodman, Alan G.; Heinen, Paul P.; Guerra, Susana; Vijayan, Aneesh; Sorzano, Carlos Oscar S.; Gomez, Carmen E.; Esteban, Mariano			A Human Multi-Epitope Recombinant Vaccinia Virus as a Universal T Cell Vaccine Candidate against Influenza Virus	PLOS ONE			English	Article							PROTECTIVE IMMUNITY; PANDEMIC INFLUENZA; INFECTED-CELLS; UNITED-STATES; NUCLEOPROTEIN; MICE; HEMAGGLUTININ; IMMUNIZATION; DNA; IMMUNOGENICITY	There is a need to develop a universal vaccine against influenza virus infection to avoid developing new formulations of a seasonal vaccine each year. Many of the vaccine strategies for a universal vaccine target strain-conserved influenza virus proteins, such as the matrix, polymerase, and nucleoproteins, rather than the surface hemagglutinin and neuraminidase proteins. In addition, non-disease-causing viral vectors are a popular choice as a delivery system for the influenza virus antigens. As a proof-of-concept, we have designed a novel influenza virus immunogen based on the NP backbone containing human T cell epitopes for M1, NS1, NP, PB1 and PA proteins (referred as NPmix) as well as a construct containing the conserved regions of influenza virus neuraminidase (N-terminal) and hemagglutinin (C-terminal) (referred as NA-HA). DNA vectors and vaccinia virus recombinants expressing NPmix (WR-NP) or both NPmix plus NA-HA (WR-flu) in the cytosol were tested in a heterologous DNA-prime/vaccinia virus-boost vaccine regimen in mice. We observed an increase in the number of influenza virus-specific IFN gamma-secreting splenocytes, composed of populations marked by CD4(+) and CD8(+) T cells producing IFN gamma or TNF alpha. Upon challenge with influenza virus, the vaccinated mice exhibited decreased viral load in the lungs and a delay in mortality. These findings suggest that DNA prime/poxvirus boost with human multi-epitope recombinant influenza virus proteins is a valid approach for a general T-cell vaccine to protect against influenza virus infection.	[Goodman, Alan G.; Heinen, Paul P.; Guerra, Susana; Vijayan, Aneesh; Gomez, Carmen E.; Esteban, Mariano] CSIC, Ctr Nacl Biotecnol, Dept Cellular & Mol Biol, Madrid, Spain; [Guerra, Susana] Univ Autonoma Madrid, Dept Preventat Med & Publ Hlth, Madrid, Spain; [Sorzano, Carlos Oscar S.] CSIC, Comp Unit, Ctr Nacl Biotecnol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Goodman, AG (corresponding author), Univ Miami, Sch Med, Sylvester Comprehens Canc Inst, Miami, FL USA.	mesteban@cnb.csic.es	Gomez, Carmen Elena/K-1940-2014; Esteban, Mariano/ABG-5375-2020; Sorzano, Carlos Oscar S S./F-2639-2016; VIJAYAN, ANEESH/K-1961-2014; Goodman, Alan/AAQ-1108-2020; Vijayan, Aneesh/AAH-5640-2019; S. Sorzano, Carlos Oscar/ABE-4884-2021; guerra, susana/K-5972-2014	Gomez, Carmen Elena/0000-0002-5414-7935; Esteban, Mariano/0000-0003-0846-2827; Sorzano, Carlos Oscar S S./0000-0002-9473-283X; VIJAYAN, ANEESH/0000-0002-2828-5285; Goodman, Alan/0000-0001-6394-332X; Vijayan, Aneesh/0000-0002-2828-5285; S. Sorzano, Carlos Oscar/0000-0002-9473-283X; guerra, susana/0000-0001-9067-2991	Ministry of Science and Education of Spain [CSIC-FSE]; Spanish Ministry of Health Ramon y Cajal Program [FIS 2009-80145]; La Caixa Foundation; Marcelino Botin Foundation;  [SAF-2008-02036]	Ministry of Science and Education of Spain(Spanish Government); Spanish Ministry of Health Ramon y Cajal Program; La Caixa Foundation(La Caixa Foundation); Marcelino Botin Foundation; 	This work was supported by Ministry of Science and Education of Spain Program JAE-DOC (CSIC-FSE) (to A.G.G), Spanish Ministry of Health Ramon y Cajal Program (FIS 2009-80145) (to S.G.), La Caixa Foundation International PhD Program Fellowship (to A.V.), and SAF-2008-02036 and the Marcelino Botin Foundation (to M.E.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altstein AD, 2006, ARCH VIROL, V151, P921, DOI 10.1007/s00705-005-0676-9; ANDREW ME, 1987, SCAND J IMMUNOL, V25, P21, DOI 10.1111/j.1365-3083.1987.tb01042.x; ANDREW ME, 1986, MICROB PATHOGENESIS, V1, P443, DOI 10.1016/0882-4010(86)90006-9; ANDREW ME, 1988, SCAND J IMMUNOL, V28, P81, DOI 10.1111/j.1365-3083.1988.tb02418.x; Araki K, 2010, IMMUNOL REV, V235, P234, DOI 10.1111/j.0105-2896.2010.00898.x; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Bergmann M, 2000, J VIROL, V74, P6203, DOI 10.1128/JVI.74.13.6203-6206.2000; Berthoud TK, 2011, CLIN INFECT DIS, V52, P1, DOI 10.1093/cid/ciq015; Currier JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013983; Depla E, 2008, J VIROL, V82, P435, DOI 10.1128/JVI.01505-07; DiazGuerra M, 1997, VIROLOGY, V227, P220, DOI 10.1006/viro.1996.8294; Du LY, 2010, MICROBES INFECT, V12, P280, DOI 10.1016/j.micinf.2010.01.001; Epstein SL, 1998, TXB INFLUENZA, P324; Garcia-Arriaza J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012395; Gibbs MJ, 2001, SCIENCE, V293, P1842, DOI 10.1126/science.1061662; Goepfert PA, 2011, J INFECT DIS, V203, P610, DOI 10.1093/infdis/jiq105; Gomez CE, 2011, CURR GENE THER, V11, P189; Hanke T, 1999, J VIROL, V73, P7524, DOI 10.1128/JVI.73.9.7524-7532.1999; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; JAKEMAN KJ, 1989, J GEN VIROL, V70, P1523, DOI 10.1099/0022-1317-70-6-1523; Jamali A, 2010, CLIN VACCINE IMMUNOL, V17, P683, DOI 10.1128/CVI.00445-09; Keefer MC, 2011, VACCINE, V29, P1948, DOI 10.1016/j.vaccine.2010.12.104; Kreijtz JHCM, 2010, J GEN VIROL, V91, P2745, DOI 10.1099/vir.0.024885-0; Kreijtz JHCM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007790; Lambert LC, 2010, NEW ENGL J MED, V363, P2036, DOI 10.1056/NEJMra1002842; LAWSON CM, 1994, J VIROL, V68, P3505, DOI 10.1128/JVI.68.6.3505-3511.1994; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; LI SQ, 1993, P NATL ACAD SCI USA, V90, P5214, DOI 10.1073/pnas.90.11.5214; Lu S, 2009, CURR OPIN IMMUNOL, V21, P346, DOI 10.1016/j.coi.2009.05.016; Najera JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011406; Meltzer MI, 1999, EMERG INFECT DIS, V5, P659, DOI 10.3201/eid0505.990507; Ohba K, 2007, VACCINE, V25, P4291, DOI 10.1016/j.vaccine.2007.02.074; Otvos L, 2008, SYNTHESIS MULTIVALEN, P263; Regoes RR, 2006, SCIENCE, V312, P389, DOI 10.1126/science.1122947; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Saha S, 2006, VIROLOGY, V354, P48, DOI 10.1016/j.virol.2006.04.015; STITZ L, 1990, J GEN VIROL, V71, P1169, DOI 10.1099/0022-1317-71-5-1169; Taubenberger JK, 2001, PHILOS T ROY SOC B, V356, P1829, DOI 10.1098/rstb.2001.1020; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; TOWNSEND A, 1988, J EXP MED, V168, P1211, DOI 10.1084/jem.168.4.1211; WEBSTER RG, 1991, VACCINE, V9, P303, DOI 10.1016/0264-410X(91)90055-B; Wei JC, 2010, BIOCHEM BIOPH RES CO, V396, P787, DOI 10.1016/j.bbrc.2010.04.133	42	37	44	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25938	10.1371/journal.pone.0025938	http://dx.doi.org/10.1371/journal.pone.0025938			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998725	gold, Green Published			2022-12-27	WOS:000295966900077
J	Kim, E; Yoon, SJ; Kim, EY; Kim, Y; Lee, HS; Kim, KH; Lee, KA				Kim, Eunju; Yoon, Se-Jin; Kim, Eun-Young; Kim, Yunna; Lee, Hyun-Seo; Kim, Kyeoung-Hwa; Lee, Kyung-Ah			Function of COP9 Signalosome in Regulation of Mouse Oocytes Meiosis by Regulating MPF Activity and Securing Degradation	PLOS ONE			English	Article							ANAPHASE-PROMOTING COMPLEX; INOSITOL 1,3,4-TRISPHOSPHATE 5/6-KINASE; HUMAN CYCLIN-A; CELL-CYCLE; PROTEIN-KINASE; COP9/SIGNALOSOME SUBUNITS; DROSOPHILA-MELANOGASTER; DEPENDENT PROTEOLYSIS; TRANSCRIPTION FACTORS; PROLIFERATION	The COP9 (constitutive photomorphogenic) signalosome (CSN), composed of eight subunits, is a highly conserved protein complex that regulates processes such as cell cycle progression and kinase signalling. Previously, we found the expression of the COP9 constitutive photomorphogenic homolog subunit 3 (CSN3) and subunit 5 (CSN5) changes as oocytes mature for the first time, and there is no report regarding roles of COP9 in the mammalian oocytes. Therefore, in the present study, we examined the effects of RNA interference (RNAi)-mediated transient knockdown of each subunit on the meiotic cell cycle in mice oocytes. Following knockdown of either CSN3 or CSN5, oocytes failed to complete meiosis I. These arrested oocytes exhibited a disrupted meiotic spindle and misarranged chromosomes. Moreover, down-regulation of each subunit disrupted the activity of maturation-promoting factor (MPF) and concurrently reduced degradation of the anaphase-promoting complex/cyclosome (APC/C) substrates Cyclin B1 and Securin. Our data suggest that the CSN3 and CSN5 are involved in oocyte meiosis by regulating degradation of Cyclin B1 and Securin via APC/C.	[Kim, Eunju; Kim, Yunna; Lee, Hyun-Seo; Kim, Kyeoung-Hwa; Lee, Kyung-Ah] CHA Univ, Coll Life Sci, Dept Biomed Sci, Seoul, South Korea; [Yoon, Se-Jin] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Kim, Eun-Young; Lee, Kyung-Ah] CHA Gen Hosp, Fertil Ctr, CHA Res Inst, Seoul, South Korea	Pochon Cha University; Stanford University; Pochon Cha University	Kim, E (corresponding author), CHA Univ, Coll Life Sci, Dept Biomed Sci, Seoul, South Korea.	leeka@ovary.co.kr		Yoon, Se-Jin/0000-0001-8412-5991	National Research Foundation of Korea (NRF); Korean Government (Ministry of Education, Science and Technology [2009-0068363]; Priority Research Centers through the National Research Foundation of Korea (NRF) [2009-0093821]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean Government (Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Priority Research Centers through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Korean Government (Ministry of Education, Science and Technology, 2009-0068363) and by Priority Research Centers Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2009-0093821). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bech-Otschir D, 2001, EMBO J, V20, P1630, DOI 10.1093/emboj/20.7.1630; Bech-Otschir D, 2002, J CELL SCI, V115, P467; Castro A, 2005, ONCOGENE, V24, P314, DOI 10.1038/sj.onc.1207973; Chamovitz DA, 1996, CELL, V86, P115, DOI 10.1016/S0092-8674(00)80082-3; Claret FX, 1996, NATURE, V383, P453, DOI 10.1038/383453a0; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Denti S, 2006, J BIOL CHEM, V281, P32188, DOI 10.1074/jbc.M604746200; Dohmann EMN, 2008, DEVELOPMENT, V135, P2013, DOI 10.1242/dev.020743; Doronkin S, 2002, DEVELOPMENT, V129, P5053; Doronkin S, 2003, DEV CELL, V4, P699, DOI 10.1016/S1534-5807(03)00121-7; Fan HY, 2004, BIOL REPROD, V70, P535, DOI 10.1095/biolreprod.103.022830; Freilich S, 1999, CURR BIOL, V9, P1187, DOI 10.1016/S0960-9822(00)80023-8; Fukumoto A, 2005, FEBS LETT, V579, P1047, DOI 10.1016/j.febslet.2004.12.076; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; Gusmaroli G, 2007, PLANT CELL, V19, P564, DOI 10.1105/tpc.106.047571; Henke W, 1999, MOL BIOL REP, V26, P29, DOI 10.1023/A:1006991419464; HERSHKO A, 1994, J BIOL CHEM, V269, P4940; Kim KH, 2008, BIOL REPROD, V79, P1192, DOI 10.1095/biolreprod.108.068478; Kob R, 2009, CELL CYCLE, V8, P2041, DOI 10.4161/cc.8.13.8850; Liu C, 2003, GENE DEV, V17, P1130, DOI 10.1101/gad.1090803; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Lykke-Andersen K, 2003, MOL CELL BIOL, V23, P6790, DOI 10.1128/MCB.23.19.6790-6797.2003; Maro B, 2002, NAT CELL BIOL, V4, pE281, DOI 10.1038/ncb1202-e281; Masui Y, 2001, DIFFERENTIATION, V69, P1, DOI 10.1046/j.1432-0436.2001.690101.x; Morgan DO, 1999, NAT CELL BIOL, V1, pE47, DOI 10.1038/10039; Mundt KE, 2002, MOL BIOL CELL, V13, P493, DOI 10.1091/mbc.01-10-0521; Oren-Giladi P, 2008, GENES CELLS, V13, P221, DOI 10.1111/j.1365-2443.2008.01164.x; Oron E, 2002, DEVELOPMENT, V129, P4399; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Petersen BO, 2000, GENE DEV, V14, P2330, DOI 10.1101/gad.832500; Peth Andreas, 2007, BMC Biochemistry, V8, P27, DOI 10.1186/1471-2091-8-27; PINES J, 1991, J CELL BIOL, V115, P1, DOI 10.1083/jcb.115.1.1; Pintard L, 2003, CURR BIOL, V13, P911, DOI 10.1016/S0960-9822(03)00336-1; Rosel D, 2006, EUR J CELL BIOL, V85, P1023, DOI 10.1016/j.ejcb.2006.04.006; Stegmuller J, 2006, NEURON, V50, P389, DOI 10.1016/j.neuron.2006.03.034; Su HB, 2009, INT J BIOCHEM CELL B, V41, P615, DOI 10.1016/j.biocel.2008.07.008; Sun Y, 2002, J BIOL CHEM, V277, P45759, DOI 10.1074/jbc.M208709200; Terret ME, 2003, CURR BIOL, V13, P1797, DOI 10.1016/j.cub.2003.09.032; Tomoda K, 1999, NATURE, V398, P160, DOI 10.1038/18230; Tomoda K, 2002, J BIOL CHEM, V277, P2302, DOI 10.1074/jbc.M104431200; Tomoda K, 2005, BLOOD, V105, P775, DOI 10.1182/blood-2004-04-1242; Tomoda K, 2004, J BIOL CHEM, V279, P43013, DOI 10.1074/jbc.M406559200; Uhle S, 2003, EMBO J, V22, P1302, DOI 10.1093/emboj/cdg127; Wang XP, 2009, PLANT J, V58, P655, DOI 10.1111/j.1365-313X.2009.03805.x; Wee S, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-15; Wei N, 1998, PHOTOCHEM PHOTOBIOL, V68, P237; Wei N, 1998, CURR BIOL, V8, P919, DOI 10.1016/S0960-9822(07)00372-7; Wei N, 2008, TRENDS BIOCHEM SCI, V33, P592, DOI 10.1016/j.tibs.2008.09.004; Wilson MP, 2001, J BIOL CHEM, V276, P40998, DOI 10.1074/jbc.M106605200; Winston N, 2000, DEV BIOL, V223, P139, DOI 10.1006/dbio.2000.9721; Yan J, 2003, MOL CELL BIOL, V23, P6798, DOI 10.1128/MCB.23.19.6798-6808.2003; Yoon SJ, 2005, FERTIL STERIL, V83, P1293, DOI 10.1016/j.fertnstert.2004.09.037	53	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25870	10.1371/journal.pone.0025870	http://dx.doi.org/10.1371/journal.pone.0025870			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991377	gold, Green Published, Green Submitted			2022-12-27	WOS:000295943000088
J	Yang, YL; Zhu, YC; Ottea, J; Husseneder, C; Leonard, BR; Abel, C; Luttrell, R; Huang, FN				Yang, Yunlong; Zhu, Yu Cheng; Ottea, James; Husseneder, Claudia; Leonard, B. Rogers; Abel, Craig; Luttrell, Randall; Huang, Fangneng			Down Regulation of a Gene for Cadherin, but Not Alkaline Phosphatase, Associated with Cry1Ab Resistance in the Sugarcane Borer Diatraea saccharalis	PLOS ONE			English	Article							MIDGUT AMINOPEPTIDASE N; EUROPEAN CORN-BORER; BACILLUS-THURINGIENSIS; MANDUCA-SEXTA; TOXIN-BINDING; HELIOTHIS-VIRESCENS; RNA INTERFERENCE; FIELD-RESISTANCE; CLONING; RECEPTOR	The sugarcane borer, Diatraea saccharalis, is a major target pest of transgenic corn expressing Bacillus thuringiensis (Bt) proteins (i.e., Cry1Ab) in South America and the mid-southern region of the United States. Evolution of insecticide resistance in such target pests is a major threat to the durability of transgenic Bt crops. Understanding the pests' resistance mechanisms will facilitate development of effective strategies for delaying or countering resistance. Alterations in expression of cadherin-and alkaline phosphatase (ALP) have been associated with Bt resistance in several species of pest insects. In this study, neither the activity nor gene regulation of ALP was associated with Cry1Ab resistance in D. saccharalis. Total ALP enzymatic activity was similar between Cry1Ab-susceptible (Cry1Ab-SS) and -resistant (Cry1Ab-RR) strains of D. saccharalis. In addition, expression levels of three ALP genes were also similar between Cry1Ab-SS and -RR, and cDNA sequences did not differ between susceptible and resistant larvae. In contrast, altered expression of a midgut cadherin (DsCAD1) was associated with the Cry1Ab resistance. Whereas cDNA sequences of DsCAD1 were identical between the two strains, the transcript abundance of DsCAD1 was significantly lower in Cry1Ab-RR. To verify the involvement of DsCAD1 in susceptibility to Cry1Ab, RNA interference (RNAi) was employed to knock-down DsCAD1 expression in the susceptible larvae. Down-regulation of DsCAD1 expression by RNAi was functionally correlated with a decrease in Cry1Ab susceptibility. These results suggest that down-regulation of DsCAD1 is associated with resistance to Cry1Ab in D. saccharalis.	[Yang, Yunlong; Ottea, James; Husseneder, Claudia; Leonard, B. Rogers; Huang, Fangneng] Louisiana State Univ, Ctr Agr, Dept Entomol, Baton Rouge, LA 70803 USA; [Zhu, Yu Cheng; Abel, Craig; Luttrell, Randall] ARS, So Insect Management Res Unit, USDA, Stoneville, MS USA; [Abel, Craig] ARS, Corn Insects & Crop Genet Res Unit, USDA, Ames, IA USA	Louisiana State University System; Louisiana State University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Yang, YL (corresponding author), Louisiana State Univ, Ctr Agr, Dept Entomol, Baton Rouge, LA 70803 USA.	yc.zhu@ars.usda.gov		Husseneder, Claudia/0000-0001-5962-9354	Board of Regents of the State of Louisiana, United States of America [LEQSF 2006-09-RD-A-0]	Board of Regents of the State of Louisiana, United States of America	This work was supported by the Board of Regents of the State of Louisiana, United States of America, under contract no. LEQSF 2006-09-RD-A-0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Araujo RN, 2006, INSECT BIOCHEM MOLEC, V36, P683, DOI 10.1016/j.ibmb.2006.05.012; Arenas I, 2010, J BIOL CHEM, V285, P12497, DOI 10.1074/jbc.M109.085266; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Bautista MAM, 2009, INSECT BIOCHEM MOLEC, V39, P38, DOI 10.1016/j.ibmb.2008.09.005; Bel Y, 2009, INSECT BIOCHEM MOLEC, V39, P218, DOI 10.1016/j.ibmb.2008.11.005; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bravo A, 2004, BBA-BIOMEMBRANES, V1667, P38, DOI 10.1016/j.bbamem.2004.08.013; Castro BA., 2004, LOUISIANA AGR, V47, P4; CHANG WS, 1993, DEVELOPMENT, V118, P651; Denolf P, 1997, EUR J BIOCHEM, V248, P748, DOI 10.1111/j.1432-1033.1997.t01-1-00748.x; Dhurua S, 2011, PEST MANAG SCI, DOI [10.1002/ps.2127, DOI 10.1002/PS.2127]; EGUCHI M, 1995, COMP BIOCHEM PHYS B, V111, P151, DOI 10.1016/0305-0491(94)00248-S; Flannagan RD, 2005, INSECT BIOCHEM MOLEC, V35, P33, DOI 10.1016/j.ibmb.2004.10.001; Gahan LJ, 2001, SCIENCE, V293, P857, DOI 10.1126/science.1060949; Hua G, 2004, J BIOL CHEM, V279, P28051, DOI 10.1074/jbc.M400237200; Huang FN, 2007, ENTOMOL EXP APPL, V124, P117, DOI 10.1111/j.1570-7458.2007.00560.x; Huang FN, 2007, J ECON ENTOMOL, V100, P164, DOI 10.1603/0022-0493(2007)100[164:SBLCRT]2.0.CO;2; Huang FN, 2011, ENTOMOL EXP APPL, V140, P1, DOI 10.1111/j.1570-7458.2011.01138.x; Huang FN, 2006, J ECON ENTOMOL, V99, P194, DOI 10.1603/0022-0493(2006)099[0194:CSOECB]2.0.CO;2; Itoh M, 1999, INSECT BIOCHEM MOLEC, V29, P121, DOI 10.1016/S0965-1748(98)00115-5; ITOH M, 1991, BIOCHIM BIOPHYS ACTA, V1129, P135, DOI 10.1016/0167-4781(91)90229-F; Jurat-Fuentes JL, 2004, EUR J BIOCHEM, V271, P3127, DOI 10.1111/j.1432-1033.2004.04238.x; Jurat-Fuentes JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017606; KNIGHT PJK, 1994, MOL MICROBIOL, V11, P429, DOI 10.1111/j.1365-2958.1994.tb00324.x; McNall RJ, 2003, INSECT BIOCHEM MOLEC, V33, P999, DOI 10.1016/S0965-1748(03)00114-0; Morin S, 2003, P NATL ACAD SCI USA, V100, P5004, DOI 10.1073/pnas.0831036100; Nagamatsu Y, 1999, FEBS LETT, V460, P385, DOI 10.1016/S0014-5793(99)01327-7; National Agricultural Statistics Service (NASS), 2010, ACR; Ning CM, 2010, J INSECT PHYSIOL, V56, P666, DOI 10.1016/j.jinsphys.2010.02.003; OKADA N, 1989, J COMP PHYSIOL B, V159, P123, DOI 10.1007/BF00691732; Oltean DI, 1999, APPL ENVIRON MICROB, V65, P4760; Perera OP, 2009, INSECT BIOCHEM MOLEC, V39, P294, DOI 10.1016/j.ibmb.2009.01.006; Rajagopal R, 2002, J BIOL CHEM, V277, P46849, DOI 10.1074/jbc.C200523200; SANGADALA S, 1994, J BIOL CHEM, V269, P10088; SAS Institute Inc, 2008, SAS STAT 9 2 US GUID; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turner CT, 2006, INSECT MOL BIOL, V15, P383, DOI 10.1111/j.1365-2583.2006.00656.x; van Rensburg J. B. J., 2007, South African Journal of Plant and Soil, V24, P147; WOLFERSBERGER MG, 1984, AM ZOOL, V24, P187; Xie RY, 2005, J BIOL CHEM, V280, P8416, DOI 10.1074/jbc.M408403200; Xu XJ, 2005, APPL ENVIRON MICROB, V71, P948, DOI 10.1128/AEM.71.2.948-954.2005; Yang YJ, 2007, APPL ENVIRON MICROB, V73, P6939, DOI 10.1128/AEM.01703-07; Yang YL, 2010, INSECT BIOCHEM MOLEC, V40, P592, DOI 10.1016/j.ibmb.2010.05.006; Yaoi K, 1999, BBA-GENE STRUCT EXPR, V1444, P131, DOI 10.1016/S0167-4781(98)00250-4; Zhu YC, 2004, INSECT BIOCHEM MOLEC, V34, P1175, DOI 10.1016/j.ibmb.2004.07.008	51	41	43	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25783	10.1371/journal.pone.0025783	http://dx.doi.org/10.1371/journal.pone.0025783			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991350	Green Published, Green Submitted, gold			2022-12-27	WOS:000295943000068
J	Naish, S; Hu, WB; Mengersen, K; Tong, SL				Naish, Suchithra; Hu, Wenbiao; Mengersen, Kerrie; Tong, Shilu			Spatio-Temporal Patterns of Barmah Forest Virus Disease in Queensland, Australia	PLOS ONE			English	Article							ROSS-RIVER-VIRUS; NEW-SOUTH-WALES; GEOGRAPHIC INFORMATION-SYSTEMS; CLIMATE-CHANGE; ENVIRONMENTAL-FACTORS; SPATIAL AUTOCORRELATION; ARBOVIRUS DISEASES; MURRAY VALLEY; HEALTH; TRANSMISSION	Background: Barmah Forest virus (BFV) disease is a common and wide-spread mosquito-borne disease in Australia. This study investigated the spatio-temporal patterns of BFV disease in Queensland, Australia using geographical information system (GIS) tools and geostatistical analysis. Methods/Principal Findings: We calculated the incidence rates and standardised incidence rates of BFV disease. Moran's I statistic was used to assess the spatial autocorrelation of BFV incidences. Spatial dynamics of BFV disease was examined using semi-variogram analysis. Interpolation techniques were applied to visualise and display the spatial distribution of BFV disease in statistical local areas (SLAs) throughout Queensland. Mapping of BFV disease by SLAs reveals the presence of substantial spatio-temporal variation over time. Statistically significant differences in BFV incidence rates were identified among age groups (x(2) = 7587, df = 7327, p<0.01). There was a significant positive spatial autocorrelation of BFV incidence for all four periods, with the Moran's I statistic ranging from 0.1506 to 0.2901 (p<0.01). Semi-variogram analysis and smoothed maps created from interpolation techniques indicate that the pattern of spatial autocorrelation was not homogeneous across the state. Conclusions/Significance: This is the first study to examine spatial and temporal variation in the incidence rates of BFV disease across Queensland using GIS and geostatistics. The BFV transmission varied with age and gender, which may be due to exposure rates or behavioural risk factors. There are differences in the spatio-temporal patterns of BFV disease which may be related to local socio-ecological and environmental factors. These research findings may have implications in the BFV disease control and prevention programs in Queensland.	[Naish, Suchithra; Tong, Shilu] Queensland Univ Technol, Sch Publ Hlth, Brisbane, Qld 4001, Australia; [Hu, Wenbiao] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia	Queensland University of Technology (QUT); University of Queensland	Naish, S (corresponding author), Queensland Univ Technol, Sch Publ Hlth, Brisbane, Qld 4001, Australia.	s.naish@qut.edu.au	Mengersen, Kerrie/AHC-4096-2022	Mengersen, Kerrie/0000-0001-8625-9168; Hu, Wenbiao/0000-0001-6422-9240	QUT; NHMRC [553043, 519788]	QUT; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	SN is supported by a QUT Scholarship. ST is supported by an NHMRC Research Fellowship (#553043) and WH is funded an NHMRC Postdoctoral Research Training Fellowship (#519788). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1985, MAPINFO PROF SOFTW M; [Anonymous], 2011, MAPINFO PROF SOFTW V; [Anonymous], 2007, KEY CONCEPTS TECHNIQ; Anselin L., 2019, GEODA WORKBOOK; Australian Bureau of Statistics, 2006, CENS POP HOUS BAS CO; Australian Bureau of Statistics, 2008, AUSTR DEM STAT SEPT; Australian Bureau of Statistics, 2009, CENS POP HOUS BAS CO; Bell N, 2008, INJURY PREV, V14, P346, DOI 10.1136/ip.2008.018903; Bi P, 2000, J EPIDEMIOL COMMUN H, V54, P69, DOI 10.1136/jech.54.1.69; Bonet M, 2007, INT J OCCUP ENV HEAL, V13, P188, DOI 10.1179/oeh.2007.13.2.188; BOUGHTON CR, 1984, MED J AUSTRALIA, V141, P700, DOI 10.5694/j.1326-5377.1984.tb113225.x; Boyd AM, 2002, AUST VET J, V80, P83, DOI 10.1111/j.1751-0813.2002.tb12057.x; Boyd AM, 2001, AM J TROP MED HYG, V65, P777, DOI 10.4269/ajtmh.2001.65.777; Breslow NE, 1987, STAT METHODS CANC RE, VII, P59; Carl G, 2007, ECOL MODEL, V207, P159, DOI 10.1016/j.ecolmodel.2007.04.024; Cleveland WS, VISUALISING DATA; Dale PER, 1998, J VECTOR ECOL, V23, P54; Dalgarno L, 1999, ENCY VIROLOGY, P1570; Department of Health and Ageing, 2009, NAT NOT DIS SURV SYS; Dhileepan K, 1996, MED VET ENTOMOL, V10, P375, DOI 10.1111/j.1365-2915.1996.tb00760.x; Doggett SL, 1999, J MED ENTOMOL, V36, P861, DOI 10.1093/jmedent/36.6.861; DOHERTY RL, 1979, AUST J EXP BIOL MED, V57, P509, DOI 10.1038/icb.1979.52; DOHERTY RL, 1972, AUST VET J, V48, P172, DOI 10.1111/j.1751-0813.1972.tb09267.x; EH Isaaks, 1989, INTRO APPL GEOSTATIS, P249; Fisher N. I., 1987, STAT ANAL SPHERICAL; Fitzsimmons GJ, 2009, COMMUN DIS INTELL, V33, P155; Flexman JP, 1998, MED J AUSTRALIA, V169, P159, DOI 10.5694/j.1326-5377.1998.tb116019.x; Gatton ML, 2004, AM J TROP MED HYG, V71, P629, DOI 10.4269/ajtmh.2004.71.629; Gould EA, 2009, T ROY SOC TROP MED H, V103, P109, DOI 10.1016/j.trstmh.2008.07.025; Hills SL, 1997, ARBOVIRUS RES AUST, V7, P95; Hu WB, 2007, AM J TROP MED HYG, V76, P814, DOI 10.4269/ajtmh.2007.76.814; Isaaks EH, 1989, APPL GEOSTATISTICS; Jacups SP, 2008, VECTOR-BORNE ZOONOT, V8, P283, DOI 10.1089/vbz.2007.0152; Kelly-Hope LA, 2002, AUST NZ J PUBL HEAL, V26, P69, DOI 10.1111/j.1467-842X.2002.tb00274.x; LaBeaud AD, 2008, GEOSPATIAL HEALTH, V2, P215, DOI 10.4081/gh.2008.245; Lafferty KD, 2009, ECOLOGY, V90, P888, DOI 10.1890/08-0079.1; Liu C, 2008, COMMUN DIS INTELL, V32, P31; Mackenzie J S, 1998, Commun Dis Intell, V22, P93; MARSHALL ID, 1982, AUST J EXP BIOL MED, V60, P457, DOI 10.1038/icb.1982.51; Merianos A, 1992, COMMUN DIS INTELL, V16, P110; Miller M, 2005, COMMUN DIS INTELL, V29, P1; Moore DA, 1999, EPIDEMIOL REV, V21, P143, DOI 10.1093/oxfordjournals.epirev.a017993; Naish S, 2006, ENVIRON HEALTH PERSP, V114, P678, DOI 10.1289/ehp.8568; Naish S, 2009, TROP MED INT HEALTH, V14, P247, DOI 10.1111/j.1365-3156.2008.02217.x; Olano JP, 2009, AGENTS EMERGING INFE, P1; OLIVER MA, 1992, J PUBLIC HEALTH MED, V14, P280; Poidinger M, 1997, AM J TROP MED HYG, V57, P230, DOI 10.4269/ajtmh.1997.57.230; Queensland Department of Health, 2009, NAT NOT DIS SURV SYS; Quinn HE, 2005, J MED ENTOMOL, V42, P882, DOI 10.1603/0022-2585(2005)042[0882:AOBFVD]2.0.CO;2; Rezaeian M, 2007, J EPIDEMIOL COMMUN H, V61, P98, DOI 10.1136/jech.2005.043117; RN Parker, 2008, GIS SPATIAL ANAL SOC; Russell R. C., 1995, Review of Medical and Veterinary Entomology, V83, P141; Russell R. C., 1994, Bulletin of the Society for Vector Ecology, V19, P73; Russell RC, 1998, J VECTOR ECOL, V23, P1; Russell RC, 1998, INT J PARASITOL, V28, P955, DOI 10.1016/S0020-7519(98)00053-8; Russell RC, 2002, ANNU REV ENTOMOL, V47, P1, DOI 10.1146/annurev.ento.47.091201.145100; Russell RC, 2000, MICROBES INFECT, V2, P1693, DOI 10.1016/S1286-4579(00)01324-1; Russell RC, 2009, AUST J ENTOMOL, V48, P1, DOI 10.1111/j.1440-6055.2008.00677.x; Selvin S., 1996, STAT ANAL EPIDEMIOLO; SIMPSON DIH, 1972, BRIT MED BULL, V28, P10, DOI 10.1093/oxfordjournals.bmb.a070876; Sipe NG, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-36; Smith DW, 2008, TOGAVIRUSES CAUSING, P83; Sweeny A, 2009, QUEENSLAND HLTH NOTI; Toivanen A, 2008, CURR OPIN RHEUMATOL, V20, P486, DOI 10.1097/BOR.0b013e328303220b; Tolle Michael A, 2009, Curr Probl Pediatr Adolesc Health Care, V39, P97, DOI 10.1016/j.cppeds.2009.01.001; Tong S, 2005, INT J ENVIRON HEAL R, V15, P89, DOI 10.1080/09603120500062060; Tong S, 2004, INTERN MED J, V34, P58, DOI 10.1111/j.1444-0903.2004.00520.x; Tran A, 2004, EMERG INFECT DIS, V10, P615, DOI 10.3201/eid1004.030186; VALE TG, 1991, AUST J ZOOL, V39, P1, DOI 10.1071/ZO9910001; Waller L.A., 2004, APPL SPATIAL STAT PU; Weinstein P, 1997, ENVIRON HEALTH PERSP, V105, P364, DOI 10.2307/3433322; Woodruff RE, 2006, EPIDEMIOLOGY, V17, P569, DOI 10.1097/01.ede.0000229467.92742.7b; Wu PC, 2009, SCI TOTAL ENVIRON, V407, P2224, DOI 10.1016/j.scitotenv.2008.11.034	73	22	22	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e25688	10.1371/journal.pone.0025688	http://dx.doi.org/10.1371/journal.pone.0025688			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022430	Green Published, Green Submitted, gold			2022-12-27	WOS:000295978600026
J	Passacquale, G; Vamadevan, P; Pereira, L; Hamid, C; Corrigall, V; Ferro, A				Passacquale, Gabriella; Vamadevan, Padman; Pereira, Luis; Hamid, Colleen; Corrigall, Valerie; Ferro, Albert			Monocyte-Platelet Interaction Induces a Pro-Inflammatory Phenotype in Circulating Monocytes	PLOS ONE			English	Article							PROSTAGLANDIN E-2; EXPRESSION; ACTIVATION; ADHESION	Background: Activated platelets exert a pro-inflammatory action that can be largely ascribed to their ability to interact with leukocytes and modulate their activity. We hypothesized that platelet activation and consequent formation of monocyte-platelet aggregates (MPA) induces a pro-inflammatory phenotype in circulating monocytes. Methodology/Principal Findings: CD62P(+) platelets and MPA were measured, and monocytes characterized, by whole blood flow cytometry in healthy subjects, before and two days after receiving influenza immunization. Three monocytic subsets were identified: CD14(+) CD16(-), CD14(high) CD16(+) and CD14(low) CD16(+). The increase in high sensitivity C-reactive protein post-immunization was accompanied by increased platelet activation and MPA formation (25.02 +/- 12.57 vs 41.48 +/- 16.81; p = 0.01), along with enhancement of circulating CD14(high) CD16(+) cells (4.7 +/- 3.6 vs 10.4 +/- 4.8; p = 0.003), their percentage being linearly related to levels of CD62P(+)-platelets (r(2) = 0.4347; p = 0.0008). In separate in vitro experiments, co-incubation of CD14(+)CD16(-) cells, isolated from healthy donor subjects, with autologous platelets gave rise to up-regulation of CD16 on monocytes as compared with those maintained in medium alone (% change in CD14(+) CD16(+) cells following 48 h co-incubation of monocytes with platelets was +106 +/- 51% vs monocytes in medium alone; p<0.001). This effect correlated directly with degree of MPA formation (r(2) = 0.7731; p<0.0001) and was associated with increased monocyte adhesion to endothelial cells. P-selectin glycoprotein ligand-1 (PSGL-1) blocking antibody, which abrogates MPA formation, abolished these effects, as did the cyclooxygenase (COX)-2 selective inhibitor NS-398, aspirin and the EP1/EP2-selective antagonist AH6809. Conclusions/Significance: These data suggest that MPA formation, as occurs in the blood under pro-inflammatory conditions, expands the pool of circulating CD14(high) CD16(+) monocytes in a COX-2 dependent manner, and these monocytes exhibit increased adhesion to endothelium. Our findings delineate a novel mechanism underlying the pro-inflammatory effect of platelet activation.	[Passacquale, Gabriella; Vamadevan, Padman; Pereira, Luis; Hamid, Colleen; Ferro, Albert] Kings Coll London, Cardiovasc Div, Dept Clin Pharmacol, London WC2R 2LS, England; [Corrigall, Valerie] Kings Coll London, Acad Dept Rheumatol, London WC2R 2LS, England	University of London; King's College London; University of London; King's College London	Passacquale, G (corresponding author), Kings Coll London, Cardiovasc Div, Dept Clin Pharmacol, London WC2R 2LS, England.	albert.ferro@kcl.ac.uk		Ferro, Albert/0000-0002-5486-9145	Guy's and St Thomas' Charity	Guy's and St Thomas' Charity	The study was funded by an Advanced Training fellowship to Dr. Passacquale from the Guy's and St Thomas' Charity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammon C, 1998, J LEUKOCYTE BIOL, V63, P469, DOI 10.1002/jlb.63.4.469; Barton GM, 2002, CURR TOP MICROBIOL, V270, P81; Belge KU, 2002, J IMMUNOL, V168, P3536, DOI 10.4049/jimmunol.168.7.3536; Cipollone F, 2004, ARTERIOSCL THROM VAS, V24, P246, DOI 10.1161/01.ATV.0000104005.92603.f2; Dixon DA, 2006, J CLIN INVEST, V116, P2727, DOI 10.1172/JC127209; Gkaliagkousi E, 2009, EUR HEART J, V30, P3048, DOI 10.1093/eurheartj/ehp330; Harding SA, 2004, ATHEROSCLEROSIS, V176, P321, DOI 10.1016/j.atherosclerosis.2004.05.008; Harizi H, 2002, J IMMUNOL, V168, P2255, DOI 10.4049/jimmunol.168.5.2255; Htun P, 2006, STROKE, V37, P2283, DOI 10.1161/01.STR.0000236638.75591.61; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Joseph JE, 2001, BRIT J HAEMATOL, V115, P451, DOI 10.1046/j.1365-2141.2001.03101.x; Kato M, 2001, J PHARM PHARMACOL, V53, P1679, DOI 10.1211/0022357011778070; Kubo N, 2000, J LIPID RES, V41, P1060; Martins PAD, 2006, J LEUKOCYTE BIOL, V79, P499, DOI 10.1189/jlb.0605318; Meja KK, 1997, BRIT J PHARMACOL, V122, P149, DOI 10.1038/sj.bjp.0701360; Michelson AD, 2001, CIRCULATION, V104, P1533, DOI 10.1161/hc3801.095588; Mickelson JK, 1996, J AM COLL CARDIOL, V28, P345, DOI 10.1016/0735-1097(96)00164-7; Penglis PS, 2000, J IMMUNOL, V165, P1605, DOI 10.4049/jimmunol.165.3.1605; Posthouwer D, 2004, VACCINE, V23, P362, DOI 10.1016/j.vaccine.2004.05.035; Smout J, 2009, ANGIOLOGY, V60, P362, DOI 10.1177/0003319709332959; Weber C, 2000, J LEUKOCYTE BIOL, V67, P699, DOI 10.1002/jlb.67.5.699; Weyrich AS, 1996, J CLIN INVEST, V97, P1525, DOI 10.1172/JCI118575; WEYRICH AS, 1995, J CLIN INVEST, V95, P2297, DOI 10.1172/JCI117921; Wu HZ, 2009, CIRCULATION, V119, P2708, DOI 10.1161/CIRCULATIONAHA.108.823740; Zhang GL, 2001, J CLIN INVEST, V107, P13, DOI 10.1172/JCI11837	25	138	148	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25595	10.1371/journal.pone.0025595	http://dx.doi.org/10.1371/journal.pone.0025595			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022418	Green Published, Green Submitted			2022-12-27	WOS:000295976000024
J	Wang, XY; Fan, J; Liu, D; Fu, SQ; Ingvarsson, S; Chen, HP				Wang, Xiyin; Fan, Jing; Liu, Dong; Fu, Siqing; Ingvarsson, Sigurdur; Chen, Huiping			Spreading of Alu Methylation to the Promoter of the MLH1 Gene in Gastrointestinal Cancer	PLOS ONE			English	Article							CPG ISLAND METHYLATION; DE-NOVO METHYLATION; HMLH1 PROMOTER; CELL-LINES; SITES; HYPOMETHYLATION; EXPRESSION; UPSTREAM; PATTERNS; ELEMENTS	The highly repetitive Alu retroelements are regarded as methylation centres in the genome. Methylation in the gene promoters could be spreading from them. Promoter methylation of MLH1 is frequently detected in cancers, but the underlying mechanism is unclear. The aim of this study is to understand whether the methylation in the Alu elements is associated with promoter methylation in the MLH1 gene. Bisulfite genomic sequencing was used to analyse the CpG sites of the 59 end (promoter, exon 1 and Alu-containing intron 1) of the MLH1 gene in colorectal cancer cells and tissues, and gastric cancer tissues. Hypomethylation in the Alu elements and hypermethylation in the promoters and the regions between the promoters and the Alu elements were detected in two cancer cell lines and seven cancer tissues. However, demethylation or hypomethylation of the MLH1 promoter and regions between promoter and the Alu elements, and hypermethylation in the Alu elements, were identified in the normal tissues. MLH1 promoter methylation may spread from Alu elements that are located in intron 1 of the MLH1 gene. The trans-acting elements binding to the mutation sites could play a role in the methylation spreading.	[Wang, Xiyin; Fan, Jing; Liu, Dong; Fu, Siqing; Chen, Huiping] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Med Genet, Wuhan 430074, Hubei, Peoples R China; [Ingvarsson, Sigurdur] Univ Iceland, Inst Expt Pathol, Reykjavik, Iceland; [Ingvarsson, Sigurdur] Univ Iceland, Fac Med, Reykjavik, Iceland	Huazhong University of Science & Technology; University of Iceland; University of Iceland	Wang, XY (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Med Genet, Wuhan 430074, Hubei, Peoples R China.	huiping@mail.hust.edu.cn	Wang, Xiyin/AAF-4747-2019; Ingvarsson, Sigurdur/E-7448-2011	Ingvarsson, Sigurdur/0000-0003-4125-1714; Wang, Xiyin/0000-0002-3642-9373	Huazhong University of Science and Technology [2010MS034]	Huazhong University of Science and Technology	This project was supported by the Huazhong University of Science and Technology (2010MS034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Chen HP, 2007, INT J CANCER, V120, P1684, DOI 10.1002/ijc.22406; Deng GR, 1999, CANCER RES, V59, P2029; Goodfellow PJ, 2003, P NATL ACAD SCI USA, V100, P5908, DOI 10.1073/pnas.1030231100; Graff JR, 1997, J BIOL CHEM, V272, P22322, DOI 10.1074/jbc.272.35.22322; Igarashi S, 2010, CLIN CANCER RES, V16, P5114, DOI 10.1158/1078-0432.CCR-10-0581; Kang GH, 2002, PATHOL INT, V52, P764, DOI 10.1046/j.1440-1827.2002.01423.x; MACLEOD D, 1994, GENE DEV, V8, P2282, DOI 10.1101/gad.8.19.2282; Mei MX, 2010, CANCER EPIDEMIOL, V34, P93, DOI 10.1016/j.canep.2009.12.009; MUMMANENI P, 1993, J BIOL CHEM, V268, P552; MUMMANENI P, 1995, J BIOL CHEM, V270, P788, DOI 10.1074/jbc.270.2.788; Smiraglia DJ, 2001, HUM MOL GENET, V10, P1413, DOI 10.1093/hmg/10.13.1413; Tellez CS, 2009, MELANOMA RES, V19, P146, DOI 10.1097/CMR.0b013e32832b274e; Turker MS, 1997, MUTAT RES-REV MUTAT, V386, P119, DOI 10.1016/S1383-5742(96)00048-8; Xiang SY, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-44	15	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25913	10.1371/journal.pone.0025913	http://dx.doi.org/10.1371/journal.pone.0025913			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022465	gold, Green Submitted, Green Published			2022-12-27	WOS:000295976000045
J	Yuan, QX; Chen, L; Liu, CP; Xu, KF; Mao, XD; Liu, C				Yuan, Qingxin; Chen, Lu; Liu, Cuiping; Xu, Kuanfeng; Mao, Xiaodong; Liu, Chao			Postnatal Pancreatic Islet beta Cell Function and Insulin Sensitivity at Different Stages of Lifetime in Rats Born with Intrauterine Growth Retardation	PLOS ONE			English	Article							THRIFTY PHENOTYPE HYPOTHESIS; LOW-BIRTH-WEIGHT; CATCH-UP GROWTH; ENDOCRINE PANCREAS; CHILDHOOD GROWTH; ADIPOSE-TISSUE; FETAL; RESTRICTION; OBESITY; ORIGINS	Epidemiological studies have linked intrauterine growth retardation (IUGR) to the metabolic diseases, consisting of insulin resistance, type 2 diabetes, obesity and coronary artery disease, during adult life. To determine the internal relationship between IUGR and islet beta cell function and insulin sensitivity, we established the IUGR model by maternal nutrition restriction during mid- to late-gestation. Glucose tolerance test and insulin tolerance test(ITT) in vivo and glucose stimulated insulin secretion(GSIS) test in vitro were performed at different stages in IUGR and normal groups. Body weight, pancreas weight and pancreas/body weight of IUGR rats were much lower than those in normal group before 3 weeks of age. While the growth of IUGR rats accelerated after 3 weeks, pancreas weight and pancreas/body weight remained lower till 15 weeks of age. In the newborns, the fasting glucose and insulin levels of IUGR rats were both lower than those of controls, whereas glucose levels at 120 and 180 min after glucose load were significantly higher in IUGR group. Between 3 and 15 weeks of age, both the fasting glucose and insulin levels were elevated and the glucose tolerance was impaired with time in IUGR rats. At age 15 weeks, the area under curve of insulin(AUCi) after glucose load in IUGR rats elevated markedly. Meanwhile, the stimulating index of islets in IUGR group during GSIS test at age 15 weeks was significantly lower than that of controls. ITT showed no significant difference in two groups before 7 weeks of age. However, in 15-week-old IUGR rats, there was a markedly blunted glycemic response to insulin load compared with normal group. These findings demonstrate that IUGR rats had both impaired pancreatic development and deteriorated glucose tolerance and insulin sensitivity, which would be the internal causes why they were prone to develop type 2 diabetes.	[Yuan, Qingxin; Chen, Lu; Liu, Cuiping; Xu, Kuanfeng; Mao, Xiaodong; Liu, Chao] Nanjing Med Univ, Dept Endocrinol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Yuan, QX (corresponding author), Nanjing Med Univ, Dept Endocrinol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China.	drliuchaonj@126.com			Chinese Jiangsu province major subject grant [SK200214]	Chinese Jiangsu province major subject grant	This research was supported by a Chinese Jiangsu province major subject grant SK200214. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHOKAS RA, 1986, J NUTR, V116, P412, DOI 10.1093/jn/116.3.412; Anazawa S, 2003, DIABETES CARE, V26, P2210, DOI 10.2337/diacare.26.7.2210; Beringue F, 2002, DIABETES, V51, P385, DOI 10.2337/diabetes.51.2.385; Bispham J, 2005, ENDOCRINOLOGY, V146, P3943, DOI 10.1210/en.2005-0246; Breant B, 2006, HORM RES, V65, P98, DOI 10.1159/000091513; De Blasio MJ, 2007, AM J PHYSIOL-REG I, V292, pR875, DOI 10.1152/ajpregu.00430.2006; DEGRAUW TJ, 1986, BIOL NEONATE, V49, P85, DOI 10.1159/000242515; Fernandez-Twinn DS, 2006, PHYSIOL BEHAV, V88, P234, DOI 10.1016/j.physbeh.2006.05.039; Forsen T, 2000, ANN INTERN MED, V133, P176, DOI 10.7326/0003-4819-133-3-200008010-00008; Fowden AL, 2001, BRIT MED BULL, V60, P123, DOI 10.1093/bmb/60.1.123; Green AS, 2010, J ENDOCRINOL, V205, P211, DOI 10.1677/JOE-09-0399; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Iliadou A, 2004, INT J EPIDEMIOL, V33, P948, DOI 10.1093/ije/dyh117; Kanaka-Gantenbein C, 2010, ANN NY ACAD SCI, V1205, P99, DOI 10.1111/j.1749-6632.2010.05683.x; Lane RH, 2001, BRAIN RES, V895, P186, DOI 10.1016/S0006-8993(01)02074-1; LangleyEvans SC, 1997, J HYPERTENS, V15, P537, DOI 10.1097/00004872-199715050-00010; Leong NM, 2003, INT J CANCER, V103, P789, DOI 10.1002/ijc.10886; Ling C, 2009, DIABETES, V58, P2718, DOI 10.2337/db09-1003; [刘翠萍 LIU Cuiping], 2007, [南京医科大学学报. 自然科学版, Acta Universitatis Medicinalis Nanjing], V27, P242; Liu XM, 2006, PANCREAS, V32, P9, DOI 10.1097/01.mpa.0000191647.40044.58; Muhlhausler BS, 2005, J PHYSIOL-LONDON, V565, P185, DOI 10.1113/jphysiol.2004.079079; NICOLINI U, 1990, HORM METAB RES, V22, P426, DOI 10.1055/s-2007-1004939; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; Osmond C, 2000, ENVIRON HEALTH PERSP, V108, P545, DOI 10.1289/ehp.00108s3545; Pallotto EK, 2006, CLIN OBSTET GYNECOL, V49, P257, DOI 10.1097/00003081-200606000-00008; Peterside IE, 2003, AM J PHYSIOL-ENDOC M, V285, pE1258, DOI 10.1152/ajpendo.00437.2002; Sadiq HF, 1998, PEDIATR RES, V43, P91, DOI 10.1203/00006450-199801000-00014; Schwitzgebel VM, 2009, MOL CELL ENDOCRINOL, V304, P78, DOI 10.1016/j.mce.2009.02.019; Setia S, 2006, PATHOLOGY, V38, P236, DOI 10.1080/00313020600696256; Shahkhalili Y, 2010, AM J PHYSIOL-REG I, V298, pR141, DOI 10.1152/ajpregu.00128.2009; Shen QA, 2011, NUTRITION, V27, P364, DOI 10.1016/j.nut.2010.03.003; Simmons RA, 2009, PEDIATR CLIN N AM, V56, P449, DOI 10.1016/j.pcl.2009.03.004; Styrud J, 2005, BIOL NEONATE, V88, P122, DOI 10.1159/000086136; Thamotharan M, 2005, AM J PHYSIOL-ENDOC M, V288, pE935, DOI 10.1152/ajpendo.00342.2004; Williams G, 2001, PHYSIOL BEHAV, V74, P683, DOI 10.1016/S0031-9384(01)00612-6; Yajnik CS, 2004, J NUTR, V134, P205, DOI 10.1093/jn/134.1.205; Yuan QX, 2010, HORM METAB RES, V42, P491, DOI 10.1055/s-0030-1249058	39	22	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25167	10.1371/journal.pone.0025167	http://dx.doi.org/10.1371/journal.pone.0025167			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022381	Green Submitted, Green Published, gold			2022-12-27	WOS:000295976000011
J	Ayrapetov, MK; Xu, C; Sun, YL; Zhu, KY; Parmar, K; D'Andrea, AD; Price, BD				Ayrapetov, Marina K.; Xu, Chang; Sun, Yingli; Zhu, Kaya; Parmar, Kalindi; D'Andrea, Alan D.; Price, Brendan D.			Activation of Hif1 alpha by the Prolylhydroxylase Inhibitor Dimethyoxalyglycine Decreases Radiosensitivity	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR; PROLYL HYDROXYLASE INHIBITORS; GENE-EXPRESSION; DNA-DAMAGE; PROLINE HYDROXYLATION; HISTONE DEMETHYLASES; HUMAN CANCERS; JMJD2 FAMILY; TUMOR-GROWTH; GAMMA-RAYS	Hypoxia inducible factor 1 alpha (Hif1 alpha) is a stress responsive transcription factor, which regulates the expression of genes required for adaption to hypoxia. Hif1 alpha is normally hydroxylated by an oxygen-dependent prolylhydroxylase, leading to degradation and clearance of Hif1 alpha from the cell. Under hypoxic conditions, the activity of the prolylhydroxylase is reduced and Hif1 alpha accumulates. Hif1 alpha is also constitutively expressed in tumor cells, where it is associated with resistance to ionizing radiation. Activation of the Hif1 alpha transcriptional regulatory pathway may therefore function to protect normal cells from DNA damage caused by ionizing radiation. Here, we utilized the prolylhydroxylase inhibitor dimethyloxalylglycine (DMOG) to elevate Hif1 alpha levels in mouse embryonic fibroblasts (MEFs) to determine if DMOG could function as a radioprotector. The results demonstrate that DMOG increased Hif1 alpha protein levels and decreased the sensitivity of MEFs to ionizing radiation. Further, the ability of DMOG to function as a radioprotector required Hif1 alpha, indicating a key role for Hif1 alpha's transcriptional activity. DMOG also induced the Hif1 alpha-dependent accumulation of several DNA damage response proteins, including CHD4 and MTA3 (sub-units of the NuRD deacetylase complex) and the Suv39h1 histone H3 methyltransferase. Depletion of Suv39h1, but not CHD4 or MTA3, reduced the ability of DMOG to protect cells from radiation damage, implicating increased histone H3 methylation in the radioprotection of cells. Finally, treatment of mice with DMOG prior to total body irradiation resulted in significant radioprotection of the mice, demonstrating the utility of DMOG and related prolylhydroxylase inhibitors to protect whole organisms from ionizing radiation. Activation of Hif1a through prolylhydroxylase inhibition therefore identifies a new pathway for the development of novel radiation protectors.	[Ayrapetov, Marina K.; Xu, Chang; Zhu, Kaya; Parmar, Kalindi; D'Andrea, Alan D.; Price, Brendan D.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Div Genom Stabil & DNA Repair,Dept Radiat Oncol, Boston, MA 02115 USA; [Sun, Yingli] Chinese Acad Sci, Beijing Inst Genom, Dis Genom & Individualized Med Key Lab, Beijing, Peoples R China	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Ayrapetov, MK (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Div Genom Stabil & DNA Repair,Dept Radiat Oncol, 44 Binney St, Boston, MA 02115 USA.	sunyl@big.ac.cn; kalindi_parmar@dfci.harvard.edu; brendan_price@dfci.harvard.edu			National Cancer Institute (NCI) [CA64585, CA93602]; Associates of the Joint Center for Radiation Therapy (AJCRT) foundation; National Institute of Allergy and Infectious Diseases (NIAID) [U19 A1067751]; NATIONAL CANCER INSTITUTE [R01CA064585, R01CA093602] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Associates of the Joint Center for Radiation Therapy (AJCRT) foundation; National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Cancer Institute (NCI) (CA64585 and CA93602), the Associates of the Joint Center for Radiation Therapy (AJCRT) foundation and by National Institute of Allergy and Infectious Diseases (NIAID) U19 A1067751 center grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold DM, 2001, CANCER RES, V61, P2911; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Beyer S, 2008, J BIOL CHEM, V283, P36542, DOI 10.1074/jbc.M804578200; Bindra RS, 2007, CANCER METAST REV, V26, P249, DOI 10.1007/s10555-007-9061-3; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Chen ZZ, 2006, CELL, V125, P691, DOI 10.1016/j.cell.2006.04.024; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; Couture JF, 2006, CURR OPIN STRUC BIOL, V16, P753, DOI 10.1016/j.sbi.2006.10.002; Cummins EP, 2008, GASTROENTEROLOGY, V134, P156, DOI 10.1053/j.gastro.2007.10.012; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; Eckle T, 2008, CIRCULATION, V118, P166, DOI 10.1161/CIRCULATIONAHA.107.758516; Elvidge GP, 2006, J BIOL CHEM, V281, P15215, DOI 10.1074/jbc.M511408200; HALL EJ, 1988, AM J CLIN ONCOL-CANC, V11, P220, DOI 10.1097/00000421-198806000-00003; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hsieh MM, 2007, BLOOD, V110, P2140, DOI 10.1182/blood-2007-02-073254; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Johnson SM, 2010, J CLIN INVEST, V120, P2528, DOI 10.1172/JCI41402; Kaelin WG, 2005, ANNU REV BIOCHEM, V74, P115, DOI 10.1146/annurev.biochem.74.082803.133142; Kasiganesan H, 2007, ACTA PHYSIOL, V190, P163, DOI 10.1111/j.1748-1716.2007.01676.x; Kim SH, 2007, ONCOL REP, V17, P647; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kouzarides T, 2007, CELL, V131, DOI 10.1016/j.cell.2007.11.005; Lerman OZ, 2010, BLOOD, V116, P3669, DOI 10.1182/blood-2009-03-213629; Liu XB, 2009, J CELL BIOCHEM, V106, P903, DOI 10.1002/jcb.22064; Lomb DJ, 2007, J NEUROCHEM, V103, P1897, DOI 10.1111/j.1471-4159.2007.04873.x; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Milkiewicz M, 2004, J PHYSIOL-LONDON, V560, P21, DOI 10.1113/jphysiol.2004.069757; Moeller BJ, 2005, CANCER CELL, V8, P99, DOI 10.1016/j.ccr.2005.06.016; Moeller BJ, 2004, CANCER CELL, V5, P429, DOI 10.1016/S1535-6108(04)00115-1; Murdoch C, 2005, J IMMUNOL, V175, P6257, DOI 10.4049/jimmunol.175.10.6257; NETA R, 1986, J IMMUNOL, V136, P2483; Ozer A, 2007, NAT CHEM BIOL, V3, P144, DOI 10.1038/nchembio863; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Piret JP, 2004, EXP CELL RES, V295, P340, DOI 10.1016/j.yexcr.2004.01.024; Polo SE, 2010, EMBO J, V29, P3130, DOI 10.1038/emboj.2010.188; RASEY JS, 1984, RADIAT RES, V97, P598, DOI 10.2307/3576151; Ryan HE, 2000, CANCER RES, V60, P4010; Safran M, 2003, J CLIN INVEST, V111, P779, DOI 10.1172/JCI200318181; Sasabe E, 2007, INT J CANCER, V120, P268, DOI 10.1002/ijc.22294; Schwartz DL, 2010, MOL CANCER THER, V9, P2057, DOI 10.1158/1535-7163.MCT-09-0768; Semenza GL, 2001, TRENDS MOL MED, V7, P345, DOI 10.1016/S1471-4914(01)02090-1; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Smeenk G, 2010, J CELL BIOL, V190, P741, DOI 10.1083/jcb.201001048; Sun YL, 2009, NAT CELL BIOL, V11, P1376, DOI 10.1038/ncb1982; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; TALMADGE JE, 1989, BLOOD, V73, P2093; Unruh A, 2003, ONCOGENE, V22, P3213, DOI 10.1038/sj.onc.1206385; vanOs R, 1997, EXP HEMATOL, V25, P205; Warnecke C, 2003, FASEB J, V17, P1186, DOI 10.1096/fj.02-1062fje; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Williams KJ, 2005, RADIOTHER ONCOL, V75, P89, DOI 10.1016/j.radonc.2005.01.009; Wirthner R, 2008, CARCINOGENESIS, V29, P2306, DOI 10.1093/carcin/bgn231; Xia XB, 2009, P NATL ACAD SCI USA, V106, P4260, DOI 10.1073/pnas.0810067106; Yoo YG, 2006, EMBO J, V25, P1231, DOI 10.1038/sj.emboj.7601025; Zhang XW, 2004, CANCER RES, V64, P8139, DOI 10.1158/0008-5472.CAN-03-2301; Zhong H, 1999, CANCER RES, V59, P5830	59	31	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e26064	10.1371/journal.pone.0026064	http://dx.doi.org/10.1371/journal.pone.0026064			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22016813	gold, Green Published, Green Submitted			2022-12-27	WOS:000295970300056
J	Borovjagin, AV; Dong, J; Passineau, MJ; Ren, CC; Lamani, E; Mamaeva, OA; Wu, HJ; Keyser, E; Murakami, M; Chen, S; MacDougall, M				Borovjagin, Anton V.; Dong, Juan; Passineau, Michael J.; Ren, Changchun; Lamani, Ejvis; Mamaeva, Olga A.; Wu, Hongju; Keyser, Enid; Murakami, Miho; Chen, Shuo; MacDougall, Mary			Adenovirus Gene Transfer to Amelogenesis Imperfecta Ameloblast-Like Cells	PLOS ONE			English	Article							CELLULAR ATTACHMENT RECEPTORS; FIBER-MODIFIED ADENOVIRUSES; OVARIAN-CANCER CELLS; ENAMEL MATRIX; TRANSFER EFFICIENCY; EXPRESSION; VECTORS; PROTEIN; ADHESION; COXSACKIEVIRUS	To explore gene therapy strategies for amelogenesis imperfecta (AI), a human ameloblast-like cell population was established from third molars of an AI-affected patient. These cells were characterized by expression of cytokeratin 14, major enamel proteins and alkaline phosphatase staining. Suboptimal transduction of the ameloblast-like cells by an adenovirus type 5 (Ad5) vector was consistent with lower levels of the coxsackie-and-adenovirus receptor (CAR) on those cells relative to CAR-positive A549 cells. To overcome CAR -deficiency, we evaluated capsid-modified Ad5 vectors with various genetic capsid modifications including "pK7'' and/or "RGD'' motif-containing short peptides incorporated in the capsid protein fiber as well as fiber chimera with the Ad serotype 3 (Ad3) fiber "knob'' domain. All fiber modifications provided an augmented transduction of AI-ameloblasts, revealed following vector dose normalization in A549 cells with a superior effect (up to 404-fold) of pK7/RGD double modification. This robust infectivity enhancement occurred through vector binding to both alpha(v)3/alpha(v)beta 5 integrins and heparan sulfate proteoglycans (HSPGs) highly expressed by AI-ameloblasts as revealed by gene transfer blocking experiments. This work thus not only pioneers establishment of human AI ameloblast-like cell population as a model for in vitro studies but also reveals an optimal infectivity-enhancement strategy for a potential Ad5 vector-mediated gene therapy for AI.	[Borovjagin, Anton V.] Univ Alabama Birmingham, Sch Dent, Dept Periodont, Birmingham, AL 35294 USA; [Dong, Juan] Univ Alabama Birmingham, Sch Dent, Dept Orthodont, Birmingham, AL 35294 USA; [Ren, Changchun; Lamani, Ejvis; MacDougall, Mary] Univ Alabama Birmingham, Sch Dent, Dept Oral & Maxillofacial Surg, Birmingham, AL 35294 USA; [Borovjagin, Anton V.; Dong, Juan; Ren, Changchun; Lamani, Ejvis; Mamaeva, Olga A.; MacDougall, Mary] Univ Alabama Birmingham, Sch Dent, Inst Oral Hlth Res, Birmingham, AL 35294 USA; [Wu, Hongju; Keyser, Enid] Univ Alabama Birmingham, Dept Obstet & Gynecol, Birmingham, AL 35294 USA; [Wu, Hongju; Murakami, Miho] Univ Alabama Birmingham, Dept Med, Div Human Gene Therapy, Gene Therapy Ctr, Birmingham, AL 35294 USA; [Passineau, Michael J.] W Penn Allegheny Hlth Syst, Div Cardiovasc Med, Pittsburgh, PA USA; [Passineau, Michael J.] W Penn Allegheny Hlth Syst, Allegheny Singer Res Inst, Pittsburgh, PA USA; [Chen, Shuo] Univ Texas Hlth Sci Ctr San Antonio, Sch Dent, Dept Pediat Dent, San Antonio, TX 78229 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Texas System; University of Texas Health San Antonio	Borovjagin, AV (corresponding author), Univ Alabama Birmingham, Sch Dent, Dept Periodont, Birmingham, AL 35294 USA.	macdougall@uab.edu	MacDougall, Mary/ABG-8212-2021		NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019802] Funding Source: NIH RePORTER; NIDCR NIH HHS [R01 DE019802-03, R01 DE019802] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Bartlett JD, 1998, CONNECT TISSUE RES, V39, P101, DOI 10.3109/03008209809023916; BELIN MT, 1993, J GEN VIROL, V74, P1485, DOI 10.1099/0022-1317-74-8-1485; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Borovjagin AV, 2005, CANCER GENE THER, V12, P475, DOI 10.1038/sj.cgt.7700806; Chartier C, 1996, J VIROL, V70, P4805, DOI 10.1128/JVI.70.7.4805-4810.1996; Ciuffi A, 2008, CURR GENE THER, V8, P419, DOI 10.2174/156652308786848021; Cohen CJ, 2001, P NATL ACAD SCI USA, V98, P15191, DOI 10.1073/pnas.261452898; Crawford PJM, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-17; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; Dhar D, 2009, J VIROL, V83, P2130, DOI 10.1128/JVI.02127-08; Dmitriev I, 1998, J VIROL, V72, P9706, DOI 10.1128/JVI.72.12.9706-9713.1998; DSOUZA SE, 1991, TRENDS BIOCHEM SCI, V16, P246, DOI 10.1016/0968-0004(91)90096-E; DSOUZA SE, 1988, SCIENCE, V242, P91, DOI 10.1126/science.3262922; Fukumoto S, 2004, J CELL BIOL, V167, P973, DOI 10.1083/jcb.200409077; Gaggar A, 2003, NAT MED, V9, P1408, DOI 10.1038/nm952; He PP, 2010, MATRIX BIOL, V29, P411, DOI 10.1016/j.matbio.2010.03.001; Hemminki A, 2003, CANCER RES, V63, P847; Hemminki A, 2001, MOL THER, V4, P223, DOI 10.1006/mthe.2001.0446; Hidaka C, 1999, J CLIN INVEST, V103, P579, DOI 10.1172/JCI5309; Hu CC, 1997, J DENT RES, V76, P1720, DOI 10.1177/00220345970760110201; Hu JCC, 2002, EUR J ORAL SCI, V110, P307, DOI 10.1034/j.1600-0722.2002.21301.x; Kanerva A, 2002, CLIN CANCER RES, V8, P275; Kanerva A, 2002, MOL THER, V5, P695, DOI 10.1006/mthe.2002.0599; Kanerva A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002917; Kasono K, 1999, CLIN CANCER RES, V5, P2571; Kawakami Y, 2003, CANCER RES, V63, P1262; Kestler DP, 2008, MOL MED, V14, P318, DOI 10.2119/2008-00010.Kestler; Kochanek S, 2001, CURR OPIN MOL THER, V3, P454; Krasnykh VN, 1996, J VIROL, V70, P6839, DOI 10.1128/JVI.70.10.6839-6846.1996; LAU EC, 1989, GENOMICS, V4, P162, DOI 10.1016/0888-7543(89)90295-4; Le LP, 2004, MOL IMAGING, V3, P105, DOI 10.1162/1535350041464874; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacDougall M, 1998, CONNECT TISSUE RES, V39, P25, DOI 10.3109/03008209809023909; MacDougall M, 1995, Connect Tissue Res, V33, P97, DOI 10.3109/03008209509016988; Majhen D, 2009, VIRUS RES, V139, P64, DOI 10.1016/j.virusres.2008.10.004; McDonald D, 1999, GENE THER, V6, P1512, DOI 10.1038/sj.gt.3301006; Moffatt P, 2008, J CELL BIOCHEM, V103, P941, DOI 10.1002/jcb.21465; Moffatt P, 2006, BIOCHEM J, V399, P37, DOI 10.1042/BJ20060662; Murakami M, 2010, PROSTATE, V70, P362, DOI 10.1002/pros.21070; Musgrave DS, 1999, BONE, V24, P541, DOI 10.1016/S8756-3282(99)00086-1; Muto Taro, 2007, J Med Invest, V54, P331, DOI 10.2152/jmi.54.331; Nemerow GR, 1999, MICROBIOL MOL BIOL R, V63, P725, DOI 10.1128/MMBR.63.3.725-734.1999; Nettelbeck DM, 2003, ANTI-CANCER DRUG, V14, P577, DOI 10.1097/00001813-200309000-00001; Pesonen S, 2011, MOL PHARMACEUT, V8, P12, DOI 10.1021/mp100219n; Reddy PS, 2002, MOL THER, V5, P63, DOI 10.1006/mthe.2001.0510; Robinson C, 1998, EUR J ORAL SCI, V106, P282, DOI 10.1111/j.1600-0722.1998.tb02188.x; Roelvink PW, 1999, SCIENCE, V286, P1568, DOI 10.1126/science.286.5444.1568; Roelvink PW, 1998, J VIROL, V72, P7909, DOI 10.1128/JVI.72.10.7909-7915.1998; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; Ryu BY, 2008, BLOOD, V111, P1866, DOI 10.1182/blood-2007-04-085506; Segerman A, 2003, J VIROL, V77, P9183, DOI 10.1128/JVI.77.17.9183-9191.2003; Short JJ, 2004, VIROLOGY, V322, P349, DOI 10.1016/j.virol.2004.02.016; Short JJ, 2006, VIRUS RES, V122, P144, DOI 10.1016/j.virusres.2006.07.009; Shriver Z, 2002, TRENDS CARDIOVAS MED, V12, P71, DOI 10.1016/S1050-1738(01)00150-5; Simmer JP, 1998, J DENT RES, V77, P377, DOI 10.1177/00220345980770020601; Simmer JP, 2002, CONNECT TISSUE RES, V43, P441, DOI 10.1080/03008200290001159; SIMMER JP, 1995, CRIT REV ORAL BIOL M, V6, P84, DOI 10.1177/10454411950060020701; Sirena D, 2004, J VIROL, V78, P4454, DOI 10.1128/JVI.78.9.4454-4462.2004; Stevenson SC, 1997, J VIROL, V71, P4782, DOI 10.1128/JVI.71.6.4782-4790.1997; Stoff-Khalili MA, 2005, CANCER BIOL THER, V4, P1203, DOI 10.4161/cbt.4.11.2084; TERMINE JD, 1980, J BIOL CHEM, V255, P9760; Tripathy SK, 1996, NAT MED, V2, P545, DOI 10.1038/nm0596-545; Tsuruta Y, 2008, CLIN CANCER RES, V14, P3582, DOI 10.1158/1078-0432.CCR-07-5053; Tuve S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000189; Wickham TJ, 1996, NAT BIOTECHNOL, V14, P1570, DOI 10.1038/nbt1196-1570; WICKHAM TJ, 1994, J CELL BIOL, V127, P257, DOI 10.1083/jcb.127.1.257; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; WOODS A, 1994, MOL BIOL CELL, V5, P183, DOI 10.1091/mbc.5.2.183; Wu HJ, 2002, HUM GENE THER, V13, P1647, DOI 10.1089/10430340260201734; XIA D, 1994, STRUCTURE, V2, P1259, DOI 10.1016/S0969-2126(94)00126-X; Zalzal SF, 2008, MATRIX BIOL, V27, P352, DOI 10.1016/j.matbio.2008.01.003; Zhen Z, 2004, HUM GENE THER, V15, P709, DOI 10.1089/1043034041361262; ZSENGELLER ZK, 1995, HUM GENE THER, V6, P457, DOI 10.1089/hum.1995.6.4-457	73	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e24281	10.1371/journal.pone.0024281	http://dx.doi.org/10.1371/journal.pone.0024281			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003382	Green Published, Green Submitted, gold			2022-12-27	WOS:000295970300003
J	Tamminga, C; Sedegah, M; Regis, D; Chuang, I; Epstein, JE; Spring, M; Mendoza-Silveiras, J; McGrath, S; Maiolatesi, S; Reyes, S; Steinbeiss, V; Fedders, C; Smith, K; House, B; Ganeshan, H; Lejano, J; Abot, E; Banania, GJ; Sayo, R; Farooq, F; Belmonte, M; Murphy, J; Komisar, J; Williams, J; Shi, M; Brambilla, D; Manohar, N; Richie, NO; Wood, C; Limbach, K; Patterson, NB; Bruder, JT; Doolan, DL; King, CR; Diggs, C; Soisson, L; Carucci, D; Levine, G; Dutta, S; Hollingdale, MR; Ockenhouse, CF; Richie, TL				Tamminga, Cindy; Sedegah, Martha; Regis, David; Chuang, Ilin; Epstein, Judith E.; Spring, Michele; Mendoza-Silveiras, Jose; McGrath, Shannon; Maiolatesi, Santina; Reyes, Sharina; Steinbeiss, Victoria; Fedders, Charlotte; Smith, Kathryn; House, Brent; Ganeshan, Harini; Lejano, Jennylynn; Abot, Esteban; Banania, Glenna J.; Sayo, Renato; Farooq, Fouzia; Belmonte, Maria; Murphy, Jittawadee; Komisar, Jack; Williams, Jackie; Shi, Meng; Brambilla, Donald; Manohar, Nalini; Richie, Nancy O.; Wood, Chloe; Limbach, Keith; Patterson, Noelle B.; Bruder, Joseph T.; Doolan, Denise L.; King, C. Richter; Diggs, Carter; Soisson, Lorraine; Carucci, Daniel; Levine, Gail; Dutta, Sheetij; Hollingdale, Michael R.; Ockenhouse, Christian F.; Richie, Thomas L.			Adenovirus-5-Vectored P. falciparum Vaccine Expressing CSP and AMA1. Part B: Safety, Immunogenicity and Protective Efficacy of the CSP Component	PLOS ONE			English	Article							APICAL MEMBRANE ANTIGEN-1; CANDIDATE MALARIA VACCINE; T-CELL RESPONSES; NATURAL IMMUNE-RESPONSES; PHASE 2A TRIAL; PLASMODIUM-FALCIPARUM; CIRCUMSPOROZOITE PROTEIN; RHESUS-MONKEYS; NAIVE ADULTS; SEQUENTIAL IMMUNIZATION	Background: A protective malaria vaccine will likely need to elicit both cell-mediated and antibody responses. As adenovirus vaccine vectors induce both these responses in humans, a Phase 1/2a clinical trial was conducted to evaluate the efficacy of an adenovirus serotype 5-vectored malaria vaccine against sporozoite challenge. Methodology/Principal Findings: NMRC-MV-Ad-PfC is an adenovirus vector encoding the Plasmodium falciparum 3D7 circumsporozoite protein (CSP). It is one component of a two-component vaccine NMRC-M3V-Ad-PfCA consisting of one adenovector encoding CSP and one encoding apical membrane antigen-1 (AMA1) that was evaluated for safety and immunogenicity in an earlier study (see companion paper, Sedegah et al). Fourteen Ad5 seropositive or negative adults received two doses of NMRC-MV-Ad-PfC sixteen weeks apart, at 1x1 (0) over cap 10 particle units per dose. The vaccine was safe and well tolerated. All volunteers developed positive ELISpot responses by 28 days after the first immunization (geometric mean 272 spot forming cells/million[sfc/m]) that declined during the following 16 weeks and increased after the second dose to levels that in most cases were less than the initial peak (geometric mean 119 sfc/m). CD8+ predominated over CD4+ responses, as in the first clinical trial. Antibody responses were poor and like ELISpot responses increased after the second immunization but did not exceed the initial peak. Pre-existing neutralizing antibodies (NAb) to Ad5 did not affect the immunogenicity of the first dose, but the fold increase in NAb induced by the first dose was significantly associated with poorer antibody responses after the second dose, while ELISpot responses remained unaffected. When challenged by the bite of P. falciparum-infected mosquitoes, two of 11 volunteers showed a delay in the time to patency compared to infectivity controls, but no volunteers were sterilely protected. Significance: The NMRC-MV-Ad-PfC vaccine expressing CSP was safe and well tolerated given as two doses, but did not provide sterile protection.	[Tamminga, Cindy; Sedegah, Martha; Regis, David; Chuang, Ilin; Epstein, Judith E.; Mendoza-Silveiras, Jose; Maiolatesi, Santina; Reyes, Sharina; Steinbeiss, Victoria; Fedders, Charlotte; Smith, Kathryn; House, Brent; Ganeshan, Harini; Lejano, Jennylynn; Abot, Esteban; Banania, Glenna J.; Sayo, Renato; Farooq, Fouzia; Belmonte, Maria; Shi, Meng; Manohar, Nalini; Limbach, Keith; Patterson, Noelle B.; Doolan, Denise L.; Carucci, Daniel; Richie, Thomas L.] USN, Med Res Ctr, US Mil Malaria Vaccine Program, Silver Spring, MD USA; [Spring, Michele; McGrath, Shannon; Murphy, Jittawadee; Komisar, Jack; Williams, Jackie; Shi, Meng; Richie, Nancy O.; Wood, Chloe; Dutta, Sheetij; Ockenhouse, Christian F.] Walter Reed Army Inst Res, US Mil Malaria Vaccine Program, Silver Spring, MD USA; [McGrath, Shannon; Williams, Jackie; Richie, Nancy O.; Wood, Chloe; Dutta, Sheetij] Clin Res Management, Hinckley, OH USA; [Spring, Michele; Mendoza-Silveiras, Jose; Maiolatesi, Santina; Reyes, Sharina; Steinbeiss, Victoria; Fedders, Charlotte; Smith, Kathryn; Ganeshan, Harini; Lejano, Jennylynn; Abot, Esteban; Banania, Glenna J.; Sayo, Renato; Farooq, Fouzia; Belmonte, Maria; Manohar, Nalini; Limbach, Keith; Patterson, Noelle B.] Henry M Jackson Fdn Adv Mil Med, Rockville, MD USA; [Brambilla, Donald] RTI Rockville, Rockville, MD USA; [Bruder, Joseph T.; King, C. Richter] GenVec Inc, Gaithersburg, MD USA; [Diggs, Carter; Soisson, Lorraine] USAID, Washington, DC USA; [Levine, Gail] Fdn Natl Inst Hlth, Bethesda, MD USA; [Hollingdale, Michael R.] NMRC, USMMVP, Malaria Dept, Silver Spring, MD USA	United States Department of Defense; United States Navy; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Research Triangle Institute; United States Agency for International Development (USAID); National Institutes of Health (NIH) - USA; Naval Medical Research Center (NMRC)	Tamminga, C (corresponding author), USN, Med Res Ctr, US Mil Malaria Vaccine Program, Silver Spring, MD USA.	cindy.tamminga@med.navy.mil	Belmonte, Maria/A-8032-2011; Doolan, Denise L/F-1969-2015	Brambilla, Donald/0000-0002-7276-4689; Farooq, Fouzia/0000-0001-6491-6323; Doolan, Denise/0000-0001-7354-8817	USAID [GHA-P00-03-00006-01, 936-3118]; Congressionally Directed Medical Research Program [W81XWH-05-2-0041]	USAID(United States Agency for International Development (USAID)); Congressionally Directed Medical Research Program(United States Department of Defense)	The following funder played a role in study design: CD and LS from USAID: "Development of Adenovirus-Vectored Malaria Vaccines" Grant #: GHA-P00-03-00006-01, PROJECT NUMBER 936-3118. Web site: http://www.usaid.gov. SM, NOR, CW, and SD are employees of Clinical Research Management and performed some of the experiments and SM also participated in writing the manuscript. JTB and CRK employees of GenVec, Inc., and participated in the design of the vaccines. The following funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript: Congressionally Directed Medical Research Program "Development of Recombinant Adenoviral-based Vaccines against Malaria" Grant #: W81XWH-05-2-0041. Website: https://cdmrp.org. Military Infectious Research Program "Phase 1/2a clinical trials assessing the safety, tolerability, immunogenicity & protective efficacy of Ad5-CA, a two-antigen, adenovirus-vectored Plasmodium falciparum malaria vaccine, in healthy, malaria-naive adults", work unit. Website: https://midrp.amedd.army.mil.	Aponte JJ, 2007, LANCET, V370, P1543, DOI 10.1016/S0140-6736(07)61542-6; Asmuth DM, 2010, J INFECT DIS, V201, P132, DOI 10.1086/648591; Beeson JG, 2008, TRENDS PARASITOL, V24, P578, DOI 10.1016/j.pt.2008.08.008; BLUMTIROUVANZIAM U, 1995, J IMMUNOL, V154, P3922; Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4; Bojang KA, 2005, VACCINE, V23, P4148, DOI 10.1016/j.vaccine.2005.03.019; Brice GT, 2007, MICROBES INFECT, V9, P1439, DOI 10.1016/j.micinf.2007.07.009; Cerullo V, 2007, MOL THER, V15, P378, DOI 10.1038/sj.mt.6300031; CHAROENVIT Y, 1991, J IMMUNOL, V146, P1020; Cheng C, 2010, J VIROL, V84, P630, DOI 10.1128/JVI.00866-09; CHULAY JD, 1986, AM J TROP MED HYG, V35, P66, DOI 10.4269/ajtmh.1986.35.66; Cox KS, 2008, J VIROL, V82, P8161, DOI 10.1128/JVI.00620-08; Dicko A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001045; Dicko A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001563; Doolan DL, 2000, J IMMUNOL, V165, P1453, DOI 10.4049/jimmunol.165.3.1453; Doolan DL, 1997, IMMUNITY, V7, P97, DOI 10.1016/S1074-7613(00)80513-0; Doolan DL, 2006, CURR MOL MED, V6, P169, DOI 10.2174/156652406776055249; Dunachie SJ, 2006, INFECT IMMUN, V74, P5933, DOI 10.1128/IAI.00590-06; Ellis RD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008787; Epstein JE, 2004, VACCINE, V22, P1592, DOI 10.1016/j.vaccine.2004.01.031; Fowkes FJ, PLOS MED, V7; Frevert U, 2009, INT J PARASITOL, V39, P119, DOI 10.1016/j.ijpara.2008.06.014; Gaziano TA, 2008, LANCET, V371, P923, DOI 10.1016/S0140-6736(08)60418-3; GOOD MF, 1988, P NATL ACAD SCI USA, V85, P1199, DOI 10.1073/pnas.85.4.1199; Harro CD, 2009, AIDS RES HUM RETROV, V25, P103, DOI 10.1089/aid.2008.0212; Harvey BG, 1999, J VIROL, V73, P6729, DOI 10.1128/JVI.73.8.6729-6742.1999; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; Huaman MC, 2009, VACCINE, V27, P5239, DOI 10.1016/j.vaccine.2009.06.066; Jiang G, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-135; Jiang G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006559; Kalia V, 2010, ADV EXP MED BIOL, V684, P79; Kester KE, 2008, VACCINE, V26, P2191, DOI 10.1016/j.vaccine.2008.02.048; Kester KE, 2007, VACCINE, V25, P5359, DOI 10.1016/j.vaccine.2007.05.005; Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120; Krieg AM, 2004, J IMMUNOTHER, V27, P460, DOI 10.1097/00002371-200411000-00006; Kumar KA, 2006, NATURE, V444, P937, DOI 10.1038/nature05361; Lal AA, 1996, INFECT IMMUN, V64, P1054, DOI 10.1128/IAI.64.3.1054-1059.1996; Leonard JR, 2007, CLIN CANCER RES, V13, P6168, DOI 10.1158/1078-0432.CCR-07-0815; Malkin EM, 2005, INFECT IMMUN, V73, P3677, DOI 10.1128/IAI.73.6.3677-3685.2005; Marsh K, 2006, PARASITE IMMUNOL, V28, P51, DOI 10.1111/j.1365-3024.2006.00808.x; McCoy K, 2007, J VIROL, V81, P6594, DOI 10.1128/JVI.02497-06; Mettens P, 2008, VACCINE, V26, P1072, DOI 10.1016/j.vaccine.2007.12.018; Moorthy VS, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-312; NARUM DL, 1994, MOL BIOCHEM PARASIT, V67, P59, DOI 10.1016/0166-6851(94)90096-5; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; Ockenhouse CF, 2006, VACCINE, V24, P3009, DOI 10.1016/j.vaccine.2005.11.028; Oliveira GA, 2008, INFECT IMMUN, V76, P1200, DOI 10.1128/IAI.00566-07; Overstreet MG, 2008, IMMUNOL REV, V225, P272, DOI 10.1111/j.1600-065X.2008.00671.x; Pichyangkul S, 2009, VACCINE, V28, P452, DOI 10.1016/j.vaccine.2009.10.022; Polley SD, 2004, VACCINE, V23, P718, DOI 10.1016/j.vaccine.2004.05.031; Priddy FH, 2008, CLIN INFECT DIS, V46, P1769, DOI 10.1086/587993; Remarque EJ, 2008, TRENDS PARASITOL, V24, P74, DOI 10.1016/j.pt.2007.12.002; Reyes-Sandoval A, 2008, EUR J IMMUNOL, V38, P732, DOI 10.1002/eji.200737672; Rodrigues EG, 1997, J IMMUNOL, V158, P1268; Rodriguez A, 2008, INFECT IMMUN, V76, P1709, DOI 10.1128/IAI.01614-07; Rogers WO, 2002, INFECT IMMUN, V70, P4329, DOI 10.1128/IAI.70.8.4329-4335.2002; SABCHAREON A, 1991, AM J TROP MED HYG, V45, P297, DOI 10.4269/ajtmh.1991.45.297; Saul A, 2005, VACCINE, V23, P3076, DOI 10.1016/j.vaccine.2004.09.040; Schmidt NW, 2008, P NATL ACAD SCI USA, V105, P14017, DOI 10.1073/pnas.0805452105; Sedegah M, 2004, GENES IMMUN, V5, P553, DOI 10.1038/sj.gene.6364125; Sedegah M, 2004, GENE THER, V11, P448, DOI 10.1038/sj.gt.3302139; Sedegah M, 2002, INFECT IMMUN, V70, P3493, DOI 10.1128/IAI.70.7.3493-3499.2002; Sedegah Martha, 2006, V127, P239; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Shiratsuchi T, 2010, J CLIN INVEST, V120, P3688, DOI 10.1172/JCI39812; SIGLER CI, 1984, AM J TROP MED HYG, V33, P544, DOI 10.4269/ajtmh.1984.33.544; Silvie O, 2004, J BIOL CHEM, V279, P9490, DOI 10.1074/jbc.M311331200; Sprangers MC, 2003, J CLIN MICROBIOL, V41, P5046, DOI 10.1128/JCM.41.11.5046-5052.2003; Spring MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005254; STEWART MJ, 1986, INFECT IMMUN, V51, P859, DOI 10.1128/IAI.51.3.859-864.1986; Stewart VA, 2007, INFECT IMMUN, V75, P2283, DOI 10.1128/IAI.01879-06; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Stowers AW, 2001, INFECT IMMUN, V69, P1536, DOI 10.1128/IAI.69.3.1536-1546.2001; Sun PF, 2003, J IMMUNOL, V171, P6961, DOI 10.4049/jimmunol.171.12.6961; Tarun AS, 2007, J INFECT DIS, V196, P608, DOI 10.1086/519742; THOMAS AW, 1994, AM J TROP MED HYG, V51, P730, DOI 10.4269/ajtmh.1994.51.730; THOMAS AW, 1994, MEM I OSWALDO CRUZ, V89, P67, DOI 10.1590/S0074-02761994000600016; Udhayakumar V, 2001, AM J TROP MED HYG, V65, P100, DOI 10.4269/ajtmh.2001.65.100; Wang RB, 2004, J IMMUNOL, V172, P5561, DOI 10.4049/jimmunol.172.9.5561; Weiss WR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001063; Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004; *WHO, 2009, WORLD MAL REP; Zhu JG, 2007, J VIROL, V81, P3170, DOI 10.1128/JVI.02192-06	84	59	61	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25868	10.1371/journal.pone.0025868	http://dx.doi.org/10.1371/journal.pone.0025868			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003411	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000295970300034
J	Takemoto, K; Borjigin, S				Takemoto, Kazuhiro; Borjigin, Suritalatu			Metabolic Network Modularity in Archaea Depends on Growth Conditions	PLOS ONE			English	Article							CELL BIOLOGY; EVOLUTION; ORGANIZATION; TEMPERATURE; ORGANISMS; LIFE	Network modularity is an important structural feature in metabolic networks. A previous study suggested that the variability in natural habitat promotes metabolic network modularity in bacteria. However, since many factors influence the structure of the metabolic network, this phenomenon might be limited and there may be other explanations for the change in metabolic network modularity. Therefore, we focus on archaea because they belong to another domain of prokaryotes and show variability in growth conditions (e.g., trophic requirement and optimal growth temperature), but not in habitats because of their specialized growth conditions (e.g., high growth temperature). The relationship between biological features and metabolic network modularity is examined in detail. We first show the absence of a relationship between network modularity and habitat variability in archaea, as archaeal habitats are more limited than bacterial habitats. Although this finding implies the need for further studies regarding the differences in network modularity, it does not contradict previous work. Further investigations reveal alternative explanations. Specifically, growth conditions, trophic requirement, and optimal growth temperature, in particular, affect metabolic network modularity. We have discussed the mechanisms for the growth condition-dependant changes in network modularity. Our findings suggest different explanations for the changes in network modularity and provide new insights into adaptation and evolution in metabolic networks, despite several limitations of data analysis.	[Takemoto, Kazuhiro] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan; [Takemoto, Kazuhiro; Borjigin, Suritalatu] Univ Tokyo, Dept Biophys & Biochem, Bunkyo Ku, Tokyo, Japan	Japan Science & Technology Agency (JST); University of Tokyo	Takemoto, K (corresponding author), Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan.	takemoto@cb.k.u-tokyo.ac.jp	Takemoto, Kazuhiro/H-2915-2019	Takemoto, Kazuhiro/0000-0002-6355-1366	JST PRESTO	JST PRESTO(Japan Science & Technology Agency (JST))	This work was supported by the JST PRESTO program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Arita M, 2004, P NATL ACAD SCI USA, V101, P1543, DOI 10.1073/pnas.0306458101; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Diaz-Mejia JJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r26; Doworkin M., 2006, PROKARYOTES, V3; Ebenhoh Oliver, 2005, Genome Inform, V16, P203; Friedman R, 2004, GENETICS, V167, P1507, DOI 10.1534/genetics.104.026344; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Holme P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016605; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kreimer A, 2008, P NATL ACAD SCI USA, V105, P6976, DOI 10.1073/pnas.0712149105; Kristjansson J. K., 1991, THERMOPHILIC BACTERI; Light S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-159; Ma HW, 2003, BIOINFORMATICS, V19, P270, DOI 10.1093/bioinformatics/19.2.270; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mazurie A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-59; Nam H, 2011, CURR OPIN BIOTECH, V22, P595, DOI 10.1016/j.copbio.2011.03.006; Pal C, 2005, NAT GENET, V37, P1372, DOI 10.1038/ng1686; Papp B, 2009, HFSP J, V3, P24, DOI 10.2976/1.3020599; Parter M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-169; Raymond J, 2006, SCIENCE, V311, P1764, DOI 10.1126/science.1118439; Robertson CE, 2005, CURR OPIN MICROBIOL, V8, P638, DOI 10.1016/j.mib.2005.10.003; Sato T, 2003, J BACTERIOL, V185, P210, DOI 10.1128/JB.185.1.210-220.2003; Schneider KL, 2006, NUCLEIC ACIDS RES, V34, pD407, DOI 10.1093/nar/gkj134; Takemoto K, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-82; Takemoto K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-303; Wang HC, 2002, NUCLEIC ACIDS RES, V30, P2501, DOI 10.1093/nar/30.11.2501; Zhu DX, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-8	30	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e25874	10.1371/journal.pone.0025874	http://dx.doi.org/10.1371/journal.pone.0025874			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998711	Green Published, gold, Green Submitted			2022-12-27	WOS:000295968700023
J	Gril, B; Palmieri, D; Qian, Y; Anwar, T; Ileva, L; Bernardo, M; Choyke, P; Liewehr, DJ; Steinberg, SM; Steeg, PS				Gril, Brunilde; Palmieri, Diane; Qian, Yong; Anwar, Talha; Ileva, Lilia; Bernardo, Marcelino; Choyke, Peter; Liewehr, David J.; Steinberg, Seth M.; Steeg, Patricia S.			The B-Raf Status of Tumor Cells May Be a Significant Determinant of Both Antitumor and Anti-Angiogenic Effects of Pazopanib in Xenograft Tumor Models	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; BREAST-CANCER CELLS; P42/P44 MAP KINASE; PHASE-II; MUTATION ANALYSIS; OPEN-LABEL; HA-RAS; BRAF; INHIBITOR; PROGRESSION	Pazopanib is an FDA approved Vascular Endothelial Growth Factor Receptor inhibitor. We previously reported that it also inhibits tumor cell B-Raf activity in an experimental brain metastatic setting. Here, we determine the effects of different B-Raf genotypes on pazopanib efficacy, in terms of primary tumor growth and anti-angiogenesis. A panel of seven human breast cancer and melanoma cell lines harboring different mutations in the Ras-Raf pathway was implanted orthotopically in mice, and tumor growth, ERK1/2, MEK1/2 and AKT activation, and blood vessel density and permeability were analyzed. Pazopanib was significantly inhibitory to xenografts expressing either exon 11 mutations of B-Raf, or HER2 activated wild type B-Raf; no significant inhibition of a xenograft expressing the common V600E B-Raf mutation was observed. Decreased pMEK staining in the responsive tumors confirmed that B-Raf was targeted by pazopanib. Interestingly, pazopanib inhibition of tumor cell B-Raf also correlated with its anti-angiogenic activity, as quantified by vessel density and area. In conclusion, using pazopanib, tumor B-Raf status was identified as a significant determinant of both tumor growth and angiogenesis.	[Gril, Brunilde; Palmieri, Diane; Qian, Yong; Anwar, Talha; Steeg, Patricia S.] NCI, Womens Canc Sect, Mol Pharmacol Lab, Ctr Canc Res, Bethesda, MD 20892 USA; [Ileva, Lilia; Bernardo, Marcelino] NCI, Lab Anim Sci Program, Sci Applicat Int Corp Frederick, Frederick, MD 21701 USA; [Bernardo, Marcelino; Choyke, Peter] NCI, Mol Imaging Program, Ctr Canc Res, Frederick, MD 21701 USA; [Liewehr, David J.; Steinberg, Seth M.] NIH, Biostat & Data Management Sect, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gril, B (corresponding author), NCI, Womens Canc Sect, Mol Pharmacol Lab, Ctr Canc Res, Bethesda, MD 20892 USA.	grilbrun@mail.nih.gov	Palmieri, Diane/B-4258-2015; Liewehr, David J/GWV-3570-2022		National Cancer Institute; Department of Defense [W81XWH-062-0033]; GlaxoSmithKline; NATIONAL CANCER INSTITUTE [ZIABC010538] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); GlaxoSmithKline(GlaxoSmithKline); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the intramural program of the National Cancer Institute, by grant W81XWH-062-0033 from the Department of Defense Breast Cancer Research Program, and by funding from GlaxoSmithKline. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonio LV, 2003, J CLIN VIROL, V27, P263, DOI 10.1016/S1386-6532(02)00181-6; Altorki N, 2010, J CLIN ONCOL, V28, P3131, DOI 10.1200/JCO.2009.23.9749; Auner V, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-111; Berra E, 2000, BIOCHEM PHARMACOL, V60, P1171, DOI 10.1016/S0006-2952(00)00423-8; Bible KC, 2010, LANCET ONCOL, V11, P962, DOI 10.1016/S1470-2045(10)70203-5; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Brose MS, 2002, CANCER RES, V62, P6997; Carbonell WS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005857; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Carnahan J, 2010, MOL CANCER THER, V9, P2399, DOI 10.1158/1535-7163.MCT-10-0181; Chiosea S, 2010, HUM PATHOL, V41, P1053, DOI 10.1016/j.humpath.2010.01.008; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Dumaz N, 2006, CANCER RES, V66, P9483, DOI 10.1158/0008-5472.CAN-05-4227; Dvorak HF, 2002, J CLIN ONCOL, V20, P4368, DOI 10.1200/JCO.2002.10.088; Estep AL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001279; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Friedlander M, 2010, GYNECOL ONCOL, V119, P32, DOI 10.1016/j.ygyno.2010.05.033; Gril B, 2011, CLIN CANCER RES, V17, P142, DOI 10.1158/1078-0432.CCR-10-1603; GRUGEL S, 1995, J BIOL CHEM, V270, P25915, DOI 10.1074/jbc.270.43.25915; Hashimoto K, 2010, MOL CANCER THER, V9, P996, DOI 10.1158/1535-7163.MCT-09-0960; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hollestelle A, 2007, MOL CANCER RES, V5, P195, DOI 10.1158/1541-7786.MCR-06-0263; Hurwitz HI, 2009, CLIN CANCER RES, V15, P4220, DOI 10.1158/1078-0432.CCR-08-2740; Hutson TE, 2010, J CLIN ONCOL, V28, P475, DOI 10.1200/JCO.2008.21.6994; Jain RK, 2001, NAT MED, V7, P987, DOI 10.1038/nm0901-987; Kaplan FM, 2011, ONCOGENE, V30, P366, DOI 10.1038/onc.2010.408; Kikuchi H, 2009, CANCER RES, V69, P8499, DOI 10.1158/0008-5472.CAN-09-2213; King AJ, 2006, CANCER RES, V66, P11100, DOI 10.1158/0008-5472.CAN-06-2554; Kozma L, 1997, CANCER LETT, V111, P127, DOI 10.1016/S0304-3835(96)04527-2; Kumar R, 2007, MOL CANCER THER, V6, P2012, DOI 10.1158/1535-7163.MCT-07-0193; Kusters B, 2002, CANCER RES, V62, P341; Leenders WPJ, 2004, CLIN CANCER RES, V10, P6222, DOI 10.1158/1078-0432.CCR-04-0823; Milanini J, 1998, J BIOL CHEM, V273, P18165, DOI 10.1074/jbc.273.29.18165; Monk BJ, 2010, J CLIN ONCOL, V28, P3562, DOI 10.1200/JCO.2009.26.9571; Olaussen KA, 2009, ONCOGENE, V28, P4249, DOI 10.1038/onc.2009.277; Palmieri D, 2007, CANCER RES, V67, P4190, DOI 10.1158/0008-5472.CAN-06-3316; Podar K, 2006, P NATL ACAD SCI USA, V103, P19478, DOI 10.1073/pnas.0609329103; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Rak J, 2000, CANCER RES, V60, P490; Slamon D, 2008, J CLIN ONCOL, V26; Sleijfer S, 2009, J CLIN ONCOL, V27, P3126, DOI 10.1200/JCO.2008.21.3223; Smalley KSM, 2009, FUTURE ONCOL, V5, P775, DOI [10.2217/fon.09.56, 10.2217/FON.09.56]; Sternberg CN, 2010, J CLIN ONCOL, V28, P1061, DOI 10.1200/JCO.2009.23.9764; Tang KT, 2010, J CHIN MED ASSOC, V73, P113, DOI 10.1016/S1726-4901(10)70025-3; Waldmann V, 1996, J CANCER RES CLIN, V122, P207, DOI 10.1007/BF01209647; Wilhelm SM, 2008, MOL CANCER THER, V7, P3129, DOI 10.1158/1535-7163.MCT-08-0013; Yoneda T, 2001, J BONE MINER RES, V16, P1486, DOI 10.1359/jbmr.2001.16.8.1486	48	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25625	10.1371/journal.pone.0025625	http://dx.doi.org/10.1371/journal.pone.0025625			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998674	Green Published, gold, Green Submitted			2022-12-27	WOS:000295966900037
J	Li, QS; Bian, S; Hong, J; Kawase-Koga, Y; Zhu, E; Zheng, YR; Yang, LZ; Sun, T				Li, Qingsong; Bian, Shan; Hong, Janet; Kawase-Koga, Yoko; Zhu, Edwin; Zheng, Yongri; Yang, Lizhuang; Sun, Tao			Timing Specific Requirement of microRNA Function is Essential for Embryonic and Postnatal Hippocampal Development	PLOS ONE			English	Article							DENTATE GYRUS; NERVOUS-SYSTEM; STEM-CELLS; DORSAL TELENCEPHALON; CONDITIONAL LOSS; CEREBRAL-CORTEX; GRANULE CELLS; SMALL RNAS; C-ELEGANS; DICER	The adult hippocampus consists of the dentate gyrus (DG) and the CA1, CA2 and CA3 regions and is essential for learning and memory functions. During embryonic development, hippocampal neurons are derived from hippocampal neuroepithelial cells and dentate granular progenitors. The molecular mechanisms that control hippocampal progenitor proliferation and differentiation are not well understood. Here we show that noncoding microRNAs (miRNAs) are essential for early hippocampal development in mice. Conditionally ablating the RNAase III enzyme Dicer at different embryonic time points utilizing three Cre mouse lines causes abnormal hippocampal morphology and affects the number of hippocampal progenitors due to altered proliferation and increased apoptosis. Lack of miRNAs at earlier stages causes early differentiation of hippocampal neurons, in particular in the CA1 and DG regions. Lack of miRNAs at a later stage specifically affects neuronal production in the CA3 region. Our results reveal a timing requirement of miRNAs for the formation of specific hippocampal regions, with the CA1 and DG developmentally hindered by an early loss of miRNAs and the CA3 region to a late loss of miRNAs. Collectively, our studies indicate the importance of the Dicer-mediated miRNA pathway in hippocampal development and functions.	[Li, Qingsong; Bian, Shan; Hong, Janet; Sun, Tao] Cornell Univ, Weill Med Coll, Dept Cell & Dev Biol, New York, NY 10021 USA; [Li, Qingsong; Zheng, Yongri; Yang, Lizhuang] Harbin Med Coll, Affiliated Hosp 2, Harbin, Heilongjiang, Peoples R China; [Kawase-Koga, Yoko] Tokyo Univ Hosp, Dept Oral & Maxillofacial Surg, Tokyo 113, Japan; [Zhu, Edwin] NYU, Dept Biol, New York, NY 10003 USA	Cornell University; Harbin Medical University; University of Tokyo; New York University	Li, QS (corresponding author), Cornell Univ, Weill Med Coll, Dept Cell & Dev Biol, New York, NY 10021 USA.	tas2009@med.cornell.edu			Ellison Medical Foundation; Hirschl/Weill-Caulier Trust; National Institute of Mental Health (NIMH) [R01MH083680]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083680] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); Hirschl/Weill-Caulier Trust; National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Ellison Medical Foundation (Dr. Sun), an award from the Hirschl/Weill-Caulier Trust (Dr. Sun) and an R01MH083680 grant from the National Institute of Mental Health (NIMH)(Dr. Sun). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Buylla A, 1998, J NEUROBIOL, V36, P105, DOI 10.1002/(SICI)1097-4695(199808)36:2<105::AID-NEU1>3.0.CO;2-5; Andersson T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013453; Bagri A, 2002, DEVELOPMENT, V129, P4249; Bulchand S, 2001, MECH DEVELOP, V100, P165, DOI 10.1016/S0925-4773(00)00515-3; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Cecchi C, 2000, TRENDS NEUROSCI, V23, P347, DOI 10.1016/S0166-2236(00)01608-8; Davis TH, 2008, J NEUROSCI, V28, P4322, DOI 10.1523/JNEUROSCI.4815-07.2008; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Eisch AJ, 2008, J NEUROSCI, V28, P11785, DOI 10.1523/JNEUROSCI.3798-08.2008; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Furuta Y, 1997, DEVELOPMENT, V124, P2203; Galceran J, 2000, DEVELOPMENT, V127, P469; Goebbels S, 2006, GENESIS, V44, P611, DOI 10.1002/dvg.20256; Gorski JA, 2002, J NEUROSCI, V22, P6309; Grove EA, 1998, DEVELOPMENT, V125, P2315; Hammond SM, 2005, FEBS LETT, V579, P5822, DOI 10.1016/j.febslet.2005.08.079; Hebert SS, 2010, HUM MOL GENET, V19, P3959, DOI 10.1093/hmg/ddq311; Huang TW, 2010, J MOL CELL BIOL, V2, P152, DOI 10.1093/jmcb/mjq008; Kawase-Koga Y, 2010, J CELL SCI, V123, P586, DOI 10.1242/jcs.059659; Kawase-Koga Y, 2009, DEV DYNAM, V238, P2800, DOI 10.1002/dvdy.22109; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kim VN, 2004, TRENDS CELL BIOL, V14, P156, DOI 10.1016/j.tcb.2004.02.006; Konopka W, 2010, J NEUROSCI, V30, P14835, DOI 10.1523/JNEUROSCI.3030-10.2010; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee SMK, 2000, DEVELOPMENT, V127, P457; Li GN, 2005, DEV NEUROSCI-BASEL, V27, P93, DOI 10.1159/000085980; Li GN, 2007, PROG BRAIN RES, V163, P143, DOI 10.1016/S0079-6123(07)63008-8; Mangale VS, 2008, SCIENCE, V319, P304, DOI 10.1126/science.1151695; Monuki ES, 2001, NEURON, V32, P591, DOI 10.1016/S0896-6273(01)00504-9; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Obernosterer G, 2007, NAT PROTOC, V2, P1508, DOI 10.1038/nprot.2007.153; Pellegrini M, 1996, DEVELOPMENT, V122, P3893; Sun T, 2000, DEVELOPMENT, V127, P4519; Tonelli DD, 2008, DEVELOPMENT, V135, P3911, DOI 10.1242/dev.025080; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Yoshida M, 1997, DEVELOPMENT, V124, P101; Zhao YU, 1999, SCIENCE, V284, P1155, DOI 10.1126/science.284.5417.1155	38	48	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e26000	10.1371/journal.pone.0026000	http://dx.doi.org/10.1371/journal.pone.0026000			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21991391	Green Submitted, Green Published, gold			2022-12-27	WOS:000295963300032
J	Li, HD; Huang, C; Huang, KJ; Wu, WD; Jiang, T; Cao, J; Feng, ZZ; Qiu, ZJ				Li, Hai Dong; Huang, Chen; Huang, Ke Jian; Wu, Wei Dong; Jiang, Tao; Cao, Jun; Feng, Zhen Zhong; Qiu, Zheng Jun			STAT3 Knockdown Reduces Pancreatic Cancer Cell Invasiveness and Matrix Metalloproteinase-7 Expression in Nude Mice	PLOS ONE			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; EPIDERMAL-GROWTH-FACTOR; NF-KAPPA-B; SIGNAL TRANSDUCERS; MMP-7 EXPRESSION; TISSUE INHIBITOR; TUMOR INVASION; METASTASIS; ACTIVATION; INDUCTION	Aims: Transducer and activator of transcription-3 (STAT3) plays an important role in tumor cell invasion and metastasis. The aim of the present study was to investigate the effects of STAT3 knockdown in nude mouse xenografts of pancreatic cancer cells and underlying gene expression. Methods: A STAT3 shRNA lentiviral vector was constructed and infected into SW1990 cells. qRT-PCR and western immunoblot were performed to detect gene expression. Nude mouse xenograft assays were used to assess changes in phenotypes of these stable cells in vivo. HE staining was utilized to evaluate tumor cell invasion and immunohistochemistry was performed to analyze gene expression. Results: STAT3 shRNA successfully silenced expression of STAT3 mRNA and protein in SW1990 cells compared to control cells. Growth rate of the STAT3-silenced tumor cells in nude mice was significantly reduced compared to in the control vector tumors and parental cells-generated tumors. Tumor invasion into the vessel and muscle were also suppressed in the STAT3-silenced tumors compared to controls. Collagen IV expression was complete and continuous surrounding the tumors of STAT3-silenced SW1990 cells, whereas collagen IV expression was incomplete and discontinuous surrounding the control tumors. Moreover, microvessel density was significantly lower in STAT3-silenced tumors than parental or control tumors of SW1990 cells. In addition, MMP-7 expression was reduced in STAT3-silenced tumors compared to parental SW1990 xenografts and controls. In contrast, expression of IL-1 beta and IgT7 alpha was not altered. Conclusion: These data clearly demonstrate that STAT3 plays an important role in regulation of tumor growth, invasion, and angiogenesis, which could be act by reducing MMP-7 expression in pancreatic cancer cells.	[Li, Hai Dong; Huang, Chen; Huang, Ke Jian; Wu, Wei Dong; Jiang, Tao; Cao, Jun; Qiu, Zheng Jun] Shanghai Jiao Tong Univ, Dept Gen Surg, Affiliated Peoples Hosp 1, Shanghai 200030, Peoples R China; [Li, Hai Dong; Huang, Chen; Qiu, Zheng Jun] Shanghai Key Lab Pancreas Dis, Shanghai, Peoples R China; [Li, Hai Dong; Huang, Chen; Qiu, Zheng Jun] Shanghai Jiao Tong Univ, Pancreat Canc Ctr, Shanghai 200030, Peoples R China; [Feng, Zhen Zhong] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 1, Dept Pathol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Li, HD (corresponding author), Shanghai Jiao Tong Univ, Dept Gen Surg, Affiliated Peoples Hosp 1, Shanghai 200030, Peoples R China.	qiuwryb@gmail.com			Science and Technology Commission of Shanghai Municipality [09QA1404600]	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by a grant (No. 09QA1404600) awarded by fund for scientific research of Science and Technology Commission of Shanghai Municipality. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara R, 2005, BRIT J SURG, V92, P454, DOI 10.1002/bjs.4868; Beeghly-Fadiel A, 2008, CANCER RES, V68, P6453, DOI 10.1158/0008-5472.CAN-08-0636; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Caldera V, 2008, J ONCOL, V2008, DOI 10.1155/2008/219241; Christine R, 2005, CANCER RES, V65, P195; Dien J, 2006, AM J PATHOL, V169, P633, DOI 10.2353/ajpath.2006.051109; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Glienke W, 2011, PANCREAS, V40, P323, DOI 10.1097/MPA.0b013e318204ea7b; Hao XS, 2004, CANCER-AM CANCER SOC, V100, P1110, DOI 10.1002/cncr.20095; HAYASHI Y, 2011, CANC SCI; Huang C, 2006, CANCER SCI, V97, P1417, DOI 10.1111/j.1349-7006.2006.00340.x; Huang C, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-51; Itoh M, 2006, ONCOGENE, V25, P1195, DOI 10.1038/sj.onc.1209149; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jones LE, 2004, CLIN CANCER RES, V10, P2832, DOI 10.1158/1078-0432.CCR-1157-03; Leslie K, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2725; Li J, 2009, WORLD J GASTROENTERO, V15, P2602, DOI 10.3748/wjg.15.2602; Li WC, 2006, CLIN CANCER RES, V12, P7140, DOI 10.1158/1078-0432.CCR-06-0484; Lopez MA, 2005, AM J PHYSIOL-CELL PH, V288, pC282, DOI 10.1152/ajpcell.00362.2003; Mukhopadhyay UK, 2010, MOL CELL BIOL, V30, P4980, DOI 10.1128/MCB.00004-10; Nagai S, 2008, CANCER SCI, V99, P1377, DOI 10.1111/j.1349-7006.2008.00822.x; Nagaraj NS, 2011, CLIN CANCER RES, V17, P483, DOI 10.1158/1078-0432.CCR-10-1670; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Niwa Y, 2005, ONCOGENE, V24, P6406, DOI 10.1038/sj.onc.1208788; O'Kane CM, 2010, AM J RESP CELL MOL, V43, P465, DOI 10.1165/rcmb.2009-0211OC; Qiu ZJ, 2007, CANCER SCI, V98, P1099, DOI 10.1111/j.1349-7006.2007.00485.x; Qu P, 2009, CANCER RES, V69, P7252, DOI 10.1158/0008-5472.CAN-09-0577; Shi M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-269; Song YH, 2008, MOL IMMUNOL, V45, P137, DOI 10.1016/j.molimm.2007.04.031; Tan X, 2005, INT J ONCOL, V26, P1283; Tsunoda S, 2007, CANCER SCI, V98, P541, DOI 10.1111/j.1349-7006.2007.00432.x; Wang L, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-14; Wang L, 2009, CANCER EPIDEM BIOMAR, V18, P2829, DOI 10.1158/1055-9965.EPI-09-0557; Wu Y, 2009, CANCER CELL, V15, P416, DOI 10.1016/j.ccr.2009.03.016; Xie TX, 2006, CANCER RES, V66, P3188, DOI 10.1158/0008-5472.CAN-05-2674; Xie TX, 2004, ONCOGENE, V23, P3550, DOI 10.1038/sj.onc.1207383; Xiong H, 2008, NEOPLASIA, V10, P287, DOI 10.1593/neo.07971; Yakata Y, 2007, INT J ONCOL, V30, P437; Yang G, 2009, WORLD J GASTROENTERO, V15, P3757, DOI 10.3748/wjg.15.3757; Yokoyama Y, 2008, CLIN CANCER RES, V14, P5503, DOI 10.1158/1078-0432.CCR-07-4041; Yuan GG, 2008, CELL SIGNAL, V20, P1284, DOI 10.1016/j.cellsig.2008.02.017; ZHAO M, 2011, LUNG CANC; Zhao SJ, 2008, CANCER RES, V68, P4221, DOI 10.1158/0008-5472.CAN-07-5123; Zhou DH, 2008, HEPATOB PANCREAT DIS, V7, P201	44	50	53	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25941	10.1371/journal.pone.0025941	http://dx.doi.org/10.1371/journal.pone.0025941			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991388	Green Published, Green Submitted, gold			2022-12-27	WOS:000295943000096
J	Marella, M; Seo, BB; Flotte, TR; Matsuno-Yagi, A; Yagi, T				Marella, Mathieu; Seo, Byoung Boo; Flotte, Terence R.; Matsuno-Yagi, Akemi; Yagi, Takao			No Immune Responses by the Expression of the Yeast Ndi1 Protein in Rats	PLOS ONE			English	Article							NADH-QUINONE OXIDOREDUCTASE; COMPLEX-I DEFECTS; GENE-THERAPY; ADENOASSOCIATED VIRUS; DEHYDROGENASE NDI1; SUBUNIT; DISEASE; CELLS; VIVO; TRANSDUCTION	Background: The rotenone-insensitive internal NADH-quinone oxidoreductase from yeast, Ndi1, has been shown to work as a replacement molecule for complex I in the respiratory chain of mammalian mitochondria. In the so-called transkingdom gene therapy, one major concern is the fact that the yeast protein is foreign in mammals. Long term expression of Ndi1 observed in rodents with no apparent damage to the target tissue was indicative of no action by the host's immune system. Methodology/Principal Findings: In the present study, we examined rat skeletal muscles expressing Ndi1 for possible signs of inflammatory or immune response. In parallel, we carried out delivery of the GFP gene using the same viral vector that was used for the NDI1 gene. The tissues were subjected to H&E staining and immunohistochemical analyses using antibodies specific for markers, CD11b, CD3, CD4, and CD8. The data showed no detectable signs of an immune response with the tissues expressing Ndi1. In contrast, mild but distinctive positive reactions were observed in the tissues expressing GFP. This clear difference most likely comes from the difference in the location of the expressed protein. Ndi1 was localized to the mitochondria whereas GFP was in the cytosol. Conclusions/Significance: We demonstrated that Ndi1 expression did not trigger any inflammatory or immune response in rats. These results push forward the Ndi1-based molecular therapy and also expand the possibility of using foreign proteins that are directed to subcellular organelle such as mitochondria.	[Marella, Mathieu; Seo, Byoung Boo; Matsuno-Yagi, Akemi; Yagi, Takao] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Flotte, Terence R.] Univ Massachusetts, Sch Med, Gene Therapy Ctr, Worcester, MA USA; [Flotte, Terence R.] Univ Massachusetts, Sch Med, Dept Pediat, Worcester, MA USA	Scripps Research Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Marella, M (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	yagi@scripps.edu			United States Public Health Service [R01EY020796, R01DK053244, R01HL069877]; NATIONAL EYE INSTITUTE [R01EY020796] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069877] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053244] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by United States Public Health Service Grants R01EY020796 and R01DK053244 (to TY and AM-Y) and R01HL069877 (to TRF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai YD, 2001, J BIOL CHEM, V276, P38808, DOI 10.1074/jbc.M106363200; Barber-Singh J., 2010, PARKINSONS DIS, V2011, DOI DOI 10.4061/2011.438370; Barber-Singh J, 2009, REJUV RES, V12, P259, DOI 10.1089/rej.2009.0854; Christ M, 2002, TOXICOLOGY, V174, P13, DOI 10.1016/S0300-483X(02)00052-5; DeCorby A, 2007, BBA-BIOENERGETICS, V1767, P1157, DOI 10.1016/j.bbabio.2007.07.003; Fisher KJ, 1997, NAT MED, V3, P306, DOI 10.1038/nm0397-306; FREGEAU DR, 1990, J IMMUNOL, V144, P1671; GEHRMANN J, 1995, BRAIN RES REV, V20, P269, DOI 10.1016/0165-0173(94)00015-H; Janssen RJRJ, 2004, EXPERT REV MOL DIAGN, V4, P143, DOI 10.1586/14737159.4.2.143; Jooss K, 1998, J VIROL, V72, P4212, DOI 10.1128/JVI.72.5.4212-4223.1998; LINDAHL KF, 1989, COLD SH Q B, V54, P563; LOVELAND B, 1990, CELL, V60, P971, DOI 10.1016/0092-8674(90)90345-F; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Marella M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001433; Marella M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011472; Marella M, 2009, J BIOENERG BIOMEMBR, V41, P493, DOI 10.1007/s10863-009-9249-z; Muruve DA, 1999, HUM GENE THER, V10, P965, DOI 10.1089/10430349950018364; Perry CN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016288; Sanz A, 2010, P NATL ACAD SCI USA, V107, P9105, DOI 10.1073/pnas.0911539107; Seo BB, 1998, P NATL ACAD SCI USA, V95, P9167, DOI 10.1073/pnas.95.16.9167; Seo BB, 2004, HUM GENE THER, V15, P887, DOI 10.1089/1043034041839217; Seo BB, 2006, J BIOL CHEM, V281, P14250, DOI 10.1074/jbc.M600922200; Simpson E, 2006, IMMUNOL REV, V213, P12, DOI 10.1111/j.1600-065X.2006.00434.x; Stripecke R, 1999, GENE THER, V6, P1305, DOI 10.1038/sj.gt.3300951; Xiao XA, 1996, J VIROL, V70, P8098, DOI 10.1128/JVI.70.11.8098-8108.1996; Yagi T, 2006, REJUV RES, V9, P191, DOI 10.1089/rej.2006.9.191; Yagi T, 2006, BBA-BIOENERGETICS, V1757, P708, DOI 10.1016/j.bbabio.2006.01.011; Zaiss AK, 2005, CURR GENE THER, V5, P323, DOI 10.2174/1566523054065039	28	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25910	10.1371/journal.pone.0025910	http://dx.doi.org/10.1371/journal.pone.0025910			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991386	Green Submitted, Green Published, gold			2022-12-27	WOS:000295943000094
J	Nilvebrant, J; Alm, T; Hober, S; Lofblom, J				Nilvebrant, Johan; Alm, Tove; Hober, Sophia; Lofblom, John			Engineering Bispecificity into a Single Albumin-Binding Domain	PLOS ONE			English	Article							HUMAN SERUM-ALBUMIN; STREPTOCOCCAL PROTEIN-G; ANTIBODY FRAGMENTS; SURFACE DISPLAY; MOLECULAR-SIZE; AFFINITY; BUNDLE; THERAPEUTICS; PURIFICATION; GENERATION	Bispecific antibodies as well as non-immunoglobulin based bispecific affinity proteins are considered to have a very high potential in future biotherapeutic applications. In this study, we report on a novel approach for generation of extremely small bispecific proteins comprised of only a single structural domain. Binding to tumor necrosis factor-alpha (TNF-alpha) was engineered into an albumin-binding domain while still retaining the original affinity for albumin, resulting in a bispecific protein composed of merely 46 amino acids. By diversification of the non albumin-binding side of the three-helix bundle domain, followed by display of the resulting library on phage particles, bispecific single-domain proteins were isolated using selections with TNF-alpha as target. Moreover, based on the obtained sequences from the phage selection, a second-generation library was designed in order to further increase the affinity of the bispecific candidates. Staphylococcal surface display was employed for the affinity maturation, enabling efficient isolation of improved binders as well as multiparameter-based sortings with both TNF-alpha and albumin as targets in the same selection cycle. Isolated variants were sequenced and the binding to albumin and TNF-alpha was analyzed. This analysis revealed an affinity for TNF-alpha below 5 nM for the strongest binders. From the multiparameter sorting that simultaneously targeted TNF-alpha and albumin, several bispecific candidates were isolated with high affinity to both antigens, suggesting that cell display in combination with fluorescence activated cell sorting is a suitable technology for engineering of bispecificity. To our knowledge, the new binders represent the smallest engineered bispecific proteins reported so far. Possibilities and challenges as well as potential future applications of this novel strategy are discussed.	[Nilvebrant, Johan; Alm, Tove; Hober, Sophia] AlbaNova Univ Ctr, Dept Prote, Sch Biotechnol, Stockholm, Sweden; [Lofblom, John] AlbaNova Univ Ctr, Dept Mol Biotechnol, Sch Biotechnol, Royal Inst Technol, Stockholm, Sweden	Royal Institute of Technology	Nilvebrant, J (corresponding author), AlbaNova Univ Ctr, Dept Prote, Sch Biotechnol, Stockholm, Sweden.	sophia@biotech.kth.se	Lofblom, John/A-6805-2012	Lofblom, John/0000-0001-9423-0541	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was funded by the Swedish Research Council (www.vr.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm T, 2010, BIOTECHNOL J, V5, P605, DOI 10.1002/biot.201000041; Andersen JT, 2011, J BIOL CHEM, V286, P5234, DOI 10.1074/jbc.M110.164848; Boder ET, 2000, P NATL ACAD SCI USA, V97, P10701, DOI 10.1073/pnas.170297297; Carter PJ, 2011, EXP CELL RES, V317, P1261, DOI 10.1016/j.yexcr.2011.02.013; Engfeldt T, 2005, CHEMBIOCHEM, V6, P1043, DOI 10.1002/cbic.200400388; Esposito E, 2009, CURR MED CHEM, V16, P3152, DOI 10.2174/092986709788803024; Gulich S, 2000, J BIOTECHNOL, V80, P169, DOI 10.1016/S0168-1656(00)00259-5; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; HOPP J, PROTEIN ENG DES SEL, V23, P827; Johansson MU, 2002, J BIOL CHEM, V277, P8114, DOI 10.1074/jbc.M109943200; Jonsson A, 2008, PROTEIN ENG DES SEL, V21, P515, DOI 10.1093/protein/gzn028; Jonsson A, 2009, BIOTECHNOL APPL BIOC, V54, P93, DOI 10.1042/BA20090085; Kraulis PJ, 1996, FEBS LETT, V378, P190, DOI 10.1016/0014-5793(95)01452-7; Kronqvist N, 2008, PROTEIN ENG DES SEL, V21, P247, DOI 10.1093/protein/gzm090; Kronqvist Nina, 2010, Recent Pat Biotechnol, V4, P171, DOI 10.2174/187220810793611536; Leader B, 2008, NAT REV DRUG DISCOV, V7, P21, DOI 10.1038/nrd2399; Lejon S, 2004, J BIOL CHEM, V279, P42924, DOI 10.1074/jbc.M406957200; Linhult M, 2002, PROTEIN SCI, V11, P206, DOI 10.1110/ps.02802; Lofblom J, 2007, J APPL MICROBIOL, V102, P736, DOI 10.1111/j.1365-2672.2006.03127.x; Lofblom J, 2005, FEMS MICROBIOL LETT, V248, P189, DOI 10.1016/j.femsle.2005.05.040; Lofblom J, 2010, FEBS LETT, V584, P2670, DOI 10.1016/j.febslet.2010.04.014; Lofblom J, 2011, CURR OPIN BIOTECH, V022, P1; Miao Z., 2010, AMINO ACIDS, P1; Nygren PA, 2008, FEBS J, V275, P2668, DOI 10.1111/j.1742-4658.2008.06438.x; Reichert JM, 2008, CURR PHARM BIOTECHNO, V9, P423, DOI 10.2174/138920108786786358; Roopenian DC, 2010, J CLIN IMMUNOL, V30, P790, DOI 10.1007/s10875-010-9458-6; RUTHER U, 1982, NUCLEIC ACIDS RES, V10, P5765, DOI 10.1093/nar/10.19.5765; Schmidt MM, 2009, MOL CANCER THER, V8, P2861, DOI 10.1158/1535-7163.MCT-09-0195; STAHL S, 1989, J IMMUNOL METHODS, V124, P43, DOI 10.1016/0022-1759(89)90184-1; Zahnd C, 2010, CANCER RES, V70, P1595, DOI 10.1158/0008-5472.CAN-09-2724	30	30	35	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25791	10.1371/journal.pone.0025791	http://dx.doi.org/10.1371/journal.pone.0025791			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991353	gold, Green Published, Green Submitted			2022-12-27	WOS:000295943000071
J	Geier, J; Hudak, M				Geier, Janos; Hudak, Mariann			Changing the Chevreul Illusion by a Background Luminance Ramp: Lateral Inhibition Fails at Its Traditional Stronghold - A Psychophysical Refutation	PLOS ONE			English	Article							HERMANN GRID ILLUSION; BRIGHTNESS PERCEPTION; NEURAL DYNAMICS; LIGHTNESS; INDUCTION; CONTRAST; MODEL; ORGANIZATION; EYE	The Chevreul illusion is a well-known 19(th) century brightness illusion, comprising adjacent homogeneous grey bands of different luminance, which are perceived as inhomogeneous. It is generally explained by lateral inhibition, according to which brighter areas projected to the retina inhibit the sensitivity of neighbouring retinal areas. Lateral inhibition has been considered the foundation-stone of early vision for a century, upon which several computational models of brightness perception are built. One of the last strongholds of lateral inhibition is the Chevreul illusion, which is often illustrated even in current textbooks. Here we prove that lateral inhibition is insufficient to explain the Chevreul illusion. For this aim, we placed the Chevreul staircase in a luminance ramp background, which noticeably changed the illusion. In our psychophysical experiments, all 23 observers reported a strong illusion, when the direction of the ramp was identical to that of the staircase, and all reported homogeneous steps (no illusion) when its direction was the opposite. When the background of the staircase was uniform, 14 saw the illusion, and 9 saw no illusion. To see whether the change of the entire background area or that of the staircase boundary edges were more important, we placed another ramp around the staircase, whose direction was opposite to that of the original, larger ramp. The result is that though the inner ramp is rather narrow (mean = 0.51 deg, SD = 0.48 deg, N = 23), it still dominates perception. Since all conditions of the lateral inhibition account were untouched within the staircase, lateral inhibition fails to model these perceptual changes. Area ratios seem insignificant; the role of boundary edges seems crucial. We suggest that long range interactions between boundary edges and areas enclosed by them, such that diffusion-based models describe, provide a much more plausible account for these brightness phenomena, and local models are insufficient.	[Geier, Janos] Stereo Vis Ltd, Budapest, Hungary; [Hudak, Mariann] Budapest Univ Technol & Econ, Fac Nat Sci, Dept Cognit Sci, H-1117 Budapest, Hungary; [Hudak, Mariann] Budapest Univ Technol & Econ, Hungarian Acad Sci, Res Grp Cognit Sci, H-1117 Budapest, Hungary	Budapest University of Technology & Economics; Budapest University of Technology & Economics; Hungarian Academy of Sciences	Geier, J (corresponding author), Stereo Vis Ltd, Budapest, Hungary.	janos@geier.hu			Stereo Vision Ltd.	Stereo Vision Ltd.	This study was funded by Stereo Vision Ltd. through the directorship and 50% ownership of Janos Geier, who designed the experiments, contributed to the analysis and wrote the paper.	Adelson E. H., 2000, NEW COGNITIVE NEUROS, V339, P339, DOI DOI 10.1068/P230869; ADELSON EH, 1993, SCIENCE, V262, P2042, DOI 10.1126/science.8266102; Anderson BL, 1997, PERCEPTION, V26, P419, DOI 10.1068/p260419; Anderson BL, 2005, NATURE, V434, P79, DOI 10.1038/nature03271; Blake  R., 2006, PERCEPTION; Blakeslee B, 1999, VISION RES, V39, P4361, DOI 10.1016/S0042-6989(99)00119-4; COHEN MA, 1984, PERCEPT PSYCHOPHYS, V36, P428, DOI 10.3758/BF03207497; Geier J, 2008, PERCEPTION, V37, P651, DOI 10.1068/p5622; Gilchrist A., 2006, SEEING BLACK WHITE; Goldstein E B, 2009, SENSATION PERCEPTION; GROSSBERG S, 1988, PERCEPT PSYCHOPHYS, V43, P241, DOI 10.3758/BF03207869; HARTLINE HK, 1956, J GEN PHYSIOL, V39, P651, DOI 10.1085/jgp.39.5.651; HARTLINE HK, 1949, FED PROC, V8, P69; JAMESON D, 1975, LEONARDO, V8, P125, DOI 10.2307/1572954; KINGDOM F, 1992, VISION RES, V32, P1565, DOI 10.1016/0042-6989(92)90212-2; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P57; Logvinenko AD, 1999, PERCEPTION, V28, P803, DOI 10.1068/p2801; McArthur JA, 1999, VISION RES, V39, P1199, DOI 10.1016/S0042-6989(98)00216-8; Otazu X, 2008, VISION RES, V48, P733, DOI 10.1016/j.visres.2007.12.008; PESSOA L, 1995, VISION RES, V35, P2201, DOI 10.1016/0042-6989(94)00313-0; Ratliff F., 1965, MACH BANDS QUANTITAT; RODIECK R. W., 1965, VISION RES, V5, P583, DOI 10.1016/0042-6989(65)90033-7; SPILLMANN L, 1994, PERCEPTION, V23, P691, DOI 10.1068/p230691; von Bekesy G, 1967, SENSORY INHIBITION; von Bezold W., 1874, FARBENLEHRER HINBLIC; Watt J., 1985, VISION RES, V25, P1661; WHITE M, 1979, PERCEPTION, V8, P413, DOI 10.1068/p080413	27	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e26062	10.1371/journal.pone.0026062	http://dx.doi.org/10.1371/journal.pone.0026062			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834QT	22022508	Green Submitted, gold, Green Published			2022-12-27	WOS:000295978600038
J	Baba-Moussa, L; Sina, H; Scheftel, JM; Moreau, B; Sainte-Marie, D; Kotchoni, SO; Prevost, G; Couppie, P				Baba-Moussa, Lamine; Sina, Haziz; Scheftel, Jean-Michel; Moreau, Brigitte; Sainte-Marie, Dominique; Kotchoni, Simeon O.; Prevost, Gilles; Couppie, Pierre			Staphylococcal Panton-Valentine Leucocidin as a Major Virulence Factor Associated to Furuncles	PLOS ONE			English	Article							SOFT-TISSUE INFECTIONS; LEUKOCIDIN GENES; NASAL CARRIAGE; S-COMPONENT; LUKE-LUKD; AUREUS; STRAINS; PNEUMONIA; FAMILY; SKIN	Panton-Valentine Leucocidin (PVL), one of the beta-barrel pore-forming staphylococcal leucotoxins, is known to be associated to furuncles and some severe community pneumonia. However, it is still uncertain how many other virulence factors are also associated to furuncles and what the risk factors of furuncles are in immuno-compromised status of patients, especially the HIV (+) patients. In this paper, we use antigen immunoprecipitation and multiplex PCR approach to determine the presence of 19 toxins, 8 adhesion factors and the PFGE profiles associated to furuncles in three independent patient study groups of S. aureus (SA) isolates collected from the Cayenne General Hospital (French Guiana). The patient groups were made of: 16 isolates from HIV (-) patients, 9 from HIV (+) patients suffering from furuncles, and 30 control isolates from patients with diverse secondary infected dermatitis. Our data reveals that the majority (96%) of SA strains isolated from HIV patient-derived furuncles significantly produced PVL (p<10(-7)), whereas only 10% of SA strains produced this toxin in secondary infected dermatosis. A high prevalence of LukE-LukD-producing isolates (56 to 78%) was recorded in patient groups. Genes encoding clumping factor B, collagen-and laminin-binding proteins (clfB, cna, lbp, respectively) were markedly frequent (30 to 55%), without being associated to a specific group. Pulse field gel electrophoresis evidenced 24 overall pulsotypes, whereas the 25 PVL-producing isolates were distributed into 15 non clonal fingerprints. These pulsotypes were not specific PVL-producing isolates. PVL appears to be the major virulence factor associated to furuncles in Europe and in South America regardless of the immune status of the HIV patients.	[Baba-Moussa, Lamine; Sina, Haziz] Univ Abomey Calavi, Dept Biochim & Biol Cellulaire, Cotonou, Benin; [Scheftel, Jean-Michel; Prevost, Gilles] Inst Bacteriol, Unite EA Physiopathol & Med 4438, Strasbourg, France; [Moreau, Brigitte] Ctr Hosp Cayenne, Serv Biol Polyvalente, Cayenne, French Guiana; [Sainte-Marie, Dominique; Couppie, Pierre] Ctr Hosp Cayenne, Serv Dermatol, Cayenne, French Guiana; [Sainte-Marie, Dominique; Couppie, Pierre] Inst Guyanais Dermatol Trop, Cayenne, French Guiana; [Kotchoni, Simeon O.] Rutgers State Univ, Dept Biol, Camden, NJ 08102 USA	University of Abomey Calavi; Rutgers State University Camden; Rutgers State University New Brunswick	Baba-Moussa, L (corresponding author), Univ Abomey Calavi, Dept Biochim & Biol Cellulaire, Cotonou, Benin.	laminesaid@yahoo.fr		SINA, Haziz/0000-0001-8630-3798; Couppie, Pierre/0000-0002-4213-2867				Baba-Moussa L, 2008, J HOSP INFECT, V68, P32, DOI 10.1016/j.jhin.2007.10.010; Baba-Moussa L, 2010, AFR J BIOTECHNOL, V9, P604; BABAMOUSSA L, 1999, MED MALADIES INFECT, V29, P689; Baggett HC, 2004, J INFECT DIS, V189, P1565, DOI 10.1086/383247; Bronner S, 2000, APPL ENVIRON MICROB, V66, P3931, DOI 10.1128/AEM.66.9.3931-3938.2000; CARRE N, 2011, MED MALADIES INFECT, V10, P1016; COUPPIE P, 1994, ARCH DERMATOL, V130, P1208, DOI 10.1001/archderm.130.9.1208; Defres S, 2009, EUR RESPIR J, V34, P1470, DOI 10.1183/09031936.00122309; Del Giudice P, 2011, DERMATOLOGY, V222, P167, DOI 10.1159/000324044; Diep BA, 2004, J CLIN MICROBIOL, V42, P2080, DOI 10.1128/JCM.42.5.2080-2084.2004; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; Gauduchon V, 2001, INFECT IMMUN, V69, P2390, DOI 10.1128/IAI.69.4.2390-2395.2001; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Gravet A, 1998, FEBS LETT, V436, P202, DOI 10.1016/S0014-5793(98)01130-2; Gravet A, 2001, J CLIN MICROBIOL, V39, P4349, DOI 10.1128/JCM.39.12.4349-4356.2001; Gravet A, 1999, J CLIN MICROBIOL, V37, P4012, DOI 10.1128/JCM.37.12.4012-4019.1999; Guillet V, 2004, J BIOL CHEM, V279, P41028, DOI 10.1074/jbc.M406904200; Holmes A, 2005, J CLIN MICROBIOL, V43, P2384, DOI 10.1128/JCM.43.5.2384-2390.2005; Liassine N, 2004, J CLIN MICROBIOL, V42, P825, DOI 10.1128/JCM.42.2.825-828.2004; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Linde H, 2005, EUR J CLIN MICROBIOL, V24, P419, DOI 10.1007/s10096-005-1341-7; MITHOE D, 2011, EUR J CLIN MICROBIOL, DOI DOI 10.1007/S10096-011-1316-9O; Naas T, 2005, J HOSP INFECT, V61, P321, DOI 10.1016/j.jhin.2005.01.027; *NAT COMM CLIN LAB, 2010, M100S12 NCCLS; Nguyen MH, 1999, ANN INTERN MED, V130, P221, DOI 10.7326/0003-4819-130-3-199902020-00026; Panton PN, 1932, LANCET, V1, P506; Pedelacq JD, 1999, STRUCTURE, V7, P277, DOI 10.1016/S0969-2126(99)80038-0; Pitche P, 1995, Sante, V5, P349; PREVOST G, 1991, J HOSP INFECT, V17, P255, DOI 10.1016/0195-6701(91)90270-I; PREVOST G, 1995, J MED MICROBIOL, V42, P237, DOI 10.1099/00222615-42-4-237; PREVOST G, 1995, INFECT IMMUN, V63, P4121; Prevost Gilles, 2005, P243; RAVIGLIONE MC, 1990, AM J INFECT CONTROL, V18, P64, DOI 10.1016/0196-6553(90)90083-5; Seiberling KA, 2005, LARYNGOSCOPE, V115, P1580, DOI 10.1097/01.mlg.0000168111.11802.9c; SMITH KJ, 1994, ARCH DERMATOL, V130, P521, DOI 10.1001/archderm.130.4.521; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; von Eiff C, 2004, DIAGN MICR INFEC DIS, V49, P157, DOI 10.1016/j.diagmicrobio.2004.03.009; WARD PD, 1980, INFECT IMMUN, V28, P393; Yamasaki O, 2005, CLIN INFECT DIS, V40, P381, DOI 10.1086/427290	39	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25716	10.1371/journal.pone.0025716	http://dx.doi.org/10.1371/journal.pone.0025716			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022439	Green Submitted, Green Published, gold			2022-12-27	WOS:000295976000033
J	Bardaji, L; Perez-Martinez, I; Rodriguez-Moreno, L; Rodriguez-Palenzuela, P; Sundin, GW; Ramos, C; Murillo, J				Bardaji, Leire; Perez-Martinez, Isabel; Rodriguez-Moreno, Luis; Rodriguez-Palenzuela, Pablo; Sundin, George W.; Ramos, Cayo; Murillo, Jesus			Sequence and Role in Virulence of the Three Plasmid Complement of the Model Tumor-Inducing Bacterium Pseudomonas savastanoi pv. savastanoi NCPPB 3335	PLOS ONE			English	Article							SYRINGAE SUBSP SAVASTANOI; ARTEMIS COMPARISON TOOL; MESORHIZOBIUM-LOTI; REPLICATION REGIONS; PHASEOLICOLA 1448A; EFFECTOR PROTEINS; SECRETION SYSTEM; GENOMIC ANALYSIS; OLIVE KNOTS; DNA	Pseudomonas savastanoi pv. savastanoi NCPPB 3335 is a model for the study of the molecular basis of disease production and tumor formation in woody hosts, and its draft genome sequence has been recently obtained. Here we closed the sequence of the plasmid complement of this strain, composed of three circular molecules of 78,357 nt (pPsv48A), 45,220 nt (pPsv48B), and 42,103 nt (pPsv48C), all belonging to the pPT23A-like family of plasmids widely distributed in the P. syringae complex. A total of 152 coding sequences were predicted in the plasmid complement, of which 38 are hypothetical proteins and seven correspond to putative virulence genes. Plasmid pPsv48A contains an incomplete Type IVB secretion system, the type III secretion system (T3SS) effector gene hopAF1, gene ptz, involved in cytokinin biosynthesis, and three copies of a gene highly conserved in plant-associated proteobacteria, which is preceded by a hrp box motif. A complete Type IVA secretion system, a well conserved origin of transfer (oriT), and a homolog of the T3SS effector gene hopAO1 are present in pPsv48B, while pPsv48C contains a gene with significant homology to isopentenyl-diphosphate delta-isomerase, type 1. Several potential mobile elements were found on the three plasmids, including three types of MITE, a derivative of IS801, and a new transposon effector, ISPsy30. Although the replication regions of these three plasmids are phylogenetically closely related, their structure is diverse, suggesting that the plasmid architecture results from an active exchange of sequences. Artificial inoculations of olive plants with mutants cured of plasmids pPsv48A and pPsv48B showed that pPsv48A is necessary for full virulence and for the development of mature xylem vessels within the knots; we were unable to obtain mutants cured of pPsv48C, which contains five putative toxin-antitoxin genes.	[Bardaji, Leire; Murillo, Jesus] Univ Publ Navarra, Dept Agr Prod, Escuela Tecn Super Ingn Agronomos, Pamplona, Spain; [Perez-Martinez, Isabel; Rodriguez-Moreno, Luis; Ramos, Cayo] Univ Malaga, Fac Ciencias, Area Genet, Inst Hort Subtrop & Mediterranea La Mayora, E-29071 Malaga, Spain; [Rodriguez-Palenzuela, Pablo] Univ Politecn Madrid, Ctr Biotecnol & Genom Plantas, Escuela Tecn Super Ingn Agronomos, Madrid, Spain; [Sundin, George W.] Michigan State Univ, Dept Plant Pathol, E Lansing, MI 48824 USA; [Sundin, George W.] Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA	Universidad Publica de Navarra; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Malaga; CSIC-UMA - Instituto de Hortofruticultura Subtropical y Mediterranea La Mayora (IHSM); Universidad Politecnica de Madrid; Michigan State University; Michigan State University	Bardaji, L (corresponding author), Univ Publ Navarra, Dept Agr Prod, Escuela Tecn Super Ingn Agronomos, Pamplona, Spain.	jesus.murillo@unavarra.es	RAMOS, CAYO/G-3818-2011; RODRIGUEZ-PALENZUELA, PABLO/A-9149-2012; Moreno, Luis Rodriguez/U-8457-2017; Rodriguez-Moreno, Luis/AAU-4085-2020; Murillo, Jesus/D-2901-2009	RAMOS, CAYO/0000-0002-2362-5041; RODRIGUEZ-PALENZUELA, PABLO/0000-0002-4963-9177; Moreno, Luis Rodriguez/0000-0003-2385-8782; Rodriguez-Moreno, Luis/0000-0003-2385-8782; Murillo, Jesus/0000-0001-6585-2421	Ministerio de Ciencia e Innovacion [AGL2008-55311-CO2-01, AGL2008-55311-CO2-02]; FEDER; Departamento de Educacion y Cultura, Gobierno de Navarra, Spain [57/2007]; Junta de Andalucia, Spain [P08-CVI-03475]; Spanish Ministry of Education and Science [AP2002-3800]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); FEDER(European Commission); Departamento de Educacion y Cultura, Gobierno de Navarra, Spain; Junta de Andalucia, Spain(Junta de AndaluciaEuropean Commission); Spanish Ministry of Education and Science(Spanish Government)	This research has been supported by the Spanish Plan Nacional I+D+I grants AGL2008-55311-CO2-01 and AGL2008-55311-CO2-02 (Ministerio de Ciencia e Innovacion; http://www.micinn.es/), co-financed by FEDER, and by grants ref. 57/2007 from the Departamento de Educacion y Cultura, Gobierno de Navarra, Spain (http://www.educacion.navarra.es/portal/) and ref. P08-CVI-03475 from the Junta de Andalucia, Spain (http://www.juntadeandalucia.es). IP-M was awarded a Spanish Ministry of Education and Science fellowship (AP2002-3800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JC, 2005, BIOINFORMATICS, V21, P3665, DOI 10.1093/bioinformatics/bti601; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132; Bardaji L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025773; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; BROM S, 1992, J BACTERIOL, V174, P5183, DOI 10.1128/JB.174.16.5183-5189.1992; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Demarre G, 2005, RES MICROBIOL, V156, P245, DOI 10.1016/j.resmic.2004.09.007; DRIVER JA, 1984, HORTSCIENCE, V19, P507; FLORES M, 1993, P NATL ACAD SCI USA, V90, P4932, DOI 10.1073/pnas.90.11.4932; Fraser CM, 2002, J BACTERIOL, V184, P6403, DOI 10.1128/JB.184.23.6403-6405.2002; Fukuda H, 2004, NAT REV MOL CELL BIO, V5, P379, DOI 10.1038/nrm1364; Gardan L, 1999, INT J SYST BACTERIOL, V49, P469, DOI 10.1099/00207713-49-2-469; Gibbon MJ, 1999, MICROBIOL-SGM, V145, P325, DOI 10.1099/13500872-145-2-325; GLASS NL, 1988, J BACTERIOL, V170, P2367, DOI 10.1128/jb.170.5.2367-2373.1988; Green S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010224; Halary S, 2010, P NATL ACAD SCI USA, V107, P127, DOI 10.1073/pnas.0908978107; IACOBELLIS NS, 1994, J PHYTOPATHOL, V140, P238, DOI 10.1111/j.1439-0434.1994.tb04813.x; Iacobellis NS, 2001, ENCY PLANT PATHOLOGY, P714; Imelfort M, 2009, BRIEF BIOINFORM, V10, P609, DOI 10.1093/bib/bbp039; Jackson Robert W, 2011, Mob Genet Elements, V1, P55; Joardar V, 2005, J BACTERIOL, V187, P6488, DOI 10.1128/JB.187.18.6488-6498.2005; Krid S, 2009, J APPL MICROBIOL, V106, P886, DOI 10.1111/j.1365-2672.2008.04058.x; Landgraf A, 2006, MOL PLANT PATHOL, V7, P355, DOI 10.1111/j.1364-3703.2006.00343.x; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; Ma ZH, 2007, APPL ENVIRON MICROB, V73, P1287, DOI 10.1128/AEM.01923-06; MACDONALD EMS, 1986, PLANT PHYSIOL, V82, P742, DOI 10.1104/pp.82.3.742; MURILLO J, 1994, MOL MICROBIOL, V12, P941, DOI 10.1111/j.1365-2958.1994.tb01082.x; MURILLO J, 1994, PLASMID, V31, P275, DOI 10.1006/plas.1994.1029; Murillo J, 2003, PSEUDOMONAS SYRINGAE AND RELATED PATHOGENS: BIOLOGY AND GENETICS, P127; Nagarajan N, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-242; Okazaki S, 2010, MOL PLANT MICROBE IN, V23, P223, DOI 10.1094/MPMI-23-2-0223; Penyalver R, 2006, PHYTOPATHOLOGY, V96, P313, DOI 10.1094/PHYTO-96-0313; Perez-Martinez I, 2008, J BACTERIOL, V190, P625, DOI 10.1128/JB.01067-07; Perez-Martinez I, 2007, RES MICROBIOL, V158, P60, DOI 10.1016/j.resmic.2006.09.008; Perez-Martinez I, 2010, APPL ENVIRON MICROB, V76, P3611, DOI 10.1128/AEM.00133-10; Qi MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016451; Quesada JM, 2010, PLANT PATHOL, V59, P262, DOI 10.1111/j.1365-3059.2009.02200.x; Rodriguez-Moreno L, 2008, PHYTOPATHOLOGY, V98, P815, DOI 10.1094/PHYTO-98-7-0815; Rodriguez-Moreno L, 2009, MICROB BIOTECHNOL, V2, P476, DOI 10.1111/j.1751-7915.2009.00101.x; Rodriguez-Palenzuela P, 2010, ENVIRON MICROBIOL, V12, P1604, DOI 10.1111/j.1462-2920.2010.02207.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sambrook J., 2002, MOL CLONING LAB MANU; Sanchez C, 2009, MOL PLANT MICROBE IN, V22, P519, DOI 10.1094/MPMI-22-5-0519; Sarkar SF, 2004, APPL ENVIRON MICROB, V70, P1999, DOI 10.1128/AEM.70.4.1999-2012.2004; Schluter A, 2007, APPL ENVIRON MICROB, V73, P6345, DOI 10.1128/AEM.01177-07; Sesma A, 1998, APPL ENVIRON MICROB, V64, P3948; Sesma A, 2000, MICROBIOL-SGM, V146, P2375, DOI 10.1099/00221287-146-10-2375; Shimoda Y, 2008, DNA RES, V15, P13, DOI 10.1093/dnares/dsm028; Siguier P, 2006, CURR OPIN MICROBIOL, V9, P526, DOI 10.1016/j.mib.2006.08.005; SILVERSTONE SE, 1993, CAN J MICROBIOL, V39, P659, DOI 10.1139/m93-095; Smith I.M., 1988, Q REV BIOL, DOI [DOI 10.1002/9781444314199, 10.1002/9781444314199]; Stavrinides J, 2004, J BACTERIOL, V186, P5101, DOI [10.1128/JB.186.15.5101-5115.2004, 10.1128/jb.186.15.5101-5115.2004]; Stavrinides J, 2006, PLOS PATHOG, V2, P913, DOI 10.1371/journal.ppat.0020104; Stevens C, 1998, MOL MICROBIOL, V29, P165, DOI 10.1046/j.1365-2958.1998.00918.x; Studholme DJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-395; Sundin GW, 2007, ANNU REV PHYTOPATHOL, V45, P129, DOI 10.1146/annurev.phyto.45.062806.094317; Sundin George W., 2009, P295; Sundin GW, 1999, MICROBIAL ECOL, V38, P27, DOI 10.1007/s002489900152; Surico G, 1992, MOL SIGNALS PLANT MI, P209; Tamura K, 2011, MOL BIOL EV IN PRESS; Underwood W, 2007, PLANT J, V52, P658, DOI 10.1111/j.1365-313X.2007.03262.x; Vencato M, 2006, MOL PLANT MICROBE IN, V19, P1193, DOI 10.1094/MPMI-19-1193; Vivian A, 2001, MICROBIOL-SGM, V147, P763, DOI 10.1099/00221287-147-4-763; Young JM, 2010, J PLANT PATHOL, V92, pS5; Zhao YF, 2005, J BACTERIOL, V187, P2113, DOI 10.1128/JB.187.6.2113-2126.2005; ZHOU C, 1990, BIOTECHNIQUES, V8, P172	71	30	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e25705	10.1371/journal.pone.0025705	http://dx.doi.org/10.1371/journal.pone.0025705			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022435	Green Published, Green Submitted, gold			2022-12-27	WOS:000295973200013
J	Romano, G; Costantini, M; Buttino, I; Ianora, A; Palumbo, A				Romano, Giovanna; Costantini, Maria; Buttino, Isabella; Ianora, Adrianna; Palumbo, Anna			Nitric Oxide Mediates the Stress Response Induced by Diatom Aldehydes in the Sea Urchin Paracentrotus lividus	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; GENE REGULATORY NETWORK; OXIDATIVE STRESS; MARINE DIATOMS; CHEMICAL DEFENSE; 2 ECOTYPES; EMBRYOS; SYNTHASE; FERTILIZATION; INHIBITION	Diatoms are ubiquitous and abundant primary producers that have been traditionally considered as a beneficial food source for grazers and for the transfer of carbon through marine food webs. However, many diatom species produce polyunsaturated aldehydes that disrupt development in the offspring of grazers that feed on these unicellular algae. Here we provide evidence that production of the physiological messenger nitric oxide increases after treatment with the polyunsaturated aldehyde decadienal in embryos of the sea urchin Paracentrotus lividus. At high decadienal concentrations, nitric oxide mediates initial apoptotic events leading to loss of mitochondrial functionality through the generation of peroxynitrite. At low decadienal concentrations, nitric oxide contributes to the activation of hsp70 gene expression thereby protecting embryos against the toxic effects of this aldehyde. When nitric oxide levels were lowered by inhibiting nitric oxide synthase activity, the expression of hsp70 in swimming blastula decreased and the proportion of abnormal plutei increased. However, in later pluteus stages nitric oxide was no longer able to exert this protective function: hsp70 and nitric oxide synthase expression decreased with a consequent increase in the expression of caspase-8. Our findings that nitric oxide production increases rapidly in response to a toxic exogenous stimulus opens new perspectives on the possible role of this gas as an important messenger to environmental stress in sea urchins and for understanding the cellular mechanisms underlying toxicity during diatom blooms.	[Romano, Giovanna; Buttino, Isabella; Ianora, Adrianna] Stn Zool Anton Dohrn, Lab Funct & Evolutionary Ecol, Naples, Italy; [Costantini, Maria; Palumbo, Anna] Stn Zool Anton Dohrn, Cellular & Dev Biol Lab, Naples, Italy	Stazione Zoologica Anton Dohrn di Napoli; Stazione Zoologica Anton Dohrn di Napoli	Romano, G (corresponding author), Stn Zool Anton Dohrn, Lab Funct & Evolutionary Ecol, Naples, Italy.	palumbo@szn.it	Costantini, Maria/AGH-4080-2022; Romano, Giovanna/F-4561-2015; Ianora, Adrianna/O-3408-2019; Buttino, Isabella/AAI-3264-2020	Romano, Giovanna/0000-0002-4898-7153; Palumbo, Anna/0000-0002-5972-5589				Adolph S, 2003, TETRAHEDRON, V59, P3003, DOI 10.1016/S0040-4020(03)00382-X; Andreou A, 2009, PROG LIPID RES, V48, P148, DOI 10.1016/j.plipres.2009.02.002; Bishop CD, 2001, BIOL BULL, V201, P394, DOI 10.2307/1543617; Bishop CD, 2007, DEV DYNAM, V236, P1535, DOI 10.1002/dvdy.21161; Bonaventura R, 2011, CELL STRESS CHA 0701; Bouchard JN, 2008, PLANT CELL PHYSIOL, V49, P641, DOI 10.1093/pcp/pcn037; Brown GC, 2003, MOL NEUROBIOL, V27, P325, DOI 10.1385/MN:27:3:325; Caldwell GS, 2009, MAR DRUGS, V7, P367, DOI 10.3390/md7030367; Caldwell GS, 2004, MAR ECOL PROG SER, V273, P97, DOI 10.3354/meps273097; Caldwell GS, 2002, AQUAT TOXICOL, V60, P123, DOI 10.1016/S0166-445X(01)00277-6; Casano C, 2003, J HISTOCHEM CYTOCHEM, V51, P1581, DOI 10.1177/002215540305101202; Cole AG, 2009, DEVELOPMENT, V136, P541, DOI 10.1242/dev.029959; Cutignano A, 2006, CHEMBIOCHEM, V7, P450, DOI 10.1002/cbic.200500343; d'Ippolito G, 2004, BBA-MOL CELL BIOL L, V1686, P100, DOI 10.1016/j.bbalip.2004.09.002; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Ettensohn CA, 2007, DEVELOPMENT, V134, P3077, DOI 10.1242/dev.009092; Fontana A, 2007, CHEMBIOCHEM, V8, P1810, DOI 10.1002/cbic.200700269; Giovine M, 2001, NITRIC OXIDE-BIOL CH, V5, P427, DOI 10.1006/niox.2001.0366; Giudice G, 1999, DEV GROWTH DIFFER, V41, P375; Hansen E, 2004, TOXICOL SCI, V81, P190, DOI 10.1093/toxsci/kfh192; Ianora A, 2010, ECOTOXICOLOGY, V19, P493, DOI 10.1007/s10646-009-0434-y; Kroncke KD, 2001, INT IMMUNOPHARMACOL, V1, P1407, DOI 10.1016/S1567-5769(01)00087-X; Laspina NV, 2005, PLANT SCI, V169, P323, DOI 10.1016/j.plantsci.2005.02.007; Leckie C, 2003, J BIOL CHEM, V278, P12247, DOI 10.1074/jbc.M210770200; Leflaive J, 2009, NEW PHYTOL, V184, P794, DOI 10.1111/j.1469-8137.2009.03033.x; Malysheva IY, 1996, FEBS LETT, V391, P21, DOI 10.1016/0014-5793(96)00691-6; Mann DG, 1999, PHYCOLOGIA, V38, P437, DOI 10.2216/i0031-8884-38-6-437.1; Matranga V, 2002, CELL MOL BIOL, V48, P345; Matranga V, 2000, CELL STRESS CHAPERON, V5, P113, DOI 10.1379/1466-1268(2000)005<0113:CABRTE>2.0.CO;2; Mattiello T, 2010, J BIOL CHEM, V285, P24154, DOI 10.1074/jbc.M109.083428; Miralto A, 1999, NATURE, V402, P173, DOI 10.1038/46023; Mohri T, 2008, DEV BIOL, V322, P251, DOI 10.1016/j.ydbio.2008.07.023; NEMER M, 1991, DEV BIOL, V145, P255, DOI 10.1016/0012-1606(91)90124-L; Oliveri P, 2004, CURR OPIN GENET DEV, V14, P351, DOI 10.1016/j.gde.2004.06.004; Pagano G, 1986, COMMUNITY TOXICITY T, P67; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Perez S, 2006, J EXP BIOL, V209, P2804, DOI 10.1242/jeb.02309; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinsino A, 2010, ECOTOXICOLOGY, V19, P555, DOI 10.1007/s10646-009-0432-0; Pohnert G, 2002, MAR ECOL PROG SER, V245, P33, DOI 10.3354/meps245033; Pohnert G, 2000, ANGEW CHEM INT EDIT, V39, P4352, DOI 10.1002/1521-3773(20001201)39:23<4352::AID-ANIE4352>3.0.CO;2-U; Ribalet F, 2007, AQUAT TOXICOL, V85, P219, DOI 10.1016/j.aquatox.2007.09.006; Roccheri Maria C., 2000, Molecular Cell Biology Research Communications, V3, P306, DOI 10.1006/mcbr.2000.0230; ROCCHERI MC, 1993, J SUBMICR CYTOL PATH, V25, P173; ROCCHERI MC, 1988, CELL DIFFER DEV, V24, P209, DOI 10.1016/0045-6039(88)90052-8; ROCCHERI MC, 1981, DEV BIOL, V83, P173, DOI 10.1016/S0012-1606(81)80020-6; Roccheri MC, 2004, BIOCHEM BIOPH RES CO, V321, P80, DOI 10.1016/j.bbrc.2004.06.108; Romano G, 2003, J EXP BIOL, V206, P3487, DOI 10.1242/jeb.00580; Romano G, 2010, MAR DRUGS, V8, P950, DOI 10.3390/md8040950; Rozen S, 2000, Methods Mol Biol, V132, P365; Sakamaki K, 2009, J FISH BIOL, V74, P727, DOI 10.1111/j.1095-8649.2009.02184.x; SCONZO G, 1992, GENE, V121, P353, DOI 10.1016/0378-1119(92)90143-D; Shi QH, 2007, PLANT PHYSIOL BIOCH, V45, P542, DOI 10.1016/j.plaphy.2007.05.005; Singh HP, 2009, NITRIC OXIDE-BIOL CH, V20, P289, DOI 10.1016/j.niox.2009.02.004; Sluder G, 1999, METHOD CELL BIOL, V61, P439; Smith KL, 2000, SCI TOTAL ENVIRON, V262, P185, DOI 10.1016/S0048-9697(00)00599-4; SNYDER SH, 1993, NATURE, V364, P577, DOI 10.1038/364577a0; Song LL, 2006, PLANT SCI, V171, P449, DOI 10.1016/j.plantsci.2006.05.002; Trapido-Rosenthal H, 2005, BIOL BULL-US, V208, P3, DOI 10.2307/3593094; Vardi A, 2006, PLOS BIOL, V4, P411, DOI 10.1371/journal.pbio.0040060; Vital SA, 2008, ENVIRON EXP BOT, V62, P60, DOI 10.1016/j.envexpbot.2007.07.006; Willmott N, 1996, J BIOL CHEM, V271, P3699; Wui MZ, 2009, GLIA, V57, P1204, DOI 10.1002/glia.20842; Zhang YM, 2009, PLANT CELL ENVIRON, V32, P509, DOI 10.1111/j.1365-3040.2009.01945.x; Zhang ZB, 2006, MED SCI MONITOR, V12, pBR75; Zhao L, 2008, J PLANT PHYSIOL, V165, P182, DOI 10.1016/j.jplph.2007.03.002	67	47	47	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e25980	10.1371/journal.pone.0025980	http://dx.doi.org/10.1371/journal.pone.0025980			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022485	Green Published, gold, Green Submitted			2022-12-27	WOS:000295973200025
J	Strengell, M; Ikonen, N; Ziegler, T; Julkunen, I				Strengell, Mari; Ikonen, Niina; Ziegler, Thedi; Julkunen, Ilkka			Minor Changes in the Hemagglutinin of Influenza A(H1N1) 2009 Virus Alter Its Antigenic Properties	PLOS ONE			English	Article							A H1N1; ASSOCIATION; RESPONSES; SEQUENCE; D222G; GENE	Background: The influenza A(H1N1) 2009 virus has been the dominant type of influenza A virus in Finland during the 20092010 and 2010-2011 epidemic seasons. We analyzed the antigenic characteristics of several influenza A(H1N1) 2009 viruses isolated during the two influenza seasons by analyzing the amino acid sequences of the hemagglutinin (HA), modeling the amino acid changes in the HA structure and measuring antibody responses induced by natural infection or influenza vaccination. Methods/Results: Based on the HA sequences of influenza A(H1N1) 2009 viruses we selected 13 different strains for antigenic characterization. The analysis included the vaccine virus, A/California/07/2009 and multiple California-like isolates from 2009-2010 and 2010-2011 epidemic seasons. These viruses had two to five amino acid changes in their HA1 molecule. The mutation(s) were located in antigenic sites Sa, Ca1, Ca2 and Cb region. Analysis of the antibody levels by hemagglutination inhibition test (HI) indicated that vaccinated individuals and people who had experienced a natural influenza A(H1N1) 2009 virus infection showed good immune responses against the vaccine virus and most of the wild-type viruses. However, one to two amino acid changes in the antigenic site Sa dramatically affected the ability of antibodies to recognize these viruses. In contrast, the tested viruses were indistinguishable in regard to antibody recognition by the sera from elderly individuals who had been exposed to the Spanish influenza or its descendant viruses during the early 20(th) century. Conclusions: According to our results, one to two amino acid changes (N125D and/or N156K) in the major antigenic sites of the hemagglutinin of influenza A(H1N1) 2009 virus may lead to significant reduction in the ability of patient and vaccine sera to recognize A(H1N1) 2009 viruses.	[Strengell, Mari; Ikonen, Niina; Ziegler, Thedi; Julkunen, Ilkka] Natl Inst Hlth & Welf, Viral Infect Unit, Dept Vaccines & Immune Protect, Helsinki, Finland	Finland National Institute for Health & Welfare	Strengell, M (corresponding author), Natl Inst Hlth & Welf, Viral Infect Unit, Dept Vaccines & Immune Protect, Helsinki, Finland.	mari.strengell@thl.fi		Julkunen, Ilkka/0000-0003-0165-2564; Ikonen, Niina/0000-0003-0724-8888	National Institute for Health and Welfare; Ministry of Health and Social Affairs (Finland); European Commission Directorate-General Research [201169]	National Institute for Health and Welfare; Ministry of Health and Social Affairs (Finland); European Commission Directorate-General Research(European CommissionEuropean Commission Joint Research Centre)	The study was supported by the funds of the National Institute for Health and Welfare, the Ministry of Health and Social Affairs (Finland) and the Identification of Mechanisms Correlating with Susceptibility for Avian Influenza project (grant no 201169) supported by the European Commission Directorate-General Research and the participating member states. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aho M, 2010, EUROSURVEILLANCE, V15, P14; Barr IG, 2010, EUROSURVEILLANCE, V15, P6; Battegay M, 2020, SWISS MED WKLY, V150, DOI [10.4414/smw.w20203, 10.4414/smw.2020.20203]; Bush RM, 1999, SCIENCE, V286, P1921, DOI 10.1126/science.286.5446.1921; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; European Medicines Agency, PAND SUMM PROD CHAR; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; HILLIS DM, 1993, METHOD ENZYMOL, V224, P456, DOI 10.1016/0076-6879(93)24035-S; Ikonen N, 2010, EUROSURVEILLANCE, V15, P16; Ikonen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013329; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Kaverin NV, 2007, J VIROL, V81, P12911, DOI 10.1128/JVI.01522-07; Kendal AP, CONCEPTS PROCEDURES; Kilander A, 2010, EUROSURVEILLANCE, V15, P6; Mak GC, 2010, EUROSURVEILLANCE, V15, P15; Maurer-Stroh Sebastian, 2010, PLoS Curr, V2, pRRN1162; McCauley J, 2011, REPORT PREPARED WHO; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Osterlund P, 2010, J VIROL, V84, P1414, DOI 10.1128/JVI.01619-09; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Suphaphiphat P, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-157; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; WHO Global Influenza Surveillance Network, 2011, MAN LAB DIAGN VIR SU; WINTER G, 1981, NATURE, V292, P72, DOI 10.1038/292072a0; Xu WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018016; Ye JQ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001145	32	55	62	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e25848	10.1371/journal.pone.0025848	http://dx.doi.org/10.1371/journal.pone.0025848			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022458	Green Published, Green Submitted, gold			2022-12-27	WOS:000295973200017
J	Ruiss, R; Jochum, S; Mocikat, R; Hammerschmidt, W; Zeidler, R				Ruiss, Romana; Jochum, Simon; Mocikat, Ralph; Hammerschmidt, Wolfgang; Zeidler, Reinhard			EBV-gp350 Confers B-Cell Tropism to Tailored Exosomes and Is a Neo-Antigen in Normal and Malignant B Cells-A New Option for the Treatment of B-CLL	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; EPSTEIN-BARR-VIRUS; CD154 GENE-THERAPY; CD4(+) T-CELLS; CD40 LIGAND; IMMUNE RECOGNITION; IN-VIVO; RESPONSES; VACCINE; IDENTIFICATION	gp350, the major envelope protein of Epstein-Barr-Virus, confers B-cell tropism to the virus by interacting with the B lineage marker CD21. Here we utilize gp350 to generate tailored exosomes with an identical tropism. These exosomes can be used for the targeted co-transfer of functional proteins to normal and malignant human B cells. We demonstrate here the co-transfer of functional CD154 protein on tailored gp350+ exosomes to malignant B blasts from patients with B chronic lymphocytic leukemia (B-CLL), rendering B blasts immunogenic to tumor-reactive autologous T cells. Intriguingly, engulfment of gp350+ exosomes by B-CLL cells and presentation of gp350-derived peptides also re-stimulated EBV-specific T cells and redirected the strong antiviral cellular immune response in patients to leukemic B cells. In essence, we show that gp350 alone confers B-cell tropism to exosomes and that these exosomes can be further engineered to simultaneously trigger virus- and tumor-specific immune responses. The simultaneous exploitation of gp350 as a tropism molecule for tailored exosomes and as a neo-antigen in malignant B cells provides a novel attractive strategy for immunotherapy of B-CLL and other B-cell malignancies.	[Ruiss, Romana; Jochum, Simon; Hammerschmidt, Wolfgang] Helmholtz Zentrum, Dept Gene Vectors, Munich, Germany; [Mocikat, Ralph] Helmholtz Zentrum, Inst Mol Immunol, Munich, Germany; [Zeidler, Reinhard] Univ Munich, Dept Otorhinolaryngol, Munich, Germany	Helmholtz Association; Helmholtz Association; University of Munich	Ruiss, R (corresponding author), Helmholtz Zentrum, Dept Gene Vectors, Munich, Germany.	Reinhard.Zeidler@med.lmu.de	Hammerschmidt, Wolfgang/ABG-3921-2021; Zeidler, Reinhard/M-9837-2014	Hammerschmidt, Wolfgang/0000-0002-4659-0427; Zeidler, Reinhard/0000-0002-3357-4954; Multhoff, Gabriele/0000-0002-2616-3137	Deutsche Krebshilfe [107793]; Deutsche Jose Carreras Leukamie-Stiftung [DJCLS R09/17]	Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsche Jose Carreras Leukamie-Stiftung	This project was supported by grant 107793 from the Deutsche Krebshilfe (www.krebshilfe.de) and grant DJCLS R09/17 from the Deutsche Jose Carreras Leukamie-Stiftung (www.carreras-stiftung.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000583; Adhikary D, 2008, J VIROL, V82, P3903, DOI 10.1128/JVI.02227-07; AvilaCarino J, 1997, INT J CANCER, V70, P1, DOI 10.1002/(SICI)1097-0215(19970106)70:1<1::AID-IJC1>3.0.CO;2-1; AvilaCarino J, 1996, IMMUNOL LETT, V54, P45, DOI 10.1016/S0165-2478(96)02643-0; Battle TE, 2003, CLIN CANCER RES, V9, P2166; Beauvillain C, 2009, VACCINE, V27, P1750, DOI 10.1016/j.vaccine.2009.01.022; Biagi E, 2005, CLIN CANCER RES, V11, P6916, DOI 10.1158/1078-0432.CCR-05-0484; Biagi E, 2003, HUM GENE THER, V14, P545, DOI 10.1089/104303403764539332; BRAUTBOUCHER F, 1995, J IMMUNOL METHODS, V178, P41, DOI 10.1016/0022-1759(94)00239-S; Cantwell M, 1997, NAT MED, V3, P984, DOI 10.1038/nm0997-984; Dilloo D, 1997, BLOOD, V90, P1927, DOI 10.1182/blood.V90.5.1927; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Hislop AD, 2007, ANNU REV IMMUNOL, V25, P587, DOI 10.1146/annurev.immunol.25.022106.141553; Kater AP, 2004, BRIT J HAEMATOL, V127, P404, DOI 10.1111/j.1365-2141.2004.05225.x; Kater AP, 2004, BRIT J HAEMATOL, V126, P512, DOI 10.1111/j.1365-2141.2004.05070.x; Kato K, 1998, J CLIN INVEST, V101, P1133, DOI 10.1172/JCI1472; Korz C, 2002, BLOOD, V99, P4554, DOI 10.1182/blood.V99.12.4554; Kronenberger K, 2008, J IMMUNOTHER, V31, P723, DOI 10.1097/CJI.0b013e318183af26; Kuate S, 2007, VIROLOGY, V362, P26, DOI 10.1016/j.virol.2006.12.011; Mackus WJM, 2003, BLOOD, V102, P1057, DOI 10.1182/blood-2003-01-0182; Mautner J, 2004, EUR J IMMUNOL, V34, P2500, DOI 10.1002/eji.200324794; Morelli AE, 2004, BLOOD, V104, P3257, DOI 10.1182/blood-2004-03-0824; NEMEROW GR, 1985, J VIROL, V55, P347, DOI 10.1128/JVI.55.2.347-351.1985; Steininger C, 2009, EUR J CLIN INVEST, V39, P497, DOI 10.1111/j.1365-2362.2009.02131.x; Takahashi S, 2001, HUM GENE THER, V12, P659, DOI 10.1089/104303401300057360; Thery C, 2002, NAT IMMUNOL, V3, P1156, DOI 10.1038/ni854; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tomita Y, 1998, IMMUNOL LETT, V60, P73, DOI 10.1016/S0165-2478(97)00142-9; Vallhov H, 2011, J IMMUNOL, V186, P73, DOI 10.4049/jimmunol.1001145; WALLACE LE, 1991, J VIROL, V65, P3821, DOI 10.1128/JVI.65.7.3821-3828.1991; WATANABE T, 1994, BLOOD, V84, P3158; Wendtner CM, 2002, BLOOD, V100, P1655, DOI 10.1182/blood.V100.5.1655.h81702001655_1655_1661; Wierda WG, 2000, BLOOD, V96, P2917; Wiesner M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001464	36	44	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25294	10.1371/journal.pone.0025294	http://dx.doi.org/10.1371/journal.pone.0025294			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22022385	Green Published, Green Submitted, gold			2022-12-27	WOS:000295971700005
J	Huang, BY; Takahashi, K; Sakata, T; Kiso, H; Sugai, M; Fujimura, K; Shimizu, A; Kosugi, S; Sato, T; Bessho, K				Huang, Boyen; Takahashi, Katsu; Sakata, Tomoko; Kiso, Honoka; Sugai, Manabu; Fujimura, Kazuma; Shimizu, Akira; Kosugi, Shinji; Sato, Tosiya; Bessho, Kazuhisa			Increased Risk of Temporomandibular Joint Closed Lock: A Case-Control Study of ANKH Polymorphisms	PLOS ONE			English	Article							ANTERIOR DISC DISPLACEMENT; INTERNAL DERANGEMENT; ANKYLOSING-SPONDYLITIS; CRANIOMETAPHYSEAL DYSPLASIA; INTRAARTICULAR ADHESIONS; MOUSE MODEL; OSTEOARTHRITIS; REDUCTION; PYROPHOSPHATE; ARTHROSCOPY	Objectives: This study aimed to carry out a histological examination of the temporomandibular joint (TMJ) in ank mutant mice and to identify polymorphisms of the human ANKH gene in order to establish the relationship between the type of temporomandibular disorders (TMD) and ANKH polymorphisms. Materials and Methods: Specimens from the TMJ of ank mutant and wild-type mice were inspected with a haematoxylin and eosin staining method. A sample of 55 TMD patients were selected. Each was examined with standard clinical procedures and genotyping techniques. Results: The major histological finding in ank mutant mice was joint space narrowing. Within TMD patients, closed lock was more prevalent among ANKH-OR homozygotes (p = 0.011, OR = 7.7, 95% CI 1.6-36.5) and the elder (p = 0.005, OR = 2.4, 95% CI 1.3-4.3). Conclusions: Fibrous ankylosis was identified in the TMJ of ank mutant mice. In the human sample, ANKH-OR polymorphism was found to be a genetic marker associated with TMJ closed lock. Future investigations correlating genetic polymorphism to TMD are indicated.	[Huang, Boyen; Takahashi, Katsu; Sakata, Tomoko; Kiso, Honoka; Fujimura, Kazuma; Bessho, Kazuhisa] Kyoto Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Kyoto, Japan; [Kosugi, Shinji] Kyoto Univ, Grad Sch Med, Dept Biomed Eth, Kyoto, Japan; [Sugai, Manabu; Shimizu, Akira] Kyoto Univ, Kyoto Univ Hosp, Translat Res Ctr, Kyoto, Japan; [Sato, Tosiya] Kyoto Univ, Sch Publ Hlth, Dept Biostat, Kyoto, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University	Huang, BY (corresponding author), Kyoto Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Kyoto, Japan.	takahask@kuhp.kyoto-u.ac.jp	Huang, Boyen/AAR-3348-2020; KOSUGI, Shinji/GYR-2946-2022; Sato, Tosiya Shun/GXV-4060-2022; Huang, Boyen/I-7768-2014; Huang, Boyen/GRE-5912-2022; KOSUGI, Shinji/HCH-0631-2022; SATO, Toshiya/GYR-2957-2022	Huang, Boyen/0000-0002-1246-7447; Sato, Tosiya Shun/0000-0001-9830-013X; Huang, Boyen/0000-0002-1246-7447; Huang, Boyen/0000-0002-1246-7447; Sugai, Manabu/0000-0003-1668-7647	Japanese Society for the Promotion of Science [P09741]	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by a JSPS (official website: http://www.jsps.go.jp/english/) Postdoctoral Fellowship for Foreign Researchers (P09741) and a Grant-in-Aid for Scientific Research (B) from Japanese Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 1990, PRACTICAL STAT MED R, P325; Bertram S, 2001, J AM DENT ASSOC, V132, P753, DOI 10.14219/jada.archive.2001.0272; CASWELL AM, 1991, CRIT REV CL LAB SCI, V28, P175, DOI 10.3109/10408369109106862; Cevidanes LHS, 2010, ORAL SURG ORAL MED O, V110, P110, DOI 10.1016/j.tripleo.2010.01.008; Chen IP, 2009, J BONE MINER RES, V24, P1206, DOI [10.1359/JBMR.090218, 10.1359/jbmr.090218]; Chen J, 2009, ARCH ORAL BIOL, V54, P1091, DOI 10.1016/j.archoralbio.2009.10.001; D'Anto Vincenzo, 2010, Prog Orthod, V11, P174, DOI 10.1016/j.pio.2010.09.007; DEBONT LGM, 1986, J ORAL MAXIL SURG, V44, P634, DOI 10.1016/S0278-2391(86)80075-1; Dijkgraaf LC, 1998, INT J ORAL MAX SURG, V27, P268, DOI 10.1016/S0901-5027(05)80509-0; Dimitroulis G, 2002, J ORAL MAXIL SURG, V60, P519, DOI 10.1053/joms.2002.31848; Dworkin Samuel F., 1992, Journal of Craniomandibular Disorders, V6, P301; Emshoff R, 2002, J ORAL REHABIL, V29, P516, DOI 10.1046/j.1365-2842.2002.00883.x; Fox N, 1997, FAM PRACT, V14, P324, DOI 10.1093/fampra/14.4.324; Gesch D, 2004, QUINTESSENCE INT, V35, P143; Gonzalez-Garcia R, 2010, J ORAL MAXIL SURG, V68, P35, DOI 10.1016/j.joms.2009.04.127; Gurley KA, 2006, AM J HUM GENET, V79, P1017, DOI 10.1086/509881; Ho AM, 2000, SCIENCE, V289, P265, DOI 10.1126/science.289.5477.265; HOLMLUND AB, 1992, ORAL SURG ORAL MED O, V73, P9, DOI 10.1016/0030-4220(92)90145-G; ISACSSON G, 1986, J ORAL MAXIL SURG, V44, P771, DOI 10.1016/0278-2391(86)90151-5; Kalaykova S, 2010, J OROFAC PAIN, V24, P373; Kalaykova SI, 2011, J OROFAC PAIN, V25, P153; Kiernan JA., 2008, HISTOLOGICAL HISTOCH, P141; Kiga N, 2010, Eur J Histochem, V54, pe34; Kohler AA, 2009, EUR ARCH PAEDIATR DE, V10, P16; Kononen M, 1996, LANCET, V347, P1080, DOI 10.1016/S0140-6736(96)90280-9; Leonardi R, 2010, ORAL SURG ORAL MED O, V109, P244, DOI 10.1016/j.tripleo.2009.09.028; Major P, 1999, J RHEUMATOL, V26, P616; Miyamoto H, 1999, ORAL SURG ORAL MED O, V88, P151, DOI 10.1016/S1079-2104(99)70109-5; MURAKAMI KI, 1992, J ORAL MAXIL SURG, V50, P705, DOI 10.1016/0278-2391(92)90102-6; Murshed M, 2005, GENE DEV, V19, P1093, DOI 10.1101/gad.1276205; Nitzan DW, 1997, J ORAL MAXIL SURG, V55, P151, DOI 10.1016/S0278-2391(97)90233-0; Nurnberg P, 2001, NAT GENET, V28, P37, DOI 10.1038/ng0501-37; Ogura N, 2002, J ORAL PATHOL MED, V31, P353, DOI 10.1034/j.1600-0714.2002.310606.x; Okawa A, 1998, NAT GENET, V19, P271, DOI 10.1038/956; Paegle DI, 2003, INT J ORAL MAX SURG, V32, P397, DOI 10.1054/ijom.2003.0375; PAESANI D, 1992, AM J ORTHOD DENTOFAC, V101, P41, DOI 10.1016/0889-5406(92)70080-T; Peach CA, 2007, CLIN ORTHOP RELAT R, P67, DOI 10.1097/BLO.0b013e31811f39de; Pendleton A, 2002, AM J HUM GENET, V71, P933, DOI 10.1086/343054; ROHLIN M, 1985, J ORAL MAXIL SURG, V43, P194, DOI 10.1016/0278-2391(85)90159-4; SAWHNEY CP, 1986, PLAST RECONSTR SURG, V77, P29, DOI 10.1097/00006534-198601000-00006; Tominaga K, 2002, BRIT J ORAL MAX SURG, V40, P232, DOI 10.1054/bjom.2001.0746; Tsui FWL, 2003, ARTHRITIS RHEUM-US, V48, P791, DOI 10.1002/art.10844; Wenghoefer M, 2008, J CRANIOFAC SURG, V19, P1114, DOI 10.1097/SCS.0b013e318176ac3b; Zhang SY, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-70	44	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25503	10.1371/journal.pone.0025503	http://dx.doi.org/10.1371/journal.pone.0025503			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003394	Green Published, gold, Green Submitted			2022-12-27	WOS:000295970300015
J	Stienen, BMC; Tanaka, A; de Gelder, B				Stienen, Bernard M. C.; Tanaka, Akihiro; de Gelder, Beatrice			Emotional Voice and Emotional Body Postures Influence Each Other Independently of Visual Awareness	PLOS ONE			English	Article							FACIAL EXPRESSIONS; INFLUENCE RECOGNITION; BODILY EXPRESSIONS; PERCEPTION; AMYGDALA; FACE; ATTENTION; MASKING; THREAT; FEAR	Multisensory integration may occur independently of visual attention as previously shown with compound face-voice stimuli. We investigated in two experiments whether the perception of whole body expressions and the perception of voices influence each other when observers are not aware of seeing the bodily expression. In the first experiment participants categorized masked happy and angry bodily expressions while ignoring congruent or incongruent emotional voices. The onset between target and mask varied from -50 to +133 ms. Results show that the congruency between the emotion in the voice and the bodily expressions influences audiovisual perception independently of the visibility of the stimuli. In the second experiment participants categorized the emotional voices combined with masked bodily expressions as fearful or happy. This experiment showed that bodily expressions presented outside visual awareness still influence prosody perception. Our experiments show that audiovisual integration between bodily expressions and affective prosody can take place outside and independent of visual awareness.	[Stienen, Bernard M. C.; de Gelder, Beatrice] Tilburg Univ, Lab Cognit & Affect Neurosci, NL-5000 LE Tilburg, Netherlands; [Tanaka, Akihiro] Waseda Inst Adv Study, Tokyo, Japan; [de Gelder, Beatrice] Massachusetts Gen Hosp, Martinos Ctr Biomed Imaging, Charlestown, MA USA; [de Gelder, Beatrice] Harvard Univ, Sch Med, Charlestown, MA USA	Tilburg University; Waseda University; Harvard University; Massachusetts General Hospital; Harvard University	Stienen, BMC (corresponding author), Tilburg Univ, Lab Cognit & Affect Neurosci, NL-5000 LE Tilburg, Netherlands.	B.deGelder@uvt.nl			Dutch Association of Scientific Research (NWO), Tango; EU [FDP6-NEST-043403]; MEXT [19001004]; European Commission, under FET-Open [249858]	Dutch Association of Scientific Research (NWO), Tango(Netherlands Organization for Scientific Research (NWO)); EU(European Commission); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); European Commission, under FET-Open(European CommissionEuropean Commission Joint Research Centre)	This project was funded by the Dutch Association of Scientific Research (NWO), Tango, the EU project COBOL (FDP6-NEST-043403) and by Grant-in-Aid of MEXT for Specially Promoted Research (no. 19001004). The project Tango acknowledges the financial support of the Future and Emerging Technologies (FET) programme within the Seventh Framework Programme for Research of the European Commission, under FET-Open (grant number 249858). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsius A, 2005, CURR BIOL, V15, P839, DOI 10.1016/j.cub.2005.03.046; BREITMEYER BG, 1976, PSYCHOL REV, V83, P1, DOI 10.1037/0033-295X.83.1.1; CHEESMAN J, 1986, CAN J PSYCHOL, V40, P343, DOI 10.1037/h0080103; De Gelder B, 2003, TRENDS COGN SCI, V7, P460, DOI 10.1016/j.tics.2003.08.014; de Gelder B, 2000, COGNITION EMOTION, V14, P289, DOI 10.1080/026999300378824; de Gelder B, 2006, NAT REV NEUROSCI, V7, P242, DOI 10.1038/nrn1872; de Gelder B, 1999, NEUROSCI LETT, V260, P133, DOI 10.1016/S0304-3940(98)00963-X; de Gelder B, 2002, P NATL ACAD SCI USA, V99, P4121, DOI 10.1073/pnas.062018499; de Gelder B, 1999, NEUROREPORT, V10, P3759, DOI 10.1097/00001756-199912160-00007; de Gelder B, 2009, PHILOS T R SOC B, V364, P3475, DOI 10.1098/rstb.2009.0190; Duncan S, 2007, TRENDS COGN SCI, V11, P190, DOI 10.1016/j.tics.2007.01.007; Enns JT, 2000, TRENDS COGN SCI, V4, P345, DOI 10.1016/S1364-6613(00)01520-5; ESTEVES F, 1993, SCAND J PSYCHOL, V34, P1, DOI 10.1111/j.1467-9450.1993.tb01096.x; Kret ME, 2011, NEUROIMAGE, V54, P1755, DOI 10.1016/j.neuroimage.2010.08.012; Massaro DW, 1996, PSYCHON B REV, V3, P215, DOI 10.3758/BF03212421; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; Ohman A, 2001, J PERS SOC PSYCHOL, V80, P381, DOI 10.1037//0022-3514.80.3.381; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; Ohman A, 2005, PSYCHONEUROENDOCRINO, V30, P953, DOI 10.1016/j.psyneuen.2005.03.019; Ohman A, 2002, CURR DIR PSYCHOL SCI, V11, P62, DOI 10.1111/1467-8721.00169; Pessoa L, 2005, CURR OPIN NEUROBIOL, V15, P188, DOI 10.1016/j.conb.2005.03.002; STIENEN BMC, EMOTION IN PRESS; Tamietto M, 2010, NAT REV NEUROSCI, V11, P697, DOI 10.1038/nrn2889; Tamietto M, 2009, P NATL ACAD SCI USA, V106, P17661, DOI 10.1073/pnas.0908994106; Tanaka A, 2010, PSYCHOL SCI, V21, P1259, DOI 10.1177/0956797610380698; Van den Stock J, 2007, EMOTION, V7, P487, DOI 10.1037/1528-3542.7.3.487; Van den Stock J, 2008, BRAIN RES, V1242, P185, DOI 10.1016/j.brainres.2008.05.040; VANDENSTOCK J, SOC NEUROSC IN PRESS; Vroomen J, 2001, COGN AFFECT BEHAV NE, V1, P382, DOI 10.3758/CABN.1.4.382; Whalen PJ, 1998, J NEUROSCI, V18, P411	30	24	24	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25517	10.1371/journal.pone.0025517	http://dx.doi.org/10.1371/journal.pone.0025517			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834OC	22003396	Green Published, Green Submitted, gold			2022-12-27	WOS:000295970300017
J	Cumbie, JS; Kimbrel, JA; Di, YM; Schafer, DW; Wilhelm, LJ; Fox, SE; Sullivan, CM; Curzon, AD; Carrington, JC; Mockler, TC; Chang, JH				Cumbie, Jason S.; Kimbrel, Jeffrey A.; Di, Yanming; Schafer, Daniel W.; Wilhelm, Larry J.; Fox, Samuel E.; Sullivan, Christopher M.; Curzon, Aron D.; Carrington, James C.; Mockler, Todd C.; Chang, Jeff H.			GENE-Counter: A Computational Pipeline for the Analysis of RNA-Seq Data for Gene Expression Differences	PLOS ONE			English	Article							DEFENSE RESPONSES; TRANSCRIPTOME; ARABIDOPSIS; SYRINGAE; INTERPLAY; TOMATO; TOOL; QUANTIFICATION; NORMALIZATION; ULTRAFAST	GENE-counter is a complete Perl-based computational pipeline for analyzing RNA-Sequencing (RNA-Seq) data for differential gene expression. In addition to its use in studying transcriptomes of eukaryotic model organisms, GENE-counter is applicable for prokaryotes and non-model organisms without an available genome reference sequence. For alignments, GENE-counter is configured for CASHX, Bowtie, and BWA, but an end user can use any Sequence Alignment/Map (SAM)-compliant program of preference. To analyze data for differential gene expression, GENE-counter can be run with any one of three statistics packages that are based on variations of the negative binomial distribution. The default method is a new and simple statistical test we developed based on an over-parameterized version of the negative binomial distribution. GENE-counter also includes three different methods for assessing differentially expressed features for enriched gene ontology (GO) terms. Results are transparent and data are systematically stored in a MySQL relational database to facilitate additional analyses as well as quality assessment. We used next generation sequencing to generate a small-scale RNA-Seq dataset derived from the heavily studied defense response of Arabidopsis thaliana and used GENE-counter to process the data. Collectively, the support from analysis of microarrays as well as the observed and substantial overlap in results from each of the three statistics packages demonstrates that GENE-counter is well suited for handling the unique characteristics of small sample sizes and high variability in gene counts.	[Cumbie, Jason S.; Kimbrel, Jeffrey A.; Wilhelm, Larry J.; Fox, Samuel E.; Sullivan, Christopher M.; Curzon, Aron D.; Carrington, James C.; Mockler, Todd C.; Chang, Jeff H.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Di, Yanming; Schafer, Daniel W.] Oregon State Univ, Dept Stat, Corvallis, OR 97331 USA; [Sullivan, Christopher M.; Mockler, Todd C.; Chang, Jeff H.] Oregon State Univ, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA; [Cumbie, Jason S.; Kimbrel, Jeffrey A.; Fox, Samuel E.; Carrington, James C.; Mockler, Todd C.; Chang, Jeff H.] Oregon State Univ, Mol & Cellular Biol Program, Corvallis, OR 97331 USA	Oregon State University; Oregon State University; Oregon State University; Oregon State University	Cumbie, JS (corresponding author), Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA.	changj@cgrb.oregonstate.edu	Mockler, Todd C/L-2609-2013; Carrington, James C/A-4656-2012; Kimbrel, Jeff/S-9638-2019	Mockler, Todd C/0000-0002-0462-5775; Carrington, James C/0000-0003-3572-129X; Kimbrel, Jeffrey/0000-0001-7213-9392; Chang, Jeff/0000-0002-1833-0695	Oregon State University (OSU); National Research Initiative from the USDA's National Institute of Food and Agriculture [2008-35600-18783]; Microbial Functional Genomics Program; National Science Foundation [MCB-0618433]; National Institutes of Health [AI43288]; Department of Energy's Plant Feedstock Genomics for Bioenergy [DE-FG02-08ER64630]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI043288, R01AI043288, R37AI043288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104977] Funding Source: NIH RePORTER	Oregon State University (OSU); National Research Initiative from the USDA's National Institute of Food and Agriculture; Microbial Functional Genomics Program; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy's Plant Feedstock Genomics for Bioenergy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by Oregon State University (OSU) and the National Research Initiative Competitive Grant no. 2008-35600-18783 from the USDA's National Institute of Food and Agriculture, Microbial Functional Genomics Program to JHC, National Science Foundation (MCB-0618433) and National Institutes of Health (AI43288) to JCC, and OSU and the Department of Energy's Plant Feedstock Genomics for Bioenergy grant DE-FG02-08ER64630 to TCM. JSC and SEF were supported by Computational and Genome Biology Initiative Fellowships from OSU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; [Anonymous], 2010, R LANG ENV STAT COMP; Bauer S, 2008, BIOINFORMATICS, V24, P1650, DOI 10.1093/bioinformatics/btn250; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bryant DW, 2010, BIOINFORMATICS, V26, P1500, DOI 10.1093/bioinformatics/btq206; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Deng WL, 1998, J BACTERIOL, V180, P4523, DOI 10.1128/JB.180.17.4523-4531.1998; Denoux C, 2008, MOL PLANT, V1, P423, DOI 10.1093/mp/ssn019; Di YM, 2011, STAT APPL GENET MOL, V10, DOI 10.2202/1544-6115.1637; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Fahlgren N, 2009, RNA, V15, P992, DOI 10.1261/rna.1473809; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Fox S, 2009, METHODS MOL BIOL, V553, P79, DOI 10.1007/978-1-60327-563-7_5; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Glazebrook J, 2003, PLANT J, V34, P217, DOI 10.1046/j.1365-313X.2003.01717.x; Goncalves A, 2011, BIOINFORMATICS, V27, P867, DOI 10.1093/bioinformatics/btr012; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grant GR, 2005, BIOINFORMATICS, V21, P2684, DOI 10.1093/bioinformatics/bti407; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Grossmann S, 2007, BIOINFORMATICS, V23, P3024, DOI 10.1093/bioinformatics/btm440; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; Langmead B, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r83; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Mahalingam R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r20; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; McIntyre LM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-293; Navarro L, 2004, PLANT PHYSIOL, V135, P1113, DOI 10.1104/pp.103.036749; Pandelova I, 2009, MOL PLANT, V2, P1067, DOI 10.1093/mp/ssp045; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roine E, 1997, P NATL ACAD SCI USA, V94, P3459, DOI 10.1073/pnas.94.7.3459; Rosenberg BR, 2011, NAT STRUCT MOL BIOL, V18, P230, DOI 10.1038/nsmb.1975; Rosenthal AZ, 2011, ISME J, V5, P1133, DOI 10.1038/ISMEJ.2011.3; Salzberg Steven L, 2010, F1000 Biol Rep, V2, P64, DOI 10.3410/B2-64; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Thilmony R, 2006, PLANT J, V46, P34, DOI 10.1111/j.1365-313X.2006.02725.x; Thomas WJ, 2009, PLANT J, V60, P919, DOI 10.1111/j.1365-313X.2009.03998.x; Toung JM, 2011, GENOME RES, V21, P991, DOI 10.1101/gr.116335.110; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Truman W, 2006, PLANT J, V46, P14, DOI 10.1111/j.1365-313X.2006.02672.x; Tsuda K, 2008, PLANT J, V53, P763, DOI 10.1111/j.1365-313X.2007.03369.x; Turro E, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r13; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622; Wang L, 2008, MOL PLANT MICROBE IN, V21, P1408, DOI 10.1094/MPMI-21-11-1408; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wettenhall JM, 2006, BIOINFORMATICS, V22, P897, DOI 10.1093/bioinformatics/btl025	53	40	41	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e25279	10.1371/journal.pone.0025279	http://dx.doi.org/10.1371/journal.pone.0025279			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998647	Green Published, Green Submitted, gold			2022-12-27	WOS:000295968700008
J	Sorbye, SW; Arbyn, M; Fismen, S; Gutteberg, TJ; Mortensen, ES				Sorbye, Sveinung Wergeland; Arbyn, Marc; Fismen, Silje; Gutteberg, Tore Jarl; Mortensen, Elin Synnove			HPV E6/E7 mRNA Testing Is More Specific than Cytology in Post-Colposcopy Follow-Up of Women with Negative Cervical Biopsy	PLOS ONE			English	Article							INTRAEPITHELIAL NEOPLASIA; INCOMPLETE EXCISION; EUROPEAN GUIDELINES; QUALITY-ASSURANCE; DNA DETECTION; CANCER; AGE; LESIONS; TRIAGE; PERFORMANCE	Background: In Norway, women with negative or low-grade cervical biopsies (normal/CIN1) are followed up after six months in order to decide on further follow-up or recall for screening at three-year intervals. A high specificity and positive predictive value (PPV) of the triage test is important to avoid unnecessary diagnostic and therapeutic procedures whereas a low risk of high-grade disease among triage negative women assures safety. Materials and Methods: At the University Hospital of North Norway, cytology and the HPV mRNA test PreTect HPV-Proofer, detecting E6/E7 mRNA from HPV types 16, 18, 31, 33 and 45, are used in post-colposcopy follow-up of women with negative or low-grade biopsy. In this study, women with negative biopsy after high grade cytology (ASC-H/HSIL) and/or positive HPV mRNA test in the period 2005-2009 were included (n = 520). Histologically confirmed cervical intraepithelial neoplasia of grade 2 or worse (CIN2+) was used as study endpoint. Results: Of 520 women with negative or low-grade biopsy, 124 women (23.8%) had CIN2+ in follow-up biopsy. The sensitivity and specificity of the HPV mRNA test were 89.1% (95% CI, 80.1-98.1) and 92.5% (95% CI, 88.2-96.7), respectively. The ratios of sensitivity, specificity and PPV of HPV mRNA testing compared to repeat cytology for finding CIN2+ was 1.05 (95% CI: 0.92-1.21), 1.21 (95% CI: 1.12-1.32), and 1.49 (95% CI: 1.20-1.86), respectively. The PPV of mRNA was 77.3% (95% CI, 59.8-94.8) in women aged 40 or older. Conclusion: Women with negative cervical biopsy require follow-up before resumption of routine screening. Postcolposcopy HPV mRNA testing was as sensitive but more specific than post-colposcopy cytology. In addition, the HPV mRNA test showed higher PPV. A positive mRNA test post-colposcopy could justify treatment in women above 40 years.	[Sorbye, Sveinung Wergeland; Fismen, Silje; Mortensen, Elin Synnove] Univ Hosp N Norway, Dept Clin Pathol, Tromso, Norway; [Arbyn, Marc] Sci Inst Publ Hlth, Canc Epidemiol Unit, Brussels, Belgium; [Gutteberg, Tore Jarl] Univ Hosp N Norway, Dept Microbiol & Infect Control, Tromso, Norway; [Gutteberg, Tore Jarl; Mortensen, Elin Synnove] Univ Tromso, Dept Med Biol, Fac Hlth Sci, Tromso, Norway	UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso	Sorbye, SW (corresponding author), Univ Hosp N Norway, Dept Clin Pathol, Tromso, Norway.	sveinung.sorbye@unn.no	Sorbye, Sveinung Wergeland/AAE-7208-2020	Sorbye, Sveinung Wergeland/0000-0002-8250-3992	University Hospital of North Norway; European Commission (Directorate of SANCO, Luxembourg, Grand-Duchy of Luxembourg),; DG Research [242061]	University Hospital of North Norway; European Commission (Directorate of SANCO, Luxembourg, Grand-Duchy of Luxembourg),(European CommissionEuropean Commission Joint Research Centre); DG Research(European Commission)	This research was supported by the University Hospital of North Norway (http://www.unn.no/). M. Arbyn received financial support from: (1) the European Commission (Directorate of SANCO, Luxembourg, Grand-Duchy of Luxembourg), through the ECCG project (European Cooperation on development and implementation of Cancer screening and prevention Guidelines, IARC, Lyon, France) and the 7th Framework Programme of DG Research through the PREHDICT project (grant No. 242061, coordinated by the Vrije Universiteit Amsterdam, the Netherlands), and (2) the Belgian Foundation Against Cancer (Brussels, Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrechtsen S, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1343; Ang C, 2011, BJOG-INT J OBSTET GY, V118, P685, DOI 10.1111/j.1471-0528.2011.02929.x; Arbyn M, 2005, GYNECOL ONCOL, V99, pS7, DOI 10.1016/j.ygyno.2005.07.033; Arbyn M, 2004, JNCI-J NATL CANCER I, V96, P280, DOI 10.1093/jnci/djh037; Arbyn M, 2011, BJOG-INT J OBSTET GY, V118, P1274, DOI 10.1111/j.1471-0528.2011.03068.x; Arbyn M, 2010, ANN ONCOL, V21, P448, DOI 10.1093/annonc/mdp471; Arbyn M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1284; ARBYN M, 2011, ANN ONCOL; Benevolo M, 2011, J CLIN MICROBIOL, V49, P2643, DOI 10.1128/JCM.02570-10; Bjerre P, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2007.11.053; BRAY F, 2010, CANC NORWAY 2008 CAN; Brismar-Wendel S, 2009, BRIT J CANCER, V101, P511, DOI 10.1038/sj.bjc.6605165; Castle PE, 2005, J INFECT DIS, V191, P1808, DOI 10.1086/428779; Cattani P, 2009, J CLIN MICROBIOL, V47, P3895, DOI 10.1128/JCM.01275-09; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; DESAI M, 2010, NHSCSP PUBLICATION, V20; Dillner L, 2011, INT J CANCER, V129, P151, DOI 10.1002/ijc.25649; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2007, IARC Monogr Eval Carcinog Risks Hum, V90, P1; JOHANSEN BK, 2009, NORWEGIAN CERVICAL C; Jordan J, 2008, CYTOPATHOLOGY, V19, P342, DOI 10.1111/j.1365-2303.2008.00623.x; Kyrgiou M, 2006, LANCET, V367, P489, DOI 10.1016/S0140-6736(06)68181-6; Lie AK, 2005, GYNECOL ONCOL, V97, P908, DOI 10.1016/j.ygyno.2005.02.026; Massad LS, 2009, J LOW GENIT TRACT DI, V13, P137, DOI 10.1097/LGT.0b013e31819308d4; Molden T, 2005, CANCER EPIDEM BIOMAR, V14, P367, DOI 10.1158/1055-9965.EPI-04-0410; Molden T, 2005, INT J CANCER, V114, P973, DOI 10.1002/ijc.20839; Nygard JF, 2002, J MED SCREEN, V9, P86, DOI 10.1136/jms.9.2.86; Paraskevaidis E, 2003, EUR J GYNAECOL ONCOL, V24, P541; Ratnam S, 2010, J CLIN MICROBIOL, V48, P2779, DOI 10.1128/JCM.00382-10; Richart R M, 1973, Pathol Annu, V8, P301; Schiffman M, 2011, JNCI-J NATL CANCER I, V103, P368, DOI 10.1093/jnci/djq562; Sjoborg KD, 2007, ACTA OBSTET GYN SCAN, V86, P423, DOI 10.1080/11038120701208158; Solomon D, 2003, AM J OBSTET GYNECOL, V188, P1393, DOI 10.1067/mob.2003.462; Solomon D, 2003, AM J OBSTET GYNECOL, V188, P1383, DOI 10.1067/mob.2003.457; Sorbye SW, 2010, J VIROL METHODS, V169, P219, DOI 10.1016/j.jviromet.2010.07.011; Sorbye SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024083; Sorbye SW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012724; Szarewski A, 2008, CANCER EPIDEM BIOMAR, V17, P3033, DOI 10.1158/1055-9965.EPI-08-0508; Trope A, 2009, J CLIN MICROBIOL, V47, P2458, DOI 10.1128/JCM.01863-08; VANOORTMARSSEN GJ, 1991, BRIT J CANCER, V64, P559, DOI 10.1038/bjc.1991.350; Zuchna C, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.05.033; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	41	35	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e26022	10.1371/journal.pone.0026022	http://dx.doi.org/10.1371/journal.pone.0026022			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998748	gold, Green Published, Green Submitted			2022-12-27	WOS:000295968700033
J	Chiarelli, V; El Yagoubi, R; Mondini, S; Bisiacchi, P; Semenza, C				Chiarelli, Valentina; El Yagoubi, Radouane; Mondini, Sara; Bisiacchi, Patrizia; Semenza, Carlo			The Syntactic and Semantic Processing of Mass and Count Nouns: An ERP Study	PLOS ONE			English	Article							BRAIN POTENTIALS; MASS/COUNT INFORMATION; ALZHEIMERS-DISEASE; LEXICAL ACCESS; WORD; COMPREHENSION; CONCRETE; APHASIA; OBJECTS; ACTIVATION	The present study addressed the question of whether count and mass nouns are differentially processed in the brain. In two different ERP (Event-Related Potentials) tasks we explored the semantic and syntactic levels of such distinction. Mass and count nouns typically differ in concreteness, hence the effect of this important variable was factorially examined in each task. Thus the stimuli presented were: count concrete, count abstract, mass concrete or mass abstract. The first experiment (concrete/abstract semantic judgment task) involved the interaction between the N400 concreteness effect and the Mass/Count condition, revealing a substantial effect between mass and count nouns at the semantic level. The second experiment (sentence syntactic violation task) showed a Mass/Count distinction on left anterior negativity (LAN) and on P600 components, confirming the difference at the syntactic level. This study suggests that the brain differentiates between count and mass nouns not only at the syntactic level but also at the semantic level. Implications for our understanding of the brain mechanisms underlying the Mass/Count distinction are discussed.	[Chiarelli, Valentina] Univ Trieste, Dept Psychol, Trieste, Italy; [El Yagoubi, Radouane] Univ Toulouse 2, CNRS, Lab CLLE LTC, UMR 5263, Toulouse, France; [Mondini, Sara; Bisiacchi, Patrizia] Univ Padua, Dept Gen Psychol, Padua, Italy; [Semenza, Carlo] Univ Padua, Dept Neurosci, Padua, Italy; [Semenza, Carlo] IRCCS Osped S Camillo, Lido Di Venezia, Italy; [Chiarelli, Valentina] Osped Civile, SOC Neurol, Gorizia, Italy	University of Trieste; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite de Toulouse; Universite de Toulouse - Jean Jaures; Universite Bordeaux-Montaigne; University of Padua; University of Padua	Chiarelli, V (corresponding author), Univ Trieste, Dept Psychol, Trieste, Italy.	patrizia.bisiacchi@unipd.it		bisiacchi, patrizia/0000-0003-2760-8000; MONDINI, SARA/0000-0002-2144-9435	Ministero dell'Istruzione, dell'Universita e della Ricerca [prot. 200879EB93_002]; Bial Foundation [146/2008]	Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Bial Foundation(Bial Foundation)	PB and SM were funded by Ministero dell'Istruzione, dell'Universita e della Ricerca prot. 200879EB93_002. The study was partially supported by a grant of the Bial Foundation (146/2008) to PB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barner D, 2005, COGNITION, V97, P41, DOI 10.1016/j.cognition.2004.06.009; Bentin S, 1985, ELECTROENCEPHALOGRAP, V60, P345; Bisiacchi P, 2005, BRAIN LANG, V95, P98, DOI 10.1016/j.bandl.2005.07.054; Bisiacchi PS, 2009, NEUROPSYCHOLOGIA, V47, P1362, DOI 10.1016/j.neuropsychologia.2009.01.034; Borgo F, 2003, COGN NEUROPSYCHOL, V20, P327, DOI 10.1080/02643290244000310; Bunt H, 2006, ENCY LANGUAGE LIGUIS, P5757; Burani C., 2001, GIORNALE ITALIANO PS, V4, P839, DOI DOI 10.1421/379; Chiang WC, 2000, COGNITION, V77, P169, DOI 10.1016/S0010-0277(00)00091-3; Chierchia G, 1998, STUD LINGUIST PHILOS, V70, P53; Coltheart M, 1980, DEEP DYSLEXIA, P326; Damasio H, 2004, COGNITION, V92, P179, DOI 10.1016/j.cognition.2002.07.001; DeLong KA, 2005, NAT NEUROSCI, V8, P1117, DOI 10.1038/nn1504; Friederici AD, 2002, J PSYCHOLINGUIST RES, V31, P45, DOI 10.1023/A:1014376204525; FRIEDERICI AD, 1995, BRAIN LANG, V50, P259, DOI 10.1006/brln.1995.1048; Gillon B, 1999, BRAIN LANG, V68, P205, DOI 10.1006/brln.1999.2081; GILLON BS, 1992, LINGUIST PHILOS, V15, P597, DOI 10.1007/BF00628112; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; GROSSMAN M, 1995, NEUROLOGY, V45, P85, DOI 10.1212/WNL.45.1.85; GROSSMAN M, 1993, BRAIN LANG, V44, P351, DOI 10.1006/brln.1993.1022; Gunter TC, 1999, PSYCHOPHYSIOLOGY, V36, P126, DOI 10.1017/S004857729997155X; Gunter TC, 1997, PSYCHOPHYSIOLOGY, V34, P660, DOI 10.1111/j.1469-8986.1997.tb02142.x; Holcomb PJ, 1999, J EXP PSYCHOL LEARN, V25, P721, DOI 10.1037/0278-7393.25.3.721; HOLCOMB PJ, 1990, LANG COGNITIVE PROC, V5, P281, DOI 10.1080/01690969008407065; HOLCOMB PJ, 1993, PSYCHOPHYSIOLOGY, V30, P47, DOI 10.1111/j.1469-8986.1993.tb03204.x; Hubbard EM, 2005, NAT REV NEUROSCI, V6, P435, DOI 10.1038/nrn1684; Huntley-Fenner G, 2002, COGNITION, V85, P203, DOI 10.1016/S0010-0277(02)00088-4; JACKENDOFF R, 1991, COGNITION, V41, P9, DOI 10.1016/0010-0277(91)90031-X; Kaan E, 2000, LANG COGNITIVE PROC, V15, P159, DOI 10.1080/016909600386084; KATZ RB, 1990, BRAIN LANG, V39, P153, DOI 10.1016/0093-934X(90)90009-6; KING JW, 1995, J COGNITIVE NEUROSCI, V7, P376, DOI 10.1162/jocn.1995.7.3.376; KOUNIOS J, 1994, J EXP PSYCHOL LEARN, V20, P804, DOI 10.1037/0278-7393.20.4.804; Kovacevic N, 2007, NEUROIMAGE, V35, P1103, DOI 10.1016/j.neuroimage.2007.01.016; KROLL JF, 1986, J EXP PSYCHOL LEARN, V12, P92, DOI 10.1037/0278-7393.12.1.92; KUTAS M, 1983, MEM COGNITION, V11, P539, DOI 10.3758/BF03196991; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Kutas M., 1994, HDB PSYCHOLINGUISTIC, P83, DOI DOI 10.1016/8978-012369374-7/50018-3; Laycock H, 2006, ENCY LANGUAGE LINGUI, P530; MACNAMARA J, 1994, LOGICAL FDN COGNITIO; Martin-Loeches M, 2001, NEUROPSYCHOLOGIA, V39, P1086, DOI 10.1016/S0028-3932(01)00033-1; Mondini S, 2004, BRAIN LANG, V91, P138, DOI 10.1016/j.bandl.2004.06.072; Mondini S, 2008, NEUROSCI LETT, V430, P48, DOI 10.1016/j.neulet.2007.10.020; Mondini S, 2009, MENT LEX, V4, P354, DOI 10.1075/ml.4.3.03mon; Munte TF, 1997, J COGNITIVE NEUROSCI, V9, P318, DOI 10.1162/jocn.1997.9.3.318; NEVILLE H, 1991, J COGNITIVE NEUROSCI, V3, P151, DOI 10.1162/jocn.1991.3.2.151; OSTERHOUT L, 1992, J MEM LANG, V31, P785, DOI 10.1016/0749-596X(92)90039-Z; OSTERHOUT L, 1994, J EXP PSYCHOL LEARN, V20, P786, DOI 10.1037/0278-7393.20.4.786; Paivio, 1986, MENTAL REPRESENTATIO; PAIVIO A, 1991, CAN J PSYCHOL, V45, P255, DOI 10.1037/h0084295; Paivio A, 1971, IMAGERY VERBAL PROCE; Pelletier F, 1979, MASS TERMS SOME PHIL; Prasada S, 2002, COGNITION, V83, P141, DOI 10.1016/S0010-0277(01)00173-1; Pulvermuller F, 1999, BEHAV BRAIN SCI, V22, P253, DOI 10.1017/S0140525X9900182X; Rothstein S, 2010, J SEMANT, V27, P343, DOI 10.1093/jos/ffq007; Schneider W., 2002, E PRIME VERSION 20 C; SCHWANENFLUGEL PJ, 1991, PSYCHOLOGY OF WORD MEANINGS, P223; Semenza C, 1997, NEUROPSYCHOLOGIA, V35, P669, DOI 10.1016/S0028-3932(96)00124-8; Semenza C, 2000, BRAIN LANG, V74, P428; Semenza C, 2005, BRAIN LANG, V95, P88, DOI 10.1016/j.bandl.2005.07.049; Semenza C, 1999, MANUALE NEUROPSICOLO, P288; Semlitsch HV, 1986, PSYCHOPHYSIOLOGY, V20, P168; Shapiro K, 2003, TRENDS COGN SCI, V7, P201, DOI 10.1016/S1364-6613(03)00060-3; SHAPIRO LP, 1989, J SPEECH HEAR RES, V32, P481, DOI 10.1044/jshr.3203.481; SOJA NN, 1991, COGNITION, V38, P179, DOI 10.1016/0010-0277(91)90051-5; Steinhauer K, 2001, NEUROREPORT, V12, P999, DOI 10.1097/00001756-200104170-00027; Swaab TY, 2002, COGNITIVE BRAIN RES, V15, P99, DOI 10.1016/S0926-6410(02)00219-7; Taler V, 2006, J NEUROLINGUIST, V19, P38, DOI 10.1016/j.jneuroling.2005.07.002; Taler V, 2005, BRAIN LANG, V95, P92, DOI 10.1016/j.bandl.2005.07.051; Taler V, 2004, BRAIN LANG, V90, P262, DOI 10.1016/S0093-934X(03)00439-5; Thorton A, 1994, BASE DATI VOCABOLARI; van Berkum JJA, 1999, J MEM LANG, V41, P147, DOI 10.1006/jmla.1999.2641; Vigliocco G, 1999, J MEM LANG, V40, P534, DOI 10.1006/jmla.1998.2626; West WC, 2000, J COGNITIVE NEUROSCI, V12, P1024, DOI 10.1162/08989290051137558; Weyerts H, 1996, NEUROSCI LETT, V206, P125, DOI 10.1016/S0304-3940(96)12442-3; Zhang Q, 2006, BRAIN LANG, V96, P59, DOI 10.1016/j.bandl.2005.04.004	74	16	16	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25885	10.1371/journal.pone.0025885	http://dx.doi.org/10.1371/journal.pone.0025885			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834NA	21998715	Green Published, Green Submitted, gold			2022-12-27	WOS:000295966900068
J	Dalsgaard, B; Magard, E; Fjeldsa, J; Gonzalez, AMM; Rahbek, C; Olesen, JM; Ollerton, J; Alarcon, R; Araujo, AC; Cotton, PA; Lara, C; Machado, CG; Sazima, I; Sazima, M; Timmermann, A; Watts, S; Sandel, B; Sutherland, WJ; Svenning, JC				Dalsgaard, Bo; Magard, Else; Fjeldsa, Jon; Gonzalez, Ana M. Martin; Rahbek, Carsten; Olesen, Jens M.; Ollerton, Jeff; Alarcon, Ruben; Araujo, Andrea Cardoso; Cotton, Peter A.; Lara, Carlos; Machado, Caio Graco; Sazima, Ivan; Sazima, Marlies; Timmermann, Allan; Watts, Stella; Sandel, Brody; Sutherland, William J.; Svenning, Jens-Christian			Specialization in Plant-Hummingbird Networks Is Associated with Species Richness, Contemporary Precipitation and Quaternary Climate-Change Velocity	PLOS ONE			English	Article							ANIMAL MUTUALISTIC NETWORKS; LATITUDINAL GRADIENT; POLLINATION NETWORKS; ECOLOGICAL NETWORKS; GEOGRAPHIC PATTERNS; BIRD; EVOLUTIONARY; DISTRIBUTIONS; COINCIDENCE; COEVOLUTION	Large-scale geographical patterns of biotic specialization and the underlying drivers are poorly understood, but it is widely believed that climate plays an important role in determining specialization. As climate-driven range dynamics should diminish local adaptations and favor generalization, one hypothesis is that contemporary biotic specialization is determined by the degree of past climatic instability, primarily Quaternary climate-change velocity. Other prominent hypotheses predict that either contemporary climate or species richness affect biotic specialization. To gain insight into geographical patterns of contemporary biotic specialization and its drivers, we use network analysis to determine the degree of specialization in plant-hummingbird mutualistic networks sampled at 31 localities, spanning a wide range of climate regimes across the Americas. We found greater biotic specialization at lower latitudes, with latitude explaining 20-22% of the spatial variation in plant-hummingbird specialization. Potential drivers of specialization - contemporary climate, Quaternary climate-change velocity, and species richness -had superior explanatory power, together explaining 53-64% of the variation in specialization. Notably, our data provides empirical evidence for the hypothesized roles of species richness, contemporary precipitation and Quaternary climate-change velocity as key predictors of biotic specialization, whereas contemporary temperature and seasonality seem unimportant in determining specialization. These results suggest that both ecological and evolutionary processes at Quaternary time scales can be important in driving large-scale geographical patterns of contemporary biotic specialization, at least for co-evolved systems such as plant-hummingbird networks.	[Dalsgaard, Bo; Sutherland, William J.] Univ Cambridge, Dept Zool, Conservat Sci Grp, Cambridge, England; [Dalsgaard, Bo; Rahbek, Carsten] Univ Copenhagen, Dept Biol, Ctr Macroecol Evolut & Climate, Copenhagen, Denmark; [Dalsgaard, Bo; Olesen, Jens M.; Timmermann, Allan; Sandel, Brody; Svenning, Jens-Christian] Aarhus Univ, Dept Biosci, Aarhus, Denmark; [Magard, Else; Sandel, Brody] Aarhus Univ, Dept Comp Sci, Ctr Mass Data Algorithm, DK-8000 Aarhus, Denmark; [Fjeldsa, Jon] Univ Copenhagen, Nat Hist Museum Denmark, Ctr Macroecol Evolut & Climate, Copenhagen, Denmark; [Gonzalez, Ana M. Martin] Pacific Ecoinformat & Computat Ecol Lab, Berkeley, CA USA; [Ollerton, Jeff; Watts, Stella] Univ Northampton, Sch Sci & Technol, Landscape & Biodivers Res Grp, Northampton, England; [Alarcon, Ruben] Calif State Univ, Biol Program, Camarillo, CA USA; [Araujo, Andrea Cardoso] Univ Fed Mato Grosso do Sul, Dept Biol, Campo Grande, Brazil; [Cotton, Peter A.] Univ Plymouth, Marine Biol & Ecol Res Ctr, Plymouth PL4 8AA, Devon, England; [Lara, Carlos] Univ Autonoma Tlaxcala, Ctr Tlaxcala Biol Conducta, Tlaxcala, Mexico; [Machado, Caio Graco] Univ Estadual Feira de Santana, Lab Ornitol, Dept Ciencias Biol, Feira De Santana, BA, Brazil; [Sazima, Ivan] Univ Estadual Campinas, Museu Zool, IB, Campinas, SP, Brazil; [Sazima, Marlies] Univ Estadual Campinas, IB, Dept Biol Vegetal, Campinias, Brazil; [Watts, Stella] Univ Haifa, Lab Pollinat Ecol, Inst Evolut, IL-31999 Haifa, Israel	University of Cambridge; University of Copenhagen; Aarhus University; Aarhus University; University of Copenhagen; University of Northampton; Universidade Federal de Mato Grosso do Sul; University of Plymouth; Universidade Estadual de Feira de Santana; Universidade Estadual de Campinas; Universidade Estadual de Campinas; University of Haifa	Dalsgaard, B (corresponding author), Univ Cambridge, Dept Zool, Conservat Sci Grp, Downing St, Cambridge, England.	b.dalsgaard@zoo.cam.ac.uk	Fjeldså, Jon/A-9699-2013; Machado, Caio G./I-1400-2012; Rahbek, Carsten/D-9372-2013; Araujo, Andréa Cardoso/D-9439-2013; Olesen, Jens M/A-3011-2009; Sazima, Marlies/B-6973-2013; Svenning, Jens-Christian/C-8977-2012; Sandel, Brody/I-8009-2013; Rahbek, Carsten/L-1129-2013; Gonzalez, Ana M. Martin/A-7827-2010; Sutherland, William/B-1291-2013; Ollerton, Jeff/AAE-3946-2020; Ollerton, Jeff/I-3946-2012	Fjeldså, Jon/0000-0003-0790-3600; Machado, Caio G./0000-0002-8070-8601; Araujo, Andréa Cardoso/0000-0003-0394-2012; Olesen, Jens M/0000-0003-1998-1083; Svenning, Jens-Christian/0000-0002-3415-0862; Rahbek, Carsten/0000-0003-4585-0300; Gonzalez, Ana M. Martin/0000-0001-9429-7180; Ollerton, Jeff/0000-0002-0887-8235; Ollerton, Jeff/0000-0002-0887-8235; Olesen, Jes/0000-0002-6712-2702; Sutherland, William/0000-0002-6498-0437; Dalsgaard, Bo/0000-0003-2867-2805; Lara, Carlos/0000-0001-6037-0327; Cotton, Peter/0000-0002-4830-0868	Frimodt-Heineke Foundation; Augustinus Foundation; Knud Hojgaard Foundation; Aarhus University; Department of Zoology, University of Cambridge; The Danish Council for Independent Research verbar Natural Sciences; Center for Massive Data Algorithmics; Danish National Research Foundation Center of Excellence; Center for Macroecology, Evolution and Climate; Svend Fiedler & Wife Foundation; Danish Council for Independent Research - Natural Sciences and Novozymes/World Wildlife Foundation-Denmark; British Ecological Society; Idea Wild; The Biodiversity Trust; The Anglo Peruvian Society; The Leslie Church Bursary Fund; The United States National Science Foundation; The California Alliance for Minority Participation; The Fundacao de Amparo a Pesquisa do Estado da Bahia (FAEP); The National Council for Scientific and Technological Development (CNPq); British Ornithologists' Union; Consejo Nacional de Ciencia y Tecnologia; FAPESB; Danish Council for Independent Research - Natural Sciences [272-07-0242]; World Wildlife Foundation; Novozymes; CEA; CNRS; EU [EVK2-CT-2002-00153]; Programme National d'Etude de la Dynamique du Climat (PNEDC)	Frimodt-Heineke Foundation; Augustinus Foundation; Knud Hojgaard Foundation; Aarhus University; Department of Zoology, University of Cambridge(University of Cambridge); The Danish Council for Independent Research verbar Natural Sciences; Center for Massive Data Algorithmics; Danish National Research Foundation Center of Excellence; Center for Macroecology, Evolution and Climate; Svend Fiedler & Wife Foundation; Danish Council for Independent Research - Natural Sciences and Novozymes/World Wildlife Foundation-Denmark; British Ecological Society; Idea Wild; The Biodiversity Trust; The Anglo Peruvian Society; The Leslie Church Bursary Fund; The United States National Science Foundation; The California Alliance for Minority Participation; The Fundacao de Amparo a Pesquisa do Estado da Bahia (FAEP); The National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); British Ornithologists' Union; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); FAPESB(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)); Danish Council for Independent Research - Natural Sciences(Det Frie Forskningsrad (DFF)); World Wildlife Foundation; Novozymes; CEA(French Atomic Energy Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); EU(European Commission); Programme National d'Etude de la Dynamique du Climat (PNEDC)	Funding for BD was supported by Frimodt-Heineke Foundation, Augustinus Foundation, Knud Hojgaard Foundation, a PhD fellowship by Aarhus University, Weis-Fogh Fund at Department of Zoology, University of Cambridge, and The Danish Council for Independent Research vertical bar Natural Sciences. EM was supported by the Center for Massive Data Algorithmics, a Danish National Research Foundation Center of Excellence. JF and CR thank the Danish National Research Foundation for its support of the Center for Macroecology, Evolution and Climate. AMG was supported by Svend Fiedler & Wife Foundation, J.Olesen by the Danish Council for Independent Research - Natural Sciences and Novozymes/World Wildlife Foundation-Denmark, J.Ollerton and SW by the British Ecological Society, Idea Wild, The Biodiversity Trust, The Anglo Peruvian Society and The Leslie Church Bursary Fund, RA by The United States National Science Foundation's Predoctoral Fellowship Program and The California Alliance for Minority Participation, ACA by The Fundacao de Amparo a Pesquisa do Estado da Bahia (FAEP) and The National Council for Scientific and Technological Development (CNPq), PC by the British Ornithologists' Union, CL by the Consejo Nacional de Ciencia y Tecnologia, CM by FAPESB and CNPq, IS and MS by FAPESP and CNPq, AT by Aarhus University, and J-CS by the Danish Council for Independent Research - Natural Sciences (grant 272-07-0242). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; J.Olesen was awarded a grant jointly by the World Wildlife Foundation and Novozymes. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.; Thanks to Nico Bluthgen and Thiago Fernando Rangel for their advice regarding calculation of specialization indices and the use of SAM, respectively. Thanks to Anders H Madsen for helping with the figures, to Silvana Buzato for providing data and insight, and to Anna Traveset, Christopher Kaiser-Bunbury and two anonymous reviewers providing useful comments improving the manuscript. The PMIP2 Data Archive is supported by CEA, CNRS, the EU project MOTIF (EVK2-CT-2002-00153) and the Programme National d'Etude de la Dynamique du Climat (PNEDC). The analysis was using version 05-26-2010 of the database. More information is available on http://pmip2.lsce.ipsl.fr/. RA thanks the US Forest Service and The Wildlands Conservancy and the Rocky Mountain Biological Laboratory for access to the field sites in CA and CO, respectively, and SW thanks the National Institute of Natural Resources (INRENA) for research permits (permit numbers: 008799 and 0001982) in Peru	Abrahamczyk S, 2010, J ORNITHOL, V151, P615, DOI 10.1007/s10336-010-0496-x; Aizen MA, 2003, TAXON, V52, P675, DOI 10.2307/3647342; Aizen Marcelo A., 1998, Ecologia Austral, V8, P217; Amano T, 2010, P ROY SOC B-BIOL SCI, V277, P2451, DOI 10.1098/rspb.2010.0291; [Anonymous], 2005, REV BRAS ZOOL, V22, P51, DOI 10.1590/S0101-81752005000100007; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Blackburn TM, 2004, ECOGRAPHY, V27, P715, DOI 10.1111/j.0906-7590.2004.03999.x; Bleiweiss R, 1998, BIOL J LINN SOC, V65, P77, DOI 10.1111/j.1095-8312.1998.tb00352.x; Bluethgen Nico, 2006, BMC Ecology, V6, P9, DOI 10.1186/1472-6785-6-9; Braconnot P, 2007, CLIM PAST, V3, P261, DOI 10.5194/cp-3-261-2007; Burkle LA, 2011, AM J BOT, V98, P528, DOI 10.3732/ajb.1000391; Buzato S, 2000, BIOTROPICA, V32, P824, DOI 10.1111/j.1744-7429.2000.tb00621.x; Colwell RK, 2010, PHILOS T R SOC B, V365, P3695, DOI 10.1098/rstb.2010.0293; Cotton PA, 1998, IBIS, V140, P639, DOI 10.1111/j.1474-919X.1998.tb04709.x; CRUDEN RW, 1972, SCIENCE, V176, P1439, DOI 10.1126/science.176.4042.1439; Dalsgaard B, 2008, OIKOS, V117, P789, DOI 10.1111/j.0030-1299.2008.16537.x; Dalsgaard B, 2009, OECOLOGIA, V159, P757, DOI 10.1007/s00442-008-1255-z; Dobzhansky T., 1950, American Scientist, V38, P209; Dupont YL, 2009, OIKOS, V118, P1261, DOI 10.1111/j.1600-0706.2009.17594.x; DUTILLEUL P, 1993, BIOMETRICS, V49, P305, DOI 10.2307/2532625; Dyer LA, 2007, NATURE, V448, P696, DOI 10.1038/nature05884; Dynesius M, 2000, P NATL ACAD SCI USA, V97, P9115, DOI 10.1073/pnas.97.16.9115; FEINSINGER P, 1978, AM ZOOL, V18, P779; Fjeldsa J, 1999, ECOGRAPHY, V22, P63, DOI 10.1111/j.1600-0587.1999.tb00455.x; Fleming TH, 2008, J BIOGEOGR, V35, P764, DOI 10.1111/j.1365-2699.2007.01833.x; Gomez JM, 2010, NATURE, V465, P918, DOI 10.1038/nature09113; Graham CH, 2010, ECOGRAPHY, V33, P1062, DOI 10.1111/j.1600-0587.2010.06430.x; Graham CH, 2009, P NATL ACAD SCI USA, V106, P19673, DOI 10.1073/pnas.0901649106; Hegland SJ, 2009, ECOL LETT, V12, P184, DOI 10.1111/j.1461-0248.2008.01269.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Ings TC, 2009, J ANIM ECOL, V78, P253, DOI 10.1111/j.1365-2656.2008.01460.x; Jansson R, 2003, P ROY SOC B-BIOL SCI, V270, P583, DOI 10.1098/rspb.2002.2283; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Jetz W, 2004, ECOL LETT, V7, P1180, DOI 10.1111/j.1461-0248.2004.00678.x; Jocque M, 2010, GLOBAL ECOL BIOGEOGR, V19, P244, DOI 10.1111/j.1466-8238.2009.00510.x; Kissling WD, 2012, GLOBAL ECOL BIOGEOGR, V21, P328, DOI 10.1111/j.1466-8238.2011.00679.x; Lavergne S, 2010, ANNU REV ECOL EVOL S, V41, P321, DOI 10.1146/annurev-ecolsys-102209-144628; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Gonzalez AMM, 2009, J TROP ECOL, V25, P493, DOI 10.1017/S0266467409990034; Memmott J, 2010, PHILOS T R SOC B, V365, P2071, DOI 10.1098/rstb.2010.0015; Nogues-Bravo D, 2010, EVOLUTION, V64, P2442, DOI 10.1111/j.1558-5646.2010.01009.x; Ohlemuller R, 2008, BIOL LETTERS, V4, P568, DOI 10.1098/rsbl.2008.0097; Olesen JM, 2002, ECOLOGY, V83, P2416, DOI 10.1890/0012-9658(2002)083[2416:GPIPPM]2.0.CO;2; Ollerton J, 2002, OIKOS, V98, P340, DOI 10.1034/j.1600-0706.2002.980215.x; Ollerton J, 2006, PLANT-POLLINATOR INTERACTIONS: FROM SPECIALIZATION TO GENERALIZATION, P283; Rahbek C, 2007, P ROY SOC B-BIOL SCI, V274, P165, DOI 10.1098/rspb.2006.3700; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Rezende EL, 2007, NATURE, V448, P925, DOI 10.1038/nature05956; Sandel B, 2011, SCIENCE, V334, P660, DOI 10.1126/science.1210173; Schemske DW, 2009, ANNU REV ECOL EVOL S, V40, P245, DOI 10.1146/annurev.ecolsys.39.110707.173430; SCHEMSKE DW, 2002, FDN TROPICAL FOREST, P163; Srivastava DS, 1998, AM NAT, V152, P510, DOI 10.1086/286187; Stefanescu C, 2009, OIKOS, V118, P1109, DOI 10.1111/j.1600-0706.2009.17274.x; STILES FG, 1981, ANN MO BOT GARD, V68, P323, DOI 10.2307/2398801; STILES FG, 1978, AM ZOOL, V18, P715; Svenning JC, 2007, GLOBAL ECOL BIOGEOGR, V16, P234, DOI 10.1111/j.1466-8238.2006.00280.x; Thompson JN, 2009, AM NAT, V173, P125, DOI 10.1086/595752; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Tylianakis JM, 2010, BIOL CONSERV, V143, P2270, DOI 10.1016/j.biocon.2009.12.004; Vazquez DP, 2009, ANN BOT-LONDON, V103, P1445, DOI 10.1093/aob/mcp057; Vazquez DP, 2005, ECOL LETT, V8, P1088, DOI 10.1111/j.1461-0248.2005.00810.x; Vazquez DP, 2004, AM NAT, V164, pE1, DOI 10.1086/421445; Waser NM, 1996, ECOLOGY, V77, P1043, DOI 10.2307/2265575; Williams RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017645; Woodward G, 2010, ADV ECOL RES, V42, P71, DOI 10.1016/S0065-2504(10)42002-4	65	120	120	1	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25891	10.1371/journal.pone.0025891	http://dx.doi.org/10.1371/journal.pone.0025891			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998716	Green Published, Green Accepted, gold			2022-12-27	WOS:000295966900069
J	Dong, C; Qin, L; Liu, YC; Zhang, XN; Sato, Y				Dong, Chao; Qin, Ling; Liu, Yongchun; Zhang, Xinan; Sato, Yu			Neural Responses in the Primary Auditory Cortex of Freely Behaving Cats While Discriminating Fast and Slow Click-Trains	PLOS ONE			English	Article							AMPLITUDE-MODULATED SOUNDS; CORTICAL DISCRIMINATION; SOMATOSENSORY CORTEX; TEMPORAL INFORMATION; ACOUSTIC FLUTTER; NATURAL SOUNDS; PATTERN CODES; PERIODICITY; PERCEPTION; STIMULI	Repeated acoustic events are ubiquitous temporal features of natural sounds. To reveal the neural representation of the sound repetition rate, a number of electrophysiological studies have been conducted on various mammals and it has been proposed that both the spike-time and firing rate of primary auditory cortex (A1) neurons encode the repetition rate. However, previous studies rarely examined how the experimental animals perceive the difference in the sound repetition rate, and a caveat to these experiments is that they compared physiological data obtained from animals with psychophysical data obtained from humans. In this study, for the first time, we directly investigated acoustic perception and the underlying neural mechanisms in the same experimental animal by examining spike activities in the A1 of free-moving cats while performing a Go/No-go task to discriminate the click-trains at different repetition rates (12.5-200 Hz). As reported by previous studies on passively listening animals, A1 neurons showed both synchronized and non-synchronized responses to the click-trains. We further found that the neural performance estimated from the precise temporal information of synchronized units was good enough to distinguish all 16.7-200 Hz from the 12.5 Hz repetition rate; however, the cats showed declining behavioral performance with the decrease of the target repetition rate, indicating an increase of difficulty in discriminating two slower click-trains. Such behavioral performance was well explained by the firing rate of some synchronized and non-synchronized units. Trial-by-trial analysis indicated that A1 activity was not affected by the cat's judgment of behavioral response. Our results suggest that the main function of A1 is to effectively represent temporal signals using both spike timing and firing rate, while the cats may read out the rate-coding information to perform the task in this experiment.	[Dong, Chao; Qin, Ling; Liu, Yongchun; Zhang, Xinan; Sato, Yu] Univ Yamanashi, Dept Physiol, Interdisciplinary Grad Sch Med & Engn, Chuo Ku, Yamanashi, Japan; [Dong, Chao] Inner Mongolia Med Coll, Clin Med Res Ctr, Hohhot, Peoples R China; [Qin, Ling] China Med Univ, Dept Physiol, Shenyang, Peoples R China	University of Yamanashi; Inner Mongolia Medical University; China Medical University	Dong, C (corresponding author), Univ Yamanashi, Dept Physiol, Interdisciplinary Grad Sch Med & Engn, Chuo Ku, Yamanashi, Japan.	qinlingling@yahoo.com		zhang, xin an/0000-0002-7854-4134	Japan Ministry of Education, Culture, Sports, Science and Technology [08038015, 23700377]; National Nature Science Foundation of China [30970979]	Japan Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Strategic Research Program for Brain Sciences 08038015 and No. 23700377 from the Japan Ministry of Education, Culture, Sports, Science and Technology (Y.S. and L.Q.), and the National Nature Science Foundation of China under grant 30970979 (L.Q.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adibi M, 2011, J NEUROPHYSIOL, V105, P356, DOI 10.1152/jn.00794.2010; Bendor D, 2005, NATURE, V436, P1161, DOI 10.1038/nature03867; Bendor D, 2007, NAT NEUROSCI, V10, P763, DOI 10.1038/nn1888; Bendor D, 2010, J NEUROPHYSIOL, V103, P1809, DOI 10.1152/jn.00281.2009; Bieser A, 1996, EXP BRAIN RES, V108, P273; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; de Lafuente V, 2005, NAT NEUROSCI, V8, P1698, DOI 10.1038/nn1587; EGGERMONT JJ, 1991, HEARING RES, V56, P153, DOI 10.1016/0378-5955(91)90165-6; Engineer CT, 2008, NAT NEUROSCI, V11, P603, DOI 10.1038/nn.2109; Fritz JB, 2010, NAT NEUROSCI, V13, P1011, DOI 10.1038/nn.2598; Gaese BH, 2003, EUR J NEUROSCI, V18, P2638, DOI 10.1046/j.1460-9568.2003.03007.x; GOLDBERG JM, 1969, J NEUROPHYSIOL, V32, P613, DOI 10.1152/jn.1969.32.4.613; Green DM, 1966, SIGNAL DETECTION THE; Hernandez A, 2000, P NATL ACAD SCI USA, V97, P6191, DOI 10.1073/pnas.120018597; Hernandez A, 2010, NEURON, V66, P300, DOI 10.1016/j.neuron.2010.03.031; Imaizumi K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011531; Jackson A, 2007, J NEUROPHYSIOL, V98, P3109, DOI 10.1152/jn.00569.2007; Joris PX, 2004, PHYSIOL REV, V84, P541, DOI 10.1152/physrev.00029.2003; KAY RH, 1982, PHYSIOL REV, V62, P894, DOI 10.1152/physrev.1982.62.3.894; Kilgard MP, 1998, NAT NEUROSCI, V1, P727, DOI 10.1038/3729; Krug K, 2004, J NEUROPHYSIOL, V92, P1586, DOI 10.1152/jn.00851.2003; LANGNER G, 1992, HEARING RES, V60, P115, DOI 10.1016/0378-5955(92)90015-F; Lemus L, 2009, P NATL ACAD SCI USA, V106, P14640, DOI 10.1073/pnas.0907505106; Lemus L, 2009, P NATL ACAD SCI USA, V106, P9471, DOI 10.1073/pnas.0904066106; Liu J, 2005, J NEUROSCI, V25, P711, DOI 10.1523/JNEUROSCI.4034-04.2005; Liu YC, 2010, BEHAV BRAIN RES, V215, P28, DOI 10.1016/j.bbr.2010.06.013; Lu T, 2000, J NEUROPHYSIOL, V84, P236, DOI 10.1152/jn.2000.84.1.236; Lu T, 2001, NAT NEUROSCI, V4, P1131, DOI 10.1038/nn737; Macmillan N. A., 1991, DETECTION THEORY USE; Malone BJ, 2007, J NEUROPHYSIOL, V98, P1451, DOI 10.1152/jn.01203.2006; Mardia KV, 2000, DIRECTIONAL STAT; Narayan R, 2006, J NEUROPHYSIOL, V96, P252, DOI 10.1152/jn.01257.2005; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; PHILLIPS DP, 1989, HEARING RES, V40, P137, DOI 10.1016/0378-5955(89)90107-X; Pruett JR, 2001, J NEUROPHYSIOL, V86, P2069, DOI 10.1152/jn.2001.86.4.2069; Qin L, 2009, J NEUROSCI, V29, P15650, DOI 10.1523/JNEUROSCI.2442-09.2009; RIBAUPIERRE FD, 1972, BRAIN RES, V48, P205, DOI 10.1016/0006-8993(72)90179-5; Romo R, 2003, NAT REV NEUROSCI, V4, P203, DOI 10.1038/nrn1058; ROSEN S, 1992, PHILOS T ROY SOC B, V336, P367, DOI 10.1098/rstb.1992.0070; Salinas E, 2000, J NEUROSCI, V20, P5503, DOI 10.1523/JNEUROSCI.20-14-05503.2000; Schnupp JWH, 2006, J NEUROSCI, V26, P4785, DOI 10.1523/JNEUROSCI.4330-05.2006; SCHREINER CE, 1988, HEARING RES, V32, P49, DOI 10.1016/0378-5955(88)90146-3; Schulze H, 1997, J COMP PHYSIOL A, V181, P651, DOI 10.1007/s003590050147; Singh NC, 2003, J ACOUST SOC AM, V114, P3394, DOI 10.1121/1.1624067; Steinschneider M, 1998, J ACOUST SOC AM, V104, P2935, DOI 10.1121/1.423877; van Rossum MCW, 2001, NEURAL COMPUT, V13, P751, DOI 10.1162/089976601300014321; Von Heimendahl M, 2007, PLOS BIOL, V5, P2696, DOI 10.1371/journal.pbio.0050305; Walker KMM, 2008, J COGNITIVE NEUROSCI, V20, P135, DOI 10.1162/jocn.2008.20012; Wang L, 2007, J NEUROSCI, V27, P582, DOI 10.1523/JNEUROSCI.3699-06.2007; Yin PB, 2011, J NEUROPHYSIOL, V105, P582, DOI 10.1152/jn.00621.2010; Zhang XN, 2011, BEHAV BRAIN RES, V217, P315, DOI 10.1016/j.bbr.2010.10.034	51	29	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25895	10.1371/journal.pone.0025895	http://dx.doi.org/10.1371/journal.pone.0025895			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998717	Green Published, Green Submitted, gold			2022-12-27	WOS:000295966900070
J	Fingelkurts, AA; Fingelkurts, AA; Bagnato, S; Boccagni, C; Galardi, G				Fingelkurts, Alexander A.; Fingelkurts, Andrew A.; Bagnato, Sergio; Boccagni, Cristina; Galardi, Giuseppe			Life or Death: Prognostic Value of a Resting EEG with Regards to Survival in Patients in Vegetative and Minimally Conscious States	PLOS ONE			English	Article							COMPRESSED SPECTRAL ARRAY; ELECTROENCEPHALOGRAPHY; VARIABILITY; FREQUENCIES; DISABILITY; RECOVERY; SCALE; COMA	Objective: To investigate the potentially prognostic value of a resting state electroencephalogram (EEG) with regards to the clinical outcome from vegetative and minimally conscious states (VS and MCS) in terms of survival six months after a brain injury. Methods: We quantified a dynamic repertoire of EEG oscillations in resting condition with eyes closed in patients in VS and MCS. The exact composition of EEG oscillations was assessed by analysing the probability-classification of short-term EEG spectral patterns. Results: Results demonstrated that (a) the diversity and the variability of EEG for Non-Survivors were significantly lower than for Survivors; and (b) a higher probability of mostly delta and slow-theta oscillations occurring either alone or in combination were found during the first assessment for patients with a bad outcome (i.e., those who died) within six months of an injury compared to patients who survived. At the same time, patients with a good outcome (i.e., those who survived) after six months post-injury had a higher probability of mostly fast-theta and alpha oscillations occurring either alone or in combination during the first assessment when compared to patients who died within six months of an injury. Conclusions: Resting state EEGs properly analysed may have a potentially prognostic value with regards to the outcome from VS or MCS in terms of survival six months after a brain injury. Significance: This work may have implications for clinical care, rehabilitative programmes and medical-legal decisions for patients with impaired consciousness states after being in a coma due to acute brain injuries.	[Fingelkurts, Alexander A.; Fingelkurts, Andrew A.] BM Sci Brain & Mind Technol Res Ctr, Espoo, Finland; [Bagnato, Sergio; Boccagni, Cristina; Galardi, Giuseppe] Fdn Ist San Raffaele G Giglio, Neurorehabil Unit, Rehabil Dept, Palermo, Italy; [Bagnato, Sergio; Boccagni, Cristina; Galardi, Giuseppe] Fdn Ist San Raffaele G Giglio, Rehabil Dept, Neurophysiol Unit, Palermo, Italy		Fingelkurts, AA (corresponding author), BM Sci Brain & Mind Technol Res Ctr, Espoo, Finland.	alexander.fingelkurts@bm-science.com	Bagnato, Sergio/H-6842-2013	Bagnato, Sergio/0000-0002-6289-1887; Boccagni, Cristina/0000-0002-6317-015X				Achimowicz JZ, 1992, EVALUATION PILOT PSY; Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Babiloni C, 2009, CLIN NEUROPHYSIOL, V120, P719, DOI 10.1016/j.clinph.2009.02.157; Bagnato S, 2010, CLIN NEUROPHYSIOL, V121, P274, DOI 10.1016/j.clinph.2009.11.008; Ball T, 2008, NEUROIMAGE, V41, P302, DOI 10.1016/j.neuroimage.2008.02.032; Basar E, 2010, BRAIN BODY MIND NEBU, P523; Bates D, 2003, CLIN MED, V3, P249; Beaumont JG, 2005, NEUROPSYCHOL REHABIL, V15, P184, DOI 10.1080/09602010443000489; Beridze M, 2010, Georgian Med News, P28; BIRMANNS B, 1990, J NEUROL SCI, V100, P22, DOI 10.1016/0022-510X(90)90007-A; BRICOLO A, 1978, ELECTROEN CLIN NEURO, V45, P211, DOI 10.1016/0013-4694(78)90005-6; Bullock TH, 2003, NEUROSCIENCE, V121, P233, DOI 10.1016/S0306-4522(03)00208-2; CANT BR, 1984, NEUROLOGY, V34, P35, DOI 10.1212/WNL.34.1.35; CELESIA, 1993, ANN NEUROL, V33, P386; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Claus JJ, 1998, ARCH NEUROL-CHICAGO, V55, P1105, DOI 10.1001/archneur.55.8.1105; Cologan V, 2010, SLEEP MED REV, V14, P97, DOI 10.1016/j.smrv.2009.04.003; Da Silva F.H.L., 1996, COMPREHENSIVE HUMAN, VVolume 1, P509; Davey MP, 2000, CLIN NEUROPHYSIOL, V111, P1949, DOI 10.1016/S1388-2457(00)00435-1; Donnelly E.M., 2007, CLIN NEUROPHYSIOLOGY, P127; DUMERMUTH G, 1987, NEUROPSYCHOBIOLOGY, V17, P85, DOI 10.1159/000118345; Ferrer R, 2011, CRIT CARE CLIN, V27, P229, DOI 10.1016/j.ccc.2010.12.008; Fingelkurts AA, 2003, INT J PSYCHOPHYSIOL, V47, P23, DOI 10.1016/S0167-8760(02)00089-2; Fingelkurts Al A, 2010, Open Neuroimag J, V4, P130, DOI 10.2174/1874440001004010130; Fingelkurts AA, 2010, NEUROSCI RES, V68, P207, DOI 10.1016/j.neures.2010.07.2031; Freeman Walter J, 2003, J Integr Neurosci, V2, P3, DOI 10.1142/S0219635203000214; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gohberg I.C., 1969, INTRO THEORY LINEAR, P1; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; JENNETT B, 2002, VEGETATIVE STATE MED; Jennings J. R., 1991, HDB COGNITIVE PSYCHO; Kane NM, 1998, ELECTROEN CLIN NEURO, V106, P244, DOI 10.1016/S0013-4694(97)00141-7; KANG DH, 1991, BEHAV NEUROSCI, V105, P860, DOI 10.1037/0735-7044.105.6.860; Kaplan A. Ya, 1998, Uspekhi Fiziologicheskikh Nauk, V29, P35; LEVY WJ, 1987, ANESTHESIOLOGY, V66, P489, DOI 10.1097/00000542-198704000-00007; Monti MM, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3765; MOULTON RJ, 1988, CAN J NEUROL SCI, V15, P82, DOI 10.1017/S0317167100027244; Muller UA, 1993, 19930618 OLS ASS; Niedermeye E., 1999, ELECTROENCEPHALOGRAP, P149; Norris PR, 2009, ANN SURG, V250, P524, DOI [10.1097/SLA.0b013e181b8fb1f, 10.1097/SLA.0b013e3181b8fb1f]; Oransky I, 2003, LANCET NEUROL, V2, P715, DOI 10.1016/S1474-4422(03)00600-8; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; PULVERMULLER F, 1995, NEUROREPORT, V6, P2059, DOI 10.1097/00001756-199510010-00025; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Robinson PA, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.021903; Rodriguez G, 1996, ELECTROEN CLIN NEURO, V99, P123, DOI 10.1016/0013-4694(96)95723-5; Rosenkranz MA, 2003, P NATL ACAD SCI USA, V100, P11148, DOI 10.1073/pnas.1534743100; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; SAPHIER D, 1990, YALE J BIOL MED, V63, P109; Sara M, 2008, BRIT J NUTR, P1, DOI DOI 10.1017/S0007114508116270; Sara M, 2011, NEUROREHAB NEURAL RE, V25, P35, DOI 10.1177/1545968310378508; Sara M, 2010, NONLIN DYNAM PSYCHOL, V14, P1; Schnakers C, 2008, BRAIN INJURY, V22, P926, DOI 10.1080/02699050802530565; Schnakers C, 2006, ANN NEUROL, V60, P744, DOI 10.1002/ana.20919; Sironi VA, 1982, ADV NEUROTRAUMATOLOG, P328; SOININEN H, 1991, ELECTROEN CLIN NEURO, V79, P342, DOI 10.1016/0013-4694(91)90198-D; Ssang-Hee Seo, 2010, Convergence and Hybrid Information Technologies, P413; Steudel W I, 1979, Acta Neurochir Suppl (Wien), V28, P40; Thatcher RW., 2001, J NEUROTHER, V3, P1; Tirsch W., 1988, PROGR COMPUTER ASSIS, P109; TRESCH DD, 1991, ARCH INTERN MED, V151, P930, DOI 10.1001/archinte.151.5.930; Tsuji H, 1996, CIRCULATION, V94, P2850, DOI 10.1161/01.CIR.94.11.2850; WALKER B B, 1983, International Journal of Psychophysiology, V1, P65, DOI 10.1016/0167-8760(83)90025-9; Whithain EM, 2007, CLIN NEUROPHYSIOL, V118, P1877, DOI 10.1016/j.clinph.2007.04.027; WINSLADE WJ, 1998, CONFRONTING TRAUMATI; Wu DY, 2011, CLIN NEUROPHYSIOL, V122, P490, DOI 10.1016/j.clinph.2010.05.036; Yuval-Greenberg S, 2008, NEURON, V58, P429, DOI 10.1016/j.neuron.2008.03.027; [No title captured]	72	30	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25967	10.1371/journal.pone.0025967	http://dx.doi.org/10.1371/journal.pone.0025967			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998732	Green Published, gold			2022-12-27	WOS:000295966900082
J	Huang, CW; Chen, HY; Yen, MH; Chen, JJW; Young, TH; Cheng, JY				Huang, Ching-Wen; Chen, Huai-Yi; Yen, Meng-Hua; Chen, Jeremy J. W.; Young, Tai-Horng; Cheng, Ji-Yen			Gene Expression of Human Lung Cancer Cell Line CL1-5 in Response to a Direct Current Electric Field	PLOS ONE			English	Article							IN-VITRO; HUMAN KERATINOCYTES; ADHESION MOLECULES; DERMAL FIBROBLASTS; KINASE-ACTIVITY; TGF-BETA; MIGRATION; RECEPTOR; GROWTH; PROTEIN	Background: Electrotaxis is the movement of adherent living cells in response to a direct current (dc) electric field (EF) of physiological strength. Highly metastatic human lung cancer cells, CL1-5, exhibit directional migration and orientation under dcEFs. To understand the transcriptional response of CL1-5 cells to a dcEF, microarray analysis was performed in this study. Methodology/Principal Findings: A large electric-field chip (LEFC) was designed, fabricated, and used in this study. CL1-5 cells were treated with the EF strength of 0mV/mm (the control group) and 300mV/mm (the EF-treated group) for two hours. Signaling pathways involving the genes that expressed differently between the two groups were revealed. It was shown that the EF-regulated genes highly correlated to adherens junction, telomerase RNA component gene regulation, and tight junction. Some up-regulated genes such as ACVR1B and CTTN, and some down-regulated genes such as PTEN, are known to be positively and negatively correlated to cell migration, respectively. The protein-protein interactions of adherens junction-associated EF-regulated genes suggested that platelet-derived growth factor (PDGF) receptors and ephrin receptors may participate in sensing extracellular electrical stimuli. We further observed a high percentage of significantly regulated genes which encode cell membrane proteins, suggesting that dcEF may directly influence the activity of cell membrane proteins in signal transduction. Conclusions/Significance: In this study, some of the EF-regulated genes have been reported to be essential whereas others are novel for electrotaxis. Our result confirms that the regulation of gene expression is involved in the mechanism of electrotactic response.	[Huang, Ching-Wen; Yen, Meng-Hua; Young, Tai-Horng] Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan; [Huang, Ching-Wen; Chen, Huai-Yi; Yen, Meng-Hua; Cheng, Ji-Yen] Acad Sinica, Res Ctr Appl Sci, Taipei 115, Taiwan; [Chen, Huai-Yi] Natl Tsing Hua Univ, Dept Engn & Syst Sci, Hsinchu, Taiwan; [Chen, Huai-Yi] Acad Sinica, TIGP, Nano Sci & Technol Program, Taipei, Taiwan; [Chen, Jeremy J. W.] Natl Chung Hsing Univ, Inst Biomed Sci & Mol Biol, Taichung 40227, Taiwan; [Cheng, Ji-Yen] Natl Taiwan Ocean Univ, Dept Mech & Mechantron Engn, Keelung, Taiwan; [Cheng, Ji-Yen] Natl Yang Ming Univ, Inst Biophoton, Taipei 112, Taiwan	National Taiwan University; Academia Sinica - Taiwan; National Tsing Hua University; Academia Sinica - Taiwan; National Chung Hsing University; National Taiwan Ocean University; National Yang Ming Chiao Tung University	Huang, CW (corresponding author), Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan.	jycheng@gate.sinica.edu.tw	Cheng, Ji-Yen/D-7272-2011	Cheng, Ji-Yen/0000-0001-7623-7555; Chen, Jeremy J.W./0000-0003-1049-3825; Huang, Ching-Wen/0000-0001-9233-3002	National Science Council of Taiwan [98-2113-M-001-013-MY2, 100-2113-M-001-014-MY3]; National Taiwan University; Academia Sinica	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University); Academia Sinica(Academia Sinica - Taiwan)	This work is partially funded by National Science Council of Taiwan (http://web1.nsc.gov.tw/) (Contract no. 98-2113-M-001-013-MY2 and 100-2113-M-001 -014 -MY3). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Mr. Hsieh-Fu Tsai and Shih-Wei Peng for the assistance in chip fabrication and data analysis, respectively. We thank the Microarray Core of Institute of NTU Center for Genomic Medicine, supported by National Taiwan University, for performing the Affymetrix GeneChip assay. We also thank the Affymetrix Gene Expression Service Lab (http://ipmb.sinica.edu.tw/affy/), supported by Academia Sinica, for performing the Affymetrix GeneChip assay. We thank Dr. Tzu-Hung Hsiao of Institute of Biomedical Sciences, Academia Sinica, for the data analysis of membrane protein percentage.	Avrov K, 2003, EXP CELL RES, V291, P426, DOI 10.1016/j.yexcr.2003.08.001; Bucciantini M, 1999, FEBS LETT, V456, P73, DOI 10.1016/S0014-5793(99)00828-5; Cheng JY, 2008, BIOMICROFLUIDICS, V2, DOI 10.1063/1.2952290; Cheng JY, 2004, SENSOR ACTUAT B-CHEM, V99, P186, DOI 10.1016/j.snb.2003.10.022; Chiarugi P, 1996, BIOCHEM BIOPH RES CO, V219, P21, DOI 10.1006/bbrc.1996.0174; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; Cuzick J, 1998, LANCET, V352, P359, DOI 10.1016/S0140-6736(97)10002-2; Djamgoz MBA, 2001, J CELL SCI, V114, P2697; Gelderloos JA, 1998, J BIOL CHEM, V273, P5908, DOI 10.1074/jbc.273.10.5908; Gomez-Duran A, 2006, J CELL BIOCHEM, V97, P380, DOI 10.1002/jcb.20637; GRIEPP EB, 1983, J CELL BIOL, V96, P693, DOI 10.1083/jcb.96.3.693; GRULER H, 1991, CELL MOTIL CYTOSKEL, V19, P121, DOI 10.1002/cm.970190207; Hammerick KE, 2010, BIOCHEM BIOPH RES CO, V397, P12, DOI 10.1016/j.bbrc.2010.05.003; Hart FX, 2008, BIOELECTROMAGNETICS, V29, P447, DOI 10.1002/bem.20411; Hock B, 1998, ONCOGENE, V17, P255, DOI 10.1038/sj.onc.1201907; Hu YH, 1998, FASEB J, V12, P1135, DOI 10.1096/fasebj.12.12.1135; Huang CW, 2009, BIOSENS BIOELECTRON, V24, P3510, DOI 10.1016/j.bios.2009.05.001; Huang HD, 2006, J CELL PHYSIOL, V209, P122, DOI 10.1002/jcp.20712; Ito H, 1998, CLIN CANCER RES, V4, P1603; Jennings J, 2008, BIOELECTROMAGNETICS, V29, P394, DOI 10.1002/bem.20408; Jennings JA, 2010, ARCH DERMATOL RES, V302, P211, DOI 10.1007/s00403-009-0995-x; Kanda I, 2008, ONCOGENE, V27, P1687, DOI 10.1038/sj.onc.1210812; Kaur S, 2010, ARTERIOSCLEROSIS THR; Knoll B, 2004, J NEUROSCI, V24, P6248, DOI 10.1523/JNEUROSCI.0985-04.2004; Kuramoto K, 2009, J NEUROSCI RES, V87, P1794, DOI 10.1002/jnr.21997; Lawrence DA, 2001, MOL CELL BIOCHEM, V219, P163, DOI 10.1023/A:1010819716023; Lewin B, 2010, ANTICANCER RES, V30, P2591; Liu CC, 2006, NUCLEIC ACIDS RES, V34, pW571, DOI 10.1093/nar/gkl279; McCaig CD, 2005, PHYSIOL REV, V85, P943, DOI 10.1152/physrev.00020.2004; Mruk DD, 2009, BIOL REPROD, V80, P590, DOI 10.1095/biolreprod.108.071647; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Nishimura KY, 1996, J CELL SCI, V109, P199; Nuccitelli R, 2011, PHYSL BIOELECTRICITY, V1, P1; Oda A, 2005, BLOOD, V105, P3141, DOI 10.1182/blood-2003-04-1319; Ozkucur N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006131; Ogita H, 2010, P JPN ACAD B-PHYS, V86, P621, DOI 10.2183/pjab.86.621; Plattner R, 2004, MOL CELL BIOL, V24, P2573, DOI 10.1128/mcb.24.6.2573-2583.2004; Pu J, 2005, J CELL SCI, V118, P1117, DOI 10.1242/jcs.01646; Pu J, 2007, J CELL SCI, V120, P3395, DOI 10.1242/jcs.002774; Pullar CE, 2005, J CELL SCI, V118, P2023, DOI 10.1242/jcs.02330; Pullar CE, 2001, CELL MOTIL CYTOSKEL, V50, P207, DOI 10.1002/cm.10009; Pullar CE, 2006, MOL BIOL CELL, V17, P4925, DOI 10.1091/mbc.E06-05-0433; RAJNICEK AM, 1992, EXP PHYSIOL, V77, P229, DOI 10.1113/expphysiol.1992.sp003580; Rajnicek AM, 2006, J CELL SCI, V119, P1723, DOI 10.1242/jcs.02896; Rajnicek AM, 2006, J CELL SCI, V119, P1736, DOI 10.1242/jcs.02897; Sangaletti S, 2008, CANCER RES, V68, P9050, DOI 10.1158/0008-5472.CAN-08-1327; Sato MJ, 2007, BIOSYSTEMS, V88, P261, DOI 10.1016/j.biosystems.2006.06.008; Sato MJ, 2009, P NATL ACAD SCI USA, V106, P6667, DOI 10.1073/pnas.0809974106; Schulz WA, 2010, BMC CANCER, V10, P9; Shanley LJ, 2006, J CELL SCI, V119, P4741, DOI 10.1242/jcs.03248; Sillman AL, 2003, EXP DERMATOL, V12, P396, DOI 10.1034/j.1600-0625.2002.120406.x; Simon DP, 2009, NEOPLASIA, V11, P365, DOI 10.1593/neo.81544; Song B, 2007, NAT PROTOC, V2, P1479, DOI 10.1038/nprot.2007.205; Sossey-Alaoui K, 2005, J BIOL CHEM, V280, P21748, DOI 10.1074/jbc.M500503200; Suetsugu S, 1999, BIOCHEM BIOPH RES CO, V260, P296, DOI 10.1006/bbrc.1999.0894; Szatkowski M, 2000, BJU INT, V86, P1068, DOI 10.1046/j.1464-410x.2000.00889.x; Tachibana K, 2000, J CELL BIOL, V150, P1161, DOI 10.1083/jcb.150.5.1161; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Tanis KQ, 2003, MOL CELL BIOL, V23, P3884, DOI 10.1128/MCB.23.11.3884-3896.2003; TWAMLEY GM, 1992, ONCOGENE, V7, P1893; Valdimarsdottir G, 2002, CIRCULATION, V106, P2263, DOI 10.1161/01.CIR.0000033830.36431.46; Wang CC, 2007, BIOMATERIALS, V28, P625, DOI 10.1016/j.biomaterials.2006.09.025; Wang CC, 2011, LAB CHIP, V11, P695, DOI 10.1039/c0lc00155d; Weaver AM, 2008, CANCER LETT, V265, P157, DOI 10.1016/j.canlet.2008.02.066; Yan XL, 2009, BIOELECTROMAGNETICS, V30, P29, DOI 10.1002/bem.20436; Yao L, 2008, J CELL PHYSIOL, V216, P527, DOI 10.1002/jcp.21431; Yeo MG, 2011, J CELL PHYSIOL, V226, P236, DOI 10.1002/jcp.22335; Zhao M, 1999, MOL BIOL CELL, V10, P1259, DOI 10.1091/mbc.10.4.1259; Zhao M, 2002, FASEB J, V16, P857, DOI 10.1096/fj.01-0811fje; Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925; Zisch AH, 2000, ONCOGENE, V19, P177, DOI 10.1038/sj.onc.1203304	71	31	33	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25928	10.1371/journal.pone.0025928	http://dx.doi.org/10.1371/journal.pone.0025928			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998723	Green Published, gold, Green Submitted			2022-12-27	WOS:000295966900075
J	Manrao, EA; Derrington, IM; Pavlenok, M; Niederweis, M; Gundlach, JH				Manrao, Elizabeth A.; Derrington, Ian M.; Pavlenok, Mikhail; Niederweis, Michael; Gundlach, Jens H.			Nucleotide Discrimination with DNA Immobilized in the MspA Nanopore	PLOS ONE			English	Article							PROTEIN NANOPORE; POLYNUCLEOTIDE MOLECULES; ELECTRONIC CONTROL; MEMBRANE CHANNEL; PROSTATE-CANCER; POLYMERASE; METHYLATION; REPLICATION; ASSOCIATION; CHALLENGES	Nanopore sequencing has the potential to become a fast and low-cost DNA sequencing platform. An ionic current passing through a small pore would directly map the sequence of single stranded DNA (ssDNA) driven through the constriction. The pore protein, MspA, derived from Mycobacterium smegmatis, has a short and narrow channel constriction ideally suited for nanopore sequencing. To study MspA's ability to resolve nucleotides, we held ssDNA within the pore using a biotin-NeutrAvidin complex. We show that homopolymers of adenine, cytosine, thymine, and guanine in MspA exhibit much larger current differences than in alpha-hemolysin. Additionally, methylated cytosine is distinguishable from unmethylated cytosine. We establish that single nucleotide substitutions within homopolymer ssDNA can be detected when held in MspA's constriction. Using genomic single nucleotide polymorphisms, we demonstrate that single nucleotides within random DNA can be identified. Our results indicate that MspA has high signal-to-noise ratio and the single nucleotide sensitivity desired for nanopore sequencing devices.	[Manrao, Elizabeth A.; Derrington, Ian M.; Gundlach, Jens H.] Univ Washington, Dept Phys, Seattle, WA 98195 USA; [Pavlenok, Mikhail; Niederweis, Michael] Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA	University of Washington; University of Washington Seattle; University of Alabama System; University of Alabama Birmingham	Manrao, EA (corresponding author), Univ Washington, Dept Phys, Seattle, WA 98195 USA.	jens@phys.washington.edu		Niederweis, Michael/0000-0003-4068-8092; Gundlach, Jens Horst/0000-0002-0773-8038	National Institutes of Health, National Human Genome Research Institute [5R21HG004145, R01HG005115]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005115, R21HG004145] Funding Source: NIH RePORTER	National Institutes of Health, National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the National Institutes of Health, National Human Genome Research Institute $1000 Genome Program Grant 5R21HG004145 and R01HG005115 (http://www.genome.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Benner S, 2007, NAT NANOTECHNOL, V2, P718, DOI 10.1038/nnano.2007.344; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495; Butler TZ, 2008, P NATL ACAD SCI USA, V105, P20647, DOI 10.1073/pnas.0807514106; Cockroft SL, 2008, J AM CHEM SOC, V130, P818, DOI 10.1021/ja077082c; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Derrington IM, 2010, P NATL ACAD SCI USA, V107, P16060, DOI 10.1073/pnas.1001831107; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Faller M, 2004, SCIENCE, V303, P1189, DOI 10.1126/science.1094114; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Fuller CW, 2009, NAT BIOTECHNOL, V27, P1013, DOI 10.1038/nbt.1585; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Gyarfas B, 2009, ACS NANO, V3, P1457, DOI 10.1021/nn900303g; Hirschhorn JN, 2009, NEW ENGL J MED, V360, P1699, DOI 10.1056/NEJMp0808934; Kahvejian A, 2008, NAT BIOTECHNOL, V26, P1125, DOI 10.1038/nbt1494; Kasianowicz JJ, 1996, P NATL ACAD SCI USA, V93, P13770, DOI 10.1073/pnas.93.24.13770; Lieberman KR, 2010, J AM CHEM SOC, V132, P17961, DOI 10.1021/ja1087612; Meller A, 2000, P NATL ACAD SCI USA, V97, P1079, DOI 10.1073/pnas.97.3.1079; Mitchell N, 2008, ANGEW CHEM INT EDIT, V47, P5565, DOI 10.1002/anie.200800183; Olasagasti F, 2010, NAT NANOTECHNOL, V5, P798, DOI [10.1038/nnano.2010.177, 10.1038/NNANO.2010.177]; Purnell RF, 2008, NANO LETT, V8, P3029, DOI 10.1021/nl802312f; Purnell RF, 2009, ACS NANO, V3, P2533, DOI 10.1021/nn900441x; RAZIN A, 1995, HUM MOL GENET, V4, P1751, DOI 10.1093/hmg/4.suppl_1.1751; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Stoddart D, 2009, P NATL ACAD SCI USA, V106, P7702, DOI 10.1073/pnas.0901054106; Wallace EVB, 2010, CHEM COMMUN, V46, P8195, DOI 10.1039/c0cc02864a; Wilson NA, 2009, ACS NANO, V3, P995, DOI 10.1021/nn9000897	29	115	148	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e25723	10.1371/journal.pone.0025723	http://dx.doi.org/10.1371/journal.pone.0025723			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21991340	Green Submitted, Green Published, gold			2022-12-27	WOS:000295963300019
J	Stamataki, Z; Tilakaratne, S; Adams, DH; McKeating, JA				Stamataki, Zania; Tilakaratne, Samantha; Adams, David H.; McKeating, Jane A.			Rituximab Treatment in Hepatitis C Infection: An In Vitro Model to Study the Impact of B Cell Depletion on Virus Infectivity	PLOS ONE			English	Article							ANTI-CD20 MONOCLONAL-ANTIBODY; CULTURE; LYMPHOCYTES; MECHANISMS; LYMPHOMA	Hepatitis C virus (HCV) infected patients with vasculitis are often treated with the B-cell-depleting anti-CD20 antibody rituximab. Treatment reduces the cryoglobulins that cause vasculitis, yet it also leads to a transient increase in liver enzymes and HCV genomic RNA in the periphery. The mechanism underlying the increased viral load is unclear and both direct and indirect roles have been proposed for B cells in HCV infection. We previously reported that HCV can associate with B cells and can trans-infect hepatocytes. We established an in vitro assay to study the effect(s) of rituximab on B cell-associated HCV infectivity. Rituximab-mediated lysis of B cells in vitro increases the level of infectious HCV released from B cells. Our results, using a model where virus does not replicate in B cells, recapitulate observations seen in patients and may explain in part the rapid increase in blood HCV RNA observed after rituximab treatment.	[Stamataki, Zania; Tilakaratne, Samantha; Adams, David H.; McKeating, Jane A.] Univ Birmingham, Ctr Immune Regulat, MRC, Birmingham, W Midlands, England; [Stamataki, Zania; Adams, David H.] Univ Birmingham, Natl Inst Hlth Res, Biomed Res Unit, Birmingham, W Midlands, England; [Stamataki, Zania; Adams, David H.] Univ Birmingham, Liver Res Ctr, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham; University of Birmingham	Stamataki, Z (corresponding author), Univ Birmingham, Ctr Immune Regulat, MRC, Birmingham, W Midlands, England.	z.stamataki@bham.ac.uk	Adams, David H/C-9092-2009; Stamataki, Zania/P-4681-2019; Stamataki, Zania/H-6541-2011	Adams, David H/0000-0001-6776-0336; Stamataki, Zania/0000-0003-3823-4497; McKeating, Jane/0000-0002-7229-5886	Medical Research Council, United Kingdom [G0400802]; National Institute for Health Research Biomedical Research Unit for the study of Liver Disease; Wellcome Trust; Medical Research Council [G9818340B, G0801976, G0400802] Funding Source: researchfish; MRC [G0801976, G0400802] Funding Source: UKRI	Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Biomedical Research Unit for the study of Liver Disease; Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Medical Research Council, United Kingdom (no. G0400802). ZS is currently funded by a Research Fellowship from the National Institute for Health Research Biomedical Research Unit for the study of Liver Disease. Funding from the Wellcome Trust to JAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Cartron G, 2004, BLOOD, V104, P2635, DOI 10.1182/blood-2004-03-1110; Cragg MS, 2004, BLOOD, V103, P2738, DOI 10.1182/blood-2003-06-2031; Galossi A, 2007, J GASTROINTEST LIVER, V16, P65; Glennie MJ, 2007, MOL IMMUNOL, V44, P3823, DOI 10.1016/j.molimm.2007.06.151; HOOFNAGLE JH, 1997, HEPATOLOGY, V26, P20; Lake-Bakaar G, 2007, BLOOD, V109, P845, DOI 10.1182/blood-2006-08-041525; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Maloney DG, 1997, J CLIN ONCOL, V15, P3266, DOI 10.1200/JCO.1997.15.10.3266; Marukian S, 2008, HEPATOLOGY, V48, P1843, DOI 10.1002/hep.22550; McLaughlin P, 1998, J CLIN ONCOL, V16, P2825, DOI 10.1200/JCO.1998.16.8.2825; Pescovitz MD, 2006, AM J TRANSPLANT, V6, P859, DOI 10.1111/j.1600-6143.2006.01288.x; Sansonno D, 2003, BLOOD, V101, P3818, DOI 10.1182/blood-2002-10-3162; Stamataki Z, 2010, EXPERT REV ANTI-INFE, V8, P977, DOI 10.1586/ERI.10.86; Stamataki Z, 2009, BLOOD, V113, P585, DOI 10.1182/blood-2008-05-158824; Uchida J, 2004, INT IMMUNOL, V16, P119, DOI 10.1093/intimm/dxh009; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	18	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2011	6	9							e25789	10.1371/journal.pone.0025789	http://dx.doi.org/10.1371/journal.pone.0025789			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834ED	21991396	Green Published, gold, Green Submitted			2022-12-27	WOS:000295941300060
J	Assassi, S; Leyva, AL; Mayes, MD; Sharif, R; Nair, DK; Fischbach, M; Nguyen, N; Reveille, JD; Gonzalez, EB; McNearney, TA				Assassi, Shervin; Leyva, Astrud L.; Mayes, Maureen D.; Sharif, Roozbeh; Nair, Deepthi K.; Fischbach, Michael; Ngan Nguyen; Reveille, John D.; Gonzalez, Emilio B.; McNearney, Terry A.		GENISOS Study Grp	Predictors of Fatigue Severity in Early Systemic Sclerosis: A Prospective Longitudinal Study of the GENISOS Cohort	PLOS ONE			English	Article							HEALTH-ASSESSMENT QUESTIONNAIRE; QUALITY-OF-LIFE; RHEUMATOID-ARTHRITIS; LUPUS-ERYTHEMATOSUS; MULTIPLE-SCLEROSIS; DISEASE SEVERITY; DISABILITY; AUTOANTIBODIES; INVOLVEMENT; SYMPTOMS	Objectives: Longitudinal studies examining the baseline predictors of fatigue in SSc have not been reported. Our objectives were to examine the course of fatigue severity over time and to identify baseline clinical, demographic, and psychosocial predictors of sequentially obtained fatigue scores in early SSc. We also examined baseline predictors of change in fatigue severity over time. Methods: We analyzed 1090 longitudinal Fatigue Severity Scale (FSS) scores belonging to 256 patients who were enrolled in the Genetics versus Environment in Scleroderma Outcomes Study (GENISOS). Predictive significance of baseline variables for sequentially obtained FSS scores was examined with generalized linear mixed models. Predictors of change in FSS over time were examined by adding an interaction term between the baseline variable and time-in-study to the model. Results: The patients' mean age was 48.6 years, 47% were Caucasians, and 59% had diffuse cutaneous involvement. The mean disease duration at enrollment was 2.5 years. The FSS was obtained at enrollment and follow-up visits (mean follow-up time = 3.8 years). Average baseline FSS score was 4.7(+/- 0.96). The FSS was relatively stable and did not show a consistent trend for change over time (p = 0.221). In a multivariable model of objective clinical variables, higher Medsger Gastrointestinal (p = 0.006) and Joint (p = 0.024) Severity Indices, and anti-U1-RNP antibodies (p = 0.024) were independent predictors of higher FSS. In the final model, ineffective coping skills captured by higher Illness Behavior Questionnaire scores (p<0.001), higher self-reported pain (p = 0.006), and higher Medsger Gastrointestinal Severity Index (p = 0.009) at enrollment were independent predictors of higher longitudinal FSS scores. Baseline DLco % predicted was the only independent variable that significantly predicted a change in FSS scores over time (p = 0.013), with lower DLco levels predicting an increase in FSS over time. Conclusions: This study identified potentially modifiable clinical and psychological factors that predict longitudinal fatigue severity in early SSc.	[Assassi, Shervin; Mayes, Maureen D.; Sharif, Roozbeh; Nair, Deepthi K.; Ngan Nguyen; Reveille, John D.] Univ Texas Hlth Sci Ctr, Div Rheumatol, Dept Med, Houston, TX 77225 USA; [Leyva, Astrud L.; Sharif, Roozbeh; Gonzalez, Emilio B.; McNearney, Terry A.] Univ Texas Med Branch, Dept Med, Galveston, TX USA; [Fischbach, Michael] Univ Texas Hlth Sci Ctr San Antonio, Div Rheumatol, Dept Med, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Health San Antonio	Assassi, S (corresponding author), Univ Texas Hlth Sci Ctr, Div Rheumatol, Dept Med, Houston, TX 77225 USA.	shervin.assassi@uth.tmc.edu	Sharif, Roozbeh/AAE-7492-2020; Leyva, Laura/B-5574-2019; Leyva, Laura/R-2187-2019	Leyva, Laura/0000-0003-0620-9625; Leyva, Laura/0000-0003-0620-9625	National Institutes of Health (NIH) Center for Research Translation [P50AR054144]; NIH [UL1-RR024148]; University Clinic Research Center [M01-RR00073, M01-RR01346]; National Center for Research Resources [TL1 RR024147];  [NIH-KL2RR024149-04];  [NIH -5T32-AR052283-03]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148, KL2RR024149, M01RR000073, TL1RR024147, M01RR001346] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR054144, T32AR052283] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Center for Research Translation(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University Clinic Research Center; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by the National Institutes of Health (NIH) Center for Research Translation P50AR054144 (Arnett and MDM); NIH-KL2RR024149-04 (SA); NIH -5T32-AR052283-03(JDR); University Clinic Research Center Grants: M01-RR00073 (UTMB) and M01-RR01346 (UT-HSC-SA); the NIH Clinical and Translational Sciences Award UL1-RR024148; and TL1 RR024147 from the National Center for Research Resources. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health. Terry A McNearney is an employee of Eli Lilly and Company and contributed to the design and analysis of the study, the performing of experiments and writing of the manuscript.	Assassi S, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3125; Assassi S, 2009, ARTHRIT CARE RES, V61, P1403, DOI 10.1002/art.24734; Bassel M, 2011, RHEUMATOLOGY, V50, P762, DOI 10.1093/rheumatology/keq310; Bodukam V, 2011, RHEUMATOLOGY, V50, P330, DOI 10.1093/rheumatology/keq296; Burgos PI, 2009, ARTHRIT RHEUM-ARTHR, V61, P1179, DOI 10.1002/art.24649; Burnet RB, 2004, BMC GASTROENTEROL, V4, DOI 10.1186/1471-230X-4-32; CLEMENTS P, 1995, J RHEUMATOL, V22, P1281; Cohen S., 1985, SOCIAL SUPPORT THEOR, P73, DOI [10.1007/978-94-009-5115-0_5, DOI 10.1007/978-94-009-5115-0_5]; Danieli E, 2005, CLIN RHEUMATOL, V24, P48, DOI 10.1007/s10067-004-0970-z; DEL RA, 2004, ARTHRITIS RHEUM, V51, P475, DOI DOI 10.1002/ART.20389; Gossec L, 2009, ANN RHEUM DIS, V68, P1680, DOI 10.1136/ard.2008.100271; Hewlett S, 2011, ANN RHEUM DIS, V70, P1060, DOI 10.1136/ard.2010.144691; Khanna D, 2005, J RHEUMATOL, V32, P832; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Lambova S, 2010, AUTOIMMUN REV, V9, P761, DOI 10.1016/j.autrev.2010.06.006; LEROY EC, 1988, J RHEUMATOL, V15, P202; Loftus EV, 2008, AM J GASTROENTEROL, V103, P3132, DOI 10.1111/j.1572-0241.2008.02175.x; Maltais F, 2008, ANN INTERN MED, V149, P869, DOI 10.7326/0003-4819-149-12-200812160-00006; Mancuso CA, 2006, J RHEUMATOL, V33, P1496; McNearney TA, 2009, J RHEUMATOL, V36, P2724, DOI 10.3899/jrheum.090295; Medsger TA, 1999, J RHEUMATOL, V26, P2159; Neill J, 2006, J ADV NURS, V56, P617, DOI 10.1111/j.1365-2648.2006.04054.x; PILOWSKY I, 1984, GEN HOSP PSYCHIAT, V6, P123, DOI 10.1016/0163-8343(84)90070-7; Reveille JD, 2001, SEMIN ARTHRITIS RHEU, V30, P332, DOI 10.1053/sarh.2001.20268; Sanchez ML, 2009, CLIN EXP RHEUMATOL, V27, P64; Sandqvist G, 2008, RHEUMATOLOGY, V47, P1708, DOI 10.1093/rheumatology/ken359; Sandusky SB, 2009, RHEUMATOLOGY, V48, P165, DOI 10.1093/rheumatology/ken455; SCHWARTZ JE, 1993, J PSYCHOSOM RES, V37, P753, DOI 10.1016/0022-3999(93)90104-N; Sharif R, 2011, SEMIN ARTHRITIS RHEU, V41, P38, DOI 10.1016/j.semarthrit.2011.01.002; Steen VD, 2005, SEMIN ARTHRITIS RHEU, V35, P35, DOI 10.1016/j.semarthrit.2005.03.005; STEEN VD, 1988, ARTHRITIS RHEUM, V31, P196, DOI 10.1002/art.1780310207; Steen VD, 1997, ARTHRITIS RHEUM, V40, P1984, DOI 10.1002/art.1780401110; Tashkin DP, 2006, NEW ENGL J MED, V354, P2655, DOI 10.1056/NEJMoa055120; Thombs BD, 2008, RHEUMATOLOGY, V47, P1559, DOI 10.1093/rheumatology/ken331; Thombs BD, 2007, ARTHRIT RHEUM-ARTHR, V57, P1089, DOI 10.1002/art.22910; Thombs BD, 2009, ARTHRIT RHEUM-ARTHR, V61, P966, DOI 10.1002/art.24614; van Lankveld WGJM, 2007, RHEUMATOLOGY, V46, P872, DOI 10.1093/rheumatology/kem008; Wagner LI, 2004, BRIT J CANCER, V91, P822, DOI 10.1038/sj.bjc.6602012; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005; Yount S, 2007, CLIN EXP RHEUMATOL, V25, P838	40	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26061	10.1371/journal.pone.0026061	http://dx.doi.org/10.1371/journal.pone.0026061			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022507	gold, Green Published, Green Submitted			2022-12-27	WOS:000295981600028
J	Allin, MPG; Kontis, D; Walshe, M; Wyatt, J; Barker, GJ; Kanaan, RAA; McGuire, P; Rifkin, L; Murray, RM; Nosarti, C				Allin, Matthew P. G.; Kontis, Dimitris; Walshe, Muriel; Wyatt, John; Barker, Gareth J.; Kanaan, Richard A. A.; McGuire, Philip; Rifkin, Larry; Murray, Robin M.; Nosarti, Chiara			White Matter and Cognition in Adults Who Were Born Preterm	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; DIFFUSION TENSOR MRI; CORPUS-CALLOSUM; YOUNG-ADULTS; BRAIN-DEVELOPMENT; ADOLESCENTS; VOXEL; CHILDREN; INJURY; AGE	Background and Purpose: Individuals born very preterm (before 33 weeks of gestation, VPT) are at risk of damage to developing white matter, which may affect later cognition and behaviour. Methods: We used diffusion tensor MRI (DT-MRI) to assess white matter microstructure (fractional anisotropy; FA) in 80 VPT and 41 term-born individuals (mean age 19.1 years, range 17-22, and 18.5 years, range17-22 years, respectively). VPT individuals were part of a 1982-1984 birth cohort which had been followed up since birth; term individuals were recruited by local press advertisement. General intellectual function, executive function and memory were assessed. Results: The VPT group had reduced FA in four clusters, and increased FA in four clusters relative to the Term group, involving several association tracts of both hemispheres. Clusters of increased FA were associated with more severe neonatal brain injury in the VPT group. Clusters of reduced FA were associated with lower birth weight and perinatal hypoxia, and with reduced adult cognitive performance in the VPT group only. Conclusions: Alterations of white matter microstructure persist into adulthood in VPT individuals and are associated with cognitive function.	[Allin, Matthew P. G.; Kontis, Dimitris; Walshe, Muriel; Barker, Gareth J.; Kanaan, Richard A. A.; McGuire, Philip; Rifkin, Larry; Murray, Robin M.; Nosarti, Chiara] Kings Coll London, Dept Psychosis Studies, Inst Psychiat, London WC2R 2LS, England; [Wyatt, John] Royal Free & Univ Coll Med Sch, Dept Neonatal Paediat, London WC1E 6BT, England	University of London; King's College London; University of London; University College London	Allin, MPG (corresponding author), Kings Coll London, Dept Psychosis Studies, Inst Psychiat, London WC2R 2LS, England.	matthew.allin@kcl.ac.uk	Kontis, Dimitrios/B-3007-2009; Murray, Robin M/F-8658-2012; Walshe, Muriel/E-5214-2010; Nosarti, Chiara/G-5638-2010; Barker, Gareth J/C-9616-2009; Walshe, Margaret/M-9102-2016	Kontis, Dimitrios/0000-0002-7626-8324; Murray, Robin M/0000-0003-0829-0519; Walshe, Muriel/0000-0001-6829-1105; Nosarti, Chiara/0000-0001-6305-9710; Barker, Gareth J/0000-0002-5214-7421; McGuire, Philip/0000-0003-4381-0532; Kanaan, Richard/0000-0003-0992-1917; Rifkin, Larry/0000-0003-2590-9010; Walshe, Margaret/0000-0003-3924-8073	Wellcome Trust [065699/Z/01/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This study was funded by a Wellcome Trust Project Grant (Ref: 065699/Z/01/Z). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allin M, 2004, DEV MED CHILD NEUROL, V46, P46, DOI 10.1017/S0012162204000088; Allin M, 2007, ARCH PEDIAT ADOL MED, V161, P1183, DOI 10.1001/archpedi.161.12.1183; Andrews JS, 2010, DEV MED CHILD NEUROL, V52, pE94, DOI 10.1111/j.1469-8749.2009.03456.x; Arzoumanian Y, 2003, AM J NEURORADIOL, V24, P1646; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Back SA, 2002, J NEUROSCI, V22, P455, DOI 10.1523/JNEUROSCI.22-02-00455.2002; Barnea-Goraly N, 2005, CEREB CORTEX, V15, P1848, DOI 10.1093/cercor/bhi062; Basser P., 2006, CLIN MAGNETIC RESONA, P320; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Bassi L, 2011, PEDIATR RES, V69, P561, DOI 10.1203/PDR.0b013e3182182836; Bullmore ET, 1999, IEEE T MED IMAGING, V18, P32, DOI 10.1109/42.750253; Burgess P. W., 1997, METHODOLOGY FRONTAL, P81, DOI DOI 10.1024//1016-264X.10.2.123; Catani M, 2005, BRAIN, V128, P2224, DOI 10.1093/brain/awh622; Catani M, 2002, NEUROIMAGE, V17, P77, DOI 10.1006/nimg.2002.1136; Cheong JLY, 2009, AM J NEURORADIOL, V30, P623, DOI 10.3174/ajnr.A1399; Constable RT, 2008, PEDIATRICS, V121, P306, DOI 10.1542/peds.2007-0414; Counsell SJ, 2006, PEDIATRICS, V117, P376, DOI 10.1542/peds.2005-0820; DELIS DC, 1988, J CONSULT CLIN PSYCH, V56, P123, DOI 10.1037/0022-006X.56.1.123; Deoni SCL, 2011, J NEUROSCI, V31, P784, DOI 10.1523/JNEUROSCI.2106-10.2011; Eikenes L, 2011, NEUROIMAGE, V54, P1774, DOI 10.1016/j.neuroimage.2010.10.037; Frangou S, 1997, BRIT J PSYCHIAT, V170, P328, DOI 10.1192/bjp.170.4.328; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gimenez M, 2006, NEUROIMAGE, V32, P1485, DOI 10.1016/j.neuroimage.2006.05.013; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Hack M, 2002, NEW ENGL J MED, V346, P149, DOI 10.1056/NEJMoa010856; Hack M, 2006, SEMIN FETAL NEONAT M, V11, P127, DOI 10.1016/j.siny.2005.11.007; Hart AR, 2008, DEV MED CHILD NEUROL, V50, P655, DOI 10.1111/j.1469-8749.2008.03050.x; Haynes RL, 2005, BRAIN PATHOL, V15, P225; Her Majesty's Stationary Office (HMSO), 1991, OFFICE POPULATION CE; Huppi PS, 2001, PEDIATRICS, V107, P455, DOI 10.1542/peds.107.3.455; Jones DK, 2002, NEUROIMAGE, V17, P592, DOI 10.1006/nimg.2002.1148; Jones DK, 2002, HUM BRAIN MAPP, V15, P216, DOI 10.1002/hbm.10018; Jones DK, 2006, HUM BRAIN MAPP, V27, P230, DOI 10.1002/hbm.20179; Kontis D, 2009, NEUROREPORT, V20, P424, DOI 10.1097/WNR.0b013e328325a8f9; Lawrence EJ, 2010, J PEDIATR-US, V156, P889, DOI 10.1016/j.jpeds.2010.01.017; Lezak DH, 2004, NEUROPSYCHOLOGICAL A, V4; Lubsen J, 2011, SEMIN PERINATOL, V35, P34, DOI 10.1053/j.semperi.2010.10.006; Luders E, 2011, NEUROIMAGE, V54, P1823, DOI 10.1016/j.neuroimage.2010.09.083; Maalouf EF, 1999, J PEDIATR-US, V135, P351, DOI 10.1016/S0022-3476(99)70133-2; Melhem ER, 2002, AM J ROENTGENOL, V178, P3, DOI 10.2214/ajr.178.1.1780003; Miller SP, 2002, J MAGN RESON IMAGING, V16, P621, DOI 10.1002/jmri.10205; Mori S., 2005, MRI ATLAS HUMAN WHIT; Mullen KM, 2011, NEUROIMAGE, V54, P2563, DOI 10.1016/j.neuroimage.2010.11.019; Myers EH, 2010, NEUROIMAGE, V51, P1445, DOI 10.1016/j.neuroimage.2010.03.049; Nagy Z, 2003, PEDIATR RES, V54, P672, DOI 10.1203/01.PDR.0000084083.71422.16; Nagy Z, 2009, PEDIATRICS, V124, pE964, DOI 10.1542/peds.2008-3801; Narberhaus A, 2009, NEUROIMAGE, V47, P1884, DOI 10.1016/j.neuroimage.2009.04.036; Neisser U, 1996, AM PSYCHOL, V51, P77, DOI 10.1037/0003-066X.51.2.77; Nosarti C, 2002, BRAIN, V125, P1616, DOI 10.1093/brain/awf157; Nosarti C, 2004, BRAIN, V127, P2080, DOI 10.1093/brain/awh230; Nosarti C, 2008, BRAIN, V131, P205, DOI 10.1093/brain/awm282; Nosarti C, 2007, J INT NEUROPSYCH SOC, V13, P571, DOI 10.1017/S1355617707070725; Nosarti C, 2009, NEUROIMAGE, V47, P1904, DOI 10.1016/j.neuroimage.2009.04.041; Oishi K, 2011, NEUROIMAGE, V56, P8, DOI 10.1016/j.neuroimage.2011.01.051; Parker J, 2008, BRAIN, V131, P1344, DOI 10.1093/brain/awn062; Partridge SC, 2004, NEUROIMAGE, V22, P1302, DOI 10.1016/j.neuroimage.2004.02.038; Perlman JM, 1998, EARLY HUM DEV, V53, P99, DOI 10.1016/S0378-3782(98)00037-1; Peterson BS, 2000, JAMA-J AM MED ASSOC, V284, P1939, DOI 10.1001/jama.284.15.1939; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Qiu DQ, 2008, NEUROIMAGE, V41, P223, DOI 10.1016/j.neuroimage.2008.02.023; Schmithorst VJ, 2005, HUM BRAIN MAPP, V26, P139, DOI 10.1002/hbm.20149; Skranes J, 2007, BRAIN, V130, P654, DOI 10.1093/brain/awm001; Snook L, 2005, NEUROIMAGE, V26, P1164, DOI 10.1016/j.neuroimage.2005.03.016; STEWART AL, 1987, DEV MED CHILD NEUROL, V29, P3; Stewart AL, 1999, LANCET, V353, P1653, DOI 10.1016/S0140-6736(98)07130-X; Thomas B, 2005, BRAIN, V128, P2562, DOI 10.1093/brain/awh600; Vangberg TR, 2006, NEUROIMAGE, V32, P1538, DOI 10.1016/j.neuroimage.2006.04.230; Volpe JJ, 2003, PEDIATRICS, V112, P176, DOI 10.1542/peds.112.1.176; Wechsler D, 1987, WMS R WECHSLER MEMOR; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wright IC, 1995, NEUROIMAGE, V2, P244, DOI 10.1006/nimg.1995.1032; Yung A, 2007, PEDIATR RES, V61, P732, DOI 10.1203/pdr.0b013e31805365db	73	101	103	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e24525	10.1371/journal.pone.0024525	http://dx.doi.org/10.1371/journal.pone.0024525			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022357	Green Published, gold			2022-12-27	WOS:000295976000002
J	Schrider, DR; Gout, JF; Hahn, MW				Schrider, Daniel R.; Gout, Jean-Francois; Hahn, Matthew W.			Very Few RNA and DNA Sequence Differences in the Human Transcriptome	PLOS ONE			English	Article							UNWINDING ACTIVITY; MESSENGER-RNA; PARALLEL DNA; COPY NUMBER; ADENOSINE; ALIGNMENT	RNA editing is an important cellular process by which the nucleotides in a mature RNA transcript are altered to cause them to differ from the corresponding DNA sequence. While this process yields essential transcripts in humans and other organisms, it is believed to occur at a relatively small number of loci. The rarity of RNA editing has been challenged by a recent comparison of human RNA and DNA sequence data from 27 individuals, which revealed that over 10,000 human exonic sites appear to exhibit RNA-DNA differences (RDDs). Many of these differences could not have been caused by either of the two previously known human RNA editing mechanisms-ADAR-mediated A -> G substitutions or APOBEC1-mediated C -> U switches-suggesting that a previously unknown mechanism of RNA editing may be active in humans. Here, we reanalyze these data and demonstrate that genomic sequences exist in these same individuals or in the human genome that match the majority of RDDs. Our results suggest that the majority of these RDD events were observed due to accurate transcription of sequences paralogous to the apparently edited gene but differing at the edited site. In light of our results it seems prudent to conclude that if indeed an unknown mechanism is causing RDD events in humans, such events occur at a much lower frequency than originally proposed.	[Schrider, Daniel R.; Gout, Jean-Francois; Hahn, Matthew W.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Schrider, Daniel R.; Hahn, Matthew W.] Indiana Univ, Sch Informat & Comp, Bloomington, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Schrider, DR (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	dschride@indiana.edu		Gout, Jean-Francois/0000-0002-4549-5647; Hahn, Matthew/0000-0002-5731-8808	National Institutes of Health [GM007757]; National Science Foundation [EF-0827411]; Alfred P. Sloan Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007757] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	D.R.S. is supported by National Institutes of Health Genetics, Cellular & Molecular Sciences Training Grant GM007757. J.F.G. is supported by National Science Foundation Grant EF-0827411. M. W. H. is supported by a fellowship from the Alfred P. Sloan Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; BASS BL, 1988, CELL, V55, P1089, DOI 10.1016/0092-8674(88)90253-X; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; CHEN SH, 1987, SCIENCE, V238, P363, DOI 10.1126/science.3659919; Demuth JP, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000085; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Ju YS, 2011, NAT GENET, V43, P745, DOI 10.1038/ng.872; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; Li MY, 2011, SCIENCE, V333, P53, DOI 10.1126/science.1207018; Maas Stefan, 2006, RNA Biol, V3, P1; POWELL LM, 1987, CELL, V50, P831, DOI 10.1016/0092-8674(87)90510-1; PRING D, 1993, PLANT MOL BIOL, V21, P1163, DOI 10.1007/BF00023611; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591; WAGNER RW, 1989, P NATL ACAD SCI USA, V86, P2647, DOI 10.1073/pnas.86.8.2647; Zhang J, 2006, CYTOGENET GENOME RES, V115, P205, DOI 10.1159/000095916; ZHENG HQ, 1992, J VIROL, V66, P4693, DOI 10.1128/JVI.66.8.4693-4697.1992	21	64	65	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25842	10.1371/journal.pone.0025842	http://dx.doi.org/10.1371/journal.pone.0025842			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022455	Green Submitted, gold, Green Published			2022-12-27	WOS:000295976000044
J	Vaughn, MP; Shinohara, DB; Castagna, N; Hicks, JL; Netto, G; De Marzo, AM; Speed, TJ; Reichert, ZR; Kwabi-Addo, B; Henderson, CJ; Wolf, CR; Yegnasubramanian, S; Nelson, WG				Vaughn, Matthew P.; Shinohara, Debika Biswal; Castagna, Nicole; Hicks, Jessica L.; Netto, George; De Marzo, Angelo M.; Speed, Traci J.; Reichert, Zachery R.; Kwabi-Addo, Bernard; Henderson, Colin J.; Wolf, C. Roland; Yegnasubramanian, Srinivasan; Nelson, William G.			Humanizing pi-Class Glutathione S-Transferase Regulation in a Mouse Model Alters Liver Toxicity in Response to Acetaminophen Overdose	PLOS ONE			English	Article							RAT CHEMICAL HEPATOCARCINOGENESIS; ISLAND DNA HYPERMETHYLATION; GSTP1 CPG ISLAND; HEPATOCELLULAR-CARCINOMA; TERMINAL KINASE; TRANSCRIPTIONAL ACTIVATION; PROMOTER HYPERMETHYLATION; GENE; MICE; JUN	Background: Glutathione S-transferases (GSTs) metabolize drugs and xenobiotics. Yet despite high protein sequence homology, expression of p-class GSTs, the most abundant of the enzymes, varies significantly between species. In mouse liver, hepatocytes exhibit high mGstp expression, while in human liver, hepatocytes contain little or no hGSTP1 mRNA or hGSTP1 protein. pi-class GSTs are known to be critical determinants of liver responses to drugs and toxins: when treated with high doses of acetaminophen, mGstp1/2+/+ mice suffer marked liver damage, while mGstp1/2-/- mice escape liver injury. Methodology/Principal Findings: To more faithfully model the contribution of p-class GSTs to human liver toxicology, we introduced hGSTP1, with its exons, introns, and flanking sequences, into the germline of mice carrying disrupted mGstp genes. In the resultant hGSTP1+ mGstp1/2-/- strain, pi-class GSTs were regulated differently than in wild-type mice. In the liver, enzyme expression was restricted to bile duct cells, Kupffer cells, macrophages, and endothelial cells, reminiscent of human liver, while in the prostate, enzyme production was limited to basal epithelial cells, reminiscent of human prostate. The human patterns of hGSTP1 transgene regulation were accompanied by human patterns of DNA methylation, with bisulfite genomic sequencing revealing establishment of an unmethylated CpG island sequence encompassing the gene promoter. Unlike wild-type or mGstp1/2-/- mice, when hGSTP1+ mGstp1/2-/- mice were overdosed with acetaminophen, liver tissues showed limited centrilobular necrosis, suggesting that pi-class GSTs may be critical determinants of toxin-induced hepatocyte injury even when not expressed by hepatocytes. Conclusions: By recapitulating human p-class GST expression, hGSTP1+ mGstp1/2-/- mice may better model human drug and xenobiotic toxicology.	[Vaughn, Matthew P.; Shinohara, Debika Biswal; Castagna, Nicole; Hicks, Jessica L.; Netto, George; De Marzo, Angelo M.; Speed, Traci J.; Reichert, Zachery R.; Yegnasubramanian, Srinivasan; Nelson, William G.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA; [Shinohara, Debika Biswal] Johns Hopkins Univ, Dept Environm Hlth Sci, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Kwabi-Addo, Bernard] Howard Univ, Ctr Canc, Washington, DC 20059 USA; [Henderson, Colin J.; Wolf, C. Roland] Univ Dundee, Ninewells Hosp & Med Sch, Canc Res United Kingdom Mol Pharmacol Unit, Biomed Res Inst, Dundee DD1 9SY, Scotland	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Howard University; University of Dundee	Vaughn, MP (corresponding author), Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA.	syegnasu@jhmi.edu; bnelson@jhmi.edu	Henderson, Colin/AAE-7141-2019; Kwabi-Addo, Bernard/A-6993-2016	Henderson, Colin/0000-0002-4764-639X; Kwabi-Addo, Bernard/0000-0003-3692-6350; Wolf, Charles Roland/0000-0002-6969-0113; Netto, George/0000-0003-3915-9134	National Institutes of Health/National Cancer Institute [CA91409, CA70196, CA58236]; Cancer Research UK [10822] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA070196, P50CA058236, P30CA006973, U54CA091409] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The studies were supported by National Institutes of Health/National Cancer Institute grants CA91409, CA70196, and CA58236. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler V, 1999, EMBO J, V18, P1321, DOI 10.1093/emboj/18.5.1321; Bakker J, 2002, J BIOL CHEM, V277, P22573, DOI 10.1074/jbc.M203009200; Bessems JGM, 2001, CRIT REV TOXICOL, V31, P55, DOI 10.1080/20014091111677; Chan KM, 2001, P NATL ACAD SCI USA, V98, P4611, DOI 10.1073/pnas.081082098; Cheung C, 2008, J PHARMACOL EXP THER, V327, P288, DOI 10.1124/jpet.108.141242; COLES B, 1988, ARCH BIOCHEM BIOPHYS, V264, P253, DOI 10.1016/0003-9861(88)90592-9; Dai GL, 2006, TOXICOL SCI, V92, P33, DOI 10.1093/toxsci/kfj192; DRAGAN YP, 1994, CARCINOGENESIS, V15, P2587, DOI 10.1093/carcin/15.11.2587; Eaton DL, 1999, TOXICOL SCI, V49, P156, DOI 10.1093/toxsci/49.2.156; Elsby R, 2003, J BIOL CHEM, V278, P22243, DOI 10.1074/jbc.M301211200; Esteller M, 1998, CANCER RES, V58, P4515; Gunawan BK, 2006, GASTROENTEROLOGY, V131, P165, DOI 10.1053/j.gastro.2006.03.045; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Henderson CJ, 1998, P NATL ACAD SCI USA, V95, P5275, DOI 10.1073/pnas.95.9.5275; Henderson CJ, 2000, P NATL ACAD SCI USA, V97, P12741, DOI 10.1073/pnas.220176997; Henderson NC, 2007, GUT, V56, P982, DOI 10.1136/gut.2006.104372; HOWIE AF, 1990, CARCINOGENESIS, V11, P451, DOI 10.1093/carcin/11.3.451; ISHIKAWA T, 1992, TRENDS BIOCHEM SCI, V17, P463, DOI 10.1016/0968-0004(92)90489-V; Jaeschke H, 2006, TOXICOL SCI, V89, P31, DOI 10.1093/toxsci/kfi336; KITAHARA A, 1984, CANCER RES, V44, P2698; LEE WH, 1994, P NATL ACAD SCI USA, V91, P11733, DOI 10.1073/pnas.91.24.11733; MANNERVIK B, 1992, BIOCHEM J, V282, P305, DOI 10.1042/bj2820305; Mannervik B, 2005, METHOD ENZYMOL, V401, P1, DOI 10.1016/S0076-6879(05)01001-3; McGlynn KA, 2003, CANCER RES, V63, P4594; Millar DS, 2000, J BIOL CHEM, V275, P24893, DOI 10.1074/jbc.M906538199; MOFFAT GJ, 1994, J BIOL CHEM, V269, P16397; Moffat GJ, 1996, J BIOL CHEM, V271, P1054, DOI 10.1074/jbc.271.2.1054; MOREL F, 1993, CANCER RES, V53, P231; Nelson WG, 2009, ENDOCRINOLOGY, V150, P3991, DOI 10.1210/en.2009-0573; Ritchie KJ, 2007, CANCER RES, V67, P9248, DOI 10.1158/0008-5472.CAN-07-1764; RITCHIE KJ, 2009, P NATL ACAD SCI US; SATO K, 1984, GANN, V75, P199; SATOH K, 1985, P NATL ACAD SCI USA, V82, P3964, DOI 10.1073/pnas.82.12.3964; Tchou JC, 2000, INT J ONCOL, V16, P663; TERRIER P, 1990, AM J PATHOL, V137, P845; VOLM M, 1991, BRIT J CANCER, V64, P700, DOI 10.1038/bjc.1991.384; Zhang YJ, 2005, CANCER LETT, V221, P135, DOI 10.1016/j.canlet.2004.08.028; Zhong S, 2002, CLIN CANCER RES, V8, P1087	38	12	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e25707	10.1371/journal.pone.0025707	http://dx.doi.org/10.1371/journal.pone.0025707			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022436	gold, Green Published, Green Submitted			2022-12-27	WOS:000295973200014
J	Balla-Jhagjhoorsingh, SS; Willems, B; Heyndrickx, L; Heyndrickx, L; Vereecken, K; Janssens, W; Seaman, MS; Corti, D; Lanzavecchia, A; Davis, D; Vanham, G				Balla-Jhagjhoorsingh, Sunita S.; Willems, Betty; Heyndrickx, Liesbeth; Heyndrickx, Leo; Vereecken, Katleen; Janssens, Wouter; Seaman, Michael S.; Corti, Davide; Lanzavecchia, Antonio; Davis, David; Vanham, Guido			Characterization of Neutralizing Profiles in HIV-1 Infected Patients from whom the HJ16, HGN194 and HK20 mAbs were Obtained	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODIES; HIV-1/SIV CHIMERIC VIRUS; MEMORY B-CELLS; POTENT NEUTRALIZATION; MUCOSAL CHALLENGE; PASSIVE TRANSFER; PROTECTION; MACAQUES; ASSAYS	Several new human monoclonal antibodies ( mAbs) with a neutralizing potential across different subtypes have recently been described. Three mAbs, HJ16, HGN194 and HK20, were obtained from patients within the HIV-1 cohort of the Institute of Tropical Medicine (ITM). Our aim was to generate immunization antibodies equivalent to those seen in plasma. Here, we describe the selection and characterization of patient plasma and their mAbs, using a range of neutralization assays, including several peripheral blood mononuclear cell (PBMC) based assays and replicating primary viruses as well as cell line based assays and pseudoviruses (PV). The principal criterion for selection of patient plasma was the activity in an 'extended incubation phase' PBMC assay. Neutralizing Abs, derived from their memory B cells, were then selected by ELISA with envelope proteins as solid phase. MAbs were subsequently tested in a high-throughput HOS-PV assay to assess functional neutralization. The present study indicates that the strong profiles in the patients' plasma were not solely due to antibodies represented by the newly isolated mAbs. Although results from the various assays were divergent, they by and large indicate that neutralizing Abs to other epitopes of the HIV-1 envelope are present in the plasma and synergy between Abs may be important. Thus, the spectrum of the obtained mAbs does not cover the range of cross-reactivity seen in plasma in these carefully selected patients irrespective of which neutralization assay is used. Nevertheless, these mAbs are relevant for immunogen discovery because they bind to the recombinant glycoproteins to which the immune response needs to be targeted in vivo. Our observations illustrate the remaining challenges required for successful immunogen design and development.	[Balla-Jhagjhoorsingh, Sunita S.; Willems, Betty; Heyndrickx, Liesbeth; Heyndrickx, Leo; Vereecken, Katleen; Janssens, Wouter; Vanham, Guido] Inst Trop Med, B-2000 Antwerp, Belgium; [Seaman, Michael S.] Beth Israel Deaconess Med Ctr, Div Viral Pathogenesis, Boston, MA 02215 USA; [Corti, Davide; Lanzavecchia, Antonio] Inst Res Biomed, Bellinzona, Switzerland; [Davis, David] Biomed Primate Res Ctr, Rijswijk, Netherlands; [Vanham, Guido] Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium; [Vanham, Guido] Free Univ Brussels, Fac Med & Pharmaceut Sci, B-1050 Brussels, Belgium	Institute of Tropical Medicine (ITM); Harvard University; Beth Israel Deaconess Medical Center; Universita della Svizzera Italiana; University of Antwerp; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Balla-Jhagjhoorsingh, SS (corresponding author), Inst Trop Med, B-2000 Antwerp, Belgium.	sballa@itg.be			Bill & Melinda Gates Foundation within the Collaboration for AIDS Vaccine Discovery	Bill & Melinda Gates Foundation within the Collaboration for AIDS Vaccine Discovery	Part of this research was supported by the Bill & Melinda Gates Foundation within the Collaboration for AIDS Vaccine Discovery and no additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara RR, 2001, SCIENCE, V292, P69, DOI 10.1126/science.1058915; Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; Bachrach E, 2005, VIROLOGY, V332, P418, DOI 10.1016/j.virol.2004.11.031; Barnett SW, 2010, J VIROL, V84, P5975, DOI 10.1128/JVI.02533-09; Beirnaert E, 1998, J VIROL METHODS, V73, P65, DOI 10.1016/S0166-0934(98)00044-5; Choudhry V, 2006, BIOCHEM BIOPH RES CO, V348, P1107, DOI 10.1016/j.bbrc.2006.07.163; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Davis D, 2006, J MED VIROL, V78, P864, DOI 10.1002/jmv.20635; Davis D, 2004, VACCINE, V22, P747, DOI 10.1016/j.vaccine.2003.08.031; Davis D, 2003, J MED VIROL, V71, P332, DOI 10.1002/jmv.10490; Donners H, 2003, VACCINE, V22, P104, DOI 10.1016/S0264-410X(03)00530-9; Edmonds TG, 2010, VIROLOGY, V408, P1, DOI 10.1016/j.virol.2010.08.028; Fenyo EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004505; Ferrantelli F, 2003, AIDS, V17, P301, DOI 10.1097/00002030-200302140-00003; Geonnotti AR, 2010, AIDS RES HUM RETROV, V26, P279, DOI 10.1089/aid.2009.0186; Gomez-Roman VR, 2005, J IMMUNOL, V174, P2185, DOI 10.4049/jimmunol.174.4.2185; Guan YJ, 2009, P NATL ACAD SCI USA, V106, P3952, DOI 10.1073/pnas.0813392106; Haynes BF, 2010, CURR OPIN HIV AIDS, V5, P362, DOI 10.1097/COH.0b013e32833d2e90; Heeney JL, 1998, P NATL ACAD SCI USA, V95, P10803, DOI 10.1073/pnas.95.18.10803; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Hessell AJ, 2010, J VIROL, V84, P1302, DOI 10.1128/JVI.01272-09; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Heyndrickx L, 2008, J VIROL METHODS, V148, P166, DOI 10.1016/j.jviromet.2007.11.009; Luo XM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001225; Mann AM, 2009, AIDS, V23, P1659, DOI 10.1097/QAD.0b013e32832e9408; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Nishimura Y, 2003, P NATL ACAD SCI USA, V100, P15131, DOI 10.1073/pnas.2436476100; Nishimura Y, 2002, J VIROL, V76, P2123, DOI 10.1128/jvi.76.5.2123-2130.2002; Ochsenbauer C, 2009, CURR OPIN HIV AIDS, V4, P418, DOI 10.1097/COH.0b013e32832f011e; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rusert P, 2009, AIDS, V23, P1319, DOI 10.1097/QAD.0b013e32832d92c2; Sabin C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001195; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Schief WR, 2009, CURR OPIN HIV AIDS, V4, P431, DOI 10.1097/COH.0b013e32832e6184; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Shibata R, 1999, NAT MED, V5, P204, DOI 10.1038/5568; Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080; Trkola A, 1999, J VIROL, V73, P8966, DOI 10.1128/JVI.73.11.8966-8974.1999; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Watkins JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018207; Wu L, 2009, J VIROL, V83, P5077, DOI 10.1128/JVI.02600-08; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zolla-Pazner S, 2004, NAT REV IMMUNOL, V4, P199, DOI 10.1038/nri1307	50	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25488	10.1371/journal.pone.0025488	http://dx.doi.org/10.1371/journal.pone.0025488			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016769	gold, Green Submitted, Green Published			2022-12-27	WOS:000295971700011
J	Mazak, JH; Christiansen, P; Kitchener, AC				Mazak, Ji H.; Christiansen, Per; Kitchener, Andrew C.			Oldest Known Pantherine Skull and Evolution of the Tiger	PLOS ONE			English	Article							PHYLOGENETIC RECONSTRUCTION; FELIDAE; CATS; PLIOPLEISTOCENE; PHYLOGEOGRAPHY; CARNIVORES; SOFTWARE; TIGRIS; MEGA	The tiger is one of the most iconic extant animals, and its origin and evolution have been intensely debated. Fossils attributable to extant pantherine species-lineages are less than 2 MYA and the earliest tiger fossils are from the Calabrian, Lower Pleistocene. Molecular studies predict a much younger age for the divergence of modern tiger subspecies at < 100 KYA, although their cranial morphology is readily distinguishable, indicating that early Pleistocene tigers would likely have differed markedly anatomically from extant tigers. Such inferences are hampered by the fact that well-known fossil tiger material is middle to late Pleistocene in age. Here we describe a new species of pantherine cat from Longdan, Gansu Province, China, Panthera zdanskyi sp. nov. With an estimated age of 2.55-2.16 MYA it represents the oldest complete skull of a pantherine cat hitherto found. Although smaller, it appears morphologically to be surprisingly similar to modern tigers considering its age. Morphological, morphometric, and cladistic analyses are congruent in confirming its very close affinity to the tiger, and it may be regarded as the most primitive species of the tiger lineage, demonstrating the first unequivocal presence of a modern pantherine species-lineage in the basal stage of the Pleistocene (Gelasian; traditionally considered to be Late Pliocene). This find supports a north-central Chinese origin of the tiger lineage, and demonstrates that various parts of the cranium, mandible, and dentition evolved at different rates. An increase in size and a reduction in the relative size of parts of the dentition appear to have been prominent features of tiger evolution, whereas the distinctive cranial morphology of modern tigers was established very early in their evolutionary history. The evolutionary trend of increasing size in the tiger lineage is likely coupled to the evolution of its primary prey species.	[Mazak, Ji H.] Shanghai Sci & Technol Museum, Shanghai, Peoples R China; [Christiansen, Per] Aalborg Univ, Dept Biotechnol Chem & Environm Engn, Aalborg, Denmark; [Kitchener, Andrew C.] Natl Museums Scotland, Edinburgh, Midlothian, Scotland	Aalborg University	Mazak, JH (corresponding author), Shanghai Sci & Technol Museum, Shanghai, Peoples R China.	jimazak@gmail.com		Kitchener, Andrew/0000-0003-2594-0827				Andheria AP, 2007, J ZOOL, V273, P169, DOI 10.1111/j.1469-7998.2007.00310.x; Barry J.C., 1987, P235; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Brongersma L. D., 1935, Zoologische Mededeelingen Leiden, V18, P1; Christiansen P, 2009, J VERTEBR PALEONTOL, V29, P934, DOI 10.1671/039.029.0314; Christiansen P, 2009, P NATL ACAD SCI USA, V106, P512, DOI 10.1073/pnas.0810435106; Christiansen P, 2008, CLADISTICS, V24, P977, DOI 10.1111/j.1096-0031.2008.00226.x; Christiansen P, 2008, MAMM BIOL, V73, P451, DOI 10.1016/j.mambio.2007.08.001; Cole Theodore M. III, 2002, Systematics Association Special Volume Series, V64, P194; Cracraft J, 1998, ANIM CONSERV, V1, P139, DOI 10.1111/j.1469-1795.1998.tb00021.x; Davis BW, 2010, MOL PHYLOGENET EVOL, V56, P64, DOI 10.1016/j.ympev.2010.01.036; Driscoll CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004125; Geist V., 1983, ASB Bulletin, V30, P109; GIBBARD P.L., 2005, GEOLOGIC TIME SCALE, P441, DOI DOI 10.1017/CBO9780511536045.023; Gradstein FM, 2004, EPISODES, V27, P83, DOI 10.18814/epiiugs/2004/v27i2/002; Guggisberg CAW, 1975, WILD CATS WORLD; Hemmer H., 1987, P28; Hemmer H., 1967, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V129, P83; HEMMER H, 1981, Palaeontologische Zeitschrift, V55, P109; Hemmer H, 1971, K NED AKAD WET B, V74, P35; Herrington S.J., 1987, P51; Hoogewerf A, 1970, UDJUNG KULON LAND LA; Hooijer D. A., 1947, AMER MUS NOVITATES, V1346, P1; Johnson WE, 2006, SCIENCE, V311, P73, DOI 10.1126/science.1122277; Johnson WE, 1997, J MOL EVOL, V44, pS98, DOI 10.1007/PL00000060; Karanth KU, 2008, J ZOOL 2, V250, P255; Kitchener AC, 2000, ANIM CONSERV, V3, P113, DOI 10.1111/j.1469-1795.2000.tb00236.x; Kitchener AC, 2010, TIGERS OF THE WORLD: THE SCIENCE, POLITICS, AND CONSERVATION OF PANTHERA TIGRIS, 2ND EDITION, P53, DOI 10.1016/B978-0-8155-1570-8.00004-9; Kitchener Andrew C., 1999, P19; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; KURTEN B, 1971, AGE MAMMALS; Luo SJ, 2004, PLOS BIOL, V2, P2275, DOI 10.1371/journal.pbio.0020442; MacEachern S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-177; Martin LD, 2000, NATURWISSENSCHAFTEN, V87, P41, DOI 10.1007/s001140050007; Mattern MY, 2000, CLADISTICS, V16, P232, DOI 10.1111/j.1096-0031.2000.tb00354.x; Mazak JH, 2006, MAMM BIOL, V71, P268, DOI 10.1016/j.mambio.2006.02.007; Mazak JH, 2004, MAMM BIOL, V69, P392, DOI 10.1078/1616-5047-00161; Mazak JH, 2010, MAMMAL REV, V40, P90, DOI 10.1111/j.1365-2907.2009.00151.x; Mazak JH, 2010, MAMM BIOL, V75, P45, DOI 10.1016/j.mambio.2008.06.003; MAZAK V, 1968, Mammalia, V32, P104, DOI 10.1515/mamm.1968.32.1.104; Mazak V, 1983, MAMM SPEC, V152, P1; Mazak V, 1983, NEUE BREHM BUCHEREI; O'Brien S.J., 1987, P10; PEI WEN-CHUNG, 1934, PALAEONT SINICA [NATION GEOL SURY CHINA], VC8, P7; POCOCK R. I., 1929, JOUR BOMBAY NAT HIST SOC, V33, P505; Qiu Z.X., 2004, PALAEONTOL SIN NEW C, P1; Rohlf FJ, 2004, TPSDIG DIGITIZE LAND; ROHLF FJ, 2004, TPSRELW VER 1 39 DEP; Salles LO., 1992, AM MUS NOVIT, V3047, P1; Schwarz E., 1912, Annals & Magazine of Natural History Series 8, V10; Schwarz E, 1913, BER SENCKENBERG NATU, V44, P70; Seidensticker J., 1987, P1; Shu-jin Luo, 2006, Zoological Research, V27, P441; Sody H. J. V., 1932, Journal of the Bombay Natural History Society, V36, P233; Sunquist Mel, 1999, P5; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TURNER A, 1990, GEOBIOS-LYON, V23, P349, DOI 10.1016/0016-6995(90)80006-2; Turner A., 1997, BIG CATS THEIR FOSSI; Werdelin L, 2005, ZOOL J LINN SOC-LOND, V144, P121, DOI 10.1111/j.1096-3642.2005.00165.x; Werdelin Lars, 2010, P59; Yu L, 2005, MOL PHYLOGENET EVOL, V35, P483, DOI 10.1016/j.ympev.2005.01.017; Zdansky O., 1924, Palaeontologia Sinica Series C, V2, P1; Zelditch ML, 2004, GEOMETRIC MORPHOMETR	64	20	26	8	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25483	10.1371/journal.pone.0025483	http://dx.doi.org/10.1371/journal.pone.0025483			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016768	Green Published, gold, Green Submitted			2022-12-27	WOS:000295971700010
J	Mourani, PM; Harris, JK; Sontag, MK; Robertson, CE; Abman, SH				Mourani, Peter M.; Harris, J. Kirk; Sontag, Marci K.; Robertson, Charles E.; Abman, Steven H.			Molecular Identification of Bacteria in Tracheal Aspirate Fluid from Mechanically Ventilated Preterm Infants	PLOS ONE			English	Article							CHRONIC LUNG-DISEASE; UREAPLASMA-UREALYTICUM COLONIZATION; BIRTH-WEIGHT INFANTS; BRONCHOPULMONARY DYSPLASIA; CHLAMYDIA-TRACHOMATIS; CHILDHOOD ASTHMA; BARCODED PRIMERS; GUT MICROBIOTA; INFLAMMATION; INFECTION	Background: Despite strong evidence linking infections to the pathogenesis of bronchopulmonary dysplasia (BPD), limitations of bacterial culture methods have precluded systematic studies of airway organisms relative to disease outcomes. Application of molecular bacterial identification strategies may provide new insight into the role of bacterial acquisition in the airways of preterm infants at risk for BPD. Methods: Serial (within 72 hours, 7, 14, and 21 days of life) tracheal aspirate samples were collected from 10 preterm infants with gestational age <= 34 weeks at birth, and birth weight of 500-1250 g who required mechanical ventilation for at least 21 days. Samples were analyzed by quantitative real time PCR assays for total bacterial load and by pyrosequencing for bacterial identification. Results: Subjects were diagnosed with mild (1), moderate (3), or severe (5) BPD. One patient died prior to determination of disease severity. 107,487 sequences were analyzed, with mean of 3,359 (range 1,724-4,915) per sample. 2 of 10 samples collected <72 hours of life contained adequate bacterial DNA for successful sequence analysis, one of which was from a subject exposed to chorioamnionitis. All other samples exhibited bacterial loads >70copies/reaction. 72 organisms were observed in total. Seven organisms represented the dominant organism (>50% of total sequences) in 31/32 samples with positive sequences. A dominant organism represented>90% of total sequences in 13 samples. Staphylococcus, Ureaplasmaparvum, and Ureaplasmaurealyticum were the most frequently identified dominant organisms, but Pseudomonas, Enterococcus, and Escherichia were also identified. Conclusions: Early bacterial colonization with diverse species occursafter the first 3 days of life in the airways of intubated preterm infants, and can be characterized by bacterial load and marked species diversity. Molecular identification of bacteria in the lower airways of preterm infants has the potential to yield further insight into the pathogenesis of BPD.	[Mourani, Peter M.; Harris, J. Kirk; Abman, Steven H.] Univ Colorado Denver, Sch Med, Dept Pediat, Pediat Heart Lung Ctr, Aurora, CO USA; [Sontag, Marci K.] Univ Colorado Denver, Dept Epidemiol, Colorado Sch Publ Hlth, Aurora, CO USA; [Robertson, Charles E.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Boulder	Mourani, PM (corresponding author), Univ Colorado Denver, Sch Med, Dept Pediat, Pediat Heart Lung Ctr, Aurora, CO USA.	Peter.Mourani@UCDenver.edu		ROBERTSON, CHARLES/0000-0002-4136-4121; Sontag, Marci/0000-0003-2501-652X; Harris, Jonathan/0000-0002-2378-4202	National Institutes of Health, National Center for Research Resources [K23 RR021021]; Colorado Clinical and Translational Sciences Institute [UL1 RR025780]; National Heart Lung Blood Institute [R01 HL085703]; Thrasher Research Fund; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR021021, UL1RR025780] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085703] Funding Source: NIH RePORTER	National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Colorado Clinical and Translational Sciences Institute; National Heart Lung Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Thrasher Research Fund; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by National Institutes of Health, National Center for Research Resources K23 RR021021, http://www.ncrr.nih.gov/ and Colorado Clinical and Translational Sciences Institute UL1 RR025780, http://cctsi.ucdenver.edu/Pages/index.aspx; National Heart Lung Blood Institute R01 HL085703, http://www.nhlbi.nih.gov/; Thrasher Research Fund, http://www.thrasherresearch.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baier R John, 2003, BMC Pediatr, V3, P10, DOI 10.1186/1471-2431-3-10; Ballard HO, 2011, PEDIATR PULM, V46, P111, DOI 10.1002/ppul.21352; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Bose CL, 2008, ARCH DIS CHILD-FETAL, V93, P1455, DOI 10.1136/adc.2007.121327; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Cayabyab R G, 2003, J Matern Fetal Neonatal Med, V14, P205, DOI 10.1080/713606608; DaSilva O, 1997, PEDIATR INFECT DIS J, V16, P364, DOI 10.1097/00006454-199704000-00006; de La Serre CB, 2010, AM J PHYSIOL-GASTR L, V299, pG440, DOI 10.1152/ajpgi.00098.2010; DiGiulio DB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003056; Dimmitt RA, 2010, J PEDIATR GASTR NUTR, V51, P262, DOI 10.1097/MPG.0b013e3181e1a114; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Frank DN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-362; Frank DN, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-420; Frank DN, 2010, XPLORSEQ TOOL KIT TO; Garland SM, 1996, PATHOLOGY, V28, P266, DOI 10.1080/00313029600169134; GRONECK P, 1995, ARCH DIS CHILD-FETAL, V73, pF1, DOI 10.1136/fn.73.1.F1; Groneck P, 2001, PEDIATR PULM, V31, P331, DOI 10.1002/ppul.1055; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Harris JK, APPL ENV MICROBIOL, V3863-3868; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Huang YJ, 2011, J ALLERGY CLIN IMMUN, V127, P372, DOI 10.1016/j.jaci.2010.10.048; Iles R, 1996, ACTA PAEDIATR, V85, P482, DOI 10.1111/j.1651-2227.1996.tb14067.x; JONSSON B, 1994, ACTA PAEDIATR, V83, P927, DOI 10.1111/j.1651-2227.1994.tb13174.x; Jonsson B, 1997, ARCH DIS CHILD-FETAL, V77, pF198, DOI 10.1136/fn.77.3.F198; Kallopur SG, 2006, ARCH DIS CHILD-FETAL, V91, pF132, DOI 10.1136/adc.2004.068544; Kotecha S, 1996, PEDIATR RES, V40, P250, DOI 10.1203/00006450-199608000-00010; Li P, 2010, NATURE, V464, P1287, DOI 10.1038/4641287a; Lyon AJ, 1998, ARCH DIS CHILD-FETAL, V78, pF10, DOI 10.1136/fn.78.1.F10; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; NORTHWAY WH, 1967, NEW ENGL J MED, V276, P357, DOI 10.1056/NEJM196702162760701; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Speer CP, 2006, SEMIN FETAL NEONAT M, V11, P354, DOI 10.1016/j.siny.2006.03.004; Speer Christian P, 2003, Semin Neonatol, V8, P29, DOI 10.1016/S1084-2756(02)00190-2; Speer Christian P, 2009, Neonatology, V95, P353, DOI 10.1159/000209301; Speer CP, 2010, BRONCHOPULMONARY DYS, Vxvii; Stressmann FA, 2010, J PERINAT MED, V38, P333, DOI 10.1515/jpm.2010.026; Suerbaum S, 2009, GASTROENTEROLOGY, V137, P419, DOI 10.1053/j.gastro.2009.06.017; Van Marter LJ, 2002, J PEDIATR-US, V140, P171, DOI 10.1067/mpd.2002.121381; van Vliet MJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000879; vanWaarde WM, 1997, EUR RESPIR J, V10, P886; Viscardi RM, 2009, PEDIATR RES, V65, p84R, DOI 10.1203/PDR.0b013e31819dc2f9; WAITES KB, 1994, PEDIATR INFECT DIS J, V13, P287, DOI 10.1097/00006454-199404000-00008; Walsh Michele C, 2003, J Perinatol, V23, P451, DOI 10.1038/sj.jp.7210963; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yang LY, 2009, GASTROENTEROLOGY, V137, P588, DOI 10.1053/j.gastro.2009.04.046; Zemanick ET, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015101	48	54	55	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25959	10.1371/journal.pone.0025959	http://dx.doi.org/10.1371/journal.pone.0025959			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016793	Green Submitted, Green Published, gold			2022-12-27	WOS:000295971700030
J	Hollmann, M; Rieger, JW; Baecke, S; Lutzkendorf, R; Muller, C; Adolf, D; Bernarding, J				Hollmann, Maurice; Rieger, Jochem W.; Baecke, Sebastian; Luetzkendorf, Ralf; Mueller, Charles; Adolf, Daniela; Bernarding, Johannes			Predicting Decisions in Human Social Interactions Using Real-Time fMRI and Pattern Classification	PLOS ONE			English	Article							NEURAL BASIS; BRAIN ACTIVITY; GAME-THEORY; PUNISHMENT; FAIRNESS; ATTENTION; MACHINE; CORTEX; STATES	Negotiation and trade typically require a mutual interaction while simultaneously resting in uncertainty which decision the partner ultimately will make at the end of the process. Assessing already during the negotiation in which direction one's counterpart tends would provide a tremendous advantage. Recently, neuroimaging techniques combined with multivariate pattern classification of the acquired data have made it possible to discriminate subjective states of mind on the basis of their neuronal activation signature. However, to enable an online-assessment of the participant's mind state both approaches need to be extended to a real-time technique. By combining real-time functional magnetic resonance imaging (fMRI) and online pattern classification techniques, we show that it is possible to predict human behavior during social interaction before the interacting partner communicates a specific decision. Average accuracy reached approximately 70% when we predicted online the decisions of volunteers playing the ultimatum game, a well-known paradigm in economic game theory. Our results demonstrate the successful online analysis of complex emotional and cognitive states using real-time fMRI, which will enable a major breakthrough for social fMRI by providing information about mental states of partners already during the mutual interaction. Interestingly, an additional whole brain classification across subjects confirmed the online results: anterior insula, ventral striatum, and lateral orbitofrontal cortex, known to act in emotional self-regulation and reward processing for adjustment of behavior, appeared to be strong determinants of later overt behavior in the ultimatum game. Using whole brain classification we were also able to discriminate between brain processes related to subjective emotional and motivational states and brain processes related to the evaluation of objective financial incentives.	[Hollmann, Maurice; Baecke, Sebastian; Luetzkendorf, Ralf; Mueller, Charles; Adolf, Daniela; Bernarding, Johannes] Univ Magdeburg, Inst Biometry & Med Comp Sci, Fac Med, D-39106 Magdeburg, Germany; [Rieger, Jochem W.] Univ Magdeburg, Dept Neurol, Fac Med, D-39106 Magdeburg, Germany; [Hollmann, Maurice] Max Planck Inst Human Cognit & Brain Sci, Dept Neurol, Leipzig, Germany	Otto von Guericke University; Otto von Guericke University; Max Planck Society	Hollmann, M (corresponding author), Univ Magdeburg, Inst Biometry & Med Comp Sci, Fac Med, D-39106 Magdeburg, Germany.	mhollmann@cbs.mpg.de		Rieger, Jochem/0000-0003-0955-2306				Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; AUMANN R, 2002, HDB GAME THEORY EC A, V11; BOLTON GE, 1995, GAME ECON BEHAV, V10, P95, DOI 10.1006/game.1995.1026; Buxton RB, 2004, NEUROIMAGE, V23, pS220, DOI 10.1016/j.neuroimage.2004.07.013; Camerer CF, 2007, ECON J, V117, pC26, DOI 10.1111/j.1468-0297.2007.02033.x; Caria A, 2007, NEUROIMAGE, V35, P1238, DOI 10.1016/j.neuroimage.2007.01.018; Chang C., 2008, LIBSVM LIB SUPPORT V; Chang EF, 2010, NAT NEUROSCI, V13, P1428, DOI 10.1038/nn.2641; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; Darcet D, 2008, J ECON INTERACT COOR, V3, P137, DOI 10.1007/s11403-007-0027-x; Davatzikos C, 2005, NEUROIMAGE, V28, P663, DOI 10.1016/j.neuroimage.2005.08.009; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Decharms RC, 2008, NAT REV NEUROSCI, V9, P720, DOI 10.1038/nrn2414; Downar J, 2000, NAT NEUROSCI, V3, P277, DOI 10.1038/72991; Eckel CC, 1996, J ECON BEHAV ORGAN, V30, P143, DOI 10.1016/S0167-2681(96)00854-2; ECKEL CC, 1999, ESA M; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; FREY BS, 1995, J INST THEOR ECON, V151, P286; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Glover GH, 1999, NEUROIMAGE, V9, P416, DOI 10.1006/nimg.1998.0419; Good P, 2005, PERMUTATION PARAMETR; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Hanke M, 2009, NEUROINFORMATICS, V7, P37, DOI 10.1007/s12021-008-9041-y; Haynes JD, 2007, CURR BIOL, V17, P323, DOI 10.1016/j.cub.2006.11.072; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Henrich J., 2005, FDN HUMAN SOCIALITY; Hollmann M, 2008, J NEUROSCI METH, V175, P154, DOI 10.1016/j.jneumeth.2008.08.013; LaConte SM, 2007, HUM BRAIN MAPP, V28, P1033, DOI 10.1002/hbm.20326; Lee D, 2008, NAT NEUROSCI, V11, P404, DOI 10.1038/nn2065; Lieberman MD, 2007, ANNU REV PSYCHOL, V58, P259, DOI 10.1146/annurev.psych.58.110405.085654; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Maunsell JHR, 2002, PHILOS T ROY SOC B, V357, P1063, DOI 10.1098/rstb.2002.1107; Mourao-Miranda J, 2005, NEUROIMAGE, V28, P980, DOI 10.1016/j.neuroimage.2005.06.070; O'Toole AJ, 2007, J COGNITIVE NEUROSCI, V19, P1735, DOI 10.1162/jocn.2007.19.11.1735; Pessoa L, 2005, P NATL ACAD SCI USA, V102, P5612, DOI 10.1073/pnas.0500566102; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; POSSE S, 2009, P 15 ANN M OHBM, V47, P78; Rieger JW, 2008, NEUROIMAGE, V42, P1056, DOI 10.1016/j.neuroimage.2008.06.014; Rilling JK, 2008, CURR OPIN NEUROBIOL, V18, P159, DOI 10.1016/j.conb.2008.06.003; Rilling JK, 2008, NEUROPSYCHOLOGIA, V46, P1256, DOI 10.1016/j.neuropsychologia.2007.11.033; Rilling JK, 2004, NEUROIMAGE, V22, P1694, DOI 10.1016/j.neuroimage.2004.04.015; Rushworth MFS, 2003, NEUROIMAGE, V20, pS89, DOI 10.1016/j.neuroimage.2003.09.011; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Sanfey AG, 2007, SCIENCE, V318, P598, DOI 10.1126/science.1142996; Scholkopf B, 1999, IEEE T NEURAL NETWOR, V10, P1000, DOI 10.1109/72.788641; Shadlen MN, 1996, J NEUROSCI, V16, P1486; SINGER T, 2008, AM ECON REV, V95, P340; Sitaram R, 2011, NEUROIMAGE, V56, P753, DOI 10.1016/j.neuroimage.2010.08.007; SLEMBECK T, 1999, 9904 U ST GALLEN; Thoenissen D, 2002, J NEUROSCI, V22, P9024; Tipping ME, 2001, J MACH LEARN RES, V1, P211, DOI 10.1162/15324430152748236; Tootell RBH, 2000, NAT NEUROSCI, V3, P206, DOI 10.1038/72904; Valley K, 2002, GAME ECON BEHAV, V38, P127, DOI 10.1006/game.2001.0855; van't Wout M, 2006, EXP BRAIN RES, V169, P564, DOI 10.1007/s00221-006-0346-5; Veit R, 2002, NEUROSCI LETT, V328, P233, DOI 10.1016/S0304-3940(02)00519-0; Weiskopf N, 2004, IEEE T BIO-MED ENG, V51, P966, DOI 10.1109/TBME.2004.827063; Weiskopf N, 2007, MAGN RESON IMAGING, V25, P989, DOI 10.1016/j.mri.2007.02.007; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2	62	29	30	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25304	10.1371/journal.pone.0025304	http://dx.doi.org/10.1371/journal.pone.0025304			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003388	Green Published, gold			2022-12-27	WOS:000295970300009
J	Park, EJ; Roh, J; Kim, SN; Kang, MS; Lee, BS; Kim, Y; Choi, S				Park, Eun-Jung; Roh, Jinkyu; Kim, Soo Nam; Kang, Min-Sung; Lee, Byoung-Seok; Kim, Younghun; Choi, Sangdun			Biological Toxicity and Inflammatory Response of Semi-Single-Walled Carbon Nanotubes	PLOS ONE			English	Article							C57BL/6 MICE; HISTAMINE; LUNG; EXPOSURE; FIBROSIS	The toxicological studies on carbon nanotubes (CNTs) have been urgently needed from the emerging diverse applications of CNTs. Physicochemical properties such as shape, diameter, conductance, surface charge and surface chemistry of CNTs gained during manufacturing processes play a key role in the toxicity. In this study, we separated the semi-conductive components of SWCNTs (semi-SWCNTs) and evaluated the toxicity on days 1, 7, 14 and 28 after intratracheal instillation in order to determine the role of conductance. Exposure to semi-SWCNTs significantly increased the growth of mice and significantly decreased the relative ratio of brain weight to body weight. Recruitment of monocytes into the bloodstream increased in a time-dependent manner, and significant hematological changes were observed 28 days after exposure. In the bronchoalveolar lavage (BAL) fluid, secretion of Th2-type cytokines, particularly IL-10, was more predominant than Th1-type cytokines, and expression of regulated on activation normal T cell expressed and secreted (RANTES), p53, transforming growth factor (TGF)-beta, and inducible nitric oxide synthase (iNOS) increased in a time-dependent manner. Fibrotic histopathological changes peaked on day 7 and decreased 14 days after exposure. Expression of cyclooxygenase-2 (COX-2), mesothelin, and phosphorylated signal transducer and activator of transcription 3 (pSTAT3) also peaked on day 7, while that of TGF-beta peaked on days 7 and 14. Secretion of histamine in BAL fluid decreased in a time-dependent manner. Consequently, we suggest that the brain is the target organ of semi-SWCNTs brought into the lung, and conductance as well as length may be critical factors affecting the intensity and duration of the inflammatory response following SWCNT exposure.	[Park, Eun-Jung; Choi, Sangdun] Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea; [Roh, Jinkyu; Kim, Younghun] Kwangwoon Univ, Dept Chem Engn, Seoul, South Korea; [Kim, Soo Nam; Kang, Min-Sung; Lee, Byoung-Seok] Korea Inst Toxicol, Inhalat Toxicol Ctr, Jeongeup, South Korea	Ajou University; Kwangwoon University; Korea Institute of Toxicology; Korea Research Institute of Chemical Technology (KRICT)	Park, EJ (corresponding author), Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea.	sangdunchoi@ajou.ac.kr	Park, Eun-Jung/Y-4427-2019		National Research Foundation of Korea; Ministry of Education, Science and Technology [2010-0016256]; Korea Food and Drug Administration [10182KFDA992-2302]; Priority Research Centers [NRF 2010-0028294]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Food and Drug Administration(Food & Drug Administration (KFDA), Republic of Korea); Priority Research Centers	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2010-0016256). This work was also partly supported by a grant from the Korea Food and Drug Administration (10182KFDA992-2302) and the Priority Research Centers Program (NRF 2010-0028294). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo Maria I., 2010, Inflammation & Allergy Drug Targets, V9, P73; Chou CC, 2008, NANO LETT, V8, P437, DOI 10.1021/nl0723634; Hakim-Rad K, 2009, CURR OPIN ALLERGY CL, V9, P427, DOI 10.1097/ACI.0b013e32832e9af1; Hellstrand K, 2000, CANCER INVEST, V18, P347, DOI 10.3109/07357900009012178; Janeway C, 2005, IMMUNOBIOLOGY IMMUNE, Vxxiii; Kim JE, 2010, J TOXICOL ENV HEAL A, V73, P1530, DOI 10.1080/15287394.2010.511578; Kim UJ, 2005, J AM CHEM SOC, V127, P15437, DOI 10.1021/ja052951o; Kobayashi N, 2010, TOXICOLOGY, V276, P143, DOI 10.1016/j.tox.2010.07.021; Lam CW, 2006, CRIT REV TOXICOL, V36, P189, DOI 10.1080/10408440600570233; Lawrence DA, 1996, EUR CYTOKINE NETW, V7, P363; Li Z, 2007, ENVIRON HEALTH PERSP, V115, P377, DOI 10.1289/ehp.9688; Miyata Y, 2006, J PHYS CHEM B, V110, P25, DOI 10.1021/jp055692y; Murray AR, 2009, TOXICOLOGY, V257, P161, DOI 10.1016/j.tox.2008.12.023; Nygaard UC, 2009, TOXICOL SCI, V109, P113, DOI 10.1093/toxsci/kfp057; Okamoto T, 2009, CLIN EXP IMMUNOL, V157, P27, DOI 10.1111/j.1365-2249.2009.03958.x; Packard KA, 2003, INT IMMUNOPHARMACOL, V3, P909, DOI 10.1016/S1567-5769(02)00235-7; Park EJ, 2011, ARCH TOXICOL; Park EJ, 2010, TOXICOL APPL PHARM, V244, P226, DOI 10.1016/j.taap.2009.12.036; Park EJ, 2009, TOXICOLOGY, V259, P113, DOI 10.1016/j.tox.2009.02.009; Shvedova AA, 2008, TOXICOL APPL PHARM, V231, P235, DOI 10.1016/j.taap.2008.04.018; Shvedova AA, 2005, AM J PHYSIOL-LUNG C, V289, pL698, DOI 10.1152/ajplung.00084.2005; Shvedova AA, 2007, TOXICOL APPL PHARM, V221, P339, DOI 10.1016/j.taap.2007.03.018; Song Y, 2009, EUR RESPIR J, V34, P559, DOI 10.1183/09031936.00178308; Stoker Emily, 2008, Int J Toxicol, V27, P441, DOI 10.1080/10915810802552138; Strano MS, 2003, SCIENCE, V301, P1519, DOI 10.1126/science.1087691; Teeguarden JG, 2011, TOXICOL SCI, V120, P123, DOI 10.1093/toxsci/kfq363; Till SJ, 2004, J ALLERGY CLIN IMMUN, V113, P1025, DOI 10.1016/j.jaci.2004.03.024; Wang LY, 2010, J TOXICOL ENV HEAL A, V73, P410, DOI 10.1080/15287390903486550; Yang CM, 2005, J PHYS CHEM B, V109, P19242, DOI 10.1021/jp053245c	29	29	31	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25892	10.1371/journal.pone.0025892	http://dx.doi.org/10.1371/journal.pone.0025892			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22016783	gold, Green Published, Green Submitted			2022-12-27	WOS:000295970300038
J	Wozniak, MA; Frost, AL; Preston, CM; Itzhaki, RF				Wozniak, Matthew A.; Frost, Alison L.; Preston, Chris M.; Itzhaki, Ruth F.			Antivirals Reduce the Formation of Key Alzheimer's Disease Molecules in Cell Cultures Acutely Infected with Herpes Simplex Virus Type 1	PLOS ONE			English	Article							GENE-EXPRESSION; APOLIPOPROTEIN E4; VIRAL GENOMES; BRAIN; LATENCY; HSV-1; DNA; VALACYCLOVIR; REACTIVATION; ASSOCIATION	Alzheimer's disease (AD) afflicts around 20 million people worldwide and so there is an urgent need for effective treatment. Our research showing that herpes simplex virus type 1 (HSV1) is a risk factor for AD for the brains of people who possess a specific genetic factor and that the virus causes accumulation of key AD proteins (beta-amyloid (A beta) and abnormally phosphorylated tau (P-tau)), suggests that anti-HSV1 antiviral agents might slow AD progression. However, currently available antiviral agents target HSV1 DNA replication and so might be successful in AD only if A beta and P-tau accumulation depend on viral DNA replication. Therefore, we investigated firstly the stage(s) of the virus replication cycle required for A beta and P-tau accumulation, and secondly whether antiviral agents prevent these changes using recombinant strains of HSV1 that progress only partly through the replication cycle and antiviral agents that inhibit HSV1 DNA replication. By quantitative immunocytochemistry we demonstrated that entry, fusion and uncoating of HSV1, are insufficient to induce A beta and P-tau production. We showed also that none of the "immediate early'' viral proteins is directly responsible, and that A beta and P-tau are produced at a subsequent stage of the HSV1 replication cycle. Importantly, the anti-HSV1 antiviral agents acyclovir, penciclovir and foscarnet reduced A beta and P-tau accumulation, as well as HSV1, with foscarnet being less effective in each case. P-tau accumulation was found to depend on HSV1 DNA replication, whereas A beta accumulation was not. The antiviral-induced decrease in A beta is attributable to the reduced number of new viruses, and hence the reduction in viral spread. Since antiviral agents reduce greatly A beta and P-tau accumulation in HSV1-infected cells, they would be suitable for treating AD with great advantage unlike current AD therapies, only the virus, not the host cell, would be targeted.	[Wozniak, Matthew A.; Frost, Alison L.; Itzhaki, Ruth F.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Preston, Chris M.] Univ Glasgow, MRC, Ctr Virus Res, Glasgow, Lanark, Scotland	University of Manchester; University of Glasgow	Wozniak, MA (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	ruth.itzhaki@manchester.ac.uk			Henry Smith Charity; Olympus Foundation; Visual Sciences Fund; MRC [MC_U130169964] Funding Source: UKRI; Medical Research Council [MC_U130169964] Funding Source: researchfish	Henry Smith Charity; Olympus Foundation; Visual Sciences Fund; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a grant from the Henry Smith Charity, an award from the Olympus Foundation, donations from the estate of Mrs. Louise de Launay and from the Visual Sciences Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACE CI, 1989, J VIROL, V63, P2260, DOI 10.1128/JVI.63.5.2260-2269.1989; BALL MJ, 1982, CAN J NEUROL SCI, V9, P303, DOI 10.1017/S0317167100044115; Beffert U, 1998, LANCET, V351, P1330, DOI 10.1016/S0140-6736(05)79057-7; Brew BJ, 2005, NEUROLOGY, V65, P1490, DOI 10.1212/01.wnl.0000183293.95787.b7; DAVISON MJ, 1984, J GEN VIROL, V65, P859, DOI 10.1099/0022-1317-65-5-859; De Chiara G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013989; DELUCA NA, 1985, MOL CELL BIOL, V5, P1997, DOI 10.1128/MCB.5.8.1997; Dobson CB, 2006, J INFECT DIS, V193, P442, DOI 10.1086/499280; EARNSHAW DL, 1992, ANTIMICROB AGENTS CH, V36, P2747, DOI 10.1128/AAC.36.12.2747; Esiri MM, 1998, J NEUROL NEUROSUR PS, V65, P29, DOI 10.1136/jnnp.65.1.29; EVERETT RD, 1984, EMBO J, V3, P3135, DOI 10.1002/j.1460-2075.1984.tb02270.x; GODOWSKI PJ, 1985, J VIROL, V55, P357, DOI 10.1128/JVI.55.2.357-365.1985; Hemling N, 2003, ANN NEUROL, V54, P267, DOI 10.1002/ana.10662; HONESS RW, 1974, J VIROL, V14, P8, DOI 10.1128/JVI.14.1.8-19.1974; Ill-Raga G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021456; Itabashi S, 1997, LANCET, V349, P1102, DOI 10.1016/S0140-6736(05)62325-2; Itzhaki RF, 2004, ANN NEUROL, V55, P299, DOI 10.1002/ana.10852; Itzhaki RF, 2001, J NEUROVIROL, V7, P570; Itzhaki RF, 1997, LANCET, V349, P241, DOI 10.1016/S0140-6736(96)10149-5; Itzhaki RF, 2008, J ALZHEIMERS DIS, V13, P393; JAMIESON DRS, 1995, J GEN VIROL, V76, P1417, DOI 10.1099/0022-1317-76-6-1417; JAMIESON GA, 1991, J MED VIROL, V33, P224, DOI 10.1002/jmv.1890330403; JAMIESON GA, 1992, J PATHOL, V167, P365, DOI 10.1002/path.1711670403; JOHNSON DC, 1988, J VIROL, V62, P1347, DOI 10.1128/JVI.62.4.1347-1354.1988; JOHNSON PA, 1991, J VIROL, V65, P700, DOI 10.1128/JVI.65.2.700-710.1991; Koelle DM, 2010, SEX TRANSM INFECT, V86, P202, DOI 10.1136/sti.2009.039735; Leary JJ, 2002, ANTIMICROB AGENTS CH, V46, P762, DOI 10.1128/AAC.46.3.762-768.2002; Lerchundi R, 2011, J ALZHEIMERS DIS, V23, P513, DOI 10.3233/JAD-2010-101386; Lin WR, 1998, ALZHEIMERS REP, V1, P173; Lukiw WJ, 2010, NEUROREPORT, V21, P922, DOI 10.1097/WNR.0b013e32833da51a; Lycke J, 2003, ANTIMICROB AGENTS CH, V47, P2438, DOI 10.1128/AAC.47.8.2438-2441.2003; Marques AR, 2001, J NEUROVIROL, V7, P82; MCQUAID S, 1994, NEUROPATH APPL NEURO, V20, P103, DOI 10.1111/j.1365-2990.1994.tb01168.x; OHARE P, 1993, SEMIN VIROL, V4, P145, DOI 10.1006/smvy.1993.1010; Piacentini R, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.06.009; Pouplin T, 2011, ANTIMICROB AGENTS CH, V55, P3624, DOI 10.1128/AAC.01023-10; Preston CM, 2005, J VIROL, V79, P525, DOI 10.1128/JVI.79.1.525-535.2005; PRESTON CM, 1979, J VIROL, V29, P275, DOI 10.1128/JVI.29.1.275-284.1979; Pulliam L, 2009, J NEUROIMMUNE PHARM, V4, P213, DOI 10.1007/s11481-009-9151-9; Santana S, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.12.010; Spear PG, 2004, CELL MICROBIOL, V6, P401, DOI 10.1111/j.1462-5822.2004.00389.x; Thackray AM, 1996, J INFECT DIS, V173, P291, DOI 10.1093/infdis/173.2.291; Thackray AM, 2000, J INFECT DIS, V181, P1517, DOI 10.1086/315408; Thackray AM, 1998, ANTIMICROB AGENTS CH, V42, P1555, DOI 10.1128/AAC.42.7.1555; Thompson RL, 2010, FUTURE MED CHEM, V2, P1099, DOI 10.4155/FMC.10.197; WAGSTAFF AJ, 1994, DRUGS, V48, P199, DOI 10.2165/00003495-199448020-00007; Wozniak MA, 2009, J PATHOL, V217, P131, DOI 10.1002/path.2449; Wozniak MA, 2005, J MED VIROL, V75, P300, DOI 10.1002/jmv.20271; Wozniak MA, 2007, NEUROSCI LETT, V429, P95, DOI 10.1016/j.neulet.2007.09.077; Wozniak Matthew A, 2010, Ther Adv Neurol Disord, V3, P141, DOI 10.1177/1756285610370069; Wozniak MA, 2009, J ALZHEIMERS DIS, V16, P341, DOI 10.3233/JAD-2009-0963; Zambrano A, 2008, J ALZHEIMERS DIS, V14, P259	52	96	103	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25152	10.1371/journal.pone.0025152	http://dx.doi.org/10.1371/journal.pone.0025152			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003387	gold, Green Submitted, Green Published			2022-12-27	WOS:000295970300008
J	Zytnicki, M; Quesneville, H				Zytnicki, Matthias; Quesneville, Hadi			S-MART, A Software Toolbox to Aid RNA-seq Data Analysis	PLOS ONE			English	Article							GENOME BROWSER; READ ALIGNMENT	High-throughput sequencing is now routinely performed in many experiments. But the analysis of the millions of sequences generated, is often beyond the expertise of the wet labs who have no personnel specializing in bioinformatics. Whereas several tools are now available to map high-throughput sequencing data on a genome, few of these can extract biological knowledge from the mapped reads. We have developed a toolbox called S-MART, which handles mapped RNA-Seq data. SMART is an intuitive and lightweight tool which performs many of the tasks usually required for the analysis of mapped RNA-Seq reads. S-MART does not require any computer science background and thus can be used by all of the biologist community through a graphical interface. S-MART can run on any personal computer, yielding results within an hour even for Gb of data for most queries. S-MART may perform the entire analysis of the mapped reads, without any need for other ad hoc scripts. With this tool, biologists can easily perform most of the analyses on their computer for their RNA-Seq data, from the mapped data to the discovery of important loci.	[Zytnicki, Matthias; Quesneville, Hadi] INRA, URGI, Versailles, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay	Zytnicki, M (corresponding author), INRA, URGI, Versailles, France.	matthias.zytnicki@versailles.inra.fr	Quesneville, Hadi/AAG-1048-2020	Quesneville, Hadi/0000-0003-3001-4908	Association pour la Recherche sur le Cancer [ARC 4017]	Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	This work has been partially funded by the Association pour la Recherche sur le Cancer (http://www.arc-cancer.net/) under grant ARC 4017, which was used to produce RNA-Seq data. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blankenberg D, 2007, GENOME RES, V17, P960, DOI 10.1101/gr.5578007; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Oshlack A, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-14; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602	13	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e25988	10.1371/journal.pone.0025988	http://dx.doi.org/10.1371/journal.pone.0025988			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998740	Green Submitted, gold, Green Published			2022-12-27	WOS:000295968700031
J	Eun, C; Lorkovic, ZJ; Naumann, U; Long, Q; Havecker, ER; Simon, SA; Meyers, BC; Matzke, AJM; Matzke, M				Eun, Changho; Lorkovic, Zdravko J.; Naumann, Ulf; Long, Quan; Havecker, Ericka R.; Simon, Stacey A.; Meyers, Blake C.; Matzke, Antonius J. M.; Matzke, Marjori			AGO6 Functions in RNA-Mediated Transcriptional Gene Silencing in Shoot and Root Meristems in Arabidopsis thaliana	PLOS ONE			English	Article							DNA-METHYLATION; SIRNA ACCUMULATION; RETROTRANSPOSITION; ARGONAUTE4; PATHWAY; PROTEIN; PLANTS	RNA-directed DNA methylation (RdDM) is a small interfering RNA (siRNA)-mediated epigenetic modification that contributes to transposon silencing in plants. RdDM requires a complex transcriptional machinery that includes specialized RNA polymerases, named Pol IV and Pol V, as well as chromatin remodelling proteins, transcription factors, RNA binding proteins, and other plant-specific proteins whose functions are not yet clarified. In Arabidopsis thaliana, DICER-LIKE3 and members of the ARGONAUTE4 group of ARGONAUTE (AGO) proteins are involved, respectively, in generating and using 24-nt siRNAs that trigger methylation and transcriptional gene silencing of homologous promoter sequences. AGO4 is the main AGO protein implicated in the RdDM pathway. Here we report the identification of the related AGO6 in a forward genetic screen for mutants defective in RdDM and transcriptional gene silencing in shoot and root apical meristems in Arabidopsis thaliana. The identification of AGO6, and not AGO4, in our screen is consistent with the primary expression of AGO6 in shoot and root growing points.	[Eun, Changho; Lorkovic, Zdravko J.; Naumann, Ulf; Long, Quan; Matzke, Antonius J. M.; Matzke, Marjori] Austrian Acad Sci, Gregor Mendel Inst, A-1010 Vienna, Austria; [Havecker, Ericka R.] Univ Cambridge, Dept Plant Sci, Cambridge, England; [Simon, Stacey A.; Meyers, Blake C.] Univ Delaware, Dept Plant & Soil Sci, Newark, DE 19716 USA; [Simon, Stacey A.; Meyers, Blake C.] Univ Delaware, Delaware Biotechnol Inst, Newark, DE 19716 USA	Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI); University of Cambridge; University of Delaware; University of Delaware	Eun, C (corresponding author), Austrian Acad Sci, Gregor Mendel Inst, A-1010 Vienna, Austria.	marjori.matzke@gmi.oeaw.ac.at	Matzke, Antonius/H-8698-2015; Meyers, Blake/B-6535-2012	Meyers, Blake/0000-0003-3436-6097; Lorkovic, Zdravko/0000-0002-3074-7258	Fonds zur Forderung der wissenschaftlichen Forschung [P20702-B03]; Austrian Academy of Sciences; National Science Foundation (NSF) [0701745]	Fonds zur Forderung der wissenschaftlichen Forschung(Austrian Science Fund (FWF)); Austrian Academy of Sciences; National Science Foundation (NSF)(National Science Foundation (NSF))	Work in the Matzke lab is supported by grant nr. P20702-B03 from the Fonds zur Forderung der wissenschaftlichen Forschung (www.fwf.ac.at) and the Austrian Academy of Sciences (www.oeaw.ac.at). Work in the Meyers lab is supported by National Science Foundation (NSF) Plant Genome Research Program (PGRP) award #0701745 (www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calarco JP, 2011, CURR OPIN GENET DEV, V21, P134, DOI 10.1016/j.gde.2011.01.014; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; Daxinger L, 2009, EMBO J, V28, P48, DOI 10.1038/emboj.2008.260; Ender C, 2010, J CELL SCI, V123, P1819, DOI 10.1242/jcs.055210; Greenberg MVC, 2011, EPIGENETICS-US, V6, P344, DOI 10.4161/epi.6.3.14242; Havecker ER, 2010, PLANT CELL, V22, P321, DOI 10.1105/tpc.109.072199; He XJ, 2011, CELL RES, V21, P442, DOI 10.1038/cr.2011.23; He XJ, 2009, GENE DEV, V23, P318, DOI 10.1101/gad.1765209; Ito H, 2011, NATURE, V472, P115, DOI 10.1038/nature09861; Kanno T, 2008, NAT GENET, V40, P670, DOI 10.1038/ng.119; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lu C, 2007, METHODS, V43, P110, DOI 10.1016/j.ymeth.2007.05.002; Mallory A, 2010, PLANT CELL, V22, P3879, DOI 10.1105/tpc.110.080671; Matzke M, 2009, CURR OPIN CELL BIOL, V21, P367, DOI 10.1016/j.ceb.2009.01.025; Mirouze M, 2009, NATURE, V461, P427, DOI 10.1038/nature08328; Mosher RA, 2008, P NATL ACAD SCI USA, V105, P3145, DOI 10.1073/pnas.0709632105; Naumann U, 2011, GENETICS, V187, P977, DOI 10.1534/genetics.110.125401; Olmedo-Monfil V, 2010, NATURE, V464, P628, DOI 10.1038/nature08828; Qi YJ, 2006, NATURE, V443, P1008, DOI 10.1038/nature05198; Saze H, 2011, CURR OPIN PLANT BIOL, V14, P81, DOI 10.1016/j.pbi.2010.08.017; Stangeland B, 2002, PLANT MOL BIOL REP, V20, P107, DOI 10.1007/BF02799426; Steiner FA, 2009, NAT STRUCT MOL BIOL, V16, P207, DOI 10.1038/nsmb.1541; Takeda A, 2008, PLANT CELL PHYSIOL, V49, P493, DOI 10.1093/pcp/pcn043; Taylor B., 1982, FOCUS, V4, P4; Tsukahara S, 2009, NATURE, V461, P423, DOI 10.1038/nature08351; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; Wierzbicki AT, 2009, NAT GENET, V41, P630, DOI 10.1038/ng.365; Zheng XW, 2007, EMBO J, V26, P1691, DOI 10.1038/sj.emboj.7601603; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	34	40	43	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25730	10.1371/journal.pone.0025730	http://dx.doi.org/10.1371/journal.pone.0025730			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998686	Green Published, Green Submitted, gold			2022-12-27	WOS:000295966900047
J	Gardner, MK; Hill, RD; Was, CA				Gardner, Michael K.; Hill, Robert D.; Was, Christopher A.			A Procedural Approach to Remembering Personal Identification Numbers among Older Adults	PLOS ONE			English	Article							DOMAIN-SPECIFIC KNOWLEDGE; MEMORY-IMPAIRED PATIENTS; CRYSTALLIZED INTELLIGENCE; IMPLICIT MEMORY; WORKING-MEMORY; RETENTION; ACQUISITION; AMNESIA; FLUID; AGE	This study investigated whether a motor skill learning intervention could provide better memory for personal identification numbers (PINs) as compared to a control group. Younger (ages 18 to 40) and older (ages 61 to 92) participants were randomly assigned to conditions. All participants received three days of training consisting of 12 blocks of 12 trials each. Participants were tested immediately after training, after four days, and after seven days. Dependent measures were errors, latencies, and number of correct responses per minute. Younger participants were less error prone, faster, and produced more correct responses than older participants. Training condition (motor skill-based versus control training) had no significant effect on any of the dependent variables. Testing time had a significant effect on latency, and the effect of testing time on latency interacted with age group. In a second study, six older individuals diagnosed as having mild cognitive impairment (MCI) were trained using the motor skill learning intervention. Their performance was compared with that of the younger and older motor skill groups from the first experiment. The results showed that the older MCI group was significantly slower, more error prone, and produced fewer correct responses per minute than the older, normal group. Thus the presence of diagnosed MCI significantly impairs memory for PINs beyond the impairment expected from normal aging.	[Gardner, Michael K.; Hill, Robert D.] Univ Utah, Dept Educ Psychol, Salt Lake City, UT 84112 USA; [Was, Christopher A.] Kent State Univ, Dept Educ Fdn & Special Serv, Kent, OH 44242 USA	Utah System of Higher Education; University of Utah; Kent State University; Kent State University Kent; Kent State University Salem	Gardner, MK (corresponding author), Univ Utah, Dept Educ Psychol, Salt Lake City, UT 84112 USA.	gardner@ed.utah.edu	Was, Christopher/P-7459-2019		University of Utah; University of Utah Research Foundation; University of Utah Center on Aging	University of Utah; University of Utah Research Foundation; University of Utah Center on Aging	This research was supported by a University of Utah Faculty Research Grant to the first author, by a University of Utah Research Foundation Grant to the first two authors, and by a University of Utah Center on Aging Pilot Grant to the first author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberto P., 2013, APPL BEHAV ANAL TEAC; BADDELEY A, 1994, NEUROPSYCHOLOGIA, V32, P53, DOI 10.1016/0028-3932(94)90068-X; BOLLA KI, 1991, ARCH NEUROL-CHICAGO, V48, P61, DOI 10.1001/archneur.1991.00530130069022; BULKELEY WM, 1995, WALL STREET J   0419; Castel AD, 2007, J GERONTOL B-PSYCHOL, V62, pP194, DOI 10.1093/geronb/62.3.P194; Cattell R. B., 1971, ABILITIES THEIR STRU; CATTELL RB, 1963, J EDUC PSYCHOL, V54, P1, DOI 10.1037/h0046743; Cattell RB, 1941, PSYCHOL BULL, V38, P592; CROOK T, 1980, J CONSULT CLIN PSYCH, V48, P228, DOI 10.1037/0022-006X.48.2.228; ENGLEY HL, 1995, SALT LAKE TRIBU 1002; GARDNER MK, 2011, OXFORD HDB SCH PSYCH, P79; GLISKY EL, 1988, J LEARN DISABIL-US, V21, P333, DOI 10.1177/002221948802100604; GLISKY EL, 1986, NEUROPSYCHOLOGIA, V24, P313, DOI 10.1016/0028-3932(86)90017-5; GLISKY EL, 1987, NEUROPSYCHOLOGIA, V25, P893, DOI 10.1016/0028-3932(87)90094-7; GLISKY EL, 1986, J CLIN EXP NEUROPSYC, V8, P292, DOI 10.1080/01688638608401320; GLISKY EL, 1988, NEUROPSYCHOLOGIA, V26, P173, DOI 10.1016/0028-3932(88)90041-3; Glisky EL, 1996, J HEAD TRAUMA REHAB, V11, P31, DOI 10.1097/00001199-199604000-00004; HARROW RO, 1995, SALT LAKE TRIBU 1117; Hill RD, 1997, EXP AGING RES, V23, P275, DOI 10.1080/03610739708254284; Horn J, 1985, HDB INTELLIGENCE; HORN JL, 1968, PSYCHOL REV, V75, P242, DOI 10.1037/h0025662; HORN JL, 1966, J EDUC PSYCHOL, V57, P253, DOI 10.1037/h0023816; HORN JL, 1967, ACTA PSYCHOL, V26, P107, DOI 10.1016/0001-6918(67)90011-X; Howard DV, 2004, PSYCHOL AGING, V19, P79, DOI 10.1037/0882-7974.19.1.79; JACOBY LL, 1983, J VERB LEARN VERB BE, V22, P485, DOI 10.1016/S0022-5371(83)90301-8; MacDonald SWS, 2006, J EXP PSYCHOL GEN, V135, P368, DOI 10.1037/0096-3445.135.3.368; Newell A., 1981, COGNITIVE SKILLS THE, P1; PARK DC, 1992, PSYCHOL AGING, V7, P632, DOI 10.1037/0882-7974.7.4.632; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; ROEDIGER HL, 1990, AM PSYCHOL, V45, P1043, DOI 10.1037/0003-066X.45.9.1043; ROEDIGER HL, 1990, IMPLICIT MEMORY THEO, P67; Schneider W., 2002, E PRIME USERS GUIDE; Shipley W. C., 1986, SHIPLEY I LIVING SCA; Song S, 2009, BEHAV BRAIN RES, V196, P328, DOI 10.1016/j.bbr.2008.09.022; Squire L. R., 1987, MEMORY BRAIN; SQUIRE LR, 1986, SCIENCE, V232, P1612, DOI 10.1126/science.3086978; VERHAEGHEN P, 1992, PSYCHOL AGING, V7, P242, DOI 10.1037/0882-7974.7.2.242; Verhaeghen P., 2000, COGNITIVE REHABILITA, P3; Was CA, 2007, J MEM LANG, V56, P86, DOI 10.1016/j.jml.2006.07.008; WILSON BA, 1994, NEUROPSYCHOL REHABIL, V4, P307, DOI 10.1080/09602019408401463; Woltz DJ, 2007, J EXP PSYCHOL LEARN, V33, P155, DOI 10.1037/0278-7393.33.1.155; Woltz DJ, 2010, J EXP PSYCHOL LEARN, V36, P1510, DOI 10.1037/a0021039; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	43	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25428	10.1371/journal.pone.0025428	http://dx.doi.org/10.1371/journal.pone.0025428			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834NA	21998656	Green Published, Green Submitted, gold			2022-12-27	WOS:000295966900025
J	Lan, AP; Liao, XX; Mo, LQ; Yang, CT; Yang, ZL; Wang, XY; Hu, F; Chen, PX; Feng, JQ; Zheng, DD; Xiao, LC				Lan, Aiping; Liao, Xinxue; Mo, Liqiu; Yang, Chuntao; Yang, Zhanli; Wang, Xiuyu; Hu, Fen; Chen, Peixi; Feng, Jianqiang; Zheng, Dongdan; Xiao, Liangcan			Hydrogen Sulfide Protects against Chemical Hypoxia-Induced Injury by Inhibiting ROS-Activated ERK1/2 and p38MAPK Signaling Pathways in PC12 Cells	PLOS ONE			English	Article							P38 MAP KINASE; INDUCED APOPTOSIS; OXIDATIVE STRESS; COBALT CHLORIDE; INVOLVEMENT; NEURONS; DAMAGE; NEUROMODULATOR; JNK; PHOSPHORYLATION	Hydrogen sulfide (H2S) has been proposed as a novel neuromodulator and neuroprotective agent. Cobalt chloride (CoCl2) is a well-known hypoxia mimetic agent. We have demonstrated that H2S protects against CoCl2-induced injuries in PC12 cells. However, whether the members of mitogen-activated protein kinases (MAPK), in particular, extracellular signal-regulated kinase1/2(ERK1/2) and p38MAPK are involved in the neuroprotection of H2S against chemical hypoxia-induced injuries of PC12 cells is not understood. We observed that CoCl2 induced expression of transcriptional factor hypoxia-inducible factor-1 alpha (HIF-1 alpha), decreased cystathionine-beta synthase (CBS, a synthase of H2S) expression, and increased generation of reactive oxygen species (ROS), leading to injuries of the cells, evidenced by decrease in cell viability, dissipation of mitochondrial membrane potential (MMP), caspase-3 activation and apoptosis, which were attenuated by pretreatment with NaHS (a donor of H2S) or N-acetyl-L cystein (NAC), a ROS scavenger. CoCl2 rapidly activated ERK1/2, p38MAPK and C-Jun N-terminal kinase (JNK). Inhibition of ERK1/2 or p38MAPK or JNK with kinase inhibitors (U0126 or SB203580 or SP600125, respectively) or genetic silencing of ERK1/2 or p38MAPK by RNAi (Si-ERK1/2 or Si-p38MAPK) significantly prevented CoCl2-induced injuries. Pretreatment with NaHS or NAC inhibited not only CoCl2-induced ROS production, but also phosphorylation of ERK1/2 and p38MAPK. Thus, we demonstrated that a concurrent activation of ERK1/2, p38MAPK and JNK participates in CoCl2-induced injuries and that H2S protects PC12 cells against chemical hypoxia-induced injuries by inhibition of ROS-activated ERK1/2 and p38MAPK pathways. Our results suggest that inhibitors of ERK1/2, p38MAPK and JNK or antioxidants may be useful for preventing and treating hypoxia-induced neuronal injury.	[Lan, Aiping; Yang, Chuntao; Yang, Zhanli; Wang, Xiuyu; Hu, Fen; Chen, Peixi; Feng, Jianqiang] Sun Yat Sen Univ, Dept Physiol, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China; [Liao, Xinxue; Zheng, Dongdan] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Cardiovasol, Guangzhou 510275, Guangdong, Peoples R China; [Mo, Liqiu; Xiao, Liangcan] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Anesthesiol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Lan, AP (corresponding author), Sun Yat Sen Univ, Dept Physiol, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China.	xiaoliangcan@hotmail.com	Yang, Chuntao/AAF-7687-2019; Zhuang, xiaodong/GPW-7235-2022; Yang, Zhan/GQG-9995-2022; lan, A/HHZ-6588-2022	Yang, Chuntao/0000-0002-5640-0930; Zhuang, xiaodong/0000-0001-6508-8507; 	Science and Technology Planning Project of Guangdong Province in China [2010B080701035, 2008B080703053]	Science and Technology Planning Project of Guangdong Province in China	This work was supported by Science and Technology Planning Project of Guangdong Province in China (2010B080701035, 2008B080703053). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 1996, J NEUROSCI, V16, P1066; Alessandrini A, 1999, P NATL ACAD SCI USA, V96, P12866, DOI 10.1073/pnas.96.22.12866; Ballif BA, 2001, CELL GROWTH DIFFER, V12, P397; Banno Y, 2001, NEUROREPORT, V12, P2271, DOI 10.1097/00001756-200107200-00045; Cao YJ, 2001, GENE THER, V8, P1357, DOI 10.1038/sj.gt.3301536; Chen L, 2009, INT J BIOCHEM CELL B, V41, P1284, DOI 10.1016/j.biocel.2008.10.029; Eto K, 2002, J NEUROSCI, V22, P3386; Furne J, 2008, AM J PHYSIOL-REG I, V295, pR1479, DOI 10.1152/ajpregu.90566.2008; Gaitanaki C, 2007, J EXP BIOL, V210, P2267, DOI 10.1242/jeb.003178; Geng B, 2004, BIOCHEM BIOPH RES CO, V318, P756, DOI 10.1016/j.bbrc.2004.04.094; GOLDBERG MA, 1988, SCIENCE, V242, P1412, DOI 10.1126/science.2849206; Harper SJ, 2001, CELL SIGNAL, V13, P299, DOI 10.1016/S0898-6568(01)00148-6; Hu LF, 2007, J NEUROCHEM, V100, P1121, DOI 10.1111/j.1471-4159.2006.04283.x; Hu LF, 2009, MOL PHARMACOL, V75, P27, DOI 10.1124/mol.108.047985; Huang Y, 2003, LEUKEMIA, V17, P2065, DOI 10.1038/sj.leu.2403141; Ishigami M, 2009, ANTIOXID REDOX SIGN, V11, P205, DOI [10.1089/ars.2008.2132, 10.1089/ARS.2008.2132]; Kim EJ, 2008, ARTERIOSCL THROM VAS, V28, P1796, DOI 10.1161/ATVBAHA.108.171546; Kimura H, 2002, MOL NEUROBIOL, V26, P13, DOI 10.1385/MN:26:1:013; Kimura H, 2000, BIOCHEM BIOPH RES CO, V267, P129, DOI 10.1006/bbrc.1999.1915; Kimura Y, 2004, FASEB J, V18, P1165, DOI 10.1096/fj.04-1815fje; Kimura Y, 2010, ANTIOXID REDOX SIGN, V12, P1, DOI 10.1089/ars.2008.2282; Kulisz A, 2002, AM J PHYSIOL-LUNG C, V282, pL1324, DOI 10.1152/ajplung.00326.2001; Laggner H, 2007, FREE RADICAL RES, V41, P741, DOI 10.1080/10715760701263265; Lee SW, 2006, GLIA, V54, P116, DOI 10.1002/glia.20362; Lee YJ, 2003, EXP CELL RES, V291, P251, DOI 10.1016/S0014-4827(03)00391-4; Lin A, 2003, BIOESSAYS, V25, P17, DOI 10.1002/bies.10204; Liu AL, 2009, EXP TOXICOL PATHOL, V61, P137, DOI 10.1016/j.etp.2008.06.004; Lu M, 2008, FREE RADICAL BIO MED, V45, P1705, DOI 10.1016/j.freeradbiomed.2008.09.014; Meng JL, 2011, CLIN EXP PHARMACOL P, V38, P42, DOI 10.1111/j.1440-1681.2010.05462.x; Nagai Y, 2004, FASEB J, V18, P557, DOI 10.1096/fj.03-1052fje; Nozaki K, 2001, MOL NEUROBIOL, V23, P1, DOI 10.1385/MN:23:1:01; Nusuetrong P, 2005, EUR J PHARMACOL, V507, P239, DOI 10.1016/j.ejphar.2004.11.046; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Rinaldi L, 2006, LAB INVEST, V86, P391, DOI 10.1038/labinvest.3700391; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Tang XQ, 2008, CLIN EXP PHARMACOL P, V35, P180, DOI 10.1111/j.1440-1681.2007.04799.x; Tang XQ, 2011, NEUROTOX RES, V19, P403, DOI 10.1007/s12640-010-9180-4; Uehara T, 1999, BRAIN RES, V823, P226, DOI 10.1016/S0006-8993(99)01178-6; Wang GC, 2000, NUCLEIC ACIDS RES, V28, P2135, DOI 10.1093/nar/28.10.2135; WANG XY, 1993, ARCH BIOCHEM BIOPHYS, V306, P402, DOI 10.1006/abbi.1993.1529; Whiteman M, 2005, BIOCHEM BIOPH RES CO, V326, P794, DOI 10.1016/j.bbrc.2004.11.110; Whiteman M, 2004, J NEUROCHEM, V90, P765, DOI 10.1111/j.1471-4159.2004.02617.x; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Zou WG, 2002, J NEUROSCI RES, V67, P837, DOI 10.1002/jnr.10168	44	97	111	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25921	10.1371/journal.pone.0025921	http://dx.doi.org/10.1371/journal.pone.0025921			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998720	Green Submitted, Green Published, gold			2022-12-27	WOS:000295966900072
J	Watson, ML; Macrae, K; Marley, AE; Hundal, HS				Watson, Maria L.; Macrae, Katherine; Marley, Anna E.; Hundal, Harinder S.			Chronic Effects of Palmitate Overload on Nutrient-Induced Insulin Secretion and Autocrine Signalling in Pancreatic MIN6 Beta Cells	PLOS ONE			English	Article							FREE FATTY-ACIDS; SKELETAL-MUSCLE CELLS; LONG-TERM EXPOSURE; PROTEIN-KINASE-C; GENE-EXPRESSION; CERAMIDE SYNTHESIS; REGULATED KINASES; COA PATHWAY; MALONYL-COA; LINE INS-1	Background: Sustained exposure of pancreatic beta cells to an increase in saturated fatty acids induces pleiotropic effects on beta-cell function, including a reduction in stimulus-induced insulin secretion. The objective of this study was to investigate the effects of chronic over supply of palmitate upon glucose- and amino acid-stimulated insulin secretion (GSIS and AASIS, respectively) and autocrine-dependent insulin signalling with particular focus on the importance of ceramide, ERK and CaMKII signalling. Principal Findings: GSIS and AASIS were both stimulated by >7-fold resulting in autocrine-dependent activation of protein kinase B (PKB, also known as Akt). Insulin release was dependent upon nutrient-induced activation of calcium/calmodulin-dependent protein kinase II (CaMKII) and extracellular signal-regulated kinase (ERK) as their pharmacological inhibition suppressed GSIS/AASIS significantly. Chronic (48 h, 0.4 mM) palmitate treatment blunted glucose/AA-induced activation of CaMKII and ERK and caused a concomitant reduction (similar to 75%) in GSIS/AASIS and autocrine-dependent activation of PKB. This inhibition could not be attributed to enhanced mitochondrial fatty acid uptake/oxidation or ceramide synthesis, which were unaffected by palmitate. In contrast, diacylglycerol synthesis was elevated suggesting increased palmitate esterification rather than oxidation may contribute to impaired stimulus-secretion coupling. Consistent with this, 2-bromopalmitate, a non-oxidisable palmitate analogue, inhibited GSIS as effectively as palmitate. Conclusions: Our results exclude changes in ceramide content or mitochondrial fatty acid handling as factors initiating palmitate-induced defects in insulin release from MIN6 beta cells, but suggest that reduced CaMKII and ERK activation associated with palmitate overload may contribute to impaired stimulus-induced insulin secretion.	[Watson, Maria L.; Macrae, Katherine; Hundal, Harinder S.] Univ Dundee, Coll Life Sci, Sir James Black Ctr, Div Cell Signalling & Immunol, Dundee, Scotland; [Marley, Anna E.] AstraZeneca, CVGI, Macclesfield, Cheshire, England	University of Dundee; AstraZeneca	Watson, ML (corresponding author), Univ Dundee, Coll Life Sci, Sir James Black Ctr, Div Cell Signalling & Immunol, Dundee, Scotland.	h.s.hundal@dundee.ac.uk	Hundal, Hari/A-8990-2008	Hundal, Hari/0000-0002-7621-4932	Biotechnology and Biological Sciences Research Council-AstraZeneca; European Commission [LSHM-CT-20004-005272]; Diabetes United Kingdom; AstraZeneca	Biotechnology and Biological Sciences Research Council-AstraZeneca(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)AstraZeneca); European Commission(European CommissionEuropean Commission Joint Research Centre); Diabetes United Kingdom(Diabetes UK); AstraZeneca(AstraZeneca)	MW and KM have been supported by Biotechnology and Biological Sciences Research Council-AstraZeneca CASE scholarships. The authors are grateful for financial support from the European Commission (contract LSHM-CT-20004-005272) and Diabetes United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; One of the authors, AM, is an employee of AstraZeneca and two of the other authors, MW and KM, have been supported by funds from AstraZeneca. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Anderwald C, 2007, EUR J CLIN INVEST, V37, P774, DOI 10.1111/j.1365-2362.2007.01858.x; AssimacopoulosJeannet F, 1997, J BIOL CHEM, V272, P1659, DOI 10.1074/jbc.272.3.1659; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Beha A, 2006, AM J PHYSIOL-ENDOC M, V290, pE989, DOI 10.1152/ajpendo.00459.2005; Benes C, 1999, BIOCHEM J, V340, P219, DOI 10.1042/0264-6021:3400219; Biden TJ, 2004, DIABETES, V53, pS159, DOI 10.2337/diabetes.53.2007.S159; Biden TJ, 2008, BIOCHEM SOC T, V36, P916, DOI 10.1042/BST0360916; Bollheimer LC, 1998, J CLIN INVEST, V101, P1094, DOI 10.1172/JCI420; Boslem E, 2011, BIOCHEM J, V435, P267, DOI 10.1042/BJ20101867; Briaud I, 2001, DIABETES, V50, P315, DOI 10.2337/diabetes.50.2.315; Brun T, 1996, DIABETES, V45, P190, DOI 10.2337/diabetes.45.2.190; Brun T, 1997, DIABETES, V46, P393, DOI 10.2337/diabetes.46.3.393; Cantley J, 2009, DIABETES, V58, P1826, DOI 10.2337/db09-0132; Chavez JA, 2003, ARCH BIOCHEM BIOPHYS, V419, P101, DOI 10.1016/j.abb.2003.08.020; Corcoran MP, 2007, AM J CLIN NUTR, V85, P662; DA SX, 2003, BIOCHEM J, V371, P761; Fontes G, 2009, DIABETES, V58, P2048, DOI 10.2337/db08-0579; Gertow K, 2006, EUR J CLIN NUTR, V60, P1406, DOI 10.1038/sj.ejcn.1602471; Gomez E, 2002, J BIOL CHEM, V277, P48146, DOI 10.1074/jbc.M209165200; Hagman DK, 2005, J BIOL CHEM, V280, P32413, DOI 10.1074/jbc.M506000200; Hajduch E, 1998, DIABETES, V47, P1006, DOI 10.2337/diabetes.47.7.1006; Hoppa MB, 2009, CELL METAB, V10, P455, DOI 10.1016/j.cmet.2009.09.011; Iizuka K, 2002, BBA-MOL BASIS DIS, V1586, P23, DOI 10.1016/S0925-4439(01)00082-5; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kelpe CL, 2003, J BIOL CHEM, V278, P30015, DOI 10.1074/jbc.M302548200; Kharroubi I, 2004, ENDOCRINOLOGY, V145, P5087, DOI 10.1210/en.2004-0478; Kowluru A, 2010, DIABETES, V59, P967, DOI 10.2337/db09-1334; Kwan EP, 2006, DIABETES, V55, P1421, DOI 10.2337/db05-1263; Latour MG, 2007, DIABETES, V56, P1087, DOI 10.2337/db06-1532; Longuet C, 2005, ENDOCRINOLOGY, V146, P643, DOI 10.1210/en.2004-0841; Lupi R, 2002, DIABETES, V51, P1437, DOI 10.2337/diabetes.51.5.1437; Maedler K, 2003, DIABETES, V52, P726, DOI 10.2337/diabetes.52.3.726; Marchesini N, 2004, BIOCHEM CELL BIOL, V82, P27, DOI 10.1139/o03-091; McGarry JD, 1999, DIABETOLOGIA, V42, P128, DOI 10.1007/s001250051130; Mynatt RL, 2009, DIABETES-METAB RES, V25, pS45, DOI 10.1002/dmrr.987; Newsholme P, 2010, ADV EXP MED BIOL, V654, P91, DOI 10.1007/978-90-481-3271-3_6; Nolan CJ, 2008, TRENDS ENDOCRIN MET, V19, P285, DOI 10.1016/j.tem.2008.07.006; Nolan CJ, 2006, DIABETES, V55, pS16, DOI 10.2337/db06-S003; PAOLISSO G, 1995, DIABETOLOGIA, V38, P1213, DOI 10.1007/BF00422371; Powell DJ, 2004, BIOCHEM J, V382, P619, DOI 10.1042/BJ20040139; Prentki M, 1996, DIABETES, V45, P273, DOI 10.2337/diabetes.45.3.273; Roduit R, 2004, DIABETES, V53, P1007, DOI 10.2337/diabetes.53.4.1007; Shimabukuro M, 1998, J BIOL CHEM, V273, P32487, DOI 10.1074/jbc.273.49.32487; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Stein DT, 1996, J CLIN INVEST, V97, P2728, DOI 10.1172/JCI118727; Thorens B, 2003, PFLUG ARCH EUR J PHY, V445, P482, DOI 10.1007/s00424-002-0954-2; Thorn K, 2010, J CELL BIOCHEM, V111, P497, DOI 10.1002/jcb.22734; Tuunanen Helena, 2008, Curr Cardiol Rep, V10, P142, DOI 10.1007/s11886-008-0024-2; Unger RH, 2001, DIABETES, V50, pS118, DOI 10.2337/diabetes.50.2007.S118; Watson ML, 2009, BIOCHEM J, V417, P791, DOI 10.1042/BJ20081149; Yoshikawa H, 2001, METABOLISM, V50, P613, DOI 10.1053/meta.2001.22565; ZHOU YP, 1994, J CLIN INVEST, V93, P870, DOI 10.1172/JCI117042; ZHOU YP, 1995, DIABETES, V44, P394, DOI 10.2337/diabetes.44.4.394	53	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25975	10.1371/journal.pone.0025975	http://dx.doi.org/10.1371/journal.pone.0025975			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998735	Green Published, Green Submitted, gold			2022-12-27	WOS:000295966900085
J	Wessa, P; De Rycker, A; Holliday, IE				Wessa, Patrick; De Rycker, Antoon; Holliday, Ian Edward			Content-Based VLE Designs Improve Learning Efficiency in Constructivist Statistics Education	PLOS ONE			English	Article							ENVIRONMENTS	Background: We introduced a series of computer-supported workshops in our undergraduate statistics courses, in the hope that it would help students to gain a deeper understanding of statistical concepts. This raised questions about the appropriate design of the Virtual Learning Environment (VLE) in which such an approach had to be implemented. Therefore, we investigated two competing software design models for VLEs. In the first system, all learning features were a function of the classical VLE. The second system was designed from the perspective that learning features should be a function of the course's core content (statistical analyses), which required us to develop a specific-purpose Statistical Learning Environment (SLE) based on Reproducible Computing and newly developed Peer Review (PR) technology. Objectives: The main research question is whether the second VLE design improved learning efficiency as compared to the standard type of VLE design that is commonly used in education. As a secondary objective we provide empirical evidence about the usefulness of PR as a constructivist learning activity which supports non-rote learning. Finally, this paper illustrates that it is possible to introduce a constructivist learning approach in large student populations, based on adequately designed educational technology, without subsuming educational content to technological convenience. Methods: Both VLE systems were tested within a two-year quasi-experiment based on a Reliable Nonequivalent Group Design. This approach allowed us to draw valid conclusions about the treatment effect of the changed VLE design, even though the systems were implemented in successive years. The methodological aspects about the experiment's internal validity are explained extensively. Results: The effect of the design change is shown to have substantially increased the efficiency of constructivist, computer-assisted learning activities for all cohorts of the student population under investigation. The findings demonstrate that a content-based design outperforms the traditional VLE-based design.	[Wessa, Patrick] Univ Leuven, Leuven Inst Res Informat Syst, Louvain, Belgium; [De Rycker, Antoon] Taylors Univ, Sch Commun, Subang Jaya, Malaysia; [Holliday, Ian Edward] Aston Univ, Sch Life & Hlth Sci, Aston Brain Ctr, Birmingham B4 7ET, W Midlands, England	KU Leuven; Taylor's University; Aston University	Wessa, P (corresponding author), Univ Leuven, Leuven Inst Res Informat Syst, Louvain, Belgium.	patrick@wessa.net			K.U. Leuven Association [OOF 2007/13]	K.U. Leuven Association	This research was funded by the OOF 2007/13 project of the K.U. Leuven Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cook T.C., 1979, QUASIEXPERIMENTATION; DELEEUW J, 2001, DEP STAT PAPERS; DONOHO DL, 2004, INT J WAVELETS MULTI, V2, P391, DOI DOI 10.1142/S0219691304000615; EGGEN P, 2001, ED PSYCHOL WINDOWS C; Fetterman D. M., 1982, EDUC EVAL POLICY AN, V4, P261; Fox J, 2005, J STAT SOFTW, V14; Garcia E, 2011, INTERNET HIGH EDUC, V14, P77, DOI 10.1016/j.iheduc.2010.07.006; GENTLEMAN R, 2005, APPL REPROD RES SCI; GREEN PJ, 2003, DIVERSITIES GIFTS SA, P423; Gress CLZ, 2010, COMPUT HUM BEHAV, V26, P806, DOI 10.1016/j.chb.2007.05.012; Harris AD, 2006, J AM MED INFORM ASSN, V13, P16, DOI 10.1197/jamia.M1749; HILL T, 2007, STATISTICS METHODS A; HORNIK Z, 2009, RWEKA R INTERFACE WE; Kampenes VB, 2009, INFORM SOFTWARE TECH, V51, P71, DOI 10.1016/j.infsof.2008.04.006; Khoshgoftaar T. M., 2000, Empirical Software Engineering, V5, P313, DOI 10.1023/A:1009896203228; Khoshgoftaar TM, 2002, IEEE T RELIAB, V51, P455, DOI 10.1109/TR.2002.804488; Koenker R., 2007, RES REPORT SERIES DE; Krause UM, 2009, LEARN INSTR, V19, P158, DOI 10.1016/j.learninstruc.2008.03.003; LAM JA, 1994, CRITICALLY EVALUATIN, V63; Leisch F., 2003, P 3 INT WORKSH DISTR; Lipsey MW, 2000, ANNU REV PSYCHOL, V51, P345, DOI 10.1146/annurev.psych.51.1.345; Liu N, 2009, LECT NOTES COMPUT SC, V5618, P650, DOI 10.1007/978-3-642-02559-4_71; Lundstrom K, 2009, J SECOND LANG WRIT, V18, P30, DOI 10.1016/j.jslw.2008.06.002; Meelissen MRM, 2008, COMPUT HUM BEHAV, V24, P969, DOI 10.1016/j.chb.2007.03.001; *MOODL, 2008, FREE OP SOURC COURS; Peng RD, 2006, AM J EPIDEMIOL, V163, P783, DOI 10.1093/aje/kwj093; Poelmans S., 2009, INT C P ED NEW LEARN, P5882; R Core Team, 2018, R LANG ENV STAT COMP; Romero C, 2008, COMPUT EDUC, V51, P368, DOI 10.1016/j.compedu.2007.05.016; Schwab M, 2000, COMPUT SCI ENG, V2, P61, DOI 10.1109/5992.881708; SJOEBERG S, 2010, INT ENCY ED, P485, DOI DOI 10.1016/B978-0-08-044894-7.00467-X; SMITH E, 1999, J MATH BEHAV, V17, P411; Stricker D, 2011, COMPUT EDUC, V56, P495, DOI 10.1016/j.compedu.2010.09.012; Strijbos JW, 2010, LEARN INSTR, V20, P265, DOI 10.1016/j.learninstruc.2009.08.002; Taylor P., 2000, TEACHING; Trochim W.M., 2006, RES METHODS KNOWLEDG; von Glasersfeld E., 1987, PROBLEMS REPRESENTAT, P3; WESSA P, 2008, STAT COMPUTATIONS AR; WESSA P, 2009, WORKSH APPL STAT C; WESSA P, IAENG T ENG TECHNOLO, V2, P86; WESSA P, 2010, FREE STAT SOFTWARE; Wessa P, 2008, PROC INT C VIRTUAL L, P91; Wessa P, 2010, PROCEEDINGS OF THE 5TH INTERNATIONAL CONFERENCE ON E-LEARNING, P408; Wessa P, 2009, ELECTRON J E-LEARN, V7, P173; Wessa P, 2009, INT J COMPUT COMMUN, V4, P185, DOI 10.15837/ijccc.2009.2.2426; Wilson S, 2007, J E-LEARN KNOWL SOC, V3, P27; Witten I. H., 2005, DATA MINING PRACTICA	47	10	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25363	10.1371/journal.pone.0025363	http://dx.doi.org/10.1371/journal.pone.0025363			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834NA	21998652	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000295966900021
J	Wong, HE; Kwon, I				Wong, H. Edward; Kwon, Inchan			Xanthene Food Dye, as a Modulator of Alzheimer's Disease Amyloid-beta Peptide Aggregation and the Associated Impaired Neuronal Cell Function	PLOS ONE			English	Article							MTT FORMAZAN EXOCYTOSIS; MASS-PER-LENGTH; A-BETA; IN-VIVO; NEUROBLASTOMA-CELLS; FIBRILLAR OLIGOMERS; COMMON MECHANISM; TOXICITY; INHIBITORS; REDUCTION	Background: Alzheimer's disease (AD) is the most common form of dementia. AD is a degenerative brain disorder that causes problems with memory, thinking and behavior. It has been suggested that aggregation of amyloid-beta peptide (A beta) is closely linked to the development of AD pathology. In the search for safe, effective modulators, we evaluated the modulating capabilities of erythrosine B (ER), a Food and Drug Administration (FDA)-approved red food dye, on A beta aggregation and A beta-associated impaired neuronal cell function. Methodology/Principal Findings: In order to evaluate the modulating ability of ER on A beta aggregation, we employed transmission electron microscopy (TEM), thioflavin T (ThT) fluorescence assay, and immunoassays using A beta-specific antibodies. TEM images and ThT fluorescence of A beta samples indicate that protofibrils are predominantly generated and persist for at least 3 days. The average length of the ER-induced protofibrils is inversely proportional to the concentration of ER above the stoichiometric concentration of A beta monomers. Immunoassay results using A beta-specific antibodies suggest that ER binds to the N-terminus of A beta and inhibits amyloid fibril formation. In order to evaluate A beta-associated toxicity we determined the reducing activity of SH-SY5Y neuroblastoma cells treated with A beta aggregates formed in the absence or in the presence of ER. As the concentration of ER increased above the stoichiometric concentration of A beta, cellular reducing activity increased and A beta-associated reducing activity loss was negligible at 500 mu M ER. Conclusions/Significance: Our findings show that ER is a novel modulator of A beta aggregation and reduces A beta-associated impaired cell function. Our findings also suggest that xanthene dye can be a new type of small molecule modulator of A beta aggregation. With demonstrated safety profiles and blood-brain permeability, ER represents a particularly attractive aggregation modulator for amyloidogenic proteins associated with neurodegenerative diseases.	[Wong, H. Edward; Kwon, Inchan] Univ Virginia, Dept Chem Engn, Charlottesville, VA 22903 USA; [Kwon, Inchan] Univ Virginia, Inst Aging, Charlottesville, VA USA	University of Virginia; University of Virginia	Wong, HE (corresponding author), Univ Virginia, Dept Chem Engn, Charlottesville, VA 22903 USA.	ik4t@virginia.edu			National Institutes of Neurological Disorders and Stroke [R21NS069946]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS069946] Funding Source: NIH RePORTER	National Institutes of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the National Institutes of Neurological Disorders and Stroke (R21NS069946). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 1998, NEUROSCI RES, V31, P295, DOI 10.1016/S0168-0102(98)00055-8; BORZELLECA JF, 1990, FOOD CHEM TOXICOL, V28, P813, DOI 10.1016/0278-6915(90)90054-Q; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Chen B, 2009, P NATL ACAD SCI USA, V106, P14339, DOI 10.1073/pnas.0907821106; Chen YR, 2006, J BIOL CHEM, V281, P24414, DOI 10.1074/jbc.M602363200; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Datki Z, 2003, BRAIN RES BULL, V62, P223, DOI 10.1016/j.brainresbull.2003.09.011; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Feng Y, 2009, BIOCHEM BIOPH RES CO, V390, P1250, DOI 10.1016/j.bbrc.2009.10.130; Feng Y, 2009, NEUROTOXICOLOGY, V30, P986, DOI 10.1016/j.neuro.2009.08.013; GARDNER DF, 1987, TOXICOL APPL PHARM, V91, P299, DOI 10.1016/0041-008X(87)90052-4; Hamaguchi T, 2006, CELL MOL LIFE SCI, V63, P1538, DOI 10.1007/s00018-005-5599-9; Hawkes CA, 2009, DRUG DEVELOP RES, V70, P111, DOI 10.1002/ddr.20290; Hertel C, 1996, J NEUROCHEM, V67, P272; Hirohashi T, 1997, J PHARMACOL EXP THER, V280, P813; Hu Y, 2010, CHEMBIOCHEM, V11, P2409, DOI 10.1002/cbic.201000435; Iijima K, 2004, P NATL ACAD SCI USA, V101, P6623, DOI 10.1073/pnas.0400895101; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006; Kimura N, 2005, NEUROPATH APPL NEURO, V31, P170, DOI 10.1111/j.1365-2990.2004.00624.x; Klyubin I, 2005, NAT MED, V11, P556, DOI 10.1038/nm1234; Komatsu H, 2010, J BIOL CHEM, V285, P41843, DOI 10.1074/jbc.M110.165068; Ladiwala ARA, 2010, J BIOL CHEM, V285, P24228, DOI 10.1074/jbc.M110.133108; Lee S, 2007, PROTEIN SCI, V16, P723, DOI 10.1110/ps.062514807; LEVINE H, 1999, QUANTIFICATION BETA, P274; LEVITAN H, 1984, BRAIN RES, V322, P131, DOI 10.1016/0006-8993(84)91191-0; Liu YB, 1997, J NEUROCHEM, V69, P2285; McLaurin J, 2000, J BIOL CHEM, V275, P18495, DOI 10.1074/jbc.M906994199; McLaurin J, 2006, NAT MED, V12, P801, DOI 10.1038/nm1423; Moss MA, 2004, MOL PHARMACOL, V66, P592; Nishimura S, 2003, PHARMACOL TOXICOL, V93, P29, DOI 10.1034/j.1600-0773.2003.930104.x; Olivieri G, 2003, NEUROSCIENCE, V120, P659, DOI 10.1016/S0306-4522(03)00342-7; Ono K, 2003, J NEUROCHEM, V87, P172, DOI 10.1046/j.1471-4159.2003.01976.x; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; POLLACK SJ, 1995, NEUROSCI LETT, V197, P211, DOI 10.1016/0304-3940(95)11939-T; Qi W, 2008, BIOTECHNOL BIOENG, V100, P1214, DOI 10.1002/bit.21846; Qi W, 2009, BIOCHEMISTRY-US, V48, P8908, DOI 10.1021/bi9006397; Reinke AA, 2007, CHEM BIOL DRUG DES, V70, P206, DOI 10.1111/j.1747-0285.2007.00557.x; Sarracino R, 2010, COLEC MONOGRAF ACAD, P1; Schmidt M, 2009, P NATL ACAD SCI USA, V106, P19813, DOI 10.1073/pnas.0905007106; Shin HJ, 2000, BBA-PROTEIN STRUCT M, V1481, P139, DOI 10.1016/S0167-4838(00)00106-0; Thakker DR, 2009, P NATL ACAD SCI USA, V106, P4501, DOI 10.1073/pnas.0813404106; Wang SSS, 2001, J BIOL CHEM, V276, P42027, DOI 10.1074/jbc.M102834200; Wu JW, 2010, J BIOL CHEM, V285, P6071, DOI 10.1074/jbc.M109.069542; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200	46	21	21	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25752	10.1371/journal.pone.0025752	http://dx.doi.org/10.1371/journal.pone.0025752			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998691	gold, Green Published			2022-12-27	WOS:000295966900051
J	Yaari, G; Eisenmann, S				Yaari, Gur; Eisenmann, Shmuel			The Hot (Invisible?) Hand: Can Time Sequence Patterns of Success/Failure in Sports Be Modeled as Repeated Random Independent Trials?	PLOS ONE			English	Article							SIMPSONS PARADOX	The long lasting debate initiated by Gilovich, Vallone and Tversky in 1985 is revisited: does a "hot hand" phenomenon exist in sports? Hereby we come back to one of the cases analyzed by the original study, but with a much larger data set: all free throws taken during five regular seasons (2005/6-2009/10) of the National Basketball Association (NBA). Evidence supporting the existence of the "hot hand" phenomenon is provided. However, while statistical traces of this phenomenon are observed in the data, an open question still remains: are these non random patterns a result of "success breeds success" and "failure breeds failure" mechanisms or simply "better" and "worse" periods? Although free throws data is not adequate to answer this question in a definite way, we speculate based on it, that the latter is the dominant cause behind the appearance of the "hot hand" phenomenon in the data.	[Yaari, Gur] Yale Univ, Yale Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Eisenmann, Shmuel] HIL Appl Med, Mishor Yamin, Arava, Israel	Yale University	Yaari, G (corresponding author), Yale Univ, Yale Sch Med, Dept Pathol, New Haven, CT 06520 USA.	gur.yaari@yale.edu	Eisenmann, Shmuel/D-1450-2013; Yaari, Gur/ABD-5122-2021	Eisenmann, Shmuel/0000-0003-1661-7040; Yaari, Gur/0000-0001-9311-9884	Yale University; Hebrew University of Jerusalem; Yale University Faculty of Arts and Sciences High Performance Computing Center	Yale University; Hebrew University of Jerusalem; Yale University Faculty of Arts and Sciences High Performance Computing Center	Yale University and the Hebrew University of Jerusalem supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Steven H. Kleinstein, Jonathan Belmaker and the anonymous reviewers for very useful comments. This work was supported in part by the facilities and staff of the Yale University Faculty of Arts and Sciences High Performance Computing Center.	ALBRIGHT SC, 1993, J AM STAT ASSOC, V88, P1175; Alter AL, 2006, THINK REASONING, V12, P431, DOI 10.1080/13546780600717244; Arkes J, 2010, J QUANT ANAL SPORTS, V6, DOI 10.2202/1559-0410.1198; Bar-Eli M, 2006, PSYCHOL SPORT EXERC, V7, P525, DOI 10.1016/j.psychsport.2006.03.001; Chuang JS, 2009, SCIENCE, V323, P272, DOI 10.1126/science.1166739; Debreu, 1974, J MATH ECON, V1, P15, DOI [DOI 10.1016/0304-4068(74)90032-9, 10.1016/0304-4068(74)90032-9]; Dorsey-Palmateer R, 2004, AM STAT, V58, P38, DOI 10.1198/0003130042809; Duch J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010937; GILOVICH T, 1985, COGNITIVE PSYCHOL, V17, P295, DOI 10.1016/0010-0285(85)90010-6; GODE DK, 1993, J POLIT ECON, V101, P119, DOI 10.1086/261868; Heuer A, 2010, EPL-EUROPHYS LETT, V89, DOI 10.1209/0295-5075/89/38007; Radicchi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017249; Reifman DA, HOT HAND SPORTS; SIMPSON EH, 1951, J ROY STAT SOC B, V13, P238; Sire C, 2009, EUROPEAN PHYS J B, V67, P9; WAGNER CH, 1982, AM STAT, V36, P46, DOI 10.2307/2684093; Wardrop R. L, 1999, STAT TESTS HOT HAND, P1; WARDROP RL, 1995, AM STAT, V49, P24, DOI 10.2307/2684806; WELSH AH, 1988, AM NAT, V132, P277, DOI 10.1086/284850; YATES F, 1984, J ROY STAT SOC A STA, V147, P426, DOI 10.2307/2981577	20	47	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e24532	10.1371/journal.pone.0024532	http://dx.doi.org/10.1371/journal.pone.0024532			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834NA	21998630	gold, Green Submitted, Green Published			2022-12-27	WOS:000295966900003
J	Wardlaw, JM; O'Connell, G; Shuler, K; DeWilde, J; Haley, J; Escobar, O; Murray, S; Rae, R; Jarvie, D; Sandercock, P; Schafer, B				Wardlaw, Joanna M.; O'Connell, Garret; Shuler, Kirsten; DeWilde, Janet; Haley, Jane; Escobar, Oliver; Murray, Shaun; Rae, Robert; Jarvie, Donald; Sandercock, Peter; Schafer, Burkhard			"Can It Read My Mind?" - What Do the Public and Experts Think of the Current (Mis)Uses of Neuroimaging?	PLOS ONE			English	Article							BRAIN; DECADE; COVERAGE; SCIENCE; MEDIA	Emerging applications of neuroimaging outside medicine and science have received intense public exposure through the media. Media misrepresentations can create a gulf between public and scientific understanding of the capabilities of neuroimaging and raise false expectations. To determine the extent of this effect and determine public opinions on acceptable uses and the need for regulation, we designed an electronic survey to obtain anonymous opinions from as wide a range of members of the public and neuroimaging experts as possible. The surveys ran from 1(st) June to 30 September 2010, asked 10 and 21 questions, respectively, about uses of neuroimaging outside traditional medical diagnosis, data storage, science communication and potential methods of regulation. We analysed the responses using descriptive statistics; 660 individuals responded to the public and 303 individuals responded to the expert survey. We found evidence of public skepticism about the use of neuroimaging for applications such as lie detection or to determine consumer preferences and considerable disquiet about use by employers or government and about how their data would be stored and used. While also somewhat skeptical about new applications of neuroimaging, experts grossly underestimated how often neuroimaging had been used as evidence in court. Although both the public and the experts rated highly the importance of a better informed public in limiting the inappropriate uses to which neuroimaging might be put, opinions differed on the need for, and mechanism of, actual regulation. Neuroscientists recognized the risks of inaccurate reporting of neuroimaging capabilities in the media but showed little motivation to engage with the public. The present study also emphasizes the need for better frameworks for scientific engagement with media and public education.	[Wardlaw, Joanna M.; O'Connell, Garret; Shuler, Kirsten; DeWilde, Janet; Sandercock, Peter] Univ Edinburgh, Div Clin Neurosci, Edinburgh, Midlothian, Scotland; [Wardlaw, Joanna M.; Shuler, Kirsten; DeWilde, Janet; Sandercock, Peter] Scottish Imaging Network A Platform Sci Excellenc, Edinburgh, Midlothian, Scotland; [Murray, Shaun; Schafer, Burkhard] Univ Edinburgh, Joseph Bell Ctr Forens Stat & Legal Reasoning, Edinburgh, Midlothian, Scotland; [Murray, Shaun; Schafer, Burkhard] Univ Edinburgh, Shepherd & Wedderburn Ctr Res Intellectual Proper, Edinburgh, Midlothian, Scotland; [Rae, Robert; Jarvie, Donald] Scottish Parliament, Futures Forum, Edinburgh, Midlothian, Scotland; [Escobar, Oliver] Univ Edinburgh, Sch Social & Polit Sci, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh	Wardlaw, JM (corresponding author), Univ Edinburgh, Div Clin Neurosci, Edinburgh, Midlothian, Scotland.	joanna.wardlaw@ed.ac.uk	Wardlaw, Joanna M/Y-3456-2019; Hernandez, María/GYU-3543-2022; Escobar, Oliver/E-5644-2019	Wardlaw, Joanna M/0000-0002-9812-6642; Sandercock, Peter/0000-0001-8484-0135; Haley, Jane/0000-0001-6178-2673; Escobar, Oliver/0000-0002-6628-9359	Scottish Universities Insight Institute; SCRIPT, University of Edinburgh; Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh; Guarantors of Brain; Institute of Physics and Engineering in Medicine (IPEM); SINAPSE (Scottish Imaging Network - A Platform for Scientific Excellence); Scottish Funding Council; AHRC [AH/D502519/1] Funding Source: UKRI; MRC [G0700704] Funding Source: UKRI; Arts and Humanities Research Council [AH/D502519/1] Funding Source: researchfish; Medical Research Council [G0700704] Funding Source: researchfish	Scottish Universities Insight Institute; SCRIPT, University of Edinburgh; Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh; Guarantors of Brain; Institute of Physics and Engineering in Medicine (IPEM); SINAPSE (Scottish Imaging Network - A Platform for Scientific Excellence); Scottish Funding Council; AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was part of three workshops on Imaging in Society funded by the Scottish Universities Insight Institute (www.scottishinsight.ac.uk; no grant number available). The authors gratefully acknowledge funding also received from SCRIPT, University of Edinburgh; The Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh (www.ccace.ed.ac.uk); The Guarantors of Brain; Institute of Physics and Engineering in Medicine (IPEM); and SINAPSE (Scottish Imaging Network - A Platform for Scientific Excellence; funded by the Scottish Funding Council) (www.sinapse.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Rached JM, 2008, EMBO REP, V9, P1158, DOI 10.1038/embor.2008.211; ALLEYNE R, 2011, CHILD BRAIN SCANS PI; [Anonymous], 2010, COMMUNICATION; Ariely D, 2010, NAT REV NEUROSCI, V11, P284, DOI 10.1038/nrn2795; Brown T, 2010, STANFORD LAW REV, V62, P1119; Deslauriers C, 2010, J EMPIR RES HUM RES, V5, P49, DOI 10.1525/jer.2010.5.1.49; Farah MJ, 2009, J COGNITIVE NEUROSCI, V21, P623, DOI 10.1162/jocn.2009.21133; *GEN PUBL POL CTR, 2007, US PUBL OP US GEN IN; GHOSH P, 2010, DREAM RECORDING DEVI; Herculano-Houzel S, 2003, NAT NEUROSCI, V6, P325, DOI 10.1038/nn0403-325; Herculano-Houzel S, 2002, NEUROSCIENTIST, V8, P98, DOI 10.1177/107385840200800206; Hughes V, 2010, NATURE, V464, P340, DOI 10.1038/464340a; Illes J, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00167; Keehner M, 2011, PSYCHON B REV, V18, P422, DOI 10.3758/s13423-010-0048-7; MADRIGAL A, 2009, MRI LIE DETECTION GE, P4; Meixner JB, 2011, PSYCHOPHYSIOLOGY, V48, P149, DOI 10.1111/j.1469-8986.2010.01050.x; O'Connell G, 2011, EMBO REP, V12, P630, DOI 10.1038/embor.2011.115; Racine E, 2006, SCI COMMUN, V28, P122, DOI 10.1177/1075547006291990; Roskies AL, 2007, PHILOS SCI, V74, P860, DOI 10.1086/525627; TAIRYAN K, 2009, NEUROETHICS RESOURCE; Wardlaw JM, 2011, CORTEX, V47, P1147, DOI 10.1016/j.cortex.2011.06.015	21	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e25829	10.1371/journal.pone.0025829	http://dx.doi.org/10.1371/journal.pone.0025829			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834MB	21991367	gold, Green Submitted, Green Published			2022-12-27	WOS:000295963300023
J	Metz, SW; Feenstra, F; Villoing, S; van Hulten, MC; van Lent, JW; Koumans, J; Vlak, JM; Pijlman, GP				Metz, Stefan W.; Feenstra, Femke; Villoing, Stephane; van Hulten, Marielle C.; van Lent, Jan W.; Koumans, Joseph; Vlak, Just M.; Pijlman, Gorben P.			Low Temperature-Dependent Salmonid Alphavirus Glycoprotein Processing and Recombinant Virus-Like Particle Formation	PLOS ONE			English	Article							SEMLIKI-FOREST-VIRUS; EQUINE ENCEPHALITIS-VIRUS; NUCLEAR POLYHEDROSIS-VIRUS; SWINE-FEVER VIRUS; PANCREAS DISEASE; ATLANTIC SALMON; SPODOPTERA-FRUGIPERDA; NUCLEOCAPSID PROTEIN; BACULOVIRUS VECTORS; SLEEPING-DISEASE	Pancreas disease (PD) and sleeping disease (SD) are important viral scourges in aquaculture of Atlantic salmon and rainbow trout. The etiological agent of PD and SD is salmonid alphavirus (SAV), an unusual member of the Togaviridae (genus Alphavirus). SAV replicates at lower temperatures in fish. Outbreaks of SAV are associated with large economic losses of similar to 17 to 50 million $/year. Current control strategies rely on vaccination with inactivated virus formulations that are cumbersome to obtain and have intrinsic safety risks. In this research we were able to obtain non-infectious virus-like particles (VLPs) of SAV via expression of recombinant baculoviruses encoding SAV capsid protein and two major immunodominant viral glycoproteins, E1 and E2 in Spodoptera frugiperda Sf9 insect cells. However, this was only achieved when a temperature shift from 27 degrees C to lower temperatures was applied. At 27 degrees C, precursor E2 (PE2) was misfolded and not processed by host furin into mature E2. Hence, E2 was detected neither on the surface of infected cells nor as VLPs in the culture fluid. However, when temperatures during protein expression were lowered, PE2 was processed into mature E2 in a temperature-dependent manner and VLPs were abundantly produced. So, temperature shift-down during synthesis is a prerequisite for correct SAV glycoprotein processing and recombinant VLP production.	[Metz, Stefan W.; Feenstra, Femke; van Lent, Jan W.; Vlak, Just M.; Pijlman, Gorben P.] Wageningen Univ, Virol Lab, Wageningen, Netherlands; [Villoing, Stephane] Intervet Norbio, Bergen, Norway; [van Hulten, Marielle C.; Koumans, Joseph] Intervet Int BV, Boxmeer, Netherlands	Wageningen University & Research; Merck & Company; Intervet International B.V.	Metz, SW (corresponding author), Wageningen Univ, Virol Lab, Wageningen, Netherlands.	gorben.pijlman@wur.nl	Metz, Stefan/J-1974-2019	Metz, Stefan/0000-0002-9249-2844; Pijlman, Gorben/0000-0001-9301-0408	Intervet International	Intervet International(Merck & CompanyIntervet International B.V.)	Intervet International provided limited funding to GP to compensate consumable costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar PV, 2007, J VIROL, V81, P3866, DOI 10.1128/JVI.02075-06; Akahata W, 2010, NAT MED, V16, P334, DOI 10.1038/nm.2105; Benmansour A, 1997, DEV BIOLOGICALS, V90, P279; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Bostock J, 2010, PHILOS T R SOC B, V365, P2897, DOI 10.1098/rstb.2010.0170; BOUCHER P, 1995, DIS AQUAT ORGAN, V22, P19, DOI 10.3354/dao022019; Boucher P, 1996, J FISH DIS, V19, P303, DOI 10.1111/j.1365-2761.1996.tb00708.x; Bouma A, 1999, VET MICROBIOL, V66, P101, DOI 10.1016/S0378-1135(99)00003-6; Cox MMJ, 2009, BIOLOGICALS, V37, P182, DOI 10.1016/j.biologicals.2009.02.014; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Desvignes L, 2002, FISH SHELLFISH IMMUN, V12, P77, DOI 10.1006/fsim.2001.0356; FROST P, 1995, J GEN VIROL, V76, P1165, DOI 10.1099/0022-1317-76-5-1165; Gibbons DL, 2000, J VIROL, V74, P7772, DOI 10.1128/JVI.74.17.7772-7780.2000; Hodgson LA, 1999, VACCINE, V17, P1151, DOI 10.1016/S0264-410X(98)00335-1; HOUGHTON G, 1995, DIS AQUAT ORGAN, V22, P193, DOI 10.3354/dao022193; HOUGHTON G, 1994, DIS AQUAT ORGAN, V18, P109, DOI 10.3354/dao018109; Kaba SA, 2004, J VIROL METHODS, V122, P113, DOI 10.1016/j.jviromet.2004.07.006; Karlsson M., 2010, APPL INNOVATION MANA, P1; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kost TA, 2005, NAT BIOTECHNOL, V23, P567, DOI 10.1038/nbt1095; Kuhn R, 2007, FIELDS VIROLOGY, P1001; Li L, 2010, NATURE, V468, P705, DOI 10.1038/nature09546; Lidbury BA, 2008, J INFECT DIS, V197, P1585, DOI 10.1086/587841; Linn ML, 2001, J VIROL, V75, P4103, DOI 10.1128/JVI.75.9.4103-4109.2001; LOBIGS M, 1990, J VIROL, V64, P4346, DOI 10.1128/JVI.64.9.4346-4355.1990; Lopez-Doriga MV, 2001, FISH SHELLFISH IMMUN, V11, P505, DOI 10.1006/fsim.2000.0330; Makela AR, 2006, ADV VIRUS RES, V68, P91, DOI 10.1016/S0065-3527(06)68003-2; McLoughlin MF, 2007, J FISH DIS, V30, P511, DOI 10.1111/j.1365-2761.2007.00848.x; McLoughlin MF, 1996, DIS AQUAT ORGAN, V26, P117, DOI 10.3354/dao026117; Metz SW, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-353; Metz SW, 2011, J INVERTEBR PATHOL, V107, pS16, DOI 10.1016/j.jip.2011.05.002; MICHEL MR, 1990, J VIROL, V64, P5123, DOI 10.1128/JVI.64.10.5123-5131.1990; Mitchell C, 1997, VIRUS RES, V47, P67, DOI 10.1016/S0168-1702(96)01408-6; Moriette C, 2006, J VIROL, V80, P4088, DOI 10.1128/JVI.80.8.4088-4098.2006; Moriette C, 2005, J GEN VIROL, V86, P3119, DOI 10.1099/vir.0.81030-0; Mulvey M, 1996, VIROLOGY, V219, P125, DOI 10.1006/viro.1996.0229; NELSON RT, 1995, DIS AQUAT ORGAN, V22, P25, DOI 10.3354/dao022025; OKERBLOM C, 1989, J VIROL, V63, P1256, DOI 10.1128/JVI.63.3.1256-1264.1989; Ozden S, 2008, J BIOL CHEM, V283, P21899, DOI 10.1074/jbc.M802444200; Paavonen J, 2008, ANN MED, V40, P162, DOI 10.1080/07853890701802404; Parker MD, 2010, J VIROL, V84, P12683, DOI 10.1128/JVI.01345-10; Petterson E, 2009, J FISH DIS, V32, P477, DOI 10.1111/j.1365-2761.2009.01038.x; Pijlman GP, 2002, J VIROL, V76, P5605, DOI 10.1128/JVI.76.11.5605-5611.2002; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; SAIJO T, 2010, VIROL J, V7, P327; Sjoberg M, 2011, J VIROL, V85, P5644, DOI 10.1128/JVI.00130-11; Snow M, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-56; Sommerset I, 2005, EXPERT REV VACCINES, V4, P89, DOI 10.1586/14760584.4.1.89; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Suzuki N, 2005, APPL ENVIRON MICROB, V71, P8472, DOI 10.1128/AEM.71.12.8472-8480.2005; van Oers MM, 2001, J BIOTECHNOL, V86, P31, DOI 10.1016/S0168-1656(00)00403-X; van Oers MM, 2006, ADV VIRUS RES, V68, P193, DOI 10.1016/S0065-3527(06)68006-8; VANLENT JWM, 1990, ARCH VIROL, V111, P103, DOI 10.1007/BF01310508; Vialard J E, 1995, Methods Mol Biol, V39, P1; VLAK JM, 1979, J INVERTEBR PATHOL, V34, P110, DOI 10.1016/0022-2011(79)90089-2; WAHLBERG JM, 1989, J VIROL, V63, P4991, DOI 10.1128/JVI.63.12.4991-4997.1989; Westenberg M, 2002, J VIROL, V76, P178, DOI 10.1128/JVI.76.1.178-184.2002; WHITE J, 1980, P NATL ACAD SCI-BIOL, V77, P3273, DOI 10.1073/pnas.77.6.3273; WRIGHT KE, 1989, VIROLOGY, V171, P417, DOI 10.1016/0042-6822(89)90610-7; ZIEMIECKI A, 1980, J GEN VIROL, V50, P111, DOI 10.1099/0022-1317-50-1-111	60	26	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25816	10.1371/journal.pone.0025816	http://dx.doi.org/10.1371/journal.pone.0025816			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991361	Green Published, Green Submitted, gold			2022-12-27	WOS:000295943000077
J	Mar, JC; Matigian, NA; Quackenbush, J; Wells, CA				Mar, Jessica C.; Matigian, Nicholas A.; Quackenbush, John; Wells, Christine A.			attract: A Method for Identifying Core Pathways That Define Cellular Phenotypes	PLOS ONE			English	Article							SET ENRICHMENT ANALYSIS; GENE	attract is a knowledge-driven analytical approach for identifying and annotating the gene-sets that best discriminate between cell phenotypes. attract finds distinguishing patterns within pathways, decomposes pathways into meta-genes representative of these patterns, and then generates synexpression groups of highly correlated genes from the entire transcriptome dataset. attract can be applied to a wide range of biological systems and is freely available as a Bioconductor package and has been incorporated into the MeV software system.	[Mar, Jessica C.; Quackenbush, John] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Mar, Jessica C.; Quackenbush, John] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Matigian, Nicholas A.; Quackenbush, John; Wells, Christine A.] Griffith Univ, Natl Ctr Adult Stem Cell Res, Eskitis Inst Cell & Mol Therapies, Brisbane, Qld 4111, Australia; [Quackenbush, John] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Wells, Christine A.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld, Australia	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; Griffith University; Harvard University; Dana-Farber Cancer Institute; University of Queensland	Mar, JC (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.	jess@jimmy.harvard.edu; johnq@jimmy.harvard.edu; c.wells@uq.edu.au	Wells, Christine A/A-5071-2010; Matigian, Nicholas A/A-4935-2009; Matigian, Nicholas/AAF-9390-2020	Wells, Christine A/0000-0003-3133-3628; Matigian, Nicholas A/0000-0001-7735-9415; Matigian, Nicholas/0000-0001-7735-9415; Quackenbush, John/0000-0002-2702-5879; Mar, Jessica/0000-0002-5147-9299	US National Human Genome Research Institute [P50-HG004233]; Griffith University; Harvard Club of Australia Foundation; US National Library of Medicine [R01-LM010129]; Australian Research Council [LX0882502]; Australian Stem Cell Centre; National Health and Medical Research Council Australia [481945]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG004233] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010129] Funding Source: NIH RePORTER	US National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Griffith University(Griffith University); Harvard Club of Australia Foundation; US National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Australian Research Council(Australian Research Council); Australian Stem Cell Centre; National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	JQ and JCM are supported by a grant from the US National Human Genome Research Institute (P50-HG004233). JQ is also supported, in part, by a Jackson Memorial Visiting Fellowship from Griffith University (www.griffith.edu.au) and a Harvard Club of Australia Foundation Fellowship (http://hcag.org.au/), and from the US National Library of Medicine (R01-LM010129). CAW is supported by the Australian Research Council (www.arc.gov.au) International linkage scheme (LX0882502), The Australian Stem Cell Centre and the National Health and Medical Research Council Australia (www.nhmrc.gov.au) CDA fellowship (481945). The funders had no role in study design, data collection and analysis, decision to publish or the preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2009, STAT METHODS MED RES, V18, P565, DOI 10.1177/0962280209351908; Jiang Z, 2007, BIOINFORMATICS, V23, P306, DOI 10.1093/bioinformatics/btl599; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Mar JC, 2011, BIOINFORMATICS, V27, P1094, DOI 10.1093/bioinformatics/btr074; Mason MJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-327; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; Niehrs C, 1999, NATURE, V402, P483, DOI 10.1038/990025; Oron AP, 2008, BIOINFORMATICS, V24, P2586, DOI 10.1093/bioinformatics/btn465; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Ulitsky I, 2009, BIOINFORMATICS, V25, P1158, DOI 10.1093/bioinformatics/btp118; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	16	46	47	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e25445	10.1371/journal.pone.0025445	http://dx.doi.org/10.1371/journal.pone.0025445			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022396	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000295981600008
J	Chouhan, B; Denesyuk, A; Heino, J; Johnson, MS; Denessiouk, K				Chouhan, Bhanupratap; Denesyuk, Alexander; Heino, Jyrki; Johnson, Mark S.; Denessiouk, Konstantin			Conservation of the Human Integrin-Type Beta-Propeller Domain in Bacteria	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; STRUCTURAL BASIS; EXTRACELLULAR SEGMENT; MEDIATED ADHESION; CALCIUM-BINDING; ALPHA-SUBUNIT; I-DOMAIN; PROTEIN; EVOLUTION; RECOGNITION	Integrins are heterodimeric cell-surface receptors with key functions in cell-cell and cell-matrix adhesion. Integrin alpha and beta subunits are present throughout the metazoans, but it is unclear whether the subunits predate the origin of multicellular organisms. Several component domains have been detected in bacteria, one of which, a specific 7-bladed beta-propeller domain, is a unique feature of the integrin alpha subunits. Here, we describe a structure-derived motif, which incorporates key features of each blade from the X-ray structures of human alpha IIb beta 3 and alpha V beta 3, includes elements of the FG-GAP/Cage and Ca2+-binding motifs, and is specific only for the metazoan integrin domains. Separately, we searched for the metazoan integrin type beta-propeller domains among all available sequences from bacteria and unicellular eukaryotic organisms, which must incorporate seven repeats, corresponding to the seven blades of the beta-propeller domain, and so that the newly found structure-derived motif would exist in every repeat. As the result, among 47 available genomes of unicellular eukaryotes we could not find a single instance of seven repeats with the motif. Several sequences contained three repeats, a predicted transmembrane segment, and a short cytoplasmic motif associated with some integrins, but otherwise differ from the metazoan integrin alpha subunits. Among the available bacterial sequences, we found five examples containing seven sequential metazoan integrin-specific motifs within the seven repeats. The motifs differ in having one Ca2+-binding site per repeat, whereas metazoan integrins have three or four sites. The bacterial sequences are more conserved in terms of motif conservation and loop length, suggesting that the structure is more regular and compact than those example structures from human integrins. Although the bacterial examples are not full-length integrins, the full-length metazoan-type 7-bladed b-propeller domains are present, and sometimes two tandem copies are found.	[Chouhan, Bhanupratap; Denesyuk, Alexander; Johnson, Mark S.] Abo Akad Univ, Dept Biosci, Turku, Finland; [Chouhan, Bhanupratap; Denessiouk, Konstantin] Univ Turku, Turku Ctr Biotechnol, Turku, Finland; [Heino, Jyrki] Univ Turku, Dept Biochem & Food Chem, Turku, Finland	Abo Akademi University; University of Turku; University of Turku	Chouhan, B (corresponding author), Abo Akad Univ, Dept Biosci, Turku, Finland.	kdenessi@btk.fi		Chouhan, Bhanupratap Singh/0000-0002-3918-5925	Stiftelsens for Abo Akademi Forskningsinstitut, Abo Akademi University Center of Excellence Program in Cell Stress and Aging; Sigrid Juselius Foundation; Joe, Pentti and Tor Borg Memorial Fund; Academy of Finland; National Doctoral Program in Informational and Structural Biology	Stiftelsens for Abo Akademi Forskningsinstitut, Abo Akademi University Center of Excellence Program in Cell Stress and Aging; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Joe, Pentti and Tor Borg Memorial Fund; Academy of Finland(Academy of Finland); National Doctoral Program in Informational and Structural Biology	This work was supported in part by grants from Stiftelsens for Abo Akademi Forskningsinstitut, Abo Akademi University Center of Excellence Program in Cell Stress and Aging, the Sigrid Juselius Foundation, the Joe, Pentti and Tor Borg Memorial Fund, and by the Academy of Finland (Bioinformatics Infrastructure Program of Biocenter Finland and FIRI program). Bhanupratap Chouhan is supported by the National Doctoral Program in Informational and Structural Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adindla S, 2007, INT J BIOL MACROMOL, V41, P454, DOI 10.1016/j.ijbiomac.2007.06.004; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Cock JM, 2010, NATURE, V465, P617, DOI 10.1038/nature09016; CORBI AL, 1987, EMBO J, V6, P4023, DOI 10.1002/j.1460-2075.1987.tb02746.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; CUSTODIO MR, 1995, J EUKARYOT MICROBIOL, V42, P721, DOI 10.1111/j.1550-7408.1995.tb01623.x; DIAMOND MS, 1993, J CELL BIOL, V120, P1031, DOI 10.1083/jcb.120.4.1031; Dominguez DC, 2004, MOL MICROBIOL, V54, P291, DOI 10.1111/j.1365-2958.2004.04276.x; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Herbaud ML, 1998, BBA-MOL CELL RES, V1448, P212, DOI 10.1016/S0167-4889(98)00145-1; Huhtala M, 2005, MATRIX BIOL, V24, P83, DOI 10.1016/j.matbio.2005.01.003; Humphries MJ, 2000, BIOCHEM SOC T, V28, P311, DOI 10.1042/0300-5127:0280311; HUTCHINSON EG, 1994, PROTEIN SCI, V3, P2207, DOI 10.1002/pro.5560031206; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Jenkins C, 2002, GENOME BIOL, V3; Johnson MS, 2009, BBA-BIOMEMBRANES, V1788, P779, DOI 10.1016/j.bbamem.2008.12.013; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LARSON RS, 1989, J CELL BIOL, V108, P703, DOI 10.1083/jcb.108.2.703; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; May AP, 1999, TRENDS BIOCHEM SCI, V24, P12, DOI 10.1016/S0968-0004(98)01310-3; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Norris V, 1996, J BACTERIOL, V178, P3677, DOI 10.1128/jb.178.13.3677-3682.1996; Ouali M, 2000, PROTEIN SCI, V9, P1162, DOI 10.1110/ps.9.6.1162; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; Quistgaard EM, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-46; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; Rigden DJ, 2004, J MOL BIOL, V343, P971, DOI 10.1016/j.jmb.2004.08.077; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Ruiz-Trillo I, 2006, J EUKARYOT MICROBIOL, V53, P379, DOI 10.1111/j.1550-7408.2006.00118.x; Sebe-Pedros A, 2010, P NATL ACAD SCI USA, V107, P10142, DOI 10.1073/pnas.1002257107; Shimaoka M, 2003, NAT REV DRUG DISCOV, V2, P703, DOI 10.1038/nrd1174; Springer TA, 1997, P NATL ACAD SCI USA, V94, P65, DOI 10.1073/pnas.94.1.65; Springer TA, 2008, J CELL BIOL, V182, P791, DOI 10.1083/jcb.200801146; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; TISA LS, 1993, J BACTERIOL, V175, P1235, DOI 10.1128/JB.175.5.1235-1238.1993; Tulla M, 2007, FEBS LETT, V581, P2434, DOI 10.1016/j.febslet.2007.04.054; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xie C, 2010, EMBO J, V29, P666, DOI 10.1038/emboj.2009.367; Xiong JP, 2009, J CELL BIOL, V186, P589, DOI 10.1083/jcb.200905085; Xiong JP, 2004, J BIOL CHEM, V279, P40252, DOI 10.1074/jbc.C400362200; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Zhao YH, 2005, P NATL ACAD SCI USA, V102, P5744, DOI 10.1073/pnas.0501782102; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018	50	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e25069	10.1371/journal.pone.0025069	http://dx.doi.org/10.1371/journal.pone.0025069			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022374	Green Published, Green Submitted, gold			2022-12-27	WOS:000295978600009
J	Gori, M; Sciutti, A; Burr, D; Sandini, G				Gori, Monica; Sciutti, Alessandra; Burr, David; Sandini, Giulio			Direct and Indirect Haptic Calibration of Visual Size Judgments	PLOS ONE			English	Article							REACH DISTANCE; PERCEPTION; EXPERIENCE; CONSTANCY; CHILDREN; GRASP; RECALIBRATION; RECOGNITION; DISTORTIONS; ILLUSIONS	It has long been suspected that touch plays a fundamental role in the calibration of visual perception, and much recent evidence supports this idea. However, as the haptic exploration workspace is limited by the kinematics of the body, the contribution of haptic information to the calibration process should occur only within the region of the haptic workspace reachable by a limb (peripersonal space). To test this hypothesis we evaluated visual size perception and showed that it is indeed more accurate inside the peripersonal space. We then show that allowing subjects to touch the (unseen) stimulus after observation restores accurate size perception; the accuracy persists for some time, implying that calibration has occurred. Finally, we show that observing an actor grasp the object also produces accurate (and lasting) size perception, suggesting that the calibration can also occur indirectly by observing goal-directed actions, implicating the involvement of the "mirror system''.	[Gori, Monica; Sciutti, Alessandra; Sandini, Giulio] Ist Italiano Tecnol, Robot Brain & Cognit Sci Dept, Genoa, Italy; [Burr, David] Univ Florence, Dept Psychol, Florence, Italy; [Burr, David] CNR, Ist Neurosci, I-56100 Pisa, Italy	Istituto Italiano di Tecnologia - IIT; University of Florence; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR)	Gori, M (corresponding author), Ist Italiano Tecnol, Robot Brain & Cognit Sci Dept, Genoa, Italy.	monica.gori@iit.it	Gori, Monica/AAS-9963-2021; Gori, Monica/A-1238-2014; Sciutti, Alessandra/E-4291-2017	Gori, Monica/0000-0002-5616-865X; Sciutti, Alessandra/0000-0002-1056-3398; Sandini, Giulio/0000-0003-3324-985X; Burr, David/0000-0003-1541-8832	EC [229445]; Italian Ministry for Universities and Research [PRIN2009]	EC(European CommissionEuropean Commission Joint Research Centre); Italian Ministry for Universities and Research(Ministry of Education, Universities and Research (MIUR))	This study was partially supported by the EC project STANIB (FP7-ERC, n. 229445), and the PRIN2009 grant from the Italian Ministry for Universities and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WJ, 2010, J NEUROSCI, V30, P14745, DOI 10.1523/JNEUROSCI.2749-10.2010; Adams WJ, 2001, NAT NEUROSCI, V4, P1063, DOI 10.1038/nn729; AGLIOTI S, 1995, CURR BIOL, V5, P679, DOI 10.1016/S0960-9822(95)00133-3; Atkins JE, 2003, VISION RES, V43, P2603, DOI 10.1016/S0042-6989(03)00470-X; Atkins JE, 2001, VISION RES, V41, P449, DOI 10.1016/S0042-6989(00)00254-6; Berkeley, 1709, ESSAY NEW THEORY VIS; Bingham GP, 2000, J EXP PSYCHOL HUMAN, V26, P1436, DOI 10.1037//0096-1523.26.4.1436; CARLSON VR, 1962, J EXP PSYCHOL, V63, P68, DOI 10.1037/h0045909; Casile A, 2010, CEREB CORTEX, V20, P1647, DOI 10.1093/cercor/bhp229; Cattaneo L, 2009, ARCH NEUROL-CHICAGO, V66, P557, DOI 10.1001/archneurol.2009.41; Coats R, 2008, EXP BRAIN RES, V189, P211, DOI 10.1007/s00221-008-1418-5; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Ernst MO, 2000, NAT NEUROSCI, V3, P69, DOI 10.1038/71140; Fabbri-Destro M, 2008, PHYSIOLOGY, V23, P171, DOI 10.1152/physiol.00004.2008; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; GENTILUCCI M, 1995, EXP BRAIN RES, V105, P291; GOODALE MA, 1986, NATURE, V320, P748, DOI 10.1038/320748a0; Gori M, 2008, CURR BIOL, V18, P694, DOI 10.1016/j.cub.2008.04.036; Gori M, 2010, CURR BIOL, V20, P223, DOI 10.1016/j.cub.2009.11.069; Granrud CE, 2006, PERCEPT PSYCHOPHYS, V68, P1372, DOI 10.3758/BF03193736; Granrud CE, 2009, ATTEN PERCEPT PSYCHO, V71, P644, DOI 10.3758/APP.71.3.644; Gregory RL, 1999, Q J EXP PSYCHOL-A, V52, P801, DOI 10.1080/027249899390800; Ho YX, 2009, J NEUROPHYSIOL, V101, P2789, DOI 10.1152/jn.91129.2008; Holway AH, 1941, AM J PSYCHOL, V54, P21, DOI 10.2307/1417790; JEANNEROD M, 1984, J MOTOR BEHAV, V16, P235; MARTENIUK RG, 1987, CAN J PSYCHOL, V41, P365, DOI 10.1037/h0084157; MARTENIUK RG, 1990, HUM MOVEMENT SCI, V9, P149, DOI 10.1016/0167-9457(90)90025-9; Mon-Williams M, 2007, J EXP PSYCHOL HUMAN, V33, P645, DOI 10.1037/0096-1523.33.3.645; Norman JF, 1996, J EXP PSYCHOL HUMAN, V22, P173, DOI 10.1037/0096-1523.22.1.173; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Van Doorn GH, 2010, ATTEN PERCEPT PSYCHO, V72, P813, DOI 10.3758/APP.72.3.813; Wallace, 1963, EXP PSYCHOL SOC MONO, V2; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Wijntjes MWA, 2009, EXP BRAIN RES, V193, P639, DOI 10.1007/s00221-009-1713-9	34	28	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e25599	10.1371/journal.pone.0025599	http://dx.doi.org/10.1371/journal.pone.0025599			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834QT	22022420	Green Submitted, Green Published, gold			2022-12-27	WOS:000295978600023
J	Georges, A; Benayoun, BA; Marongiu, M; Dipietromaria, A; L'Hote, D; Todeschini, AL; Auer, J; Crisponi, L; Veitia, RA				Georges, Adrien; Benayoun, Berenice A.; Marongiu, Mara; Dipietromaria, Aurelie; L'Hote, David; Todeschini, Anne-Laure; Auer, Jana; Crisponi, Laura; Veitia, Reiner A.			SUMOylation of the Forkhead Transcription Factor FOXL2 Promotes Its Stabilization/Activation through Transient Recruitment to PML Bodies	PLOS ONE			English	Article							CELL LINE; NUCLEAR; ACTIVATION; PROTEINS; SUMO; LOCALIZATION; EXPRESSION; STRESS; OVARY; IDENTIFICATION	Background: FOXL2 is a transcription factor essential for ovarian development and maintenance. It is mutated in the genetic condition called Blepharophimosis Ptosis Epicantus inversus Syndrome (BPES) and in cases of isolated premature ovarian failure. We and others have previously shown that FOXL2 undergoes several post-translational modifications. Methods and Principal Findings: Here, using cells in culture, we show that interference with FOXL2 SUMOylation leads to a robust inhibition of its transactivation ability, which correlates with a decreased stability. Interestingly, FOXL2 SUMOylation promotes its transient recruitment to subnuclear structures that we demonstrate to be PML (Promyelocytic Leukemia) Nuclear Bodies. Since PML bodies are known to be sites where post-translational modifications of nuclear factors take place, we used tandem mass spectrometry to identify new post-translational modifications of FOXL2. Specifically, we detected four phosphorylated, one sulfated and three acetylated sites. Conclusions: By analogy with other transcription factors, we propose that PML Nuclear Bodies might transiently recruit FOXL2 to the vicinity of locally concentrated enzymes that could be involved in the post-translational maturation of FOXL2. FOXL2 acetylation, sulfation, phosphorylation as well as other modifications yet to be discovered might alter the transactivation capacity of FOXL2 and/or its stability, thus modulating its global intracellular activity.	[Georges, Adrien; Benayoun, Berenice A.; Dipietromaria, Aurelie; L'Hote, David; Todeschini, Anne-Laure; Veitia, Reiner A.] UMR 7592 CNRS Univ Paris Diderot, Inst Jacques Monod, Programme Pathol Mol & Cellulaire, Paris, France; [Georges, Adrien; Benayoun, Berenice A.; Dipietromaria, Aurelie; L'Hote, David; Todeschini, Anne-Laure; Veitia, Reiner A.] Univ Paris 07, Paris, France; [Georges, Adrien] Ecole Normale Super, F-75231 Paris, France; [Marongiu, Mara; Crisponi, Laura] CNR, Ist Ric Genet & Biomed, Cagliari, Italy; [Dipietromaria, Aurelie] Univ Paris 11, Orsay, France; [Auer, Jana] Univ Paris 05, Fac Med Cochin Port Royal, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite	Georges, A (corresponding author), UMR 7592 CNRS Univ Paris Diderot, Inst Jacques Monod, Programme Pathol Mol & Cellulaire, Paris, France.	veitia.reiner@ijm.univ-paris-diderot.fr	Crisponi, Laura/AAC-2642-2019; LHOTE, David/AAD-5390-2020; Benayoun, Bérénice A./K-7048-2012; Georges, Adrien/ABD-6348-2021; Marongiu, Mara/H-9437-2019; L'Hote, David/L-2653-2017	Crisponi, Laura/0000-0001-9128-8537; Benayoun, Bérénice A./0000-0002-7401-4777; Marongiu, Mara/0000-0002-7321-2384; Georges, Adrien/0000-0003-4208-2393; L'Hote, David/0000-0001-5658-5018	AMN/Universite Paris VII; Fondation pour la Recherche Medicale; Universite Paris VII; Consiglio Nationale de la Richerca; Institut National de la Sante et la Recherche Medicale, Centre National de la Recherche Scientifique (CNRS); Universite Paris V; Institut Universitaire de France; Ligue Nationale Contre le Cancer (Comite de Paris); Groupement d'Entreprises Francaises dans la Lutte contre le Cancer; CNRS	AMN/Universite Paris VII; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Universite Paris VII; Consiglio Nationale de la Richerca; Institut National de la Sante et la Recherche Medicale, Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Universite Paris V; Institut Universitaire de France; Ligue Nationale Contre le Cancer (Comite de Paris); Groupement d'Entreprises Francaises dans la Lutte contre le Cancer; CNRS(Centre National de la Recherche Scientifique (CNRS))	AG and BB are supported by an AMN/Universite Paris VII fellowship; AD is supported by the Fondation pour la Recherche Medicale; DL and A-LT are funded by Universite Paris VII; MM and LC are funded by Consiglio Nationale de la Richerca; JA is funded by Institut National de la Sante et la Recherche Medicale, Centre National de la Recherche Scientifique (CNRS) and Universite Paris V; RV is funded by Institut Universitaire de France, Fondation pour la Recherche Medicale, Ligue Nationale Contre le Cancer (Comite de Paris), Groupement d'Entreprises Francaises dans la Lutte contre le Cancer, CNRS and Universite Paris VII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batista F, 2007, P NATL ACAD SCI USA, V104, P3330, DOI 10.1073/pnas.0611326104; Batty E, 2009, FRONT BIOSCI-LANDMRK, V14, P1182, DOI 10.2741/3302; Benayoun BA, 2011, HUM MOL GENET, V20, P1673, DOI 10.1093/hmg/ddr042; Benayoun BA, 2009, TRENDS CELL BIOL, V19, P189, DOI 10.1016/j.tcb.2009.02.003; Benayoun BA, 2009, HUM MOL GENET, V18, P632, DOI 10.1093/hmg/ddn389; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Beysen D, 2008, HUM MOL GENET, V17, P2030, DOI 10.1093/hmg/ddn100; Bundgaard Jens R., 2008, V446, P47, DOI 10.1007/978-1-60327-084-7_4; Caburet S, 2004, J MED GENET, V41, P932, DOI 10.1136/jmg.2004.024356; Ching RW, 2005, J CELL SCI, V118, P847, DOI 10.1242/jcs.01700; Cocquet J, 2002, J MED GENET, V39, P916, DOI 10.1136/jmg.39.12.916; Condemine W, 2006, CANCER RES, V66, P6192, DOI 10.1158/0008-5472.CAN-05-3792; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; Dave KA, 2009, MOL CELL PROTEOMICS, V8, P706, DOI 10.1074/mcp.M800459-MCP200; Ellsworth BS, 2006, MOL ENDOCRINOL, V20, P2796, DOI 10.1210/me.2005-0303; Escudero JM, 2010, J OVARIAN RES, V3, DOI 10.1186/1757-2215-3-4; Garaude J, 2008, J IMMUNOL, V180, P5983, DOI 10.4049/jimmunol.180.9.5983; Garcia-Dominguez M, GENE REGULATORY MECH, V1789, P451; Goodson ML, 2001, J BIOL CHEM, V276, P18513, DOI 10.1074/jbc.M008066200; Harris SE, 2002, MOL HUM REPROD, V8, P729, DOI 10.1093/molehr/8.8.729; Hattori T, 2006, J BIOL CHEM, V281, P14417, DOI 10.1074/jbc.M511330200; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hong YL, 2001, J BIOL CHEM, V276, P40263, DOI 10.1074/jbc.M104714200; Hwang EJ, 2009, BIOCHEM BIOPH RES CO, V378, P513, DOI 10.1016/j.bbrc.2008.11.072; Itahana Y, 2006, MOL CELL BIOL, V26, P4675, DOI 10.1128/MCB.01830-05; Janer A, 2006, J CELL BIOL, V174, P65, DOI 10.1083/jcb.200511045; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kannan N, 2004, PROTEIN SCI, V13, P2059, DOI 10.1110/ps.04637904; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kim HP, 1999, J BIOL CHEM, V274, P37455, DOI 10.1074/jbc.274.52.37455; Kumar A, 2004, MOL VIS, V10, P445; Kuo FT, 2009, CELL SIGNAL, V21, P1935, DOI 10.1016/j.cellsig.2009.09.001; Laissue P, 2009, J MED GENET, V46, P455, DOI 10.1136/jmg.2008.065086; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Lang M, 2010, J CELL SCI, V123, P392, DOI 10.1242/jcs.053496; Lee CC, 2006, CANCER CAUSE CONTROL, V17, P525, DOI 10.1007/s10552-005-9003-8; Lee K, 2005, BIOCHEM BIOPH RES CO, V336, P876, DOI 10.1016/j.bbrc.2005.08.184; Marongiu M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009477; Medzihradszky KF, 2004, MOL CELL PROTEOMICS, V3, P429, DOI 10.1074/mcp.M300140-MCP200; Mo YY, 2004, CANCER RES, V64, P2793, DOI 10.1158/0008-5472.CAN-03-2410; Morris GE, 2008, BBA-MOL CELL RES, V1783, P2108, DOI 10.1016/j.bbamcr.2008.07.016; Moumne L, 2008, HUM MOL GENET, V17, P1010, DOI 10.1093/hmg/ddm373; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; Negorev D, 2001, ONCOGENE, V20, P7234, DOI 10.1038/sj.onc.1204764; Nishi Y, 2001, ENDOCRINOLOGY, V142, P437, DOI 10.1210/en.142.1.437; Oberley LW, 2005, BIOMED PHARMACOTHER, V59, P143, DOI 10.1016/j.biopha.2005.03.006; Ottolenghi C, 2007, HUM MOL GENET, V16, P2795, DOI 10.1093/hmg/ddm235; Pisarska MD, 2011, ENDOCRINOLOGY, V152, P1199, DOI 10.1210/en.2010-1041; Pisarska MD, 2010, AM J PHYSIOL-ENDOC M, V299, pE101, DOI 10.1152/ajpendo.00534.2009; Pisarska MD, 2004, ENDOCRINOLOGY, V145, P3424, DOI 10.1210/en.2003-1141; Sambrook J., 2001, MOL CLONING LAB MANU; Schmidt D, 2004, DEVELOPMENT, V131, P933, DOI 10.1242/dev.00969; Shah SP, 2009, NEW ENGL J MED, V360, P2719, DOI 10.1056/NEJMoa0902542; Stielow B, 2008, MOL CELL, V29, P742, DOI 10.1016/j.molcel.2007.12.032; Strott CA, 2002, ENDOCR REV, V23, P703, DOI 10.1210/er.2001-0040; Sutherland H, 2009, NAT REV GENET, V10, P457, DOI 10.1038/nrg2592; Tao WF, 1999, NAT GENET, V21, P177, DOI 10.1038/5960; Terui Y, 2004, J BIOL CHEM, V279, P28257, DOI 10.1074/jbc.M403153200; Thompson PR, 2001, J BIOL CHEM, V276, P33721, DOI 10.1074/jbc.M104736200; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; Van Damme E, 2010, INT J BIOL SCI, V6, P51, DOI 10.7150/ijbs.6.51; Wojcik C, 2003, INT J BIOCHEM CELL B, V35, P579, DOI 10.1016/S1357-2725(02)00380-1; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; ZLOTOGORA J, 1983, AM J HUM GENET, V35, P1020	65	21	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25463	10.1371/journal.pone.0025463	http://dx.doi.org/10.1371/journal.pone.0025463			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022399	Green Published, Green Submitted, gold			2022-12-27	WOS:000295976000017
J	Pidasheva, S; Trifari, S; Phillips, A; Hackney, JA; Ma, Y; Smith, A; Sohn, SJ; Spits, H; Little, RD; Behrens, TW; Honigberg, L; Ghilardi, N; Clark, HF				Pidasheva, Svetlana; Trifari, Sara; Phillips, Anne; Hackney, Jason A.; Ma, Yan; Smith, Ashley; Sohn, Sue J.; Spits, Hergen; Little, Randall D.; Behrens, Timothy W.; Honigberg, Lee; Ghilardi, Nico; Clark, Hilary F.			Functional Studies on the IBD Susceptibility Gene IL23R Implicate Reduced Receptor Function in the Protective Genetic Variant R381Q	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INFLAMMATORY-BOWEL-DISEASE; ACTIVE CROHNS-DISEASE; ULCERATIVE-COLITIS; SEQUENCE VARIANTS; T-CELLS; CYTOKINE; POPULATION; DISTINCT; POLYMORPHISM	Genome-wide association studies (GWAS) in several populations have demonstrated significant association of the IL23R gene with IBD (Crohn's disease (CD) and ulcerative colitis (UC)) and psoriasis, suggesting that perturbation of the IL-23 signaling pathway is relevant to the pathophysiology of these diseases. One particular variant, R381Q (rs11209026), confers strong protection against development of CD. We investigated the effects of this variant in primary T cells from healthy donors carrying IL23R(R381) and IL23R(Q381) haplotypes. Using a proprietary anti-IL23R antibody, ELISA, flow cytometry, phosphoflow and real-time RT-PCR methods, we examined IL23R expression and STAT3 phosphorylation and activation in response to IL-23. IL23R(Q381) was associated with reduced STAT3 phosphorylation upon stimulation with IL-23 and decreased number of IL-23 responsive T-cells. We also observed slightly reduced levels of proinflammatory cytokine secretion in IL23R(Q381) positive donors. Our study shows conclusively that IL23R(Q381) is a loss-of-function allele, further strengthening the implication from GWAS results that the IL-23 pathway is pathogenic in human disease. This data provides an explanation for the protective role of R381Q in CD and may lead to the development of improved therapeutics for autoimmune disorders like CD.	[Pidasheva, Svetlana; Phillips, Anne; Hackney, Jason A.; Ma, Yan; Clark, Hilary F.] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Pidasheva, Svetlana; Trifari, Sara; Sohn, Sue J.; Spits, Hergen; Ghilardi, Nico; Clark, Hilary F.] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; [Behrens, Timothy W.] Genentech Inc, ITGR Biomarker Discovery Grp, San Francisco, CA 94080 USA; [Smith, Ashley; Honigberg, Lee] Genentech Inc, ITGR Early Dev, San Francisco, CA 94080 USA; [Ghilardi, Nico] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Little, Randall D.] Genizon BioSci Inc, St Laurent, PQ, Canada	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Pidasheva, S (corresponding author), Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA.	svetlana.pidasheva@gmail.com; clark.hilary@gene.com	Spits, Hergen/N-2581-2019; Little, Randall/O-7172-2014	Spits, Hergen/0000-0003-3269-8338; Ghilardi, Nico/0000-0003-4945-3097; Hackney, Jason/0000-0002-5922-563X; Miller, Allison/0000-0003-3816-2251	Genentech; Genizon	Genentech(Roche HoldingGenentech); Genizon	The funders (Genentech and Genizon) did have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, since the authors are employees of these companies.	Abraham C, 2006, INFLAMM BOWEL DIS, V12, P641, DOI 10.1097/01.MIB.0000225332.83861.5f; Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Bernstein CN, 2006, AM J GASTROENTEROL, V101, P1559, DOI 10.1111/j.1572-0241.2006.00603.x; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Capon F, 2007, HUM GENET, V122, P201, DOI 10.1007/s00439-007-0397-0; Chaligne R, 2008, LEUKEMIA, V22, P1557, DOI 10.1038/leu.2008.137; Crellin NK, 2007, J IMMUNOL METHODS, V324, P92, DOI 10.1016/j.jim.2007.05.008; Di Meglio P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017160; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Franke A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000691; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Khader SA, 2009, MUCOSAL IMMUNOL, V2, P403, DOI 10.1038/mi.2009.100; Kuballa P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003391; Lerch-Bader M, 2008, P NATL ACAD SCI USA, V105, P4127, DOI 10.1073/pnas.0711580105; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Loftus CG, 2007, INFLAMM BOWEL DIS, V13, P254, DOI 10.1002/ibd.20029; MALEFYT RDW, 2008, EXPERT REV DERMATOL, V3, pS13; Momozawa Y, 2011, NAT GENET, V43, P43, DOI 10.1038/ng.733; Newman WG, 2009, J CLIN GASTROENTEROL, V43, P444, DOI 10.1097/MCG.0b013e318168bdf0; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Raelson JV, 2007, P NATL ACAD SCI USA, V104, P14747, DOI 10.1073/pnas.0706645104; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Roberts RL, 2007, AM J GASTROENTEROL, V102, P2754, DOI 10.1111/j.1572-0241.2007.01525.x; Rueda B, 2008, ANN RHEUM DIS, V67, P1451, DOI 10.1136/ard.2007.080283; Sandborn WJ, 2008, GASTROENTEROLOGY, V135, P1130, DOI 10.1053/j.gastro.2008.07.014; Sarin R, 2011, P NATL ACAD SCI USA, V108, P9560, DOI 10.1073/pnas.1017854108; Schmechel S, 2008, INFLAMM BOWEL DIS, V14, P204, DOI 10.1002/ibd.20315; Schulz KR, 2007, CURR PROTOC IMMUNOL; Seiderer J, 2008, INFLAMM BOWEL DIS, V14, P437, DOI 10.1002/ibd.20339; Silverberg MS, 2009, NAT GENET, V41, P216, DOI 10.1038/ng.275; Thompson NP, 1996, BRIT MED J, V312, P95; Trifari S, 2006, J IMMUNOL, V177, P7451, DOI 10.4049/jimmunol.177.10.7451; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; TYSK C, 1988, GUT, V29, P990, DOI 10.1136/gut.29.7.990; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Yamazaki K, 2005, HUM MOL GENET, V14, P3499, DOI 10.1093/hmg/ddi379; Yssel Hans, 2002, Curr Protoc Immunol, VChapter 7, DOI 10.1002/0471142735.im0719s47	45	80	86	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25038	10.1371/journal.pone.0025038	http://dx.doi.org/10.1371/journal.pone.0025038			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022372	Green Published, Green Submitted, gold			2022-12-27	WOS:000295976000007
J	Catry, P; Dias, MP; Phillips, RA; Granadeiro, JP				Catry, Paulo; Dias, Maria P.; Phillips, Richard A.; Granadeiro, Jose P.			Different Means to the Same End: Long-Distance Migrant Seabirds from Two Colonies Differ in Behaviour, Despite Common Wintering Grounds	PLOS ONE			English	Article							SHEARWATER CALONECTRIS-DIOMEDEA; CORYS SHEARWATER; PELAGIC SEABIRD; MIGRATION; ALBATROSSES; ISOTOPES; TRACKING; ECOLOGY; SUMMER; OCEAN	Although seabirds that are trans-equatorial migrants show apparently broad overlap among populations in the non-breeding season, such large-scale pattern may conceal subtle but nevertheless key differences in migratory behaviour. These specializations could reflect adaptation to different environments during the breeding season, carry-over effects from the breeding to the nonbreeding period, or asymmetries in competitive ability of birds of different origin. We compared the migratory and wintering behaviour of Cory's shearwaters Calonectris diomedea nesting in Berlengas and in the Selvagens, two colonies in contrasting oceanographic environments, separated by ca. 1200 km. Although no differences were found in winter distribution, there was a marked divergence in timing, route and the use of staging areas during the postbreeding (autumn) migration. Birds from Berlengas typically travelled to oceanic waters in the North Atlantic for an extended stopover, whereas those from Selvagens rarely did so. In the South Atlantic, birds from Selvagens spent more time in flight, perhaps because they had higher energy and nutrient requirements for feather replacement compared to birds from Berlengas, which moult more flight feathers during breeding. Stable isotope analyses of feathers suggested that this variation in activity patterns was unrelated to trophic ecology. Differences in migration routes and stopovers may expose populations to distinct threats, and should be taken into consideration when defining units for conservation purposes and developing appropriate management strategies.	[Catry, Paulo; Dias, Maria P.] ISPA, Ecoethol Res Unit, Lisbon, Portugal; [Phillips, Richard A.] British Antarctic Survey, Nat Environm Res Council, Cambridge CB3 0ET, England; [Granadeiro, Jose P.] Univ Lisbon, CESAM, Museu Nacl Hist Nat, P-1699 Lisbon, Portugal	Instituto Superior Psicologia Aplicada (ISPA); UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Universidade de Lisboa	Catry, P (corresponding author), ISPA, Ecoethol Res Unit, Lisbon, Portugal.	paulo.catry@gmail.com	Dias, Maria/D-1331-2012; Catry, Paulo/I-5408-2013; Granadeiro, José Pedro/E-8060-2011; Dias, Maria/AAK-1171-2021	Catry, Paulo/0000-0003-3000-0522; Granadeiro, José Pedro/0000-0002-7207-3474; Dias, Maria/0000-0002-7281-4391	Fundacao para a Ciencia e a Tecnologia [PTDC/MAR/71927/2006, UID 331/94]; FCT [BPD/46827/08]; NERC [bas0100025] Funding Source: UKRI; Natural Environment Research Council [bas0100025] Funding Source: researchfish	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was financed by Fundacao para a Ciencia e a Tecnologia (www.fct.mctes.pt, Portugal) through Project PTDC/MAR/71927/2006 and as part of the Programa Plurianual (UI&D 331/94). MD benefited from a fellowship from FCT (BPD/46827/08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso H, 2009, J ORNITHOL, V150, P329, DOI 10.1007/s10336-008-0354-2; Bogdanova MI, 2011, P ROY SOC B-BIOL SCI, V278, P2412, DOI 10.1098/rspb.2010.2601; Brothers N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012491; Catry P, 2011, J ORNITHOL, V152, P549, DOI 10.1007/s10336-010-0616-7; Catry P, 2009, J ORNITHOL, V150, P103, DOI 10.1007/s10336-008-0322-x; Dias MP, 2011, P ROY SOC B-BIOL SCI, V278, P1786, DOI 10.1098/rspb.2010.2114; Egevang C, 2010, P NATL ACAD SCI USA, V107, P2078, DOI 10.1073/pnas.0909493107; Gomez-Diaz E, 2006, MOL PHYLOGENET EVOL, V41, P322, DOI 10.1016/j.ympev.2006.05.006; Gomez-Diaz E, 2009, MAR ECOL PROG SER, V382, P197, DOI 10.3354/meps07974; Gonzalez-Solis J, 2007, FRONT ECOL ENVIRON, V5, P297, DOI 10.1890/1540-9295(2007)5[297:TMAMIT]2.0.CO;2; Granadeiro JP, 2006, WATERBIRDS, V29, P56, DOI 10.1675/1524-4695(2006)29[56:NAPTOC]2.0.CO;2; Granadeiro JP, 1998, ANIM BEHAV, V56, P1169, DOI 10.1006/anbe.1998.0827; Gremillet D, 2009, MAR ECOL PROG SER, V391, P121, DOI 10.3354/meps08212; Inger R, 2008, IBIS, V150, P447, DOI 10.1111/j.1474-919X.2008.00839.x; Lecoq Miguel, 2010, Airo, V20, P36; Marra PP, 1998, SCIENCE, V282, P1884, DOI 10.1126/science.282.5395.1884; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Paiva VH, 2010, MAR BIOL, V157, P1385, DOI 10.1007/s00227-010-1417-5; Phillips RA, 2007, MAR ECOL PROG SER, V345, P281, DOI 10.3354/meps06991; Phillips RA, 2004, P ROY SOC B-BIOL SCI, V271, P1283, DOI 10.1098/rspb.2004.2718; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; Ramos R, 2009, OECOLOGIA, V160, P97, DOI 10.1007/s00442-008-1273-x; Rayner MJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1330; Ristow D, 2000, CONDOR, V102, P696, DOI 10.1650/0010-5422(2000)102[0696:STOCSS]2.0.CO;2; Shaffer SA, 2001, FUNCT ECOL, V15, P203, DOI 10.1046/j.1365-2435.2001.00514.x; Shaffer SA, 2006, P NATL ACAD SCI USA, V103, P12799, DOI 10.1073/pnas.0603715103; Wakefield ED, 2011, ECOL MONOGR, V81, P141, DOI 10.1890/09-0763.1; Young LC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007623	28	46	49	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e26079	10.1371/journal.pone.0026079	http://dx.doi.org/10.1371/journal.pone.0026079			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022513	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000295973200031
J	Larsen, L; Rosenstierne, MW; Gaarn, LW; Bagge, A; Pedersen, L; Dahmcke, CM; Nielsen, JH; Dalgaard, LT				Larsen, Louise; Rosenstierne, Maiken W.; Gaarn, Louise W.; Bagge, Annika; Pedersen, Lykke; Dahmcke, Christina M.; Nielsen, Jens H.; Dalgaard, Louise T.			Expression and Localization of microRNAs in Perinatal Rat Pancreas: Role of miR-21 in Regulation of Cholesterol Metabolism	PLOS ONE			English	Article							GENE-EXPRESSION; BETA-CELLS; INSULIN; ALPHA; FETAL; ACTIVATION; SECRETION; GENECODIS; REVEALS; BINDING	Objective: To investigate the expression of pancreatic microRNAs (miRNAs) during the period of perinatal beta-cell expansion and maturation in rats, determine the localization of these miRNAs and perform a pathway analysis with predicted target mRNAs expressed in perinatal pancreas. Research Design and Methods: RNA was extracted from whole pancreas at embryonic day 20 (E20), on the day of birth (P0) and two days after birth (P2) and hybridized to miRNA microarrays. Differentially expressed miRNAs were verified by northern blotting and their pancreatic localization determined by in situ hybridization. Pathway analysis was done using regulated sets of mRNAs predicted as targets of the miRNAs. Possible target genes were tested using reporter-gene analysis in INS-1E cells. Results: Nine miRNAs were differentially expressed perinatally, seven were confirmed to be regulated at the level of the mature miRNA. The localization studies showed endocrine localization of six of these miRNAs (miR-21, -23a, -29a, -125b-5p, -376b-3p and -451), and all were expressed in exocrine cells at one time point at least. Pathways involving metabolic processes, terpenoid and sterol metabolism were selectively affected by concomitant regulation by miRNAs and mRNAs, and Srebf1 was validated as a target of miR-21. Conclusions: The findings suggest that miRNAs are involved in the functional maturation of pancreatic exocrine and endocrine tissue following birth. Pathway analysis of target genes identify changes in sterol metabolism around birth as being selectively affected by differential miRNA expression during this period.	[Larsen, Louise; Rosenstierne, Maiken W.; Gaarn, Louise W.; Nielsen, Jens H.] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; [Pedersen, Lykke] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Rosenstierne, Maiken W.; Bagge, Annika; Dahmcke, Christina M.; Dalgaard, Louise T.] Roskilde Univ, Dept Sci, Roskilde, Denmark	University of Copenhagen; University of Copenhagen; Niels Bohr Institute; Roskilde University	Larsen, L (corresponding author), Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark.	jenshn@sund.ku.dk; ltd@ruc.dk	Bagge, Annika/A-4151-2015; Pedersen, Lykke/AAM-2297-2020; Pedersen, Lykke/J-8049-2012; Dalgaard, Louise/O-3788-2015	Bagge, Annika/0000-0002-3897-9512; Pedersen, Lykke/0000-0002-8935-415X; Pedersen, Lykke/0000-0002-8935-415X; Dalgaard, Louise/0000-0002-3598-2775; Nielsen, Jens Hoiriis/0000-0001-8252-3048	Danish Research Council for Technology and Production; Novo Nordisk Foundation; European Foundation for the Study of Diabetes; Danish microRNA Consortium	Danish Research Council for Technology and Production; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); European Foundation for the Study of Diabetes; Danish microRNA Consortium	These studies were supported by the Danish Research Council for Technology and Production, The Novo Nordisk Foundation, the European Foundation for the Study of Diabetes and the Danish microRNA Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baroukh N, 2007, J BIOL CHEM, V282, P19575, DOI 10.1074/jbc.M611841200; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bennett MK, 2008, J BIOL CHEM, V283, P15628, DOI 10.1074/jbc.M800391200; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Bravo-Egana V, 2008, BIOCHEM BIOPH RES CO, V366, P922, DOI 10.1016/j.bbrc.2007.12.052; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Correa-Medina M, 2009, GENE EXPR PATTERNS, V9, P193, DOI 10.1016/j.gep.2008.12.003; Dillhoff M, 2008, J GASTROINTEST SURG, V12, P2171, DOI 10.1007/s11605-008-0584-x; Dore LC, 2008, P NATL ACAD SCI USA, V105, P3333, DOI 10.1073/pnas.0712312105; Fryirs M, 2009, CURR OPIN LIPIDOL, V20, P159, DOI 10.1097/MOL.0b013e32832ac180; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Haave NC, 2001, METABOLISM, V50, P12, DOI 10.1053/meta.2001.19498; He A, 2007, MOL ENDOCRINOL; HELLERSTROM C, 1984, DIABETOLOGIA, V26, P393; Herrera BM, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-54; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Iwasaki Y, 2009, BIOCHEM BIOPH RES CO, V378, P545, DOI 10.1016/j.bbrc.2008.11.105; Jensen J, 2005, J ENDOCRINOL, V187, P25, DOI 10.1677/joe.1.06086; Johansson M, 2006, J ANAT, V208, P191, DOI 10.1111/j.1469-7580.2006.00520.x; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Jorgensen MC, 2007, ENDOCR REV; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; KAUNG HLC, 1994, DEV DYNAM, V200, P163, DOI 10.1002/aja.1002000208; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Larsson E, 2009, GENOME MED, V1, DOI 10.1186/gm108; Lee EJ, 2007, INT J CANCER, V120, P1046, DOI 10.1002/ijc.22394; Lovis P, 2008, BIOL CHEM, V389, P305, DOI 10.1515/BC.2008.026; Lynn FC, 2007, DIABETES, V56, P2938, DOI 10.2337/db07-0175; Muniyappa MK, 2009, EUR J CANCER, V45, P3104, DOI 10.1016/j.ejca.2009.09.014; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; Oliveros J.C., 2007, VENNY INTERACTIVE TO; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Plaisance V, 2006, J BIOL CHEM, V281, P26932, DOI 10.1074/jbc.M601225200; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Ravnskjaer K, 2006, J MOL ENDOCRINOL, V36, P289, DOI 10.1677/jme.1.01965; Roldo C, 2006, J CLIN ONCOL, V24, P4677, DOI 10.1200/JCO.2005.05.5194; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Seo YK, 2009, P NATL ACAD SCI USA, V106, P13765, DOI 10.1073/pnas.0904246106; SODOYEZGOFFAUX F, 1979, DIABETOLOGIA, V16, P121, DOI 10.1007/BF01225461; Song Lin, 2006, Birth Defects Research, V78, P140, DOI 10.1002/bdrc.20070; Takahashi A, 2005, DIABETES, V54, P492, DOI 10.2337/diabetes.54.2.492; Vikman J, 2009, FASEB J, V23, P58, DOI 10.1096/fj.08-105734; Yamashita T, 2004, ENDOCRINOLOGY	49	28	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e25997	10.1371/journal.pone.0025997	http://dx.doi.org/10.1371/journal.pone.0025997			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022489	Green Published, gold, Green Submitted			2022-12-27	WOS:000295973200026
J	Palmieri, G; Bergamo, P; Luini, A; Ruvo, M; Gogliettino, M; Langella, E; Saviano, M; Hegde, RN; Sandomenico, A; Rossi, M				Palmieri, Gianna; Bergamo, Paolo; Luini, Alberto; Ruvo, Menotti; Gogliettino, Marta; Langella, Emma; Saviano, Michele; Hegde, Ramanath N.; Sandomenico, Annamaria; Rossi, Mose			Acylpeptide Hydrolase Inhibition as Targeted Strategy to Induce Proteasomal Down-Regulation	PLOS ONE			English	Article							OXIDIZED PROTEIN HYDROLASE; CELL LUNG-CARCINOMA; NF-KAPPA-B; SULFOLOBUS-SOLFATARICUS; THERAPEUTIC TARGET; UBIQUITIN SYSTEM; FATTY-ACIDS; DEGRADATION; APOPTOSIS; PATHWAY	Acylpeptide hydrolase (APEH), one of the four members of the prolyl oligopeptidase class, catalyses the removal of N-acylated amino acids from acetylated peptides and it has been postulated to play a key role in protein degradation machinery. Disruption of protein turnover has been established as an effective strategy to down-regulate the ubiquitin-proteasome system (UPS) and as a promising approach in anticancer therapy. Here, we illustrate a new pathway modulating UPS and proteasome activity through inhibition of APEH. To find novel molecules able to down-regulate APEH activity, we screened a set of synthetic peptides, reproducing the reactive-site loop of a known archaeal inhibitor of APEH (SsCEI), and the conjugated linoleic acid (CLA) isomers. A 12-mer SsCEI peptide and the trans10-cis12 isomer of CLA, were identified as specific APEH inhibitors and their effects on cell-based assays were paralleled by a dose-dependent reduction of proteasome activity and the activation of the pro-apoptotic caspase cascade. Moreover, cell treatment with the individual compounds increased the cytoplasm levels of several classic hallmarks of proteasome inhibition, such as NFkappaB, p21, and misfolded or polyubiquitinylated proteins, and additive effects were observed in cells exposed to a combination of both inhibitors without any cytotoxicity. Remarkably, transfection of human bronchial epithelial cells with APEH siRNA, promoted a marked accumulation of a mutant of the cystic fibrosis transmembrane conductance regulator (CFTR), herein used as a model of misfolded protein typically degraded by UPS. Finally, molecular modeling studies, to gain insights into the APEH inhibition by the trans10-cis12 CLA isomer, were performed. Our study supports a previously unrecognized role of APEH as a negative effector of proteasome activity by an unknown mechanism and opens new perspectives for the development of strategies aimed at modulation of cancer progression.	[Palmieri, Gianna; Gogliettino, Marta; Rossi, Mose] Natl Res Council CNR IBP, Inst Prot Biochem, Naples, Italy; [Bergamo, Paolo] Natl Res Council CNR ISA, Inst Food Sci, Avellino, Italy; [Ruvo, Menotti; Langella, Emma; Sandomenico, Annamaria] Natl Res Council CNR IBB, Inst Biostruct & Bioimaging, Naples, Italy; [Saviano, Michele] Natl Council Res Italy CNR IC, Inst Crystallog, Bari, Italy; [Luini, Alberto; Hegde, Ramanath N.] Telethon Inst Genet & Med TIGEM, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto Di Cristallografia (IC-CNR); Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM)	Palmieri, G (corresponding author), Natl Res Council CNR IBP, Inst Prot Biochem, Naples, Italy.	g.palmieri@ibp.cnr.it	Bergamo, Paolo/F-7835-2013; Palmieri, Gianna/AAW-6176-2020; Saviano, Michele/R-1693-2016; Langella, Emma/ABE-6901-2020; Palmieri, Gianna/S-4872-2017; Sandomenico, Annamaria/AAS-4957-2020; Luini, Alberto/L-1372-2013	Bergamo, Paolo/0000-0002-1726-7911; Palmieri, Gianna/0000-0002-9007-4075; Saviano, Michele/0000-0001-5086-2459; Luini, Alberto/0000-0002-8729-2549; Sandomenico, Annamaria/0000-0001-5255-3668; Hegde, Ramanath Narayana/0000-0001-7224-3544; LANGELLA, EMMA/0000-0002-9033-1975	Agenzia Spaziale Italiana [1/014/06/0]	Agenzia Spaziale Italiana(Agenzia Spaziale Italiana (ASI))	fundings for this study were from the project MoMa n. 1/014/06/0 of the Agenzia Spaziale Italiana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnesen T, 2009, P NATL ACAD SCI USA, V106, P8157, DOI 10.1073/pnas.0901931106; Bartlam M, 2004, STRUCTURE, V12, P1481, DOI 10.1016/j.str.2004.05.019; Ben-Saadon R, 2004, J BIOL CHEM, V279, P41414, DOI 10.1074/jbc.M407201200; Bloom J, 2003, CELL, V115, P71, DOI 10.1016/S0092-8674(03)00755-4; BOISSEL JP, 1988, J BIOL CHEM, V263, P8443; Busse A, 2008, CANCER, V112, P659, DOI 10.1002/cncr.23224; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; DECKER T, 1988, J IMMUNOL METHODS, V115, P61, DOI 10.1016/0022-1759(88)90310-9; Drexler HCA, 1997, P NATL ACAD SCI USA, V94, P855, DOI 10.1073/pnas.94.3.855; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Goetze S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000236; Hamel FG, 2009, METABOLISM, V58, P1047, DOI 10.1016/j.metabol.2009.04.005; Hamilton JA, 2004, PROG LIPID RES, V43, P177, DOI 10.1016/j.plipres.2003.09.002; Hideshima T, 2002, J BIOL CHEM, V277, P16639, DOI 10.1074/jbc.M200360200; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; Ichinose Y, 2003, JNCI-J NATL CANCER I, V95, P605, DOI 10.1093/jnci/95.8.605; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Landis-Piwowar KR, 2006, DRUG RESIST UPDATE, V9, P263, DOI 10.1016/j.drup.2006.11.001; Moore HE, 2009, MOL CANCER THER, V8, P762, DOI 10.1158/1535-7163.MCT-08-0735; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Naujokat C, 2000, EUR J HAEMATOL, V65, P221, DOI 10.1034/j.1600-0609.2000.065004221.x; Nencioni A, 2007, LEUKEMIA, V21, P30, DOI 10.1038/sj.leu.2404444; Orlowski RZ, 2008, CLIN CANCER RES, V14, P1649, DOI 10.1158/1078-0432.CCR-07-2218; Palmieri G, 2010, MOL BIOSYST, V6, P2498, DOI 10.1039/c005293k; Palmieri G, 2009, J PROTEOME RES, V8, P327, DOI 10.1021/pr800587t; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Park Y, 2009, J FOOD COMPOS ANAL, V22, pS4, DOI 10.1016/j.jfca.2008.12.002; Perrier J, 2005, BIOCHIMIE, V87, P673, DOI 10.1016/j.biochi.2005.04.002; Ponticelli S, 2008, J BIOL CHEM, V283, P34250, DOI 10.1074/jbc.M806607200; Rajkumar SV, 2005, J CLIN ONCOL, V23, P630, DOI 10.1200/JCO.2005.11.030; Reynolds CM, 2010, PROSTAG LEUKOTR ESS, V82, P199, DOI 10.1016/j.plefa.2010.02.021; SACCHETTINI JC, 1992, J BIOL CHEM, V267, P23534; Saric T, 2004, J BIOL CHEM, V279, P46723, DOI 10.1074/jbc.M406537200; SCALONI A, 1992, J LAB CLIN MED, V120, P546; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Serini S, 2009, APOPTOSIS, V14, P135, DOI 10.1007/s10495-008-0298-2; Shah Imtiaz M., 2007, Cardiovascular & Hematological Disorders - Drug Targets, V7, P250, DOI 10.2174/187152907782793572; Shimizu K, 2004, BIOCHEM BIOPH RES CO, V324, P140, DOI 10.1016/j.bbrc.2004.08.231; Shimizu K, 2003, BIOCHEM BIOPH RES CO, V304, P766, DOI 10.1016/S0006-291X(03)00657-0; Suzuki Y, 2001, P NATL ACAD SCI USA, V98, P8662, DOI 10.1073/pnas.161506698; Vlahakis SR, 2006, CURR OPIN CLIN NUTR, V9, P42, DOI 10.1097/01.mco.0000196144.11104.69; Wahle KWJ, 2004, PROG LIPID RES, V43, P553, DOI 10.1016/j.plipres.2004.08.002; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Wertz IE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003350	48	39	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25888	10.1371/journal.pone.0025888	http://dx.doi.org/10.1371/journal.pone.0025888			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016782	gold, Green Submitted, Green Published			2022-12-27	WOS:000295971700021
J	Broadway, JM; Engle, RW				Broadway, James M.; Engle, Randall W.			Individual Differences in Working Memory Capacity and Temporal Discrimination	PLOS ONE			English	Article							GENERAL FLUID INTELLIGENCE; SHORT-TERM-MEMORY; EXECUTIVE ATTENTION; PARKINSONS-DISEASE; SERIAL ORDER; DURATION JUDGMENTS; TIME PERCEPTION; SPAN TASKS; COGNITION; RETRIEVAL	Temporal judgment in the milliseconds-to-seconds range depends on consistent attention to time and robust working memory representation. Individual differences in working memory capacity (WMC) predict a wide range of higher-order and lower-order cognitive abilities. In the present work we examined whether WMC would predict temporal discrimination. High-WMC individuals were more sensitive than low-WMC at discriminating the longer of two temporal intervals across a range of temporal differences. WMC-related individual differences in temporal discrimination were not eliminated by including a measure of fluid intelligence as a covariate. Results are discussed in terms of attention, working memory and other psychological constructs.	[Broadway, James M.; Engle, Randall W.] Georgia Inst Technol, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Broadway, JM (corresponding author), Georgia Inst Technol, Atlanta, GA 30332 USA.	jbroadway@gatech.edu	Engle, Randall W./B-5031-2008; Engle, Randall/ABH-6484-2020	Engle, Randall W./0000-0003-0816-7406; 				Baddeley A. D, 1986, WORKING MEMORY; Barrouillet P, 2008, PSYCHON B REV, V15, P528, DOI 10.3758/PBR.15.3.528; Baudouin A, 2006, BRAIN COGNITION, V62, P17, DOI 10.1016/j.bandc.2006.03.003; Block RA, 1998, PSYCHOL AGING, V13, P584, DOI 10.1037/0882-7974.13.4.584; Block RA, 2010, ACTA PSYCHOL, V134, P330, DOI 10.1016/j.actpsy.2010.03.006; Botvinick M, 2007, J NEUROSCI, V27, P8636, DOI 10.1523/JNEUROSCI.2110-07.2007; BROADBENT HA, 1994, J EXP PSYCHOL-ANIM B, V20, P156, DOI 10.1037/0097-7403.20.2.156; Broadway JM, 2011, ACTA PSYCHOL, V137, P115, DOI 10.1016/j.actpsy.2011.03.008; Broadway JM, 2010, BEHAV RES METHODS, V42, P563, DOI 10.3758/BRM.42.2.563; Brown GDA, 2000, PSYCHOL REV, V107, P127, DOI 10.1037/0033-295X.107.1.127; Brown GDA, 1999, INT J PSYCHOL, V34, P389, DOI 10.1080/002075999399747; Brown GDA, 2007, PSYCHOL REV, V114, P539, DOI 10.1037/0033-295X.114.3.539; Brown GDA, 2009, J MEM LANG, V60, P194, DOI 10.1016/j.jml.2008.09.003; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; CHURCH RM, 1990, COGNITION, V37, P55, DOI 10.1016/0010-0277(90)90018-F; Clement A, 2006, BEHAV PROCESS, V71, P164, DOI 10.1016/j.beproc.2005.08.007; Conway ARA, 2005, PSYCHON B REV, V12, P769, DOI 10.3758/BF03196772; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Cowan N., 1995, ATTENTION MEMORY INT; Cowan N, 1999, MODELS WORKING MEMOR, P62, DOI [10.1017/CBO9781139174909.006, DOI 10.1017/CBO9781139174909.006]; Deary I. J., 2000, LOOKING HUMAN INTELL; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Dutke S, 2005, PERCEPT PSYCHOPHYS, V67; Elvevag B, 2004, J ABNORM PSYCHOL, V113, P509, DOI 10.1037/0021-843X.113.4.509; Elvevag B, 2003, PSYCHOL MED, V33, P1249, DOI 10.1017/S0033291703008122; Engle RW, 1999, J EXP PSYCHOL GEN, V128, P309, DOI 10.1037/0096-3445.128.3.309; Engle RW, 2002, CURR DIR PSYCHOL SCI, V11, P19, DOI 10.1111/1467-8721.00160; Fortin C, 2007, ACTA PSYCHOL, V126, P18, DOI 10.1016/j.actpsy.2006.10.002; Frank MJ, 2001, COGN AFFECT BEHAV NE, V1, P137, DOI 10.3758/CABN.1.2.137; GIBBON J, 1984, ANN NY ACAD SCI, V423, P52, DOI 10.1111/j.1749-6632.1984.tb23417.x; Grondin S, 2010, ATTEN PERCEPT PSYCHO, V72, P561, DOI 10.3758/APP.72.3.561; Harrington DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017461; Helmbold N, 2006, J INDIVID DIFFER, V27, P20, DOI [DOI 10.1027/1614-0001.27.1.20, 10.1027/1614-0001.27.1.20]; Hinton SC, 2004, COGNITIVE BRAIN RES, V21, P183, DOI 10.1016/j.cogbrainres.2004.04.009; Ivry RB, 2008, TRENDS COGN SCI, V12, P273, DOI 10.1016/j.tics.2008.04.002; James W, 1890, PRINCIPLES PSYCHOL, V1; JENSEN AR, 1993, CURRENT DIRECTIONS P, V2, P53, DOI DOI 10.1111/1467-8721.EP10770697; Jones CRG, 2008, BRAIN COGNITION, V68, P30, DOI 10.1016/j.bandc.2008.02.121; Jonides J, 2008, ANNU REV PSYCHOL, V59, P193, DOI 10.1146/annurev.psych.59.103006.093615; Kane MJ, 2006, J EXP PSYCHOL LEARN, V32, P749, DOI 10.1037/0278-7393.32.4.749; Kane MJ, 2003, J EXP PSYCHOL GEN, V132, P47, DOI 10.1037/0096-3445.132.1.47; Kane MJ, 2002, PSYCHON B REV, V9, P637, DOI 10.3758/BF03196323; Kane MJ, 2008, VARIATION WORKING ME, P21; Lewis PA, 2002, CURR BIOL, V12, pR9, DOI 10.1016/S0960-9822(01)00638-8; Lewis PA, 2006, TRENDS COGN SCI, V10, P401, DOI 10.1016/j.tics.2006.07.006; Lustig C, 2005, MEMORY, V13, P441, DOI 10.1080/09658210344000404; Macmillan N. A., 2008, DETECTION THEORY USE; Malapani C, 2002, J COGNITIVE NEUROSCI, V14, P311, DOI 10.1162/089892902317236920; Malapani C, 1998, J COGNITIVE NEUROSCI, V10, P316, DOI 10.1162/089892998562762; Marshuetz C, 2005, PSYCHOL BULL, V131, P323, DOI 10.1037/0033-2909.131.3.323; Matell MS, 2004, COGNITIVE BRAIN RES, V21, P139, DOI 10.1016/j.cogbrainres.2004.06.012; McCormack T, 2004, J EXP CHILD PSYCHOL, V87, P33, DOI 10.1016/j.jecp.2003.10.001; McCormack T, 1999, DEV PSYCHOL, V35, P1143, DOI 10.1037/0012-1649.35.4.1143; Nobre AC, 2001, NEUROSCI BIOBEHAV R, V25, P477, DOI 10.1016/S0149-7634(01)00028-8; Oberauer K, 2003, INTELLIGENCE, V31, P167, DOI 10.1016/S0160-2896(02)00115-0; Preacher KJ, 2005, PSYCHOL METHODS, V10, P178, DOI 10.1037/1082-989X.10.2.178; RAAIJMAKERS JGW, 1981, PSYCHOL REV, V88, P93, DOI 10.1037/0033-295X.88.2.93; Rajah MN, 2008, NEUROPSYCHOLOGIA, V46, P1088, DOI 10.1016/j.neuropsychologia.2007.10.023; Rammsayer TH, 2002, J RES PERS, V36, P507, DOI 10.1016/S0092-6566(02)00006-5; Rammsayer TH, 2001, EUR J COGN PSYCHOL, V13, P549, DOI 10.1080/09541440042000322; Raven J. C., 1998, RAVEN MANUAL; Saito S, 2001, MEMORY, V9, P313, DOI 10.1080/09658210143000164; Schneider W., 2002, E PRIME USERS GUIDE; Staddon JER, 2005, TRENDS COGN SCI, V9, P312, DOI 10.1016/j.tics.2005.05.013; Taatgen NA, 2007, PSYCHOL REV, V114, P577, DOI 10.1037/0033-295X.114.3.577; Troche SJ, 2009, INTELLIGENCE, V37; Troche SJ, 2009, PERS INDIV DIFFER, V47, P52, DOI 10.1016/j.paid.2009.02.001; Tuholski SW, 2001, MEM COGNITION, V29, P484, DOI 10.3758/BF03196399; Unsworth N, 2006, J MEM LANG, V54, P346, DOI 10.1016/j.jml.2005.11.004; Unsworth N, 2005, BEHAV RES METHODS, V37, P498, DOI 10.3758/BF03192720; Unsworth N, 2004, J EXP PSYCHOL LEARN, V30, P1302, DOI 10.1037/0278-7393.30.6.1302; Unsworth N, 2007, PSYCHOL REV, V114, P104, DOI 10.1037/0033-295X.114.1.104; Unsworth N, 2010, INTELLIGENCE, V38, P111, DOI 10.1016/j.intell.2009.08.002; Unsworth N, 2009, MEMORY, V17, P635, DOI 10.1080/09658210902998047; Verhaeghen P, 1997, PSYCHOL BULL, V122, P231, DOI 10.1037/0033-2909.122.3.231; Wittmann M, 2009, PHILOS T R SOC B, V364, P1955, DOI 10.1098/rstb.2009.0003; Zakay D, 1997, CURR DIR PSYCHOL SCI, V6, P12, DOI 10.1111/1467-8721.ep11512604	77	31	32	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25422	10.1371/journal.pone.0025422	http://dx.doi.org/10.1371/journal.pone.0025422			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834OC	22003391	Green Published, Green Submitted, gold			2022-12-27	WOS:000295970300012
J	Lee, YJ; Mou, Y; Maric, D; Klimanis, D; Auh, S; Hallenbeck, JM				Lee, Yang-Ja; Mou, Yongshan; Maric, Dragan; Klimanis, Dace; Auh, Sungyoung; Hallenbeck, John M.			Elevated Global SUMOylation in Ubc9 Transgenic Mice Protects Their Brains against Focal Cerebral Ischemic Damage	PLOS ONE			English	Article							IN-VITRO; MAMMALIAN HIBERNATION; ACTIVATING ENZYME; SUMO; STROKE; TOLERANCE; PATHOPHYSIOLOGY; INHIBITION; MECHANISM; CELLS	We have previously shown that a massive increase in global SUMOylation occurs during torpor in ground squirrels, and that overexpression of Ubc9 and/or SUMO-1 in cell lines and cortical neurons protects against oxygen and glucose deprivation. To examine whether increased global SUMOylation protects against ischemic brain damage, we have generated transgenic mice in which Ubc9 is expressed strongly in all tissues under the chicken beta-actin promoter. Ubc9 expression levels in 10 founder lines ranged from 2 to 30 times the endogenous level, and lines that expressed Ubc9 at modestly increased levels showed robust resistance to brain ischemia compared to wild type mice. The infarction size was inversely correlated with the Ubc9 expression levels for up to five times the endogenous level. Although further increases showed no additional benefit, the Ubc9 expression level was highly correlated with global SUMO-1 conjugation levels (and SUMO-2,3 levels to a lesser extent) up to a five-fold Ubc9 increase. Most importantly, there were striking reciprocal relationships between SUMO-1 (and SUMO-2,3) conjugation levels and cerebral infarction volumes among all tested animals, suggesting that the limit in cytoprotection by global SUMOylation remains undefined. These results support efforts to further augment global protein SUMOylation in brain ischemia.	[Lee, Yang-Ja; Mou, Yongshan; Klimanis, Dace; Hallenbeck, John M.] NINDS, Stroke Branch, NIH, Bethesda, MD 20892 USA; [Maric, Dragan] NINDS, Neurophysiol Lab, NIH, Bethesda, MD 20892 USA; [Auh, Sungyoung] NINDS, Clin Neurosci Program HNQ22, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Lee, YJ (corresponding author), NINDS, Stroke Branch, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	hallenbj@ninds.nih.gov			National Institute of Neurological Disorders and Stroke (NINDS)/National Institutes of Health (NIH); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002856] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)/National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the Intramural Research Program of the National Institute of Neurological Disorders and Stroke (NINDS)/National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsenijevic D, 2006, J CEREBR BLOOD F MET, V26, P433, DOI 10.1038/sj.jcbfm.9600200; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; Cimarosti H, 2008, NEUROPHARMACOLOGY, V54, P280, DOI 10.1016/j.neuropharm.2007.09.010; Cimarosti H, 2008, NEUROSCIENTIST, V14, P626, DOI 10.1177/1073858408322677; Datwyler AL, 2011, J CEREBR BLOOD F MET, V31, P2152, DOI 10.1038/jcbfm.2011.112; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; FRERICHS KU, 1994, J CEREBR BLOOD F MET, V14, P193, DOI 10.1038/jcbfm.1994.26; Frerichs KU, 1998, P NATL ACAD SCI USA, V95, P14511, DOI 10.1073/pnas.95.24.14511; Frerichs KU, 1998, J CEREBR BLOOD F MET, V18, P168, DOI 10.1097/00004647-199802000-00007; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Ginsberg MD, 2003, STROKE, V34, P214, DOI 10.1161/01.STR.0000048846.09677.62; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; HALLENBECK JM, 1993, ARCH NEUROL-CHICAGO, V50, P768, DOI 10.1001/archneur.1993.00540070080020; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Jaber T, 2009, J VIROL, V83, P10448, DOI 10.1128/JVI.00237-09; Kaul S, 2002, J BIOL CHEM, V277, P12541, DOI 10.1074/jbc.M112330200; Kobayashi S, 2004, ENDOCR RES, V30, P617, DOI 10.1081/ERC-200043789; Kurihara I, 2005, J BIOL CHEM, V280, P6721, DOI 10.1074/jbc.M411820200; Kurtzman AL, 2001, P NATL ACAD SCI USA, V98, P5602, DOI 10.1073/pnas.101129698; LEACH MJ, 1993, STROKE, V24, P1063, DOI 10.1161/01.STR.24.7.1063; Lee Y, 2007, J CEREBR BLOOD F MET, V27, P950, DOI 10.1038/sj.jcbfm.9600395; Lee YJ, 2009, J NEUROCHEM, V109, P257, DOI 10.1111/j.1471-4159.2009.05957.x; Loftus LT, 2009, BRAIN RES, V1272, P71, DOI 10.1016/j.brainres.2009.03.034; Mergenthaler P, 2004, METAB BRAIN DIS, V19, P151, DOI 10.1023/B:MEBR.0000043966.46964.e6; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Olsen SK, 2010, NATURE, V463, P906, DOI 10.1038/nature08765; Siepmann TJ, 2003, J BIOL CHEM, V278, P9448, DOI 10.1074/jbc.M211240200; Storey KB, 2003, ADV EXP MED BIOL, V543, P21; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Tempe D, 2008, BIOCHEM SOC T, V36, P874, DOI 10.1042/BST0360874; Tomoiu A, 2006, J VIROL, V80, P10218, DOI 10.1128/JVI.00375-06; Walden H, 2003, NATURE, V422, P330, DOI 10.1038/nature01456; Wang JH, 2010, J BIOL CHEM, V285, P33457, DOI 10.1074/jbc.M110.135582; Wee KE, 2000, J PROTEIN CHEM, V19, P489, DOI 10.1023/A:1026501515450; Xu J, 2009, INT J ONCOL, V34, P939, DOI 10.3892/ijo_00000220; Yang W, 2008, J CEREBR BLOOD F MET, V28, P892, DOI 10.1038/sj.jcbfm.9600601; Yang W, 2008, J CEREBR BLOOD F MET, V28, P269, DOI 10.1038/sj.jcbfm.9600523; Zhu S, 2010, ONCOGENE, V29, P1763, DOI 10.1038/onc.2009.459	40	82	86	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25852	10.1371/journal.pone.0025852	http://dx.doi.org/10.1371/journal.pone.0025852			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22016779	Green Submitted, Green Published, gold			2022-12-27	WOS:000295970300031
J	Martins, M; Rosa, A; Guedes, LC; Fonseca, BV; Gotovac, K; Violante, S; Mestre, T; Coelho, M; Rosa, MM; Martin, ER; Vance, JM; Outeiro, TF; Wang, LY; Borovecki, F; Ferreira, JJ; Oliveira, SA				Martins, Madalena; Rosa, Alexandra; Guedes, Leonor C.; Fonseca, Benedita V.; Gotovac, Kristina; Violante, Sara; Mestre, Tiago; Coelho, Miguel; Rosa, Mario M.; Martin, Eden R.; Vance, Jeffery M.; Outeiro, Tiago F.; Wang, Liyong; Borovecki, Fran; Ferreira, Joaquim J.; Oliveira, Sofia A.			Convergence of miRNA Expression Profiling, alpha-Synuclein Interacton and GWAS in Parkinson's Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GLUCOCEREBROSIDASE MUTATIONS; GENE-EXPRESSION; RISK-FACTORS; PREDICTION; TOXICITY; PATHWAYS; SEMA5A; SITE; SNCA	miRNAs were recently implicated in the pathogenesis of numerous diseases, including neurological disorders such as Parkinson's disease (PD). miRNAs are abundant in the nervous system, essential for efficient brain function and play important roles in neuronal patterning and cell specification. To further investigate their involvement in the etiology of PD, we conducted miRNA expression profiling in peripheral blood mononuclear cells (PBMCs) of 19 patients and 13 controls using microarrays. We found 18 miRNAs differentially expressed, and pathway analysis of 662 predicted target genes of 11 of these miRNAs revealed an over-representation in pathways previously linked to PD as well as novel pathways. To narrow down the genes for further investigations, we undertook a parallel approach using chromatin immunoprecipitation-sequencing (ChIP-seq) analysis to uncover genome-wide interactions of alpha-synuclein, a molecule with a central role in both monogenic and idiopathic PD. Convergence of ChIP-seq and miRNomics data highlighted the glycosphingolipid biosynthesis and the ubiquitin proteasome system as key players in PD. We then tested the association of target genes belonging to these pathways with PD risk, and identified nine SNPs in USP37 consistently associated with PD susceptibility in three genome-wide association studies (GWAS) datasets (0.46 <= OR <= 0.63) and highly significant in the meta-dataset (3.36x10(-4)< p < 1.94x10(-3)). A SNP in ST8SIA4 was also highly associated with PD (p = 6.15x10(-3)) in the meta-dataset. These findings suggest that several miRNAs may act as regulators of both known and novel biological processes leading to idiopathic PD.	[Martins, Madalena; Guedes, Leonor C.; Fonseca, Benedita V.; Mestre, Tiago; Coelho, Miguel; Rosa, Mario M.; Ferreira, Joaquim J.; Oliveira, Sofia A.] Inst Mol Med, Neurol Clin Res Unit, Lisbon, Portugal; [Martins, Madalena; Rosa, Alexandra; Fonseca, Benedita V.; Violante, Sara; Oliveira, Sofia A.] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Rosa, Alexandra] Univ Madeira, Ctr Competencias Ciencias Vida, Unidade Ciencias Med, Funchal, Portugal; [Guedes, Leonor C.; Mestre, Tiago; Coelho, Miguel; Rosa, Mario M.; Ferreira, Joaquim J.] Ctr Hosp Lisboa Norte, Hosp Santa Maria, Serv Neurol, Lisbon, Portugal; [Gotovac, Kristina; Borovecki, Fran] Univ Zagreb, Sch Med, Univ Hosp Ctr Zagreb, Dept Funct Genom,Ctr Translat & Clin Res, Zagreb 41001, Croatia; [Martin, Eden R.; Vance, Jeffery M.; Wang, Liyong] Univ Miami, Miller Sch Med, Hussman Inst Human Genom, Miami, FL 33136 USA; [Outeiro, Tiago F.] Inst Mol Med, Cell & Mol Neurosci Unit, Lisbon, Portugal; [Outeiro, Tiago F.] Univ Lisbon, Fac Med, Inst Fisiol, Lisbon, Portugal; [Outeiro, Tiago F.] Univ Med Gottingen, Ctr Mol Physiol Brain, Dept Neurodegenerat & Restaurat Res, Gottingen, Germany	Universidade de Lisboa; Instituto Gulbenkian de Ciencia; Universidade da Madeira; Universidade de Lisboa; Hospital Santa Maria; University of Zagreb; University of Miami; Universidade de Lisboa; Universidade de Lisboa; University of Gottingen	Martins, M (corresponding author), Inst Mol Med, Neurol Clin Res Unit, Lisbon, Portugal.	aaoliveira@fm.ul.pt	Rosa, Alexandra/AAA-3224-2022; Ferreira, Joaquim/AAA-1837-2020; Outeiro, Tiago/M-8106-2019; Outeiro, Tiago F/C-1067-2008; Outeiro, Tiago/L-7351-2019	Rosa, Alexandra/0000-0002-1827-6828; Outeiro, Tiago F/0000-0003-1679-1727; Outeiro, Tiago/0000-0003-1679-1727; Correia Guedes, Leonor/0000-0002-8422-0494; Martins, Madalena/0000-0001-8360-6806; Vance, Jeffery/0000-0003-3815-8199; Oliveira, Sofia A/0000-0001-7919-4191; Coelho, Miguel/0000-0002-4008-8110; Ferreira, Joaquim J/0000-0003-3950-5113	Fundacao para a Ciencia e a Tecnologia (FCT) [FCT/SAU/GMG/64428/2006, SFRH/BPD/29354/2006]; Center for Human Genetics at Duke University Medical Center (USA); NINDS [NS39764]; Portuguese Instituto do Emprego e Formacao Profissional; World Bank/Ministry of Science of the Republic of Croatia [24/08]; European Molecular Biology Organization (EMBO); Marie Curie International Reintegration Grant (Neurofold); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS039764] Funding Source: NIH RePORTER	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Center for Human Genetics at Duke University Medical Center (USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Portuguese Instituto do Emprego e Formacao Profissional; World Bank/Ministry of Science of the Republic of Croatia; European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Marie Curie International Reintegration Grant (Neurofold)(European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the Fundacao para a Ciencia e a Tecnologia (FCT) (FCT/SAU/GMG/64428/2006 to S.A.O., SFRH/BPD/29354/2006 to M.M.); the Center for Human Genetics at Duke University Medical Center (USA) for the grant awarded to S.A.O.; the NINDS grant NS39764 (HIHG); the fellowships from the Portuguese Instituto do Emprego e Formacao Profissional (B.V.F. and S.V.); and the Unity through Knowledge Fund (World Bank/Ministry of Science of the Republic of Croatia) grant 24/08 (F.B.). T.F.O. is supported by a European Molecular Biology Organization (EMBO) Installation Grant and a Marie Curie International Reintegration Grant (Neurofold). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bialecka M, 2006, NEUROSCI LETT, V399, P121, DOI 10.1016/j.neulet.2006.01.038; Catto JWF, 2009, CANCER RES, V69, P8472, DOI 10.1158/0008-5472.CAN-09-0744; Clarimon J, 2006, AM J HUM GENET, V78, P1082, DOI 10.1086/504727; Devine MJ, 2008, FEBS J, V275, P5748, DOI 10.1111/j.1742-4658.2008.06707.x; Ding HX, 2008, BRAIN RES, V1245, P126, DOI 10.1016/j.brainres.2008.09.080; Doxakis E, 2010, J BIOL CHEM, V285, P12726, DOI 10.1074/jbc.M109.086827; Edwards TL, 2010, ANN HUM GENET, V74, P97, DOI 10.1111/j.1469-1809.2009.00560.x; Elbaz A, 2006, LANCET NEUROL, V5, P917, DOI 10.1016/S1474-4422(06)70579-8; Enright Anton J, 2003, Genome Biol, V5, pR1, DOI 10.1186/gb-2003-5-1-r1; Fahn S., 1987, RECENT DEV PARKINSON, V2, P153; Fung HC, 2006, LANCET NEUROL, V5, P911, DOI 10.1016/S1474-4422(06)70578-6; Gehrke S, 2010, NATURE, V466, P637, DOI 10.1038/nature09191; Goetz CG, 2004, MOVEMENT DISORD, V19, P1020, DOI 10.1002/mds.20213; Hardy J, 2010, NEURON, V68, P201, DOI 10.1016/j.neuron.2010.10.014; Haugarvoll K, 2009, EUR J HUM GENET, V17, P336, DOI 10.1038/ejhg.2008.187; Hauser MA, 2005, ARCH NEUROL-CHICAGO, V62, P917, DOI 10.1001/archneur.62.6.917; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Junn E, 2009, P NATL ACAD SCI USA, V106, P13052, DOI 10.1073/pnas.0906277106; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li YH, 2006, HUM MUTAT, V27, P1017, DOI 10.1002/humu.20382; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Liew CC, 2006, J LAB CLIN MED, V147, P126, DOI 10.1016/j.lab.2005.10.005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lukiw WJ, 2007, NEUROREPORT, V18, P297, DOI 10.1097/WNR.0b013e3280148e8b; Lwin A, 2004, MOL GENET METAB, V81, P70, DOI 10.1016/j.ymgme.2003.11.004; Maraganore DM, 2005, AM J HUM GENET, V77, P685, DOI 10.1086/496902; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Mayer R J, 1989, Prog Clin Biol Res, V317, P809; Ngamukote S, 2007, J NEUROCHEM, V103, P2327, DOI 10.1111/j.1471-4159.2007.04910.x; Nuytemans K, 2010, HUM MUTAT, V31, P763, DOI 10.1002/humu.21277; Oliveira SA, 2005, AM J HUM GENET, V77, P252, DOI 10.1086/432588; Outeiro TF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006906; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Outeiro TF, 2008, PERSPECT MED CHEM, V2, P41; Pankratz N, 2009, HUM GENET, V124, P593, DOI 10.1007/s00439-008-0582-9; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Satterlee JS, 2007, J NEUROSCI, V27, P11856, DOI 10.1523/JNEUROSCI.3624-07.2007; Saykin AJ, 2010, ALZHEIMERS DEMENT, V6, P265, DOI 10.1016/j.jalz.2010.03.013; Scherzer CR, 2007, P NATL ACAD SCI USA, V104, P955, DOI 10.1073/pnas.0610204104; Schwab R.S., 1969, 3 S PARK DIS, P152; Sethi P, 2009, NEUROSCI LETT, V459, P100, DOI 10.1016/j.neulet.2009.04.052; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sonntag KC, 2010, BRAIN RES, V1338, P48, DOI 10.1016/j.brainres.2010.03.106; Wang G, 2008, AM J HUM GENET, V82, P283, DOI 10.1016/j.ajhg.2007.09.021; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Wu YR, 2010, CLIN CHIM ACTA, V411, P955, DOI 10.1016/j.cca.2010.03.013; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Xie WL, 2010, BBA-MOL BASIS DIS, V1802, P935, DOI 10.1016/j.bbadis.2010.07.014; Zhong N, 2006, J BIOL CHEM, V281, P20940, DOI 10.1074/jbc.M601935200	62	185	196	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25443	10.1371/journal.pone.0025443	http://dx.doi.org/10.1371/journal.pone.0025443			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003392	Green Published, gold, Green Submitted			2022-12-27	WOS:000295970300013
J	Tromans, JM; Harris, M; Stringer, SM				Tromans, James Matthew; Harris, Mitchell; Stringer, Simon Maitland			A Computational Model of the Development of Separate Representations of Facial Identity and Expression in the Primate Visual System	PLOS ONE			English	Article							INVARIANT OBJECT RECOGNITION; MULTIPLE STIMULI PRESENT; SELF-ORGANIZATION; NEURONS; CORTEX; ORIENTATION; CONNECTIONS; INFORMATION; INHIBITION; ACTIVATION	Experimental studies have provided evidence that the visual processing areas of the primate brain represent facial identity and facial expression within different subpopulations of neurons. For example, in non-human primates there is evidence that cells within the inferior temporal gyrus (TE) respond primarily to facial identity, while cells within the superior temporal sulcus (STS) respond to facial expression. More recently, it has been found that the orbitofrontal cortex (OFC) of non-human primates contains some cells that respond exclusively to changes in facial identity, while other cells respond exclusively to facial expression. How might the primate visual system develop physically separate representations of facial identity and expression given that the visual system is always exposed to simultaneous combinations of facial identity and expression during learning? In this paper, a biologically plausible neural network model, VisNet, of the ventral visual pathway is trained on a set of carefully-designed cartoon faces with different identities and expressions. The VisNet model architecture is composed of a hierarchical series of four Self-Organising Maps (SOMs), with associative learning in the feedforward synaptic connections between successive layers. During learning, the network develops separate clusters of cells that respond exclusively to either facial identity or facial expression. We interpret the performance of the network in terms of the learning properties of SOMs, which are able to exploit the statistical indendependence between facial identity and expression.	[Tromans, James Matthew; Harris, Mitchell; Stringer, Simon Maitland] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, Oxon, England	University of Oxford	Tromans, JM (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, Oxon, England.	james.tromans@psy.ox.ac.uk			The Economic and Social Research Council	The Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This research was supported by The Economic and Social Research Council via a studentship awarded to J.M. Tromans. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bednar JA, 2006, NEUROCOMPUTING, V69, P1272, DOI 10.1016/j.neucom.2005.12.090; Bosking WH, 1997, J NEUROSCI, V17, P2112; Calder AJ, 2005, NAT REV NEUROSCI, V6, P641, DOI 10.1038/nrn1724; Calder AJ, 2001, VISION RES, V41, P1179, DOI 10.1016/S0042-6989(01)00002-5; Choe Y, 1998, NEUROCOMPUTING, V21, P139, DOI 10.1016/S0925-2312(98)00040-X; FITZPATRICK D, 1985, J NEUROSCI, V5, P3329; Fox CJ, 2009, NEUROIMAGE, V44, P569, DOI 10.1016/j.neuroimage.2008.09.011; GARY GC, 2002, P 24 ANN C COGN SCI, P238; Gothard KM, 2007, J NEUROPHYSIOL, V97, P1671, DOI 10.1152/jn.00714.2006; HASSELMO ME, 1989, BEHAV BRAIN RES, V32, P203, DOI 10.1016/S0166-4328(89)80054-3; HASSELMO ME, 1989, EXP BRAIN RES, V75, P417; HAWKEN MJ, 1987, PROC R SOC SER B-BIO, V231, P251, DOI 10.1098/rspb.1987.0044; Hertz JA, 2018, INTRO THEORY NEURAL; Higgins IV, 2011, VISION RES, V51, P553, DOI 10.1016/j.visres.2011.01.016; Kadosh KC, 2010, J COGNITIVE NEUROSCI, V22, P903, DOI 10.1162/jocn.2009.21224; Kang KJ, 2003, P NATL ACAD SCI USA, V100, P2848, DOI 10.1073/pnas.0138051100; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; MALSBURG CV, 1973, KYBERNETIK, V14, P85, DOI 10.1007/BF00288907; MELTZOFF AN, 1977, SCIENCE, V198, P75, DOI 10.1126/science.198.4312.75; MELTZOFF AN, 1983, CHILD DEV, V54, P702, DOI 10.2307/1130058; PERRETT DI, 1992, PHILOS T ROY SOC B, V335, P23, DOI 10.1098/rstb.1992.0003; Rolls ET, 2006, EXP BRAIN RES, V170, P74, DOI 10.1007/s00221-005-0191-y; Rolls ET, 2000, NEURAL COMPUT, V12, P2547, DOI 10.1162/089976600300014845; Rolls ET, 1997, J COMPUT NEUROSCI, V4, P309, DOI 10.1023/A:1008899916425; Royer S, 2003, NATURE, V422, P518, DOI 10.1038/nature01530; SIROSH J, 1994, BIOL CYBERN, V71, P65, DOI 10.1007/BF00198912; Stringer SM, 2008, NEURAL NETWORKS, V21, P888, DOI 10.1016/j.neunet.2007.11.004; Stringer SM, 2007, NETWORK-COMP NEURAL, V18, P161, DOI 10.1080/09548980701556055; Stringer SM, 2002, NEURAL COMPUT, V14, P2585, DOI 10.1162/089976602760407982; Stringer SM, 2006, BIOL CYBERN, V94, P128, DOI 10.1007/s00422-005-0030-z; Stringer SM, 2000, NEURAL NETWORKS, V13, P305, DOI 10.1016/S0893-6080(00)00017-4; TROMANS JM, 2011, LEARNING SEPAR UNPUB; Tucker TR, 2003, J NEUROPHYSIOL, V89, P488, DOI 10.1152/jn.00869.2001; WALLIS G, 1993, LEARNING INVARIANT R, V2, P1087; WALLIS G, 1997, INVARIANT FACE OBJEC; WALTON GE, 1992, INFANT BEHAV DEV, V15, P265, DOI 10.1016/0163-6383(92)80027-R; Winston JS, 2004, J NEUROPHYSIOL, V92, P1830, DOI 10.1152/jn.00155.2004; Xu XK, 2010, J VISION, V10, DOI 10.1167/10.14.36	38	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e25616	10.1371/journal.pone.0025616	http://dx.doi.org/10.1371/journal.pone.0025616			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998673	Green Published, Green Submitted, gold			2022-12-27	WOS:000295968700014
J	Holman, RM; Carson, V; Janssen, I				Holman, Rebecca M.; Carson, Valerie; Janssen, Ian			Does the Fractionalization of Daily Physical Activity (Sporadic vs. Bouts) Impact Cardiometabolic Risk Factors in Children and Youth?	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; CARDIOVASCULAR RISK; ADOLESCENTS; POPULATION; FREQUENCY; HEALTH	Objective: Children and youth accumulate their daily moderate-to-vigorous physical activity (MVPA) in bouts (i.e., >= 5 consecutive minutes) and in a sporadic manner (i.e., <5 consecutive minutes). The study objective was to determine, within children and youth, whether MVPA accumulated in bouts is more strongly associated with cardiometabolic risk factors than an equivalent volume of MVPA accumulated sporadically. Methods: Participants consisted of 2754 children and youth aged 6-19 years from the 2003-2006 National Health and Nutrition Examination Survey, a representative cross-sectional study. Bouts and sporadic MVPA were measured objectively over 7 days using Actigraph accelerometers. Thresholds of 5 and 10 consecutive minutes were used to differentiate between bouts and sporadic MVPA. A high cardiometabolic risk factor score (CRS) was created based on measures of waist circumference, non-high-density lipoprotein cholesterol, C-reactive protein, and systolic blood pressure. Associations were examined using logistic regression and controlled for covariates (sex, age, ethnicity, socioeconomic status, dietary fat and sodium, smoking, and accelerometry wear time). Results: The odds of a high CRS decreased in a dose-response for both the sporadic and bout MVPA measures. Relative to quartile 1, the odds ratio (95% confidence interval) for a high CRS in quartile 4 was 0.25 (0.10-0.60) for sporadic MVPA, 0.17 (0.09-0.34) for >= 5 minute bouts of MVPA, and 0.19 (0.11-0.34) for >= 10 minute bouts of MVPA. The sporadic and bout MVPA measures had a similar ability to distinguish between participants with high and normal CRS. Relative to 0 minutes of MVPA, an equivalent number of minutes of sporadic MVPA and bouts of MVPA had an almost identical odds ratio for a high CRS. The findings were consistent for 5 and 10 minute bout thresholds. Conclusions: The relations between sporadic MVPA and bouts of MVPA with cardiometabolic risk factors were remarkably similar in children and youth.	[Holman, Rebecca M.; Carson, Valerie; Janssen, Ian] Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada; [Janssen, Ian] Queens Univ, Dept Community Hlth & Epidemiol, Kingston, ON, Canada	Queens University - Canada; Queens University - Canada	Holman, RM (corresponding author), Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada.	ian.janssen@queenu.ca	Carson, Valerie/ABG-2853-2021; Janssen, Ian/B-7700-2009	Carson, Valerie/0000-0002-3009-3282; Janssen, Ian/0000-0003-2159-3012	Heart and Stroke Foundation of Ontario; Canadian Institutes of Health Research; Ontario Ministry of Research and Innovation	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario)	This study was supported by a research grant from the Heart and Stroke Foundation of Ontario. VC was supported by a doctoral scholarship from the Canadian Institutes of Health Research. IJ was supported by a Canada Research Chair and an Early Researcher Award from the Ontario Ministry of Research and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo KB, 2009, INT J PEDIATR OBES, V4, P2, DOI 10.1080/17477160802315010; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Andersen LB, 2006, LANCET, V368, P299, DOI 10.1016/S0140-6736(06)69075-2; Colley Rachel, 2010, Health Rep, V21, P63; Cook Stephen, 2009, J Pediatr, V155, DOI 10.1016/j.jpeds.2009.04.051; Eston RG, 1998, J APPL PHYSIOL, V84, P362, DOI 10.1152/jappl.1998.84.1.362; Freedson P, 2005, MED SCI SPORT EXER, V37, pS523, DOI 10.1249/01.mss.0000185658.28284.ba; Gardner CD, 2000, AM J CARDIOL, V86, P299, DOI 10.1016/S0002-9149(00)00918-8; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Janssen I, 2005, PEDIATRICS, V115, P1623, DOI 10.1542/peds.2004-2588; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Lakka TA, 2007, APPL PHYSIOL NUTR ME, V32, P76, DOI [10.1139/H06-113, 10.1139/h06-113]; Liu J, 2009, APPL PHYSIOL NUTR ME, V34, P136, DOI 10.1139/H08-149; Mark AE, 2009, AM J PREV MED, V36, P416, DOI 10.1016/j.amepre.2009.01.027; Masse LC, 2005, MED SCI SPORT EXER, V37, pS544, DOI 10.1249/01.mss.0000185674.09066.8a; McGuire KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020503; Moliner-Urdiales D, 2009, INT J OBESITY, V33, P1126, DOI 10.1038/ijo.2009.139; Oliveira AC, 2008, OBESITY, V16, P1094, DOI 10.1038/oby.2008.43; Ridker PM, 2003, CIRCULATION, V108, pE81, DOI 10.1161/01.CIR.0000093381.57779.67; Rowlands AV, 2007, J SPORT SCI MED, V6, P270; Rowlands AV, 2007, MED SCI SPORT EXER, V39, P716, DOI 10.1249/mss.0b013e318031126c; Tremblay MS, 2011, APPL PHYSIOL NUTR ME, V36, P36, DOI [10.1139/H11-009, 10.1139/H11-010]; Treuth MS, 2004, MED SCI SPORT EXER, V36, P198, DOI 10.1249/01.MSS.0000113666.98463.B0; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Trost SG, 2000, MED SCI SPORT EXER, V32, P426, DOI 10.1097/00005768-200002000-00025; U.S. Census Bureau Population Division Fertility Family Statistics Branch, 2004, CURR POP SURV DEF EX; U.S. Department of Health and Human Services, 2008, 2008 PHYS ACT GUID A; *US DEP HHS, 2005, US DEP AGR DIET GUID; Welk GJ, 2000, RES Q EXERCISE SPORT, V71, pS59, DOI 10.1080/02701367.2000.11082788; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15	30	48	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25733	10.1371/journal.pone.0025733	http://dx.doi.org/10.1371/journal.pone.0025733			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998688	gold, Green Published, Green Submitted			2022-12-27	WOS:000295966900049
J	Magnee, MJCM; Lamme, VAF; de Sain-van der Velden, MGM; Vorstman, JAS; Kemner, C				Magnee, Maurice J. C. M.; Lamme, Victor A. F.; de Sain-van der Velden, Monique G. M.; Vorstman, Jacob A. S.; Kemner, Chantal			Proline and COMT Status Affect Visual Connectivity in Children with 22q11.2 Deletion Syndrome	PLOS ONE			English	Article							CARDIO-FACIAL SYNDROME; FIGURE-GROUND SEGREGATION; VELOCARDIOFACIAL SYNDROME; CHROMOSOME 22Q11; SPECTRUM DISORDERS; SCHIZOPHRENIA; BRAIN; ADULTS; AUTISM; PERCEPTION	Background: Individuals with the 22q11.2 deletion syndrome (22q11DS) are at increased risk for schizophrenia and Autism Spectrum Disorders (ASDs). Given the prevalence of visual processing deficits in these three disorders, a causal relationship between genes in the deleted region of chromosome 22 and visual processing is likely. Therefore, 22q11DS may represent a unique model to understand the neurobiology of visual processing deficits related with ASD and psychosis. Methodology: We measured Event-Related Potentials (ERPs) during a texture segregation task in 58 children with 22q11DS and 100 age-matched controls. The C1 component was used to index afferent activity of visual cortex area V1; the texture negativity wave provided a measure for the integrity of recurrent connections in the visual cortical system. COMT genotype and plasma proline levels were assessed in 22q11DS individuals. Principal Findings: Children with 22q11DS showed enhanced feedforward activity starting from 70 ms after visual presentation. ERP activity related to visual feedback activity was reduced in the 22q11DS group, which was seen as less texture negativity around 150 ms post presentation. Within the 22q11DS group we further demonstrated an association between high plasma proline levels and aberrant feedback/feedforward ratios, which was moderated by the COMT 158 genotype. Conclusions: These findings confirm the presence of early visual processing deficits in 22q11DS. We discuss these in terms of dysfunctional synaptic plasticity in early visual processing areas, possibly associated with deviant dopaminergic and glutamatergic transmission. As such, our findings may serve as a promising biomarker related to the development of schizophrenia among 22q11DS individuals.	[Magnee, Maurice J. C. M.; Vorstman, Jacob A. S.; Kemner, Chantal] Univ Med Ctr Utrecht, Dept Child & Adolescent Psychiat, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [Lamme, Victor A. F.] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Lamme, Victor A. F.] Netherlands Ophthalm Res Inst, NL-1100 AC Amsterdam, Netherlands; [de Sain-van der Velden, Monique G. M.] Univ Med Ctr Utrecht, Dept Metab & Endocrine Dis, Utrecht, Netherlands; [de Sain-van der Velden, Monique G. M.] Univ Med Ctr Utrecht, Netherlands Metabol Ctr, Utrecht, Netherlands; [Magnee, Maurice J. C. M.; Kemner, Chantal] Univ Utrecht, Dept Dev Psychol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; University of Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University	Magnee, MJCM (corresponding author), Univ Med Ctr Utrecht, Dept Child & Adolescent Psychiat, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands.	M.J.C.M.Magnee@umcutrecht.nl			Netherlands Organization for Scientific Research [402-01-094]; Utrecht University; European Research Council	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Utrecht University; European Research Council(European Research Council (ERC)European Commission)	The work described was supported by an Innovational Research Incentives grant (VIDI-scheme, 402-01-094) of The Netherlands Organization for Scientific Research, a Neuroscience and Cognition Utrecht grant from Utrecht University to Chantal Kemner and an European Research Council advanced investigator grant to Victor Lamme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson F, 2008, BIOL PSYCHIAT, V63, P49, DOI 10.1016/j.biopsych.2007.02.022; Antshel KM, 2007, J AUTISM DEV DISORD, V37, P1776, DOI 10.1007/s10803-006-0308-6; Baker KD, 2005, BRIT J PSYCHIAT, V186, P115, DOI 10.1192/bjp.186.2.115; Bender HU, 2005, AM J HUM GENET, V76, P409, DOI 10.1086/428142; Butler PD, 2008, BIOL PSYCHIAT, V64, P40, DOI 10.1016/j.biopsych.2008.03.023; Campbell LE, 2006, BRAIN, V129, P1218, DOI 10.1093/brain/awl066; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Cohen SM, 1997, BRAIN RES, V769, P333, DOI 10.1016/S0006-8993(97)00721-X; Cohen SM, 1997, BRAIN RES, V761, P271, DOI 10.1016/S0006-8993(97)00352-1; Dakin S, 2005, NEURON, V48, P497, DOI 10.1016/j.neuron.2005.10.018; duMontcel ST, 1996, J MED GENET, V33, P719, DOI 10.1136/jmg.33.8.719; Edelmann L, 1999, HUM MOL GENET, V8, P1157, DOI 10.1093/hmg/8.7.1157; Feinstein C, 2002, BIOL PSYCHIAT, V51, P312, DOI 10.1016/S0006-3223(01)01231-8; Fine SE, 2005, J AUTISM DEV DISORD, V35, P461, DOI 10.1007/s10803-005-5036-9; Foxe JJ, 2008, BRAIN TOPOGR, V21, P11, DOI 10.1007/s10548-008-0063-4; FREMEAU RT, 1992, NEURON, V8, P915, DOI 10.1016/0896-6273(92)90206-S; Goodship J, 1998, ARCH DIS CHILD, V79, P348, DOI 10.1136/adc.79.4.348; Gothelf D, 2004, AM J MED GENET B, V126B, P99, DOI 10.1002/ajmg.b.20124; Gothelf D, 2005, NAT NEUROSCI, V8, P1500, DOI 10.1038/nn1572; Gothelf D, 2008, DEV DISABIL RES REV, V14, P59, DOI 10.1002/ddrr.9; Javitt DC, 2010, ISR J PSYCHIATR REL, V47, P4; Javitt DC, 2009, ANNU REV CLIN PSYCHO, V5, P249, DOI 10.1146/annurev.clinpsy.032408.153502; JAVITT DC, 1991, AM J PSYCHIAT, V148, P1301; Jolij J, 2007, NEUROREPORT, V18, P39, DOI 10.1097/01.wnr.0000236863.46952.a6; Kates WR, 2001, BIOL PSYCHIAT, V49, P677, DOI 10.1016/S0006-3223(00)01002-7; Lajiness-O'Neill RR, 2005, CHILD NEUROPSYCHOL, V11, P55, DOI 10.1080/09297040590911202; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; LAMME VAF, 1992, VISION RES, V32, P797, DOI 10.1016/0042-6989(92)90022-B; LAMME VAF, 1995, J NEUROSCI, V15, P1605; Lepage N, 1997, CLIN CHEM, V43, P2397; Lewis DA, 2001, J COMP NEUROL, V432, P119, DOI 10.1002/cne.1092; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Mansour A M, 1987, J Pediatr Ophthalmol Strabismus, V24, P263; McDermid HE, 2002, AM J HUM GENET, V70, P1077, DOI 10.1086/340363; Murphy KC, 2001, BRIT J PSYCHIAT, V179, P397, DOI 10.1192/bjp.179.5.397; Niklasson L, 2001, GENET MED, V3, P79, DOI 10.1097/00125817-200101000-00017; Oskarsdottir S, 2004, ARCH DIS CHILD, V89, P148, DOI 10.1136/adc.2003.026880; Paterlini M, 2005, NAT NEUROSCI, V8, P1586, DOI 10.1038/nn1562; PULVER AE, 1994, J NERV MENT DIS, V182, P476, DOI 10.1097/00005053-199408000-00010; Roelfsema PR, 2002, J COGNITIVE NEUROSCI, V14, P525, DOI 10.1162/08989290260045756; Ryan AK, 1997, J MED GENET, V34, P798, DOI 10.1136/jmg.34.10.798; Sesack SR, 2003, ANN NY ACAD SCI, V1003, P36, DOI 10.1196/annals.1300.066; Shaikh TH, 2000, HUM MOL GENET, V9, P489, DOI 10.1093/hmg/9.4.489; Stephan KE, 2009, SCHIZOPHRENIA BULL, V35, P509, DOI 10.1093/schbul/sbn176; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Super H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021641; Swillen A, 1997, J MED GENET, V34, P453, DOI 10.1136/jmg.34.6.453; Van Amelsvoort T, 2001, BRIT J PSYCHIAT, V178, P412; van Amelsvoort T, 2004, ARCH GEN PSYCHIAT, V61, P1085, DOI 10.1001/archpsyc.61.11.1085; Van Amelsvoort T, 2006, BRIT J PSYCHIAT, V189, P560, DOI 10.1192/bjp.bp.105.019876; Vandenbroucke MWG, 2008, BRAIN, V131, P1013, DOI 10.1093/brain/awm321; Vorstman JAS, 2006, J AM ACAD CHILD PSY, V45, P1104, DOI 10.1097/01.chi.0000228131.56956.c1; Vorstman JAS, 2009, NEUROPSYCHOPHARMACOL, V34, P739, DOI 10.1038/npp.2008.132; Wang PP, 2000, DEV MED CHILD NEUROL, V42, P422, DOI 10.1017/S0012162200000785	54	19	20	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25882	10.1371/journal.pone.0025882	http://dx.doi.org/10.1371/journal.pone.0025882			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998713	Green Published, Green Submitted, gold			2022-12-27	WOS:000295966900067
J	Manente, AG; Pinton, G; Tavian, D; Lopez-Rodas, G; Brunelli, E; Moro, L				Manente, Arcangela Gabriella; Pinton, Giulia; Tavian, Daniela; Lopez-Rodas, Gerardo; Brunelli, Elisa; Moro, Laura			Coordinated Sumoylation and Ubiquitination Modulate EGF Induced EGR1 Expression and Stability	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; GENE-EXPRESSION; CELL-SURVIVAL; A EGR-1; GROWTH; INDUCTION; APOPTOSIS; PHOSPHORYLATION; DIFFERENTIATION; ACTIVATION	Background: Human early growth response-1 (EGR1) is a member of the zing-finger family of transcription factors induced by a range of molecular and environmental stimuli including epidermal growth factor (EGF). In a recently published paper we demonstrated that integrin/EGFR cross-talk was required for Egr1 expression through activation of the Erk1/2 and PI3K/Akt/Forkhead pathways. EGR1 activity and stability can be influenced by many different post-translational modifications such as acetylation, phosphorylation, ubiquitination and the recently discovered sumoylation. The aim of this work was to assess the influence of sumoylation on EGF induced Egr1 expression and/or stability. Methods: We modulated the expression of proteins involved in the sumoylation process in ECV304 cells by transient transfection and evaluated Egr1 expression in response to EGF treatment at mRNA and protein levels. Results: We demonstrated that in ECV304 cells Egr1 was transiently induced upon EGF treatment and a fraction of the endogenous protein was sumoylated. Moreover, SUMO-1/Ubc9 over-expression stabilized EGF induced ERK1/2 phosphorylation and increased Egr1 gene transcription. Conversely, in SUMO-1/Ubc9 transfected cells, EGR1 protein levels were strongly reduced. Data obtained from protein expression and ubiquitination analysis, in the presence of the proteasome inhibitor MG132, suggested that upon EGF stimuli EGR1 sumoylation enhanced its turnover, increasing ubiquitination and proteasome mediated degradation. Conclusions: Here we demonstrate that SUMO-1 modification improving EGR1 ubiquitination is involved in the modulation of its stability upon EGF mediated induction.	[Manente, Arcangela Gabriella; Pinton, Giulia; Brunelli, Elisa; Moro, Laura] Univ Piemonte Orientale, Dipartimento Sci Chim Alimentari Farmaceut & Farm, Novara, Italy; [Tavian, Daniela] Univ Cattolica Sacro Cuore, Dept Psychol, I-20123 Milan, Italy; [Lopez-Rodas, Gerardo] Univ Valencia, Dept Biochem, Valencia, Spain	University of Eastern Piedmont Amedeo Avogadro; Catholic University of the Sacred Heart; University of Valencia	Manente, AG (corresponding author), Univ Piemonte Orientale, Dipartimento Sci Chim Alimentari Farmaceut & Farm, Novara, Italy.	moro@pharm.unipmn.it	Moro, Laura/ABF-2175-2020; Pinton, Giulia/ABF-2199-2020; tavian, daniela/AAE-4584-2020; LOPEZ-RODAS, GERARDO/I-1349-2015	LOPEZ-RODAS, GERARDO/0000-0001-8367-653X; Moro, Laura/0000-0003-3421-2522; Pinton, Giulia/0000-0003-0496-0378	Italian Ministry for Research; Ministerio de Ciencia y Tecnologia [BFU2007-63120]	Italian Ministry for Research(Ministry of Education, Universities and Research (MIUR)); Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by Italian Ministry for Research to LM and by Ministerio de Ciencia y Tecnologia (BFU2007-63120) to GL-R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson ED, 2002, TUMOR BIOL, V23, P93, DOI 10.1159/000059711; Bae MH, 2002, BBA-MOL CELL RES, V1592, P163, DOI 10.1016/S0167-4889(02)00310-5; Bae SK, 1999, CANCER RES, V59, P5989; Baron V, 2006, CANCER GENE THER, V13, P115, DOI 10.1038/sj.cgt.7700896; Blume A, 2009, BRAIN RES, V1302, P34, DOI 10.1016/j.brainres.2009.09.047; Boone DN, 2011, P NATL ACAD SCI USA, V108, P632, DOI 10.1073/pnas.1008848108; Cabodi S, 2009, J CELL PHYSIOL, V218, P294, DOI 10.1002/jcp.21603; CAO XM, 1993, J BIOL CHEM, V268, P16949; CAO XM, 1992, J BIOL CHEM, V267, P12991; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, P1; Copland IB, 2007, J CELL PHYSIOL, V210, P133, DOI 10.1002/jcp.20840; Figliola R, 2008, J MOL BIOL, V380, P265, DOI 10.1016/j.jmb.2008.05.004; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Gitenay D, 2009, FUTURE ONCOL, V5, P993, DOI 10.2217/FON.09.67; Gousseva N, 2001, J CELL BIOCHEM, V81, P523, DOI 10.1002/1097-4644(20010601)81:3<523::AID-JCB1066>3.0.CO;2-E; Groot M, 2000, EUR J CELL BIOL, V79, P924, DOI 10.1078/0171-9335-00126; Hannoun Z, 2010, TOXICOLOGY, V278, P288, DOI 10.1016/j.tox.2010.07.013; Huang RP, 1998, CELL DEATH DIFFER, V5, P96, DOI 10.1038/sj.cdd.4400322; HUANG RP, 1995, ONCOGENE, V10, P467; Jeong SH, 2010, EXP DERMATOL, V19, pE206, DOI 10.1111/j.1600-0625.2009.01050.x; Jin EJ, 2009, BLOOD, V114, P5557, DOI 10.1182/blood-2009-05-220434; Lee KH, 2009, CLIN EXP METASTAS, V26, P685, DOI 10.1007/s10585-009-9266-7; Liu CT, 1996, CRIT REV ONCOGENESIS, V7, P101, DOI 10.1615/CritRevOncog.v7.i1-2.70; Liu CT, 1998, CANCER GENE THER, V5, P3; Liu T, 2005, BRIT J CANCER, V93, P310, DOI 10.1038/sj.bjc.6602700; Mayer SI, 2009, J CELL SCI, V122, P3340, DOI 10.1242/jcs.048272; MITEVA M, 2010, SUMOYLATION SIGNAL P; Moro L, 2002, J BIOL CHEM, V277, P9405, DOI 10.1074/jbc.M109101200; PYU J, 2009, EMBO J, V28, P21; Rafty LA, 2001, NUCLEIC ACIDS RES, V29, P1027, DOI 10.1093/nar/29.5.1027; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Shareef MM, 2007, CANCER RES, V67, P11811, DOI 10.1158/0008-5472.CAN-07-0722; SUKHATME VP, 1991, AM J KIDNEY DIS, V17, P615, DOI 10.1016/S0272-6386(12)80333-7; SUKHATME VP, 1990, J AM SOC NEPHROL, V1, P859; Svaren J, 1996, MOL CELL BIOL, V16, P3545; Swirnoff AH, 1998, MOL CELL BIOL, V18, P512, DOI 10.1128/MCB.18.1.512; Tang KF, 2010, BBA-GEN SUBJECTS, V1800, P380, DOI 10.1016/j.bbagen.2009.11.009; Teutschbein J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-386; Townsend KJ, 1999, J BIOL CHEM, V274, P1801, DOI 10.1074/jbc.274.3.1801; Yu J, 2007, CELL DEATH DIFFER, V14, P436, DOI 10.1038/sj.cdd.4402029; Yu JX, 2004, MOL CELL, V15, P83, DOI 10.1016/j.molcel.2004.06.030	41	27	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25676	10.1371/journal.pone.0025676	http://dx.doi.org/10.1371/journal.pone.0025676			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998680	Green Published, gold, Green Submitted			2022-12-27	WOS:000295966900043
J	Ashley, JW; Shi, ZQ; Zhao, HB; Li, XS; Kesterson, RA; Feng, X				Ashley, Jason W.; Shi, Zhenqi; Zhao, Haibo; Li, Xingsheng; Kesterson, Robert A.; Feng, Xu			Genetic Ablation of CD68 Results in Mice with Increased Bone and Dysfunctional Osteoclasts	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; MACROSIALIN MOUSE CD68; VESICULAR TRAFFICKING; SURFACE EXPRESSION; KUPFFER CELLS; MACROPHAGES; RESORPTION; RECEPTOR; PROTEIN; IDENTIFICATION	CD68 is a member of the lysosome associated membrane protein (LAMP) family that is restricted in its expression to cells of the monocyte/macrophage lineage. This lineage restriction includes osteoclasts, and, while previous studies of CD68 in macrophages and dendritic cells have proposed roles in lipid metabolism, phagocytosis, and antigen presentation, the expression and function of CD68 in osteoclasts have not been explored. In this study, we investigated the expression and localization of CD68 in macrophages and osteoclasts in response to the monocyte/macrophage-colony stimulating factor (M-CSF) and the receptor activator of NF-kappa B ligand (RANKL). We found that M-CSF stimulates CD68 expression and RANKL alters the apparent molecular weight of CD68 as measured by Western immunoblotting. In addition, we explored the significance of CD68 expression in osteoclasts by generating mice that lack expression of CD68. These mice have increased trabecular bone, and in vitro assessment of CD68(-/-) osteoclasts revealed that, in the absence of CD68, osteoclasts demonstrate an accumulation of intracellular vesicle-like structures, and do not efficiently resorb bone. These findings demonstrate a role for CD68 in the function of osteoclasts, and future studies will determine the mechanistic nature of the defects seen in CD68(-/-) osteoclasts.	[Ashley, Jason W.; Shi, Zhenqi; Feng, Xu] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA; [Zhao, Haibo] Univ Arkansas Med Sci, Dept Internal Med, Little Rock, AR 72205 USA; [Li, Xingsheng] Univ Alabama, Dept Nutr Sci, Birmingham, AL 35294 USA; [Kesterson, Robert A.] Univ Alabama, Dept Genet, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Arkansas System; University of Arkansas Medical Sciences; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Ashley, JW (corresponding author), Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA.	xufeng@uab.edu	Zhao, Haibo/ABG-9729-2021; Ashley, Jason Waid/S-9142-2019	Ashley, Jason/0000-0003-1064-542X; ZHAO, HAIBO/0000-0003-0836-7555	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [AR47830]; University of Alabama at Birmingham's Center for Metabolic Bone Disease [T32 AR047512-09]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR047512, R01AR047830] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); University of Alabama at Birmingham's Center for Metabolic Bone Disease; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work is supported by grant number AR47830 (to XF) from National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), and a training fellowship (to JWA) from the University of Alabama at Birmingham's Center for Metabolic Bone Disease (T32 AR047512-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alakangas A, 2002, CALCIFIED TISSUE INT, V70, P40, DOI 10.1007/s002230010047; ATHANASOU NA, 1991, J CLIN PATHOL, V44, P664, DOI 10.1136/jcp.44.8.664; Bruun JM, 2006, AM J PHYSIOL-ENDOC M, V290, pE961, DOI 10.1152/ajpendo.00506.2005; Burghardt AJ, 2008, CALCIFIED TISSUE INT, V83, P129, DOI 10.1007/s00223-008-9158-x; Carron CP, 2000, J ENDOCRINOL, V165, P587, DOI 10.1677/joe.0.1650587; Coxon FP, 2001, J BIOL CHEM, V276, P48213, DOI 10.1074/jbc.M106473200; Coxon FP, 2008, SEMIN CELL DEV BIOL, V19, P424, DOI 10.1016/j.semcdb.2008.08.004; da Silva RP, 1999, BIOCHEM J, V338, P687, DOI 10.1042/bj3380687; de Beer MC, 2003, J LIPID RES, V44, P674, DOI 10.1194/jlr.M200444-JLR200; Gough PJ, 2003, BLOOD, V101, P485, DOI 10.1182/blood-2002-07-2131; Gough PJ, 2001, IMMUNOLOGY, V103, P351, DOI 10.1046/j.1365-2567.2001.01256.x; GRAEBER MB, 1990, J NEUROIMMUNOL, V27, P121, DOI 10.1016/0165-5728(90)90061-Q; Hall SL, 2007, MOL THER, V15, P1881, DOI 10.1038/sj.mt.6300258; Jules J, 2010, J BIOL CHEM, V285, P37427, DOI 10.1074/jbc.M110.149484; Karsdal MA, 2008, BIOCHEM BIOPH RES CO, V366, P483, DOI 10.1016/j.bbrc.2007.11.168; Karsdal MA, 2007, J BONE MINER RES, V22, P487, DOI 10.1359/JBMR.070109; Kurushima H, 2000, J LEUKOCYTE BIOL, V67, P104, DOI 10.1002/jlb.67.1.104; Li AC, 1998, J BIOL CHEM, V273, P5389, DOI 10.1074/jbc.273.9.5389; Li S, 2011, J LIPID RES, V52, P1542; Liu C, 2010, LAB INVEST, V90, P1805, DOI 10.1038/labinvest.2010.123; Llaverias G, 2004, BIOCHEM BIOPH RES CO, V318, P265, DOI 10.1016/j.bbrc.2004.04.021; Luegmayr E, 2004, CELL DEATH DIFFER, V11, pS108, DOI 10.1038/sj.cdd.4401399; Makitie T, 2001, INVEST OPHTH VIS SCI, V42, P1414; McHugh KP, 2000, J CLIN INVEST, V105, P433, DOI 10.1172/JCI8905; MINKIN C, 1982, CALCIFIED TISSUE INT, V34, P285, DOI 10.1007/BF02411252; Pavlos NJ, 2011, MOL CELL BIOL, V31, P1551, DOI 10.1128/MCB.00834-10; Pavlos NJ, 2005, MOL CELL BIOL, V25, P5253, DOI 10.1128/MCB.25.12.5253-5269.2005; RABINOWITZ SS, 1991, J EXP MED, V174, P827, DOI 10.1084/jem.174.4.827; Ramprasad MP, 1996, P NATL ACAD SCI USA, V93, P14833, DOI 10.1073/pnas.93.25.14833; RAMPRASAD MP, 1995, P NATL ACAD SCI USA, V92, P9580, DOI 10.1073/pnas.92.21.9580; Roelofs AJ, 2010, CURR PHARM DESIGN, V16, P2950; Ryder M, 2008, ENDOCR-RELAT CANCER, V15, P1069, DOI 10.1677/ERC-08-0036; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Taylor R, 2011, J PATHOL, V225, P195, DOI 10.1002/path.2869; TOMITA M, 1994, HEPATOLOGY, V20, P317, DOI 10.1002/hep.1840200208; Van Wesenbeeck L, 2007, J CLIN INVEST, V117, P919, DOI 10.1172/JCI30328; vanderKooij MA, 1997, ARTERIOSCL THROM VAS, V17, P3107, DOI 10.1161/01.ATV.17.11.3107; VanVelzen AG, 1997, BIOCHEM J, V322, P411; Xu DR, 2006, J BIOL CHEM, V281, P4678, DOI 10.1074/jbc.M510383200; Zeibig S, 2011, CIRC RES, V108, P695, DOI 10.1161/CIRCRESAHA.111.240515; Zhao HB, 2006, J BONE MINER RES, V21, P456, DOI 10.1359/JBMR.051204; Zhao HB, 2001, J BIOL CHEM, V276, P39295, DOI 10.1074/jbc.M010999200	42	27	27	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25838	10.1371/journal.pone.0025838	http://dx.doi.org/10.1371/journal.pone.0025838			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991369	Green Submitted, gold, Green Published			2022-12-27	WOS:000295943000083
J	Kottler, B; Lampin-Saint-Amaux, A; Comas, D; Preat, T; Goguel, V				Kottler, Benjamin; Lampin-Saint-Amaux, Aurelie; Comas, Daniel; Preat, Thomas; Goguel, Valerie			Debra, a Protein Mediating Lysosomal Degradation, Is Required for Long-Term Memory in Drosophila	PLOS ONE			English	Article							OLFACTORY MEMORY; MUSHROOM BODY; GENE-EXPRESSION; CONSOLIDATED MEMORY; SYNAPTIC PLASTICITY; MELANOGASTER; UBIQUITIN; BODIES; PROTEASOME; NEURONS	A central goal of neuroscience is to understand how neural circuits encode memory and guide behavior changes. Many of the molecular mechanisms underlying memory are conserved from flies to mammals, and Drosophila has been used extensively to study memory processes. To identify new genes involved in long-term memory, we screened Drosophila enhancer-trap P(Gal4) lines showing Gal4 expression in the mushroom bodies, a specialized brain structure involved in olfactory memory. This screening led to the isolation of a memory mutant that carries a P-element insertion in the debra locus. debra encodes a protein involved in the Hedgehog signaling pathway as a mediator of protein degradation by the lysosome. To study debra's role in memory, we achieved debra overexpression, as well as debra silencing mediated by RNA interference. Experiments conducted with a conditional driver that allowed us to specifically restrict transgene expression in the adult mushroom bodies led to a long-term memory defect. Several conclusions can be drawn from these results: i) debra levels must be precisely regulated to support normal long-term memory, ii) the role of debra in this process is physiological rather than developmental, and iii) debra is specifically required for long-term memory, as it is dispensable for earlier memory phases. Drosophila long-term memory is the only long-lasting memory phase whose formation requires de novo protein synthesis, a process underlying synaptic plasticity. It has been shown in several organisms that regulation of proteins at synapses occurs not only at translation level of but also via protein degradation, acting in remodeling synapses. Our work gives further support to a role of protein degradation in long-term memory, and suggests that the lysosome plays a role in this process.	[Kottler, Benjamin; Lampin-Saint-Amaux, Aurelie; Comas, Daniel; Preat, Thomas; Goguel, Valerie] ESPCI, CNRS, Neurobiol Unit, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI)	Kottler, B (corresponding author), Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia.	valerie.goguel@espci.fr	Kottler, Benjamin/K-4073-2014; KOTTLER, Benjamin/ABC-5926-2020	Kottler, Benjamin/0000-0002-4551-5791; Preat, Thomas/0000-0001-9976-1763	Agence Nationale pour la Recherche; Fondation Bettencourt-Schueller; Fondation pour la Recherche Medicale; Ministry of Research; European Marie Curie Program	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Fondation Bettencourt-Schueller; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Ministry of Research(Ministry of Research and Technology of the Republic of Indonesia (RISTEK)); European Marie Curie Program(European Commission)	This work was supported by the Agence Nationale pour la Recherche, the Fondation Bettencourt-Schueller and the Fondation pour la Recherche Medicale (to TP). BK was supported by the Ministry of Research and by the Fondation pour la Recherche Medicale, and DC was supported by the European Marie Curie Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelilah-Seyfried S, 2000, GENETICS, V155, P733; Akalal DBG, 2010, J NEUROSCI, V30, P16699, DOI 10.1523/JNEUROSCI.1882-10.2010; Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; Artinian J, 2008, EUR J NEUROSCI, V27, P3009, DOI 10.1111/j.1460-9568.2008.06262.x; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Benito E, 2010, TRENDS NEUROSCI, V33, P230, DOI 10.1016/j.tins.2010.02.001; Berry J, 2008, PROG BRAIN RES, V169, P293, DOI 10.1016/S0079-6123(07)00018-0; Bilen J, 2007, PLOS GENET, V3, P1950, DOI 10.1371/journal.pgen.003177; Bingol B, 2011, NEURON, V69, P22, DOI 10.1016/j.neuron.2010.11.006; Boquet I, 2000, J NEUROBIOL, V42, P33; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chabaud MA, 2009, CURR BIOL, V19, P1654, DOI 10.1016/j.cub.2009.08.017; Chain DG, 1999, MOL NEUROBIOL, V20, P125, DOI 10.1007/BF02742438; Comas D, 2004, NATURE, V430, P460, DOI 10.1038/nature02726; Copf T, 2011, P NATL ACAD SCI USA, V108, P8059, DOI 10.1073/pnas.1012919108; Costa-Mattioli M, 2008, PROG BRAIN RES, V169, P81, DOI 10.1016/S0079-6123(07)00005-2; Crittenden JR, 1998, LEARN MEMORY, V5, P38; Dai P, 2003, DEV CELL, V4, P917, DOI 10.1016/S1534-5807(03)00158-8; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; Deshapriya RMC, 2007, ZOOL SCI, V24, P21, DOI 10.2108/zsj.24.21; DeZazzo J, 2000, NEURON, V27, P145, DOI 10.1016/S0896-6273(00)00016-7; Didelot G, 2006, SCIENCE, V313, P851, DOI 10.1126/science.1127215; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; Ge XC, 2004, P NATL ACAD SCI USA, V101, P10172, DOI 10.1073/pnas.0403497101; Hegde AN, 1997, CELL, V89, P115, DOI 10.1016/S0092-8674(00)80188-9; HEGDE AN, 1993, P NATL ACAD SCI USA, V90, P7436, DOI 10.1073/pnas.90.16.7436; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932; Ito K, 1998, LEARN MEMORY, V5, P52; Keene AC, 2007, NAT REV NEUROSCI, V8, P341, DOI 10.1038/nrn2098; Khokhar A, 2008, GENETICS, V178, P1283, DOI 10.1534/genetics.106.065912; Lai EC, 2001, DEV CELL, V1, P783, DOI 10.1016/S1534-5807(01)00092-2; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Lopez-Salon M, 2001, EUR J NEUROSCI, V14, P1820, DOI 10.1046/j.0953-816x.2001.01806.x; Mao ZM, 2004, P NATL ACAD SCI USA, V101, P198, DOI 10.1073/pnas.0306128101; Merlo E, 2007, NEUROSCIENCE, V147, P46, DOI 10.1016/j.neuroscience.2007.04.022; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; Pavlopoulos E, 2008, P NATL ACAD SCI USA, V105, P14674, DOI 10.1073/pnas.0801605105; Perazzona B, 2004, J NEUROSCI, V24, P8823, DOI 10.1523/JNEUROSCI.4542-03.2004; Piccin A, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.12.e55; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Preat T, 1998, J NEUROSCI, V18, P8534; Presente A, 2004, P NATL ACAD SCI USA, V101, P1764, DOI 10.1073/pnas.0308259100; Rodriguez-Ortiz CJ, 2011, NEUROBIOL LEARN MEM, V95, P311, DOI 10.1016/j.nlm.2010.12.010; Roman G, 2001, P NATL ACAD SCI USA, V98, P12602, DOI 10.1073/pnas.221303998; Schwaerzel M, 2002, NEURON, V35, P951, DOI 10.1016/S0896-6273(02)00832-2; Szuperak M, 2005, GENE EXPR PATTERNS, V5, P717, DOI 10.1016/j.modgep.2005.02.004; Tai HC, 2008, NAT REV NEUROSCI, V9, P826, DOI 10.1038/nrn2499; Tseng ASK, 2002, GENETICS, V162, P229; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Wu JS, 2006, NAT PROTOC, V1, P2110, DOI 10.1038/nprot.2006.336; Yin JCP, 1996, CURR OPIN NEUROBIOL, V6, P264, DOI 10.1016/S0959-4388(96)80082-1; Yu DH, 2006, NEURON, V52, P845, DOI 10.1016/j.neuron.2006.10.030	54	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25902	10.1371/journal.pone.0025902	http://dx.doi.org/10.1371/journal.pone.0025902			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991383	gold, Green Published, Green Submitted			2022-12-27	WOS:000295943000093
J	Yao, S; Sucheston, LE; Smiley, SL; Davis, W; Conroy, JM; Nowak, NJ; Ambrosone, CB; McCarthy, PL; Hahn, T				Yao, Song; Sucheston, Lara E.; Smiley, Shannon L.; Davis, Warren; Conroy, Jeffrey M.; Nowak, Norma J.; Ambrosone, Christine B.; McCarthy, Philip L., Jr.; Hahn, Theresa			Common Genetic Variants Are Associated with Accelerated Bone Mineral Density Loss after Hematopoietic Cell Transplantation	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MARROW STROMAL CELLS; OSTEOPOROSIS; FRACTURES; CANCER	Background: Bone mineral density (BMD) loss commonly occurs after hematopoietic cell transplantation (HCT). Hypothesizing that genetic variants may influence post-HCT BMD loss, we conducted a prospective study to examine the associations of single nucleotide polymorphisms (SNP) in bone metabolism pathways and acute BMD loss after HCT. Methods and Findings: We genotyped 122 SNPs in 45 genes in bone metabolism pathways among 121 autologous and allogeneic HCT patients. BMD changes from pre-HCT to day + 100 post-HCT were analyzed in relation to these SNPs in linear regression models. After controlling for clinical risk factors, we identified 16 SNPs associated with spinal or femoral BMD loss following HCT, three of which have been previously implicated in genome-wide association studies of bone phenotypes, including rs2075555 in COL1A1, rs9594738 in RANKL, and rs4870044 in ESR1. When multiple SNPs were considered simultaneously, they explained 5-35% of the variance in post-HCT BMD loss. There was a significant trend between the number of risk alleles and the magnitude of BMD loss, with patients carrying the most risk alleles having the greatest loss. Conclusion: Our data provide the first evidence that common genetic variants play an important role in BMD loss among HCT patients similar to age-related BMD loss in the general population. This infers that the mechanism for post-HCT bone loss is a normal aging process that is accelerated during HCT. A limitation of our study comes from its small patient population; hence future larger studies are warranted to validate our findings.	[Yao, Song; Sucheston, Lara E.; Davis, Warren; Ambrosone, Christine B.] Roswell Pk Canc Inst, Dept Canc Prevent & Control, Buffalo, NY 14263 USA; [Smiley, Shannon L.; McCarthy, Philip L., Jr.; Hahn, Theresa] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA; [Conroy, Jeffrey M.; Nowak, Norma J.] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA; [Nowak, Norma J.] SUNY Buffalo, Dept Biochem, Buffalo, NY 14214 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Yao, S (corresponding author), Roswell Pk Canc Inst, Dept Canc Prevent & Control, Buffalo, NY 14263 USA.	Theresa.hahn@roswellpark.org	Yao, Song/A-2534-2012; McCarthy, Philip/ABA-5329-2020	Yao, Song/0000-0001-9442-1313	Cancer and Leukemia Group B (CALGB); NIH [5P30CA016056-34]; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER	Cancer and Leukemia Group B (CALGB); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in part, by a Cancer and Leukemia Group B (CALGB) Investigator Award for junior oncology faculty (S.L.S). The DataBank and BioRepository and the Genomics Shared Resource at Roswell Park Cancer Institute are Cancer Center Support Grant (CCSG) Shared Resources (NIH 5P30CA016056-34). The funding organizations played no roles during the conduct of the study or the preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosone CB, 2006, CANCER EPIDEM BIOMAR, V15, P1575, DOI 10.1158/1055-9965.EPI-06-0628; Amling M, 1996, J BONE MINER RES, V11, P36, DOI 10.1002/jbmr.5650110107; Benjamin RM, 2010, J AM DIET ASSOC, V110, P498, DOI 10.1016/j.jada.2010.02.018; Chen Bowang, 2009, BMC Res Notes, V2, P214, DOI 10.1186/1756-0500-2-214; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Eisman JA, 1999, ENDOCR REV, V20, P788, DOI 10.1210/er.20.6.788; Gamazon ER, 2010, BIOINFORMATICS, V26, P259, DOI 10.1093/bioinformatics/btp644; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; KELLY PJ, 1990, TRANSPLANTATION, V50, P881; Kiel DP, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S14; Lee WY, 2002, J CLIN ENDOCR METAB, V87, P329, DOI 10.1210/jc.87.1.329; Liu YZ, 2003, J ENDOCRINOL, V177, P147, DOI 10.1677/joe.0.1770147; McClune BL, 2011, BONE MARROW TRANSPL, V46, P1, DOI 10.1038/bmt.2010.198; Murabito JM, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S6; Peacock M, 2002, ENDOCR REV, V23, P303, DOI 10.1210/er.23.3.303; PERRONE M, 2010, FDA CLEARS AMGENS BO; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Richards JB, 2009, ANN INTERN MED, V151, P528, DOI 10.7326/0003-4819-151-8-200910200-00006; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Schulte CMS, 2004, BLOOD, V103, P3635, DOI 10.1182/blood-2003-09-3081; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Styrkarsdottir U, 2009, NAT GENET, V41, P15, DOI 10.1038/ng.284; Tauchmanova L, 2002, J CLIN ENDOCR METAB, V87, P5058, DOI 10.1210/jc.2002-020800; Yao S, 2008, BONE MARROW TRANSPL, V41, P393, DOI 10.1038/sj.bmt.1705918; Yao S, 2010, BIOL BLOOD MARROW TR, V16, P1130, DOI 10.1016/j.bbmt.2010.02.017	26	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e25940	10.1371/journal.pone.0025940	http://dx.doi.org/10.1371/journal.pone.0025940			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022476	Green Submitted, Green Published, gold			2022-12-27	WOS:000295981600021
J	Chua, KB; Voon, K; Yu, M; Keniscope, C; Rasid, KA; Wang, LF				Chua, Kaw Bing; Voon, Kenny; Yu, Meng; Keniscope, Canady; Rasid, Kasri Abdul; Wang, Lin-Fa			Investigation of a Potential Zoonotic Transmission of Orthoreovirus Associated with Acute Influenza-Like Illness in an Adult Patient	PLOS ONE			English	Article							VIRUS	Bats are increasingly being recognized as important reservoir hosts for a large number of viruses, some of them can be highly virulent when they infect human and livestock animals. Among the new bat zoonotic viruses discovered in recent years, several reoviruses (respiratory enteric orphan viruses) were found to be able to cause acute respiratory infections in humans, which included Melaka and Kampar viruses discovered in Malaysia, all of them belong to the genus Orthoreovirus, family Reoviridae. In this report, we describe the isolation of a highly related virus from an adult patient who suffered acute respiratory illness in Malaysia. Although there was no direct evidence of bat origin, epidemiological study indicated the potential exposure of the patient to bats before the onset of disease. The current study further demonstrates that spillover events of different strains of related orthoreoviruses from bats to humans are occurring on a regular basis, which calls for more intensive and systematic surveillances to fully assess the true public health impact of these newly discovered bat-borne zoonotic reoviruses.	[Chua, Kaw Bing; Keniscope, Canady; Rasid, Kasri Abdul] Natl Publ Hlth Lab, Sg Buloh, Selangor, Malaysia; [Chua, Kaw Bing; Voon, Kenny] Int Med Univ, Kuala Lumpur 57000, Malaysia; [Yu, Meng; Wang, Lin-Fa] Commonwealth Sci & Ind Res Org Livestock Ind, Australian Anim Hlth Lab, Geelong, Vic, Australia	International Medical University Malaysia; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Chua, KB (corresponding author), Natl Publ Hlth Lab, Sg Buloh, Selangor, Malaysia.	chuakawbing@yahoo.com.sg; linfa.wang@csiro.au	Voon, Kenny/AAF-8611-2019; wang, lin/GSE-3040-2022; Voon, Kenny/I-8827-2017	Wang, Lin-Fa/0000-0003-2752-0535; Voon, Kenny/0000-0002-5418-5309	International Medical University, Malaysia; CSIRO Australian Animal Health Laboratory	International Medical University, Malaysia; CSIRO Australian Animal Health Laboratory	This work was partially supported by institute funding from the International Medical University, Malaysia, and CSIRO Australian Animal Health Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng P, 2009, J CLIN VIROL, V45, P79, DOI 10.1016/j.jcv.2009.03.001; Chua K. B., 1996, Southeast Asian Journal of Tropical Medicine and Public Health, V27, P91; Chua K B, 2004, Malays J Pathol, V26, P69; Chua KB, 2007, P NATL ACAD SCI USA, V104, P11424, DOI 10.1073/pnas.0701372104; Chua KB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003803; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Du LF, 2010, ARCH VIROL, V155, P1295, DOI 10.1007/s00705-010-0690-4; Duncan R, 1999, VIROLOGY, V260, P316, DOI 10.1006/viro.1999.9832; GARD G, 1970, J VIROL, V6, P100, DOI 10.1128/JVI.6.1.100-106.1970; GARD GP, 1973, ARCH GES VIRUSFORSCH, V43, P34, DOI 10.1007/BF01249346; HIRSCH MS, 1996, FIELDS VIROLOGY, P1953; Ksiazek TG, 2003, NEW ENGL J MED, V30, P30; Mertens PPC, 2005, VIRUS TAXONOMY, P447; Pritchard LI, 2006, ARCH VIROL, V151, P229, DOI 10.1007/s00705-005-0644-4; Schiff L.A., 2007, FIELDS VIROLOGY, V2, P1853; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Woolhouse MEJ, 2008, P ROY SOC B-BIOL SCI, V275, P2111, DOI 10.1098/rspb.2008.0294	17	67	73	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e25434	10.1371/journal.pone.0025434	http://dx.doi.org/10.1371/journal.pone.0025434			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022394	Green Published, Green Submitted, gold			2022-12-27	WOS:000295978600013
J	Dodds, TJ; Mohler, BJ; Bulthoff, HH				Dodds, Trevor J.; Mohler, Betty J.; Buelthoff, Heinrich H.			Talk to the Virtual Hands: Self-Animated Avatars Improve Communication in Head-Mounted Display Virtual Environments	PLOS ONE			English	Article							TASK-PERFORMANCE; GESTURE; REPRESENTATION; ONLINE	Background: When we talk to one another face-to-face, body gestures accompany our speech. Motion tracking technology enables us to include body gestures in avatar-mediated communication, by mapping one's movements onto one's own 3D avatar in real time, so the avatar is self-animated. We conducted two experiments to investigate (a) whether head-mounted display virtual reality is useful for researching the influence of body gestures in communication; and (b) whether body gestures are used to help in communicating the meaning of a word. Participants worked in pairs and played a communication game, where one person had to describe the meanings of words to the other. Principal Findings: In experiment 1, participants used significantly more hand gestures and successfully described significantly more words when nonverbal communication was available to both participants (i.e. both describing and guessing avatars were self-animated, compared with both avatars in a static neutral pose). Participants 'passed' (gave up describing) significantly more words when they were talking to a static avatar (no nonverbal feedback available). In experiment 2, participants' performance was significantly worse when they were talking to an avatar with a prerecorded listening animation, compared with an avatar animated by their partners' real movements. In both experiments participants used significantly more hand gestures when they played the game in the real world. Conclusions: Taken together, the studies show how (a) virtual reality can be used to systematically study the influence of body gestures; (b) it is important that nonverbal communication is bidirectional (real nonverbal feedback in addition to nonverbal communication from the describing participant); and (c) there are differences in the amount of body gestures that participants use with and without the head-mounted display, and we discuss possible explanations for this and ideas for future investigation.	[Dodds, Trevor J.; Mohler, Betty J.; Buelthoff, Heinrich H.] Max Planck Inst Biol Cybernet, Tubingen, Germany; [Buelthoff, Heinrich H.] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea	Max Planck Society; Korea University	Dodds, TJ (corresponding author), Max Planck Inst Biol Cybernet, Tubingen, Germany.	trevor.dodds@tuebingen.mpg.de	Bülthoff, Heinrich H/J-6579-2012; Bülthoff, Heinrich/AAC-8818-2019	Bülthoff, Heinrich H/0000-0003-2568-0607; 	Max Planck Society; WCU (World Class University); Ministry of Education, Science and Technology through the National Research Foundation of Korea [R31-10008]	Max Planck Society(Max Planck SocietyFoundation CELLEX); WCU (World Class University); Ministry of Education, Science and Technology through the National Research Foundation of Korea	This research was supported by a post doctoral grant from the Max Planck Society, and by the WCU (World Class University) program funded by the Ministry of Education, Science and Technology through the National Research Foundation of Korea (R31-10008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], MICROSOFT KINECT; Ashenfelter KT, 2009, J EXP PSYCHOL HUMAN, V35, P1072, DOI 10.1037/a0015017; Bailenson JN, 2002, J VISUAL COMP ANIMAT, V13, P313, DOI 10.1002/vis.297; Bailenson JN, 2008, MEDIATED INTERPERSON, V6, P77, DOI 10.4324/9780203926864; BARONI M, 2006, P EUR CHAP ASS COMP; CHARTRAND TL, 2005, NEW UNCONSCIOUS, P334, DOI DOI 10.1093/ACPROF:OSO/9780195307696.003; Choi YS., 2005, NEW UNCONSCIOUS, P309; Di Luca M, 2010, PRESENCE-TELEOP VIRT, V19, P569, DOI 10.1162/pres_a_00023; Dodds TJ, 2009, COMPUT GRAPH-UK, V33, P130, DOI 10.1016/j.cag.2009.01.001; Ennis C, 2010, ACM T GRAPHIC, V29, DOI 10.1145/1778765.1778828; Goldin-Meadow S, 1999, TRENDS COGN SCI, V3, P419, DOI 10.1016/S1364-6613(99)01397-2; Iverson JM, 1998, NATURE, V396, P228, DOI 10.1038/24300; KENDON A, 1970, ACTA PSYCHOL, V32, P100; Kendon A, 1990, CONDUCTING INTERACTI; KNOPF M, 1992, ANN NY ACAD SCI, V673, P172, DOI 10.1111/j.1749-6632.1992.tb27450.x; Lenggenhager B, 2009, CONSCIOUS COGN, V18, P110, DOI 10.1016/j.concog.2008.11.003; Lindeman RW, 2009, IEEE COMPUT GRAPH, V29, P80, DOI 10.1109/MCG.2009.28; Lok B, 2003, PRESENCE-VIRTUAL AUG, V12, P615, DOI 10.1162/105474603322955914; McDonnell R, 2009, ACM T APPL PERCEPT, V6, DOI 10.1145/1609967.1609969; Mcneill David, 2007, GESTURE THOUGHT; Mehrabian A., 1972, NONVERBAL COMMUNICAT; Mohler BJ, 2010, PRESENCE-TELEOP VIRT, V19, P230, DOI 10.1162/pres.19.3.230; Morsella E, 2004, AM J PSYCHOL, V117, P411, DOI 10.2307/4149008; OMalley J.M, 1990, LEARNING STRATEGIES; Pertaub DP, 2001, STUD HEALTH TECHNOL, V81, P372; Rowe ML, 2009, SCIENCE, V323, P951, DOI 10.1126/science.1167025; Sanchez-Vives MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010381; Schroeder R, 2006, PRESENCE-VIRTUAL AUG, V15, P655, DOI 10.1162/pres.15.6.655; Slater M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000039; Slater M, 2010, ACM T GRAPHIC, V29, DOI 10.1145/1778765.1778829; Slater M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010564; Slater M, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.006.2008; STEPTOE W, 2010, P 28 ACM SIGCHI C HU; *U STUTTG, TREETAGGER LANG IND; VINAYAGAMOORTHY V, 2006, EUR C STAT OF THE AR, P21; Whittaker S., 2003, HDB DISCOURSE PROCES, P253; Yee N, 2007, HUM COMMUN RES, V33, P271, DOI 10.1111/j.1468-2958.2007.00299.x; Yee N, 2006, PRESENCE-VIRTUAL AUG, V15, P309, DOI 10.1162/pres.15.3.309; Yee N, 2009, COMMUN RES, V36, P285, DOI 10.1177/0093650208330254; Zanbaka Catherine, 2006, P SIGCHI C HUM FACT, pD01, DOI [10.1145/1124772.1124945, DOI 10.1145/1124772.1124945]	40	36	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25759	10.1371/journal.pone.0025759	http://dx.doi.org/10.1371/journal.pone.0025759			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834PW	22022442	Green Submitted, gold, Green Published			2022-12-27	WOS:000295976000036
J	Hutchinson, JR; Bates, KT; Molnar, J; Allen, V; Makovicky, PJ				Hutchinson, John R.; Bates, Karl T.; Molnar, Julia; Allen, Vivian; Makovicky, Peter J.			A Computational Analysis of Limb and Body Dimensions in Tyrannosaurus rex with Implications for Locomotion, Ontogeny, and Growth	PLOS ONE			English	Article							MUSCLE MOMENT ARMS; ELITE SPRINTING ATHLETE; BIPEDAL RUNNING ABILITY; FUNCTIONAL SPECIALIZATION; PELVIC LIMB; ALLOMETRIC EQUATIONS; SENSITIVITY-ANALYSIS; INERTIAL PROPERTIES; HINDLIMB MUSCULATURE; POSTNATAL ONTOGENY	The large theropod dinosaur Tyrannosaurus rex underwent remarkable changes during its growth from <10 kg hatchlings to >6000 kg adults in <20 years. These changes raise fascinating questions about the morphological transformations involved, peak growth rates, and scaling of limb muscle sizes as well as the body's centre of mass that could have influenced ontogenetic changes of locomotion in T. rex. Here we address these questions using three-dimensionally scanned computer models of four large, well-preserved fossil specimens as well as a putative juvenile individual. Furthermore we quantify the variations of estimated body mass, centre of mass and segment dimensions, to characterize inaccuracies in our reconstructions. These inaccuracies include not only subjectivity but also incomplete preservation and inconsistent articulations of museum skeletons. Although those problems cause ambiguity, we conclude that adult T. rex had body masses around 6000-8000 kg, with the largest known specimen ("Sue") perhaps similar to 9500 kg. Our results show that during T. rex ontogeny, the torso became longer and heavier whereas the limbs became proportionately shorter and lighter. Our estimates of peak growth rates are about twice as rapid as previous ones but generally support previous methods, despite biases caused by the usage of scale models and equations that underestimate body masses. We tentatively infer that the hindlimb extensor muscles masses, including the large tail muscle M. caudofemoralis longus, may have decreased in their relative size as the centre of mass shifted craniodorsally during T. rex ontogeny. Such ontogenetic changes would have worsened any relative or absolute decline of maximal locomotor performance. Regardless, T. rex probably had hip and thigh muscles relatively larger than any extant animal's. Overall, the limb "antigravity" muscles may have been as large as or even larger than those of ratite birds, which themselves have the most muscular limbs of any living animal.	[Hutchinson, John R.; Molnar, Julia; Allen, Vivian] Royal Vet Coll, Dept Vet Basic Sci, Struct & Mot Lab, Hatfield, Herts, England; [Bates, Karl T.] Univ Liverpool, Inst Aging & Chron Dis, Dept Musculoskeletal Biol, Liverpool L69 3BX, Merseyside, England; [Makovicky, Peter J.] Field Museum Nat Hist, Dept Geol, Chicago, IL 60605 USA	University of London; University of London Royal Veterinary College; University of Liverpool; Field Museum of Natural History (Chicago)	Hutchinson, JR (corresponding author), Royal Vet Coll, Dept Vet Basic Sci, Struct & Mot Lab, Hatfield, Herts, England.	jrhutch@rvc.ac.uk	Hutchinson, John/AAH-1593-2020	Hutchinson, John/0000-0002-6767-7038; Molnar, Julia/0000-0003-1455-0487	Natural Environment Research Council [NE/G00711X/1]; NERC [NE/G005877/1, NE/G00711X/1] Funding Source: UKRI; Natural Environment Research Council [NE/G005877/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	JH and JM were funded by Natural Environment Research Council (www.nerc.ac.uk) grant number NE/G00711X/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R.M., 1989, DYNAMICS DINOSAURS O; ALEXANDER RM, 1985, ZOOL J LINN SOC-LOND, V83, P1, DOI 10.1111/j.1096-3642.1985.tb00871.x; ALEXANDER RM, 1975, J ZOOL, V177, P265, DOI 10.1111/j.1469-7998.1975.tb05983.x; Alexander RM., 2003, PRINCIPLES ANIMAL LO; ALEXANDER RMN, 1977, J ZOOL, V183, P125, DOI 10.1111/j.1469-7998.1977.tb04177.x; Allen V, 2010, J ANAT, V216, P423, DOI 10.1111/j.1469-7580.2009.01202.x; Allen V, 2009, ANAT REC, V292, P1442, DOI 10.1002/ar.20973; ANDERSON JF, 1985, J ZOOL, V207, P53, DOI 10.1111/j.1469-7998.1985.tb04915.x; [Anonymous], 2009, SKELETAL MUSCLE STRU; Bakker R.T., 1988, HUNTERIA, V1, P1, DOI DOI 10.5281/ZEN0D0.1037529; Bates KT, 2010, J VERTEBR PALEONTOL, V30, P458, DOI 10.1080/02724630903409329; Bates KT, 2009, PALAEONTOL ELECTRON, V12; Bates KT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004532; Bates KT, 2008, J VERTEBRATE PALEO S, V28; BIEWENER AA, 1989, SCIENCE, V245, P45, DOI 10.1126/science.2740914; Biewener AA, 2005, J EXP BIOL, V208, P1665, DOI 10.1242/jeb.01520; Biewener AA., 2003, ANIMAL LOCOMOTION; Brochu CA, 2003, J VERTEBR PALEONTOL, V22, P1, DOI [10.1080/02724634.2003.10010947, DOI 10.1080/02724634.2003.10010947, 10.2307/3889334, DOI 10.2307/3889334]; Brusatte SL, 2010, SCIENCE, V329, P1481, DOI 10.1126/science.1193304; Buchner HHF, 1997, J BIOMECH, V30, P653, DOI 10.1016/S0021-9290(97)00005-5; Bybee PJ, 2006, J MORPHOL, V267, P347, DOI 10.1002/jmor.10406; Carlson KJ, 2006, PRIMATES, V47, P218, DOI 10.1007/s10329-005-0166-4; Carpenter K., 1990, P141, DOI 10.1017/CBO9780511608377.013; Carr TD, 2004, ZOOL J LINN SOC-LOND, V142, P479, DOI 10.1111/j.1096-3642.2004.00130.x; Carr TD, 1999, J VERTEBR PALEONTOL, V19, P497, DOI 10.1080/02724634.1999.10011161; Carrano MT, 2002, J MORPHOL, V253, P207, DOI 10.1002/jmor.10018; Carrano MT, 2001, J ZOOL, V254, P41, DOI 10.1017/S0952836901000541; Carrano MT, 1999, J ZOOL, V247, P29, DOI 10.1111/j.1469-7998.1999.tb00190.x; CARRIER D, 1990, J ZOOL, V222, P375, DOI 10.1111/j.1469-7998.1990.tb04039.x; Carrier DR, 1996, PHYSIOL ZOOL, V69, P467, DOI 10.1086/physzool.69.3.30164211; CARRIER DR, 1983, J ZOOL, V201, P27; Cawley GC, 2010, J ZOOL, V280, P355, DOI 10.1111/j.1469-7998.2009.00665.x; Christiansen P., 2004, Historical Biology, V16, P85, DOI 10.1080/08912960412331284313; CLARK J, 1975, J ZOOL, V176, P87; COOMBS WP, 1978, Q REV BIOL, V53, P393, DOI 10.1086/410790; Currie Philip J., 2000, Gaia (Lisboa), V15, P271; Currie PJ, 2003, CAN J EARTH SCI, V40, P651, DOI 10.1139/E02-083; DODSON P, 1975, J ZOOL, V175, P315; Erickson GM, 2004, NATURE, V430, P772, DOI 10.1038/nature02699; Erickson GM, 2000, ZOOL J LINN SOC-LOND, V130, P551, DOI 10.1006/zjls.2000.0243; Erickson GM, 2001, NATURE, V412, P429, DOI 10.1038/35086558; Erickson GM, 2006, SCIENCE, V313, P213, DOI 10.1126/science.1125721; Erickson GM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007390; Farlow JO, 1995, J VERTEBR PALEONTOL, V15, P713, DOI 10.1080/02724634.1995.10011257; FEDAK MA, 1982, J EXP BIOL, V97, P23; GATESY SM, 1990, PALEOBIOLOGY, V16, P170, DOI 10.1017/S0094837300009866; GATESY SM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P219; Gatesy SM, 2009, J VERTEBR PALEONTOL, V29, P535, DOI 10.1671/039.029.0213; Hand S, 2004, J VERTEBRATE PALEO S, V24; Henderson DM, 1999, PALEOBIOLOGY, V25, P88; Henderson DM, 2004, P ROY SOC B-BIOL SCI, V271, pS57, DOI 10.1098/rsbl.2003.0097; Henderson MD, 2008, TYRANNOSAURUS REX TY, P83; Herrel A, 2006, PHYSIOL BIOCHEM ZOOL, V79, P1, DOI 10.1086/498196; Herzog W., 2000, SKELETAL MUSCLE MECH; HILDEBRAND M, 1985, J MORPHOL, V184, P23, DOI 10.1002/jmor.1051840103; Horner JR, 2004, P ROY SOC B-BIOL SCI, V271, P1875, DOI 10.1098/rspb.2004.2829; Hudson PE, 2011, J ANAT, V218, P375, DOI 10.1111/j.1469-7580.2011.01344.x; Hudson PE, 2011, J ANAT, V218, P363, DOI 10.1111/j.1469-7580.2010.01310.x; Hutchinson JR, 2007, J THEOR BIOL, V246, P660, DOI 10.1016/j.jtbi.2007.01.023; Hutchinson JR, 2006, J EXP BIOL, V209, P3812, DOI 10.1242/jeb.02443; Hutchinson JR, 2011, ANAT REC, V294, P756, DOI 10.1002/ar.21356; Hutchinson JR, 2009, NATURWISSENSCHAFTEN, V96, P423, DOI 10.1007/s00114-008-0488-3; Hutchinson JR, 2005, PALEOBIOLOGY, V31, P676; Hutchinson JR, 2004, J MORPHOL, V262, P441, DOI 10.1002/jmor.10240; Hutchinson JR, 2004, J MORPHOL, V262, P421, DOI 10.1002/jmor.10241; Hutchinson JR, 2002, NATURE, V415, P1018, DOI 10.1038/4151018a; Irschick DJ, 2000, J EXP BIOL, V203, P2133; Kilbourne BM, 2010, J ANAT, V217, P135, DOI 10.1111/j.1469-7580.2010.01253.x; Larson Neal L., 2008, P1; Larson Peter L., 1994, Paleontological Society Special Publication, V7, P139; Larson PL, 1998, DIN INT S 3; Lipkin C, 2007, J PALEONTOL, V81, P1523, DOI 10.1666/06-024.1; Main RP, 2007, J EXP BIOL, V210, P2676, DOI 10.1242/jeb.004580; Molnar R.E., 1990, P71, DOI 10.1017/CBO9780511608377.008; Newman B. H., 1970, Biol. J. Linn. Soc., V2, P119, DOI 10.1111/j.1095-8312.1970.tb01707.x; Osborn HF, 1906, B AM MUS NAT HIST, V22, P281; Osborn HF, 1916, B AM MUS NAT HIST, V35, P733; Packard GC, 2010, J ZOOL, V282, P221, DOI 10.1111/j.1469-7998.2010.00737.x; Packard GC, 2009, J ZOOL, V279, P102, DOI 10.1111/j.1469-7998.2009.00594.x; PAGEL M, 1991, NATURE, V351, P532, DOI 10.1038/351532a0; Paul G., 1988, PREDATORY DINOSAURS; Paul Gregory S., 2000, Gaia (Lisboa), V15, P257; Paul Gregory S., 2008, P306; Paxton H, 2010, J ANAT, V217, P153, DOI 10.1111/j.1469-7580.2010.01251.x; Payne RC, 2005, J ANAT, V206, P557, DOI 10.1111/j.1469-7580.2005.00420.x; Payne RC, 2004, J ANAT, V206, P557; Persons W, 2009, J VERTEBRATE PALE S3, V29; Persons WS, 2011, ANAT REC, V294, P119, DOI 10.1002/ar.21290; Peterson JE, 2009, PALAIOS, V24, P780, DOI 10.2110/palo.2009.p09-056r; Qi Z, 2007, PALAEONTOLOGY, V50, P1023, DOI 10.1111/j.1475-4983.2007.00709.x; Reilly SA, 2005, J EXP BIOL, V208, P993, DOI 10.1242/jeb.01473; Reilly SM, 1998, BRAIN BEHAV EVOLUT, V52, P126, DOI 10.1159/000006557; Ricklefs RE, 2007, BIOL LETTERS, V3, P214, DOI 10.1098/rsbl.2006.0597; Romer AS, 1923, B AM MUS NAT HIST, V48, P605; Rubenson J, 2006, J EXP BIOL, V209, P2395, DOI 10.1242/jeb.02310; Rubenson J, 2011, J R SOC INTERFACE, V8, P740, DOI 10.1098/rsif.2010.0466; Russell D. A., 1970, Publs Palaeont. nat. Mus. Canada, VNo. 1, P1; Schauder W., 1924, Zeitschrift Ges Anat Munchen Abt 1, V71, P559, DOI 10.1007/BF02117347; Schoonaert K, 2007, J ANAT, V210, P518, DOI 10.1111/j.1469-7580.2007.00720.x; Seebacher F, 2001, J VERTEBR PALEONTOL, V21, P51, DOI 10.1671/0272-4634(2001)021[0051:ANMTCA]2.0.CO;2; Sellers WI, 2007, P ROY SOC B-BIOL SCI, V274, P2711, DOI 10.1098/rspb.2007.0846; Smith NC, 2010, J EXP BIOL, V213, P1347, DOI 10.1242/jeb.020271; Snively E, 2003, J MORPHOL, V255, P215, DOI 10.1002/jmor.10059; Snively E, 2007, PALEOBIOLOGY, V33, P610, DOI 10.1666/06059.1; Snively Eric, 2002, Senckenbergiana Lethaea, V82, P35; TARSITANO S, 1983, Acta Palaeontologica Polonica, V28, P251; Usherwood JR, 2005, NATURE, V438, P753, DOI 10.1038/438753a; Verstappen M, 1998, ZOOMORPHOLOGY, V118, P207, DOI 10.1007/s004350050070; Walker A.D., 1977, Linnean Soc Symp Ser, VNo. 4, P319; Weyand PG, 2000, J APPL PHYSIOL, V89, P1991, DOI 10.1152/jappl.2000.89.5.1991; Weyand PG, 2005, J EXP BIOL, V208, P2625, DOI 10.1242/jeb.01609; Williams SB, 2008, J ANAT, V213, P361, DOI [10.1111/j.1469-7580.2008.00961.x, 10.1111/j.1469-7580.2008.00962.x]; Williams SB, 2007, J ANAT, V210, P472, DOI 10.1111/j.1469-7580.2007.00704.x; Williams SB, 2007, J ANAT, V210, P491, DOI 10.1111/j.1469-7580.2007.00703.x; Winter D. A., 2009, BIOMECHANICS MOTOR C, DOI DOI 10.1002/9780470549148; Zaaf A, 1999, ZOOMORPHOLOGY, V119, P9, DOI 10.1007/s004350050077	116	76	80	1	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26037	10.1371/journal.pone.0026037	http://dx.doi.org/10.1371/journal.pone.0026037			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022500	Green Published, Green Submitted, gold			2022-12-27	WOS:000295976000058
J	Robles, MTS; Case, A; Chong, JL; Leone, G; Pipas, JM				Robles, Maria Teresa Saenz; Case, Ashley; Chong, Jean-Leon; Leone, Gustavo; Pipas, James M.			The Retinoblastoma Tumor Suppressor Regulates a Xenobiotic Detoxification Pathway	PLOS ONE			English	Article							DRUG-METABOLIZING-ENZYMES; LARGE T-ANTIGEN; RB/E2F PATHWAY; RB; CANCER; TUMORIGENESIS; DEFICIENT; ROLES; MOUSE; MICE	The retinoblastoma tumor suppressor (pRb) regulates cell cycle entry, progression and exit by controlling the activity of the E2F-family of transcription factors. During cell cycle exit pRb acts as a transcriptional repressor by associating with E2F proteins and thereby inhibiting their ability to stimulate the expression of genes required for S phase. Indeed, many tumors harbor mutations in the RB gene and the pRb-E2F pathway is compromised in nearly all types of cancers. In this report we show that both pRb and its interacting partners, the transcriptional factors E2F1-2-3, act as positive modulators of detoxification pathways important for metabolizing and clearing xenobiotics-such as toxins and drugs-from the body. Using a combination of conventional molecular biology techniques and microarray analysis of specific cell populations, we have analyzed the detoxification pathway in murine samples in the presence or absence of pRb and/or E2F1-2-3. In this report, we show that both pRb and E2F1-2-3 act as positive modulators of detoxification pathways in mice, challenging the conventional view of E2F1-2-3 as transcriptional repressors negatively regulated by pRb. These results suggest that mutations altering the pRb-E2F axis may have consequences beyond loss of cell cycle control by altering the ability of tissues to remove toxins and to properly metabolize anticancer drugs, and might help to understand the formation and progression rates of different types of cancer, as well as to better design appropriate therapies based on the particular genetic composition of the tumors.	[Robles, Maria Teresa Saenz; Case, Ashley; Pipas, James M.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Chong, Jean-Leon; Leone, Gustavo] Ohio State Univ, Coll Med, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Chong, Jean-Leon; Leone, Gustavo] Ohio State Univ, Coll Biol Sci, Dept Mol Genet, Columbus, OH 43210 USA; [Chong, Jean-Leon; Leone, Gustavo] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Robles, MTS (corresponding author), Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA.	pipas@pitt.edu			NIH [CA098956]; NATIONAL CANCER INSTITUTE [R01CA098956] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by an NIH grant to J. M. P. (CA098956). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja D, 2005, ONCOGENE, V24, P7729, DOI 10.1038/sj.onc.1209046; Bosco EE, 2007, CELL CYCLE, V6, P667, DOI 10.4161/cc.6.6.3988; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Chong JL, 2009, NATURE, V462, P930, DOI 10.1038/nature08677; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; de Bruin A, 2003, P NATL ACAD SCI USA, V100, P6546, DOI 10.1073/pnas.1031853100; DeCaprio JA, 2009, VIROLOGY, V384, P274, DOI 10.1016/j.virol.2008.12.010; Gu XS, 2010, DRUG METAB REV, V42, P482, DOI 10.3109/03602531003654915; GUENGERICH FP, 1991, J BIOL CHEM, V266, P10019; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Jancova P, 2010, BIOMED PAP, V154, P103, DOI 10.5507/bp.2010.017; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; Markovics JA, 2005, J VIROL, V79, P7492, DOI 10.1128/JVI.79.12.7492-7502.2005; Nassar AF, 2009, DRUG METABOLISM HDB; Nelson David R., 2009, Human Genomics, V4, P59; Nevins JR, 1997, J CELL PHYSIOL, V173, P233, DOI 10.1002/(SICI)1097-4652(199711)173:2<233::AID-JCP27>3.0.CO;2-F; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; NEVINS JR, 1992, NATURE, V358, P375, DOI 10.1038/358375a0; Reed CA, 2009, ONCOGENE, V28, P4434, DOI 10.1038/onc.2009.303; Robles MTS, 2009, SEMIN CANCER BIOL, V19, P229, DOI 10.1016/j.semcancer.2009.02.002; Saenz-Robles MT, 2007, ONCOGENE, V26, P5124, DOI 10.1038/sj.onc.1210310; Saenz-Robles MT, 2001, ONCOGENE, V20, P7899, DOI 10.1038/sj.onc.1204936; Scripture CD, 2005, LANCET ONCOL, V6, P780, DOI 10.1016/S1470-2045(05)70388-0; Stengel KR, 2008, CELL CYCLE, V7, DOI 10.4161/cc.7.8.5737; Wu LZ, 2003, NATURE, V421, P942, DOI 10.1038/nature01417	26	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26019	10.1371/journal.pone.0026019	http://dx.doi.org/10.1371/journal.pone.0026019			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022495	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000295976000055
J	Kawakubo, Y; Suga, M; Tochigi, M; Yumoto, M; Itoh, K; Sasaki, T; Kano, Y; Kasai, K				Kawakubo, Yuki; Suga, Motomu; Tochigi, Mamoru; Yumoto, Masato; Itoh, Kenji; Sasaki, Tsukasa; Kano, Yukiko; Kasai, Kiyoto			Effects of Metabotropic Glutamate Receptor 3 Genotype on Phonetic Mismatch Negativity	PLOS ONE			English	Article							DENDRITIC SPINE DENSITY; TYPE-3 GENE GRM3; SPEECH SOUNDS; AUDITORY MISMATCH; SCHIZOPHRENIA; ASSOCIATION; GLUTAMATE-RECEPTOR-3; POPULATION; MATTER; CORTEX	Background: The genetic and molecular basis of glutamatergic dysfunction is one key to understand schizophrenia, with the identification of an intermediate phenotype being an essential step. Mismatch negativity (MMN) or its magnetic counterpart, magnetic mismatch field (MMF) is an index of preattentive change detection processes in the auditory cortex and is generated through glutamatergic neurotransmission. We have previously shown that MMN/MMF in response to phoneme change is markedly reduced in schizophrenia. Variations in metabotropic glutamate receptor (GRM3) may be associated with schizophrenia, and has been shown to affect cortical function. Here we investigated the effect of GRM3 genotypes on phonetic MMF in healthy men. Methods: MMF in response to phoneme change was recorded using magnetoencephalography in 41 right-handed healthy Japanese men. Based on previous genetic association studies in schizophrenia, 4 candidate SNPs (rs6465084, rs2299225, rs1468412, rs274622) were genotyped. Results: GRM3 rs274622 genotype variations significantly predicted MMF strengths (p = 0.009), with C carriers exhibiting significantly larger MMF strengths in both hemispheres compared to the TT subjects. Conclusions: These results suggest that variations in GRM3 genotype modulate the auditory cortical response to phoneme change in humans. MMN/MMF, particularly those in response to speech sounds, may be a promising and sensitive intermediate phenotype for clarifying glutamatergic dysfunction in schizophrenia.	[Kawakubo, Yuki; Kano, Yukiko] Univ Tokyo, Dept Child Neuropsychiat, Tokyo, Japan; [Suga, Motomu; Tochigi, Mamoru; Kasai, Kiyoto] Univ Tokyo, Dept Neuropsychiat, Tokyo, Japan; [Yumoto, Masato] Univ Tokyo, Dept Lab Med, Tokyo, Japan; [Itoh, Kenji] Univ Tokyo, Dept Cognit & Speech Sci, Tokyo, Japan; [Sasaki, Tsukasa] Univ Tokyo, Hlth Serv Ctr, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo	Kawakubo, Y (corresponding author), Univ Tokyo, Dept Child Neuropsychiat, Tokyo, Japan.	yukik-tky@umin.ac.jp		Kasai, Kiyoto/0000-0002-4443-4535	Ministry of Health, Labour, and Welfare [H19-kokoro-ippan-012, H20-kokoro-ippan-001, H20-3]; JSPS/MEXT, Japan [20023009, 21249064]	Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan); JSPS/MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by grants from the Ministry of Health, Labour, and Welfare (Health and Labour Sciences Research Grants, Research on Psychiatric and Neurological Diseases and Mental Health, H19-kokoro-ippan-012, H20-kokoro-ippan-001, and H20-3 to KK), and from the JSPS/MEXT (No. 20023009 and 21249064 to KK), Japan. A part of this study was also the result of "Development of biomarker candidates for social behavior", carried out under the Strategic Research Program for Brain Sciences by the MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop JR, 2005, SCHIZOPHR RES, V77, P253, DOI 10.1016/j.schres.2005.04.001; Chen Q, 2005, SCHIZOPHR RES, V73, P21, DOI 10.1016/j.schres.2004.07.002; Corti C, 2007, BIOL PSYCHIAT, V62, P747, DOI 10.1016/j.biopsych.2006.12.005; Egan MF, 2004, P NATL ACAD SCI USA, V101, P12604, DOI 10.1073/pnas.0405077101; Fujii Y, 2003, PSYCHIAT GENET, V13, P71, DOI 10.1097/01.ypg.0000056682.82896.b0; Glantz LA, 2000, ARCH GEN PSYCHIAT, V57, P65, DOI 10.1001/archpsyc.57.1.65; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Javitt DC, 1996, P NATL ACAD SCI USA, V93, P11962, DOI 10.1073/pnas.93.21.11962; Kasai K, 2003, ARCH GEN PSYCHIAT, V60, P766, DOI 10.1001/archpsyc.60.8.766; Kasai K, 2003, SCHIZOPHR RES, V59, P159, DOI 10.1016/S0920-9964(01)00382-6; Kasai K, 2002, AM J PSYCHIAT, V159, P546, DOI 10.1176/appi.ajp.159.4.546; Konradi C, 2003, PHARMACOL THERAPEUT, V97, P153, DOI 10.1016/S0163-7258(02)00328-5; Marenco S, 2006, AM J PSYCHIAT, V163, P740, DOI 10.1176/appi.ajp.163.4.740; Matsubayashi J, 2008, BRAIN RES, V1236, P159, DOI 10.1016/j.brainres.2008.07.120; Naatanen R, 1997, NATURE, V385, P432, DOI 10.1038/385432a0; Norton N, 2005, BMC PSYCHIATRY, V5, DOI 10.1186/1471-244X-5-23; Salisbury DF, 2007, ARCH GEN PSYCHIAT, V64, P521, DOI 10.1001/archpsyc.64.5.521; Sweet RA, 2009, NEUROPSYCHOPHARMACOL, V34, P374, DOI 10.1038/npp.2008.67; Takei Y, 2009, PSYCHOPHYSIOLOGY, V46, P52, DOI 10.1111/j.1469-8986.2008.00748.x; Tochigi M, 2006, SCHIZOPHR RES, V88, P260, DOI 10.1016/j.schres.2006.07.008; Umbricht D, 2005, SCHIZOPHR RES, V76, P1, DOI 10.1016/j.schres.2004.12.002; Yamasue H, 2004, NEUROIMAGE, V22, P720, DOI 10.1016/j.neuroimage.2004.01.042	22	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e24929	10.1371/journal.pone.0024929	http://dx.doi.org/10.1371/journal.pone.0024929			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022368	gold, Green Published, Green Submitted			2022-12-27	WOS:000295973200004
J	Belgrano, A; Rakicevic, L; Mittempergher, L; Campanaro, S; Martinelli, VC; Mouly, V; Valle, G; Kojic, S; Faulkner, G				Belgrano, Anna; Rakicevic, Ljiljana; Mittempergher, Lorenza; Campanaro, Stefano; Martinelli, Valentina C.; Mouly, Vincent; Valle, Giorgio; Kojic, Snezana; Faulkner, Georgine			Multi-Tasking Role of the Mechanosensing Protein Ankrd2 in the Signaling Network of Striated Muscle	PLOS ONE			English	Article							ANKYRIN-REPEAT PROTEIN; SKELETAL-MUSCLE; NUCLEAR-PROTEIN; GENE-EXPRESSION; TIGHT JUNCTION; PDZ DOMAINS; CELL; BINDING; FAMILY; CARP	Background: Ankrd2 (also known as Arpp) together with Ankrd1/CARP and DARP are members of the MARP mechanosensing proteins that form a complex with titin (N2A)/calpain 3 protease/myopalladin. In muscle, Ankrd2 is located in the I-band of the sarcomere and moves to the nucleus of adjacent myofibers on muscle injury. In myoblasts it is predominantly in the nucleus and on differentiation shifts from the nucleus to the cytoplasm. In agreement with its role as a sensor it interacts both with sarcomeric proteins and transcription factors. Methodology/Principal Findings: Expression profiling of endogenous Ankrd2 silenced in human myotubes was undertaken to elucidate its role as an intermediary in cell signaling pathways. Silencing Ankrd2 expression altered the expression of genes involved in both intercellular communication (cytokine-cytokine receptor interaction, endocytosis, focal adhesion, tight junction, gap junction and regulation of the actin cytoskeleton) and intracellular communication (calcium, insulin, MAPK, p53, TGF-beta and Wnt signaling). The significance of Ankrd2 in cell signaling was strengthened by the fact that we were able to show for the first time that Nkx2.5 and p53 are upstream effectors of the Ankrd2 gene and that Ankrd1/CARP, another MARP member, can modulate the transcriptional ability of MyoD on the Ankrd2 promoter. Another novel finding was the interaction between Ankrd2 and proteins with PDZ and SH3 domains, further supporting its role in signaling. It is noteworthy that we demonstrated that transcription factors PAX6, LHX2, NFIL3 and MECP2, were able to bind both the Ankrd2 protein and its promoter indicating the presence of a regulatory feedback loop mechanism. Conclusions/Significance: In conclusion we demonstrate that Ankrd2 is a potent regulator in muscle cells affecting a multitude of pathways and processes.	[Belgrano, Anna; Martinelli, Valentina C.; Faulkner, Georgine] Int Ctr Genet Engn & Biotechnol, Muscle Mol Biol Grp, I-34012 Trieste, Italy; [Rakicevic, Ljiljana; Kojic, Snezana] Univ Belgrade, Inst Mol Genet & Genet Engn, Belgrade, Serbia; [Mittempergher, Lorenza; Campanaro, Stefano; Valle, Giorgio; Faulkner, Georgine] Univ Padua, Ctr Ric Interdipartimentale Biotecnol Innovat, Padua, Italy; [Mouly, Vincent] Univ Paris 06, Inst Myol, UM76, Paris, France	International Center for Genetic Engineering & Biotechnology (ICGEB); University of Belgrade; University of Padua; UDICE-French Research Universities; Sorbonne Universite	Belgrano, A (corresponding author), Int Ctr Genet Engn & Biotechnol, Muscle Mol Biol Grp, Padriciano 99, I-34012 Trieste, Italy.	snezanakojic@imgge.bg.ac.rs; faulkner@cribi.unipd.it	Campanaro, Stefano/I-5657-2019; Kojic, Snezana/AAF-4873-2019	CAMPANARO, STEFANO/0000-0002-9431-1648; Kojic, Snezana/0000-0001-5090-1278; Mittempergher, Lorenza/0000-0003-3425-3965; Mouly, Vincent/0000-0003-3809-4033; VALLE, GIORGIO/0000-0003-4377-5685	Telethon Foundation of Italy [GGP04088, GSP042894B]; Fondazione Cariparo, Italy; ICGEB, Italy [CRP/YUG-05-01]; Ministry of Education and Science of Serbia [173008]	Telethon Foundation of Italy(Fondazione Telethon); Fondazione Cariparo, Italy(Fondazione Cariparo); ICGEB, Italy; Ministry of Education and Science of Serbia(Ministry of Education, Science & Technological Development, Serbia)	This study was supported by grants from the Telethon Foundation of Italy (grant GGP04088 to GF and grant GSP042894B to GV), the Fondazione Cariparo, Italy (Progetto Eccellenza 2010 CHROMUS to GV), the Collaborative Research Programme, ICGEB, Italy (grant CRP/YUG-05-01 to SK) and the Ministry of Education and Science of Serbia (Project No. 173008). (http://www. telethon. it/en, http://www.fondazionecariparo. it/index.php, http://www.mpn.gov.rs/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa H, 2003, CIRC RES, V92, P1079, DOI 10.1161/01.RES.0000072977.86706.23; Arimura T, 2009, J AM COLL CARDIOL, V54, P334, DOI 10.1016/j.jacc.2008.12.082; Bakkar N, 2008, J CELL BIOL, V180, P787, DOI 10.1083/jcb.200707179; Band M, 2010, J MOL EVOL, V70, P1, DOI 10.1007/s00239-009-9306-6; Barash IA, 2007, AM J PHYSIOL-CELL PH, V293, pC218, DOI 10.1152/ajpcell.00055.2007; Baumeister A, 1997, J CELL BIOL, V139, P1231, DOI 10.1083/jcb.139.5.1231; Bean C, 2005, J MOL BIOL, V349, P349, DOI 10.1016/j.jmb.2005.03.063; Bean C, 2008, BBA-MOL CELL RES, V1783, P1023, DOI 10.1016/j.bbamcr.2008.01.027; Blais A, 2005, GENE DEV, V19, P553, DOI 10.1101/gad.1281105; Cenni V, 2011, MOL BIOL CELL   0707, V7; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chen EH, 2004, TRENDS CELL BIOL, V14, P452, DOI 10.1016/j.tcb.2004.07.008; CHU W, 1995, J BIOL CHEM, V270, P10236, DOI 10.1074/jbc.270.17.10236; Duboscq-Bidot L, 2009, EUR HEART J, V30, P2128, DOI 10.1093/eurheartj/ehp225; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Faulkner G, 1999, J BIOL CHEM, V275, P41234; Frey N, 2004, NAT MED, V10, P1336, DOI 10.1038/nm1132; Frey N, 2000, P NATL ACAD SCI USA, V97, P14632, DOI 10.1073/pnas.260501097; Frey N, 2008, J CLIN INVEST, V118, P3598, DOI 10.1172/JCI36277; Galvao TC, 2005, NUCLEIC ACIDS RES, V33, P6603, DOI 10.1093/nar/gki971; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; Hamazaki Y, 2002, J BIOL CHEM, V277, P455, DOI 10.1074/jbc.M109005200; Harris BZ, 2001, J CELL SCI, V114, P3219; Hayashi C, 2008, J BIOL CHEM, V283, P14801, DOI 10.1074/jbc.M708262200; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Hoffman EP, 2004, NAT MED, V10, P584, DOI 10.1038/nm0604-584; Horsley V, 2004, CELLS TISSUES ORGANS, V176, P67, DOI 10.1159/000075028; Ikeda K, 2003, J BIOL CHEM, V278, P3514, DOI 10.1074/jbc.M204563200; Ishiguro N, 2005, HUM PATHOL, V36, P620, DOI 10.1016/j.humpath.2005.04.014; Ishiguro N, 2002, AM J PATHOL, V160, P1767, DOI 10.1016/S0002-9440(10)61123-6; Itoh M, 1997, J CELL BIOL, V138, P181, DOI 10.1083/jcb.138.1.181; Jelen F, 2003, ACTA BIOCHIM POL, V50, P985; Jeyaseelan R, 1997, J BIOL CHEM, V272, P22800, DOI 10.1074/jbc.272.36.22800; Katsube T, 1998, J BIOL CHEM, V273, P29672, DOI 10.1074/jbc.273.45.29672; Kemp TJ, 2000, GENOMICS, V66, P229, DOI 10.1006/geno.2000.6213; Kojic S, 2004, J MOL BIOL, V339, P313, DOI 10.1016/j.jmb.2004.03.071; Kojic S, 2010, ARCH BIOCHEM BIOPHYS, V502, P60, DOI 10.1016/j.abb.2010.06.029; KOMURO I, 1993, P NATL ACAD SCI USA, V90, P8145, DOI 10.1073/pnas.90.17.8145; Kou CYC, 2010, BIOCHEM BIOPH RES CO, V400, P278, DOI 10.1016/j.bbrc.2010.08.064; Krauss RS, 2005, J CELL SCI, V118, P2355, DOI 10.1242/jcs.02397; Krcmery J, 2010, BIOESSAYS, V32, P100, DOI 10.1002/bies.200900148; Kumar A, 2003, FASEB J, V17, P386, DOI 10.1096/fj.02-0542com; Laure L, 2010, FEBS J, V277, P4322, DOI 10.1111/j.1742-4658.2010.07820.x; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Matter K, 2003, NAT REV MOL CELL BIO, V4, P225, DOI 10.1038/nrm1055; Meacci E, 2010, CELL MOL LIFE SCI, V67, P4269, DOI 10.1007/s00018-010-0442-3; Michaely P, 1992, Trends Cell Biol, V2, P127, DOI 10.1016/0962-8924(92)90084-Z; Miller MK, 2003, J MOL BIOL, V333, P951, DOI 10.1016/j.jmb.2003.09.012; Mohamed JS, 2010, FASEB J, V24, P3330, DOI 10.1096/fj.10-158386; Moriyama M, 2001, BIOCHEM BIOPH RES CO, V285, P715, DOI 10.1006/bbrc.2001.5216; Moulik M, 2009, J AM COLL CARDIOL, V54, P325, DOI 10.1016/j.jacc.2009.02.076; Nakada C, 2004, PATHOBIOLOGY, V71, P43, DOI 10.1159/000072961; Pallavicini A, 2001, BIOCHEM BIOPH RES CO, V285, P378, DOI 10.1006/bbrc.2001.5131; Piro S, 2010, ENDOCRINOLOGY, V151, P4197, DOI 10.1210/en.2009-1472; Polesskaya A, 2003, CELL, V113, P841, DOI 10.1016/S0092-8674(03)00437-9; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Shimada T, 2004, ANAT REC PART A, V280A, P940, DOI 10.1002/ar.a.20109; Singh S, 2010, AM J PATHOL, V177, P2055, DOI 10.2353/ajpath.2010.091195; Siu PM, 2005, J APPL PHYSIOL, V99, P1897, DOI 10.1152/japplphysiol.00374.2005; Takada F, 2001, P NATL ACAD SCI USA, V98, P1595, DOI 10.1073/pnas.041609698; Takebayashi-Suzuki K, 2001, DEV BIOL, V234, P390, DOI 10.1006/dbio.2001.0270; Toko H, 2002, J BIOL CHEM, V277, P24735, DOI 10.1074/jbc.M107669200; Tsukamoto Y, 2002, LAB INVEST, V82, P645, DOI 10.1038/labinvest.3780459; Tsukamoto Y, 2008, HISTOCHEM CELL BIOL, V129, P55, DOI 10.1007/s00418-007-0348-9; von Nandelstadh P, 2009, MOL CELL BIOL, V29, P822, DOI 10.1128/MCB.01454-08; Wittchen ES, 1999, J BIOL CHEM, V274, P35179, DOI 10.1074/jbc.274.49.35179; Wu CL, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016171, 10.1371/journal.pone.0022314]; Xu XS, 2008, MOL CELL, V30, P403, DOI 10.1016/j.molcel.2008.03.009; Yakabe S, 2008, GENES GENET SYST, V83, P199, DOI 10.1266/ggs.83.199; Zetser A, 1999, J BIOL CHEM, V274, P5193, DOI 10.1074/jbc.274.8.5193; Zou YM, 1997, DEVELOPMENT, V124, P793	72	29	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25519	10.1371/journal.pone.0025519	http://dx.doi.org/10.1371/journal.pone.0025519			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016770	Green Submitted, Green Published, gold			2022-12-27	WOS:000295971700012
J	Bergouignan, L; Lefranc, JP; Chupin, M; Morel, N; Spano, JP; Fossati, P				Bergouignan, Loretxu; Lefranc, Jean Pierre; Chupin, Marie; Morel, Nastassja; Spano, Jean Philippe; Fossati, Philippe			Breast Cancer Affects Both the Hippocampus Volume and the Episodic Autobiographical Memory Retrieval	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; MILD COGNITIVE IMPAIRMENT; TEMPORAL-LOBE EPILEPSY; AUTONOETIC CONSCIOUSNESS; ALZHEIMERS-DISEASE; AUTOMATED SEGMENTATION; DEPRESSION; METAANALYSIS; SURVIVORS; PERSPECTIVE	Background: Neuroimaging studies show the hippocampus is a crucial node in the neural network supporting episodic autobiographical memory retrieval. Stress-related psychiatric disorders, namely Major Depression and Post Traumatic Stress Disorder (PTSD), are related to reduced hippocampus volume. However, this is not the case for remitted breast cancer patients with co-morbid stress-related psychiatric disorders. This exception may be due to the fact that, consequently to the cancer experience as such, this population might already be characterized by a reduced hippocampus with an episodic autobiographical memory deficit. Methodology: We scanned, with a 3T Siemens TRIO, 16 patients who had lived through a "standard experience of breast cancer'' (breast cancer and a standard treatment in remission since 18 month) in the absence of any associated stress-related psychiatric or neurological disorder and 21 matched controls. We then assessed their episodic autobiographical memory retrieval ability. Principal Findings: Remitted breast cancer patients had both a significantly smaller hippocampus and a significant deficit in episodic autobiographical memory retrieval. The hippocampus atrophy was characterized by a smaller posterior hippocampus. The posterior hippocampus volume was intimately related to the ability to retrieve negative memories and to the past experience of breast cancer or not. Conclusions/Significance: These results provide two main findings: (1) we identify a new population with a specific reduction in posterior hippocampus volume that is independent of any psychiatric or neurological pathology; (2) we show the intimate relation of the posterior hippocampus to the ability to retrieve episodic autobiographical memories. These are significant findings as it is the first demonstration that indicates considerable long-term effects of living through the experience of breast cancer and shows very specific hippocampal atrophy with a functional deficit without any presence of psychiatric pathology.	[Bergouignan, Loretxu; Morel, Nastassja; Fossati, Philippe] Hop La Pitie Salpetriere, CNRS, USR 3246, CR ICM, Paris, France; [Bergouignan, Loretxu] Karolinska Inst, Dept Neurosci, Brain Body & Self Lab, Stockholm, Sweden; [Bergouignan, Loretxu] Hop La Pitie Salpetriere, Ctr NeuroImaging Res, Paris, France; [Lefranc, Jean Pierre] Hop La Pitie Salpetriere, AP HP, Dept Gynecol Surg, Paris, France; [Chupin, Marie] Univ Paris 06, CNRS 7225, Inst Brain & Spinal Cord, INSERM,Ctr Res,UMR S875,U975, Paris, France; [Morel, Nastassja] Caen Basse Normandie Univ, INSERM, UMR S 923, EPHE,INSERM, Caen, France; [Spano, Jean Philippe] Hop La Pitie Salpetriere, AP HP, Dept Med Oncol, Paris, France; [Fossati, Philippe] Univ Paris 06, Pitie Salpetriere Hosp, AP HP, Dept Psychiat, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Karolinska Institutet; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite de Caen Normandie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Bergouignan, L (corresponding author), Hop La Pitie Salpetriere, CNRS, USR 3246, CR ICM, Paris, France.	loretxu@alternatiba.org	Bergouignan, Loretxu/I-6465-2015	Bergouignan, Loretxu/0000-0002-4521-6206	National Institute of Cancer (France); Wenner-Gren Foundation (Sweden); League Against Cancer (France)	National Institute of Cancer (France); Wenner-Gren Foundation (Sweden); League Against Cancer (France)	This work was supported by the National Institute of Cancer (France) and Wenner-Gren Foundation (Sweden) fellowships to LB. This work was also supported by League Against Cancer (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis DR, 2007, BRAIN, V130, P2327, DOI 10.1093/brain/awm166; Barrientos RM, 2003, NEUROSCIENCE, V121, P847, DOI 10.1016/S0306-4522(03)00564-5; Bergouignan L, 2008, BEHAV RES THER, V46, P322, DOI 10.1016/j.brat.2007.12.007; Bonne O, 2008, J CLIN PSYCHIAT, V69, P1087, DOI 10.4088/JCP.v69n0707; BUKBERG J, 1984, PSYCHOSOM MED, V46, P199, DOI 10.1097/00006842-198405000-00002; Campbell S, 2004, AM J PSYCHIAT, V161, P598, DOI 10.1176/appi.ajp.161.4.598; Carver CS, 2005, HEALTH PSYCHOL, V24, P508, DOI 10.1037/0278-6133.24.5.508; Chupin M, 2009, NEUROIMAGE, V46, P749, DOI 10.1016/j.neuroimage.2009.02.013; Chupin M, 2007, NEUROIMAGE, V34, P996, DOI 10.1016/j.neuroimage.2006.10.035; Chupin M, 2009, HIPPOCAMPUS, V19, P579, DOI 10.1002/hipo.20626; Coluccia D, 2008, J NEUROSCI, V28, P3474, DOI 10.1523/JNEUROSCI.4893-07.2008; Conrad CD, 2007, J NEUROSCI, V27, P8278, DOI 10.1523/JNEUROSCI.2121-07.2007; Conway MA, 2000, PSYCHOL REV, V107, P261, DOI 10.1037//0033-295X.107.2.261; Csernansky JG, 2002, AM J PSYCHIAT, V159, P2000, DOI 10.1176/appi.ajp.159.12.2000; Dalgleish T, 2008, J ABNORM PSYCHOL, V117, P236, DOI 10.1037/0021-843X.117.1.236; de Geus EJC, 2007, BIOL PSYCHIAT, V61, P1062, DOI 10.1016/j.biopsych.2006.07.026; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Gardiner JM, 2001, PHILOS T R SOC B, V356, P1351, DOI 10.1098/rstb.2001.0955; GERLACH JL, 1972, SCIENCE, V175, P1133, DOI 10.1126/science.175.4026.1133; Hakamata Y, 2007, NEUROSCI RES, V59, P383, DOI 10.1016/j.neures.2007.08.012; Hara E, 2008, J NEUROPSYCH CLIN N, V20, P302, DOI 10.1176/appi.neuropsych.20.3.302; Inagaki M, 2004, AM J PSYCHIAT, V161, P2263, DOI 10.1176/appi.ajp.161.12.2263; Kitayama N, 2005, J AFFECT DISORDERS, V88, P79, DOI 10.1016/j.jad.2005.05.014; Koolschijn PCMP, 2009, HUM BRAIN MAPP, V30, P3719, DOI 10.1002/hbm.20801; KOPELMAN MD, 1989, J CLIN EXP NEUROPSYC, V11, P724, DOI 10.1080/01688638908400928; Lemogne C, 2006, CONSCIOUS COGN, V15, P258, DOI 10.1016/j.concog.2005.07.005; Libby LK, 2005, J PERS SOC PSYCHOL, V88, P50, DOI 10.1037/0022-3514.88.1.50; Libby LK, 2002, J PERS SOC PSYCHOL, V82, P167, DOI 10.1037//0022-3514.82.2.167; Magarinos AM, 1997, P NATL ACAD SCI USA, V94, P14002, DOI 10.1073/pnas.94.25.14002; Maller JJ, 2007, HIPPOCAMPUS, V17, P1023, DOI 10.1002/hipo.20339; Matsuoka Y, 2003, BIOL PSYCHIAT, V54, P736, DOI 10.1016/S0006-3223(02)01907-8; McGregor BA, 2009, BRAIN BEHAV IMMUN, V23, P159, DOI 10.1016/j.bbi.2008.08.002; Murray CA, 1998, J NEUROSCI, V18, P2974; Nilsson-Ihrfelt E, 2004, J PSYCHOSOM RES, V57, P363, DOI 10.1016/j.jpsychores.2004.01.009; Noulhiane M, 2007, BRAIN, V130, P3184, DOI 10.1093/brain/awm258; Piolino P, 2003, BRAIN, V126, P2203, DOI 10.1093/brain/awg222; Piolino P, 2007, NEUROPSYCHOLOGIA, V45, P2730, DOI 10.1016/j.neuropsychologia.2007.04.013; Piolino P, 2007, CORTEX, V43, P176, DOI 10.1016/S0010-9452(08)70474-X; Schonfeld S, 2007, MEMORY, V15, P339, DOI 10.1080/09658210701256571; Sharot T, 2007, NATURE, V450, P102, DOI 10.1038/nature06280; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; St Jacques P, 2008, J COGNITIVE NEUROSCI, V20, P1327, DOI 10.1162/jocn.2008.20091; Sumner JA, 2010, BEHAV RES THER, V48, P614, DOI 10.1016/j.brat.2010.03.013; TULVING E, 1985, AM PSYCHOL, V40, P385, DOI 10.1037/0003-066x.40.4.385; UNO H, 1989, J NEUROSCI, V9, P1705, DOI 10.1523/jneurosci.09-05-01705.1989; Videbech P, 2004, AM J PSYCHIAT, V161, P1957, DOI 10.1176/appi.ajp.161.11.1957; VINOKUR AD, 1990, CANCER-AM CANCER SOC, V65, P1242, DOI 10.1002/1097-0142(19900301)65:5<1242::AID-CNCR2820650535>3.0.CO;2-1; Viskontas IV, 2000, J NEUROSCI, V20, P5853, DOI 10.1523/JNEUROSCI.20-15-05853.2000; Whitwell JL, 2007, BRAIN, V130, P1777, DOI 10.1093/brain/awm112; Williams JMG, 2007, PSYCHOL BULL, V133, P122, DOI 10.1037/0033-2909.133.1.122; WILLIAMS JMG, 1986, J ABNORM PSYCHOL, V95, P144, DOI 10.1037/0021-843X.95.2.144; Yoshikawa E, 2005, BREAST CANCER RES TR, V92, P81, DOI 10.1007/s10549-005-1412-6	54	42	44	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25349	10.1371/journal.pone.0025349	http://dx.doi.org/10.1371/journal.pone.0025349			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834OO	22016764	Green Submitted, Green Published, gold			2022-12-27	WOS:000295971700006
J	Jeong, SY; Crooks, DR; Wilson-Ollivierre, H; Ghosh, MC; Sougrat, R; Lee, J; Cooperman, S; Mitchell, JB; Beaumont, C; Rouault, TA				Jeong, Suh Young; Crooks, Daniel R.; Wilson-Ollivierre, Hayden; Ghosh, Manik C.; Sougrat, Rachid; Lee, Jaekwon; Cooperman, Sharon; Mitchell, James B.; Beaumont, Carole; Rouault, Tracey A.			Iron Insufficiency Compromises Motor Neurons and Their Mitochondrial Function in Irp2-Null Mice	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; REGULATORY PROTEIN-2; NEURODEGENERATIVE DISEASE; TRANSFERRIN RECEPTOR; TARGETED DELETION; KNOCKOUT MICE; H-FERRITIN; HOMEOSTASIS; DEFICIENT; TDP-43	Genetic ablation of Iron Regulatory Protein 2 (Irp2, Ireb2), which post-transcriptionally regulates iron metabolism genes, causes a gait disorder in mice that progresses to hind-limb paralysis. Here we have demonstrated that misregulation of iron metabolism from loss of Irp2 causes lower motor neuronal degeneration with significant spinal cord axonopathy. Mitochondria in the lumbar spinal cord showed significantly decreased Complex I and II activities, and abnormal morphology. Lower motor neurons appeared to be the most adversely affected neurons, and we show that functional iron starvation due to misregulation of iron import and storage proteins, including transferrin receptor 1 and ferritin, may have a causal role in disease. We demonstrated that two therapeutic approaches were beneficial for motor neuron survival. First, we activated a homologous protein, IRP1, by oral Tempol treatment and found that axons were partially spared from degeneration. Secondly, we genetically decreased expression of the iron storage protein, ferritin, to diminish functional iron starvation. These data suggest that functional iron deficiency may constitute a previously unrecognized molecular basis for degeneration of motor neurons in mice.	[Jeong, Suh Young; Crooks, Daniel R.; Wilson-Ollivierre, Hayden; Ghosh, Manik C.; Cooperman, Sharon; Rouault, Tracey A.] Eunice Kennedy Shriver Natl Inst Child Hlth & Dev, NIH, Bethesda, MD 20892 USA; [Sougrat, Rachid] KAUST, Nanobiol Lab, Thuwal, Saudi Arabia; [Lee, Jaekwon] Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA; [Mitchell, James B.] NCI, NIH, Bethesda, MD 20892 USA; [Beaumont, Carole] Univ Paris Diderot, INSERM, U773, Ctr Rech Biomed Bichat Beaujon, Paris, France	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); King Abdullah University of Science & Technology; University of Nebraska System; University of Nebraska Lincoln; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Jeong, SY (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Dev, NIH, Bethesda, MD 20892 USA.	rouault@mail.nih.gov		Jeong, Suh Young/0000-0002-6376-7001; Sougrat, Rachid/0000-0001-6476-1886	Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001602] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIASC006387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079209] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the intramural program of Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altan-Bonnet N, 2006, MOL BIOL CELL, V17, P990, DOI 10.1091/mbc.E05-02-0155; Blasco H, 2011, J NEUROL SCI, V303, P124, DOI 10.1016/j.jns.2010.12.018; Cooperman SS, 2005, BLOOD, V106, P1084, DOI 10.1182/blood-2004-12-4703; Crooks DR, 2010, BLOOD, V115, P860, DOI 10.1182/blood-2009-09-243105; DALCANTO MC, 1995, BRAIN RES, V676, P25, DOI 10.1016/0006-8993(95)00063-V; Danzeisen R, 2006, J BIOL INORG CHEM, V11, P489, DOI 10.1007/s00775-006-0099-4; Dhib-Jalbut S, 2006, J NEUROIMMUNOL, V176, P198, DOI 10.1016/j.jneuroim.2006.03.027; DYCK PJ, 1975, NEUROLOGY, V25, P781, DOI 10.1212/WNL.25.8.781; Ferreira C, 2000, J BIOL CHEM, V275, P3021, DOI 10.1074/jbc.275.5.3021; Galy B, 2005, BLOOD, V106, P2580, DOI 10.1182/blood-2005-04-1365; Galy B, 2010, CELL METAB, V12, P194, DOI 10.1016/j.cmet.2010.06.007; Ghosh MC, 2008, P NATL ACAD SCI USA, V105, P12028, DOI 10.1073/pnas.0805361105; Goodall EF, 2008, J NEUROL, V255, P1652, DOI 10.1007/s00415-008-0945-0; Grabill C, 2003, BRAIN RES, V971, P95, DOI 10.1016/S0006-8993(03)02366-7; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Huang GC, 2004, MOL CELL BIOL, V24, P8447, DOI 10.1128/MCB.24.19.8447-8456.2004; JEFFERIES WA, 1984, NATURE, V312, P162, DOI 10.1038/312162a0; Jeong SY, 2009, J NEUROSCI, V29, P570, DOI 10.1523/JNEUROSCI.5443-08.2009; Kaur D, 2009, BRAIN RES, V1297, P17, DOI 10.1016/j.brainres.2009.08.043; Kim H, 2009, AM J PHYSIOL-GASTR L, V296, pG356, DOI 10.1152/ajpgi.90632.2008; KOPPENOL WH, 1993, FREE RADICAL BIO MED, V15, P645, DOI 10.1016/0891-5849(93)90168-T; Lagier-Tourenne C, 2009, CELL, V136, P1001, DOI 10.1016/j.cell.2009.03.006; LaVaute T, 2001, NAT GENET, V27, P209, DOI 10.1038/84859; Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2; Meyron-Holtz EG, 2004, EMBO J, V23, P386, DOI 10.1038/sj.emboj.7600041; Mitchell RM, 2010, MUSCLE NERVE, V42, P95, DOI 10.1002/mus.21625; Mori F, 2008, ACTA NEUROPATHOL, V116, P193, DOI 10.1007/s00401-008-0396-9; Muckenthaler MU, 2008, ANNU REV NUTR, V28, P197, DOI 10.1146/annurev.nutr.28.061807.155521; MUNUJOS P, 1993, ANAL BIOCHEM, V212, P506, DOI 10.1006/abio.1993.1360; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Rouault TA, 2008, TRENDS GENET, V24, P398, DOI 10.1016/j.tig.2008.05.008; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Ryberg H, 2010, MUSCLE NERVE, V42, P104, DOI 10.1002/mus.21683; Salahudeen AA, 2009, SCIENCE, V326, P722, DOI 10.1126/science.1176326; Schubert R, 2004, HUM MOL GENET, V13, P1793, DOI 10.1093/hmg/ddh189; Smith SR, 2004, ANN NY ACAD SCI, V1012, P65, DOI 10.1196/annals.1306.006; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Thompson K, 2003, J NEUROSCI RES, V71, P46, DOI 10.1002/jnr.10463; Tradewell ML, 2009, J NEUROPATH EXP NEUR, V68, P642, DOI 10.1097/NEN.0b013e3181a5deeb; Valdmanis PN, 2009, CURR NEUROL NEUROSCI, V9, P198, DOI 10.1007/s11910-009-0030-9; Vashisht AA, 2009, SCIENCE, V326, P718, DOI 10.1126/science.1176333; ZHELEV Z, 2009, MOL PHARM	42	49	51	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25404	10.1371/journal.pone.0025404	http://dx.doi.org/10.1371/journal.pone.0025404			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003390	Green Published, Green Submitted, gold			2022-12-27	WOS:000295970300011
J	Morse, M; Tran, E; Sun, HY; Levenson, R; Fang, Y				Morse, Megan; Tran, Elizabeth; Sun, Haiyan; Levenson, Robert; Fang, Ye			Ligand-Directed Functional Selectivity at the Mu Opioid Receptor Revealed by Label-Free Integrative Pharmacology On-Target	PLOS ONE			English	Article							DYNAMIC MASS REDISTRIBUTION; 7 TRANSMEMBRANE RECEPTORS; FREE OPTICAL BIOSENSOR; SIGNAL INTEGRATION; MORPHINE-TOLERANCE; ADENYLYL-CYCLASE; AGONIST; KINASE; TRAFFICKING; OPIATE	Development of new opioid drugs that provide analgesia without producing dependence is important for pain treatment. Opioid agonist drugs exert their analgesia effects primarily by acting at the mu opioid receptor (MOR) sites. High-resolution differentiation of opioid ligands is crucial for the development of new lead drug candidates with better tolerance profiles. Here, we use a label-free integrative pharmacology on-target (iPOT) approach to characterize the functional selectivity of a library of known opioid ligands for the MOR. This approach is based on the ability to detect dynamic mass redistribution (DMR) arising from the activation of the MOR in living cells. DMR assays were performed in HEK-MOR cells with and without preconditioning with probe molecules using label-free resonant waveguide grating biosensors, wherein the probe molecules were used to modify the activity of specific signaling proteins downstream the MOR. DMR signals obtained were then translated into high resolution heat maps using similarity analysis based on a numerical matrix of DMR parameters. Our data indicate that the iPOT approach clearly differentiates functional selectivity for distinct MOR signaling pathways among different opioid ligands, thus opening new avenues to discover and quantify the functional selectivity of currently used and novel opioid receptor drugs.	[Morse, Megan; Levenson, Robert] Penn State Univ, Coll Med, Dept Pharmacol, Hershey, PA 17033 USA; [Tran, Elizabeth; Sun, Haiyan; Fang, Ye] Corning Inc, Biochem Technol, Div Sci & Technol, Corning, NY 14831 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Corning Inc; State University of New York (SUNY) System; SUNY Community College	Morse, M (corresponding author), Penn State Univ, Coll Med, Dept Pharmacol, Hershey, PA 17033 USA.	rlevenson@hmc.psu.edu; fangy2@corning.com		Fang, Ye/0000-0002-1322-7365; Levenson, Robert/0000-0002-0936-8421	Corning Inc.	Corning Inc.	Corning Inc. funded this study through the employment of Elizabeth Tran, Haiyan Sun and Ye Fang, who conceived, designed and performed the experiments, and analyzed the data for this study.	AMICHE M, 1989, MOL PHARMACOL, V35, P774; ARDEN JR, 1995, J NEUROCHEM, V65, P1636; Belcheva MM, 2002, NEUROSIGNALS, V11, P34, DOI 10.1159/000057320; Bohn LM, 2000, NATURE, V408, P720, DOI 10.1038/35047086; CHANG AC, 1994, J MED CHEM, V37, P1547, DOI 10.1021/jm00037a001; CHEN JC, 1993, LIFE SCI, V52, P389, DOI 10.1016/0024-3205(93)90152-S; Cvejic S, 1997, J BIOL CHEM, V272, P26959, DOI 10.1074/jbc.272.43.26959; Deupi X, 2010, PHYSIOLOGY, V25, P293, DOI 10.1152/physiol.00002.2010; Dhawan BN, 1996, PHARMACOL REV, V48, P567; Dodgson K, 2009, J RECEPT SIG TRANSD, V29, P163, DOI 10.1080/10799890903079844; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fang Y, 2005, ANAL CHEM, V77, P5720, DOI 10.1021/ac050887n; Fang Y, 2005, FEBS LETT, V579, P6365, DOI 10.1016/j.febslet.2005.10.019; Fang Y, 2008, FEBS LETT, V582, P558, DOI 10.1016/j.febslet.2008.01.021; Fang Y, 2006, BIOPHYS J, V91, P1925, DOI [10.1529/biophysj.105.077818, 10.1529/biophysj.105.007818]; [Anonymous], 2010, Drug Discov Today Technol, V7, pe1, DOI 10.1016/j.ddtec.2010.05.001; Fang Y, 2010, EXPERT OPIN DRUG DIS, V5, P1237, DOI 10.1517/17460441.2010.533652; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Ferrie AM, 2011, SCI REP-UK, V1, DOI 10.1038/srep00033; Fichna J, 2008, BIOORG MED CHEM LETT, V18, P1350, DOI 10.1016/j.bmcl.2008.01.009; Galandrin S, 2007, TRENDS PHARMACOL SCI, V28, P423, DOI 10.1016/j.tips.2007.06.005; Galandrin S, 2006, MOL PHARMACOL, V70, P1575, DOI 10.1124/mol.106.026716; Gaveriaux-Ruff C, 2001, J PHARMACOL EXP THER, V298, P1193; George SR, 2000, J BIOL CHEM, V275, P26128, DOI 10.1074/jbc.M000345200; Giraldo J, 2008, BRIT J PHARMACOL, V155, P17, DOI 10.1038/bjp.2008.234; Gleeson MP, 2011, NAT REV DRUG DISCOV, V10, P197, DOI 10.1038/nrd3367; Gomes I, 2004, P NATL ACAD SCI USA, V101, P5135, DOI 10.1073/pnas.0307601101; Goral V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019282; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Hancock CN, 2006, MED CHEM, V2, P213, DOI 10.2174/157340606776056151; He L, 2002, CELL, V108, P271, DOI 10.1016/S0092-8674(02)00613-X; Henstridge CM, 2010, BRIT J PHARMACOL, V160, P604, DOI 10.1111/j.1476-5381.2009.00625.x; Hermans E, 2003, PHARMACOL THERAPEUT, V99, P25, DOI 10.1016/S0163-7258(03)00051-2; JAMES MK, 1991, J PHARMACOL EXP THER, V259, P712; Jiang JX, 2010, P NATL ACAD SCI USA, V107, P2307, DOI 10.1073/pnas.0909310107; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Jordan BA, 2001, P NATL ACAD SCI USA, V98, P343, DOI 10.1073/pnas.011384898; Kebig A, 2009, J RECEPT SIG TRANSD, V29, P140, DOI 10.1080/10799890903047437; Keith DE, 1996, J BIOL CHEM, V271, P19021, DOI 10.1074/jbc.271.32.19021; Kenakin T, 2011, J PHARMACOL EXP THER, V336, P296, DOI 10.1124/jpet.110.173948; Kenakin T, 2010, PHARMACOL REV, V62, P265, DOI 10.1124/pr.108.000992; Law PY, 2000, ANNU REV PHARMACOL, V40, P389, DOI 10.1146/annurev.pharmtox.40.1.389; Liu AMF, 2005, NEUROSIGNALS, V14, P136, DOI 10.1159/000086296; Mace T, 2005, EMBO J, V24, P3235, DOI 10.1038/sj.emboj.7600799; Mailman RB, 2007, TRENDS PHARMACOL SCI, V28, P390, DOI 10.1016/j.tips.2007.06.002; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; Minneman K P, 2001, Mol Interv, V1, P108; Nemoto S, 1998, J BIOL CHEM, V273, P16415, DOI 10.1074/jbc.273.26.16415; Neve Kim A., 2009, P87, DOI 10.1007/978-1-60327-335-0_6; Pawson CT, 2010, NAT STRUCT MOL BIOL, V17, P653, DOI 10.1038/nsmb.1843; RAYNOR K, 1994, MOL PHARMACOL, V45, P330; REISINE T, 1995, NEUROPHARMACOLOGY, V34, P463, DOI 10.1016/0028-3908(95)00025-2; Schroder R, 2010, NAT BIOTECHNOL, V28, P943, DOI 10.1038/nbt.1671; SEAMON KB, 1981, J CYCLIC NUCL PROT, V7, P201; Stanasila L, 2000, J NEUROCHEM, V75, P1190, DOI 10.1046/j.1471-4159.2000.0751190.x; TAKEMORI AE, 1984, EUR J PHARMACOL, V104, P101, DOI 10.1016/0014-2999(84)90374-1; Tanowitz M, 2008, J BIOL CHEM, V283, P35614, DOI 10.1074/jbc.M806588200; THOMPSON RC, 1993, NEURON, V11, P903, DOI 10.1016/0896-6273(93)90120-G; Tran E, 2009, J RECEPT SIG TRANSD, V29, P154, DOI 10.1080/10799890903052544; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Vaidehi N, 2010, CURR OPIN PHARMACOL, V10, P775, DOI 10.1016/j.coph.2010.09.004; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; WALDENBERG MLG, 2003, CNS DRUG REV, V9, P187; WARD SJ, 1982, J PHARMACOL EXP THER, V220, P494; Wess J, 1998, PHARMACOL THERAPEUT, V80, P231, DOI 10.1016/S0163-7258(98)00030-8; YOUNG AM, 1984, J PHARMACOL EXP THER, V229, P118; Zubieta JK, 2001, SCIENCE, V293, P311, DOI 10.1126/science.1060952	69	40	41	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25643	10.1371/journal.pone.0025643	http://dx.doi.org/10.1371/journal.pone.0025643			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003401	Green Submitted, Green Published, gold			2022-12-27	WOS:000295970300022
J	Mosher, RA; Tan, EH; Shin, J; Fischer, RL; Pikaard, CS; Baulcombe, DC				Mosher, Rebecca A.; Tan, Ek Han; Shin, Juhyun; Fischer, Robert L.; Pikaard, Craig S.; Baulcombe, David C.			An Atypical Epigenetic Mechanism Affects Uniparental Expression of Pol IV-Dependent siRNAs	PLOS ONE			English	Article							DIRECTED DNA-METHYLATION; SEED DEVELOPMENT; POLYCOMB GENE; ARABIDOPSIS; MAINTENANCE; CHROMOSOME; ENDOSPERM; DEMETER; METHYLTRANSFERASE; DEMETHYLATION	Background: Small RNAs generated by RNA polymerase IV (Pol IV) are the most abundant class of small RNAs in flowering plants. In Arabidopsis thaliana Pol IV-dependent short interfering (p4-si) RNAs are imprinted and accumulate specifically from maternal chromosomes in the developing seeds. Imprinted expression of protein-coding genes is controlled by differential DNA or histone methylation placed in gametes. To identify epigenetic factors required for maternal-specific expression of p4-siRNAs we analyzed the effect of a series of candidate mutations, including those required for genomic imprinting of protein-coding genes, on uniparental expression of a representative p4-siRNA locus. Results: Paternal alleles of imprinted genes are marked by DNA or histone methylation placed by DNA METHYLTRANSFERASE 1 or the Polycomb Repressive Complex 2. Here we demonstrate that repression of paternal p4-siRNA expression at locus 08002 is not controlled by either of these mechanisms. Similarly, loss of several chromatin modification enzymes, including a histone acetyltransferase, a histone methyltransferase, and two nucleosome remodeling proteins, does not affect maternal expression of locus 08002. Maternal alleles of imprinted genes are hypomethylated by DEMETER DNA glycosylase, yet expression of p4-siRNAs occurs irrespective of demethylation by DEMETER or related glycosylases. Conclusions: Differential DNA methylation and other chromatin modifications associated with epigenetic silencing are not required for maternal-specific expression of p4-siRNAs at locus 08002. These data indicate that there is an as yet unknown epigenetic mechanism causing maternal-specific p4-siRNA expression that is distinct from the well-characterized mechanisms associated with DNA methylation or the Polycomb Repressive Complex 2.	[Mosher, Rebecca A.; Baulcombe, David C.] Univ Cambridge, Dept Plant Sci, Cambridge, England; [Mosher, Rebecca A.] Univ Arizona, Sch Plant Sci, Tucson, AZ USA; [Tan, Ek Han; Pikaard, Craig S.] Indiana Univ, Dept Biol, Bloomington, IN USA; [Shin, Juhyun; Fischer, Robert L.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of Cambridge; University of Arizona; Indiana University System; Indiana University Bloomington; University of California System; University of California Berkeley	Mosher, RA (corresponding author), Univ Cambridge, Dept Plant Sci, Cambridge, England.	rmosher@cals.arizona.edu	Mosher, Rebecca/F-4800-2010; Pikaard, Craig S/K-8772-2012; Shin, Juhyun/ABA-5432-2020	Mosher, Rebecca/0000-0003-2195-0825; Pikaard, Craig S/0000-0001-8204-7459; Baulcombe, David/0000-0003-0780-6878; Tan, Ek Han/0000-0001-8872-7404	Gatsby Charitable Foundation; EU [LSHG-CT-2006-037900]; National Science Foundation [OISE 0502199, MCB 0918821]; NIH [R01-GM069415]; Royal Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069415, R01GM077590] Funding Source: NIH RePORTER	Gatsby Charitable Foundation; EU(European Commission); National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal Society(Royal Society of London); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Gatsby Charitable Foundation and the EU Sixth Framework Programme Integrated Project SIROCCO (LSHG-CT-2006-037900). RAM was supported in part by a National Science Foundation International Research Fellowship (OISE 0502199); JS was supported by NSF (MCB 0918821) and NIH (R01-GM069415) grants to RLF; DCB was supported as a Royal Society Research Professor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agius F, 2006, P NATL ACAD SCI USA, V103, P11796, DOI 10.1073/pnas.0603563103; Amedeo P, 2000, NATURE, V405, P203, DOI 10.1038/35012108; Bean CJ, 2004, NAT GENET, V36, P100, DOI 10.1038/ng1283; Bongiorni S, 2003, GENETICA, V117, P271, DOI 10.1023/A:1022964700446; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; Chan SWL, 2006, PLOS BIOL, V4, P1923, DOI 10.1371/journal.pbio.0040363; Chan SWL, 2006, PLOS GENET, V2, P791, DOI 10.1371/journal.pgen.0020083; Choi YH, 2002, CELL, V110, P33, DOI 10.1016/S0092-8674(02)00807-3; CROUSE HV, 1960, GENETICS, V45, P1429; Earley K, 2006, GENE DEV, V20, P1283, DOI 10.1101/gad.1417706; Earley KW, 2010, GENE DEV, V24, P1119, DOI 10.1101/gad.1914110; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Fujimoto R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000048; Garnier O, 2008, EPIGENETICS-US, V3, P14, DOI 10.4161/epi.3.1.5554; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Gehring M, 2009, SCIENCE, V324, P1447, DOI 10.1126/science.1171609; Goday C, 2001, BIOESSAYS, V23, P242, DOI 10.1002/1521-1878(200103)23:3&lt;242::AID-BIES1034&gt;3.0.CO;2-P; Gong ZH, 2002, CELL, V111, P803, DOI 10.1016/S0092-8674(02)01133-9; Guitton AE, 2004, DEVELOPMENT, V131, P2971, DOI 10.1242/dev.01168; Henderson IR, 2008, GENE DEV, V22, P1597, DOI 10.1101/gad.1667808; Hirochika H, 2000, PLANT CELL, V12, P357, DOI 10.1105/tpc.12.3.357; Hsieh T-F, 2011, P NATL ACAD SCI US; Hsieh TF, 2009, SCIENCE, V324, P1451, DOI [10.1126/science.1172417, 10.1126/science.112417]; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jahnke S, 2009, CURR BIOL, V19, P1677, DOI 10.1016/j.cub.2009.08.053; Jullien PE, 2006, PLANT CELL, V18, P1360, DOI 10.1105/tpc.106.041178; Jullien PE, 2006, CURR BIOL, V16, P486, DOI 10.1016/j.cub.2006.01.020; Kankel MW, 2003, GENETICS, V163, P1109; Kinoshita T, 2004, SCIENCE, V303, P521, DOI 10.1126/science.1089835; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Lippman Z, 2003, PLOS BIOL, V1, P420, DOI 10.1371/journal.pbio.0000067; Lloyd VK, 1999, GENETICS, V151, P1503; Maggert KA, 2002, GENETICS, V162, P1245; Makarevich G, 2008, J CELL SCI, V121, P906, DOI 10.1242/jcs.023077; MARTIN CC, 1995, DEV GENET, V17, P233, DOI 10.1002/dvg.1020170308; Mosher RA, 2008, P NATL ACAD SCI USA, V105, P3145, DOI 10.1073/pnas.0709632105; Mosher RA, 2009, NATURE, V460, P283, DOI 10.1038/nature08084; Ortega-Galisteo AP, 2008, PLANT MOL BIOL, V67, P671, DOI 10.1007/s11103-008-9346-0; Sha K, 2005, GENETICS, V170, P1633, DOI 10.1534/genetics.104.040303; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Tiwari S, 2008, PLANT CELL, V20, P2387, DOI 10.1105/tpc.108.061929; Vaillant I, 2006, EMBO REP IN PRESS; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832; Xiao WY, 2003, DEV CELL, V5, P891, DOI 10.1016/S1534-5807(03)00361-7	45	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25756	10.1371/journal.pone.0025756	http://dx.doi.org/10.1371/journal.pone.0025756			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003406	Green Published, gold			2022-12-27	WOS:000295970300027
J	Levic, S; Bouleau, Y; Dulon, D				Levic, Snezana; Bouleau, Yohan; Dulon, Didier			Developmental Acquisition of a Rapid Calcium-Regulated Vesicle Supply Allows Sustained High Rates of Exocytosis in Auditory Hair Cells	PLOS ONE			English	Article							DEPENDENT EXOCYTOSIS; AFFERENT SYNAPSE; RELEASE SITES; OTOFERLIN; REPLENISHMENT; RESPONSES; CHANNELS; INNERVATION; MATURATION; DEPLETION	Auditory hair cells (HCs) have the remarkable property to indefinitely sustain high rates of synaptic vesicle release during ongoing sound stimulation. The mechanisms of vesicle supply that allow such indefatigable exocytosis at the ribbon active zone remain largely unknown. To address this issue, we characterized the kinetics of vesicle recruitment and release in developing chick auditory HCs. Experiments were done using the intact chick basilar papilla from E10 (embryonic day 10) to P2 (two days post-hatch) by monitoring changes in membrane capacitance and Ca2+ currents during various voltage stimulations. Compared to immature pre-hearing HCs (E10-E12), mature post-hearing HCs (E18-P2) can steadily mobilize a larger readily releasable pool (RRP) of vesicles with faster kinetics and higher Ca2+ efficiency. As assessed by varying the inter-pulse interval of a 100 ms paired-pulse depolarization protocol, the kinetics of RRP replenishment were found much faster in mature HCs. Unlike mature HCs, exocytosis in immature HCs showed large depression during repetitive stimulations. Remarkably, when the intracellular concentration of EGTA was raised from 0.5 to 2 mM, the paired-pulse depression level remained unchanged in immature HCs but was drastically increased in mature HCs, indicating that the Ca2+ sensitivity of the vesicle replenishment process increases during maturation. Concomitantly, the immunoreactivity of the calcium sensor otoferlin and the number of ribbons at the HC plasma membrane largely increased, reaching a maximum level at E18-P2. Our results suggest that the efficient Ca2+-dependent vesicle release and supply in mature HCs essentially rely on the concomitant engagement of synaptic ribbons and otoferlin at the plasma membrane.	[Levic, Snezana] INSERM, Equipe Neurophysiol Synapse Audit, U587, Unite Mixte Rech, Bordeaux, France; Univ Pellegrin, Cent Hosp, Univ Victor Segalen, Inst Neurosci Bordeaux, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Levic, S (corresponding author), INSERM, Equipe Neurophysiol Synapse Audit, U587, Unite Mixte Rech, Bordeaux, France.	snezana.levic@inserm.fr; didier.dulon@inserm.fr	DULON, Didier/I-7881-2016	DULON, Didier/0000-0003-1541-6861; Levic, Snezana/0000-0002-6171-896X	INSERM (Institut National de la Santeet de la Recherche Medicale); University of Bordeaux Segalen; Fondation Voir et Entendre	INSERM (Institut National de la Santeet de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm)); University of Bordeaux Segalen; Fondation Voir et Entendre	This work was supported by INSERM (Institut National de la Santeet de la Recherche Medicale), the University of Bordeaux Segalen and the Fondation Voir et Entendre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babai N, 2010, J NEUROSCI, V30, P15866, DOI 10.1523/JNEUROSCI.2891-10.2010; Beurg M, 2008, J NEUROSCI, V28, P1798, DOI 10.1523/JNEUROSCI.4653-07.2008; Beurg M, 2010, J NEUROSCI, V30, P13281, DOI 10.1523/JNEUROSCI.2528-10.2010; Beutner D, 2001, J NEUROSCI, V21, P4593, DOI 10.1523/JNEUROSCI.21-13-04593.2001; Buran BN, 2010, J NEUROSCI, V30, P7587, DOI 10.1523/JNEUROSCI.0389-10.2010; Cho S, 2011, J NEUROSCI, V31, P5682, DOI 10.1523/JNEUROSCI.5453-10.2011; Dulon D, 2009, J NEUROSCI, V29, P10474, DOI 10.1523/JNEUROSCI.1009-09.2009; Frank T, 2010, NEURON, V68, P724, DOI 10.1016/j.neuron.2010.10.027; Fuchs PA, 2003, CURR OPIN NEUROBIOL, V13, P452, DOI 10.1016/S0959-4388(03)00098-9; FUCHS PA, 1990, J PHYSIOL-LONDON, V429, P553, DOI 10.1113/jphysiol.1990.sp018272; FURUKAWA T, 1978, J PHYSIOL-LONDON, V276, P193, DOI 10.1113/jphysiol.1978.sp012228; Goodyear RJ, 2010, JARO-J ASSOC RES OTO, V11, P573, DOI 10.1007/s10162-010-0231-6; Grant L, 2008, J NEUROPHYSIOL, V99, P2183, DOI 10.1152/jn.01174.2007; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Johnson CP, 2010, J CELL BIOL, V191, P187, DOI 10.1083/jcb.201002089; JOHNSON SL, 2005, CELL, V563, P177; Johnson SL, 2009, J PHYSIOL-LONDON, V587, P1715, DOI 10.1113/jphysiol.2009.168542; Jones TA, 2001, J NEUROSCI, V21, P8129, DOI 10.1523/JNEUROSCI.21-20-08129.2001; Jones TA, 2006, J NEUROPHYSIOL, V96, P128, DOI 10.1152/jn.00599.2005; Kiang NYS, 1965, DISCHARGE PATTERNS S; Levic S, 2007, P NATL ACAD SCI USA, V104, P19108, DOI 10.1073/pnas.0705927104; MANLEY GA, 1987, SCIENCE, V237, P655, DOI 10.1126/science.3603046; MartinezDunst C, 1997, J NEUROSCI, V17, P9133; Moser T, 2000, P NATL ACAD SCI USA, V97, P883, DOI 10.1073/pnas.97.2.883; Pangrsic T, 2010, NAT NEUROSCI, V13, P869, DOI 10.1038/nn.2578; REBILLARD G, 1981, BRAIN RES, V229, P15, DOI 10.1016/0006-8993(81)90741-1; REBILLARD M, 1983, ACTA OTO-LARYNGOL, V96, P379, DOI 10.3109/00016488309132723; Roux I, 2006, CELL, V127, P277, DOI 10.1016/j.cell.2006.08.040; SAUNDERS JC, 1973, BRAIN RES, V63, P59, DOI 10.1016/0006-8993(73)90076-0; Schnee ME, 2011, NEURON, V70, P326, DOI 10.1016/j.neuron.2011.01.031; Singer JH, 2006, J NEUROPHYSIOL, V95, P3191, DOI 10.1152/jn.01309.2005; Spassova M, 2001, J PHYSIOL-LONDON, V535, P689, DOI 10.1111/j.1469-7793.2001.00689.x; Spassova MA, 2004, JARO-J ASSOC RES OTO, V5, P376, DOI 10.1007/s10162-004-5003-8; Uthaiah RC, 2010, J NEUROSCI, V30, P12387, DOI 10.1523/JNEUROSCI.1014-10.2010; vonGersdorff H, 1997, J NEUROSCI, V17, P1919; Walsh Edward J., 1992, P161; WALSH EJ, 1987, HEARING RES, V28, P97, DOI 10.1016/0378-5955(87)90157-2; WHITEHEAD MC, 1985, NEUROSCIENCE, V14, P255, DOI 10.1016/0306-4522(85)90177-0; ZAMPINI V, 2010, CELL, V588, P187	39	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e25714	10.1371/journal.pone.0025714	http://dx.doi.org/10.1371/journal.pone.0025714			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998683	Green Published, gold, Green Submitted			2022-12-27	WOS:000295968700015
J	Schonfeld-Dado, E; Segal, M				Schonfeld-Dado, Eldi; Segal, Menahem			Activity Deprivation Induces Neuronal Cell Death: Mediation by Tissue-Type Plasminogen Activator	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MECHANISMS; APOPTOSIS; STROKE	Spontaneous activity is an essential attribute of neuronal networks and plays a critical role in their development and maintenance. Upon blockade of activity with tetrodotoxin (TTX), neurons degenerate slowly and die in a manner resembling neurodegenerative diseases-induced neuronal cell death. The molecular cascade leading to this type of slow cell death is not entirely clear. Primary post-natal cortical neurons were exposed to TTX for up to two weeks, followed by molecular, biochemical and immunefluorescence analysis. The expression of the neuronal marker, neuron specific enolase (NSE), was down-regulated, as expected, but surprisingly, there was a concomitant and striking elevation in expression of tissue-type plasminogen activator (tPA). Immunofluorescence analysis indicated that tPA was highly elevated inside affected neurons. Transfection of an endogenous tPA inhibitor, plasminogen activator inhibitor-1 (PAI-1), protected the TTX-exposed neurons from dying. These results indicate that tPA is a pivotal player in slowly progressing activity deprivation-induced neurodegeneration.	[Schonfeld-Dado, Eldi; Segal, Menahem] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Schonfeld-Dado, E (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	eldis@stanford.edu	SEGAL, MENAHEM/K-1577-2012		Israel Science Foundation	Israel Science Foundation(Israel Science Foundation)	This work was funded by the Israel Science Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buisson A, 1998, FASEB J, V12, P1683, DOI 10.1096/fasebj.12.15.1683; Clark WM, 1999, JAMA-J AM MED ASSOC, V282, P2019, DOI 10.1001/jama.282.21.2019; Corredor RG, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/5/055001; Echeverry R, 2010, J CLIN INVEST, V120, P2194, DOI 10.1172/JCI41722; Fishbein I, 2007, CEREB CORTEX, V17, P1292, DOI 10.1093/cercor/bhl037; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Flavin MP, 2001, J NEUROSCI RES, V63, P388, DOI 10.1002/1097-4547(20010301)63:5<388::AID-JNR1033>3.0.CO;2-T; Flavin MP, 2000, GLIA, V29, P347, DOI 10.1002/(SICI)1098-1136(20000215)29:4<347::AID-GLIA5>3.3.CO;2-#; Gabriel C, 2002, FASEB J, V16, P277, DOI 10.1096/fj.02-0403fje; Head BP, 2009, ANESTHESIOLOGY, V110, P813, DOI 10.1097/ALN.0b013e31819b602b; Ho-Tin-Noe B, 2009, MOL CELL NEUROSCI, V42, P288, DOI 10.1016/j.mcn.2009.08.001; Loebrich S, 2009, PHYSIOL REV, V89, P1079, DOI 10.1152/physrev.00013.2009; Mataga N, 2004, NEURON, V44, P1031, DOI 10.1016/j.neuron.2004.11.028; Medina MG, 2005, EMBO J, V24, P1706, DOI 10.1038/sj.emboj.7600650; Schonfeld-Dado E, 2009, J NEURAL TRANSM, V116, P1363, DOI 10.1007/s00702-009-0256-3; Schonfeld-Dado E, 2009, J NEUROCHEM, V110, P1203, DOI 10.1111/j.1471-4159.2009.06204.x; Soeda S, 2008, THROMB HAEMOSTASIS, V100, P1014, DOI 10.1160/TH08-04-0259; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Tabuchi A, 2008, BIOL PHARM BULL, V31, P327, DOI 10.1248/bpb.31.327; Takahashi H, 2005, NEUROSCI LETT, V381, P189, DOI 10.1016/j.neulet.2005.02.031; Xin HQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009027	21	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e25919	10.1371/journal.pone.0025919	http://dx.doi.org/10.1371/journal.pone.0025919			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998719	Green Submitted, Green Published, gold			2022-12-27	WOS:000295968700025
J	Wahl-Jensen, V; Cann, JA; Rubins, KH; Huggins, JW; Fisher, RW; Johnson, AJ; de Kok-Mercado, F; Larsen, T; Raymond, JL; Hensley, LE; Jahrling, PB				Wahl-Jensen, Victoria; Cann, Jennifer A.; Rubins, Kathleen H.; Huggins, John W.; Fisher, Robert W.; Johnson, Anthony J.; de Kok-Mercado, Fabian; Larsen, Thomas; Raymond, Jo Lynne; Hensley, Lisa E.; Jahrling, Peter B.			Progression of Pathogenic Events in Cynomolgus Macaques Infected with Variola Virus	PLOS ONE			English	Article							GLOBAL ERADICATION; SMALLPOX; PREGNANCY; HISTOLOGY; MOUSEPOX	Smallpox, caused by variola virus (VARV), is a devastating human disease that affected millions worldwide until the virus was eradicated in the 1970 s. Subsequent cessation of vaccination has resulted in an immunologically naive human population that would be at risk should VARV be used as an agent of bioterrorism. The development of antivirals and improved vaccines to counter this threat would be facilitated by the development of animal models using authentic VARV. Towards this end, cynomolgus macaques were identified as adequate hosts for VARV, developing ordinary or hemorrhagic smallpox in a dose-dependent fashion. To further refine this model, we performed a serial sampling study on macaques exposed to doses of VARV strain Harper calibrated to induce ordinary or hemorrhagic disease. Several key differences were noted between these models. In the ordinary smallpox model, lymphoid and myeloid hyperplasias were consistently found whereas lymphocytolysis and hematopoietic necrosis developed in hemorrhagic smallpox. Viral antigen accumulation, as assessed immunohistochemically, was mild and transient in the ordinary smallpox model. In contrast, in the hemorrhagic model antigen distribution was widespread and included tissues and cells not involved in the ordinary model. Hemorrhagic smallpox developed only in the presence of secondary bacterial infections - an observation also commonly noted in historical reports of human smallpox. Together, our results support the macaque model as an excellent surrogate for human smallpox in terms of disease onset, acute disease course, and gross and histopathological lesions.	[Wahl-Jensen, Victoria; Cann, Jennifer A.; Johnson, Anthony J.; de Kok-Mercado, Fabian; Jahrling, Peter B.] NIAID, Integrated Res Facil Ft Detrick, NIH, Frederick, MD 21701 USA; [Rubins, Kathleen H.] MIT, Whitehead Inst Biomed Res, Cambridge, MA USA; [Huggins, John W.; Fisher, Robert W.; Larsen, Thomas; Raymond, Jo Lynne; Hensley, Lisa E.] USA, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Massachusetts Institute of Technology (MIT); Whitehead Institute	Wahl-Jensen, V (corresponding author), NIAID, Integrated Res Facil Ft Detrick, NIH, Frederick, MD 21701 USA.	jahrlingp@niaid.nih.gov	; Wahl, Victoria/K-9267-2015	Larsen, Thomas/0000-0002-3609-9490; Hensley, Lisa/0000-0003-1188-4342; Wahl, Victoria/0000-0002-6588-4308	U.S. Department of Homeland Security for the management for the management and operation of the National Biodefense Analysis and Countermeasures Center (NBACC) [HSHQDC-07-C-00020]; National Institute of Allergy and Infectious Diseases [HHSN27220020000161]	U.S. Department of Homeland Security for the management for the management and operation of the National Biodefense Analysis and Countermeasures Center (NBACC); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded in part under agreement no. HSHQDC-07-C-00020 awarded by the U.S. Department of Homeland Security for the management and operation of the National Biodefense Analysis and Countermeasures Center (NBACC), a Federally Funded Research and Development Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The principal authors (WWJ and JAC) are employees of Battelle Memorial Institute under its prime contract with National Institute of Allergy and Infectious Diseases # HHSN27220020000161.	Gonzalez DA, 2010, IMMUNOL LETT, V133, P6, DOI 10.1016/j.imlet.2010.07.001; BRAS G, 1952, Doc Med Geogr Trop, V4, P303; Councilman W T, 1905, Public Health Pap Rep, V31, P218; Councilman WT, 1904, J MED RES, V11, P12; DAMON IK, 2007, FIELDS VIROLOGY, P2948; FENNER F, 1982, REV INFECT DIS, V4, P916; Fenner F, 1977, Prog Med Virol, V23, P1; FENNER F, 1980, MED J AUSTRALIA, V1, P455, DOI 10.5694/j.1326-5377.1980.tb135034.x; FENNER F, 1993, HIST PHIL LIFE SCI, V15, P397; FENNER F, 1988, CLIN FEATURES SMALLP, P1; Food and Drug Administration HHS, 2002, Fed Regist, V67, P37988; Geisbert TW, 2003, AM J PATHOL, V163, P2371, DOI 10.1016/S0002-9440(10)63592-4; Henderson DA, 1999, JAMA-J AM MED ASSOC, V281, P2127, DOI 10.1001/jama.281.22.2127; Hopkins Donald R., 2002, GREATEST KILLER SMAL, DOI [10.7208/chicago/9780226189529.001.0001, DOI 10.7208/CHICAGO/9780226189529.001.0001]; Jahrling PB, 2004, P NATL ACAD SCI USA, V101, P15196, DOI 10.1073/pnas.0405954101; Karupiah G, 1998, VET IMMUNOL IMMUNOP, V63, P105, DOI 10.1016/S0165-2427(98)00086-5; KARUPIAH G, 1993, SCIENCE, V261, P1445, DOI 10.1126/science.7690156; Kulesh DA, 2004, J CLIN MICROBIOL, V42, P601, DOI 10.1128/JCM.42.2.601-609.2004; Lillie RD, 1930, ARCH PATHOL, V10, P241; NIEMIALTOWSKI MG, 1994, ACTA VIROL, V38, P299; Ostensen M, 1999, ANN NY ACAD SCI, V876, P131, DOI 10.1111/j.1749-6632.1999.tb07630.x; Prophet E.B., 1992, LAB METHODS HISTOTEC, P25; Raghupathy R, 1997, IMMUNOL TODAY, V18, P478, DOI 10.1016/S0167-5699(97)01127-4; Rao AR, 1972, SMALLPOX; ROBERTS JA, 1962, BRIT J EXP PATHOL, V43, P451; Shames RS, 2002, J ADOLESCENT HEALTH, V30, P59, DOI 10.1016/S1054-139X(01)00382-2; Zaucha GM, 2001, LAB INVEST, V81, P1581, DOI 10.1038/labinvest.3780373; Zelicoff AP, 2003, CRIT REV MICROBIOL, V29, P97, DOI 10.1080/713610418	28	19	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e24832	10.1371/journal.pone.0024832	http://dx.doi.org/10.1371/journal.pone.0024832			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998632	Green Published, gold, Green Submitted			2022-12-27	WOS:000295968700005
J	Alphey, N; Alphey, L; Bonsall, MB				Alphey, Nina; Alphey, Luke; Bonsall, Michael B.			A Model Framework to Estimate Impact and Cost of Genetics-Based Sterile Insect Methods for Dengue Vector Control	PLOS ONE			English	Article							AEDES-AEGYPTI DIPTERA; MOSQUITO-BORNE DISEASES; MARK-RELEASE-RECAPTURE; HEMORRHAGIC-FEVER; ECONOMIC-IMPACT; LATIN-AMERICA; BODY-SIZE; POPULATION; THAILAND; CULICIDAE	Vector-borne diseases impose enormous health and economic burdens and additional methods to control vector populations are clearly needed. The Sterile Insect Technique (SIT) has been successful against agricultural pests, but is not in large-scale use for suppressing or eliminating mosquito populations. Genetic RIDL technology (Release of Insects carrying a Dominant Lethal) is a proposed modification that involves releasing insects that are homozygous for a repressible dominant lethal genetic construct rather than being sterilized by irradiation, and could potentially overcome some technical difficulties with the conventional SIT technology. Using the arboviral disease dengue as an example, we combine vector population dynamics and epidemiological models to explore the effect of a program of RIDL releases on disease transmission. We use these to derive a preliminary estimate of the potential cost-effectiveness of vector control by applying estimates of the costs of SIT. We predict that this genetic control strategy could eliminate dengue rapidly from a human community, and at lower expense (approximately US$ 2 similar to 30 per case averted) than the direct and indirect costs of disease (mean US$ 86-190 per case of dengue). The theoretical framework has wider potential use; by appropriately adapting or replacing each component of the framework (entomological, epidemiological, vector control bio-economics and health economics), it could be applied to other vector-borne diseases or vector control strategies and extended to include other health interventions.	[Alphey, Nina; Bonsall, Michael B.] Univ Oxford, Dept Zool, Math Ecol Res Grp, Oxford OX1 3PS, England; [Alphey, Nina; Alphey, Luke] Oxitec Ltd, Oxford, England	University of Oxford	Alphey, N (corresponding author), Univ Oxford, Dept Zool, Math Ecol Res Grp, S Parks Rd, Oxford OX1 3PS, England.	nina.alphey@zoo.ox.ac.uk	Alphey, Nina/A-1734-2010	Alphey, Nina/0000-0002-1458-2406; Alphey, Luke/0000-0002-2916-3802; Bonsall, Michael/0000-0003-0250-0423	Royal Society; UK Biotechnology and Biological Sciences Research Council [BB/C512702/1, BBS/S/J/2005/12055, BB/H01814X/1]; Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative; Oxitec Ltd.; University of Oxford; Biotechnology and Biological Sciences Research Council [BB/H01814X/1, BB/C512702/1] Funding Source: researchfish; BBSRC [BB/H01814X/1] Funding Source: UKRI	Royal Society(Royal Society of London); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oxitec Ltd.; University of Oxford; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Royal Society (University Research Fellowship to MBB), the UK Biotechnology and Biological Sciences Research Council (BB/C512702/1, BBS/S/J/2005/12055, BB/H01814X/1), by a grant to the Regents of the University of California from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by internal funds of Oxitec Ltd. Oxitec provided salary and other support for the research program of LA as an employee of the company, and financial support to NA through the University of Oxford under a collaborative PhD studentship agreement. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. URLs:http://royalsociety.org/, http://www.bbsrc.ac.uk/, http://www.grandchallenges.org/, http://www.oxitec.com/.	Alphey L., 2007, TRANSGENICS MANAGEME; Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014; Alphey N, 2011, J THEOR BIOL, V270, P42, DOI 10.1016/j.jtbi.2010.11.016; [Anonymous], 2011, B WORLD HEALTH ORGAN, V89, P476, DOI 10.2471/BLT.11.030711; [Anonymous], US FED RES H10 FOR E; [Anonymous], WHO GLOB BURD DIS 20; [Anonymous], WORLD POP PROSP 2008; [Anonymous], WHO FACT SHEET NO 11; ASMAN SM, 1981, ANNU REV ENTOMOL, V26, P289, DOI 10.1146/annurev.en.26.010181.001445; Atkinson MP, 2007, P NATL ACAD SCI USA, V104, P9540, DOI 10.1073/pnas.0610685104; Balmaseda A, 2006, TROP MED INT HEALTH, V11, P935, DOI 10.1111/j.1365-3156.2006.01641.x; Benedict MQ, 2003, TRENDS PARASITOL, V19, P349, DOI 10.1016/S1471-4922(03)00144-2; BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172; Clark DV, 2005, AM J TROP MED HYG, V72, P786, DOI 10.4269/ajtmh.2005.72.786; DAY JF, 1994, J MED ENTOMOL, V31, P611, DOI 10.1093/jmedent/31.4.611; Durbin AP, 2010, CURR TOP MICROBIOL, V338, P129, DOI 10.1007/978-3-642-02215-9_10; Dyck V.A., 2006, STERILE INSECT TECHN; DYE C, 1984, J ANIM ECOL, V53, P247, DOI 10.2307/4355; Endy TP, 2010, CURR TOP MICROBIOL, V338, P1, DOI 10.1007/978-3-642-02215-9_1; Endy TP, 2002, AM J EPIDEMIOL, V156, P40, DOI 10.1093/aje/kwf005; Fine P. E. M., 1982, Population biology of infectious diseases. (Report of the Dahlem Workshop on Population Biology of Infectious Disease Agents, Berlin, 1982, March 14-19.) (Life Science Research Report, 25), P121; Fu GL, 2007, NAT BIOTECHNOL, V25, P353, DOI 10.1038/nbt1283; Fu GL, 2010, P NATL ACAD SCI USA, V107, P4550, DOI 10.1073/pnas.1000251107; Gong P, 2005, NAT BIOTECHNOL, V23, P453, DOI 10.1038/nbt1071; Gubler DJ, 1997, DENGUE DENGUE HEMORR; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Harrington LC, 2001, J MED ENTOMOL, V38, P537, DOI 10.1603/0022-2585-38.4.537; (IAEA) International Atomic Energy Agency, 2008, MOD BUS PLAN STER IN; Jeffery JAL, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000552; Legros M, 2009, J MED ENTOMOL, V46, P409, DOI 10.1603/033.046.0301; Lenhart A, 2008, TROP MED INT HEALTH, V13, P56, DOI 10.1111/j.1365-3156.2007.01966.x; Lenhart A, 2010, AM J TROP MED HYG, V83, P138; Maciel-De-Freitas R, 2007, MED VET ENTOMOL, V21, P284, DOI 10.1111/j.1365-2915.2007.00694.x; Mammen MP, 2008, PLOS MED, V5, P1605, DOI 10.1371/journal.pmed.0050205; May RM, 2007, TRENDS ECOL EVOL, V22, P497, DOI 10.1016/j.tree.2007.08.009; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; National Statistical Office of Thailand, 1996, 1995 1996 SURV POP C; Ooi EE, 2006, EMERG INFECT DIS, V12, P887, DOI 10.3201/eid1206.051210; Phuc HK, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-11; Porter KR, 2005, AM J TROP MED HYG, V72, P60, DOI 10.4269/ajtmh.2005.72.60; SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; SANGKAWIBHA N, 1984, AM J EPIDEMIOL, V120, P653, DOI 10.1093/oxfordjournals.aje.a113932; Schetelig MF, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-4; Schneider JR, 2007, MED VET ENTOMOL, V21, P370, DOI 10.1111/j.1365-2915.2007.00699.x; SCOTT TW, 1993, J MED ENTOMOL, V30, P922, DOI 10.1093/jmedent/30.5.922; Shepard DS, 2004, VACCINE, V22, P1275, DOI 10.1016/j.vaccine.2003.09.019; SHEPPARD PM, 1969, J ANIM ECOL, V38, P661, DOI 10.2307/3042; SILER J. F., 1926, PHILIPPINE JOUR SCI, V29, P1; Siqueira JB, 2005, EMERG INFECT DIS, V11, P48, DOI 10.3201/eid1101.031091; SLOSEK J, 1986, SOC SCI MED, V23, P249, DOI 10.1016/0277-9536(86)90345-X; SOUTHWOOD T R E, 1972, Bulletin of the World Health Organization, V46, P211; Stainton KC, DEV FEMALE LET UNPUB; Stoddard ST, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000481; Suaya JA, 2009, AM J TROP MED HYG, V80, P846, DOI 10.4269/ajtmh.2009.80.846; Torres JR, 2007, CAD SAUDE PUBLICA, V23, pS23, DOI 10.1590/S0102-311X2007001300004; TRPIS M, 1986, AM J TROP MED HYG, V35, P1263, DOI 10.4269/ajtmh.1986.35.1263; TRPIS M, 1995, J MED ENTOMOL, V32, P27, DOI 10.1093/jmedent/32.1.27; United Nations Population Division, 2006, WORLD MORT REP 2005; US Office of Management and Budget, 2008, BUDG US GOV HIST TAB; Vasan S, 2008, SCI REPORT INNOVATIV; WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143; Wearing HJ, 2006, P NATL ACAD SCI USA, V103, P11802, DOI 10.1073/pnas.0602960103; WHO-TDR, 2007, TDRSWG08160 WHO; Wight A, 2009, THIRST BLOOD GROWS D; World Bank, 1993, WORLD DEV REP 1992 I; YASUNO M, 1970, B WORLD HEALTH ORGAN, V43, P319	68	61	64	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25384	10.1371/journal.pone.0025384	http://dx.doi.org/10.1371/journal.pone.0025384			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998654	Green Published, gold, Green Submitted			2022-12-27	WOS:000295966900023
J	Li, CI; Chien, L; Liu, CS; Lin, WY; Lai, MM; Lee, CC; Chen, FN; Li, TC; Lin, CC				Li, Chia-Ing; Chien, Ling; Liu, Chiu-Shong; Lin, Wen-Yuan; Lai, Ming-May; Lee, Cheng-Chun; Chen, Fei-Na; Li, Tsai-Chung; Lin, Cheng-Chieh			Prospective Validation of American Diabetes Association Risk Tool for Predicting Pre-Diabetes and Diabetes in Taiwan-Taichung Community Health Study	PLOS ONE			English	Article							FASTING GLUCOSE; SCORE; MELLITUS; PREVALENCE; PERFORMANCE	Background: A simple diabetes risk tool that does not require laboratory tests would be beneficial in screening individuals at higher risk. Few studies have evaluated the ability of these tools to identify new cases of pre-diabetes. This study aimed to assess the ability of the American Diabetes Association Risk Tool (ADART) to predict the 3-year incidence of pre-diabetes and diabetes in Taiwanese. Methods: This was a 3-year prospective study of 1021 residents with normoglycemia at baseline, gathered from a random sample of residents aged 40-88 years in a metropolitan city in Taiwan. The areas under the curve (AUCs) of three models were compared: ADART only, ADART plus lifestyle behaviors at baseline, and ADART plus lifestyle behaviors and biomarkers at baseline. The performance of ADART was compared with that of 16 tools that had been reported in the literature. Results: The AUCs and their 95% confidence intervals (CIs) were 0.60 (0.54-0.66) for men and 0.72 (0.66-0.77) for women in model 1; 0.62 (0.56-0.68) for men and 0.74 (0.68-0.80) for women in model 2; and 0.64 (0.58-0.71) for men and 0.75 (0.69-0.80) for women in model 3. The AUCs of these three models were all above 0.7 in women, but not in men. No significant difference in either women or men (p = 0.268 and 0.156, respectively) was observed in the AUC of these three models. Compared to 16 tools published in the literature, ADART had the second largest AUC in both men and women. Conclusions: ADART is a good screening tool for predicting the three-year incidence of pre-diabetes and diabetes in females of a Taiwanese population. The performance of ADART in men was similar to the results with other tools published in the literature. Its performance was one of the best among the tools reported in the literature.	[Li, Chia-Ing; Lin, Cheng-Chieh] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Li, Chia-Ing; Lee, Cheng-Chun] China Med Univ, Coll Med, Sch Med, Taichung, Taiwan; [Li, Chia-Ing] China Med Univ, Coll Publ Hlth, Inst Publ Hlth, Taichung, Taiwan; [Chien, Ling; Li, Tsai-Chung] China Med Univ, Coll Publ Hlth, Grad Inst Biostat, Taichung, Taiwan; [Liu, Chiu-Shong; Lin, Wen-Yuan; Lai, Ming-May; Lin, Cheng-Chieh] China Med Univ Hosp, Dept Family Med, Taichung, Taiwan; [Liu, Chiu-Shong; Chen, Fei-Na] China Med Univ, Coll Med, Dept Social Med, Taichung, Taiwan; [Lin, Wen-Yuan; Lai, Ming-May; Lin, Cheng-Chieh] China Med Univ, Coll Med, Dept Family Med, Taichung, Taiwan; [Lee, Cheng-Chun] China Med Univ Hosp, Dept Neurol, Taichung, Taiwan; [Li, Tsai-Chung] China Med Univ, Coll Chinese Med, Grad Inst China Med Sci, Taichung, Taiwan; [Li, Tsai-Chung] China Med Univ, Ctr Biostat, Taichung, Taiwan; [Li, Tsai-Chung] Asia Univ, Coll Hlth Sci, Inst Hlth Care Adm, Taichung, Taiwan; [Lin, Cheng-Chieh] China Med Univ, Coll Publ Hlth, Sch Hlth Care Adm, Taichung, Taiwan; [Lin, Cheng-Chieh] China Med Univ, Coll Publ Hlth, Grad Inst Hlth Care Adm, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan; China Medical University Taiwan; China Medical University Taiwan	Li, CI (corresponding author), China Med Univ Hosp, Dept Med Res, Taichung, Taiwan.	cclin@mail.cmu.edu.tw	Lin, Cheng-Chieh/P-2564-2015; Li, Tsai-Chung/P-2052-2015	Lin, Cheng-Chieh/0000-0002-9625-6216; Li, Tsai-Chung/0000-0002-3346-7462	National Science Council of Taiwan [NSC93-2314-B-039-025, NSC94-2314-B-039-024, NSC96-2628-B-039-011-MY3]; Taiwan Department of Health Clinical Trial and Research Center for Excellence [DOH100-TD-B-111-004]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Taiwan Department of Health Clinical Trial and Research Center for Excellence	This study was supported by grants from the National Science Council of Taiwan (NSC93-2314-B-039-025 & NSC94-2314-B-039-024 & NSC96-2628-B-039-011-MY3) and the Taiwan Department of Health Clinical Trial and Research Center for Excellence (DOH100-TD-B-111-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aekplakorn W, 2006, DIABETES CARE, V29, P1872, DOI 10.2337/dc05-2141; Al-Lawati JA, 2007, DIABETES RES CLIN PR, V77, P438, DOI 10.1016/j.diabres.2007.01.013; American Diabetes Association, 2004, Diabetes Care, V27 Suppl 1, pS11; Baan CA, 1999, DIABETES CARE, V22, P213, DOI 10.2337/diacare.22.2.213; Balkau B, 2008, DIABETES CARE, V31, P2056, DOI 10.2337/dc08-0368; Bindraban NR, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-271; de Leon AC, 2008, DIABETES RES CLIN PR, V80, P128, DOI 10.1016/j.diabres.2007.10.022; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Gavin JR, 1999, DIABETES CARE, V22, pS5; Glumer C, 2004, DIABETES CARE, V27, P727, DOI 10.2337/diacare.27.3.727; Griffin SJ, 2000, DIABETES-METAB RES, V16, P164, DOI 10.1002/1520-7560(200005/06)16:3<164::AID-DMRR103>3.0.CO;2-R; HOSMER DW, 1989, APPL LOGISTIC REGRES; Lin CC, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-239; Lin L, 2009, OBES REV, V10, P420, DOI 10.1111/j.1467-789X.2009.00600.x; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Mamdani M, 2005, BMJ-BRIT MED J, V330, P960, DOI 10.1136/bmj.330.7497.960; Mohan V, 2005, J Assoc Physicians India, V53, P759; Pan WH, 2003, DIABETIC MED, V20, P182, DOI 10.1046/j.1464-5491.2003.00772.x; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Phillips LS, 2006, DIABETES CARE, V29, P1405, DOI 10.2337/dc06-0242; Ramachandran A, 2005, DIABETES RES CLIN PR, V70, P63, DOI 10.1016/j.diabres.2005.02.016; Roglic G, 2005, DIABETES CARE, V28, P2130, DOI 10.2337/diacare.28.9.2130; Schmidt MI, 2005, DIABETES CARE, V28, P2013, DOI 10.2337/diacare.28.8.2013; Schulze MB, 2007, DIABETES CARE, V30, P510, DOI 10.2337/dc06-2089; Stern MP, 2002, ANN INTERN MED, V136, P575, DOI 10.7326/0003-4819-136-8-200204160-00006; TAI T-Y, 1987, Journal of the Medical Association of Thailand, V70, P42; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068	28	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25906	10.1371/journal.pone.0025906	http://dx.doi.org/10.1371/journal.pone.0025906			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998718	Green Published, Green Submitted, gold			2022-12-27	WOS:000295966900071
J	Oidovsambuu, O; Nyamsuren, G; Liu, SA; Goring, W; Engel, W; Adham, IM				Oidovsambuu, Odgerel; Nyamsuren, Gunsmaa; Liu, Shuai; Goering, Wolfgang; Engel, Wolfgang; Adham, Ibrahim M.			Adhesion Protein VSIG1 Is Required for the Proper Differentiation of Glandular Gastric Epithelia	PLOS ONE			English	Article							IMMUNOGLOBULIN SUPERFAMILY; A33 ANTIGEN; MOUSE; ENDODERM; CELLS; MICE; MOLECULE; STOMACH; CLONING; TESTIS	VSIG1, a cell adhesion protein of the immunoglobulin superfamily, is preferentially expressed in stomach, testis, and certain gastric, esophageal and ovarian cancers. Here, we describe the expression patterns of three alternatively spliced isoforms of mouse Vsig1 during pre- and postnatal development of stomach and potential function of Vsig1 in differentiation of gastric epithelia. We show that isoforms Vsig1A and Vsig1B, which differ in the 3'untranslated region, are expressed in the early stages of stomach development. Immunohistochemical analysis revealed that VSIG1 is restricted to the adherens junction of the glandular epithelium. The shorter transcript Vsig1C is restricted to the testis, encodes an N-terminal truncated protein and is presumably regulated by an internal promoter, which is located upstream of exon 1b. To determine whether the 59 flanking region of exon 1a specifically targets the expression of Vsig1 to stomach epithelia, we generated and analyzed transgenic mice. The 4.8-kb fragment located upstream of exon 1a was sufficient to direct the expression of the reporter gene to the glandular epithelia of transgenic stomach. To determine the role of VSIG1 during the development of stomach epithelia, an X-linked Vsig1 was inactivated in embryonic stem cells (ESCs). Although Vsig1(-/Y) ESCs were only able to generate low coat color chimeric mice, no male chimeras transmitted the targeted allele to their progeny suggesting that the high contribution of Vsig1(-/Y) cells leads to the lethality of chimeric embryos. Analysis of chimeric stomachs revealed the differentiation of VSIG1-null cells into squamous epithelia inside the glandular region. These results suggest that VSIG1 is required for the establishment of glandular versus squamous epithelia in the stomach.	[Oidovsambuu, Odgerel; Nyamsuren, Gunsmaa; Liu, Shuai; Goering, Wolfgang; Engel, Wolfgang; Adham, Ibrahim M.] Univ Gottingen, Inst Human Genet, D-3400 Gottingen, Germany	University of Gottingen	Oidovsambuu, O (corresponding author), Univ Gottingen, Inst Human Genet, Gosslerstr 12D, D-3400 Gottingen, Germany.	iadham@gwdg.de	Oidovsambuu, Odgerel/AHE-0868-2022	Oidovsambuu, Odgerel/0000-0001-6872-3385				Beck F, 2003, DEV BIOL, V255, P399, DOI 10.1016/S0012-1606(02)00096-9; CHO C, 1997, TECHNICAL TIPS ONLIN, V1, P20; CUMBINER BM, 2000, J CELL BIOL, V148, P399; DUAN HJ, 1993, CELL MOL BIOL, V39, P309; FUKUMACHI H, 1979, ANAT EMBRYOL, V157, P151; Gao N, 2009, DEV CELL, V16, P588, DOI 10.1016/j.devcel.2009.02.010; Heath JK, 1997, P NATL ACAD SCI USA, V94, P469, DOI 10.1073/pnas.94.2.469; Hirata K, 2001, J BIOL CHEM, V276, P16223, DOI 10.1074/jbc.M100630200; Jacobsen CM, 2002, DEV BIOL, V241, P34, DOI 10.1006/dbio.2001.0424; Johnstone CN, 2000, AM J PHYSIOL-GASTR L, V279, pG500, DOI 10.1152/ajpgi.2000.279.3.G500; Karam SM, 1997, AM J PHYSIOL-GASTR L, V272, pG1209, DOI 10.1152/ajpgi.1997.272.5.G1209; Kim E, 2010, MOL CELLS, V30, P443, DOI 10.1007/s10059-010-0138-4; Kim SK, 2000, GENE DEV, V14, P1866; Mirza M, 2006, EXP CELL RES, V312, P817, DOI 10.1016/j.yexcr.2005.11.030; Nagamatsu G, 2006, MOL CELL BIOL, V26, P8498, DOI 10.1128/MCB.01502-06; Que J, 2007, DEVELOPMENT, V134, P2521, DOI 10.1242/dev.003855; Ramalho-Santos M, 2000, DEVELOPMENT, V127, P2763; Scanlan Matthew J, 2006, Cancer Immun, V6, P2; Spencer-Dene B, 2006, GASTROENTEROLOGY, V130, P1233, DOI 10.1053/j.gastro.2006.02.018; Suzu S, 2002, BIOCHEM BIOPH RES CO, V296, P1215, DOI 10.1016/S0006-291X(02)02025-9; Takamoto N, 2005, DEVELOPMENT, V132, P2179, DOI 10.1242/dev.01808; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; van den Brink GR, 2007, PHYSIOL REV, V87, P1343, DOI 10.1152/physrev.00054.2006; Wells JM, 1999, ANNU REV CELL DEV BI, V15, P393, DOI 10.1146/annurev.cellbio.15.1.393; Wurst W., 1993, Gene targeting: a practical approach., P33	25	14	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e25908	10.1371/journal.pone.0025908	http://dx.doi.org/10.1371/journal.pone.0025908			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21991385	Green Submitted, Green Published, gold			2022-12-27	WOS:000295963300030
J	Gan, XB; Duan, YC; Xiong, XQ; Li, P; Cui, BP; Gao, XY; Zhu, GQ				Gan, Xian-Bing; Duan, Yang-Can; Xiong, Xiao-Qing; Li, Peng; Cui, Bai-Ping; Gao, Xing-Ya; Zhu, Guo-Qing			Inhibition of Cardiac Sympathetic Afferent Reflex and Sympathetic Activity by Baroreceptor and Vagal Afferent Inputs in Chronic Heart Failure	PLOS ONE			English	Article							PARAVENTRICULAR NUCLEUS MEDIATE; ANG-II; HYDROGEN-PEROXIDE; AT(1) RECEPTORS; NERVE ACTIVITY; RATS; BAROREFLEX; ACTIVATION; RESPONSES; PATHWAY	Background: Cardiac sympathetic afferent reflex (CSAR) contributes to sympathetic activation and angiotensin II (Ang II) in paraventricular nucleus (PVN) augments the CSAR in vagotomized (VT) and baroreceptor denervated (BD) rats with chronic heart failure (CHF). This study was designed to determine whether it is true in intact (INT) rats with CHF and to determine the effects of cardiac and baroreceptor afferents on the CSAR and sympathetic activity in CHF. Methodology/Principal Findings: Sham-operated (Sham) or coronary ligation-induced CHF rats were respectively subjected to BD+VT, VT, cardiac sympathetic denervation (CSD) or INT. Under anesthesia, renal sympathetic nerve activity (RSNA) and mean arterial pressure (MAP) were recorded, and the CSAR was evaluated by the RSNA and MAP responses to epicardial application of capsaicin. Either CSAR or the responses of RSNA, MAP and CSAR to Ang II in PVN were enhanced in CHF rats treated with BD+VT, VT or INT. Treatment with VT or BD+VT potentiated the CSAR and the CSAR responses to Ang II in both Sham and CHF rats. Treatment with CSD reversed the capsaicin-induced RSNA and MAP changes and the CSAR responses to Ang II in both Sham and CHF rats, and reduced the RSNA and MAP responses to Ang II only in CHF rats. Conclusions: The CSAR and the CSAR responses to Ang II in PVN are enhanced in intact CHF rats. Baroreceptor and vagal afferent activities inhibit CSAR and the CSAR responses to Ang II in intact Sham and CHF rats.	[Gan, Xian-Bing; Duan, Yang-Can; Xiong, Xiao-Qing; Li, Peng; Cui, Bai-Ping; Gao, Xing-Ya; Zhu, Guo-Qing] Nanjing Med Univ, Dept Physiol, Nanjing, Peoples R China; [Gan, Xian-Bing; Xiong, Xiao-Qing; Zhu, Guo-Qing] Nanjing Med Univ, Key Lab Cardiovasc Dis & Mol Intervent, Nanjing, Peoples R China; [Duan, Yang-Can] Jining Med Univ, Dept Med Ultrasound, Affiliated Hosp, Jining, Peoples R China	Nanjing Medical University; Nanjing Medical University; Jining Medical University	Gan, XB (corresponding author), Nanjing Med Univ, Dept Physiol, Nanjing, Peoples R China.	gqzhucn@njmu.edu.cn		Zhu, Guo-Qing/0000-0002-3132-9592	Chinese National Natural Science fund [30670768, 30870908]	Chinese National Natural Science fund(National Natural Science Foundation of China (NSFC))	This work was supported by Chinese National Natural Science fund (30670768 & 30870908). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuaje F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009661; Badoer E, 2001, CLIN EXP PHARMACOL P, V28, P95, DOI 10.1046/j.1440-1681.2001.03413.x; BARBER MJ, 1984, CIRC RES, V55, P532, DOI 10.1161/01.RES.55.4.532; Chen AD, 2011, EXP PHYSIOL, V96, P94, DOI 10.1113/expphysiol.2010.054353; Dans AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013694; Du YH, 2007, J APPL PHYSIOL, V102, P9, DOI 10.1152/japplphysiol.01032.2006; Gao L, 2005, HYPERTENSION, V45, P1173, DOI 10.1161/01.HYP.0000168056.66981.c2; Gao L, 2004, AM J PHYSIOL-HEART C, V286, pH1706, DOI 10.1152/ajpheart.01097.2003; Gao L, 2007, J APPL PHYSIOL, V102, P37, DOI 10.1152/japplphysiol.00681.2006; Gu R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014633; Guo ZL, 2004, BRAIN RES, V1006, P36, DOI 10.1016/j.brainres.2004.01.057; Han Y, 2005, BRAIN RES, V1058, P82, DOI 10.1016/j.brainres.2005.07.055; Han Y, 2007, EUR J HEART FAIL, V9, P967, DOI 10.1016/j.ejheart.2007.07.004; Han Y, 2011, J APPL PHYSIOL, V110, P646, DOI 10.1152/japplphysiol.00908.2010; Han Y, 2011, PFLUG ARCH EUR J PHY, V461, P437, DOI 10.1007/s00424-011-0932-7; HUANG HS, 1995, AM J PHYSIOL-HEART C, V268, pH2114, DOI 10.1152/ajpheart.1995.268.5.H2114; Kuenzli A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009946; Ma R, 1999, AM J PHYSIOL-HEART C, V277, pH15, DOI 10.1152/ajpheart.1999.277.1.H15; Malliani A, 2002, HYPERTENSION, V39, P63, DOI 10.1161/hy0102.099200; Schultz HD, 2001, ANN NY ACAD SCI, V940, P59; Shi Z, 2011, ACTA PHYSIOL, V203, P289, DOI 10.1111/j.1748-1716.2011.02313.x; Shi Z, 2009, PFLUG ARCH EUR J PHY, V458, P247, DOI 10.1007/s00424-008-0627-x; Wang HJ, 2005, AUTON NEUROSCI-BASIC, V121, P56, DOI 10.1016/j.autneu.2005.07.003; Wang W, 2000, Heart Fail Rev, V5, P57; Xu B, 2011, EXP PHYSIOL, V96, P295, DOI 10.1113/expphysiol.2010.055475; Yoshimoto M, 2008, AM J PHYSIOL-HEART C, V295, pH2447, DOI 10.1152/ajpheart.00958.2008; Yu Y, 2007, PFLUG ARCH EUR J PHY, V454, P551, DOI 10.1007/s00424-007-0256-9; Zhang Y, 2006, BRAIN RES, V1082, P132, DOI 10.1016/j.brainres.2006.01.113; Zheng H, 2009, AM J PHYSIOL-REG I, V297, pR1364, DOI 10.1152/ajpregu.00149.2009; Zhong MK, 2008, EXP PHYSIOL, V93, P746, DOI 10.1113/expphysiol.2007.041632; Zhong MK, 2008, EUR J NEUROSCI, V27, P3226, DOI 10.1111/j.1460-9568.2008.06261.x; Zhou LM, 2010, PFLUG ARCH EUR J PHY, V459, P681, DOI 10.1007/s00424-010-0793-5; Zhu GQ, 2004, J APPL PHYSIOL, V97, P1746, DOI 10.1152/japplphysiol.00573.2004; Zhu GQ, 2002, BASIC RES CARDIOL, V97, P320, DOI 10.1007/s00395-002-0353-z; Zhu GQ, 2002, AM J PHYSIOL-HEART C, V282, pH2039, DOI 10.1152/ajpheart.00854.2001; Zhu GQ, 2009, EXP PHYSIOL, V94, P785, DOI 10.1113/expphysiol.2008.046565; Zucker Irving H, 2002, Heart Fail Monit, V3, P2	38	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25784	10.1371/journal.pone.0025784	http://dx.doi.org/10.1371/journal.pone.0025784			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991351	Green Published, Green Submitted, gold			2022-12-27	WOS:000295943000069
J	Teng, F; Zhou, YB; Jin, R; Chen, Y; Pei, XY; Liu, YF; Dong, JE; Wang, W; Pang, XW; Qian, XP; Chen, WF; Zhang, Y; Ge, Q				Teng, Fei; Zhou, Yubin; Jin, Rong; Chen, Yu; Pei, Xiaoyan; Liu, Yuanfeng; Dong, Jie; Wang, Wei; Pang, Xuewen; Qian, Xiaoping; Chen, Wei-Feng; Zhang, Yu; Ge, Qing			The Molecular Signature Underlying the Thymic Migration and Maturation of TCR alpha beta(+) CD4(+) CD8(-) Thymocytes	PLOS ONE			English	Article							SPHINGOSINE 1-PHOSPHATE RECEPTOR; POSITIVELY SELECTED THYMOCYTES; MACROPHAGE-DERIVED CHEMOKINE; MEDULLARY EPITHELIAL-CELLS; T-CELLS; NEGATIVE SELECTION; CENTRAL TOLERANCE; GENE-EXPRESSION; LYMPHOKINE SECRETION; LYMPHOCYTE EGRESS	Background: After positive selection, the newly generated single positive (SP) thymocytes migrate to the thymic medulla, where they undergo negative selection to eliminate autoreactive T cells and functional maturation to acquire immune competence and egress capability. Methodology/Principal Findings: To elucidate the genetic program underlying this process, we analyzed changes in gene expression in four subsets of mouse TCR alpha beta(+) CD4(+) CD8-thymocytes (SP1 to SP4) representative of sequential stages in a previously defined differentiation program. A genetic signature of the migration of thymocytes was thus revealed. CCR7 and PlexinD1 are believed to be important for the medullary positioning of SP thymocytes. Intriguingly, their expression remains at low levels in the newly generated thymocytes, suggesting that the cortex-medulla migration may not occur until the SP2 stage. SP2 and SP3 cells gradually up-regulate transcripts involved in T cell functions and the Foxo1-KLF2-S1P(1) axis, but a number of immune function-associated genes are not highly expressed until cells reach the SP4 stage. Consistent with their critical role in thymic emigration, the expression of S1P(1) and CD62L are much enhanced in SP4 cells. Conclusions: These results support at the molecular level that single positive thymocytes undergo a differentiation program and further demonstrate that SP4 is the stage at which thymocytes acquire the immunocompetence and the capability of emigration from the thymus.	[Teng, Fei; Zhou, Yubin; Jin, Rong; Chen, Yu; Pei, Xiaoyan; Liu, Yuanfeng; Dong, Jie; Wang, Wei; Pang, Xuewen; Qian, Xiaoping; Chen, Wei-Feng; Zhang, Yu; Ge, Qing] Peking Univ, Hlth Sci Ctr, Dept Immunol, Beijing 100871, Peoples R China	Peking University	Ge, Q (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Immunol, Beijing 100871, Peoples R China.	zhangyu007@bjmu.edu.cn; qingge@bjmu.edu.cn	Ge, Qing/A-6551-2012; Chen, Wei/GZK-7348-2022		Natural Basic Research Program of China [2010CB945300, 2011CB711000, 2011CB946100]; National Natural Sciences Foundation of China [31070787, 30830091]; Program for New Century Excellent Talents in University [NCET-10-0175/BMU20100005]; Research Fund for the Doctoral Program of Higher Education [20100001110049]; Key Laboratory of Medical Immunology, Ministry of Health	Natural Basic Research Program of China(National Basic Research Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP)); Key Laboratory of Medical Immunology, Ministry of Health	This work was supported by grants from the Natural Basic Research Program of China (2010CB945300, Dr. Ge, 2011CB711000, Dr. Ge and 2011CB946100, Dr. Zhang), the National Natural Sciences Foundation of China (31070787, Dr. Ge, 30830091, Dr. Zhang), Program for New Century Excellent Talents in University (NCET-10-0175/BMU20100005), the Research Fund for the Doctoral Program of Higher Education (20100001110049), and Key Laboratory of Medical Immunology, Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUS DB, 1991, J EXP MED, V173, P1039, DOI 10.1084/jem.173.5.1039; Akiyama T, 2005, SCIENCE, V308, P248, DOI 10.1126/science.1105677; Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Annunziato F, 2000, J IMMUNOL, V165, P238, DOI 10.4049/jimmunol.165.1.238; Bai AL, 2007, J IMMUNOL, V178, P7632, DOI 10.4049/jimmunol.178.12.7632; BENDELAC A, 1991, NATURE, V353, P68, DOI 10.1038/353068a0; Boehm T, 2003, J EXP MED, V198, P757, DOI 10.1084/jem.20030794; Bosco N, 2009, IMMUNOL CELL BIOL, V87, P50, DOI 10.1038/icb.2008.83; Boursalian TE, 2004, NAT IMMUNOL, V5, P418, DOI 10.1038/ni1049; Bunting MD, 2010, IMMUNOL CELL BIOL; Bupp MRG, 2009, EUR J IMMUNOL, V39, P2991, DOI 10.1002/eji.200939427; BURKLY L, 1995, NATURE, V373, P531, DOI 10.1038/373531a0; Campbell JJ, 1999, J IMMUNOL, V163, P2353; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Carpenter AC, 2010, NAT IMMUNOL, V11, P666, DOI 10.1038/ni.1887; Chantry D, 1999, BLOOD, V94, P1890; Chin RK, 2003, NAT IMMUNOL, V4, P1121, DOI 10.1038/ni982; Choi YI, 2008, IMMUNITY, V29, P888, DOI 10.1016/j.immuni.2008.10.008; Davalos-Misslitz ACM, 2007, BLOOD, V110, P4351, DOI 10.1182/blood-2007-01-070284; Davalos-Misslitz ACM, 2007, EUR J IMMUNOL, V37, P613, DOI 10.1002/eji.200636656; DeRyckere D, 2003, J IMMUNOL, V171, P802, DOI 10.4049/jimmunol.171.2.802; DYALL R, 1995, J EXP MED, V181, P235, DOI 10.1084/jem.181.1.235; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ehrlich LIR, 2009, IMMUNITY, V31, P986, DOI 10.1016/j.immuni.2009.09.020; Fabre S, 2008, J IMMUNOL, V181, P2980, DOI 10.4049/jimmunol.181.5.2980; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gabor MJ, 1997, EUR J IMMUNOL, V27, P2010, DOI 10.1002/eji.1830270827; Gopinathan R, 2001, TRANSPLANTATION, V72, P1533, DOI 10.1097/00007890-200111150-00011; Hale JS, 2006, P NATL ACAD SCI USA, V103, P8447, DOI 10.1073/pnas.0601040103; Heino M, 2000, EUR J IMMUNOL, V30, P1884, DOI 10.1002/1521-4141(200007)30:7<1884::AID-IMMU1884>3.0.CO;2-P; Hoffmann R, 2003, J IMMUNOL, V170, P1339, DOI 10.4049/jimmunol.170.3.1339; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; Huang YH, 2004, P NATL ACAD SCI USA, V101, P4936, DOI 10.1073/pnas.0401133101; Jin R, 2008, J IMMUNOL, V180, P2256, DOI 10.4049/jimmunol.180.4.2256; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kajiura F, 2004, J IMMUNOL, V172, P2067, DOI 10.4049/jimmunol.172.4.2067; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Kishimoto H, 1997, J EXP MED, V185, P263, DOI 10.1084/jem.185.2.263; Koble C, 2009, J EXP MED, V206, P1505, DOI 10.1084/jem.20082449; Kurobe H, 2006, IMMUNITY, V24, P165, DOI 10.1016/j.immuni.2005.12.011; Kwan J, 2004, J IMMUNOL, V172, P3999, DOI 10.4049/jimmunol.172.7.3999; Laan M, 2009, J IMMUNOL, V183, P7682, DOI 10.4049/jimmunol.0804133; Li J, 2007, P NATL ACAD SCI USA, V104, P18175, DOI 10.1073/pnas.0708884104; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; LUCAS B, 1994, J IMMUNOL, V153, P53; Makaroff LE, 2009, P NATL ACAD SCI USA, V106, P4799, DOI 10.1073/pnas.0812354106; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; McCaughtry TM, 2007, J EXP MED, V204, P2513, DOI 10.1084/jem.20070601; Mick VE, 2004, J IMMUNOL, V173, P5434, DOI 10.4049/jimmunol.173.9.5434; Nitta T, 2009, P NATL ACAD SCI USA, V106, P17129, DOI 10.1073/pnas.0906956106; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Puthier D, 2004, J IMMUNOL, V173, P6109, DOI 10.4049/jimmunol.173.10.6109; RAMSDELL F, 1991, J IMMUNOL, V147, P1779; Rodewald HR, 2008, ANNU REV IMMUNOL, V26, P355, DOI 10.1146/annurev.immunol.26.021607.090408; Rosen H, 2003, P NATL ACAD SCI USA, V100, P10907, DOI 10.1073/pnas.1832725100; Schmitz I, 2003, INT IMMUNOL, V15, P1237, DOI 10.1093/intimm/dxg125; Schnell FJ, 2005, J IMMUNOL, V175, P2270, DOI 10.4049/jimmunol.175.4.2270; SCOLLAY R, 1995, IMMUNOL TODAY, V16, P268, DOI 10.1016/0167-5699(95)80179-0; Scollay R, 1995, IMMUNOL TODAY; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Suzuki G, 1999, J IMMUNOL, V162, P5981; Tabrizifard S, 2004, J IMMUNOL, V173, P1094, DOI 10.4049/jimmunol.173.2.1094; Takahama Y, 2006, NAT REV IMMUNOL, V6, P127, DOI 10.1038/nri1781; Tanzola MB, 2006, MOL IMMUNOL, V43, P754, DOI 10.1016/j.molimm.2005.03.006; Tian CR, 2004, J IMMUNOL, V173, P7217, DOI 10.4049/jimmunol.173.12.7217; Uehara S, 2002, J IMMUNOL, V168, P134, DOI 10.4049/jimmunol.168.1.134; Ueno T, 2004, J EXP MED, V200, P493, DOI 10.1084/jem.20040643; VICARI A, 1994, J IMMUNOL, V152, P2207; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; Weinreich MA, 2008, J IMMUNOL, V181, P2265, DOI 10.4049/jimmunol.181.4.2265; Wurbel MA, 2000, EUR J IMMUNOL, V30, P262, DOI 10.1002/1521-4141(200001)30:1<262::AID-IMMU262>3.0.CO;2-0; Yagi H, 2000, EUR J IMMUNOL, V30, P1435, DOI 10.1002/(SICI)1521-4141(200005)30:5<1435::AID-IMMU1435>3.0.CO;2-O; Zachariah Marcus A, 2009, F1000 Biol Rep, V1, P60, DOI 10.3410/B1-60; Zachariah MA, 2010, SCIENCE, V328, P1129, DOI 10.1126/science.1188222; Zhu MZ, 2006, J CLIN INVEST, V116, P2964, DOI 10.1172/JCI28326	76	21	22	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e25567	10.1371/journal.pone.0025567	http://dx.doi.org/10.1371/journal.pone.0025567			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022412	Green Published, Green Submitted, gold			2022-12-27	WOS:000295978600022
J	Lee, SH; Lee, ST; Kim, BJ; Park, HK; Kim, CK; Jung, KH; Roh, JK				Lee, Seung-Hoon; Lee, Soon-Tae; Kim, Beom Joon; Park, Hee-Kwon; Kim, Chi-Kyung; Jung, Keun-Hwa; Roh, Jae-Kyu			Dynamic Temporal Change of Cerebral Microbleeds: Long-Term Follow-Up MRI Study	PLOS ONE			English	Article							SERUM TOTAL CHOLESTEROL; RISK-FACTOR; INTRACEREBRAL HEMORRHAGE; BLOOD-PRESSURE; SIGNAL LOSS; STROKE; MORTALITY; LESIONS; PROGRESS; MEN	Background: Cerebral microbleeds (MBs) are understood as an important radiologic marker of intracerebral hemorrhage. We sought to investigate the temporal changes of MBs and clinical factors associated with the changes using long-term follow-up MRI. Methods/Principal Findings: From October 2002 to July 2006, we prospectively enrolled patients with stroke or transient ischemic attack, and followed-up their brain MRIs with an interval >12 mo. We compared demographic factors, vascular risk factors, laboratory findings, and radiologic factors according to the presence or changes of MBs. A total of 224 patients successfully completed the follow-up examinations (mean, 27 months). Newly developed MBs were noted in 10 patients (6.8%) among those without MBs at baseline (n = 148), and in those with MBs at baseline (n = 76), the MB count had decreased in 11 patients (14.5%), and increased in 41 patients (53.9%). The estimated annual rate of change of MB numbers was 0.80 lesions per year in all patients, a value which became greater in those patients who exhibited MBs at baseline (MBs >= 5, 5.43 lesions per year). Strokes due to small vessel occlusion and intracerebral hemorrhage, as well as white matter lesions were independently associated with an increased MB count, whereas the highest quartile of low-density lipoprotein (LDL) cholesterol was associated with a decreased MB count. Conclusion: During the follow-up period, most of MBs showed dynamic temporal change. Symptomatic or asymptomatic small vessel diseases appear to act as risk factors while in contrast, a high level of LDL cholesterol may act as a protective factor against MB increase.	[Lee, Seung-Hoon; Lee, Soon-Tae; Kim, Beom Joon; Kim, Chi-Kyung; Jung, Keun-Hwa; Roh, Jae-Kyu] Seoul Natl Univ, Coll Med, Dept Neurol, Seoul, South Korea; [Lee, Seung-Hoon; Kim, Beom Joon; Kim, Chi-Kyung] Seoul Natl Univ Hosp, Clin Res Ctr Stroke, Seoul 110744, South Korea; [Park, Hee-Kwon] Inha Univ Hosp, Dept Neurol, Inchon, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Inha University; Inha University Hospital	Lee, SH (corresponding author), Seoul Natl Univ, Coll Med, Dept Neurol, Seoul, South Korea.	rohjk@snu.ac.kr	Kim, Chi Kyung/AAR-9819-2020; Roh, Jae Kyu/J-5459-2012; Kim, Beom Joon/C-2904-2011; Lee, Soon-Tae/C-4663-2013	Kim, Beom Joon/0000-0002-2719-3012; Lee, Soon-Tae/0000-0003-4767-7564	National Research Foundation of Korea; Ministry of Education, Science and Technology [2011-0026315]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2011-0026315). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Amarenco P, 2009, LANCET NEUROL, V8, P453, DOI 10.1016/S1474-4422(09)70058-4; Amarenco P, 2006, NEW ENGL J MED, V355, P549; Dufouil C, 2005, CIRCULATION, V112, P1644, DOI 10.1161/CIRCULATIONAHA.104.501163; Fazekas F, 1999, AM J NEURORADIOL, V20, P637; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Greenberg SM, 2004, STROKE, V35, P1415, DOI 10.1161/01.STR.0000126807.69758.0e; Greenberg SM, 1999, NEUROLOGY, V53, P1135, DOI 10.1212/WNL.53.5.1135; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Gregoire SM, 2009, STROKE; Henneman WJP, 2009, STROKE, V40, P492, DOI 10.1161/STROKEAHA.108.516286; Inzitari D, 2003, STROKE, V34, P2067, DOI 10.1161/01.STR.0000080934.68280.82; ISO H, 1989, NEW ENGL J MED, V320, P904, DOI 10.1056/NEJM198904063201405; Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017; Kim BJ, 2008, J NEUROL, V255, P1176, DOI 10.1007/s00415-008-0864-0; KONISHI M, 1993, STROKE, V24, P954, DOI 10.1161/01.STR.24.7.954; Lee SH, 2009, NEUROLOGY, V72, P171, DOI 10.1212/01.wnl.0000339060.11702.dd; Lee SH, 2004, NEUROLOGY, V63, P16, DOI 10.1212/01.WNL.0000132525.36804.A1; Lee SH, 2004, J NEUROL NEUROSUR PS, V75, P423, DOI 10.1136/jnnp.2003.015990; Lee SH, 2004, NEUROLOGY, V62, P72, DOI 10.1212/01.WNL.0000101463.50798.0D; Lee SH, 2002, STROKE, V33, P2845, DOI 10.1161/01.STR.0000036092.23649.2E; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; REED DM, 1990, AM J EPIDEMIOL, V131, P579, DOI 10.1093/oxfordjournals.aje.a115542; Roob G, 1999, NEUROLOGY, V52, P991, DOI 10.1212/WNL.52.5.991; Roob G, 2000, CURR OPIN NEUROL, V13, P69, DOI 10.1097/00019052-200002000-00013; Rothwell Peter M, 2005, Cerebrovasc Dis, V20 Suppl 1, P24, DOI 10.1159/000088234; Tanaka A, 1999, STROKE, V30, P1637, DOI 10.1161/01.STR.30.8.1637; TANAKA H, 1982, STROKE, V13, P62, DOI 10.1161/01.STR.13.1.62; Tatsumi S, 2008, CEREBROVASC DIS, V26, P142, DOI 10.1159/000139661; UEDA K, 1988, STROKE, V19, P48, DOI 10.1161/01.STR.19.1.48; Vergouwen MDI, 2008, STROKE, V39, P497, DOI 10.1161/STROKEAHA.107.488791; Vernooij MW, 2008, NEUROLOGY, V70, P1208, DOI 10.1212/01.wnl.0000307750.41970.d9; Wong KS, 2003, NEUROLOGY, V60, P511, DOI 10.1212/01.WNL.0000046583.40125.20; YAMORI Y, 1976, JPN HEART J, V17, P390; YANO K, 1989, STROKE, V20, P1460, DOI 10.1161/01.STR.20.11.1460; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	36	40	43	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e25930	10.1371/journal.pone.0025930	http://dx.doi.org/10.1371/journal.pone.0025930			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022473	Green Published, Green Submitted, gold			2022-12-27	WOS:000295973200022
J	Mordant, P; Loriot, Y; Lahon, B; Castier, Y; Leseche, G; Soria, JC; Vozenin, MC; Decraene, C; Deutsch, E				Mordant, Pierre; Loriot, Yohann; Lahon, Benoit; Castier, Yves; Leseche, Guy; Soria, Jean-Charles; Vozenin, Marie-Catherine; Decraene, Charles; Deutsch, Eric			Bioluminescent Orthotopic Mouse Models of Human Localized Non-Small Cell Lung Cancer: Feasibility and Identification of Circulating Tumour Cells	PLOS ONE			English	Article							PHASE-III TRIAL; GROWTH-FACTOR RECEPTOR; ATHYMIC NUDE-MICE; PERIPHERAL-BLOOD; METASTATIC MODEL; INHIBITS GROWTH; IMAGING-SYSTEM; PLEURAL CAVITY; BREAST-CANCER; INTACT TISSUE	Background: Preclinical models of non-small cell lung cancer (NSCLC) require better clinical relevance to study disease mechanisms and innovative therapeutics. We sought to compare and refine bioluminescent orthotopic mouse models of human localized NSCLC. Methods: Athymic nude mice underwent subcutaneous injection (group 1-SC, n = 15, control), percutaneous orthotopic injection (group 2-POI, n = 30), surgical orthotopic implantation of subcutaneously grown tumours (group 3-SOI, n = 25), or transpleural orthotopic injection (group 4-TOI, n = 30) of A549-luciferase cells. Bioluminescent in vivo imaging was then performed weekly. Circulating tumour cells (CTCs) were searched using Cellsearch (R) system in SC and TOI models. Results: Group 2-POI was associated with unexpected direct pleural spreading of the cellular solution in 53% of the cases, forbidding further evaluation of any localized lung tumour. Group 3-SOI was characterized by high perioperative mortality, initially localized lung tumours, and local evolution. Group 4-TOI was associated with low perioperative mortality, initially localized lung tumours, loco regional extension, and distant metastasis. CTCs were detected in 83% of nude mice bearing subcutaneous or orthotopic NSCLC tumours. Conclusions: Transpleural orthotopic injection of A549-luc cells in nude mouse lung induces localized tumour, followed by lymphatic extension and specific mortality, and allowed the first time identification of CTCs in a NSCLC mice model.	[Mordant, Pierre; Loriot, Yohann; Lahon, Benoit; Vozenin, Marie-Catherine; Deutsch, Eric] INSERM, U1030, Villejuif, France; [Mordant, Pierre; Loriot, Yohann; Lahon, Benoit; Soria, Jean-Charles; Vozenin, Marie-Catherine; Deutsch, Eric] Univ Paris 11, Inst Gustave Roussy, Villejuif, France; [Mordant, Pierre; Castier, Yves; Leseche, Guy] Univ Paris 07, Hop Bichat, AP HP, Paris, France; [Mordant, Pierre; Castier, Yves; Leseche, Guy] Serv Chirurg Thorac, Paris, France; [Loriot, Yohann; Soria, Jean-Charles] SITEP, Dept Med, Villejuif, France; [Decraene, Charles] Inst Curie, Dept Rech Translat, Paris, France; [Decraene, Charles] CNRS, UMR144, Paris, France; [Deutsch, Eric] Dept Radiotherapie, Villejuif, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay	Mordant, P (corresponding author), INSERM, U1030, Villejuif, France.	eric.deutsch@igr.fr	Soria, Jean-Charles/F-3619-2014; Loriot, Yohann/W-5572-2019; Vozenin, Marie-Catherine/AAR-2268-2021; Mordant, Pierre/J-3603-2017	Vozenin, Marie-Catherine/0000-0002-2109-8073; deutsch, eric/0000-0002-8223-3697	French Society of Thoracic Surgery (SFCTCV); French Medical Research Foundation (FRM); Generation Thorax; French Cancer Research Association; Gustave Roussy Foundation (Fondation Gustave Roussy)	French Society of Thoracic Surgery (SFCTCV); French Medical Research Foundation (FRM)(Fondation pour la Recherche Medicale); Generation Thorax; French Cancer Research Association(Fondation ARC pour la Recherche sur le Cancer); Gustave Roussy Foundation (Fondation Gustave Roussy)	PM has been supported by the French Society of Thoracic Surgery (SFCTCV). BL has been supported by the French Medical Research Foundation (FRM) and Generation Thorax. This project has been supported by the French Cancer Research Association (ARC to MCV and ED) and the Gustave Roussy Foundation (Fondation Gustave Roussy to MCV and ED). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Boehle AS, 2001, ANN THORAC SURG, V71, P1657, DOI 10.1016/S0003-4975(01)02408-0; Boehle AS, 2001, INT J CANCER, V94, P420, DOI 10.1002/ijc.1471; Buckle T, 2010, LAB ANIM-UK, V44, P40, DOI 10.1258/la.2009.009030; Chen Z, 2010, CANCER RES, V70, P9827, DOI 10.1158/0008-5472.CAN-10-1671; Dolgin E, 2010, NAT MED, V16, P1348, DOI 10.1038/nm1210-1348; Eberhard DA, 2005, J CLIN ONCOL, V23, P5900, DOI 10.1200/JCO.2005.02.857; Eccles SA, 2007, LANCET, V369, P1742, DOI 10.1016/S0140-6736(07)60781-8; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Fujino H, 2003, ONCOL REP, V10, P1709; Gatzemeier U, 2007, J CLIN ONCOL, V25, P1545, DOI 10.1200/JCO.2005.05.1474; Giaccone G, 2004, J CLIN ONCOL, V22, P777, DOI 10.1200/JCO.2004.08.001; Graves EE, 2010, CLIN CANCER RES, V16, P4843, DOI 10.1158/1078-0432.CCR-10-1206; Herbst RS, 2004, J CLIN ONCOL, V22, P785, DOI 10.1200/JCO.2004.07.215; Herbst RS, 2005, J CLIN ONCOL, V23, P5892, DOI 10.1200/JCO.2005.02.840; Higgins B, 2004, ANTI-CANCER DRUG, V15, P503, DOI 10.1097/01.cad.0000127664.66472.60; Hoffman RM, 1999, INVEST NEW DRUG, V17, P343, DOI 10.1023/A:1006326203858; Hoffman RM, 2006, NAT PROTOC, V1, P1429, DOI 10.1038/nprot.2006.223; Hoffman RM, 2006, NAT PROTOC, V1, P928, DOI 10.1038/nprot.2006.119; Hu JT, 2005, ONCOGENE, V24, P1212, DOI 10.1038/sj.onc.1208242; Jacoby JJ, 2010, J THORAC ONCOL, V5, P940, DOI 10.1097/JTO.0b013e3181dc211f; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kang Y, 2006, CANCER SCI, V97, P996, DOI 10.1111/j.1349-7006.2006.00276.x; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kraus-Berthier L, 2000, CLIN CANCER RES, V6, P297; KUBOTA T, 1994, J CELL BIOCHEM, V56, P4, DOI 10.1002/jcb.240560103; KUO TH, 1993, ANTICANCER RES, V13, P627; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Li DN, 2007, J CLIN INVEST, V117, P346, DOI 10.1172/JCI30446; March TH, 2001, VET PATHOL, V38, P483, DOI 10.1354/vp.38-5-483; Matsumoto S, 2009, LUNG CANCER, V66, P75, DOI 10.1016/j.lungcan.2008.12.010; MCLEMORE TL, 1988, CANCER RES, V48, P2880; MCLEMORE TL, 1987, CANCER RES, V47, P5132; Meuwissen R, 2001, ONCOGENE, V20, P6551, DOI 10.1038/sj.onc.1204837; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Nagamachi Y, 1998, CANCER LETT, V127, P203, DOI 10.1016/S0304-3835(98)00039-1; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Onn A, 2003, CLIN CANCER RES, V9, P5532; Pantel K, 1999, JNCI-J NATL CANCER I, V91, P1113, DOI 10.1093/jnci/91.13.1113; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Pinzani P, 2006, HUM PATHOL, V37, P711, DOI 10.1016/j.humpath.2006.01.026; Pritchard C, 2007, BIOCHEM SOC T, V35, P1329, DOI 10.1042/BST0351329; Rasanen K, 2010, EXP CELL RES, V316, P2713, DOI 10.1016/j.yexcr.2010.04.032; Reck M, 2010, ANN ONCOL, V21, P1804, DOI 10.1093/annonc/mdq020; REDDY S, 1987, CANCER RES, V47, P2456; Rolle Axel, 2005, World J Surg Oncol, V3, P18, DOI 10.1186/1477-7819-3-18; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Sausville EA, 2006, CANCER RES, V66, P3351, DOI 10.1158/0008-5472.CAN-05-3627; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Singh M, 2010, NAT BIOTECHNOL, V28, P585, DOI 10.1038/nbt.1640; Sirotnak FM, 2000, CLIN CANCER RES, V6, P4885; Soria JC, 2011, ANN ONCOL, V22, P1703, DOI 10.1093/annonc/mdq675; TEICHER BA, 1992, HIGH DOSE CANCER THE, P14; Teicher BA, 2006, MOL CANCER THER, V5, P2435, DOI 10.1158/1535-7163.MCT-06-0391; Thatcher N, 2005, LANCET, V366, P1527, DOI 10.1016/S0140-6736(05)67625-8; Tsao MS, 2005, NEW ENGL J MED, V353, P133, DOI 10.1056/NEJMoa050736; Wang HY, 1997, ANN THORAC SURG, V64, P216, DOI 10.1016/S0003-4975(97)00343-3; WANG XE, 1992, ANTICANCER RES, V12, P1403; WANG XE, 1992, ANTICANCER RES, V12, P1399; WANG XO, 1992, INT J CANCER, V51, P992; Whiteside TL, 2008, ONCOGENE, V27, P5904, DOI 10.1038/onc.2008.271; Wittenburg LA, 2011, CHEM-BIOL INTERACT, V190, P73, DOI 10.1016/j.cbi.2011.01.029; Yamauchi K, 2006, CANCER RES, V66, P4208, DOI 10.1158/0008-5472.CAN-05-3927	63	37	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e26073	10.1371/journal.pone.0026073	http://dx.doi.org/10.1371/journal.pone.0026073			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022511	gold, Green Published, Green Submitted			2022-12-27	WOS:000295973200029
J	Pan, XQ; Suzuki, N; Hirano, I; Yamazaki, S; Minegishi, N; Yamamoto, M				Pan, Xiaoqing; Suzuki, Norio; Hirano, Ikuo; Yamazaki, Shun; Minegishi, Naoko; Yamamoto, Masayuki			Isolation and Characterization of Renal Erythropoietin-Producing Cells from Genetically Produced Anemia Mice	PLOS ONE			English	Article							PAS DOMAIN PROTEIN; GENE-EXPRESSION; TRANSGENIC MICE; MESSENGER-RNA; RAT-KIDNEY; HYPOXIA; FIBROBLASTS; ENHANCER; HIF-1; HYDROXYLATION	Understanding the nature of renal erythropoietin-producing cells (REPs) remains a central challenge for elucidating the mechanisms involved in hypoxia and/or anemia-induced erythropoietin (Epo) production in adult mammals. Previous studies have shown that REPs are renal peritubular cells, but further details are lacking. Here, we describe an approach to isolate and characterize REPs. We bred mice bearing an Epo gene allele to which green fluorescent protein (GFP) reporter cDNA was knocked-in (Epo(GFP)) with mice bearing an Epo gene allele lacking the 3' enhancer (Epo Delta(3'E)). Mice harboring the mutant Epo(GFP/Delta 3'E) gene exhibited anemia (average Hematocrit 18% at 4 to 6 days after birth), and this perinatal anemia enabled us to identify and purify REPs based on GFP expression from the kidney. Light and confocal microscopy revealed that GFP immunostaining was confined to fibroblastic cells that reside in the peritubular interstitial space, confirming our previous observation in Epo-GFP transgenic reporter assays. Flow cytometry analyses revealed that the GFP fraction constitutes approximately 0.2% of the whole kidney cells and 63% of GFP-positive cells co-express CD73 (a marker for cortical fibroblasts and Epo-expressing cells in the kidney). Quantitative RT-PCR analyses confirmed that Epo expression was increased by approximately 100-fold in the purified population of REPs compared with that of the unsorted cells or CD73-positive fraction. Gene expression analyses showed enrichment of Hif2 alpha and Hif3 alpha mRNA in the purified population of REPs. The genetic approach described here provides a means to isolate a pure population of REPs, allowing the analysis of gene expression of a defined population of cells essential for Epo production in the kidney. This has provided evidence that positive regulation by HIF2 alpha and negative regulation by HIF3 alpha might be necessary for correct renal Epo induction. (282 words)	[Pan, Xiaoqing; Suzuki, Norio; Hirano, Ikuo; Yamazaki, Shun; Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Sendai, Miyagi 980, Japan; [Minegishi, Naoko] Miyagi Univ, Sch Nursing, Sendai, Miyagi, Japan	Tohoku University; Miyagi University	Pan, XQ (corresponding author), Tohoku Univ, Grad Sch Med, Dept Med Biochem, Sendai, Miyagi 980, Japan.	masiyamamoto@med.tohoku.ac.jp	Yamamoto, Masayuki/A-4873-2010; Suzuki, Norio/F-3456-2010; Suzuki, Norio/AAZ-9458-2021	Yamamoto, Masayuki/0000-0002-9073-9436; Suzuki, Norio/0000-0001-6100-3350; Hirano, Ikuo/0000-0003-2304-3583	Ministry of Education, Science, Sports and Culture Scientific Research from Japan Society for the Promotion of Science; Tohoku University; Global COE for Conquest of Signal Transduction Diseases with Network Medicine; Grants-in-Aid for Scientific Research [10J06108] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture Scientific Research from Japan Society for the Promotion of Science; Tohoku University; Global COE for Conquest of Signal Transduction Diseases with Network Medicine; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Creative Scientific Research, Scientific Research on Priority Areas and Scientific Research from the Ministry of Education, Science, Sports and Culture Scientific Research from Japan Society for the Promotion of Science, Tohoku University, Global COE for Conquest of Signal Transduction Diseases with Network Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACHMANN S, 1993, J HISTOCHEM CYTOCHEM, V41, P335, DOI 10.1177/41.3.8429197; Bechtel W, 2010, NAT MED, V16, P544, DOI 10.1038/nm.2135; D'Angelo G, 2003, J BIOL CHEM, V278, P38183, DOI 10.1074/jbc.M302244200; ECKARDT KU, 1993, KIDNEY INT, V43, P815, DOI 10.1038/ki.1993.115; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fisher TS, 2009, BIOCHEM BIOPH RES CO, V388, P683, DOI 10.1016/j.bbrc.2009.08.058; Frede S, 2011, BLOOD, V117, P4905, DOI 10.1182/blood-2010-07-298083; Fried W, 2009, EXP HEMATOL, V37, P1007, DOI 10.1016/j.exphem.2009.05.010; Grenz A, 2007, AM J PHYSIOL-RENAL, V293, pF1501, DOI 10.1152/ajprenal.00243.2007; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; Haase VH, 2010, AM J PHYSIOL-RENAL, V299, pF1, DOI 10.1152/ajprenal.00174.2010; Jelkmann W, 2007, EUR J HAEMATOL, V78, P183, DOI 10.1111/j.1600-0609.2007.00818.x; Kaissling B, 2008, HISTOCHEM CELL BIOL, V130, P247, DOI 10.1007/s00418-008-0452-5; Kapitsinou PP, 2010, BLOOD, V116, P3039, DOI 10.1182/blood-2010-02-270322; KOURY MJ, 1988, J CLIN INVEST, V82, P154, DOI 10.1172/JCI113564; KOURY ST, 1993, MICROSC RES TECHNIQ, V25, P29, DOI 10.1002/jemt.1070250106; Lendahl U, 2009, NAT REV GENET, V10, P821, DOI 10.1038/nrg2665; MADAN A, 1995, BLOOD, V85, P2735; Makino Y, 2001, NATURE, V414, P550, DOI 10.1038/35107085; Makino Y, 2007, J BIOL CHEM, V282, P14073, DOI 10.1074/jbc.M700732200; Marxer-Meier A, 1998, ANAT EMBRYOL, V197, P143, DOI 10.1007/s004290050126; Maxwell PH, 1997, KIDNEY INT, V51, P393, DOI 10.1038/ki.1997.52; MAXWELL PH, 1993, KIDNEY INT, V44, P1149, DOI 10.1038/ki.1993.362; McIntosh BE, 2010, ANNU REV PHYSIOL, V72, P625, DOI 10.1146/annurev-physiol-021909-135922; Minamishima YA, 2010, SCIENCE, V329, P407, DOI 10.1126/science.1192811; Minegishi N, 2003, BLOOD, V102, P896, DOI 10.1182/blood-2002-12-3809; MULLER GA, 1995, KIDNEY INT, V48, pS33; Obara N, 2008, BLOOD, V111, P5223, DOI 10.1182/blood-2007-10-115857; Paliege A, 2010, KIDNEY INT, V77, P312, DOI 10.1038/ki.2009.460; Pasanen A, 2010, INT J BIOCHEM CELL B, V42, P1189, DOI 10.1016/j.biocel.2010.04.008; Patel SA, 2008, CELL DEATH DIFFER, V15, P628, DOI 10.1038/cdd.2008.17; PUGH CW, 1991, P NATL ACAD SCI USA, V88, P10553, DOI 10.1073/pnas.88.23.10553; Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117; Schodel J, 2009, AM J PATHOL, V174, P1663, DOI 10.2353/ajpath.2009.080687; Scortegagna M, 2005, BLOOD, V105, P3133, DOI 10.1182/blood-2004-05-1695; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 2004, PHYSIOLOGY, V19, P176, DOI 10.1152/physiol.00001.2004; SEMENZA GL, 1991, P NATL ACAD SCI USA, V88, P5680, DOI 10.1073/pnas.88.13.5680; Semenza GL, 2009, BLOOD, V114, P2015, DOI 10.1182/blood-2009-05-189985; Stockmann C, 2006, CLIN EXP PHARMACOL P, V33, P968, DOI 10.1111/j.1440-1681.2006.04474.x; SUNDELIN B, 1990, ANAT EMBRYOL, V182, P307, DOI 10.1007/BF02433491; Suzuki N, 2003, BLOOD, V102, P3575, DOI 10.1182/blood-2003-04-1154; Suzuki N, 2007, METHOD ENZYMOL, V435, P157, DOI 10.1016/S0076-6879(07)35009-X; Suzuki N, 2011, MOL CELL BIOL, V31, P3896, DOI 10.1128/MCB.05463-11; Takayama M, 2010, MOL CELL BIOL, V30, P2668, DOI 10.1128/MCB.01304-09; Tanabe O, 2007, EMBO J, V26, P2295, DOI 10.1038/sj.emboj.7601676; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Tian H, 1998, GENE DEV, V12, P3320, DOI 10.1101/gad.12.21.3320; Vengellur A, 2004, TOXICOL SCI, V82, P638, DOI 10.1093/toxsci/kfh278; Wenger RH, 2010, AM J PHYSIOL-RENAL, V298, pF1287, DOI 10.1152/ajprenal.00736.2009; Wiesener MS, 2002, FASEB J, V16, P271, DOI 10.1096/fj.02-0445fje; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Yamashita T, 2008, MOL CELL BIOL, V28, P1285, DOI 10.1128/MCB.01332-07	53	72	77	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e25839	10.1371/journal.pone.0025839	http://dx.doi.org/10.1371/journal.pone.0025839			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022454	Green Submitted, gold, Green Published			2022-12-27	WOS:000295973200016
J	Muller, J; Stadler, J; Jarzabek-Muller, A; Hacker, H; ter Braak, C; Brandl, R				Mueller, Joerg; Stadler, Jutta; Jarzabek-Mueller, Andrea; Hacker, Hermann; ter Braak, Cajo; Brandl, Roland			The Predictability of Phytophagous Insect Communities: Host Specialists as Habitat Specialists	PLOS ONE			English	Article							ARTHROPOD ASSEMBLAGES; HERBIVOROUS INSECTS; PIERID BUTTERFLIES; SPECIES RICHNESS; BETA-DIVERSITY; NICHE BREADTH; DIET BREADTH; DISPERSAL; CONSERVATION; LEPIDOPTERA	The difficulties specialized phytophagous insects face in finding habitats with an appropriate host should constrain their dispersal. Within the concept of metacommunities, this leads to the prediction that host-plant specialists should sort into local assemblages according to the local environmental conditions, i.e. habitat conditions, whereas assemblages of host-plant generalists should depend also on regional processes. Our study aimed at ranking the importance of local environmental factors and species composition of the vegetation for predicting the species composition of phytophagous moth assemblages with either a narrow or a broad host range. Our database consists of 351,506 specimens representing 820 species of nocturnal Macrolepidoptera sampled between 1980 and 2006 using light traps in 96 strict forest reserves in southern Germany. Species were grouped as specialists or generalists according to the food plants of the larvae; specialists use host plants belonging to one genus. We used predictive canonical correspondence and co-correspondence analyses to rank the importance of local environmental factors, the species composition of the vegetation and the role of host plants for predicting the species composition of host-plant specialists and generalists. The cross-validatory fit for predicting the species composition of phytophagous moths was higher for host-plant specialists than for host-plant generalists using environmental factors as well as the composition of the vegetation. As expected for host-plant specialists, the species composition of the vegetation was a better predictor of the composition of these assemblages than the environmental variables. But surprisingly, this difference for specialized insects was not due to the occurrence of their host plants. Overall, our study supports the idea that owing to evolutionary constraints in finding a host, host-plant specialists and host-plant generalists follow two different models of metacommunities: the species-sorting and the mass-effect model.	[Mueller, Joerg; Jarzabek-Mueller, Andrea] Bavarian Forest Natl Pk, Grafenau, Germany; [Mueller, Joerg] Tech Univ Munich, Chair Terr Ecol, Res Dept Ecol & Ecosyst Management, D-8050 Freising Weihenstephan, Germany; [Stadler, Jutta] UFZ Leipzig Halle Ltd, Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Germany; [Hacker, Hermann] Bavarian State Collect Zool, Munich, Germany; [ter Braak, Cajo] WUR, Wageningen, Netherlands; [Brandl, Roland] Univ Marburg, Dept Ecol, Fac Biol, Marburg, Germany	Technical University of Munich; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Wageningen University & Research; Philipps University Marburg	Muller, J (corresponding author), Bavarian Forest Natl Pk, Grafenau, Germany.	joerg.mueller@npv-bw.bayern.de	Braak, Cajo J. F. ter/G-7006-2011; Stadler, Jutta/ABC-2494-2021	Braak, Cajo J. F. ter/0000-0002-0414-8745; Muller, Jorg/0000-0002-1409-1586	Bavarian State Institute of Forestry	Bavarian State Institute of Forestry	The study was financially supported by the Bavarian State Institute of Forestry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew NR, 2005, AUSTRAL ECOL, V30, P281, DOI 10.1111/j.1442-9993.2005.01464.x; Axmacher JC, 2009, J BIOGEOGR, V36, P337, DOI 10.1111/j.1365-2699.2008.01997.x; Balmford A, 1996, TRENDS ECOL EVOL, V11, P193, DOI 10.1016/0169-5347(96)10026-4; Basset Y, 2008, CONSERV BIOL, V22, P1552, DOI 10.1111/j.1523-1739.2008.01017.x; Beck J, 2002, J TROP ECOL, V18, P33, DOI 10.1017/S026646740200202X; Bonte D, 2009, P ROYAL SOC B, V270, P1601; Brandle M, 2006, OIKOS, V113, P296, DOI 10.1111/j.2006.0030-1299.14418.x; Brandle M, 2001, J ANIM ECOL, V70, P491, DOI 10.1046/j.1365-2656.2001.00506.x; Brehm G, 2003, DIVERS DISTRIB, V9, P351, DOI 10.1046/j.1472-4642.2003.00023.x; COURTNEY SP, 1987, OECOLOGIA, V71, P210, DOI 10.1007/BF00377286; COURTNEY SP, 1982, OECOLOGIA, V54, P101, DOI 10.1007/BF00541116; Davies KF, 2009, J ANIM ECOL, V78, P937, DOI 10.1111/j.1365-2656.2009.01559.x; Didham RK, 2003, ARTHROPODS OF TROPICAL FORESTS, P28; Ellenberg H., 1991, SCR GEOBOT, DOI DOI 10.1002/FEDR.19931040323; Fauth JE, 1996, AM NAT, V147, P282, DOI 10.1086/285850; Franklin J, 2009, DIVERS DISTRIB, V15, P167, DOI 10.1111/j.1472-4642.2008.00536.x; Frenzel M, 2000, GLOBAL ECOL BIOGEOGR, V9, P293, DOI 10.1046/j.1365-2699.2000.00195.x; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Gossner MM, 2011, LANDSCAPE ECOL, V26, P411, DOI 10.1007/s10980-010-9568-9; Guichard F, 2008, J THEOR BIOL, V250, P113, DOI 10.1016/j.jtbi.2007.09.018; Hacker H, BEITRAGE BAYERISCHEN, V1; HAMILTON WD, 1977, NATURE, V269, P578, DOI 10.1038/269578a0; Hanski I, 2003, THEOR POPUL BIOL, V64, P281, DOI 10.1016/S0040-5809(03)00093-5; Hanski I., 1999, METAPOPULATION ECOLO; Harrison S, 2008, ECOL LETT, V11, P969, DOI 10.1111/j.1461-0248.2008.01210.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Howeth JG, 2010, J ANIM ECOL, V79, P1000, DOI 10.1111/j.1365-2656.2010.01715.x; Huston MA, 1999, OIKOS, V86, P393, DOI 10.2307/3546645; Intachat J., 1997, Journal of Tropical Forest Science, V9, P411; JAENIKE J, 1990, ANNU REV ECOL SYST, V21, P243, DOI 10.1146/annurev.es.21.110190.001331; Jervis MA, 2007, EVOL ECOL, V21, P307, DOI 10.1007/s10682-006-9102-3; Jocque M, 2010, GLOBAL ECOL BIOGEOGR, V19, P244, DOI 10.1111/j.1466-8238.2009.00510.x; Jost L, 2010, ECOLOGY, V91, P1969, DOI 10.1890/09-0368.1; Keil P, 2005, DIVERS DISTRIB, V11, P417, DOI 10.1111/j.1366-9516.2005.00172.x; Kisdi E, 2002, AM NAT, V159, P579, DOI 10.1086/339989; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Komonen A, 2004, OIKOS, V105, P41, DOI 10.1111/j.0030-1299.2004.12958.x; Lawton JH, 1999, OIKOS, V84, P177, DOI 10.2307/3546712; Lawton JH, 1998, NATURE, V391, P72, DOI 10.1038/34166; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Leibold MA, 2002, OIKOS, V97, P237, DOI 10.1034/j.1600-0706.2002.970210.x; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Marten A, 2006, MOL ECOL, V15, P2643, DOI 10.1111/j.1365-294X.2006.02940.x; MCPEEK MA, 1992, AM NAT, V140, P1010, DOI 10.1086/285453; Muller J, 2010, EUR J FOREST RES, V129, P981, DOI 10.1007/s10342-010-0400-5; Muller J, 2010, BIOL CONSERV, V143, P625, DOI 10.1016/j.biocon.2009.11.027; Novotny V, 2005, J BIOGEOGR, V32, P1303, DOI 10.1111/j.1365-2699.2005.01225.x; Novotny V, 2007, NATURE, V448, P692, DOI 10.1038/nature06021; Ostermann OP, 1998, J APPL ECOL, V35, P968, DOI 10.1111/j.1365-2664.1998.tb00016.x; Parvinen K, 2004, THEOR POPUL BIOL, V66, P233, DOI 10.1016/j.tpb.2004.06.002; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Peterson MA, 1998, AM NAT, V152, P428, DOI 10.1086/286180; Presley SJ, 2010, OIKOS, V119, P908, DOI 10.1111/j.1600-0706.2010.18544.x; Quinn RM, 1998, ECOGRAPHY, V21, P279, DOI 10.1111/j.1600-0587.1998.tb00565.x; Quinn RM, 1997, ECOL ENTOMOL, V22, P197, DOI 10.1046/j.1365-2311.1997.00050.x; Rova E, 2010, J EVOLUTION BIOL, V23, P1657, DOI 10.1111/j.1420-9101.2010.02031.x; Schaffers AP, 2008, ECOLOGY, V89, P782, DOI 10.1890/07-0361.1; SCHOWALTER TD, 1986, ANNU REV ENTOMOL, V31, P177, DOI 10.1146/annurev.en.31.010186.001141; Schulze CH, 2003, ARTHROPODS OF TROPICAL FORESTS, P69; Segurado P, 2004, J BIOGEOGR, V43, P433; Shreeve T.G., 1992, P120; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; SOUTHWOOD TRE, 1977, J ANIM ECOL, V46, P337; SPITZER K, 1988, OIKOS, V53, P31, DOI 10.2307/3565659; Stefanescu C, 2011, ECOGRAPHY, V34, P353, DOI 10.1111/j.1600-0587.2010.06264.x; Stork N. E., 1997, P551; STRONG DR, 1984, INSECTS PLANTS; Summerville KS, 2008, CAN ENTOMOL, V140, P475, DOI 10.4039/N07-Ls06; Summerville KS, 2002, ECOL APPL, V12, P820, DOI 10.1890/1051-0761(2002)012[0820:EOTHOF]2.0.CO;2; Swihart RK, 2003, DIVERS DISTRIB, V9, P1, DOI 10.1046/j.1472-4642.2003.00158.x; ter Braak CJF, 2004, ECOLOGY, V85, P834, DOI 10.1890/03-0021; Tscharntke T, 2004, ANNU REV ENTOMOL, V49, P405, DOI 10.1146/annurev.ento.49.061802.123339; VANDERVOET H, 1994, CHEMOMETR INTELL LAB, V25, P313, DOI 10.1016/0169-7439(94)85050-X; Veech JA, 2010, ECOLOGY, V91, P1988, DOI 10.1890/09-1140.1; Wright SJ, 2006, BIOTROPICA, V38, P287, DOI 10.1111/j.1744-7429.2006.00154.x; Zayed A, 2005, CONSERV GENET, V6, P1017, DOI 10.1007/s10592-005-9094-5; Zobel M, 1997, TRENDS ECOL EVOL, V12, P266, DOI 10.1016/S0169-5347(97)01096-3	79	17	17	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25986	10.1371/journal.pone.0025986	http://dx.doi.org/10.1371/journal.pone.0025986			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22016796	Green Published, Green Submitted, gold			2022-12-27	WOS:000295970300045
J	Shehadeh, LA; Webster, KA; Hare, JM; Vazquez-Padron, RI				Shehadeh, Lina A.; Webster, Keith A.; Hare, Joshua M.; Vazquez-Padron, Roberto I.			Dynamic Regulation of Vascular Myosin Light Chain (MYL9) with Injury and Aging	PLOS ONE			English	Article							SMOOTH-MUSCLE; ATHEROSCLEROSIS; ARTERY; AGE; PHOSPHORYLATION; DISEASE; AORTA; RELAXATION; ISOFORMS; CELLS	Background: Aging-associated changes in the cardiovascular system increase the risk for disease development and lead to profound alterations in vascular reactivity and stiffness. Elucidating the molecular response of arteries to injury and age will help understand the exaggerated remodeling of aging vessels. Methodology/Principal Findings: We studied the gene expression profile in a model of mechanical vascular injury in the iliac artery of aging (22 months old) and young rats (4 months old). We investigated aging-related variations in gene expression at 30 min, 3 d and 7 d post injury. We found that the Myosin Light Chain gene (MYL9) was the only gene differentially expressed in the aged versus young injured arteries at all time points studied, peaking at day 3 after injury (4.6 fold upregulation (p<0.05) in the smooth muscle cell layers. We confirmed this finding on an aging aortic microarray experiment available through NCBI's GEO database. We found that Myl9 was consistently upregulated with age in healthy rat aortas. To determine the arterial localization of Myl9 with age and injury, we performed immunohistochemistry for Myl9 in rat iliac arteries and found that in healthy and injured (30 days post injury) arteries, Myl9 expression increased with age in the endothelial layers. Conclusions/Significance: The consistent upregulation of the myosin light chain protein (Myl9) with age and injury in arterial tissue draws attention to the increased vascular permeability and to the age-caused predisposition to arterial constriction after balloon angioplasty.	[Shehadeh, Lina A.; Hare, Joshua M.] Univ Miami, Dept Med, Div Cardiol, Leonard M Miller Sch Med, Miami, FL USA; [Shehadeh, Lina A.; Webster, Keith A.; Vazquez-Padron, Roberto I.] Univ Miami, Leonard M Miller Sch Med, Vasc Biol Inst, Miami, FL USA; [Shehadeh, Lina A.; Webster, Keith A.; Hare, Joshua M.; Vazquez-Padron, Roberto I.] Univ Miami, Leonard M Miller Sch Med, Interdisciplinary Stem Cell Inst, Miami, FL USA; [Webster, Keith A.] Univ Miami, Leonard M Miller Sch Med, Dept Pharmacol, Miami, FL USA; [Vazquez-Padron, Roberto I.] Univ Miami, Leonard M Miller Sch Med, Dept Surg, Miami, FL USA	University of Miami; University of Miami; University of Miami; University of Miami; University of Miami	Shehadeh, LA (corresponding author), Univ Miami, Dept Med, Div Cardiol, Leonard M Miller Sch Med, Miami, FL USA.	lshehadeh@med.miami.edu; RVazquez@med.miami.edu		Webster, Keith A/0000-0002-6431-3642	American Heart Association [0930169N, 0535167B]; American Federation for Aging Research [M1001096]; NIH-NHLBI [1K01HL096413-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL096413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098511] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); American Federation for Aging Research; NIH-NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by awards from the American Heart Association (Scientist Development Grant 0930169N) and American Federation for Aging Research (M1001096) to LAS; and by the American Heart Association (Scientist Development Award 0535167B) and NIH-NHLBI [1K01HL096413-01] to RIVP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASHOUR TT, 1990, CLIN CARDIOL, V13, P267, DOI 10.1002/clc.4960130407; BELMIN J, 1993, AM J PHYSIOL, V264, pH679, DOI 10.1152/ajpheart.1993.264.3.H679; Gabeler Edward E E, 2002, BMC Cardiovasc Disord, V2, P16, DOI 10.1186/1471-2261-2-16; HASEGAWA Y, 1992, J BIOCHEM-TOKYO, V111, P804, DOI 10.1093/oxfordjournals.jbchem.a123840; HATAKE K, 1990, STROKE, V21, P1039, DOI 10.1161/01.STR.21.7.1039; KRENDEL M, 2005, MYOSINS TAILS HEADS, P239; Lakatta EG, 2003, CIRCULATION, V107, P490, DOI 10.1161/01.CIR.0000048894.99865.02; Levy B. I., 2001, DIALOG CARDIOVASC ME, V6, P104; Licht AH, 2010, J CLIN INVEST, V120, P2307, DOI 10.1172/JCI41749; Loukianov E, 1997, COMP BIOCHEM PHYS B, V117, P13, DOI 10.1016/S0305-0491(96)00309-4; Luo HA, 1996, ARTERIOSCL THROM VAS, V16, P1393, DOI 10.1161/01.ATV.16.11.1393; Miller SJ, 2007, AM J PHYSIOL-HEART C, V293, pH2634, DOI 10.1152/ajpheart.00397.2007; MIZUNO K, 1992, NEW ENGL J MED, V326, P287, DOI 10.1056/NEJM199201303260502; RAPOPORT RM, 1983, J CYCLIC NUCL PROT, V9, P281; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Shehadeh LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009104; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; SPAGNOLI LG, 1991, ATHEROSCLEROSIS, V89, P11, DOI 10.1016/0021-9150(91)90003-L; Steinberg D, 1997, ATHEROSCLEROSIS, V131, pS5, DOI 10.1016/S0021-9150(97)06115-7; STEMERMAN MB, 1982, P NATL ACAD SCI-BIOL, V79, P3863, DOI 10.1073/pnas.79.12.3863; TAN JL, 1992, ANNU REV BIOCHEM, V61, P721, DOI 10.1146/annurev.bi.61.070192.003445; TOKUNAGA O, 1989, AM J PATHOL, V135, P967; Torella D, 2004, AM J PHYSIOL-HEART C, V287, pH2850, DOI 10.1152/ajpheart.01119.2003; Vazquez-Padron RI, 2004, J VASC SURG, V40, P1199, DOI 10.1016/j.jvs.2004.08.034; WEINGAND KW, 1986, ATHEROSCLEROSIS, V62, P137, DOI 10.1016/0021-9150(86)90059-6; WONG MKK, 1990, ARTERIOSCLEROSIS, V10, P76, DOI 10.1161/01.ATV.10.1.76; WYSOLMERSKI RB, 1991, AM J PHYSIOL, V261, pC32, DOI 10.1152/ajpcell.1991.261.1.C32; Zanetti M, 2010, EXP GERONTOL, V45, P848, DOI 10.1016/j.exger.2010.07.002; Zeng LX, 2005, FASEB J, V19, P1845, DOI 10.1096/fj.05-4240fje	29	27	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25855	10.1371/journal.pone.0025855	http://dx.doi.org/10.1371/journal.pone.0025855			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003410	Green Published, gold, Green Submitted			2022-12-27	WOS:000295970300032
J	Wehling-Henricks, M; Tidball, JG				Wehling-Henricks, Michelle; Tidball, James G.			Neuronal Nitric Oxide Synthase-Rescue of Dystrophin/Utrophin Double Knockout Mice does not Require nNOS Localization to the Cell Membrane	PLOS ONE			English	Article							DEFICIENT SKELETAL-MUSCLE; HYDROXY-L-ARGININE; MUSCULAR-DYSTROPHY; GLYCOPROTEIN COMPLEX; RESIDENT MACROPHAGES; LIFE-SPAN; MDX; EXPRESSION; UTROPHIN; TRANSGENE	Survival of dystrophin/utrophin double-knockout (dko) mice was increased by muscle-specific expression of a neuronal nitric oxide synthase (nNOS) transgene. Dko mice expressing the transgene (nNOS TG+/dko) experienced delayed onset of mortality and increased life-span. The nNOS TG+/dko mice demonstrated a significant decrease in the concentration of CD163+, M2c macrophages that can express arginase and promote fibrosis. The decrease in M2c macrophages was associated with a significant reduction in fibrosis of heart, diaphragm and hindlimb muscles of nNOS TG+/dko mice. The nNOS transgene had no effect on the concentration of cytolytic, CD68+, M1 macrophages. Accordingly, we did not observe any change in the extent of muscle fiber lysis in the nNOS TG+/dko mice. These findings show that nNOS/NO (nitric oxide)mediated decreases in M2c macrophages lead to a reduction in the muscle fibrosis that is associated with increased mortality in mice lacking dystrophin and utrophin. Interestingly, the dramatic and beneficial effects of the nNOS transgene were not attributable to localization of nNOS protein at the cell membrane. We did not detect any nNOS protein at the sarcolemma in nNOS TG+/dko muscles. This important observation shows that sarcolemmal localization is not necessary for nNOS to have beneficial effects in dystrophic tissue and the presence of nNOS in the cytosol of dystrophic muscle fibers can ameliorate the pathology and most importantly, significantly increase life-span.	[Wehling-Henricks, Michelle; Tidball, James G.] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90024 USA; [Tidball, James G.] Univ Calif Los Angeles, Mol Cellular & Integrat Physiol Program, Los Angeles, CA USA; [Tidball, James G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Wehling-Henricks, M (corresponding author), Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90024 USA.	jtidball@physci.ucla.edu	Tidball, James/H-7970-2012	Tidball, James/0000-0003-1202-8038	Muscular Dystrophy Association [3068, 157881, 4006]; National Institutes of Health [RO1 AR40343, RO1 AR47721]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047721, R01AR040343] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the Muscular Dystrophy Association (3068 and 157881 to JGT; 4006 to Dr. Wehling-Henricks) and the National Institutes of Health (RO1 AR40343, RO1 AR47721 to Dr. Tidball). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amalfitano A, 1996, MUSCLE NERVE, V19, P1549, DOI 10.1002/(SICI)1097-4598(199612)19:12<1549::AID-MUS4>3.0.CO;2-A; Bauer PM, 2001, J BIOL CHEM, V276, P34458, DOI 10.1074/jbc.M105219200; Bia BL, 1999, J MOL CELL CARDIOL, V31, P1857, DOI 10.1006/jmcc.1999.1018; Blake DJ, 1996, BRAIN PATHOL, V6, P37, DOI 10.1111/j.1750-3639.1996.tb00781.x; BLAU HM, 1983, P NATL ACAD SCI-BIOL, V80, P4856, DOI 10.1073/pnas.80.15.4856; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; BRENMAN JE, 1995, CELL, V82, P743, DOI 10.1016/0092-8674(95)90471-9; Buga GM, 1996, AM J PHYSIOL-HEART C, V271, pH1988, DOI 10.1152/ajpheart.1996.271.5.H1988; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Chamberlain JS, 2007, FASEB J, V21, P2195, DOI 10.1096/fj.06-7353com; Chang WJ, 1996, P NATL ACAD SCI USA, V93, P9142, DOI 10.1073/pnas.93.17.9142; CLANCY RM, 1992, J CLIN INVEST, V90, P1116, DOI 10.1172/JCI115929; COULTON GR, 1988, NEUROPATH APPL NEURO, V14, P53, DOI 10.1111/j.1365-2990.1988.tb00866.x; Crisp A, 2011, HUM MOL GENET, V20, P413, DOI 10.1093/hmg/ddq477; Curran JN, 2006, WOUND REPAIR REGEN, V14, P376, DOI 10.1111/j.1743-6109.2006.00151.x; Deconinck AE, 1997, CELL, V90, P717, DOI 10.1016/S0092-8674(00)80532-2; Deng B, 2009, J PHYSIOL-LONDON, V587, P1769, DOI 10.1113/jphysiol.2008.166256; EMERY AEH, 1993, GENETICS DUCHENNE MU; Finsterer J, 2003, CARDIOLOGY, V99, P1, DOI 10.1159/000068446; Grady RM, 1997, CELL, V90, P729, DOI 10.1016/S0092-8674(00)80533-4; Grange RW, 2002, AM J PHYSIOL-CELL PH, V283, pC1090, DOI 10.1152/ajpcell.00450.2001; Hainsey TA, 2003, NEUROMUSCULAR DISORD, V13, P294, DOI 10.1016/S0960-8966(02)00286-9; Harper SQ, 2002, NAT MED, V8, P253, DOI 10.1038/nm0302-253; HECKER M, 1995, P NATL ACAD SCI USA, V92, P4671, DOI 10.1073/pnas.92.10.4671; Heydemann A, 2004, J MOL CELL CARDIOL, V36, P213, DOI 10.1016/j.yjmcc.2003.09.020; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; HONDA H, 1990, IMMUNOLOGY, V70, P272; Hrabak A, 1996, FEBS LETT, V390, P203, DOI 10.1016/0014-5793(96)00659-X; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; INKLEY SR, 1974, AM J MED, V56, P297, DOI 10.1016/0002-9343(74)90611-1; Ishizaki M, 2008, NEUROMUSCULAR DISORD, V18, P342, DOI 10.1016/j.nmd.2008.02.002; Janssen PML, 2005, AM J PHYSIOL-HEART C, V289, pH2373, DOI 10.1152/ajpheart.00448.2005; Judge LM, 2006, J CELL SCI, V119, P1537, DOI 10.1242/jcs.02857; Kawano R, 2008, MOL THER, V16, P825, DOI 10.1038/mt.2008.23; KIVIRIKKO KI, 1967, ANAL BIOCHEM, V19, P249, DOI 10.1016/0003-2697(67)90160-1; Kobayashi YM, 2008, NATURE, V456, P511, DOI 10.1038/nature07414; KUBES P, 1992, AM J PHYSIOL, V262, pH611, DOI 10.1152/ajpheart.1992.262.2.H611; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee JJ, 1997, J EXP MED, V185, P2143, DOI 10.1084/jem.185.12.2143; McLennan IS, 1996, J ANAT, V188, P17; MCLENNAN IS, 1993, CELL TISSUE RES, V272, P193, DOI 10.1007/BF00323586; MENDELL JR, 1995, J CHILD NEUROL, V10, P150, DOI 10.1177/088307389501000219; MINAMIDE LS, 1990, ANAL BIOCHEM, V190, P66, DOI 10.1016/0003-2697(90)90134-U; MIYOSHI K, 1991, BRIT HEART J, V66, P452; Moriuchi T, 1993, Tokushima J Exp Med, V40, P83; Nguyen HX, 2003, J PHYSIOL-LONDON, V550, P347, DOI 10.1113/jphysiol.2003.040907; NIGRO G, 1990, INT J CARDIOL, V26, P271, DOI 10.1016/0167-5273(90)90082-G; OHLENDIECK K, 1991, J CELL BIOL, V115, P1685, DOI 10.1083/jcb.115.6.1685; PASTORET C, 1995, J NEUROL SCI, V129, P97, DOI 10.1016/0022-510X(94)00276-T; Percival JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003387; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Rafael JA, 1998, NAT GENET, V19, P79, DOI 10.1038/ng0598-79; SAKELLARIOU GK, 2011, AGING CELL, DOI DOI 10.1111/J.1474-9726.2011.00709.X/ABSTRACT; Sander M, 2000, P NATL ACAD SCI USA, V97, P13818, DOI 10.1073/pnas.250379497; Shearer JD, 1997, AM J PHYSIOL-ENDOC M, V272, pE181, DOI 10.1152/ajpendo.1997.272.2.E181; Shiao T, 2004, HUM MOL GENET, V13, P1873, DOI 10.1093/hmg/ddh204; STPIERRE BA, 1994, J APPL PHYSIOL, V77, P290, DOI 10.1152/jappl.1994.77.1.290; Thomas GD, 2003, CIRC RES, V92, P554, DOI 10.1161/01.RES.0000061570.83105.52; Thomas GD, 1998, P NATL ACAD SCI USA, V95, P15090, DOI 10.1073/pnas.95.25.15090; Thomazzi SM, 2001, BIOCHEM PHARMACOL, V62, P1417, DOI 10.1016/S0006-2952(01)00782-1; Tinsley JM, 1996, NATURE, V384, P349, DOI 10.1038/384349a0; Toussaint M, 2007, Chron Respir Dis, V4, P167, DOI 10.1177/1479972307080697; Villalta SA, 2011, HUM MOL GENET, V20, P790, DOI 10.1093/hmg/ddq523; Villalta SA, 2009, HUM MOL GENET, V18, P482, DOI 10.1093/hmg/ddn376; Warner LE, 2002, HUM MOL GENET, V11, P1095, DOI 10.1093/hmg/11.9.1095; Wehling M, 2001, J CELL BIOL, V155, P123, DOI 10.1083/jcb.200105110; Wehling-Henricks M, 2005, HUM MOL GENET, V14, P1921, DOI 10.1093/hmg/ddi197; Wehling-Henricks M, 2004, NEUROMUSCULAR DISORD, V14, P483, DOI 10.1016/j.nmd.2004.04.008; Wehling-Henricks M, 2008, HUM MOL GENET, V17, P2280, DOI 10.1093/hmg/ddn129; Wehling-Henricks M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010763; Wehling-Henricks M, 2009, HUM MOL GENET, V18, P3439, DOI 10.1093/hmg/ddp288; Wink DA, 1995, TOXICOL LETT, V82-3, P221, DOI 10.1016/0378-4274(95)03557-5; Witte MB, 2003, WOUND REPAIR REGEN, V11, P419, DOI 10.1046/j.1524-475X.2003.11605.x; Witte MB, 2003, J GASTROINTEST SURG, V7, P378, DOI 10.1016/S1091-255X(02)00431-6; Yue YP, 2006, MOL THER, V14, P79, DOI 10.1016/j.ymthe.2006.01.007	76	25	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25071	10.1371/journal.pone.0025071	http://dx.doi.org/10.1371/journal.pone.0025071			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003386	gold, Green Published, Green Submitted			2022-12-27	WOS:000295970300007
J	Muir, P; Schwartz, Z; Malek, S; Kreines, A; Cabrera, SY; Buote, NJ; Bleedorn, JA; Schaefer, SL; Holzman, G; Hao, ZL				Muir, Peter; Schwartz, Zeev; Malek, Sarah; Kreines, Abigail; Cabrera, Sady Y.; Buote, Nicole J.; Bleedorn, Jason A.; Schaefer, Susan L.; Holzman, Gerianne; Hao, Zhengling			Contralateral Cruciate Survival in Dogs with Unilateral Non-Contact Cranial Cruciate Ligament Rupture	PLOS ONE			English	Article							INFLAMMATORY STIFLE ARTHRITIS; TIBIAL PLATEAU ANGLE; SYNOVIAL-FLUID; BACTERIAL LOAD; CANINE OSTEOARTHRITIS; RISK-FACTORS; JOINT; DOXYCYCLINE; DISEASE; IDENTIFICATION	Background: Non-contact cranial cruciate ligament rupture (CrCLR) is an important cause of lameness in client-owned dogs and typically occurs without obvious injury. There is a high incidence of bilateral rupture at presentation or subsequent contralateral rupture in affected dogs. Although stifle synovitis increases risk of contralateral CrCLR, relatively little is known about risk factors for subsequent contralateral rupture, or whether therapeutic intervention may modify this risk. Methodology/Principal Findings: We conducted a longitudinal study examining survival of the contralateral CrCL in client-owned dogs with unilateral CrCLR in a large baseline control population (n = 380), and a group of dogs that received disease-modifying therapy with arthroscopic lavage, intra-articular hyaluronic acid and oral doxycycline (n = 16), and were followed for one year. Follow-up in treated dogs included analysis of mobility, radiographic evaluation of stifle effusion and arthritis, and quantification of biomarkers of synovial inflammation. We found that median survival of the contralateral CrCL was 947 days. Increasing tibial plateau angle decreased contralateral ligament survival, whereas increasing age at diagnosis increased survival. Contralateral ligament survival was reduced in neutered dogs. Our disease-modifying therapy did not significantly influence contralateral ligament survival. Correlative analysis of clinical and biomarker variables with development of subsequent contralateral rupture revealed few significant results. However, increased expression of T lymphocyte-associated genes in the index unstable stifle at diagnosis was significantly related to development of subsequent non-contact contralateral CrCLR. Conclusion: Subsequent contralateral CrCLR is common in client-owned dogs, with a median ligament survival time of 947 days. In this naturally occurring model of non-contact cruciate ligament rupture, cranial tibial translation is preceded by development of synovial inflammation. However, treatment with arthroscopic lavage, intra-articular hyaluronic acid and oral doxycycline does not significantly influence contralateral CrCL survival.	[Muir, Peter; Schwartz, Zeev; Malek, Sarah; Kreines, Abigail; Bleedorn, Jason A.; Schaefer, Susan L.; Holzman, Gerianne; Hao, Zhengling] Univ Wisconsin, Sch Vet Med, Comparat Orthopaed Res Lab, Madison, WI 53706 USA; [Cabrera, Sady Y.] VCA W Angeles Anim Hosp, Dept Surg, Los Angeles, CA USA; [Buote, Nicole J.] Calif Anim Hosp Inc, Los Angeles, CA USA	University of Wisconsin System; University of Wisconsin Madison	Muir, P (corresponding author), Univ Wisconsin, Sch Vet Med, Comparat Orthopaed Res Lab, Madison, WI 53706 USA.	muirp@vetmed.wisc.edu	Bleedorn, Jason A/AAE-2115-2019; Fiumefreddo, Andrea/T-2977-2019; Malek, Sarah/AAT-5214-2020; Muir, Peter/AAH-8057-2021	Bleedorn, Jason A/0000-0003-2987-7722; Malek, Sarah/0000-0001-8809-8388; Muir, Peter/0000-0003-0028-6005	American Kennel Club Canine Health Foundation	American Kennel Club Canine Health Foundation	This work was supported by the American Kennel Club Canine Health Foundation (www.akcchf.org). The contents of this publication are solely the responsibility of the authors and do not necessarily reflect the views of the Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin AR, 1996, P NATL ACAD SCI USA, V93, P14014, DOI 10.1073/pnas.93.24.14014; Ayral X, 1996, BRIT J RHEUMATOL, V35, P14; BANIYASH M, 1988, J BIOL CHEM, V263, P9874; Bleedorn JA, 2011, VET SURG, V40, P531, DOI 10.1111/j.1532-950X.2011.00841.x; Boissier MC, 2009, JOINT BONE SPINE, V76, P10, DOI 10.1016/j.jbspin.2008.08.002; Brandt KD, 2005, ARTHRITIS RHEUM-US, V52, P2015, DOI 10.1002/art.21122; Buote N, 2009, VET SURG, V38, P481, DOI 10.1111/j.1532-950X.2009.00532.x; Cabrera SY, 2008, JAVMA-J AM VET MED A, V232, P889, DOI 10.2460/javma.232.6.889; Chevalier X, 2010, ANN RHEUM DIS, V69, P113, DOI 10.1136/ard.2008.094623; Clements DN, 2011, VET COMP ORTHOPAED, V24, P262, DOI [10.3415/VCOT-11-03-0048, 10.3415/VCOT-11-03-008]; Comerford EJ, 2005, J ORTHOP RES, V23, P61, DOI 10.1016/j.orthres.2004.05.016; de Bruin T, 2007, VET REC, V161, P745, DOI 10.1136/vr.161.22.745; de Bruin T, 2007, J VET MED A, V54, P292, DOI 10.1111/j.1439-0442.2007.00977.x; de Bruin T, 2007, AM J VET RES, V68, P283, DOI 10.2460/ajvr.68.3.283; de Rooster H, 2000, AM J VET RES, V61, P1456, DOI 10.2460/ajvr.2000.61.1456; De Rooster H, 2006, VET SURG, V35, P769, DOI 10.1111/j.1532-950X.2006.00221.x; Doom M, 2008, VET IMMUNOL IMMUNOP, V125, P143, DOI 10.1016/j.vetimm.2008.05.023; DOVERSPIKE M, 1993, J AM ANIM HOSP ASSOC, V29, P167; Dreitz MJ, 1999, VET IMMUNOL IMMUNOP, V69, P113, DOI 10.1016/S0165-2427(99)00047-1; Erne JB, 2009, JAVMA-J AM VET MED A, V235, P386, DOI 10.2460/javma.235.4.386; Faldyna M, 2004, ACTA VET BRNO, V73, P73, DOI 10.2754/avb200473010073; Fernandes JC, 2002, BIORHEOLOGY, V39, P237; Fu X, 2009, J ORTHOP RES, V27, P91, DOI 10.1002/jor.20720; GALLOWAY RH, 1995, J AM ANIM HOSP ASSOC, V31, P289, DOI 10.5326/15473317-31-4-289; GOLDBERG VM, 1982, J BONE JOINT SURG AM, V64, P900, DOI 10.2106/00004623-198264060-00014; Guerrero TG, 2007, AM J VET RES, V68, P1332, DOI 10.2460/ajvr.68.12.1332; Hayashi K, 2004, J AM ANIM HOSP ASSOC, V40, P385, DOI 10.5326/0400385; Hercock CA, 2009, J SMALL ANIM PRACT, V50, P266, DOI 10.1111/j.1748-5827.2009.00765.x; Hiraoka N, 2011, J ORTHOP RES, V29, P354, DOI 10.1002/jor.21240; Horz HP, 2005, J CLIN MICROBIOL, V43, P5332, DOI 10.1128/JCM.43.10.5332-5337.2005; Innes JF, 2004, VET RADIOL ULTRASOUN, V45, P143, DOI 10.1111/j.1740-8261.2004.04024.x; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Klocke NW, 2005, AM J VET RES, V66, P493, DOI 10.2460/ajvr.2005.66.493; Kobayashi S, 2006, J ORTHOP RES, V24, P1509, DOI 10.1002/jor.20183; Lemburg AK, 2004, VET IMMUNOL IMMUNOP, V97, P231, DOI 10.1016/j.vetimm.2003.09.007; Maccoux LJ, 2007, VET IMMUNOL IMMUNOP, V118, P59, DOI 10.1016/j.vetimm.2007.04.006; Miur P, 2007, MICROB PATHOGENESIS, V42, P47, DOI 10.1016/j.micpath.2006.10.002; MOORE KW, 1995, AUST VET J, V72, P281, DOI 10.1111/j.1751-0813.1995.tb03555.x; Muir P, 2005, VET SURG, V34, P239, DOI 10.1111/j.1532-950X.2005.00036.x; Muir P, 2011, VET SURG, V40, P753, DOI 10.1111/j.1532-950X.2011.00867.x; Muir P, 2010, VET MICROBIOL, V141, P127, DOI 10.1016/j.vetmic.2009.08.015; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; NASH RA, 1991, IMMUNOGENETICS, V33, P396, DOI 10.1007/BF00216700; Ohno K, 2006, J VET MED SCI, V68, P1275, DOI 10.1292/jvms.68.1275; Pond M J, 1973, Ann Rheum Dis, V32, P387, DOI 10.1136/ard.32.4.387; Posthumus M, 2009, AM J SPORT MED, V37, P2234, DOI 10.1177/0363546509338266; Quinn MM, 2007, VET SURG, V36, P360, DOI 10.1111/j.1532-950X.2007.00276.x; SAMELSON LE, 1985, CELL, V43, P223, DOI 10.1016/0092-8674(85)90027-3; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Schwartz Z, 2011, VET MICROBIOL, V148, P308, DOI 10.1016/j.vetmic.2010.09.011; Short AD, 2009, VET IMMUNOL IMMUNOP, V128, P137, DOI 10.1016/j.vetimm.2008.10.301; Smith GN, 1996, ARTHRITIS RHEUM, V39, P235, DOI 10.1002/art.1780390209; Smith MM, 2008, RHEUMATOLOGY, V47, P1172, DOI 10.1093/rheumatology/ken219; STEFANINI M, 1967, NATURE, V216, P173, DOI 10.1038/216173a0; Sumner JP, 2010, VET SURG, V39, P936, DOI 10.1111/j.1532-950X.2010.00738.x; Toth A P, 2001, J Gend Specif Med, V4, P25; Wang YS, 2007, VET IMMUNOL IMMUNOP, V118, P186, DOI 10.1016/j.vetimm.2007.05.010; WHITEHAIR JG, 1993, J AM VET MED ASSOC, V203, P1016; Wilke VL, 2009, AM J VET RES, V70, P1013, DOI 10.2460/ajvr.70.8.1013; Wilke VL, 2006, JAVMA-J AM VET MED A, V228, P61, DOI 10.2460/javma.228.1.61; Wilke VL, 2005, JAVMA-J AM VET MED A, V227, P1604, DOI 10.2460/javma.2005.227.1604; Wilke VL, 2002, J AM VET MED ASSOC, V221, P1426, DOI 10.2460/javma.2002.221.1426; Witsberger TH, 2008, JAVMA-J AM VET MED A, V232, P1818, DOI 10.2460/javma.232.12.1818; Yang S, 2002, J CLIN MICROBIOL, V40, P3449, DOI 10.1128/JCM.40.9.3449-3454.2002; Ying BW, 2011, MOL BIOL REP, V38, P379, DOI 10.1007/s11033-010-0119-x; YU LP, 1991, J RHEUMATOL, V18, P1450; YU LP, 1992, ARTHRITIS RHEUM, V35, P1150, DOI 10.1002/art.1780351007	67	35	36	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25331	10.1371/journal.pone.0025331	http://dx.doi.org/10.1371/journal.pone.0025331			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998650	gold, Green Published, Green Submitted			2022-12-27	WOS:000295966900019
J	Peralvarez-Marin, A; Tae, H; Board, PG; Casarotto, MG; Dulhunty, AF; Samso, M				Peralvarez-Marin, Alex; Tae, HanShen; Board, Philip G.; Casarotto, Marco G.; Dulhunty, Angela F.; Samso, Montserrat			3D Mapping of the SPRY2 Domain of Ryanodine Receptor 1 by Single-Particle Cryo-EM	PLOS ONE			English	Article							CALCIUM-RELEASE CHANNEL; MONOCLONAL FAB FRAGMENT; SKELETAL-MUSCLE; 3-DIMENSIONAL RECONSTRUCTION; DIHYDROPYRIDINE RECEPTOR; CRYOELECTRON MICROSCOPY; SARCOPLASMIC-RETICULUM; TRANSMEMBRANE DOMAINS; UCSF CHIMERA; RYR1	The type 1 skeletal muscle ryanodine receptor (RyR1) is principally responsible for Ca2+ release from the sarcoplasmic reticulum and for the subsequent muscle contraction. The RyR1 contains three SPRY domains. SPRY domains are generally known to mediate protein-protein interactions, however the location of the three SPRY domains in the 3D structure of the RyR1 is not known. Combining immunolabeling and single-particle cryo-electron microscopy we have mapped the SPRY2 domain (S1085-V1208) in the 3D structure of RyR1 using three different antibodies against the SPRY2 domain. Two obstacles for the image processing procedure; limited amount of data and signal dilution introduced by the multiple orientations of the antibody bound in the tetrameric RyR1, were overcome by modifying the 3D reconstruction scheme. This approach enabled us to ascertain that the three antibodies bind to the same region, to obtain a 3D reconstruction of RyR1 with the antibody bound, and to map SPRY2 to the periphery of the cytoplasmic domain of RyR1. We report here the first 3D localization of a SPRY2 domain in any known RyR isoform.	[Peralvarez-Marin, Alex; Samso, Montserrat] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Anesthesia, Boston, MA 02115 USA; [Peralvarez-Marin, Alex] Univ Autonoma Barcelona, Ctr Estudis Biofis, E-08193 Barcelona, Spain; [Tae, HanShen; Board, Philip G.; Casarotto, Marco G.; Dulhunty, Angela F.] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia; [Samso, Montserrat] Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Autonomous University of Barcelona; Australian National University; John Curtin School of Medical Research; Virginia Commonwealth University	Peralvarez-Marin, A (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Anesthesia, Boston, MA 02115 USA.	msamso@vcu.edu	Dulhunty, Angela/AAO-5421-2020; Tae, Han-Shen/AAA-1904-2020; Peralvarez-Marin, Alex/AAH-4305-2020; Peralvarez-Marin, Alex/A-8958-2017	Tae, Han-Shen/0000-0001-8961-7194; Peralvarez-Marin, Alex/0000-0002-3457-0875; Casarotto, Marco/0000-0002-0571-7671; Dulhunty, Angela/0000-0001-9493-4944; Samso, Montserrat/0000-0002-2788-3283	Brigham and Women's Hospital Biomedical Research Institute; Australian National Health and the Medical Research Council [471418]; European Commission (Marie Curie Action) [PIOF-GA-2009-237120]	Brigham and Women's Hospital Biomedical Research Institute; Australian National Health and the Medical Research Council; European Commission (Marie Curie Action)(European CommissionEuropean Commission Joint Research Centre)	The authors want to thank the Brigham and Women's Hospital Biomedical Research Institute (to MS), the Australian National Health and the Medical Research Council (471418 to AD, MC and PB), and the European Commission (Marie Curie Action PIOF-GA-2009-237120 to AP-M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker RT, 2005, METHOD ENZYMOL, V398, P540, DOI 10.1016/S0076-6879(05)98044-0; Benacquista BL, 2000, BIOPHYS J, V78, P1349, DOI 10.1016/S0006-3495(00)76689-6; BLOCK BA, 1988, J CELL BIOL, V107, P2587, DOI 10.1083/jcb.107.6.2587; BOARD PG, 1987, P NATL ACAD SCI USA, V84, P2377, DOI 10.1073/pnas.84.8.2377; BOISSET N, 1993, J STRUCT BIOL, V111, P234, DOI 10.1006/jsbi.1993.1053; BOISSET N, 1995, J STRUCT BIOL, V115, P16, DOI 10.1006/jsbi.1995.1025; Casarotto MG, 2006, CLIN EXP PHARMACOL P, V33, P1114, DOI 10.1111/j.1440-1681.2006.04501.x; Cornea RL, 2009, P NATL ACAD SCI USA, V106, P6128, DOI 10.1073/pnas.0813010106; Cui YF, 2009, INT J BIOCHEM CELL B, V41, P677, DOI 10.1016/j.biocel.2008.08.004; Dulhunty AF, 2002, PROG BIOPHYS MOL BIO, V79, P45, DOI 10.1016/S0079-6107(02)00013-5; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; GOGOL EP, 1989, BIOCHEMISTRY-US, V28, P4717, DOI 10.1021/bi00437a031; Hamilton SL, 2009, J BIOL CHEM, V284, P4047, DOI 10.1074/jbc.R800054200; Harlow E, 1988, ANTIBODIES LAB MANUU; James LC, 2007, P NATL ACAD SCI USA, V104, P6200, DOI 10.1073/pnas.0609174104; Kimura T, 2007, BIOCHEM J, V401, P317, DOI 10.1042/BJ20060686; Kuang ZH, 2010, J CELL BIOL, V190, P129, DOI 10.1083/jcb.200912087; Kuang ZH, 2009, J MOL BIOL, V386, P662, DOI 10.1016/j.jmb.2008.12.078; Liu Z, 2004, J MOL BIOL, V338, P533, DOI 10.1016/j.jmb.2004.03.011; Ludtke SJ, 2005, STRUCTURE, V13, P1203, DOI 10.1016/j.str.2005.06.005; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Marx SO, 1998, SCIENCE, V281, P818, DOI 10.1126/science.281.5378.818; Paolini C, 2004, J MOL BIOL, V342, P145, DOI 10.1016/j.jmb.2004.07.035; Perez CF, 2003, J BIOL CHEM, V278, P39644, DOI 10.1074/jbc.M305160200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ponting C, 1997, TRENDS BIOCHEM SCI, V22, P193, DOI 10.1016/S0968-0004(97)01049-9; RADERMACHER M, 1992, BIOPHYS J, V61, P936, DOI 10.1016/S0006-3495(92)81900-8; RADERMACHER M, 1994, J CELL BIOL, V127, P411, DOI 10.1083/jcb.127.2.411; Rhodes DA, 2005, IMMUNOLOGY, V116, P411, DOI 10.1111/j.1365-2567.2005.02248.x; Samso M, 2006, J MOL BIOL, V356, P917, DOI 10.1016/j.jmb.2005.12.023; Samso M, 2005, NAT STRUCT MOL BIOL, V12, P539, DOI 10.1038/nsmb938; Samso M, 2002, J BIOL CHEM, V277, P1349, DOI 10.1074/jbc.M109196200; Samso M, 2009, PLOS BIOL, V7, P980, DOI 10.1371/journal.pbio.1000085; Sandin S, 2004, STRUCTURE, V12, P409, DOI 10.1016/j.str.2004.02.011; Sencer S, 2001, J BIOL CHEM, V276, P38237; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Tae H, 2011, CHANNELS, V5, P148, DOI 10.4161/chan.5.2.14407; Tae H, 2009, EUR BIOPHYS J BIOPHY, V39, P51, DOI 10.1007/s00249-009-0455-8; Treves S, 2002, CELL CALCIUM, V31, P1, DOI 10.1054/ceca.2001.0252; Wagenknecht T, 1997, J BIOL CHEM, V272, P32463, DOI 10.1074/jbc.272.51.32463; Wolf M, 2003, J MOL BIOL, V332, P171, DOI 10.1016/S0022-2836(03)00899-4; Woo JS, 2006, EMBO J, V25, P1353, DOI 10.1038/sj.emboj.7600994; Yamazawa T, 1997, J BIOL CHEM, V272, P8161, DOI 10.1074/jbc.272.13.8161; Yao SG, 2006, PROTEIN SCI, V15, P2761, DOI 10.1110/ps.062477806	44	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25813	10.1371/journal.pone.0025813	http://dx.doi.org/10.1371/journal.pone.0025813			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998699	Green Submitted, Green Published, gold			2022-12-27	WOS:000295966900056
J	Zou, Q; Yao, X; Feng, J; Yin, ZN; Flavell, R; Hu, YX; Zheng, GX; Jin, J; Kang, YM; Wu, B; Liang, XX; Feng, CC; Liu, H; Li, WY; Wang, XZ; Wen, YM; Wang, B				Zou, Qiang; Yao, Xin; Feng, Jin; Yin, Zhinan; Flavell, Richard; Hu, Yanxin; Zheng, Guoxing; Jin, Jin; Kang, Youmin; Wu, Bing; Liang, Xiaoxuan; Feng, Congcong; Liu, Hu; Li, Weiyi; Wang, Xianzheng; Wen, Yumei; Wang, Bin			Praziquantel Facilitates IFN-gamma-Producing CD8(+) T Cells (Tc1) and IL-17-Producing CD8(+) T Cells (Tc17) Responses to DNA Vaccination in Mice	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; CONTACT HYPERSENSITIVITY RESPONSES; DELAYED-TYPE HYPERSENSITIVITY; VACCINIA VIRUS; SCHISTOSOMA-MANSONI; IMMUNE-RESPONSES; TRANSGENIC MICE; HOST-DEFENSE; INFECTION; ANTIGEN	Background: CD8(+) cytotoxic T lymphocytes (CTLs) are crucial for eliminating hepatitis B virus (HBV) infected cells. DNA vaccination, a novel therapeutic strategy for chronic virus infection, has been shown to induce CTL responses. However, accumulated data have shown that CTLs could not be effectively induced by HBV DNA vaccination. Methodology/principal Findings: Here, we report that praziquantel (PZQ), an anti-schistoma drug, could act as an adjuvant to overcome the lack of potent CTL responses by HBV DNA vaccination in mice. PZQ in combination with HBV DNA vaccination augmented the induction of CD8(+) T cell-dependent and HBV-specific delayed hypersensitivity responses (DTH) in C57BL/6 mice. Furthermore, the induced CD8(+) T cells consisted of both Tc1 and Tc17 subtypes. By using IFN-gamma knockout (KO) mice and IL-17 KO mice, both cytokines were found to be involved in the DTH. The relevance of these findings to HBV immunization was established in HBsAg transgenic mice, in which PZQ also augmented the induction of HBV-specific Tc1 and Tc17 cells and resulted in reduction of HBsAg positive hepatocytes. Adoptive transfer experiments further showed that PZQ-primed CD8(+) T cells from wild type mice, but not the counterpart from IFN-gamma KO or IL-17 KO mice, resulted in elimination of HBsAg positive hepatocytes. Conclusions/Significance: Our results suggest that PZQ is an effective adjuvant to facilitate Tc1 and Tc17 responses to HBV DNA vaccination, inducing broad CD8(+) T cell-based immunotherapy that breaks tolerance to HBsAg.	[Zou, Qiang; Jin, Jin; Kang, Youmin; Wu, Bing; Liang, Xiaoxuan; Feng, Congcong; Liu, Hu; Li, Weiyi; Wang, Xianzheng; Wang, Bin] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Yao, Xin; Wen, Yumei; Wang, Bin] Fudan Univ, Shanghai Med Coll, Key Lab Med Mol Virol MOH, Shanghai 200433, Peoples R China; [Feng, Jin] Chinese Acad Sci, Inst Biophys, Ctr Infect & Immun, Beijing 100080, Peoples R China; [Yin, Zhinan] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Flavell, Richard] Yale Sch Med, Dept Immunobiol, New Haven, CT USA; [Hu, Yanxin] China Agr Univ, Coll Vet Med, Beijing 100094, Peoples R China; [Zheng, Guoxing] Univ Illinois, Coll Med, Dept Biomed Sci, Rockford, IL 61107 USA; [Yao, Xin; Wen, Yumei; Wang, Bin] Fudan Univ, Shanghai Med Coll, MOE, Shanghai 200433, Peoples R China	China Agricultural University; Fudan University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Nankai University; Yale University; China Agricultural University; University of Illinois System; University of Illinois Chicago; University of Illinois Rockford; Fudan University	Zou, Q (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	bwang3@cau.edu.cn	YAO, XIN/G-5370-2014; wen, yu/AAJ-7482-2021	Jin, Jin/0000-0001-7887-5972; Kang, Youmin/0000-0003-2597-6117	National Key Technology Research & Development Program of China [2004BA519A39, 2006BAD06A06]; National Nature Science Foundation [30771602]; National Mega Grand Program on Key Infectious Diseases of China [2008ZX10001-012]	National Key Technology Research & Development Program of China; National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); National Mega Grand Program on Key Infectious Diseases of China	This work was supported in part by National Key Technology Research & Development Program of China (2004BA519A39 and 2006BAD06A06), National Nature Science Foundation (30771602) and National Mega Grand Program on Key Infectious Diseases of China (2008ZX10001-012) to B.Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDO K, 1994, J IMMUNOL, V152, P3245; Brignone C, 2007, J IMMUNOL, V179, P4202, DOI 10.4049/jimmunol.179.6.4202; BRINDLEY PJ, 1987, J IMMUNOL, V139, P215; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.iy.13.040195.000333; Cioli D, 2003, PARASITOL RES, V90, pS3, DOI 10.1007/s00436-002-0751-z; Ciric B, 2009, J IMMUNOL, V182, P5296, DOI 10.4049/jimmunol.0900036; CROFT M, 1994, J EXP MED, V180, P1715, DOI 10.1084/jem.180.5.1715; CUA DJ, 1995, EUR J IMMUNOL, V25, P2318, DOI 10.1002/eji.1830250830; ERARD F, 1993, SCIENCE, V260, P1802, DOI 10.1126/science.8511588; FERRARI C, 1990, J IMMUNOL, V145, P3442; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Grabbe S, 1998, IMMUNOL TODAY, V19, P37, DOI 10.1016/S0167-5699(97)01186-9; Guidotti LG, 1996, IMMUNITY, V4, P25, DOI 10.1016/S1074-7613(00)80295-2; Hamada H, 2009, J IMMUNOL, V182, P3469, DOI 10.4049/jimmunol.0801814; He DG, 2006, J IMMUNOL, V177, P6852, DOI 10.4049/jimmunol.177.10.6852; He DG, 2009, J IMMUNOL, V183, P1463, DOI 10.4049/jimmunol.0804108; Hinrichs CS, 2009, BLOOD, V114, P596, DOI 10.1182/blood-2009-02-203935; Hirata T, 2002, J IMMUNOL, V169, P4307, DOI 10.4049/jimmunol.169.8.4307; Huber M, 2009, EUR J IMMUNOL, V39, P1716, DOI 10.1002/eji.200939412; Ishii Akina, 2010, Allergology International, V59, P399, DOI 10.2332/allergolint.10-OA-0218; Iwakura Y, 2008, IMMUNOL REV, V226, P57, DOI 10.1111/j.1600-065X.2008.00699.x; Joseph S, 2004, J INFECT DIS, V190, P835, DOI 10.1086/422604; Kienzle N, 2002, J IMMUNOL, V168, P1672, DOI 10.4049/jimmunol.168.4.1672; Kohyama S, 2007, J IMMUNOL, V179, P3917, DOI 10.4049/jimmunol.179.6.3917; Kondo T, 2009, J IMMUNOL, V182, P1794, DOI 10.4049/jimmunol.0801347; Kosinska AD, 2010, HEPAT RES TREAT; Li XM, 2005, INT IMMUNOL, V17, P1293, DOI 10.1093/intimm/dxh305; Maini MK, 2000, J EXP MED, V191, P1269, DOI 10.1084/jem.191.8.1269; Maini MK, 1999, GASTROENTEROLOGY, V117, P1386, DOI 10.1016/S0016-5085(99)70289-1; Mancini-Bourgine M, 2004, HEPATOLOGY, V40, P874, DOI 10.1002/hep.20408; Martins-Leite P, 2008, ANTIMICROB AGENTS CH, V52, P2780, DOI 10.1128/AAC.00173-08; Nair S, 2001, HEPATOLOGY, V34, P1021, DOI 10.1053/jhep.2001.28459; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Niesner U, 2008, J EXP MED, V205, P1889, DOI 10.1084/jem.20072468; Nigam P, 2011, J IMMUNOL, V186, P745, DOI 10.4049/jimmunol.1002807; Oyoshi MK, 2009, P NATL ACAD SCI USA, V106, P14954, DOI 10.1073/pnas.0904021106; Penna A, 1997, HEPATOLOGY, V25, P1022, DOI 10.1002/hep.510250438; PENNA A, 1991, J EXP MED, V174, P1565, DOI 10.1084/jem.174.6.1565; Phillips S, 2010, J IMMUNOL, V184, P287, DOI 10.4049/jimmunol.0902761; REHERMANN B, 1995, J EXP MED, V181, P1047, DOI 10.1084/jem.181.3.1047; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Riedl P, 2009, J IMMUNOL, V183, P370, DOI 10.4049/jimmunol.0900505; Sallberg M, 1998, HUM GENE THER, V9, P1719, DOI 10.1089/hum.1998.9.12-1719; Schirmbeck R, 2003, EUR J IMMUNOL, V33, P3342, DOI 10.1002/eji.200324403; Webster GJM, 2000, HEPATOLOGY, V32, P1117, DOI 10.1053/jhep.2000.19324; Yang KJ, 2008, J IMMUNOL, V180, P6159, DOI 10.4049/jimmunol.180.9.6159; Yeh N, 2010, J IMMUNOL, V185, P2089, DOI 10.4049/jimmunol.1000818; Yen HR, 2009, J IMMUNOL, V183, P7161, DOI 10.4049/jimmunol.0900368; Zhang XL, 2005, J VIROL, V79, P15289, DOI 10.1128/JVI.79.24.15289-15301.2005; Zhao Y, 2009, BRIT J DERMATOL, V161, P1301, DOI 10.1111/j.1365-2133.2009.09400.x; Zou Q, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/562356; Zou Q, 2010, VACCINE, V28, P2032, DOI 10.1016/j.vaccine.2009.10.101	52	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25525	10.1371/journal.pone.0025525	http://dx.doi.org/10.1371/journal.pone.0025525			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998665	Green Submitted, Green Published, gold			2022-12-27	WOS:000295966900032
J	Annesley, SJ; Bago, R; Bosnar, MH; Filic, V; Marinovic, M; Weber, I; Mehta, A; Fisher, PR				Annesley, Sarah J.; Bago, Ruzica; Bosnar, Maja Herak; Filic, Vedrana; Marinovic, Maja; Weber, Igor; Mehta, Anil; Fisher, Paul R.			Dictyostelium discoideum Nucleoside Diphosphate Kinase C Plays a Negative Regulatory Role in Phagocytosis, Macropinocytosis and Exocytosis	PLOS ONE			English	Article							PATHWAYS MEDIATING CHEMOTAXIS; HEPATOCYTE GROWTH-FACTOR; FLUID-PHASE PINOCYTOSIS; X-RAY-STRUCTURE; TUMOR-METASTASIS; GENE-EXPRESSION; CELL-ADHESION; BREAST-CANCER; SOCIAL AMEBA; NM23	Nucleoside diphosphate kinases (NDPKs) are ubiquitous phosphotransfer enzymes responsible for producing most of the nucleoside triphosphates except for ATP. This role is important for the synthesis of nucleic acids and proteins and the metabolism of sugars and lipids. Apart from this housekeeping role NDPKs have been shown to have many regulatory functions in diverse cellular processes including proliferation and endocytosis. Although the protein has been shown to have a positive regulatory role in clathrin-and dynamin-mediated micropinocytosis, its roles in macropinocytosis and phagocytosis have not been studied. The additional non-housekeeping roles of NDPK are often independent of enzyme activity but dependent on the expression level of the protein. In this study we altered the expression level of NDPK in the model eukaryotic organism Dictyostelium discoideum through antisense inhibition and overexpression. We demonstrate that NDPK levels affect growth, endocytosis and exocytosis. In particular we find that Dictyostelium NDPK negatively regulates endocytosis in contrast to the positive regulatory role identified in higher eukaryotes. This can be explained by the differences in types of endocytosis that have been studied in the different systems - phagocytosis and macropinocytosis in Dictyostelium compared with micropinocytosis in mammalian cells. This is the first report of a role for NDPK in regulating macropinocytosis and phagocytosis, the former being the major fluid phase uptake mechanism for macrophages, dendritic cells and other (non dendritic) cells exposed to growth factors.	[Annesley, Sarah J.; Bago, Ruzica; Fisher, Paul R.] La Trobe Univ, Dept Microbol, Bundoora, Vic 3086, Australia; [Bago, Ruzica; Bosnar, Maja Herak] Rudjer Boskovic Inst, Div Mol Med, Zagreb, Croatia; [Filic, Vedrana; Marinovic, Maja; Weber, Igor] Rudjer Boskovic Inst, Div Mol Biol, Zagreb, Croatia; [Mehta, Anil] Ninewells Hosp, Div Med Sci, Dundee DD1 9SY, Scotland; [Mehta, Anil] Univ Dundee, Sch Med, Dundee, Scotland	La Trobe University; Rudjer Boskovic Institute; Rudjer Boskovic Institute; University of Dundee; University of Dundee	Annesley, SJ (corresponding author), La Trobe Univ, Dept Microbol, Bundoora, Vic 3086, Australia.	P.Fisher@latrobe.edu.au	Weber, Igor/J-3947-2012; Filić, Vedrana/ABH-5748-2020; Annesley, Sarah/K-6985-2019; Bosnar, Maja Herak/AAN-6122-2020; Fisher, Paul/F-2870-2011	Weber, Igor/0000-0003-4296-3166; Filić, Vedrana/0000-0001-6597-1607; Annesley, Sarah/0000-0002-7604-3985; Fisher, Paul/0000-0003-1884-6306	Thyne Reid Memorial Trusts; Australian Research Council; Wellcome Trust [WT086370MA]	Thyne Reid Memorial Trusts; Australian Research Council(Australian Research Council); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by grants to PRF from the Thyne Reid Memorial Trusts and the Australian Research Council, and to AM from Wellcome Trust WT086370MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almgren MAE, 2004, MOL CANCER RES, V2, P387; Amrein L, 2005, CELL TISSUE RES, V322, P365, DOI 10.1007/s00441-005-0036-9; Annesley SJ, 2011, N-S ARCH PHARMACOL, V384, P341, DOI 10.1007/s00210-011-0615-0; Annesley SJ, 2009, MOL CELL BIOCHEM, V329, P73, DOI 10.1007/s11010-009-0111-8; BARSAGI D, 1987, J CELL PHYSIOL, P69; BARSAGI D, 1986, SCIENCE, V233, P1061, DOI 10.1126/science.3090687; Barth C, 1998, PLASMID, V39, P141, DOI 10.1006/plas.1997.1326; BAZARI WL, 1982, CELL MOTIL CYTOSKEL, V2, P471, DOI 10.1002/cm.970020506; BIGGS J, 1990, CELL, V63, P933, DOI 10.1016/0092-8674(90)90496-2; Bokko PB, 2007, MOL BIOL CELL, V18, P1874, DOI 10.1091/mbc.E06-09-0881; Bosnar MH, 2008, CROAT CHEM ACTA, V81, P183; Buczynski G, 1997, MOL BIOL CELL, V8, P1343, DOI 10.1091/mbc.8.7.1343; Caligo MA, 1997, INT J CANCER, V74, P102, DOI 10.1002/(SICI)1097-0215(19970220)74:1<102::AID-IJC18>3.0.CO;2-H; CHERFILS J, 1994, BIOCHEMISTRY-US, V33, P9062, DOI 10.1021/bi00197a006; Chubb JR, 2000, J CELL SCI, V113, P709; Cipollini G, 1997, INT J CANCER, V73, P297, DOI 10.1002/(SICI)1097-0215(19971009)73:2<297::AID-IJC22>3.0.CO;2-B; Clarke M, 1990, CALCIUM INTRACELLULA, P375; Cox AD, 2002, CANCER BIOL THER, V1, P599, DOI 10.4161/cbt.306; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; DOWRICK P, 1993, EUR J CELL BIOL, V61, P44; DUMAS C, 1992, EMBO J, V11, P3203, DOI 10.1002/j.1460-2075.1992.tb05397.x; Dumontier M, 2000, J CELL SCI, V113, P2253; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Fisher Paul R., 2006, V346, P137; Fournier HN, 2002, J BIOL CHEM, V277, P20895, DOI 10.1074/jbc.M200200200; Fournier HN, 2003, J BIOENERG BIOMEMBR, V35, P81, DOI 10.1023/A:1023450008347; Garin J, 2001, J CELL BIOL, V152, P165, DOI 10.1083/jcb.152.1.165; Gervasi F, 1996, CELL GROWTH DIFFER, V7, P1689; Hacker U, 1997, J CELL SCI, V110, P105; Hartsough MT, 2000, J BIOENERG BIOMEMBR, V32, P301, DOI 10.1023/A:1005597231776; HEWLETT LJ, 1994, J CELL BIOL, V124, P689, DOI 10.1083/jcb.124.5.689; Kang Y, 2007, BIOCHEM BIOPH RES CO, V359, P76, DOI 10.1016/j.bbrc.2007.05.090; Kapetanovich L, 2005, MOL BIOL CELL, V16, P835, DOI 10.1091/mbc.e04-09-0785; Karlsson A, 1996, J BIOL CHEM, V271, P19928, DOI 10.1074/jbc.271.33.19928; Khosla M, 2000, J CELL SCI, V113, P1427; KHOSRAVIFAR R, 1995, MOL CELL BIOL, V15, P6443; Kimura N, 2000, J BIOENERG BIOMEMBR, V32, P309, DOI 10.1023/A:1005549315846; KLEIN G, 1986, BIOCHEM BIOPH RES CO, V138, P1146, DOI 10.1016/S0006-291X(86)80402-8; Kotsifas M, 2002, J MUSCLE RES CELL M, V23, P839, DOI 10.1023/A:1024444215766; Krishnan KS, 2001, NEURON, V30, P197, DOI 10.1016/S0896-6273(01)00273-2; Kumari S, 2010, CELL RES, V20, P256, DOI 10.1038/cr.2010.19; LACOMBE ML, 1991, EUR J CANCER, V27, P1302, DOI 10.1016/0277-5379(91)90101-I; LACOMBE ML, 1990, J BIOL CHEM, V265, P10012; LAKSO M, 1992, CELL GROWTH DIFFER, V3, P873; Lombardi D, 2000, J CELL PHYSIOL, V182, P144, DOI 10.1002/(SICI)1097-4652(200002)182:2<144::AID-JCP2>3.3.CO;2-Y; Lombardi D, 2001, CELL DEATH DIFFER, V8, P470, DOI 10.1038/sj.cdd.4400842; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Maniak M, 2002, INT REV CYTOL, V221, P257; Maselli A, 2002, MICROBIOL-SGM, V148, P413, DOI 10.1099/00221287-148-2-413; MELKI R, 1992, BIOCHEM BIOPH RES CO, V187, P65, DOI 10.1016/S0006-291X(05)81459-7; Miyazaki H, 1999, CLIN CANCER RES, V5, P4301; Mizrahi A, 2005, J BIOL CHEM, V280, P3802, DOI 10.1074/jbc.M410257200; MORERA S, 1994, BIOCHEMISTRY-US, V33, P459, DOI 10.1021/bi00168a010; MORERA S, 1995, BIOCHEMISTRY-US, V34, P11062, DOI 10.1021/bi00035a011; MORERA S, 1994, J MOL BIOL, V243, P873, DOI 10.1006/jmbi.1994.1689; Narayanan R, 2003, J BIOENERG BIOMEMBR, V35, P49, DOI 10.1023/A:1023441806530; NELLEN W, 1984, MOL CELL BIOL, V4, P2890, DOI 10.1128/MCB.4.12.2890; Noegel AA, 2000, J CELL SCI, V113, P759; Otero AD, 2000, J BIOENERG BIOMEMBR, V32, P269, DOI 10.1023/A:1005589029959; Otsuki Y, 2001, P NATL ACAD SCI USA, V98, P4385, DOI 10.1073/pnas.071411598; Palacios F, 2002, NAT CELL BIOL, V4, P929, DOI 10.1038/ncb881; Parent CA, 2004, CURR OPIN CELL BIOL, V16, P4, DOI 10.1016/j.ceb.2003.11.008; Parks R.E., 1973, ENZYMES, V8, P307, DOI [10.1016/S1874-6047(08)60069-4, DOI 10.1016/S1874-6047(08)60069-4]; Postel EH, 2009, MOL CELL BIOCHEM, V329, P45, DOI 10.1007/s11010-009-0110-9; Postel EH, 2000, J BIOENERG BIOMEMBR, V32, P277, DOI 10.1023/A:1005541114029; Postel EH, 2003, J BIOENERG BIOMEMBR, V35, P31, DOI 10.1023/A:1023485505621; RACOOSIN EL, 1992, J CELL SCI, V102, P867; RACOOSIN EL, 1989, J EXP MED, V170, P1635, DOI 10.1084/jem.170.5.1635; Sager R, 1997, P NATL ACAD SCI USA, V94, P952, DOI 10.1073/pnas.94.3.952; SASTREGARAU X, 1992, INT J CANCER, V50, P533, DOI 10.1002/ijc.2910500406; SAWAN A, 1994, J PATHOL, V172, P27, DOI 10.1002/path.1711720107; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; SELLAM O, 1995, MOL MICROBIOL, V16, P79, DOI 10.1111/j.1365-2958.1995.tb02393.x; SHPETNER HS, 1992, NATURE, V355, P733, DOI 10.1038/355733a0; Srinivasan S, 2001, PROTEOMICS, V1, P1119, DOI 10.1002/1615-9861(200109)1:9<1119::AID-PROT1119>3.3.CO;2-O; STEEG PS, 1988, J NATL CANCER I, V80, P200, DOI 10.1093/jnci/80.3.200; Sussman M., 1966, METHOD CELL PHYSIOL, V2, P397; TIMMONS L, 1993, DEV BIOL, V158, P364, DOI 10.1006/dbio.1993.1195; TROLL H, 1993, J BIOL CHEM, V268, P25469; Veithen A, 1996, J CELL SCI, V109, P2005; Veltman DM, 2008, J CELL BIOL, V180, P747, DOI 10.1083/jcb.200709180; WALLET V, 1990, J NATL CANCER I, V82, P1199, DOI 10.1093/jnci/82.14.1199; WATTS DJ, 1970, BIOCHEM J, V119, P171, DOI 10.1042/bj1190171; WEST MA, 1989, J CELL BIOL, V109, P2731, DOI 10.1083/jcb.109.6.2731; Wilczynska Z, 1997, BIOCHEM BIOPH RES CO, V234, P39, DOI 10.1006/bbrc.1997.6574; WILCZYNSKA Z, 1994, PLASMID, V32, P182, DOI 10.1006/plas.1994.1054; Wilkins A, 2000, CURR BIOL, V10, P1427, DOI 10.1016/S0960-9822(00)00797-1; Willard SS, 2006, EUR J CELL BIOL, V85, P897, DOI 10.1016/j.ejcb.2006.06.003; Ye M, 2008, INVEST OPHTH VIS SCI, V49, P497, DOI 10.1167/iovs.07-0975; Zhou KM, 1998, J CELL SCI, V111, P283; ZICHA D, 1991, J CELL SCI, V99, P769	91	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e26024	10.1371/journal.pone.0026024	http://dx.doi.org/10.1371/journal.pone.0026024			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21991393	Green Submitted, gold, Green Published			2022-12-27	WOS:000295963300034
J	Bikadi, Z; Hazai, I; Malik, D; Jemnitz, K; Veres, Z; Hari, P; Ni, ZL; Loo, TW; Clarke, DM; Hazai, E; Mao, QC				Bikadi, Zsolt; Hazai, Istvan; Malik, David; Jemnitz, Katalin; Veres, Zsuzsa; Hari, Peter; Ni, Zhanglin; Loo, Tip W.; Clarke, David M.; Hazai, Eszter; Mao, Qingcheng			Predicting P-Glycoprotein-Mediated Drug Transport Based On Support Vector Machine and Three-Dimensional Crystal Structure of P-glycoprotein	PLOS ONE			English	Article							PASSIVE PERMEABILITY; BINDING-SITE; CLASSIFICATION; IDENTIFICATION; RESISTANCE; INHIBITORS; ACCURACY; DOXORUBICIN; ABSORPTION; GENOMICS	Human P-glycoprotein (P-gp) is an ATP-binding cassette multidrug transporter that confers resistance to a wide range of chemotherapeutic agents in cancer cells by active efflux of the drugs from cells. P-gp also plays a key role in limiting oral absorption and brain penetration and in facilitating biliary and renal elimination of structurally diverse drugs. Thus, identification of drugs or new molecular entities to be P-gp substrates is of vital importance for predicting the pharmacokinetics, efficacy, safety, or tissue levels of drugs or drug candidates. At present, publicly available, reliable in silico models predicting P-gp substrates are scarce. In this study, a support vector machine (SVM) method was developed to predict P-gp substrates and P-gp-substrate interactions, based on a training data set of 197 known P-gp substrates and non-substrates collected from the literature. We showed that the SVM method had a prediction accuracy of approximately 80% on an independent external validation data set of 32 compounds. A homology model of human P-gp based on the X-ray structure of mouse P-gp as a template has been constructed. We showed that molecular docking to the P-gp structures successfully predicted the geometry of P-gp-ligand complexes. Our SVM prediction and the molecular docking methods have been integrated into a free web server (http://pgp.althotas.com), which allows the users to predict whether a given compound is a P-gp substrate and how it binds to and interacts with P-gp. Utilization of such a web server may prove valuable for both rational drug design and screening.	[Bikadi, Zsolt; Hazai, Istvan; Malik, David; Hazai, Eszter] Virtua Drug Ltd, Budapest, Hungary; [Jemnitz, Katalin; Veres, Zsuzsa] Hungary Acad Sci, Chem Res Ctr, Budapest, Hungary; [Hari, Peter] Delta Serv Ltd, Budapest, Hungary; [Loo, Tip W.; Clarke, David M.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Ni, Zhanglin; Mao, Qingcheng] Univ Washington, Sch Pharm, Dept Pharmaceut, Seattle, WA 98195 USA	Hungarian Academy of Sciences; University of Toronto; University of Washington; University of Washington Seattle	Bikadi, Z (corresponding author), Virtua Drug Ltd, Budapest, Hungary.	qmao@u.washington.edu	Clarke, David M./A-1112-2008	Clarke, David M./0000-0003-4335-7184; Loo, Tip W/0000-0003-2108-0188; Jemnitz, Katalin/0000-0003-1943-3108	Hungarian State; European Union [KMOP-1.1.1-09/1-2009-0044]; National Cancer Institute of Canada through the Canadian Cancer Society [19074]; Canadian Institutes of Health Research [25043]; National Institutes of Health [GM073715]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073715] Funding Source: NIH RePORTER	Hungarian State; European Union(European Commission); National Cancer Institute of Canada through the Canadian Cancer Society; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Hungarian State and the European Union (European Regional Development Fund), under the aegis of New Hungary Development Plan (KMOP-1.1.1-09/1-2009-0044). Dr. Clarke is the holder of the Canada Research Chair in Membrane Biology and the research was supported by grants from the National Cancer Institute of Canada through the Canadian Cancer Society (Grant 19074) and from the Canadian Institutes of Health Research (Grant 25043). Dr. Mao gratefully acknowledges financial support by the National Institutes of Health Grant (GM073715). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Y, 2001, PHARMACEUT RES, V18, P1660, DOI 10.1023/A:1013358126640; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Ambudkar SV, 2003, ONCOGENE, V22, P7468, DOI 10.1038/sj.onc.1206948; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Balimane PV, 2004, EUR J PHARM BIOPHARM, V58, P99, DOI 10.1016/j.ejpb.2004.02.014; Bikadi Z, 2009, J CHEMINFORMATICS, V1, DOI 10.1186/1758-2946-1-15; Cabrera MA, 2006, J PHARM SCI-US, V95, P589, DOI 10.1002/jps.20449; Chang C, 2006, DRUG METAB DISPOS, V34, P1976, DOI 10.1124/dmd.106.012351; Doan KMM, 2002, J PHARMACOL EXP THER, V303, P1029, DOI 10.1124/jpet.102.039255; Eytan GD, 1997, EUR J BIOCHEM, V248, P104, DOI 10.1111/j.1432-1033.1997.00104.x; Feng B, 2008, DRUG METAB DISPOS, V36, P268, DOI 10.1124/dmd.107.017434; GASTEIGER J, 1980, TETRAHEDRON, V36, P3219, DOI 10.1016/0040-4020(80)80168-2; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Huang JP, 2007, J CHEM INF MODEL, V47, P1638, DOI 10.1021/ci700083n; Kaiser D, 2007, J MED CHEM, V50, P1698, DOI 10.1021/jm060604z; Kim RB, 1998, J CLIN INVEST, V101, P289, DOI 10.1172/JCI1269; Klepsch F, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002036; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee CGL, 1998, BIOCHEMISTRY-US, V37, P3594, DOI 10.1021/bi972709x; Lima PDC, 2006, J CHEM INF MODEL, V46, P1245, DOI 10.1021/ci0504317; Loo TW, 2010, BIOCHEM BIOPH RES CO, V395, P436, DOI 10.1016/j.bbrc.2010.04.057; Loo TW, 2009, J BIOL CHEM, V284, P24074, DOI 10.1074/jbc.M109.023267; Loo TW, 2002, J BIOL CHEM, V277, P44332, DOI 10.1074/jbc.M208433200; Luts J, 2010, ANAL CHIM ACTA, V665, P129, DOI 10.1016/j.aca.2010.03.030; Mishra Nitish K., 2010, BMC Pharmacology, V10, P8, DOI 10.1186/1471-2210-10-8; Noble W.S., 2004, KERNEL METHODS COMPU, P71; Penzotti JE, 2002, J MED CHEM, V45, P1737, DOI 10.1021/jm0255062; Perloff MD, 2003, PHARMACEUT RES, V20, P1177, DOI 10.1023/A:1025092829696; Polli JW, 2001, J PHARMACOL EXP THER, V299, P620; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sauna ZE, 2007, J BIOENERG BIOMEMBR, V39, P481, DOI 10.1007/s10863-007-9115-9; Seelig A, 1998, EUR J BIOCHEM, V251, P252, DOI 10.1046/j.1432-1327.1998.2510252.x; Susanto M, 2002, PHARM RES-DORDR, V19, P457, DOI 10.1023/A:1015191511817; Tarcsay A, 2011, FUTURE MED CHEM, V3, P297, DOI [10.4155/FMC.10.276, 10.4155/fmc.10.276]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; UEDA K, 1987, P NATL ACAD SCI USA, V84, P3004, DOI 10.1073/pnas.84.9.3004; Uhr M, 2003, BIOL PSYCHIAT, V54, P840, DOI 10.1016/S0006-3223(03)00074-X; van der Sandt ICJ, 2000, EUR J PHARM SCI, V11, P207, DOI 10.1016/S0928-0987(00)00097-X; Vapnik V., 2013, NATURE STAT LAERNING; Varma MVS, 2005, MOL PHARMACEUT, V2, P12, DOI 10.1021/mp0499196; Wang YH, 2005, J CHEM INF MODEL, V45, P750, DOI 10.1021/ci050041k; Wang Z, 2011, J CHEM INF MODEL; Warren GL, 2006, J MED CHEM, V49, P5912, DOI 10.1021/jm050362n; Xue Y, 2004, J CHEM INF COMP SCI, V44, P1497, DOI 10.1021/ci049971e; Xue Y, 2004, J CHEM INF COMP SCI, V44, P1630, DOI 10.1021/ci049869h; Zhang L, 2007, INT J PHARMACEUT, V343, P98, DOI 10.1016/j.ijpharm.2007.05.017; Zsila F, 2011, BIOINFORMATICS	48	83	84	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e25815	10.1371/journal.pone.0025815	http://dx.doi.org/10.1371/journal.pone.0025815			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21991360	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000295963300022
J	Rands, SA; Whitney, HM				Rands, Sean A.; Whitney, Heather M.			Field Margins, Foraging Distances and Their Impacts on Nesting Pollinator Success	PLOS ONE			English	Article							AGRI-ENVIRONMENT SCHEMES; AGRICULTURAL LANDSCAPES; BUMBLEBEES HYMENOPTERA; EUROPEAN LANDSCAPE; BEE; HEDGEROWS; CONSERVATION; BOMBUS; BIODIVERSITY; DIVERSITY	The areas of wild land around the edges of agricultural fields are a vital resource for many species. These include insect pollinators, to whom field margins provide both nest sites and important resources (especially when adjacent crops are not in flower). Nesting pollinators travel relatively short distances from the nest to forage: most species of bee are known to travel less than two kilometres away. In order to ensure that these pollinators have sufficient areas of wild land within reach of their nests, agricultural landscapes need to be designed to accommodate the limited travelling distances of nesting pollinators. We used a spatially-explicit modelling approach to consider whether increasing the width of wild strips of land within the agricultural landscape will enhance the amount of wild resources available to a nesting pollinator, and if it would impact differently on pollinators with differing foraging strategies. This was done both by creating field structures with a randomised geography, and by using landscape data based upon the British agricultural landscape. These models demonstrate that enhancing field margins should lead to an increase in the availability of forage to pollinators that nest within the landscape. With the exception of species that only forage within a very short range of their nest (less than 125 m), a given amount of field margin manipulation should enhance the proportion of land available to a pollinator for foraging regardless of the distance over which it normally travels to find food. A fixed amount of field edge manipulation should therefore be equally beneficial for both longer-distance nesting foragers such as honeybees, and short-distance foragers such as solitary bees.	[Rands, Sean A.] Univ Bristol, Sch Vet Sci, Ctr Behav Biol, Bristol BS18 7DU, Avon, England; [Whitney, Heather M.] Univ Bristol, Sch Biol Sci, Bristol BS18 7DU, Avon, England	University of Bristol; University of Bristol	Rands, SA (corresponding author), Univ Bristol, Sch Vet Sci, Ctr Behav Biol, Bristol BS18 7DU, Avon, England.	sean.rands@bristol.ac.uk	Rands, Sean A/B-2243-2008	Rands, Sean A/0000-0002-7400-005X; Whitney, Heather/0000-0001-6450-8266	ERC [260920]	ERC(European Research Council (ERC)European Commission)	HMW was supported by an ERC Starting Grant (#260920). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aavik T, 2008, APPL VEG SCI, V11, P375, DOI 10.3170/2008-7-18486; Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Alaux C, 2010, BIOL LETTERS, V6, P562, DOI 10.1098/rsbl.2009.0986; Allen-Wardell G, 1998, CONSERV BIOL, V12, P8; Baudry J, 2000, J ENVIRON MANAGE, V60, P7, DOI 10.1006/jema.2000.0358; Baudry J, 2000, LANDSCAPE URBAN PLAN, V50, P119, DOI 10.1016/S0169-2046(00)00084-0; BEDFORD SE, 1994, AGR ECOSYST ENVIRON, V48, P295, DOI 10.1016/0167-8809(94)90111-2; Beekman M, 2000, FUNCT ECOL, V14, P490, DOI 10.1046/j.1365-2435.2000.00443.x; Beil M, 2008, APIDOLOGIE, V39, P456, DOI 10.1051/apido:2008021; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Blackwell G, 2008, NEW ZEAL J AGR RES, V51, P473, DOI 10.1080/00288230809510478; Boutin C, 2002, BIODIVERS CONSERV, V11, P1, DOI 10.1023/A:1014023326658; Brown MJF, 2009, APIDOLOGIE, V40, P410, DOI 10.1051/apido/2009019; Buddle CM, 2004, AM MIDL NAT, V151, P15, DOI 10.1674/0003-0031(2004)151[0015:GSAIRF]2.0.CO;2; Carvalheiro LG, 2011, ECOL LETT, V14, P251, DOI 10.1111/j.1461-0248.2010.01579.x; Carvell C, 2004, BIOL CONSERV, V118, P327, DOI 10.1016/j.biocon.2003.09.012; Carvell C, 2007, J APPL ECOL, V44, P29, DOI 10.1111/j.1365-2664.2006.01249.x; Colla SR, 2008, BIODIVERS CONSERV, V17, P1379, DOI 10.1007/s10531-008-9340-5; Davies ZG, 2007, LANDSCAPE ECOL, V22, P333, DOI 10.1007/s10980-006-9064-4; DENNIS P, 1992, AGR ECOSYST ENVIRON, V40, P95, DOI 10.1016/0167-8809(92)90086-Q; Dramstad WE, 1996, J INSECT BEHAV, V9, P163, DOI 10.1007/BF02213863; Elliott SE, 2009, ENVIRON ENTOMOL, V38, P748, DOI 10.1603/022.038.0327; Fahrig L, 2011, ECOL LETT, V14, P101, DOI 10.1111/j.1461-0248.2010.01559.x; FORMAN RTT, 1984, ENVIRON MANAGE, V8, P495, DOI 10.1007/BF01871575; Forrest J, 2009, P ROY SOC B-BIOL SCI, V276, P935, DOI 10.1098/rspb.2008.1434; FOWLES AP, 1996, PROVISIONAL CHECKLIS, V2; Franzen M, 2009, J INSECT CONSERV, V13, P89, DOI 10.1007/s10841-007-9123-4; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Gaucherel C, 2006, ECOL MODEL, V194, P233, DOI 10.1016/j.ecolmodel.2005.10.026; Gaucherel C, 2006, ECOL MODEL, V197, P159, DOI 10.1016/j.ecolmodel.2006.02.044; Goulson D, 2008, ANNU REV ENTOMOL, V53, P191, DOI 10.1146/annurev.ento.53.103106.093454; Goulson D, 2001, APIDOLOGIE, V32, P105, DOI 10.1051/apido:2001115; Goulson D, 2009, BUMBLEBEES BEHAV ECO, V2nd; Goulson D, 2010, J APPL ECOL, V47, P1207, DOI 10.1111/j.1365-2664.2010.01872.x; Grashof-Bokdam CJ, 2005, LANDSCAPE ECOL, V20, P417, DOI 10.1007/s10980-004-5646-1; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; Grixti JC, 2009, BIOL CONSERV, V142, P75, DOI 10.1016/j.biocon.2008.09.027; Hannon LE, 2009, BIOL CONSERV, V142, P2140, DOI 10.1016/j.biocon.2009.04.014; Jongman RHG, 2002, LANDSCAPE URBAN PLAN, V58, P211, DOI 10.1016/S0169-2046(01)00222-5; Karanja R. H. N., 2010, Journal of Pollination Ecology, V2, P7; Kells AR, 2001, J INSECT CONSERV, V5, P283, DOI 10.1023/A:1013307822575; Kleijn D, 2003, J APPL ECOL, V40, P947, DOI 10.1111/j.1365-2664.2003.00868.x; Knight ME, 2009, INSECT CONSERV DIVER, V2, P116, DOI 10.1111/j.1752-4598.2009.00049.x; Kosior A, 2007, ORYX, V41, P79, DOI 10.1017/S0030605307001597; Kreyer D, 2004, BIOL CONSERV, V116, P111, DOI 10.1016/S0006-3207(03)00182-4; Kuhn-Neto B, 2009, APIDOLOGIE, V40, P472, DOI 10.1051/apido/2009007; Kurz WA, 2000, COMPUT ELECTRON AGR, V27, P227, DOI 10.1016/S0168-1699(00)00109-5; Larsson M, 2007, BIOL CONSERV, V134, P405, DOI 10.1016/j.biocon.2006.08.030; Le Ber F, 2009, ECOL MODEL, V220, P3536, DOI 10.1016/j.ecolmodel.2009.06.019; Leon MC, 2006, AGROFOREST SYST, V68, P15, DOI 10.1007/s10457-005-5831-5; Lihoreau M, 2010, AM NAT, V176, P744, DOI 10.1086/657042; Lima SL, 1996, TRENDS ECOL EVOL, V11, P131, DOI 10.1016/0169-5347(96)81094-9; Marshall EJP, 2006, AGR ECOSYST ENVIRON, V113, P36, DOI 10.1016/j.agee.2005.08.036; Marshall EJP, 2002, AGR ECOSYST ENVIRON, V89, P1, DOI 10.1016/S0167-8809(01)00314-0; Marshall EJR, 2002, AGR ECOSYST ENVIRON, V89, P5, DOI 10.1016/S0167-8809(01)00315-2; Maudsley MJ, 2000, J ENVIRON MANAGE, V60, P65, DOI 10.1006/jema.2000.0362; McCollin D, 2000, J ENVIRON MANAGE, V60, P77, DOI 10.1006/jema.2000.0363; MEEUS JHA, 1995, LANDSCAPE URBAN PLAN, V31, P57, DOI 10.1016/0169-2046(94)01036-8; MEEUS JHA, 1990, LANDSCAPE URBAN PLAN, V18, P289, DOI 10.1016/0169-2046(90)90016-U; MEEUS JHA, 1993, SCI TOTAL ENVIRON, V129, P171, DOI 10.1016/0048-9697(93)90169-7; Mucher CA, 2010, ECOL INDIC, V10, P87, DOI 10.1016/j.ecolind.2009.03.018; Muller H, 2010, ANIM BEHAV, V80, P1065, DOI 10.1016/j.anbehav.2010.09.016; Olson DM, 2007, J APPL ECOL, V44, P13, DOI 10.1111/j.1365-2664.2006.01241.x; Orians G.H., 1979, P155; Osborne JL, 1999, J APPL ECOL, V36, P519, DOI 10.1046/j.1365-2664.1999.00428.x; Osborne JL, 2008, J ANIM ECOL, V77, P406, DOI 10.1111/j.1365-2656.2007.01333.x; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Rands SA, 2000, J THEOR BIOL, V202, P161, DOI 10.1006/jtbi.1999.1048; Rands SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002007; Rands SA, 2010, ECOL MODEL, V221, P1310, DOI 10.1016/j.ecolmodel.2010.01.014; Roulston TH, 2011, ANNU REV ENTOMOL, V56, P293, DOI 10.1146/annurev-ento-120709-144802; Rudner M, 2007, ENVIRON MODELL SOFTW, V22, P177, DOI 10.1016/j.envsoft.2005.07.016; Sanderson EW, 2002, LANDSCAPE URBAN PLAN, V58, P41, DOI 10.1016/S0169-2046(01)00231-6; Saura S, 2000, LANDSCAPE ECOL, V15, P661, DOI 10.1023/A:1008107902848; Schweiger O, 2005, J APPL ECOL, V42, P1129, DOI 10.1111/j.1365-2664.2005.01085.x; Sedivy C, 2011, FUNCT ECOL, V25, P718, DOI 10.1111/j.1365-2435.2010.01828.x; Steffan-Dewenter I, 2008, J APPL ECOL, V45, P737, DOI 10.1111/j.1365-2664.2008.01483.x; TSCHARNTKE T, AGR ECOSYST IN PRESS; Varchola JM, 2001, AGR ECOSYST ENVIRON, V83, P153, DOI 10.1016/S0167-8809(00)00249-8; Westphal C, 2006, OECOLOGIA, V149, P289, DOI 10.1007/s00442-006-0448-6; Winfree R, 2010, ANN NY ACAD SCI, V1195, P169, DOI 10.1111/j.1749-6632.2010.05449.x; Wolf S, 2008, APIDOLOGIE, V39, P419, DOI 10.1051/apido:2008020; Zurbuchen A, 2010, BIOL CONSERV, V143, P669, DOI 10.1016/j.biocon.2009.12.003; Zurbuchen A, 2010, J ANIM ECOL, V79, P674, DOI 10.1111/j.1365-2656.2010.01675.x; Zuria I, 2006, HUM ECOL, V34, P53, DOI 10.1007/s10745-005-9002-0	85	39	42	2	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25971	10.1371/journal.pone.0025971	http://dx.doi.org/10.1371/journal.pone.0025971			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991390	gold, Green Submitted, Green Published			2022-12-27	WOS:000295943000097
J	Fernandez-Fernandez, C; Gonzalez, D; Collier, J				Fernandez-Fernandez, Carmen; Gonzalez, Diego; Collier, Justine			Regulation of the Activity of the Dual-Function DnaA Protein in Caulobacter crescentus	PLOS ONE			English	Article							BACTERIAL-CELL CYCLE; ESCHERICHIA-COLI; REPLICATION INITIATION; CHROMOSOMAL REPLICATION; MOLECULAR SWITCH; HDA; EXPRESSION; ATP; INACTIVATION; GENE	DnaA is a conserved essential bacterial protein that acts as the initiator of chromosomal replication as well as a master transcriptional regulator in Caulobacter crescentus. Thus, the intracellular levels of active DnaA need to be tightly regulated during the cell cycle. Our previous work suggested that DnaA may be regulated at the level of its activity by the replisome-associated protein HdaA. Here, we describe the construction of a mutant DnaA protein [DnaA(R357A)]. The R357 residue in the AAA+ domain of the C. crescentus DnaA protein is equivalent to the R334 residue of the E. coli DnaA protein, which is required for the Regulatory Inactivation of DnaA (RIDA). We found that the expression of the DnaA(R357A) mutant protein in C. crescentus, but not the expression of the wild-type DnaA protein at similar levels, causes a severe phenotype of over-initiation of chromosomal replication and that it blocks cell division. Thus, the mutant DnaA(R357A) protein is hyper-active to promote the initiation of DNA replication, compared to the wild-type DnaA protein. DnaA(R357A) could not replace DnaA in vivo, indicating that the switch in DnaA activity once chromosomal replication has started may be an essential process in C. crescentus. We propose that the inactivation of DnaA is the main mechanism ensuring that chromosomal replication starts only once per cell cycle. We further observed that the R357A substitution in DnaA does not promote the activity of DnaA as a direct transcriptional activator of four important genes, encoding HdaA, the GcrA master cell cycle regulator, the FtsZ cell division protein and the MipZ spatial regulator of cell division. Thus, the AAA+ domain of DnaA may play a role in temporally regulating the bifunctionality of DnaA by reallocating DnaA molecules from initiating DNA replication to transcribing genes within the unique DnaA regulon of C. crescentus.	[Fernandez-Fernandez, Carmen; Gonzalez, Diego; Collier, Justine] Univ Lausanne, Fac Biol & Med, Dept Fundamental Microbiol, Lausanne, Switzerland	University of Lausanne	Fernandez-Fernandez, C (corresponding author), Univ Lausanne, Fac Biol & Med, Dept Fundamental Microbiol, Lausanne, Switzerland.	Justine.collier@unil.ch		Collier, Justine/0000-0003-4213-9687; Gonzalez, Diego/0000-0003-3414-1461	Swiss National Science Foundation (SNSF) [31003A_122541, 316030_121391]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF))	This work was supported by the Swiss National Science Foundation (SNSF) fellowship 31003A_122541 and the SNSF R'Equip grant 316030_121391 (SNSF: http://www.snf.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Camara JE, 2005, EMBO REP, V6, P736, DOI 10.1038/sj.embor.7400467; Camara JE, 2003, J BACTERIOL, V185, P3244, DOI 10.1128/JB.185.10.3244-3248.2003; Chen YE, 2011, P NATL ACAD SCI USA, V108, P1052, DOI 10.1073/pnas.1015397108; Cheng L, 2009, J BACTERIOL, V191, P4268, DOI 10.1128/JB.00362-09; Collier J, 2006, EMBO J, V25, P346, DOI 10.1038/sj.emboj.7600927; Collier J, 2007, P NATL ACAD SCI USA, V104, P17111, DOI 10.1073/pnas.0708112104; Collier J, 2007, CURR OPIN BIOTECH, V18, P333, DOI 10.1016/j.copbio.2007.07.007; Collier J, 2009, J BACTERIOL, V191, P5706, DOI 10.1128/JB.00525-09; Curtis PD, 2010, MICROBIOL MOL BIOL R, V74, P13, DOI 10.1128/MMBR.00040-09; Domian IJ, 1997, CELL, V90, P415, DOI 10.1016/S0092-8674(00)80502-4; ELY B, 1991, METHOD ENZYMOL, V204, P372; EVINGER M, 1977, J BACTERIOL, V132, P294, DOI 10.1128/JB.132.1.294-301.1977; GOBER JW, 1992, MOL BIOL CELL, V3, P913, DOI 10.1091/mbc.3.8.913; Gon S, 2006, EMBO J, V25, P1137, DOI 10.1038/sj.emboj.7600990; Goranov AI, 2005, P NATL ACAD SCI USA, V102, P12932, DOI 10.1073/pnas.0506174102; Gorbatyuk B, 2005, MOL MICROBIOL, V55, P1233, DOI 10.1111/j.1365-2958.2004.04459.x; Gorbatyuk B, 2001, MOL MICROBIOL, V40, P485, DOI 10.1046/j.1365-2958.2001.02404.x; Hayashi M, 2005, FEMS MICROBIOL LETT, V247, P73, DOI 10.1016/j.femsle.2005.04.028; Holtzendorff J, 2004, SCIENCE, V304, P983, DOI 10.1126/science.1095191; Hottes AK, 2005, MOL MICROBIOL, V58, P1340, DOI 10.1111/j.1365-2958.2005.04912.x; Jonas K, 2011, CURR BIOL, V21, P1092, DOI 10.1016/j.cub.2011.05.040; Katayama T, 1998, CELL, V94, P61, DOI 10.1016/S0092-8674(00)81222-2; Kato J, 2001, EMBO J, V20, P4253, DOI 10.1093/emboj/20.15.4253; Kelly AJ, 1998, GENE DEV, V12, P880, DOI 10.1101/gad.12.6.880; Laub MT, 2002, P NATL ACAD SCI USA, V99, P4632, DOI 10.1073/pnas.062065699; Lesley JA, 2008, J BACTERIOL, V190, P6867, DOI 10.1128/JB.00700-08; Marczynski GT, 2002, ANNU REV MICROBIOL, V56, P625, DOI 10.1146/annurev.micro.56.012302.161103; Meisenzahl AC, 1997, J BACTERIOL, V179, P592, DOI 10.1128/jb.179.3.592-600.1997; MILLER JH, 1972, EXPRERIMENTS MOL GEN; Mott ML, 2007, NAT REV MICROBIOL, V5, P343, DOI 10.1038/nrmicro1640; Nakamura K, 2010, MOL MICROBIOL, V76, P302, DOI 10.1111/j.1365-2958.2010.07074.x; Nishida S, 2002, J BIOL CHEM, V277, P14986, DOI 10.1074/jbc.M108303200; Noirot-Gros MF, 2002, P NATL ACAD SCI USA, V99, P8342, DOI 10.1073/pnas.122040799; Olliver A, 2010, MOL MICROBIOL, V76, P1555, DOI 10.1111/j.1365-2958.2010.07185.x; PRENTKI P, 1984, GENE, V29, P303, DOI 10.1016/0378-1119(84)90059-3; Quardokus E, 1996, P NATL ACAD SCI USA, V93, P6314, DOI 10.1073/pnas.93.13.6314; Quon KC, 1998, P NATL ACAD SCI USA, V95, P120, DOI 10.1073/pnas.95.1.120; Quon KC, 1996, CELL, V84, P83, DOI 10.1016/S0092-8674(00)80995-2; Riber L, 2006, GENE DEV, V20, P2121, DOI 10.1101/gad.379506; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Scholefield G, 2011, TRENDS CELL BIOL, V21, P188, DOI 10.1016/j.tcb.2010.10.006; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Speck C, 1999, EMBO J, V18, P6169, DOI 10.1093/emboj/18.21.6169; Su'etsugu M, 2005, J BIOL CHEM, V280, P6528, DOI 10.1074/jbc.M412060200; Thanbichler M, 2006, CELL, V126, P147, DOI 10.1016/j.cell.2006.05.038; ZWEIGER G, 1994, J BACTERIOL, V176, P401, DOI 10.1128/JB.176.2.401-408.1994	46	29	29	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26028	10.1371/journal.pone.0026028	http://dx.doi.org/10.1371/journal.pone.0026028			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022497	Green Published, gold, Green Submitted			2022-12-27	WOS:000295981600027
J	Belhouchet, M; Jaafar, FM; Firth, AE; Grimes, JM; Mertens, PPC; Attoui, H				Belhouchet, Mourad; Jaafar, Fauziah Mohd; Firth, Andrew E.; Grimes, Jonathan M.; Mertens, Peter P. C.; Attoui, Houssam			Detection of a Fourth Orbivirus Non-Structural Protein	PLOS ONE			English	Article							OUTER-CAPSID PROTEINS; S1 MESSENGER-RNA; REOVIRUS-SPECIFIED POLYPEPTIDES; BLUETONGUE VIRUS SEROTYPE-1; CRYOELECTRON MICROSCOPY; FAMILY REOVIRIDAE; COMPLETE SEQUENCE; MAMMALIAN-CELLS; GENOME SEGMENTS; AVIAN REOVIRUS	The genus Orbivirus includes both insect and tick-borne viruses. The orbivirus genome, composed of 10 segments of dsRNA, encodes 7 structural proteins (VP1-VP7) and 3 non-structural proteins (NS1-NS3). An open reading frame (ORF) that spans almost the entire length of genome segment-9 (Seg-9) encodes VP6 (the viral helicase). However, bioinformatic analysis recently identified an overlapping ORF (ORFX) in Seg-9. We show that ORFX encodes a new non-structural protein, identified here as NS4. Western blotting and confocal fluorescence microscopy, using antibodies raised against recombinant NS4 from Bluetongue virus (BTV, which is insect-borne), or Great Island virus (GIV, which is tick-borne), demonstrate that these proteins are synthesised in BTV or GIV infected mammalian cells, respectively. BTV NS4 is also expressed in Culicoides insect cells. NS4 forms aggregates throughout the cytoplasm as well as in the nucleus, consistent with identification of nuclear localisation signals within the NS4 sequence. Bioinformatic analyses indicate that NS4 contains coiled-coils, is related to proteins that bind nucleic acids, or are associated with membranes and shows similarities to nucleolar protein UTP20 (a processome subunit). Recombinant NS4 of GIV protects dsRNA from degradation by endoribonucleases of the RNAse III family, indicating that it interacts with dsRNA. However, BTV NS4, which is only half the putative size of the GIV NS4, did not protect dsRNA from RNAse III cleavage. NS4 of both GIV and BTV protect DNA from degradation by DNAse. NS4 was found to associate with lipid droplets in cells infected with BTV or GIV or transfected with a plasmid expressing NS4.	[Belhouchet, Mourad; Jaafar, Fauziah Mohd; Mertens, Peter P. C.; Attoui, Houssam] Inst Anim Hlth, Vector Borne Viral Dis Programme, Pirbright, England; [Firth, Andrew E.] Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England; [Belhouchet, Mourad; Grimes, Jonathan M.] Div Struct Biol, Oxford, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; University of Cambridge; University of Oxford	Belhouchet, M (corresponding author), Inst Anim Hlth, Vector Borne Viral Dis Programme, Pirbright, England.	houssam.attoui@iah.ac.uk		Grimes, Jonathan Mark/0000-0001-9698-0389; Attoui, Houssam/0000-0001-9639-9981; Firth, Andrew/0000-0002-7986-9520; Mertens, Peter/0000-0002-3438-3738	Defra; Biotechnology and Biological Sciences Research Council (BBSRC); Pfizer; European Union [OrbiVac 245266, WildTech 222633-2, OrbiNet K1303206]; BBSRC/Pfizer; Wellcome Trust [088789]	Defra(Department for Environment, Food & Rural Affairs (DEFRA)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Pfizer(Pfizer); European Union(European Commission); BBSRC/Pfizer(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)Pfizer); Wellcome Trust(Wellcome TrustEuropean Commission)	Work within the Vector-borne disease programme at the Institute for Animal Health is supported by Defra, the Biotechnology and Biological Sciences Research Council (BBSRC) and Pfizer and by European Union contracts OrbiVac 245266, WildTech 222633-2, and OrbiNet K1303206. M. B. is supported by a BBSRC/Pfizer funded Ph.D. studentship. AEF is supported by the Wellcome Trust (grant number 088789). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalto AP, 2007, RNA, V13, P422, DOI 10.1261/rna.348307; Anantharaman V, 2002, GENOME BIOL, V3; Attoui H, 2000, J VIROL METHODS, V89, P147, DOI 10.1016/S0166-0934(00)00212-3; Attoui H, 2001, J GEN VIROL, V82, P795, DOI 10.1099/0022-1317-82-4-795; Belhouchet M, 2010, J GEN VIROL, V91, P2985, DOI 10.1099/vir.0.024760-0; BERNARDI A, 1975, EUR J BIOCHEM, V52, P451, DOI 10.1111/j.1432-1033.1975.tb04013.x; Camproux AC, 1999, PROTEIN ENG, V12, P1063, DOI 10.1093/protein/12.12.1063; Chen HY, 2002, J VIROL, V76, P5233, DOI 10.1128/JVI.76.10.5233-5250.2002; Cheung W, 2010, J VIROL, V84, P6782, DOI 10.1128/JVI.01757-09; Diprose JM, 2001, EMBO J, V20, P7229, DOI 10.1093/emboj/20.24.7229; DOOHAN JP, 1993, J BIOL CHEM, V268, P18313; Firth AE, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-75; Firth AE, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-14; Firth AE, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-48; Gouet P, 1999, CELL, V97, P481, DOI 10.1016/S0092-8674(00)80758-8; Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694; GRUBMAN MJ, 1983, VIROLOGY, V131, P355, DOI 10.1016/0042-6822(83)90503-2; Hales KG, 1997, CELL, V90, P121, DOI 10.1016/S0092-8674(00)80319-0; HEWAT EA, 1992, J STRUCT BIOL, V109, P61, DOI 10.1016/1047-8477(92)90068-L; Hiscox JA, 2002, ARCH VIROL, V147, P1077, DOI 10.1007/s00705-001-0792-0; HUISMANS H, 1979, VIROLOGY, V92, P397, DOI 10.1016/0042-6822(79)90144-2; HYATT AD, 1993, VIROLOGY, V193, P592, DOI 10.1006/viro.1993.1167; Jaafar FM, 2005, J GEN VIROL, V86, P1147, DOI 10.1099/vir.0.80578-0; Jaafar FM, 2005, STRUCTURE, V13, P17, DOI 10.1016/j.str.2004.10.017; Jaafar FM, 2003, J CLIN MICROBIOL, V41, P2102, DOI [10.1128/JCM.41.5.2102-2105.2003, 10.1128/JCM.41.5.2102.2105.2003]; JACOBS BL, 1985, VIROLOGY, V147, P9, DOI 10.1016/0042-6822(85)90222-3; Jaroszewski L, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000205; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; KUMAR S, 1994, COMPUT APPL BIOSCI, V10, P189; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lange A, 2010, TRAFFIC, V11, P311, DOI 10.1111/j.1600-0854.2009.01028.x; Maan S, 2007, J GEN VIROL, V88, P621, DOI 10.1099/vir.0.82456-0; Martin D, 2010, J VIROL, V84, P2522, DOI 10.1128/JVI.01883-09; MERTENS PPC, 1984, VIROLOGY, V135, P207, DOI 10.1016/0042-6822(84)90131-4; MERTENS PPC, 1987, VIROLOGY, V157, P375, DOI 10.1016/0042-6822(87)90280-7; Mertens PPC, 2005, VIRUS TAXONOMY, P447; Mortola E, 2004, J VIROL, V78, P2875, DOI 10.1128/JVI.78.6.2875-2883.2004; Murayama K, 2001, J MOL BIOL, V314, P789, DOI 10.1006/jmbi.2001.5157; Nagaleekar VK, 2007, ARCH VIROL, V152, P1751, DOI 10.1007/s00705-007-0988-z; O'Hara RS, 1998, ARCH VIROL, P259; Owens RJ, 2004, J VIROL, V78, P6649, DOI 10.1128/JVI.78.12.6649-6656.2004; Racine T, 2007, J BIOL CHEM, V282, P25613, DOI 10.1074/jbc.M703708200; Racine T, 2010, NUCLEIC ACIDS RES, V38, P7260, DOI 10.1093/nar/gkq611; Rainsford EW, 2007, VIRUS RES, V130, P193, DOI 10.1016/j.virusres.2007.06.011; Ren B, 2010, J VIROL, V84, P12914, DOI 10.1128/JVI.00864-10; Sangar D. V., 1983, Double-stranded RNA viruses. Proceedings of the First International Symposium, October 5-10, 1982, U.S. Virgin Islands, P183; Schoehn G, 1997, VIROLOGY, V235, P191, DOI 10.1006/viro.1997.8685; Sonnhammer ELL, 1998, NUCLEIC ACIDS RES, V26, P320, DOI 10.1093/nar/26.1.320; STJOHNSTON D, 1992, P NATL ACAD SCI USA, V89, P10979, DOI 10.1073/pnas.89.22.10979; Stuart DI, 1998, ARCH VIROL, P235; Suzuki N, 1996, J VIROL, V70, P8155, DOI 10.1128/JVI.70.11.8155-8159.1996; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; WADEEVANS AM, 1992, J GEN VIROL, V73, P3023, DOI 10.1099/0022-1317-73-11-3023; Wang Y, 2007, BBA-MOL CELL RES, V1773, P863, DOI 10.1016/j.bbamcr.2007.04.002; WECHSLER SJ, 1988, J CLIN MICROBIOL, V26, P2324, DOI 10.1128/JCM.26.11.2324-2327.1988; WECHSLER SJ, 1989, J INVERTEBR PATHOL, V54, P385, DOI 10.1016/0022-2011(89)90123-7; Yue ZY, 1996, J VIROL, V70, P3497, DOI 10.1128/JVI.70.6.3497-3501.1996	57	161	173	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25697	10.1371/journal.pone.0025697	http://dx.doi.org/10.1371/journal.pone.0025697			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022432	Green Published, Green Submitted, gold			2022-12-27	WOS:000295976000031
J	Xue, C; Fu, YX; Zhao, YH; Gong, Y; Liu, XM				Xue, Cheng; Fu, Yun-Xin; Zhao, Yuhai; Gong, Yun; Liu, Xiaoming			Smaller Genetic Risk in Catabolic Process Explains Lower Energy Expenditure, More Athletic Capability and Higher Prevalence of Obesity in Africans	PLOS ONE			English	Article							BATON-ROUGE CHILDRENS; RACIAL-DIFFERENCES; WHITE BOYS; DUPLICATION; AMERICAN; WOMEN; BLACK; GIRLS	Lower energy expenditure (EE) for physical activity was observed in Africans than in Europeans, which might contribute to the higher prevalence of obesity and more athletic capability in Africans. But it is still unclear why EE is lower among African populations. In this study we tried to explore the genetic mechanism underlying lower EE in Africans. We screened 231 common variants with possibly harmful impact on 182 genes in the catabolic process. The genetic risk, including the total number of mutations and the sum of harmful probabilities, was calculated and analyzed for the screened variants at a population level. Results of the genetic risk among human groups showed that most Africans (3 out of 4 groups) had a significantly smaller genetic risk in the catabolic process than Europeans and Asians, which might result in higher efficiency of generating energy among Africans. In sport competitions, athletes need massive amounts of energy expenditure in a short period of time, so higher efficiency of energy generation might help make African-descendent athletes more powerful. On the other hand, higher efficiency of generating energy might also result in consuming smaller volumes of body mass. As a result, Africans might be more vulnerable to obesity compared to the other races when under the same or similar conditions. Therefore, the smaller genetic risk in the catabolic process might be at the core of understanding lower EE, more athletic capability and higher prevalence of obesity in Africans.	[Xue, Cheng; Fu, Yun-Xin; Gong, Yun; Liu, Xiaoming] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX USA; [Xue, Cheng] GuangDong Inst Monitoring Lab Anim, Guangzhou, Guangdong, Peoples R China; [Fu, Yun-Xin] Yunnan Univ, Lab Conservat & Utilizat Bioresources, Yunnan, Peoples R China; [Zhao, Yuhai] Univ Texas Hlth Sci Ctr Houston, Sch Med, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; Yunnan University; University of Texas System; University of Texas Health Science Center Houston	Xue, C (corresponding author), Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX USA.	lflf27@yahoo.com.cn	Liu, Xiaoming/C-2743-2008	Liu, Xiaoming/0000-0001-8285-5528	Yunnan University	Yunnan University	This work is supported by funds from Yunnan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; DeLany JP, 2004, AM J CLIN NUTR, V79, P268; DeLany JP, 2002, AM J CLIN NUTR, V75, P705, DOI 10.1093/ajcn/75.4.705; Gannon B, 2000, INT J OBESITY, V24, P4, DOI 10.1038/sj.ijo.0801115; GEISSLER CA, 1985, ANN NUTR METAB, V29, P40, DOI 10.1159/000176952; Hunter GR, 2000, AM J CLIN NUTR, V71, P500; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lomax ME, 2008, SPORTS AND THE RACIAL DIVIDE: AFRICAN AMERICAN AND LATINO EXPERIENCE IN AN ERA OF CHANGE, P1; Luke Amy, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P370, DOI 10.1097/MED.0b013e3282c48a7c; Pan L., 2009, Morbidity and Mortality Weekly Report, V58, P740; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; THOMAS JH, 1993, TRENDS GENET, V9, P395, DOI 10.1016/0168-9525(93)90140-D; Weinsier RL, 2000, AM J CLIN NUTR, V71, P1138; Xue C, 2010, GENETICS, V186, P287, DOI 10.1534/genetics.110.118646; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8	15	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e26027	10.1371/journal.pone.0026027	http://dx.doi.org/10.1371/journal.pone.0026027			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016803	Green Published, gold, Green Submitted			2022-12-27	WOS:000295971700033
J	Caronia, D; Patino-Garcia, A; Perez-Martinez, A; Pita, G; Moreno, LT; Zalacain-Diez, M; Molina, B; Colmenero, I; Sierrasesumaga, L; Benitez, J; Gonzalez-Neira, A				Caronia, Daniela; Patino-Garcia, Ana; Perez-Martinez, Antonio; Pita, Guillermo; Tais Moreno, Leticia; Zalacain-Diez, Marta; Molina, Blanca; Colmenero, Isabel; Sierrasesumaga, Luis; Benitez, Javier; Gonzalez-Neira, Anna			Effect of ABCB1 and ABCC3 Polymorphisms on Osteosarcoma Survival after Chemotherapy: A Pharmacogenetic Study	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE PROTEIN-3; DRUG TRANSPORTERS; P-GLYCOPROTEIN; MESSENGER-RNA; GENE; EXPRESSION; MRP3; CANCER; PHARMACOKINETICS; GENOTYPE	Background: Standard treatment for osteosarcoma patients consists of a combination of cisplatin, adriamycin, and methotrexate before surgical resection of the primary tumour, followed by postoperative chemotherapy including vincristine and cyclophosphamide. Unfortunately, many patients still relapse or suffer adverse events. We examined whether common germline polymorphisms in chemotherapeutic transporter and metabolic pathway genes of the drugs used in standard osteosarcoma treatment may predict treatment response. Methodology/Principal Findings: In this study we screened 102 osteosarcoma patients for 346 Single Nucleotide Polymorphisms (SNPs) and 2 Copy Number Variants (CNVs) in 24 genes involved in the metabolism or transport of cisplatin, adriamycin, methotrexate, vincristine, and cyclophosphamide. We studied the association of the genotypes with tumour response and overall survival. We found that four SNPs in two ATP-binding cassette genes were significantly associated with overall survival: rs4148416 in ABCC3 (per-allele HR = 8.14, 95% CI = 2.73-20.2, p-value = 5.1x10(-5)), and three SNPs in ABCB1, rs4148737 (per-allele HR = 3.66, 95% CI = 1.85-6.11, p-value = 6.9x10(-5)), rs1128503 and rs10276036 (r(2) = 1, per-allele HR = 0.24, 95% CI = 0.11-0.47 p-value = 7.9x10(-5)). Associations with these SNPs remained statistically significant after correction for multiple testing (all corrected p-values [permutation test] <= 0.03). Conclusions: Our findings suggest that these polymorphisms may affect osteosarcoma treatment efficacy. If these associations are independently validated, these variants could be used as genetic predictors of clinical outcome in the treatment of osteosarcoma, helping in the design of individualized therapy.	[Caronia, Daniela; Pita, Guillermo; Tais Moreno, Leticia; Benitez, Javier; Gonzalez-Neira, Anna] Spanish Natl Canc Res Ctr, Human Genotyping Unit CeGen, Madrid, Spain; [Patino-Garcia, Ana; Zalacain-Diez, Marta; Sierrasesumaga, Luis] Univ Navarra, Dept Pediat, E-31080 Pamplona, Spain; [Perez-Martinez, Antonio; Zalacain-Diez, Marta; Sierrasesumaga, Luis] Univ Clin, Pamplona, Spain; [Perez-Martinez, Antonio; Molina, Blanca; Colmenero, Isabel] Univ Childrens Hosp Nino Jesus, Dept Pediat Oncol, Madrid, Spain; [Benitez, Javier] Spanish Natl Canc Res Ctr, Human Genet Grp, Human Canc Genet Programme, Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); University of Navarra; Centro Nacional de Investigaciones Oncologicas (CNIO)	Caronia, D (corresponding author), Spanish Natl Canc Res Ctr, Human Genotyping Unit CeGen, Madrid, Spain.	agonzalez@cnio.es	Gonzalez-Neira, Anna/C-5791-2015; Pérez-Martínez, Antonio/AAF-5797-2019; Colmenero, Isabel/AAM-1316-2020; Perez, Antonio/I-6032-2012; Patiño-Garcia, Ana/I-4299-2012	Gonzalez-Neira, Anna/0000-0002-5421-2020; Patiño-Garcia, Ana/0000-0002-4066-8203; Perez Martinez, Antonio/0000-0002-6436-9195; colmenero, isabel/0000-0001-6859-187X	AECC (Asociacion Espanola contra el Cancer); "Inocente Inocente'' Foundation; FIS (Fondo de Investigacion Sanitaria-Instituto de Salud Carlos III)	AECC (Asociacion Espanola contra el Cancer); "Inocente Inocente'' Foundation; FIS (Fondo de Investigacion Sanitaria-Instituto de Salud Carlos III)(Instituto de Salud Carlos III)	This work was supported by the AECC (Asociacion Espanola contra el Cancer), FIS (Fondo de Investigacion Sanitaria-Instituto de Salud Carlos III) and the "Inocente Inocente'' Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacci G, 2003, CANCER, V97, P3068, DOI 10.1002/cncr.11456; BALCERCZAK E, INT J COLORECTAL DIS, V25, P1167; Borst P, 2000, JNCI-J NATL CANCER I, V92, P1295, DOI 10.1093/jnci/92.16.1295; Caronia D, 2009, PHARMACOGENOMICS J, V9, P347, DOI 10.1038/tpj.2009.19; CASCORBI I, METHODS MOL BIOL, V596, P95; Chou AJ, 2006, EXPERT REV ANTICANC, V6, P1075, DOI 10.1586/14737140.6.7.1075; Estrela RC, 2009, PHARMACOGENOMICS, V10, P311, DOI 10.2217/14622416.10.2.311; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; Hirohashi T, 2000, J BIOL CHEM, V275, P2905, DOI 10.1074/jbc.275.4.2905; Hoffmeyer S, 2000, P NATL ACAD SCI USA, V97, P3473, DOI 10.1073/pnas.050585397; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Huang R, 2006, BIOCHEM PHARMACOL, V71, P1695, DOI 10.1016/j.bcp.2006.03.009; Innocenti F, 2009, J CLIN ONCOL, V27, P2604, DOI 10.1200/JCO.2008.20.6300; Jamroziak K, 2009, LEUKEMIA RES, V33, P332, DOI 10.1016/j.leukres.2008.06.008; JURANKA PF, 1989, FASEB J, V3, P2583, DOI 10.1096/fasebj.3.14.2574119; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kindla J, 2009, EXPERT OPIN DRUG MET, V5, P489, DOI [10.1517/17425250902911463 , 10.1517/17425250902911463]; Kobayashi K, 2008, PHARMACOGENET GENOM, V18, P823, DOI 10.1097/FPC.0b013e328306e9ae; Lal S, 2008, CANCER SCI, V99, P816, DOI 10.1111/j.1349-7006.2008.00744.x; Lang T, 2004, PHARMACOGENETICS, V14, P155, DOI 10.1097/00008571-200403000-00003; Leschziner GD, 2007, PHARMACOGENOMICS J, V7, P154, DOI 10.1038/sj.tpj.6500413; Mathijssen RHJ, 2003, CLIN CANCER RES, V9, P3246; Morita N, 2003, BIOCHEM PHARMACOL, V65, P1843, DOI 10.1016/S0006-2952(03)00178-3; Redlich G, 2008, J PROTEOME RES, V7, P4678, DOI 10.1021/pr800231w; Rost D, 2001, GASTROENTEROLOGY, V121, P1203, DOI 10.1053/gast.2001.28648; Sakaeda Toshiyuki, 2005, Drug Metab Pharmacokinet, V20, P391, DOI 10.2133/dmpk.20.391; Schaich M, 2009, ANN ONCOL, V20, P175, DOI 10.1093/annonc/mdn548; Sissung Tristan M., 2008, V448, P41, DOI 10.1007/978-1-59745-205-2_4; Young LC, 2001, CLIN CANCER RES, V7, P1798; Zelcer N, 2001, J BIOL CHEM, V276, P46400, DOI 10.1074/jbc.M107041200; Zeng H, 2000, CANCER RES, V60, P4779; Zhang YT, 2008, BRIT J CLIN PHARMACO, V66, P240, DOI 10.1111/j.1365-2125.2008.03180.x; Zhou SF, 2008, CURR DRUG METAB, V9, P738, DOI 10.2174/138920008786049302	34	66	69	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e26091	10.1371/journal.pone.0026091	http://dx.doi.org/10.1371/journal.pone.0026091			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22016816	Green Submitted, Green Published, gold			2022-12-27	WOS:000295970300059
J	Gelmedin, V; Brodigan, T; Gao, X; Krause, M; Wang, Z; Hawdon, JM				Gelmedin, Verena; Brodigan, Thomas; Gao, Xin; Krause, Michael; Wang, Zhu; Hawdon, John M.			Transgenic C. elegans Dauer Larvae Expressing Hookworm Phospho Null DAF-16/FoxO Exit Dauer	PLOS ONE			English	Article							3RD-STAGE INFECTIVE LARVAE; AGE-1 PI3 KINASE; CAENORHABDITIS-ELEGANS; TRANSCRIPTION FACTOR; ANCYLOSTOMA-CANINUM; FEEDING INVITRO; LIFE-SPAN; PHOSPHORYLATION SITES; SIGNALING PATHWAY; FAMILY-MEMBER	Parasitic hookworms and the free-living model nematode Caenorhabtidis elegans share a developmental arrested stage, called the dauer stage in C. elegans and the infective third-stage larva (L3) in hookworms. One of the key transcription factors that regulate entrance to and exit from developmental arrest is the forkhead transcription factor DAF-16/FoxO. During the dauer stage, DAF-16 is activated and localized in the nucleus. DAF-16 is negatively regulated by phosphorylation by the upstream kinase AKT, which causes DAF-16 to localize out of the nucleus and the worm to exit from dauer. DAF-16 is conserved in hookworms, and hypothesized to control recovery from L3 arrest during infection. Lacking reverse genetic techniques for use in hookworms, we used C. elegans complementation assays to investigate the function of Ancylostoma caninum DAF-16 during entrance and exit from L3 developmental arrest. We performed dauer switching assays and observed the restoration of the dauer phenotype when Ac-DAF-16 was expressed in temperature-sensitive dauer defective C. elegans daf-2(e1370);daf-16(mu86) mutants. AKT phosphorylation site mutants of Ac-DAF-16 were also able to restore the dauer phenotype, but surprisingly allowed dauer exit when temperatures were lowered. We used fluorescence microscopy to localize DAF-16 during dauer and exit from dauer in C. elegans DAF-16 mutant worms expressing Ac-DAF-16, and found that Ac-DAF-16 exited the nucleus during dauer exit. Surprisingly, Ac-DAF-16 with mutated AKT phosphorylation sites also exited the nucleus during dauer exit. Our results suggest that another mechanism may be involved in the regulation DAF-16 nuclear localization during recovery from developmental arrest.	[Gelmedin, Verena; Gao, Xin; Hawdon, John M.] Washington Univ, Med Ctr, Dept Microbiol Immunol & Trop Med, Washington, DC 20037 USA; [Brodigan, Thomas; Krause, Michael] NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Wang, Zhu] UT SW Med Sch, Dept Pharmacol, Dallas, TX USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Texas System; University of Texas Southwestern Medical Center Dallas	Gelmedin, V (corresponding author), Washington Univ, Med Ctr, Dept Microbiol Immunol & Trop Med, Washington, DC 20037 USA.	mtmvxg@gwumc.edu	Hawdon, John/I-1201-2019; Gao, Cyan/O-9316-2014	Hawdon, John/0000-0002-6164-1413; Krause, Michael/0000-0001-6127-3940	NIH from the National Institute of Allergy and Infectious Diseases [R01AI069293]; National Institute of Diabetes and Digestive and Kidney Diseases of the NIH; NIH [SIG S10RR025565]; NIH National Center for Research Resources (NCRR); NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069293] Funding Source: NIH RePORTER	NIH from the National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Diabetes and Digestive and Kidney Diseases of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by NIH Grant R01AI069293 from the National Institute of Allergy and Infectious Diseases and, in part, by the National Institute of Diabetes and Digestive and Kidney Diseases of the Intramural Research Program of the NIH. The confocal microscope Zeiss 710 was funded by NIH SIG S10RR025565. Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAM H, CELL METAB, V12, P30; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Benito M, 1996, INT J BIOCHEM CELL B, V28, P499, DOI 10.1016/1357-2725(95)00168-9; Berdichevsky A, 2006, CELL, V125, P1165, DOI 10.1016/j.cell.2006.04.036; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Brownawell AM, 2001, MOL CELL BIOL, V21, P3534, DOI 10.1128/MCB.21.10.3534-3546.2001; Burglin TR, 1998, INT J PARASITOL, V28, P395, DOI 10.1016/S0020-7519(97)00208-7; Cahill CM, 2001, J BIOL CHEM, V276, P13402, DOI 10.1074/jbc.M010042200; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Castelletto ML, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000370; CHUNG H, FEBS LETT, V584, P3609; GAO X, 2008, INT J PARASITOL; Gao X, 2009, INT J PARASITOL, V39, P407, DOI 10.1016/j.ijpara.2008.09.005; GOTTLIEB S, 1994, GENETICS, V137, P107; HAWDON JM, 1990, J PARASITOL, V76, P394, DOI 10.2307/3282673; HAWDON JM, 1993, PARASITOLOGY, V106, P163, DOI 10.1017/S0031182000074953; HAWDON JM, 1992, EXP PARASITOL, V75, P40, DOI 10.1016/0014-4894(92)90120-Y; HAWDON JM, 1991, J PARASITOL, V77, P587, DOI 10.2307/3283164; HAWDON JM, 1993, EXP PARASITOL, V77, P489, DOI 10.1006/expr.1993.1110; HAWDON JM, 1992, J PARASITOL, V78, P1036, DOI 10.2307/3283226; HOTEZ P, 1993, PARASITOL TODAY, V9, P23, DOI 10.1016/0169-4758(93)90159-D; HOTEZ P, 1990, INFECT IMMUN, V58, P3883, DOI 10.1128/IAI.58.12.3883-3892.1990; HUANG H, BIOCH BIOPHYS ACTA; Kenyon C, 2001, CELL, V105, P165, DOI 10.1016/S0092-8674(01)00306-3; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kiss JE, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-21; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Massey HC, 2006, INT J PARASITOL, V36, P347, DOI 10.1016/j.ijpara.2005.11.007; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Mukhopadhyay A, 2006, EXP GERONTOL, V41, P928, DOI 10.1016/j.exger.2006.05.020; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Narbonne P, 2009, NATURE, V457, P210, DOI 10.1038/nature07536; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Ogg S, 1998, MOL CELL, V2, P887, DOI 10.1016/S1097-2765(00)80303-2; Paradis S, 1999, GENE DEV, V13, P1438, DOI 10.1101/gad.13.11.1438; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; QIANG L, J BIOL CHEM, V285, P27396; ROGERS WP, 1963, ADV PARASIT, V1, P109, DOI 10.1016/S0065-308X(08)60503-5; Sim C, 2008, P NATL ACAD SCI USA, V105, P6777, DOI 10.1073/pnas.0802067105; Tissenbaum HA, 1998, GENETICS, V148, P703; Tsai WC, 2003, ENDOCRINOLOGY, V144, P5615, DOI 10.1210/en.2003-0481; Wolff S, 2006, CELL, V124, P1039, DOI 10.1016/j.cell.2005.12.042; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yamagata K, 2008, MOL CELL, V32, P221, DOI 10.1016/j.molcel.2008.09.013	46	13	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25996	10.1371/journal.pone.0025996	http://dx.doi.org/10.1371/journal.pone.0025996			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22016799	Green Published, gold, Green Submitted			2022-12-27	WOS:000295970300047
J	Wiskerke, J; Stoop, N; Schetters, D; Schoffelmeer, ANM; Pattij, T				Wiskerke, Joost; Stoop, Nicky; Schetters, Dustin; Schoffelmeer, Anton N. M.; Pattij, Tommy			Cannabinoid CB1 Receptor Activation Mediates the Opposing Effects of Amphetamine on Impulsive Action and Impulsive Choice	PLOS ONE			English	Article							REACTION-TIME-TASK; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; MU-OPIOID RECEPTORS; INDUCED BEHAVIORAL SENSITIZATION; NUCLEUS-ACCUMBENS CORE; ENDOCANNABINOID SYSTEM; DOPAMINE NEURONS; GENE CNR1; PREFRONTAL CORTEX; RAT-BRAIN	It is well known that acute challenges with psychostimulants such as amphetamine affect impulsive behavior. We here studied the pharmacology underlying the effects of amphetamine in two rat models of impulsivity, the 5-choice serial reaction time task (5-CSRTT) and the delayed reward task (DRT), providing measures of inhibitory control, an aspect of impulsive action, and impulsive choice, respectively. We focused on the role of cannabinoid CB1 receptor activation in amphetamine-induced impulsivity as there is evidence that acute challenges with psychostimulants activate the endogenous cannabinoid system, and CB1 receptor activity modulates impulsivity in both rodents and humans. Results showed that pretreatment with either the CB1 receptor antagonist/inverse agonist SR141716A or the neutral CB1 receptor antagonist O-2050 dose-dependently improved baseline inhibitory control in the 5-CSRTT. Moreover, both compounds similarly attenuated amphetamine-induced inhibitory control deficits, suggesting that CB1 receptor activation by endogenously released cannabinoids mediates this aspect of impulsive action. Direct CB1 receptor activation by Delta 9-Tetrahydrocannabinol (Delta 9-THC) did, however, not affect inhibitory control. Although neither SR141716A nor O-2050 affected baseline impulsive choice in the DRT, both ligands completely prevented amphetamine-induced reductions in impulsive decision making, indicating that CB1 receptor activity may decrease this form of impulsivity. Indeed, acute Delta 9-THC was found to reduce impulsive choice in a CB1 receptor-dependent way. Together, these results indicate an important, though complex role for cannabinoid CB1 receptor activity in the regulation of impulsive action and impulsive choice as well as the opposite effects amphetamine has on both forms of impulsive behavior.	[Wiskerke, Joost; Stoop, Nicky; Schetters, Dustin; Schoffelmeer, Anton N. M.; Pattij, Tommy] Vrije Univ Amsterdam Med Ctr, Dept Anat & Neurosci, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Wiskerke, J (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Anat & Neurosci, Amsterdam, Netherlands.	t.pattij@vumc.nl	Wiskerke, Joost/L-5271-2017; Stoop, Nicky/GPG-0589-2022	Wiskerke, Joost/0000-0001-5029-341X; Pattij, Tommy/0000-0002-0079-7385	Dutch Top Institute Pharma [T5-107-1]	Dutch Top Institute Pharma	This research was supported by a grant from the Dutch Top Institute Pharma (T5-107-1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Arguello PA, 2004, PSYCHOPHARMACOLOGY, V177, P141, DOI 10.1007/s00213-004-1953-0; Bizarro L, 2004, BEHAV PHARMACOL, V15, P195, DOI 10.1097/01.fbp.0000131574.61491.50; Bizarro L, 2003, PSYCHOPHARMACOLOGY, V170, P271, DOI 10.1007/s00213-003-1543-6; Caille S, 2007, J NEUROSCI, V27, P3695, DOI 10.1523/JNEUROSCI.4403-06.2007; Canals M, 2008, J BIOL CHEM, V283, P11424, DOI 10.1074/jbc.M710300200; Centonze D, 2009, NEUROLOGY, V72, P1526, DOI 10.1212/WNL.0b013e3181a2e8f6; Cheer JF, 2004, J NEUROSCI, V24, P4393, DOI 10.1523/JNEUROSCI.0529-04.2004; Clark L, 2009, J PSYCHOPHARMACOL, V23, P14, DOI 10.1177/0269881108089587; COLE BJ, 1987, PSYCHOPHARMACOLOGY, V91, P458, DOI 10.1007/BF00216011; COLE BJ, 1989, BEHAV BRAIN RES, V33, P165, DOI 10.1016/S0166-4328(89)80048-8; Coull JT, 2011, NEUROPSYCHOPHARMACOL, V36, P3, DOI 10.1038/npp.2010.113; Dalley JW, 2007, SCIENCE, V315, P1267, DOI 10.1126/science.1137073; Dalley JW, 2011, NEURON, V69, P680, DOI 10.1016/j.neuron.2011.01.020; Dalley JW, 2005, NEUROPSYCHOPHARMACOL, V30, P525, DOI 10.1038/sj.npp.1300590; de Bruin NMWJ, 2011, BEHAV BRAIN RES, V217, P408, DOI 10.1016/j.bbr.2010.11.013; De Vries TJ, 2001, NAT MED, V7, P1151, DOI 10.1038/nm1001-1151; de Wit H, 2002, NEUROPSYCHOPHARMACOL, V27, P813, DOI 10.1016/S0893-133X(02)00343-3; Di Marzo V, 2009, INT J OBESITY, V33, pS18, DOI 10.1038/ijo.2009.67; Egerton A, 2006, NEUROSCI BIOBEHAV R, V30, P680, DOI 10.1016/j.neubiorev.2005.12.002; Ehlers CL, 2007, TWIN RES HUM GENET, V10, P805, DOI 10.1375/twin.10.6.805; Elia J, 1999, NEW ENGL J MED, V340, P780, DOI 10.1056/NEJM199903113401007; Evenden JL, 1999, PSYCHOPHARMACOLOGY, V146, P348, DOI 10.1007/PL00005481; Fernandez-Ruiz J, 2009, BRIT J PHARMACOL, V156, P1029, DOI 10.1111/j.1476-5381.2008.00088.x; Fillmore MT, 2003, DRUG ALCOHOL DEPEN, V71, P143, DOI 10.1016/S0376-8716(03)00089-9; Gardner A, 2006, EUR J PHARMACOL, V530, P103, DOI 10.1016/j.ejphar.2005.11.032; Giuffrida A, 1999, NAT NEUROSCI, V2, P358, DOI 10.1038/7268; Grottick AJ, 2000, BEHAV BRAIN RES, V117, P197, DOI 10.1016/S0166-4328(00)00305-3; Haj-Dahmane S, 2011, NEUROPHARMACOLOGY, V61, P414, DOI 10.1016/j.neuropharm.2011.02.016; Han CJ, 2001, BEHAV NEUROSCI, V115, P243, DOI 10.1037/0735-7044.115.1.243; Harrison AA, 1997, PSYCHOPHARMACOLOGY, V133, P329, DOI 10.1007/s002130050410; Heifets BD, 2009, ANNU REV PHYSIOL, V71, P283, DOI 10.1146/annurev.physiol.010908.163149; HERKENHAM M, 1990, P NATL ACAD SCI USA, V87, P1932, DOI 10.1073/pnas.87.5.1932; Hojo M, 2008, J PHARMACOL SCI, V108, P308, DOI 10.1254/jphs.08244FP; Iversen L, 2003, BRAIN, V126, P1252, DOI 10.1093/brain/awg143; Kutcher S, 2004, EUR NEUROPSYCHOPHARM, V14, P11, DOI 10.1016/S0924-977X(03)00045-2; Lu AT, 2008, AM J MED GENET B, V147B, P1488, DOI 10.1002/ajmg.b.30693; Lupica CR, 2005, NEUROPHARMACOLOGY, V48, P1105, DOI 10.1016/j.neuropharm.2005.03.016; MAILLEUX P, 1992, NEUROSCIENCE, V48, P655, DOI 10.1016/0306-4522(92)90409-U; McDonald J, 2003, NEUROPSYCHOPHARMACOL, V28, P1356, DOI 10.1038/sj.npp.1300176; Melis M, 2004, J NEUROSCI, V24, P53, DOI 10.1523/JNEUROSCI.4503-03.2004; Melis M, 2004, J NEUROSCI, V24, P10707, DOI 10.1523/JNEUROSCI.3502-04.2004; Mendiguren A, 2007, NEUROPHARMACOLOGY, V52, P617, DOI 10.1016/j.neuropharm.2006.09.004; Moeller FG, 2001, AM J PSYCHIAT, V158, P1783, DOI 10.1176/appi.ajp.158.11.1783; Patel S, 2003, J PHARMACOL EXP THER, V306, P880, DOI 10.1124/jpet.103.054270; Paterson NE, 2011, NEUROSCI RES, V69, P41, DOI 10.1016/j.neures.2010.10.001; Pattij T, 2008, EUR J PHARMACOL, V585, P458, DOI 10.1016/j.ejphar.2008.02.099; Pattij T, 2008, TRENDS PHARMACOL SCI, V29, P192, DOI 10.1016/j.tips.2008.01.002; Pattij T, 2007, PSYCHOPHARMACOLOGY, V193, P85, DOI 10.1007/s00213-007-0773-4; Pattij T, 2007, PSYCHOPHARMACOLOGY, V191, P587, DOI 10.1007/s00213-006-0533-x; Pertwee RG, 2010, PHARMACOL REV, V62, P588, DOI 10.1124/pr.110.003004; Pertwee RG, 2010, CURR MED CHEM, V17, P1360, DOI 10.2174/092986710790980050; Pertwee RG, 2006, INT J OBESITY, V30, pS13, DOI 10.1038/sj.ijo.0803272; Pertwee RG, 2005, LIFE SCI, V76, P1307, DOI 10.1016/j.lfs.2004.10.025; Ponce G, 2003, MOL PSYCHIATR, V8, P466, DOI 10.1038/sj.mp.4001278; PRYOR GT, 1978, PHARMACOL BIOCHEM BE, V8, P295, DOI 10.1016/0091-3057(78)90320-9; Ramaekers JG, 2009, J PSYCHOPHARMACOL, V23, P266, DOI 10.1177/0269881108092393; Ramaekers JG, 2006, NEUROPSYCHOPHARMACOL, V31, P2296, DOI 10.1038/sj.npp.1301068; Robbins TW, 2002, PSYCHOPHARMACOLOGY, V163, P362, DOI 10.1007/s00213-002-1154-7; Robledo P, 2008, ADDICT BIOL, V13, P213, DOI 10.1111/j.1369-1600.2008.00107.x; Schlicker E, 2001, TRENDS PHARMACOL SCI, V22, P565, DOI 10.1016/S0165-6147(00)01805-8; Schoffelmeer ANM, 2006, NEUROPHARMACOLOGY, V51, P773, DOI 10.1016/j.neuropharm.2006.05.019; Skelly MJ, 2010, PHARMACOL BIOCHEM BE, V97, P144, DOI 10.1016/j.pbb.2010.05.024; Solinas M, 2008, BRIT J PHARMACOL, V154, P369, DOI 10.1038/bjp.2008.130; Solinas M, 2007, J PHARMACOL EXP THER, V321, P370, DOI 10.1124/jpet.106.114124; Solowij N, 2007, J PSYCHIATR NEUROSCI, V32, P30; Sonuga-Barke EJS, 2002, BEHAV BRAIN RES, V130, P29, DOI 10.1016/S0166-4328(01)00432-6; Sonuga-Barke EJS, 2005, BIOL PSYCHIAT, V57, P1231, DOI 10.1016/j.biopsych.2004.09.008; Sugiura T, 2002, PROSTAG LEUKOTR ESS, V66, P173, DOI 10.1054/plef.2001.0356; Tanda G, 1997, SCIENCE, V276, P2048, DOI 10.1126/science.276.5321.2048; Taylor KM, 2007, BEHAV PROCESS, V74, P168, DOI 10.1016/j.beproc.2006.11.005; Thiemann G, 2008, PHARMACOL BIOCHEM BE, V89, P384, DOI 10.1016/j.pbb.2008.01.010; Thiemann G, 2008, BEHAV BRAIN RES, V187, P289, DOI 10.1016/j.bbr.2007.09.022; Tzavara ET, 2009, EUR NEUROPSYCHOPHARM, V19, P196, DOI 10.1016/j.euroneuro.2008.11.003; Tzavara ET, 2003, BRIT J PHARMACOL, V138, P544, DOI 10.1038/sj.bjp.0705100; van Gaalen MM, 2006, PSYCHOPHARMACOLOGY, V187, P73, DOI 10.1007/s00213-006-0396-1; van Gaalen MM, 2009, BEHAV PHARMACOL, V20, P484, DOI 10.1097/FBP.0b013e3283305e3b; van Gaalen MM, 2006, BIOL PSYCHIAT, V60, P66, DOI 10.1016/j.biopsych.2005.06.005; Wade TR, 2000, PSYCHOPHARMACOLOGY, V150, P90; Wiley JL, 2011, EUR J PHARMACOL, V651, P96, DOI 10.1016/j.ejphar.2010.10.085; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545; Winstanley CA, 2005, NEUROPSYCHOPHARMACOL, V30, P669, DOI 10.1038/sj.npp.1300610; Winstanley CA, 2003, PSYCHOPHARMACOLOGY, V170, P320, DOI 10.1007/s00213-003-1546-3; Winstanley CA, 2006, CLIN PSYCHOL REV, V26, P379, DOI 10.1016/j.cpr.2006.01.001; Winstanley CA, 2011, BRIT J PHARMACOL, V164, P1301, DOI 10.1111/j.1476-5381.2011.01323.x; Winstanley CA, 2010, ALCOHOL CLIN EXP RES, V34, P1306, DOI 10.1111/j.1530-0277.2010.01215.x; Wiskerke J, 2008, ADDICT BIOL, V13, P225, DOI 10.1111/j.1369-1600.2008.00109.x; Wiskerke J, 2011, J NEUROSCI, V31, P262, DOI 10.1523/JNEUROSCI.4794-10.2011; Zacny JP, 2009, PHARMACOL BIOCHEM BE, V94, P108, DOI 10.1016/j.pbb.2009.07.010	89	48	49	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25856	10.1371/journal.pone.0025856	http://dx.doi.org/10.1371/journal.pone.0025856			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22016780	Green Published, gold			2022-12-27	WOS:000295970300033
J	De Ridder, D; Vanneste, S; Congedo, M				De Ridder, Dirk; Vanneste, Sven; Congedo, Marco			The Distressed Brain: A Group Blind Source Separation Analysis on Tinnitus	PLOS ONE			English	Article							DEFAULT-MODE NETWORK; POSTTRAUMATIC-STRESS-DISORDER; ACTIVITY FLUCTUATIONS; CINGULATE CORTEX; VERBAL MEMORY; RESTING-STATE; PAIN; PERCEPTION; MECHANISMS; REGIONS	Background: Tinnitus, the perception of a sound without an external sound source, can lead to variable amounts of distress. Methodology: In a group of tinnitus patients with variable amounts of tinnitus related distress, as measured by the Tinnitus Questionnaire (TQ), an electroencephalography (EEG) is performed, evaluating the patients' resting state electrical brain activity. This resting state electrical activity is compared with a control group and between patients with low (N = 30) and high distress (N = 25). The groups are homogeneous for tinnitus type, tinnitus duration or tinnitus laterality. A group blind source separation (BSS) analysis is performed using a large normative sample (N = 84), generating seven normative components to which high and low tinnitus patients are compared. A correlation analysis of the obtained normative components' relative power and distress is performed. Furthermore, the functional connectivity as reflected by lagged phase synchronization is analyzed between the brain areas defined by the components. Finally, a group BSS analysis on the Tinnitus group as a whole is performed. Conclusions: Tinnitus can be characterized by at least four BSS components, two of which are posterior cingulate based, one based on the subgenual anterior cingulate and one based on the parahippocampus. Only the subgenual component correlates with distress. When performed on a normative sample, group BSS reveals that distress is characterized by two anterior cingulate based components. Spectral analysis of these components demonstrates that distress in tinnitus is related to alpha and beta changes in a network consisting of the subgenual anterior cingulate cortex extending to the pregenual and dorsal anterior cingulate cortex as well as the ventromedial prefrontal cortex/orbitofrontal cortex, insula, and parahippocampus. This network overlaps partially with brain areas implicated in distress in patients suffering from pain, functional somatic syndromes and posttraumatic stress disorder, and might therefore represent a specific distress network.	[De Ridder, Dirk; Vanneste, Sven] Univ Antwerp Hosp, TRI, Antwerp, Belgium; [De Ridder, Dirk; Vanneste, Sven] Univ Antwerp Hosp, Dept Neurosurg, Antwerp, Belgium; [Congedo, Marco] Grenoble Univ, Natl Ctr Sci Res, Team ViBS Vis & Brain Signal Proc, GIPSA Lab, Grenoble, France	University of Antwerp; University of Antwerp; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS)	De Ridder, D (corresponding author), Univ Antwerp Hosp, TRI, Antwerp, Belgium.	dirk.de.ridder@uza.be		Vanneste, Sven/0000-0003-1513-5752				ALSTER J, 1993, BIOL PSYCHIAT, V34, P84, DOI 10.1016/0006-3223(93)90260-K; Axelsson Alf, 2000, Noise Health, V2, P47; Baguley DM, 2002, BRIT MED BULL, V63, P195, DOI 10.1093/bmb/63.1.195; BEARD AW, 1965, J PSYCHOSOM RES, V9, P29, DOI 10.1016/0022-3999(65)90008-5; Begic D, 2001, INT J PSYCHOPHYSIOL, V40, P167, DOI 10.1016/S0167-8760(00)00153-7; Bluhm RL, 2008, NEUROREPORT, V19, P887, DOI 10.1097/WNR.0b013e328300ebbf; Boly M, 2007, P NATL ACAD SCI USA, V104, P12187, DOI 10.1073/pnas.0611404104; Boutros NN, 2008, HIPPOCAMPUS, V18, P310, DOI 10.1002/hipo.20388; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bush G, 2002, P NATL ACAD SCI USA, V99, P523, DOI 10.1073/pnas.012470999; CLARK WW, 1991, J ACOUST SOC AM, V90, P175, DOI 10.1121/1.401285; Cohen RA, 1999, NEUROLOGY, V53, P819, DOI 10.1212/WNL.53.4.819; Congedo M, 2010, INT J PSYCHOPHYSIOL; Congedo M., 2002, EUREKA VERSION 3 0 C; Congedo M, 2010, BRAIN TOPOGR, V23, P134, DOI 10.1007/s10548-009-0113-6; Congedo M, 2008, CLIN NEUROPHYSIOL, V119, P2677, DOI 10.1016/j.clinph.2008.09.007; Cronlein T, 2007, PROG BRAIN RES, V166, P227, DOI 10.1016/S0079-6123(07)66021-X; De Ridder D, 2006, ACTA OTO-LARYNGOL, V126, P50, DOI 10.1080/03655230600895580; De Ridder D, 2011, P NATL ACAD SCI USA, V108, P8075, DOI 10.1073/pnas.1018466108; Diederen KMJ, 2010, AM J PSYCHIAT, V167, P427, DOI 10.1176/appi.ajp.2009.09040456; Dille MF, 2010, J AM ACAD AUDIOL, V21, P409, DOI 10.3766/jaaa.21.6.6; Dobie RA, 2003, OTOLARYNG CLIN N AM, V36, P383, DOI 10.1016/S0030-6665(02)00168-8; Dobie RA, 1999, LARYNGOSCOPE, V109, P1202, DOI 10.1097/00005537-199908000-00004; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; ELITHORN A, 1954, P ROY SOC MED, V46, P832; FLETCHER PC, 1995, BRAIN, V118, P401, DOI 10.1093/brain/118.2.401; Folmer RL, 2003, LARYNGOSCOPE, V113, P821, DOI 10.1097/00005537-200305000-00010; GOEBEL G, 1994, HNO, V42, P166; GRASBY PM, 1993, BRAIN, V116, P1, DOI 10.1093/brain/116.1.1; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Hallam RS, 2004, INT J AUDIOL, V43, P218, DOI 10.1080/14992020400050030; Heller AJ, 2003, OTOLARYNG CLIN N AM, V36, P239, DOI 10.1016/S0030-6665(02)00160-3; Jokic-Begic N, 2003, NORD J PSYCHIAT, V57, P351, DOI 10.1080/08039480310002688; Kleinjung T, 2008, OTOLARYNG HEAD NECK, V138, P497, DOI 10.1016/j.otohns.2007.12.022; Kross E, 2007, J COGNITIVE NEUROSCI, V19, P945, DOI 10.1162/jocn.2007.19.6.945; Landgrebe M, 2008, NEUROIMAGE, V41, P1336, DOI 10.1016/j.neuroimage.2008.04.171; Langguth B, 2007, PROG BRAIN RES, V166, P221, DOI 10.1016/S0079-6123(07)66020-8; Laufer I, 2009, NEUROIMAGE, V44, P546, DOI 10.1016/j.neuroimage.2008.09.010; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; Lorenz I, 2009, NEUROSCI LETT, V453, P225, DOI 10.1016/j.neulet.2009.02.028; Meeus O, 2007, B-ENT, P11; Mirz F, 2000, NEUROREPORT, V11, P633, DOI 10.1097/00001756-200002280-00039; Moazami-Goudarzi M, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-40; Moisset X, 2007, NEUROIMAGE, V37, pS80, DOI 10.1016/j.neuroimage.2007.03.054; Moller A., 1994, NEUROTOLOGY, P153; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Pascual-Marqui R. D., 2007, ARXIV07111455; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Paul RH, 2007, INT J NEUROSCI, V117, P549, DOI 10.1080/00207450600773665; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Rauschecker JP, 2010, NEURON, V66, P819, DOI 10.1016/j.neuron.2010.04.032; Sadaghiani S, 2009, J NEUROSCI, V29, P13410, DOI 10.1523/JNEUROSCI.2592-09.2009; Scheeringa R, 2008, INT J PSYCHOPHYSIOL, V67, P242, DOI 10.1016/j.ijpsycho.2007.05.017; Schlee W, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-80; Schlee W, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-11; Schlee W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003720; Schmithorst VJ, 2004, J MAGN RESON IMAGING, V19, P365, DOI 10.1002/jmri.20009; Schreiber BE, 2010, LANCET, V375, P1203, DOI 10.1016/S0140-6736(09)62071-7; Shannon BJ, 2004, J NEUROSCI, V24, P10084, DOI 10.1523/JNEUROSCI.2625-04.2004; Sinha R, 2004, ANN NY ACAD SCI, V1032, P254, DOI 10.1196/annals.1314.032; Stern J, 2006, NEUROIMAGE, V31, P721, DOI 10.1016/j.neuroimage.2005.12.042; van der Loo E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007396; Vanneste S, 2011, CLIN NEUROPHYSIOL; Vanneste S, 2010, B ENT; Vanneste S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013618; Vanneste S, 2010, NEUROIMAGE, V52, P470, DOI 10.1016/j.neuroimage.2010.04.029; Vanneste S, 2010, EXP BRAIN RES, V202, P779, DOI 10.1007/s00221-010-2183-9; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a; von Leupoldt A, 2009, NEUROIMAGE, V48, P200, DOI 10.1016/j.neuroimage.2009.06.015; Waldorp LJ, 2005, IEEE T BIO-MED ENG, V52, P414, DOI 10.1109/TBME.2004.842982; Weisz N, 2007, J NEUROSCI, V27, P1479, DOI 10.1523/JNEUROSCI.3711-06.2007	72	96	98	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e24273	10.1371/journal.pone.0024273	http://dx.doi.org/10.1371/journal.pone.0024273			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834NO	21998628	Green Published, gold, Green Submitted			2022-12-27	WOS:000295968700004
J	Lindstrom, ES; Ostman, O				Lindstrom, Eva S.; Ostman, Orjan			The Importance of Dispersal for Bacterial Community Composition and Functioning	PLOS ONE			English	Article							BIODIVERSITY; PRODUCTIVITY; IMMIGRATION; DIVERSITY	We conducted a metacommunity experiment to investigate the role of dispersal for bacterial community composition (BCC) and function of freshwater bacteria. Bacteria were dispersed from a common source pool into three different lake communities in their natural lake water. The experiment was conducted in dialysis bags to enable a decoupling between a change in the local environment and dispersal. BCC was determined by terminal restriction fragment length polymorphism (tRFLP) of the 16S rRNA gene. We show that the greatest changes in BCC occurred between 10% and 43% of dispersal of standing stock per day. Functioning, measured as growth rate, was also affected by dispersal in all three communities but the qualitative pattern differed between communities, sometimes showing a hump-shaped relationship to dispersal and sometimes decreasing with increasing dispersal. In all waters, functioning was related to BCC. Our results show that dispersal does affect BCC and functioning but that high dispersal rates are needed. Further, the effect of dispersal on BCC and function seem to depend on the quality of the habitat to which bacteria disperse into.	[Lindstrom, Eva S.] Uppsala Univ, Dept Ecol & Genet Limnol, Uppsala, Sweden; [Ostman, Orjan] Uppsala Univ, Dept Ecol & Genet Populat Biol, Uppsala, Sweden	Uppsala University; Uppsala University	Lindstrom, ES (corresponding author), Uppsala Univ, Dept Ecol & Genet Limnol, Uppsala, Sweden.	Eva.Lindstrom@ebc.uu.se	LindstrÃm, Eva/H-5930-2016; Östman, Örjan/ABF-8714-2020	LindstrÃm, Eva/0000-0001-8920-3071; Östman, Örjan/0000-0002-1930-0148	Swedish Research Council [2009-5172, 2005-5307, 2007-5932]; Olsson-Borgh foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Olsson-Borgh foundation	This study was financed by a grant from the Olsson-Borgh foundation to the authors, and by one grant each to both authors from the Swedish Research Council (contract number 2009-5172 (ESL), 2005-5307 and 2007-5932 (OO)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Bell T, 2005, NATURE, V436, P1157, DOI 10.1038/nature03891; Bertilsson S, 2007, ISME J, V1, P532, DOI 10.1038/ismej.2007.64; Bond EM, 2002, ECOL LETT, V5, P467, DOI 10.1046/j.1461-0248.2002.00350.x; Comte J, 2009, ENVIRON MICROBIOL, V11, P1704, DOI 10.1111/j.1462-2920.2009.01897.x; delGiorgio P, 1996, LIMNOL OCEANOGR, V41, P783, DOI 10.4319/lo.1996.41.4.0783; Hillebrand H., 2009, ECOL LETT, V12, P1; Hodgson DJ, 2002, P ROY SOC B-BIOL SCI, V269, P2277, DOI 10.1098/rspb.2002.2146; Jessup CM, 2004, TRENDS ECOL EVOL, V19, P189, DOI 10.1016/j.tree.2004.01.008; Jousset A, 2011, ISME J, V5, P1108, DOI 10.1038/ismej.2011.9; Langenheder S, 2005, LIMNOL OCEANOGR, V50, P957, DOI 10.4319/lo.2005.50.3.0957; Langenheder S, 2006, APPL ENVIRON MICROB, V72, P212, DOI 10.1128/AEM.72.1.212-220.2006; Legendre P., 2012, NUMERICAL ECOLOGY; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Lindstrom ES, 2006, LIMNOL OCEANOGR, V51, P339, DOI 10.4319/lo.2006.51.1.0339; Lindstrom ES, 2010, LIMNOL OCEANOGR, V55, P2052, DOI 10.4319/lo.2010.55.5.2052; Logue JB, 2010, ISME J, V4, P729, DOI 10.1038/ismej.2009.156; Loreau M, 2003, P NATL ACAD SCI USA, V100, P12765, DOI 10.1073/pnas.2235465100; Loreau M, 1999, AM NAT, V154, P427, DOI 10.1086/303252; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Matthiessen B, 2006, ECOL LETT, V9, P652, DOI 10.1111/j.1461-0248.2006.00916.x; Matthiessen B, 2010, HYDROBIOLOGIA, V653, P65, DOI 10.1007/s10750-010-0349-x; Mouquet N, 2003, AM NAT, V162, P544, DOI 10.1086/378857; Mouquet N, 2002, ECOL LETT, V5, P56, DOI 10.1046/j.1461-0248.2002.00281.x; Nelson CE, 2009, LIMNOL OCEANOGR, V54, P1292, DOI 10.4319/lo.2009.54.4.1292; Ostman O, 2010, ECOL LETT, V13, P118, DOI 10.1111/j.1461-0248.2009.01413.x; Simek K, 2001, APPL ENVIRON MICROB, V67, P2723, DOI 10.1128/AEM.67.6.2723-2733.2001; Sloan WT, 2006, ENVIRON MICROBIOL, V8, P732, DOI 10.1111/j.1462-2920.2005.00956.x; Smith David C., 1992, Marine Microbial Food Webs, V6, P107; Sobek S, 2003, GLOBAL CHANGE BIOL, V9, P630, DOI 10.1046/j.1365-2486.2003.00619.x; Strickland MS, 2009, ECOLOGY, V90, P441, DOI 10.1890/08-0296.1; Van der Gucht K, 2007, P NATL ACAD SCI USA, V104, P20404, DOI 10.1073/pnas.0707200104; Venail PA, 2008, NATURE, V452, P210, DOI 10.1038/nature06554; Wu FC, 2003, BIOGEOCHEMISTRY, V65, P245, DOI 10.1023/A:1026074318377	35	65	65	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e25883	10.1371/journal.pone.0025883	http://dx.doi.org/10.1371/journal.pone.0025883			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998714	Green Published, Green Submitted, gold			2022-12-27	WOS:000295968700024
J	Merhi, F; Tang, RP; Piedfer, M; Mathieu, J; Bombarda, I; Zaher, M; Kolb, JP; Billard, C; Bauvois, B				Merhi, Faten; Tang, Ruoping; Piedfer, Marion; Mathieu, Julie; Bombarda, Isabelle; Zaher, Murhaf; Kolb, Jean-Pierre; Billard, Christian; Bauvois, Brigitte			Hyperforin Inhibits Akt1 Kinase Activity and Promotes Caspase-Mediated Apoptosis Involving Bad and Noxa Activation in Human Myeloid Tumor Cells	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; FACTOR-KAPPA-B; HYPERICUM-PERFORATUM; PHOSPHATIDYLINOSITOL 3-KINASE; ANTIINFLAMMATORY COMPOUNDS; DOWN-REGULATION; GENE-PRODUCTS; PLANT-ORIGIN; DNA-DAMAGE; IN-VITRO	Background: The natural phloroglucinol hyperforin HF displays anti-inflammatory and anti-tumoral properties of potential pharmacological interest. Acute myeloid leukemia (AML) cells abnormally proliferate and escape apoptosis. Herein, the effects and mechanisms of purified HF on AML cell dysfunction were investigated in AML cell lines defining distinct AML subfamilies and primary AML cells cultured ex vivo. Methodology and Results: HF inhibited in a time-and concentration-dependent manner the growth of AML cell lines (U937, OCI-AML3, NB4, HL-60) by inducing apoptosis as evidenced by accumulation of sub-G1 population, phosphatidylserine externalization and DNA fragmentation. HF also induced apoptosis in primary AML blasts, whereas normal blood cells were not affected. The apoptotic process in U937 cells was accompanied by downregulation of antiapoptotic Bcl-2, upregulation of pro-apoptotic Noxa, mitochondrial membrane depolarization, activation of procaspases and cleavage of the caspase substrate PARP-1. The general caspase inhibitor Z-VAD-fmk and the caspase-9- and -3-specific inhibitors, but not caspase-8 inhibitor, significantly attenuated apoptosis. HF-mediated apoptosis was associated with dephosphorylation of active Akt1 (at Ser(473)) and Akt1 substrate Bad (at Ser(136)) which activates Bad pro-apoptotic function. HF supppressed the kinase activity of Akt1, and combined treatment with the allosteric Akt1 inhibitor Akt-I-VIII significantly enhanced apoptosis of U937 cells. Significance: Our data provide new evidence that HF's pro-apoptotic effect in AML cells involved inhibition of Akt1 signaling, mitochondria and Bcl-2 members dysfunctions, and activation of procaspases -9/-3. Combined interruption of mitochondrial and Akt1 pathways by HF may have implications for AML treatment.	[Merhi, Faten; Tang, Ruoping; Piedfer, Marion; Zaher, Murhaf; Kolb, Jean-Pierre; Billard, Christian; Bauvois, Brigitte] Univ Paris 05, Univ Paris 06, Ctr Rech Cordeliers, INSERM U872, Paris, France; [Tang, Ruoping] Hop St Antoine, AP HP, Dept Hematol, F-75571 Paris, France; [Mathieu, Julie] Hop St Louis, INSERM U685, Paris, France; [Bombarda, Isabelle] Univ Paul Cezanne, CNRS, ISM2 AD2M, UMR 6263, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Merhi, F (corresponding author), Univ Paris 05, Univ Paris 06, Ctr Rech Cordeliers, INSERM U872, Paris, France.	brigitte.bauvois@crc.jussieu.fr	Bauvois, Brigitte/F-6776-2013	Bauvois, Brigitte/0000-0002-1751-6922	Institut National de la Sante et de la Recherche Medicale; Ligue contre le Cancer (Comite de Paris; Servier Institute (Neuilly-sur-Seine, France); Societe Francaise d'Hematologie (Paris, France)	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Ligue contre le Cancer (Comite de Paris(Ligue nationale contre le cancer); Servier Institute (Neuilly-sur-Seine, France); Societe Francaise d'Hematologie (Paris, France)	This work was supported by grants from the Institut National de la Sante et de la Recherche Medicale and the Ligue contre le Cancer (Comite de Paris. Faten Merhi was funded by Servier Institute (Neuilly-sur-Seine, France) and Societe Francaise d'Hematologie (Paris, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afanasyeva EA, 2007, INT J CANCER, V121, P2615, DOI 10.1002/ijc.22974; Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; Bailly C, 2009, BIOCHEM PHARMACOL, V77, P1447, DOI 10.1016/j.bcp.2008.12.013; Barnett SF, 2005, BIOCHEM J, V385, P399, DOI 10.1042/BJ20041140; Bauvois B, 1996, EXP CELL RES, V222, P209, DOI 10.1006/excr.1996.0026; Bhardwaj A, 2007, BLOOD, V109, P2293, DOI 10.1182/blood-2006-02-003988; Billen LP, 2008, ONCOGENE, V27, pS93, DOI 10.1038/onc.2009.47; Borrelli F, 2009, AAPS J, V11, P710, DOI 10.1208/s12248-009-9146-8; Braun T, 2006, CELL DEATH DIFFER, V13, P748, DOI 10.1038/sj.cdd.4401874; Bremer E, 2006, TRENDS MOL MED, V12, P382, DOI 10.1016/j.molmed.2006.06.002; Calixto JB, 2003, PLANTA MED, V69, P973, DOI [10.1055/s-2003-45141, 10.1055/s-2004-815483]; Calixto Joao B., 2004, Planta Medica, V70, P93, DOI 10.1055/s-2004-815483; Calleja V, 2009, PLOS BIOL, V7, P189, DOI 10.1371/journal.pbio.1000017; Carter BZ, 2008, BLOOD, V111, P3742, DOI 10.1182/blood-2007-05-091504; Chapuis N, 2010, LEUKEMIA, V24, P1686, DOI 10.1038/leu.2010.170; Cilloni D, 2007, HAEMATOLOGICA, V92, P1224, DOI 10.3324/haematol.11199; Cristobal I, 2011, LEUKEMIA, V25, P606, DOI 10.1038/leu.2010.294; Dai Y, 2004, BLOOD, V104, P509, DOI 10.1182/blood-2003-12-4121; Dalle S, 2011, CURR MOL PHARM; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Decker RH, 2002, CANCER BIOL THER, V1, P136, DOI 10.4161/cbt.58; Dell'Aica I, 2007, CLIN CHIM ACTA, V381, P69, DOI 10.1016/j.cca.2007.02.022; Duncan JS, 2010, BBA-PROTEINS PROTEOM, V1804, P505, DOI 10.1016/j.bbapap.2009.11.001; Feisst C, 2009, CELL MOL LIFE SCI, V66, P2759, DOI 10.1007/s00018-009-0078-3; Fourneron JD, 2006, PHYTOCHEM ANALYSIS, V17, P71, DOI 10.1002/pca.888; Giles FJ, 2005, CURR MOL MED, V5, P653, DOI 10.2174/156652405774641034; Griffith TN, 2010, CURR MED CHEM, V17, P391, DOI 10.2174/092986710790226156; Guan LY, 2008, BMB REP, V41, P745, DOI 10.5483/BMBRep.2008.41.10.745; Hers I, 2011, CELL SIGNAL IN PRESS; Hostanska K, 2003, EUR J PHARM BIOPHARM, V56, P121, DOI 10.1016/S0939-6411(03)00046-8; Kharas MG, 2010, BLOOD, V115, P1406, DOI 10.1182/blood-2009-06-229443; KIM YR, 1991, LEUKEMIA RES, V15, P409, DOI 10.1016/0145-2126(91)90050-4; King ME, 2007, ONCOLOGIST, V12, P14, DOI 10.1634/theoncologist.12-S2-14; Komeno Y, 2009, J CELL PHYSIOL, V219, P529, DOI 10.1002/jcp.21739; LANOTTE M, 1991, BLOOD, V77, P1080; Liao Y, 2010, AM J TRANSL RES, V2, P19; Liu JY, 2011, CHEM-BIOL INTERACT, V190, P91, DOI 10.1016/j.cbi.2011.02.026; Lorusso G, 2009, EUR J CANCER, V45, P1474, DOI 10.1016/j.ejca.2009.01.014; Lucas DM, 2009, BLOOD, V113, P4656, DOI 10.1182/blood-2008-09-175430; Maddika S, 2007, DRUG RESIST UPDATE, V10, P13, DOI 10.1016/j.drup.2007.01.003; Martelli AM, 2006, LEUKEMIA, V20, P911, DOI 10.1038/sj.leu.2404245; Martelli AM, 2007, EUR J HISTOCHEM, V51, P125; Martelli AM, 2009, EXPERT OPIN INV DRUG, V18, P1333, DOI 10.1517/14728220903136775; Mason KD, 2006, BLOOD REV, V20, P71, DOI 10.1016/j.blre.2005.08.002; Mathieu J, 2005, ONCOGENE, V24, P7145, DOI 10.1038/sj.onc.1208889; Medina MA, 2006, LIFE SCI, V79, P105, DOI 10.1016/j.lfs.2005.12.027; Meuillet EJ, 2011, CURR MED CH IN PRESS; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Newcomb EW, 2004, ANTI-CANCER DRUG, V15, P411, DOI 10.1097/01.cad.0000127332.06439.47; Park C, 2008, TOXICOL APPL PHARM, V227, P219, DOI 10.1016/j.taap.2007.10.003; Peng A, 2010, ONCOGENE, V29, P5977, DOI 10.1038/onc.2010.371; Plesa C, 2008, CANCER-AM CANCER SOC, V112, P572, DOI 10.1002/cncr.23219; Ploner C, 2008, ONCOGENE, V27, pS84, DOI 10.1038/onc.2009.46; Qin JZ, 2004, MOL CANCER THER, V3, P895; Quentmeier H, 2005, LEUKEMIA, V19, P1760, DOI 10.1038/sj.leu.2403899; Quiney C, 2006, LEUKEMIA, V20, P1519, DOI 10.1038/sj.leu.2404301; Quiney C, 2006, LEUKEMIA, V20, P491, DOI 10.1038/sj.leu.2404098; Quiney C, 2007, LEUKEMIA LYMPHOMA, V48, P1587, DOI 10.1080/10428190701474332; Rosato RR, 2007, MOL CANCER THER, V6, P692, DOI 10.1158/1535-7163.MCT-06-0562; Rothley M, 2009, INT J CANCER, V125, P34, DOI 10.1002/ijc.24295; Sanceau J, 2002, J BIOL CHEM, V277, P35766, DOI 10.1074/jbc.M202959200; Scaffidi C, 1999, J BIOL CHEM, V274, P22532, DOI 10.1074/jbc.274.32.22532; Schulz HU, 2005, ARZNEIMITTELFORSCH, V55, P15; Sedlacek HH, 2001, CRIT REV ONCOL HEMAT, V38, P139, DOI 10.1016/S1040-8428(00)00124-4; Song G, 2010, CURR CANCER DRUG TAR, V10, P584, DOI 10.2174/156800910791859515; Sonneveld P, 2001, BEST PRACT RES CL HA, V14, P211, DOI 10.1053/beha.2000.0124; Stankovic T, 2004, BLOOD, V103, P291, DOI 10.1182/blood-2003-04-1161; Stock Wendy, 2006, Hematology Am Soc Hematol Educ Program, P185; Stoddart A, 2011, ONCOGENE; SUGIMOTO K, 1992, BLOOD, V79, P2378, DOI 10.1182/blood.V79.9.2378.2378; Takada Y, 2004, J BIOL CHEM, V279, P4750, DOI 10.1074/jbc.M304546200; Takada Y, 2008, MOL PHARMACOL, V73, P1549, DOI 10.1124/mol.107.041350; Trayner ID, 1998, LEUKEMIA RES, V22, P537, DOI 10.1016/S0145-2126(98)00041-1; Wang ZB, 2005, CELL BIOL INT, V29, P489, DOI 10.1016/j.cellbi.2005.04.001; Wurglics M, 2006, CLIN PHARMACOKINET, V45, P449, DOI 10.2165/00003088-200645050-00002; Yamamoto M, 1999, LEUKEMIA, V13, P595, DOI 10.1038/sj.leu.2401372; Zaher M, 2009, LEUKEMIA, V23, P594, DOI 10.1038/leu.2008.239; Zanoli P, 2004, CNS DRUG REV, V10, P203; Zeng ZH, 2007, BLOOD, V109, P3509, DOI 10.1182/blood-2006-06-030833; Zhao S, 2004, LEUKEMIA, V18, P267, DOI 10.1038/sj.leu.2403220	80	45	46	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e25963	10.1371/journal.pone.0025963	http://dx.doi.org/10.1371/journal.pone.0025963			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998731	Green Published, gold, Green Submitted			2022-12-27	WOS:000295968700027
J	Bouletreau, S; Cucherousset, J; Villeger, S; Masson, R; Santoul, F				Bouletreau, Stephanie; Cucherousset, Julien; Villeger, Sebastien; Masson, Remi; Santoul, Frederic			Colossal Aggregations of Giant Alien Freshwater Fish as a Potential Biogeochemical Hotspot	PLOS ONE			English	Article							CATFISH SILURUS-GLANIS; PHOSPHORUS; ECOLOGY	The ubiquity and fascinating nature of animal aggregations are widely recognised. We report here consistent and previously undocumented occurences of aggregations of a giant alien freshwater fish, the Wels catfish (Silurus glanis). Aggregative groups were on average composed of 25 (+/- 10 SD, ranging from 15 to 44) adults with estimated average total biomass of 651 kg (386 - 1132) and biomass density of 23 kg m(-2) (14 - 40). Aggregations always occurred within the same location. No foraging, reproductive or anti-predator behaviour were observed during the aggregations. A mass-balance model estimated that these colossal aggregations of an alien species can locally release, through excretion only, up to 70 mg P m(-2) h(-1) and 400 mg N m(-2) h(-1), potentially representing the highest biogeochemical hotspots reported in freshwater ecosystems and another unexpected ecological effect of alien species.	[Bouletreau, Stephanie; Masson, Remi; Santoul, Frederic] Univ Toulouse, UPS, INP, UMR EcoLab Lab Ecol Fonct & Environm 5245, Toulouse, France; [Bouletreau, Stephanie; Santoul, Frederic] CNRS, EcoLab, Toulouse, France; [Cucherousset, Julien; Villeger, Sebastien] CNRS, UPS, ENFA, UMR EDB Lab Evolut & Divers Biol 5174, Toulouse, France; [Cucherousset, Julien; Villeger, Sebastien] Univ Toulouse, UPS, UMR EDB 5174, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA)	Bouletreau, S (corresponding author), Univ Toulouse, UPS, INP, UMR EcoLab Lab Ecol Fonct & Environm 5245, Toulouse, France.	santoul@cict.fr	Villéger, Sébastien/AAW-9949-2021; Cucherousset, Julien/B-5709-2011; Bouletreau, Stephanie/T-2915-2019; Villéger, Sébastien/C-6272-2011	Villéger, Sébastien/0000-0002-2362-7178; Villéger, Sébastien/0000-0002-2362-7178; Santoul, Frederic/0000-0002-2932-2172; Bouletreau, Stephanie/0000-0002-0094-0196; Cucherousset, Julien/0000-0003-0533-9479				Alp A, 2011, REV FISH BIOL FISHER, V21, P283, DOI 10.1007/s11160-010-9168-4; Britton JR, 2007, FISHERIES MANAG ECOL, V14, P263, DOI 10.1111/j.1365-2400.2007.00554.x; Copp GH, 2009, FISH FISH, V10, P252, DOI 10.1111/j.1467-2979.2008.00321.x; Cucherousset J, 2011, FISHERIES, V36, P215, DOI 10.1080/03632415.2011.574578; DAVIS JA, 1978, T AM FISH SOC, V107, P862, DOI 10.1577/1548-8659(1978)107<862:COSEAA>2.0.CO;2; Groves TDD, 1979, FISH PHYSL, VVII; Hanson P. C., 1997, WISCUT97001 U WISC S; Krause J, 2002, LIVING GROUPS; Krone R, 2008, CORAL REEFS, V27, P619, DOI 10.1007/s00338-008-0365-8; McIntyre PB, 2008, ECOLOGY, V89, P2335, DOI 10.1890/07-1552.1; MEYER JL, 1983, SCIENCE, V220, P1047, DOI 10.1126/science.220.4601.1047; NAKASHIMA BS, 1980, CAN J FISH AQUAT SCI, V37, P1540, DOI 10.1139/f80-199; NAKASHIMA BS, 1980, CAN J FISH AQUAT SCI, V37, P679, DOI 10.1139/f80-085; Parrish JK, 1999, SCIENCE, V284, P99, DOI 10.1126/science.284.5411.99; PENCZAK T, 1985, HYDROBIOLOGIA, V120, P159, DOI 10.1007/BF00032137; PITCHER TJ, 1983, ANIM BEHAV, V31, P611, DOI 10.1016/S0003-3472(83)80087-6; Schaus MH, 1997, LIMNOL OCEANOGR, V42, P1386, DOI 10.4319/lo.1997.42.6.1386; Schindler DE, 2003, FRONT ECOL ENVIRON, V1, P31, DOI 10.1890/1540-9295(2003)001[0031:PSATEO]2.0.CO;2; Stone R, 2007, SCIENCE, V316, P1684, DOI 10.1126/science.316.5832.1684; Syvaranta J, 2010, AQUAT BIOL, V8, P137, DOI 10.3354/ab00220	20	26	26	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25732	10.1371/journal.pone.0025732	http://dx.doi.org/10.1371/journal.pone.0025732			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998687	Green Submitted, gold, Green Published			2022-12-27	WOS:000295966900048
J	Ferrara, F; Listwan, P; Waldo, GS; Bradbury, ARM				Ferrara, Fortunato; Listwan, Pawel; Waldo, Geoffrey S.; Bradbury, Andrew R. M.			Fluorescent Labeling of Antibody Fragments Using Split GFP	PLOS ONE			English	Article							LINKED IMMUNOSORBENT-ASSAY; RECOMBINANT-ANTIBODIES; MONOCLONAL-ANTIBODIES; ESCHERICHIA-COLI; FUSION PROTEINS; PHAGE; PHOSPHATASE; LIBRARIES; AFFINITY; ANTIGEN	Antibody fragments are easily isolated from in vitro selection systems, such as phage and yeast display. Lacking the Fc portion of the antibody, they are usually labeled using small peptide tags recognized by antibodies. In this paper we present an efficient method to fluorescently label single chain Fvs (scFvs) using the split green fluorescent protein (GFP) system. A 13 amino acid tag, derived from the last beta strand of GFP (termed GFP11), is fused to the C terminus of the scFv. This tag has been engineered to be non-perturbing, and we were able to show that it exerted no effect on scFv expression or functionality when compared to a scFv without the GFP11 tag. Effective functional fluorescent labeling is demonstrated in a number of different assays, including fluorescence linked immunosorbant assays, flow cytometry and yeast display. Furthermore, we were able to show that this split GFP system can be used to determine the concentration of scFv in crude samples, as well an estimate of antibody affinity, without the need for antibody purification. We anticipate this system will be of widespread interest in antibody engineering and in vitro display systems.	[Ferrara, Fortunato; Listwan, Pawel; Waldo, Geoffrey S.; Bradbury, Andrew R. M.] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM USA	United States Department of Energy (DOE); Los Alamos National Laboratory	Ferrara, F (corresponding author), Los Alamos Natl Lab, Biosci Div, Los Alamos, NM USA.	amb@lanl.gov	Ferrara, Fortunato/AAD-5947-2019	Bradbury, Andrew/0000-0002-5567-8172; Ferrara, Fortunato/0000-0002-4615-035X	NIH [P50GM085273, R01-HG004852-01A1]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM085273] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by the NIH (P50GM085273 and R01-HG004852-01A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayriss J, 2007, J PROTEOME RES, V6, P1072, DOI 10.1021/pr0604108; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Bradbury ARM, 2004, J IMMUNOL METHODS, V290, P29, DOI 10.1016/j.jim.2004.04.007; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Cabantous S, 2006, NAT METHODS, V3, P845, DOI 10.1038/nmeth932; Cabantous Stephanie, 2005, Journal of Structural and Functional Genomics, V6, P113, DOI 10.1007/s10969-005-5247-5; Casey JL, 2000, PROTEIN ENG, V13, P445, DOI 10.1093/protein/13.6.445; Chang WR, 1996, J MOL BIOL, V262, P721, DOI 10.1006/jmbi.1996.0547; De Crescenzo G, 2003, BIOCHEMISTRY-US, V42, P1754, DOI 10.1021/bi0268450; England P, 1999, J IMMUNOL, V162, P2129; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Feilmeier BJ, 2000, J BACTERIOL, V182, P4068, DOI 10.1128/JB.182.14.4068-4076.2000; FOOTE J, 1992, J MOL BIOL, V224, P487, DOI 10.1016/0022-2836(92)91010-M; Griep RA, 1999, PROTEIN EXPRES PURIF, V16, P63, DOI 10.1006/prep.1999.1041; Griep RA, 1999, J IMMUNOL METHODS, V230, P121, DOI 10.1016/S0022-1759(99)00131-3; Han ZZ, 2004, COMB CHEM HIGH T SCR, V7, P55, DOI 10.2174/138620704772884823; Hanes J, 1997, P NATL ACAD SCI USA, V94, P4937, DOI 10.1073/pnas.94.10.4937; HANKE T, 1992, J GEN VIROL, V73, P653, DOI 10.1099/0022-1317-73-3-653; HARPER M, 1987, MOL IMMUNOL, V24, P97, DOI 10.1016/0161-5890(87)90081-2; HAWKINS RE, 1993, J MOL BIOL, V234, P958, DOI 10.1006/jmbi.1993.1650; Hink MA, 2000, J BIOL CHEM, V275, P17556, DOI 10.1074/jbc.M001348200; HUSTON JS, 1988, P NATL ACAD SCI USA, V85, P5879, DOI 10.1073/pnas.85.16.5879; Kaddoum L, 2010, BIOTECHNIQUES, V49, P727, DOI 10.2144/000113512; Lindner P, 1997, BIOTECHNIQUES, V22, P140, DOI 10.2144/97221rr01; Listwan Pawel, 2010, Journal of Structural and Functional Genomics, V11, P41, DOI 10.1007/s10969-009-9077-8; Listwan Pawel, 2009, Journal of Structural and Functional Genomics, V10, P47, DOI 10.1007/s10969-008-9049-4; MAGNUSSON KE, 1987, IMMUNOL INVEST, V16, P227, DOI 10.3109/08820138709030578; MARKS JD, 1991, J MOL BIOL, V222, P581, DOI 10.1016/0022-2836(91)90498-U; Morino K, 2001, J IMMUNOL METHODS, V257, P175, DOI 10.1016/S0022-1759(01)00462-8; Muller BH, 1999, J IMMUNOL METHODS, V227, P177, DOI 10.1016/S0022-1759(99)00071-X; NERI D, 1995, J MOL BIOL, V246, P367, DOI 10.1006/jmbi.1994.0091; Nizak C, 2003, SCIENCE, V300, P984, DOI 10.1126/science.1083911; Oelschlaeger P, 2002, ANAL BIOCHEM, V309, P27, DOI 10.1016/S0003-2697(02)00290-7; OI VT, 1982, J CELL BIOL, V93, P981, DOI 10.1083/jcb.93.3.981; Pavoor TV, 2009, P NATL ACAD SCI US; Pluckthun A, 1990, Behring Inst Mitt, P48; PORTER RR, 1959, BIOCHEM J, V73, P119, DOI 10.1042/bj0730119; REIMANN KA, 1994, CYTOMETRY, V17, P102, DOI 10.1002/cyto.990170113; Remy I, 2004, METHODS, V32, P381, DOI 10.1016/j.ymeth.2003.10.011; Sblattero D, 2000, NAT BIOTECHNOL, V18, P75, DOI 10.1038/71958; Siegel RW, 2003, NAT BIOTECHNOL; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; VanAntwerp JJ, 1998, J MOL RECOGNIT, V11, P10, DOI 10.1002/(SICI)1099-1352(199812)11:1/6<10::AID-JMR381>3.0.CO;2-H; VANDYKE MW, 1992, GENE, V111, P99, DOI 10.1016/0378-1119(92)90608-R; Velappan N, 2008, J IMMUNOL METHODS, V336, P135, DOI 10.1016/j.jim.2008.04.007; Wilson CG, 2004, NAT METHODS, V1, P255, DOI 10.1038/nmeth1204-255; Wingren C, 2007, PROTEOMICS, V7, P3055, DOI 10.1002/pmic.200700025	47	12	15	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25727	10.1371/journal.pone.0025727	http://dx.doi.org/10.1371/journal.pone.0025727			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998685	Green Published, Green Submitted, gold			2022-12-27	WOS:000295966900046
J	Rampersad, RR; Tarrant, TK; Vallanat, CT; Quintero-Matthews, T; Weeks, MF; Esserman, DA; Clark, J; Di Padova, F; Patel, DD; Fong, AM; Liu, P				Rampersad, Rishi R.; Tarrant, Teresa K.; Vallanat, Christopher T.; Quintero-Matthews, Tatiana; Weeks, Michael F.; Esserman, Denise A.; Clark, Jennifer; Di Padova, Franco; Patel, Dhavalkumar D.; Fong, Alan M.; Liu, Peng			Enhanced Th17-Cell Responses Render CCR2-Deficient Mice More Susceptible for Autoimmune Arthritis	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; T-HELPER-CELLS; SYNOVIAL INFLAMMATION; RHEUMATOID-ARTHRITIS; CC-CHEMOKINE; BONE-MARROW; INTERLEUKIN-17; EXPRESSION; IL-17; INDUCTION	CCR2 is considered a proinflammatory mediator in many inflammatory diseases such as rheumatoid arthritis. However, mice lacking CCR2 develop exacerbated collagen-induced arthritis. To explore the underlying mechanism, we investigated whether autoimmune-associated Th17 cells were involved in the pathogenesis of the severe phenotype of autoimmune arthritis. We found that Th17 cells were expanded approximately 3-fold in the draining lymph nodes of immunized CCR2(-/-) mice compared to WT controls (p = 0.017), whereas the number of Th1 cells and regulatory T cells are similar between these two groups of mice. Consistently, levels of the Th17 cell cytokine IL-17A and Th17 cell-associated cytokines, IL-6 and IL-1 beta were approximately 2-6-fold elevated in the serum and 22-28-fold increased in the arthritic joints in CCR2(-/-) mice compared to WT mice (p = 0.04, 0.0004, and 0.01 for IL-17, IL-6, and IL-1 beta, respectively, in the serum and p = 0.009, 0.02, and 0.02 in the joints). Furthermore, type II collagen-specific antibodies were significantly increased, which was accompanied by B cell and neutrophil expansion in CCR2(-/-) mice. Finally, treatment with an anti-IL-17A antibody modestly reduced the disease severity in CCR2(-/-) mice. Therefore, we conclude that while we detect markedly enhanced Th17-cell responses in collagen-induced arthritis in CCR2-deficient mice and IL-17A blockade does have an ameliorating effect, factors additional to Th17 cells and IL-17A also contribute to the severe autoimmune arthritis seen in CCR2 deficiency. CCR2 may have a protective role in the pathogenesis of autoimmune arthritis. Our data that monocytes were missing from the spleen while remained abundant in the bone marrow and joints of immunized CCR2(-/-) mice suggest that there is a potential link between CCR2-expressing monocytes and Th17 cells during autoimmunity.	[Rampersad, Rishi R.; Tarrant, Teresa K.; Vallanat, Christopher T.; Quintero-Matthews, Tatiana; Weeks, Michael F.; Patel, Dhavalkumar D.; Fong, Alan M.; Liu, Peng] Univ N Carolina, Dept Med, Thurston Arthrit Res Ctr, Chapel Hill, NC 27515 USA; [Esserman, Denise A.] Univ N Carolina, Dept Med, Div Gen Med & Clin Epidemiol, Chapel Hill, NC USA; [Esserman, Denise A.; Clark, Jennifer] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Di Padova, Franco; Patel, Dhavalkumar D.] Novartis Inst BioMed Res, Basel, Switzerland	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Novartis	Rampersad, RR (corresponding author), Univ N Carolina, Dept Med, Thurston Arthrit Res Ctr, Chapel Hill, NC 27515 USA.	liupz@med.unc.edu		Tarrant, Teresa/0000-0003-4067-5363	Arthritis Foundation; North Carolina Translational and Clinical Science (NC TraCS) Institute; home of the UNC-Chapel Hill Clinical and Translational Science Award (CTSA); NIH [HL077406]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077406] Funding Source: NIH RePORTER	Arthritis Foundation; North Carolina Translational and Clinical Science (NC TraCS) Institute; home of the UNC-Chapel Hill Clinical and Translational Science Award (CTSA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by an Arthritis Foundation Postdoctoral Fellowship, a pilot grant from the North Carolina Translational and Clinical Science (NC TraCS) Institute, home of the UNC-Chapel Hill Clinical and Translational Science Award (CTSA), and NIH grant HL077406. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annunziato F, 2009, NAT REV RHEUMATOL, V5, P325, DOI 10.1038/nrrheum.2009.80; Awasthi A, 2009, NAT IMMUNOL, V10, P568, DOI 10.1038/ni0609-568; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Bruhl H, 2007, ARTHRITIS RHEUM, V56, P2975, DOI 10.1002/art.22854; Bruhl H, 2004, J IMMUNOL, V172, P890, DOI 10.4049/jimmunol.172.2.890; Bruhl H, 2001, CLIN EXP IMMUNOL, V126, P551, DOI 10.1046/j.1365-2249.2001.01679.x; Chabaud M, 2001, ARTHRITIS RHEUM, V44, P1293, DOI 10.1002/1529-0131(200106)44:6<1293::AID-ART221>3.0.CO;2-T; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Doreau A, 2009, NAT IMMUNOL, V10, P778, DOI 10.1038/ni.1741; Ferber IA, 1996, J IMMUNOL, V156, P5; Fujii H, 2001, ARTHRITIS RHEUM, V63, P96; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Genovese MC, 1929, ARTHRITIS RHEUM, V62, P929; Gran B, 2002, J IMMUNOL, V169, P7104, DOI 10.4049/jimmunol.169.12.7104; Haringman JJ, 2006, ARTHRITIS RHEUM, V54, P2387, DOI 10.1002/art.21975; Horai R, 2000, J EXP MED, V191, P313, DOI 10.1084/jem.191.2.313; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Jerath MR, 2010, THROMB J, V8, DOI 10.1186/1477-9560-8-14; Jovanovic DV, 1998, J IMMUNOL, V160, P3513; Kato H, 1917, CTS-CLIN TRANSL SCI, V3, P319; Katz Y, 2001, ARTHRITIS RHEUM-US, V44, P2176, DOI 10.1002/1529-0131(200109)44:9<2176::AID-ART371>3.0.CO;2-4; Kelchtermans H, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2787; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Lam QLK, 2008, P NATL ACAD SCI USA, V105, P14993, DOI 10.1073/pnas.0806044105; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Liu P, 2008, ARTERIOSCL THROM VAS, V28, P243, DOI 10.1161/ATVBAHA.107.158675; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lubberts E, 2004, ARTHRITIS RHEUM-US, V50, P650, DOI 10.1002/art.20001; Lubberts E, 2001, J IMMUNOL, V167, P1004, DOI 10.4049/jimmunol.167.2.1004; Lubberts E, 2008, CYTOKINE, V41, P84, DOI 10.1016/j.cyto.2007.09.014; McGeachy MJ, 2008, IMMUNITY, V28, P445, DOI 10.1016/j.immuni.2008.03.001; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Page G, 2005, ARTHRITIS RHEUM-US, V52, P2307, DOI 10.1002/art.21211; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Quinones MP, 2004, J CLIN INVEST, V113, P856, DOI 10.1172/JCI200420126; Rampersad RR, 2009, SCAND J RHEUMATOL, V38, P445, DOI 10.3109/03009740902895743; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; Schwarzenberger P, 1998, J IMMUNOL, V161, P6383; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Shahrara S, 2010, J IMMUNOL, V184, P4479, DOI 10.4049/jimmunol.0901942; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Tacke F, 2006, IMMUNOBIOLOGY, V211, P609, DOI 10.1016/j.imbio.2006.05.025; Tarrant Teresa K, 2006, Pathophysiology, V13, P1, DOI 10.1016/j.pathophys.2005.11.001; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; van den Berg WB, 2009, NAT REV RHEUMATOL, V5, P549, DOI 10.1038/nrrheum.2009.179; Vergunst CE, 2008, ARTHRITIS RHEUM-US, V58, P1931, DOI 10.1002/art.23591; WOOLEY PH, 1981, J EXP MED, V154, P688, DOI 10.1084/jem.154.3.688; Zhu B, 2007, J IMMUNOL, V179, P5228, DOI 10.4049/jimmunol.179.8.5228	52	31	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e25833	10.1371/journal.pone.0025833	http://dx.doi.org/10.1371/journal.pone.0025833			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21991368	Green Published, Green Submitted, gold			2022-12-27	WOS:000295963300024
J	Celotto, AM; Chiu, WK; Van Voorhies, W; Palladino, MJ				Celotto, Alicia M.; Chiu, Wai Kan; Van Voorhies, Wayne; Palladino, Michael J.			Modes of Metabolic Compensation during Mitochondrial Disease Using the Drosophila Model of ATP6 Dysfunction	PLOS ONE			English	Article							ESCHERICHIA-COLI; LEIGH-SYNDROME; RESPIRATORY-CHAIN; SYNTHASE; SUBUNIT; DNA; MUTATION; DISORDERS; MUTANTS; MTDNA	Numerous mitochondrial DNA mutations cause mitochondrial encephalomyopathy: a collection of related diseases for which there exists no effective treatment. Mitochondrial encephalomyopathies are complex multisystem diseases that exhibit a relentless progression of severity, making them both difficult to treat and study. The pathogenic and compensatory metabolic changes that are associated with chronic mitochondrial dysfunction are not well understood. The Drosophila ATP6(1) mutant models human mitochondrial encephalomyopathy and allows the study of metabolic changes and compensation that occur throughout the lifetime of an affected animal. ATP6(1) animals have a nearly complete loss of ATP synthase activity and an acute bioenergetic deficit when they are asymptomatic, but surprisingly we discovered no chronic bioenergetic deficit in these animals during their symptomatic period. Our data demonstrate dynamic metabolic compensatory mechanisms that sustain normal energy availability and activity despite chronic mitochondrial complex V dysfunction resulting from an endogenous mutation in the mitochondrial DNA. ATP6(1) animals compensate for their loss of oxidative phosphorylation through increases in glycolytic flux, ketogenesis and Kreb's cycle activity early during pathogenesis. However, succinate dehydrogenase activity is reduced and mitochondrial supercomplex formation is severely disrupted contributing to the pathogenesis seen in ATP6(1) animals. These studies demonstrate the dynamic nature of metabolic compensatory mechanisms and emphasize the need for time course studies in tractable animal systems to elucidate disease pathogenesis and novel therapeutic avenues.	[Celotto, Alicia M.; Chiu, Wai Kan; Palladino, Michael J.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA; [Celotto, Alicia M.; Chiu, Wai Kan; Palladino, Michael J.] Univ Pittsburgh, Sch Med, Pittsburgh Inst Neurodegenerat Dis, Pittsburgh, PA USA; [Van Voorhies, Wayne] New Mexico State Univ, Program Mol Biol, Las Cruces, NM 88003 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; New Mexico State University	Celotto, AM (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA.	amc41@pitt.edu			National Institutes of Health (NIH) [R01 AG025046, AG027453]; U.S. National Cancer Institute [NCI U56 CA96286]; NATIONAL CANCER INSTITUTE [U56CA096286, U54CA132383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025046, R01AG027453] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health (NIH) R01 AG025046 and AG027453 to Dr. Palladino and U.S. National Cancer Institute (NCI U56 CA96286) to Dr. Van Voorhies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amemiya A, 1993, MITOCHONDRIAL DNA AS; Ashmore LJ, 2009, HUM GENET, V126, P431, DOI 10.1007/s00439-009-0673-2; Beal MF, 1996, CURR OPIN NEUROBIOL, V6, P661, DOI 10.1016/S0959-4388(96)80100-0; Brookes PS, 2002, PROTEOMICS, V2, P969, DOI 10.1002/1615-9861(200208)2:8<969::AID-PROT969>3.0.CO;2-3; Carelli V, 2002, ARCH NEUROL-CHICAGO, V59, P264, DOI 10.1001/archneur.59.2.264; Castagna AE, 2007, AM J MED GENET A, V143A, P808, DOI 10.1002/ajmg.a.31637; Celotto AM, 2006, GENETICS, V174, P1237, DOI 10.1534/genetics.106.063206; Celotto AM, 2006, J NEUROSCI, V26, P810, DOI 10.1523/JNEUROSCI.4162-05.2006; Chakrapani A, 1998, J INHERIT METAB DIS, V21, P685, DOI 10.1023/A:1005401121344; D'Aurelio M, 2010, HUM MOL GENET, V19, P374, DOI 10.1093/hmg/ddp503; de Moura MB, 2010, ENVIRON MOL MUTAGEN, V51, P391, DOI 10.1002/em.20575; Debray FG, 2007, AM J MED GENET A, V143A, P2046, DOI 10.1002/ajmg.a.31880; Di Donato S, 2000, J INHERIT METAB DIS, V23, P247, DOI 10.1023/A:1005684029429; Di Donato S, 2009, J NEUROL, V256, P693, DOI 10.1007/s00415-009-5028-3; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Enns GM, 2006, MOL GENET METAB, V88, P364, DOI 10.1016/j.ymgme.2006.02.001; Fergestad T, 2006, GENETICS, V172, P1031, DOI 10.1534/genetics.105.050625; Fergestad T, 2008, GENETICS, V178, P947, DOI 10.1534/genetics.107.082115; Fernandez-Vizarra E, 2009, BBA-MOL CELL RES, V1793, P200, DOI 10.1016/j.bbamcr.2008.05.028; Ferreira IL, 2010, CURR DRUG TARGETS, V11, P1193; Forester BP, 2010, NMR BIOMED, V23, P242, DOI 10.1002/nbm.1444; GANETZKY B, 1982, GENETICS, V100, P597; GASNIER F, 1993, ANAL BIOCHEM, V212, P173, DOI 10.1006/abio.1993.1309; Gonzalez CD, 2011, AUTOPHAGY, V7, P2, DOI 10.4161/auto.7.1.13044; Goyon V, 2008, J BIOL CHEM, V283, P9749, DOI 10.1074/jbc.M800204200; HARTZOG PE, 1993, J BACTERIOL, V175, P1337, DOI 10.1128/JB.175.5.1337-1343.1993; HARTZOG PE, 1993, J BIOL CHEM, V268, P12250; Hulbert AJ, 2004, PHYSIOL BIOCHEM ZOOL, V77, P869, DOI 10.1086/422768; Jung J, 2007, NEUROLOGY, V68, P1429, DOI 10.1212/01.wnl.0000264019.53959.10; Kucharczyk R, 2009, BBA-MOL CELL RES, V1793, P186, DOI 10.1016/j.bbamcr.2008.06.012; LINTS FA, 1968, EXP GERONTOL, V3, P341, DOI 10.1016/0531-5565(68)90047-8; Lopez-Gallardo E, 2009, J MED GENET, V46, P64, DOI 10.1136/jmg.2008.060616; Matthews RT, 1998, J NEUROSCI, V18, P156; MORRISON JF, 1957, BIOCHEM J, V65, P143, DOI 10.1042/bj0650143; MUNUJOS P, 1993, ANAL BIOCHEM, V212, P506, DOI 10.1006/abio.1993.1360; Nation JL, 2008, INS PHYS BIOCH, P509; Palladino MJ, 2010, NEUROBIOL DIS, V40, P40, DOI 10.1016/j.nbd.2010.05.009; Palladino MJ, 2003, J NEUROSCI, V23, P1276, DOI 10.1523/JNEUROSCI.23-04-01276.2003; Palladino MJ, 2002, GENETICS, V161, P1197; Pallotti F, 2004, BIOCHEM J, V384, P287, DOI 10.1042/BJ20040561; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; Rak M, 2007, J BIOL CHEM, V282, P10853, DOI 10.1074/jbc.M608692200; Rantamaki MT, 2005, ANN NEUROL, V58, P337, DOI 10.1002/ana.20555; Rastogi VK, 1999, NATURE, V402, P263, DOI 10.1038/46224; Ren J, 2010, J MOL MED, V88, P993, DOI 10.1007/s00109-010-0663-9; SANTORELLI FM, 1993, ANN NEUROL, V34, P827, DOI 10.1002/ana.410340612; Schapira AHV, 1999, BBA-BIOENERGETICS, V1410, P99, DOI 10.1016/S0005-2728(98)00160-1; Schmidt-Nielsen K., 1997, ANIMAL PHYSL; Schon EA, 2003, J CLIN INVEST, V111, P303, DOI 10.1172/JCI200317741; Schon EA, 2001, SEMIN CELL DEV BIOL, V12, P441, DOI 10.1006/scdb.2001.0281; Seigle JL, 2008, GENETICS, V179, P855, DOI 10.1534/genetics.108.087551; Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490; Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35; TATUCH Y, 1992, AM J HUM GENET, V50, P852; Tillement L, 2011, MITOCHONDRION, V11, P13, DOI 10.1016/j.mito.2010.08.009; Tucker EJ, 2010, CURR NEUROL NEUROSCI, V10, P277, DOI 10.1007/s11910-010-0112-8; Valiyaveetil FI, 1998, J BIOL CHEM, V273, P16241, DOI 10.1074/jbc.273.26.16241; Van Voorhies W, 2003, EXP GERONTOL, V38, P343, DOI 10.1016/S0531-5565(02)00272-3; Van Voorhies WA, 2004, J APPL PHYSIOL, V97, P1915, DOI 10.1152/japplphysiol.00505.2004; Van Voorhies WA, 1999, P NATL ACAD SCI USA, V96, P11399, DOI 10.1073/pnas.96.20.11399; Van Voorhies WA, 2002, FREE RADICAL BIO MED, V33, P587; Van Voorhies WA, 2008, J INSECT PHYSIOL, V54, P1132, DOI 10.1016/j.jinsphys.2008.04.022; Viant MR, 2001, J CHROMATOGR B, V765, P107, DOI 10.1016/S0378-4347(01)00428-5; Vik SB, 2005, J BIOENERG BIOMEMBR, V37, P445, DOI 10.1007/s10863-005-9488-6; Vilarinho L, 2001, J INHERIT METAB DIS, V24, P883, DOI 10.1023/A:1013908728445; Vockley J, 2008, J INHERIT METAB DIS, V31, P619, DOI 10.1007/s10545-008-1005-8; Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586; Wittig I, 2008, BBA-BIOENERGETICS, V1777, P592, DOI 10.1016/j.bbabio.2008.04.027; Wittig I, 2008, MOL CELL PROTEOMICS, V7, P995, DOI 10.1074/mcp.M700465-MCP200; Xue XF, 2009, J AGR FOOD CHEM, V57, P4500, DOI 10.1021/jf900853q; Yoon Y, 2011, ANTIOXID REDOX SIGN, V14, P439, DOI 10.1089/ars.2010.3286; Zsurka G, 2010, J BIOENERG BIOMEMBR, V42, P443, DOI 10.1007/s10863-010-9314-7	72	43	46	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25823	10.1371/journal.pone.0025823	http://dx.doi.org/10.1371/journal.pone.0025823			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991365	Green Published, gold			2022-12-27	WOS:000295943000081
J	Sanabani, SS; Pastena, ERD; da Costa, AC; Martinez, VP; Kleine-Neto, W; de Oliveira, ACS; Sauer, MM; Bassichetto, KC; Oliveira, SMS; Tomiyama, HTI; Sabino, EC; Kallas, EG				Sanabani, Sabri Saeed; de Souza Pastena, Evelyn Regina; da Costa, Antonio Charlys; Martinez, Vanessa Pouza; Kleine-Neto, Walter; Soares de Oliveira, Ana Carolina; Sauer, Mariana Melillo; Bassichetto, Katia Cristina; Santos Oliveira, Solange Maria; Iwashita Tomiyama, Helena Tomoko; Sabino, Ester Cerdeira; Kallas, Esper Georges			Characterization of Partial and Near Full-Length Genomes of HIV-1 Strains Sampled from Recently Infected Individuals in Sao Paulo, Brazil	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL DRUG-RESISTANCE; SUBTYPE-B; MOLECULAR CHARACTERIZATION; GENETIC DIVERSITY; TYPE-1; PREVALENCE; TROPISM; RECOMBINATION; TRANSMISSION	Background: Genetic variability is a major feature of human immunodeficiency virus type 1 (HIV-1) and is considered the key factor frustrating efforts to halt the HIV epidemic. A proper understanding of HIV-1 genomic diversity is a fundamental prerequisite for proper epidemiology, genetic diagnosis, and successful drugs and vaccines design. Here, we report on the partial and near full-length genomic (NFLG) variability of HIV-1 isolates from a well-characterized cohort of recently infected patients in Sao Paul, Brazil. Methodology: HIV-1 proviral DNA was extracted from the peripheral blood mononuclear cells of 113 participants. The NFLG and partial fragments were determined by overlapping nested PCR and direct sequencing. The data were phylogenetically analyzed. Results: Of the 113 samples (90.3% male; median age 31 years; 79.6% homosexual men) studied, 77 (68.1%) NFLGs and 32 (29.3%) partial fragments were successfully subtyped. Of the successfully subtyped sequences, 88 (80.7%) were subtype B sequences, 12 (11%) BF1 recombinants, 3 (2.8%) subtype C sequences, 2 (1.8%) BC recombinants and subclade F1 each, 1 (0.9%) CRF02 AG, and 1 (0.9%) CRF31 BC. Primary drug resistance mutations were observed in 14/101 (13.9%) of samples, with 5.9% being resistant to protease inhibitors and nucleoside reverse transcriptase inhibitors (NRTI) and 4.9% resistant to non-NRTIs. Predictions of viral tropism were determined for 86 individuals. X4 or X4 dual or mixed-tropic viruses (X4/DM) were seen in 26 (30.2%) of subjects. The proportion of X4 viruses in homosexuals was detected in 19/69 (27.5%). Conclusions: Our results confirm the existence of various HIV-1 subtypes circulating in Sao Paulo, and indicate that subtype B account for the majority of infections. Antiretroviral (ARV) drug resistance is relatively common among recently infected patients. The proportion of X4 viruses in homosexuals was significantly higher than the proportion seen in other study populations.	[Sanabani, Sabri Saeed; Sauer, Mariana Melillo; Iwashita Tomiyama, Helena Tomoko; Kallas, Esper Georges] Univ Sao Paulo, Fac Med, Div Clin Immunol & Allergy, Sao Paulo, Brazil; [Sanabani, Sabri Saeed; da Costa, Antonio Charlys; Kleine-Neto, Walter; Soares de Oliveira, Ana Carolina] Univ Fed Sao Paulo, Dept Translat Med, Sao Paulo, Brazil; [Sanabani, Sabri Saeed; Kleine-Neto, Walter; Sabino, Ester Cerdeira] Fundacao Pro Sangue, Blood Ctr Sau Paulo, Sao Paulo, Brazil; [de Souza Pastena, Evelyn Regina; da Costa, Antonio Charlys; Martinez, Vanessa Pouza; Soares de Oliveira, Ana Carolina; Sabino, Ester Cerdeira] Univ Sao Paulo, Dept Infect Dis, Sao Paulo, Brazil; [Bassichetto, Katia Cristina; Santos Oliveira, Solange Maria] Publ Hlth Dept Sao Paulo, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo	Sanabani, SS (corresponding author), Univ Sao Paulo, Fac Med, Div Clin Immunol & Allergy, Sao Paulo, Brazil.	sabyem_63@yahoo.com	da-Costa, Antonio Charlys/G-1548-2010; Sabino, Ester C/F-7750-2010; Sanabani, Sabri Saeed/F-5600-2012; Kallas, Esper G/C-9539-2012	da-Costa, Antonio Charlys/0000-0001-5516-5177; Sabino, Ester C/0000-0003-2623-5126; Sanabani, Sabri Saeed/0000-0002-8876-8262; Kallas, Esper/0000-0003-2026-6925	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [04/15856-9, 2006/50096-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The study was supported by grants 04/15856-9 and 2006/50096-0 from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Batista MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005613; Bello G, 2007, INFECT GENET EVOL, V7, P263, DOI 10.1016/j.meegid.2006.11.002; Passaes CPB, 2009, AIDS RES HUM RETROV, V25, P1339, DOI 10.1089/aid.2009.0167; Brennan CA, 2007, AIDS RES HUM RETROV, V23, P1434, DOI 10.1089/aid.2007.0121; Brennan CA, 2006, J MED VIROL, V78, pS24, DOI 10.1002/jmv.20603; Brigido LFM, 2005, AIDS RES HUM RETROV, V21, P673, DOI 10.1089/aid.2005.21.673; Brindeiro RM, 2003, AIDS, V17, P1063, DOI 10.1097/00002030-200305020-00016; Brown BK, 2005, J VIROL, V79, P6089, DOI 10.1128/JVI.79.10.6089-6101.2005; Brumme ZL, 2005, J INFECT DIS, V192, P466, DOI 10.1086/431519; Carr JK, 2001, AIDS, V15, pF41, DOI 10.1097/00002030-200110190-00002; Chueca N, 2009, J MED VIROL, V81, P763, DOI 10.1002/jmv.21425; Cohen OJ, 1998, NEW ENGL J MED, V339, P341, DOI 10.1056/NEJM199807303390511; de Mendoza C, 2007, J ANTIMICROB CHEMOTH, V59, P698, DOI 10.1093/jac/dkm012; Eshleman SH, 2007, AIDS, V21, P1165, DOI 10.1097/QAD.0b013e32810fd72e; Essex M, 1999, ADV VIRUS RES, V53, P71, DOI 10.1016/S0065-3527(08)60343-7; Frange P, 2009, J ANTIMICROB CHEMOTH, V64, P135, DOI 10.1093/jac/dkp151; Gao F, 1998, J VIROL, V72, P5680, DOI 10.1128/JVI.72.7.5680-5698.1998; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; Hunt PW, 2006, J INFECT DIS, V194, P926, DOI 10.1086/507312; Kandathil AJ, 2005, INDIAN J MED RES, V121, P333; Kato S, 2003, AIDS RES HUM RETROV, V19, P1057, DOI 10.1089/088922203322588431; Koopman JS, 1997, J ACQ IMMUN DEF SYND, V14, P249, DOI 10.1097/00042560-199703010-00009; Kuiken C, 2000, AM J EPIDEMIOL, V152, P814, DOI 10.1093/aje/152.9.814; Lehmann C, 2006, J CLIN VIROL, V37, P300, DOI 10.1016/j.jcv.2006.08.008; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; de Souza ACMF, 2008, AIDS RES HUM RETROV, V24, P1521, DOI 10.1089/aid.2008.0089; Mansky LM, 1996, VIROLOGY, V222, P391, DOI 10.1006/viro.1996.0436; McGovern RA, 2010, AIDS, V24, P2512, DOI 10.1097/QAD.0b013e32833e6cfb; Nicastri E, 2003, J MED VIROL, V69, P1, DOI 10.1002/jmv.10269; Nye TMW, 2006, BIOINFORMATICS, V22, P117, DOI 10.1093/bioinformatics/bti720; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Pilcher CD, 2004, J CLIN INVEST, V113, P937, DOI [10.1172/JCI200421540, 10.1172/JCI21540]; Plantier JC, 2009, NAT MED, V15, P871, DOI 10.1038/nm.2016; Raymond S, 2008, AIDS, V22, pF11, DOI 10.1097/QAD.0b013e32830ebcd4; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; ROBERTSON DL, 1995, J MOL EVOL, V40, P249, DOI 10.1007/BF00163230; Sa-Ferreira JA, 2007, TRANSFUSION, V47, P97, DOI 10.1111/j.1537-2995.2007.01069.x; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Salustiano Cavalcanti AM, 2007, MEM I OSWALDO CRUZ, V102, P785, DOI 10.1590/S0074-02762007005000109; Sanabani S, 2006, AIDS RES HUM RETROV, V22, P171, DOI 10.1089/aid.2006.22.171; Sanabani S, 2006, INFECT GENET EVOL, V6, P368, DOI 10.1016/j.meegid.2006.01.003; Sanabani SS, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-78; Saracino A, 2009, J MED VIROL, V81, P2036, DOI 10.1002/jmv.21598; Schultz AK, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-265; Skrabal K, 2007, J CLIN MICROBIOL, V45, P279, DOI 10.1128/JCM.01118-06; Soares EAJM, 2005, AIDS, V19, pS81, DOI 10.1097/01.aids.0000191497.00928.e4; Soares EAJM, 2003, JAIDS-J ACQ IMM DEF, V34, P520, DOI 10.1097/00126334-200312150-00012; Stefani MMA, 2007, J CLIN VIROL, V39, P205, DOI 10.1016/j.jcv.2007.04.012; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; de Castro CAV, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-224; Worobey M, 2001, MOL BIOL EVOL, V18, P254, DOI 10.1093/oxfordjournals.molbev.a003799; Zhong P, 2007, AIDS RES HUM RETROV, V23, P847, DOI 10.1089/aid.2006.0196	55	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e25869	10.1371/journal.pone.0025869	http://dx.doi.org/10.1371/journal.pone.0025869			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022460	gold, Green Published, Green Submitted			2022-12-27	WOS:000295981600017
J	Chang, CJ; Mitra, K; Koya, M; Velho, M; Desprat, R; Lenz, J; Bouhassira, EE				Chang, Chan-Jung; Mitra, Koyel; Koya, Mariko; Velho, Michelle; Desprat, Romain; Lenz, Jack; Bouhassira, Eric E.			Production of Embryonic and Fetal-Like Red Blood Cells from Human Induced Pluripotent Stem Cells	PLOS ONE			English	Article							HEMATOPOIETIC DIFFERENTIATION; DIRECTED DIFFERENTIATION; EPIGENETIC MEMORY; IPS CELLS; FIBROBLASTS; METHYLATION; PROGENITORS; INTEGRATION; GENERATION; EXPRESSION	We have previously shown that human embryonic stem cells can be differentiated into embryonic and fetal type of red blood cells that sequentially express three types of hemoglobins recapitulating early human erythropoiesis. We report here that we have produced iPS from three somatic cell types: adult skin fibroblasts as well as embryonic and fetal mesenchymal stem cells. We show that regardless of the age of the donor cells, the iPS produced are fully reprogrammed into a pluripotent state that is undistinguishable from that of hESCs by low and high-throughput expression and detailed analysis of globin expression patterns by HPLC. This suggests that reprogramming with the four original Yamanaka pluripotency factors leads to complete erasure of all functionally important epigenetic marks associated with erythroid differentiation regardless of the age or the tissue type of the donor cells, at least as detected in these assays. The ability to produce large number of erythroid cells with embryonic and fetal-like characteristics is likely to have many translational applications.	[Chang, Chan-Jung; Koya, Mariko; Velho, Michelle; Desprat, Romain; Bouhassira, Eric E.] Albert Einstein Coll Med, Dept Med, Dept Cell Biol, Bronx, NY 10467 USA; [Mitra, Koyel; Lenz, Jack] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Chang, CJ (corresponding author), Albert Einstein Coll Med, Dept Med, Dept Cell Biol, Bronx, NY 10467 USA.	eric.bouhassira@einstein.yu.edu	Bouhassira, Eric/AAZ-4184-2021		NYSTEM, the funding agency of New York State Empire Stem Cell Board [HL08846, N08T-006 (C024405), N08S-001 (C024172)]	NYSTEM, the funding agency of New York State Empire Stem Cell Board	Dr. Chang, Dr. Desprat, Dr. Velho, and Dr. Bouhassira are supported in part by grants HL08846 and by Grants N08T-006 (C024405) and N08S-001 (C024172) from NYSTEM, the funding agency of New York State Empire Stem Cell Board. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; Chadwick K, 2003, BLOOD, V102, P906, DOI 10.1182/blood-2003-03-0832; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chang KH, 2006, BLOOD, V108, P1515, DOI 10.1182/blood-2005-11-011874; Chang KH, 2010, BLOOD, V115, P2553, DOI 10.1182/blood-2009-11-252650; Choi KD, 2009, STEM CELLS, V27, P559, DOI 10.1634/stemcells.2008-0922; Daley GQ, 2009, CELL STEM CELL, V4, P200, DOI 10.1016/j.stem.2009.02.009; Deng J, 2009, NAT BIOTECHNOL, V27, P353, DOI 10.1038/nbt.1530; Desprat R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005956; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Feng Q, 2010, STEM CELLS, V28, P704, DOI 10.1002/stem.321; FINA L, 1990, BLOOD, V75, P2417; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Grigoriadis AE, 2010, BLOOD, V115, P2769, DOI 10.1182/blood-2009-07-234690; Hawley RG, 2008, MOL THER, V16, P1354, DOI 10.1038/mt.2008.142; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; Kaufman DS, 2001, P NATL ACAD SCI USA, V98, P10716, DOI 10.1073/pnas.191362598; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Lengerke C, 2009, ANN NY ACAD SCI, V1176, P191, DOI 10.1111/j.1749-6632.2009.04962.x; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; NICKOLOFF BJ, 1991, ARCH DERMATOL, V127, P523, DOI 10.1001/archderm.127.4.523; Nienhuis AW, 2006, MOL THER, V13, P1031, DOI 10.1016/j.ymthe.2006.03.001; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Olivier EN, 2006, EXP HEMATOL, V34, P1635, DOI 10.1016/j.exphem.2006.07.003; Olivier EN, 2006, STEM CELLS, V24, P1914, DOI 10.1634/stemcells.2005-0648; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pick M, 2009, STEM CELLS, V27, P2686, DOI 10.1002/stem.205; POBLET E, 1994, J CUTAN PATHOL, V21, P224, DOI 10.1111/j.1600-0560.1994.tb00264.x; Qiu CH, 2008, BLOOD, V111, P2400, DOI 10.1182/blood-2007-07-102087; Qiu CH, 2005, EXP HEMATOL, V33, P1450, DOI 10.1016/j.exphem.2005.09.003; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Umeda K, 2004, DEVELOPMENT, V131, P1869, DOI 10.1242/dev.01065; Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649; Vodyanik MA, 2006, BLOOD, V108, P2095, DOI 10.1182/blood-2006-02-003327; Wang GP, 2007, GENOME RES, V17, P1186, DOI 10.1101/gr.6286907; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yao S, 2006, P NATL ACAD SCI USA, V103, P6907, DOI 10.1073/pnas.0602280103; Ye L, 2009, P NATL ACAD SCI USA, V106, P9826, DOI 10.1073/pnas.0904689106; Ye ZH, 2009, BLOOD, V114, P5473, DOI 10.1182/blood-2009-04-217406; Yen BL, 2009, STEM CELLS, V27, P451, DOI 10.1634/stemcells.2008-0390; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zambidis ET, 2005, BLOOD, V106, P860, DOI 10.1182/blood-2004-11-4522; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267	52	46	47	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e25761	10.1371/journal.pone.0025761	http://dx.doi.org/10.1371/journal.pone.0025761			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022444	Green Published, gold, Green Submitted			2022-12-27	WOS:000295978600029
J	Kaddurah-Daouk, R; Baillie, RA; Zhu, HJ; Zeng, ZB; Wiest, MM; Nguyen, UT; Wojnoonski, K; Watkins, SM; Trupp, M; Krauss, RM				Kaddurah-Daouk, Rima; Baillie, Rebecca A.; Zhu, Hongjie; Zeng, Zhao-Bang; Wiest, Michelle M.; Uyen Thao Nguyen; Wojnoonski, Katie; Watkins, Steven M.; Trupp, Miles; Krauss, Ronald M.			Enteric Microbiome Metabolites Correlate with Response to Simvastatin Treatment	PLOS ONE			English	Article							GLOBAL BIOCHEMICAL APPROACH; TANDEM MASS-SPECTROMETRY; BILE-ACIDS; LIQUID-CHROMATOGRAPHY; REDUCTASE INHIBITORS; LACTONE FORMS; CARDIOVASCULAR-DISEASE; SLCO1B1 POLYMORPHISM; RANDOMIZED-TRIALS; DRUG-INTERACTIONS	Although statins are widely prescribed medications, there remains considerable variability in therapeutic response. Genetics can explain only part of this variability. Metabolomics is a global biochemical approach that provides powerful tools for mapping pathways implicated in disease and in response to treatment. Metabolomics captures net interactions between genome, microbiome and the environment. In this study, we used a targeted GC-MS metabolomics platform to measure a panel of metabolites within cholesterol synthesis, dietary sterol absorption, and bile acid formation to determine metabolite signatures that may predict variation in statin LDL-C lowering efficacy. Measurements were performed in two subsets of the total study population in the Cholesterol and Pharmacogenetics (CAP) study: Full Range of Response (FR), and Good and Poor Responders (GPR) were 100 individuals randomly selected from across the entire range of LDL-C responses in CAP. GPR were 48 individuals, 24 each from the top and bottom 10% of the LDL-C response distribution matched for body mass index, race, and gender. We identified three secondary, bacterial-derived bile acids that contribute to predicting the magnitude of statin-induced LDL-C lowering in good responders. Bile acids and statins share transporters in the liver and intestine; we observed that increased plasma concentration of simvastatin positively correlates with higher levels of several secondary bile acids. Genetic analysis of these subjects identified associations between levels of seven bile acids and a single nucleotide polymorphism (SNP), rs4149056, in the gene encoding the organic anion transporter SLCO1B1. These findings, along with recently published results that the gut microbiome plays an important role in cardiovascular disease, indicate that interactions between genome, gut microbiome and environmental influences should be considered in the study and management of cardiovascular disease. Metabolic profiles could provide valuable information about treatment outcomes and could contribute to a more personalized approach to therapy.	[Kaddurah-Daouk, Rima] Duke Univ, Med Ctr, Durham, NC 27708 USA; [Baillie, Rebecca A.] Rosa & Co, Cupertino, CA USA; [Zhu, Hongjie; Zeng, Zhao-Bang] N Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA; [Zhu, Hongjie; Zeng, Zhao-Bang] N Carolina State Univ, Bioinformat Res Ctr, Raleigh, NC 27695 USA; [Wiest, Michelle M.] Univ Idaho, Dept Stat, Moscow, ID 83843 USA; [Uyen Thao Nguyen; Watkins, Steven M.] Lipom Technol Tethys Biosci, W Sacramento, CA USA; [Trupp, Miles] SRI Int, AI Ctr, Bioinformat Res Grp, Menlo Pk, CA 94025 USA; [Wojnoonski, Katie; Krauss, Ronald M.] Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA	Duke University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; Idaho; University of Idaho; SRI International; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute	Kaddurah-Daouk, R (corresponding author), Duke Univ, Med Ctr, Durham, NC 27708 USA.	kaddu001@mc.duke.edu; rkrauss@chori.org	baillie, rebecca/AAQ-3400-2020	baillie, rebecca/0000-0003-3966-6320; Kaddurah-Daouk, Rima/0000-0003-1858-5732	National Institute of General Medical Sciences [R24, GM078233, U01 HL069757]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL069757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM078233] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by National Institute of General Medical Sciences grants R24, GM078233, "The Metabolomics Research Network for Drug Response Phenotype'' (RKD, RMK); and U01 HL069757, "Pharmacogenomics and Risk of Cardiovascular Disease'' (RMK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AM HEART ASS, 2004, HEART DIS STROK STAT; Ayroles JF, 2009, NAT GENET, V41, P299, DOI 10.1038/ng.332; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Barber MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009763; Burkard I, 2005, J CHROMATOGR B, V826, P147, DOI 10.1016/j.jchromb.2005.08.016; Chen CP, 2005, DRUG METAB DISPOS, V33, P537, DOI 10.1124/dmd.104.002477; Chen C, 2007, DRUG METAB DISPOS, V35, P1725, DOI 10.1124/dmd.107.015677; Clayton TA, 2009, P NATL ACAD SCI USA, V106, P14728, DOI 10.1073/pnas.0904489106; Deo AK, 2008, DRUG METAB DISPOS, V36, P1983, DOI 10.1124/dmd.108.022194; Gnerre C, 2004, PHARMACOGENETICS, V14, P635, DOI 10.1097/00008571-200410000-00001; Holtzman CW, 2006, PHARMACOTHERAPY, V26, P1601, DOI 10.1592/phco.26.11.1601; Houten SM, 2006, EMBO J, V25, P1419, DOI 10.1038/sj.emboj.7601049; Hsiang BN, 1999, J BIOL CHEM, V274, P37161, DOI 10.1074/jbc.274.52.37161; Ji Y, 2011, CLIN PHARMACOL THER, V89, P97, DOI 10.1038/clpt.2010.250; Kaddurah-Daouk R, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.22; Kaddurah-Daouk R, 2008, ANNU REV PHARMACOL, V48, P653, DOI 10.1146/annurev.pharmtox.48.113006.094715; Kaddurah-Daouk R, 2010, METABOLOMICS, V6, P191, DOI 10.1007/s11306-010-0207-x; Kaddurah-Daouk R, 2009, NEUROPSYCHOPHARMACOL, V34, P173, DOI 10.1038/npp.2008.174; Keskitalo JE, 2008, CLIN PHARMACOL THER, V84, P457, DOI 10.1038/clpt.2008.25; Kinross JM, 2011, GENOME MED, V3, DOI 10.1186/gm228; Klaassen CD, 2010, PHARMACOL REV, V62, P1, DOI 10.1124/pr.109.002014; Lindon JC, 2007, FEBS J, V274, P1140, DOI 10.1111/j.1742-4658.2007.05673.x; Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936; Lye HS, 2010, J DAIRY SCI, V93, P1383, DOI 10.3168/jds.2009-2574; Mangravite LM, 2008, CURR OPIN MOL THER, V10, P555; Pasanen MK, 2006, PHARMACOGENET GENOM, V16, P873, DOI 10.1097/01.fpc.0000230416.82349.90; Phillips KM, 1999, J CHROMATOGR B, V732, P17, DOI 10.1016/S0378-4347(99)00257-1; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2009, CIRC-CARDIOVASC QUAL, V2, P279, DOI 10.1161/CIRCOUTCOMES.109.868299; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Rodrigues AC, 2009, ACTA PHARMACOL SIN, V30, P956, DOI 10.1038/aps.2009.85; Shitara Y, 2006, PHARMACOL THERAPEUT, V112, P71, DOI 10.1016/j.pharmthera.2006.03.003; Simon JA, 2006, AM J CARDIOL, V97, P843, DOI 10.1016/j.amjcard.2005.09.134; Tagliacozzi D, 2003, CLIN CHEM LAB MED, V41, P1633, DOI 10.1515/CCLM.2003.247; Tazuma S, 1998, J CLIN GASTROENTEROL, V26, P287, DOI 10.1097/00004836-199806000-00015; Veiga P, 2005, FEMS MICROBIOL LETT, V242, P81, DOI 10.1016/j.femsle.2004.10.042; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Xiang XQ, 2009, PHARMACOGENET GENOM, V19, P447, DOI 10.1097/FPC.0b013e32832bcf7b; Yamasaki D, 2009, EUR J PHARM SCI, V37, P126, DOI 10.1016/j.ejps.2009.01.009; Zhao JJ, 2000, J MASS SPECTROM, V35, P1133, DOI 10.1002/1096-9888(200009)35:9<1133::AID-JMS42>3.0.CO;2-X; Zhou Z, 2006, AM HEART J, V151, P273, DOI 10.1016/j.ahj.2005.04.003	42	130	139	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e25482	10.1371/journal.pone.0025482	http://dx.doi.org/10.1371/journal.pone.0025482			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022402	Green Submitted, gold, Green Published			2022-12-27	WOS:000295978600017
J	Beurel, E				Beurel, Eleonore			HDAC6 Regulates LPS-Tolerance in Astrocytes	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; FACTOR-KAPPA-B; GROWTH-FACTOR-BETA; HISTONE DEACETYLASE; ENDOTOXIN TOLERANCE; MOLECULAR-MECHANISM; VALPROIC ACID; LIPOPOLYSACCHARIDE; INFLAMMATION; INHIBITORS	Inflammatory tolerance is a crucial mechanism that limits inflammatory responses in order to avoid prolonged inflammation that may damage the host. Evidence that chronic inflammation contributes to the neuropathology of prevalent neurodegenerative and psychiatric diseases suggests that inflammatory tolerance mechanisms are often inadequate to control detrimental inflammation in the central nervous system. Thus, identifying mechanisms that regulate neuroinflammatory tolerance may reveal opportunities for bolstering tolerance to reduce chronic inflammation in these diseases. Examination of tolerance after repeated lipopolysaccharide (LPS) treatment of mouse primary astrocytes demonstrated that histone deacetylase (HDAC) activity promoted tolerance, opposite to the action of glycogen synthase kinase-3 (GSK3), which counteracts tolerance. HDAC6 in particular was found to be critical for tolerance induction, as its deacetylation of acetyl-tubulin was increased during LPS tolerance, this was enhanced by inhibition of GSK3, and the HDAC6 inhibitor tubacin completely blocked tolerance and the promotion of tolerance by inhibition of GSK3. These results reveal opposing interactions between HDAC6 and GSK3 in regulating tolerance, and indicate that shifting the balance between these two opposing forces on inflammatory tolerance can obliterate or enhance tolerance to LPS in astrocytes.	Univ Miami, Dept Psychiat & Behav Sci, Miami, FL 33152 USA	University of Miami	Beurel, E (corresponding author), Univ Miami, Dept Psychiat & Behav Sci, Miami, FL 33152 USA.	eleonore_beurel@hotmail.fr			National Instute of Mental Health (NIMH), National Institutes of Health (NIH) [MH090236, MH038752]; NATIONAL INSTITUTE OF MENTAL HEALTH [R00MH090236, R01MH038752, K99MH090236, R56MH038752] Funding Source: NIH RePORTER	National Instute of Mental Health (NIMH), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)NIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by grants from the National Instute of Mental Health (NIMH), National Institutes of Health (NIH)(MH090236 and MH038752). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AYALA A, 1993, ARCH SURG-CHICAGO, V128, P89; Ayala A., 1993, ARCH SURG-CHICAGO, V128, P94; Beurel E, 2010, NEUROSCIENCE, V169, P1063, DOI 10.1016/j.neuroscience.2010.05.044; Beurel E, 2008, J BIOL CHEM, V283, P21934, DOI 10.1074/jbc.M802481200; Beurel E, 2009, CELL SIGNAL, V21, P978, DOI 10.1016/j.cellsig.2009.02.019; Blackwell TS, 1997, J LEUKOCYTE BIOL, V62, P885, DOI 10.1002/jlb.62.6.885; Brandtzaeg P, 1996, J EXP MED, V184, P51, DOI 10.1084/jem.184.1.51; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; Brush MH, 2004, J BIOL CHEM, V279, P7685, DOI 10.1074/jbc.M310997200; CAMPBELL IL, 1993, P NATL ACAD SCI USA, V90, P10061, DOI 10.1073/pnas.90.21.10061; Cavaillon JM, 2006, CRIT CARE, V10, DOI 10.1186/cc5055; Chen PS, 2007, NEUROSCIENCE, V149, P203, DOI 10.1016/j.neuroscience.2007.06.053; Chen WJ, 2001, IMMUNITY, V14, P715, DOI 10.1016/S1074-7613(01)00147-9; Craft JM, 2005, EXPERT OPIN THER TAR, V9, P887, DOI 10.1517/14728222.9.5.887; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Ding HP, 2008, J NEUROCHEM, V106, P2119, DOI 10.1111/j.1471-4159.2008.05564.x; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Gurvich N, 2004, CANCER RES, V64, P1079, DOI 10.1158/0008-5472.CAN-03-0799; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Into T, 2010, J BIOL CHEM, V285, P35759, DOI 10.1074/jbc.M110.126904; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kim SU, 2005, J NEUROSCI RES, V81, P302, DOI 10.1002/jnr.20562; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Li Y, 2008, J BIOL CHEM, V283, P12686, DOI 10.1074/jbc.C700185200; Marie C, 2000, CYTOKINE, V12, P55, DOI 10.1006/cyto.1999.0517; Martinez A, 2002, J MED CHEM, V45, P1292, DOI 10.1021/jm011020u; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; MILLERGRAZIANO CL, 1991, J CLIN IMMUNOL, V11, P95, DOI 10.1007/BF00917745; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; Sanchez JF, 2003, MOL CELL BIOL, V23, P4649, DOI 10.1128/MCB.23.13.4649-4662.2003; Schneider DS, 2008, NAT REV IMMUNOL, V8, P889, DOI 10.1038/nri2432; Serrador JM, 2004, IMMUNITY, V20, P417, DOI 10.1016/S1074-7613(04)00078-0; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Villagra A, 2009, NAT IMMUNOL, V10, P92, DOI 10.1038/ni.1673; Wagman AS, 2004, CURR PHARM DESIGN, V10, P1105, DOI 10.2174/1381612043452668; ZIEGLERHEITBROCK HWL, 1995, J INFLAMM, V45, P13; ZIEGLERHEITBROCK HWL, 1994, J BIOL CHEM, V269, P17001; Zipp F, 2006, TRENDS NEUROSCI, V29, P518, DOI 10.1016/j.tins.2006.07.006	43	30	35	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25804	10.1371/journal.pone.0025804	http://dx.doi.org/10.1371/journal.pone.0025804			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022450	gold, Green Submitted, Green Published			2022-12-27	WOS:000295976000040
J	Liu, YN; Wang, W; Li, X; Wang, H; Luo, YX; Wu, LJ; Guo, XH				Liu, Yunning; Wang, Wei; Li, Xia; Wang, Hong; Luo, Yanxia; Wu, Lijuan; Guo, Xiuhua			Geographic Distribution and Risk Factors of the Initial Adult Hospitalized Cases of 2009 Pandemic Influenza A (H1N1) Virus Infection in Mainland China	PLOS ONE			English	Article								Background: As of 31(st) March 2010, more than 127,000 confirmed cases of 2009 pandemic influenza A (H1N1), including 800 deaths, were reported in mainland China. The distribution and characteristics of the confirmed cases in the initial phase of this pandemic in this country are largely unknown. The present study aimed to characterize the geographic distribution and patient characteristics of H1N1 infection in the 2009 pandemic as well as to identify potential risk factors associated with adverse patient outcome in China, through retrospective analyses of 885 hospitalized cases with confirmed H1N1 infection. Methodology/Principal Findings: The proportional hazards model was employed to detect risk factors for adverse outcome; the geo-statistical maps were used to characterize the distribution of all 2668 confirmed H1N1 patients throughout mainland China. The number of new cases increased slowly in May, 2009, but rapidly between June and August of the year. Confirmed cases were reported in 26 provinces; Beijing, Guangdong, Shanghai, Zhejiang and Fujian were the top five regions of the incidence of the virus infection. After being adjusted for gender, age, chronic pulmonary disease and other general symptoms, delay for more than two days before hospital admission (HR: 0.6; 95% CI: 0.5-0.7) and delayed onset of the H1N1-specific respiratory symptoms (HR: 0.3; 95% CI: 0.2-0.4) were associated with adverse patient outcome. Conclusions/Significance: The 2009 pandemic influenza A affected east and southeast coastal provinces and most populous cities more severely than other regions in mainland China due to higher risk of high level traffic-, high population density-, and high population mobility-associated H1N1 transmission. The clinical symptoms were mild in the initial phase of infection. Delayed hospital admission and delayed appearance of respiratory symptoms were among the major risk factors for poor patient outcome. These findings may have significant implications in the future pandemic preparedness and response.	[Liu, Yunning; Wang, Wei; Li, Xia; Wang, Hong; Luo, Yanxia; Wu, Lijuan; Guo, Xiuhua] Capital Med Univ, Sch Publ Hlth & Family Med, Dept Epidemiol & Hlth Stat, Beijing, Peoples R China; [Li, Xia; Wang, Hong; Luo, Yanxia; Wu, Lijuan; Guo, Xiuhua] Beijing Municipal Key Lab Clin Epidemiol, Beijing, Peoples R China	Capital Medical University	Liu, YN (corresponding author), Capital Med Univ, Sch Publ Hlth & Family Med, Dept Epidemiol & Hlth Stat, Beijing, Peoples R China.	guoxiuh@ccmu.edu.cn	liu, li/HGC-0900-2022	wang, wei/0000-0002-1430-1360	Jurisdiction of Beijing Municipality [PHR201007112]; National ST Major Project [2010ZX09401]	Jurisdiction of Beijing Municipality; National ST Major Project	This work was supported by Funding Project for Academic Human Resources Development in Institutions of Higher Learning under the Jurisdiction of Beijing Municipality (PHR201007112); National S&T Major Project (2010ZX09401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulos Maged N Kamel, 2004, Int J Health Geogr, V3, P2, DOI 10.1186/1476-072X-3-2; Campbell A, 2010, CAN MED ASSOC J, V182, P349, DOI 10.1503/cmaj.091823; Chowell G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021287; Fowlkes AL, 2011, CLIN INFECT DIS, V52, pS60, DOI 10.1093/cid/ciq022; Graham AJ, 2004, ACTA TROP, V91, P219, DOI 10.1016/j.actatropica.2004.05.001; Guarner J, 2009, ARCH MED RES, V40, P655, DOI 10.1016/j.arcmed.2009.10.001; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Jeong I, 2010, AM J INFECT CONTROL, V38, P482, DOI 10.1016/j.ajic.2010.02.006; Khandaker G, 2011, INFLUENZA OTHER RESP, V5, P148, DOI 10.1111/j.1750-2659.2011.00199.x; *MIN HLTH PEOPL RE, 3 VERS CLIN GUID PAN; *MIN HLTH PEOPL RE, 2010, NAT INFL H1N1 PREV C; Nolan T, 2010, JAMA-J AM MED ASSOC, V303, P37, DOI 10.1001/jama.2009.1911; Rogers DJ, 2003, NAT REV MICROBIOL, V1, P231, DOI 10.1038/nrmicro776; WENGER JD, 2011, J INFECT DIS, V203, P828; WHO, CURR WHO PHAS PAND A; *WHO, PAND H1N1 2009 UPD 9	16	6	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25934	10.1371/journal.pone.0025934	http://dx.doi.org/10.1371/journal.pone.0025934			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022474	Green Published, Green Submitted, gold			2022-12-27	WOS:000295976000048
J	Nakayama, S; Sawamura, K; Mohri, K; Uchiyama, T				Nakayama, Shinsuke; Sawamura, Kenta; Mohri, Kaneo; Uchiyama, Tsuyoshi			Pulse-Driven Magnetoimpedance Sensor Detection of Cardiac Magnetic Activity	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; MAGNETOCARDIOGRAPHY; SEGMENT; WIRE	This study sought to establish a convenient method for detecting biomagnetic activity in the heart. Electrical activity of the heart simultaneously induces a magnetic field. Detection of this magnetic activity will enable non-contact, noninvasive evaluation to be made. We improved the sensitivity of a pulse-driven magnetoimpedance (PMI) sensor, which is used as an electric compass in mobile phones and as a motion sensor of the operation handle in computer games, toward a pico-Tesla (pT) level, and measured magnetic fields on the surface of the thoracic wall in humans. The changes in magnetic field detected by this sensor synchronized with the electric activity of the electrocardiogram (ECG). The shape of the magnetic wave was largely altered by shifting the sensor position within 20 mm in parallel and/or perpendicular to the thoracic wall. The magnetic activity was maximal in the 4th intercostals near the center of the sterna. Furthermore, averaging the magnetic activity at 15 mm in the distance between the thoracic wall and the sensor demonstrated magnetic waves mimicking the P wave and QRS complex. The present study shows the application of PMI sensor in detecting cardiac magnetic activity in several healthy subjects, and suggests future applications of this technology in medicine and biology.	[Nakayama, Shinsuke; Sawamura, Kenta] Nagoya Univ, Dept Cell Physiol, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Mohri, Kaneo; Uchiyama, Tsuyoshi] Nagoya Univ, Dept Elect, Grad Sch Engn, Nagoya, Aichi 4648601, Japan	Nagoya University; Nagoya University	Nakayama, S (corresponding author), Nagoya Univ, Dept Cell Physiol, Grad Sch Med, Nagoya, Aichi 4648601, Japan.	tutiyama@nuee.nagoya-u.ac.jp			Japan Society for the Promotion of Science; Japan Science and Technology Agency (JST) [b120058]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	This work was partly supported by grants-in-aid for scientific research from the Japan Society for the Promotion of Science, and Japan Science and Technology Agency (JST, b120058). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	COHEN D, 1971, SCIENCE, V172, P1329, DOI 10.1126/science.172.3990.1329; Fenici R, 2005, EXPERT REV MOL DIAGN, V5, P291, DOI 10.1586/14737159.5.3.291; Ikefuji Hiroyuki, 2007, J Med Invest, V54, P116, DOI 10.2152/jmi.54.116; INADA K, 1994, IEEE T MAGN, V30, P4263; Ishikawa T, 2004, AM J PHYSIOL-CELL PH, V286, pC1344, DOI 10.1152/ajpcell.00392.2003; Itzhaki I, 2011, NATURE, V471, P225, DOI 10.1038/nature09747; Kaichi S, 2010, CARDIOVASC RES, V88, P314, DOI 10.1093/cvr/cvq189; Katritsis D, 2010, J AM COLL CARDIOL, V55, P2293, DOI 10.1016/j.jacc.2010.03.016; Koch H, 2004, J ELECTROCARDIOL, V37, P117, DOI 10.1016/j.jelectrocard.2004.08.035; Mallinson JC, 1993, FDN MAGNETIC RECORDI; Melo LGC, 2008, J APPL PHYS, V103, DOI 10.1063/1.2837106; Mohri K, 2007, SENS LETT, V5, P267, DOI 10.1166/sl.2007.082; NAKAYA Y, 1992, CLIN PHYS PHYSIOL M, V13, P191, DOI 10.1088/0143-0815/13/3/001; Nakayama S, 2011, BIOSENS BIOELECTRON, V27, P34, DOI 10.1016/j.bios.2011.05.041; Nelson TJ, 2010, NAT REV CARDIOL, V7, P700, DOI 10.1038/nrcardio.2010.159; Sanacci S., 2004, IEEE T MAGN, V40, P3505; Srinivasan S, 2008, CURR OPIN PEDIATR, V20, P522, DOI 10.1097/MOP.0b013e32830f93ec; STROINK G, 1985, MED BIOL ENG COMPUT, V23, P61; Takaki M, 2006, STEM CELLS, V24, P1414, DOI 10.1634/stemcells.2005-0394; Takaki M, 2010, PROG BIOPHYS MOL BIO, V102, P129, DOI 10.1016/j.pbiomolbio.2010.05.007; Uchiyama T, 2009, PHYS STATUS SOLIDI A, V206, P639, DOI 10.1002/pssa.200881251; Uetani T, 2009, JACC-CARDIOVASC INTE, V2, P127, DOI 10.1016/j.jcin.2008.07.010	22	21	25	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25834	10.1371/journal.pone.0025834	http://dx.doi.org/10.1371/journal.pone.0025834			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022453	Green Submitted, Green Published, gold			2022-12-27	WOS:000295976000043
J	Ni, MJ; Hu, ZH; Liu, Q; Liu, MF; Lu, MH; Zhang, JS; Zhang, L; Zhang, YL				Ni, Min-Jie; Hu, Zhi-Hong; Liu, Qiang; Liu, Mo-Fang; Lu, Min-hua; Zhang, Jin-Song; Zhang, Li; Zhang, Yong-Lian			Identification and Characterization of a Novel Non-Coding RNA Involved in Sperm Maturation	PLOS ONE			English	Article							TYROSINE PHOSPHORYLATION; POSTTRANSCRIPTIONAL REGULATION; EPIDIDYMAL DEVELOPMENT; PRIMARY MICRORNAS; MESSENGER-RNA; DICER; GENE; CAPACITATION; EXPRESSION; BIOGENESIS	A long and ever-expanding roster of small (similar to 20-30 nucleotides) RNAs has emerged during the last decade, and most can be subsumed under the three main headings of microRNAs(miRNAs), Piwi-interacting RNAs(piRNAs), and short interferingRNAs(siRNAs). Among the three categories, miRNAs is the most quickly expanded group. The most recent number of identified miRNAs is 16,772 (Sanger miRbase, April 2011). However, there are insufficient publications on their primary forms, and no tissue-specific small RNAs precursors have been reported in the epididymis. Here, we report the identification in rats of an epididymis-specific, chimeric, noncoding RNA that is spliced from two different chromosomes (chromosomes 5 and 19), which we named HongrES2. HongrES2 is a 1.6 kb mRNA-like precursor that gives rise to a new microRNA-like small RNA (mil-HongrES2) in rat epididymis. The generation of mil-HongrES2 is stimulated during epididymitis. An epididymis-specific carboxylesterase named CES7 had 100% cDNA sequence homology at the 3' end with HongrES2 and its protein product could be downregulated by HongrES2 via mil-HongrES2. This was confirmed in vivo by initiating mil-HongrES2 over-expression in rats and observing an effect on sperm capacitation.	[Ni, Min-Jie; Hu, Zhi-Hong; Liu, Qiang; Zhang, Jin-Song; Zhang, Li; Zhang, Yong-Lian] State Key Lab Mol Biol, Shanghai Key Lab Mol Androl, Shanghai, Peoples R China; [Liu, Mo-Fang; Lu, Min-hua] Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Core Facil Noncoding RNA, Shanghai, Peoples R China; [Zhang, Yong-Lian] Shanghai Inst Planned Parenthood Res, Shanghai, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Ni, MJ (corresponding author), State Key Lab Mol Biol, Shanghai Key Lab Mol Androl, Shanghai, Peoples R China.	ylzhang@sibs.ac.cn	Liu, Qiang/HHZ-3181-2022	Zhang, Jinsong/0000-0002-6457-0235	National Basic Science Research and Development Project of China [2006CB504002]; Chinese Academy of Sciences [2006CB944002]	National Basic Science Research and Development Project of China; Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by grants from the National Basic Science Research and Development Project of China [2006CB504002] and the Chinese Academy of Sciences Knowledge Innovation Program [2006CB944002]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Ambros Victor, 2004, Methods Mol Biol, V265, P131; Araki Y, 2002, J ANDROL, V23, P854; Asada S, 2008, AM J PHYSIOL-HEART C, V295, pH2512, DOI 10.1152/ajpheart.00233.2008; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bilen J, 2006, MOL CELL, V24, P157, DOI 10.1016/j.molcel.2006.07.030; Bracht J, 2004, RNA, V10, P1586, DOI 10.1261/rna.7122604; Buffone MG, 2009, J ANDROL, V30, P552, DOI 10.2164/jandrol.108.006551; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Chen LL, 2010, CURR OPIN CELL BIOL, V22, P357, DOI 10.1016/j.ceb.2010.03.003; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Corsten MF, 2007, CANCER RES, V67, P8994, DOI 10.1158/0008-5472.CAN-07-1045; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Diederichs S, 2007, CELL, V131, P1097, DOI 10.1016/j.cell.2007.10.032; Farazi TA, 2008, DEVELOPMENT, V135, P1201, DOI 10.1242/dev.005629; Golden DE, 2008, MOL CELL, V31, P309, DOI 10.1016/j.molcel.2008.07.008; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; HOU J, CANC CELL, V19, P232; Hu ZH, 2002, CELL RES, V12, P407, DOI 10.1038/sj.cr.7290143; Huang MG, 2008, DEV BIOL, V322, P394, DOI 10.1016/j.ydbio.2008.06.031; Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235; Kappler-Hanno K, 2003, ASIAN J ANDROL, V5, P277; Lai EC, 2003, CURR BIOL, V13, pR925, DOI 10.1016/j.cub.2003.11.017; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Leuschner PJF, 2007, METHODS, V43, P105, DOI 10.1016/j.ymeth.2007.04.005; Li H, 2008, SCIENCE, V321, P1357, DOI 10.1126/science.1156725; Li H, 2009, CELL CYCLE, V8, P218, DOI 10.4161/cc.8.2.7358; Li JJ, 2010, MOL BIOL EVOL, V27, P671, DOI 10.1093/molbev/msp284; Li P, 2001, SCIENCE, V291, P1783, DOI 10.1126/science.1056545; Li X, 2009, J MOL EVOL, V68, P56, DOI 10.1007/s00239-008-9187-0; Luconi M, 1998, BIOL REPROD, V58, P1476, DOI 10.1095/biolreprod58.6.1476; Luconi M, 1996, BIOL REPROD, V55, P207, DOI 10.1095/biolreprod55.1.207; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Matson CK, 2010, DEV CELL, V19, P612, DOI 10.1016/j.devcel.2010.09.010; Meltzer PS, 2005, NATURE, V435, P745, DOI 10.1038/435745a; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Raymond CK, 2005, RNA, V11, P1737, DOI 10.1261/rna.2148705; Robaire B., 1988, P999; Roberts KP, 2003, BIOL REPROD, V69, P572, DOI 10.1095/biolreprod.102.013771; Schmittgen TD, 2008, J CELL MOL MED, V12, P1811, DOI 10.1111/j.1582-4934.2008.00483.x; Smalheiser NR, 2005, TRENDS GENET, V21, P322, DOI 10.1016/j.tig.2005.04.008; Stefani G, 2007, EXPERT OPIN BIOL TH, V7, P1833, DOI 10.1517/14712598.7.12.1833; Tang KF, 2007, BBA-GEN SUBJECTS, V1770, P820, DOI 10.1016/j.bbagen.2007.01.004; Tian ZM, 2008, GENOME RES, V18, P404, DOI 10.1101/gr.6587008; Tolia NH, 2007, NAT CHEM BIOL, V3, P36, DOI 10.1038/nchembio848; TURNER TT, 1991, ANN NY ACAD SCI, V637, P364, DOI 10.1111/j.1749-6632.1991.tb27323.x; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129; Wang JF, 2010, BIOCHEM BIOPH RES CO, V402, P222, DOI 10.1016/j.bbrc.2010.10.002; Wang JF, 2010, ACTA BIOCH BIOPH SIN, V42, P628, DOI 10.1093/abbs/gmq073; Yang JS, 2010, CELL CYCLE, V9, P4455, DOI 10.4161/cc.9.22.13958; Yang JS, 2010, P NATL ACAD SCI USA, V107, P15163, DOI 10.1073/pnas.1006432107; Yang L, 2004, J BIOL CHEM, V279, P46253, DOI 10.1074/jbc.M408155200; Zeng Y, 2005, J BIOL CHEM, V280, P27595, DOI 10.1074/jbc.M504714200; Zhang L, 2010, BIOCHEM BIOPH RES CO, V400, P696, DOI 10.1016/j.bbrc.2010.08.130; Zhang L, 2009, ACTA BIOCH BIOPH SIN, V41, P809, DOI 10.1093/abbs/gmp075; Zhang L, 2009, ACTA BIOCH BIOPH SIN, V41, P731, DOI 10.1093/abbs/gmp061; Zhou CX, 2004, NAT CELL BIOL, V6, P458, DOI 10.1038/ncb1127; Zhou YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004106; Zhu CF, 2007, BIOL REPROD, V76, P63, DOI 10.1095/biolreprod.106.054635	66	47	56	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26053	10.1371/journal.pone.0026053	http://dx.doi.org/10.1371/journal.pone.0026053			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022505	gold, Green Submitted, Green Published			2022-12-27	WOS:000295976000061
J	Maharjan, AS; Pilling, D; Gomer, RH				Maharjan, Anu S.; Pilling, Darrell; Gomer, Richard H.			High and Low Molecular Weight Hyaluronic Acid Differentially Regulate Human Fibrocyte Differentiation	PLOS ONE			English	Article							SERUM-AMYLOID-P; PERIPHERAL-BLOOD FIBROCYTES; TOLL-LIKE RECEPTOR-4; INDUCED PULMONARY-FIBROSIS; CIRCULATING FIBROCYTES; BONE-MARROW; LUNG INJURY; DENDRITIC CELLS; HUMAN-MONOCYTES; TISSUE-REPAIR	Background: Following tissue injury, monocytes can enter the tissue and differentiate into fibroblast-like cells called fibrocytes, but little is known about what regulates this differentiation. Extracellular matrix contains high molecular weight hyaluronic acid (HMWHA; similar to 2x10(6) Da). During injury, HMWHA breaks down to low molecular weight hyaluronic acid (LMWHA;, similar to 0.8-8x10(5) Da). Methods and Findings: In this report, we show that HMWHA potentiates the differentiation of human monocytes into fibrocytes, while LMWHA inhibits fibrocyte differentiation. Digestion of HMWHA with hyaluronidase produces small hyaluronic acid fragments, and these fragments inhibit fibrocyte differentiation. Monocytes internalize HMWHA and LMWHA equally well, suggesting that the opposing effects on fibrocyte differentiation are not due to differential internalization of HMWHA or LMWHA. Adding HMWHA to PBMC does not appear to affect the levels of the hyaluronic acid receptor CD44, whereas adding LMWHA decreases CD44 levels. The addition of anti-CD44 antibodies potentiates fibrocyte differentiation, suggesting that CD44 mediates at least some of the effect of hyaluronic acid on fibrocyte differentiation. The fibrocyte differentiation-inhibiting factor serum amyloid P (SAP) inhibits HMWHA-induced fibrocyte differentiation and potentiates LMWHA-induced inhibition. Conversely, LMWHA inhibits the ability of HMWHA, interleukin-4 (IL-4), or interleukin-13 (IL-13) to promote fibrocyte differentiation. Conclusions: We hypothesize that hyaluronic acid signals at least in part through CD44 to regulate fibrocyte differentiation, with a dominance hierarchy of SAP>LMWHA>HMWHA>IL-4 or IL-13.	[Maharjan, Anu S.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA; [Maharjan, Anu S.; Pilling, Darrell; Gomer, Richard H.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA	Rice University; Texas A&M University System; Texas A&M University College Station	Maharjan, AS (corresponding author), Rice Univ, Dept Biochem & Cell Biol, MS-140, Houston, TX 77251 USA.	rgomer@bio.tamu.edu		Gomer, Richard/0000-0003-2361-4307; Pilling, Darrell/0000-0002-7413-2773	National Institutes of Health [HL083029]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083029] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grant HL083029. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe R, 2001, J IMMUNOL, V166, P7556, DOI 10.4049/jimmunol.166.12.7556; Bai KJ, 2005, AM J RESP CRIT CARE, V172, P92, DOI 10.1164/rccm.200405-652OC; Bellini A, 2007, LAB INVEST, V87, P858, DOI 10.1038/labinvest.3700654; BIANCHETTI L, 2011, J CELL MOL MED, DOI DOI 10.1111/J.1582-4934; Bollyky PL, 2007, J IMMUNOL, V179, P744, DOI 10.4049/jimmunol.179.2.744; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; Campo GM, 2010, BIOCHIMIE, V92, P204, DOI 10.1016/j.biochi.2009.10.006; Chang EJ, 2007, J CELL SCI, V120, P166, DOI 10.1242/jcs.03310; Chesney J, 1997, BIOCHEM SOC T, V25, P520, DOI 10.1042/bst0250520; Day AJ, 2005, TRENDS IMMUNOL, V26, P637, DOI 10.1016/j.it.2005.09.009; ENGSTROMLAURENT A, 1985, HEPATOLOGY, V5, P638, DOI 10.1002/hep.1840050420; Filion MC, 2001, J PHARM PHARMACOL, V53, P555, DOI 10.1211/0022357011775677; FORRESTER JV, 1980, IMMUNOLOGY, V40, P435; Girish KS, 2007, LIFE SCI, V80, P1921, DOI 10.1016/j.lfs.2007.02.037; Gomperts BN, 2007, J LEUKOCYTE BIOL, V82, P449, DOI 10.1189/jlb.0906587; Grenier J, 2002, EXP HEMATOL, V30, P1029, DOI 10.1016/S0301-472X(02)00874-3; Grishko V, 2009, J BIOL CHEM, V284, P9132, DOI 10.1074/jbc.M804178200; Hamilton SR, 2007, J BIOL CHEM, V282, P16667, DOI 10.1074/jbc.M702078200; HARDWICK C, 1992, J CELL BIOL, V117, P1343, DOI 10.1083/jcb.117.6.1343; Hartlapp I, 2001, FASEB J, V15, P2215, DOI 10.1096/fj.01-0049com; Hashimoto N, 2004, J CLIN INVEST, V113, P243, DOI 10.1172/JCI200418847; Herzog EL, 2010, EXP HEMATOL, V38, P548, DOI 10.1016/j.exphem.2010.03.004; HodgeDufour J, 1997, J IMMUNOL, V159, P2492; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Johnson LA, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702889200; KANSAS GS, 1989, J IMMUNOL, V142, P3050; Kuang DM, 2007, BLOOD, V110, P587, DOI 10.1182/blood-2007-01-068031; KUO JW, 2005, PRACTICAL ASPECTS HY, P1; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; LEE HG, 1994, ANAL BIOCHEM, V219, P278, DOI 10.1006/abio.1994.1267; LESLEY J, 1993, ADV IMMUNOL, V54, P271, DOI 10.1016/S0065-2776(08)60537-4; Li YJ, 2011, J EXP MED, V208, P1459, DOI 10.1084/jem.20102510; Maharjan AS, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-23; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Mattoli S, 2009, CURR STEM CELL RES T, V4, P266, DOI 10.2174/157488809789649232; McKee CM, 1996, J CLIN INVEST, V98, P2403, DOI 10.1172/JCI119054; Moore BB, 2005, AM J PATHOL, V166, P675, DOI 10.1016/S0002-9440(10)62289-4; Mori L, 2005, EXP CELL RES, V304, P81, DOI 10.1016/j.yexcr.2004.11.011; Murray LA, 2011, INT J BIOCHEM CELL B, V43, P154, DOI 10.1016/j.biocel.2010.10.013; Murray LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009683; Naik-Mathuria B, 2008, WOUND REPAIR REGEN, V16, P266, DOI 10.1111/j.1524-475X.2008.00366.x; Nakamura K, 2004, J GASTROENTEROL, V39, P346, DOI 10.1007/s00535-003-1301-x; Nedvetzki S, 2004, P NATL ACAD SCI USA, V101, P18081, DOI 10.1073/pnas.0407378102; Niedermeier M, 2009, P NATL ACAD SCI USA, V106, P17892, DOI 10.1073/pnas.0906070106; NONG YH, 1989, J EXP MED, V170, P259, DOI 10.1084/jem.170.1.259; PEACH RJ, 1993, J CELL BIOL, V122, P257, DOI 10.1083/jcb.122.1.257; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Pilling D, 2003, J IMMUNOL, V171, P5537, DOI 10.4049/jimmunol.171.10.5537; Pilling D, 2007, J IMMUNOL, V179, P4035, DOI 10.4049/jimmunol.179.6.4035; Pilling D, 2009, J IMMUNOL METHODS, V351, P62, DOI 10.1016/j.jim.2009.09.011; Pilling D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007475; Pilling D, 2006, J LEUKOCYTE BIOL, V79, P1242, DOI 10.1189/jlb.0805456; Powell JD, 2005, IMMUNOL RES, V31, P207, DOI 10.1385/IR:31:3:207; Quan TE, 2004, INT J BIOCHEM CELL B, V36, P598, DOI 10.1016/j.biocel.2003.10.005; Reilkoff RA, 2011, NAT REV IMMUNOL, V11, P427, DOI 10.1038/nri2990; Scheibner KA, 2006, J IMMUNOL, V177, P1272, DOI 10.4049/jimmunol.177.2.1272; Shao DD, 2008, J LEUKOCYTE BIOL, V83, P1323, DOI 10.1189/jlb.1107782; SHARP PA, 1973, BIOCHEMISTRY-US, V12, P3055, DOI 10.1021/bi00740a018; Siegelman MH, 1999, J LEUKOCYTE BIOL, V66, P315, DOI 10.1002/jlb.66.2.315; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Strieter Robert M, 2009, Trans Am Clin Climatol Assoc, V120, P49; Svee K, 1996, J CLIN INVEST, V98, P1713, DOI 10.1172/JCI118970; Taylor KR, 2007, J BIOL CHEM, V282, P18265, DOI 10.1074/jbc.M606352200; Teder P, 2002, SCIENCE, V296, P155, DOI 10.1126/science.1069659; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; Termeer CC, 2000, J IMMUNOL, V165, P1863, DOI 10.4049/jimmunol.165.4.1863; Trujillo G, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001510; Wang JF, 2007, WOUND REPAIR REGEN, V15, P113, DOI 10.1111/j.1524-475X.2006.00192.x; Wang JF, 2007, J INTERF CYTOK RES, V27, P921, DOI 10.1089/jir.2007.0008; Weiss JM, 1998, J INVEST DERMATOL, V111, P227, DOI 10.1046/j.1523-1747.1998.00286.x; Yang LJ, 2002, LAB INVEST, V82, P1183, DOI 10.1097/01.LAB.0000027841.50269.61; Zaman A, 2005, AM J RESP CELL MOL, V33, P447, DOI 10.1165/rcmb.2004-0333OC	74	115	121	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e26078	10.1371/journal.pone.0026078	http://dx.doi.org/10.1371/journal.pone.0026078			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022512	Green Published, gold, Green Submitted			2022-12-27	WOS:000295973200030
J	Boreddy, SR; Sahu, RP; Srivastava, SK				Boreddy, Srinivas Reddy; Sahu, Ravi P.; Srivastava, Sanjay K.			Benzyl Isothiocyanate Suppresses Pancreatic Tumor Angiogenesis and Invasion by Inhibiting HIF-alpha/VEGF/Rho-GTPases: Pivotal Role of STAT-3	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CELL-CYCLE ARREST; VEGF EXPRESSION; RHO-GTPASES; CANCER CELLS; HYPOXIA; APOPTOSIS; MIGRATION; ORGANIZATION; METASTASIS	Our previous studies have shown that benzyl isothiocyanate (BITC) suppresses pancreatic tumor growth by inhibiting STAT-3; however, the exact mechanism of tumor growth suppression was not clear. Here we evaluated the effects and mechanism of BITC on pancreatic tumor angiogenesis. Our results reveal that BITC significantly inhibits neovasularization on rat aorta and Chicken-Chorioallantoic membrane. Furthermore, BITC blocks the migration and invasion of BxPC-3 and PanC-1 pancreatic cancer cells in a dose dependant manner. Moreover, secretion of VEGF and MMP-2 in normoxic and hypoxic BxPC-3 and PanC-1 cells was significantly suppressed by BITC. Both VEGF and MMP-2 play a critical role in angiogenesis and metastasis. Our results reveal that BITC significantly suppresses the phosphorylation of VEGFR-2 (Tyr-1175), and expression of HIF-alpha. Rho-GTPases, which are regulated by VEGF play a crucial role in pancreatic cancer progression. BITC treatment reduced the expression of RhoC whereas up-regulated the expression of tumor suppressor RhoB. STAT-3 over-expression or IL-6 treatment significantly induced HIF-1 alpha and VEGF expression; however, BITC substantially suppressed STAT-3 as well as STAT-3-induced HIF-1 alpha and VEGF expression. Finally, in vivo tumor growth and matrigel-plug assay show reduced tumor growth and substantial reduction of hemoglobin content in the matrigel plugs and tumors of mice treated orally with 12 mu mol BITC, indicating reduced tumor angiogenesis. Immunoblotting of BITC treated tumors show reduced expression of STAT-3 phosphorylation (Tyr-705), HIF-alpha, VEGFR-2, VEGF, MMP-2, CD31 and RhoC. Taken together, our results suggest that BITC suppresses pancreatic tumor growth by inhibiting tumor angiogenesis through STAT-3-dependant pathway.	[Boreddy, Srinivas Reddy] Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Dept Biomed Sci, Amarillo, TX USA; Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Canc Biol Ctr, Amarillo, TX USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo	Boreddy, SR (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Dept Biomed Sci, Amarillo, TX USA.	Sanjay.Srivastava@ttuhsc.edu	Srivastava, Sanjay K./AAE-7635-2020; Sahu, Ravi Prakash/AFQ-3359-2022	Sahu, Ravi Prakash/0000-0003-3857-9073	National Cancer Institute (NCI); National Institutes of Health (NIH) [R01 CA106953, R01 CA129038]; NATIONAL CANCER INSTITUTE [R01CA106953, R01CA129038] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute (NCI), National Institutes of Health (NIH) (R01 CA106953 and R01 CA129038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhavani MA, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2689; Aspenstrom P, 2004, BIOCHEM J, V377, P327, DOI 10.1042/BJ20031041; Batra S, 2010, MOL CANCER THER, V9, P1596, DOI 10.1158/1535-7163.MCT-09-1146; Ben-Yosef Y, 2002, CIRC RES, V90, P784, DOI 10.1161/01.RES.0000015588.70132.DC; Boreddy SR, 2011, CLIN CANCER RES, V17, P1784, DOI 10.1158/1078-0432.CCR-10-1891; Boyd PJ, 2005, AM J PHYSIOL-CELL PH, V288, pC659, DOI 10.1152/ajpcell.00211.2004; Bryan BA, 2007, CELL MOL LIFE SCI, V64, P2053, DOI 10.1007/s00018-007-7008-z; Cho SG, 2009, CANCER RES, V69, P7062, DOI 10.1158/0008-5472.CAN-09-0476; DEMESQUITA HBB, 1991, INT J CANCER, V48, P540, DOI 10.1002/ijc.2910480411; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Haas TL, 2000, AM J PHYSIOL-HEART C, V279, pH1540, DOI 10.1152/ajpheart.2000.279.4.H1540; Hecht SS, 1999, J NUTR, V129, p768S, DOI 10.1093/jn/129.3.768S; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hoang MV, 2004, P NATL ACAD SCI USA, V101, P1874, DOI 10.1073/pnas.0308525100; Ikeda N, 1999, BRIT J CANCER, V79, P1553, DOI 10.1038/sj.bjc.6690248; Ishikawa T, 2003, ONCOGENE, V22, P1238, DOI 10.1038/sj.onc.1206207; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; JEMAL A, 2010, CA CANC J CLIN; JI BT, 1995, CANCER EPIDEM BIOMAR, V4, P885; Jung JE, 2005, FASEB J, V19, P1296, DOI 10.1096/fj.04-3099fje; Kruger EA, 2001, SEMIN ONCOL, V28, P570, DOI 10.1053/sonc.2001.28600; Lang SA, 2007, CLIN CANCER RES, V13, P6459, DOI 10.1158/1078-0432.CCR-07-1104; Li J, 2010, AAPS J, V12, P223, DOI 10.1208/s12248-010-9181-5; Liu AX, 2001, MOL CELL BIOL, V21, P6906, DOI 10.1128/MCB.21.20.6906-6912.2001; Mabjeesh NJ, 2003, CANCER CELL, V3, P363, DOI 10.1016/S1535-6108(03)00077-1; Maruyama Y, 2006, CANCER RES, V66, P6233, DOI 10.1158/0008-5472.CAN-06-0183; Milkiewicz M, 2006, INT J BIOCHEM CELL B, V38, P333, DOI 10.1016/j.biocel.2005.10.006; Oh J, 2004, ONCOGENE, V23, P5041, DOI 10.1038/sj.onc.1207688; Philip PA, 2008, LANCET, V371, P2062, DOI 10.1016/S0140-6736(08)60770-9; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Pyun BJ, 2008, CANCER RES, V68, P227, DOI 10.1158/0008-5472.CAN-07-2799; Sahu RP, 2009, CARCINOGENESIS, V30, P1744, DOI 10.1093/carcin/bgp157; Sahu RP, 2009, JNCI-J NATL CANCER I, V101, P176, DOI 10.1093/jnci/djn470; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; Slomiany MG, 2006, J PHARMACOL EXP THER, V318, P666, DOI 10.1124/jpet.106.104158; Stoeltzing O, 2004, JNCI-J NATL CANCER I, V96, P946, DOI 10.1093/jnci/djh168; Suwa H, 1998, BRIT J CANCER, V77, P147, DOI 10.1038/bjc.1998.23; Tournaire R, 2004, EMBO REP, V5, P262, DOI 10.1038/sj.embor.7400100; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Wei DY, 2004, CANCER RES, V64, P2030, DOI 10.1158/0008-5472.CAN-03-1945; Xu Q, 2005, ONCOGENE, V24, P5552, DOI 10.1038/sj.onc.1208719; Zhang GS, 2004, JNCI-J NATL CANCER I, V96, P683, DOI 10.1093/jnci/djh120; Zhang RF, 2006, J NUTR, V136, P2728, DOI 10.1093/jn/136.11.2728; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399	46	68	69	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25799	10.1371/journal.pone.0025799	http://dx.doi.org/10.1371/journal.pone.0025799			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016776	Green Submitted, Green Published, gold			2022-12-27	WOS:000295971700018
J	Mercer, N; Ramakrishnan, B; Boeggeman, E; Qasba, PK				Mercer, Natalia; Ramakrishnan, Boopathy; Boeggeman, Elizabeth; Qasba, Pradman K.			Applications of Site-Specific Labeling to Study HAMLET, a Tumoricidal Complex of alpha-Lactalbumin and Oleic Acid	PLOS ONE			English	Article							TUMOR-CELL DEATH; MOLTEN GLOBULE STATE; BREAST CARCINOMAS; PROGNOSTIC-SIGNIFICANCE; N-ACETYLGLUCOSAMINE; CRYSTAL-STRUCTURE; MAMMARY-GLAND; APOPTOSIS; PROTEIN; LETHAL	Background: Alpha-lactalbumin (a-LA) is a calcium-bound mammary gland-specific protein that is found in milk. This protein is a modulator of beta 1,4-galactosyltransferase enzyme, changing its acceptor specificity from N-acetyl-glucosamine to glucose, to produce lactose, milk's main carbohydrate. When calcium is removed from alpha-LA, it adopts a molten globule form, and this form, interestingly, when complexed with oleic acid (OA) acquires tumoricidal activity. Such a complex made from human alpha-LA (hLA) is known as HAMLET (Human A-lactalbumin Made Lethal to Tumor cells), and its tumoricidal activity has been well established. Methodology/Principal Findings: In the present work, we have used site-specific labeling, a technique previously developed in our laboratory, to label HAMLET with biotin, or a fluoroprobe for confocal microscopy studies. In addition to full length hLA, the alpha-domain of hLA (alpha D-hLA) alone is also included in the present study. We have engineered these proteins with a 17-amino acid C-terminal extension (hLA-ext and alpha D-hLA-ext). A single Thr residue in this extension is glycosylated with 2-acetonyl-galactose (C2-keto-galactose) using polypeptide-alpha-N-acetylgalactosaminyltransferase II (ppGalNAc-T2) and further conjugated with aminooxy-derivatives of fluoroprobe or biotin molecules. Conclusions/Significance: We found that the molten globule form of hLA and alpha D-hLA proteins, with or without C-terminal extension, and with and without the conjugated fluoroprobe or biotin molecule, readily form a complex with OA and exhibits tumoricidal activity similar to HAMLET made with full-length hLA protein. The confocal microscopy studies with fluoroprobe-labeled samples show that these proteins are internalized into the cells and found even in the nucleus only when they are complexed with OA. The HAMLET conjugated with a single biotin molecule will be a useful tool to identify the cellular components that are involved with it in the tumoricidal activity.	[Mercer, Natalia; Ramakrishnan, Boopathy; Boeggeman, Elizabeth; Qasba, Pradman K.] NCI Frederick, Struct Glycobiol Sect, CCR Nanobiol Program, Ctr Canc Res, Frederick, MD USA; [Ramakrishnan, Boopathy; Boeggeman, Elizabeth] NCI Frederick, Basic Sci Program, SAIC Frederick Inc, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Mercer, N (corresponding author), NCI Frederick, Struct Glycobiol Sect, CCR Nanobiol Program, Ctr Canc Res, Frederick, MD USA.	qasba@helix.nih.gov			NCI, NIH [HHSN261200800001E]; National Institutes of Health, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010804, ZIABC011385] Funding Source: NIH RePORTER	NCI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been funded in part with Federal funds from NCI, NIH under contract HHSN261200800001E. This research was supported ( in part) by the Intramural Research Program at the National Institutes of Health, National Cancer Institute, Center for Cancer Research. No external funding was received for this study. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aits S, 2009, INT J CANCER, V124, P1008, DOI 10.1002/ijc.24076; Boeggeman EE, 2003, PROTEIN EXPRES PURIF, V30, P219, DOI 10.1016/S1046-5928(03)00093-7; Brest P, 2007, CANCER RES, V67, P11327, DOI 10.1158/0008-5472.CAN-07-1153; BRODBECK U, 1967, J BIOL CHEM, V242, P1391; COHEN C, 1987, CANCER, V60, P1294, DOI 10.1002/1097-0142(19870915)60:6<1294::AID-CNCR2820600622>3.0.CO;2-2; DANDEKAR AM, 1981, P NATL ACAD SCI-BIOL, V78, P4853, DOI 10.1073/pnas.78.8.4853; de Laureto PP, 2001, EUR J BIOCHEM, V268, P4324, DOI 10.1046/j.1432-1327.2001.02352.x; DOLGIKH DA, 1981, FEBS LETT, V136, P311, DOI 10.1016/0014-5793(81)80642-4; Gustafsson L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005229; HAKANSSON A, 1995, P NATL ACAD SCI USA, V92, P8064, DOI 10.1073/pnas.92.17.8064; Hakansson A, 1999, EXP CELL RES, V246, P451, DOI 10.1006/excr.1998.4265; Hallgren O, 2006, APOPTOSIS, V11, P221, DOI 10.1007/s10495-006-3607-7; Hallgren O, 2008, ADV EXP MED BIOL, V606, P217, DOI 10.1007/978-0-387-74087-4_8; Hao G, 2007, J AM SOC MASS SPECTR, V18, P1579, DOI 10.1016/j.jasms.2007.05.019; Kamijima T, 2008, BIOCHEM BIOPH RES CO, V376, P211, DOI 10.1016/j.bbrc.2008.08.127; Kohler C, 2001, EUR J BIOCHEM, V268, P186, DOI 10.1046/j.1432-1327.2001.01870.x; Kuwajima K, 1996, FASEB J, V10, P102, DOI 10.1096/fasebj.10.1.8566530; LALA AK, 1992, J BIOL CHEM, V267, P19914; LEE AK, 1985, AM J CLIN PATHOL, V84, P687, DOI 10.1093/ajcp/84.6.687; Mossberg AK, 2010, FEBS J, V277, P4614, DOI 10.1111/j.1742-4658.2010.07890.x; Mossberg AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009384; NAKHASI HL, 1979, J BIOL CHEM, V254, P6016; NARIMATSU H, 1986, P NATL ACAD SCI USA, V83, P4720, DOI 10.1073/pnas.83.13.4720; Nollen EAA, 2001, P NATL ACAD SCI USA, V98, P12038, DOI 10.1073/pnas.201112398; Olson MOJ, 2000, TRENDS CELL BIOL, V10, P189, DOI 10.1016/S0962-8924(00)01738-4; PENG ZY, 1994, BIOCHEMISTRY-US, V33, P2136, DOI 10.1021/bi00174a021; Pettersson-Kastberg J, 2009, J MOL BIOL, V394, P994, DOI 10.1016/j.jmb.2009.09.026; QASBA PK, 1984, NATURE, V308, P377, DOI 10.1038/308377a0; Qasba PK, 2008, CURR DRUG TARGETS, V9, P292, DOI 10.2174/138945008783954943; Ramakrishnan B, 2004, CURR OPIN STRUC BIOL, V14, P593, DOI 10.1016/j.sbi.2004.09.006; Ramakrishnan B, 2001, J BIOL CHEM, V276, P37665, DOI 10.1074/jbc.M102458200; Ramakrishnan B, 2001, J MOL BIOL, V310, P205, DOI 10.1006/jmbi.2001.4757; RAMAKRISHNAN B, 2011, METHODS MOL BIOL BIO, P281; Ramakrishnan B, 2007, BIOCONJUGATE CHEM, V18, P1912, DOI 10.1021/bc7002346; Rammer P, 2010, MOL CANCER THER, V9, P24, DOI 10.1158/1535-7163.MCT-09-0559; Sharp JA, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-48; Svensson M, 2000, P NATL ACAD SCI USA, V97, P4221, DOI 10.1073/pnas.97.8.4221; Svensson M, 1999, J BIOL CHEM, V274, P6388, DOI 10.1074/jbc.274.10.6388; THOMPSON MP, 1992, PROTOPLASMA, V167, P134, DOI 10.1007/BF01403376; Tolin S, 2010, FEBS J, V277, P163, DOI 10.1111/j.1742-4658.2009.07466.x; WRBA F, 1988, PATHOL RES PRACT, V183, P277, DOI 10.1016/S0344-0338(88)80122-5	41	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e26093	10.1371/journal.pone.0026093	http://dx.doi.org/10.1371/journal.pone.0026093			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016817	Green Published, Green Submitted, gold			2022-12-27	WOS:000295971700038
J	Alvarez-Suarez, JM; Dekanski, D; Ristic, S; Radonjic, NV; Petronijevic, ND; Giampieri, F; Astolfi, P; Gonzalez-Paramas, AM; Santos-Buelga, C; Tulipani, S; Quiles, JL; Mezzetti, B; Battino, M				Alvarez-Suarez, Jose M.; Dekanski, Dragana; Ristic, Slavica; Radonjic, Nevena V.; Petronijevic, Natasa D.; Giampieri, Francesca; Astolfi, Paola; Gonzalez-Paramas, Ana M.; Santos-Buelga, Celestino; Tulipani, Sara; Quiles, Jose L.; Mezzetti, Bruno; Battino, Maurizio			Strawberry Polyphenols Attenuate Ethanol-Induced Gastric Lesions in Rats by Activation of Antioxidant Enzymes and Attenuation of MDA Increase	PLOS ONE			English	Article							ANTIULCER ACTIVITY; PHENOLIC-COMPOUNDS; VITAMIN-C; IN-VITRO; CAPACITY; FLAVONOIDS; DAMAGE; GASTROPROTECTION; IDENTIFICATION; ANTHOCYANINS	Background and Aim: Free radicals are implicated in the aetiology of gastrointestinal disorders such as gastric ulcer, colorectal cancer and inflammatory bowel disease. Strawberries are common and important fruit due to their high content of essential nutrient and beneficial phytochemicals which seem to have relevant biological activity on human health. In the present study we investigated the antioxidant and protective effects of three strawberry extracts against ethanol-induced gastric mucosa damage in an experimental in vivo model and to test whether strawberry extracts affect antioxidant enzyme activities in gastric mucosa. Methods/Principal Findings: Strawberry extracts were obtained from Adria, Sveva and Alba cultivars. Total antioxidant capacity and radical scavenging capacity were performed by TEAC, ORAC and electron paramagnetic resonance assays. Identification and quantification of anthocyanins was carried out by HPLC-DAD-MS analyses. Different groups of animals received 40 mg/day/kg body weight of strawberry crude extracts for 10 days. Gastric damage was induced by ethanol. The ulcer index was calculated together with the determination of catalase and SOD activities and MDA contents. Strawberry extracts are rich in anthocyanins and present important antioxidant capacity. Ethanol caused severe gastric damage and strawberry consumption protected against its deleterious role. Antioxidant enzyme activities increased significantly after strawberry extract intake and a concomitantly decrease in gastric lipid peroxidation was found. A significant correlation between total anthocyanin content and percent of inhibition of ulcer index was also found. Conclusions: Strawberry extracts prevented exogenous ethanol-induced damage to rats' gastric mucosa. These effects seem to be associated with the antioxidant activity and phenolic content in the extract as well as with the capacity of promoting the action of antioxidant enzymes. A diet rich in strawberries might exert a beneficial effect in the prevention of gastric diseases related to generation of reactive oxygen species.	[Alvarez-Suarez, Jose M.; Giampieri, Francesca; Battino, Maurizio] Univ Politecn Marche, Fac Med, Sez Biochim, Dipartimento Sci Clin Specialist & Odontostomatol, Ancona, Italy; [Dekanski, Dragana; Ristic, Slavica] Galenika Ad, R&D Inst, Biomed Res, Belgrade, Serbia; [Radonjic, Nevena V.; Petronijevic, Natasa D.] Univ Belgrade, Inst Med & Clin Biochem, Sch Med, Belgrade, Serbia; [Astolfi, Paola] Marche Polytech Univ, ISAC Chem Div, Ancona, Italy; [Gonzalez-Paramas, Ana M.; Santos-Buelga, Celestino] Univ Salamanca, Grp Invest Polifenoles GIP USAL, Fac Pharm, E-37008 Salamanca, Spain; [Tulipani, Sara] Univ Barcelona, Fac Pharm, Dept Nutr & Food Sci CeRTA, Barcelona, Spain; [Quiles, Jose L.] Univ Granada, Biomed Res Ctr, Inst Nutr & Food Technol Jose Mataix, Dept Physiol, Granada, Spain; [Mezzetti, Bruno] Marche Polytech Univ, Fac Agr, Dept Environm & Crop Sci SAPROV, Ancona, Italy	Marche Polytechnic University; University of Belgrade; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell'Atmosfera e del Clima (ISAC-CNR); Marche Polytechnic University; University of Salamanca; University of Barcelona; University of Granada; Marche Polytechnic University	Alvarez-Suarez, JM (corresponding author), Univ Politecn Marche, Fac Med, Sez Biochim, Dipartimento Sci Clin Specialist & Odontostomatol, Ancona, Italy.	m.a.battino@univpm.it	Astolfi, Paola/C-5953-2008; Quiles, José L./C-6911-2013; Santos-Buelga, Celestino/U-1358-2019; González-Paramás, Ana María/O-3771-2019; Mezzetti, Bruno/AAE-7696-2019; Alvarez-Suarez, José M./M-7160-2014; Lin, KuanYu/L-9195-2016; Battino, Maurizio/E-6103-2012; Tulipani, Sara/K-8285-2019; Mezzetti, Bruno/AAB-8500-2019; Giampieri, Francesca/I-1911-2015; González-Paramás, Ana M/D-2229-2011; Dekanski, Dragana/H-4584-2019; Santos-Buelga, Celestino/A-1071-2008	Astolfi, Paola/0000-0003-3226-082X; Quiles, José L./0000-0002-9048-9086; González-Paramás, Ana María/0000-0001-5477-0703; Alvarez-Suarez, José M./0000-0001-8509-1498; Lin, KuanYu/0000-0002-5291-0909; Battino, Maurizio/0000-0002-7250-1782; Tulipani, Sara/0000-0001-5658-8462; Giampieri, Francesca/0000-0002-8151-9132; González-Paramás, Ana M/0000-0001-5477-0703; Dekanski, Dragana/0000-0001-8467-4165; Santos-Buelga, Celestino/0000-0001-6592-5299; Petronijevic, Natasa/0000-0002-4338-1953; Mezzetti, Bruno/0000-0001-9307-812X; Radonjic, Nevena/0000-0002-1272-2284	EU [KBBE-2010-4, 265942]; Consolider-Ingenio [FUN-C-FOOD, CSD2007-00063]; Junta de Castilla y Leon (Grupo de Investigacion de Excelencia) [GR133]	EU(European Commission); Consolider-Ingenio(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Castilla y Leon (Grupo de Investigacion de Excelencia)(Junta de Castilla y Leon)	The research was partially granted by EUBerry Project: EU FP7 KBBE-2010-4 Grant Agreement No. 265942. The GIP-USAL is financially supported by the Consolider-Ingenio 2010 Programme (FUN-C-FOOD, CSD2007-00063) and Junta de Castilla y Leon (Grupo de Investigacion de Excelencia GR133). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCARAZ MJ, 1985, BIOCHEM PHARMACOL, V34, P2477, DOI 10.1016/0006-2952(85)90529-5; Azzi A, 2004, FEBS LETT, V558, P3, DOI 10.1016/S0014-5793(03)01526-6; Battino M, 2000, J BIOENERG BIOMEMBR, V32, P163, DOI 10.1023/A:1005559930210; BATTINO M, 1995, MECH AGEING DEV, V78, P173, DOI 10.1016/0047-6374(94)01535-T; Battino M, 2009, NUTR REV, V67, pS145, DOI 10.1111/j.1753-4887.2009.00178.x; Becker JC, 2003, BIOCHEM BIOPH RES CO, V312, P507, DOI 10.1016/j.bbrc.2003.10.146; Bompadre S, 2004, FREE RADICAL RES, V38, P831, DOI 10.1080/10715760410001715158; BRONNER C, 1985, AGENTS ACTIONS, V16, P147, DOI 10.1007/BF01983124; Brzozowski T, 1998, J PHYSIOL PHARMACOL, V49, P83; Buege J A, 1978, Methods Enzymol, V52, P302; Cao GH, 1998, J NUTR, V128, P2383, DOI 10.1093/jn/128.12.2383; Capocasa F, 2008, FOOD CHEM, V111, P872, DOI 10.1016/j.foodchem.2008.04.068; Dekanski D, 2009, MEDITERR J NUTR META, V2, P205, DOI 10.1007/s12349-009-0068-x; Dekanski D, 2009, GEN PHYSIOL BIOPHYS, V28, P135; DELALASTRA CA, 1992, J PHARM PHARMACOL, V44, P929; DICARLO G, 1994, PHYTOTHER RES, V8, P42, DOI 10.1002/ptr.2650080110; El-Abhar HS, 2010, EUR J PHARMACOL, V649, P314, DOI 10.1016/j.ejphar.2010.09.012; Gillespie KM, 2007, NAT PROTOC, V2, P867, DOI 10.1038/nprot.2007.100; GOTH L, 1991, CLIN CHIM ACTA, V196, P143, DOI 10.1016/0009-8981(91)90067-M; Graziani G, 2005, GUT, V54, P193, DOI 10.1136/gut.2004.046292; Havsteen BH, 2002, PHARMACOL THERAPEUT, V96, P67, DOI 10.1016/S0163-7258(02)00298-X; Henriques A, 2006, J ANTIMICROB CHEMOTH, V58, P773, DOI 10.1093/jac/dkl336; HUERTAS JR, 1991, BIOCHEM BIOPH RES CO, V181, P375, DOI 10.1016/S0006-291X(05)81429-9; Hung HC, 2004, JNCI-J NATL CANCER I, V96, P1577, DOI 10.1093/jnci/djh296; Hwang YP, 2011, FOOD CHEM TOXICOL, V49, P93, DOI 10.1016/j.fct.2010.10.002; IZZO AA, 1994, PHYTOTHER RES, V8, P179, DOI 10.1002/ptr.2650080313; Kim SJ, 2011, BRIT J NUTR, V106, P1792, DOI 10.1017/S000711451100242X; Li CY, 2008, ALCOHOL, V42, P683, DOI 10.1016/j.alcohol.2008.08.009; Li GG, 2011, BRIT J NUTR, V106, P1632, DOI 10.1017/S0007114511003813; da Silva FL, 2007, LWT-FOOD SCI TECHNOL, V40, P374, DOI 10.1016/j.lwt.2005.09.018; Lopes-da-Silva F, 2002, EUR FOOD RES TECHNOL, V214, P248, DOI 10.1007/s00217-001-0434-5; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARTIBONMATI E, 1980, EUR J PHARMACOL, V68, P49, DOI 10.1016/0014-2999(80)90059-X; Matsumoto M, 2004, J AGR FOOD CHEM, V52, P2226, DOI 10.1021/jf034818q; MISRA HP, 1972, J BIOL CHEM, V247, P3170; Miyazawa T, 1998, BIOSCI BIOTECH BIOCH, V62, P829, DOI 10.1271/bbb.62.829; Olaleye SB, 2006, PHYTOTHER RES, V20, P14, DOI 10.1002/ptr.1793; Oliveira CPMS, 2003, WORLD J GASTROENTERO, V9, P446; Osakabe N, 1998, BIOSCI BIOTECH BIOCH, V62, P1535, DOI 10.1271/bbb.62.1535; Pinto MD, 2010, J MED FOOD, V13, P1027, DOI 10.1089/jmf.2009.0257; Pohle T, 2001, ALIMENT PHARM THER, V15, P677, DOI 10.1046/j.1365-2036.2001.00975.x; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Saito M, 1998, J AGR FOOD CHEM, V46, P1460, DOI 10.1021/jf9709156; Sannomiya M, 2005, J ETHNOPHARMACOL, V97, P1, DOI 10.1016/j.jep.2004.09.053; Scalzo J, 2005, NUTRITION, V21, P207, DOI 10.1016/j.nut.2004.03.025; Seeram NP, 2006, FOOD CHEM, V97, P1, DOI 10.1016/j.foodchem.2005.02.047; Sun J, 2002, J AGR FOOD CHEM, V50, P7449, DOI 10.1021/jf0207530; Talavera S, 2004, J NUTR, V134, P2275, DOI 10.1093/jn/134.9.2275; Tulipani S, 2008, J AGR FOOD CHEM, V56, P696, DOI 10.1021/jf0719959; Tulipani S, 2011, FOOD CHEM, V128, P180, DOI 10.1016/j.foodchem.2011.03.025; Tulipani S, 2011, FOOD CHEM, V124, P906, DOI 10.1016/j.foodchem.2010.07.018; Tulipani S, 2008, BIOFACTORS, V34, P47, DOI 10.1002/biof.5520340106; Tulipani S, 2009, FOOD CHEM, V117, P181, DOI 10.1016/j.foodchem.2009.03.096; Ustun O, 2006, J ETHNOPHARMACOL, V108, P457, DOI 10.1016/j.jep.2006.06.001; Wang H, 1996, J AGR FOOD CHEM, V44, P701, DOI 10.1021/jf950579y; Wang H, 1997, J AGR FOOD CHEM, V45, P304, DOI 10.1021/jf960421t; Wang SY, 2009, J AGR FOOD CHEM, V57, P9651, DOI 10.1021/jf9020575; Wang SY, 2000, J AGR FOOD CHEM, V48, P140, DOI 10.1021/jf9908345	59	150	153	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25878	10.1371/journal.pone.0025878	http://dx.doi.org/10.1371/journal.pone.0025878			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22016781	Green Published, gold, Green Submitted			2022-12-27	WOS:000295970300036
J	Zhang, XH; Seftel, A; DiSanto, ME				Zhang, Xinhua; Seftel, Allen; DiSanto, Michael E.			Blebbistain, a Myosin II Inhibitor, as a Novel Strategy to Regulate Detrusor Contractility in a Rat Model of Partial Bladder Outlet Obstruction	PLOS ONE			English	Article							SMOOTH-MUSCLE MYOSIN; PARTIAL URETHRAL OBSTRUCTION; CHAIN ISOFORM EXPRESSION; ESSENTIAL LIGHT-CHAIN; IN-VIVO RELAXATION; URINARY-BLADDER; HEAVY-CHAIN; SHORTENING VELOCITY; NONMUSCLE MYOSIN; SINGLE-GENE	Partial bladder outlet obstruction (PBOO), a common urologic pathology mostly caused by benign prostatic hyperplasia, can coexist in 40-45% of patients with overactive bladder (OAB) and is associated with detrusor overactivity (DO). PBOO that induces DO results in alteration in bladder myosin II type and isoform composition. Blebbistatin (BLEB) is a myosin II inhibitor we recently demonstrated potently relaxed normal detrusor smooth muscle (SM) and reports suggest varied BLEB efficacy for different SM myosin (SMM) isoforms and/or SMM vs nonmuscle myosin (NMM). We hypothesize BLEB inhibition of myosin II as a novel contraction protein targeted strategy to regulate DO. Using a surgically-induced male rat PBOO model, organ bath contractility, competitive and Real-Time-RT-PCR were performed. It was found that obstructed-bladder weight significantly increased 2.74-fold while in vitro contractility of detrusor to various stimuli was impaired similar to 50% along with decreased shortening velocity. Obstruction also altered detrusor spontaneous activities with significantly increased amplitude but depressed frequency. PBOO switched bladder from a phasic-type to a more tonic-type SM. Expression of 5' myosin heavy chain (MHC) alternatively spliced isoform SM-A (associated with tonic-type SM) increased 3-fold while 3' MHC SM1 and essential light chain isoform MLC17b also exhibited increased relative expression. Total SMMHC expression was decreased by 25% while the expression of NMM IIB (SMemb) was greatly increased by 4.5-fold. BLEB was found to completely relax detrusor strips from both sham-operated and PBOO rats pre-contracted with KCl, carbachol or electrical field stimulation although sensitivity was slightly decreased (20%) only at lower doses for PBOO. Thus we provide the first thorough characterization of the response of rat bladder myosin to PBOO and demonstrate complete BLEB-induced PBOO bladder SM relaxation. Furthermore, the present study provides valuable evidence that BLEB may be a novel type of potential therapeutic agent for regulation of myogenic and nerve-evoked DO in OAB.	[Zhang, Xinhua; DiSanto, Michael E.] Albert Einstein Coll Med, Dept Urol, Bronx, NY 10467 USA; [Zhang, Xinhua; Seftel, Allen; DiSanto, Michael E.] Rowan Univ, Cooper Med Sch, Div Urol, Dept Surg, Camden, NJ USA	Yeshiva University; Albert Einstein College of Medicine; Rowan University; Cooper Medical School of Rowan University	Zhang, XH (corresponding author), Albert Einstein Coll Med, Dept Urol, Bronx, NY 10467 USA.	disanto-michael@cooperhealth.edu			United States National Institutes of Health [5R01DK077116]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077116] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by United States National Institutes of Health Grant 5R01DK077116. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS PH, 1979, J UROLOGY, V121, P640, DOI 10.1016/S0022-5347(17)56918-9; ADELSTEIN RS, 1980, ANNU REV BIOCHEM, V49, P921, DOI 10.1146/annurev.bi.49.070180.004421; Austin JC, 2004, J UROLOGY, V172, P1524, DOI 10.1097/01.ju.0000138045.61378.96; Aydin M, 2010, BJU INT, V106, P562, DOI 10.1111/j.1464-410X.2009.09156.x; Babu GJ, 2001, NAT CELL BIOL, V3, P1025, DOI 10.1038/ncb1101-1025; Bing W, 2003, AM J PHYSIOL-RENAL, V285, pF990, DOI 10.1152/ajprenal.00378.2002; Braverman AS, 2006, NEUROUROL URODYNAM, V25, P55, DOI 10.1002/nau.20180; CAI S, 1995, AM J PHYSIOL-CELL PH, V269, pC1126, DOI 10.1152/ajpcell.1995.269.5.C1126; Chapple CR, 2006, EUR UROL, V49, P651, DOI 10.1016/j.eururo.2006.02.018; Cher ML, 1996, WORLD J UROL, V14, P295; Chi M, 2008, P NATL ACAD SCI USA, V105, P18614, DOI 10.1073/pnas.0808162105; Chua RG, 2009, MOL CELL ENDOCRINOL, V303, P67, DOI 10.1016/j.mce.2009.02.001; DiSanto ME, 1998, AM J PHYSIOL-CELL PH, V275, pC976, DOI 10.1152/ajpcell.1998.275.4.C976; DiSanto ME, 2003, AM J PHYSIOL-CELL PH, V285, pC1397, DOI 10.1152/ajpcell.00513.2002; DiSanto ME, 1997, AM J PHYSIOL-CELL PH, V272, pC1532, DOI 10.1152/ajpcell.1997.272.5.C1532; Eddinger TJ, 2007, J PHARMACOL EXP THER, V320, P865, DOI 10.1124/jpet.106.109363; Ekman M, 2005, J GEN PHYSIOL, V125, P187, DOI 10.1085/jgp.200409212; GARRAWAY WM, 1991, LANCET, V338, P469, DOI 10.1016/0140-6736(91)90543-X; Gomes CM, 2000, J UROLOGY, V163, P2008, DOI 10.1016/S0022-5347(05)67619-7; HASEGAWA Y, 1992, J BIOCHEM-TOKYO, V111, P798, DOI 10.1093/oxfordjournals.jbchem.a123839; Hashitani H, 2004, BRIT J PHARMACOL, V141, P183, DOI 10.1038/sj.bjp.0705602; Hypolite JA, 2001, AM J PHYSIOL-CELL PH, V280, pC254, DOI 10.1152/ajpcell.2001.280.2.C254; Karagiannis P, 2004, J MUSCLE RES CELL M, V25, P149, DOI 10.1023/B:JURE.0000035879.87045.4b; KELLEY CA, 1993, J BIOL CHEM, V268, P12848; Koi PT, 2007, INT J IMPOT RES, V19, P62, DOI 10.1038/sj.ijir.3901503; Lavelle JP, 2000, AM J PHYSIOL-RENAL, V278, pF540, DOI 10.1152/ajprenal.2000.278.4.F540; LENZ S, 1989, J BIOL CHEM, V264, P9009; LEVIN RM, 1995, ADV EXP MED BIOL, V385, P7; Levin RM, 2000, NEUROUROL URODYNAM, V19, P609, DOI 10.1002/1520-6777(2000)19:5<609::AID-NAU7>3.0.CO;2-H; Limouze J, 2004, J MUSCLE RES CELL M, V25, P337, DOI 10.1007/s10974-004-6060-7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lofgren M, 2003, J GEN PHYSIOL, V121, P301, DOI 10.1085/jgp.200208720; MALMQVIST U, 1991, AM J PHYSIOL, V260, pC1085, DOI 10.1152/ajpcell.1991.260.5.C1085; MALMQVIST U, 1991, PFLUG ARCH EUR J PHY, V418, P523, DOI 10.1007/BF00370566; Martin AF, 1997, COMP BIOCHEM PHYS B, V117, P3, DOI 10.1016/S0305-0491(96)00308-2; Martin AF, 2007, AM J PHYSIOL-CELL PH, V293, pC238, DOI 10.1152/ajpcell.00567.2006; Matthew JD, 1998, J BIOL CHEM, V273, P31289, DOI 10.1074/jbc.273.47.31289; Melman A, 2005, UROLOGY, V66, P1127, DOI 10.1016/j.urology.2005.06.070; Morano I, 2000, NAT CELL BIOL, V2, P371, DOI 10.1038/35014065; Morano I, 2003, J MOL MED-JMM, V81, P481, DOI 10.1007/s00109-003-0451-x; NABESHIMA Y, 1987, J BIOL CHEM, V262, P10608; Oelke M, 2008, EUR UROL, V54, P419, DOI 10.1016/j.eururo.2008.02.017; Ren J, 2002, PHARMACOL RES, V45, P195, DOI 10.1006/phrs.2002.0947; Rhee AY, 2006, PFLUG ARCH EUR J PHY, V452, P766, DOI 10.1007/s00424-006-0091-4; Ruggieri M. R. Sr., 2006, Autonomic & Autacoid Pharmacology, V26, P311, DOI 10.1111/j.1474-8673.2006.00377.x; SAITO M, 1993, NEUROUROL URODYNAM, V12, P573, DOI 10.1002/nau.1930120610; SAITO M, 1994, NEUROUROL URODYNAM, V13, P297, DOI 10.1002/1520-6777(1994)13:3<297::AID-NAU1930130311>3.0.CO;2-Y; Sandhu KS, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.12.007; Sjuve R, 1996, J CELL BIOCHEM, V63, P86; Somlyo AV, 1998, ACTA PHYSIOL SCAND, V164, P381, DOI 10.1111/j.1365-201X.1998.tb10695.x; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Takahashi N, 2009, NEUROUROL URODYNAM, V28, P257, DOI 10.1002/nau.20625; WANG Z, 1995, LAB INVEST, V73, P244; YAMAMOTO M, 1992, P NATL ACAD SCI USA, V89, P5326, DOI 10.1073/pnas.89.12.5326; Yuan X, 2011, UROLOGY, V77, P1008; Zhang XH, 2009, J SEX MED, V6, P2661, DOI 10.1111/j.1743-6109.2009.01424.x; Zhang XH, 2011, BJU INT, V107, P310, DOI 10.1111/j.1464-410X.2010.09366.x	57	11	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25958	10.1371/journal.pone.0025958	http://dx.doi.org/10.1371/journal.pone.0025958			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22016792	gold, Green Published, Green Submitted			2022-12-27	WOS:000295970300042
J	Dixit, A; Verkhivker, GM				Dixit, Anshuman; Verkhivker, Gennady M.			The Energy Landscape Analysis of Cancer Mutations in Protein Kinases	PLOS ONE			English	Article							C-TERMINAL TAIL; ALLOSTERIC TRANSITIONS; MOLECULAR-DYNAMICS; CONFORMATIONAL TRANSITIONS; CATALYTIC DOMAIN; ADENYLATE KINASE; EGF RECEPTOR; NORMAL-MODES; DIHYDROFOLATE-REDUCTASE; BIOLOGICAL NANOMACHINES	The growing interest in quantifying the molecular basis of protein kinase activation and allosteric regulation by cancer mutations has fueled computational studies of allosteric signaling in protein kinases. In the present study, we combined computer simulations and the energy landscape analysis of protein kinases to characterize the interplay between oncogenic mutations and locally frustrated sites as important catalysts of allostetric kinase activation. While structurally rigid kinase core constitutes a minimally frustrated hub of the catalytic domain, locally frustrated residue clusters, whose interaction networks are not energetically optimized, are prone to dynamic modulation and could enable allosteric conformational transitions. The results of this study have shown that the energy landscape effect of oncogenic mutations may be allosteric eliciting global changes in the spatial distribution of highly frustrated residues. We have found that mutation-induced allosteric signaling may involve a dynamic coupling between structurally rigid (minimally frustrated) and plastic (locally frustrated) clusters of residues. The presented study has demonstrated that activation cancer mutations may affect the thermodynamic equilibrium between kinase states by allosterically altering the distribution of locally frustrated sites and increasing the local frustration in the inactive form, while eliminating locally frustrated sites and restoring structural rigidity of the active form. The energy landsape analysis of protein kinases and the proposed role of locally frustrated sites in activation mechanisms may have useful implications for bioinformatics-based screening and detection of functional sites critical for allosteric regulation in complex biomolecular systems.	[Dixit, Anshuman] Univ Kansas, Sch Pharm, Dept Pharmaceut Chem, Lawrence, KS 66045 USA; [Verkhivker, Gennady M.] Chapman Univ, Sch Computat Sci, Orange, CA USA; [Verkhivker, Gennady M.] Chapman Univ, Crean Sch Hlth & Life Sci, Schmid Coll Sci & Technol, Orange, CA USA; [Verkhivker, Gennady M.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	University of Kansas; Chapman University System; Chapman University; Chapman University System; Chapman University; University of California System; University of California San Diego	Dixit, A (corresponding author), Univ Kansas, Sch Pharm, Dept Pharmaceut Chem, Lawrence, KS 66045 USA.	gverkhiv@ucsd.edu	Verkhivker, Gennady/V-9404-2018	Verkhivker, Gennady/0000-0002-4507-4471	The University of Kansas	The University of Kansas	This work is partly supported by funding from The University of Kansas. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian FJ, 2006, NAT CHEM BIOL, V2, P95, DOI 10.1038/nchembio760; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Arora K, 2007, P NATL ACAD SCI USA, V104, P18496, DOI 10.1073/pnas.0706443104; Azam M, 2008, NAT STRUCT MOL BIOL, V15, P1109, DOI 10.1038/nsmb.1486; Bae JH, 2010, MOL CELLS, V29, P443, DOI 10.1007/s10059-010-0080-5; Bahar I, 2007, CURR OPIN STRUC BIOL, V17, P633, DOI 10.1016/j.sbi.2007.09.011; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Banavali NK, 2007, PROTEINS, V67, P1096, DOI 10.1002/prot.21334; Berteotti A, 2009, J AM CHEM SOC, V131, P244, DOI 10.1021/ja806846q; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Boutet Emmanuel, 2007, V406, P89; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; BRYNGELSON JD, 1987, P NATL ACAD SCI USA, V84, P7524, DOI 10.1073/pnas.84.21.7524; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Cecchini M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000129; Chen J, 2007, J MOL BIOL, V374, P250, DOI 10.1016/j.jmb.2007.08.047; Chennubhotla C, 2008, MOL BIOSYST, V4, P287, DOI 10.1039/b717819k; Chennubhotla C, 2007, PLOS COMPUT BIOL, V3, P1716, DOI 10.1371/journal.pcbi.0030172; Chennubhotla C, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100075; Conde L, 2004, NUCLEIC ACIDS RES, V32, pW242, DOI 10.1093/nar/gkh438; Cui Q, 2008, PROTEIN SCI, V17, P1295, DOI 10.1110/ps.03259908; Dawson JP, 2007, STRUCTURE, V15, P942, DOI 10.1016/j.str.2007.06.013; del Sol A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r92; del Sol A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100063; del Sol A, 2009, STRUCTURE, V17, P1042, DOI 10.1016/j.str.2009.06.008; Dima RI, 2006, PROTEIN SCI, V15, P258, DOI 10.1110/ps.051767306; Dixit A, 2011, PLOS COMPUT IN PRESS; Dixit A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007485; Dixit A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000487; Dixit A, 2009, BIOPHYS J, V96, P858, DOI 10.1016/j.bpj.2008.10.041; Eargle J, 2006, BIOINFORMATICS, V22, P504, DOI 10.1093/bioinformatics/bti825; Ferreiro DU, 2007, P NATL ACAD SCI USA, V104, P19819, DOI 10.1073/pnas.0709915104; Ferreiro DU, 2011, P NATL ACAD SCI USA, V108, P3499, DOI 10.1073/pnas.1018980108; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Formaneck MS, 2006, PROTEINS, V63, P846, DOI 10.1002/prot.20893; Gazdar AF, 2009, ONCOGENE, V28, pS24, DOI 10.1038/onc.2009.198; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; Gunasekaran K, 2004, PROTEINS, V57, P433, DOI 10.1002/prot.20232; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hunter T, 1997, TRENDS BIOCHEM SCI, V22, P18, DOI 10.1016/S0968-0004(96)10068-2; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Hyeon C, 2006, P NATL ACAD SCI USA, V103, P18939, DOI 10.1073/pnas.0608759103; Iacob RE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015929; Iacob RE, 2009, P NATL ACAD SCI USA, V106, P1386, DOI 10.1073/pnas.0811912106; Isin B, 2008, BIOPHYS J, V95, P789, DOI 10.1529/biophysj.107.120691; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jura N, 2011, MOL CELL, V42, P9, DOI 10.1016/j.molcel.2011.03.004; Jura N, 2009, P NATL ACAD SCI USA, V106, P21608, DOI 10.1073/pnas.0912101106; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Kannan N, 2005, J MOL BIOL, V351, P956, DOI 10.1016/j.jmb.2005.06.057; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; Kidd BA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000484; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Knight ZA, 2010, NAT REV CANCER, V10, P130, DOI 10.1038/nrc2787; Kong YF, 2006, J MOL BIOL, V356, P237, DOI 10.1016/j.jmb.2005.10.064; Kornev AP, 2008, P NATL ACAD SCI USA, V105, P14377, DOI 10.1073/pnas.0807988105; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Kouranov A, 2006, NUCLEIC ACIDS RES, V34, pD302, DOI 10.1093/nar/gkj120; Krawczak M, 2000, HUM MUTAT, V15, P45, DOI 10.1002/(SICI)1098-1004(200001)15:1<45::AID-HUMU10>3.0.CO;2-T; Kumar S, 2000, PROTEIN SCI, V9, P10; Latzer J, 2008, BIOCHEMISTRY-US, V47, P2110, DOI 10.1021/bi701350v; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Levy Y, 2004, P NATL ACAD SCI USA, V101, P511, DOI 10.1073/pnas.2534828100; Li WF, 2011, P NATL ACAD SCI USA, V108, P3504, DOI 10.1073/pnas.1018983108; Liccardi G, 2011, CANCER RES, V71, P1103, DOI 10.1158/0008-5472.CAN-10-2384; Liu T, 2007, P NATL ACAD SCI USA, V104, P4347, DOI 10.1073/pnas.0607132104; Liu Y, 2006, NAT CHEM BIOL, V2, P358, DOI 10.1038/nchembio799; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Ma BY, 1999, PROTEIN ENG, V12, P713, DOI 10.1093/protein/12.9.713; Ma JP, 1998, P NATL ACAD SCI USA, V95, P8502, DOI 10.1073/pnas.95.15.8502; Ma JP, 2000, J MOL BIOL, V302, P303, DOI 10.1006/jmbi.2000.4014; Ma L, 2007, J AM CHEM SOC, V129, P10261, DOI 10.1021/ja073059f; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Mirny L, 2001, ANNU REV BIOPH BIOM, V30, P361, DOI 10.1146/annurev.biophys.30.1.361; Miyashita O, 2003, P NATL ACAD SCI USA, V100, P12570, DOI 10.1073/pnas.2135471100; Modugno M, 2007, CANCER RES, V67, P7987, DOI 10.1158/0008-5472.CAN-07-1825; Mol CD, 2004, J BIOL CHEM, V279, P31655, DOI 10.1074/jbc.M403319200; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Mustafa M, 2011, PROTEINS, V79, P99, DOI 10.1002/prot.22862; Nagar B, 2006, MOL CELL, V21, P787, DOI 10.1016/j.molcel.2006.01.035; Nagar B, 2002, CANCER RES, V62, P4236; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Niedner RH, 2006, PROTEINS, V63, P78, DOI 10.1002/prot.20825; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Okazaki KI, 2008, P NATL ACAD SCI USA, V105, P11182, DOI 10.1073/pnas.0802524105; Okazaki K, 2006, P NATL ACAD SCI USA, V103, P11844, DOI 10.1073/pnas.0604375103; Okram B, 2006, CHEM BIOL, V13, P779, DOI 10.1016/j.chembiol.2006.05.015; Onaran HO, 2009, CURR PROTEIN PEPT SC, V10, P110, DOI 10.2174/138920309787847644; Onuchic JN, 2000, ADV PROTEIN CHEM, V53, P87; Onuchic JN, 2004, CURR OPIN STRUC BIOL, V14, P70, DOI 10.1016/j.sbi.2004.01.009; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; Ortutay C, 2005, HUM MUTAT, V25, P435, DOI 10.1002/humu.20166; Pan H, 2000, P NATL ACAD SCI USA, V97, P12020, DOI 10.1073/pnas.220240297; Papakyriakou A, 2009, PROTEINS, V76, P375, DOI 10.1002/prot.22353; Pargellis C, 2002, NAT STRUCT BIOL, V9, P268, DOI 10.1038/nsb770; Pawson T, 2005, TRENDS BIOCHEM SCI, V30, P286, DOI 10.1016/j.tibs.2005.04.013; Pellicena P, 2006, CURR OPIN STRUC BIOL, V16, P702, DOI 10.1016/j.sbi.2006.10.007; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Plotkin SS, 2002, Q REV BIOPHYS, V35, P205, DOI 10.1017/S0033583502003785; Plotkin SS, 2002, Q REV BIOPHYS, V35, P111, DOI 10.1017/S0033583502003761; Rebholz-Schuhmann D, 2004, NUCLEIC ACIDS RES, V32, P135, DOI 10.1093/nar/gkh162; Red Brewer M, 2009, MOL CELL, V34, P641, DOI 10.1016/j.molcel.2009.04.034; Richardson CJ, 2009, NUCLEIC ACIDS RES, V37, pD824, DOI 10.1093/nar/gkn832; Sayar K, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-23; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Shakhnovich E, 2006, CHEM REV, V106, P1559, DOI 10.1021/cr040425u; Shan YB, 2009, P NATL ACAD SCI USA, V106, P139, DOI 10.1073/pnas.0811223106; Sherry ST, 1999, GENOME RES, V9, P677; Shi ZS, 2006, CURR OPIN STRUC BIOL, V16, P686, DOI 10.1016/j.sbi.2006.10.011; Shigematsu H, 2006, INT J CANCER, V118, P257, DOI 10.1002/ijc.21496; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Socci ND, 1998, PROTEINS, V32, P136, DOI 10.1002/(SICI)1097-0134(19980801)32:2<136::AID-PROT2>3.3.CO;2-5; Stan G, 2007, P NATL ACAD SCI USA, V104, P8803, DOI 10.1073/pnas.0700607104; Stenberg KAE, 2000, NUCLEIC ACIDS RES, V28, P369, DOI 10.1093/nar/28.1.369; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Sutto L, 2007, P NATL ACAD SCI USA, V104, P19825, DOI 10.1073/pnas.0709922104; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Tokarski JS, 2006, CANCER RES, V66, P5790, DOI 10.1158/0008-5472.CAN-05-4187; Torkamani A, 2008, P NATL ACAD SCI USA, V105, P9011, DOI 10.1073/pnas.0802403105; Torkamani A, 2008, CANCER RES, V68, P1675, DOI 10.1158/0008-5472.CAN-07-5283; Torkamani A, 2007, BIOINFORMATICS, V23, P2918, DOI 10.1093/bioinformatics/btm437; Tsai CJ, 2008, J MOL BIOL, V378, P1, DOI 10.1016/j.jmb.2008.02.034; Tsai CJ, 2009, MOL BIOSYST, V5, P207, DOI 10.1039/b819720b; Tsai CJ, 1999, PROTEIN SCI, V8, P1181, DOI 10.1110/ps.8.6.1181; Tsai CJ, 1999, P NATL ACAD SCI USA, V96, P9970, DOI 10.1073/pnas.96.18.9970; Valiaho J, 2006, HUM MUTAT, V27, P1209, DOI 10.1002/humu.20410; Verkhivker GM, 2002, CURR OPIN STRUC BIOL, V12, P197, DOI 10.1016/S0959-440X(02)00310-X; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Whitford PC, 2007, J MOL BIOL, V366, P1661, DOI 10.1016/j.jmb.2006.11.085; Whitford PC, 2008, HFSP J, V2, P61, DOI 10.2976/1.2894846; Wolynes PG, 2005, Q REV BIOPHYS, V38, P405, DOI 10.1017/S0033583505004075; Wolynes PG, 2005, PHILOS T R SOC A, V363, P453, DOI 10.1098/rsta.2004.1502; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Xu CY, 2003, J MOL BIOL, V333, P153, DOI 10.1016/j.jmb.2003.08.027; Yang L, 2009, P NATL ACAD SCI USA, V106, P12347, DOI 10.1073/pnas.0902159106; Yang S, 2009, P NATL ACAD SCI USA, V106, P3776, DOI 10.1073/pnas.0808261106; Yang S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000047; Yang Z, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000360; Yanga S, 2008, EXP CELL RES, V314, P413, DOI 10.1016/j.yexcr.2007.09.002; Young MA, 2001, CELL, V105, P115, DOI 10.1016/S0092-8674(01)00301-4; Yu HB, 2007, PLOS COMPUT BIOL, V3, P199, DOI 10.1371/journal.pcbi.0030021; Yu H, 2007, PLOS COMPUT BIOL, V3, P214, DOI 10.1371/journal.pcbi.0030023; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zandany N, 2008, P NATL ACAD SCI USA, V105, P11697, DOI 10.1073/pnas.0804104105; Zhang HJ, 1997, BIOCHEM BIOPH RES CO, V238, P382, DOI 10.1006/bbrc.1997.7301; Zhang JM, 2010, NATURE, V463, P501, DOI 10.1038/nature08675; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zheng W, 2007, BIOPHYS J, V93, P2289, DOI 10.1529/biophysj.107.105270; Zheng WJ, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-45; Zheng WJ, 2009, BIOPHYS J, V96, P2128, DOI [10.1016/j.bpj.2008.12.3897, 10.1016/j.bpj.200X.12.3X97]; Zheng WJ, 2009, CURR PROTEIN PEPT SC, V10, P128, DOI 10.2174/138920309787847608; Zheng WJ, 2006, P NATL ACAD SCI USA, V103, P7664, DOI 10.1073/pnas.0510426103; Zheng WJ, 2005, J MOL BIOL, V346, P745, DOI 10.1016/j.jmb.2004.12.020; Zhou TJ, 2007, CHEM BIOL DRUG DES, V70, P171, DOI 10.1111/j.1747-0285.2007.00556.x; Zhou XB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-40; Zhuravlev PI, 2010, Q REV BIOPHYS, V43, P295, DOI 10.1017/S0033583510000119; Zou J, 2008, PROTEINS, V72, P323, DOI 10.1002/prot.21928	171	30	30	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e26071	10.1371/journal.pone.0026071	http://dx.doi.org/10.1371/journal.pone.0026071			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998754	Green Published, Green Submitted, gold			2022-12-27	WOS:000295968700037
J	Italia, JL; Sharp, A; Carter, KC; Warn, P; Kumar, MNVR				Italia, Jagdishbhai L.; Sharp, Andrew; Carter, Katharine C.; Warn, Peter; Kumar, M. N. V. Ravi			Peroral Amphotericin B Polymer Nanoparticles Lead to Comparable or Superior In Vivo Antifungal Activity to That of Intravenous Ambisome (R) or Fungizone (TM)	PLOS ONE			English	Article							ASPERGILLUS-FUMIGATUS; CELL TRANSPLANTATION; MURINE MODEL; THERAPY; FORMULATION; DIFFUSION	Background: Despite advances in the treatment, the morbidity and mortality rate associated with invasive aspergillosis remains unacceptably high (70-90%) in immunocompromised patients. Amphotericin B (AMB), a polyene antibiotic with broad spectrum antifungal activity appears to be a choice of treatment but is available only as an intravenous formulation; development of an oral formulation would be beneficial as well as economical. Methodology: Poly(lactide-co-glycolode) (PLGA) nanoparticles encapsulating AMB (AMB-NPs) were developed for oral administration. The AMB-NPs were 113 +/- 20 nm in size with similar to 70% entrapment efficiency at 30% AMB w/w of polymer. The in vivo therapeutic efficacy of oral AMB-NPs was evaluated in neutropenic murine models of disseminated and invasive pulmonary aspergillosis. AMB-NPs exhibited comparable or superior efficacy to that of Ambisome (R) or Fungizone (TM) administered parenterally indicating potential of NPs as carrier for oral delivery. Conclusions: The present investigation describes an efficient way of producing AMB-NPs with higher AMB pay-load and entrapment efficiency employing DMSO as solvent and ethanol as non-solvent. The developed oral formulation was highly efficacious in murine models of disseminated aspergillosis as well as an invasive pulmonary aspergillosis, which is refractory to treatment with IP Fungizone (TM) and responds only modestly to AmBisome (R).	[Italia, Jagdishbhai L.; Carter, Katharine C.; Kumar, M. N. V. Ravi] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland; [Sharp, Andrew; Warn, Peter] Univ Manchester, Sch Translat Med, Manchester, Lancs, England	University of Strathclyde; University of Manchester	Italia, JL (corresponding author), Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland.	peter.warn@manchester.ac.uk; mnvrkumar@strath.ac.uk			University of Strathclyde	University of Strathclyde	The study was funded by startup funds from University of Strathclyde (www.strath.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allemann E, 1998, ADV DRUG DELIVER REV, V34, P171, DOI 10.1016/S0169-409X(98)00039-8; Annaloro C, 2009, J ANTIMICROB CHEMOTH, V63, P625, DOI 10.1093/jac/dkn549; Bhardwaj V, 2005, J BIOMED NANOTECHNOL, V1, P235, DOI 10.1166/jbn.2005.033; Dagenais TRT, 2009, CLIN MICROBIOL REV, V22, P447, DOI 10.1128/CMR.00055-08; Delmas G, 2002, ANTIMICROB AGENTS CH, V46, P2704, DOI 10.1128/AAC.46.8.2704-2707.2002; Denning DW, 1996, CLIN INFECT DIS, V23, P608, DOI 10.1093/clinids/23.3.608; Egger SS, 2010, BONE MARROW TRANSPL, V45, P1197, DOI 10.1038/bmt.2009.325; Erjavec Z, 2009, CLIN MICROBIOL INFEC, V15, P625, DOI 10.1111/j.1469-0691.2009.02929.x; Galindo-Rodriguez S, 2004, PHARM RES-DORDR, V21, P1428, DOI 10.1023/B:PHAM.0000036917.75634.be; Hariharan S, 2006, PHARM RES-DORDR, V23, P184, DOI 10.1007/s11095-005-8418-y; Hirvonen J., 2002, AAPS PHARMSCITECH, V3, P52; Italia JL, 2009, PHARM RES-DORDR, V26, P1324, DOI 10.1007/s11095-009-9841-2; Kayser O, 2003, INT J PHARM, V254, P73, DOI 10.1016/S0378-5173(02)00686-5; Lehrnbecher T, 2010, J INFECTION, V61, P259, DOI 10.1016/j.jinf.2010.06.018; Murakami H, 2000, POWDER TECHNOL, V107, P137, DOI 10.1016/S0032-5910(99)00182-5; Neofytos D, 2009, CLIN INFECT DIS, V48, P265, DOI 10.1086/595846; Nussbaum JC, 2010, CLIN INFECT DIS, V50, P338, DOI 10.1086/649861; Risovic V, 2007, DRUG DEV IND PHARM, V33, P703, DOI 10.1080/03639040601077349; Sheppard DC, 2006, ANTIMICROB AGENTS CH, V50, P3501, DOI 10.1128/AAC.00787-06; Singh UK, 2010, J TROP PEDIATRICS, V56, P321, DOI 10.1093/tropej/fmp132; Upton A, 2007, CLIN INFECT DIS, V44, P531, DOI 10.1086/510592; van Griensven J, 2010, LANCET INFECT DIS, V10, P184, DOI 10.1016/S1473-3099(10)70011-6; Warn PA, 2010, INT J ANTIMICROB AG, V35, P146, DOI 10.1016/j.ijantimicag.2009.09.029; Wasan EK, 2009, INT J PHARMACEUT, V372, P76, DOI 10.1016/j.ijpharm.2009.01.003; Xiong JY, 2005, J PHYS CHEM B, V109, P13877, DOI 10.1021/jp0446480	25	43	43	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e25744	10.1371/journal.pone.0025744	http://dx.doi.org/10.1371/journal.pone.0025744			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998690	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000295968700017
J	Riedel, TJ; Johnson, LC; Knight, J; Hantgan, RR; Holmes, RP; Lowther, WT				Riedel, Travis J.; Johnson, Lynnette C.; Knight, John; Hantgan, Roy R.; Holmes, Ross P.; Lowther, W. Todd			Structural and Biochemical Studies of Human 4-hydroxy-2-oxoglutarate Aldolase: Implications for Hydroxyproline Metabolism in Primary Hyperoxaluria	PLOS ONE			English	Article							COLI DIHYDRODIPICOLINATE SYNTHASE; CRYSTAL-STRUCTURE; QUATERNARY STRUCTURE; 2-KETO-4-HYDROXYGLUTARATE ALDOLASE; 4-HYDROXY-2-KETOGLUTARATE ALDOLASE; DIRECTED EVOLUTION; GLYOXYLATE; SUBSTRATE; OXALATE; ENZYME	Background: 4-hydroxy-2-oxoglutarate (HOG) aldolase is a unique enzyme in the hydroxyproline degradation pathway catalyzing the cleavage of HOG to pyruvate and glyoxylate. Mutations in this enzyme are believed to be associated with the excessive production of oxalate in primary hyperoxaluria type 3 (PH3), although no experimental data is available to support this hypothesis. Moreover, the identity, oligomeric state, enzymatic activity, and crystal structure of human HOGA have not been experimentally determined. Methodology/Principal Findings: In this study human HOGA (hHOGA) was identified by mass spectrometry of the mitochondrial enzyme purified from bovine kidney. hHOGA performs a retro-aldol cleavage reaction reminiscent of the trimeric 2-keto-3-deoxy-6-phosphogluconate aldolases. Sequence comparisons, however, show that HOGA is related to the tetrameric, bacterial dihydrodipicolinate synthases, but the reaction direction is reversed. The 1.97 A resolution crystal structure of hHOGA bound to pyruvate was determined and enabled the modeling of the HOG-Schiff base intermediate and the identification of active site residues. Kinetic analyses of site-directed mutants support the importance of Lys196 as the nucleophile, Tyr168 and Ser77 as components of a proton relay, and Asn78 and Ser198 as unique residues that facilitate substrate binding. Conclusions/Significance: The biochemical and structural data presented support that hHOGA utilizes a type I aldolase reaction mechanism, but employs novel residue interactions for substrate binding. A mapping of the PH3 mutations identifies potential rearrangements in either the active site or the tetrameric assembly that would likely cause a loss in activity. Altogether, these data establish a foundation to assess mutant forms of hHOGA and how their activity could be pharmacologically restored.	[Riedel, Travis J.; Johnson, Lynnette C.; Hantgan, Roy R.; Lowther, W. Todd] Wake Forest Sch Med, Struct Biol Ctr, Winston Salem, NC 27157 USA; [Riedel, Travis J.; Johnson, Lynnette C.; Hantgan, Roy R.; Lowther, W. Todd] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC USA; [Knight, John; Holmes, Ross P.] Wake Forest Sch Med, Div Urol, Dept Surg, Winston Salem, NC USA	Wake Forest University; Wake Forest University; Wake Forest University	Riedel, TJ (corresponding author), Wake Forest Sch Med, Struct Biol Ctr, Winston Salem, NC 27157 USA.	tlowther@wakehealth.edu	Knight, John/J-8739-2012	Knight, John/0000-0002-9683-8064; Holmes, Ross/0000-0002-8994-0159	The Oxalosis and Hyperoxaluria Foundation; National Institutes of Health [DK54468, DK73732, DK074945]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083527, R21DK074945, R01DK073732, R01DK054468] Funding Source: NIH RePORTER	The Oxalosis and Hyperoxaluria Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by The Oxalosis and Hyperoxaluria Foundation and the National Institutes of Health (Grants DK54468, DK73732 and DK074945). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS E, 1980, ANNU REV BIOCHEM, V49, P1005, DOI 10.1146/annurev.bi.49.070180.005041; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AISAKA K, 1991, BIOCHEM J, V276, P541, DOI 10.1042/bj2760541; ANDERSON M, 1985, ARCH BIOCHEM BIOPHYS, V236, P82, DOI 10.1016/0003-9861(85)90608-3; Belostotsky R, 2010, AM J HUM GENET, V87, P392, DOI 10.1016/j.ajhg.2010.07.023; Blagova E, 2006, PROTEINS, V62, P297, DOI 10.1002/prot.20684; Blickling S, 1997, BIOCHEMISTRY-US, V36, P24, DOI 10.1021/bi962272d; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheriyan M, 2007, PROTEIN SCI, V16, P2368, DOI 10.1110/ps.073042907; Coulter-Mackie MB, 2006, KIDNEY INT, V70, P1891, DOI 10.1038/sj.ki.5001987; da Costa TPS, 2010, BIOCHIMIE, V92, P837, DOI 10.1016/j.biochi.2010.03.004; Danpure C. J., 2001, METABOLIC MOL BASES, V2, P3323; Danpure CJ, 2005, AM J NEPHROL, V25, P303, DOI 10.1159/000086362; DEKKER EE, 1992, J BIOL CHEM, V267, P10507; Devenish SRA, 2008, ACTA CRYSTALLOGR F, V64, P1092, DOI 10.1107/S1744309108033654; Dobson RCJ, 2005, BIOCHEMISTRY-US, V44, P13007, DOI 10.1021/bi051281w; Dobson RCJ, 2004, J MOL BIOL, V338, P329, DOI 10.1016/j.jmb.2004.02.060; Dobson RCJ, 2009, BIOCHIMIE, V91, P1036, DOI 10.1016/j.biochi.2009.05.013; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fullerton SWB, 2006, BIOORGAN MED CHEM, V14, P3002, DOI 10.1016/j.bmc.2005.12.022; GOLDSTONE A, 1962, J BIOL CHEM, V237, P3476; GRADY SR, 1981, BIOCHEMISTRY-US, V20, P2497, DOI 10.1021/bi00512a021; Griffiths JS, 2004, BIOORGAN MED CHEM, V12, P4067, DOI 10.1016/j.bmc.2004.05.034; Guo BBB, 2009, BIOCHEM BIOPH RES CO, V380, P802, DOI 10.1016/j.bbrc.2009.01.169; Holmes RP, 1998, J UROLOGY, V160, P1617, DOI 10.1016/S0022-5347(01)62363-2; Hoppe B, 2009, KIDNEY INT, V75, P1264, DOI 10.1038/ki.2009.32; Jones JM, 2000, J BIOL CHEM, V275, P12590, DOI 10.1074/jbc.275.17.12590; Kefala G, 2008, BIOCHEM J, V411, P351, DOI 10.1042/BJ20071360; Kivirikko K I, 1970, Int Rev Connect Tissue Res, V5, P93; Knight J, 2006, KIDNEY INT, V70, P1929, DOI 10.1038/sj.ki.5001906; KOBES RD, 1966, BIOCHEM BIOPH RES CO, V25, P329, DOI 10.1016/0006-291X(66)90781-9; KRAMER DN, 1959, ANAL CHEM, V31, P250, DOI 10.1021/ac60146a028; Lawrence MC, 1997, J MOL BIOL, V266, P381, DOI 10.1006/jmbi.1996.0769; Lumb MJ, 2003, BIOCHEM J, V374, P79, DOI 10.1042/BJ20030371; MAITRA U, 1963, J BIOL CHEM, V238, P3660; MAITRA U, 1964, J BIOL CHEM, V239, P1485; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Monico CG, 2011, CLIN J AM SOC NEPHRO, V6, P2289, DOI 10.2215/CJN.02760311; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Muscroft-Taylor AC, 2010, ARCH BIOCHEM BIOPHYS, V503, P202, DOI 10.1016/j.abb.2010.08.009; NEIMS AH, 1962, J BIOL CHEM, V237, pP976; Pauluhn A, 2008, PROTEINS, V72, P35, DOI 10.1002/prot.21890; Pearce FG, 2008, BIOCHEMISTRY-US, V47, P12108, DOI 10.1021/bi801094t; Perugini MA, 2005, EUR BIOPHYS J BIOPHY, V34, P469, DOI 10.1007/s00249-005-0491-y; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Phang J. M., 2001, METABOLIC MOL BASES, P1821; Poore RE, 1997, AM J PHYSIOL-CELL PH, V272, pC289, DOI 10.1152/ajpcell.1997.272.1.C289; ROSSO RG, 1967, J BIOL CHEM, V242, P5524; RUFFO A, 1962, BIOCHEM J, V85, P588, DOI 10.1042/bj0850588; Samland AK, 2006, APPL MICROBIOL BIOT, V71, P253, DOI 10.1007/s00253-006-0422-6; SCHOLTZ JM, 1984, BIOORG CHEM, V12, P229, DOI 10.1016/0045-2068(84)90006-3; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Theodossis A, 2004, J BIOL CHEM, V279, P43886, DOI 10.1074/jbc.M407702200; VALLE D, 1979, J CLIN INVEST, V64, P1365, DOI 10.1172/JCI109593; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Walters MJ, 2008, BIOORGAN MED CHEM, V16, P710, DOI 10.1016/j.bmc.2007.10.043; Wymer N, 2001, STRUCTURE, V9, P1, DOI 10.1016/S0969-2126(00)00555-4	58	42	45	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e26021	10.1371/journal.pone.0026021	http://dx.doi.org/10.1371/journal.pone.0026021			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998747	gold, Green Published, Green Submitted			2022-12-27	WOS:000295968700032
J	Deraz, EM; Kudo, Y; Yoshida, M; Obayashi, M; Tsunematsu, T; Tani, H; Siriwardena, SBSM; Kiekhaee, MR; Qi, GY; Iizuka, S; Ogawa, I; Campisi, G; Lo Muzio, L; Abiko, Y; Kikuchi, A; Takata, T				Deraz, Elsayed Mohamed; Kudo, Yasusei; Yoshida, Maki; Obayashi, Mariko; Tsunematsu, Takaaki; Tani, Hirotaka; Siriwardena, Samadarani B. S. M.; Kiekhaee, Mohammad Reza; Qi, Guangying; Iizuka, Shinji; Ogawa, Ikuko; Campisi, Giuseppina; Lo Muzio, Lorenzo; Abiko, Yoshimitsu; Kikuchi, Akira; Takata, Takashi			MMP-10/Stromelysin-2 Promotes Invasion of Head and Neck Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; LYMPH-NODE METASTASIS; MATRIX METALLOPROTEINASES; ORAL-CANCER; GASTRIC-CANCER; EXPRESSION; WNT5A; PERIOSTIN; TARGET; GENES	Background: Periostin, IFN-induced transmembrane protein 1 (IFITM1) and Wingless-type MMTV integration site family, member 5B (Wnt-5b) were previously identified as the invasion promoted genes of head and neck squamous cell carcinoma (HNSCC) by comparing the gene expression profiles between parent and a highly invasive clone. We have previously reported that Periostin and IFITM1 promoted the invasion of HNSCC cells. Here we demonstrated that Wnt-5b overexpression promoted the invasion of HNSCC cells. Moreover, stromelysin-2 (matrix metalloproteinase-10; MMP-10) was identified as a common up-regulated gene among Periostin, IFITM1 and Wnt-5b overexpressing HNSCC cells by using microarray data sets. In this study, we investigated the roles of MMP-10 in the invasion of HNSCC. Methods and Findings: We examined the expression of MMP-10 in HNSCC cases by immunohistochemistry. High expression of MMP-10 was frequently observed and was significantly correlated with the invasiveness and metastasis in HNSCC cases. Next, we examined the roles of MMP-10 in the invasion of HNSCC cells in vitro. Ectopic overexpression of MMP-10 promoted the invasion of HNSCC cells, and knockdown of MMP-10 suppressed the invasion of HNSCC cells. Moreover, MMP-10 knockdown suppressed Periostin and Wnt-5b-promoted invasion. Interestingly, MMP-10 overexpression induced the decreased p38 activity and MMP-10 knockdown induced the increased p38 activity. In addition, treatment with a p38 inhibitor SB203580 in HNSCC cells inhibited the invasion. Conclusions: These results suggest that MMP-10 plays an important role in the invasion and metastasis of HNSCC, and that invasion driven by MMP-10 is partially associated with p38 MAPK inhibition. We suggest that MMP-10 can be used as a marker for prediction of metastasis in HNSCC.	[Deraz, Elsayed Mohamed; Kudo, Yasusei; Yoshida, Maki; Obayashi, Mariko; Tsunematsu, Takaaki; Tani, Hirotaka; Siriwardena, Samadarani B. S. M.; Kiekhaee, Mohammad Reza; Qi, Guangying; Iizuka, Shinji; Takata, Takashi] Hiroshima Univ, Div Frontier Med Sci, Dept Oral & Maxillofacial Pathobiol, Grad Sch Biomed Sci, Hiroshima, Japan; [Ogawa, Ikuko] Hiroshima Univ Hosp, Ctr Oral Clin Examinat, Hiroshima, Japan; [Campisi, Giuseppina] Univ Palermo, Dept Stomatol Sci, Palermo, Italy; [Lo Muzio, Lorenzo] Univ Foggia, Dept Surg Sci, Foggia, Italy; [Abiko, Yoshimitsu] Nihon Univ, Sch Dent Matsudo, Dept Biochem, Tokyo, Japan; [Takata, Takashi] Osaka Univ, Dept Mol Biol & Biochem, Grad Sch Med, Suita, Osaka, Japan	Hiroshima University; Hiroshima University; University of Palermo; University of Foggia; Nihon University; Osaka University	Deraz, EM (corresponding author), Hiroshima Univ, Div Frontier Med Sci, Dept Oral & Maxillofacial Pathobiol, Grad Sch Biomed Sci, Hiroshima, Japan.	ykudo@hiroshima-u.ac.jp; ttakata@hiroshima-u.ac.jp	Muzio, Lorenzo Lo/C-8533-2011	Muzio, Lorenzo Lo/0000-0003-4633-4893; Kudo, Yasusei/0000-0002-0392-7720; campisi, giuseppina/0000-0002-9443-0495	Ministry of Education, Science and Culture of Japan; Kurozumi Memorial Foundation; Grants-in-Aid for Scientific Research [23659858] Funding Source: KAKEN	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kurozumi Memorial Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The work was funded in part by the Ministry of Education, Science and Culture of Japan grants-in-aid (Y. Kudo and T. Takata) and Kurozumi Memorial Foundation grant (Y. Kudo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Brakebusch C, 2002, J CLIN INVEST, V109, P999, DOI 10.1172/JCI200215468; Chen RS, 2009, ONCOGENE, V28, P599, DOI 10.1038/onc.2008.414; Dissanayake SK, 2007, J BIOL CHEM, V282, P17259, DOI 10.1074/jbc.M700075200; Enomoto M, 2009, ONCOGENE, V28, P3197, DOI 10.1038/onc.2009.175; FIDLER IJ, 1990, CANCER RES, V50, P6130; Frederick LA, 2008, ONCOGENE, V27, P4841, DOI 10.1038/onc.2008.119; Gill JH, 2004, NEOPLASIA, V6, P777, DOI 10.1593/neo.04283; Han X, 2002, CONNECT TISSUE RES, V43, P63; Hatano H, 2008, CLIN CANCER RES, V14, P6097, DOI 10.1158/1078-0432.CCR-07-4761; Hickson JA, 2006, CANCER RES, V66, P2264, DOI 10.1158/0008-5472.CAN-05-3676; Howell GMS, 2005, HEAD NECK-J SCI SPEC, V27, P710, DOI 10.1002/hed.20222; Ishikawa F, 2010, ONCOGENE, V29, P909, DOI 10.1038/onc.2009.387; JACOBSSON PA, 1973, ACTA RADIOL THER PHY, V12, P1; Japan Society for Head and Neck Cancer, 2005, GEN RUL CLIN PATH ST; Kawata R, 2002, ACTA OTO-LARYNGOL, V122, P101, DOI 10.1080/00016480252775823; Kudo Y, 2007, HISTOL HISTOPATHOL, V22, P1167, DOI 10.14670/HH-22.1167; Kudo Y, 2004, CLIN CANCER RES, V10, P5455, DOI 10.1158/1078-0432.CCR-04-0372; Kudo Y, 2003, ORAL ONCOL, V39, P515, DOI 10.1016/S1368-8375(03)00015-0; Kudo Y, 2006, CANCER RES, V66, P6928, DOI 10.1158/0008-5472.CAN-05-4540; Kurahara S, 1999, HEAD NECK-J SCI SPEC, V21, P627, DOI 10.1002/(SICI)1097-0347(199910)21:7<627::AID-HED7>3.3.CO;2-U; Kurayoshi M, 2006, CANCER RES, V66, P10439, DOI 10.1158/0008-5472.CAN-06-2359; Madlener H, 1997, GENE, V202, P75, DOI 10.1016/S0378-1119(97)00456-3; MAMELLE G, 1994, AM J SURG, V168, P494, DOI 10.1016/S0002-9610(05)80109-6; Mao L, 2004, CANCER CELL, V5, P311, DOI 10.1016/S1535-6108(04)00090-X; Masckauchan TNH, 2006, MOL BIOL CELL, V17, P5163, DOI 10.1091/mbc.E06-04-0320; Milner Jennifer M., 2005, Current Drug Targets - Inflammation and Allergy, V4, P363, DOI 10.2174/1568010054022141; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Neville BW, 1995, EPITHELIAL PTHOLOGY, P295; Pukrop T, 2006, P NATL ACAD SCI USA, V103, P5454, DOI 10.1073/pnas.0509703103; Ripka S, 2007, CARCINOGENESIS, V28, P1178, DOI 10.1093/carcin/bgl255; SAARIALHOKERE UK, 1994, J CLIN INVEST, V94, P79, DOI 10.1172/JCI117351; Saitoh T, 2002, INT J MOL MED, V10, P345; Seiki M, 1999, APMIS, V107, P137, DOI 10.1111/j.1699-0463.1999.tb01536.x; Siriwardena BSMS, 2006, BRIT J CANCER, V95, P1396, DOI 10.1038/sj.bjc.6603431; SIRUM KL, 1989, BIOCHEMISTRY-US, V28, P8691, DOI 10.1021/bi00448a004; Sternlicht MD, 2000, ONCOGENE, V19, P1102, DOI 10.1038/sj.onc.1203347; STOCKER W, 1995, PROTEIN SCI, V4, P823; Van Themsche C, 2004, J IMMUNOL, V173, P3605, DOI 10.4049/jimmunol.173.6.3605; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Werner JA, 2002, CLIN EXP METASTAS, V19, P275, DOI 10.1023/A:1015531319087; WINDSOR LJ, 1993, J BIOL CHEM, V268, P17341; Yamamoto H, 2010, ONCOGENE, V29, P2036, DOI 10.1038/onc.2009.496; Yamamoto H, 2009, GASTROENTEROLOGY, V137, P242, DOI 10.1053/j.gastro.2009.02.003; Ye H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-69; Yen CY, 2009, BIOMARKERS, V14, P244, DOI 10.1080/13547500902829375	45	61	62	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25438	10.1371/journal.pone.0025438	http://dx.doi.org/10.1371/journal.pone.0025438			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998657	Green Published, gold			2022-12-27	WOS:000295966900026
J	Masuda, N				Masuda, Naoki			Clustering in Large Networks Does Not Promote Upstream Reciprocity	PLOS ONE			English	Article							GENERALIZED EXCHANGE; SOCIAL DILEMMAS; EVOLUTION; COOPERATION; DYNAMICS	Upstream reciprocity (also called generalized reciprocity) is a putative mechanism for cooperation in social dilemma situations with which players help others when they are helped by somebody else. It is a type of indirect reciprocity. Although upstream reciprocity is often observed in experiments, most theories suggest that it is operative only when players form short cycles such as triangles, implying a small population size, or when it is combined with other mechanisms that promote cooperation on their own. An expectation is that real social networks, which are known to be full of triangles and other short cycles, may accommodate upstream reciprocity. In this study, I extend the upstream reciprocity game proposed for a directed cycle by Boyd and Richerson to the case of general networks. The model is not evolutionary and concerns the conditions under which the unanimity of cooperative players is a Nash equilibrium. I show that an abundance of triangles or other short cycles in a network does little to promote upstream reciprocity. Cooperation is less likely for a larger population size even if triangles are abundant in the network. In addition, in contrast to the results for evolutionary social dilemma games on networks, scale-free networks lead to less cooperation than networks with a homogeneous degree distribution.	[Masuda, Naoki] Univ Tokyo, Dept Math Informat, Bunkyo Ku, Tokyo, Japan; [Masuda, Naoki] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Masuda, N (corresponding author), Univ Tokyo, Dept Math Informat, Bunkyo Ku, Tokyo, Japan.	masuda@mist.i.u-tokyo.ac.jp		Masuda, Naoki/0000-0003-1567-801X	MEXT, Japan [20760258, 23681033]; Grants-in-Aid for Scientific Research [23681033] Funding Source: KAKEN	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The present work is financially supported by Grants-in-Aid for Scientific Research (Grant Nos. 20760258 and 23681033, and Innovative Areas "Systems Molecular Ethology") from MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barta Z, 2011, P ROY SOC B-BIOL SCI, V278, P843, DOI 10.1098/rspb.2010.1634; Bartlett MY, 2006, PSYCHOL SCI, V17, P319, DOI 10.1111/j.1467-9280.2006.01705.x; BOYD R, 1989, SOC NETWORKS, V11, P213, DOI 10.1016/0378-8733(89)90003-8; Dufwenberg Martin, 2001, HOMO OECON, V18, P19; Duran O, 2005, PHYSICA D, V208, P257, DOI 10.1016/j.physd.2005.07.005; Fortunato S, 2006, P 4 WORKSH ALG MOD W, P59; Ghoshal G, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1396; Greiner B, 2005, J ECON PSYCHOL, V26, P711, DOI 10.1016/j.joep.2004.04.003; Hamilton IM, 2005, P ROY SOC B-BIOL SCI, V272, P2259, DOI 10.1098/rspb.2005.3248; Iwagami A, 2010, J THEOR BIOL, V265, P297, DOI 10.1016/j.jtbi.2010.05.010; Klemm K, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.057102; Klemm K, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.036123; Malinowski B., 1961, ARGONAUTS W PACIFIC; Masuda N, 2007, P R SOC B, V274, P1815, DOI 10.1098/rspb.2007.0294; Masuda N, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/113002; Molm LD, 2007, AM J SOCIOL, V113, P205, DOI 10.1086/517900; Motter AE, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.065102; Newman M., 2010, NETWORKS INTRO, DOI [10.1162/artl_r_00062, 10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2007, P R SOC B, V274, P605, DOI 10.1098/rspb.2006.0125; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Pfeiffer T, 2005, P ROY SOC B-BIOL SCI, V272, P1115, DOI 10.1098/rspb.2004.2988; Rankin DJ, 2009, EVOLUTION, V63, P1913, DOI 10.1111/j.1558-5646.2009.00656.x; Rutte C, 2007, PLOS BIOL, V5, P1421, DOI 10.1371/journal.pbio.0050196; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Santos FC, 2006, J EVOLUTION BIOL, V19, P726, DOI 10.1111/j.1420-9101.2005.01063.x; Santos FC, 2006, P NATL ACAD SCI USA, V103, P3490, DOI 10.1073/pnas.0508201103; Sigmund K., 2010, CALCULUS SELFISHNESS; Stanca L, 2009, J ECON PSYCHOL, V30, P190, DOI 10.1016/j.joep.2008.07.010; Tomassini M, 2007, INT J MOD PHYS C, V18, P1173, DOI 10.1142/S0129183107011212; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Wasserman S, 1994, SOCIAL NETWORK ANAL; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; YAMAGISHI T, 1993, SOC PSYCHOL QUART, V56, P235, DOI 10.2307/2786661; ZIEGLER R, 1990, SOC ECON, P141	40	8	8	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25190	10.1371/journal.pone.0025190	http://dx.doi.org/10.1371/journal.pone.0025190			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834NA	21998641	Green Published, Green Submitted, gold			2022-12-27	WOS:000295966900013
J	Pan, N; Jiang, W; Sun, H; Miao, FQ; Qiu, J; Jin, H; Xu, JH; Shi, Q; Xie, W; Zhang, JQ				Pan, Ning; Jiang, Wei; Sun, Hang; Miao, Fengqin; Qiu, Jie; Jin, Hui; Xu, Jinhuan; Shi, Qian; Xie, Wei; Zhang, Jianqiong			KIR and HLA Loci Are Associated with Hepatocellular Carcinoma Development in Patients with Hepatitis B Virus Infection: A Case-Control Study	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; IMMUNOGLOBULIN-LIKE RECEPTOR; MHC CLASS-I; INHIBITORY RECEPTORS; TRANSGENIC MICE; LIVER-INJURY; RECOGNITION; GENE; GENOTYPES; KIR2DS4	Background: Natural killer (NK) cells activation has been reported to contribute to inflammation and liver injury during hepatitis B virus (HBV) infection both in transgenic mice and in patients. However, the role of NK cells in the process of HBV-associated hepatocellular carcinoma (HCC) development has not been addressed. Killer cell immunoglobulin-like receptors (KIRs) are involved in regulating NK cell activation through recognition of specific human leukocyte antigen (HLA) class I allotypes. Methodology/Principal Findings: To investigate whether KIR and HLA genes could influence the risk of HBV-associated HCC development, 144 HBV-infected patients with HCC and 189 well-matched HBV infectors with chronic hepatitis or cirrhosis as non-HCC controls were enrolled in this study. The presence of 12 loci of KIR was detected individually. HLA-A, -B, -C loci were genotyped with high-resolution. HLA-C group 1 homozygote (OR = 2.02; p= 0.005), HLA-Bw4-80I (OR = 2.67; p = 2.0E-04) and combination of full-length form and 22 bp-deleted form of KIR2DS4 (KIR2DS4/1D) (OR = 1.89; p = 0.017) were found associated with HCC incidence. When the combined effects of these three genetic factors were evaluated, more risk factors were observed correlating with higher odds ratios for HCC incidence (P trend = 7.4E-05). Because all the risk factors we found have been reported to result in high NK cell functional potential by previous studies, our observations suggest that NK cell activation may contribute to HBV-associated HCC development. Conclusions/Significance: In conclusion, this study has identified significant associations that suggest an important role for NK cells in HCC incidence in HBV-infected patients. Our study is useful for HCC surveillance and has implications for novel personalized therapy strategy development aiming at HCC prevention in HBV-infected patients.	[Pan, Ning; Miao, Fengqin; Xie, Wei; Zhang, Jianqiong] Southeast Univ, Sch Med, Dept Immunol & Pathogen Biol, Nanjing, Jiangsu Provinc, Peoples R China; [Pan, Ning; Jiang, Wei; Sun, Hang; Miao, Fengqin; Qiu, Jie; Xu, Jinhuan; Shi, Qian; Xie, Wei; Zhang, Jianqiong] Southeast Univ, Key Lab Dev Genes & Human Dis, Minist Educ, Inst Life Sci, Nanjing, Jiangsu Provinc, Peoples R China; [Pan, Ning; Jiang, Wei; Sun, Hang; Miao, Fengqin; Xu, Jinhuan; Shi, Qian; Xie, Wei; Zhang, Jianqiong] Southeast Univ, Sch Med, Dept Med Genet, Nanjing, Jiangsu Provinc, Peoples R China; [Jin, Hui] Southeast Univ, Sch Publ Hlth, Dept Epidemiol, Nanjing, Jiangsu Provinc, Peoples R China; [Qiu, Jie] Southeast Univ, Affiliated Hosp 2, Nanjing, Jiangsu Provinc, Peoples R China	Southeast University - China; Southeast University - China; Southeast University - China; Southeast University - China; Southeast University - China	Zhang, JQ (corresponding author), Southeast Univ, Sch Med, Dept Immunol & Pathogen Biol, Nanjing, Jiangsu Provinc, Peoples R China.	wei.xie@seu.edu.cn; zhjq@seu.edu.cn	JIN, HUI/AAA-8732-2019; Jin, Hui/GXG-2296-2022	Pan, Ning/0000-0001-8795-6926; Jiang, Wei/0000-0002-6119-3331	National Natural Science Foundation [30571703]; National Natural Science Foundation for Distinguished Young Scholars of China [30325017]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	This work is funded by National Natural Science Foundation (30571703) and National Natural Science Foundation for Distinguished Young Scholars of China (30325017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlenstiel G, 2008, J CLIN INVEST, V118, P1017, DOI 10.1172/JCI32400; Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Berasain C, 2009, ANN NY ACAD SCI, V1155, P206, DOI 10.1111/j.1749-6632.2009.03704.x; Boulet S, 2010, J IMMUNOL, V184, P2057, DOI 10.4049/jimmunol.0902621; Brodin P, 2009, TRENDS IMMUNOL, V30, P143, DOI 10.1016/j.it.2009.01.006; Carr WH, 2005, J IMMUNOL, V175, P5222, DOI 10.4049/jimmunol.175.8.5222; Carrington M, 2005, J EXP MED, V201, P1069, DOI 10.1084/jem.20042158; CELLA M, 1994, J EXP MED, V180, P1235, DOI 10.1084/jem.180.4.1235; Chan HLY, 2004, GUT, V53, P1494, DOI 10.1136/gut.2003.033324; Chen YY, 2007, J HEPATOL, V47, P183, DOI 10.1016/j.jhep.2007.02.020; Chen YY, 2007, HEPATOLOGY, V46, P706, DOI 10.1002/hep.21872; Dunn C, 2007, J EXP MED, V204, P667, DOI 10.1084/jem.20061287; Dunn Paul P J, 2003, Methods Mol Biol, V210, P191; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; GUMPERZ JE, 1995, J EXP MED, V181, P1133, DOI 10.1084/jem.181.3.1133; Gumperz JE, 1997, J IMMUNOL, V158, P5237; Hansasuta P, 2004, EUR J IMMUNOL, V34, P1673, DOI 10.1002/eji.200425089; Helmberg W, 2004, NUCLEIC ACIDS RES, V32, pW173, DOI 10.1093/nar/gkh424; Hsu KC, 2002, J IMMUNOL, V169, P5118, DOI 10.4049/jimmunol.169.9.5118; Hui CK, 2007, HEPATOLOGY, V46, P395, DOI 10.1002/hep.21724; Jiang W, 2008, TISSUE ANTIGENS, V71, P479, DOI 10.1111/j.1399-0039.2008.01028.x; Kafrouni MI, 2001, J IMMUNOL, V167, P1566, DOI 10.4049/jimmunol.167.3.1566; Kakimi K, 2001, J EXP MED, V194, P1755, DOI 10.1084/jem.194.12.1755; Katz G, 2004, J IMMUNOL, V173, P1819, DOI 10.4049/jimmunol.173.3.1819; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Kim S, 2008, P NATL ACAD SCI USA, V105, P3053, DOI 10.1073/pnas.0712229105; Kovacic MB, 2005, CANCER EPIDEM BIOMAR, V14, P2673, DOI 10.1158/1055-9965.EPI-05-0229; Kulkarni S, 2008, SEMIN IMMUNOL, V20, P343, DOI 10.1016/j.smim.2008.06.003; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Livingston SE, 2007, J INFECT DIS, V195, P5, DOI 10.1086/509894; Lopez-Vazquez A, 2005, J INFECT DIS, V192, P162, DOI 10.1086/430351; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Maxwell LD, 2002, TISSUE ANTIGENS, V60, P254, DOI 10.1034/j.1399-0039.2002.600307.x; Miao F, 2010, TISSUE ANTIGENS, V75, P737, DOI 10.1111/j.1399-0039.2010.01456.x; Middleton D, 2007, HUM IMMUNOL, V68, P128, DOI 10.1016/j.humimm.2006.12.007; Parsons MS, 2010, J LEUKOCYTE BIOL, V88, P905, DOI 10.1189/jlb.1009687; Rani M, 2009, B WORLD HEALTH ORGAN, V87, P707, DOI 10.2471/BLT.08.059220; Shamliyan TA, 2009, ANN INTERN MED, V150, P111, DOI 10.7326/0003-4819-150-2-200901200-00101; Stern M, 2008, BLOOD, V112, P708, DOI 10.1182/blood-2008-02-137521; Winter CC, 1998, J IMMUNOL, V161, P571; Yao GB, 1996, GUT, V38, pS39, DOI 10.1136/gut.38.Suppl_2.S39; Yin Xiao-lin, 2004, Di Yi Jun Yi Da Xue Xue Bao, V24, P1416; Zhang HX, 2010, NAT GENET, V42, P755, DOI 10.1038/ng.638	44	35	42	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25682	10.1371/journal.pone.0025682	http://dx.doi.org/10.1371/journal.pone.0025682			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998681	Green Published, Green Submitted, gold			2022-12-27	WOS:000295966900044
J	Sharlow, ER; Wilson, GM; Close, D; Leimgruber, S; Tandon, M; Reed, RB; Shun, TY; Wang, QJ; Wipf, P; Lazo, JS				Sharlow, Elizabeth R.; Wilson, Gabriela Mustata; Close, David; Leimgruber, Stephanie; Tandon, Manuj; Reed, Robyn B.; Shun, Tong Ying; Wang, Q. Jane; Wipf, Peter; Lazo, John S.			Discovery of Diverse Small Molecule Chemotypes with Cell-Based PKD1 Inhibitory Activity	PLOS ONE			English	Article							PROTEIN-KINASE-D; ENDOTHELIAL-CELLS; C-MU; GROWTH; CANCER; POTENT; DISEASE; D2; PHOSPHORYLATION; IMPLEMENTATION	Protein kinase D (PKD) is a novel family of serine/threonine kinases regulated by diacylglycerol, which is involved in multiple cellular processes and various pathological conditions. The limited number of cell-active, selective inhibitors has historically restricted biochemical and pharmacological studies of PKD. We now markedly expand the PKD1 inhibitory chemotype inventory with eleven additional novel small molecule PKD1 inhibitors derived from our high throughput screening campaigns. The in vitro IC(50)s for these eleven compounds ranged in potency from 0.4 to 6.1 mu M with all of the evaluated compounds being competitive with ATP. Three of the inhibitors (CID 1893668, (1Z)-1-(3-ethyl-5-methoxy-1,3-benzothiazol-2-ylidene)propan-2-one; CID 2011756, 5-(3-chlorophenyl)-N-[4-(morpholin-4-ylmethyl)phenyl]furan-2-carboxamide; CID 5389142, (6Z)-6-[4-(3-aminopropylamino)-6-methyl-1H-pyrimidin-2-ylidene]cyclohexa-2,4-dien-1-one) inhibited phorbol ester-induced endogenous PKD1 activation in LNCaP prostate cancer cells in a concentration-dependent manner. The specificity of these compounds for PKD1 inhibitory activity was supported by kinase assay counter screens as well as by bioinformatics searches. Moreover, computational analyses of these novel cell-active PKD1 inhibitors indicated that they were structurally distinct from the previously described cell-active PKD1 inhibitors while computational docking of the new cell-active compounds in a highly conserved ATP-binding cleft suggests opportunities for structural modification. In summary, we have discovered novel PKD1 inhibitors with in vitro and cell-based inhibitory activity, thus successfully expanding the structural diversity of small molecule inhibitors available for this important pharmacological target.	[Sharlow, Elizabeth R.; Lazo, John S.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Lazo, John S.] Univ Virginia, Dept Chem, Charlottesville, VA USA; [Wilson, Gabriela Mustata] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA USA; [Wilson, Gabriela Mustata; Close, David; Leimgruber, Stephanie; Reed, Robyn B.; Shun, Tong Ying; Wang, Q. Jane; Wipf, Peter] Univ Pittsburgh, Drug Discovery Inst, Pittsburgh, PA USA; [Close, David; Leimgruber, Stephanie; Tandon, Manuj; Reed, Robyn B.; Shun, Tong Ying; Wang, Q. Jane] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Wipf, Peter] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA	University of Virginia; University of Virginia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Sharlow, ER (corresponding author), Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA.	ers7g@virginia.edu	Wipf, Peter/AAG-1771-2021; Reed, Robyn/P-4381-2014; Mustata Wilson, Gabriela/GPW-8746-2022; Wang, Qiming Jane/B-6064-2012	Wipf, Peter/0000-0001-7693-5863; Reed, Robyn/0000-0003-2141-0490; Mustata Wilson, Gabriela/0000-0003-3090-9242; Wang, Qiming Jane/0000-0002-9502-4851	National Institutes of Health [R03DA24898, R01CA142580, R01CA129127, U54MH074411]; Fiske Drug Discovery Fund; NATIONAL CANCER INSTITUTE [R01CA129127, R01CA142580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH074411] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA024898] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fiske Drug Discovery Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grants R03DA24898, R01CA142580, R01CA129127 and U54MH074411 as well as the Fiske Drug Discovery Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auer A, 2005, MOL BIOL CELL, V16, P4375, DOI 10.1091/mbc.E05-03-0251; Avkiran M, 2008, CIRC RES, V102, P157, DOI 10.1161/CIRCRESAHA.107.168211; Azoitei N, 2010, GUT, V59, P1316, DOI 10.1136/gut.2009.206813; Besirli CG, 2006, J NEUROCHEM, V99, P218, DOI 10.1111/j.1471-4159.2006.04116.x; Bravo-Altamirano K, 2011, ACS MED CHEM LETT, V2, P154, DOI 10.1021/ml100230n; Chen J, 2008, CANCER RES, V68, P3844, DOI 10.1158/0008-5472.CAN-07-5156; Evans IM, 2010, BIOCHEM J, V429, P565, DOI 10.1042/BJ20100578; Gamber GG, 2011, BIOORG MED CHEM LETT, V21, P1447, DOI 10.1016/j.bmcl.2011.01.014; Goekjian PG, 1999, CURR MED CHEM, V6, P877; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Ha CH, 2008, J BIOL CHEM, V283, P14590, DOI 10.1074/jbc.M800264200; Hao Q, 2009, AM J PHYSIOL-CELL PH, V296, pC821, DOI 10.1152/ajpcell.00504.2008; Hao Q, 2009, J BIOL CHEM, V284, P799, DOI 10.1074/jbc.M807546200; Harikumar KB, 2010, MOL CANCER THER, V9, P1136, DOI 10.1158/1535-7163.MCT-09-1145; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; JOHANNES FJ, 1995, EUR J BIOCHEM, V227, P303, DOI 10.1111/j.1432-1033.1995.tb20389.x; Kim M, 2008, CARCINOGENESIS, V29, P629, DOI 10.1093/carcin/bgm291; LaValle Courtney R., 2010, BMC Chemical Biology, V10, P5, DOI 10.1186/1472-6769-10-5; Lochner A, 2006, CARDIOVASC DRUG REV, V24, P261, DOI 10.1111/j.1527-3466.2006.00261.x; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Matthews SA, 2010, BIOCHEM J, V432, P153, DOI 10.1042/BJ20101188; Meredith EL, 2010, J MED CHEM, V53, P5400, DOI 10.1021/jm100075z; Meredith EL, 2010, J MED CHEM, V53, P5422, DOI 10.1021/jm100076w; Monovich L, 2010, FEBS LETT, V584, P631, DOI 10.1016/j.febslet.2009.12.014; Muraki M, 2004, J BIOL CHEM, V279, P24246, DOI 10.1074/jbc.M314298200; Oster H, 2006, GENE EXPR PATTERNS, V6, P400, DOI 10.1016/j.modgep.2005.09.006; Rey O, 2003, J BIOL CHEM, V278, P23773, DOI 10.1074/jbc.M300226200; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Rozengurt E, 2011, PHYSIOLOGY, V26, P23, DOI 10.1152/physiol.00037.2010; Sharlow ER, 2008, NAT PROTOC, V3, P1350, DOI 10.1038/nprot.2008.111; Sharlow ER, 2007, ASSAY DRUG DEV TECHN, V5, P723, DOI 10.1089/adt.2007.102; Sharlow ER, 2008, J BIOL CHEM, V283, P33516, DOI 10.1074/jbc.M805358200; Soares KM, 2010, ASSAY DRUG DEV TECHN, V8, P152, DOI 10.1089/adt.2009.0247; Thompson EE, 2009, PROTEIN SCI, V18, P2016, DOI 10.1002/pro.209; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; Thrower EC, 2011, AM J PHYSIOL-GASTR L, V300, pG120, DOI 10.1152/ajpgi.00300.2010; Wang QMJ, 2006, TRENDS PHARMACOL SCI, V27, P317, DOI 10.1016/j.tips.2006.04.003	37	15	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25134	10.1371/journal.pone.0025134	http://dx.doi.org/10.1371/journal.pone.0025134			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998636	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000295966900009
J	Sugranyes, G; Kyriakopoulos, M; Corrigall, R; Taylor, E; Frangou, S				Sugranyes, Gisela; Kyriakopoulos, Marinos; Corrigall, Richard; Taylor, Eric; Frangou, Sophia			Autism Spectrum Disorders and Schizophrenia: Meta-Analysis of the Neural Correlates of Social Cognition	PLOS ONE			English	Article							FACIAL EMOTION DISCRIMINATION; FUNCTIONING AUTISM; FRONTAL-CORTEX; FEARFUL FACES; AMYGDALA; BRAIN; ACTIVATION; MIND; DYSFUNCTION; PERCEPTION	Context: Impaired social cognition is a cardinal feature of Autism Spectrum Disorders (ASD) and Schizophrenia (SZ). However, the functional neuroanatomy of social cognition in either disorder remains unclear due to variability in primary literature. Additionally, it is not known whether deficits in ASD and SZ arise from similar or disease-specific disruption of the social cognition network. Objective: To identify regions most robustly implicated in social cognition processing in SZ and ASD. Data Sources: Systematic review of English language articles using MEDLINE (1995-2010) and reference lists. Study Selection: Studies were required to use fMRI to compare ASD or SZ subjects to a matched healthy control group, provide coordinates in standard stereotactic space, and employ standardized facial emotion recognition (FER) or theory of mind (TOM) paradigms. Data Extraction: Activation foci from studies meeting inclusion criteria (n = 33) were subjected to a quantitative voxel-based meta-analysis using activation likelihood estimation, and encompassed 146 subjects with ASD, 336 SZ patients and 492 healthy controls. Results: Both SZ and ASD showed medial prefrontal hypoactivation, which was more pronounced in ASD, while ventrolateral prefrontal dysfunction was associated mostly with SZ. Amygdala hypoactivation was observed in SZ patients during FER and in ASD during more complex ToM tasks. Both disorders were associated with hypoactivation within the Superior Temporal Sulcus (STS) during ToM tasks, but activation in these regions was increased in ASD during affect processing. Disease-specific differences were noted in somatosensory engagement, which was increased in SZ and decreased in ASD. Reduced thalamic activation was uniquely seen in SZ. Conclusions: Reduced frontolimbic and STS engagement emerged as a shared feature of social cognition deficits in SZ and ASD. However, there were disease-and stimulus-specific differences. These findings may aid future studies on SZ and ASD and facilitate the formulation of new hypotheses regarding their pathophysiology.	[Sugranyes, Gisela; Taylor, Eric] Kings Coll London, Inst Psychiat, Dept Child & Adolescent Psychiat, London WC2R 2LS, England; [Sugranyes, Gisela; Kyriakopoulos, Marinos; Frangou, Sophia] Kings Coll London, Inst Psychiat, Dept Psychosis Studies, Sect Neurobiol Psychosis, London WC2R 2LS, England; [Sugranyes, Gisela] Univ Barcelona, Inst Neurosci, Dept Child & Adolescent Psychiat & Psychol, Barcelona, Spain; [Kyriakopoulos, Marinos; Corrigall, Richard] S London & Maudsley NHS Fdn Trust, Child & Adolescent Mental Hlth Serv, London, England	University of London; King's College London; University of London; King's College London; University of Barcelona; South London & Maudsley NHS Trust	Sugranyes, G (corresponding author), Kings Coll London, Inst Psychiat, Dept Child & Adolescent Psychiat, London WC2R 2LS, England.	Sophia.frangou@kcl.ac.uk	Kyriakopoulos, Marinos/F-8310-2014; Frangou, Sophia/A-2672-2013	Kyriakopoulos, Marinos/0000-0002-4594-2646; Sugranyes, Gisela/0000-0002-2545-7862; Frangou, Sophia/0000-0002-3210-6470	Alicia Koplowitz Foundation; Medical Research Council [G9817803B] Funding Source: researchfish	Alicia Koplowitz Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Dr Sugranyes received sponsorship by the Alicia Koplowitz Foundation. The Alicia Koplowitz Foundation played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Adolphs R, 1998, NATURE, V393, P470, DOI 10.1038/30982; Adolphs R, 2010, CURR BIOL, V20, pR1071, DOI 10.1016/j.cub.2010.11.019; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Andreasen N., 1984, SCALE ASSESSMENT POS; Andreasen N. C., 1984, SCALE ASSESSMENT POS; Anticevic A, 2012, SCHIZOPHRENIA BULL, V38, P608, DOI 10.1093/schbul/sbq131; Ashwin C, 2007, NEUROPSYCHOLOGIA, V45, P2, DOI 10.1016/j.neuropsychologia.2006.04.014; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 1999, EUR J NEUROSCI, V11, P1891, DOI 10.1046/j.1460-9568.1999.00621.x; Baron-Cohen S, 2000, NEUROSCI BIOBEHAV R, V24, P355, DOI 10.1016/S0149-7634(00)00011-7; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Bechara A, 2002, BRAIN, V125, P1673, DOI 10.1093/brain/awf169; Beer JS, 2006, PSYCHOL SCI, V17, P448, DOI 10.1111/j.1467-9280.2006.01726.x; Benedetti F, 2009, SCHIZOPHR RES, V114, P154, DOI 10.1016/j.schres.2009.06.021; Berthoz S, 2002, BRAIN, V125, P1696, DOI 10.1093/brain/awf190; Bora E, 2009, SCHIZOPHR RES, V109, P1, DOI 10.1016/j.schres.2008.12.020; Brothers L., 1990, CONCEPTS NEUROSCIENC, V1, P27, DOI DOI 10.1093/SCHBUL/SBQ012; Brune M, 2008, NEUROPSYCHOLOGIA, V46, P1992, DOI 10.1016/j.neuropsychologia.2008.01.023; Cheung C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012233; Couture SM, 2010, PSYCHOL MED, V40, P569, DOI 10.1017/S003329170999078X; Critchley HD, 2005, NEUROIMAGE, V24, P751, DOI 10.1016/j.neuroimage.2004.10.013; Critchley HD, 2000, BRAIN, V123, P2203, DOI 10.1093/brain/123.11.2203; Dapretto M, 2006, NAT NEUROSCI, V9, P28, DOI 10.1038/nn1611; Das P, 2007, SCHIZOPHR RES, V90, P284, DOI 10.1016/j.schres.2006.11.023; Deeley Q, 2007, BIOL PSYCHIAT, V62, P207, DOI 10.1016/j.biopsych.2006.09.037; Di Martino A, 2009, BIOL PSYCHIAT, V65, P63, DOI 10.1016/j.biopsych.2008.09.022; Dollfus S, 2008, SCHIZOPHR RES, V99, P304, DOI 10.1016/j.schres.2007.11.016; Dowd EC, 2010, BIOL PSYCHIAT, V67, P902, DOI 10.1016/j.biopsych.2009.10.020; Friston KJ, 2011, BIOL CYBERN, V104, P137, DOI 10.1007/s00422-011-0424-z; Frith CD, 1996, PSYCHOL MED, V26, P521, DOI 10.1017/S0033291700035601; Frith CD, 2007, PHILOS T R SOC B, V362, P671, DOI 10.1098/rstb.2006.2003; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Fusar-Poli P, 2009, J PSYCHIATR NEUROSCI, V34, P418; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Gallagher HL, 2002, NEUROIMAGE, V16, P814, DOI 10.1006/nimg.2002.1117; Grosbras MH, 2012, HUM BRAIN MAPP, V33, P431, DOI 10.1002/hbm.21222; Gur RE, 2007, ARCH GEN PSYCHIAT, V64, P1356, DOI 10.1001/archpsyc.64.12.1356; Hall GBC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010804; Hall J, 2008, BIOL PSYCHIAT, V64, P70, DOI 10.1016/j.biopsych.2007.12.014; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Healey KM, 2010, SCHIZOPHR RES, V122, P144, DOI 10.1016/j.schres.2010.04.004; Holt DJ, 2011, BIOL PSYCHIAT, V69, P415, DOI 10.1016/j.biopsych.2010.10.003; Holt DJ, 2006, SCHIZOPHR RES, V82, P153, DOI 10.1016/j.schres.2005.09.021; Huang MX, 2010, BRAIN TOPOGR, V23, P82, DOI 10.1007/s10548-009-0122-5; Johnson SC, 2002, BRAIN, V125, P1808, DOI 10.1093/brain/awf181; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; King BH, 2011, BRAIN RES, V1380, P34, DOI 10.1016/j.brainres.2010.11.031; Kosaka H, 2002, SCHIZOPHR RES, V57, P87, DOI 10.1016/S0920-9964(01)00324-3; Laird AR, 2005, HUM BRAIN MAPP, V25, P155, DOI 10.1002/hbm.20136; Lee KH, 2006, AM J PSYCHIAT, V163, P1926, DOI 10.1176/appi.ajp.163.11.1926; Lee SJ, 2010, PSYCHIAT RES-NEUROIM, V181, P121, DOI 10.1016/j.pscychresns.2009.08.003; Leitman DI, 2011, SOC COGN AFFECT NEUR, V6, P66, DOI 10.1093/scan/nsq018; Li HJ, 2009, SCHIZOPHRENIA BULL, V35, P291; Lombardo MV, 2010, BRAIN, V133, P611, DOI 10.1093/brain/awp306; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Lord C., 1999, AUTISM DIAGNOSTIC OB; Meyer-Lindenberg A, 2010, NATURE, V468, P194, DOI 10.1038/nature09569; Michalopoulou PG, 2008, BRIT J PSYCHIAT, V192, P191, DOI 10.1192/bjp.bp.106.032649; Minzenberg MJ, 2009, ARCH GEN PSYCHIAT, V66, P811, DOI 10.1001/archgenpsychiatry.2009.91; Monk CS, 2010, J PSYCHIATR NEUROSCI, V35, P105, DOI 10.1503/jpn.090085; NICKLJOCKSCHAT T, 2011, HUM BRAIN MAPP, DOI [DOI 10.1002/HBM.21299, 10.1002/hbm.23882, DOI 10.1002/HBM.10061]; Norra C, 2004, NEUROPSYCHOBIOLOGY, V49, P71, DOI 10.1159/000076413; Park IH, 2011, ACTA PSYCHIAT SCAND, V123, P43, DOI 10.1111/j.1600-0447.2010.01597.x; Pelphrey K, 2004, MENT RETARD DEV D R, V10, P259, DOI 10.1002/mrdd.20040; Pelphrey KA, 2005, BRAIN, V128, P1038, DOI 10.1093/brain/awh404; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Pinkham AE, 2003, AM J PSYCHIAT, V160, P815, DOI 10.1176/appi.ajp.160.5.815; Pinkham AE, 2008, SCHIZOPHR RES, V99, P164, DOI 10.1016/j.schres.2007.10.024; Quirk GJ, 2006, CURR OPIN NEUROBIOL, V16, P723, DOI 10.1016/j.conb.2006.07.004; Rapoport J, 2009, J AM ACAD CHILD PSY, V48, P10, DOI 10.1097/CHI.0b013e31818b1c63; Rauch AV, 2010, PSYCHIAT RES-NEUROIM, V182, P200, DOI 10.1016/j.pscychresns.2010.03.005; Reske M, 2009, J PSYCHIATR RES, V43, P592, DOI 10.1016/j.jpsychires.2008.10.012; Reynders HJ, 2005, EPILEPSY BEHAV, V7, P419, DOI 10.1016/j.yebeh.2005.07.013; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 2010, EXP BRAIN RES, V200, P223, DOI 10.1007/s00221-009-2002-3; Russell TA, 2000, AM J PSYCHIAT, V157, P2040, DOI 10.1176/appi.ajp.157.12.2040; Santos A, 2011, NEUROIMAGE, V54, P3111, DOI 10.1016/j.neuroimage.2010.11.024; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Saxe R, 2006, PSYCHOL SCI, V17, P692, DOI 10.1111/j.1467-9280.2006.01768.x; Schultz RT, 2005, INT J DEV NEUROSCI, V23, P125, DOI 10.1016/j.ijdevneu.2004.12.012; Seiferth NY, 2009, NEUROPSYCHOPHARMACOL, V34, P477, DOI 10.1038/npp.2008.93; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; Surguladze S, 2006, BIOL PSYCHIAT, V60, P423, DOI 10.1016/j.biopsych.2005.11.021; Talairach J., 1988, COPLANAR STEREOTAXIC; Tremeau Fabien, 2006, Dialogues Clin Neurosci, V8, P59; Uddin LQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003526; Vytal K, 2010, J COGNITIVE NEUROSCI, V22, P2864, DOI 10.1162/jocn.2009.21366; Walter H, 2009, SOC COGN AFFECT NEUR, V4, P166, DOI 10.1093/scan/nsn047; Wang AT, 2007, ARCH GEN PSYCHIAT, V64, P698, DOI 10.1001/archpsyc.64.6.698; Wild B, 2001, PSYCHIAT RES, V102, P109, DOI 10.1016/S0165-1781(01)00225-6; Williams JHG, 2006, NEUROPSYCHOLOGIA, V44, P610, DOI 10.1016/j.neuropsychologia.2005.06.010; Williams LM, 2007, PSYCHIAT RES-NEUROIM, V155, P29, DOI 10.1016/j.pscychresns.2006.12.018; Zysset S, 2002, NEUROIMAGE, V15, P983, DOI 10.1006/nimg.2001.1008	96	186	190	3	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25322	10.1371/journal.pone.0025322	http://dx.doi.org/10.1371/journal.pone.0025322			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834NA	21998649	Green Published			2022-12-27	WOS:000295966900018
J	Bakker, PR; de Groot, IW; van Os, J; van Harten, PN				Bakker, P. Roberto; de Groot, Izaak W.; van Os, Jim; van Harten, Peter N.			Long-Stay Psychiatric Patients: A Prospective Study Revealing Persistent Antipsychotic-Induced Movement Disorder	PLOS ONE			English	Article							INDUCED EXTRAPYRAMIDAL SYNDROMES; RANDOMIZED CONTROLLED-TRIAL; TARDIVE-DYSKINESIA; CHRONIC-SCHIZOPHRENIA; 1ST-EPISODE SCHIZOPHRENIA; BOTULINUM TOXIN; RATING-SCALE; PREVALENCE; AKATHISIA; PARKINSONISM	Objective: The purpose of this study was to assess the frequency of persistent drug-induced movement disorders namely, tardive dyskinesia (TD), parkinsonism, akathisia and tardive dystonia in a representative sample of long-stay patients with chronic severe mental illness. Method: Naturalistic study of 209, mainly white, antipsychotic-treated patients, mostly diagnosed with psychotic disorder. Of this group, the same rater examined 194 patients at least two times over a 4-year period, with a mean follow-up time of 1.1 years, with validated scales for TD, parkinsonism, akathisia, and tardive dystonia. Results: The frequencies of persistent movement disorders in the sample were 28.4% for TD, 56.2% for parkinsonism, 4.6% for akathisia and 5.7% for tardive dystonia. Two-thirds of the participants displayed at least one type of persistent movement disorder. Conclusions: Persistent movement disorder continues to be the norm for long-stay patients with chronic mental illness and long-term antipsychotic treatment. Measures are required to remedy this situation.	[Bakker, P. Roberto; van Harten, Peter N.] Psychiat Ctr GGZ Cent, Amersfoort, Netherlands; [de Groot, Izaak W.] Ctr Mental Hlth Care, Deventer, Netherlands; [van Os, Jim; van Harten, Peter N.] Maastricht Univ, EURON, S Limburg Mental Hlth Res & Teaching Network, Dept Psychiat & Psychol, Maastricht, Netherlands; [van Os, Jim] Kings Coll London, Dept Psychosis Studies, Inst Psychiat, London WC2R 2LS, England	Maastricht University; University of London; King's College London	Bakker, PR (corresponding author), Psychiat Ctr GGZ Cent, Amersfoort, Netherlands.	robertobakker@gmail.com	Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; van Os, Jim/V-8884-2019; van Os, Jim/C-2113-2014; van Os, Jim/I-9496-2012	van Os, Jim/0000-0002-7245-1586; van Os, Jim/0000-0002-7245-1586; Bakker, P. Roberto/0000-0002-9964-9939	Foundation, 'The Open Ankh', The Netherlands [SG 21.02]; Eli Lilly company; BMS company; Lundbeck company; Organon company; Janssen-Cilag company; GSK company; AstraZeneca company; Pfizer company; Servier company	Foundation, 'The Open Ankh', The Netherlands; Eli Lilly company(Eli Lilly); BMS company; Lundbeck company(Lundbeck Corporation); Organon company; Janssen-Cilag company; GSK company; AstraZeneca company(AstraZeneca); Pfizer company; Servier company	This work was supported by grant from the Foundation, 'The Open Ankh', The Netherlands [grant number SG 21.02]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: Dr. Bakker and Dr. de Groot have declared that no competing interests exist. Dr. van Os has been an unrestricted research grant holder with, or has received financial compensation as an independent symposium speaker from Eli Lilly, BMS, Lundbeck, Organon, Janssen-Cilag, GSK, AstraZeneca, Pfizer and Servier, companies that have an interest in the treatment of psychosis. Dr. van Harten has received financial compensation as an independent symposium speaker from Eli Lilly, BMS, Janssen-Cilag, GSK, and AstraZeneca, companies that have an interest in the treatment of psychosis. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	American Psychiatry Association, 1992, TARD DYSK TASK FORC; Arango C, 1999, AM J PSYCHIAT, V156, P1097; Ballesteros J, 2000, J CLIN PSYCHOPHARM, V20, P188, DOI 10.1097/00004714-200004000-00011; BARNES TRE, 1989, BRIT J PSYCHIAT, V154, P672, DOI 10.1192/bjp.154.5.672; BARNES TRE, 1985, ARCH GEN PSYCHIAT, V42, P874; Broekema WJ, 2007, PHARM WORLD SCI, V29, P126, DOI 10.1007/s11096-006-9063-1; BURKE RE, 1985, NEUROLOGY, V35, P73, DOI 10.1212/WNL.35.1.73; Burke RE, 1992, DRUG INDUCED MOVEMEN, P167; Casey DE, 2006, CNS SPECTRUMS, V11, P25, DOI 10.1017/S1092852900026651; Chakos MH, 1996, ARCH GEN PSYCHIAT, V53, P313; Chong SA, 2009, J CLIN PSYCHOPHARM, V29, P5, DOI 10.1097/JCP.0b013e3181929f94; Correll CU, 2008, CURR OPIN PSYCHIATR, V21, P151, DOI 10.1097/YCO.0b013e3282f53132; Correll CU, 2004, AM J PSYCHIAT, V161, P414, DOI 10.1176/appi.ajp.161.3.414; Dean CE, 2009, BRIT J PSYCHIAT, V194, P360, DOI 10.1192/bjp.bp.108.049395; EMSLEY R, 2010, EUR PSYCHIAT; Esper CD, 2008, MOVEMENT DISORD, V23, P401, DOI 10.1002/mds.21854; FACTOR SA, 2009, DRUG INDUCED MOVEMEN; Factor SA., 2005, DRUG INDUCED MOVEMEN, V2nd; Fahn S., 1987, RECENT DEV PARKINSON, P153; Fisher WH, 2001, PSYCHIATR SERV, V52, P1051, DOI 10.1176/appi.ps.52.8.1051; Fisher WH, 2009, HEALTH AFFAIR, V28, P676, DOI 10.1377/hlthaff.28.3.676; Friedman JH, 2004, J GERIATR PSYCH NEUR, V17, P39, DOI 10.1177/0891988703262001; Guy W, 1975, ECDEU ASSESSMENT MAN, P534; Guy W, 1976, ECDEU ASSESSMENT MAN, DOI DOI 10.1037/E591322011-001; HALSTEAD SM, 1994, BRIT J PSYCHIAT, V164, P177, DOI 10.1192/bjp.164.2.177; HOFFMAN WF, 1994, NEUROPSYCHOPHARMAC S, V135; Janno S, 2004, AM J PSYCHIAT, V161, P160, DOI 10.1176/appi.ajp.161.1.160; Jones PB, 2006, ARCH GEN PSYCHIAT, V63, P1079, DOI 10.1001/archpsyc.63.10.1079; Kahn RS, 2008, LANCET, V371, P1085, DOI 10.1016/S0140-6736(08)60486-9; KEEPERS GA, 1983, ARCH GEN PSYCHIAT, V40, P1113; Kefalopoulou Z, 2009, ACTA NEUROL SCAND, V119, P269, DOI 10.1111/j.1600-0404.2008.01115.x; Koning JPF, 2010, SCHIZOPHRENIA BULL, V36, P723, DOI 10.1093/schbul/sbn146; Lambert M, 2004, EUR PSYCHIAT, V19, P415, DOI 10.1016/j.eurpsy.2004.06.031; Laugharne J, 2004, INT J LAW PSYCHIAT, V27, P101, DOI 10.1016/j.ijlp.2003.12.004; Lerner V, 2007, ISR J PSYCHIATR REL, V44, P20; Leucht S, 2009, PSYCHOL MED, V39, P1591, DOI 10.1017/S0033291709005455; Leucht S, 2009, LANCET, V373, P31, DOI 10.1016/S0140-6736(08)61764-X; Leung JG, 2011, ANN PHARMACOTHER, V45, P525, DOI 10.1345/aph.1P312; Lewis S, 2008, BRIT J PSYCHIAT, V192, P161, DOI 10.1192/bjp.bp.107.037218; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; MACPHERSON R, 1992, BRIT J PSYCHIAT, V160, P110, DOI 10.1192/bjp.160.1.110; Miller DD, 2008, BRIT J PSYCHIAT, V193, P279, DOI 10.1192/bjp.bp.108.050088; Mittal V, 2010, POLYM SCI TECHNOL SE, P1, DOI 10.1039/9781849732192-00001; Modestin J, 2008, SCHIZOPHR RES, V100, P97, DOI 10.1016/j.schres.2007.10.018; OWENS DC, 1999, GUIDE EXTRAPYRAMIDAL; Pappa S, 2009, PSYCHOL MED, V39, P1065, DOI 10.1017/S0033291708004716; Procyshyn RM, 2001, CAN J PSYCHIAT, V46, P334, DOI 10.1177/070674370104600404; RICHARDSON MA, 1991, AM J PSYCHIAT, V148, P1322; Richardson MA, 2003, AM J PSYCHIAT, V160, P1117, DOI 10.1176/appi.ajp.160.6.1117; Rijcken CAW, 2003, J CLIN PSYCHOPHARM, V23, P657, DOI 10.1097/01.jcp.0000096247.29231.3a; Robinson DG, 2002, SCHIZOPHR RES, V57, P209, DOI 10.1016/S0920-9964(01)00312-7; Rosenheck R, 2003, JAMA-J AM MED ASSOC, V290, P2693, DOI 10.1001/jama.290.20.2693; Sachdev PS, 2005, PSYCHIAT CLIN N AM, V28, P255, DOI 10.1016/j.psc.2004.10.004; SCHOOLER NR, 1982, ARCH GEN PSYCHIAT, V39, P486; SETHI KD, 1990, MOVEMENT DISORD, V5, P319, DOI 10.1002/mds.870050411; Slotema CW, 2008, PROG NEURO-PSYCHOPH, V32, P507, DOI 10.1016/j.pnpbp.2007.10.004; Soares-Weiser K, 2007, SEMIN NEUROL, V27, P159, DOI 10.1055/s-2007-971169; Tamminga CA, 2006, AM J PSYCHIAT, V163, P563, DOI 10.1176/appi.ajp.163.4.563; Taylor D, 2010, PSYCHIATR BULL, V34, P41, DOI 10.1192/pb.bp.109.027086; Tenback DE, 2005, J CLIN PSYCHIAT, V66, P1130, DOI 10.4088/JCP.v66n0907; Tenback DE, 2009, MOVEMENT DISORD, V24, P2309, DOI 10.1002/mds.22707; van Harten PN, 2009, PSYCHOL MED, V39, P1754, DOI 10.1017/S0033291709990456; Van Harten P. N., 1996, Schizophrenia Research, V19, P195; van Harten PN, 2006, MOVEMENT DISORD, V21, P1276, DOI 10.1002/mds.20904; van Harten PN, 1999, SCHIZOPHRENIA BULL, V25, P741, DOI 10.1093/oxfordjournals.schbul.a033415; VANHARTEN PN, 1998, MOVEMENT DISORDERS A; Weiden Peter J, 2007, J Psychiatr Pract, V13, P13, DOI 10.1097/00131746-200701000-00003; WOODS SW, 2010, J CLIN PSYCHIAT; YASSA R, 1992, SCHIZOPHRENIA BULL, V18, P701, DOI 10.1093/schbul/18.4.701	69	41	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25588	10.1371/journal.pone.0025588	http://dx.doi.org/10.1371/journal.pone.0025588			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	22022416	gold, Green Published, Green Submitted			2022-12-27	WOS:000295943000044
J	Dvorkin-Gheva, A; Hassell, JA				Dvorkin-Gheva, Anna; Hassell, John A.			Hormone Receptor and ERBB2 Status in Gene Expression Profiles of Human Breast Tumor Samples	PLOS ONE			English	Article							ESTROGEN-REGULATED GENES; MOLECULAR PORTRAITS; CANCER; PROGESTERONE; ALPHA; SENSITIVITY; TAMOXIFEN; SUBTYPES; IDENTIFICATION; ACTIVATION	The occurrence of large publically available repositories of human breast tumor gene expression profiles provides an important resource to discover new breast cancer biomarkers and therapeutic targets. For example, knowledge of the expression of the estrogen and progesterone hormone receptors (ER and PR), and that of the ERBB2 in breast tumor samples enables choice of therapies for the breast cancer patients that express these proteins. Identifying new biomarkers and therapeutic agents affecting the activity of signaling pathways regulated by the hormone receptors or ERBB2 might be accelerated by knowledge of their expression levels in large gene expression profiling data sets. Unfortunately, the status of these receptors is not invariably reported in public databases of breast tumor gene expression profiles. Attempts have been made to employ a single probe set to identify ER, PR and ERBB2 status, but the specificity or sensitivity of their prediction is low. We enquired whether estimation of ER, PR and ERBB2 status of profiled tumor samples could be improved by using multiple probe sets representing these three genes and others with related expression. We used 8 independent datasets of human breast tumor samples to define gene expression signatures comprising 24, 51 and 14 genes predictive of ER, PR and ERBB2 status respectively. These signatures, as demonstrated by sensitivity and specificity measures, reliably identified hormone receptor and ERBB2 expression in breast tumors that had been previously determined using protein and DNA based assays. Our findings demonstrate that gene signatures can be identified which reliably predict the expression status of the estrogen and progesterone hormone receptors and that of ERBB2 in publically available gene expression profiles of breast tumor samples. Using these signatures to query transcript profiles of breast tumor specimens may enable discovery of new biomarkers and therapeutic targets for particular subtypes of breast cancer.	[Dvorkin-Gheva, Anna; Hassell, John A.] McMaster Univ, Ctr Funct Genom, Dept Biochem & Biomed Sci, Hamilton, ON, Canada	McMaster University	Dvorkin-Gheva, A (corresponding author), McMaster Univ, Ctr Funct Genom, Dept Biochem & Biomed Sci, Hamilton, ON, Canada.	hassell@mcmaster.ca		Dvorkin-Gheva, Anna/0000-0001-7295-7440	The Canadian Breast Cancer Foundation; Stem Cell Network; Terry Fox Research Institute; Ontario Institute for Cancer Research	The Canadian Breast Cancer Foundation; Stem Cell Network; Terry Fox Research Institute; Ontario Institute for Cancer Research	The Canadian Breast Cancer Foundation, the Stem Cell Network, the Terry Fox Research Institute, and the Ontario Institute for Cancer Research provided operating grants to JAH to support the research described herein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Barnett DH, 2008, CANCER RES, V68, P3505, DOI 10.1158/0008-5472.CAN-07-6151; Barrett T, 2005, NUCLEIC ACIDS RES, V33, pD562; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Boersma BJ, 2008, INT J CANCER, V122, P1324, DOI 10.1002/ijc.23237; Campone M, 2008, BREAST CANCER RES TR, V109, P491, DOI 10.1007/s10549-007-9673-x; Casey T, 2009, BREAST CANCER RES TR, V114, P47, DOI 10.1007/s10549-008-9982-8; Cheng CJ, 2009, CANCER RES, V69, P3634, DOI 10.1158/0008-5472.CAN-08-3615; Daidone MG, 2004, EUR J NUCL MED MOL I, V31, pS3, DOI 10.1007/s00259-004-1522-0; Demir H, 2010, J BUON, V15, P774; Esseghir S, 2007, CANCER RES, V67, P11732, DOI 10.1158/0008-5472.CAN-07-2343; Everitt B. S., 1981, FINITE MIXTURE DISTR; Fan C, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-3; FOEKENS JA, 1989, CANCER RES, V49, P5823; Gandhi S, 2011, ONCOLOGIST, V16, P479, DOI 10.1634/theoncologist.2010-0279; Ghosh MG, 2000, CANCER RES, V60, P6367; Gong Y, 2007, LANCET ONCOL, V8, P203, DOI 10.1016/S1470-2045(07)70042-6; Gruvberger-Saal SK, 2007, CLIN CANCER RES, V13, P1987, DOI 10.1158/1078-0432.CCR-06-1823; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Han JS, 2011, AM J CLIN PATHOL, V135, P230, DOI 10.1309/AJCP9DV3EVZUATFV; Hu Z, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2487; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Huang HJ, 2005, BREAST CANCER RES TR, V91, P81, DOI 10.1007/s10549-004-8235-8; Ikeda H, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2598; Ismail-Khan R, 2010, CANCER CONTROL, V17, P173, DOI 10.1177/107327481001700305; Jonsson G, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2596; Karn A, 2010, J NEPAL MED ASSOC, V49, P62; Kauraniemi P, 2006, ENDOCR-RELAT CANCER, V13, P39, DOI 10.1677/erc.1.01147; Lacroix M, 2001, BREAST CANCER RES TR, V67, P263, DOI 10.1023/A:1017946810277; Layfield Lester J, 2003, Breast J, V9, P257, DOI 10.1046/j.1524-4741.2003.09325.x; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Li CI, 2003, J CLIN ONCOL, V21, P28, DOI 10.1200/JCO.2003.03.088; Lo R, 2010, BBA-GENE REGUL MECH, V1799, P469, DOI 10.1016/j.bbagrm.2010.01.005; Maller JL, 2002, MOL CELL ENDOCRINOL, V187, P173, DOI 10.1016/S0303-7207(01)00695-5; MANNING DL, 1995, ACTA ONCOL, V34, P641, DOI 10.3109/02841869509094041; Mannocci A, 2010, TUMORI J, V96, P385, DOI 10.1177/030089161009600302; MARTIN M, 2011, BREAST CANC RES TREA; Matsumoto H, 2002, DEV BIOL, V245, P280, DOI 10.1006/dbio.2002.0645; McCall MN, 2010, BIOSTATISTICS, V11, P242, DOI 10.1093/biostatistics/kxp059; Miller WR, 2007, PHARMACOGENET GENOM, V17, P813, DOI 10.1097/FPC.0b013e32820b853a; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Parkinson H, 2009, NUCLEIC ACIDS RES, V37, pD868, DOI 10.1093/nar/gkn889; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pusztai L, 2003, CLIN CANCER RES, V9, P2406; Rhodes A, 2000, J CLIN PATHOL, V53, P125, DOI 10.1136/jcp.53.2.125; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Roche PC, 2002, JNCI-J NATL CANCER I, V94, P855, DOI 10.1093/jnci/94.11.855; Rody A, 2009, EUR J CANCER, V45, P405, DOI 10.1016/j.ejca.2008.10.016; Rudiger T, 2002, AM J SURG PATHOL, V26, P873, DOI 10.1097/00000478-200207000-00005; Sabatier R, 2011, BREAST CANCER RES TR, V126, P407, DOI 10.1007/s10549-010-0897-9; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Song G, 2006, BIOL REPROD, V74, P913, DOI 10.1095/biolreprod.106.050807; Song G, 2009, ENDOCRINOLOGY, V150, P936, DOI 10.1210/en.2008-1026; Staaf J, 2010, J CLIN ONCOL, V28, P1813, DOI 10.1200/JCO.2009.22.8775; Stacey SN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001029; Staff S, 2010, ONCOL REP, V23, P307, DOI 10.3892/or_00000637; Telli ML, 2010, CLIN BREAST CANCER, V10, pE16, DOI 10.3816/CBC.2010.s.003; Tozlu S, 2006, ENDOCR-RELAT CANCER, V13, P1109, DOI 10.1677/erc.1.01120; Tung JJ, 2005, CELL CYCLE, V4, P478, DOI 10.4161/cc.4.3.1532; Turashvili G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-55; Wilson BJ, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-49; Wolff AC, 2007, ARCH PATHOL LAB MED, V131, P18, DOI 10.1043/1543-2165(2007)131[18:ASOCCO]2.0.CO;2; Wu HJ, 2005, NATURE, V438, P981, DOI 10.1038/nature04225; Yang J, 2010, CANCER RES, V70, P6456, DOI 10.1158/0008-5472.CAN-10-0413	64	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e26023	10.1371/journal.pone.0026023	http://dx.doi.org/10.1371/journal.pone.0026023			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022496	Green Submitted, Green Published, gold			2022-12-27	WOS:000295978600036
J	Wolz, R; Julkunen, V; Koikkalainen, J; Niskanen, E; Zhang, DP; Rueckert, D; Soininen, H; Lotjonen, J				Wolz, Robin; Julkunen, Valtteri; Koikkalainen, Juha; Niskanen, Eini; Zhang, Dong Ping; Rueckert, Daniel; Soininen, Hilkka; Lotjonen, Jyrki		Alzheimers Dis Neuroimaging	Multi-Method Analysis of MRI Images in Early Diagnostics of Alzheimer's Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; NEUROIMAGING INITIATIVE ADNI; BRAIN; BIOMARKERS; HIPPOCAMPAL; VOLUME; CLASSIFICATION; SEGMENTATION; ACCUMULATION; PARAMETER	The role of structural brain magnetic resonance imaging (MRI) is becoming more and more emphasized in the early diagnostics of Alzheimer's disease (AD). This study aimed to assess the improvement in classification accuracy that can be achieved by combining features from different structural MRI analysis techniques. Automatically estimated MR features used are hippocampal volume, tensor-based morphometry, cortical thickness and a novel technique based on manifold learning. Baseline MRIs acquired from all 834 subjects (231 healthy controls (HC), 238 stable mild cognitive impairment (S-MCI), 167 MCI to AD progressors (P-MCI), 198 AD) from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database were used for evaluation. We compared the classification accuracy achieved with linear discriminant analysis (LDA) and support vector machines (SVM). The best results achieved with individual features are 90% sensitivity and 84% specificity (HC/AD classification), 64%/66% (S-MCI/P-MCI) and 82%/76% (HC/P-MCI) with the LDA classifier. The combination of all features improved these results to 93% sensitivity and 85% specificity (HC/AD), 67%/69% (S-MCI/P-MCI) and 86%/82% (HC/P-MCI). Compared with previously published results in the ADNI database using individual MR-based features, the presented results show that a comprehensive analysis of MRI images combining multiple features improves classification accuracy and predictive power in detecting early AD. The most stable and reliable classification was achieved when combining all available features.	[Wolz, Robin; Zhang, Dong Ping; Rueckert, Daniel] Univ London Imperial Coll Sci Technol & Med, Dept Comp, Biomed Image Anal Grp, London, England; [Julkunen, Valtteri; Niskanen, Eini; Soininen, Hilkka] Kuopio Univ Hosp, Dept Neurol, SF-70210 Kuopio, Finland; [Koikkalainen, Juha; Lotjonen, Jyrki] VTT Tech Res Ctr Finland, Knowledge Intens Serv, Tampere, Finland; [Niskanen, Eini] Univ Eastern Finland, Dept Appl Phys, Kuopio, Finland; [Soininen, Hilkka] Univ Eastern Finland, Inst Clin Med, Kuopio, Finland	Imperial College London; Kuopio University Hospital; University of Eastern Finland; VTT Technical Research Center Finland; University of Eastern Finland; University of Eastern Finland	Wolz, R (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Comp, Biomed Image Anal Grp, London, England.	jyrki.lotjonen@vtt.fi	Rueckert, Daniel/C-4393-2008; Levey, Allan/F-2104-2011; Hsiung, Robin/AAT-1661-2021; Preda, Adrian/K-8889-2013	Levey, Allan/0000-0002-3153-502X; Hsiung, Robin/0000-0002-8017-0856; Preda, Adrian/0000-0003-3373-2438; Julkunen, Valtteri/0000-0002-8727-8536; Rueckert, Daniel/0000-0002-5683-5889	European Commission; Alzheimer's Disease Neuroimaging Initiative (ADNI) [U01 AG024904]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering (NIBIB); Northern California Institute for Research and Education; NATIONAL INSTITUTE ON AGING [R01AG012101, P30AG013846, U01AG024904, R01AG022374, U19AG010483, P30AG019610] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); Alzheimer's Disease Neuroimaging Initiative (ADNI); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering (NIBIB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Northern California Institute for Research and Education; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project is partially funded under the 7th Framework Programme by the European Commission (http://cordis.europa.eu/ist/). Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI; Principal Investigator: Michael Weiner; NIH grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering (NIBIB), and through generous contributions from the following: Pzer Inc., Wyeth Research, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Merck & Co. Inc., AstraZeneca AB, Novartis Pharmaceuticals Corporation, Alzheimer's Association, Eisai Global Clinical Development, Elan Corporation, plc, Forest Laboratories, and the Institute for the Study of Aging, with participation from the U.S. Food and Drug Administration. Industry partnerships are coordinated through the Foundation for the National Institutes of Health. The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California San Diego. ADNI data are disseminated by the Laboratory of Neuro Imaging at the University of California Los Angeles. Data used in the preparation of this article were obtained from the ADNI database (www.loni.ucla.edu/ADNI). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. ADNI investigators include (complete listing available at http://adni.loni.ucla.edu/wp-content/uploads/how_to_apply/ADNI_Authorship_List.pdf).	Belkin M, 2003, NEURAL COMPUT, V15, P1373, DOI 10.1162/089976603321780317; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Brun CC, 2009, NEUROIMAGE, V48, P37, DOI 10.1016/j.neuroimage.2009.05.022; Chung MK, 2004, 2004 2ND IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING: MACRO TO NANO, VOLS 1 AND 2, P432; Chupin M, 2009, NEUROIMAGE, V46, P749, DOI 10.1016/j.neuroimage.2009.02.013; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cuingnet R, 2010, NEUROIMAGE IN PRESS; Cummings JL, 2007, NEUROLOGY, V69, P1622, DOI 10.1212/01.wnl.0000295996.54210.69; Davatzikos C, 2010, NEUROBIOLOG IN PRESS; Devanand DP, 2007, NEUROLOGY, V68, P828, DOI 10.1212/01.wnl.0000256697.20968.d7; Draper N. R., 1998, WILEY SERIES PROBABI, V3rd, DOI DOI 10.1111/ecog.01134; Eckerstrom C, 2010, DEMENT GERIATR COGN, V29, P294, DOI 10.1159/000289814; Fan Y, 2008, NEUROIMAGE, V41, P277, DOI 10.1016/j.neuroimage.2008.02.043; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gauthier S, 2006, LANCET, V367, P1262, DOI 10.1016/S0140-6736(06)68542-5; Gerardin E, 2009, NEUROIMAGE, V47, P1476, DOI 10.1016/j.neuroimage.2009.05.036; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; Hampel H, 2008, ALZHEIMERS DEMENT, V4, P38, DOI 10.1016/j.jalz.2007.08.006; Hampel H, 2010, NAT REV DRUG DISCOV, V9, P560, DOI 10.1038/nrd3115; Hinrichs C, 2009, LECT NOTES COMPUT SC, V5762, P786, DOI 10.1007/978-3-642-04271-3_95; HYMAN BT, 1993, J NEUROPATH EXP NEUR, V52, P594, DOI 10.1097/00005072-199311000-00006; Ingelsson M, 2004, NEUROLOGY, V62, P925, DOI 10.1212/01.WNL.0000115115.98960.37; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Jack Jr C, 2010, LANCET NEUROL, V27, P685; Kim JS, 2005, NEUROIMAGE, V27, P210, DOI 10.1016/j.neuroimage.2005.03.036; Kohannim O, 2010, NEUROBIOL AGING, V31, P1429, DOI 10.1016/j.neurobiolaging.2010.04.022; Koikkalainen J, 2011, NEUROIMAGE, V56, P1134, DOI 10.1016/j.neuroimage.2011.03.029; Krzanowski W. J., 1988, PRINCIPLES MULTIVARI; Landau SM, 2010, NEUROLOGY, V75, P230, DOI 10.1212/WNL.0b013e3181e8e8b8; Lerch JP, 2005, NEUROIMAGE, V24, P163, DOI 10.1016/j.neuroimage.2004.07.045; Liu Y, 2009, NEUROBIOLOG IN PRESS; Liu YW, 2010, NEUROBIOL AGING, V31, P1375, DOI 10.1016/j.neurobiolaging.2010.01.022; Lotjonen J, 2011, NEUROIMAGE, V56, P185, DOI 10.1016/j.neuroimage.2011.01.062; Lotjonen JMP, 2010, NEUROIMAGE, V49, P2352, DOI 10.1016/j.neuroimage.2009.10.026; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; McEvoy LK, 2009, RADIOLOGY, V251, P195, DOI 10.1148/radiol.2511080924; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Mueller SG, 2005, NEUROIMAG CLIN N AM, V15, P869, DOI 10.1016/j.nic.2005.09.008; Petersen RC, 2010, NEUROLOGY, V74, P201, DOI 10.1212/WNL.0b013e3181cb3e25; Petersen RC, 2001, NEUROLOGY, V56, P1133, DOI 10.1212/WNL.56.9.1133; Querbes O, 2009, BRAIN, V132, P2036, DOI 10.1093/brain/awp105; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Tohka J, 2004, NEUROIMAGE, V23, P84, DOI 10.1016/j.neuroimage.2004.05.007; Van Leemput K, 1999, IEEE T MED IMAGING, V18, P897, DOI 10.1109/42.811270; Vemuri P, 2008, NEUROIMAGE, V39, P1186, DOI 10.1016/j.neuroimage.2007.09.073; Walhovd KB, 2010, AM J NEURORADIOL, V31, P347, DOI 10.3174/ajnr.A1809; Wenk G, 2003, J CLIN PSYCHIAT S9, V64; Westman E, 2011, NEUROIMAGE, V54, P1178, DOI 10.1016/j.neuroimage.2010.08.044; Wolz R, 2011, IEEE INT S BIOM IM, P960; Wolz R, 2010, NEUROIMAGE, V52, P109, DOI 10.1016/j.neuroimage.2010.04.006; Zijdenbos A, 1998, LECT NOTES COMPUT SC, V1496, P439, DOI 10.1007/BFb0056229	55	211	212	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e25446	10.1371/journal.pone.0025446	http://dx.doi.org/10.1371/journal.pone.0025446			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022397	gold, Green Published			2022-12-27	WOS:000295978600014
J	Da Silva-Ferrada, E; Torres-Ramos, M; Aillet, F; Campagna, M; Matute, C; Rivas, C; Rodriguez, MS; Lang, V				Da Silva-Ferrada, Elisa; Torres-Ramos, Monica; Aillet, Fabienne; Campagna, Michela; Matute, Carlos; Rivas, Carmen; Rodriguez, Manuel S.; Lang, Valerie			Role of Monoubiquitylation on the Control of I kappa B alpha Degradation and NF-kappa B Activity	PLOS ONE			English	Article							SIGNAL-INDUCED DEGRADATION; GENE-EXPRESSION; ACTIVATION; UBIQUITINATION; BINDING; MONOUBIQUITINATION; PHOSPHORYLATION; PROTEINS	The NF-kappa B pathway is regulated by multiple post-translational modifications including phosphorylation, ubiquitylation and SUMOylation. Many of these modifications act on the natural inhibitor I kappa B alpha modulating its capacity to control signalmediated NF-kappa B activity. While the canonical pathway involving the phosphorylation and polyubiquitylation of I kappa B alpha has been well characterized, the role of these post-translational modifications in the control of basal NF-kappa B activity has not been deeply explored. Using the recently developed Tandem-repeated Ubiquitin Binding Entities (also known as ubiquitin traps) to capture ubiquitylated proteins, we identified monoubiquitylated forms of I kappa B alpha from multiple rat organs and cell types. The identification of these forms was demonstrated through different procedures such as immunoprecipitations with specific ubiquitin antibodies or His6-Ubiquitin pull downs. Monoubiquitylated forms of I kappa B alpha are resistant to TNF alpha-mediated degradation and can be captured using TUBEs, even after proteasome inhibitors treatment. As it occurs for monoSUMOylation, monoubiquitylation is not dependent of the phosphorylation of I kappa B alpha on the serines 32/36 and is not optimally degraded after TNF alpha stimulation. A ubiquitin-I kappa B alpha fusion exhibits phosphorylation defects and resistance to TNF alpha mediated degradation similar to the ones observed for endogenous monoubiquitylated I kappa B alpha. The N-terminal attachment of a single ubiquitin moiety on the I kappa B alpha fusion results in a deficient binding to the IKK beta kinase and recruitment of the SCF ligase component beta TrCP, promoting a negative impact on the NF-kappa B activity. Altogether, our results suggest the existence of a reservoir of monoubiquitylated I kappa B alpha resistant to TNF alpha-induced proteolysis, which is able to interact and repress DNA binding and NF-kappa B transcriptional activity. Such pool of I kappa B alpha may play an important role in the control of basal and signal-mediated NF-kappa B activity.	[Da Silva-Ferrada, Elisa; Torres-Ramos, Monica; Aillet, Fabienne; Rodriguez, Manuel S.; Lang, Valerie] CIBERehd, CIC BioGUNE, Prote Unit, Derio, Spain; [Campagna, Michela; Rivas, Carmen] Campus Univ Autonoma Madrid, CSIC, Ctr Nacl Biotecnol, Madrid, Spain; [Matute, Carlos] Dept Neurosci Univ Basque Country UPV EHU, CIBERNED, Leioa, Bizkaia, Spain; [Rodriguez, Manuel S.] Dept Biochem Univ Basque Country UPV EHU, Leioa, Bizkaia, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; CIC bioGUNE; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); CIBERNED; University of Basque Country	Da Silva-Ferrada, E (corresponding author), CIBERehd, CIC BioGUNE, Prote Unit, Bizkaia Technol Pk, Derio, Spain.	mrodriguez@cicbiogune.es	RODRIGUEZ, Manuel S./D-5439-2018; Rivas, Carmen/AAB-6278-2019; Matute, Carlos/N-5559-2014; Rivas, Carmen/L-3162-2017; Torres-Ramos, Mónica/AAU-7618-2020	Rivas, Carmen/0000-0002-0518-7199; Matute, Carlos/0000-0001-8672-711X; Rivas, Carmen/0000-0002-0518-7199; Torres-Ramos, Mónica/0000-0002-8900-4037; Da Silva-Ferrada, Elisa Aida/0000-0003-0282-3855	Ministerio de Educacion y Ciencia [BFU2006-12991, BFU2008-01108/BMC]; Fondo de Investigaciones Sanitarias (FIS) CIBERhed, Government of the Autonomous Community of the Basque Country [PI09-05]; Department of Industry, Tourism and Trade of the Government of the Autonomous Community of the Basque Country; Innovation Technology Department of the Bizkaia Country	Ministerio de Educacion y Ciencia(Spanish Government); Fondo de Investigaciones Sanitarias (FIS) CIBERhed, Government of the Autonomous Community of the Basque Country(Instituto de Salud Carlos III); Department of Industry, Tourism and Trade of the Government of the Autonomous Community of the Basque Country; Innovation Technology Department of the Bizkaia Country	This work was funded by the Ramon y Cajal Program, Ministerio de Educacion y Ciencia grant BFU2006-12991 and BFU2008-01108/BMC, Fondo de Investigaciones Sanitarias (FIS) CIBERhed, Government of the Autonomous Community of the Basque Country grant PI09-05, Department of Industry, Tourism and Trade of the Government of the Autonomous Community of the Basque Country (Etortek Research Programs 2008/2009) and from the Innovation Technology Department of the Bizkaia Country. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARENZANASEISDEDOS F, 1995, MOL CELL BIOL, V15, P2689; Baldi L, 1996, J BIOL CHEM, V271, P376, DOI 10.1074/jbc.271.1.376; Carter S, 2008, CELL CYCLE, V7, P2519, DOI 10.4161/cc.7.16.6422; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; GHOSH S, 1990, NATURE, V344, P678, DOI 10.1038/344678a0; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hjerpe R, 2009, EMBO REP, V10, P1250, DOI 10.1038/embor.2009.192; Hoeller D, 2007, MOL CELL, V26, P891, DOI 10.1016/j.molcel.2007.05.014; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Isasa M, 2010, MOL CELL, V38, P733, DOI 10.1016/j.molcel.2010.05.001; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Krappmann D, 2005, EMBO REP, V6, P321, DOI 10.1038/sj.embor.7400380; Lang V, 2008, BIOCHEM SOC T, V36, P853, DOI 10.1042/BST0360853; Li HX, 2008, CYTOKINE, V41, P1, DOI 10.1016/j.cyto.2007.09.016; LIU S, 2010, CELL RES; Mabb AM, 2007, CELL MOL LIFE SCI, V64, P1979, DOI 10.1007/s00018-007-7005-2; Mathes E, 2010, J BIOL CHEM, V285, P32927, DOI 10.1074/jbc.M110.107326; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Rodriguez MS, 1999, J BIOL CHEM, V274, P9108, DOI 10.1074/jbc.274.13.9108; Rodriguez MS, 1996, ONCOGENE, V12, P2425; Salmena L, 2007, NAT REV CANCER, V7, P409, DOI 10.1038/nrc2145; SCHERER DC, 1995, P NATL ACAD SCI USA, V92, P11259, DOI 10.1073/pnas.92.24.11259; Tian B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-137	24	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25397	10.1371/journal.pone.0025397	http://dx.doi.org/10.1371/journal.pone.0025397			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022389	Green Published, gold			2022-12-27	WOS:000295976000013
J	McMahon, CR; Buscot, MJ; Wiggins, NL; Collier, N; Maindonald, JH; McCallum, HI; Bowman, DMJS				McMahon, Clive R.; Buscot, Marie-Jeanne; Wiggins, Natasha L.; Collier, Neil; Maindonald, John H.; McCallum, Hamish I.; Bowman, David M. J. S.			A Two-Phase Model for Smoothly Joining Disparate Growth Phases in the Macropodid Thylogale billardierii	PLOS ONE			English	Article							POPULATION-DYNAMICS; AGE-DETERMINATION; ELEPHANT SEAL; MAMMALS; DENSITY	Generally, sigmoid curves are used to describe the growth of animals over their lifetime. However, because growth rates often differ over an animal's lifetime a single curve may not accurately capture the growth. Broken-stick models constrained to pass through a common point have been proposed to describe the different growth phases, but these are often unsatisfactory because essentially there are still two functions that describe the lifetime growth. To provide a single, converged model to age animals with disparate growth phases we developed a smoothly joining two-phase nonlinear function (SJ2P), tailored to provide a more accurate description of lifetime growth of the macropod, the Tasmanian pademelon Thylogale billardierii. The model consists of the Verhulst logistic function, which describes pouch-phase growth - joining smoothly to the Brody function, which describes post-pouch growth. Results from the model demonstrate that male pademelons grew faster and bigger than females. Our approach provides a practical means of ageing wild pademelons for life history studies but given the high variability of the data used to parametrise the second growth phase of the model, the accuracy of ageing of post-weaned animals is low: accuracy might be improved with collection of longitudinal growth data. This study provides a unique, first robust method that can be used to characterise growth over the lifespan of pademelons. The development of this method is relevant to collecting age-specific vital rates from commonly used wildlife management practices to provide crucial insights into the demographic behaviour of animal populations.	[McMahon, Clive R.; Buscot, Marie-Jeanne; Collier, Neil] Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT 0909, Australia; [Wiggins, Natasha L.; Bowman, David M. J. S.] Univ Tasmania, Sch Plant Sci, Hobart, Tas, Australia; [Maindonald, John H.] Australian Natl Univ, Ctr Math & Its Applicat, Canberra, ACT, Australia; [McCallum, Hamish I.] Griffith Univ, Griffith Sch Environm, Environm Futures Ctr, Nathan, Qld 4111, Australia	Charles Darwin University; University of Tasmania; Australian National University; Griffith University	McMahon, CR (corresponding author), Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT 0909, Australia.	wigginsn@utas.edu.au	Collier, Neil/F-4729-2010; McMahon, Clive R/D-5713-2013; Bowman, David M.J.S./A-2930-2011; McCallum, Hamish/E-1638-2013	McMahon, Clive R/0000-0001-5241-8917; Bowman, David M.J.S./0000-0001-8075-124X; McCallum, Hamish/0000-0002-3493-0412; Collier, Neil/0000-0003-0115-0564; BUSCOT, Marie-jeanne/0000-0002-9055-5928	Tasmanian Community Forest Agreement; University of Tasmania; Tasmanian Community Forest Agreement: [1080]	Tasmanian Community Forest Agreement; University of Tasmania; Tasmanian Community Forest Agreement:	Financial support was provided by the Tasmanian Community Forest Agreement: Alternatives to 1080 Programme. In-kind support was provided by the University of Tasmania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBON SD, 1983, J ANIM ECOL, V52, P969, DOI 10.2307/4467; Beckerman AP, 2002, TRENDS ECOL EVOL, V17, P263, DOI 10.1016/S0169-5347(02)02469-2; Benton TG, 1999, TRENDS ECOL EVOL, V14, P467, DOI 10.1016/S0169-5347(99)01724-3; Brody S., 1945, BIOENERGETICS GROWTH; Caswell, 2000, MATRIX POPULATION MO; Caswell H, 2007, ECOL LETT, V10, P1, DOI 10.1111/j.1461-0248.2006.01001.x; Caughley G., 1996, CONSERVATION BIOL TH; Caughley G., 1977, ANAL VERTEBRATE POPU; Caughley GJ, 1994, WILDLIFE ECOLOGY MAN; Chiu G, 2006, J AM STAT ASSOC, V101, P542, DOI 10.1198/016214505000001177; Coleman JD, 2006, LC0506144 DEP PRIM I; Driessen M. M, 1992, EFFECTS HUNTING RAIN; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; Gaillard JM, 1997, P ROY SOC B-BIOL SCI, V264, P859, DOI 10.1098/rspb.1997.0120; Garel M, 2009, J MAMMAL, V90, P954, DOI 10.1644/08-MAMM-A-287.1; Johnson K.A., 2008, MAMMALS AUSTR, P395; KIRKPATRICK T. H., 1965, QUEENSLAND J AGR ANIM SCI, V22, P301; Kirkpatrick T. H., 1964, Queensland Journal of Agricultural Science, V21, P163; LAWS RM, 1956, NATURE, V178, P193, DOI 10.1038/178193a0; Maindonald J, 2010, DATA ANAL GRAPHICS U; McMahon CR, 2010, METHODS ECOL EVOL, V1, P53, DOI 10.1111/j.2041-210X.2009.00002.x; McMahon CR, 2005, P ROY SOC B-BIOL SCI, V272, P923, DOI 10.1098/rspb.2004.3038; McMahon CR, 2005, MAR ECOL PROG SER, V288, P273, DOI 10.3354/meps288273; Otway NM, 2004, BIOL CONSERV, V119, P341, DOI 10.1016/j.biocon.2003.11.017; POOLE WE, 1982, AUST WILDLIFE RES, V9, P9; POOLE WE, 1985, AUST WILDLIFE RES, V12, P127; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; ROSE RW, 1982, AUST WILDLIFE RES, V9, P33; ROUNSEVELL DE, 1991, WILDLIFE RES, V18, P699, DOI 10.1071/WR9910699; Sharman G. B., 1964, Wildlife Res, V9, P20; Topal M, 2004, SMALL RUMINANT RES, V55, P229, DOI 10.1016/j.smallrumres.2004.01.007; Verhulst P. F., 1838, CORRES MATH PHYS, V10, P113, DOI DOI 10.1007/BF02309004; VONBERTALANFFY L, 1957, Q REV BIOL, V32, P217, DOI 10.1086/401873; Wiggins NL, 2010, WILDLIFE RES, V37, P379, DOI 10.1071/WR09144; Wisdom MJ, 2000, ECOLOGY, V81, P628, DOI 10.1890/0012-9658(2000)081[0628:LSSAEV]2.0.CO;2	36	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e24934	10.1371/journal.pone.0024934	http://dx.doi.org/10.1371/journal.pone.0024934			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022369	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000295976000006
J	Teichroeb, JH; Betts, DH; Vaziri, H				Teichroeb, Jonathan H.; Betts, Dean H.; Vaziri, Homayoun			Suppression of the Imprinted Gene NNAT and X-Chromosome Gene Activation in Isogenic Human iPS Cells	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; METHYLATION STATUS; NUCLEAR TRANSFER; NEURONATIN GENE; EXPRESSION; INACTIVATION; RTL1	Genetic comparison between human embryonic stem cells and induced pluripotent stem cells has been hampered by genetic variation. To solve this problem, we have developed an isogenic system that allows direct comparison of induced pluripotent stem cells (hiPSCs) to their genetically matched human embryonic stem cells (hESCs). We show that hiPSCs have a highly similar transcriptome to hESCs. Global transcriptional profiling identified 102-154 genes (>2 fold) that showed a difference between isogenic hiPSCs and hESCs. A stringent analysis identified NNAT as a key imprinted gene that was dysregulated in hiPSCs. Furthermore, a disproportionate number of X-chromosome localized genes were over-expressed in female hiPSCs. Our results indicate that despite a remarkably close transcriptome to hESCs, isogenic hiPSCs have alterations in imprinting and regulation of X-chromosome genes.	[Teichroeb, Jonathan H.; Vaziri, Homayoun] Univ Toronto, Dept Med Biophys, Ontario Canc Inst, Toronto, ON, Canada; [Teichroeb, Jonathan H.; Betts, Dean H.] Univ Western Ontario, Dept Physiol & Pharmacol, Schulich Sch Med & Dent, London, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Western University (University of Western Ontario)	Teichroeb, JH (corresponding author), Univ Toronto, Dept Med Biophys, Ontario Canc Inst, Toronto, ON, Canada.	h.vaziri@utoronto.ca	Betts, Dean H/B-7414-2015	Betts, Dean H/0000-0002-5528-9142	Natural Sciences and Engineering Research Coucil	Natural Sciences and Engineering Research Coucil	Postdoctoral funding was provided by Natural Sciences and Engineering Research Coucil. Otherwise there are no current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruck T, 2011, STEM CELL RES, V6, P187, DOI 10.1016/j.scr.2010.12.001; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; CARREL L, 1999, HETEROGENEOUS GENE E, P7364; Chang G, 2009, GENOMICS, V93, P112, DOI 10.1016/j.ygeno.2008.09.011; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Cui XS, 2009, BIOCHEM BIOPH RES CO, V379, P390, DOI 10.1016/j.bbrc.2008.12.148; Da Rocha ST, 2008, TRENDS GENET, V24, P306, DOI 10.1016/j.tig.2008.03.011; Dvash T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011330; Edwards RG, 2001, NATURE, V413, P349, DOI 10.1038/35096649; Evans HK, 2001, GENOMICS, V77, P99, DOI 10.1006/geno.2001.6612; Feng Q, 2010, STEM CELLS, V28, P704, DOI 10.1002/stem.321; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Han DW, 2008, MOL REPROD DEV, V75, P777, DOI 10.1002/mrd.20802; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; JIN SG, 2010, EXAMINATION SPECIFIC; Kagami M, 2008, NAT GENET, V40, P237, DOI 10.1038/ng.2007.56; Kagami M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000992; LENGNER CJ, 2010, CELL; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; LIU L, 2010, J BIOL CHEM; Marchetto MCN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007076; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Navarro P, 2008, SCIENCE, V321, P1693, DOI 10.1126/science.1160952; Navarro P, 2009, FEBS LETT, V583, P1721, DOI 10.1016/j.febslet.2009.03.043; SATO S, 2011, GENOMICS IN PRESS; Sekita Y, 2008, NAT GENET, V40, P243, DOI 10.1038/ng.2007.51; SILVA SS, 2008, X CHROMOSOME INACTIV, P4820; Simerly C, 2004, DEV BIOL, V276, P237, DOI 10.1016/j.ydbio.2004.10.006; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tchieu J, 2010, CELL STEM CELL, V7, P329, DOI 10.1016/j.stem.2010.06.024; Vaziri H, 2010, REGEN MED, V5, P345, DOI 10.2217/RME.10.21; West MD, 2008, REGEN MED, V3, P287, DOI 10.2217/17460751.3.3.287; WIJNHOLDS J, 1995, DEV BIOL, V171, P73, DOI 10.1006/dbio.1995.1261; WRIGHT K, 2011, HUMAN REPROD, P1; Young LE, 2003, MECH DEVELOP, V120, P1433, DOI 10.1016/j.mod.2003.09.006; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	38	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e23436	10.1371/journal.pone.0023436	http://dx.doi.org/10.1371/journal.pone.0023436			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022350	Green Published, Green Submitted, gold			2022-12-27	WOS:000295976000001
J	Yang, SW; Chanda, D; Cody, JJ; Rivera, AA; Waehler, R; Siegal, GP; Douglas, JT; Ponnazhagan, S				Yang, Sherry W.; Chanda, Diptiman; Cody, James J.; Rivera, Angel A.; Waehler, Reinhard; Siegal, Gene P.; Douglas, Joanne T.; Ponnazhagan, Selvarangan			Conditionally Replicating Adenovirus Expressing TIMP2 Increases Survival in a Mouse Model of Disseminated Ovarian Cancer	PLOS ONE			English	Article							TISSUE INHIBITOR; IN-VIVO; TUMOR-GROWTH; SELECTIVE VIRUSES; CELL-MIGRATION; GENE DELIVERY; CARCINOMA; METALLOPROTEINASE-2; ANGIOGENESIS; THERAPY	Ovarian cancer remains difficult to treat mainly due to presentation of the disease at an advanced stage. Conditionally-replicating adenoviruses (CRAds) are promising anti-cancer agents that selectively kill the tumor cells. The present study evaluated the efficacy of a novel CRAd (Ad5/3-CXCR4-TIMP2) containing the CXCR4 promoter for selective viral replication in cancer cells together with TIMP2 as a therapeutic transgene, targeting the matrix metalloproteases (MMPs) in a murine orthotopic model of disseminated ovarian cancer. An orthotopic model of ovarian cancer was established in athymic nude mice by intraperitonal injection of the human ovarian cancer cell line, SKOV3-Luc, expressing luciferase. Upon confirmation of peritoneal dissemination of the cells by non-invasive imaging, mice were randomly divided into four treatment groups: PBS, Ad-Delta E1-TIMP2, Ad5/3-CXCR4, and Ad5/3-CXCR4-TIMP2. All mice were imaged weekly to monitor tumor growth and were sacrificed upon reaching any of the predefined endpoints, including high tumor burden and significant weight loss along with clinical evidence of pain and distress. Survival analysis was performed using the Log-rank test. The median survival for the PBS cohort was 33 days; for Ad-Delta E1-TIMP2, 39 days; for Ad5/3-CXCR4, 52.5 days; and for Ad5/3-CXCR4-TIMP2, 63 days. The TIMP2-armed CRAd delayed tumor growth and significantly increased survival when compared to the unarmed CRAd. This therapeutic effect was confirmed to be mediated through inhibition of MMP9. Results of the in vivo study support the translational potential of Ad5/3-CXCR4-TIMP2 for treatment of human patients with advanced ovarian cancer.	[Yang, Sherry W.; Chanda, Diptiman; Cody, James J.; Siegal, Gene P.; Ponnazhagan, Selvarangan] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Rivera, Angel A.; Waehler, Reinhard; Douglas, Joanne T.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Rivera, Angel A.] Univ Alabama Birmingham, Dept Obstet & Gynecol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Yang, SW (corresponding author), Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA.	pons@uab.edu	Rivera, Ángel/GRJ-2093-2022		National Institutes of Health [R01CA108585, T32 CA075930]; University of Alabama at Birmingham, Department of Pathology; NATIONAL CANCER INSTITUTE [T32CA075930, R01CA108585] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Alabama at Birmingham, Department of Pathology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grants R01CA108585, T32 CA075930, and the University of Alabama at Birmingham, Department of Pathology Research Fund is appreciated. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Baker AH, 1996, MATRIX BIOL, V15, P383, DOI 10.1016/S0945-053X(96)90158-4; Biederer C, 2002, J MOL MED-JMM, V80, P163, DOI 10.1007/s00109-001-0295-1; Brand K, 2000, CANCER RES, V60, P5723; Brand Karsten, 2002, Current Gene Therapy, V2, P255, DOI 10.2174/1566523024605564; Davidson B, 1999, CLIN EXP METASTAS, V17, P799, DOI 10.1023/A:1006723011835; Davidson B, 2001, EUR J CANCER, V37, P2040, DOI 10.1016/S0959-8049(01)00235-0; Deng XY, 2008, INT J CANCER, V122, P209, DOI 10.1002/ijc.23053; Edinger M, 2002, EUR J CANCER, V38, P2128, DOI 10.1016/S0959-8049(02)00410-0; El Hilali N, 2002, LAB INVEST, V82, P1563, DOI 10.1097/01.LAB.0000036877.36379.1F; Feldman AL, 2004, CANCER RES, V64, P4481, DOI 10.1158/0008-5472.CAN-03-2929; Fidler I J, 2001, Surg Oncol Clin N Am, V10, P257; Fidler IJ, 2007, J CELL BIOCHEM, V101, P927, DOI 10.1002/jcb.21148; Hakkarainen T, 2006, INT J MOL MED, V18, P751; Heideman DAM, 2005, MOL THER, V12, P1083, DOI 10.1016/j.ymthe.2005.06.443; Hemminki O, 2011, CANCER GENE THER, V18, P288, DOI 10.1038/cgt.2010.79; Hermiston T, 2000, J CLIN INVEST, V105, P1169, DOI 10.1172/JCI9973; Huang SY, 2002, J NATL CANCER I, V94, P1134; JEMAL A, 2010, CA CANC J CLIN; Kamat AA, 2006, CLIN CANCER RES, V12, P1707, DOI 10.1158/1078-0432.CCR-05-2338; Kanerva A, 2002, CLIN CANCER RES, V8, P275; Kanerva A, 2005, GENE THER, V12, P87, DOI 10.1038/sj.gt.3302387; Kanerva A, 2004, GENE THER, V11, P552, DOI 10.1038/sj.gt.3302181; Kanerva A, 2002, MOL THER, V5, P695, DOI 10.1006/mthe.2002.0599; Kenny HA, 2008, J CLIN INVEST, V118, P1367, DOI 10.1172/JCI33775; Kim TJ, 2006, HUM PATHOL, V37, P906, DOI 10.1016/j.humpath.2006.02.017; Kurman RJ, 2008, INT J GYNECOL PATHOL, V27, P151, DOI 10.1097/PGP.0b013e318161e4f5; Lam JT, 2004, J GENE MED, V6, P1333, DOI 10.1002/jgm.635; Li H, 2001, HUM GENE THER, V12, P515, DOI 10.1089/104303401300042429; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; McNally LR, 2009, CANCER GENE THER, V16, P246, DOI 10.1038/cgt.2008.76; Mittereder N, 1996, J VIROL, V70, P7498, DOI 10.1128/JVI.70.11.7498-7509.1996; Oh J, 2004, CANCER RES, V64, P9062, DOI 10.1158/0008-5472.CAN-04-1981; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Ozols RF, 2004, CANCER CELL, V5, P19, DOI 10.1016/S1535-6108(04)00002-9; PAGET S, 1989, CANCER METAST REV, V8, P98; Partridge EE, 1999, CA-CANCER J CLIN, V49, P297, DOI 10.3322/canjclin.49.5.297; Perreau M, 2007, J VIROL, V81, P3272, DOI 10.1128/JVI.01530-06; Raki M, 2005, GENE THER, V12, P1198, DOI 10.1038/sj.gt.3302517; Raki M, 2008, GYNECOL ONCOL, V108, P166, DOI 10.1016/j.ygyno.2007.09.013; Rein DT, 2005, CLIN CANCER RES, V11, P1327; Rigg AS, 2001, CANCER GENE THER, V8, P869, DOI 10.1038/sj.cgt.7700387; Rocconi RP, 2007, GYNECOL ONCOL, V105, P113, DOI 10.1016/j.ygyno.2006.10.057; Schmalfeldt B, 2001, CLIN CANCER RES, V7, P2396; Scotton CJ, 2001, CANCER RES, V61, P4961; Scotton CJ, 2002, CANCER RES, V62, P5930; Seo DW, 2003, CELL, V114, P171, DOI 10.1016/S0092-8674(03)00551-8; Torng PL, 2004, GYNECOL ONCOL, V92, P559, DOI 10.1016/j.ygyno.2003.11.011; Tsuruta Y, 2008, CLIN CANCER RES, V14, P3582, DOI 10.1158/1078-0432.CCR-07-5053; van Beusechem VW, 2005, MOL CANCER THER, V4, P1013, DOI 10.1158/1535-7163.MCT-05-0010; Vasey PA, 2002, J CLIN ONCOL, V20, P1562, DOI 10.1200/JCO.20.6.1562; Vincent L, 2003, INT J CANCER, V105, P419, DOI 10.1002/ijc.11105; Yang SW, 2011, CLIN CANCER RES, V17, P538, DOI 10.1158/1078-0432.CCR-10-1628; Zeamari S, 2004, BRIT J CANCER, V90, P1259, DOI 10.1038/sj.bjc.6601637; Zhu ZB, 2004, CANCER GENE THER, V11, P256, DOI 10.1038/sj.cgt.7700679; Zhu ZB, 2008, INT J ONCOL, V32, P1179; Zucker S, 2000, ONCOGENE, V19, P6642, DOI 10.1038/sj.onc.1204097	56	38	42	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25131	10.1371/journal.pone.0025131	http://dx.doi.org/10.1371/journal.pone.0025131			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022379	Green Published, gold, Green Submitted			2022-12-27	WOS:000295976000010
J	Yuan, Q; Hong, SJ; Han, S; Zeng, L; Liu, F; Ding, GS; Kang, YD; Mao, JY; Cai, M; Zhu, YH; Wang, QX				Yuan, Qing; Hong, Shanjuan; Han, Shu; Zeng, Li; Liu, Fang; Ding, Guoshan; Kang, Yindong; Mao, Jingyan; Cai, Ming; Zhu, Youhua; Wang, Quan-xing			Preconditioning with Physiological Levels of Ethanol Protect Kidney against Ischemia/Reperfusion Injury by Modulating Oxidative Stress	PLOS ONE			English	Article							RENAL TUBULAR CELLS; ALCOHOL-CONSUMPTION; LIPID-PEROXIDATION; REPERFUSION INJURY; IN-VIVO; ISCHEMIA; MORTALITY; ACTIVATION; QUERCETIN; DISEASE	Background: Oxidative stress due to excessive production of reactive oxygen species (ROS) and subsequent lipid peroxidation plays a critical role in renal ischemia/reperfusion (IR) injury. The purpose of current study is to demonstrate the effect of antecedent ethanol exposure on IR-induced renal injury by modulation of oxidative stress. Materials and Methods: Bilateral renal warm IR was induced in male C57BL/6 mice after ethanol or saline administration. Blood ethanol concentration, kidney function, histological damage, inflammatory infiltration, cytokine production, oxidative stress, antioxidant capacity and Aldehyde dehydrogenase (ALDH) enzymatic activity were assessed to evaluate the impact of antecedent ethanol exposure on IR-induced renal injury. Results: After bilateral kidney ischemia, mice preconditioned with physiological levels of ethanol displayed significantly preserved renal function along with less histological tubular damage as manifested by the reduced inflammatory infiltration and cytokine production. Mechanistic studies revealed that precondition of mice with physiological levels of ethanol 3 h before IR induction enhanced antioxidant capacity characterized by significantly higher superoxidase dismutase (SOD) activities. Our studies further demonstrated that ethanol pretreatment specifically increased ALDH2 activity, which then suppressed lipid peroxidation by promoting the detoxification of Malondialdehyde (MDA) and 4-hydroxynonenal (HNE). Conclusions: Our results provide first line of evidence indicating that antecedent ethanol exposure can provide protection for kidneys against IR-induced injury by enhancing antioxidant capacity and preventing lipid peroxidation. Therefore, ethanol precondition and ectopic ALDH2 activation could be potential therapeutic approaches to prevent renal IR injury relevant to various clinical conditions.	[Yuan, Qing; Han, Shu; Zeng, Li; Liu, Fang; Ding, Guoshan; Kang, Yindong; Zhu, Youhua] Second Mil Med Univ, Changzheng Hosp, Organ Transplantat Inst PLA, Shanghai, Peoples R China; [Hong, Shanjuan; Mao, Jingyan; Wang, Quan-xing] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai, Peoples R China; [Yuan, Qing; Cai, Ming] 309th Hosp PLA, Organ Transplant Ctr, Beijing, Peoples R China	Naval Medical University; Naval Medical University	Yuan, Q (corresponding author), Second Mil Med Univ, Changzheng Hosp, Organ Transplantat Inst PLA, Shanghai, Peoples R China.	zhuyouhua@126.com; wangqx64@hotmail.com			National Key Basic Research Program of China [2009CB522402]; National Natural Science Foundation of China [U0832009, 30872581]; Science and Technology Foundation of Shanghai, China [09JC1405500]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Foundation of Shanghai, China	This work was supported by grants from the National Key Basic Research Program of China (2009CB522402) and the National Natural Science Foundation of China (U0832009, 30872581) and the Science and Technology Foundation of Shanghai, China (09JC1405500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcay A, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/137072; Aragno M, 2003, KIDNEY INT, V64, P836, DOI 10.1046/j.1523-1755.2003.00152.x; Bonventre JV, 2004, KIDNEY INT, V66, P480, DOI 10.1111/j.1523-1755.2004.761_2.x; Budas GR, 2010, J MOL CELL CARDIOL, V48, P757, DOI 10.1016/j.yjmcc.2009.10.030; Castilla R, 2004, ALCOHOL ALCOHOLISM, V39, P290, DOI 10.1093/alcalc/agh065; Cecchin E, 1996, ADDICT BIOL, V1, P7, DOI 10.1080/1355621961000124656; Chen CH, 2008, SCIENCE, V321, P1493, DOI 10.1126/science.1158554; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Churchill EN, 2009, J MOL CELL CARDIOL, V46, P278, DOI 10.1016/j.yjmcc.2008.09.713; Dayton C, 2004, MICROCIRCULATION, V11, P709, DOI 10.1080/10739680490521014; DELABRY LO, 1992, J STUD ALCOHOL, V53, P25, DOI 10.15288/jsa.1992.53.25; Eschwege P, 1999, J UROLOGY, V162, P553, DOI 10.1016/S0022-5347(05)68626-0; ESTERBAUER H, 1986, BIOCHEM J, V239, P405, DOI 10.1042/bj2390405; Facchini FS, 2003, DIABETES, V52, P1204, DOI 10.2337/diabetes.52.5.1204; FUCHS CS, 1995, NEW ENGL J MED, V332, P1245, DOI 10.1056/NEJM199505113321901; Gaziano JM, 2000, J AM COLL CARDIOL, V35, P96, DOI 10.1016/S0735-1097(99)00531-8; GELMAN S, 1995, ANESTHESIOLOGY, V82, P1026, DOI 10.1097/00000542-199504000-00027; Hart ML, 2008, AM J PHYSIOL-GASTR L, V294, pG1431, DOI 10.1152/ajpgi.00083.2008; HAYAMA T, 2007, TRANSPL P, V123, P7; Ishikawa Y, 2000, BIOCHEM BIOPH RES CO, V279, P629, DOI 10.1006/bbrc.2000.4016; Kahraman A, 2003, J NEPHROL, V16, P219; Kim JI, 2010, BMB REP, V43, P629, DOI 10.3858/BMBRep.2010.43.9.629; Kim J, 2010, AM J PHYSIOL-RENAL, V298, pF158, DOI 10.1152/ajprenal.00474.2009; Kim KH, 2009, SURGERY, V146, P181, DOI 10.1016/j.surg.2009.06.011; Kinsey GR, 2008, NEPHRON EXP NEPHROL, V109, pE102, DOI 10.1159/000142934; Krajka-Kuzniak V, 2003, TOXICOL LETT, V143, P209, DOI 10.1016/S0378-4274(03)00177-2; Li X, 2005, KIDNEY INT, V68, P569, DOI 10.1111/j.1523-1755.2005.00435.x; Lloberas NR, 2002, FASEB J, V16, P908, DOI 10.1096/fj.01-0880fje; Lo Presti R, 2007, NUTRITION, V23, P598, DOI 10.1016/j.nut.2007.04.012; MCCORD JM, 1985, NEW ENGL J MED, V312, P159; Meldrum KK, 2001, J SURG RES, V99, P288, DOI 10.1006/jsre.2001.6201; Niki E, 2005, BIOCHEM BIOPH RES CO, V338, P668, DOI 10.1016/j.bbrc.2005.08.072; Noiri E, 2001, AM J PHYSIOL-RENAL, V281, pF948, DOI 10.1152/ajprenal.0071.2001; Pearson TA, 1996, CIRCULATION, V94, P3023, DOI 10.1161/01.CIR.94.11.3023; Pomfret EA, 2008, AM J TRANSPLANT, V8, P745, DOI 10.1111/j.1600-6143.2007.02146.x; RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W; Satyanarayana PSV, 2001, METHOD FIND EXP CLIN, V23, P175, DOI 10.1358/mf.2001.23.4.634641; Sheridan AM, 2000, CURR OPIN NEPHROL HY, V9, P427, DOI 10.1097/00041552-200007000-00015; Shigematsu S, 2003, FREE RADICAL BIO MED, V34, P810, DOI 10.1016/S0891-5849(02)01430-2; Vasiliou Vasilis, 2005, Human Genomics, V2, P138; Walker LM, 2001, TOXICOL SCI, V63, P143, DOI 10.1093/toxsci/63.1.143; Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008; WUTHRICH RP, 1990, KIDNEY INT, V37, P783, DOI 10.1038/ki.1990.46; Yamaguchi T, 2003, FREE RADICAL BIO MED, V34, P365, DOI 10.1016/S0891-5849(02)01292-3; Yamaguchi T, 2002, AM J PHYSIOL-HEART C, V283, pH1019, DOI 10.1152/ajpheart.00173.2002	46	38	50	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25811	10.1371/journal.pone.0025811	http://dx.doi.org/10.1371/journal.pone.0025811			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022451	Green Submitted, Green Published, gold			2022-12-27	WOS:000295976000041
J	Herbert, C; Kubler, A				Herbert, Cornelia; Kuebler, Andrea			Dogs Cannot Bark: Event-Related Brain Responses to True and False Negated Statements as Indicators of Higher-Order Conscious Processing	PLOS ONE			English	Article							LOCKED-IN SYNDROME; VEGETATIVE STATE; OWN-NAME; LANGUAGE COMPREHENSION; SENTENCE COMPREHENSION; TEXT INFORMATION; TIME-COURSE; VERIFICATION; POTENTIALS; ACTIVATION	The present study investigated event-related brain potentials elicited by true and false negated statements to evaluate if discrimination of the truth value of negated information relies on conscious processing and requires higher-order cognitive processing in healthy subjects across different levels of stimulus complexity. The stimulus material consisted of true and false negated sentences (sentence level) and prime-target expressions (word level). Stimuli were presented acoustically and no overt behavioral response of the participants was required. Event-related brain potentials to target words preceded by true and false negated expressions were analyzed both within group and at the single subject level. Across the different processing conditions (word pairs and sentences), target words elicited a frontal negativity and a late positivity in the time window from 600-1000 msec post target word onset. Amplitudes of both brain potentials varied as a function of the truth value of the negated expressions. Results were confirmed at the single-subject level. In sum, our results support recent suggestions according to which evaluation of the truth value of a negated expression is a time-and cognitively demanding process that cannot be solved automatically, and thus requires conscious processing. Our paradigm provides insight into higher-order processing related to language comprehension and reasoning in healthy subjects. Future studies are needed to evaluate if our paradigm also proves sensitive for the detection of consciousness in non-responsive patients.	[Herbert, Cornelia; Kuebler, Andrea] Univ Wurzburg, Dept Psychol, Wurzburg, Germany	University of Wurzburg	Herbert, C (corresponding author), Univ Wurzburg, Dept Psychol, Wurzburg, Germany.	cornelia.herbert@psychologie.uni-wuerzburg.de		Kubler, Andrea/0000-0003-4876-0415	German Research Foundation [DFG/HE5880]; European ICT Programme Project [FP7-247919]	German Research Foundation(German Research Foundation (DFG)); European ICT Programme Project	This research was supported by the German Research Foundation (DFG/HE5880) and the European ICT Programme Project FP7-247919 (http://cordis.europa.eu/fetch?CALLER = PROJ_ICT&ACTION = D&CAT = PROJ&RCN = 93827). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagnato S, 2010, CLIN NEUROPHYSIOL, V121, P274, DOI 10.1016/j.clinph.2009.11.008; Bekinschtein TA, 2009, P NATL ACAD SCI USA, V106, P1672, DOI 10.1073/pnas.0809667106; Boly M, 2011, SCIENCE, V332, P858, DOI 10.1126/science.1202043; Carpenter PA, 1999, NEUROIMAGE, V10, P216, DOI 10.1006/nimg.1999.0465; CARPENTER PA, 1975, PSYCHOL REV, V82, P45, DOI 10.1037/h0076248; CLARK HH, 1972, COGNITIVE PSYCHOL, V3, P472, DOI 10.1016/0010-0285(72)90019-9; Dehaene S, 2001, COGNITION, V79, P1, DOI 10.1016/S0010-0277(00)00123-2; Dehaene S, 1998, NATURE, V395, P597, DOI 10.1038/26967; Deutsch R, 2006, J PERS SOC PSYCHOL, V91, P385, DOI 10.1037/0022-3514.91.3.385; Di HB, 2007, NEUROLOGY, V68, P895, DOI 10.1212/01.wnl.0000258544.79024.d0; Ferguson HJ, 2008, BRAIN RES, V1236, P113, DOI 10.1016/j.brainres.2008.07.099; Fischer C, 2010, CLIN NEUROPHYSIOL, V121, P1032, DOI 10.1016/j.clinph.2010.02.005; FISCHLER I, 1983, PSYCHOPHYSIOLOGY, V20, P400, DOI 10.1111/j.1469-8986.1983.tb00920.x; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Hagoort P, 2004, SCIENCE, V304, P438, DOI 10.1126/science.1095455; Holler Y, 2011, CLIN NEUROPHYSIOL, V122, P99, DOI 10.1016/j.clinph.2010.05.029; Kaup B, 2003, J EXP PSYCHOL LEARN, V29, P439, DOI 10.1037/0278-7393.29.3.439; Kaup B, 2001, MEM COGNITION, V29, P960, DOI 10.3758/BF03195758; Kaup B., 2007, HIGHER LEVEL LANGUAG, P255, DOI [10.4324/9780203936443, DOI 10.4324/9780203936443]; Kircher TTJ, 2001, COGNITION, V78, pB1, DOI 10.1016/S0010-0277(00)00104-9; Kok A, 1997, BIOL PSYCHOL, V45, P19, DOI 10.1016/S0301-0511(96)05221-0; Kotchoubey B, 2005, CLIN NEUROPHYSIOL, V116, P2441, DOI 10.1016/j.clinph.2005.03.028; Kotchoubey B, 2004, BRAINWAVES MIND RECE, P75; Kubler A, 2008, CLIN NEUROPHYSIOL, V119, P2658, DOI 10.1016/j.clinph.2008.06.019; KUJALA T, 1995, NEUROSCI LETT, V183, P143, DOI 10.1016/0304-3940(94)11135-6; Kuperberg GR, 2003, COGNITIVE BRAIN RES, V17, P117, DOI 10.1016/S0926-6410(03)00086-7; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; KUTAS M, 1984, NATURE, V307, P161, DOI 10.1038/307161a0; Laureys S, 2005, PROG BRAIN RES, V150, P495, DOI 10.1016/S0079-6123(05)50034-7; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Laureys S, 2007, CONSCIOUS COGN, V16, P722, DOI 10.1016/j.concog.2007.04.004; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Ludtke J, 2008, J COGNITIVE NEUROSCI, V20, P1355, DOI 10.1162/jocn.2008.20093; MACDONALD MC, 1989, J EXP PSYCHOL LEARN, V15, P633, DOI 10.1037/0278-7393.15.4.633; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; NACHEV P, 2007, SCIENCE, V1221, P315; Nieuwland MS, 2006, J COGNITIVE NEUROSCI, V18, P1098, DOI 10.1162/jocn.2006.18.7.1098; Owen AM, 2007, ARCH NEUROL-CHICAGO, V64, P1098, DOI 10.1001/archneur.64.8.1098; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Paivio A., 2006, MIND ITS EVOLUTION D; PALLER KA, 1995, PSYCHOL SCI, V6, P107, DOI 10.1111/j.1467-9280.1995.tb00315.x; Perrin F, 2005, NEUROPSYCHOLOGIA, V43, P12, DOI 10.1016/j.neuropsychologia.2004.07.002; Perrin F, 2006, ARCH NEUROL-CHICAGO, V63, P562, DOI 10.1001/archneur.63.4.562; Ropper AH, 2010, NEW ENGL J MED, V362, P648, DOI 10.1056/NEJMe0909667; Schnakers C, 2008, J NEUROL, V255, P323, DOI 10.1007/s00415-008-0544-0; SKRANDIES W, 1990, Brain Topography, V3, P137, DOI 10.1007/BF01128870; Staffen W, 2006, J NEUROL NEUROSUR PS, V77, P1383, DOI 10.1136/jnnp.2006.095166; van Herten M, 2005, COGNITIVE BRAIN RES, V22, P241, DOI 10.1016/j.cogbrainres.2004.09.002	49	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e25574	10.1371/journal.pone.0025574	http://dx.doi.org/10.1371/journal.pone.0025574			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834OZ	22022414	Green Published, Green Submitted, gold			2022-12-27	WOS:000295973200011
J	Vatolina, TY; Boldyreva, LV; Demakova, OV; Demakov, SA; Kokoza, EB; Semeshin, VF; Babenko, VN; Goncharov, FP; Belyaeva, ES; Zhimulev, IF				Vatolina, Tatyana Yu.; Boldyreva, Lidiya V.; Demakova, Olga V.; Demakov, Sergey A.; Kokoza, Elena B.; Semeshin, Valeriy F.; Babenko, Vladimir N.; Goncharov, Fedor P.; Belyaeva, Elena S.; Zhimulev, Igor F.			Identical Functional Organization of Nonpolytene and Polytene Chromosomes in Drosophila melanogaster	PLOS ONE			English	Article							RNA-POLYMERASE-II; X-CHROMOSOME; IN-VIVO; INTERCALARY HETEROCHROMATIN; GENETIC ORGANIZATION; BINDING-SITES; NOTCH LOCUS; BAND 10A1-2; HISTONE H3; CHROMATIN	Salivary gland polytene chromosomes demonstrate banding pattern, genetic meaning of which is an enigma for decades. Till now it is not known how to mark the band/interband borders on physical map of DNA and structures of polytene chromosomes are not characterized in molecular and genetic terms. It is not known either similar banding pattern exists in chromosomes of regular diploid mitotically dividing nonpolytene cells. Using the newly developed approach permitting to identify the interband material and localization data of interband-specific proteins from modENCODE and other genome-wide projects, we identify physical limits of bands and interbands in small cytological region 9F13-10B3 of the X chromosome in D. melanogaster, as well as characterize their general molecular features. Our results suggests that the polytene and interphase cell line chromosomes have practically the same patterns of bands and interbands reflecting, probably, the basic principle of interphase chromosome organization. Two types of bands have been described in chromosomes, early and late-replicating, which differ in many aspects of their protein and genetic content. As appeared, origin recognition complexes are located almost totally in the interbands of chromosomes.	[Vatolina, Tatyana Yu.; Boldyreva, Lidiya V.; Demakova, Olga V.; Demakov, Sergey A.; Kokoza, Elena B.; Semeshin, Valeriy F.; Babenko, Vladimir N.; Goncharov, Fedor P.; Belyaeva, Elena S.; Zhimulev, Igor F.] Russian Acad Sci, Inst Mol & Cellular Biol, Siberian Branch, Novosibirsk, Russia	Russian Academy of Sciences	Vatolina, TY (corresponding author), Russian Acad Sci, Inst Mol & Cellular Biol, Siberian Branch, Novosibirsk, Russia.	zhimulev@mcb.nsc.ru	Goncharov, Fedor/C-8891-2018; Kokoza, E l e n a/N-8507-2015; Zhimulev, Igor F/N-7978-2015; Babenko, Vladimir/K-5609-2014; Demakova, Olga/N-7478-2015; Belyaeva, Elena S/N-8066-2015; Demakov, Sergey A/N-6543-2015; Boldyreva, Lidiya/N-6978-2015; Zykova (Vatolina), Tatyana/I-3897-2014	Goncharov, Fedor/0000-0001-9728-2670; Boldyreva, Lidiya/0000-0003-0716-4545; Babenko, Vladimir/0000-0002-3077-9559; Demakov, Sergey/0000-0002-5526-6784; Demakova, Olga/0000-0002-8538-7384; Zhimulev, Igor/0000-0002-6220-3028	Ministry of Education and Science of Russian Federation (ROSNAUKA) [02.740.11.0099]; RAS "Molecular and Cellular Biology" [6.4]; SB RAS [37]; Russian Foundation for Basic Research [09-04-00409]	Ministry of Education and Science of Russian Federation (ROSNAUKA)(Ministry of Education and Science, Russian Federation); RAS "Molecular and Cellular Biology"; SB RAS(Russian Academy of Sciences); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This research was funded by grant of Ministry of Education and Science of Russian Federation (ROSNAUKA), governmental contract 02.740.11.0099; Programm of RAS "Molecular and Cellular Biology" 6.4; Integration project of SB RAS #37, and the Russian Foundation for Basic Research (#09-04-00409). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreyenkov OV, 2010, DOKL BIOCHEM BIOPHYS, V431, P57, DOI 10.1134/S1607672910020018; Andreyenkova NG, 2009, CHROMOSOMA, V118, P747, DOI 10.1007/s00412-009-0232-6; Armstrong JA, 2002, EMBO J, V21, P5245, DOI 10.1093/emboj/cdf517; Ashburner M., 2004, DROSOPHILA LAB HDB; Babenko VN, 2009, DOKL BIOCHEM BIOPHYS, V424, P27, DOI 10.1134/S1607672909010086; Beermann W, 1972, Results Probl Cell Differ, V4, P1; Belyaeva ES, 1998, P NATL ACAD SCI USA, V95, P7532, DOI 10.1073/pnas.95.13.7532; Belyakin SN, 2005, P NATL ACAD SCI USA, V102, P8269, DOI 10.1073/pnas.0502702102; Belyakin SN, 2010, CHROMOSOMA, V119, P589, DOI 10.1007/s00412-010-0280-y; Braunschweig U, 2009, EMBO J, V28, P3635, DOI 10.1038/emboj.2009.301; Bridges CB, 1938, J HERED, V29, P11, DOI 10.1093/oxfordjournals.jhered.a104399; Carre C, 2008, EMBO REP, V9, P187, DOI 10.1038/sj.embor.7401141; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; DEMAKOV SA, 1993, MOL GEN GENET, V238, P437, DOI 10.1007/BF00292003; Demakov SA, 2011, RUSSIAN J GENETICS, P15; Deng H, 2005, CHROMOSOMA, V114, P173, DOI 10.1007/s00412-005-0006-8; DONAHUE PR, 1986, P NATL ACAD SCI USA, V83, P4744, DOI 10.1073/pnas.83.13.4744; Eaton ML, 2011, GENOME RES, V21, P164, DOI 10.1101/gr.116038.110; Eggert H, 2004, J CELL SCI, V117, P4253, DOI 10.1242/jcs.01292; ELGIN SCR, 1988, CHROMOSOME STRUCTURE, P145; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Gan M, 2011, J BIOSCIENCES, V36, P425, DOI 10.1007/s12038-011-9089-y; Gerber M, 2001, EMBO J, V20, P6104, DOI 10.1093/emboj/20.21.6104; GILMOUR DS, 1986, MOL CELL BIOL, V6, P3984, DOI 10.1128/MCB.6.11.3984; Gortchakov AA, 2005, CHROMOSOMA, V114, P54, DOI 10.1007/s00412-005-0339-3; Hollmann M, 2002, MOL GENET GENOMICS, V268, P425, DOI 10.1007/s00438-002-0768-0; JAMRICH M, 1977, P NATL ACAD SCI USA, V74, P2079, DOI 10.1073/pnas.74.5.2079; Jiang N, 2009, MOL CELL BIOL, V29, P3556, DOI 10.1128/MCB.01748-08; Jin Y, 1999, MOL CELL, V4, P129, DOI 10.1016/S1097-2765(00)80195-1; Kalverda B, 2010, CELL, V140, P360, DOI 10.1016/j.cell.2010.01.011; Kaplan CD, 2000, GENE DEV, V14, P2623, DOI 10.1101/gad.831900; KEPPY DO, 1977, GENETICS, V85, P497; Kharchenko PV, 2011, NATURE, V471, P480, DOI 10.1038/nature09725; KOZLOVA TY, 1994, GENETICS, V136, P1063; Lavrov S, 2004, METH MOL B, V247, P289; Law A, 1998, NUCLEIC ACIDS RES, V26, P919, DOI 10.1093/nar/26.4.919; Leach TJ, 2000, MOL CELL BIOL, V20, P6308, DOI 10.1128/MCB.20.17.6308-6316.2000; LEFEVRE G, 1971, GENETICS, V67, P497; LEFEVRE G, 1969, GENETICS, V63, P589; Li YP, 2011, MOL BIOL REP, V38, P3795, DOI 10.1007/s11033-010-0495-2; Lis JT, 2000, GENE DEV, V14, P792; MacAlpine HK, 2010, GENOME RES, V20, P201, DOI 10.1101/gr.097873.109; Markov A. V., 2003, Genetika, V39, P1203; Park JM, 2001, MOL CELL BIOL, V21, P2312, DOI 10.1128/MCB.21.7.2312-2323.2001; Pindyurin AV, 2007, J CELL SCI, V120, P2344, DOI 10.1242/jcs.006007; Raja SJ, 2010, MOL CELL, V38, P827, DOI 10.1016/j.molcel.2010.05.021; RAMOS RGP, 1989, GENETICS, V123, P337; Rath U, 2004, J CELL BIOCHEM, V93, P1033, DOI 10.1002/jcb.20243; SASS H, 1982, CHROMOSOMA, V86, P77, DOI 10.1007/BF00330731; SASS H, 1982, CELL, V28, P269, DOI 10.1016/0092-8674(82)90345-2; SASS H, 1982, CHROMOSOMA, V85, P633, DOI 10.1007/BF00330777; Saunders A, 2003, SCIENCE, V301, P1094, DOI 10.1126/science.1085712; Schwaiger M, 2009, GENE DEV, V23, P589, DOI 10.1101/gad.511809; Schwartz BE, 2003, MOL CELL BIOL, V23, P6876, DOI 10.1128/MCB.23.19.6876-6886.2003; Schwendemann A, 2002, P NATL ACAD SCI USA, V99, P12883, DOI 10.1073/pnas.202341499; Sedkov Y, 2003, NATURE, V426, P78, DOI 10.1038/nature02080; Semeshin VF, 2004, METH MOL B, V247, P305; Sorsa V, 1988, CHROMOSOME MAPS DROS, V2, P147; Stokes DG, 1996, P NATL ACAD SCI USA, V93, P7137, DOI 10.1073/pnas.93.14.7137; Tariq M, 2009, P NATL ACAD SCI USA, V106, P1157, DOI 10.1073/pnas.0809669106; van Steensel B, 2010, GENOME RES, V20, P190, DOI 10.1101/gr.098822.109; Vazquez J, 2000, GENETICS, V155, P1297; WEEKS JR, 1993, GENE DEV, V7, P2329, DOI 10.1101/gad.7.12a.2329; ZHAO K, 1995, CELL, V81, P879, DOI 10.1016/0092-8674(95)90008-X; Zhimolev IF, 1996, ADV GENET, V34, P1; ZHIMULEV IF, 1982, CHROMOSOMA, V87, P197, DOI 10.1007/BF00338489; Zhimulev IF, 2004, INT REV CYTOL, V241, P203, DOI 10.1016/S0074-7696(04)41004-3; Zhimulev IF, 1999, ADV GENET, V39, P1, DOI 10.1016/S0065-2660(08)60476-9; ZHIMULEV IF, 1981, CHROMOSOMA, V82, P25, DOI 10.1007/BF00285747	71	41	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e25960	10.1371/journal.pone.0025960	http://dx.doi.org/10.1371/journal.pone.0025960			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022482	gold, Green Published, Green Submitted			2022-12-27	WOS:000295973200024
J	Sommer, G; Rossa, C; Chi, AC; Neville, BW; Heise, T				Sommer, Gunhild; Rossa, Carlos; Chi, Angela C.; Neville, Brad W.; Heise, Tilman			Implication of RNA-Binding Protein La in Proliferation, Migration and Invasion of Lymph Node-Metastasized Hypopharyngeal SCC Cells	PLOS ONE			English	Article							AUTOANTIGEN LA/SS-B; BETA-CATENIN; MATRIX METALLOPROTEINASES; CANCER STATISTICS; HEAD; PHOSPHORYLATION; CARCINOMA; TRANSLATION; IDENTIFICATION; EXPRESSION	The 5-year survival rate for oral cavity cancer is poorer than for breast, colon or prostate cancer, and has improved only slightly in the last three decades. Hence, new therapeutic strategies are urgently needed. Here we demonstrate by tissue micro array analysis for the first time that RNA-binding protein La is significantly overexpressed in oral squamous cell carcinoma (SCC). Within this study we therefore addressed the question whether siRNA-mediated depletion of the La protein may interfere with known tumor-promoting characteristics of head and neck SCC cells. Our studies demonstrate that the La protein promotes cell proliferation, migration and invasion of lymph node-metastasized hypopharyngeal SCC cells. We also reveal that La is required for the expression of beta-catenin as well as matrix metalloproteinase type 2 (MMP-2) within these cells. Taken together these data suggest a so far unknown function of the RNA-binding protein La in promoting tumor progression of head and neck SCC.	[Sommer, Gunhild; Heise, Tilman] Med Univ S Carolina, Coll Dent Med, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Sommer, Gunhild] Med Univ S Carolina, Coll Dent Med, Dept Craniofacial Biol, Charleston, SC 29425 USA; [Rossa, Carlos] Univ Estadual Paulista UNESP, Dept Diag & Surg, Araraquara, Brazil; [Chi, Angela C.; Neville, Brad W.] Med Univ S Carolina, Div Oral Pathol, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; Universidade Estadual Paulista; Medical University of South Carolina	Sommer, G (corresponding author), Med Univ S Carolina, Coll Dent Med, Dept Biochem & Mol Biol, Charleston, SC 29425 USA.	sommerg@musc.edu	Rossa, Carlos/D-8328-2012	Rossa, Carlos/0000-0003-1705-5481	Department of Biochemistry & Molecular Biology (MUSC); SC COBRE for Oral Health Research [P20RR017696-09]; NIH/NCRR [1R03DE021729-01]; Cancer Center [P30 CA138313]; NATIONAL CANCER INSTITUTE [P30CA138313] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017696] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R03DE021729] Funding Source: NIH RePORTER	Department of Biochemistry & Molecular Biology (MUSC); SC COBRE for Oral Health Research; NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the Department of Biochemistry & Molecular Biology (MUSC), by SC COBRE for Oral Health Research P20RR017696-09 and NIH/NCRR 1R03DE021729-01. FACS analysis was performed at the Flow Cytometry Shared Resource as part of the Hollings Cancer Center at MUSC, which is funded by a Cancer Center Support Grant P30 CA138313. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ejeh F, 2007, CLIN CANCER RES, V13, p5509S, DOI 10.1158/1078-0432.CCR-07-0922; BEENKEN SW, 2003, CURRENT SURG DIAGNOS, P282; Belisova A, 2005, RNA, V11, P1084, DOI 10.1261/rna.7263905; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Brenet F, 2009, ONCOGENE, V28, P128, DOI 10.1038/onc.2008.376; Broekhuis CHD, 2000, BIOCHEMISTRY-US, V39, P3023, DOI 10.1021/bi992308c; CAREY TE, 1983, OTOLARYNG HEAD NECK, V91, P482, DOI 10.1177/019459988309100503; Carter MS, 2000, J BIOL CHEM, V275, P28301; CHAMBERS JC, 1988, J BIOL CHEM, V263, P18043; Chen P, 2009, J CELL BIOCHEM, V108, P1233, DOI 10.1002/jcb.22363; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Deryugina EI, 2010, BBA-MOL CELL RES, V1803, P103, DOI 10.1016/j.bbamcr.2009.09.017; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Elbashir SM, 2002, METHODS, V26, P199, DOI 10.1016/S1046-2023(02)00023-3; Fok V, 2006, J CELL BIOL, V173, P319, DOI 10.1083/jcb.200601026; Gao ZB, 2005, INT J MOL MED, V16, P599; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Goto M, 2010, CLIN CANCER RES, V16, P65, DOI 10.1158/1078-0432.CCR-09-1122; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; Heuberger J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002915; Holcik M, 2000, MOL CELL BIOL, V20, P4648, DOI 10.1128/MCB.20.13.4648-4657.2000; Horke S, 2004, J BIOL CHEM, V279, P26563, DOI 10.1074/jbc.M401017200; Inge LJ, 2008, MOL CANCER THER, V7, P1386, DOI 10.1158/1535-7163.MCT-07-2029; Intine RVA, 2000, MOL CELL, V6, P339, DOI 10.1016/S1097-2765(00)00034-4; Iwai S, 2010, INT J ONCOL, V37, P1095, DOI 10.3892/ijo_00000761; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jones KJ, 2008, GLIA, V56, P1401, DOI 10.1002/glia.20707; Kenan DJ, 2004, NAT STRUCT MOL BIOL, V11, P303, DOI 10.1038/nsmb0404-303; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kremerskothen J, 1998, DNA CELL BIOL, V17, P751, DOI 10.1089/dna.1998.17.751; Lai SL, 2009, CELL RES, V19, P532, DOI 10.1038/cr.2009.41; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lo Muzio L, 2001, CRIT REV ORAL BIOL M, V12, P152, DOI 10.1177/10454411010120020501; Mitra RS, 2008, CANCER RES, V68, P3959, DOI 10.1158/0008-5472.CAN-07-2755; Molinolo AA, 2009, ORAL ONCOL, V45, P324, DOI 10.1016/j.oraloncology.2008.07.011; Pannone BK, 1998, EMBO J, V17, P7442, DOI 10.1093/emboj/17.24.7442; Park JM, 2006, MOL CELL BIOL, V26, P1445, DOI 10.1128/MCB.26.4.1445-1451.2006; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Patel BP, 2007, HEAD NECK-J SCI SPEC, V29, P564, DOI 10.1002/hed.20561; Rodriguez Luis G., 2004, V294, P23; Rosenthal EL, 2006, HEAD NECK-J SCI SPEC, V28, P639, DOI 10.1002/hed.20365; Ruokolainen H, 2006, MODERN PATHOL, V19, P208, DOI 10.1038/modpathol.3800506; Sano D, 2007, CANCER METAST REV, V26, P645, DOI 10.1007/s10555-007-9082-y; Schwartz EI, 2004, MOL CELL BIOL, V24, P9580, DOI 10.1128/MCB.24.21.9580-9591.2004; Sommer G, 2011, ONCOGENE, V30, P434, DOI 10.1038/onc.2010.425; Takemaru K. -I., 2008, V186, P261, DOI 10.1007/978-3-540-72843-6_11; TROSTER H, 1994, J EXP MED, V180, P2059, DOI 10.1084/jem.180.6.2059; Trotta R, 2003, CANCER CELL, V3, P145, DOI 10.1016/S1535-6108(03)00020-5; Ueda G, 2006, INT J ORAL MAX SURG, V35, P356, DOI 10.1016/j.ijom.2005.07.023; van Niekerk EA, 2007, P NATL ACAD SCI USA, V104, P12913, DOI 10.1073/pnas.0611562104; Windler-Hart SL, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-14; Wolin SL, 2002, ANNU REV BIOCHEM, V71, P375, DOI 10.1146/annurev.biochem.71.090501.150003; Yang F, 2006, CELL SIGNAL, V18, P679, DOI 10.1016/j.cellsig.2005.06.015; Yu ZW, 2005, CLIN CANCER RES, V11, P2471, DOI 10.1158/1078-0432.CCR-04-2199; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4	56	36	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25402	10.1371/journal.pone.0025402	http://dx.doi.org/10.1371/journal.pone.0025402			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016766	Green Published, gold, Green Submitted			2022-12-27	WOS:000295971700008
J	Abu Dayyeh, BK; Gupta, N; Sherman, KE; de Bakker, PIW; Chung, RT				Abu Dayyeh, Barham K.; Gupta, Namrata; Sherman, Kenneth E.; de Bakker, Paul I. W.; Chung, Raymond T.		Aids Clinical Trials Grp A5178	IL28B Alleles Exert an Additive Dose Effect When Applied to HCV-HIV Coinfected Persons Undergoing Peginterferon and Ribavirin Therapy	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; SUSTAINED VIROLOGICAL RESPONSE; INTERFERON PLUS RIBAVIRIN; AMINO-ACID SUBSTITUTIONS; GENETIC-VARIATION; LIVER-DISEASE; GENOTYPE 1B; VIRAL LOAD; ASSOCIATION	Background: Genetic studies have demonstrated a strong association between single nucleotide polymorphisms (SNPs) at IL28B and response to treatment with peginterferon (PEG) and ribavirin (RBV) in HCV monoinfected persons. We sought to test these associations in a prospective PEG / weight based ribavirin (WBR) treatment trial (ACTG A5178) (National Institution of Health registration number NCT00078403) in persons with HCV-HIV coinfection, and to develop a prediction score. Methods: We selected subjects enrolled in A5178 who completed at least the first 12 weeks of the trial and had DNA available, and genotyped three SNPs at IL28B (rs12979860, rs12980275, rs8099917). We used multivariate logistic regression analysis to evaluate the association between IL28B SNPs and HCV treatment outcomes and to develop the prediction score. Results: 231 HCV/HIV coinfected subjects were included. We observed a strong association between IL28B genotype and response to therapy among those with genotypes 1 or 4 (odds ratio for complete early virologic responses (cEVR) and sustained virologic response (SVR) was 2.98 [1.7-5.3] and 3.4 [1.7-6.9], respectively, for each additional copy of the C allele of rs12979860). Differences in frequency of the responder allele explained some of the discrepancy in HCV treatment outcomes between blacks and whites. A simple pretreatment prediction score that incorporates the IL28B genotype and baseline HCV viral load has a 93% negative predictive value (NPV) for SVR. Conclusions: IL28B SNPs have an additive allele dose effect in predicting HCV treatment outcomes in HCV/HIV coinfected persons and can be incorporated into a simple pretreatment prediction score that could minimize the risk of exposure to PEG/RBV therapy for persons with unfavorable scores.	[Abu Dayyeh, Barham K.; Chung, Raymond T.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Abu Dayyeh, Barham K.; Chung, Raymond T.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Gupta, Namrata; de Bakker, Paul I. W.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA; [Sherman, Kenneth E.] Univ Cincinnati, Dept Internal Med, Cincinnati, OH USA; [de Bakker, Paul I. W.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Genet,Dept Med, Boston, MA 02115 USA; [de Bakker, Paul I. W.] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [de Bakker, Paul I. W.] Univ Med Ctr, Dept Med Genet, Div Biomed Genet, Utrecht, Netherlands	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University System of Ohio; University of Cincinnati; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Abu Dayyeh, BK (corresponding author), Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA.	rtchung@partners.org	de Bakker, Paul IW/B-8730-2009	de Bakker, Paul IW/0000-0001-7735-7858	National Institute of Health [K27 5K24DK078772-04]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK078772] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institute of Health [K27 5K24DK078772-04 to R.T.C.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2011, J HEPATOL, V54, P1094, DOI 10.1016/j.jhep.2010.09.019; Akuta N, 2005, INTERVIROLOGY, V48, P372, DOI 10.1159/000086064; Akuta N, 2007, J HEPATOL, V46, P403, DOI 10.1016/j.jhep.2006.09.019; Aparicio E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013771; Balagopal A, 2010, GASTROENTEROLOGY, V139, P1865, DOI 10.1053/j.gastro.2010.10.004; Bica I, 2001, CLIN INFECT DIS, V32, P492, DOI 10.1086/318501; Chen TY, 2009, CLIN INFECT DIS, V49, P1605, DOI 10.1086/644771; Chung RT, 2004, NEW ENGL J MED, V351, P451, DOI 10.1056/NEJMoa032653; Clausen LN, 2011, J VIRAL HEPATITIS, V18, pe66, DOI 10.1111/j.1365-2893.2010.01392.x; Davis GL, 2003, HEPATOLOGY, V38, P645, DOI 10.1053/jhep.2003.50364; Dill MT, 2011, GASTROENTEROLOGY, V140, P1021, DOI 10.1053/j.gastro.2010.11.039; ENOMOTO N, 1995, J CLIN INVEST, V96, P224, DOI 10.1172/JCI118025; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Giordano TP, 2004, ARCH INTERN MED, V164, P2349, DOI 10.1001/archinte.164.21.2349; Hayes CN, 2011, GUT, V60, P261, DOI 10.1136/gut.2010.223495; Honda M, 2010, GASTROENTEROLOGY, V139, P499, DOI 10.1053/j.gastro.2010.04.049; Kau A, 2008, J HEPATOL, V49, P634, DOI 10.1016/j.jhep.2008.07.013; Kurosaki M, 2011, J HEPATOL, V54, P439, DOI 10.1016/j.jhep.2010.07.037; Laguno M, 2007, JAIDS-J ACQ IMM DEF, V44, P174, DOI 10.1097/QAI.0b013e31802b812d; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Medrano J, 2010, CLIN INFECT DIS, V51, P1209, DOI 10.1086/656811; Monga HK, 2001, CLIN INFECT DIS, V33, P240, DOI 10.1086/321819; Morgan TR, 2011, CLIN GASTROENTEROL H, V9, P293, DOI 10.1016/j.cgh.2010.12.014; Okanoue T, 2009, J GASTROENTEROL, V44, P952, DOI 10.1007/s00535-009-0087-x; Pineda JA, 2007, HEPATOLOGY, V46, P622, DOI 10.1002/hep.21757; Pineda JA, 2010, CLIN INFECT DIS, V51, P788, DOI 10.1086/656235; Rallon NI, 2010, AIDS, V24, pF23, DOI 10.1097/QAD.0b013e3283391d6d; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Sherman KE, 2010, J ACQUIR IMMUNE DEFI; Soriano V, 2007, AIDS, V21, P1073, DOI 10.1097/QAD.0b013e3281084e4d; Stattermayer AF, 2011, CLIN GASTROENTEROL H, V9, P344, DOI 10.1016/j.cgh.2010.07.019; Sulkowski MS, 2000, CLIN INFECT DIS, V30, pS77, DOI 10.1086/313842; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thio CL, 2010, GASTROENTEROLOGY, V138, P1240, DOI 10.1053/j.gastro.2010.02.033; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013; Torriani FJ, 2004, NEW ENGL J MED, V351, P438, DOI 10.1056/NEJMoa040842; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; Verucchi G, 2004, INFECTION, V32, P33, DOI 10.1007/s15010-004-3063-7; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; Zhang LL, 2011, J HEPATOL, V55, P289, DOI 10.1016/j.jhep.2010.11.019	41	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25753	10.1371/journal.pone.0025753	http://dx.doi.org/10.1371/journal.pone.0025753			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003405	Green Submitted, gold, Green Published			2022-12-27	WOS:000295970300026
J	Putila, JJ; Guo, NL				Putila, Joseph J.; Guo, Nancy Lan			Association of Arsenic Exposure with Lung Cancer Incidence Rates in the United States	PLOS ONE			English	Article							DRINKING-WATER; US POPULATION; EPIDEMIOLOGY; PREVALENCE; MORTALITY; SMOKING; RISK	Background: Although strong exposure to arsenic has been shown to be carcinogenic, its contribution to lung cancer incidence in the United States is not well characterized. We sought to determine if the low-level exposures to arsenic seen in the U.S. are associated with lung cancer incidence after controlling for possible confounders, and to assess the interaction with smoking behavior. Methodology: Measurements of arsenic stream sediment and soil concentration obtained from the USGS National Geochemical Survey were combined, respectively, with 2008 BRFSS estimates on smoking prevalence and 2000 U.S. Census county level income to determine the effects of these factors on lung cancer incidence, as estimated from respective state-wide cancer registries and the SEER database. Poisson regression was used to determine the association between each variable and age-adjusted county-level lung cancer incidence. ANOVA was used to assess interaction effects between covariates. Principal Findings: Sediment levels of arsenic were significantly associated with an increase in incident cases of lung cancer (P>0.0001). These effects persisted after controlling for smoking and income (P>0.0001). Across the U.S., exposure to arsenic may contribute to up to 5,297 lung cancer cases per year. There was also a significant interaction between arsenic exposure levels and smoking prevalence (P>0.05). Conclusions/Significance: Arsenic was significantly associated with lung cancer incidence rates in the U.S. after controlling for smoking and income, indicating that low-level exposure to arsenic is responsible for excess cancer cases in many parts of the U.S. Elevated county smoking prevalence strengthened the association between arsenic exposure and lung cancer incidence rate, an effect previously unseen on a population level.	[Putila, Joseph J.; Guo, Nancy Lan] W Virginia Univ, Mary Babb Randolph Canc Ctr, Morgantown, WV 26506 USA; [Putila, Joseph J.; Guo, Nancy Lan] W Virginia Univ, Dept Community Med, Morgantown, WV 26506 USA	West Virginia University; West Virginia University	Putila, JJ (corresponding author), W Virginia Univ, Mary Babb Randolph Canc Ctr, Morgantown, WV 26506 USA.	lguo@hsc.wvu.edu			National Institutes of Health (NIH)/National Library of Medicine (NLM) [R01LM009500]; NIH/National Center for Research Resources (NCRR) [P20RR16440]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016440] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009500] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Library of Medicine (NLM)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NIH/National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This study is supported by National Institutes of Health (NIH)/National Library of Medicine (NLM) R01LM009500 (PI: Dr. Guo) and NIH/National Center for Research Resources (NCRR) P20RR16440 and Supplement (PD: Dr. Guo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloise-Young PA, 2002, SUBST USE MISUSE, V37, P613, DOI 10.1081/JA-120004276; Beeson WL, 1998, ENVIRON HEALTH PERSP, V106, P813, DOI 10.2307/3434125; BRIGGS PH, 2002, 02223G1G18 US GEOL S; BUDAHN JR, 2002, 02223Y1Y9 US GEOL SU; Centers for Disease Control and Prevention, 2008, BEH RISK FACT SURV S; Clegg LX, 2009, CANCER CAUSE CONTROL, V20, P417, DOI 10.1007/s10552-008-9256-0; COLSHER P, 2009, CANC INCIDENCE W VIR; CRONBACH LJ, 1987, PSYCHOL BULL, V102, P414, DOI 10.1037/0033-2909.102.3.414; *DHHS, 2006, 11 US DHHS; HAGEMAN PL, 2002, 02223L1L7 US GEOL SU; HERTZPICCIOTTO I, 1992, EPIDEMIOLOGY, V3, P23, DOI 10.1097/00001648-199201000-00006; Kandel D, 1997, DRUG ALCOHOL DEPEN, V44, P11, DOI 10.1016/S0376-8716(96)01315-4; Karagas MR, 1998, ENVIRON HEALTH PERSP, V106, P1047, DOI 10.1289/ehp.98106s41047; Liu J, 2008, TOXICOL SCI, V105, P24, DOI 10.1093/toxsci/kfn120; Marshall G, 2007, JNCI-J NATL CANCER I, V99, P920, DOI 10.1093/jnci/djm004; *MO DEP HLTH SEN S, 2010, MISS INF COMM ASS; MUSHAK P, 1995, ENVIRON HEALTH PERSP, V103, P684, DOI 10.2307/3432859; National Cancer Institute Surveillance, 2010, SEER STAT DAT INC SE; NHANES III. National Health and Nutrition Examination Survey, 2009, NAT HLTH NUTR EX SUR; *OH DEP HLTH, 2010, ODH INF WAR; *PA DEP HLTH, 2010, EP QUER MAPP SYST; Smith AH, 2002, SCIENCE, V296, P2145, DOI 10.1126/science.1072896; SMITH AH, 1992, ENVIRON HEALTH PERSP, V97, P259, DOI 10.2307/3431362; U.S. Geological Survey, 2004, NAT GEOCH SURV DAT D	24	73	75	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25886	10.1371/journal.pone.0025886	http://dx.doi.org/10.1371/journal.pone.0025886			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003413	Green Published, Green Submitted, gold			2022-12-27	WOS:000295970300037
J	Avnir, Y; Turjeman, K; Tulchinsky, D; Sigal, A; Kizelsztein, P; Tzemach, D; Gabizon, A; Barenholz, Y				Avnir, Yuval; Turjeman, Keren; Tulchinsky, Deborah; Sigal, Alex; Kizelsztein, Pablo; Tzemach, Dina; Gabizon, Alberto; Barenholz, Yechezkel			Fabrication Principles and Their Contribution to the Superior In Vivo Therapeutic Efficacy of Nano-Liposomes Remote Loaded with Glucocorticoids	PLOS ONE			English	Article							GLATIRAMER ACETATE; DELIVERY; MODEL; METHYLPREDNISOLONE; PHARMACOKINETICS; DOXORUBICIN; MECHANISMS; DRUGS; MICE; ENCEPHALOMYELITIS	We report here the design, development and performance of a novel formulation of liposome- encapsulated glucocorticoids (GCs). A highly efficient (>90%) and stable GC encapsulation was obtained based on a transmembrane calcium acetate gradient driving the active accumulation of an amphipathic weak acid GC pro-drug into the intraliposome aqueous compartment, where it forms a GC-calcium precipitate. We demonstrate fabrication principles that derive from the physicochemical properties of the GC and the liposomal lipids, which play a crucial role in GC release rate and kinetics. These principles allow fabrication of formulations that exhibit either a fast, second-order (t(1/2) similar to 1 h), or a slow, zero-order release rate (t(1/2) similar to 50 h) kinetics. A high therapeutic efficacy was found in murine models of experimental autoimmune encephalomyelitis (EAE) and hematological malignancies.	[Avnir, Yuval; Turjeman, Keren; Tulchinsky, Deborah; Sigal, Alex; Kizelsztein, Pablo; Barenholz, Yechezkel] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem, Lab Membrane & Liposome Res, IL-91010 Jerusalem, Israel; [Tzemach, Dina; Gabizon, Alberto] Shaare Zedek Med Ctr, Expt Oncol Lab, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Shaare Zedek Medical Center	Avnir, Y (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem, Lab Membrane & Liposome Res, IL-91010 Jerusalem, Israel.	yb@cc.huji.ac.il	Gabizon, Alberto/C-6171-2009		Barenholz Fund	Barenholz Fund	This study was supported in part by the Barenholz Fund. The Barenholz Fund is a fund established by Professor Barenholz from royalties that the Hebrew University and Professor Barenholz get from various patents which are dedicated to support research in his lab. There are no connections between the patents for which he gets the royalties and this research, so it is basically a research fund. The other support was the Hebrew University regular support system. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Hai A, 2007, BONE MARROW TRANSPL, V40, P881, DOI 10.1038/sj.bmt.1705819; Abraham SA, 2004, J CONTROL RELEASE, V96, P449, DOI 10.1016/j.jconrel.2004.02.017; *ACS, 2006, SCIFINDER SCHOL SOFT; ANDERSON BD, 1981, J PHARM SCI, V70, P181, DOI 10.1002/jps.2600700217; Avnir Y, 2005, ANAL BIOCHEM, V347, P34, DOI 10.1016/j.ab.2005.09.026; Avnir Y, 2008, ARTHRITIS RHEUM-US, V58, P119, DOI 10.1002/art.23230; Banciu M, 2008, J STEROID BIOCHEM, V111, P101, DOI 10.1016/j.jsbmb.2008.05.004; Barenholz Y, 2003, J LIPOSOME RES, V13, P1, DOI 10.1081/LPR-120017482; Barenholz Y, 2000, PHYSICAL CHEMISTRY OF BIOLOGICAL INTERFACES, P171; Barenholz Y, 2001, CURR OPIN COLLOID IN, V6, P66, DOI 10.1016/S1359-0294(00)00090-X; Barenholz Y., 2007, LIPOSOME TECHNOLOGY, V2, P1; Blanchette F, 2008, J NEUROL, V255, P26, DOI 10.1007/s00415-008-1005-5; Breimer DD, 1999, J CONTROL RELEASE, V62, P3, DOI 10.1016/S0168-3659(99)00060-7; Buttmann Mathias, 2007, Expert Rev Neurother, V7, P227, DOI 10.1586/14737175.7.3.227; Champion JA, 2007, J CONTROL RELEASE, V121, P3, DOI 10.1016/j.jconrel.2007.03.022; Chang PL, 1999, TRENDS BIOTECHNOL, V17, P78, DOI 10.1016/S0167-7799(98)01250-5; Charmandari E, 2010, NEONATAL PEDIAT PHAR, P760; CHEMIN C, 2008, BIOCH BIOPHYS ACTA; Ciccone A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006264.pub2; Clerc S, 1995, BBA-BIOMEMBRANES, V1240, P257, DOI 10.1016/0005-2736(95)00214-6; Czock D, 2005, CLIN PHARMACOKINET, V44, P61, DOI 10.2165/00003088-200544010-00003; Dubois EFL, 2005, CURR RESPIR MED REV, V1, P103, DOI 10.2174/1573398052953604; Fritze A, 2006, BBA-BIOMEMBRANES, V1758, P1633, DOI 10.1016/j.bbamem.2006.05.028; GABIZON A, 1980, BRIT J CANCER, V42, P551, DOI 10.1038/bjc.1980.279; Gabizon A, 2003, CLIN PHARMACOKINET, V42, P419, DOI 10.2165/00003088-200342050-00002; Garbuzenko O, 2005, CHEM PHYS LIPIDS, V135, P117, DOI 10.1016/j.chemphyslip.2005.02.003; Garbuzenko O, 2005, LANGMUIR, V21, P2560, DOI 10.1021/la0479105; Grant GJ, 2004, ANESTHESIOLOGY, V101, P133, DOI 10.1097/00000542-200407000-00021; Greenstein S, 2002, CLIN CANCER RES, V8, P1681; HARAN G, 1993, BIOCHIM BIOPHYS ACTA, V1151, P201, DOI 10.1016/0005-2736(93)90105-9; KALEDIN VI, 1981, J NATL CANCER I, V66, P881; Kluza E, 2011, J CONTROL RELEASE, V151, P10, DOI 10.1016/j.jconrel.2010.11.031; Kornek B, 2000, AM J PATHOL, V157, P267, DOI 10.1016/S0002-9440(10)64537-3; LASIC DD, 1995, BBA-BIOMEMBRANES, V1239, P145, DOI 10.1016/0005-2736(95)00159-Z; LONDON E, 1978, ANAL BIOCHEM, V88, P203, DOI 10.1016/0003-2697(78)90412-8; Maeda H, 2009, EUR J PHARM BIOPHARM, V71, P409, DOI 10.1016/j.ejpb.2008.11.010; MCKAY LI, 2000, CANC MED, P730; Metselaar JM, 2003, ARTHRITIS RHEUM-US, V48, P2059, DOI 10.1002/art.11140; Metselaar Josbert M, 2005, Expert Opin Drug Deliv, V2, P465, DOI 10.1517/17425247.2.3.465; Moreau T, 2009, J NEUROL SCI, V277, pS12, DOI 10.1016/S0022-510X(09)70005-X; MUKERJEE P, 1971, 36 NSRDS NBS, P8; MUNSHI NC, 2001, CANC PRINCIPLES PRAC, P2465; Peleg-Shulman T, 2001, BBA-BIOMEMBRANES, V1510, P278, DOI 10.1016/S0005-2736(00)00359-X; RANADE VV, 1990, J CLIN PHARMACOL, V30, P871, DOI 10.1002/j.1552-4604.1990.tb03566.x; Rousseau V, 1999, EXP BRAIN RES, V125, P255, DOI 10.1007/s002210050681; Samuni AM, 1997, FREE RADICAL BIO MED, V22, P1165, DOI 10.1016/S0891-5849(96)00509-6; Schleimer RP, 2003, MIDDLETONS ALLERGY P, P870; Schmidt J, 2003, BRAIN, V126, P1895, DOI 10.1093/brain/awg176; Schroeder A, 2007, LANGMUIR, V23, P4019, DOI 10.1021/la0631668; SHAW IH, 1976, BIOCHEM J, V158, P473, DOI 10.1042/bj1580473; SHINITZKY M, 1978, BIOCHIM BIOPHYS ACTA, V515, P367, DOI 10.1016/0304-4157(78)90010-2; Shmeeda H, 2003, METHOD ENZYMOL, V367, P272; SIEGAL T, 1995, J NEUROSURG, V83, P1029, DOI 10.3171/jns.1995.83.6.1029; Sionov RV, 2006, J EXP MED, V203, P189, DOI 10.1084/jem.20050433; SMITH MD, 1979, J CHROMATOGR, V164, P129, DOI 10.1016/S0378-4347(00)81182-2; Stein W., 2012, TRANSPORT DIFFUSION; Steinman L, 2006, ANN NEUROL, V60, P12, DOI 10.1002/ana.20913; Wasserman V, 2007, LANGMUIR, V23, P1937, DOI 10.1021/la060218k; WHITHAM RH, 1991, J IMMUNOL, V146, P101; WILLIAMS BD, 1987, ANN RHEUM DIS, V46, P314, DOI 10.1136/ard.46.4.314; Wong JP, 2003, J CONTROL RELEASE, V92, P265, DOI 10.1016/S0168-3659(03)00358-4; Yetgin S, 1998, LEUKEMIA RES, V22, P485, DOI 10.1016/S0145-2126(98)00003-4; Ziemssen T, 2007, INT REV NEUROBIOL, V79, P537, DOI 10.1016/S0074-7742(07)79024-4; Zucker D, 2010, J CONTROL RELEASE, V146, P326, DOI 10.1016/j.jconrel.2010.05.024; Zucker D, 2009, J CONTROL RELEASE, V139, P73, DOI 10.1016/j.jconrel.2009.05.036; Zuidam NJ, 1997, BBA-BIOMEMBRANES, V1329, P211, DOI 10.1016/S0005-2736(97)00110-7	66	51	51	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e25721	10.1371/journal.pone.0025721	http://dx.doi.org/10.1371/journal.pone.0025721			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998684	Green Published, gold, Green Submitted			2022-12-27	WOS:000295968700016
J	Tao, LZ; Li, XF; Zhang, LL; Tian, JY; Li, XB; Sun, X; Li, XF; Jiang, L; Zhang, XJ; Chen, JZ				Tao, Lizhen; Li, Xiaofeng; Zhang, Lingling; Tian, Jiyu; Li, Xiaobing; Sun, Xin; Li, Xuefen; Jiang, Lin; Zhang, Xiaojun; Chen, Jianzong			Protective Effect of Tetrahydroxystilbene Glucoside on 6-OHDA-Induced Apoptosis in PC12 Cells through the ROS-NO Pathway	PLOS ONE			English	Article							NITRIC-OXIDE; POLYGONUM-MULTIFLORUM; PARKINSONS-DISEASE; 6-HYDROXYDOPAMINE-INDUCED APOPTOSIS; NEURODEGENERATIVE DISORDERS; OXIDATIVE STRESS; NEUROTOXICITY; 6-OHDA; PEROXYNITRITE; BRAIN	Oxidative stress plays an important role in the pathogenesis of neurodegenerative diseases, such as Parkinson's disease. The molecule, 2,3,5,4'-tetrahydr-oxystilbene-2-O-beta-D-glucoside (TSG), is a potent antioxidant derived from the Chinese herb, Polygonum multiflorum Thunb. In this study, we investigated the protective effect of TSG against 6-hydroxydopamine-induced apoptosis in rat adrenal pheochromocytoma PC12 cells and the possible mechanisms. Our data demonstrated that TSG significantly reversed the 6-hydroxydopamine-induced decrease in cell viability, prevented 6-hydroxydopamine-induced changes in condensed nuclei and decreased the percentage of apoptotic cells in a dose-dependent manner. In addition, TSG slowed the accumulation of intracellular reactive oxygen species and nitric oxide, counteracted the overexpression of inducible nitric oxide syntheses as well as neuronal nitric oxide syntheses, and also reduced the level of protein-bound 3-nitrotyrosine. These results demonstrate that the protective effects of TSG on rat adrenal pheochromocytoma PC12 cells are mediated, at least in part, by the ROS-NO pathway. Our results indicate that TSG may be effective in providing protection against neurodegenerative diseases associated with oxidative stress.	[Tao, Lizhen; Li, Xiaofeng; Zhang, Lingling; Tian, Jiyu; Li, Xiaobing; Sun, Xin; Li, Xuefen; Jiang, Lin; Chen, Jianzong] Fourth Mil Med Univ, Xijing Hosp, Res Ctr Tradit Chinese Med, Xian 710032, Peoples R China; [Zhang, Xiaojun] Fourth Mil Med Univ, Dept Math & Phys, Sch Biomed Engn, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Tao, LZ (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Res Ctr Tradit Chinese Med, Xian 710032, Peoples R China.	zy04310@fmmu.edu.cn; jzchen57@fmmu.edu.cn	zhang, lingling/HDM-2189-2022	Zhang, Lingling/0000-0002-6272-7171	National Natural Science Foundation of China [30772743]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the funding support from National Natural Science Foundation of China (No. 30772743). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althaus JS, 2000, FREE RADICAL BIO MED, V29, P1085, DOI 10.1016/S0891-5849(00)00350-6; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Bharath S, 2002, NEUROTOXICOLOGY, V23, P479, DOI 10.1016/S0161-813X(02)00035-9; Blum D, 2001, PROG NEUROBIOL, V65, P135, DOI 10.1016/S0301-0082(01)00003-X; Boje KMK, 2004, FRONT BIOSCI-LANDMRK, V9, P763, DOI 10.2741/1268; Brown GC, 1999, BBA-BIOENERGETICS, V1411, P351, DOI 10.1016/S0005-2728(99)00025-0; Brown GC, 2010, NITRIC OXIDE-BIOL CH, V23, P153, DOI 10.1016/j.niox.2010.06.001; Castillo MR, 1998, NEUROSCIENCE, V86, P1133, DOI 10.1016/S0306-4522(98)00070-0; Chan YC, 2003, AM J CHINESE MED, V31, P171, DOI 10.1142/S0192415X03000862; Chen Y, 1999, J AGR FOOD CHEM, V47, P2226, DOI 10.1021/jf990092f; Chung KKK, 2010, NITRIC OXIDE-BIOL CH, V22, P290, DOI 10.1016/j.niox.2010.02.002; DAWSON TM, 1992, ANN NEUROL, V32, P297, DOI 10.1002/ana.410320302; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Dehmer T, 2000, J NEUROCHEM, V74, P2213, DOI 10.1046/j.1471-4159.2000.0742213.x; Duncan Andrew J., 2005, Molecular Aspects of Medicine, V26, P67, DOI 10.1016/j.mam.2004.09.004; Feng L, 2008, INT J DEV NEUROSCI, V26, P323, DOI 10.1016/j.ijdevneu.2008.01.003; Fujita H, 2006, BRAIN RES, V1113, P10, DOI 10.1016/j.brainres.2006.06.079; Gatto EM, 1999, J NEUROL SCI, V165, P66, DOI 10.1016/S0022-510X(99)00079-9; Godber BLJ, 2000, J BIOL CHEM, V275, P7757, DOI 10.1074/jbc.275.11.7757; Gorman AM, 2005, BIOCHEM BIOPH RES CO, V327, P801, DOI 10.1016/j.bbrc.2004.12.066; Guix FX, 2005, PROG NEUROBIOL, V76, P126, DOI 10.1016/j.pneurobio.2005.06.001; Guo SH, 2005, FREE RADICAL BIO MED, V39, P682, DOI 10.1016/j.freeradbiomed.2005.04.022; Heales SJR, 1999, BBA-BIOENERGETICS, V1410, P215, DOI 10.1016/S0005-2728(98)00168-6; Hornykiewicz O, 1987, Adv Neurol, V45, P19; JELLINGER KA, 1993, ADV NEUROL, V60, P267; Ju MS, 2010, TOXICOL IN VITRO, V24, P759, DOI 10.1016/j.tiv.2009.12.026; Keller JN, 2004, INT J BIOCHEM CELL B, V36, P2376, DOI 10.1016/j.biocel.2004.05.003; Kojima H, 1999, ANGEW CHEM INT EDIT, V38, P3209, DOI 10.1002/(SICI)1521-3773(19991102)38:21<3209::AID-ANIE3209>3.0.CO;2-6; KOPPENOL WH, 1992, CHEM RES TOXICOL, V5, P834, DOI 10.1021/tx00030a017; Li X, 2005, PHARMACOL BIOCHEM BE, V82, P345, DOI 10.1016/j.pbb.2005.09.004; Li XB, 2010, NEUROSCI LETT, V483, P1, DOI 10.1016/j.neulet.2010.07.027; Liu B, 2001, J NEUROCHEM, V77, P182, DOI 10.1046/j.1471-4159.2001.t01-1-00216.x; Luo HB, 2009, NEUROSCI BULL, V25, P391, DOI 10.1007/s12264-009-0601-4; Mayo JC, 1999, BRAIN RES, V818, P221, DOI 10.1016/S0006-8993(98)01262-1; Nie GJ, 2002, ARCH BIOCHEM BIOPHYS, V397, P84, DOI 10.1006/abbi.2001.2636; Padiglia A, 1997, BIOCHEM PHARMACOL, V53, P1065, DOI 10.1016/S0006-2952(96)00716-2; Qin R, 2011, TOXICOL LETT, V202, P1, DOI 10.1016/j.toxlet.2011.01.001; Schober A, 2004, CELL TISSUE RES, V318, P215, DOI 10.1007/s00441-004-0938-y; SIAN J, 1994, ANN NEUROL, V36, P348, DOI 10.1002/ana.410360305; Smith MP, 2007, NEUROSCI LETT, V412, P259, DOI 10.1016/j.neulet.2006.11.017; Tatton WG, 2002, J PHARMACOL EXP THER, V301, P753, DOI 10.1124/jpet.301.2.753; Tian LL, 2008, INT J BIOCHEM CELL B, V40, P409, DOI 10.1016/j.biocel.2007.08.005; Torreilles F, 1999, BRAIN RES REV, V30, P153, DOI 10.1016/S0165-0173(99)00014-4; WALKINSHAW G, 1994, NEUROSCIENCE, V63, P975, DOI 10.1016/0306-4522(94)90566-5; Wang T, 2009, FREE RADICAL BIO MED, V47, P229, DOI 10.1016/j.freeradbiomed.2009.02.027; Watanabe H, 2004, EUR NEUROPSYCHOPHARM, V14, P93, DOI 10.1016/S0924-977X(03)00065-8; Yamada K, 1997, BRAIN RES BULL, V43, P573, DOI 10.1016/S0361-9230(96)00336-X; Yang Xiuwei, 1996, Zhongguo Zhongyao Zazhi, V21, P48; Yao S, 2006, J CHROMATOGR A, V1115, P64, DOI 10.1016/j.chroma.2006.02.071; Ye Shaojian, 2006, J Huazhong Univ Sci Technolog Med Sci, V26, P13; Zhang L, 2006, PHARMACOL THERAPEUT, V109, P33, DOI 10.1016/j.pharmthera.2005.05.007; Zhang L, 2006, BEHAV BRAIN RES, V173, P246, DOI 10.1016/j.bbr.2006.06.034; Zhang YD, 2007, J COMB CHEM, V9, P9, DOI 10.1021/cc0601231	53	55	58	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e26055	10.1371/journal.pone.0026055	http://dx.doi.org/10.1371/journal.pone.0026055			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998750	Green Published, Green Submitted, gold			2022-12-27	WOS:000295968700035
J	Lepore, AC; O'Donnell, J; Kim, AS; Williams, T; Tuteja, A; Rao, MS; Kelley, LL; Campanelli, JT; Maragakis, NJ				Lepore, Angelo C.; O'Donnell, John; Kim, Andrew S.; Williams, Timothy; Tuteja, Alicia; Rao, Mahendra S.; Kelley, Linda L.; Campanelli, James T.; Maragakis, Nicholas J.			Human Glial-Restricted Progenitor Transplantation into Cervical Spinal Cord of the SOD1(G93A) Mouse Model of ALS	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURON DISEASE; TRANSGENIC RAT MODEL; FAMILIAL ALS; CELL GRAFTS; STEM-CELLS; DEGENERATION; ASTROCYTES; SURVIVAL; MICE	Cellular abnormalities are not limited to motor neurons in amyotrophic lateral sclerosis (ALS). There are numerous observations of astrocyte dysfunction in both humans with ALS and in SOD1(G93A) rodents, a widely studied ALS model. The present study therapeutically targeted astrocyte replacement in this model via transplantation of human Glial-Restricted Progenitors (hGRPs), lineage-restricted progenitors derived from human fetal neural tissue. Our previous findings demonstrated that transplantation of rodent-derived GRPs into cervical spinal cord ventral gray matter (in order to target therapy to diaphragmatic function) resulted in therapeutic efficacy in the SOD1(G93A) rat. Those findings demonstrated the feasibility and efficacy of transplantation-based astrocyte replacement for ALS, and also show that targeted multi-segmental cell delivery to cervical spinal cord is a promising therapeutic strategy, particularly because of its relevance to addressing respiratory compromise associated with ALS. The present study investigated the safety and in vivo survival, distribution, differentiation, and potential efficacy of hGRPs in the SOD1(G93A) mouse. hGRP transplants robustly survived and migrated in both gray and white matter and differentiated into astrocytes in SOD1(G93A) mice spinal cord, despite ongoing disease progression. However, cervical spinal cord transplants did not result in motor neuron protection or any therapeutic benefits on functional outcome measures. This study provides an in vivo characterization of this glial progenitor cell and provides a foundation for understanding their capacity for survival, integration within host tissues, differentiation into glial subtypes, migration, and lack of toxicity or tumor formation.	[Lepore, Angelo C.] Thomas Jefferson Univ, Coll Med, Dept Neurosci, Philadelphia, PA 19107 USA; [O'Donnell, John; Kim, Andrew S.; Williams, Timothy; Tuteja, Alicia; Maragakis, Nicholas J.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Rao, Mahendra S.] Life Technol, Carlsbad, CA USA; [Kelley, Linda L.] Univ Utah, Dept Internal Med, Hlth Sci Ctr, Salt Lake City, UT 84112 USA; [Rao, Mahendra S.; Campanelli, James T.] Q Therapeut, Salt Lake City, UT USA; [Campanelli, James T.] Univ Utah, Dept Neurol, Salt Lake City, UT USA	Jefferson University; Johns Hopkins University; Thermo Fisher Scientific; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Lepore, AC (corresponding author), Thomas Jefferson Univ, Coll Med, Dept Neurosci, Philadelphia, PA 19107 USA.	nmaragak@jhmi.edu		O'Donnell, John/0000-0002-0774-9028	National Institutes of Health (NIH) [F32-NS059155, NIH U01 NS062713]; The Robert Packard Center for Lou Gehrig's Disease (ALS) Research; Muscular Dystrophy Association; The Maryland Stem Cell Research Fund; Q Therapeutics Inc.; The ALS Association; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS062713, F32NS059155] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Robert Packard Center for Lou Gehrig's Disease (ALS) Research; Muscular Dystrophy Association(Muscular Dystrophy Association); The Maryland Stem Cell Research Fund; Q Therapeutics Inc.; The ALS Association; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by: National Institutes of Health (NIH) F32-NS059155 (AL), NIH U01 NS062713 (NM, JC, LK), The Robert Packard Center for Lou Gehrig's Disease (ALS) Research (NM), Muscular Dystrophy Association (NM), The ALS Association (NM), The Maryland Stem Cell Research Fund (NM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; JC and MR have a financial interest and are associated with Q Therapeutics Inc., which provided the hGRPs for transplantation. MR is the Vice President for Research, Regenerative Medicine and Stem Cells at Life Technologies. Q Therapeutics, Inc. has patents on hGRPs and is currently developing these for potential clinical study. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Campanelli James T, 2008, BMC Dev Biol, V8, P102, DOI 10.1186/1471-213X-8-102; Chandran S, 2004, GLIA, V47, P314, DOI 10.1002/glia.20011; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Han SSW, 2002, EXP NEUROL, V177, P360, DOI 10.1006/exnr.2002.7995; HAVERKAMP LJ, 1995, BRAIN, V118, P707, DOI 10.1093/brain/118.3.707; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Lepore AC, 2007, NEUROCHEM INT, V50, P966, DOI 10.1016/j.neuint.2006.09.005; Lepore AC, 2006, NEUROSCIENCE, V142, P285, DOI 10.1016/j.neuroscience.2005.12.068; Lepore AC, 2005, EXP NEUROL, V194, P230, DOI 10.1016/j.expneurol.2005.02.020; Lepore AC, 2008, NAT NEUROSCI, V11, P1294, DOI 10.1038/nn.2210; Lepore AC, 2008, EXP NEUROL, V211, P423, DOI 10.1016/j.expneurol.2008.02.020; Lepore AC, 2007, BRAIN RES, V1185, P256, DOI 10.1016/j.brainres.2007.09.034; Lepore AC, 2010, NEUROBIOL DIS, V39, P252, DOI 10.1016/j.nbd.2010.03.021; Llado J, 2006, NEUROBIOL DIS, V21, P110, DOI 10.1016/j.nbd.2005.06.019; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Maragakis NJ, 2004, GLIA, V45, P133, DOI 10.1002/glia.10310; Matsumoto A, 2006, J NEUROSCI RES, V83, P119, DOI 10.1002/jnr.20708; Mitsumoto H, 1998, AMYOTROPHIC LATERAL, Vxxv; Nagai M, 2001, J NEUROSCI, V21, P9246, DOI 10.1523/JNEUROSCI.21-23-09246.2001; Papadeas ST, 2009, CURR OPIN BIOTECH, V20, P545, DOI 10.1016/j.copbio.2009.09.003; Park S, 2009, EXP MOL MED, V41, P487, DOI 10.3858/emm.2009.41.7.054; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Ray J, 2006, MOL CELL NEUROSCI, V31, P560, DOI 10.1016/j.mcn.2005.11.010; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; ROTHSTEIN JD, 1992, NEW ENGL J MED, V326, P1464, DOI 10.1056/NEJM199205283262204; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Sandrock RW, 2010, REGEN MED, V5, P381, DOI 10.2217/RME.10.24; Suzuki M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000689; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Walczak P, 2011, GLIA, V59, P499, DOI 10.1002/glia.21119; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Xu LY, 2011, NEUROSCI LETT, V494, P222, DOI 10.1016/j.neulet.2011.03.017; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Yan J, 2006, STEM CELLS, V24, P1976, DOI 10.1634/stemcells.2005-0518; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135	39	87	87	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25968	10.1371/journal.pone.0025968	http://dx.doi.org/10.1371/journal.pone.0025968			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998733	Green Published, gold			2022-12-27	WOS:000295966900083
J	Novick, I; Vaadia, E				Novick, Itai; Vaadia, Eilon			Just Do It: Action-Dependent Learning Allows Sensory Prediction	PLOS ONE			English	Article							POSTERIOR PARIETAL; INTERNAL-MODELS; MOTOR CONTROL; ADAPTATION; CORTEX; SPECIFICITY; PRINCIPLES; STATE	Sensory-motor learning is commonly considered as a mapping process, whereby sensory information is transformed into the motor commands that drive actions. However, this directional mapping, from inputs to outputs, is part of a loop; sensory stimuli cause actions and vice versa. Here, we explore whether actions affect the understanding of the sensory input that they cause. Using a visuo-motor task in humans, we demonstrate two types of learning-related behavioral effects. Stimulus-dependent effects reflect stimulus-response learning, while action-dependent effects reflect a distinct learning component, allowing the brain to predict the forthcoming sensory outcome of actions. Together, the stimulus-dependent and the action-dependent learning components allow the brain to construct a complete internal representation of the sensory-motor loop.	[Novick, Itai; Vaadia, Eilon] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Med Neurobiol, Edmond & Lily Safra Ctr Brain Sci, IL-91010 Jerusalem, Israel	Hebrew University of Jerusalem	Novick, I (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Med Neurobiol, Edmond & Lily Safra Ctr Brain Sci, IL-91010 Jerusalem, Israel.	itain@ekmd.huji.ac.il			US-Israel Binational Science Foundation; Israeli Science foundation; Rosetrees Trust; Ida Baruch fund	US-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Israeli Science foundation(Israel Science Foundation); Rosetrees Trust(Rosetrees Trust); Ida Baruch fund	This work was supported in part by the US-Israel Binational Science Foundation, by the Israeli Science foundation, and special contributions by the Rosetrees Trust and the Ida Baruch fund. EV is the Jack H. Skirball Chair of Brain Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahissar M, 1997, NATURE, V387, P401, DOI 10.1038/387401a0; Cullen KE, 2004, J NEUROPHYSIOL, V91, P1919, DOI 10.1152/jn.00988.2003; Diedrichsen J, 2010, J NEUROSCI, V30, P5159, DOI 10.1523/JNEUROSCI.5406-09.2010; Ebner T, 2008, CEREBELLUM, V7, P583, DOI 10.1007/s12311-008-0059-3; Flanagan JR, 2003, CURR BIOL, V13, P146, DOI 10.1016/S0960-9822(03)00007-1; Gandolfo F, 1996, P NATL ACAD SCI USA, V93, P3843, DOI 10.1073/pnas.93.9.3843; Ghahramani Z, 1996, J NEUROSCI, V16, P7085; Gollisch T, 2010, NEURON, V65, P150, DOI 10.1016/j.neuron.2009.12.009; GUTTMAN N, 1956, J EXP PSYCHOL, V51, P79, DOI 10.1037/h0046219; Huang VS, 2011, NEURON, V70, P787, DOI 10.1016/j.neuron.2011.04.012; Hwang EJ, 2006, EXP BRAIN RES, V169, P496, DOI 10.1007/s00221-005-0163-2; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; Krakauer JW, 2000, J NEUROSCI, V20, P8916, DOI 10.1523/jneurosci.20-23-08916.2000; Lalazar H, 2008, CURR OPIN NEUROBIOL, V18, P573, DOI 10.1016/j.conb.2008.11.003; Mattar AAG, 2007, J NEUROPHYSIOL, V98, P3321, DOI 10.1152/jn.00576.2007; Miall RC, 2007, PLOS BIOL, V5, P2733, DOI 10.1371/journal.pbio.0050316; Mulliken GH, 2008, P NATL ACAD SCI USA, V105, P8170, DOI 10.1073/pnas.0802602105; Paz R, 2004, J PHYSIOL-PARIS, V98, P331, DOI 10.1016/j.jphysparis.2005.09.005; Paz R, 2003, NAT NEUROSCI, V6, P882, DOI 10.1038/nn1097; POGGIO T, 1992, SCIENCE, V256, P1018, DOI 10.1126/science.1589770; Shadmehr R, 2010, ANNU REV NEUROSCI, V33, P89, DOI 10.1146/annurev-neuro-060909-153135; Tanaka H, 2009, J NEUROPHYSIOL, V102, P2921, DOI 10.1152/jn.90834.2008; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Vaziri S, 2006, J NEUROSCI, V26, P4188, DOI 10.1523/JNEUROSCI.4747-05.2006; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497	25	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e26020	10.1371/journal.pone.0026020	http://dx.doi.org/10.1371/journal.pone.0026020			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998746	Green Submitted, Green Published, gold			2022-12-27	WOS:000295966900092
J	Chisti, MJ; Salam, MA; Smith, JH; Ahmed, T; Ashraf, H; Bardhan, PK; Pietroni, MAC				Chisti, Mohammod J.; Salam, Mohammed A.; Smith, Jonathan Harvey; Ahmed, Tahmeed; Ashraf, Hasan; Bardhan, Pradip K.; Pietroni, Mark A. C.			Impact of Lack of Breast Feeding during Neonatal Age on the Development of Clinical Signs of Pneumonia and Hypoxemia in Young Infants with Diarrhea	PLOS ONE			English	Article							MALNOURISHED CHILDREN; LUNG-FUNCTION; RISK-FACTORS; MORTALITY; BANGLADESH; CHILDHOOD; INFECTION; MADAGASCAR; MANAGEMENT; INITIATION	Background: Hypoxemia is a grave sequel of pneumonia, and an important predictor of a fatal outcome. Pneumonia in the neonatal period is often associated with lack of breast feeding. However, there is no published report on the impact of the cessation of breast feeding in the neonatal period on the development of pneumonia and hypoxemia. The purpose of our study was to assess the impact of non-breast feeding or stopping breast feeding during the neonatal period (henceforth to be referred to as non-breast fed) on clinical features of pneumonia and hypoxemia in 0-6-month-old infants with diarrhea admitted to an urban hospital in Bangladesh. Methods: We prospectively enrolled all infants (n = 107) aged 0 to 6 months who were admitted to the Special Care Ward (SCW) of the Dhaka Hospital of the International Centre for Diarrhoeal Disease Research Bangladesh (ICDDR,B) with diarrhea and pneumonia from September 2007 through December 2007. We compared the clinical features of pneumonia and hypoxemia of breast fed infants (n = 34) with those who were non-breast fed (n = 73). Results: The median (inter-quartile range) duration of hypoxemia (hours) in non-breast-feds was longer than breast-fed infants [0.0 (0.0, 12.0) vs. 12.0 (0.0, 21.75); p = 0.021]. After adjusting for potential confounders such as inability to drink, fever, head nodding, cyanosis, grunting respiration, and lower chest wall in drawing, the non-breast-fed infants with pneumonia along with diarrhea had a higher probability of cough (OR 9.09; CI 1.34-61.71; p = 0.024), hypoxemia (OR 3.32; CI 1.23-8.93; p = 0.017), and severe undernutrition (OR 3.42; CI 1.29-9.12; p = 0.014). Conclusions and Significance: Non-breast feeding or cessation of breast feeding during the neonatal period may substantially increase the incidence of severe malnutrition, incidence of cough, and both the incidence and duration of hypoxemia in young infants presenting with pneumonia and diarrhea. The findings emphasize the paramount importance of the continuation of breast feeding in the neonatal period and early infancy.	[Chisti, Mohammod J.; Ahmed, Tahmeed] Int Ctr Diarrhoeal Dis Res, Div Clin Sci, Nutr Programme, Dhaka 1000, Bangladesh; [Chisti, Mohammod J.; Smith, Jonathan Harvey; Bardhan, Pradip K.; Pietroni, Mark A. C.] Int Ctr Diarrhoeal Dis Res, Execut Directors Div, Dhaka 1000, Bangladesh; [Smith, Jonathan Harvey] UCL, Inst Child Hlth, Portex Dept Paediat Anaesthesia, London, England	International Centre for Diarrhoeal Disease Research (ICDDR); International Centre for Diarrhoeal Disease Research (ICDDR); University of London; University College London	Chisti, MJ (corresponding author), Int Ctr Diarrhoeal Dis Res, Div Clin Sci, Nutr Programme, GPO Box 128, Dhaka 1000, Bangladesh.	chisti@icddrb.org	Chisti, Mohammod J/A-7216-2018; Smith, Jonathan/S-9476-2019	Smith, Jonathan/0000-0002-0295-6773	Dhaka Hospital of International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B) [Gr-00233]; Australian Agency for International Development; Government of the People's Republic of Bangladesh; Canadian International Development Agency; Swedish International Development Cooperation Agency; Department for International Development, United Kingdom	Dhaka Hospital of International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B); Australian Agency for International Development; Government of the People's Republic of Bangladesh; Canadian International Development Agency; Swedish International Development Cooperation Agency; Department for International Development, United Kingdom	This research study was funded by the Dhaka Hospital of International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B; grant no Gr-00233) and its donors, which provide unrestricted support to ICDDR,B for its operations and research. Current donors providing unrestricted support include: Australian Agency for International Development, Government of the People's Republic of Bangladesh, Canadian International Development Agency, Swedish International Development Cooperation Agency, and the Department for International Development, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed T, 1999, LANCET, V353, P1919, DOI 10.1016/S0140-6736(98)07499-6; Baker EJ, 2006, J HEALTH POPUL NUTR, V24, P530; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Brady JP, 2000, J TROP PEDIATRICS, V46, P200, DOI 10.1093/tropej/46.4.200; BROWN KH, 1992, ACTA PAEDIATR, V81, P127, DOI 10.1111/j.1651-2227.1992.tb12386.x; Castro-Rodriguez JA, 2008, ALLERGOL IMMUNOPATH, V36, P3, DOI 10.1157/13115664; Chantry CJ, 2006, PEDIATRICS, V117, P425, DOI 10.1542/peds.2004-2283; Chisti MJ, 2007, ACTA PAEDIATR, V96, P693, DOI 10.1111/j.1651-2227.2007.00192.x; Chisti MJ, 2010, PEDIATR INFECT DIS J, V29, P444, DOI 10.1097/INF.0b013e3181cb4608; Chisti MJ, 2010, PEDIATR INFECT DIS J, V29, P174, DOI 10.1097/INF.0b013e3181b9a4d5; Duke T, 2001, INT J TUBERC LUNG D, V5, P511; Guilbert TW, 2007, AM J RESP CRIT CARE, V176, P843, DOI 10.1164/rccm.200610-1507OC; Kelly D, 2000, P NUTR SOC, V59, P177, DOI 10.1017/S0029665100000197; LETTERIO JJ, 1994, SCIENCE, V264, P1936, DOI 10.1126/science.8009224; Libster R, 2009, PEDIATR INFECT DIS J, V28, P131, DOI 10.1097/INF.0b013e31818a8a82; Lopez-Alarcon M, 2004, ADV EXP MED BIOL, V554, P371; Major Vicki, 2002, J Okla State Med Assoc, V95, P711; MAJUMDER AK, 1991, J BIOSOC SCI, V23, P297, DOI 10.1017/S0021932000019362; MARQUIS GS, 1993, AM J CLIN NUTR, V57, P218, DOI 10.1093/ajcn/57.2.218; Montgomery-Downs HE, 2007, PEDIATRICS, V120, P1030, DOI 10.1542/peds.2007-0722; Mulholland K, 2007, LANCET, V370, P285, DOI 10.1016/S0140-6736(07)61130-1; Nagel G, 2009, EUR RESPIR J, V33, P993, DOI 10.1183/09031936.00075708; Ogawa J, 2004, EARLY HUM DEV, V77, P67, DOI 10.1016/j.earlhumdev.2004.01.005; Raisler J, 1999, AM J PUBLIC HEALTH, V89, P25, DOI 10.2105/AJPH.89.1.25; RAVELOMANANA N, 1995, EUR J CLIN NUTR, V49, P91; Ryan AS, 2006, WOMEN HEALTH ISS, V16, P243, DOI 10.1016/j.whi.2006.08.001; SAZAWAL S, 1992, LANCET, V340, P528, DOI 10.1016/0140-6736(92)91720-S; Subhi R, 2009, LANCET INFECT DIS, V9, P219, DOI 10.1016/S1473-3099(09)70071-4; World Health Organization, 1990, AC RESP INF CHILDR C; World Health Organization, 1999, MAN SEV MALN MAN PHY; World Health Organization (WHO), 2005, POCK BOOK HOSP CAR C	31	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25817	10.1371/journal.pone.0025817	http://dx.doi.org/10.1371/journal.pone.0025817			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991362	Green Submitted, Green Published, gold			2022-12-27	WOS:000295943000078
J	Chua, KYL; Seemann, T; Harrison, PF; Monagle, S; Korman, TM; Johnson, PDR; Coombs, GW; Howden, BO; Davies, JK; Howden, BP; Stinear, TP				Chua, Kyra Y. L.; Seemann, Torsten; Harrison, Paul F.; Monagle, Shaun; Korman, Tony M.; Johnson, Paul D. R.; Coombs, Geoffrey W.; Howden, Brian O.; Davies, John K.; Howden, Benjamin P.; Stinear, Timothy P.			The Dominant Australian Community-Acquired Methicillin-Resistant Staphylococcus aureus Clone ST93-IV [2B] Is Highly Virulent and Genetically Distinct	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; COMPLETE GENOME SEQUENCE; VANCOMYCIN RESISTANCE; NECROTIZING PNEUMONIA; SKIN INFECTIONS; STRAINS; EVOLUTION; EPIDEMIC; DETERMINANTS; INSIGHTS	Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) USA300 has spread rapidly across North America, and CA-MRSA is also increasing in Australia. However, the dominant Australian CA-MRSA strain, ST93-IV [2B] appears distantly related to USA300 despite strikingly similar clinical and epidemiological profiles. Here, we compared the virulence of a recent Australian ST93 isolate (JKD6159) to other MRSA, including USA300, and found that JKD6159 was the most virulent in a mouse skin infection model. We fully sequenced the genome of JKD6159 and confirmed that JKD6159 is a distinct clone with 7616 single nucleotide polymorphisms (SNPs) distinguishing this strain from all other S. aureus genomes. Despite its high virulence there were surprisingly few virulence determinants. However, genes encoding a-hemolysin, Panton-Valentine leukocidin (PVL) and alpha-type phenol soluble modulins were present. Genome comparisons revealed 32 additional CDS in JKD6159 but none appeared to encode new virulence factors, suggesting that this clone's enhanced pathogenicity could lie within subtler genome changes, such as SNPs within regulatory genes. To investigate the role of accessory genome elements in CA-MRSA epidemiology, we next sequenced three additional Australian non-ST93 CA-MRSA strains and compared them with JKD6159, 19 completed S. aureus genomes and 59 additional S. aureus genomes for which unassembled genome sequence data was publicly available (82 genomes in total). These comparisons showed that despite its distinctive genotype, JKD6159 and other CA-MRSA clones (including USA300) share a conserved repertoire of three notable accessory elements (SSCmecIV, PVL prophage, and pMW2). This study demonstrates that the genetically distinct ST93 CA-MRSA from Australia is highly virulent. Our comparisons of geographically and genetically diverse CA-MRSA genomes suggest that apparent convergent evolution in CA-MRSA may be better explained by the rapid dissemination of a highly conserved accessory genome from a common source.	[Chua, Kyra Y. L.; Davies, John K.; Howden, Benjamin P.; Stinear, Timothy P.] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia; [Chua, Kyra Y. L.; Howden, Benjamin P.; Stinear, Timothy P.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Seemann, Torsten; Harrison, Paul F.] Monash Univ, Victorian Bioinformat Consortium, Clayton, Vic 3168, Australia; [Chua, Kyra Y. L.; Johnson, Paul D. R.; Howden, Benjamin P.] Austin Hlth, Austin Ctr Infect Res, Dept Infect Dis, Heidelberg, Vic, Australia; [Howden, Benjamin P.] Austin Hlth, Dept Microbiol, Heidelberg, Vic, Australia; [Korman, Tony M.] Monash Med Ctr, Dept Infect Dis, Clayton, Vic 3168, Australia; [Monagle, Shaun] Eastern Hlth, Dept Anat Pathol, Box Hill, Vic, Australia; [Coombs, Geoffrey W.] Royal Perth Hosp, Dept Microbiol & Infect Dis, PathWest Lab Med WA, Perth, WA, Australia; [Howden, Brian O.] Microsurg Consultants, Blackburn, Australia	Monash University; University of Melbourne; Monash University; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Monash University; Royal Perth Hospital; University of Western Australia	Chua, KYL (corresponding author), Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia.	Benjamin.Howden@austin.org.au; tstinear@unimelb.edu.au	Harrison, Paul/V-6978-2019; Seemann, Torsten/B-2318-2010; Korman, Tony M/I-3099-2013	Harrison, Paul/0000-0002-3980-268X; Seemann, Torsten/0000-0001-6046-610X; Korman, Tony M/0000-0002-6155-8353; Howden, Benjamin/0000-0003-0237-1473; Stinear, Timothy/0000-0003-0150-123X; Chua, Kyra Yu Lin/0000-0001-8826-7137; Coombs, Geoffrey/0000-0003-1635-6506	National Health and Medical Research Council of Australia [1008656]; CASS Foundation; Austin Hospital Medical Research Foundation	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); CASS Foundation; Austin Hospital Medical Research Foundation	This research was supported by the National Health and Medical Research Council of Australia Project Grant 1008656, the CASS Foundation and the Austin Hospital Medical Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Brown EL, 2009, CLIN MICROBIOL INFEC, V15, P156, DOI 10.1111/j.1469-0691.2008.02648.x; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Chua K, 2010, J BACTERIOL, V192, P5556, DOI 10.1128/JB.00878-10; Coombs GW, 2009, COMMUN DIS INTELL, V33, P10; Coombs GW, 2010, ANTIMICROB AGENTS CH, V54, P1914, DOI 10.1128/AAC.01287-09; Coombs GW, 2004, J CLIN MICROBIOL, V42, P4735, DOI 10.1128/JCM.42.10.4735-4743.2004; Corvaglia AR, 2010, P NATL ACAD SCI USA, V107, P11954, DOI 10.1073/pnas.1000489107; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Diep BA, 2010, P NATL ACAD SCI USA, V107, P5587, DOI 10.1073/pnas.0912403107; Diep BA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003198; Ellington MJ, 2010, CLIN MICROBIOL INFEC, V16, P1009, DOI 10.1111/j.1469-0691.2009.02994.x; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Fitzgerald JR, 2001, P NATL ACAD SCI USA, V98, P8821, DOI 10.1073/pnas.161098098; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Gao W, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000944; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Gillaspy A.F., 2006, GRAM POSITIVE PATHOG, P381; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Herron-Olson L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001120; Highlander SK, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-99; Holden MTG, 2010, J BACTERIOL, V192, P888, DOI 10.1128/JB.01255-09; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Horne KC, 2009, ANTIMICROB AGENTS CH, V53, P3447, DOI 10.1128/AAC.01365-08; Howden BP, 2008, ANTIMICROB AGENTS CH, V52, P3755, DOI 10.1128/AAC.01613-07; Howden BP, 2010, J BACTERIOL, V192, P5848, DOI 10.1128/JB.00951-10; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Kennedy AD, 2008, P NATL ACAD SCI USA, V105, P1327, DOI 10.1073/pnas.0710217105; Kobayashi SD, 2011, J INFECT DIS, V204, P937, DOI 10.1093/infdis/jir441; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; Li M, 2010, J INFECT DIS, V202, P1866, DOI 10.1086/657419; Li M, 2009, P NATL ACAD SCI USA, V106, P5883, DOI 10.1073/pnas.0900743106; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Lindsay JA, 2004, TRENDS MICROBIOL, V12, P378, DOI 10.1016/j.tim.2004.06.004; Loffler B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000715; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Munckhof Wendy J., 2003, International Journal of Infectious Diseases, V7, P259, DOI 10.1016/S1201-9712(03)90104-4; Murray NE, 2000, MICROBIOL MOL BIOL R, V64, P412, DOI 10.1128/MMBR.64.2.412-434.2000; Mwangi MM, 2007, P NATL ACAD SCI USA, V104, P9451, DOI 10.1073/pnas.0609839104; Neoh HM, 2008, ANTIMICROB AGENTS CH, V52, P45, DOI 10.1128/AAC.00534-07; Nubel U, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000855; Peleg AY, 2009, J INFECT DIS, V199, P532, DOI 10.1086/596511; Peleg AY, 2005, EUR J CLIN MICROBIOL, V24, P384, DOI 10.1007/s10096-005-1329-3; Rasband W., 2006, IMAGEJ; Rumble SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000386; Schijffelen MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-376; Tong SYC, 2009, CLIN MICROBIOL INFEC, V15, P1126, DOI 10.1111/j.1469-0691.2009.02732.x; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Voyich JA, 2005, J IMMUNOL, V175, P3907, DOI 10.4049/jimmunol.175.6.3907; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Wardenburg JB, 2008, J INFECT DIS, V198, P1166, DOI 10.1086/592053; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	60	51	51	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25887	10.1371/journal.pone.0025887	http://dx.doi.org/10.1371/journal.pone.0025887			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991381	Green Published, gold			2022-12-27	WOS:000295943000092
J	Pons, E; Navarro, A; Ollitrault, P; Pena, L				Pons, Elsa; Navarro, Antonio; Ollitrault, Patrick; Pena, Leandro			Pollen Competition as a Reproductive Isolation Barrier Represses Transgene Flow between Compatible and Co-Flowering Citrus Genotypes	PLOS ONE			English	Article							GENE FLOW; MATING PATTERNS; RISK-ASSESSMENT; TUBE GROWTH; FRUIT-SET; DISPERSAL; POPULATION; L.; HYBRIDIZATION; NEIGHBORHOOD	Background/Objective: Despite potential benefits granted by genetically modified (GM) fruit trees, their release and commercialization raises concerns about their potential environmental impact, and the transfer via pollen of transgenes to cross-compatible cultivars is deemed to be the greatest source for environmental exposure. Information compiled from field trials on GM trees is essential to propose measures to minimize the transgene dispersal. We have conducted a field trial of seven consecutive years to investigate the maximum frequency of pollen-mediated crop-to-crop transgene flow in a citrus orchard, and its relation to the genetic, phenological and environmental factors involved. Methodology/Principal Findings: Three different citrus genotypes carrying the uidA (GUS) tracer marker gene (pollen donors) and a non-GM self-incompatible contiguous citrus genotype (recipient) were used in conditions allowing natural entomophilous pollination to occur. The examination of 603 to 2990 seeds per year showed unexpectedly low frequencies (0.17-2.86%) of transgene flow. Paternity analyses of the progeny of subsets of recipient plants using 10 microsatellite (SSR) loci demonstrated a higher mating competence of trees from another non-GM pollen source population that greatly limited the mating chance of the contiguous cross-compatible and flowering-synchronized transgenic pollen source. This mating superiority could be explained by a much higher pollen competition capacity of the non-GM genotypes, as was confirmed through mixed-hand pollinations. Conclusions/Significance: Pollen competition strongly contributed to transgene confinement. Based on this finding, suitable isolation measures are proposed for the first time to prevent transgene outflow between contiguous plantings of citrus types that may be extendible to other entomophilous transgenic fruit tree species.	[Pons, Elsa; Navarro, Antonio; Ollitrault, Patrick; Pena, Leandro] Inst Valenciano Invest Agr, Ctr Protecc Vegetal & Biotecnol, Valencia, Spain; [Ollitrault, Patrick] Ctr Cooperat Int Rech Agron Dev CIRAD, UPR Ameliorat Genet Especes Multiplicat Vegetat, Montpellier, France	Instituto Valenciano de Investigaciones Agrarias (IVIA); CIRAD	Pons, E (corresponding author), Inst Valenciano Invest Agr, Ctr Protecc Vegetal & Biotecnol, Valencia, Spain.	lpenya@ivia.es	Pons Bayarri, Elsa/J-5403-2016; Peña, Leandro/F-9089-2014	Pons Bayarri, Elsa/0000-0002-2736-9276; Peña, Leandro/0000-0002-9853-366X; Ollitrault, Patrick/0000-0002-9456-5517	Fondo Europeo de Desarrollo Regional (FEDER) [AGL2009-08052]; Ministerio de Ciencia e Innovacion (MICINN)	Fondo Europeo de Desarrollo Regional (FEDER)(European CommissionSpanish Government); Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This research was supported by grant AGL2009-08052, co-financed by the Fondo Europeo de Desarrollo Regional (FEDER) and the Ministerio de Ciencia e Innovacion (MICINN). Elsa Pons was a recipient of a PhD fellowship from the MICINN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti M., 1997, Fruits (Paris), V52, P287; Aldridge G, 2006, AM J BOT, V93, P903, DOI 10.3732/ajb.93.6.903; Aleza P, 2010, PLANT CELL REP, V29, P1023, DOI 10.1007/s00299-010-0888-7; Aleza P, 2011, ANN BOT-LONDON, V108, P37, DOI 10.1093/aob/mcr099; [Anonymous], 1877, DIFFERENT FORMS FLOW; Bock Anne-Katrin, 2002, SCENARIOS COEXISTENC; Bossart JL, 1998, TRENDS ECOL EVOL, V13, P202, DOI 10.1016/S0169-5347(97)01284-6; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Breton C, 2006, J BIOGEOGR, V33, P1916, DOI 10.1111/j.1365-2699.2006.01544.x; Cameron JW, 1968, CITRUS IND, V1, P325; CAMPBELL DR, 1985, EVOLUTION, V39, P418, DOI [10.2307/2408374, 10.1111/j.1558-5646.1985.tb05678.x]; Carney SE, 1996, EVOLUTION, V50, P1871, DOI [10.2307/2410745, 10.1111/j.1558-5646.1996.tb03574.x]; Cervera M, 2000, THEOR APPL GENET, V100, P670, DOI 10.1007/s001220051338; Chandler S, 2008, CRIT REV PLANT SCI, V27, P25, DOI 10.1080/07352680802053916; Chapman MA, 2006, NEW PHYTOL, V170, P429, DOI 10.1111/j.1469-8137.2006.01710.x; Coart E, 2003, MOL ECOL, V12, P845, DOI 10.1046/j.1365-294X.2003.01778.x; Cottrell JE, 2009, HEREDITY, V103, P118, DOI 10.1038/hdy.2009.39; Cuenca J, 2010, HEREDITY IN PRESS; de Jong TJ, 2005, ACTA OECOL, V28, P331, DOI 10.1016/j.actao.2005.07.001; DEGANI C, 1995, J AM SOC HORTIC SCI, V120, P523, DOI 10.21273/JASHS.120.3.523; DEGANI C, 1990, HORTSCIENCE, V25, P471, DOI 10.21273/HORTSCI.25.4.471; Delph LF., 1998, SPERM COMPETITION SE, P149, DOI [10.1016/B978-012100543-6/50030-1, DOI 10.1016/B978-012100543-6/50030-1]; ENNOS RA, 1994, HEREDITY, V72, P250, DOI 10.1038/hdy.1994.35; FitzJohn RG, 2007, EUPHYTICA, V158, P209, DOI 10.1007/s10681-007-9444-0; FREE JB, 1960, J ANIM ECOL, V29, P385, DOI 10.2307/2211; Froelicher Y, 2008, MOL ECOL RESOUR, V8, P119, DOI 10.1111/j.1471-8286.2007.01893.x; Garcia C, 2005, MOL ECOL, V14, P1821, DOI 10.1111/j.1365-294X.2005.02542.x; Ghazoul J, 2005, BIOL REV, V80, P413, DOI 10.1017/S1464793105006731; Howard DJ, 1998, ENDLESS FORMS, P279; Howard DJ, 1999, ANNU REV ECOL SYST, V30, P109, DOI 10.1146/annurev.ecolsys.30.1.109; Jackson JF, 1996, SEX PLANT REPROD, V9, P367, DOI 10.1007/BF02441958; Jia HJ, 2008, J INTEGR PLANT BIOL, V50, P203, DOI 10.1111/j.1744-7909.2007.00382.x; Jorgensen RB, 2005, BIOL SCI SER, P113; Kijas JMH, 1997, THEOR APPL GENET, V94, P701, DOI 10.1007/s001220050468; Levin D. A., 1974, EVOL BIOL, V7, P139, DOI DOI 10.1007/978-1-4615-6944-2_5; LEVIN DA, 1969, EVOLUTION, V23, P560, DOI 10.1111/j.1558-5646.1969.tb03541.x; LEVIN DA, 1981, ANN MO BOT GARD, V68, P233, DOI 10.2307/2398797; Lu BR, 2009, BIOTECHNOL ADV, V27, P1083, DOI 10.1016/j.biotechadv.2009.05.018; Lu BaoRong, 2009, Biodiversity Science, V17, P362, DOI 10.3724/SP.J.1003.2009.09132; LUBY JJ, 1995, THEOR APPL GENET, V90, P1133, DOI 10.1007/BF00222933; MARSHALL DL, 1991, ANNU REV ECOL SYST, V22, P37, DOI 10.1146/annurev.es.22.110191.000345; Mateu, 2003, REV EPIDEM MED PREV, V1, P8; Matsumoto S, 2008, SCI HORTIC-AMSTERDAM, V117, P151, DOI 10.1016/j.scienta.2008.03.025; MCGARVEY P, 1991, BIOTECHNIQUES, V11, P428; MOFFETT J O, 1974, American Bee Journal, V114, P21; Mulas M., 2008, Informatore Agrario, V64, P57; National Research Council, 2010, STRAT PLANN FLOR CIT; Niesenbaum RA, 1997, SEX PLANT REPROD, V10, P101, DOI 10.1007/s004970050074; NRC (National Research Council), 2000, GEN MOD PESTPR PLANT; Pasquet RS, 2008, P NATL ACAD SCI USA, V105, P13456, DOI 10.1073/pnas.0806040105; Pena L, 2008, COMPENDIUM TRANSGENI, P1; Ricroch A, 2009, CR BIOL, V332, P861, DOI 10.1016/j.crvi.2009.07.001; Rieseberg LH, 1998, NEW PHYTOL, V140, P599, DOI 10.1046/j.1469-8137.1998.00315.x; RIESEBERG LH, 1995, AM J BOT, V82, P515, DOI 10.2307/2445699; Saeglitz C, 2000, MOL ECOL, V9, P2035, DOI 10.1046/j.1365-294X.2000.01109.x; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; SNOW AA, 1994, AM NAT, V144, pS69, DOI 10.1086/285653; Soost R. K., 1975, Advances in fruit breeding. Subtropical fruits., P507; Wallace HM, 2002, HORTSCIENCE, V37, P84, DOI 10.21273/HORTSCI.37.1.84; Wallace HM, 1999, J HORTIC SCI BIOTECH, V74, P82, DOI 10.1080/14620316.1999.11511077; Waser N.M., 1983, P277; Williams JH, 1999, P NATL ACAD SCI USA, V96, P9201, DOI 10.1073/pnas.96.16.9201; WILLSON MF, 1979, AM NAT, V113, P777, DOI 10.1086/283437	63	10	12	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25810	10.1371/journal.pone.0025810	http://dx.doi.org/10.1371/journal.pone.0025810			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991359	Green Published, gold			2022-12-27	WOS:000295943000076
J	Rai, MF; Graeve, T; Twardziok, S; Schmidt, MFG				Rai, Muhammad Farooq; Graeve, Thomas; Twardziok, Sven; Schmidt, Michael F. G.			Evidence for Regulated Interleukin-4 Expression in Chondrocyte-Scaffolds under In Vitro Inflammatory Conditions	PLOS ONE			English	Article							NF-KAPPA-B; ARTICULAR-CARTILAGE; GENE-TRANSFER; OSTEOARTHRITIS; CYTOKINES; IL-4; ARTHRITIS; MEDIATORS; RECEPTOR; DEFECTS	Objective: To elucidate the anti-inflammatory and anabolic effects of regulated expression of IL-4 in chondrocyte-scaffolds under in vitro inflammatory conditions. Methods: Mature articular chondrocytes from dogs (n = 3) were conditioned through transient transfection using pcDNA3.1. cIL-4 (constitutive) or pCOX-2. cIL-4 (cytokine-responsive) plasmids. Conditioned cells were seeded in alginate microspheres and rat-tail collagen type I matrix (CaReS (R)) to generate two types of tissue-engineered 3-dimensional scaffolds. Inflammatory arthritis was simulated in the packed chondrocytes through exogenous addition of recombinant canine (rc) IL-1 beta (100 ng/ml) plus rcTNF alpha (50 ng/ml) in culture media for 96 hours. Harvested cells and culture media were analyzed by various assays to monitor the anti-inflammatory and regenerative (anabolic) properties of cIL-4. Results: cIL-4 was expressed from COX-2 promoter exclusively on the addition of rcIL-1 beta and rcTNF alpha while its expression from CMV promoter was constitutive. The expressed cIL-4 downregulated the mRNA expression of IL-1 beta, TNF alpha, IL-6, iNOS and COX-2 in the cells and inhibited the production of NO and PGE(2) in culture media. At the same time, it up-regulated the expression of IGF-1, IL-1ra, COL2a1 and aggrecan in conditioned chondrocytes in both scaffolds along with a diminished release of total collagen and sGAG into the culture media. An increased amount of cIL-4 protein was detected both in chondrocyte cell lysate and in concentrated culture media. Neutralizing anti-cIL-4 antibody assay confirmed that the anti-inflammatory and regenerative effects seen are exclusively driven by cIL-4. There was a restricted expression of IL-4 under COX-2 promoter possibly due to negative feedback loop while it was over-expressed under CMV promoter (undesirable). Furthermore, the anti-inflammatory/anabolic outcomes from both scaffolds were reproducible and the therapeutic effects of cIL-4 were both scaffold-and promoter-independent. Conclusions: Regulated expression of therapeutic candidate gene(s) coupled with suitable scaffold(s) could potentially serve as a useful tissue-engineering tool to devise future treatment strategies for osteoarthritis.	[Rai, Muhammad Farooq; Graeve, Thomas; Schmidt, Michael F. G.] Free Univ Berlin, Inst Immunol & Mol Biol, Dept Vet Med, Berlin, Germany; Amedrix GmbH, Esslingen, Germany; [Twardziok, Sven] Charite, Inst Mol Biol & Bioinformat, D-13353 Berlin, Germany	Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Rai, MF (corresponding author), Washington Univ, Sch Med, Dept Orthopaed Surg, Sch Med,Barnes Jewish Hosp, St Louis, MO 63130 USA.	schmidt.mfg@vetmed.fu-berlin.de	Farooq, Muhammad/ABE-6335-2021	Rai, Muhammad Farooq/0000-0003-4826-4331; Twardziok, Sven/0000-0002-0326-5704	Freie Universitat Berlin, Germany; DFG [Schm 442/11-2]	Freie Universitat Berlin, Germany; DFG(German Research Foundation (DFG))	This study was supported through Freie Universitat Berlin, Germany albeit the initiating work was funded by the DFG through project Schm 442/11-2 to MFGS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CaReS matrix were provided by Amedrix Esslingen, Germany.	Amos N, 2006, RHEUMATOLOGY, V45, P1201, DOI 10.1093/rheumatology/kel078; Andereya S, 2007, Z ORTHOP UNFALLCHIR, V145, P139, DOI 10.1055/s-2007-965181; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Chomarat P, 1998, Int Rev Immunol, V17, P1, DOI 10.3109/08830189809084486; CHOMARAT P, 1995, J IMMUNOL, V154, P1432; Dare EV, 2009, TISSUE ENG PT A, V15, P2285, DOI 10.1089/ten.tea.2008.0228; Fernandes JC, 2002, BIORHEOLOGY, V39, P237; Fosang AJ, 1996, FEBS LETT, V380, P17, DOI 10.1016/0014-5793(95)01539-6; Frenkel SR, 2004, ANN BIOMED ENG, V32, P26, DOI 10.1023/B:ABME.0000007788.41804.0d; Fukui N, 2003, J BONE JOINT SURG AM, V85A, P59, DOI 10.2106/00004623-200300003-00011; Garvican ER, 2010, J ORTHOP RES, V28, P370, DOI 10.1002/jor.21001; GENG Y, 1995, J IMMUNOL, V155, P796; Geurts J, 2007, GENE THER, V14, P1632, DOI 10.1038/sj.gt.3303022; Goldring MB, 1999, CONNECT TISSUE RES, V40, P1, DOI 10.3109/03008209909005273; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Hardingham T, 2002, ARTHRITIS RES THER, V4, pS63, DOI 10.1186/ar561; Hegemann N, 2005, VET COMP ORTHOPAED, V18, P67, DOI 10.1055/s-0038-1632931; Hennerbichler A, 2008, ARCH ORTHOP TRAUM SU, V128, P61, DOI 10.1007/s00402-007-0360-5; Jovanovic D, 1998, OSTEOARTHR CARTILAGE, V6, P40, DOI 10.1053/joca.1997.0091; Lubberts E, 1999, J IMMUNOL, V163, P4546; Madry H, 2003, J GENE MED, V5, P502, DOI 10.1002/jgm.368; Malda J, 2003, CRIT REV BIOTECHNOL, V23, P175, DOI 10.1080/714037688; Manna SK, 1998, J BIOL CHEM, V273, P33333, DOI 10.1074/jbc.273.50.33333; Marcacci M, 2005, CLIN ORTHOP RELAT R, P96, DOI 10.1097/01.blo.0000165737.87628.5b; Marlovits S, 2006, EUR J RADIOL, V57, P24, DOI 10.1016/j.ejrad.2005.08.009; Martel-Pelletier J, 1999, FRONT BIOSCI, V4, pD694; Masuko-Hongo K, 2004, ARTHRITIS RHEUM-US, V50, P2829, DOI 10.1002/art.20437; Nuki G, 1999, OSTEOARTHRITIS CLIN, P101; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; Pelletier JP, 2001, ARTHRITIS RHEUM-US, V44, P1237, DOI 10.1002/1529-0131(200106)44:6<1237::AID-ART214>3.0.CO;2-F; Pelletier JP, 2000, ARTHRITIS ALLIED CON, P2195; Rachakonda PS, 2008, CYTOKINE, V44, P179, DOI 10.1016/j.cyto.2008.07.470; Rachakonda PS, 2008, ARTHRITIS RHEUM-US, V58, P2088, DOI 10.1002/art.23598; Rai MF, 2008, CYTOKINE, V42, P8, DOI 10.1016/j.cyto.2008.02.004; Rai MF, 2009, RES VET SCI, V87, P399, DOI 10.1016/j.rvsc.2009.04.008; Relic B, 2001, J IMMUNOL, V166, P2775, DOI 10.4049/jimmunol.166.4.2775; Salter DM, 2002, BIORHEOLOGY, V39, P97; Samuels J, 2008, BULL HOSP JT DIS, V66, P244; Sandell LJ, 2001, ARTHRITIS RES, V3, P107, DOI 10.1186/ar148; Schulz RM, 2008, BIO-MED MATER ENG, V18, pS55; SEITZ M, 1994, BRIT J RHEUMATOL, V33, P613; Studer RK, 2004, OSTEOARTHR CARTILAGE, V12, P863, DOI 10.1016/j.joca.2004.07.005; Van den Berg Wim B, 2002, Curr Rheumatol Rep, V4, P232; Watanabe S, 2000, MOL THER, V2, P147, DOI 10.1006/mthe.2000.0111; Welsch GH, 2010, AM J SPORT MED, V38, P934, DOI 10.1177/0363546509354971; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Williams CJ, 1999, OSTEOARTHRITIS CLIN, P134; Wondimu A, 2001, CYTOKINE, V16, P88, DOI 10.1006/cyto.2001.0953; Woods JM, 2001, J IMMUNOL, V166, P1214, DOI 10.4049/jimmunol.166.2.1214; Yanez JA, 2008, J MED SCI, V8, P98	50	14	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25749	10.1371/journal.pone.0025749	http://dx.doi.org/10.1371/journal.pone.0025749			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991344	Green Published, Green Submitted, gold			2022-12-27	WOS:000295943000063
J	Chen, GF; Zhang, CY; Zhang, BY; Wang, GC; Lu, DD; Xu, Z; Yan, PS				Chen, Guofu; Zhang, Chunyu; Zhang, Baoyu; Wang, Guangce; Lu, Douding; Xu, Zhong; Yan, Peishen			Development of a PNA Probe for Fluorescence In Situ Hybridization Detection of Prorocentrum donghaiense	PLOS ONE			English	Article							RNA-TARGETED PROBES; DINOFLAGELLATES ALEXANDRIUM-TAMARENSE; PSEUDO-NITZSCHIA-AUSTRALIS; NUCLEIC-ACID PNA; RIBOSOMAL-RNA; SANDWICH HYBRIDIZATION; WHOLE-CELL; RAPID IDENTIFICATION; HETEROSIGMA-AKASHIWO; SEQUENCE-ANALYSIS	Prorocentrum donghaiense is a common but dominant harmful algal bloom (HAB) species, which is widely distributed along the China Sea coast. Development of methods for rapid and precise identification and quantification is prerequisite for early-stage warning and monitoring of blooms due to P. donghaiense. In this study, sequences representing the partial large subunit rDNA (D1-D2), small subunit rDNA and internal transcribed spacer region (ITS-1, 5.8S rDNA and ITS-2) of P. donghaiense were firstly obtained, and then seven candidate DNA probes were designed for performing fluorescence in situ hybridization (FISH) tests on P. donghaiense. Based on the fluorescent intensity of P. donghaiense cells labeled by the DNA probes, the probe DP0443A displayed the best hybridization performance. Therefore, a PNA probe (PP0443A) analogous to DP0443A was used in the further study. The cells labeled with the PNA probe displayed more intensive green fluorescence than that labeled with its DNA analog. The PNA probe was used to hybridize with thirteen microalgae belonging to five families, i.e., Dinophyceae, Prymnesiophyceae, Raphidophyceae, Chlorophyceae and Bacillariophyceae, and showed no visible cross-reaction. Finally, FISH with the probes PP0443A and DP0443A and light microscopy (LM) analysis aiming at enumerating P. donghaiense cells were performed on the field samples. Statistical comparisons of the cell densities (cells/L) of P. donghaiense in the natural samples determined by FISH and LM were performed using one-way ANOVA and Duncan's multiple comparisons of the means. The P. donghaiense cell densities determined by LM and the PNA probe are remarkably higher than (p < 0.05) that determined by the DNA probe, while no significant difference is observed between LM and the PNA probe. All results suggest that the PNA probe is more sensitive that its DNA analog, and therefore is promising for the monitoring of harmful algal blooms of P. donghaiense in the future.	[Chen, Guofu; Zhang, Chunyu; Xu, Zhong; Yan, Peishen] Harbin Inst Technol, State Key Lab Urban Water Resource & Environm, Harbin 150006, Peoples R China; [Chen, Guofu; Zhang, Baoyu; Wang, Guangce] Tianjin Univ Sci & Technol, Tianjin Key Lab Marine Resources & Chem, Tianjin, Peoples R China; [Wang, Guangce] Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China; [Chen, Guofu] SOA, Inst Oceanog 1, Qingdao, Peoples R China; [Lu, Douding] SOA, Inst Oceanog 2, Hangzhou, Zhejiang, Peoples R China	Harbin Institute of Technology; Tianjin University Science & Technology; Chinese Academy of Sciences; Institute of Oceanology, CAS; State Oceanic Administration; State Oceanic Administration	Chen, GF (corresponding author), Harbin Inst Technol, State Key Lab Urban Water Resource & Environm, Harbin 150006, Peoples R China.	linmeng23@sohu.com; byzhang@163.com; gcwang@ms.qdio.ac.cn	Zhang, Chun-yu/HDP-5776-2022		Shangdong Province Young and Middle-Aged Scientists Research Awards Fund [2010BSA10004]; Foundation of Tianjin Key Laboratory of Marine Resources and Chemistry [200904]; Tianjin University of Science Technology [2010-027]; State Key Laboratory of Urban Water Resource and Environment, Harbin Institute of Technology [ES200802]; National Scientific foundation of China [41106082, 41176141]; Key Laboratory of Marine Ecology and Environmental Science and Engineering [MESE-2011-06]; Natural Scientific Research Innovation Foundation in Harbin Institute of Technology [HIT.NSRIF.200808]; Harbin Institute of Techonology	Shangdong Province Young and Middle-Aged Scientists Research Awards Fund; Foundation of Tianjin Key Laboratory of Marine Resources and Chemistry; Tianjin University of Science Technology; State Key Laboratory of Urban Water Resource and Environment, Harbin Institute of Technology(Harbin Institute of Technology); National Scientific foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Marine Ecology and Environmental Science and Engineering; Natural Scientific Research Innovation Foundation in Harbin Institute of Technology(Harbin Institute of Technology); Harbin Institute of Techonology	This work was supported by Shangdong Province Young and Middle-Aged Scientists Research Awards Fund (2010BSA10004); the Foundation (No. 200904) of Tianjin Key Laboratory of Marine Resources and Chemistry; Tianjin University of Science & Technology, Technology and Development Program of Weihai (2010-027); Open Project of State Key Laboratory of Urban Water Resource and Environment, Harbin Institute of Technology (ES200802); National Scientific foundation of China (No. 41106082, 41176141); Key Laboratory of Marine Ecology and Environmental Science and Engineering (MESE-2011-06); Natural Scientific Research Innovation Foundation in Harbin Institute of Technology (HIT.NSRIF.200808); and Program of Excellent Team in Harbin Institute of Techonology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 1996, J PHYCOL, V32, P1049, DOI 10.1111/j.0022-3646.1996.01049.x; Alm EW, 1996, APPL ENVIRON MICROB, V62, P3557, DOI 10.1128/AEM.62.10.3557-3559.1996; Anderson DM, 1999, J PHYCOL, V35, P870, DOI 10.1046/j.1529-8817.1999.3540870.x; Chen GF, 2011, CAHIERS BIO IN PRESS; Chen GF, 2008, J EXP MAR BIOL ECOL, V355, P66, DOI 10.1016/j.jembe.2007.12.012; Chen GF, 2007, CAH BIOL MAR, V48, P55; Chen J, 2009, ACTA OCEANOL SIN, V28, P121; Congestri R, 2008, PLANT BIOSYST, V142, P337, DOI 10.1080/11263500802150746; Connell L, 2006, AFR J MAR SCI, V28, P237, DOI 10.2989/18142320609504154; Connell LB, 2000, MAR BIOL, V136, P953, DOI 10.1007/s002270000314; Diercks S, 2008, HARMFUL ALGAE, V7, P137, DOI 10.1016/j.hal.2007.06.005; EGHOLM M, 1993, NATURE, V365, P566, DOI 10.1038/365566a0; EMBLEY TM, 1992, J GEN MICROBIOL, V138, P1479, DOI 10.1099/00221287-138-7-1479; FIELD KG, 1988, SCIENCE, V239, P748, DOI 10.1126/science.3277277; Fuchs BM, 1998, APPL ENVIRON MICROB, V64, P4973; Grzebyk D, 1998, J PHYCOL, V34, P1055, DOI 10.1046/j.1529-8817.1998.341055.x; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Hallegraeff G.M., 2003, Monographs on Oceanographic Methodology, V11, P25; Hosoi-Tanabe S, 2006, FISHERIES SCI, V72, P77, DOI 10.1111/j.1444-2906.2006.01119.x; Hosoi-Tanabe S, 2005, HARMFUL ALGAE, V4, P319, DOI 10.1016/j.hal.2004.04.002; Huang BQ, 2008, HARMFUL ALGAE, V7, P495, DOI 10.1016/j.hal.2007.11.006; KIM SK, 1993, J AM CHEM SOC, V115, P6477, DOI 10.1021/ja00068a001; Litaker RW, 2002, J PHYCOL, V38, P442, DOI 10.1046/j.1529-8817.2002.t01-1-01242.x; Lu DD, 2005, HARMFUL ALGAE, V4, P493, DOI 10.1016/j.hal.2004.08.015; LU DD, 2003, CHINESE J APPL ECOLO, V14, P1060; Lu Dou-ding, 2001, Chinese Journal of Oceanology and Limnology, V19, P337; Mikulski CM, 2008, HARMFUL ALGAE, V7, P347, DOI 10.1016/j.hal.2007.12.015; Miller PE, 1998, J PHYCOL, V34, P371, DOI 10.1046/j.1529-8817.1998.340371.x; NIELSEN PE, 1994, BIOCONJUGATE CHEM, V5, P3, DOI 10.1021/bc00025a001; NIELSEN PE, 1991, SCIENCE, V254, P1497, DOI 10.1126/science.1962210; Park TG, 2010, HARMFUL ALGAE, V9, P59, DOI 10.1016/j.hal.2009.08.002; QI Y, 2003, CHIN J APPL ECOL, V14, P1188; Sako Y, 2004, J PHYCOL, V40, P598, DOI 10.1111/j.1529-8817.2004.03035.x; SCHLOTTERER C, 1994, MOL BIOL EVOL, V11, P513; Scholin C, 1997, LIMNOL OCEANOGR, V42, P1265, DOI 10.4319/lo.1997.42.5_part_2.1265; Scholin CA, 1996, PHYCOLOGIA, V35, P190, DOI 10.2216/i0031-8884-35-3-190.1; SCHOLIN CA, 1994, J PHYCOL, V30, P999, DOI 10.1111/j.0022-3646.1994.00999.x; Sen S, 1998, J AM CHEM SOC, V120, P619, DOI 10.1021/ja972234x; [石彦红 SHI Yanhong], 2010, [中国水产科学, Journal of Fishery Sciences of China], V17, P267; STEANE DA, 1991, J PHYCOL, V27, P758, DOI 10.1111/j.0022-3646.1991.00758.x; Tyrrell John V., 2002, Harmful Algae, V1, P205, DOI 10.1016/S1568-9883(02)00012-4; Tyrrell JV, 2001, PHYCOLOGIA, V40, P457, DOI 10.2216/i0031-8884-40-5-457.1; Ulrich RM, 2010, HARMFUL ALGAE, V9, P116, DOI 10.1016/j.hal.2009.08.010; Wang DZ, 2007, J APPL PHYCOL, V19, P325, DOI 10.1007/s10811-006-9139-2; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Worden AZ, 2003, J PHYCOL, V39, P527, DOI 10.1046/j.1529-8817.2003.01248.x; Worden AZ, 2000, APPL ENVIRON MICROB, V66, P284, DOI 10.1128/AEM.66.1.284-289.2000; [张宝玉 Zhang bao yu], 2005, [高技术通讯, High Technology Letters], V15, P101; Zhang FY, 2009, HARMFUL ALGAE, V8, P839, DOI 10.1016/j.hal.2009.03.004; Zhen Y, 2009, HARMFUL ALGAE, V8, P651, DOI 10.1016/j.hal.2008.12.001; Zhou M., 2007, CHIN J NAT, V29, P72, DOI DOI 10.3969/j.issn.0253-9608.2007.02.003	51	21	23	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e25527	10.1371/journal.pone.0025527	http://dx.doi.org/10.1371/journal.pone.0025527			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022408	Green Published, gold, Green Submitted			2022-12-27	WOS:000295981600009
J	Tan, G; Pan, SH; Li, J; Dong, XS; Kang, K; Zhao, MY; Jiang, X; Kanwar, JR; Qiao, HQ; Jiang, HC; Sun, XY				Tan, Gang; Pan, Shangha; Li, Jie; Dong, Xuesong; Kang, Kai; Zhao, Mingyan; Jiang, Xian; Kanwar, Jagat R.; Qiao, Haiquan; Jiang, Hongchi; Sun, Xueying			Hydrogen Sulfide Attenuates Carbon Tetrachloride-Induced Hepatotoxicity, Liver Cirrhosis and Portal Hypertension in Rats	PLOS ONE			English	Article							MYOCARDIAL-ISCHEMIA; REPERFUSION INJURY; 3RD GAS; H2S; VASORELAXATION; PATHOGENESIS; CONTRIBUTES; FIBROSIS; STRESS	Background: Hydrogen sulfide (H2S) displays vasodilative, anti-oxidative, anti-inflammatory and cytoprotective activities. Impaired production of H2S contributes to the increased intrahepatic resistance in cirrhotic livers. The study aimed to investigate the roles of H2S in carbon tetrachloride (CCl4)-induced hepatotoxicity, cirrhosis and portal hypertension. Methods and Findings: Sodium hydrosulfide (NaHS), a donor of H2S, and DL-propargylglycine (PAG), an irreversible inhibitor of cystathionine gamma-lyase (CSE), were applied to the rats to investigate the effects of H2S on CCl4-induced acute hepatotoxicity, cirrhosis and portal hypertension by measuring serum levels of H2S, hepatic H2S producing activity and CSE expression, liver function, activity of cytochrome P450 (CYP) 2E1, oxidative and inflammatory parameters, liver fibrosis and portal pressure. CCl4 significantly reduced serum levels of H2S, hepatic H2S production and CSE expression. NaHS attenuated CCl4-induced acute hepatotoxicity by supplementing exogenous H2S, which displayed anti-oxidative activities and inhibited the CYP2E1 activity. NaHS protected liver function, attenuated liver fibrosis, inhibited inflammation, and reduced the portal pressure, evidenced by the alterations of serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), hyaluronic acid (HA), albumin, tumor necrosis factor (TNF)-alpha, interleukin (IL)-1 beta, IL-6 and soluble intercellular adhesion molecule (ICAM)-1, liver histology, hepatic hydroxyproline content and a-smooth muscle actin (SMA) expression. PAG showed opposing effects to NaHS on most of the above parameters. Conclusions: Exogenous H2S attenuates CCl4-induced hepatotoxicity, liver cirrhosis and portal hypertension by its multiple functions including anti-oxidation, anti-inflammation, cytoprotection and anti-fibrosis, indicating that targeting H2S may present a promising approach, particularly for its prophylactic effects, against liver cirrhosis and portal hypertension.	[Tan, Gang; Pan, Shangha; Dong, Xuesong; Jiang, Xian; Qiao, Haiquan; Jiang, Hongchi; Sun, Xueying] Harbin Med Univ, Affiliated Hosp 1, Dept Gen Surg, Hepatosplen Surg Ctr, Harbin, Peoples R China; [Kang, Kai; Zhao, Mingyan] Harbin Med Univ, Affiliated Hosp 1, Dept ICU, Harbin, Peoples R China; [Li, Jie] Shandong Univ, Affiliated Qianfoshan Hosp, Dept Hepatobiliary Surg, Jinan 250100, Peoples R China; [Kanwar, Jagat R.] Deakin Univ, Lab Immunol & Mol Biomed Res, Ctr Biotechnol & Interdisciplinary Biosci, Inst Technol & Res Innovat, Geelong, Vic 3217, Australia; [Sun, Xueying] Univ Auckland, Dept Mol Med & Pathol, Fac Med & Hlth Sci, Auckland 1, New Zealand	Harbin Medical University; Harbin Medical University; Shandong University; Deakin University; University of Auckland	Tan, G (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Dept Gen Surg, Hepatosplen Surg Ctr, Harbin, Peoples R China.	jianghc@vip.163.com; k.sun@auckland.ac.nz	Jiang, HongChi/M-5031-2018; wang, jianqi/G-6194-2013	Jiang, HongChi/0000-0001-8215-8984; Sun, Xueying/0000-0002-8065-8747	National Natural Scientific Foundation of China [30872987, 30973474]; Heilongjiang Provincial Scientific and Technology Bureau, China [QC06C075]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Heilongjiang Provincial Scientific and Technology Bureau, China	Grants from the National Natural Scientific Foundation of China (30872987 and 30973474)(www.nsfc.gov.cn), and Heilongjiang Provincial Scientific and Technology Bureau, China (QC06C075)(http://www.hljkjt.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatia M, 2005, FASEB J, V19, P623, DOI 10.1096/fj.04-3023fje; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chang T K, 1998, Methods Mol Biol, V107, P147; Distrutti E, 2008, HEPATOLOGY, V47, P659, DOI 10.1002/hep.22037; Dranoff JA, 2010, HEPATOLOGY, V51, P1438, DOI 10.1002/hep.23405; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Fang LP, 2009, CAN J PHYSIOL PHARM, V87, P531, DOI [10.1139/Y09-039, 10.1139/y09-039]; Fiorucci S, 2007, DIGEST LIVER DIS, V39, P1043, DOI 10.1016/j.dld.2007.09.001; Fiorucci S, 2005, HEPATOLOGY, V42, P539, DOI 10.1002/hep.20817; Fiorucci S, 2006, GASTROENTEROLOGY, V131, P259, DOI 10.1053/j.gastro.2006.02.033; Fujii K, 2005, ANTIOXID REDOX SIGN, V7, P788, DOI 10.1089/ars.2005.7.788; Fukao T, 2004, BIOFACTORS, V21, P171, DOI 10.1002/biof.552210135; Gao Y, 2011, INT J CARDIOL, V152, P177, DOI 10.1016/j.ijcard.2010.07.012; Guidotti TL, 1996, OCCUP MED-OXFORD, V46, P367, DOI 10.1093/occmed/46.5.367; Hosono-Fukao T, 2009, J NUTR, V139, P2252, DOI 10.3945/jn.109.109611; Kabil O, 2011, ANTIOXID REDOX SIGN, V15, P363, DOI 10.1089/ars.2010.3781; Kang K, 2009, LIVER TRANSPLANT, V15, P1306, DOI 10.1002/lt.21810; Kimura Y, 2010, ANTIOXID REDOX SIGN, V12, P1, DOI 10.1089/ars.2008.2282; Li L, 2009, FREE RADICAL BIO MED, V47, P103, DOI 10.1016/j.freeradbiomed.2009.04.014; Lou LX, 2008, CLIN EXP PHARMACOL P, V35, P223, DOI 10.1111/j.1440-1681.2007.04812.x; Lowicka E, 2007, PHARMACOL REP, V59, P4; Morsy MA, 2010, LIFE SCI, V87, P692, DOI 10.1016/j.lfs.2010.10.004; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; PREDMORE BL, 2010, J AM COLL CARDIOL, V55, pA116; Siebert N, 2008, AM J PHYSIOL-GASTR L, V295, pG1266, DOI 10.1152/ajpgi.90484.2008; Sivarajah A, 2006, SHOCK, V26, P154, DOI 10.1097/01.shk.0000225722.56681.64; STEGEMAN.H, 1967, CLIN CHIM ACTA, V18, P267, DOI 10.1016/0009-8981(67)90167-2; Steib CJ, 2010, GUT, V59, P827, DOI 10.1136/gut.2009.197756; Weber LWD, 2003, CRIT REV TOXICOL, V33, P105, DOI 10.1080/713611034; Yonezawa D, 2007, TOXICOLOGY, V241, P11, DOI 10.1016/j.tox.2007.07.020; Yuan LY, 2009, MOL ASPECTS MED, V30, P29, DOI 10.1016/j.mam.2008.08.003; Zhang CY, 2003, BIOCHEM BIOPH RES CO, V302, P810, DOI 10.1016/S0006-291X(03)00256-0; Zhang LM, 2009, NEUROCHEM RES, V34, P1984, DOI 10.1007/s11064-009-0006-9; Zhang QY, 2004, BIOCHEM BIOPH RES CO, V317, P30, DOI 10.1016/j.bbrc.2004.02.176; Zhao WM, 2002, AM J PHYSIOL-HEART C, V283, pH474, DOI 10.1152/ajpheart.00013.2002; Zhong GZ, 2010, CARDIOLOGY, V115, P120, DOI 10.1159/000260073; Zhong GZ, 2003, J HYPERTENS, V21, P1879, DOI 10.1097/00004872-200310000-00015	37	93	100	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e25943	10.1371/journal.pone.0025943	http://dx.doi.org/10.1371/journal.pone.0025943			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022478	Green Published, Green Submitted, gold			2022-12-27	WOS:000295981600023
J	Palazzo, AL; Evensen, E; Huang, YW; Cesano, A; Nolan, GP; Fantl, WJ				Palazzo, Adam L.; Evensen, Erik; Huang, Ying-Wen; Cesano, Alessandra; Nolan, Garry P.; Fantl, Wendy J.			Association of Reactive Oxygen Species-Mediated Signal Transduction with In Vitro Apoptosis Sensitivity in Chronic Lymphocytic Leukemia B Cells	PLOS ONE			English	Article							GENE MUTATION STATUS; RECEPTOR-TYPE-O; NF-KAPPA-B; TYROSINE KINASE; DISEASE PROGRESSION; ANTIGEN RECEPTOR; THERAPEUTIC TARGET; CD38 EXPRESSION; FLOW-CYTOMETRY; GROWTH-FACTORS	Background: Chronic lymphocytic leukemia (CLL) is a B cell malignancy with a variable clinical course and unpredictable response to therapeutic agents. Single cell network profiling (SCNP) utilizing flow cytometry measures alterations in signaling biology in the context of molecular changes occurring in malignancies. In this study SCNP was used to identify proteomic profiles associated with in vitro apoptotic responsiveness of CLL B cells to fludarabine, as a basis for ultimately linking these with clinical outcome. Methodology/Principal Finding: SCNP was used to quantify modulated-signaling of B cell receptor (BCR) network proteins and in vitro F-ara-A mediated apoptosis in 23 CLL samples. Of the modulators studied the reactive oxygen species, hydrogen peroxide (H(2)O(2)), a known intracellular second messenger and a general tyrosine phosphatase inhibitor stratified CLL samples into two sub-groups based on the percentage of B cells in a CLL sample with increased phosphorylation of BCR network proteins. Separately, in the same patient samples, in vitro exposure to F-ara-A also identified two sub-groups with B cells showing competence or refractoriness to apoptotic induction. Statistical analysis showed that in vitro F-ara-A apoptotic proficiency was highly associated with the proficiency of CLL B cells to undergo H(2)O(2)-augmented signaling. Conclusions/Significance: This linkage in CLL B cells among the mechanisms governing chemotherapy-induced apoptosis increased signaling of BCR network proteins and a likely role of phosphatase activity suggests a means of stratifying patients for their response to F-ara-A based regimens. Future studies will examine the clinical applicability of these findings and also the utility of this approach in relating mechanism to function of therapeutic agents.	[Palazzo, Adam L.; Evensen, Erik; Huang, Ying-Wen; Cesano, Alessandra; Fantl, Wendy J.] Nodality Inc, San Francisco, CA USA; [Nolan, Garry P.; Fantl, Wendy J.] Stanford Univ, Baxter Lab Stem Cell Biol, Palo Alto, CA 94304 USA; [Nolan, Garry P.; Fantl, Wendy J.] Stanford Univ, Dept Microbiol & Immunol, Palo Alto, CA 94304 USA	Stanford University; Stanford University	Palazzo, AL (corresponding author), Nodality Inc, San Francisco, CA USA.	wjfantl@stanford.edu	Nolan, Garry/AAE-7903-2019	Huang, Ying-Wen/0000-0003-3727-7903; Nolan, Garry/0000-0002-8862-9043	Nodality, Inc.	Nodality, Inc.	This work was supported by research funding from Nodality, Inc. to WJF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoni L, 2007, NAT REV CANCER, V7, P925, DOI 10.1038/nrc2251; BREZSKI RJ, 2008, MULTICHAIN IMMUNE RE; Buchner M, 2009, CANCER RES, V69, P5424, DOI 10.1158/0008-5472.CAN-08-4252; Chen LG, 2008, BLOOD, V111, P2685, DOI 10.1182/blood-2006-12-062265; Chen LF, 2006, BLOOD, V108, P3428, DOI 10.1182/blood-2006-03-013821; Chiorazzi N, 2011, BLOOD, V117, P1781, DOI 10.1182/blood-2010-07-155663; Contri A, 2005, J CLIN INVEST, V115, P369, DOI 10.1172/JC1200522094; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; DOHNER H, 1995, BLOOD, V85, P1580, DOI 10.1182/blood.V85.6.1580.bloodjournal8561580; Du J., 2002, COMBINED ALGORITHMS; Efroni S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000425; Friedberg JW, 2010, BLOOD, V115, P2578, DOI 10.1182/blood-2009-08-236471; Fuentes-Panana EM, 2006, J IMMUNOL, V177, P7913, DOI 10.4049/jimmunol.177.11.7913; Gandhi V, 2002, CLIN PHARMACOKINET, V41, P93, DOI 10.2165/00003088-200241020-00002; Gauld SB, 2002, SCIENCE, V296, P1641, DOI 10.1126/science.1071546; Ghia P, 2008, J INTERN MED, V264, P549, DOI 10.1111/j.1365-2796.2008.02030.x; Ghia P, 2003, BLOOD, V101, P1262, DOI 10.1182/blood-2002-06-1801; Gobessi S, 2009, LEUKEMIA, V23, P686, DOI 10.1038/leu.2008.346; Gobessi S, 2007, BLOOD, V109, P2032, DOI 10.1182/blood-2006-03-011759; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Hamblin TJ, 2007, BEST PRACT RES CL HA, V20, P455, DOI 10.1016/j.beha.2007.02.001; Han L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007989; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hertlein E, 2008, BLOOD, V111, P4427, DOI 10.1182/blood-2008-02-137802; Hewamana S, 2008, BLOOD, V111, P4681, DOI 10.1182/blood-2007-11-125278; Irish JM, 2006, NAT REV CANCER, V6, P146, DOI 10.1038/nrc1804; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Irish JM, 2006, BLOOD, V108, P3135, DOI 10.1182/blood-2006-02-003921; Irish JM, 2006, J IMMUNOL, V177, P1581, DOI 10.4049/jimmunol.177.3.1581; Irish JM, 2010, P NATL ACAD SCI USA, V107, P12747, DOI 10.1073/pnas.1002057107; Jumaa H, 2005, ANNU REV IMMUNOL, V23, P415, DOI 10.1146/annurev.immunol.23.021704.115606; Kaplan D, 2010, CYTOM PART B-CLIN CY, V78B, P115, DOI 10.1002/cyto.b.20506; Kato Y, 2005, J EXP MED, V202, P169, DOI 10.1084/jem.20042541; Kay NE, 2007, LEUKEMIA, V21, P1885, DOI 10.1038/sj.leu.2404802; Kolb Jean-Pierre, 2003, Current Drug Targets - Cardiovascular & Haematological Disorders, V3, P261, DOI 10.2174/1568006033481384; Kornblau SM, 2010, CLIN CANCER RES, V16, P3721, DOI 10.1158/1078-0432.CCR-10-0093; Kotecha N, 2008, CANCER CELL, V14, P335, DOI 10.1016/j.ccr.2008.08.014; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; Kraus M, 2001, J EXP MED, V194, P455, DOI 10.1084/jem.194.4.455; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; Monroe JG, 2006, NAT REV IMMUNOL, V6, P283, DOI 10.1038/nri1808; Motiwala T, 2007, CLIN CANCER RES, V13, P3174, DOI 10.1158/1078-0432.CCR-06-1720; Rao GN, 1997, CELL SIGNAL, V9, P181, DOI 10.1016/S0898-6568(96)00139-8; Rassenti LZ, 2008, BLOOD, V112, P1923, DOI 10.1182/blood-2007-05-092882; Rassenti LZ, 2004, NEW ENGL J MED, V351, P893, DOI 10.1056/NEJMoa040857; Reth M, 2002, NAT IMMUNOL, V3, P1129, DOI 10.1038/ni1202-1129; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Rolli V, 2002, MOL CELL, V10, P1057, DOI 10.1016/S1097-2765(02)00739-6; Rosen DB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013543; Rosen DB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012405; Sattler M, 1999, BLOOD, V93, P2928; Singh DK, 2005, CELL, V121, P281, DOI 10.1016/j.cell.2005.02.036; Smith SH, 2004, MOL CELL, V14, P696, DOI 10.1016/j.molcel.2004.06.015; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Tam CS, 2009, BLOOD, V114, P957, DOI 10.1182/blood-2009-03-210591; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Wienands J, 1996, P NATL ACAD SCI USA, V93, P7865, DOI 10.1073/pnas.93.15.7865; Xiao WB, 2009, CANCER CELL, V16, P161, DOI 10.1016/j.ccr.2009.05.018	62	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e24592	10.1371/journal.pone.0024592	http://dx.doi.org/10.1371/journal.pone.0024592			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016760	Green Submitted, gold, Green Published			2022-12-27	WOS:000295971700001
J	Chen, LN; Liu, JN; Xu, CS; Keblesh, J; Zang, WJ; Xiong, HG				Chen, Lina; Liu, Jianuo; Xu, Changshui; Keblesh, James; Zang, Weijin; Xiong, Huangui			HIV-1gp120 Induces Neuronal Apoptosis through Enhancement of 4-Aminopyridine-Senstive Outward K+ Currents	PLOS ONE			English	Article							PROTEIN-KINASE-C; PROSTATE-CANCER CELLS; CHEMOKINE RECEPTOR CXCR4; CEREBELLAR GRANULE CELL; ESTER-INDUCED APOPTOSIS; HIV-ASSOCIATED DEMENTIA; CENTRAL-NERVOUS-SYSTEM; NEUROCOGNITIVE DISORDERS; GP120 NEUROTOXICITY; HIPPOCAMPAL-NEURONS	Human immunodeficiency virus type 1 (HIV-1)-associated dementia (HAD) usually occurs late in the course of HIV-1 infection and the mechanisms underlying HAD pathogenesis are not well understood. Accumulating evidence indicates that neuronal voltage-gated potassium (Kv) channels play an important role in memory processes and acquired neuronal channelopathies in HAD. To examine whether Kv channels are involved in HIV-1-associated neuronal injury, we studied the effects of HIV-1 glycoprotein 120 (gp120) on outward K+ currents in rat cortical neuronal cultures using whole-cell patch techniques. Exposure of cortical neurons to gp120 produced a dose-dependent enhancement of A-type transient outward K+ currents (IA). The gp120-induced increase of IA was attenuated by T140, a specific antagonist for chemokine receptor CXCR4, suggesting gp120 enhancement of neuronal IA via CXCR4. Pretreatment of neuronal cultures with a protein kinase C (PKC) inhibitor, GF109203X, inhibited the gp120-induced increase of IA. Biological significance of gp120 enhancement of IA was demonstrated by experimental results showing that gp120-induced neuronal apoptosis, as detected by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay and caspase-3 staining, was attenuated by either an IA blocker 4-aminopyridine or a specific CXCR4 antagonist T140. Taken together, these results suggest that gp120 may induce caspase-3 dependent neuronal apoptosis by enhancing IA via CXCR4-PKC signaling.	[Chen, Lina; Liu, Jianuo; Xu, Changshui; Keblesh, James; Xiong, Huangui] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Neurophysiol Lab, Omaha, NE 68198 USA; [Xiong, Huangui] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA; [Chen, Lina; Zang, Weijin] Xi An Jiao Tong Univ, Coll Med, Dept Pharmacol, Xian 710049, Peoples R China	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Xi'an Jiaotong University	Chen, LN (corresponding author), Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Neurophysiol Lab, Omaha, NE 68198 USA.	hxiong@unmc.edu			National Institutes of Health [2R01NS041862]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA028555] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by research grants by the National Institutes of Health: 2R01NS041862 to HX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquas E, 2004, NEUROTOX RES, V5, P605; AggounZouaoui D, 1996, NEUROREPORT, V7, P433, DOI 10.1097/00001756-199601310-00014; Alkon DL, 2007, TRENDS PHARMACOL SCI, V28, P51, DOI 10.1016/j.tips.2006.12.002; Anderson E, 2002, JAIDS-J ACQ IMM DEF, V31, pS43, DOI 10.1097/00126334-200210012-00004; Anderson P, 1997, MICROBIOL MOL BIOL R, V61, P33, DOI 10.1128/.61.1.33-46.1997; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Bachis A, 2004, J NEUROSCI RES, V75, P75, DOI 10.1002/jnr.10826; Bachis A, 2003, J NEUROSCI, V23, P5715; Bansal AK, 2000, BRAIN RES, V879, P42, DOI 10.1016/S0006-8993(00)02725-6; BEAUVAIS F, 1995, J LEUKOCYTE BIOL, V57, P851, DOI 10.1002/jlb.57.6.851; Bonini JS, 2007, NEUROSCIENCE, V147, P37, DOI 10.1016/j.neuroscience.2007.04.013; Burg ED, 2006, J MEMBRANE BIOL, V209, P3, DOI 10.1007/s00232-005-0838-4; Catani MV, 2000, J NEUROCHEM, V74, P2373, DOI 10.1046/j.1471-4159.2000.0742373.x; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; Ekhterae D, 2001, AM J PHYSIOL-CELL PH, V281, pC157, DOI 10.1152/ajpcell.2001.281.1.C157; Everall IP, 1999, BRAIN PATHOL, V9, P209; FELIPO V, 1993, BRAIN RES, V604, P192, DOI 10.1016/0006-8993(93)90368-W; Ferrando S, 1998, AIDS, V12, pF65, DOI 10.1097/00002030-199808000-00002; Flavin MP, 1997, NEUROSCIENCE, V80, P437, DOI 10.1016/S0306-4522(97)00078-X; Fujii T, 2000, J BIOL CHEM, V275, P7574, DOI 10.1074/jbc.275.11.7574; Garden GA, 2002, J NEUROSCI, V22, P4015, DOI 10.1523/JNEUROSCI.22-10-04015.2002; Gelman BB, 2004, J NEUROIMMUNOL, V157, P111, DOI 10.1016/j.jneuroim.2004.08.044; GENDELMAN HE, 1994, J LEUKOCYTE BIOL, V56, P389, DOI 10.1002/jlb.56.3.389; Gonzalez-Guerrico AM, 2005, J BIOL CHEM, V280, P38982, DOI 10.1074/jbc.M506767200; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; Gray F, 2001, CLIN NEUROPATHOL, V20, P146; Hesselgesser J, 1998, CURR BIOL, V8, P595, DOI 10.1016/S0960-9822(98)70230-1; Hesselgesser J, 1999, J NEUROVIROL, V5, P13, DOI 10.3109/13550289909029741; Hu CL, 2008, J NEUROCHEM, V106, P1125, DOI 10.1111/j.1471-4159.2008.05449.x; Hu CL, 2006, NEUROPHARMACOLOGY, V51, P737, DOI 10.1016/j.neuropharm.2006.05.013; Hu DH, 2010, EUR J NEUROSCI, V31, P214, DOI 10.1111/j.1460-9568.2009.07063.x; Humphries MJ, 2006, J BIOL CHEM, V281, P9728, DOI 10.1074/jbc.M507851200; Ito Y, 2001, CELL DEATH DIFFER, V8, P794, DOI 10.1038/sj.cdd.4400886; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Keblesh J, 2009, J NEUROIMMUNE PHARM, V4, P60, DOI 10.1007/s11481-008-9106-6; Keblesh JP, 2009, J NEUROIMMUNE PHARM, V4, P317, DOI 10.1007/s11481-009-9161-7; KLEE R, 1995, J NEUROPHYSIOL, V74, P1982, DOI 10.1152/jn.1995.74.5.1982; LAURIE DJ, 1995, MOL BRAIN RES, V32, P94, DOI 10.1016/0169-328X(95)00067-3; Liu WS, 1998, CELL SIGNAL, V10, P529, DOI 10.1016/S0898-6568(98)00012-6; Masliah E, 1997, ANN NEUROL, V42, P963, DOI 10.1002/ana.410420618; MASLIAH E, 1992, J NEUROPATH EXP NEUR, V51, P585; McArthur JC, 2005, LANCET NEUROL, V4, P543, DOI 10.1016/S1474-4422(05)70165-4; McCutchan JA, 2007, AIDS, V21, P1109, DOI 10.1097/QAD.0b013e3280ef6acd; McLaughlin B, 2001, J NEUROSCI, V21, P3303, DOI 10.1523/JNEUROSCI.21-10-03303.2001; Meucci O, 1996, J NEUROSCI, V16, P4080; Meucci O, 1998, P NATL ACAD SCI USA, V95, P14500, DOI 10.1073/pnas.95.24.14500; Nelson TJ, 2009, TRENDS BIOCHEM SCI, V34, P136, DOI 10.1016/j.tibs.2008.11.006; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; Ohagen A, 1999, J VIROL, V73, P897, DOI 10.1128/JVI.73.2.897-906.1999; Parsons TD, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-11; PETITO CK, 1995, AM J PATHOL, V146, P1121; Redman PT, 2006, NEUROSCIENCE, V143, P1, DOI 10.1016/j.neuroscience.2006.08.039; Remillard CV, 2004, AM J PHYSIOL-LUNG C, V286, pL49, DOI 10.1152/ajplung.00041.2003; Reyland ME, 2007, BIOCHEM SOC T, V35, P1001, DOI 10.1042/BST0351001; Sa MJ, 2000, ACTA NEUROPATHOL, V99, P643, DOI 10.1007/s004010051175; Sacktor N, 2006, NEUROLOGY, V67, P311, DOI 10.1212/01.wnl.0000225183.74521.72; Schrader LA, 2006, AM J PHYSIOL-CELL PH, V290, pC852, DOI 10.1152/ajpcell.00358.2005; SEILHEAN D, 1993, NEUROLOGY, V43, P1492, DOI 10.1212/WNL.43.8.1492; Shen QJ, 2009, J NEUROSCI RES, V87, P3153, DOI 10.1002/jnr.22136; Singh IN, 2004, J NEUROVIROL, V10, P141, DOI 10.1080/13550280490441103; Tamamura H, 2003, ORG BIOMOL CHEM, V1, P3663, DOI 10.1039/b306613b; Tamamura H, 2004, FEBS LETT, V569, P99, DOI 10.1016/j.febslet.2004.05.056; Tanaka Y, 2003, J BIOL CHEM, V278, P33753, DOI 10.1074/jbc.M303313200; TOGGAS SM, 1994, NATURE, V367, P188, DOI 10.1038/367188a0; Xu Y, 2004, P NATL ACAD SCI USA, V101, P7070, DOI 10.1073/pnas.0304859101; Yu SP, 1997, SCIENCE, V278, P114, DOI 10.1126/science.278.5335.114; Yu SP, 2003, PROG NEUROBIOL, V70, P363, DOI 10.1016/S0301-0082(03)00090-X; Yuan LL, 2002, J NEUROSCI, V22, P4860, DOI 10.1523/JNEUROSCI.22-12-04860.2002; Zhu DM, 2004, NEUROTOX RES, V6, P281, DOI 10.1007/BF03033438	69	33	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25994	10.1371/journal.pone.0025994	http://dx.doi.org/10.1371/journal.pone.0025994			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22016798	Green Submitted, gold, Green Published			2022-12-27	WOS:000295970300046
J	Gotoh, K; Ito, Y; Maruo, S; Takada, K; Mizuno, T; Teranishi, M; Nakata, S; Nakashima, T; Iwata, S; Goshima, F; Nakamura, S; Kimura, H				Gotoh, Kensei; Ito, Yoshinori; Maruo, Seiji; Takada, Kenzo; Mizuno, Terukazu; Teranishi, Masaaki; Nakata, Seiichi; Nakashima, Tsutomu; Iwata, Seiko; Goshima, Fumi; Nakamura, Shigeo; Kimura, Hiroshi			Replication of Epstein-Barr Virus Primary Infection in Human Tonsil Tissue Explants	PLOS ONE			English	Article							HUMAN LYMPHOID-TISSUE; TIME PCR ASSAY; HUMAN CD34(+) CELLS; B-CELL; EBV INFECTION; LYMPHOPROLIFERATIVE DISEASE; QUANTITATIVE-ANALYSIS; IMMUNE-RESPONSES; MOUSE MODEL; EX-VIVO	Epstein-Barr virus (EBV) may cause a variety of virus-associated diseases, but no antiviral agents have yet been developed against this virus. Animal models are thus indispensable for the pathological analysis of EBV-related infections and the elucidation of therapeutic methods. To establish a model system for the study of EBV infection, we tested the ability of B95-8 virus and recombinant EBV expressing enhanced green fluorescent protein (EGFP) to replicate in human lymphoid tissue. Human tonsil tissues that had been surgically removed during routine tonsillectomy were sectioned into small blocks and placed on top of collagen sponge gels in culture medium at the air-interface, then a cell-free viral suspension was directly applied to the top of each tissue block. Increasing levels of EBV DNA in culture medium were observed after 12-15 days through 24 days post-infection in tissue models infected with B95-8 and EGFP-EBV. Expression levels of eight EBV-associated genes in cells collected from culture medium were increased during culture. EBV-encoded small RNA-positive cells were detected in the interfollicular areas in paraffin-embedded sections. Flow cytometric analyses revealed that most EGFP(+) cells were CD3(-) CD56(-) CD19(+) HLA-DR(+), and represented both naive (immunoglobulin D(+)) and memory (CD27(+)) B cells. Moreover, EBV replication in this model was suppressed by acyclovir treatment in a dose-dependent manner. These data suggest that this model has potential for use in the pathological analysis of local tissues at the time of primary infection, as well as for screening novel antiviral agents.	[Gotoh, Kensei; Ito, Yoshinori] Nagoya Univ, Grad Sch Med, Dept Pediat, Nagoya, Aichi 4648601, Japan; [Maruo, Seiji; Takada, Kenzo] Hokkaido Univ, Dept Tumor Virol, Inst Med Genet, Sapporo, Hokkaido, Japan; [Mizuno, Terukazu; Teranishi, Masaaki; Nakata, Seiichi; Nakashima, Tsutomu] Nagoya Univ, Grad Sch Med, Dept Otorhinolaryngol, Nagoya, Aichi 4648601, Japan; [Iwata, Seiko; Goshima, Fumi; Kimura, Hiroshi] Nagoya Univ, Grad Sch Med, Dept Virol, Nagoya, Aichi 4648601, Japan; [Nakamura, Shigeo] Nagoya Univ Hosp, Dept Pathol & Lab Med, Nagoya, Aichi, Japan	Nagoya University; Hokkaido University; Nagoya University; Nagoya University; Nagoya University	Gotoh, K (corresponding author), Nagoya Univ, Grad Sch Med, Dept Pediat, Nagoya, Aichi 4648601, Japan.	yoshi-i@med.nagoya-u.ac.jp	Maruo, Seiji/A-4288-2012; Teranishi, Masaaki/I-1956-2012; Nakashima, Tsutomu/B-8259-2012; Kimura, Hiroshi/I-2246-2012; GOSHIMA, Fumi/I-7241-2014; Takada, Kenzo/A-6666-2012; Ito, Yoshinori/A-7591-2016	Nakashima, Tsutomu/0000-0003-3930-9120; Kimura, Hiroshi/0000-0001-8063-5660; 	Japan Society for the Promotion of Science [20591276]; Health and Labour Science Research [22091401]; Grants-in-Aid for Scientific Research [23591564, 21591384] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Health and Labour Science Research; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants from the Japan Society for the Promotion of Science (20591276) to YI and from Health and Labour Science Research (22091401) to YI and HK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAN B, 2007, FIELDS VIROLOGY, P2655; ALLAUDEEN HS, 1982, ANTIVIR RES, V2, P123, DOI 10.1016/0166-3542(82)90014-6; ANAGNOSTOPOULOS I, 1995, BLOOD, V85, P744, DOI 10.1182/blood.V85.3.744.bloodjournal853744; Babcock GJ, 2000, IMMUNITY, V13, P497, DOI 10.1016/S1074-7613(00)00049-2; Chaganti S, 2009, BLOOD, V113, P6372, DOI 10.1182/blood-2008-08-175828; Cohen JI, 2000, NEW ENGL J MED, V343, P481, DOI 10.1056/NEJM200008173430707; Condit R. C., 2007, FIELDS VIROLOGY, V1, P25; Gimeno R, 2004, BLOOD, V104, P3886, DOI 10.1182/blood-2004-02-0656; Glushakova S, 1997, AIDS RES HUM RETROV, V13, P461, DOI 10.1089/aid.1997.13.461; GLUSHAKOVA S, 1995, NAT MED, V1, P1320, DOI 10.1038/nm1295-1320; Glushakova S, 1998, NAT MED, V4, P346, DOI 10.1038/nm0398-346; Grivel JC, 2003, J VIROL, V77, P8280, DOI 10.1128/JVI.77.15.8280-8289.2003; Grivel JC, 2009, NAT PROTOC, V4, P256, DOI 10.1038/nprot.2008.245; Hong GK, 2005, J VIROL, V79, P13993, DOI 10.1128/JVI.79.22.13993-14003.2005; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Islas-Ohlmayer M, 2004, J VIROL, V78, P13891, DOI 10.1128/JVI.78.24.13891-13900.2004; Ito Y, 2004, J INFECT DIS, V189, P506, DOI 10.1086/381153; Iwata S, 2010, J GEN VIROL, V91, P42, DOI 10.1099/vir.0.013482-0; Johannessen I, 1999, REV MED VIROL, V9, P263, DOI 10.1002/(SICI)1099-1654(199910/12)9:4<263::AID-RMV256>3.0.CO;2-D; Johnston Andrew, 2009, Curr Protoc Immunol, VChapter 7, DOI 10.1002/0471142735.im0708s86; Joseph AM, 2000, J VIROL, V74, P9964, DOI 10.1128/JVI.74.21.9964-9971.2000; Kimura H, 2001, BLOOD, V98, P280, DOI 10.1182/blood.V98.2.280; Kimura H, 1999, J CLIN MICROBIOL, V37, P132, DOI 10.1128/JCM.37.1.132-136.1999; Kimura H, 2009, J INFECT DIS, V200, P1078, DOI 10.1086/605610; Kubota N, 2008, J VIROL METHODS, V147, P26, DOI 10.1016/j.jviromet.2007.08.012; Kurth J, 2000, IMMUNITY, V13, P485, DOI 10.1016/S1074-7613(00)00048-0; Laichalk LL, 2002, IMMUNITY, V16, P745, DOI 10.1016/S1074-7613(02)00318-7; Lisco A, 2008, CELL HOST MICROBE, V4, P260, DOI 10.1016/j.chom.2008.07.008; Lisco A, 2007, J VIROL, V81, P708, DOI 10.1128/JVI.01367-06; Long MC, 2003, ANTIVIR RES, V58, P149, DOI 10.1016/S0166-3542(02)00210-3; Maruo S, 2001, J GEN VIROL, V82, P2373, DOI 10.1099/0022-1317-82-10-2373; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; Nakamura S, 1999, AM J SURG PATHOL, V23, P363, DOI 10.1097/00000478-199904000-00001; Niedobitek G, 1997, J PATHOL, V182, P151, DOI 10.1002/(SICI)1096-9896(199706)182:2<151::AID-PATH824>3.0.CO;2-3; Pegtel DM, 2004, J VIROL, V78, P12613, DOI 10.1128/JVI.78.22.12613-12624.2004; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Strowig T, 2009, J EXP MED, V206, P1423, DOI 10.1084/jem.20081720; Takashima K, 2008, J MED VIROL, V80, P455, DOI 10.1002/jmv.21102; Thorley-Lawson DA, 2005, J ALLERGY CLIN IMMUN, V116, P251, DOI 10.1016/j.jaci.2005.05.038; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Trempat P, 2002, J VIROL, V76, P11139, DOI 10.1128/JVI.76.21.11139-11142.2002; Wada K, 2007, J CLIN MICROBIOL, V45, P1426, DOI 10.1128/JCM.01515-06; Woodford NL, 2004, COMPARATIVE MED, V54, P209; Yajima M, 2008, J INFECT DIS, V198, P673, DOI 10.1086/590502	44	2	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25490	10.1371/journal.pone.0025490	http://dx.doi.org/10.1371/journal.pone.0025490			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998663	Green Published, gold, Green Submitted			2022-12-27	WOS:000295966900030
J	Hu, J; Wang, Z; Fan, J; Dai, Z; He, YF; Qiu, SJ; Huang, XW; Sun, J; Xiao, YS; Song, K; Shi, YH; Sun, QM; Yang, XR; Shi, GM; Yu, L; Yang, GH; Ding, ZB; Gao, Q; Tang, ZY; Zhou, J				Hu, Jie; Wang, Zheng; Fan, Jia; Dai, Zhi; He, Yi-Feng; Qiu, Shuang-Jian; Huang, Xiao-Wu; Sun, Jian; Xiao, Yong-Sheng; Song, Kang; Shi, Ying-Hong; Sun, Qi-Man; Yang, Xin-Rong; Shi, Guo-Ming; Yu, Lei; Yang, Guo-Huan; Ding, Zhen-Bin; Gao, Qiang; Tang, Zhao-You; Zhou, Jian			Genetic Variations in Plasma Circulating DNA of HBV-Related Hepatocellular Carcinoma Patients Predict Recurrence after Liver Transplantation	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; SIROLIMUS-BASED IMMUNOSUPPRESSION; NUCLEIC-ACIDS; POOR-PROGNOSIS; CANCER; SERUM; METHYLATION; METASTASIS; OVEREXPRESSION; IDENTIFICATION	Background:Recurrence prediction of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) patients undergoing liver transplantation (LT) present a great challenge because of a lack of biomarkers. Genetic variations play an important role in tumor development and metastasis. Methods:Oligonucleotide microarrays were used to evaluate the genetic characteristics of tumor DNA in 30 HBV-related HCC patients who were underwent LT. Recurrence-related single-nucleotide polymorphism were selected, and their prognostic value was assessed and validated in two independent cohorts of HCC patients (N = 102 and N = 77), using pretransplant plasma circulating DNA. Prognostic significance was assessed by Kaplan-Meier survival estimates and log-rank tests. Multivariate analyses were performed to evaluate prognosis-related factors. Results:rs894151 and rs12438080 were significantly associated with recurrence (P = .003 and P = .004, respectively). Multivariate analyses demonstrated that the co-index of the 2 SNPs was an independent prognostic factor for recurrence (P = .040). Similar results were obtained in the third cohort (N = 77). Furthermore, for HCC patients (all the 3 cohorts) exceeding Milan criteria, the co-index was a prognostic factor for recurrence and survival (P<.001 and P = .002, respectively). Conclusions:Our study demonstrated first that genetic variations of rs894151 and rs12438080 in pretransplant plasma circulating DNA are promising prognostic markers for tumor recurrence in HCC patients undergoing LT and identify a subgroup of patients who, despite having HCC exceeding Milan criteria, have a low risk of post-transplant recurrence.	[Hu, Jie; Wang, Zheng; Fan, Jia; Dai, Zhi; He, Yi-Feng; Qiu, Shuang-Jian; Huang, Xiao-Wu; Sun, Jian; Xiao, Yong-Sheng; Song, Kang; Shi, Ying-Hong; Sun, Qi-Man; Yang, Xin-Rong; Shi, Guo-Ming; Yu, Lei; Yang, Guo-Huan; Ding, Zhen-Bin; Gao, Qiang; Tang, Zhao-You; Zhou, Jian] Fudan Univ, Key Lab Carcinogenesis & Canc Invas, Shanghai Key Lab Organ Transplantat, Zhong Shan Hosp,Liver Canc Inst,Chinese Minist Ed, Shanghai 200433, Peoples R China; [Fan, Jia; Tang, Zhao-You; Zhou, Jian] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Fan, Jia; Zhou, Jian] Fudan Univ, Zhongshan Hosp, Shanghai Key Lab Organ Transplantat, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University	Hu, J (corresponding author), Fudan Univ, Key Lab Carcinogenesis & Canc Invas, Shanghai Key Lab Organ Transplantat, Zhong Shan Hosp,Liver Canc Inst,Chinese Minist Ed, Shanghai 200433, Peoples R China.	zhou.jian@zs-hospital.sh.cn	Fan, Jia/C-6689-2017; Shi, Ying-Hong/B-7063-2017	Hu, Jie/0000-0003-3518-6477; Gao, Qiang/0000-0002-6695-9906	National Natural Science Foundation of China [30972949, 30700815]; Shanghai Key-Tech Research and Development Program [09411951700]; Program for Shanghai Excellent Subject Leaders [10XD1401200]; Fudan University [211XK21]; Research Fund for the Doctoral Program of Higher Education of China [20090071110022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Key-Tech Research and Development Program; Program for Shanghai Excellent Subject Leaders; Fudan University; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was funded by grants from National Natural Science Foundation of China (No. 30972949 and No. 30700815, http://www.nsfc.gov.cn/), Shanghai Key-Tech Research and Development Program (No. 09411951700, www.stcsm.gov.cn), Program for Shanghai Excellent Subject Leaders (No. 10XD1401200, www.stcsm.gov.cn), Leading Academic Discipline Program, 211 Project for Fudan University (the 3rd phase, No. 211XK21, http://www.fudan.edu.cn/) and Research Fund for the Doctoral Program of Higher Education of China (No. 20090071110022, http://www.moe.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anker P, 2003, INT J CANCER, V103, P149, DOI 10.1002/ijc.10791; Bai DS, 2009, HEPATOLOGY, V49, P460, DOI 10.1002/hep.22638; Bucasas KL, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-85; Deng YB, 2010, CANCER SCI, V101, P1501, DOI 10.1111/j.1349-7006.2010.01549.x; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; El-Serag HB, 2007, HEPATOL RES, V37, pS88, DOI 10.1111/j.1872-034X.2007.00168.x; Fabris C, 2009, ALCOHOL CLIN EXP RES, V33, P102, DOI 10.1111/j.1530-0277.2008.00816.x; Fan J, 2009, J CANCER RES CLIN, V135, P1403, DOI 10.1007/s00432-009-0584-6; Feo F, 2006, BBA-REV CANCER, V1765, P126, DOI 10.1016/j.bbcan.2005.08.007; Fleischhacker M, 2007, BBA-REV CANCER, V1775, P181, DOI 10.1016/j.bbcan.2006.10.001; Fleischhacker M, 2008, NAT MED, V14, P914, DOI 10.1038/nm0908-914; Fujiki M, 2009, AM J TRANSPLANT, V9, P2362, DOI 10.1111/j.1600-6143.2009.02783.x; Goebel G, 2005, DIS MARKERS, V21, P105, DOI 10.1155/2005/218759; Guiteau JJ, 2010, AM J TRANSPLANT, V10, P2092, DOI 10.1111/j.1600-6143.2010.03222.x; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hernandez-Vargas H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009749; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Hu GH, 2009, CANCER CELL, V15, P9, DOI 10.1016/j.ccr.2008.11.013; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kim BK, 2008, LIVER INT, V28, P393, DOI 10.1111/j.1478-3231.2007.01625.x; KIM CM, 1991, NATURE, V351, P317, DOI 10.1038/351317a0; Kudo Masatoshi, 2008, Oncology, V75 Suppl 1, P1, DOI 10.1159/000181865; Li CF, 2008, J MOL MED, V86, P471, DOI 10.1007/s00109-007-0298-7; Li Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017794; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; Lu B, 2008, CLIN CANCER RES, V14, P7405, DOI 10.1158/1078-0432.CCR-08-0409; Lux H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008686; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Mazzaferro V, 2009, LANCET ONCOL, V10, P35, DOI 10.1016/S1470-2045(08)70284-5; McShane LM, 2005, JNCI-J NATL CANCER I, V97, P1180, DOI 10.1093/jnci/dji237; Minmin Shi, 2011, PLoS One, V6, pe19466, DOI 10.1371/journal.pone.0019466; Mizuguchi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015304; Mizutani Y, 2006, BIOCHEM J, V398, P531, DOI 10.1042/BJ20060379; Niu DD, 2010, J PROTEOMICS, V73, P1283, DOI 10.1016/j.jprot.2010.02.016; Paez G, 2001, MUTAT RES-FUND MOL M, V484, P103, DOI 10.1016/S0027-5107(01)00262-7; PATERLINI P, 1995, HEPATOLOGY, V21, P313, DOI 10.1002/hep.1840210208; Poon RTP, 2002, ANN SURG, V235, P466, DOI 10.1097/00000658-200204000-00004; Portolani N, 2006, ANN SURG, V243, P229, DOI 10.1097/01.sla.0000197706.21803.a1; Qiu P, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-4; Ramirez JL, 2005, J CLIN ONCOL, V23, P9105, DOI 10.1200/JCO.2005.02.2905; Ren N, 2006, J CANCER RES CLIN, V132, P399, DOI 10.1007/s00432-005-0049-5; Sato F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016435; Schiffman JD, 2010, CANCER RES, V70, P512, DOI 10.1158/0008-5472.CAN-09-1851; Schwartz M, 2008, J HEPATOL, V49, P581, DOI 10.1016/j.jhep.2008.03.032; Schwartz M, 2007, NAT CLIN PRACT ONCOL, V4, P424, DOI 10.1038/ncponc0844; Sidransky D, 2002, NAT REV CANCER, V2, P210, DOI 10.1038/nrc755; Stroun M, 2001, CLIN CHIM ACTA, V313, P139, DOI 10.1016/S0009-8981(01)00665-9; Sugimoto N, 2001, J HUM GENET, V46, P21, DOI 10.1007/s100380170119; Tang DJ, 2010, HEPATOLOGY, V51, P1255, DOI 10.1002/hep.23451; Toso C, 2010, HEPATOLOGY, V51, P1237, DOI 10.1002/hep.23437; Tuefferd M, 2008, GENE CHROMOSOME CANC, V47, P957, DOI 10.1002/gcc.20599; Villanueva A, 2010, CLIN CANCER RES, V16, P4688, DOI 10.1158/1078-0432.CCR-09-1811; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Washburn K, 2010, AM J TRANSPLANT, V10, P1643, DOI 10.1111/j.1600-6143.2010.03127.x; Wu LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014460; Yao FY, 2001, HEPATOLOGY, V33, P1394, DOI 10.1053/jhep.2001.24563; Ye QH, 2003, NAT MED, V9, P416, DOI 10.1038/nm843; Zhou J, 2008, TRANSPL P, V40, P3548, DOI 10.1016/j.transproceed.2008.03.165	58	10	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e26003	10.1371/journal.pone.0026003	http://dx.doi.org/10.1371/journal.pone.0026003			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998744	Green Published, gold, Green Submitted			2022-12-27	WOS:000295966900090
J	Liu, G; Yang, YP; Yang, SZ; Banerjee, S; De Freitas, A; Friggeri, A; Davis, KI; Abraham, E				Liu, Gang; Yang, Yanping; Yang, Shanzhong; Banerjee, Sami; De Freitas, Andressa; Friggeri, Arnaud; Davis, Kasey I.; Abraham, Edward			The Receptor for Urokinase Regulates TLR2 Mediated Inflammatory Responses in Neutrophils	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR RECEPTOR; KAPPA-B ACTIVATION; INTERLEUKIN-1 RECEPTOR; KRINGLE DOMAIN; DEFICIENT MICE; LIPOPOLYSACCHARIDE; INVOLVEMENT; EFFEROCYTOSIS; JNK	The urokinase-type plasminogen activator receptor (uPAR), a glycosylphosphatidylinositol (GPI) anchored membrane protein, regulates urokinase (uPA) protease activity, chemotaxis, cell-cell interactions, and phagocytosis of apoptotic cells. uPAR expression is increased in cytokine or bacteria activated cell populations, including macrophages and monocytes. However, it is unclear if uPAR has direct involvement in the response of inflammatory cells, such as neutrophils and macrophages, to Toll like receptor (TLR) stimulation. In this study, we found that uPAR is required for optimal neutrophil activation after TLR2, but not TLR4 stimulation. We found that the expression of TNF-alpha and IL-6 induced by TLR2 engagement in uPAR-/-neutrophils was less than that in uPAR+/+ (WT) neutrophils. Pretreatment of neutrophils with PIPLC, which cleaves GPI moieties, significantly decreased TLR2 induced expression of TNF-alpha in WT neutrophils, but demonstrated only marginal effects on TNF-alpha expression in PAM treated uPAR-/- neutrophils. I kappa B-alpha degradation and NF-kappa B activation were not different in uPAR-/-or WT neutrophils after TLR2 stimulation. However, uPAR is required for optimal p38 MAPK activation after TLR2 engagement. Consistent with the in vitro findings that uPAR modulates TLR2 engagement induced neutrophil activation, we found that pulmonary and systemic inflammation induced by TLR2, but not TLR4 stimulation is reduced in uPAR-/-mice compared to WT counterparts. Therefore, our data suggest that neutrophil associated uPAR could be a potential target for treating acute inflammation, sepsis, and organ injury related to severe bacterial and other microbial infections in which TLR2 engagement plays a major role.	[Liu, Gang; Yang, Yanping; Yang, Shanzhong; Banerjee, Sami; De Freitas, Andressa; Friggeri, Arnaud; Abraham, Edward] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Davis, Kasey I.] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL USA; [Friggeri, Arnaud] CHU Amiens, Amiens, France; [Friggeri, Arnaud] INSERM, ERI 12, Amiens, France	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Institut National de la Sante et de la Recherche Medicale (Inserm)	Liu, G (corresponding author), Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA.	eabraham@uab.edu	Friggeri, Arnaud/AAE-7644-2020; de Freitas, Andressa/B-7264-2012	Friggeri, Arnaud/0000-0003-4687-2173; de Freitas, Andressa/0000-0001-8453-7742; Liu, Gang/0000-0003-2615-131X; , Gang/0000-0002-6999-7633	National Institutes of Health [HL76206, GM87748]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105473, R01HL076206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087748] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health grants HL76206 and GM87748 to Edward Abraham. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abraham E, 2000, AM J PHYSIOL-LUNG C, V279, pL1137, DOI 10.1152/ajplung.2000.279.6.L1137; Abraham E, 2006, J IMMUNOL, V176, P7753, DOI 10.4049/jimmunol.176.12.7753; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Asehnoune K, 2004, J IMMUNOL, V172, P2522, DOI 10.4049/jimmunol.172.4.2522; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Bhandary YP, 2008, AM J RESP CRIT CARE; Briassouli P, 2010, CIRC RES, V107, P374, DOI 10.1161/CIRCRESAHA.109.213629; Cario E, 2000, J IMMUNOL, V164, P966, DOI 10.4049/jimmunol.164.2.966; Coleman JL, 2003, INFECT IMMUN, V71, P5556, DOI 10.1128/IAI.71.10.5556-5564.2003; D'mello V, 2009, J BIOL CHEM, V284, P17030, DOI 10.1074/jbc.M109.010066; Dekkers PEP, 2000, INFECT IMMUN, V68, P2156, DOI 10.1128/IAI.68.4.2156-2160.2000; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Gerold G, 2008, NAT IMMUNOL, V9, P761, DOI 10.1038/ni.1618; Gyetko MR, 2000, J IMMUNOL, V165, P1513, DOI 10.4049/jimmunol.165.3.1513; Huang QJ, 2004, NAT IMMUNOL, V5, P98, DOI 10.1038/ni1014; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Koay MA, 2002, AM J RESP CELL MOL, V26, P572, DOI 10.1165/ajrcmb.26.5.4748; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Kwak SH, 2006, THROMB HAEMOSTASIS, V95, P829, DOI 10.1160/TH05-12-0782; Kwak SH, 2005, J LEUKOCYTE BIOL, V78, P937, DOI 10.1189/jlb.0305158; Lee YB, 2000, CYTOKINE, V12, P874, DOI 10.1006/cyto.2000.0688; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Liu G, 2008, J IMMUNOL, V181, P4240, DOI 10.4049/jimmunol.181.6.4240; Liu G, 2008, FASEB J, V22, P2285, DOI 10.1096/fj.07-101816; Mondino A, 2004, TRENDS IMMUNOL, V25, P450, DOI 10.1016/j.it.2004.06.004; O'Neill L.A., 2000, SCI STKE, V2000, pRE1, DOI DOI 10.1126/STKE.2000.44.RE1; Pages G, 2000, J BIOL CHEM, V275, P26484, DOI 10.1074/jbc.M002104200; Park YJ, 2009, BLOOD, V114, P860, DOI 10.1182/blood-2008-12-193524; Qureshi ST, 2006, J IMMUNOL, V176, P4950, DOI 10.4049/jimmunol.176.8.4950; Ragno P, 2006, CELL MOL LIFE SCI, V63, P1028, DOI 10.1007/s00018-005-5428-1; Rajasingh J, 2006, FASEB J, V20, P2112, DOI 10.1096/fj.06-6084fje; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Srikrishna G, 2009, NEOPLASIA, V11, P615, DOI 10.1593/neo.09284; Tang CH, 2008, CELL MOL LIFE SCI, V65, P1916, DOI 10.1007/s00018-008-7573-9; Tsuruta Y, 2007, J IMMUNOL, V179, P7079, DOI 10.4049/jimmunol.179.10.7079; van Zoelen MAD, 2009, AM J PATHOL, V174, P2182, DOI 10.2353/ajpath.2009.080914; Waltz DA, 2000, AM J RESP CELL MOL, V22, P316, DOI 10.1165/ajrcmb.22.3.3713; Wang XQ, 2006, J IMMUNOL, V177, P5550, DOI 10.4049/jimmunol.177.8.5550; Wiersinga WJ, 2010, J IMMUNOL, V184, P3079, DOI 10.4049/jimmunol.0901008; Yamamoto M, 2004, MOL IMMUNOL, V40, P861, DOI 10.1016/j.molimm.2003.10.006	41	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25843	10.1371/journal.pone.0025843	http://dx.doi.org/10.1371/journal.pone.0025843			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998707	Green Published, gold, Green Submitted			2022-12-27	WOS:000295966900063
J	Resch, S; Korenromp, E; Stover, J; Blakley, M; Krubiner, C; Thorien, K; Hecht, R; Atun, R				Resch, Stephen; Korenromp, Eline; Stover, John; Blakley, Matthew; Krubiner, Carleigh; Thorien, Kira; Hecht, Robert; Atun, Rifat			Economic Returns to Investment in AIDS Treatment in Low and Middle Income Countries	PLOS ONE			English	Article							QUALITY-OF-LIFE; ANTIRETROVIRAL THERAPY; COST-EFFECTIVENESS; HIV/AIDS; HIV; IMPACT; MORTALITY; IMPROVEMENTS; PERFORMANCE; EMPLOYMENT	Since the early 2000s, aid organizations and developing country governments have invested heavily in AIDS treatment. By 2010, more than five million people began receiving antiretroviral therapy (ART) - yet each year, 2.7 million people are becoming newly infected and another two million are dying without ever having received treatment. As the need for treatment grows without commensurate increase in the amount of available resources, it is critical to assess the health and economic gains being realized from increasingly large investments in ART. This study estimates total program costs and compares them with selected economic benefits of ART, for the current cohort of patients whose treatment is cofinanced by the Global Fund to Fight AIDS, Tuberculosis and Malaria. At end 2011, 3.5 million patients in low and middle income countries will be receiving ART through treatment programs cofinanced by the Global Fund. Using 2009 ART prices and program costs, we estimate that the discounted resource needs required for maintaining this cohort are $14.2 billion for the period 2011-2020. This investment is expected to save 18.5 million life-years and return $12 to $34 billion through increased labor productivity, averted orphan care, and deferred medical treatment for opportunistic infections and end-of-life care. Under alternative assumptions regarding the labor productivity effects of HIV infection, AIDS disease, and ART, the monetary benefits range from 81 percent to 287 percent of program costs over the same period. These results suggest that, in addition to the large health gains generated, the economic benefits of treatment will substantially offset, and likely exceed, program costs within 10 years of investment.	[Resch, Stephen] Harvard Univ, Sch Publ Hlth, Ctr Hlth Decis Sci, Boston, MA 02115 USA; [Korenromp, Eline; Blakley, Matthew; Atun, Rifat] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland; [Korenromp, Eline] Univ Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [Stover, John] Futures Inst, Glastonbury, CT USA; [Krubiner, Carleigh; Thorien, Kira; Hecht, Robert] Results Dev Inst, Washington, DC USA; [Atun, Rifat] Univ London Imperial Coll Sci Technol & Med, London, England	Harvard University; Harvard T.H. Chan School of Public Health; Imperial College London	Resch, S (corresponding author), Harvard Univ, Sch Publ Hlth, Ctr Hlth Decis Sci, 665 Huntington Ave, Boston, MA 02115 USA.	stephen_resch@harvard.edu	Atun, Rifat/AAH-5537-2021	Atun, Rifat/0000-0002-1531-5983	Global Fund to Fight AIDS, Tuberculosis and Malaria	Global Fund to Fight AIDS, Tuberculosis and Malaria	Funded by The Global Fund to Fight AIDS, Tuberculosis and Malaria. The Global Fund commissioned the study, provided the data for analysis, and staff co-authored the paper.	Adam Taghreed, 2003, Cost Eff Resour Alloc, V1, P3, DOI 10.1186/1478-7547-1-3; Barnighausen T, 2007, AIDS, V21, pS29, DOI 10.1097/01.aids.0000300533.59483.95; Beard J, 2009, AIDS CARE, V21, P1343, DOI 10.1080/09540120902889926; Becker G. S., 2003, 9765 NAT BUR EC RES; Beegle K, 2007, ORPHANHOOD LONG RUN; Bell C, 2004, MACROECONOMICS HIV A; Bishai D, 2007, AIDS, V21, P1333, DOI 10.1097/QAD.0b013e328137709e; Bollinger L, 2007, FINANACIAL RESOURCES; Booysen FL, 2003, SOC SCI MED, V56, P2391, DOI 10.1016/S0277-9536(02)00243-5; Bussmann H, 2008, AIDS, V22, P2303, DOI 10.1097/QAD.0b013e3283129db0; Coetzee C, 2008, S AFR J ECON, V76, pS75, DOI 10.1111/j.1813-6982.2008.00166.x; Cuddington J T, 1995, J Afr Econ, V4, P1; Eholie S., 2003, EC AIDS ACCESS HIV A, P329; Foster C, 2000, AIDS, V14, pS275; Fox MP, 2010, AIDS CARE, V22, P137, DOI 10.1080/09540120903038366; Fox MP, 2004, TROP MED INT HEALTH, V9, P318, DOI 10.1111/j.1365-3156.2004.01207.x; Gillespie S, 2007, AIDS, V21, pS5, DOI 10.1097/01.aids.0000300531.74730.72; Gold MR, 1996, COST EFFECTIVENESS H; Goldstein MPG-Z J, 2009, ANN WORLD BANK C DEV; Haacker M, 2010, SOCIOECONOMIC DIMENS; Haacker M, 2004, MACROECONOMICS HIV A; Habyarimana J, 2007, HIV AIDS ARV TREATM; Hogan DR, 2005, BRIT MED J, V331, P1431, DOI 10.1136/bmj.38643.368692.68; International Labour Organization, 2009, LABORSTA LAB STAT DA; Izazola-Licea JA, 2009, JAIDS-J ACQ IMM DEF, V52, pS119, DOI 10.1097/QAI.0b013e3181baeeda; Jamison D.T., 2001, EFFECT AIDS EPIDEMIC; Jeffries K, 2006, EC IMPACT HIV AIDS B; [Joint United Nations Programme on HIV/AIDS (UNAIDS) World Health Organization (WHO)], 2009, AIDS EP UPD NOV 2009; King JT, 2003, MED DECIS MAKING, V23, P9, DOI 10.1177/0272989X02239652; Larson BA, 2008, AIDS, V22, P421, DOI 10.1097/QAD.0b013e3282f3cc0c; Larson BA, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-240; Linnemayr S, 2011, J AFR ECON, V20, P505, DOI 10.1093/jae/ejr014; Lu CL, 2010, LANCET, V375, P1375, DOI 10.1016/S0140-6736(10)60233-4; Mahal A, 2008, AIDS, V22, pS95, DOI 10.1097/01.aids.0000327629.62350.59; Mahy M, 2010, SEX TRANSM INFECT, V86, pI28, DOI 10.1136/sti.2010.044255; Marston M, 2007, AIDS, V21, pS65, DOI 10.1097/01.aids.0000299412.82893.62; Morineau G, 2009, AIDS PATIENT CARE ST, V23, P669, DOI 10.1089/apc.2008.0241; MUIRHEAD D, 2006, 16 INT AIDS C TOR CA; Murray CJL, 2000, HEALTH ECON, V9, P235, DOI 10.1002/(SICI)1099-1050(200004)9:3<235::AID-HEC502>3.0.CO;2-O; Renaud-Thery F, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/749041; Rosen S, 2008, AIDS, V22, pS131, DOI 10.1097/01.aids.0000327634.92844.91; Sabot O, 2010, LANCET, V376, P1604, DOI 10.1016/S0140-6736(10)61355-4; Sgombich X, 2006, 16 INT AIDS C TOR CA; Stover J, 2008, SEX TRANSM INFECT, V84, pI24, DOI 10.1136/sti.2008.029868; Stover J, 2007, HEALTH POLICY PLANN, V22, P21, DOI 10.1093/heapol/czl033; Stover J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021048; Tan-Torres ET, 2003, MAKING CHOICES HLTH; The Global Fund to Fight AIDS Tuberculosis and Malaria, 2010, GLOB FUND RES REP 20; The Global Fund to Fight AIDS Tuberculosis and Malaria, 2010, FIN HLTH IMP CONT SU; The Global Fund to Fight AIDS Tuberculosis and Malaria, 2010, PRIC QUAL REP SYST; THIRUMURTHY H, 2008, 17 INT AIDS C MEX CI; Thirumurthy H, 2008, J HUM RESOUR, V43, P511, DOI 10.3368/jhr.43.3.511; Thirumurthy H, 2011, AIDS, V25, P239, DOI 10.1097/QAD.0b013e328341b928; Thurlow J, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-18; Todd J, 2007, AIDS, V21, pS55, DOI 10.1097/01.aids.0000299411.75269.e8; Tsai AC, 2009, AIDS CARE, V21, P59, DOI 10.1080/09540120802068811; [UNAIDS UNICEF USAID], 2004, CHILDR BRINK JOINT R; UNAIDS, 2009, AIDS EP UPD NOV 2009; UNAIDS, 2010, GLOB REP UNAIDS REP; van Zyl A, 2009, COSTBENEFIT ANAL EMP; Ventelou B, 2008, AIDS, V22, P107, DOI 10.1097/QAD.0b013e3282f1d49f; Viscusi WK, 2003, J RISK UNCERTAINTY, V27, P5, DOI 10.1023/A:1025598106257; WHO, 2010, ANT THER HIV INF AD; World Bank, 2009, WORLD DEV IND ONL 8; World Health Organization, 2010, WHO CHOICE COST EFF; World Health Organization, 2009, GLOB PRIC REP MECH; World Health Organization HIV/AIDS Programme, 2009, RAP ADV ANT THER HIV; [World Health Organization HIV/AIDS Programme UNAIDS UNICEF], 2010, UN ACC SCAL PRIOR HI; Yamano T, 2004, WORLD DEV, V32, P91, DOI 10.1016/j.worlddev.2003.07.004; Zwahlen M, 2008, SEX TRANSM INFECT, V84, pI31, DOI 10.1136/sti.2008.029793	70	54	55	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25310	10.1371/journal.pone.0025310	http://dx.doi.org/10.1371/journal.pone.0025310			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834NA	21998648	Green Published, gold, Green Submitted			2022-12-27	WOS:000295966900017
J	Gan, L; Schwengberg, S; Denecke, B				Gan, Lin; Schwengberg, Silke; Denecke, Bernd			MicroRNA Profiling during Cardiomyocyte-Specific Differentiation of Murine Embryonic Stem Cells Based on Two Different miRNA Array Platforms	PLOS ONE			English	Article							GENE-EXPRESSION; BIOLOGY; MOUSE; LINES	MicroRNA (miRNA) plays a critical role in a wide variety of biological processes. Profiling miRNA expression during differentiation of embryonic stem cells will help to understand the regulation pathway of differentiation, which in turn may elucidate disease mechanisms. The identified miRNAs could then serve as a new group of possible therapeutic targets. In the present paper, miRNA expression profiles were determined during cardiomyocyte-specific differentiation and maturation of murine embryonic stem (ES) cells. For this purpose a homogeneous cardiomyocyte population was generated from a transgenic murine ES cell line. Two high throughput array platforms (Affymetrix and Febit) were used for miRNA profiling in order to compare the effect of the platforms on miRNA profiling as well as to increase the validity of target miRNA identification. Four time points (i.e. day 0, day 12, day 19 and day 26) were chosen for the miRNA profiling study, which corresponded to different stages during cardiomyocyte-specific differentiation and maturation. Fifty platform and preprocessing method-independent miRNAs were identified as being regulated during the differentiation and maturation processes. The identification of these miRNAs is an important step for characterizing and understanding the events involved in cardiomyocyte-specific differentiation of ES cells and may also highlight candidate target molecules for therapeutic purposes.	[Gan, Lin; Denecke, Bernd] Rhein Westfal TH Aachen, Interdisciplinary Ctr Clin Res IZKF Aachen, Aachen, Germany; [Schwengberg, Silke] Axiogenesis AG, Cologne, Germany	RWTH Aachen University	Gan, L (corresponding author), Rhein Westfal TH Aachen, Interdisciplinary Ctr Clin Res IZKF Aachen, Aachen, Germany.	bernd.denecke@rwth-aachen.de			Interdisciplinary Centre for Clinical Research Aachen, Rheinisch Westfalische Technische Hochschule (RWTH) Aachen [VVB-110e]	Interdisciplinary Centre for Clinical Research Aachen, Rheinisch Westfalische Technische Hochschule (RWTH) Aachen	This work was supported by the Interdisciplinary Centre for Clinical Research Aachen within the Rheinisch Westfalische Technische Hochschule (RWTH) Aachen -grant#VVB-110e, which had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. Silke Schwengberg is an employee of Axiogenesis AG (www.axiogenesis.com). Axiogenesis AG provided all cell culture material used in this study, including the cells. Axiogenesis AG had no role in study design, data collection and analysis, or manuscript preparation, but endorsed the decision to publish after reviewing the manuscript.	Barone AD, 2001, NUCLEOS NUCLEOT NUCL, V20, P525, DOI 10.1081/NCN-100002328; Bhattacharya B, 2009, CURR STEM CELL RES T, V4, P98, DOI 10.2174/157488809788167409; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cordes KR, 2010, PEDIATR CARDIOL, V31, P349, DOI 10.1007/s00246-010-9639-3; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Elaut G, 2006, CURR DRUG METAB, V7, P629, DOI 10.2174/138920006778017759; Enver T, 2009, CELL STEM CELL, V4, P387, DOI 10.1016/j.stem.2009.04.011; Foshay KM, 2009, DEV BIOL, V326, P431, DOI 10.1016/j.ydbio.2008.11.016; Friedman Y, 2010, BIOINFORMATICS, V26, P1920, DOI 10.1093/bioinformatics/btq298; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Glaser T, 2008, J NEUROL SCI, V265, P47, DOI 10.1016/j.jns.2007.09.018; Hatfield S, 2008, CELL TISSUE RES, V331, P57, DOI 10.1007/s00441-007-0530-3; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Huber W, 2002, BIOINFORMATICS, V18, pS96; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ivey KN, 2008, CELL STEM CELL, V2, P219, DOI 10.1016/j.stem.2008.01.016; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Katsumoto K, 2010, DEV GROWTH DIFFER, V52, P115, DOI 10.1111/j.1440-169X.2009.01160.x; Kolossov E, 2005, FASEB J, V19, P577, DOI 10.1096/fj.03-1451fje; Kolossov E, 1998, J CELL BIOL, V143, P2045, DOI 10.1083/jcb.143.7.2045; Kolossov E, 2006, J EXP MED, V203, P2315, DOI 10.1084/jem.20061469; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Liang Y, 2009, CRIT REV EUKAR GENE, V19, P289, DOI 10.1615/CritRevEukarGeneExpr.v19.i4.30; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Minard ME, 2009, GENESIS, V47, P559, DOI 10.1002/dvg.20534; Murray P, 2004, PHILOS T R SOC B, V359, P1009, DOI 10.1098/rstb.2003.1460; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Puceat M, 2008, METHODS, V45, P168, DOI 10.1016/j.ymeth.2008.03.003; Rowe C, 2010, J PROTEOME RES, V9, P2658, DOI 10.1021/pr1001687; Sachinidis A, 2003, CARDIOVASC RES, V58, P278, DOI 10.1016/S0008-6363(03)00248-7; Smyth G, 2002, STAT APPL GENETICS M; Sone M, 2007, ARTERIOSCL THROM VAS, V27, P2127, DOI 10.1161/ATVBAHA.107.143149; Tang FC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj009; Team RDC, 2019, R LANG ENV STAT COMP; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Vorwerk S, 2008, NEW BIOTECHNOL, V25, P142, DOI 10.1016/j.nbt.2008.08.005; Wang YL, 2009, CURR OPIN MOL THER, V11, P292; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yin JQ, 2008, TRENDS BIOTECHNOL, V26, P70, DOI 10.1016/j.tibtech.2007.11.007; Zeineddine D, 2005, METH MOLEC MED, V112, P175; Zhang CX, 2008, CLIN SCI, V114, P699, DOI 10.1042/CS20070211; Zhang Y, 2009, HUM GENE THER, V20, P1687, DOI 10.1089/hum.2009.057; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	44	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25809	10.1371/journal.pone.0025809	http://dx.doi.org/10.1371/journal.pone.0025809			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991358	Green Submitted, Green Published, gold			2022-12-27	WOS:000295943000075
J	Gao, JB; Hu, J; Mao, X; Zhou, M; Gurbaxani, B; Lin, J				Gao, Jianbo; Hu, Jing; Mao, Xiang; Zhou, Mi; Gurbaxani, Brian; Lin, Johnny			Entropies of Negative Incomes, Pareto-Distributed Loss, and Financial Crises	PLOS ONE			English	Article							SOCIAL PHASE-TRANSITIONS; LAW; ECONOMICS; MARKETS	Health monitoring of world economy is an important issue, especially in a time of profound economic difficulty world-wide. The most important aspect of health monitoring is to accurately predict economic downturns. To gain insights into how economic crises develop, we present two metrics, positive and negative income entropy and distribution analysis, to analyze the collective "spatial'' and temporal dynamics of companies in nine sectors of the world economy over a 19 year period from 1990-2008. These metrics provide accurate predictive skill with a very low false-positive rate in predicting downturns. The new metrics also provide evidence of phase transition-like behavior prior to the onset of recessions. Such a transition occurs when negative pretax incomes prior to or during economic recessions transition from a thin-tailed exponential distribution to the higher entropy Pareto distribution, and develop even heavier tails than those of the positive pretax incomes. These features propagate from the crisis initiating sector of the economy to other sectors.	[Gao, Jianbo] PMB Intelligence LLC, W Lafayette, IN 47996 USA; [Gao, Jianbo] Chinese Acad Sci, Inst Mech, LNM, Beijing 100080, Peoples R China; [Gao, Jianbo] Wright State Univ, Dayton, OH 45435 USA; [Hu, Jing] Affymetrix Inc, Santa Clara, CA USA; [Mao, Xiang] Univ Florida, Dept Elect & Comp Engn, Gainesville, FL USA; [Zhou, Mi] Univ Florida, Fredric G Levin Coll Law, Gainesville, FL USA; [Gurbaxani, Brian] Georgia Inst Technol, Sch Elect & Comp Engn, Atlanta, GA 30332 USA; [Lin, Johnny] N Pk Univ, Dept Phys, Chicago, IL USA	Chinese Academy of Sciences; Institute of Mechanics, CAS; University System of Ohio; Wright State University Dayton; Affymetrix; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University System of Georgia; Georgia Institute of Technology	Gao, JB (corresponding author), PMB Intelligence LLC, W Lafayette, IN 47996 USA.	jbgao@pmbintelligence.com			State Key Laboratory of Non-linear Mechanics (LNM), Institute of Mechanics, Chinese Academy of Sciences, Beijing, People's Republic of China; Directorate For Engineering [1031958] Funding Source: National Science Foundation	State Key Laboratory of Non-linear Mechanics (LNM), Institute of Mechanics, Chinese Academy of Sciences, Beijing, People's Republic of China; Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work is partially supported by the State Key Laboratory of Non-linear Mechanics (LNM), Institute of Mechanics, Chinese Academy of Sciences, Beijing, People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axtell RL, 2001, SCIENCE, V293, P1818, DOI 10.1126/science.1062081; AZIZ J, 2000, 67 IMF; Cover T. M., 1991, ELEMENTS INFORM THEO; Feynman Richard Phillips, 1969, FEYNMAN LECT PHYS; Furceri D, 2008, APPL ECON LETT, V15, P921, DOI 10.1080/13504850600972261; Gabaix X, 2003, NATURE, V423, P267, DOI 10.1038/nature01624; Gao J., 2007, MULTISCALE ANAL COMP; Hors I, 1997, J EVOL ECON, V7, P355, DOI 10.1007/s001910050048; *INT MON FUND, 1998, FIN CRIS CHAR IND VU, P74; JORGE CL, 2002, REV INT ECON, V10, P53; Kindleberger Charles, 1996, MANIAS PANICS CRASHE; Levy M, 2005, J ECON BEHAV ORGAN, V57, P71, DOI 10.1016/j.jebo.2003.11.013; Levy M, 2008, J ECON DYN CONTROL, V32, P137, DOI 10.1016/j.jedc.2007.01.023; McCauley JL, 2003, PHYSICA A, V329, P199, DOI 10.1016/S0378-4371(03)00591-0; *NAT BUR EC RES, BUS CYCL EXP CONTR; Niemira MP, 2004, INT J FORECASTING, V20, P573, DOI 10.1016/j.ijforecast.2003.09.013; Ozkan-Gunay EN, 2007, J RISK FINANC, V8, P465, DOI 10.1108/15265940710834753; Perc M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015117; Plerou V, 2003, NATURE, V421, P130, DOI 10.1038/421130a; Rachev S. T., 2005, FAT TAILED SKEWED AS; Roll R., 1988, FINANC ANAL J, V44, P19; Schweitzer F, 2009, SCIENCE, V325, P422, DOI 10.1126/science.1173644; UTSU T, 1995, J PHYS EARTH, V43, P1, DOI 10.4294/jpe1952.43.1; Yeh YH, 2005, J BANK FINANC, V29, P1857, DOI 10.1016/j.jbankfin.2004.07.004	24	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25053	10.1371/journal.pone.0025053	http://dx.doi.org/10.1371/journal.pone.0025053			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834EU	22007270	Green Published, Green Submitted, gold			2022-12-27	WOS:000295943000009
J	Ehlken, H; Kondylis, V; Heinrichsdorff, J; Ochoa-Callejero, L; Roskams, T; Pasparakis, M				Ehlken, Hanno; Kondylis, Vangelis; Heinrichsdorff, Jan; Ochoa-Callejero, Laura; Roskams, Tania; Pasparakis, Manolis			Hepatocyte IKK2 Protects Mdr2(-/-) Mice from Chronic Liver Failure	PLOS ONE			English	Article							NF-KAPPA-B; MDR2-KNOCKOUT MICE; INDUCED APOPTOSIS; ACTIVATION; FIBROSIS; INFLAMMATION; DISEASE; HEPATOCARCINOGENESIS; CARCINOGENESIS; MECHANISMS	Mice lacking the Abc4 protein encoded by the multidrug resistance-2 gene (Mdr2(-/-)) develop chronic periductular inflammation and cholestatic liver disease resulting in the development of hepatocellular carcinoma (HCC). Inhibition of NF-kappa B by expression of an I kappa B alpha super-repressor (I kappa B alpha SR) transgene in hepatocytes was shown to prevent HCC development in Mdr2(-/-) mice, suggesting that NF-kappa B acts as a tumour promoter in this model of inflammation-associated carcinogenesis. On the other hand, inhibition of NF-kappa B by hepatocyte specific ablation of IKK2 resulted in increased liver tumour development induced by the chemical carcinogen DEN. To address the role of IKK2-mediated NF-kappa B activation in hepatocytes in the pathogenesis of liver disease and HCC in Mdr2(-/-) mice, we generated Mdr2-deficient animals lacking IKK2 specifically in hepatocytes using the Cre-loxP system. Mdr2(-/-) mice lacking IKK2 in hepatocytes developed spontaneously a severe liver disease characterized by cholestasis, major hyperbilirubinemia and severe to end-stage fibrosis, which caused muscle wasting, loss of body weight, lethargy and early spontaneous death. Cell culture experiments showed that primary hepatocytes lacking IKK2 were more sensitive to bile acid induced death, suggesting that hepatocyte-specific IKK2 deficiency sensitized hepatocytes to the toxicity of bile acids under conditions of cholestasis resulting in greatly exacerbated liver damage. Mdr2(-/-) IKK2(Hep-KO) mice remarkably recapitulate chronic liver failure in humans and might be of special importance for the study of the mechanisms contributing to the pathogenesis of end-stage chronic liver disease or its implications on other organs. Conclusion: IKK2-mediated signaling in hepatocytes protects the liver from damage under conditions of chronic inflammatory cholestasis and prevents the development of severe fibrosis and liver failure.	[Ehlken, Hanno; Kondylis, Vangelis; Heinrichsdorff, Jan; Ochoa-Callejero, Laura; Pasparakis, Manolis] Univ Cologne, Inst Genet, Ctr Mol Med CMMC, Cologne Excellence Cluster Cellular Stress Respon, D-5000 Cologne, Germany; [Roskams, Tania] Catholic Univ Louvain, Dept Pathol, B-3000 Louvain, Belgium	University of Cologne; Universite Catholique Louvain	Ehlken, H (corresponding author), Univ Cologne, Inst Genet, Ctr Mol Med CMMC, Cologne Excellence Cluster Cellular Stress Respon, Weyertal 121, D-5000 Cologne, Germany.	pasparakis@uni-koeln.de	Kondylis, Vangelis/S-6276-2019; Pasparakis, Manolis/H-9292-2017; Ochoa-Callejero, Laura/K-2560-2012; Pasparakis, Manolis/N-4350-2019	Kondylis, Vangelis/0000-0002-6970-8731; Pasparakis, Manolis/0000-0002-9870-0966; Ochoa-Callejero, Laura/0000-0001-5366-6613; Pasparakis, Manolis/0000-0002-9870-0966; Roskams, Tania/0000-0002-2816-1530	European Commission (EC) [223151]	European Commission (EC)(European CommissionEuropean Commission Joint Research Centre)	This work was funded by European Commission FP7 program grant "INFLA-CARE" (EC contract number 223151) to MP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Becker S, 2007, CELL PHYSIOL BIOCHEM, V19, P89, DOI 10.1159/000099197; BLAAS L, HEPATOLOGY BALTIMORE, V51, P1319; Elsharkawy AM, 2007, HEPATOLOGY, V46, P590, DOI 10.1002/hep.21802; Faubion WA, 1999, J CLIN INVEST, V103, P137, DOI 10.1172/JCI4765; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Kamath PS, 1996, MAYO CLIN PROC, V71, P1089, DOI 10.4065/71.11.1089; Katzenellenbogen M, 2006, CANCER RES, V66, P4001, DOI 10.1158/0008-5472.CAN-05-2937; Katzenellenbogen M, 2007, MOL CANCER RES, V5, P1159, DOI 10.1158/1541-7786.MCR-07-0172; Keasler VV, 2006, VIROLOGY, V347, P466, DOI 10.1016/j.virol.2005.11.050; Klopstock N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005025; Luedde T, 2008, P NATL ACAD SCI USA, V105, P9733, DOI 10.1073/pnas.0800198105; Luedde T, 2007, CANCER CELL, V11, P119, DOI 10.1016/j.ccr.2006.12.016; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; MAIR M, GASTROENTEROLOGY, V138, P2499; MAUAD TH, 1994, AM J PATHOL, V145, P1237; Miyoshi H, 2001, AM J PATHOL, V158, P967, DOI 10.1016/S0002-9440(10)64043-6; Najimi Mustapha, 2009, V481, P59, DOI 10.1007/978-1-59745-201-4_6; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Poynard T, 2003, J HEPATOL, V38, P257, DOI 10.1016/S0168-8278(02)00413-0; Reinehr R, 2003, GASTROENTEROLOGY, V125, P839, DOI 10.1016/S0016-5085(03)01055-2; Reinehr R, 2005, GASTROENTEROLOGY, V129, P2009, DOI 10.1053/j.gastro.2005.09.023; Schoemaker MH, 2003, J HEPATOL, V39, P153, DOI 10.1016/S0168-8278(03)00214-9; Trauner M, 2007, SEMIN LIVER DIS, V27, P77, DOI 10.1055/s-2006-960172; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641	29	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e25942	10.1371/journal.pone.0025942	http://dx.doi.org/10.1371/journal.pone.0025942			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022477	Green Published, Green Submitted, gold			2022-12-27	WOS:000295981600022
J	Biesmans, L; Macquaide, N; Heinzel, FR; Bito, V; Smith, GL; Sipido, KR				Biesmans, Liesbeth; Macquaide, Niall; Heinzel, Frank R.; Bito, Virginie; Smith, Godfrey L.; Sipido, Karin R.			Subcellular Heterogeneity of Ryanodine Receptor Properties in Ventricular Myocytes with Low T- Tubule Density	PLOS ONE			English	Article							CARDIAC CA2+ SPARKS; SARCOPLASMIC-RETICULUM; SR CA2+; TRANSVERSE TUBULES; CALCIUM-RELEASE; SPATIOTEMPORAL CHARACTERISTICS; REDUCED SYNCHRONY; CONFOCAL IMAGES; NA/CA EXCHANGE; LOCAL CA2+	Rationale: In ventricular myocytes of large mammals, not all ryanodine receptor (RyR) clusters are associated with T-tubules (TTs); this fraction increases with cellular remodeling after myocardial infarction (MI). Objective: To characterize RyR functional properties in relation to TT proximity, at baseline and after MI. Methods: Myocytes were isolated from left ventricle of healthy pigs (CTRL) or from the area adjacent to a myocardial infarction (MI). Ca2+ transients were measured under whole-cell voltage clamp during confocal linescan imaging (fluo-3) and segmented according to proximity of TTs (sites of early Ca2+ release, F > F-50 within 20 ms) or their absence (delayed areas). Spontaneous Ca2+ release events during diastole, Ca2+ sparks, reflecting RyR activity and properties, were subsequently assigned to either category. Results: In CTRL, spark frequency was higher in proximity of TTs, but spark duration was significantly shorter. Block of Na+/Ca2+ exchanger (NCX) prolonged spark duration selectively near TTs, while block of Ca2+ influx via Ca2+ channels did not affect sparks properties. In MI, total spark mass was increased in line with higher SR Ca2+ content. Extremely long sparks (> 47.6 ms) occurred more frequently. The fraction of near-TT sparks was reduced; frequency increased mainly in delayed sites. Increased duration was seen in near-TT sparks only; Ca2+ removal by NCX at the membrane was significantly lower in MI. Conclusion: TT proximity modulates RyR cluster properties resulting in intracellular heterogeneity of diastolic spark activity. Remodeling in the area adjacent to MI differentially affects these RyR subpopulations. Reduction of the number of sparks near TTs and reduced local NCX removal limit cellular Ca2+ loss and raise SR Ca2+ content, but may promote Ca2+ waves.	[Biesmans, Liesbeth; Macquaide, Niall; Heinzel, Frank R.; Bito, Virginie; Sipido, Karin R.] Univ Leuven, Lab Expt Cardiol, Louvain, Belgium; [Macquaide, Niall; Smith, Godfrey L.] Univ Glasgow, Fac Biomed & Life Sci, Glasgow, Lanark, Scotland; [Heinzel, Frank R.] Med Univ Graz, Div Cardiol, Graz, Austria	KU Leuven; University of Glasgow; Medical University of Graz	Biesmans, L (corresponding author), Univ Leuven, Lab Expt Cardiol, Louvain, Belgium.	Karin.Sipido@med.kuleuven.be		Bito, Virginie/0000-0003-0986-7906; Macquaide, Niall/0000-0001-9026-0073; Heinzel, Frank R./0000-0002-4529-5282	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen); Belgian Science Policy program (IUAP) [P6/31]; European Union [LSHM-CT-2005-018833, EUGeneHeart]; EC [FP7/2007-2013, HEALTH-F2-2009-241526]	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Belgian Science Policy program (IUAP); European Union(European Commission); EC(European CommissionEuropean Commission Joint Research Centre)	This study was supported by a fellowship to LB by the "Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen),'' and by grants from the Belgian Science Policy program (IUAP, P6/31) and the European Union (LSHM-CT-2005-018833, EUGeneHeart) and from the EC FP7/2007-2013 under grant agreement no HEALTH-F2-2009-241526, EUTrigTreat (to K.R.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acsai K, 2011, J PHYSIOL-LONDON, V589, P2569, DOI 10.1113/jphysiol.2010.202663; BASSANI JWM, 1994, J PHYSIOL-LONDON, V476, P279, DOI 10.1113/jphysiol.1994.sp020130; Brette F, 2005, J MOL CELL CARDIOL, V39, P804, DOI 10.1016/j.yjmcc.2005.08.005; Cheng H, 1999, BIOPHYS J, V76, P606, DOI 10.1016/S0006-3495(99)77229-2; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; Cleemann L, 1998, P NATL ACAD SCI USA, V95, P10984, DOI 10.1073/pnas.95.18.10984; Cordeiro JM, 2001, J PHYSIOL-LONDON, V531, P301, DOI 10.1111/j.1469-7793.2001.0301i.x; Crossman DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017901; Despa S, 2003, BIOPHYS J, V85, P3388, DOI 10.1016/S0006-3495(03)74758-4; Franzini-Armstrong C, 1999, BIOPHYS J, V77, P1528, DOI 10.1016/S0006-3495(99)77000-1; Goldhaber JI, 1999, J PHYSIOL-LONDON, V520, P431, DOI 10.1111/j.1469-7793.1999.00431.x; Gomez AM, 1996, J PHYSIOL-LONDON, V496, P575, DOI 10.1113/jphysiol.1996.sp021708; Gomez AM, 2009, CIRCULATION, V119, P2179, DOI 10.1161/CIRCULATIONAHA.108.805804; Haddock PS, 1999, CIRC RES, V85, P415, DOI 10.1161/01.RES.85.5.415; Heinzel FR, 2002, CIRC RES, V91, P1023, DOI 10.1161/01.RES.0000045940.67060.DD; Heinzel FR, 2008, CIRC RES, V102, P338, DOI 10.1161/CIRCRESAHA.107.160085; Huser J, 1996, J PHYSIOL-LONDON, V494, P641; Katoh H, 2000, CIRC RES, V87, P106, DOI 10.1161/01.RES.87.2.106; Lipp P, 1996, J PHYSIOL-LONDON, V497, P589, DOI 10.1113/jphysiol.1996.sp021792; LOPEZLOPEZ JR, 1995, SCIENCE, V268, P1042, DOI 10.1126/science.7754383; Louch WE, 2004, CARDIOVASC RES, V62, P63, DOI 10.1016/j.cardiores.2003.12.031; Lukyanenko V, 2007, J PHYSIOL-LONDON, V583, P251, DOI 10.1113/jphysiol.2007.136549; Lukyanenko V, 2001, BIOPHYS J, V81, P785, DOI 10.1016/S0006-3495(01)75741-4; Lyon AR, 2009, P NATL ACAD SCI USA, V106, P6854, DOI 10.1073/pnas.0809777106; Mackenzie L, 2001, J PHYSIOL-LONDON, V530, P417, DOI 10.1111/j.1469-7793.2001.0417k.x; Meethal SV, 2007, CELL CALCIUM, V41, P123, DOI 10.1016/j.ceca.2006.05.006; Neco P, 2010, BIOPHYS J, V99, P755, DOI 10.1016/j.bpj.2010.04.071; Santiago DJ, 2010, BIOPHYS J, V98, P2111, DOI 10.1016/j.bpj.2010.01.042; Satoh H, 1997, AM J PHYSIOL-HEART C, V272, pH657, DOI 10.1152/ajpheart.1997.272.2.H657; Saucerman JJ, 2008, BIOPHYS J, V95, P4597, DOI 10.1529/biophysj.108.128728; Scriven DRL, 2000, BIOPHYS J, V79, P2682, DOI 10.1016/S0006-3495(00)76506-4; Seki S, 2003, CARDIOVASC RES, V58, P535, DOI 10.1016/S0008-6363(03)00255-4; SHACKLOCK PS, 1995, J PHYSIOL-LONDON, V487, P601, DOI 10.1113/jphysiol.1995.sp020903; Shannon TR, 2003, CIRC RES, V93, P592, DOI 10.1161/01.RES.0000093399.11734.B3; Shannon TR, 2002, CIRC RES, V91, P594, DOI 10.1161/01.RES.0000036914.12686.28; Sheehan KA, 2006, J PHYSIOL-LONDON, V572, P799, DOI 10.1113/jphysiol.2005.103267; Sipido KR, 2002, CARDIOVASC RES, V53, P782, DOI 10.1016/S0008-6363(01)00470-9; Sobie EA, 2002, BIOPHYS J, V83, P59, DOI 10.1016/S0006-3495(02)75149-7; Sobie EA, 2008, BIOPHYS J, V94, pL54, DOI 10.1529/biophysj.107.127878; Song QJ, 2008, J BIOL CHEM, V283, P31531, DOI 10.1074/jbc.M804902200; Toischer K, 2010, CIRCULATION, V122, P993, DOI 10.1161/CIRCULATIONAHA.110.943431; TRAFFORD AW, 1995, J PHYSIOL-LONDON, V488, P577, DOI 10.1113/jphysiol.1995.sp020991; Volkers M, 2007, CELL CALCIUM, V41, P135, DOI 10.1016/j.ceca.2006.06.001; Woo SH, 2003, CIRC RES, V92, pE1, DOI 10.1161/01.RES.0000051887.97625.07; Xiao RP, 1997, J PHYSIOL-LONDON, V500, P343, DOI 10.1113/jphysiol.1997.sp022025; Zima AV, 2008, CIRC RES, V103, pE105, DOI 10.1161/CIRCRESAHA.107.183236; Zima AV, 2008, BIOPHYS J, V94, P1867, DOI 10.1529/biophysj.107.114694; Zima AV, 2010, J PHYSIOL-LONDON, V588, P4743, DOI 10.1113/jphysiol.2010.197913	48	43	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e25100	10.1371/journal.pone.0025100	http://dx.doi.org/10.1371/journal.pone.0025100			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022376	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000295978600010
J	Arslan, SC; Scheidereit, C				Arslan, Seda Coel; Scheidereit, Claus			The Prevalence of TNF alpha-Induced Necrosis over Apoptosis Is Determined by TAK1-RIP1 Interplay	PLOS ONE			English	Article							KAPPA-B ACTIVATION; CELL-DEATH; RIP1 KINASE; TAK1; IDENTIFICATION; INFLAMMATION; REGULATOR; PATHWAYS; FAMILY	Death receptor-induced programmed necrosis is regarded as a secondary death mechanism dominating only in cells that cannot properly induce caspase-dependent apoptosis. Here, we show that in cells lacking TGF beta-activated Kinase-1 (TAK1) expression, catalytically active Receptor Interacting Protein 1 (RIP1)-dependent programmed necrosis overrides apoptotic processes following Tumor Necrosis Factor-alpha (TNF alpha) stimulation and results in rapid cell death. Importantly, the activation of the caspase cascade and caspase-8-mediated RIP1 cleavage in TNF alpha-stimulated TAK1 deficient cells is not sufficient to prevent RIP1-dependent necrosome formation and subsequent programmed necrosis. Our results demonstrate that TAK1 acts independently of its kinase activity to prevent the premature dissociation of ubiquitinated-RIP1 from TNF alpha-stimulated TNF-receptor I and also to inhibit the formation of TNF alpha-induced necrosome complex consisting of RIP1, RIP3, FADD, caspase-8 and cFLIPL. The surprising prevalence of catalytically active RIP1-dependent programmed necrosis over apoptosis despite ongoing caspase activity implicates a complex regulatory mechanism governing the decision between both cell death pathways following death receptor stimulation.	[Arslan, Seda Coel; Scheidereit, Claus] Max Delbruck Ctr Mol Med, Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine	Arslan, SC (corresponding author), Max Delbruck Ctr Mol Med, Berlin, Germany.	scheidereit@mdc-berlin.de			Deutsche Forschungsgemeinschaft [TRR54]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by grants from the Deutsche Forschungsgemeinschaft (TRR54) to C.S. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettermann K, 2010, CANCER CELL, V17, P481, DOI 10.1016/j.ccr.2010.03.021; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Geserick P, 2009, J CELL BIOL, V187, P1037, DOI 10.1083/jcb.200904158; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Kajino-Sakamoto R, 2008, J IMMUNOL, V181, P1143, DOI 10.4049/jimmunol.181.2.1143; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Morioka S, 2009, ONCOGENE, V28, P2257, DOI 10.1038/onc.2009.110; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Omori E, 2008, J BIOL CHEM, V283, P26161, DOI 10.1074/jbc.M804513200; Omori E, 2006, J BIOL CHEM, V281, P19610, DOI 10.1074/jbc.M603384200; Rudolph D, 2000, GENE DEV, V14, P854; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Smith CCT, 2007, CARDIOVASC DRUG THER, V21, P227, DOI 10.1007/s10557-007-6035-1; Stilmann M, 2009, MOL CELL, V36, P365, DOI 10.1016/j.molcel.2009.09.032; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vandenabeele P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115re4; Vanlangenakker N, 2011, CELL DEATH DIFFER, V18, P656, DOI 10.1038/cdd.2010.138; Varfolomeev EE, 2004, CELL, V116, P491, DOI 10.1016/S0092-8674(04)00166-7; Vince JE, 2009, J BIOL CHEM, V284, P35906, DOI 10.1074/jbc.M109.072256; Wajant H, 2011, FEBS J, V278, P862, DOI 10.1111/j.1742-4658.2011.08015.x; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yu JW, 2008, ONCOGENE, V27, P6216, DOI 10.1038/onc.2008.299; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308	27	35	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e26069	10.1371/journal.pone.0026069	http://dx.doi.org/10.1371/journal.pone.0026069			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016814	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000295971700037
J	Zhang, T; Zhang, XX; Ye, L				Zhang, Tong; Zhang, Xu-Xiang; Ye, Lin			Plasmid Metagenome Reveals High Levels of Antibiotic Resistance Genes and Mobile Genetic Elements in Activated Sludge	PLOS ONE			English	Article							WATER TREATMENT-PLANT; SEWAGE-TREATMENT PLANTS; WASTE-WATER; ANTIMICROBIAL RESISTANCE; BACTERIAL COMMUNITY; PROVIDES EVIDENCE; INCP-1-BETA GROUP; TRANSPORT-SYSTEM; VIRULENCE FACTOR; INTEGRONS	The overuse or misuse of antibiotics has accelerated antibiotic resistance, creating a major challenge for the public health in the world. Sewage treatment plants (STPs) are considered as important reservoirs for antibiotic resistance genes (ARGs) and activated sludge characterized with high microbial density and diversity facilitates ARG horizontal gene transfer (HGT) via mobile genetic elements (MGEs). However, little is known regarding the pool of ARGs and MGEs in sludge microbiome. In this study, the transposon aided capture (TRACA) system was employed to isolate novel plasmids from activated sludge of one STP in Hong Kong, China. We also used Illumina Hiseq 2000 high-throughput sequencing and metagenomics analysis to investigate the plasmid metagenome. Two novel plasmids were acquired from the sludge microbiome by using TRACA system and one novel plasmid was identified through metagenomics analysis. Our results revealed high levels of various ARGs as well as MGEs for HGT, including integrons, transposons and plasmids. The application of the TRACA system to isolate novel plasmids from the environmental metagenome, coupled with subsequent high-throughput sequencing and metagenomic analysis, highlighted the prevalence of ARGs and MGEs in microbial community of STPs.	[Zhang, Tong; Zhang, Xu-Xiang; Ye, Lin] Univ Hong Kong, Dept Civil Engn, Environm Biotechnol Lab, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Zhang, T (corresponding author), Univ Hong Kong, Dept Civil Engn, Environm Biotechnol Lab, Hong Kong, Hong Kong, Peoples R China.	zhangt@hkucc.hku.hk	Zhang, Tong/HGC-1090-2022; 張彤, Tong Zhang/C-6786-2008; Ye, Lin/F-9709-2013	Ye, Lin/0000-0002-4682-8917; Zhang, Tong/0000-0003-1148-4322	Research Grants Council of Hong Kong [HKU 7201/11E, HKU7202/09E]; University of Hong Kong [201007176069]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); University of Hong Kong(University of Hong Kong)	This study was financially supported by the Research Grants Council of Hong Kong (HKU 7201/11E) and (HKU7202/09E), Small Project Fund (201007176069) and SPACE Research Fund of the University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekshun MN, 2007, CELL, V128, P1037, DOI 10.1016/j.cell.2007.03.004; Auerbach EA, 2007, WATER RES, V41, P1143, DOI 10.1016/j.watres.2006.11.045; Bonemann G, 2006, ANTIMICROB AGENTS CH, V50, P3075, DOI 10.1128/AAC.00378-06; Boerlin Patrick, 2008, Animal Health Research Reviews, V9, P115, DOI 10.1017/S146625230800159X; Carlson JH, 2008, INFECT IMMUN, V76, P2273, DOI 10.1128/IAI.00102-08; da Silva MF, 2007, FEMS MICROBIOL ECOL, V60, P166, DOI 10.1111/j.1574-6941.2006.00268.x; Heuer H, 2004, MICROBIOL-SGM, V150, P3591, DOI 10.1099/mic.0.27304-0; Hooper SD, 2010, BIOINFORMATICS, V26, P295, DOI 10.1093/bioinformatics/btp687; Jencova V, 2008, RES MICROBIOL, V159, P118, DOI 10.1016/j.resmic.2007.11.018; Jensen LJ, 2008, NUCLEIC ACIDS RES, V36, pD250, DOI 10.1093/nar/gkm796; Jones BV, 2007, NAT METHODS, V4, P55, DOI 10.1038/NMETH964; Jones BV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-46; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kislyuk AO, 2010, BIOINFORMATICS, V26, P1819, DOI 10.1093/bioinformatics/btq284; Kristiansson E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017038; Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656; Liu YF, 2007, J ANTIMICROB CHEMOTH, V59, P1167, DOI 10.1093/jac/dkm106; Luck SN, 2001, INFECT IMMUN, V69, P6012, DOI 10.1128/IAI.69.10.6012-6021.2001; Ma LP, 2011, ECOTOXICOLOGY, V20, P968, DOI 10.1007/s10646-011-0652-y; Moura A, 2009, BIOINFORMATICS, V25, P1096, DOI 10.1093/bioinformatics/btp105; Munoz-Lopez M, 2010, CURR GENOMICS, V11, P115, DOI 10.2174/138920210790886871; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Noguchi H, 2006, NUCLEIC ACIDS RES, V34, P5623, DOI 10.1093/nar/gkl723; Okitsu N, 2005, J CLIN MICROBIOL, V43, P168, DOI 10.1128/JCM.43.1.168-173.2005; Partridge SR, 2009, FEMS MICROBIOL REV, V33, P757, DOI 10.1111/j.1574-6976.2009.00175.x; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; RATHER PN, 1992, ANTIMICROB AGENTS CH, V36, P2222, DOI 10.1128/AAC.36.10.2222; Roberts MC, 2008, FEMS MICROBIOL LETT, V282, P147, DOI 10.1111/j.1574-6968.2008.01145.x; Salanoubat M, 2002, NATURE, V415, P497, DOI 10.1038/415497a; Schluter A, 2008, J BIOTECHNOL, V136, P65, DOI 10.1016/j.jbiotec.2008.03.017; Schluter A, 2007, FEMS MICROBIOL REV, V31, P449, DOI 10.1111/j.1574-6976.2007.00074.x; Schluter A, 2003, MICROBIOL-SGM, V149, P3139, DOI 10.1099/mic.0.26570-0; Schwartz T, 2003, FEMS MICROBIOL ECOL, V43, P325, DOI 10.1111/j.1574-6941.2003.tb01073.x; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Szczepanowski R, 2004, MICROBIOL-SGM, V150, P3613, DOI 10.1099/mic.0.27317-0; Szczepanowski R, 2008, J BIOTECHNOL, V136, P54, DOI 10.1016/j.jbiotec.2008.03.020; Tauch A, 2003, MOL GENET GENOMICS, V268, P570, DOI 10.1007/s00438-002-0785-z; Taviani E, 2008, FEMS MICROBIOL ECOL, V64, P45, DOI 10.1111/j.1574-6941.2008.00455.x; Tennstedt T, 2005, PLASMID, V53, P218, DOI 10.1016/j.plasmid.2004.09.004; Tennstedt T, 2003, FEMS MICROBIOL ECOL, V45, P239, DOI 10.1016/S0168-6496(03)00164-8; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; VANDERPLOEG J, 1995, J BACTERIOL, V177, P1348, DOI 10.1128/jb.177.5.1348-1356.1995; Walsh F, 2010, INT J ANTIMICROB AG, V35, P593, DOI 10.1016/j.ijantimicag.2010.02.011; Yan QM, 2011, FRONT ENVIRON SCI EN, V5, P40, DOI 10.1007/s11783-011-0304-8; Yang J, 2008, NUCLEIC ACIDS RES, V36, pD539, DOI 10.1093/nar/gkm951; Ye L, 2011, WATER RES, V45, P4390, DOI 10.1016/j.watres.2011.05.028; Zhang T, 2009, ENVIRON SCI TECHNOL, V43, P3455, DOI 10.1021/es803309m; Zhang XX, 2011, ENVIRON SCI TECHNOL, V45, P2598, DOI 10.1021/es103672x; Zhang XX, 2009, APPL MICROBIOL BIOT, V82, P1169, DOI 10.1007/s00253-009-1886-y; Zhang XX, 2009, APPL MICROBIOL BIOT, V82, P397, DOI 10.1007/s00253-008-1829-z	50	254	271	18	317	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e26041	10.1371/journal.pone.0026041	http://dx.doi.org/10.1371/journal.pone.0026041			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016806	gold, Green Published			2022-12-27	WOS:000295971700034
J	Gu, Y; Runyan, C; Shoemaker, A; Surani, MA; Wylie, C				Gu, Ying; Runyan, Christopher; Shoemaker, Amanda; Surani, M. Azim; Wylie, Christopher			Membrane-Bound Steel Factor Maintains a High Local Concentration for Mouse Primordial Germ Cell Motility, and Defines the Region of Their Migration	PLOS ONE			English	Article							C-KIT LIGAND; GROWTH-FACTOR; GENE-PRODUCT; MUTANT MICE; PROLIFERATION; SURVIVAL; CULTURE; FORMS; TRANSMEMBRANE; SPECIFICATION	Steel factor, the protein product of the Steel locus in the mouse, is a multifunctional signal for the primordial germ cell population. We have shown previously that its expression accompanies the germ cells during migration to the gonads, forming a "travelling niche'' that controls their survival, motility, and proliferation. Here we show that these functions are distributed between the alternatively spliced membrane-bound and soluble forms of Steel factor. The germ cells normally migrate as individuals from E7.5 to E11.5, when they aggregate together in the embryonic gonads. Movie analysis of Steel-dickie mutant embryos, which make only the soluble form, at E7.5, showed that the germ cells fail to migrate normally, and undergo "premature aggregation'' in the base of the allantois. Survival and directionality of movement is not affected. Addition of excess soluble Steel factor to Steel-dickie embryos rescued germ cell motility, and addition of Steel factor to germ cells in vitro showed that a fourfold higher dose was required to increase motility, compared to survival. These data show that soluble Steel factor is sufficient for germ cell survival, and suggest that the membrane-bound form provides a higher local concentration of Steel factor that controls the balance between germ cell motility and aggregation. This hypothesis was tested by addition of excess soluble Steel factor to slice cultures of E11.5 embryos, when migration usually ceases, and the germ cells aggregate. This reversed the aggregation process, and caused increased motility of the germ cells. We conclude that the two forms of Steel factor control different aspects of germ cell behavior, and that membrane-bound Steel factor controls germ cell motility within a "motility niche'' that moves through the embryo with the germ cells. Escape from this niche causes cessation of motility and death by apoptosis of the ectopic germ cells.	[Gu, Ying; Shoemaker, Amanda; Wylie, Christopher] Cincinnati Childrens Hosp, Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Gu, Ying] Univ Cincinnati, Mol & Dev Biol Grad Program, Sch Med, Cincinnati, OH USA; [Runyan, Christopher] Cincinnati Childrens Hosp, Med Ctr, Div Plast Surg, Cincinnati, OH USA; [Surani, M. Azim] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon, Inst Canc & Dev Biol, Cambridge, England	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University of Cambridge	Gu, Y (corresponding author), Cincinnati Childrens Hosp, Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA.	Christopher.Wylie@cchmc.org	Runyan, Christopher/AAE-5656-2019	Runyan, Christopher/0000-0002-3985-7250; Surani, Azim/0000-0002-8640-4318	National Institutes of Health [1R01HD060578-01]; Albert J. Ryan Foundation; Cincinnati Children's Hospital Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD060578] Funding Source: NIH RePORTER; MRC [G0800784] Funding Source: UKRI; Medical Research Council [G0800784, G0800784B] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert J. Ryan Foundation; Cincinnati Children's Hospital Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work is supported in part by funding from National Institutes of Health (1R01HD060578-01), the Albert J. Ryan Foundation, and the Cincinnati Children's Hospital Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson R, 2000, MECH DEVELOP, V91, P61, DOI 10.1016/S0925-4773(99)00271-3; Bendel-Stenzel MR, 2000, MECH DEVELOP, V91, P143, DOI 10.1016/S0925-4773(99)00287-7; Bennett D, 1956, J MORPHOL, V98, P57; BESMER P, 1993, DEVELOPMENT, P125; BRANNAN CI, 1991, P NATL ACAD SCI USA, V88, P4671, DOI 10.1073/pnas.88.11.4671; BUEHR M, 1993, DEV DYNAM, V198, P182, DOI 10.1002/aja.1001980304; DOLCI S, 1991, NATURE, V352, P809, DOI 10.1038/352809a0; FLANAGAN JG, 1991, CELL, V64, P1025, DOI 10.1016/0092-8674(91)90326-T; Friel J, 2002, GROWTH FACTORS, V20, P35, DOI 10.1080/08977190290022211; GALLI SJ, 1992, ANN NY ACAD SCI, V664, P69, DOI 10.1111/j.1749-6632.1992.tb39750.x; GODIN I, 1991, NATURE, V352, P807, DOI 10.1038/352807a0; Gu Y, 2009, DEVELOPMENT, V136, P1295, DOI 10.1242/dev.030619; Hayashi K, 2007, SCIENCE, V316, P394, DOI 10.1126/science.1137545; HUANG EJ, 1992, MOL BIOL CELL, V3, P349, DOI 10.1091/mbc.3.3.349; IEMURA A, 1994, AM J PATHOL, V144, P321; KINASHI T, 1994, BLOOD, V83, P1033; MATSUI Y, 1991, NATURE, V353, P750, DOI 10.1038/353750a0; MCCOSHEN JA, 1975, EXPERIENTIA, V31, P589, DOI 10.1007/BF01932475; MINTZ B, 1957, J EXP ZOOL, V134, P207, DOI 10.1002/jez.1401340202; MIYAZAWA K, 1995, BLOOD, V85, P641, DOI 10.1182/blood.V85.3.641.bloodjournal853641; Molyneaux KA, 2001, DEV BIOL, V240, P488, DOI 10.1006/dbio.2001.0436; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Payer B, 2006, GENESIS, V44, P75, DOI 10.1002/gene.20187; Runyan C, 2006, DEVELOPMENT, V133, P4861, DOI 10.1242/dev.02688; Stallock J, 2003, DEVELOPMENT, V130, P6589, DOI 10.1242/dev.00898; TOKSOZ D, 1992, P NATL ACAD SCI USA, V89, P7350, DOI 10.1073/pnas.89.16.7350; WEHRLEHALLER B, 1995, DEVELOPMENT, V121, P731; YEE NS, 1994, J EXP MED, V179, P1777, DOI 10.1084/jem.179.6.1777; Zama AM, 2005, BIOL REPROD, V73, P639, DOI 10.1095/biolreprod.105.042846; ZSEBO KM, 1990, CELL, V63, P213, DOI 10.1016/0092-8674(90)90302-U	30	21	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e25984	10.1371/journal.pone.0025984	http://dx.doi.org/10.1371/journal.pone.0025984			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998739	Green Published, Green Submitted, gold			2022-12-27	WOS:000295968700030
J	Gomez-Benito, M; Loayza-Puch, F; Vrielink, JO; Odero, MD; Agami, R				Gomez-Benito, Maria; Loayza-Puch, Fabricio; Vrielink, Joachim Oude; Odero, Maria D.; Agami, Reuven			3'UTR-Mediated Gene Silencing of the Mixed Lineage Leukemia (MLL) Gene	PLOS ONE			English	Article							11Q23 CHROMOSOMAL TRANSLOCATIONS; TARGET MESSENGER-RNA; CELLS; TRANSFORMATION; MICRORNAS; LET-7	Translocations involving the Mixed Lineage Leukemia (MLL) gene generate in-frame fusions of MLL with more than 50 different partner genes (PGs). Common to all MLL translocations is the exchange not only of coding regions, but also of MLL and PG 3'-untranslated regions (3'UTRs). As a result, the MLL-PG fusion is normally highly expressed and considered the main driver of leukemia development, whereas the function of the PG-MLL fusions in leukemic disease is unclear. As 3'UTRs have been recognized as determinant regions for regulation of gene expression, we hypothesized that loss of the MLL 3'UTR could have a role in generating high MLL-PG levels and leukemia development. Here, we first tested the MLL-PG and PG-MLL mRNA levels in different leukemic cells and tumours and uncovered differential expression that indicates strong repression by the MLL-3'UTR. Reporter assays confirmed that the 3'UTR of MLL, but not of its main PGs, harbours a region that imposes a strong gene silencing effect. Gene suppression by the MLL 3'UTR was largely microRNA independent and did not affect mRNA stability, but inhibited transcription. This effect can at least partially be attributed to a tighter interaction of the MLL 3'UTR with RNA polymerase II than PG 3'UTRs, affecting its phosphorylation state. Altogether, our findings indicate that MLL translocations relieve oncogenic MLL-PG fusions from the repressive MLL 3'UTR, contributing to higher activity of these genes and leukaemia development.	[Gomez-Benito, Maria; Loayza-Puch, Fabricio; Vrielink, Joachim Oude; Agami, Reuven] Netherlands Canc Inst, Div Gene Regulat, Amsterdam, Netherlands; [Gomez-Benito, Maria; Odero, Maria D.] Ctr Appl Med Res, Pamplona, Spain; [Agami, Reuven] Ctr Biomed Genet, Utrecht, Netherlands	Netherlands Cancer Institute; University of Navarra	Gomez-Benito, M (corresponding author), Netherlands Canc Inst, Div Gene Regulat, Amsterdam, Netherlands.	r.agami@nki.nl	agami, reuven/GOG-8289-2022; Odero/ABG-9860-2020	Odero/0000-0002-8858-2054; Agami, Reuven/0000-0002-2848-2473; Loayza-Puch, Fabricio/0000-0002-2999-8594	European Research Council [58196]; Horizon-NWO (Dutch Science Organization) [59140]; Spanish Ministry of Health (instituto de Salud Carlos III)	European Research Council(European Research Council (ERC)European Commission); Horizon-NWO (Dutch Science Organization); Spanish Ministry of Health (instituto de Salud Carlos III)(Instituto de Salud Carlos IIISpanish Government)	This work was supported by the European Research Council (miReg number 58196) and Horizon-NWO (Dutch Science Organization) to RA; number 59140; and by the Spanish Ministry of Health (instituto de Salud Carlos III) fellowship to MG-B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Ayton PM, 2001, ONCOGENE, V20, P5695, DOI 10.1038/sj.onc.1204639; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Burmeister T, 2010, BLOOD, V115, P4627, DOI 10.1182/blood-2010-03-275214; CIERPICKI T, NAT STRUCT MOL BIOL, V17, P62; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Dolken L, 2008, RNA, V14, P1959, DOI 10.1261/rna.1136108; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Keefe JG, 2010, J MOL DIAGN, V12, P441, DOI 10.2353/jmoldx.2010.090214; Kimura H, 2002, J CELL BIOL, V159, P777, DOI 10.1083/jcb.200206019; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Lahortiga I, 2004, GENE CHROMOSOME CANC, V40, P179, DOI 10.1002/gcc.20033; Lavau C, 1997, EMBO J, V16, P4226, DOI 10.1093/emboj/16.14.4226; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; Liedtke M, 2009, BLOOD, V113, P6061, DOI 10.1182/blood-2008-12-197061; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Martin ME, 2003, CANCER CELL, V4, P197, DOI 10.1016/S1535-6108(03)00214-9; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Popovic R, 2005, J CELL BIOCHEM, V95, P234, DOI 10.1002/jcb.20430; THIRMAN MJ, 1993, NEW ENGL J MED, V329, P909, DOI 10.1056/NEJM199309233291302; TKACHUK DC, 1992, CELL, V71, P691, DOI 10.1016/0092-8674(92)90602-9	24	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25449	10.1371/journal.pone.0025449	http://dx.doi.org/10.1371/journal.pone.0025449			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998658	gold, Green Submitted, Green Published			2022-12-27	WOS:000295966900027
J	Bezuidt, O; Pierneef, R; Mncube, K; Lima-Mendez, G; Reva, ON				Bezuidt, Oliver; Pierneef, Rian; Mncube, Kingdom; Lima-Mendez, Gipsi; Reva, Oleg N.			Mainstreams of Horizontal Gene Exchange in Enterobacteria: Consideration of the Outbreak of Enterohemorrhagic E. coli O104:H4 in Germany in 2011	PLOS ONE			English	Article							UROPATHOGENIC ESCHERICHIA-COLI; PATHOGENICITY ISLANDS; BACTERIAL GENOMES; MOLECULAR EPIDEMIOLOGY; PROKARYOTIC GENOMES; TRANSFERRED GENES; RHS ELEMENTS; VIRULENCE; EVOLUTION; SIGNATURE	Background: Escherichia coli O104:H4 caused a severe outbreak in Europe in 2011. The strain TY-2482 sequenced from this outbreak allowed the discovery of its closest relatives but failed to resolve ways in which it originated and evolved. On account of the previous statement, may we expect similar upcoming outbreaks to occur recurrently or spontaneously in the future? The inability to answer these questions shows limitations of the current comparative and evolutionary genomics methods. Principal Findings: The study revealed oscillations of gene exchange in enterobacteria, which originated from marine gamma-Proteobacteria. These mobile genetic elements have become recombination hotspots and effective 'vehicles' ensuring a wide distribution of successful combinations of fitness and virulence genes among enterobacteria. Two remarkable peculiarities of the strain TY-2482 and its relatives were observed: i) retaining the genetic primitiveness by these strains as they somehow avoided the main fluxes of horizontal gene transfer which effectively penetrated other enetrobacteria; ii) acquisition of antibiotic resistance genes in a plasmid genomic island of beta-Proteobacteria origin which ontologically is unrelated to the predominant genomic islands of enterobacteria. Conclusions: Oscillations of horizontal gene exchange activity were reported which result from a counterbalance between the acquired resistance of bacteria towards existing mobile vectors and the generation of new vectors in the environmental microflora. We hypothesized that TY-2482 may originate from a genetically primitive lineage of E. coli that has evolved in confined geographical areas and brought by human migration or cattle trade onto an intersection of several independent streams of horizontal gene exchange. Development of a system for monitoring the new and most active gene exchange events was proposed.	[Bezuidt, Oliver; Pierneef, Rian; Mncube, Kingdom; Reva, Oleg N.] Univ Pretoria, Bioinformat & Computat Biol Unit, Dept Biochem, ZA-0002 Pretoria, South Africa; [Lima-Mendez, Gipsi] Univ Libre Bruxelles, Lab Bioinformat Genomes & Reseaux BiGRe, Brussels, Belgium	University of Pretoria; Universite Libre de Bruxelles	Bezuidt, O (corresponding author), Univ Pretoria, Bioinformat & Computat Biol Unit, Dept Biochem, ZA-0002 Pretoria, South Africa.	oleg.reva@up.ac.za	Lima-Mendez, Gipsi/AAV-4158-2021; Reva, Oleg N/A-7316-2009; Lima-Mendez, Gipsi/AAX-6291-2021	Lima-Mendez, Gipsi/0000-0002-5309-1845; Reva, Oleg N/0000-0002-5459-2772; Lima-Mendez, Gipsi/0000-0002-5309-1845; Pierneef, Rian/0000-0002-0619-0058; bezuidt, keoagile oliver/0000-0002-1690-9716	National Research Foundation (South Africa) [71261]	National Research Foundation (South Africa)(National Research Foundation - South Africa)	This work was funded by the National Research Foundation (South Africa) grant #71261 for National Bioinformatics and Functional Genomics Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2003, GENOME RES, V13, P693, DOI 10.1101/gr.634603; Alonso A, 2001, ENVIRON MICROBIOL, V3, P1, DOI 10.1046/j.1462-2920.2001.00161.x; Azad RK, 2005, PLOS COMPUT BIOL, V1, P461, DOI 10.1371/journal.pcbi.0010056; Aziz RK, 2010, NUCLEIC ACIDS RES, V38, P4207, DOI 10.1093/nar/gkq140; Becq J, 2007, MOL BIOL EVOL, V24, P1861, DOI 10.1093/molbev/msm111; Beiko RG, 2005, P NATL ACAD SCI USA, V102, P14332, DOI 10.1073/pnas.0504068102; Bhowmick PP, 2011, MICROBIOL-SGM, V157, P160, DOI 10.1099/mic.0.043596-0; Brzuszkiewicz E, 2011, ARCH MICROBIOL, V193, P883, DOI 10.1007/s00203-011-0725-6; Bugarel M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-142; Canchaya C, 2003, MICROBIOL MOL BIOL R, V67, P238, DOI 10.1128/MMBR.67.2.238-276.2003; Choi IG, 2007, P NATL ACAD SCI USA, V104, P4489, DOI 10.1073/pnas.0611557104; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Coenye T, 2004, SYST APPL MICROBIOL, V27, P175, DOI 10.1078/072320204322881790; Dale C, 2001, P NATL ACAD SCI USA, V98, P1883, DOI 10.1073/pnas.021450998; Davenport CF, 2009, ENVIRON MICROBIOL, V11, P1092, DOI 10.1111/j.1462-2920.2008.01839.x; Deschavanne PJ, 1999, MOL BIOL EVOL, V16, P1391, DOI 10.1093/oxfordjournals.molbev.a026048; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; Dufraigne C, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni004; Durante-Mangoni E, 2011, FUTURE MICROBIOL, V6, P407, DOI [10.2217/FMB.11.23, 10.2217/fmb.11.23]; Dutta C, 2002, J BIOSCIENCES, V27, P27, DOI 10.1007/BF02703681; Ejrnaes K, 2011, DAN MED BULL, V58; Escobar-Paramo P, 2004, MOL BIOL EVOL, V21, P1085, DOI 10.1093/molbev/msh118; Escobar-Paramo P, 2004, APPL ENVIRON MICROB, V70, P5698, DOI 10.1128/AEM.70.9.5698-5700.2004; Ferens WA, 2011, FOODBORNE PATHOG DIS, V8, P465, DOI 10.1089/fpd.2010.0673; FLEISS JL, 1973, STAT METHODS RATES P, V13, P223; Fluit AC, 2005, FEMS IMMUNOL MED MIC, V43, P1, DOI 10.1016/j.femsim.2004.10.007; Ganesan H, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-333; Garenaux A, 2011, VET MICROBIOL, V153, P89, DOI 10.1016/j.vetmic.2011.05.023; Gordon DM, 2008, ENVIRON MICROBIOL, V10, P2484, DOI 10.1111/j.1462-2920.2008.01669.x; Guyer DM, 2002, INFECT IMMUN, V70, P4539, DOI 10.1128/IAI.70.8.4539-4546.2002; Hacker J, 2001, EMBO REP, V2, P376, DOI 10.1093/embo-reports/kve097; Hao WL, 2006, GENOME RES, V16, P636, DOI 10.1101/gr.4746406; HERZER PJ, 1990, J BACTERIOL, V172, P6175, DOI 10.1128/jb.172.11.6175-6181.1990; HILL CW, 1994, MOL MICROBIOL, V12, P865, DOI 10.1111/j.1365-2958.1994.tb01074.x; Jackson AP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-584; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Jernigan RW, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-23; Karasova D, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-75; KARLIN S, 1995, TRENDS GENET, V11, P283; Karlin S, 1997, J BACTERIOL, V179, P3899, DOI 10.1128/jb.179.12.3899-3913.1997; Karlin S, 1998, CURR OPIN MICROBIOL, V1, P598, DOI 10.1016/S1369-5274(98)80095-7; Kiewitz C, 2000, MICROBIOL-UK, V146, P2365, DOI 10.1099/00221287-146-10-2365; Klockgether J, 2007, J BACTERIOL, V189, P2443, DOI 10.1128/JB.01688-06; Kuo CH, 2009, FEMS MICROBIOL REV, V33, P38, DOI 10.1111/j.1574-6976.2008.00140.x; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; Lawrence JG, 1999, CURR OPIN MICROBIOL, V2, P519, DOI 10.1016/S1369-5274(99)00010-7; Lawrence JG, 1997, J MOL EVOL, V44, P383, DOI 10.1007/PL00006158; Le Gall T, 2007, MOL BIOL EVOL, V24, P2373, DOI 10.1093/molbev/msm172; Levings RS, 2007, ANTIMICROB AGENTS CH, V51, P317, DOI 10.1128/AAC.01229-06; Lewin A, 1998, J BASIC MICROB, V38, P17, DOI 10.1002/(SICI)1521-4028(199803)38:1<17::AID-JOBM17>3.0.CO;2-D; Lima-Mendez G, 2008, MOL BIOL EVOL, V25, P762, DOI 10.1093/molbev/msn023; Lima-Mendez G, 2011, RES MICROBIOL, V162, P737, DOI 10.1016/j.resmic.2011.06.006; Liu B, 2008, FEMS MICROBIOL REV, V32, P627, DOI 10.1111/j.1574-6976.2008.00114.x; Lukacova M, 2008, CLIN MICROBIOL INFEC, V14, P200, DOI 10.1111/j.1469-0691.2007.01876.x; Mainil JG, 2005, J APPL MICROBIOL, V98, P1332, DOI 10.1111/j.1365-2672.2005.02653.x; Mantri Y, 2004, NUCLEIC ACIDS RES, V32, pD55, DOI 10.1093/nar/gkh059; MARKLEIN G, 1981, KLIN PADIATR, V193, P394, DOI 10.1055/s-2008-1034507; Marri PR, 2008, GENOME, V51, P164, DOI [10.1139/G07-105, 10.1139/g07-105]; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Mrazek J, 1999, ANN NY ACAD SCI, V870, P314, DOI 10.1111/j.1749-6632.1999.tb08893.x; Nakamura Y, 2004, NAT GENET, V36, P760, DOI 10.1038/ng1381; Nogueira T, 2009, CURR BIOL, V19, P1683, DOI 10.1016/j.cub.2009.08.056; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Oelschlaeger TA, 2002, INT J ANTIMICROB AG, V19, P517, DOI 10.1016/S0924-8579(02)00092-4; Ogura Y, 2009, P NATL ACAD SCI USA, V106, P17939, DOI 10.1073/pnas.0903585106; Pal C, 2005, BIOINFORMATICS, V21, P222, DOI 10.1093/bioinformatics/bti1136; Pallen MJ, 2007, NATURE, V449, P835, DOI 10.1038/nature06248; Plainvert C, 2007, J BACTERIOL, V189, P8528, DOI 10.1128/JB.01013-07; Pride DT, 2003, GENOME RES, V13, P145, DOI 10.1101/gr.335003; Pride DT, 2002, GENOME LETT, V1, P2, DOI [doi.org/10.1166/gl.2002.003, DOI 10.1166/GL.2002.003]; Ramaiah N, 2003, MICROB ECOL, V45, P444, DOI 10.1007/s00248-001-1068-7; Ray JL, 2005, METHOD ENZYMOL, V395, P491, DOI 10.1016/S0076-6879(05)95026-X; Rendon MA, 2007, P NATL ACAD SCI USA, V104, P10637, DOI 10.1073/pnas.0704104104; Reva ON, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-251; Reva ON, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-90; Riesenfeld CS, 2004, ENVIRON MICROBIOL, V6, P981, DOI 10.1111/j.1462-2920.2004.00664.x; Ripoll F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005660; RITTER A, 1995, MOL MICROBIOL, V17, P109, DOI 10.1111/j.1365-2958.1995.mmi_17010109.x; Rosewarne CP, 2010, FEMS MICROBIOL ECOL, V72, P35, DOI 10.1111/j.1574-6941.2009.00823.x; Rowley G, 2011, MICROBIOL-SGM, V157, P848, DOI 10.1099/mic.0.046011-0; Sasaki Y, 2011, VET MICROBIOL, V150, P140, DOI 10.1016/j.vetmic.2010.12.024; Sun YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019267; Teeling H, 2004, ENVIRON MICROBIOL, V6, P938, DOI 10.1111/j.1462-2920.2004.00624.x; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; Tobes R., 2011, NAT PRECEDI IN PRESS, DOI [10.1038/npre.2011.6001.1, DOI 10.1038/NPRE.2011.6001.1]; Touchon M, 2011, J BACTERIOL, V193, P2460, DOI 10.1128/JB.01307-10; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Turner SA, 2003, ANTIMICROB AGENTS CH, V47, P727, DOI 10.1128/AAC.47.2.727-734.2003; Van Dongen S, 2008, SIAM J MATRIX ANAL A, V30, P121, DOI 10.1137/040608635; van Passel MWJ, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-84; van Passel MWJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000059; Wang L, 1998, INFECT IMMUN, V66, P3545, DOI 10.1128/IAI.66.8.3545-3551.1998; Wang YD, 1998, J BACTERIOL, V180, P4102, DOI 10.1128/JB.180.16.4102-4110.1998; WEINER M, 1973, NEW YORK STATE J MED, V73, P2256; Yoon SH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-184; Yoon SH, 2007, NUCLEIC ACIDS RES, V35, pD395, DOI 10.1093/nar/gkl790	96	25	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e25702	10.1371/journal.pone.0025702	http://dx.doi.org/10.1371/journal.pone.0025702			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022434	Green Submitted, gold, Green Published			2022-12-27	WOS:000295981600013
J	Lu, ZJ; Yuan, ZB; Miyoshi, T; Wang, Q; Su, ZG; Chang, CC; Shi, WB				Lu, Zongji; Yuan, Zuobiao; Miyoshi, Toru; Wang, Qian; Su, Zhiguang; Chang, Catherine C.; Shi, Weibin			Identification of Soat1 as a Quantitative Trait Locus Gene on Mouse Chromosome 1 Contributing to Hyperlipidemia	PLOS ONE			English	Article							APOLIPOPROTEIN-A-II; ATHEROSCLEROTIC LESIONS; ACAT INHIBITION; HDL CHOLESTEROL; ACYL-COA; MICE; INTERCROSS; C57BL/6; C3H; HYPERCHOLESTEROLEMIA	We previously identified two closely linked quantitative trait loci (QTL) on distal chromosome 1 contributing to major variations in plasma cholesterol and triglyceride levels in an intercross derived from C57BL/6 (B6) and C3H/HeJ (C3H) apolipoprotein E-deficient (apoE(-/-)) mice. Soat1, encoding sterol o-acyltransferase 1, is a functional candidate gene located underneath the proximal linkage peak. We sequenced the coding region of Soat1 and identified four single nucleotide polymorphisms (SNPs) between B6 and C3H mice. Two of the SNPs resulted in amino-acid substitutions (Ile147Val and His205Tyr). Functional assay revealed an increased enzyme activity of Soat1 in peritoneal macrophages of C3H mice relative to those of B6 mice despite comparable protein expression levels. Allelic variants of Soat1 were associated with variations in plasma cholesterol and triglyceride levels in an intercross between B6.apoE(-/-) and C3H.apoE(-/-) mice. Inheritance of the C3H allele resulted in significantly higher plasma lipid levels than inheritance of the B6 allele. Soat1 variants were also significantly linked to major variations in plasma esterified cholesterol levels but not with free cholesterol levels. Trangenic expression of C3H Soat1 in B6.apoE(-/-) mice resulted in elevations of plasma cholesterol and triglyceride levels. These results indicate that Soat1 is a QTL gene contributing to hyperlipidemia.	[Lu, Zongji; Yuan, Zuobiao; Miyoshi, Toru; Wang, Qian; Su, Zhiguang; Shi, Weibin] Univ Virginia, Dept Radiol & Med Imaging, Charlottesville, VA 22903 USA; [Shi, Weibin] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA USA; [Chang, Catherine C.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Biochem, Hanover, NH 03756 USA	University of Virginia; University of Virginia; Dartmouth College	Lu, ZJ (corresponding author), Univ Virginia, Dept Radiol & Med Imaging, Charlottesville, VA 22903 USA.	ws4v@virginia.edu	, ws4v/L-4372-2019; Su, Zhiguang/AFS-0022-2022	Su, Zhiguang/0000-0001-8635-9310; shi, weibin/0000-0002-9155-613X	NIH [HL82881]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082881] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH grant HL82881. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bocan TMA, 2000, ARTERIOSCL THROM VAS, V20, P70, DOI 10.1161/01.ATV.20.1.70; Bocan TMA, 2001, ATHEROSCLEROSIS, V157, P97, DOI 10.1016/S0021-9150(00)00713-9; Chang CCY, 2000, J BIOL CHEM, V275, P28083; Chang TY, 2009, AM J PHYSIOL-ENDOC M, V297, pE1, DOI 10.1152/ajpendo.90926.2008; Dansky HM, 2002, GENETICS, V160, P1599; Delsing DJM, 2001, CIRCULATION, V103, P1778, DOI 10.1161/01.CIR.103.13.1778; DOOLITTLE MH, 1990, J BIOL CHEM, V265, P16380; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; HEDRICK CC, 1993, J BIOL CHEM, V268, P20676; LEBOEUF RC, 1990, J LIPID RES, V31, P91; Machleder D, 1997, J CLIN INVEST, V99, P1406, DOI 10.1172/JCI119300; Nissen SE, 2006, NEW ENGL J MED, V354, P1253, DOI 10.1056/NEJMoa054699; Ohta T, 2004, BBA-MOL CELL BIOL L, V1682, P56, DOI 10.1016/S1388-1981(04)00025-3; Perrey S, 2001, ATHEROSCLEROSIS, V155, P359, DOI 10.1016/S0021-9150(00)00599-2; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Shi WB, 2000, CIRC RES, V86, P1078, DOI 10.1161/01.RES.86.10.1078; Shi WB, 2003, ARTERIOSCL THROM VAS, V23, P1901, DOI 10.1161/01.ATV.0000091249.34404.B7; Shi WB, 2002, CIRCULATION, V105, P2078, DOI 10.1161/01.CIR.0000015853.59427.32; Su YR, 2005, CIRCULATION, V111, P2373, DOI 10.1161/01.CIR.0000164236.19860.13; Su ZG, 2006, GENETICS, V172, P1799, DOI 10.1534/genetics.105.051912; Suto J, 1999, BBA-MOL BASIS DIS, V1453, P385, DOI 10.1016/S0925-4439(99)00013-7; Tardif JC, 2006, NAT CLIN PRACT CARD, V3, P366, DOI 10.1038/ncpcardio0599; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tian J, 2005, BIOCHEM BIOPH RES CO, V329, P1102, DOI 10.1016/j.bbrc.2005.02.090; Wang SS, 2007, ARTERIOSCL THROM VAS, V27, P2671, DOI 10.1161/ATVBAHA.107.148106; Wang XS, 2005, CIRC RES, V96, P27, DOI 10.1161/01.RES.0000151332.39871.13; Wang XS, 2004, GENOME RES, V14, P1767, DOI 10.1101/gr.2668204; Wang XS, 2003, GENOME RES, V13, P1654, DOI 10.1101/gr.1185803; Weng W, 1996, P NATL ACAD SCI USA, V93, P14788, DOI 10.1073/pnas.93.25.14788; Wierzbicki AS, 2008, CURR VASC PHARMACOL, V6, P13, DOI 10.2174/157016108783331268; Yagyu H, 2000, J BIOL CHEM, V275, P21324, DOI 10.1074/jbc.M002541200; Yuan ZB, 2009, CIRC-CARDIOVASC GENE, V2, P220, DOI 10.1161/CIRCGENETICS.108.792499; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543	33	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e25344	10.1371/journal.pone.0025344	http://dx.doi.org/10.1371/journal.pone.0025344			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022387	gold, Green Published, Green Submitted			2022-12-27	WOS:000295981600006
J	Domenichini, A; Dadda, M; Facchin, L; Bisazza, A; Argenton, F				Domenichini, Alice; Dadda, Marco; Facchin, Lucilla; Bisazza, Angelo; Argenton, Francesco			Isolation and Genetic Characterization of Mother-of-Snow-White, a Maternal Effect Allele Affecting Laterality and Lateralized Behaviors in Zebrafish	PLOS ONE			English	Article							LEFT-RIGHT ASYMMETRY; HAIR-WHORL DIRECTION; KUPFFERS VESICLE; EMBRYONIC-DEVELOPMENT; BRAIN LATERALIZATION; CEREBRAL ASYMMETRY; LEFTWARD FLOW; NODAL FLOW; EXPRESSION; HANDEDNESS	In the present work we report evidence compatible with a maternal effect allele affecting left-right development and functional lateralization in vertebrates. Our study demonstrates that the increased frequency of reversed brain asymmetries in a zebrafish line isolated through a behavioral assay is due to selection of mother-of-snow-white (msw), a maternal effect allele involved in early stages of left-right development in zebrafish. msw homozygous females could be identified by screening of their progeny for the position of the parapineal organ because in about 50% of their offspring we found an altered, either bilateral or right-sided, expression of lefty1 and spaw. Deeper investigations at earlier stages of development revealed that msw is involved in the specification and differentiation of precursors of the Kupffer's vesicle, a structure homologous to the mammalian node. To test the hypothesis that msw, by controlling Kupffer's vesicle morphogenesis, controls lateralized behaviors related to diencephalic asymmetries, we analyzed left-and right-parapineal offspring in a "viewing test''. As a result, left-and right-parapineal individuals showed opposite and complementary eye preference when scrutinizing a model predator, and a different degree of lateralization when scrutinizing a virtual companion. As maternal effect genes are expected to evolve more rapidly when compared to zygotic ones, our results highlight the driving force of maternal effect alleles in the evolution of vertebrates behaviors.	[Domenichini, Alice; Facchin, Lucilla; Argenton, Francesco] Univ Padua, Dipartimento Biol, Padua, Italy; [Dadda, Marco; Bisazza, Angelo] Univ Padua, Dipartimento Psicol Gen, Padua, Italy	University of Padua; University of Padua	Domenichini, A (corresponding author), Univ Padua, Dipartimento Biol, Padua, Italy.	francesco.argenton@unipd.it	Dadda, Marco/D-2417-2014; DADDA, Marco/ABI-7266-2020; Argenton, Francesco/AAS-8494-2021	DADDA, Marco/0000-0001-7944-4058; Argenton, Francesco/0000-0002-0803-8236; Bisazza, Angelo/0000-0003-0209-7638				AFZELIUS B A, 1976, Science (Washington D C), V193, P317; Alexander J, 1999, CURR BIOL, V9, P1147, DOI 10.1016/S0960-9822(00)80016-0; Amack JD, 2007, DEV BIOL, V310, P196, DOI 10.1016/j.ydbio.2007.05.039; ANNETT M, 1995, RIGHT SHIFT THEORY G; BARKER MS, 2005, PLOS GENETICS, V1; Barth KA, 2005, CURR BIOL, V15, P844, DOI 10.1016/j.cub.2005.03.047; Bisazza A, 1998, NEUROSCI BIOBEHAV R, V22, P411, DOI 10.1016/S0149-7634(97)00050-X; Bisgrove BW, 2000, DEVELOPMENT, V127, P3567; Blum M, 2009, SEMIN CELL DEV BIOL, V20, P464, DOI 10.1016/j.semcdb.2008.11.005; Boycott AE, 1923, P R SOC LOND B-CONTA, V95, P207, DOI 10.1098/rspb.1923.0033; Bryden M. P., 1982, LATERALITY FUNCTIONA; Capdevila J, 2000, CELL, V101, P9, DOI 10.1016/S0092-8674(00)80619-4; COLLINS RL, 1985, CEREBRAL LATERALIZAT, P41; Cooper MS, 1996, DEV BIOL, V180, P184, DOI 10.1006/dbio.1996.0294; Corballis MC, 1998, TRENDS COGN SCI, V2, P152, DOI 10.1016/S1364-6613(98)01156-5; Coutellier L, 2009, BEHAV BRAIN RES, V196, P192, DOI 10.1016/j.bbr.2008.08.042; Dadda M, 2010, BEHAV BRAIN RES, V206, P208, DOI 10.1016/j.bbr.2009.09.019; Davison A, 2009, BIOL LETTERS, V5, P20, DOI 10.1098/rsbl.2008.0528; Demuth JP, 2007, GENETICA, V129, P37, DOI 10.1007/s10709-006-0031-4; ELIASSON R, 1977, NEW ENGL J MED, V297, P1, DOI 10.1056/NEJM197707072970101; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Facchin L, 1999, BEHAV BRAIN RES, V103, P229, DOI 10.1016/S0166-4328(99)00043-1; Facchin L, 2009, BEHAV BRAIN RES, V197, P157, DOI 10.1016/j.bbr.2008.08.033; FREEMAN G, 1982, ROUX ARCH DEV BIOL, V191, P69, DOI 10.1007/BF00848443; Gamse JT, 2005, DEVELOPMENT, V132, P4869, DOI 10.1242/dev.02046; Gamse JT, 2003, DEVELOPMENT, V130, P1059, DOI 10.1242/dev.00270; Ghirlanda S, 2004, P ROY SOC B-BIOL SCI, V271, P853, DOI 10.1098/rspb.2003.2669; Gilmour DT, 2002, NEURON, V34, P577, DOI 10.1016/S0896-6273(02)00683-9; Grande C, 2009, NATURE, V457, P1007, DOI 10.1038/nature07603; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; Hopkins WD, 2001, PSYCHOL SCI, V12, P299, DOI 10.1111/1467-9280.00355; Hosoiri Y, 2003, DEV GENES EVOL, V213, P193, DOI 10.1007/s00427-003-0315-y; Jansen A, 2007, NEUROIMAGE, V35, P853, DOI 10.1016/j.neuroimage.2006.12.025; Kanka J, 2003, THERIOGENOLOGY, V59, P3, DOI 10.1016/S0093-691X(02)01267-0; Karlsson J, 2001, MAR BIOTECHNOL, V3, P522, DOI 10.1007/s1012601-0053-4; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Klar AJS, 1996, COLD SPRING HARB SYM, V61, P59; Klar AJS, 2003, GENETICS, V165, P269; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Kreiling JA, 2007, DEV DYNAM, V236, P1963, DOI 10.1002/dvdy.21191; Latham KE, 2001, FRONT BIOSCI, V6, pD748, DOI 10.2741/Latham; Levin M, 2005, MECH DEVELOP, V122, P3, DOI 10.1016/j.mod.2004.08.006; Long S, 2003, DEVELOPMENT, V130, P2303, DOI 10.1242/dev.00436; Maynard Smith J., 1982, pi; McManus IC, 2009, LANGUAGE LATERALIZATION AND PSYCHOSIS, P37, DOI 10.1017/CBO9780511576744.004; McManus IC, 1992, HDB NEUROPSYCHOLOGY, V6, P115, DOI DOI 10.1037/0894-4105.6.2.115; MCMANUS IC, 2002, LEFT HAND RIGHT HAND; Meno C, 1997, GENES CELLS, V2, P513, DOI 10.1046/j.1365-2443.1997.1400338.x; Meno C, 1998, CELL, V94, P287, DOI 10.1016/S0092-8674(00)81472-5; Miklosi A, 1997, PHYSIOL BEHAV, V63, P127, DOI 10.1016/S0031-9384(97)00418-6; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; NEUGEBAUER JM, 2009, NATURE; Nonaka S, 2005, PLOS BIOL, V3, P1467, DOI 10.1371/journal.pbio.0030268; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Nonaka S, 2002, NATURE, V418, P96, DOI 10.1038/nature00849; Okada Y, 1999, MOL CELL, V4, P459, DOI 10.1016/S1097-2765(00)80197-5; Okada Y, 2005, CELL, V121, P633, DOI 10.1016/j.cell.2005.04.008; Oteiza P, 2008, DEVELOPMENT, V135, P2807, DOI 10.1242/dev.022228; Payer B, 2003, CURR BIOL, V13, P2110, DOI 10.1016/j.cub.2003.11.026; Priebe K, 2005, DEV PSYCHOBIOL, V47, P398, DOI 10.1002/dev.20098; Rebagliati MR, 1998, P NATL ACAD SCI USA, V95, P9932, DOI 10.1073/pnas.95.17.9932; Rife DC, 1940, GENETICS, V25, P0178; Rogers LJ, 2002, COMP VERTEBRATE LATE; Schaafsma SM, 2009, PHILOS T R SOC B, V364, P915, DOI 10.1098/rstb.2008.0244; Schneider I, 2008, DEVELOPMENT, V135, P75, DOI 10.1242/dev.004713; SCHULTEMERKER S, 1994, DEVELOPMENT, V120, P1009; Schweickert A, 2007, CURR BIOL, V17, P60, DOI 10.1016/j.cub.2006.10.067; Shu XD, 2007, DEVELOPMENT, V134, P1921, DOI 10.1242/dev.02851; Sicotte N L, 1999, Laterality, V4, P265, DOI 10.1080/135765099396980; Sovrano VA, 2006, BEHAV BRAIN RES, V167, P226, DOI 10.1016/j.bbr.2005.09.021; Sturtevant AH, 1923, SCIENCE, V58, P269, DOI 10.1126/science.58.1501.269; TELFORD NA, 1990, MOL REPROD DEV, V26, P90, DOI 10.1002/mrd.1080260113; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Vallortigara G, 1999, BRAIN RES REV, V30, P164, DOI 10.1016/S0165-0173(99)00012-0; Vallortigara G, 2005, BEHAV BRAIN SCI, V28, P575, DOI 10.1017/S0140525X05000105; Vallortigara G, 2005, BEHAV BRAIN SCI, V28, P615, DOI 10.1017/S0140525X05480103; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wolf JB, 2009, PHILOS T R SOC B, V364, P1107, DOI 10.1098/rstb.2008.0238; Wolf JB, 1998, TRENDS ECOL EVOL, V13, P64, DOI 10.1016/S0169-5347(97)01233-0; Zheng P, 2009, P NATL ACAD SCI USA, V106, P7473, DOI 10.1073/pnas.0900519106	80	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e25972	10.1371/journal.pone.0025972	http://dx.doi.org/10.1371/journal.pone.0025972			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022484	Green Published, gold, Green Submitted			2022-12-27	WOS:000295978600033
J	Sheldon, KL; Maldonado, EN; Lemasters, JJ; Rostovtseva, TK; Bezrukov, SM				Sheldon, Kely L.; Maldonado, Eduardo N.; Lemasters, John J.; Rostovtseva, Tatiana K.; Bezrukov, Sergey M.			Phosphorylation of Voltage-Dependent Anion Channel by Serine/Threonine Kinases Governs Its Interaction with Tubulin	PLOS ONE			English	Article							PROTEIN-KINASE; PERMEABILITY TRANSITION; MITOCHONDRIA; VDAC; CAMP; INHIBITION; APOPTOSIS; BINDING; DRP1; PH	Tubulin was recently found to be a uniquely potent regulator of the voltage-dependent anion channel (VDAC), the most abundant channel of the mitochondrial outer membrane, which constitutes a major pathway for ATP/ADP and other metabolites across this membrane. Dimeric tubulin induces reversible blockage of VDAC reconstituted into a planar lipid membrane and dramatically reduces respiration of isolated mitochondria. Here we show that VDAC phosphorylation is an important determinant of its interaction with dimeric tubulin. We demonstrate that in vitro phosphorylation of VDAC by either glycogen synthase kinase-3 beta (GSK3 beta) or cAMP-dependent protein kinase A (PKA), increases the on-rate of tubulin binding to the reconstituted channel by orders of magnitude, but only for tubulin at the cis side of the membrane. This and the fact the basic properties of VDAC, such as single-channel conductance and selectivity, remained unaltered by phosphorylation allowed us to suggest the phosphorylation regions positioned on the cytosolic loops of VDAC and establish channel orientation in our reconstitution experiments. Experiments on human hepatoma cells HepG2 support our conjecture that VDAC permeability for the mitochondrial respiratory substrates is regulated by dimeric tubulin and channel phosphorylation. Treatment of HepG2 cells with colchicine prevents microtubule polymerization, thus increasing dimeric tubulin availability in the cytosol. Accordingly, this leads to a decrease of mitochondrial potential measured by assessing mitochondrial tetramethylrhodamine methyester uptake with confocal microscopy. Inhibition of PKA activity blocks and reverses mitochondrial depolarization induced by colchicine. Our findings suggest a novel functional link between serine/threonine kinase signaling pathways, mitochondrial respiration, and the highly dynamic microtubule network which is characteristic of cancerogenesis and cell proliferation.	[Sheldon, Kely L.; Rostovtseva, Tatiana K.; Bezrukov, Sergey M.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Lab Phys & Struct Biol, Program Phys Biol, NIH, Bethesda, MD 20892 USA; [Sheldon, Kely L.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Maldonado, Eduardo N.; Lemasters, John J.] Med Univ S Carolina, Charleston, SC 29425 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Medical University of South Carolina	Sheldon, KL (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Lab Phys & Struct Biol, Program Phys Biol, NIH, Bethesda, MD 20892 USA.	rostovtt@mail.nih.gov	Maldonado, Eduardo/AAN-3907-2020	Maldonado, Eduardo/0000-0002-5285-3027	NIH, Eunice Kennedy Shriver National Institute of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073336] Funding Source: NIH RePORTER	NIH, Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were supported by the Intramural Research Program of the NIH, Eunice Kennedy Shriver National Institute of Child Health and Human Development (for K.L.S., T.K.R., and S.M.B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre N, 2000, CANCER RES, V60, P5349; Anesti V, 2006, BBA-BIOENERGETICS, V1757, P692, DOI 10.1016/j.bbabio.2006.04.013; APELL HJ, 1977, J MEMBRANE BIOL, V31, P171, DOI 10.1007/BF01869403; Baines CP, 2003, CIRC RES, V92, P873, DOI 10.1161/01.RES.0000069215.36389.8D; BERA AK, 1995, BIOCHEM BIOPH RES CO, V209, P213, DOI 10.1006/bbrc.1995.1491; BLACHLYDYSON E, 1990, SCIENCE, V247, P1233, DOI 10.1126/science.1690454; Capone RF, 2007, BIOPHYS J, p609A; Carlucci A, 2008, TRENDS CELL BIOL, V18, P604, DOI 10.1016/j.tcb.2008.09.006; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Chen Y, 2009, CELL CYCLE, V8, P257, DOI 10.4161/cc.8.2.7551; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; CORTESE JD, 1992, BIOCHIM BIOPHYS ACTA, V1100, P189; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Das S, 2008, CIRC RES, V103, P983, DOI 10.1161/CIRCRESAHA.108.178970; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Distler AM, 2007, BBA-PROTEINS PROTEOM, V1774, P628, DOI 10.1016/j.bbapap.2007.03.012; Esteve MA, 2007, CURR CANCER DRUG TAR, V7, P713; Feliciello A, 2005, CELL SIGNAL, V17, P279, DOI 10.1016/j.cellsig.2004.09.009; GLASS DB, 1986, J BIOL CHEM, V261, P2166; Goncalves A, 2001, P NATL ACAD SCI USA, V98, P11737, DOI 10.1073/pnas.191388598; Graef M, 2011, EMBO J, V30, P2101, DOI 10.1038/emboj.2011.104; Gurnev PA, 2011, FEBS LETT, V585, P2363, DOI 10.1016/j.febslet.2011.06.008; Guzun R, 2011, BBA-BIOENERGETICS, V1807, P458, DOI 10.1016/j.bbabio.2011.01.010; Karbowski M, 2001, J CELL SCI, V114, P281; Lemasters JJ, 2006, BBA-MOL BASIS DIS, V1762, P181, DOI 10.1016/j.bbadis.2005.10.006; Lemasters JJ, 2007, METHOD CELL BIOL, V80, P283, DOI 10.1016/S0091-679X(06)80014-2; Lemeshko VV, 2006, EUR BIOPHYS J BIOPHY, V36, P57, DOI 10.1007/s00249-006-0101-7; Liberatori S, 2004, PROTEOMICS, V4, P1335, DOI 10.1002/pmic.200300734; Maldonado EN, 2010, CANCER RES, V70, P10192, DOI 10.1158/0008-5472.CAN-10-2429; Monge C., 2008, MOL CELL BIOCHEM, V318, P94; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Okamoto K, 2011, EMBO J, V30, P2095, DOI 10.1038/emboj.2011.149; PALMIERI F, 1989, J BIOENERG BIOMEMBR, V21, P417, DOI 10.1007/BF00762514; Pastorino JG, 2005, CANCER RES, V65, P10545, DOI 10.1158/0008-5472.CAN-05-1925; Pediaditakis P, 2010, BIOCHEM J, V431, P411, DOI 10.1042/BJ20091741; Porcelli AM, 2005, BIOCHEM BIOPH RES CO, V326, P799, DOI 10.1016/j.bbrc.2004.11.105; Priel A., 2005, EUR BIOPHYS J, V35; Rostovtseva T, 1996, J BIOL CHEM, V271, P28006, DOI 10.1074/jbc.271.45.28006; Rostovtseva TK, 2008, J BIOENERG BIOMEMBR, V40, P163, DOI 10.1007/s10863-008-9145-y; Rostovtseva TK, 2006, J BIOL CHEM, V281, P37496, DOI 10.1074/jbc.M602548200; Rostovtseva TK, 2008, P NATL ACAD SCI USA, V105, P18746, DOI 10.1073/pnas.0806303105; Rostovtseva TK, 2005, J BIOENERG BIOMEMBR, V37, P129, DOI 10.1007/s10863-005-6566-8; Rovini A, 2011, BBA-BIOENERGETICS, V1807, P679, DOI 10.1016/j.bbabio.2011.01.001; Saks V, 2010, BBA-BIOENERGETICS, V1797, P678, DOI 10.1016/j.bbabio.2010.01.011; Schmidt O, 2011, CELL, V144, P227, DOI 10.1016/j.cell.2010.12.015; Schwertz H, 2007, PROTEOMICS, V7, P4579, DOI 10.1002/pmic.200700734; Shoshan-Barmatz V, 2006, CURR PHARM DESIGN, V12, P2249, DOI 10.2174/138161206777585111; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; Wolff J, 1996, PROTEIN SCI, V5, P2020, DOI 10.1002/pro.5560051008; Yuan SP, 2008, FASEB J, V22, P2809, DOI 10.1096/fj.08-107417	51	77	78	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e25539	10.1371/journal.pone.0025539	http://dx.doi.org/10.1371/journal.pone.0025539			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022409	Green Published, gold, Green Submitted			2022-12-27	WOS:000295978600021
J	Siddiqui, MSM; Bhaumik, B				Siddiqui, Mohammed Sultan Mohiuddin; Bhaumik, Basabi			A Reaction-Diffusion Model to Capture Disparity Selectivity in Primary Visual Cortex	PLOS ONE			English	Article							SPATIAL-FREQUENCY SELECTIVITY; CELL RECEPTIVE-FIELDS; SELF-ORGANIZING MODEL; OCULAR DOMINANCE; BINOCULAR DISPARITY; ORIENTATION SELECTIVITY; COMPLEX CELLS; HORIZONTAL DISPARITY; FUNCTIONAL ARCHITECTURE; DEPTH DISCRIMINATION	Decades of experimental studies are available on disparity selective cells in visual cortex of macaque and cat. Recently, local disparity map for iso-orientation sites for near-vertical edge preference is reported in area 18 of cat visual cortex. No experiment is yet reported on complete disparity map in V1. Disparity map for layer IV in V1 can provide insight into how disparity selective complex cell receptive field is organized from simple cell subunits. Though substantial amounts of experimental data on disparity selective cells is available, no model on receptive field development of such cells or disparity map development exists in literature. We model disparity selectivity in layer IV of cat V1 using a reaction-diffusion two-eye paradigm. In this model, the wiring between LGN and cortical layer IV is determined by resource an LGN cell has for supporting connections to cortical cells and competition for target space in layer IV. While competing for target space, the same type of LGN cells, irrespective of whether it belongs to left-eye-specific or right-eye-specific LGN layer, cooperate with each other while trying to push off the other type. Our model captures realistic 2D disparity selective simple cell receptive fields, their response properties and disparity map along with orientation and ocular dominance maps. There is lack of correlation between ocular dominance and disparity selectivity at the cell population level. At the map level, disparity selectivity topography is not random but weakly clustered for similar preferred disparities. This is similar to the experimental result reported for macaque. The details of weakly clustered disparity selectivity map in V1 indicate two types of complex cell receptive field organization.	[Siddiqui, Mohammed Sultan Mohiuddin; Bhaumik, Basabi] Indian Inst Technol Delhi, Dept Elect Engn, New Delhi, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Siddiqui, MSM (corresponding author), Indian Inst Technol Delhi, Dept Elect Engn, New Delhi, India.	bhaumik@ee.iitd.ac.in			IIT Delhi	IIT Delhi	IIT Delhi provides the PhD scholarship of MSMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Alonso JM, 1998, NAT NEUROSCI, V1, P395, DOI 10.1038/1609; ANDREWS BW, 1979, J PHYSIOL-LONDON, V287, P163, DOI 10.1113/jphysiol.1979.sp012652; Anzai A, 1999, J NEUROPHYSIOL, V82, P874, DOI 10.1152/jn.1999.82.2.874; BARLOW HB, 1967, J PHYSIOL-LONDON, V193, P327, DOI 10.1113/jphysiol.1967.sp008360; Bednar JA, 2006, NEUROCOMPUTING, V69, P1272, DOI 10.1016/j.neucom.2005.12.090; BERNS GS, 1993, P NATL ACAD SCI USA, V90, P8277, DOI 10.1073/pnas.90.17.8277; BETZ WJ, 1989, J PHYSIOL-LONDON, V418, P25, DOI 10.1113/jphysiol.1989.sp017827; Bhaumik B, 2003, J COMPUT NEUROSCI, V14, P211, DOI 10.1023/A:1021911019241; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; BLAKEMORE C, 1972, J PHYSIOL-LONDON, V226, P725, DOI 10.1113/jphysiol.1972.sp010006; BLAKEMORE C, 1970, VISION RES, V10, P1181, DOI 10.1016/0042-6989(70)90036-2; BLASDEL GG, 1992, J NEUROSCI, V12, P3115, DOI 10.1523/JNEUROSCI.12-08-03115.1992; Bonhoeffer T, 1996, CURR OPIN NEUROBIOL, V6, P119, DOI 10.1016/S0959-4388(96)80017-1; BONHOEFFER T, 1989, P NATL ACAD SCI USA, V86, P8113, DOI 10.1073/pnas.86.20.8113; Bridge H, 2001, J NEUROSCI, V21, P7293, DOI 10.1523/JNEUROSCI.21-18-07293.2001; Cellerino A, 1996, PROG NEUROBIOL, V49, P53, DOI 10.1016/0301-0082(96)00008-1; Chapman B, 2000, J NEUROSCI, V20, P1922; Chapman B, 2000, SCIENCE, V287, P2479, DOI 10.1126/science.287.5462.2479; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; Cheng H, 1995, J NEUROPHYSIOL, V74, P2548, DOI 10.1152/jn.1995.74.6.2548; CHINO YM, 1994, J NEUROSCI, V14, P5050; Chino YM, 1997, J NEUROSCI, V17, P296, DOI 10.1523/JNEUROSCI.17-01-00296.1997; Cowan AI, 1998, J NEUROPHYSIOL, V79, P13, DOI 10.1152/jn.1998.79.1.13; Crair MC, 1997, J NEUROPHYSIOL, V77, P3381, DOI 10.1152/jn.1997.77.6.3381; Cumming BG, 2002, NATURE, V418, P633, DOI 10.1038/nature00909; DeAngelis GC, 1999, J NEUROSCI, V19, P4046; Durand JB, 2007, CEREB CORTEX, V17, P1260, DOI 10.1093/cercor/bhl050; Engert F, 1997, NATURE, V388, P279, DOI 10.1038/40870; Erwin E, 1998, J NEUROSCI, V18, P9870; Erwin E., 1995, Society for Neuroscience Abstracts, V21, P2025; FERSTER D, 1981, J PHYSIOL-LONDON, V311, P623, DOI 10.1113/jphysiol.1981.sp013608; FIORENTINI A, 1971, VISION RES, V11, P1299, DOI 10.1016/0042-6989(71)90012-5; Fitzsimonds RM, 1998, PHYSIOL REV, V78, P143, DOI 10.1152/physrev.1998.78.1.143; Fleet DJ, 1996, VISION RES, V36, P1839, DOI 10.1016/0042-6989(95)00313-4; FREEMAN RD, 1992, J NEUROSCI, V12, P4721; GARDNER JC, 1986, EXP BRAIN RES, V64, P505, DOI 10.1007/BF00340488; Gerstner W, 1998, PULSED NEURAL NETWORKS, P3; GOODHILL GJ, 1993, BIOL CYBERN, V69, P109, DOI 10.1007/BF00226194; HAMMOND P, 1991, EXP BRAIN RES, V85, P631; HAYES WP, 1989, J NEUROSCI, V9, P1414; HEYDT RVD, 1978, EXP BRAIN RES, V31, P523; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Huberman AD, 2008, ANNU REV NEUROSCI, V31, P479, DOI 10.1146/annurev.neuro.31.060407.125533; Jaubert-Miazza L, 2005, VISUAL NEUROSCI, V22, P661, DOI 10.1017/S0952523805225154; Jegelka S, 2006, NEUROCOMPUTING, V69, P1291, DOI 10.1016/j.neucom.2005.12.094; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; JOSHUA DE, 1970, EXP BRAIN RES, V10, P389, DOI 10.1007/BF02324766; Kara P, 2009, NATURE, V458, P627, DOI 10.1038/nature07721; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kossel A, 1990, Neuroreport, V1, P115, DOI 10.1097/00001756-199010000-00008; LEVAY S, 1988, VISUAL NEUROSCI, V1, P395, DOI 10.1017/S0952523800004168; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; LO YJ, 1991, SCIENCE, V254, P1019, DOI 10.1126/science.1658939; Mathur M, 2005, NEUROCOMPUTING, V65, P85, DOI 10.1016/j.neucom.2004.10.059; MILLER KD, 1994, J NEUROSCI, V14, P409; Mitchell D, 2004, VISUAL NEUROSCIENCES, P189; NELSON JI, 1977, J NEUROPHYSIOL, V40, P260, DOI 10.1152/jn.1977.40.2.260; NIKARA T, 1968, EXP BRAIN RES, V6, P353; Ohzawa I, 1997, J NEUROPHYSIOL, V77, P2879, DOI 10.1152/jn.1997.77.6.2879; OHZAWA I, 1986, J NEUROPHYSIOL, V56, P243, DOI 10.1152/jn.1986.56.1.243; Ohzawa I, 1996, J NEUROPHYSIOL, V75, P1779, DOI 10.1152/jn.1996.75.5.1779; OHZAWA I, 1986, J NEUROPHYSIOL, V56, P221, DOI 10.1152/jn.1986.56.1.221; OHZAWA I, 1990, SCIENCE, V249, P1037, DOI 10.1126/science.2396096; Olson SJ, 1998, NEURAL NETWORKS, V11, P189, DOI 10.1016/S0893-6080(98)00003-3; Orban GA, 1991, VISION VISUAL DYSFUN, P173; PACKWOOD J, 1975, J NEUROPHYSIOL, V38, P1485, DOI 10.1152/jn.1975.38.6.1485; PEICHL L, 1979, J PHYSIOL-LONDON, V291, P117, DOI 10.1113/jphysiol.1979.sp012803; Piepenbrock C, 1997, NEURAL COMPUT, V9, P959, DOI 10.1162/neco.1997.9.5.959; Piepenbrock C, 1996, NEURAL P LETT, V3, P1; POGGIO GF, 1990, COLD SPRING HARB SYM, V55, P749; POGGIO GF, 1988, J NEUROSCI, V8, P4531; POGGIO GF, 1977, J NEUROPHYSIOL, V40, P1392, DOI 10.1152/jn.1977.40.6.1392; Pollen DA, 1989, MODELS BRAIN FUNCTIO, P115; Prince SJD, 2002, J NEUROPHYSIOL, V87, P209, DOI 10.1152/jn.00466.2000; Prince SJD, 2002, J NEUROPHYSIOL, V87, P191, DOI 10.1152/jn.00465.2000; Ramoa AS, 2001, J NEUROSCI, V21, P4299, DOI 10.1523/JNEUROSCI.21-12-04299.2001; Read JCA, 2004, J NEUROPHYSIOL, V91, P1271, DOI 10.1152/jn.00588.2003; Read JCA, 2003, J NEUROPHYSIOL, V90, P2795, DOI 10.1152/jn.01110.2002; RIDGE RMAP, 1984, J NEUROSCI, V4, P2614; Sanada TM, 2006, J NEUROPHYSIOL, V95, P2768, DOI 10.1152/jn.00955.2005; Sasaki KS, 2007, J NEUROPHYSIOL, V98, P1194, DOI 10.1152/jn.00429.2007; Sasaki KS, 2010, J NEUROSCI, V30, P13826, DOI 10.1523/JNEUROSCI.1135-10.2010; SCHUMAN EM, 1994, SCIENCE, V263, P532, DOI 10.1126/science.8290963; Shouval H, 1996, NEURAL COMPUT, V8, P1021, DOI 10.1162/neco.1996.8.5.1021; Shouval H, 1997, VISION RES, V37, P3339, DOI 10.1016/S0042-6989(97)00087-4; Smith EL, 1997, J NEUROPHYSIOL, V78, P351, DOI 10.1152/jn.1997.78.1.351; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Ts'o DY, 2009, J PHYSIOL-LONDON, V587, P2791, DOI 10.1113/jphysiol.2009.171082; Tsao DY, 2003, NEURON, V38, P103, DOI 10.1016/S0896-6273(03)00150-8; TYLER CW, 1979, VISION RES, V19, P859, DOI 10.1016/0042-6989(79)90019-1; Wehmeier U., 1989, METHODS NEURONAL MOD, P335; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599; Wheatstone C., 1838, PHILOS T ROY SOC LON, P371, DOI DOI 10.1098/RSTL.1838.0019; WILSON HR, 1976, VISION RES, V16, P983, DOI 10.1016/0042-6989(76)90230-3; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29; WORGOTTER F, 1991, J NEUROSCI, V11, P1959; XIONG MJ, 1994, J COMP NEUROL, V344, P581, DOI 10.1002/cne.903440407	99	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e24997	10.1371/journal.pone.0024997	http://dx.doi.org/10.1371/journal.pone.0024997			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022370	Green Submitted, Green Published, gold			2022-12-27	WOS:000295978600007
J	Jankovic, J; Yeeles, K; Katsakou, C; Amos, T; Morriss, R; Rose, D; Nichol, P; McCabe, R; Priebe, S				Jankovic, Jelena; Yeeles, Ksenija; Katsakou, Christina; Amos, Tim; Morriss, Richard; Rose, Diana; Nichol, Peter; McCabe, Rosemarie; Priebe, Stefan			Family Caregivers' Experiences of Involuntary Psychiatric Hospital Admissions of Their Relatives - a Qualitative Study	PLOS ONE			English	Article							MENTAL-HEALTH-SERVICES; CARE; BURDEN; USERS; SCHIZOPHRENIA; INFORMATION; ILLNESS; PEOPLE	Background: Family caregivers of people with mental disorders are frequently involved in involuntary hospital admissions of their relatives. Objective: To explore family caregivers' experience of involuntary admission of their relative. Method: 30 in-depth interviews were conducted with family caregivers of 29 patients who had been involuntarily admitted to 12 hospitals across England. Interviews were analysed using thematic analysis. Results: Four major themes of experiences were identified: relief and conflicting emotions in response to the relative's admission; frustration with a delay in getting help; being given the burden of care by services; and difficulties with confidentiality. Relief was a predominant emotion as a response to the relative's admission and it was accompanied by feelings of guilt and worry. Family caregivers frequently experienced difficulties in obtaining help from services prior to involuntary admission and some thought that services responded to crises rather than prevented them. Family caregivers experienced increased burden when services shifted the responsibility of caring for their mentally unwell relatives to them. Confidentiality was a delicate issue with family caregivers wanting more information and a say in decisions when they were responsible for aftercare, and being concerned about confidentiality of information they provided to services. Conclusion: Compulsory admission of a close relative can be a complex and stressful experience for family caregivers. In order for caregivers to be effective partners in care, a balance needs to be struck between valuing their involvement in providing care for a patient and not overburdening them.	[Jankovic, Jelena; Yeeles, Ksenija; Katsakou, Christina; Nichol, Peter; McCabe, Rosemarie; Priebe, Stefan] Queen Mary Univ London, Barts & London Sch Med & Dent, Unit Social & Community Psychiat, London, England; [Amos, Tim] Univ Bristol, Acad Unit Psychiat, Bristol, Avon, England; [Morriss, Richard] Univ Nottingham, Sch Community Hlth Sci, Nottingham NG7 2RD, England; [Rose, Diana] Kings Coll London, Inst Psychiat, London WC2R 2LS, England	University of London; Queen Mary University London; University of Bristol; University of Nottingham; University of London; King's College London	Jankovic, J (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Unit Social & Community Psychiat, London, England.	j.jankovic@qmul.ac.uk	Rose, Diana/HGE-8574-2022; Rose, Diana S/D-1387-2010; McCabe, Rose/A-9802-2013	Rose, Diana S/0000-0002-6393-6389; McCabe, Rose/0000-0003-2041-7383; Morriss, Richard/0000-0003-2910-4121; Yeeles, Ksenija/0000-0002-7757-0154; Priebe, Stefan/0000-0001-9864-3394	Department of Health, United Kingdom [0230072]; National Institute for Health Research (NIHR) United Kingdom Mental Health Research Network; NIHR Specialist Biomedical Research Centre; Maudsley National Health Service Foundation Trust; Institute of Psychiatry, King's College London	Department of Health, United Kingdom; National Institute for Health Research (NIHR) United Kingdom Mental Health Research Network(National Institute for Health Research (NIHR)); NIHR Specialist Biomedical Research Centre; Maudsley National Health Service Foundation Trust; Institute of Psychiatry, King's College London	The study was funded by a grant from the Policy Research Programme of the Department of Health, United Kingdom (Commission no 0230072). The views expressed in the publication are those of the authors and not necessarily those of the Department of Health. This study was supported by the National Institute for Health Research (NIHR) United Kingdom Mental Health Research Network. DR acknowledges financial support from the NIHR Specialist Biomedical Research Centre for Mental Health award to the South London and Maudsley National Health Service Foundation Trust and the Institute of Psychiatry, King's College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awad AG, 2008, PHARMACOECONOMICS, V26, P149, DOI 10.2165/00019053-200826020-00005; Cormac I, 2006, ADV PSYCHIAT TREAT, V12, P162, DOI DOI 10.1192/APT.12.3.162; Department of Health, 1999, NAT SERV FRAM MENT H; Department of Health, 2008, MENT HLTH ACT 1983 C; FRANCELL CG, 1988, HOSP COMMUNITY PSYCH, V39, P1296; Henderson C, 2004, BRIT MED J, V329, P136, DOI 10.1136/bmj.38155.585046.63; HERVEY N, 2004, ADV PSYCHIAT TREATME, V10, P81; Jones IR, 2009, SOC SCI MED, V69, P632, DOI 10.1016/j.socscimed.2009.06.015; Jungbauer J, 2004, SCHIZOPHRENIA BULL, V30, P665, DOI 10.1093/oxfordjournals.schbul.a007114; Katsakou C, 2010, PSYCHIAT SERV, V61, P286, DOI 10.1176/ps.2010.61.3.286; Kersten P, 2001, HEALTH SOC CARE COMM, V9, P235, DOI 10.1046/j.1365-2524.2001.00297.x; Lakeman R, 2008, J PSYCHIATR MENT HLT, V15, P203, DOI 10.1111/j.1365-2850.2007.01213.x; Lammers J, 2003, J Psychiatr Ment Health Nurs, V10, P385, DOI 10.1046/j.1365-2850.2003.00598.x; Noble LM, 2004, CURR OPIN PSYCHIATR, V17, P289, DOI 10.1097/01.yco.0000133832.42167.76; Ohaeri JU, 2003, CURR OPIN PSYCHIATR, V16, P457, DOI 10.1097/01.yco.0000079212.36371.c0; Pescosolido BA, 2004, SOC SCI MED, V58, P1795, DOI 10.1016/S0277-9536(03)00398-8; PINFOLD V, 2003, UNDER PRESSURE IMPAC; Pinfold V, 2007, MENT HEALTH REV J, V12, P7, DOI 10.1108/13619322200700015; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Priebe S, 2009, BRIT J PSYCHIAT, V194, P49, DOI 10.1192/bjp.bp.108.052266; Simpson EL, 2002, BRIT MED J, V325, P1265, DOI 10.1136/bmj.325.7375.1265; Slade M, 2007, BRIT J PSYCHIAT, V190, P148, DOI 10.1192/bjp.bp.106.024935; Szmukler GI, 1997, BRIT J PSYCHIAT, V171, P401, DOI 10.1192/bjp.171.5.401; Zahid MA, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-71	24	54	56	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25425	10.1371/journal.pone.0025425	http://dx.doi.org/10.1371/journal.pone.0025425			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834PW	22022393	Green Published, gold			2022-12-27	WOS:000295976000015
J	Menezes, AM; Torelly, J; Real, L; Bay, M; Poeta, J; Sprinz, E				Menezes, Andreia M.; Torelly, Jorge, Jr.; Real, Lucia; Bay, Monica; Poeta, Julia; Sprinz, Eduardo			Prevalence and Risk Factors Associated to Chronic Kidney Disease in HIV-Infected Patients on HAART and Undetectable Viral Load in Brazil	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; RENAL-DISEASE; SERUM CREATININE; DYSFUNCTION; PREDICTION; MORTALITY; COHORT; DIET; ERA	Background: To determine the prevalence and associated factors with chronic kidney disease (CKD) in a cohort of HIV-positive individuals with undetectable viral load on HAART. Methods: From March, 2009 to September 2009, 213 individuals between 18-70 years, period on HAART >= 12 months, viral load < 50 copies/mm(3), and CD4 >= 200 cells/mm(3), were consecutively enrolled at the outpatient clinic of Hospital de Clinicas, Porto Alegre, Brazil. Exclusion criteria were obesity, malnourishment, amputee, paraplegic, previous history of renal disease, pregnancy and hepatic insufficiency. Renal function was determined by estimated glomerular filtration rate (eGFR) assessed by the modification of diet in renal disease. CKD was defined as an eGFR less or equal than 60 ml/min/1.73 m(2), for a period of at least 3 months. Poisson regression was used to determine factors associated with CKD. Results: CKD was diagnosed in 8.4% of the population, and after adjustment, the risk factors were hypertension (RR = 3.88, 95%CI, 1.84 - 8.16), time on HAART (RR = 1.15, 95%CI, 1.03-1.27) and tenofovir exposure (RR = 2.25, 95%CI, 1.04-4.95). Higher weight (RR = ,0.88 95%CI, 0.82-0.96) was associated to normal function. Conclusions: CKD was a common finding in this cohort of patients and was related to hypertension, time on HAART and tenofovir exposure. We suggest a more frequent monitoring of renal function, especially for those with risk factors to early identify renal impairment.	[Menezes, Andreia M.; Torelly, Jorge, Jr.; Real, Lucia; Poeta, Julia; Sprinz, Eduardo] Univ Fed Rio Grande do Sul, Fac Med, Porto Alegre, RS, Brazil; [Bay, Monica; Sprinz, Eduardo] Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul	Menezes, AM (corresponding author), Univ Fed Rio Grande do Sul, Fac Med, Porto Alegre, RS, Brazil.	eduardo.sprinz@gmail.com.br	sprinz, eduardo/V-7961-2019	sprinz, eduardo/0000-0003-4343-8304	Fundo de incentivo a Pesquisa do Hospital de Clinicas de Porto Alegre (FIPE); Center for Reseach Support (CAPES/REUNI); National Research Council (CNPq) of Brazil	Fundo de incentivo a Pesquisa do Hospital de Clinicas de Porto Alegre (FIPE); Center for Reseach Support (CAPES/REUNI)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Research Council (CNPq) of Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was partially supported by Fundo de incentivo a Pesquisa do Hospital de Clinicas de Porto Alegre (FIPE), Center for Reseach Support (CAPES/REUNI) and National Research Council (CNPq) of Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AM DIAB ASS, 2010, DIABETES CARE, V33, P57; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; [Anonymous], 1995, WHO TECH REP SER, V854, P1; Barrios A, 2004, AIDS, V18, P960, DOI 10.1097/00002030-200404090-00019; Cheung CY, 2007, NEPHROL DIAL TRANSPL, V22, P3186, DOI 10.1093/ndt/gfm350; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Crum-Cianflone N, 2010, AIDS PATIENT CARE ST, V24, P353, DOI 10.1089/apc.2009.0326; Deti EK, 2010, HIV MED, V11, P308, DOI 10.1111/j.1468-1293.2009.00780.x; Gardner LI, 2003, JAIDS-J ACQ IMM DEF, V34, P320, DOI 10.1097/00126334-200311010-00011; Gupta SK, 2004, CLIN NEPHROL, V61, P1; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lucas GM, 2008, J INFECT DIS, V197, P1548, DOI 10.1086/587994; LUGON JR, 2009, JORNAL BRASILEIRO S1, V31, P2; Michaels SH, 1998, NEW ENGL J MED, V339, P405, DOI 10.1056/NEJM199808063390612; Mocroft A, 2007, AIDS, V21, P1119, DOI 10.1097/QAD.0b013e3280f774ee; Mocroft A, 2010, AIDS, V24, P1667, DOI 10.1097/QAD.0b013e328339fe53; Overton ET, 2009, HIV MED, V10, P343, DOI 10.1111/j.1468-1293.2009.00693.x; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; PERRONE RD, 1992, CLIN CHEM, V38, P1933; Romao JE, 2004, J BRAS NEPHROL, V26, P1; SHEMESH O, 1985, KIDNEY INT, V28, P830, DOI 10.1038/ki.1985.205; Soares A, 2010, AM J KIDNEY DIS, V55, P1162, DOI 10.1053/j.ajkd.2010.03.008; Sorli ML, 2008, JAIDS-J ACQ IMM DEF, V48, P506, DOI 10.1097/QAI.0b013e31817bbecb; Stevens LA, 2005, MED CLIN N AM, V89, P457, DOI 10.1016/j.mcna.2004.11.009; Stohr W, 2008, ANTIVIR THER, V13, P761; Tozzi V, 2010, ANTIVIR RES, V85, P190, DOI 10.1016/j.antiviral.2009.09.001; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865; World Health Organization (WHO), 2008, GLOB DAT BOD MASS IN; Wyatt CM, 2007, AIDS, V21, P2101, DOI 10.1097/QAD.0b013e3282ef1bb4	30	30	31	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26042	10.1371/journal.pone.0026042	http://dx.doi.org/10.1371/journal.pone.0026042			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022501	gold, Green Published, Green Submitted			2022-12-27	WOS:000295976000059
J	Mui, UN; Lubczyk, CM; Nam, SC				Uyen Ngoc Mui; Lubczyk, Christina M.; Nam, Sang-Chul			Role of Spectraplakin in Drosophila Photoreceptor Morphogenesis	PLOS ONE			English	Article							ESSENTIAL STRUCTURAL ROLE; MICROTUBULE PLUS END; RETINITIS-PIGMENTOSA; ADHERENS JUNCTIONS; EPITHELIAL-CELLS; AXON EXTENSION; SHORT-STOP; CRUMBS; EYE; PROTEIN	Background: Crumbs (Crb), a cell polarity gene, has been shown to provide a positional cue for the apical membrane domain and adherens junction during Drosophila photoreceptor morphogenesis. It has recently been found that stable microtubules in developing Drosophila photoreceptors were linked to Crb localization. Coordinated interactions between microtubule and actin cytoskeletons are involved in many polarized cellular processes. Since Spectraplakin is able to bind both microtubule and actin cytoskeletons, the role of Spectraplakin was analyzed in the regulations of apical Crb domain in developing Drosophila photoreceptors. Methodology/Principal Findings: The localization pattern of Spectraplakin in developing pupal photoreceptors showed a unique intracellular distribution. Spectraplakin localized at rhabdomere terminal web which is at the basal side of the apical Crb or rhabdomere, and in between the adherens junctions. The spectraplakin mutant photoreceptors showed dramatic mislocalizations of Crb, adherens junctions, and the stable microtubules. This role of Spectraplakin in Crb and adherens junction regulation was further supported by spectraplakin's gain-of-function phenotype. Spectraplakin overexpression in photoreceptors caused a cell polarity defect including dramatic mislocalization of Crb, adherens junctions and the stable microtubules in the developing photoreceptors. Furthermore, a strong genetic interaction between spectraplakin and crb was found using a genetic modifier test. Conclusions/Significance: In summary, we found a unique localization of Spectraplakin in photoreceptors, and identified the role of spectraplakin in the regulation of the apical Crb domain and adherens junctions through genetic mutational analysis. Our data suggest that Spectraplakin, an actin-microtubule cross-linker, is essential in the apical and adherens junction controls during the photoreceptors morphogenesis.	[Uyen Ngoc Mui; Lubczyk, Christina M.; Nam, Sang-Chul] Baylor Univ, Dept Biol, Waco, TX 76798 USA	Baylor University	Nam, SC (corresponding author), Baylor Univ, Dept Biol, Waco, TX 76798 USA.	Sang-Chul_Nam@baylor.edu	Nam, Sang-Chul/J-5518-2014	Nam, Sang-Chul/0000-0001-7176-601X	Knights Templar Eye Foundation; University Research Committee of Baylor University	Knights Templar Eye Foundation; University Research Committee of Baylor University	This study was supported by Ophthalmology Research Grant of Knights Templar Eye Foundation (http://www.knightstemplar.org/ktef/), and University Research Committee Grant of Baylor University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Bhat MA, 1999, CELL, V96, P833, DOI 10.1016/S0092-8674(00)80593-0; CAGAN RL, 1989, DEV BIOL, V136, P346, DOI 10.1016/0012-1606(89)90261-3; Chang HY, 2000, SCIENCE, V290, P1978, DOI 10.1126/science.290.5498.1978; Chen G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016127; Chen G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009480; Chen TW, 2009, GENESIS, V47, P744, DOI 10.1002/dvg.20555; den Hollander AI, 1999, NAT GENET, V23, P217, DOI 10.1038/13848; den Hollander AI, 2001, AM J HUM GENET, V69, P198; Fan SS, 1997, DEVELOPMENT, V124, P1497; Fischer JA, 2004, GENETICS, V168, P1385, DOI 10.1534/genetics.104.028662; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Izaddoost S, 2002, NATURE, V416, P178, DOI 10.1038/nature720; Jefferson JJ, 2004, NAT REV MOL CELL BIO, V5, P542, DOI 10.1038/nrm1425; Karagiosis SA, 2004, DEVELOPMENT, V131, P725, DOI 10.1242/dev.00976; Klebes A, 2000, CURR BIOL, V10, P76, DOI 10.1016/S0960-9822(99)00277-8; Knust E, 2002, SCIENCE, V298, P1955, DOI 10.1126/science.1072161; Kumar JP, 1995, DEVELOPMENT, V121, P4359; Lansbergen G, 2006, TRAFFIC, V7, P499, DOI 10.1111/j.1600-0854.2006.00400.x; League GP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021218; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Lee M, 2003, DEVELOPMENT, V130, P5989, DOI 10.1242/dev.00806; Lee S, 2000, J NEUROSCI, V20, P1096, DOI 10.1523/JNEUROSCI.20-03-01096.2000; Lee S, 2002, DEVELOPMENT, V129, P1195; Leung CL, 1999, J CELL BIOL, V147, P1275, DOI 10.1083/jcb.147.6.1275; Li BX, 2007, J CELL BIOL, V177, P659, DOI 10.1083/jcb.200610157; LONGLEY RL, 1995, DEV BIOL, V171, P415, DOI 10.1006/dbio.1995.1292; Mosley-Bishop KL, 1999, CURR BIOL, V9, P1211, DOI 10.1016/S0960-9822(99)80501-6; Mukhopadhyay B, 2010, GENESIS, V48, P522, DOI 10.1002/dvg.20642; Nam SC, 2007, DEV BIOL, V306, P624, DOI 10.1016/j.ydbio.2007.03.522; Nam SC, 2006, DEV DYNAM, V235, P1501, DOI 10.1002/dvdy.20726; Nam SC, 2003, DEVELOPMENT, V130, P4363, DOI 10.1242/dev.00648; Newsome TP, 2000, DEVELOPMENT, V127, P851; ODA H, 1994, DEV BIOL, V165, P716, DOI 10.1006/dbio.1994.1287; Pellikka M, 2002, NATURE, V416, P143, DOI 10.1038/nature721; Prokop A, 1998, J CELL BIOL, V143, P1283, DOI 10.1083/jcb.143.5.1283; Roper K, 2004, CURR BIOL, V14, P99, DOI 10.1016/j.cub.2003.12.056; Roper K, 2003, J CELL BIOL, V162, P1305, DOI 10.1083/jcb.200307089; Roper K, 2002, J CELL SCI, V115, P4215, DOI 10.1242/jcs.00157; Satoh AK, 2005, DEVELOPMENT, V132, P1487, DOI 10.1242/dev.01704; Siegrist SE, 2007, GENE DEV, V21, P483, DOI 10.1101/gad.1511207; Slep KC, 2005, J CELL BIOL, V168, P587, DOI 10.1083/jcb.200410114; Sonnenberg A, 2007, EXP CELL RES, V313, P2189, DOI 10.1016/j.yexcr.2007.03.039; Subramanian A, 2003, CURR BIOL, V13, P1086, DOI 10.1016/S0960-9822(03)00416-0; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; XU T, 1993, DEVELOPMENT, V117, P1223	46	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25965	10.1371/journal.pone.0025965	http://dx.doi.org/10.1371/journal.pone.0025965			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022483	Green Published, Green Submitted, gold			2022-12-27	WOS:000295976000051
J	Paini, DR; Bianchi, FJJA; Northfield, TD; De Barro, PJ				Paini, Dean R.; Bianchi, Felix J. J. A.; Northfield, Tobin D.; De Barro, Paul J.			Predicting Invasive Fungal Pathogens Using Invasive Pest Assemblages: Testing Model Predictions in a Virtual World	PLOS ONE			English	Article							BIOLOGICAL INVASIONS; ECONOMIC-IMPACT; PATTERNS; DIVERSITY; RISK	Predicting future species invasions presents significant challenges to researchers and government agencies. Simply considering the vast number of potential species that could invade an area can be insurmountable. One method, recently suggested, which can analyse large datasets of invasive species simultaneously is that of a self organising map (SOM), a form of artificial neural network which can rank species by establishment likelihood. We used this method to analyse the worldwide distribution of 486 fungal pathogens and then validated the method by creating a virtual world of invasive species in which to test the SOM. This novel validation method allowed us to test SOM's ability to rank those species that can establish above those that can't. Overall, we found the SOM highly effective, having on average, a 96-98% success rate (depending on the virtual world parameters). We also found that regions with fewer species present (i.e. 1-10 species) were more difficult for the SOM to generate an accurately ranked list, with success rates varying from 100% correct down to 0% correct. However, we were able to combine the numbers of species present in a region with clustering patterns in the SOM, to further refine confidence in lists generated from these sparsely populated regions. We then used the results from the virtual world to determine confidences for lists generated from the fungal pathogen dataset. Specifically, for lists generated for Australia and its states and territories, the reliability scores were between 84-98%. We conclude that a SOM analysis is a reliable method for analysing a large dataset of potential invasive species and could be used by biosecurity agencies around the world resulting in a better overall assessment of invasion risk.	[Paini, Dean R.] Commonwealth Sci & Ind Res Org, Canberra, ACT, Australia; [Paini, Dean R.; De Barro, Paul J.] Cooperat Res Ctr Natl Plant Biosecur, Canberra, ACT, Australia; [Bianchi, Felix J. J. A.; De Barro, Paul J.] Commonwealth Sci & Ind Res Org, Brisbane, Qld, Australia; [Northfield, Tobin D.] Washington State Univ, Dept Entomol, Pullman, WA 99164 USA	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Washington State University	Paini, DR (corresponding author), Commonwealth Sci & Ind Res Org, Canberra, ACT, Australia.	Dean.Paini@csiro.au	Bianchi, Felix JJA/B-6044-2011; De Barro, Paul J/C-1724-2008; Northfield, Tobin/I-2323-2013; Paini, Dean R/C-2341-2009	Northfield, Tobin/0000-0002-0563-485X; 	Cooperative Research Corporation for National Plant Biosecurity [CRC 10001]	Cooperative Research Corporation for National Plant Biosecurity(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This work was supported by the Cooperative Research Corporation for National Plant Biosecurity (http://www.crcplantbiosecurity.com.au/), CRC 10001. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asner GP, 2008, P NATL ACAD SCI USA, V105, P4519, DOI 10.1073/pnas.0710811105; Bomford M, 2009, BIOL INVASIONS, V11, P713, DOI 10.1007/s10530-008-9285-3; Brown KA, 2008, J APPL ECOL, V45, P1639, DOI 10.1111/j.1365-2664.2008.01550.x; Burgman M., 2005, RISKS DECISIONS CONS; CABI, 2003, CROP PROT COMP; Cereghino R, 2005, BIOL CONSERV, V125, P459, DOI 10.1016/j.biocon.2005.04.018; Cook DC, 2008, AUST FORESTRY, V71, P107, DOI 10.1080/00049158.2008.10676277; Cook DC, 2007, ECOL APPL, V17, P1832, DOI 10.1890/06-1632.1; Davis M. A., 2009, INVASION BIOL; Fridley JD, 2007, ECOLOGY, V88, P3, DOI 10.1890/0012-9658(2007)88[3:TIPRPA]2.0.CO;2; Hulme PE, 2009, SCIENCE, V324, P40, DOI 10.1126/science.1171111; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Jacobs MJ, 2009, FRESHWATER BIOL, V54, P296, DOI 10.1111/j.1365-2427.2008.02108.x; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Kier G, 2005, J BIOGEOGR, V32, P1107, DOI 10.1111/j.1365-2699.2005.01272.x; Kohonen T., 2001, SELF ORG MAPS, DOI [DOI 10.1007/978-3-642-56927-2, 10.1007/978-3-642-56927-2, DOI 10.1007/978-3-642-56927-2_1]; KRITICOS D, 2001, WEED RISK ASSESSMENT; Levine JM, 1999, OIKOS, V87, P15, DOI 10.2307/3546992; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Mathworks, 2007, MATL VERS 7 4; Paini DR, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1118; Paini DR, 2010, J APPL ECOL, V47, P290, DOI 10.1111/j.1365-2664.2010.01782.x; Pinkard EA, 2010, ECOL MODEL, V221, P2828, DOI 10.1016/j.ecolmodel.2010.08.017; R Core Development Team, 2010, R LANG ENV STAT COMP; Traveset A, 2006, TRENDS ECOL EVOL, V21, P208, DOI 10.1016/j.tree.2006.01.006; Underwood EC, 2004, DIVERS DISTRIB, V10, P447, DOI 10.1111/j.1366-9516.2004.00093.x; Vesanto J., 2000, SOM TOOLBOX MATLAB 5, V57, P60; White GC, 1996, ECOLOGY, V77, P2549, DOI 10.2307/2265753; Worner SP, 2006, J APPL ECOL, V43, P858, DOI 10.1111/j.1365-2664.2006.01202.x	29	18	20	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25695	10.1371/journal.pone.0025695	http://dx.doi.org/10.1371/journal.pone.0025695			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016773	Green Published, Green Accepted, gold			2022-12-27	WOS:000295971700015
J	Ward-Paige, CA; Lotze, HK				Ward-Paige, Christine A.; Lotze, Heike K.			Assessing the Value of Recreational Divers for Censusing Elasmobranchs	PLOS ONE			English	Article							PRESENCE-ABSENCE DATA; REEF FISHES; SHARK; ABUNDANCE; BEHAVIOR; TRENDS; CONSEQUENCES; TELEOSTEI; DENSITY; DECLINE	Background: Around the world, researchers are using the observations and experiences of citizens to describe patterns in animal populations. This data is often collected via ongoing sampling or by synthesizing past experiences. Since elasmobranchs are relatively rare, obtaining data for broad-scale trend analysis requires high sampling effort. Elasmobranchs are also relatively large and conspicuous and therefore it may be possible to enlist recreational divers to collect data on their occurrence and relative abundance from daily dive activities. For this, however, a good understanding of the value of data collected by recreational divers is essential. Methodology/Principal Findings: Here, we explore the value of recreational divers for censusing elasmobranchs using a diverse set of data sources. First, we use a simulation experiment to explore detection rates of the roving diver technique, used by recreational divers, across a range of fish densities and speeds. Next, using a field survey, we show that inexperienced recreational divers detect and count elasmobranchs as well as experienced recreational divers. Finally, we use semi-structured interviews of recreational dive instructors to demonstrate the value of their recollections in terms of effort and their descriptions of spatial and temporal distributions of sharks in Thailand. Conclusions/Significance: Overall, this study provides initial ground-work for using recreational divers for monitoring elasmobranch populations. If used appropriately, citizen-collected data may provide additional information that can be used to complement more standardized surveys and to describe population trends across a range of spatial and temporal scales. Due to the non-extractive nature of this data, recreational divers may also provide important insight into the success of conservation initiatives, such as shark sanctuaries and no-take zones.	[Ward-Paige, Christine A.; Lotze, Heike K.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada	Dalhousie University	Ward-Paige, CA (corresponding author), Natl Marine Fisheries Serv, SEFSC, Panama City Lab, Panama City, FL USA.	globalshark@gmail.com		Ward-Paige, Christine A./0000-0002-2394-9898; Lotze, Heike/0000-0001-6258-1304	Natural Sciences and Engineering Research Council of Canada; NSERC	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Financial support was provided by the Natural Sciences and Engineering Research Council of Canada with grants to Dr. Lotze, and by the NSERC: http://www.nserc-crsng.gc.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohnsack JA, 1986, STATIONARY VISUAL CE; Boudreau SA, 2010, MAR ECOL PROG SER, V403, P181, DOI 10.3354/meps08473; BRES M, 1993, REV FISH BIOL FISHER, V3, P133, DOI 10.1007/BF00045229; BROCK VE, 1954, J WILDLIFE MANAGE, V18, P297, DOI 10.2307/3797016; Brunnschweiler JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016597; Bunce M, 2008, OCEAN COAST MANAGE, V51, P285, DOI 10.1016/j.ocecoaman.2007.09.006; Calix M., 2018, EUROPEAN RED LIST SA; Castro JI, 2000, ENVIRON BIOL FISH, V58, P1, DOI 10.1023/A:1007698017645; Cooper CB, 2007, ECOL SOC, V12; Darwall WRT, 1996, BIOL CONSERV, V78, P223, DOI 10.1016/0006-3207(95)00147-6; Davis D, 1997, TOURISM MANAGE, V18, P259, DOI 10.1016/S0261-5177(97)00015-0; Dulvy NK, 2004, ANIM CONSERV, V7, P365, DOI 10.1017/S1367943004001519; Dulvy NK, 2008, AQUATIC CONSERVATION; Ferretti F, 2010, ECOL LETT, V13, P1055, DOI 10.1111/j.1461-0248.2010.01489.x; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Genet KS, 2003, WILDLIFE SOC B, V31, P703; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Holt BG, 2010, GLOBAL ECOL BIOGEOGR, V19, P432, DOI 10.1111/j.1466-8238.2010.00539.x; Huveneers C, 2009, AQUAT LIVING RESOUR, V22, P255, DOI 10.1051/alr/2009046; JONES R S, 1975, Micronesica, V11, P127; KIMMEL JJ, 1985, ENVIRON BIOL FISH, V12, P23, DOI 10.1007/BF00007707; Kulbicki M, 1998, J EXP MAR BIOL ECOL, V222, P11, DOI 10.1016/S0022-0981(97)00133-0; Martin RA, 2007, MAR FRESHW BEHAV PHY, V40, P3, DOI 10.1080/10236240601154872; McPherson JM, 2009, DIVERS DISTRIB, V15, P880, DOI 10.1111/j.1472-4642.2009.00596.x; Meyer CG, 2009, ENVIRON CONSERV, V36, P104, DOI 10.1017/S0376892909990038; Neis B, 1999, CAN J FISH AQUAT SCI, V56, P1949, DOI 10.1139/cjfas-56-10-1949; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Quiros AL, 2007, FISH RES, V84, P102, DOI 10.1016/j.fishres.2006.11.017; Robbins WD, 2006, CURR BIOL, V16, P2314, DOI 10.1016/j.cub.2006.09.044; Royle JA, 2003, ECOLOGY, V84, P777, DOI 10.1890/0012-9658(2003)084[0777:EAFRPA]2.0.CO;2; Saenz-Arroyo A, 2005, FISH FISH, V6, P280; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Schmeller DS, 2009, CONSERV BIOL, V23, P307, DOI 10.1111/j.1523-1739.2008.01125.x; Schmitt EF, 1996, B MAR SCI, V59, P404; Schmitt EF, 1993, RES APPL VOLUNTEER G; Semmens BX, 2004, MAR ECOL PROG SER, V266, P239, DOI 10.3354/meps266239; Silvertown J, 2009, TRENDS ECOL EVOL, V24, P467, DOI 10.1016/j.tree.2009.03.017; Stallings CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005333; Stevenson C, 2007, CORAL REEFS, V26, P47, DOI 10.1007/s00338-006-0158-x; Strayer DL, 1999, CONSERV BIOL, V13, P1034, DOI 10.1046/j.1523-1739.1999.98143.x; Sullivan BL, 2009, BIOL CONSERV, V142, P2282, DOI 10.1016/j.biocon.2009.05.006; Theberge MM, 2006, ORYX, V40, P337, DOI 10.1017/S0030605306000998; THRESHER RE, 1986, ENVIRON BIOL FISH, V17, P93, DOI 10.1007/BF00001740; Topelko Karen N., 2005, Journal of Ecotourism, V4, P108, DOI 10.1080/14724040409480343; Vidthayanon, 1997, ELASMOBRANCH BIODIVE; Ward-Paige C, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011722, 10.1371/journal.pone.0011968]; Ward-Paige CA, 2011, ENVIRON BIOL FISH, V90, P263, DOI 10.1007/s10641-010-9739-1; Ward-Paige CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011968; Weaver DC, 2007, COPEIA, P798, DOI 10.1643/0045-8511(2007)7[798:ANSOHT]2.0.CO;2; WEBB PW, 1982, FISH B-NOAA, V80, P803; Williams ID, 2000, ENVIRON CONSERV, V27, P382, DOI 10.1017/S0376892900000436; WILSON MV, 1984, J ECOL, V72, P1055, DOI 10.2307/2259551	52	46	46	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25609	10.1371/journal.pone.0025609	http://dx.doi.org/10.1371/journal.pone.0025609			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016771	Green Submitted, Green Published, gold			2022-12-27	WOS:000295971700013
J	Afify, AMR; El-Beltagi, HS; Abd El-Salam, SM; Omran, AA				Afify, Abd El-Moneim M. R.; El-Beltagi, Hossam S.; Abd El-Salam, Samiha M.; Omran, Azza A.			Bioavailability of Iron, Zinc, Phytate and Phytase Activity during Soaking and Germination of White Sorghum Varieties	PLOS ONE			English	Article							VITRO PROTEIN DIGESTIBILITY; PHYTIC ACID; PHENOLIC-COMPOUNDS; ALKALINE PHYTASE; LEGUME SEEDS; ABSORPTION; FERMENTATION; CEREALS; FOODS; PURIFICATION	The changes in phytate, phytase activity and in vitro bioavailability of iron and zinc during soaking and germination of three white sorghum varieties (Sorghum bicolor L. Moench), named Dorado, Shandweel-6, and Giza-15 were investigated. Sorghum varieties were soaked for 20 h and germinated for 72 h after soaking for 20 h to reduce phytate content and increase iron and zinc in vitro bioavailability. The results revealed that iron and zinc content was significantly reduced from 28.16 to 32.16% and 13.78 to 26.69% for soaking treatment and 38.43 to 39.18% and 21.80 to 31.27% for germination treatments, respectively. Phytate content was significantly reduced from 23.59 to 32.40% for soaking treatment and 24.92 to 35.27% for germination treatments, respectively. Phytase enzymes will be activated during drying in equal form in all varieties. The results proved that the main distinct point is the change of phytase activity as well as specific activity during different treatment which showed no significant differences between the varieties used. The in vitro bioavailability of iron and zinc were significantly improved as a result of soaking and germination treatments.	[Afify, Abd El-Moneim M. R.; El-Beltagi, Hossam S.] Cairo Univ, Dept Biochem, Fac Agr, Cairo, Egypt; [Abd El-Salam, Samiha M.; Omran, Azza A.] Agr Res Ctr, Dept Crops Technol, Food Technol Res Inst, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Agricultural Research Center - Egypt	Afify, AMR (corresponding author), Cairo Univ, Dept Biochem, Fac Agr, Cairo, Egypt.	lbltg@yahoo.com	Omran, Azza A./AAY-3922-2020; El-Beltagi, Hossam/T-2547-2018; Omran, Azza A. A./ABF-3888-2021; El-Beltagi, Hossam S./L-8546-2019	Omran, Azza A./0000-0002-9328-8087; El-Beltagi, Hossam/0000-0003-4433-2034; Omran, Azza A. A./0000-0002-9328-8087; 	Department of Biochemistry, Faculty of Agriculture, Cairo University	Department of Biochemistry, Faculty of Agriculture, Cairo University(Cairo University)	This work was supported by the Department of Biochemistry, Faculty of Agriculture, Cairo University. The Department of Crops Technology, the Food Technology Research Institute, and the Agricultural Research Center cooperated in study design, data collection and analysis, and decision to publish.	Abdel-Rahim E. A., 2010, Electronic Journal of Environmental, Agricultural and Food Chemistry, V9, P1117; Adeyeye EI, 2000, FOOD CHEM, V71, P435, DOI 10.1016/S0308-8146(00)00159-X; Agte V. V., 1999, Journal of Food Composition and Analysis, V12, P161, DOI 10.1006/jfca.1999.0826; Agte VV, 2000, TRACE ELEMENTS IN MAN AND ANIMALS 10, P261; ALLEN LH, 1997, IMPROVING IRON STATU, P1; [Anonymous], 1939, INDIAN ENG CHEM ANN; [Anonymous], 2000, OFF METH AN ASS OFF; BARRIENTOS L, 1994, PLANT PHYSIOL, V106, P1489, DOI 10.1104/pp.106.4.1489; BARRIER GB, 1996, J SCI FOOD AGR, V70, P69; BRUNE M, 1989, AM J CLIN NUTR, V49, P542, DOI 10.1093/ajcn/49.3.542; Egli I, 2002, J FOOD SCI, V67, P3484, DOI 10.1111/j.1365-2621.2002.tb09609.x; El-Beltagi HES, 2011, INT J FOOD SCI NUTR, V62, P453, DOI 10.3109/09637486.2010.544642; Elkhalifa AEO, 2005, FOOD CHEM, V92, P1, DOI 10.1016/j.foodchem.2004.05.058; Elkhalil EAI, 2001, FOOD CHEM, V72, P29, DOI 10.1016/S0308-8146(00)00195-3; Elsheikh EAE, 2000, FOOD CHEM, V68, P211, DOI 10.1016/S0308-8146(99)00153-3; FERGUSON E L, 1988, Journal of Food Composition and Analysis, V1, P316, DOI 10.1016/0889-1575(88)90031-2; FROLICH W, 1995, EUR J CLIN NUTR, V49, pS116; Gibson Rosalind S., 1994, Nutrition Research Reviews, V7, P151, DOI 10.1079/NRR19940010; Godoy S, 2005, INTERCIENCIA, V30, P24; Greiner R, 2002, J AGR FOOD CHEM, V50, P6858, DOI 10.1021/jf025619u; Greiner R, 2001, J AGR FOOD CHEM, V49, P2234, DOI 10.1021/jf0100806; Greiner R, 1999, J FOOD PROCESS PRES, V23, P249, DOI 10.1111/j.1745-4549.1999.tb00383.x; Greiner R, 2006, FOOD TECHNOL BIOTECH, V44, P125; HALLBERG L, 1989, AM J CLIN NUTR, V49, P140, DOI 10.1093/ajcn/49.1.140; HENRIKSEN LK, 1985, J AM DIET ASSOC, V85, P563; Hulse JH, 1980, SORGHUM MILLETS THEI; IQBAL TH, 1994, GUT, V35, P1233, DOI 10.1136/gut.35.9.1233; Jambunathan R., 1980, Food and Nutrition Bulletin, V2, P11; Jog SP, 2005, ARCH BIOCHEM BIOPHYS, V440, P133, DOI 10.1016/j.abb.2005.05.029; Kayode APP, 2007, LWT-FOOD SCI TECHNOL, V40, P834, DOI 10.1016/j.lwt.2006.04.001; Kayode APP, 2006, J SCI FOOD AGR, V86, P1032, DOI 10.1002/jsfa.2451; Kayode APP, 2006, THESIS WAGENINGEN U, P1; Kiers JL, 2000, J SCI FOOD AGR, V80, P1325, DOI 10.1002/1097-0010(200007)80:9&lt;1325::AID-JSFA648&gt;3.0.CO;2-K; Konietzny U, 2002, INT J FOOD SCI TECH, V37, P791, DOI 10.1046/j.1365-2621.2002.00617.x; Lestienne I, 2005, FOOD CHEM, V89, P421, DOI 10.1016/j.foodchem.2004.03.040; Lind T, 2003, AM J CLIN NUTR, V78, P168, DOI 10.1093/ajcn/78.1.168; Lonnerdal B, 2000, J NUTR, V130, p1378S, DOI 10.1093/jn/130.5.1378S; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mahgoub SEO, 1998, FOOD CHEM, V61, P77, DOI 10.1016/S0308-8146(97)00109-X; MARERO LM, 1991, FOOD SCI TECHNOL-LEB, V24, P177; MOHAMED AI, 1986, CEREAL CHEM, V63, P475; MOSHA MC, 1990, FOOD NUTR BULL, V12, P69; MULIMANI VH, 1994, PLANT FOOD HUM NUTR, V46, P27, DOI 10.1007/BF01088458; RABOY V, 1990, PLANT BIOL, V9, P55; RADHAKRISHNAN MR, 1980, J AGR FOOD CHEM, V28, P55, DOI 10.1021/jf60227a038; Reddy NR, 2002, FOOD PHYTATES, P25; Saharan K., 2001, Innovative Food Science & Emerging Technologies, V2, P323, DOI 10.1016/S1466-8564(01)00044-3; SANDBERG AS, 1991, J FOOD SCI, V56, P1330, DOI 10.1111/j.1365-2621.1991.tb04765.x; SANDSTROM B, 1992, P NUTR SOC, V51, P211, DOI 10.1079/PNS19920031; Serna-Saldivar S., 1995, SORGHUM MILLETS CHEM, P69; Shallan M. A., 2010, Australian Journal of Basic and Applied Sciences, V4, P114; Shallan M. A., 2010, Electronic Journal of Environmental, Agricultural and Food Chemistry, V9, P958; Shehab GG, 2010, NOT BOT HORTI AGROBO, V38, P139; Steiner T, 2007, ANIM FEED SCI TECH, V133, P320, DOI 10.1016/j.anifeedsci.2006.04.007; Svanberg U, 1997, FOOD CONTROL, V8, P319, DOI 10.1016/S0956-7135(97)00018-2; SVANBERG U, 1987, IMPROVING YOUNG CHIL; Towo E, 2006, FOOD CHEM, V94, P369, DOI 10.1016/j.foodchem.2004.11.027; Troost FJ, 2003, AM J CLIN NUTR, V78, P1018, DOI 10.1093/ajcn/78.5.1018	58	94	98	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25512	10.1371/journal.pone.0025512	http://dx.doi.org/10.1371/journal.pone.0025512			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003395	Green Submitted, gold, Green Published			2022-12-27	WOS:000295970300016
J	Gaballah, A; Kloeckner, A; Otten, C; Sahl, HG; Henrichfreise, B				Gaballah, Ahmed; Kloeckner, Anna; Otten, Christian; Sahl, Hans-Georg; Henrichfreise, Beate			Functional Analysis of the Cytoskeleton Protein MreB from Chlamydophila pneumoniae	PLOS ONE			English	Article							CELL-WALL; ESCHERICHIA-COLI; BACILLUS-SUBTILIS; CAULOBACTER-CRESCENTUS; CHLAMYDIA-TRACHOMATIS; DIVISION MACHINE; ACTIN MREB; PEPTIDOGLYCAN; MEMBRANE; BACTERIA	In rod-shaped bacteria, the bacterial actin ortholog MreB is considered to organize the incorporation of cell wall precursors into the side-wall, whereas the tubulin homologue FtsZ is known to tether incorporation of cell wall building blocks at the developing septum. For intracellular bacteria, there is no need to compensate osmotic pressure by means of a cell wall, and peptidoglycan has not been reliably detected in Chlamydiaceae. Surprisingly, a nearly complete pathway for the biosynthesis of the cell wall building block lipid II has been found in the genomes of Chlamydiaceae. In a previous study, we discussed the hypothesis that conservation of lipid II biosynthesis in cell wall-lacking bacteria may reflect the intimate molecular linkage of cell wall biosynthesis and cell division and thus an essential role of the precursor in cell division. Here, we investigate why spherical-shaped chlamydiae harbor MreB which is almost exclusively found in elongated bacteria (i.e. rods, vibrios, spirilla) whereas they lack the otherwise essential division protein FtsZ. We demonstrate that chlamydial MreB polymerizes in vitro and that polymerization is not inhibited by the blocking agent A22. As observed for MreB from Bacillus subtilis, chlamydial MreB does not require ATP for polymerization but is capable of ATP hydrolysis in phosphate release assays. Co-pelleting and bacterial two-hybrid experiments indicate that MreB from Chlamydophila (Chlamydia) pneumoniae interacts with MurF, MraY and MurG, three key components in lipid II biosynthesis. In addition, MreB polymerization is improved in the presence of MurF. Our findings suggest that MreB is involved in tethering biosynthesis of lipid II and as such may be necessary for maintaining a functional divisome machinery in Chlamydiaceae.	[Gaballah, Ahmed; Kloeckner, Anna; Otten, Christian; Sahl, Hans-Georg; Henrichfreise, Beate] Univ Bonn, Inst Med Microbiol Immunol & Parasitol, Pharmaceut Microbiol Sect, D-5300 Bonn, Germany	University of Bonn	Gaballah, A (corresponding author), Univ Bonn, Inst Med Microbiol Immunol & Parasitol, Pharmaceut Microbiol Sect, D-5300 Bonn, Germany.	bhenrich@uni-bonn.de	Gaballah, Ahmed/AFL-6554-2022	Gaballah, Ahmed/0000-0002-9038-6597	European Union; Medical Faculty of Bonn; DAAD	European Union(European Commission); Medical Faculty of Bonn; DAAD(Deutscher Akademischer Austausch Dienst (DAAD))	BH was supported by the European Union ("New Antimicrobials" project, people programme, FP7) (http://cordis.europa.eu/fetch?CALLER=FP7_PROJ_EN&ACTION=D&DOC=1&CAT=PROJ&QUERY=01321ea9dcd3:5038:207a143f&RCN=86714). Support for this study was received by the intramural funding scheme of the Medical Faculty of Bonn (http://www.meb.uni-bonn.de/bonfor/). A. Gaballah received a PhD fellowship from the DAAD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bean GJ, 2009, BIOCHEMISTRY-US, V48, P4852, DOI 10.1021/bi900014d; Bean GJ, 2008, BIOCHEMISTRY-US, V47, P826, DOI 10.1021/bi701538e; Bouhss A, 1999, MOL MICROBIOL, V34, P576, DOI 10.1046/j.1365-2958.1999.01623.x; Carballido-Lopez R, 2006, MICROBIOL MOL BIOL R, V70, P888, DOI 10.1128/MMBR.00014-06; Dominguez-Escobar J, 2011, SCIENCE, V333, P225, DOI 10.1126/science.1203466; Figge RM, 2004, MOL MICROBIOL, V51, P1321, DOI 10.1111/j.1365-2958.2003.03936.x; Garner EC, 2011, SCIENCE, V333, P222, DOI 10.1126/science.1203285; Ghuysen JM, 1999, ANTIMICROB AGENTS CH, V43, P2339, DOI 10.1128/AAC.43.10.2339; Gital Z, 2005, CELL, V120, P329, DOI 10.1016/j.cell.2005.01.007; Goehring NW, 2005, CURR BIOL, V15, pR514, DOI 10.1016/j.cub.2005.06.038; Goley ED, 2011, MOL MICROBIOL, V80, P1680, DOI 10.1111/j.1365-2958.2011.07677.x; Ha S, 2000, PROTEIN SCI, V9, P1045, DOI 10.1110/ps.9.6.1045; Henrichfreise B, 2009, MOL MICROBIOL, V73, P913, DOI 10.1111/j.1365-2958.2009.06815.x; Himmelreich R, 1996, NUCLEIC ACIDS RES, V24, P4420, DOI 10.1093/nar/24.22.4420; Hurley JH, 1996, ANNU REV BIOPH BIOM, V25, P137; Iwai N, 2007, BIOSCI BIOTECH BIOCH, V71, P246, DOI 10.1271/bbb.60443; Jantos CA, 1997, J CLIN MICROBIOL, V35, P620, DOI 10.1128/JCM.35.3.620-623.1997; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Kruse T, 2005, MOL MICROBIOL, V55, P78, DOI 10.1111/j.1365-2958.2004.04367.x; Leaver M, 2009, NATURE, V457, P849, DOI 10.1038/nature07742; Mattei PJ, 2010, CURR OPIN STRUC BIOL, V20, P749, DOI 10.1016/j.sbi.2010.09.014; Mayer JA, 2009, CELL MOTIL CYTOSKEL, V66, P109, DOI 10.1002/cm.20332; McCoy AJ, 2006, TRENDS MICROBIOL, V14, P70, DOI 10.1016/j.tim.2005.12.004; Mccoy AJ, 2006, P NATL ACAD SCI USA, V103, P17909, DOI 10.1073/pnas.0608643103; Mohammadi T, 2007, MOL MICROBIOL, V65, P1106, DOI 10.1111/j.1365-2958.2007.05851.x; Mohammadi T, 2011, EMBO J, V30, P1425, DOI 10.1038/emboj.2011.61; Ogata H, 2001, SCIENCE, V293, P2093, DOI 10.1126/science.1061471; Patin D, 2009, J BACTERIOL, V191, P7430, DOI 10.1128/JB.01029-09; Shih YL, 2006, MICROBIOL MOL BIOL R, V70, P729, DOI 10.1128/MMBR.00017-06; Skilton RJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007723; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Takacs CN, 2010, J BACTERIOL, V192, P1671, DOI 10.1128/JB.01311-09; Tatar LD, 2007, MICROBIOL-SGM, V153, P2518, DOI 10.1099/mic.0.2007/006312-0; van den Ent F, 2010, EMBO J, V29, P1081, DOI 10.1038/emboj.2010.9; VANVELDHOVEN PP, 1987, ANAL BIOCHEM, V161, P45, DOI 10.1016/0003-2697(87)90649-X; Vats P, 2009, CELL MOL LIFE SCI, V66, P3353, DOI 10.1007/s00018-009-0092-5; Vats P, 2009, MOL MICROBIOL, V72, P170, DOI 10.1111/j.1365-2958.2009.06632.x; WHATMORE AM, 1990, J GEN MICROBIOL, V136, P2527, DOI 10.1099/00221287-136-12-2527; White CL, 2010, MOL MICROBIOL, V76, P616, DOI 10.1111/j.1365-2958.2010.07108.x; Wu X, 2011, RES MICROBIOL, V162, P375, DOI 10.1016/j.resmic.2011.02.001	41	30	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25129	10.1371/journal.pone.0025129	http://dx.doi.org/10.1371/journal.pone.0025129			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	22022378	Green Submitted, Green Published, gold			2022-12-27	WOS:000295966900008
J	Giangreco, I; Lattanzi, G; Nicolotti, O; Catto, M; Laghezza, A; Leonetti, F; Stefanachi, A; Carotti, A				Giangreco, Ilenia; Lattanzi, Gianluca; Nicolotti, Orazio; Catto, Marco; Laghezza, Antonio; Leonetti, Francesco; Stefanachi, Angela; Carotti, Angelo			Insights into the Complex Formed by Matrix Metalloproteinase-2 and Alloxan Inhibitors: Molecular Dynamics Simulations and Free Energy Calculations	PLOS ONE			English	Article							SELECTIVE-INHIBITION; COLLAGENASE; BINDING; DOMAIN	Matrix metalloproteinases (MMP) are well-known biological targets implicated in tumour progression, homeostatic regulation, innate immunity, impaired delivery of pro-apoptotic ligands, and the release and cleavage of cell-surface receptors. Hence, the development of potent and selective inhibitors targeting these enzymes continues to be eagerly sought. In this paper, a number of alloxan-based compounds, initially conceived to bias other therapeutically relevant enzymes, were rationally modified and successfully repurposed to inhibit MMP-2 (also named gelatinase A) in the nanomolar range. Importantly, the alloxan core makes its debut as zinc binding group since it ensures a stable tetrahedral coordination of the catalytic zinc ion in concert with the three histidines of the HExxHxxGxxH metzincin signature motif, further stabilized by a hydrogen bond with the glutamate residue belonging to the same motif. The molecular decoration of the alloxan core with a biphenyl privileged structure allowed to sample the deep S-1' specificity pocket of MMP-2 and to relate the high affinity towards this enzyme with the chance of forming a hydrogen bond network with the backbone of Leu116 and Asn147 and the side chains of Tyr144, Thr145 and Arg149 at the bottom of the pocket. The effect of even slight structural changes in determining the interaction at the S-1' subsite of MMP-2 as well as the nature and strength of the binding is elucidated via molecular dynamics simulations and free energy calculations. Among the herein presented compounds, the highest affinity (pIC(50) = 7.06) is found for BAM, a compound exhibiting also selectivity (>20) towards MMP2, as compared to MMP-9, the other member of the gelatinases.	[Giangreco, Ilenia; Nicolotti, Orazio; Catto, Marco; Laghezza, Antonio; Leonetti, Francesco; Stefanachi, Angela; Carotti, Angelo] Univ Bari Aldo Moro, Dipartimento Farmacochim, Bari, Italy; [Lattanzi, Gianluca] Univ Bari Aldo Moro, Dipartimento Sci Med Base, Bari, Italy; [Lattanzi, Gianluca; Nicolotti, Orazio; Carotti, Angelo] Univ Bari Aldo Moro, Ctr Ric Tires, Bari, Italy; [Lattanzi, Gianluca] Univ Bari Aldo Moro, Ist Nazl Fis Nucl, Bari, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Istituto Nazionale di Fisica Nucleare (INFN); Universita degli Studi di Bari Aldo Moro	Giangreco, I (corresponding author), Univ Bari Aldo Moro, Dipartimento Farmacochim, Bari, Italy.	gl.lattanzi@gmail.com; nicolotti@farmchim.uniba.it	Lattanzi, Gianluca/E-1753-2011; Laghezza, Antonio/F-7420-2014; Nicolotti, Orazio/F-3209-2012; Giangreco, Ilenia/AAF-6203-2020; Lattanzi, Gianluca/AAA-3173-2019; LATTANZI, GIOVANNA/P-8214-2015	Lattanzi, Gianluca/0000-0002-0808-6457; Nicolotti, Orazio/0000-0001-6533-5539; Lattanzi, Gianluca/0000-0002-0808-6457; LATTANZI, GIOVANNA/0000-0002-7103-8722; STEFANACHI, Angela/0000-0002-9430-7972; Leonetti, Francesco/0000-0003-2043-7464; Laghezza, Antonio/0000-0001-6221-6155; CATTO, Marco/0000-0002-8411-304X; Giangreco, Ilenia/0000-0002-3345-0230	University of Bari "Aldo Moro'' (Progetto IDEA - Giovani Ricercatori)	University of Bari "Aldo Moro'' (Progetto IDEA - Giovani Ricercatori)	The authors acknowledge financial support from the University of Bari "Aldo Moro'' (Progetto IDEA - Giovani Ricercatori 2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2008, CHEMMEDCHEM, V3, P812, DOI 10.1002/cmdc.200700290; AIMES RT, 1995, J BIOL CHEM, V270, P5872, DOI 10.1074/jbc.270.11.5872; Altomare C, 1998, J MED CHEM, V41, P3812, DOI 10.1021/jm981005y; AQVIST J, 1990, J PHYS CHEM-US, V94, P8021, DOI 10.1021/j100384a009; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Blagg JA, 2005, BIOORG MED CHEM LETT, V15, P1807, DOI 10.1016/j.bmcl.2005.02.038; Brandstetter H, 2001, J BIOL CHEM, V276, P17405, DOI 10.1074/jbc.M007475200; CancerGrid STREP project, CANCERGRID STREP PRO; Case D.A., 2022, AMBER 2020; Cheatham TE, 1999, J BIOMOL STRUCT DYN, V16, P845, DOI 10.1080/07391102.1999.10508297; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Conejo-Garcia A, 2011, J MED CHEM, V54, P2627, DOI 10.1021/jm101299d; CORINA website, CORINA; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Diaz N, 2008, PROTEINS, V72, P50, DOI 10.1002/prot.21894; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Feng YQ, 2002, BBA-PROTEINS PROTEOM, V1598, P10, DOI 10.1016/S0167-4838(02)00307-2; Foley LH, 2001, BIOORG MED CHEM LETT, V11, P969, DOI 10.1016/S0960-894X(01)00104-4; Frisch M. J., 2016, GAUSSIAN 16 REVISION, V16; Giangreco I, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-500; Hammett LP, 1937, J AM CHEM SOC, V59, P96, DOI 10.1021/ja01280a022; Hemmings FJ, 2001, RHEUMATOLOGY, V40, P537, DOI 10.1093/rheumatology/40.5.537; Hu JL, 2007, NAT REV DRUG DISCOV, V6, P480, DOI 10.1038/nrd2308; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Malemud CJ, 2006, FRONT BIOSCI-LANDMRK, V11, P1696, DOI 10.2741/1915; Millar AW, 1998, BRIT J CLIN PHARMACO, V45, P21, DOI 10.1046/j.1365-2125.1998.00639.x; Nicolescu AC, 2009, BIOCHEM BIOPH RES CO, V387, P646, DOI 10.1016/j.bbrc.2009.07.080; Nicolotti O, 2007, J CHEM INF MODEL, V47, P2439, DOI 10.1021/ci700119r; Nuti E, 2007, CURR PHARM DESIGN, V13, P2087; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Peterson JT, 2006, CARDIOVASC RES, V69, P677, DOI 10.1016/j.cardiores.2005.11.032; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pirard B, 2007, DRUG DISCOV TODAY, V12, P640, DOI 10.1016/j.drudis.2007.06.003; Pisani L, 2009, J MED CHEM, V52, P6685, DOI 10.1021/jm9010127; Pospisil P, 2003, J RECEPT SIG TRANSD, V23, P361, DOI 10.1081/RRS-120026975; Radmer RJ, 1997, J COMPUT CHEM, V18, P902, DOI 10.1002/(SICI)1096-987X(199705)18:7<902::AID-JCC4>3.0.CO;2-V; Rundhaug JE, 2005, J CELL MOL MED, V9, P267, DOI 10.1111/j.1582-4934.2005.tb00355.x; SIMONSON T, 1993, MOL PHYS, V80, P441, DOI 10.1080/00268979300102371; Stefanachi A, 2011, J MED CHEM, V54, P1613, DOI 10.1021/jm101120u; Steinbrecher T, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2799191; Tochowicz A, 2007, J MOL BIOL, V371, P989, DOI 10.1016/j.jmb.2007.05.068; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Wang J, 2011, N SUBSTITUTED HOMOPI; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Yan YL, 2009, BIOORG MED CHEM LETT, V19, P1970, DOI 10.1016/j.bmcl.2009.02.044	47	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25597	10.1371/journal.pone.0025597	http://dx.doi.org/10.1371/journal.pone.0025597			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998672	Green Submitted, Green Published, gold			2022-12-27	WOS:000295966900036
J	Hiratsuka, M; Uno, N; Ueda, K; Kurosaki, H; Imaoka, N; Kazuki, K; Ueno, E; Akakura, Y; Katoh, M; Osaki, M; Kazuki, Y; Nakagawa, M; Yamanaka, S; Oshimura, M				Hiratsuka, Masaharu; Uno, Narumi; Ueda, Kana; Kurosaki, Hajime; Imaoka, Natsuko; Kazuki, Kanako; Ueno, Etsuya; Akakura, Yutaro; Katoh, Motonobu; Osaki, Mitsuhiko; Kazuki, Yasuhiro; Nakagawa, Masato; Yamanaka, Shinya; Oshimura, Mitsuo			Integration-Free iPS Cells Engineered Using Human Artificial Chromosome Vectors	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; EXPRESSION; GENERATION; INDUCTION; DIFFERENTIATION; FIBROBLASTS; VIRUS; NANOG; SOX2; HAC	Human artificial chromosomes (HACs) have unique characteristics as gene-delivery vectors, including episomal transmission and transfer of multiple, large transgenes. Here, we demonstrate the advantages of HAC vectors for reprogramming mouse embryonic fibroblasts (MEFs) into induced pluripotent stem (iPS) cells. Two HAC vectors (iHAC1 and iHAC2) were constructed. Both carried four reprogramming factors, and iHAC2 also encoded a p53-knockdown cassette. iHAC1 partially reprogrammed MEFs, and iHAC2 efficiently reprogrammed MEFs. Global gene expression patterns showed that the iHACs, unlike other vectors, generated relatively uniform iPS cells. Under non-selecting conditions, we established iHAC-free iPS cells by isolating cells that spontaneously lost iHAC2. Analyses of pluripotent markers, teratomas and chimeras confirmed that these iHAC-free iPS cells were pluripotent. Moreover, iHAC-free iPS cells with a re-introduced HAC encoding Herpes Simplex virus thymidine kinase were eliminated by ganciclovir treatment, indicating that the HAC safeguard system functioned in iPS cells. Thus, the HAC vector could generate uniform, integration-free iPS cells with a built-in safeguard system.	[Hiratsuka, Masaharu; Oshimura, Mitsuo] Tottori Univ, Fac Med, Sch Life Sci, Div Mol & Cell Genet,Dept Mol & Cellular Biol, Yonago, Tottori 683, Japan; [Uno, Narumi; Ueda, Kana; Kurosaki, Hajime; Imaoka, Natsuko; Ueno, Etsuya; Akakura, Yutaro; Osaki, Mitsuhiko; Kazuki, Yasuhiro; Oshimura, Mitsuo] Tottori Univ, Grad Sch Med Sci, Inst Regenerat Med & Biofunct, Dept Biomed Sci, Yonago, Tottori, Japan; [Kazuki, Kanako; Kazuki, Yasuhiro; Oshimura, Mitsuo] Tottori Univ, Chromosome Engn Res Ctr, Yonago, Tottori, Japan; [Katoh, Motonobu] Tottori Univ, Fac Med, Sch Life Sci, Dept Mol & Cellular Biol,Div Human Genome Sci, Yonago, Tottori 683, Japan; [Nakagawa, Masato; Yamanaka, Shinya] Kyoto Univ, Ctr iPS Cell Res & Applicat, Kyoto, Japan; [Oshimura, Mitsuo] Japan Sci & Technol Agcy, CREST, Tokyo, Japan	Tottori University; Tottori University; Tottori University; Tottori University; Kyoto University; Japan Science & Technology Agency (JST)	Hiratsuka, M (corresponding author), Tottori Univ, Fac Med, Sch Life Sci, Div Mol & Cell Genet,Dept Mol & Cellular Biol, Yonago, Tottori 683, Japan.	oshimura@med.tottori-u.ac.jp	Narumi, Uno/AAP-3936-2021	Narumi, Uno/0000-0002-4218-1167	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Funding was provided by the Core Research for Evolutional Science and Technology (CREST) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www.jst.jp/kisoken/crest/en/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Hoshiya H, 2009, MOL THER, V17, P309, DOI 10.1038/mt.2008.253; Iida Y, 2010, DNA RES, V17, P293, DOI 10.1093/dnares/dsq020; Jia FJ, 2010, NAT METHODS, V7, P197, DOI [10.1038/NMETH.1426, 10.1038/nmeth.1426]; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kakeda M, 2005, GENE THER, V12, P852, DOI 10.1038/sj.gt.3302483; Katoh M, 2004, BIOCHEM BIOPH RES CO, V321, P280, DOI 10.1016/j.bbrc.2004.06.145; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kazuki Y, 2008, GENE THER, V15, P617, DOI 10.1038/sj.gt.3303091; Kazuki Y, 2011, GENE THER, V18, P384, DOI 10.1038/gt.2010.147; Kazuki Y, 2010, MOL THER, V18, P386, DOI 10.1038/mt.2009.274; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Papapetrou EP, 2009, P NATL ACAD SCI USA, V106, P12759, DOI 10.1073/pnas.0904825106; Pauwels K, 2009, CURR GENE THER, V9, P459, DOI 10.2174/156652309790031120; Rudd MK, 2003, MOL CELL BIOL, V23, P7689, DOI 10.1128/MCB.23.21.7689-7697.2003; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tomizuka K, 1997, NAT GENET, V16, P133, DOI 10.1038/ng0697-133; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Yusa K, 2009, NAT METHODS, V6, P363, DOI [10.1038/NMETH.1323, 10.1038/nmeth.1323]; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	39	52	56	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25961	10.1371/journal.pone.0025961	http://dx.doi.org/10.1371/journal.pone.0025961			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998730	Green Published, gold, Green Submitted			2022-12-27	WOS:000295966900081
J	Kalinkat, G; Rall, BC; Vucic-Pestic, O; Brose, U				Kalinkat, Gregor; Rall, Bjoern Christian; Vucic-Pestic, Olivera; Brose, Ulrich			The Allometry of Prey Preferences	PLOS ONE			English	Article							FUNCTIONAL-RESPONSE; FOOD WEBS; BODY-SIZE; PREDATOR INTERFERENCE; INTERACTION STRENGTHS; ECOLOGICAL NETWORKS; STABILITY; CONSTRAINTS; POPULATION; BEHAVIOR	The distribution of weak and strong non-linear feeding interactions (i.e., functional responses) across the links of complex food webs is critically important for their stability. While empirical advances have unravelled constraints on single-prey functional responses, their validity in the context of complex food webs where most predators have multiple prey remain uncertain. In this study, we present conceptual evidence for the invalidity of strictly density-dependent consumption as the null model in multi-prey experiments. Instead, we employ two-prey functional responses parameterised with allometric scaling relationships of the functional response parameters that were derived from a previous single-prey functional response study as novel null models. Our experiments included predators of different sizes from two taxonomical groups (wolf spiders and ground beetles) simultaneously preying on one small and one large prey species. We define compliance with the null model predictions (based on two independent single-prey functional responses) as passive preferences or passive switching, and deviations from the null model as active preferences or active switching. Our results indicate active and passive preferences for the larger prey by predators that are at least twice the size of the larger prey. Moreover, our approach revealed that active preferences increased significantly with the predator-prey body-mass ratio. Together with prior allometric scaling relationships of functional response parameters, this preference allometry may allow estimating the distribution of functional response parameters across the myriads of interactions in natural ecosystems.	[Kalinkat, Gregor; Vucic-Pestic, Olivera] Tech Univ Darmstadt, Dept Biol, Darmstadt, Germany; [Kalinkat, Gregor; Rall, Bjoern Christian; Brose, Ulrich] Univ Gottingen, Blumenbach Inst Zool & Anthropol, Gottingen, Germany	Technical University of Darmstadt; University of Gottingen	Kalinkat, G (corresponding author), Tech Univ Darmstadt, Dept Biol, Darmstadt, Germany.	kalinkat@bio.tu-darmstadt.de	Rall, Björn C./G-1508-2013; Brose, Ulrich/AAT-7547-2020; Kalinkat, Gregor/H-5401-2013; Brose, Ulrich/I-3488-2014	Rall, Björn C./0000-0002-3191-8389; Brose, Ulrich/0000-0001-9156-583X; Kalinkat, Gregor/0000-0003-3529-5681; Chiaradia, Andre/0000-0002-6178-4211	German Research Foundation [BR 2315/6, BR 2315/13]	German Research Foundation(German Research Foundation (DFG))	Funding has been provided by the German Research Foundation (BR 2315/6, BR 2315/13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljetlawi AA, 2004, J ANIM ECOL, V73, P239, DOI 10.1111/j.0021-8790.2004.00800.x; [Anonymous], 2010, R LANG ENV STAT COMP; Berlow EL, 2004, J ANIM ECOL, V73, P585, DOI 10.1111/j.0021-8790.2004.00833.x; Berlow EL, 2009, P NATL ACAD SCI USA, V106, P187, DOI 10.1073/pnas.0806823106; Brose U, 2008, J ANIM ECOL, V77, P1072, DOI 10.1111/j.1365-2656.2008.01408.x; Brose U, 2008, P ROY SOC B-BIOL SCI, V275, P2507, DOI 10.1098/rspb.2008.0718; Brose U, 2006, ECOL LETT, V9, P1228, DOI 10.1111/j.1461-0248.2006.00978.x; Brose U, 2006, ECOLOGY, V87, P2411, DOI 10.1890/0012-9658(2006)87[2411:CBRINF]2.0.CO;2; Brose U, 2010, FUNCT ECOL, V24, P28, DOI 10.1111/j.1365-2435.2009.01618.x; Carbone C, 1999, NATURE, V402, P286, DOI 10.1038/46266; Carnicer J, 2008, ECOL LETT, V11, P802, DOI 10.1111/j.1461-0248.2008.01195.x; COHEN JE, 1993, J ANIM ECOL, V62, P67, DOI 10.2307/5483; COLTON TF, 1987, ECOLOGY, V68, P900, DOI 10.2307/1938361; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; Ehnes RB, 2011, ECOL LETT, V14, P993, DOI 10.1111/j.1461-0248.2011.01660.x; Elliott JM, 2006, FRESHWATER BIOL, V51, P913, DOI 10.1111/j.1365-2427.2006.01549.x; Elliott JM, 2004, FRESHWATER BIOL, V49, P709, DOI 10.1111/j.1365-2427.2004.01222.x; Emmerson MC, 2004, J ANIM ECOL, V73, P399, DOI 10.1111/j.0021-8790.2004.00818.x; Englund G, 2011, ECOL LETT, V14, P914, DOI 10.1111/j.1461-0248.2011.01661.x; Galarowicz TL, 2005, CAN J FISH AQUAT SCI, V62, P2330, DOI 10.1139/F05-148; Gentleman W, 2003, DEEP-SEA RES PT II, V50, P2847, DOI 10.1016/J.DSR2.2003.07.001; Gross T, 2009, SCIENCE, V325, P747, DOI 10.1126/science.1173536; Hansen PJ, 1997, LIMNOL OCEANOGR, V42, P687, DOI 10.4319/lo.1997.42.4.0687; HASSELL MP, 1976, J ANIM ECOL, V45, P135, DOI 10.2307/3772; Holling C. S., 1959, Canadian Entomologist, V91, P385; HOUDE ED, 1980, ENVIRON BIOL FISH, V5, P315, DOI 10.1007/BF00005186; Hubbell Stephen P., 2001, V32, pi; HUGHES RN, 1993, J ANIM ECOL, V62, P341, DOI 10.2307/5365; Ings TC, 2009, J ANIM ECOL, V78, P253, DOI 10.1111/j.1365-2656.2008.01460.x; Jeschke JM, 2004, BIOL REV, V79, P337, DOI 10.1017/S1464793103006286; Koen-Alonso Mariano, 2007, P1; Kondoh M, 2003, SCIENCE, V299, P1388, DOI 10.1126/science.1079154; LANDRY MR, 1981, MAR BIOL, V65, P77, DOI 10.1007/BF00397070; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; McKee MH, 1997, FRESHWATER BIOL, V38, P193, DOI 10.1046/j.1365-2427.1997.00205.x; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Murdoch W.W., 1975, ADV ECOL RES, V9, P1, DOI DOI 10.1016/S0065-2504(08)60288-3; MURDOCH WW, 1973, J APPL ECOL, V10, P335; MURDOCH WW, 1975, ECOLOGY, V56, P1094, DOI 10.2307/1936149; MURDOCH WW, 1969, ECOL MONOGR, V39, P335, DOI 10.2307/1942352; Neutel AM, 2002, SCIENCE, V296, P1120, DOI 10.1126/science.1068326; OATEN A, 1975, AM NAT, V109, P299, DOI 10.1086/282999; Otto SB, 2007, NATURE, V450, P1226, DOI 10.1038/nature06359; Pervez A, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.5; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Rall BC, 2008, OIKOS, V117, P202, DOI 10.1111/j.2007.0030-1299.15491.x; Rall BC, 2010, GLOBAL CHANGE BIOL, V16, P2145, DOI 10.1111/j.1365-2486.2009.02124.x; Rall BC, 2011, OIKOS, V120, P483, DOI 10.1111/j.1600-0706.2010.18860.x; REAL LA, 1977, AM NAT, V111, P289, DOI 10.1086/283161; Riede JO, 2011, ECOL LETT, V14, P169, DOI 10.1111/j.1461-0248.2010.01568.x; ROGERS D, 1972, J ANIM ECOL, V41, P369, DOI 10.2307/3474; Royama T., 1971, Researches Popul Ecol Kyoto Univ, V1, P1; Skalski GT, 2001, ECOLOGY, V82, P3083; Smout S, 2007, MAR ECOL PROG SER, V341, P277, DOI 10.3354/meps341277; Soetaert K, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i09; SOLOMON ME, 1949, J ANIM ECOL, V18, P1, DOI 10.2307/1578; SPITZE K, 1985, ECOLOGY, V66, P938, DOI 10.2307/1940556; Sundell J, 2003, OIKOS, V101, P615, DOI 10.1034/j.1600-0706.2003.12264.x; THOMPSON DJ, 1975, J ANIM ECOL, V44, P907, DOI 10.2307/3727; Valdovinos FS, 2010, ECOL LETT, V13, P1546, DOI 10.1111/j.1461-0248.2010.01535.x; Vonesh JR, 2005, ECOLOGY, V86, P1580, DOI 10.1890/04-0535; Vucic-Pestic O, 2011, GLOBAL CHANGE BIOL, V17, P1301, DOI 10.1111/j.1365-2486.2010.02329.x; Vucic-Pestic O, 2010, J ANIM ECOL, V79, P249, DOI 10.1111/j.1365-2656.2009.01622.x; Wahlstrom E, 2000, OECOLOGIA, V123, P138, DOI 10.1007/s004420050999; Williams RJ, 2004, EUR PHYS J B, V38, P297, DOI 10.1140/epjb/e2004-00122-1	66	46	47	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25937	10.1371/journal.pone.0025937	http://dx.doi.org/10.1371/journal.pone.0025937			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998724	Green Published, gold			2022-12-27	WOS:000295966900076
J	Murphy, TF; Lesse, AJ; Kirkham, C; Zhong, HC; Sethi, S; Munson, RS				Murphy, Timothy F.; Lesse, Alan J.; Kirkham, Charmaine; Zhong, Huachun; Sethi, Sanjay; Munson, Robert S., Jr.			A Clonal Group of Nontypeable Haemophilus influenzae with Two IgA Proteases Is Adapted to Infection in Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; HUMAN RESPIRATORY-TRACT; OTITIS-MEDIA; HEMOPHILUS-INFLUENZAE; IMMUNE-RESPONSE; BACTERIAL PATHOGENS; CHRONIC-BRONCHITIS; ANTIGENIC DRIFT; STRAINS; DIVERSITY	Strains of nontypeable Haemophilus influenzae show enormous genetic heterogeneity and display differential virulence potential in different clinical settings. The igaB gene, which encodes a newly identified IgA protease, is more likely to be present in the genome of COPD strains of H. influenzae than in otitis media strains. Analysis of igaB and surrounding sequences in the present study showed that H. influenzae likely acquired igaB from Neisseria meningitidis and that the acquisition was accompanied by a similar to 20 kb genomic inversion that is present only in strains that have igaB. As part of a long running prospective study of COPD, molecular typing of H. influenzae strains identified a clonally related group of strains, a surprising observation given the genetic heterogeneity that characterizes strains of nontypeable H. influenzae. Analysis of strains by 5 independent methods (polyacrylamide gel electrophoresis, multilocus sequence typing, igaB gene sequences, P2 gene sequences, pulsed field gel electrophoresis) established the clonal relationship among the strains. Analysis of 134 independent strains collected prospectively from a cohort of adults with COPD demonstrated that similar to 10% belonged to the clonal group. We conclude that a clonally related group of strains of nontypeable H. influenzae that has two IgA1 protease genes (iga and igaB) is adapted for colonization and infection in COPD. This observation has important implications in understanding population dynamics of H. influenzae in human infection and in understanding virulence mechanisms specifically in the setting of COPD.	[Murphy, Timothy F.; Lesse, Alan J.; Kirkham, Charmaine] SUNY Buffalo, Dept Med, Div Infect Dis, Buffalo, NY 14260 USA; [Sethi, Sanjay] SUNY Buffalo, Dept Med, Div Pulm & Crit Care Med, Buffalo, NY 14260 USA; [Murphy, Timothy F.; Lesse, Alan J.] SUNY Buffalo, Dept Microbiol, Buffalo, NY 14260 USA; [Lesse, Alan J.] SUNY Buffalo, Dept Pharmacol & Toxicol, Buffalo, NY 14260 USA; [Murphy, Timothy F.; Kirkham, Charmaine] SUNY Buffalo, New York State Ctr Excellence Bioinformat & Life, Buffalo, NY 14260 USA; [Murphy, Timothy F.; Lesse, Alan J.; Sethi, Sanjay] Vet Affairs Western New York Healthcare Syst, Buffalo, NY USA; [Zhong, Huachun; Munson, Robert S., Jr.] Nationwide Childrens Hosp, Res Inst, Columbus, OH USA; [Zhong, Huachun; Munson, Robert S., Jr.] Ohio State Univ, Columbus, OH 43210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University	Murphy, TF (corresponding author), SUNY Buffalo, Dept Med, Div Infect Dis, Buffalo, NY 14260 USA.	murphyt@buffalo.edu	Munson, Jr, Robert/E-3710-2011	Munson, Jr, Robert/0000-0002-3204-3019; Murphy, Timothy/0000-0002-3496-2641	National Institutes of Health [AI19741]; Department of Veterans Affairs;  [N01-AI-30040]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI030040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant AI19741 (TFM), the Department of Veterans Affairs (TFM, SS), and a subcontract of N01-AI-30040 (RSM; PI, Michael Apicella). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARENKAMP SJ, 1982, INFECT IMMUN, V36, P535, DOI 10.1128/IAI.36.2.535-540.1982; BELL J, 1994, INFECT IMMUN, V62, P2639, DOI 10.1128/IAI.62.6.2639-2643.1994; Chonmaitree T, 2008, CLIN INFECT DIS, V46, P815, DOI 10.1086/528685; Dautin N, 2007, ANNU REV MICROBIOL, V61, P89, DOI 10.1146/annurev.micro.61.080706.093233; De Palmenaer D, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-18; DUIM B, 1994, MOL MICROBIOL, V11, P1181, DOI 10.1111/j.1365-2958.1994.tb00394.x; DUIM B, 1993, MICROB PATHOGENESIS, V14, P451, DOI 10.1006/mpat.1993.1044; Dworkin MS, 2007, CLIN INFECT DIS, V44, P810, DOI 10.1086/511861; Erwin AL, 2005, INFECT IMMUN, V73, P5853, DOI 10.1128/IAI.73.9.5853-5863.2005; Erwin AL, 2008, J BACTERIOL, V190, P1473, DOI 10.1128/JB.01207-07; FADEN H, 1995, J INFECT DIS, V172, P132, DOI 10.1093/infdis/172.1.132; Farjo RS, 2004, PEDIATR INFECT DIS J, V23, P41, DOI 10.1097/01.inf.0000106981.89572.d1; FARLEY MM, 1992, ANN INTERN MED, V116, P806, DOI 10.7326/0003-4819-116-10-806; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Feil EJ, 2004, CURR OPIN MICROBIOL, V7, P308, DOI 10.1016/j.mib.2004.04.002; Fernaays MM, 2006, INFECT IMMUN, V74, P5860, DOI 10.1128/IAI.00796-06; Fernaays MM, 2006, INFECT IMMUN, V74, P3366, DOI 10.1128/IAI.01904-05; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Gilsdorf JR, 1998, INFECT IMMUN, V66, P5053, DOI 10.1128/IAI.66.11.5053-5059.1998; GROENEVELD K, 1990, AM REV RESPIR DIS, V141, P1316, DOI 10.1164/ajrccm/141.5_Pt_1.1316; GROENEVELD K, 1989, INFECT IMMUN, V57, P3038, DOI 10.1128/IAI.57.10.3038-3044.1989; Harrison A, 2005, J BACTERIOL, V187, P4627, DOI 10.1128/JB.187.13.4627-4636.2005; Hiltke TJ, 2002, J INFECT DIS, V185, P627, DOI 10.1086/339362; Hogg JS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r103; Juliao PC, 2007, J BACTERIOL, V189, P4994, DOI 10.1128/JB.00146-07; LaCross NC, 2008, J CLIN MICROBIOL, V46, P3817, DOI 10.1128/JCM.00940-08; Maughan H, 2009, EVOLUTION, V63, P1852, DOI 10.1111/j.1558-5646.2009.00658.x; MUNSON RS, 1983, J CLIN INVEST, V72, P677, DOI 10.1172/JCI111017; Murphy TF, 2005, AM J RESP CRIT CARE, V172, P195, DOI 10.1164/rccm.200412-1747OC; Murphy TF, 2004, AM J RESP CRIT CARE, V170, P266, DOI 10.1164/rccm.200403-354OC; Murphy TF, 2008, AM J RESP CRIT CARE, V177, P853, DOI 10.1164/rccm.200709-1413OC; Murphy TF, 2007, J INFECT DIS, V195, P81, DOI 10.1086/509824; Murphy TF, 2009, PEDIATR INFECT DIS J, V28, P43, DOI 10.1097/INF.0b013e318184dba2; MUSSER JM, 1986, INFECT IMMUN, V52, P183, DOI 10.1128/IAI.52.1.183-191.1986; O'Neill JM, 2003, J CLIN MICROBIOL, V41, P3064, DOI 10.1128/JCM.41.7.3064-3069.2003; Ostberg KL, 2009, MUCOSAL IMMUNOL, V2, P63, DOI 10.1038/mi.2008.70; Peerbooms PGH, 2002, J CLIN MICROBIOL, V40, P2832, DOI 10.1128/JCM.40.8.2832-2836.2002; Pettigrew MM, 2008, EMERG INFECT DIS, V14, P1584, DOI 10.3201/eid1410.080119; Pettigrew MM, 2002, INFECT IMMUN, V70, P3551, DOI 10.1128/IAI.70.7.3551-3556.2002; Sapey E, 2006, THORAX, V61, P250, DOI 10.1136/thx.2005.041822; Sethi S, 2004, AM J RESP CRIT CARE, V169, P448, DOI 10.1164/rccm.200308-1181OC; Sethi S, 2002, NEW ENGL J MED, V347, P465, DOI 10.1056/NEJMoa012561; Sethi S, 2008, NEW ENGL J MED, V359, P2355, DOI 10.1056/NEJMra0800353; SIKKEMA DJ, 1992, INFECT IMMUN, V60, P5204, DOI 10.1128/IAI.60.12.5204-5211.1992; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Weiser LN, 2000, TRENDS MICROBIOL, V8, P433, DOI 10.1016/S0966-842X(00)01839-4; Xie JP, 2006, J CLIN MICROBIOL, V44, P4316, DOI 10.1128/JCM.01331-06; Yi KC, 1997, J INFECT DIS, V176, P1247, DOI 10.1086/514119	48	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25923	10.1371/journal.pone.0025923	http://dx.doi.org/10.1371/journal.pone.0025923			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998721	Green Published, Green Submitted, gold			2022-12-27	WOS:000295966900073
J	Yuan, DS				Yuan, Daniel S.			Dithizone Staining of Intracellular Zinc: An Unexpected and Versatile Counterscreen for Auxotrophic Marker Genes in Saccharomyces cerevisiae	PLOS ONE			English	Article							FLUORESCENT SENSORS; CELL BIOLOGY; YEAST; MUTANTS; PROTEIN; TRANSPORTER; GENOME; IDENTIFICATION; DEFICIENCY; ENRICHMENT	Auxotrophic marker genes such as URA3, LEU2, and HIS3 in Saccharomyces cerevisiae have long been used to select cells that have been successfully transformed with recombinant DNA. A longstanding challenge in working with these genes is that counterselection procedures are often lacking. This paper describes the unexpected discovery of a simple plate assay that imparts a bright red stain to cells experiencing nutritional stress from the lack of a marker gene. The procedure specifically stains a zinc-rich vesicular compartment analogous to the zinc-rich secretory vesicles found in insulin-secreting pancreatic islet cells and glutamate-secreting neurons. Staining was greatly diminished in zap1 mutants, which lack a homeostatic activator of zinc uptake, and in cot1 zrc1 double mutants, which lack the two yeast homologs of mammalian vesicle-specific zinc export proteins. Only one of 93 strains with temperature-sensitive alleles of essential genes exhibited an increase in dithizone staining at its non-permissive temperature, indicating that staining is not simply a sign of growth-arrested or dying cells. Remarkably, the procedure works with most commonly used marker genes, highlights subtle defects, uses no reporter constructs or expensive reagents, requires only a few hours of incubation, yields visually striking results without any instrumentation, and is not toxic to the cells. Many potential applications exist for dithizone staining, both as a versatile counterscreen for auxotrophic marker genes and as a powerful new tool for the genetic analysis of a biomedically important vesicular organelle.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Johns Hopkins University	Yuan, DS (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	dyuan@jhmi.edu			discretionary laboratory funds of Jef Boeke	discretionary laboratory funds of Jef Boeke	Recent work was generously supported by discretionary laboratory funds of Jef Boeke and by Beverly Wendland. Funding sources had no influence on study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Aroya S, 2008, MOL CELL, V30, P248, DOI 10.1016/j.molcel.2008.02.021; Bitanihirwe BKY, 2009, SYNAPSE, V63, P1029, DOI 10.1002/syn.20683; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Boer VM, 2008, P NATL ACAD SCI USA, V105, P6930, DOI 10.1073/pnas.0802601105; BOTSTEIN D, 1982, MOL BIOL YEAST SACCH, P607; Brachmann CB, 1998, YEAST, V14, P115; Carbon John, 1993, P375; Chimienti F, 2004, DIABETES, V53, P2330, DOI 10.2337/diabetes.53.9.2330; Cole TB, 1999, P NATL ACAD SCI USA, V96, P1716, DOI 10.1073/pnas.96.4.1716; CONKLIN DS, 1992, MOL CELL BIOL, V12, P3678, DOI 10.1128/MCB.12.9.3678; Corbacho I, 2011, ANTON LEEUW INT J G, V99, P591, DOI 10.1007/s10482-010-9530-5; Cuesta R, 1998, GENETICS, V148, P1007; Dainty SJ, 2008, EUKARYOT CELL, V7, P454, DOI 10.1128/EC.00408-07; Devirgiliis C, 2004, BIOCHEM BIOPH RES CO, V323, P58, DOI 10.1016/j.bbrc.2004.08.051; Domaille DW, 2008, NAT CHEM BIOL, V4, P168, DOI 10.1038/nchembio.69; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; Eide DJ, 2009, J BIOL CHEM, V284, P18565, DOI 10.1074/jbc.R900014200; Gomes P, 2007, MECH AGEING DEV, V128, P383, DOI 10.1016/j.mad.2007.04.003; Haase H, 2002, BIOCHEM BIOPH RES CO, V296, P923, DOI 10.1016/S0006-291X(02)02017-X; HENRY SA, 1975, MOL GEN GENET, V143, P5, DOI 10.1007/BF00269415; HIBBARD P. L., 1937, Industrial and Engineering Chemistry. Analytical edition, V9, P127, DOI 10.1021/ac50107a009; HIETER P, 1985, CELL, V40, P381, DOI 10.1016/0092-8674(85)90152-7; HORN P, 1966, J BACTERIOL, V91, P1388, DOI 10.1128/JB.91.3.1388-.1966; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; KAMIZONO A, 1989, MOL GEN GENET, V219, P161, DOI 10.1007/BF00261172; Kissler HJ, 2010, CLIN TRANSPLANT, V24, P236, DOI 10.1111/j.1399-0012.2009.01052.x; KOSHLAND D, 1985, CELL, V40, P393, DOI 10.1016/0092-8674(85)90153-9; Kucsera J, 2000, J MICROBIOL METH, V41, P19, DOI 10.1016/S0167-7012(00)00136-6; LACROUTE F, 1968, J BACTERIOL, V95, P824, DOI 10.1128/JB.95.3.824-832.1968; Li LT, 2001, J BIOL CHEM, V276, P5036, DOI 10.1074/jbc.M008969200; Liebhafsky HA, 1937, J AM CHEM SOC, V59, P1966, DOI 10.1021/ja01289a051; LITTLEWOOD BS, 1973, MUTAT RES, V17, P315, DOI 10.1016/0027-5107(73)90003-1; MAWBY A, 1972, J INORG NUCL CHEM, V34, P109, DOI 10.1016/0022-1902(72)80367-1; MCCAMMON MT, 1982, MOL GEN GENET, V186, P295, DOI 10.1007/BF00331865; MIDDELHOVEN WJ, 1976, J BACTERIOL, V128, P851, DOI 10.1128/JB.128.3.851-852.1976; NAGAI S, 1963, J BACTERIOL, V86, P299, DOI 10.1128/JB.86.2.299-302.1963; Nasir MS, 1999, J BIOL INORG CHEM, V4, P775, DOI 10.1007/s007750050350; Nolan EM, 2009, ACCOUNTS CHEM RES, V42, P193, DOI 10.1021/ar8001409; ONO BI, 1991, APPL ENVIRON MICROB, V57, P3183, DOI 10.1128/AEM.57.11.3183-3186.1991; Pan XW, 2007, METHODS, V41, P206, DOI 10.1016/j.ymeth.2006.07.033; Pan XW, 2004, MOL CELL, V16, P487, DOI 10.1016/j.molcel.2004.09.035; PARADKAR RP, 1994, ANAL CHEM, V66, P2752, DOI 10.1021/ac00089a024; Pronk JT, 2002, APPL ENVIRON MICROB, V68, P2095, DOI 10.1128/AEM.68.5.2095-2100.2002; ROMAN H, 1956, COLD SPRING HARB SYM, V21, P175, DOI 10.1101/SQB.1956.021.01.015; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; Sensi SL, 2009, NAT REV NEUROSCI, V10, P780, DOI 10.1038/nrn2734; Shima C, 1996, ANAL BIOCHEM, V236, P173, DOI 10.1006/abio.1996.0148; SIKORSKI RS, 1989, GENETICS, V122, P19; SIKORSKI RS, 1991, METHOD ENZYMOL, V194, P302; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Slattery MG, 2008, EUKARYOT CELL, V7, P358, DOI 10.1128/EC.00334-07; SNOW R, 1966, NATURE, V211, P206, DOI 10.1038/211206a0; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Walhout AJM, 2001, METHODS, V24, P297, DOI 10.1006/meth.2001.1190; Wenzlau JM, 2007, P NATL ACAD SCI USA, V104, P17040, DOI 10.1073/pnas.0705894104; Wieczorke R, 1999, FEBS LETT, V464, P123, DOI 10.1016/S0014-5793(99)01698-1; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; YOUNG JD, 1976, MUTAT RES, V35, P423, DOI 10.1016/0027-5107(76)90204-9; Yuan DS, 2000, GENETICS, V156, P45; ZALEWSKI PD, 1993, BIOCHEM J, V296, P403, DOI 10.1042/bj2960403; Zhao H, 1997, MOL CELL BIOL, V17, P5044, DOI 10.1128/MCB.17.9.5044; Zhao H, 1996, P NATL ACAD SCI USA, V93, P2454, DOI 10.1073/pnas.93.6.2454	62	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25830	10.1371/journal.pone.0025830	http://dx.doi.org/10.1371/journal.pone.0025830			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998704	Green Published, Green Submitted, gold			2022-12-27	WOS:000295966900061
J	Kumar, A; Chen, T; Pakkanen, S; Kantele, A; Soderlund-Venermo, M; Hedman, K; Franssila, R				Kumar, Arun; Chen, Tingting; Pakkanen, Sari; Kantele, Anu; Soderlund-Venermo, Maria; Hedman, Klaus; Franssila, Rauli			T-helper Cell-Mediated Proliferation and Cytokine Responses against Recombinant Merkel Cell Polyomavirus-Like Particles	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; INTERFERON-GAMMA; IFN-GAMMA; IMMUNE-RESPONSE; TUMOR-GROWTH; B-CELLS; CARCINOMA; INTERLEUKIN-10; ANTIBODIES; CANCER	The newly discovered Merkel Cell Polyomavirus (MCPyV) resides in approximately 80% of Merkel cell carcinomas (MCC). Causal role of MCPyV for this rare and aggressive skin cancer is suggested by monoclonal integration and truncation of large T (LT) viral antigen in MCC cells. The mutated MCPyV has recently been found in highly purified leukemic cells from patients with chronic lymphocytic leukemia (CLL), suggesting a pathogenic role also in CLL. About 50-80% of adults display MCPyV-specific antibodies. The humoral immunity does not protect against the development of MCC, as neutralizing MCPyV antibodies occur in higher levels among MCC patients than healthy controls. Impaired T-cell immunity has been linked with aggressive MCC behavior. Therefore, cellular immunity appears to be important in MCPyV infection surveillance. In order to elucidate the role of MCPyV-specific Th-cell immunity, peripheral blood mononuclear cells (PBMC) of healthy adults were stimulated with MCPyV VP1 virus-like particles (VLPs), using human bocavirus (HBoV) VLPs and Candida albicans antigen as positive controls. Proliferation, IFN-gamma, IL-13 and IL-10 responses were examined in 15 MCPyV-seropositive and 15 seronegative volunteers. With the MCPyV antigen, significantly stronger Th-cell responses were found in MCPyV-seropositive than MCPyV-seronegative subjects, whereas with the control antigens, the responses were statistically similar. The most readily detectable cytokine was IFN-gamma. The MCPyV antigen tended to induce stronger IFN-gamma responses than HBoV VLP antigen. Taken together, MCPyV-specific Th-cells elicit vigorous IFN-gamma responses. IFN-gamma being a cytokine with major antiviral and tumor suppressing functions, Th-cells are suggested to be important mediators of MCPyV-specific immune surveillance.	[Kumar, Arun; Chen, Tingting; Soderlund-Venermo, Maria; Hedman, Klaus; Franssila, Rauli] Univ Helsinki, Dept Virol, Haartman Inst, Helsinki, Finland; [Pakkanen, Sari; Kantele, Anu] Univ Helsinki, Dept Bacteriol & Immunol, Haartman Inst, Helsinki, Finland; [Kantele, Anu] Univ Helsinki, Cent Hosp, Div Infect Dis, Helsinki, Finland; [Hedman, Klaus] Univ Helsinki, Cent Hosp, Lab Div, Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital	Kumar, A (corresponding author), Univ Helsinki, Dept Virol, Haartman Inst, Helsinki, Finland.	arun.kumar@helsinki.fi	Söderlund-Venermo, Maria/AAX-2112-2020; Kumar, Arun/C-9466-2013; Hedman, Klaus/D-5379-2009; Chen, Tingting/I-8274-2019; Kantele, Anu/AAS-4131-2021	Chen, Tingting/0000-0002-2227-3208; Kantele, Anu/0000-0002-0004-1000; Pakkanen, Sari/0000-0003-4522-5337; Hedman, Klaus/0000-0003-1779-7960; Kumar, Arun/0000-0003-4483-7585	Helsinki University Central Hospital; Medical Society of Finland; Academy of Finland [1122539]; Clinical Chemistry Research Foundation; Orion-Farmos Research Foundation; University of Helsinki; Sigrid Juselius Foundation	Helsinki University Central Hospital; Medical Society of Finland; Academy of Finland(Academy of Finland); Clinical Chemistry Research Foundation; Orion-Farmos Research Foundation; University of Helsinki; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This study was supported by the Helsinki University Central Hospital Research and Education Fund, the Medical Society of Finland, the Academy of Finland (project 1122539), the Clinical Chemistry Research Foundation Grant (A. Kumar), the Orion-Farmos Research Foundation Grant (A. Kumar), the University of Helsinki Funds Grant (A. Kumar), and the Sigrid Juselius Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres C, 2010, J CUTAN PATHOL, V37, P28, DOI 10.1111/j.1600-0560.2009.01352.x; Arany I, 1998, J Cutan Med Surg, V2, P138; Beatty GL, 2001, IMMUNOL RES, V24, P201, DOI 10.1385/IR:24:2:201; Becker JC, 2009, J INVEST DERMATOL, V129, P248, DOI 10.1038/jid.2008.198; Berman RM, 1996, J IMMUNOL, V157, P231; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Carter JJ, 2009, JNCI-J NATL CANCER I, V101, P1510, DOI 10.1093/jnci/djp332; Chaouchi N, 1996, BLOOD, V87, P1022, DOI 10.1182/blood.V87.3.1022.bloodjournal8731022; Chen TT, 2011, J CLIN VIROL, V50, P125, DOI 10.1016/j.jcv.2010.10.015; CHERWINSKI HM, 1987, J EXP MED, V166, P1229, DOI 10.1084/jem.166.5.1229; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Foulongne V, 2008, EMERG INFECT DIS, V14, P1491, DOI 10.3201/eid1409.080651; Franssila R, 2004, VACCINE, V22, P3809, DOI 10.1016/j.vaccine.2003.06.003; Garneski KM, 2009, J INVEST DERMATOL, V129, P246, DOI 10.1038/jid.2008.229; Hemmer B, 1998, J IMMUNOL, V160, P3631; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; Kapp U, 1999, J EXP MED, V189, P1939, DOI 10.1084/jem.189.12.1939; Kassem A, 2008, CANCER RES, V68, P5009, DOI 10.1158/0008-5472.CAN-08-0949; Kaufman HL, 1999, J IMMUNOTHER, V22, P489, DOI 10.1097/00002371-199911000-00003; Kean JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000363; Koljonen V, 2009, BRIT J CANCER, V101, P1444, DOI 10.1038/sj.bjc.6605306; Kornacker M, 2006, INT J CANCER, V119, P1377, DOI 10.1002/ijc.21994; Kumar A, 2011, SCAND J IMMUNOL, V73, P135, DOI 10.1111/j.1365-3083.2010.02483.x; Kundu N, 1996, JNCI-J NATL CANCER I, V88, P536, DOI 10.1093/jnci/88.8.536; Lang HLE, 2002, NAT IMMUNOL, V3, P940, DOI 10.1038/ni835; Ma HL, 2004, INT IMMUNOL, V16, P1009, DOI 10.1093/intimm/dxh105; Mapara MY, 2004, J CLIN ONCOL, V22, P1136, DOI 10.1200/JCO.2004.10.041; MCKENZIE ANJ, 1993, P NATL ACAD SCI USA, V90, P3735, DOI 10.1073/pnas.90.8.3735; Mertz KD, 2010, J INVEST DERMATOL, V130, P1146, DOI 10.1038/jid.2009.392; Mocellin S, 2005, J LEUKOCYTE BIOL, V78, P1043, DOI 10.1189/jlb.0705358; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Muller-Hermelink N, 2008, CANCER CELL, V13, P507, DOI 10.1016/j.ccr.2008.04.001; Mycko MP, 2004, J IMMUNOL, V173, P1689, DOI 10.4049/jimmunol.173.3.1689; Pancaldi C, 2011, BLOOD, V117, P7099, DOI 10.1182/blood-2010-09-310557; Pantulu ND, 2010, BLOOD, V116, P5280, DOI 10.1182/blood-2010-02-269829; Paolini F, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-103; Pastrana DV, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000578; Paulson KG, 2011, J CLIN ONCOL, V29, P1539, DOI 10.1200/JCO.2010.30.6308; Paulson KG, 2010, CANCER RES, V70, P8388, DOI 10.1158/0008-5472.CAN-10-2128; Posavad CM, 2010, J IMMUNOL, V184, P3250, DOI 10.4049/jimmunol.0900722; Posavad CM, 2003, J IMMUNOL, V170, P4380, DOI 10.4049/jimmunol.170.8.4380; PUNNONEN J, 1993, P NATL ACAD SCI USA, V90, P3730, DOI 10.1073/pnas.90.8.3730; Shuda M, 2008, P NATL ACAD SCI USA, V105, P16272, DOI 10.1073/pnas.0806526105; Soderlund-Venermo M, 2009, EMERG INFECT DIS, V15, P1423, DOI 10.3201/eid1509.090204; Tannenbaum CS, 2000, SEMIN CANCER BIOL, V10, P113, DOI 10.1006/scbi.2000.0314; Teman CJ, 2011, LEUKEMIA RES, V35, P689, DOI 10.1016/j.leukres.2011.01.032; Terabe M, 2004, CANCER IMMUNOL IMMUN, V53, P79, DOI 10.1007/s00262-003-0445-0; Tolstov YL, 2009, INT J CANCER, V125, P1250, DOI 10.1002/ijc.24509; Touze A, 2011, J CLIN ONCOL, V29, P1612, DOI 10.1200/JCO.2010.31.1704; van der Meijden E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001024; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8; Wynn TA, 2003, ANNU REV IMMUNOL, V21, P425, DOI 10.1146/annurev.immunol.21.120601.141142; Zaninoni A, 2003, EXP HEMATOL, V31, P185, DOI 10.1016/S0301-472X(02)01046-9; Zheng LM, 1996, J EXP MED, V184, P579, DOI 10.1084/jem.184.2.579	55	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25751	10.1371/journal.pone.0025751	http://dx.doi.org/10.1371/journal.pone.0025751			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991346	gold, Green Published, Green Submitted			2022-12-27	WOS:000295943000065
J	Segev, E; Shefer, G; Adar, R; Chapal-Ilani, N; Itzkovitz, S; Horovitz, I; Reizel, Y; Benayahu, D; Shapiro, E				Segev, Elad; Shefer, Gabi; Adar, Rivka; Chapal-Ilani, Noa; Itzkovitz, Shalev; Horovitz, Inna; Reizel, Yitzhak; Benayahu, Dafna; Shapiro, Ehud			Muscle-Bound Primordial Stem Cells Give Rise to Myofiber-Associated Myogenic and Non-Myogenic Progenitors	PLOS ONE			English	Article							SKELETAL-MUSCLE; SATELLITE CELLS; BONE-MARROW; SOMITIC ORIGIN; DISTINCT; FATE; PROLIFERATION; HETEROGENEITY; REGENERATION; POPULATION	Myofiber cultures give rise to myogenic as well as to non-myogenic cells. Whether these myofiber-associated non-myogenic cells develop from resident stem cells that possess mesenchymal plasticity or from other stem cells such as mesenchymal stem cells (MSCs) remain unsolved. To address this question, we applied a method for reconstructing cell lineage trees from somatic mutations to MSCs and myogenic and non-myogenic cells from individual myofibers that were cultured at clonal density. Our analyses show that (i) in addition to myogenic progenitors, myofibers also harbor non-myogenic progenitors of a distinct, yet close, lineage; (ii) myofiber-associated non-myogenic and myogenic cells share the same muscle-bound primordial stem cells of a lineage distinct from bone marrow MSCs; (iii) these muscle-bound primordial stem-cells first part to individual muscles and then differentiate into myogenic and non-myogenic stem cells.	[Segev, Elad; Chapal-Ilani, Noa; Itzkovitz, Shalev; Horovitz, Inna; Shapiro, Ehud] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; [Shefer, Gabi; Benayahu, Dafna] Tel Aviv Univ, Sackler Sch Med, Dept Cell & Dev Biol, IL-69978 Tel Aviv, Israel; [Adar, Rivka; Shapiro, Ehud] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Reizel, Yitzhak] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine; Weizmann Institute of Science; Weizmann Institute of Science	Segev, E (corresponding author), Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel.	Ehud.Shapiro@weizmann.ac.il		Segev, Elad/0000-0002-2786-324X	Israel Science Foundation [1694/07]; European Union; Miel de Botton Aynsley Foundation; Paul Sparr Foundation	Israel Science Foundation(Israel Science Foundation); European Union(European Commission); Miel de Botton Aynsley Foundation; Paul Sparr Foundation	This research was supported by The Converging Technologies Program (Grant No 1694/07) of The Israel Science Foundation, The European Union FP7-ERC-AdG, Miel de Botton Aynsley and Paul Sparr Foundations, Excell project 214706 to Dr. Benayahu. Dr. Shapiro is the Incumbent of The Harry Weinrebe Professorial Chair of Computer Science and Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm JJ, 2010, J ORTHOP RES; Andreeva ER, 1998, TISSUE CELL, V30, P127, DOI 10.1016/S0040-8166(98)80014-1; Asakura A, 2001, DIFFERENTIATION, V68, P245, DOI 10.1046/j.1432-0436.2001.680412.x; Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; BENAYAHU D, 1991, CALCIFIED TISSUE INT, V49, P202, DOI 10.1007/BF02556119; BERNASCONI P, 1995, J CLIN INVEST, V96, P1137, DOI 10.1172/JCI118101; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Brand-Saberi B, 2000, CURR TOP DEV BIOL, V48, P1; Brent AE, 2002, CURR OPIN GENET DEV, V12, P548, DOI 10.1016/S0959-437X(02)00339-8; BRUDER SP, 1994, J CELL BIOCHEM, V56, P283, DOI 10.1002/jcb.240560303; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; Ciciliot S, 2010, CURR PHARM DESIGN, V16, P906, DOI 10.2174/138161210790883453; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Corselli M, 2010, ARTERIOSCL THROM VAS, V30, P1104, DOI 10.1161/ATVBAHA.109.191643; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Csete M, 2001, J CELL PHYSIOL, V189, P189, DOI 10.1002/jcp.10016; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; De Angelis L, 1999, J CELL BIOL, V147, P869, DOI 10.1083/jcb.147.4.869; Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009; Frumkin D, 2005, PLOS COMPUT BIOL, V1, P382, DOI 10.1371/journal.pcbi.0010050; Frumkin D, 2008, CANCER RES, V68, P5924, DOI 10.1158/0008-5472.CAN-07-6216; Gros J, 2005, NATURE, V435, P954, DOI 10.1038/nature03572; Grounds M D, 1993, Mol Cell Biol Hum Dis Ser, V3, P210; Harel I, 2009, DEV CELL, V16, P822, DOI 10.1016/j.devcel.2009.05.007; Huang RJ, 2000, ANAT EMBRYOL, V202, P369, DOI 10.1007/s004290000130; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Kaariainen M, 2000, SCAND J MED SCI SPOR, V10, P332, DOI 10.1034/j.1600-0838.2000.010006332.x; Kanisicak O, 2009, DEV BIOL, V332, P131, DOI 10.1016/j.ydbio.2009.05.554; Kumar G, 2008, BIOTECHNIQUES, V44, P879, DOI 10.2144/000112755; Kuznetsov SA, 1997, J BONE MINER RES, V12, P1335, DOI 10.1359/jbmr.1997.12.9.1335; Liu ZD, 2000, J CELL BIOCHEM, V76, P509, DOI 10.1002/(SICI)1097-4644(20000301)76:3<509::AID-JCB17>3.0.CO;2-R; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Morrison JI, 2010, FASEB J, V24, P750, DOI 10.1096/fj.09-134825; Ono Y, 2010, DEV BIOL, V337, P29, DOI 10.1016/j.ydbio.2009.10.005; OWEN M, 1988, J CELL SCI, P63; Pouget C, 2008, DEV BIOL, V315, P437, DOI 10.1016/j.ydbio.2007.12.045; Reizel Y, 2011, PLOS GENETICS; Reizel Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002192; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Rossi CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008523; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salipante SJ, 2006, P NATL ACAD SCI USA, V103, P5448, DOI 10.1073/pnas.0601265103; Salipante SJ, 2007, CURR TOP DEV BIOL, V79, P157, DOI 10.1016/S0070-2153(06)79006-8; Salipante SJ, 2008, GENETICS, V178, P967, DOI 10.1534/genetics.107.081018; Salipante SJ, 2010, EVOL DEV, V12, P84, DOI 10.1111/j.1525-142X.2009.00393.x; Schienda J, 2006, P NATL ACAD SCI USA, V103, P945, DOI 10.1073/pnas.0510164103; Seale P, 2009, GENE DEV, V23, P788, DOI 10.1101/gad.1779209; Shefer G, 2008, J CELL PHYSIOL, V215, P265, DOI 10.1002/jcp.21306; Shefer G, 2004, J CELL SCI, V117, P5393, DOI 10.1242/jcs.01419; Shefer G, 2007, CRIT REV EUKAR GENE, V17, P13, DOI 10.1615/CritRevEukarGeneExpr.v17.i1.20; Shefer Gabi, 2005, Methods Mol Biol, V290, P281; Shefer G, 2010, STEM CELL REV REP, V6, P42, DOI 10.1007/s12015-009-9106-9; Shepard JL, 2000, CURR OPIN HEMATOL, V7, P3, DOI 10.1097/00062752-200001000-00002; Starkey JD, 2011, J HISTOCHEM CYTOCHEM, V59, P33, DOI 10.1369/jhc.2010.956995; Stockdale FE, 2000, DEV DYNAM, V219, P304, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1057>3.0.CO;2-5; Tajbakhsh S, 2003, CURR OPIN GENET DEV, V13, P413, DOI 10.1016/S0959-437X(03)00090-X; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Wada MR, 2002, DEVELOPMENT, V129, P2987; Wagner KR, 2008, NEUROTHERAPEUTICS, V5, P583, DOI 10.1016/j.nurt.2008.08.013; Wasserstrom A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000058; Wasserstrom A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001939; Young HE, 2004, ANAT REC PART A, V276A, P75, DOI 10.1002/ar.a.10134	65	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e25605	10.1371/journal.pone.0025605	http://dx.doi.org/10.1371/journal.pone.0025605			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022423	Green Published, gold, Green Submitted			2022-12-27	WOS:000295981600011
J	Campo, JJ; Dobano, C; Sacarlal, J; Guinovart, C; Mayor, A; Angov, E; Dutta, S; Chitnis, C; Macete, E; Aponte, JJ; Alonso, PL				Campo, Joseph J.; Dobano, Carlota; Sacarlal, Jahit; Guinovart, Caterina; Mayor, Alfredo; Angov, Evelina; Dutta, Sheetij; Chitnis, Chetan; Macete, Eusebio; Aponte, John J.; Alonso, Pedro L.			Impact of the RTS,S Malaria Vaccine Candidate on Naturally Acquired Antibody Responses to Multiple Asexual Blood Stage Antigens	PLOS ONE			English	Article							CIRCUMSPOROZOITE PROTEIN VACCINE; PLASMODIUM-FALCIPARUM INFECTION; ERYTHROCYTE-MEMBRANE PROTEIN-1; MOZAMBICAN CHILDREN; MEROZOITE ANTIGENS; DOUBLE-BLIND; FOLLOW-UP; PROTECTION; EFFICACY; RTS,S/AS02A	Background: Partial protective efficacy lasting up to 43 months after vaccination with the RTS, S malaria vaccine has been reported in one cohort (C1) of a Phase IIb trial in Mozambique, but waning efficacy was observed in a smaller contemporaneous cohort (C2). We hypothesized that low dose exposure to asexual stage parasites resulting from partial pre-erythrocytic protection afforded by RTS, S may contribute to long-term vaccine efficacy to clinical disease, which was not observed in C2 due to intense active detection of infection and treatment. Methodology/Principal Findings: Serum collected 6 months post-vaccination was screened for antibodies to asexual blood stage antigens AMA-1, MSP-1(42), EBA-175, DBL-alpha and variant surface antigens of the R29 laboratory strain (VSA(R29)). Effect of IgG on the prospective hazard of clinical malaria was estimated. No difference was observed in antibody levels between RTS, S and control vaccine when all children aged 1-4 years at enrollment in both C1 and C2 were analyzed together, and no effects were observed between cohort and vaccine group. RTS, S-vaccinated children <2 years of age at enrollment had lower levels of IgG for AMA-1 and MSP-1(42) (p<0.01, all antigens), while no differences were observed in children >= 2 years. Lower risk of clinical malaria was associated with high IgG to EBA-175 and VSA(R29) in C2 only (Hazard Ratio [HR]: 0.76, 95% CI 0.66-0.88; HR: 0.75, 95% CI 0.62-0.92, respectively). Conclusions: Vaccination with RTS, S modestly reduces anti-AMA-1 and anti-MSP-1 antibodies in very young children. However, for antigens associated with lower risk of clinical malaria, there were no vaccine group or cohort-specific effects, and age did not influence antibody levels between treatment groups for these antigens. The antigens tested do not explain the difference in protective efficacy in C1 and C2. Other less-characterized antigens or VSA may be important to protection.	[Campo, Joseph J.; Dobano, Carlota; Guinovart, Caterina; Mayor, Alfredo; Aponte, John J.; Alonso, Pedro L.] Univ Barcelona, Hosp Clin, Ctr Recerca Salut Int Barcelona, Barcelona, Spain; [Campo, Joseph J.; Dobano, Carlota; Sacarlal, Jahit; Guinovart, Caterina; Mayor, Alfredo; Macete, Eusebio; Aponte, John J.; Alonso, Pedro L.] Ctr Invest Saude Manhica, Manhica, Mozambique; [Angov, Evelina; Dutta, Sheetij] Walter Reed Army Inst Res, US Mil Malaria Vaccine Program, Silver Spring, MD USA; [Chitnis, Chetan] Int Ctr Genet Engn & Biotechnol, New Delhi, India	University of Barcelona; Hospital Clinic de Barcelona; Centro de Investigacao em Saude de Manhica; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Campo, JJ (corresponding author), Univ Barcelona, Hosp Clin, Ctr Recerca Salut Int Barcelona, Barcelona, Spain.	cdobano@clinic.ub.es	Mayor, Alfredo/H-7488-2017; Alonso, Pedro L/AAZ-3645-2020; Guinovart, Caterina/ABH-2981-2020; Dobaño, Carlota/N-4119-2014; Sacarlal, Jahit/R-3172-2016	Mayor, Alfredo/0000-0003-3890-2897; Alonso, Pedro L/0000-0003-3292-3443; Dobaño, Carlota/0000-0002-6751-4060; Sacarlal, Jahit/0000-0003-1059-217X; Chitnis, Chetan/0000-0002-8773-9865	Program for Appropriate Technology in Health-Malaria Vaccine Initiative; Fundacion Ramon Areces; Agencia de Gestio d'Ajuts Universitaris i de Recerca [2010FI_B 00168]; Spanish Ministry of Science and Innovation [RYC-2008-02631]	Program for Appropriate Technology in Health-Malaria Vaccine Initiative; Fundacion Ramon Areces; Agencia de Gestio d'Ajuts Universitaris i de Recerca(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by the Program for Appropriate Technology in Health-Malaria Vaccine Initiative, the Fundacion Ramon Areces, the Agencia de Gestio d'Ajuts Universitaris i de Recerca [2010FI_B 00168 to JC] and the Spanish Ministry of Science and Innovation [RYC-2008-02631 to CD]. The Centro de Investigacao em Saude da Manhica receives core support from the Spanish Agency for International Cooperation and Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDE P, 2011, VACCINE; Aide P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013838; Alonso PL, 2005, LANCET, V366, P2012, DOI 10.1016/S0140-6736(05)67669-6; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Angov E, 2003, MOL BIOCHEM PARASIT, V128, P195, DOI 10.1016/S0166-6851(03)00077-X; Angov E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002189; Aponte JJ, 2007, PLOS MED, V4, P1259, DOI 10.1371/journal.pmed.0040242; Aponte JJ, 2007, LANCET, V370, P1543, DOI 10.1016/S0140-6736(07)61542-6; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Bejon P, 2011, J INFECT DIS, V204, P9, DOI 10.1093/infdis/jir222; Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4; Casares S, 2010, VACCINE, V28, P4880, DOI 10.1016/j.vaccine.2010.05.033; Cham GKK, 2010, INFECT IMMUN, V78, P4653, DOI 10.1128/IAI.00593-10; Cohen J, 2010, HUM VACCINES, V6, P90, DOI 10.4161/hv.6.1.9677; Conway DJ, 2000, NAT MED, V6, P689, DOI 10.1038/76272; Crompton PD, 2010, J CLIN INVEST, V120, P4168, DOI 10.1172/JCI44423; Crompton PD, 2010, P NATL ACAD SCI USA, V107, P6958, DOI 10.1073/pnas.1001323107; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Ferreira MU, 1996, AM J TROP MED HYG, V55, P315, DOI 10.4269/ajtmh.1996.55.315; Garcon N, 2007, EXPERT REV VACCINES, V6, P723, DOI 10.1586/14760584.6.5.723; Gottschalk PG, 2005, ANAL BIOCHEM, V343, P54, DOI 10.1016/j.ab.2005.04.035; Greenhouse B, 2011, J INFECT DIS, V204, P19, DOI 10.1093/infdis/jir223; Guinovart C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005165; Kester KE, 2001, J INFECT DIS, V183, P640, DOI 10.1086/318534; Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120; Kocken CHM, 2002, INFECT IMMUN, V70, P4471, DOI 10.1128/IAI.70.8.4471-4476.2002; Little JA, 2004, CHROMATOGRAPHIA, V59, pS177, DOI 10.1365/s10337-003-0182-8; Mayor A, 2009, INFECT IMMUN, V77, P3857, DOI 10.1128/IAI.00049-09; Miura K, 2008, VACCINE, V26, P193, DOI 10.1016/j.vaccine.2007.10.064; Moorthy VS, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-312; Okech BA, 2004, INFECT IMMUN, V72, P1557, DOI 10.1128/IAI.72.3.1557-1567.2004; Okenu DMN, 2000, INFECT IMMUN, V68, P5559, DOI 10.1128/IAI.68.10.5559-5566.2000; Olotu A, 2011, LANCET INFECT DIS, V11, P102, DOI 10.1016/S1473-3099(10)70262-0; Osier FHA, 2008, INFECT IMMUN, V76, P2240, DOI 10.1128/IAI.01585-07; Pandey KC, 2002, MOL BIOCHEM PARASIT, V123, P23, DOI 10.1016/S0166-6851(02)00122-6; Quelhas D, 2008, CLIN VACCINE IMMUNOL, V15, P1282, DOI 10.1128/CVI.00044-08; REED GF, 1995, PEDIATRICS, V96, P600; Richards JS, 2010, CLIN INFECT DIS, V51, pE50, DOI 10.1086/656413; Sacarlal J, 2008, VACCINE, V26, P174, DOI 10.1016/j.vaccine.2007.11.003; Sacarlal J, 2009, J INFECT DIS, V200, P329, DOI 10.1086/600119; Schellenberg D, 2005, LANCET, V365, P1481, DOI 10.1016/S0140-6736(05)66418-5; Serra-Casas E, 2010, J INFECT DIS, V201, P123, DOI 10.1086/648595; SIM BKL, 1994, SCIENCE, V264, P1941, DOI 10.1126/science.8009226; Stanisic DI, 2009, INFECT IMMUN, V77, P1165, DOI 10.1128/IAI.01129-08; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Stoute JA, 1998, J INFECT DIS, V178, P1139, DOI 10.1086/515657; Sutherland CJ, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-161; Triglia T, 2000, MOL MICROBIOL, V38, P706, DOI 10.1046/j.1365-2958.2000.02175.x; Vestergaard LS, 2008, INFECT IMMUN, V76, P2706, DOI 10.1128/IAI.01401-06	49	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25779	10.1371/journal.pone.0025779	http://dx.doi.org/10.1371/journal.pone.0025779			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022448	Green Published, Green Submitted, gold			2022-12-27	WOS:000295976000038
J	Menuet, C; Cazals, Y; Gestreau, C; Borghgraef, P; Gielis, L; Dutschmann, M; Van Leuven, F; Hilaire, G				Menuet, Clement; Cazals, Yves; Gestreau, Christian; Borghgraef, Peter; Gielis, Lies; Dutschmann, Mathias; Van Leuven, Fred; Hilaire, Gerard			Age-Related Impairment of Ultrasonic Vocalization in Tau.P301L Mice: Possible Implication for Progressive Language Disorders	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; FINAL COMMON PATHWAY; BRAIN-STEM NUCLEI; PERIAQUEDUCTAL GRAY; ALZHEIMERS-DISEASE; RETROAMBIGUUS PROJECTIONS; MONOSYNAPTIC PROJECTIONS; LARYNGEAL MOTONEURONS; COGNITIVE IMPAIRMENT; NONFLUENT APHASIA	Background: Tauopathies, including Alzheimer's Disease, are the most frequent neurodegenerative diseases in elderly people and cause various cognitive, behavioural and motor defects, but also progressive language disorders. For communication and social interactions, mice produce ultrasonic vocalization (USV) via expiratory airflow through the larynx. We examined USV of Tau.P301L mice, a mouse model for tauopathy expressing human mutant tau protein and developing cognitive, motor and upper airway defects. Methodology/Principal Findings: At age 4-5 months, Tau.P301L mice had normal USV, normal expiratory airflow and no brainstem tauopathy. At age 8-10 months, Tau.P301L mice presented impaired USV, reduced expiratory airflow and severe tauopathy in the periaqueductal gray, Kolliker-Fuse and retroambiguus nuclei. Tauopathy in these nuclei that control upper airway function and vocalization correlates well with the USV impairment of old Tau.P301L mice. Conclusions: In a mouse model for tauopathy, we report for the first time an age-related impairment of USV that correlates with tauopathy in midbrain and brainstem areas controlling vocalization. The vocalization disorder of old Tau.P301L mice could be, at least in part, reminiscent of language disorders of elderly suffering tauopathy.	[Menuet, Clement; Cazals, Yves] Univ Paul Cezanne, Univ Mediterranee, CNRS, Neurovegetat Physiol Lab,Unite Mixte Rech 6231, Marseille, France; [Borghgraef, Peter; Gielis, Lies; Van Leuven, Fred] Katholieke Univ Leuven, Expt Genet Grp, Dept Human Genet, Louvain, Belgium; [Dutschmann, Mathias] Univ Leeds, Inst Membrane & Syst Biol, Leeds, W Yorkshire, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; KU Leuven; University of Leeds	Menuet, C (corresponding author), Univ Paul Cezanne, Univ Mediterranee, CNRS, Neurovegetat Physiol Lab,Unite Mixte Rech 6231, Marseille, France.	gerard.hilaire@univ-cezanne.fr	Gestreau, Christian/K-5161-2017	Gestreau, Christian/0000-0001-5069-482X; Dutschmann, Mathias/0000-0002-0692-746X; Menuet, Clement/0000-0002-7419-6427	Centre National de la Recherche Scientifique; Universite Paul Cezanne; Universite de la Mediterranee (Unite Mixte de Recherche) [6231]; Fonds Wetenschappelijk Onderzoek-Vlaanderen (FWO-Vlaanderen); Instituut voor Wetenschap en Techniek (IWT); KULeuven-Research Fund (BOF); KULeuven-Research Development; NHLBI [R33HL087377]; EEC Framework program FP6; EEC Framework program FP7; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R33HL087377] Funding Source: NIH RePORTER	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite Paul Cezanne; Universite de la Mediterranee (Unite Mixte de Recherche); Fonds Wetenschappelijk Onderzoek-Vlaanderen (FWO-Vlaanderen)(FWO); Instituut voor Wetenschap en Techniek (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); KULeuven-Research Fund (BOF)(KU Leuven); KULeuven-Research Development; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); EEC Framework program FP6; EEC Framework program FP7; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank the support of the Centre National de la Recherche Scientifique, the Universite Paul Cezanne and the Universite de la Mediterranee (Unite Mixte de Recherche 6231). Dr. Borghgraef, Dr. Gielis, Dr. Van Leuven acknowledge support by Fonds Wetenschappelijk Onderzoek-Vlaanderen (FWO-Vlaanderen), Instituut voor Wetenschap en Techniek (IWT), KULeuven-Research Fund (BOF), KULeuven-Research & Development and EEC Framework programs FP6 & FP7. Dr. Dutschmann was supported by NHLBI (Cluster Grant R33HL087377). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancoli-Israel S, 2008, J AM GERIATR SOC, V56, P2076, DOI 10.1111/j.1532-5415.2008.01934.x; Attems J, 2005, J ALZHEIMERS DIS, V8, P57; Baekey DM, 2001, J PHYSIOL-LONDON, V534, P565, DOI 10.1111/j.1469-7793.2001.t01-1-00565.x; Bajic D, 2000, J COMP NEUROL, V427, P649, DOI 10.1002/1096-9861(20001127)427:4<649::AID-CNE11>3.0.CO;2-M; Bajic D, 1999, J COMP NEUROL, V405, P359; Bianchi AL, 2009, RESP PHYSIOL NEUROBI, V168, P4, DOI 10.1016/j.resp.2009.04.019; Boccardi M, 2005, NEUROBIOL AGING, V26, P37, DOI 10.1016/j.neurobiolaging.2004.02.019; Boers J, 2006, BRAIN RES BULL, V68, P249, DOI 10.1016/j.brainresbull.2005.08.011; Boers J, 2002, NEUROSCI LETT, V319, P5, DOI 10.1016/S0304-3940(01)02395-3; Bonis JM, 2011, RESP PHYSIOL NEUROBI, V175, P272, DOI 10.1016/j.resp.2010.12.002; Braak H, 2000, ACTA NEUROPATHOL, V99, P489, DOI 10.1007/s004010051150; Braak H, 2011, ACTA NEUROPATHOL, V121, P171, DOI 10.1007/s00401-010-0789-4; Braz JM, 2009, J COMP NEUROL, V514, P145, DOI 10.1002/cne.22003; Chapman SB, 1997, NEUROLOGY, V49, P1298, DOI 10.1212/WNL.49.5.1298; Chong MS, 2006, J AM GERIATR SOC, V54, P777, DOI 10.1111/j.1532-5415.2006.00694.x; Cooke Jana R, 2006, Behav Sleep Med, V4, P219, DOI 10.1207/s15402010bsm0404_2; Cooke JR, 2009, J CLIN SLEEP MED, V5, P305; Dutschmann M, 2006, EUR J NEUROSCI, V24, P1071, DOI 10.1111/j.1460-9568.2006.04981.x; Dutschmann M, 2010, J NEUROSCI, V30, P1810, DOI 10.1523/JNEUROSCI.5261-09.2010; Dutschmann M, 2009, J PHYSIOL-LONDON, V587, P4931, DOI 10.1113/jphysiol.2009.174599; Duyckaerts C, 2011, ACTA NEUROPATHOL, V121, P145, DOI 10.1007/s00401-010-0794-7; Esposito A, 1999, NEUROREPORT, V10, P681, DOI 10.1097/00001756-199903170-00004; Fischer J, 2011, GENES BRAIN BEHAV, V10, P17, DOI 10.1111/j.1601-183X.2010.00610.x; FUH JL, 1994, CORTEX, V30, P701, DOI 10.1016/S0010-9452(13)80246-8; Gerrits PO, 1996, J COMP NEUROL, V373, P173, DOI 10.1002/(SICI)1096-9861(19960916)373:2<173::AID-CNE2>3.0.CO;2-0; Gerstner E, 2007, COGN BEHAV NEUROL, V20, P15, DOI 10.1097/WNN.0b013e31802b6c45; Gestreau C, 2005, RESP PHYSIOL NEUROBI, V147, P159, DOI 10.1016/j.resp.2005.03.015; Grimsley JMS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017460; Grossman M, 2010, NAT REV NEUROL, V6, P88, DOI 10.1038/nrneurol.2009.216; Gunawardena D, 2010, NEUROLOGY, V75, P588, DOI 10.1212/WNL.0b013e3181ed9c7d; HOFER MA, 1993, BEHAV NEUROSCI, V107, P354, DOI 10.1037/0735-7044.107.2.354; HOIT JD, 1987, J SPEECH HEAR RES, V30, P351, DOI 10.1044/jshr.3003.351; HOLSTEGE G, 1989, J COMP NEUROL, V284, P242, DOI 10.1002/cne.902840208; Holstege G, 1997, NEUROSCIENCE, V80, P587, DOI 10.1016/S0306-4522(97)00061-4; Holy TE, 2005, PLOS BIOL, V3, P2177, DOI 10.1371/journal.pbio.0030386; Hu WT, 2010, NEUROLOGY, V75, P595, DOI 10.1212/WNL.0b013e3181ed9c52; Huber JE, 2008, J SPEECH LANG HEAR R, V51, P651, DOI 10.1044/1092-4388(2008/047); Huber JE, 2008, RESP PHYSIOL NEUROBI, V164, P323, DOI 10.1016/j.resp.2008.08.007; Humbert IA, 2010, J ALZHEIMERS DIS, V19, P1185, DOI 10.3233/JAD-2010-1316; Jiang YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012278; Johnson AM, 2010, J ACOUST SOC AM, V128, pEL75, DOI 10.1121/1.3462234; Jourdan D, 1997, J PHARMACOL TOXICOL, V38, P109, DOI 10.1016/S1056-8719(97)00067-1; Klop EM, 2002, J COMP NEUROL, V445, P47, DOI 10.1002/cne.10151; Lahvis GP, 2011, GENES BRAIN BEHAV, V10, P4, DOI 10.1111/j.1601-183X.2010.00603.x; Lee Eiyai, 2007, Brain and Nerve (Tokyo), V59, P629; LI YQ, 1993, BRAIN RES, V608, P138, DOI 10.1016/0006-8993(93)90784-K; Menuet C, 2011, RESP PHYSIOL NEUROBI, V178, P290, DOI 10.1016/j.resp.2011.06.030; Mesulam M, 2008, ANN NEUROL, V63, P709, DOI 10.1002/ana.21388; Morgan MM, 2008, PAIN, V140, P376, DOI 10.1016/j.pain.2008.09.009; Munoz David G, 2007, Am J Alzheimers Dis Other Demen, V22, P294, DOI 10.1177/1533317507302320; NASTITI K, 1991, NEUROSCI BIOBEHAV R, V15, P483, DOI 10.1016/S0149-7634(05)80136-8; NUNEZ AA, 1985, PHYSIOL BEHAV, V34, P901, DOI 10.1016/0031-9384(85)90011-3; Ogar JM, 2007, ALZ DIS ASSOC DIS, V21, pS23, DOI 10.1097/WAD.0b013e31815d19fe; Oka T, 2008, NEUROSCI RES, V62, P286, DOI 10.1016/j.neures.2008.10.004; Onen F, 2010, PSYCHOL NEUROPSYCHIA, V8, P163, DOI 10.1684/pnv.2010.0219; Parvizi J, 2000, ANN NEUROL, V48, P344, DOI 10.1002/1531-8249(200009)48:3<344::AID-ANA9>3.3.CO;2-J; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Portfors CV, 2007, J AM ASSOC LAB ANIM, V46, P28; ROHRER JD, 2011, CURR ALZHEIMER RES; Rohrer JD, 2010, NEUROLOGY, V75, P603, DOI 10.1212/WNL.0b013e3181ed9c6b; Rohrer JD, 2010, J NEUROL, V257, P569, DOI 10.1007/s00415-009-5371-4; Scattoni ML, 2010, BEHAV BRAIN RES, V208, P250, DOI 10.1016/j.bbr.2009.12.002; Scattoni ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003067; Shiba K, 2007, J NEUROSCI, V27, P5156, DOI 10.1523/JNEUROSCI.0001-07.2007; SPERRY EE, 1992, J SPEECH HEAR RES, V35, P1246, DOI 10.1044/jshr.3506.1246; Subramanian HH, 2009, J NEUROSCI, V29, P3824, DOI 10.1523/JNEUROSCI.0607-09.2009; Subramanian HH, 2008, J NEUROSCI, V28, P12274, DOI 10.1523/JNEUROSCI.4168-08.2008; Sugiyama Y, 2010, NEUROSCI RES, V66, P359, DOI 10.1016/j.neures.2009.12.006; Suh MK, 2009, ALZ DIS ASSOC DIS, V23, P178, DOI 10.1097/WAD.0b013e318192a539; Suthers RA, 2006, J EXP BIOL, V209, P4984, DOI 10.1242/jeb.02594; Taler V, 2008, J CLIN EXP NEUROPSYC, V30, P501, DOI 10.1080/13803390701550128; Terwel D, 2005, J BIOL CHEM, V280, P3963, DOI 10.1074/jbc.M409876200; Terwel D, 2008, AM J PATHOL, V172, P786, DOI 10.2353/ajpath.2008.070904; Tsuchiya K, 2000, ACTA NEUROPATHOL, V99, P81, DOI 10.1007/PL00007411; VanderHorst VGJM, 2000, J COMP NEUROL, V424, P251, DOI 10.1002/1096-9861(20000821)424:2<251::AID-CNE5>3.0.CO;2-D; VanderHorst VGJM, 2005, J COMP NEUROL, V488, P180, DOI 10.1002/cne.20574; VANDERHORST VGJM, 1995, J COMP NEUROL, V359, P457, DOI 10.1002/cne.903590308; Vanderhorst VGJM, 2001, NEUROSCIENCE, V107, P117, DOI 10.1016/S0306-4522(01)00343-8; Wilson SM, 2010, BRAIN, V133, P2069, DOI 10.1093/brain/awq129; YAJIMA Y, 1983, EXP BRAIN RES, V50, P359; Zhang SP, 1995, J NEUROPHYSIOL, V74, P2500, DOI 10.1152/jn.1995.74.6.2500	81	24	26	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e25770	10.1371/journal.pone.0025770	http://dx.doi.org/10.1371/journal.pone.0025770			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022446	Green Published, gold			2022-12-27	WOS:000295976000037
J	Miao, XY; Wu, X; Li, R; Chen, KW; Yao, L				Miao, Xiaoyan; Wu, Xia; Li, Rui; Chen, Kewei; Yao, Li			Altered Connectivity Pattern of Hubs in Default-Mode Network with Alzheimer's Disease: An Granger Causality Modeling Approach	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; RESTING-STATE NETWORKS; FUNCTIONAL CONNECTIVITY; CINGULATE CORTEX; WANDERING MINDS; BRAIN ACTIVITY; BASE-LINE; FMRI; ATTENTION; DEMENTIA	Background: Evidences from normal subjects suggest that the default-mode network (DMN) has posterior cingulate cortex (PCC), medial prefrontal cortex (MPFC) and inferior parietal cortex (IPC) as its hubs; meanwhile, these DMN nodes are often found to be abnormally recruited in Alzheimer's disease (AD) patients. The issues on how these hubs interact to each other, with the rest nodes of the DMN and the altered pattern of hubs with respect to AD, are still on going discussion for eventual final clarification. Principal Findings: To address these issues, we investigated the causal influences between any pair of nodes within the DMN using Granger causality analysis and graph-theoretic methods on resting-state fMRI data of 12 young subjects, 16 old normal controls and 15 AD patients respectively. We found that: (1) PCC/MPFC/IPC, especially the PCC, showed the widest and distinctive causal effects on the DMN dynamics in young group; (2) the pattern of DMN hubs was abnormal in AD patients compared to old control: MPFC and IPC had obvious causal interaction disruption with other nodes; the PCC showed outstanding performance for it was the only region having causal relation with all other nodes significantly; (3) the altered relation between hubs and other DMN nodes held potential as a noninvasive biomarker of AD. Conclusions: Our study, to the best of our knowledge, is the first to support the hub configuration of the DMN from the perspective of causal relationship, and reveal abnormal pattern of the DMN hubs in AD. Findings from young subjects provide additional evidence for the role of PCC/MPFC/IPC acting as hubs in the DMN. Compared to old control, MPFC and IPC lost their roles as hubs owing to the obvious causal interaction disruption, and PCC was preserved as the only hub showing significant causal relations with all other nodes.	[Miao, Xiaoyan; Li, Rui; Yao, Li] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Wu, Xia; Yao, Li] Beijing Normal Univ, Sch Informat Sci & Technol, Beijing 100875, Peoples R China; [Chen, Kewei] BAI, Banner Good Samaritan PET Ctr, Phoenix, AZ USA; [Miao, Xiaoyan] Beijing Inst Informat & Control, Beijing, Peoples R China	Beijing Normal University; Beijing Normal University; Banner Research; Banner Health	Miao, XY (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	yaoli@bnu.edu.cn	Chen, kewei/P-6304-2015	Chen, kewei/0000-0001-8497-3069	National Natural Science Foundation of China [60931003, 60905063, 81000603, 60805040]; National Institute of Mental Health, United States of America [RO1 MH57899]; National Institute on Aging, United States of America [R01AG031581-10, P30 AG19610, k23 AG24062]; State of Arizona; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG024062, P30AG019610, R01AG031581] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institute of Mental Health, United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Aging, United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); State of Arizona; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work is supported by the National Natural Science Foundation of China (60931003, 60905063, 81000603, and 60805040). It is also supported by the National Institute of Mental Health, United States of America (RO1 MH57899), the National Institute on Aging, United States of America (R01AG031581-10 and P30 AG19610, k23 AG24062) and the State of Arizona. The funders had no role in study desigh, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander GE, 2002, AM J PSYCHIAT, V159, P738, DOI 10.1176/appi.ajp.159.5.738; Allen G, 2007, ARCH NEUROL-CHICAGO, V64, P1482, DOI 10.1001/archneur.64.10.1482; Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Bagarinao E, 2002, ANN BIOMED ENG, V30, P260, DOI 10.1114/1.1454134; Bai F, 2009, BIOL PSYCHIAT, V65, P951, DOI 10.1016/j.biopsych.2008.10.017; BAKARDJIAN H, 2006, CLIN NEUROPHYSIOL, V117, P149; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; BENSON DF, 1983, ARCH NEUROL-CHICAGO, V40, P711, DOI 10.1001/archneur.1983.04050110029003; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Calhoun VD, 2001, NEUROIMAGE, V14, P1080, DOI 10.1006/nimg.2001.0921; Castellanos FX, 2008, BIOL PSYCHIAT, V63, P332, DOI 10.1016/j.biopsych.2007.06.025; Celone KA, 2006, J NEUROSCI, V26, P10222, DOI 10.1523/JNEUROSCI.2250-06.2006; Cherkassky VL, 2006, NEUROREPORT, V17, P1687, DOI 10.1097/01.wnr.0000239956.45448.4c; Chetelat G, 2003, NEUROLOGY, V60, P1374, DOI 10.1212/01.WNL.0000055847.17752.E6; Collette F, 1999, COGNITIVE BRAIN RES, V7, P411, DOI 10.1016/S0926-6410(98)00045-7; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Delbeuck X, 2003, NEUROPSYCHOL REV, V13, P79, DOI 10.1023/A:1023832305702; Durston S, 2006, BIOL PSYCHIAT, V60, P1062, DOI 10.1016/j.biopsych.2005.12.020; Fleisher AS, 2009, NEUROIMAGE, V47, P1678, DOI 10.1016/j.neuroimage.2009.06.021; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Gao Q, 2008, NEUROSCI LETT, V443, P1, DOI 10.1016/j.neulet.2008.07.036; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; Gilbert DT, 2007, SCIENCE, V317, P1351, DOI 10.1126/science.1144161; Gilbert SJ, 2007, SCIENCE, V317, P43, DOI 10.1126/science.1140801; Goebel R, 2003, MAGN RESON IMAGING, V21, P1251, DOI 10.1016/j.mri.2003.08.026; Gold BT, 2002, NEURON, V35, P803, DOI 10.1016/S0896-6273(02)00800-0; Goldberg S, 2004, NEUROBIOL AGING, V25, P167, DOI 10.1016/S0197-4580(03)00088-5; Grady CL, 2006, J COGNITIVE NEUROSCI, V18, P227, DOI 10.1162/jocn.2006.18.2.227; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; GRANGER CWJ, 1980, J ECON DYN CONTROL, V2, P329, DOI 10.1016/0165-1889(80)90069-X; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Haznedar MM, 2000, AM J PSYCHIAT, V157, P1994, DOI 10.1176/appi.ajp.157.12.1994; Herholz K, 2002, NEUROIMAGE, V17, P302, DOI 10.1006/nimg.2002.1208; Hirao K, 2005, NEUROIMAGE, V28, P1014, DOI 10.1016/j.neuroimage.2005.06.066; Kaminski M, 2001, BIOL CYBERN, V85, P145, DOI 10.1007/s004220000235; Kennedy DP, 2006, P NATL ACAD SCI USA, V103, P8275, DOI 10.1073/pnas.0600674103; Lee TW, 1999, NEURAL COMPUT, V11, P417, DOI 10.1162/089976699300016719; LI R, 2011, NEUROIMAGE; Lustig C, 2004, NEURON, V42, P865, DOI 10.1016/j.neuron.2004.04.002; Lustig C, 2003, P NATL ACAD SCI USA, V100, P14504, DOI 10.1073/pnas.2235925100; Macey PM, 2004, NEUROIMAGE, V22, P360, DOI 10.1016/j.neuroimage.2003.12.042; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Maxim V, 2005, NEUROIMAGE, V25, P141, DOI 10.1016/j.neuroimage.2004.10.044; Mazoyer B, 2001, BRAIN RES BULL, V54, P287, DOI 10.1016/S0361-9230(00)00437-8; Minoshima S, 1997, ANN NEUROL, V42, P85, DOI 10.1002/ana.410420114; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Mulas F, 2006, BIOL PSYCHIAT, V59, P373, DOI 10.1016/j.biopsych.2005.06.031; Pardo JV, 2007, NEUROIMAGE, V35, P1231, DOI 10.1016/j.neuroimage.2006.12.044; Perry RJ, 1999, BRAIN, V122, P383, DOI 10.1093/brain/122.3.383; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Reiman EM, 2004, P NATL ACAD SCI USA, V101, P284, DOI 10.1073/pnas.2635903100; Reiman EM, 1996, NEW ENGL J MED, V334, P752, DOI 10.1056/NEJM199603213341202; Roebroeck A, 2005, NEUROIMAGE, V25, P230, DOI 10.1016/j.neuroimage.2004.11.017; Rombouts SARB, 2005, HUM BRAIN MAPP, V26, P231, DOI 10.1002/hbm.20160; Rubia K, 2009, AM J PSYCHIAT, V166, P83, DOI 10.1176/appi.ajp.2008.08020212; Sambataro F, 2010, NEUROBIOL AGING, V31, P839, DOI 10.1016/j.neurobiolaging.2008.05.022; Seth AK, 2005, NETWORK-COMP NEURAL, V16, P35, DOI 10.1080/09548980500238756; SHANNON BJ, FUNCTIONAL ANATOMIC; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Svoboda E, 2006, NEUROPSYCHOLOGIA, V44, P2189, DOI 10.1016/j.neuropsychologia.2006.05.023; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Wicker B, 2003, BRAIN RES REV, V43, P224, DOI 10.1016/j.brainresrev.2003.08.003; WU X, 2011, HUMAN BRAIN MAPPING; Zhang HY, 2009, BEHAV BRAIN RES, V197, P103, DOI 10.1016/j.bbr.2008.08.012; ZWEIG MH, 1993, CLIN CHEM, V39, P561	78	58	59	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e25546	10.1371/journal.pone.0025546	http://dx.doi.org/10.1371/journal.pone.0025546			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022410	Green Published, Green Submitted, gold			2022-12-27	WOS:000295973200010
J	Moores, B; Drolle, E; Attwood, SJ; Simons, J; Leonenko, Z				Moores, Bradley; Drolle, Elizabeth; Attwood, Simon J.; Simons, Janet; Leonenko, Zoya			Effect of Surfaces on Amyloid Fibril Formation	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; BETA-PROTEIN; CONFORMATIONAL-CHANGES; STRUCTURAL BASIS; LIPID-BILAYERS; PHASE DOMAINS; LIGHT-CHAIN; IN-VITRO; PEPTIDE; AGGREGATION	Using atomic force microscopy (AFM) we investigated the interaction of amyloid beta (A beta) (1-42) peptide with chemically modified surfaces in order to better understand the mechanism of amyloid toxicity, which involves interaction of amyloid with cell membrane surfaces. We compared the structure and density of A beta fibrils on positively and negatively charged as well as hydrophobic chemically-modified surfaces at physiologically relevant conditions. We report that due to the complex distribution of charge and hydrophobicity amyloid oligomers bind to all types of surfaces investigated (CH3, COOH, and NH2) although the charge and hydrophobicity of surfaces affected the structure and size of amyloid deposits as well as surface coverage. Hydrophobic surfaces promote formation of spherical amorphous clusters, while charged surfaces promote protofibril formation. We used the nonlinear Poisson-Boltzmann equation (PBE) approach to analyze the electrostatic interactions of amyloid monomers and oligomers with modified surfaces to complement our AFM data.	[Moores, Bradley; Attwood, Simon J.; Leonenko, Zoya] Univ Waterloo, Dept Phys & Astron, Waterloo, ON N2L 3G1, Canada; [Drolle, Elizabeth; Simons, Janet; Leonenko, Zoya] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada	University of Waterloo; University of Waterloo	Moores, B (corresponding author), Univ Waterloo, Dept Phys & Astron, Waterloo, ON N2L 3G1, Canada.	zleonenk@uwaterloo.ca	attwood, simon J/N-7237-2014	attwood, simon J/0000-0002-2973-2059; MOORES, BRADLEY/0000-0002-4745-606X	Natural Science and Engineering Council of Canada (NSERC); Canada Foundation for Innovation; Ontario Ministry of Research and Innovation; Ontario Research Fund (ORF); Waterloo Institute for Nanotechnology (WIN)	Natural Science and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Ontario Research Fund (ORF); Waterloo Institute for Nanotechnology (WIN)	This work was supported by the Natural Science and Engineering Council of Canada (NSERC), http://www.nserc-crsng.gc.ca, Canada Foundation for Innovation, www.innovation.ca, and Ontario Ministry of Research and Innovation, www.mri.gov.on.ca: Ontario Research Fund (ORF), and Waterloo Institute for Nanotechnology (WIN), www.nano.uwaterloo.ca. JS is an undergraduate student supported by NSERC USRA award, BM is a MS student supported by NSERC Discovery grant (ZL) and WIN Graduate Fellowship (BM), ED is a PhD student supported by NSERC Graduate Scholarship (ED), Simon Attwood is a Postdoctoral Fellow supported by NSERC Discovery grant (ZL). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ambroggio EE, 2005, BIOPHYS J, V88, P2706, DOI 10.1529/biophysj.104.055582; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Blackley HKL, 2000, J MOL BIOL, V298, P833, DOI 10.1006/jmbi.2000.3711; Blackley HKL, 1999, EXP NEUROL, V158, P437, DOI 10.1006/exnr.1999.7114; Boucher G, 2006, PROTEINS, V65, P877, DOI 10.1002/prot.21134; Buxbaum J, 1999, HEMATOL ONCOL CLIN N, V13, P1235, DOI 10.1016/S0889-8588(05)70123-4; Carrell RW, 1998, CURR OPIN STRUC BIOL, V8, P799, DOI 10.1016/S0959-440X(98)80101-2; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; ChooSmith LP, 1997, J BIOL CHEM, V272, P22987, DOI 10.1074/jbc.272.37.22987; Choucair A, 2007, BBA-BIOMEMBRANES, V1768, P146, DOI 10.1016/j.bbamem.2006.09.005; Cohen FS, 2004, J MEMBRANE BIOL, V199, P1, DOI 10.1007/s00232-004-0669-8; Cordy JM, 2006, MOL MEMBR BIOL, V23, P111, DOI 10.1080/09687860500496417; Crescenzi O, 2002, EUR J BIOCHEM, V269, P5642, DOI 10.1046/j.1432-1033.2002.03271.x; Dobson CM, 2001, PHILOS T R SOC B, V356, P133, DOI 10.1098/rstb.2000.0758; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; DYRKS T, 1993, FEBS LETT, V324, P231, DOI 10.1016/0014-5793(93)81399-K; Ege C, 2005, CHEMPHYSCHEM, V6, P226, DOI 10.1002/cphc.200400468; Fezoui Y, 2000, AMYLOID, V7, P166, DOI 10.3109/13506120009146831; Giacomelli CE, 2005, MACROMOL BIOSCI, V5, P401, DOI 10.1002/mabi.200400189; Goldberg MS, 2000, NAT CELL BIOL, V2, pE115, DOI 10.1038/35017124; Guo T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008900; Hammarstrom P, 2008, J PHYS CONF SER, V100, DOI 10.1088/1742-6596/100/5/052039; HOWLETT DR, 1995, NEURODEGENERATION, V4, P23, DOI 10.1006/neur.1995.0003; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Johansson J, 2003, SWISS MED WKLY, V133, P275; Kakio A, 2002, BIOCHEMISTRY-US, V41, P7385, DOI 10.1021/bi0255874; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kowalewski T, 1999, P NATL ACAD SCI USA, V96, P3688, DOI 10.1073/pnas.96.7.3688; Kuo YM, 1996, J BIOL CHEM, V271, P4077; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lashuel HA, 1998, BIOCHEMISTRY-US, V37, P17851, DOI 10.1021/bi981876+; Latour RA, 2002, J BIOMED MATER RES, V60, P564, DOI 10.1002/jbm.10052; LEVINE H, 1995, NEUROBIOL AGING, V16, P755, DOI 10.1016/0197-4580(95)00052-G; Lin H, 2001, FASEB J, V15, P2433, DOI 10.1096/fj.01-0377com; Lomakin A, 1996, P NATL ACAD SCI USA, V93, P1125, DOI 10.1073/pnas.93.3.1125; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; McMasters MJ, 2005, LANGMUIR, V21, P4464, DOI 10.1021/la047044w; Melquiond A, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2435358; Nayak A, 2008, BIOCHEM BIOPH RES CO, V369, P303, DOI 10.1016/j.bbrc.2008.01.159; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; PIKE CJ, 1991, BRAIN RES, V563, P311, DOI 10.1016/0006-8993(91)91553-D; PIKE CJ, 1993, J NEUROSCI, V13, P1676; Powers ET, 2001, J AM CHEM SOC, V123, P775, DOI 10.1021/ja005528i; Qin ZJ, 2007, BIOCHEMISTRY-US, V46, P3521, DOI 10.1021/bi061716v; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Rauk A, 2009, CHEM SOC REV, V38, P2698, DOI 10.1039/b807980n; Rocha S, 2005, CHEMPHYSCHEM, V6, P2527, DOI 10.1002/cphc.200500158; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; Roher AE, 1996, J BIOL CHEM, V271, P20631, DOI 10.1074/jbc.271.34.20631; Seilheimer B, 1997, J STRUCT BIOL, V119, P59, DOI 10.1006/jsbi.1997.3859; Sethuraman A, 2005, BIOPHYS J, V88, P1322, DOI 10.1529/biophysj.104.051797; Sharp JS, 2002, BIOCHEMISTRY-US, V41, P15810, DOI 10.1021/bi020525z; SHARP KA, 1994, CURR OPIN STRUC BIOL, V4, P234, DOI 10.1016/S0959-440X(94)90314-X; SHARP KA, 1990, J PHYS CHEM-US, V94, P7684, DOI 10.1021/j100382a068; Sigal GB, 1998, J AM CHEM SOC, V120, P3464, DOI 10.1021/ja970819l; Stefani M, 2007, NEUROSCIENTIST, V13, P519, DOI 10.1177/1073858407303428; TERZI E, 1995, J MOL BIOL, V252, P633, DOI 10.1006/jmbi.1995.0525; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Wang QM, 2010, LANGMUIR, V26, P12722, DOI 10.1021/la1017906; Wang QM, 2010, LANGMUIR, V26, P3308, DOI 10.1021/la903070y; YANAGISAWA K, 1995, NAT MED, V1, P1062, DOI 10.1038/nm1095-1062; Yang H, 2007, J AM CHEM SOC, V129, P12200, DOI 10.1021/ja073168u; Yip CM, 2001, J MOL BIOL, V311, P723, DOI 10.1006/jmbi.2001.4881; Yokoyama K, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/10/105101; Zhu M, 2002, J BIOL CHEM, V277, P50914, DOI 10.1074/jbc.M207225200	65	123	124	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25954	10.1371/journal.pone.0025954	http://dx.doi.org/10.1371/journal.pone.0025954			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016789	Green Submitted, gold, Green Published			2022-12-27	WOS:000295971700028
J	Wood, R; Lawn, SD; Caldwell, J; Kaplan, R; Middelkoop, K; Bekker, LG				Wood, Robin; Lawn, Stephen D.; Caldwell, Judy; Kaplan, Richard; Middelkoop, Keren; Bekker, Linda-Gail			Burden of New and Recurrent Tuberculosis in a Major South African City Stratified by Age and HIV-Status	PLOS ONE			English	Article							HIGH PREVALENCE; ANNUAL RISK; INFECTION; REINFECTION; COMMUNITY; TRANSMISSION; CHILDREN	Aim: To describe the burden of tuberculosis (TB) in Cape Town by calculating TB incidence rates stratified by age and HIV-status, assessing the contribution of retreatment disease and estimating the cumulative lifetime TB risk in HIV-negative individuals. Methods: Details of TB cases were abstracted from the 2009 electronic TB register. Population denominators were estimated from census data and actuarial estimates of HIV prevalence, allowing calculation of age-specific and HIV-stratified TB notification rates. Results: The 2009 mid-year population was 3,443,010 (3,241,508 HIV-negative and 201,502 HIV-positive individuals). There were 29,478 newly notified TB cases of which 56% were laboratory confirmed. HIV status was recorded for 87% of cases and of those with known HIV-status 49% were HIV-negative and 51% were positive. Discrete peaks in the incidence of non-HIV-associated TB occurred at three ages: 511/100,000 at 0-4 years of age, 553/100,000 at 20-24 years and 628/100,000 at 45-49 years with 1.5%, 19% and 45% being due to retreatment TB, respectively. Only 15.5% of recurrent cases had a history of TB treatment failure or default. The cumulative lifetime risks in the HIV-negative population of all new TB episodes and new smear-positive TB episodes were 24% and 12%, respectively; the lifetime risk of retreatment disease was 9%. The HIV-positive notification rate was 6,567/100,000 (HIV-associated TB rate ratio = 17). Although retreatment cases comprised 30% of the HIV-associated TB burden, 88% of these patients had no history of prior treatment failure or default. Conclusions: The annual burden of TB in this city is huge. TB in the HIV-negative population contributed almost half of the overall disease burden and cumulative lifetime risks were similar to those reported in the pre-chemotherapy era. Retreatment TB contributed significantly to both HIV-associated and non-HIV-associated TB but infrequently followed prior inadequate treatment. This likely reflects ongoing TB transmission to both HIV-negative and positive individuals.	[Wood, Robin; Lawn, Stephen D.; Kaplan, Richard; Middelkoop, Keren; Bekker, Linda-Gail] Univ Cape Town, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa; [Wood, Robin; Lawn, Stephen D.; Kaplan, Richard; Middelkoop, Keren; Bekker, Linda-Gail] Univ Cape Town, Fac Hlth Sci, Dept Med, ZA-7925 Cape Town, South Africa; [Wood, Robin] Univ Stellenbosch, Ctr Excellence Epidemiol Modeling & Anal, Natl Res Fdn, Dept Sci & Technol, Cape Town, South Africa; [Lawn, Stephen D.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Clin Res, London WC1, England; [Caldwell, Judy] City Cape Town Dept Hlth, Cape Town, South Africa	University of Cape Town; University of Cape Town; National Research Foundation - South Africa; Stellenbosch University; University of London; London School of Hygiene & Tropical Medicine	Wood, R (corresponding author), Univ Cape Town, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa.	Linda-Gail.Bekker@hiv-research.org.za	Wood, Robin/G-8509-2011; Bekker, Linda-Gail/AAZ-8929-2020	Kaplan, Richard/0000-0003-1565-4704; BEKKER, LINDA-GAIL/0000-0002-0755-4386; Middelkoop, Keren/0000-0001-9922-4263	National Institutes of Health (NIH) [1U19AI53217-01, A1058736-02, IeDEA 5U01A1069924-02]; USAID [CA 674A00080000700]; Wellcome Trust, London, UK; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI053217, U01AI069924, R01AI058736] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USAID(United States Agency for International Development (USAID)); Wellcome Trust, London, UK(Wellcome Trust); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	RW, LGB and KM were funded in part by the National Institutes of Health (NIH) through CIPRA grant 1U19AI53217-01, RO1 grant A1058736-02, and IeDEA 5U01A1069924-02 and USAID grant CA 674A00080000700. SDL was funded by the Wellcome Trust, London, UK. No additional funding was obtained for this study. The funding sources played no part in the decision to publish this data or any role in the design, analysis or writing of this manuscript.	ABBEY HELEN, 1952, HUMAN BIOL, V24, P201; *ACT SOC S AFR, ASSA 2003 AIDS DEM M; [Anonymous], MIDYEAR POPULATION E; Charalambous S, 2008, INT J TUBERC LUNG D, V12, P942; CLAYTON D, 1993, CONSECUTIVE FOLLOW I; Department of Health (South Africa), 2009, NAT ANT SENT HIV SYP; Kritzinger FE, 2009, TROP MED INT HEALTH, V14, P136, DOI 10.1111/j.1365-3156.2008.02213.x; Lawn SD, 2006, CLIN INFECT DIS, V42, P1040, DOI 10.1086/501018; LAWN SD, 2010, SAMJ, V100, P1; Middelkoop K, 2008, CLIN INFECT DIS, V47, P349, DOI 10.1086/589750; Middelkoop K, 2009, SAMJ S AFR MED J, V99, P738; REIDER HI, 1999, EPIDEMIOLOGICAL BASI; Shanaube K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007749; Sonnenberg P, 2001, LANCET, V358, P1687, DOI 10.1016/S0140-6736(01)06712-5; Sutherland I., 10 YEAR INC CLIN TUB; Uys PW, 2009, J R SOC INTERFACE, V6, P11, DOI 10.1098/rsif.2008.0184; Van Rie A, 1999, NEW ENGL J MED, V341, P1174, DOI 10.1056/NEJM199910143411602; Verver S, 2005, AM J RESP CRIT CARE, V171, P1430, DOI 10.1164/rccm.200409-1200OC; Vynnycky E, 1999, INT J EPIDEMIOL, V28, P327, DOI 10.1093/ije/28.2.327; Vynnycky E, 2000, AM J EPIDEMIOL, V152, P247, DOI 10.1093/aje/152.3.247; *WHO, WHO TUB REP 2011 ANN; *WHO, 2009, GLOB TUB CONTR SHORT; *WHO, WHOHTMTB2009411; Wiker HG, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-37; Wood R, 2010, INT J TUBERC LUNG D, V14, P406; Wood R, 2011, SAMJ S AFR MED J, V101, P111, DOI 10.7196/SAMJ.4587; Wood R, 2010, CLIN INFECT DIS, V51, P401, DOI 10.1086/655129; World Health Organization, 2006, WHOHTMTB2006368; World Health Organization (WHO), TUB PROF; DEV DISTRICT HLTH IN; CITY CAPE TOWN HIV A; S AFRICAN TUBERCULOS; CAPE TOWN TB CONTROL	33	78	79	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25098	10.1371/journal.pone.0025098	http://dx.doi.org/10.1371/journal.pone.0025098			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016763	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000295971700004
J	Januchowski-Hartley, SR; Pearson, RG; Puschendorf, R; Rayner, T				Januchowski-Hartley, Stephanie R.; Pearson, Richard G.; Puschendorf, Robert; Rayner, Thomas			Fresh Waters and Fish Diversity: Distribution, Protection and Disturbance in Tropical Australia	PLOS ONE			English	Article							ADAPTIVE REGRESSION SPLINES; GREAT-BARRIER-REEF; SPECIES DISTRIBUTIONS; RIVER CONSERVATION; AREAS; MODELS; QUEENSLAND; NETWORKS; BASIN; BIODIVERSITY	Background: Given the globally poor protection of fresh waters for their intrinsic ecological values, assessments are needed to determine how well fresh waters and supported fish species are incidentally protected within existing terrestrial protected-area networks, and to identify their vulnerability to human-induced disturbances. To date, gaps in data have severely constrained any attempt to explore the representation of fresh waters in tropical regions. Methodology and Results: We determined the distribution of fresh waters and fish diversity in the Wet Tropics of Queensland, Australia. We then used distribution data of fresh waters, fish species, human-induced disturbances, and the terrestrial protected-area network to assess the effectiveness of terrestrial protected areas for fresh waters and fish species. We also identified human-induced disturbances likely to influence the effectiveness of freshwater protection and evaluated the vulnerability of fresh waters to these disturbances within and outside protected areas. The representation of fresh waters and fish species in the protected areas of the Wet Tropics is poor: 83% of stream types defined by order, 75% of wetland types, and 89% of fish species have less than 20% of their total Wet Tropics length, area or distribution completely within IUCN category II protected areas. Numerous disturbances affect fresh waters both within and outside of protected areas despite the high level of protection afforded to terrestrial areas in the Wet Tropics (>60% of the region). High-order streams and associated wetlands are influenced by the greatest number of human-induced disturbances and are also the least protected. Thirty-two percent of stream length upstream of protected areas has at least one human-induced disturbance present. Conclusions/Significance: We demonstrate the need for greater consideration of explicit protection and off-reserve management for fresh waters and supported biodiversity by showing that, even in a region where terrestrial protection is high, it does not adequately capture fresh waters.	[Januchowski-Hartley, Stephanie R.] James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia; [Pearson, Richard G.; Puschendorf, Robert] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld, Australia; [Rayner, Thomas] Univ New S Wales, Australian Wetlands & Rivers Ctr, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia	James Cook University; James Cook University; University of New South Wales Sydney	Januchowski-Hartley, SR (corresponding author), James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia.	stephierenee@gmail.com	Puschendorf, Robert/B-6280-2011; Pearson, Richard/GQH-2760-2022; Januchowski, Stephanie/F-1636-2011	Puschendorf, Robert/0000-0002-8105-171X; Januchowski-Hartley, Stephanie/0000-0002-1661-917X; Pearson, Richard/0000-0001-6047-031X	Atherton Tablelands Environmental Trust, James Cook University	Atherton Tablelands Environmental Trust, James Cook University	This work was funded by Atherton Tablelands Environmental Trust Fund, James Cook University (http://www.jcu.edu.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell R, 2007, BIOL CONSERV, V134, P48, DOI 10.1016/j.biocon.2006.08.017; Abellan P, 2007, AQUAT CONSERV, V17, P361, DOI 10.1002/aqc.778; [Anonymous], C PART CONV BIOL DIV; Bainbridge ZT, 2009, MAR FRESHWATER RES, V60, P1081, DOI 10.1071/MF08333; Boyero L, 2009, J N AM BENTHOL SOC, V28, P397, DOI 10.1899/08-146.1; Daam MA, 2010, ECOTOXICOLOGY, V19, P24, DOI 10.1007/s10646-009-0402-6; *DERM, 2009, QUEENSL WETL MAPP CL; *DERM, 2008, PROT AR QUEENSL EST; Devlin MJ, 2005, MAR POLLUT BULL, V51, P9, DOI 10.1016/j.marpolbul.2004.10.037; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Dudley N, 2008, GUIDELINES APPL PROT, DOI DOI 10.2305/IUCN.CH.2008.PAPS.2.EN; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2007, DIVERS DISTRIB, V13, P265, DOI 10.1111/j.1472-4642.2007.00340.x; Esselman PC, 2011, FRESHWATER BIOL, V56, P71, DOI 10.1111/j.1365-2427.2010.02417.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Herbert ME, 2010, CONSERV BIOL, V24, P1002, DOI 10.1111/j.1523-1739.2010.01460.x; Hermoso V, 2011, FRESHWATER BIOL, V56, P57, DOI 10.1111/j.1365-2427.2009.02390.x; Hermoso V, 2011, ECOL APPL, V21, P175, DOI 10.1890/09-2011.1; Hughes RM, 2011, J N AM BENTHOL SOC, V30, P103, DOI 10.1899/09-174.1; Januchowski SR, 2010, INT J GEOGR INF SCI, V24, P1327, DOI 10.1080/13658811003591680; Januchowski-Hartley SR, 2011, BIOL INVASIONS, V13, P1241, DOI 10.1007/s10530-011-9960-7; Keith P, 2000, BIOL CONSERV, V92, P265, DOI 10.1016/S0006-3207(99)00041-5; LAWRENCE DJ, 2011, CONSERVAITO IN PRESS, DOI DOI 10.1111/J.1755-263X.2011.00185.X; Leathwick JR, 2006, ECOL MODEL, V199, P188, DOI 10.1016/j.ecolmodel.2006.05.022; Leathwick JR, 2005, FRESHWATER BIOL, V50, P2034, DOI 10.1111/j.1365-2427.2005.01448.x; Linke S, 2008, J APPL ECOL, V45, P1486, DOI 10.1111/j.1365-2664.2008.01520.x; Linke S, 2007, FRESHWATER BIOL, V52, P918, DOI 10.1111/j.1365-2427.2006.01690.x; Linke S, 2011, FRESHWATER BIOL, V56, P6, DOI 10.1111/j.1365-2427.2010.02456.x; Maidment D.R., 2002, ARC HYDRO GIS WATER; Mancini L, 2005, BIODIVERS CONSERV, V14, P351, DOI 10.1007/s10531-004-5355-8; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; McJannet D, 2007, HYDROL PROCESS, V21, P3549, DOI 10.1002/hyp.6576; Nel JL, 2007, DIVERS DISTRIB, V13, P341, DOI 10.1111/j.1472-4642.2007.00308.x; Nel JL, 2009, BIOL CONSERV, V142, P1605, DOI 10.1016/j.biocon.2009.02.031; Oberdorff T, 1995, ECOGRAPHY, V18, P345, DOI 10.1111/j.1600-0587.1995.tb00137.x; Pearson Richard G., 2005, P470; Pusey B.J., 2008, LIVING DYNAMIC TROPI, P150; Rowley JJL, 2007, WILDLIFE RES, V34, P371, DOI 10.1071/WR07014; Sanchez-Arguello R, 2010, ANN LIMNOL-INT J LIM, V46, P149, DOI 10.1051/limn/2010019; Saunders DL, 2002, CONSERV BIOL, V16, P30, DOI 10.1046/j.1523-1739.2002.99562.x; Stork NE, 2008, LIVING DYNAMIC TROPI, P4, DOI DOI 10.1002/9781444300321; SYDES T, 2009, CROSS REGIONAL HYMEN; Thieme M, 2007, BIOL CONSERV, V135, P484, DOI 10.1016/j.biocon.2006.10.054; Turak E, 2011, MAR FRESHWATER RES, V62, P300, DOI 10.1071/MF09297; Turak E, 2011, FRESHWATER BIOL, V56, P39, DOI 10.1111/j.1365-2427.2009.02394.x; Vorosmarty CJ, 2010, NATURE, V468, P334, DOI 10.1038/nature09549; Wantzen KM, 2006, J N AM BENTHOL SOC, V25, P61, DOI 10.1899/0887-3593(2006)25[61:NVINSE]2.0.CO;2; Witte C., 2006, MAPPING LAND USE QUE	48	22	23	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2011	6	10							e25846	10.1371/journal.pone.0025846	http://dx.doi.org/10.1371/journal.pone.0025846			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NO	21998708	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000295968700022
J	Liu, Y; Xue, JY; Wang, B; Li, LB; Qiu, YL				Liu, Yang; Xue, Jia-Yu; Wang, Bin; Li, Libo; Qiu, Yin-Long			The Mitochondrial Genomes of the Early Land Plants Treubia lacunosa and Anomodon rugelii: Dynamic and Conservative Evolution	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; GENE-CLUSTER; DNA-SEQUENCE; GREEN-ALGA; NAD7 GENE; RECOMBINATION; ORGANIZATION; CHLOROPLAST; LIVERWORTS; INTRONS	Early land plant mitochondrial genomes captured important changes of mitochondrial genome evolution when plants colonized land. The chondromes of seed plants show several derived characteristics, e. g., large genome size variation, rapid intra-genomic rearrangement, abundant introns, and highly variable levels of RNA editing. On the other hand, the chondromes of charophytic algae are still largely ancestral in these aspects, resembling those of early eukaryotes. When the transition happened has been a long-standing question in studies of mitochondrial genome evolution. Here we report complete mitochondrial genome sequences from an early-diverging liverwort, Treubia lacunosa, and a late-evolving moss, Anomodon rugelii. The two genomes, 151,983 and 104,239 base pairs in size respectively, contain standard sets of protein coding genes for respiration and protein synthesis, as well as nearly full sets of rRNA and tRNA genes found in the chondromes of the liverworts Marchantia polymorpha and Pleurozia purpurea and the moss Physcomitrella patens. The gene orders of these two chondromes are identical to those of the other liverworts and moss. Their intron contents, with all cis-spliced group I or group II introns, are also similar to those in the previously sequenced liverwort and moss chondromes. These five chondromes plus the two from the hornworts Phaeoceros laevis and Megaceros aenigmaticus for the first time allowed comprehensive comparative analyses of structure and organization of mitochondrial genomes both within and across the three major lineages of bryophytes. These analyses led to the conclusion that the mitochondrial genome experienced dynamic evolution in genome size, gene content, intron acquisition, gene order, and RNA editing during the origins of land plants and their major clades. However, evolution of this organellar genome has remained rather conservative since the origin and initial radiation of early land plants, except within vascular plants.	[Liu, Yang; Xue, Jia-Yu; Wang, Bin; Li, Libo; Qiu, Yin-Long] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Xue, Jia-Yu] Nanjing Univ, Sch Life Sci, Nanjing 210008, Jiangsu, Peoples R China	University of Michigan System; University of Michigan; Nanjing University	Liu, Y (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA.	ylqiu@umich.edu	liu, yang/H-6324-2011; Li, Li/AEM-3636-2022; li, li/GPX-3938-2022; LI, LI/GVS-5344-2022; li, li/HII-4157-2022; Wang, Bin/A-8639-2013	Wang, Bin/0000-0003-2481-735X; Xue, Jia-Yu/0000-0002-7128-9935; Liu, Yang/0000-0002-5942-839X	NSF [DEB 0531689, 0332298]	NSF(National Science Foundation (NSF))	This work was supported by NSF grants DEB 0531689 and 0332298 to YLQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JO, 2007, GENETICS, V177, P1173, DOI 10.1534/genetics.107.073312; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alverson AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016404; Alverson AJ, 2010, MOL BIOL EVOL, V27, P1436, DOI 10.1093/molbev/msq029; Berner R. A., 2001, PLANTS INVADE LAND E, P173; BLAND MM, 1986, MOL GEN GENET, V204, P8, DOI 10.1007/BF00330180; Chaw SM, 2008, MOL BIOL EVOL, V25, P603, DOI 10.1093/molbev/msn009; Clifton SW, 2004, PLANT PHYSIOL, V136, P3486, DOI 10.1104/pp.104.044602; Crosby MR, 1999, CHECKLIST MOSSES TRO; Dombrovska O, 2004, MOL PHYLOGENET EVOL, V32, P246, DOI 10.1016/j.ympev.2003.12.013; Doyle J. J., 1987, PHYTOCHEM B, P11; Duff RJ, 2004, MONOG SYST BOTAN, V98, P41; Faircloth BC, 2008, MOL ECOL RESOUR, V8, P92, DOI 10.1111/j.1471-8286.2007.01884.x; Forrest LL, 2006, BRYOLOGIST, V109, P303, DOI 10.1639/0007-2745(2006)109[303:UTEHOT]2.0.CO;2; Gagliardi D, 2004, ADV PHOTO RESPIRAT, V17, P55; Goffinet B, 2001, ANN BOT-LONDON, V87, P191, DOI 10.1006/anbo.2000.1318; Goremykin VV, 2009, MOL BIOL EVOL, V26, P99, DOI 10.1093/molbev/msn226; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Grewe F, 2010, NUCL ACIDS IN PRESS; Grewe F, 2009, NUCLEIC ACIDS RES, V37, P5093, DOI 10.1093/nar/gkp532; Groth-Malonek M, 2007, INT J PLANT SCI, V168, P709, DOI 10.1086/513472; Groth-Malonek M, 2007, MOL BIOL EVOL, V24, P1068, DOI 10.1093/molbev/msm026; Handa H, 2003, NUCLEIC ACIDS RES, V31, P5907, DOI 10.1093/nar/gkg795; Hecht J, 2011, GENOME BIOL EVOL, V3, P344, DOI 10.1093/gbe/evr027; Hernick LV, 2008, REV PALAEOBOT PALYNO, V148, P154, DOI 10.1016/j.revpalbo.2007.09.002; Hoffmann M, 1999, MOL GEN GENET, V261, P537, DOI 10.1007/s004380050998; Jobson RW, 2011, J MOL EVOL, V72, P204, DOI 10.1007/s00239-010-9416-1; Jobson RW, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-43; KANNO A, 1993, CURR GENET, V23, P166, DOI 10.1007/BF00352017; Kenrick P., 1997, ORIGIN EARLY DIVERSI; Knoop V, 2004, CURR GENET, V46, P123, DOI 10.1007/s00294-004-0522-8; Knoop V, 2010, PLANT MITOCHONDRIA, P3; Kobayashi Y, 1997, MOL GEN GENET, V256, P589, DOI 10.1007/PL00008616; KOZAK M, 1983, MICROBIOL REV, V47, P1; Kubo N, 2010, DNA RES, V17, P1, DOI 10.1093/dnares/dsp024; Kubo T, 2000, NUCLEIC ACIDS RES, V28, P2571, DOI 10.1093/nar/28.13.2571; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Lang BF, 1997, NATURE, V387, P493, DOI 10.1038/387493a0; Li LB, 2009, J MOL EVOL, V68, P665, DOI 10.1007/s00239-009-9240-7; Liu Y, 2011, GENOMICS CH IN PRESS; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; LONSDALE DM, 1988, PHILOS T ROY SOC B, V319, P149, DOI 10.1098/rstb.1988.0039; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Marechal A, 2010, NEW PHYTOL, V186, P299, DOI 10.1111/j.1469-8137.2010.03195.x; MISHLER BD, 1984, BRITTONIA, V36, P406, DOI 10.2307/2806602; Mora CI, 1996, SCIENCE, V271, P1105, DOI 10.1126/science.271.5252.1105; Mower JP, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-265; Notsu Y, 2002, MOL GENET GENOMICS, V268, P434, DOI 10.1007/s00438-002-0767-1; NUGENT JM, 1991, CELL, V66, P473, DOI 10.1016/0092-8674(81)90011-8; ODA K, 1992, J MOL BIOL, V223, P1, DOI 10.1016/0022-2836(92)90708-R; Odahara M, 2009, PLANT CELL, V21, P1182, DOI 10.1105/tpc.108.064709; Ohta N, 1998, NUCLEIC ACIDS RES, V26, P5190, DOI 10.1093/nar/26.22.5190; Palmer JD, 2000, P NATL ACAD SCI USA, V97, P6960, DOI 10.1073/pnas.97.13.6960; PALMER JD, 1985, ANNU REV GENET, V19, P325, DOI 10.1146/annurev.ge.19.120185.001545; PALMER JD, 1988, J MOL EVOL, V28, P87, DOI 10.1007/BF02143500; PALMER JD, 1992, CURR GENET, V21, P125, DOI 10.1007/BF00318471; Qiu Y-L, 2011, J SYST EVOL IN PRESS; Qiu YL, 2006, P NATL ACAD SCI USA, V103, P15511, DOI 10.1073/pnas.0603335103; Qiu YL, 1998, NATURE, V394, P671, DOI 10.1038/29286; Rudinger M, 2009, MOL GENET GENOMICS, V281, P473, DOI 10.1007/s00438-009-0424-z; SCHUSTER W, 1994, ANNU REV PLANT PHYS, V45, P61, DOI 10.1146/annurev.pp.45.060194.000425; SCHWARTZMAN DW, 1989, NATURE, V340, P457, DOI 10.1038/340457a0; Shedge V, 2007, PLANT CELL, V19, P1251, DOI 10.1105/tpc.106.048355; SMALL I, 1989, CELL, V58, P69, DOI 10.1016/0092-8674(89)90403-0; Sugiyama Y, 2005, MOL GENET GENOMICS, V272, P603, DOI 10.1007/s00438-004-1075-8; Terasawa K, 2007, MOL BIOL EVOL, V24, P699, DOI 10.1093/molbev/msl198; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Turmel M, 1999, PLANT CELL, V11, P1717, DOI 10.1105/tpc.11.9.1717; Turmel M, 2003, PLANT CELL, V15, P1888, DOI 10.1105/tpc.013169; Turmel M, 2002, P NATL ACAD SCI USA, V99, P11275, DOI 10.1073/pnas.162203299; Turmel M, 2002, MOL BIOL EVOL, V19, P24, DOI 10.1093/oxfordjournals.molbev.a003979; Turmel M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-137; Unseld M, 1997, NAT GENET, V15, P57, DOI 10.1038/ng0197-57; Villarreal JC, 2010, BRYOLOGIST, V113, P106, DOI 10.1639/0007-2745-113.1.106; Wahrmund U, 2008, J MOL EVOL, V66, P621, DOI 10.1007/s00239-008-9114-4; Wang B, 2010, J INTEGR PLANT BIOL, V52, P1100, DOI 10.1111/j.1744-7909.2010.00998.x; Wang B, 2009, CURR GENET, V55, P601, DOI 10.1007/s00294-009-0273-7; WARD BL, 1981, CELL, V25, P793, DOI 10.1016/0092-8674(81)90187-2; Wellman CH, 2003, NATURE, V425, P282, DOI 10.1038/nature01884; Xue JY, 2010, CURR GENET, V56, P53, DOI 10.1007/s00294-009-0279-1; Qiu YL, 2008, J SYST EVOL, V46, P287, DOI [10.3724/SP.J.1002.2008.08035, 10.1111/j.1439-0469.2008.00465.x]	81	59	60	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25836	10.1371/journal.pone.0025836	http://dx.doi.org/10.1371/journal.pone.0025836			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998706	gold, Green Published, Green Submitted			2022-12-27	WOS:000295966900062
J	Mondani, L; Benzerara, K; Carriere, M; Christen, R; Mamindy-Pajany, Y; Fevrier, L; Marmier, N; Achouak, W; Nardoux, P; Berthomieu, C; Chapon, V				Mondani, Laure; Benzerara, Karim; Carriere, Marie; Christen, Richard; Mamindy-Pajany, Yannick; Fevrier, Laureline; Marmier, Nicolas; Achouak, Wafa; Nardoux, Pascal; Berthomieu, Catherine; Chapon, Virginie			Influence of Uranium on Bacterial Communities: A Comparison of Natural Uranium-Rich Soils with Controls	PLOS ONE			English	Article							CONTAMINATED SUBSURFACE SEDIMENTS; SULFATE-REDUCING BACTERIA; MICROBIAL-POPULATIONS; SEQUENCE ALIGNMENT; REDUCTION; DIVERSITY; BIOMINERALIZATION; BIOREMEDIATION; AMPLIFICATION; GROUNDWATER	This study investigated the influence of uranium on the indigenous bacterial community structure in natural soils with high uranium content. Radioactive soil samples exhibiting 0.26% - 25.5% U in mass were analyzed and compared with nearby control soils containing trace uranium. EXAFS and XRD analyses of soils revealed the presence of U(VI) and uranium-phosphate mineral phases, identified as sabugalite and meta-autunite. A comparative analysis of bacterial community fingerprints using denaturing gradient gel electrophoresis (DGGE) revealed the presence of a complex population in both control and uranium-rich samples. However, bacterial communities inhabiting uraniferous soils exhibited specific fingerprints that were remarkably stable over time, in contrast to populations from nearby control samples. Representatives of Acidobacteria, Proteobacteria, and seven others phyla were detected in DGGE bands specific to uraniferous samples. In particular, sequences related to iron-reducing bacteria such as Geobacter and Geothrix were identified concomitantly with iron-oxidizing species such as Gallionella and Sideroxydans. All together, our results demonstrate that uranium exerts a permanent high pressure on soil bacterial communities and suggest the existence of a uranium redox cycle mediated by bacteria in the soil.	[Mondani, Laure; Berthomieu, Catherine; Chapon, Virginie] CEA, DSV, IBEB, Lab Interact Prot Met, St Paul Les Durance, France; [Mondani, Laure; Achouak, Wafa; Berthomieu, Catherine; Chapon, Virginie] CNRS, UMR 6191, St Paul Les Durance, France; [Mondani, Laure; Achouak, Wafa; Berthomieu, Catherine; Chapon, Virginie] Univ Aix Marseille, St Paul Les Durance, France; [Benzerara, Karim] UPMC, IMPMC, CNRS, UMR 7590,IPGP, Paris, France; [Carriere, Marie] CEA, LSDRM, SIS2M, CNRS,UMR 3299, Gif Sur Yvette, France; [Mamindy-Pajany, Yannick; Marmier, Nicolas] Univ Nice, LRSAE, Nice, France; [Christen, Richard] CNRS, UMR 6543, Ctr Biochim, Nice, France; [Fevrier, Laureline] LRE, SECRE, DEI, IRSN, St Paul Les Durance, France; [Achouak, Wafa] CEA, DSV, IBEB, Lab Ecol Microbienne Rhizosphere & Environm Extre, St Paul Les Durance, France; [Nardoux, Pascal] AREVA NC, SEPA, Bessines Sur Gartempe, France	CEA; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; CEA; UDICE-French Research Universities; Aix-Marseille Universite; Areva	Mondani, L (corresponding author), CEA, DSV, IBEB, Lab Interact Prot Met, St Paul Les Durance, France.	virginie.chapon@cea.fr	Achouak, Wafa/AAX-8916-2021; Berthomieu, Catherine/AAX-9559-2021; chapon, virginie/AAY-1669-2021; BM30, Beamline FAME/G-9313-2012; Février, Laureline/H-1751-2019; Février, Laureline/M-6651-2019; carriere, marie/F-2149-2011; Benzerara, Karim/J-1532-2016	Achouak, Wafa/0000-0003-4297-6661; chapon, virginie/0000-0002-2365-3464; Février, Laureline/0000-0002-5274-6846; Février, Laureline/0000-0002-5274-6846; Christen, Richard/0000-0002-3396-4362; Berthomieu, Catherine/0000-0001-8784-5396; carriere, marie/0000-0001-8446-6462; Benzerara, Karim/0000-0002-0553-0137	Centre National de la Recherche Scientifique	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the EC2CO program (CYTRIX & Microbien) of the Centre National de la Recherche Scientifique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abulencia CB, 2006, APPL ENVIRON MICROB, V72, P3291, DOI 10.1128/AEM.72.5.3291-3301.2006; AFNOR, 1998, AFNOR DECH ESS LIX X, P31; Akob DM, 2007, FEMS MICROBIOL ECOL, V59, P95, DOI 10.1111/j.1574-6941.2006.00203.x; Barns SM, 2007, APPL ENVIRON MICROB, V73, P3113, DOI 10.1128/AEM.02012-06; Beazley MJ, 2007, ENVIRON SCI TECHNOL, V41, P5701, DOI 10.1021/es070567g; Beller HR, 2005, APPL ENVIRON MICROB, V71, P2170, DOI 10.1128/AEM.71.4.2170-2174.2005; Benzerara K, 2008, GEOCHIM COSMOCHIM AC, V72, P3949, DOI 10.1016/j.gca.2008.05.046; Brodie EL, 2006, APPL ENVIRON MICROB, V72, P6288, DOI 10.1128/AEM.00246-06; Bruun AM, 2010, GEOMICROBIOL J, V27, P15, DOI 10.1080/01490450903232165; Burkhardt EM, 2010, ENVIRON SCI TECHNOL, V44, P177, DOI 10.1021/es902038e; Cardenas E, 2008, APPL ENVIRON MICROB, V74, P3718, DOI 10.1128/AEM.02308-07; Catalano JG, 2004, AM MINERAL, V89, P1004; Chang YJ, 2001, APPL ENVIRON MICROB, V67, P3149, DOI 10.1128/AEM.67.7.3149-3160.2001; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Coates JD, 1999, INT J SYST BACTERIOL, V49, P1615, DOI 10.1099/00207713-49-4-1615; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elias DA, 2003, MICROBIAL ECOL, V46, P83, DOI 10.1007/s00248-002-1060-x; FARGES F, 1992, GEOCHIM COSMOCHIM AC, V56, P4205, DOI 10.1016/0016-7037(92)90261-G; Ferris FG, 2000, APPL GEOCHEM, V15, P1035, DOI 10.1016/S0883-2927(99)00093-1; Fields MW, 2005, FEMS MICROBIOL ECOL, V53, P417, DOI 10.1016/j.femsec.2005.01.010; FRANCIS AJ, 1994, ENVIRON SCI TECHNOL, V28, P636, DOI 10.1021/es00053a016; Geissler A, 2005, GEOBIOLOGY, V3, P275, DOI 10.1111/j.1472-4669.2006.00061.x; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Green SJ, 2004, FEMS MICROBIOL LETT, V233, P115, DOI 10.1016/j.femsle.2004.01.049; Hemme CL, 2010, ISME J, V4, P660, DOI 10.1038/ismej.2009.154; Holmes DE, 2002, APPL ENVIRON MICROB, V68, P2300, DOI 10.1128/AEM.68.5.2300-2306.2002; Hwang CC, 2009, ISME J, V3, P47, DOI 10.1038/ismej.2008.77; Jroundi F, 2007, GEOMICROBIOL J, V24, P441, DOI 10.1080/01490450701437651; LOVLEY DR, 1991, NATURE, V350, P413, DOI 10.1038/350413a0; LOVLEY DR, 1992, APPL ENVIRON MICROB, V58, P850, DOI 10.1128/AEM.58.3.850-856.1992; Martins M, 2010, SCI TOTAL ENVIRON, V408, P2621, DOI 10.1016/j.scitotenv.2010.02.032; Merroun M, 2006, RADIOCHIM ACTA, V94, P723, DOI 10.1524/ract.2006.94.9.723; Merroun ML, 2005, APPL ENVIRON MICROB, V71, P5532, DOI 10.1128/AEM.71.9.5532-5543.2005; Merroun ML, 2008, J CONTAM HYDROL, V102, P285, DOI 10.1016/j.jconhyd.2008.09.019; Michalsen MM, 2007, APPL ENVIRON MICROB, V73, P5885, DOI 10.1128/AEM.00309-07; Mohanty SR, 2008, ENVIRON SCI TECHNOL, V42, P4384, DOI 10.1021/es703082v; Moreels D, 2008, ENVIRON SCI POLLUT R, V15, P481, DOI 10.1007/s11356-008-0034-z; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; N'Guessan AL, 2010, FEMS MICROBIOL ECOL, V74, P184, DOI 10.1111/j.1574-6941.2010.00933.x; Nedelkova M, 2007, FEMS MICROBIOL ECOL, V59, P694, DOI 10.1111/j.1574-6941.2006.00261.x; Nevin KP, 2003, APPL ENVIRON MICROB, V69, P3672, DOI 10.1128/AEM.69.6.3672-3675.2003; North NN, 2004, APPL ENVIRON MICROB, V70, P4911, DOI 10.1128/aem.70.8.4911-4920.2004; Proux O, 2005, PHYS SCR, P970; Radeva G, 2005, CAN J MICROBIOL, V51, P910, DOI 10.1139/W05-082; Rastogi G, 2010, MICROB ECOL, V59, P94, DOI 10.1007/s00248-009-9598-5; Ravel B, 1998, J SYNCHROTRON RADIAT, V12, P537; Schabereiter-Gurtner C, 2003, J MICROBIOL METH, V52, P251, DOI 10.1016/S0167-7012(02)00186-0; SCHIPPERS A, 1995, APPL ENVIRON MICROB, V61, P2930, DOI 10.1128/AEM.61.8.2930-2935.1995; Shelobolina ES, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-16; Suzuki Y, 2003, APPL ENVIRON MICROB, V69, P1337, DOI 10.1128/AEM.69.3.1337-1346.2003; Waldron PJ, 2009, ENVIRON SCI TECHNOL, V43, P3529, DOI 10.1021/es803423p; Wall JD, 2006, ANNU REV MICROBIOL, V60, P149, DOI 10.1146/annurev.micro.59.030804.121357; Weber KA, 2011, APPL E IN PRESS 0513; Wolfaardt GM, 2008, CAN J MICROBIOL, V54, P932, DOI [10.1139/W08-084, 10.1139/w08-084]; Xu MY, 2010, ISME J, V4, P1060, DOI 10.1038/ismej.2010.31; Yang CH, 2000, APPL ENVIRON MICROB, V66, P345, DOI 10.1128/AEM.66.1.345-351.2000; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996	57	52	53	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25771	10.1371/journal.pone.0025771	http://dx.doi.org/10.1371/journal.pone.0025771			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998695	gold, Green Published, Green Submitted			2022-12-27	WOS:000295966900055
J	Brewer, TF; Choi, HW; Seas, C; Krapp, F; Zamudio, C; Shah, L; Ciampi, A; Heymann, SJ; Gotuzzo, E				Brewer, Timothy F.; Choi, Howard W.; Seas, Carlos; Krapp, Fiorella; Zamudio, Carlos; Shah, Lena; Ciampi, Antonio; Heymann, S. Jody; Gotuzzo, Eduardo			Self-Reported Risks for Multiple-Drug Resistance among New Tuberculosis Cases: Implications for Drug Susceptibility Screening and Treatment	PLOS ONE			English	Article							MULTIDRUG-RESISTANT; MYCOBACTERIUM-TUBERCULOSIS; MDR-TB; DIAGNOSIS; ASSAY; PROGRAM; COST	Background: Multiple drug-resistance in new tuberculosis (TB) cases accounts for the majority of all multiple drug-resistant TB (MDR-TB) worldwide. Effective control requires determining which new TB patients should be tested for MDR disease, yet the effectiveness of global screening recommendations of high-risk groups is unknown. Methods: Sixty MDR-TB cases with no history of previous TB treatment, 80 drug-sensitive TB and 80 community-based controls were recruited in Lima, Peru between August and December, 2008 to investigate whether recommended screening practices identify individuals presenting with MDR-TB. Odd ratios (OR) and 95% confidence intervals (CI) were calculated using logistic regression to study the association of potential risk factors with case/control variables. Results: MDR-TB cases did not differ from drug-sensitive TB and community controls in rates of human immunodeficiency virus infection, reported hospital or prison visits in the 3 years prior to diagnosis. MDR-TB cases were more likely than drug-sensitive TB controls to have had a recent MDR-TB household contact (OR 4.66, (95% CI 1.56-13.87)); however, only 15 cases (28.3%) reported this exposure. In multivariate modeling, recent TB household contact, but not contact with an MDR-TB case, remained predictive of MDR-TB, OR 7.47, (95% CI 1.91-29.3). Living with a partner rather than parents was associated with a lower risk of MDR-TB, OR 0.15, (95% CI 0.04-0.51). Conclusion: Targeted drug susceptibility testing (DST) linked to reported MDR-TB contact or other high-risk exposures does not identify the majority of new TB cases with MDR disease in Lima where it is endemic. All new TB cases should be screened with DST to identify MDR patients. These findings are likely applicable to other regions with endemic MDR-TB.	[Brewer, Timothy F.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Brewer, Timothy F.; Shah, Lena; Ciampi, Antonio; Heymann, S. Jody] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Heymann, S. Jody] McGill Univ, Inst Hlth & Social Policy, Montreal, PQ, Canada; [Choi, Howard W.] Johns Hopkins Univ, Dept Int Hlth, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Seas, Carlos; Krapp, Fiorella; Zamudio, Carlos; Gotuzzo, Eduardo] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru	McGill University; McGill University; McGill University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Universidad Peruana Cayetano Heredia	Brewer, TF (corresponding author), McGill Univ, Dept Med, Montreal, PQ, Canada.	timothy.brewer@mcgill.ca	Krapp, Fiorella/ABG-7436-2021	Krapp, Fiorella/0000-0002-8404-2827; Seas, Carlos/0000-0001-7067-9141; Zamudio, Carlos/0000-0001-7479-127X	Royal Victoria Hospital Foundation; Fonds de la Recherche en Sante, Quebec; National Institutes of Health	Royal Victoria Hospital Foundation; Fonds de la Recherche en Sante, Quebec(Fonds de la Recherche en Sante du Quebec); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Royal Victoria Hospital Foundation and Fonds de la Recherche en Sante, Quebec. Dr. Krapp was supported in part by a National Institutes of Health International Clinical, Operational, and Health Services Research and Training Award to the Universidad Peruana Cayetano Heredia. The authors had full access to all data and final responsibility for the decision to submit this study for publication. The funder had no role in the study design, implementation, data collection, analyses, interpretation or the writing of this report.	Banerjee R, 2010, J CLIN MICROBIOL, V48, P3779, DOI 10.1128/JCM.01236-10; Becerra MC, 2011, LANCET, V377, P147, DOI 10.1016/S0140-6736(10)61972-1; BLONDAL K, 2007, ORGAN, V85, P391; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Bonilla Asalde Cesar, 2008, Acta méd. peruana, V25, P163; Borgdorff MW, 2009, LANCET, V373, P1822, DOI 10.1016/S0140-6736(09)60557-2; Breslow N E, 1987, IARC Sci Publ, P1; BUSKIN SE, 1994, AM J PUBLIC HEALTH, V84, P1750, DOI 10.2105/AJPH.84.11.1750; Chan ED, 2008, CURR OPIN INFECT DIS, V21, P587, DOI 10.1097/QCO.0b013e328319bce6; Cox HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013901; Crampin AC, 2001, T ROY SOC TROP MED H, V95, P481, DOI 10.1016/S0035-9203(01)90009-4; Faustini A, 2006, THORAX, V61, P158, DOI 10.1136/thx.2005.045963; Fitzwater SP, 2010, CLIN INFECT DIS, V51, P371, DOI 10.1086/655127; Frieden TR, 1996, JAMA-J AM MED ASSOC, V276, P1229, DOI 10.1001/jama.276.15.1229; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Heymann SJ, 1997, PUBLIC HEALTH REP, V112, P513; Law WS, 2008, INT J TUBERC LUNG D, V12, P1065; Luciani F, 2009, P NATL ACAD SCI USA, V106, P14711, DOI 10.1073/pnas.0902437106; Martinez D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012082; Moore DAJ, 2007, FUTURE MICROBIOL, V2, P97, DOI 10.2217/17460913.2.2.97; Moore DAJ, 2006, NEW ENGL J MED, V355, P1539, DOI 10.1056/NEJMoa055524; Pardini M, 2009, TUBERCULOSIS, V89, P317, DOI 10.1016/j.tube.2009.04.002; Pillay M, 2007, CLIN INFECT DIS, V45, P1409, DOI 10.1086/522987; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Suarez PG, 2001, J INFECT DIS, V184, P473, DOI 10.1086/322777; Timperi R, 2005, INT J TUBERC LUNG D, V9, P175; *TUB PER INF, 2006, EV ESTR SAN NAC PREV; *USAID, 2009, HLTH INF DIS; Uys PW, 2009, J CLIN MICROBIOL, V47, P1484, DOI 10.1128/JCM.02289-08; Vazquez-Gallardo R, 2007, INT J TUBERC LUNG D, V11, P429; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; *WHO, 2008, ANT DRUG RES WORLD; World Health Organization, 2011, WHOHTMTB20113; Yagui M, 2006, INT J TUBERC LUNG D, V10, P838; Zhao M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004370	36	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e25861	10.1371/journal.pone.0025861	http://dx.doi.org/10.1371/journal.pone.0025861			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022459	Green Published, gold, Green Submitted			2022-12-27	WOS:000295981600016
J	de Jong, PA; Gondrie, MJA; Buckens, CFM; Jacobs, PC; Mali, WPTHM; van der Graaf, Y				de Jong, Pim A.; Gondrie, Martijn J. A.; Buckens, Constantinus F. M.; Jacobs, Peter C.; Mali, Willem P. T. H. M.; van der Graaf, Yolanda		PROVIDI Study Grp	Prediction of Cardiovascular Events by Using Non-Vascular Findings on Routine Chest CT	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; RISK REDUCTION; MORTALITY; BRONCHIECTASIS	Background: Routine computed tomography (CT) examinations contain an abundance of findings unrelated to the diagnostic question. Those with prognostic significance may contribute to early detection and treatment of disease, irrelevant findings can be ignored. We aimed to assess the association between unrequested chest CT findings in lungs, mediastinum and pleura and future cardiovascular events. Methods: Multi-center case-cohort study in 5 tertiary and 3 secondary care hospitals involving 10410 subjects who underwent routine chest CT for non-cardiovascular reasons. 493 cardiovascular hospitalizations or deaths were recorded during an average follow-up time of 17.8 months. 1191 patients were randomly sampled to serve as a control subcohort. Hazard ratios and annualized event rates were calculated. Results: Abnormalities in the lung (26-44%), pleura (14-15%) and mediastinum (20%) were common. Hazard ratios after adjustment for age and sex were for airway wall thickening 2.26 (1.59-3.22), ground glass opacities 2.50 (1.72-3.62), consolidations 1.97 (1.12-3.47), pleural effusions 2.77 (1.81-4.25) and lymph-nodes 2.04 (1.40-2.96). Corresponding annual event rates were 5.5%, 6.0%, 3.8%, 10.2% and 4.4%. Conclusions: We have identified several common chest CT findings that are predictive for future risk of cardiovascular events and found that other findings have little utility for this. The added value of the non-vascular predictors to established vascular calcifications on CT remains to be determined.	[de Jong, Pim A.; Jacobs, Peter C.; Mali, Willem P. T. H. M.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Gondrie, Martijn J. A.; Buckens, Constantinus F. M.; van der Graaf, Yolanda] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	de Jong, PA (corresponding author), Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands.	pimdejong@gmail.com	de Jong, Pim A/G-7220-2014; Mali, Willem PThM/I-1123-2014; Prokop, W.M./H-8081-2014	de Jong, Pim A/0000-0003-4840-6854; Mali, Willem PThM/0000-0003-4391-0904; Prokop, Mathias/0000-0001-8157-8055; Buckens, Constantinus F/0000-0002-3190-258X	Netherlands Organization for Scientific Research-Medical Sciences (NWO-MW) [40-00812-98-07-005]	Netherlands Organization for Scientific Research-Medical Sciences (NWO-MW)(Netherlands Organization for Scientific Research (NWO))	This study was funded by a program grant from the Netherlands Organization for Scientific Research-Medical Sciences (NWO-MW, www.nwo.nl) grant 40-00812-98-07-005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad K, 2008, AM J MED SCI, V335, P484, DOI 10.1097/MAJ.0b013e318160ede9; Akalin F, 2003, PEDIATR INT, V45, P169, DOI 10.1046/j.1442-200X.2003.01692.x; BADUI E, 1985, ANGIOLOGY, V36, P431, DOI 10.1177/000331978503600705; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Critchley JA, 2003, JAMA-J AM MED ASSOC, V290, P86, DOI 10.1001/jama.290.1.86; DEBRUIN A, 2004, STAT J UN EC COMM EU, V21, P23; Fishman A, 2001, NEW ENGL J MED, V345, P1075; Fox CS, 2004, CIRCULATION, V110, P522, DOI 10.1161/01.CIR.0000136993.34344.41; Gondrie MJA, 2010, EUR J EPIDEMIOL, V25, P751, DOI 10.1007/s10654-010-9514-9; Gondrie MJA, 2011, EUR RADIOL, V21, P963, DOI 10.1007/s00330-010-1995-0; Gondrie MJA, 2010, RADIOLOGY, V257, P549, DOI 10.1148/radiol.10100054; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Jacobs PCA, 2008, J COMPUT ASSIST TOMO, V32, P214, DOI 10.1097/RCT.0b013e3181585ff2; Keistinen T, 1997, EUR RESPIR J, V10, P2784, DOI 10.1183/09031936.97.10122784; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Lee CI, 2010, RADIOLOGY, V257, P313, DOI 10.1148/radiol.10101437; Lee SH, 2007, NAT MED, V13, P567, DOI 10.1038/nm1583; Liu SF, 2005, INT J TUBERC LUNG D, V9, P111; Macnee William, 2008, Proc Am Thorac Soc, V5, P824, DOI 10.1513/pats.200807-071TH; Man SFP, 2008, EUR RESPIR J, V32, P1451, DOI 10.1183/09031936.00153207; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mayne TJ, 2006, J CLIN EPIDEMIOL, V59, P217, DOI 10.1016/j.jclinepi.2005.07.006; McAllister DA, 2007, AM J RESP CRIT CARE, V176, P1208, DOI 10.1164/rccm.200707-1080OC; Nakano Y, 2002, CHEST, V122, p271S, DOI 10.1378/chest.122.6_suppl.271S-a; Ngom A, 2001, CHEST, V119, P653, DOI 10.1378/chest.119.2.653; Paas G, 2002, RES VALIDITY LMR; Patel BD, 2008, AM J RESP CRIT CARE, V178, P500, DOI 10.1164/rccm.200801-059OC; PENTICE RL, 1986, BIOMETRIKA, V73, P1; Sin DD, 2009, CHEST, V136, P329, DOI 10.1378/chest.09-0808; TIDDENS H, AM J RESP CRIT CAR 2, V162, pS7; van Eeden SF, 2008, RESPIRATION, V75, P224, DOI 10.1159/000111820; Vehmas T, 2008, EUR J CARDIOV PREV R, V15, P599, DOI 10.1097/HJR.0b013e328309a224; Wells DK, 2010, CLIN EXP RHEUMATOL, V28, P223; WILLIAMS FLR, 1989, COMMUNITY MED, V11, P306	34	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26036	10.1371/journal.pone.0026036	http://dx.doi.org/10.1371/journal.pone.0026036			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022499	Green Published, gold, Green Submitted			2022-12-27	WOS:000295976000057
J	Flower, K; Thomas, D; Heather, J; Ramasubramanyan, S; Jones, S; Sinclair, AJ				Flower, Kirsty; Thomas, David; Heather, James; Ramasubramanyan, Sharada; Jones, Susan; Sinclair, Alison J.			Epigenetic Control of Viral Life-Cycle by a DNA-Methylation Dependent Transcription Factor	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; LYTIC TRANSACTIVATOR ZTA; INDUCTION; ACTIVATION; PROTEIN; BZLF1; GENE; EXPRESSION; PROMOTER; SITES	Epstein-Barr virus (EBV) encoded transcription factor Zta (BZLF1, ZEBRA, EB1) is the prototype of a class of transcription factor (including C/EBPalpha) that interact with CpG-containing DNA response elements in a methylation-dependent manner. The EBV genome undergoes a biphasic methylation cycle; it is extensively methylated during viral latency but is reset to an unmethylated state following viral lytic replication. Zta is expressed transiently following infection and again during the switch between latency and lytic replication. The requirement for CpG-methylation at critical Zta response elements (ZREs) has been proposed to regulate EBV replication, specifically it could aid the activation of viral lytic gene expression from silenced promoters on the methylated genome during latency in addition to preventing full lytic reactivation from the non-methylated EBV genome immediately following infection. We developed a computational approach to predict the location of ZREs which we experimentally assessed using in vitro and in vivo DNA association assays. A remarkably different binding motif is apparent for the CpG and non-CpG ZREs. Computational prediction of the location of these binding motifs in EBV revealed that the majority of lytic cycle genes have at least one and many have multiple copies of methylation-dependent CpG ZREs within their promoters. This suggests that the abundance of Zta protein coupled with the methylation status of the EBV genome act together to co-ordinate the expression of lytic cycle genes at the majority of EBV promoters.	[Flower, Kirsty; Thomas, David; Heather, James; Ramasubramanyan, Sharada; Jones, Susan; Sinclair, Alison J.] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England; [Flower, Kirsty] Univ London Imperial Coll Sci Technol & Med, Epigenet Unit, Dept Surg & Canc, London, England; [Heather, James] UCL, Infect & Immun Div, London, England; [Jones, Susan] James Hutton Inst, Dundee, Scotland	University of Sussex; Imperial College London; University of London; University College London; James Hutton Institute	Flower, K (corresponding author), Univ Sussex, Sch Life Sci, Brighton, E Sussex, England.	a.j.sinclair@sussex.ac.uk	Heather, James/I-1123-2019	Heather, James/0000-0002-1783-5181; Sinclair, Alison/0000-0001-8510-8691; Flower, Kirsty/0000-0002-5473-1197	Wellcome Trust, United Kingdom; University of Sussex	Wellcome Trust, United Kingdom(Wellcome Trust); University of Sussex	This research was supported by grants from the Wellcome Trust, United Kingdom, and University of Sussex. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bark-Jones SJ, 2006, ONCOGENE, V25, P1775, DOI 10.1038/sj.onc.1209205; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bergbauer M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001114; Bhende PM, 2005, J VIROL, V79, P7338, DOI 10.1128/JVI.79.12.7338-7348.2005; Bhende PM, 2004, NAT GENET, V36, P1099, DOI 10.1038/ng1424; Blanco E, 2006, PLOS COMPUT BIOL, V2, P403, DOI 10.1371/journal.pcbi.0020049; Broderick P, 2009, CHINESE J C IN PRESS; Chang Y, 2006, J VIROL, V80, P7748, DOI 10.1128/JVI.02608-05; Countryman J, 1985, P NATL ACAD SCI USA, V81, P7632; Dickerson SJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000356; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Farrell PJ, 2005, EPSTEIN-BARR VIRUS, P263; Fernandez AF, 2009, GENOME RES, V19, P438, DOI 10.1101/gr.083550.108; FLEMINGTON E, 1990, J VIROL, V64, P1227, DOI 10.1128/JVI.64.3.1227-1232.1990; Flower K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009443; Fu Yutao, 2005, Genome Inform, V16, P68; Heather J, 2009, J GEN VIROL, V90, P1450, DOI 10.1099/vir.0.007922-0; Hsu M, 2008, J VIROL, V82, P3679, DOI 10.1128/JVI.02301-07; Jones RJ, 2007, J BIOL CHEM, V282, P8317, DOI 10.1074/jbc.M608667200; Kalla M, 2010, P NATL ACAD SCI USA, V107, P850, DOI 10.1073/pnas.0911948107; Karlsson QH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000005; Karlsson QH, 2008, BIOCHEM SOC T, V36, P637, DOI 10.1042/BST0360637; Li D, 2009, J IMMUNOL, V182, P1799, DOI 10.4049/jimmunol.0802686; LIEBERMAN PM, 1990, J VIROL, V64, P1143, DOI 10.1128/JVI.64.3.1143-1155.1990; Mahot S, 2003, J GEN VIROL, V84, P965, DOI 10.1099/vir.0.18845-0; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Miller G, 2007, ADV CANCER RES, V97, P81, DOI 10.1016/S0065-230X(06)97004-3; Minarovits J, 2006, CURR TOP MICROBIOL, V310, P61; Morrison TE, 2001, IMMUNITY, V15, P787, DOI 10.1016/S1074-7613(01)00226-6; PACKHAM G, 1990, J VIROL, V64, P2110, DOI 10.1128/JVI.64.5.2110-2116.1990; Petosa C, 2006, MOL CELL, V21, P565, DOI 10.1016/j.molcel.2006.01.006; Rishi V, 2010, P NATL ACAD SCI USA, V107, P20311, DOI 10.1073/pnas.1008688107; Rowe M, 2009, SEMIN CANCER BIOL, V19, P377, DOI 10.1016/j.semcancer.2009.07.004; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Sinclair AJ, 2003, J GEN VIROL, V84, P1941, DOI 10.1099/vir.0.19112-0; SINCLAIR AJ, 1991, J VIROL, V65, P2237, DOI 10.1128/JVI.65.5.2237-2244.1991; Sinclair AJ, 2006, TRENDS MICROBIOL, V14, P289, DOI 10.1016/j.tim.2006.05.003; TAKADA K, 1989, J VIROL, V63, P445, DOI 10.1128/JVI.63.1.445-449.1989; TAYLOR N, 1991, J VIROL, V65, P4033, DOI 10.1128/JVI.65.8.4033-4041.1991; Tsai SC, 2009, BLOOD, V114, P109, DOI 10.1182/blood-2008-12-193375; URIER G, 1989, EMBO J, V8, P1447, DOI 10.1002/j.1460-2075.1989.tb03527.x; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; Yuan J, 2006, J VIROL, V80, P2548, DOI 10.1128/JVI.80.5.2548-2565.2006	43	35	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e25922	10.1371/journal.pone.0025922	http://dx.doi.org/10.1371/journal.pone.0025922			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022468	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000295973200021
J	Rupf, S; Idlibi, AN; Al Marrawi, F; Hannig, M; Schubert, A; von Mueller, L; Spitzer, W; Holtmann, H; Lehmann, A; Rueppell, A; Schindler, A				Rupf, Stefan; Idlibi, Ahmad Nour; Al Marrawi, Fuad; Hannig, Matthias; Schubert, Andreas; von Mueller, Lutz; Spitzer, Wolfgang; Holtmann, Henrik; Lehmann, Antje; Rueppell, Andre; Schindler, Axel			Removing Biofilms from Microstructured Titanium Ex Vivo: A Novel Approach Using Atmospheric Plasma Technology	PLOS ONE			English	Article							ARGON PLASMA; IN-VITRO; DENTAL IMPLANTS; DISCHARGE; INACTIVATION; VIABILITY; EFFICACY; ADHERENT; CELLS	The removal of biofilms from microstructured titanium used for dental implants is a still unresolved challenge. This experimental study investigated disinfection and removal of in situ formed biofilms from microstructured titanium using cold atmospheric plasma in combination with air/water spray. Titanium discs (roughness (Ra): 1.96 mu m) were exposed to human oral cavities for 24 and 72 hours (n = 149 each) to produce biofilms. Biofilm thickness was determined using confocal laser scanning microscopy (n = 5 each). Plasma treatment of biofilms was carried out ex vivo using a microwave-driven pulsed plasma source working at temperatures from 39 to 43 degrees C. Following plasma treatment, one group was air/water spray treated before re-treatment by second plasma pulses. Vital microorganisms on the titanium surfaces were identified by contact culture (Rodac agar plates). Biofilm presence and bacterial viability were quantified by fluorescence microscopy. Morphology of titanium surfaces and attached biofilms was visualized by scanning electron microscopy (SEM). Total protein amounts of biofilms were colorimetrically quantified. Untreated and air/water treated biofilms served as controls. Cold plasma treatment of native biofilms with a mean thickness of 19 mu m (24 h) to 91 mm (72 h) covering the microstructure of the titanium surface caused inactivation of biofilm bacteria and significant reduction of protein amounts. Total removal of biofilms, however, required additional application of air/water spray, and a second series of plasma treatment. Importantly, the microstructure of the titanium discs was not altered by plasma treatment. The combination of atmospheric plasma and non-abrasive air/water spray is applicable for complete elimination of oral biofilms from microstructured titanium used for dental implants and may enable new routes for the therapy of periimplant disease.	[Rupf, Stefan; Idlibi, Ahmad Nour; Al Marrawi, Fuad; Hannig, Matthias; Rueppell, Andre] Saarland Univ Hosp, Clin Operat Dent Periodontol & Prevent Dent, Homburg, Germany; [Schubert, Andreas] Fraunhofer Inst, Vasc Biol Grp, Leipzig, Germany; [von Mueller, Lutz] Saarland Univ Hosp, Dept Med Microbiol, Homburg, Germany; [Spitzer, Wolfgang; Holtmann, Henrik] Univ Clin Saarland, Clin Oral & Maxillofacial Surg, Homburg, Germany; [Lehmann, Antje; Rueppell, Andre; Schindler, Axel] Leibniz Inst Surface Modificat IOM, Leipzig, Germany; [Idlibi, Ahmad Nour] Univ Aleppo, Fac Dent, Dept Periodontol, Aleppo, Syria	Universitatsklinikum des Saarlandes; Fraunhofer Gesellschaft; Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes; Leibniz Institut fur Oberflachenmodifizierung (IOM)	Rupf, S (corresponding author), Saarland Univ Hosp, Clin Operat Dent Periodontol & Prevent Dent, Homburg, Germany.	Stefan.rupf@uks.eu			Federal Ministry of Education and Research Germany (BMBF) [FKZ 01 EZ 0730, 01 EZ 0731]; Freunde des Universitatsklinikums des Saarlandes e.V.	Federal Ministry of Education and Research Germany (BMBF)(Federal Ministry of Education & Research (BMBF)); Freunde des Universitatsklinikums des Saarlandes e.V.	This study was supported by grants from the Federal Ministry of Education and Research Germany (BMBF; FKZ 01 EZ 0730 and 01 EZ 0731) and of the "Freunde des Universitatsklinikums des Saarlandes e.V.''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augthun M, 1998, J PERIODONTOL, V69, P857, DOI 10.1902/jop.1998.69.8.857; Burgers R, 2010, CLIN ORAL IMPLAN RES, V21, P156, DOI 10.1111/j.1600-0501.2009.01815.x; Coulombe S, 2006, PURE APPL CHEM, V78, P1147, DOI 10.1351/pac200678061147; do Nascimento C, 2011, INT J ORAL MAX IMPL, V26, P782; Dobrynin D, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115020; Duan YX, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2409624; Ermolaeva SA, 2011, J MED MICROBIOL, V60, P75, DOI 10.1099/jmm.0.020263-0; Fridman A, 2005, J PHYS D APPL PHYS, V38, pR1, DOI 10.1088/0022-3727/38/2/R01; Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154; Goncalves F, 2010, PHOTOMED LASER SURG, V28, P273, DOI 10.1089/pho.2009.2496; Gosau M, 2010, CLIN ORAL IMPLAN RES, V21, P866, DOI 10.1111/j.1600-0501.2009.01908.x; Grossner-Schreiber B, 2009, CLIN ORAL IMPLAN RES, V20, P817, DOI 10.1111/j.1600-0501.2009.01729.x; Hannig C, 2009, CLIN ORAL INVEST, V13, P123, DOI 10.1007/s00784-008-0243-3; Hubner NO, 2010, SKIN PHARMACOL PHYS, V23, P28, DOI 10.1159/000318265; Isbary G, 2010, BRIT J DERMATOL, V163, P78, DOI 10.1111/j.1365-2133.2010.09744.x; Joaquin JC, 2009, MICROBIOL-SGM, V155, P724, DOI 10.1099/mic.0.021501-0; Joshi SG, 2010, AM J INFECT CONTROL, V38, P293, DOI 10.1016/j.ajic.2009.11.002; Kamgang JO, 2007, J APPL MICROBIOL, V103, P621, DOI 10.1111/j.1365-2672.2007.03286.x; Kieft I.E., 2005, PLASMA PROCESS POLYM, P295; Laroussi M, 2004, INT J MASS SPECTROM, V233, P81, DOI 10.1016/j.ijms.2003.11.016; Lopez-Heredia MA, 2008, ACTA BIOMATER, V4, P1953, DOI 10.1016/j.actbio.2008.04.024; Manner H, 2008, CURR OPIN GASTROEN, V24, P612, DOI 10.1097/MOG.0b013e32830bf825; Marsh Philip D, 2006, BMC Oral Health, V6 Suppl 1, pS14, DOI 10.1186/1472-6831-6-S1-S14; Masaoka Satoshi, 2007, Biocontrol Science, V12, P59; Mombelli A, 2002, PERIODONTOL 2000, V28, P177, DOI 10.1034/j.1600-0757.2002.280107.x; RUHLING A, 1994, CLIN ORAL IMPLAN RES, V5, P19, DOI 10.1034/j.1600-0501.1994.050103.x; Rupf S, 2010, J MED MICROBIOL, V59, P206, DOI 10.1099/jmm.0.013714-0; Schwarz F, 2005, CLIN ORAL INVEST, V9, P111, DOI 10.1007/s00784-005-0305-8; Schwarz F, 2006, J BIOMED MATER RES A, V77A, P437, DOI 10.1002/jbm.a.30628; Schwarz F, 2009, J BIOMED MATER RES B, V88B, P83, DOI 10.1002/jbm.b.31154; Sladek REJ, 2007, LETT APPL MICROBIOL, V45, P318, DOI 10.1111/j.1472-765X.2007.02194.x; Subramani K, 2009, INT J ORAL MAX IMPL, V24, P616; Vleugels M, 2005, IEEE T PLASMA SCI, V33, P824, DOI 10.1109/TPS.2005.844524; Wennerberg A, 2009, CLIN ORAL IMPLAN RES, V20, P172, DOI 10.1111/j.1600-0501.2009.01775.x; Yoshinari M., 2009, WORLD ACAD SCI ENG T, V58, P171	35	63	66	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25893	10.1371/journal.pone.0025893	http://dx.doi.org/10.1371/journal.pone.0025893			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016784	gold, Green Published, Green Submitted			2022-12-27	WOS:000295971700022
J	Sztriha, LK; Manawadu, D; Jarosz, J; Keep, J; Kalra, L				Sztriha, Laszlo K.; Manawadu, Dulka; Jarosz, Jozef; Keep, Jeff; Kalra, Lalit			Safety and Clinical Outcome of Thrombolysis in Ischaemic Stroke Using a Perfusion CT Mismatch between 3 and 6 Hours	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; TIME; ALTEPLASE; THERAPY; DIFFUSION; TRIALS; MRI	Objective: It may be possible to thrombolyse ischaemic stroke (IS) patients up to 6 h by using penumbral imaging. We investigated whether a perfusion CT (CTP) mismatch can help to select patients for thrombolysis up to 6 h. Methods: A cohort of 254 thrombolysed IS patients was studied. 174 (69%) were thrombolysed at 0-3 h by using non-contrast CT (NCCT), and 80 (31%) at 3-6 h (35 at 3-4.5 h and 45 at 4.5-6 h) by using CTP mismatch criteria. Symptomatic intracerebral haemorrhage (SICH), the mortality and the modified Rankin Score (mRS) were assessed at 3 months. Independent determinants of outcome in patients thrombolysed between 3 and 6 h were identified. Results: The baseline characteristics were comparable in the two groups. There were no differences in SICH (3% v 4%, p = 0.71), any ICH (7% v 9%, p = 0.61), or mortality (16% v 9%, p = 0.15) or mRS 0-2 at 3 months (55% v 54%, p = 0.96) between patients thrombolysed at 0-3 h (NCCT only) or at 3-6 h (CTP mismatch). There were no significant differences in outcome between patients thrombolysed at 3-4.5 h or 4.5-6 h. The NIHSS score was the only independent determinant of a mRS of 0-2 at 3 months (OR 0.89, 95% CI 0.82-0.97, p = 0.007) in patients treated using CTP mismatch criteria beyond 3 h. Conclusions: The use of a CTP mismatch model may help to guide thrombolysis decisions up to 6 h after IS onset.	[Sztriha, Laszlo K.; Manawadu, Dulka; Kalra, Lalit] Kings Coll London, Inst Psychiat, Dept Clin Neurosci, London WC2R 2LS, England; [Jarosz, Jozef] Kings Coll Hosp London, Dept Neuroradiol, London, England	University of London; King's College London; King's College Hospital NHS Foundation Trust; King's College Hospital	Sztriha, LK (corresponding author), Kings Coll London, Inst Psychiat, Dept Clin Neurosci, London WC2R 2LS, England.	laszlo.sztriha@kcl.ac.uk		Sztriha, Laszlo/0000-0003-4639-3180				Ahmed N, 2010, LANCET NEUROL, V9, P866, DOI 10.1016/S1474-4422(10)70165-4; Albers GW, 2006, ANN NEUROL, V60, P508, DOI 10.1002/ana.20976; [Anonymous], EXTENDING TIME THROM; Barber PA, 2000, LANCET, V355, P1670, DOI 10.1016/S0140-6736(00)02237-6; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Butcher K, 2008, STROKE, V39, P75, DOI 10.1161/STROKEAHA.107.490524; Donnan GA, 2009, LANCET NEUROL, V8, P261, DOI 10.1016/S1474-4422(09)70041-9; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Johnson SC, 2005, NEUROLOGY, V64, P654; Kohrmann M, 2006, LANCET NEUROL, V5, P661, DOI 10.1016/S1474-4422(06)70499-9; Kohrmann M, 2009, RADIOLOGY, V251, P627, DOI 10.1148/radiol.2513081074; Konstas AA, 2010, RADIOLOGY, V254, P22, DOI 10.1148/radiol.09091610; Lees KR, 2010, LANCET, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; Lin K, 2009, NEURORADIOLOGY, V51, P17, DOI 10.1007/s00234-008-0454-y; Mishra NK, 2010, STROKE, V41, pE25, DOI 10.1161/STROKEAHA.109.566869; Parsons MW, 2005, ANN NEUROL, V58, P672, DOI 10.1002/ana.20638; RANKIN J, 1957, Scott Med J, V2, P200; Schellinger PD, 2007, STROKE, V38, P2640, DOI 10.1161/STROKEAHA.107.483255; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4; Wintermark M, 2006, STROKE, V37, P979, DOI 10.1161/01.STR.0000209238.61459.39	20	16	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25796	10.1371/journal.pone.0025796	http://dx.doi.org/10.1371/journal.pone.0025796			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22016775	Green Published, gold, Green Submitted			2022-12-27	WOS:000295971700017
J	Kemp, K; Mallam, E; Hares, K; Witherick, J; Scolding, N; Wilkins, A				Kemp, Kevin; Mallam, Elizabeth; Hares, Kelly; Witherick, Jonathan; Scolding, Neil; Wilkins, Alastair			Mesenchymal Stem Cells Restore Frataxin Expression and Increase Hydrogen Peroxide Scavenging Enzymes in Friedreich Ataxia Fibroblasts	PLOS ONE			English	Article							RECOMBINANT-HUMAN-ERYTHROPOIETIN; IRON ACCUMULATION; OXIDATIVE STRESS; MESSENGER-RNA; INHIBITORS; BLOOD; MOUSE; DEFICIENCY; LYMPHOBLASTS; SENSITIVITY	Dramatic advances in recent decades in understanding the genetics of Friedreich ataxia (FRDA)-a GAA triplet expansion causing greatly reduced expression of the mitochondrial protein frataxin-have thus far yielded no therapeutic dividend, since there remain no effective treatments that prevent or even slow the inevitable progressive disability in affected individuals. Clinical interventions that restore frataxin expression are attractive therapeutic approaches, as, in theory, it may be possible to re-establish normal function in frataxin deficient cells if frataxin levels are increased above a specific threshold. With this in mind several drugs and cytokines have been tested for their ability to increase frataxin levels. Cell transplantation strategies may provide an alternative approach to this therapeutic aim, and may also offer more widespread cellular protective roles in FRDA. Here we show a direct link between frataxin expression in fibroblasts derived from FRDA patients with both decreased expression of hydrogen peroxide scavenging enzymes and increased sensitivity to hydrogen peroxide-mediated toxicity. We demonstrate that normal human mesenchymal stem cells (MSCs) induce both an increase in frataxin gene and protein expression in FRDA fibroblasts via secretion of soluble factors. Finally, we show that exposure to factors produced by human MSCs increases resistance to hydrogen peroxide-mediated toxicity in FRDA fibroblasts through, at least in part, restoring the expression of the hydrogen peroxide scavenging enzymes catalase and glutathione peroxidase 1. These findings suggest, for the first time, that stem cells may increase frataxin levels in FRDA and transplantation of MSCs may offer an effective treatment for these patients.	[Kemp, Kevin; Mallam, Elizabeth; Hares, Kelly; Witherick, Jonathan; Scolding, Neil; Wilkins, Alastair] Univ Bristol, Inst Clin Neurosci, Sch Clin Sci, Multiple Sclerosis & Stem Cell Grp, Bristol, Avon, England	University of Bristol	Kemp, K (corresponding author), Univ Bristol, Inst Clin Neurosci, Sch Clin Sci, Multiple Sclerosis & Stem Cell Grp, Bristol, Avon, England.	kevin.kemp@bristol.ac.uk	Resource Center, NINDS Human Genetics/AGF-2474-2022; Sander-Effron, Samuel/AAX-2231-2020; Kemp, Kevin/B-9755-2017	Scolding, Neil/0000-0001-9177-1043; Kemp, Kevin/0000-0003-1465-1309	Ataxia UK; Ataxia UK [7160] Funding Source: researchfish	Ataxia UK; Ataxia UK	The study was funded by Ataxia UK research grant. www.ataxia.org.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquaviva F, 2008, CEREBELLUM, V7, P360, DOI 10.1007/s12311-008-0036-x; Anderson PR, 2008, P NATL ACAD SCI USA, V105, P611, DOI 10.1073/pnas.0709691105; Babady NE, 2007, MOL GENET METAB, V92, P23, DOI 10.1016/j.ymgme.2007.05.009; Bidichandani SI, 1997, AM J HUM GENET, V60, P1251; Boesch S, 2007, ANN NEUROL, V62, P521, DOI 10.1002/ana.21177; Burt RK, 2008, JAMA-J AM MED ASSOC, V299, P925, DOI 10.1001/jama.299.8.925; Calabrese V, 2005, J NEUROL SCI, V233, P145, DOI 10.1016/j.jns.2005.03.012; Calmels N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006379; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Chantrel-Groussard K, 2001, HUM MOL GENET, V10, P2061, DOI 10.1093/hmg/10.19.2061; Crigler L, 2006, EXP NEUROL, V198, P54, DOI 10.1016/j.expneurol.2005.10.029; Delatycki MB, 1999, ANN NEUROL, V45, P673, DOI 10.1002/1531-8249(199905)45:5<673::AID-ANA20>3.3.CO;2-H; Di Prospero NA, 2007, LANCET NEUROL, V6, P878, DOI 10.1016/S1474-4422(07)70220-X; Dion V, 2009, TRENDS GENET, V25, P288, DOI 10.1016/j.tig.2009.04.007; Durr A, 1996, NEW ENGL J MED, V335, P1169, DOI 10.1056/NEJM199610173351601; Foury F, 1997, FEBS LETT, V411, P373, DOI 10.1016/S0014-5793(97)00734-5; Gakh O, 2006, HUM MOL GENET, V15, P467, DOI 10.1093/hmg/ddi461; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Goncalves S, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-20; Gordon D, 2010, J NEUROPATH EXP NEUR, V69, P1087, DOI 10.1097/NEN.0b013e3181f97392; Gordon D, 2008, NEUROSCI LETT, V448, P71, DOI 10.1016/j.neulet.2008.10.040; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Kassis I, 2008, ARCH NEUROL-CHICAGO, V65, P753, DOI 10.1001/archneur.65.6.753; Kemp K, 2011, NEUROPATH APPL NEURO, V37, P166, DOI 10.1111/j.1365-2990.2010.01122.x; Kemp K, 2010, STEM CELL REV REP, V6, P548, DOI 10.1007/s12015-010-9178-6; Kemp K, 2010, J NEUROCHEM, V114, P1569, DOI 10.1111/j.1471-4159.2009.06553.x; Lanza C, 2009, J NEUROCHEM, V110, P1674, DOI 10.1111/j.1471-4159.2009.06268.x; Li KY, 2008, HUM MOL GENET, V17, P2265, DOI 10.1093/hmg/ddn127; Lim CK, 2008, MOL PHARMACOL, V74, P225, DOI 10.1124/mol.108.046847; Mahmood A, 2005, NEUROSURGERY, V57, P1026, DOI 10.1227/01.NEU.0000181369.76323.50; Mallam E, 2010, MULT SCLER J, V16, P909, DOI 10.1177/1352458510371959; Mancuso M, 2010, NEUROPSYCH DIS TREAT, V6, P491; Marmolino D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010025; Marmolino D, 2009, CEREBELLUM, V8, P245, DOI 10.1007/s12311-008-0084-2; Monros E, 1997, AM J HUM GENET, V61, P101, DOI 10.1086/513887; NACHBAUER W, 2011, CEREBELLUM IN PRESS; Pandolfo M, 2008, NAT CLIN PRACT NEURO, V4, P86, DOI 10.1038/ncpneuro0704; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Paupe V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004253; Pianese L, 2004, J NEUROL NEUROSUR PS, V75, P1061, DOI 10.1136/jnnp.2003.028605; Piemonte F, 2001, EUR J CLIN INVEST, V31, P1007, DOI 10.1046/j.1365-2362.2001.00922.x; Pook MA, 2001, NEUROGENETICS, V3, P185; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Punga T, 2010, EMBO MOL MED, V2, P120, DOI 10.1002/emmm.201000064; Rai M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001958; Rai M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008825; Sacca F, 2011, MOVEMENT DISORD, V26, P739, DOI 10.1002/mds.23435; Shoichet SA, 2002, HUM MOL GENET, V11, P815, DOI 10.1093/hmg/11.7.815; Sturm B, 2005, EUR J CLIN INVEST, V35, P711, DOI 10.1111/j.1365-2362.2005.01568.x; Sturm B, 2005, J BIOL CHEM, V280, P6701, DOI 10.1074/jbc.M408717200; Tozzi G, 2002, ARCH DIS CHILD, V86, P376, DOI 10.1136/adc.86.5.376; Voncken M, 2004, NEUROGENETICS, V5, P1, DOI 10.1007/s10048-003-0170-z; Wang T, 2007, CRIT CARE MED, V35, P2587, DOI 10.1097/01.CCM.0000285992.99391.7E; Weimann JM, 2003, P NATL ACAD SCI USA, V100, P2088, DOI 10.1073/pnas.0337659100; Wilkins A, 2009, STEM CELL RES, V3, P63, DOI 10.1016/j.scr.2009.02.006; Wong A, 1999, HUM MOL GENET, V8, P425, DOI 10.1093/hmg/8.3.425; Wong A, 2000, ANTIOXID REDOX SIGN, V2, P461, DOI 10.1089/15230860050192233; Zhang M, 2007, FASEB J, V21, P3197, DOI 10.1096/fj.06-6558com	59	24	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e26098	10.1371/journal.pone.0026098	http://dx.doi.org/10.1371/journal.pone.0026098			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22016819	gold, Green Published, Green Submitted			2022-12-27	WOS:000295970300060
J	Proft, J; Faraji, J; Robbins, JC; Zucchi, FCR; Zhao, XX; Metz, GA; Braun, JEA				Proft, Juliane; Faraji, Jamshid; Robbins, Jerrah C.; Zucchi, Fabiola C. R.; Zhao, Xiaoxi; Metz, Gerlinde A.; Braun, Janice E. A.			Identification of Bilateral Changes in TID1 Expression in the 6-OHDA Rat Model of Parkinson's Disease	PLOS ONE			English	Article							PRION PROTEIN PRPC; HUMAN DNAJ PROTEIN; ALPHA-SYNUCLEIN; CSP-ALPHA; MOLECULAR CHAPERONES; HOMOLOG; HSP70; GENE; SUPPRESSION; APOPTOSIS	Parkinson's disease (PD) is a common neurodegenerative disease characterized by the loss of dopaminergic neurons in the substantia nigra and the aggregation of alpha-synuclein into Lewy bodies. Existing therapies address motor dysfunction but do not halt progression of the disease. A still unresolved question is the biochemical pathway that modulates the outcome of protein misfolding and aggregation processes in PD. The molecular chaperone network plays an important defensive role against cellular protein misfolding and has been identified as protective in experimental models of protein misfolding diseases like PD. Molecular mechanisms underlying chaperone-neuroprotection are actively under investigation. Current evidence implicates a number of molecular chaperones in PD including Hsp25, Hsp70 and Hsp90, however their precise involvement in the neurodegenerative cascade is unresolved. The J protein family (DnaJ or Hsp40 protein family) has long been known to be important in protein conformational processes. We assessed sensory and motor function of control and PD rats and then evaluated the brain region-specific expression levels of select J proteins by Western analysis. Surprisingly, we observed a widespread 26 kDa breakdown product of the J protein, TID1, (tumorous imaginal discs, mtHsp40 or DnaJ3) in a 6-hydroxydopamine (6-OHDA) rat model of PD in which food handling, gait symmetry and sensory performance were impaired. Greater behavioral deficits were associated with lower TID1 expression. Furthermore, direct application of either 6-OHDA or MPP+ (1-methyl-4-phenylpyridinum) to CAD (CNS-derived catecholinaminergic neuronal cell line) cell cultures, reduced TID1 expression levels. Our results suggest that changes in cellular TID1 are a factor in the pathogenesis of PD by impeding functional and structural compensation and exaggerating neurodegenerative processes. In contrast, no changes were observed in CSP alpha, Hsp40, Hsp70, Hsc70 and PrPC levels and no activation of caspase3 was observed. This study links TID1 to PD and provides a new target for therapeutics that halts the PD progression.	[Proft, Juliane; Zhao, Xiaoxi; Braun, Janice E. A.] Univ Calgary, Hotchkiss Brain Inst, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Faraji, Jamshid; Robbins, Jerrah C.; Zucchi, Fabiola C. R.; Metz, Gerlinde A.] Univ Lethbridge, Canadian Ctr Behav Neurosci, Lethbridge, AB T1K 3M4, Canada; [Faraji, Jamshid] Golestan Univ Med Sci, Neurosci Res Ctr, Gorgan, Iran	University of Calgary; University of Lethbridge; Golestan University of Medical Sciences	Proft, J (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Dept Physiol & Pharmacol, Calgary, AB, Canada.	braunj@ucalgary.ca	Proft, Juliane/H-6549-2014; Zucchi, Fabiola/K-1296-2017	Proft, Juliane/0000-0003-0980-8930; Zucchi, Fabiola/0000-0002-2252-613X; Metz, Gerlinde/0000-0002-5801-7716	Canadian Institute of Health Research [MOP74713]; Alberta Prion Research Institute; National Institutes of Neurological Disorders and Stroke, National Institutes of Health [NS043588]; Canada Foundation for Innovation; Natural Sciences and Engineering Research Council of Canada; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS043588] Funding Source: NIH RePORTER	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Prion Research Institute; National Institutes of Neurological Disorders and Stroke, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by funding from the Canadian Institute of Health Research #MOP74713, the Alberta Prion Research Institute, the National Institutes of Neurological Disorders and Stroke, National Institutes of Health Grant #NS043588, the Canada Foundation for Innovation and the Natural Sciences and Engineering Research Council of Canada (GM). JEAB and GM are Senior Scholars of Alberta Innovates-Health Solutions. Dr. Jamshid Faraji is a CCBN visiting scholar from Golestan University of Medical Sciences, Gorgan, Iran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn BY, 2010, ONCOGENE, V29, P1155, DOI 10.1038/onc.2009.413; Allred RP, 2008, J NEUROSCI METH, V170, P229, DOI 10.1016/j.jneumeth.2008.01.015; Auluck PK, 2010, ANNU REV CELL DEV BI, V26, P211, DOI 10.1146/annurev.cellbio.042308.113313; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Bandopadhyay R, 2010, TRENDS MOL MED, V16, P27, DOI 10.1016/j.molmed.2009.11.004; Bjorklund A, 2010, PROG BRAIN RES, V184, P17, DOI 10.1016/S0079-6123(10)84002-6; Bounhar Y, 2001, J BIOL CHEM, V276, P39145, DOI 10.1074/jbc.C100443200; BRAUN JEA, 1995, NEUROPHARMACOLOGY, V34, P1361, DOI 10.1016/0028-3908(95)00114-L; Braun JEA, 1996, J BIOL CHEM, V271, P25989, DOI 10.1074/jbc.271.42.25989; Brundin P, 2011, EXPERT REV NEUROTHER, V11, P917, DOI [10.1586/ERN.11.73, 10.1586/ern.11.73]; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Do T, 2007, J NEUROCHEM, V101, P619, DOI 10.1111/j.1471-4159.2006.04388.x; Fornaguera J, 1999, PROG NEURO-PSYCHOPH, V23, P1353, DOI 10.1016/S0278-5846(99)00071-8; Forno LS, 1996, J NEUROPATH EXP NEUR, V55, P259, DOI 10.1097/00005072-199603000-00001; Gibbs SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004595; Gomez-Lazaro M, 2008, J NEUROCHEM, V104, P1599, DOI 10.1111/j.1471-4159.2007.05115.x; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; JOHNSON JN, 2009, BIOCH CELL IN PRESS; Kalia SK, 2004, NEURON, V44, P931, DOI 10.1016/j.neuron.2004.11.026; Khosravani H, 2008, J CELL BIOL, V181, P551, DOI 10.1083/jcb.200711002; Klein A, 2011, BEHAV BRAIN RES, V222, P33, DOI 10.1016/j.bbr.2011.03.018; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; Kuwahara C, 1999, NATURE, V400, P225, DOI 10.1038/22241; Lee KJ, 2007, J CELL SCI, V120, P2663, DOI 10.1242/jcs.004598; Lim Y, 2011, J NEUROSCI, V31, P10076, DOI 10.1523/JNEUROSCI.0618-11.2011; Linnoila J, 2008, NEURON, V60, P625, DOI 10.1016/j.neuron.2008.09.025; Liu HY, 2005, J BIOL CHEM, V280, P19461, DOI 10.1074/jbc.M500313200; Lo JF, 2004, MOL CELL BIOL, V24, P2226, DOI 10.1128/MCB.24.6.2226-2236.2004; Lu B, 2006, J BIOL CHEM, V281, P13150, DOI 10.1074/jbc.M509179200; Luk KC, 2008, BIOCHEMISTRY-US, V47, P12614, DOI 10.1021/bi801475r; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Martins AR, 2011, J NEUROSCI METH, V198, P16, DOI 10.1016/j.jneumeth.2011.02.024; Martins AR, 1999, J NEUROSCI METH, V92, P25, DOI 10.1016/S0165-0270(99)00090-4; McLean PJ, 2002, J NEUROCHEM, V83, P846, DOI 10.1046/j.1471-4159.2002.01190.x; McLennan NF, 2004, AM J PATHOL, V165, P227, DOI 10.1016/S0002-9440(10)63291-9; Metz GA, 2005, EUR J NEUROSCI, V22, P735, DOI 10.1111/j.1460-9568.2005.04238.x; Metz GA, 2002, NEUROSCIENCE, V111, P325, DOI 10.1016/S0306-4522(02)00013-1; Mitteregger G, 2007, BRAIN PATHOL, V17, P174, DOI 10.1111/j.1750-3639.2007.00061.x; Nishida N, 1999, LAB INVEST, V79, P689; Opazo F, 2008, J NEUROCHEM, V106, P529, DOI 10.1111/j.1471-4159.2008.05407.x; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Roodveldt C, 2009, EMBO J, V28, P3758, DOI 10.1038/emboj.2009.298; RUIPEREZ V, 2010, ALPHA SYNUCLEIN LIPI; Ryu EJ, 2005, NEUROBIOL DIS, V18, P54, DOI 10.1016/j.nbd.2004.08.016; Sarkar S, 2001, J BIOL CHEM, V276, P49034, DOI 10.1074/jbc.M103683200; SCHALLERT T, 1988, BEHAV BRAIN RES, V30, P15, DOI 10.1016/0166-4328(88)90003-4; Schilling B, 1998, VIROLOGY, V247, P74, DOI 10.1006/viro.1998.9220; Sharma M, 2011, NAT CELL BIOL, V13, P30, DOI 10.1038/ncb2131; Sheng JZ, 2008, AM J PHYSIOL-CELL PH, V294, pC1531, DOI 10.1152/ajpcell.00561.2007; Shimshek DR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010014; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Shyu WC, 2005, J NEUROSCI, V25, P8967, DOI 10.1523/JNEUROSCI.1115-05.2005; Smith LK, 2008, EUR J NEUROSCI, V27, P2133, DOI 10.1111/j.1460-9568.2008.06177.x; Spudich A, 2005, NEUROBIOL DIS, V20, P442, DOI 10.1016/j.nbd.2005.04.002; STEELE AD, 2008, P NATL ACAD SCI US; Syken J, 1999, P NATL ACAD SCI USA, V96, P8499, DOI 10.1073/pnas.96.15.8499; Trentin GA, 2004, FEBS LETT, V578, P323, DOI 10.1016/j.febslet.2004.11.034; Trentin GA, 2001, J BIOL CHEM, V276, P13087, DOI 10.1074/jbc.M009267200; Walz R, 1999, EPILEPSIA, V40, P1679, DOI 10.1111/j.1528-1157.1999.tb01583.x; Weise J, 2004, NEUROSCI LETT, V372, P146, DOI 10.1016/j.neulet.2004.09.030; Weise J, 2008, RESTOR NEUROL NEUROS, V26, P57; Whishaw IQ, 1997, BEHAV BRAIN RES, V84, P167, DOI 10.1016/S0166-4328(96)00148-9; Xu FL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011045; Yakunin E, 2010, J NEUROSCI RES, V88, P866, DOI 10.1002/jnr.22246; Yin X, 2001, GENE, V278, P201, DOI 10.1016/S0378-1119(01)00720-X; Young JC, 2010, BIOCHEM CELL BIOL, V88, P291, DOI [10.1139/o09-175, 10.1139/O09-175]; Zhao X, 2008, CELL MOL LIFE SCI, V65, P2385, DOI 10.1007/s00018-008-8089-z; Zourlidou A, 2004, J NEUROCHEM, V88, P1439, DOI 10.1046/j.1471-4159.2003.02273.x; Zucchi Fabiola Cr, 2010, Exp Transl Stroke Med, V2, P18, DOI 10.1186/2040-7378-2-18	69	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e26045	10.1371/journal.pone.0026045	http://dx.doi.org/10.1371/journal.pone.0026045			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22016808	Green Published, gold, Green Submitted			2022-12-27	WOS:000295970300052
J	Stanton, MC; Taylor-Robinson, D; Harris, D; Paize, F; Makwana, N; Hackett, SJ; Baines, PB; Riordan, FAI; Marzouk, O; Thomson, APJ; Diggle, PJ; Hart, CA; Carrol, ED				Stanton, Michelle C.; Taylor-Robinson, David; Harris, David; Paize, Fauzia; Makwana, Nick; Hackett, Scott J.; Baines, Paul B.; Riordan, F. Andrew I.; Marzouk, Omnia; Thomson, Alistair P. J.; Diggle, Peter J.; Hart, C. Anthony; Carrol, Enitan D.			Meningococcal Disease in Children in Merseyside, England: A 31 Year Descriptive Study	PLOS ONE			English	Article							MORTALITY; DEPRIVATION; CONFIRMATION; EPIDEMIOLOGY	Meningococcal disease (MCD) is the leading infectious cause of death in early childhood in the United Kingdom, making it a public health priority. MCD most commonly presents as meningococcal meningitis (MM), septicaemia (MS), or as a combination of the two syndromes (MM/MS). We describe the changing epidemiology and clinical presentation of MCD, and explore associations with socioeconomic status and other risk factors. A hospital-based study of children admitted to a tertiary children's centre, Alder Hey Children's Foundation Trust, with MCD, was undertaken between 1977 to 2007 (n = 1157). Demographics, clinical presentations, microbiological confirmation and measures of deprivation were described. The majority of cases occurred in the 1-4 year age group and there was a dramatic fall in serogroup C cases observed with the introduction of the meningococcal C conjugate (MCC) vaccine. The proportion of MS cases increased over the study period, from 11% in the first quarter to 35% in the final quarter. Presentation with MS (compared to MM) and serogroup C disease (compared to serogroup B) were demonstrated to be independent risk factors for mortality, with odds ratios of 3.5 (95% CI 1.18 to 10.08) and 2.18 (95% CI 1.26 to 3.80) respectively. Cases admitted to Alder Hey were from a relatively more deprived population (mean Townsend score 1.25, 95% CI 1.09 to 1.41) than the Merseyside reference population. Our findings represent one of the largest single-centre studies of MCD. The presentation of MS is confirmed to be a risk factor of mortality from MCD. Our study supports the association between social deprivation and MCD.	[Stanton, Michelle C.; Diggle, Peter J.] Univ Lancaster, Lancaster Med Sch, Fac Hlth & Med, Lancaster, England; [Taylor-Robinson, David] Univ Liverpool, Inst Psychol Hlth & Soc, Dept Hlth Inequal & Social Determinants Hlth, Liverpool L69 3BX, Merseyside, England; [Harris, David; Paize, Fauzia; Carrol, Enitan D.] Univ Liverpool, Inst Translat Med, Dept Womens & Childrens Hlth, Liverpool L69 3BX, Merseyside, England; [Makwana, Nick] Sandwell & W Birmingham NHS Trust, Dept Child Hlth, W Bromwich, W Midlands, England; [Hackett, Scott J.] Birmingham Heartlands Hosp, Dept Paediat Infect Dis & Immunol, Birmingham B9 5ST, W Midlands, England; [Baines, Paul B.] Keele Univ, Dept Profess Eth, Keele, Staffs, England; [Baines, Paul B.; Riordan, F. Andrew I.; Marzouk, Omnia; Carrol, Enitan D.] Alder Hey Childrens NHS Fdn Trust, Liverpool, Merseyside, England; [Thomson, Alistair P. J.] Leighton Hosp, Crewe, Cheshire, England; [Diggle, Peter J.; Carrol, Enitan D.] Univ Liverpool, Dept Clin Infect Microbiol & Immunol, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England	Lancaster University; University of Liverpool; University of Liverpool; Heart of England NHS Foundation Trust; University of Birmingham; Keele University; Alder Hey Children's NHS Foundation Trust; University of Liverpool	Stanton, MC (corresponding author), Univ Lancaster, Lancaster Med Sch, Fac Hlth & Med, Lancaster, England.	m.stanton@lancaster.ac.uk	Stanton, Michelle/AAB-5291-2021	Stanton, Michelle/0000-0002-1754-4894; Carrol, Enitan/0000-0001-8357-7726; Diggle, Peter/0000-0003-3521-5020	Alder Hey Children's NHS Foundation Trust; Meningitis Merseyside; The Meningitis Research Foundation [MRF] [0605.1]; Medical Research Council [G0802448]; Engineering and Physical Sciences Research Council; MRC [G0802448] Funding Source: UKRI	Alder Hey Children's NHS Foundation Trust; Meningitis Merseyside; The Meningitis Research Foundation [MRF]; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by The Johanne Holly Fund, Alder Hey Children's NHS Foundation Trust Charitable Funds; Meningitis Merseyside; The Meningitis Research Foundation [MRF project 0605.1]; Medical Research Council Population Health Scientist Fellowship [G0802448 to D.T.R.]; and Engineering and Physical Sciences Research Council Doctoral Training Account [to M.C.S.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGENCY HP, 2010, MEN REF UN IS NEISS; Booy R, 2001, ARCH DIS CHILD, V85, P386, DOI 10.1136/adc.85.5.386; Carrol ED, 2000, ARCH DIS CHILD, V83, P271, DOI 10.1136/adc.83.3.271; Carrol ED, 2000, CLIN MICROBIOL INFEC, V6, P259, DOI 10.1046/j.1469-0691.2000.00078.x; DEWALS P, 1984, J INFECTION, V8, P264, DOI 10.1016/S0163-4453(84)94123-9; Fone DL, 2003, EPIDEMIOL INFECT, V130, P53, DOI 10.1017/S095026880200794X; Gray SJ, 2006, J MED MICROBIOL, V55, P887, DOI 10.1099/jmm.0.46288-0; Hackett SJ, 2002, ARCH DIS CHILD, V86, P449, DOI 10.1136/adc.86.6.449; Heyderman RS, 2004, ARCH DIS CHILD, V89, P1064, DOI 10.1136/adc.2003.036004; Howitz M, 2009, EPIDEMIOL INFECT, V137, P1631, DOI 10.1017/S0950268809002428; JACOBSSON S, 2008, SCAND J INFECT DIS, P1; Jones D M, 1995, Commun Dis Rep CDR Rev, V5, pR125; Lloyd, 2004, ENGLISH INDICES DEPR; Martinez AI, 2009, VACCINE, V27, P3496, DOI 10.1016/j.vaccine.2009.01.045; Olowokure B, 2006, J INFECTION, V52, P61, DOI 10.1016/j.jinf.2005.01.013; PIANTADOSI S, 1988, AM J EPIDEMIOL, V127, P893, DOI 10.1093/oxfordjournals.aje.a114892; Pollard AJ, 2007, ARCH DIS CHILD, V92, P283, DOI 10.1136/adc.2006.102384; Ramsay M, 1997, COMMUN DIS REP CDR R, V7, pR49; Ramsay ME, 2001, LANCET, V357, P195, DOI 10.1016/S0140-6736(00)03594-7; Rolleston H, 1919, LANCET, V1, P541; Stuart J M, 1997, Commun Dis Rep CDR Rev, V7, pR3; Thorburn K, 2001, ARCH DIS CHILD, V85, P382, DOI 10.1136/adc.85.5.382; Townsend PP., 1988, HLTH DEPRIVATION INE; Williams CJ, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-30	24	11	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25957	10.1371/journal.pone.0025957	http://dx.doi.org/10.1371/journal.pone.0025957			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22016791	Green Published, gold, Green Accepted			2022-12-27	WOS:000295970300041
J	Moumen, A; Virard, I; Raoul, C				Moumen, Anice; Virard, Isabelle; Raoul, Cedric			Accumulation of Wildtype and ALS-Linked Mutated VAPB Impairs Activity of the Proteasome	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURON DISEASE; ENDOPLASMIC-RETICULUM; ER STRESS; LIVING CELLS; PROTEIN AGGREGATION; QUALITY-CONTROL; MOUSE MODEL; MUTANT; UBIQUITIN	Cellular homeostasis relies on a tight control of protein synthesis, folding and degradation, in which the endoplasmic reticulum (ER) quality control and the ubiquitin proteasome system (UPS) have an instrumental function. ER stress and aberrant accumulation of misfolded proteins represent a pathological signature of amyotrophic lateral sclerosis (ALS), a fatal paralytic disorder caused by the selective degeneration of motoneurons in the brain and spinal cord. Mutations in the ER-resident protein VAPB have been associated with familial forms of the disease. ALS-linked mutations cause VAPB to form cytoplasmic aggregates. We previously demonstrated that viral-mediated expression of both wildtype and mutant human VAPB (hVAPB) leads to an ER stress response that contributes to the selective death of motoneurons. However, the mechanisms behind ER stress, defective UPS and hVAPB-associated motoneuron degeneration remain elusive. Here, we show that the overexpression of wildtype and mutated hVAPB, which is found to be less stable than the wildtype protein, leads to the abnormal accumulation of ubiquitin and ubiquitin-like protein conjugates in non-human primate cells. We observed that overexpression of both forms of hVAPB elicited an ER stress response. Treatment of wildtype and mutated hVAPB expressing cells with the ER stress inhibitor salubrinal diminished the burden of ubiquitinated proteins, suggesting that ER stress contributes to the impairment of proteasome function. We also found that both wildtype and mutated hVAPB can associate with the 20S proteasome, which was found to accumulate at the ER with wildtype hVAPB or in mutant hVAPB aggregates. Our results suggest that ER stress and corruption of the proteasome function might contribute to the aberrant protein homeostasis associated with hVAPB.	[Moumen, Anice; Virard, Isabelle; Raoul, Cedric] INMED, Mediterranean Inst Neurobiol, Inserm Avenir Team, Marseille, France; [Moumen, Anice; Virard, Isabelle; Raoul, Cedric] Univ Aix Marseille 2, UMR Aix Marseille 2 S901, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Moumen, A (corresponding author), INMED, Mediterranean Inst Neurobiol, Inserm Avenir Team, Marseille, France.	cedric.raoul@inserm.fr	Raoul, Cedric/H-6517-2016	Raoul, Cedric/0000-0003-0561-6851; Virard, Isabelle/0000-0002-3980-0078	Institut National de la Sante et de la Recherche Medicale (INSERM); Association Francaise contre les Myopathies (AFM); American ALS Association (ALSA); Conseil General des Bouches-du-Rhone	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); American ALS Association (ALSA); Conseil General des Bouches-du-Rhone(Region Provence-Alpes-Cote d'Azur)	This work was supported by grants from the Institut National de la Sante et de la Recherche Medicale (INSERM), the Association Francaise contre les Myopathies (AFM), the American ALS Association (ALSA) and the Conseil General des Bouches-du-Rhone. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebischer J, 2011, CELL DEATH DIFFER, V18, P754, DOI 10.1038/cdd.2010.143; Amarilio R, 2005, J BIOL CHEM, V280, P5934, DOI 10.1074/jbc.M409566200; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Chen HJ, 2010, J BIOL CHEM, V285, P40266, DOI 10.1074/jbc.M110.161398; Cheroni C, 2005, NEUROBIOL DIS, V18, P509, DOI 10.1016/j.nbd.2004.12.007; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; Deng HX, 2010, ANN NEUROL, V67, P739, DOI 10.1002/ana.22051; Diestel S, 2007, J CELL SCI, V120, P4035, DOI 10.1242/jcs.019729; Fan JQ, 1999, NAT MED, V5, P112, DOI 10.1038/4801; Fasana E, 2010, FASEB J, V24, P1419, DOI 10.1096/fj.09-147850; Fricke B, 2007, EMBO REP, V8, P1170, DOI 10.1038/sj.embor.7401091; GKOGKAS C, 2008, HUM MOL GENET; Gkogkas C, 2011, J NEUROCHEM, V117, P286, DOI 10.1111/j.1471-4159.2011.07201.x; Hipp MS, 2005, MOL CELL BIOL, V25, P3483, DOI 10.1128/MCB.25.9.3483-3491.2005; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Jung T, 2008, IUBMB LIFE, V60, P743, DOI 10.1002/iub.114; Kabashi E, 2004, J NEUROCHEM, V89, P1325, DOI 10.1111/j.1471-4159.2004.02453.x; Kabuta T, 2006, J BIOL CHEM, V281, P30524, DOI 10.1074/jbc.M603337200; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kanekura K, 2006, J BIOL CHEM, V281, P30223, DOI 10.1074/jbc.M605049200; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; Langou K, 2010, J NEUROCHEM, V114, P795, DOI 10.1111/j.1471-4159.2010.06806.x; Lev S, 2008, TRENDS CELL BIOL, V18, P282, DOI 10.1016/j.tcb.2008.03.006; Majoul I, 2001, DEV CELL, V1, P139, DOI 10.1016/S1534-5807(01)00004-1; Matias AC, 2010, BIOCHEM SOC T, V38, P29, DOI 10.1042/BST0380029; Mendonca DMF, 2006, NEUROSCI LETT, V404, P315, DOI 10.1016/j.neulet.2006.06.009; Menendez-Benito V, 2005, HUM MOL GENET, V14, P2787, DOI 10.1093/hmg/ddi312; Nalivaeva NN, 2008, CURR ALZHEIMER RES, V5, P212, DOI 10.2174/156720508783954785; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Nishitoh H, 2008, GENE DEV, V22, P1451, DOI 10.1101/gad.1640108; Peretti D, 2008, MOL BIOL CELL, V19, P3871, DOI 10.1091/mbc.E08-05-0498; Perroy J, 2004, NAT METHODS, V1, P203, DOI 10.1038/NMETH722; Piao YS, 2003, BRAIN PATHOL, V13, P10; Prosser DC, 2008, J CELL SCI, V121, P3052, DOI 10.1242/jcs.028696; Rao SNR, 2010, HUM MOL GENET, V19, P4726, DOI 10.1093/hmg/ddq407; Raoul C, 2005, NAT MED, V11, P423, DOI 10.1038/nm1207; Saxena S, 2009, NAT NEUROSCI, V12, P627, DOI 10.1038/nn.2297; Schafer MKE, 2010, NEUROBIOL DIS, V40, P222, DOI 10.1016/j.nbd.2010.05.029; Scheper W, 2009, CURR MED CHEM, V16, P615, DOI 10.2174/092986709787458506; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; Soussan L, 1999, J CELL BIOL, V146, P301, DOI 10.1083/jcb.146.2.301; Strong MJ, 2005, J NEUROPATH EXP NEUR, V64, P649, DOI 10.1097/01.jnen.0000173889.71434.ea; Suzuki H, 2009, J NEUROCHEM, V108, P973, DOI [10.1111/j.1471-4159.2008.05857.x, 10.1111/j.0022-3042.2008.05857.x]; Tagawa A, 2007, ACTA NEUROPATHOL, V113, P205, DOI 10.1007/s00401-006-0151-z; Teuling E, 2007, J NEUROSCI, V27, P9801, DOI 10.1523/JNEUROSCI.2661-07.2007; Tudor EL, 2010, NEUROSCIENCE, V167, P774, DOI 10.1016/j.neuroscience.2010.02.035; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang XZ, 1996, MOL CELL BIOL, V16, P4273; Watanabe M, 2001, NEUROBIOL DIS, V8, P933, DOI 10.1006/nbdi.2001.0443; Watson P, 2005, NAT CELL BIOL, V7, P48, DOI 10.1038/ncb1206; Wood JD, 2003, NEUROPATH APPL NEURO, V29, P529, DOI 10.1046/j.0305-1846.2003.00518.x; Yang M, 1998, J EXP MED, V187, P835, DOI 10.1084/jem.187.6.835	58	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e26066	10.1371/journal.pone.0026066	http://dx.doi.org/10.1371/journal.pone.0026066			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998752	Green Published, Green Submitted, gold			2022-12-27	WOS:000295966900093
J	Muto, J; Naidu, NN; Yamasaki, K; Pineau, N; Breton, L; Gallo, RL				Muto, Jun; Naidu, Nandita Natasha; Yamasaki, Kenshi; Pineau, Nathalie; Breton, Lionel; Gallo, Richard L.			Exogenous Addition of a C-Xylopyranoside Derivative Stimulates Keratinocyte Dermatan Sulfate Synthesis and Promotes Migration	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; HEPARAN-SULFATE; SEQUENCE; OLIGOSACCHARIDES; BIOSYNTHESIS; PROTEOGLYCAN; FGFR2-IIIB; RECEPTORS; BINDING; FGF10	As C-Xyloside has been suggested to be an initiator of glycosaminoglycan (GAG) synthesis, and GAGs such as Dermatan sulfate (DS) are potent enhancers of fibroblast growth factor (FGF) - 10 action, we investigated if a C-Xylopyranoside derivative, (C-beta-D-xylopyranoside-2-hydroxy-propane, C-Xyloside), could promote DS production by cultured normal human keratinocytes, how this occurs and if C-Xyloside could also stimulate FGF-dependent cell migration and proliferation. C-Xyloside-treated keratinocytes greatly increased secretion of total sulfated GAGs. Majority of the induced GAG was chondroitin sulfate/dermatan sulfate (CS/DS) of which the major secreted GAG was DS. Cells lacking xylosyltransferase enzymatic activity demonstrated that C-Xyloside was able to stimulate GAG synthesis without addition to core proteins. Consistent with the observed increase in DS, keratinocytes treated with C-Xyloside showed enhanced migration in response to FGF-10 and secreted into their culture media GAGs that promoted FGF-10-dependent cellular proliferation. These results indicate that C-Xyloside may enhance epithelial repair by serving as an initiator of DS synthesis.	[Muto, Jun; Yamasaki, Kenshi; Gallo, Richard L.] Univ Calif San Diego, Div Dermatol, San Diego, CA 92103 USA; [Muto, Jun; Yamasaki, Kenshi; Gallo, Richard L.] Vet Affairs San Diego Hlth Care Syst, San Diego, CA USA; [Pineau, Nathalie; Breton, Lionel] LOreal Rech, Clichy, France	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; L'Oreal Group	Muto, J (corresponding author), Univ Calif San Diego, Div Dermatol, San Diego, CA 92103 USA.	rgallo@ucsd.edu	Gallo, Richard L/A-8931-2009; Yamasaki, Kenshi/C-8905-2018	Gallo, Richard L/0000-0002-1401-7861; Yamasaki, Kenshi/0000-0002-5495-4956	L'Oreal; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107150] Funding Source: NIH RePORTER	L'Oreal(L'Oreal Group); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by an investigator initiated grant from L'Oreal. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHIKARI S, 1995, J BIOL CHEM, V270, P29586, DOI 10.1074/jbc.270.49.29586; Bechard D, 2001, J BIOL CHEM, V276, P48341, DOI 10.1074/jbc.M108395200; Cha D, 1996, J INVEST DERMATOL, V106, P590, DOI 10.1111/1523-1747.ep12345083; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Eswarakumar VP, 2002, DEVELOPMENT, V129, P3783; FRITZ TA, 1994, J BIOL CHEM, V269, P300; Komi-Kuramochi A, 2005, J ENDOCRINOL, V186, P273, DOI 10.1677/joe.1.06055; Lawrence R, 2008, J BIOL CHEM, V283, P33674, DOI 10.1074/jbc.M804288200; Lawrence R, 2008, NAT METHODS, V5, P291, DOI 10.1038/nmeth0408-291; Lee PHA, 2004, J BIOL CHEM, V279, P48640, DOI 10.1074/jbc.M407241200; Lyon M, 1998, J BIOL CHEM, V273, P271, DOI 10.1074/jbc.273.1.271; MACCARANA M, 1993, J BIOL CHEM, V268, P23898; Marguerie A, 2006, CARDIOVASC RES, V71, P50, DOI 10.1016/j.cardiores.2006.03.021; Penc SF, 1998, J BIOL CHEM, V273, P28116, DOI 10.1074/jbc.273.43.28116; Petiot A, 2003, DEVELOPMENT, V130, P5493, DOI 10.1242/dev.00788; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; Radek KA, 2009, WOUND REPAIR REGEN, V17, P118, DOI 10.1111/j.1524-475X.2008.00449.x; Revest JM, 2001, J IMMUNOL, V167, P1954, DOI 10.4049/jimmunol.167.4.1954; Revest JM, 2001, DEV BIOL, V231, P47, DOI 10.1006/dbio.2000.0144; Sakai S, 2002, ANAL BIOCHEM, V302, P169, DOI 10.1006/abio.2001.5545; Taylor KR, 2005, J BIOL CHEM, V280, P5300, DOI 10.1074/jbc.m410412200; Trowbridge JM, 2002, J BIOL CHEM, V277, P42815, DOI 10.1074/jbc.M204959200; TURNBULL JE, 1992, J BIOL CHEM, V267, P10337	23	15	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2011	6	10							e25480	10.1371/journal.pone.0025480	http://dx.doi.org/10.1371/journal.pone.0025480			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834NA	21998662	Green Published, Green Submitted, gold			2022-12-27	WOS:000295966900029
J	King, CM; Hentges, ST				King, Connie M.; Hentges, Shane T.			Relative Number and Distribution of Murine Hypothalamic Proopiomelanocortin Neurons Innervating Distinct Target Sites	PLOS ONE			English	Article							MELANOCYTE-STIMULATING HORMONE; NUCLEUS TRACTUS SOLITARIUS; RAT ARCUATE NUCLEUS; BETA-ENDORPHIN; ALPHA-MSH; PARAVENTRICULAR NUCLEUS; GENE-EXPRESSION; FOOD-INTAKE; BRAIN-STEM; MELANOCORTIN RECEPTOR	Proopiomelanocortin (POMC) neurons send projections widely throughout the brain consistent with their role in regulating numerous homeostatic processes and mediating analgesia and reward. Recent data suggest that POMC neurons located in the rostral and caudal extents of the arcuate nucleus of the hypothalamus may mediate selective actions, however it is not clear if POMC neurons in these regions of the arcuate nucleus innervate specific target sites. In the present study, fluorescent microspheres and cholera toxin B were used to retrogradely label POMC neurons in POMC-DsRed transgenic mice. The number and location of POMC cells projecting to the supraoptic nucleus, periaqueductal gray, ventral tegmental area, paraventricular nucleus, lateral hypothalamic nucleus, amygdala and the dosal vagal complex was determined. Tracer injected unilaterally labeled POMC neurons in both sides of the arcuate nucleus. While the total number of retrogradely labeled cells in the arcuate nucleus varied by injection site, less than 10% of POMC neurons were labeled with tracer injected into any target area. Limited target sites appear to be preferentially innervated by POMC neurons that reside in the rostral or caudal extremes of the arcuate nucleus, whereas the majority of target sites are innervated by diffusely distributed POMC neurons. The modest number of cells projecting to each target site indicates that relatively few POMC neurons may mediate potent and specific physiologic responses and therefore disturbed signaling in a very few POMC neurons may have significant consequences.	[King, Connie M.; Hentges, Shane T.] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA	Colorado State University	King, CM (corresponding author), Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA.	hentgess@colostate.edu	Hentges, Shane T/B-9747-2012		National Institutes of Health [R01DK0798749]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a grant from the National Institutes of Health (R01DK0798749 to STH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelucci A, 1996, J NEUROSCI METH, V65, P101, DOI 10.1016/0165-0270(95)00155-7; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Barna I, 1997, BRAIN RES BULL, V42, P353, DOI 10.1016/S0361-9230(96)00298-5; BASBAUM AI, 1984, ANNU REV NEUROSCI, V7, P309, DOI 10.1146/annurev.ne.07.030184.001521; Boghossian S, 2010, AM J PHYSIOL-REG I, V298, pR385, DOI 10.1152/ajpregu.00591.2009; BUNEL DT, 1990, BRAIN RES, V513, P299, DOI 10.1016/0006-8993(90)90471-M; Caquineau C, 2006, J NEUROENDOCRINOL, V18, P685, DOI 10.1111/j.1365-2826.2006.01465.x; CHEUNG S, 1995, NEUROENDOCRINOLOGY, V62, P283, DOI 10.1159/000127015; CHOWENBREED JA, 1989, ENDOCRINOLOGY, V124, P2875, DOI 10.1210/endo-124-6-2875; CHRONWALL BM, 1985, PEPTIDES, V6, P1, DOI 10.1016/0196-9781(85)90128-7; Coll AP, 2007, CLIN SCI, V113, P171, DOI 10.1042/CS20070105; Collin M, 2003, EUR J NEUROSCI, V18, P1265, DOI 10.1046/j.1460-9568.2003.02840.x; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Cowley MA, 1999, NEURON, V24, P155, DOI 10.1016/S0896-6273(00)80829-6; DENNIS M, 1983, LIFE SCI, V33, P49, DOI 10.1016/0024-3205(83)90441-1; Douglas AJ, 2002, J NEUROENDOCRINOL, V14, P768, DOI 10.1046/j.1365-2826.2002.00837.x; Elias CF, 1999, NEURON, V23, P775, DOI 10.1016/S0896-6273(01)80035-0; Elias CF, 1998, J COMP NEUROL, V402, P442, DOI 10.1002/(SICI)1096-9861(19981228)402:4<442::AID-CNE2>3.0.CO;2-R; Ellacott KLJ, 2006, ENDOCRINOLOGY, V147, P3190, DOI 10.1210/en.2005-0877; Elmquist JK, 2001, PHYSIOL BEHAV, V74, P703, DOI 10.1016/S0031-9384(01)00613-8; ESKAY RL, 1979, BRAIN RES, V178, P55, DOI 10.1016/0006-8993(79)90087-8; Fekete C, 2000, J NEUROSCI, V20, P1550; FINLEY JCW, 1981, NEUROENDOCRINOLOGY, V33, P28, DOI 10.1159/000123197; GANTZ I, 1993, J BIOL CHEM, V268, P15174; Hahn JD, 2010, BRAIN RES REV, V64, P14, DOI 10.1016/j.brainresrev.2010.02.002; Hentges ST, 2009, J NEUROSCI, V29, P13684, DOI 10.1523/JNEUROSCI.3770-09.2009; Hentges ST, 2004, J NEUROSCI, V24, P1578, DOI 10.1523/JNEUROSCI.3952-03.2004; HUGHES AM, 1987, NEUROSCIENCE, V23, P1063, DOI 10.1016/0306-4522(87)90181-3; Huo LH, 2006, DIABETES, V55, P567, DOI 10.2337/diabetes.55.03.06.db05-1143; Ibrahim N, 2003, ENDOCRINOLOGY, V144, P1331, DOI 10.1210/en.2002-221033; JOSEPH SA, 1983, NEUROSCI LETT, V38, P221, DOI 10.1016/0304-3940(83)90372-5; JOSEPH SA, 1988, PEPTIDES, V9, P193, DOI 10.1016/0196-9781(88)90027-7; KAPCALA LP, 1986, BRAIN RES, V364, P350, DOI 10.1016/0006-8993(86)90847-4; Kask A, 2000, BRAIN RES, V887, P460, DOI 10.1016/S0006-8993(00)03034-1; KISS JZ, 1984, BRAIN RES, V324, P91, DOI 10.1016/0006-8993(84)90625-5; Klusa V, 1998, NEUROPEPTIDES, V32, P573, DOI 10.1016/S0143-4179(98)90088-9; Kokare DM, 2010, NEUROPHARMACOLOGY, V58, P1009, DOI 10.1016/j.neuropharm.2010.01.006; LAM MP, 2011, PSYCHOPHARMACOLOGY B; Li SJ, 1996, J NEUROSCI, V16, P5182; Lindblom J, 2001, NEUROREPORT, V12, P2155, DOI 10.1097/00001756-200107200-00022; LUPPI PH, 1987, BRAIN RES, V402, P339, DOI 10.1016/0006-8993(87)90041-2; Maolood N, 2010, J NEUROENDOCRINOL, V22, P75, DOI 10.1111/j.1365-2826.2009.01946.x; Meister B, 2007, PHYSIOL BEHAV, V92, P263, DOI 10.1016/j.physbeh.2007.05.021; Meister B, 2006, EUR J NEUROSCI, V24, P2731, DOI 10.1111/j.1460-9568.2006.05157.x; MILLINGTON WR, 1984, PEPTIDES, V5, P841, DOI 10.1016/0196-9781(84)90033-0; MOUNTJOY KG, 1994, MOL ENDOCRINOL, V8, P1298, DOI 10.1210/me.8.10.1298; Munzberg H, 2003, ENDOCRINOLOGY, V144, P2121, DOI 10.1210/en.2002-221037; ODONOHUE TL, 1979, BRAIN RES, V176, P101, DOI 10.1016/0006-8993(79)90873-4; ODONOHUE TL, 1982, PEPTIDES, V3, P353, DOI 10.1016/0196-9781(82)90098-5; Ohgami Y, 2010, BRAIN RES, V1366, P38, DOI 10.1016/j.brainres.2010.10.010; Palkovits M, 1999, FRONT NEUROENDOCRIN, V20, P270, DOI 10.1006/frne.1999.0186; PALKOVITS M, 1987, NEUROPEPTIDES, V9, P123, DOI 10.1016/0143-4179(87)90051-5; PELLETIER G, 1993, ANN NY ACAD SCI, V680, P246, DOI 10.1111/j.1749-6632.1993.tb19688.x; Pennock RL, 2011, J NEUROSCI, V31, P281, DOI 10.1523/JNEUROSCI.4654-10.2011; Priest CA, 2000, NEUROENDOCRINOLOGY, V72, P293, DOI 10.1159/000054598; Rossi J, 2011, CELL METAB, V13, P195, DOI 10.1016/j.cmet.2011.01.010; Roth-Deri I, 2008, PROG NEUROBIOL, V86, P1, DOI 10.1016/j.pneurobio.2008.06.003; Rubinstein M, 1996, P NATL ACAD SCI USA, V93, P3995, DOI 10.1073/pnas.93.9.3995; Sabatier N, 2003, J NEUROSCI, V23, P10351; Vercelli A, 2000, BRAIN RES BULL, V51, P11, DOI 10.1016/S0361-9230(99)00229-4; Vrang N, 1999, J Neurosci, V19, pRC5; Williams DL, 2000, ENDOCRINOLOGY, V141, P1332, DOI 10.1210/en.141.4.1332; Williams KW, 2010, J NEUROSCI, V30, P2472, DOI 10.1523/JNEUROSCI.3118-09.2010; Yang J, 2007, REGUL PEPTIDES, V142, P29, DOI 10.1016/j.regpep.2007.01.006; Ye ZY, 2011, REGUL PEPTIDES, V166, P112, DOI 10.1016/j.regpep.2010.10.001; YOSHIDA M, 1988, ARCH HISTOL CYTOL, V51, P175, DOI 10.1679/aohc.51.175; Zheng HY, 2010, AM J PHYSIOL-REG I, V298, pR720, DOI 10.1152/ajpregu.00619.2009; Zheng HY, 2005, AM J PHYSIOL-REG I, V289, pR247, DOI 10.1152/ajpregu.00869.2004	68	47	48	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e25864	10.1371/journal.pone.0025864	http://dx.doi.org/10.1371/journal.pone.0025864			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21991375	Green Submitted, gold, Green Published			2022-12-27	WOS:000295963300027
J	Wang, MH; Marinotti, O; Vardo-Zalik, A; Boparai, R; Yan, GY				Wang, Mei-Hui; Marinotti, Osvaldo; Vardo-Zalik, Anne; Boparai, Rajni; Yan, Guiyun			Genome-Wide Transcriptional Analysis of Genes Associated with Acute Desiccation Stress in Anopheles gambiae	PLOS ONE			English	Article							DRY SEASON; DROSOPHILA-MELANOGASTER; MALARIA TRANSMISSION; DNA-REPAIR; CHROMOSOMAL INVERSION; OXIDATIVE STRESS; PEA APHID; EXPRESSION; ADAPTATION; RESISTANCE	Malaria transmission in sub-Saharan Africa varies seasonally in intensity. Outbreaks of malaria occur after the beginning of the rainy season, whereas, during the dry season, reports of the disease are less frequent. Anopheles gambiae mosquitoes, the main malaria vector, are observed all year long but their densities are low during the dry season that generally lasts several months. Aestivation, seasonal migration, and local adaptation have been suggested as mechanisms that enable mosquito populations to persist through the dry season. Studies of chromosomal inversions have shown that inversions 2La, 2Rb, 2Rc, 2Rd, and 2Ru are associated with various physiological changes that confer aridity resistance. However, little is known about how phenotypic plasticity responds to seasonally dry conditions. This study examined the effects of desiccation stress on transcriptional regulation in An. gambiae. We exposed female An. gambiae G3 mosquitoes to acute desiccation and conducted a genome-wide analysis of their transcriptomes using the Affymetrix Plasmodium/Anopheles Genome Array. The transcription of 248 genes (1.7% of all transcripts) was significantly affected in all experimental conditions, including 96 with increased expression and 152 with decreased expression. In general, the data indicate a reduction in the metabolic rate of mosquitoes exposed to desiccation. Transcripts accumulated at higher levels during desiccation are associated with oxygen radical detoxification, DNA repair and stress responses. The proportion of transcripts within 2La and 2Rs (2Rb, 2Rc, 2Rd, and 2Ru) (67/248, or 27%) is similar to the percentage of transcripts located within these inversions (31%). These data may be useful in efforts to elucidate the role of chromosomal inversions in aridity tolerance. The scope of application of the anopheline genome demonstrates that examining transcriptional activity in relation to genotypic adaptations greatly expands the number of candidate regions involved in the desiccation response in this important malaria vector.	[Wang, Mei-Hui; Boparai, Rajni; Yan, Guiyun] Univ Calif Irvine, Program Publ Hlth, Irvine, CA 92717 USA; [Marinotti, Osvaldo] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA; [Vardo-Zalik, Anne] Penn State Univ, Dept Biol, York, PA USA	University of California System; University of California Irvine; University of California System; University of California Irvine; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Wang, MH (corresponding author), Univ Calif Irvine, Program Publ Hlth, Irvine, CA 92717 USA.	meihuiw@uci.edu		Marinotti, Osvaldo/0000-0002-7173-7160	National Institutes of Health [R01 AI050243, R21 AI078463]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050243, R21AI078463] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research is supported by grants from the National Institutes of Health (R01 AI050243 and R21 AI078463). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrane YA, 2006, AM J TROP MED HYG, V74, P772, DOI 10.4269/ajtmh.2006.74.772; [Anonymous], 2008, WORLD MAL REP 2008; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benoit JB, 2007, J EXP BIOL, V210, P217, DOI 10.1242/jeb.02630; Benoit JB, 2010, J INSECT PHYSIOL, V56, P151, DOI 10.1016/j.jinsphys.2009.09.012; Boubriak I, 1997, SEED SCI RES, V7, P97, DOI 10.1017/S0960258500003433; Boubriak II, 2008, ANN BOT-LONDON, V101, P267, DOI 10.1093/aob/mcm276; CHARLWOOD JD, 1995, B ENTOMOL RES, V85, P37, DOI 10.1017/S0007485300051993; Charlwood JD, 2000, AM J TROP MED HYG, V62, P726, DOI 10.4269/ajtmh.2000.62.726; Colinet H, 2010, FEBS J, V277, P174, DOI 10.1111/j.1742-4658.2009.07470.x; Coluzzi M, 2002, SCIENCE, V298, P1415, DOI 10.1126/science.1077769; COLUZZI M, 1979, T ROY SOC TROP MED H, V73, P483, DOI 10.1016/0035-9203(79)90036-1; Cortes T, 2008, GENE, V408, P146, DOI 10.1016/j.gene.2007.10.030; CREWSOYEN AE, 1993, AM J TROP MED HYG, V49, P341, DOI 10.4269/ajtmh.1993.49.341; Djawdan M, 1998, PHYSIOL ZOOL, V71, P584, DOI 10.1086/515963; Dobzhansky T, 1970, GENETICS EVOLUTIONAR; Franca MB, 2007, COMP BIOCHEM PHYS A, V146, P621, DOI 10.1016/j.cbpa.2006.02.030; Gray EM, 2005, AM J TROP MED HYG, V73, P553, DOI 10.4269/ajtmh.2005.73.553; Gray EM, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-215; HADLEY NF, 1979, SCIENCE, V203, P367, DOI 10.1126/science.203.4378.367; Hamad AA, 2000, PARASITOLOGY, V120, P447, DOI 10.1017/S0031182099005818; Hansen JM, 2006, ANNU REV PHARMACOL, V46, P215, DOI 10.1146/annurev.pharmtox.46.120604.141122; Hoepfner D, 2005, CELL, V122, P85, DOI 10.1016/j.cell.2005.04.025; Hoffmann AA, 2004, TRENDS ECOL EVOL, V19, P482, DOI 10.1016/j.tree.2004.06.013; Huang ZY, 2008, ANN BOT-LONDON, V101, P277, DOI 10.1093/aob/mcm089; Ibrahima B, 2010, PLOS ONE, V5; Ito C, 2008, P NATL ACAD SCI USA, V105, P8446, DOI 10.1073/pnas.0800145105; Jawara M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-156; Katoh H, 2004, MICROB ECOL, V47, P164, DOI 10.1007/s00248-003-1043-6; Kirkpatrick M, 2006, GENETICS, V173, P419, DOI 10.1534/genetics.105.047985; Le Trionnaire G, 2007, INSECT BIOCHEM MOLEC, V37, P1094, DOI 10.1016/j.ibmb.2007.06.008; Le Trionnaire G, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-456; Lehmann T, 1998, MOL BIOL EVOL, V15, P264, DOI 10.1093/oxfordjournals.molbev.a025923; Lehmann T, 2010, AM J TROP MED HYG, V83, P601, DOI 10.4269/ajtmh.2010.09-0779; Lighton JRB, 1996, ANNU REV ENTOMOL, V41, P309, DOI 10.1146/annurev.en.41.010196.001521; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lupu A, 2004, MUTAGENESIS, V19, P383, DOI 10.1093/mutage/geh045; Mahajan A, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.151re12; Marinotti O, 2006, INSECT MOL BIOL, V15, P1, DOI 10.1111/j.1365-2583.2006.00610.x; Midega JT, 2007, J MED ENTOMOL, V44, P923, DOI 10.1603/0022-2585(2007)44[923:EDASOA]2.0.CO;2; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Morris ER, 2006, PLANT PHYSIOL, V141, P932, DOI 10.1104/pp.106.076893; OMER SM, 1968, NATURE, V217, P879, DOI 10.1038/217879b0; OMER SM, 1970, B WORLD HEALTH ORGAN, V42, P319; Paaijmans KP, 2010, P NATL ACAD SCI USA, V107, P15135, DOI 10.1073/pnas.1006422107; Paaijmans KP, 2009, P NATL ACAD SCI USA, V106, P13844, DOI 10.1073/pnas.0903423106; Parham PE, 2010, ADV EXP MED BIOL, V673, P184; Perez-Ortin JE, 2002, GENOME RES, V12, P1533, DOI 10.1101/gr.436602; Puig M, 2004, P NATL ACAD SCI USA, V101, P9013, DOI 10.1073/pnas.0403090101; REBERS JE, 1988, J MOL BIOL, V203, P411, DOI 10.1016/0022-2836(88)90009-5; Ribeiro JMC, 2004, INSECT MOL BIOL, V13, P449, DOI 10.1111/j.0962-1075.2004.00503.x; Sama W, 2006, PARASITOLOGY, V132, P13, DOI 10.1017/S0031182005008607; Sharakhova MV, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-91; Somvanshi VS, 2008, MOL BIOCHEM PARASIT, V158, P65, DOI 10.1016/j.molbiopara.2007.11.012; Toure Y. T., 1998, Parassitologia (Rome), V40, P477; Venn J, 1880, LONDON EDINBURGH DUB, V10, P1, DOI [DOI 10.1080/14786448008626877, 10.1080/14786448008626877]; Wang MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013359; Watanabe M, 2006, APPL ENTOMOL ZOOL, V41, P15, DOI 10.1303/aez.2006.15; White BJ, 2009, GENETICS, V183, P275, DOI 10.1534/genetics.109.105817; White BJ, 2007, PLOS GENET, V3, P2404, DOI 10.1371/journal.pgen.0030217; Willis J.H., 2005, P79; Xia A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010592; Yakob L, 2010, T ROY SOC TROP MED H, V104, P669, DOI 10.1016/j.trstmh.2010.07.014; Yoshida H, 2009, IUBMB LIFE, V61, P871, DOI 10.1002/iub.229	64	13	13	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2011	6	10							e26011	10.1371/journal.pone.0026011	http://dx.doi.org/10.1371/journal.pone.0026011			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834MB	21991392	Green Published, gold			2022-12-27	WOS:000295963300033
J	El-Kassaby, YA; Cappa, EP; Liewlaksaneeyanawin, C; Klapste, J; Lstiburek, M				El-Kassaby, Yousry A.; Cappa, Eduardo P.; Liewlaksaneeyanawin, Cherdsak; Klapste, Jaroslav; Lstiburek, Milan			Breeding without Breeding: Is a Complete Pedigree Necessary for Efficient Breeding?	PLOS ONE			English	Article							QUANTITATIVE INHERITANCE; MICROSATELLITE LOCI; INFERENCES; SUCCESS; PROGENY; COEFFICIENTS; MARKERS	Complete pedigree information is a prerequisite for modern breeding and the ranking of parents and offspring for selection and deployment decisions. DNA fingerprinting and pedigree reconstruction can substitute for artificial matings, by allowing parentage delineation of naturally produced offspring. Here, we report on the efficacy of a breeding concept called 'Breeding without Breeding" (BwB) that circumvents artificial matings, focusing instead on a subset of randomly sampled, maternally known but paternally unknown offspring to delineate their paternal parentage. We then generate the information needed to rank those offspring and their paternal parents, using a combination of complete (full-sib: FS) and incomplete (half-sib: HS) analyses of the constructed pedigrees. Using a random sample of wind-pollinated offspring from 15 females (seed donors), growing in a 41-parent western larch population, BwB is evaluated and compared to two commonly used testing methods that rely on either incomplete (maternal half-sib, open-pollinated: OP) or complete (FS) pedigree designs. BwB produced results superior to those from the incomplete design and virtually identical to those from the complete pedigree methods. The combined use of complete and incomplete pedigree information permitted evaluating all parents, both maternal and paternal, as well as all offspring, a result that could not have been accomplished with either the OP or FS methods alone. We also discuss the optimum experimental setting, in terms of the proportion of fingerprinted offspring, the size of the assembled maternal and paternal half-sib families, the role of external gene flow, and selfing, as well as the number of parents that could be realistically tested with BwB.	[El-Kassaby, Yousry A.; Liewlaksaneeyanawin, Cherdsak; Klapste, Jaroslav] Univ British Columbia, Dept Forest Sci, Fac Forestry, Vancouver, BC V6T 1W5, Canada; [Cappa, Eduardo P.] Inst Recursos Biol, INTA, Buenos Aires, DF, Argentina; [Lstiburek, Milan] Czech Univ Life Sci Prague, Dept Dendrol & Forest Tree Breeding, Fac Forestry & Wood Sci, Prague, Czech Republic	University of British Columbia; Instituto Nacional de Tecnologia Agropecuaria (INTA); Czech University of Life Sciences Prague	El-Kassaby, YA (corresponding author), Univ British Columbia, Dept Forest Sci, Fac Forestry, Vancouver, BC V6T 1W5, Canada.	y.el-kassaby@ubc.ca	Klapste, Jaroslav/B-6668-2016; Lstiburek, Milan/G-5669-2010; Lstiburek, Milan/AAE-4280-2022; El-Kassaby, Yousry A/K-9856-2016	Klapste, Jaroslav/0000-0001-5504-3735; Lstiburek, Milan/0000-0002-6304-6669; Lstiburek, Milan/0000-0002-6304-6669; El-Kassaby, Yousry A/0000-0002-4887-8977	Natural Sciences and Engineering Research Council of Canada; Johnson's Family Forest Biotechnology Endowment	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Johnson's Family Forest Biotechnology Endowment	This study is supported by the Natural Sciences and Engineering Research Council of Canada - Discovery and IRC Grants and the Johnson's Family Forest Biotechnology Endowment to YAE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard RW, PRINCIPLES PLANT BRE; ASKEW GR, 1994, THEOR APPL GENET, V88, P267, DOI 10.1007/BF00225908; BURDON R D, 1971, New Zealand Journal of Forestry Science, V1, P174; Cappa EP, 2011, SILVAE GENET, V60, P25, DOI 10.1515/sg-2011-0004; Chen C, 2009, MOL ECOL RESOUR, V9, P843, DOI 10.1111/j.1755-0998.2008.02289.x; COTTERILL PP, 1986, SILVAE GENET, V35, P212; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; Doerksen TK, 2010, TREE GENET GENOMES, V6, P591, DOI 10.1007/s11295-010-0274-1; El-Kassaby YA, 2006, LOW INPUT BREEDING G, P43; El-Kassaby YA, 2009, GENET RES, V91, P111, DOI 10.1017/S001667230900007X; ELKASSABY YA, 1993, CAN J FOREST RES, V23, P1096, DOI 10.1139/x93-139; Falconer D., INTRO QUANTITATIVE G, V4th; Funda T, 2011, CAN J FOREST RES, V41, P380, DOI 10.1139/X10-190; Gilmour A. R., ASREML USER GUIDE RE; Gilmour AR, 1995, BIOMETRICS, V51, P1440, DOI 10.2307/2533274; Grattapaglia D, 2004, THEOR APPL GENET, V109, P192, DOI 10.1007/s00122-004-1617-9; Hansen OK, 2010, TREE GENET GENOMES, V6, P345, DOI 10.1007/s11295-009-0253-6; Henderson CR, APPL LINEAR MODELS A; International Seed Testing Association, 1993, SEED SCI TECHNOL S, V21, p1B259; Isoda K, 2006, MOL ECOL NOTES, V6, P664, DOI 10.1111/j.1471-8286.2006.01291.x; Gaspar MJ, 2009, TREE GENET GENOMES, V5, P609, DOI 10.1007/s11295-009-0213-1; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Khasa PD, 2000, GENOME, V43, P439, DOI 10.1139/gen-43-3-439; Lambeth C, 2001, THEOR APPL GENET, V103, P930, DOI 10.1007/s001220100627; Lynch M, GENETICS ANAL QUANTI; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; NAMKOONG G, 1966, FOREST SCI, V12, P8; Namkoong G, TECH B USDA; Namkoong G, MONOGRAPH THEOR APPL, V11; Ritland K, 1996, EVOLUTION, V50, P1074, DOI 10.1111/j.1558-5646.1996.tb02348.x; Ritland K, 1996, EVOLUTION, V50, P1062, DOI [10.2307/2410647, 10.1111/j.1558-5646.1996.tb02347.x]; Ritland K, 2004, FOREST ECOL MANAG, V197, P171, DOI 10.1016/j.foreco.2004.05.012; Ronningen K, WORLD ANIMAL SCI, P187; Squillace A. E., 1974, Silvae Genetica, V23, P149; Stern K, GENETICS FOREST ECOS; WHITE T.L., FOREST GENETICS	36	68	78	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25737	10.1371/journal.pone.0025737	http://dx.doi.org/10.1371/journal.pone.0025737			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991342	Green Published, Green Submitted, gold			2022-12-27	WOS:000295943000061
J	Hoey, AS; Pratchett, MS; Cvitanovic, C				Hoey, Andrew S.; Pratchett, Morgan S.; Cvitanovic, Christopher			High Macroalgal Cover and Low Coral Recruitment Undermines the Potential Resilience of the World's Southernmost Coral Reef Assemblages	PLOS ONE			English	Article							CLIMATE-CHANGE; COMMUNITY STRUCTURE; HERBIVOROUS FISHES; RANGE SHIFTS; PHASE-SHIFTS; PATTERNS; IMPACTS; NORTHWESTERN; MORTALITY; ABUNDANCE	Coral reefs are under increasing pressure from anthropogenic and climate-induced stressors. The ability of reefs to reassemble and regenerate after disturbances (i.e., resilience) is largely dependent on the capacity of herbivores to prevent macroalgal expansion, and the replenishment of coral populations through larval recruitment. Currently there is a paucity of this information for higher latitude, subtropical reefs. To assess the potential resilience of the benthic reef assemblages of Lord Howe Island (31 degrees 32'S, 159 degrees 04'E), the worlds' southernmost coral reef, we quantified the benthic composition, densities of juvenile corals (as a proxy for coral recruitment), and herbivorous fish communities. Despite some variation among habitats and sites, benthic communities were dominated by live scleractinian corals (mean cover 37.4%) and fleshy macroalgae (20.9%). Live coral cover was higher than in most other subtropical reefs and directly comparable to lower latitude tropical reefs. Juvenile coral densities (0.8 ind.m(-2)), however, were 5-200 times lower than those reported for tropical reefs. Overall, macroalgal cover was negatively related to the cover of live coral and the density of juvenile corals, but displayed no relationship with herbivorous fish biomass. The biomass of herbivorous fishes was relatively low (204 kg.ha(-1)), and in marked contrast to tropical reefs was dominated by macroalgal browsing species (84.1%) with relatively few grazing species. Despite their extremely low biomass, grazing fishes were positively related to both the density of juvenile corals and the cover of bare substrata, suggesting that they may enhance the recruitment of corals through the provision of suitable settlement sites. Although Lord Howe Islands' reefs are currently coral-dominated, the high macroalgal cover, coupled with limited coral recruitment and low coral growth rates suggest these reefs may be extremely susceptible to future disturbances.	[Hoey, Andrew S.] King Abdullah Univ Sci & Technol, Red Sea Res Ctr, Thuwal, Saudi Arabia; [Hoey, Andrew S.; Pratchett, Morgan S.; Cvitanovic, Christopher] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia	King Abdullah University of Science & Technology; James Cook University	Hoey, AS (corresponding author), King Abdullah Univ Sci & Technol, Red Sea Res Ctr, Thuwal, Saudi Arabia.	andrew.hoey@kaust.edu.sa	Hoey, Andrew S/B-5457-2015; Pratchett, Morgan/AAW-5179-2020; Pratchett, Morgan S/A-9256-2010	Pratchett, Morgan/0000-0002-1862-8459; Pratchett, Morgan S/0000-0002-1862-8459; Cvitanovic, Christopher/0000-0002-2565-3396; Hoey, Andrew/0000-0002-4261-5594	Australian Government Department of Sustainability, Environment, Water, Population and Communities; Australian Research Council Centre of Excellence for Coral Reef Studies	Australian Government Department of Sustainability, Environment, Water, Population and Communities(Australian Government); Australian Research Council Centre of Excellence for Coral Reef Studies(Australian Research Council)	Financial support was provided by the Australian Government Department of Sustainability, Environment, Water, Population and Communities, and the Australian Research Council Centre of Excellence for Coral Reef Studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird AH, 2006, CORAL REEFS, V25, P73, DOI 10.1007/s00338-005-0072-7; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Bellwood DR, 2006, CURR BIOL, V16, P2434, DOI 10.1016/j.cub.2006.10.030; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Burkepile DE, 2006, ECOLOGY, V87, P3128, DOI 10.1890/0012-9658(2006)87[3128:HVNCOM]2.0.CO;2; Carpenter RC, 2006, ECOL LETT, V9, P268, DOI 10.1111/j.1461-0248.2005.00866.x; CARPENTER RC, 1986, ECOL MONOGR, V56, P345, DOI 10.2307/1942551; Cheung WWL, 2009, FISH FISH, V10, P235, DOI 10.1111/j.1467-2979.2008.00315.x; Choat J.H., 1991, P120; Choat JH, 2002, MAR BIOL, V140, P613, DOI 10.1007/s00227-001-0715-3; CHOAT JH, 2006, REPORT ECOLOGICAL SU; Connell JH, 1997, ECOL MONOGR, V67, P461, DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Connolly SR, 2010, ECOLOGY, V91, P3572, DOI 10.1890/10-0143.1; Cvitanovic C, 2009, CORAL REEFS, V28, P127, DOI 10.1007/s00338-008-0433-0; Donner SD, 2005, GLOBAL CHANGE BIOL, V11, P2251, DOI 10.1111/j.1365-2486.2005.01073.x; Edgar GJ, 2010, AQUAT CONSERV, V20, P378, DOI 10.1002/aqc.1075; Emslie MJ, 2010, CORAL REEFS, V29, P705, DOI 10.1007/s00338-010-0619-0; Ferreira CEL, 1998, J FISH BIOL, V53, P222, DOI 10.1006/jfbi.1998.0824; Figueira WF, 2010, GLOBAL CHANGE BIOL, V16, P506, DOI 10.1111/j.1365-2486.2009.01934.x; Floeter SR, 2005, MAR BIOL, V147, P1435, DOI 10.1007/s00227-005-0027-0; Fox RJ, 2007, MAR ECOL PROG SER, V339, P49, DOI 10.3354/meps339049; Friedlander AM, 2007, MAR ECOL PROG SER, V351, P221, DOI 10.3354/meps07112; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Glassom D, 2006, MAR ECOL PROG SER, V318, P111, DOI 10.3354/meps318111; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Greenstein BJ, 2008, GLOBAL CHANGE BIOL, V14, P513, DOI 10.1111/j.1365-2486.2007.01506.x; Harriott VJ, 1999, CORAL REEFS, V18, P281, DOI 10.1007/s003380050195; HARRIOTT VJ, 1995, MAR FRESHWATER RES, V46, P457, DOI 10.1071/MF9950457; HARRIOTT VJ, 1992, CORAL REEFS, V11, P215, DOI 10.1007/BF00301996; HARRIOTT VJ, 1995, AQUAT CONSERV, V5, P179, DOI 10.1002/aqc.3270050303; Harriott VJ, 2002, CORAL REEFS, V21, P83, DOI 10.1007/s00338-001-0201-x; Harrison PL, 2011, CORAL REEFS, V30, P775, DOI 10.1007/s00338-011-0778-7; Hoey AS, 2008, CORAL REEFS, V27, P37, DOI 10.1007/s00338-007-0287-x; Hoey AS, 2010, MAR ECOL PROG SER, V411, P299, DOI 10.3354/meps08660; Hoey AS, 2010, CORAL REEFS, V29, P499, DOI 10.1007/s00338-010-0605-6; Hoey AS, 2011, ECOL LETT, V14, P267, DOI 10.1111/j.1461-0248.2010.01581.x; Hoey AS, 2010, MAR BIOL, V157, P189, DOI 10.1007/s00227-009-1309-8; Hoey AS, 2009, ECOSYSTEMS, V12, P1316, DOI 10.1007/s10021-009-9291-z; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; HUGHES TP, 1987, J EXP MAR BIOL ECOL, V113, P39, DOI 10.1016/0022-0981(87)90081-5; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Johansson CL, 2010, MAR ECOL PROG SER, V414, P65, DOI 10.3354/meps08730; Jompa J, 2002, J EXP MAR BIOL ECOL, V271, P25, DOI 10.1016/S0022-0981(02)00040-0; Kleypas JA, 1999, AM ZOOL, V39, P146; Mumby PJ, 2007, P NATL ACAD SCI USA, V104, P8362, DOI 10.1073/pnas.0702602104; Nugues MM, 2006, MAR ECOL PROG SER, V315, P75, DOI 10.3354/meps315075; Nystrom M, 2008, CORAL REEFS, V27, P795, DOI 10.1007/s00338-008-0426-z; Nystrom M, 2001, ECOSYSTEMS, V4, P406, DOI 10.1007/s10021-001-0019-y; PAYRI CE, 1984, BOT MAR, V27, P327, DOI 10.1515/botm.1984.27.7.327; POLUNIN NVC, 1992, J EXP MAR BIOL ECOL, V164, P1, DOI 10.1016/0022-0981(92)90132-T; Pratchett MS, 2011, CORAL REEFS, V30, P183, DOI 10.1007/s00338-010-0678-2; Precht WF, 2004, FRONT ECOL ENVIRON, V2, P307; Rasher DB, 2010, P NATL ACAD SCI USA, V107, P9683, DOI 10.1073/pnas.0912095107; Riegl B, 2003, CORAL REEFS, V22, P433, DOI 10.1007/s00338-003-0335-0; Riegl B, 2003, INT J EARTH SCI, V92, P520, DOI 10.1007/s00531-003-0328-9; RYLAARSDAM KW, 1983, MAR ECOL PROG SER, V13, P249, DOI 10.3354/meps013249; Schleyer MH, 2008, MAR POLLUT BULL, V56, P493, DOI 10.1016/j.marpolbul.2007.11.011; Sheppard CRC, 2003, NATURE, V425, P294, DOI 10.1038/nature01987; Smith JE, 2001, CORAL REEFS, V19, P332, DOI 10.1007/s003380000124; TRIBBLE GW, 1986, CORAL REEFS, V4, P151, DOI 10.1007/BF00427936; Valentine JP, 2010, CORAL REEFS, V29, P399, DOI 10.1007/s00338-010-0610-9; VERON JEN, 1979, AUST J MAR FRESH RES, V30, P203, DOI 10.1071/MF9790203; Vroom PS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009733; Williams ID, 2001, CORAL REEFS, V19, P358, DOI 10.1007/s003380000121; Wismer S, 2009, MAR ECOL PROG SER, V376, P45, DOI 10.3354/meps07790; Yamano H, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046474	68	84	84	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25824	10.1371/journal.pone.0025824	http://dx.doi.org/10.1371/journal.pone.0025824			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991366	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000295943000082
J	Zhao, K; Blacker, K; Luo, YH; Bryant, B; Jiang, JB				Zhao, Kai; Blacker, Kara; Luo, Yuehao; Bryant, Bruce; Jiang, Jianbo			Perceiving Nasal Patency through Mucosal Cooling Rather than Air Temperature or Nasal Resistance	PLOS ONE			English	Article							TOPOGRAPHICAL DIFFERENCES; TRIGEMINAL SENSITIVITY; SUBJECTIVE MEASURES; FLOW	Adequate perception of nasal airflow (i.e., nasal patency) is an important consideration for patients with nasal sinus diseases. The perception of a lack of nasal patency becomes the primary symptom that drives these patients to seek medical treatment. However, clinical assessment of nasal patency remains a challenge because we lack objective measurements that correlate well with what patients perceive. The current study examined factors that may influence perceived patency, including air temperature, humidity, mucosal cooling, nasal resistance, and trigeminal sensitivity. Forty-four healthy subjects rated nasal patency while sampling air from three facial exposure boxes that were ventilated with untreated room air, cold air, and dry air, respectively. In all conditions, air temperature and relative humidity inside each box were recorded with sensors connected to a computer. Nasal resistance and minimum airway cross-sectional area (MCA) were measured using rhinomanometry and acoustic rhinometry, respectively. General trigeminal sensitivity was assessed through lateralization thresholds to butanol. No significant correlation was found between perceived patency and nasal resistance or MCA. In contrast, air temperature, humidity, and butanol threshold combined significantly contributed to the ratings of patency, with mucosal cooling (heat loss) being the most heavily weighted predictor. Air humidity significantly influences perceived patency, suggesting that mucosal cooling rather than air temperature alone provides the trigeminal sensation that results in perception of patency. The dynamic cooling between the airstream and the mucosal wall may be quantified experimentally or computationally and could potentially lead to a new clinical evaluation tool.	[Zhao, Kai; Blacker, Kara; Luo, Yuehao; Bryant, Bruce; Jiang, Jianbo] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA	Monell Chemical Senses Center	Zhao, K (corresponding author), Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.	kzhao@monell.org	Bianconi, Ginestra/I-5742-2018	Bianconi, Ginestra/0000-0002-3380-887X; Karsai, Marton/0000-0001-5382-8950	 [NIH P50 DC00006760];  [NIH 5R03DC008187]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC008187, P50DC006760] Funding Source: NIH RePORTER	; ; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study is supported in part by a grant to PD (NIH P50 DC00006760) and a grant to KZ (NIH 5R03DC008187). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre RF, 2009, CLIN OTOLARYNGOL, V34, P518, DOI 10.1111/j.1749-4486.2009.02042.x; Cahusac PMB, 2007, NEUROSCIENCE, V148, P489, DOI 10.1016/j.neuroscience.2007.06.018; Clarke JD, 2005, CLIN OTOLARYNGOL, V30, P35, DOI 10.1111/j.1365-2273.2004.00915.x; CLARKE RW, 1994, J LARYNGOL OTOL, V108, P1045, DOI 10.1017/S0022215100128853; CLARKE RW, 1992, CLIN OTOLARYNGOL, V17, P388, DOI 10.1111/j.1365-2273.1992.tb01680.x; Clement P A, 1984, Rhinology, V22, P151; ECCLES R, 1983, J LARYNGOL OTOL, V97, P705, DOI 10.1017/S002221510009486X; Fontanari P, 1996, J APPL PHYSIOL, V81, P1739, DOI 10.1152/jappl.1996.81.4.1739; Inoue T, 2005, PAIN, V117, P193, DOI 10.1016/j.pain.2005.06.012; JONES AS, 1987, CLIN OTOLARYNGOL, V12, P461, DOI 10.1111/j.1365-2273.1987.tb00233.x; Lam DJ, 2006, AM J RHINOL, V20, P463, DOI 10.2500/ajr.2006.20.2940; Lindemann J, 2002, CLIN OTOLARYNGOL, V27, P135, DOI 10.1046/j.1365-2273.2002.00544.x; Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Meusel T, 2010, PAIN, V151, P516, DOI 10.1016/j.pain.2010.08.013; Naftali S, 2005, ANN BIOMED ENG, V33, P545, DOI 10.1007/s10439-005-2513-4; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Rouadi P, 1999, J APPL PHYSIOL, V87, P400, DOI 10.1152/jappl.1999.87.1.400; Scheibe M, 2006, NEUROREPORT, V17, P1417, DOI 10.1097/01.wnr.0000224764.61959.e8; Voets T., 2007, V179, P329; Wrobel BB, 2006, AM J RHINOL, V20, P364, DOI 10.2500/ajr.2006.20.2862; Wysocki CJ, 2003, PERCEPT PSYCHOPHYS, V65, P115, DOI 10.3758/BF03194788; Yogeetha R., 2007, SMJ Singapore Medical Journal, V48, P304; Zhao K, 2004, CHEM SENSES, V29, P365, DOI 10.1093/chemse/bjh033	24	86	89	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e24618	10.1371/journal.pone.0024618	http://dx.doi.org/10.1371/journal.pone.0024618			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22194809	Green Submitted, gold, Green Published			2022-12-27	WOS:000295978600005
J	Tseng, YC; Chen, RD; Lucassen, M; Schmidt, MM; Dringen, R; Abele, D; Hwang, PP				Tseng, Yung-Che; Chen, Ruo-Dong; Lucassen, Magnus; Schmidt, Maike M.; Dringen, Ralf; Abele, Doris; Hwang, Pung-Pung			Exploring Uncoupling Proteins and Antioxidant Mechanisms under Acute Cold Exposure in Brains of Fish	PLOS ONE			English	Article							OXYGEN SPECIES PRODUCTION; OXIDATIVE STRESS; GENE-EXPRESSION; NONSHIVERING THERMOGENESIS; SUPEROXIDE-DISMUTASE; ENERGY-METABOLISM; SKELETAL-MUSCLE; UP-REGULATION; HYPOXIA; ZEBRAFISH	Exposure to fluctuating temperatures accelerates the mitochondrial respiration and increases the formation of mitochondrial reactive oxygen species (ROS) in ectothermic vertebrates including fish. To date, little is known on potential oxidative damage and on protective antioxidative defense mechanisms in the brain of fish under cold shock. In this study, the concentration of cellular protein carbonyls in brain was significantly increased by 38% within 1 h after cold exposure (from 28 degrees C to 18 degrees C) of zebrafish (Danio rerio). In addition, the specific activity of superoxide dismutase (SOD) and the mRNA level of catalase (CAT) were increased after cold exposure by about 60% (6 h) and by 60%-90% (1 and 24 h), respectively, while the specific glutathione content as well as the ratio of glutathione disulfide to glutathione remained constant and at a very low level. In addition, cold exposure increased the protein level of hypoxia-inducible factor (HIF) by about 50% and the mRNA level of the glucose transporter zglut3 in brain by 50%-100%. To test for an involvement of uncoupling proteins (UCPs) in the cold adaptation of zebrafish, five UCP members were annotated and identified (zucp1-5). With the exception of zucp1, the mRNA levels of the other four zucps were significantly increased after cold exposure. In addition, the mRNA levels of four of the fish homologs (zppar) of the peroxisome proliferator-activated receptor (PPAR) were increased after cold exposure. These data suggest that PPARs and UCPs are involved in the alterations observed in zebrafish brain after exposure to 18 degrees C. The observed stimulation of the PPAR-UCP axis may help to prevent oxidative damage and to maintain metabolic balance and cellular homeostasis in the brains of ectothermic zebrafish upon cold exposure.	[Tseng, Yung-Che; Chen, Ruo-Dong; Hwang, Pung-Pung] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Tseng, Yung-Che] Leibniz Inst Marine Sci, IFM GEOMAR, D-24105 Kiel, Germany; [Chen, Ruo-Dong] Natl Taiwan Univ, Inst Zool, Taipei 10764, Taiwan; [Lucassen, Magnus; Abele, Doris] Alfred Wegener Inst Polar & Marine Res, D-2850 Bremerhaven, Germany; [Schmidt, Maike M.; Dringen, Ralf] Univ Bremen, Ctr Biomol Interact Bremen, Bremen, Germany	Academia Sinica - Taiwan; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Academia Sinica - Taiwan; National Taiwan University; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Bremen	Tseng, YC (corresponding author), Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan.	pphwang@gate.sinica.edu.tw	Hwang, Pung-Pung/AEQ-4633-2022; hwang, pp/A-3641-2011; Tseng, Yung-Che/AAE-7509-2022; Lucassen, Magnus/E-8433-2011; Lucassen, Magnus/ABA-8396-2021; Hwang, Pung-Pung/AAH-1538-2022	Tseng, Yung-Che/0000-0001-7489-0403; Lucassen, Magnus/0000-0003-4276-4781; Lucassen, Magnus/0000-0003-4276-4781; Dringen, Ralf/0000-0001-7869-1305; Abele, Doris/0000-0002-5766-5017	Academia Sinica; Alfred-Wegener Institute for Polar and Marine Research; National Science of Council of Taiwan; International Bureau of the Germany Federal Ministry of Education and Research	Academia Sinica(Academia Sinica - Taiwan); Alfred-Wegener Institute for Polar and Marine Research; National Science of Council of Taiwan(Ministry of Science and Technology, Taiwan); International Bureau of the Germany Federal Ministry of Education and Research	This study was financially supported by Academia Sinica (P. P. Hwang) and Alfred-Wegener Institute for Polar and Marine Research (D. Abele). Y. C. Tseng was awarded the Postdoc Scholarship supported by both the National Science of Council of Taiwan and the Bilateral Cooperation in Science and Technology grant from International Bureau of the Germany Federal Ministry of Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele D, 2004, COMP BIOCHEM PHYS A, V138, P405, DOI 10.1016/j.cbpb.2004.05.013; Airaksinen S, 2003, COMP BIOCHEM PHYS B, V136, P275, DOI 10.1016/S1096-4959(03)00205-7; Amo R, 2010, J NEUROSCI, V30, P1566, DOI 10.1523/JNEUROSCI.3690-09.2010; Andrews ZB, 2005, NAT REV NEUROSCI, V6, P829, DOI 10.1038/nrn1767; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Azzu V, 2010, TRENDS BIOCHEM SCI, V35, P298, DOI 10.1016/j.tibs.2009.11.001; Bell EL, 2007, J CELL BIOL, V177, P1029, DOI 10.1083/jcb.200609074; Benarroch EE, 2009, NEUROLOGY, V73, P560, DOI 10.1212/WNL.0b013e3181b2a719; Bermejo-Nogales A, 2010, J COMP PHYSIOL B, V180, P685, DOI 10.1007/s00360-009-0441-6; Blanquart C, 2003, J STEROID BIOCHEM, V85, P267, DOI 10.1016/S0960-0760(03)00214-0; Blomgren K, 2006, FREE RADICAL BIO MED, V40, P388, DOI 10.1016/j.freeradbiomed.2005.08.040; Bordet R, 2006, BIOCHEM SOC T, V34, P1341, DOI 10.1042/BST0341341; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; Bugge A, 2010, J BIOL CHEM, V285, P17310, DOI 10.1074/jbc.M110.120584; Cannon B, 2006, BBA-BIOENERGETICS, V1757, P449, DOI 10.1016/j.bbabio.2006.05.016; CHAN PH, 1991, ANN NEUROL, V29, P482, DOI 10.1002/ana.410290506; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chavez A, 2008, ANN NY ACAD SCI, V1147, P312, DOI 10.1196/annals.1427.021; Chou MY, 2008, J EXP BIOL, V211, P3077, DOI 10.1242/jeb.019950; Cossins AR, 2002, BIOCHEM SOC T, V30, P1082, DOI 10.1042/bst0301082; CRAWSHAW L, 1985, PHARMACOL THERAPEUT, V30, P19, DOI 10.1016/0163-7258(85)90045-2; Dringen R, 1996, J NEUROCHEM, V67, P1375, DOI 10.1046/j.1471-4159.1996.67041375.x; Echtay KS, 2003, EMBO J, V22, P4103, DOI 10.1093/emboj/cdg412; Fandrey J, 2006, CARDIOVASC RES, V71, P642, DOI 10.1016/j.cardiores.2006.05.005; FRIEDLANDER MJ, 1976, J COMP PHYSIOL, V112, P19, DOI 10.1007/BF00612674; Girnun GD, 2002, MOL ENDOCRINOL, V16, P2793, DOI 10.1210/me.2002-0020; Hansford RG, 1997, J BIOENERG BIOMEMBR, V29, P89, DOI 10.1023/A:1022420007908; HAZEL JR, 1995, ANNU REV PHYSIOL, V57, P19, DOI 10.1146/annurev.ph.57.030195.000315; Heise K, 2007, J COMP PHYSIOL B, V177, P765, DOI 10.1007/s00360-007-0173-4; Heise K, 2006, J EXP BIOL, V209, P353, DOI 10.1242/jeb.01977; Hwang PP, 2010, FISH PHYSIOL, V29, P311, DOI 10.1016/S1546-5098(10)02908-0; JACOB RA, 1995, NUTR RES, V15, P755, DOI 10.1016/0271-5317(95)00041-G; Jastroch M, 2005, PHYSIOL GENOMICS, V22, P150, DOI 10.1152/physiolgenomics.00070.2005; Jastroch M, 2007, J COMP PHYSIOL B, V177, P743, DOI 10.1007/s00360-007-0171-6; Kasai H, 1997, MUTAT RES-REV MUTAT, V387, P147, DOI 10.1016/S1383-5742(97)00035-5; Katz LM, 2004, BRAIN RES, V1017, P85, DOI 10.1016/j.brainres.2004.05.020; Kern B, 2009, COMP BIOCHEM PHYS D, V4, P121, DOI 10.1016/j.cbd.2008.12.006; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Li JF, 2005, CIRC RES, V97, P474, DOI 10.1161/01.RES.0000181132.11393.18; Liu D, 2006, NEUROMOL MED, V8, P389, DOI 10.1385/NMM:8:3:389; Malek RL, 2004, COMP BIOCHEM PHYS C, V138, P363, DOI 10.1016/j.cca.2004.08.014; Mao WG, 1999, FEBS LETT, V443, P326, DOI 10.1016/S0014-5793(98)01713-X; Mark FC, 2006, COMP BIOCHEM PHYS D, V1, P365, DOI 10.1016/j.cbd.2006.08.004; Portner H.-O., 2005, FISH PHYSIOL, V22, P79, DOI DOI 10.1016/S1546-5098(04)22003-9; Rial Eduardo, 2009, Journal of Biology (London), V8, P58, DOI 10.1186/jbiol155; Richardson SM, 2008, HISTOCHEM CELL BIOL, V129, P503, DOI 10.1007/s00418-007-0372-9; Ricquier D, 2000, BIOCHEM J, V345, P161, DOI 10.1042/0264-6021:3450161; Saito S, 2008, GENE, V408, P37, DOI 10.1016/j.gene.2007.10.018; Schwartz TS, 2008, P ROY SOC B-BIOL SCI, V275, P979, DOI 10.1098/rspb.2007.1761; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; SHAKLEE JB, 1977, J EXP ZOOL, V201, P1, DOI 10.1002/jez.1402010102; Soitamo AJ, 2001, J BIOL CHEM, V276, P19699, DOI 10.1074/jbc.M009057200; Sokolova IM, 2005, FEBS LETT, V579, P313, DOI 10.1016/j.febslet.2004.11.103; Tang RY, 2007, ACTA BIOCH BIOPH SIN, V39, P384, DOI 10.1111/j.1745-7270.2007.00283.x; Thisse B, 2004, METHOD CELL BIOL, V77, P505; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Toyama T, 2004, BIOCHEM BIOPH RES CO, V324, P697, DOI 10.1016/j.bbrc.2004.09.110; Tseng YC, 2008, COMP BIOCHEM PHYS C, V148, P419, DOI 10.1016/j.cbpc.2008.04.009; TYLER S, 1984, J EXP ZOOL, V232, P1, DOI 10.1002/jez.1402320102; van den Burg EH, 2005, J NEUROPHYSIOL, V93, P2849, DOI 10.1152/jn.01113.2004; Vannucci SJ, 1997, GLIA, V21, P2, DOI 10.1002/(SICI)1098-1136(199709)21:1<2::AID-GLIA2>3.0.CO;2-C; VidalPuig A, 1997, BIOCHEM BIOPH RES CO, V235, P79, DOI 10.1006/bbrc.1997.6740; Villarroya F, 2007, PPAR RES, V2007, DOI 10.1155/2007/74364; Votyakova TV, 2001, J NEUROCHEM, V79, P266, DOI 10.1046/j.1471-4159.2001.00548.x; Wang PY, 2010, CIRC RES, V106, P911, DOI 10.1161/CIRCRESAHA.109.206185; WULLIMANN M, 1997, PHYSL FISHES, V2007, P245; Yoo HY, 1999, GENE, V234, P87, DOI 10.1016/S0378-1119(99)00176-6; Zhang X, 2007, TOXICOL APPL PHARM, V223, P10, DOI 10.1016/j.taap.2007.05.002	69	76	83	7	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2011	6	3							e18180	10.1371/journal.pone.0018180	http://dx.doi.org/10.1371/journal.pone.0018180			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	740SE	21464954	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000288813900047
J	Santana, SE; Geipel, I; Dumont, ER; Kalka, MB; Kalko, EKV				Santana, Sharlene E.; Geipel, Inga; Dumont, Elizabeth R.; Kalka, Margareta B.; Kalko, Elisabeth K. V.			All You Can Eat: High Performance Capacity and Plasticity in the Common Big-Eared Bat, Micronycteris microtis (Chiroptera: Phyllostomidae)	PLOS ONE			English	Article							BITE FORCE; FOOD HARDNESS; DIET; ECHOLOCATION; INSECTIVORY; ASSEMBLAGE; EVOLUTION; BEHAVIOR; FOREST; SIZE	Ecological specialization and resource partitioning are expected to be particularly high in the species-rich communities of tropical vertebrates, yet many species have broader ecological niches than expected. In Neotropical ecosystems, Neotropical leaf-nosed bats (Phyllostomidae) are one of the most ecologically and functionally diverse vertebrate clades. Resource partitioning in phyllostomids might be achieved through differences in the ability to find and process food. We selected Micronycteris microtis, a very small (5-7 g) animalivorous phyllostomid, to explore whether broad resource use is associated with specific morphological, behavioral and performance traits within the phyllostomid radiation. We documented processing of natural prey and measured bite force in free-ranging M. microtis and other sympatric phyllostomids. We found that M. microtis had a remarkably broad diet for prey size and hardness. For the first time, we also report the consumption of vertebrates (lizards), which makes M. microtis the smallest carnivorous bat reported to date. Compared to other phyllostomids, M. microtis had the highest bite force for its size and cranial shape and high performance plasticity. Bite force and cranial shape appear to have evolved rapidly in the M. microtis lineage. High performance capacity and high efficiency in finding motionless prey might be key traits that allow M. microtis, and perhaps other species, to successfully co-exist with other gleaning bats.	[Santana, Sharlene E.] Univ Calif Los Angeles, Ctr Soc & Genet, Los Angeles, CA 90095 USA; [Santana, Sharlene E.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Geipel, Inga; Kalko, Elisabeth K. V.] Univ Ulm, Inst Expt Ecol, Ulm, Germany; [Dumont, Elizabeth R.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; [Kalka, Margareta B.] Univ Calif Berkeley, Energy & Resources Grp, Berkeley, CA 94720 USA; [Kalko, Elisabeth K. V.] Smithsonian Trop Res Inst, Balboa, Panama	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Ulm University; University of Massachusetts System; University of Massachusetts Amherst; University of California System; University of California Berkeley; Smithsonian Institution; Smithsonian Tropical Research Institute	Santana, SE (corresponding author), Univ Calif Los Angeles, Ctr Soc & Genet, Los Angeles, CA 90095 USA.	sesantana@ucla.edu	D, Betsy/ABD-1855-2020; Alfaro, Michael/Q-2113-2017	Eiting, Thomas/0000-0001-8544-0993; Geipel, Inga/0000-0003-3118-2460; Alfaro, Michael/0000-0002-8898-8230	University of Massachusetts; Institute of Experimental Ecology, University of Ulm; DAAD; NSF [IOB 0447616]; European Union	University of Massachusetts; Institute of Experimental Ecology, University of Ulm; DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); NSF(National Science Foundation (NSF)); European Union(European Commission)	S.E.S. was supported by University of Massachusetts Graduate School Fellowship and travel funds from the Institute of Experimental Ecology, University of Ulm; M.B.K. by a DAAD fellowship; E.R.D. by a NSF grant (IOB 0447616); and G.G. and E.K.V.K. by the European Union project ChiRoPing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre LF, 2003, FUNCT ECOL, V17, P201, DOI 10.1046/j.1365-2435.2003.00721.x; Albrecht L, 2007, ACTA THERIOL, V52, P141, DOI 10.1007/BF03194209; Bumrungsri S, 2007, BIOTROPICA, V39, P241, DOI 10.1111/j.1744-7429.2006.00245.x; Dondini G, 2000, J ZOOL, V251, P233, DOI 10.1111/j.1469-7998.2000.tb00606.x; Dumont ER, 1999, J ZOOL, V248, P219, DOI 10.1017/S0952836999006093; Dumont ER, 2003, J EXP BIOL, V206, P2117, DOI 10.1242/jeb.00375; Evans AR, 2005, AUST J ZOOL, V53, P9, DOI 10.1071/ZO04018; FREEMAN PW, 1984, BIOL J LINN SOC, V21, P387, DOI 10.1111/j.1095-8312.1984.tb01601.x; FREEMAN PW, 1979, J MAMMAL, V60, P467, DOI 10.2307/1380088; Geipel I, 2007, PREY DETECTION NEOTR; GENTRY AH, 1988, P NATL ACAD SCI USA, V85, P156, DOI 10.1073/pnas.85.1.156; Giannini NP, 2005, ACTA CHIROPTEROL, V7, P131, DOI 10.3161/1733-5329(2005)7[131:TGSOAL]2.0.CO;2; Giannini NP, 2004, OIKOS, V105, P209, DOI 10.1111/j.0030-1299.2004.12690.x; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Herrel A, 1999, FUNCT ECOL, V13, P289, DOI 10.1046/j.1365-2435.1999.00305.x; Herrel A, 2008, J EXP BIOL, V211, P86, DOI 10.1242/jeb.012211; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Jungers WL, 1995, YEARB PHYS ANTHROPOL, V38, P137; Kalka M, 2006, J TROP ECOL, V22, P1, DOI 10.1017/S0266467405002920; Kalko EKV, 2004, BAT ECHOLOCATION RES, P63; Kalko EKV, 2008, INTEGR COMP BIOL, V48, P60, DOI 10.1093/icb/icn030; Kalko Elisabeth K.V., 1998, P197; MCPEEK MA, 1995, AM NAT, V145, P686, DOI 10.1086/285763; Meyer CFJ, 2008, J BIOGEOGR, V35, P1711, DOI 10.1111/j.1365-2699.2008.01916.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NORBERG UM, 1988, BIOL J LINN SOC, V33, P383, DOI 10.1111/j.1095-8312.1988.tb00451.x; Paradis E., 2006, APE ANAL PHYLOGENETI; Rojas D, 2011, MOL ECOL, V20, P2217, DOI 10.1111/j.1365-294X.2011.05082.x; Santana SE, 2009, J EVOLUTION BIOL, V22, P2131, DOI 10.1111/j.1420-9101.2009.01827.x; Santana SE, 2011, FUNCT ECOL, V25, P839, DOI 10.1111/j.1365-2435.2011.01832.x; Santana SE, 2011, BIOL J LINN SOC, V102, P1, DOI 10.1111/j.1095-8312.2010.01551.x; Santana SE, 2010, FUNCT ECOL, V24, P776, DOI 10.1111/j.1365-2435.2010.01703.x; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; Siemers BM, 2004, NATURE, V429, P657, DOI 10.1038/nature02547; SIMMONS N.B., 1998, B AM MUSEUM NATURAL, V237; SIMMONS NB, 2004, MAMMAL SPECIES WORLD, P2; STRAIT SG, 1993, J MAMMAL, V74, P391, DOI 10.2307/1382395; TOFT CA, 1980, OECOLOGIA, V45, P131, DOI 10.1007/BF00346717; TUTTLE MD, 1981, SCIENCE, V214, P677, DOI 10.1126/science.214.4521.677; van de Sand M, 2004, OKOLOGIE VERHALTEN N; Wetterer AL, 2000, B AM MUS NAT HIST, P4, DOI 10.1206/0003-0090(2000)248<0001:POPBMC>2.0.CO;2; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809	43	53	56	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28584	10.1371/journal.pone.0028584	http://dx.doi.org/10.1371/journal.pone.0028584			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	21991371	gold, Green Published			2022-12-27	WOS:000298171400110
J	Wang, CQF; Cruz-Inigo, AE; Fuentes-Duculan, J; Moussai, D; Gulati, N; Sullivan-Whalen, M; Gilleaudeau, P; Cohen, JA; Krueger, JG				Wang, Claire Q. F.; Cruz-Inigo, Andres E.; Fuentes-Duculan, Judilyn; Moussai, Dariush; Gulati, Nicholas; Sullivan-Whalen, Mary; Gilleaudeau, Patricia; Cohen, Jules A.; Krueger, James G.			Th17 Cells and Activated Dendritic Cells Are Increased in Vitiligo Lesions	PLOS ONE			English	Article							REGULATORY T-CELLS; ATOPIC-DERMATITIS; AUTOIMMUNE-DISEASE; PSORIASIS; MELANOMA; HELPER; INFLAMMASOME; EXPRESSION; PATHWAYS; DISTINCT	Background: Vitiligo is a common skin disorder, characterized by progressive skin de-pigmentation due to the loss of cutaneous melanocytes. The exact cause of melanocyte loss remains unclear, but a large number of observations have pointed to the important role of cellular immunity in vitiligo pathogenesis. Methodology/Principal Findings: In this study, we characterized T cell and inflammation-related dermal dendritic cell (DC) subsets in pigmented non-lesional, leading edge and depigmented lesional vitiligo skin. By immunohistochemistry staining, we observed enhanced populations of CD11c+ myeloid dermal DCs and CD207+ Langerhans cells in leading edge vitiligo biopsies. DC-LAMP+ and CD1c+ sub-populations of dermal DCs expanded significantly in leading edge and lesional vitiligo skin. We also detected elevated tissue mRNA levels of IL-17A in leading edge skin biopsies of vitiligo patients, as well as IL-17A positive T cells by immunohistochemistry and immunofluorescence. Langerhans cells with activated inflammasomes were also noted in lesional vitiligo skin, along with increased IL-1 beta mRNA, which suggest the potential of Langerhans cells to drive Th17 activation in vitiligo. Conclusions/Significance: These studies provided direct tissue evidence that implicates active Th17 cells in vitiligo skin lesions. We characterized new cellular immune elements, in the active margins of vitiligo lesions (e. g. populations of epidermal and dermal dendritic cells subsets), which could potentially drive the inflammatory responses.	[Wang, Claire Q. F.; Fuentes-Duculan, Judilyn; Gulati, Nicholas; Sullivan-Whalen, Mary; Gilleaudeau, Patricia; Cohen, Jules A.; Krueger, James G.] Rockefeller Univ, Invest Dermatol Lab, New York, NY 10021 USA; [Cruz-Inigo, Andres E.; Moussai, Dariush] Weill Cornell Med Coll, New York, NY USA	Rockefeller University; Cornell University	Wang, CQF (corresponding author), Rockefeller Univ, Invest Dermatol Lab, 1230 York Ave, New York, NY 10021 USA.	jgk@rockefeller.edu	Neyrolles, Olivier/AAG-3692-2019; Wang, Claire/K-8793-2012	Neyrolles, Olivier/0000-0003-0047-5885; wang, chuan/0000-0001-6104-6342	Clinical and Translational Science Award [UL1RR024143]; National Institutes of Health (NIH) [GM07739]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	Clinical and Translational Science Award; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Milstein Medical Program provided the major support for this study. Research was also supported by a Clinical and Translational Science Award grant UL1RR024143. Nicholas Gulati was supported by National Institutes of Health (NIH) MSTP grant GM07739. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Basak PY, 2009, J AM ACAD DERMATOL, V60, P256, DOI 10.1016/j.jaad.2008.09.048; Becker JC, 1999, J INVEST DERMATOL, V113, P1033, DOI 10.1046/j.1523-1747.1999.00805.x; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Bluth MJ, 2009, J INVEST DERMATOL, V129, P2451, DOI 10.1038/jid.2009.96; Chamian F, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-27; Chen YT, 1996, P NATL ACAD SCI USA, V93, P5915, DOI 10.1073/pnas.93.12.5915; Chiang EY, 2009, NAT MED, V15, P766, DOI 10.1038/nm.1984; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Fujita H, 2009, P NATL ACAD IN PRESS; Ghoreschi K, 2007, CLIN DERMATOL, V25, P574, DOI 10.1016/j.clindermatol.2007.08.012; Guttman-Yassky E, 2007, J ALLERGY CLIN IMMUN, V119, P1210, DOI 10.1016/j.jaci.2007.03.006; Haider AS, 2008, J IMMUNOL, V180, P1913, DOI 10.4049/jimmunol.180.3.1913; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; HOWITZ J, 1977, ARCH DERMATOL, V113, P47, DOI 10.1001/archderm.113.1.47; Jacobs JFM, 2009, CANCER IMMUNOL IMMUN, V58, P145, DOI 10.1007/s00262-008-0506-5; Jariwala SP, 2007, ARCH DERMATOL RES, V299, P359, DOI 10.1007/s00403-007-0775-4; Jarrett P, 1999, BRIT J DERMATOL, V141, P361; Jin Y, 2009, J INVEST DERMATOL; Jin Y, 2007, NEW ENGL J MED, V356, P1216, DOI 10.1056/NEJMoa061592; Kirkham BW, 2006, ARTHRITIS RHEUM, V54, P1122, DOI 10.1002/art.21749; Krueger GG, 2007, NEW ENGL J MED, V356, P580, DOI 10.1056/NEJMoa062382; Kryczek I, 2008, J IMMUNOL, V181, P4733, DOI 10.4049/jimmunol.181.7.4733; Lambe T, 2006, J IMMUNOL, V177, P3055, DOI 10.4049/jimmunol.177.5.3055; Le Poole IC, 2004, J INVEST DERM SYMP P, V9, P68, DOI 10.1111/j.1087-0024.2004.00825.x; LePoole IC, 1996, AM J PATHOL, V148, P1219; Lowes MA, 2005, P NATL ACAD SCI USA, V102, P19057, DOI 10.1073/pnas.0509736102; Lowes MA, 2008, J INVEST DERMATOL, V128, P1207, DOI 10.1038/sj.jid.5701213; Mantovani S, 2003, J INVEST DERMATOL, V121, P308, DOI 10.1046/j.1523-1747.2003.12368.x; Matusevicius D, 1999, MULT SCLER J, V5, P101, DOI 10.1177/135245859900500206; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Nograles KE, 2008, BRIT J DERMATOL, V159, P1092, DOI 10.1111/j.1365-2133.2008.08769.x; Nograles KE, 2009, J ALLERGY CLIN IMMUN, V123, P1244, DOI 10.1016/j.jaci.2009.03.041; Ongenae K, 2003, PIGM CELL RES, V16, P90, DOI 10.1034/j.1600-0749.2003.00023.x; Orosz Z, 1999, HISTOPATHOLOGY, V34, P517, DOI 10.1111/j.1365-2559.1999.00679.x; Oyarbide-Valencia K, 2006, AUTOIMMUN REV, V5, P486, DOI 10.1016/j.autrev.2006.03.012; Peck A, 2009, CLIN IMMUNOL, V132, P295, DOI 10.1016/j.clim.2009.03.522; Petrilli V, 2005, CURR BIOL, V15, pR581, DOI 10.1016/j.cub.2005.07.049; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Skurkovich B, 2006, E SCHERING RES FDN W, V56, P1; Steitz J, 2004, EUR J CELL BIOL, V83, P797, DOI 10.1078/0171-9335-00423; Steitz J, 2005, J INVEST DERMATOL, V124, P144, DOI 10.1111/j.0022-202X.2004.23538.x; Stummvoll GH, 2008, J IMMUNOL, V181, P1908, DOI 10.4049/jimmunol.181.3.1908; Sugita K, 2006, CLIN EXP DERMATOL, V31, P80, DOI 10.1111/j.1365-2230.2005.01987.x; Taieb A, 2009, NEW ENGL J MED, V360, P160, DOI 10.1056/NEJMcp0804388; van den Boorn JG, 2009, J INVEST DERMATOL; Wankowicz-Kalinska A, 2003, LAB INVEST, V83, P683, DOI 10.1097/01.LAB.0000069521.42488.1B; Waterman EA, 2009, J INVEST DE IN PRESS; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Yee C, 2000, J EXP MED, V192, P1637, DOI 10.1084/jem.192.11.1637; Zaba LC, 2007, J EXP MED, V204, P3183, DOI 10.1084/jem.20071094; Zaba LC, 2007, J CLIN INVEST, V117, P2517, DOI 10.1172/JCI32282; Zaba LC, 2009, J INVEST DERMATOL, V129, P302, DOI 10.1038/jid.2008.225; Zaba LC, 2009, J INVEST DERMATOL, V129, P79, DOI 10.1038/jid.2008.194	57	237	267	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2011	6	4							e18907	10.1371/journal.pone.0018907	http://dx.doi.org/10.1371/journal.pone.0018907			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MU	22003408	Green Published, gold, Green Submitted			2022-12-27	WOS:000290016800026
J	Wang, C; Yang, SY; Sun, G; Tang, XY; Lu, SH; Neyrolles, O; Gao, Q				Wang, Chuan; Yang, Shunyao; Sun, Gang; Tang, Xuying; Lu, Shuihua; Neyrolles, Olivier; Gao, Qian			Comparative miRNA Expression Profiles in Individuals with Latent and Active Tuberculosis	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; MICRORNA EXPRESSION; GENE-EXPRESSION; ARCHITECTURE; REGULATORS; SIGNATURE; INFECTION; SYSTEM	The mechanism of latent tuberculosis (TB) infection remains elusive. Several host factors that are involved in this complex process were previously identified. Micro RNAs (miRNAs) are endogenous similar to 22 nt RNAs that play important regulatory roles in a wide range of biological processes. Several studies demonstrated the clinical usefulness of miRNAs as diagnostic or prognostic biomarkers in various malignancies and in a few nonmalignant diseases. To study the role of miRNAs in the transition from latent to active TB and to discover candidate biomarkers of this transition, we used human miRNA microarrays to probe the transcriptome of peripheral blood mononuclear cells (PBMCs) in patients with active TB, latent TB infection (LTBI), and healthy controls. Using the software package BRB Array Tools for data analyses, 17 miRNAs were differentially expressed between the three groups (P<0.01). Hierarchical clustering of the 17 miRNAs expression profiles showed that individuals with active TB clustered independently of individuals with LTBI or from healthy controls. Using the predicted target genes and previously published genome-wide transcriptional profiles, we constructed the regulatory networks of miRNAs that were differentially expressed between active TB and LTBI. The regulatory network revealed that several miRNAs, with previously established functions in hematopoietic cell differentiation and their target genes may be involved in the transition from latent to active TB. These results increase the understanding of the molecular basis of LTBI and confirm that some miRNAs may control gene expression of pathways that are important for the pathogenesis of this infectious disease.	[Wang, Chuan; Yang, Shunyao; Sun, Gang; Gao, Qian] Fudan Univ, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China; [Wang, Chuan; Yang, Shunyao; Sun, Gang; Gao, Qian] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Tang, Xuying; Lu, Shuihua] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Resp Branch, Shanghai 200433, Peoples R China; [Neyrolles, Olivier] Univ Toulouse, Toulouse, France; [Neyrolles, Olivier] CNRS, Inst Pharmacol & Biol Struct, Toulouse, France	Fudan University; Fudan University; Fudan University; Universite de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Wang, C (corresponding author), Fudan Univ, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China.	qgao99@yahoo.com	Neyrolles, Olivier/AAG-3692-2019; Wang, Claire/K-8793-2012	Neyrolles, Olivier/0000-0003-0047-5885; wang, chuan/0000-0001-6104-6342	Bill & Melinda Gates Foundation [ID: 52226]; Key Project of the Chinese National Program [2012ZX10003-004]; European Community [TB-VIR, 200973]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Key Project of the Chinese National Program; European Community(European Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Bill & Melinda Gates Foundation Grand Challenges Explorations, Phase I (ID: 52226), Key Project of the Chinese National Program (2012ZX10003-004) and European Community (FP7 project TB-VIR, 200973). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey SG, 2010, APOPTOSIS, V15, P541, DOI 10.1007/s10495-010-0456-1; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Behar SM, 2011, MUCOSAL IMMUNOL, V4, P279, DOI 10.1038/mi.2011.3; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Chao MC, 2010, ANNU REV MICROBIOL, V64, P293, DOI 10.1146/annurev.micro.112408.134043; Coolen M, 2009, CURR OPIN NEUROBIOL, V19, P461, DOI 10.1016/j.conb.2009.09.006; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Dykxhoorn DM, 2010, CANCER RES, V70, P6401, DOI 10.1158/0008-5472.CAN-10-1346; Forrest ARR, 2010, LEUKEMIA, V24, P460, DOI 10.1038/leu.2009.246; Gan HX, 2008, NAT IMMUNOL, V9, P1189, DOI 10.1038/ni.1654; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Igarashi K, 2007, J BIOCHEM, V141, P783, DOI 10.1093/jb/mvm106; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Ivey KN, 2010, CELL STEM CELL, V7, P36, DOI 10.1016/j.stem.2010.06.012; Jacobsen M, 2007, J MOL MED, V85, P613, DOI 10.1007/s00109-007-0157-6; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Joung JG, 2007, BIOINFORMATICS, V23, P1141, DOI 10.1093/bioinformatics/btm045; Kaufmann SHE, 2005, NAT MED, V11, pS33, DOI 10.1038/nm1221; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Lin PL, 2010, J IMMUNOL, V185, P15, DOI 10.4049/jimmunol.0903856; Lodish HF, 2008, NAT REV IMMUNOL, V8, P120, DOI 10.1038/nri2252; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Maertzdorf J, 2011, GENES IMMUN, V12, P15, DOI 10.1038/gene.2010.51; Otake Y, 2007, BLOOD, V109, P3069, DOI 10.1182/blood-2006-08-043257; Pankla R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r127; Rasmussen KD, 2010, J EXP MED, V207, P1351, DOI 10.1084/jem.20100458; Rosa A, 2007, P NATL ACAD SCI USA, V104, P19849, DOI 10.1073/pnas.0706963104; SELWYN PA, 1993, NEW ENGL J MED, V328, P671; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243; Ura S, 2009, HEPATOLOGY, V49, P1098, DOI 10.1002/hep.22749; van Doorn R, 2005, J CLIN ONCOL, V23, P3886, DOI 10.1200/JCO.2005.11.353; Verver S, 2004, INT J EPIDEMIOL, V33, P351, DOI 10.1093/ije/dyh021; Wang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017167; World Health Organization, 2009, WHO REP 2009; Zhang JL, 2005, MICROBIOL IMMUNOL, V49, P845, DOI 10.1111/j.1348-0421.2005.tb03673.x; Zhao YD, 2008, CANCER INFORM, V6, P9	40	237	267	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25832	10.1371/journal.pone.0025832	http://dx.doi.org/10.1371/journal.pone.0025832			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003408	gold, Green Published, Green Submitted			2022-12-27	WOS:000295970300029
J	Santana, SE; Dial, TO; Eiting, TP; Alfaro, ME				Santana, Sharlene E.; Dial, Thomas O.; Eiting, Thomas P.; Alfaro, Michael E.			Roosting Ecology and the Evolution of Pelage Markings in Bats	PLOS ONE			English	Article							FRUIT-EATING BATS; DISRUPTIVE COLORATION; SPERM COMPETITION; ECHOLOCATION; STRIPES; CRYPSIS; DISCRIMINATION; CHIROPTERA; CAMOUFLAGE; PATTERNS	Multiple lineages of bats have evolved striking facial and body pelage makings, including spots, stripes and countershading. Although researchers have hypothesized that these markings mainly evolved for crypsis, this idea has never been tested in a quantitative and comparative context. We present the first comparative study integrating data on roosting ecology (roost type and colony size) and pelage coloration patterns across bats, and explore the hypothesis that the evolution of bat pelage markings is associated with roosting ecologies that benefit from crypsis. We find that lineages that roost in the vegetation have evolved pelage markings, especially stripes and neck collars, which may function in crypsis through disruptive coloration and a type of countershading that might be unique to bats. We also demonstrate that lineages that live in larger colonies and are larger in size tend not to have pelage markings, possibly because of reduced predation pressures due to the predator dilution effect and a lower number of potential predators. Although social functions for pelage color patterns are also possible, our work provides strong support for the idea that roosting ecology has driven the evolution of pelage markings in bats.	[Santana, Sharlene E.] Univ Calif Los Angeles, Ctr Soc & Genet, Los Angeles, CA 90095 USA; [Santana, Sharlene E.; Dial, Thomas O.; Alfaro, Michael E.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Eiting, Thomas P.] Univ Massachusetts, Amherst, MA 01003 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Massachusetts System; University of Massachusetts Amherst	Santana, SE (corresponding author), Univ Calif Los Angeles, Ctr Soc & Genet, Los Angeles, CA 90095 USA.	sesantana@ucla.edu	D, Betsy/ABD-1855-2020; Alfaro, Michael/Q-2113-2017	Eiting, Thomas/0000-0001-8544-0993; Geipel, Inga/0000-0003-3118-2460; Alfaro, Michael/0000-0002-8898-8230	Center for Society and Genetics; National Science Foundation [0918748]	Center for Society and Genetics; National Science Foundation(National Science Foundation (NSF))	Funding was provided by a Center for Society and Genetics (http://socgen.ucla.edu) Postdoctoral Fellowship to SES and National Science Foundation grant 0918748 to MEA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altringham John D., 2005, P280; Baron G, 1996, COMP NEUROBIOLOGY CH; Bates P, 1998, BATS INDIAN SUBCONTI; Behrens RR, 2009, PHILOS T R SOC B, V364, P497, DOI 10.1098/rstb.2008.0250; Bonaccorso FJ, 1998, BATS PAPUA NEW GUINE; Bradley BJ, 2008, EVOL ANTHROPOL, V17, P97, DOI 10.1002/evan.20164; Caro T, 2005, BIOSCIENCE, V55, P125, DOI 10.1641/0006-3568(2005)055[0125:TASOCI]2.0.CO;2; Caro T, 2011, EVOL ECOL, V25, P1231, DOI 10.1007/s10682-011-9479-5; Caro T, 2010, BEHAV ECOL, V21, P78, DOI 10.1093/beheco/arp165; Caro Tim, 2005, pXIII; Clough D, 2009, INT J PRIMATOL, V30, P859, DOI 10.1007/s10764-009-9379-5; COHEN JE, 1993, J ANIM ECOL, V62, P67, DOI 10.2307/5483; Cott H.B., 1940, ADAPTIVE COLORATION; Csorba G., 2003, HORSESHOE BATS WORLD; Dechmann DKN, 2004, EVOL ECOL RES, V6, P1037; DEFANIS E, 1995, ANIM BEHAV, V49, P835; EDMUNDS M, 1994, BIOL J LINN SOC, V51, P447, DOI 10.1006/bijl.1994.1034; Edmunds M., 1974, DEFENCE ANIMALS; Endler J.A., 1978, Evolutionary Biology (New York), V11, P319; Ewer RF, 1997, CARNIVORES; Fenton BM, 2008, KOEDOE AFRICAN PROTE, V35, P49; FENTON MB, 1994, ANIM BEHAV, V48, P9, DOI 10.1006/anbe.1994.1207; Frey JK, 2006, J MAMMAL, V87, P1175, DOI 10.1644/05-MAMM-A-374R2.1; Garnett Stephen, 1999, Australian Zoologist, V31, P38; GITTLEMAN JL, 1985, OECOLOGIA, V67, P540, DOI 10.1007/BF00790026; GODFREY D, 1987, BIOL J LINN SOC, V32, P427, DOI 10.1111/j.1095-8312.1987.tb00442.x; GUSTIN MK, 1987, ANIM BEHAV, V35, P13, DOI 10.1016/S0003-3472(87)80205-1; Hodgkison R, 2003, J TROP ECOL, V19, P667, DOI 10.1017/S0266467403006060; Hoekstra HE, 2004, EVOLUTION, V58, P1329; Hosken DJ, 1997, P ROY SOC B-BIOL SCI, V264, P385, DOI 10.1098/rspb.1997.0055; Hosken DJ, 1998, BEHAV ECOL SOCIOBIOL, V44, P169, DOI 10.1007/s002650050529; Hutson A, 2001, MICROCHIROPTERAN BAT; Ives AR, 2010, SYST BIOL, V59, P9, DOI 10.1093/sysbio/syp074; Jones KE, 2005, EVOLUTION, V59, P2243, DOI 10.1111/j.0014-3820.2005.tb00932.x; Jones KE, 2002, BIOL REV, V77, P223, DOI 10.1017/S1464793101005899; Kamilar JM, 2011, J ZOOL, V283, P227, DOI 10.1111/j.1469-7998.2010.00765.x; KILTIE RA, 1989, ANIM BEHAV, V38, P542, DOI 10.1016/S0003-3472(89)80048-X; Korine C, 2005, BEHAV ECOL SOCIOBIOL, V59, P12, DOI 10.1007/s00265-005-0003-1; Kunz T.H., 1982, P1; Kunz TH, 2003, BAT ECOLOGY, P3; LANGEVIN P, 1990, Mammalian Species, P1, DOI 10.2307/3504110; Law BS, 2000, AUSTRAL ECOL, V25, P352, DOI 10.1046/j.1442-9993.2000.01046.x; Majerus M, 1998, MELANISM EVOLUTION A; Marshall Justin, 2011, P186; Merilaita S, 2005, P ROY SOC B-BIOL SCI, V272, P665, DOI 10.1098/rspb.2004.3000; Merilaita S, 1998, P ROY SOC B-BIOL SCI, V265, P1059, DOI 10.1098/rspb.1998.0399; Mickleburgh S.P., 1992, OLD WORLD FRUIT BATS; Nowak RM, 1994, WALKERS BATS WORLD; Ortolani A, 1999, BIOL J LINN SOC, V67, P433; Plumpton D.L., 1992, Mammalian Species, P1, DOI 10.2307/3504230; Poulton E.B., 1890, COLOURS ANIMALS THEI, DOI [10.1126/science.ns-16.407.286.a, DOI 10.1126/SCIENCE.NS-16.407.286.A]; Reid F., 2009, FIELD GUIDE MAMMALS, V2nd; Safi K, 2003, ANIM BEHAV, V65, P363, DOI 10.1006/anbe.2003.2067; Sandoval CP, 2008, BIOL J LINN SOC, V94, P1, DOI 10.1111/j.1095-8312.2007.00941.x; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; SIMMONS NB, 2004, MAMMAL SPECIES WORLD, P2; Stankowich T, 2011, EVOLUTION, V65, P3090, DOI 10.1111/j.1558-5646.2011.01334.x; Stevens M, 2006, P R SOC B, V273, P2141, DOI 10.1098/rspb.2006.3556; Stevens M, 2009, PHILOS T R SOC B, V364, P423, DOI 10.1098/rstb.2008.0217; Stoner CJ, 2003, BEHAV ECOL, V14, P823, DOI 10.1093/beheco/arg072; TAYLOR PJ, 2000, BATS SO AFRICA; Thies W, 1998, BEHAV ECOL SOCIOBIOL, V42, P397, DOI 10.1007/s002650050454; Tullberg BS, 2005, P ROY SOC B-BIOL SCI, V272, P1315, DOI 10.1098/rspb.2005.3079; Voigt CC, 1999, BEHAV ECOL SOCIOBIOL, V47, P29, DOI 10.1007/s002650050646; von Helversen D, 1999, NATURE, V398, P759, DOI 10.1038/19648; von Helversen O, 2000, J COMP PHYSIOL A, V186, P143, DOI 10.1007/s003590050014; WICKLER W, 1976, Z TIERPSYCHOL, V40, P345; Wilkinson GS, 2002, AGING CELL, V1, P124, DOI 10.1046/j.1474-9728.2002.00020.x	68	53	56	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25845	10.1371/journal.pone.0025845	http://dx.doi.org/10.1371/journal.pone.0025845			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991371	Green Submitted, Green Published, gold			2022-12-27	WOS:000295943000084
J	Li, JS; Bi, YT; Dong, C; Yang, JF; Liang, WD				Li, Jin-song; Bi, Yun-tian; Dong, Cheng; Yang, Ji-feng; Liang, Wan-dong			Transcriptome Analysis of Adaptive Heat Shock Response of Streptococcus thermophilus	PLOS ONE			English	Article							GROWTH TEMPERATURE; LACTOCOCCUS-LACTIS; GENE-EXPRESSION; CLPL; METABOLISM; BULGARICUS; REGULATORS; TOLERANCE; BACTERIA; SYSTEMS	Streptococcus thermophilus, a gram-positive facultative anaerobe, is one of the most important lactic acid bacteria widely used in the dairy fermentation industry. In this study, we have analyzed the global transcriptional profiling of S. thermophilus upon temperature change. During a temperature shift from 42 degrees C to 50 degrees C, it is found that 196 (10.4%) genes show differential expression with 102 up-regulated and 94 down-regulated at 50 degrees C. In particular, 1) Heat shock genes, such as DnaK, GroESL and clpL, are identified to be elevated at 50 degrees C; 2) Transcriptional regulators, such as HrcA, CtsR, Fur, MarR and MerR family, are differentially expressed, indicating the complex molecular mechanisms of S. thermophilus adapting to heat shock; 3) Genes associated with signal transduction, cell wall genes, iron homeostasis, ABC transporters and restriction-modification system were induced; 4) A large number of the differentially expressed genes are hypothetical genes of unknown function, indicating that much remains to be investigated about the heat shock response of S. thermophilus. Experimental investigation of selected heat shock gene ClpL shows that it plays an important role in the physiology of S. thermophilus at high temperature and meanwhile we confirmed ClpL as a member of the CtsR regulon. Overall, this study has contributed to the underlying adaptive molecular mechanisms of S. thermophilus upon temperature change and provides a basis for future in-depth functional studies.	[Li, Jin-song; Yang, Ji-feng; Liang, Wan-dong] Wenzhou Med Coll, Coll Life Sci, Zhejiang Prov Key Lab Med Genet, Wenzhou, Peoples R China; [Bi, Yun-tian] Wenzhou Med Coll, Sch Basic Med Sci, Wenzhou, Peoples R China; [Dong, Cheng] Harbin Med Univ, Hosp 4, Harbin, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Harbin Medical University	Li, JS (corresponding author), Wenzhou Med Coll, Coll Life Sci, Zhejiang Prov Key Lab Med Genet, Wenzhou, Peoples R China.	liliang2011@yahoo.com	; Zhang, Yanfeng/E-6971-2016	Mao, Bingyu/0000-0002-7993-3158; li, Jinsong/0000-0003-0764-3706; Zhang, Yanfeng/0000-0002-3859-3839; Sun, Jian/0000-0002-4732-3152; Maity, Sankar/0000-0002-2387-6545	Natural Science Foundation of Zhejiang Province [Y2090642]; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA098258, P50CA140388] Funding Source: NIH RePORTER	Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Natural Science Foundation of Zhejiang Province (Y2090642), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azizoglu RO, 2009, APPL ENVIRON MICROB, V75, P5315, DOI 10.1128/AEM.00458-09; Bolotin A, 2004, NAT BIOTECHNOL, V22, P1554, DOI 10.1038/nbt1034; Brown NL, 2003, FEMS MICROBIOL REV, V27, P145, DOI 10.1016/S0168-6445(03)00051-2; Ferenci T, 2007, ANN NY ACAD SCI, V1113, P105, DOI 10.1196/annals.1391.003; Frees D, 2004, MOL MICROBIOL, V54, P1445, DOI 10.1111/j.1365-2958.2004.04368.x; Gao HC, 2004, J BACTERIOL, V186, P7796, DOI 10.1128/JB.186.22.7796-7803.2004; Hantke K, 2001, CURR OPIN MICROBIOL, V4, P172, DOI 10.1016/S1369-5274(00)00184-3; Herve-Jimenez L, 2009, APPL ENVIRON MICROB, V75, P2062, DOI 10.1128/AEM.01984-08; Hols P, 2005, FEMS MICROBIOL REV, V29, P435, DOI 10.1016/j.femsre.2005.04.008; Kwon HY, 2003, INFECT IMMUN, V71, P3757, DOI 10.1128/IAI.71.7.3757-3765.2003; Mereghetti L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002785; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Novak L, 1997, APPL ENVIRON MICROB, V63, P2665, DOI 10.1128/AEM.63.7.2665-2670.1997; O'Connell-Motherway M, 2000, MICROBIOL-SGM, V146, P935, DOI 10.1099/00221287-146-4-935; Pysz MA, 2004, EXTREMOPHILES, V8, P209, DOI 10.1007/s00792-004-0379-2; Rodrigues DF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-547; Sieuwerts S, 2010, APPL ENVIRON MICROB, V76, P7775, DOI 10.1128/AEM.01122-10; Snyder JA, 2004, INFECT IMMUN, V72, P6373, DOI 10.1128/IAI.72.11.6373-6381.2004; Stintzi A, 2003, J BACTERIOL, V185, P2009, DOI 10.1128/JB.185.6.2009-2016.2003; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Suokko A, 2008, PROTEOMICS, V8, P1029, DOI 10.1002/pmic.200700925; van Veen HW, 1997, ANTON LEEUW INT J G, V72, P299, DOI 10.1023/A:1000530927928; Varcamonti M, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-6; Ward SK, 2008, J BACTERIOL, V190, P2939, DOI 10.1128/JB.01847-07; WILSON GG, 1991, ANNU REV GENET, V25, P585, DOI 10.1146/annurev.ge.25.120191.003101; ZEILSTRARYALLS J, 1991, ANNU REV MICROBIOL, V45, P301, DOI 10.1146/annurev.mi.45.100191.001505; Zotta T, 2009, INT J FOOD MICROBIOL, V129, P211, DOI 10.1016/j.ijfoodmicro.2008.11.024; ZUBER U, 1994, J BACTERIOL, V176, P1359, DOI 10.1128/jb.176.5.1359-1363.1994	28	140	145	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e25777	10.1371/journal.pone.0025777	http://dx.doi.org/10.1371/journal.pone.0025777			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22194926	Green Published, Green Submitted, gold			2022-12-27	WOS:000295978600030
J	Li, J; Ding, ZY; Wang, ZX; Lu, JF; Maity, SN; Navone, NM; Logothetis, CJ; Mills, GB; Kim, J				Li, Jin; Ding, Zhiyong; Wang, Zhengxin; Lu, Jing-Fang; Maity, Sankar N.; Navone, Nora M.; Logothetis, Christopher J.; Mills, Gordon B.; Kim, Jeri			Androgen Regulation of 5 alpha-Reductase Isoenzymes in Prostate Cancer: Implications for Prostate Cancer Prevention	PLOS ONE			English	Article							DIFFERENTIAL REGULATION; DEPENDENT INHIBITION; SERUM TESTOSTERONE; GENE-EXPRESSION; MESSENGER-RNA; ADULT-RAT; FINASTERIDE; RECEPTOR; DUTASTERIDE; TYPE-1	The enzyme 5 alpha-reductase, which converts testosterone to dihydrotestosterone (DHT), performs key functions in the androgen receptor (AR) signaling pathway. The three isoenzymes of 5 alpha-reductase identified to date are encoded by different genes: SRD5A1, SRD5A2, and SRD5A3. In this study, we investigated mechanisms underlying androgen regulation of 5 alpha-reductase isoenzyme expression in human prostate cells. We found that androgen regulates the mRNA level of 5 alpha-reductase isoenzymes in a cell type-specific manner, that such regulation occurs at the transcriptional level, and that AR is necessary for this regulation. In addition, our results suggest that AR is recruited to a negative androgen response element (nARE) on the promoter of SRD5A3 in vivo and directly binds to the nARE in vitro. The different expression levels of 5 alpha-reductase isoenzymes may confer response or resistance to 5 alpha-reductase inhibitors and thus may have importance in prostate cancer prevention.	[Li, Jin; Ding, Zhiyong; Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Wang, Zhengxin] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Lu, Jing-Fang; Maity, Sankar N.; Navone, Nora M.; Logothetis, Christopher J.; Kim, Jeri] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Li, J (corresponding author), Childrens Hosp Philadelphia, Abramson Res Ctr, Ctr Appl Genom, Philadelphia, PA 19104 USA.	jekim@mdanderson.org	; Zhang, Yanfeng/E-6971-2016	Mao, Bingyu/0000-0002-7993-3158; li, Jinsong/0000-0003-0764-3706; Zhang, Yanfeng/0000-0002-3859-3839; Sun, Jian/0000-0002-4732-3152; Maity, Sankar/0000-0002-2387-6545	MD Anderson Cancer Center; National Institutes of Health through MD Anderson's Cancer Center [CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA098258, P50CA140388] Funding Source: NIH RePORTER	MD Anderson Cancer Center; National Institutes of Health through MD Anderson's Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by the Prostate Cancer Research Program at MD Anderson Cancer Center and supported in part by the National Institutes of Health through MD Anderson's Cancer Center Support Grant, CA016672. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriole G, 2004, J UROLOGY, V172, P1314, DOI 10.1097/01.ju.0000139320.78673.2a; Andriole GL, 2010, NEW ENGL J MED, V362, P1192, DOI 10.1056/NEJMoa0908127; Aparicio A, 2011, PROSTATE, V71, P846, DOI 10.1002/pros.21301; Bjelfman C, 1997, J CLIN ENDOCR METAB, V82, P2210, DOI 10.1210/jc.82.7.2210; Cantagrel V, 2010, CELL, V142, P203, DOI 10.1016/j.cell.2010.06.001; Chesire DR, 2002, ONCOGENE, V21, P8453, DOI 10.1038/sj.onc.1206049; Cinar B, 2004, BIOCHEM J, V379, P421, DOI 10.1042/BJ20031661; DAI WS, 1981, AM J EPIDEMIOL, V114, P804, DOI 10.1093/oxfordjournals.aje.a113251; El-Awady MK, 2004, ENDOCR J, V51, P37, DOI 10.1507/endocrj.51.37; Fitzpatrick JM, 2009, BJU INT, V103, P864, DOI 10.1111/j.1464-410X.2008.08206.x; George FW, 1997, ENDOCRINOLOGY, V138, P871, DOI 10.1210/en.138.3.871; GEORGE FW, 1991, P NATL ACAD SCI USA, V88, P8044, DOI 10.1073/pnas.88.18.8044; Godoy A, 2011, PROSTATE, V71, P1033, DOI 10.1002/pros.21318; Kahrizi K, 2011, EUR J HUM GENET, V19, P115, DOI 10.1038/ejhg.2010.132; Luo J, 2003, PROSTATE, V57, P134, DOI 10.1002/pros.10284; Makridakis N, 2005, J MOL ENDOCRINOL, V34, P617, DOI 10.1677/jme.1.01725; Makridakis NM, 2000, PHARMACOGENETICS, V10, P407, DOI 10.1097/00008571-200007000-00004; Melcangi RC, 1998, J STEROID BIOCHEM, V65, P295, DOI 10.1016/S0960-0760(98)00030-2; Morava E, 2010, BRAIN, V133, P3210, DOI 10.1093/brain/awq261; Noss KR, 2002, GENE, V285, P247, DOI 10.1016/S0378-1119(02)00397-9; Parsons JK, 2005, CANCER EPIDEM BIOMAR, V14, P2257, DOI 10.1158/1055-9965.EPI-04-0715; Pienta KJ, 2006, CLIN CANCER RES, V12, P1665, DOI 10.1158/1078-0432.CCR-06-0067; Pratis K, 2003, J ENDOCRINOL, V176, P393, DOI 10.1677/joe.0.1760393; Qi W, 2008, BIOCHEM J, V416, P453, DOI 10.1042/BJ20080651; Reddy G Kesava, 2004, Clin Prostate Cancer, V2, P209; Reid J, 2002, J BIOL CHEM, V277, P41247, DOI 10.1074/jbc.M205220200; Rittmaster R, 2008, UROLOGY, V72, P808, DOI 10.1016/j.urology.2008.06.032; Romano P, 2009, NUCLEIC ACIDS RES, V37, pD925, DOI 10.1093/nar/gkn730; Schatzl G, 2001, PROSTATE, V47, P52; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; SILVER RI, 1994, J UROLOGY, V152, P433, DOI 10.1016/S0022-5347(17)32757-X; Steiner JF, 1996, CLIN PHARMACOKINET, V30, P16, DOI 10.2165/00003088-199630010-00002; STONER E, 1990, J STEROID BIOCHEM, V37, P375, DOI 10.1016/0960-0760(90)90487-6; Thomas LN, 2005, PROSTATE, V63, P231, DOI 10.1002/pros.20188; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; TIAN GC, 1995, BIOCHEMISTRY-US, V34, P13453, DOI 10.1021/bi00041a024; TITUS MA, 2009, 5ALPHA REDUCTASE I 2, P175; Torres JM, 2003, FASEB J, V17, P1428, DOI 10.1096/fj.02-1119com; Torres JM, 2003, BIOCHEM BIOPH RES CO, V308, P469, DOI 10.1016/S0006-291X(03)01423-2; Uemura M, 2008, CANCER SCI, V99, P81, DOI 10.1111/j.1349-7006.2007.00656.x; Wako K, 2008, J CLIN PATHOL, V61, P448, DOI 10.1136/jcp.2007.050906; WILBERT DM, 1983, J CLIN ENDOCR METAB, V56, P113, DOI 10.1210/jcem-56-1-113; WILSON EM, 1976, J BIOL CHEM, V251, P5620; Wilson JD, 1996, PROSTATE, P88; Xu Y, 2006, CLIN CANCER RES, V12, P4072, DOI 10.1158/1078-0432.CCR-06-0184; Yamana K, 2010, HORM MOL BIOL CLIN I, V2, P293, DOI 10.1515/HMBCI.2010.035; Zhang M, 1997, P NATL ACAD SCI USA, V94, P5673, DOI 10.1073/pnas.94.11.5673; Zhou ZF, 1999, MOL GENET METAB, V68, P410, DOI 10.1006/mgme.1999.2898; Zhu YS, 2009, ANN NY ACAD SCI, V1155, P43, DOI 10.1111/j.1749-6632.2009.04115.x	49	140	145	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28840	10.1371/journal.pone.0028840	http://dx.doi.org/10.1371/journal.pone.0028840			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194926	Green Published, Green Submitted, gold			2022-12-27	WOS:000298369100109
